Majority protein IDs Entry Name Protein names Gene Names Organism Gene Ontology (biological process) Gene Ontology (cellular component) Gene Ontology (GO) Gene Ontology IDs Gene Ontology (molecular function) Peptide sequences Q-value Score Intensity 60_RE8_01_28057 Intensity 60_RE8_01_28058 Intensity 60_RE8_01_28059 Intensity 61_GB1_01_28060 Intensity 61_GB1_01_28061 Intensity 61_GB1_01_28062 Intensity 62_GB2_01_28063 Intensity 62_GB2_01_28064 Intensity 62_GB2_01_28089 Intensity 63_GB3_01_28090 Intensity 63_GB3_01_28091 Intensity 63_GB3_01_28092 Intensity 64_GB4_01_28093 Intensity 64_GB4_01_28094 Intensity 64_GB4_01_28095 Intensity 66_GB6_01_28100 Intensity 66_GB6_01_28101 Intensity 66_GB6_01_28102 Intensity 67_GB7_01_28103 Intensity 67_GB7_01_28104 Intensity 67_GB7_01_28105 Intensity 68_GB8_01_28106 Intensity 68_GB8_01_28107 Intensity 68_GB8_01_28108 Intensity 69_GC1_01_28110 Intensity 69_GC1_01_28111 Intensity 69_GC1_01_28112 Intensity 70_GC2_01_28113 Intensity 70_GC2_01_28114 Intensity 70_GC2_01_28115 Intensity 71_GC3_01_28116 Intensity 71_GC3_01_28117 Intensity 71_GC3_01_28118 Intensity 72_GC4_01_28120 Intensity 72_GC4_01_28121 Intensity 72_GC4_01_28122 Intensity 73_GC5_01_28123 Intensity 73_GC5_01_28124 Intensity 73_GC5_01_28125 Intensity 74_GC6_01_28126 Intensity 74_GC6_01_28127 Intensity 74_GC6_01_28128 Intensity 75_GC7_01_28130 Intensity 75_GC7_01_28131 Intensity 75_GC7_01_28132 Intensity 76_GC8_01_28133 Intensity 76_GC8_01_28134 Intensity 76_GC8_01_28135 Intensity 77_GD1_01_28136 Intensity 77_GD1_01_28137 Intensity 77_GD1_01_28138 Intensity 86_BA1_01_28197 Intensity 86_BA1_01_28198 Intensity 86_BA1_01_28199 Intensity 87_BA2_01_28200 Intensity 87_BA2_01_28201 Intensity 87_BA2_01_28202 Intensity 88_BA3_01_28203 Intensity 88_BA3_01_28204 Intensity 88_BA3_01_28205 Intensity 94_BA5_01_28210 Intensity 94_BA5_01_28211 Intensity 94_BA5_01_28212 Intensity 95_BA6_01_28213 Intensity 95_BA6_01_28214 Intensity 95_BA6_01_28215 Intensity 98_BA8_01_28269 Intensity 98_BA8_01_28270 Intensity 98_BA8_01_28271 Intensity 99_BB1_01_28272 Intensity 99_BB1_01_28273 Intensity 99_BB1_01_28274 Intensity 100_BB2_01_28276 Intensity 100_BB2_01_28277 Intensity 100_BB2_01_28278 Intensity 101_BB3_01_28279 Intensity 101_BB3_01_28280 Intensity 101_BB3_01_28281 Intensity 102_BB4_01_28282 Intensity 102_BB4_01_28283 Intensity 102_BB4_01_28284 Intensity 103_BB5_01_28286 Intensity 103_BB5_01_28287 Intensity 103_BB5_01_28288 Intensity 104_BB6_01_28289 Intensity 104_BB6_01_28290 Intensity 104_BB6_01_28291 Intensity 105_BB7_01_28292 Intensity 105_BB7_01_28293 Intensity 105_BB7_01_28294 Intensity 106_BB8_01_28296 Intensity 106_BB8_01_28297 Intensity 106_BB8_01_28298 Intensity 107_BC1_01_28299 Intensity 107_BC1_01_28300 Intensity 107_BC1_01_28301 Intensity 108_BC2_01_28302 Intensity 108_BC2_01_28303 Intensity 108_BC2_01_28304 Intensity 109_BC3_01_28306 Intensity 109_BC3_01_28307 Intensity 109_BC3_01_28308 Intensity 110_BC4_01_28309 Intensity 110_BC4_01_28310 Intensity 110_BC4_01_28311 Intensity 111_BC5_01_28312 Intensity 111_BC5_01_28313 Intensity 111_BC5_01_28314 Intensity 112_BC6_01_28316 Intensity 112_BC6_01_28317 Intensity 112_BC6_01_28318 Intensity 113_BC7_01_28319 Intensity 113_BC7_01_28320 Intensity 113_BC7_01_28321 Intensity 114_BC8_01_28322 Intensity 114_BC8_01_28323 Intensity 114_BC8_01_28324 Intensity 115_BD1_01_28326 Intensity 115_BD1_01_28327 Intensity 115_BD1_01_28328 Intensity 116_BD2_01_28329 Intensity 116_BD2_01_28330 Intensity 116_BD2_01_28331 Intensity 117_BD3_01_28332 Intensity 117_BD3_01_28333 Intensity 117_BD3_01_28334 Intensity 118_BD4_01_28336 Intensity 118_BD4_01_28337 Intensity 118_BD4_01_28338 Intensity 119_BD5_01_28339 Intensity 119_BD5_01_28340 Intensity 119_BD5_01_28341 Intensity 120_BD6_01_28342 Intensity 120_BD6_01_28343 Intensity 120_BD6_01_28344 Intensity 121_BD7_01_28346 Intensity 121_BD7_01_28347 Intensity 121_BD7_01_28348 Intensity 122_BD8_01_28349 Intensity 122_BD8_01_28350 Intensity 122_BD8_01_28351 Intensity 131_RA1_01_28379 Intensity 131_RA1_01_28380 Intensity 131_RA1_01_28381 Intensity 132_RA2_01_28382 Intensity 132_RA2_01_28383 Intensity 132_RA2_01_28384 Intensity 133_RA3_01_28386 Intensity 133_RA3_01_28387 Intensity 133_RA3_01_28388 Intensity 138_RA8_01_28402 Intensity 138_RA8_01_28403 Intensity 138_RA8_01_28404 Intensity 139_RB1_01_28406 Intensity 139_RB1_01_28407 Intensity 139_RB1_01_28408 Intensity 142_RB4_01_28416 Intensity 142_RB4_01_28417 Intensity 142_RB4_01_28418 Intensity 143_RB5_01_28419 Intensity 143_RB5_01_28420 Intensity 143_RB5_01_28421 Intensity 144_RB6_01_28422 Intensity 144_RB6_01_28423 Intensity 144_RB6_01_28424 Intensity 145_RB7_01_28426 Intensity 145_RB7_01_28427 Intensity 145_RB7_01_28428 Intensity 146_RB8_01_28429 Intensity 146_RB8_01_28430 Intensity 146_RB8_01_28431 Intensity 147_RC1_01_28432 Intensity 147_RC1_01_28433 Intensity 147_RC1_01_28434 Intensity 148_RC2_01_28436 Intensity 148_RC2_01_28437 Intensity 148_RC2_01_28438 Intensity 149_RC3_01_28439 Intensity 149_RC3_01_28440 Intensity 149_RC3_01_28441 P04264 K2C1_HUMAN "Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1, CK-1) (Hair alpha protein) (Keratin-1, K1) (Type-II keratin Kb1)" KRT1 KRTA Homo sapiens (Human) "complement activation, lectin pathway [GO:0001867]; establishment of skin barrier [GO:0061436]; fibrinolysis [GO:0042730]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; negative regulation of inflammatory response [GO:0050728]; peptide cross-linking [GO:0018149]; protein heterotetramerization [GO:0051290]; regulation of angiogenesis [GO:0045765]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; structural constituent of skin epidermis [GO:0030280]; complement activation, lectin pathway [GO:0001867]; establishment of skin barrier [GO:0061436]; fibrinolysis [GO:0042730]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; negative regulation of inflammatory response [GO:0050728]; peptide cross-linking [GO:0018149]; protein heterotetramerization [GO:0051290]; regulation of angiogenesis [GO:0045765]; response to oxidative stress [GO:0006979]; retina homeostasis [GO:0001895]" GO:0001533; GO:0001867; GO:0001895; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006979; GO:0016020; GO:0018149; GO:0030246; GO:0030280; GO:0031424; GO:0038023; GO:0042730; GO:0045095; GO:0045109; GO:0045765; GO:0046982; GO:0050728; GO:0051290; GO:0061436; GO:0062023; GO:0070062; GO:0072562; GO:1904813 carbohydrate binding [GO:0030246]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; structural constituent of skin epidermis [GO:0030280] AEAESLYQSK 0 323.31 15.4238 15.0006 14.4282 17.8523 18.1151 18.0503 17.4334 17.6549 0 12.6303 9.14982 10.3188 11.4778 12.2003 9.2368 13.0091 14.0251 13.1998 12.7233 15.5974 16.1001 17.2663 16.6747 16.843 14.3072 13.0981 14.0649 12.7433 9.89251 11.6163 12.7261 10.1798 12.7199 12.1563 10.0935 10.9067 10.4727 0 11.9241 0 11.2298 12.6611 13.3344 12.175 10.4054 14.6455 15.2432 13.7806 0 13.5715 11.0053 19.0352 16.7082 15.7384 15.688 14.3648 15.0767 13.7762 12.8775 13.5749 13.92 13.943 12.4696 0 13.3408 13.9643 17.0936 16.9652 17.4989 15.2853 15.7038 14.1804 15.7927 15.0457 16.3207 17.9178 17.9857 17.9392 21.3373 20.982 21.3791 22.6008 22.7349 22.4637 21.0453 19.9277 21.4821 20.7458 20.9184 20.8368 21.0145 20.9247 20.7295 21.1903 21.3928 21.3718 21.5416 21.7097 21.4674 20.6244 20.8973 20.5514 20.994 21.0094 20.6478 18.3031 18.3192 17.8843 20.0554 20.0874 20.0194 19.4926 21.3364 21.0516 18.7391 18.6756 18.0201 20.7008 20.915 20.6568 20.7467 20.6123 20.5092 20.2477 20.12 20.274 19.6214 19.2905 19.1172 20.0371 19.4093 19.4224 19.979 19.3079 19.4645 18.8259 18.6164 17.6007 21.0647 20.9959 20.6793 18.5626 18.257 17.8782 18.5653 17.7616 17.0294 16.3988 11.9567 14.2638 19.6105 18.9219 16.8736 20.2136 20.4355 20.632 17.0084 11.0176 12.0404 0 13.105 11.9343 12.2038 12.5503 15.1097 16.8065 12.894 14.6923 12.5036 14.0702 11.8879 19.7322 19.2629 19.5011 20.0059 15.6785 16.4411 13.3811 16.1949 15.9932 P13645 K1C10_HUMAN "Keratin, type I cytoskeletal 10 (Cytokeratin-10, CK-10) (Keratin-10, K10)" KRT10 KPP Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; keratinocyte differentiation [GO:0030216]; morphogenesis of an epithelium [GO:0002009]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]; protein heterotetramerization [GO:0051290] cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cell surface [GO:0009986]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; structural constituent of skin epidermis [GO:0030280]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; keratinocyte differentiation [GO:0030216]; morphogenesis of an epithelium [GO:0002009]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684]; protein heterotetramerization [GO:0051290] GO:0001533; GO:0002009; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0009986; GO:0016020; GO:0018149; GO:0030216; GO:0030280; GO:0030855; GO:0045095; GO:0045684; GO:0046982; GO:0051290; GO:0070062 protein heterodimerization activity [GO:0046982]; structural constituent of skin epidermis [GO:0030280] AETECQNTEYQQLLDIK 0 258.34 15.7999 15.5737 14.7801 17.6971 17.9089 18.0561 17.0956 16.73 0 11.3701 12.3663 13.6712 0 0 10.5475 13.1707 14.6579 14.4155 14.5963 15.8519 15.9491 17.8707 17.427 17.8781 14.3773 13.1484 14.6849 12.6034 0 0 12.6925 0 10.8065 0 11.395 0 0 0 10.8861 10.7634 12.4363 11.4088 12.2672 15.0524 14.2667 14.1395 12.8083 14.3018 12.1498 11.3035 12.917 18.3449 17.5286 16.2899 15.3803 14.6841 13.3299 13.7728 10.166 10.968 12.4286 14.9256 12.8854 0 12.0792 13.4903 14.5116 14.4805 15.7866 15.0208 15.5644 13.8488 14.7082 14.2476 15.8193 18.1873 18.5111 18.0578 20.3758 19.7588 20.5118 21.2936 21.4008 20.7166 20.5569 19.4453 20.6127 20.3575 20.6184 20.173 20.3963 20.5276 20.5925 21.2507 21.2431 21.2849 20.53 20.6233 20.3187 20.4388 20.5722 20.4089 20.2413 20.2638 20.16 18.1603 17.5862 17.7603 20.3675 20.3689 20.1269 18.3893 20.7608 20.657 18.0926 18.0336 17.77 19.7672 19.9668 20.0399 20.2738 20.0325 20.156 19.7309 19.8388 19.5407 19.0217 18.9156 18.8976 19.4712 19.1665 19.7141 19.3063 18.6577 18.2868 18.018 17.9193 17.9964 20.7473 20.3875 19.2488 18.5162 17.9026 18.1024 18.3335 17.9061 17.4014 16.6906 0 13.9754 19.1394 18.539 16.185 20.3001 19.9955 20.2663 16.674 13.7187 14.7147 14.9532 14.0378 10.2093 13.3863 12.1437 13.9191 15.3457 14.4783 12.3884 13.2482 14.34 14.5961 19.6001 19.6906 19.3762 19.4342 14.3009 16.5826 14.8389 16.5107 11.4437 P35527 K1C9_HUMAN "Keratin, type I cytoskeletal 9 (Cytokeratin-9, CK-9) (Keratin-9, K9)" KRT9 Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; skin development [GO:0043588]; spermatogenesis [GO:0007283] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; skin development [GO:0043588]; spermatogenesis [GO:0007283] GO:0005200; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0007283; GO:0008544; GO:0016020; GO:0030855; GO:0043588; GO:0045095; GO:0045109; GO:0070062 structural constituent of cytoskeleton [GO:0005200] DIENQYETQITQIEHEVSSSGQEVQSSAK 0 166.61 14.1528 14.6224 11.012 17.3626 17.0542 16.6777 16.4113 16.7498 11.8389 11.9469 0 0 11.1499 0 11.3599 10.798 0 10.6545 13.4848 15.1831 15.5089 11.531 12.0269 12.9732 0 10.3721 12.5674 0 10.7334 0 11.4526 13.0079 11.8871 10.8083 0 11.9604 12.1748 11.3963 11.5291 0 11.6327 12.3345 12.3347 12.4277 0 13.6425 13.3788 12.7619 10.0719 11.2609 0 17.7487 17.5161 15.9501 15.4421 14.3514 14.8332 12.3206 13.4041 13.0223 12.8925 12.3406 13.361 11.1581 11.0823 0 15.8729 15.7472 15.4216 0 0 12.6658 10.856 11.2669 13.9629 16.0366 16.2994 16.3831 19.768 19.2099 19.8676 21.0555 21.2746 20.9796 19.5297 19.4942 19.5768 18.9553 19.2265 18.7922 19.1373 19.1248 19.3588 19.1469 19.2623 19.5993 19.9134 20.1104 20.0044 18.3323 18.6698 18.4955 19.3789 19.4445 19.0853 16.7439 16.0592 15.3063 17.5942 17.1778 17.4625 18.1393 20.1094 19.8419 17.4646 17.4276 16.8676 18.7878 18.745 18.8306 18.7054 17.4848 18.147 18.3108 17.9667 18.527 17.7509 17.9826 17.5756 18.224 17.5 17.0846 18.4086 17.9391 18.2125 16.3882 16.6402 16.5908 19.659 19.4269 18.7203 17.0661 16.0988 16.0413 16.8677 15.8288 15.9226 15.36 12.9332 0 18.3312 17.199 16.3863 19.0189 19.1035 19.0074 15.5729 12.4597 11.5282 11.4242 10.8341 0 0 0 12.8798 14.7608 12.7357 14.4025 14.8628 12.2561 0 17.3556 17.8492 17.9479 18.8027 14.2941 0 12.9954 11.3096 11.1715 P35908 K22E_HUMAN "Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e, CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e, K2e) (Type-II keratin Kb2)" KRT2 KRT2A KRT2E Homo sapiens (Human) epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte activation [GO:0032980]; keratinocyte development [GO:0003334]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]; epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte activation [GO:0032980]; keratinocyte development [GO:0003334]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; peptide cross-linking [GO:0018149]; positive regulation of epidermis development [GO:0045684] GO:0001533; GO:0003334; GO:0005200; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0008092; GO:0008544; GO:0016020; GO:0018149; GO:0030280; GO:0031424; GO:0032980; GO:0043616; GO:0045095; GO:0045109; GO:0045684; GO:0051546; GO:0070062 cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280] AQYEEIAQR 0 56.179 12.0917 11.5767 10.6476 14.5893 14.8696 0 12.4019 13.6229 10.9958 12.7205 0 0 10.8604 0 0 11.8441 0 13.7741 11.5701 11.029 12.5754 0 10.1929 13.1142 12.0114 12.5485 0 0 0 10.3363 0 0 12.9284 0 12.3626 9.95108 11.8385 0 0 0 0 12.956 12.776 10.6782 11.8174 10.5546 12.7738 12.0494 0 12.3363 0 16.2355 15.4886 15.8458 14.4126 13.3201 12.5787 12.8973 12.4845 0 0 0 0 0 0 10.3569 13.7922 13.315 14.0539 0 0 0 12.5325 11.2504 12.7762 15.6674 16.2132 16.3513 17.4375 15.359 16.9921 19.8539 19.9583 19.2364 18.3245 17.8655 18.7569 18.9094 18.8452 18.8525 18.8078 18.8029 18.8888 19.0844 19.1853 19.4507 18.5522 18.5166 18.1794 18.48 18.9355 18.5616 17.4385 16.681 15.7027 16.4552 16.3022 16.4431 18.6509 18.6551 18.7237 15.1387 17.5526 17.8689 16.1392 15.8984 15.6529 15.9015 16.9351 16.4839 18.3577 17.8339 18.0989 18.1567 18.8316 18.6656 17.3836 16.7998 17.3419 18.141 17.4032 17.8405 18.2735 17.1186 17.1813 17.2134 16.3934 15.7763 18.0009 18.2331 17.596 16.6433 16.1458 16.1619 16.495 15.9839 14.2468 14.964 10.514 14.1736 16.4528 15.0178 14.3632 17.2274 17.6234 17.3631 13.9325 0 14.0531 0 0 12.656 0 11.8933 14.3505 15.0803 11.3056 12.1012 0 0 12.0741 17.9675 17.9338 17.7942 15.8872 12.47 12.7916 12.84 0 14.0495 P07911 UROM_HUMAN "Uromodulin (Tamm-Horsfall urinary glycoprotein, THP) [Cleaved into: Uromodulin, secreted form ]" UMOD Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular defense response [GO:0006968]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; spindle pole [GO:0000922] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; IgG binding [GO:0019864]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular chloride ion homeostasis [GO:0030644]; cellular defense response [GO:0006968]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to unfolded protein [GO:0034620]; cellular sodium ion homeostasis [GO:0006883]; chaperone-mediated protein folding [GO:0061077]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; creatinine homeostasis [GO:0097273]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; juxtaglomerular apparatus development [GO:0072051]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell population proliferation [GO:0008285]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; peptidyl-threonine phosphorylation [GO:0018107]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to lipopolysaccharide [GO:0032496]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; ubiquitin-dependent ERAD pathway [GO:0030433]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918] GO:0000922; GO:0002251; GO:0003091; GO:0003094; GO:0005201; GO:0005509; GO:0005615; GO:0005783; GO:0005796; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006954; GO:0006968; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008285; GO:0008380; GO:0009410; GO:0009414; GO:0009986; GO:0015747; GO:0016323; GO:0016324; GO:0018107; GO:0019864; GO:0019898; GO:0030433; GO:0030643; GO:0030644; GO:0031225; GO:0032496; GO:0033209; GO:0033555; GO:0034620; GO:0035809; GO:0044861; GO:0046720; GO:0050829; GO:0051223; GO:0055075; GO:0060073; GO:0060170; GO:0061077; GO:0070062; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097273; GO:0097709; GO:0097744; GO:1990266 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; IgG binding [GO:0019864] DGPCGTVLTR 0 13.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1914 0 0 0 0 0 15.7723 0 0 0 0 0 0 9.99831 0 0 9.82413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4683 0 11.7457 11.8541 0 13.1411 0 12.945 0 0 0 0 0 0 0 12.4827 0 0 0 0 0 10.32 0 0 0 0 0 0 0 0 0 12.4264 0 10.9174 13.9496 14.0018 13.9763 12.4798 0 0 0 0 0 13.7934 12.6255 0 0 0 0 0 0 0 13.4705 0 14.6083 0 0 0 11.566 12.0264 12.6774 0 16.4335 0 0 10.8335 0 0 0 0 0 0 0 0 0 12.3795 0 0 12.3165 0 12.1891 0 0 0 0 0 0 0 13.491 13.5119 13.6372 0 13.4301 0 11.8808 0 0 13.7811 0 0 11.8676 0 16.5257 19.4976 19.5169 19.7036 0 10.4114 0 0 13.4358 0 12.0961 0 0 0 0 0 0 0 0 0 12.3786 0 10.6283 0 0 0 11.5298 0 P02533 K1C14_HUMAN "Keratin, type I cytoskeletal 14 (Cytokeratin-14, CK-14) (Keratin-14, K14)" KRT14 Homo sapiens (Human) aging [GO:0007568]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; hair cycle [GO:0042633]; intermediate filament bundle assembly [GO:0045110]; intermediate filament organization [GO:0045109] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634]; keratin filament binding [GO:1990254]; structural constituent of cytoskeleton [GO:0005200]; aging [GO:0007568]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; hair cycle [GO:0042633]; intermediate filament bundle assembly [GO:0045110]; intermediate filament organization [GO:0045109] GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0007568; GO:0008544; GO:0030855; GO:0042633; GO:0045095; GO:0045109; GO:0045110; GO:0070062; GO:1990254 keratin filament binding [GO:1990254]; structural constituent of cytoskeleton [GO:0005200] ALEEANADLEVK 0 47.649 0 0 0 0 0 0 0 0 0 16.5721 0 10.9158 0 0 0 0 0 0 9.77304 10.6829 11.62 0 0 0 0 0 0 0 0 0 0 0 0 10.8452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7278 0 0 11.8179 0 0 11.9204 0 12.1649 0 0 0 0 10.3403 10.4105 0 0 0 13.2973 15.8347 13.5723 11.5615 0 13.6844 13.3824 12.8898 11.4272 12.6274 13.8748 14.1129 17.369 15.4547 17.7016 18.3262 18.1728 17.9738 17.5527 17.4861 17.5065 16.0392 15.5811 16.0887 16.6031 17.3112 16.2925 15.1048 15.8592 15.6495 17.4771 18.0961 18.0855 16.8172 17.1632 16.4222 11.889 12.0836 14.1257 0 11.9743 13.1721 17.0086 15.8193 16.1742 16.9173 17.1363 16.7596 11.2339 0 0 13.6987 12.7776 11.4825 14.863 14.4125 12.7196 14.5341 15.2411 14.9859 14.5329 14.3744 14.492 0 12.3504 0 13.5916 14.128 12.5585 14.1846 10.2537 13.9484 16.877 16.4336 0 14.3717 12.8234 13.6763 15.0625 0 13.3555 13.2781 13.0531 0 0 0 0 14.205 13.2049 14.9508 0 0 0 13.354 0 11.5706 10.9058 10.8777 11.8607 12.7126 12.5174 0 10.2938 0 0 14.2367 16.0029 15.5283 0 11.5135 0 10.9755 11.8841 0 Q7Z628 ARHG8_HUMAN Neuroepithelial cell-transforming gene 1 protein (Proto-oncogene p65 Net1) (Rho guanine nucleotide exchange factor 8) NET1 ARHGEF8 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0001558; GO:0005085; GO:0005634; GO:0005829; GO:0007165; GO:0035025; GO:0035556; GO:0043065; GO:0043547; GO:0051056; GO:0051451; GO:0070301; GO:0071479 guanyl-nucleotide exchange factor activity [GO:0005085] CGSGMQMAEDSK 0 12.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9207 13.3773 15.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1413 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2084 17.0085 16.6926 15.3726 13.685 0 0 15.1982 16.0665 15.5546 15.1336 14.9342 0 16.2157 15.2203 14.9214 14.582 15.9609 13.9989 14.7088 0 16.6555 16.451 16.8363 17.1229 16.8539 15.8608 16.2056 16.2604 16.1029 17.0946 14.4936 15.8924 16.5474 16.1572 16.6869 0 0 0 16.5422 15.5467 16.4632 16.064 16.0439 15.9311 0 16.3294 17.0427 15.4117 16.9781 16.4551 14.8782 16.3452 16.5268 17.0345 15.7484 16.7064 19.3173 16.4712 15.9312 16.3812 16.3511 16.8331 16.8801 15.67 15.67 14.6681 17.1401 16.8422 16.0037 16.3559 14.6403 0 16.4536 17.4216 15.8225 0 15.6703 16.7669 17.0263 16.2934 11.8395 0 0 0 14.8298 15.5735 14.6353 15.6849 15.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2983 15.7405 16.208 19.1407 14.5499 0 0 0 15.8849 0 P02538 K2C6A_HUMAN "Keratin, type II cytoskeletal 6A (Cytokeratin-6A, CK-6A) (Cytokeratin-6D, CK-6D) (Keratin-6A, K6A) (Type-II keratin Kb6) (allergen Hom s 5)" KRT6A K6A KRT6D Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell differentiation [GO:0030154]; cytolysis by host of symbiont cells [GO:0051838]; defense response to Gram-positive bacterium [GO:0050830]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cytolysis by symbiont of host cells [GO:0001899]; negative regulation of entry of bacterium into host cell [GO:2000536]; positive regulation of cell population proliferation [GO:0008284]; wound healing [GO:0042060] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell differentiation [GO:0030154]; cytolysis by host of symbiont cells [GO:0051838]; defense response to Gram-positive bacterium [GO:0050830]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cytolysis by symbiont of host cells [GO:0001899]; negative regulation of entry of bacterium into host cell [GO:2000536]; positive regulation of cell population proliferation [GO:0008284]; wound healing [GO:0042060] GO:0001899; GO:0002009; GO:0005200; GO:0005634; GO:0005829; GO:0008284; GO:0016020; GO:0030154; GO:0030280; GO:0031424; GO:0042060; GO:0045095; GO:0045109; GO:0050830; GO:0051838; GO:0061844; GO:0070062; GO:2000536 structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280] AIGGGLSSVGGGSSTIK 0 12.815 0 0 0 0 0 0 0 0 0 0 12.1093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5315 0 0 0 0 0 0 0 13.3006 0 12.9063 10.6443 15.2954 12.9379 14.2948 15.5387 18.036 17.8378 16.3873 15.2813 16.6747 12.7274 0 13.9464 13.3151 14.9796 13.9531 13.6454 12.3528 12.2337 15.24 15.1776 12.664 15.1735 16.3912 15.2993 0 13.7897 0 12.4796 0 12.5064 11.4726 11.8813 13.5282 0 13.7641 0 0 0 0 11.3502 0 0 0 0 0 0 0 0 0 0 13.0549 0 0 0 0 0 0 0 12.212 0 0 0 0 0 0 11.1376 12.9101 0 0 0 0 0 0 12.6791 0 0 0 12.4526 0 0 0 0 0 0 0 11.9592 0 0 0 11.9014 0 0 0 0 0 12.4508 12.035 0 0 0 0 0 Q07954 LRP1_HUMAN "Prolow-density lipoprotein receptor-related protein 1, LRP-1 (Alpha-2-macroglobulin receptor, A2MR) (Apolipoprotein E receptor, APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit, LRP-85; Low-density lipoprotein receptor-related protein 1 515 kDa subunit, LRP-515; Low-density lipoprotein receptor-related protein 1 intracellular domain, LRPICD ]" LRP1 A2MR APR Homo sapiens (Human) amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein receptor complex [GO:0062136]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein receptor complex [GO:0062136]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104] GO:0001523; GO:0001540; GO:0002265; GO:0003723; GO:0005041; GO:0005044; GO:0005509; GO:0005634; GO:0005765; GO:0005769; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0005905; GO:0005925; GO:0006629; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0010629; GO:0010715; GO:0010875; GO:0010942; GO:0014912; GO:0016020; GO:0016323; GO:0016964; GO:0030178; GO:0030226; GO:0030666; GO:0031623; GO:0032050; GO:0032092; GO:0032370; GO:0032374; GO:0032429; GO:0032956; GO:0034185; GO:0035909; GO:0038023; GO:0038024; GO:0042953; GO:0043235; GO:0043277; GO:0043395; GO:0044877; GO:0045056; GO:0045807; GO:0060392; GO:0060394; GO:0062136; GO:0070325; GO:0097242; GO:0098797; GO:0150093; GO:0150094; GO:0150104; GO:1900223; GO:1903078; GO:1904300; GO:1904646; GO:1905049; GO:1905167; GO:2000587 alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023] AAQTRKTLIEGK 0 24.652 13.2367 0 14.1596 0 11.6599 0 12.3992 12.538 14.9214 12.4373 13.4077 15.8199 0 0 13.1681 13.1381 14.2976 12.7287 14.9806 13.4436 13.8796 0 14.8226 15.2773 12.5656 11.0767 14.7117 15.0784 0 10.5653 14.9624 13.3143 14.7453 12.8825 12.7049 13.9468 14.3973 11.231 10.8968 15.1894 13.4762 12.3238 0 11.8836 11.3171 13.0337 13.8036 13.7004 0 0 13.5021 0 14.3678 12.178 11.0461 10.6139 13.4633 0 0 13.2069 11.2219 11.3299 11.6998 0 12.6973 12.6973 16.2594 15.6688 16.192 16.1906 15.3404 12.438 14.3021 14.3369 12.46 13.7247 16.2524 15.8593 14.8057 16.7199 13.0549 15.677 14.36 16.0971 15.2242 14.4231 14.1216 13.6826 15.785 14.572 15.4604 12.9106 13.9347 13.1375 0 14.7435 14.7803 15.9046 13.3461 16.094 15.4548 13.4728 13.1918 0 16.2637 15.4886 15.9426 14.7594 15.2745 15.135 15.6878 15.5828 16.1584 15.5657 14.5877 16.3356 13.1817 14.5551 15.0105 12.6024 15.014 16.0402 14.7596 13.6096 16.1628 16.537 15.5056 16.0898 14.3697 14.1914 15.323 15.2743 15.5355 16.5295 15.8118 13.8837 17.1278 15.6051 17.2479 15.3236 16.5533 16.8821 15.6764 15.4731 16.7839 15.7969 16.6307 15.9998 16.1271 13.8095 17.0495 16.0303 14.9451 16.1064 14.5627 12.3555 14.9544 15.9173 14.5686 13.7092 15.9866 15.5665 12.2672 10.8183 13.416 15.5129 14.6264 15.516 15.4469 13.6841 0 13.7389 11.62 14.7595 14.8891 15.0114 15.9995 13.5874 14.3743 14.4263 P08779 K1C16_HUMAN "Keratin, type I cytoskeletal 16 (Cytokeratin-16, CK-16) (Keratin-16, K16)" KRT16 KRT16A Homo sapiens (Human) aging [GO:0007568]; cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; establishment of skin barrier [GO:0061436]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; keratinocyte migration [GO:0051546]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; aging [GO:0007568]; cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; establishment of skin barrier [GO:0061436]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; keratinocyte migration [GO:0051546]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336] GO:0001533; GO:0002009; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005882; GO:0006954; GO:0007010; GO:0007568; GO:0030216; GO:0030336; GO:0030855; GO:0031424; GO:0042633; GO:0045087; GO:0045109; GO:0051546; GO:0061436; GO:0070062 structural constituent of cytoskeleton [GO:0005200] ALEEANADLEVK 0 25.578 0 0 0 0 0 0 9.57505 0 0 0 0 0 10.9267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7603 0 0 0 0 0 0 0 0 0 0 0 12.2574 11.2755 0 0 14.8901 0 15.3361 15.3823 15.3889 0 0 0 14.2225 14.2504 14.6119 12.1878 0 0 14.4609 14.5859 14.4982 0 14.2259 13.3089 10.6452 0 0 0 0 0 12.8501 0 12.2813 0 0 12.3831 0 0 0 0 0 0 0 12.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0978 0 0 13.6544 0 0 0 0 12.663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0892 0 A0A286YEY9 SCGR1_HUMAN Small cysteine and glycine repeat-containing protein 1 (Keratin-associated protein 28-1) SCYGR1 KRTAP28-1 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CCCQKQCCC 0 11.351 0 0 0 0 10.763 0 0 0 15.5907 12.2438 14.007 0 9.79181 0 0 0 13.4995 12.6076 12.607 12.6219 13.3629 0 14.1272 10.2377 0 0 0 0 12.3182 0 12.0625 12.2238 0 12.6228 0 0 13.9427 13.7005 11.1862 10.5865 0 11.0664 0 0 13.5656 0 10.8747 14.2231 11.5306 0 0 0 0 11.8488 11.5564 0 0 0 0 0 0 0 10.4165 0 10.4666 0 14.9248 0 14.3929 12.894 0 10.6029 10.6951 0 13.7953 0 14.0747 10.8136 0 15.1267 0 14.3098 14.5406 0 0 0 14.8464 0 13.4422 15.6414 13.9787 14.759 0 0 10.6483 0 11.4206 11.3377 14.6811 14.788 0 10.6373 12.4729 0 14.3836 14.9666 15.864 11.7312 11.5085 14.242 0 0 0 13.4046 13.9959 0 0 11.5564 0 14.0043 0 11.5628 10.2891 0 0 13.6308 0 0 14.3595 11.2138 0 0 14.681 14.3341 11.0094 14.5436 13.4025 15.341 14.7393 10.3824 13.7697 12.2992 15.9151 16.1792 0 10.3012 0 0 0 13.7155 0 12.475 14.2722 0 9.83738 11.4461 0 11.7902 0 0 0 0 0 0 0 13.3439 16.0504 13.388 12.2396 12.101 0 0 0 10.1307 0 13.871 0 14.2046 0 0 Q5T1H1 EYS_HUMAN "Protein eyes shut homolog (Epidermal growth factor-like protein 10, EGF-like protein 10) (Epidermal growth factor-like protein 11, EGF-like protein 11) (Protein spacemaker homolog)" EYS C6orf178 C6orf179 C6orf180 EGFL10 EGFL11 SPAM UNQ9424/PRO34591 Homo sapiens (Human) detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; interphotoreceptor matrix [GO:0033165]; microtubule organizing center [GO:0005815]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; detection of light stimulus involved in visual perception [GO:0050908]; skeletal muscle tissue regeneration [GO:0043403] GO:0001750; GO:0005509; GO:0005737; GO:0005815; GO:0033165; GO:0043403; GO:0050908; GO:0070062 calcium ion binding [GO:0005509] CKISPCLDEENCVYR 0 13.378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0658 13.0053 0 0 0 0 12.3098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3714 0 11.1145 0 10.3113 0 12.3168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.198 0 0 0 11.7149 0 0 0 0 12.7 0 0 15.6915 0 0 15.7782 14.7228 0 14.5549 0 0 0 13.3161 14.7296 0 14.0923 13.587 0 13.2956 15.5868 10.9946 0 0 12.9459 0 0 12.9369 0 0 0 0 0 14.3147 11.6974 0 0 13.7838 0 13.6671 0 11.8334 14.3961 0 11.6388 0 0 0 0 0 0 0 0 0 15.2752 0 10.0316 15.7182 0 0 16.0404 0 0 13.975 0 0 0 0 12.3433 12.2927 0 0 0 0 0 0 12.8402 0 0 0 13.6041 0 13.6841 0 13.481 0 0 12.5986 0 0 0 12.5757 13.9472 0 0 10.8385 0 0 0 13.5956 Q9BYQ5 KRA46_HUMAN Keratin-associated protein 4-6 (Keratin-associated protein 4-15) (Keratin-associated protein 4.15) (Keratin-associated protein 4.6) (Ultrahigh sulfur keratin-associated protein 4.15) KRTAP4-6 KAP4.15 KRTAP4-15 KRTAP4.15 KRTAP4.6 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 CCRSQCCQSVCCQPTCCR 0 12.039 0 12.4829 0 11.0823 0 0 0 0 14.0604 12.2286 0 13.5358 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0566 0 0 0 0 0 0 12.2336 0 10.2471 12.3275 11.0014 0 0 11.123 0 0 11.5454 0 0 0 0 0 0 0 0 0 0 12.3888 0 0 0 0 0 0 0 0 0 0 0 0 0 13.879 11.4717 12.0592 14.1986 12.4417 12.6937 13.3491 0 15.4179 14.7395 0 11.7518 11.7478 11.5207 0 12.7702 0 15.2194 0 12.4828 12.2569 10.4753 12.0056 0 12.619 12.1458 12.1151 12.6485 11.1881 0 15.1566 12.2611 13.4561 13.2246 13.9945 0 12.227 12.6245 11.7291 0 12.8964 11.2814 14.4674 15.3164 0 0 14.6218 0 11.8548 0 14.5366 0 11.2985 0 0 14.2519 0 0 0 12.9588 12.0473 0 0 0 15.7442 12.4905 15.3895 13.5316 0 15.3359 13.1714 11.6182 12.2178 0 10.7868 0 14.1763 0 14.7478 14.0817 13.7773 14.6083 12.2057 12.0891 13.0348 0 0 14.6424 12.2742 0 0 0 0 0 12.0459 13.2916 0 0 0 11.0284 0 14.5592 0 12.7416 11.8562 0 0 0 0 11.731 11.0819 0 12.5942 Q9BYR2 KRA45_HUMAN Keratin-associated protein 4-5 (Keratin-associated protein 4.5) (Ultrahigh sulfur keratin-associated protein 4.5) KRTAP4-5 KAP4.5 KRTAP4.5 Homo sapiens (Human) aging [GO:0007568]; hair cycle [GO:0042633] cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; aging [GO:0007568]; hair cycle [GO:0042633] GO:0005829; GO:0007568; GO:0042633; GO:0045095 MVSSCCGSVSSEQSCGLENCCR 0 11.685 0 13.8193 0 0 0 0 0 13.5162 0 14.3988 0 0 10.9612 0 0 0 0 0 10.2126 0 12.9619 0 0 0 0 0 0 0 0 14.4219 12.0735 12.0581 0 0 10.7718 0 0 0 0 0 0 0 13.2344 11.9139 0 0 14.5993 0 0 0 0 0 0 13.8688 0 13.2325 0 0 0 0 12.0043 0 0 0 0 0 0 0 0 0 11.3188 12.7644 0 12.4436 14.9066 0 0 0 0 14.7655 13.2468 0 14.5353 0 0 13.1363 13.567 13.4622 0 12.8299 0 14.7347 13.1796 11.8288 12.8134 0 0 10.6534 0 0 0 0 10.822 10.7986 0 12.0121 13.3036 11.336 0 15.0696 0 16.0564 14.0067 15.7398 0 13.1389 0 12.1005 14.8028 10.1444 0 11.5246 14.1896 12.7607 0 14.8915 0 12.892 0 13.4493 14.1718 0 0 14.4871 11.1021 0 12.7553 11.499 12.8078 13.9046 14.6637 0 0 13.5841 0 0 13.1944 12.1744 0 0 14.3654 11.8204 11.3806 13.0201 13.5976 12.3933 0 12.7243 13.3075 12.9169 13.4576 12.3102 14.7353 0 0 11.2867 14.3755 13.2043 11.2558 14.4548 0 0 0 0 0 14.1509 11.7142 0 15.0538 0 Q9UKF2 ADA30_HUMAN "Disintegrin and metalloproteinase domain-containing protein 30, ADAM 30, EC 3.4.24.-" ADAM30 UNQ2509/PRO5997 Homo sapiens (Human) proteolysis [GO:0006508] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0031902; GO:1990913 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] ATISTCMGGLRGVFNIDAKHYQIEPLK 0 12.365 12.2416 0 0 0 0 0 9.2475 0 11.6141 0 11.8587 10.9049 15.0017 10.1094 13.2572 12.2551 0 0 0 0 0 11.0825 0 0 0 13.2082 12.2607 0 0 0 13.514 10.3912 12.4598 0 13.9461 0 11.8429 14.296 13.128 12.8552 14.2678 0 0 0 10.6443 0 14.5382 12.5992 0 0 11.6248 10.3927 0 0 0 12.4866 0 0 0 0 0 0 0 0 0 0 0 13.6786 0 0 0 14.1486 0 0 13.2212 13.2289 0 14.5422 14.4281 12.0856 0 11.3978 14.089 17.3144 16.5235 14.6579 11.9077 17.2038 17.2018 0 14.0756 12.9453 0 0 13.6094 13.6715 15.1751 14.619 0 13.2348 13.4574 11.6743 0 0 0 0 14.2033 11.891 13.5064 13.9946 12.5344 13.7921 15.8196 13.9726 0 0 0 0 12.988 13.6977 12.2801 11.4118 13.7137 12.9603 14.5109 0 0 0 0 13.8871 0 0 0 13.0827 0 14.996 0 14.4368 12.9771 12.7898 0 12.9374 14.3924 0 0 0 0 0 0 0 0 0 14.2783 0 0 13.0935 0 0 0 0 12.8438 13.7747 12.0557 14.3271 0 0 11.5985 0 12.4564 0 0 10.3618 0 0 0 0 0 11.8121 0 0 P05106 ITB3_HUMAN "Integrin beta-3 (Platelet membrane glycoprotein IIIa, GPIIIa) (CD antigen CD61)" ITGB3 GP3A Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; angiogenesis involved in wound healing [GO:0060055]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to xenobiotic stimulus [GO:0071466]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein localization [GO:0032880]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of serotonin uptake [GO:0051611]; regulation of trophoblast cell migration [GO:1901163]; response to activity [GO:0014823]; response to radiation [GO:0009314]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; tube development [GO:0035295]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060] alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; alphav-beta3 integrin-vitronectin complex [GO:0071062]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; synapse [GO:0045202] alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; alphav-beta3 integrin-vitronectin complex [GO:0071062]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; platelet-derived growth factor receptor binding [GO:0005161]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618]; activation of protein kinase activity [GO:0032147]; angiogenesis involved in wound healing [GO:0060055]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to xenobiotic stimulus [GO:0071466]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of extracellular matrix organization [GO:1903053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein localization [GO:0032880]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of serotonin uptake [GO:0051611]; regulation of trophoblast cell migration [GO:1901163]; response to activity [GO:0014823]; response to radiation [GO:0009314]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; tube development [GO:0035295]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060] GO:0001618; GO:0001934; GO:0001938; GO:0001954; GO:0001968; GO:0002020; GO:0003756; GO:0005080; GO:0005161; GO:0005178; GO:0005634; GO:0005654; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007044; GO:0007155; GO:0007160; GO:0007229; GO:0007566; GO:0007596; GO:0008305; GO:0009314; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0010745; GO:0010763; GO:0010888; GO:0014823; GO:0014909; GO:0014911; GO:0015026; GO:0016324; GO:0016477; GO:0019899; GO:0030168; GO:0030949; GO:0031092; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032147; GO:0032369; GO:0032587; GO:0032880; GO:0032956; GO:0032991; GO:0033627; GO:0033630; GO:0033690; GO:0034113; GO:0034446; GO:0034683; GO:0035295; GO:0035866; GO:0035867; GO:0035868; GO:0036120; GO:0038027; GO:0042060; GO:0042470; GO:0042802; GO:0043184; GO:0043235; GO:0043277; GO:0045124; GO:0045202; GO:0045211; GO:0045766; GO:0045780; GO:0046718; GO:0048008; GO:0048146; GO:0048333; GO:0048661; GO:0050731; GO:0050748; GO:0050839; GO:0050840; GO:0050919; GO:0051279; GO:0051611; GO:0060055; GO:0060548; GO:0061097; GO:0070051; GO:0070062; GO:0070374; GO:0070527; GO:0071062; GO:0071133; GO:0071260; GO:0071466; GO:0072126; GO:0098978; GO:0099149; GO:0099699; GO:1900026; GO:1900731; GO:1901163; GO:1903053; GO:1905598; GO:1990314; GO:2000406 cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; platelet-derived growth factor receptor binding [GO:0005161]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618] CECGSCVCIQPGSYGDTCEK 0.25 10.658 0 0 0 0 0 0 0 0 11.1721 11.595 0 12.2342 0 0 0 0 0 0 15.6581 0 0 10.7157 0 11.2114 0 11.2492 11.097 0 12.0943 12.5721 13.9356 12.6334 0 14.7636 14.8946 11.2488 11.6042 9.36363 13.6179 12.2215 10.378 11.2285 0 12.7649 0 0 0 10.9026 12.8881 13.6204 0 0 11.2981 0 0 10.7555 0 0 0 0 0 0 0 0 0 0 11.449 0 0 0 12.9924 0 0 10.7804 14.3309 13.9063 12.934 0 13.5174 12.1163 13.1763 14.6464 0 15.7593 12.8552 15.6225 17.2676 15.6093 0 14.6863 0 13.9068 13.3076 16.726 16.8041 16.3875 15.5533 17.2824 16.5527 15.652 0 16.0379 15.8265 0 16.1066 16.3474 16.9372 16.3453 0 14.5193 14.4863 0 15.5454 15.1816 0 15.4307 15.8754 12.8573 15.616 10.5796 0 15.8191 16.2137 15.0141 16.5024 14.0663 14.4937 0 14.2214 15.1809 15.0241 0 0 14.5937 0 13.0137 14.2208 0 14.5008 0 0 0 0 14.7578 12.966 0 14.8532 11.8609 0 0 0 0 0 0 14.5251 0 14.5394 15.1316 14.6167 14.0458 0 0 0 0 12.4793 0 0 0 0 15.4446 0 13.3896 12.1068 0 12.9317 12.7633 0 12.8603 0 0 Q8TES7 FBF1_HUMAN "Fas-binding factor 1, FBF-1 (Protein albatross)" FBF1 ALB KIAA1863 Homo sapiens (Human) apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162] anchoring junction [GO:0070161]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; spindle pole [GO:0000922] anchoring junction [GO:0070161]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; spindle pole [GO:0000922]; apical junction assembly [GO:0043297]; cilium assembly [GO:0060271]; establishment of epithelial cell polarity [GO:0090162] GO:0000922; GO:0005813; GO:0005814; GO:0005829; GO:0036064; GO:0043297; GO:0060271; GO:0070161; GO:0090162; GO:0097539 EGTLISLAKQAELKIR 0.27778 10.057 0 0 0 0 0 0 0 0 12.6788 12.4212 0 0 12.6842 0 12.6345 0 12.2983 0 13.7861 0 0 0 0 0 0 12.7296 12.4974 12.6987 0 12.4447 12.4903 12.8808 12.492 12.6444 12.4809 0 12.6439 0 12.5768 9.9042 12.4573 12.6179 0 0 13.5915 12.8802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2838 0 12.0541 0 12.3424 0 0 0 15.6135 13.6999 0 11.4615 11.2894 0 14.7857 0 0 0 13.4118 0 0 0 0 0 0 0 0 0 13.5638 0 0 0 0 0 0 13.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0678 0 0 0 0 0 0 0 0 0 0 12.7362 0 0 11.4103 0 0 0 13.0815 0 0 0 0 12.5088 14.3684 0 14.4175 0 15.1315 0 11.8752 14.7307 14.4099 0 0 0 0 0 15.3108 14.0423 10.7118 14.0391 0 14.0164 0 14.0511 0 14.2208 0 0 14.044 0 0 0 0 0 15.1978 0 0 0 0 Q9UKK3 PARP4_HUMAN "Protein mono-ADP-ribosyltransferase PARP4, EC 2.4.2.- (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4, ARTD4) (PARP-related/IalphaI-related H5/proline-rich, PH5P) (Poly [ADP-ribose] polymerase 4, PARP-4) (Vault poly(ADP-ribose) polymerase, VPARP)" PARP4 ADPRTL1 KIAA0177 PARPL Homo sapiens (Human) cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; protein modification process [GO:0036211]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; protein modification process [GO:0036211]; protein mono-ADP-ribosylation [GO:0140289]; regulation of telomerase activity [GO:0051972]; response to xenobiotic stimulus [GO:0009410] GO:0003677; GO:0003950; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005876; GO:0006281; GO:0006471; GO:0006954; GO:0006974; GO:0008219; GO:0009410; GO:0016020; GO:0019899; GO:0036211; GO:0051972; GO:0070062; GO:0140289; GO:1990404; GO:1990904 DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404] AEGILLLVK 0.29412 10.162 0 0 0 0 0 0 0 0 11.9426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3839 0 0 0 0 0 12.362 11.9822 0 13.6695 0 0 11.9574 0 9.5898 0 0 0 0 0 0 11.123 13.2176 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 0 0 0 0 0 0 0 13.5116 0 11.818 13.2523 0 0 12.6074 0 0 0 13.5801 0 11.8358 13.207 13.3238 0 0 0 10.9711 13.7746 0 0 0 10.5451 0 0 11.8176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0834 0 11.3158 0 0 0 0 0 0 0 0 12.4409 12.7746 0 0 10.893 10.6567 0 0 0 0 0 0 12.5901 0 11.9412 0 11.1531 0 0 0 0 0 11.04 0 0 0 0 0 0 0 0 0 0 Q5VY43 PEAR1_HUMAN "Platelet endothelial aggregation receptor 1, hPEAR1 (Multiple epidermal growth factor-like domains protein 12, Multiple EGF-like domains protein 12)" PEAR1 MEGF12 Homo sapiens (Human) phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654] integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic cup [GO:0001891] integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; signaling receptor activity [GO:0038023]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654] GO:0001891; GO:0014065; GO:0016020; GO:0016021; GO:0038023; GO:0043491; GO:0043654; GO:0070527 signaling receptor activity [GO:0038023] CAPGYTGDRCR 0.36364 9.6037 0 0 11.2226 9.58971 0 0 0 0 0 12.024 0 0 0 0 0 0 11.7518 0 0 12.6119 0 0 0 0 0 0 0 0 0 11.1303 0 0 0 10.9115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8139 0 13.884 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2332 0 0 0 0 0 0 0 13.0707 0 11.9127 0 0 0 12.6349 0 12.5795 0 0 0 14.5476 11.4316 0 0 12.0879 0 0 12.7515 0 12.5802 12.1986 0 0 14.0145 0 0 13.8152 12.3033 13.5704 0 0 0 0 0 0 0 0 12.5922 13.3508 12.7579 0 12.0855 0 12.6622 0 14.4481 0 0 0 11.8981 0 0 0 0 10.6516 12.5361 12.5628 0 14.2507 14.5331 0 14.9726 13.3912 0 0 0 12.4721 12.5168 0 12.0159 0 0 0 0 0 11.2279 10.3544 0 12.147 0 0 0 12.0472 0 0 0 0 0 0 12.004 0 12.8358 0 0 0 12.3928 0 0 0 0 0 14.083 0 0 Q02928 CP4AB_HUMAN "Cytochrome P450 4A11, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase, EC 1.14.14.80)" CYP4A11 CYP4A2 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078] GO:0001676; GO:0001822; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006631; GO:0006691; GO:0008391; GO:0008392; GO:0016324; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0031408; GO:0032305; GO:0043231; GO:0043651; GO:0046456; GO:0048252; GO:0050051; GO:0055078; GO:0070330; GO:0097267; GO:0102033 alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497] FELLPDPTRIPIPIARLVLK 0.38095 9.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.839 0 0 0 0 12.5603 0 0 14.0816 0 0 0 0 0 0 13.9126 0 0 0 0 0 0 13.6099 14.043 0 12.5624 0 11.7494 0 0 0 10.4078 0 0 0 0 0 0 0 0 0 11.4432 0 0 0 0 0 0 0 0 0 0 14.9298 0 10.8777 10.4324 14.4831 14.5718 12.9629 14.0748 0 14.9684 13.2769 14.9239 13.2453 0 12.8409 0 0 0 13.169 15.3027 0 11.1999 0 15.7849 0 0 14.1695 13.0147 0 13.2932 0 0 0 0 0 0 0 0 0 0 0 0 14.1028 0 0 10.251 0 0 0 13.9842 0 14.5127 14.3705 14.8962 0 13.7902 0 11.4468 14.7181 15.0224 14.8511 0 14.9539 12.7445 0 12.8593 15.528 0 0 14.5242 13.7814 13.7041 0 12.3846 0 0 0 0 14.2455 0 11.1206 13.9433 14.7875 0 0 11.7247 0 10.4085 0 0 10.1049 0 12.6324 0 0 0 0 0 14.3212 0 0 0 16.2822 0 14.3001 11.8285 10.979 0 14.1953 0 0 0 0 15.1144 Q6L8H4 KRA51_HUMAN "Keratin-associated protein 5-1 (Keratin, cuticle, ultrahigh sulphur 1-like) (Keratin-associated protein 5.1) (Ultrahigh sulfur keratin-associated protein 5.1)" KRTAP5-1 KAP5.1 KRN1L KRTAP5.1 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GACGSCGGSKGGCGSCGGCK 0.4 9.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4497 0 0 0 0 0 0 0 0 12.1881 0 0 0 12.3668 12.8147 0 12.6113 0 0 11.223 0 0 0 0 10.5432 0 0 0 13.9936 0 10.3246 0 13.5552 0 0 0 0 11.0443 0 0 0 0 0 0 0 0 0 0 0 14.0664 0 12.084 12.6247 0 12.6817 14.0671 0 0 0 9.96651 0 0 13.4189 0 0 0 11.8746 14.178 12.6842 0 12.9307 0 0 0 0 0 0 0 0 0 10.8136 0 0 0 0 0 0 0 0 0 0 0 11.8006 0 0 0 0 0 0 11.3376 0 0 0 12.1138 0 0 0 0 0 15.3594 13.5897 0 11.5332 0 0 0 11.4902 0 0 12.7416 0 0 0 11.4489 0 0 0 0 13.4638 0 0 11.151 0 13.2234 13.502 11.6721 0 0 0 0 0 0 0 0 0 13.7278 12.8551 0 0 0 11.7713 15.0967 0 11.2213 0 0 10.07 0 12.9434 0 0 0 0 P35556 FBN2_HUMAN Fibrillin-2 [Cleaved into: Placensin ] FBN2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179]; anatomical structure morphogenesis [GO:0009653]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; glucose homeostasis [GO:0042593]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of trophoblast cell migration [GO:1901163]; sequestering of TGFbeta in extracellular matrix [GO:0035583] GO:0001527; GO:0001890; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0009653; GO:0030023; GO:0030326; GO:0030501; GO:0031012; GO:0035583; GO:0042593; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023; GO:1901163 calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; hormone activity [GO:0005179] AFNTTKAKCCCSK 0.42105 9.8361 13.8632 0 0 10.6557 12.8923 0 0 11.0543 0 0 11.6889 0 0 12.0526 0 0 0 0 0 13.5548 14.2457 13.6196 0 0 10.9542 0 13.795 12.1437 0 0 0 0 14.5186 0 0 0 10.3696 0 0 10.327 0 0 12.2013 0 0 0 10.8701 0 0 0 0 10.9325 0 0 0 11.1968 0 0 0 0 0 0 0 0 0 0 12.2175 10.4885 11.8594 15.637 11.2901 0 11.837 14.5899 12.6971 14.2065 0 11.646 14.3325 12.3276 11.0192 12.3592 15.1456 13.6033 13.6003 13.9169 15.0964 14.6137 14.6876 13.4921 13.2178 15.6769 15.9619 10.4554 15.2547 14.8534 0 12.0037 22.666 0 11.2429 16.1545 0 12.0239 13.4544 15.9728 11.2708 14.2446 0 13.6846 15.9428 0 0 14.6491 12.5735 13.6818 11.2264 10.5174 11.8786 14.0839 15.5275 12.1718 0 14.5706 0 11.741 0 0 0 12.2535 13.1275 15.0812 12.4479 14.9798 11.8242 12.0578 12.9144 12.2702 11.6506 0 0 0 0 0 0 12.455 13.0998 0 12.6285 13.4539 12.4475 0 0 0 11.9279 14.0736 13.7924 0 0 13.6985 0 12.0112 0 12.4134 9.84237 14.0118 12.439 0 0 0 0 0 12.7992 0 14.5892 0 0 11.8105 13.0691 12.9756 Q701N4 KRA52_HUMAN Keratin-associated protein 5-2 (Keratin-associated protein 5-8) (Keratin-associated protein 5.2) (Keratin-associated protein 5.8) (Ultrahigh sulfur keratin-associated protein 5.2) KRTAP5-2 KAP5-8 KAP5.2 KRTAP5-8 KRTAP5.2 KRTAP5.8 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GCCGCSRGCGSGCGGCGSSCGGCGSGCGGCGSGR 0.47826 9.389 0 11.5854 0 0 0 0 0 12.8954 0 13.3001 12.144 0 0 0 0 0 0 0 11.3907 0 0 0 12.1853 0 0 0 0 0 0 10.4854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6902 0 0 10.8502 10.251 0 11.0882 0 0 0 10.7051 0 14.0766 0 0 0 0 0 0 0 0 0 18.9427 18.9619 19.382 15.5218 0 17.1934 17.8168 17.4481 0 16.3927 0 16.2094 15.1753 15.5374 14.7484 14.7606 14.7288 0 12.461 12.7015 0 11.8476 11.4195 0 13.7041 0 0 13.4214 0 12.6824 0 0 11.3793 0 15.2383 0 10.9339 0 0 15.325 0 14.2038 0 14.1403 12.5407 0 0 12.0628 12.3665 0 11.2722 14.0591 12.0992 12.3317 0 0 0 12.7783 14.032 12.4801 0 12.2997 0 0 13.92 0 0 12.0946 0 12.6525 10.7152 14.8181 10.4312 0 9.99845 0 12.2153 0 14.9628 14.023 0 0 0 0 0 0 12.3858 0 0 0 0 0 12.6617 0 0 0 13.8179 13.4401 0 0 0 0 0 14.1552 11.9277 0 15.4157 0 14.5563 0 0 0 0 0 P07438 MT1B_HUMAN "Metallothionein-1B, MT-1B (Metallothionein-IB, MT-IB)" MT1B MT1Q Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010273; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CCCSCCPVGCAK 0.51852 9.0101 0 0 0 0 0 0 0 0 10.4277 0 0 11.1014 0 0 0 9.58033 0 14.1029 0 0 0 0 0 0 14.4845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3657 0 0 0 0 0 0 0 0 0 11.2829 0 0 0 10.4706 0 0 0 0 0 0 0 0 13.1673 0 0 10.7873 0 0 0 0 0 0 12.105 11.2415 0 0 13.0641 0 14.2829 0 13.6795 12.2722 11.1166 0 0 14.2654 0 0 12.5176 0 0 0 14.4353 0 10.8703 0 0 11.5378 0 0 12.3909 0 0 0 0 10.9617 0 0 0 0 11.8713 0 0 0 10.8479 12.1841 0 0 0 0 0 14.5126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6338 0 0 0 0 0 0 0 10.555 0 0 0 0 0 0 0 0 10.5283 0 11.8723 0 12.4285 12.0577 0 0 0 0 0 0 0 0 0 10.4466 14.4476 0 0 11.718 Q93083 MT1L_HUMAN "Metallothionein-1L, MT-1L (Metallothionein-IL, MT-IL)" MT1L Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010273; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCVCKGASEKCSCCA 0.53571 8.8294 0 0 0 0 0 0 0 9.95565 0 0 0 0 13.1939 0 0 0 10.4617 0 0 0 9.59733 0 0 0 0 0 0 0 0 0 0 13.3882 13.5358 0 13.1563 0 13.7612 0 0 0 0 0 0 0 0 13.445 14.2148 0 0 10.454 13.4035 0 0 0 13.0094 0 0 0 0 0 0 0 12.636 0 0 0 14.6544 0 0 0 13.2127 0 14.1073 0 15.0374 0 0 12.5045 0 0 0 0 0 0 0 0 12.6982 0 13.1761 11.597 0 0 0 15.3884 14.8245 13.7681 14.5331 15.654 15.5968 0 0 0 0 14.6059 14.6138 14.5143 0 11.8762 14.1211 0 14.8127 0 0 0 0 0 15.1166 13.1978 14.5714 14.4682 0 14.6213 0 13.6578 0 16.2868 0 0 12.0309 0 0 11.3529 15.5501 14.5423 0 0 12.4655 0 0 0 0 0 0 15.1021 14.8744 0 0 15.6096 0 0 0 15.2888 0 11.8558 0 11.7933 14.4141 14.8549 15.999 0 0 13.5337 0 0 0 0 0 0 0 0 15.5079 0 12.339 12.47 0 15.6183 0 0 0 0 Q8NBT3 TM145_HUMAN Transmembrane protein 145 TMEM145 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236] GO:0007186; GO:0016021; GO:0019236 FCFLSDYGRLDFRFR 0.53846 9.1152 0 0 0 0 12.2898 0 0 0 10.5309 13.1293 13.4837 0 12.3161 0 0 0 9.89005 0 0 0 0 0 0 11.9328 0 0 0 12.7366 0 11.4219 10.9132 0 11.9176 0 0 0 0 15.606 0 0 0 0 0 0 0 0 0 0 12.1909 0 10.7816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9454 14.6433 0 15.2175 0 14.223 14.102 11.0863 12.0438 11.5699 14.9833 0 0 0 0 0 12.6278 0 0 12.3127 0 12.5697 0 13.2939 13.15 11.0142 13.7603 0 13.168 0 0 0 13.7982 12.6477 13.6823 13.7148 12.3502 12.9985 0 13.1317 0 0 0 0 0 13.7619 0 11.9405 10.8791 0 12.7738 0 0 0 0 11.4993 0 0 11.4991 0 10.4082 0 0 15.4438 0 0 10.4266 10.086 0 11.9895 0 0 11.7142 14.6104 14.1912 0 15.0387 13.6582 14.3285 0 0 0 0 12.3917 11.7452 13.4362 13.2349 0 0 13.8225 0 0 0 11.8172 0 0 0 0 0 15.6024 0 11.1521 0 12.5277 13.4418 10.3555 0 11.504 0 0 13.7156 0 0 0 Q9BYR0 KRA47_HUMAN Keratin-associated protein 4-7 (Keratin-associated protein 4.7) (Ultrahigh sulfur keratin-associated protein 4.7) KRTAP4-7 KAP4.7 KRTAP4.7 Homo sapiens (Human) aging [GO:0007568]; hair cycle [GO:0042633] cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; aging [GO:0007568]; hair cycle [GO:0042633] GO:0005829; GO:0007568; GO:0042633; GO:0045095 CCISSCCRPSCCMSSCCK 0.54167 9.3015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2415 13.7977 0 0 0 0 0 0 9.48804 0 12.359 0 0 0 0 0 0 0 13.7472 0 0 0 12.3219 0 0 0 0 0 0 11.2221 0 0 12.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4919 12.7202 0 13.1536 0 14.113 11.5896 13.5702 14.6547 15.7768 14.6754 0 14.561 13.7404 14.8068 14.7824 14.0586 14.0869 14.3557 13.7722 13.8762 0 0 0 13.8354 14.6004 14.7954 0 13.1184 13.6502 11.4975 14.7312 13.3636 0 15.2269 0 14.2223 10.8335 0 15.1234 0 13.8089 0 14.304 0 12.7531 13.9317 0 14.8516 13.1699 0 16.0603 14.8269 0 0 14.7971 13.6862 0 15.9382 14.5401 12.2782 0 12.5661 11.0206 13.186 10.2193 11.139 0 0 13.2928 13.6588 0 0 0 12.586 15.629 10.9001 13.6162 0 12.5817 0 12.1933 0 12.5926 14.8467 11.235 0 0 11.1616 0 0 0 0 0 0 0 13.8043 0 0 0 10.4887 12.3622 0 13.9439 0 0 0 12.8675 0 12.2011 12.5364 P26371 KRA59_HUMAN "Keratin-associated protein 5-9 (Keratin, cuticle, ultrahigh sulfur 1) (Keratin, ultra high-sulfur matrix protein A) (Keratin-associated protein 5.9) (UHS keratin A, UHS KerA) (Ultrahigh sulfur keratin-associated protein 5.9)" KRTAP5-9 KAP5.9 KRN1 KRTAP5.9 UHSK1 Homo sapiens (Human) epidermis development [GO:0008544] cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; identical protein binding [GO:0042802]; epidermis development [GO:0008544] GO:0005829; GO:0008544; GO:0042802; GO:0045095 identical protein binding [GO:0042802] CCVPVCYQCK 0.55172 8.6852 0 0 0 0 0 0 0 0 0 0 10.0558 0 0 0 13.0581 0 11.2279 11.665 0 0 0 0 0 0 0 0 0 0 0 0 11.8397 0 12.3234 0 0 0 0 0 0 0 0 12.3951 0 0 0 11.8555 0 0 0 0 13.6864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0288 0 11.0142 0 15.2523 16.0497 14.7899 16.3837 12.6395 0 0 11.957 0 0 11.5219 0 11.7175 10.9094 14.0756 12.6251 13.8381 11.8791 0 13.5352 11.5992 0 11.9414 0 0 0 0 12.6372 14.5705 11.9217 0 0 0 12.1875 15.2386 12.3846 12.1315 0 10.9115 12.8001 12.4374 13.3216 0 0 13.1152 14.4307 13.3538 13.689 12.4867 14.1069 0 0 12.8178 0 0 0 12.6625 13.5088 0 14.9483 0 12.9441 0 11.7275 0 0 0 0 12.8881 11.315 11.978 0 11.867 0 12.3547 11.9805 13.7691 12.8975 0 9.95887 13.354 11.1476 10.9811 12.1702 12.6317 14.7362 11.4332 0 12.0778 11.1295 0 9.95622 0 0 0 11.5957 0 0 0 14.3951 11.4019 12.7186 13.0753 14.2179 12.5999 0 0 0 14.016 11.6807 P04278 SHBG_HUMAN "Sex hormone-binding globulin, SHBG (Sex steroid-binding protein, SBP) (Testis-specific androgen-binding protein, ABP) (Testosterone-estradiol-binding globulin, TeBG) (Testosterone-estrogen-binding globulin)" SHBG Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular region [GO:0005576] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; androgen binding [GO:0005497]; steroid binding [GO:0005496] GO:0005496; GO:0005497; GO:0005576; GO:0070062 androgen binding [GO:0005497]; steroid binding [GO:0005496] ALALPPLGLAPLLNLWAKPQGR 0.56 9.1682 0 11.2229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7363 10.5787 10.9499 0 0 0 0 0 0 0 0 0 0 11.4105 9.79364 0 0 0 12.8433 0 0 0 11.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6865 0 13.7237 0 12.1301 0 0 0 0 11.1822 0 0 11.5182 0 0 0 0 13.2666 9.89008 0 11.4415 0 0 0 10.4886 0 0 0 12.9861 0 0 0 0 0 0 0 0 0 10.3712 0 0 0 0 0 12.5468 0 0 10.7859 12.6989 0 0 0 0 0 9.94522 0 0 13.0708 11.8892 11.6174 0 0 0 0 11.2773 0 0 0 0 0 0 0 11.6914 0 0 0 0 0 0 0 10.7405 12.4063 0 0 11.5272 0 0 0 11.0038 12.099 10.8678 0 12.1394 9.40229 0 12.6308 11.9349 10.2261 14.1963 12.3888 0 0 0 0 0 0 0 0 Q9H4L4 SENP3_HUMAN "Sentrin-specific protease 3, EC 3.4.22.- (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3)" SENP3 SSP3 SUSP3 Homo sapiens (Human) protein desumoylation [GO:0016926] cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; deSUMOylase activity [GO:0016929]; protein desumoylation [GO:0016926] GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008234; GO:0016926; GO:0016929; GO:0071339 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; deSUMOylase activity [GO:0016929] ELLLIPIHLEVHWSLISVDVRRR 0.64286 6.4695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4531 0 0 0 0 0 0 12.5709 0 0 14.6574 15.2208 0 0 13.1733 13.6003 14.1077 0 0 0 15.453 0 14.6267 13.9641 0 12.7265 0 12.3306 0 0 0 0 0 0 0 0 0 0 0 11.4112 0 13.4791 12.978 0 0 12.2203 0 0 0 0 0 0 0 0 13.2176 0 14.1924 14.1125 0 0 0 0 14.8504 12.6247 12.3403 0 0 0 0 0 0 14.6746 0 0 12.8717 12.9741 0 0 11.7935 0 0 11.8928 0 0 0 0 14.2412 13.5166 11.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6966 0 0 0 0 0 0 0 P02795 MT2_HUMAN "Metallothionein-2, MT-2 (Metallothionein-2A) (Metallothionein-II, MT-II)" MT2A CES1 MT2 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to erythropoietin [GO:0036018]; cellular response to interleukin-3 [GO:0036016]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular copper ion homeostasis [GO:0006878]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to erythropoietin [GO:0036018]; cellular response to interleukin-3 [GO:0036016]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0005829; GO:0006878; GO:0006882; GO:0008270; GO:0010273; GO:0036016; GO:0036018; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCICKGASDKCSCCA 0.6506 6.5269 0 0 0 0 0 0 11.4278 0 0 13.3397 0 0 0 11.2904 11.8959 0 0 13.8729 0 10.9389 0 0 0 0 12.4307 11.7492 0 0 0 10.2417 12.5396 0 0 14.2242 13.0657 13.413 0 11.6017 0 0 0 11.9377 0 0 13.2909 12.2396 10.6005 11.0477 0 0 0 11.9299 0 12.9008 15.1629 14.467 15.241 14.4697 13.7397 14.7862 0 0 11.9265 13.452 14.4234 0 0 0 0 13.2216 0 0 0 0 0 0 13.7282 0 13.8391 13.3426 0 0 0 0 0 15.0782 0 0 12.7123 0 0 14.9151 13.7593 13.5258 0 0 0 0 0 0 12.0417 11.9218 0 0 12.8619 12.4266 12.4483 0 13.5289 0 0 15.534 11.646 0 0 0 0 14.9297 14.3951 0 13.0803 0 0 0 0 0 13.7343 0 0 0 12.2613 14.0546 0 0 0 0 0 0 0 12.0354 0 14.7569 0 0 10.6888 0 0 12.5911 0 0 11.3188 13.363 0 11.5925 0 14.5008 12.6728 0 0 0 12.4617 0 15.244 12.9419 14.697 15.2359 15.131 15.1999 13.1246 0 0 0 10.9383 11.7846 0 0 0 0 0 0 O75077 ADA23_HUMAN "Disintegrin and metalloproteinase domain-containing protein 23, ADAM 23 (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3, MDC-3)" ADAM23 MDC3 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; proteolysis [GO:0006508] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; proteolysis [GO:0006508] GO:0004222; GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0006508; GO:0007155; GO:0007417; GO:0008237; GO:0098978; GO:0099056; GO:1990830 integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] CYNGECKTRDNQCQYIWGTK 0.65432 6.5833 0 0 0 0 0 0 0 11.8803 0 0 0 0 0 15.3943 0 0 14.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.228 0 0 0 0 0 0 0 12.642 0 0 0 0 0 0 12.4807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9098 0 0 0 0 0 0 0 0 0 0 15.441 10.9452 0 0 0 0 0 0 0 0 11.8221 13.8427 0 0 0 0 0 0 0 0 0 15.6314 0 0 0 0 12.0316 0 0 0 14.9967 0 14.8536 12.4359 0 0 0 0 0 0 0 0 12.7761 12.9963 0 0 0 0 0 0 0 0 11.5686 14.744 16.3535 0 0 0 0 0 0 0 15.2184 0 0 14.3285 0 0 0 0 0 0 14.3587 0 0 0 0 0 0 0 0 0 12.2538 0 0 14.4267 0 0 0 0 0 0 0 0 0 0 0 15.9504 0 Q8N5K1 CISD2_HUMAN "CDGSH iron-sulfur domain-containing protein 2 (Endoplasmic reticulum intermembrane small protein) (MitoNEET-related 1 protein, Miner1) (Nutrient-deprivation autophagy factor-1, NAF-1)" CISD2 CDGSH2 ERIS ZCD2 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; regulation of autophagy [GO:0010506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear endoplasmic reticulum [GO:0097038]; protein-containing complex [GO:0032991] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear endoplasmic reticulum [GO:0097038]; protein-containing complex [GO:0032991]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; autophagy of mitochondrion [GO:0000422]; regulation of autophagy [GO:0010506]" GO:0000422; GO:0003723; GO:0005741; GO:0005783; GO:0005789; GO:0010506; GO:0016020; GO:0016021; GO:0032991; GO:0042803; GO:0046872; GO:0051537; GO:0097038 "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]" DSLINLKIQKENPK 0.65854 6.5373 0 0 0 0 0 0 0 0 0 12.3589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3284 0 12.227 15.9031 0 0 0 0 13.0231 13.2193 13.0461 0 0 0 13.1076 0 0 11.8415 0 0 14.9529 0 0 0 12.7479 0 0 13.5018 0 0 0 0 11.8981 13.6654 0 0 0 0 0 12.4003 0 13.2293 0 0 12.6961 15.0013 15.2293 14.8989 13.9641 0 14.2902 15.8904 13.7243 0 0 0 0 0 0 14.2461 12.3278 0 0 0 0 0 0 0 12.768 0 0 11.8299 0 13.4354 11.861 11.2456 15.0871 15.5056 0 0 0 0 0 11.8227 12.0415 0 12.286 0 0 0 0 0 11.5545 0 11.7202 0 0 0 0 0 0 0 0 0 0 0 0 P09131 P3_HUMAN P3 protein (Solute carrier family 10 member 3) SLC10A3 DXS253E P3 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526] GO:0008508; GO:0015721; GO:0016021; GO:0032526 bile acid:sodium symporter activity [GO:0008508] FSQLLLQVVKPFSFVLLLGGLFLAYR 0.66154 7.042 0 0 0 11.0206 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5122 0 0 13.7642 0 0 11.5347 0 13.9033 0 0 0 0 13.5247 12.5099 0 14.3001 14.4516 0 0 0 14.9811 0 0 0 0 12.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1899 0 0 0 0 0 0 0 0 10.0877 0 0 0 0 0 0 0 0 0 0 13.4861 0 0 14.4037 11.5338 0 0 0 13.6697 0 0 0 0 0 0 0 0 0 11.8972 0 0 0 0 12.1109 0 11.7118 12.5121 0 13.8241 0 14.0645 0 12.557 12.8151 14.218 0 0 0 12.554 0 0 13.2841 12.5911 0 0 0 0 13.0103 11.6425 13.9161 0 0 0 0 0 13.5957 0 12.1699 0 12.3629 0 0 0 0 11.9743 0 0 0 0 0 14.5155 12.0097 0 13.5223 0 0 0 0 0 11.2412 16.0178 14.7197 0 0 0 15.0487 0 0 15.0696 15.002 12.8993 12.246 0 0 0 9.982 0 0 0 12.6383 0 0 15.9494 Q9Y5Y6 ST14_HUMAN "Suppressor of tumorigenicity 14 protein, EC 3.4.21.109 (Matriptase) (Membrane-type serine protease 1, MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)" ST14 PRSS14 SNC19 TADG15 Homo sapiens (Human) epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016323; GO:0019897; GO:0030163; GO:0030216; GO:0060672 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] CDGWADCTDHSDELNCSCDAGHQFTCK 0.66176 6.9937 10.3426 0 0 0 11.7754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.83 13.1412 0 12.1666 0 0 0 0 11.3601 0 0 0 14.5548 0 0 0 12.6636 0 0 0 10.9469 0 0 0 11.5549 0 12.9393 13.119 0 0 13.2272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2732 0 0 0 0 12.2828 0 11.3106 0 0 14.6134 0 0 13.6757 13.0489 14.5578 0 0 15.439 14.3649 13.0865 13.4153 0 13.854 18.1208 13.0923 0 0 0 0 0 0 15.1225 0 12.7441 13.1272 19.0739 13.4359 0 11.6147 13.3567 13.7429 12.4328 14.5851 15.7158 0 12.8511 14.1057 13.5111 0 13.2082 13.0602 11.5478 0 12.9446 0 12.5669 0 17.9748 17.8926 17.9411 0 0 14.5943 14.3591 18.8578 10.9339 0 10.5043 12.1073 17.873 0 0 13.5023 13.6637 12.9214 0 0 14.5686 18.8178 0 0 13.3537 12.6574 17.959 19.3541 14.9989 15.6297 12.1193 13.4188 0 12.6451 14.9584 0 0 0 0 0 0 10.1624 13.9767 0 0 13.4415 17.9197 14.3697 0 14.4981 11.3351 12.927 0 0 0 P25713 MT3_HUMAN "Metallothionein-3, MT-3 (GIFB, GIF) (Growth inhibitory factor) (Metallothionein-III, MT-III)" MT3 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; astrocyte development [GO:0014002]; brain development [GO:0007420]; cadmium ion homeostasis [GO:0055073]; cellular lipid catabolic process [GO:0044242]; cellular metal ion homeostasis [GO:0006875]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to nitric oxide [GO:0071732]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; cholesterol catabolic process [GO:0006707]; detoxification of copper ion [GO:0010273]; energy reserve metabolic process [GO:0006112]; ERK1 and ERK2 cascade [GO:0070371]; histone modification [GO:0016570]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of hydrogen peroxide catabolic process [GO:2000296]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell death [GO:0010942]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of oxygen metabolic process [GO:2000376]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of protein glycosylation [GO:0060049]; regulation of response to food [GO:0032095]; removal of superoxide radicals [GO:0019430]; response to hypoxia [GO:0001666]; zinc ion homeostasis [GO:0055069]; zinc ion transport [GO:0006829]" astrocyte end-foot [GO:0097450]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; inclusion body [GO:0016234]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synaptic vesicle [GO:0008021] "astrocyte end-foot [GO:0097450]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; inclusion body [GO:0016234]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synaptic vesicle [GO:0008021]; antioxidant activity [GO:0016209]; cadmium ion binding [GO:0046870]; copper ion binding [GO:0005507]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; zinc ion binding [GO:0008270]; activation of protein kinase B activity [GO:0032148]; astrocyte development [GO:0014002]; brain development [GO:0007420]; cadmium ion homeostasis [GO:0055073]; cellular lipid catabolic process [GO:0044242]; cellular metal ion homeostasis [GO:0006875]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to nitric oxide [GO:0071732]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; cholesterol catabolic process [GO:0006707]; detoxification of copper ion [GO:0010273]; energy reserve metabolic process [GO:0006112]; ERK1 and ERK2 cascade [GO:0070371]; histone modification [GO:0016570]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of hydrogen peroxide catabolic process [GO:2000296]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell death [GO:0010942]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of oxygen metabolic process [GO:2000376]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of protein glycosylation [GO:0060049]; regulation of response to food [GO:0032095]; removal of superoxide radicals [GO:0019430]; response to hypoxia [GO:0001666]; zinc ion homeostasis [GO:0055069]; zinc ion transport [GO:0006829]" GO:0001666; GO:0001934; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005741; GO:0005791; GO:0005829; GO:0005840; GO:0005874; GO:0005886; GO:0006112; GO:0006707; GO:0006829; GO:0006875; GO:0006882; GO:0007420; GO:0008021; GO:0008270; GO:0010273; GO:0010507; GO:0010628; GO:0010940; GO:0010942; GO:0010977; GO:0014002; GO:0014069; GO:0016209; GO:0016234; GO:0016570; GO:0019430; GO:0030295; GO:0030308; GO:0030424; GO:0030517; GO:0030949; GO:0032095; GO:0032148; GO:0033210; GO:0034599; GO:0036091; GO:0043027; GO:0043066; GO:0043085; GO:0043154; GO:0043197; GO:0043491; GO:0043524; GO:0044242; GO:0045892; GO:0045893; GO:0046870; GO:0046872; GO:0048471; GO:0050821; GO:0051354; GO:0055069; GO:0055073; GO:0060049; GO:0060547; GO:0070371; GO:0070374; GO:0071276; GO:0071280; GO:0071294; GO:0071456; GO:0071732; GO:0097214; GO:0097450; GO:2000117; GO:2000296; GO:2000376; GO:2000378 antioxidant activity [GO:0016209]; cadmium ion binding [GO:0046870]; copper ion binding [GO:0005507]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; zinc ion binding [GO:0008270] CEGCKCTSCK 0.66216 6.7498 0 0 10.4137 0 0 0 0 0 0 0 10.8839 0 0 0 0 0 0 0 13.9665 0 13.3805 11.4223 14.2575 13.2088 0 0 0 0 0 13.1537 13.224 0 11.4121 0 0 0 0 0 0 11.3428 0 11.6865 0 0 0 0 11.6715 0 10.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.919 0 0 0 10.8631 0 15.6304 15.331 14.8351 12.3159 10.5735 15.1778 15.4929 14.6466 0 13.3619 13.8701 0 13.8486 0 0 13.7703 14.1009 13.9343 0 14.6891 15.1433 0 12.2915 0 0 13.8845 11.441 15.1628 14.4877 0 13.7021 0 0 0 14.4107 16.1647 16.1495 0 15.9987 0 0 13.9927 14.8423 0 15.5021 0 10.4962 0 13.0697 0 11.5761 14.5246 14.9507 14.4647 14.5062 14.3266 0 0 0 14.7913 12.5795 0 0 11.1474 15.752 14.5783 15.1924 11.6962 0 0 15.2631 12.5206 16.7496 12.4071 0 0 15.6535 0 0 15.0538 0 0 0 0 0 11.6006 0 0 11.8235 0 14.0842 0 0 13.8342 0 0 13.802 0 14.9833 0 0 0 0 0 0 0 O14924 RGS12_HUMAN "Regulator of G-protein signaling 12, RGS12" RGS12 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] anchoring junction [GO:0070161]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase regulator activity [GO:0030695]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0000794; GO:0003924; GO:0005096; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0016363; GO:0030425; GO:0030695; GO:0045202; GO:0070161 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase regulator activity [GO:0030695] AFLDGDADAHQNNSTSSNSDSGIGNFHQEEK 0.66234 6.6409 0 0 0 0 0 0 0 0 0 10.7211 0 0 0 0 0 0 0 0 13.9024 0 13.8266 0 0 0 0 0 0 0 13.3311 0 0 0 0 0 0 10.0226 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4211 0 0 14.4457 14.366 14.7346 13.8243 14.7536 14.7963 14.2527 0 14.1339 14.4533 14.9311 14.561 14.5767 0 0 13.6517 13.7134 13.9726 13.4944 0 0 0 14.8466 13.6425 0 0 13.4856 0 13.2968 0 13.7318 13.2388 0 13.2183 14.4814 10.7306 13.035 13.4834 0 0 0 13.4606 0 0 13.3688 0 0 0 0 0 12.6881 14.8871 0 0 0 0 0 0 14.9496 0 0 0 0 0 0 0 0 0 0 11.7753 0 0 0 13.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBW0 LPAR2_HUMAN "Lysophosphatidic acid receptor 2, LPA receptor 2, LPA-2 (Lysophosphatidic acid receptor Edg-4)" LPAR2 EDG4 LPA2 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of metabolic process [GO:0019222] cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; lysophosphatidic acid receptor activity [GO:0070915]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of metabolic process [GO:0019222] GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007202; GO:0007204; GO:0008289; GO:0009986; GO:0019222; GO:0070915 G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; lysophosphatidic acid receptor activity [GO:0070915] DVVVVALGLTVSVLVLLTNLLVIAAIASNR 0.6625 6.592 0 0 0 12.0796 0 0 0 0 0 0 12.5195 0 0 0 12.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5979 0 0 0 0 0 0 0 0 14.5841 0 0 0 12.2066 0 0 0 0 0 13.8025 0 11.3713 0 0 0 0 0 0 0 14.3851 0 0 11.9361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8184 0 0 0 0 0 0 13.765 0 0 0 12.3316 0 0 0 11.7302 0 11.2044 0 0 0 0 0 0 0 0 0 0 0 13.4473 0 14.7841 0 0 0 14.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5578 0 0 0 0 0 0 0 11.7543 0 Q9BW91 NUDT9_HUMAN "ADP-ribose pyrophosphatase, mitochondrial, EC 3.6.1.13 (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase, ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9, Nudix motif 9)" NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 Homo sapiens (Human) ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule metabolic process [GO:0055086] cell junction [GO:0030054]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965] cell junction [GO:0030054]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule metabolic process [GO:0055086] GO:0005739; GO:0005759; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0046709; GO:0047631; GO:0055086; GO:0070062 ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144] DAHWSEDSEADCHAL 0.66279 6.3982 0 11.3392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4928 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 0 0 0 0 0 0 0 0 13.9535 0 0 0 0 0 0 0 12.7424 15.5906 0 0 0 0 0 0 0 0 0 0 0 10.5609 12.6873 13.4188 0 0 0 0 0 0 0 11.603 0 0 11.5011 0 0 0 11.8691 0 0 13.3133 13.6591 0 0 0 11.9176 14.4546 0 0 14.2058 0 14.0595 0 0 0 11.8927 0 0 0 0 0 13.5525 0 0 0 0 0 14.049 0 0 13.3486 13.2458 14.2204 12.7799 0 0 9.65542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6246 0 0 0 0 0 0 0 0 14.5215 13.2247 0 0 0 0 0 Q6L8H1 KRA54_HUMAN Keratin-associated protein 5-4 (Keratin-associated protein 5.4) (Ultrahigh sulfur keratin-associated protein 5.4) KRTAP5-4 KAP5.4 KRTAP5.4 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GGCGSCGCSQCSCCK 0.66667 6.3915 0 0 0 0 0 0 0 0 11.7205 12.5205 0 0 0 0 0 0 0 0 0 0 11.034 12.2026 0 0 0 0 0 0 0 0 0 0 0 0 11.6475 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3675 11.6373 12.3239 0 0 14.9261 12.753 0 13.0761 0 11.9308 0 12.0885 12.5523 0 11.9393 12.4888 0 0 0 0 12.7548 0 15.274 11.7181 0 11.6562 13.3947 12.1958 0 0 0 0 0 0 0 0 0 0 0 13.1122 0 13.232 0 13.8361 10.7515 13.759 0 12.809 0 10.398 0 0 12.5617 12.0978 0 0 12.7692 0 0 12.8545 0 0 0 0 0 0 0 0 12.4466 0 0 0 0 0 11.885 12.7268 13.2278 0 0 11.98 14.6629 0 0 0 0 0 0 0 13.4454 11.4782 0 12.1533 12.6522 0 0 14.884 13.9484 0 11.8662 0 0 0 0 0 0 0 0 10.876 0 0 12.3671 0 0 Q9NRS4 TMPS4_HUMAN "Transmembrane protease serine 4, EC 3.4.21.- (Channel-activating protease 2, CAPH2) (Membrane-type serine protease 2, MT-SP2) [Cleaved into: Transmembrane protease serine 4 catalytic chain ]" TMPRSS4 TMPRSS3 UNQ776/PRO1570 Homo sapiens (Human) negative regulation of growth rate [GO:0045967]; positive regulation of viral entry into host cell [GO:0046598]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of gene expression [GO:0010468]; response to wounding [GO:0009611] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; negative regulation of growth rate [GO:0045967]; positive regulation of viral entry into host cell [GO:0046598]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of gene expression [GO:0010468]; response to wounding [GO:0009611] GO:0004252; GO:0005044; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0009611; GO:0010468; GO:0016021; GO:0016485; GO:0030141; GO:0045967; GO:0046598 scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] AGSDKLGSFPSLAVAKIIIIEFNPMYPK 0.66667 6.9553 0 0 0 10.4009 0 0 0 0 0 0 0 0 0 0 0 0 11.6924 0 0 0 0 0 0 11.239 0 0 11.9221 11.7798 11.8699 0 0 0 11.6388 0 0 0 11.8025 0 0 0 0 0 11.6354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5323 0 0 13.7753 0 0 13.9346 11.8908 0 0 0 0 13.5566 12.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2422 0 0 0 0 12.6885 0 0 0 0 0 0 0 13.1283 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8011 11.5022 0 13.5069 13.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2394 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDF5 NETO1_HUMAN Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1) NETO1 BTCL1 Homo sapiens (Human) memory [GO:0007613]; positive regulation of excitatory postsynaptic potential [GO:2000463]; receptor localization to synapse [GO:0097120]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; visual learning [GO:0008542] anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; ionotropic glutamate receptor binding [GO:0035255]; memory [GO:0007613]; positive regulation of excitatory postsynaptic potential [GO:2000463]; receptor localization to synapse [GO:0097120]; regulation of kainate selective glutamate receptor activity [GO:2000312]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; visual learning [GO:0008542] GO:0005576; GO:0007613; GO:0008542; GO:0014069; GO:0035255; GO:0048169; GO:0060076; GO:0070161; GO:0097120; GO:0098839; GO:0098978; GO:0099061; GO:2000312; GO:2000463 ionotropic glutamate receptor binding [GO:0035255] ATASEAVDCK 0.67045 6.3465 0 0 0 0 0 0 0 0 0 0 14.0381 0 0 0 0 0 12.5158 0 0 0 0 0 0 0 0 0 0 0 12.5337 0 0 0 0 0 0 0 14.0674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.279 14.6155 0 11.4478 0 11.3477 0 0 0 0 0 0 0 12.5612 0 0 12.3896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4163 13.0261 0 13.0216 13.384 0 13.1869 11.263 11.7498 0 0 13.5487 0 0 0 0 0 13.3026 0 0 0 13.0602 13.4217 13.7865 0 17.1474 0 12.6415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1071 0 0 0 13.8863 14.9343 0 0 0 0 0 0 0 0 0 0 0 0 0 P02774 VTDB_HUMAN "Vitamin D-binding protein, DBP, VDB (Gc protein-derived macrophage activating factor, Gc-MAF, GcMAF) (Gc-globulin) (Group-specific component, Gc) (Vitamin D-binding protein-macrophage activating factor, DBP-maf)" GC Homo sapiens (Human) vitamin D metabolic process [GO:0042359]; vitamin transport [GO:0051180] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; actin binding [GO:0003779]; calcidiol binding [GO:1902118]; vitamin D binding [GO:0005499]; vitamin transmembrane transporter activity [GO:0090482]; vitamin D metabolic process [GO:0042359]; vitamin transport [GO:0051180] GO:0003779; GO:0005499; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0042359; GO:0043202; GO:0051180; GO:0070062; GO:0072562; GO:0090482; GO:1902118 actin binding [GO:0003779]; calcidiol binding [GO:1902118]; vitamin D binding [GO:0005499]; vitamin transmembrane transporter activity [GO:0090482] CCESASEDCMAK 0.67059 6.4059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1458 0 0 0 0 0 0 0 0 0 11.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1987 0 0 14.6065 10.3209 0 0 0 0 14.1748 0 0 15.5694 0 13.3644 0 14.1831 0 10.9513 0 0 0 0 0 13.8012 0 13.7414 0 0 0 0 0 0 0 12.6372 0 0 0 0 0 0 0 14.2317 0 0 0 0 0 0 0 0 0 9.64874 0 13.0742 11.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.527 0 0 0 0 0 0 Q6AZY7 SCAR3_HUMAN Scavenger receptor class A member 3 (Cellular stress response gene protein) SCARA3 CSR Homo sapiens (Human) response to oxidative stress [GO:0006979]; UV protection [GO:0009650] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; response to oxidative stress [GO:0006979]; UV protection [GO:0009650] GO:0000139; GO:0005044; GO:0005581; GO:0005615; GO:0005783; GO:0005789; GO:0006979; GO:0009650; GO:0016021; GO:0062023 scavenger receptor activity [GO:0005044] AVDTQHGEILRNVTILRGAPGPPGPR 0.67089 6.6135 0 0 0 0 11.3417 0 0 0 0 0 0 13.9495 0 0 0 13.6901 0 0 0 0 0 0 12.9857 0 10.1508 0 0 0 14.9661 0 0 0 0 0 0 0 13.2143 0 0 0 11.6291 0 12.5428 0 0 0 0 13.2475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9039 13.3868 13.6214 0 11.3549 0 0 0 11.4688 10.6403 0 12.4992 0 15.148 13.5636 0 0 13.9974 0 13.2623 16.1029 13.2899 0 13.8531 0 0 0 0 0 0 0 13.6628 0 0 11.3049 14.0239 0 14.0498 0 0 13.5977 0 0 0 0 0 0 0 0 0 0 14.4547 0 0 0 14.6241 0 0 0 14.5099 13.2527 0 13.9992 11.5594 12.9061 0 0 13.2204 0 0 12.731 12.9108 0 0 0 0 0 0 13.7803 12.9222 0 0 14.5581 0 14.7064 0 0 0 0 0 0 0 10.5235 14.3426 0 0 0 0 0 0 0 14.0116 13.8351 13.1418 0 16.9696 0 0 0 0 0 0 0 0 Q5T4B2 GT253_HUMAN Inactive glycosyltransferase 25 family member 3 (Cerebral endothelial cell adhesion molecule) CERCAM CEECAM1 GLT25D3 KIAA1502 Homo sapiens (Human) cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159] endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886] endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159] GO:0005788; GO:0005886; GO:0007155; GO:0007159; GO:0042802 identical protein binding [GO:0042802] AAPLLQLLLLLGPWLEAAGVAESPLPAVVLAILAR 0.67105 6.6928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9979 13.2422 0 0 0 12.1893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0379 0 0 11.9255 0 0 0 0 0 0 0 0 0 0 13.4394 0 0 0 0 0 0 0 0 0 0 12.2909 0 0 0 0 14.3906 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0653 0 14.1084 13.3021 0 0 12.2906 0 0 0 0 0 0 0 0 0 0 13.1178 0 0 0 0 0 0 0 0 13.5396 13.0555 12.2687 0 0 0 13.074 0 0 0 0 0 0 0 13.3606 0 13.34 0 0 0 0 0 0 0 0 0 0 14.0345 0 0 P15088 CBPA3_HUMAN "Mast cell carboxypeptidase A, MC-CPA, EC 3.4.17.1 (Carboxypeptidase A3)" CPA3 Homo sapiens (Human) angiotensin maturation [GO:0002003]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; proteolysis [GO:0006508] GO:0002003; GO:0004181; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0030133; GO:0030141; GO:0062023 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] ETMLAVKFIAKYILK 0.67123 6.7593 0 0 0 0 11.5085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4428 0 13.5134 0 0 12.6882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1748 13.0318 0 0 0 0 0 0 14.5308 0 11.4689 12.5599 0 12.1152 13.8323 13.9017 13.4949 14.975 13.5207 0 0 11.6587 13.2098 13.1129 14.7018 0 0 0 0 0 0 14.6638 13.3311 0 14.0204 0 14.3807 0 0 0 0 0 12.8267 0 12.031 11.5086 0 15.5133 12.3286 0 0 13.4171 15.218 0 14.1945 14.0428 0 0 15.5858 0 0 10.1653 0 0 0 0 0 0 0 12.8018 0 0 0 0 0 0 12.793 0 0 0 0 0 0 0 0 10.6076 0 0 0 0 0 0 0 0 0 0 0 A0A286YFB4 SCGR2_HUMAN Small cysteine and glycine repeat-containing protein 2 (Keratin-associated protein 28-2) SCYGR2 KRTAP28-2 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CCCQKQCCC 0.67164 6.9948 0 0 0 0 0 0 0 0 0 11.7384 0 0 0 0 11.6437 0 0 0 0 0 9.38819 0 12.042 0 0 0 0 0 0 0 0 0 0 12.5602 11.4342 11.6134 0 0 10.7807 0 0 0 11.2072 0 0 0 0 10.2642 0 0 9.78573 13.5498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1523 13.9866 15.0608 0 0 12.6266 0 0 11.1182 0 14.321 12.568 0 11.7248 0 0 15.2387 12.2101 12.5613 0 0 0 11.3931 11.3744 0 0 0 14.0397 0 0 0 11.7895 0 0 0 0 0 0 0 0 0 11.3535 0 11.0846 0 0 0 0 0 0 0 0 0 12.9063 0 11.6044 0 0 12.0271 0 0 11.3911 11.1279 0 12.6377 0 0 0 0 0 0 11.309 0 0 0 0 0 0 0 0 10.8691 0 0 0 0 0 0 0 0 0 0 0 11.8858 0 11.9046 0 0 0 13.0822 12.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYQ6 KR411_HUMAN Keratin-associated protein 4-11 (Keratin-associated protein 4-14) (Keratin-associated protein 4.11) (Keratin-associated protein 4.14) (Ultrahigh sulfur keratin-associated protein 4.14) KRTAP4-11 KAP4.14 KRTAP4-14 KRTAP4.11 KRTAP4.14 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 CCISSCCRPSCCVSSCCK 0.67188 7.0665 0 0 0 0 0 12.7678 0 0 0 0 12.0287 0 13.8167 12.5461 0 0 0 13.0734 0 0 0 14.586 0 0 0 10.6411 11.5205 0 12.0169 0 0 0 0 0 9.64956 0 0 0 0 0 0 0 10.9945 0 0 0 0 0 0 0 0 12.2407 0 11.0802 0 0 0 0 0 0 0 0 0 0 9.04475 0 14.6642 14.4927 15.1056 0 11.97 13.7439 13.0013 11.5517 0 0 12.073 13.8033 14.6073 0 12.6354 0 13.5753 0 0 10.0056 10.8148 0 13.7819 13.3615 10.6869 0 13.5969 13.7626 12.4392 11.542 12.1733 12.5738 0 0 12.1426 12.7567 11.7033 14.9769 0 0 14.1942 0 12.5726 0 13.0965 0 13.8993 10.4483 13.1132 0 14.4335 0 0 14.6639 13.4616 13.1334 14.287 14.2094 0 0 12.7498 0 13.2966 11.2321 10.7609 12.5249 12.4826 0 0 10.5228 0 13.6862 13.0806 0 0 0 12.7941 12.3181 13.0381 14.3167 12.4398 0 0 12.8397 10.5131 12.4186 0 0 14.2445 13.6007 0 0 0 0 13.3498 0 15.2615 13.8783 12.6286 0 12.0742 12.8083 0 13.1986 11.9343 15.0603 0 0 10.5018 0 0 10.1241 12.8354 0 Q5T4D3 TMTC4_HUMAN "Protein O-mannosyl-transferase TMTC4, EC 2.4.1.109 (Transmembrane and TPR repeat-containing protein 4)" TMTC4 Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605] GO:0000030; GO:0004169; GO:0005783; GO:0007605; GO:0016021; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584 ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] FEAAEQSYRTAIKHR 0.67416 6.3372 11.5173 0 0 0 0 0 0 0 10.8228 0 0 0 0 0 0 0 0 13.8912 0 13.4779 0 0 15.2593 14.4918 14.7181 13.7527 13.1555 0 10.5097 0 11.9009 0 11.8109 0 12.4524 10.5559 0 0 0 0 0 11.0049 0 0 10.7426 11.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7286 12.6587 0 0 0 0 0 0 12.7691 0 0 14.9434 11.3191 17.4589 0 15.5812 17.9505 0 0 15.8182 0 12.551 0 13.5028 15.8677 0 15.14 0 0 15.4599 0 0 14.1422 0 0 15.6147 14.7741 0 11.8456 0 0 12.808 0 0 15.4466 12.9364 0 0 0 13.6519 13.2791 0 11.282 0 0 0 12.5778 0 0 12.4277 0 0 0 10.7709 13.4361 0 13.5852 15.1574 13.1771 12.8679 12.9378 0 0 0 15.5734 0 14.0918 12.508 0 13.9479 0 0 11.1595 14.8338 12.9606 0 14.0439 11.9978 12.5832 0 0 0 0 0 0 0 0 0 12.2971 0 0 0 0 11.6914 0 0 0 12.7834 12.4305 0 0 0 Q6DN90 IQEC1_HUMAN "IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein, BRAG2)" IQSEC1 ARFGEP100 BRAG2 KIAA0763 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012] anchoring junction [GO:0070161]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012] GO:0005085; GO:0005730; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0043547; GO:0051549; GO:0060996; GO:0070161; GO:0120183 guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] EIFLFNDLLVVTKIFQK 0.67778 6.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7596 0 14.2076 0 0 0 0 0 0 14.6643 0 15.0027 0 0 14.6175 0 0 0 0 0 0 12.5349 0 13.1874 0 12.9487 0 0 11.5986 0 0 0 0 0 0 0 10.1727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6252 0 0 0 0 0 0 0 0 0 0 0 0 11.8932 0 0 0 0 0 12.6779 0 0 0 0 0 0 12.2451 12.6393 0 0 0 0 0 0 13.202 0 0 0 0 0 0 0 0 0 12.3369 0 0 0 0 0 0 0 0 0 0 11.6122 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0405 0 0 0 0 0 13.2656 11.7494 13.2708 0 13.9537 0 0 0 0 12.2169 0 0 0 0 0 0 0 0 Q9NYM4 GPR83_HUMAN G-protein coupled receptor 83 (G-protein coupled receptor 72) GPR83 GPR72 JP05 KIAA1540 Homo sapiens (Human) feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; response to glucocorticoid [GO:0051384] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; response to glucocorticoid [GO:0051384] GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0007200; GO:0007218; GO:0007631; GO:0008188; GO:0051384; GO:0097730 G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983] ALLIVAYSFIIVFSLFGNVLVCHVIFK 0.67949 6.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.051 0 0 0 0 0 0 0 12.4006 0 0 0 0 0 14.0899 0 0 0 0 0 13.3845 0 0 0 0 12.3644 0 0 0 0 13.1949 0 0 0 0 0 0 0 0 0 0 0 11.3245 0 0 0 0 0 0 0 0 0 14.8384 13.7586 0 12.4289 0 0 0 0 0 0 13.9716 12.5595 0 0 0 0 0 0 0 0 13.7372 11.494 0 11.5318 0 0 0 12.3754 0 0 0 0 0 0 0 12.3028 0 0 0 0 0 11.8709 0 0 0 12.2628 0 0 0 0 15.2818 14.119 0 0 12.8665 13.2479 11.8376 0 0 0 0 0 0 0 13.3912 0 0 11.9102 13.544 12.5099 14.5631 0 0 0 0 0 0 0 0 0 0 0 0 14.6794 14.1766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.823 0 0 0 13.782 0 Q9H4B8 DPEP3_HUMAN Dipeptidase 3 DPEP3 UNQ834/PRO1772 Homo sapiens (Human) proteolysis [GO:0006508] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; proteolysis [GO:0006508] GO:0001669; GO:0005886; GO:0006508; GO:0016805; GO:0031225; GO:0046872; GO:0070573 dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573] GNLLRVFRQVEK 0.68 6.6942 15.2336 0 0 0 0 0 15.4455 0 0 13.5588 14.9102 14.1325 11.9971 0 14.6144 15.0391 13.6148 0 13.9817 15.6169 0 13.624 14.7549 15.2768 0 15.6002 13.8101 0 0 12.4355 10.371 0 0 0 0 0 13.4448 0 0 0 0 14.9724 0 0 0 0 0 13.1699 14.4145 0 0 0 11.0669 0 0 0 12.5806 0 0 0 0 0 0 0 0 0 0 0 13.419 12.1542 0 0 0 12.4842 0 0 13.7599 15.0878 12.7509 14.279 13.8 16.0734 0 0 14.1624 0 14.5793 15.9837 16.5091 16.6677 11.2161 15.9729 0 15.6992 0 16.4202 15.8438 12.5446 0 15.1616 14.5145 16.563 13.9913 15.0888 16.4013 16.5987 15.2886 15.1467 16.3473 13.1561 14.8643 15.4511 15.9635 15.825 16.6542 16.4281 15.5304 11.7998 14.8493 0 14.8311 16.012 15.309 15.7691 15.375 14.6662 15.3957 0 16.1027 15.4798 0 14.75 14.7271 15.8679 0 13.8541 13.4243 0 14.7417 0 15.3367 16.4529 14.2137 0 14.4951 15.628 15.1669 0 12.3304 14.4033 0 14.8905 0 14.1597 15.2526 15.497 0 0 0 0 0 11.8416 0 12.3619 12.2606 0 0 0 0 13.7151 13.5565 14.655 14.6547 0 11.9921 0 15.6992 10.7248 14.9285 12.6178 Q701N2 KRA55_HUMAN Keratin-associated protein 5-5 (Keratin-associated protein 5-11) (Keratin-associated protein 5.11) (Keratin-associated protein 5.5) (Ultrahigh sulfur keratin-associated protein 5.5) KRTAP5-5 KAP5-11 KAP5.5 KRTAP5-11 KRTAP5.11 KRTAP5.5 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GCCGCSGGCGSGCGGR 0.68056 6.8025 0 0 0 11.0135 0 0 0 0 0 0 0 0 14.3439 0 11.5108 15.2102 0 0 11.0897 14.0845 14.3663 0 15.5916 0 15.1825 14.4959 0 0 0 0 12.9451 15.277 0 0 14.3615 0 0 14.8139 0 15.3411 0 15.7351 0 0 0 0 0 0 0 14.284 0 0 11.9995 0 0 13.1128 0 0 11.1859 0 0 0 0 0 10.9572 0 0 0 16.406 11.0885 0 0 0 0 0 12.8363 0 11.8692 0 11.7287 13.2431 0 0 11.4435 13.8978 0 0 0 0 11.7773 0 11.005 0 12.3835 12.5045 12.1847 0 0 12.7398 0 0 13.9003 13.6566 0 14.3628 13.4667 0 10.7442 0 0 9.9969 13.4175 13.0918 0 11.8598 0 0 12.9401 0 0 12.6909 13.6591 10.5185 0 13.5537 0 0 0 13.3699 0 0 0 13.6358 0 0 0 15.2517 11.5778 14.47 13.3753 12.623 0 0 0 0 0 12.7371 0 12.038 14.0781 0 0 0 0 9.90474 13.4035 0 0 0 15.373 0 0 14.0612 0 11.9487 0 0 0 12.308 12.2338 14.2536 0 0 0 0 0 0 0 0 10.9249 O60812 HNRC1_HUMAN "Heterogeneous nuclear ribonucleoprotein C-like 1, hnRNP C-like-1 (hnRNP core protein C-like 1)" HNRNPCL1 HNRPCL1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0042802 identical protein binding [GO:0042802]; RNA binding [GO:0003723] DDEKEAEEGEDDR 0.68182 6.9954 0 0 0 0 0 0 0 0 0 0 12.1189 0 0 0 0 0 0 12.485 0 0 13.2864 0 0 0 12.1774 12.4061 0 0 0 12.3327 0 0 0 0 0 0 0 0 11.7659 10.6888 0 0 12.429 0 0 12.9735 0 12.8221 0 0 0 0 0 0 0 11.6967 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4642 0 0 0 0 0 0 14.1238 0 12.9643 13.5993 0 0 0 0 0 0 0 0 12.7757 0 0 0 0 0 0 0 0 12.9581 12.1787 0 0 0 0 0 13.1813 0 0 0 13.0976 0 0 10.0031 0 0 13.7942 0 0 0 0 0 13.2672 0 13.5603 0 0 0 0 0 0 0 0 0 13.4686 0 12.6244 0 0 0 14.1686 13.9742 0 0 0 0 14.253 14.4654 0 0 0 0 0 0 0 10.6107 0 12.8635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1268 0 12.5944 12.7706 0 0 0 11.3772 P19876 CXCL3_HUMAN "C-X-C motif chemokine 3 (GRO-gamma(1-73)) (Growth-regulated protein gamma, GRO-gamma) (Macrophage inflammatory protein 2-beta, MIP2-beta) [Cleaved into: GRO-gamma(5-73) ]" CXCL3 GRO3 GROG SCYB3 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593] GO:0005576; GO:0005615; GO:0006954; GO:0008009; GO:0030593; GO:0031640; GO:0045236; GO:0061844; GO:0070098; GO:0071222 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236] AAGASVVTELRCQCLQTLQGIHLKNIQSVNVR 0.68254 7.0945 0 0 0 0 0 0 0 13.9696 12.0673 0 11.5376 0 0 0 13.8271 0 0 0 9.95492 11.2404 0 0 0 0 0 0 0 0 0 13.3888 0 0 0 13.4225 0 0 0 14.2438 14.7727 0 0 0 0 14.9548 0 12.1667 0 0 0 10.7539 11.3809 0 0 0 10.2051 0 0 0 0 12.5831 0 0 0 0 0 0 16.0494 10.7218 14.5828 11.9779 0 0 10.2489 0 15.7748 13.0659 15.103 13.1898 0 18.3545 0 11.4885 0 12.4142 0 13.015 0 0 0 0 12.4284 11.1224 13.8393 13.0493 0 12.4756 12.3051 0 0 12.522 0 12.0871 13.0759 0 0 0 0 12.6046 13.5148 10.7987 0 0 12.8479 0 0 0 0 0 0 12.7916 18.3757 17.3581 13.6106 11.8011 14.862 16.5592 0 12.7022 12.3679 17.4336 14.6645 12.5844 18.2449 0 13.3818 0 0 12.774 0 0 0 0 0 0 0 12.6153 11.5776 0 0 0 17.6424 12.2744 0 0 0 12.821 0 12.449 0 0 0 0 0 0 0 0 0 0 0 12.351 12.6426 0 12.7696 13.3707 0 0 0 0 10.9794 0 P53618 COPB_HUMAN "Coatomer subunit beta (Beta-coat protein, Beta-COP)" COPB1 COPB MSTP026 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886] GO:0000139; GO:0005198; GO:0005789; GO:0005793; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030667; GO:0043231; GO:0070821; GO:0101003 structural molecule activity [GO:0005198] DLQHPNEFIR 0.68333 7.1433 0 0 0 0 0 0 0 12.794 0 12.0515 9.79216 0 0 0 13.4299 0 0 13.3353 0 0 13.4261 12.0309 13.9538 12.8618 0 0 0 10.1802 0 0 9.23709 0 10.6049 0 0 0 0 0 11.0062 0 0 0 11.9082 0 10.9053 13.8563 12.9771 14.1238 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8583 0 0 0 0 12.6462 0 13.1958 13.1493 0 0 0 0 0 13.2309 0 0 13.5703 0 14.5095 0 12.9421 0 15.4344 0 0 0 0 0 0 15.0882 0 0 0 13.9323 0 15.1544 0 14.3803 14.6966 14.1592 0 13.2574 0 10.9975 0 13.4295 12.801 0 13.3567 0 0 0 0 0 0 15.6792 0 0 0 0 12.8151 0 0 0 14.6376 0 0 0 14.5752 0 15.0952 0 0 15.9143 0 10.1276 15.8412 13.1161 0 12.5189 12.6327 0 13.2703 15.128 0 0 0 0 0 13.9879 0 0 10.5286 0 0 13.9608 0 0 0 0 0 11.776 12.4161 11.8916 0 0 0 0 0 14.0774 0 0 0 11.9186 0 11.8053 0 0 Q7Z695 ADCK2_HUMAN "Uncharacterized aarF domain-containing protein kinase 2, EC 2.7.11.-" ADCK2 AARF Homo sapiens (Human) phosphorylation [GO:0016310] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; phosphorylation [GO:0016310] GO:0004674; GO:0005524; GO:0016021; GO:0016310 ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] AGPLGGVFLHLRLWLR 0.68478 6.2623 9.70067 0 0 0 0 0 0 0 0 0 0 0 0 11.715 0 0 0 0 0 0 0 0 0 10.9513 0 11.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0741 0 0 0 0 13.1609 0 0 0 0 0 10.8028 0 0 0 10.5145 0 0 0 0 0 0 0 0 0 13.9529 0 0 13.9396 0 0 0 0 12.3071 12.8683 0 0 0 0 13.0437 0 0 0 0 0 0 0 12.7935 14.0646 0 0 12.5907 12.8483 10.3489 13.8148 12.4073 11.5629 11.0264 0 0 12.1988 12.0434 0 13.9245 0 0 12.21 0 13.4507 14.3221 14.8427 14.0398 13.6876 12.9731 0 12.3486 0 0 13.4302 0 0 13.002 11.0177 12.3891 12.8497 0 0 0 0 0 15.1984 14.161 0 11.6966 0 0 0 0 0 0 10.8399 10.8924 0 0 0 0 0 11.5189 14.478 0 0 0 0 0 0 0 12.418 0 0 0 0 0 0 0 0 12.746 11.2751 0 0 0 0 0 0 0 Q8IV16 HDBP1_HUMAN "Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1, GPI-HBP1, GPI-anchored HDL-binding protein 1 (High density lipoprotein-binding protein 1)" GPIHBP1 HBP1 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; intracellular protein transport [GO:0006886]; positive regulation of chylomicron remnant clearance [GO:0090321]; positive regulation of lipoprotein lipase activity [GO:0051006]; protein import [GO:0017038]; protein localization to cell surface [GO:0034394]; protein stabilization [GO:0050821]; response to heparin [GO:0071503]; transcytosis [GO:0045056]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328] anchored component of external side of plasma membrane [GO:0031362]; anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; catalytic complex [GO:1902494]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of external side of plasma membrane [GO:0031362]; anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; catalytic complex [GO:1902494]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; chylomicron binding [GO:0035478]; lipase binding [GO:0035473]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; lipoprotein particle binding [GO:0071813]; protein transporter activity [GO:0140318]; cholesterol homeostasis [GO:0042632]; intracellular protein transport [GO:0006886]; positive regulation of chylomicron remnant clearance [GO:0090321]; positive regulation of lipoprotein lipase activity [GO:0051006]; protein import [GO:0017038]; protein localization to cell surface [GO:0034394]; protein stabilization [GO:0050821]; response to heparin [GO:0071503]; transcytosis [GO:0045056]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328] GO:0005576; GO:0005886; GO:0006886; GO:0008289; GO:0009897; GO:0016323; GO:0016324; GO:0017038; GO:0019433; GO:0031225; GO:0031362; GO:0034394; GO:0035473; GO:0035478; GO:0042632; GO:0045056; GO:0050821; GO:0051006; GO:0060230; GO:0070328; GO:0071503; GO:0071813; GO:0090321; GO:0140318; GO:1902494 chylomicron binding [GO:0035478]; lipase binding [GO:0035473]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; lipoprotein particle binding [GO:0071813]; protein transporter activity [GO:0140318] ALGAVLLALLLFGR 0.69014 6.8839 0 0 0 12.0417 0 0 0 10.4624 0 0 0 0 0 12.4531 13.0303 10.881 10.257 0 0 10.5926 0 10.5201 0 0 0 0 0 0 0 0 11.4406 0 0 0 0 12.5967 0 0 0 0 0 13.6279 13.3529 0 10.5646 0 0 11.1286 0 12.8968 0 0 0 0 0 0 0 0 0 10.4133 0 0 11.428 0 0 0 12.6408 0 14.8886 0 12.0316 14.8278 0 0 12.5434 0 10.9873 0 0 0 0 0 0 0 14.2567 0 14.3086 14.2982 14.176 12.8317 0 0 0 0 13.8736 0 0 0 0 0 12.5004 14.7476 0 0 0 0 0 0 0 0 11.4061 0 14.8199 12.86 14.615 0 0 0 0 14.0552 0 14.1215 0 0 0 10.7031 0 0 0 11.24 13.0255 12.6189 0 0 0 0 0 0 15.2568 0 0 0 12.5635 0 0 13.0265 0 15.8233 0 0 0 15.5953 13.1881 11.77 12.5782 13.5895 9.92177 0 0 0 0 11.7489 0 15.7945 14.9276 19.8841 19.9026 0 15.0272 12.827 0 0 12.1517 12.3281 0 0 0 14.8016 12.2728 0 Q01974 ROR2_HUMAN "Tyrosine-protein kinase transmembrane receptor ROR2, EC 2.7.10.1 (Neurotrophic tyrosine kinase, receptor-related 2)" ROR2 NTRKR2 Homo sapiens (Human) "astrocyte development [GO:0014002]; bone mineralization [GO:0030282]; macrophage migration [GO:1905517]; male genitalia development [GO:0030539]; positive regulation of cell migration [GO:0030335]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; bone mineralization [GO:0030282]; macrophage migration [GO:1905517]; male genitalia development [GO:0030539]; positive regulation of cell migration [GO:0030335]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0004714; GO:0005524; GO:0005874; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0030282; GO:0030335; GO:0030425; GO:0030539; GO:0030669; GO:0031435; GO:0033674; GO:0043025; GO:0043235; GO:0043507; GO:0045651; GO:0046872; GO:0051968; GO:1900020; GO:1904929; GO:1905517 "ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]" CEALPMPESPDAANCMR 0.69231 6.3078 0 11.0276 0 0 0 0 0 0 0 0 0 0 12.3996 0 0 16.6712 0 12.1578 0 0 0 0 9.39941 10.1687 0 0 0 0 0 0 12.2807 13.1292 12.5071 0 14.238 0 0 13.3497 0 0 11.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2328 0 0 0 13.9868 0 0 0 0 0 0 0 0 0 0 0 10.3755 0 11.1215 0 0 0 12.4436 13.2387 13.4533 0 0 0 0 13.378 13.9849 13.9612 0 0 12.2418 0 0 0 0 13.5343 13.7859 0 0 0 0 12.0062 0 0 0 13.819 14.1935 13.3852 0 0 14.3192 0 0 0 10.9492 0 0 0 11.6388 0 0 0 14.0284 0 0 0 0 0 0 0 0 14.5498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2714 13.7286 0 0 0 0 0 0 0 0 0 0 0 0 0 14.265 13.3692 0 14.5803 0 0 0 14.1584 13.4696 0 0 0 0 12.9352 0 0 0 0 0 Q8WWI5 CTL1_HUMAN Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92) SLC44A1 CD92 CDW92 CTL1 Homo sapiens (Human) choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline catabolic process [GO:0042426]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0042426; GO:0055085; GO:0070062; GO:0150104 choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857] ALLIYAISATVFTVILFLIMLVMRKR 0.69355 7.1135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1355 0 0 0 12.1935 0 0 0 0 0 0 14.8022 13.8923 0 14.8731 0 0 0 0 14.8737 0 0 0 0 0 0 14.5533 13.8594 12.7374 13.6698 0 0 0 0 0 0 12.2746 13.5298 0 0 0 0 11.4249 0 0 0 0 0 0 11.7865 0 0 0 0 0 0 13.013 0 0 0 0 0 0 0 0 0 12.4001 0 0 0 0 0 0 0 0 0 0 13.4098 0 14.4571 0 0 0 0 11.5625 0 0 0 0 0 0 0 0 0 0 0 11.3249 13.1312 0 0 0 0 0 0 Q6P3W7 SCYL2_HUMAN SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa) SCYL2 CVAK104 KIAA1360 Homo sapiens (Human) brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; protein phosphorylation [GO:0006468]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286] clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794] clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; brain development [GO:0007420]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of receptor internalization [GO:0002092]; protein phosphorylation [GO:0006468]; pyramidal neuron development [GO:0021860]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286] GO:0002092; GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0006468; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0090090; GO:2000286; GO:2000370 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102] ASLTLEEKQKLAK 0.69492 7.153 0 0 0 0 0 0 0 0 0 12.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8656 0 0 0 0 0 0 12.0418 0 0 0 12.0355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6926 0 0 13.6068 0 0 0 0 13.4662 14.1518 0 12.643 0 14.8188 0 0 13.8209 0 0 0 0 0 0 0 0 0 13.8006 0 0 14.8086 0 0 0 0 0 0 0 0 0 0 0 10.48 0 14.4604 0 13.8986 10.7943 0 0 0 12.5834 10.6444 0 0 0 0 0 15.592 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4625 12.9633 0 0 0 13.6751 13.6175 0 0 12.5522 0 0 0 0 12.7919 0 0 12.6038 0 0 0 0 0 0 14.0087 0 0 0 0 0 0 Q969X6 UTP4_HUMAN U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component) UTP4 CIRH1A cPERP-E KIAA1988 Homo sapiens (Human) "maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]" 90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] "90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455 RNA binding [GO:0003723] DTPITHISFHPKRPMHILLHDAYMFCIIDK 0.69892 6.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2701 0 11.9195 0 0 0 10.855 0 0 11.8681 0 0 0 0 0 0 0 11.5698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3602 11.047 14.3117 0 0 14.9245 0 0 15.3886 0 12.3933 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 14.4964 12.4229 0 0 0 0 0 11.9751 0 0 0 0 0 0 0 0 0 0 11.7523 14.2867 14.0792 0 0 0 0 0 0 0 0 0 0 11.2322 0 0 0 0 0 0 0 0 0 0 0 13.1104 0 0 10.4629 0 0 11.4096 13.1641 0 0 0 0 0 10.8194 0 0 0 0 0 0 0 11.4074 0 0 0 0 11.1699 13.2928 0 0 0 0 0 Q8NC42 RN149_HUMAN "E3 ubiquitin-protein ligase RNF149, EC 2.3.2.27 (DNA polymerase-transactivated protein 2) (RING finger protein 149) (RING-type E3 ubiquitin transferase RNF149)" RNF149 DNAPTP2 Homo sapiens (Human) cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of MAPK cascade [GO:0043409]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of MAPK cascade [GO:0043409]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005737; GO:0006511; GO:0016020; GO:0016021; GO:0031647; GO:0043409; GO:0046872; GO:0061630; GO:0071466 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] EASVGARGVLALALLALALCVPGARGR 0.7 6.9029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8016 0 0 0 0 0 0 0 10.0588 0 0 0 0 0 0 12.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2648 0 12.5394 12.0609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0743 0 0 0 0 0 0 11.3411 0 0 12.2939 0 0 0 0 12.7367 0 0 0 0 0 0 0 0 0 14.2189 0 0 0 0 0 11.6282 0 0 0 0 0 12.6284 0 13.1757 13.2514 0 0 0 0 0 0 0 0 12.1744 0 0 0 13.9596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3754 0 0 0 0 0 0 0 0 0 O43451 MGA_HUMAN "Maltase-glucoamylase (Alpha-1,4-glucosidase, EC 3.2.1.20)" MGAM MGA MGAML Homo sapiens (Human) dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] "apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983]" GO:0000025; GO:0003824; GO:0004339; GO:0004553; GO:0004558; GO:0005886; GO:0005983; GO:0016021; GO:0016324; GO:0030246; GO:0032450; GO:0070062; GO:0070821; GO:0101003; GO:1901027 "alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]" DASLNHPPYMPYLESRDRGLSSK 0.7069 7.1707 0 10.6781 0 0 0 0 0 0 0 11.4781 16.0538 0 0 14.5032 0 15.2515 0 0 0 0 14.2201 0 11.2905 10.608 11.0231 0 0 10.8868 15.6468 13.7658 0 0 0 0 0 0 0 0 0 0 0 0 12.5619 14.5562 14.7244 0 11.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.615 0 0 0 0 0 15.9326 0 0 0 0 0 0 0 13.9436 0 0 0 0 0 13.0506 0 0 0 0 13.3298 0 0 0 0 12.0327 11.1168 0 0 0 0 12.1215 0 0 0 12.6608 0 0 11.3846 0 0 11.6683 0 0 0 0 0 0 11.1158 0 12.7513 13.1331 13.0435 0 12.6334 11.7479 0 12.5916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5925 0 0 0 0 0 0 0 0 0 0 0 13.1965 0 0 0 0 0 12.741 0 0 13.7147 0 0 0 11.7521 0 10.037 0 0 0 11.7107 0 0 12.2545 0 12.6247 11.673 Q8N690 DB119_HUMAN "Beta-defensin 119 (Beta-defensin 120) (Beta-defensin 19, DEFB-19) (Beta-defensin 20, DEFB-20) (Defensin, beta 119) (Defensin, beta 120) (ESC42-RELA)" DEFB119 DEFB120 DEFB19 DEFB20 UNQ2449/PRO5729 Homo sapiens (Human) antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; lipopolysaccharide binding [GO:0001530]; antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] GO:0001530; GO:0005576; GO:0045087; GO:0050829; GO:0050830; GO:0061760 lipopolysaccharide binding [GO:0001530] EENTDWSYEKQWPRLP 0.71875 6.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8719 0 0 0 0 0 0 0 0 0 0 0 11.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1641 0 0 14.8918 14.4018 15.5525 0 14.4922 14.2819 0 0 14.0337 13.2685 0 0 13.9823 0 0 13.7146 0 0 0 13.4764 0 12.3813 0 0 0 0 0 13.8114 0 0 13.6077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0447 0 0 0 0 0 0 0 14.1439 0 0 0 0 0 0 13.3817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.538 0 0 0 0 0 0 0 0 Q9P0L2 MARK1_HUMAN "Serine/threonine-protein kinase MARK1, EC 2.7.11.1, EC 2.7.11.26 (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c, Par-1c, Par1c)" MARK1 KIAA1477 MARK Homo sapiens (Human) cytoskeleton organization [GO:0007010]; establishment of mitochondrion localization [GO:0051654]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of neuron projection development [GO:0010975]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; cytoskeleton organization [GO:0007010]; establishment of mitochondrion localization [GO:0051654]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of neuron projection development [GO:0010975]; Wnt signaling pathway [GO:0016055]" GO:0000226; GO:0000287; GO:0001764; GO:0001786; GO:0004674; GO:0005524; GO:0005546; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0015630; GO:0016055; GO:0018105; GO:0030425; GO:0035556; GO:0048156; GO:0050321; GO:0050773; GO:0051654; GO:0070300; GO:0106310 "ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]" EARAKFR 0.7193 7.2223 0 0 0 0 0 0 0 0 0 0 0 14.0182 0 13.9449 0 0 0 0 0 0 0 0 0 0 0 0 11.6986 11.1376 0 0 0 0 0 0 0 10.9741 0 0 13.7859 11.1279 11.2307 0 0 0 11.4275 0 0 11.5425 0 0 0 11.3806 12.0482 0 0 0 0 0 0 0 0 10.2125 0 0 0 0 0 11.0359 12.0789 0 0 0 11.6502 13.2316 12.3075 0 13.6136 12.723 0 15.0565 0 14.0778 14.4708 14.5568 0 12.7177 14.9026 0 0 0 12.1842 14.3624 0 0 0 13.9392 14.1574 14.4225 0 13.4857 0 0 12.0495 0 0 0 12.574 0 13.2315 13.8886 13.5537 13.8617 12.9974 13.4866 0 14.0177 0 0 0 14.5429 0 12.7396 0 0 0 0 0 13.0963 0 11.6102 11.363 0 11.2931 14.0318 13.9206 0 12.5852 0 0 11.5795 0 0 0 12.8215 0 0 0 13.2858 0 0 0 11.6607 0 0 0 0 12.8675 0 0 10.4109 13.0788 0 14.4155 11.2036 14.0273 14.6878 13.8384 0 15.3745 14.0125 12.3552 0 11.0813 0 0 0 10.552 0 0 0 Q14697 GANAB_HUMAN "Neutral alpha-glucosidase AB, EC 3.2.1.207 (Alpha-glucosidase 2) (Glucosidase II subunit alpha)" GANAB G2AN KIAA0088 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020] "endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491]" GO:0003723; GO:0004553; GO:0005788; GO:0005794; GO:0005975; GO:0006491; GO:0016020; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0043231; GO:0070062; GO:0090599 "alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; RNA binding [GO:0003723]" DENSVELTMAEGPYK 0.73196 6.1296 0 0 0 0 0 0 0 0 0 0 0 0 10.7034 0 0 12.2394 11.9073 0 0 0 0 0 0 0 9.50585 0 12.761 0 0 0 0 0 0 0 0 0 0 11.019 0 0 0 0 9.63472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4648 15.0072 14.608 0 14.5126 0 0 0 0 0 16.3465 12.8021 14.818 0 12.0677 0 12.1485 0 0 0 0 0 0 0 0 14.6968 0 0 0 0 0 10.9138 0 0 0 0 11.4999 0 0 0 0 0 0 0 0 0 0 10.31 0 0 15.2387 0 0 0 0 13.1609 0 0 0 0 0 15.1978 15.2396 0 0 0 0 0 13.1613 0 0 14.9896 0 0 0 12.7806 0 0 0 0 11.0821 0 0 0 0 0 0 0 0 0 0 11.9069 0 0 0 0 0 0 0 13.1287 0 0 0 11.7324 0 Q99081 HTF4_HUMAN "Transcription factor 12, TCF-12 (Class B basic helix-loop-helix protein 20, bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4)" TCF12 BHLHB20 HEB HTF4 Homo sapiens (Human) cell differentiation [GO:0030154]; gene expression [GO:0010467]; immune response [GO:0006955]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; cell differentiation [GO:0030154]; gene expression [GO:0010467]; immune response [GO:0006955]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006955; GO:0007399; GO:0007517; GO:0010467; GO:0010628; GO:0016607; GO:0030154; GO:0035497; GO:0043231; GO:0043425; GO:0045666; GO:0045944; GO:0046332; GO:0046982; GO:0070888; GO:0071837; GO:0090575; GO:0140297; GO:1990837 "bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]" DENLHEPPSSDDMKSDDESSQKDIK 0.73404 6.1853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0958 0 0 0 0 0 0 0 13.7183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4404 0 0 0 0 14.2968 0 11.0859 0 0 0 14.0067 0 13.9791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0987 0 0 0 13.3632 13.5761 14.6108 0 0 0 0 13.6846 13.3164 0 12.8657 0 0 0 0 0 14.346 13.1587 0 0 0 0 0 0 0 12.9499 0 0 0 10.9171 0 0 0 0 0 0 0 0 0 0 12.7224 14.0856 0 0 0 12.658 0 0 0 0 0 0 0 12.7625 0 0 0 0 0 12.6314 0 0 15.0347 0 0 0 Q6UWM7 LCTL_HUMAN Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein) LCTL KLPH UNQ3022/PRO9820 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; response to stimulus [GO:0050896]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" GO:0004553; GO:0005789; GO:0005975; GO:0007601; GO:0016021; GO:0050896 "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" FHCTQLCDEWR 0.73469 6.1262 0 13.0651 0 0 13.4106 0 0 0 12.3516 0 0 0 0 0 0 0 0 0 0 0 0 13.1885 0 0 0 10.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2109 0 0 0 0 15.0295 14.7545 0 0 0 14.293 0 15.6258 15.5336 14.5612 15.2128 14.6223 16.2326 14.3868 12.8093 14.3348 14.738 13.805 15.6837 13.9544 15.6276 13.8436 0 15.3375 15.455 13.016 13.6794 14.823 0 15.4578 13.9532 12.7079 13.6951 13.0485 0 0 0 14.3856 13.7307 15.358 13.9663 12.8305 12.0029 0 16.2548 13.1902 14.5303 13.3803 0 14.7914 0 0 13.2903 0 13.0485 0 0 14.6799 12.4209 14.0146 0 15.3663 0 12.4798 0 0 0 13.6614 0 0 0 12.8695 0 0 0 13.8841 15.0127 15.3805 13.839 12.4323 13.1914 0 0 0 12.6079 0 0 12.6383 0 0 14.1536 11.6281 0 11.5687 0 0 0 0 0 0 0 0 0 11.944 0 P78312 F193A_HUMAN Protein FAM193A (Protein IT14) FAM193A C4orf8 RES4-22 Homo sapiens (Human) CENGVYDPQQDDGDESADEDSCSEHSSSTSTSTNQK 0.73737 6.1128 0 0 0 0 0 0 0 0 12.1075 0 0 0 0 0 0 0 0 0 11.9312 0 0 10.8782 0 0 0 0 0 0 11.6285 0 0 0 0 0 0 0 0 0 13.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0978 0 0 0 0 0 0 0 0 11.4745 0 11.7673 0 0 0 0 0 0 13.7243 0 0 0 0 0 0 0 12.2911 0 0 0 0 14.1227 0 12.1505 14.4175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5007 0 0 0 0 0 0 14.1238 0 0 0 0 0 0 0 0 13.616 0 0 13.3059 0 0 12.8416 11.1575 0 12.9019 0 0 0 0 0 0 0 0 0 0 0 0 0 10.612 0 0 12.864 0 0 12.3517 0 0 0 0 0 0 0 10.932 0 0 0 0 0 0 0 12.5111 0 12.1385 P04731 MT1A_HUMAN "Metallothionein-1A, MT-1A (Metallothionein-IA, MT-IA)" MT1A MT1S Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0005829; GO:0006882; GO:0008270; GO:0010273; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCICKGASEK 0.73913 7.7613 0 0 0 12.7165 12.3454 0 0 0 0 11.7406 0 0 0 0 10.5031 0 11.1347 11.12 0 11.4448 11.554 10.1417 0 10.3176 0 0 10.8185 0 0 0 0 0 10.6573 0 0 0 0 0 0 0 0 0 12.9573 10.2389 0 0 0 0 0 0 10.9153 0 0 0 0 10.7371 0 0 0 0 0 0 0 0 0 0 14.9295 13.5682 13.5961 13.7716 13.5578 11.8483 0 14.6909 14.1621 0 13.1543 13.4842 14.3985 0 13.0106 11.5336 14.8738 14.7185 14.9827 16.2477 15.2728 13.8148 0 12.3661 14.5923 13.5719 0 14.0773 12.4883 14.0945 13.6997 0 14.5324 12.686 0 0 11.6799 0 14.5831 14.085 12.4392 13.4628 11.6957 0 12.898 0 14.3562 14.3875 13.5229 12.2409 13.2483 0 10.6059 14.0918 0 14.6265 13.6476 0 12.1874 13.153 12.8855 13.1821 13.7079 10.4889 10.2457 13.3332 13.3425 12.3093 11.7978 0 13.3002 11.1471 12.1845 0 12.1745 12.8052 0 0 13.2281 13.0848 14.1504 10.8194 10.3305 0 13.6873 0 0 0 0 11.4961 0 10.9351 0 0 11.2423 10.9979 13.4164 0 0 13.7566 13.5887 0 0 0 0 0 0 0 0 0 0 0 11.0013 0 P24043 LAMA2_HUMAN Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain) LAMA2 LAMM Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]" basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083] "basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]" GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0030334; GO:0031594; GO:0032224; GO:0035633; GO:0042383; GO:0043083; GO:0045785; GO:0045995; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046 extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] ACNCSTVGSLDFQCNVNTGQCNCHPK 0.74194 8.4157 0 0 0 0 0 0 0 11.069 0 12.475 0 0 12.8637 0 0 12.5624 0 0 13.6297 0 0 10.6355 0 0 0 0 15.3595 0 0 0 0 0 0 12.8119 12.8473 0 11.7832 12.7667 0 0 13.7136 10.1568 13.6954 0 10.0638 0 12.8823 0 0 13.3937 0 14.363 0 12.4831 0 0 0 15.0753 10.2639 0 0 0 0 0 0 0 17.1496 10.7675 16.8133 17.3572 11.7722 14.4045 13.7535 11.5933 0 11.7358 0 0 13.5057 15.0449 14.8897 0 0 13.5628 0 12.7646 13.7542 0 11.1589 11.5975 0 0 12.3402 0 0 0 15.5064 0 10.9984 12.5738 12.8164 13.5023 0 13.4936 0 12.1542 0 0 14.6761 0 14.7576 13.5046 0 0 14.4684 10.148 13.194 0 0 11.7467 15.7642 0 13.6323 12.1276 14.2666 12.5785 0 10.4685 11.9805 0 14.0422 0 14.0693 13.6598 16.4727 0 13.7674 0 11.9322 0 0 14.6625 11.1579 13.745 13.3346 11.3966 0 13.5933 0 11.0525 13.6267 0 11.4718 13.2857 0 10.3947 0 0 0 12.3476 10.0761 0 14.0955 0 12.8218 0 13.6511 13.6565 12.7905 9.29002 0 9.59811 0 14.189 11.9557 0 0 0 0 13.8952 P53671 LIMK2_HUMAN "LIM domain kinase 2, LIMK-2, EC 2.7.11.1" LIMK2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; phosphorylation [GO:0016310]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; astral microtubule organization [GO:0030953]; cornea development in camera-type eye [GO:0061303]; establishment of vesicle localization [GO:0051650]; head development [GO:0060322]; negative regulation of cilium assembly [GO:1902018]; phosphorylation [GO:0016310]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005801; GO:0005813; GO:0006468; GO:0007283; GO:0016310; GO:0030036; GO:0030953; GO:0046872; GO:0048471; GO:0051650; GO:0060322; GO:0061303; GO:0072686; GO:0106310; GO:1900182; GO:1902018 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CPGCGDHIAPSQIWYR 0.74257 6.0916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3404 0 0 0 0 0 0 12.526 0 0 0 0 0 15.3154 0 0 11.2291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6026 0 0 0 0 0 0 0 0 14.2145 0 14.052 0 18.3441 0 0 0 0 0 0 0 13.6634 0 14.7236 0 0 0 0 0 0 0 0 0 11.01 0 0 0 0 0 0 0 14.761 0 0 0 14.2622 14.1523 0 0 0 12.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8378 0 0 0 13.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6501 0 0 0 0 13.4031 0 0 0 0 0 0 0 0 14.7186 0 0 0 0 0 0 0 0 P46531 NOTC1_HUMAN "Neurogenic locus notch homolog protein 1, Notch 1, hN1 (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation, NEXT; Notch 1 intracellular domain, NICD ]" NOTCH1 TAN1 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" GO:0000122; GO:0000139; GO:0001669; GO:0001701; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005912; GO:0006355; GO:0006357; GO:0006366; GO:0006606; GO:0006955; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007411; GO:0007440; GO:0007492; GO:0007507; GO:0008284; GO:0008285; GO:0009912; GO:0009957; GO:0009986; GO:0010614; GO:0010628; GO:0010629; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016021; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0030163; GO:0030216; GO:0030279; GO:0030324; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031490; GO:0031960; GO:0032495; GO:0032496; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042246; GO:0042670; GO:0042802; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045608; GO:0045618; GO:0045662; GO:0045668; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048873; GO:0050673; GO:0050679; GO:0050680; GO:0050768; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061384; GO:0061419; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0120163; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027 calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transmembrane signaling receptor activity [GO:0004888] AEGQCNPLYDQYCK 0.74419 7.9285 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0873 0 14.9072 0 0 0 0 13.003 0 0 9.68034 0 12.3776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1483 0 10.9715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7735 0 0 0 0 0 0 14.7221 0 0 0 0 11.0513 0 0 0 0 0 0 0 0 0 0 0 0 13.6269 0 0 0 0 14.0913 0 0 13.1666 0 0 0 0 0 0 0 0 13.1038 0 13.761 0 0 0 0 0 0 13.4569 13.9585 0 0 12.3489 12.8259 0 0 13.451 0 0 0 0 13.18 0 0 0 13.8046 0 0 12.5715 13.1529 11.6001 10.0062 0 0 11.4468 0 12.6563 0 0 11.7841 12.6659 0 0 0 0 0 0 12.8507 0 0 0 0 0 0 0 0 10.1343 0 0 0 0 0 12.531 0 0 0 0 Q96RQ9 OXLA_HUMAN "L-amino-acid oxidase, LAAO, LAO, EC 1.4.3.2, EC 1.4.3.25 (Interleukin-4-induced protein 1, IL4-induced protein 1, hIL4I1) (Protein Fig-1, hFIG1)" IL4I1 FIG1 UNQ636/PRO1265 Homo sapiens (Human) adaptive immune response [GO:0002250]; cellular amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225]; L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; adaptive immune response [GO:0002250]; cellular amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572] GO:0001669; GO:0001716; GO:0001772; GO:0002250; GO:0002819; GO:0002841; GO:0005576; GO:0005764; GO:0006559; GO:0006569; GO:0006572; GO:0009063; GO:0016491; GO:0019440; GO:0042130; GO:0045577; GO:0045591; GO:0045944; GO:0046592; GO:0050868; GO:0097225; GO:0106329 L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592] ALLSSLSGLVLLNAPVVAMTQGPHDVHVQIETSPPARNLKVLK 0.74468 7.7279 0 0 0 0 0 0 0 0 12.3989 0 12.07 0 0 0 0 13.8317 0 0 0 12.8107 0 0 0 11.0541 0 0 11.4027 0 0 0 0 11.8275 0 0 0 0 0 11.1407 0 13.139 0 0 13.1212 0 0 11.9479 0 0 0 0 0 0 0 0 0 14.0212 0 0 0 0 0 0 0 0 0 0 13.6336 0 14.4397 12.2989 0 0 0 0 13.4165 12.8295 0 14.1528 11.5662 0 0 14.5143 0 0 14.5548 13.4106 0 15.0827 0 0 11.3128 0 0 0 14.1163 13.3971 14.4898 14.3808 0 13.6349 12.9705 0 0 0 13.1022 12.041 0 0 0 0 14.4059 12.9394 0 11.6353 13.7387 14.7182 0 0 12.6967 0 0 0 0 0 14.3531 15.0376 0 0 0 11.1057 0 0 13.8723 0 0 0 0 0 0 0 0 0 0 0 13.7647 12.5344 0 0 0 0 0 0 13.1774 13.8499 13.3818 0 0 0 0 15.4651 0 15.1727 0 0 0 0 0 0 0 12.46 14.7705 13.061 11.8836 0 0 0 13.3035 10.4544 0 0 Q92990 GLMN_HUMAN "Glomulin (FK506-binding protein-associated protein, FAP) (FKBP-associated protein)" GLMN FAP48 FAP68 VMGLOM Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; muscle cell differentiation [GO:0042692]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression, epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570]" Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737] "Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; cell surface receptor signaling pathway [GO:0007166]; muscle cell differentiation [GO:0042692]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression, epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570]" GO:0001570; GO:0001819; GO:0001843; GO:0005102; GO:0005171; GO:0005737; GO:0007166; GO:0008285; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031625; GO:0032434; GO:0032743; GO:0040029; GO:0042130; GO:0042327; GO:0042692; GO:0055105 hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105] IMASLNLLRYLVIK 0.74766 5.9863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4335 0 0 0 0 0 11.0386 0 0 13.0454 0 0 0 0 0 11.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99746 0 0 0 0 0 0 0 0 0 0 0 0 12.6642 0 0 0 0 0 10.9984 0 0 14.8889 0 9.89052 0 0 0 0 0 0 0 12.2942 0 0 0 0 0 16.8193 0 0 0 0 0 10.8195 0 0 0 0 0 0 0 0 0 13.7976 14.2199 0 0 0 0 13.3354 0 11.3126 17.4864 13.066 0 0 0 0 0 0 0 0 0 0 0 0 10.2022 15.0362 0 0 0 0 14.0193 0 12.864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3545 P46940 IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 (p195) IQGAP1 KIAA0051 Homo sapiens (Human) cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165] actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057] "actin filament [GO:0005884]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytokine production [GO:0001817]; regulation of GTPase activity [GO:0043087]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165]" GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0010761; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031234; GO:0031267; GO:0032956; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043087; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0045860; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0071277; GO:0071364; GO:0072015; GO:1990138; GO:1990904 "actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]" DHINDIIKIQAFIR 0.75 6.0942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9319 0 0 0 0 0 12.8995 0 0 0 0 0 0 0 0 0 13.0288 0 0 0 0 0 0 0 0 0 0 12.6432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1582 15.2884 0 0 0 0 0 0 11.6072 0 0 0 0 0 0 13.2408 0 0 0 0 0 0 0 0 12.2161 0 10.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.997 0 0 0 0 0 0 0 0 12.7894 0 0 0 0 0 0 0 0 12.6784 12.0064 0 0 0 14.8226 14.2057 0 12.7201 0 0 0 11.9039 0 0 12.248 0 0 13.4707 12.4283 13.1065 0 13.1603 0 12.0221 0 0 Q9H2P0 ADNP_HUMAN Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein) ADNP ADNP1 KIAA0784 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; estrous cycle [GO:0044849]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synaptic transmission [GO:0050805]; neuron apoptotic process [GO:0051402]; nitric oxide homeostasis [GO:0033484]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of synapse assembly [GO:0051965]; regulation of gene expression [GO:0010468]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of transcription by RNA polymerase II [GO:0006357]; response to carbohydrate [GO:0009743]; response to inorganic substance [GO:0010035]; short-term memory [GO:0007614] axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; copper ion binding [GO:0005507]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptide binding [GO:0042277]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; activation of protein kinase activity [GO:0032147]; cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; estrous cycle [GO:0044849]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synaptic transmission [GO:0050805]; neuron apoptotic process [GO:0051402]; nitric oxide homeostasis [GO:0033484]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of synapse assembly [GO:0051965]; regulation of gene expression [GO:0010468]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of transcription by RNA polymerase II [GO:0006357]; response to carbohydrate [GO:0009743]; response to inorganic substance [GO:0010035]; short-term memory [GO:0007614]" GO:0000785; GO:0000977; GO:0000981; GO:0003682; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006357; GO:0007614; GO:0009743; GO:0010035; GO:0010468; GO:0010629; GO:0010835; GO:0010976; GO:0019934; GO:0030424; GO:0030425; GO:0031668; GO:0032091; GO:0032147; GO:0033484; GO:0042277; GO:0043025; GO:0043524; GO:0044849; GO:0045773; GO:0048487; GO:0050731; GO:0050805; GO:0051402; GO:0051965; GO:0090575 "beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; copper ion binding [GO:0005507]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptide binding [GO:0042277]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CTYRDPLYEIVR 0.75238 6.0454 0 0 0 0 0 0 10.7272 0 11.0566 0 0 0 12.7183 0 0 0 0 0 0 0 10.878 11.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4138 0 0 0 0 0 0 0 11.203 0 0 0 0 0 12.9107 0 0 0 0 0 17.4321 0 0 17.3714 0 17.1069 17.1142 0 17.2892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5414 12.866 0 12.0657 0 0 0 0 0 11.6488 0 0 12.2248 0 0 13.3558 0 13.6611 0 0 0 0 0 0 0 0 11.3806 0 0 0 0 11.0277 0 12.7806 11.8873 0 11.5413 0 14.5947 0 12.8024 19.9118 0 0 0 0 13.5492 0 0 0 0 0 12.8557 0 0 11.5095 0 0 0 15.1411 12.1426 0 14.7498 0 0 0 0 12.8973 0 0 0 Q8IY26 PLPP6_HUMAN "Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6, EC 3.1.3.-, EC 3.6.1.-, EC 3.6.1.68 (Lipid phosphatase-related protein-B, LPRP-B) (PA-PSP) (Phosphatidic acid phosphatase type 2 domain-containing protein 2, PPAP2 domain-containing protein 2) (Phospholipid phosphatase 6) (Presqualene diphosphate phosphatase) (Type 1 polyisoprenoid diphosphate phosphatase)" PLPP6 PDP1 PPAPDC2 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate catabolic process [GO:0045339]; geranyl diphosphate metabolic process [GO:0033383]; geranylgeranyl diphosphate catabolic process [GO:1902247]; innate immune response [GO:0045087]; isoprenoid metabolic process [GO:0006720]; phospholipid dephosphorylation [GO:0046839]; positive regulation of neutrophil activation [GO:1902565]; protein prenylation [GO:0018342] integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; isoprenoid diphosphate phosphatase activity [GO:0106405]; lipid phosphatase activity [GO:0042577]; lyase activity [GO:0016829]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate catabolic process [GO:0045339]; geranyl diphosphate metabolic process [GO:0033383]; geranylgeranyl diphosphate catabolic process [GO:1902247]; innate immune response [GO:0045087]; isoprenoid metabolic process [GO:0006720]; phospholipid dephosphorylation [GO:0046839]; positive regulation of neutrophil activation [GO:1902565]; protein prenylation [GO:0018342] GO:0005637; GO:0005886; GO:0006695; GO:0006720; GO:0008195; GO:0016020; GO:0016787; GO:0016829; GO:0018342; GO:0030176; GO:0031965; GO:0033383; GO:0042392; GO:0042577; GO:0045087; GO:0045339; GO:0046839; GO:0052642; GO:0106405; GO:1902247; GO:1902565 hydrolase activity [GO:0016787]; isoprenoid diphosphate phosphatase activity [GO:0106405]; lipid phosphatase activity [GO:0042577]; lyase activity [GO:0016829]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392] AALMSRFILNHLVLAIPLRVLVVLWAFVLGLSR 0.7549 6.0801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2305 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4905 0 0 0 0 0 0 0 12.7551 0 0 12.1134 0 0 0 11.5985 0 0 0 13.9502 13.9204 13.8553 0 12.281 14.6234 14.0947 0 15.5029 13.9554 11.3641 0 0 0 0 13.9823 13.9696 13.217 0 11.2837 0 12.9578 0 0 0 13.3021 0 0 13.2198 13.1724 13.6734 0 0 0 11.452 12.1935 0 13.6646 13.6739 0 0 0 0 12.7789 0 0 0 0 13.0026 0 0 0 0 0 0 0 11.4289 0 11.6608 12.5467 0 0 12.1313 0 0 0 0 0 0 0 0 0 0 0 10.7263 0 0 0 0 0 0 0 12.8659 0 0 0 11.5804 0 0 11.997 0 O00533 NCHL1_HUMAN Neural cell adhesion molecule L1-like protein (Close homolog of L1) [Cleaved into: Processed neural cell adhesion molecule L1-like protein ] CHL1 CALL Homo sapiens (Human) adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cognition [GO:0050890]; exploration behavior [GO:0035640]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; signal transduction [GO:0007165] apical part of cell [GO:0045177]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protease binding [GO:0002020]; adult locomotory behavior [GO:0008344]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cognition [GO:0050890]; exploration behavior [GO:0035640]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; signal transduction [GO:0007165] GO:0001764; GO:0002020; GO:0005886; GO:0007155; GO:0007165; GO:0007411; GO:0008344; GO:0016021; GO:0030425; GO:0035640; GO:0043524; GO:0045177; GO:0050890; GO:0070062 protease binding [GO:0002020] DETFGEYSDSDEK 0.75556 7.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6107 0 0 13.7978 11.179 0 0 0 0 0 0 10.7718 0 0 0 0 0 0 0 0 0 0 12.5296 0 0 0 0 0 0 0 0 11.8843 0 0 0 0 0 0 0 0 0 11.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0558 0 0 12.8171 0 14.675 11.6473 0 20.2183 0 0 11.5732 12.9665 0 0 14.3552 0 16.0389 0 0 0 0 13.3784 14.2584 0 0 12.3039 0 16.208 0 0 13.2177 16.6022 11.2735 0 11.1358 0 11.9078 0 0 13.3795 15.1848 12.9198 0 0 0 0 10.0566 13.2197 0 0 0 0 0 12.7155 0 0 0 0 16.2322 14.8271 10.4465 0 16.5829 16.1808 0 0 0 0 0 0 0 0 0 0 0 0 0 14.685 0 0 0 0 0 0 0 0 0 0 0 0 11.7058 0 0 0 0 0 0 0 0 0 0 11.962 Q8WX77 IBPL1_HUMAN "Insulin-like growth factor-binding protein-like 1 (IGFBP-related protein 10) (Insulin-like growth factor-binding-related protein 4, IGFBP-rP4)" IGFBPL1 IGFBPRP4 Homo sapiens (Human) cellular response to tumor cell [GO:0071228]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966] extracellular space [GO:0005615] extracellular space [GO:0005615]; insulin-like growth factor binding [GO:0005520]; cellular response to tumor cell [GO:0071228]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966] GO:0001558; GO:0005520; GO:0005615; GO:0009966; GO:0071228 insulin-like growth factor binding [GO:0005520] AVPTPVITWRK 0.75758 8.2378 0 0 10.2355 0 13.2279 0 0 0 11.6862 0 11.6148 12.8585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6129 0 11.7445 0 0 0 12.0578 0 0 11.1486 0 0 0 0 12.0086 0 0 11.6791 0 0 0 0 0 10.632 0 0 0 0 0 0 0 0 0 12.8471 0 11.7857 0 14.0394 11.1193 0 14.0571 0 0 0 10.8315 0 0 12.0883 13.6149 0 0 0 13.27 14.6667 13.4987 0 0 13.4873 0 11.9209 0 0 0 11.9676 12.6957 0 0 0 11.8149 0 11.9274 12.6139 12.4777 0 12.7272 0 0 12.1877 12.8698 14.0074 14.1151 0 12.3251 11.3942 0 0 0 0 0 11.4073 10.6213 0 0 13.0856 0 0 11.111 0 0 10.9449 11.5958 0 12.1042 0 12.7106 0 13.1496 0 0 0 0 0 0 0 0 0 13.2379 0 0 12.4631 11.4983 0 0 0 0 0 0 0 11.8117 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1598 0 0 0 0 A6NMU1 O52A4_HUMAN Olfactory receptor 52A4 OR52A4P OR52A4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AIVFTRQLVTYIVVGVTLRPAILVIPCLLLIK 0.75962 6.0457 0 0 0 0 0 0 0 0 0 12.834 0 0 0 0 14.209 0 0 0 0 0 0 0 0 14.5286 0 0 0 13.3045 0 0 11.1353 0 12.9577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2501 0 0 13.2926 11.7525 0 11.8677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3198 0 0 0 0 0 0 0 0 0 13.4235 0 0 13.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5529 14.3598 12.549 0 0 12.5128 0 0 0 0 0 0 0 14.2453 0 0 0 0 0 12.0676 0 0 0 0 15.1332 12.0176 12.0513 12.8215 0 0 0 0 0 0 0 12.8703 0 0 0 0 0 0 0 0 0 0 12.6422 0 0 12.0077 0 0 14.2432 0 0 14.6299 0 0 0 0 0 0 Q3ZCQ3 F174B_HUMAN Membrane protein FAM174B FAM174B Homo sapiens (Human) Golgi organization [GO:0007030] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Golgi organization [GO:0007030] GO:0005794; GO:0005886; GO:0007030; GO:0016021 AAVIVAFAFTTLLIACLLLR 0.7619 7.9462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2212 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7804 11.5052 0 0 0 11.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4972 0 12.1002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9078 13.6295 0 14.1172 0 0 0 11.7446 16.4597 15.9747 14.5328 15.929 14.1476 16.1718 13.6432 12.8288 0 0 14.1057 0 12.7199 0 0 0 13.4054 0 0 14.4227 0 0 14.7358 0 0 14.5229 0 14.9978 0 16.2634 12.4837 14.3815 13.9517 0 0 15.4541 14.0835 0 12.7389 0 12.6711 0 13.6182 0 0 13.9347 0 0 0 15.0319 13.0757 0 14.0835 16.4598 13.6656 13.6937 14.8808 13.8448 0 0 0 0 0 0 15.0458 10.3628 0 0 15.7058 10.3675 16.1358 13.3542 0 0 0 13.6154 0 0 0 15.0886 0 13.7955 0 0 0 0 0 0 15.1017 0 0 0 0 0 0 0 0 0 12.008 12.8309 14.1467 0 0 0 14.5355 0 P33993 MCM7_HUMAN "DNA replication licensing factor MCM7, EC 3.6.4.12 (CDC47 homolog) (P1.1-MCM3)" MCM7 CDC47 MCM2 Homo sapiens (Human) cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of phosphorylation [GO:0042325] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of phosphorylation [GO:0042325]" GO:0000727; GO:0000781; GO:0000785; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006268; GO:0006270; GO:0006271; GO:0006974; GO:0007049; GO:0008283; GO:0016020; GO:0016887; GO:0030174; GO:0042325; GO:0042555; GO:0071162; GO:0071364; GO:0071466 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] ALLLLLVGGVDQSPRGMKIR 0.76316 8.127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2232 0 0 0 0 0 0 0 0 0 0 0 0 10.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0112 0 11.8043 13.7199 13.4939 12.2188 0 12.6276 0 0 0 0 0 0 12.445 0 0 13.5882 15.0838 0 0 15.0006 0 10.3184 13.5741 0 0 13.0484 0 0 0 13.9064 0 0 11.5125 11.9198 0 0 0 0 0 0 0 0 0 0 0 13.2083 0 13.4305 0 0 0 13.3209 15.5581 0 0 0 14.5951 0 0 0 0 0 0 13.4774 0 0 0 0 15.7605 13.6357 10.1258 0 13.4437 0 0 0 0 0 0 0 12.0811 0 13.6013 0 13.2032 0 0 0 0 0 0 0 0 0 0 11.2494 0 0 0 13.9651 0 0 0 0 14.121 0 0 0 0 12.8232 P43005 EAA3_HUMAN Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Neuronal and epithelial glutamate transporter) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) SLC1A1 EAAC1 EAAT3 HEAAC1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of protein kinase B activity [GO:0032148]; adult behavior [GO:0030534]; behavioral fear response [GO:0001662]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cellular response to ammonium ion [GO:0071242]; cellular response to bisphenol A [GO:1903926]; cellular response to cocaine [GO:0071314]; cellular response to mercury ion [GO:0071288]; cellular response to organic cyclic compound [GO:0071407]; cellular zinc ion homeostasis [GO:0006882]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; conditioned place preference [GO:1990708]; cysteine transport [GO:0042883]; cytokine-mediated signaling pathway [GO:0019221]; D-aspartate import across plasma membrane [GO:0070779]; D-aspartate transport [GO:0070777]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate receptor signaling pathway [GO:0007215]; glutathione biosynthetic process [GO:0006750]; grooming behavior [GO:0007625]; heart contraction [GO:0060047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; neuron death in response to oxidative stress [GO:0036475]; neurotransmitter receptor transport to plasma membrane [GO:0098877]; neurotransmitter transport [GO:0006836]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of heart rate [GO:0010460]; regulation of protein targeting to membrane [GO:0090313]; response to amphetamine [GO:0001975]; response to anesthetic [GO:0072347]; response to axon injury [GO:0048678]; response to decreased oxygen levels [GO:0036293]; response to morphine [GO:0043278]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; righting reflex [GO:0060013]; superoxide metabolic process [GO:0006801]; synapse organization [GO:0050808]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; zinc ion transmembrane transport [GO:0071577] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; distal dendrite [GO:0150002]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; proximal dendrite [GO:1990635]; recycling endosome membrane [GO:0055038]; synaptic cleft [GO:0043083] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; distal dendrite [GO:0150002]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; proximal dendrite [GO:1990635]; recycling endosome membrane [GO:0055038]; synaptic cleft [GO:0043083]; anion channel activity [GO:0005253]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; D-aspartate transmembrane transporter activity [GO:0140010]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of protein kinase B activity [GO:0032148]; adult behavior [GO:0030534]; behavioral fear response [GO:0001662]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cellular response to ammonium ion [GO:0071242]; cellular response to bisphenol A [GO:1903926]; cellular response to cocaine [GO:0071314]; cellular response to mercury ion [GO:0071288]; cellular response to organic cyclic compound [GO:0071407]; cellular zinc ion homeostasis [GO:0006882]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; conditioned place preference [GO:1990708]; cysteine transport [GO:0042883]; cytokine-mediated signaling pathway [GO:0019221]; D-aspartate import across plasma membrane [GO:0070779]; D-aspartate transport [GO:0070777]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate receptor signaling pathway [GO:0007215]; glutathione biosynthetic process [GO:0006750]; grooming behavior [GO:0007625]; heart contraction [GO:0060047]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; neuron death in response to oxidative stress [GO:0036475]; neurotransmitter receptor transport to plasma membrane [GO:0098877]; neurotransmitter transport [GO:0006836]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of heart rate [GO:0010460]; regulation of protein targeting to membrane [GO:0090313]; response to amphetamine [GO:0001975]; response to anesthetic [GO:0072347]; response to axon injury [GO:0048678]; response to decreased oxygen levels [GO:0036293]; response to morphine [GO:0043278]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; righting reflex [GO:0060013]; superoxide metabolic process [GO:0006801]; synapse organization [GO:0050808]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; zinc ion transmembrane transport [GO:0071577] GO:0001662; GO:0001975; GO:0005253; GO:0005313; GO:0005314; GO:0005783; GO:0005886; GO:0005887; GO:0006750; GO:0006801; GO:0006811; GO:0006836; GO:0006882; GO:0006919; GO:0007212; GO:0007215; GO:0007268; GO:0007420; GO:0007613; GO:0007625; GO:0007626; GO:0009410; GO:0009986; GO:0010460; GO:0010467; GO:0010842; GO:0015108; GO:0015175; GO:0015183; GO:0015501; GO:0015813; GO:0016020; GO:0016021; GO:0016324; GO:0016595; GO:0018105; GO:0019221; GO:0022008; GO:0030424; GO:0030425; GO:0030534; GO:0031901; GO:0031902; GO:0032148; GO:0032279; GO:0033229; GO:0035633; GO:0036293; GO:0036475; GO:0042417; GO:0042802; GO:0042883; GO:0043025; GO:0043083; GO:0043197; GO:0043198; GO:0043204; GO:0043278; GO:0043524; GO:0043679; GO:0045121; GO:0046872; GO:0048514; GO:0048678; GO:0050808; GO:0051938; GO:0055038; GO:0060013; GO:0060047; GO:0060291; GO:0061744; GO:0070062; GO:0070161; GO:0070633; GO:0070777; GO:0070778; GO:0070779; GO:0071242; GO:0071288; GO:0071314; GO:0071407; GO:0071577; GO:0071944; GO:0072347; GO:0090313; GO:0090461; GO:0097049; GO:0097386; GO:0097440; GO:0098712; GO:0098793; GO:0098877; GO:0099544; GO:0140009; GO:0140010; GO:0150002; GO:0150104; GO:1902476; GO:1903926; GO:1990635; GO:1990708 anion channel activity [GO:0005253]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; D-aspartate transmembrane transporter activity [GO:0140010]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175] IGLRAVVYYFCTTLIAVILGIVLVVSIK 0.76471 8.2188 0 0 0 0 0 0 0 0 0 0 0 13.6742 0 0 0 13.3132 0 13.0794 11.1977 12.9836 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1625 0 0 0 0 0 0 13.3769 12.4081 0 0 13.3688 0 0 0 0 0 0 0 11.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6397 0 0 0 0 14.92 13.9699 0 0 14.826 0 0 0 13.3857 0 0 0 0 0 0 14.6143 14.623 0 13.8901 0 0 0 11.2996 0 0 0 0 0 0 13.0003 0 13.5892 0 0 0 14.2389 0 12.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7816 0 0 0 0 0 14.0042 0 0 12.2989 13.0888 0 0 13.7692 0 0 0 12.559 0 13.9223 12.547 12.4747 0 11.3098 0 0 0 0 14.2814 11.4619 0 0 0 0 15.85 0 0 13.3323 0 14.0345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A286YF01 SCGR7_HUMAN Small cysteine and glycine repeat-containing protein 7 (Keratin-associated protein 28-7) SCYGR7 KRTAP28-7 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CYRVGCCSSCCPCCR 0.76699 6.0473 0 0 0 0 0 0 0 0 0 0 0 11.3539 0 0 11.0752 0 0 0 0 0 14.0479 0 0 0 14.9067 12.605 0 12.7856 0 0 0 0 0 11.3409 0 0 0 0 0 0 0 11.9873 0 0 11.1917 12.1641 0 0 0 0 0 14.3987 0 0 10.8164 12.7754 0 0 0 0 0 0 0 0 0 0 0 0 12.7898 12.8685 0 0 0 11.9293 0 12.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2376 0 0 0 0 12.0925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2022 0 0 12.3041 0 13.9281 0 0 0 12.6415 0 0 0 0 0 12.6691 0 12.2746 0 10.2232 0 11.7121 0 13.5511 0 0 0 13.8766 0 0 0 0 0 0 0 0 0 Q9BYQ8 KRA49_HUMAN Keratin-associated protein 4-9 (Keratin-associated protein 4.9) (Ultrahigh sulfur keratin-associated protein 4.9) KRTAP4-9 KAP4.9 KRTAP4.9 Homo sapiens (Human) aging [GO:0007568]; hair cycle [GO:0042633] cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; aging [GO:0007568]; hair cycle [GO:0042633] GO:0005829; GO:0007568; GO:0042633; GO:0045095 CCISSCCRPSCCVSSCCK 0.76923 8.1123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3602 10.1785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3519 12.4039 14.2157 0 15.1686 0 0 0 11.4321 14.3168 0 0 0 12.6145 0 12.1985 0 0 12.5293 0 0 0 0 13.8794 0 0 0 0 11.9947 0 0 11.6727 0 0 0 15.0533 12.608 0 0 0 0 0 14.774 0 0 0 0 13.619 0 0 14.0999 0 0 0 0 0 10.8991 0 11.0718 0 0 13.0999 11.1203 14.3959 0 0 0 13.8112 13.2217 13.9409 0 0 0 11.4125 11.5924 0 0 13.4564 0 0 0 12.6973 14.4972 0 0 0 0 0 0 10.9165 0 0 0 0 0 0 0 0 13.8957 0 0 0 0 0 0 13.5289 0 0 0 0 0 0 0 Q9H9P5 UNKL_HUMAN "Putative E3 ubiquitin-protein ligase UNKL, EC 2.3.2.- (RING finger protein unkempt-like) (Zinc finger CCCH domain-containing protein 5-like)" UNKL C16orf28 ZC3H5L ZC3HDC5L Homo sapiens (Human) protein ubiquitination [GO:0016567] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005829; GO:0016567; GO:0016740; GO:0046872 metal ion binding [GO:0046872]; transferase activity [GO:0016740] CDGGDGCQYCHSR 0.77083 7.589 0 0 0 0 0 0 10.7846 0 0 0 0 0 0 0 0 12.5176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3189 0 0 0 0 0 0 0 0 0 0 0 12.9256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6911 0 0 0 0 0 0 0 0 0 0 0 0 11.7558 0 0 14.0608 13.1675 0 0 0 0 0 12.361 12.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7194 0 0 0 0 0 0 14.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6319 0 0 0 14.2353 0 0 0 0 0 0 0 12.522 0 0 0 0 0 10.2771 0 11.5361 0 0 0 0 0 0 0 13.7256 14.5126 0 0 0 0 0 0 10.3471 0 0 0 0 0 0 0 Q9UBM8 MGT4C_HUMAN "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C, EC 2.4.1.145 (N-acetylglucosaminyltransferase IV homolog, hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc, GlcNAc-T IVc, GnT-IVc, N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)" MGAT4C Homo sapiens (Human) protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]" GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0016021; GO:0019082; GO:0046872 "acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]" GLLAQKNVIRFK 0.77273 7.7765 0 0 0 0 0 0 0 0 0 11.5018 0 0 13.7347 0 0 0 0 12.2948 0 0 0 0 0 0 0 0 0 0 0 0 12.1403 13.7632 13.206 0 0 14.1007 0 0 14.8091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2271 14.0165 0 12.1191 0 0 0 0 0 0 0 0 12.2315 0 0 11.2206 0 0 0 0 0 0 0 13.6928 0 0 0 0 0 13.0672 11.5121 0 0 0 13.367 0 0 0 0 0 12.7701 0 0 12.5388 12.7094 0 0 11.7607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7534 0 13.8476 0 0 15.1704 14.2905 0 11.2395 0 0 13.6881 0 0 0 0 Q7L622 G2E3_HUMAN "G2/M phase-specific E3 ubiquitin-protein ligase, EC 2.3.2.26 (G2/M phase-specific HECT-type E3 ubiquitin transferase)" G2E3 KIAA1333 Homo sapiens (Human) apoptotic process [GO:0006915] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915] GO:0004842; GO:0005634; GO:0005730; GO:0005794; GO:0005829; GO:0006915; GO:0043231; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] CKRSYHFPCGLQR 0.775 8.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6947 0 0 12.0537 0 0 0 12.1483 0 0 0 0 0 13.4126 0 0 0 0 12.4546 16.8585 0 0 14.7787 0 0 0 11.12 14.6566 0 0 0 13.6813 0 14.5159 14.6679 0 0 0 0 0 0 0 0 14.0658 0 0 13.413 0 0 12.6936 14.2726 0 0 0 0 0 13.1898 0 0 14.3552 0 12.8577 0 0 0 14.2576 13.9715 0 0 0 0 0 11.828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5846 0 0 0 13.6437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2 Q9UF33 EPHA6_HUMAN "Ephrin type-A receptor 6, EC 2.7.10.1 (EPH homology kinase 2, EHK-2) (EPH-like kinase 12, EK12)" EPHA6 EHK2 HEK12 Homo sapiens (Human) axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005005; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0033674; GO:0043005; GO:0043235 ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] CGLDTSQCEDCGGGLRFIPR 0.77551 7.5396 0 0 0 0 0 0 0 0 0 0 12.7438 0 0 12.0552 0 0 0 0 0 0 13.6726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5076 0 0 0 0 0 0 0 12.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7228 13.5476 0 13.7154 12.6224 0 13.6195 0 0 0 0 0 11.2673 19.1339 0 0 0 0 10.7036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5507 0 0 0 12.3879 13.3726 13.8392 13.0767 13.092 14.9578 14.9189 0 0 0 0 0 0 0 0 13.1698 0 0 13.1959 14.0511 0 0 0 13.9679 14.2432 0 0 12.8579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6857 0 0 10.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZWH5 NEK10_HUMAN "Serine/threonine-protein kinase Nek10, EC 2.7.11.1 (Never in mitosis A-related kinase 10, NimA-related protein kinase 10)" NEK10 Homo sapiens (Human) mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] extracellular region [GO:0005576]; protein kinase complex [GO:1902911] extracellular region [GO:0005576]; protein kinase complex [GO:1902911]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372] GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AGGHRAR 0.78 7.4696 10.6474 11.561 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2917 13.3719 14.3455 11.7385 14.347 18.2599 0 18.6498 0 13.6434 0 13.9552 0 13.1995 10.7998 0 11.839 0 0 12.5741 12.795 0 0 0 0 0 0 0 0 13.1618 0 9.82906 0 0 0 12.6026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4523 12.5364 12.8601 0 0 11.9595 11.4747 14.5085 0 13.587 14.1994 12.5765 13.6339 12.7278 12.4144 0 12.847 12.6512 0 0 0 13.984 0 12.2885 0 0 0 0 19.2456 19.2338 0 12.0103 16.0343 12.7896 13.1671 0 0 0 0 13.6928 0 0 11.4887 13.6641 11.6392 19.2276 14.644 19.1813 14.6712 19.2524 0 0 12.9083 19.101 12.6439 12.477 0 11.9148 19.0578 0 0 14.5658 14.1773 0 11.95 12.2877 15.0946 13.9047 0 14.7449 13.96 0 14.3085 11.5751 15.3631 13.2428 14.4893 12.9362 14.1832 0 13.4601 0 0 0 0 0 0 0 0 13.7041 13.5893 14.2225 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4078 12.1941 0 11.508 0 0 0 0 O95759 TBCD8_HUMAN TBC1 domain family member 8 (AD 3) (Vascular Rab-GAP/TBC-containing protein) TBC1D8 VRP Homo sapiens (Human) activation of GTPase activity [GO:0090630]; blood circulation [GO:0008015]; positive regulation of cell population proliferation [GO:0008284] membrane [GO:0016020] membrane [GO:0016020]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; blood circulation [GO:0008015]; positive regulation of cell population proliferation [GO:0008284] GO:0005096; GO:0008015; GO:0008284; GO:0016020; GO:0090630 GTPase activator activity [GO:0005096] AFFRLPRK 0.78049 8.0377 0 0 0 0 0 0 0 0 0 0 11.0317 0 0 11.6421 0 0 0 0 14.8832 0 0 0 0 0 0 0 0 0 0 14.3332 0 0 0 0 14.3198 13.7609 0 14.6657 0 14.7168 0 0 0 14.8803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3638 12.705 0 0 0 0 12.9507 0 0 0 0 10.5876 0 0 0 13.933 0 0 0 0 0 0 0 0 0 0 12.2513 0 0 0 0 0 0 0 0 16.0472 0 0 0 0 0 0 0 0 0 0 0 0 13.7871 14.4128 13.314 16.6325 14.2311 16.5505 0 0 14.1042 0 0 0 0 0 13.1675 0 0 13.0625 0 0 13.2831 13.2568 0 0 0 0 14.1073 0 0 15.7602 14.0937 15.839 12.8262 14.5548 0 0 0 13.8328 0 0 12.6419 0 16.3827 0 0 14.5035 0 0 0 0 0 0 0 0 13.4329 0 0 0 0 11.8329 13.7281 0 0 0 16.7179 0 P48169 GBRA4_HUMAN Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) GABRA4 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0070161; GO:0098794; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315 benzodiazepine receptor activity [GO:0008503]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] HPEAPLQNTNANLNMRK 0.78125 8.3088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5267 0 0 0 0 0 0 0 10.7083 0 0 0 0 0 0 12.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3018 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9844 0 0 0 0 0 12.1857 13.5609 14.2654 13.849 0 0 0 0 0 12.576 0 11.5238 12.9761 0 12.7093 0 0 0 14.6655 0 0 12.5191 0 0 0 0 0 14.2656 0 14.9273 0 0 14.5257 14.5041 14.5641 12.7671 14.8433 0 0 0 0 0 12.2783 0 0 0 0 0 10.7572 0 0 12.2467 14.5972 0 0 13.1368 11.4838 0 0 13.9042 0 0 0 0 0 0 0 14.6316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7491 15.1376 0 0 0 13.9228 0 Q9ULK5 VANG2_HUMAN Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2) VANGL2 KIAA1215 STB1 Homo sapiens (Human) "apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; apical protein localization [GO:0045176]; cell migration involved in kidney development [GO:0035787]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001736; GO:0001843; GO:0001947; GO:0005886; GO:0005911; GO:0016021; GO:0016324; GO:0016328; GO:0035787; GO:0045176; GO:0060071; GO:1905515 ALLMVLVFLLVVSYWLFYGVR 0.78378 8.1375 0 0 11.42 0 0 0 0 0 10.7624 0 0 10.9813 0 0 11.3647 9.91037 0 11.8781 13.0574 0 0 13.1748 13.0567 0 0 10.872 10.0799 0 12.9274 0 0 0 0 0 11.4356 10.0366 0 0 0 0 0 11.4762 0 12.7636 9.78157 9.6357 11.5254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4078 0 0 12.5194 0 0 0 0 13.001 0 0 14.8943 15.0974 0 0 0 0 10.9155 15.8685 0 10.9374 0 13.4197 16.9552 0 0 13.688 0 0 13.5744 0 13.4784 0 0 15.3007 0 0 0 0 0 12.3219 0 13.8973 0 16.6055 0 13.9343 0 12.516 14.5615 0 12.1404 0 0 0 0 16.2691 14.2597 0 0 14.127 14.9458 13.7573 0 0 0 12.9464 0 12.2689 0 13.7916 14.4173 0 0 13.4855 0 13.8942 14.1636 11.6661 14.5923 0 0 0 0 0 0 13.029 0 0 0 13.3376 0 0 0 0 0 12.0341 11.1793 10.9353 0 0 0 0 0 0 0 0 0 0 12.4864 0 14.6696 Q92743 HTRA1_HUMAN "Serine protease HTRA1, EC 3.4.21.- (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11)" HTRA1 HTRA PRSS11 Homo sapiens (Human) chorionic trophoblast cell differentiation [GO:0060718]; dentinogenesis [GO:0097187]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of defense response to virus [GO:0050687]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation [GO:0050679]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; chorionic trophoblast cell differentiation [GO:0060718]; dentinogenesis [GO:0097187]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of defense response to virus [GO:0050687]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation [GO:0050679]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] GO:0001890; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006508; GO:0008236; GO:0012501; GO:0019838; GO:0030512; GO:0030514; GO:0042802; GO:0043065; GO:0050679; GO:0050687; GO:0060718; GO:0062023; GO:0070062; GO:0097187 growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] AALLPLLLLLLAAPASAQLSRAGR 0.78431 7.4404 14.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4043 0 0 11.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.427 0 12.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1571 0 0 0 12.1075 14.0938 0 0 14.6405 14.0593 13.9669 0 0 0 0 0 0 0 0 13.0957 0 0 0 13.5895 14.9909 0 0 0 13.3979 12.1322 0 0 0 0 0 13.2912 12.4705 0 0 0 0 0 0 0 11.5447 13.0364 0 0 12.5477 0 12.7196 0 0 0 0 0 0 13.1447 0 0 0 0 0 0 0 0 13.3451 0 0 13.292 13.6247 0 0 0 13.3566 12.8705 0 0 0 0 0 0 0 0 0 13.9867 0 13.5591 12.9155 0 0 12.9341 0 0 0 14.6869 0 0 0 0 0 0 10.8014 0 0 0 0 0 0 0 Q9Y2G0 EFR3B_HUMAN Protein EFR3 homolog B EFR3B KIAA0953 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005829; GO:0005886; GO:0015629; GO:0046854; GO:0072659 FPDLCVY 0.78846 7.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1878 0 0 0 0 0 0 0 0 0 0 0 14.2488 13.3821 0 0 0 0 15.3224 0 0 0 0 0 0 0 0 0 0 12.6535 0 0 0 0 0 0 0 12.0909 0 0 10.8814 0 0 0 0 0 0 0 0 0 12.8917 0 0 0 0 0 14.3373 0 0 0 0 0 11.7987 0 0 0 0 0 12.756 0 0 0 0 0 0 0 0 0 0 0 10.8026 12.1899 0 0 13.3895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1644 0 0 Q16671 AMHR2_HUMAN "Anti-Muellerian hormone type-2 receptor, EC 2.7.11.30 (Anti-Muellerian hormone type II receptor, AMH type II receptor) (MIS type II receptor, MISRII, MRII)" AMHR2 AMHR MISR2 Homo sapiens (Human) activin receptor signaling pathway [GO:0032924]; anti-Mullerian hormone signaling pathway [GO:1990262]; cellular response to growth factor stimulus [GO:0071363]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; Mullerian duct regression [GO:0001880]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; transforming growth factor beta receptor signaling pathway [GO:0007179] activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "activin receptor complex [GO:0048179]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity [GO:0017002]; anti-Mullerian hormone receptor activity [GO:1990272]; ATP binding [GO:0005524]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transforming growth factor beta receptor activity, type II [GO:0005026]; activin receptor signaling pathway [GO:0032924]; anti-Mullerian hormone signaling pathway [GO:1990262]; cellular response to growth factor stimulus [GO:0071363]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; Mullerian duct regression [GO:0001880]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0001880; GO:0004674; GO:0005026; GO:0005524; GO:0005886; GO:0006468; GO:0007179; GO:0007548; GO:0008584; GO:0008585; GO:0017002; GO:0032924; GO:0042562; GO:0042803; GO:0043235; GO:0046872; GO:0048179; GO:0048185; GO:0060389; GO:0071363; GO:1990262; GO:1990272 "activin binding [GO:0048185]; activin receptor activity [GO:0017002]; anti-Mullerian hormone receptor activity [GO:1990272]; ATP binding [GO:0005524]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; transforming growth factor beta receptor activity, type II [GO:0005026]" ADIYSLALLLWEILSRCPDLR 0.7963 5.8916 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7303 0 0 0 12.2247 0 0 0 0 0 11.7503 0 0 11.5162 0 0 0 0 0 0 0 0 11.9373 13.1685 12.3295 0 0 0 0 0 0 0 0 0 11.3494 0 0 11.9871 0 0 0 0 0 0 11.9517 0 0 0 0 0 13.0849 0 11.9654 0 15.0391 0 14.1909 0 0 0 14.9767 0 0 0 0 0 0 0 0 0 0 0 0 14.7166 0 12.6784 0 11.1061 0 0 0 0 0 0 0 0 0 11.6355 0 0 12.1415 0 0 0 0 0 0 0 0 0 0 14.3389 0 0 0 11.2587 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2234 0 0 0 12.1766 12.7896 0 0 11.2518 13.7847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8221 0 0 0 0 0 P57075 UBS3A_HUMAN "Ubiquitin-associated and SH3 domain-containing protein A (Cbl-interacting protein 4, CLIP4) (Suppressor of T-cell receptor signaling 2, STS-2) (T-cell ubiquitin ligand 1, TULA-1)" UBASH3A STS2 Homo sapiens (Human) negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of cytokine production [GO:0001817] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; negative regulation of T cell receptor signaling pathway [GO:0050860]; regulation of cytokine production [GO:0001817] GO:0001817; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0050860; GO:0070062 AAGETQLYAKVSNKLK 0.8 5.8642 0 0 0 0 0 11.9865 0 0 0 10.9143 0 0 9.88018 0 0 0 0 0 16.1092 0 0 0 0 0 0 11.3946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8041 0 0 0 0 0 0 0 0 12.5845 0 0 0 0 0 0 0 0 0 0 12.2906 12.8358 0 0 0 12.1378 0 12.5643 12.3711 13.986 13.192 12.0856 0 0 0 0 0 0 0 13.6925 0 13.5757 0 13.4267 14.451 0 11.861 0 0 0 0 0 0 0 0 0 11.1969 0 16.538 13.9095 0 0 0 0 0 0 0 0 12.5474 0 0 0 0 0 0 0 0 12.0601 0 0 0 10.7554 13.0585 0 0 0 0 0 0 0 0 0 0 0 13.4311 0 0 11.6628 0 0 12.6224 0 0 0 0 13.1821 0 16.5464 0 13.2634 0 0 0 11.941 0 0 0 0 0 10.3041 12.4937 0 0 0 0 0 0 12.1871 0 0 0 0 0 0 Q9BVC6 TM109_HUMAN "Transmembrane protein 109 (Mitsugumin-23, Mg23)" TMEM109 Homo sapiens (Human) cellular response to gamma radiation [GO:0071480]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell death [GO:0060548]; regulation of ion transmembrane transport [GO:0034765] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear outer membrane [GO:0005640]; sarcoplasmic reticulum membrane [GO:0033017] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear outer membrane [GO:0005640]; sarcoplasmic reticulum membrane [GO:0033017]; voltage-gated ion channel activity [GO:0005244]; cellular response to gamma radiation [GO:0071480]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell death [GO:0060548]; regulation of ion transmembrane transport [GO:0034765] GO:0005244; GO:0005640; GO:0016021; GO:0033017; GO:0034765; GO:0042771; GO:0060548; GO:0070062; GO:0071480 voltage-gated ion channel activity [GO:0005244] AILMVLVALILLHSALAQSR 0.8 8.1801 0 0 0 0 0 14.3641 0 0 0 0 0 0 0 0 0 0 0 14.1991 0 0 0 0 0 0 13.4791 14.1513 13.6873 0 14.3963 0 12.0477 0 0 0 0 12.1609 0 0 12.8451 0 0 0 11.4691 0 0 0 0 11.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2012 14.053 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2159 0 0 0 0 14.1683 0 0 0 0 0 0 0 13.3969 0 13.022 13.8569 0 0 14.1393 14.3933 0 0 0 14.9485 14.03 15.32 0 0 10.694 0 0 0 14.0884 12.8412 0 14.049 0 0 0 0 0 13.5201 0 0 13.979 0 0 0 12.221 13.5289 13.4708 14.411 13.5243 14.1204 0 0 0 14.1225 0 13.4194 0 10.1678 13.8082 0 10.1292 0 0 0 0 0 0 14.1261 0 0 13.4539 0 0 0 0 0 0 13.4543 13.352 0 0 0 0 0 0 0 11.4513 14.1377 0 0 0 12.6451 P98155 VLDLR_HUMAN "Very low-density lipoprotein receptor, VLDL receptor, VLDL-R" VLDLR Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; memory [GO:0007613]; nervous system development [GO:0007399]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447] GO:0005041; GO:0005509; GO:0005765; GO:0005886; GO:0005905; GO:0006869; GO:0006898; GO:0007165; GO:0007399; GO:0007613; GO:0008203; GO:0016020; GO:0016021; GO:0021517; GO:0030229; GO:0034185; GO:0034189; GO:0034361; GO:0034436; GO:0034447; GO:0038024; GO:0038025; GO:0038026; GO:0043235; GO:0045860; GO:0048306; GO:0048813; GO:1900006 apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229] CDGDEDCVDGSDEK 0.80556 8.1456 0 0 0 0 0 0 0 0 0 0 0 12.3195 0 10.5337 0 11.3451 13.084 12.6562 0 0 12.8677 0 10.7091 0 0 13.0843 11.5741 0 0 0 0 0 11.2379 0 15.1976 0 0 0 12.741 0 12.7302 0 10.9656 0 0 12.6281 0 10.6298 0 0 0 0 0 10.7437 0 0 0 0 0 0 0 0 0 0 0 0 16.2873 0 0 14.2772 12.3679 0 15.3502 12.4339 16.3252 14.2453 0 14.2221 0 0 0 0 12.7656 0 13.4475 13.9263 15.1074 13.2061 15.4299 13.9429 12.3804 14.5105 12.8571 14.8541 0 14.325 13.0264 0 14.2441 13.1392 14.4394 14.32 13.9621 15.3503 0 15.5501 0 0 13.4384 0 0 14.0646 13.7244 13.7286 11.434 0 15.4989 11.94 0 13.4344 14.4984 14.8901 0 0 14.6419 14.534 13.9771 14.5741 0 0 12.4339 0 12.2077 14.6133 13.5616 15.4865 15.4087 0 0 16.2329 13.4017 12.4305 13.9306 11.6259 11.2559 0 14.6824 13.3582 0 0 0 13.049 14.0989 0 12.5427 0 0 11.3744 13.9326 0 10.6123 13.1813 0 14.3007 0 11.2862 14.1176 0 12.5917 11.1851 12.1034 0 0 0 0 0 0 10.9578 12.4908 0 O95837 GNA14_HUMAN "Guanine nucleotide-binding protein subunit alpha-14, G alpha-14, G-protein subunit alpha-14" GNA14 Homo sapiens (Human) action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; signal transduction [GO:0007165] GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0031683; GO:0046872; GO:0060158; GO:0070062 G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] DTILQLNLREFNLV 0.80734 5.879 0 0 0 11.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7434 0 14.2387 11.5886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.94 0 0 0 12.3653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9777 0 16.8998 0 0 0 0 0 0 0 0 0 14.1815 0 0 0 0 0 10.8492 0 0 0 0 0 0 0 0 Q8IZT8 HS3S5_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 5, EC 2.8.2.23 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5, 3-OST-5, Heparan sulfate 3-O-sulfotransferase 5, h3-OST-5)" HS3ST5 3OST5 HS3OST5 Homo sapiens (Human) "glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; negative regulation of coagulation [GO:0050819]; protein sulfation [GO:0006477]; regulation of viral entry into host cell [GO:0046596]" GO:0000139; GO:0006024; GO:0006477; GO:0008467; GO:0015015; GO:0016021; GO:0046596; GO:0050656; GO:0050819 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467] AIIIGVRK 0.82883 5.8546 0 0 0 0 12.5534 13.9212 12.5784 0 0 0 0 0 0 10.7079 0 10.4535 10.4212 13.7897 0 0 13.8057 10.6159 0 0 14.9242 0 0 0 0 0 0 11.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9011 0 0 0 0 0 0 0 0 10.5282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6454 0 0 15.7553 15.8023 0 15.6798 0 0 0 12.8831 0 0 0 0 0 0 0 13.6361 0 14.8392 0 0 0 12.7528 13.4985 0 13.333 0 0 0 0 0 0 0 14.6574 0 0 0 14.2799 0 14.9824 13.1727 14.6226 15.0721 0 0 0 13.3592 0 15.3856 0 0 0 12.635 0 0 14.0244 14.7231 0 0 0 0 14.9249 0 14.7623 0 0 0 14.7951 15.0002 0 13.4945 12.1224 12.4091 12.6237 12.0234 12.34 0 0 0 0 12.905 12.9977 14.0008 12.8933 0 0 0 0 0 10.8667 0 0 0 0 0 0 0 0 0 0 14.368 0 0 9.63007 0 0 0 Q9NXB9 ELOV2_HUMAN "Elongation of very long chain fatty acids protein 2, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL2) (ELOVL fatty acid elongase 2, ELOVL FA elongase 2) (Very long chain 3-ketoacyl-CoA synthase 2) (Very long chain 3-oxoacyl-CoA synthase 2)" ELOVL2 ELG3 SSC2 Homo sapiens (Human) "alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042761; GO:0043651; GO:0102756 fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756] AYFTAANGVMNK 0.84615 5.6152 0 0 0 0 0 0 0 0 0 0 0 12.0288 0 12.3647 0 0 0 0 11.4119 0 0 0 0 0 0 13.073 0 0 0 0 0 12.9083 0 0 0 0 0 0 0 0 0 15.3577 0 0 0 0 0 0 0 0 13.1228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1744 0 0 0 0 0 0 0 0 0 0 0 0 11.4859 0 0 0 12.9508 17.0114 0 0 0 0 0 0 0 0 0 0 0 0 12.4841 0 0 0 0 0 0 0 0 10.7059 14.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.627 0 0 0 0 0 13.2899 0 0 0 0 0 0 0 0 13.8713 0 12.5305 0 0 0 0 0 0 0 10.7606 0 0 0 0 0 0 0 0 0 11.2395 12.4874 0 0 0 0 0 0 0 0 0 0 17.52 12.32 0 0 0 0 0 0 0 10.2053 0 Q14929 ZN169_HUMAN Zinc finger protein 169 ZNF169 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CGRAFGFKSLLTR 0.84733 5.6065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7757 0 0 10.8777 0 0 0 0 0 9.45978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2334 0 0 0 0 0 0 0 0 0 0 0 14.1435 0 11.7367 0 0 0 0 0 0 0 10.9813 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2261 12.3209 0 0 0 0 10.8204 0 0 0 0 0 11.9866 0 0 0 0 0 0 0 13.3896 13.8814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0387 O75690 KRA58_HUMAN "Keratin-associated protein 5-8 (Keratin, ultra high-sulfur matrix protein B) (Keratin-associated protein 5.8) (UHS keratin B, UHS KerB) (Ultrahigh sulfur keratin-associated protein 5.8)" KRTAP5-8 KAP5.8 KRTAP5.8 UHSKB Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280] GO:0005829; GO:0030280; GO:0045095 structural constituent of skin epidermis [GO:0030280] GDCGSCGGSKGGCGSCGCSQCSCYK 0.85271 5.6373 0 0 0 0 0 0 0 0 0 0 10.6495 0 0 0 0 0 0 0 0 13.4587 0 11.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8541 11.6427 0 0 0 0 0 0 0 0 0 0 12.3978 0 0 0 0 12.8944 0 0 10.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5177 0 0 0 14.3819 0 0 0 0 13.8739 10.8311 0 0 0 12.5722 0 12.2687 0 13.4546 0 13.0623 0 0 0 12.0371 11.9039 0 0 0 0 0 0 0 0 0 0 0 13.602 0 0 11.9607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5875 14.2586 0 0 0 0 12.4864 14.8578 14.0997 0 13.4578 0 0 0 0 0 0 12.0972 0 0 0 0 0 13.1828 0 13.6725 12.1999 0 0 0 0 11.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78539 SRPX_HUMAN Sushi repeat-containing protein SRPX SRPX ETX1 Homo sapiens (Human) autophagy [GO:0006914]; cell adhesion [GO:0007155]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976] autophagosome [GO:0005776]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] autophagosome [GO:0005776]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; autophagy [GO:0006914]; cell adhesion [GO:0007155]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; phagolysosome assembly [GO:0001845]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; response to endoplasmic reticulum stress [GO:0034976] GO:0001845; GO:0005776; GO:0005783; GO:0006914; GO:0007155; GO:0009986; GO:0016020; GO:0034976; GO:0060244; GO:0062023; GO:2001241 CVDGAYFNSRCEYYCSPGYTLK 0.85714 5.6567 0 0 0 0 0 0 10.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3533 11.2227 12.3784 0 11.1076 0 0 12.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5491 9.57713 0 0 0 0 0 0 0 0 0 9.82498 0 0 0 0 0 0 0 0 10.6862 0 13.8524 0 0 0 0 12.2674 0 15.4184 0 0 0 0 0 0 0 13.2155 12.9008 12.1371 0 0 0 0 0 0 0 0 0 0 14.1059 0 11.4918 0 0 0 0 0 0 0 0 13.1795 0 11.3866 0 14.4034 0 0 12.571 11.7425 0 10.4061 15.2972 0 0 0 0 13.8822 12.479 0 0 0 0 0 0 0 0 0 11.7446 14.9324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5824 0 0 0 12.0635 0 0 0 12.2322 13.8933 13.9594 14.074 0 0 14.0485 0 12.3639 0 0 0 0 0 0 14.3343 11.6083 Q9HD45 TM9S3_HUMAN Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein) TM9SF3 SMBP UNQ245/PRO282 Homo sapiens (Human) protein localization to membrane [GO:0072657] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657] GO:0016020; GO:0016021; GO:0072657 EEEMDDMDR 0.85827 5.6557 0 0 0 0 0 0 0 0 0 0 14.2921 0 0 0 0 0 0 0 0 13.3271 13.6266 0 12.2873 0 0 13.246 0 0 0 12.3638 0 13.9755 13.8822 0 0 0 0 13.437 0 0 0 0 0 0 0 0 0 13.547 0 13.2827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3113 0 10.5275 0 0 0 0 10.5173 0 0 0 14.2622 0 0 0 0 11.6491 0 0 13.5002 12.6254 0 0 12.3124 11.582 0 0 11.7076 12.1102 10.7485 10.6411 13.2416 0 11.815 0 11.3134 12.517 0 0 0 0 0 12.1299 0 0 0 0 0 0 0 0 10.9012 0 0 0 9.55509 15.0428 0 0 0 10.6455 0 0 0 0 0 0 9.63902 0 0 0 0 10.9719 0 0 0 13.5977 0 0 0 0 13.0747 10.7785 0 11.4066 0 0 0 0 0 0 14.2056 12.8839 0 0 0 0 15.0076 0 0 0 11.0116 0 0 0 0 0 Q86SQ3 AGRE4_HUMAN Putative adhesion G protein-coupled receptor E4P (EGF-like module receptor 4) (EGF-like module-containing mucin-like hormone receptor-like 4) (G-protein coupled receptor 127) (G-protein coupled receptor PGR16) ADGRE4P EMR4 EMR4P GPR127 PGR16 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005509; GO:0005576; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] CFHLSSFAVLVALAPK 0.85938 5.6496 0 0 0 0 0 0 0 0 0 0 12.8819 0 0 0 0 0 0 13.3081 0 0 12.9372 0 0 0 0 0 0 0 0 0 0 0 12.834 0 14.4529 0 0 0 12.7367 0 14.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4144 0 0 0 13.7761 0 0 0 0 0 0 0 0 14.6025 0 0 14.4041 0 0 0 0 0 0 0 0 0 0 0 14.6185 0 13.8035 14.0103 0 0 0 0 0 0 0 15.0809 0 0 0 0 0 0 0 0 0 0 0 0 13.6957 14.249 13.7448 0 0 0 0 0 0 0 0 0 15.287 0 0 0 0 0 0 0 0 13.6539 0 0 0 0 0 0 0 0 0 0 0 13.7695 0 0 11.2898 14.1745 O94819 KBTBB_HUMAN Kelch repeat and BTB domain-containing protein 11 (Chronic myelogenous leukemia-associated protein) (Kelch domain-containing protein 7B) KBTBD11 CMLAP KIAA0711 KLHDC7C Homo sapiens (Human) ARPSDQVFCYNPATDSWSAVR 0.8595 5.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9474 0 0 0 0 0 0 0 0 14.0773 0 0 13.9996 0 0 0 0 0 0 0 10.998 13.7383 0 0 0 0 0 0 0 0 0 13.3469 0 0 0 0 0 0 14.4965 0 0 0 0 12.6996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1156 0 0 0 0 15.6926 0 13.0446 14.4517 0 0 0 13.4567 13.0576 0 0 0 0 15.1607 0 10.9273 0 11.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9418 0 14.9459 13.0605 13.8916 0 0 0 0 15.0632 0 P59827 BPIB4_HUMAN "BPI fold-containing family B member 4 (Ligand-binding protein RY2G5) (Long palate, lung and nasal epithelium carcinoma-associated protein 4)" BPIFB4 C20orf186 LPLUNC4 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular region [GO:0005576] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lipid binding [GO:0008289] GO:0005576; GO:0005829; GO:0008289; GO:0015629 lipid binding [GO:0008289] CDTLLGGIKVKLLR 0.86325 5.7725 0 0 0 13.1626 11.445 0 0 0 0 0 0 0 12.5278 0 0 0 0 0 0 0 14.4802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7927 0 0 0 0 0 0 0 0 0 0 14.8737 0 0 0 15.2378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.037 13.1547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0519 0 0 12.19 0 0 0 0 0 0 0 0 11.7399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99808 S29A1_HUMAN "Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter, Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1)" SLC29A1 ENT1 Homo sapiens (Human) adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; transport across blood-brain barrier [GO:0150104]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]; adenosine transport [GO:0032238]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; excitatory postsynaptic potential [GO:0060079]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; sleep [GO:0030431]; transport across blood-brain barrier [GO:0150104]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] GO:0001504; GO:0005326; GO:0005337; GO:0005886; GO:0005887; GO:0006139; GO:0006836; GO:0006855; GO:0007595; GO:0015211; GO:0015213; GO:0015858; GO:0015860; GO:0015862; GO:0016020; GO:0016323; GO:0016324; GO:0030431; GO:0032238; GO:0060079; GO:0071333; GO:0071456; GO:0072531; GO:0098793; GO:0098794; GO:0098810; GO:0150104; GO:1901642 neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213] AVWLIFFMLGLGTLLPWNFFMTATQYFTNR 0.864 5.6598 14.1388 0 12.7602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6373 0 0 0 12.3957 0 0 0 0 0 0 0 0 0 12.5152 16.8527 0 0 0 0 0 0 0 0 12.2641 0 0 13.0235 0 0 0 0 0 0 0 11.6662 0 0 0 0 12.5676 0 0 12.0853 0 0 0 0 13.4567 11.365 13.2219 0 0 0 0 0 0 0 0 0 10.6344 0 0 0 0 0 11.6179 0 0 12.6935 0 0 0 0 11.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8364 11.2734 0 0 11.7169 0 0 0 11.8995 13.4921 0 0 0 10.5871 0 0 0 0 0 12.5027 0 Q96NZ9 PRAP1_HUMAN Proline-rich acidic protein 1 (Epididymis tissue protein Li 178) (Uterine-specific proline-rich acidic protein) PRAP1 UPA UNQ608/PRO1195 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of apoptotic process [GO:0043066]; positive regulation of intestinal lipid absorption [GO:1904731]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of triglyceride transport [GO:1905885]" endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576] "endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; triglyceride binding [GO:0017129]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of apoptotic process [GO:0043066]; positive regulation of intestinal lipid absorption [GO:1904731]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of triglyceride transport [GO:1905885]" GO:0005576; GO:0005783; GO:0006974; GO:0006977; GO:0017129; GO:0043066; GO:0071481; GO:1902426; GO:1904731; GO:1905885; GO:2001140 triglyceride binding [GO:0017129] HWPSEQDPEKAWGAR 0.86441 5.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.072 0 0 0 0 0 14.7703 14.6465 0 14.1662 0 0 13.8283 14.7526 13.8437 14.0182 0 13.7837 0 0 0 0 0 0 0 0 15.3725 13.7519 14.8643 13.8398 0 14.2746 0 14.1813 0 14.8937 0 0 0 0 0 0 0 0 0 0 0 14.8784 0 13.1575 0 0 13.3389 0 11.6725 0 13.1886 14.6988 0 0 0 13.5175 0 13.824 0 14.5715 0 13.6578 0 0 0 0 14.4219 13.6381 0 0 0 0 0 13.8871 0 11.1024 13.7399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8067 0 0 13.5305 13.4528 0 0 0 0 0 0 Q50LG9 LRC24_HUMAN Leucine-rich repeat-containing protein 24 LRRC24 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965] GO:0005615; GO:0016021; GO:0031012; GO:0051965 ALGVATQTAIAAAIALLALTALLLVAMICR 0.86555 5.746 0 0 0 0 0 0 0 0 0 15.8267 0 0 0 14.9946 14.588 14.7323 0 14.5299 0 0 14.0357 0 0 0 0 14.7936 0 12.3567 0 13.8733 0 0 0 15.3647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1435 0 0 12.8737 0 0 0 0 14.1822 12.8722 12.0283 12.8205 0 0 0 0 0 0 0 14.318 0 0 0 0 13.4394 0 0 14.0345 0 14.4429 0 0 0 12.3714 13.3875 11.0551 12.2934 0 12.4422 13.6511 13.0839 0 0 0 0 0 12.7032 0 0 0 11.9565 0 0 0 0 0 0 0 0 0 0 0 12.8098 0 0 0 0 0 0 13.9996 0 11.4266 11.9189 0 0 14.2235 0 13.7467 0 0 0 12.4018 0 0 15.2907 0 0 0 14.2935 0 0 0 0 0 0 0 0 0 0 11.6506 0 0 0 0 0 0 0 0 Q6ZMP0 THSD4_HUMAN "Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6, ADAMTS-like protein 6, ADAMTSL-6)" THSD4 UNQ9334/PRO34005 Homo sapiens (Human) elastic fiber assembly [GO:0048251] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; hydrolase activity [GO:0016787]; elastic fiber assembly [GO:0048251] GO:0001527; GO:0016787; GO:0048251; GO:0062023; GO:0070062 hydrolase activity [GO:0016787] CELNCQAMGYR 0.86607 5.8251 0 0 0 0 0 0 0 0 0 12.7274 0 0 0 0 0 0 0 13.0562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.692 0 0 0 0 0 0 11.6864 0 0 13.8452 11.5187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1254 0 0 0 0 0 13.4693 10.9963 0 13.407 0 0 0 0 0 12.7093 0 0 13.4436 0 0 12.5622 13.4538 0 0 0 0 0 0 0 14.6565 0 0 0 0 0 11.5304 0 0 0 0 0 0 11.0105 12.7328 12.1578 0 0 0 0 0 0 12.6648 0 0 12.0301 10.1625 0 0 0 0 0 0 0 11.6671 12.5138 0 0 0 0 0 12.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68CZ6 HAUS3_HUMAN HAUS augmin-like complex subunit 3 HAUS3 C4orf15 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:0072686; GO:1990498 GDFDLQIAKQDYYTAR 0.86667 5.5455 0 0 0 0 0 0 0 0 0 0 0 13.6975 0 0 0 0 0 0 0 0 0 0 0 9.58646 0 0 0 0 0 0 0 0 0 0 0 0 12.1269 0 0 0 0 0 0 0 0 0 0 0 11.8886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4356 0 0 0 0 0 0 0 11.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8778 0 0 0 13.8701 0 0 0 0 0 0 0 11.1716 0 0 13.9064 0 10.8888 0 0 0 13.3436 0 0 0 0 0 0 0 14.8329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2285 0 11.5447 14.8037 0 0 10.373 11.144 0 13.8536 0 0 0 0 13.1414 0 0 12.7204 0 14.7425 0 0 0 14.1388 14.934 11.771 0 0 0 0 0 0 0 0 Q9H1C3 GL8D2_HUMAN "Glycosyltransferase 8 domain-containing protein 2, EC 2.4.1.-" GLT8D2 GALA4A UNQ1901/PRO4347 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757] GO:0005794; GO:0016021; GO:0016757 glycosyltransferase activity [GO:0016757] ALLRKINQVLLFLLIVTLCVILYK 0.86667 5.7301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3622 11.5974 0 0 0 0 0 0 0 0 0 0 0 16.409 0 0 0 0 0 0 12.8543 0 0 0 0 0 0 0 14.9993 0 0 0 13.8933 0 12.6086 14.2014 13.47 0 0 0 0 0 0 15.7028 0 0 0 0 0 0 13.0644 0 13.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7811 0 13.4184 0 12.4479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8733 0 0 0 0 0 0 0 0 0 0 0 P35414 APJ_HUMAN Apelin receptor (Angiotensin receptor-like 1) (G-protein coupled receptor APJ) (G-protein coupled receptor HG11) APLNR AGTRL1 APJ Homo sapiens (Human) adult heart development [GO:0007512]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; apelin receptor signaling pathway [GO:0060183]; atrioventricular valve development [GO:0003171]; blood vessel development [GO:0001568]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; heart development [GO:0007507]; heart looping [GO:0001947]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of inhibitory G protein-coupled receptor phosphorylation [GO:1904325]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of body fluid levels [GO:0050878]; regulation of gap junction assembly [GO:1903596]; regulation of gene expression [GO:0010468]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; apelin receptor activity [GO:0060182]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; adult heart development [GO:0007512]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; apelin receptor signaling pathway [GO:0060183]; atrioventricular valve development [GO:0003171]; blood vessel development [GO:0001568]; coronary vasculature development [GO:0060976]; endocardial cushion formation [GO:0003272]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; heart development [GO:0007507]; heart looping [GO:0001947]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of inhibitory G protein-coupled receptor phosphorylation [GO:1904325]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of body fluid levels [GO:0050878]; regulation of gap junction assembly [GO:1903596]; regulation of gene expression [GO:0010468]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412] GO:0001525; GO:0001568; GO:0001570; GO:0001944; GO:0001947; GO:0003171; GO:0003272; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007369; GO:0007507; GO:0007512; GO:0010468; GO:0010629; GO:0031065; GO:0035886; GO:0035904; GO:0038023; GO:0043951; GO:0045766; GO:0050878; GO:0051281; GO:0060182; GO:0060183; GO:0060412; GO:0060841; GO:0060976; GO:1903589; GO:1903596; GO:1904325 apelin receptor activity [GO:0060182]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023] DYDWPFGTFFCK 0.86885 5.6811 0 0 0 0 0 0 0 0 14.3858 10.5439 0 0 0 13.2695 0 0 0 13.1092 0 0 0 0 0 0 0 0 0 0 12.5523 12.9542 0 12.503 0 0 0 0 13.6396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0611 0 0 0 14.4849 14.3733 14.5748 0 0 0 0 14.0862 0 0 0 13.8929 14.0757 13.814 13.8622 11.2969 14.2001 0 0 0 13.7667 13.7739 13.9016 0 13.2792 0 13.2985 0 0 0 0 0 11.4622 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1624 11.5506 13.1907 0 13.2752 0 0 0 0 11.3915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IK5 GMCL1_HUMAN Germ cell-less protein-like 1 (Spermatogenesis-associated protein 29) GMCL1 BTBD13 GCL SPATA29 Homo sapiens (Human) germ cell development [GO:0007281]; spermatogenesis [GO:0007283] nuclear matrix [GO:0016363]; nucleus [GO:0005634] nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; germ cell development [GO:0007281]; spermatogenesis [GO:0007283] GO:0005634; GO:0007281; GO:0007283; GO:0016363; GO:0042802 identical protein binding [GO:0042802] DGEYCWRWTGFNFGFDLLVTYTNR 0.86957 5.7914 11.7329 0 10.9606 0 0 0 0 0 12.3451 0 12.2814 12.6294 0 0 11.6479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5218 0 0 0 0 11.5804 0 0 0 0 0 0 0 0 0 0 14.5996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5453 0 13.7063 0 0 0 0 0 0 0 0 0 0 0 13.4259 13.3403 12.2843 10.6659 0 0 0 13.6448 0 0 13.2641 0 0 0 0 0 11.9879 0 0 0 0 14.3476 0 0 0 0 0 13.2737 0 15.1193 0 0 0 0 0 0 13.0778 0 0 0 0 0 0 0 0 0 0 11.3314 0 0 0 0 0 0 0 0 0 0 14.3 12.2949 0 0 0 0 0 0 0 0 P60508 SYCY2_HUMAN "Syncytin-2 (Endogenous retrovirus group FRD member 1) (Envelope polyprotein) (HERV-FRD) (HERV-FRD_6p24.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERVFRD-1 ERVFRDE1 UNQ6191/PRO20218 Homo sapiens (Human) myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768] GO:0000768; GO:0005886; GO:0006949; GO:0007520; GO:0016021 CCFWVNQSGKVQDNIRQLLNQASSLR 0.86992 5.6705 0 0 0 0 0 0 0 0 0 12.5782 0 13.8928 0 0 13.525 0 0 0 0 0 0 0 11.8579 0 12.144 14.2447 14.8151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6339 0 0 0 0 0 0 0 0 10.5188 0 0 0 0 0 11.9222 0 14.072 10.6013 0 11.3642 0 0 0 0 0 0 14.0634 0 0 0 0 0 0 0 15.1747 0 0 0 0 14.5727 0 0 0 12.7923 0 0 15.0036 12.0817 0 0 0 0 11.2246 0 0 14.6128 0 0 14.6887 0 0 10.9781 0 0 0 0 14.4164 0 0 11.4823 11.8032 0 15.3612 15.2987 0 0 0 0 0 0 0 0 0 0 12.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.258 0 12.3526 11.6532 0 11.0981 0 0 0 12.3591 0 Q5H9J9 T11X2_HUMAN T-complex protein 11 X-linked protein 2 TCP11X2 Homo sapiens (Human) protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165] GO:0001669; GO:0007165; GO:0010737; GO:0036126; GO:1902490 CTTKALTEEFISR 0.87069 5.7883 0 0 0 0 0 0 0 0 0 0 0 11.8462 0 11.6695 0 0 13.4424 11.6014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5723 14.1883 0 0 13.5448 0 12.6122 14.6183 0 14.5877 0 14.1221 13.5963 13.0599 0 0 0 13.1075 0 0 0 11.3663 11.0169 0 0 0 12.4084 0 0 0 14.3773 0 0 14.1463 0 0 0 0 0 0 0 0 0 14.2987 0 0 0 0 12.173 14.2421 0 13.2809 14.1192 12.5358 0 0 0 0 0 0 0 0 0 14.1154 0 0 0 0 0 0 12.6517 0 0 0 0 0 0 0 12.263 0 0 0 0 0 0 0 12.4656 0 0 0 0 0 13.1127 0 0 11.3825 0 0 0 0 0 P61978 HNRPK_HUMAN "Heterogeneous nuclear ribonucleoprotein K, hnRNP K (Transformation up-regulated nuclear protein, TUNP)" HNRNPK HNRPK Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; signal transduction [GO:0007165]" catalytic step 2 spliceosome [GO:0071013]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; ribonucleoprotein complex [GO:1990904]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; signal transduction [GO:0007165]" GO:0000398; GO:0000785; GO:0002102; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006357; GO:0006396; GO:0007165; GO:0010468; GO:0010494; GO:0010988; GO:0016020; GO:0019904; GO:0042802; GO:0042995; GO:0043066; GO:0045296; GO:0045892; GO:0045944; GO:0048024; GO:0048025; GO:0048260; GO:0070062; GO:0071013; GO:1902165; GO:1905599; GO:1990904 cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] ALRTDYNASVSVPDSSGPER 0.87313 5.5458 0 0 0 0 0 0 0 0 11.4831 15.0464 15.357 0 14.9501 0 14.3045 0 0 0 0 0 0 0 0 0 0 0 14.7339 0 14.7753 0 14.7083 14.8368 0 0 0 0 0 0 0 0 14.9041 14.9856 0 0 0 0 0 13.0762 0 0 0 0 12.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5893 0 15.1478 14.8495 12.7601 0 0 0 0 12.6036 0 0 0 0 0 0 0 12.5074 10.9181 13.689 0 0 0 0 0 0 0 0 12.6334 0 0 0 0 0 11.8826 14.2457 0 0 0 0 0 14.802 14.2258 14.1321 0 0 13.0495 0 0 14.1548 11.1824 12.5191 0 0 0 0 0 0 14.9928 0 0 0 15.0487 0 14.9841 0 14.8125 0 14.7475 0 0 0 14.1596 12.3622 12.4711 0 0 0 0 10.7121 0 14.7872 0 0 0 0 0 0 0 0 11.6471 11.5117 0 0 11.3968 12.2331 11.3706 0 0 0 0 0 0 0 11.4028 P05155 IC1_HUMAN "Plasma protease C1 inhibitor, C1 Inh, C1Inh (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)" SERPING1 C1IN C1NH Homo sapiens (Human) "aging [GO:0007568]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; complement activation, classical pathway [GO:0006958]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; negative regulation of complement activation, lectin pathway [GO:0001869]; negative regulation of endopeptidase activity [GO:0010951]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; serine-type endopeptidase inhibitor activity [GO:0004867]; aging [GO:0007568]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; complement activation, classical pathway [GO:0006958]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; negative regulation of complement activation, lectin pathway [GO:0001869]; negative regulation of endopeptidase activity [GO:0010951]" GO:0001869; GO:0004867; GO:0005576; GO:0005615; GO:0005788; GO:0006958; GO:0007568; GO:0007596; GO:0008015; GO:0010951; GO:0031093; GO:0042730; GO:0045087; GO:0062023; GO:0070062; GO:0072562 serine-type endopeptidase inhibitor activity [GO:0004867] AKVGQLQLSHNLSLVILVPQNLK 0.875 5.274 10.8035 0 0 0 14.6714 0 0 0 0 0 0 0 0 0 0 0 12.7645 0 0 0 13.8162 0 0 0 0 0 0 0 11.7391 0 0 12.7871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9109 0 0 0 0 11.3076 0 0 0 0 0 0 0 0 0 0 10.9569 12.2254 0 0 0 0 0 0 13.9101 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1959 0 0 0 0 0 0 0 0 14.5712 11.9723 0 0 0 0 0 0 0 0 0 0 14.0527 0 0 0 0 0 0 0 0 0 0 0 0 10.4374 0 0 0 0 0 0 12.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAS3 S28A3_HUMAN "Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3, CNT 3, hCNT3)" SLC28A3 CNT3 Homo sapiens (Human) nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] brush border membrane [GO:0031526]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]; nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] GO:0005337; GO:0005345; GO:0005415; GO:0005789; GO:0005886; GO:0005887; GO:0006855; GO:0015213; GO:0015293; GO:0015389; GO:0015390; GO:0015860; GO:0015862; GO:0015864; GO:0031526; GO:0072531; GO:1901642; GO:1904823 nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213] EHMEDDDEEMQQK 0.87611 5.8155 0 0 0 0 0 0 0 0 0 0 0 0 12.675 0 0 10.3951 0 0 0 0 0 13.264 11.8719 0 0 0 0 0 0 0 11.4974 0 0 0 0 0 0 0 0 0 10.9226 0 0 11.2619 0 12.3434 0 0 0 11.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3168 0 0 0 0 12.5718 0 0 0 15.2116 0 0 0 0 0 0 14.1284 12.5716 0 0 0 0 0 10.3881 0 0 13.8352 0 0 0 0 0 0 0 0 13.2027 12.7167 0 0 0 0 14.6688 14.2412 10.8875 0 0 0 13.099 12.7813 14.0472 0 13.4794 0 0 11.6107 0 0 0 14.1621 0 14.3085 0 0 13.6608 15.0513 12.8709 11.5876 0 12.2531 13.8337 0 12.2911 0 0 0 0 0 0 0 0 0 0 11.7411 0 0 0 0 0 0 0 0 0 11.744 0 0 0 0 11.4975 0 0 12.9312 0 0 0 0 0 0 0 Q9NYW1 TA2R9_HUMAN "Taste receptor type 2 member 9, T2R9 (Taste receptor family B member 6, TRB6)" TAS2R9 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] AIKAVIIFLLLLIVYYPVFLVMTSSALIPQGK 0.87719 5.8011 13.0309 0 0 0 0 0 0 0 12.3233 0 0 0 0 0 0 0 0 13.9806 11.8667 0 13.2539 11.958 0 0 13.4969 0 0 0 0 0 0 0 0 0 0 0 12.1143 0 0 0 10.79 0 0 0 0 0 0 0 0 0 0 0 13.479 0 0 0 0 0 0 0 0 0 0 0 0 0 12.861 0 12.5631 13.1483 13.5688 0 0 12.2151 0 0 0 14.9216 15.0979 13.5342 13.6374 0 0 12.3321 0 0 13.7582 12.5765 0 12.7446 12.6123 0 13.4662 14.7204 0 13.1154 0 0 13.9474 14.4627 0 14.3325 13.3951 13.5587 0 14.9138 0 12.8166 13.3711 13.3887 14.9845 13.5399 13.3582 14.4444 0 12.9622 0 0 0 15.367 13.5841 13.1633 15.11 0 0 0 14.2208 14.5777 0 12.9125 0 0 13.2406 0 14.4108 12.461 0 13.2656 0 0 12.7456 13.9096 0 0 14.4182 0 0 0 14.8033 0 14.4184 10.8597 0 13.1024 15.8364 14.9438 0 0 12.8991 0 12.5412 0 0 0 0 12.0701 0 0 11.4725 0 0 0 0 0 12.6926 12.4923 0 0 0 14.6212 Q9UKC9 FBXL2_HUMAN F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2) (F-box protein FBL2/FBL3) FBXL2 FBL2 FBL3 Homo sapiens (Human) modulation by host of viral RNA genome replication [GO:0044830]; protein modification process [GO:0036211]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; modulation by host of viral RNA genome replication [GO:0044830]; protein modification process [GO:0036211]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0005516; GO:0005737; GO:0006508; GO:0006513; GO:0010506; GO:0014066; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036211; GO:0036312; GO:0044830 calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903] CSHLTDAGFTLLAR 0.8797 5.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5202 0 0 0 0 15.2936 0 0 0 0 0 0 0 0 0 0 13.6089 0 0 0 0 0 0 12.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6718 0 0 0 13.2537 0 0 0 0 0 12.0789 0 12.8712 12.3078 0 0 0 0 0 0 0 0 0 0 0 0 0 12.594 0 0 0 0 0 0 0 0 0 0 0 0 11.2838 0 0 0 Q9NS15 LTBP3_HUMAN "Latent-transforming growth factor beta-binding protein 3, LTBP-3" LTBP3 Homo sapiens (Human) bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; chondrocyte differentiation [GO:0002062]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; chondrocyte differentiation [GO:0002062]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0002062; GO:0005509; GO:0005576; GO:0007179; GO:0030282; GO:0030502; GO:0032331; GO:0036363; GO:0045780; GO:0046849; GO:0048251; GO:0050431; GO:0060349; GO:0060430; GO:0062023; GO:0070062; GO:1902462; GO:2000741 calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431] CIACQPGYRSQGGGACR 0.88024 5.2767 0 0 0 0 0 0 0 0 0 0 0 0 11.5464 0 0 0 12.6579 0 0 0 0 11.8849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4612 13.994 0 14.2707 14.2507 0 0 0 0 0 0 11.0284 0 0 0 0 12.3565 0 11.1206 0 0 0 10.7164 9.46795 0 0 0 0 0 0 0 10.715 12.1236 0 0 0 12.7731 13.4319 12.1167 0 0 0 0 0 0 10.5936 0 13.1005 0 0 0 0 0 0 13.1302 0 11.5485 0 10.443 10.3514 0 0 11.9079 11.0505 0 14.3672 0 12.2206 0 0 0 0 11.0752 9.42811 9.70073 0 12.079 0 11.0587 10.7351 0 0 0 9.94212 12.1602 0 0 0 12.4059 14.5542 12.8549 0 11.9532 0 0 0 11.3022 10.9883 0 0 11.1601 10.5095 0 12.7131 12.0724 0 0 0 0 0 0 0 0 0 Q9HBI1 PARVB_HUMAN Beta-parvin (Affixin) PARVB CGI-56 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0031532; GO:0034446; GO:0071963 actin binding [GO:0003779] AREVSDLQEEGK 0.88415 5.3036 0 0 0 0 0 0 0 0 0 0 0 13.9049 13.4703 0 13.2286 0 14.7767 0 0 0 0 0 0 0 12.9492 12.9297 14.9025 0 11.7807 13.4543 0 0 0 0 13.5005 0 13.0356 0 0 17.1115 17.0959 0 15.2835 0 0 0 0 15.0767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7938 0 0 0 0 0 0 16.3582 0 0 19.0223 17.7808 13.3659 17.5943 0 0 0 17.8462 18.6182 0 0 0 0 0 0 0 0 0 0 17.0838 0 0 16.5468 16.3049 0 0 0 16.8212 0 0 10.9831 16.448 16.2984 0 0 13.9219 16.8347 17.0566 11.3418 0 16.2975 16.4663 0 0 0 0 0 0 11.5019 17.8851 16.1292 0 0 0 16.0134 15.7487 0 0 0 0 13.8641 0 0 0 11.8471 0 0 0 0 16.6042 0 0 0 0 0 0 15.0714 0 0 0 0 0 0 0 0 0 0 15.6662 0 0 0 0 0 P59047 NALP5_HUMAN "NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog) (Maternal Antigen that Embryos Require)" NLRP5 MATER NALP5 Homo sapiens (Human) actin filament organization [GO:0007015]; cortical granule exocytosis [GO:0060471]; establishment of organelle localization [GO:0051656]; establishment of spindle localization [GO:0051293]; exocytosis [GO:0006887]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302]; regulation of inflammatory response [GO:0050727]; regulation of localization [GO:0032879] cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; subcortical maternal complex [GO:0106333] cell cortex [GO:0005938]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; subcortical maternal complex [GO:0106333]; ATP binding [GO:0005524]; tubulin binding [GO:0015631]; actin filament organization [GO:0007015]; cortical granule exocytosis [GO:0060471]; establishment of organelle localization [GO:0051656]; establishment of spindle localization [GO:0051293]; exocytosis [GO:0006887]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302]; regulation of inflammatory response [GO:0050727]; regulation of localization [GO:0032879] GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005938; GO:0006887; GO:0007015; GO:0015631; GO:0032879; GO:0040019; GO:0043231; GO:0050727; GO:0051293; GO:0051302; GO:0051656; GO:0060471; GO:0060473; GO:0106333 ATP binding [GO:0005524]; tubulin binding [GO:0015631] DWAEKQPPFTLIR 0.88554 5.2793 14.5112 15.2058 14.6211 0 0 0 0 0 0 12.4737 0 0 0 0 13.6414 0 0 0 0 13.4876 0 0 12.247 0 0 0 0 0 0 0 0 0 0 0 0 14.0423 0 0 0 12.0025 10.4307 0 0 0 0 0 11.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3239 0 0 0 11.5756 0 0 0 13.8761 0 0 0 0 0 0 11.7706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0042 0 13.1652 0 0 0 0 0 0 0 0 13.7569 0 15.8027 0 0 0 0 0 0 0 0 11.6159 0 0 16.029 14.619 0 0 0 0 0 0 0 0 0 13.3622 0 0 15.7783 0 0 0 0 13.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N339 MT1M_HUMAN "Metallothionein-1M, MT-1M (Metallothionein-IM, MT-IM)" MT1M MT1K Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010273; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAHGCVCKGTLENCSCCA 0.88636 5.5579 0 0 0 0 0 0 0 11.7077 13.7177 15.2964 0 0 14.5365 0 0 0 0 0 12.8503 12.034 0 0 11.5259 0 12.9742 12.6252 11.5259 0 0 13.7985 0 0 13.1555 0 0 0 0 0 0 0 0 0 0 0 14.2398 0 0 13.5376 0 0 10.3097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5465 0 0 0 0 0 0 11.1529 0 0 0 14.3365 13.9632 13.0169 0 13.9217 0 0 0 0 0 11.3526 0 11.3975 13.2558 0 0 11.8809 0 0 12.5962 11.4836 0 0 11.7108 0 0 12.6009 0 11.5892 15.0508 12.8314 15.1694 15.4464 11.8822 0 12.9131 0 0 13.059 0 0 0 14.0283 0 13.8409 12.0573 0 0 14.5322 0 11.4712 0 14.3943 13.5631 13.7323 0 0 0 0 0 0 14.3775 0 0 0 14.8748 13.4342 0 13.3071 0 0 0 13.8529 13.2353 0 0 0 0 0 0 0 12.0744 0 0 0 0 0 10.7062 0 13.2945 0 0 0 0 0 10.9837 0 0 0 12.5054 0 0 0 Q8TD46 MO2R1_HUMAN Cell surface glycoprotein CD200 receptor 1 (CD200 cell surface glycoprotein receptor) (Cell surface glycoprotein OX2 receptor 1) CD200R1 CD200R CRTR2 MOX2R OX2R UNQ2522/PRO6015 Homo sapiens (Human) heterotypic cell-cell adhesion [GO:0034113]; intracellular signal transduction [GO:0035556]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; negative regulation of T cell migration [GO:2000405]; regulation of neuroinflammatory response [GO:0150077]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; glycosylated region protein binding [GO:0140081]; immunoglobulin receptor activity [GO:0019763]; signaling receptor activity [GO:0038023]; heterotypic cell-cell adhesion [GO:0034113]; intracellular signal transduction [GO:0035556]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; negative regulation of T cell migration [GO:2000405]; regulation of neuroinflammatory response [GO:0150077]; signal transduction [GO:0007165] GO:0005576; GO:0005886; GO:0007165; GO:0009897; GO:0009986; GO:0016021; GO:0019763; GO:0032715; GO:0034113; GO:0035556; GO:0038023; GO:0043235; GO:0140081; GO:0150077; GO:0150079; GO:1901215; GO:1905522; GO:2000405 glycosylated region protein binding [GO:0140081]; immunoglobulin receptor activity [GO:0019763]; signaling receptor activity [GO:0038023] ETNCTDER 0.88957 5.3043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3158 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4235 0 0 0 10.7534 0 0 0 0 0 0 0 9.38329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.548 0 0 14.9821 0 14.7913 0 0 0 14.6282 14.6015 0 14.8791 0 0 13.7695 0 0 14.4761 0 0 0 0 0 0 12.9592 0 0 0 13.133 0 12.6578 10.5135 0 0 12.5095 0 0 0 0 14.7586 12.3985 0 13.7811 0 0 0 0 0 0 0 0 12.7439 0 0 0 0 0 12.7445 0 13.4229 13.1587 0 0 13.1215 0 11.8473 0 0 14.1748 0 0 0 0 0 0 0 13.8969 0 0 0 11.8872 0 12.6395 11.937 0 0 0 12.0583 0 0 0 0 0 0 0 13.3385 0 0 0 0 14.5263 O75914 PAK3_HUMAN "Serine/threonine-protein kinase PAK 3, EC 2.7.11.1 (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3, PAK-3)" PAK3 OPHN3 Homo sapiens (Human) axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; synapse organization [GO:0050808] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; axonogenesis [GO:0007409]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; synapse organization [GO:0050808] GO:0002223; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006468; GO:0007409; GO:0010763; GO:0014069; GO:0016358; GO:0017124; GO:0030833; GO:0031267; GO:0032956; GO:0035556; GO:0043408; GO:0043525; GO:0046872; GO:0048013; GO:0050770; GO:0050808; GO:0060997; GO:0061003; GO:0071407; GO:0098978; GO:0106310; GO:2000573 ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] CLEMDVDRR 0.89412 5.2633 0 0 0 13.7053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7699 14.7782 13.8651 12.3239 0 0 0 14.634 0 0 0 0 0 14.4123 15.0233 0 14.8576 0 0 0 14.2375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7496 0 0 0 11.2016 0 0 0 0 0 0 0 0 0 0 0 14.4428 0 0 0 0 0 14.7176 0 0 0 0 0 0 0 13.9163 0 0 0 14.3148 0 0 0 0 0 13.9098 0 0 15.2725 0 0 0 0 14.8192 0 14.1008 0 0 15.0641 0 0 0 0 13.8702 14.796 0 0 15.5285 0 15.0305 15.318 15.8026 0 0 0 14.3752 15.088 15.6337 16.1695 15.0615 13.7888 13.8127 0 17.4017 0 0 0 0 17.3681 16.6748 0 15.7862 14.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.668 0 0 15.5643 16.8394 0 0 0 0 0 0 Q13002 GRIK2_HUMAN "Glutamate receptor ionotropic, kainate 2, GluK2 (Excitatory amino acid receptor 4, EAA4) (Glutamate receptor 6, GluR-6, GluR6)" GRIK2 GLUR6 Homo sapiens (Human) "behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of synaptic transmission [GO:0050806]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] "anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; behavioral fear response [GO:0001662]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of cold stimulus involved in thermoception [GO:0120169]; glutamate receptor signaling pathway [GO:0007215]; inhibitory postsynaptic potential [GO:0060080]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; positive regulation of synaptic transmission [GO:0050806]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic transmission, glutamatergic [GO:0035249]" GO:0001662; GO:0005234; GO:0005886; GO:0005887; GO:0006874; GO:0007215; GO:0007268; GO:0008066; GO:0014069; GO:0015276; GO:0015277; GO:0019228; GO:0032983; GO:0035249; GO:0038023; GO:0042734; GO:0043025; GO:0043524; GO:0045211; GO:0048169; GO:0048172; GO:0050804; GO:0050806; GO:0051402; GO:0051967; GO:0060080; GO:0070161; GO:0098686; GO:0098978; GO:0099171; GO:0099507; GO:0120169; GO:1904315 extracellularly glutamate-gated ion channel activity [GO:0005234]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] AILDLVQFFK 0.89506 5.3046 0 0 11.1662 15.0628 0 0 11.6989 0 0 0 0 0 0 0 13.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3669 11.7117 0 0 0 0 0 0 0 0 0 10.2261 0 0 0 0 0 0 0 0 0 0 0 0 14.423 0 0 0 0 0 0 0 10.1964 0 0 0 0 0 0 0 0 13.6821 0 13.9955 13.086 10.8007 0 13.2455 0 13.1555 0 0 0 0 0 0 0 0 0 12.5776 12.2392 0 0 0 0 0 0 12.765 14.6014 0 0 0 0 0 0 13.467 0 12.9133 12.0204 0 0 11.563 0 0 14.2899 0 0 13.2194 13.9444 11.9402 0 0 13.1282 11.6476 0 13.2414 12.048 15.7244 0 0 12.0923 0 0 0 0 12.6915 12.6145 0 0 15.0015 12.8167 12.2094 0 0 0 0 12.8319 0 0 0 0 0 12.6153 0 11.7655 0 12.3968 0 0 0 0 0 0 0 13.2122 0 0 0 0 0 12.8301 14.0004 12.9256 13.3188 0 0 0 0 0 P35858 ALS_HUMAN "Insulin-like growth factor-binding protein complex acid labile subunit, ALS" IGFALS ALS Homo sapiens (Human) cell adhesion [GO:0007155]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor ternary complex [GO:0042567]; insulin-like growth factor binding [GO:0005520]; cell adhesion [GO:0007155]; signal transduction [GO:0007165] GO:0005520; GO:0005576; GO:0005615; GO:0007155; GO:0007165; GO:0031012; GO:0042567; GO:0070062 insulin-like growth factor binding [GO:0005520] ALRKGGLALALLLLSWVALGPR 0.89595 5.2285 0 0 0 0 0 0 0 0 0 12.5099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7829 0 0 0 0 0 13.9311 0 0 0 0 0 0 0 0 0 12.6084 0 9.99393 12.2616 0 0 0 0 0 0 0 0 0 10.8756 0 0 0 0 0 0 0 0 0 0 0 14.9509 11.8374 0 11.6688 0 0 0 0 0 13.4409 0 0 0 0 0 0 0 0 0 0 0 13.0084 0 0 0 0 0 0 14.074 0 0 0 13.3967 0 0 0 0 0 13.0753 0 0 0 14.5191 0 0 0 0 0 0 14.2373 14.9315 0 0 0 0 12.2371 0 0 0 13.2174 0 14.4376 0 0 0 0 0 0 12.7305 14.0547 0 0 0 14.307 14.7501 13.7902 13.9426 0 15.3158 0 0 0 0 0 14.664 14.6763 0 15.8438 0 0 0 0 0 0 14.8551 0 0 0 0 0 0 0 0 0 0 12.4938 0 0 13.3239 0 14.1588 11.5454 Q7Z6B0 CCD91_HUMAN Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein) CCDC91 GGABP HSD8 Homo sapiens (Human) Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031] GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0015031; GO:0016020; GO:0090160 ALLQSSVKQQVEAIEK 0.89655 5.213 0 0 0 14.5343 0 15.0521 0 0 0 0 0 0 0 15.1041 0 14.9065 0 0 0 0 0 13.4849 14.5703 0 0 0 9.58032 0 0 0 0 0 0 0 0 0 13.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1408 0 18.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1949 0 0 0 0 0 13.2919 0 0 0 0 0 0 13.4712 12.9526 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0196 0 0 0 0 0 0 0 0 0 12.9224 0 0 13.317 0 13.1506 0 0 0 0 0 12.9483 0 0 0 0 0 0 11.7861 0 0 0 0 0 0 0 0 0 0 0 12.5292 0 0 0 0 0 0 0 0 Q8WTP8 AEN_HUMAN "Apoptosis-enhancing nuclease, EC 3.1.-.- (Interferon-stimulated 20 kDa exonuclease-like 1)" AEN ISG20L1 SBBI58 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; response to ionizing radiation [GO:0010212] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; response to ionizing radiation [GO:0010212] GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0010212; GO:0031965; GO:0042771 exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] ARVSLKDLALQLLHK 0.89831 5.184 0 0 0 0 0 0 0 11.5045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6542 0 0 0 0 0 13.1331 0 0 0 0 0 0 14.4798 0 13.1932 0 0 0 12.6176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9795 0 0 11.3218 10.3492 0 0 0 0 0 0 0 0 13.1907 14.1356 0 13.189 0 0 0 0 13.647 0 0 0 0 0 0 0 12.0956 13.3133 0 0 0 0 0 0 0 0 0 0 11.7551 0 0 0 0 0 0 0 0 0 0 0 14.2535 0 0 11.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5554 0 12.5975 0 0 0 12.7645 0 14.6073 0 0 0 0 0 0 0 0 0 Q96EK6 GNA1_HUMAN "Glucosamine 6-phosphate N-acetyltransferase, EC 2.3.1.4 (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase)" GNPNAT1 GNA1 Homo sapiens (Human) UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] GO:0000139; GO:0004343; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0006048; GO:0008080; GO:0010008; GO:0042802; GO:0048029 glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; N-acetyltransferase activity [GO:0008080] FGYTVSEENYMCRR 0.89941 5.2645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9327 0 0 0 0 0 0 10.1562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4266 0 0 0 0 0 0 0 12.705 0 0 0 11.8606 0 0 0 0 0 0 0 0 0 0 0 13.9368 0 0 0 11.9973 0 0 0 15.6063 0 0 0 13.6225 0 14.4061 0 15.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8392 12.6743 0 0 14.6256 0 0 13.2326 10.2241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2044 0 12.8621 0 0 13.4027 0 0 0 0 0 0 0 15.5492 13.8693 0 0 0 0 17.952 10.7498 15.3769 0 15.0494 12.5177 0 11.1492 0 0 0 16.2033 0 0 O14717 TRDMT_HUMAN "tRNA (cytosine(38)-C(5))-methyltransferase, EC 2.1.1.204 (DNA (cytosine-5)-methyltransferase-like protein 2, Dnmt2) (DNA methyltransferase homolog HsaIIP, DNA MTase homolog HsaIIP, M.HsaIIP) (PuMet)" TRDMT1 DNMT2 Homo sapiens (Human) response to amphetamine [GO:0001975]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA methyltransferase activity [GO:0008175]; response to amphetamine [GO:0001975]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] GO:0001975; GO:0002946; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006400; GO:0008175; GO:0016428; GO:0030488; GO:0036416 RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA methyltransferase activity [GO:0008175] IGRQGDMTDSR 0.9 5.403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7769 0 0 0 0 0 12.808 0 15.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2761 0 0 Q13162 PRDX4_HUMAN "Peroxiredoxin-4, EC 1.11.1.24 (Antioxidant enzyme AOE372, AOE37-2) (Peroxiredoxin IV, Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4)" PRDX4 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; I-kappaB phosphorylation [GO:0007252]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] GO:0005576; GO:0005634; GO:0005783; GO:0005829; GO:0006979; GO:0007252; GO:0007283; GO:0008379; GO:0008584; GO:0018401; GO:0022417; GO:0030198; GO:0034774; GO:0042802; GO:0045454; GO:0070062; GO:0072593; GO:1904813; GO:2000255 identical protein binding [GO:0042802]; thioredoxin peroxidase activity [GO:0008379] DYGVYLEDSGHTLRGLFIIDDKGILR 0.90062 5.3058 0 0 0 0 0 10.807 0 11.4663 14.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5343 0 0 0 0 0 12.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1582 0 0 13.2973 0 0 13.3305 0 0 0 0 0 0 0 0 0 0 13.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1685 0 0 0 0 0 0 0 0 12.6801 13.7726 0 0 0 0 0 0 13.3711 0 0 0 0 0 0 0 13.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 13.53 0 0 0 0 O75882 ATRN_HUMAN Attractin (DPPT-L) (Mahogany homolog) ATRN KIAA0548 MGCA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005604; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0006979; GO:0009887; GO:0009888; GO:0016477; GO:0021549; GO:0030246; GO:0034446; GO:0038023; GO:0040014; GO:0042552; GO:0043473; GO:0070062 carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023] CDQHTDCYSCTANTNDCHWCNDHCVPR 0.9011 5.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4443 9.98456 0 0 0 11.7606 0 0 0 0 0 0 0 0 10.5329 18.3161 0 0 9.90094 0 0 0 0 0 0 0 10.7479 11.3406 0 0 0 0 0 0 9.33374 0 0 0 0 0 0 0 0 0 0 0 10.6976 0 0 0 11.093 0 11.9756 10.3524 0 0 0 0 0 12.3896 0 13.2749 0 0 0 0 0 0 12.1627 0 0 0 0 0 11.9263 0 0 0 11.5539 0 11.1182 0 0 0 13.0605 0 0 11.303 0 0 0 0 11.5563 12.1316 0 0 0 13.1746 10.691 11.5467 0 0 0 0 0 0 0 0 12.2136 0 10.4789 0 0 0 9.45107 0 0 0 0 0 0 13.8596 0 0 12.7498 0 0 0 0 12.6406 0 0 0 0 0 0 0 0 0 0 0 15.5675 13.0042 0 0 0 0 11.5076 0 0 0 0 0 0 0 0 0 12.7069 P50454 SERPH_HUMAN "Serpin H1 (47 kDa heat shock protein) (Arsenic-transactivated protein 3, AsTP3) (Cell proliferation-inducing gene 14 protein) (Collagen-binding protein, Colligin) (Rheumatoid arthritis-related antigen RA-A47)" SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 Homo sapiens (Human) chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; negative regulation of endopeptidase activity [GO:0010951]; protein maturation [GO:0051604]; response to unfolded protein [GO:0006986] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; membrane raft [GO:0045121] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; collagen binding [GO:0005518]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; unfolded protein binding [GO:0051082]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; negative regulation of endopeptidase activity [GO:0010951]; protein maturation [GO:0051604]; response to unfolded protein [GO:0006986] GO:0003433; GO:0003723; GO:0004867; GO:0005518; GO:0005615; GO:0005783; GO:0005788; GO:0005793; GO:0006986; GO:0010951; GO:0030199; GO:0032964; GO:0045121; GO:0051082; GO:0051604; GO:0062023 collagen binding [GO:0005518]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; unfolded protein binding [GO:0051082] AVAISLPKGVVEVTHDLQK 0.90116 5.2435 0 0 0 0 0 0 0 14.5435 10.4965 0 0 0 0 11.3856 0 0 0 0 0 0 0 0 13.3285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6143 0 0 0 0 0 0 0 0 11.463 0 0 11.7052 0 0 12.1725 12.1978 13.7005 11.2898 0 0 0 13.167 13.1925 0 0 0 12.8934 0 11.8426 0 12.5667 12.2942 12.3469 0 11.038 0 0 0 0 0 12.6008 0 0 0 0 0 0 0 0 12.8614 0 0 0 0 0 0 0 0 0 12.303 12.3125 0 0 11.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9698 0 0 0 10.8184 0 0 0 0 13.9907 0 0 0 0 0 0 0 0 0 10.7812 0 0 0 0 10.8759 0 11.2394 0 0 Q8NCW0 KREM2_HUMAN Kremen protein 2 (Dickkopf receptor 2) (Kringle domain-containing transmembrane protein 2) (Kringle-containing protein marking the eye and the nose) KREMEN2 KRM2 Homo sapiens (Human) limb development [GO:0060173]; negative regulation of ossification [GO:0030279]; Wnt signaling pathway [GO:0016055] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; limb development [GO:0060173]; negative regulation of ossification [GO:0030279]; Wnt signaling pathway [GO:0016055] GO:0005886; GO:0016021; GO:0016055; GO:0030279; GO:0031901; GO:0060173 GYQLAGVEAGYACFCGSESDLAR 0.90341 5.1893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1284 0 0 12.4877 11.3166 0 12.6143 12.4443 12.8717 12.154 0 0 0 0 0 13.1236 0 0 0 0 0 13.6677 0 0 0 0 0 0 0 0 13.8684 0 0 13.0936 12.1898 0 13.6334 0 12.5391 16.3237 0 0 0 0 0 0 13.0937 13.7824 0 0 0 0 0 0 0 0 13.6337 12.2717 0 0 12.1026 13.7108 0 0 0 0 0 0 0 13.7679 12.0636 11.8293 0 0 0 0 0 0 0 12.0982 14.4603 0 0 0 0 0 0 0 0 0 0 0 0 15.3217 0 0 16.4524 0 15.2055 0 15.5353 13.6647 0 0 0 12.2998 12.2379 0 16.0989 12.3537 14.5532 11.5194 0 Q12864 CAD17_HUMAN "Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin, LI-cadherin)" CDH17 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; germinal center B cell differentiation [GO:0002314]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; integrin-mediated signaling pathway [GO:0007229]; marginal zone B cell differentiation [GO:0002315]; oligopeptide transmembrane transport [GO:0035672]; oligopeptide transport [GO:0006857]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; spleen development [GO:0048536] basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; germinal center B cell differentiation [GO:0002314]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; integrin-mediated signaling pathway [GO:0007229]; marginal zone B cell differentiation [GO:0002315]; oligopeptide transmembrane transport [GO:0035672]; oligopeptide transport [GO:0006857]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; spleen development [GO:0048536] GO:0002314; GO:0002315; GO:0005178; GO:0005427; GO:0005509; GO:0005654; GO:0005886; GO:0006857; GO:0007155; GO:0007156; GO:0007229; GO:0009986; GO:0016021; GO:0016323; GO:0016339; GO:0016342; GO:0030054; GO:0033626; GO:0035672; GO:0045296; GO:0048536; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427] ALDRETRSTHNLQVAALDANGIIVEGPVPITIK 0.90449 5.1831 0 12.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.252 0 0 0 12.4255 0 0 0 0 12.5627 0 0 0 0 0 0 17.6979 0 0 0 0 12.0735 0 13.9619 0 0 0 0 11.614 0 0 10.6027 0 0 0 0 0 14.0663 12.2034 0 0 0 0 11.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3508 0 0 0 0 12.2169 0 13.0749 0 0 0 0 0 0 0 0 17.1912 0 0 0 0 0 0 0 0 0 0 0 0 12.3996 0 0 0 0 0 0 11.7854 0 13.2603 0 P22888 LSHR_HUMAN "Lutropin-choriogonadotropic hormone receptor, LH/CG-R (Luteinizing hormone receptor, LHR, LSH-R)" LHCGR LCGR LGR2 LHRHR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; arachidonic acid secretion [GO:0050482]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; central nervous system development [GO:0007417]; cognition [GO:0050890]; development of secondary male sexual characteristics [GO:0046544]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; protein targeting to lysosome [GO:0006622]; regulation of steroid hormone biosynthetic process [GO:0090030]; response to xenobiotic stimulus [GO:0009410]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]; uterus development [GO:0060065]" endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of external side of plasma membrane [GO:0031233]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of external side of plasma membrane [GO:0031233]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATPase binding [GO:0051117]; choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; identical protein binding [GO:0042802]; luteinizing hormone receptor activity [GO:0004964]; peptide hormone binding [GO:0017046]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; arachidonic acid secretion [GO:0050482]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to luteinizing hormone stimulus [GO:0071373]; central nervous system development [GO:0007417]; cognition [GO:0050890]; development of secondary male sexual characteristics [GO:0046544]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; protein targeting to lysosome [GO:0006622]; regulation of steroid hormone biosynthetic process [GO:0090030]; response to xenobiotic stimulus [GO:0009410]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283]; uterus development [GO:0060065]" GO:0001541; GO:0004964; GO:0005615; GO:0005634; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0006622; GO:0007186; GO:0007187; GO:0007189; GO:0007190; GO:0007200; GO:0007283; GO:0007417; GO:0008528; GO:0008584; GO:0009410; GO:0009755; GO:0010524; GO:0017046; GO:0022602; GO:0030539; GO:0031233; GO:0032962; GO:0035472; GO:0038106; GO:0042700; GO:0042802; GO:0043235; GO:0046544; GO:0046886; GO:0050482; GO:0050850; GO:0050890; GO:0051117; GO:0051281; GO:0060065; GO:0071371; GO:0071373; GO:0072520; GO:0090030 ATPase binding [GO:0051117]; choriogonadotropin hormone binding [GO:0038106]; choriogonadotropin hormone receptor activity [GO:0035472]; G protein-coupled peptide receptor activity [GO:0008528]; identical protein binding [GO:0042802]; luteinizing hormone receptor activity [GO:0004964]; peptide hormone binding [GO:0017046] FSALQLLKLLLLLQPPLPR 0.90503 5.1798 13.9318 0 0 0 0 0 11.1311 0 0 0 0 11.4513 0 0 0 0 0 0 11.3106 0 0 12.6824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5981 0 12.3738 0 11.1019 0 0 0 0 0 0 0 0 12.2726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7332 0 0 0 0 0 0 0 0 13.231 0 0 0 12.9814 13.0863 12.9336 0 13.1727 11.2342 11.9414 14.2481 0 0 13.6214 12.862 0 0 0 0 14.7285 0 10.8305 0 0 0 14.4828 12.7989 11.1392 0 0 0 0 0 13.1583 10.3137 0 0 0 0 0 12.0353 13.4593 0 0 0 0 0 13.107 14.389 0 12.7037 0 13.0228 0 0 13.4319 0 0 0 12.8528 0 0 13.3682 13.5037 0 0 11.3926 0 0 0 0 13.3295 0 0 0 0 12.9181 0 13.2172 13.0917 0 0 14.2682 14.32 0 0 0 0 0 0 0 0 0 0 15.3184 0 0 12.8472 0 15.3483 0 0 13.2772 13.6933 Q14112 NID2_HUMAN "Nidogen-2, NID-2 (Osteonidogen)" NID2 Homo sapiens (Human) basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160] GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007155; GO:0007160; GO:0062023; GO:0070062; GO:0071711 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201] CECRSGYEFADDR 0.90556 5.1734 0 0 0 0 0 0 0 0 0 0 0 0 16.1325 0 12.159 0 0 0 11.8237 0 0 0 0 12.8184 0 0 0 0 0 10.1525 0 11.4511 0 11.6244 0 0 0 11.1645 0 0 15.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3062 0 12.8111 10.4703 13.9772 0 0 0 12.255 0 0 0 13.4767 0 10.6913 0 12.9312 11.2136 0 10.7672 0 12.9506 0 0 0 0 13.8862 0 10.8996 0 0 0 0 0 0 13.3453 0 0 0 0 0 0 0 0 11.9591 12.6792 12.0381 12.4827 0 0 0 0 11.045 13.1841 12.5003 0 0 0 15.3963 0 0 0 0 0 0 12.3328 0 0 0 0 0 12.2195 0 0 0 0 0 0 0 0 11.8298 18.1401 0 0 0 0 0 0 0 12.4837 0 0 0 0 0 0 0 0 0 0 0 13.8165 0 P09327 VILI_HUMAN Villin-1 VIL1 VIL Homo sapiens (Human) actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell differentiation [GO:0030855]; intestinal D-glucose absorption [GO:0001951]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein-containing complex assembly [GO:0065003]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of microvillus length [GO:0032532]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617]; terminal web assembly [GO:1902896]" GO:0001726; GO:0001951; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007173; GO:0008154; GO:0008360; GO:0009617; GO:0010634; GO:0015629; GO:0030027; GO:0030041; GO:0030042; GO:0030175; GO:0030335; GO:0030836; GO:0030855; GO:0032233; GO:0032432; GO:0032433; GO:0032532; GO:0035727; GO:0035729; GO:0040018; GO:0042802; GO:0042803; GO:0043027; GO:0045010; GO:0051014; GO:0051015; GO:0051016; GO:0051125; GO:0051693; GO:0060327; GO:0061041; GO:0065003; GO:0070062; GO:0071364; GO:1902896; GO:1903078; GO:2000392; GO:2000394 "actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]" AAVPDTVVEPALKAALK 0.90604 5.4037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9311 0 0 0 0 0 0 0 0 0 10.5804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6951 0 0 0 0 12.9312 0 0 0 0 0 0 0 0 0 0 0 0 12.7274 0 0 0 0 0 0 11.0503 10.8978 0 0 0 0 10.8882 0 0 0 0 0 0 Q96N87 S6A18_HUMAN Inactive sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3) SLC6A18 XTRP2 Homo sapiens (Human) amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; neurotransmitter transport [GO:0006836]; sodium ion transmembrane transport [GO:0035725] GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0015171; GO:0015293; GO:0016324; GO:0031526; GO:0035725 amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293] AACVLLSLLPVLWVPVAALAQLLTR 0.90625 5.3124 0 0 0 0 0 0 10.6762 0 0 12.5985 0 0 0 0 0 0 0 0 0 0 0 11.2926 0 0 0 0 0 11.9648 0 0 0 0 0 0 0 0 10.6612 0 0 10.5379 0 0 10.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9248 0 0 11.0664 0 0 0 0 0 0 0 15.2445 0 0 14.5854 12.3881 0 0 16.1565 0 14.9443 14.6853 15.1931 0 0 14.7218 14.0955 14.9551 0 15.0436 0 0 15.3957 0 15.0939 0 13.6065 0 15.765 0 15.4792 15.128 0 15.0892 15.906 0 0 14.5112 14.7077 0 15.8672 15.7894 15.7435 0 0 15.5854 14.4798 14.8497 14.9632 0 0 0 15.2861 0 15.0066 0 0 0 15.3754 0 0 15.6691 14.778 0 15.8074 15.9967 0 14.6654 0 0 0 0 0 0 0 0 0 0 14.0134 13.5745 0 14.3392 0 0 0 0 0 0 0 0 0 0 0 0 13.3556 0 14.8766 15.3069 14.7856 0 0 0 0 0 0 P53675 CLH2_HUMAN "Clathrin heavy chain 2 (Clathrin heavy chain on chromosome 22, CLH-22)" CLTCL1 CLH22 CLTCL CLTD Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; positive regulation of glucose import [GO:0046326]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to Golgi [GO:0042147]" clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; coated vesicle [GO:0030135]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; membrane [GO:0016020]; sorting endosome [GO:0097443]; spindle [GO:0005819]; trans-Golgi network [GO:0005802] "clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; coated vesicle [GO:0030135]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; membrane [GO:0016020]; sorting endosome [GO:0097443]; spindle [GO:0005819]; trans-Golgi network [GO:0005802]; clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198]; anatomical structure morphogenesis [GO:0009653]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; positive regulation of glucose import [GO:0046326]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000278; GO:0005198; GO:0005770; GO:0005802; GO:0005819; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0009653; GO:0016020; GO:0030130; GO:0030135; GO:0030136; GO:0032051; GO:0042147; GO:0045334; GO:0046326; GO:0070062; GO:0071439; GO:0097443 clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198] ASIDAYDNFDNISLAQQLEKHQLMEFR 0.90643 5.2514 0 0 0 0 0 0 0 11.9733 0 0 0 0 12.3522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6483 0 0 0 0 0 0 0 0 11.5071 0 13.5336 0 0 0 0 0 12.4666 0 11.7389 0 0 12.1932 15.7043 0 0 0 0 0 12.3159 0 0 0 0 0 0 0 0 12.35 0 0 0 0 0 0 0 0 10.1468 0 0 0 0 0 0 0 0 0 0 13.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7119 0 0 0 10.9307 0 0 0 0 0 0 0 11.7158 0 0 0 0 0 0 0 0 10.1361 0 0 11.2388 0 0 0 0 Q9UL54 TAOK2_HUMAN "Serine/threonine-protein kinase TAO2, EC 2.7.11.1 (Kinase from chicken homolog C, hKFC-C) (Prostate-derived sterile 20-like kinase 1, PSK-1, PSK1, Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2)" TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; basal dendrite arborization [GO:0150020]; basal dendrite morphogenesis [GO:0150019]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; regulation of MAPK cascade [GO:0043408]; stress-activated MAPK cascade [GO:0051403] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; neuropilin binding [GO:0038191]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; basal dendrite arborization [GO:0150020]; basal dendrite morphogenesis [GO:0150019]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; focal adhesion assembly [GO:0048041]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360]; regulation of MAPK cascade [GO:0043408]; stress-activated MAPK cascade [GO:0051403] GO:0000165; GO:0001558; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0006612; GO:0006915; GO:0006974; GO:0007095; GO:0007409; GO:0008360; GO:0015629; GO:0016021; GO:0016477; GO:0030036; GO:0030424; GO:0030659; GO:0031410; GO:0031434; GO:0031954; GO:0032147; GO:0032874; GO:0032956; GO:0035556; GO:0038191; GO:0043005; GO:0043235; GO:0043408; GO:0043410; GO:0043539; GO:0044294; GO:0044295; GO:0046330; GO:0046777; GO:0048041; GO:0048156; GO:0048812; GO:0050321; GO:0051403; GO:0106310; GO:0150019; GO:0150020 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; neuropilin binding [GO:0038191]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] DLECALLLR 0.90761 5.1312 0 0 0 0 0 0 0 0 0 0 0 0 10.3925 12.8491 0 14.5095 14.3596 13.5037 14.4138 0 0 0 13.3515 0 14.4972 0 0 14.0047 0 0 0 0 12.8954 0 0 0 0 0 0 13.0761 11.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7559 10.9541 10.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6373 0 13.0156 0 12.8793 13.2599 13.1992 12.8962 0 0 0 0 0 0 0 0 0 0 15.1931 0 0 0 0 10.9687 0 0 0 13.8735 0 14.1516 13.7312 0 0 0 14.1455 0 0 13.8928 14.1478 0 13.1861 12.8734 0 13.5145 14.256 0 0 0 0 0 0 0 0 0 0 14.6545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5106 16.5519 0 13.8558 0 0 0 0 0 0 0 0 Q9BQ66 KR412_HUMAN Keratin-associated protein 4-12 (Keratin-associated protein 4.12) (Ultrahigh sulfur keratin-associated protein 4.12) KRTAP4-12 KAP4.12 KRTAP4.12 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MVNSCCGSVCSDQGCGLENCCR 0.90772 1.4594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5812 0 0 15.7596 0 0 14.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7996 12.1954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7175 0 11.2543 0 0 0 0 0 13.597 15.8391 0 15.5661 15.2818 0 0 0 14.9506 0 0 15.0431 0 0 13.2071 0 15.4432 14.149 0 0 0 14.7748 0 0 0 14.5214 0 0 0 15.7355 0 13.5565 0 0 0 0 14.7161 0 0 13.9813 0 0 0 0 13.3222 0 0 0 0 14.761 0 0 16.0776 15.3436 14.8427 14.4892 0 0 0 0 0 0 14.9666 0 0 13.0116 0 14.6054 0 0 0 0 15.135 0 0 0 0 14.03 12.733 13.5529 14.2053 15.356 0 0 12.6499 0 0 12.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1524 P0DTE5 UD2A2_HUMAN "UDP-glucuronosyltransferase 2A2, UDPGT 2A2, EC 2.4.1.17" UGT2A2 Homo sapiens (Human) bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695] GO:0005789; GO:0008206; GO:0015020; GO:0016021; GO:0052695 glucuronosyltransferase activity [GO:0015020] AEIWLIR 0.90806 1.4602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6301 0 Q9BRJ2 RM45_HUMAN "39S ribosomal protein L45, mitochondrial, L45mt, MRP-L45 (Mitochondrial large ribosomal subunit protein mL45)" MRPL45 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543] GO:0003723; GO:0005739; GO:0005743; GO:0005762; GO:0032543 RNA binding [GO:0003723] DYDANFKIKDFPEK 0.90809 1.4596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6487 0 0 0 0 0 15.9513 0 14.9983 0 0 13.4202 13.2151 0 0 0 0 0 0 13.8333 12.1477 0 13.7897 0 13.3418 0 13.4761 0 12.3534 0 0 0 0 0 15.0079 14.5955 0 0 13.2587 0 13.7472 15.1504 15.4788 0 0 0 14.0971 0 13.1556 0 0 0 0 13.4961 0 0 14.1224 13.3489 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8528 0 13.0382 13.3081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.365 0 0 Q6ZMY9 ZN517_HUMAN Zinc finger protein 517 ZNF517 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EPGEDTEGRRAPCWAS 0.90839 1.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2815 0 11.4743 0 0 0 0 0 0 0 0 0 0 17.7619 18.0966 18.1565 18.3217 18.3732 0 14.0991 14.8589 12.3731 17.2862 0 13.927 0 13.7671 0 0 0 0 0 14.7313 0 0 0 0 0 0 11.6594 0 0 0 0 0 12.5875 0 0 0 0 0 0 0 0 0 0 0 11.3352 0 0 0 0 0 0 0 0 0 0 0 14.4343 0 0 12.5035 13.5289 0 0 0 0 0 0 13.911 0 11.003 0 12.8796 0 0 0 0 0 0 0 0 0 0 0 0 12.992 0 0 0 0 0 0 0 12.5855 0 0 0 0 0 Q08345 DDR1_HUMAN "Epithelial discoidin domain-containing receptor 1, Epithelial discoidin domain receptor 1, EC 2.7.10.1 (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10, MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)" DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE Homo sapiens (Human) "axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]" extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]" GO:0001558; GO:0001952; GO:0004714; GO:0005518; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0014909; GO:0033674; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:0070062; GO:1990138 ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] AEGSPTAILIGCLVAIILLLLLIIALMLWR 0.90857 5.1961 0 0 0 0 0 0 0 0 14.4595 0 0 0 0 0 0 0 14.095 0 11.4903 0 0 0 11.8461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2142 14.1357 14.0065 13.5655 0 10.1712 0 12.9033 14.2894 14.5286 14.1951 13.9855 13.6999 13.8253 17.1932 0 13.4872 0 0 13.839 0 13.4147 0 0 13.5742 0 0 0 13.6064 0 0 14.5747 14.0593 14.4875 0 13.675 0 0 0 14.599 0 0 13.7232 0 0 0 13.4798 0 0 13.9359 10.875 0 0 14.7661 0 0 0 0 0 0 14.7112 0 0 13.2494 13.2233 0 14.0062 0 12.5345 13.4333 13.016 13.1865 0 13.2971 11.9198 0 13.4892 0 12.8366 12.6728 0 13.7417 12.7224 13.0173 13.3364 13.2693 0 0 0 0 13.1363 0 0 0 0 0 0 13.8693 0 0 0 0 0 10.1717 0 0 0 0 0 0 0 0 14.3597 0 Q15072 OZF_HUMAN Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146) ZNF146 OZF Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0008201; GO:0008270 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; heparin binding [GO:0008201]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" HQNTHTGEKLFECNECGKSFSQK 0.90876 1.4622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CD0 FBXL8_HUMAN F-box/LRR-repeat protein 8 (F-box and leucine-rich repeat protein 8) (F-box protein FBL8) FBXL8 FBL8 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0005634; GO:0005829; GO:0019005; GO:0031146; GO:0043153; GO:0051726 CACPEDARASPLPNEAWVALRR 0.90898 1.4582 0 0 0 0 0 0 0 0 0 13.1551 0 0 11.9254 0 0 0 0 10.8683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1026 0 13.0725 0 0 0 0 0 0 0 14.1182 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2667 12.8645 0 0 0 0 0 0 0 0 0 0 12.5337 0 13.6413 0 0 0 0 0 0 0 0 0 12.9432 0 0 12.3793 0 0 0 12.6975 0 0 0 0 0 0 0 0 0 0 0 12.4599 0 0 12.0376 0 0 0 0 0 0 0 0 0 0 12.1563 0 0 0 0 0 0 11.8971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3J6 MTRFR_HUMAN Mitochondrial translation release factor in rescue MTRFR C12orf65 My030 Homo sapiens (Human) rescue of stalled ribosome [GO:0072344] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; translation release factor activity [GO:0003747]; tRNA binding [GO:0000049]; rescue of stalled ribosome [GO:0072344] GO:0000049; GO:0003747; GO:0005739; GO:0043023; GO:0072344 ribosomal large subunit binding [GO:0043023]; translation release factor activity [GO:0003747]; tRNA binding [GO:0000049] KILQEKVDVFYNGENSPVHK 0.90902 1.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05814 CASB_HUMAN Beta-casein CSN2 CASB Homo sapiens (Human) calcium ion transport [GO:0006816]; lactation [GO:0007595]; negative regulation of cysteine-type endopeptidase activity [GO:2000117] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; enzyme inhibitor activity [GO:0004857]; calcium ion transport [GO:0006816]; lactation [GO:0007595]; negative regulation of cysteine-type endopeptidase activity [GO:2000117] GO:0004857; GO:0004869; GO:0005509; GO:0005576; GO:0005615; GO:0006816; GO:0007595; GO:2000117 calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; enzyme inhibitor activity [GO:0004857] HEDQQQGEDEHQDK 0.90913 1.4622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8482 0 15.6538 0 14.5202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NV96 CC50A_HUMAN Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A) TMEM30A C6orf67 CDC50A Homo sapiens (Human) aminophospholipid transport [GO:0015917]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]; xenobiotic transmembrane transport [GO:0006855] apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; transport vesicle membrane [GO:0030658] apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; transport vesicle membrane [GO:0030658]; aminophospholipid flippase activity [GO:0015247]; aminophospholipid transport [GO:0015917]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]; xenobiotic transmembrane transport [GO:0006855] GO:0005783; GO:0005794; GO:0005886; GO:0006855; GO:0010976; GO:0015247; GO:0015917; GO:0016020; GO:0016021; GO:0016324; GO:0030658; GO:0031901; GO:0031902; GO:0035577; GO:0035579; GO:0036010; GO:0045332; GO:0061092; GO:0070863; GO:1990531 aminophospholipid flippase activity [GO:0015247] DEVDGGPPCAPGGTAK 0.90913 1.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53H54 TYW2_HUMAN "tRNA wybutosine-synthesizing protein 2 homolog, tRNA-yW-synthesizing protein 2, EC 2.5.1.114 (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase)" TRMT12 TRM12 TYW2 Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488] GO:0005737; GO:0008175; GO:0030488; GO:0102522 tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175] IATLLQQVHGK 0.90942 1.463 0 0 0 10.4047 0 0 0 0 0 0 0 0 11.0462 0 0 0 0 0 0 0 0 0 0 0 10.8175 0 0 0 11.6604 0 0 0 0 0 0 0 0 0 0 0 10.8798 0 0 0 0 0 10.9633 0 0 0 11.1511 0 0 9.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5927 0 0 0 0 0 0 0 0 12.9135 0 0 11.7919 13.1816 13.2032 0 12.9753 0 0 0 0 11.3454 0 0 0 0 0 0 0 14.0371 0 0 12.1721 13.4705 0 0 0 0 13.8498 13.0856 0 0 0 12.9839 0 12.8097 0 0 0 0 0 14.2493 0 0 0 0 11.7108 0 0 0 0 0 11.2886 0 0 0 12.6987 0 0 0 0 0 0 0 0 0 14.6683 12.0432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92530 PSMF1_HUMAN "Proteasome inhibitor PI31 subunit, hPI31" PSMF1 Homo sapiens (Human) negative regulation of proteasomal protein catabolic process [GO:1901799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; proteasome core complex [GO:0005839] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; proteasome core complex [GO:0005839]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of proteasomal protein catabolic process [GO:1901799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004866; GO:0005654; GO:0005783; GO:0005829; GO:0005839; GO:0006511; GO:0016020; GO:0042803; GO:0043161; GO:0046982; GO:0048471; GO:0070628; GO:1901799 endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] DLYVLRYEYK 0.90946 1.4626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.545 0 0 0 0 0 0 0 0 0 0 12.9042 0 0 0 Q8NI08 NCOA7_HUMAN Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1) NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 Homo sapiens (Human) negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979] nucleus [GO:0005634] nucleus [GO:0005634]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to oxidative stress [GO:0006979] GO:0005634; GO:0006357; GO:0006979; GO:0016922; GO:0030374; GO:0045944; GO:1900408; GO:1902083; GO:1903204 nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374] CNIAVEEEYMTDEKK 0.9095 1.4568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3386 0 0 0 0 0 14.2479 0 0 0 0 0 0 0 14.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.432 0 12.7012 0 0 0 0 0 0 0 0 10.6587 0 0 0 0 0 15.2487 0 0 0 0 0 Q9NPG2 NGB_HUMAN Neuroglobin NGB Homo sapiens (Human) apoptotic process [GO:0006915]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666] cytosol [GO:0005829]; mitochondrion [GO:0005739]; perikaryon [GO:0043204] cytosol [GO:0005829]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; apoptotic process [GO:0006915]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666] GO:0001666; GO:0005344; GO:0005739; GO:0005829; GO:0006915; GO:0015671; GO:0019825; GO:0020037; GO:0043204; GO:0046872 heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] ERPEPELIRQSWR 0.9095 1.4623 0 0 0 0 0 13.4672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P7N7 TMM81_HUMAN Transmembrane protein 81 TMEM81 UNQ2788/PRO7178 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 KKVASALGIGIAIGVVGGVLVR 0.90972 5.4361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7162 0 0 0 0 0 0 13.805 0 11.4752 0 0 0 11.9277 0 0 12.0402 0 0 0 14.2742 0 0 0 0 0 0 0 0 0 0 12.4964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8828 0 0 11.3987 0 12.9886 0 15.9795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0959 13.8548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5467 13.7613 0 15.5445 0 0 0 0 0 0 0 0 0 15.0148 12.7037 16.1527 14.9537 0 14.6261 11.6805 0 12.8171 0 13.0759 0 0 0 0 12.0873 0 0 0 0 0 0 0 15.7173 15.572 0 13.3718 0 12.5638 0 0 12.5532 0 0 0 0 12.8155 0 13.007 0 0 10.1306 0 0 14.1533 0 15.0549 14.7183 15.1553 0 13.2347 0 Q01546 K22O_HUMAN "Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P, CK-2P, K2P) (Keratin-76, K76) (Type-II keratin Kb9)" KRT76 KRT2B KRT2P Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; pigmentation [GO:0043473]; sebaceous gland development [GO:0048733] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; nucleus [GO:0005634]; structural constituent of skin epidermis [GO:0030280]; cytoskeleton organization [GO:0007010]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; pigmentation [GO:0043473]; sebaceous gland development [GO:0048733] GO:0005634; GO:0005829; GO:0005882; GO:0007010; GO:0030280; GO:0031424; GO:0043473; GO:0045095; GO:0045109; GO:0048733; GO:0070062 structural constituent of skin epidermis [GO:0030280] AQYEEIAQR 0.90987 1.4695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5726 13.6439 0 0 0 0 14.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57054 PIGP_HUMAN "Phosphatidylinositol N-acetylglucosaminyltransferase subunit P (Down syndrome critical region protein 5) (Down syndrome critical region protein C) (Phosphatidylinositol-glycan biosynthesis class P protein, PIG-P)" PIGP DCRC DSCR5 DSCRC NPD010 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; GPI anchor biosynthetic process [GO:0006506] GO:0000506; GO:0005783; GO:0005789; GO:0006506; GO:0008194; GO:0016021; GO:0017176 phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194] STSLTLIVFLFHR 0.90998 1.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2234 0 0 0 0 0 0 0 12.4098 0 0 0 0 0 0 0 0 12.9043 0 0 0 0 0 0 0 0 0 0 11.7729 0 10.3404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01602 KV105_HUMAN Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue) IGKV1-5 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062; GO:0072562 antigen binding [GO:0003823] PGKAPKLLIYK 0.91012 1.2233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4206 0 0 0 A6NKC0 F90A7_HUMAN Putative protein FAM90A7 FAM90A7 FAM90A7P Homo sapiens (Human) APENLQPPPAATELGPSTSPQMGRR 0.91017 1.4723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99445 GML_HUMAN Glycosyl-phosphatidylinositol-anchored molecule-like protein GML LY6DL Homo sapiens (Human) "apoptotic process [GO:0006915]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of cell population proliferation [GO:0008285]" anchored component of membrane [GO:0031225]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] "anchored component of membrane [GO:0031225]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of cell population proliferation [GO:0008285]" GO:0005886; GO:0006915; GO:0006977; GO:0008285; GO:0019898; GO:0031225 CMTISIRINSRELLVYK 0.91021 1.4711 0 0 0 0 0 13.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22234 PUR6_HUMAN "Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase, PAICS [Includes: Phosphoribosylaminoimidazole carboxylase, EC 4.1.1.21 (AIR carboxylase, AIRC); Phosphoribosylaminoimidazole succinocarboxamide synthetase, EC 6.3.2.6 (SAICAR synthetase) ]" PAICS ADE2 AIRC PAIS Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113] GO:0004638; GO:0004639; GO:0005524; GO:0005737; GO:0005829; GO:0006177; GO:0006189; GO:0009113; GO:0016020; GO:0042802; GO:0043727; GO:0044208; GO:0045296; GO:0070062; GO:0097294 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639] EIVLADVIDNDSWR 0.91025 1.4705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2397 0 0 0 0 12.772 0 0 0 0 0 0 14.5484 0 0 0 0 14.1704 0 13.9706 0 0 0 0 0 0 0 0 14.1238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05111 INHA_HUMAN Inhibin alpha chain INHA Homo sapiens (Human) cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; erythrocyte differentiation [GO:0030218]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell cycle [GO:0045786]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; ovarian follicle development [GO:0001541]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; inhibin B complex [GO:0043513]; inhibin-betaglycan-ActRII complex [GO:0034673]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; inhibin B complex [GO:0043513]; inhibin-betaglycan-ActRII complex [GO:0034673]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; inhibin binding [GO:0034711]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; erythrocyte differentiation [GO:0030218]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell cycle [GO:0045786]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; ovarian follicle development [GO:0001541]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] GO:0001501; GO:0001541; GO:0001750; GO:0001917; GO:0005102; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007166; GO:0007267; GO:0008083; GO:0008584; GO:0010862; GO:0030154; GO:0030218; GO:0032689; GO:0034673; GO:0034711; GO:0042127; GO:0042326; GO:0042541; GO:0043025; GO:0043512; GO:0043513; GO:0044877; GO:0045578; GO:0045650; GO:0045786; GO:0046881; GO:0046882; GO:0051726; GO:0060395 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; inhibin binding [GO:0034711]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] LPRRHALGGFTHR 0.91027 1.4501 12.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9201 0 0 0 0 0 0 11.0218 0 0 0 0 0 11.1305 0 0 0 0 0 0 11.4304 0 0 0 0 0 0 0 0 11.3542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMR5 PPT2_HUMAN "Lysosomal thioesterase PPT2, PPT-2, EC 3.1.2.- (S-thioesterase G14)" PPT2 Homo sapiens (Human) fatty-acyl-CoA biosynthetic process [GO:0046949] extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; palmitoyl hydrolase activity [GO:0098599]; palmitoyl-(protein) hydrolase activity [GO:0008474]; thiolester hydrolase activity [GO:0016790]; fatty-acyl-CoA biosynthetic process [GO:0046949] GO:0005764; GO:0008474; GO:0016790; GO:0043202; GO:0043231; GO:0046949; GO:0070062; GO:0098599 palmitoyl hydrolase activity [GO:0098599]; palmitoyl-(protein) hydrolase activity [GO:0008474]; thiolester hydrolase activity [GO:0016790] LPAAWVLLLLPFLPLLLLAAPAPHR 0.9103 1.4499 0 0 0 0 0 0 0 12.439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3761 0 0 0 0 11.933 11.6457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7959 0 0 0 11.554 0 0 0 0 0 0 0 0 0 12.2522 0 0 0 0 0 0 0 0 0 0 0 0 11.4957 0 0 0 0 0 0 0 0 0 11.5599 0 0 0 11.7748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0046 0 0 11.2238 0 0 P46098 5HT3A_HUMAN "5-hydroxytryptamine receptor 3A, 5-HT3-A, 5-HT3A (5-hydroxytryptamine receptor 3, 5-HT-3, 5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor)" HTR3A 5HT3R HTR3 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202] anchoring junction [GO:0070161]; cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0032154; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051378; GO:0070161; GO:0098662; GO:1904315; GO:1904602 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] EFSMESSNYYAEMKFYVVIR 0.91032 1.4759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4782 0 0 0 14.433 0 0 0 0 0 0 0 0 0 12.8605 0 0 0 12.4614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6635 13.0078 13.1207 11.7225 0 0 0 0 0 0 0 0 13.8238 0 0 13.2516 13.3341 10.8106 12.2057 0 0 0 0 0 0 12.7005 0 0 0 0 0 12.0065 0 15.0706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3343 0 0 0 0 0 0 0 0 0 0 0 O43300 LRRT2_HUMAN Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein) LRRTM2 KIAA0416 LRRN2 Homo sapiens (Human) long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; synapse organization [GO:0050808] anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; Schaffer collateral - CA1 synapse [GO:0098685]; neurexin family protein binding [GO:0042043]; long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; synapse organization [GO:0050808] GO:0002091; GO:0005615; GO:0042043; GO:0050808; GO:0051965; GO:0060076; GO:0060291; GO:0070161; GO:0098685; GO:0098686; GO:0098978; GO:0098982; GO:0099060; GO:0099061; GO:0099151 neurexin family protein binding [GO:0042043] LRELHLEHNQLTKINFAHFLR 0.91036 1.4752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7349 0 12.8626 0 12.8915 0 0 0 15.1041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2551 0 0 0 0 14.236 0 0 0 0 0 0 15.0394 0 0 15.0309 0 0 0 0 0 0 0 0 14.0631 0 0 0 14.2418 0 0 0 0 0 0 0 14.2401 0 14.3494 0 0 0 0 0 0 14.1304 0 14.2349 0 0 14.9743 0 0 0 0 0 0 14.8047 0 0 0 14.493 0 0 0 13.8297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15165 PON2_HUMAN "Serum paraoxonase/arylesterase 2, PON 2, EC 3.1.1.2, EC 3.1.1.81 (Aromatic esterase 2, A-esterase 2) (Serum aryldialkylphosphatase 2)" PON2 Homo sapiens (Human) aromatic compound catabolic process [GO:0019439]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636] extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; arylesterase activity [GO:0004064]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; aromatic compound catabolic process [GO:0019439]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636] GO:0004064; GO:0005576; GO:0005634; GO:0005739; GO:0005764; GO:0005886; GO:0006979; GO:0009636; GO:0019439; GO:0042802; GO:0046872; GO:0102007 acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; arylesterase activity [GO:0004064]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] ARELRISR 0.9104 1.4747 0 0 0 0 0 0 0 0 13.7778 0 0 0 15.5317 15.6416 0 0 0 0 0 0 0 0 0 0 0 14.3701 0 0 0 0 14.3981 0 14.553 0 0 0 0 0 14.7325 16.2393 13.8335 0 0 13.9602 0 0 13.9929 0 0 0 0 12.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0274 0 0 11.0585 0 0 0 13.0165 0 14.7195 0 0 0 13.1971 0 0 0 0 0 14.1675 0 0 14.8709 0 0 0 0 0 0 0 0 14.0901 0 13.2293 0 12.6005 0 11.2233 13.9182 13.904 16.4611 0 0 0 14.0064 0 13.4439 0 11.3735 0 0 0 0 0 13.423 13.1469 0 0 14.4492 0 0 0 12.9919 14.7807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2738 0 0 0 0 0 0 0 0 13.0739 0 0 0 0 0 0 0 0 0 14.9594 0 12.0688 14.065 14.8188 0 13.5188 0 0 0 0 0 0 0 P23276 KELL_HUMAN "Kell blood group glycoprotein, EC 3.4.24.- (CD antigen CD238)" KEL Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; establishment of localization in cell [GO:0051649]; myelination [GO:0042552]; negative regulation of potassium ion transmembrane transport [GO:1901380]; potassium ion transmembrane transport [GO:0071805]; protein processing [GO:0016485]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]; vasoconstriction [GO:0042310] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; establishment of localization in cell [GO:0051649]; myelination [GO:0042552]; negative regulation of potassium ion transmembrane transport [GO:1901380]; potassium ion transmembrane transport [GO:0071805]; protein processing [GO:0016485]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741]; vasoconstriction [GO:0042310] GO:0004222; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0006874; GO:0008361; GO:0010961; GO:0016021; GO:0016485; GO:0031133; GO:0042310; GO:0042552; GO:0046872; GO:0048741; GO:0051649; GO:0071805; GO:1901380 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AFQFYNSCMDTLAIEAAGTGPLR 0.91042 1.3711 0 0 0 0 0 0 0 0 14.3299 13.1852 14.3707 17.557 13.4555 14.1384 14.3599 14.4261 14.2412 13.6797 0 13.3436 12.958 0 13.2301 0 13.151 14.3511 15.1316 13.7955 13.1137 0 14.2368 0 13.0173 13.9094 14.1361 0 12.949 13.1242 13.964 13.1652 13.7567 12.7384 0 13.0751 13.8181 13.049 12.7742 0 13.9765 13.9567 13.1325 13.3563 13.8671 0 17.3494 17.4313 0 0 12.5625 0 0 0 0 11.8453 0 12.5513 0 0 0 0 0 0 0 0 0 0 14.1088 0 14.4462 14.7788 12.5106 14.4402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3346 0 0 0 13.6616 13.9974 0 0 0 0 0 0 0 0 0 0 0 12.2862 0 0 0 0 0 0 13.0824 0 0 13.4902 13.7297 13.6713 0 13.9115 0 0 13.5114 0 0 14.5679 13.4413 0 0 0 0 0 0 15.7105 0 0 0 0 0 0 0 15.256 0 19.4899 15.2194 0 15.1592 15.4575 0 0 16.4788 0 16.4345 0 14.8003 13.9961 13.9102 0 0 10.6906 16.3419 0 0 P30559 OXYR_HUMAN "Oxytocin receptor, OT-R" OXTR Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; muscle contraction [GO:0006936]; negative regulation of gastric acid secretion [GO:0060455]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of penile erection [GO:0060406]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to anoxia [GO:0034059]; response to cocaine [GO:0042220]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; suckling behavior [GO:0001967]; telencephalon development [GO:0021537]" adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxytocin receptor activity [GO:0004990]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000]; cell surface receptor signaling pathway [GO:0007166]; digestive tract development [GO:0048565]; eating behavior [GO:0042755]; ERK1 and ERK2 cascade [GO:0070371]; estrous cycle [GO:0044849]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; muscle contraction [GO:0006936]; negative regulation of gastric acid secretion [GO:0060455]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of penile erection [GO:0060406]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to anoxia [GO:0034059]; response to cocaine [GO:0042220]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; suckling behavior [GO:0001967]; telencephalon development [GO:0021537]" GO:0001967; GO:0001975; GO:0001992; GO:0004930; GO:0004990; GO:0005000; GO:0005886; GO:0005887; GO:0005902; GO:0005912; GO:0006936; GO:0007166; GO:0007186; GO:0007204; GO:0007507; GO:0007565; GO:0007595; GO:0007613; GO:0009410; GO:0010701; GO:0016324; GO:0017046; GO:0021537; GO:0030431; GO:0032230; GO:0032355; GO:0032570; GO:0034059; GO:0034097; GO:0035176; GO:0042220; GO:0042277; GO:0042711; GO:0042713; GO:0042755; GO:0043434; GO:0044849; GO:0045777; GO:0045907; GO:0048565; GO:0051965; GO:0051968; GO:0060137; GO:0060406; GO:0060455; GO:0070371; GO:0070474; GO:0120162 G protein-coupled receptor activity [GO:0004930]; oxytocin receptor activity [GO:0004990]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; vasopressin receptor activity [GO:0005000] AYITWITLAVYIVPVIVLAACYGLISFKIWQNLRLK 0.91044 1.2236 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6988 0 0 0 0 0 0 0 0 13.2737 0 0 0 0 0 0 0 0 0 0 0 11.5379 0 0 0 0 0 0 0 0 0 0 0 0 12.0645 13.7677 0 14.7865 0 13.4001 0 0 0 0 0 0 0 0 0 13.3544 0 13.4993 0 14.3707 0 0 0 0 0 0 0 13.5735 0 0 0 0 0 13.1224 0 0 0 0 0 13.8594 0 0 0 0 13.1011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6772 0 0 0 0 13.3566 0 Q6UWH6 TX261_HUMAN Protein TEX261 TEX261 UNQ1882/PRO4325 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of apoptotic process [GO:0043065] COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173] COPII-coated ER to Golgi transport vesicle [GO:0030134]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; COPII receptor activity [GO:0097020]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of apoptotic process [GO:0043065] GO:0006888; GO:0030134; GO:0030173; GO:0030176; GO:0043065; GO:0097020 COPII receptor activity [GO:0097020] EAILPSR 0.91045 1.453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4157 0 0 0 14.2718 0 0 0 0 0 0 0 0 0 13.6017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.541 14.874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6295 0 0 0 0 0 0 0 0 0 15.0186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3021 0 13.9244 0 0 0 0 0 0 0 0 0 0 0 0 13.5087 0 0 0 0 0 0 0 0 0 13.3478 0 Q9H2C1 LHX5_HUMAN "LIM/homeobox protein Lhx5, LIM homeobox protein 5" LHX5 Homo sapiens (Human) "cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell proliferation in forebrain [GO:0021846]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord association neuron differentiation [GO:0021527]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0021527; GO:0021702; GO:0021766; GO:0021846; GO:0021879; GO:0021937; GO:0030182; GO:0045893; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AAFAATPK 0.91046 1.2538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6855 0 11.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5511 0 0 0 0 0 0 13.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03828 EVX2_HUMAN Homeobox even-skipped homolog protein 2 (EVX-2) EVX2 Homo sapiens (Human) limb morphogenesis [GO:0035108]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; limb morphogenesis [GO:0035108]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0035108; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EFYRENYVSRPR 0.91053 1.2532 0 0 0 0 0 0 0 0 0 0 0 10.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZN3 ZDH14_HUMAN "Palmitoyltransferase ZDHHC14, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 14, DHHC-14) (NEW1 domain-containing protein, NEW1CP) (Zinc finger DHHC domain-containing protein 14)" ZDHHC14 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] ASHCSLCDNCVER 0.91054 1.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2165 0 0 0 0 0 0 9.81806 0 0 0 0 0 0 0 0 14.2586 0 0 0 0 0 0 0 0 13.9034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0AV02 S12A8_HUMAN Solute carrier family 12 member 8 (Cation-chloride cotransporter 9) SLC12A8 CCC9 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; potassium:chloride symporter activity [GO:0015379]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] GO:0006884; GO:0015379; GO:0016021; GO:0055064; GO:0055075; GO:1902476; GO:1990573 potassium:chloride symporter activity [GO:0015379] GISVAVLLALLGINLAGVK 0.91055 1.4724 0 0 11.9412 0 12.9965 0 0 0 0 0 0 12.9293 13.0172 0 0 0 0 0 0 0 0 11.9739 0 0 12.3306 0 0 0 0 0 13.0833 0 0 0 0 12.5722 0 0 0 0 0 0 0 0 13.4944 0 0 0 14.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1814 0 0 13.762 0 0 0 0 13.1329 0 0 0 0 0 0 0 0 0 0 10.4599 0 0 0 0 0 0 0 0 0 0 0 13.4376 0 0 0 0 13.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6191 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9965 12.4374 0 0 0 0 Q8NGV0 OR2Y1_HUMAN Olfactory receptor 2Y1 (Olfactory receptor OR5-2) OR2Y1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GALWKVLWRGR 0.91062 1.2513 12.9433 0 0 0 11.2967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41597 CCR2_HUMAN "C-C chemokine receptor type 2, C-C CKR-2, CC-CKR-2, CCR-2, CCR2 (Monocyte chemoattractant protein 1 receptor, MCP-1-R) (CD antigen CD192)" CCR2 CMKBR2 Homo sapiens (Human) "blood vessel remodeling [GO:0001974]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular homeostasis [GO:0019725]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to wounding [GO:0090594]; macrophage migration [GO:1905517]; monocyte extravasation [GO:0035696]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of angiogenesis [GO:0016525]; negative regulation of eosinophil degranulation [GO:0043310]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of astrocyte chemotaxis [GO:2000464]; positive regulation of CD8-positive, alpha-beta T cell extravasation [GO:2000451]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of immune complex clearance by monocytes and macrophages [GO:0090265]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of thymocyte migration [GO:2000412]; positive regulation of tumor necrosis factor production [GO:0032760]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of inflammatory response [GO:0050727]; regulation of T cell cytokine production [GO:0002724]; regulation of T cell differentiation [GO:0045580]; regulation of vascular endothelial growth factor production [GO:0010574]; response to wounding [GO:0009611]; sensory perception of pain [GO:0019233]; T-helper 17 cell chemotaxis [GO:0035705]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR2 chemokine receptor binding [GO:0031727]; chemokine receptor activity [GO:0004950]; identical protein binding [GO:0042802]; blood vessel remodeling [GO:0001974]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular homeostasis [GO:0019725]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to wounding [GO:0090594]; macrophage migration [GO:1905517]; monocyte extravasation [GO:0035696]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of angiogenesis [GO:0016525]; negative regulation of eosinophil degranulation [GO:0043310]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of astrocyte chemotaxis [GO:2000464]; positive regulation of CD8-positive, alpha-beta T cell extravasation [GO:2000451]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of immune complex clearance by monocytes and macrophages [GO:0090265]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of thymocyte migration [GO:2000412]; positive regulation of tumor necrosis factor production [GO:0032760]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of inflammatory response [GO:0050727]; regulation of T cell cytokine production [GO:0002724]; regulation of T cell differentiation [GO:0045580]; regulation of vascular endothelial growth factor production [GO:0010574]; response to wounding [GO:0009611]; sensory perception of pain [GO:0019233]; T-helper 17 cell chemotaxis [GO:0035705]" GO:0001650; GO:0001974; GO:0002407; GO:0002724; GO:0002827; GO:0002829; GO:0004950; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006874; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007194; GO:0007204; GO:0007259; GO:0009611; GO:0009897; GO:0010574; GO:0010820; GO:0016021; GO:0016493; GO:0016525; GO:0019221; GO:0019233; GO:0019722; GO:0019725; GO:0019957; GO:0030425; GO:0031727; GO:0032729; GO:0032743; GO:0032760; GO:0035696; GO:0035705; GO:0042802; GO:0043025; GO:0043204; GO:0043310; GO:0045580; GO:0046641; GO:0048471; GO:0050727; GO:0050729; GO:0050870; GO:0051968; GO:0060326; GO:0070098; GO:0090026; GO:0090265; GO:0090594; GO:0120162; GO:1904783; GO:1905517; GO:2000412; GO:2000439; GO:2000451; GO:2000464; GO:2000473 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR2 chemokine receptor binding [GO:0031727]; chemokine receptor activity [GO:0004950]; identical protein binding [GO:0042802] EDSVYVCGPYFPR 0.91063 1.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3834 0 0 16.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7K2 ZN467_HUMAN Zinc finger protein 467 ZNF467 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FSKKAHLTR 0.9107 1.2255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9037 0 0 0 10.5681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2082 10.6191 0 12.6093 0 0 0 0 10.6165 0 0 0 0 0 0 0 0 0 0 11.3461 13.4624 0 11.7679 0 13.8022 0 0 0 0 0 0 0 12.1984 0 0 0 0 0 11.5398 0 0 0 0 0 14.2614 0 11.9133 0 0 0 0 0 0 0 0 0 11.7798 0 0 0 14.9958 0 0 0 0 14.3093 0 0 0 15.0021 13.0958 0 0 11.0679 0 0 0 0 0 0 11.1327 0 12.9018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27352 IF_HUMAN "Cobalamin binding intrinsic factor (Gastric intrinsic factor) (Intrinsic factor, IF, INF)" CBLIF GIF IFMH Homo sapiens (Human) cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] apical plasma membrane [GO:0016324]; endosome [GO:0005768]; external side of apical plasma membrane [GO:0098591]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; microvillus [GO:0005902] apical plasma membrane [GO:0016324]; endosome [GO:0005768]; external side of apical plasma membrane [GO:0098591]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; microvillus [GO:0005902]; cargo receptor ligand activity [GO:0140355]; cobalamin binding [GO:0031419]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] GO:0005576; GO:0005615; GO:0005768; GO:0005902; GO:0006824; GO:0009235; GO:0015889; GO:0016324; GO:0031419; GO:0043202; GO:0098591; GO:0140355 cargo receptor ligand activity [GO:0140355]; cobalamin binding [GO:0031419] SLFGQVLKDIVEK 0.91073 1.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N427 TXND3_HUMAN "Thioredoxin domain-containing protein 3 (NM23-H8) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2, Sptrx-2)" NME8 SPTRX2 TXNDC3 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer dynein arm [GO:0036157]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; microtubule binding [GO:0008017]; cell differentiation [GO:0030154]; cellular response to reactive oxygen species [GO:0034614]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0005829; GO:0005930; GO:0007283; GO:0008017; GO:0016607; GO:0030154; GO:0030317; GO:0034614; GO:0036157; GO:0060271; GO:0097225; GO:0097228; GO:0097598 microtubule binding [GO:0008017] AMQPLFRKLK 0.91074 1.3717 0 0 0 12.0209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4281 0 0 0 0 0 11.2891 0 0 11.8 0 11.4134 0 0 0 0 0 0 0 11.9815 0 11.3424 11.5688 0 0 11.1567 0 0 0 0 0 12.0314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8377 0 12.2467 0 0 0 0 12.4131 0 0 0 0 0 11.8125 0 11.4812 0 0 12.2577 0 0 0 12.2405 13.803 0 0 0 0 0 0 0 0 0 10.3824 0 0 0 0 0 12.8777 0 0 0 18.2452 0 12.2279 14.3399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5561 0 0 0 0 0 14.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2046 0 0 0 0 18.0375 0 0 0 0 0 0 0 12.0639 0 12.2973 11.9785 0 0 P78549 NTH_HUMAN "Endonuclease III-like protein 1, hNTH1, EC 3.2.2.-, EC 4.2.99.18 (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase, DNA glycosylase/AP lyase)" NTHL1 NTH1 OCTS3 Homo sapiens (Human) "base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]" mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]" GO:0000703; GO:0003684; GO:0003690; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0006285; GO:0006289; GO:0006296; GO:0008534; GO:0019104; GO:0045008; GO:0046872; GO:0051539; GO:0140078 "4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]" AQRLRVAYEGSDSEK 0.91076 1.2301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1217 0 0 0 0 0 12.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H479 FN3K_HUMAN "Fructosamine-3-kinase, EC 2.7.1.171 (Protein-psicosamine 3-kinase FN3K) (Protein-ribulosamine 3-kinase FN3K, EC 2.7.1.172)" FN3K Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]; fructoselysine metabolic process [GO:0030393]; phosphorylation [GO:0016310]; post-translational protein modification [GO:0043687]; protein deglycation [GO:0036525] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-fructosamine 3-kinase activity [GO:0102194]; protein-ribulosamine 3-kinase activity [GO:0102193]; epithelial cell differentiation [GO:0030855]; fructosamine metabolic process [GO:0030389]; fructoselysine metabolic process [GO:0030393]; phosphorylation [GO:0016310]; post-translational protein modification [GO:0043687]; protein deglycation [GO:0036525] GO:0005524; GO:0005829; GO:0016301; GO:0016310; GO:0030389; GO:0030393; GO:0030855; GO:0036525; GO:0043687; GO:0102193; GO:0102194 ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-fructosamine 3-kinase activity [GO:0102194]; protein-ribulosamine 3-kinase activity [GO:0102193] APGFDQRLLLYQLFNYLNHWNHFGR 0.91078 1.3711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1955 0 0 0 0 0 0 12.652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7824 0 0 11.1228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8296 0 0 12.0293 0 0 16.5269 0 0 0 0 13.1182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1578 12.5295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07602 SAP_HUMAN "Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator, CSAct) (Dispersin) (Sphingolipid activator protein 1, SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2, SAP-2); Saposin-D (Component C) (Protein C) ]" PSAP GLBA SAP1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; positive regulation of beta-galactosidase activity [GO:1903771]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; ganglioside GM1 transport to membrane [GO:1905572]; lysosomal transport [GO:0007041]; positive regulation of beta-galactosidase activity [GO:1903771]; prostate gland growth [GO:0060736]; regulation of autophagy [GO:0010506]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] GO:0002020; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0006665; GO:0007041; GO:0007193; GO:0008047; GO:0010506; GO:0019216; GO:0035577; GO:0042802; GO:0042803; GO:0043202; GO:0043231; GO:0060736; GO:0060742; GO:0062023; GO:0070062; GO:0097110; GO:1903771; GO:1905572; GO:1905573; GO:1905574; GO:1905575; GO:1905576; GO:1905577 enzyme activator activity [GO:0008047]; ganglioside GM1 binding [GO:1905573]; ganglioside GM2 binding [GO:1905574]; ganglioside GM3 binding [GO:1905575]; ganglioside GP1c binding [GO:1905577]; ganglioside GT1b binding [GO:1905576]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110] KHEVPAK 0.9108 1.2295 0 0 0 0 0 0 0 0 12.8568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.601 0 0 0 0 0 0 0 0 0 0 12.9785 0 0 0 0 0 14.1877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4649 13.5719 14.9917 0 0 0 0 0 0 11.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5762 15.6157 0 0 0 0 0 0 0 12.3682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7924 0 15.1401 0 0 0 0 0 0 0 0 0 0 0 11.302 0 0 0 0 0 0 0 0 0 0 0 0 P54687 BCAT1_HUMAN "Branched-chain-amino-acid aminotransferase, cytosolic, BCAT(c), EC 2.6.1.42 (Protein ECA39)" BCAT1 BCT1 ECA39 Homo sapiens (Human) branched-chain amino acid biosynthetic process [GO:0009082]; G1/S transition of mitotic cell cycle [GO:0000082]; leucine biosynthetic process [GO:0009098]; lipid metabolic process [GO:0006629]; valine biosynthetic process [GO:0009099] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-leucine:2-oxoglutarate aminotransferase activity [GO:0050048]; L-valine transaminase activity [GO:0052655]; branched-chain amino acid biosynthetic process [GO:0009082]; G1/S transition of mitotic cell cycle [GO:0000082]; leucine biosynthetic process [GO:0009098]; lipid metabolic process [GO:0006629]; valine biosynthetic process [GO:0009099] GO:0000082; GO:0004084; GO:0005739; GO:0005829; GO:0006629; GO:0009082; GO:0009098; GO:0009099; GO:0050048; GO:0052654; GO:0052655; GO:0052656 branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-leucine:2-oxoglutarate aminotransferase activity [GO:0050048]; L-valine transaminase activity [GO:0052655] DCSNGCSAECTGEGGSK 0.91082 1.4531 9.95321 0 0 0 0 0 0 0 0 0 0 0 10.9067 0 0 0 0 11.2391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7121 0 0 0 0 0 0 0 0 0 0 0 0 12.7698 0 0 0 0 0 0 12.85 0 12.7984 0 0 0 0 0 0 0 0 0 12.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43490 PROM1_HUMAN Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133) PROM1 PROML1 MSTP061 Homo sapiens (Human) camera-type eye photoreceptor cell differentiation [GO:0060219]; glomerular parietal epithelial cell differentiation [GO:0072139]; photoreceptor cell maintenance [GO:0045494]; podocyte differentiation [GO:0072112]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; retina layer formation [GO:0010842]; retina morphogenesis in camera-type eye [GO:0060042] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; vesicle [GO:0031982]; actinin binding [GO:0042805]; cadherin binding [GO:0045296]; cholesterol binding [GO:0015485]; camera-type eye photoreceptor cell differentiation [GO:0060219]; glomerular parietal epithelial cell differentiation [GO:0072139]; photoreceptor cell maintenance [GO:0045494]; podocyte differentiation [GO:0072112]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; retina layer formation [GO:0010842]; retina morphogenesis in camera-type eye [GO:0060042] GO:0001750; GO:0005615; GO:0005783; GO:0005793; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0010842; GO:0015485; GO:0016324; GO:0031528; GO:0031982; GO:0042622; GO:0042805; GO:0045296; GO:0045494; GO:0060042; GO:0060219; GO:0070062; GO:0071914; GO:0072112; GO:0072139; GO:2000768 actinin binding [GO:0042805]; cadherin binding [GO:0045296]; cholesterol binding [GO:0015485] ATVFLLPALIFAVKLAK 0.91083 5.335 0 0 0 0 0 0 0 0 12.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9928 0 0 0 0 11.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1765 0 0 0 0 0 0 0 0 0 0 0 11.316 12.3662 0 0 10.9011 0 0 0 0 0 0 0 0 0 0 0 11.0015 0 0 13.0182 0 0 0 0 0 0 0 0 11.015 0 0 0 0 0 0 0 11.1692 0 10.8888 0 0 14.9987 0 0 0 0 0 0 11.2858 14.2239 0 0 0 0 0 0 0 14.3029 0 0 0 0 0 14.2486 0 0 0 0 0 0 12.3906 10.4058 0 0 0 0 0 0 0 0 0 0 10.5624 0 10.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1501 0 0 0 0 0 Q9H819 DJC18_HUMAN DnaJ homolog subfamily C member 18 DNAJC18 Homo sapiens (Human) cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005789; GO:0016021; GO:0030433; GO:0030544; GO:0051085; GO:0071218 Hsp70 protein binding [GO:0030544] AYRGASLHDLEK 0.91085 1.4736 11.9622 16.4117 0 0 0 0 0 0 0 16.7994 0 0 0 0 0 0 0 0 0 0 15.5018 0 0 0 0 15.9455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7569 0 0 0 0 0 0 0 0 12.3581 13.607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6697 0 0 15.2169 0 0 0 0 0 0 13.1908 15.4601 0 0 0 0 14.5668 0 0 16.0523 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9298 0 0 0 0 12.4531 0 0 0 0 0 15.3927 0 15.3923 0 0 0 0 0 0 15.2122 15.9482 0 0 0 0 0 0 0 0 0 14.9473 15.2154 0 0 0 16.7608 0 0 0 15.2646 P60372 KR104_HUMAN Keratin-associated protein 10-4 (High sulfur keratin-associated protein 10.4) (Keratin-associated protein 10.4) (Keratin-associated protein 18-4) (Keratin-associated protein 18.4) KRTAP10-4 KAP10.4 KAP18-4 KRTAP10.4 KRTAP18-4 KRTAP18.4 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 PACCVPVPSCCAPTSSCQPSCCR 0.9109 1.4518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3187 14.4969 0 0 0 0 0 0 0 0 13.1736 0 0 0 0 15.9007 0 0 0 13.6266 0 0 0 0 0 14.413 0 15.2365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0323 0 0 0 0 0 0 0 0 0 0 11.6885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1214 15.1781 14.3003 0 0 0 0 0 0 Q3BBV0 NBPF1_HUMAN Neuroblastoma breakpoint family member 1 NBPF1 KIAA1693 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DQEEEEDQGPPCPR 0.91092 1.4724 0 0 0 0 0 0 0 0 0 0 0 0 11.6194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8078 0 0 0 0 0 0 0 13.2672 0 0 0 0 0 14.7969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5325 0 14.5545 14.5638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6C2 EMIL1_HUMAN "EMILIN-1 (Elastin microfibril interface-located protein 1, Elastin microfibril interfacer 1)" EMILIN1 EMI Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell activation [GO:0050866]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage migration [GO:1905522]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; EMILIN complex [GO:1990971]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integrin alpha4-beta1 complex [GO:0034668] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; EMILIN complex [GO:1990971]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integrin alpha4-beta1 complex [GO:0034668]; extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802]; integrin binding involved in cell-matrix adhesion [GO:0098640]; aortic valve morphogenesis [GO:0003180]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell activation [GO:0050866]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of collagen fibril organization [GO:1904027]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage migration [GO:1905522]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] GO:0003180; GO:0005576; GO:0005581; GO:0005615; GO:0007155; GO:0007160; GO:0008217; GO:0010628; GO:0010629; GO:0010811; GO:0016477; GO:0016525; GO:0030023; GO:0030194; GO:0030512; GO:0030948; GO:0032966; GO:0033627; GO:0034668; GO:0042127; GO:0042802; GO:0045766; GO:0048251; GO:0050866; GO:0060394; GO:0062023; GO:0070062; GO:0070373; GO:0098640; GO:1900426; GO:1901203; GO:1904027; GO:1905522; GO:1990971 extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802]; integrin binding involved in cell-matrix adhesion [GO:0098640] AMEKLLASVEER 0.91095 1.2525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9703 13.0424 13.6783 12.7871 0 0 13.1042 0 0 14.522 0 0 0 0 0 0 13.8498 0 0 0 0 14.7308 0 0 0 12.5045 0 0 0 13.4472 0 0 0 0 0 0 11.1822 0 13.1876 0 0 0 0 13.6118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4111 0 0 0 0 0 0 Q15836 VAMP3_HUMAN "Vesicle-associated membrane protein 3, VAMP-3 (Cellubrevin, CEB) (Synaptobrevin-3)" VAMP3 SYB3 Homo sapiens (Human) "calcium-ion regulated exocytosis [GO:0017156]; cellular response to interferon-gamma [GO:0071346]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; membrane fusion [GO:0061025]; negative regulation of secretion by cell [GO:1903531]; positive regulation of receptor recycling [GO:0001921]; protein-containing complex assembly [GO:0065003]; retrograde transport, endosome to Golgi [GO:0042147]; SNARE complex assembly [GO:0035493]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]" anchoring junction [GO:0070161]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] "anchoring junction [GO:0070161]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to interferon-gamma [GO:0071346]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; membrane fusion [GO:0061025]; negative regulation of secretion by cell [GO:1903531]; positive regulation of receptor recycling [GO:0001921]; protein-containing complex assembly [GO:0065003]; retrograde transport, endosome to Golgi [GO:0042147]; SNARE complex assembly [GO:0035493]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]" GO:0001921; GO:0005484; GO:0005769; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0006906; GO:0009986; GO:0016021; GO:0016192; GO:0017075; GO:0017156; GO:0019905; GO:0030133; GO:0030136; GO:0030141; GO:0030669; GO:0030670; GO:0031201; GO:0032588; GO:0034446; GO:0035493; GO:0042147; GO:0043001; GO:0043005; GO:0043231; GO:0045202; GO:0048471; GO:0055037; GO:0055038; GO:0061025; GO:0065003; GO:0070161; GO:0071346; GO:1903531 SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] MWAIGITVLVIFIIIIIVWVVSS 0.91097 1.4509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P81133 SIM1_HUMAN "Single-minded homolog 1 (Class E basic helix-loop-helix protein 14, bHLHe14)" SIM1 BHLHE14 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]" GO:0000785; GO:0000977; GO:0000981; GO:0001657; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0030154; GO:0046982 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ASIIRLTTSYLKMR 0.91099 1.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y698 CCG2_HUMAN "Voltage-dependent calcium channel gamma-2 subunit (Neuronal voltage-gated calcium channel gamma-2 subunit) (Transmembrane AMPAR regulatory protein gamma-2, TARP gamma-2)" CACNG2 Homo sapiens (Human) "eye blink reflex [GO:0060082]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of protein localization to basolateral plasma membrane [GO:1904510]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein targeting to membrane [GO:0006612]; regulation of AMPA receptor activity [GO:2000311]; response to calcium ion [GO:0051592]; transmission of nerve impulse [GO:0019226]" AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; cell surface [GO:0009986]; cerebellar mossy fiber [GO:0044300]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; voltage-gated calcium channel complex [GO:0005891] "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; cell surface [GO:0009986]; cerebellar mossy fiber [GO:0044300]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; voltage-gated calcium channel complex [GO:0005891]; channel regulator activity [GO:0016247]; ionotropic glutamate receptor binding [GO:0035255]; voltage-gated calcium channel activity [GO:0005245]; eye blink reflex [GO:0060082]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; neuromuscular junction development [GO:0007528]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of protein localization to basolateral plasma membrane [GO:1904510]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein targeting to membrane [GO:0006612]; regulation of AMPA receptor activity [GO:2000311]; response to calcium ion [GO:0051592]; transmission of nerve impulse [GO:0019226]" GO:0005245; GO:0005829; GO:0005886; GO:0005891; GO:0006612; GO:0007528; GO:0009986; GO:0016247; GO:0019226; GO:0030666; GO:0032281; GO:0035255; GO:0036477; GO:0044300; GO:0051592; GO:0051899; GO:0051968; GO:0060081; GO:0060082; GO:0070161; GO:0098685; GO:0098686; GO:0098839; GO:0098943; GO:0098970; GO:0098978; GO:0099061; GO:0099590; GO:0099645; GO:1904510; GO:2000311; GO:2000969 channel regulator activity [GO:0016247]; ionotropic glutamate receptor binding [GO:0035255]; voltage-gated calcium channel activity [GO:0005245] AATTPTATYNSDR 0.91099 1.2319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3247 14.3227 13.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61619 S61A1_HUMAN "Protein transport protein Sec61 subunit alpha isoform 1, Sec61 alpha-1" SEC61A1 SEC61A Homo sapiens (Human) "cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum organization [GO:0007029]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784] "endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]; calcium channel activity [GO:0005262]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum organization [GO:0007029]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]; pronephric nephron development [GO:0039019]; protein insertion into ER membrane [GO:0045048]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" GO:0005048; GO:0005262; GO:0005784; GO:0005789; GO:0006613; GO:0006614; GO:0006616; GO:0006620; GO:0007029; GO:0008320; GO:0016020; GO:0030176; GO:0031204; GO:0039019; GO:0043022; GO:0045047; GO:0045048 calcium channel activity [GO:0005262]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048] FLEVIKPFCVILPEIQKPER 0.911 1.2635 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5678 0 0 0 0 0 0 0 0 0 0 0 11.833 0 0 0 0 0 0 0 0 0 0 O60478 G137B_HUMAN Integral membrane protein GPR137B (Transmembrane 7 superfamily member 1 protein) GPR137B TM7SF1 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of GTPase activity [GO:0043087]; regulation of macrophage activation [GO:0043030] integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; autophagy [GO:0006914]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of GTPase activity [GO:0043087]; regulation of macrophage activation [GO:0043030] GO:0005765; GO:0005887; GO:0006914; GO:0010506; GO:0016020; GO:0043030; GO:0043087; GO:0045671; GO:0045779; GO:0150032; GO:1904263 LGLTVVYTVFYALLFVFIYVQLWLVLRYR 0.91102 1.2259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5388 0 0 13.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5321 0 0 0 0 0 13.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8314 12.7845 0 0 0 0 0 0 0 12.3566 0 0 0 0 0 0 13.3563 0 0 0 0 0 0 0 0 0 0 12.1155 0 0 0 0 0 0 0 P17024 ZNF20_HUMAN Zinc finger protein 20 (Zinc finger protein KOX13) ZNF20 KOX13 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFRCTSDLQRHEK 0.91106 1.2627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9111 0 0 0 0 15.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5114 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0661 0 0 0 0 14.7517 0 0 0 0 0 13.2575 0 0 14.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7394 0 0 0 0 0 0 13.5187 0 0 0 0 0 0 10.6497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1343 Q3MII6 TBC25_HUMAN TBC1 domain family member 25 TBC1D25 OATL1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096] GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:0090630; GO:1901096 GTPase activator activity [GO:0005096] AMATKFAHLKLLLR 0.91106 1.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5156 14.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16853 AOC3_HUMAN "Membrane primary amine oxidase, EC 1.4.3.21 (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase, SSAO) (Vascular adhesion protein 1, VAP-1)" AOC3 VAP1 Homo sapiens (Human) amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of primary amine oxidase activity [GO:1902283]; response to antibiotic [GO:0046677] GO:0005507; GO:0005509; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005902; GO:0006954; GO:0007155; GO:0008131; GO:0009308; GO:0009986; GO:0016021; GO:0042802; GO:0046677; GO:0046982; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596; GO:1902283 aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593] DVTVERHGGPLPYHR 0.91107 1.4768 0 0 0 0 0 0 0 10.8844 0 0 0 0 0 0 0 0 13.1859 13.234 0 13.1913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.617 10.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4903 0 0 0 0 12.0182 0 14.269 0 0 0 0 0 0 0 11.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7172 0 0 11.2091 0 0 0 12.9759 0 0 0 13.023 10.9121 0 0 0 0 11.6666 0 0 0 0 0 0 0 0 0 0 0 12.8803 0 0 0 0 0 13.0471 10.7399 11.8546 0 0 0 0 0 0 0 13.2063 0 0 13.4866 12.7486 12.4178 11.4033 0 0 0 0 0 0 0 0 12.2762 0 0 0 0 0 0 0 0 0 0 0 0 13.213 0 13.5215 Q9NQT5 EXOS3_HUMAN Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10) EXOSC3 RRP40 CGI-102 Homo sapiens (Human) "CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0000791; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0034427; GO:0034475; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071051; GO:0101019 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723] DMEPEMVCIDSCGR 0.91109 1.3723 0 0 0 0 0 0 0 0 0 0 0 12.0641 0 0 0 12.9157 0 0 0 0 0 0 0 0 11.5152 0 0 0 0 0 0 0 0 0 0 0 0 11.2873 13.0676 0 11.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7403 0 0 0 0 0 0 0 0 13.364 0 0 0 0 0 0 0 0 13.4607 0 0 13.2774 0 0 0 0 0 0 0 0 13.9974 0 0 Q9NZP0 OR6C3_HUMAN Olfactory receptor 6C3 (HSA8) OR6C3 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NFSFLEISFTTVCIPRFLGAIITRNK 0.91109 1.2302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JSJ3 MEIOS_HUMAN Meiosis initiator protein (Basic helix-loop-helix and HMG box domain-containing protein 1) MEIOSIN BHMG1 Homo sapiens (Human) activation of meiosis [GO:0090427]; cellular response to retinoic acid [GO:0071300]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; activation of meiosis [GO:0090427]; cellular response to retinoic acid [GO:0071300]; meiotic cell cycle [GO:0051321]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] GO:0003677; GO:0005634; GO:0006357; GO:0007283; GO:0046983; GO:0048477; GO:0051321; GO:0071300; GO:0090427 DNA binding [GO:0003677]; protein dimerization activity [GO:0046983] CPDSCGHPRPASSSPPGDR 0.91112 1.2543 0 0 0 0 0 0 11.0333 0 13.7054 13.015 0 14.5302 14.4707 11.7443 15.0349 13.1546 13.078 15.2539 14.145 14.8854 0 0 15.1944 13.2788 13.0179 0 0 15.2663 0 0 14.7593 0 0 0 0 0 11.0112 12.914 12.0133 0 14.8399 14.206 13.3949 13.3674 11.4483 12.8867 0 12.9933 0 14.7267 0 0 0 0 0 0 0 0 0 0 0 0 14.3416 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1645 0 0 0 14.4613 0 13.7575 14.4335 11.3229 14.6457 14.7675 14.0076 0 0 14.1591 14.4314 15.1379 14.8076 0 14.5725 14.7261 0 0 13.7341 13.8408 0 17.3335 0 14.5892 14.8772 14.7149 15.645 15.1345 0 17.0012 0 13.9639 0 15.1467 14.9752 16.4632 15.894 0 16.0098 0 15.6834 0 14.3933 0 14.9793 16.0362 15.107 0 0 0 14.2889 0 0 16.888 15.5818 0 15.9459 15.6463 13.7062 0 15.1777 0 15.0693 15.4068 15.7285 15.4352 14.1346 15.9383 0 0 0 0 14.2464 0 15.3779 0 17.0231 0 16.3848 13.7508 0 17.0497 16.9496 0 14.6563 15.2419 0 16.7914 16.556 15.4498 14.1428 15.685 14.4629 14.0244 16.9815 0 14.1525 16.7936 0 Q9NZR4 VSX1_HUMAN Visual system homeobox 1 (Homeodomain protein RINX) (Retinal inner nuclear layer homeobox protein) (Transcription factor VSX1) VSX1 RINX Homo sapiens (Human) "neuron development [GO:0048666]; neuron maturation [GO:0042551]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; neuron development [GO:0048666]; neuron maturation [GO:0042551]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; retinal bipolar neuron differentiation [GO:0060040]; visual perception [GO:0007601]" GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0007601; GO:0042551; GO:0048666; GO:0050896; GO:0060040; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" HCIPLPDSVLNSAEGGLLGSCAPWLLGMHKK 0.91114 1.2663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96346 0 10.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07476 INVO_HUMAN Involucrin IVL Homo sapiens (Human) isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; response to UV-B [GO:0010224] centrosome [GO:0005813]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604] centrosome [GO:0005813]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine [GO:0018153]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; response to UV-B [GO:0010224] GO:0001533; GO:0005737; GO:0005813; GO:0005829; GO:0010224; GO:0016604; GO:0018149; GO:0018153; GO:0030216; GO:0031424; GO:0070062 GEVLLPVEHQQQKQEVQWPPKHK 0.91121 1.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0929 0 0 0 0 0 0 0 0 0 0 14.8561 0 0 14.1922 0 0 0 0 0 0 0 0 14.4882 0 0 0 0 0 0 0 0 0 0 0 11.8964 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2936 0 0 0 0 0 0 0 0 0 0 0 13.0494 0 0 0 0 0 0 P62068 UBP46_HUMAN "Ubiquitin carboxyl-terminal hydrolase 46, EC 3.4.19.12 (Deubiquitinating enzyme 46) (Ubiquitin thioesterase 46) (Ubiquitin-specific-processing protease 46)" USP46 Homo sapiens (Human) "adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; adult feeding behavior [GO:0008343]; behavioral fear response [GO:0001662]; behavioral response to ethanol [GO:0048149]; protein deubiquitination [GO:0016579]; regulation of synaptic transmission, GABAergic [GO:0032228]; righting reflex [GO:0060013]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0001662; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0008343; GO:0016579; GO:0032228; GO:0046872; GO:0048149; GO:0060013 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872] KLPMILALHLKR 0.91121 1.2715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6XGL0 YJEN3_HUMAN "YjeF N-terminal domain-containing protein 3, YjeF_N3, hYjeF_N3 (ApoA-I-binding protein 2)" YJEFN3 AIBP2 Homo sapiens (Human) hematopoietic stem cell proliferation [GO:0071425]; lipid transport [GO:0006869]; membrane raft distribution [GO:0031580]; negative regulation of angiogenesis [GO:0016525]; regulation of cholesterol efflux [GO:0010874]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; NADHX epimerase activity [GO:0052856]; hematopoietic stem cell proliferation [GO:0071425]; lipid transport [GO:0006869]; membrane raft distribution [GO:0031580]; negative regulation of angiogenesis [GO:0016525]; regulation of cholesterol efflux [GO:0010874]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040] GO:0002040; GO:0005739; GO:0006869; GO:0008593; GO:0010874; GO:0016525; GO:0031580; GO:0052856; GO:0071425 NADHX epimerase activity [GO:0052856] AFPLPALSRKQR 0.91123 1.3699 0 0 0 0 9.78573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0527 0 0 0 12.7023 0 12.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2911 0 0 0 0 11.927 0 0 0 13.0872 14.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98168 ZXDA_HUMAN Zinc finger X-linked protein ZXDA ZXDA Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0045893; GO:0046872; GO:0070742 C2H2 zinc finger domain binding [GO:0070742]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] ACRLKIHLR 0.91124 1.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9968 13.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2533 13.4819 0 0 14.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5872 0 0 0 0 0 0 13.7327 0 0 0 0 0 0 0 0 0 0 12.2876 0 0 0 0 0 0 0 0 0 0 Q9BVV8 F174C_HUMAN Protein FAM174C FAM174C C19orf24 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] GO:0005576; GO:0005737; GO:0016021 GPRVLQPPLLLLLLALLLAALPCGAEEASPLR 0.91128 1.233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8395 0 0 0 0 0 0 0 0 0 14.4153 0 15.1911 14.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0984 0 0 0 0 0 14.163 0 0 0 0 0 12.3814 0 0 0 0 11.9066 0 0 0 0 14.1966 0 0 0 0 0 0 0 0 13.6797 14.4313 0 0 0 0 0 0 0 0 0 A0PJE2 DHR12_HUMAN "Dehydrogenase/reductase SDR family member 12, EC 1.1.-.- (Short-chain dehydrogenase/reductase family 40C member 1, Protein SDR40C1)" DHRS12 SDR40C1 Homo sapiens (Human) oxidoreductase activity [GO:0016491] GO:0016491 oxidoreductase activity [GO:0016491] DQAPAEDAR 0.91129 1.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5784 0 0 0 0 0 0 0 0 0 11.5923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6G2 TEX26_HUMAN Testis-expressed protein 26 TEX26 C13orf26 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DRQIIDRFIR 0.91129 1.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6455 12.9909 13.063 0 14.061 13.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4561 0 0 0 0 0 0 0 0 0 0 0 0 13.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75752 B3GL1_HUMAN "UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1, Beta-1,3-GalNAc-T1, EC 2.4.1.79 (Beta-1,3-galactosyltransferase 3, Beta-1,3-GalTase 3, Beta3Gal-T3, Beta3GalT3, b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)" B3GALNT1 B3GALT3 UNQ531/PRO1074 Homo sapiens (Human) glycosphingolipid metabolic process [GO:0006687]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [GO:0047273]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; glycosphingolipid metabolic process [GO:0006687]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]" GO:0000139; GO:0006486; GO:0006687; GO:0008194; GO:0008499; GO:0009312; GO:0016021; GO:0016757; GO:0047273 "galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity [GO:0047273]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" DLVPRIYEMMGHVK 0.9113 1.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5871 15.266 0 0 0 0 10.8146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4853 0 12.8471 0 12.0689 12.1933 0 12.4179 0 0 0 12.2048 0 12.4854 0 0 0 0 0 0 0 0 0 0 12.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9672 0 0 0 0 0 0 0 0 11.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2177 0 0 11.1603 0 0 0 0 0 0 0 A1L453 PRS38_HUMAN "Serine protease 38, EC 3.4.21.- (Marapsin-2)" PRSS38 MPN2 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508 serine-type endopeptidase activity [GO:0004252] AAPASVMGPLGPSALGLLLLLLVVAPPR 0.91131 1.3751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1874 0 0 0 0 0 10.4902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5595 0 0 0 0 0 11.8663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78414 IRX1_HUMAN Iroquois-class homeodomain protein IRX-1 (Homeodomain protein IRXA1) (Iroquois homeobox protein 1) IRX1 IRXA1 Homo sapiens (Human) cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0030182; GO:0043565; GO:0048468; GO:0072086; GO:0072272; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" DQEDGALFGSDTEGDPEK 0.91131 1.2264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14780 MMP9_HUMAN "Matrix metalloproteinase-9, MMP-9, EC 3.4.24.35 (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B, GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9 ]" MMP9 CLG4B Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; leukocyte migration [GO:0050900]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; leukocyte migration [GO:0050900]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501] GO:0001501; GO:0001503; GO:0001934; GO:0004175; GO:0004222; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0006915; GO:0007566; GO:0008233; GO:0008237; GO:0008270; GO:0022617; GO:0030198; GO:0030225; GO:0030335; GO:0030574; GO:0034614; GO:0035987; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0045742; GO:0048013; GO:0050900; GO:0051549; GO:0062023; GO:0070062; GO:0071276; GO:0071492; GO:0090200; GO:0150077; GO:1900122; GO:1904645; GO:1904707; GO:1904724; GO:1904813; GO:2000697; GO:2001243; GO:2001258; GO:2001268 collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] DGKYWRFSEGR 0.91132 1.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6445 13.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9262 0 0 0 0 0 0 0 0 A6NJL1 ZSA5B_HUMAN Zinc finger and SCAN domain-containing protein 5B ZSCAN5B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KLTELCHLWLR 0.91133 1.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.421 0 0 0 12.7012 0 0 0 0 0 14.1709 13.2677 0 0 0 0 0 13.1583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6577 0 0 0 0 0 0 0 0 0 0 0 0 14.5217 0 0 12.7836 0 0 0 0 0 0 0 A6NKF7 TM88B_HUMAN Transmembrane protein 88B TMEM88B Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165] GO:0005886; GO:0016021; GO:0030165 PDZ domain binding [GO:0030165] GSAALIVFGLLSLPPLLVLASAVRAR 0.91134 1.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8174 0 0 0 0 0 0 0 0 0 0 0 11.6824 0 0 0 0 10.204 0 11.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2059 0 0 0 0 0 0 0 0 0 0 0 10.6372 0 0 0 0 12.2187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5953 0 0 14.5427 0 13.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04727 TLE4_HUMAN Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4) TLE4 GRG4 KIAA1261 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055] GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714] HVYTGGK 0.91134 1.4784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2372 0 0 0 0 0 0 0 0 0 0 0 15.9582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4941 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92599 SEPT8_HUMAN Septin-8 SEPTIN8 KIAA0202 SEPT8 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of intracellular protein transport [GO:0033157]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542] anchoring junction [GO:0070161]; axon [GO:0030424]; cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; axon [GO:0030424]; cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of intracellular protein transport [GO:0033157]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542] GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0030424; GO:0030672; GO:0031105; GO:0031647; GO:0032153; GO:0033157; GO:0035542; GO:0060090; GO:0061640; GO:0070161; GO:0098793 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] ADTISKSELHKFK 0.91134 1.2263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7256 0 0 0 0 14.474 0 0 0 0 14.3421 0 0 0 0 0 0 0 13.0258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8652 0 14.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPI3 FLVC2_HUMAN "Feline leukemia virus subgroup C receptor-related protein 2 (Calcium-chelate transporter, CCT)" FLVCR2 C14orf58 Homo sapiens (Human) heme export [GO:0097037] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; heme export [GO:0097037] GO:0005886; GO:0015232; GO:0016021; GO:0020037; GO:0097037 heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232] ETLENKLQEEEEESNTSK 0.91134 1.2689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9045 0 0 0 0 0 0 0 12.5472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76093 FGF18_HUMAN "Fibroblast growth factor 18, FGF-18 (zFGF5)" FGF18 UNQ420/PRO856 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0001525; GO:0001934; GO:0001957; GO:0001958; GO:0002063; GO:0005104; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008283; GO:0008284; GO:0008543; GO:0009653; GO:0009887; GO:0010628; GO:0030154; GO:0030324; GO:0030334; GO:0030949; GO:0032332; GO:0043406; GO:0043536; GO:0045766; GO:0048010; GO:0070371; GO:0070374; GO:2000546 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111] HIQVLGRRISAR 0.9114 1.2673 0 0 0 0 0 0 0 0 0 11.879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2489 12.4313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04155 TFF1_HUMAN "Trefoil factor 1 (Breast cancer estrogen-inducible protein) (PNR-2) (Polypeptide P1.A, hP1.A) (Protein pS2)" TFF1 BCEI PS2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cell population proliferation [GO:0008285]; response to immobilization stress [GO:0035902]; response to iron ion [GO:0010039]; response to peptide hormone [GO:0043434] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cell population proliferation [GO:0008285]; response to immobilization stress [GO:0035902]; response to iron ion [GO:0010039]; response to peptide hormone [GO:0043434] GO:0005576; GO:0005615; GO:0005975; GO:0008083; GO:0008283; GO:0008285; GO:0010039; GO:0030154; GO:0030277; GO:0035902; GO:0043434 growth factor activity [GO:0008083] GCCFDDTVR 0.91142 1.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.037 15.9223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PX8 SLIK1_HUMAN SLIT and NTRK-like protein 1 (Leucine-rich repeat-containing protein 12) SLITRK1 KIAA1910 LRRC12 UNQ233/PRO266 Homo sapiens (Human) adult behavior [GO:0030534]; axonogenesis [GO:0007409]; homeostatic process [GO:0042592]; multicellular organism growth [GO:0035264]; positive regulation of axonogenesis [GO:0050772]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; synapse [GO:0045202]; adult behavior [GO:0030534]; axonogenesis [GO:0007409]; homeostatic process [GO:0042592]; multicellular organism growth [GO:0035264]; positive regulation of axonogenesis [GO:0050772]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560] GO:0005576; GO:0005886; GO:0007409; GO:0007416; GO:0030534; GO:0035264; GO:0042592; GO:0045202; GO:0050772; GO:0051965; GO:0070161; GO:0098978; GO:0098982; GO:0099061; GO:0099560; GO:1905606 CETPVNFFRK 0.91145 1.2545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1195 0 0 0 0 0 0 0 0 10.9229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1468 0 0 14.7017 0 0 0 0 0 0 0 0 0 12.5883 13.8024 0 14.9772 0 0 0 14.556 15.1351 15.3815 0 0 0 14.5448 0 13.3729 12.9236 14.6656 0 13.0869 0 12.926 0 0 0 13.9279 0 0 0 0 0 0 0 0 13.1801 0 0 12.8259 0 0 0 13.6283 0 14.7779 0 0 0 14.2758 0 0 0 0 0 0 0 0 0 0 12.2664 0 0 0 13.3706 0 12.7469 0 0 0 0 11.7812 0 0 0 0 14.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9374 0 0 0 0 0 0 P39905 GDNF_HUMAN "Glial cell line-derived neurotrophic factor, hGDNF (Astrocyte-derived trophic factor, ATF)" GDNF Homo sapiens (Human) adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676] GO:0001656; GO:0001658; GO:0001755; GO:0001759; GO:0001941; GO:0003337; GO:0005102; GO:0005576; GO:0005615; GO:0005794; GO:0007165; GO:0007399; GO:0007422; GO:0008083; GO:0008284; GO:0008344; GO:0010468; GO:0021516; GO:0021784; GO:0030116; GO:0030432; GO:0030971; GO:0031175; GO:0032770; GO:0033603; GO:0042803; GO:0043066; GO:0043524; GO:0045597; GO:0045944; GO:0048255; GO:0048484; GO:0048485; GO:0048568; GO:0051584; GO:0060676; GO:0060688; GO:0071679; GO:0072107; GO:0072108; GO:0090190; GO:1902379; GO:2000736; GO:2001240; GO:2001260 chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] ILKNLSRNR 0.91147 1.2664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9235 0 0 0 0 0 0 0 0 0 14.7352 0 0 0 0 14.7367 0 0 0 0 0 0 14.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54257 HAP1_HUMAN "Huntingtin-associated protein 1, HAP-1 (Neuroan 1)" HAP1 HAP2 HLP1 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; autophagy [GO:0006914]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; hypothalamus cell differentiation [GO:0021979]; mitochondrion distribution [GO:0048311]; negative regulation of amyloid-beta formation [GO:1902430]; neurogenesis [GO:0022008]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of exocytosis [GO:0017157]; regulation of organelle transport along microtubule [GO:1902513]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]" actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; autophagosome [GO:0005776]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021] "actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; autophagosome [GO:0005776]; axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021]; brain-derived neurotrophic factor binding [GO:0048403]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; anterograde axonal transport [GO:0008089]; anterograde axonal transport of mitochondrion [GO:0098957]; autophagy [GO:0006914]; brain development [GO:0007420]; cell projection organization [GO:0030030]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; hypothalamus cell differentiation [GO:0021979]; mitochondrion distribution [GO:0048311]; negative regulation of amyloid-beta formation [GO:1902430]; neurogenesis [GO:0022008]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotrophin production [GO:0032901]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of exocytosis [GO:0017157]; regulation of organelle transport along microtubule [GO:1902513]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496]" GO:0005102; GO:0005730; GO:0005739; GO:0005764; GO:0005769; GO:0005776; GO:0005783; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0006605; GO:0006887; GO:0006914; GO:0007268; GO:0007420; GO:0008021; GO:0008089; GO:0008090; GO:0008104; GO:0015629; GO:0016234; GO:0017022; GO:0017157; GO:0021549; GO:0021979; GO:0022008; GO:0030030; GO:0030425; GO:0030426; GO:0031410; GO:0031587; GO:0032230; GO:0032901; GO:0043197; GO:0044325; GO:0045742; GO:0047496; GO:0048011; GO:0048311; GO:0048403; GO:0050769; GO:0070161; GO:0098957; GO:1902430; GO:1902513; GO:1902857; GO:1904115 brain-derived neurotrophic factor binding [GO:0048403]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] ERDLNTAAR 0.91154 1.2721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5027 0 0 13.4555 0 0 0 0 0 0 0 10.9034 0 0 0 0 0 13.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4915 10.5498 0 0 0 0 0 0 0 11.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31942 HNRH3_HUMAN "Heterogeneous nuclear ribonucleoprotein H3, hnRNP H3 (Heterogeneous nuclear ribonucleoprotein 2H9, hnRNP 2H9)" HNRNPH3 HNRPH3 Homo sapiens (Human) "epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0030855; GO:0043484; GO:1990904 RNA binding [GO:0003723] GGDGYDGGYGGFDDYGGYNNYGYGNDGFDDRMR 0.91158 1.2348 0 13.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9477 14.3449 0 15.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1511 0 0 0 0 0 14.8881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3982 0 0 0 0 14.2353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12798 CETN1_HUMAN Centrin-1 (Caltractin isoform 2) CETN1 CEN1 CETN Homo sapiens (Human) cell division [GO:0051301]; cellular response to heat [GO:0034605]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair [GO:0006289] GO:0000278; GO:0000922; GO:0005509; GO:0005813; GO:0005814; GO:0005829; GO:0006289; GO:0007099; GO:0008017; GO:0031683; GO:0032391; GO:0032795; GO:0034605; GO:0051301 calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017] ASGFKKPSAASTGQK 0.91159 1.2651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4529 13.9817 0 0 0 0 0 0 0 0 13.8406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8723 0 0 0 17.2853 17.246 15.7602 16.0965 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTR8 NET5_HUMAN Netrin-5 (Netrin-1-like protein) NTN5 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; neurogenesis [GO:0022008]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576] basement membrane [GO:0005604]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; neurogenesis [GO:0022008]; tissue development [GO:0009888] GO:0005102; GO:0005576; GO:0005604; GO:0008045; GO:0009887; GO:0009888; GO:0016358; GO:0022008 signaling receptor binding [GO:0005102] CQCHGHAARCAAR 0.91161 1.2339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6067 0 0 0 0 0 0 0 10.8221 0 0 0 0 0 11.8707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8073 12.5988 15.5579 13.3673 0 0 12.6735 0 12.6352 15.5679 0 0 0 0 0 0 12.7036 0 0 0 0 14.6663 0 0 13.3437 0 0 0 15.3162 0 0 12.4874 0 0 0 0 0 0 13.6945 13.2264 13.3817 0 0 14.1856 0 0 0 0 13.8407 0 13.0894 0 0 12.9069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9519 13.9797 14.0341 0 0 0 0 0 12.8174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7521 13.8045 0 0 0 0 0 0 Q96A22 CK052_HUMAN Uncharacterized protein C11orf52 C11orf52 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 EVKHVHLENATEYATLRFPQATPR 0.91163 1.3763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4795 0 0 0 0 0 0 0 0 0 0 16.6117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4913 0 0 0 13.1722 0 10.5593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9N2J8 ENH3_HUMAN "HERV-H_2q24.1 provirus ancestral Env polyprotein (Env protein HERV-H/p59) (Envelope polyprotein) (HERV-H/env59) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 LKNVSSNYCLGRHLPYISLHPWLPSPCSSDSPPR 0.91163 1.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYX4 DND1_HUMAN "Dead end protein homolog 1 (RNA-binding motif, single-stranded-interacting protein 4)" DND1 RBMS4 Homo sapiens (Human) 3'-UTR-mediated mRNA destabilization [GO:0061158]; germ cell development [GO:0007281]; mRNA stabilization [GO:0048255]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; germ cell development [GO:0007281]; mRNA stabilization [GO:0048255]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; spermatogenesis [GO:0007283] GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0007281; GO:0007283; GO:0048255; GO:0060965; GO:0061158 mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] DGHEVAKDAVSVRLLQALSESGANLLWSAGAEAGTMVK 0.91165 1.3687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6474 0 0 0 0 0 0 0 0 0 0 15.9909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.056 0 0 0 0 0 11.8423 0 0 0 0 10.6834 0 0 0 0 P49765 VEGFB_HUMAN "Vascular endothelial growth factor B, VEGF-B (VEGF-related factor, VRF)" VEGFB VRF Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; coronary vasculature development [GO:0060976]; induction of positive chemotaxis [GO:0050930]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular wound healing [GO:0035470]; protein O-linked glycosylation [GO:0006493]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor binding [GO:0005172]; cardiac muscle contraction [GO:0060048]; coronary vasculature development [GO:0060976]; induction of positive chemotaxis [GO:0050930]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular wound healing [GO:0035470]; protein O-linked glycosylation [GO:0006493]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] GO:0001666; GO:0001934; GO:0001938; GO:0002040; GO:0005172; GO:0005576; GO:0005615; GO:0006493; GO:0008083; GO:0008201; GO:0010629; GO:0016020; GO:0030949; GO:0031093; GO:0035470; GO:0038084; GO:0042056; GO:0042802; GO:0043066; GO:0043183; GO:0043524; GO:0045766; GO:0048010; GO:0050731; GO:0050930; GO:0051781; GO:0051897; GO:0060048; GO:0060754; GO:0060976; GO:0070374 chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor binding [GO:0005172] MSPLLRR 0.91166 1.3755 0 0 0 0 0 0 0 0 0 0 13.5053 0 13.5036 13.1812 0 0 0 0 0 0 0 0 0 0 0 0 13.3103 0 0 0 13.0958 13.1918 0 15.9154 0 0 13.4896 0 0 13.0054 0 0 12.0209 0 0 0 12.3178 0 12.7218 0 0 0 0 12.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 12.0227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8606 0 0 0 0 11.6471 0 0 0 0 14.7673 0 14.601 14.5035 14.4875 14.4769 0 14.6323 0 14.7018 0 0 14.4729 0 0 0 0 0 0 0 0 0 0 Q5JS13 RGPS1_HUMAN "Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2, RalGEF 2) (RalA exchange factor RalGPS1)" RALGPS1 KIAA0351 RALGEF2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] GO:0005085; GO:0005737; GO:0005886; GO:0007265; GO:0032485; GO:0035556; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] LTKTWALLNRK 0.91166 1.4664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1081 0 13.1052 0 0 0 0 0 0 12.235 0 0 0 0 0 0 0 12.0861 11.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9603 0 0 0 13.661 13.4547 0 0 0 0 0 0 0 11.07 0 0 0 0 11.3852 0 0 0 0 0 0 0 0 0 12.5922 13.2827 14.8725 0 13.1906 12.9432 12.2547 0 0 0 0 0 0 0 0 0 0 12.2675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUB9 KR191_HUMAN Keratin-associated protein 19-1 (High tyrosine-glycine keratin-associated protein 19.1) KRTAP19-1 KAP19.1 KRTAP19.1 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 RGSGCGYGGYGYGSGFGSYGYGSGFGGYGYGSGFGGYGYGCCR 0.91167 1.2693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9077 0 0 0 0 0 0 0 12.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9689 0 0 13.1868 0 0 0 12.6987 0 0 0 0 0 0 0 0 0 0 0 0 12.6663 0 0 0 0 13.0137 12.3516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3588 0 0 0 0 0 0 0 0 0 0 12.3562 0 0 0 Q8WUH1 CHUR_HUMAN Protein Churchill CHURC1 C14orf52 CHCH My015 Homo sapiens (Human) "fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of transcription, DNA-templated [GO:0045893]" "zinc ion binding [GO:0008270]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0008270; GO:0008543; GO:0045893 zinc ion binding [GO:0008270] HEYTFSIMDEFQEYTMLCLLCGK 0.91168 1.2752 12.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7992 0 0 0 0 0 0 11.6736 0 12.8124 0 0 0 0 0 0 0 0 0 0 0 0 12.9455 0 0 0 12.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6481 0 0 0 0 0 0 Q9UKA1 FBXL5_HUMAN F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5) (F-box protein FBL4/FBL5) (p45SKP2-like protein) FBXL5 FBL4 FBL5 FLR1 Homo sapiens (Human) iron ion homeostasis [GO:0055072]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; iron ion binding [GO:0005506]; ubiquitin-protein transferase activity [GO:0004842]; iron ion homeostasis [GO:0055072]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000151; GO:0004842; GO:0005506; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0045732; GO:0048471; GO:0055072 iron ion binding [GO:0005506]; ubiquitin-protein transferase activity [GO:0004842] ALLQSLYATFK 0.91168 1.2564 0 0 0 0 12.0014 0 0 0 0 0 0 0 0 13.9254 0 11.8945 0 0 0 0 0 9.21592 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6024 0 0 0 0 0 0 0 0 0 0 9.67354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3816 0 0 10.4994 0 0 0 0 0 0 0 0 0 13.1531 0 0 0 0 0 0 0 0 0 0 0 0 0 12.334 0 0 0 0 0 0 0 0 0 0 0 0 12.2921 0 0 0 0 0 10.7334 0 0 0 0 0 0 0 0 0 0 0 0 12.0982 0 0 11.1369 0 0 0 0 0 13.0743 0 0 0 13.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2751 11.5578 11.8009 0 0 0 0 12.1597 0 0 0 0 0 0 10.785 0 0 0 0 0 0 12.008 0 0 P0DPK4 NT2NC_HUMAN Notch homolog 2 N-terminal-like protein C NOTCH2NLC Homo sapiens (Human) cerebral cortex development [GO:0021987]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cerebral cortex development [GO:0021987]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747] GO:0005509; GO:0005576; GO:0007219; GO:0021987; GO:0045747 calcium ion binding [GO:0005509] CWRSGCAARPPR 0.91172 1.4786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6384 0 0 0 0 0 0 15.4603 0 14.2579 0 0 0 0 0 0 0 14.4696 17.3079 0 0 0 14.6705 13.851 0 0 0 0 0 0 15.476 15.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7433 0 0 0 0 15.13 0 15.0281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5461 14.4373 0 0 0 0 0 0 P14151 LYAM1_HUMAN "L-selectin (CD62 antigen-like family member L) (Leukocyte adhesion molecule 1, LAM-1) (Leukocyte surface antigen Leu-8) (Leukocyte-endothelial cell adhesion molecule 1, LECAM1) (Lymph node homing receptor) (TQ1) (gp90-MEL) (CD antigen CD62L)" SELL LNHR LYAM1 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; glycosphingolipid binding [GO:0043208]; heparin binding [GO:0008201]; oligosaccharide binding [GO:0070492]; protease binding [GO:0002020]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901] GO:0002020; GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007159; GO:0008201; GO:0016339; GO:0030246; GO:0030667; GO:0043208; GO:0050901; GO:0070492 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; glycosphingolipid binding [GO:0043208]; heparin binding [GO:0008201]; oligosaccharide binding [GO:0070492]; protease binding [GO:0002020] DAGKWNDDACHK 0.91174 1.2547 0 0 0 0 0 0 0 0 0 12.428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2622 15.5036 15.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6973 0 0 0 0 0 0 0 0 15.2511 0 0 Q8NBW4 S38A9_HUMAN Sodium-coupled neutral amino acid transporter 9 (Solute carrier family 38 member 9) (Up-regulated in lung cancer 11) SLC38A9 URLC11 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008] integral component of lysosomal membrane [GO:1905103]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] integral component of lysosomal membrane [GO:1905103]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-leucine transmembrane transporter activity [GO:0015190]; metal ion binding [GO:0046872]; amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008] GO:0003333; GO:0005764; GO:0005765; GO:0005770; GO:0015171; GO:0015179; GO:0015190; GO:0031902; GO:0032008; GO:0046872; GO:0061459; GO:0071230; GO:1905103 amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-leucine transmembrane transporter activity [GO:0015190]; metal ion binding [GO:0046872] FNILGTVSVLYLIFLVTFKAVR 0.91174 1.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2351 0 0 0 13.5071 0 0 0 0 0 0 11.4384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.483 0 0 0 0 0 0 0 0 0 Q6UXG8 BTNL9_HUMAN Butyrophilin-like protein 9 BTNL9 UNQ1900/PRO4346 Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0005102; GO:0005886; GO:0009897; GO:0016021; GO:0050852 signaling receptor binding [GO:0005102] ELVVQIADVFVPGASAWKSAFVATLPLLLVLAALALGVLR 0.91176 5.4953 0 0 0 0 0 0 0 0 11.9947 17.2769 12.0571 0 0 11.8953 0 0 0 0 0 0 0 11.0451 12.3904 0 0 0 0 0 12.3474 11.6475 14.6782 12.1581 0 10.5268 0 0 0 15.2139 0 0 0 0 0 0 0 14.5153 15.1428 0 0 0 0 0 0 0 0 0 11.2259 11.8664 0 0 0 0 0 0 0 0 13.3983 0 13.4115 0 12.2959 0 12.3767 12.1176 12.4977 0 14.9598 0 14.102 12.715 13.6546 12.1954 13.2691 0 0 0 0 12.3702 11.1903 11.4839 14.9885 12.0935 0 11.096 13.4439 13.8722 0 13.0948 13.4726 12.5081 14.0007 11.7432 12.671 13.0894 14.2953 0 0 13.9285 14.5308 0 14.3716 12.3357 13.7081 12.2492 15.9049 0 12.671 0 0 13.0318 13.3229 13.2776 13.9237 0 14.0112 12.9042 0 0 14.2389 14.8631 0 12.1195 13.3482 12.1307 0 0 11.9916 0 12.55 10.7986 0 0 0 12.9738 0 0 11.5862 0 0 14.6292 0 11.7761 0 13.4607 0 0 11.9902 0 0 11.7938 0 12.6605 0 16.3864 0 11.952 0 0 0 12.411 0 0 0 0 0 12.7066 12.0937 15.0923 13.4823 0 Q96SK3 ZN607_HUMAN Zinc finger protein 607 ZNF607 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSVHGRLTR 0.91176 1.2497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8746 0 0 0 0 0 12.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6S5 AR6P6_HUMAN "ADP-ribosylation factor-like protein 6-interacting protein 6, ARL-6-interacting protein 6, Aip-6 (Phosphonoformate immuno-associated protein 1)" ARL6IP6 PFAAP1 Homo sapiens (Human) integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] GO:0005637; GO:0016021 AQPRRWPVQVLSILCSLLFAILLAFLLAIAYLIVK 0.91179 1.4778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ52 RNZ2_HUMAN "Zinc phosphodiesterase ELAC protein 2, EC 3.1.26.11 (ElaC homolog protein 2) (Heredity prostate cancer protein 2) (Ribonuclease Z 2, RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2)" ELAC2 HPC2 Homo sapiens (Human) "mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; mitochondrial tRNA processing [GO:0090646]; tRNA 3'-end processing [GO:0042780]; tRNA catabolic process [GO:0016078]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific ribonuclease activity [GO:0004549]; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic [GO:0072684]; mitochondrial tRNA processing [GO:0090646]; tRNA 3'-end processing [GO:0042780]; tRNA catabolic process [GO:0016078]" GO:0003723; GO:0004521; GO:0004549; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0016078; GO:0042645; GO:0042780; GO:0042781; GO:0046872; GO:0072684; GO:0090646 3'-tRNA processing endoribonuclease activity [GO:0042781]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific ribonuclease activity [GO:0004549] ALASLGKPLHPLLVVAPNQLK 0.9118 1.4432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1858 11.7171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4357 13.6069 0 13.8976 0 0 13.2996 0 0 14.7586 0 0 0 0 13.229 0 14.5669 0 0 0 0 0 0 0 0 0 0 12.9116 0 11.9961 0 0 0 13.2489 14.691 0 14.4802 0 0 0 0 0 13.1276 13.551 12.7511 0 15.0631 14.5661 0 0 0 0 0 13.2654 0 0 0 0 0 14.7071 0 0 13.2339 0 14.5796 0 12.2989 14.6963 0 14.5401 0 0 0 14.9737 14.9077 0 0 0 0 14.6631 0 0 0 0 0 0 0 11.3654 0 0 0 0 0 0 0 0 0 0 0 0 13.5028 0 0 14.28 0 0 0 0 Q9Y5H5 PCDA9_HUMAN "Protocadherin alpha-9, PCDH-alpha-9" PCDHA9 KIAA0345 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] ALDETDAPRQRLLVLVK 0.91181 1.2358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4387 0 0 0 0 0 0 0 0 0 0 0 11.7175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2288 0 0 0 0 0 0 0 0 0 0 0 0 13.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8869 0 0 0 0 0 0 0 0 0 14.7876 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0D2J5 ZN763_HUMAN Zinc finger protein 763 ZNF763 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AVHCLRLYLIHER 0.91183 1.4776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60409 KR107_HUMAN Keratin-associated protein 10-7 (High sulfur keratin-associated protein 10.7) (Keratin-associated protein 10.7) (Keratin-associated protein 18-7) (Keratin-associated protein 18.7) KRTAP10-7 KAP10.7 KAP18-7 KRTAP10.7 KRTAP18-7 KRTAP18.7 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; identical protein binding [GO:0042802] GO:0005829; GO:0042802; GO:0045095 identical protein binding [GO:0042802] PACCVPVPSCCAPTSSCQASCCR 0.91184 1.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0571 0 14.7467 0 0 0 14.4788 0 0 0 14.9528 0 0 0 0 0 0 0 0 0 13.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4996 0 0 0 13.2936 0 0 0 0 0 0 0 0 0 0 0 12.5849 0 0 0 0 0 0 0 0 0 0 0 Q9BV57 MTND_HUMAN "Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring), ARD', Fe-ARD, EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring), ARD, Ni-ARD, EC 1.13.11.53) (Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1, MTCBP-1) (Submergence-induced protein-like factor, Sip-L)" ADI1 MTCBP1 HMFT1638 Homo sapiens (Human) L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; acireductone dioxygenase (Ni2+-requiring) activity [GO:0010308]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555] GO:0005506; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006555; GO:0010308; GO:0010309; GO:0016491; GO:0019509 acireductone dioxygenase (Ni2+-requiring) activity [GO:0010308]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491] NYTKAMRLFVGEPVWTAYNR 0.91184 1.2357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3421 0 12.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5652 0 0 0 0 0 12.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8595 0 0 0 0 0 0 0 0 0 13.6121 0 0 0 0 0 0 0 0 0 0 0 0 13.8454 13.2636 0 0 0 0 0 0 0 0 0 0 13.3341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00445 SYT5_HUMAN "Synaptotagmin-5 (Synaptotagmin V, SytV)" SYT5 Homo sapiens (Human) calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of neuronal dense core vesicle membrane [GO:0099066]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proximal neuron projection [GO:1990769]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0043025; GO:0046982; GO:0048471; GO:0048488; GO:0048791; GO:0055038; GO:0070161; GO:0070382; GO:0071277; GO:0099066; GO:1990769 "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" HWADMLANPRRPIAQWHSLR 0.91187 1.2724 0 0 0 0 0 0 0 0 0 0 0 0 13.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2009 0 0 0 0 0 0 0 0 0 0 0 14.3963 0 0 15.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G112 HSF5_HUMAN "Heat shock factor protein 5, HSF 5 (Heat shock transcription factor 5, HSTF 5)" HSF5 HSTF5 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:1990837 DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] DQPQLLVHLKRLTSANK 0.91188 1.2591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5626 0 0 0 0 0 0 0 0 0 0 12.2481 0 0 14.2442 0 0 12.4213 0 0 0 0 0 0 0 14.1879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4235 0 0 13.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8017 0 0 0 0 0 0 0 0 Q63HM1 KFA_HUMAN "Kynurenine formamidase, KFA, KFase, EC 3.5.1.9 (Arylformamidase) (N-formylkynurenine formamidase, FKF)" AFMID Homo sapiens (Human) 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441] GO:0004061; GO:0005634; GO:0005737; GO:0005829; GO:0019441; GO:0034354 arylformamidase activity [GO:0004061] TYSQIGIEATTR 0.91189 1.2464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14165 MLEC_HUMAN Malectin MLEC KIAA0152 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; carbohydrate metabolic process [GO:0005975]; protein N-linked glycosylation [GO:0006487] GO:0005783; GO:0005789; GO:0005886; GO:0005975; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0019899; GO:0030246; GO:0035579 carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899] LLLLLLPPAIR 0.9119 1.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15265 ATX7_HUMAN Ataxin-7 (Spinocerebellar ataxia type 7 protein) ATXN7 SCA7 Homo sapiens (Human) "histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of microtubule depolymerization [GO:0007026]; nucleus organization [GO:0006997]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of microtubule depolymerization [GO:0007026]; nucleus organization [GO:0006997]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" GO:0000124; GO:0000226; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006282; GO:0006357; GO:0006997; GO:0007026; GO:0007601; GO:0015630; GO:0016363; GO:0016578; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893 CALNLMVEK 0.91192 1.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0541 12.3708 12.754 12.9017 12.5595 0 0 12.8559 0 13.0516 0 0 0 0 0 0 0 0 0 0 0 10.7278 0 0 0 0 0 0 0 0 0 0 11.4025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1283 0 0 0 0 0 0 0 0 0 0 0 11.9614 0 0 0 0 11.0148 0 0 0 11.2838 0 0 0 0 18.1131 0 0 0 0 14.7543 14.0541 0 13.5008 0 0 0 0 0 0 13.1186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1418 0 13.7676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8147 13.8479 0 0 13.737 0 0 0 11.7211 0 0 0 0 0 0 0 0 0 0 13.3358 0 0 0 0 P00558 PGK1_HUMAN "Phosphoglycerate kinase 1, EC 2.7.2.3 (Cell migration-inducing gene 10 protein) (Primer recognition protein 2, PRP 2)" PGK1 PGKA MIG10 OK/SW-cl.110 Homo sapiens (Human) canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase (NAD(P)) activity [GO:0047134]; canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639] GO:0004618; GO:0005524; GO:0005615; GO:0005829; GO:0006094; GO:0006096; GO:0016020; GO:0016310; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0045121; GO:0047134; GO:0061621; GO:0070062; GO:0071456 ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase (NAD(P)) activity [GO:0047134] SLLGKDVLFLK 0.91195 1.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2897 0 0 0 0 10.6323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5431 0 0 13.0905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5169 0 0 0 12.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L4E1 MIGA2_HUMAN Mitoguardin 2 (Protein FAM73B) MIGA2 C9orf54 FAM73B PSEC0112 Homo sapiens (Human) bone development [GO:0060348]; mitochondrial fusion [GO:0008053] integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741] integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; bone development [GO:0060348]; mitochondrial fusion [GO:0008053] GO:0005741; GO:0005887; GO:0008053; GO:0042803; GO:0046982; GO:0060348 protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] KVLFATALGTVALALAAHQLK 0.91195 5.3131 0 0 0 0 0 0 0 0 0 0 11.4867 0 0 0 0 0 0 0 0 0 0 0 13.6499 0 0 0 0 14.0238 0 0 0 0 0 12.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6287 0 0 0 0 0 12.9571 0 0 13.565 0 0 0 0 0 13.9321 0 0 0 12.2016 0 0 0 0 0 0 0 0 0 0 12.5402 13.5326 11.5428 0 12.2327 0 0 0 0 0 0 0 13.1533 12.4559 11.8789 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1015 0 0 0 0 0 0 0 0 0 0 12.5983 0 0 0 0 0 0 0 0 0 11.4911 0 0 0 0 0 0 0 0 0 14.3993 0 0 12.7739 0 0 0 Q92876 KLK6_HUMAN "Kallikrein-6, EC 3.4.21.- (Neurosin) (Protease M) (SP59) (Serine protease 18) (Serine protease 9) (Zyme)" KLK6 PRSS18 PRSS9 Homo sapiens (Human) amyloid precursor protein metabolic process [GO:0042982]; central nervous system development [GO:0007417]; collagen catabolic process [GO:0030574]; hormone metabolic process [GO:0042445]; myelination [GO:0042552]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein autoprocessing [GO:0016540]; regulation of cell differentiation [GO:0045595]; regulation of neuron projection development [GO:0010975]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; secretory granule [GO:0030141] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; amyloid precursor protein metabolic process [GO:0042982]; central nervous system development [GO:0007417]; collagen catabolic process [GO:0030574]; hormone metabolic process [GO:0042445]; myelination [GO:0042552]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein autoprocessing [GO:0016540]; regulation of cell differentiation [GO:0045595]; regulation of neuron projection development [GO:0010975]; response to wounding [GO:0009611]; tissue regeneration [GO:0042246] GO:0001533; GO:0004252; GO:0005576; GO:0005615; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0007417; GO:0009611; GO:0010975; GO:0016540; GO:0030141; GO:0030574; GO:0042246; GO:0042445; GO:0042552; GO:0042982; GO:0045595; GO:0045745 serine-type endopeptidase activity [GO:0004252] LARPAKLSELIQPLPLER 0.91196 1.4672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4875 0 0 14.4418 0 0 0 0 11.4305 0 0 0 0 13.2254 12.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95460 MATN4_HUMAN Matrilin-4 MATN4 Homo sapiens (Human) extracellular matrix organization [GO:0030198] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix organization [GO:0030198] GO:0005509; GO:0005576; GO:0030198; GO:0062023 calcium ion binding [GO:0005509] DQCAEGGHGCQHQCVNAWAMFHCTCNPGYKLAADNK 0.91198 1.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8064 0 0 0 0 0 0 0 0 0 10.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7078 0 0 0 0 0 0 0 0 0 0 0 14.2973 0 0 0 0 0 0 13.7368 0 11.1364 0 0 0 0 0 0 0 0 11.7692 0 0 0 0 15.831 16.7292 14.7757 0 0 0 0 0 0 14.6879 0 0 0 0 0 0 13.5241 13.0594 13.5157 19.4043 0 0 0 0 0 0 0 14.5606 0 0 0 0 14.7935 13.847 0 14.4469 0 0 0 0 0 0 12.6377 0 14.9063 18.3505 18.5984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RU14 TM218_HUMAN Transmembrane protein 218 TMEM218 Homo sapiens (Human) cilium [GO:0005929]; integral component of membrane [GO:0016021] cilium [GO:0005929]; integral component of membrane [GO:0016021] GO:0005929; GO:0016021 AGTVLGVGAGVFILALLWVAVLLLCVLLSR 0.912 1.2693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1902 P36382 CXA5_HUMAN "Gap junction alpha-5 protein (Connexin-40, Cx40)" GJA5 Homo sapiens (Human) angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; atrial cardiac muscle cell to AV node cell communication by electrical coupling [GO:0086044]; atrial septum development [GO:0003283]; AV node cell to bundle of His cell communication by electrical coupling [GO:0086053]; bundle of His cell to Purkinje myocyte communication by electrical coupling [GO:0086054]; cardiac conduction system development [GO:0003161]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell signaling [GO:0007267]; endothelium development [GO:0003158]; gap junction assembly [GO:0016264]; mitral valve development [GO:0003174]; negative regulation of blood pressure [GO:0045776]; negative regulation of glomerular filtration [GO:0003105]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell communication by chemical coupling [GO:0010652]; positive regulation of vasoconstriction [GO:0045907]; potassium ion transport [GO:0006813]; pulmonary valve formation [GO:0003193]; Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling [GO:0086055]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of AV node cell action potential [GO:0098904]; regulation of bundle of His cell action potential [GO:0098905]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of Purkinje myocyte action potential [GO:0098906]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell to atrial cardiac muscle cell communication by electrical coupling [GO:0086021]; vasodilation [GO:0042311]; vasomotion [GO:1990029]; ventricular septum development [GO:0003281] cell projection [GO:0042995]; connexin complex [GO:0005922]; gap junction [GO:0005921]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704] cell projection [GO:0042995]; connexin complex [GO:0005922]; gap junction [GO:0005921]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; connexin binding [GO:0071253]; disordered domain specific binding [GO:0097718]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling [GO:0086076]; gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling [GO:0086077]; gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling [GO:0086078]; gap junction channel activity involved in cardiac conduction electrical coupling [GO:0086075]; gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling [GO:0086079]; gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling [GO:0086020]; gap junction hemi-channel activity [GO:0055077]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; atrial cardiac muscle cell to AV node cell communication by electrical coupling [GO:0086044]; atrial septum development [GO:0003283]; AV node cell to bundle of His cell communication by electrical coupling [GO:0086053]; bundle of His cell to Purkinje myocyte communication by electrical coupling [GO:0086054]; cardiac conduction system development [GO:0003161]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell signaling [GO:0007267]; endothelium development [GO:0003158]; gap junction assembly [GO:0016264]; mitral valve development [GO:0003174]; negative regulation of blood pressure [GO:0045776]; negative regulation of glomerular filtration [GO:0003105]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell communication by chemical coupling [GO:0010652]; positive regulation of vasoconstriction [GO:0045907]; potassium ion transport [GO:0006813]; pulmonary valve formation [GO:0003193]; Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling [GO:0086055]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of AV node cell action potential [GO:0098904]; regulation of bundle of His cell action potential [GO:0098905]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of Purkinje myocyte action potential [GO:0098906]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; SA node cell to atrial cardiac muscle cell communication by electrical coupling [GO:0086021]; vasodilation [GO:0042311]; vasomotion [GO:1990029]; ventricular septum development [GO:0003281] GO:0001525; GO:0003105; GO:0003151; GO:0003158; GO:0003161; GO:0003174; GO:0003193; GO:0003281; GO:0003283; GO:0005243; GO:0005887; GO:0005921; GO:0005922; GO:0006813; GO:0007267; GO:0010643; GO:0010649; GO:0010652; GO:0014704; GO:0016264; GO:0042311; GO:0042995; GO:0045776; GO:0045907; GO:0048844; GO:0055077; GO:0055117; GO:0060307; GO:0060371; GO:0060373; GO:0071253; GO:0086020; GO:0086021; GO:0086044; GO:0086053; GO:0086054; GO:0086055; GO:0086064; GO:0086075; GO:0086076; GO:0086077; GO:0086078; GO:0086079; GO:0097718; GO:0098904; GO:0098905; GO:0098906; GO:0098910; GO:1990029 connexin binding [GO:0071253]; disordered domain specific binding [GO:0097718]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling [GO:0086076]; gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling [GO:0086077]; gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling [GO:0086078]; gap junction channel activity involved in cardiac conduction electrical coupling [GO:0086075]; gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling [GO:0086079]; gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling [GO:0086020]; gap junction hemi-channel activity [GO:0055077] AELSCWEEGNGR 0.91201 1.2754 0 0 0 0 0 0 0 0 12.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07358 CO8B_HUMAN Complement component C8 beta chain (Complement component 8 subunit beta) C8B Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]" GO:0005576; GO:0005579; GO:0005615; GO:0005886; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0016020; GO:0019835; GO:0044877; GO:0050778; GO:0070062; GO:1903561 protein-containing complex binding [GO:0044877] EAMERGDYTLNNVHACAKNDFK 0.91203 1.4665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8937 16.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9293 0 0 0 0 0 0 0 0 0 0 13.4856 0 0 0 0 0 0 0 10.5951 0 13.8204 0 11.3418 0 10.8914 0 0 0 0 0 0 0 16.4204 0 0 0 0 0 13.7567 0 11.8336 0 0 0 13.426 0 0 0 10.7626 13.7821 13.5922 0 0 0 0 0 0 0 0 0 0 0 13.4293 10.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95222 OR6A2_HUMAN "Olfactory receptor 6A2 (Olfactory receptor 11-55, OR11-55) (Olfactory receptor 6A1) (Olfactory receptor OR11-83) (hP2 olfactory receptor)" OR6A2 OR6A1 OR6A2P Homo sapiens (Human) sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LVSVLYAVIVPLLNPIIYCLRNQEVK 0.91204 1.2369 0 0 0 0 0 0 0 0 0 0 0 0 12.2467 0 0 0 0 0 0 0 0 12.6546 0 12.8201 0 0 0 0 0 0 0 0 0 0 0 12.4078 0 0 0 0 0 0 0 0 0 0 0 11.7638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7479 0 0 0 0 0 0 12.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3038 12.3293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43290 SNUT1_HUMAN "U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog, hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1, SART-1, hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1)" SART1 Homo sapiens (Human) "maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0000398; GO:0000481; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015030; GO:0016607; GO:0045292; GO:0045585; GO:0046540; GO:0071005; GO:0071013 RNA binding [GO:0003723] AKLGLKPLEVNAIK 0.91207 1.2549 0 0 0 0 0 0 9.8418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0979 0 0 0 0 0 0 0 0 13.8775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0988 0 0 0 0 0 0 0 0 0 0 14.3571 0 13.9636 13.7206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1657 Q658P3 STEA3_HUMAN "Metalloreductase STEAP3, EC 1.16.1.- (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6, hTSAP6) (pHyde, hpHyde)" STEAP3 TSAP6 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; protein secretion [GO:0009306]; transferrin transport [GO:0033572] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; copper ion import [GO:0015677]; iron ion homeostasis [GO:0055072]; protein secretion [GO:0009306]; transferrin transport [GO:0033572]" GO:0005737; GO:0005768; GO:0005771; GO:0005886; GO:0006915; GO:0007049; GO:0008823; GO:0009306; GO:0010008; GO:0015677; GO:0016021; GO:0016723; GO:0033572; GO:0042802; GO:0046872; GO:0052851; GO:0055072 "cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]" AHRYDLVNLAVK 0.91207 1.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3387 13.0438 13.0219 12.8885 0 12.6428 0 0 12.8813 13.1318 12.3531 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6018 0 0 0 12.4061 14.137 12.247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4941 0 0 0 0 0 0 0 Q8TCC7 S22A8_HUMAN "Solute carrier family 22 member 8 (Organic anion transporter 3, hOAT3)" SLC22A8 OAT3 Homo sapiens (Human) response to toxic substance [GO:0009636]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; response to toxic substance [GO:0009636]; transport across blood-brain barrier [GO:0150104] GO:0005452; GO:0005886; GO:0009636; GO:0015301; GO:0016021; GO:0016323; GO:0016324; GO:0070062; GO:0150104 anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452] HTTQAAALLLAGGAILALTFVPLDLQTVRTVLAVFGK 0.91208 1.2743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7398 0 0 0 0 0 0 12.7848 0 0 0 0 0 0 0 13.2579 0 0 0 0 0 0 0 0 0 0 13.1132 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 12.8472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5702 0 0 0 0 0 Q96AH8 RAB7B_HUMAN Ras-related protein Rab-7b RAB7B Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; endosome to lysosome transport [GO:0008333]; late endosome to Golgi transport [GO:0034499]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; phagosome-lysosome fusion [GO:0090385]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031] Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802] Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; endosome to lysosome transport [GO:0008333]; late endosome to Golgi transport [GO:0034499]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; phagosome-lysosome fusion [GO:0090385]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031] GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005794; GO:0005802; GO:0008333; GO:0015031; GO:0030670; GO:0031902; GO:0032755; GO:0034144; GO:0034164; GO:0034499; GO:0045335; GO:0045654; GO:0051092; GO:0071346; GO:0090385 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IIILGDTTLKLQIWDTGGQER 0.91209 1.4786 0 0 0 0 0 0 0 0 14.7077 16.9378 17.7275 17.0596 16.3876 16.551 16.2732 17.419 17.8011 18.1292 14.9354 14.4144 0 0 0 10.5071 14.029 17.171 16.8281 16.228 15.8094 16.0802 18.1624 18.1513 17.328 15.8856 17.2709 16.7685 16.4974 16.5125 16.6956 19.0367 19.826 18.8912 18.4927 18.9347 18.8429 19.7071 18.5639 19.6264 15.7522 15.6426 0 12.6289 14.0701 17.0241 17.7169 17.7076 17.9995 16.86 17.7646 17.7732 16.5137 16.644 17.4853 16.6405 17.6021 17.5522 0 0 0 14.1116 13.5249 0 0 0 0 11.0353 0 0 0 12.8249 0 11.2768 0 11.51 0 0 0 0 0 0 0 0 0 0 0 0 17.6358 0 0 0 0 0 0 0 0 0 0 11.1047 0 0 0 14.5831 0 0 0 0 0 0 0 0 0 13.9532 0 0 0 12.5942 0 0 13.2395 0 12.2639 0 0 12.8336 0 13.0368 12.108 0 0 0 0 0 11.6909 0 0 13.4503 0 0 0 18.1565 0 0 0 0 0 0 19.0206 19.0699 18.9319 17.3941 17.0581 16.8814 17.9895 18.571 18.7104 18.7175 19.1298 18.272 16.6863 17.0059 16.8357 12.9015 12.4046 0 0 17.8826 18.946 18.3211 17.893 18.1923 Q6UXK2 ISLR2_HUMAN Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein) ISLR2 KIAA1465 LINX UNQ1885/PRO4329 Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773] GO:0005886; GO:0007399; GO:0009986; GO:0016021; GO:0045773 AHNELGANSTSIRVAVAATGPPK 0.9121 1.4447 0 0 0 0 0 0 0 0 0 0 0 0 11.7537 0 0 0 0 11.0301 0 0 0 0 0 10.7098 11.1551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1987 0 12.6515 0 12.7124 0 0 0 0 0 0 14.3204 0 0 0 0 0 0 0 14.0202 0 0 0 0 13.2377 0 0 0 0 0 0 0 0 12.7363 0 0 0 12.9327 0 0 0 0 0 0 0 0 0 13.6951 0 0 0 13.8951 0 0 0 0 0 12.856 0 13.6533 14.1641 0 0 0 14.5427 0 0 0 13.0206 12.9816 0 0 12.3364 0 13.1459 12.4935 0 0 0 0 0 12.2917 12.2314 13.2462 0 0 0 0 0 0 12.6989 0 13.4808 0 0 12.0708 0 0 0 0 12.9774 0 0 0 0 0 0 C9JN71 ZN878_HUMAN Zinc finger protein 878 ZNF878 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CKQCDKAFNCPSSFQYHER 0.91213 1.2362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.036 0 0 0 0 0 0 0 0 0 0 P62888 RL30_HUMAN 60S ribosomal protein L30 (Large ribosomal subunit protein eL30) RPL30 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-negative bacterium [GO:0050829]; killing of cells of another organism [GO:0031640]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-negative bacterium [GO:0050829]; killing of cells of another organism [GO:0031640]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0031640; GO:0042788; GO:0050829; GO:0061844; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] LQLVMKSGKYVLGYK 0.91213 1.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3323 0 12.4095 0 0 13.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS68 TNR19_HUMAN Tumor necrosis factor receptor superfamily member 19 (TRADE) (Toxicity and JNK inducer) TNFRSF19 TAJ TROY UNQ1888/PRO4333 Homo sapiens (Human) apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031]; apoptotic process [GO:0006915]; hair follicle development [GO:0001942]; JNK cascade [GO:0007254]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330] GO:0001942; GO:0005031; GO:0005886; GO:0006915; GO:0007254; GO:0016021; GO:0038023; GO:0043123; GO:0046330 signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031] ECGFGYGEDAQCVTCR 0.91219 1.2477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8637 0 12.8196 0 0 0 0 0 0 0 0 13.4834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.662 0 0 0 0 0 0 0 0 0 0 B4DX44 ZN736_HUMAN Zinc finger protein 736 ZNF736 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASSWFSHLIRHKR 0.91222 1.2354 0 0 0 0 0 0 0 0 11.82 11.5388 0 12.1036 0 0 11.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.692 0 10.4652 0 11.8278 11.7995 12.0936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4423 0 0 14.6497 0 0 0 0 0 0 12.2252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1378 0 0 0 10.8 0 0 0 0 0 0 0 0 11.6246 0 0 0 0 0 0 0 13.5805 0 0 0 0 0 0 0 0 0 13.4476 0 0 0 0 0 0 0 0 13.8845 0 12.5071 13.0305 12.4245 0 0 0 0 13.7739 13.701 12.8095 0 0 0 12.8335 0 0 0 0 14.0563 0 0 Q8NBR9 CK072_HUMAN Uncharacterized protein NDUFV1-DT (NDUFV1 divergent transcript) NDUFV1-DT C11orf72 Homo sapiens (Human) SPNNKSPTGPHPLEHLLARLLK 0.91222 1.247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8335 0 0 0 0 0 0 0 0 0 12.1206 14.7921 0 0 11.5777 0 0 0 0 0 0 0 0 0 0 12.0101 12.8557 0 0 12.6404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6933 12.6517 0 0 0 0 0 12.8265 0 0 0 0 0 0 0 0 0 0 0 0 12.8915 0 0 0 0 0 0 0 11.3461 0 0 0 0 0 0 13.5254 0 0 14.2924 0 0 0 0 0 0 0 0 0 12.9421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6609 12.4438 13.2881 0 12.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 Q63HN1 F205B_HUMAN Putative protein FAM205B FAM205BP C9orf144 C9orf144A FAM205B Homo sapiens (Human) HPMALHMVLPAHLPFLSPEVLRLLEVHVK 0.91226 1.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.508 0 0 0 0 0 0 0 0 0 0 0 13.5934 0 0 0 0 0 0 0 0 0 12.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9748 0 0 0 0 0 0 0 0 0 0 12.4513 0 0 0 0 0 0 12.2309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1009 0 0 0 0 0 0 0 0 0 13.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ72 ANX10_HUMAN Annexin A10 (Annexin-10) (Annexin-14) ANXA10 ANX14 Homo sapiens (Human) calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] GO:0005509; GO:0005544 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] ALLAICAGDAEDY 0.91226 1.2208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8412 0 0 0 0 13.3725 13.5813 13.7959 13.3822 13.379 13.3112 0 13.5421 13.5344 13.0019 13.1727 13.4053 0 0 13.1107 0 0 0 0 0 0 0 0 0 0 12.2447 0 0 0 0 0 14.5848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9882 0 0 0 0 0 0 0 0 0 0 0 11.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0783 0 0 0 0 0 0 0 0 0 0 14.5132 13.8261 13.7485 0 0 10.7901 0 0 0 13.8132 13.8844 13.7493 13.9866 0 14.4052 11.5225 0 0 0 0 0 0 14.4762 0 13.3622 0 0 P49238 CX3C1_HUMAN "CX3C chemokine receptor 1, C-X3-C CKR-1, CX3CR1 (Beta chemokine receptor-like 1, CMK-BRL-1, CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28)" CX3CR1 CMKBRL1 GPR13 Homo sapiens (Human) "adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; autocrine signaling [GO:0035425]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system maturation [GO:0021626]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; immune response [GO:0006955]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; leukocyte tethering or rolling [GO:0050901]; memory [GO:0007613]; microglial cell activation involved in immune response [GO:0002282]; modulation of chemical synaptic transmission [GO:0050804]; multiple spine synapse organization, single dendrite [GO:0150090]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of microglial cell mediated cytotoxicity [GO:1904150]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of microglial cell migration [GO:1904139]; regulation of neurogenesis [GO:0050767]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of synaptic plasticity [GO:0048167]; regulation of tumor necrosis factor production [GO:0032680]; response to ischemia [GO:0002931]; response to wounding [GO:0009611]; social behavior [GO:0035176]; synapse maturation [GO:0060074]; synapse pruning [GO:0098883]" cell surface [GO:0009986]; dendritic tree [GO:0097447]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; dendritic tree [GO:0097447]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X3-C chemokine binding [GO:0019960]; C-X3-C chemokine receptor activity [GO:0016495]; chemokine receptor activity [GO:0004950]; CX3C chemokine receptor binding [GO:0031737]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; autocrine signaling [GO:0035425]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system maturation [GO:0021626]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; immune response [GO:0006955]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; leukocyte tethering or rolling [GO:0050901]; memory [GO:0007613]; microglial cell activation involved in immune response [GO:0002282]; modulation of chemical synaptic transmission [GO:0050804]; multiple spine synapse organization, single dendrite [GO:0150090]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of microglial cell mediated cytotoxicity [GO:1904150]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of microglial cell migration [GO:1904139]; regulation of neurogenesis [GO:0050767]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of synaptic plasticity [GO:0048167]; regulation of tumor necrosis factor production [GO:0032680]; response to ischemia [GO:0002931]; response to wounding [GO:0009611]; social behavior [GO:0035176]; synapse maturation [GO:0060074]; synapse pruning [GO:0098883]" GO:0002052; GO:0002250; GO:0002282; GO:0002931; GO:0004930; GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0006968; GO:0007155; GO:0007186; GO:0007200; GO:0007204; GO:0007267; GO:0007420; GO:0007613; GO:0008528; GO:0009611; GO:0009897; GO:0009986; GO:0016493; GO:0016495; GO:0019722; GO:0019957; GO:0019960; GO:0021626; GO:0030336; GO:0030595; GO:0031737; GO:0032680; GO:0032691; GO:0032809; GO:0035176; GO:0035425; GO:0043005; GO:0045087; GO:0045428; GO:0045766; GO:0048167; GO:0048471; GO:0048874; GO:0050767; GO:0050769; GO:0050804; GO:0050901; GO:0051092; GO:0051897; GO:0060074; GO:0060326; GO:0061760; GO:0071222; GO:0071560; GO:0090026; GO:0097447; GO:0098883; GO:0110091; GO:0150090; GO:1900272; GO:1903721; GO:1904139; GO:1904141; GO:1904150; GO:2001234 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X3-C chemokine binding [GO:0019960]; C-X3-C chemokine receptor activity [GO:0016495]; chemokine receptor activity [GO:0004950]; CX3C chemokine receptor binding [GO:0031737]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930] LILLVVIVFFLFWTPYNVMIFLETLK 0.91234 1.2756 0 0 0 0 0 0 0 11.7318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3319 0 0 0 10.453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z402 TMC7_HUMAN Transmembrane channel-like protein 7 TMC7 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381] GO:0005887; GO:0008381 mechanosensitive ion channel activity [GO:0008381] AREMTTHLELWR 0.91241 5.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3267 0 0 14.118 0 13.4939 0 0 0 0 0 0 13.6035 0 0 0 11.8906 0 0 0 15.3727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3555 0 0 0 0 0 0 0 0 0 0 0 12.1059 0 0 0 0 0 0 0 12.9345 0 11.463 0 11.7208 0 0 0 11.2857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0079 18.1586 0 0 0 0 0 0 0 0 0 0 Q8N349 OR2LD_HUMAN Olfactory receptor 2L13 (Olfactory receptor 2L14) OR2L13 OR2L14 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ILAVFYTILTPMLNPIIYSLRNK 0.91246 1.4448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.164 0 0 0 0 0 0 0 0 0 0 0 O75563 SKAP2_HUMAN "Src kinase-associated phosphoprotein 2 (Pyk2/RAFTK-associated protein) (Retinoic acid-induced protein 70) (SKAP55 homolog, SKAP-55HOM, SKAP-HOM) (Src family-associated phosphoprotein 2) (Src kinase-associated phosphoprotein 55-related protein) (Src-associated adapter protein with PH and SH3 domains)" SKAP2 PRAP RA70 SAPS SCAP2 SKAP55R Homo sapiens (Human) B cell activation [GO:0042113]; negative regulation of cell population proliferation [GO:0008285]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; B cell activation [GO:0042113]; negative regulation of cell population proliferation [GO:0008285]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008285; GO:0042113; GO:0065003 DHSFLGFEWQKR 0.91261 1.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.621 0 0 0 0 0 0 0 0 0 0 0 0 11.1219 0 0 0 0 0 0 0 12.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYU5 KRA21_HUMAN Keratin-associated protein 2-1 (High sulfur keratin-associated protein 2.1) (Keratin-associated protein 2.1) KRTAP2-1 KAP2.1 KRTAP2.1A KRTAP2.1B Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTGSCCGSTFSSLSYGGGCCQPCCCR 0.91265 1.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0521 0 0 14.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9234 13.4005 0 0 0 0 11.6987 13.9228 0 11.393 0 0 0 0 0 0 0 14.867 0 0 0 0 0 0 14.4468 0 0 0 0 0 0 0 14.6559 0 0 14.0625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3886 0 0 0 0 0 0 0 0 0 0 0 Q9NUE0 ZDH18_HUMAN "Palmitoyltransferase ZDHHC18, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 18, DHHC-18) (Zinc finger DHHC domain-containing protein 18)" ZDHHC18 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] FDHHCPWVGNCVGRR 0.91266 1.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3521 0 0 10.6248 0 0 0 0 0 0 13.9611 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8483 0 0 13.5097 0 0 0 0 0 13.7407 0 0 0 0 0 0 13.9897 0 10.9067 0 0 0 0 0 0 0 0 13.8962 0 0 0 0 0 0 0 0 13.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5506 0 0 0 0 P41181 AQP2_HUMAN "Aquaporin-2, AQP-2 (ADH water channel) (Aquaporin-CD, AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct)" AQP2 Homo sapiens (Human) cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; glycerol transmembrane transport [GO:0015793]; metanephric collecting duct development [GO:0072205]; protein homotetramerization [GO:0051289]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; water transport [GO:0006833] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lumenal side of membrane [GO:0098576]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transport vesicle membrane [GO:0030658] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lumenal side of membrane [GO:0098576]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transport vesicle membrane [GO:0030658]; glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372]; cellular response to copper ion [GO:0071280]; cellular response to mercury ion [GO:0071288]; cellular response to water deprivation [GO:0042631]; glycerol transmembrane transport [GO:0015793]; metanephric collecting duct development [GO:0072205]; protein homotetramerization [GO:0051289]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; water transport [GO:0006833] GO:0003091; GO:0003097; GO:0005372; GO:0005794; GO:0005886; GO:0005887; GO:0006833; GO:0015168; GO:0015250; GO:0015793; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0030658; GO:0042631; GO:0048471; GO:0051289; GO:0055037; GO:0070062; GO:0071280; GO:0071288; GO:0072205; GO:0098576 glycerol transmembrane transporter activity [GO:0015168]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372] FDDHWVFWIGPLVGAILGSLLYNYVLFPPAK 0.91269 1.3778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0056 13.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHP8 PLBL2_HUMAN "Putative phospholipase B-like 2, EC 3.1.1.- (76 kDa protein, p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative phospholipase B-like 2 32 kDa form; Putative phospholipase B-like 2 45 kDa form ]" PLBD2 Homo sapiens (Human) phospholipid catabolic process [GO:0009395] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; phospholipase activity [GO:0004620]; phospholipid catabolic process [GO:0009395] GO:0004620; GO:0005576; GO:0009395; GO:0043202; GO:0070062 phospholipase activity [GO:0004620] ALTRALALALVLALLVGPFLSGLAGAIPAPGGR 0.91269 1.2369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9798 0 0 0 0 0 0 0 0 P20382 MCH_HUMAN "Pro-MCH [Cleaved into: Neuropeptide-glycine-glutamic acid, NGE, Neuropeptide G-E; Neuropeptide-glutamic acid-isoleucine, NEI, Neuropeptide E-I; Melanin-concentrating hormone, MCH ]" PMCH MCH Homo sapiens (Human) cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; spermatogenesis [GO:0007283] extracellular region [GO:0005576]; nucleus [GO:0005634]; synapse [GO:0045202] extracellular region [GO:0005576]; nucleus [GO:0005634]; synapse [GO:0045202]; melanin-concentrating hormone activity [GO:0030354]; type 1 melanin-concentrating hormone receptor binding [GO:0031777]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; spermatogenesis [GO:0007283] GO:0005576; GO:0005634; GO:0007218; GO:0007268; GO:0007283; GO:0007631; GO:0030154; GO:0030354; GO:0031777; GO:0045202 melanin-concentrating hormone activity [GO:0030354]; type 1 melanin-concentrating hormone receptor binding [GO:0031777] NDESSFMNEEENK 0.9128 1.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXB0 MKS1_HUMAN Tectonic-like complex member MKS1 (Meckel syndrome type 1 protein) MKS1 Homo sapiens (Human) "branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]" centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038] "centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]" GO:0001843; GO:0003271; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1901620; GO:1905515; GO:1990403; GO:2000095 AFMESSSLQK 0.91295 1.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3402 0 0 0 0 0 11.9579 12.3638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5767 0 0 0 0 0 0 0 13.3453 13.4398 13.1287 0 0 0 0 0 0 0 0 0 0 0 0 O43765 SGTA_HUMAN "Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein, UBP)" SGTA SGT SGT1 Homo sapiens (Human) negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; TRC complex [GO:0072380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; TRC complex [GO:0072380]; BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein self-association [GO:0043621]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005634; GO:0005737; GO:0005829; GO:0006620; GO:0016020; GO:0030433; GO:0042802; GO:0043621; GO:0060090; GO:0071816; GO:0072380; GO:1903070; GO:1903071; GO:1904288; GO:2000059 BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein self-association [GO:0043621] HVEAVAYYKK 0.91301 1.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0397 P10253 LYAG_HUMAN "Lysosomal alpha-glucosidase, EC 3.2.1.20 (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase ]" GAA Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181] autolysosome lumen [GO:0120282]; azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] "autolysosome lumen [GO:0120282]; azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maltose metabolic process [GO:0000023]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; sucrose metabolic process [GO:0005985]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181]" GO:0000023; GO:0002026; GO:0002086; GO:0003007; GO:0004553; GO:0004558; GO:0005764; GO:0005765; GO:0005886; GO:0005980; GO:0005985; GO:0006006; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0032450; GO:0035577; GO:0043181; GO:0043202; GO:0043231; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0070062; GO:0070821; GO:0090599; GO:0101003; GO:0120282 "alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]" DFTFNKDGFR 0.91303 1.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2599 0 0 12.2023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.884 0 0 0 0 0 0 0 0 0 0 Q6NT32 EST5A_HUMAN "Carboxylesterase 5A, EC 3.1.1.1 (Carboxylesterase-like urinary excreted protein homolog, Cauxin)" CES5A CES7 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; methyl indole-3-acetate esterase activity [GO:0080030] GO:0005576; GO:0080030 methyl indole-3-acetate esterase activity [GO:0080030] DAGAPVYFYEFRHR 0.91304 1.4414 0 11.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5071 0 0 0 0 0 0 0 0 0 0 0 12.2613 0 0 12.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7944 0 0 0 0 0 0 0 11.4131 0 0 0 12.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MHD2 LSM12_HUMAN Protein LSM12 LSM12 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 LSQAYAISAGVSLEGQQLFQTIHKTIK 0.91308 1.4409 0 0 0 0 0 0 0 0 12.6071 0 0 0 0 0 0 13.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9728 0 0 0 0 0 0 0 0 0 0 12.6931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A494C0Y3 F246A_HUMAN Protein FAM246A FAM246A Homo sapiens (Human) AELRAELDALR 0.91309 1.2195 0 0 0 0 0 0 0 0 0 9.92544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3651 0 0 0 14.5783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6122 0 0 0 0 0 0 0 0 0 0 0 13.1665 0 0 O95336 6PGL_HUMAN "6-phosphogluconolactonase, 6PGL, EC 3.1.1.31" PGLS Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]" GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009051; GO:0017057; GO:0070062 6-phosphogluconolactonase activity [GO:0017057] TVIFVATGEGK 0.91317 1.4454 0 0 0 0 12.4908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6084 0 12.9735 0 0 0 0 0 0 13.7296 0 0 0 0 0 14.4183 0 0 0 13.8084 13.795 0 14.871 14.8101 0 0 14.6484 0 0 13.9036 0 0 0 14.5327 13.7308 0 0 15.3116 14.1266 0 0 0 0 0 0 0 14.7439 0 0 0 0 0 0 0 0 12.9798 0 0 13.5199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9036 0 0 0 0 0 12.6927 0 0 0 0 0 13.4337 13.1935 0 0 0 0 0 0 12.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPY5 XCT_HUMAN Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT) SLC7A11 Homo sapiens (Human) adult behavior [GO:0030534]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179]; adult behavior [GO:0030534]; cellular response to oxidative stress [GO:0034599]; dipeptide import across plasma membrane [GO:0140206]; glutamate homeostasis [GO:0090461]; glutathione metabolic process [GO:0006749]; glutathione transmembrane transport [GO:0034775]; L-glutamate import across plasma membrane [GO:0098712]; lens fiber cell differentiation [GO:0070306]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; platelet aggregation [GO:0070527]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine metabolic process [GO:1901494]; regulation of glutamate metabolic process [GO:2000211]; regulation of glutathione biosynthetic process [GO:1903786]; regulation of melanin biosynthetic process [GO:0048021]; regulation of neutrophil apoptotic process [GO:0033029]; regulation of protein transport [GO:0051223]; regulation of synapse organization [GO:0050807]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to redox state [GO:0051775]; response to toxic substance [GO:0009636]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual learning [GO:0008542] GO:0005791; GO:0005856; GO:0005886; GO:0006749; GO:0008542; GO:0009636; GO:0009986; GO:0014070; GO:0015179; GO:0015327; GO:0016021; GO:0021591; GO:0021756; GO:0030534; GO:0031526; GO:0033029; GO:0034599; GO:0034775; GO:0035094; GO:0042127; GO:0045177; GO:0048021; GO:0048286; GO:0050804; GO:0050807; GO:0051223; GO:0051775; GO:0060173; GO:0070306; GO:0070527; GO:0090461; GO:0097449; GO:0098712; GO:0140206; GO:1901494; GO:1903204; GO:1903786; GO:1904717; GO:2000211 cystine:glutamate antiporter activity [GO:0015327]; L-amino acid transmembrane transporter activity [GO:0015179] IQIFLTFCKLTAILIIIVPGVMQLIKGQTQNFK 0.91322 1.479 0 14.6043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6199 0 0 0 11.125 0 0 0 0 0 0 0 12.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8991 0 0 0 0 0 0 0 13.1405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08138 TNR16_HUMAN "Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor, NGF receptor) (p75 ICD) (CD antigen CD271)" NGFR TNFRSF16 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; detection of temperature stimulus [GO:0016048]; dorsal aorta development [GO:0035907]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast proliferation [GO:0048144]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; intracellular protein transport [GO:0006886]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of hair follicle development [GO:0051799]; nerve development [GO:0021675]; neuron apoptotic process [GO:0051402]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of protein localization to nucleus [GO:1900182]; Rho protein signal transduction [GO:0007266] GO:0001540; GO:0001678; GO:0004888; GO:0005035; GO:0005516; GO:0005576; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0006886; GO:0006919; GO:0007266; GO:0007411; GO:0007417; GO:0008543; GO:0009986; GO:0014069; GO:0015026; GO:0016021; GO:0016048; GO:0021675; GO:0030336; GO:0030426; GO:0031069; GO:0031267; GO:0031625; GO:0032922; GO:0035907; GO:0038023; GO:0040037; GO:0042475; GO:0042488; GO:0042593; GO:0043121; GO:0043197; GO:0043204; GO:0048144; GO:0048146; GO:0048406; GO:0051402; GO:0051799; GO:1900182; GO:1902895; GO:1903588; GO:1904646; GO:2001235 amyloid-beta binding [GO:0001540]; calmodulin binding [GO:0005516]; coreceptor activity [GO:0015026]; death receptor activity [GO:0005035]; nerve growth factor binding [GO:0048406]; neurotrophin binding [GO:0043121]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625] ALLASWATQDSATLDALLAALRRIQR 0.91323 1.2093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3497 0 0 0 0 0 11.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14498 ISLR_HUMAN Immunoglobulin superfamily containing leucine-rich repeat protein ISLR UNQ189/PRO215 Homo sapiens (Human) cell adhesion [GO:0007155] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; cell adhesion [GO:0007155] GO:0005576; GO:0007155; GO:0031093; GO:0070062 ALRSLQLNHNR 0.91327 1.2163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DQD5 NPY42_HUMAN Neuropeptide Y receptor type 4-2 NPY4R2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; pancreatic polypeptide receptor activity [GO:0001602]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001602; GO:0005886; GO:0007186; GO:0008188; GO:0016021; GO:0042923; GO:0043005 neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; pancreatic polypeptide receptor activity [GO:0001602] MNTSHLLALLLPK 0.91333 1.3794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9482 0 0 0 0 0 0 0 0 0 0 0 0 11.7827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2324 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6008 0 0 0 11.8675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.025 0 0 0 0 0 0 Q7Z5L4 SPT19_HUMAN "Spermatogenesis-associated protein 19, mitochondrial (Spermatogenic cell-specific gene 1 protein, Spergen-1)" SPATA19 SPERGEN1 Homo sapiens (Human) cell differentiation [GO:0030154]; sperm mitochondrion organization [GO:0030382]; spermatogenesis [GO:0007283] mitochondrial outer membrane [GO:0005741]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] mitochondrial outer membrane [GO:0005741]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; sperm mitochondrion organization [GO:0030382]; spermatogenesis [GO:0007283] GO:0005741; GO:0007283; GO:0030154; GO:0030382; GO:0036126; GO:0097225 IEQVRRSISR 0.91333 1.2148 0 0 0 0 0 0 0 0 0 0 11.526 0 0 0 0 0 0 0 0 0 11.3937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5016 11.3513 0 0 0 12.5036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6133 0 0 0 13.1765 0 0 0 0 0 0 13.122 0 0 14.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0071 0 0 0 0 0 0 0 0 A8MZ97 CB074_HUMAN Uncharacterized protein C2orf74 C2orf74 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 SFETTAITFFIILLICLICILLLLVVFLYK 0.91334 1.2377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1589 0 0 0 0 0 0 11.7314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6675 0 0 0 0 0 10.9176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P33241 LSP1_HUMAN "Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein, pp52) (Lymphocyte-specific antigen WP34)" LSP1 WP34 Homo sapiens (Human) cellular defense response [GO:0006968]; cellular response to interleukin-7 [GO:0098761]; chemotaxis [GO:0006935]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cellular defense response [GO:0006968]; cellular response to interleukin-7 [GO:0098761]; chemotaxis [GO:0006935]; signal transduction [GO:0007165] GO:0003779; GO:0005886; GO:0006935; GO:0006968; GO:0007165; GO:0015629; GO:0016020; GO:0070062; GO:0098761 actin binding [GO:0003779] EDSDEVHLEELSLSK 0.91341 1.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6499 0 0 0 0 0 14.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5U3C3 TM164_HUMAN Transmembrane protein 164 TMEM164 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LLESVVVLTLALLEILVALR 0.91353 1.4797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3032 12.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8473 17.4754 0 0 0 0 0 12.7205 0 0 0 0 14.8558 0 0 0 0 14.99 0 0 0 14.3261 0 0 14.334 0 0 0 0 0 0 11.8882 15.8336 0 0 0 0 0 0 14.5305 0 0 0 0 0 0 0 0 0 0 14.7153 0 0 15.4033 0 0 0 0 0 0 0 0 0 0 12.0682 0 15.0136 0 0 0 0 0 0 0 0 0 13.9702 0 14.4856 13.9887 0 0 0 0 0 0 0 12.5152 0 0 0 0 0 11.4067 0 0 0 0 0 0 0 0 0 Q9Y5Z9 UBIA1_HUMAN "UbiA prenyltransferase domain-containing protein 1, EC 2.5.1.- (Transitional epithelial response protein 1)" UBIAD1 TERE1 Homo sapiens (Human) "menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]; vitamin K metabolic process [GO:0042373]" cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; prenyltransferase activity [GO:0004659]; menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]; vitamin K metabolic process [GO:0042373]" GO:0004659; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006744; GO:0009234; GO:0016020; GO:0016209; GO:0030173; GO:0031966; GO:0032194; GO:0042371; GO:0042373 antioxidant activity [GO:0016209]; prenyltransferase activity [GO:0004659] LNLLLGLFYVFGIILAPAGSLPK 0.91355 1.4246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6463 0 0 0 11.2876 0 0 0 0 0 0 0 0 0 0 0 0 10.7841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P15 SPB11_HUMAN Serpin B11 SERPINB11 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0005737; GO:0010951 serine-type endopeptidase inhibitor activity [GO:0004867] LSMIILLPVGIANLK 0.91356 1.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15596 NCOA2_HUMAN "Nuclear receptor coactivator 2, NCoA-2 (Class E basic helix-loop-helix protein 75, bHLHe75) (Transcriptional intermediary factor 2, hTIF2)" NCOA2 BHLHE75 SRC2 TIF2 Homo sapiens (Human) "cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]; response to progesterone [GO:0032570]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription coactivator activity [GO:0003713]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]; response to progesterone [GO:0032570]" GO:0000122; GO:0000785; GO:0000978; GO:0001162; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0010906; GO:0016604; GO:0016922; GO:0017162; GO:0019216; GO:0019904; GO:0030374; GO:0032570; GO:0032870; GO:0032922; GO:0032991; GO:0035357; GO:0042789; GO:0045475; GO:0045944; GO:0046983; GO:0090575; GO:1900076; GO:1904017; GO:1904179 aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; transcription coactivator activity [GO:0003713] CAILKETVKQIR 0.91358 1.2804 0 0 0 15.6551 0 0 0 0 0 0 0 0 0 0 0 15.9235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7185 13.7459 0 0 12.2483 0 0 0 12.0729 0 0 0 0 0 0 0 0 13.9521 0 0 0 0 0 0 0 0 12.9253 12.7757 0 15.6998 0 0 12.0314 0 0 0 13.4735 0 0 0 0 0 0 0 13.3417 0 0 0 0 0 0 0 15.3062 12.7594 0 0 0 13.4885 0 0 0 0 0 11.8259 13.1914 0 0 0 0 0 0 0 0 0 0 0 11.5411 0 0 0 0 0 0 0 0 0 0 11.4981 0 0 0 0 0 0 0 0 0 0 12.6114 0 0 0 0 0 0 0 B6SEH8 ERVV1_HUMAN Endogenous retrovirus group V member 1 Env polyprotein (HERV-V_19q13.41 provirus ancestral Env polyprotein 1) ERVV-1 ENVV1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CAAWEGKELITWRVLYLLPK 0.91359 1.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0131 0 0 0 13.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2353 0 0 0 0 0 0 0 0 0 14.3757 15.0318 15.6374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09681 GIP_HUMAN "Gastric inhibitory polypeptide, GIP (Glucose-dependent insulinotropic polypeptide) (Incretin hormone)" GIP Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; digestive system development [GO:0055123]; endocrine pancreas development [GO:0031018]; exploration behavior [GO:0035640]; female pregnancy [GO:0007565]; gastric inhibitory peptide signaling pathway [GO:0038192]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of insulin secretion [GO:0050796]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to selenium ion [GO:0010269]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]; gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; digestive system development [GO:0055123]; endocrine pancreas development [GO:0031018]; exploration behavior [GO:0035640]; female pregnancy [GO:0007565]; gastric inhibitory peptide signaling pathway [GO:0038192]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of insulin secretion [GO:0050796]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to selenium ion [GO:0010269]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328] GO:0005179; GO:0005576; GO:0005615; GO:0005788; GO:0007165; GO:0007189; GO:0007565; GO:0007613; GO:0008344; GO:0009410; GO:0009749; GO:0010269; GO:0010447; GO:0010828; GO:0014070; GO:0019233; GO:0031018; GO:0031767; GO:0031769; GO:0032024; GO:0033993; GO:0034774; GO:0035640; GO:0038192; GO:0042304; GO:0042594; GO:0043025; GO:0043200; GO:0043434; GO:0043950; GO:0048678; GO:0050796; GO:0055123; GO:0060291; GO:0070094; GO:0070328 gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179] TFALLLLSLFLAVGLGEKK 0.9136 1.4791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3061 0 0 0 0 0 11.3161 0 0 0 0 0 0 13.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.672 0 0 13.2903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5706 0 0 0 0 0 0 0 0 0 12.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99581 FEV_HUMAN "Protein FEV (Fifth Ewing variant protein) (PC12 ETS domain-containing transcription factor 1, PC12 ETS factor 1, Pet-1)" FEV PET1 Homo sapiens (Human) cell differentiation [GO:0030154]; neuron fate specification [GO:0048665]; neuron maturation [GO:0042551]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; neuron fate specification [GO:0048665]; neuron maturation [GO:0042551]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0010628; GO:0016607; GO:0030154; GO:0042551; GO:0048665; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ALRYYYDKNIMSK 0.91366 1.2378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9488 13.1444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4033 0 0 0 0 0 14.5661 13.7297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.205 0 0 0 0 0 0 0 13.0707 13.8236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5396 13.924 12.835 13.3707 13.4657 0 0 0 0 0 0 0 14.8133 0 0 0 14.021 0 0 0 0 0 0 0 13.208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2743 0 0 0 0 14.8975 0 0 0 0 0 0 14.6612 A0A0A6YYK6 TVA16_HUMAN T cell receptor alpha variable 16 TRAV16 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 GETSFHLKKPFAQEEDSAMYYCALS 0.91367 5.4632 0 0 0 0 0 0 0 0 13.2627 0 0 0 0 11.5222 0 0 0 0 0 0 0 0 0 0 13.5151 0 11.4783 0 0 0 0 0 0 15.2773 0 0 0 0 0 0 0 0 0 0 0 12.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1223 0 10.1422 0 14.9144 0 0 14.165 14.6915 0 0 0 0 0 0 0 11.0224 14.8465 0 0 0 0 0 0 0 0 0 0 0 12.0639 12.2998 0 0 13.2797 0 0 0 10.0649 0 0 0 11.1934 13.3805 0 0 11.5095 0 0 10.9758 12.021 0 0 13.4726 0 0 0 0 11.4041 0 0 0 0 14.2306 0 10.6679 0 0 0 0 11.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5865 13.3059 0 0 0 0 0 0 0 0 0 0 11.7211 0 0 0 11.9418 0 0 10.4296 0 0 0 14.7337 0 0 0 A8MXZ3 KRA91_HUMAN Keratin-associated protein 9-1 (Keratin-associated protein 9-like 3) KRTAP9-1 KAP9.1 KRTAP9.1 KRTAP9L3 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTHCCSPCCQPTCCR 0.91371 1.2443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7653 0 0 0 13.5068 10.9945 0 0 0 0 0 0 0 0 0 0 12.5204 0 11.5479 0 0 0 10.2174 11.2388 0 0 0 11.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5918 0 0 10.5314 0 0 0 0 12.5621 0 0 0 12.0423 0 0 0 0 0 0 0 0 0 13.0283 0 0 0 0 0 0 11.2726 0 0 0 10.8152 0 0 0 12.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77923 11.692 0 0 0 0 0 11.7687 0 0 11.7077 0 0 10.6226 0 0 13.4355 0 0 11.4586 0 10.6324 0 0 0 12.1142 0 13.3931 0 0 0 0 0 0 0 0 0 0 0 12.4401 13.3421 0 11.2831 0 0 0 0 10.5181 0 0 0 0 0 Q13278 RIG_HUMAN Putative protein RIG (Protein regulated in glioma) RIG Homo sapiens (Human) LTPALSIIISVVYLRCPEMVENRIGFLLNVK 0.91374 1.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0506 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPP5 K1107_HUMAN "AP2-interacting clathrin-endocytosis protein, APache" KIAA1107 Homo sapiens (Human) clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; neuron projection development [GO:0031175]; synaptic vesicle recycling via endosome [GO:0036466] anchoring junction [GO:0070161]; axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle [GO:0030136]; neuron projection terminus [GO:0044306]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle [GO:0030136]; neuron projection terminus [GO:0044306]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; neuron projection development [GO:0031175]; synaptic vesicle recycling via endosome [GO:0036466] GO:0008021; GO:0030136; GO:0030424; GO:0031175; GO:0036466; GO:0044297; GO:0044306; GO:0070161; GO:0098793; GO:0150007 ARLENMSPR 0.91376 1.2838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0009 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.492 11.3194 0 0 0 0 0 0 0 0 0 14.621 11.5894 0 0 0 0 0 11.1148 0 0 0 11.2316 0 0 12.2078 0 12.2573 13.8949 0 0 13.5067 12.6208 15.4851 0 12.3038 0 0 11.8337 12.4901 0 13.7834 0 0 12.6007 13.5944 0 0 0 0 9.88527 0 13.4034 0 0 0 13.5687 0 0 0 0 0 11.4738 0 0 0 0 0 0 0 0 11.0454 0 12.7825 0 0 0 0 0 12.176 0 0 0 0 0 0 0 0 0 0 0 0 10.9943 0 12.7428 0 0 0 0 0 0 0 0 0 0 0 A6NK02 TRI75_HUMAN Tripartite motif-containing protein 75 TRIM75 TRIM75P Homo sapiens (Human) female meiosis I [GO:0007144]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; spindle [GO:0005819] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; spindle [GO:0005819]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; female meiosis I [GO:0007144]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005615; GO:0005737; GO:0005819; GO:0007144; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] HFWEIEVGDKSEWAIGICKDSLPTK 0.91382 1.282 0 0 0 0 0 0 0 0 0 14.2452 0 0 13.3078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1995 0 0 0 0 0 0 0 0 0 14.1798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6547 0 0 0 0 0 0 0 0 0 0 0 0 Q13387 JIP2_HUMAN "C-Jun-amino-terminal kinase-interacting protein 2, JIP-2, JNK-interacting protein 2 (Islet-brain-2, IB-2) (JNK MAP kinase scaffold protein 2) (Mitogen-activated protein kinase 8-interacting protein 2)" MAPK8IP2 IB2 JIP2 PRKM8IPL Homo sapiens (Human) "behavioral fear response [GO:0001662]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; mating behavior [GO:0007617]; negative regulation of apoptotic signaling pathway [GO:2001234]; nonassociative learning [GO:0046958]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of AMPA receptor activity [GO:2000311]; regulation of JNK cascade [GO:0046328]; regulation of NMDA receptor activity [GO:2000310]; regulation of signaling receptor activity [GO:0010469]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal complex assembly [GO:0007172]; social behavior [GO:0035176]" cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; amyloid-beta binding [GO:0001540]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; behavioral fear response [GO:0001662]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; mating behavior [GO:0007617]; negative regulation of apoptotic signaling pathway [GO:2001234]; nonassociative learning [GO:0046958]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of AMPA receptor activity [GO:2000311]; regulation of JNK cascade [GO:0046328]; regulation of NMDA receptor activity [GO:2000310]; regulation of signaling receptor activity [GO:0010469]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal complex assembly [GO:0007172]; social behavior [GO:0035176]" GO:0000165; GO:0001540; GO:0001662; GO:0005078; GO:0005198; GO:0005737; GO:0007172; GO:0007254; GO:0007617; GO:0010469; GO:0014069; GO:0019894; GO:0019901; GO:0030295; GO:0032874; GO:0032991; GO:0035176; GO:0043025; GO:0044877; GO:0046328; GO:0046958; GO:0048813; GO:0051966; GO:0060079; GO:2000310; GO:2000311; GO:2001234 amyloid-beta binding [GO:0001540]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] ACSAACSEEEDEEDDEEEEDAEDSAGSPGGR 0.91384 1.2902 0 0 0 0 0 10.9959 0 0 0 0 0 11.1389 0 0 11.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5337 0 0 13.0283 0 0 0 0 11.8854 15.5301 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8832 0 0 0 0 0 0 0 12.5829 0 0 0 0 0 0 0 0 0 0 12.4434 0 0 0 0 0 0 12.8949 0 0 0 0 0 0 13.6715 0 0 0 0 11.2584 0 0 0 0 0 0 0 13.8548 11.2132 0 0 0 11.4452 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5709 0 0 0 11.3755 0 0 0 0 0 0 0 0 0 0 12.1759 P28068 DMB_HUMAN "HLA class II histocompatibility antigen, DM beta chain (MHC class II antigen DMB) (Really interesting new gene 7 protein)" HLA-DMB DMB RING7 Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; MHC class II protein complex assembly [GO:0002399]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of T cell proliferation [GO:0042102] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; MHC class II protein complex binding [GO:0023026]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; MHC class II protein complex assembly [GO:0002399]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of T cell proliferation [GO:0042102] GO:0002250; GO:0002399; GO:0002503; GO:0005765; GO:0016021; GO:0019886; GO:0023026; GO:0031902; GO:0042102; GO:0042613; GO:0043231; GO:0050870; GO:2001190 MHC class II protein complex binding [GO:0023026] DFTYCISFNK 0.91386 1.2816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2305 10.8066 0 0 0 0 11.7263 0 0 0 0 0 0 0 0 0 12.7594 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8492 0 0 0 0 0 0 0 0 0 0 P35504 UD15_HUMAN "UDP-glucuronosyltransferase 1A5, UGT1A5, EC 2.4.1.17 (UDP-glucuronosyltransferase 1-5, UDPGT 1-5, UGT1*5, UGT1-05, UGT1.5) (UDP-glucuronosyltransferase 1-E, UGT-1E, UGT1E)" UGT1A5 GNT1 UGT1 Homo sapiens (Human) cellular glucuronidation [GO:0052695] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695] GO:0005783; GO:0005789; GO:0015020; GO:0016021; GO:0019899; GO:0052695 enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020] LLLGHTQSFFETEHLLMKFSR 0.91388 1.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1651 0 0 0 0 0 0 12.0513 0 0 0 0 0 0 0 0 12.4528 0 0 0 0 0 0 12.4973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6657 0 0 0 0 0 10.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYW0 T2R10_HUMAN "Taste receptor type 2 member 10, T2R10 (Taste receptor family B member 2, TRB2)" TAS2R10 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] LKQASLRVLQQLK 0.91389 1.281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9185 12.9271 0 11.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2938 11.752 13.9727 0 0 0 0 0 0 0 0 0 0 11.1733 0 14.5096 0 0 0 0 0 13.8994 0 0 0 0 13.1721 0 11.9389 0 0 0 0 0 0 12.0962 0 12.7187 12.2284 0 13.367 0 0 13.0837 0 0 0 12.9629 0 13.2979 0 14.6973 14.3701 0 0 0 0 0 13.7465 13.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1495 14.4704 13.0936 13.4127 0 0 0 0 0 0 0 0 0 0 0 14.3573 0 Q86VW1 S22AG_HUMAN "Solute carrier family 22 member 16 (Carnitine transporter 2, CT2) (Fly-like putative transporter 2, FLIPT2, Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6)" SLC22A16 OCT6 Homo sapiens (Human) acid secretion [GO:0046717]; carnitine transport [GO:0015879]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; organic cation transport [GO:0015695]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amine transmembrane transporter activity [GO:0005275]; carnitine transmembrane transporter activity [GO:0015226]; organic cation transmembrane transporter activity [GO:0015101]; acid secretion [GO:0046717]; carnitine transport [GO:0015879]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; organic cation transport [GO:0015695]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] GO:0005275; GO:0005829; GO:0005886; GO:0007283; GO:0007338; GO:0015101; GO:0015226; GO:0015695; GO:0015879; GO:0016021; GO:0030154; GO:0030317; GO:0046717 amine transmembrane transporter activity [GO:0005275]; carnitine transmembrane transporter activity [GO:0015226]; organic cation transmembrane transporter activity [GO:0015101] NKRENTSSLGYEYTGSK 0.91391 1.4248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1875 0 0 0 0 0 0 0 0 0 0 0 0 11.8685 0 0 0 Q9BZL1 UBL5_HUMAN Ubiquitin-like protein 5 UBL5 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein modification process [GO:0036211]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein tag [GO:0031386]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein modification process [GO:0036211]" GO:0000398; GO:0005634; GO:0005737; GO:0031386; GO:0036211; GO:1903955 protein tag [GO:0031386] CNTDDTIGDLK 0.91391 1.2167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MWX3 WASH4_HUMAN Putative WAS protein family homolog 4 (Protein FAM39CP) WASH4P FAM39CP Homo sapiens (Human) "Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203] "cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; WASH complex [GO:0071203]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0003779; GO:0005769; GO:0005829; GO:0006887; GO:0016197; GO:0031901; GO:0032456; GO:0034314; GO:0034315; GO:0042147; GO:0043014; GO:0043015; GO:0055037; GO:0055038; GO:0071203 actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015] HTRMHLAHLGNSRQLISLGPPR 0.91392 1.2807 12.5254 0 12.7946 0 0 12.834 12.7645 0 0 0 0 0 0 0 0 0 0 0 0 11.2401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4954 0 16.855 0 0 17.4091 17.2897 17.2225 0 0 0 0 0 0 0 0 0 0 11.874 0 0 17.6615 17.5726 0 0 0 14.7111 0 11.9331 0 0 0 0 0 0 0 0 0 0 0 12.9358 0 0 0 0 0 17.4973 0 0 0 0 0 0 0 0 0 0 0 0 14.1636 14.029 0 0 13.3497 0 0 0 0 0 0 0 0 0 0 0 0 13.7182 12.6475 11.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7241 0 0 0 0 13.0006 0 Q96S82 UBL7_HUMAN "Ubiquitin-like protein 7 (Bone marrow stromal cell ubiquitin-like protein, BMSC-UbP) (Ubiquitin-like protein SB132)" UBL7 BMSCUBP SB132 Homo sapiens (Human) cellular response to stress [GO:0033554]; regulation of cellular protein metabolic process [GO:0032268]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829] cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; cellular response to stress [GO:0033554]; regulation of cellular protein metabolic process [GO:0032268]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005829; GO:0006511; GO:0030162; GO:0031593; GO:0032268; GO:0033554 polyubiquitin modification-dependent protein binding [GO:0031593] LADQPLTPKSILRLPETELGEYSLGGYSISFLK 0.91395 1.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6113 12.9385 0 13.0117 13.0672 0 0 12.7833 0 13.1219 12.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.45 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6018 0 0 0 0 0 0 0 Q9Y4H4 GPSM3_HUMAN G-protein-signaling modulator 3 (Activator of G-protein signaling 4) (G18.1b) (Protein G18) GPSM3 AGS4 C6orf9 G18 Homo sapiens (Human) positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte chemotaxis [GO:0002690] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte chemotaxis [GO:0002690] GO:0002690; GO:0005737; GO:0005886; GO:0030695; GO:0050729; GO:1900017 GTPase regulator activity [GO:0030695] EQLYSTILSHQCQR 0.91399 1.2378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRI5 DISC1_HUMAN Disrupted in schizophrenia 1 protein DISC1 KIAA0457 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of protein binding [GO:0032091]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to centrosome [GO:0071539]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of dendritic spine development [GO:0060998]; regulation of synapse maturation [GO:0090128]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to electrical stimulus [GO:0051602]; TOR signaling [GO:0031929]; ubiquitin-dependent protein catabolic process [GO:0006511]" anchoring junction [GO:0070161]; cell body [GO:0044297]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; dynein complex [GO:0030286]; endoplasmic reticulum [GO:0005783]; intermediate filament cytoskeleton [GO:0045111]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021] "anchoring junction [GO:0070161]; cell body [GO:0044297]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; dynein complex [GO:0030286]; endoplasmic reticulum [GO:0005783]; intermediate filament cytoskeleton [GO:0045111]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of protein binding [GO:0032091]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to centrosome [GO:0071539]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of dendritic spine development [GO:0060998]; regulation of synapse maturation [GO:0090128]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to electrical stimulus [GO:0051602]; TOR signaling [GO:0031929]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000226; GO:0001764; GO:0001954; GO:0002052; GO:0005634; GO:0005739; GO:0005783; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0006511; GO:0008021; GO:0010976; GO:0014069; GO:0019894; GO:0021846; GO:0021852; GO:0030177; GO:0030286; GO:0031929; GO:0032091; GO:0036064; GO:0042802; GO:0044297; GO:0044877; GO:0045111; GO:0045773; GO:0048471; GO:0051560; GO:0051602; GO:0051966; GO:0060070; GO:0060090; GO:0060271; GO:0060998; GO:0070050; GO:0070161; GO:0071539; GO:0090128; GO:0090724; GO:0097546; GO:1905515; GO:2000060 identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877] AGSRDCLPPAACFRR 0.914 1.3659 0 0 0 0 11.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0943 0 0 0 0 14.2118 13.9732 0 0 0 13.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8325 15.5998 0 0 0 0 0 15.8254 0 0 0 0 0 0 0 0 0 12.0919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7943 0 0 0 0 14.9037 0 0 0 0 0 0 0 0 0 12.7204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZP0 ABI1_HUMAN "Abl interactor 1 (Abelson interactor 1, Abi-1) (Abl-binding protein 4, AblBP4) (Eps8 SH3 domain-binding protein, Eps8-binding protein) (Nap1-binding protein, Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1)" ABI1 SSH3BP1 Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-tyrosine phosphorylation [GO:0018108]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209] anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; actin polymerization or depolymerization [GO:0008154]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-tyrosine phosphorylation [GO:0018108]; somitogenesis [GO:0001756]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001756; GO:0005634; GO:0005783; GO:0005829; GO:0005856; GO:0007169; GO:0008092; GO:0008154; GO:0008285; GO:0014069; GO:0017124; GO:0018108; GO:0030027; GO:0030296; GO:0030426; GO:0031209; GO:0032433; GO:0035591; GO:0035855; GO:0045296; GO:0048813; GO:0070062; GO:0070161; GO:0072673 cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] DDELSFMEGAIIYVIK 0.91404 1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.153 0 0 0 12.241 0 0 11.1322 0 0 0 10.5931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7984 0 Q9UI17 M2GD_HUMAN "Dimethylglycine dehydrogenase, mitochondrial, EC 1.5.8.4 (ME2GLYDH)" DMGDH Homo sapiens (Human) amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723]; amino-acid betaine catabolic process [GO:0006579]; choline catabolic process [GO:0042426]; choline metabolic process [GO:0019695] GO:0003723; GO:0005737; GO:0005739; GO:0005759; GO:0006579; GO:0009055; GO:0016491; GO:0019695; GO:0042426; GO:0047865 dimethylglycine dehydrogenase activity [GO:0047865]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; RNA binding [GO:0003723] ESYGFNNIVGYPKEER 0.91407 1.4073 0 0 0 0 0 0 0 0 0 0 0 14.8234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6319 16.5245 13.3748 15.8422 0 0 0 13.4314 13.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.112 0 0 0 0 0 14.3238 14.612 0 0 12.8336 12.8616 0 0 0 0 12.6426 0 0 0 0 12.9654 0 0 0 0 0 0 0 0 0 0 0 0 13.372 13.6372 0 0 0 0 0 13.4397 0 0 0 0 0 0 0 0 13.0832 0 0 0 0 0 12.4313 0 0 0 0 0 0 0 0 0 15.1182 0 14.883 14.2126 0 0 14.7955 14.2782 13.407 0 0 0 0 0 15.2134 0 0 0 0 0 0 0 0 0 0 0 15.5193 0 0 0 12.9121 0 13.5637 0 0 0 14.8897 0 0 11.8949 0 0 0 0 14.7756 0 Q9BRL6 SRSF8_HUMAN "Serine/arginine-rich splicing factor 8 (Pre-mRNA-splicing factor SRP46, Splicing factor SRp46) (Splicing factor, arginine/serine-rich 2B)" SRSF8 SFRS2B SRP46 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0016607 RNA binding [GO:0003723] GFAFVRFHDRR 0.9141 1.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0796 0 11.5614 0 0 0 11.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55808 XG_HUMAN Glycoprotein Xg (Protein PBDX) XG PBDX Homo sapiens (Human) homotypic cell-cell adhesion [GO:0034109]; positive regulation of neutrophil extravasation [GO:2000391]; T cell extravasation [GO:0072683] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; homotypic cell-cell adhesion [GO:0034109]; positive regulation of neutrophil extravasation [GO:2000391]; T cell extravasation [GO:0072683] GO:0005887; GO:0034109; GO:0072683; GO:2000391 GQRDFDLADALDDPEPTKK 0.91416 1.2104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96B97 SH3K1_HUMAN "SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3, CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1, HSB-1)" SH3KBP1 CIN85 Homo sapiens (Human) actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0045202; GO:0050871 SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] DCIDVGWWEGELNGR 0.91418 1.2903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.961 0 0 0 0 12.5304 0 0 0 0 0 0 0 0 0 0 0 0 12.5006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02083 NAAA_HUMAN "N-acylethanolamine-hydrolyzing acid amidase, EC 3.5.1.60 (Acid ceramidase-like protein) (Acylsphingosine deacylase NAAA, EC 3.5.1.23) (N-acylsphingosine amidohydrolase-like, ASAH-like protein) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta ]" NAAA ASAHL PLT Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; sphingosine metabolic process [GO:0006670] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; ceramidase activity [GO:0102121]; DNA-binding transcription factor binding [GO:0140297]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-(long-chain-acyl)ethanolamine deacylase activity [GO:0047412]; N-acylsphingosine amidohydrolase activity [GO:0017040]; fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; sphingosine metabolic process [GO:0006670]" GO:0005737; GO:0005764; GO:0006631; GO:0006670; GO:0016042; GO:0016810; GO:0017040; GO:0017064; GO:0019898; GO:0043202; GO:0047412; GO:0070062; GO:0070291; GO:0070292; GO:0102121; GO:0140297 "ceramidase activity [GO:0102121]; DNA-binding transcription factor binding [GO:0140297]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-(long-chain-acyl)ethanolamine deacylase activity [GO:0047412]; N-acylsphingosine amidohydrolase activity [GO:0017040]" IRNPSRK 0.9142 1.3621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5628 0 11.0053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20718 GRAH_HUMAN "Granzyme H, EC 3.4.21.- (CCP-X) (Cathepsin G-like 2, CTSGL2) (Cytotoxic T-lymphocyte proteinase) (Cytotoxic serine protease C, CSP-C)" GZMH CGL2 CTSGL2 Homo sapiens (Human) apoptotic process [GO:0006915]; cytolysis [GO:0019835]; proteolysis [GO:0006508] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; proteolysis [GO:0006508] GO:0004252; GO:0005737; GO:0006508; GO:0006915; GO:0016020; GO:0019835; GO:0043231; GO:0044194 serine-type endopeptidase activity [GO:0004252] AKWTTAVRPLR 0.91423 1.4106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.174 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8606 0 0 0 0 0 0 P50749 RASF2_HUMAN Ras association domain-containing protein 2 RASSF2 CENP-34 KIAA0168 Homo sapiens (Human) bone remodeling [GO:0046849]; cell cycle [GO:0007049]; epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade [GO:0038168]; homeostasis of number of cells [GO:0048872]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; protein stabilization [GO:0050821]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; signal transduction [GO:0007165]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase activity [GO:0004672]; bone remodeling [GO:0046849]; cell cycle [GO:0007049]; epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade [GO:0038168]; homeostasis of number of cells [GO:0048872]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; protein stabilization [GO:0050821]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; signal transduction [GO:0007165]; skeletal system development [GO:0001501] GO:0000776; GO:0001501; GO:0001503; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007049; GO:0007165; GO:0031954; GO:0032991; GO:0033137; GO:0038168; GO:0043065; GO:0045667; GO:0045670; GO:0045860; GO:0046330; GO:0046849; GO:0048872; GO:0050821; GO:1901222; GO:1901223 protein kinase activity [GO:0004672] DQVEEVTYDVAQYIK 0.91424 1.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NFI3 ZN316_HUMAN Zinc finger protein 316 ZNF316 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" AEDGSECDPDQEEEEEEEEK 0.91429 1.4806 10.3829 0 0 0 0 0 0 0 0 0 0 12.96 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8519 0 13.2445 0 0 0 0 0 0 12.6992 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9713 12.4379 12.8808 0 0 0 0 0 0 0 0 0 14.7178 13.8912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6045 0 0 0 0 0 12.3278 0 0 0 0 13.1776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0248 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16630 CPSF6_HUMAN "Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit, CPSF 68 kDa subunit) (Cleavage factor Im complex 68 kDa subunit, CFIm68) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7)" CPSF6 CFIM68 Homo sapiens (Human) messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005847; GO:0005849; GO:0006397; GO:0016020; GO:0016607; GO:0031124; GO:0035061; GO:0042382; GO:0043023; GO:0046833; GO:0051262; GO:0051290; GO:0098789; GO:0110104; GO:1990120; GO:1990448; GO:1990904 exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723] EREYRHR 0.9143 1.3595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1448 0 0 0 0 0 11.3964 0 0 0 11.4537 0 0 0 12.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8312 0 0 0 0 0 0 0 0 0 13.8679 0 0 0 0 0 0 14.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5906 0 0 12.7189 13.444 0 0 0 12.4531 13.8095 0 0 0 0 0 0 0 0 0 0 0 Q86VN1 VPS36_HUMAN Vacuolar protein-sorting-associated protein 36 (ELL-associated protein of 45 kDa) (ESCRT-II complex subunit VPS36) VPS36 C13orf9 EAP45 CGI-145 Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328] cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nucleus [GO:0005634] cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nucleus [GO:0005634]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein C-terminus binding [GO:0008022]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328] GO:0000814; GO:0005634; GO:0005764; GO:0005768; GO:0005829; GO:0008022; GO:0016236; GO:0031902; GO:0032266; GO:0036258; GO:0043130; GO:0043328; GO:0070062; GO:0090148 phosphatidylinositol-3-phosphate binding [GO:0032266]; protein C-terminus binding [GO:0008022]; ubiquitin binding [GO:0043130] GPQPGRIRAVGIVGIER 0.91432 1.4396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3708 0 0 0 0 14.2329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6863 0 0 0 0 0 0 0 0 0 0 0 12.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCQ1 MARH1_HUMAN "E3 ubiquitin-protein ligase MARCHF1, EC 2.3.2.27 (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I, MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1)" MARCHF1 MARCH1 RNF171 Homo sapiens (Human) antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0016021; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630 MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CCELCKYDFIMETK 0.91432 1.2378 0 0 0 0 0 0 0 14.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3197 10.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5949 0 0 0 11.7889 0 0 0 0 14.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5629 0 10.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75414 NDK6_HUMAN "Nucleoside diphosphate kinase 6, NDK 6, NDP kinase 6, EC 2.7.4.6 (Inhibitor of p53-induced apoptosis-alpha, IPIA-alpha) (nm23-H6)" NME6 Homo sapiens (Human) apoptotic process [GO:0006915]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; apoptotic process [GO:0006915]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] GO:0004550; GO:0005524; GO:0005739; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0006915; GO:0030308; GO:0045839; GO:0046872 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550] NTTHGSDSVVSASREIAAFFPDFSEQR 0.91436 1.3581 0 0 0 0 0 0 0 0 15.7281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2WEN9 CEA16_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 16 (Carcinoembryonic antigen-like 2) CEACAM16 CEAL2 Homo sapiens (Human) sensory perception of sound [GO:0007605] extracellular space [GO:0005615]; stereocilium tip [GO:0032426] extracellular space [GO:0005615]; stereocilium tip [GO:0032426]; identical protein binding [GO:0042802]; sensory perception of sound [GO:0007605] GO:0005615; GO:0007605; GO:0032426; GO:0042802 identical protein binding [GO:0042802] DLLVYAWYRGPASEPNR 0.91437 1.2065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13467 FZD5_HUMAN "Frizzled-5, Fz-5, hFz5 (FzE5)" FZD5 C2orf31 Homo sapiens (Human) "angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye morphogenesis [GO:0048596]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; post-embryonic camera-type eye development [GO:0031077]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; synapse assembly [GO:0007416]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]" axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] "axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; angiogenesis [GO:0001525]; anterior/posterior axis specification, embryo [GO:0008595]; apoptotic process involved in morphogenesis [GO:0060561]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; cellular response to molecule of bacterial origin [GO:0071219]; chorionic trophoblast cell differentiation [GO:0060718]; embryonic axis specification [GO:0000578]; embryonic camera-type eye morphogenesis [GO:0048596]; glandular epithelial cell maturation [GO:0002071]; intestinal epithelial cell maturation [GO:0060574]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; post-embryonic camera-type eye development [GO:0031077]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; Spemann organizer formation [GO:0060061]; synapse assembly [GO:0007416]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell differentiation in thymus [GO:0033077]" GO:0000139; GO:0000578; GO:0001525; GO:0001540; GO:0002071; GO:0002726; GO:0004930; GO:0005886; GO:0005887; GO:0005923; GO:0007416; GO:0008285; GO:0008289; GO:0008595; GO:0009986; GO:0016021; GO:0017147; GO:0019901; GO:0030182; GO:0030424; GO:0030425; GO:0030669; GO:0031077; GO:0031625; GO:0031901; GO:0032729; GO:0032731; GO:0032760; GO:0033077; GO:0042813; GO:0043204; GO:0043507; GO:0044877; GO:0045202; GO:0045944; GO:0048471; GO:0048596; GO:0060061; GO:0060070; GO:0060561; GO:0060574; GO:0060670; GO:0060715; GO:0060716; GO:0060718; GO:0071219; GO:1901382; GO:1903146; GO:1903955; GO:2000810 amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] ARPDPSAPPSLLLLLLAQLVGRAAAASK 0.9144 1.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.028 11.4358 0 11.358 0 0 0 0 0 0 11.3553 0 0 0 0 10.836 0 0 11.0941 0 0 0 0 0 0 0 0 0 0 0 0 0 9.05997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9876 13.2205 0 0 0 0 0 0 0 12.911 0 0 0 0 0 0 0 0 0 0 0 0 12.4356 13.0953 0 0 0 0 0 0 0 0 0 0 0 12.5331 0 0 0 0 0 0 0 13.6192 0 0 0 0 12.3075 0 0 0 12.3717 0 0 13.031 0 0 0 0 0 0 12.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4965 0 11.4725 0 0 0 0 0 0 0 0 13.0604 12.0172 0 0 0 0 0 0 0 0 0 0 11.8019 0 0 0 0 0 Q13568 IRF5_HUMAN "Interferon regulatory factor 5, IRF-5" IRF5 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0006954; GO:0019221; GO:0019901; GO:0032481; GO:0032494; GO:0032495; GO:0032727; GO:0032728; GO:0032735; GO:0042802; GO:0043065; GO:0043565; GO:0045087; GO:0045944; GO:0051607; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" KLITVQVVPVAAR 0.91442 1.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.423 0 0 13.6582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0403 0 0 0 0 0 0 10.0531 0 0 0 0 0 0 0 0 0 0 0 0 13.5044 0 0 0 0 0 0 0 0 0 0 0 0 0 12.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZM9 S38A6_HUMAN "Probable sodium-coupled neutral amino acid transporter 6 (N-system amino acid transporter 1, NAT-1) (Na(+)-coupled neutral amino acid transporter 6) (Solute carrier family 38 member 6)" SLC38A6 NAT1 SNAT6 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; glutamine transport [GO:0006868]; sodium ion transport [GO:0006814] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; amino acid transmembrane transport [GO:0003333]; glutamine transport [GO:0006868]; sodium ion transport [GO:0006814] GO:0003333; GO:0005886; GO:0005887; GO:0006814; GO:0006868; GO:0015179; GO:0015186 L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186] HFLITLALNIIIVLLAIYVPDIR 0.91442 1.4382 0 0 0 0 0 0 0 0 0 0 0 0 10.7552 0 11.8234 0 0 0 0 0 10.4734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7182 0 11.1604 12.4999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6964 0 0 0 0 0 0 0 0 0 0 0 12.751 0 0 0 0 13.1893 0 0 14.2487 12.4249 0 0 13.0374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9707 0 0 0 12.424 0 0 0 0 0 0 12.0297 0 0 0 0 Q9BXJ0 C1QT5_HUMAN Complement C1q tumor necrosis factor-related protein 5 C1QTNF5 CTRP5 UNQ303/PRO344 Homo sapiens (Human) inner ear development [GO:0048839]; protein secretion [GO:0009306] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; inner ear development [GO:0048839]; protein secretion [GO:0009306] GO:0005581; GO:0005615; GO:0005886; GO:0005923; GO:0009306; GO:0016324; GO:0016328; GO:0030133; GO:0042802; GO:0042995; GO:0048839 identical protein binding [GO:0042802] MRPLLVLLLLGLAAGSPPLDDNK 0.91442 1.2129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1949 0 0 0 0 0 0 0 0 16.0787 0 0 15.074 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8332 0 0 0 0 0 18.0908 0 0 0 0 0 0 13.4357 15.9365 16.6767 0 0 0 14.7498 12.9225 15.7488 14.0789 15.6059 13.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3752 0 0 0 0 0 0 0 0 0 0 0 11.4423 0 0 0 0 0 0 0 0 19.0313 0 0 0 0 0 0 0 0 0 18.0912 18.3311 18.2749 18.1565 0 0 0 0 0 0 0 0 0 0 17.0581 16.7528 17.773 0 18.5297 18.5482 18.9294 18.0184 0 0 16.388 0 0 19.5517 0 17.8826 17.9163 18.1286 17.893 18.0607 Q6PXP3 GTR7_HUMAN "Solute carrier family 2, facilitated glucose transporter member 7 (Glucose transporter type 7, GLUT-7, hGLUT7)" SLC2A7 GLUT7 Homo sapiens (Human) fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; monosaccharide transmembrane transport [GO:0015749] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; fructose transmembrane transporter activity [GO:0005353]; hexose transmembrane transporter activity [GO:0015149]; sugar transmembrane transporter activity [GO:0051119]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; monosaccharide transmembrane transport [GO:0015749] GO:0005353; GO:0005886; GO:0005887; GO:0008645; GO:0015149; GO:0015749; GO:0015755; GO:0016020; GO:0051119; GO:0055056; GO:1904659 D-glucose transmembrane transporter activity [GO:0055056]; fructose transmembrane transporter activity [GO:0005353]; hexose transmembrane transporter activity [GO:0015149]; sugar transmembrane transporter activity [GO:0051119] EETIDAGPPTASPAKETSF 0.91443 1.4075 0 0 0 0 0 0 0 0 14.181 13.5418 13.9108 13.2598 0 13.1226 0 0 17.445 0 0 0 0 0 16.2195 0 0 13.8309 14.3574 0 0 11.9961 0 0 0 0 12.2727 0 0 0 0 11.7921 11.1667 0 13.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1667 11.2087 0 0 0 0 0 12.582 10.4986 0 0 0 0 11.3475 0 19.9604 0 0 0 0 0 0 0 13.9074 0 0 0 12.1263 0 0 0 0 0 0 0 0 0 9.95257 0 0 0 0 0 0 0 10.9543 0 0 0 0 0 0 0 0 12.3141 0 13.8622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7241 0 0 0 0 12.1451 0 0 11.2295 0 0 0 13.3287 13.8473 0 0 0 0 0 0 0 0 0 0 0 0 Q63HM9 PLCX3_HUMAN PI-PLC X domain-containing protein 3 PLCXD3 Homo sapiens (Human) lipid catabolic process [GO:0016042]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; synapse [GO:0045202] cytoplasm [GO:0005737]; synapse [GO:0045202]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165] GO:0005737; GO:0007165; GO:0008081; GO:0016042; GO:0045202 phosphoric diester hydrolase activity [GO:0008081] KKGSFFISQVVLTPK 0.91448 1.3642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9918 0 0 0 0 0 0 Q6P5W5 S39A4_HUMAN "Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4, ZIP-4)" SLC39A4 ZIP4 Homo sapiens (Human) cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; zinc ion transmembrane transporter activity [GO:0005385]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] GO:0005385; GO:0005886; GO:0005887; GO:0006882; GO:0016324; GO:0031410; GO:0034224; GO:0055038; GO:0071577; GO:0071578 zinc ion transmembrane transporter activity [GO:0005385] DPRPWLLFLLHNVGLLGGWTVLLLLSLYEDDITF 0.91449 1.3559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0521 15.9391 0 14.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H223 EHD4_HUMAN EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) cellular response to growth factor stimulus [GO:0071363]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; pinocytosis [GO:0006907]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of endocytosis [GO:0030100] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; cellular response to growth factor stimulus [GO:0071363]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; pinocytosis [GO:0006907]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of endocytosis [GO:0030100] GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005769; GO:0005783; GO:0005886; GO:0006897; GO:0006907; GO:0016020; GO:0016197; GO:0030100; GO:0030139; GO:0031901; GO:0032456; GO:0043231; GO:0045296; GO:0048471; GO:0050731; GO:0051260; GO:0055038; GO:0060271; GO:0070062; GO:0071363; GO:0072659 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676] AMQEQLENYDFTK 0.9145 1.4067 0 0 0 14.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZR6 RTN4R_HUMAN "Reticulon-4 receptor (Nogo receptor, NgR) (Nogo-66 receptor)" RTN4R NOGOR UNQ330/PRO526 Homo sapiens (Human) axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; neuronal signal transduction [GO:0023041]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025] anchored component of external side of plasma membrane [GO:0031362]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793] anchored component of external side of plasma membrane [GO:0031362]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977]; neuronal signal transduction [GO:0023041]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0005783; GO:0005886; GO:0005887; GO:0007166; GO:0007409; GO:0008201; GO:0009986; GO:0010977; GO:0022038; GO:0023041; GO:0030517; GO:0031362; GO:0035025; GO:0035374; GO:0038023; GO:0038131; GO:0043005; GO:0043025; GO:0043198; GO:0043204; GO:0043547; GO:0044295; GO:0044877; GO:0045121; GO:0048681; GO:0070062; GO:0098793; GO:0098978; GO:1905573; GO:1905576 chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] SVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 0.91452 1.2407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHK6 AMACR_HUMAN "Alpha-methylacyl-CoA racemase, EC 5.1.99.4 (2-methylacyl-CoA racemase)" AMACR Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540] GO:0005102; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0005886; GO:0006699; GO:0008111; GO:0008206; GO:0033540; GO:0043231 alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102] LCKRSDVLLEPFR 0.91452 1.291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8137 0 0 14.3663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6915 0 0 0 0 0 0 0 0 0 0 0 0 12.8404 14.052 0 0 0 13.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0857 0 0 0 0 0 Q9Y5J7 TIM9_HUMAN Mitochondrial import inner membrane translocase subunit Tim9 TIMM9 TIM9 TIM9A TIMM9A Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0051087 chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] LTETCFLDCVK 0.91453 1.2174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6017 11.2489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1685 10.9719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0013 0 0 0 0 0 0 0 0 0 P01911 DRB1_HUMAN "HLA class II histocompatibility antigen, DRB1 beta chain (Human leukocyte antigen DRB1, HLA-DRB1)" HLA-DRB1 Homo sapiens (Human) "antigen processing and presentation of endogenous peptide antigen via MHC class II [GO:0002491]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; detection of bacterium [GO:0016045]; epidermis development [GO:0008544]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; macrophage differentiation [GO:0030225]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of T cell proliferation [GO:0042130]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; protein tetramerization [GO:0051262]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-4 production [GO:0032673]; regulation of T-helper cell differentiation [GO:0045622]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]" cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; intermediate filament [GO:0005882]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] "cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; intermediate filament [GO:0005882]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; CD4 receptor binding [GO:0042609]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; polysaccharide binding [GO:0030247]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608]; antigen processing and presentation of endogenous peptide antigen via MHC class II [GO:0002491]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; detection of bacterium [GO:0016045]; epidermis development [GO:0008544]; humoral immune response [GO:0006959]; immune response [GO:0006955]; inflammatory response to antigenic stimulus [GO:0002437]; macrophage differentiation [GO:0030225]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of T cell proliferation [GO:0042130]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; protein tetramerization [GO:0051262]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-4 production [GO:0032673]; regulation of T-helper cell differentiation [GO:0045622]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]" GO:0000139; GO:0001772; GO:0001916; GO:0001934; GO:0002437; GO:0002469; GO:0002491; GO:0002503; GO:0002842; GO:0002862; GO:0005200; GO:0005615; GO:0005765; GO:0005882; GO:0005886; GO:0005887; GO:0006955; GO:0006959; GO:0007165; GO:0008544; GO:0009897; GO:0009986; GO:0012507; GO:0016020; GO:0016045; GO:0019886; GO:0023026; GO:0030225; GO:0030247; GO:0030658; GO:0030666; GO:0030669; GO:0031902; GO:0032395; GO:0032588; GO:0032653; GO:0032673; GO:0032689; GO:0032831; GO:0033674; GO:0035774; GO:0042088; GO:0042130; GO:0042605; GO:0042608; GO:0042609; GO:0042613; GO:0043123; GO:0043382; GO:0043410; GO:0045622; GO:0045657; GO:0045893; GO:0046598; GO:0050852; GO:0050870; GO:0051262; GO:0070062; GO:0070374; GO:0071556; GO:2000516 CD4 receptor binding [GO:0042609]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; polysaccharide binding [GO:0030247]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608] FLDRYFYNQEESVRFDSDVGEFR 0.91454 1.4272 0 0 0 0 0 0 0 0 0 0 12.445 0 0 0 0 0 0 0 0 0 0 12.0031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.143 0 12.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0413 0 0 0 0 11.5898 0 0 0 0 0 0 13.1501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QE5 TEFM_HUMAN "Transcription elongation factor, mitochondrial" TEFM C17orf42 Homo sapiens (Human) mitochondrial transcription [GO:0006390]; oxidative phosphorylation [GO:0006119]; transcription elongation from mitochondrial promoter [GO:0006392] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]; DNA polymerase processivity factor activity [GO:0030337]; RNA binding [GO:0003723]; mitochondrial transcription [GO:0006390]; oxidative phosphorylation [GO:0006119]; transcription elongation from mitochondrial promoter [GO:0006392] GO:0003723; GO:0005739; GO:0005759; GO:0006119; GO:0006390; GO:0006392; GO:0030337; GO:0042645; GO:1990904 DNA polymerase processivity factor activity [GO:0030337]; RNA binding [GO:0003723] ELEAFRLLRGR 0.91455 1.3622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.016 0 0 0 0 0 0 12.107 12.1747 0 0 0 0 0 0 0 0 0 0 10.9196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5723 12.3479 0 15.1641 13.4911 14.7124 0 0 0 0 0 0 13.7339 0 0 13.6435 0 0 0 0 12.6261 0 0 14.6523 13.7381 0 0 0 0 0 13.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10747 CD28_HUMAN T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28) CD28 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell surface receptor signaling pathway [GO:0007166]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative thymic T cell selection [GO:0045060]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cytokine production [GO:0001819]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; protein kinase B signaling [GO:0043491]; regulation of regulatory T cell differentiation [GO:0045589]; regulatory T cell differentiation [GO:0045066]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transcription by RNA polymerase II [GO:0006366]" cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636] "cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; apoptotic signaling pathway [GO:0097190]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell surface receptor signaling pathway [GO:0007166]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative thymic T cell selection [GO:0045060]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cytokine production [GO:0001819]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; protein kinase B signaling [GO:0043491]; regulation of regulatory T cell differentiation [GO:0045589]; regulatory T cell differentiation [GO:0045066]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transcription by RNA polymerase II [GO:0006366]" GO:0001772; GO:0001819; GO:0002020; GO:0002863; GO:0005829; GO:0005886; GO:0005887; GO:0006366; GO:0006959; GO:0007166; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0014065; GO:0014068; GO:0015026; GO:0019901; GO:0031295; GO:0032733; GO:0032743; GO:0032753; GO:0035739; GO:0042102; GO:0042110; GO:0042802; GO:0043066; GO:0043491; GO:0045060; GO:0045066; GO:0045070; GO:0045589; GO:0045727; GO:0045840; GO:0045944; GO:0048304; GO:0050852; GO:0051897; GO:0097190; GO:0098636; GO:2000563 coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein kinase binding [GO:0019901] LLLALNLFPSIQVTGNKILVK 0.91456 1.2172 13.9419 14.5893 14.078 13.638 13.7434 0 13.9242 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4471 15.7028 0 14.378 0 0 0 0 0 0 10.7813 11.4078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0164 18.3894 18.3032 0 13.9086 18.1125 0 0 16.2086 16.2677 15.106 19.4033 15.7855 16.3043 15.6022 13.9606 0 15.1075 20.2698 19.9287 13.7225 14.9784 0 17.0448 0 14.8685 14.8014 18.0721 16.0657 15.6355 14.9888 15.9788 16.2086 15.6148 19.4294 15.3406 15.0821 14.836 16.3126 15.7663 15.6828 15.8925 15.8223 16.7196 15.5855 0 14.5064 0 19.6782 15.3063 19.6776 19.2829 15.1222 0 19.119 19.0338 19.1026 14.7092 19.4301 16.1437 19.0643 19.2051 16.0047 16.4167 0 19.4731 19.0574 16.766 18.0835 16.3215 14.5236 19.4273 19.9074 16.2276 20.0247 15.3191 15.8809 19.0729 17.8856 18.9991 0 19.1221 19.1639 19.2393 19.4698 16.3579 15.4818 19.5844 14.6367 14.3009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6572 15.7248 0 14.4287 0 0 0 16.2242 0 P25942 TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40) CD40 TNFRSF5 Homo sapiens (Human) B cell activation [GO:0042113]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to tumor necrosis factor [GO:0071356]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; response to interferon-gamma [GO:0034341]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] CD40 receptor complex [GO:0035631]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] CD40 receptor complex [GO:0035631]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; B cell activation [GO:0042113]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to tumor necrosis factor [GO:0071356]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; platelet activation [GO:0030168]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase B signaling [GO:0043491]; protein-containing complex assembly [GO:0065003]; response to interferon-gamma [GO:0034341]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] GO:0001934; GO:0002768; GO:0003823; GO:0005886; GO:0005887; GO:0006874; GO:0006954; GO:0009897; GO:0009986; GO:0019724; GO:0019899; GO:0023035; GO:0030168; GO:0030890; GO:0031625; GO:0032735; GO:0034341; GO:0035631; GO:0035666; GO:0038023; GO:0042100; GO:0042113; GO:0042531; GO:0042832; GO:0043123; GO:0043231; GO:0043406; GO:0043491; GO:0043536; GO:0043547; GO:0045766; GO:0045944; GO:0048304; GO:0051092; GO:0051607; GO:0065003; GO:0070062; GO:0071260; GO:0071347; GO:0071356; GO:0090037; GO:2000353 antigen binding [GO:0003823]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625] ALVVIPIIFGILFAILLVLVFIK 0.91456 1.3545 0 0 0 14.9858 11.2779 0 0 0 0 0 12.4341 17.3787 16.3206 16.4356 0 0 0 12.0541 0 0 16.2192 0 0 0 10.9378 0 0 10.3573 16.1942 0 0 16.2856 15.5634 0 0 0 0 0 16.4991 15.972 0 0 0 9.68626 16.2563 0 14.4712 0 0 0 10.436 0 12.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8504 14.3312 0 0 0 0 0 12.0232 0 14.4799 0 0 12.0064 0 0 0 13.7583 0 12.5175 14.4708 11.0957 0 0 11.158 0 15.0881 0 14.4284 0 11.3472 0 0 0 0 14.4789 10.7663 0 14.0771 0 0 0 0 0 14.4596 0 0 14.8907 11.7655 10.9041 14.1623 0 0 0 0 15.4581 0 0 0 0 0 0 0 0 0 0 11.411 0 0 0 0 0 0 0 11.4491 11.677 0 14.2007 15.5132 0 0 14.2137 17.0299 0 0 10.3539 0 12.3609 11.5078 12.3399 0 0 15.354 15.7204 15.3458 16.1023 15.7023 0 0 16.0148 15.4411 15.727 15.9236 0 0 14.6171 0 13.6933 0 11.638 0 0 15.3611 11.8308 0 Q6IEE8 SN12L_HUMAN Schlafen family member 12-like SLFN12L SLFN5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EWIQFMVDSEPVCEELPSPASTSSPVSQSYPLR 0.91457 1.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8231 14.5694 13.7856 0 0 0 14.3961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZWJ1 STXB4_HUMAN "Syntaxin-binding protein 4 (Syntaxin 4-interacting protein, STX4-interacting protein, Synip)" STXBP4 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to interferon-gamma [GO:0071346]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; syntaxin binding [GO:0019905]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interferon-gamma [GO:0071346]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808 syntaxin binding [GO:0019905] EVNTLKEKLLESDK 0.91458 1.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9742 0 0 0 0 0 0 0 0 0 13.2809 0 0 0 0 0 0 0 0 13.3184 0 0 0 0 0 0 0 0 0 0 0 0 0 P28067 DMA_HUMAN "HLA class II histocompatibility antigen, DM alpha chain (MHC class II antigen DMA) (Really interesting new gene 6 protein)" HLA-DMA DMA RING6 Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; MHC class II protein complex binding [GO:0023026]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] GO:0002250; GO:0002503; GO:0005765; GO:0009986; GO:0016020; GO:0016021; GO:0019886; GO:0023026; GO:0031902; GO:0042613; GO:0043231; GO:0050870 MHC class II protein complex binding [GO:0023026] GFPIAEVFTLK 0.91459 1.3541 0 0 0 11.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7959 12.5746 13.5632 13.4354 12.7356 0 0 0 12.5001 11.5762 11.7627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3663 0 0 0 0 0 0 0 0 13.1627 13.3682 0 0 0 12.5671 0 0 0 13.9629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2812 0 0 0 0 0 0 Q5HYM0 ZC12B_HUMAN "Probable ribonuclease ZC3H12B, EC 3.1.-.- (MCP-induced protein 2) (Zinc finger CCCH domain-containing protein 12B)" ZC3H12B CXorf32 MCPIP2 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0046872; GO:0090502 endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729] EKILVFTPSR 0.91459 1.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.348 0 0 13.1204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00287 RFXAP_HUMAN "Regulatory factor X-associated protein, RFX-associated protein (RFX DNA-binding complex 36 kDa subunit)" RFXAP Homo sapiens (Human) positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0005634; GO:0006357; GO:0016607; GO:0045348; GO:0045944; GO:0090575 DNA binding [GO:0003677] LSLLRSPEVVQFLQK 0.91461 1.4185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.743 0 13.5943 13.0209 0 0 0 0 13.6207 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGT5 OR9A2_HUMAN Olfactory receptor 9A2 (Olfactory receptor OR7-2) OR9A2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] PKQTQGVEYNKIVSLLVSVLTPFLNPFIFTLR 0.91461 1.2381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6516 0 0 0 0 0 0 13.2856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5715 0 13.5817 0 14.0645 0 0 14.3701 0 14.3663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5852 0 0 0 0 0 14.4629 0 0 0 0 15.2757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14651 HXB3_HUMAN Homeobox protein Hox-B3 (Homeobox protein Hox-2.7) (Homeobox protein Hox-2G) HOXB3 HOX2G Homo sapiens (Human) angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; face development [GO:0060324]; glossopharyngeal nerve morphogenesis [GO:0021615]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere development [GO:0021546]; thyroid gland development [GO:0030878] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; face development [GO:0060324]; glossopharyngeal nerve morphogenesis [GO:0021615]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere development [GO:0021546]; thyroid gland development [GO:0030878]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0002244; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0021546; GO:0021615; GO:0030878; GO:0045944; GO:0048704; GO:0050767; GO:0051216; GO:0060216; GO:0060324 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ESRQTSK 0.91462 1.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0203 0 0 0 11.2133 0 10.5058 0 0 0 0 0 0 0 0 0 0 12.1892 0 0 0 0 0 0 0 0 11.8096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6GPH6 IPIL1_HUMAN "Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1" ITPRIPL1 KIAA1754L Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 FAPENTCHLKCLQIILSLRQHQSLPHGASR 0.91464 1.2381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2109 0 12.6429 0 0 0 0 0 0 0 14.1159 0 0 0 0 0 0 0 0 11.6858 0 0 0 0 0 0 0 0 10.8797 0 0 10.4224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4275 0 0 0 0 0 0 0 0 10.2339 0 0 0 0 12.0587 0 14.8574 10.013 0 0 12.8204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.42811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5735 0 0 0 0 P17152 TMM11_HUMAN "Transmembrane protein 11, mitochondrial (Protein PM1) (Protein PMI)" TMEM11 C17orf35 PM1 Homo sapiens (Human) inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005] integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005] GO:0005739; GO:0005887; GO:0007005; GO:0007007; GO:0031305 LPLHTLTSSTPVVLVR 0.91465 1.3595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2124 12.6127 0 0 15.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2772 0 13.8753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00327 BMAL1_HUMAN "Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5, bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3)" ARNTL BHLHE5 BMAL1 MOP3 PASD3 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]" aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016 "aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" DKMNSFIDELASLVPTCNAMSR 0.91466 1.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9186 0 0 0 0 0 0 0 0 12.9645 0 0 0 0 0 0 0 0 12.0381 0 0 0 0 0 0 0 0 0 12.2011 0 0 0 0 0 0 0 0 0 0 11.4527 0 0 11.5598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2288 0 Q8NEV9 IL27A_HUMAN "Interleukin-27 subunit alpha, IL-27 subunit alpha, IL-27-A, IL27-A (Interleukin-30) (p28)" IL27 IL27A IL30 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; regulation of T cell proliferation [GO:0042129]; regulation of T-helper 1 cell differentiation [GO:0045625]; response to Gram-positive bacterium [GO:0140459] cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-27 receptor binding [GO:0045523]; signaling receptor binding [GO:0005102]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; regulation of T cell proliferation [GO:0042129]; regulation of T-helper 1 cell differentiation [GO:0045625]; response to Gram-positive bacterium [GO:0140459] GO:0002230; GO:0005102; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005829; GO:0006954; GO:0009986; GO:0032729; GO:0042129; GO:0045087; GO:0045523; GO:0045625; GO:0140459 cytokine activity [GO:0005125]; interleukin-27 receptor binding [GO:0045523]; signaling receptor binding [GO:0005102] LLHSLELVLSRAVR 0.91471 1.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NSW5 DE10B_HUMAN Putative DENN domain-containing protein 10 B (DENND10 pseudogene 1) (Putative protein FAM45B) DENND10P1 FAM45 FAM45BP HT011 Homo sapiens (Human) protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641] late endosome [GO:0005770] late endosome [GO:0005770]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; protein transport [GO:0015031]; regulation of early endosome to late endosome transport [GO:2000641] GO:0005085; GO:0005770; GO:0015031; GO:0031267; GO:2000641 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] IVVYHPK 0.91472 1.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6489 0 0 0 0 0 0 13.8408 0 0 0 11.4804 0 14.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6844 18.8744 0 0 15.9606 0 0 0 15.5626 0 0 0 0 0 0 0 0 0 0 0 11.5131 0 0 0 0 0 0 16.1648 0 0 0 0 15.7127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2402 0 0 0 0 0 0 0 0 0 0 0 11.0107 0 0 0 0 0 0 0 0 14.8312 11.8545 0 15.8409 0 15.9709 0 0 P14207 FOLR2_HUMAN "Folate receptor beta, FR-beta (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein, FBP)" FOLR2 Homo sapiens (Human) cell adhesion [GO:0007155]; folate import across plasma membrane [GO:1904447]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; inflammatory response [GO:0006954]; positive regulation of cell population proliferation [GO:0008284]; sperm-egg recognition [GO:0035036] anchored component of external side of plasma membrane [GO:0031362]; cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of external side of plasma membrane [GO:0031362]; cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; folate import across plasma membrane [GO:1904447]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; inflammatory response [GO:0006954]; positive regulation of cell population proliferation [GO:0008284]; sperm-egg recognition [GO:0035036] GO:0005542; GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0007342; GO:0008284; GO:0009986; GO:0015884; GO:0031362; GO:0035036; GO:0038023; GO:0061714; GO:1904447 folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023] EDCQRWWEDCHTSHTCKSNWHR 0.91475 1.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13541 4EBP1_HUMAN "Eukaryotic translation initiation factor 4E-binding protein 1, 4E-BP1, eIF4E-binding protein 1 (Phosphorylated heat- and acid-stable protein regulated by insulin 1, PHAS-I)" EIF4EBP1 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929] GO:0000082; GO:0005737; GO:0005829; GO:0008190; GO:0030371; GO:0031929; GO:0045931; GO:0045947 eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371] AIPATRR 0.91476 1.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4463 0 0 0 17.7129 0 0 0 17.8352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13747 HLAE_HUMAN "HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain E, sHLA-E ]" HLA-E HLA-6.2 HLAE Homo sapiens (Human) "adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class Ib [GO:0002477]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; CD8-positive, alpha-beta T cell activation [GO:0036037]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; natural killer cell tolerance induction [GO:0002519]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of antibody-dependent cellular cytotoxicity [GO:0001815]; positive regulation of CD8-positive, alpha-beta T cell activation [GO:2001187]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated immunity [GO:0002717]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of natural killer cell mediated immunity [GO:0002715]" cell surface [GO:0009986]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; MHC class I protein complex [GO:0042612]; MHC class Ib protein complex [GO:0032398]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] "cell surface [GO:0009986]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; MHC class I protein complex [GO:0042612]; MHC class Ib protein complex [GO:0032398]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; beta-2-microglobulin binding [GO:0030881]; MHC class I protein binding [GO:0042288]; natural killer cell lectin-like receptor binding [GO:0046703]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class Ib [GO:0002477]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; CD8-positive, alpha-beta T cell activation [GO:0036037]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; natural killer cell tolerance induction [GO:0002519]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of antibody-dependent cellular cytotoxicity [GO:0001815]; positive regulation of CD8-positive, alpha-beta T cell activation [GO:2001187]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated immunity [GO:0002717]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of natural killer cell mediated immunity [GO:0002715]" GO:0000139; GO:0001815; GO:0001916; GO:0002250; GO:0002474; GO:0002476; GO:0002477; GO:0002519; GO:0002639; GO:0002715; GO:0002717; GO:0002729; GO:0005102; GO:0005615; GO:0005886; GO:0009897; GO:0009986; GO:0012507; GO:0019731; GO:0030670; GO:0030881; GO:0031901; GO:0032398; GO:0032736; GO:0032753; GO:0032759; GO:0032760; GO:0032819; GO:0036037; GO:0042270; GO:0042288; GO:0042605; GO:0042608; GO:0042612; GO:0045087; GO:0045953; GO:0045954; GO:0046703; GO:0050830; GO:0055038; GO:0070062; GO:0071556; GO:2000566; GO:2001187 beta-2-microglobulin binding [GO:0030881]; MHC class I protein binding [GO:0042288]; natural killer cell lectin-like receptor binding [GO:0046703]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608] FLRGYEQFAYDGKDYLTLNEDLR 0.91482 1.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9553 0 11.3535 0 0 0 0 0 0 0 0 12.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2154 0 0 0 0 12.7532 14.2137 15.6018 14.8138 14.989 0 14.0224 13.9461 14.2098 0 12.3877 0 17.5052 0 0 0 12.3622 15.1261 0 13.4589 0 0 0 0 0 0 11.8447 0 0 0 0 13.6106 13.5547 0 0 0 0 14.5888 12.4876 0 0 0 0 11.7657 12.0997 0 0 12.5186 0 0 13.1403 14.1306 13.4785 12.7133 0 0 0 12.6383 0 13.7816 0 0 0 13.1924 0 0 11.8885 0 0 11.9867 0 0 0 0 0 0 12.4559 0 0 0 0 0 0 0 12.2951 0 0 0 0 0 0 0 0 11.9047 0 0 0 11.6641 0 Q96AQ1 CC74A_HUMAN Coiled-coil domain-containing protein 74A CCDC74A Homo sapiens (Human) DGPSGNHLSR 0.91484 1.3562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3R2 MUC13_HUMAN "Mucin-13, MUC-13 (Down-regulated in colon cancer 1)" MUC13 DRCC1 RECC UNQ6194/PRO20221 Homo sapiens (Human) maintenance of gastrointestinal epithelium [GO:0030277] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; maintenance of gastrointestinal epithelium [GO:0030277] GO:0005615; GO:0005796; GO:0005829; GO:0005886; GO:0016021; GO:0016324; GO:0030277; GO:0042803 protein homodimerization activity [GO:0042803] CDYYGCNQTADDCLNGLACDCK 0.91484 1.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4918 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4726 0 0 0 0 0 12.1538 0 0 0 0 13.4353 0 0 0 0 0 0 0 0 0 0 12.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEC7 GSTCD_HUMAN Glutathione S-transferase C-terminal domain-containing protein GSTCD Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] GO:0005737; GO:0070062 AGLAVVLRHIIQK 0.91485 1.241 0 0 0 13.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0157 0 0 0 0 0 10.6323 0 0 0 0 0 0 12.8458 13.6092 0 0 0 0 0 0 0 0 0 15.088 0 0 0 0 0 0 10.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2247 0 0 0 13.8924 0 18.218 0 0 0 0 0 15.1591 0 15.0166 12.7022 0 0 18.1113 0 15.3039 14.9638 0 0 0 0 0 12.2729 0 13.5084 13.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4439 0 14.9581 0 13.6012 0 14.523 0 0 0 0 Q12889 OVGP1_HUMAN Oviduct-specific glycoprotein (Estrogen-dependent oviduct protein) (Mucin-9) (Oviductal glycoprotein) (Oviductin) OVGP1 MUC9 OGP Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]; female pregnancy [GO:0007565]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; single fertilization [GO:0007338] cytosol [GO:0005829]; egg coat [GO:0035805]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; perivitelline space [GO:0098595]; transport vesicle [GO:0030133] cytosol [GO:0005829]; egg coat [GO:0035805]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; perivitelline space [GO:0098595]; transport vesicle [GO:0030133]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032]; female pregnancy [GO:0007565]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; single fertilization [GO:0007338] GO:0004568; GO:0005576; GO:0005829; GO:0005975; GO:0006032; GO:0007338; GO:0007565; GO:0008061; GO:0015630; GO:0030133; GO:0035805; GO:0043231; GO:0098595; GO:2000360 chitin binding [GO:0008061]; chitinase activity [GO:0004568] EKFIASVISLLR 0.91486 1.437 9.92435 0 0 0 0 0 0 0 0 13.4424 0 0 0 0 15.0489 0 13.7139 10.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3978 0 0 16.9897 11.2302 0 0 15.582 13.138 0 12.6056 0 0 0 13.0896 0 0 0 13.2721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9727 12.5958 13.7326 0 12.978 0 13.7139 0 0 12.7846 12.8909 13.2023 0 0 0 0 0 12.2577 0 11.3842 11.1771 0 0 0 0 0 0 12.1918 0 0 0 13.4951 0 0 11.3776 0 0 13.3507 12.8266 0 0 0 0 0 0 0 0 11.9704 0 0 0 0 0 11.5911 0 15.5696 0 14.3105 0 0 11.8641 0 0 0 0 0 0 0 0 12.5995 0 0 12.4438 0 0 0 0 0 0 0 0 14.3155 0 0 0 12.6736 0 13.0417 0 0 0 0 0 0 0 0 13.7212 0 0 0 0 0 0 0 0 0 Q4ADV7 RIC1_HUMAN Guanine nucleotide exchange factor subunit RIC1 (Connexin-43-interacting protein of 150 kDa) (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1) RIC1 CIP150 KIAA1432 Homo sapiens (Human) "cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; cranial skeletal system development [GO:1904888]; intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; regulation of extracellular matrix constituent secretion [GO:0003330]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0003330; GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547; GO:1904888 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] DSDCAENMYIDMMLWR 0.91489 5.4524 0 0 0 0 0 0 0 0 0 0 0 0 13.8402 0 10.4442 0 0 0 0 0 11.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2421 0 0 0 0 0 0 0 0 0 11.4438 0 0 0 0 0 0 0 0 0 0 13.3405 0 0 15.7955 12.0454 12.3097 0 0 0 0 0 12.1328 13.6562 0 0 13.1443 0 12.4925 0 14.7734 11.9799 0 12.3412 13.4093 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0774 0 0 0 0 12.9942 0 0 0 0 0 0 0 0 0 0 0 13.5292 0 0 0 12.516 0 0 0 12.3007 11.8708 0 0 14.7087 14.3287 0 0 0 0 0 0 12.0505 0 12.2541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2899 0 11.889 0 0 0 0 0 0 0 0 0 0 0 16.1748 0 Q5TA81 LCE2C_HUMAN Late cornified envelope protein 2C (Late envelope protein 11) LCE2C LEP11 Homo sapiens (Human) keratinization [GO:0031424] identical protein binding [GO:0042802]; keratinization [GO:0031424] GO:0031424; GO:0042802 identical protein binding [GO:0042802] HQSPDCCESEPSGGSGCCHSSGGCC 0.9149 1.3633 0 0 0 0 0 0 0 0 0 13.9219 0 0 13.3103 0 0 0 0 12.9036 0 0 0 0 0 12.7184 0 0 12.1054 11.2847 0 0 0 0 0 0 0 0 0 0 0 12.6797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7847 0 0 0 0 15.8939 16.6618 16.0393 0 15.7377 0 0 0 0 0 0 0 15.8973 15.1422 0 0 14.5789 0 14.452 0 0 13.9353 0 16.5662 14.8605 0 0 0 0 13.7598 0 0 0 0 14.0434 14.2861 13.8672 13.9468 13.8282 15.6537 0 0 0 0 0 0 13.4603 0 14.0942 0 13.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1303 0 13.2797 0 0 0 0 0 0 0 0 0 13.7261 0 0 0 13.0597 0 0 0 0 0 0 Q9NQE7 TSSP_HUMAN "Thymus-specific serine protease, EC 3.4.-.- (Serine protease 16)" PRSS16 TSSP Homo sapiens (Human) protein catabolic process [GO:0030163]; proteolysis [GO:0006508] endosome [GO:0005768]; lysosome [GO:0005764] endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508] GO:0005764; GO:0005768; GO:0006508; GO:0008236; GO:0008239; GO:0030163 dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] AVWLAQWLGPLLLVSLWGLLAPASLLR 0.9149 1.4274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1822 14.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TAA5 ALG11_HUMAN "GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, EC 2.4.1.131 (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)" ALG11 GT8 Homo sapiens (Human) oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]" GO:0000026; GO:0004377; GO:0005789; GO:0006487; GO:0006490; GO:0016020; GO:0016021 "alpha-1,2-mannosyltransferase activity [GO:0000026]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]" DDELRVNQLRR 0.91491 1.3548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1303 13.5984 0 14.2618 0 0 0 0 0 13.3813 0 0 0 0 0 0 0 0 0 0 0 0 12.9935 0 0 0 0 0 0 0 17.8444 0 14.139 0 0 0 0 0 0 0 0 18.1076 0 0 17.1283 0 0 0 0 0 0 0 0 0 0 15.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 S4R3Y5 HMN11_HUMAN "Humanin-like 11, HN11 (MT-RNR2-like protein 11)" MTRNR2L11 Homo sapiens (Human) negative regulation of execution phase of apoptosis [GO:1900118] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; receptor antagonist activity [GO:0048019]; negative regulation of execution phase of apoptosis [GO:1900118] GO:0005576; GO:0005737; GO:0048019; GO:1900118 receptor antagonist activity [GO:0048019] GFSCLLLVISEIDLSVKR 0.91492 1.4119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16539 MK14_HUMAN "Mitogen-activated protein kinase 14, MAP kinase 14, MAPK 14, EC 2.7.11.24 (Cytokine suppressive anti-inflammatory drug-binding protein, CSAID-binding protein, CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha, MAP kinase p38 alpha) (Stress-activated protein kinase 2a, SAPK2a)" MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint signaling [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose import [GO:0046323]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; platelet activation [GO:0030168]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of ossification [GO:0030278]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to dietary excess [GO:0002021]; response to insulin [GO:0032868]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transcription by RNA polymerase II [GO:0006366]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint signaling [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose import [GO:0046323]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; platelet activation [GO:0030168]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of ossification [GO:0030278]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to dietary excess [GO:0002021]; response to insulin [GO:0032868]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transcription by RNA polymerase II [GO:0006366]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0000077; GO:0000902; GO:0000922; GO:0001502; GO:0001525; GO:0001649; GO:0001890; GO:0002021; GO:0002062; GO:0002862; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006006; GO:0006357; GO:0006366; GO:0006915; GO:0006935; GO:0007165; GO:0007166; GO:0007178; GO:0007519; GO:0010628; GO:0010831; GO:0016607; GO:0018105; GO:0019395; GO:0019899; GO:0019903; GO:0030168; GO:0030278; GO:0030316; GO:0031281; GO:0031663; GO:0032495; GO:0032735; GO:0032868; GO:0034774; GO:0035331; GO:0035556; GO:0035924; GO:0035994; GO:0038066; GO:0042307; GO:0042770; GO:0045648; GO:0045663; GO:0045944; GO:0046323; GO:0046326; GO:0048010; GO:0048273; GO:0048863; GO:0051146; GO:0051149; GO:0051525; GO:0060045; GO:0060348; GO:0070935; GO:0071222; GO:0071223; GO:0071356; GO:0071479; GO:0090090; GO:0090336; GO:0090398; GO:0090400; GO:0098586; GO:0098978; GO:0099179; GO:0106310; GO:1900015; GO:1901741; GO:1904813; GO:2000379 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CQKLTDDHVQFLIYQILRGLK 0.91493 1.4356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5096 12.8619 0 0 11.8864 0 12.9408 0 13.1259 0 12.0581 0 0 0 0 0 13.3863 0 0 13.8018 0 0 0 0 13.6036 0 0 0 0 0 13.6735 13.4977 0 0 0 0 0 12.4401 0 0 13.2568 0 0 11.9187 0 0 13.1228 15.5889 0 13.9786 14.1609 0 0 0 0 12.1491 0 12.4045 12.1039 0 0 11.9558 13.3116 13.488 13.7756 0 0 0 12.6724 0 0 0 0 0 0 0 0 0 11.4565 0 14.2528 0 0 0 0 0 0 0 0 0 0 0 11.5917 0 0 0 12.9326 0 0 0 0 0 0 0 0 0 0 O95758 PTBP3_HUMAN "Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1, Rod1)" PTBP3 ROD1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] nucleus [GO:0005634] nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0008380; GO:0009653; GO:0033119; GO:0043249; GO:0043484; GO:0045595 mRNA binding [GO:0003729]; RNA binding [GO:0003723] DFSNSPLHRFKK 0.91494 1.2385 0 0 0 10.7746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2441 0 0 0 0 0 0 0 0 0 0 0 Q9BW11 MAD3_HUMAN "Max dimerization protein 3, Max dimerizer 3 (Class C basic helix-loop-helix protein 13, bHLHc13) (Max-associated protein 3) (Max-interacting transcriptional repressor MAD3) (Myx)" MXD3 BHLHC13 MAD3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0006357; GO:0046983; GO:0090575 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EREAEHGYASLCPHR 0.91495 1.4112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2392 0 0 0 0 0 18.0153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2409 0 0 0 Q01196 RUNX1_HUMAN "Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2, CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit, PEA2-alpha B, PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit)" RUNX1 AML1 CBFA2 Homo sapiens (Human) "cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203 "ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]" FNDLRFVGR 0.91499 1.4037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6534 12.6722 0 12.5927 0 13.1275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZY8 MFF_HUMAN Mitochondrial fission factor MFF C2orf33 AD030 AD033 GL004 Homo sapiens (Human) mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; release of cytochrome c from mitochondria [GO:0001836] anchoring junction [GO:0070161]; integral component of mitochondrial membrane [GO:0032592]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; integral component of mitochondrial membrane [GO:0032592]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; release of cytochrome c from mitochondria [GO:0001836] GO:0000266; GO:0001836; GO:0005739; GO:0005741; GO:0005777; GO:0006626; GO:0008021; GO:0008053; GO:0010821; GO:0016559; GO:0031307; GO:0032592; GO:0032991; GO:0042802; GO:0042803; GO:0043653; GO:0070161; GO:0070584; GO:0090141; GO:0090200; GO:0090314; GO:1900063 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] AYQQILDVLDENRR 0.915 1.4348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5W7 SNX14_HUMAN Sorting nexin-14 SNX14 Homo sapiens (Human) autophagosome maturation [GO:0097352]; protein transport [GO:0015031] cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] "cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; autophagosome maturation [GO:0097352]; protein transport [GO:0015031]" GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016021; GO:0030425; GO:0031902; GO:0035091; GO:0043231; GO:0080025; GO:0097352 "phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]" AAMKHIEVIVK 0.91501 1.2069 0 0 11.0389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2531 0 14.4963 0 0 0 0 0 10.7405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8647 0 0 0 12.2631 0 0 0 0 0 0 0 11.7151 12.9418 0 14.4137 14.8533 15.5252 0 0 10.7819 0 14.6867 0 15.8015 0 10.9152 14.7299 0 11.8445 0 0 0 13.5493 12.4546 13.8083 13.8215 0 0 0 12.8737 13.813 12.9919 12.7565 13.2347 0 13.6328 0 0 0 13.7308 0 15.0023 10.3219 0 13.2894 0 12.4557 13.624 0 13.0033 13.5289 12.1046 13.0869 0 14.9463 12.9068 0 0 0 14.9299 0 0 0 0 0 14.9261 0 0 15.2183 15.3194 0 0 0 0 0 0 0 14.844 11.4248 0 0 0 0 0 0 0 14.5685 0 13.6238 0 0 0 0 0 11.8907 Q9UI43 MRM2_HUMAN "rRNA methyltransferase 2, mitochondrial, EC 2.1.1.- (16S rRNA (uridine(1369)-2'-O)-methyltransferase) (16S rRNA [Um1369] 2'-O-methyltransferase) (Protein ftsJ homolog 2)" MRM2 FJH1 FTSJ2 Homo sapiens (Human) mitochondrial large ribosomal subunit assembly [GO:1902775]; RNA methylation [GO:0001510]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; mitochondrial large ribosomal subunit assembly [GO:1902775]; RNA methylation [GO:0001510]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364] GO:0000451; GO:0001510; GO:0005730; GO:0005739; GO:0005759; GO:0006364; GO:0008173; GO:0008650; GO:0031167; GO:1902775 RNA methyltransferase activity [GO:0008173]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650] CKNRTGAEHLWLTR 0.91503 1.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9981 0 0 0 0 0 0 0 10.5073 0 0 11.1642 11.0766 0 0 0 0 0 0 13.462 17.0113 0 0 0 0 0 0 0 0 9.97097 0 15.3878 0 0 0 0 0 0 13.3429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0943 13.88 0 0 0 0 0 0 13.0923 0 0 Q86YH6 DLP1_HUMAN "All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2, EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2)" PDSS2 C6orf210 DLP1 Homo sapiens (Human) cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744] GO:0000010; GO:0004659; GO:0005759; GO:0005829; GO:0006744; GO:0008299; GO:0021549; GO:0046982; GO:0050347; GO:0050878; GO:0097269; GO:1990234 all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347] GLVHDSWNSLQLRGLVVLLISK 0.91504 1.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7753 0 0 0 0 13.0543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H171 ZBP1_HUMAN "Z-DNA-binding protein 1 (DNA-dependent activator of IFN-regulatory factors, DAI) (Tumor stroma and activated macrophage protein DLM-1)" ZBP1 C20orf183 DLM1 Homo sapiens (Human) activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of necroptotic process [GO:0060545]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1-mediated signaling pathway [GO:2000659] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; left-handed Z-DNA binding [GO:0003692]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of necroptotic process [GO:0060545]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1-mediated signaling pathway [GO:2000659] GO:0002218; GO:0003677; GO:0003692; GO:0003725; GO:0003726; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0042802; GO:0043065; GO:0045087; GO:0050727; GO:0050729; GO:0050832; GO:0051607; GO:0060340; GO:0060545; GO:0070269; GO:2000659 DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; left-handed Z-DNA binding [GO:0003692] DIGQPITPSHSK 0.91505 1.3097 13.2847 0 0 0 0 13.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1906 0 10.8728 0 0 0 0 0 13.539 14.4913 0 0 0 11.8566 0 0 0 0 0 11.7945 0 0 11.6425 0 12.6318 13.3637 13.9497 0 11.8849 0 13.7222 0 14.4237 0 0 0 0 0 0 11.12 11.898 0 14.7135 0 14.6221 0 0 0 14.1697 0 0 0 0 12.8671 0 14.2386 0 14.6704 0 0 13.2527 0 0 0 12.5408 0 13.9656 12.8447 11.9775 14.3244 0 13.9788 0 0 0 0 0 12.5792 0 0 0 0 15.069 11.9732 0 0 14.643 0 12.3954 0 0 0 0 0 0 0 12.6008 0 12.5606 0 12.8146 0 0 0 0 0 0 14.7212 12.8962 0 0 11.5518 0 Q96DE0 NUD16_HUMAN "U8 snoRNA-decapping enzyme, EC 3.6.1.62 (IDP phosphatase, IDPase, EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16, Nudix motif 16) (Nudix hydrolase 16) (U8 snoRNA-binding protein H29K) (m7GpppN-mRNA hydrolase)" NUDT16 Homo sapiens (Human) "adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; sno(s)RNA catabolic process [GO:0016077]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dIDP diphosphatase activity [GO:0097383]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; inosine-diphosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]; adenosine to inosine editing [GO:0006382]; dITP catabolic process [GO:0035863]; IDP catabolic process [GO:0046709]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; sno(s)RNA catabolic process [GO:0016077]" GO:0000287; GO:0003729; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006402; GO:0008235; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0046709; GO:0050072; GO:0050897; GO:0090068; GO:0090502; GO:0097383; GO:0098519; GO:0110153; GO:0110155; GO:1901640; GO:1901641; GO:1990003; GO:1990174; GO:2000233 "chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dIDP diphosphatase activity [GO:0097383]; dITP diphosphatase activity [GO:0035870]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; inosine-diphosphatase activity [GO:1990003]; ITP binding [GO:1901641]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; snoRNA binding [GO:0030515]; XTP binding [GO:1901640]" DGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLK 0.91507 1.2869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16422 EPCAM_HUMAN "Epithelial cell adhesion molecule, Ep-CAM (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein, EGP) (Epithelial glycoprotein 314, EGP314, hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326)" EPCAM GA733-2 M1S2 M4S1 MIC18 TACSTD1 TROP1 Homo sapiens (Human) negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; ureteric bud development [GO:0001657] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; cadherin binding involved in cell-cell adhesion [GO:0098641]; protein-containing complex binding [GO:0044877]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; ureteric bud development [GO:0001657] GO:0001657; GO:0005886; GO:0005923; GO:0008284; GO:0009986; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0023019; GO:0044877; GO:0045944; GO:0048863; GO:0070062; GO:0098641; GO:2000048; GO:2000648 cadherin binding involved in cell-cell adhesion [GO:0098641]; protein-containing complex binding [GO:0044877] AGVIAVIVVVVIAVVAGIVVLVISRK 0.91508 1.4171 0 0 0 0 0 0 0 0 0 0 0 0 13.2112 0 0 0 13.5158 0 13.3176 13.4303 13.3061 0 0 0 0 13.2086 13.925 13.0708 10.9743 11.7054 10.633 0 0 0 0 10.6062 0 13.4991 0 0 0 12.0954 0 13.5265 11.4057 12.8613 0 0 13.1823 0 0 0 12.4947 0 15.6578 13.5497 0 0 0 0 0 0 13.0898 0 0 0 0 0 0 11.8 0 0 0 0 15.1012 0 0 12.7778 14.9417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1245 0 0 0 0 11.6941 0 0 0 0 0 0 0 0 0 12.4987 0 0 0 0 18.7159 12.3765 12.7655 0 0 0 0 0 0 0 0 0 13.7103 11.4373 0 15.2359 14.4426 0 0 0 14.2861 0 18.1446 0 0 0 11.9577 0 0 0 0 0 0 11.3414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1759 12.5695 0 10.9688 0 0 0 0 0 Q96JH7 VCIP1_HUMAN "Deubiquitinating protein VCPIP1, EC 3.4.19.12 (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135, VCP/p47 complex-interacting 135-kDa protein)" VCPIP1 KIAA1850 VCIP135 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of protein localization to chromatin [GO:1905634] GO:0000278; GO:0004843; GO:0005634; GO:0005737; GO:0005788; GO:0005795; GO:0006974; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0071108; GO:0090168; GO:0106300; GO:1905634 cysteine-type deubiquitinase activity [GO:0004843] ARETSVVR 0.91508 1.3087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0955 14.2826 0 0 13.2519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MX6 DAA10_HUMAN Dynein axonemal assembly factor 10 (WD repeat-containing protein 92) (WD repeat-containing protein Monad) DNAAF10 WDR92 Homo sapiens (Human) apoptotic process [GO:0006915]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821] dynein axonemal particle [GO:0120293]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] dynein axonemal particle [GO:0120293]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821] GO:0006915; GO:0043130; GO:0050821; GO:0070286; GO:0120293; GO:1990062 ubiquitin binding [GO:0043130] FVTMGNFAR 0.91508 1.3831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1455 0 12.6621 0 0 12.1344 12.3859 0 0 0 0 0 0 0 0 0 10.5728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8332 0 0 11.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PD5 PGRP2_HUMAN "N-acetylmuramoyl-L-alanine amidase, EC 3.5.1.28 (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long, PGRP-L)" PGLYRP2 PGLYRPL PGRPL UNQ3103/PRO10102 Homo sapiens (Human) biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; innate immune response [GO:0045087]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptide amidation [GO:0001519]; peptidoglycan catabolic process [GO:0009253]; regulation of inflammatory response [GO:0050727] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; innate immune response [GO:0045087]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptide amidation [GO:0001519]; peptidoglycan catabolic process [GO:0009253]; regulation of inflammatory response [GO:0050727] GO:0001519; GO:0005576; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016020; GO:0016045; GO:0032689; GO:0032827; GO:0042834; GO:0045087; GO:0050727; GO:0050830; GO:0051701; GO:0070062 N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; zinc ion binding [GO:0008270] AGLLRPDYALLGHRQLVR 0.9151 1.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3412 14.4466 0 0 0 0 11.6961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.82 0 0 0 0 0 0 0 0 0 0 14.2629 14.5829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHC8 OR2T6_HUMAN Olfactory receptor 2T6 (OST703) (Olfactory receptor 2T9) OR2T6 OR2T6P OR2T9 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DVMGALK 0.91512 1.4084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2339 0 0 11.9526 0 0 0 0 0 0 12.4738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UE6 LRRT1_HUMAN Leucine-rich repeat transmembrane neuronal protein 1 LRRTM1 UNQ675/PRO1309 Homo sapiens (Human) establishment of localization in cell [GO:0051649]; exploration behavior [GO:0035640]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; receptor internalization [GO:0031623]; synapse organization [GO:0050808] anchoring junction [GO:0070161]; axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; integral component of postsynaptic specialization membrane [GO:0099060] anchoring junction [GO:0070161]; axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; integral component of postsynaptic specialization membrane [GO:0099060]; establishment of localization in cell [GO:0051649]; exploration behavior [GO:0035640]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; negative regulation of receptor internalization [GO:0002091]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; receptor internalization [GO:0031623]; synapse organization [GO:0050808] GO:0002091; GO:0005615; GO:0005783; GO:0007626; GO:0030424; GO:0030426; GO:0031012; GO:0031623; GO:0035418; GO:0035640; GO:0050808; GO:0051649; GO:0051965; GO:0060291; GO:0070161; GO:0098982; GO:0099060 ELTLSSNQITQLPNTTFRPMPNLR 0.91516 1.2933 0 0 0 0 0 10.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.963 0 0 0 0 0 0 0 11.619 0 0 0 0 0 0 0 0 0 0 0 0 11.0308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3803 0 0 0 0 0 0 0 P0C866 F91A2_HUMAN Putative uncharacterized protein encoded by LINC00869 LINC00869 FAM91A2 KIAA0493 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] GO:0005802; GO:0006886; GO:0031410; GO:0099041 EAQRYFEHALTLR 0.9152 1.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20916 MAG_HUMAN Myelin-associated glycoprotein (Siglec-4a) MAG GMA Homo sapiens (Human) axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; substantia nigra development [GO:0021762]; transmission of nerve impulse [GO:0019226] compact myelin [GO:0043218]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220] compact myelin [GO:0043218]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mesaxon [GO:0097453]; myelin sheath [GO:0043209]; myelin sheath adaxonal region [GO:0035749]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to mechanical stimulus [GO:0071260]; central nervous system myelin formation [GO:0032289]; negative regulation of axon extension [GO:0030517]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of myelination [GO:0031643]; substantia nigra development [GO:0021762]; transmission of nerve impulse [GO:0019226] GO:0005102; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0010977; GO:0019226; GO:0019901; GO:0021762; GO:0030246; GO:0030517; GO:0031103; GO:0031643; GO:0032289; GO:0033270; GO:0033691; GO:0035749; GO:0042803; GO:0043209; GO:0043218; GO:0043220; GO:0043524; GO:0045121; GO:0045665; GO:0048711; GO:0071260; GO:0097453; GO:0098742; GO:1905576 carbohydrate binding [GO:0030246]; ganglioside GT1b binding [GO:1905576]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] GQAQAPPRVICTAR 0.91527 1.2385 0 0 0 0 0 0 11.9999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6109 0 10.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEV1 CSK23_HUMAN "Casein kinase II subunit alpha 3, CK II alpha 3, EC 2.7.11.1 (Casein kinase II alpha 1 polypeptide pseudogene)" CSNK2A3 CSNK2A1P Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726] GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005956; GO:0006468; GO:0008284; GO:0018105; GO:0018107; GO:0030307; GO:0045732; GO:0051726; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALDYCHSMGIMHR 0.91527 1.4276 0 12.126 0 0 0 0 11.8101 0 12.5323 0 0 0 9.23965 0 12.0583 11.9622 0 0 0 0 0 0 0 0 13.3994 0 0 11.9562 0 12.6264 0 13.457 0 0 0 12.2856 0 12.5079 0 12.4061 0 0 0 0 0 0 11.9919 0 0 0 0 9.66126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7893 0 11.7474 13.3602 0 0 0 14.2896 13.2667 0 0 13.7282 13.6012 0 0 11.7389 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3719 0 0 0 13.5225 11.6233 0 0 12.3946 0 0 0 0 13.5741 0 14.067 13.9702 13.2095 0 0 0 12.3383 13.291 14.1567 14.0122 12.9855 13.5243 14.2701 0 0 0 0 13.3637 13.3202 13.3016 0 13.0631 0 0 0 12.8228 0 13.2674 0 0 0 12.6959 0 13.0712 0 0 10.2965 0 0 13.1315 0 12.1458 0 0 Q96A84 EMID1_HUMAN "EMI domain-containing protein 1 (Emilin and multimerin domain-containing protein 1, Emu1)" EMID1 EMU1 Homo sapiens (Human) collagen trimer [GO:0005581]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] collagen trimer [GO:0005581]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] GO:0005576; GO:0005581; GO:0005783; GO:0005794; GO:0031012 GGPRAWALLCLGLLLPGGGAAWSIGAAPFSGRR 0.91528 1.4122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6C5 IGSF1_HUMAN "Immunoglobulin superfamily member 1, IgSF1 (Immunoglobulin-like domain-containing protein 1) (Inhibin-binding protein, InhBP) (Pituitary gland-specific factor 2) (p120)" IGSF1 IGDC1 KIAA0364 PGSF2 Homo sapiens (Human) "negative regulation of activin receptor signaling pathway [GO:0032926]; regulation of transcription, DNA-templated [GO:0006355]" extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; activin receptor antagonist activity [GO:0038102]; coreceptor activity [GO:0015026]; inhibin binding [GO:0034711]; negative regulation of activin receptor signaling pathway [GO:0032926]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005576; GO:0006355; GO:0015026; GO:0016020; GO:0016021; GO:0032926; GO:0034711; GO:0038102 activin receptor antagonist activity [GO:0038102]; coreceptor activity [GO:0015026]; inhibin binding [GO:0034711] CRGPVDGVGLALYK 0.91529 1.3183 11.3172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4503 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9248 0 0 12.3592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6792 14.0262 0 0 0 0 0 0 0 0 0 0 12.604 0 0 0 13.9769 11.5972 0 0 0 19.5585 0 0 0 0 19.5686 0 0 14.1264 11.0402 0 0 0 0 11.298 0 15.419 0 0 10.0926 0 0 0 0 12.7068 0 0 0 11.8072 0 0 11.404 12.4035 11.4054 0 0 0 11.4947 0 0 13.3505 11.8204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9534 0 12.2436 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3533 0 0 0 0 0 0 0 13.4639 0 14.3082 0 0 0 0 14.016 14.6227 13.0715 0 0 P18074 ERCC2_HUMAN "General transcription and DNA repair factor IIH helicase subunit XPD, TFIIH subunit XPD, EC 3.6.4.12 (Basic transcription factor 2 80 kDa subunit, BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit, TFIIH 80 kDa subunit, TFIIH p80) (Xeroderma pigmentosum group D-complementing protein)" ERCC2 XPD XPDC Homo sapiens (Human) "aging [GO:0007568]; apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; embryonic cleavage [GO:0040016]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; in utero embryonic development [GO:0001701]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of DNA binding [GO:0043388]; positive regulation of mitotic recombination [GO:0045951]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] "CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]; aging [GO:0007568]; apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; embryonic cleavage [GO:0040016]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; in utero embryonic development [GO:0001701]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of DNA binding [GO:0043388]; positive regulation of mitotic recombination [GO:0045951]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to oxidative stress [GO:0006979]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" GO:0000439; GO:0000462; GO:0000717; GO:0001701; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0005737; GO:0005819; GO:0005829; GO:0006283; GO:0006289; GO:0006362; GO:0006366; GO:0006915; GO:0006979; GO:0007059; GO:0007568; GO:0008022; GO:0009650; GO:0009791; GO:0016887; GO:0021510; GO:0030198; GO:0030282; GO:0030674; GO:0032289; GO:0033683; GO:0035264; GO:0035315; GO:0040016; GO:0043139; GO:0043249; GO:0043388; GO:0045951; GO:0046872; GO:0047485; GO:0048820; GO:0051539; GO:0060218; GO:0070516; GO:0071425; GO:0071817; GO:1901990 "4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]" AYPLEVTKLIYCSR 0.91531 1.4194 0 0 0 0 0 0 0 0 0 13.061 0 0 0 0 13.5244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6872 0 0 0 0 0 0 0 12.7917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8987 0 0 0 0 0 0 0 0 15.1802 13.4374 0 0 14.5076 0 11.3516 14.2671 0 0 14.8412 13.8837 14.0543 15.5453 14.3428 0 0 11.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1057 0 0 0 12.5952 0 0 0 12.6436 0 0 0 14.0134 0 0 13.2195 0 0 0 0 0 0 0 0 0 11.4879 0 0 0 0 0 10.9628 0 0 0 0 0 0 0 0 0 0 16.1514 14.7816 0 0 0 0 0 0 0 O15164 TIF1A_HUMAN "Transcription intermediary factor 1-alpha, TIF1-alpha, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)" TRIM24 RNF82 TIF1 TIF1A Homo sapiens (Human) "calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]" cytosol [GO:0005829]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726] "cytosol [GO:0005829]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; transcription by RNA polymerase II [GO:0006366]" GO:0000791; GO:0001673; GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0005102; GO:0005634; GO:0005654; GO:0005726; GO:0005739; GO:0005829; GO:0006366; GO:0008270; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0045892; GO:0046777; GO:0050673; GO:0050680; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796 chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CLPAPQR 0.91534 5.0611 0 0 0 0 0 0 0 0 0 0 0 0 12.6383 0 0 0 11.4117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3692 0 0 0 0 0 0 0 0 0 0 0 0 12.9999 10.7925 0 14.1971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7153 11.5384 11.1335 0 10.9145 0 0 0 16.3769 15.2022 11.8137 0 0 12.5123 0 12.0823 0 15.0731 15.3929 13.8056 0 15.0136 12.8913 16.2466 15.7313 16.6074 17.0469 17.2383 14.2669 16.5534 13.5878 14.5723 0 13.8914 0 9.93874 14.5704 16.1454 14.6873 14.6116 13.5405 16.1048 0 0 0 12.3779 0 14.7053 0 13.7185 14.0469 0 0 14.0179 0 14.6331 13.0888 0 0 0 0 0 11.9796 0 0 0 0 14.9342 0 0 0 0 0 15.7443 0 14.6743 0 0 12.9672 0 0 0 0 0 0 0 0 0 0 0 14.2925 0 0 0 0 12.8989 13.1977 0 0 10.9316 14.6935 0 13.8813 0 15.057 13.9126 0 0 0 12.5251 0 0 0 0 P05187 PPB1_HUMAN "Alkaline phosphatase, placental type, EC 3.1.3.1 (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1, PLAP-1)" ALPP PLAP Homo sapiens (Human) dephosphorylation [GO:0016311] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]; dephosphorylation [GO:0016311] GO:0000287; GO:0004035; GO:0005886; GO:0008270; GO:0009986; GO:0016021; GO:0016311; GO:0031225 alkaline phosphatase activity [GO:0004035]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270] DGARPDVTESESGSPEYR 0.91535 1.4041 12.6708 12.9962 0 16.9773 0 13.0021 14.0135 13.463 16.7555 0 0 11.3903 0 16.7498 10.8778 0 0 11.1795 0 0 11.569 13.3826 0 13.741 10.5123 0 0 0 0 0 17.2789 17.2498 0 17.2151 0 17.2505 17.226 0 10.3014 9.84558 10.518 0 0 17.2193 0 12.7248 10.5637 0 0 0 17.2967 0 0 0 0 17.0173 0 0 0 16.5787 16.0582 16.0465 0 0 0 0 0 0 0 0 0 0 0 19.0453 0 0 0 0 0 0 0 0 14.4658 19.649 0 14.6845 0 15.9413 0 19.6342 0 0 0 0 0 0 13.6919 14.0013 0 0 0 0 13.1794 0 0 11.0719 0 0 0 15.7033 14.5459 12.3059 0 0 0 0 0 0 11.4264 15.1184 0 0 13.3837 0 13.3405 13.3684 13.5084 0 0 0 0 0 19.4742 13.0705 0 13.3028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.578 0 14.8046 12.4686 0 12.626 0 12.599 14.3496 12.9765 18.1763 12.7565 0 13.3106 12.7285 0 0 16.3732 0 18.072 0 12.2503 18.0213 18.0242 O43920 NDUS5_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa, CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit)" NDUFS5 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] IEYDDFVECLLRQKTMR 0.91536 1.4351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12841 FSTL1_HUMAN Follistatin-related protein 1 (Follistatin-like protein 1) FSTL1 FRP Homo sapiens (Human) cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510] GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0008201; GO:0030154; GO:0030510; GO:0043066; GO:0043542; GO:0045446; GO:0061484; GO:0070062 calcium ion binding [GO:0005509]; heparin binding [GO:0008201] CVCACGNWVCTAMTCDGK 0.9154 1.3865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXA5 SACA3_HUMAN "Sperm acrosome membrane-associated protein 3 (Cancer/testis antigen 54, CT54) (Lysozyme-like acrosomal sperm-specific secretory protein ALLP-17) (Lysozyme-like protein 3) (Sperm lysozyme-like protein 1) (Sperm protein reactive with antisperm antibodies, Sperm protein reactive with ASA) [Cleaved into: Sperm acrosome membrane-associated protein 3, membrane form; Sperm acrosome membrane-associated protein 3, processed form ]" SPACA3 LYC3 LYZL3 SLLP1 SPRASA UNQ424/PRO862 Homo sapiens (Human) fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; monocyte activation [GO:0042117]; positive regulation of macrophage activation [GO:0043032]; positive regulation of phagocytosis [GO:0050766]; sperm-egg recognition [GO:0035036] acrosomal matrix [GO:0043159]; acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; sperm flagellum [GO:0036126] acrosomal matrix [GO:0043159]; acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; sperm flagellum [GO:0036126]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; monocyte activation [GO:0042117]; positive regulation of macrophage activation [GO:0043032]; positive regulation of phagocytosis [GO:0050766]; sperm-egg recognition [GO:0035036] GO:0001669; GO:0002080; GO:0005576; GO:0007342; GO:0016021; GO:0030141; GO:0035036; GO:0036126; GO:0042117; GO:0043032; GO:0043159; GO:0050766 MVSALRGAPLIR 0.91542 1.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6253 12.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14678 ABCD4_HUMAN "Lysosomal cobalamin transporter ABCD4, EC 7.6.2.8 (ATP-binding cassette sub-family D member 4) (PMP70-related protein, P70R) (Peroxisomal membrane protein 1-like, PXMP1-L) (Peroxisomal membrane protein 69, PMP69)" ABCD4 PXMP1L Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760] ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760] GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016021; GO:0042626; GO:0042760; GO:0042802; GO:0043190; GO:0055085; GO:1990830 ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324] EVYPDSGSADDER 0.91543 1.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00400 ACATN_HUMAN "Acetyl-coenzyme A transporter 1, AT-1, Acetyl-CoA transporter 1 (Solute carrier family 33 member 1)" SLC33A1 ACATN AT1 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085] GO:0000139; GO:0005789; GO:0005887; GO:0008521; GO:0015295; GO:0016020; GO:0030509; GO:0055085; GO:0060395 acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295] AELSSILLLLFLYVLQGIPLGLAGSIPLILQSK 0.91544 1.2042 0 12.8906 0 0 0 0 14.3578 0 0 0 12.5384 0 12.602 0 0 14.5668 0 0 0 0 0 0 0 0 0 0 0 12.8858 11.1248 12.7619 13.7863 0 0 12.6072 14.2417 14.0889 0 0 14.6047 13.0165 12.8311 0 12.7548 12.3983 12.9925 15.0692 12.6532 0 14.3222 14.4215 14.0853 0 0 0 0 13.2495 0 0 0 0 0 0 0 10.3384 0 13.2031 0 0 0 0 0 0 0 0 13.9168 13.3749 14.8211 12.7623 13.5409 12.9931 16.7875 15.6813 11.9824 0 14.8707 0 0 15.7179 15.9754 16.2024 17.5517 15.4556 14.664 16.928 17.081 14.7185 14.0657 14.4596 0 16.1608 15.3456 13.2134 0 13.7074 15.1417 14.1356 14.3298 0 14.218 14.1238 12.9518 0 15.1781 15.0808 0 15.9517 13.0349 13.583 14.1169 0 15.26 12.4037 12.7531 15.8844 15.4403 0 0 0 15.1966 12.6778 0 13.031 0 0 14.272 14.1141 13.3214 14.6895 14.5207 0 13.9512 0 14.7541 0 13.5886 14.1133 0 0 11.1081 0 11.4601 11.7691 0 10.8578 0 14.0502 11.2318 0 0 0 14.0259 0 0 0 0 0 0 0 0 13.2264 0 0 0 14.617 13.9281 0 0 0 0 14.6578 Q8N0Z2 ABRA_HUMAN "Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling, STARS)" ABRA Homo sapiens (Human) positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; transcription by RNA polymerase II [GO:0006366] actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; actin binding [GO:0003779]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; transcription by RNA polymerase II [GO:0006366] GO:0003779; GO:0005886; GO:0006366; GO:0006606; GO:0015629; GO:0030017; GO:0035025; GO:0045944; GO:0051091 actin binding [GO:0003779] IRTATLVISLAR 0.91546 1.4334 0 0 0 0 0 0 0 0 12.7365 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1928 12.1697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2048 0 0 13.2817 11.429 0 0 0 0 11.9152 0 0 0 0 0 0 15.2334 0 13.5359 11.7607 0 0 0 0 0 0 15.8197 0 15.1252 0 0 0 0 0 0 0 0 0 13.6449 0 0 0 12.5212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7919 0 0 0 0 0 0 0 0 12.5909 0 0 0 0 13.6805 0 13.4261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGW2 STRCL_HUMAN Putative stereocilin-like protein (Stereocilin pseudogene 1) STRCP1 STRCP Homo sapiens (Human) cell-matrix adhesion [GO:0007160] cell surface [GO:0009986]; extracellular region [GO:0005576]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426] cell surface [GO:0009986]; extracellular region [GO:0005576]; kinocilium [GO:0060091]; stereocilium tip [GO:0032426]; cell-matrix adhesion [GO:0007160] GO:0005576; GO:0007160; GO:0009986; GO:0032426; GO:0060091 AMLPVLQGTSVTPAQAVLLLGRLLPR 0.91547 1.2036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4885 14.7778 0 0 0 13.1429 11.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6167 14.3169 0 12.248 0 0 12.9825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7645 0 0 0 0 0 0 13.1444 0 0 0 0 0 0 13.0613 0 0 0 0 0 0 13.7091 0 0 11.7327 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9731 0 0 12.5387 13.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15151 PVR_HUMAN "Poliovirus receptor (Nectin-like protein 5, NECL-5) (CD antigen CD155)" PVR PVS Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370] GO:0001618; GO:0002860; GO:0005615; GO:0005737; GO:0005886; GO:0005912; GO:0005925; GO:0007156; GO:0007157; GO:0009986; GO:0016021; GO:0038023; GO:0042271; GO:0045954; GO:0050839; GO:0060370 cell adhesion molecule binding [GO:0050839]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] EGPPSEHSGISRNAIIFLVLGILVFLILLGIGIYFYWSK 0.91548 1.4089 0 0 0 0 0 0 0 0 0 0 0 12.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7159 0 0 0 11.6764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1896 0 13.8459 13.8858 13.6392 0 0 0 0 0 0 0 0 0 0 0 14.3496 13.2985 0 0 12.6452 0 0 13.1062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0545 0 0 0 0 0 0 0 0 13.0628 0 0 0 0 11.5573 0 0 0 0 0 0 0 0 12.7597 10.853 0 0 0 12.4871 12.8811 0 0 0 12.2208 0 12.5599 13.531 0 0 0 0 0 0 12.8321 0 0 0 0 0 0 0 Q6UXH1 CREL2_HUMAN "Protein disulfide isomerase CRELD2, EC 5.3.4.1 (Cysteine-rich with EGF-like domain protein 2)" CRELD2 UNQ185/PRO211 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756] GO:0003756; GO:0005509; GO:0005615; GO:0005783; GO:0005794 calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756] AALGLLPLLLLLPPAPEAAK 0.91549 5.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9277 0 0 15.7113 0 14.374 0 0 0 0 0 0 13.9471 0 0 0 0 11.3218 0 0 13.5725 0 0 0 13.6932 0 10.8635 12.0084 0 11.8916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9309 0 16.1528 0 10.6404 0 0 0 14.6913 11.2399 0 0 0 15.6638 0 0 0 0 0 13.4219 0 12.3381 0 0 0 0 11.3987 0 14.7174 15.8662 0 0 15.9446 0 0 0 0 13.4569 0 0 11.0733 0 0 0 12.2279 0 0 0 10.7142 12.9361 0 10.8814 0 0 12.9765 12.688 0 0 0 0 10.7836 0 0 14.3371 0 17.6225 0 0 10.2475 0 0 0 0 0 15.8941 14.8662 0 15.9703 0 0 0 0 0 14.8386 0 15.7447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4484 0 0 0 15.8233 17.2003 0 0 15.9687 0 0 10.8957 Q9UJ68 MSRA_HUMAN "Mitochondrial peptide methionine sulfoxide reductase, EC 1.8.4.11 (Peptide-methionine (S)-S-oxide reductase, Peptide Met(O) reductase) (Protein-methionine-S-oxide reductase, PMSR)" MSRA Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; methionine metabolic process [GO:0006555]; protein modification process [GO:0036211]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular response to oxidative stress [GO:0034599]; methionine metabolic process [GO:0006555]; protein modification process [GO:0036211]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979] GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006555; GO:0006979; GO:0008113; GO:0015629; GO:0030091; GO:0034599; GO:0036211; GO:0036456; GO:0070062 L-methionine-(S)-S-oxide reductase activity [GO:0036456]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113] EGQTFYYAEDYHQQYLSK 0.9155 1.2028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1342 0 0 0 14.1708 0 0 0 0 0 0 0 0 12.6634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6594 0 Q8NGG5 OR8K1_HUMAN Olfactory receptor 8K1 (Olfactory receptor OR11-182) OR8K1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] HLSITDLGYSTVIAPKMLVNFIVHK 0.91553 1.2014 0 0 0 0 0 0 0 0 0 13.2268 0 0 0 0 0 0 0 0 10.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4852 13.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7884 0 0 0 0 0 11.014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9163 0 0 0 0 0 13.5503 0 0 0 0 11.9287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2041 0 0 0 0 0 0 0 0 0 0 0 0 Q92882 OSTF1_HUMAN Osteoclast-stimulating factor 1 OSTF1 Homo sapiens (Human) ossification [GO:0001503]; signal transduction [GO:0007165] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; SH3 domain binding [GO:0017124]; ossification [GO:0001503]; signal transduction [GO:0007165] GO:0001503; GO:0005576; GO:0007165; GO:0017124; GO:0034774; GO:1904813 SH3 domain binding [GO:0017124] PVKPGQVKVFR 0.91555 1.3565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8214 0 0 0 13.9227 0 0 13.0498 0 0 0 13.4148 0 13.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2426 0 0 13.3615 0 0 14.9963 14.0495 0 0 0 13.5016 13.8893 0 0 0 0 0 15.2889 0 0 14.508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22352 GPX3_HUMAN "Glutathione peroxidase 3, GPx-3, GSHPx-3, EC 1.11.1.9 (Extracellular glutathione peroxidase) (Plasma glutathione peroxidase, GPx-P, GSHPx-P)" GPX3 GPXP Homo sapiens (Human) hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982] GO:0004601; GO:0004602; GO:0005576; GO:0005615; GO:0006982; GO:0008430; GO:0042744; GO:0042802; GO:0070062 glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; selenium binding [GO:0008430] LFWEPMKVHDIR 0.91557 1.4204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2258 0 0 0 0 0 0 0 12.0844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RS6 NUDC1_HUMAN NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66) NUDCD1 CML66 Homo sapiens (Human) immune system process [GO:0002376] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; immune system process [GO:0002376] GO:0002376; GO:0005654; GO:0005829 KFFACAPNYSYAALCECLRR 0.9156 1.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.694 0 0 0 P16581 LYAM2_HUMAN "E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1, ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2, LECAM2) (CD antigen CD62E)" SELE ELAM1 Homo sapiens (Human) actin filament-based process [GO:0030029]; activation of phospholipase C activity [GO:0007202]; calcium-mediated signaling [GO:0019722]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of receptor internalization [GO:0002092]; regulation of inflammatory response [GO:0050727]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612] caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888]; actin filament-based process [GO:0030029]; activation of phospholipase C activity [GO:0007202]; calcium-mediated signaling [GO:0019722]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of receptor internalization [GO:0002092]; regulation of inflammatory response [GO:0050727]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612] GO:0002092; GO:0002523; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0005901; GO:0005905; GO:0006954; GO:0007157; GO:0007159; GO:0007202; GO:0009897; GO:0019722; GO:0030029; GO:0030863; GO:0032496; GO:0033691; GO:0034097; GO:0034612; GO:0043274; GO:0045121; GO:0046872; GO:0048471; GO:0050727; GO:0050901; GO:0070492; GO:0070555; GO:1903238 metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888] CSHSPAGEFTFK 0.91561 1.4202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1272 0 0 0 0 0 0 0 0 0 0 0 13.4298 0 0 0 0 0 0 0 0 0 0 0 12.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPC6 MYOZ2_HUMAN Myozenin-2 (Calsarcin-1) (FATZ-related protein 2) MYOZ2 C4orf5 Homo sapiens (Human) negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sarcomere organization [GO:0045214]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle tissue development [GO:0007519] actin cytoskeleton [GO:0015629]; sarcomere [GO:0030017]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; sarcomere [GO:0030017]; Z disc [GO:0030018]; actin binding [GO:0003779]; FATZ binding [GO:0051373]; protein phosphatase 2B binding [GO:0030346]; telethonin binding [GO:0031433]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sarcomere organization [GO:0045214]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle tissue development [GO:0007519] GO:0000122; GO:0003779; GO:0007519; GO:0015629; GO:0030017; GO:0030018; GO:0030346; GO:0031433; GO:0043503; GO:0045214; GO:0051373; GO:0070885 actin binding [GO:0003779]; FATZ binding [GO:0051373]; protein phosphatase 2B binding [GO:0030346]; telethonin binding [GO:0031433] AELPDYRSFNR 0.91563 1.4278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9691 0 0 0 0 0 0 0 0 12.9825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96009 NAPSA_HUMAN "Napsin-A, EC 3.4.23.- (Aspartyl protease 4, ASP4, Asp 4) (Napsin-1) (TA01/TA02)" NAPSA NAP1 NAPA Homo sapiens (Human) membrane protein proteolysis [GO:0033619]; proteolysis [GO:0006508]; surfactant homeostasis [GO:0043129] alveolar lamellar body [GO:0097208]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body lumen [GO:0097486] alveolar lamellar body [GO:0097208]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body lumen [GO:0097486]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; membrane protein proteolysis [GO:0033619]; proteolysis [GO:0006508]; surfactant homeostasis [GO:0043129] GO:0004175; GO:0004190; GO:0005615; GO:0005764; GO:0006508; GO:0008233; GO:0033619; GO:0043129; GO:0070062; GO:0097208; GO:0097486 aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233] MSPPPLLQPLLLLLPLLNVEPSGATLIRIPLHRVQPGR 0.91564 1.3186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0547 0 Q86YW5 TRML1_HUMAN "Trem-like transcript 1 protein, TLT-1 (Triggering receptor expressed on myeloid cells-like protein 1)" TREML1 TLT1 UNQ1825/PRO3438 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; innate immune response [GO:0045087]; platelet activation [GO:0030168] cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091] cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; transmembrane signaling receptor activity [GO:0004888]; calcium-mediated signaling [GO:0019722]; innate immune response [GO:0045087]; platelet activation [GO:0030168] GO:0004888; GO:0005794; GO:0005829; GO:0005886; GO:0009986; GO:0016021; GO:0016607; GO:0019722; GO:0030168; GO:0031091; GO:0045087 transmembrane signaling receptor activity [GO:0004888] SIPLIWGAVLLVGLLVAAVVLFAVMAK 0.91564 1.4125 0 0 0 0 0 0 0 0 12.4951 0 0 0 0 0 10.3907 0 0 0 0 0 0 0 0 0 11.3203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6047 0 12.2836 0 12.5939 12.6339 0 0 0 0 17.7287 15.2995 17.3068 17.3467 16.6015 18.3504 16.9826 17.0851 17.2962 16.6778 15.9205 17.1144 16.2825 16.1533 14.4519 16.3384 14.4793 15.9834 15.0938 0 0 12.7719 12.1421 16.3214 14.874 13.1207 0 0 0 0 0 16.3697 15.8056 15.6293 14.5161 0 0 0 0 13.6639 14.1704 0 13.7801 13.3906 13.4648 0 14.4381 0 12.4788 12.5682 12.5173 0 13.268 0 0 0 13.9378 0 12.4987 0 0 0 12.5465 0 0 0 0 0 0 0 0 0 0 0 12.3487 0 0 13.1282 0 0 0 0 0 11.7422 0 14.0984 0 0 11.3785 0 0 13.0529 12.1372 0 0 0 12.1928 0 P27449 VATL_HUMAN "V-type proton ATPase 16 kDa proteolipid subunit c, V-ATPase 16 kDa proteolipid subunit c (Vacuolar proton pump 16 kDa proteolipid subunit c)" ATP6V0C ATP6C ATP6L ATPL Homo sapiens (Human) endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "azurophil granule membrane [GO:0035577]; clathrin-coated vesicle membrane [GO:0030665]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "azurophil granule membrane [GO:0035577]; clathrin-coated vesicle membrane [GO:0030665]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" GO:0000139; GO:0000220; GO:0005765; GO:0005886; GO:0005925; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016021; GO:0016241; GO:0030177; GO:0030665; GO:0030670; GO:0030672; GO:0031625; GO:0033176; GO:0035577; GO:0046933; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:0070821; GO:0101003; GO:1902600 "proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]" GTAQQPRLFVGMILILIFAEVLGLYGLIVALILSTK 0.9157 1.31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7148 0 0 0 0 0 0 0 0 0 0 12.8847 0 0 0 0 0 0 0 0 0 0 0 12.2027 0 0 13.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92688 AN32B_HUMAN "Acidic leucine-rich nuclear phosphoprotein 32 family member B (Acidic protein rich in leucines) (Putative HLA-DR-associated protein I-2, PHAPI2) (Silver-stainable protein SSP29)" ANP32B APRIL PHAPI2 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; inner ear development [GO:0048839]; negative regulation of cell differentiation [GO:0045596]; nucleosome assembly [GO:0006334]; positive regulation of protein export from nucleus [GO:0046827]; regulation of apoptotic process [GO:0042981]; roof of mouth development [GO:0060021]; vasculature development [GO:0001944]; ventricular system development [GO:0021591] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; RNA polymerase binding [GO:0070063]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; inner ear development [GO:0048839]; negative regulation of cell differentiation [GO:0045596]; nucleosome assembly [GO:0006334]; positive regulation of protein export from nucleus [GO:0046827]; regulation of apoptotic process [GO:0042981]; roof of mouth development [GO:0060021]; vasculature development [GO:0001944]; ventricular system development [GO:0021591] GO:0001944; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0006919; GO:0021591; GO:0042393; GO:0042981; GO:0045596; GO:0046827; GO:0048839; GO:0060021; GO:0070062; GO:0070063 histone binding [GO:0042393]; RNA polymerase binding [GO:0070063] ESVFKLLPQLTYLDGYDR 0.91571 1.405 0 0 0 0 0 11.0293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9307 0 0 10.4202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1735 0 10.6019 0 0 0 0 0 0 0 0 0 0 0 0 14.4728 0 0 11.6909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0019 0 0 0 0 12.4304 0 15.6576 0 0 0 0 0 0 12.0131 0 0 0 0 0 0 0 0 0 0 0 10.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5619 0 0 0 0 0 Q9Y6M0 TEST_HUMAN "Testisin, EC 3.4.21.- (Eosinophil serine protease 1, ESP-1) (Serine protease 21)" PRSS21 ESP1 TEST1 UNQ266/PRO303 Homo sapiens (Human) proteolysis [GO:0006508]; spermatogenesis [GO:0007283] anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007283; GO:0008236; GO:0016020; GO:0031225 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GALLLALLLARAGLR 0.91572 1.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5581 0 0 0 0 0 0 0 0 0 11.1787 0 10.6823 0 0 12.8951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4003 12.8763 12.6978 13.7941 14.128 0 12.9329 14.948 13.8221 0 0 0 0 13.3665 0 0 0 0 0 11.161 0 12.5017 11.9279 0 0 0 0 0 0 0 0 0 12.8021 13.9566 14.0942 13.1831 0 0 13.0834 0 0 14.5432 0 0 0 13.453 14.0283 0 12.8334 0 13.1024 0 0 0 13.5528 14.5536 0 14.2287 14.5503 13.5657 12.8506 13.0513 0 12.3112 14.4257 14.4477 0 13.12 0 11.9195 13.1575 12.7808 0 13.6233 0 0 0 0 0 0 12.0918 0 0 0 0 11.577 12.1608 0 0 0 0 12.435 0 0 0 0 0 13.9531 13.1253 13.1988 0 11.9729 0 0 0 0 P62341 SELT_HUMAN "Thioredoxin reductase-like selenoprotein T, SelT, EC 1.8.1.9" SELENOT SELT UNQ150/PRO176 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; pancreas development [GO:0031016]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of growth hormone secretion [GO:0060124]; response to glucose [GO:0009749]; selenocysteine incorporation [GO:0001514] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; selenium binding [GO:0008430]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glucose homeostasis [GO:0042593]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; pancreas development [GO:0031016]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of growth hormone secretion [GO:0060124]; response to glucose [GO:0009749]; selenocysteine incorporation [GO:0001514] GO:0001514; GO:0004791; GO:0005783; GO:0005789; GO:0007204; GO:0008430; GO:0009749; GO:0016021; GO:0031016; GO:0035773; GO:0042593; GO:0045454; GO:0060124; GO:0098869 selenium binding [GO:0008430]; thioredoxin-disulfide reductase activity [GO:0004791] HIASFLSVFKLVLIGLIIVGK 0.91574 1.3025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0041 0 11.3012 12.5419 0 0 0 0 11.0922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV99 LRC61_HUMAN Leucine-rich repeat-containing protein 61 LRRC61 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829] GO:0005737; GO:0005829 DLDSSLRPSSSPGPR 0.91576 1.3866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H0YM25 GG6LV_HUMAN Golgin subfamily A member 6-like protein 22 GOLGA6L22 Homo sapiens (Human) EEEKMHEQEK 0.91577 1.3023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6421 0 0 0 0 0 10.7808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53992 SC24C_HUMAN Protein transport protein Sec24C (SEC24-related protein C) SEC24C KIAA0079 Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110 SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] KVRGLIDSLR 0.91577 1.4813 0 0 0 0 0 0 0 0 0 0 0 10.2761 0 0 0 0 0 0 0 0 0 0 12.2761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8621 0 0 0 0 0 0 0 0 12.3601 0 0 0 0 0 0 0 14.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7H3 CATIP_HUMAN Ciliogenesis-associated TTC17-interacting protein CATIP C2orf62 Homo sapiens (Human) actin filament polymerization [GO:0030041]; cilium organization [GO:0044782] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782] GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782 GFISEAANLVLLR 0.91577 1.2941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2935 15.9213 0 11.5222 11.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMJ2 SCAR5_HUMAN Scavenger receptor class A member 5 (Scavenger receptor hlg) SCARA5 UNQ2938/PRO28700 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to heat [GO:0034605]; endocytosis [GO:0006897]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; ferritin receptor activity [GO:0070287]; scavenger receptor activity [GO:0005044]; cellular iron ion homeostasis [GO:0006879]; cellular response to heat [GO:0034605]; endocytosis [GO:0006897]; iron ion transmembrane transport [GO:0034755]; protein homotrimerization [GO:0070207] GO:0005044; GO:0005887; GO:0006879; GO:0006897; GO:0009897; GO:0034605; GO:0034755; GO:0070207; GO:0070287 ferritin receptor activity [GO:0070287]; scavenger receptor activity [GO:0005044] DWEHSIALRNISLAK 0.91579 5.0463 0 0 11.448 0 0 0 0 0 0 0 12.9476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9064 0 0 0 10.7288 0 0 0 0 0 0 0 0 0 12.4213 0 0 0 0 13.6278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8511 10.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7449 0 0 0 0 0 0 0 0 Q9BUT1 BDH2_HUMAN "3-hydroxybutyrate dehydrogenase type 2, EC 1.1.1.30 (4-oxo-L-proline reductase, EC 1.1.1.104) (Dehydrogenase/reductase SDR family member 6) (Oxidoreductase UCPA) (R-beta-hydroxybutyrate dehydrogenase) (Short chain dehydrogenase/reductase family 15C member 1)" BDH2 DHRS6 SDR15C1 UNQ6308/PRO20933 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290]" GO:0003858; GO:0005737; GO:0005829; GO:0006635; GO:0016491; GO:0016616; GO:0016628; GO:0019290; GO:0030855; GO:0042168; GO:0051287; GO:0055072; GO:0070062 "3-hydroxybutyrate dehydrogenase activity [GO:0003858]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" SMYLMIKAFLPKMLAQK 0.91584 1.2939 0 0 0 0 0 0 0 9.91922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.797 12.7894 0 0 0 0 0 0 0 0 0 0 0 0 14.8531 0 0 0 0 0 15.0156 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0383 0 0 0 0 12.8373 0 0 0 0 0 0 0 12.1576 0 0 13.069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2G2 CARD8_HUMAN "Caspase recruitment domain-containing protein 8, EC 3.4.-.- (CARD-inhibitor of NF-kappa-B-activating ligand, CARDINAL) (Tumor up-regulated CARD-containing antagonist of CASP9, TUCAN) [Cleaved into: Caspase recruitment domain-containing protein 8, C-terminus, CARD8-CT; Caspase recruitment domain-containing protein 8, N-terminus, CARD8-NT ]" CARD8 DACAR KIAA0955 NDPP1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; CARD8 inflammasome complex assembly [GO:0140633]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; self proteolysis [GO:0097264] CARD8 inflammasome complex [GO:0140634]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] CARD8 inflammasome complex [GO:0140634]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; endopeptidase activity [GO:0004175]; NACHT domain binding [GO:0032089]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; CARD8 inflammasome complex assembly [GO:0140633]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; self proteolysis [GO:0097264] GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006919; GO:0006954; GO:0008233; GO:0008656; GO:0010804; GO:0031665; GO:0032088; GO:0032089; GO:0032691; GO:0032731; GO:0032991; GO:0038187; GO:0042803; GO:0042981; GO:0043122; GO:0043124; GO:0043280; GO:0043621; GO:0050700; GO:0051260; GO:0051607; GO:0061702; GO:0070269; GO:0072559; GO:0097264; GO:0097340; GO:0140374; GO:0140608; GO:0140633; GO:0140634; GO:1900226 CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; endopeptidase activity [GO:0004175]; NACHT domain binding [GO:0032089]; pattern recognition receptor activity [GO:0038187]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621] GDLALDVLFRSISER 0.91584 1.4091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1587 0 0 0 0 0 0 0 13.5134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX39 AMTN_HUMAN Amelotin AMTN UNQ689/PRO1329 Homo sapiens (Human) biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of enamel mineralization [GO:0070175] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of enamel mineralization [GO:0070175] GO:0005576; GO:0005604; GO:0005788; GO:0005911; GO:0007155; GO:0031012; GO:0031214; GO:0042475; GO:0070169; GO:0070175 SLPQLKPALGLPPTK 0.91597 1.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.637 0 14.1335 0 0 0 0 13.7807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3405 12.7977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5531 0 0 11.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WH2 RASF3_HUMAN Ras association domain-containing protein 3 RASSF3 Homo sapiens (Human) regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0007165; GO:0042802; GO:0042981 identical protein binding [GO:0042802] LKMTLNSNGIYTGFIK 0.91597 1.4289 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1707 0 0 0 0 0 0 0 0 0 0 0 0 13.5288 0 0 0 0 11.503 0 11.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9029 0 0 15.0826 0 12.8126 12.9326 0 0 0 0 0 0 0 0 0 0 13.6843 0 0 0 0 0 15.8468 0 13.877 0 0 0 0 0 14.146 0 12.9208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0009 0 13.1441 0 0 13.0045 0 0 0 0 0 0 0 0 0 0 14.3813 13.1751 0 0 0 0 0 12.7734 0 0 0 0 13.3336 0 11.4816 0 0 13.5609 0 0 0 13.4049 0 0 0 0 0 0 0 0 0 12.7915 0 P86397 HTD2_HUMAN "Hydroxyacyl-thioester dehydratase type 2, mitochondrial, HsHTD2, EC 4.2.1.59 (3-hydroxyacyl-[acyl-carrier-protein] dehydratase)" HTD2 Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949] GO:0004317; GO:0005730; GO:0005739; GO:0005759; GO:0006633; GO:0008659; GO:0008693; GO:0018812; GO:0019171; GO:0046949; GO:0047451 (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317] TVCLNLPVLTLQHFQHMHIKVGDR 0.91601 1.4129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EBN2 TRI61_HUMAN Putative tripartite motif-containing protein 61 (RING finger protein 35) TRIM61 RNF35 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DLHDSFPCPFCHFCCPERK 0.91601 1.3107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1637 0 0 0 0 0 11.9812 12.8786 0 0 13.5786 12.7611 0 0 13.3502 12.4619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31483 TIA1_HUMAN "Cytotoxic granule associated RNA binding protein TIA1 (Nucleolysin TIA-1 isoform p40) (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1, TIA-1) (p40-TIA-1)" TIA1 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; negative regulation of cytokine production [GO:0001818]; negative regulation of translation [GO:0017148]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; stress granule assembly [GO:0034063]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; negative regulation of cytokine production [GO:0001818]; negative regulation of translation [GO:0017148]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; stress granule assembly [GO:0034063]" GO:0000381; GO:0001818; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0006915; GO:0008143; GO:0008380; GO:0010494; GO:0017148; GO:0034063; GO:0035925; GO:0048024; GO:0097165; GO:1903608 mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723] GYGFVSFFNK 0.91604 1.3103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1D0 BWR1B_HUMAN "Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein (Organic cation transporter-like protein 2 antisense protein) (Solute carrier family 22 member 1-like antisense protein) (Solute carrier family 22 member 18 antisense protein) (p27-Beckwith-Wiedemann region 1 B, p27-BWR1B)" SLC22A18AS BWR1B BWSCR1B ORCTL2S SLC22A1LS Homo sapiens (Human) ITGKCLSVCSEENAK 0.91604 1.4194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3806 0 0 0 0 0 0 0 0 0 0 0 12.2231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9807 0 0 0 0 0 0 0 0 0 0 0 11.8576 0 0 0 0 0 0 0 11.274 0 0 0 0 0 11.8489 0 0 11.7798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6558 11.2227 0 0 0 0 P0DSN6 T2R33_HUMAN "Putative taste receptor type 2 member 33, T2R33, hGR33" TAS2R33 Homo sapiens (Human) sensory perception of taste [GO:0050909] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of taste [GO:0050909] GO:0004930; GO:0005886; GO:0016021; GO:0050909 G protein-coupled receptor activity [GO:0004930] EYEGNVTWKIKLR 0.91608 1.3874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7669 0 0 0 0 0 0 0 0 0 0 0 0 10.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFJ6 PKR2_HUMAN "Prokineticin receptor 2, PK-R2 (G-protein coupled receptor 73-like 1) (G-protein coupled receptor I5E) (GPR73b) (GPRg2)" PROKR2 GPR73L1 PKR2 Homo sapiens (Human) circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0007186; GO:0007623 G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983] ISRELWFK 0.91608 1.3027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7169 12.4871 0 12.3458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8468 14.0993 0 0 0 0 0 0 0 0 0 13.5707 0 0 0 12.9547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1397 0 0 0 0 0 0 0 0 0 0 13.7624 0 0 0 0 0 0 0 0 Q96KA5 CLP1L_HUMAN "Lipid scramblase CLPTM1L (Cisplatin resistance-related protein 9, CRR9p) (Cleft lip and palate transmembrane protein 1-like protein, CLPTM1-like protein)" CLPTM1L CRR9 Homo sapiens (Human) apoptotic process [GO:0006915] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid scramblase activity [GO:0017128]; apoptotic process [GO:0006915] GO:0005789; GO:0006915; GO:0016020; GO:0016021; GO:0017128 phospholipid scramblase activity [GO:0017128] GLMPEFQFGTYSESER 0.91608 5.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2396 0 0 0 0 0 0 0 0 0 0 10.3325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8264 0 0 0 13.4083 12.6956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8708 0 0 0 0 0 0 0 13.5245 0 10.8712 0 10.6221 0 0 0 0 0 0 10.4107 0 10.041 0 0 11.5783 0 0 11.8224 0 0 10.9047 12.4125 0 0 12.7383 0 0 13.4405 0 0 0 13.1876 11.1117 11.1706 0 0 0 12.7129 0 13.1857 0 0 12.2302 11.377 0 0 0 0 0 0 0 0 0 0 0 13.2349 0 12.0587 0 0 0 0 0 0 9.98285 0 0 10.8653 0 0 0 0 0 0 0 9.36363 0 0 0 0 0 0 13.3544 0 0 0 0 Q86X40 LRC28_HUMAN Leucine-rich repeat-containing protein 28 LRRC28 UNQ436/PRO867 Homo sapiens (Human) ELQTLDISTNRLLTLPERLHMCLSLQYLTVDR 0.91611 1.2942 0 0 12.6049 0 0 0 0 14.7324 0 0 0 0 0 0 0 0 0 0 0 0 11.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6359 0 0 0 0 0 0 0 0 16.7545 0 0 0 17.4694 0 0 11.7328 0 0 16.8912 0 0 16.9848 0 0 0 0 0 0 0 12.9475 0 13.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2784 0 0 15.4528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.925 0 0 0 13.0752 0 Q5TAH2 SL9C2_HUMAN "Sodium/hydrogen exchanger 11 (Na(+)/H(+) exchanger 11, NHE-11) (Solute carrier family 9 member 11) (Solute carrier family 9 member C2)" SLC9C2 SLC9A11 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] GO:0005886; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] DVVIALK 0.91613 5.346 12.9578 11.9585 12.9218 0 0 0 0 0 13.5684 12.7964 0 14.1191 12.7679 0 0 0 0 0 12.763 0 0 16.3665 0 16.2067 0 0 12.2356 9.78865 0 0 0 13.339 0 0 12.2973 0 13.1469 0 0 0 10.8153 0 0 0 0 0 0 0 14.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5308 0 0 0 0 11.4637 11.175 0 0 10.4939 11.1174 0 14.6055 15.2838 14.8188 13.7363 15.4596 0 0 0 13.2164 14.2639 15.6387 14.7007 15.0218 14.942 15.7227 15.4941 15.3063 15.4422 0 15.3957 13.3143 16.5405 16.0289 15.7612 16.9544 15.3459 15.5955 14.3053 15.2582 15.3491 15.3736 15.3945 14.6728 0 15.6439 14.5324 15.2155 14.4405 13.5237 15.9868 15.6401 14.7987 15.3043 16.2094 0 15.3382 16.3408 14.056 15.5213 14.425 15.5542 14.6697 0 14.9019 16.5219 14.0092 14.6389 14.2641 12.5585 0 13.5495 14.0251 0 14.653 14.7016 0 13.6641 0 0 0 11.2943 0 12.801 0 9.75939 15.22 15.0655 12.208 13.7977 10.722 0 11.2671 0 12.1546 0 11.544 13.2069 12.338 0 0 0 13.1346 0 13.8397 13.8396 0 14.5904 0 0 0 13.7297 12.1314 O95835 LATS1_HUMAN "Serine/threonine-protein kinase LATS1, EC 2.7.11.1 (Large tumor suppressor homolog 1) (WARTS protein kinase, h-warts)" LATS1 WARTS Homo sapiens (Human) cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819] GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005815; GO:0005829; GO:0006468; GO:0009755; GO:0017015; GO:0018105; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033138; GO:0033146; GO:0035329; GO:0035556; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051220; GO:0051301; GO:0060644; GO:0090090; GO:0106310; GO:1900181; GO:2000058 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AKMDKSMFVK 0.91615 1.4814 0 0 0 0 0 0 0 0 0 11.2341 11.1967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7737 0 0 0 0 0 10.5843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8532 0 0 11.9199 0 0 11.7816 0 0 0 0 0 12.7891 0 0 0 0 0 0 0 0 0 12.2569 0 11.0581 0 13.986 12.8647 12.6128 0 0 13.1128 0 0 0 13.1187 12.3048 0 0 0 0 11.6939 0 0 0 0 0 0 0 0 11.9077 0 12.7156 0 0 0 12.1547 0 0 13.7207 0 13.9269 0 0 0 0 0 0 0 0 0 12.2213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9022 0 0 0 P60370 KR105_HUMAN Keratin-associated protein 10-5 (High sulfur keratin-associated protein 10.5) (Keratin-associated protein 10.5) (Keratin-associated protein 18-5) (Keratin-associated protein 18.5) KRTAP10-5 KAP10.5 KAP18-5 KRTAP10.5 KRTAP18-5 KRTAP18.5 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; identical protein binding [GO:0042802] GO:0005829; GO:0042802; GO:0045095 identical protein binding [GO:0042802] AACTMSVCSSACSDSWR 0.91616 1.3515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYV1 AGT2_HUMAN "Alanine--glyoxylate aminotransferase 2, mitochondrial, AGT 2, EC 2.6.1.44 ((R)-3-amino-2-methylpropionate--pyruvate transaminase, EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)" AGXT2 AGT2 Homo sapiens (Human) "glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]" mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429]" GO:0005739; GO:0005759; GO:0008453; GO:0009436; GO:0019265; GO:0019481; GO:0030170; GO:0045429; GO:0047305 (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170] CSCAPDCCQAK 0.91617 1.294 0 0 10.2981 0 0 0 0 11.8447 13.5895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4885 11.8947 12.4848 12.3561 0 0 0 0 0 13.4159 0 13.5965 0 0 0 0 0 0 0 0 12.6272 0 0 0 0 0 0 0 0 0 12.0036 0 0 0 11.9767 14.4442 0 0 0 0 12.1046 0 13.5236 0 0 0 11.7581 0 0 0 0 12.9584 13.4169 14.539 0 0 0 12.313 0 14.5186 12.9379 12.7834 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 0 0 0 12.8188 0 0 0 14.2862 0 13.7533 0 0 14.6727 0 0 0 0 0 0 13.3424 12.2525 0 0 12.6326 0 0 13.9454 0 0 0 13.1082 0 0 0 0 0 0 0 14.0107 0 0 13.8447 0 0 14.9267 0 11.8721 12.0191 13.6888 13.83 0 0 0 0 12.0943 0 0 0 0 0 12.9822 0 0 0 0 13.8967 14.3296 0 12.472 0 0 0 0 0 0 0 0 0 0 P31268 HXA7_HUMAN Homeobox protein Hox-A7 (Homeobox protein Hox 1.1) (Homeobox protein Hox-1A) HOXA7 HOX1A Homo sapiens (Human) "angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]" chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001953; GO:0002686; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0031965; GO:0043565; GO:0045617; GO:0045656; GO:0045892; GO:0045944; GO:0048704; GO:0048863; GO:0140297; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ADEEDDDEEEEDEEE 0.9162 1.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1271 0 0 0 0 14.4662 0 0 0 0 9.43584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0819 0 0 0 0 0 0 0 0 0 0 O94886 CSCL1_HUMAN CSC1-like protein 1 (Transmembrane protein 63A) TMEM63A KIAA0489 KIAA0792 Homo sapiens (Human) centriolar satellite [GO:0034451]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] centriolar satellite [GO:0034451]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; nucleic acid binding [GO:0003676]; osmolarity-sensing cation channel activity [GO:1990760] GO:0003676; GO:0005227; GO:0005765; GO:0005886; GO:0008381; GO:0016021; GO:0034451; GO:0035579; GO:0043231; GO:0070062; GO:0070821; GO:1990760 calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; nucleic acid binding [GO:0003676]; osmolarity-sensing cation channel activity [GO:1990760] ELYTSKWTVTFAADPEDICWK 0.91629 1.1797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0111 0 0 0 0 0 0 15.087 0 0 15.6685 14.9542 0 11.8244 0 0 0 0 15.2209 0 0 0 15.51 0 0 0 0 0 15.7353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62072 TIM10_HUMAN Mitochondrial import inner membrane translocase subunit Tim10 TIMM10 TIM10 Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] GO:0005739; GO:0005743; GO:0005744; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0032977; GO:0042719; GO:0042721; GO:0042803; GO:0045039; GO:0051087 chaperone binding [GO:0051087]; membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] LTELSMQDEELMK 0.9163 1.4315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SXY7 LRIT3_HUMAN "Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3" LRIT3 Homo sapiens (Human) regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; response to stimulus [GO:0050896]; visual perception [GO:0007601] dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204] dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005789; GO:0007601; GO:0016021; GO:0030425; GO:0040036; GO:0043204; GO:0050896 ETYIQFETLFPRSQSVGELWTRSHR 0.91632 1.1796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0063 0 0 0 0 0 0 0 0 0 0 0 0 14.7707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2499 0 12.2772 0 0 0 0 0 0 11.6791 0 0 13.0564 0 0 0 12.8043 0 0 0 0 0 0 0 13.0767 0 0 0 0 0 0 0 0 0 13.8701 12.9858 13.0117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VXJ0 LIPK_HUMAN "Lipase member K, EC 3.1.1.- (Lipase-like abhydrolase domain-containing protein 2)" LIPK LIPL2 Homo sapiens (Human) cornification [GO:0070268]; lipid catabolic process [GO:0016042] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lipoprotein lipase activity [GO:0004465]; cornification [GO:0070268]; lipid catabolic process [GO:0016042] GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268 lipoprotein lipase activity [GO:0004465] KIKIFFALAPVVTVK 0.91633 1.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6073 0 0 11.1927 0 0 0 0 13.934 0 0 0 12.7852 0 0 0 0 0 0 0 0 0 13.2507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4043 18.3113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZX3 CHST6_HUMAN "Carbohydrate sulfotransferase 6 (Corneal N-acetylglucosamine-6-O-sulfotransferase, C-GlcNAc6ST, hCGn6ST, EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta, GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5, GlcNAc6ST-5, Gn6st-5)" CHST6 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0016021; GO:0018146; GO:0045130 keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517] GLNGFTWASSTASHPR 0.91633 1.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7498 0 0 0 Q9NXR5 ANR10_HUMAN Ankyrin repeat domain-containing protein 10 ANKRD10 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 CLEDSEDFGVK 0.91634 1.4155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1986 0 11.2351 0 0 0 0 0 0 16.8184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H867 MT21D_HUMAN "Protein N-lysine methyltransferase METTL21D, EC 2.1.1.- (Methyltransferase-like protein 21D) (VCP lysine methyltransferase, VCP-KMT) (Valosin-containing protein lysine methyltransferase)" VCPKMT C14orf138 METTL21D Homo sapiens (Human) negative regulation of ATP-dependent activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of ATP-dependent activity [GO:0032780]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] GO:0005737; GO:0005829; GO:0006479; GO:0016279; GO:0018022; GO:0018023; GO:0032780; GO:0032991; GO:0051117 ATPase binding [GO:0051117]; protein-lysine N-methyltransferase activity [GO:0016279] MNINMNKHLVTGSVQAK 0.91635 1.1795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KV6 BT2A3_HUMAN Putative butyrophilin subfamily 2 member A3 BTN2A3P BTN2A3 Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0005102; GO:0009897; GO:0016021; GO:0050852 signaling receptor binding [GO:0005102] RKYWALTSLK 0.91636 1.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 11.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14662 STX16_HUMAN "Syntaxin-16, Syn16" STX16 Homo sapiens (Human) "Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031985; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471; GO:0090161 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] ATRRLTDAFLLLR 0.91642 1.3028 14.8455 15.9305 0 0 0 0 0 0 0 0 0 0 13.8421 0 0 0 0 0 14.5387 12.0746 0 15.3161 0 0 0 12.8434 12.0565 0 0 12.2109 12.3106 12.738 0 0 0 0 11.4116 0 0 0 12.3907 14.301 0 0 0 0 0 0 0 0 0 0 0 0 10.4732 0 0 0 0 0 0 0 0 0 0 0 11.4743 0 0 0 0 0 0 0 0 13.1182 0 12.6299 13.8658 15.6991 0 0 0 11.4573 0 0 12.3587 0 0 13.0227 0 0 0 11.5558 0 11.2735 0 0 0 0 12.6521 14.0135 0 14.4088 0 14.0267 0 13.8515 13.6136 0 14.5904 0 13.8646 0 0 0 0 0 0 0 15.3318 0 0 0 14.0434 10.6887 13.3396 0 0 12.8527 0 13.6363 14.526 14.1971 12.7051 13.7909 12.2982 16.1096 0 14.3002 14.4313 15.1953 14.6346 12.5287 13.5023 0 0 0 13.9707 0 0 0 0 13.4596 0 0 0 12.8512 0 0 0 13.8544 13.1908 0 0 11.7683 14.0857 0 0 0 12.6051 13.2437 12.1484 12.6241 0 13.7356 0 17.1117 0 0 Q02747 GUC2A_HUMAN "Guanylin (Guanylate cyclase activator 2A) (Guanylate cyclase-activating protein 1) (Guanylate cyclase-activating protein I, GCAP-I) [Cleaved into: HMW-guanylin; Guanylin ]" GUCA2A GUCA2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; guanylate cyclase activator activity [GO:0030250]; hormone activity [GO:0005179] GO:0005179; GO:0005576; GO:0030250 guanylate cyclase activator activity [GO:0030250]; hormone activity [GO:0005179] LEEIAEDPGTCEICAYAACTGC 0.91644 1.3875 0 0 0 0 0 10.3006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z419 R144B_HUMAN "E3 ubiquitin-protein ligase RNF144B, EC 2.3.2.31 (IBR domain-containing protein 2) (RING finger protein 144B) (p53-inducible RING finger protein)" RNF144B IBRDC2 P53RFP Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016021; GO:0031624; GO:0031966; GO:0032436; GO:0043066; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] HTFCWYCLQNLDNDIFLR 0.91645 1.3334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7666 0 10.9404 0 0 0 0 0 0 0 0 0 11.8365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9557 0 12.0578 0 0 0 0 0 0 0 0 11.7631 0 0 0 0 0 0 0 11.5968 11.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1218 0 0 12.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8137 0 0 0 12.401 0 0 0 0 0 0 0 0 11.5849 12.0881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V40 TIKI1_HUMAN "Metalloprotease TIKI1, EC 3.4.-.- (TRAB domain-containing protein 2A)" TRABD2A C2orf89 TIKI1 Homo sapiens (Human) head development [GO:0060322]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]; head development [GO:0060322]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] GO:0004175; GO:0004222; GO:0005887; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031301; GO:0031334; GO:0046872; GO:0060322; GO:1904808 endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147] GLYADYLFNAIAGNWERKR 0.91645 1.2946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PGQ1 DRIC1_HUMAN Aspartate-rich protein 1 DRICH1 C22orf43 Homo sapiens (Human) DEEEEDDDDIHITAR 0.91649 1.4828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5356 0 0 0 0 0 0 0 0 0 12.619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08912 ACM5_HUMAN Muscarinic acetylcholine receptor M5 CHRM5 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transmission of nerve impulse [GO:0019226]" anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; phosphatidylinositol phospholipase C activity [GO:0004435]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transmission of nerve impulse [GO:0019226]" GO:0001696; GO:0004435; GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007197; GO:0007213; GO:0007268; GO:0015872; GO:0016907; GO:0019226; GO:0030425; GO:0030594; GO:0045202; GO:0045211; GO:0060304; GO:0070161 G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; phosphatidylinositol phospholipase C activity [GO:0004435] KTFKMLLLCR 0.91651 1.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDZ6 T161B_HUMAN Transmembrane protein 161B TMEM161B UNQ679/PRO1313 Homo sapiens (Human) regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate [GO:0002027] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate [GO:0002027] GO:0002027; GO:0005886; GO:0016021; GO:0098901 MKVTVTQITVALSSLKNIFTPLLFR 0.91653 1.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7212 0 0 0 0 0 12.3973 0 0 17.4047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SVJ3 CA100_HUMAN Uncharacterized protein C1orf100 C1orf100 Homo sapiens (Human) APRPLIDLTIPPK 0.91657 1.3508 0 0 0 10.3208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VZ4 LRP11_HUMAN "Low-density lipoprotein receptor-related protein 11, LRP-11" LRP11 Homo sapiens (Human) multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414] GO:0005886; GO:0009408; GO:0009409; GO:0009414; GO:0009612; GO:0016021; GO:0033555; GO:0035902; GO:0042594; GO:0051219 phosphoprotein binding [GO:0051219] GWRQCVAACCSEPR 0.9166 1.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61952 GBG11_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 GNG11 GNGT11 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] GO:0003924; GO:0005834; GO:0005886; GO:0007165; GO:0007186; GO:0031681 G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924] EVKLQRQQVSK 0.91661 1.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX65 ZSC32_HUMAN "Zinc finger and SCAN domain-containing protein 32 (Human cervical cancer suppressor gene 5 protein, HCCS-5) (Zinc finger protein 434)" ZSCAN32 ZNF434 HCCS5 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FNNSSQFSAHR 0.91661 1.1605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KJ9 COX42_HUMAN "Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (Cytochrome c oxidase subunit IV isoform 2, COX IV-2)" COX4I2 COX4L2 Homo sapiens (Human) "cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751] "integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" GO:0004129; GO:0005751; GO:0006091; GO:0006123; GO:0016021; GO:0045333 cytochrome-c oxidase activity [GO:0004129] KAQQLQR 0.91663 1.3502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2474 0 0 13.5701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7911 0 12.6371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3233 13.5308 0 0 13.5764 0 0 0 0 0 0 0 13.4995 0 0 0 0 A0A0C4DH33 HV124_HUMAN Immunoglobulin heavy variable 1-24 IGHV1-24 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] DCTWRILFLVAAATGTHAQVQLVQSGAEVK 0.91664 1.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBJ7 SUMF2_HUMAN "Inactive C-alpha-formylglycine-generating enzyme 2 (Paralog of formylglycine-generating enzyme, pFGE) (Sulfatase-modifying factor 2)" SUMF2 PSEC0171 UNQ1968/PRO4500 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GO:0005783; GO:0005788; GO:0042802; GO:0046872 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] ARHGLPLLPLLSLLVGAWLK 0.91664 1.2986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95274 LYPD3_HUMAN "Ly6/PLAUR domain-containing protein 3 (GPI-anchored metastasis-associated protein C4.4A homolog) (Matrigel-induced gene C4 protein, MIG-C4)" LYPD3 C4.4A UNQ491/PRO1007 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; negative regulation of smooth muscle cell apoptotic process [GO:0034392] anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; laminin binding [GO:0043236]; cell-matrix adhesion [GO:0007160]; negative regulation of smooth muscle cell apoptotic process [GO:0034392] GO:0005576; GO:0005615; GO:0005886; GO:0007160; GO:0016021; GO:0034392; GO:0043236; GO:0046658 laminin binding [GO:0043236] GGAQALECYSCVQKADDGCSPNK 0.91667 1.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6L8H2 KRA53_HUMAN Keratin-associated protein 5-3 (Keratin-associated protein 5-9) (Keratin-associated protein 5.3) (Keratin-associated protein 5.9) (UHS KerB-like) (Ultrahigh sulfur keratin-associated protein 5.3) KRTAP5-3 KAP5-9 KAP5.3 KRTAP5-9 KRTAP5.3 KRTAP5.9 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GGCGSCGCSQCSCYK 0.91667 5.3358 0 0 0 0 0 10.3995 0 0 0 0 0 13.6649 15.2458 0 0 0 0 0 0 0 11.9869 0 14.1004 13.4667 0 0 0 10.9915 0 0 0 0 0 0 0 0 0 12.304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.139 0 0 0 0 0 11.1781 0 0 12.9543 0 0 0 10.9022 12.0589 0 0 12.5308 13.2383 0 11.2077 0 0 0 0 0 0 0 0 12.7442 0 0 11.939 0 13.0206 0 0 0 0 0 0 0 0 0 0 11.2454 14.3064 0 12.7255 0 0 0 0 13.8482 12.8024 0 0 13.7641 0 0 12.3141 12.9326 0 0 0 13.3784 0 0 0 0 0 0 12.2411 13.6736 0 0 0 12.8729 0 0 0 0 0 0 0 0 12.9255 0 0 0 0 0 0 0 12.0429 11.9587 0 0 0 12.8431 0 12.5872 0 11.4843 0 0 0 0 0 12.8334 0 0 0 Q86WV1 SKAP1_HUMAN "Src kinase-associated phosphoprotein 1 (Src family-associated phosphoprotein 1) (Src kinase-associated phosphoprotein of 55 kDa, SKAP-55, pp55)" SKAP1 SCAP1 SKAP55 Homo sapiens (Human) "adaptive immune response [GO:0002250]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of integrin activation [GO:0033625]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852]" cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; T cell receptor complex [GO:0042101] "cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; T cell receptor complex [GO:0042101]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; adaptive immune response [GO:0002250]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of integrin activation [GO:0033625]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852]" GO:0001772; GO:0001954; GO:0002250; GO:0002821; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0017124; GO:0019901; GO:0019903; GO:0033625; GO:0033634; GO:0034116; GO:0042101; GO:0042169; GO:0044853; GO:0045893; GO:0045944; GO:0050852; GO:0072659; GO:1903039 protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124] DLSSLTIPYEEDEEEEEKEETYDDIDGFDSPSCGSQCR 0.91667 1.3201 12.8422 0 0 0 0 0 0 13.556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9846 13.8296 0 0 12.9886 0 14.6722 0 14.4902 14.3065 14.7424 15.7946 15.4376 0 0 14.9418 13.246 0 0 15.7803 0 0 0 0 0 0 0 0 0 14.6377 15.065 0 15.2876 14.3622 0 14.6299 0 14.6129 14.521 14.4858 0 0 0 0 0 0 0 0 14.2834 0 0 0 0 0 12.7263 0 0 0 13.183 0 0 11.8947 12.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1665 14.4877 0 0 0 0 0 0 Q075Z2 BSPH1_HUMAN Binder of sperm protein homolog 1 (Bovine seminal plasma protein homolog 1) (Bovine seminal plasma protein-like 1) BSPH1 Homo sapiens (Human) single fertilization [GO:0007338]; sperm capacitation [GO:0048240] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240] GO:0005576; GO:0007338; GO:0008201; GO:0009986; GO:0048240 heparin binding [GO:0008201] RLIYWECTDDGEAFGK 0.91673 1.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.926 0 0 12.5171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5648 0 0 0 0 0 P56746 CLD15_HUMAN Claudin-15 CLDN15 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811] GO:0005198; GO:0005886; GO:0005923; GO:0006811; GO:0007155; GO:0016021; GO:0016328; GO:0016338; GO:0042802; GO:0070830 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] ALMITAILLGFLGLLLGIAGLR 0.91676 1.3044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2661 0 0 0 13.5785 0 0 0 0 0 0 11.3712 0 0 13.2479 0 0 15.1907 14.93 0 0 0 0 0 0 14.4029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6976 0 12.4495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J275 TVA17_HUMAN T cell receptor alpha variable 17 TRAV17 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 AADTASYFCATD 0.91679 1.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7474 0 0 0 0 0 13.5753 0 0 0 0 0 0 0 0 0 0 0 0 13.4984 0 0 0 0 0 13.0977 0 0 0 0 0 0 0 10.9012 0 0 0 0 0 0 0 0 0 10.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13148 TADBP_HUMAN "TAR DNA-binding protein 43, TDP-43" TARDBP TDP43 Homo sapiens (Human) 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380] cytoplasmic stress granule [GO:0010494]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasmic stress granule [GO:0010494]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380] GO:0000978; GO:0001933; GO:0003690; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005739; GO:0006397; GO:0008380; GO:0010468; GO:0010494; GO:0010629; GO:0031647; GO:0042307; GO:0042752; GO:0042802; GO:0042981; GO:0043922; GO:0048511; GO:0051726; GO:0061158; GO:0070935; GO:0071765; GO:0097157 double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] HMIDGRWCDCK 0.91679 1.3335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3831 0 0 0 0 14.4471 0 0 0 13.7024 0 0 12.848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15240 VGF_HUMAN "Neurosecretory protein VGF [Cleaved into: Neuroendocrine regulatory peptide-1, NERP-1; Neuroendocrine regulatory peptide-2, NERP-2; VGF-derived peptide TLQP-21; VGF-derived peptide TLQP-62; Antimicrobial peptide VGF[554-577] ]" VGF Homo sapiens (Human) carbohydrate homeostasis [GO:0033500]; defense response to bacterium [GO:0042742]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; ovarian follicle development [GO:0001541]; penile erection [GO:0043084]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to insulin [GO:0032868]; sexual reproduction [GO:0019953] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; transport vesicle [GO:0030133] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; transport vesicle [GO:0030133]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; carbohydrate homeostasis [GO:0033500]; defense response to bacterium [GO:0042742]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; ovarian follicle development [GO:0001541]; penile erection [GO:0043084]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to insulin [GO:0032868]; sexual reproduction [GO:0019953] GO:0001541; GO:0002021; GO:0005179; GO:0005184; GO:0005615; GO:0005788; GO:0005794; GO:0006091; GO:0008083; GO:0009409; GO:0019953; GO:0030073; GO:0030133; GO:0030667; GO:0031410; GO:0032868; GO:0033500; GO:0042593; GO:0042742; GO:0043005; GO:0043025; GO:0043084; GO:0043231; GO:0045202; GO:0048167; GO:0048168; GO:0051591 growth factor activity [GO:0008083]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184] ALRLSASALFCLLLINGLGAAPPGR 0.9168 1.3876 0 0 0 0 0 0 0 13.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8704 0 12.9828 14.1295 0 14.6626 10.3437 13.6917 0 0 0 0 0 0 0 0 13.1101 0 0 0 0 0 15.6357 0 0 0 0 0 0 0 0 0 0 0 0 13.6582 14.4091 0 0 14.4622 0 0 14.7873 0 12.8369 0 0 0 0 13.0788 14.0707 0 13.9793 0 0 0 0 0 0 0 13.6672 15.0805 13.9112 13.7532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B734 AQP7B_HUMAN Aquaporin-7B AQP7B Homo sapiens (Human) glycerol transmembrane transport [GO:0015793]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; glycerol transmembrane transport [GO:0015793]; water transport [GO:0006833] GO:0005886; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016021; GO:0016323 glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] DPPPSIFTFIAGWGK 0.91685 1.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15858 SCN9A_HUMAN "Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel, hNE-Na) (Peripheral sodium channel 1, PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7)" SCN9A NENA Homo sapiens (Human) behavioral response to formalin induced pain [GO:0061368]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; negative regulation of action potential [GO:0045759]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; behavioral response to formalin induced pain [GO:0061368]; inflammatory response [GO:0006954]; membrane depolarization during action potential [GO:0086010]; negative regulation of action potential [GO:0045759]; neuronal action potential [GO:0019228]; post-embryonic development [GO:0009791]; regulation of ion transmembrane transport [GO:0034765]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006814; GO:0006954; GO:0009408; GO:0009409; GO:0009636; GO:0009791; GO:0019228; GO:0019233; GO:0030424; GO:0031402; GO:0034765; GO:0035725; GO:0045759; GO:0061368; GO:0086010 sodium ion binding [GO:0031402]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] ALKTISVIPGLK 0.91687 1.4829 0 0 0 0 0 0 9.71058 0 0 0 0 0 13.2949 14.7081 0 0 0 0 0 0 0 0 0 0 11.7568 0 0 0 9.68233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2724 15.8047 0 0 0 0 0 0 0 0 0 0 0 0 12.4961 0 0 12.3365 0 0 0 0 13.4402 13.2582 0 14.3218 14.0097 14.4437 0 0 12.3959 0 0 0 17.9282 0 0 13.1952 12.2217 12.1791 14.2524 0 0 11.9062 12.5614 0 0 13.0378 0 0 0 0 12.7326 0 0 0 0 0 12.932 0 0 0 0 0 0 0 0 14.4696 13.5275 0 11.4401 0 13.8561 0 0 0 0 0 0 0 13.7075 0 0 0 12.7247 10.6263 0 0 0 13.1775 0 12.4119 0 0 14.4687 12.517 0 14.3101 0 0 11.2729 0 0 0 0 0 0 0 0 12.8262 0 0 0 0 0 0 0 0 13.0581 0 0 0 0 0 Q9Y2L8 ZKSC5_HUMAN "Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog, Zfp-95)" ZKSCAN5 KIAA1015 ZFP95 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CGECGKSYNQRVHLTQHQR 0.91692 1.161 0 0 0 0 0 0 0 11.7833 0 0 0 0 0 0 0 0 0 0 12.0364 0 0 0 13.3137 0 13.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8869 0 0 12.2045 12.094 0 12.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7688 15.7602 0 12.7546 12.3506 0 0 0 0 15.7667 0 0 0 0 0 15.7303 15.8449 0 0 0 0 0 0 0 12.5216 0 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6697 0 0 0 0 0 0 12.2545 0 0 0 0 0 0 A6NK44 GLOD5_HUMAN Glyoxalase domain-containing protein 5 GLOD5 Homo sapiens (Human) LRHLPSRLPVK 0.91698 1.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8232 0 0 0 11.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17658 KCNA6_HUMAN Potassium voltage-gated channel subfamily A member 6 (Voltage-gated potassium channel HBK2) (Voltage-gated potassium channel subunit Kv1.6) KCNA6 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076] axon terminus [GO:0043679]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0034705; GO:0034765; GO:0043679; GO:0051260; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] GIAIVSVLVILISIVIFCLETLPQFR 0.91698 1.2993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95390 GDF11_HUMAN "Growth/differentiation factor 11, GDF-11 (Bone morphogenetic protein 11, BMP-11)" GDF11 BMP11 Homo sapiens (Human) amacrine cell differentiation [GO:0035881]; camera-type eye morphogenesis [GO:0048593]; cell population proliferation [GO:0008283]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; type B pancreatic cell maturation [GO:0072560]; ureteric bud development [GO:0001657] extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; amacrine cell differentiation [GO:0035881]; camera-type eye morphogenesis [GO:0048593]; cell population proliferation [GO:0008283]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; type B pancreatic cell maturation [GO:0072560]; ureteric bud development [GO:0001657] GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0005654; GO:0007399; GO:0007498; GO:0008083; GO:0008283; GO:0008285; GO:0010862; GO:0021512; GO:0032991; GO:0035881; GO:0043231; GO:0048593; GO:0060021; GO:0060395; GO:0072560; GO:1902870 cytokine activity [GO:0005125]; growth factor activity [GO:0008083] ANYCSGQCEYMFMQKYPHTHLVQQANPR 0.91699 1.3506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3183 0 0 0 0 0 0 0 0 0 12.6321 0 0 0 0 0 0 13.6117 12.7484 0 0 0 12.0082 0 0 0 0 0 14.942 0 0 11.1159 0 13.2883 14.1956 0 11.3095 0 0 0 0 0 0 10.7036 0 0 0 0 12.0711 0 0 0 12.6628 0 10.3237 0 11.6798 0 0 13.6024 0 0 0 0 0 0 0 0 11.8638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5225 0 0 13.876 0 12.7977 12.9248 14.0696 0 0 0 0 0 0 0 14.6931 0 0 0 0 0 10.5217 0 0 0 11.8371 0 11.538 Q2T9L4 INSY1_HUMAN "Inhibitory synaptic factor 1, InSyn1" INSYN1 C15orf59 Homo sapiens (Human) inhibitory postsynaptic potential [GO:0060080] anchoring junction [GO:0070161]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; postsynaptic density [GO:0014069]; inhibitory postsynaptic potential [GO:0060080] GO:0014069; GO:0060080; GO:0070161 LMNGGTPIPNGPR 0.91701 1.3288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9225 12.6905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9647 13.1698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7419 0 0 P78426 NKX61_HUMAN Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A) NKX6-1 NKX6A Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system neuron differentiation [GO:0021953]; detection of glucose [GO:0051594]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; oligodendrocyte differentiation [GO:0048709]; pancreas development [GO:0031016]; pancreatic A cell differentiation [GO:0003310]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of axon extension [GO:0030516]; regulation of neuron migration [GO:2001222]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell maturation [GO:0072560]; type B pancreatic cell proliferation [GO:0044342] chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular response to cytokine stimulus [GO:0071345]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system neuron differentiation [GO:0021953]; detection of glucose [GO:0051594]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; oligodendrocyte differentiation [GO:0048709]; pancreas development [GO:0031016]; pancreatic A cell differentiation [GO:0003310]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of axon extension [GO:0030516]; regulation of neuron migration [GO:2001222]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell maturation [GO:0072560]; type B pancreatic cell proliferation [GO:0044342]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001764; GO:0003310; GO:0003682; GO:0005634; GO:0006357; GO:0006366; GO:0007224; GO:0009410; GO:0009887; GO:0021953; GO:0030154; GO:0030516; GO:0031016; GO:0032024; GO:0035094; GO:0044342; GO:0045666; GO:0045944; GO:0048709; GO:0048714; GO:0048715; GO:0051091; GO:0051594; GO:0070062; GO:0071345; GO:0071375; GO:0072560; GO:2000078; GO:2001222 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GASENEEEDDDYNK 0.91704 1.3116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5895 0 13.3257 0 13.0636 0 0 13.0048 0 0 0 0 0 0 0 13.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0676 0 0 0 0 0 0 Q5TEU4 NDUF5_HUMAN "Arginine-hydroxylase NDUFAF5, mitochondrial, EC 1.-.-.- (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5) (Putative methyltransferase NDUFAF5, EC 2.1.1.-)" NDUFAF5 C20orf7 Homo sapiens (Human) methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491]; methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine hydroxylation [GO:0030961] GO:0005739; GO:0005743; GO:0008168; GO:0016491; GO:0030961; GO:0031314; GO:0032259; GO:0032981 methyltransferase activity [GO:0008168]; oxidoreductase activity [GO:0016491] MLRPAGLWR 0.91707 1.1788 13.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9641 0 0 0 0 0 0 0 0 0 0 13.2496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N428 GLT16_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 16, EC 2.4.1.41 (Polypeptide GalNAc transferase 16, GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1, GalNAc-T-like protein 1, pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1)" GALNT16 GALNTL1 KIAA1130 Homo sapiens (Human) protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0018242; GO:0018243; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] EGKQKWR 0.91707 1.3055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3909 15.6024 15.3882 0 0 0 0 0 0 15.5816 0 0 0 0 0 0 0 0 0 0 15.3747 0 0 15.4606 0 0 10.9718 0 15.5663 0 0 0 0 0 0 0 0 0 0 0 15.518 0 0 0 0 0 13.4547 0 15.3372 0 0 0 0 0 0 0 0 0 15.3931 15.2046 0 15.4027 15.2961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0679 12.0437 0 0 0 0 0 0 0 0 0 12.8371 0 0 0 0 0 0 15.2011 11.5641 0 0 0 0 0 Q08623 HDHD1_HUMAN "Pseudouridine-5'-phosphatase, EC 3.1.3.96 (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase, 5'-PsiMPase)" PUDP DXF68S1E FAM16AX GS1 HDHD1 HDHD1A Homo sapiens (Human) nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] cytosol [GO:0005829]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117] GO:0005829; GO:0009117; GO:0016791; GO:0046872; GO:1990738 metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738] LKEVFPTAALMPGAEKLIIHLR 0.91712 1.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0777 0 0 0 0 0 11.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43493 TGON2_HUMAN "Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46, TGN38 homolog, hTGN46) (Trans-Golgi network glycoprotein 48, hTGN48) (Trans-Golgi network glycoprotein 51, hTGN51) (Trans-Golgi network protein 2)" TGOLN2 TGN46 TGN51 Homo sapiens (Human) clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] GO:0005654; GO:0005768; GO:0005788; GO:0005794; GO:0005802; GO:0005886; GO:0016021; GO:0030133; GO:0030140; GO:0030669 EAEDDDTGPEEGSPPKEEKEK 0.91713 1.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6474 11.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8972 0 0 14.5289 0 12.5619 12.387 0 0 0 0 0 0 0 12.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2187 0 0 0 0 0 0 0 0 0 0 0 11.7953 0 0 0 11.8221 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2079 0 0 0 Q6IF63 O52W1_HUMAN Olfactory receptor 52W1 (Olfactory receptor OR11-71) OR52W1 OR52W1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ACVGYAALALALKAVAIVVPFPLLVAK 0.91714 1.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1798 0 0 0 0 11.6995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.69 0 0 0 0 0 0 0 0 0 18.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCK7 MOT11_HUMAN "Monocarboxylate transporter 11, MCT 11 (Solute carrier family 16 member 11)" SLC16A11 MCT11 Homo sapiens (Human) lipid metabolic process [GO:0006629]; monocarboxylic acid transport [GO:0015718] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lipid metabolic process [GO:0006629]; monocarboxylic acid transport [GO:0015718] GO:0005789; GO:0005886; GO:0005887; GO:0006629; GO:0008028; GO:0015293; GO:0015718; GO:0016021; GO:0050833 monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] GALLLLGAITLHLTPCGALLLPLVLPGDPPAPPR 0.91716 1.3878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.279 0 12.7168 11.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6961 0 13.2388 0 14.5037 0 0 0 0 0 12.8306 0 0 0 13.3073 0 15.0714 13.6736 13.3722 0 12.5875 0 0 0 0 0 0 0 0 0 13.0886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZD1 GPC5D_HUMAN G-protein coupled receptor family C group 5 member D GPRC5D Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295] GO:0004930; GO:0005886; GO:0016021; GO:0030295; GO:0043231; GO:0043235; GO:0070062 G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295] LIFITVLFSIIIWVVWISMLLRGNPQFQR 0.91717 1.3261 13.5933 0 0 0 0 0 0 0 0 10.795 0 0 0 0 11.3297 0 0 0 0 0 0 0 12.2125 0 0 0 0 12.1285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8262 0 0 0 10.2866 0 0 0 12.1243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5749 0 0 0 0 11.9744 0 11.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0718 0 0 0 0 0 0 0 0 0 0 12.4181 0 0 0 0 0 0 0 0 0 P48454 PP2BC_HUMAN "Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform, EC 3.1.3.16 (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)" PPP3CC CALNA3 CNA3 Homo sapiens (Human) brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470] calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynapse [GO:0098793]; protein serine/threonine phosphatase complex [GO:0008287] calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; presynapse [GO:0098793]; protein serine/threonine phosphatase complex [GO:0008287]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470] GO:0004723; GO:0005516; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0007420; GO:0008287; GO:0017018; GO:0033173; GO:0033192; GO:0046872; GO:0070886; GO:0097720; GO:0098793; GO:0098978; GO:1900244; GO:1901386; GO:1901387; GO:1905665; GO:1905949 calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018] EVFENGKPKVDVLK 0.91719 1.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0908 0 0 0 0 12.725 0 0 10.4842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2745 0 0 0 0 0 0 0 0 0 0 13.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2883 0 0 0 0 12.4837 0 0 0 0 0 0 0 0 0 12.0216 0 0 0 0 0 0 0 0 0 P32247 BRS3_HUMAN "Bombesin receptor subtype-3, BRS-3" BRS3 Homo sapiens (Human) adult feeding behavior [GO:0008343]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose metabolic process [GO:0006006]; regulation of blood pressure [GO:0008217] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; adult feeding behavior [GO:0008343]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose metabolic process [GO:0006006]; regulation of blood pressure [GO:0008217] GO:0004930; GO:0004946; GO:0005886; GO:0005887; GO:0006006; GO:0007186; GO:0008188; GO:0008217; GO:0008343; GO:0016021; GO:0043005; GO:0043025 bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188] AQLFCCKAER 0.9172 1.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQR4 NIT2_HUMAN "Omega-amidase NIT2, EC 3.5.1.3 (Nitrilase homolog 2)" NIT2 CUA002 Homo sapiens (Human) asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; 2-oxoglutaramate amidase activity [GO:0106008]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107] GO:0005576; GO:0005813; GO:0005829; GO:0006107; GO:0006528; GO:0006541; GO:0035580; GO:0050152; GO:0070062; GO:0106008; GO:1904724 2-oxoglutaramate amidase activity [GO:0106008]; omega-amidase activity [GO:0050152] AGTEEAIVYSDIDLK 0.91721 1.1801 0 0 0 0 0 13.4971 0 12.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5885 0 0 0 0 0 0 0 0 0 0 0 13.7894 0 13.4286 0 0 0 0 12.9706 0 0 0 0 13.3625 0 0 0 0 0 0 13.7066 0 0 0 0 0 11.2135 0 0 0 0 0 0 0 12.8283 0 12.9958 0 0 12.5058 0 0 0 13.0898 13.3716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30556 AGTR1_HUMAN "Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor, AT1 receptor)" AGTR1 AGTR1A AGTR1B AT2R1 AT2R1B Homo sapiens (Human) angiotensin-activated signaling pathway [GO:0038166]; blood vessel diameter maintenance [GO:0097746]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; renin-angiotensin regulation of aldosterone production [GO:0002018]; Rho protein signal transduction [GO:0007266]; viral entry into host cell [GO:0046718] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; angiotensin type I receptor activity [GO:0001596]; angiotensin type II receptor activity [GO:0004945]; bradykinin receptor binding [GO:0031711]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; angiotensin-activated signaling pathway [GO:0038166]; blood vessel diameter maintenance [GO:0097746]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; renin-angiotensin regulation of aldosterone production [GO:0002018]; Rho protein signal transduction [GO:0007266]; viral entry into host cell [GO:0046718] GO:0001558; GO:0001596; GO:0001822; GO:0002018; GO:0002034; GO:0003081; GO:0004930; GO:0004945; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007200; GO:0007204; GO:0007266; GO:0010744; GO:0016021; GO:0019229; GO:0019722; GO:0031711; GO:0032430; GO:0033864; GO:0034374; GO:0035813; GO:0038166; GO:0042127; GO:0046718; GO:0046982; GO:0050727; GO:0050729; GO:0051247; GO:0051482; GO:0060326; GO:0086097; GO:0097746; GO:1903589; GO:1905920; GO:2000379 angiotensin type I receptor activity [GO:0001596]; angiotensin type II receptor activity [GO:0004945]; bradykinin receptor binding [GO:0031711]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982] KAYEIQKNK 0.91722 1.4842 0 0 0 0 0 0 0 0 0 0 12.8086 0 0 0 0 0 0 0 0 0 0 0 0 13.5013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5872 0 0 0 0 14.3047 0 0 14.6616 0 0 0 0 0 0 0 0 0 13.8807 0 0 0 0 0 0 14.383 0 0 13.941 13.92 0 0 0 13.5661 0 0 0 13.8446 0 14.0826 0 0 0 0 0 0 0 0 14.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43628 KI2L3_HUMAN "Killer cell immunoglobulin-like receptor 2DL3 (CD158 antigen-like family member B2) (KIR-023GB) (Killer inhibitory receptor cl 2-3) (NKAT2a) (NKAT2b) (Natural killer-associated transcript 2, NKAT-2) (p58 natural killer cell receptor clone CL-6, p58 NK receptor CL-6) (p58.2 MHC class-I-specific NK receptor) (CD antigen CD158b2)" KIR2DL3 CD158B2 KIRCL23 NKAT2 Homo sapiens (Human) immune response [GO:0006955] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; immune response [GO:0006955] GO:0003823; GO:0005886; GO:0005887; GO:0006955; GO:0016021; GO:0038023; GO:0042802 antigen binding [GO:0003823]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] HLHVLIGTSVVIILFILLLFFLLHR 0.91723 1.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN32 ETV3L_HUMAN ETS translocation variant 3-like protein ETV3L Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]" APPSPHLLLGAPALCR 0.91723 1.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43813 LANC1_HUMAN "Glutathione S-transferase LANCL1, EC 2.5.1.18 (40 kDa erythrocyte membrane protein, p40) (LanC-like protein 1)" LANCL1 GPR69A Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron death [GO:1903203] GO:0004364; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0005975; GO:0007186; GO:0008270; GO:0017124; GO:0043295; GO:0043523; GO:0050750; GO:1903203 G protein-coupled receptor activity [GO:0004930]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; low-density lipoprotein particle receptor binding [GO:0050750]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270] FAEWCLEYGEHGCR 0.91726 1.3228 0 0 0 0 0 9.71215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0361 0 0 0 0 10.9887 0 11.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7639 0 0 0 0 0 0 0 0 12.8001 0 0 0 0 12.5166 12.6098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3858 0 12.3587 0 0 0 0 0 0 0 0 0 0 Q86W67 F228A_HUMAN Protein FAM228A FAM228A C2orf84 Homo sapiens (Human) ARSKTYK 0.91726 1.3143 0 0 0 0 0 0 0 0 0 10.7712 0 10.9487 0 12.9334 0 0 0 0 0 0 0 0 10.4575 0 0 0 0 0 0 0 0 14.6362 0 0 0 0 0 13.2952 0 12.2773 14.0289 0 0 0 12.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5421 13.5 0 13.242 0 0 0 0 0 11.5031 0 0 12.3016 0 0 0 0 0 13.7021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9232 0 0 0 0 0 0 11.7507 0 0 0 0 0 15.5829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7478 0 0 0 0 12.4356 0 0 0 0 0 0 0 Q9H832 UBE2Z_HUMAN "Ubiquitin-conjugating enzyme E2 Z, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme Z) (Uba6-specific E2 conjugating enzyme 1, Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z)" UBE2Z HOYS7 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0006915; GO:0043065; GO:0043066; GO:0061631 ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631] CPCPEPLRGVMEKSFLEYYDFYEVACK 0.91726 1.4832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4411 0 0 0 11.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2496 0 0 0 0 0 0 0 0 0 0 12.3342 0 0 0 0 0 0 12.1305 0 0 13.1593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3589 0 0 0 0 0 0 0 Q8N535 CB052_HUMAN Putative uncharacterized protein encoded by LINC00471 LINC00471 C2orf52 Homo sapiens (Human) DEVLVPHKNCR 0.91729 1.3221 0 11.4417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3961 0 0 0 0 0 0 0 0 0 0 0 12.6263 0 0 0 P09496 CLCA_HUMAN "Clathrin light chain A, Lca" CLTA Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886] clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network membrane [GO:0032588] clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network membrane [GO:0032588]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886] GO:0005198; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0007049; GO:0016020; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030672; GO:0031410; GO:0032050; GO:0032588; GO:0036020; GO:0042277; GO:0044877; GO:0045334; GO:0048268; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0099631 clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] ELEEWYARQDEQLQK 0.9173 1.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00526 UPK2_HUMAN "Uroplakin-2, UP2 (Uroplakin II, UPII)" UPK2 Homo sapiens (Human) epithelial cell differentiation [GO:0030855] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; epithelial cell differentiation [GO:0030855] GO:0005887; GO:0016324; GO:0030855; GO:0070062 TGGMVVITVLLSVAMFLLVLGFIIALALGSRK 0.91732 1.1754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H86 ZN764_HUMAN Zinc finger protein 764 ZNF764 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EEWGCLR 0.91733 1.3295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8631 14.9894 13.6954 13.7405 0 14.1787 11.4835 0 0 0 0 0 0 0 0 0 14.1482 0 0 13.8924 0 0 0 0 13.8111 0 0 0 0 0 0 0 12.8269 0 12.4944 0 12.7628 0 0 13.6025 0 15.2619 0 0 13.2973 0 15.8824 0 0 15.426 0 0 15.2933 13.859 0 0 0 0 0 0 0 0 0 10.6745 11.959 0 0 0 12.2829 14.7731 14.2525 13.1823 0 0 13.4892 0 0 0 12.8868 0 0 0 0 0 0 0 14.4355 0 0 0 0 0 0 0 0 0 14.3097 0 0 0 0 0 0 0 P22033 MUTA_HUMAN "Methylmalonyl-CoA mutase, mitochondrial, MCM, EC 5.4.99.2 (Methylmalonyl-CoA isomerase)" MMUT MUT Homo sapiens (Human) "homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; propionate metabolic process, methylmalonyl pathway [GO:0019678]" cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; propionate metabolic process, methylmalonyl pathway [GO:0019678]" GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0009791; GO:0019678; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341 cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803] AGRRLWAHLIEK 0.91735 1.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7344 0 0 15.6407 0 17.3524 18.2527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1592 12.0766 0 0 0 0 0 0 0 0 0 16.2985 0 0 0 0 0 11.9696 12.1748 18.3916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4434 0 0 0 0 0 0 0 Q9Y6L7 TLL2_HUMAN "Tolloid-like protein 2, EC 3.4.24.-" TLL2 KIAA0932 Homo sapiens (Human) cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of skeletal muscle tissue growth [GO:0048632]; protein processing [GO:0016485] GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0048632 calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] ATALGALVSLLLLLPLPR 0.91735 1.1583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0895 13.2711 0 0 0 13.1853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3028 0 0 14.6175 0 12.4862 0 0 0 0 0 0 0 13.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2356 0 11.6364 0 13.0696 0 0 0 0 0 10.9791 11.7885 0 17.0699 0 0 0 0 0 0 0 0 0 0 0 13.3309 0 0 0 0 0 13.7202 0 15.1309 0 0 0 0 13.2676 0 13.2295 15.4294 14.7448 13.3794 0 0 0 0 13.6149 14.0158 0 0 0 0 14.1798 0 13.3849 0 0 11.8352 0 0 0 14.1945 0 0 0 0 0 0 0 0 0 11.4138 0 0 0 0 0 0 0 0 15.4488 12.0782 0 0 0 0 12.2599 15.4064 0 0 0 14.2717 0 0 13.275 13.4872 0 13.3708 10.9956 0 15.5412 12.0617 0 0 0 Q8NFJ5 RAI3_HUMAN "Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1, PEIG-1) (Retinoic acid-induced gene 1 protein, RAIG-1)" GPRC5A GPCR5A RAI3 RAIG1 Homo sapiens (Human) negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; signal transduction [GO:0007165] cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; vesicle [GO:0031982] cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; signal transduction [GO:0007165] GO:0004930; GO:0005730; GO:0005886; GO:0005887; GO:0007165; GO:0007175; GO:0030295; GO:0030659; GO:0031982; GO:0043231; GO:0043235; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295] AHAWPSPYKDYEVKK 0.91736 1.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PE5 OPALI_HUMAN Opalin (Oligodendrocytic myelin paranodal and inner loop protein) (Transmembrane protein 10) OPALIN HTMP10 TMEM10 Homo sapiens (Human) regulation of oligodendrocyte differentiation [GO:0048713] cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of oligodendrocyte differentiation [GO:0048713] GO:0005794; GO:0005886; GO:0016021; GO:0044291; GO:0048713 PCEISEIDDNPK 0.91738 1.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6151 0 0 0 0 0 0 0 0 0 15.5691 0 0 0 0 0 0 0 0 O95249 GOSR1_HUMAN "Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28, GOS-28)" GOSR1 GS28 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]" cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]" GO:0000139; GO:0005484; GO:0005794; GO:0005797; GO:0005801; GO:0005829; GO:0006888; GO:0006891; GO:0006906; GO:0015031; GO:0016020; GO:0016021; GO:0030133; GO:0031201; GO:0042147 SNAP receptor activity [GO:0005484] DILQDYTHEFHKTK 0.91739 1.3363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2458 0 0 0 0 14.4246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5634 0 0 0 0 0 0 0 0 0 0 0 Q9H1D9 RPC6_HUMAN "DNA-directed RNA polymerase III subunit RPC6, RNA polymerase III subunit C6 (DNA-directed RNA polymerase III subunit F) (RNA polymerase III 39 kDa subunit, RPC39)" POLR3F Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] GO:0003690; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607 DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690] ILKNLESKK 0.91741 1.3056 0 0 0 0 0 13.2182 0 0 0 0 0 0 0 0 0 0 0 13.7453 0 0 9.25913 0 0 0 13.0209 13.8053 0 11.3708 0 13.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8509 10.7827 0 0 13.2496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6092 0 0 0 0 0 16.644 0 0 0 0 0 0 0 0 13.0185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0212 12.7281 0 0 0 0 0 0 0 14.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3973 0 0 0 0 0 0 0 0 12.0011 13.0435 0 12.5267 14.7488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78540 ARGI2_HUMAN "Arginase-2, mitochondrial, EC 3.5.3.1 (Arginase II) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase)" ARG2 Homo sapiens (Human) "adaptive immune response [GO:0002250]; arginine catabolic process to ornithine [GO:0019547]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657]" cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginase activity [GO:0004053]; manganese ion binding [GO:0030145]; adaptive immune response [GO:0002250]; arginine catabolic process to ornithine [GO:0019547]; innate immune response [GO:0045087]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine (C-C motif) ligand 4 production [GO:0071644]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of cellular senescence [GO:2000774]; regulation of interleukin-1 beta production [GO:0032651]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; striated muscle contraction [GO:0006941]; urea cycle [GO:0000050]; ureteric bud development [GO:0001657]" GO:0000050; GO:0001657; GO:0002250; GO:0002829; GO:0004053; GO:0005737; GO:0005739; GO:0005759; GO:0006809; GO:0006941; GO:0019547; GO:0030145; GO:0032651; GO:0032696; GO:0032700; GO:0032720; GO:0045087; GO:0071641; GO:0071644; GO:0071650; GO:1900425; GO:1903426; GO:1905403; GO:2000562; GO:2000774 arginase activity [GO:0004053]; manganese ion binding [GO:0030145] LLQTRVHSILK 0.91742 1.4005 0 0 0 0 0 0 0 0 0 11.8688 0 0 0 0 12.3975 0 0 11.9213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3725 0 14.103 13.7934 13.6968 0 0 14.0473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8282 0 0 0 0 0 0 0 0 0 0 11.2712 13.9067 0 0 0 0 0 0 14.1154 0 0 0 0 O95639 CPSF4_HUMAN "Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit, CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1, Neb-1) (No arches homolog)" CPSF4 CPSF30 NAR NEB1 Homo sapiens (Human) pre-mRNA cleavage required for polyadenylation [GO:0098789] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789] GO:0003723; GO:0005654; GO:0005847; GO:0008270; GO:0043231; GO:0098789; GO:1990837 RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] GDQCEFLHEYDMTK 0.91751 1.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.603 0 0 0 0 12.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H207 O10A5_HUMAN "Olfactory receptor 10A5 (HP3) (Olfactory receptor 10A1) (Olfactory receptor 11-403, OR11-403) (Olfactory receptor-like protein JCG6)" OR10A5 OR10A1 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IAAAILKIPSAK 0.91751 1.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0981 0 0 0 0 15.7412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUT1 NKAP1_HUMAN Uncharacterized protein NKAPD1 (NKAP domain containing protein 1) NKAPD1 C11orf57 Homo sapiens (Human) identical protein binding [GO:0042802] GO:0042802 identical protein binding [GO:0042802] FYDYEANMPDRWGHSGYKELYPEEFETDSDQQDITNGK 0.91752 1.3989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2447 17.4564 17.345 17.532 0 17.96 0 12.3778 0 16.525 0 0 17.0967 0 17.1968 0 0 0 0 15.4596 0 11.6075 0 15.8068 12.0789 15.3533 13.8568 0 0 0 0 11.7947 12.1835 16.7156 11.8935 0 0 0 0 0 0 0 0 0 0 14.3664 0 0 0 0 12.9058 0 0 0 0 0 0 0 0 0 0 0 0 11.5895 0 10.7645 0 0 11.5974 13.5927 0 0 0 0 0 0 0 0 0 0 10.5488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95169 NDUB8_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI, CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)" NDUFB8 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0005783; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] KYNMRVEDYEPYPDDGMGYGDYPK 0.91753 1.1805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13884 SNTB1_HUMAN "Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1, DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43, TIP-43)" SNTB1 SNT2B1 Homo sapiens (Human) muscle contraction [GO:0006936] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; muscle contraction [GO:0006936] GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202 actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] ENKMPILISKIFK 0.91753 1.1766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12314 FCGR1_HUMAN "High affinity immunoglobulin gamma Fc receptor I, IgG Fc receptor I (Fc-gamma RI, FcRI) (Fc-gamma RIA, FcgammaRIa) (CD antigen CD64)" FCGR1A FCG1 FCGR1 IGFR1 Homo sapiens (Human) "antibody-dependent cellular cytotoxicity [GO:0001788]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; cell surface receptor signaling pathway [GO:0007166]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of type III hypersensitivity [GO:0001805]; receptor-mediated endocytosis [GO:0006898]; regulation of immune response [GO:0050776]; signal transduction [GO:0007165]" clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; high-affinity IgG receptor activity [GO:0019771]; IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888]; antibody-dependent cellular cytotoxicity [GO:0001788]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; cell surface receptor signaling pathway [GO:0007166]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of type III hypersensitivity [GO:0001805]; receptor-mediated endocytosis [GO:0006898]; regulation of immune response [GO:0050776]; signal transduction [GO:0007165]" GO:0001788; GO:0001798; GO:0001805; GO:0004888; GO:0005886; GO:0005887; GO:0006898; GO:0006910; GO:0006911; GO:0006955; GO:0007165; GO:0007166; GO:0009897; GO:0019771; GO:0019864; GO:0030669; GO:0031901; GO:0042590; GO:0042742; GO:0045087; GO:0050766; GO:0050776; GO:0061098 high-affinity IgG receptor activity [GO:0019771]; IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888] HLEEELKCQEQK 0.91755 1.1612 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8019 0 0 0 13.4281 0 0 0 0 0 0 0 11.4836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6608 13.2656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48050 KCNJ4_HUMAN "Inward rectifier potassium channel 4 (HIRK2) (HRK1) (Hippocampal inward rectifier, HIR) (Inward rectifier K(+) channel Kir2.3, IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)" KCNJ4 IRK3 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; PDZ domain binding [GO:0030165]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005886; GO:0006813; GO:0008076; GO:0016323; GO:0030165; GO:0030659; GO:0034765; GO:0045211; GO:0070161; GO:1990573 inward rectifier potassium channel activity [GO:0005242]; PDZ domain binding [GO:0030165] KRAQTLLFSHHAVISVR 0.91757 1.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHA2 S18L2_HUMAN SS18-like protein 2 (SYT homolog 2) SS18L2 Homo sapiens (Human) positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003713; GO:0005634; GO:0045944; GO:0050775 transcription coactivator activity [GO:0003713] GKAEVNQETIQRLLEENDQLIR 0.91758 1.1759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59536 T2R41_HUMAN "Taste receptor type 2 member 41, T2R41 (Taste receptor type 2 member 59, T2R59)" TAS2R41 Homo sapiens (Human) sensory perception of taste [GO:0050909] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of taste [GO:0050909] GO:0004930; GO:0005886; GO:0016021; GO:0050909 G protein-coupled receptor activity [GO:0004930] IANITHSTFLWLKWR 0.91761 1.1757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8782 0 12.0537 0 0 0 11.8036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRJ1 MOST1_HUMAN Protein MOST-1 C8orf17 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] GO:0005634; GO:0005737; GO:0005789; GO:0008284; GO:0043066 MGECPHLVDVR 0.91765 1.3952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3594 0 11.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08218 CEL2B_HUMAN "Chymotrypsin-like elastase family member 2B, EC 3.4.21.71 (Elastase-2B)" CELA2B ELA2B Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005615; GO:0006508 serine-type endopeptidase activity [GO:0004252] QGQLLVVDYATCSSSGWWGSTVK 0.91766 1.3138 0 0 14.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXQ8 PDZD9_HUMAN PDZ domain-containing protein 9 PDZD9 C16orf65 Homo sapiens (Human) KKNHTISVGK 0.91766 1.1583 0 0 0 0 0 0 0 0 0 11.1604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6984 0 0 11.2021 0 0 0 0 0 0 0 0 0 0 0 0 11.5732 10.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6368 0 0 0 0 0 0 0 0 0 0 0 Q9Y5G2 PCDGE_HUMAN "Protocadherin gamma-B2, PCDH-gamma-B2" PCDHGB2 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] FILKSSSKNYYK 0.91772 5.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5063 0 0 0 0 0 0 0 12.5717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3425 0 0 0 0 0 0 13.7897 0 0 13.1886 0 0 0 0 0 0 0 16.2113 0 0 12.8091 0 0 0 12.6349 14.8803 0 0 0 0 0 0 14.9516 0 0 10.4757 0 0 0 0 0 0 0 0 10.4091 0 0 12.4749 13.7089 0 0 0 14.6896 0 0 12.3871 0 0 14.1159 13.6834 0 0 0 13.6619 0 0 0 0 0 0 0 11.7457 0 0 0 13.0418 13.7493 0 14.3221 14.1895 0 0 0 0 0 0 0 0 0 15.1398 14.9071 0 0 14.7881 0 14.3569 0 0 0 0 0 0 0 0 12.5769 0 0 0 0 0 12.9568 0 P04632 CPNS1_HUMAN "Calpain small subunit 1, CSS1 (Calcium-activated neutral proteinase small subunit, CANP small subunit) (Calcium-dependent protease small subunit, CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit)" CAPNS1 CAPN4 CAPNS Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241] calpain complex [GO:0110158]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] calpain complex [GO:0110158]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241] GO:0004198; GO:0005509; GO:0005829; GO:0005886; GO:0006508; GO:0008284; GO:0016020; GO:0016241; GO:0070062; GO:0110158 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] RYSDESGNMDFDNFISCLVR 0.91774 1.3367 0 0 0 10.6713 0 0 0 0 0 0 0 0 0 13.9271 0 0 0 0 0 0 14.411 0 15.018 0 10.8274 0 14.3095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4841 0 0 0 0 0 0 0 0 14.4914 0 0 0 0 0 0 0 14.6938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15467 CCL16_HUMAN "C-C motif chemokine 16 (Chemokine CC-4, HCC-4) (Chemokine LEC) (IL-10-inducible chemokine) (LCC-1) (Liver-expressed chemokine) (Lymphocyte and monocyte chemoattractant, LMC) (Monotactin-1, MTN-1) (NCC-4) (Small-inducible cytokine A16)" CCL16 ILINCK NCC4 SCYA16 Homo sapiens (Human) cell communication [GO:0007154]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; cell communication [GO:0007154]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] GO:0002548; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007154; GO:0007186; GO:0007267; GO:0008009; GO:0030593; GO:0042056; GO:0043547; GO:0048020; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009] DPNLPLLPTRNLSTVK 0.91776 1.5577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8984 0 0 0 12.2134 12.6592 0 12.6527 0 0 0 0 0 12.6899 14.6414 0 0 0 0 0 0 0 0 0 0 13.6144 14.8472 0 0 13.5847 0 14.9431 0 0 0 0 12.9346 0 0 0 15.0822 0 0 0 14.4708 13.211 0 14.5134 0 0 0 14.1335 0 0 0 0 14.1502 0 0 0 0 14.3036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1477 0 12.938 12.9165 0 0 0 11.911 11.4091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6F2 TM38A_HUMAN "Trimeric intracellular cation channel type A, TRIC-A, TRICA (Transmembrane protein 38A)" TMEM38A Homo sapiens (Human) cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; sarcoplasmic reticulum membrane [GO:0033017] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; sarcoplasmic reticulum membrane [GO:0033017]; identical protein binding [GO:0042802]; potassium channel activity [GO:0005267]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808] GO:0005267; GO:0007029; GO:0010881; GO:0014808; GO:0016021; GO:0031965; GO:0033017; GO:0042802; GO:0070062; GO:0071313 identical protein binding [GO:0042802]; potassium channel activity [GO:0005267] LIFVAMKEVVRVR 0.91777 1.1967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0611 0 0 0 0 0 0 0 0 11.7432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09693 CD3G_HUMAN T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g) CD3G T3G Homo sapiens (Human) adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; establishment or maintenance of cell polarity [GO:0007163]; gamma-delta T cell activation [GO:0046629]; positive thymic T cell selection [GO:0045059]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of lymphocyte apoptotic process [GO:0070228]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; establishment or maintenance of cell polarity [GO:0007163]; gamma-delta T cell activation [GO:0046629]; positive thymic T cell selection [GO:0045059]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of lymphocyte apoptotic process [GO:0070228]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] GO:0002250; GO:0004888; GO:0005829; GO:0005886; GO:0005887; GO:0007163; GO:0007166; GO:0009897; GO:0015031; GO:0030159; GO:0030669; GO:0042105; GO:0042106; GO:0042110; GO:0042608; GO:0042802; GO:0045059; GO:0046629; GO:0046631; GO:0050852; GO:0065003; GO:0070228 identical protein binding [GO:0042802]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888] EQGKGLAVLILAIILLQGTLAQSIK 0.91778 1.1779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7J1 PPR3E_HUMAN Protein phosphatase 1 regulatory subunit 3E PPP1R3E Homo sapiens (Human) glycogen metabolic process [GO:0005977]; positive regulation of glycogen biosynthetic process [GO:0045725]; regulation of glycogen biosynthetic process [GO:0005979] glycogen granule [GO:0042587]; protein phosphatase type 1 complex [GO:0000164] glycogen granule [GO:0042587]; protein phosphatase type 1 complex [GO:0000164]; [phosphorylase] phosphatase activity [GO:0050196]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen biosynthetic process [GO:0045725]; regulation of glycogen biosynthetic process [GO:0005979] GO:0000164; GO:0005977; GO:0005979; GO:0008157; GO:0042587; GO:0045725; GO:0050196; GO:2001069 [phosphorylase] phosphatase activity [GO:0050196]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157] ADRFAFR 0.91781 1.1774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82828 0 0 0 0 12.4342 12.6945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7167 0 0 0 0 0 0 0 0 0 0 0 0 0 11.897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7464 0 0 0 12.3336 0 0 0 0 12.3138 12.6003 14.5559 0 0 0 0 14.4767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8104 0 0 0 0 0 0 0 Q58FF7 H90B3_HUMAN "Putative heat shock protein HSP 90-beta-3 (Heat shock protein 90-beta c, Heat shock protein 90Bc)" HSP90AB3P HSP90BC Homo sapiens (Human) cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0005524; GO:0005829; GO:0005886; GO:0006457; GO:0016887; GO:0019899; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082; GO:0070062; GO:0097718 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082] GEKEEEDKDDEEK 0.91783 1.3279 0 0 0 0 0 0 0 0 0 0 0 0 12.8884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1706 0 0 0 0 0 0 0 0 0 0 0 13.4463 0 0 0 13.1317 0 11.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42262 GRIA2_HUMAN "Glutamate receptor 2, GluR-2 (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2, GluA2)" GRIA2 GLUR2 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]" AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843] "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]" GO:0001540; GO:0004970; GO:0004971; GO:0005789; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0009897; GO:0014069; GO:0015276; GO:0030425; GO:0030666; GO:0032279; GO:0032281; GO:0035235; GO:0035249; GO:0038023; GO:0043025; GO:0043197; GO:0060076; GO:0070161; GO:0098794; GO:0098839; GO:0098843 AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023] ADIAIAPLTITLVR 0.91784 1.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3825 0 0 0 0 0 0 0 0 0 0 0 12.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7979 0 0 0 13.0175 13.0713 0 0 0 0 0 0 0 0 0 0 0 0 12.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9823 0 0 0 0 0 0 Q9C0D9 EPT1_HUMAN "Ethanolaminephosphotransferase 1, hEPT1, EC 2.7.8.1 (Selenoprotein I, SelI)" SELENOI EPT1 KIAA1724 SELI Homo sapiens (Human) phosphatidylethanolamine biosynthetic process [GO:0006646] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphatidylethanolamine biosynthetic process [GO:0006646] GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0016021; GO:0046872 ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872] PNSDULGMEEK 0.91785 1.1806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4279 0 0 0 0 0 0 0 0 0 11.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.154 0 0 0 0 0 0 0 0 0 10.7549 0 0 0 0 0 0 0 0 0 0 0 0 13.2358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAV0 GBB4_HUMAN Guanine nucleotide-binding protein subunit beta-4 (Transducin beta chain 4) GNB4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; substantia nigra development [GO:0021762] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; G protein-coupled receptor signaling pathway [GO:0007186]; substantia nigra development [GO:0021762] GO:0005737; GO:0005765; GO:0005829; GO:0005834; GO:0007186; GO:0021762; GO:0030159; GO:0044297; GO:0044877; GO:0070062 protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159] LIIWDSYTTNK 0.91788 1.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9496 0 13.454 0 0 0 0 0 0 0 0 0 0 0 14.1931 0 0 0 0 0 0 0 0 0 0 0 0 14.4907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5129 0 0 0 0 0 0 13.8765 0 0 0 0 14.4523 0 0 0 13.6807 0 13.1898 0 12.5738 0 0 0 0 0 0 0 0 0 14.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2142 0 0 0 0 0 P79522 PRR3_HUMAN Proline-rich protein 3 (MHC class I region proline-rich protein CAT56) PRR3 CAT56 Homo sapiens (Human) metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723] GPIRRGLGPR 0.9179 1.3399 13.0907 0 12.0478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9739 13.1093 0 0 0 0 0 0 0 0 0 0 13.2716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7029 0 0 13.1325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFP7 NUD10_HUMAN "Diphosphoinositol polyphosphate phosphohydrolase 3-alpha, DIPP-3-alpha, DIPP3-alpha, hDIPP3alpha, EC 3.6.1.52 (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-alpha) (Diadenosine hexaphosphate hydrolase (AMP-forming), EC 3.6.1.60) (Nucleoside diphosphate-linked moiety X motif 10, Nudix motif 10) (hAps2)" NUDT10 APS2 DIPP3A Homo sapiens (Human) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate metabolic process [GO:0071543] GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0008486; GO:0034431; GO:0034432; GO:0046872; GO:0050072; GO:0052840; GO:0052842; GO:0071543; GO:1901907; GO:1901909; GO:1901911 bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; metal ion binding [GO:0046872] LKLGGSPTNGNSMAPSSPDSDP 0.9179 1.5083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.433 0 0 0 0 0 0 0 0 12.2587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7568 0 0 0 13.2664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4675 13.1831 0 0 0 13.7432 13.1436 0 0 0 0 0 12.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L08 SUSD3_HUMAN Sushi domain-containing protein 3 SUSD3 UNQ9387/PRO34275 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 DPGIPRALSLSGSSSSPQAQVMVHMANPR 0.9179 1.1761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7579 0 0 0 0 0 0 0 0 0 Q9Y316 MEMO1_HUMAN "Protein MEMO1 (C21orf19-like protein) (Hepatitis C virus NS5A-transactivated protein 7, HCV NS5A-transactivated protein 7) (Mediator of ErbB2-driven cell motility 1, Mediator of cell motility 1, Memo-1)" MEMO1 C2orf4 MEMO NS5ATP7 CGI-27 Homo sapiens (Human) regulation of microtubule-based process [GO:0032886] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; regulation of microtubule-based process [GO:0032886] GO:0005634; GO:0005829; GO:0032886 EQEFGKLFSKYLADPSNLFVVSSDFCHWGQR 0.91791 1.1887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8X2 IPPK_HUMAN "Inositol-pentakisphosphate 2-kinase, EC 2.7.1.158 (IPK1 homolog) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase, InsP5 2-kinase)" IPPK C9orf12 Homo sapiens (Human) inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; molecular adaptor activity [GO:0060090]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol phosphorylation [GO:0052746]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838] GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0032958; GO:0035299; GO:0043647; GO:0052746; GO:0060090; GO:1901838 ATP binding [GO:0005524]; inositol pentakisphosphate 2-kinase activity [GO:0035299]; molecular adaptor activity [GO:0060090] AVIRELVHVITR 0.91794 1.3975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.463 0 0 0 0 0 0 0 0 0 0 0 0 13.2622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.31 15.1325 0 12.6155 13.2734 0 0 15.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1078 0 16.1327 0 0 12.7546 0 0 0 0 0 16.5265 0 14.5205 0 13.0199 0 0 0 0 0 0 17.9656 17.6633 0 15.2599 0 15.2189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0497 0 0 0 0 0 0 0 0 14.9239 0 0 0 0 0 13.4018 14.0076 14.2732 12.9461 13.6504 0 0 13.0269 12.8554 0 0 0 0 14.9399 0 14.2009 0 0 Q8NH85 OR5R1_HUMAN Olfactory receptor 8U3 (Olfactory receptor 5R1) (Olfactory receptor OR11-185) OR8U3 OR5R1 OR5R1P Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] AEVNIIYVTVFILK 0.91795 1.4854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYE3 LCE3D_HUMAN Late cornified envelope protein 3D (Late envelope protein 16) (Small proline-rich-like epidermal differentiation complex protein 6A) (Small proline-rich-like epidermal differentiation complex protein 6B) LCE3D LEP16 SPRL6A SPRL6B Homo sapiens (Human) keratinization [GO:0031424] cytosol [GO:0005829] cytosol [GO:0005829]; keratinization [GO:0031424] GO:0005829; GO:0031424 GSGQQGGGSGCGHGSGGCC 0.91797 1.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8899 0 13.7477 0 11.0023 0 0 0 0 9.78942 0 0 0 0 0 0 0 0 11.8341 11.7777 0 0 0 0 0 0 11.1428 0 0 0 0 0 0 0 0 0 0 0 0 12.393 0 0 0 0 0 0 0 12.4368 0 0 0 0 0 0 11.9543 11.7879 11.4994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87604 Q86YB8 ERO1B_HUMAN "ERO1-like protein beta, ERO1-L-beta, EC 1.8.4.- (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta)" ERO1B ERO1LB Homo sapiens (Human) protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975] GO:0005783; GO:0005789; GO:0006457; GO:0015035; GO:0016491; GO:0016972; GO:0034975; GO:0051082; GO:0071949 FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972]; unfolded protein binding [GO:0051082] DCHVEPCPESK 0.918 1.1987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7072 0 0 0 0 0 0 0 0 0 0 0 13.3894 13.5838 11.1161 15.0472 14.3359 15.4158 16.0151 16.4194 14.1688 0 14.3534 14.5128 0 14.7801 0 11.4345 0 0 0 15.1988 0 0 0 0 0 0 0 0 0 0 0 14.2275 0 0 0 0 0 0 12.3314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5886 0 Q9HA82 CERS4_HUMAN "Ceramide synthase 4, CerS4, EC 2.3.1.- (LAG1 longevity assurance homolog 4) (Sphingosine N-acyltransferase CERS4, EC 2.3.1.24)" CERS4 LASS4 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148] GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291 DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] MLYSFMKKGQMEK 0.91801 1.3959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7936 0 10.2096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1409 0 0 12.43 0 0 0 0 15.5728 0 0 0 0 11.1844 0 0 0 0 13.0624 12.9113 0 0 0 0 0 0 12.8462 0 11.2321 0 11.3734 0 11.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2448 0 0 0 0 0 0 0 0 12.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.281 0 0 0 10.645 0 Q8NGI7 O10V1_HUMAN Olfactory receptor 10V1 (Olfactory receptor OR11-256) OR10V1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] TALYIISFIVLSIPLSLISISYVFIVVAILR 0.91802 1.5645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.607 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1815 0 0 0 11.5344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9319 P48059 LIMS1_HUMAN "LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1, PINCH-1) (Renal carcinoma antigen NY-REN-48)" LIMS1 PINCH PINCH1 Homo sapiens (Human) "cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0008270; GO:0010628; GO:0010811; GO:0019901; GO:0033209; GO:0043547; GO:0045184; GO:0045216; GO:0045892; GO:0048471; GO:0051894; GO:0071560; GO:0098609; GO:1900026; GO:1901224; GO:2001046 protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] AWCVNCFACSTCNTK 0.91803 1.1983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YD1 PTOV1_HUMAN "Prostate tumor-overexpressed gene 1 protein, PTOV-1 (Activator interaction domain-containing protein 2)" PTOV1 ACID2 PP642 UNQ6127/PRO20092 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005654; GO:0005667; GO:0005886; GO:0045944; GO:0048471 APYRSGAGGPLGGRGR 0.91804 1.5053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9161 0 14.5562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9353 0 0 12.1523 0 0 0 0 0 0 0 0 0 0 14.5004 14.4073 0 14.8814 11.8496 15.0449 14.9841 14.7028 15.5776 14.3456 14.5834 13.9921 15.1205 13.9051 13.5542 14.0628 0 0 13.0013 0 0 0 12.9355 0 0 0 13.1696 13.3457 13.1318 0 0 0 0 13.8287 0 0 0 0 0 13.6359 13.8238 13.8552 0 14.8642 14.2254 0 13.7871 13.8927 14.7605 13.4311 0 0 0 13.9075 13.7875 14.0024 0 0 0 0 0 14.0205 0 13.7853 16.5204 14.8798 0 0 13.6445 0 0 13.9457 14.8904 0 14.0393 0 13.142 13.432 13.3844 0 0 0 0 0 13.5194 0 13.8111 13.5227 0 0 0 14.1913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.389 9.66473 0 0 0 14.2923 0 P49810 PSN2_HUMAN "Presenilin-2, PS-2, EC 3.4.23.- (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit ]" PSEN2 AD4 PS2 PSNL2 STM2 Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of apoptotic process [GO:0043066]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of calcium import into the mitochondrion [GO:0110097]; response to hypoxia [GO:0001666] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synaptic vesicle [GO:0008021]; Z disc [GO:0030018] "apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synaptic vesicle [GO:0008021]; Z disc [GO:0030018]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; endopeptidase activity [GO:0004175]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; calcium ion transport [GO:0006816]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of apoptotic process [GO:0043066]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of catalytic activity [GO:0043085]; protein processing [GO:0016485]; regulation of calcium import into the mitochondrion [GO:0110097]; response to hypoxia [GO:0001666]" GO:0000139; GO:0000776; GO:0001666; GO:0004175; GO:0005634; GO:0005637; GO:0005743; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005813; GO:0005886; GO:0005887; GO:0005938; GO:0006509; GO:0006816; GO:0007219; GO:0007220; GO:0008021; GO:0009986; GO:0016020; GO:0016324; GO:0016485; GO:0030018; GO:0030426; GO:0031594; GO:0032991; GO:0034205; GO:0035253; GO:0035556; GO:0042500; GO:0042987; GO:0043025; GO:0043066; GO:0043085; GO:0043198; GO:0045121; GO:0048471; GO:0050435; GO:0070765; GO:0099056; GO:0110097; GO:1990456 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; endopeptidase activity [GO:0004175]" GPLRMLVETAQER 0.91805 1.5639 0 0 12.8824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8995 0 0 13.7339 0 0 0 14.0443 0 0 0 0 0 11.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.324 0 0 Q8TBB6 S7A14_HUMAN Probable cationic amino acid transporter (Solute carrier family 7 member 14) SLC7A14 KIAA1613 Homo sapiens (Human) amino acid transport [GO:0006865] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid transport [GO:0006865] GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0006865; GO:0015171; GO:0016021; GO:0043231 amino acid transmembrane transporter activity [GO:0015171] LIGPHYYTMRIRLGLPGK 0.91805 1.1848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9592 13.8042 0 0 0 0 0 0 0 0 0 0 14.056 0 0 0 14.0825 0 0 0 0 0 0 0 13.8912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95825 QORL1_HUMAN "Quinone oxidoreductase-like protein 1, EC 1.-.-.- (Protein 4P11) (Quinone oxidoreductase homolog 1, QOH-1) (Zeta-crystallin homolog)" CRYZL1 4P11 Homo sapiens (Human) quinone metabolic process [GO:1901661] cytosol [GO:0005829] cytosol [GO:0005829]; NADP binding [GO:0050661]; NADPH:quinone reductase activity [GO:0003960]; quinone metabolic process [GO:1901661] GO:0003960; GO:0005829; GO:0050661; GO:1901661 NADP binding [GO:0050661]; NADPH:quinone reductase activity [GO:0003960] ACALSQINTKLLAEMK 0.91806 1.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30511 HLAF_HUMAN "HLA class I histocompatibility antigen, alpha chain F (CDA12) (HLA F antigen) (Leukocyte antigen F) (MHC class I antigen F)" HLA-F HLA-5.4 HLAF Homo sapiens (Human) antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class Ib [GO:0002477]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; negative regulation of natural killer cell cytokine production [GO:0002728]; negative regulation of natural killer cell degranulation [GO:0043322]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of neuron death [GO:1901215]; negative regulation of T cell cytokine production [GO:0002725]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of T cell mediated cytotoxicity [GO:0001916] cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; MHC class Ib protein complex [GO:0032398]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; MHC class Ib protein complex [GO:0032398]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; 14-3-3 protein binding [GO:0071889]; beta-2-microglobulin binding [GO:0030881]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class Ib [GO:0002477]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; negative regulation of natural killer cell cytokine production [GO:0002728]; negative regulation of natural killer cell degranulation [GO:0043322]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of neuron death [GO:1901215]; negative regulation of T cell cytokine production [GO:0002725]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of T cell mediated cytotoxicity [GO:0001916] GO:0000139; GO:0001916; GO:0002474; GO:0002476; GO:0002477; GO:0002725; GO:0002728; GO:0002729; GO:0005615; GO:0005765; GO:0005783; GO:0005886; GO:0009897; GO:0009986; GO:0012507; GO:0016020; GO:0030670; GO:0030881; GO:0031901; GO:0032398; GO:0042605; GO:0042612; GO:0043322; GO:0043323; GO:0045953; GO:0046978; GO:0046979; GO:0055038; GO:0071556; GO:0071889; GO:1901215 14-3-3 protein binding [GO:0071889]; beta-2-microglobulin binding [GO:0030881]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979] CWALGFYPAEITLTWQRDGEEQTQDTELVETR 0.91807 1.3943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6686 0 0 0 13.1303 0 0 0 0 0 0 0 0 0 0 12.5023 0 0 0 0 0 0 0 0 13.2246 0 0 0 0 0 0 0 0 0 0 0 11.8158 0 0 0 0 0 13.0667 0 0 0 0 0 0 0 0 0 0 0 12.6651 0 0 0 11.789 0 0 0 0 0 0 0 11.5298 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6519 0 0 0 0 0 0 0 0 0 0 11.7917 0 0 0 Q92622 RUBIC_HUMAN "Run domain Beclin-1-interacting and cysteine-rich domain-containing protein, Rubicon (Beclin-1 associated RUN domain containing protein, Baron)" RUBCN KIAA0226 Homo sapiens (Human) autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909] cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; phosphatidylinositol phosphate binding [GO:1901981]; autophagy [GO:0006914]; endocytosis [GO:0006897]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; phagocytosis [GO:0006909] GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006897; GO:0006909; GO:0006914; GO:0010507; GO:0043231; GO:0043553; GO:0045806; GO:0071985; GO:1901097; GO:1901981 phosphatidylinositol phosphate binding [GO:1901981] ACFKSGSCPRCER 0.91809 1.1972 0 0 0 0 0 0 0 0 12.9763 0 11.7 0 11.8135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5467 0 0 0 12.8576 0 0 0 0 11.2952 0 0 0 0 0 0 10.281 0 0 9.79863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5824 0 0 0 11.6941 13.6878 0 13.0163 0 0 0 0 0 0 14.2274 0 0 0 13.9385 0 0 0 14.2515 0 11.735 0 0 0 0 0 0 13.3264 0 0 11.5898 0 0 11.6388 13.9932 0 0 0 12.8177 11.0462 0 12.8833 12.8194 0 0 14.5608 0 0 0 0 0 0 0 0 0 0 14.6398 0 0 14.2731 14.5179 0 0 14.1115 14.7652 0 13.7082 14.051 0 13.7786 13.5932 0 0 0 0 0 13.73 13.4359 0 0 0 13.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2349 13.5458 0 0 11.6813 0 13.1019 Q96JK2 DCAF5_HUMAN "DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2, BCRP2) (WD repeat-containing protein 22)" DCAF5 BCRG2 KIAA1824 WDR22 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567] GO:0005654; GO:0005737; GO:0016567; GO:0080008 DCCGSEMACETPNAGTR 0.91809 1.3369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7437 0 0 0 0 0 12.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3942 0 0 0 0 0 0 0 0 0 14.6653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8D1 PDCD7_HUMAN "Programmed cell death protein 7 (ES18, hES18)" PDCD7 Homo sapiens (Human) apoptotic process [GO:0006915]; response to glucocorticoid [GO:0051384]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689] nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]; apoptotic process [GO:0006915]; response to glucocorticoid [GO:0051384]; RNA splicing [GO:0008380] GO:0005654; GO:0005689; GO:0006915; GO:0008380; GO:0051384 ASAEASR 0.91811 1.5037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7234 0 0 0 0 0 12.7439 14.0382 0 0 14.1102 14.4524 12.9117 0 0 0 0 0 0 0 14.5485 0 0 0 0 14.5452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9366 0 0 0 0 0 0 0 0 14.47 0 0 0 0 16.9818 0 14.4179 0 0 16.5754 0 0 0 0 12.8599 0 0 12.3416 0 0 0 0 0 14.1132 0 0 14.1106 0 0 0 0 0 15.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2835 0 0 0 0 12.824 0 0 0 Q8NH63 O51H1_HUMAN Olfactory receptor 51H1 (Olfactory receptor OR11-25) OR51H1 OR51H1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] INSLYGLIVVIFTLGLDVLLTLLSYVLTLKTVLGIVSR 0.91813 1.1823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18084 ITB5_HUMAN Integrin beta-5 ITGB5 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta5 complex [GO:0034684]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta5 complex [GO:0034684]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001618; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0009986; GO:0016477; GO:0033627; GO:0034684; GO:0035987; GO:0038023; GO:0043149; GO:0043235; GO:0045335; GO:0070062; GO:0090136 integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] CHAGYIGDNCNCSTDISTCRGR 0.91814 1.3932 0 0 0 0 0 0 0 0 12.9954 13.7909 0 0 0 0 0 0 15.376 0 12.7351 12.1582 0 0 0 0 12.3509 0 13.6378 0 0 13.5171 12.8281 0 0 0 13.231 12.6297 0 0 0 12.2971 0 0 0 0 0 12.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1157 0 15.3043 11.2295 0 0 0 12.9654 13.886 13.3986 13.658 0 0 12.6611 12.1594 13.6807 12.573 0 16.7292 14.2601 0 0 0 0 14.8556 0 13.3437 0 0 0 13.3486 14.7354 0 0 0 12.6856 0 0 0 0 13.3677 0 0 0 16.1134 0 0 0 14.7049 18.5463 10.582 11.4962 0 0 17.1764 13.7282 12.4713 0 18.2147 13.3426 0 11.6503 13.2972 0 13.0371 0 13.2761 13.8573 13.2175 0 12.8729 0 14.2308 17.3794 0 16.3278 0 12.8185 9.96694 0 12.0208 13.5663 0 0 13.7223 0 0 12.1516 0 12.6266 14.7796 0 0 13.0234 12.3986 0 0 13.191 0 14.3348 13.4883 13.3821 0 0 0 11.4026 0 12.6148 14.1383 0 0 0 12.7939 0 Q6ICG8 WBP2L_HUMAN Postacrosomal sheath WW domain-binding protein (WW domain-binding protein 2-like) WBP2NL PAWP Homo sapiens (Human) "egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]" nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827] "nucleus [GO:0005634]; perinuclear theca [GO:0033011]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699]; egg activation [GO:0007343]; female pronucleus assembly [GO:0035038]; male pronucleus assembly [GO:0035039]; meiotic cell cycle [GO:0051321]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003713; GO:0005634; GO:0007343; GO:0031490; GO:0033011; GO:0035038; GO:0035039; GO:0036126; GO:0045893; GO:0050699; GO:0051321; GO:0061827 chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; WW domain binding [GO:0050699] AVNQSHTENRR 0.91814 1.1543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3888 0 0 13.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2733 0 0 0 0 0 0 0 0 0 13.7305 0 0 0 0 0 0 0 0 0 0 0 13.1694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6723 0 0 0 0 0 0 0 0 Q9NVD7 PARVA_HUMAN Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2) PARVA MXRA2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; protein kinase inhibitor activity [GO:0004860]; actin cytoskeleton reorganization [GO:0031532]; actin-mediated cell contraction [GO:0070252]; cell projection assembly [GO:0030031]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0002040; GO:0003148; GO:0003779; GO:0004860; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007163; GO:0008360; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0031532; GO:0034113; GO:0034446; GO:0045296; GO:0050821; GO:0060271; GO:0070252; GO:0071670 actin binding [GO:0003779]; cadherin binding [GO:0045296]; protein kinase inhibitor activity [GO:0004860] INETLKLPPR 0.91815 1.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4178 0 11.0885 0 0 0 0 0 0 0 12.6338 0 0 0 0 0 0 0 0 0 0 0 0 15.5057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1354 0 0 0 0 0 0 0 0 0 12.659 0 0 0 12.4058 0 0 0 0 0 14.3609 0 0 0 0 0 0 0 0 0 0 11.2015 0 0 0 0 0 0 0 0 11.853 0 0 0 0 0 0 0 0 14.7264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0216 0 0 14.2889 0 0 Q01892 SPIB_HUMAN Transcription factor Spi-B SPIB Homo sapiens (Human) cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005737; GO:0006357; GO:0030154; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" KLTYQFDSALLPAVR 0.91816 1.1814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4851 0 0 0 0 0 14.6051 0 0 13.4305 0 0 0 0 0 0 0 0 0 0 0 0 14.3444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVS5 TR61B_HUMAN "tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial, EC 2.1.1.220 (mRNA methyladenosine-N(1)-methyltransferase, EC 2.1.1.-)" TRMT61B Homo sapiens (Human) mitochondrial tRNA methylation [GO:0070901]; mRNA methylation [GO:0080009]; protein homooligomerization [GO:0051260]; tRNA methylation [GO:0030488] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tRNA (m1A) methyltransferase complex [GO:0031515] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; rRNA (adenine) methyltransferase activity [GO:0016433]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mitochondrial tRNA methylation [GO:0070901]; mRNA methylation [GO:0080009]; protein homooligomerization [GO:0051260]; tRNA methylation [GO:0030488] GO:0005739; GO:0005759; GO:0016429; GO:0016433; GO:0030488; GO:0031515; GO:0051260; GO:0061953; GO:0070901; GO:0080009 mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; rRNA (adenine) methyltransferase activity [GO:0016433]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429] EESSPRELEDSSGDQGR 0.91816 1.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2268 0 0 0 0 0 11.7203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.054 13.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y256 FACE2_HUMAN "CAAX prenyl protease 2, EC 3.4.-.- (Farnesylated proteins-converting enzyme 2, FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog, hRCE1)" RCE1 FACE2 RCE1A RCE1B Homo sapiens (Human) CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342] GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005887; GO:0008238; GO:0016020; GO:0018342; GO:0030176; GO:0071586 cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222] AGDSEAPLCS 0.91818 1.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20337 RAB3B_HUMAN Ras-related protein Rab-3B RAB3B Homo sapiens (Human) antigen processing and presentation [GO:0019882]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of vesicle size [GO:0097494]; vesicle docking involved in exocytosis [GO:0006904] anchored component of synaptic vesicle membrane [GO:0098993]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] anchored component of synaptic vesicle membrane [GO:0098993]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; antigen processing and presentation [GO:0019882]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of vesicle size [GO:0097494]; vesicle docking involved in exocytosis [GO:0006904] GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0006904; GO:0008021; GO:0009306; GO:0017157; GO:0019003; GO:0019882; GO:0031489; GO:0031982; GO:0043231; GO:0048471; GO:0051586; GO:0070062; GO:0072659; GO:0097494; GO:0098691; GO:0098693; GO:0098993 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] ENISVRQAFER 0.91819 1.3424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11487 FGF3_HUMAN "Fibroblast growth factor 3, FGF-3 (Heparin-binding growth factor 3, HBGF-3) (Proto-oncogene Int-2)" FGF3 INT2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cardiac muscle tissue development [GO:0055026]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cardiac muscle tissue development [GO:0055026]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165] GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008284; GO:0008543; GO:0009653; GO:0009887; GO:0010628; GO:0030154; GO:0030334; GO:0051781; GO:0055026 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] GLIWLLLLSLLEPGWPAAGPGARLR 0.9182 1.3918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0789 0 0 0 0 0 0 0 0 0 0 0 0 13.9744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 U3KPV4 A3LT2_HUMAN "Alpha-1,3-galactosyltransferase 2, EC 2.4.1.87 (Isoglobotriaosylceramide synthase, iGb3 synthase, iGb3S)" A3GALT2 A3GALT2P IGBS3S Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular response to manganese ion [GO:0071287]; glycosphingolipid biosynthetic process [GO:0006688]; lipid glycosylation [GO:0030259] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; N-acetyllactosaminide 3-alpha-galactosyltransferase activity [GO:0047276]; carbohydrate metabolic process [GO:0005975]; cellular response to manganese ion [GO:0071287]; glycosphingolipid biosynthetic process [GO:0006688]; lipid glycosylation [GO:0030259] GO:0005794; GO:0005975; GO:0006688; GO:0016021; GO:0030259; GO:0031982; GO:0032580; GO:0046872; GO:0047276; GO:0071287 metal ion binding [GO:0046872]; N-acetyllactosaminide 3-alpha-galactosyltransferase activity [GO:0047276] HLEALIPMGVCPSATMSQLR 0.9182 1.3488 0 0 0 0 0 0 0 0 0 11.0118 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3861 9.81775 0 0 15.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0358 10.5872 0 0 0 12.1092 0 11.5915 0 15.3357 11.9624 0 0 0 0 14.7175 0 0 0 0 15.4265 0 0 0 15.7506 0 15.1378 14.2968 0 15.3694 0 14.0136 0 0 13.3973 12.9266 14.8997 0 0 0 0 0 0 0 0 0 12.7341 0 0 11.2396 11.7814 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6292 0 0 0 0 0 0 0 P17980 PRS6A_HUMAN "26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1, TBP-1)" PSMC3 TBP1 Homo sapiens (Human) modulation by host of viral transcription [GO:0043921]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; modulation by host of viral transcription [GO:0043921]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0000932; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0034774; GO:0036402; GO:0042802; GO:0043161; GO:0043921; GO:0045944; GO:1901800; GO:1904813 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402] ATFLKLAGPQLVQMFIGDGAKLVR 0.91821 1.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4065 0 11.9501 13.2217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7492 0 0 0 0 0 0 0 0 13.6178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9B4 ANR42_HUMAN Ankyrin repeat domain-containing protein 42 ANKRD42 Homo sapiens (Human) positive regulation of NF-kappaB transcription factor activity [GO:0051092] nucleus [GO:0005634] nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] GO:0005634; GO:0051059; GO:0051092 NF-kappaB binding [GO:0051059] HGVEGSTDAK 0.91823 1.189 0 0 0 11.9317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3252 0 13.743 0 0 0 0 0 13.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.852 0 0 0 0 0 0 0 0 0 13.7068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.499 Q96AG3 S2546_HUMAN Mitochondrial outer membrane protein SLC25A46 (Solute carrier family 25 member 46) SLC25A46 TB1 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; cerebellar Purkinje cell differentiation [GO:0021702]; cristae formation [GO:0042407]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial fission [GO:0000266]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; phospholipid homeostasis [GO:0055091]; protein-containing complex assembly [GO:0065003]; respiratory chain complex IV assembly [GO:0008535]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex binding [GO:0044877]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; cerebellar Purkinje cell differentiation [GO:0021702]; cristae formation [GO:0042407]; dendrite development [GO:0016358]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial fission [GO:0000266]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; phospholipid homeostasis [GO:0055091]; protein-containing complex assembly [GO:0065003]; respiratory chain complex IV assembly [GO:0008535]; synapse assembly [GO:0007416] GO:0000266; GO:0000422; GO:0005739; GO:0005741; GO:0006839; GO:0007416; GO:0008535; GO:0016021; GO:0016358; GO:0021554; GO:0021702; GO:0022011; GO:0031987; GO:0042407; GO:0044877; GO:0048936; GO:0055091; GO:0061564; GO:0065003; GO:0090149 protein-containing complex binding [GO:0044877] EVLHKWSPKQIGEHLLLK 0.91823 1.3897 10.2423 12.0921 11.9749 0 0 0 9.48878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5703 0 0 10.4444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2138 0 0 0 0 0 0 0 0 0 0 10.1949 9.87758 0 10.3808 0 13.8904 12.8339 0 15.9978 0 0 0 0 0 0 0 0 0 13.2259 15.8408 0 15.1363 0 15.225 15.2826 14.2378 15.9596 15.968 15.4818 16.0511 0 0 0 0 13.6786 13.8483 14.3592 0 0 0 12.8113 0 0 15.2577 14.157 14.9697 13.6563 0 0 0 0 0 15.8189 15.8654 15.3029 13.9496 13.8921 13.5601 0 13.2681 0 15.5353 14.7657 14.5939 16.3454 14.7875 15.1209 15.1489 15.7403 15.1278 15.9843 16.9104 17.4653 17.0893 16.7503 16.2557 16.9283 16.4997 0 0 14.0412 13.669 0 0 14.1907 0 13.8739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.873 0 13.8708 0 0 0 0 13.5545 14.859 Q7LDG7 GRP2_HUMAN "RAS guanyl-releasing protein 2 (Calcium and DAG-regulated guanine nucleotide exchange factor I, CalDAG-GEFI) (Cdc25-like protein, hCDC25L) (F25B3.3 kinase-like protein)" RASGRP2 CDC25L MCG7 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202] anchoring junction [GO:0070161]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; cellular response to calcium ion [GO:0071277]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; signal transduction [GO:0007165] GO:0001558; GO:0005085; GO:0005509; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0008289; GO:0019992; GO:0032587; GO:0043005; GO:0043547; GO:0045202; GO:0070161; GO:0071277 calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] ACGVNCHKQCKDR 0.91824 1.5712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1293 0 0 0 12.7721 0 12.8353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6279 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKY3 CES1P_HUMAN "Putative inactive carboxylesterase 4 (Inactive carboxylesterase 1 pseudogene 1) (Placental carboxylesterase 3, PCE-3)" CES1P1 CES4 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; lipid catabolic process [GO:0016042] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; anatomical structure morphogenesis [GO:0009653]; lipid catabolic process [GO:0016042] GO:0005576; GO:0005783; GO:0005811; GO:0009653; GO:0016042; GO:0052689 carboxylic ester hydrolase activity [GO:0052689] KENIPLK 0.91825 1.3406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.274 0 0 0 10.9689 0 0 0 0 10.7374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3269 0 0 0 0 0 0 0 0 10.7868 0 0 0 11.7809 0 0 12.2538 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6873 0 0 0 0 0 0 0 0 0 0 0 0 13.3868 0 0 0 0 12.006 0 12.2418 0 0 0 0 0 0 0 0 0 12.0023 0 0 0 12.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14787 TNPO2_HUMAN Transportin-2 (Karyopherin beta-2b) TNPO2 Homo sapiens (Human) protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606] GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0031267; GO:0061608 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] ATIGILITTIASK 0.91826 1.1943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MUM7 LEG16_HUMAN Galectin-16 LGALS16 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of T cell apoptotic process [GO:0070234] lactose binding [GO:0030395]; apoptotic process [GO:0006915]; positive regulation of T cell apoptotic process [GO:0070234] GO:0006915; GO:0030395; GO:0070234 lactose binding [GO:0030395] IPPSYVKMIQVWR 0.9183 1.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6737 13.5525 12.8558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3834 0 0 0 13.4182 0 0 0 0 0 0 11.1581 0 0 0 0 0 0 0 14.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8694 0 0 14.1064 0 0 0 0 0 0 0 0 0 0 13.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5H3 RHG22_HUMAN Rho GTPase-activating protein 22 (Rho-type GTPase-activating protein 22) ARHGAP22 RHOGAP2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634] cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0001525; GO:0005096; GO:0005634; GO:0005829; GO:0005925; GO:0007165; GO:0030154; GO:0051056; GO:0090630; GO:0098978; GO:0099175 GTPase activator activity [GO:0005096] DLQDSFDCGEK 0.91831 1.1864 0 0 0 0 0 0 0 0 11.0522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2348 0 0 0 0 0 10.9853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28336 NMBR_HUMAN "Neuromedin-B receptor, NMB-R (Epididymis tissue protein Li 185a) (Neuromedin-B-preferring bombesin receptor)" NMBR Homo sapiens (Human) antiviral innate immune response [GO:0140374]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of interleukin-6 production [GO:0032715]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; sneeze reflex [GO:0160023] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; antiviral innate immune response [GO:0140374]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of interleukin-6 production [GO:0032715]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; sneeze reflex [GO:0160023] GO:0004930; GO:0004946; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0008188; GO:0032715; GO:0032727; GO:0090290; GO:0140374; GO:0160023; GO:1903942 bombesin receptor activity [GO:0004946]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188] RHFNSQLCCGR 0.91832 1.1932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5136 0 0 11.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8216 0 0 0 0 0 0 12.2539 0 0 0 0 0 0 0 11.9449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S95 CK2N2_HUMAN "Calcium/calmodulin-dependent protein kinase II inhibitor 2 (CaM-KII inhibitory protein, CaM-KIIN)" CAMK2N2 Homo sapiens (Human) negative regulation of protein kinase activity [GO:0006469] anchoring junction [GO:0070161]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202] anchoring junction [GO:0070161]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; protein kinase binding [GO:0019901]; negative regulation of protein kinase activity [GO:0006469] GO:0005654; GO:0005813; GO:0005829; GO:0006469; GO:0008427; GO:0019901; GO:0045202; GO:0070161 calcium-dependent protein kinase inhibitor activity [GO:0008427]; protein kinase binding [GO:0019901] MSEILPYSEDK 0.91833 1.4858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6FI81 CPIN1_HUMAN Anamorsin (Cytokine-induced apoptosis inhibitor 1) (Fe-S cluster assembly protein DRE2 homolog) CIAPIN1 CUA001 PRO0915 Homo sapiens (Human) apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066] cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]" GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0006915; GO:0008168; GO:0009055; GO:0016226; GO:0030097; GO:0043066; GO:0046872; GO:0051537; GO:0051539 "2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]" EPVETAVDNNSKVKTASK 0.91835 1.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09683 SECR_HUMAN Secretin SCT Homo sapiens (Human) brain development [GO:0007420]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; embryonic digestive tract development [GO:0048566]; hippocampus development [GO:0021766]; negative regulation of gastrin-induced gastric acid secretion [GO:1903640]; pancreatic juice secretion [GO:0030157]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of somatostatin secretion [GO:0090274]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; response to nutrient levels [GO:0031667] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; digestive hormone activity [GO:0046659]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; brain development [GO:0007420]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; embryonic digestive tract development [GO:0048566]; hippocampus development [GO:0021766]; negative regulation of gastrin-induced gastric acid secretion [GO:1903640]; pancreatic juice secretion [GO:0030157]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of somatostatin secretion [GO:0090274]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; response to nutrient levels [GO:0031667] GO:0001664; GO:0002024; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0007420; GO:0009992; GO:0021766; GO:0030157; GO:0031667; GO:0032098; GO:0043950; GO:0046659; GO:0047485; GO:0048167; GO:0048566; GO:0050996; GO:0090187; GO:0090274; GO:1903640 digestive hormone activity [GO:0046659]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102] APRPLLLLLLLLGGSAAR 0.91837 5.4138 0 0 0 0 0 0 0 0 0 0 0 9.93834 0 0 0 0 0 0 0 0 0 0 0 0 10.2637 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2187 0 0 0 0 0 0 0 0 13.5529 0 15.2004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9088 14.24 13.5897 0 0 14.251 0 0 0 0 13.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2547 0 0 0 14.2315 0 0 0 0 0 0 12.2376 14.9288 0 0 0 0 0 0 0 0 0 0 0 0 12.7103 0 0 0 0 0 0 0 0 0 0 0 13.6801 0 0 0 14.7381 0 0 0 12.5823 12.3954 0 13.4018 0 0 0 0 0 0 0 0 13.04 0 12.1848 0 0 0 12.3232 0 0 11.4205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAI6 TASL_HUMAN TLR adapter interacting with SLC15A4 on the lysosome TASL CXorf21 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; regulation of lysosomal lumen pH [GO:0035751] endolysosome membrane [GO:0036020]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] endolysosome membrane [GO:0036020]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; regulation of lysosomal lumen pH [GO:0035751] GO:0005654; GO:0034157; GO:0034161; GO:0035751; GO:0036020; GO:0043231; GO:0045087; GO:0045089 SQRVTVLQTNPNPVFESPNLAAVEICR 0.91837 1.1852 0 0 0 0 0 0 0 0 0 11.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5798 0 12.092 0 0 11.9142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43676 NDUB3_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12, CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit)" NDUFB3 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] IEGTPLETIQKKLAAK 0.91838 1.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.37345 0 0 0 0 0 0 0 0 10.4508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4514 0 0 0 0 0 0 0 0 0 0 0 0 12.7852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG38 POTEI_HUMAN POTE ankyrin domain family member I POTEI Homo sapiens (Human) retina homeostasis [GO:0001895] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; retina homeostasis [GO:0001895] GO:0001895; GO:0005615; GO:0070062 DFLHENSTLR 0.91838 1.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83216 0 12.9635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.921 0 0 0 12.6113 0 0 0 0 0 0 0 0 10.6524 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGX3 O10T2_HUMAN Olfactory receptor 10T2 (Olfactory receptor OR1-3) OR10T2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] AFVTCASHLTVVFVHYGCASIIYLRPKSK 0.9184 1.1916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1907 0 0 0 0 0 0 0 0 0 0 0 0 11.7582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HY6 DDRGK_HUMAN DDRGK domain-containing protein 1 (Dashurin) (UFM1-binding and PCI domain-containing protein 1) DDRGK1 C20orf116 UFBP1 Homo sapiens (Human) cartilage development [GO:0051216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein K69-linked ufmylation [GO:1990592]; protein localization to endoplasmic reticulum [GO:0070972]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleolus [GO:0005730]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin-like protein ligase binding [GO:0044389]; cartilage development [GO:0051216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein K69-linked ufmylation [GO:1990592]; protein localization to endoplasmic reticulum [GO:0070972]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0008284; GO:0010628; GO:0010629; GO:0030335; GO:0031647; GO:0032435; GO:0032436; GO:0033146; GO:0034976; GO:0043066; GO:0044389; GO:0045944; GO:0051092; GO:0051216; GO:0061629; GO:0061709; GO:0070972; GO:0071569; GO:1901800; GO:1902808; GO:1903721; GO:1903895; GO:1905050; GO:1905552; GO:1905636; GO:1990592 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin-like protein ligase binding [GO:0044389] GRVSIAELAQASNSLIAWGR 0.91841 1.3373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95843 GUC1C_HUMAN "Guanylyl cyclase-activating protein 3, GCAP 3 (Guanylate cyclase activator 1C)" GUCA1C GCAP3 Homo sapiens (Human) signal transduction [GO:0007165]; visual perception [GO:0007601] photoreceptor disc membrane [GO:0097381] photoreceptor disc membrane [GO:0097381]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0005509; GO:0007165; GO:0007601; GO:0008048; GO:0097381 calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048] QPDMETDSSKSPDK 0.91842 1.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13631 RARG_HUMAN "Retinoic acid receptor gamma, RAR-gamma (Nuclear receptor subfamily 1 group B member 3)" RARG NR1B3 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to retinoic acid [GO:0071300]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; face development [GO:0060324]; glandular epithelial cell development [GO:0002068]; growth plate cartilage chondrocyte growth [GO:0003430]; Harderian gland development [GO:0070384]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell size [GO:0008361]; regulation of myelination [GO:0031641]; regulation of myeloid cell differentiation [GO:0045637]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; stem cell proliferation [GO:0072089]; trachea cartilage development [GO:0060534] chromatin [GO:0000785]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to retinoic acid [GO:0071300]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; face development [GO:0060324]; glandular epithelial cell development [GO:0002068]; growth plate cartilage chondrocyte growth [GO:0003430]; Harderian gland development [GO:0070384]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell size [GO:0008361]; regulation of myelination [GO:0031641]; regulation of myeloid cell differentiation [GO:0045637]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; stem cell proliferation [GO:0072089]; trachea cartilage development [GO:0060534]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001843; GO:0002068; GO:0003430; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006915; GO:0008270; GO:0008284; GO:0008285; GO:0008361; GO:0009755; GO:0009952; GO:0010628; GO:0016021; GO:0030154; GO:0031076; GO:0031641; GO:0032331; GO:0032526; GO:0035116; GO:0035264; GO:0043065; GO:0043068; GO:0045637; GO:0045944; GO:0046965; GO:0048048; GO:0048384; GO:0060070; GO:0060324; GO:0060534; GO:0060740; GO:0070384; GO:0071300; GO:0072089; GO:1990830; GO:1990837; GO:2000647 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" FSELATK 0.91842 1.565 0 0 0 0 0 0 0 0 0 0 0 0 12.1024 0 0 0 0 0 0 0 0 0 0 0 10.6831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4285 0 0 0 0 13.8068 0 0 0 14.8025 0 13.6822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3754 0 0 14.0421 0 0 0 0 13.7151 0 0 0 0 0 13.669 13.6153 0 13.2116 0 0 0 0 0 0 0 0 0 0 13.1394 0 0 13.8501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15784 NDF2_HUMAN "Neurogenic differentiation factor 2, NeuroD2 (Class A basic helix-loop-helix protein 1, bHLHa1) (NeuroD-related factor, NDRF)" NEUROD2 BHLHA1 NDRF Homo sapiens (Human) associative learning [GO:0008306]; behavioral fear response [GO:0001662]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cerebellar cortex development [GO:0021695]; negative regulation of synapse maturation [GO:2000297]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; cellular response to calcium ion [GO:0071277]; cellular response to electrical stimulus [GO:0071257]; cerebellar cortex development [GO:0021695]; negative regulation of synapse maturation [GO:2000297]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001662; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0008306; GO:0016567; GO:0021695; GO:0030182; GO:0031915; GO:0045666; GO:0046982; GO:0048666; GO:0050850; GO:0051091; GO:0070888; GO:0071257; GO:0071277; GO:0090129; GO:1990837; GO:2000297 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EEGELGGEEEEEEEEEEGLDEAEGER 0.91843 1.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3389 0 0 0 0 13.2606 0 14.3204 14.3579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2706 0 0 0 0 0 0 12.3995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0631 0 0 0 0 0 11.2822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q495W5 FUT11_HUMAN "Alpha-(1,3)-fucosyltransferase 11, EC 2.4.1.- (Fucosyltransferase XI, Fuc-TXI, FucT-XI) (Galactoside 3-L-fucosyltransferase 11, Fucosyltransferase 11)" FUT11 Homo sapiens (Human) fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; protein glycosylation [GO:0006486] GO:0000139; GO:0006486; GO:0008417; GO:0016021; GO:0032580; GO:0036065; GO:0036071; GO:0046920 alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] CLQNRELPTAR 0.91845 1.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2511 12.2935 0 0 0 12.5823 0 0 0 0 0 0 0 17.0523 0 0 0 0 0 0 14.6271 0 0 0 0 0 16.527 14.7592 0 0 0 0 0 0 0 13.7215 0 0 0 0 0 0 0 0 0 0 13.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4031 0 13.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZA5 TXNG2_HUMAN "Putative gamma-taxilin 2 (Gamma-taxilin 2 pseudogene) (Taxilin gamma pseudogene, Y-linked)" TXLNGY CYorf15A CYorf15B TXLNG2P Homo sapiens (Human) syntaxin binding [GO:0019905] GO:0019905 syntaxin binding [GO:0019905] EEAGLCGLREKADMLCNSESHDILQHQDSNCSATSNK 0.91845 1.1544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0121 0 0 0 14.0323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2956 0 0 0 0 14.0642 0 0 0 0 0 0 0 0 0 0 0 13.4401 0 0 0 13.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSH3 NICN1_HUMAN "Nicolin-1 (NPCEDRG) (Tubulin polyglutamylase complex subunit 5, PGs5)" NICN1 Homo sapiens (Human) microtubule [GO:0005874]; nucleoplasm [GO:0005654] microtubule [GO:0005874]; nucleoplasm [GO:0005654] GO:0005654; GO:0005874 DYCLMPDPHSEEGAQEYVSLFKHQMLCDMAR 0.91846 1.1617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7485 0 0 12.9904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8892 Q6BDI9 REP15_HUMAN Rab15 effector protein REP15 Homo sapiens (Human) receptor recycling [GO:0001881]; transferrin transport [GO:0033572] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572] GO:0001881; GO:0010008; GO:0031901; GO:0033572; GO:0048471; GO:0055037 DGLREVGKVYISIL 0.91848 1.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2288 0 0 0 13.3382 0 0 0 0 0 0 0 14.7731 0 0 0 12.8615 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2326 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0733 0 0 0 0 0 0 0 0 0 P58004 SESN2_HUMAN "Sestrin-2, EC 1.11.1.- (Hypoxia-induced gene)" SESN2 Hi95 SEST2 Homo sapiens (Human) "cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]" Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932] "Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; sulfiredoxin activity [GO:0032542]; cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]" GO:0001932; GO:0005092; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006111; GO:0006635; GO:0009749; GO:0016239; GO:0016684; GO:0030308; GO:0030330; GO:0031588; GO:0031932; GO:0032042; GO:0032542; GO:0032868; GO:0034198; GO:0034599; GO:0036091; GO:0042149; GO:0042593; GO:0043491; GO:0044877; GO:0046323; GO:0070328; GO:0070728; GO:0071230; GO:0071233; GO:0072593; GO:0098869; GO:0140311; GO:1900182; GO:1901031; GO:1902010; GO:1904262; GO:1904504; GO:1990253; GO:1990316; GO:2000479 "GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; sulfiredoxin activity [GO:0032542]" DEGTSQEEMESR 0.9185 1.3933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1484 0 0 0 0 0 0 15.6159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2833 0 0 0 0 0 0 0 0 12.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGQ2 OOEP_HUMAN "Oocyte-expressed protein homolog (KH homology domain-containing protein 2) (Oocyte- and embryo-specific protein 19, hOEP19)" OOEP C6orf156 KHDC2 OEP19 Homo sapiens (Human) actin filament organization [GO:0007015]; embryonic pattern specification [GO:0009880]; establishment of spindle localization [GO:0051293]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of meiotic nuclear division [GO:0045836]; regulation of cell division [GO:0051302]; regulation of establishment of protein localization [GO:0070201]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297] apical cortex [GO:0045179]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333] apical cortex [GO:0045179]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; embryonic pattern specification [GO:0009880]; establishment of spindle localization [GO:0051293]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of meiotic nuclear division [GO:0045836]; regulation of cell division [GO:0051302]; regulation of establishment of protein localization [GO:0070201]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297] GO:0003723; GO:0005634; GO:0005737; GO:0005938; GO:0007015; GO:0009880; GO:0031297; GO:0032880; GO:0032991; GO:0035088; GO:0045179; GO:0045836; GO:0051293; GO:0051302; GO:0070201; GO:0106333; GO:1905168; GO:2000781 RNA binding [GO:0003723] LPLPPPQIR 0.91851 1.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6006 0 0 0 13.8468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78381 S35A2_HUMAN "UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter, UDP-Gal-Tr, UGT)" SLC35A2 UGALT UGT UGTL Homo sapiens (Human) carbohydrate transport [GO:0008643]; galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate transport [GO:0008643]; galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334] GO:0000139; GO:0005459; GO:0005654; GO:0005783; GO:0005794; GO:0006012; GO:0008643; GO:0030173; GO:0072334 UDP-galactose transmembrane transporter activity [GO:0005459] ILTTALFSVLMLNR 0.91853 1.5618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86X19 TMM17_HUMAN Transmembrane protein 17 TMEM17 Homo sapiens (Human) cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224] ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038] ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224] GO:0007224; GO:0016021; GO:0035869; GO:0036038; GO:0060170; GO:0060271; GO:1905515 AIHIIFTLFLAFQVVAAFLTLR 0.91854 1.1895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8346 0 0 0 0 0 0 0 11.3648 0 0 0 0 0 11.0288 14.6184 12.4681 0 0 0 0 14.3499 0 14.1399 0 0 14.0829 13.7829 0 0 11.6826 0 0 0 12.3515 0 0 0 13.4528 0 13.7777 0 0 0 0 12.6566 0 0 0 0 0 0 0 13.1367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2996 13.1171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5001 0 0 0 0 0 0 0 0 0 13.241 0 12.701 0 0 0 0 0 0 0 0 Q9BYQ3 KRA93_HUMAN Keratin-associated protein 9-3 (Keratin-associated protein 9.3) (Ultrahigh sulfur keratin-associated protein 9.3) KRTAP9-3 KAP9.3 KRTAP9.3 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; identical protein binding [GO:0042802] GO:0005829; GO:0042802; GO:0045095 identical protein binding [GO:0042802] MTHCCSPCCQPTCCR 0.91854 1.3425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5951 0 0 0 0 0 13.2146 0 12.2295 0 0 0 11.4956 0 0 12.1002 0 0 0 0 0 0 11.8574 0 0 0 0 0 11.864 0 0 0 0 0 0 0 11.7107 12.6545 0 0 0 0 0 0 0 0 0 12.9728 0 0 0 0 0 0 0 0 0 0 0 0 12.3345 0 0 0 0 0 0 0 0 0 0 13.1208 0 0 0 0 0 11.9444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8771 0 0 0 0 0 0 0 A0A286YFG1 SCGR8_HUMAN Small cysteine and glycine repeat-containing protein 8 (Keratin-associated protein 28-8) SCYGR8 KRTAP28-8 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CCCQKQCCC 0.91855 1.1946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7142 0 10.5284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0391 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2739 10.4848 0 0 0 0 0 0 0 0 0 0 0 0 10.0441 0 0 0 0 0 0 0 11.1813 0 0 0 0 10.9895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY91 SC5A4_HUMAN Solute carrier family 5 member 4 SLC5A4 SAAT1 SGLT3 Homo sapiens (Human) sodium ion transport [GO:0006814] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; sodium ion transport [GO:0006814] GO:0005412; GO:0005886; GO:0006814; GO:0016021 glucose:sodium symporter activity [GO:0005412] KLTDTSERPSWR 0.91856 1.3925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2924 0 0 0 11.5269 0 0 0 0 0 13.2544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVJ1 S41A1_HUMAN Solute carrier family 41 member 1 SLC41A1 Homo sapiens (Human) cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857]; cellular magnesium ion homeostasis [GO:0010961]; cellular response to magnesium ion [GO:0071286]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001] GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0022890; GO:0030001; GO:0032991; GO:0061768; GO:0071286; GO:1903830 inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857] EVLYSGWEPVIIAMAISSVGGLILDK 0.91857 1.5034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9Q2 CSN7B_HUMAN "COP9 signalosome complex subunit 7b, SGN7b, Signalosome subunit 7b (JAB1-containing signalosome subunit 7b)" COPS7B CSN7B Homo sapiens (Human) COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] GO:0000338; GO:0005654; GO:0005829; GO:0008180; GO:0010387; GO:0045116; GO:2000434 AGEQKPSSNLLEQFILLAK 0.91858 1.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7875 0 0 0 0 0 12.0813 0 11.726 12.006 0 0 0 11.8429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5398 0 14.6574 0 0 0 0 0 0 0 0 13.3403 0 14.6697 0 0 0 0 13.5129 0 13.6611 0 14.7477 14.7004 0 0 0 13.1791 0 13.1186 0 0 0 13.7128 0 0 0 0 14.0711 13.5454 13.1756 13.7273 13.5223 0 14.0543 14.6126 13.5527 0 18.6048 0 0 14.1305 13.7253 0 0 0 14.0259 0 13.728 13.9577 13.4346 15.9328 13.6003 13.7845 13.4035 16.0037 0 13.6765 0 16.0001 14.0648 0 13.731 13.7146 0 0 13.9394 0 0 15.5901 0 0 0 0 13.7769 13.51 18.0904 14.7184 13.8733 0 15.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.756 18.4174 15.1581 0 0 0 0 0 O95059 RPP14_HUMAN Ribonuclease P protein subunit p14 RPP14 Homo sapiens (Human) tRNA 5'-leader removal [GO:0001682] mitochondrion [GO:0005739]; multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mitochondrion [GO:0005739]; multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; tRNA 5'-leader removal [GO:0001682] GO:0001682; GO:0004526; GO:0005654; GO:0005730; GO:0005739; GO:0030681; GO:0033204 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204] KCAFRVIQVSPFLLALSGNSR 0.9186 1.3406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.65 0 0 0 0 0 0 12.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8983 0 0 0 0 0 0 14.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH59 O51Q1_HUMAN Olfactory receptor 51Q1 OR51Q1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALNNCLSHILAVLVLYIPMVGVSMTHR 0.91861 1.3485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31415 CASQ1_HUMAN "Calsequestrin-1 (Calmitine) (Calsequestrin, skeletal muscle isoform)" CASQ1 CASQ Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to heat [GO:0009408]; response to organic substance [GO:0010033]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; terminal cisterna lumen [GO:0014804]; Z disc [GO:0030018] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; terminal cisterna lumen [GO:0014804]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of store-operated calcium channel activity [GO:1901341]; protein polymerization [GO:0051258]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of store-operated calcium entry [GO:2001256]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to heat [GO:0009408]; response to organic substance [GO:0010033]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519] GO:0005509; GO:0005739; GO:0005759; GO:0005783; GO:0005790; GO:0005794; GO:0007029; GO:0007519; GO:0009408; GO:0010033; GO:0014804; GO:0014809; GO:0014894; GO:0016529; GO:0030018; GO:0030315; GO:0033017; GO:0033018; GO:0042802; GO:0045214; GO:0051258; GO:0051279; GO:0051281; GO:1901341; GO:2001256 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] AVPGLRLALLLLLVLGTPK 0.91862 1.5784 0 0 0 0 0 0 0 0 13.5052 0 0 0 0 13.2699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9925 0 0 0 0 0 0 0 13.1985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5501 0 14.0769 0 0 0 0 13.4196 0 0 0 0 0 0 0 0 0 0 0 12.6825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GVK7 F240A_HUMAN Protein FAM240A FAM240A Homo sapiens (Human) MRLFSGMNNQYTRR 0.91863 1.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCC9 LST2_HUMAN "Lateral signaling target protein 2 homolog, hLst2 (Zinc finger FYVE domain-containing protein 28)" ZFYVE28 KIAA1643 LST2 Homo sapiens (Human) negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175] cytosol [GO:0005829]; early endosome membrane [GO:0031901] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175] GO:0005829; GO:0007175; GO:0031901; GO:0032266; GO:0042059; GO:0046872 metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266] DPDAELACSMQYDDQELEQLSR 0.91865 1.4875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9162 0 0 13.9458 0 0 0 0 0 0 0 0 0 14.0651 11.9925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5295 0 0 0 0 0 0 0 0 12.1777 0 0 0 11.826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN74 PCDA4_HUMAN "Protocadherin alpha-4, PCDH-alpha-4" PCDHA4 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0042802 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] GYIDFEESK 0.91865 1.5714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4142 0 0 11.7851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.46 0 14.9148 0 0 0 0 0 0 0 12.2603 0 0 Q9NZN8 CNOT2_HUMAN CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2) CNOT2 CDC36 NOT2 HSPC131 MSTP046 Homo sapiens (Human) "gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]" CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886] "CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; transcription coregulator activity [GO:0003712]; transcription corepressor binding [GO:0001222]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]" GO:0000122; GO:0000289; GO:0000932; GO:0001222; GO:0001829; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0010606; GO:0016020; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:0090503; GO:2000036 transcription coregulator activity [GO:0003712]; transcription corepressor binding [GO:0001222] DPTSSNDDSKSNLNTSGK 0.91866 1.1651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2982 0 0 0 0 13.016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8959 0 0 0 0 12.1278 0 0 0 0 0 0 12.3684 0 0 0 0 0 0 0 13.593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9467 0 13.0807 0 0 0 0 0 0 0 0 0 0 0 0 14.0308 0 0 0 0 0 0 0 0 0 0 0 0 13.4941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16563 SYPL1_HUMAN Synaptophysin-like protein 1 (Pantophysin) SYPL1 SYPL Homo sapiens (Human) chemical synaptic transmission [GO:0007268] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672]; chemical synaptic transmission [GO:0007268] GO:0005887; GO:0007268; GO:0016021; GO:0030141; GO:0030285; GO:0030672; GO:0042470; GO:0070062 APNIYLVRQRISR 0.91867 1.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5495 0 0 0 11.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1075 0 0 0 0 0 0 0 0 13.2459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5729 0 13.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91377 0 0 0 10.5564 0 10.718 0 0 0 0 0 0 0 0 0 0 0 A6NE02 BTBDH_HUMAN BTB/POZ domain-containing protein 17 (Galectin-3-binding protein-like) BTBD17 Homo sapiens (Human) negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] GO:0005576; GO:0005886; GO:0009615; GO:0045071 NSEYLVENALHLHLIVKPVYHTLIR 0.91868 1.4866 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1888 14.8712 0 17.6969 17.3926 16.9607 0 0 0 0 0 0 15.2719 15.5227 0 0 0 16.8216 0 0 0 0 0 0 0 0 0 16.3519 16.2178 16.5601 16.5804 16.7702 17.4138 17.1953 17.1535 14.4216 0 0 0 17.9206 18.88 17.4414 17.0199 18.19 18.365 16.6384 15.6628 18.6282 18.8767 16.036 15.1743 15.1271 16.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.542 0 11.2617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8443 0 0 12.4678 12.1803 0 12.8817 0 0 0 0 18.3274 0 13.2163 12.4041 0 12.0458 0 19.6789 0 0 0 0 0 0 10.203 0 0 0 0 0 0 17.4782 20.5646 0 0 0 13.5483 0 11.6542 0 0 A6NFH5 FBP12_HUMAN Fatty acid-binding protein 12 FABP12 Homo sapiens (Human) fatty acid transport [GO:0015908] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; fatty acid transport [GO:0015908] GO:0005504; GO:0005634; GO:0005829; GO:0015908 fatty acid binding [GO:0005504] NNEISFKLGEEFEEITPGGHK 0.91869 1.1643 0 0 0 0 0 0 0 0 12.845 0 0 13.2852 0 0 0 12.3557 0 0 0 0 0 0 0 0 0 12.5811 12.1334 0 0 0 13.3476 12.6619 13.2083 0 0 0 13.071 13.6887 13.9795 14.1335 0 12.4134 12.6186 0 12.3327 0 13.8774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4986 12.9884 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9112 13.3276 12.9292 14.0192 0 0 0 0 0 0 13.1382 0 14.3601 0 0 15.6528 0 0 0 0 0 0 0 0 0 0 0 0 14.8194 0 12.9616 0 0 0 0 0 12.4178 13.2268 0 0 0 0 0 0 0 0 0 O43761 SNG3_HUMAN Synaptogyrin-3 SYNGR3 Homo sapiens (Human) neurotransmitter uptake [GO:0001504]; positive regulation of transporter activity [GO:0032411]; regulated exocytosis [GO:0045055]; substantia nigra development [GO:0021762] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; protein N-terminus binding [GO:0047485]; SH2 domain binding [GO:0042169]; neurotransmitter uptake [GO:0001504]; positive regulation of transporter activity [GO:0032411]; regulated exocytosis [GO:0045055]; substantia nigra development [GO:0021762] GO:0001504; GO:0008021; GO:0016021; GO:0021762; GO:0030672; GO:0031594; GO:0032411; GO:0042169; GO:0045055; GO:0047485; GO:0070161 protein N-terminus binding [GO:0047485]; SH2 domain binding [GO:0042169] CVFNGNAGACRFGVALGLGAFLACAAFLLLDVR 0.91869 1.1925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2678 13.7389 0 0 13.3869 14.0044 0 0 0 0 0 0 0 0 14.2538 0 0 0 13.6962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969E4 TCAL3_HUMAN "Transcription elongation factor A protein-like 3, TCEA-like protein 3 (Transcription elongation factor S-II protein-like 3)" TCEAL3 MSTP072 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] GO:0005634; GO:0050699 WW domain binding [GO:0050699] EDEGEPGDEGQLEDEGSQEK 0.9187 1.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75508 CLD11_HUMAN Claudin-11 (Oligodendrocyte-specific protein) CLDN11 OSP OTM Homo sapiens (Human) axon ensheathment [GO:0008366]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; spermatogenesis [GO:0007283]; tight junction assembly [GO:0120192] axon [GO:0030424]; basal part of cell [GO:0045178]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; tight junction [GO:0070160] axon [GO:0030424]; basal part of cell [GO:0045178]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axon ensheathment [GO:0008366]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; spermatogenesis [GO:0007283]; tight junction assembly [GO:0120192] GO:0005198; GO:0005811; GO:0005883; GO:0005886; GO:0005923; GO:0007155; GO:0007283; GO:0008366; GO:0016021; GO:0016338; GO:0030054; GO:0030424; GO:0042802; GO:0045178; GO:0070160; GO:0070830; GO:0120192 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] ALMIAASVLGLPAILLLLTVLPCIR 0.91872 1.164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7349 0 0 0 0 0 0 0 0 13.6168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32881 IFNA8_HUMAN "Interferon alpha-8, IFN-alpha-8 (Interferon alpha-B, LeIF B) (Interferon alpha-B2)" IFNA8 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132] DRHDFEFPQEEFDDKQFQK 0.91872 1.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9487 0 0 0 0 0 0 11.0506 0 0 0 0 0 0 0 0 0 11.9633 0 0 0 0 0 0 0 Q969N4 TAAR8_HUMAN "Trace amine-associated receptor 8, TaR-8, Trace amine receptor 8 (G-protein coupled receptor 102) (Trace amine receptor 5, TaR-5)" TAAR8 GPR102 TA5 TAR5 TRAR5 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594] AIKLILSGDVLK 0.91874 1.1554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3242 0 0 12.8139 0 0 0 0 0 0 0 0 0 0 12.4041 0 0 0 0 0 0 0 0 12.8683 0 0 0 12.7194 0 0 0 11.6645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYV9 T2R13_HUMAN "Taste receptor type 2 member 13, T2R13 (Taste receptor family B member 3, TRB3)" TAS2R13 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; positive regulation of cytokinesis [GO:0032467] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; positive regulation of cytokinesis [GO:0032467] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0032467; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] LLIILAISR 0.91874 1.5537 0 0 0 0 0 0 0 0 13.2522 0 0 0 0 12.7663 0 0 0 0 0 0 0 11.9658 0 11.6147 0 13.1767 0 0 0 13.515 0 0 0 0 0 0 0 0 0 12.8741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2628 0 0 0 0 0 0 0 0 0 0 0 13.7827 11.8144 0 0 0 0 0 0 0 0 0 0 0 17.9407 0 0 0 0 0 0 0 0 13.1911 13.9093 11.0452 0 0 13.569 12.8445 14.247 0 0 12.1341 0 13.7252 13.4446 0 0 0 12.9674 12.1699 12.7918 0 13.4881 17.9166 0 12.0651 13.5866 13.5643 0 12.6458 0 13.3693 0 0 13.4981 0 0 0 0 0 0 0 13.7401 0 13.5094 13.1831 0 0 13.6731 13.6107 0 0 17.324 0 0 12.9171 0 13.2929 0 13.1879 13.4526 0 0 0 0 0 13.4735 12.8089 13.2269 0 0 0 0 0 0 0 0 13.0327 0 0 0 0 0 0 12.7865 13.1128 0 0 0 0 0 0 0 P14679 TYRO_HUMAN "Tyrosinase, EC 1.14.18.1 (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB)" TYR Homo sapiens (Human) cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanin biosynthetic process from tyrosine [GO:0006583]; pigmentation [GO:0043473]; response to blue light [GO:0009637]; response to cAMP [GO:0051591]; response to UV [GO:0009411]; response to vitamin D [GO:0033280]; thymus development [GO:0048538]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503]; cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanin biosynthetic process from tyrosine [GO:0006583]; pigmentation [GO:0043473]; response to blue light [GO:0009637]; response to cAMP [GO:0051591]; response to UV [GO:0009411]; response to vitamin D [GO:0033280]; thymus development [GO:0048538]; visual perception [GO:0007601] GO:0004503; GO:0005507; GO:0005634; GO:0005737; GO:0005764; GO:0005798; GO:0005829; GO:0006583; GO:0006726; GO:0007601; GO:0008283; GO:0009411; GO:0009637; GO:0016021; GO:0033162; GO:0033280; GO:0042438; GO:0042470; GO:0042802; GO:0042803; GO:0043231; GO:0043473; GO:0048471; GO:0048538; GO:0051591 copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503] FGFWGPNCTER 0.91875 1.3375 0 0 0 0 0 0 0 0 12.6367 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH79 OR6X1_HUMAN Olfactory receptor 6X1 (Olfactory receptor OR11-270) OR6X1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] INKVVSVLNTILTPLLNPFIYTIR 0.91876 1.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6276 0 0 0 0 0 0 0 0 0 10.3949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1994 0 0 0 0 0 0 0 0 0 0 11.8966 12.3656 13.3068 0 0 0 0 0 0 0 0 12.6001 0 0 0 0 0 0 13.3278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29400 CO4A5_HUMAN Collagen alpha-5(IV) chain COL4A5 Homo sapiens (Human) collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528] GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007528; GO:0030020; GO:0030198; GO:0031012; GO:0031594; GO:0038063; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GDPGQTITQPGKPGLPGNPGR 0.91877 1.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9597 11.8152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19256 LFA3_HUMAN "Lymphocyte function-associated antigen 3, Ag3 (Surface glycoprotein LFA-3) (CD antigen CD58)" CD58 LFA3 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cellular response to interferon-gamma [GO:0071346]; cellular response to tumor necrosis factor [GO:0071356]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of interleukin-8 production [GO:0032757] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; signaling receptor binding [GO:0005102]; cell-cell adhesion [GO:0098609]; cellular response to interferon-gamma [GO:0071346]; cellular response to tumor necrosis factor [GO:0071356]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of interleukin-8 production [GO:0032757] GO:0005102; GO:0005886; GO:0005887; GO:0009986; GO:0016020; GO:0030667; GO:0032757; GO:0034113; GO:0070062; GO:0071346; GO:0071356; GO:0098609; GO:0101003 signaling receptor binding [GO:0005102] GLIMYSWDCPMEQCKR 0.91878 1.1911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9484 0 0 0 12.9616 0 10.6667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0109 0 0 0 0 0 0 0 0 13.8857 0 0 0 0 0 0 0 14.1089 0 0 0 0 0 0 0 0 0 0 0 0 11.1317 0 0 0 11.7208 0 0 15.5889 0 0 0 0 0 15.699 0 0 0 10.6352 0 0 0 0 15.7043 0 0 0 0 0 0 0 0 0 0 0 0 10.2776 0 0 0 0 0 0 0 0 0 10.3198 0 0 0 0 Q9Y385 UB2J1_HUMAN "Ubiquitin-conjugating enzyme E2 J1, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1, NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E, HsUBC6e)" UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205 Homo sapiens (Human) "negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]" endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000209; GO:0005524; GO:0005634; GO:0005789; GO:0007286; GO:0010935; GO:0016021; GO:0018279; GO:0030433; GO:0031625; GO:0032680; GO:0061631; GO:1904153 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625] GPPDSDFDGGVYHGR 0.91879 1.5666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5321 0 0 0 0 0 0 0 0 0 11.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0673 0 0 0 0 0 0 0 0 0 11.1189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1945 0 0 0 0 0 10.5002 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9289 0 0 0 0 0 0 0 0 Q9NPI6 DCP1A_HUMAN "mRNA-decapping enzyme 1A, EC 3.6.1.62 (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF)" DCP1A SMIF Homo sapiens (Human) "deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]; protein localization to cytoplasmic stress granule [GO:1903608]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]; protein localization to cytoplasmic stress granule [GO:1903608]" GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0008047; GO:0016020; GO:0016787; GO:0019894; GO:0031087; GO:0036464; GO:0042802; GO:0043085; GO:0110156; GO:1903608 enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; mRNA binding [GO:0003729] DLEFQLHEPFLLYRNASLSIYSIWFYDKNDCHR 0.91881 1.1701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6449 0 0 0 0 0 0 0 0 0 0 0 13.9433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1688 0 0 0 13.8384 0 0 0 0 0 0 12.997 0 0 Q6MZM9 PRR27_HUMAN Proline-rich protein 27 PRR27 C4orf40 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 LLLWACIVCVAFAR 0.91886 1.1896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXQ3 CI040_HUMAN Uncharacterized protein C9orf40 C9orf40 Homo sapiens (Human) DSGDNSAPSGQER 0.91887 1.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S06 LMF1_HUMAN Lipase maturation factor 1 (Transmembrane protein 112) LMF1 C16orf26 TMEM112 HMFN1876 JFP11 Homo sapiens (Human) protein maturation [GO:0051604]; triglyceride metabolic process [GO:0006641] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein maturation [GO:0051604]; triglyceride metabolic process [GO:0006641] GO:0005789; GO:0006641; GO:0016021; GO:0051604 FGSVVRR 0.91888 1.5512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7578 0 0 0 0 0 0 0 0 0 0 0 11.8939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQM4 DAAF6_HUMAN Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3) (Sarcoma antigen NY-SAR-97) DNAAF6 CXorf41 PIH1D3 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286 chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505] DSSTGCCSELVAK 0.91894 1.5413 0 0 0 0 0 0 0 0 0 0 0 0 12.9804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3103 0 0 0 0 0 0 11.4616 11.7581 0 12.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58317 ZN121_HUMAN Zinc finger protein 121 (Zinc finger protein 20) ZNF121 ZNF20 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFAGRSGLTKHVR 0.91895 1.1664 0 0 0 0 0 0 0 0 0 0 14.601 13.0526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8042 0 0 14.7472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6MZW2 FSTL4_HUMAN Follistatin-related protein 4 (Follistatin-like protein 4) FSTL4 KIAA1061 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031549]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000] extracellular region [GO:0005576]; secretory granule [GO:0030141] extracellular region [GO:0005576]; secretory granule [GO:0030141]; brain-derived neurotrophic factor binding [GO:0048403]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; negative regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031549]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000] GO:0005509; GO:0005576; GO:0030141; GO:0030154; GO:0031549; GO:0048403; GO:0048671; GO:0061000 brain-derived neurotrophic factor binding [GO:0048403]; calcium ion binding [GO:0005509] DSGLFGQYLLTPAR 0.919 1.5114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.855 0 0 0 13.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95665 NTR2_HUMAN "Neurotensin receptor type 2, NT-R-2, NTR2 (Levocabastine-sensitive neurotensin receptor)" NTSR2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of membrane potential [GO:0042391]; sensory perception [GO:0007600] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of membrane potential [GO:0042391]; sensory perception [GO:0007600] GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007200; GO:0007218; GO:0007600; GO:0016492; GO:0042391 G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930] SLLTPRR 0.91902 1.5481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7758 0 0 0 0 0 13.3957 0 Q96P68 OXGR1_HUMAN "2-oxoglutarate receptor 1 (Alpha-ketoglutarate receptor 1) (G-protein coupled receptor 80) (G-protein coupled receptor 99) (P2Y purinoceptor 15, P2Y15) (P2Y-like GPCR) (P2Y-like nucleotide receptor)" OXGR1 GPR80 GPR99 P2RY15 P2Y15 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0016021; GO:0038023 G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023] ARRLTILLLLAFYVCFLPFHILR 0.91902 1.3476 0 0 0 0 0 0 0 0 0 0 11.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1676 0 0 15.2397 0 0 0 0 0 0 12.2816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3J9 ZN664_HUMAN Zinc finger protein 664 (Zinc finger protein 176) (Zinc finger protein from organ of Corti) ZNF664 ZFOC1 ZNF176 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DHTGEKVYKCDDCGK 0.91903 1.5107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9886 0 10.7248 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0414 12.0039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2203 16.3516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5G3 PCDGD_HUMAN "Protocadherin gamma-B1, PCDH-gamma-B1" PCDHGB1 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887] growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0030426 calcium ion binding [GO:0005509] PEPSDPQTELQFYLVVALALISVLFLLAVILAIALR 0.91903 1.5795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6988 0 0 11.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3894 0 0 11.4705 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75955 FLOT1_HUMAN Flotillin-1 FLOT1 Homo sapiens (Human) "axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; plasma membrane raft organization [GO:0044857]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]" adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; sarcolemma [GO:0042383]; uropod [GO:0001931] "adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; sarcolemma [GO:0042383]; uropod [GO:0001931]; ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020]; axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; plasma membrane raft organization [GO:0044857]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]" GO:0001819; GO:0001931; GO:0001934; GO:0002020; GO:0002090; GO:0005765; GO:0005768; GO:0005769; GO:0005815; GO:0005886; GO:0005901; GO:0005911; GO:0005912; GO:0005925; GO:0007409; GO:0009897; GO:0016020; GO:0016323; GO:0016600; GO:0022617; GO:0030027; GO:0031410; GO:0032092; GO:0032226; GO:0032728; GO:0033227; GO:0034116; GO:0034141; GO:0034451; GO:0034976; GO:0035023; GO:0035255; GO:0042383; GO:0042470; GO:0044291; GO:0044854; GO:0044857; GO:0045121; GO:0045807; GO:0048643; GO:0048786; GO:0050821; GO:0051092; GO:0051580; GO:0070062; GO:0070528; GO:0071360; GO:0072659; GO:0098691; GO:0098978; GO:0098982; GO:1901741; GO:1901890; GO:2000049 ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020] RAQADLAYQLQVAKTK 0.91905 1.5714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0088 0 0 13.1739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YL0 NCAS2_HUMAN Protein NCBP2AS2 (Hypoxia-induced angiogenesis regulator) (NCBP2 antisense gene protein 2) NCBP2AS2 HIAR Homo sapiens (Human) AAQLTAFALLQAQLRGQDAARR 0.91907 1.5092 0 0 0 0 0 0 0 0 0 0 14.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6772 0 0 0 0 0 0 0 0 11.4319 0 0 0 0 0 0 0 0 0 0 14.1598 0 0 0 0 0 0 0 0 13.0462 0 0 13.3559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9551 13.9249 0 0 0 16.3886 0 0 0 0 0 0 0 0 0 0 0 0 12.9463 0 0 12.0045 0 0 0 15.0643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCW7 ZPLD1_HUMAN "Zona pellucida-like domain-containing protein 1, ZP domain-containing protein 1 (Cupulin) [Cleaved into: Zona pellucida-like domain-containing protein 1, secreted form ]" ZPLD1 Homo sapiens (Human) vestibular reflex [GO:0060005] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; extracellular matrix structural constituent [GO:0005201]; vestibular reflex [GO:0060005] GO:0005201; GO:0005615; GO:0009986; GO:0016021; GO:0030659; GO:0060005 extracellular matrix structural constituent [GO:0005201] ENNGTFVSTLNLLLYNDSTYNQQLIIPSIGLPLKTK 0.91908 1.5202 0 0 0 0 0 0 0 0 0 0 0 10.9322 0 0 11.5116 0 0 0 0 14.0498 11.7907 0 0 0 0 0 0 0 0 0 10.9018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2843 13.9732 0 0 0 17.0247 0 0 12.9736 12.117 13.276 12.5432 13.2481 12.4626 0 0 0 14.1184 13.543 13.6577 14.029 0 0 17.61 0 12.934 0 13.0413 13.5148 13.3045 12.6777 0 0 16.479 0 0 12.2003 0 0 0 0 11.8009 12.8762 0 0 0 0 18.2942 0 0 0 0 0 12.9841 0 12.8394 0 17.4018 13.5125 17.4627 17.2962 12.9964 0 13.762 0 0 12.771 13.1147 0 0 0 0 17.0563 0 0 0 0 14.3981 0 13.7676 0 0 0 0 0 0 0 0 13.5317 0 0 0 0 0 0 0 0 0 11.5935 0 0 0 0 0 17.5704 0 0 0 0 0 0 0 0 Q9UBX3 DIC_HUMAN "Mitochondrial dicarboxylate carrier, DIC (Solute carrier family 25 member 10)" SLC25A10 DIC Homo sapiens (Human) "dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]" integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; phosphate ion transmembrane transporter activity [GO:0015114]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]" GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006839; GO:0008272; GO:0015114; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0022857; GO:0035435; GO:0070221; GO:0071422; GO:0071423 antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; phosphate ion transmembrane transporter activity [GO:0015114]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857] GLVPAGIRLIPHTVLTFVFLEQLR 0.9191 1.3378 0 0 0 0 0 0 0 0 0 0 0 0 12.8282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0283 0 0 0 0 0 0 0 0 0 0 Q02505 MUC3A_HUMAN "Mucin-3A, MUC-3A (Intestinal mucin-3A)" MUC3A MUC3 Homo sapiens (Human) extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent, lubricant activity [GO:0030197]; extracellular matrix structural constituent [GO:0005201]" GO:0005201; GO:0005576; GO:0005796; GO:0005886; GO:0016021; GO:0030197 "extracellular matrix constituent, lubricant activity [GO:0030197]; extracellular matrix structural constituent [GO:0005201]" ALVGGLTAGAALLVLLLLALGVR 0.91912 1.171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7985 12.5019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8293 0 0 0 0 0 0 0 0 11.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIR3 AGAP5_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5, AGAP-5 (Centaurin-gamma-like family member 2)" AGAP5 CTGLF2 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630] GO:0003924; GO:0005096; GO:0046872; GO:0090630 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] AIPIKQGMLLK 0.91913 1.5766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17707 DCAM_HUMAN "S-adenosylmethionine decarboxylase proenzyme, AdoMetDC, SAMDC, EC 4.1.1.50 [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain ]" AMD1 AMD Homo sapiens (Human) polyamine metabolic process [GO:0006595]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; S-adenosylmethionine metabolic process [GO:0046500]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597] cytosol [GO:0005829] cytosol [GO:0005829]; adenosylmethionine decarboxylase activity [GO:0004014]; identical protein binding [GO:0042802]; putrescine binding [GO:0019810]; polyamine metabolic process [GO:0006595]; S-adenosylmethioninamine biosynthetic process [GO:0006557]; S-adenosylmethionine metabolic process [GO:0046500]; spermidine biosynthetic process [GO:0008295]; spermine biosynthetic process [GO:0006597] GO:0004014; GO:0005829; GO:0006557; GO:0006595; GO:0006597; GO:0008295; GO:0019810; GO:0042802; GO:0046500 adenosylmethionine decarboxylase activity [GO:0004014]; identical protein binding [GO:0042802]; putrescine binding [GO:0019810] FILKTCGTTLLLK 0.91914 1.554 0 0 0 0 0 0 0 0 14.8858 11.7375 13.204 0 0 12.4575 11.8673 13.1703 13.6267 13.5002 0 0 0 0 11.1012 0 0 0 13.0109 0 11.9421 12.7356 13.2208 12.9535 14.7016 0 13.1632 11.3707 0 12.7359 13.0706 13.3408 12.6013 0 11.5313 14.0534 12.5413 0 0 0 0 12.0174 0 11.0297 0 15.7638 15.8409 15.6263 15.2734 14.5077 15.784 15.874 15.6664 12.4776 13.2027 13.8175 13.1859 14.4577 0 0 0 0 0 13.8605 0 0 0 0 0 13.8122 0 0 0 0 0 0 0 13.458 16.1995 0 0 0 0 10.5614 12.9521 0 0 11.7188 0 13.7551 0 12.8592 0 12.9116 0 0 0 0 0 13.6011 13.0361 0 0 15.2571 15.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4231 0 0 0 0 19.1351 0 0 12.9332 0 0 0 0 0 0 0 15.3219 0 0 0 0 0 0 0 13.2086 14.6665 13.7686 14.1906 13.0533 11.1759 14.9183 18.3423 15.6594 14.8453 14.7953 15.9621 15.701 13.4074 0 12.601 0 12.3695 0 0 15.8481 0 14.1682 0 0 P80365 DHI2_HUMAN "11-beta-hydroxysteroid dehydrogenase type 2, 11-DH2, 11-beta-HSD2, EC 1.1.1.- (11-beta-hydroxysteroid dehydrogenase type II, 11-HSD type II, 11-beta-HSD type II) (Corticosteroid 11-beta-dehydrogenase isozyme 2) (NAD-dependent 11-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 3)" HSD11B2 HSD11K SDR9C3 Homo sapiens (Human) cortisol metabolic process [GO:0034650]; female pregnancy [GO:0007565]; glucocorticoid metabolic process [GO:0008211]; regulation of blood volume by renal aldosterone [GO:0002017]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; 11-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0070523]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; cortisol metabolic process [GO:0034650]; female pregnancy [GO:0007565]; glucocorticoid metabolic process [GO:0008211]; regulation of blood volume by renal aldosterone [GO:0002017]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] GO:0001666; GO:0002017; GO:0005496; GO:0005654; GO:0005789; GO:0005811; GO:0007565; GO:0008202; GO:0008211; GO:0009410; GO:0016229; GO:0016491; GO:0032094; GO:0032868; GO:0034650; GO:0043231; GO:0051287; GO:0051384; GO:0070523 11-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0070523]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229] ALLQLLRSDLRLGR 0.91915 1.1901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1824 13.6468 0 0 0 0 0 0 0 0 0 0 14.4517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P272 TRM9B_HUMAN "Probable tRNA methyltransferase 9B (Probable tRNA methyltransferase 9-like protein, EC 2.1.1.-)" TRMT9B C8orf79 KIAA1456 TRM9L Homo sapiens (Human) tRNA modification [GO:0006400]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; tRNA methyltransferase activity [GO:0008175]; tRNA modification [GO:0006400]; tRNA wobble uridine modification [GO:0002098] GO:0000049; GO:0002098; GO:0005634; GO:0005737; GO:0006400; GO:0008175; GO:0016300 tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; tRNA methyltransferase activity [GO:0008175] DEGFDAIISIGVIHHFSTK 0.91917 1.5765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FI4 NEIL1_HUMAN "Endonuclease 8-like 1, EC 3.2.2.-, EC 4.2.99.18 (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (FPG1) (Nei homolog 1, NEH1) (Nei-like protein 1)" NEIL1 Homo sapiens (Human) "base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; response to oxidative stress [GO:0006979]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; depyrimidination [GO:0045008]; negative regulation of nuclease activity [GO:0032074]; response to oxidative stress [GO:0006979]" GO:0003684; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005829; GO:0006284; GO:0006287; GO:0006979; GO:0008022; GO:0008270; GO:0016798; GO:0019104; GO:0032074; GO:0045008; GO:0140078 "class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]" CYGMPGMSSLQDR 0.91918 1.1898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC07 TM165_HUMAN Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL) TMEM165 TPARL Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transmembrane transport [GO:0071421]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751] GO:0000139; GO:0005384; GO:0005765; GO:0005794; GO:0006487; GO:0006874; GO:0010008; GO:0015085; GO:0016021; GO:0031901; GO:0031902; GO:0032468; GO:0032472; GO:0032588; GO:0035751; GO:0043231; GO:0046873; GO:0070588; GO:0071421 calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion transmembrane transporter activity [GO:0046873] LLLLFLVPLLWAPAAVR 0.91922 1.5378 0 0 0 0 0 0 0 0 15.1923 14.3178 0 13.5464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.028 0 14.1951 0 0 0 0 14.2901 0 0 0 0 14.3569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7825 0 0 12.5154 0 0 12.7724 0 0 13.703 12.9162 0 13.3146 0 14.4018 0 0 0 0 13.2622 0 0 0 0 0 13.9592 13.5002 14.0864 0 0 0 0 0 0 0 0 0 0 0 0 13.0232 0 0 13.7312 0 0 0 0 13.6783 0 0 0 12.9867 12.9932 0 12.7993 0 0 13.6214 0 0 13.1399 0 0 0 13.1974 0 0 0 0 0 0 0 13.2615 0 15.1572 0 0 0 0 0 0 0 13.6248 0 0 14.5302 14.9368 0 14.9715 14.7277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60014 KR10A_HUMAN Keratin-associated protein 10-10 (High sulfur keratin-associated protein 10.10) (Keratin-associated protein 10.10) (Keratin-associated protein 18-10) (Keratin-associated protein 18.10) KRTAP10-10 KAP10.10 KAP18-10 KRTAP10.10 KRTAP18-1 KRTAP18.10 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 AASTMSICSSACTDSWR 0.91926 1.5376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3815 0 11.8605 0 12.1653 0 0 0 0 0 0 0 0 0 11.2265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2445 0 0 0 0 0 0 0 0 0 0 0 0 14.8001 0 0 15.305 0 0 0 11.6936 0 0 0 0 0 0 0 0 13.1532 0 0 0 0 0 11.9825 0 0 11.5968 0 0 0 0 0 0 0 0 11.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5984 0 0 0 0 0 0 0 0 0 0 12.3983 12.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.227 0 0 0 Q6FIF0 ZFAN6_HUMAN AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3) ZFAND6 AWP1 ZA20D3 HT032 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122] cytosol [GO:0005829] cytosol [GO:0005829]; DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122] GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0031593; GO:0043066; GO:0043122; GO:0071356 DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270] KENPVVVGEKIQK 0.91926 1.4994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4791 Q9HCU0 CD248_HUMAN Endosialin (Tumor endothelial marker 1) (CD antigen CD248) CD248 CD164L1 TEM1 Homo sapiens (Human) anatomical structure regression [GO:0060033]; cell migration [GO:0016477]; endothelial cell apoptotic process [GO:0072577]; fibroblast migration [GO:0010761]; fibroblast proliferation [GO:0048144]; lymph node development [GO:0048535]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of fibroblast proliferation [GO:0048146] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; anatomical structure regression [GO:0060033]; cell migration [GO:0016477]; endothelial cell apoptotic process [GO:0072577]; fibroblast migration [GO:0010761]; fibroblast proliferation [GO:0048144]; lymph node development [GO:0048535]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of fibroblast proliferation [GO:0048146] GO:0005509; GO:0005737; GO:0009897; GO:0010761; GO:0016021; GO:0016477; GO:0030246; GO:0031012; GO:0048144; GO:0048146; GO:0048535; GO:0050840; GO:0060033; GO:0070062; GO:0072577; GO:1990430; GO:2000353 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430] SCEDPCAQAPCEQQCEPGGPQGYSCHCR 0.91931 1.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3818 0 14.7639 0 0 0 0 0 0 0 0 13.5493 0 12.4056 0 0 0 0 0 0 0 0 0 13.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0079 0 0 0 0 0 11.233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6325 0 0 0 0 0 0 0 0 0 0 14.8581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9105 0 0 0 13.9236 14.2309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17752 TPH1_HUMAN "Tryptophan 5-hydroxylase 1, EC 1.14.16.4 (Tryptophan 5-monooxygenase 1)" TPH1 TPH TPRH TRPH Homo sapiens (Human) aromatic amino acid family metabolic process [GO:0009072]; bone remodeling [GO:0046849]; circadian rhythm [GO:0007623]; mammary gland alveolus development [GO:0060749]; negative regulation of ossification [GO:0030279]; platelet degranulation [GO:0002576]; positive regulation of fat cell differentiation [GO:0045600]; regulation of hemostasis [GO:1900046]; response to immobilization stress [GO:0035902]; serotonin biosynthetic process [GO:0042427] cytosol [GO:0005829]; neuron projection [GO:0043005] cytosol [GO:0005829]; neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; bone remodeling [GO:0046849]; circadian rhythm [GO:0007623]; mammary gland alveolus development [GO:0060749]; negative regulation of ossification [GO:0030279]; platelet degranulation [GO:0002576]; positive regulation of fat cell differentiation [GO:0045600]; regulation of hemostasis [GO:1900046]; response to immobilization stress [GO:0035902]; serotonin biosynthetic process [GO:0042427] GO:0002576; GO:0004510; GO:0005506; GO:0005829; GO:0007623; GO:0009072; GO:0030279; GO:0035902; GO:0042427; GO:0043005; GO:0045600; GO:0046849; GO:0060749; GO:1900046 iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510] ASLIFSLKNEVGGLIK 0.91932 1.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4387 0 0 0 0 9.68633 0 0 0 0 0 0 12.7322 0 0 0 0 15.2934 15.4384 12.7276 0 15.3668 0 0 0 0 16.1163 0 0 0 0 0 0 15.4124 0 0 0 0 0 15.2823 0 0 14.6313 0 14.488 0 15.3396 0 14.8426 15.1759 14.9727 14.7388 0 0 0 14.9983 0 0 0 14.7016 0 14.7969 14.3343 14.4567 0 0 13.9852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7831 0 0 0 14.7165 0 0 0 0 0 0 0 0 13.6787 0 0 0 0 0 0 0 P52569 CTR2_HUMAN "Cationic amino acid transporter 2, CAT-2, CAT2 (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2)" SLC7A2 ATRC2 CAT2 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] GO:0000064; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352 amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] KIVTLDSLEDTK 0.91938 1.4896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IX19 MCEM1_HUMAN Mast cell-expressed membrane protein 1 MCEMP1 C19orf59 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; identical protein binding [GO:0042802] GO:0005886; GO:0016021; GO:0035579; GO:0042802; GO:0070821 identical protein binding [GO:0042802] AILSLYILLALAFVLCIILSAFIMVKNAEMSKELLGFK 0.9194 1.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3931 0 0 0 0 0 0 0 13.5317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43169 CYB5B_HUMAN Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform) CYB5B CYB5M OMB5 Homo sapiens (Human) nitric oxide biosynthetic process [GO:0006809]; response to oxidative stress [GO:0006979]; xenobiotic metabolic process [GO:0006805] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nitric-oxide synthase complex [GO:1903958] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nitric-oxide synthase complex [GO:1903958]; enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide biosynthetic process [GO:0006809]; response to oxidative stress [GO:0006979]; xenobiotic metabolic process [GO:0006805] GO:0005741; GO:0006805; GO:0006809; GO:0006979; GO:0008047; GO:0016020; GO:0016021; GO:0020037; GO:0043231; GO:0046872; GO:1903958 enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872] NDTCKSCWAYWILPIIGAVLLGFLYR 0.91942 1.4886 0 0 0 0 0 0 0 0 0 0 11.6059 0 0 11.8671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7443 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7N9 T179B_HUMAN Transmembrane protein 179B TMEM179B Homo sapiens (Human) azurophil granule membrane [GO:0035577]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] azurophil granule membrane [GO:0035577]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] GO:0005730; GO:0005886; GO:0016021; GO:0016607; GO:0030667; GO:0035577; GO:0101003 GAIGLRIALAISAIAVFLVLVSACILR 0.91942 1.5724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86361 0 0 0 0 0 0 0 0 0 0 10.9467 0 0 0 0 0 10.6378 11.5698 10.0496 0 0 0 0 0 0 0 0 0 0 15.3045 13.789 0 0 0 0 11.6742 0 11.5954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.834 0 0 0 0 0 0 0 0 11.8918 0 12.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAZ1 CLK4_HUMAN "Dual specificity protein kinase CLK4, EC 2.7.12.1 (CDC-like kinase 4)" CLK4 Homo sapiens (Human) peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0006468; GO:0018108; GO:0043484; GO:0046777; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] CKPLKEFMLCHDEEHEK 0.91943 1.5485 0 0 0 0 0 0 0 0 0 0 0 11.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3514 0 0 0 0 0 0 0 0 0 0 0 0 11.1282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1332 0 0 0 0 0 0 0 0 12.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4276 0 0 0 0 0 0 13.2841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26718 NKG2D_HUMAN NKG2-D type II integral membrane protein (Killer cell lectin-like receptor subfamily K member 1) (NK cell receptor D) (NKG2-D-activating NK receptor) (CD antigen CD314) KLRK1 D12S2489E NKG2D Homo sapiens (Human) adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of GTPase activity [GO:0034260]; negative regulation of natural killer cell chemotaxis [GO:2000502]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib receptor activity [GO:0032394]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of GTPase activity [GO:0034260]; negative regulation of natural killer cell chemotaxis [GO:2000502]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295] GO:0002223; GO:0002250; GO:0005886; GO:0005887; GO:0006809; GO:0007165; GO:0009897; GO:0009986; GO:0016021; GO:0030101; GO:0030154; GO:0030246; GO:0031295; GO:0032394; GO:0032729; GO:0034260; GO:0038023; GO:0042267; GO:0042288; GO:0042802; GO:0045429; GO:0045954; GO:0050830; GO:0071222; GO:2000502 carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; MHC class Ib receptor activity [GO:0032394]; signaling receptor activity [GO:0038023] GYIENCSTPNTYICMQR 0.91944 1.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LI60 KR203_HUMAN Keratin-associated protein 20-3 KRTAP20-3 KAP20.3 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 SYYGNYYGGLGYGYDCKYSYTSGFGAFR 0.91945 1.3382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0561 0 13.1618 0 0 0 0 12.7974 12.9072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5H4 PCDG1_HUMAN "Protocadherin gamma-A1, PCDH-gamma-A1" PCDHGA1 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] KSHLIFPQPNYADTLISQESCEKK 0.91945 1.5716 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2074 13.8905 0 11.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.628 0 0 0 0 0 0 0 Q16537 2A5E_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform (PP2A B subunit isoform B'-epsilon) (PP2A B subunit isoform B56-epsilon) (PP2A B subunit isoform PR61-epsilon) (PP2A B subunit isoform R5-epsilon) PPP2R5E Homo sapiens (Human) protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] GO:0000159; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007165; GO:0019888; GO:0072542 protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] AEHKQFLVKVLIPLHTVR 0.91946 1.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6812 13.8157 0 0 14.0786 0 0 0 13.1945 0 12.5255 0 0 0 0 0 0 0 0 0 0 10.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4256 0 11.8424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15198 SMAD9_HUMAN "Mothers against decapentaplegic homolog 9, MAD homolog 9, Mothers against DPP homolog 9 (Madh6) (SMAD family member 9, SMAD 9, Smad9)" SMAD9 MADH6 MADH9 SMAD8 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007179; GO:0009653; GO:0030154; GO:0030509; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144; GO:0071773; GO:1901522 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GVHLYYVGGEVYAECVSDSSIFVQSR 0.91947 1.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P45880 VDAC2_HUMAN "Voltage-dependent anion-selective channel protein 2, VDAC-2, hVDAC2 (Outer mitochondrial membrane protein porin 2)" VDAC2 Homo sapiens (Human) anion transport [GO:0006820]; binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272] acrosomal vesicle [GO:0001669]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; sperm midpiece [GO:0097225]; ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308]; anion transport [GO:0006820]; binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272] GO:0000166; GO:0001669; GO:0005634; GO:0005739; GO:0005741; GO:0006820; GO:0007339; GO:0008308; GO:0015288; GO:0015485; GO:0016020; GO:0031210; GO:0031966; GO:0032272; GO:0042645; GO:0045121; GO:0046930; GO:0097001; GO:0097225; GO:0097345; GO:2001243 ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308] GFGFGLVKLDVKTK 0.9195 1.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.56 0 0 11.309 10.9638 0 0 13.5954 0 0 0 0 0 0 0 0 0 0 0 0 12.5335 0 0 12.3113 0 0 0 0 0 0 0 0 0 12.5203 12.9636 0 12.8769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2322 0 0 0 0 0 0 Q9NR71 ASAH2_HUMAN "Neutral ceramidase, N-CDase, NCDase, EC 3.5.1.-, EC 3.5.1.23 (Acylsphingosine deacylase 2) (BCDase) (LCDase, hCD) (N-acylsphingosine amidohydrolase 2) (Non-lysosomal ceramidase) [Cleaved into: Neutral ceramidase soluble form ]" ASAH2 HNAC1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; lipid digestion [GO:0044241]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of apoptotic signaling pathway [GO:2001234]; regulation of mitotic cell cycle [GO:0007346]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] caveola [GO:0005901]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] caveola [GO:0005901]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to cytokine stimulus [GO:0071345]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; lipid digestion [GO:0044241]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of apoptotic signaling pathway [GO:2001234]; regulation of mitotic cell cycle [GO:0007346]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] GO:0000139; GO:0005509; GO:0005576; GO:0005739; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0006670; GO:0006672; GO:0006915; GO:0007346; GO:0008270; GO:0017040; GO:0042759; GO:0044241; GO:0046512; GO:0046513; GO:0046514; GO:0070062; GO:0071345; GO:0102121; GO:2001234 calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270] FYWHKGLLGLSNATVEWHIPDTAQPGIYR 0.91953 1.5463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86501 0 0 0 0 0 0 14.5424 16.0112 0 0 0 0 12.8049 0 0 0 0 13.9315 0 0 14.5423 13.5084 0 0 0 13.4915 0 0 0 14.9438 14.3837 0 0 14.5234 0 0 0 13.8792 0 0 0 14.0624 18.9154 12.8747 10.9999 0 0 0 0 0 0 14.2461 0 0 0 0 13.7311 14.9077 13.8251 18.6411 14.8639 0 0 0 14.3066 0 0 0 0 0 0 0 14.2171 18.3793 0 0 0 0 0 0 18.646 0 0 0 0 0 0 0 0 11.6487 0 12.6821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXV0 GFRAL_HUMAN GDNF family receptor alpha-like GFRAL C6orf144 UNQ9356/PRO34128 Homo sapiens (Human) glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; stress-activated protein kinase signaling cascade [GO:0031098] actin cytoskeleton [GO:0015629]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; stress-activated protein kinase signaling cascade [GO:0031098] GO:0002023; GO:0005654; GO:0005886; GO:0005925; GO:0007399; GO:0009897; GO:0015629; GO:0016021; GO:0016167; GO:0030971; GO:0031098; GO:0035860; GO:0038023; GO:0043235; GO:0043410; GO:0043524; GO:0051897; GO:2001240 glial cell-derived neurotrophic factor receptor activity [GO:0016167]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023] CHEDENCISTLSK 0.91957 1.5178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9194 0 0 0 12.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.445 0 0 0 0 0 0 10.5214 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHV2 SRTD1_HUMAN "SERTA domain-containing protein 1 (CDK4-binding protein p34SEI1, SEI-1, p34(SEI-1)) (Transcriptional regulator interacting with the PHD-bromodomain 1, TRIP-Br1)" SERTAD1 SEI1 TRIPBR1 Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] nucleus [GO:0005634]; sarcoplasm [GO:0016528] nucleus [GO:0005634]; sarcoplasm [GO:0016528]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0005634; GO:0008284; GO:0016528; GO:0045944 HLVLVVNTLRR 0.91958 1.1533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15366 PCBP2_HUMAN "Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2, hnRNP E2)" PCBP2 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; mRNA metabolic process [GO:0016071]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; C-rich single-stranded DNA binding [GO:1990829]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; mRNA metabolic process [GO:0016071]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694] GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0010468; GO:0014069; GO:0016020; GO:0016071; GO:0019899; GO:0031625; GO:0039694; GO:0043161; GO:0045087; GO:0045944; GO:0050687; GO:0051252; GO:0051607; GO:0070062; GO:0075522; GO:1990829 C-rich single-stranded DNA binding [GO:1990829]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] LLMHGKEVGSIIGKK 0.91959 1.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5349 0 0 0 0 0 0 0 0 0 10.1601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AQ2 TM125_HUMAN Transmembrane protein 125 TMEM125 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LATGTVLCLLALLVLVK 0.91959 1.3441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.161 0 0 0 0 0 0 0 0 0 13.5889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14735 CDIPT_HUMAN "CDP-diacylglycerol--inositol 3-phosphatidyltransferase, EC 2.7.8.11 (Phosphatidylinositol synthase, PI synthase, PtdIns synthase)" CDIPT PIS PIS1 Homo sapiens (Human) CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145]; CDP-diacylglycerol metabolic process [GO:0046341]; phosphatidylinositol biosynthetic process [GO:0006661] GO:0003881; GO:0005789; GO:0005794; GO:0005886; GO:0006661; GO:0016020; GO:0016021; GO:0019992; GO:0030145; GO:0030246; GO:0043178; GO:0046341 alcohol binding [GO:0043178]; carbohydrate binding [GO:0030246]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; diacylglycerol binding [GO:0019992]; manganese ion binding [GO:0030145] MGLWVTAPIALLKSLISVIHLITAAR 0.9196 1.5323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6711 0 0 0 0 0 0 0 0 0 0 0 15.3082 15.3587 0 15.1924 0 0 0 0 0 0 0 0 15.1514 15.0707 0 14.4327 0 0 0 14.4433 13.5339 11.5505 0 14.7153 13.9603 14.2768 0 0 13.1055 0 0 0 0 0 0 0 0 0 0 14.3873 0 14.3777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.552 0 0 0 0 0 0 0 0 13.5739 0 0 0 0 0 0 0 P06881 CALCA_HUMAN "Calcitonin gene-related peptide 1 (Alpha-type CGRP) (Calcitonin gene-related peptide I, CGRP-I)" CALCA CALC1 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell-cell signaling [GO:0007267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor internalization [GO:0002031]; innate immune response [GO:0045087]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of blood pressure [GO:0045776]; negative regulation of bone resorption [GO:0045779]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of osteoclast differentiation [GO:0045671]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage differentiation [GO:0045651]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to yeast [GO:0001878]; vasculature development [GO:0001944]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell-cell signaling [GO:0007267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor internalization [GO:0002031]; innate immune response [GO:0045087]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of blood pressure [GO:0045776]; negative regulation of bone resorption [GO:0045779]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of osteoclast differentiation [GO:0045671]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage differentiation [GO:0045651]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to yeast [GO:0001878]; vasculature development [GO:0001944]; vasodilation [GO:0042311] GO:0001878; GO:0001935; GO:0001944; GO:0001976; GO:0002031; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0006468; GO:0007159; GO:0007189; GO:0007190; GO:0007267; GO:0008217; GO:0010523; GO:0019731; GO:0019732; GO:0031623; GO:0032730; GO:0032757; GO:0042311; GO:0043542; GO:0044877; GO:0045087; GO:0045651; GO:0045671; GO:0045776; GO:0045779; GO:0050829; GO:0050830; GO:0051480; GO:0051482; GO:0061844; GO:0097647; GO:1990408 hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] ACDTATCVTHRLAGLLSR 0.91961 1.1528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96B36 AKTS1_HUMAN Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate) AKT1S1 PRAS40 Homo sapiens (Human) negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; neurotrophin TRK receptor signaling pathway [GO:0048011]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523] GO:0005654; GO:0005737; GO:0005829; GO:0006469; GO:0032007; GO:0042981; GO:0043523; GO:0045792; GO:0048011 IAASMRALVLR 0.91962 1.1488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9674 12.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5108 0 0 0 0 0 0 0 Q9H0P7 AGIT1_HUMAN Putative uncharacterized protein encoded by AGPAT4-IT1 (AGPAT4 intronic transcript 1) AGPAT4-IT1 C6orf59 NCRNA00241 Homo sapiens (Human) CAGIWNHMDEEPDNGDDR 0.91962 1.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1507 0 0 0 0 0 0 13.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYQ7 THNS1_HUMAN "Threonine synthase-like 1, TSH1" THNSL1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 FAPAIMQALK 0.91964 1.5442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0844 0 0 0 0 0 0 0 0 0 0 0 13.932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4415 0 0 0 0 0 0 13.697 12.3203 12.676 0 0 0 0 0 0 0 13.4272 10.8777 0 12.9104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0015 0 0 0 13.2692 0 14.2277 12.6833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3878 A6NCC3 GOG8O_HUMAN Golgin subfamily A member 8O GOLGA8O Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 DECAEHIEGERAR 0.91965 1.1484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5329 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3357 13.9287 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4398 0 0 15.1349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11233 RALA_HUMAN "Ras-related protein Ral-A, EC 3.6.5.2" RALA RAL Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165] cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton reorganization [GO:0031532]; cell cycle [GO:0007049]; cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; signal transduction [GO:0007165] GO:0001843; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007049; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031532; GO:0031625; GO:0031755; GO:0032154; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0070062; GO:0072655; GO:0090141; GO:0090543 ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625] ANVDKVFFDLMREIR 0.91965 1.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8804 11.6965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7445 0 0 0 0 14.4868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7076 0 0 0 0 0 0 0 0 0 0 12.5578 0 0 0 0 0 0 0 0 12.7758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14618 KPYM_HUMAN "Pyruvate kinase PKM, EC 2.7.1.40 (Cytosolic thyroid hormone-binding protein, CTHBP) (Opa-interacting protein 3, OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2, EC 2.7.11.1) (Thyroid hormone-binding protein 1, THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2, EC 2.7.10.2) (p58)" PKM OIP3 PK2 PK3 PKM2 Homo sapiens (Human) canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone kinase activity (H3-T11 specific) [GO:0035402]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501] GO:0000287; GO:0003713; GO:0003723; GO:0003729; GO:0004713; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006096; GO:0012501; GO:0023026; GO:0030955; GO:0031982; GO:0032869; GO:0034774; GO:0035402; GO:0042803; GO:0045296; GO:0045944; GO:0061621; GO:0062023; GO:0070062; GO:1903561; GO:1903672; GO:1904813; GO:2000767 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone kinase activity (H3-T11 specific) [GO:0035402]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] CDENILWLDYK 0.91967 1.5436 0 14.4921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P298 HIG1B_HUMAN HIG1 domain family member 1B (Protein CLST 11240) HIGD1B Homo sapiens (Human) mitochondrial respirasome assembly [GO:0097250] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; mitochondrial respirasome assembly [GO:0097250] GO:0005739; GO:0016021; GO:0097250 SANRRWWVPPDDEDCVSEK 0.91968 1.5149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6658 0 0 10.9475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NT89 TRNP1_HUMAN TMF-regulated nuclear protein 1 TRNP1 C1orf225 TRNP Homo sapiens (Human) cell cycle [GO:0007049]; cerebellar cortex morphogenesis [GO:0021696]; neural precursor cell proliferation [GO:0061351]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127] euchromatin [GO:0000791]; nucleus [GO:0005634] euchromatin [GO:0000791]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cerebellar cortex morphogenesis [GO:0021696]; neural precursor cell proliferation [GO:0061351]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127] GO:0000791; GO:0003677; GO:0005634; GO:0007049; GO:0021696; GO:0042127; GO:0051726; GO:0061351 DNA binding [GO:0003677] GHGPEPDSPFRR 0.91969 1.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7262 0 13.0084 0 12.4532 0 12.2059 0 0 0 11.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6311 13.0852 0 12.4719 0 0 12.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3507 0 0 0 0 0 0 0 0 0 0 12.1213 0 0 0 12.16 0 0 0 0 13.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30711 GSTT1_HUMAN "Glutathione S-transferase theta-1, EC 2.5.1.18 (GST class-theta-1) (Glutathione transferase T1-1)" GSTT1 Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749] GO:0004364; GO:0004602; GO:0005737; GO:0005829; GO:0006749; GO:0070062 glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] GQHLSDAFAQVNPLKKVPALK 0.91971 1.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.656 0 0 0 0 0 12.8618 0 0 0 13.1291 12.7578 0 0 0 0 0 0 0 0 0 12.5348 0 0 0 0 0 12.1222 0 14.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14773 ICAM4_HUMAN "Intercellular adhesion molecule 4, ICAM-4 (Landsteiner-Wiener blood group glycoprotein, LW blood group protein) (CD antigen CD242)" ICAM4 LW Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609] GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0016021; GO:0098609 integrin binding [GO:0005178] FTGLDLANVTLTYEFAAGPR 0.91972 1.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3798 0 0 0 11.5525 0 0 13.379 13.1113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MTY7 KRA97_HUMAN Keratin-associated protein 9-7 (Keratin-associated protein 9-like 1) KRTAP9-7 KAP9.7 KRTAP9.7 KRTAP9L1 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTHCCSPCCQPTCCR 0.91973 1.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8529 0 0 0 0 12.1228 0 0 0 0 0 0 0 0 10.3763 0 0 0 0 0 0 0 0 0 0 12.007 0 0 0 0 0 0 0 0 0 0 0 0 0 14.313 0 0 0 0 0 0 0 0 0 0 12.0397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB14 KCNKD_HUMAN "Potassium channel subfamily K member 13 (Tandem pore domain halothane-inhibited potassium channel 1, THIK-1)" KCNK13 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] GO:0005886; GO:0005887; GO:0015271; GO:0022841; GO:0030322; GO:0034765; GO:0071805 outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841] KMDSGCCPQCQR 0.91975 1.6105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3H9 TCAL2_HUMAN "Transcription elongation factor A protein-like 2, TCEA-like protein 2 (Transcription elongation factor S-II protein-like 2)" TCEAL2 My048 MY0876G0 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] GO:0005634; GO:0050699 WW domain binding [GO:0050699] AEGEGEPDSEREPESEGEPESETR 0.91977 1.4897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2201 0 0 0 0 0 0 0 A8MTI9 PRS47_HUMAN "Putative serine protease 47, EC 3.4.21.- (Serine protease 47, pseudogene)" PRSS47P PRSS47 Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508 serine-type endopeptidase activity [GO:0004252] AAGLPGPCAALVLPQTWLLLPLTLR 0.91978 1.4975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1041 0 0 14.0692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5013 0 0 0 0 13.989 0 0 0 12.2911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13796 PLSL_HUMAN "Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1, LCP-1)" LCP1 PLS2 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; integrin binding [GO:0005178]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; animal organ regeneration [GO:0031100]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; extracellular matrix disassembly [GO:0022617]; positive regulation of podosome assembly [GO:0071803]; protein kinase A signaling [GO:0010737]; regulation of intracellular protein transport [GO:0033157]; T cell activation involved in immune response [GO:0002286] GO:0001726; GO:0001891; GO:0002102; GO:0002286; GO:0003779; GO:0005178; GO:0005509; GO:0005615; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0010737; GO:0015629; GO:0016477; GO:0022617; GO:0030054; GO:0030175; GO:0030866; GO:0031100; GO:0032432; GO:0032587; GO:0033157; GO:0048471; GO:0051015; GO:0051017; GO:0051020; GO:0051639; GO:0051764; GO:0070062; GO:0071803; GO:0097386 actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; GTPase binding [GO:0051020]; integrin binding [GO:0005178] AECMLQQAERLGCR 0.91979 5.0808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7487 0 0 0 0 0 0 0 0 11.9077 0 0 0 0 12.4324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.652 0 0 0 0 0 12.5976 13.6988 0 0 0 12.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1722 0 0 0 0 0 0 12.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6317 0 0 0 0 0 0 0 0 0 0 0 0 12.0587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2G4 TSYL2_HUMAN "Testis-specific Y-encoded-like protein 2, TSPY-like protein 2 (Cell division autoantigen 1) (Cutaneous T-cell lymphoma-associated antigen se20-4, CTCL-associated antigen se20-4) (Differentially-expressed nucleolar TGF-beta1 target protein) (Nuclear protein of 79 kDa, NP79)" TSPYL2 CDA1 DENTT TSPX HRIHFB2216 Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]; regulation of signal transduction [GO:0009966] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; rDNA binding [GO:0000182]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]; regulation of signal transduction [GO:0009966] GO:0000182; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006334; GO:0007049; GO:0008156; GO:0009966; GO:0030308; GO:0042393; GO:0045786; GO:0045859 chromatin binding [GO:0003682]; histone binding [GO:0042393]; rDNA binding [GO:0000182] AFLNHPRISILINRR 0.91979 1.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2516 0 0 0 0 14.281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0653 0 0 0 0 0 Q86SG7 LYG2_HUMAN "Lysozyme g-like protein 2, EC 3.2.1.-" LYG2 LYGH Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; peptidoglycan catabolic process [GO:0009253] extracellular region [GO:0005576] extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; peptidoglycan catabolic process [GO:0009253] GO:0003796; GO:0005576; GO:0009253; GO:0042742; GO:0050830 lysozyme activity [GO:0003796] GSYPFSHSMKPHLHPR 0.9198 1.5233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6691 0 0 10.0443 0 0 0 0 0 0 11.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q58FF8 H90B2_HUMAN "Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b, Heat shock protein 90Bb)" HSP90AB2P HSP90BB Homo sapiens (Human) cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0005524; GO:0005829; GO:0005886; GO:0006457; GO:0016887; GO:0019899; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082; GO:0070062; GO:0097718 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082] AKFENLCKFMK 0.91981 1.5809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK41 VPS28_HUMAN "Vacuolar protein sorting-associated protein 28 homolog, H-Vps28 (ESCRT-I complex subunit VPS28)" VPS28 Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] GO:0000813; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010008; GO:0016236; GO:0031397; GO:0031902; GO:0036258; GO:0039702; GO:0043130; GO:0043162; GO:0043328; GO:0044877; GO:0045732; GO:0070062; GO:0090148; GO:2000397 protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130] DCVSPSEYTAACSRLLVQYK 0.91983 1.5488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1419 11.111 0 0 0 0 0 0 0 0 11.4616 0 0 15.4377 0 0 0 0 0 0 11.3889 0 0 0 0 0 0 0 0 0 0 10.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9084 Q6IWH7 ANO7_HUMAN "Anoctamin-7 (Dresden transmembrane protein of the prostate, D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G)" ANO7 NGEP PCANAP5 TMEM16G Homo sapiens (Human) calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0006821; GO:0016021; GO:0034220; GO:0046983; GO:0055085; GO:0061588; GO:0070161; GO:1902476 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] AYYRWTR 0.91985 1.4961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7541 0 0 0 0 0 0 0 0 0 12.3384 0 0 0 0 12.3554 0 0 0 0 0 13.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8692 0 13.722 0 0 12.7056 12.4849 0 11.2028 10.1829 0 0 12.5674 0 0 0 0 0 0 0 0 0 0 0 0 12.1731 0 0 11.269 0 0 0 13.8844 0 0 0 0 14.8442 0 0 0 0 0 0 0 12.7698 0 0 11.7598 0 0 0 0 0 0 0 11.3679 0 12.4777 0 0 0 0 0 0 11.4797 0 9.68724 0 0 0 10.924 0 0 0 0 0 0 0 0 0 0 0 0 10.4719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6153 0 0 0 11.2089 0 0 0 0 0 0 0 0 0 Q8WWB3 DYDC1_HUMAN DPY30 domain-containing protein 1 DYDC1 DPY30D1 RSD-9 RSD9 Homo sapiens (Human) histone H3-K4 methylation [GO:0051568] MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188] MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568] GO:0044666; GO:0048188; GO:0051568 LERERELALMEQEMMER 0.91985 1.3453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95521 PRAM1_HUMAN PRAME family member 1 PRAMEF1 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 CHHYTSDNELEGR 0.91987 2.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6477 11.8248 0 0 0 0 0 0 0 0 15.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2308 0 0 0 0 0 13.9097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4742 0 0 13.7227 0 12.801 0 0 0 0 0 0 13.4742 0 0 0 0 13.8886 0 Q96DI7 SNR40_HUMAN "U5 small nuclear ribonucleoprotein 40 kDa protein, U5 snRNP 40 kDa protein, U5-40K (38 kDa-splicing factor) (Prp8-binding protein, hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57)" SNRNP40 PRP8BP SFP38 WDR57 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0046540; GO:0071007; GO:0071013 RNA binding [GO:0003723] GPELPLVPVK 0.91988 1.3449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7856 14.0728 13.4819 0 0 0 0 15.5451 0 0 0 0 0 0 0 0 0 14.0501 15.5391 0 0 13.5536 0 0 0 0 0 0 14.28 0 0 0 0 0 13.7888 0 0 0 0 0 16.03 0 0 0 0 0 0 0 0 0 14.4996 13.138 0 0 0 0 0 0 0 0 0 0 0 13.9064 0 0 0 0 12.7284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3261 0 0 0 0 0 0 0 O75072 FKTN_HUMAN "Ribitol-5-phosphate transferase FKTN, EC 2.7.8.- (Fukutin) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase)" FKTN FCMD Homo sapiens (Human) muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of JNK cascade [GO:0046329]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049] cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634] "cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleus [GO:0005634]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of JNK cascade [GO:0046329]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]" GO:0000139; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005801; GO:0006486; GO:0006493; GO:0007399; GO:0007517; GO:0008285; GO:0016780; GO:0030173; GO:0035269; GO:0046329; GO:0060049 "phosphotransferase activity, for other substituted phosphate groups [GO:0016780]" FFCVPRDFTAFALQYHLWK 0.91991 1.8923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.589 0 Q9Y2A9 B3GN3_HUMAN "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3, EC 2.4.1.149 (Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase, EC 2.4.1.146) (Beta-1,3-galactosyltransferase 8, Beta-1,3-GalTase 8, Beta3Gal-T8, Beta3GalT8, b3Gal-T8) (Beta-3-Gx-T8) (Core 1 extending beta-1,3-N-acetylglucosaminyltransferase) (Core1-beta3GlcNAcT) (Transmembrane protein 3) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, BGnT-3, Beta-1,3-Gn-T3, Beta-1,3-N-acetylglucosaminyltransferase 3, Beta3Gn-T3) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8)" B3GNT3 B3GALT8 TMEM3 UNQ637/PRO1266 Homo sapiens (Human) keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311] Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] "Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" GO:0000139; GO:0005887; GO:0008194; GO:0008457; GO:0008499; GO:0008532; GO:0016266; GO:0016757; GO:0018146; GO:0030311; GO:0047223 "beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" CAQPVFLLLVIK 0.91991 1.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2962 0 0 0 0 0 0 0 0 0 0 11.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1107 0 0 0 0 0 0 0 0 0 0 11.1586 0 0 13.2887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07098 LIPG_HUMAN "Gastric triacylglycerol lipase, GL, Gastric lipase, EC 3.1.1.3" LIPF Homo sapiens (Human) lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]; triglyceride metabolic process [GO:0006641] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]; triglyceride metabolic process [GO:0006641] GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006641; GO:0008289; GO:0016042; GO:0016615; GO:0043231 lipid binding [GO:0008289]; malate dehydrogenase activity [GO:0016615]; triglyceride lipase activity [GO:0004806] DLLADPQDVGLLLPK 0.91993 1.5464 0 0 0 0 0 0 0 0 0 10.7615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0899 0 0 0 0 0 0 0 0 12.1088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0658 14.8304 0 0 11.6952 0 14.9675 0 0 0 0 0 0 0 0 12.9949 0 0 12.003 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3513 0 0 12.5633 0 0 0 0 0 12.4389 0 0 0 0 0 12.4823 12.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8344 0 0 0 0 12.3239 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2484 0 0 Q8N9N7 LRC57_HUMAN Leucine-rich repeat-containing protein 57 LRRC57 Homo sapiens (Human) extracellular exosome [GO:0070062]; membrane [GO:0016020] extracellular exosome [GO:0070062]; membrane [GO:0016020] GO:0016020; GO:0070062 IESLPPLLIGKFTLLK 0.91994 2.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86683 0 0 0 0 0 0 10.7178 0 0 0 0 0 0 0 0 0 0 0 0 11.3242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8041 12.2552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9091 0 0 0 11.4863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2422 Q96N21 AP4AT_HUMAN AP-4 complex accessory subunit Tepsin (ENTH domain-containing protein 2) (Epsin for AP-4) (Tetra-epsin) TEPSIN C17orf56 ENTHD2 Homo sapiens (Human) coated vesicle membrane [GO:0030662]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; trans-Golgi network membrane [GO:0032588] coated vesicle membrane [GO:0030662]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of organelle membrane [GO:0031312]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; trans-Golgi network membrane [GO:0032588] GO:0005737; GO:0005794; GO:0005829; GO:0016607; GO:0030662; GO:0031312; GO:0031965; GO:0032588 HFEASCGQLSPAR 0.91994 1.3443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5714 0 0 0 0 0 12.7796 0 0 0 0 0 0 0 0 0 13.4804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2619 0 0 0 0 14.3787 11.9039 0 0 0 0 0 0 0 14.8191 11.636 0 0 15.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8742 14.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1088 0 0 0 13.9135 0 0 0 0 14.2708 14.5857 0 0 0 0 0 P42898 MTHR_HUMAN "Methylenetetrahydrofolate reductase, EC 1.5.1.20" MTHFR Homo sapiens (Human) heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; response to xenobiotic stimulus [GO:0009410]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999] cytosol [GO:0005829]; synapse [GO:0045202] cytosol [GO:0005829]; synapse [GO:0045202]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase NADH activity [GO:0106312]; methylenetetrahydrofolate reductase NADPH activity [GO:0106313]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877]; heterochromatin organization [GO:0070828]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; regulation of histone methylation [GO:0031060]; response to amino acid [GO:0043200]; response to folic acid [GO:0051593]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to vitamin B2 [GO:0033274]; response to xenobiotic stimulus [GO:0009410]; S-adenosylmethionine metabolic process [GO:0046500]; tetrahydrofolate interconversion [GO:0035999] GO:0001666; GO:0001843; GO:0004489; GO:0005829; GO:0006555; GO:0009086; GO:0009410; GO:0031060; GO:0033274; GO:0035999; GO:0043200; GO:0044877; GO:0045202; GO:0046500; GO:0050660; GO:0050661; GO:0050667; GO:0051593; GO:0070555; GO:0070828; GO:0071949; GO:0072341; GO:0106312; GO:0106313 FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase NADH activity [GO:0106312]; methylenetetrahydrofolate reductase NADPH activity [GO:0106313]; modified amino acid binding [GO:0072341]; NADP binding [GO:0050661]; protein-containing complex binding [GO:0044877] DEAFALWIER 0.91997 1.1523 0 0 0 0 0 0 0 0 12.8129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4749 0 0 0 0 0 0 0 0 0 0 0 11.7686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7521 0 0 0 0 12.7912 0 0 0 0 0 0 10.5472 0 0 0 0 0 0 0 0 11.1954 10.9234 0 11.2951 0 0 0 0 0 0 0 13.5119 0 0 0 0 0 0 0 13.4747 0 11.7159 0 0 0 0 0 0 0 0 0 10.8029 0 0 0 0 0 0 0 0 12.9701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W50 MET16_HUMAN "RNA N6-adenosine-methyltransferase METTL16 (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (N6-adenosine-methyltransferase METTL16, EC 2.1.1.348) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase, EC 2.1.1.346)" METTL16 METT10D Homo sapiens (Human) "mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; negative regulation of 3'-UTR-mediated mRNA stabilization [GO:1905869]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]" GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0052907; GO:0061157; GO:0070475; GO:0080009; GO:0120048; GO:0120049; GO:1905869 23S rRNA (adenine(1618)-N(6))-methyltransferase activity [GO:0052907]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629] DLMNQLCTYIRNQIFRLVAVN 0.91997 1.5182 0 0 9.93035 0 0 0 0 0 0 0 0 0 12.0985 12.9065 13.3442 0 0 0 0 0 0 9.83674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3845 0 0 0 0 0 0 0 0 0 0 12.0842 0 11.2995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7786 0 0 0 0 0 12.8618 0 12.8406 0 12.3704 0 12.8654 13.113 0 12.5307 0 0 0 0 0 13.6959 0 0 12.5377 0 0 0 0 11.8081 0 13.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6482 0 0 13.3961 0 13.1408 12.9581 0 0 0 0 12.8426 0 0 12.0647 12.6867 0 0 0 14.2173 13.214 0 0 0 0 0 14.7887 0 12.0817 12.312 0 0 0 15.8919 0 0 0 11.9206 0 0 0 11.0819 0 0 12.7011 0 16.192 12.3884 0 0 16.2966 16.057 0 0 0 0 0 0 14.1917 0 0 0 0 12.5506 0 10.0312 Q6ZRV3 CC074_HUMAN Putative uncharacterized protein encoded by LINC00696 LINC00696 C3orf74 Homo sapiens (Human) DPSGCCVGNDCR 0.91998 1.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0249 0 0 0 0 0 0 10.8696 0 0 0 0 0 0 0 0 0 13.2465 0 0 0 0 0 0 0 0 0 0 11.3747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2844 0 0 0 0 0 15.5075 15.601 0 0 12.1842 0 14.246 14.319 14.6678 13.5827 12.1278 14.5582 13.9324 13.5465 0 0 12.0587 13.6884 15.046 13.978 0 13.888 0 13.7838 12.9358 0 0 13.0152 15.3905 14.8025 0 15.0943 14.7309 0 12.4587 13.572 0 0 0 0 13.5495 0 0 13.8968 0 14.169 14.7826 14.4456 13.5799 0 14.5163 14.3819 14.0781 15.5853 14.3034 0 13.1111 14.1625 14.0151 14.4018 0 0 14.539 14.4123 12.3153 0 0 0 0 0 0 0 13.6065 15.2264 13.0847 12.253 0 0 12.462 0 14.7214 0 0 14.5862 0 0 0 0 0 0 0 0 0 12.8704 10.8696 0 0 0 0 13.6741 12.8109 13.53 14.1525 0 0 0 0 13.2303 O00165 HAX1_HUMAN "HCLS1-associated protein X-1 (HS1-associating protein X-1, HAX-1) (HS1-binding protein 1, HSP1BP-1)" HAX1 HS1BP1 Homo sapiens (Human) cellular response to cytokine stimulus [GO:0071345]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin filament polymerization [GO:0030833]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein targeting to mitochondrion [GO:1903214] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum [GO:0005783]; lamellipodium [GO:0030027]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; P-body [GO:0000932]; sarcoplasmic reticulum [GO:0016529]; transcription regulator complex [GO:0005667] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum [GO:0005783]; lamellipodium [GO:0030027]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; P-body [GO:0000932]; sarcoplasmic reticulum [GO:0016529]; transcription regulator complex [GO:0005667]; interleukin-1 binding [GO:0019966]; protein N-terminus binding [GO:0047485]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin filament polymerization [GO:0030833]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein targeting to mitochondrion [GO:1903214] GO:0000932; GO:0005635; GO:0005667; GO:0005739; GO:0005741; GO:0005758; GO:0005783; GO:0005938; GO:0014068; GO:0015629; GO:0016324; GO:0016529; GO:0019966; GO:0030027; GO:0030136; GO:0030833; GO:0030854; GO:0031965; GO:0033138; GO:0042981; GO:0043066; GO:0045944; GO:0047485; GO:0050731; GO:0051897; GO:0071345; GO:1903146; GO:1903214; GO:2000251 interleukin-1 binding [GO:0019966]; protein N-terminus binding [GO:0047485] DEDDDEEEEEEGGSWGR 0.92 1.5324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.08706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQD3 KXDL1_HUMAN KxDL motif-containing protein 1 KXD1 C19orf50 Homo sapiens (Human) lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; vesicle-mediated transport [GO:0016192] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; vesicle-mediated transport [GO:0016192] GO:0016192; GO:0032418; GO:0051036; GO:0062196; GO:0072384; GO:0098574; GO:0099078 FLHHTRTLVEMKR 0.92 1.6063 0 0 0 0 0 0 0 0 0 0 13.361 0 0 0 0 0 0 0 0 0 0 9.99251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BR01 ST4A1_HUMAN "Sulfotransferase 4A1, ST4A1, EC 2.8.2.- (Brain sulfotransferase-like protein, hBR-STL, hBR-STL-1) (Nervous system sulfotransferase, NST)" SULT4A1 SULTX3 Homo sapiens (Human) dendrite arborization [GO:0140059]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146]; dendrite arborization [GO:0140059]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] GO:0005737; GO:0005739; GO:0005829; GO:0008146; GO:0008202; GO:0042802; GO:0051923; GO:0140059 identical protein binding [GO:0042802]; sulfotransferase activity [GO:0008146] DLVVSYYQFHR 0.92001 1.1483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8555 0 0 0 12.0829 0 0 0 0 0 0 0 0 Q9BXU3 TX13A_HUMAN Testis-expressed protein 13A TEX13A Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005737; GO:0046872 metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] LRAILEDSEVPSEVK 0.92002 1.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1785 0 0 0 0 0 0 0 0 0 0 0 13.6402 0 0 0 0 0 0 0 0 0 Q9NQE9 HINT3_HUMAN "Adenosine 5'-monophosphoramidase HINT3, EC 3.9.1.- (Histidine triad nucleotide-binding protein 3, HINT-3)" HINT3 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; adenosine 5'-monophosphoramidase activity [GO:0043530]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166] GO:0000166; GO:0005634; GO:0005737; GO:0042802; GO:0043530 adenosine 5'-monophosphoramidase activity [GO:0043530]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166] DYDSTCVFCR 0.92002 1.5382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7047 0 0 12.3418 0 0 0 0 0 12.5216 0 13.3684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5495 0 0 0 0 0 0 0 0 P08729 K2C7_HUMAN "Keratin, type II cytoskeletal 7 (Cytokeratin-7, CK-7) (Keratin-7, K7) (Sarcolectin) (Type-II keratin Kb7)" KRT7 SCL Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0045111; GO:0070062 structural constituent of skin epidermis [GO:0030280] AEAEAWYQTK 0.92003 1.5162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.06137 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6508 12.5649 0 0 14.412 0 14.9193 13.1892 0 0 10.5184 13.184 0 0 13.1552 0 13.0269 0 0 0 0 0 0 0 12.5411 0 0 0 0 0 0 14.4207 13.129 12.5489 0 0 0 0 0 0 0 0 13.0161 0 0 0 14.3697 0 0 12.9559 0 0 0 0 12.8064 0 0 0 12.9005 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0997 0 0 0 12.9274 14.561 0 0 0 0 0 0 0 0 0 0 0 0 11.2654 0 0 0 0 0 0 0 0 0 0 0 0 Q5SZD1 CF141_HUMAN Uncharacterized protein C6orf141 C6orf141 Homo sapiens (Human) EKVLFLLHPER 0.92003 1.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P37837 TALDO_HUMAN "Transaldolase, EC 2.2.1.2" TALDO1 TAL TALDO TALDOR Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; glyceraldehyde-3-phosphate metabolic process [GO:0019682]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]" GO:0004801; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0006002; GO:0009052; GO:0019682; GO:0048029; GO:0070062 monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801] ALAGCDFLTISPKLLGELLQDNAK 0.92004 1.6055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0619 0 0 0 0 0 0 0 0 0 0 0 15.1415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y289 SC5A6_HUMAN "Sodium-dependent multivitamin transporter, Na(+)-dependent multivitamin transporter (Solute carrier family 5 member 6)" SLC5A6 SMVT Homo sapiens (Human) biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; iodide transmembrane transport [GO:1904200]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; vitamin transmembrane transporter activity [GO:0090482]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; iodide transmembrane transport [GO:1904200]; pantothenate transmembrane transport [GO:0015887]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104] GO:0005886; GO:0005887; GO:0006814; GO:0008523; GO:0009925; GO:0012506; GO:0015225; GO:0015233; GO:0015293; GO:0015878; GO:0015887; GO:0016020; GO:0016323; GO:0016324; GO:0031526; GO:0090482; GO:0150104; GO:1904200; GO:1905135 biotin transmembrane transporter activity [GO:0015225]; pantothenate transmembrane transporter activity [GO:0015233]; sodium-dependent multivitamin transmembrane transporter activity [GO:0008523]; symporter activity [GO:0015293]; vitamin transmembrane transporter activity [GO:0090482] LHCRSYGQDHLDTGLFPEKPR 0.92007 1.5153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5563 0 0 0 0 13.6808 14.2813 0 0 0 0 0 0 0 0 0 0 0 14.2266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUV7 SPTC3_HUMAN "Serine palmitoyltransferase 3, EC 2.3.1.50 (Long chain base biosynthesis protein 2b, LCB2b) (Long chain base biosynthesis protein 3, LCB 3) (Serine-palmitoyl-CoA transferase 3, SPT 3)" SPTLC3 C20orf38 SPTLC2L Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; sphingoid biosynthetic process [GO:0046520]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; sphingoid biosynthetic process [GO:0046520]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] GO:0004758; GO:0005789; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046512; GO:0046513; GO:0046520 pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] AWKKILILVEGVYSMEGSIVHLPQIIALK 0.92008 1.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6165 0 0 0 0 0 P00918 CAH2_HUMAN "Carbonic anhydrase 2, EC 4.2.1.1 (Carbonate dehydratase II) (Carbonic anhydrase C, CAC) (Carbonic anhydrase II, CA-II) (Cyanamide hydratase CA2, EC 4.2.1.69)" CA2 Homo sapiens (Human) "angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; secretion [GO:0046903]" apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886] "apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; secretion [GO:0046903]" GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0006730; GO:0008270; GO:0015670; GO:0016836; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225 arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] AVQQPDGLAVLGIFLKVGSAKPGLQK 0.92012 1.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15363 TMED2_HUMAN "Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1, p24beta1)" TMED2 RNP24 Homo sapiens (Human) allantois development [GO:1905069]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; chorion development [GO:0060717]; COPI coating of Golgi vesicle [GO:0048205]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; heart looping [GO:0001947]; intracellular protein transport [GO:0006886]; labyrinthine layer blood vessel development [GO:0060716]; maternal placenta development [GO:0001893]; multicellular organism growth [GO:0035264]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of GTPase activity [GO:0034260]; neural tube closure [GO:0001843]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]; regulation of SREBP signaling pathway [GO:2000638]; somite rostral/caudal axis specification [GO:0032525]; vesicle cargo loading [GO:0035459] COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; transport vesicle [GO:0030133]; zymogen granule membrane [GO:0042589] COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; transport vesicle [GO:0030133]; zymogen granule membrane [GO:0042589]; allantois development [GO:1905069]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; chorion development [GO:0060717]; COPI coating of Golgi vesicle [GO:0048205]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; heart looping [GO:0001947]; intracellular protein transport [GO:0006886]; labyrinthine layer blood vessel development [GO:0060716]; maternal placenta development [GO:0001893]; multicellular organism growth [GO:0035264]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of GTPase activity [GO:0034260]; neural tube closure [GO:0001843]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]; regulation of SREBP signaling pathway [GO:2000638]; somite rostral/caudal axis specification [GO:0032525]; vesicle cargo loading [GO:0035459] GO:0000139; GO:0001843; GO:0001893; GO:0001947; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0010628; GO:0012507; GO:0016021; GO:0030133; GO:0030134; GO:0030137; GO:0030663; GO:0032525; GO:0032580; GO:0033116; GO:0034260; GO:0035264; GO:0035459; GO:0036342; GO:0036499; GO:0042589; GO:0043231; GO:0048205; GO:0048208; GO:0060670; GO:0060716; GO:0060717; GO:0072659; GO:0090158; GO:1903912; GO:1905069; GO:2000638 AINDNTNSRVVLWSFFEALVLVAMTLGQIYYLKR 0.92012 1.5749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1567 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0086 0 0 0 0 10.8787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.516 0 14.6962 0 0 0 0 0 0 0 0 0 0 11.1531 11.3008 0 0 0 15.132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RY0 CPEB4_HUMAN "Cytoplasmic polyadenylation element-binding protein 4, CPE-BP4, CPE-binding protein 4, hCPEB-4" CPEB4 KIAA1673 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of neuron apoptotic process [GO:0043524]; response to ischemia [GO:0002931] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synapse [GO:0045202] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid stimulus [GO:0071230]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of neuron apoptotic process [GO:0043524]; response to ischemia [GO:0002931]" GO:0000900; GO:0002931; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005783; GO:0008135; GO:0014069; GO:0030425; GO:0030426; GO:0035235; GO:0036294; GO:0042149; GO:0043005; GO:0043022; GO:0043197; GO:0043524; GO:0045202; GO:0046872; GO:0048471; GO:0070161; GO:0071230; GO:1990124; GO:2000766 "metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]" DKPVQIR 0.92012 1.5935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWE3 COLL2_HUMAN Colipase-like protein 2 CLPSL2 C6orf126 UNQ3045/PRO9861 Homo sapiens (Human) digestion [GO:0007586]; lipid catabolic process [GO:0016042]; response to food [GO:0032094] extracellular region [GO:0005576] extracellular region [GO:0005576]; enzyme activator activity [GO:0008047]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; response to food [GO:0032094] GO:0005576; GO:0007586; GO:0008047; GO:0016042; GO:0032094 enzyme activator activity [GO:0008047] AAALALVAGVLSGAVLPLWSALPQYK 0.92012 1.4901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QE2 MYCT_HUMAN "Proton myo-inositol cotransporter, H(+)-myo-inositol cotransporter, Hmit (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13)" SLC2A13 Homo sapiens (Human) myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020]; transmembrane transporter activity [GO:0022857]; myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0002020; GO:0005365; GO:0005366; GO:0005737; GO:0005886; GO:0005887; GO:0015798; GO:0016020; GO:0016324; GO:0022857; GO:0030426; GO:0031090; GO:0042995; GO:0043231; GO:0044297; GO:0051117; GO:0055085; GO:0071944; GO:0097450; GO:0150104; GO:1902004 ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020]; transmembrane transporter activity [GO:0022857] GKKLEEIESLFDNR 0.92014 1.5834 0 0 0 0 13.7724 0 0 0 0 0 0 0 0 0 0 0 14.9586 0 0 13.7093 0 0 0 0 13.663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3486 0 0 0 0 0 0 0 0 0 0 0 0 11.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0447 0 0 0 0 0 0 P14061 DHB1_HUMAN "17-beta-hydroxysteroid dehydrogenase type 1, 17-beta-HSD 1, EC 1.1.1.51 (20 alpha-hydroxysteroid dehydrogenase, 20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 1, EC 1.1.1.62) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1)" HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 Homo sapiens (Human) bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; estrogen metabolic process [GO:0008210]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; catalytic activity [GO:0003824]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estradiol binding [GO:1903924]; NADP binding [GO:0050661]; NADP+ binding [GO:0070401]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; bone development [GO:0060348]; cellular response to metal ion [GO:0071248]; estrogen biosynthetic process [GO:0006703]; estrogen metabolic process [GO:0008210]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370] GO:0003824; GO:0004303; GO:0005496; GO:0005737; GO:0005829; GO:0006694; GO:0006703; GO:0008210; GO:0016491; GO:0030283; GO:0035410; GO:0042803; GO:0044594; GO:0047035; GO:0047045; GO:0050661; GO:0060348; GO:0061370; GO:0070401; GO:0071248; GO:0072582; GO:1903924 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; catalytic activity [GO:0003824]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; estradiol binding [GO:1903924]; NADP binding [GO:0050661]; NADP+ binding [GO:0070401]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283] FYQYLAHSK 0.92015 1.4898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5412 0 0 0 0 0 0 0 0 0 0 0 12.7079 0 0 0 0 0 0 0 0 0 13.525 0 0 0 0 0 0 0 0 0 0 0 0 11.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MIV0 KR221_HUMAN Keratin-associated protein 22-1 KRTAP22-1 KAP22.1 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 GGLGCSYGCGLSGYGYACYCPWCYER 0.92016 1.5748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3267 0 0 0 0 0 11.9391 0 0 0 0 0 0 0 0 0 0 0 14.6608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6811 0 0 0 0 0 0 0 0 0 0 0 9.50672 0 0 0 0 0 0 0 12.9901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULM6 CNOT6_HUMAN "CCR4-NOT transcription complex subunit 6, EC 3.1.13.4 (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase)" CNOT6 CCR4 CCR4a KIAA1194 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; miRNA-mediated gene silencing [GO:0035195]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]" CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] "CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; miRNA-mediated gene silencing [GO:0035195]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]" GO:0000175; GO:0000289; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0008284; GO:0010606; GO:0016020; GO:0030014; GO:0030374; GO:0035195; GO:0043928; GO:0046872; GO:0070966 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723] QLYGYCPSWALNWDYR 0.92016 1.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3931 0 0 0 0 0 0 0 0 Q86UV7 TRI73_HUMAN Tripartite motif-containing protein 73 (Tripartite motif-containing protein 50B) TRIM73 TRIM50B Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567] GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] IVNESDVFSWVIRREFQELR 0.92018 1.8879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1046 P20248 CCNA2_HUMAN "Cyclin-A2, Cyclin-A (Cyclin A)" CCNA2 CCN1 CCNA Homo sapiens (Human) "animal organ regeneration [GO:0031100]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hypoxia [GO:0071456]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to nitric oxide [GO:0071732]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cochlea development [GO:0090102]; G2/M transition of mitotic cell cycle [GO:0000086]; histone phosphorylation [GO:0016572]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription, DNA-templated [GO:0045893]; Ras protein signal transduction [GO:0007265]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA replication [GO:0006275]; response to glucagon [GO:0033762]; transcription, DNA-templated [GO:0006351]" cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; animal organ regeneration [GO:0031100]; cell cycle G1/S phase transition [GO:0044843]; cell division [GO:0051301]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hypoxia [GO:0071456]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to nitric oxide [GO:0071732]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cochlea development [GO:0090102]; G2/M transition of mitotic cell cycle [GO:0000086]; histone phosphorylation [GO:0016572]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription, DNA-templated [GO:0045893]; Ras protein signal transduction [GO:0007265]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA replication [GO:0006275]; response to glucagon [GO:0033762]; transcription, DNA-templated [GO:0006351]" GO:0000079; GO:0000086; GO:0000307; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006275; GO:0006351; GO:0007265; GO:0016538; GO:0016572; GO:0019901; GO:0019904; GO:0031100; GO:0033762; GO:0036120; GO:0044320; GO:0044772; GO:0044843; GO:0045893; GO:0048146; GO:0051301; GO:0071314; GO:0071373; GO:0071392; GO:0071456; GO:0071732; GO:0090102; GO:0097124; GO:1990314 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] APQHAQQSIR 0.92019 1.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2548 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8468 0 0 0 0 12.8231 0 0 0 0 14.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BR61 ACBD6_HUMAN Acyl-CoA-binding domain-containing protein 6 ACBD6 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289] GO:0000062; GO:0005829; GO:0008289 fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289] AIKSKNVDVNVK 0.92019 1.5359 0 0 0 0 0 0 0 0 0 0 10.8414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULD4 BRPF3_HUMAN Bromodomain and PHD finger-containing protein 3 BRPF3 KIAA1286 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; extracellular region [GO:0005576]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776] cytosol [GO:0005829]; extracellular region [GO:0005576]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000123; GO:0005576; GO:0005829; GO:0006325; GO:0006357; GO:0043966; GO:0044154; GO:0045740; GO:0046872; GO:0050793; GO:0070776; GO:1903706 metal ion binding [GO:0046872] AAVRLRDLGGAILR 0.92019 1.5739 0 0 0 0 0 0 12.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5024 0 0 0 0 15.5041 12.9316 0 0 0 0 10.7923 0 0 0 0 12.8741 15.5918 0 0 0 0 13.1638 15.1579 13.1012 0 13.4631 0 0 12.8763 0 13.216 0 12.5251 0 0 0 0 0 0 0 0 0 15.026 0 0 0 0 10.9699 0 0 0 0 0 15.9023 0 15.3792 0 0 0 13.1351 0 12.8675 0 14.1336 12.5686 0 13.939 13.3692 12.3124 0 0 0 0 13.2743 0 0 15.8457 0 0 0 0 0 0 0 0 0 0 0 0 9.80697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.577 0 Q9BV23 ABHD6_HUMAN "Monoacylglycerol lipase ABHD6, EC 3.1.1.23 (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 6)" ABHD6 Homo sapiens (Human) acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; long-term synaptic depression [GO:0060292]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid catabolic process [GO:0009395]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of endocannabinoid signaling pathway [GO:2000124] AMPA glutamate receptor complex [GO:0032281]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] AMPA glutamate receptor complex [GO:0032281]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; long-term synaptic depression [GO:0060292]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid catabolic process [GO:0009395]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of endocannabinoid signaling pathway [GO:2000124] GO:0004620; GO:0005739; GO:0005765; GO:0005886; GO:0009395; GO:0016021; GO:0019369; GO:0030336; GO:0031902; GO:0031966; GO:0032281; GO:0046464; GO:0046889; GO:0047372; GO:0052651; GO:0060292; GO:0098978; GO:0098982; GO:0099055; GO:0120163; GO:2000124; GO:2001311 acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620] IYYWYWRRTLGMQVR 0.92021 1.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6976 0 0 0 0 0 0 0 0 0 10.8774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5986 0 0 0 0 0 0 0 0 11.4366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14863 PO6F1_HUMAN "POU domain, class 6, transcription factor 1 (Brain-specific homeobox/POU domain protein 5, Brain-5, Brn-5) (mPOU homeobox protein)" POU6F1 BRN5 MPOU TCFB1 Homo sapiens (Human) brain development [GO:0007420]; heart development [GO:0007507]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; heart development [GO:0007507]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0007507; GO:0007517; GO:0043565; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" SAQKLKPVLEK 0.92022 1.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0215 0 0 12.1447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8321 12.5998 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXI1 MIRO2_HUMAN "Mitochondrial Rho GTPase 2, MIRO-2, hMiro-2, EC 3.6.5.- (Ras homolog gene family member T2)" RHOT2 ARHT2 C16orf39 Homo sapiens (Human) cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0097345 calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] EDRLTLDGFLFLNTLFIQRGR 0.92022 1.6001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75908 SOAT2_HUMAN "Sterol O-acyltransferase 2, EC 2.3.1.26 (Acyl-coenzyme A:cholesterol acyltransferase 2, ACAT-2) (Cholesterol acyltransferase 2)" SOAT2 ACACT2 ACAT2 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; low-density lipoprotein particle clearance [GO:0034383]; macrophage derived foam cell differentiation [GO:0010742]; very-low-density lipoprotein particle assembly [GO:0034379] brush border [GO:0005903]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] brush border [GO:0005903]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acyltransferase activity [GO:0016746]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]; cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; low-density lipoprotein particle clearance [GO:0034383]; macrophage derived foam cell differentiation [GO:0010742]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0000062; GO:0004772; GO:0005783; GO:0005789; GO:0005903; GO:0008203; GO:0008374; GO:0010742; GO:0015485; GO:0016021; GO:0016746; GO:0030299; GO:0033344; GO:0034379; GO:0034383; GO:0034435; GO:0034736; GO:0042632 acyltransferase activity [GO:0016746]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772] EPGGARLRLQR 0.92029 1.3443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.934 0 0 0 Q6ZN03 CU136_HUMAN Putative uncharacterized protein encoded by LINC00322 LINC00322 C21orf136 NCRNA00322 Homo sapiens (Human) NDLESLLSEGR 0.92029 1.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3062 0 0 0 0 0 0 0 0 0 0 11.0765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1955 0 0 0 0 0 0 0 0 0 0 12.0046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5694 0 0 0 0 P23946 CMA1_HUMAN "Chymase, EC 3.4.21.39 (Alpha-chymase) (Mast cell protease I)" CMA1 CYH CYM Homo sapiens (Human) angiotensin maturation [GO:0002003]; basement membrane disassembly [GO:0034769]; cellular response to glucose stimulus [GO:0071333]; cytokine precursor processing [GO:0140447]; extracellular matrix disassembly [GO:0022617]; midbrain development [GO:0030901]; positive regulation of angiogenesis [GO:0045766]; protein catabolic process [GO:0030163]; regulation of inflammatory response [GO:0050727] collagen-containing extracellular matrix [GO:0062023]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] collagen-containing extracellular matrix [GO:0062023]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; endopeptidase activity [GO:0004175]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiotensin maturation [GO:0002003]; basement membrane disassembly [GO:0034769]; cellular response to glucose stimulus [GO:0071333]; cytokine precursor processing [GO:0140447]; extracellular matrix disassembly [GO:0022617]; midbrain development [GO:0030901]; positive regulation of angiogenesis [GO:0045766]; protein catabolic process [GO:0030163]; regulation of inflammatory response [GO:0050727] GO:0002003; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0008236; GO:0022617; GO:0030141; GO:0030163; GO:0030901; GO:0034769; GO:0036464; GO:0042277; GO:0045766; GO:0050727; GO:0062023; GO:0071333; GO:0140447 endopeptidase activity [GO:0004175]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] ISHYRPWINQILQAN 0.92032 1.5978 0 0 0 0 0 0 0 0 0 0 0 0 11.4644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2966 0 0 0 0 0 0 0 0 0 11.2207 0 0 0 0 0 0 0 0 0 0 10.5282 9.91995 0 0 0 0 0 10.6068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3873 0 0 0 11.6406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7042 0 0 0 0 0 0 0 12.7307 0 0 12.7381 0 0 11.2663 13.1796 0 12.8684 0 0 0 0 0 0 12.744 12.7232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1881 0 0 0 13.6169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96008 TOM40_HUMAN Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5) TOMM40 C19orf1 PEREC1 TOM40 Homo sapiens (Human) ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; porin activity [GO:0015288]; protein transmembrane transporter activity [GO:0008320]; ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626] GO:0005739; GO:0005741; GO:0005742; GO:0005743; GO:0005829; GO:0006626; GO:0006811; GO:0008320; GO:0015288; GO:0016021; GO:0030150; GO:0031307; GO:0044233; GO:0045040; GO:0046930 porin activity [GO:0015288]; protein transmembrane transporter activity [GO:0008320] KLPPLPLTLALGAFLNHRK 0.92035 1.5387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0319 0 0 0 0 0 0 0 0 0 0 13.6282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5828 0 0 0 0 0 14.4984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95772 STR3N_HUMAN STARD3 N-terminal-like protein (MLN64 N-terminal domain homolog) STARD3NL MENTHO UNQ855/PRO1864 Homo sapiens (Human) cholesterol transport [GO:0030301]; vesicle tethering to endoplasmic reticulum [GO:0099044] cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232] cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; vesicle tethering to endoplasmic reticulum [GO:0099044] GO:0005765; GO:0005768; GO:0005829; GO:0015485; GO:0016020; GO:0016021; GO:0030301; GO:0031902; GO:0042803; GO:0043231; GO:0044232; GO:0099044; GO:0140284 cholesterol binding [GO:0015485]; protein homodimerization activity [GO:0042803] EKKGISDVR 0.9204 1.5328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.577 0 0 0 13.0337 12.3466 0 0 0 12.8211 12.8608 13.0305 11.7626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7175 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4054 0 0 0 13.2865 0 0 0 0 0 0 13.5143 0 0 0 0 0 Q8WWG1 NRG4_HUMAN "Pro-neuregulin-4, membrane-bound isoform, Pro-NRG4 [Cleaved into: Neuregulin-4, NRG-4 ]" NRG4 Homo sapiens (Human) ERBB4-ERBB4 signaling pathway [GO:0038138]; nervous system development [GO:0007399] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; ERBB4-ERBB4 signaling pathway [GO:0038138]; nervous system development [GO:0007399] GO:0005576; GO:0005615; GO:0005886; GO:0007399; GO:0008083; GO:0016021; GO:0038138; GO:0048018 growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018] PTDHEEPCGPSHK 0.92041 1.587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7957 0 0 0 0 0 0 0 0 11.7802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0555 0 Q92819 HYAS2_HUMAN "Hyaluronan synthase 2, EC 2.4.1.212 (Hyaluronate synthase 2) (Hyaluronic acid synthase 2, HA synthase 2)" HAS2 Homo sapiens (Human) atrioventricular canal development [GO:0036302]; bone morphogenesis [GO:0060349]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion to mesenchymal transition [GO:0090500]; estrous cycle [GO:0044849]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; kidney development [GO:0001822]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of urine volume [GO:0035810]; regulation of extracellular matrix assembly [GO:1901201]; renal water absorption [GO:0070295]; vasculogenesis [GO:0001570] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802]; atrioventricular canal development [GO:0036302]; bone morphogenesis [GO:0060349]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; endocardial cushion to mesenchymal transition [GO:0090500]; estrous cycle [GO:0044849]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; kidney development [GO:0001822]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of urine volume [GO:0035810]; regulation of extracellular matrix assembly [GO:1901201]; renal water absorption [GO:0070295]; vasculogenesis [GO:0001570] GO:0000139; GO:0001570; GO:0001822; GO:0005764; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0008284; GO:0010838; GO:0014911; GO:0030213; GO:0030335; GO:0031410; GO:0035810; GO:0036120; GO:0036302; GO:0042802; GO:0044849; GO:0044853; GO:0045226; GO:0050501; GO:0051549; GO:0060349; GO:0070295; GO:0071347; GO:0071356; GO:0071498; GO:0085029; GO:0090500; GO:1900026; GO:1900127; GO:1900625; GO:1901201; GO:1903561 hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802] GKIWNILLFLLTVQLVGLIK 0.92041 1.6067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0245 0 14.8216 13.887 0 0 0 0 11.7633 0 11.7201 0 0 0 0 0 11.5092 0 0 0 0 0 0 0 0 0 12.8872 0 0 0 0 0 0 0 0 13.3852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8337 0 0 0 P33261 CP2CJ_HUMAN "Cytochrome P450 2C19, EC 1.14.14.1 ((R)-limonene 6-monooxygenase, EC 1.14.14.53) ((S)-limonene 6-monooxygenase, EC 1.14.14.51) ((S)-limonene 7-monooxygenase, EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating), EC 1.14.14.75) (Mephenytoin 4-hydroxylase)" CYP2C19 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; heterocycle metabolic process [GO:0046483]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; (R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; heterocycle metabolic process [GO:0046483]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0001676; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0005886; GO:0006082; GO:0006805; GO:0008202; GO:0008392; GO:0008395; GO:0016098; GO:0016491; GO:0016712; GO:0018675; GO:0018676; GO:0019373; GO:0019825; GO:0019899; GO:0020037; GO:0042178; GO:0043231; GO:0046483; GO:0052741; GO:0070330; GO:0097267; GO:0120319 "(R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]" DQQFLNLMEK 0.92042 1.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0058 0 13.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0488 13.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0P0 RN181_HUMAN "E3 ubiquitin-protein ligase RNF181, EC 2.3.2.27 (RING finger protein 181)" RNF181 HSPC238 Homo sapiens (Human) protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005737; GO:0016567; GO:0046872; GO:0051865; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] TNMLLELARSLFNR 0.92042 1.8926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTD8 RBM42_HUMAN RNA-binding protein 42 (RNA-binding motif protein 42) RBM42 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]" GO:0000398; GO:0003723; GO:0005634; GO:0005737; GO:0046540; GO:0048025; GO:1990904 RNA binding [GO:0003723] APILRPAFVPHVLQR 0.92047 1.4906 0 0 0 0 0 0 0 0 0 10.9814 0 0 0 11.1035 11.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6184 11.6978 0 12.0754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5421 12.9152 0 0 0 0 0 0 12.794 13.043 12.2533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6412 0 13.7705 14.0699 13.1909 0 13.6931 0 13.8971 13.6094 0 0 13.3467 0 0 0 0 0 0 0 0 0 Q9H8G2 CAAP1_HUMAN "Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein, CAAP)" CAAP1 C9orf82 CAAP Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268] apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268] GO:0006915; GO:2001268 ILEGDNGMDSDMEEEADDGSK 0.92049 1.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3814 0 0 12.987 12.3327 0 12.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1169 0 0 0 0 0 0 0 0 12.8444 0 0 0 0 0 0 0 0 12.75 13.6287 0 0 0 0 0 0 0 0 13.3028 12.4644 0 0 0 0 12.8136 13.4476 0 0 0 0 0 0 13.5857 0 0 12.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8401 0 13.8782 0 0 0 0 0 0 Q92959 SO2A1_HUMAN "Solute carrier organic anion transporter family member 2A1 (Prostaglandin transporter, PGT) (Solute carrier family 21 member 2)" SLCO2A1 OATP2A1 SLC21A2 Homo sapiens (Human) lipid transport [GO:0006869]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; lipid transporter activity [GO:0005319]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; lipid transport [GO:0006869]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252] GO:0005319; GO:0005886; GO:0005887; GO:0006869; GO:0015132; GO:0015347; GO:0015732; GO:0016020; GO:0043252 lipid transporter activity [GO:0005319]; prostaglandin transmembrane transporter activity [GO:0015132]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] GSLVDFIKRFPCIFLR 0.92051 1.8916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5775 0 0 0 0 0 0 0 0 12.1541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53365 ARFP2_HUMAN "Arfaptin-2 (ADP-ribosylation factor-interacting protein 2) (Partner of RAC1, POR1)" ARFIP2 POR1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; intracellular protein transport [GO:0006886]; lamellipodium assembly [GO:0030032]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; small GTPase mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; intracellular protein transport [GO:0006886]; lamellipodium assembly [GO:0030032]; mitophagy [GO:0000423]; protein localization to phagophore assembly site [GO:0034497]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; small GTPase mediated signal transduction [GO:0007264] GO:0000423; GO:0001726; GO:0005525; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006886; GO:0007264; GO:0019904; GO:0030032; GO:0030036; GO:0030742; GO:0031267; GO:0031529; GO:0032588; GO:0034315; GO:0034497; GO:0042802; GO:0045296; GO:0070273; GO:0140090 cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267] FGRGSRTVDLELELQIELLR 0.92052 1.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10323 ACRO_HUMAN "Acrosin, EC 3.4.21.10 [Cleaved into: Acrosin light chain; Acrosin heavy chain ]" ACR ACRS Homo sapiens (Human) acrosome matrix dispersal [GO:0002077]; acrosome reaction [GO:0007340]; activation of adenylate cyclase activity [GO:0007190]; binding of sperm to zona pellucida [GO:0007339]; penetration of zona pellucida [GO:0007341]; response to steroid hormone [GO:0048545]; single fertilization [GO:0007338] acrosomal matrix [GO:0043159]; extracellular region [GO:0005576]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] acrosomal matrix [GO:0043159]; extracellular region [GO:0005576]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; amidase activity [GO:0004040]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; zinc ion binding [GO:0008270]; acrosome matrix dispersal [GO:0002077]; acrosome reaction [GO:0007340]; activation of adenylate cyclase activity [GO:0007190]; binding of sperm to zona pellucida [GO:0007339]; penetration of zona pellucida [GO:0007341]; response to steroid hormone [GO:0048545]; single fertilization [GO:0007338] GO:0002020; GO:0002077; GO:0003677; GO:0004040; GO:0004252; GO:0005507; GO:0005537; GO:0005576; GO:0005634; GO:0005798; GO:0007190; GO:0007338; GO:0007339; GO:0007340; GO:0007341; GO:0008236; GO:0008270; GO:0032991; GO:0042806; GO:0043159; GO:0048545 amidase activity [GO:0004040]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; zinc ion binding [GO:0008270] FIGPGCLPHFKAGLPR 0.92053 1.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6642 0 0 15.2156 14.7481 15.9012 0 0 14.4344 0 0 0 0 0 0 11.1562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70SY1 CR3L2_HUMAN "Cyclic AMP-responsive element-binding protein 3-like protein 2, cAMP-responsive element-binding protein 3-like protein 2 (BBF2 human homolog on chromosome 7) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2 ]" CREB3L2 BBF2H7 Homo sapiens (Human) "cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to wounding [GO:0009611]" chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038] "chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]; cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to wounding [GO:0009611]" GO:0000785; GO:0000976; GO:0000981; GO:0001228; GO:0002062; GO:0005634; GO:0005654; GO:0005783; GO:0005789; GO:0006357; GO:0006888; GO:0009611; GO:0010628; GO:0010976; GO:0016021; GO:0030968; GO:0034976; GO:0035497; GO:0045893; GO:0051216; GO:0097038 "cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]" LAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATK 0.92053 1.1495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YR6 POTED_HUMAN "POTE ankyrin domain family member D (ANKRD26-like family B member 3) (Ankyrin repeat domain-containing protein 21) (Prostate, ovary, testis-expressed protein, Protein POTE)" POTED A26B3 ANKRD21 POTE Homo sapiens (Human) plasma membrane [GO:0005886] plasma membrane [GO:0005886] GO:0005886 CCRHCFPCCR 0.92053 1.6214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.279 0 0 0 0 0 0 0 0 0 0 0 13.1167 0 0 0 0 13.2773 0 0 0 11.5933 0 0 12.0654 0 0 0 0 0 12.4528 14.1878 13.5282 0 0 11.2997 0 0 0 0 0 0 0 12.6685 11.4336 13.2933 12.2999 0 12.7678 0 0 0 0 0 12.6015 0 13.5742 12.5001 0 0 0 0 12.8934 0 14.6633 Q6UUV7 CRTC3_HUMAN "CREB-regulated transcription coactivator 3 (Transducer of regulated cAMP response element-binding protein 3, TORC-3, Transducer of CREB protein 3)" CRTC3 TORC3 Homo sapiens (Human) energy homeostasis [GO:0097009]; lipid catabolic process [GO:0016042]; macrophage activation [GO:0042116]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; lipid catabolic process [GO:0016042]; macrophage activation [GO:0042116]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008140; GO:0016042; GO:0032793; GO:0042116; GO:0045944; GO:0050995; GO:0051289; GO:0071878; GO:0097009 cAMP response element binding protein binding [GO:0008140] AFEQLMTDLTLSRVQFQKLQQLR 0.92054 1.5935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0511 0 0 0 0 0 0 0 0 0 0 12.0965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.639 0 0 0 0 0 0 0 0 0 0 0 12.4875 0 0 0 0 0 0 0 0 0 12.7036 0 0 0 0 0 0 0 0 0 0 0 0 14.5066 0 0 0 12.1974 0 0 0 0 0 0 0 0 0 0 11.5608 0 0 0 11.7583 0 12.9427 0 0 0 0 12.3877 0 0 0 0 12.883 0 0 0 0 0 12.0639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6X784 ZPBP2_HUMAN Zona pellucida-binding protein 2 (ZPBP-like protein) ZPBP2 ZPBPL Homo sapiens (Human) acrosome assembly [GO:0001675]; binding of sperm to zona pellucida [GO:0007339]; circadian regulation of gene expression [GO:0032922]; membrane lipid catabolic process [GO:0046466]; negative regulation of immunoglobulin production [GO:0002638]; sphingolipid metabolic process [GO:0006665] acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; extracellular region [GO:0005576]; nucleus [GO:0005634]; zona pellucida receptor complex [GO:0002199] acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; extracellular region [GO:0005576]; nucleus [GO:0005634]; zona pellucida receptor complex [GO:0002199]; acrosome assembly [GO:0001675]; binding of sperm to zona pellucida [GO:0007339]; circadian regulation of gene expression [GO:0032922]; membrane lipid catabolic process [GO:0046466]; negative regulation of immunoglobulin production [GO:0002638]; sphingolipid metabolic process [GO:0006665] GO:0001669; GO:0001675; GO:0002199; GO:0002638; GO:0005576; GO:0005634; GO:0006665; GO:0007339; GO:0032922; GO:0044297; GO:0046466 FTLFNKKGFIYGK 0.92054 1.8966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9448 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0851 0 0 0 0 0 0 11.9716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2235 0 0 12.9236 0 0 0 0 0 0 0 0 0 0 11.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4845 0 0 0 0 0 0 0 O75323 NIPS2_HUMAN "Protein NipSnap homolog 2, NipSnap2 (Glioblastoma-amplified sequence)" NIPSNAP2 GBAS Homo sapiens (Human) mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]; positive regulation of high voltage-gated calcium channel activity [GO:1901843] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitochondrion organization [GO:0007005]; oxidative phosphorylation [GO:0006119]; positive regulation of high voltage-gated calcium channel activity [GO:1901843] GO:0005739; GO:0005741; GO:0006119; GO:0007005; GO:1901843 HGWEELVYYTVPLIQEMESR 0.92057 1.5298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8772 0 13.518 13.2184 13.5377 0 0 0 0 13.4063 0 0 13.9546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8514 0 0 0 0 0 Q86VK4 ZN410_HUMAN Zinc finger protein 410 (Another partner for ARF 1) ZNF410 APA1 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; negative regulation of gene expression [GO:0010629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003712; GO:0005634; GO:0005694; GO:0006357; GO:0010629; GO:0045944; GO:0046872; GO:1990837 metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712] KLKCTVEGCDR 0.92058 1.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.39637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6679 0 0 16.715 16.7839 0 0 0 16.8424 0 0 12.9489 0 0 0 0 0 0 0 0 12.4987 12.5203 0 0 0 0 0 13.5159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7002 0 9.32089 0 0 0 0 0 0 0 0 Q13190 STX5_HUMAN Syntaxin-5 STX5 STX5A Homo sapiens (Human) "early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]" cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982] "cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]" GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0012505; GO:0012507; GO:0016021; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0042147; GO:0045296; GO:0045732; GO:0047485; GO:0048278; GO:0048280; GO:0090166; GO:1903358 cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] IFLILIVFFIIFVVFLA 0.9206 2.329 9.75293 0 0 0 0 0 0 0 0 0 0 11.0126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3343 13.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0666 0 0 17.3297 0 0 0 0 0 0 0 0 0 0 0 12.3111 0 0 0 0 0 13.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5952 0 0 0 0 12.0587 0 0 0 0 0 0 12.0993 12.1865 0 0 0 0 0 0 9.47318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15205 UBD_HUMAN Ubiquitin D (Diubiquitin) (Ubiquitin-like protein FAT10) UBD FAT10 Homo sapiens (Human) aggresome assembly [GO:0070842]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome binding [GO:0070628]; aggresome assembly [GO:0070842]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006511; GO:0016235; GO:0016567; GO:0032446; GO:0034341; GO:0034612; GO:0043011; GO:0043065; GO:0043123; GO:0070628; GO:0070842; GO:1901990 proteasome binding [GO:0070628] GNLLFLACYCIGG 0.92062 1.5823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8667 0 0 0 0 0 0 0 11.6574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.766 0 16.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C645 OR4E1_HUMAN Olfactory receptor 4E1 (Olfactory receptor OR14-43) OR4E1 OR4E1P Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] MEEAILLNQTSLVTYFRLRGLSVNHK 0.92063 1.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41214 EIF2D_HUMAN "Eukaryotic translation initiation factor 2D, eIF2d (Hepatocellular carcinoma-associated antigen 56) (Ligatin)" EIF2D HCA56 LGTN Homo sapiens (Human) formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790] GO:0001731; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006886; GO:0016604; GO:0032790; GO:0038023; GO:0075522 RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743] DSLQVQIQGNQVHHLGWLLLEEYQLPRK 0.92063 1.6003 0 0 0 0 0 0 0 0 0 0 0 0 11.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0447 0 0 0 0 0 0 0 0 12.1036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GR4 ZDH12_HUMAN "Palmitoyltransferase ZDHHC12, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 12, DHHC-12) (Zinc finger DHHC domain-containing protein 12) (Zinc finger protein 400)" ZDHHC12 ZNF400 PSEC0008 Homo sapiens (Human) "gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]" GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032230; GO:0097116 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] CRYCLVLQPLRAR 0.92064 1.8891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTI6 RFLA_HUMAN "Refilin-A (Regulator of filamin protein A, RefilinA)" RFLNA FAM101A Homo sapiens (Human) actin filament bundle organization [GO:0061572]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte development [GO:0061182]; skeletal system morphogenesis [GO:0048705] actin filament bundle [GO:0032432]; cytoplasm [GO:0005737] actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filamin binding [GO:0031005]; actin filament bundle organization [GO:0061572]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte development [GO:0061182]; skeletal system morphogenesis [GO:0048705] GO:0005737; GO:0031005; GO:0032432; GO:0048705; GO:0061182; GO:0061572; GO:1900158 filamin binding [GO:0031005] ALRFRSTTIIFPK 0.92068 1.5898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8775 0 0 0 0 0 0 0 0 0 16.8886 0 0 0 0 0 0 13.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4266 0 0 0 0 0 P53778 MK12_HUMAN "Mitogen-activated protein kinase 12, MAP kinase 12, MAPK 12, EC 2.7.11.24 (Extracellular signal-regulated kinase 6, ERK-6) (Mitogen-activated protein kinase p38 gamma, MAP kinase p38 gamma) (Stress-activated protein kinase 3)" MAPK12 ERK6 SAPK3 Homo sapiens (Human) cell cycle [GO:0007049]; DNA damage induced protein phosphorylation [GO:0006975]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; negative regulation of cell cycle [GO:0045786]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; DNA damage induced protein phosphorylation [GO:0006975]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; negative regulation of cell cycle [GO:0045786]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165] GO:0000165; GO:0000287; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006975; GO:0007049; GO:0007165; GO:0007517; GO:0010952; GO:0018105; GO:0035556; GO:0045445; GO:0045786; GO:0051149; GO:0051726; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ELRLLKHMR 0.92069 1.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8984 0 0 0 0 0 0 0 14.7566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8012 0 0 0 0 0 0 0 0 0 0 0 0 12.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0H9 C4F30_HUMAN Putative cytochrome P450 family member 4F30 CYP4F30P C2orf14 Homo sapiens (Human) LGLVPTPPRIQKETK 0.9207 1.5984 0 0 13.2391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6PVI3 NCB2L_HUMAN Nuclear cap-binding protein subunit 2-like NCBP2L Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" nuclear cap binding complex [GO:0005846] "nuclear cap binding complex [GO:0005846]; RNA cap binding [GO:0000339]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000339; GO:0000398; GO:0005846; GO:0045292 RNA cap binding [GO:0000339] IKKTACGFCFVECHNR 0.92071 1.6181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00325 MPCP_HUMAN "Phosphate carrier protein, mitochondrial (Phosphate transport protein, PTP) (Solute carrier family 25 member 3)" SLC25A3 PHC OK/SW-cl.48 Homo sapiens (Human) mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435] extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate:proton symporter activity [GO:0015317]; protein-containing complex binding [GO:0044877]; mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435] GO:0005315; GO:0005739; GO:0005743; GO:0005887; GO:0015317; GO:0016020; GO:0031305; GO:0035435; GO:0044877; GO:0070062; GO:1990547 inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate:proton symporter activity [GO:0015317]; protein-containing complex binding [GO:0044877] ANPFNTPHLQLVHDGLGDLR 0.92071 1.5897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3795 0 11.4668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5836 0 0 0 0 0 0 0 0 0 0 12.8392 0 0 0 0 0 13.3516 12.7237 0 0 0 0 0 0 0 0 13.1675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8792 0 0 0 13.7161 0 0 0 13.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NA61 CBY2_HUMAN Protein chibby homolog 2 (Spermatid-associated protein) CBY2 SPERT Homo sapiens (Human) cytoplasmic vesicle [GO:0031410] cytoplasmic vesicle [GO:0031410]; identical protein binding [GO:0042802] GO:0031410; GO:0042802 identical protein binding [GO:0042802] EMRQALQALLKENR 0.92072 1.5336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8961 0 0 0 13.9221 0 0 0 0 0 14.8115 0 0 0 0 18.024 0 18.0881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4251 0 0 0 0 0 0 12.1351 0 0 0 0 0 0 0 0 11.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8269 0 0 0 0 P15036 ETS2_HUMAN Protein C-ets-2 ETS2 Homo sapiens (Human) cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; ectodermal cell fate commitment [GO:0001712]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0001712; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0007498; GO:0019904; GO:0030154; GO:0045944; GO:0061629; GO:0090009; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" FGMNGQMLCNLGK 0.92074 1.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3081 0 0 0 10.192 0 0 0 0 0 0 0 0 0 0 0 10.9723 0 0 0 0 0 11.8595 0 0 0 0 0 12.0779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4047 0 0 0 Q5VXI9 LIPN_HUMAN "Lipase member N, EC 3.1.1.- (Lipase-like abhydrolase domain-containing protein 4)" LIPN LIPL4 Homo sapiens (Human) cornification [GO:0070268]; lipid catabolic process [GO:0016042] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lipoprotein lipase activity [GO:0004465]; cornification [GO:0070268]; lipid catabolic process [GO:0016042] GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268 lipoprotein lipase activity [GO:0004465] FFLLPNSIIKAVFGTK 0.92074 1.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1011 0 0 0 0 0 0 13.1544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00590 ACKR2_HUMAN Atypical chemokine receptor 2 (C-C chemokine receptor D6) (Chemokine receptor CCR-10) (Chemokine receptor CCR-9) (Chemokine-binding protein 2) (Chemokine-binding protein D6) ACKR2 CCBP2 CCR10 CMKBR9 D6 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of cytosolic calcium ion concentration [GO:0007204] actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0004950; GO:0005044; GO:0005654; GO:0005769; GO:0005829; GO:0005884; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0031965; GO:0035556; GO:0043231; GO:0055037; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044] LRPAGQGRALK 0.92076 1.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LX7 CCD17_HUMAN Coiled-coil domain-containing protein 17 CCDC17 Homo sapiens (Human) ALREAYIRDGGR 0.92076 1.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8046 0 0 0 0 0 13.0624 0 11.2274 0 O95156 NXPH2_HUMAN Neurexophilin-2 NXPH2 NPH2 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; neuropeptide signaling pathway [GO:0007218] GO:0005102; GO:0005576; GO:0007218 signaling receptor binding [GO:0005102] IISPLRLFVK 0.92077 1.1475 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0283 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1548 0 0 0 13.2366 0 0 0 14.3676 0 0 0 13.0962 0 14.6236 0 0 12.2807 0 0 0 0 0 0 0 11.8684 12.9364 0 0 14.1202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3012 0 0 0 0 0 0 0 12.1716 0 0 0 0 12.1887 0 0 0 0 0 0 0 14.7464 0 0 0 O76062 ERG24_HUMAN "Delta(14)-sterol reductase TM7SF2, Delta-14-SR, EC 1.3.1.70 (3-beta-hydroxysterol Delta (14)-reductase) (Another new gene 1 protein) (C-14 sterol reductase, C14SR) (Putative sterol reductase SR-1) (Sterol C14-reductase) (Transmembrane 7 superfamily member 2)" TM7SF2 ANG1 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; receptor complex [GO:0043235] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; receptor complex [GO:0043235]; delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol biosynthetic process [GO:0006695]; sterol biosynthetic process [GO:0016126]" GO:0005637; GO:0005783; GO:0005789; GO:0005887; GO:0006695; GO:0016126; GO:0016627; GO:0030176; GO:0043231; GO:0043235; GO:0050613; GO:0050661 "delta14-sterol reductase activity [GO:0050613]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]" ALLLWLAWLGLQAALYLLPAR 0.92078 1.887 0 0 0 0 0 0 0 0 0 0 0 14.3678 0 0 0 0 0 13.031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7408 0 0 0 0 0 13.5539 0 0 0 0 0 0 14.9306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9365 0 13.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7L9 ZSCA2_HUMAN "Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog, Zfp-29) (Zinc finger protein 854)" ZSCAN2 ZFP29 ZNF854 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007283; GO:0030154; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CLMCGKSFSR 0.92078 2.3272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2051 0 0 0 0 0 11.3894 0 12.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.085 0 13.7117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6138 0 0 0 12.6276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2841 0 0 0 0 0 0 12.5674 0 10.951 11.9948 0 0 0 0 0 0 0 0 0 0 0 0 11.767 0 0 Q92572 AP3S1_HUMAN "AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Clathrin-associated/assembly/adaptor protein, small 3) (Sigma-3A-adaptin, Sigma3A-adaptin) (Sigma-adaptin 3a)" AP3S1 CLAPS3 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; presynapse [GO:0098793]; transport vesicle [GO:0030133] "AP-3 adaptor complex [GO:0030123]; AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; presynapse [GO:0098793]; transport vesicle [GO:0030133]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" GO:0005769; GO:0005794; GO:0006886; GO:0006896; GO:0008089; GO:0008286; GO:0016183; GO:0016192; GO:0030119; GO:0030123; GO:0030133; GO:0030659; GO:0035654; GO:0036465; GO:0043231; GO:0046907; GO:0048490; GO:0060155; GO:0098793; GO:1903232; GO:1904115 AILIFNNHGK 0.92078 1.5876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1223 11.9547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1273 0 0 0 10.6776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9995 0 0 Q8WUF5 IASPP_HUMAN "RelA-associated inhibitor (Inhibitor of ASPP protein, Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein)" PPP1R13L IASPP NKIP1 PPP1R13BL RAI Homo sapiens (Human) apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular cardiac muscle tissue development [GO:0003229] cell junction [GO:0030054]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cell junction [GO:0030054]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cardiac right ventricle morphogenesis [GO:0003215]; embryonic camera-type eye development [GO:0031076]; hair cycle [GO:0042633]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular cardiac muscle tissue development [GO:0003229] GO:0000122; GO:0003215; GO:0003229; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0009791; GO:0030054; GO:0031076; GO:0035264; GO:0042633; GO:0042802; GO:0045171; GO:0045296; GO:0045597; GO:0048871; GO:0060048 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714] KQYQQIISRLFHR 0.9208 1.8941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7112 0 0 0 0 12.9127 0 0 0 0 0 0 12.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCP0 KC1G1_HUMAN "Casein kinase I isoform gamma-1, CKI-gamma 1, EC 2.7.11.1" CSNK1G1 Homo sapiens (Human) endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0016055; GO:0018105; GO:0090263; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] IGCGNFGELRLGK 0.92081 1.5385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5U1 M4A15_HUMAN Membrane-spanning 4-domains subfamily A member 15 MS4A15 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166] GO:0005886; GO:0007166; GO:0016021 VLGTVQILIGLIHLGFGSVLLMVR 0.92083 1.6071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIM6 S15A5_HUMAN Solute carrier family 15 member 5 SLC15A5 Homo sapiens (Human) peptide transport [GO:0015833]; protein transport [GO:0015031] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; symporter activity [GO:0015293]; peptide transport [GO:0015833]; protein transport [GO:0015031] GO:0015031; GO:0015293; GO:0015833; GO:0016021 symporter activity [GO:0015293] RCSLLTGVGVLVSALK 0.92084 1.1495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RD2 O52B2_HUMAN Olfactory receptor 52B2 (Olfactory receptor OR11-70) OR52B2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FVAICAPLRYTTVLTWPVVGRIALAVITR 0.92085 1.4918 0 13.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA76 LCE3A_HUMAN Late cornified envelope protein 3A (Late envelope protein 13) LCE3A LEP13 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; keratinization [GO:0031424]; killing of cells of another organism [GO:0031640] defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; keratinization [GO:0031424]; killing of cells of another organism [GO:0031640] GO:0031424; GO:0031640; GO:0050829; GO:0050830 CQSSNSCDR 0.92087 1.5249 0 0 0 0 0 0 0 10.4795 0 0 0 0 0 13.9008 0 0 0 0 0 13.9057 0 0 0 0 0 0 0 0 0 14.7067 13.0644 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4767 15.0603 0 10.9784 10.7234 0 0 0 0 0 0 15.4777 0 0 0 0 0 0 0 0 0 11.4421 0 0 0 0 0 12.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5626 0 13.6183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1775 0 0 Q8N5Y8 PAR16_HUMAN "Protein mono-ADP-ribosyltransferase PARP16, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16, PARP-16)" PARP16 ARTD15 C15orf30 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of cell death [GO:0060548]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; viral protein processing [GO:0019082] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of cell death [GO:0060548]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; viral protein processing [GO:0019082] GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006471; GO:0016020; GO:0016021; GO:0019082; GO:0019900; GO:0030968; GO:0034356; GO:0036498; GO:0043539; GO:0060548; GO:0070213; GO:0071782; GO:0071902; GO:0140289; GO:1990404; GO:1990830 kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; protein serine/threonine kinase activator activity [GO:0043539] DMLAADLRCSLFASALQSYKR 0.92089 1.5859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8258 0 0 0 0 14.3964 0 0 14.8577 0 0 14.3634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6981 0 0 0 0 0 0 10.5291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14061 COX17_HUMAN Cytochrome c oxidase copper chaperone COX17 Homo sapiens (Human) copper ion transport [GO:0006825]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytochrome-c oxidase activity [GO:1904960] cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758] cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; enzyme activator activity [GO:0008047]; copper ion transport [GO:0006825]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytochrome-c oxidase activity [GO:1904960] GO:0005507; GO:0005737; GO:0005758; GO:0006091; GO:0006825; GO:0008047; GO:0008284; GO:0016531; GO:0033617; GO:1903136; GO:1904960 copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; enzyme activator activity [GO:0008047] KPLKPCCACPETK 0.92091 1.6228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8136 0 0 0 0 0 0 0 0 12.1657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVS7 F183B_HUMAN Protein FAM183BP (Testis highly expressed protein 6) FAM183BP FAM183B THEG6 Homo sapiens (Human) ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] GO:0005737; GO:0005856; GO:0097546 ELRTQKLHTQYHVNPLR 0.92091 1.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3462 0 0 0 0 0 0 0 0 0 14.5826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NU7 HUTI_HUMAN "Probable imidazolonepropionase, EC 3.5.2.7 (Amidohydrolase domain-containing protein 1)" AMDHD1 HMFT1272 Homo sapiens (Human) histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] cytosol [GO:0005829] "cytosol [GO:0005829]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]" GO:0005829; GO:0006548; GO:0016812; GO:0019556; GO:0019557; GO:0046872; GO:0050480 "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]" GVFDLDSTRRILQR 0.92092 1.5857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NCS4 NKX26_HUMAN Homeobox protein Nkx-2.6 (Homeobox protein NK-2 homolog F) NKX2-6 NKX2F Homo sapiens (Human) atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell apoptotic process [GO:1904036]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell apoptotic process [GO:1904036]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008284; GO:0021854; GO:0030154; GO:0030855; GO:0035050; GO:0043066; GO:0043586; GO:0045944; GO:0048565; GO:0050673; GO:0050679; GO:0055014; GO:0055015; GO:0060037; GO:0060039; GO:1904019; GO:1904036 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" MGEPQPGLNAASPLGGGTR 0.92093 1.53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6929 0 12.6034 0 0 0 0 0 0 0 15.7672 0 0 0 0 15.5964 0 14.5434 0 0 13.9062 0 15.5645 0 0 0 13.2734 0 0 0 0 0 0 0 0 11.7423 0 14.1584 12.9454 0 13.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 15.228 11.8069 0 0 11.2259 12.1476 0 14.6328 0 0 0 13.8897 0 11.5005 0 0 0 0 0 0 0 13.4927 14.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31350 RIR2_HUMAN "Ribonucleoside-diphosphate reductase subunit M2, EC 1.17.4.1 (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit)" RRM2 RR2 Homo sapiens (Human) 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoside-diphosphate reductase complex [GO:0005971] "cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185]" GO:0001824; GO:0004748; GO:0005634; GO:0005829; GO:0005971; GO:0006260; GO:0008199; GO:0009185; GO:0009263; GO:0009265; GO:0042803; GO:0051290; GO:1900087 "ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]" ENTPPALSGTR 0.92094 1.8931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5596 0 0 0 0 0 15.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00187 MASP2_HUMAN "Mannan-binding lectin serine protease 2, EC 3.4.21.104 (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2, MASP-2) [Cleaved into: Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain ]" MASP2 Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370] "external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; complement component C4b binding [GO:0001855]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" GO:0001855; GO:0001867; GO:0002752; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0006958; GO:0008233; GO:0009897; GO:0042802; GO:0048306; GO:0070062; GO:1903028; GO:1905370 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; complement component C4b binding [GO:0001855]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] GSVTANMLCAGLESGGKDSCR 0.92095 1.5944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6099 12.1117 0 0 0 0 0 0 0 0 0 0 0 0 13.6278 0 0 12.997 0 12.5996 0 0 0 0 13.3079 0 0 13.4769 0 0 0 0 0 0 0 0 0 0 0 14.5447 0 0 12.3805 0 0 0 0 0 0 0 13.8038 15.2316 0 13.6515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7793 0 0 0 0 12.8795 0 0 0 0 13.7635 0 0 0 0 0 0 0 12.353 0 0 0 0 0 0 O76038 SEGN_HUMAN Secretagogin SCGN SECRET Homo sapiens (Human) regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; terminal bouton [GO:0043195]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0030425; GO:0030658; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0099509; GO:1900271 calcium ion binding [GO:0005509] ILALQENFLLQFK 0.92095 1.6215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9V2 TRIML_HUMAN "Probable E3 ubiquitin-protein ligase TRIML1, EC 2.3.2.27 (RING finger protein 209) (RING-type E3 ubiquitin transferase TRIML1) (Tripartite motif family-like protein 1)" TRIML1 RNF209 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0046872; GO:0051092; GO:0061630 metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630] IGDDYSLWVSSPLK 0.92096 1.8991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6469 0 0 0 0 0 14.3956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92543 SNX19_HUMAN Sorting nexin-19 SNX19 KIAA0254 Homo sapiens (Human) chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073] GO:0002062; GO:0005737; GO:0006887; GO:0030073; GO:0031901; GO:0035091; GO:0043231; GO:0051649; GO:1990502 phosphatidylinositol binding [GO:0035091] EINRTIQMIIRDFVLSWYR 0.92096 1.5838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8491 0 0 0 12.7069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2777 0 0 0 0 0 0 0 0 0 0 0 0 13.1221 0 0 0 0 0 0 0 0 0 0 0 0 12.2972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9066 0 0 0 0 0 0 12.9558 0 0 13.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9143 0 0 0 0 0 13.6398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3525 0 0 0 0 0 0 0 O95868 LY66D_HUMAN "Lymphocyte antigen 6 complex locus protein G6d, Protein Ly6-D (Megakaryocyte-enhanced gene transcript 1 protein)" LY6G6D C6orf23 G6D MEGT1 NG25 Homo sapiens (Human) acetylcholine receptor signaling pathway [GO:0095500] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; filopodium [GO:0030175]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; filopodium [GO:0030175]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; acetylcholine receptor inhibitor activity [GO:0030550]; identical protein binding [GO:0042802]; acetylcholine receptor signaling pathway [GO:0095500] GO:0005576; GO:0005886; GO:0009897; GO:0030175; GO:0030550; GO:0031225; GO:0032991; GO:0042802; GO:0045202; GO:0095500 acetylcholine receptor inhibitor activity [GO:0030550]; identical protein binding [GO:0042802] CYNCGGSPSSSCK 0.92099 1.6133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3491 0 0 0 0 0 0 0 0 14.3782 0 0 0 0 0 0 0 11.0166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4L1 T151A_HUMAN Transmembrane protein 151A TMEM151A TMEM151 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CFSFGSAEAEASYLTQR 0.92101 1.8983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3582 0 0 0 0 0 0 0 13.0094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5785 0 0 0 0 0 0 0 0 12.1863 0 0 0 0 0 11.3519 11.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8475 15.9045 14.7192 14.767 14.4059 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1094 0 0 0 0 0 0 0 0 0 15.5343 15.3824 0 0 14.451 14.4581 0 0 14.6518 0 0 0 0 0 0 14.5647 0 15.2053 0 0 0 14.0911 0 0 15.303 15.233 13.5256 0 0 14.3429 15.3142 14.5218 14.35 15.2784 0 0 0 0 14.1149 0 14.2167 14.3005 14.1293 14.0846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3529 Q8NFU4 FDSCP_HUMAN "Follicular dendritic cell secreted peptide, FDC secreted protein, FDC-SP" FDCSP C4orf7 UNQ733/PRO1419 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 KKVLLLITAILAVAVGFPVSQDQER 0.92104 1.6004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5902 0 0 0 12.2584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3353 0 0 0 0 0 0 0 0 0 0 0 0 11.2051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UDR5 AASS_HUMAN "Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase, LKR, LOR, EC 1.5.1.8; Saccharopine dehydrogenase, SDH, EC 1.5.1.9 ]" AASS Homo sapiens (Human) L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; histone binding [GO:0042393]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; transcription corepressor activity [GO:0003714]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]" GO:0000122; GO:0003714; GO:0004753; GO:0004754; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006554; GO:0019878; GO:0031061; GO:0033512; GO:0042393; GO:0043231; GO:0047130; GO:0047131 "histone binding [GO:0042393]; saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; transcription corepressor activity [GO:0003714]" AIHDKDYVK 0.92104 1.1508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6253 0 0 0 0 13.4747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8942 14.1304 0 0 0 0 0 0 0 0 0 14.8442 0 0 0 0 0 13.1683 11.6982 0 0 0 15.3163 13.873 0 0 12.5566 0 0 0 0 15.3091 0 11.9119 0 0 0 0 0 13.4676 15.6648 14.8803 14.5708 14.0674 0 12.7621 12.8384 0 0 0 0 0 0 14.3435 15.4322 0 0 0 0 0 0 0 0 13.7422 0 0 0 0 0 0 14.1486 0 0 0 0 0 0 0 0 0 0 0 0 0 14.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4729 0 0 0 Q8WVV9 HNRLL_HUMAN "Heterogeneous nuclear ribonucleoprotein L-like, hnRNPLL (Stromal RNA-regulating factor)" HNRNPLL HNRPLL SRRF BLOCK24 Homo sapiens (Human) mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484] membrane [GO:0016020]; nucleus [GO:0005634] membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484] GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0016020; GO:0033120; GO:0043484 mRNA binding [GO:0003729]; RNA binding [GO:0003723] DFAMSKNNRFTSAGQASK 0.92105 1.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5MNZ9 WIPI1_HUMAN "WD repeat domain phosphoinositide-interacting protein 1, WIPI-1 (Atg18 protein homolog) (WD40 repeat protein interacting with phosphoinositides of 49 kDa, WIPI 49 kDa)" WIPI1 WIPI49 Homo sapiens (Human) "autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; vesicle targeting, trans-Golgi to endosome [GO:0048203]" autophagosome membrane [GO:0000421]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; trans-Golgi network [GO:0005802] "autophagosome membrane [GO:0000421]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; trans-Golgi network [GO:0005802]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; signaling receptor binding [GO:0005102]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; vesicle targeting, trans-Golgi to endosome [GO:0048203]" GO:0000045; GO:0000139; GO:0000407; GO:0000421; GO:0000422; GO:0005102; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0006497; GO:0006914; GO:0009267; GO:0010008; GO:0019898; GO:0030136; GO:0030331; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0048203; GO:0050681; GO:0080025; GO:2000786 "nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; signaling receptor binding [GO:0005102]" MFMAATNYLPTQVSDMMHQDR 0.92106 1.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9236 0 0 0 0 0 0 0 0 0 10.9604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4894 0 0 0 0 0 0 9.82939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51671 CCL11_HUMAN Eotaxin (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11) CCL11 SCYA11 Homo sapiens (Human) actin filament organization [GO:0007015]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; chronic inflammatory response [GO:0002544]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; mast cell chemotaxis [GO:0002551]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to interleukin-13 [GO:0035962]; response to interleukin-4 [GO:0070670]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018]; actin filament organization [GO:0007015]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; chronic inflammatory response [GO:0002544]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; mast cell chemotaxis [GO:0002551]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to interleukin-13 [GO:0035962]; response to interleukin-4 [GO:0070670]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165] GO:0001938; GO:0002544; GO:0002548; GO:0002551; GO:0005576; GO:0005615; GO:0006468; GO:0006874; GO:0006935; GO:0006954; GO:0007010; GO:0007015; GO:0007155; GO:0007165; GO:0007186; GO:0007611; GO:0008009; GO:0008360; GO:0009314; GO:0009615; GO:0030335; GO:0030593; GO:0030838; GO:0031640; GO:0031728; GO:0035962; GO:0043547; GO:0045766; GO:0046983; GO:0048018; GO:0048020; GO:0048245; GO:0048247; GO:0050768; GO:0060444; GO:0060763; GO:0061844; GO:0070098; GO:0070371; GO:0070374; GO:0070670; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018] CPQKAVIFKTK 0.92107 1.1504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.45619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9966 0 0 0 0 0 0 0 0 12.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27348 1433T_HUMAN 14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1) YWHAQ Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; substantia nigra development [GO:0021762]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; negative regulation of transcription, DNA-templated [GO:0045892]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; substantia nigra development [GO:0021762]" GO:0005737; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0007264; GO:0008104; GO:0016020; GO:0019904; GO:0021762; GO:0032991; GO:0042802; GO:0045892; GO:0047485; GO:0070062 identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485] GDYFRYLAEVACGDDRK 0.92111 1.8905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9582 0 0 0 0 0 0 0 0 0 0 0 0 12.5047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2206 0 0 0 0 0 0 0 0 0 Q8N8L6 ARL10_HUMAN ADP-ribosylation factor-like protein 10 ARL10 ARL10A Homo sapiens (Human) GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525 GTP binding [GO:0005525]; GTPase activity [GO:0003924] APRPLGPLVLALGGAAAVLGSVLFILWK 0.92112 1.5338 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7378 0 0 14.1764 12.9914 0 0 12.593 0 11.7987 0 0 0 0 0 0 13.5741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8004 12.8386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1898 0 0 0 0 0 0 0 0 13.7708 0 0 14.7807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5223 0 0 0 0 0 12.4277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0395 0 0 0 0 0 0 0 0 14.0885 0 0 0 13.3176 0 0 13.7512 0 0 13.8088 0 13.8097 0 0 0 0 0 0 0 0 0 Q96ER3 SAAL1_HUMAN "Protein SAAL1 (Synoviocyte proliferation-associated in collagen-induced arthritis protein 1, SPACIA1)" SAAL1 Homo sapiens (Human) positive regulation of synoviocyte proliferation [GO:1901647] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of synoviocyte proliferation [GO:1901647] GO:0005634; GO:0005654; GO:1901647 SSSDDEEQLTELDEEMENEICR 0.92112 1.6184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3316 0 0 0 0 0 0 0 0 0 0 0 13.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5916 0 0 0 0 0 0 0 11.0716 0 P30154 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta) PPP2R1B Homo sapiens (Human) apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470] GO:0000159; GO:0005737; GO:0006470; GO:0019888; GO:0045121; GO:0060561; GO:0070062; GO:2001241 protein phosphatase regulator activity [GO:0019888] ENTIEHLLPLFLAQLK 0.92114 1.8959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7925 0 9.94295 0 0 10.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.014 0 0 0 0 12.2392 0 12.6699 0 0 0 14.9662 0 0 0 0 0 0 14.7152 0 0 0 0 13.1127 0 0 17.2468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6244 0 0 0 0 0 0 0 0 0 0 13.6308 0 0 0 12.8009 0 0 0 0 0 11.6385 0 0 0 0 15.5204 0 14.9814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3433 0 P56750 CLD17_HUMAN Claudin-17 CLDN17 UNQ758/PRO1489 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] bicellular tight junction [GO:0005923]; chloride channel complex [GO:0034707]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] GO:0005198; GO:0005254; GO:0005886; GO:0005923; GO:0007155; GO:0016338; GO:0034707; GO:0042802; GO:0070830 chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] AKAYLLGTSGVLFILTGIFVLIPVSWTANIIIR 0.92115 1.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L2K0 TEDC2_HUMAN Tubulin epsilon and delta complex protein 2 TEDC2 C16orf59 Homo sapiens (Human) positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0005737; GO:0005814; GO:0005929; GO:0045880 EKGHLLRLPAAFR 0.92115 1.8893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9152 9.68464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7543 0 0 0 0 12.0622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9896 0 0 0 0 0 0 0 0 10.6294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8237 0 13.8771 0 0 0 0 Q9BQA1 MEP50_HUMAN "Methylosome protein 50, MEP-50 (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50)" WDR77 MEP50 WD45 HKMT1069 Nbla10071 Homo sapiens (Human) "epithelial cell proliferation involved in prostate gland development [GO:0060767]; histone H4-R3 methylation [GO:0043985]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; histone H4-R3 methylation [GO:0043985]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0007309; GO:0008284; GO:0008327; GO:0030374; GO:0034709; GO:0043985; GO:0048026; GO:0060528; GO:0060767; GO:0060770 methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374] EWNLPPNAPACMERQLEAARYR 0.92117 1.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8094 0 0 0 0 0 0 14.8642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8275 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2059 0 0 0 0 0 0 0 0 0 P02775 CXCL7_HUMAN "Platelet basic protein, PBP (C-X-C motif chemokine 7) (Leukocyte-derived growth factor, LDGF) (Macrophage-derived growth factor, MDGF) (Small-inducible cytokine B7) [Cleaved into: Connective tissue-activating peptide III, CTAP-III (LA-PF4) (Low-affinity platelet factor IV); TC-2; Connective tissue-activating peptide III(1-81), CTAP-III(1-81); Beta-thromboglobulin, Beta-TG; Neutrophil-activating peptide 2(74), NAP-2(74); Neutrophil-activating peptide 2(73), NAP-2(73); Neutrophil-activating peptide 2, NAP-2; TC-1; Neutrophil-activating peptide 2(1-66), NAP-2(1-66); Neutrophil-activating peptide 2(1-63), NAP-2(1-63) ]" PPBP CTAP3 CXCL7 SCYB7 TGB1 THBGB1 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; defense response to bacterium [GO:0042742]; glucose transmembrane transport [GO:1904659]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell division [GO:0051781] extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; tertiary granule lumen [GO:1904724] extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; tertiary granule lumen [GO:1904724]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; glucose transmembrane transporter activity [GO:0005355]; growth factor activity [GO:0008083]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; defense response to bacterium [GO:0042742]; glucose transmembrane transport [GO:1904659]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell division [GO:0051781] GO:0005355; GO:0005576; GO:0005615; GO:0006954; GO:0008009; GO:0008083; GO:0030593; GO:0031091; GO:0031093; GO:0031640; GO:0042742; GO:0045236; GO:0051781; GO:0061844; GO:0070098; GO:0071222; GO:1904659; GO:1904724 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; glucose transmembrane transporter activity [GO:0005355]; growth factor activity [GO:0008083] GKEESLDSDLYAELRCMCIK 0.92119 1.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16401 PSMD5_HUMAN 26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B) PSMD5 KIAA0072 Homo sapiens (Human) proteasome regulatory particle assembly [GO:0070682] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle assembly [GO:0070682] GO:0000502; GO:0005654; GO:0005829; GO:0022624; GO:0070682 AAQALALLREVARLEAPLEELR 0.92119 1.8953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1083 0 0 0 0 0 0 0 0 0 11.7781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3434 0 0 11.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2405 0 0 0 0 0 10.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IN85 P4R3A_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1) PPP4R3A KIAA2010 PP4R3A SMEK1 MSTP033 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] GO:0005654; GO:0005815; GO:0005829; GO:0006470; GO:0006974; GO:0016607; GO:0030289; GO:0072542 protein phosphatase activator activity [GO:0072542] DARTLEDEEEMWFNTDEDDMEDGEAVVSPSDK 0.92121 1.4932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7508 0 0 0 12.7537 0 0 0 0 0 0 0 0 0 11.2617 0 0 0 0 0 0 0 0 10.1749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72228 0 0 0 0 0 0 0 0 0 0 0 12.2829 0 0 0 0 15.0904 12.3701 13.2306 0 0 0 14.4714 15.1507 0 0 0 0 14.4912 0 0 0 0 0 0 0 0 0 0 0 0 12.9155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6055 12.5972 0 0 0 0 0 0 Q99571 P2RX4_HUMAN "P2X purinoceptor 4, P2X4 (ATP receptor) (Purinergic receptor)" P2RX4 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195] cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein kinase B signaling [GO:0051897]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] GO:0001614; GO:0001894; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005507; GO:0005524; GO:0005639; GO:0005765; GO:0005886; GO:0005887; GO:0007165; GO:0008217; GO:0008270; GO:0010524; GO:0010614; GO:0014069; GO:0016020; GO:0019228; GO:0019233; GO:0019722; GO:0030054; GO:0032308; GO:0033198; GO:0034220; GO:0034405; GO:0035590; GO:0042118; GO:0042802; GO:0043025; GO:0043195; GO:0043197; GO:0043536; GO:0044297; GO:0045296; GO:0045429; GO:0048266; GO:0048471; GO:0048678; GO:0050850; GO:0050920; GO:0050975; GO:0051897; GO:0051899; GO:0051928; GO:0055117; GO:0055119; GO:0070062; GO:0070588; GO:0071294; GO:0071318; GO:0097190; GO:0099604; GO:1904141; GO:2001028 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] FDIIPTMINIGSGLALLGMATVLCDIIVLYCMKKR 0.92123 1.8948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0721 0 0 0 0 0 0 0 0 0 Q6P1J9 CDC73_HUMAN Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein) CDC73 C1orf28 HRPT2 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] "Cdc73/Paf1 complex [GO:0016593]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "Cdc73/Paf1 complex [GO:0016593]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0000781; GO:0000993; GO:0001558; GO:0001711; GO:0005634; GO:0005654; GO:0005829; GO:0006368; GO:0006378; GO:0007049; GO:0008285; GO:0010390; GO:0016055; GO:0016593; GO:0019827; GO:0030177; GO:0031442; GO:0031648; GO:0032968; GO:0033523; GO:0034402; GO:0043066; GO:0045638; GO:0048147; GO:0050680; GO:0071222; GO:1902808; GO:2000134 RNA polymerase II complex binding [GO:0000993] IAAIKAKIMAK 0.92124 1.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2152 0 0 0 0 0 0 0 0 0 14.1315 0 0 0 0 0 0 0 0 0 0 0 0 15.1188 0 0 0 0 0 0 0 0 0 14.2743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1201 0 Q92771 DDX12_HUMAN "Putative ATP-dependent RNA helicase DDX12, EC 3.6.4.13 (CHL1-related protein 2, hCHLR2) (DEAD/H box protein 12)" DDX12P CHLR2 DDX12 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139] GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006139; GO:0016887; GO:0032508; GO:0034085 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] EDFMAELYRVLEAGK 0.92124 1.6075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6941 0 0 0 0 13.2488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1364 0 0 0 14.1215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5393 0 0 0 0 0 0 0 0 12.4002 0 0 14.5891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5655 0 0 0 0 0 0 0 0 12.838 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2414 0 P22681 CBL_HUMAN "E3 ubiquitin-protein ligase CBL, EC 2.3.2.27 (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL)" CBL CBL2 RNF55 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cytokine-mediated signaling pathway [GO:0019221]; entry of bacterium into host cell [GO:0035635]; epidermal growth factor receptor signaling pathway [GO:0007173]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron death [GO:1901215]; neuron death [GO:0070997]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0001784; GO:0004842; GO:0005509; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0006511; GO:0006513; GO:0006974; GO:0007165; GO:0007166; GO:0007173; GO:0007175; GO:0008584; GO:0010332; GO:0014068; GO:0014823; GO:0016567; GO:0016600; GO:0017124; GO:0019221; GO:0030426; GO:0030971; GO:0032487; GO:0033574; GO:0035635; GO:0036120; GO:0036312; GO:0042059; GO:0042594; GO:0043066; GO:0043303; GO:0045121; GO:0045296; GO:0045471; GO:0045742; GO:0046677; GO:0046875; GO:0048260; GO:0048471; GO:0051865; GO:0061630; GO:0070997; GO:0090650; GO:1901215; GO:1990090; GO:2000583 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ITKADAAEFWR 0.92126 2.3301 0 0 0 0 0 0 0 0 0 12.6025 0 0 0 0 0 0 0 0 0 11.2992 0 0 0 0 0 0 0 12.0182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4618 0 12.6652 0 0 0 0 0 0 0 0 0 0 0 0 12.9066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9557 0 0 0 0 0 0 0 13.9706 14.274 0 0 14.4051 0 0 0 0 12.4638 0 0 0 0 0 0 0 0 0 0 0 0 12.9295 0 13.339 0 0 12.0833 0 0 0 0 0 0 0 0 0 0 0 0 11.6076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1471 P03952 KLKB1_HUMAN "Plasma kallikrein, EC 3.4.21.34 (Fletcher factor) (Kininogenin) (Plasma prekallikrein, PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain ]" KLKB1 KLK3 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" GO:0002542; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0031638; GO:0031639; GO:0042730; GO:0051919; GO:0070062; GO:1905370 serine-type endopeptidase activity [GO:0004252] CQFFTYSLLPEDCKEEKCK 0.92132 2.3292 0 0 0 0 0 0 0 0 12.3482 0 0 0 0 0 0 0 0 0 11.3348 0 0 0 11.9321 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9736 11.2671 11.3058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3177 0 0 0 0 0 0 0 12.5112 0 12.9184 0 12.9401 0 0 0 0 0 0 0 0 0 0 0 0 12.1748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1942 0 0 0 0 0 0 0 14.2394 17.0155 15.3045 0 14.5226 0 15.5351 0 0 0 0 14.1262 0 0 0 0 0 0 11.1381 0 0 Q8IZT9 FAM9C_HUMAN Protein FAM9C FAM9C Homo sapiens (Human) meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] synaptonemal complex [GO:0000795] synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] GO:0000795; GO:0007286; GO:0051321 EHLAAKR 0.92132 1.8941 0 0 0 0 0 0 0 0 0 0 13.5539 14.7565 12.2547 14.0513 0 0 0 0 0 0 0 0 0 0 0 0 12.5675 12.503 0 0 0 0 0 0 0 0 0 0 0 11.896 0 11.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8657 0 11.5216 0 12.6587 0 11.9738 0 0 0 0 0 12.1375 11.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5278 13.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9X3 YA026_HUMAN Putative uncharacterized protein encoded by LINC01356 LINC01356 Homo sapiens (Human) WLFLFLFQKLR 0.92139 1.1476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q58G82 SY14L_HUMAN Putative synaptotagmin-14-like protein (Synaptotagmin XIV protein pseudogene 1) (Synaptotagmin XIV-derived protein) (Synaptotagmin XIV-like protein) SYT14P1 SYT14L SYT14LP1 SYTDEP Homo sapiens (Human) cell differentiation [GO:0030154]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite extension [GO:1903861]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] phospholipid binding [GO:0005543]; cell differentiation [GO:0030154]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite extension [GO:1903861]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] GO:0005543; GO:0030154; GO:0032793; GO:0070374; GO:1903861 phospholipid binding [GO:0005543] LSAEVIKGSHLK 0.9214 1.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2I2 ZN619_HUMAN Zinc finger protein 619 ZNF619 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFRWNASFIQHQKWHTR 0.9214 2.3185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9634 0 0 0 0 0 15.8296 13.9177 0 0 0 0 0 0 12.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4344 0 0 0 0 0 0 0 0 0 11.4072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV56 PRR15_HUMAN Proline-rich protein 15 PRR15 Homo sapiens (Human) MADSGDAGSSGPWWK 0.92141 1.6134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49790 NU153_HUMAN Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) mRNA transport [GO:0051028]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732] cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear localization sequence binding [GO:0008139]; protein-membrane adaptor activity [GO:0043495]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732] GO:0003677; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0008139; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0042405; GO:0042802; GO:0043495; GO:0043657; GO:0044615; GO:0046718; GO:0046832; GO:0046872; GO:0051028; GO:0051292; GO:0075732 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear localization sequence binding [GO:0008139]; protein-membrane adaptor activity [GO:0043495]; structural constituent of nuclear pore [GO:0017056] DTAKQTGIETPNK 0.92143 5.4542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2499 0 0 0 0 0 0 0 0 0 0 0 13.3173 12.7394 0 13.1916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9069 0 0 0 0 0 0 0 0 0 12.9963 0 0 0 0 0 0 0 0 0 0 12.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9415 0 0 0 0 0 13.2361 0 0 0 0 0 0 0 0 0 0 0 0 15.6303 0 13.2923 0 0 0 0 12.5337 0 0 0 14.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5117 0 0 0 0 0 0 0 0 0 0 12.6614 0 0 12.2231 0 0 0 0 0 0 0 0 0 0 14.2121 0 0 0 0 13.0702 0 Q5QJ74 TBCEL_HUMAN "Tubulin-specific chaperone cofactor E-like protein, EL (Leucine-rich repeat-containing protein 35)" TBCEL LRRC35 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; alpha-tubulin binding [GO:0043014]; microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021] GO:0000226; GO:0005737; GO:0005856; GO:0007021; GO:0007023; GO:0043014 alpha-tubulin binding [GO:0043014] LDQTVAELKKQLK 0.92144 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.12526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47756 CAPZB_HUMAN F-actin-capping protein subunit beta (CapZ beta) CAPZB Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; sarcomere [GO:0030017]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm connecting piece [GO:0097224]; WASH complex [GO:0071203] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; sarcomere [GO:0030017]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm connecting piece [GO:0097224]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591] GO:0000902; GO:0003779; GO:0005829; GO:0005856; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0010591; GO:0014069; GO:0015629; GO:0016020; GO:0022604; GO:0030017; GO:0030027; GO:0030032; GO:0030863; GO:0045296; GO:0051015; GO:0051016; GO:0051490; GO:0070062; GO:0071203; GO:0097224; GO:0098685; GO:0098686 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296] DLYFEGGVSSVYLWDLDHGFAGVILIKK 0.92145 1.8931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4304 0 0 0 0 0 0 10.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0647 0 0 0 0 0 0 0 11.2261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FM1 PGAP3_HUMAN "Post-GPI attachment to proteins factor 3 (COS16 homolog, hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1)" PGAP3 CAB2 PERLD1 UNQ546/PRO1100 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; hydrolase activity, acting on ester bonds [GO:0016788]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]" GO:0000139; GO:0006505; GO:0006506; GO:0016021; GO:0016788; GO:0031227 "hydrolase activity, acting on ester bonds [GO:0016788]" FDYGYNLVANVAIGLVNVVWWLAWCLWNQRR 0.92146 2.3174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7781 0 0 11.4439 0 0 0 0 0 0 0 0 0 11.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.01 0 0 10.8187 0 0 0 0 0 0 0 0 10.5967 0 0 0 Q96KX0 LYZL4_HUMAN "Lysozyme-like protein 4, Lysozyme-4" LYZL4 LYC4 Homo sapiens (Human) fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; lysozyme activity [GO:0003796]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] GO:0001669; GO:0003796; GO:0005615; GO:0005634; GO:0007342; GO:0009566; GO:0036126 lysozyme activity [GO:0003796] CHMSCSALLNPNLEK 0.92146 1.1499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6757 0 0 0 0 0 0 0 0 0 0 O75678 RFPL2_HUMAN Ret finger protein-like 2 (RING finger protein 79) RFPL2 RNF79 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000785; GO:0004842; GO:0005654; GO:0045893; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] EPHGEDLLCCCSSMVSRK 0.92147 1.9075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7064 0 0 0 12.6165 0 0 0 0 0 0 0 0 0 0 0 11.3363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8998 0 12.9861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4731 0 0 0 0 13.9294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.27 14.6998 0 0 0 0 13.4743 0 0 0 0 0 0 0 0 12.8737 12.8607 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8909 0 0 0 0 0 0 0 0 0 0 0 0 10.1367 0 0 10.1768 0 0 0 0 0 0 0 Q6ZTZ1 MSD1_HUMAN Myb/SANT-like DNA-binding domain-containing protein 1 MSANTD1 C4orf44 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" nuclear body [GO:0016604] "nuclear body [GO:0016604]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0016604; GO:0045893 ARNWTDAEMR 0.92147 1.6203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0862 11.1849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.846 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6751 0 0 0 0 12.584 0 0 0 0 0 0 12.0964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7355 0 13.9418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7085 0 0 0 0 0 0 0 0 0 0 11.5622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYD2 RM09_HUMAN "39S ribosomal protein L9, mitochondrial, L9mt, MRP-L9 (Mitochondrial large ribosomal subunit protein bL9m)" MRPL9 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ALLRAGAGRLLR 0.92151 1.9071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2951 0 0 0 0 0 0 0 13.7194 0 13.7731 0 13.7295 13.713 0 0 0 0 11.1114 0 0 0 0 0 13.4863 0 13.0958 12.793 0 0 0 13.628 0 0 0 0 12.6729 13.0041 0 0 0 0 0 0 0 13.9846 13.2821 13.2705 0 0 0 13.8587 0 0 0 0 0 0 0 0 0 12.2727 0 12.9141 0 0 12.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9578 15.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4105 0 0 0 0 0 0 0 Q9H649 NSUN3_HUMAN "tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 3)" NSUN3 MSTP077 UG0651E06 Homo sapiens (Human) regulation of mitochondrial translation [GO:0070129]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]; tRNA wobble base cytosine methylation [GO:0002127] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; regulation of mitochondrial translation [GO:0070129]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]; tRNA wobble base cytosine methylation [GO:0002127] GO:0000049; GO:0001510; GO:0002127; GO:0005739; GO:0005759; GO:0005762; GO:0008168; GO:0016428; GO:0031167; GO:0070129 methyltransferase activity [GO:0008168]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] ALRPGGILVYSTCTLSK 0.92152 2.3147 0 0 0 0 0 0 0 9.89697 12.6107 0 0 0 0 0 0 0 0 0 0 0 11.1111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3198 0 0 0 0 0 0 0 0 0 0 0 11.7331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.261 14.7088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4732 0 0 0 0 0 0 0 0 0 P43356 MAGA2_HUMAN "Melanoma-associated antigen 2 (Cancer/testis antigen 1.2, CT1.2) (MAGE-2 antigen)" MAGEA2 MAGE2 MAGEA2A; MAGEA2B MAGE2 MAGEA2 Homo sapiens (Human) cellular senescence [GO:0090398]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein catabolic process [GO:0030163]; signal transduction by p53 class mediator [GO:0072331] nucleus [GO:0005634]; PML body [GO:0016605] nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; ubiquitin protein ligase binding [GO:0031625]; cellular senescence [GO:0090398]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein catabolic process [GO:0030163]; signal transduction by p53 class mediator [GO:0072331] GO:0000122; GO:0005634; GO:0016605; GO:0030163; GO:0031625; GO:0033234; GO:0042826; GO:0051443; GO:0072331; GO:0090398; GO:0140297; GO:1901984 DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; ubiquitin protein ligase binding [GO:0031625] KMVELVHFLLLKYR 0.92153 1.5285 0 0 0 0 0 0 0 0 0 0 0 0 14.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2057 0 0 12.7479 0 0 12.8673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3554 0 0 0 0 0 13.3031 0 0 13.5494 0 0 0 0 0 0 Q8NGJ5 O51L1_HUMAN Olfactory receptor 51L1 (Olfactory receptor OR11-31) OR51L1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LGILHKFVLR 0.92156 1.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5695 0 0 0 0 Q401N2 ZACN_HUMAN Zinc-activated ligand-gated ion channel (Ligand-gated ion channel zinc-activated 1) (Ligand-gated ion-channel receptor L2) ZACN L2 LGICZ LGICZ1 ZAC Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to zinc ion [GO:0010043]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to zinc ion [GO:0010043]; signal transduction [GO:0007165] GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0008270; GO:0010043; GO:0015276; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270] EHGNPGPHPAEEPSRGVKGSQR 0.92159 1.5276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7B8 DB128_HUMAN "Beta-defensin 128 (Beta-defensin 28, DEFB-28) (Defensin, beta 128)" DEFB128 DEFB28 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640] GO:0005576; GO:0031640; GO:0045087; GO:0050829; GO:0050830 KHVSFKK 0.92159 1.4941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4148 0 0 0 0 0 0 0 13.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3236 0 0 0 0 11.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2044 15.0018 15.0532 0 14.604 16.0262 0 14.8023 0 14.741 14.6422 14.7352 0 0 0 0 0 15.3158 0 15.1338 0 15.5922 14.9873 0 0 15.3043 0 0 14.6174 15.468 0 15.6816 15.7494 0 12.4027 0 15.2025 13.0508 14.8458 0 0 0 0 13.1957 16.0489 0 0 15.1503 0 0 0 0 0 15.0205 15.1694 0 0 14.7477 16.2969 15.2861 0 0 14.9461 15.6692 0 0 0 0 0 14.1594 0 0 14.0425 0 12.2313 0 14.4005 15.1947 15.6938 0 0 15.499 14.0278 0 0 15.6499 11.8287 15.2719 0 0 0 0 0 0 15.7373 0 Q9NTX9 F217B_HUMAN Protein FAM217B FAM217B C20orf177 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 ENADEDSASDLSDSER 0.92163 2.3272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4478 Q9NXF1 TEX10_HUMAN Testis-expressed protein 10 TEX10 L18 Nbla10363 Homo sapiens (Human) mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0071339 AVYTLYQQRGLILPVR 0.92169 1.905 0 0 0 0 0 0 0 0 0 12.2252 0 0 0 16.0011 0 0 0 15.9005 16.0806 0 14.716 0 16.1141 0 0 15.8782 0 0 12.2796 15.9187 0 0 0 0 0 10.8245 0 0 0 15.7581 0 0 0 0 0 0 0 0 0 0 0 14.4359 11.1709 15.8416 0 0 0 0 0 12.394 0 0 0 0 0 0 0 0 11.5924 0 0 13.2189 0 0 0 0 0 0 13.7506 14.2813 0 0 12.4306 0 14.0761 12.7001 0 0 0 15.6402 15.1118 0 0 0 0 12.6009 18.2062 0 0 0 13.4819 14.9905 15.6283 0 15.765 0 12.9982 12.6512 0 18.6228 14.5566 0 14.6285 0 0 13.226 0 16.3191 13.7307 0 0 0 14.1524 18.2811 0 9.93518 14.4267 13.6797 11.4043 0 0 13.3354 0 12.2332 0 18.5007 18.5704 13.6458 0 0 0 0 12.8405 11.9902 14.9436 0 12.1744 15.375 0 0 0 0 0 11.9881 0 12.6422 14.7644 0 0 12.1055 0 0 11.261 0 0 0 0 11.7328 0 17.891 0 12.9254 12.9739 18.795 0 0 0 0 18.3813 12.3009 Q96ME1 FXL18_HUMAN F-box/LRR-repeat protein 18 (F-box and leucine-rich repeat protein 18) FBXL18 FBL18 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0005829; GO:0019005; GO:0031146 GFGKKVR 0.92178 1.9042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5638 0 12.7746 0 0 17.1199 17.0885 17.0124 0 0 0 0 11.8057 0 0 0 0 0 0 17.3123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1802 0 Q6ZVX9 PAQR9_HUMAN "Membrane progestin receptor epsilon, mPR epsilon (Membrane progesterone P4 receptor epsilon) (Membrane progesterone receptor epsilon) (Progesterone and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member 9) (Progestin and adipoQ receptor family member IX)" PAQR9 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496] GO:0005496; GO:0005886; GO:0016021; GO:0038023 signaling receptor activity [GO:0038023]; steroid binding [GO:0005496] GENPTLFVHFYRR 0.92179 1.6148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0Z8 PUSL1_HUMAN "tRNA pseudouridine synthase-like 1, EC 5.4.99.- (tRNA pseudouridylate synthase-like 1) (tRNA-uridine isomerase-like 1)" PUSL1 Homo sapiens (Human) tRNA pseudouridine synthesis [GO:0031119] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthesis [GO:0031119] GO:0003723; GO:0005739; GO:0009982; GO:0031119; GO:0043231 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] MSSAPASGSVRAR 0.92183 1.6138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXN7 RIMKA_HUMAN "N-acetylaspartylglutamate synthase A, NAAG synthetase A, NAAGS, EC 6.3.2.41 (N-acetylaspartylglutamylglutamate synthase A, EC 6.3.2.42) (Ribosomal protein S6 modification-like protein A)" RIMKLA FAM80A Homo sapiens (Human) glutamine family amino acid metabolic process [GO:0009064] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]; glutamine family amino acid metabolic process [GO:0009064]" GO:0005524; GO:0005737; GO:0005829; GO:0009064; GO:0016879; GO:0046872; GO:0072590 "ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]" DIRVVVVGGQVIGSMLR 0.92187 1.9005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5724 0 0 0 0 Q8NEU8 DP13B_HUMAN "DCC-interacting protein 13-beta, Dip13-beta (Adapter protein containing PH domain, PTB domain and leucine zipper motif 2)" APPL2 DIP13B Homo sapiens (Human) "adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cold acclimation [GO:0009631]; diet induced thermogenesis [GO:0002024]; glucose homeostasis [GO:0042593]; negative regulation of cellular response to insulin stimulus [GO:1900077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of glucose import [GO:0046325]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of phagocytosis, engulfment [GO:0060100]; protein homotetramerization [GO:0051289]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]" cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; early phagosome membrane [GO:0036186]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982] "cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; early phagosome membrane [GO:0036186]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cold acclimation [GO:0009631]; diet induced thermogenesis [GO:0002024]; glucose homeostasis [GO:0042593]; negative regulation of cellular response to insulin stimulus [GO:1900077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of glucose import [GO:0046325]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of phagocytosis, engulfment [GO:0060100]; protein homotetramerization [GO:0051289]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0001726; GO:0001786; GO:0002024; GO:0005634; GO:0005768; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0009631; GO:0010008; GO:0010762; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0031982; GO:0032009; GO:0032587; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0036186; GO:0042593; GO:0042802; GO:0042803; GO:0044354; GO:0044877; GO:0045088; GO:0046322; GO:0046325; GO:0050768; GO:0051289; GO:0060100; GO:0070062; GO:0120162; GO:1900016; GO:1900077; GO:1905303; GO:1905451; GO:2000045; GO:2000178 identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] KQHLSSLQYYCALNALQYR 0.92199 2.3302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTU0 DDI1_HUMAN "Protein DDI1 homolog 1, EC 3.4.23.-" DDI1 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] aspartic-type endopeptidase activity [GO:0004190]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] GO:0004190; GO:0010498; GO:0031647; GO:0072711; GO:0097752 aspartic-type endopeptidase activity [GO:0004190] EITHSVMDSGR 0.92199 1.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9795 12.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3176 0 0 0 0 0 0 0 0 0 0 Q6ZRC1 CD050_HUMAN Uncharacterized protein C4orf50 C4orf50 Homo sapiens (Human) LAVTPLKAKIASLVR 0.92205 2.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6942 13.7518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CK96 S352B_HUMAN Solute carrier family 35 member E2B SLC35E2B KIAA0447 Homo sapiens (Human) blastocyst hatching [GO:0001835] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; blastocyst hatching [GO:0001835] GO:0001835; GO:0005794; GO:0015297; GO:0016021 antiporter activity [GO:0015297] FATVVLGLVSLKNVAVSFAETVK 0.92206 1.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3387 0 0 0 0 0 0 0 12.1411 0 0 13.2521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8507 12.4101 0 0 12.4309 0 0 0 11.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N128 F177A_HUMAN Protein FAM177A1 FAM177A1 C14orf24 Homo sapiens (Human) DVLPTVDPTKLTWGPYLWFYMLRAATSTLSVCDFLGEK 0.92206 2.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6581 0 0 13.224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02768 ALBU_HUMAN Albumin ALB GIG20 GIG42 PRO0903 PRO1708 PRO2044 PRO2619 PRO2675 UNQ696/PRO1341 Homo sapiens (Human) cellular response to starvation [GO:0009267]; maintenance of mitochondrion location [GO:0051659]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; retina homeostasis [GO:0001895] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; antioxidant activity [GO:0016209]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; maintenance of mitochondrion location [GO:0051659]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; retina homeostasis [GO:0001895] GO:0001895; GO:0003677; GO:0005504; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0005794; GO:0008270; GO:0009267; GO:0015643; GO:0016209; GO:0030170; GO:0031093; GO:0032991; GO:0042802; GO:0043066; GO:0043069; GO:0051087; GO:0051659; GO:0070062; GO:0072562; GO:0140272; GO:1903981 antioxidant activity [GO:0016209]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; enterobactin binding [GO:1903981]; exogenous protein binding [GO:0140272]; fatty acid binding [GO:0005504]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; toxic substance binding [GO:0015643]; zinc ion binding [GO:0008270] AWAVARLSQRFPK 0.92208 5.3472 0 0 0 14.1756 0 0 14.5716 14.118 0 11.9683 0 12.319 12.9608 14.2766 14.2139 0 12.0133 11.9122 0 0 10.5763 0 0 11.4857 0 0 12.519 0 0 0 0 0 11.9426 11.643 0 0 0 0 0 0 13.0543 13.3288 12.2177 0 0 0 0 0 0 0 11.5585 0 0 13.4261 0 0 12.658 0 0 0 0 0 0 0 0 0 16.398 16.4517 16.0668 15.5688 16.2207 15.8095 16.446 16.4674 16.4774 15.9011 16.3613 15.8763 16.0631 12.6344 15.406 16.9627 16.4008 15.3322 14.7573 0 12.3718 14.8768 16.2443 13.9958 16.583 14.7357 15.0702 16.4379 15.392 16.7142 0 16.0309 0 15.7846 16.4254 16.0922 16.2914 17.0031 16.4908 16.8407 15.9557 16.1188 16.7209 16.2025 16.5684 13.4837 16.0451 16.3928 15.5814 16.0175 15.3078 12.7938 13.9319 14.0475 13.0428 15.233 14.2403 15.2503 15.9858 15.2702 15.7519 15.9094 16.2288 14.355 15.3793 15.8343 15.9156 15.3689 16.2171 16.1042 16.1887 16.2592 13.7066 14.9429 13.5287 16.9753 15.9928 15.3635 16.1897 15.6059 14.2978 15.7877 0 0 12.6863 13.2678 13.2432 14.2665 16.8479 16.2642 15.6819 0 12.7288 14.1763 12.9748 15.7322 13.2779 13.1922 14.4037 0 14.3058 14.1654 14.4839 12.2931 13.0642 13.2081 15.4388 15.5081 13.2787 13.0113 0 0 0 0 O75436 VP26A_HUMAN "Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A, hVPS26)" VPS26A VPS26 Homo sapiens (Human) "endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosome [GO:0005764]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; vesicle [GO:0031982]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosome [GO:0005764]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; vesicle [GO:0031982]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0010008; GO:0016241; GO:0030904; GO:0030906; GO:0031982; GO:0032456; GO:0042147; GO:0097422 DVIVGKIYFLLVR 0.92208 2.2185 0 0 0 0 0 0 0 0 0 0 0 11.2365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3128 0 12.1744 0 0 0 0 0 0 0 0 0 11.1449 0 0 0 0 0 0 0 0 0 0 0 13.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51959 CCNG1_HUMAN "Cyclin-G1, Cyclin-G" CCNG1 CCNG CYCG1 Homo sapiens (Human) brain development [GO:0007420]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to gravity [GO:0009629]; response to organonitrogen compound [GO:0010243]; syncytium formation [GO:0006949] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; brain development [GO:0007420]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to gravity [GO:0009629]; response to organonitrogen compound [GO:0010243]; syncytium formation [GO:0006949] GO:0000079; GO:0000307; GO:0005634; GO:0005654; GO:0005737; GO:0006949; GO:0007095; GO:0007420; GO:0009629; GO:0010243; GO:0016538; GO:0030425; GO:0043025; GO:0043066; GO:0044772; GO:0048471; GO:0051301 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] IIFSKAKPSVLALSIIALEIQAQK 0.92213 2.2179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8803 0 0 0 13.641 0 11.4974 0 0 0 0 0 0 13.1565 0 0 13.1183 0 13.1007 12.2134 0 0 0 0 0 10.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61604 CH10_HUMAN "10 kDa heat shock protein, mitochondrial, Hsp10 (10 kDa chaperonin) (Chaperonin 10, CPN10) (Early-pregnancy factor, EPF)" HSPE1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; chaperone cofactor-dependent protein refolding [GO:0051085]; osteoblast differentiation [GO:0001649]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986] extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; chaperone cofactor-dependent protein refolding [GO:0051085]; osteoblast differentiation [GO:0001649]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986] GO:0001649; GO:0003723; GO:0005524; GO:0005739; GO:0005759; GO:0006457; GO:0006919; GO:0006986; GO:0016020; GO:0046872; GO:0051082; GO:0051085; GO:0051087; GO:0070062; GO:0140662 ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] FLPLFDRVLVER 0.92213 2.0246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14207 NPAT_HUMAN "Protein NPAT (Nuclear protein of the ataxia telangiectasia mutated locus, Nuclear protein of the ATM locus) (p220)" NPAT CAND3 E14 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" GO:0000083; GO:0001701; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008022; GO:0010468; GO:0015030; GO:0045893; GO:0045944; GO:0097504 protein C-terminus binding [GO:0008022]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] EKPPLPKILSK 0.92213 1.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4146 14.0142 0 0 0 0 0 13.2622 0 0 0 0 0 0 0 0 12.9944 13.2227 0 0 0 0 12.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9795 14.3421 14.2991 0 14.5913 15.2422 0 0 0 0 0 11.9719 13.2323 0 14.2858 0 0 0 11.9245 0 0 14.2945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14610 GBGT2_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 (G gamma-C) (G-gamma-8) (G-gamma-9) (Guanine nucleotide binding protein gamma transducing activity polypeptide 2) GNGT2 GNG8 GNG9 GNGT8 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602] heterotrimeric G-protein complex [GO:0005834] heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602] GO:0003924; GO:0005834; GO:0007186; GO:0007602; GO:0031681 G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924] EYVEAQAGNDPFLKGIPEDK 0.92214 1.147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75426 FBX24_HUMAN F-box only protein 24 FBXO24 FBX24 Homo sapiens (Human) protein ubiquitination [GO:0016567] ubiquitin ligase complex [GO:0000151] ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567] GO:0000151; GO:0004842; GO:0016567 ubiquitin-protein transferase activity [GO:0004842] ACDCVEVYLQSSGQR 0.92214 1.6156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3797 0 12.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.076 0 0 0 0 0 14.5679 0 0 0 14.8313 0 0 14.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 14.358 0 0 14.2017 13.705 0 14.244 0 0 0 12.2151 13.9445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15771 RAB30_HUMAN Ras-related protein Rab-30 RAB30 Homo sapiens (Human) Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802] cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0003924; GO:0005525; GO:0005795; GO:0005801; GO:0005802; GO:0007030; GO:0016192; GO:0031985; GO:0032482; GO:0043231 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IVLIGNAGVGKTCLVR 0.92217 1.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4886 0 0 0 11.9214 0 0 0 0 0 11.3755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3056 11.0696 0 0 11.4297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9373 0 0 0 0 0 0 0 Q8N6K0 TEX29_HUMAN Testis-expressed protein 29 TEX29 C13orf16 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DRCQELGCCFYEGVCYK 0.92219 1.8711 0 0 0 0 0 0 0 14.2064 14.5498 0 0 0 0 0 0 0 0 14.0439 0 0 0 0 0 13.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.169 0 0 0 0 0 0 0 13.135 15.2053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9421 0 16.9168 0 0 0 0 0 0 0 0 0 0 0 15.3995 0 0 0 19.7899 0 0 0 0 0 0 0 0 0 13.8627 0 0 0 0 0 13.6091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.624 Q96H40 ZN486_HUMAN Zinc finger protein 486 (KRAB domain only protein 2) ZNF486 KRBO2 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" extracellular exosome [GO:0070062]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:0070062 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFISSSILSKHEK 0.9222 1.6306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6453 0 0 0 0 0 0 0 0 0 0 0 0 11.3687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7319 0 0 0 0 0 0 0 0 0 0 0 Q5VXU1 NKAI2_HUMAN "Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2, Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 2 (Protein FAM77B) (T-cell lymphoma breakpoint-associated target protein 1)" NKAIN2 FAM77B TCBA1 Homo sapiens (Human) regulation of sodium ion transport [GO:0002028] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028] GO:0002028; GO:0005886; GO:0016021 PRYITGYAVWLVLWVTWNVFVICFYLEAGDLSK 0.92221 1.9053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3711 0 12.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6931 0 0 0 16.3012 12.4575 14.1057 0 0 0 0 12.5561 0 0 0 16.2792 0 0 10.97 0 0 0 10.3462 0 0 10.0611 0 0 12.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9221 0 0 0 0 0 0 0 0 10.1529 0 0 0 0 0 0 0 0 0 0 0 10.233 0 0 0 0 0 Q5I7T1 AG10B_HUMAN "Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase, EC 2.4.1.256 (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-B) (Asparagine-linked glycosylation protein 10 homolog B) (Potassium channel regulator 1)" ALG10B KCR1 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073]; transferase activity [GO:0016740]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]" GO:0005783; GO:0005886; GO:0006486; GO:0006487; GO:0006488; GO:0016021; GO:0016740; GO:0060050; GO:0106073; GO:1901980 "dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073]; transferase activity [GO:0016740]" IKTFLSLVWKHGILFLVVTLVSVFLVWK 0.92228 1.8702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2M3 BHMT2_HUMAN "S-methylmethionine--homocysteine S-methyltransferase BHMT2, SMM-hcy methyltransferase, EC 2.1.1.10 (Betaine--homocysteine S-methyltransferase 2)" BHMT2 Homo sapiens (Human) L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477] GO:0005829; GO:0008270; GO:0009086; GO:0032259; GO:0033477; GO:0046500; GO:0061627; GO:0070062; GO:0071267 S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270] AIAEELAPER 0.9223 1.9042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8954 0 0 12.2945 0 0 0 0 0 0 0 14.7266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.981 0 0 13.9074 0 0 0 14.2069 0 0 0 12.9735 0 0 0 0 12.9067 0 0 0 0 13.4041 0 0 0 0 0 0 0 0 0 13.9942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3006 13.8424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0209 0 0 0 0 0 0 Q8NGK4 O52K1_HUMAN Olfactory receptor 52K1 (Olfactory receptor OR11-8) OR52K1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVTLMTPLPFLLRR 0.92238 1.9005 0 0 0 0 0 0 0 0 0 0 0 11.5594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5985 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9885 0 0 0 0 0 0 0 0 0 0 12.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6688 0 12.6274 0 0 0 0 0 0 0 0 Q8WWC4 MAIP1_HUMAN "m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)" MAIP1 C2orf47 Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ribosome binding [GO:0043022]; calcium import into the mitochondrion [GO:0036444]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204] GO:0005743; GO:0005759; GO:0007007; GO:0032979; GO:0036444; GO:0043022; GO:0051204; GO:0051560 ribosome binding [GO:0043022] ALAARLLPQFLHSR 0.92242 1.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72108 0 0 0 0 0 10.8981 0 0 15.5286 10.9947 0 0 0 0 0 0 0 0 0 0 0 0 0 14.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8316 0 0 9.97585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2848 0 0 11.0714 0 0 0 0 12.6621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19075 TSN8_HUMAN "Tetraspanin-8, Tspan-8 (Transmembrane 4 superfamily member 3) (Tumor-associated antigen CO-029)" TSPAN8 TM4SF3 Homo sapiens (Human) negative regulation of blood coagulation [GO:0030195]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integrin binding [GO:0005178]; negative regulation of blood coagulation [GO:0030195]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] GO:0005178; GO:0005887; GO:0007283; GO:0009986; GO:0010468; GO:0030195; GO:0070062 integrin binding [GO:0005178] CMLLLFFIGLLLILLLQVATGILGAVFK 0.92247 1.908 0 0 0 0 0 11.2976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8776 0 0 0 0 0 13.0705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6614 0 0 0 0 0 12.1968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3505 0 0 0 0 0 0 0 0 0 P24385 CCND1_HUMAN "G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein, BCL-1) (BCL-1 oncogene) (PRAD1 oncogene)" CCND1 BCL1 PRAD1 Homo sapiens (Human) cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum unfolded protein response [GO:0030968]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; lactation [GO:0007595]; Leydig cell differentiation [GO:0033327]; liver regeneration [GO:0097421]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; mitotic cell cycle phase transition [GO:0044772]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to leptin [GO:0044321]; response to magnesium ion [GO:0032026]; response to organonitrogen compound [GO:0010243]; response to UV-A [GO:0070141]; response to vitamin E [GO:0033197]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway [GO:0016055] bicellular tight junction [GO:0005923]; cyclin D1-CDK4 complex [GO:0097128]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] bicellular tight junction [GO:0005923]; cyclin D1-CDK4 complex [GO:0097128]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; proline-rich region binding [GO:0070064]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; endoplasmic reticulum unfolded protein response [GO:0030968]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; lactation [GO:0007595]; Leydig cell differentiation [GO:0033327]; liver regeneration [GO:0097421]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; mitotic cell cycle phase transition [GO:0044772]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to leptin [GO:0044321]; response to magnesium ion [GO:0032026]; response to organonitrogen compound [GO:0010243]; response to UV-A [GO:0070141]; response to vitamin E [GO:0033197]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway [GO:0016055] GO:0000079; GO:0000082; GO:0000122; GO:0000307; GO:0000320; GO:0001934; GO:0003714; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005923; GO:0006468; GO:0006974; GO:0007595; GO:0009410; GO:0010039; GO:0010165; GO:0010243; GO:0010971; GO:0016055; GO:0016538; GO:0017053; GO:0019899; GO:0019901; GO:0030182; GO:0030857; GO:0030968; GO:0031571; GO:0031965; GO:0032026; GO:0032355; GO:0033197; GO:0033327; GO:0033598; GO:0033601; GO:0042826; GO:0043524; GO:0043627; GO:0044321; GO:0044772; GO:0044877; GO:0045444; GO:0045471; GO:0045737; GO:0051301; GO:0051412; GO:0051592; GO:0060749; GO:0070064; GO:0070141; GO:0097128; GO:0097421; GO:1900087 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; proline-rich region binding [GO:0070064]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714] AYPDANLLNDR 0.9225 2.2602 0 0 0 0 0 0 0 0 0 11.7885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6503 13.7211 0 0 0 0 0 0 0 0 0 0 12.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4044 0 0 0 0 0 0 0 0 0 12.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5J8X5 M4A13_HUMAN Membrane-spanning 4-domains subfamily A member 13 (Testis-expressed transmembrane protein 4) MS4A13 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166] GO:0005886; GO:0007166; GO:0016021 GAFGTYEPVTYK 0.92251 1.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6L8Q7 PDE12_HUMAN "2',5'-phosphodiesterase 12, 2'-PDE, 2-PDE, EC 3.1.4.- (Mitochondrial deadenylase, EC 3.1.13.4)" PDE12 Homo sapiens (Human) "cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0005829; GO:0006397; GO:0034611; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0051607; GO:0060548; GO:0071346; GO:0071359; GO:0090305; GO:0090324; GO:0090503 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535] ELLEKLVLYPSAQEKVLQR 0.92254 2.3254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0202 12.1865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5936 0 0 0 0 0 0 0 0 13.0558 0 13.8324 0 0 12.8466 0 0 0 13.6581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2729 0 0 0 0 12.7054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7073 0 0 0 0 0 0 0 0 0 0 0 18.9654 0 0 0 P86791 CCZ1_HUMAN Vacuolar fusion protein CCZ1 homolog CCZ1 C7orf28A CGI-43 Homo sapiens (Human) vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085]; vesicle-mediated transport [GO:0016192] GO:0005085; GO:0005765; GO:0005829; GO:0016192; GO:0035658; GO:0043231 guanyl-nucleotide exchange factor activity [GO:0005085] CRFPKIFVNTDDTYEELHLIVYK 0.92255 1.6252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5845 0 0 0 0 0 0 0 0 16.2694 0 0 0 0 0 0 0 0 0 0 14.8055 14.7662 11.7964 0 0 10.4052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9632 13.334 0 12.0928 0 0 0 0 0 0 0 0 0 13.4043 0 0 0 12.823 11.3114 0 0 0 10.8591 0 0 0 0 0 0 12.106 0 0 13.8719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8854 0 0 0 0 0 14.1527 13.8241 0 0 0 0 0 0 0 0 0 12.9916 0 0 0 0 0 0 0 0 13.1223 0 0 0 0 0 0 0 0 0 0 0 10.198 O15484 CAN5_HUMAN "Calpain-5, EC 3.4.22.- (Calpain htra-3) (New calpain 3, nCL-3)" CAPN5 NCL3 Homo sapiens (Human) proteolysis [GO:0006508]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165] GO:0004198; GO:0005737; GO:0005925; GO:0006508; GO:0007165; GO:0009986; GO:0045202; GO:0070062 calcium-dependent cysteine-type endopeptidase activity [GO:0004198] EQEWDPEK 0.92256 2.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4774 0 0 0 0 0 0 0 0 0 0 11.1415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2157 0 12.9256 13.2472 0 0 0 13.2655 0 0 0 0 0 0 0 0 0 11.3377 0 0 0 0 10.5755 0 0 0 0 0 13.9252 0 0 0 0 0 0 11.4974 0 0 0 0 0 13.2688 0 0 13.3704 0 0 0 12.1997 0 0 0 0 0 12.8758 0 13.043 0 0 0 0 0 0 0 14.1572 0 0 0 0 0 0 0 13.768 11.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19387 RPB3_HUMAN "DNA-directed RNA polymerase II subunit RPB3, RNA polymerase II subunit 3, RNA polymerase II subunit B3 (DNA-directed RNA polymerase II 33 kDa polypeptide, RPB33) (DNA-directed RNA polymerase II subunit C) (RPB31)" POLR2C A-152E5.7 Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366]" GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0046983 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983] CNEDQTRHVTSR 0.92256 2.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2793 0 0 0 0 0 0 0 0 0 0 11.5727 0 0 0 0 0 0 0 0 0 13.3722 0 0 0 0 0 16.994 0 10.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0643 0 0 0 0 0 0 0 0 11.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7689 0 0 0 0 P20155 ISK2_HUMAN Serine protease inhibitor Kazal-type 2 (Acrosin-trypsin inhibitor) (Epididymis tissue protein Li 172) (HUSI-II) SPINK2 Homo sapiens (Human) acrosome assembly [GO:0001675]; negative regulation of serine-type endopeptidase activity [GO:1900004]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acrosome assembly [GO:0001675]; negative regulation of serine-type endopeptidase activity [GO:1900004]; spermatid development [GO:0007286] GO:0001669; GO:0001675; GO:0004866; GO:0004867; GO:0005576; GO:0007286; GO:1900004 endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] LALLLLAVTFAASLIPQFGLFSK 0.92257 1.8734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4329 0 0 0 0 12.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3R5 CENPH_HUMAN "Centromere protein H, CENP-H (Interphase centromere complex protein 35)" CENPH ICEN35 Homo sapiens (Human) chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; kinetochore organization [GO:0051383]; mitotic spindle organization [GO:0007052] chromosome [GO:0005694]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinetochore binding [GO:0043515]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; kinetochore organization [GO:0051383]; mitotic spindle organization [GO:0007052] GO:0000776; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0007052; GO:0007059; GO:0043515; GO:0051382; GO:0051383 kinetochore binding [GO:0043515] AQTKQQLLEYK 0.92258 1.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94988 FA13A_HUMAN Protein FAM13A FAM13A FAM13A1 KIAA0914 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0007165; GO:0051056 GTPase activator activity [GO:0005096] DQIANEKVALQKALLYYESIHGR 0.92261 2.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1848 0 0 9.99251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9939 0 0 0 0 0 0 0 0 0 0 12.0314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2986 0 11.1563 12.3204 13.6577 0 0 0 0 10.8767 0 11.8451 0 0 0 16.8936 12.8166 12.0367 0 0 0 0 0 0 12.025 11.384 0 0 0 13.0984 10.6046 0 0 11.5222 0 11.4132 0 0 12.7067 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7155 0 0 0 0 0 13.6289 0 0 0 0 0 12.2278 0 12.818 0 0 0 0 0 0 0 0 0 0 0 11.3681 0 0 0 0 0 0 0 0 12.2339 0 0 0 0 0 9.31365 0 0 0 0 0 0 0 0 0 11.2175 0 0 13.5734 0 Q9H1Z9 TSN10_HUMAN "Tetraspanin-10, Tspan-10 (Oculospanin)" TSPAN10 OCSP Homo sapiens (Human) establishment of protein localization to organelle [GO:0072594] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; enzyme binding [GO:0019899]; establishment of protein localization to organelle [GO:0072594] GO:0005887; GO:0019899; GO:0072594 enzyme binding [GO:0019899] EDGASVNDQCGFGVLR 0.92261 1.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4192 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1887 13.9683 0 0 0 0 0 0 0 0 0 0 0 13.5647 0 0 0 13.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5L2 HLPDA_HUMAN Hypoxia-inducible lipid droplet-associated protein (Hypoxia-inducible gene 2 protein) HILPDA C7orf68 HIG2 Homo sapiens (Human) autocrine signaling [GO:0035425]; cellular response to hypoxia [GO:0071456]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of lipid storage [GO:0010884] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; signaling receptor binding [GO:0005102]; autocrine signaling [GO:0035425]; cellular response to hypoxia [GO:0071456]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of lipid storage [GO:0010884] GO:0001819; GO:0005102; GO:0005615; GO:0005654; GO:0005811; GO:0005829; GO:0008284; GO:0009986; GO:0010884; GO:0016021; GO:0030141; GO:0035425; GO:0071456 signaling receptor binding [GO:0005102] KHVLNLYLLGVVLTLLSIFVR 0.92262 1.6309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2768 0 0 0 0 0 0 11.542 0 0 0 0 0 12.4872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8334 0 12.5924 0 0 0 0 0 0 0 10.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7165 0 0 0 0 P30518 V2R_HUMAN "Vasopressin V2 receptor, V2R (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor)" AVPR2 ADHR DIR DIR3 V2R Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; hemostasis [GO:0007599]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of renal sodium excretion [GO:0035814]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; renal water retention [GO:0003092]; response to cytokine [GO:0034097]; telencephalon development [GO:0021537] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; hemostasis [GO:0007599]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of renal sodium excretion [GO:0035814]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; renal water retention [GO:0003092]; response to cytokine [GO:0034097]; telencephalon development [GO:0021537] GO:0001992; GO:0003084; GO:0003092; GO:0004930; GO:0005000; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007186; GO:0007188; GO:0007190; GO:0007249; GO:0007599; GO:0008284; GO:0008285; GO:0010628; GO:0016021; GO:0021537; GO:0030139; GO:0030669; GO:0034097; GO:0035814; GO:0042277; GO:0045907; GO:0048471 G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000] AELALLSIVFVAVALSNGLVLAALAR 0.9227 1.872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.339 0 0 0 0 0 13.8803 13.9026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9603 0 13.1628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95484 CLD9_HUMAN Claudin-9 CLDN9 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] GO:0001618; GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016338; GO:0030054; GO:0042802; GO:0043231; GO:0070830 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618] GPRLGYSIPSRSGASGLDK 0.92271 2.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14954 KI2S1_HUMAN Killer cell immunoglobulin-like receptor 2DS1 (CD158 antigen-like family member H) (MHC class I NK cell receptor Eb6 ActI) (CD antigen CD158h) KIR2DS1 CD158H Homo sapiens (Human) immune response [GO:0006955] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; immune response [GO:0006955] GO:0004888; GO:0005886; GO:0006955; GO:0016021 transmembrane signaling receptor activity [GO:0004888] KPSLLAHPGR 0.92273 2.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11509 CP2A6_HUMAN "Cytochrome P450 2A6, EC 1.14.14.- (1,4-cineole 2-exo-monooxygenase) (CYPIIA6) (Coumarin 7-hydroxylase) (Cytochrome P450 IIA3) (Cytochrome P450(I))" CYP2A6 CYP2A3 Homo sapiens (Human) coumarin catabolic process [GO:0046226]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; coumarin catabolic process [GO:0046226]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0005506; GO:0005737; GO:0005789; GO:0005881; GO:0006082; GO:0006805; GO:0008202; GO:0008389; GO:0008392; GO:0008395; GO:0009804; GO:0016712; GO:0019373; GO:0019899; GO:0020037; GO:0042178; GO:0043231; GO:0046226 "arachidonic acid epoxygenase activity [GO:0008392]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" GTGGANIDPTFFLSR 0.92274 2.2187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7682 0 0 0 0 13.4005 13.4878 14.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7653 13.4634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1541 0 12.884 14.55 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8177 0 14.5905 0 0 0 0 0 0 0 14.841 14.6531 0 0 13.6583 0 13.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9166 0 0 0 0 0 0 Q9BUY7 EFC11_HUMAN EF-hand calcium-binding domain-containing protein 11 EFCAB11 C14orf143 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] AFRQVAPKLPER 0.92278 2.3207 0 0 0 0 0 0 0 0 12.8311 0 0 0 0 12.9103 0 0 0 0 13.3719 0 0 0 0 0 12.1025 0 0 12.9209 0 0 0 0 0 12.5624 0 0 0 0 0 0 0 0 0 0 12.2608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7592 0 12.1194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6051 0 0 0 0 0 0 0 0 0 14.3622 13.6006 13.7211 0 13.8779 0 0 0 0 14.2701 0 0 0 0 Q9H342 O51J1_HUMAN Olfactory receptor 51J1 (Odorant receptor HOR5'beta8) (Olfactory receptor 51J2) OR51J1 OR51J1P OR51J2 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KALNTCGSHVCAVLAYYVPMIGLSIVHRLGHR 0.92289 2.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9279 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQG6 MID51_HUMAN "Mitochondrial dynamics protein MID51 (Mitochondrial dynamics protein of 51 kDa) (Mitochondrial elongation factor 1) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like, SMCR7-like protein)" MIEF1 MID51 SMCR7L Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; mitochondrial fission [GO:0000266]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; GDP binding [GO:0019003]; identical protein binding [GO:0042802]; cellular response to hypoxia [GO:0071456]; mitochondrial fission [GO:0000266]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314] GO:0000266; GO:0005739; GO:0005741; GO:0016021; GO:0019003; GO:0042802; GO:0043531; GO:0071456; GO:0090141; GO:0090314 ADP binding [GO:0043531]; GDP binding [GO:0019003]; identical protein binding [GO:0042802] LRALDQADSGCR 0.92295 1.9089 0 0 0 0 0 0 0 0 0 0 0 0 13.1012 0 0 0 0 11.9814 0 12.69 0 0 0 0 11.7908 0 0 0 0 0 11.3596 0 0 0 0 0 14.5546 14.2195 0 0 0 0 0 0 11.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5894 0 0 0 0 0 0 0 0 14.456 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1507 15.1115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2872 Q9Y2Z0 SGT1_HUMAN Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog) SUGT1 Homo sapiens (Human) mitotic cell cycle [GO:0000278]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; chaperone binding [GO:0051087]; mitotic cell cycle [GO:0000278]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647] GO:0000151; GO:0000278; GO:0000776; GO:0005634; GO:0005829; GO:0031647; GO:0032991; GO:0050821; GO:0051087 chaperone binding [GO:0051087] LPSGEDYNLKLELLHPIIPEQSTFKVLSTK 0.92295 1.137 0 0 11.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2858 0 0 0 0 0 0 0 12.5832 13.527 0 0 10.6031 0 0 0 0 12.3295 0 12.0654 0 0 0 0 13.1176 0 0 0 0 0 0 10.7456 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9966 0 0 0 O43808 PM34_HUMAN Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17) SLC25A17 PMP34 Homo sapiens (Human) ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; chaperone binding [GO:0051087]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724]; ATP transport [GO:0015867]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; fatty acid transport [GO:0015908] GO:0000295; GO:0001561; GO:0005347; GO:0005777; GO:0005778; GO:0005779; GO:0005829; GO:0006635; GO:0015217; GO:0015228; GO:0015230; GO:0015867; GO:0015908; GO:0016020; GO:0044610; GO:0051087; GO:0051724; GO:0080122 adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; chaperone binding [GO:0051087]; coenzyme A transmembrane transporter activity [GO:0015228]; FAD transmembrane transporter activity [GO:0015230]; FMN transmembrane transporter activity [GO:0044610]; NAD transmembrane transporter activity [GO:0051724] DLVVGFVAGVVNVLLTTPLWVVNTR 0.92297 1.6252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4202 0 0 12.6995 0 0 0 0 0 Q6GMR7 FAAH2_HUMAN "Fatty-acid amide hydrolase 2, EC 3.5.1.99 (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)" FAAH2 AMDD Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077]; arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042] GO:0005811; GO:0016021; GO:0016042; GO:0017064; GO:0019369; GO:0102077; GO:0103073 anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; oleamide hydrolase activity [GO:0102077] ALGFLIGLVGRAALVLGGPKFASK 0.92298 2.0167 0 0 0 0 0 0 0 0 14.524 15.3352 0 14.5226 0 0 14.6934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0672 0 0 13.4822 13.9593 0 0 0 0 12.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5468 0 0 0 0 0 0 0 0 0 14.1024 0 15.4746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6257 0 0 0 0 0 14.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N114 SHSA5_HUMAN Protein shisa-5 (Putative NF-kappa-B-activating protein 120) (Scotin) SHISA5 SCOTIN PSEC0133 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; WW domain binding [GO:0050699]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005783; GO:0005788; GO:0005789; GO:0016021; GO:0031965; GO:0042771; GO:0043123; GO:0050699 WW domain binding [GO:0050699] GLSLFPESCPDFCCGTCDDQYCCSDVLK 0.92299 1.8757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0486 0 0 0 0 0 0 0 0 0 0 14.2419 13.6431 14.5861 15.2592 0 0 13.4752 0 0 14.6109 0 0 0 15.9695 0 16.0486 0 0 0 11.1217 0 0 0 0 14.5913 0 0 0 0 0 0 0 0 0 0 0 14.5598 0 0 14.5367 0 0 0 0 0 15.4048 0 13.5596 0 0 0 0 0 0 11.8555 0 0 14.2566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3925 0 0 0 0 0 0 11.0647 12.8719 0 0 0 11.0814 0 0 Q86YW7 GPHB5_HUMAN Glycoprotein hormone beta-5 (Thyrostimulin subunit beta) GPHB5 GPB5 ZLUT1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of thyroid hormone mediated signaling pathway [GO:0002155] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of thyroid hormone mediated signaling pathway [GO:0002155] GO:0002155; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007186; GO:0007189; GO:0031531; GO:0046982 hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531] CDCGACSTATTECETI 0.923 1.1348 0 0 0 0 0 0 0 9.28947 10.7984 0 0 9.23513 0 0 0 0 11.152 0 0 0 0 0 0 0 0 0 0 11.7108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1496 0 0 0 11.2736 13.2053 0 0 0 0 0 0 0 0 12.5714 0 0 12.3829 0 0 12.4746 0 0 0 0 12.8505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4459 0 0 12.4568 0 0 0 0 0 0 0 0 0 0 13.3582 0 0 0 0 0 0 0 0 0 P16035 TIMP2_HUMAN "Metalloproteinase inhibitor 2 (CSC-21K) (Tissue inhibitor of metalloproteinases 2, TIMP-2)" TIMP2 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; metalloendopeptidase inhibitor activity [GO:0008191]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033] GO:0002020; GO:0005576; GO:0005615; GO:0008191; GO:0008270; GO:0009725; GO:0010033; GO:0010951; GO:0030414; GO:0031012; GO:0034097; GO:0035580; GO:0051045; GO:0062023; GO:1904724; GO:1904813; GO:1905049 metalloendopeptidase inhibitor activity [GO:0008191]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270] GAAARTLRLALGLLLLATLLR 0.92301 1.6324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.512 0 0 0 0 0 0 0 0 9.26444 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6194 10.4961 14.2693 0 0 0 0 0 12.4214 0 12.1005 11.5398 0 13.3648 12.1588 0 0 13.1794 0 0 13.2752 0 0 0 0 0 12.0085 0 13.1743 0 0 0 0 12.1194 12.1421 0 0 0 0 0 0 0 14.8552 0 14.4821 0 0 0 12.7433 14.8818 0 12.9077 14.0347 13.7116 15.5047 0 13.2391 0 0 13.4234 0 0 0 0 0 14.4903 12.519 14.1556 11.4658 13.4353 0 0 13.1096 14.3814 0 0 0 0 0 13.8848 14.2603 0 13.2616 0 0 12.8712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0059 C0HM01 RBRP_HUMAN "Putative RNA-binding regulatory peptide, RBRP (Septin 14 pseudogene 20)" SEPTIN14P20 C20orf69 LINC00266-1 Homo sapiens (Human) mRNA stabilization [GO:0048255]; positive regulation of mRNA binding [GO:1902416] mRNA stabilization [GO:0048255]; positive regulation of mRNA binding [GO:1902416] GO:0048255; GO:1902416 DKHPDPYEFLLLR 0.92308 1.8735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4897 0 0 0 13.3697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0177 0 0 0 12.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2654 0 0 0 0 0 0 0 0 13.691 0 0 0 14.8653 0 0 0 13.6602 14.5899 0 0 0 0 13.9586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4285 0 Q9UHX1 PUF60_HUMAN "Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor, FBP-interacting repressor) (Ro-binding protein 1, RoBP1) (Siah-binding protein 1, Siah-BP1)" PUF60 FIR ROBPI SIAHBP1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cell junction [GO:0030054]; nucleoplasm [GO:0005654] "cell junction [GO:0030054]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; apoptotic process [GO:0006915]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" GO:0000380; GO:0000381; GO:0003677; GO:0003723; GO:0005654; GO:0006376; GO:0006915; GO:0030054; GO:0042802; GO:0045296 cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] PPIPVTIPSVGVVNPILASPPTLGLLEPK 0.92308 2.0146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4974 11.3665 0 0 0 0 0 12.1837 0 0 0 0 0 0 10.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULD5 ZN777_HUMAN Zinc finger protein 777 ZNF777 KIAA1285 Homo sapiens (Human) "negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; protein heterooligomerization [GO:0051291]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; protein heterooligomerization [GO:0051291]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008285; GO:0045892; GO:0046872; GO:0051291 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CPECDSSFSHK 0.92308 1.9991 0 0 0 0 0 0 0 0 0 13.7964 0 0 0 0 13.7053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6531 0 11.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3829 0 0 13.2527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7125 0 0 0 0 0 11.2404 0 0 0 0 0 0 0 0 0 0 0 13.0552 14.6772 0 13.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5N4 CC022_HUMAN Uncharacterized protein C3orf22 C3orf22 Homo sapiens (Human) HTEAACPQTSKAAGLSR 0.92314 2.3124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3485 0 0 0 13.8009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6624 0 0 13.7576 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8631 14.6806 0 0 14.6872 13.5807 0 0 0 0 0 14.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NC97 F172B_HUMAN Putative protein FAM172B (FAM172B pseudogene) FAM172BP FAM172B Homo sapiens (Human) heterochromatin assembly by small RNA [GO:0031048] integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634]; heterochromatin assembly by small RNA [GO:0031048] GO:0005634; GO:0016021; GO:0031048 DIAFIVHGYGGLVFMDLLVR 0.92318 1.1463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0525 0 0 0 0 0 0 8.57084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9424 0 0 0 0 0 0 0 11.3172 0 0 0 16.2741 16.3128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8778 Q8N6F8 MET27_HUMAN Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein) METTL27 WBSCR27 Homo sapiens (Human) organic substance metabolic process [GO:0071704] methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; organic substance metabolic process [GO:0071704] GO:0008168; GO:0008757; GO:0071704 methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] MASSPALSTCTESGRR 0.92319 2.2604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5543 0 0 0 0 0 0 0 0 10.5526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95747 OXSR1_HUMAN "Serine/threonine-protein kinase OSR1, EC 2.7.11.1 (Oxidative stress-responsive 1 protein)" OXSR1 KIAA1101 OSR1 Homo sapiens (Human) cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006979; GO:0007165; GO:0007231; GO:0009410; GO:0010820; GO:0018107; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0046777; GO:0070062; GO:0071476; GO:0106310; GO:1901017; GO:1990869 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AAISQLRSPRVK 0.9232 1.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.414 0 0 0 0 0 0 0 11.39 0 0 11.1587 0 0 0 0 0 0 0 0 0 0 0 11.3665 0 0 0 0 0 0 10.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9901 0 0 0 12.3939 0 0 0 0 0 0 0 0 10.9304 0 0 12.9711 0 0 12.7605 13.3302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6456 0 0 13.7659 0 0 13.7756 0 0 12.9215 0 0 0 14.0668 11.8663 10.9683 0 0 0 11.7057 0 0 0 0 0 0 0 0 13.8097 0 12.3335 12.6976 0 0 0 0 0 0 0 12.9496 0 0 0 0 0 0 0 0 14.3009 0 0 0 0 0 0 0 0 13.3231 0 0 0 0 0 12.4632 0 0 13.8145 0 0 0 0 P41182 BCL6_HUMAN "B-cell lymphoma 6 protein, BCL-6 (B-cell lymphoma 5 protein, BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51)" BCL6 BCL5 LAZ3 ZBTB27 ZNF51 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; pyramidal neuron differentiation [GO:0021859]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; T-helper 2 cell differentiation [GO:0045064]; transcription by RNA polymerase II [GO:0006366]; type 2 immune response [GO:0042092]" Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382] "Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; actin cytoskeleton organization [GO:0030036]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to DNA damage stimulus [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; pyramidal neuron differentiation [GO:0021859]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of GTPase activity [GO:0043087]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; T-helper 2 cell differentiation [GO:0045064]; transcription by RNA polymerase II [GO:0006366]; type 2 immune response [GO:0042092]" GO:0000122; GO:0000902; GO:0000978; GO:0001161; GO:0001222; GO:0001227; GO:0001817; GO:0001953; GO:0002317; GO:0002467; GO:0002634; GO:0002682; GO:0002903; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006357; GO:0006366; GO:0006954; GO:0006974; GO:0007160; GO:0007266; GO:0007283; GO:0008104; GO:0016575; GO:0021859; GO:0030036; GO:0030308; GO:0030890; GO:0031065; GO:0031490; GO:0032764; GO:0035024; GO:0042092; GO:0042100; GO:0042127; GO:0042129; GO:0042382; GO:0042802; GO:0043065; GO:0043087; GO:0043380; GO:0043565; GO:0045064; GO:0045591; GO:0045595; GO:0045629; GO:0045666; GO:0045746; GO:0045892; GO:0046872; GO:0048289; GO:0048294; GO:0048821; GO:0050727; GO:0050776; GO:0070664; GO:0140297; GO:1900099; GO:1903464; GO:1990837; GO:2000773 "chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]" FRHLQTLKSHLR 0.9232 1.8721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 11.879 0 0 0 0 14.1651 0 0 11.4269 0 0 0 0 11.6033 0 0 0 0 0 12.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4759 0 0 0 0 0 0 0 Q13889 TF2H3_HUMAN "General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit, BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit)" GTF2H3 Homo sapiens (Human) DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366] GO:0000438; GO:0000439; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006366; GO:0016251; GO:0046872; GO:0047485; GO:0070816; GO:0097550 metal ion binding [GO:0046872]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251] EVKDNQEMKSR 0.92322 2.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54920 SNAA_HUMAN "Alpha-soluble NSF attachment protein, SNAP-alpha (N-ethylmaleimide-sensitive factor attachment protein alpha)" NAPA SNAPA Homo sapiens (Human) "apical protein localization [GO:0045176]; brain development [GO:0007420]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neuron differentiation [GO:0030182]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082]" cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; apical protein localization [GO:0045176]; brain development [GO:0007420]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neuron differentiation [GO:0030182]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082]" GO:0000149; GO:0005483; GO:0005829; GO:0005886; GO:0006886; GO:0006891; GO:0007420; GO:0010807; GO:0016020; GO:0016082; GO:0019905; GO:0030182; GO:0031201; GO:0035249; GO:0035494; GO:0044877; GO:0045176; GO:0061025; GO:0070044; GO:0070062; GO:0098793; GO:0098978 protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905] ADPQEAINCLMR 0.92324 2.2216 0 0 0 0 0 0 0 0 11.6523 0 0 0 0 11.3678 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.556 0 0 0 11.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5294 0 0 0 11.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3889 0 11.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01889 HLAB_HUMAN "HLA class I histocompatibility antigen, B alpha chain (Human leukocyte antigen B, HLA-B)" HLA-B HLAB Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; defense response [GO:0006952]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of T cell anergy [GO:0002667]" cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667] "cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; chaperone binding [GO:0051087]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP binding [GO:0046977]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; defense response [GO:0006952]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of T cell anergy [GO:0002667]" GO:0000139; GO:0001916; GO:0002250; GO:0002486; GO:0002667; GO:0005102; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006952; GO:0006955; GO:0009986; GO:0012507; GO:0016020; GO:0016045; GO:0030667; GO:0030670; GO:0031901; GO:0032655; GO:0032675; GO:0042270; GO:0042605; GO:0042612; GO:0045087; GO:0046977; GO:0051087; GO:0055038; GO:0070062; GO:0071556; GO:2001198 chaperone binding [GO:0051087]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP binding [GO:0046977] AYLEGECVEWLRRYLENGK 0.92325 1.9058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95522 PRA12_HUMAN PRAME family member 12 PRAMEF12 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 AVLEGLDALLAQKVR 0.92326 1.1371 0 0 0 0 0 0 0 0 10.3179 11.2593 0 0 0 0 0 0 0 0 0 0 0 10.1434 11.7287 0 0 0 10.968 0 0 10.8906 0 0 0 0 10.3078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6922 0 0 14.4162 0 0 0 0 0 0 0 0 0 14.0826 0 0 0 0 0 0 13.312 12.6784 0 12.1843 0 0 0 0 0 12.3074 0 0 0 13.2374 0 0 13.5031 0 0 0 0 0 0 12.9552 0 0 0 0 0 0 0 0 0 12.3231 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4397 0 0 11.9056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5153 12.0829 0 0 0 0 0 0 O60725 ICMT_HUMAN "Protein-S-isoprenylcysteine O-methyltransferase, EC 2.1.1.100 (Isoprenylcysteine carboxylmethyltransferase) (Prenylated protein carboxyl methyltransferase, PPMT) (Prenylcysteine carboxyl methyltransferase, pcCMT)" ICMT PCCMT Homo sapiens (Human) C-terminal protein methylation [GO:0006481]; protein modification process [GO:0036211]; protein targeting to membrane [GO:0006612]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethioninamine metabolic process [GO:0046499] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671]; C-terminal protein methylation [GO:0006481]; protein modification process [GO:0036211]; protein targeting to membrane [GO:0006612]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethioninamine metabolic process [GO:0046499] GO:0003880; GO:0004671; GO:0005783; GO:0005789; GO:0006481; GO:0006612; GO:0016020; GO:0016021; GO:0036211; GO:0046498; GO:0046499 protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671] APPGSEARLSLATFLLGASVLALPLLTRAGLQGR 0.92327 2.0248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9912 0 0 0 0 0 0 0 0 11.9549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92187 SIA8D_HUMAN "CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase, EC 2.4.99.- (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D, SIAT8-D) (Sialyltransferase St8Sia IV, ST8SiaIV)" ST8SIA4 PST PST1 SIAT8D Homo sapiens (Human) ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialic acid binding [GO:0033691]; ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]" GO:0000139; GO:0001574; GO:0003828; GO:0006486; GO:0006491; GO:0007399; GO:0009311; GO:0016021; GO:0033691; GO:0036211 "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialic acid binding [GO:0033691]" CNLAPVVEFAADVGTK 0.92329 2.1863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0505 0 0 0 0 0 0 0 0 0 0 Q59EK9 RUN3A_HUMAN "RUN domain-containing protein 3A (Rap2-interacting protein 8, RPIP-8)" RUNDC3A RAP2IP RPIP8 Homo sapiens (Human) positive regulation of cGMP-mediated signaling [GO:0010753]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; positive regulation of cGMP-mediated signaling [GO:0010753]; small GTPase mediated signal transduction [GO:0007264] GO:0005829; GO:0005886; GO:0007264; GO:0010753; GO:0030695; GO:0043231 GTPase regulator activity [GO:0030695] AWIRVALMEK 0.92333 1.1305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8066 0 0 0 0 0 0 0 0 0 0 0 13.8044 0 0 0 0 0 0 0 0 0 12.9099 0 0 0 0 0 0 12.8914 12.5586 0 0 0 0 0 0 0 0 0 12.9216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8478 0 13.0056 0 0 0 0 12.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01344 IL5RA_HUMAN "Interleukin-5 receptor subunit alpha, IL-5 receptor subunit alpha, IL-5R subunit alpha, IL-5R-alpha, IL-5RA (CDw125) (CD antigen CD125)" IL5RA IL5R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of interleukin-5 production [GO:0032674]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-5 receptor activity [GO:0004914]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of interleukin-5 production [GO:0032674]; signal transduction [GO:0007165] GO:0002437; GO:0004896; GO:0004914; GO:0005615; GO:0005886; GO:0007165; GO:0009897; GO:0016021; GO:0019221; GO:0019955; GO:0032674; GO:0043235; GO:0070665 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-5 receptor activity [GO:0004914] GFSASVR 0.92336 2.2577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.061 0 0 0 0 0 0 0 0 13.2337 0 15.6406 0 15.1281 13.6235 14.2249 0 12.6728 0 13.8917 0 0 13.3994 0 13.8522 0 15.1425 0 0 0 13.9374 0 0 14.5986 14.5007 14.464 0 14.3265 14.4018 0 13.8811 0 0 14.7935 14.7585 0 14.0724 0 0 0 15.6828 0 14.1805 14.7661 14.6031 0 13.5043 15.1773 14.9647 0 13.9814 0 13.5831 0 0 13.8446 0 0 0 14.499 0 0 14.0558 14.0937 13.8922 13.6503 12.9027 0 0 0 0 0 14.2162 14.2054 0 13.7581 0 14.302 13.5407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.753 0 0 0 0 0 Q17RY6 LY6K_HUMAN "Lymphocyte antigen 6K, Ly-6K" LY6K CO16 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339] GO:0001669; GO:0005576; GO:0005886; GO:0007339; GO:0031225; GO:0045121 ALLALLLVVALPR 0.92336 1.6332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8917 0 0 0 0 0 0 0 15.2034 0 15.2817 0 0 0 0 0 0 0 0 0 15.6633 0 0 0 0 0 15.0425 15.0023 14.9888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4788 0 0 0 0 0 0 0 0 0 0 0 11.9966 14.5356 0 0 13.6698 0 0 0 0 0 0 0 0 0 12.8218 0 0 13.4486 0 0 0 0 0 0 0 0 0 0 0 0 14.967 0 0 0 15.29 0 0 13.8214 14.6758 0 15.0726 0 0 0 0 0 0 0 14.453 0 0 0 14.8275 0 13.9995 0 0 0 13.7543 0 0 15.6669 0 0 0 0 0 13.9551 0 0 0 0 0 0 15.2053 0 13.7356 0 0 0 15.0427 0 13.945 13.5713 0 13.9595 13.7245 15.2974 13.921 0 0 0 0 14.8245 0 0 0 0 0 14.0823 Q96NX5 KCC1G_HUMAN "Calcium/calmodulin-dependent protein kinase type 1G, EC 2.7.11.17 (CaM kinase I gamma, CaM kinase IG, CaM-KI gamma, CaMKI gamma, CaMKIG) (CaMK-like CREB kinase III, CLICK III)" CAMK1G CLICK3 VWS1 Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; peptidyl-serine phosphorylation [GO:0018105] GO:0000139; GO:0004683; GO:0005516; GO:0005524; GO:0005886; GO:0005954; GO:0018105; GO:0043005; GO:0106310 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310] EEDDCSSWK 0.92336 1.6256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.343 0 Q9UGQ3 GTR6_HUMAN "Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6, GLUT-6)" SLC2A6 GLUT6 Homo sapiens (Human) dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; regulation of glycolytic process [GO:0006110]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; transmembrane transporter activity [GO:0022857]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; regulation of glycolytic process [GO:0006110]; transmembrane transport [GO:0055085] GO:0005353; GO:0005355; GO:0005765; GO:0005886; GO:0006110; GO:0008645; GO:0015755; GO:0016020; GO:0016021; GO:0022857; GO:0033300; GO:0055056; GO:0055085; GO:0070837; GO:1904659 D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; transmembrane transporter activity [GO:0022857] LLSVLIAALTMDLAGRK 0.92336 2.2195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.352 0 0 0 0 0 0 0 0 0 0 0 13.4689 0 0 0 0 0 0 0 0 0 0 0 12.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.351 0 0 14.739 0 14.2403 0 0 14.3637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVU0 YK022_HUMAN Putative uncharacterized protein FLJ42102 Homo sapiens (Human) MVTKWWGQDPPVQLR 0.92337 2.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5176 0 0 0 0 0 0 0 12.7182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9004 0 0 0 0 0 0 0 13.1646 0 0 0 0 0 14.6871 14.3826 15.5307 0 0 0 12.3888 0 0 15.8942 0 0 0 0 0 0 0 0 0 15.2864 0 0 0 0 0 0 0 0 16.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVM0 CCD50_HUMAN Coiled-coil domain-containing protein 50 (Protein Ymer) CCDC50 C3orf6 Homo sapiens (Human) sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase binding [GO:0031625]; sensory perception of sound [GO:0007605] GO:0005737; GO:0005829; GO:0007605; GO:0031625 ubiquitin protein ligase binding [GO:0031625] AYADSYYYEDGGMK 0.92338 1.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.255 0 0 0 0 12.4787 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3728 13.0208 0 0 0 0 0 0 0 0 0 0 0 15.6003 0 0 0 0 0 0 12.6326 12.4248 0 0 0 0 0 12.0096 12.9081 0 0 0 0 12.3877 0 0 0 12.4541 12.8687 0 0 0 0 0 0 0 0 14.9833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1856 0 0 0 0 0 0 0 0 15.2647 0 0 0 11.5193 0 0 0 0 0 0 0 0 0 0 0 0 10.3775 0 P37840 SYUA_HUMAN "Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor, NACP)" SNCA NACP PARK1 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adult locomotory behavior [GO:0008344]; cellular response to copper ion [GO:0071280]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; dopamine uptake involved in synaptic transmission [GO:0051583]; excitatory postsynaptic potential [GO:0060079]; fatty acid metabolic process [GO:0006631]; long-term synaptic potentiation [GO:0060291]; microglial cell activation [GO:0001774]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial membrane organization [GO:0007006]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dopamine uptake involved in synaptic transmission [GO:0051585]; negative regulation of exocytosis [GO:0045920]; negative regulation of histone acetylation [GO:0035067]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of monooxygenase activity [GO:0032769]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of norepinephrine uptake [GO:0051622]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; neuron apoptotic process [GO:0051402]; neutral lipid metabolic process [GO:0006638]; phospholipid metabolic process [GO:0006644]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutathione peroxidase activity [GO:1903284]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of neuron death [GO:1901216]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of receptor recycling [GO:0001921]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of SNARE complex assembly [GO:0035543]; protein destabilization [GO:0031648]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of acyl-CoA biosynthetic process [GO:0050812]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of locomotion [GO:0040012]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of macrophage activation [GO:0043030]; regulation of neuron death [GO:1901214]; regulation of norepinephrine uptake [GO:0051621]; regulation of phospholipase activity [GO:0010517]; regulation of presynapse assembly [GO:1905606]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transmembrane transporter activity [GO:0022898]; response to interferon-gamma [GO:0034341]; response to interleukin-1 [GO:0070555]; response to iron(II) ion [GO:0010040]; response to lipopolysaccharide [GO:0032496]; response to magnesium ion [GO:0032026]; response to xenobiotic stimulus [GO:0009410]; SNARE complex assembly [GO:0035493]; supramolecular fiber organization [GO:0097435]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]" actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; supramolecular fiber [GO:0099512]; synaptic vesicle membrane [GO:0030672] "actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; supramolecular fiber [GO:0099512]; synaptic vesicle membrane [GO:0030672]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dynein complex binding [GO:0070840]; ferrous iron binding [GO:0008198]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; oxidoreductase activity [GO:0016491]; phospholipid binding [GO:0005543]; phosphoprotein binding [GO:0051219]; protein kinase inhibitor activity [GO:0004860]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adult locomotory behavior [GO:0008344]; cellular response to copper ion [GO:0071280]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; dopamine uptake involved in synaptic transmission [GO:0051583]; excitatory postsynaptic potential [GO:0060079]; fatty acid metabolic process [GO:0006631]; long-term synaptic potentiation [GO:0060291]; microglial cell activation [GO:0001774]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial membrane organization [GO:0007006]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dopamine uptake involved in synaptic transmission [GO:0051585]; negative regulation of exocytosis [GO:0045920]; negative regulation of histone acetylation [GO:0035067]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of monooxygenase activity [GO:0032769]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of norepinephrine uptake [GO:0051622]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; neuron apoptotic process [GO:0051402]; neutral lipid metabolic process [GO:0006638]; phospholipid metabolic process [GO:0006644]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutathione peroxidase activity [GO:1903284]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of neuron death [GO:1901216]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of receptor recycling [GO:0001921]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of SNARE complex assembly [GO:0035543]; protein destabilization [GO:0031648]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of acyl-CoA biosynthetic process [GO:0050812]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of locomotion [GO:0040012]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of macrophage activation [GO:0043030]; regulation of neuron death [GO:1901214]; regulation of norepinephrine uptake [GO:0051621]; regulation of phospholipase activity [GO:0010517]; regulation of presynapse assembly [GO:1905606]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transmembrane transporter activity [GO:0022898]; response to interferon-gamma [GO:0034341]; response to interleukin-1 [GO:0070555]; response to iron(II) ion [GO:0010040]; response to lipopolysaccharide [GO:0032496]; response to magnesium ion [GO:0032026]; response to xenobiotic stimulus [GO:0009410]; SNARE complex assembly [GO:0035493]; supramolecular fiber organization [GO:0097435]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]" GO:0000122; GO:0000149; GO:0000287; GO:0000976; GO:0001774; GO:0001921; GO:0001956; GO:0003779; GO:0004860; GO:0005507; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0005886; GO:0005938; GO:0006469; GO:0006631; GO:0006638; GO:0006644; GO:0006919; GO:0007006; GO:0007268; GO:0008198; GO:0008270; GO:0008344; GO:0009410; GO:0010040; GO:0010517; GO:0010642; GO:0014048; GO:0014059; GO:0015629; GO:0016020; GO:0016079; GO:0016082; GO:0016234; GO:0016491; GO:0019894; GO:0022898; GO:0030424; GO:0030426; GO:0030544; GO:0030672; GO:0031115; GO:0031623; GO:0031648; GO:0032026; GO:0032410; GO:0032496; GO:0032769; GO:0032991; GO:0033138; GO:0034341; GO:0034599; GO:0035067; GO:0035493; GO:0035543; GO:0040012; GO:0042393; GO:0042416; GO:0042775; GO:0042802; GO:0043014; GO:0043025; GO:0043027; GO:0043030; GO:0043065; GO:0043066; GO:0043154; GO:0043524; GO:0043679; GO:0045807; GO:0045920; GO:0045921; GO:0048156; GO:0048169; GO:0048471; GO:0048488; GO:0048489; GO:0050729; GO:0050808; GO:0050812; GO:0051219; GO:0051262; GO:0051281; GO:0051402; GO:0051583; GO:0051585; GO:0051612; GO:0051621; GO:0051622; GO:0060079; GO:0060291; GO:0060732; GO:0070161; GO:0070495; GO:0070555; GO:0070840; GO:0071280; GO:0071872; GO:0071902; GO:0097435; GO:0098794; GO:0099512; GO:1901214; GO:1901215; GO:1901216; GO:1902957; GO:1903136; GO:1903284; GO:1903285; GO:1903421; GO:1903426; GO:1904715; GO:1905606 actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dynein complex binding [GO:0070840]; ferrous iron binding [GO:0008198]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; oxidoreductase activity [GO:0016491]; phospholipid binding [GO:0005543]; phosphoprotein binding [GO:0051219]; protein kinase inhibitor activity [GO:0004860]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] EGVLYVGSKTK 0.92339 1.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00273 DFFA_HUMAN "DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit, DFF-45) (Inhibitor of CAD, ICAD)" DFFA DFF1 DFF45 H13 Homo sapiens (Human) apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; thymocyte apoptotic process [GO:0070242] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; deoxyribonuclease inhibitor activity [GO:0060703]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; thymocyte apoptotic process [GO:0070242] GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006309; GO:0019904; GO:0032076; GO:0032991; GO:0042981; GO:0043065; GO:0044183; GO:0060703; GO:0061077; GO:0070242; GO:1900118; GO:1902511 deoxyribonuclease inhibitor activity [GO:0060703]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183] ASPPGDLQNPKR 0.92341 2.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9671 0 0 0 0 0 0 0 0 0 14.4798 0 0 0 0 0 13.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG35 TB15B_HUMAN Thymosin beta-15B TMSB15B Homo sapiens (Human) actin filament organization [GO:0007015]; positive regulation of cell migration [GO:0030335]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015]; positive regulation of cell migration [GO:0030335]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989] GO:0003785; GO:0005737; GO:0005856; GO:0007015; GO:0030334; GO:0030335; GO:0042989 actin monomer binding [GO:0003785] TNTEEKNTLPSK 0.92341 1.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43357 MAGA3_HUMAN "Melanoma-associated antigen 3 (Antigen MZ2-D) (Cancer/testis antigen 1.3, CT1.3) (MAGE-3 antigen)" MAGEA3 MAGE3 Homo sapiens (Human) negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of protein processing [GO:0010955]; negative regulation of transcription by RNA polymerase II [GO:0000122] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; caspase binding [GO:0089720]; histone deacetylase binding [GO:0042826]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of protein processing [GO:0010955]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005783; GO:0010507; GO:0010955; GO:0042826; GO:0043154; GO:0089720; GO:1902236 caspase binding [GO:0089720]; histone deacetylase binding [GO:0042826] AGLLIIVLAIIAR 0.92341 2.0213 0 0 0 0 0 0 0 0 10.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4167 10.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8189 0 0 0 0 11.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4743 13.9742 0 0 0 0 0 15.4117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15499 GSC2_HUMAN "Homeobox protein goosecoid-2, GSC-2 (Homeobox protein goosecoid-like, GSC-L)" GSC2 GSCL Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0009653; GO:0043565; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" LAWPLRLGPAVPLSLGAPAGGSGALPGAVGPGSQR 0.92342 1.8775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9422 0 0 0 0 0 0 0 10.0137 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9222 0 11.4347 0 0 0 P08151 GLI1_HUMAN Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI) GLI1 GLI Homo sapiens (Human) "cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hh target transcription factor activity [GO:1990787]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; spermatid development [GO:0007286]; ventral midline development [GO:0007418]" axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; cerebellar cortex morphogenesis [GO:0021696]; digestive tract morphogenesis [GO:0048546]; dorsal/ventral pattern formation [GO:0009953]; epidermal cell differentiation [GO:0009913]; liver regeneration [GO:0097421]; lung development [GO:0030324]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hh target transcription factor activity [GO:1990787]; notochord regression [GO:0060032]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of hepatocyte proliferation [GO:2000345]; regulation of osteoblast differentiation [GO:0045667]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; response to wounding [GO:0009611]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; spermatid development [GO:0007286]; ventral midline development [GO:0007418]" GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005930; GO:0006357; GO:0007224; GO:0007286; GO:0007418; GO:0008017; GO:0008284; GO:0008589; GO:0009611; GO:0009913; GO:0009953; GO:0009954; GO:0021696; GO:0021938; GO:0021983; GO:0030324; GO:0030335; GO:0030850; GO:0043565; GO:0045667; GO:0045740; GO:0045880; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0060032; GO:0060045; GO:0090090; GO:0097421; GO:0097542; GO:0097546; GO:1902808; GO:1990787; GO:1990788; GO:2000345 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" AQYMLVVHMR 0.92342 2.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0262 14.2886 13.8496 13.7729 13.4574 13.093 11.7761 0 0 0 0 0 0 0 0 0 12.449 0 11.9062 0 0 0 0 13.0696 0 0 0 0 0 0 15.7531 0 0 0 10.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09936 UCHL1_HUMAN "Ubiquitin carboxyl-terminal hydrolase isozyme L1, UCH-L1, EC 3.4.19.12 (Neuron cytoplasmic protein 9.5) (PGP 9.5, PGP9.5) (Ubiquitin thioesterase L1)" UCHL1 Homo sapiens (Human) adult walking behavior [GO:0007628]; axon target recognition [GO:0007412]; axonal transport of mitochondrion [GO:0019896]; cellular response to xenobiotic stimulus [GO:0071466]; eating behavior [GO:0042755]; male germ cell proliferation [GO:0002176]; muscle cell development [GO:0055001]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of macroautophagy [GO:0016241]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adult walking behavior [GO:0007628]; axon target recognition [GO:0007412]; axonal transport of mitochondrion [GO:0019896]; cellular response to xenobiotic stimulus [GO:0071466]; eating behavior [GO:0042755]; male germ cell proliferation [GO:0002176]; muscle cell development [GO:0055001]; negative regulation of MAP kinase activity [GO:0043407]; neuromuscular process [GO:0050905]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of macroautophagy [GO:0016241]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233] GO:0002176; GO:0002931; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0007412; GO:0007628; GO:0008242; GO:0016241; GO:0016579; GO:0016874; GO:0019233; GO:0019896; GO:0031625; GO:0031694; GO:0042755; GO:0043025; GO:0043130; GO:0043161; GO:0043407; GO:0044306; GO:0050905; GO:0055001; GO:0071466; GO:1904115 alpha-2A adrenergic receptor binding [GO:0031694]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; ligase activity [GO:0016874]; omega peptidase activity [GO:0008242]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] AKCFEKNEAIQAAHDAVAQEGQCR 0.92343 2.3091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1697 0 0 0 0 0 0 0 0 12.0899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9584 0 0 0 12.5475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3C7 MED31_HUMAN "Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit SOH1, hSOH1)" MED31 SOH1 CGI-125 Homo sapiens (Human) limb development [GO:0060173]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; limb development [GO:0060173]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0000151; GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0016592; GO:0032968; GO:0048147; GO:0051123; GO:0060173; GO:0060261; GO:0061630; GO:0070847 transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] AAAVAMETDDAGNRLR 0.92343 1.6326 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7222 14.5061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20338 RAB4A_HUMAN "Ras-related protein Rab-4A, EC 3.6.5.2" RAB4A RAB4 Homo sapiens (Human) antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982] cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005886; GO:0015031; GO:0016192; GO:0019003; GO:0019882; GO:0030100; GO:0030659; GO:0031901; GO:0031982; GO:0032482; GO:0032593; GO:0048471; GO:0055037; GO:0055038; GO:0070062; GO:0098837 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] EVTFLEASRFAQENELMFLETSALTGENVEEAFVQCAR 0.92344 2.3227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3574 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1178 0 0 0 0 0 0 0 0 13.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.122 0 0 0 0 0 0 0 0 0 0 0 Q9UNN8 EPCR_HUMAN "Endothelial protein C receptor (Activated protein C receptor, APC receptor) (Endothelial cell protein C receptor) (CD antigen CD201)" PROCR EPCR Homo sapiens (Human) blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819] cell surface [GO:0009986]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell surface [GO:0009986]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; blood coagulation [GO:0007596]; negative regulation of coagulation [GO:0050819] GO:0005576; GO:0005615; GO:0005813; GO:0005886; GO:0005887; GO:0005925; GO:0007596; GO:0009986; GO:0038023; GO:0048471; GO:0050819; GO:0070062 signaling receptor activity [GO:0038023] HISAENTKGSQTSRSYTSLVLGVLVGSFIIAGVAVGIFLCTGGR 0.92344 2.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8429 0 0 0 0 0 0 0 0 0 13.8667 0 0 0 0 0 0 13.2969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6053 0 0 0 0 0 0 0 0 12.8519 0 0 0 0 0 0 0 0 0 0 Q9UHA7 IL36A_HUMAN "Interleukin-36 alpha (FIL1 epsilon) (Interleukin-1 epsilon, IL-1 epsilon) (Interleukin-1 family member 6, IL-1F6)" IL36A FIL1E IL1E IL1F6 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755] GO:0002437; GO:0005125; GO:0005149; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0006955; GO:0010628; GO:0019221; GO:0032755; GO:0045087; GO:0071222 cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149] EKDIMDLYNQPEPVK 0.92346 1.8767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5645 0 0 0 0 0 0 0 13.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16678 CP1B1_HUMAN "Cytochrome P450 1B1, EC 1.14.14.1 (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)" CYP1B1 Homo sapiens (Human) adrenal gland development [GO:0030325]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; benzene-containing compound metabolic process [GO:0042537]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to cAMP [GO:0071320]; cellular response to cortisol stimulus [GO:0071387]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to organic cyclic compound [GO:0071407]; cellular response to progesterone stimulus [GO:0071393]; cellular response to tumor necrosis factor [GO:0071356]; collagen fibril organization [GO:0030199]; DNA modification [GO:0006304]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; estrous cycle [GO:0044849]; ganglion development [GO:0061548]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; male gonad development [GO:0008584]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of translation [GO:0045727]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to arsenic-containing substance [GO:0046685]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to indole-3-methanol [GO:0071680]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; adrenal gland development [GO:0030325]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; benzene-containing compound metabolic process [GO:0042537]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to cAMP [GO:0071320]; cellular response to cortisol stimulus [GO:0071387]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to organic cyclic compound [GO:0071407]; cellular response to progesterone stimulus [GO:0071393]; cellular response to tumor necrosis factor [GO:0071356]; collagen fibril organization [GO:0030199]; DNA modification [GO:0006304]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; estrous cycle [GO:0044849]; ganglion development [GO:0061548]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; male gonad development [GO:0008584]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of translation [GO:0045727]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to arsenic-containing substance [GO:0046685]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to indole-3-methanol [GO:0071680]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; xenobiotic metabolic process [GO:0006805]" GO:0001525; GO:0002930; GO:0004497; GO:0005506; GO:0005634; GO:0005739; GO:0005789; GO:0006304; GO:0006805; GO:0006809; GO:0007155; GO:0007584; GO:0008202; GO:0008210; GO:0008285; GO:0008584; GO:0008631; GO:0009404; GO:0009636; GO:0010575; GO:0014911; GO:0016125; GO:0016712; GO:0019369; GO:0019373; GO:0020037; GO:0030199; GO:0030325; GO:0030336; GO:0032088; GO:0032354; GO:0032355; GO:0033629; GO:0042537; GO:0042572; GO:0042574; GO:0043065; GO:0043231; GO:0043534; GO:0043542; GO:0044849; GO:0045727; GO:0045766; GO:0046427; GO:0046466; GO:0046685; GO:0048514; GO:0061304; GO:0061548; GO:0070301; GO:0070330; GO:0071320; GO:0071356; GO:0071373; GO:0071387; GO:0071393; GO:0071407; GO:0071548; GO:0071603; GO:0071680; GO:0097267; GO:0101020; GO:0106256; GO:2000377; GO:2000379; GO:2000573 "aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]" AAGDSHGGGAR 0.92347 1.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0538 0 0 0 0 0 0 0 0 0 0 13.4691 0 0 0 0 0 0 0 0 0 0 0 0 11.7686 0 0 0 0 0 0 0 0 0 0 0 13.7572 0 0 0 0 0 0 0 0 0 0 0 12.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86T13 CLC14_HUMAN "C-type lectin domain family 14 member A (Epidermal growth factor receptor 5, EGFR-5)" CLEC14A C14orf27 EGFR5 UNQ236/PRO269 Homo sapiens (Human) cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; lymphangiogenesis [GO:0001946]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor-3 signaling pathway [GO:0036325] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; lymphangiogenesis [GO:0001946]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor-3 signaling pathway [GO:0036325] GO:0001946; GO:0002042; GO:0009897; GO:0016021; GO:0016477; GO:0030246; GO:0036324; GO:0036325; GO:0050840; GO:0062023; GO:1990430 carbohydrate binding [GO:0030246]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430] DLLFWVALERRR 0.92349 2.3088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71721 0 0 0 0 0 0 Q04760 LGUL_HUMAN "Lactoylglutathione lyase, EC 4.4.1.5 (Aldoketomutase) (Glyoxalase I, Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)" GLO1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0004462; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005975; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066; GO:0070062 lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270] DFLLQQTMLRVK 0.9235 2.3212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4423 0 0 0 0 0 0 14.5572 0 14.0797 0 0 0 0 0 0 0 0 13.5571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4748 0 0 0 0 0 13.883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8836 0 0 13.6074 0 0 0 0 0 0 0 0 0 0 0 10.7394 0 0 0 0 0 0 0 0 0 0 0 0 O95371 OR2C1_HUMAN Olfactory receptor 2C1 (OLFmf3) (Olfactory receptor 2C2) (Olfactory receptor OR16-1) (Olfactory receptor OR16-2) OR2C1 OR2C2P Homo sapiens (Human) cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0005938; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] FISLFYSLVTPMVNPLIYTLRNMEVK 0.92351 1.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3185 0 11.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1624 0 0 0 0 0 0 0 0 0 Q9H9H4 VP37B_HUMAN "Vacuolar protein sorting-associated protein 37B, hVps37B (ESCRT-I complex subunit VPS37B)" VPS37B Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0048306; GO:0070062; GO:0090148; GO:1903774 calcium-dependent protein binding [GO:0048306] TKLDRQSSSASLETLLALLQAEGAK 0.92355 2.0182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8781 0 12.0605 0 0 0 0 0 0 0 13.4571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5308 0 0 0 0 0 0 0 0 Q9BUD6 SPON2_HUMAN "Spondin-2 (Differentially expressed in cancerous and non-cancerous lung cells 1, DIL-1) (Mindin)" SPON2 DIL1 UNQ435/PRO866 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760] GO:0001530; GO:0002448; GO:0003823; GO:0007155; GO:0008228; GO:0031012; GO:0032755; GO:0032760; GO:0043152; GO:0045087; GO:0046872; GO:0050832; GO:0051607; GO:0060907; GO:0070062; GO:0071222 antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872] ALPPIARVTLVRLR 0.92356 1.1371 0 0 0 0 10.3337 0 0 0 0 0 0 0 10.2426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0964 0 0 0 0 0 10.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.268 0 0 12.0874 0 14.8416 0 0 0 0 0 0 0 0 0 0 0 Q5VY80 ULBP6_HUMAN UL16-binding protein 6 (Retinoic acid early transcript 1L protein) RAET1L ULBP6 Homo sapiens (Human) immune system process [GO:0002376] anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; immune system process [GO:0002376] GO:0002376; GO:0005576; GO:0005615; GO:0005783; GO:0005886; GO:0009897; GO:0031225; GO:0043231 AAAAIPALLLCLPLLFLLFGWSRARR 0.92358 1.8739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.356 0 0 0 0 0 0 0 11.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13643 FHL3_HUMAN "Four and a half LIM domains protein 3, FHL-3 (Skeletal muscle LIM-protein 2, SLIM-2)" FHL3 SLIM2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517] focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] focal adhesion [GO:0005925]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517] GO:0001725; GO:0003712; GO:0003779; GO:0005634; GO:0005925; GO:0007517; GO:0030018; GO:0030036; GO:0046872 actin binding [GO:0003779]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] DEDPYCVACFGELFAPKCSSCKR 0.92359 2.2553 0 0 0 0 0 0 0 0 0 0 0 10.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3573 0 0 13.4274 0 0 0 0 0 0 11.4927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9884 0 0 P17538 CTRB1_HUMAN "Chymotrypsinogen B, EC 3.4.21.1 [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C ]" CTRB1 CTRB Homo sapiens (Human) digestion [GO:0007586]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0007586 serine-type endopeptidase activity [GO:0004252] NPKFSILTVNNDITLLKLATPAR 0.92364 2.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08648 SG11B_HUMAN "Sperm-associated antigen 11B (Human epididymis-specific protein 2, He2) (Protein EP2) (Sperm antigen HE2)" SPAG11B EP2 HE2 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; spermatogenesis [GO:0007283] extracellular region [GO:0005576] extracellular region [GO:0005576]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; spermatogenesis [GO:0007283] GO:0005576; GO:0007283; GO:0042742; GO:0051838; GO:0061844 ERAPGQGTNGFQLLR 0.92364 1.9993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q71SY5 MED25_HUMAN "Mediator of RNA polymerase II transcription subunit 25 (Activator interaction domain-containing protein 1) (Activator-recruited cofactor 92 kDa component, ARC92) (Mediator complex subunit 25) (p78)" MED25 ACID1 ARC92 PTOV2 TCBAP0758 Homo sapiens (Human) negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of mediator complex assembly [GO:2001178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; transcription coactivator binding [GO:0001223]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of mediator complex assembly [GO:2001178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0000122; GO:0001223; GO:0005634; GO:0005654; GO:0005667; GO:0016592; GO:0032968; GO:0035563; GO:0042974; GO:0045944; GO:0046965; GO:0048147; GO:0051123; GO:0060261; GO:0070847; GO:2001178 nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; transcription coactivator binding [GO:0001223] KLPALRLLFEK 0.92364 1.1307 0 0 0 0 0 0 0 0 0 0 0 10.5425 0 0 0 0 0 0 0 0 0 0 12.9547 12.7991 0 0 13.2377 12.1089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2694 0 0 0 0 0 0 10.2861 0 0 0 0 0 0 0 0 0 0 14.1137 13.3401 0 0 0 0 0 0 0 15.2204 0 0 0 0 13.215 0 13.9127 12.2891 13.4207 0 0 0 11.7743 0 0 0 0 0 13.8328 0 11.3625 0 0 Q05519 SRS11_HUMAN "Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein, p54) (Splicing factor, arginine/serine-rich 11)" SRSF11 SFRS11 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0042802 identical protein binding [GO:0042802]; RNA binding [GO:0003723] ESKVNGDDHHEEDMDMSD 0.92371 1.1299 0 0 0 0 0 0 0 10.9878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9605 0 0 0 0 0 0 0 0 13.6032 0 0 0 0 0 0 13.5159 0 0 0 0 0 10.7193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9321 0 0 0 0 0 0 0 0 12.0734 0 13.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1978 0 0 14.285 Q14849 STAR3_HUMAN "StAR-related lipid transfer protein 3 (Metastatic lymph node gene 64 protein, MLN 64) (Protein CAB1) (START domain-containing protein 3, StARD3)" STARD3 CAB1 MLN64 Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; lipid metabolic process [GO:0006629]; mitochondrial transport [GO:0006839]; progesterone biosynthetic process [GO:0006701]; steroid metabolic process [GO:0008202]; vesicle tethering to endoplasmic reticulum [GO:0099044] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; organelle membrane contact site [GO:0044232] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; lipid metabolic process [GO:0006629]; mitochondrial transport [GO:0006839]; progesterone biosynthetic process [GO:0006701]; steroid metabolic process [GO:0008202]; vesicle tethering to endoplasmic reticulum [GO:0099044] GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005768; GO:0005829; GO:0006629; GO:0006701; GO:0006839; GO:0008202; GO:0008203; GO:0015485; GO:0016021; GO:0030301; GO:0031902; GO:0042803; GO:0043231; GO:0044232; GO:0099044; GO:0120020; GO:0140284 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803] HWWVIAVTTLVSSAFLIVK 0.92377 1.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4002 0 0 17.535 13.788 0 0 0 0 13.0763 0 13.0388 0 0 0 0 11.9453 0 13.7179 0 16.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2239 0 0 0 0 0 0 0 0 12.7222 0 0 0 0 0 0 0 0 13.7911 0 0 0 0 0 0 0 0 0 0 13.1194 0 0 0 0 0 0 0 0 0 0 0 0 13.3429 0 0 0 0 0 0 0 0 0 0 0 0 0 11.207 0 0 0 0 0 0 0 0 P05413 FABPH_HUMAN "Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein, H-FABP) (Mammary-derived growth inhibitor, MDGI) (Muscle fatty acid-binding protein, M-FABP)" FABP3 FABP11 MDGI Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; cholesterol homeostasis [GO:0042632]; fatty acid transport [GO:0015908]; intracellular lipid transport [GO:0032365]; long-chain fatty acid transport [GO:0015909]; negative regulation of cell population proliferation [GO:0008285]; phospholipid homeostasis [GO:0055091]; positive regulation of long-chain fatty acid import into cell [GO:0140214]; positive regulation of phospholipid biosynthetic process [GO:0071073]; regulation of fatty acid oxidation [GO:0046320]; regulation of phosphatidylcholine biosynthetic process [GO:2001245] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; oleic acid binding [GO:0070538]; brown fat cell differentiation [GO:0050873]; cholesterol homeostasis [GO:0042632]; fatty acid transport [GO:0015908]; intracellular lipid transport [GO:0032365]; long-chain fatty acid transport [GO:0015909]; negative regulation of cell population proliferation [GO:0008285]; phospholipid homeostasis [GO:0055091]; positive regulation of long-chain fatty acid import into cell [GO:0140214]; positive regulation of phospholipid biosynthetic process [GO:0071073]; regulation of fatty acid oxidation [GO:0046320]; regulation of phosphatidylcholine biosynthetic process [GO:2001245] GO:0005504; GO:0005615; GO:0005634; GO:0005829; GO:0008092; GO:0008285; GO:0015908; GO:0015909; GO:0032365; GO:0036041; GO:0042632; GO:0046320; GO:0050873; GO:0055091; GO:0070062; GO:0070538; GO:0071073; GO:0140214; GO:2001245 cytoskeletal protein binding [GO:0008092]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; oleic acid binding [GO:0070538] LILTLTHGTAVCTRTYEKEA 0.92378 1.6333 0 0 0 0 0 12.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4529 0 0 0 0 14.024 0 0 0 0 14.4865 0 0 0 0 0 0 0 11.0301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1918 0 0 0 0 0 0 0 0 0 12.808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9116 0 0 0 0 0 0 0 0 0 14.1742 0 0 0 13.6243 Q8NGY9 OR2L8_HUMAN Olfactory receptor 2L8 (Olfactory receptor OR1-46) OR2L8 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] RVCVLMITGSWIIGSINACAHTVYVLHIPYCRSR 0.92379 2.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPD7 NRN1_HUMAN Neuritin NRN1 NRN Homo sapiens (Human) neuron projection extension [GO:1990138] anchored component of plasma membrane [GO:0046658]; anchoring junction [GO:0070161]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchored component of plasma membrane [GO:0046658]; anchoring junction [GO:0070161]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; neuron projection extension [GO:1990138] GO:0005576; GO:0005886; GO:0045202; GO:0046658; GO:0070161; GO:1990138 LNGRYISLILAVQIAYLVQAVR 0.92382 1.9965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3502 0 0 0 0 11.4089 13.688 0 0 0 0 0 0 12.5012 13.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5058 0 0 13.1149 0 0 0 0 0 0 0 0 0 0 0 0 15.0416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15555 MARE2_HUMAN "Microtubule-associated protein RP/EB family member 2 (APC-binding protein EB2) (End-binding protein 2, EB2)" MAPRE2 RP1 Homo sapiens (Human) cell division [GO:0051301]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; spindle midzone [GO:0051233] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; focal adhesion [GO:0005925]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225] GO:0005737; GO:0005815; GO:0005881; GO:0005925; GO:0008017; GO:0015630; GO:0019901; GO:0031110; GO:0032014; GO:0035371; GO:0042802; GO:0043547; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0051549; GO:0120183; GO:1904825 identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901] LLQASFKRMNVDK 0.92387 1.1381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7039 0 0 0 0 0 12.8455 0 0 0 0 14.1177 0 0 0 0 0 0 0 0 0 12.0372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2042 0 0 0 0 0 0 0 0 0 0 0 12.1302 0 0 0 0 0 0 0 0 0 0 0 P16671 CD36_HUMAN "Platelet glycoprotein 4 (Fatty acid translocase, FAT) (Glycoprotein IIIb, GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV, GPIV) (Thrombospondin receptor) (CD antigen CD36)" CD36 GP3B GP4 Homo sapiens (Human) "amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; defense response to Gram-positive bacterium [GO:0050830]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; immune response [GO:0006955]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipid transport across blood-brain barrier [GO:1990379]; lipoprotein transport [GO:0042953]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitric oxide mediated signal transduction [GO:0007263]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of cell death [GO:0010942]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of tumor necrosis factor production [GO:0032760]; production of molecular mediator involved in inflammatory response [GO:0002532]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein-containing complex assembly [GO:0043254]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; short-chain fatty acid transport [GO:0015912]; triglyceride transport [GO:0034197]" apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579] "apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; amyloid-beta binding [GO:0001540]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid immune receptor activity [GO:0070892]; long-chain fatty acid transporter activity [GO:0005324]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; oleate transmembrane transporter activity [GO:1901480]; oxidised low-density lipoprotein particle receptor activity [GO:0150025]; protein-containing complex binding [GO:0044877]; scavenger receptor activity [GO:0005044]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; thrombospondin receptor activity [GO:0070053]; Toll-like receptor binding [GO:0035325]; transforming growth factor beta binding [GO:0050431]; amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to hydroperoxide [GO:0071447]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cGMP-mediated signaling [GO:0019934]; cholesterol import [GO:0070508]; cholesterol transport [GO:0030301]; defense response to Gram-positive bacterium [GO:0050830]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; immune response [GO:0006955]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; lipid transport across blood-brain barrier [GO:1990379]; lipoprotein transport [GO:0042953]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle mediated signaling [GO:0055096]; MAPK cascade [GO:0000165]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitric oxide mediated signal transduction [GO:0007263]; oxidised low-density lipoprotein particle clearance [GO:0150024]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of cell death [GO:0010942]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of tumor necrosis factor production [GO:0032760]; production of molecular mediator involved in inflammatory response [GO:0002532]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of action potential [GO:0098900]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein-containing complex assembly [GO:0043254]; regulation of removal of superoxide radicals [GO:2000121]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; response to stilbenoid [GO:0035634]; sensory perception of taste [GO:0050909]; short-chain fatty acid transport [GO:0015912]; triglyceride transport [GO:0034197]" GO:0000122; GO:0000165; GO:0001540; GO:0001954; GO:0002532; GO:0005041; GO:0005044; GO:0005324; GO:0005615; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0006629; GO:0006631; GO:0006898; GO:0006910; GO:0006911; GO:0006955; GO:0007155; GO:0007166; GO:0007204; GO:0007263; GO:0007596; GO:0008035; GO:0008289; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010744; GO:0010886; GO:0010942; GO:0015636; GO:0015909; GO:0015911; GO:0015912; GO:0016020; GO:0016324; GO:0019915; GO:0019934; GO:0030169; GO:0030194; GO:0030299; GO:0030301; GO:0030666; GO:0031092; GO:0031526; GO:0031623; GO:0031664; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033993; GO:0034121; GO:0034197; GO:0034381; GO:0034383; GO:0035325; GO:0035579; GO:0035634; GO:0042308; GO:0042953; GO:0043123; GO:0043235; GO:0043254; GO:0043277; GO:0044539; GO:0044877; GO:0045121; GO:0045335; GO:0045429; GO:0050431; GO:0050731; GO:0050830; GO:0050892; GO:0050909; GO:0051092; GO:0055096; GO:0060100; GO:0060907; GO:0070053; GO:0070374; GO:0070508; GO:0070542; GO:0070543; GO:0070892; GO:0071222; GO:0071223; GO:0071404; GO:0071447; GO:0071726; GO:0071813; GO:0071944; GO:0097009; GO:0098900; GO:0120162; GO:0140052; GO:0150024; GO:0150025; GO:0150094; GO:1900227; GO:1901480; GO:1903428; GO:1904646; GO:1990000; GO:1990379; GO:2000121; GO:2000334 amyloid-beta binding [GO:0001540]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid immune receptor activity [GO:0070892]; long-chain fatty acid transporter activity [GO:0005324]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; oleate transmembrane transporter activity [GO:1901480]; oxidised low-density lipoprotein particle receptor activity [GO:0150025]; protein-containing complex binding [GO:0044877]; scavenger receptor activity [GO:0005044]; short-chain fatty acid transmembrane transporter activity [GO:0015636]; thrombospondin receptor activity [GO:0070053]; Toll-like receptor binding [GO:0035325]; transforming growth factor beta binding [GO:0050431] CKEGRPVYISLPHFLYASPDVSEPIDGLNPNEEEHR 0.92388 2.2604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1973 0 15.0547 14.1523 14.825 12.6376 0 13.6401 12.9985 0 0 0 0 0 14.3347 0 13.1199 15.5325 13.9264 0 12.5628 14.8368 17.0547 17.0623 0 0 0 0 17.1445 16.7193 12.2325 0 12.6372 0 17.4392 16.9729 16.5535 13.2988 13.4018 16.0681 14.9889 13.3787 16.5092 17.1171 0 16.1389 13.8866 0 0 0 16.6317 12.3654 12.9998 13.2835 0 13.344 0 15.6331 14.047 13.8232 13.0223 0 11.3443 0 0 14.9828 0 0 13.6498 14.5627 0 0 14.5077 0 0 13.983 0 0 0 0 0 0 0 0 0 14.8669 0 0 0 0 0 0 0 0 0 0 0 0 12.2051 0 15.5284 14.5163 13.7558 0 13.0469 0 0 0 0 P30279 CCND2_HUMAN G1/S-specific cyclin-D2 CCND2 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; cell division [GO:0051301]; cellular response to X-ray [GO:0071481]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term memory [GO:0007616]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] chromatin [GO:0000785]; cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cyclin D2-CDK4 complex [GO:0097129]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; adult locomotory behavior [GO:0008344]; cell division [GO:0051301]; cellular response to X-ray [GO:0071481]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term memory [GO:0007616]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000082; GO:0000307; GO:0000785; GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007616; GO:0008284; GO:0008344; GO:0016538; GO:0019901; GO:0031965; GO:0043066; GO:0044772; GO:0045737; GO:0051301; GO:0071481; GO:0097129; GO:1900087 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] ELLCHEVDPVRR 0.92391 2.2223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.89 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34925 RYK_HUMAN "Tyrosine-protein kinase RYK, EC 2.7.10.1" RYK JTK5A Homo sapiens (Human) axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; phosphorylation [GO:0016310]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; protein kinase activity [GO:0004672]; transmembrane signaling receptor activity [GO:0004888]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway [GO:0035567]; phosphorylation [GO:0016310]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" GO:0004672; GO:0004888; GO:0005109; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007409; GO:0007411; GO:0007416; GO:0016020; GO:0016021; GO:0016310; GO:0017147; GO:0022008; GO:0022038; GO:0030182; GO:0031175; GO:0033278; GO:0033674; GO:0035567; GO:0036518; GO:0042813; GO:0043235; GO:0043410; GO:0048705; GO:0048843; GO:0048846; GO:0060070; GO:0071679; GO:1904929; GO:1904938; GO:1904948; GO:1904953 "ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; frizzled binding [GO:0005109]; protein kinase activity [GO:0004672]; transmembrane signaling receptor activity [GO:0004888]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]" APPPPPLLLLLALLPLLPAPGAAAAPAPR 0.92393 1.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3285 14.024 0 14.0968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5898 0 0 0 13.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4332 0 0 0 0 0 0 0 12.3586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAF7 ZN461_HUMAN "Zinc finger protein 461 (Gonadotropin-inducible ovary transcription repressor 1, GIOT-1)" ZNF461 GIOT1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DIYETELSQWVNMEEFK 0.92394 2.1877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2449 0 13.1261 11.414 0 0 0 0 0 13.309 0 0 0 0 0 0 12.4234 0 11.2469 0 0 0 0 0 0 13.2181 0 12.2485 0 0 0 0 0 0 13.2181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4512 0 0 0 0 12.3082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1263 0 0 0 0 0 0 0 0 0 0 14.3759 0 0 0 0 0 12.6418 0 0 12.6333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6678 0 0 Q16557 PSG3_HUMAN "Pregnancy-specific beta-1-glycoprotein 3, PS-beta-G-3, PSBG-3, Pregnancy-specific glycoprotein 3 (Carcinoembryonic antigen SG5)" PSG3 Homo sapiens (Human) defense response [GO:0006952]; female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; defense response [GO:0006952]; female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] GO:0002682; GO:0005576; GO:0005886; GO:0006952; GO:0007165; GO:0007565; GO:0009986; GO:1990782 protein tyrosine kinase binding [GO:1990782] EDAGSYTLHIVKRGDGTR 0.92395 1.1308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5452 0 0 0 0 0 0 0 0 12.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17039 ZNF30_HUMAN Zinc finger protein 30 (Zinc finger protein KOX28) ZNF30 KOX28 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRLSSFLHAHQRIHAEIK 0.92397 2.0073 0 0 0 0 0 0 0 0 0 13.2844 0 0 0 0 0 0 0 12.0701 0 0 0 0 0 0 12.6248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8733 14.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.903 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9074 0 0 0 0 0 0 0 0 0 0 0 0 13.9086 0 0 0 0 0 0 0 0 P20132 SDHL_HUMAN "L-serine dehydratase/L-threonine deaminase, SDH, EC 4.3.1.17 (L-serine deaminase) (L-threonine dehydratase, TDH, EC 4.3.1.19)" SDS SDH Homo sapiens (Human) gluconeogenesis [GO:0006094]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; lipid metabolic process [GO:0006629]; pyruvate biosynthetic process [GO:0042866]; threonine catabolic process [GO:0006567] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; gluconeogenesis [GO:0006094]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; lipid metabolic process [GO:0006629]; pyruvate biosynthetic process [GO:0042866]; threonine catabolic process [GO:0006567] GO:0003941; GO:0004794; GO:0005739; GO:0005829; GO:0006094; GO:0006565; GO:0006567; GO:0006629; GO:0009097; GO:0030170; GO:0042803; GO:0042866 L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] GIGHFCKRWAK 0.92399 1.9709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4912 0 0 0 P21815 SIAL_HUMAN "Bone sialoprotein 2 (Bone sialoprotein II, BSP II) (Cell-binding sialoprotein) (Integrin-binding sialoprotein)" IBSP BNSP Homo sapiens (Human) bone mineralization [GO:0030282]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; extracellular matrix organization [GO:0030198]; osteoblast differentiation [GO:0001649]; positive regulation of cell adhesion [GO:0045785] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; vesicle [GO:0031982] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; vesicle [GO:0031982]; integrin binding [GO:0005178]; bone mineralization [GO:0030282]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; extracellular matrix organization [GO:0030198]; osteoblast differentiation [GO:0001649]; positive regulation of cell adhesion [GO:0045785] GO:0001649; GO:0005178; GO:0005576; GO:0005615; GO:0007155; GO:0016020; GO:0030198; GO:0030282; GO:0031982; GO:0045785; GO:0071363 integrin binding [GO:0005178] AYEDEYSYFKGQGYDGYDGQNYYHHQ 0.92399 1.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1257 0 0 0 11.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4666 12.7907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9026 0 0 0 0 0 0 12.6946 0 0 0 0 0 0 0 12.6573 0 0 0 0 0 0 0 0 0 0 P55075 FGF8_HUMAN "Fibroblast growth factor 8, FGF-8 (Androgen-induced growth factor, AIGF) (Heparin-binding growth factor 8, HBGF-8)" FGF8 AIGF Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell migration involved in mesendoderm migration [GO:0090134]; cell proliferation in forebrain [GO:0021846]; corticotropin hormone secreting cell differentiation [GO:0060128]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic neurocranium morphogenesis [GO:0048702]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; gastrulation [GO:0007369]; gonad development [GO:0008406]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; larynx morphogenesis [GO:0120223]; limb morphogenesis [GO:0035108]; lung morphogenesis [GO:0060425]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesodermal cell migration [GO:0008078]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; midbrain-hindbrain boundary development [GO:0030917]; mitotic nuclear division [GO:0140014]; negative regulation of cardiac muscle tissue development [GO:0055026]; negative regulation of neuron apoptotic process [GO:0043524]; neural plate morphogenesis [GO:0001839]; neuroepithelial cell differentiation [GO:0060563]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; pallium development [GO:0021543]; pharyngeal system development [GO:0060037]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration [GO:0030334]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell proliferation [GO:0072089]; subpallium development [GO:0021544]; thyroid gland development [GO:0030878]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell migration involved in mesendoderm migration [GO:0090134]; cell proliferation in forebrain [GO:0021846]; corticotropin hormone secreting cell differentiation [GO:0060128]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic neurocranium morphogenesis [GO:0048702]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; gastrulation [GO:0007369]; gonad development [GO:0008406]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; larynx morphogenesis [GO:0120223]; limb morphogenesis [GO:0035108]; lung morphogenesis [GO:0060425]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesodermal cell migration [GO:0008078]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; midbrain-hindbrain boundary development [GO:0030917]; mitotic nuclear division [GO:0140014]; negative regulation of cardiac muscle tissue development [GO:0055026]; negative regulation of neuron apoptotic process [GO:0043524]; neural plate morphogenesis [GO:0001839]; neuroepithelial cell differentiation [GO:0060563]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; pallium development [GO:0021543]; pharyngeal system development [GO:0060037]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration [GO:0030334]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell proliferation [GO:0072089]; subpallium development [GO:0021544]; thyroid gland development [GO:0030878]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129] GO:0000165; GO:0001569; GO:0001656; GO:0001658; GO:0001759; GO:0001823; GO:0001839; GO:0001934; GO:0001947; GO:0001974; GO:0003007; GO:0003148; GO:0003198; GO:0005104; GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0007369; GO:0008078; GO:0008083; GO:0008284; GO:0008406; GO:0008543; GO:0009653; GO:0009887; GO:0009953; GO:0010628; GO:0021543; GO:0021544; GO:0021798; GO:0021846; GO:0023019; GO:0030154; GO:0030182; GO:0030334; GO:0030539; GO:0030878; GO:0030916; GO:0030917; GO:0035050; GO:0035108; GO:0035116; GO:0035265; GO:0035909; GO:0042476; GO:0042487; GO:0043524; GO:0045165; GO:0045597; GO:0045745; GO:0045840; GO:0046622; GO:0048702; GO:0048853; GO:0050731; GO:0051402; GO:0051781; GO:0055026; GO:0060037; GO:0060128; GO:0060129; GO:0060348; GO:0060425; GO:0060445; GO:0060563; GO:0070374; GO:0071542; GO:0072089; GO:0090134; GO:0120223; GO:0140014; GO:2000648 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111] ELASLFRAGREPQGVSQQHVR 0.924 1.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8007 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8007 0 0 0 0 0 0 0 0 0 0 11.8745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8058 0 0 0 0 0 0 0 Q92583 CCL17_HUMAN C-C motif chemokine 17 (CC chemokine TARC) (Small-inducible cytokine A17) (Thymus and activation-regulated chemokine) CCL17 SCYA17 TARC Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR4 chemokine receptor binding [GO:0031729]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] GO:0002548; GO:0005102; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007186; GO:0007267; GO:0008009; GO:0030593; GO:0031640; GO:0031729; GO:0043547; GO:0045662; GO:0048020; GO:0048247; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; CCR4 chemokine receptor binding [GO:0031729]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102] APLKMLALVTLLLGASLQHIHAARGTNVGR 0.92401 2.0059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95168 NDUB4_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (Complex I-B15, CI-B15) (NADH-ubiquinone oxidoreductase B15 subunit)" NDUFB4 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0006979; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] EYLLQYNDPNRR 0.92403 2.1673 0 0 0 0 0 0 0 0 0 11.6011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCJ1 ANKH_HUMAN "Progressive ankylosis protein homolog, ANK" ANKH KIAA1581 UNQ241/PRO274 Homo sapiens (Human) bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; phosphate ion homeostasis [GO:0055062]; regulation of bone mineralization [GO:0030500]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]; transmembrane transport [GO:0055085] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; outer membrane [GO:0019867]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; outer membrane [GO:0019867]; plasma membrane [GO:0005886]; inorganic diphosphate transmembrane transporter activity [GO:0030504]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transporter activity [GO:0015114]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; phosphate ion homeostasis [GO:0055062]; regulation of bone mineralization [GO:0030500]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501]; transmembrane transport [GO:0055085] GO:0001501; GO:0005315; GO:0005576; GO:0005886; GO:0005887; GO:0007626; GO:0010467; GO:0015114; GO:0016021; GO:0019867; GO:0030282; GO:0030500; GO:0030504; GO:0055062; GO:0055074; GO:0055085; GO:0071344; GO:0071529; GO:1904383 inorganic diphosphate transmembrane transporter activity [GO:0030504]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transporter activity [GO:0015114] AHLTGWLMTLKKTFVLAPSSVLR 0.92404 1.9705 0 0 0 0 0 0 0 12.7355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5749 0 0 0 0 12.9223 0 0 0 0 0 0 0 0 0 0 0 14.1372 13.9946 0 0 0 0 0 13.4694 0 0 0 0 12.4965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7264 0 0 0 13.8657 0 14.6818 0 0 0 0 0 0 0 0 0 13.8801 0 0 0 0 0 0 13.2443 0 0 12.3348 0 0 0 0 0 0 0 0 0 0 0 0 12.8085 0 0 0 0 0 12.5731 0 0 0 0 0 13.0957 0 0 0 12.7828 0 0 0 13.0524 0 0 0 12.5616 0 0 0 0 12.514 0 0 0 0 14.9814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15391 TYY2_HUMAN "Transcription factor YY2 (Yin and yang 2, YY-2) (Zinc finger protein 631)" YY2 ZNF631 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667] "nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0031519; GO:0043565; GO:0045944; GO:0046872; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" FAQSTNLKTHILTHVKTK 0.92406 1.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3223 0 0 0 0 0 0 0 0 11.6699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3482 0 0 0 0 0 0 0 11.4112 0 0 0 0 0 0 0 11.8851 0 0 0 0 0 14.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DN6 MBD6_HUMAN Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6) MBD6 KIAA1887 Homo sapiens (Human) chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682] GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369 chromatin binding [GO:0003682] HPIQPSLPGTTSGSLSSVPGAPAPPAASK 0.92408 1.9691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1807 13.4359 0 13.5435 14.9196 11.6521 0 0 0 0 0 13.8786 11.7011 12.9974 0 0 0 13.1243 0 0 0 0 0 0 0 0 0 0 0 15.9813 11.0751 0 0 0 15.0687 0 13.3149 0 0 13.6689 0 0 0 0 13.9376 13.3063 0 0 0 0 0 14.3194 13.5813 0 0 13.5436 0 13.8798 0 0 0 13.9778 0 0 0 13.7797 0 0 13.7751 14.1761 0 0 0 14.5965 0 0 14.5234 0 0 0 0 0 0 0 0 0 0 0 0 13.6144 0 15.0387 0 0 0 0 0 0 12.7667 13.9464 0 0 0 14.2206 0 14.3392 12.931 0 17.318 0 0 0 0 14.7496 13.807 14.5144 14.3596 0 13.2703 13.7779 0 0 0 0 0 15.8351 15.0778 14.2984 0 13.7365 0 P52743 ZN137_HUMAN Putative zinc finger protein 137 (Zinc finger protein 137 pseudogene) ZNF137P ZNF137 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] CGKVFSLWALHAEHQKIHF 0.92409 2.3096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0557 13.7344 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5807 0 0 0 0 0 0 0 13.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2852 0 0 0 11.4382 0 0 0 0 0 0 0 0 0 0 0 0 0 O75907 DGAT1_HUMAN "Diacylglycerol O-acyltransferase 1, EC 2.3.1.20 (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase, ARAT, Retinol O-fatty-acyltransferase, EC 2.3.1.76) (Diglyceride acyltransferase)" DGAT1 AGRP1 DGAT Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; acyltransferase activity [GO:0016746]; diacylglycerol O-acyltransferase activity [GO:0004144]; identical protein binding [GO:0042802]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252]; diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0003846; GO:0004144; GO:0005789; GO:0005886; GO:0006640; GO:0006641; GO:0008374; GO:0016021; GO:0016746; GO:0019432; GO:0019915; GO:0034379; GO:0035336; GO:0035579; GO:0042802; GO:0046339; GO:0050252; GO:0055089 2-acylglycerol O-acyltransferase activity [GO:0003846]; acyltransferase activity [GO:0016746]; diacylglycerol O-acyltransferase activity [GO:0004144]; identical protein binding [GO:0042802]; O-acyltransferase activity [GO:0008374]; retinol O-fatty-acyltransferase activity [GO:0050252] FLLRRILEMLFFTQLQVGLIQQWMVPTIQNSMK 0.9241 1.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9538 0 0 0 14.871 0 0 0 0 0 0 0 0 0 0 0 0 14.8016 0 0 0 14.2819 0 0 0 0 14.6472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXH3 PP14D_HUMAN "Protein phosphatase 1 regulatory subunit 14D (Gastrointestinal and brain-specific PP1-inhibitory protein 1, GBPI-1)" PPP1R14D GBPI Homo sapiens (Human) negative regulation of protein serine/threonine phosphatase activity [GO:1905183]; positive regulation of protein serine/threonine phosphatase activity [GO:1905184]; regulation of phosphorylation [GO:0042325] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; negative regulation of protein serine/threonine phosphatase activity [GO:1905183]; positive regulation of protein serine/threonine phosphatase activity [GO:1905184]; regulation of phosphorylation [GO:0042325] GO:0004865; GO:0005737; GO:0042325; GO:1905183; GO:1905184 protein serine/threonine phosphatase inhibitor activity [GO:0004865] TQLEAILGNCPRPTEAFISELLSQLKK 0.9241 1.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6422 0 0 0 0 0 0 0 0 0 0 12.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5798 0 0 0 0 0 0 0 0 0 0 11.9877 0 0 0 0 11.6774 0 0 0 0 0 11.9249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95633 FSTL3_HUMAN Follistatin-related protein 3 (Follistatin-like protein 3) (Follistatin-related gene protein) FSTL3 FLRG UNQ674/PRO1308 Homo sapiens (Human) cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; ossification [GO:0001503]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]; regulation of transcription by RNA polymerase II [GO:0006357] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activin binding [GO:0048185]; fibronectin binding [GO:0001968]; cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; ossification [GO:0001503]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0001503; GO:0001968; GO:0002244; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005788; GO:0006357; GO:0022409; GO:0030154; GO:0030510; GO:0030514; GO:0032926; GO:0045671; GO:0045944; GO:0048185; GO:0090101 activin binding [GO:0048185]; fibronectin binding [GO:0001968] CECAPDCSGLPAR 0.92413 1.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7N4 T191B_HUMAN Transmembrane protein 191B TMEM191B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ATLGLPLPPIVIQPAR 0.92413 1.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7418 12.4268 0 11.9734 0 0 11.3633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6315 0 0 0 12.6438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGZ3 O13G1_HUMAN Olfactory receptor 13G1 (Olfactory receptor OR1-37) OR13G1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] KPELQGIIFLFFLIVYLVAFLGNMLIIIAK 0.92414 2.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01225 FSHB_HUMAN "Follitropin subunit beta (Follicle-stimulating hormone beta subunit, FSH-B, FSH-beta) (Follitropin beta chain)" FSHB Homo sapiens (Human) female gamete generation [GO:0007292]; female pregnancy [GO:0007565]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone biosynthetic process [GO:0006701]; regulation of osteoclast differentiation [GO:0045670]; regulation of signaling receptor activity [GO:0010469]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914]; follicle-stimulating hormone activity [GO:0016913]; female gamete generation [GO:0007292]; female pregnancy [GO:0007565]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone biosynthetic process [GO:0006701]; regulation of osteoclast differentiation [GO:0045670]; regulation of signaling receptor activity [GO:0010469]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0005576; GO:0005615; GO:0005737; GO:0006701; GO:0007179; GO:0007186; GO:0007283; GO:0007292; GO:0007565; GO:0008284; GO:0010469; GO:0010628; GO:0010893; GO:0016913; GO:0016914; GO:0030335; GO:0042699; GO:0045670; GO:0045780; GO:0045944; GO:0060011 follicle-stimulating hormone activity [GO:0016913] CDSDSTDCTVRGLGPSYCSFGEMK 0.92417 1.6347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9562 0 0 0 0 0 0 0 0 12.6863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.185 0 0 0 0 0 0 0 0 0 0 0 0 Q5T5M9 CCNJ_HUMAN Cyclin-J CCNJ Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0016538; GO:0044772 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] ELKLPSYKGQSPQLSLR 0.92417 2.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5309 0 0 0 0 0 0 14.8767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08431 MFGM_HUMAN "Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8, MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin ]" MFGE8 Homo sapiens (Human) "angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]" acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020] "acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]" GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0016020; GO:0019897; GO:0043277; GO:0050766; GO:0062023; GO:0070062; GO:1903561 integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786] GDVFPSYTCTCLKGYAGNHCETK 0.9242 1.626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5609 10.9482 0 11.1275 0 0 0 0 0 0 12.1426 12.4119 0 0 0 0 0 0 11.1917 0 0 0 0 0 0 0 0 16.4007 0 0 11.1623 0 0 0 0 0 0 0 0 0 0 11.9206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9931 11.146 0 12.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8775 0 0 0 0 0 0 12.9131 0 0 12.3406 0 0 12.7974 0 0 13.8796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6326 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYD6 HXC10_HUMAN Homeobox protein Hox-C10 (Homeobox protein Hox-3I) HOXC10 HOX3I Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuromuscular process [GO:0050905]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuromuscular process [GO:0050905]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; spinal cord motor neuron cell fate specification [GO:0021520]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0008284; GO:0009952; GO:0009954; GO:0016604; GO:0021520; GO:0030326; GO:0045944; GO:0050905; GO:0120163; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" EENVCCMYSAEK 0.9242 2.0019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7733 0 0 0 0 0 0 0 0 0 0 0 12.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0811 12.5147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0849 0 0 0 0 0 0 P49901 MCSP_HUMAN Sperm mitochondrial-associated cysteine-rich protein SMCP MCS MCSP Homo sapiens (Human) flagellated sperm motility [GO:0030317]; penetration of zona pellucida [GO:0007341] cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; flagellated sperm motility [GO:0030317]; penetration of zona pellucida [GO:0007341] GO:0005737; GO:0005739; GO:0007341; GO:0030317; GO:0031966 CCPAKGNQCCPPQQNQCCQSK 0.92428 2.2555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8279 12.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4098 0 0 0 0 13.5631 0 0 14.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P9G4 TM154_HUMAN Transmembrane protein 154 TMEM154 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MQAPRAALVFALVIALVPVGR 0.92429 1.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2789 11.8135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76076 CCN5_HUMAN "CCN family member 5 (Connective tissue growth factor-like protein, CTGF-L) (Connective tissue growth factor-related protein 58) (WNT1-inducible-signaling pathway protein 2, WISP-2)" CCN5 CT58 CTGFL WISP2 UNQ228/PRO261 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of cell death [GO:0060548]; signal transduction [GO:0007165] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of cell death [GO:0060548]; signal transduction [GO:0007165] GO:0005178; GO:0005615; GO:0005634; GO:0007155; GO:0007165; GO:0007267; GO:0008201; GO:0031012; GO:0060548 heparin binding [GO:0008201]; integrin binding [GO:0005178] CEDGGFTCVPLCSEDVR 0.92432 2.3072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7568 0 0 0 12.2387 0 0 12.0699 10.7339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7984 0 0 0 0 0 0 0 0 0 0 0 10.0532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77391 0 9.81231 0 Q6ZMZ3 SYNE3_HUMAN "Nesprin-3 (KASH domain-containing protein 3, KASH3) (Nuclear envelope spectrin repeat protein 3)" SYNE3 C14orf139 C14orf49 LINC00341 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; establishment of protein localization to membrane [GO:0090150]; nuclear migration [GO:0007097]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; rough endoplasmic reticulum [GO:0005791] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; rough endoplasmic reticulum [GO:0005791]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; cytoskeleton organization [GO:0007010]; establishment of protein localization to membrane [GO:0090150]; nuclear migration [GO:0007097]; regulation of cell shape [GO:0008360] GO:0005635; GO:0005640; GO:0005737; GO:0005791; GO:0007010; GO:0007097; GO:0008360; GO:0016020; GO:0016021; GO:0031965; GO:0034993; GO:0051015; GO:0090150; GO:0140444 actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444] ACCVALPLQLLLLLFLLLLFLLPIR 0.92432 5.1005 12.0276 11.7304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0392 0 0 0 0 12.8352 0 0 0 10.1011 0 0 0 0 11.4811 0 0 0 0 0 0 0 0 0 0 0 0 11.6116 0 13.0996 13.1347 0 0 12.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2708 0 0 0 11.6539 0 0 13.6654 12.4283 13.5704 13.4451 13.5139 0 0 13.3699 0 0 0 13.1196 16.6092 14.1265 0 0 14.2816 0 0 0 12.6308 11.6057 0 0 0 0 14.4019 0 11.9437 0 13.967 14.2351 10.8559 13.6217 0 15.1006 14.5522 14.1984 0 13.4715 0 11.6966 12.7631 14.9086 13.9605 13.9152 0 0 0 13.4701 14.3961 0 13.7823 0 13.7018 12.1281 0 13.5813 0 14.1072 15.0357 0 12.0844 0 13.8398 14.2327 13.7347 0 0 12.7796 0 13.611 0 10.491 13.7226 0 11.3963 0 14.0786 0 12.6764 0 13.6454 12.7051 0 0 0 0 0 0 0 11.2412 0 0 0 0 11.7829 0 14.1548 0 0 13.9216 0 0 0 0 0 Q9NX31 OSER1_HUMAN Oxidative stress-responsive serine-rich protein 1 (Oxidative stress-responsive protein 1) (Peroxide-inducible transcript 1 protein) OSER1 C20orf111 BM-038 HSPC168 HSPC207 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301] cellular response to hydrogen peroxide [GO:0070301] GO:0070301 PCTCIGKECQCK 0.92433 1.9971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13239 SLAP1_HUMAN "Src-like-adapter (Src-like-adapter protein 1, SLAP-1, hSLAP)" SLA SLAP SLAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; regulation of signal transduction [GO:0009966]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925] cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; regulation of signal transduction [GO:0009966]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005102; GO:0005768; GO:0005829; GO:0005925; GO:0007169; GO:0009966; GO:0030154; GO:0031234; GO:0043197; GO:0045087 signaling receptor binding [GO:0005102] GEKLRVISDEGGWWK 0.92435 2.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4625 0 0 13.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3D4 P63_HUMAN "Tumor protein 63, p63 (Chronic ulcerative stomatitis protein, CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63, TP63) (Tumor protein p73-like, p73L) (p40) (p51)" TP63 KET P63 P73H P73L TP73L Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WW domain binding [GO:0050699]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; multicellular organism aging [GO:0010259]; negative regulation of cellular senescence [GO:2000773]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein tetramerization [GO:0051262]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001736; GO:0002039; GO:0002064; GO:0003677; GO:0003682; GO:0003684; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0006338; GO:0006357; GO:0006366; GO:0006915; GO:0006974; GO:0007219; GO:0007283; GO:0007499; GO:0009954; GO:0010259; GO:0010481; GO:0010482; GO:0010838; GO:0030216; GO:0030425; GO:0030859; GO:0031069; GO:0032991; GO:0033147; GO:0035115; GO:0035116; GO:0036342; GO:0042475; GO:0042771; GO:0042802; GO:0043281; GO:0043589; GO:0043616; GO:0045617; GO:0045669; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048485; GO:0048807; GO:0050699; GO:0051262; GO:0051402; GO:0060197; GO:0060513; GO:0060529; GO:0061436; GO:0072089; GO:0090398; GO:0097371; GO:1902808; GO:1904674; GO:1904888; GO:2000271; GO:2000381; GO:2000648; GO:2000773; GO:2001235 "chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WW domain binding [GO:0050699]" FVETPAHFSWKESYYR 0.92435 2.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3417 0 13.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5873 0 0 11.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6013 0 0 0 0 0 0 Q9Y2W3 S45A1_HUMAN "Proton-associated sugar transporter A, PAST-A (Deleted in neuroblastoma 5 protein, DNb-5) (Solute carrier family 45 member 1)" SLC45A1 DNB5 Homo sapiens (Human) galactose transmembrane transport [GO:0015757]; glucose transmembrane transport [GO:1904659] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose:proton symporter activity [GO:0015517]; glucose:proton symporter activity [GO:0005356]; sucrose:proton symporter activity [GO:0008506]; galactose transmembrane transport [GO:0015757]; glucose transmembrane transport [GO:1904659] GO:0005356; GO:0008506; GO:0015517; GO:0015757; GO:0016020; GO:0016021; GO:1904659 galactose:proton symporter activity [GO:0015517]; glucose:proton symporter activity [GO:0005356]; sucrose:proton symporter activity [GO:0008506] PFILVLAIGALLGLSLLLNGR 0.92438 2.1924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55829 10.7678 0 0 0 0 0 11.9717 0 0 0 11.4409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6213 0 0 0 0 0 0 0 0 0 0 0 12.5035 0 0 0 0 0 0 0 0 0 0 0 0 12.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0397 11.2102 0 0 13.3222 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DMT0 MLN_HUMAN Myoregulin MRLN MLN Homo sapiens (Human) calcium ion import into sarcoplasmic reticulum [GO:1990036]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import into sarcoplasmic reticulum [GO:1902081]; response to wounding [GO:0009611] integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017] integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; enzyme inhibitor activity [GO:0004857]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import into sarcoplasmic reticulum [GO:1902081]; response to wounding [GO:0009611] GO:0004857; GO:0009611; GO:0016021; GO:0033017; GO:1901877; GO:1901895; GO:1902081; GO:1990036 enzyme inhibitor activity [GO:0004857] ILFVIFVDLISIIYVVITS 0.92439 1.8791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9921 13.4381 0 0 0 14.6732 0 11.0867 0 15.1772 0 0 0 11.8279 0 0 0 0 10.8774 0 0 0 0 0 0 15.1125 13.4188 0 13.5937 0 0 11.127 0 0 14.0274 13.6489 0 0 13.6617 14.6678 0 0 13.6486 0 0 0 0 0 0 11.783 0 0 10.7812 12.9885 0 0 0 0 0 0 0 11.9131 0 0 0 0 0 0 10.9362 11.263 0 12.0548 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3141 0 0 0 0 0 Q96DR4 STAR4_HUMAN "StAR-related lipid transfer protein 4 (START domain-containing protein 4, StARD4)" STARD4 Homo sapiens (Human) cholesterol import [GO:0070508]; cholesterol transport involved in cholesterol storage [GO:0010879]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of cholesterol metabolic process [GO:0090205] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol import [GO:0070508]; cholesterol transport involved in cholesterol storage [GO:0010879]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of cholesterol metabolic process [GO:0090205] GO:0005737; GO:0005783; GO:0005829; GO:0010879; GO:0015485; GO:0031410; GO:0032367; GO:0070508; GO:0070859; GO:0090205; GO:0120020 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020] GMIPQSAVDTAMASTLTNFYGDLRKAL 0.92441 1.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1858 0 0 0 0 0 0 0 16.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7241 0 0 0 0 10.8199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2958 0 0 0 0 0 0 0 Q06481 APLP2_HUMAN "Amyloid beta precursor like protein 2 (APPH) (Amyloid beta (A4) precursor-like protein 2) (Amyloid protein homolog) (Amyloid-like protein 2, APLP-2) (CDEI box-binding protein, CDEBP) (Sperm membrane protein YWK-II)" APLP2 APPL2 Homo sapiens (Human) axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of cellular protein metabolic process [GO:0032268] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of cellular protein metabolic process [GO:0032268] GO:0003677; GO:0004867; GO:0005634; GO:0005788; GO:0005886; GO:0007186; GO:0007409; GO:0007417; GO:0008201; GO:0016020; GO:0016021; GO:0031092; GO:0032268; GO:0042802; GO:0046914; GO:0070062 DNA binding [GO:0003677]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914] AERQTLIQHFQAMVKALEK 0.92442 1.9864 0 0 0 12.4824 0 0 0 0 0 13.3351 0 13.2841 0 0 0 0 0 0 0 0 0 0 11.4877 12.2345 0 0 0 0 0 0 0 12.1759 0 0 0 12.3289 14.7503 0 0 0 13.8553 0 14.4643 13.8191 0 13.6771 0 0 0 0 0 0 0 0 0 0 10.9273 0 0 0 0 0 0 0 0 0 0 0 14.5515 0 0 0 13.2128 0 0 0 14.173 0 14.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5874 0 0 0 0 0 13.2444 0 0 15.3247 0 11.895 0 0 0 0 0 0 0 14.1649 12.8494 0 0 0 0 0 0 0 0 0 0 0 0 12.7506 0 0 0 0 0 0 0 0 0 0 0 13.0268 0 0 0 0 13.4558 0 0 0 0 0 0 0 0 0 13.2281 0 0 0 0 0 12.9479 0 0 12.599 13.7526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95073 FSBP_HUMAN Fibrinogen silencer-binding protein FSBP Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802] GO:0005634; GO:0005654; GO:0042802 identical protein binding [GO:0042802] ETQSDFKSNISEPTKK 0.92444 1.1391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8561 0 0 0 0 0 0 12.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GX49 TVB64_HUMAN T cell receptor beta variable 6-4 TRBV6-4 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 SMTLRCTQDMR 0.92445 1.1278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1333 0 0 0 0 11.2682 0 0 0 0 0 0 0 0 0 11.4244 0 0 0 11.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBR0 P5I13_HUMAN Tumor protein p53-inducible protein 13 (Damage-stimulated cytoplasmic protein 1) TP53I13 DSCP1 Homo sapiens (Human) negative regulation of cell cycle [GO:0045786]; response to organic cyclic compound [GO:0014070]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of cell cycle [GO:0045786]; response to organic cyclic compound [GO:0014070]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410] GO:0005737; GO:0005886; GO:0009410; GO:0009411; GO:0014070; GO:0016021; GO:0045786 APPPPSPQLLLLAALAR 0.92449 1.1385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6987 0 14.0656 14.7833 14.0385 13.3887 0 0 0 14.3251 0 14.9881 14.3869 14.1848 15.1215 13.6898 15.165 15.5862 14.7626 15.2837 0 0 13.0367 13.1271 0 14.8032 16.0177 15.4782 15.4207 14.9772 0 12.5794 14.1538 0 14.4997 0 14.2152 14.703 0 15.1235 14.2876 14.2742 13.7824 14.9643 16.1319 14.7024 14.657 0 14.5762 14.9471 14.9017 13.68 11.5507 14.5719 14.909 15.3998 15.1311 0 15.5175 14.802 12.6908 0 0 14.8732 0 13.8787 0 0 0 14.1038 0 0 0 0 14.6209 11.3724 0 13.7758 14.7881 15.2272 0 0 0 0 0 0 0 13.535 0 0 12.1396 0 0 0 0 15.0185 14.5927 0 15.2594 0 0 0 0 0 P06727 APOA4_HUMAN "Apolipoprotein A-IV, Apo-AIV, ApoA-IV (Apolipoprotein A4)" APOA4 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron assembly [GO:0034378]; chylomicron remodeling [GO:0034371]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle remodeling [GO:0034375]; hydrogen peroxide catabolic process [GO:0042744]; innate immune response in mucosa [GO:0002227]; leukocyte cell-cell adhesion [GO:0007159]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; negative regulation of plasma lipoprotein oxidation [GO:0034445]; peripheral nervous system axon regeneration [GO:0014012]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of triglyceride catabolic process [GO:0010898]; protein-lipid complex assembly [GO:0065005]; regulation of cholesterol transport [GO:0032374]; regulation of intestinal cholesterol absorption [GO:0030300]; removal of superoxide radicals [GO:0019430]; response to lipid hydroperoxide [GO:0006982]; response to stilbenoid [GO:0035634]; response to triglyceride [GO:0034014]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361]; antioxidant activity [GO:0016209]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron assembly [GO:0034378]; chylomicron remodeling [GO:0034371]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle remodeling [GO:0034375]; hydrogen peroxide catabolic process [GO:0042744]; innate immune response in mucosa [GO:0002227]; leukocyte cell-cell adhesion [GO:0007159]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; negative regulation of plasma lipoprotein oxidation [GO:0034445]; peripheral nervous system axon regeneration [GO:0014012]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of triglyceride catabolic process [GO:0010898]; protein-lipid complex assembly [GO:0065005]; regulation of cholesterol transport [GO:0032374]; regulation of intestinal cholesterol absorption [GO:0030300]; removal of superoxide radicals [GO:0019430]; response to lipid hydroperoxide [GO:0006982]; response to stilbenoid [GO:0035634]; response to triglyceride [GO:0034014]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372] GO:0002227; GO:0005319; GO:0005507; GO:0005543; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005829; GO:0006695; GO:0006869; GO:0006982; GO:0007159; GO:0008203; GO:0008289; GO:0010873; GO:0010898; GO:0014012; GO:0015485; GO:0016042; GO:0016209; GO:0019430; GO:0030300; GO:0031210; GO:0032374; GO:0033344; GO:0033700; GO:0034014; GO:0034361; GO:0034364; GO:0034371; GO:0034372; GO:0034375; GO:0034378; GO:0034380; GO:0034445; GO:0035634; GO:0042157; GO:0042627; GO:0042632; GO:0042744; GO:0042802; GO:0042803; GO:0043691; GO:0045202; GO:0045723; GO:0046470; GO:0046889; GO:0051006; GO:0055088; GO:0060228; GO:0062023; GO:0065005; GO:0070062; GO:0070328; GO:0072562; GO:0120020; GO:1905920 antioxidant activity [GO:0016209]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] ISASAEELRQR 0.9245 2.303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4954 0 0 0 0 0 0 0 0 16.4019 0 0 17.0552 0 0 0 0 0 0 0 0 0 0 0 0 0 12.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1068 0 0 0 0 0 13.9436 0 13.5445 0 0 0 0 13.029 0 0 0 0 0 0 12.4252 0 0 14.2563 14.0293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8636 0 0 0 0 0 0 12.7485 Q96MY1 NOL4L_HUMAN Nucleolar protein 4-like NOL4L C20orf112 C20orf113 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 APTADDDDDDHDDHEDNDK 0.92451 1.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1406 0 14.4251 0 0 0 0 0 0 0 0 13.158 11.0455 0 0 0 0 0 13.6233 0 0 0 0 0 0 0 0 0 15.0881 0 0 0 0 0 0 11.9786 0 0 0 0 0 0 0 0 0 0 0 12.3862 0 0 0 13.6306 0 13.8062 0 0 0 0 0 13.5681 0 0 0 0 13.8008 0 0 0 0 10.6955 0 0 0 13.4752 0 0 10.1716 10.7524 0 0 0 0 12.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2094 0 0 0 0 P40259 CD79B_HUMAN B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b) CD79B B29 IGB Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; immune response [GO:0006955]; signal transduction [GO:0007165] B cell receptor complex [GO:0019815]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] B cell receptor complex [GO:0019815]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; immune response [GO:0006955]; signal transduction [GO:0007165] GO:0002250; GO:0004888; GO:0005886; GO:0005887; GO:0006955; GO:0007165; GO:0009897; GO:0019815; GO:0030183; GO:0042802; GO:0050853; GO:0070062 identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888] CNNTSEVYQGCGTELR 0.92452 1.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2036 0 0 0 0 0 Q6P988 NOTUM_HUMAN "Palmitoleoyl-protein carboxylesterase NOTUM, EC 3.1.1.98 (hNOTUM)" NOTUM OK/SW-CL.30 Homo sapiens (Human) bone development [GO:0060348]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; regulation of bone mineralization [GO:0030500]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; palmitoleyl hydrolase activity [GO:1990699]; phospholipase C activity [GO:0004629]; bone development [GO:0060348]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; protein depalmitoleylation [GO:1990697]; regulation of bone mineralization [GO:0030500]; Wnt signaling pathway [GO:0016055] GO:0004629; GO:0005576; GO:0005788; GO:0016055; GO:0030178; GO:0030500; GO:0060348; GO:0090090; GO:1990697; GO:1990699 palmitoleyl hydrolase activity [GO:1990699]; phospholipase C activity [GO:0004629] CRRQFQEGEEWNCFFGYK 0.92453 2.2237 0 0 0 0 0 0 0 0 0 0 0 10.2073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0467 0 11.6158 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6832 0 0 0 0 12.489 0 0 0 0 0 12.5492 0 11.6413 0 9.94062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5791 0 0 0 0 0 0 0 Q6ZYL4 TF2H5_HUMAN General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit) (TFIIH subunit p8) GTF2H5 C6orf175 TTDA Homo sapiens (Human) "cellular response to gamma radiation [GO:0071480]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; cellular response to gamma radiation [GO:0071480]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, preincision complex assembly [GO:0006294]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000439; GO:0000462; GO:0005654; GO:0005669; GO:0005675; GO:0005730; GO:0005737; GO:0006289; GO:0006294; GO:0006362; GO:0006366; GO:0006367; GO:0070816; GO:0071480 MVNVLKGVLIECDPAMK 0.92453 1.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6705 0 0 0 0 0 13.4656 0 12.478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9914 0 0 11.7926 13.3208 0 12.1875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6QHK4 FIGLA_HUMAN "Factor in the germline alpha, FIGalpha (Class C basic helix-loop-helix protein 8, bHLHc8) (Folliculogenesis-specific basic helix-loop-helix protein) (Transcription factor FIGa)" FIGLA BHLHC8 Homo sapiens (Human) developmental process [GO:0032502]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; developmental process [GO:0032502]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0032502; GO:0043425; GO:0046983; GO:0048599; GO:1990837 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" NEEEGPWADGGSGEPAHACR 0.92454 1.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6469 0 0 0 0 12.8705 12.654 0 0 0 0 0 0 0 0 12.8982 13.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2131 0 0 10.5279 0 0 0 0 0 11.3554 11.445 0 0 0 0 0 0 0 0 0 0 0 0 13.5907 0 0 0 0 0 0 0 0 0 0 0 12.2055 0 0 0 0 0 0 0 0 0 12.0045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9726 0 0 13.9536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.036 0 0 0 0 13.8027 0 0 0 0 10.6576 0 0 0 13.3725 0 10.4699 0 0 0 0 0 0 0 0 0 Q13324 CRFR2_HUMAN "Corticotropin-releasing factor receptor 2, CRF-R-2, CRF-R2, CRFR-2 (Corticotropin-releasing hormone receptor 2, CRH-R-2, CRH-R2)" CRHR2 CRF2R CRH2R Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; long-term synaptic potentiation [GO:0060291] axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon terminus [GO:0043679]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; long-term synaptic potentiation [GO:0060291] GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0008528; GO:0015056; GO:0017046; GO:0030425; GO:0043404; GO:0043679; GO:0060291 corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046] ILMTKLR 0.92455 1.9848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6002 0 0 0 11.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4492 0 0 0 0 12.4939 10.4487 0 11.743 0 0 0 0 0 0 0 0 0 Q2M3C6 TM266_HUMAN "Transmembrane protein 266, hTMEM266 (HV1-related protein 1, HsHVRP1)" TMEM266 C15orf27 HVRP1 Homo sapiens (Human) cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803] GO:0005829; GO:0005886; GO:0005887; GO:0030425; GO:0042803; GO:0043204 protein homodimerization activity [GO:0042803] AAVWQVFLLSASLNSFLVACVILVVILLTLELLIDIK 0.92457 2.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0341 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8096 0 0 0 0 0 0 0 13.8756 0 0 0 0 0 0 12.7465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2634 0 0 0 0 13.8657 0 0 13.2627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31321 KAP1_HUMAN cAMP-dependent protein kinase type I-beta regulatory subunit PRKAR1B Homo sapiens (Human) learning or memory [GO:0007611]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fear response [GO:1903367]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of sensory perception of pain [GO:1904058]; protein phosphorylation [GO:0006468]; regulation of synaptic vesicle cycle [GO:0098693] cAMP-dependent protein kinase complex [GO:0005952]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] cAMP-dependent protein kinase complex [GO:0005952]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase A catalytic subunit binding [GO:0034236]; learning or memory [GO:0007611]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fear response [GO:1903367]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of sensory perception of pain [GO:1904058]; protein phosphorylation [GO:0006468]; regulation of synaptic vesicle cycle [GO:0098693] GO:0004862; GO:0005737; GO:0005771; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007611; GO:0008603; GO:0030552; GO:0034236; GO:0097546; GO:0098685; GO:0098686; GO:0098693; GO:0098978; GO:1900273; GO:1903367; GO:1904058; GO:2000463; GO:2000480 cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase A catalytic subunit binding [GO:0034236] DSYRRILMGSTLR 0.92458 2.2228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7139 13.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRL7 SC22C_HUMAN Vesicle-trafficking protein SEC22c (SEC22 vesicle-trafficking protein homolog C) (SEC22 vesicle-trafficking protein-like 3) SEC22C SEC22L3 UNQ459/PRO784 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031] GO:0005783; GO:0005789; GO:0006888; GO:0015031; GO:0016021 QLQEKQSDCGV 0.92458 1.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.259 0 0 0 11.3715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5711 0 0 0 0 0 0 0 0 0 0 0 0 11.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XA0 MET23_HUMAN "Histone-arginine methyltransferase METTL23, EC 2.1.1.319 (Methyltransferase-like protein 23)" METTL23 C17orf95 Homo sapiens (Human) chromatin organization [GO:0006325]; chromatin reprogramming in the zygote [GO:0044725]; cognition [GO:0050890]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-R17 methylation [GO:0034971]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; chromatin organization [GO:0006325]; chromatin reprogramming in the zygote [GO:0044725]; cognition [GO:0050890]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-R17 methylation [GO:0034971]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001939; GO:0001940; GO:0005634; GO:0005737; GO:0006325; GO:0031072; GO:0032991; GO:0034971; GO:0035242; GO:0035642; GO:0044725; GO:0044727; GO:0045944; GO:0050890; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242] AILEIGAGVSLPGILAAK 0.9246 1.6349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3524 0 0 0 0 0 P59190 RAB15_HUMAN Ras-related protein Rab-15 RAB15 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; positive regulation of regulated secretory pathway [GO:1903307]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] cilium [GO:0005929]; cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021] cilium [GO:0005929]; cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to insulin stimulus [GO:0032869]; positive regulation of regulated secretory pathway [GO:1903307]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] GO:0003924; GO:0005525; GO:0005737; GO:0005768; GO:0005794; GO:0005886; GO:0005929; GO:0006904; GO:0008021; GO:0009306; GO:0010008; GO:0017157; GO:0032482; GO:0032593; GO:0032869; GO:0043231; GO:0048471; GO:0055037; GO:0070062; GO:0072659; GO:1903307 GTP binding [GO:0005525]; GTPase activity [GO:0003924] ADEEQKRQVGR 0.92462 1.6267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.39 0 0 0 0 0 0 12.6672 0 0 0 0 0 12.6292 0 0 0 0 0 11.7231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08043 ACTN3_HUMAN Alpha-actinin-3 (Alpha-actinin skeletal muscle isoform 3) (F-actin cross-linking protein) ACTN3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; bone morphogenesis [GO:0060349]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of glycolytic process [GO:0045820]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of relaxation of muscle [GO:1901078]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of glucose catabolic process to lactate via pyruvate [GO:1904025]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of skeletal muscle tissue growth [GO:0048633]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of the force of skeletal muscle contraction [GO:0014728]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; skeletal muscle atrophy [GO:0014732]; transition between fast and slow fiber [GO:0014883] actin filament [GO:0005884]; brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; Z disc [GO:0030018] actin filament [GO:0005884]; brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; structural constituent of muscle [GO:0008307]; transmembrane transporter binding [GO:0044325]; actin cytoskeleton organization [GO:0030036]; bone morphogenesis [GO:0060349]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of glycolytic process [GO:0045820]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of relaxation of muscle [GO:1901078]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of glucose catabolic process to lactate via pyruvate [GO:1904025]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of skeletal muscle tissue growth [GO:0048633]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of the force of skeletal muscle contraction [GO:0014728]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; skeletal muscle atrophy [GO:0014732]; transition between fast and slow fiber [GO:0014883] GO:0005178; GO:0005509; GO:0005829; GO:0005884; GO:0005886; GO:0005903; GO:0005925; GO:0008307; GO:0014728; GO:0014732; GO:0014883; GO:0014894; GO:0030018; GO:0030036; GO:0030054; GO:0030864; GO:0031143; GO:0031448; GO:0042802; GO:0042981; GO:0042995; GO:0044325; GO:0045820; GO:0048041; GO:0048633; GO:0048743; GO:0051015; GO:0055001; GO:0060349; GO:0070062; GO:0070885; GO:0090324; GO:0120163; GO:1900159; GO:1901078; GO:1903715; GO:1904025 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; structural constituent of muscle [GO:0008307]; transmembrane transporter binding [GO:0044325] ALDFIASKGVKLVSIGAEEIVDGNLK 0.92466 5.4159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2292 0 0 11.7352 0 0 0 0 12.1866 0 0 0 0 0 0 0 0 0 0 13.5239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8904 0 13.4243 0 15.1226 12.6471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6316 0 0 0 0 0 0 0 0 0 0 0 0 14.5064 0 13.9237 13.6726 0 13.5908 0 0 0 15.3402 0 0 0 0 0 0 0 0 14.0806 0 0 13.8478 0 0 0 0 0 0 0 0 0 0 0 0 13.4061 0 0 0 0 0 13.3078 0 0 0 0 P15502 ELN_HUMAN Elastin (Tropoelastin) ELN Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; extracellular matrix organization [GO:0030198]; outflow tract morphogenesis [GO:0003151]; regulation of actin filament polymerization [GO:0030833]; regulation of smooth muscle cell proliferation [GO:0048660]; respiratory gaseous exchange by respiratory system [GO:0007585]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149] collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; extracellular matrix organization [GO:0030198]; outflow tract morphogenesis [GO:0003151]; regulation of actin filament polymerization [GO:0030833]; regulation of smooth muscle cell proliferation [GO:0048660]; respiratory gaseous exchange by respiratory system [GO:0007585]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149] GO:0003151; GO:0003180; GO:0005201; GO:0005576; GO:0007519; GO:0007585; GO:0008015; GO:0009887; GO:0030198; GO:0030833; GO:0031012; GO:0043149; GO:0048660; GO:0050840; GO:0062023; GO:0071953 extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201] AGLTAAAPRPGVLLLLLSILHPSR 0.92467 2.0039 0 0 0 0 0 0 10.7447 0 0 0 0 0 10.7749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3234 0 0 0 0 0 0 0 11.8592 0 0 13.5816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6964 0 0 0 0 0 0 0 0 0 0 12.5496 0 0 0 0 0 0 13.3228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VL8 S47A2_HUMAN "Multidrug and toxin extrusion protein 2, MATE-2, hMATE-2 (Kidney-specific H(+)/organic cation antiporter) (Solute carrier family 47 member 2)" SLC47A2 MATE2 Homo sapiens (Human) transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] GO:0005886; GO:0015299; GO:0016020; GO:0016021; GO:0022857; GO:0042910; GO:0055085; GO:1990961 solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910] GSAYANIISQFAQTVFLLLYIVLK 0.92471 2.0035 11.454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4652 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9429 0 0 0 0 0 0 0 0 P19793 RXRA_HUMAN Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) RXRA NR2B1 Homo sapiens (Human) "anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]" chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LBD domain binding [GO:0050693]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; nuclear steroid receptor activity [GO:0003707]; nuclear vitamin D receptor binding [GO:0042809]; peptide binding [GO:0042277]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001972; GO:0002157; GO:0003690; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006357; GO:0008270; GO:0009755; GO:0010875; GO:0016922; GO:0019899; GO:0030154; GO:0030501; GO:0032411; GO:0032526; GO:0035357; GO:0042277; GO:0042789; GO:0042802; GO:0042809; GO:0043235; GO:0043565; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0048856; GO:0050692; GO:0050693; GO:0070564; GO:0090575; GO:1990837 "DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LBD domain binding [GO:0050693]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; nuclear steroid receptor activity [GO:0003707]; nuclear vitamin D receptor binding [GO:0042809]; peptide binding [GO:0042277]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" AIVLFNPDSKGLSNPAEVEALREK 0.92473 5.085 0 0 0 0 0 0 0 0 0 11.1602 0 0 0 0 0 0 0 0 0 0 12.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7144 0 0 0 0 0 0 0 11.1702 0 0 0 0 0 0 0 0 0 0 11.0447 0 0 0 0 0 0 0 0 0 0 10.7023 0 0 0 0 0 0 0 0 0 15.8941 0 11.5214 0 0 0 0 16.4177 15.3739 0 15.8836 0 0 14.7406 14.7757 0 0 12.6633 0 0 0 0 0 15.7976 0 0 0 0 14.2644 0 0 0 0 0 0 10.9378 0 11.3237 0 0 0 0 0 0 0 15.1222 0 14.0484 0 0 13.9208 0 0 0 14.7192 14.6017 0 0 0 0 0 15.1349 0 0 15.0637 15.0228 0 14.3325 0 14.2522 0 0 0 0 0 14.2145 0 0 0 11.592 0 0 0 0 10.1697 0 0 0 0 0 10.5095 11.4888 0 0 0 0 0 0 0 0 14.1948 0 11.9232 0 14.7233 0 Q16647 PTGIS_HUMAN "Prostacyclin synthase, EC 5.3.99.4 (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152) (Prostaglandin I2 synthase)" PTGIS CYP8 CYP8A1 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516] caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]; apoptotic signaling pathway [GO:0097190]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of angiogenesis [GO:0045766]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostaglandin biosynthetic process [GO:0001516]" GO:0001516; GO:0004497; GO:0005506; GO:0005615; GO:0005634; GO:0005783; GO:0005789; GO:0005901; GO:0006690; GO:0008116; GO:0016021; GO:0016705; GO:0019371; GO:0020037; GO:0032088; GO:0034356; GO:0035360; GO:0045019; GO:0045766; GO:0050728; GO:0071347; GO:0071354; GO:0071456; GO:0097190; GO:0106256; GO:1900119 "heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; prostaglandin-I synthase activity [GO:0008116]" AWAALLGLLAALLLLLLLSR 0.92473 2.2993 0 0 0 0 0 0 11.4319 0 0 0 0 0 0 0 0 11.1955 0 0 0 0 0 0 0 13.1764 0 0 0 0 0 0 0 0 0 0 0 0 13.0591 12.2457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9487 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6475 14.6205 0 0 0 0 0 0 0 12.4385 0 0 12.0168 11.5681 0 0 0 0 15.9788 14.2288 0 13.0895 0 0 0 0 0 0 0 0 0 0 13.0078 10.9696 0 0 12.0129 0 0 0 0 0 0 0 0 13.7122 0 0 0 0 0 0 0 0 0 13.2985 0 0 0 13.1636 0 0 12.3352 0 0 13.4324 13.0435 0 12.8782 0 0 0 0 12.7085 0 0 0 0 0 13.3813 10.9365 10.847 0 0 10.2467 0 0 0 11.5862 0 12.8254 10.6062 0 0 0 12.9096 13.5171 0 0 0 12.0207 0 0 0 0 0 0 0 0 0 0 12.5933 0 Q02108 GCYA1_HUMAN "Guanylate cyclase soluble subunit alpha-1, GCS-alpha-1, EC 4.6.1.2 (Guanylate cyclase soluble subunit alpha-3, GCS-alpha-3) (Soluble guanylate cyclase large subunit)" GUCY1A1 GUC1A3 GUCSA3 GUCY1A3 Homo sapiens (Human) "blood circulation [GO:0008015]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; regulation of blood pressure [GO:0008217]; relaxation of vascular associated smooth muscle [GO:0060087]; response to oxygen levels [GO:0070482]; retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission [GO:0098925]" "GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]" "GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; signaling receptor activity [GO:0038023]; blood circulation [GO:0008015]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; regulation of blood pressure [GO:0008217]; relaxation of vascular associated smooth muscle [GO:0060087]; response to oxygen levels [GO:0070482]; retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission [GO:0098925]" GO:0004383; GO:0005525; GO:0006182; GO:0007263; GO:0008015; GO:0008074; GO:0008217; GO:0010750; GO:0019934; GO:0020037; GO:0038023; GO:0060087; GO:0070482; GO:0098925; GO:0098978; GO:0098982 GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; signaling receptor activity [GO:0038023] LNVALQRTLAKHK 0.92475 1.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61812 TGFB2_HUMAN "Transforming growth factor beta-2 proprotein (Cetermin) (Glioblastoma-derived T-cell suppressor factor, G-TSF) [Cleaved into: Latency-associated peptide, LAP; Transforming growth factor beta-2, TGF-beta-2 ]" TGFB2 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell junction organization [GO:0045216]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060] axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126] axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714]; activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell junction organization [GO:0045216]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060] GO:0000902; GO:0001501; GO:0001540; GO:0001654; GO:0001666; GO:0001822; GO:0001837; GO:0001843; GO:0001942; GO:0003007; GO:0003148; GO:0003149; GO:0003179; GO:0003181; GO:0003184; GO:0003203; GO:0003215; GO:0003222; GO:0003274; GO:0003289; GO:0003407; GO:0005102; GO:0005114; GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0005886; GO:0006468; GO:0007179; GO:0007435; GO:0007507; GO:0008083; GO:0008219; GO:0008284; GO:0008285; GO:0008347; GO:0008584; GO:0009410; GO:0009611; GO:0009792; GO:0010002; GO:0010629; GO:0010634; GO:0010693; GO:0010718; GO:0010862; GO:0010936; GO:0014068; GO:0016477; GO:0016525; GO:0030097; GO:0030199; GO:0030307; GO:0030308; GO:0030326; GO:0030424; GO:0030509; GO:0030593; GO:0031069; GO:0031093; GO:0032147; GO:0032570; GO:0032874; GO:0032909; GO:0033630; GO:0034714; GO:0035910; GO:0042060; GO:0042127; GO:0042416; GO:0042476; GO:0042704; GO:0042803; GO:0043025; GO:0043525; GO:0045216; GO:0045726; GO:0045747; GO:0045778; GO:0045787; GO:0045823; GO:0046580; GO:0048103; GO:0048566; GO:0048666; GO:0048699; GO:0048839; GO:0050680; GO:0050714; GO:0050778; GO:0051781; GO:0051794; GO:0051795; GO:0051891; GO:0060038; GO:0060065; GO:0060317; GO:0060389; GO:0060395; GO:0060412; GO:0060413; GO:0061626; GO:0062009; GO:0062023; GO:0097191; GO:0099126; GO:1902256; GO:1902895; GO:1903701; GO:1904888; GO:1905006; GO:1905007 amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714] IELYQILKSKDLTSPTQR 0.92476 2.0024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.87 0 0 0 0 13.79 0 0 0 0 14.0836 0 0 0 0 14.3277 0 0 14.2505 0 0 0 0 0 0 14.1051 14.4006 0 0 0 0 0 0 13.4555 0 0 0 0 0 0 0 14.1474 0 0 0 0 0 0 0 0 0 0 13.4276 0 0 0 13.3143 0 0 0 0 0 0 0 0 12.8717 0 0 0 0 0 0 0 14.0774 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6739 12.8153 0 0 0 0 Q14534 ERG1_HUMAN "Squalene monooxygenase, EC 1.14.14.17 (Squalene epoxidase, SE)" SQLE ERG1 Homo sapiens (Human) cellular aromatic compound metabolic process [GO:0006725]; cholesterol metabolic process [GO:0008203]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to organic substance [GO:0010033]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506]; cellular aromatic compound metabolic process [GO:0006725]; cholesterol metabolic process [GO:0008203]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to organic substance [GO:0010033]; sterol biosynthetic process [GO:0016126] GO:0004506; GO:0005783; GO:0005789; GO:0006725; GO:0008203; GO:0010033; GO:0016021; GO:0016126; GO:0042127; GO:0043231; GO:0071949; GO:0140042 FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506] CRHRNGGLLGR 0.92476 1.1278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1983 0 11.1983 0 11.5093 10.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9452 0 0 0 11.1374 0 0 0 0 0 15.2012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3868 0 12.2872 0 0 0 0 0 0 0 0 0 0 0 0 12.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9861 0 0 0 0 0 0 11.6154 0 0 0 0 0 0 0 0 0 0 12.9806 0 0 0 11.3485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0803 0 0 0 0 0 0 0 0 0 0 Q8NDX5 PHC3_HUMAN "Polyhomeotic-like protein 3 (Early development regulatory protein 3) (Homolog of polyhomeotic 3, hPH3)" PHC3 EDR3 PH3 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0008270; GO:0031519; GO:0035102; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] CEFCGKMGYANEFLRSK 0.92478 2.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL41 PNMA3_HUMAN Paraneoplastic antigen Ma3 PNMA3 MA3 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] nucleolus [GO:0005730] nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; positive regulation of apoptotic process [GO:0043065] GO:0003676; GO:0005730; GO:0008270; GO:0043065 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] KPPGFLALVKLLR 0.92478 1.8803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6498 14.6092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3573 17.2665 0 12.2689 0 0 0 0 11.7613 0 0 0 0 12.9273 0 0 0 0 14.2431 12.739 0 0 0 0 0 0 0 0 12.9166 13.0571 0 0 12.7655 0 0 0 0 13.703 0 0 0 0 0 0 0 0 0 0 11.7796 0 0 0 0 0 0 0 0 0 0 12.9248 0 0 12.0469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZL4 PP12C_HUMAN "Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa, Protein phosphatase 1 myosin-binding subunit p85)" PPP1R12C LENG3 MBS85 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; signal transduction [GO:0007165] GO:0004857; GO:0005737; GO:0005856; GO:0007165; GO:0019208; GO:0019901 enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901] EQLRQWGAR 0.92479 2.2983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4955 0 0 0 0 0 0 0 0 11.1042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0736 0 0 0 0 0 0 12.4438 0 0 0 0 0 0 0 0 0 0 0 11.5286 0 0 0 0 0 13.5738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4634 0 0 0 0 0 P48230 T4S4_HUMAN "Transmembrane 4 L6 family member 4 (Intestine and liver tetraspan membrane protein, IL-TMP)" TM4SF4 ILTMP Homo sapiens (Human) tissue regeneration [GO:0042246] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; tissue regeneration [GO:0042246] GO:0016021; GO:0042246 NNDCCGCCGNEGCGK 0.92481 2.1847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1597 0 0 12.9176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3623 0 0 0 0 0 0 0 0 10.9241 0 0 0 0 0 0 0 0 12.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0978 0 0 0 0 0 0 0 0 0 0 0 14.4762 0 0 0 0 0 14.2816 0 0 0 15.3461 14.5223 13.9495 0 0 0 0 11.9247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5972 0 14.6516 0 13.9597 0 A8MVA2 KRA96_HUMAN Keratin-associated protein 9-6 (Keratin-associated protein 9-like 2) KRTAP9-6 KAP9.6 KRTAP9.6 KRTAP9L2 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTHCCSPGCQPTCCR 0.92482 1.8797 0 0 0 0 0 0 0 0 0 10.4753 0 0 0 11.8933 0 0 0 11.3323 0 0 0 0 0 0 0 0 0 0 14.1329 0 0 0 10.209 0 0 0 10.947 0 0 0 13.5458 13.3042 0 12.3738 13.7144 13.5249 0 0 0 0 0 9.90854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1093 0 0 0 0 0 11.7058 0 11.4902 12.8736 0 13.153 0 13.3865 0 0 0 13.4606 0 0 13.2421 13.8018 0 11.7566 0 0 0 0 0 12.8677 0 0 0 0 12.0453 0 12.6923 11.4943 0 13.9573 13.7869 13.6089 12.4236 0 13.6902 10.3437 0 14.5655 14.1203 13.2445 14.5901 0 13.3102 0 0 12.8761 0 0 13.795 13.1651 12.7937 0 13.3236 0 0 0 11.3886 0 0 12.8724 13.6574 13.0671 0 0 14.0308 13.2273 12.6807 0 12.4278 0 14.0766 0 0 12.0561 12.1972 11.2359 0 0 0 0 0 0 11.0859 0 11.4802 0 0 0 0 0 0 0 0 0 0 11.498 12.0412 0 0 0 0 11.3809 12.2393 0 Q30KQ5 DB115_HUMAN "Beta-defensin 115 (Beta-defensin 15, DEFB-15) (Defensin, beta 115)" DEFB115 DEFB15 Homo sapiens (Human) defense response to bacterium [GO:0042742] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742] GO:0005576; GO:0042742 CGEKHICCVPK 0.92482 1.9764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1486 0 0 0 0 0 0 0 0 0 0 0 12.2378 0 0 0 0 0 0 12.1536 0 0 0 0 11.3119 0 0 0 0 0 0 0 0 0 0 0 13.5348 0 0 0 12.57 0 0 0 12.8793 0 0 0 12.1692 0 0 0 0 0 0 13.4439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8A2 ANR44_HUMAN "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B, PP6-ARS-B, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B (Ankyrin repeat domain-containing protein 44)" ANKRD44 Homo sapiens (Human) GANINAFDKK 0.92483 1.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5035 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1988 0 0 0 0 0 0 0 0 0 0 10.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6684 0 0 0 0 0 0 0 0 0 10.4852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T5B0 LCE3E_HUMAN Late cornified envelope protein 3E (Late envelope protein 17) LCE3E LEP17 Homo sapiens (Human) keratinization [GO:0031424] keratinization [GO:0031424] GO:0031424 GSGQQGGGSGCCHGSGGCC 0.92487 2.2682 0 0 0 0 0 12.0226 0 0 0 0 0 0 10.9807 0 0 0 0 0 0 13.0172 0 0 0 13.0119 0 0 0 0 0 0 0 0 0 0 10.8103 0 0 0 0 0 0 0 12.2641 11.6155 9.96346 0 0 0 12.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0902 0 0 0 13.8383 13.0926 0 0 0 0 15.4395 0 0 0 0 0 0 0 0 0 0 0 10.9166 0 0 0 0 0 0 14.8531 0 13.6242 11.129 12.2121 11.3942 12.5565 0 13.8803 14.4501 14.5261 0 0 0 0 0 15.1662 11.3687 0 0 14.0952 0 0 0 13.9618 0 0 15.5332 14.4975 0 0 14.3445 14.8291 0 0 0 0 0 0 13.6299 13.9376 0 13.8283 0 0 14.0118 0 0 0 13.4684 0 0 0 11.6436 0 0 0 0 0 0 0 0 0 0 0 13.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZS2 KLRF1_HUMAN "Killer cell lectin-like receptor subfamily F member 1, Lectin-like receptor F1 (Activating coreceptor NKp80) (C-type lectin domain family 5 member C)" KLRF1 CLEC5C ML Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; MHC class I receptor activity [GO:0032393]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166] GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0016020; GO:0030246; GO:0032393 carbohydrate binding [GO:0030246]; MHC class I receptor activity [GO:0032393]; transmembrane signaling receptor activity [GO:0004888] CQKGSCSNATQYEDTGDLK 0.92487 2.2292 0 11.7971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.02 0 0 0 0 0 0 0 11.3141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2667 0 0 14.8658 0 0 0 0 0 0 0 0 0 13.461 0 14.6735 0 0 0 12.6819 0 0 0 0 12.8088 0 0 0 0 0 0 0 0 0 12.5043 12.8704 0 0 12.3302 0 13.582 0 0 13.2169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5627 0 0 P25963 IKBA_HUMAN "NF-kappa-B inhibitor alpha (I-kappa-B-alpha, IkB-alpha, IkappaBalpha) (Major histocompatibility complex enhancer-binding protein MAD3)" NFKBIA IKBA MAD3 NFKBI Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; cytoplasmic sequestering of transcription factor [GO:0042994]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of DNA binding [GO:0043392]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; regulation of cell population proliferation [GO:0042127]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; I-kappaB/NF-kappaB complex [GO:0033256]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; I-kappaB/NF-kappaB complex [GO:0033256]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; nuclear localization sequence binding [GO:0008139]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; cytoplasmic sequestering of transcription factor [GO:0042994]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of DNA binding [GO:0043392]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; regulation of cell population proliferation [GO:0042127]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006915; GO:0007219; GO:0007249; GO:0007253; GO:0008139; GO:0010745; GO:0010875; GO:0010888; GO:0019899; GO:0031625; GO:0031663; GO:0032088; GO:0032495; GO:0033209; GO:0033256; GO:0034142; GO:0035994; GO:0042127; GO:0042802; GO:0042994; GO:0043330; GO:0043392; GO:0045638; GO:0045746; GO:0045944; GO:0050729; GO:0051059; GO:0051247; GO:0070417; GO:0070427; GO:0070431; GO:0071356; GO:1901222 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; nuclear localization sequence binding [GO:0008139]; ubiquitin protein ligase binding [GO:0031625] ALTMEVIRQVK 0.92488 1.1269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9106 10.6721 0 0 0 0 0 10.8191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2664 0 0 0 0 13.6065 0 0 0 0 13.6551 0 0 0 0 14.2186 12.8366 0 0 0 0 0 0 14.1827 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2755 0 0 0 0 0 14.1525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYH8 IKBZ_HUMAN "NF-kappa-B inhibitor zeta (I-kappa-B-zeta, IkB-zeta, IkappaBzeta) (IL-1 inducible nuclear ankyrin-repeat protein, INAP) (Molecule possessing ankyrin repeats induced by lipopolysaccharide, MAIL)" NFKBIZ IKBZ INAP MAIL Homo sapiens (Human) inflammatory response [GO:0006954]; positive regulation of inflammatory response [GO:0050729]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; inflammatory response [GO:0006954]; positive regulation of inflammatory response [GO:0050729]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852] GO:0005634; GO:0006954; GO:0010468; GO:0016607; GO:0036464; GO:0050729; GO:0050852; GO:2000321 ALSYVLARKMNALHMLDIK 0.9249 2.3334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5525 0 0 0 12.8493 0 0 0 0 0 0 0 0 0 0 0 0 12.5509 12.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYG5 APC11_HUMAN "Anaphase-promoting complex subunit 11, APC11 (Cyclosome subunit 11) (Hepatocellular carcinoma-associated RING finger protein)" ANAPC11 HSPC214 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; ubiquitin-dependent protein catabolic process [GO:0006511] anaphase-promoting complex [GO:0005680]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex [GO:0005680]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000278; GO:0005634; GO:0005654; GO:0005680; GO:0005730; GO:0005829; GO:0006511; GO:0007346; GO:0008270; GO:0016567; GO:0031145; GO:0031461; GO:0034450; GO:0045842; GO:0051301; GO:0051445; GO:0061630; GO:0070979; GO:0097602 cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] MAFNGCCPDCK 0.9249 1.8792 0 0 0 0 12.8685 0 0 0 0 0 0 0 0 0 12.388 0 0 0 14.5353 0 0 0 0 13.7161 14.3898 0 0 0 13.6528 0 0 15.1869 0 14.8573 0 0 0 0 0 0 13.9622 0 0 16.7249 0 0 13.9322 14.2418 0 0 0 0 0 0 0 0 13.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7155 0 10.7711 0 0 0 0 0 0 0 0 0 12.1756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8473 0 13.973 0 0 0 0 12.0382 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1359 0 0 0 0 0 0 0 12.2951 0 0 0 0 0 0 0 0 12.0883 0 0 0 0 0 0 11.2921 0 0 0 0 0 0 0 0 15.4575 0 12.8204 0 14.0999 0 0 0 0 16.4515 11.0922 0 16.1484 0 0 0 0 0 0 11.7668 0 0 A6NLJ0 C2C4B_HUMAN C2 calcium-dependent domain-containing protein 4B (Nuclear-localized factor 2) (Protein FAM148B) C2CD4B FAM148B NLF2 Homo sapiens (Human) positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528] nucleus [GO:0005634] nucleus [GO:0005634]; positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528] GO:0002528; GO:0002675; GO:0005634; GO:0030155 AVRCRLSLVLR 0.92491 1.912 0 0 0 0 0 0 0 0 0 0 12.5993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9222 0 0 0 0 12.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3067 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JU69 TOR2A_HUMAN Torsin-2A (Torsin family 2 member A) (Torsin-related protein 1) TOR2A TORP1 UNQ6408/PRO21181 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085] endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635] endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; chaperone cofactor-dependent protein refolding [GO:0051085] GO:0005524; GO:0005635; GO:0005788; GO:0016887; GO:0042802; GO:0051085 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] LLDAVVPFLPLQR 0.92492 2.0259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27701 CD82_HUMAN "CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27, Tspan-27) (CD antigen CD82)" CD82 KAI1 SAR2 ST6 TSPAN27 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] GO:0005886; GO:0005887; GO:0070062 CLLGLYFAFLLLILIAQVTAGALFYFNMGKLK 0.92497 1.9869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5194 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1821 0 0 0 0 15.4728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4128 0 0 11.1716 0 0 0 0 0 12.1726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8871 0 0 0 0 0 0 13.3795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY64 UDB28_HUMAN "UDP-glucuronosyltransferase 2B28, UDPGT 2B28, UGT2B28, EC 2.4.1.17" UGT2B28 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear outer membrane [GO:0005640]; perinuclear region of cytoplasm [GO:0048471]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697] GO:0005640; GO:0005783; GO:0005789; GO:0008202; GO:0008210; GO:0015020; GO:0016021; GO:0048471; GO:0052695; GO:0052697 glucuronosyltransferase activity [GO:0015020] AKGAAVR 0.92498 1.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.42 0 17.4057 0 17.2966 0 0 0 16.5349 0 0 0 0 14.6997 16.4889 16.5483 0 0 15.7221 0 16.9434 0 16.6802 0 0 18.105 0 0 0 0 17.3016 0 17.9623 17.8909 17.9011 0 0 0 0 0 0 0 0 0 17.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0884 13.4226 0 0 0 13.5254 0 14.2519 0 0 13.487 0 13.5227 13.4679 0 17.6382 0 0 0 0 0 0 0 Q9H3N1 TMX1_HUMAN Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein) TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 Homo sapiens (Human) response to endoplasmic reticulum stress [GO:0034976] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; response to endoplasmic reticulum stress [GO:0034976] GO:0005789; GO:0012505; GO:0015036; GO:0016021; GO:0034976 disulfide oxidoreductase activity [GO:0015036] EGTNKDFPQNAIRQR 0.925 1.911 0 0 0 12.8794 0 0 0 0 0 0 0 0 0 0 0 14.3403 13.582 0 0 0 0 0 14.0944 0 0 13.7995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6381 14.1881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5431 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14210 LY6D_HUMAN "Lymphocyte antigen 6D, Ly-6D (E48 antigen)" LY6D E48 Homo sapiens (Human) cell adhesion [GO:0007155]; lymphocyte differentiation [GO:0030098]; response to stilbenoid [GO:0035634] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; lymphocyte differentiation [GO:0030098]; response to stilbenoid [GO:0035634] GO:0005576; GO:0005886; GO:0007155; GO:0009986; GO:0016020; GO:0030098; GO:0031225; GO:0035634 KDCAESCTPSYTLQGQVSSGTSSTQCCQEDLCNEK 0.92504 2.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5982 0 0 12.2741 0 0 0 0 0 0 0 0 0 0 0 12.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1558 0 0 0 0 0 0 13.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NVV7 CDPF1_HUMAN Cysteine-rich DPF motif domain-containing protein 1 CDPF1 C22orf40 Homo sapiens (Human) DPFTSDKDRFLVLGSCCSLCSR 0.92504 2.2655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7262 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RK4 BBS4_HUMAN Bardet-Biedl syndrome 4 protein BBS4 Homo sapiens (Human) adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601] GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010467; GO:0010629; GO:0015031; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034260; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:1902855; GO:1903546; GO:1905515 alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] NALAQYQEMEKKVSLLK 0.92504 2.1936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9476 13.6514 0 0 14.4849 14.6304 0 0 0 0 0 14.0861 0 0 0 0 0 0 0 13.5292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.243 0 13.4213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPF8 ADAP2_HUMAN "Arf-GAP with dual PH domain-containing protein 2 (Centaurin-alpha-2, Cnt-a2)" ADAP2 CENTA2 Homo sapiens (Human) heart development [GO:0007507]; inositol lipid-mediated signaling [GO:0048017]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial envelope [GO:0005740]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial envelope [GO:0005740]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-macromolecule adaptor activity [GO:0030674]; heart development [GO:0007507]; inositol lipid-mediated signaling [GO:0048017]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]" GO:0005096; GO:0005546; GO:0005547; GO:0005737; GO:0005740; GO:0005886; GO:0007507; GO:0030674; GO:0043087; GO:0043231; GO:0043325; GO:0043533; GO:0043547; GO:0046872; GO:0048017 "GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-macromolecule adaptor activity [GO:0030674]" DGHTRNLFVYHESGKEIVDWFNALR 0.92505 1.6269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54802 ANAG_HUMAN "Alpha-N-acetylglucosaminidase, EC 3.2.1.50 (N-acetyl-alpha-glucosaminidase, NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form ]" NAGLU UFHSD1 Homo sapiens (Human) cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548] GO:0004561; GO:0005764; GO:0006027; GO:0007040; GO:0007399; GO:0021680; GO:0042474; GO:0043202; GO:0045475; GO:0046548; GO:0060119; GO:0070062 alpha-N-acetylglucosaminidase activity [GO:0004561] ALAAKPGLDTYSLGGGGAAR 0.92509 1.9714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6966 0 0 14.9185 0 0 0 0 13.0461 13.5445 11.7588 12.0347 12.1303 12.4268 12.3167 0 0 0 0 0 0 11.0647 0 11.1337 0 0 0 0 0 0 0 0 0 0 0 0 13.0836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3165 0 0 0 0 0 0 0 0 0 0 0 0 13.3607 0 0 0 0 11.3335 0 0 0 0 0 0 0 0 0 0 11.7904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H009 NACA2_HUMAN "Nascent polypeptide-associated complex subunit alpha-2 (Alpha-NAC-like) (Hom s 2.01) (Nascent polypeptide-associated complex subunit alpha-like, NAC-alpha-like)" NACA2 NACAL Homo sapiens (Human) protein targeting to membrane [GO:0006612] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; unfolded protein binding [GO:0051082]; protein targeting to membrane [GO:0006612] GO:0005634; GO:0005737; GO:0005854; GO:0006612; GO:0051082 unfolded protein binding [GO:0051082] AKQSRSEK 0.92512 1.9938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7063 0 11.1304 0 10.2937 0 10.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPC5 GPR34_HUMAN Probable G-protein coupled receptor 34 GPR34 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005887; GO:0007186; GO:0045028 G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930] LLSTVLTTSYSVIFIVGLVGNIIALYVFLGIHRKR 0.92513 2.2536 0 0 0 0 0 0 0 0 0 0 0 0 12.3349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2443 0 0 0 13.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0727 11.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2377 0 0 0 0 0 0 0 0 0 12.6858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXC1 GP174_HUMAN Probable G-protein coupled receptor 174 GPR174 FKSG79 GPCR17 Homo sapiens (Human) positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; T cell homeostasis [GO:0043029] centriolar satellite [GO:0034451]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] centriolar satellite [GO:0034451]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; bioactive lipid receptor activity [GO:0045125]; G protein-coupled receptor activity [GO:0004930]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; T cell homeostasis [GO:0043029] GO:0004930; GO:0005886; GO:0005887; GO:0034451; GO:0035025; GO:0043029; GO:0043231; GO:0045125; GO:0051482 bioactive lipid receptor activity [GO:0045125]; G protein-coupled receptor activity [GO:0004930] AVIFMINLAIADLLQVLSLPLR 0.92515 2.3053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4109 0 0 0 0 0 0 0 0 12.8943 12.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6306 0 0 0 0 0 0 0 0 0 0 0 12.4705 0 0 0 0 0 0 0 0 0 0 0 0 12.6227 0 11.8419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8723 11.7495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31997 CEAM8_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b) CEACAM8 CGM6 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955] anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; protein heterodimerization activity [GO:0046982]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955] GO:0005615; GO:0005886; GO:0006955; GO:0007157; GO:0009986; GO:0031225; GO:0035577; GO:0035579; GO:0046982; GO:0070062; GO:0070821 protein heterodimerization activity [GO:0046982] ATVSIMIGVLARVALI 0.92522 1.1421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2C8 O51V1_HUMAN Olfactory receptor 51V1 (Odorant receptor HOR3'beta1) (Olfactory receptor 51A12) (Olfactory receptor OR11-36) OR51V1 OR51A12 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IGLTIIGRSFFFITPPIICLK 0.92524 1.1418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04628 WNT1_HUMAN Proto-oncogene Wnt-1 (Proto-oncogene Int-1 homolog) WNT1 INT1 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; fat cell differentiation [GO:0045444]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cellular senescence [GO:2000773]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; fat cell differentiation [GO:0045444]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cellular senescence [GO:2000773]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" GO:0000578; GO:0001658; GO:0001934; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0007267; GO:0007520; GO:0008284; GO:0009611; GO:0009986; GO:0010592; GO:0010812; GO:0016015; GO:0019904; GO:0021527; GO:0021536; GO:0021551; GO:0021588; GO:0021797; GO:0022004; GO:0022408; GO:0030182; GO:0030512; GO:0030514; GO:0030579; GO:0030666; GO:0030901; GO:0031100; GO:0033077; GO:0033278; GO:0036520; GO:0042472; GO:0042770; GO:0043066; GO:0043568; GO:0045165; GO:0045444; GO:0045599; GO:0045747; GO:0045893; GO:0045944; GO:0048018; GO:0048146; GO:0048664; GO:0051091; GO:0060061; GO:0060070; GO:0060348; GO:0061184; GO:0070062; GO:0070365; GO:0071375; GO:0071425; GO:1902035; GO:1903204; GO:1904953; GO:1904954; GO:1990403; GO:2000059; GO:2000773 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018] ACNSSSPALDGCELLCCGRGHRTR 0.92525 2.1905 0 0 0 0 0 0 0 11.6941 0 12.2568 12.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4663 11.6177 0 0 0 0 0 0 0 11.0958 0 12.9791 0 0 0 12.0036 10.2732 0 0 11.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3334 0 0 0 0 0 17.6722 0 0 0 11.4662 17.4905 17.5116 0 17.6198 17.6126 12.1972 17.4626 0 10.4266 0 0 0 0 0 0 0 0 0 0 12.2801 0 0 0 11.4783 0 12.2098 0 0 17.5758 13.2584 11.3735 11.2454 0 0 0 0 0 12.9449 13.7419 0 0 11.1953 12.4738 12.6731 0 0 18.0953 0 0 0 0 0 0 0 13.1474 0 17.5329 0 0 0 11.5741 0 0 0 11.226 0 13.6136 0 0 18.0383 0 11.5401 0 0 0 0 11.0653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3826 0 0 0 0 0 0 G5E9R7 KR416_HUMAN Putative keratin-associated protein 4-16 (Keratin-associated protein 4 pseudogene 1) (Keratin-associated protein 4-16 pseudogene) KRTAP4-16 KRTAP4-16P KRTAP4P1 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 CSSKMPCSPSASSLCAASPPNCCHPSCCQTTCCR 0.92526 2.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9732 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2833 0 0 0 0 0 0 0 0 0 0 0 10.4048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.304 0 13.2763 0 0 0 11.6197 10.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0836 0 0 0 0 0 12.902 0 13.0982 0 0 0 0 0 10.8415 0 0 0 0 0 0 0 0 0 0 0 11.9187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0079 0 0 0 0 0 0 0 0 0 0 0 12.7776 0 0 0 10.8907 Q06413 MEF2C_HUMAN Myocyte-specific enhancer factor 2C (Myocyte enhancer factor 2C) MEF2C Homo sapiens (Human) "apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; excitatory postsynaptic potential [GO:0060079]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; myotube differentiation [GO:0014902]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary heart field specification [GO:0003138]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine development [GO:0060998]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of neuron apoptotic process [GO:0043523]; regulation of neurotransmitter secretion [GO:0046928]; regulation of NMDA receptor activity [GO:2000310]; regulation of synapse assembly [GO:0051963]; regulation of synaptic activity [GO:0060025]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal tubule morphogenesis [GO:0061333]; response to ischemia [GO:0002931]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; excitatory postsynaptic potential [GO:0060079]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; myotube differentiation [GO:0014902]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; nephron tubule epithelial cell differentiation [GO:0072160]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primary heart field specification [GO:0003138]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine development [GO:0060998]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of neuron apoptotic process [GO:0043523]; regulation of neurotransmitter secretion [GO:0046928]; regulation of NMDA receptor activity [GO:2000310]; regulation of synapse assembly [GO:0051963]; regulation of synaptic activity [GO:0060025]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal tubule morphogenesis [GO:0061333]; response to ischemia [GO:0002931]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012]" GO:0000122; GO:0000165; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001764; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0002931; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003680; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006915; GO:0006959; GO:0007399; GO:0007507; GO:0007517; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0010694; GO:0014033; GO:0014902; GO:0016528; GO:0016607; GO:0030154; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035984; GO:0042100; GO:0042826; GO:0043231; GO:0043406; GO:0043523; GO:0043524; GO:0043537; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046928; GO:0046982; GO:0048167; GO:0048643; GO:0048666; GO:0048667; GO:0050853; GO:0051145; GO:0051963; GO:0051966; GO:0055012; GO:0060025; GO:0060045; GO:0060079; GO:0060998; GO:0061333; GO:0061629; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:0098794; GO:0140297; GO:1904706; GO:1904753; GO:1905563; GO:1990837; GO:2000111; GO:2000310; GO:2000311; GO:2000727; GO:2000987; GO:2001013; GO:2001016 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GLNGCDSPDPDADDSVGHSPESEDK 0.92526 1.1259 0 0 0 0 0 11.8846 0 0 0 0 0 0 0 0 0 0 0 11.1476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3662 0 0 0 0 0 0 0 0 0 0 0 0 12.7363 0 0 0 0 0 0 0 0 Q86Y30 BAGE2_HUMAN "B melanoma antigen 2 (Cancer/testis antigen 2.2, CT2.2)" BAGE2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 ISVTSSCFVQNTLTKLLK 0.92527 1.1412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR97 TLR8_HUMAN Toll-like receptor 8 (CD antigen CD288) TLR8 UNQ249/PRO286 Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-12 production [GO:0032695]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; regulation of protein phosphorylation [GO:0001932]; response to virus [GO:0009615]; toll-like receptor 8 signaling pathway [GO:0034158]; toll-like receptor signaling pathway [GO:0002224] endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-12 production [GO:0032695]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; regulation of protein phosphorylation [GO:0001932]; response to virus [GO:0009615]; toll-like receptor 8 signaling pathway [GO:0034158]; toll-like receptor signaling pathway [GO:0002224] GO:0000139; GO:0001932; GO:0002224; GO:0002755; GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0004888; GO:0005789; GO:0005886; GO:0006954; GO:0007249; GO:0009615; GO:0009897; GO:0010008; GO:0016021; GO:0016064; GO:0032695; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0034158; GO:0036020; GO:0038023; GO:0038187; GO:0042802; GO:0045087; GO:0045089; GO:0051607; GO:0071260 DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transmembrane signaling receptor activity [GO:0004888] DASVTDWVINELRYHLEESRDK 0.92527 2.2335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2036 15.3306 0 0 12.1006 0 0 0 0 15.8355 13.8639 0 13.6688 15.6471 0 0 0 14.3906 0 0 14.1056 13.3599 0 14.3049 0 0 0 0 0 0 0 0 0 0 14.769 0 0 0 13.7775 0 0 14.8816 0 0 0 0 0 0 0 0 0 0 10.594 11.5459 0 12.9152 0 0 15.2237 15.8438 14.8893 0 14.7818 14.4718 0 0 0 14.7482 0 14.0092 0 15.2615 0 0 0 10.2373 0 0 0 0 0 0 15.4553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9A8 NEPR1_HUMAN "Nuclear envelope phosphatase-regulatory subunit 1, NEP1-R1 (Transmembrane protein 188)" CNEP1R1 C16orf69 TMEM188 Homo sapiens (Human) lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504] GO:0005635; GO:0005737; GO:0005829; GO:0006629; GO:0010867; GO:0016021; GO:0031965; GO:0034504; GO:0035307; GO:0071595 CRTVLAEYNMSCDDTGK 0.92529 1.1257 0 10.5802 0 0 0 0 0 0 0 0 0 0 0 13.411 0 0 0 0 0 0 11.5088 0 0 0 12.2051 0 0 0 0 0 0 0 12.2792 0 12.4549 0 0 0 0 0 0 0 0 11.8355 0 0 0 0 0 0 0 0 0 12.0065 0 10.4993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7533 11.4704 0 0 0 0 0 0 0 0 0 14.4151 14.7195 0 0 0 0 0 0 0 0 15.0429 0 0 0 0 0 13.572 0 0 13.9762 0 0 14.6511 0 13.9253 0 0 9.55505 12.5861 13.029 0 0 14.1046 0 0 0 0 0 0 0 0 0 0 15.0574 0 0 13.176 0 10.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1086 0 0 0 0 0 0 0 0 0 13.5684 14.8146 14.6594 0 0 11.3683 0 14.4523 0 0 0 0 0 0 0 12.8438 0 0 0 0 0 0 0 Q96RD1 OR6C1_HUMAN Olfactory receptor 6C1 (OST267) OR6C1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GVAILNTSVAPMMNPFIYSLRNQQVKQAFINMAR 0.92529 1.1403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1U1 ARP3B_HUMAN Actin-related protein 3B (ARP3-beta) (Actin-like protein 3B) (Actin-related protein ARP4) ACTR3B ARP11 ARP4 Homo sapiens (Human) cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; actin binding [GO:0003779]; ATP binding [GO:0005524] GO:0003779; GO:0005524; GO:0005737; GO:0005856; GO:0042995; GO:0070062 actin binding [GO:0003779]; ATP binding [GO:0005524] DYEEYGPSICR 0.92529 1.8812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2892 0 0 0 0 0 13.7513 0 0 0 0 0 0 14.1133 0 0 0 0 0 0 0 0 12.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9293 0 0 0 0 11.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0622 0 10.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75354 ENTP6_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 6, NTPDase 6, EC 3.6.1.6 (CD39 antigen-like 2)" ENTPD6 CD39L2 IL6ST2 Homo sapiens (Human) nucleoside diphosphate catabolic process [GO:0009134]; response to calcium ion [GO:0051592]; response to magnesium ion [GO:0032026] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytidine-diphosphatase activity [GO:0036384]; guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [GO:0008894]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; nucleoside diphosphate catabolic process [GO:0009134]; response to calcium ion [GO:0051592]; response to magnesium ion [GO:0032026]" GO:0000139; GO:0004382; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0008894; GO:0009134; GO:0009986; GO:0016020; GO:0016021; GO:0017110; GO:0017111; GO:0032026; GO:0036384; GO:0045134; GO:0051592; GO:1990003 "cytidine-diphosphatase activity [GO:0036384]; guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [GO:0008894]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]" ATPLVLKATAGLRLLPGEK 0.92531 2.1675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.535 0 0 0 0 0 11.4274 0 0 0 0 0 0 0 0 0 0 0 12.4451 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17948 VGFR1_HUMAN "Vascular endothelial growth factor receptor 1, VEGFR-1, EC 2.7.10.1 (Fms-like tyrosine kinase 1, FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT, FLT) (Vascular permeability factor receptor)" FLT1 FLT FRT VEGFR1 Homo sapiens (Human) angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323] actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; endosome [GO:0005768]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; cell migration [GO:0016477]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaloid vascular plexus regression [GO:1990384]; monocyte chemotaxis [GO:0002548]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323] GO:0001525; GO:0002244; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005768; GO:0005886; GO:0005887; GO:0005925; GO:0007169; GO:0008284; GO:0010863; GO:0014068; GO:0015629; GO:0016477; GO:0018108; GO:0019838; GO:0030335; GO:0033674; GO:0035924; GO:0036323; GO:0036332; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048598; GO:1905563; GO:1990384 ATP binding [GO:0005524]; growth factor binding [GO:0019838]; placental growth factor receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021] AFITVKHR 0.92531 1.6398 0 0 0 0 0 0 11.0053 0 0 0 12.8577 0 0 0 12.7077 0 12.9729 0 0 12.5869 13.0485 13.2263 12.365 12.8122 0 0 12.2393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7496 0 0 0 13.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3211 0 0 0 0 0 0 11.5087 0 0 0 0 0 0 0 0 0 0 0 0 12.1702 14.3503 11.9747 13.3006 0 13.3451 0 0 0 12.0081 13.5844 13.5516 12.6732 0 13.2656 14.7526 14.9018 13.333 15.6605 0 0 0 0 14.3671 0 0 0 17.6017 0 0 0 0 0 0 0 0 0 15.0936 0 14.2455 0 0 0 0 14.7612 0 0 0 14.5028 14.3931 0 11.6597 13.569 13.4831 0 0 0 14.0009 0 13.4733 16.4784 0 0 14.3794 13.4073 0 0 0 0 0 0 0 0 13.8829 14.3476 13.2389 15.6729 11.5448 13.996 0 0 0 0 14.5198 13.735 14.5492 0 15.3823 16.1597 15.7954 13.4694 0 0 15.343 14.245 0 14.7984 11.9247 0 Q8IUB3 WF10B_HUMAN Protein WFDC10B WFDC10B WAP12 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] GO:0004867; GO:0005615; GO:0019731; GO:0045087 serine-type endopeptidase inhibitor activity [GO:0004867] ICCSAFCGNICMSIL 0.92531 1.1253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75096 LRP4_HUMAN "Low-density lipoprotein receptor-related protein 4, LRP-4 (Multiple epidermal growth factor-like domains 7)" LRP4 KIAA0816 LRP10 MEGF7 Homo sapiens (Human) amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055] GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0016021; GO:0016055; GO:0030279; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0044853; GO:0048699; GO:0048813; GO:0050731; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150094; GO:1901631; GO:1904395 apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] CDGDADCDDQSDER 0.92533 2.2334 0 12.4085 0 12.4286 0 11.9841 0 0 0 10.9993 0 0 0 0 10.1814 0 0 0 0 11.4045 0 0 10.6798 0 0 11.7116 12.9774 10.6232 0 11.4646 10.9342 13.1553 11.1515 0 13.4731 0 0 10.1401 0 0 0 0 0 0 10.9147 12.8277 0 0 0 0 11.4839 0 0 0 0 12.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3185 10.7528 0 0 15.6199 16.2018 15.686 12.1399 0 14.3259 15.8481 16.2286 15.5309 17.039 15.33 16.2829 15.0045 15.3013 15.8089 0 15.4258 17.1946 15.6434 14.5423 12.8982 14.0309 13.4393 10.5716 10.8392 0 0 16.1167 15.2069 0 11.3401 0 14.8376 15.1549 13.8905 16.1675 14.0593 13.5097 15.0697 11.0902 12.7655 15.1959 15.4236 0 12.1699 15.8836 15.9523 14.9072 0 12.4862 10.772 0 0 0 11.3549 13.9723 12.8649 11.7385 10.9482 14.4083 13.4396 15.4957 11.5011 14.9825 13.6422 0 0 11.2134 0 11.5378 13.3069 0 0 0 0 0 13.6341 15.6309 10.9279 0 11.719 14.8859 13.9649 12.9511 12.9499 11.4824 11.1048 0 11.3458 12.9565 11.8294 0 0 14.3149 15.3074 12.5262 12.921 11.9379 13.9358 15.8435 12.9005 0 11.2068 A6NH57 ARL5C_HUMAN Putative ADP-ribosylation factor-like protein 5C (ADP-ribosylation factor-like protein 12) ARL5C ARL12 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] trans-Golgi network [GO:0005802] trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0016192; GO:1903292 GTP binding [GO:0005525]; GTPase activity [GO:0003924] DRLLTTREELYK 0.92534 2.3434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.613 0 0 0 0 0 0 0 0 9.71425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7065 0 0 0 14.2226 0 0 16.1159 0 0 0 0 0 0 0 0 10.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86638 0 0 0 10.5402 0 10.8888 0 0 0 0 0 0 0 0 0 0 0 16.054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14558 KPRA_HUMAN "Phosphoribosyl pyrophosphate synthase-associated protein 1, PRPP synthase-associated protein 1 (39 kDa phosphoribosypyrophosphate synthase-associated protein, PAP39)" PRPSAP1 Homo sapiens (Human) 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164] GO:0000287; GO:0002189; GO:0004749; GO:0004857; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0042802 enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749] ASPFLLQYIQEEIPNYR 0.92534 1.6592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6596 0 0 0 14.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4213 0 0 16.5356 16.4233 0 0 0 0 0 16.2276 0 0 0 0 0 0 0 0 0 0 0 16.5457 0 0 0 0 16.3578 0 16.4666 0 0 16.4531 0 0 15.0359 0 0 0 0 0 0 0 0 0 12.255 0 0 0 0 0 16.6213 0 0 0 16.7192 0 15.6839 16.474 0 14.5745 0 15.8318 0 0 0 0 0 0 0 0 0 0 9.77137 0 0 0 0 0 0 0 0 0 0 0 16.6221 15.192 16.7507 0 0 0 0 0 0 Q96CX3 ZN501_HUMAN Zinc finger protein 501 (Zinc finger protein 52) ZNF501 ZNF52 Homo sapiens (Human) Golgi organization [GO:0007030]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; Golgi organization [GO:0007030]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0046872; GO:1990837 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] AFSQSICLTRHQRSHSGDK 0.92534 2.2738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4004 0 0 0 0 0 0 0 0 0 11.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1642 12.7607 0 0 0 11.3 0 0 0 0 0 0 0 0 12.4831 0 0 0 0 13.4046 11.9948 0 0 0 0 0 0 0 0 14.0615 13.9326 13.866 14.2956 0 0 0 0 0 0 0 0 0 0 0 11.5426 0 0 0 0 0 13.8026 0 14.1323 0 0 14.3465 0 14.6994 14.1708 11.8187 0 0 0 0 0 0 0 14.5881 0 0 0 0 0 0 14.1822 0 14.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4265 0 12.2977 0 0 0 0 0 Q9NRK6 ABCBA_HUMAN "ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein, ABC-me protein) (ATP-binding cassette transporter 10, ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2, M-ABC2)" ABCB10 Homo sapiens (Human) erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985] integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985] GO:0005524; GO:0005739; GO:0005743; GO:0006783; GO:0006839; GO:0016887; GO:0032592; GO:0034514; GO:0042803; GO:0045648; GO:0046985; GO:0048821; GO:0070455; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803] FPGGPAAAAWAGDEAWR 0.92535 1.989 0 0 0 0 12.7515 0 0 12.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0688 0 0 0 12.3481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1094 0 0 12.3736 12.2457 0 0 10.9212 14.1745 14.2968 0 0 17.527 0 0 15.5383 0 0 0 0 0 12.6353 0 0 0 0 0 17.3014 0 0 0 0 0 0 0 0 0 17.3076 0 0 17.2677 0 0 0 0 0 0 0 17.3079 0 0 0 18.7128 0 0 0 0 0 13.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0978 0 18.1007 0 0 0 0 0 18.6394 0 0 0 0 0 0 0 11.0119 0 0 0 0 0 0 0 0 0 12.9186 0 0 0 0 0 0 0 0 0 0 A8MZ59 LEUTX_HUMAN "Paired-like homeodomain transcription factor LEUTX (Leucine-twenty homeobox) (Paired-like homeobox transcription factor LEUTX, PRD-LIKE homeobox transcription factor LEUTX)" LEUTX Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" PSLGPANQTTSVKK 0.92537 2.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3964 0 0 0 0 O60934 NBN_HUMAN Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1) NBN NBS NBS1 P95 Homo sapiens (Human) "blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated DNA replication initiation [GO:0030174]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485]; blastocyst growth [GO:0001832]; cell population proliferation [GO:0008283]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; neuromuscular process controlling balance [GO:0050885]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated DNA replication initiation [GO:0030174]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]" GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001832; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005730; GO:0005829; GO:0006302; GO:0007095; GO:0008283; GO:0016605; GO:0030174; GO:0030330; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042405; GO:0044818; GO:0045190; GO:0047485; GO:0050885; GO:0051321; GO:0051726; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0098687; GO:0110025; GO:0140297; GO:1904354 damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485] DEENQEMSSCK 0.92537 1.9768 0 0 0 0 11.3666 0 0 0 0 0 0 12.4005 12.2954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4239 0 11.7793 0 0 0 0 0 12.7334 0 0 0 0 0 0 0 0 0 0 13.4315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0765 13.9395 0 0 0 0 13.3022 0 0 0 0 0 13.665 11.1558 0 0 0 0 0 13.9132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7982 15.0945 0 0 0 14.6269 0 0 0 0 0 14.6862 0 0 11.3838 0 12.2554 13.0559 14.2127 13.9099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3254 0 0 0 0 0 Q96DC7 TMCO6_HUMAN Transmembrane and coiled-coil domain-containing protein 6 TMCO6 PRO1580 Homo sapiens (Human) protein import into nucleus [GO:0006606] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; nuclear import signal receptor activity [GO:0061608]; protein import into nucleus [GO:0006606] GO:0006606; GO:0016021; GO:0061608 nuclear import signal receptor activity [GO:0061608] EQQLVSKRLLR 0.92537 1.1394 14.7289 13.4269 13.8134 0 0 0 15.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2963 13.9662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6513 0 0 0 0 0 11.9839 0 0 0 0 0 14.032 0 0 13.4074 0 0 0 0 0 0 13.6276 17.0318 11.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90046 0 0 0 13.2715 0 Q5JVL4 EFHC1_HUMAN EF-hand domain-containing protein 1 (Myoclonin-1) EFHC1 Homo sapiens (Human) cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302] GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005879; GO:0005930; GO:0007052; GO:0008022; GO:0021795; GO:0043014; GO:0043025; GO:0051302; GO:0060285; GO:0072686 alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022] DNIREAFQIYDK 0.92538 2.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0066 12.685 0 0 13.0387 0 0 0 0 14.3856 0 12.7731 0 0 0 0 0 0 0 0 Q9Y663 HS3SA_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 3A1, EC 2.8.2.30 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1, 3-OST-3A, Heparan sulfate 3-O-sulfotransferase 3A1, h3-OST-3A)" HS3ST3A1 3OST3A1 HS3ST3A UNQ2551/PRO6180 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; glycosaminoglycan biosynthetic process [GO:0006024] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; sulfotransferase activity [GO:0008146]; branching involved in ureteric bud morphogenesis [GO:0001658]; glycosaminoglycan biosynthetic process [GO:0006024] GO:0000139; GO:0001658; GO:0006024; GO:0008146; GO:0008467; GO:0016021; GO:0033872 [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [GO:0033872]; sulfotransferase activity [GO:0008146] ALLEFLR 0.92538 2.3011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6111 0 0 0 0 0 0 0 0 0 0 0 10.6903 0 0 0 0 0 11.619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0508 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0358 0 0 0 14.8669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5908 0 Q99704 DOK1_HUMAN Docking protein 1 (Downstream of tyrosine kinase 1) (p62(dok)) (pp62) DOK1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell surface receptor signaling pathway [GO:0007166]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007166; GO:0007169; GO:0007265; GO:0038145; GO:0048471 ADSHEGEVAEGK 0.9254 1.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4022 0 0 0 0 0 0 0 0 0 0 Q9GZP0 PDGFD_HUMAN "Platelet-derived growth factor D, PDGF-D (Iris-expressed growth factor) (Spinal cord-derived growth factor B, SCDGF-B) [Cleaved into: Platelet-derived growth factor D, latent form, PDGFD latent form; Platelet-derived growth factor D, receptor-binding form, PDGFD receptor-binding form ]" PDGFD IEGF SCDGFB MSTP036 UNQ1899/PRO4345 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] GO:0000139; GO:0005161; GO:0005576; GO:0005615; GO:0005788; GO:0008083; GO:0008284; GO:0014068; GO:0030335; GO:0031954; GO:0036120; GO:0043406; GO:0048008; GO:0048146; GO:0048661; GO:0050730; GO:0051781; GO:0070301; GO:0070374; GO:0070851; GO:0071230; GO:0071560; GO:0071673; GO:0072126; GO:2000439 growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161] EELKLANVVFFPRCLLVQR 0.92541 1.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7042 0 13.6832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3493 12.8503 12.2128 0 12.4791 0 0 0 0 11.823 0 0 0 0 0 0 0 12.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0201 0 0 10.8183 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2021 0 0 12.7588 0 O15120 PLCB_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase beta, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 2, 1-AGP acyltransferase 2, 1-AGPAT 2) (Lysophosphatidic acid acyltransferase beta, LPAAT-beta)" AGPAT2 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; epidermis development [GO:0008544]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; response to xenobiotic stimulus [GO:0009410] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; epidermis development [GO:0008544]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; response to xenobiotic stimulus [GO:0009410] GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0005886; GO:0006644; GO:0006654; GO:0008544; GO:0009410; GO:0016021; GO:0016024; GO:0035579 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] ELWPCLAAALLLLLLLVQLSR 0.92544 1.9122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7591 0 0 0 0 13.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.936 0 0 0 0 0 0 0 0 0 0 0 14.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31937 3HIDH_HUMAN "3-hydroxyisobutyrate dehydrogenase, mitochondrial, HIBADH, EC 1.1.1.31" HIBADH Homo sapiens (Human) valine catabolic process [GO:0006574] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574]" GO:0005739; GO:0005759; GO:0006574; GO:0008442; GO:0016616; GO:0050661; GO:0051287 "3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" DFSSVFQFLREEETF 0.92544 1.9883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.722 0 0 13.7038 0 0 0 0 15.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2507 13.6209 0 0 0 12.6473 0 0 0 15.0915 0 0 0 0 0 0 0 0 14.7805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9326 14.638 0 0 14.2183 0 15.2019 0 0 0 0 0 0 0 0 0 12.33 12.1657 14.6823 0 0 0 0 0 0 10.8899 0 0 0 0 0 0 13.0743 0 0 0 0 0 0 0 13.5585 0 0 Q5VTA0 PRA17_HUMAN PRAME family member 17 PRAMEF17 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 LMVQAWPFLRLPLGSLMKTPHLETLQAVLK 0.92544 2.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3624 0 10.5116 0 0 0 0 0 0 0 0 0 12.3365 0 0 11.1538 0 0 13.3629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8841 0 0 0 0 0 0 0 11.6375 0 0 0 11.8265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9939 0 0 0 0 0 0 0 0 0 11.0244 0 0 0 0 0 0 0 13.1206 0 0 0 0 0 11.6175 0 0 0 0 0 0 Q9UHJ6 SHPK_HUMAN "Sedoheptulokinase, SHK, EC 2.7.1.14 (Carbohydrate kinase-like protein)" SHPK CARKL Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; glycerol metabolic process [GO:0006071]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; sedoheptulokinase activity [GO:0050277]; carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; glycerol metabolic process [GO:0006071]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]" GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006071; GO:0006098; GO:0009052; GO:0016310; GO:0016773; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353 "ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; sedoheptulokinase activity [GO:0050277]" AARPITLGIDLGTTSVKAALLR 0.92544 2.2994 0 0 0 0 0 11.2162 0 0 0 0 0 11.7207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8383 0 0 0 0 0 0 14.2683 0 13.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.124 0 11.5347 0 0 0 0 0 0 0 0 0 0 13.576 0 0 13.7563 0 0 0 0 11.7122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3796 0 0 0 0 0 O95944 NCTR2_HUMAN "Natural cytotoxicity triggering receptor 2 (Lymphocyte antigen 95 homolog) (NK cell-activating receptor) (Natural killer cell p44-related protein, NK-p44, NKp44) (CD antigen CD336)" NCR2 LY95 Homo sapiens (Human) cellular defense response [GO:0006968]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cellular defense response [GO:0006968]; signal transduction [GO:0007165] GO:0004888; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0038023 signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] AWRALHPLLLLLLLFPGSQAQSKAQVLQSVAGQTLTVR 0.92546 2.1852 0 0 0 0 0 0 0 0 0 0 0 12.0085 0 0 0 0 0 0 12.372 0 0 0 0 0 0 0 0 0 13.1697 0 0 0 0 0 0 0 0 0 0 0 0 12.925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0901 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4863 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3297 0 0 0 0 0 13.3593 0 0 0 0 0 0 0 0 0 0 13.4526 0 0 0 0 11.0546 0 13.8438 0 0 13.502 0 0 0 0 0 0 0 0 13.445 0 0 Q16769 QPCT_HUMAN "Glutaminyl-peptide cyclotransferase, EC 2.3.2.5 (Glutaminyl cyclase, QC, sQC) (Glutaminyl-tRNA cyclotransferase) (Glutamyl cyclase, EC)" QPCT Homo sapiens (Human) "peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]; protein modification process [GO:0036211]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]; protein modification process [GO:0036211]" GO:0005576; GO:0008270; GO:0016603; GO:0017186; GO:0035580; GO:0036211; GO:0070062; GO:1904724; GO:1904813 glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270] LQAIEHELHELGLLKDHSLEGR 0.92547 1.6273 0 0 0 0 0 0 0 0 0 0 0 13.187 0 0 0 0 0 0 0 0 0 0 0 9.64384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4429 10.5882 0 0 0 0 0 0 13.6396 11.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7912 0 0 0 0 0 0 0 0 0 0 13.0439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4951 0 0 0 0 0 0 0 0 0 0 0 Q75MW2 ZN767_HUMAN Protein ZNF767 (Zinc finger protein 767 pseudogene) ZNF767P ZNF767 Homo sapiens (Human) FQMFLWTPVQMQKLRPSR 0.92549 2.0263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2413 13.3864 13.9652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6623 12.374 0 0 12.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15525 MAFG_HUMAN Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF) MAFG Homo sapiens (Human) adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of cellular pH [GO:0030641]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030534; GO:0030641; GO:0042127; GO:0042802; GO:0045604; GO:0046982; GO:0090575; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GPLAAGLGPLVPGKVAATSVITIVK 0.92551 2.2698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66621 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7344 13.3886 0 0 0 0 0 0 0 0 0 0 13.1268 0 0 13.2348 0 0 0 0 0 0 0 0 11.4155 0 0 0 0 0 12.9514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BU19 ZN692_HUMAN Zinc finger protein 692 (AICAR responsive element binding protein) ZNF692 AREBP ZFP692 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0005730; GO:0006111; GO:0006357; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IFSNRQYLNHHK 0.92552 2.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1191 0 0 0 0 0 0 0 12.9376 0 0 0 0 15.6569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5072 11.4342 0 0 10.2125 13.5649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76003 GLRX3_HUMAN "Glutaredoxin-3 (PKC-interacting cousin of thioredoxin, PICOT) (PKC-theta-interacting protein, PKCq-interacting protein) (Thioredoxin-like protein 2)" GLRX3 PICOT TXNL2 HUSSY-22 Homo sapiens (Human) [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; Z disc [GO:0030018] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; Z disc [GO:0030018]; glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026] GO:0002026; GO:0003723; GO:0005080; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006879; GO:0010614; GO:0016226; GO:0030018; GO:0030425; GO:0042802; GO:0044571; GO:0045454; GO:0046872; GO:0051536; GO:0055072; GO:0097428; GO:0097573; GO:1990229 glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723] LKKLTHAAPCMLFMK 0.92553 1.9111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6892 0 0 13.4883 0 0 0 0 0 0 0 0 Q75QN2 INT8_HUMAN "Integrator complex subunit 8, Int8 (Protein kaonashi-1)" INTS8 C8orf52 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243; GO:0034472 EPLVLTIILSLFVKLHNVR 0.92553 1.1422 0 0 0 0 0 0 0 0 14.4214 0 0 12.8521 0 0 0 0 0 10.9441 0 0 0 0 0 0 0 0 0 0 14.0137 0 0 0 0 0 0 12.9962 0 0 0 0 11.133 12.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9593 0 0 14.0515 13.3487 14.8809 0 0 0 0 0 0 0 0 0 14.6728 11.7616 14.2274 0 0 13.1312 0 0 13.8593 0 0 0 0 0 0 13.4477 12.8237 0 0 0 0 0 13.897 14.1473 0 0 13.56 13.9095 0 12.8547 14.3392 14.6422 9.81105 0 0 0 13.1983 14.5428 14.5723 14.3814 14.7191 0 0 0 0 0 0 0 0 0 15.4254 0 11.9299 0 13.6823 0 0 15.4099 0 0 0 14.605 13.3647 0 0 14.7783 14.1611 0 0 0 0 0 14.4577 0 0 14.5906 0 0 11.5519 0 0 0 0 0 0 0 0 0 0 11.5271 0 0 0 0 0 0 0 0 0 0 0 Q8N4T0 CBPA6_HUMAN "Carboxypeptidase A6, EC 3.4.17.-" CPA6 CPAH Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0004181; GO:0005615; GO:0006508; GO:0008270 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] AVNALQSVYGVRYR 0.92553 1.9872 0 0 0 0 0 0 0 0 0 0 10.9085 0 0 0 0 0 0 0 0 0 0 12.1236 0 0 0 0 0 0 11.6651 11.5438 0 0 0 10.6445 0 0 0 0 0 0 0 0 0 11.8544 0 0 0 0 0 0 0 11.142 10.7471 0 0 0 0 0 0 0 11.1568 0 0 0 0 0 12.7679 0 13.0103 0 0 0 0 0 11.3878 13.2743 0 12.6062 0 0 0 0 12.9371 0 13.7412 11.9131 0 0 0 0 0 0 0 13.7942 0 0 0 13.1364 14.9001 12.5875 0 0 0 13.4971 0 0 0 13.0469 0 0 0 0 11.9163 0 0 11.9452 0 0 0 12.2864 14.072 0 12.0023 0 13.6298 0 12.8195 13.854 0 0 13.5204 11.6201 12.3742 13.5992 0 13.0239 13.5949 0 0 0 0 14.041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5561 0 0 0 0 0 0 0 0 0 12.1382 0 0 0 0 0 0 0 0 0 Q8NEP3 DAAF1_HUMAN Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50) DNAAF1 LRRC50 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; left/right pattern formation [GO:0060972]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; left/right pattern formation [GO:0060972]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356] GO:0000922; GO:0001947; GO:0003341; GO:0003356; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0005930; GO:0016607; GO:0030324; GO:0035082; GO:0035469; GO:0036158; GO:0036159; GO:0044458; GO:0060271; GO:0060287; GO:0060972; GO:0070286; GO:0070840; GO:0071907; GO:0071910 dynein complex binding [GO:0070840] ESQERGEMTSSDDGENVPASAEGK 0.92555 2.2293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2203 12.0689 0 0 13.2886 0 0 0 11.8896 13.0422 0 0 0 0 0 0 0 12.9465 12.5213 0 0 13.3927 0 0 13.978 0 0 0 0 13.4441 0 0 0 0 0 0 0 0 13.0784 14.0671 0 0 0 13.2925 0 0 0 0 0 10.1836 0 0 0 0 0 0 12.7278 0 0 0 0 0 0 0 12.8209 0 0 0 0 0 0 0 15.6585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6545 11.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8171 0 12.3392 0 0 Q9UKJ0 PILRB_HUMAN Paired immunoglobulin-like type 2 receptor beta (Activating receptor PILR-beta) (Cell surface receptor FDFACT) PILRB FDFACT PP1551 Homo sapiens (Human) activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class I protein binding [GO:0042288]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005886; GO:0005887; GO:0007169; GO:0007171; GO:0042288 MHC class I protein binding [GO:0042288] PPSIHKDYVNR 0.92555 1.9726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4176 0 0 0 0 14.3836 14.4598 0 0 0 0 0 0 0 0 0 13.9243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4325 0 0 0 14.1944 0 0 0 14.3173 0 0 0 0 0 14.4083 0 0 0 0 0 0 13.8939 0 14.1945 0 0 14.4541 0 0 0 0 14.2309 0 0 0 0 13.9764 14.909 0 14.962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3834 0 0 0 0 15.1653 0 0 0 0 0 0 Q08289 CACB2_HUMAN "Voltage-dependent L-type calcium channel subunit beta-2, CAB2 (Calcium channel voltage-dependent subunit beta 2) (Lambert-Eaton myasthenic syndrome antigen B, MYSB)" CACNB2 CACNLB2 MYSB Homo sapiens (Human) calcium ion import [GO:0070509]; chemical synaptic transmission [GO:0007268]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; neuromuscular junction development [GO:0007528]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of voltage-gated calcium channel activity [GO:1901385]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891] integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; calcium ion import [GO:0070509]; chemical synaptic transmission [GO:0007268]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; neuromuscular junction development [GO:0007528]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of voltage-gated calcium channel activity [GO:1901385]; visual perception [GO:0007601] GO:0005245; GO:0005262; GO:0005886; GO:0005887; GO:0005891; GO:0007268; GO:0007528; GO:0007601; GO:0051015; GO:0051928; GO:0070509; GO:0072659; GO:0086045; GO:0086091; GO:0098684; GO:0098793; GO:0098912; GO:0099635; GO:1901385; GO:1901843; GO:1904879; GO:1990454 actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635] LVKEGCEIGFIPSPVKLENMR 0.9256 1.9722 0 0 0 0 0 0 0 0 0 0 0 11.1508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1884 0 0 0 0 0 0 0 0 0 10.7643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99774 0 0 0 0 0 0 0 0 0 0 11.3358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96ID5 IGS21_HUMAN "Immunoglobulin superfamily member 21, IgSF21" IGSF21 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse maturation [GO:0060074] adherens junction [GO:0005912]; anchored component of external side of plasma membrane [GO:0031362]; inhibitory synapse [GO:0060077]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] adherens junction [GO:0005912]; anchored component of external side of plasma membrane [GO:0031362]; inhibitory synapse [GO:0060077]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse maturation [GO:0060074] GO:0005912; GO:0007156; GO:0007157; GO:0031362; GO:0042734; GO:0045211; GO:0060074; GO:0060077 EFPRWVHSAEPTYFLRHSR 0.92563 2.334 0 0 0 0 0 0 0 0 12.9113 0 0 0 0 0 0 0 0 0 9.56889 0 0 0 11.0741 0 0 0 0 0 0 0 0 0 0 11.4739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0131 0 0 0 0 0 0 0 0 11.745 0 13.6531 0 13.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7964 0 0 0 0 0 0 11.7373 0 11.6298 0 0 0 0 0 0 0 0 0 12.1718 0 0 0 0 0 0 0 12.0826 12.8035 0 0 0 14.3831 0 0 13.2521 0 0 0 0 0 0 12.9155 0 0 0 12.7822 12.4664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7224 12.4491 Q5H9I0 TFDP3_HUMAN "Transcription factor Dp family member 3 (Cancer/testis antigen 30, CT30) (Hepatocellular carcinoma-associated antigen 661)" TFDP3 DP4 HCA661 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000082; GO:0000785; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006974; GO:0043433; GO:0061629; GO:0140297; GO:0140416; GO:2000134 DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416] IKWIGLTTNSAQNCQNLRVER 0.92564 2.1943 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9829 0 0 0 0 0 0 0 0 0 0 0 0 10.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5653 0 0 0 0 0 0 0 0 0 0 10.9602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J234 TVA2_HUMAN T cell receptor alpha variable 2 TRAV2 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0006955; GO:0042101 ALQSTLGAVWLGLLLNSLWKVAESK 0.92568 1.1395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWA4 MFN1_HUMAN "Mitofusin-1, EC 3.6.5.- (Fzo homolog) (Transmembrane GTPase MFN1)" MFN1 Homo sapiens (Human) GTP metabolic process [GO:0046039]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; positive regulation of mitochondrial membrane potential [GO:0010918] integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799] integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; GTP metabolic process [GO:0046039]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; positive regulation of mitochondrial membrane potential [GO:0010918] GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0008053; GO:0010918; GO:0016021; GO:0031306; GO:0031307; GO:0042802; GO:0046039; GO:0051646; GO:0098799 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] DKLSIIGEVLSRR 0.92568 2.2676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0813 0 0 0 0 0 0 0 0 0 0 0 11.8949 12.0759 0 0 12.9917 0 13.5232 13.2343 13.6419 0 0 0 0 0 12.6185 0 12.1848 0 0 13.2114 0 0 0 0 0 0 11.5872 0 0 14.0317 14.1262 0 0 13.0061 12.3968 0 10.4081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T88 UHRF1_HUMAN "E3 ubiquitin-protein ligase UHRF1, EC 2.3.2.27 (Inverted CCAAT box-binding protein of 90 kDa) (Nuclear protein 95) (Nuclear zinc finger protein Np95, HuNp95, hNp95) (RING finger protein 106) (RING-type E3 ubiquitin transferase UHRF1) (Transcription factor ICBP90) (Ubiquitin-like PHD and RING finger domain-containing protein 1, hUHRF1) (Ubiquitin-like-containing PHD and RING finger domains protein 1)" UHRF1 ICBP90 NP95 RNF106 Homo sapiens (Human) cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of epithelial cell proliferation [GO:0050678]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657] chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of epithelial cell proliferation [GO:0050678]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0000987; GO:0004842; GO:0005634; GO:0005654; GO:0005657; GO:0006281; GO:0006325; GO:0006511; GO:0007049; GO:0008270; GO:0008327; GO:0010216; GO:0010390; GO:0016363; GO:0016567; GO:0016574; GO:0035064; GO:0042393; GO:0042802; GO:0044729; GO:0045944; GO:0050678; GO:0051247; GO:0051865; GO:0061630; GO:2000373 cis-regulatory region sequence-specific DNA binding [GO:0000987]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] DDDEPGPWTK 0.92569 2.194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6325 0 0 0 0 12.6722 0 12.7559 0 13.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6847 14.77 13.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07947 YES_HUMAN "Tyrosine-protein kinase Yes, EC 2.7.10.2 (Proto-oncogene c-Yes) (p61-Yes)" YES1 YES Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of glucose transmembrane transport [GO:0010827]; regulation of vascular permeability [GO:0043114]; T cell costimulation [GO:0031295]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of glucose transmembrane transport [GO:0010827]; regulation of vascular permeability [GO:0043114]; T cell costimulation [GO:0031295]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001784; GO:0002862; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005794; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007169; GO:0010827; GO:0019899; GO:0030154; GO:0031234; GO:0031295; GO:0036120; GO:0036211; GO:0038096; GO:0043114; GO:0044325; GO:0045087; GO:0045944; GO:0048013; GO:0050731; GO:0050900; GO:0070062; GO:0071300; GO:0071560 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] ESLRLEVK 0.9257 2.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.013 0 Q15323 K1H1_HUMAN "Keratin, type I cuticular Ha1 (Hair keratin, type I Ha1) (Keratin-31, K31)" KRT31 HHA1 HKA1 KRTHA1 Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; structural constituent of cytoskeleton [GO:0005200]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005200; GO:0005615; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0030855; GO:0045109; GO:0070062 structural constituent of cytoskeleton [GO:0005200] EELLCLK 0.92571 2.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2313 0 0 13.6498 0 14.7692 13.9155 0 0 0 0 0 0 0 0 14.244 0 0 14.3922 0 0 0 0 0 0 0 0 0 0 13.0606 0 0 0 14.0329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L945 ZN627_HUMAN Zinc finger protein 627 ZNF627 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFSRSTYFRVHEK 0.92573 2.2657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7644 0 0 0 0 0 0 0 0 0 0 12.9245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6409 0 0 0 0 0 0 0 0 13.7043 0 0 0 11.9964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0837 0 11.4405 0 0 12.083 0 0 0 0 0 0 0 0 0 12.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8Z8 ZN441_HUMAN Zinc finger protein 441 ZNF441 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CKQCGKAFR 0.92574 1.64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8696 0 0 11.9664 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6B4 CLMP_HUMAN "CXADR-like membrane protein (Adipocyte adhesion molecule) (Coxsackie- and adenovirus receptor-like membrane protein, CAR-like membrane protein)" CLMP ACAM ASAM UNQ318/PRO363 Homo sapiens (Human) digestive tract development [GO:0048565] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; digestive tract development [GO:0048565] GO:0005881; GO:0005886; GO:0005923; GO:0009986; GO:0016021; GO:0048565 EDAEAPK 0.92574 2.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7521 0 0 12.3712 0 0 11.9022 0 0 0 0 0 15.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5047 0 O00571 DDX3X_HUMAN "ATP-dependent RNA helicase DDX3X, EC 3.6.4.13 (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform, DBX) (Helicase-like protein 2, HLP2)" DDX3X DBX DDX3 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055] cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]; cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055] GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031053; GO:0031252; GO:0031333; GO:0031369; GO:0031954; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043186; GO:0043273; GO:0043280; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1901985; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369] DSSGWSSSKDKDAYSSFGSR 0.92575 1.9586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0005 0 0 0 16.0574 16.6623 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4136 0 0 14.308 0 0 0 0 0 0 0 0 0 0 15.4533 0 0 0 0 0 0 0 0 0 12.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2926 0 16.0111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y253 POLH_HUMAN "DNA polymerase eta, EC 2.7.7.7 (RAD30 homolog A) (Xeroderma pigmentosum variant type protein)" POLH RAD30 RAD30A XPV Homo sapiens (Human) cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to UV-C [GO:0071494]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; pyrimidine dimer repair [GO:0006290]; regulation of DNA repair [GO:0006282]; response to radiation [GO:0009314]; response to UV-C [GO:0010225] GO:0000731; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005657; GO:0005829; GO:0006260; GO:0006281; GO:0006282; GO:0006290; GO:0009314; GO:0010225; GO:0035861; GO:0042276; GO:0046872; GO:0070987; GO:0071494 damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] ASIDEAYVDLTSAVQER 0.92577 1.6595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8008 0 0 0 0 0 14.7493 0 0 0 0 0 0 0 0 0 0 0 0 15.1631 14.0509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P39687 AN32A_HUMAN "Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32, pp32) (Leucine-rich acidic nuclear protein, LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I, PHAPI)" ANP32A C15orf1 LANP MAPM PHAP1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; nucleocytoplasmic transport [GO:0006913]; regulation of apoptotic process [GO:0042981] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; histone binding [GO:0042393]; RNA binding [GO:0003723]; intracellular signal transduction [GO:0035556]; nucleocytoplasmic transport [GO:0006913]; regulation of apoptotic process [GO:0042981] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006913; GO:0035556; GO:0042393; GO:0042981; GO:0048471 histone binding [GO:0042393]; RNA binding [GO:0003723] DLSTIEPLKKLENLK 0.9258 1.9567 0 0 0 0 0 0 0 0 0 13.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4619 0 0 0 0 0 0 15.8732 0 0 0 11.8531 0 0 0 0 0 0 0 0 11.35 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2125 0 0 0 0 0 0 0 0 0 0 0 12.683 0 0 0 0 0 0 0 0 0 0 0 15.3452 14.1678 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4W5P6 SIM43_HUMAN Small integral membrane protein 43 SMIM43 TMEM155 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EWELNLLLYLALFFFLLFLLFLLLFVVIK 0.9258 1.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0134 0 10.8621 0 0 0 0 0 0 0 0 0 0 0 11.4167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8941 0 0 0 0 0 0 14.1454 0 12.1063 0 0 0 0 0 0 11.7636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9335 10.8263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUX1 T126B_HUMAN "Complex I assembly factor TMEM126B, mitochondrial (Transmembrane protein 126B)" TMEM126B HT007 Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005739; GO:0005743; GO:0016021; GO:0032981 PRDSGVVPVGTEEAPK 0.92581 1.1424 0 0 10.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NZ63 STEAL_HUMAN STEAP family member 1B STEAP1B Homo sapiens (Human) endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endosome [GO:0005768]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005768; GO:0005886; GO:0016021 IAAVMASLTFLYTLLR 0.92584 1.1423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.862 0 12.0412 0 0 0 0 0 0 0 0 11.2428 13.6905 0 0 0 0 0 0 0 0 11.7648 0 11.9578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MI6 PPM1M_HUMAN "Protein phosphatase 1M, EC 3.1.3.16 (Protein phosphatase 2C isoform eta, PP2C-eta, PP2CE)" PPM1M PPM1E Homo sapiens (Human) protein dephosphorylation [GO:0006470] nucleus [GO:0005634] nucleus [GO:0005634]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein dephosphorylation [GO:0006470] GO:0005634; GO:0006470; GO:0017018; GO:0030145 manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018] IQQLAFVYPELLAGEFTRLEFPRR 0.92584 1.9562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4476 0 0 0 0 0 0 0 0 0 0 0 0 14.3671 0 14.5327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXH5 SOCS4_HUMAN "Suppressor of cytokine signaling 4, SOCS-4 (Suppressor of cytokine signaling 7, SOCS-7)" SOCS4 SOCS7 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] phosphatidylinositol 3-kinase complex [GO:0005942] phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] GO:0005942; GO:0007175; GO:0016567; GO:0032436; GO:0035556; GO:0040008; GO:0046854; GO:0046935 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935] DSAQEDYLFSVSFRR 0.92585 2.1692 0 0 0 0 0 0 0 0 0 0 0 0 0 13.799 0 0 0 0 0 0 0 0 10.6584 0 0 0 0 0 0 13.9515 0 0 0 0 0 0 0 0 0 0 0 0 0 13.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2054 0 0 0 0 0 0 0 0 0 0 0 0 12.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9219 0 0 0 0 0 0 0 0 13.4413 0 0 0 0 P59533 T2R38_HUMAN "Taste receptor type 2 member 38, T2R38 (PTC bitter taste receptor) (Taste receptor type 2 member 61, T2R61)" TAS2R38 PTC Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] FSHTFLICLASWVSRK 0.92589 1.6456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGH6 O52L2_HUMAN Putative olfactory receptor 52L2 (Olfactory receptor OR11-74) OR52L2P OR52L2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AYGLTVALLVVGLDVLAIGVSYAHILQAVLK 0.9259 1.9896 0 0 0 15.2341 12.3809 0 13.043 0 0 0 0 0 0 0 0 0 15.8858 16.1502 16.349 16.2315 16.3477 0 16.6409 0 16.6145 16.4616 16.5702 11.3492 16.5368 16.6044 16.5348 16.7789 12.7331 0 0 13.476 0 0 13.7658 0 16.7638 16.7095 17.0712 16.7379 16.5684 0 13.9119 16.7197 0 14.8767 0 0 15.7921 15.8696 16.091 16.1321 0 0 0 0 0 0 15.454 0 0 0 0 12.8935 0 0 0 0 0 0 12.5655 0 13.0998 13.4075 12.3557 13.8485 13.5072 14.4671 17.3207 13.7715 14.9096 13.7503 16.1083 13.3974 0 0 0 13.4902 12.8431 12.2763 12.2583 12.4168 0 13.3496 0 13.4677 13.9832 0 0 0 0 13.413 13.5908 13.257 13.5985 12.4355 11.2226 0 14.0504 13.6965 0 0 0 0 0 13.0012 14.2619 13.4423 13.4143 0 0 13.7223 12.7011 0 12.3094 12.6977 0 12.3191 12.8936 11.2625 11.7459 12.6081 0 12.3898 14.8317 0 0 0 0 12.8626 0 12.0572 0 12.5204 0 0 12.9543 10.675 0 0 0 13.5422 10.6637 11.3334 0 0 0 0 14.696 11.9114 0 0 0 11.0924 13.026 0 12.5064 13.3404 11.3601 12.4213 0 14.0514 0 0 0 0 Q8NHL6 LIRB1_HUMAN "Leukocyte immunoglobulin-like receptor subfamily B member 1, LIR-1, Leukocyte immunoglobulin-like receptor 1 (CD85 antigen-like family member J) (Immunoglobulin-like transcript 2, ILT-2) (Monocyte/macrophage immunoglobulin-like receptor 7, MIR-7) (CD antigen CD85j)" LILRB1 ILT2 LIR1 MIR7 Homo sapiens (Human) "adaptive immune response [GO:0002250]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; dendritic cell differentiation [GO:0097028]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of CD8-positive, alpha-beta T cell activation [GO:2001186]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of endocytosis [GO:0045806]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of osteoclast development [GO:2001205]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transforming growth factor beta production [GO:0071635]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gamma-delta T cell activation involved in immune response [GO:2001193]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor internalization [GO:0031623]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell proliferation involved in immune response [GO:0002309]" cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; HLA-A specific inhibitory MHC class I receptor activity [GO:0030107]; HLA-B specific inhibitory MHC class I receptor activity [GO:0030109]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; MHC class Ib receptor activity [GO:0032394]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; SH2 domain binding [GO:0042169]; adaptive immune response [GO:0002250]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; dendritic cell differentiation [GO:0097028]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of CD8-positive, alpha-beta T cell activation [GO:2001186]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of endocytosis [GO:0045806]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of osteoclast development [GO:2001205]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transforming growth factor beta production [GO:0071635]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gamma-delta T cell activation involved in immune response [GO:2001193]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor internalization [GO:0031623]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell proliferation involved in immune response [GO:0002309]" GO:0001915; GO:0002230; GO:0002250; GO:0002309; GO:0002719; GO:0002767; GO:0002774; GO:0005576; GO:0005737; GO:0005886; GO:0007165; GO:0008157; GO:0009615; GO:0009897; GO:0010628; GO:0014063; GO:0016021; GO:0019221; GO:0023025; GO:0023029; GO:0030107; GO:0030109; GO:0031623; GO:0032393; GO:0032394; GO:0032396; GO:0032688; GO:0032689; GO:0032693; GO:0032695; GO:0032720; GO:0032729; GO:0032945; GO:0042130; GO:0042169; GO:0042288; GO:0042803; GO:0043065; GO:0045786; GO:0045806; GO:0045944; GO:0045953; GO:0046636; GO:0051607; GO:0051926; GO:0060907; GO:0071222; GO:0071635; GO:0097028; GO:2000669; GO:2001186; GO:2001189; GO:2001193; GO:2001199; GO:2001205 HLA-A specific inhibitory MHC class I receptor activity [GO:0030107]; HLA-B specific inhibitory MHC class I receptor activity [GO:0030109]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; MHC class Ib receptor activity [GO:0032394]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; SH2 domain binding [GO:0042169] CQGGQETQEYR 0.9259 2.1689 0 0 0 0 0 0 10.3627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8275 0 12.4376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1585 0 12.8244 0 0 0 0 0 0 0 0 0 12.4166 0 0 0 0 0 0 0 0 0 0 11.7794 11.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1686 0 0 0 0 12.0985 0 0 0 0 0 0 13.0419 0 0 12.8816 0 0 0 0 0 0 0 0 Q9BY84 DUS16_HUMAN "Dual specificity protein phosphatase 16, EC 3.1.3.16, EC 3.1.3.48 (Mitogen-activated protein kinase phosphatase 7, MAP kinase phosphatase 7, MKP-7)" DUSP16 KIAA1700 MKP7 Homo sapiens (Human) dephosphorylation [GO:0016311]; MAPK export from nucleus [GO:0045204]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; JUN kinase binding [GO:0008432]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; MAPK export from nucleus [GO:0045204]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008330; GO:0008432; GO:0016311; GO:0016791; GO:0017017; GO:0017018; GO:0031410; GO:0043409; GO:0043508; GO:0045204; GO:0048273; GO:0051019 JUN kinase binding [GO:0008432]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase p38 binding [GO:0048273]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] LVALLESGTEK 0.9259 2.1906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7703 0 0 0 0 0 0 0 0 0 0 0 0 10.8016 0 0 0 0 0 0 0 0 0 12.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 10.314 0 0 0 0 12.6263 0 0 0 0 0 0 0 0 0 0 0 11.3104 0 13.8267 0 0 0 0 0 0 0 0 11.318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P67936 TPM4_HUMAN Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4) TPM4 Homo sapiens (Human) actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; osteoblast differentiation [GO:0001649] actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; muscle thin filament tropomyosin [GO:0005862]; podosome [GO:0002102]; stress fiber [GO:0001725] actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; muscle thin filament tropomyosin [GO:0005862]; podosome [GO:0002102]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; osteoblast differentiation [GO:0001649] GO:0001649; GO:0001725; GO:0002102; GO:0005509; GO:0005829; GO:0005856; GO:0005862; GO:0005884; GO:0005925; GO:0006936; GO:0007015; GO:0008307; GO:0016020; GO:0030863; GO:0042802; GO:0042803; GO:0046982; GO:0051015; GO:0070062 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307] AEFAERTVAK 0.92593 1.9769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0215 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1856 0 11.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1939 0 0 0 0 0 0 0 0 0 0 13.318 0 0 0 0 0 0 0 0 0 15.3275 14.9796 14.7397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5729 0 0 0 0 O43752 STX6_HUMAN Syntaxin-6 STX6 Homo sapiens (Human) "endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" GO:0000139; GO:0000149; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0016189; GO:0019905; GO:0030136; GO:0030285; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048278; GO:0048471; GO:0090161 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] LDNVMKKLAK 0.92595 2.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1092 0 0 0 0 0 10.9766 0 0 0 10.149 0 0 12.7277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8519 0 0 0 0 0 0 0 0 0 13.6478 0 0 0 0 0 0 0 0 11.5341 0 0 0 0 0 0 0 0 0 0 11.8651 11.3109 Q8TDS4 HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 (G-protein coupled receptor 109A) (G-protein coupled receptor HM74A) (Niacin receptor 1) (Nicotinic acid receptor) HCAR2 GPR109A HCA2 HM74A NIACR1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of lipid catabolic process [GO:0050995]; neutrophil apoptotic process [GO:0001781]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of neutrophil apoptotic process [GO:0033031] cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; nicotinic acid receptor activity [GO:0070553]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of lipid catabolic process [GO:0050995]; neutrophil apoptotic process [GO:0001781]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of neutrophil apoptotic process [GO:0033031] GO:0001781; GO:0004930; GO:0005886; GO:0007186; GO:0016021; GO:0030054; GO:0033031; GO:0050995; GO:0070165; GO:0070553 G protein-coupled receptor activity [GO:0004930]; nicotinic acid receptor activity [GO:0070553] AITFIMVVAIVFVICFLPSVVVR 0.92595 2.2336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6837 12.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6762 0 0 0 0 0 0 0 0 0 0 0 19.4312 0 0 12.5169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9154 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3372 0 0 0 0 0 13.8193 0 0 0 0 0 0 0 13.4023 0 0 0 0 0 13.1842 0 0 12.4974 0 0 0 0 0 0 12.6116 0 0 0 0 0 0 13.4079 0 0 13.3259 Q8WVM0 TFB1M_HUMAN "Dimethyladenosine transferase 1, mitochondrial, EC 2.1.1.- (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1, h-mtTFB, h-mtTFB1, hTFB1M, mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)" TFB1M CGI-75 Homo sapiens (Human) rRNA methylation [GO:0031167]; rRNA modification [GO:0000154]; transcription initiation from mitochondrial promoter [GO:0006391] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645] "mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; DNA binding [GO:0003677]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; rRNA methylation [GO:0031167]; rRNA modification [GO:0000154]; transcription initiation from mitochondrial promoter [GO:0006391]" GO:0000154; GO:0000179; GO:0003677; GO:0003723; GO:0005759; GO:0006391; GO:0031167; GO:0034246; GO:0042645 "DNA binding [GO:0003677]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" EIIKLLRLQAAK 0.92595 2.2635 0 0 0 0 0 0 0 0 0 13.3708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.485 0 13.145 0 0 0 0 0 0 0 0 11.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1774 0 0 11.4303 0 0 0 0 0 0 0 12.2543 13.4026 16.4896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9287 0 0 0 0 0 0 0 0 0 0 12.6895 0 0 11.265 13.1897 0 0 0 0 0 13.3655 0 0 0 0 0 0 13.4648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2317 0 Q96P66 GP101_HUMAN Probable G-protein coupled receptor 101 GPR101 Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880] integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880] GO:0004930; GO:0005887; GO:0043235; GO:0071880 G protein-coupled receptor activity [GO:0004930] DCVENEDEEGAEK 0.92597 1.9129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1671 0 0 0 0 0 0 0 0 0 0 0 0 12.2374 13.3654 0 0 0 0 0 0 0 0 11.9291 0 0 0 0 0 11.6855 0 0 11.709 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6505 0 0 0 12.2165 0 0 12.9535 0 0 0 0 0 0 0 0 0 0 0 11.3219 0 0 0 0 0 0 0 11.7598 0 0 0 12.4534 0 0 0 0 0 0 0 0 0 0 0 Q8N912 NRAC_HUMAN Nutritionally-regulated adipose and cardiac enriched protein homolog NRAC C14orf180 C14orf77 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ARLLGLVLHLR 0.92599 1.9885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1943 0 0 0 12.8407 0 13.5942 0 0 0 0 0 0 0 13.5546 0 12.8879 14.2808 0 13.1451 0 0 12.5838 0 0 0 0 0 0 12.8306 12.8107 14.1656 0 0 0 0 0 0 0 11.0332 0 0 0 0 0 0 0 0 0 0 0 12.4048 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30043 BLVRB_HUMAN "Flavin reductase (NADPH), FR, EC 1.5.1.30 (Biliverdin reductase B, BVR-B, EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein, GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase, FLR)" BLVRB FLR Homo sapiens (Human) heme catabolic process [GO:0042167] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO:0016646]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167]" GO:0004074; GO:0005654; GO:0005829; GO:0005886; GO:0016646; GO:0042167; GO:0042602; GO:0043231; GO:0070062; GO:0106276; GO:0106277 "biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO:0016646]; riboflavin reductase (NADPH) activity [GO:0042602]" MAVKKIAIFGATGQTGLTTLAQAVQAGYEVTVLVR 0.92606 1.1004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1326 0 0 13.4473 11.5567 0 0 0 0 0 0 13.5454 0 0 0 0 0 0 0 0 0 0 0 Q9BU64 CENPO_HUMAN "Centromere protein O, CENP-O (Interphase centromere complex protein 36)" CENPO ICEN36 MCM21R Homo sapiens (Human) centromere complex assembly [GO:0034508] cytosol [GO:0005829]; Mis6-Sim4 complex [GO:0031511]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; Mis6-Sim4 complex [GO:0031511]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; centromere complex assembly [GO:0034508] GO:0005654; GO:0005829; GO:0016604; GO:0031511; GO:0034508 GGVLAHLERLETQVSRSR 0.92606 2.0266 0 0 0 0 0 0 0 0 0 0 0 0 13.2981 0 0 0 11.3905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.817 0 0 12.5397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13268 DHRS2_HUMAN "Dehydrogenase/reductase SDR family member 2, mitochondrial, EC 1.1.1.- (Dicarbonyl reductase HEP27) (Protein D) (Short chain dehydrogenase/reductase family 25C member 1, Protein SDR25C1)" DHRS2 SDR25C1 Homo sapiens (Human) C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; electron transport chain [GO:0022900]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to toxic substance [GO:0009636] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; C21-steroid hormone metabolic process [GO:0008207]; cellular response to oxidative stress [GO:0034599]; electron transport chain [GO:0022900]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to toxic substance [GO:0009636]" GO:0004090; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0008207; GO:0008285; GO:0009636; GO:0016616; GO:0022900; GO:0034599; GO:0043011; GO:0043066 "carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" ILSVNVKSPALLLSQLLPYMENR 0.92611 2.2064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8472 0 0 0 15.5786 15.7357 0 15.7474 15.7966 12.1828 15.7641 13.6531 15.6644 15.7703 15.7172 15.646 15.6344 15.7765 15.6484 15.2623 0 0 12.5071 14.0249 0 12.4504 14.0139 14.5378 14.475 0 0 13.4807 0 12.9282 0 0 15.567 15.2432 14.4429 0 13.103 13.3004 13.3299 12.8907 0 14.9703 14.1371 0 12.5548 0 12.2262 0 0 12.6001 12.6688 0 0 0 0 0 14.0816 0 12.9006 0 0 0 0 0 0 0 0 0 12.8828 0 14.7395 12.2357 0 13.5344 0 0 0 12.8576 0 0 12.6197 0 13.0154 11.5137 13.579 0 0 0 0 0 14.4745 0 0 0 0 13.3435 11.4226 0 Q86TY3 ARMD4_HUMAN Armadillo-like helical domain-containing protein 4 ARMH4 C14orf37 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LESVSRIRTPK 0.92613 1.1004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.855 0 0 0 13.1913 12.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7912 13.5062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1215 0 0 0 0 0 0 0 O43182 RHG06_HUMAN Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1) ARHGAP6 RHOGAP6 Homo sapiens (Human) actin filament polymerization [GO:0030041]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124]; actin filament polymerization [GO:0030041]; activation of phospholipase C activity [GO:0007202]; focal adhesion assembly [GO:0048041]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phospholipase activity [GO:0010518]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0005096; GO:0005737; GO:0005829; GO:0005884; GO:0007202; GO:0007266; GO:0010518; GO:0015629; GO:0016004; GO:0017124; GO:0030041; GO:0043274; GO:0043547; GO:0048041; GO:0051056; GO:0051497; GO:0051895 GTPase activator activity [GO:0005096]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; SH3 domain binding [GO:0017124] ESSPGPR 0.92615 2.2726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.043 14.3836 11.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8934 0 0 0 0 0 0 0 0 0 0 11.9008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q587J8 KHDC3_HUMAN KH domain-containing protein 3 (ES cell-associated transcript 1 protein) (KHDC3-like protein) KHDC3L C6orf221 ECAT1 Homo sapiens (Human) actin filament organization [GO:0007015]; establishment of organelle localization [GO:0051656]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite development [GO:1900006]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297] apical cortex [GO:0045179]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333] apical cortex [GO:0045179]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; establishment of organelle localization [GO:0051656]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite development [GO:1900006]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of embryonic development [GO:0040019]; positive regulation of neurogenesis [GO:0050769]; regulation of protein localization [GO:0032880]; replication fork processing [GO:0031297] GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005813; GO:0005938; GO:0007015; GO:0031297; GO:0032880; GO:0032991; GO:0040019; GO:0043066; GO:0045179; GO:0050769; GO:0051656; GO:0106333; GO:1900006; GO:1905168; GO:2000781 RNA binding [GO:0003723] ALAQDVATQK 0.92617 1.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8828 0 0 0 0 0 0 0 0 0 0 13.4921 0 0 0 0 0 0 14.0923 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9375 0 16.0573 0 0 0 0 17.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0328 0 0 0 0 0 0 0 12.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.14 0 0 13.741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG24 ZN883_HUMAN Zinc finger protein 883 ZNF883 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IHTRERPYQCTK 0.92619 2.3386 9.78044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6016 10.437 0 0 0 0 0 0 0 16.1732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79102 0 0 0 0 9.85772 0 0 11.6988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7M0 DYLT5_HUMAN Dynein light chain Tctex-type 5 (Tctex1 domain-containing protein 1) DYNLT5 TCTEX1D1 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; microtubule-based movement [GO:0007018] GO:0005737; GO:0005868; GO:0007018; GO:0045505 dynein intermediate chain binding [GO:0045505] DLMIPRYKLIVIVHIGQLNR 0.92619 2.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7177 0 0 0 0 0 12.7794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0138 0 0 0 0 0 0 0 11.867 0 0 0 0 11.1244 0 12.4041 0 0 12.5588 12.7511 0 0 0 0 15.7555 13.8869 0 0 0 0 0 0 0 0 0 0 0 0 12.8014 11.6301 0 0 0 0 0 0 0 0 0 0 0 0 11.8407 0 0 0 0 0 0 0 0 0 11.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01242 SOM2_HUMAN "Growth hormone variant, GH-V (Growth hormone 2) (Placenta-specific growth hormone)" GH2 Homo sapiens (Human) animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667] endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667] GO:0005131; GO:0005179; GO:0005576; GO:0005615; GO:0008083; GO:0031667; GO:0031904; GO:0042531; GO:0045927; GO:0046427; GO:0048513; GO:0060396 growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179] ARRLYQLAYDTYQEFEEAYILK 0.9262 2.2703 11.3817 0 0 10.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2494 0 0 0 0 0 0 0 0 15.0224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7504 0 14.6828 0 0 0 0 0 0 0 0 0 0 12.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49721 PSB2_HUMAN Proteasome subunit beta type-2 (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I) PSMB2 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]" GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010243; GO:0010498; GO:0014070; GO:0016020; GO:0019774; GO:0043161; GO:0070062 CLEELQKRFILNLPTFSVR 0.9262 1.66 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3526 0 0 0 0 11.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUE5 CT55_HUMAN Cancer/testis antigen 55 (Tumor antigen BJ-HCC-20) CT55 CXorf48 Homo sapiens (Human) AISITPVHK 0.92622 2.2298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1323 13.3089 0 13.3048 0 0 0 0 0 0 0 13.08 0 0 0 0 0 0 0 0 0 0 P46060 RAGP1_HUMAN "Ran GTPase-activating protein 1, RanGAP1" RANGAP1 KIAA1835 SD Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165] aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SUMO ligase complex [GO:0106068] aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SUMO ligase complex [GO:0106068]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165] GO:0000776; GO:0003723; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006913; GO:0007165; GO:0016235; GO:0016925; GO:0030425; GO:0031267; GO:0031625; GO:0031965; GO:0043231; GO:0044614; GO:0045296; GO:0046826; GO:0048471; GO:0048678; GO:0051168; GO:0072686; GO:0090630; GO:0106068; GO:1904115; GO:1904117; GO:1990723 cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] GAVAIADAIRGGLPK 0.92624 2.197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6376 0 0 0 0 0 0 0 13.4829 0 0 0 0 0 0 0 0 13.5184 0 0 0 0 0 0 0 0 0 0 0 12.6749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZJ6 TDH_HUMAN "Inactive L-threonine 3-dehydrogenase, mitochondrial (Short chain dehydrogenase/reductase family 14E member 1 pseudogene)" TDH SDR14E1P Homo sapiens (Human) threonine catabolic process [GO:0006567] mitochondrial inner membrane [GO:0005743] mitochondrial inner membrane [GO:0005743]; L-threonine 3-dehydrogenase activity [GO:0008743]; threonine catabolic process [GO:0006567] GO:0005743; GO:0006567; GO:0008743 L-threonine 3-dehydrogenase activity [GO:0008743] NLREIVVNNR 0.92626 1.1012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1302 0 0 0 0 0 0 0 0 14.2133 0 0 0 0 0 0 13.5201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJJ7 RUSD1_HUMAN RNA pseudouridylate synthase domain-containing protein 1 (Ribosomal large subunit pseudouridine synthase C-like protein) RPUSD1 C16orf40 RLUCL Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455] GO:0000455; GO:0003723; GO:0009982 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] EDRPFRMMLHAFYLR 0.92627 2.0373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6029 0 0 0 13.2596 0 13.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9176 0 0 13.3447 13.0567 0 0 0 0 0 0 13.1884 14.566 15.8281 13.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.379 Q8TC92 ENOX1_HUMAN "Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase, cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX, cNOX) [Includes: Hydroquinone [NADH] oxidase, EC 1.-.-.-; Protein disulfide-thiol oxidoreductase, EC 1.-.-.- ]" ENOX1 PIG38 Homo sapiens (Human) ultradian rhythm [GO:0007624] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; NADH dehydrogenase activity [GO:0003954]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; ultradian rhythm [GO:0007624] GO:0003723; GO:0003756; GO:0003954; GO:0005615; GO:0005886; GO:0007624; GO:0009897; GO:0015035 NADH dehydrogenase activity [GO:0003954]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723] DDFYEWECK 0.92629 2.1947 0 0 0 0 0 0 0 0 0 14.243 13.2802 13.7211 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5022 0 0 13.2728 0 13.2116 10.4884 0 12.7282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9062 0 10.6546 0 0 0 13.1794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.434 0 0 15.356 0 0 0 0 11.808 0 0 15.9022 0 0 15.6299 0 0 0 0 0 0 0 0 0 0 13.3819 0 15.876 0 0 0 0 0 0 0 0 0 0 15.055 0 0 0 0 0 0 14.1282 0 9.98684 0 0 0 14.6198 0 0 0 0 11.646 0 0 0 0 0 14.3874 0 0 0 0 0 0 0 15.5337 0 0 14.8377 10.1586 0 0 0 0 0 0 0 0 0 0 0 13.334 14.3276 0 0 14.5017 13.2876 0 0 0 0 12.5498 0 0 14.9914 0 0 0 0 0 0 0 13.4898 0 12.0777 Q9UH73 COE1_HUMAN "Transcription factor COE1, O/E-1, OE-1 (Early B-cell factor)" EBF1 COE1 EBF Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:0070742 "C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FIYTALNEPTIDYGFQR 0.9263 1.9587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84221 0 0 13.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61086 UBE2K_HUMAN "Ubiquitin-conjugating enzyme E2 K, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2, HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa, Ubiquitin-conjugating enzyme E2(25K), Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase)" UBE2K HIP2 LIG Homo sapiens (Human) cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; filopodium tip [GO:0032433]; nucleus [GO:0005634] cytosol [GO:0005829]; filopodium tip [GO:0032433]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0010800; GO:0010994; GO:0031625; GO:0032433; GO:0032434; GO:0034450; GO:0035458; GO:0043161; GO:0060340; GO:0061631; GO:0070936; GO:1903265 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] EVLKSEETSKNQIK 0.92633 2.0786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4146 0 0 0 0 0 0 0 13.9952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AB6 NTAN1_HUMAN "Protein N-terminal asparagine amidohydrolase, EC 3.5.1.121 (Protein NH2-terminal asparagine amidohydrolase, PNAA) (Protein NH2-terminal asparagine deamidase, PNAD, Protein N-terminal Asn amidase, Protein N-terminal asparagine amidase, Protein NTN-amidase)" NTAN1 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418 protein-N-terminal asparagine amidohydrolase activity [GO:0008418] MPLLVEGRRVR 0.92636 1.1005 0 0 0 0 0 14.213 15.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6108 0 0 0 0 12.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9599 18.1001 0 13.4151 13.1398 0 0 0 0 0 0 13.4308 0 13.2531 0 0 0 0 0 0 13.6088 0 14.2158 12.6098 0 0 0 0 0 0 13.0929 0 0 0 0 0 0 0 0 0 17.7402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5804 0 0 0 0 0 0 0 0 Q9H1Y3 OPN3_HUMAN Opsin-3 (Encephalopsin) (Panopsin) OPN3 ECPN Homo sapiens (Human) cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; detection of light stimulus [GO:0009583]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of melanin biosynthetic process [GO:0048022]; phototransduction [GO:0007602]; positive regulation of cellular respiration [GO:1901857]; positive regulation of glucose import [GO:0046326]; positive regulation of melanin biosynthetic process [GO:0048023]; regulation of circadian rhythm [GO:0042752]; response to blue light [GO:0009637] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; all-trans retinal binding [GO:0005503]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881]; cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; detection of light stimulus [GO:0009583]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of melanin biosynthetic process [GO:0048022]; phototransduction [GO:0007602]; positive regulation of cellular respiration [GO:1901857]; positive regulation of glucose import [GO:0046326]; positive regulation of melanin biosynthetic process [GO:0048023]; regulation of circadian rhythm [GO:0042752]; response to blue light [GO:0009637] GO:0001750; GO:0004930; GO:0005502; GO:0005503; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007602; GO:0008020; GO:0009583; GO:0009637; GO:0009881; GO:0016021; GO:0030216; GO:0042752; GO:0043066; GO:0046326; GO:0048022; GO:0048023; GO:0071482; GO:0071492; GO:1901857 11-cis retinal binding [GO:0005502]; all-trans retinal binding [GO:0005503]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; photoreceptor activity [GO:0009881] AITYIWLYSLAWAGAPLLGWNR 0.92637 2.3345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8593 0 0 0 0 0 13.6521 0 0 0 12.1049 0 14.0513 0 11.5777 0 0 12.0215 0 12.7164 0 11.8188 0 0 14.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6339 0 11.8333 0 0 0 0 0 0 0 0 0 15.4639 0 11.6389 0 0 0 0 11.4058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1806 0 0 0 0 0 0 0 0 0 0 0 13.6206 0 13.4281 0 12.5382 Q16774 KGUA_HUMAN "Guanylate kinase, EC 2.7.4.8 (GMP kinase) (Guanylate kinase 1)" GUK1 GMK GMPK Homo sapiens (Human) dGDP biosynthetic process [GO:0006185]; nucleobase-containing small molecule interconversion [GO:0015949]; phosphorylation [GO:0016310]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917] cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; dGDP biosynthetic process [GO:0006185]; nucleobase-containing small molecule interconversion [GO:0015949]; phosphorylation [GO:0016310]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805] GO:0001917; GO:0004385; GO:0005524; GO:0005829; GO:0006163; GO:0006185; GO:0006805; GO:0015949; GO:0016310 ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385] ATDLRPIYISVQPPSLHVLEQRLR 0.92638 2.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6822 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KNS6 ZN829_HUMAN Zinc finger protein 829 ZNF829 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFGSRSDLIR 0.92642 2.2384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1572 0 10.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8491 0 11.4285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7805 0 0 0 0 0 0 0 0 0 0 0 0 16.7441 0 0 0 0 0 0 0 0 11.1829 0 0 0 0 0 0 0 0 0 11.0209 0 0 0 0 0 0 0 0 11.0937 0 0 0 0 0 0 Q8TBJ5 FEZF2_HUMAN Fez family zinc finger protein 2 (Forebrain embryonic zinc finger-like protein 2) (Zinc finger protein 312) (Zinc finger protein Fez-like) FEZF2 FEZL ZNF312 FKSG36 Homo sapiens (Human) axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axonal fasciculation [GO:0007413]; cell dedifferentiation [GO:0043697]; cerebral cortex GABAergic interneuron migration [GO:0021853]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; dendrite development [GO:0016358]; dentate gyrus development [GO:0021542]; forebrain anterior/posterior pattern specification [GO:0021797]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; neuron fate determination [GO:0048664]; positive regulation of neuron differentiation [GO:0045666]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]" GO:0000978; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0007413; GO:0007626; GO:0008285; GO:0010468; GO:0016358; GO:0021542; GO:0021797; GO:0021853; GO:0021902; GO:0043697; GO:0045665; GO:0045666; GO:0046872; GO:0048664; GO:0050767; GO:1902667 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AGGGGGGGGGGGGGGGGAPVCGASGLCKTNCGVCCK 0.92644 1.9792 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4013 0 0 0 0 0 0 0 0 0 0 0 9.93515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0029 0 0 0 0 0 0 0 0 0 16.2703 0 0 0 0 0 0 0 0 0 0 0 17.0837 0 0 15.0123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13641 TPBG_HUMAN "Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein, 5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1, WAIF1)" TPBG 5T4 Homo sapiens (Human) "cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; dendrite arborization [GO:0140059]; mesenchymal cell migration [GO:0090497]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; olfactory learning [GO:0008355]; positive regulation of chemotaxis [GO:0050921]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of synapse assembly [GO:0051965]; protein localization to plasma membrane [GO:0072659]; synaptic transmission, GABAergic [GO:0051932]" axon terminus [GO:0043679]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "axon terminus [GO:0043679]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; dendrite arborization [GO:0140059]; mesenchymal cell migration [GO:0090497]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; olfactory learning [GO:0008355]; positive regulation of chemotaxis [GO:0050921]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of synapse assembly [GO:0051965]; protein localization to plasma membrane [GO:0072659]; synaptic transmission, GABAergic [GO:0051932]" GO:0005783; GO:0005886; GO:0005887; GO:0007155; GO:0008285; GO:0008355; GO:0009986; GO:0016020; GO:0030425; GO:0043679; GO:0050921; GO:0051897; GO:0051932; GO:0051965; GO:0060326; GO:0070374; GO:0072659; GO:0090090; GO:0090497; GO:0140059 DACRDHMEGYHYR 0.92646 1.9901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3D2 MSRB2_HUMAN "Methionine-R-sulfoxide reductase B2, mitochondrial, MsrB2, EC 1.8.4.12, EC 1.8.4.14" MSRB2 CBS-1 MSRB CGI-131 Homo sapiens (Human) actin filament polymerization [GO:0030041]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; actin filament polymerization [GO:0030041]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979] GO:0003779; GO:0005737; GO:0005739; GO:0005829; GO:0006979; GO:0008270; GO:0030041; GO:0030091; GO:0033743; GO:0033745 actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270] ARLLWLLRGLTLGTAPR 0.92647 2.2362 0 0 0 14.4811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1443 0 0 0 12.9573 0 0 0 0 0 0 14.1221 0 0 0 0 0 13.1586 0 0 0 0 0 0 0 0 0 0 12.6089 0 0 0 0 12.8018 12.8227 0 0 0 0 0 0 0 0 11.1964 0 0 13.6267 11.6273 13.7945 0 0 14.3247 0 11.7376 0 0 0 0 0 13.7062 13.44 0 0 0 0 13.4508 0 0 0 0 0 0 0 0 0 0 12.6554 0 0 0 12.7811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFT6 DBF4B_HUMAN "Protein DBF4 homolog B (Activator of S phase kinase-like protein 1, ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1)" DBF4B ASKL1 DRF1 Homo sapiens (Human) cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987] cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987] GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987 nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270] GPLLFPEARPWLMSAR 0.92648 1.9778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7685 0 0 0 0 0 0 0 0 0 0 0 0 11.8352 13.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3466 0 0 0 0 0 0 0 0 14.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6966 0 0 0 0 0 0 0 0 0 0 0 14.2131 0 0 0 0 0 Q9GZZ7 GFRA4_HUMAN "GDNF family receptor alpha-4, GDNF receptor alpha-4, GDNFR-alpha-4, GFR-alpha-4 (Persephin receptor)" GFRA4 Homo sapiens (Human) negative regulation of ossification [GO:0030279]; nervous system development [GO:0007399]; ossification [GO:0001503] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; negative regulation of ossification [GO:0030279]; nervous system development [GO:0007399]; ossification [GO:0001503] GO:0001503; GO:0005576; GO:0005886; GO:0007399; GO:0009897; GO:0016167; GO:0030279; GO:0031225; GO:0038023; GO:0043235 glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023] ALERRSLLSILPVLALPALL 0.92648 1.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0812 0 0 0 12.8861 0 0 11.6892 0 0 0 0 0 0 0 0 14.7986 0 0 0 0 0 0 0 0 0 0 0 10.2541 0 10.4326 0 0 0 0 0 0 0 0 0 0 10.2791 0 11.4276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2884 0 0 0 0 0 0 0 0 0 13.9869 0 0 11.3556 0 A0A0B4J2D5 GAL3B_HUMAN "Putative glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial (Keio novel protein-I, KNP-I) (Protein GT335) (Protein HES1)" GATD3B HES1 KNPI Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 GQPSEGESRNVLTESAR 0.92649 1.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5827 0 14.4775 0 0 0 0 0 0 14.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7078 12.0519 0 0 0 0 0 0 0 0 0 0 0 0 13.5709 0 0 12.1685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3558 0 0 0 0 0 0 0 O60309 L37A3_HUMAN Leucine-rich repeat-containing protein 37A3 LRRC37A3 KIAA0563 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AYSWTEKLILR 0.92649 2.1695 0 0 0 0 0 0 0 0 0 12.3104 0 0 0 0 0 0 11.2613 0 0 0 0 0 0 0 0 0 0 0 11.7901 0 0 12.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.286 0 0 12.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2942 0 0 0 0 0 0 0 0 0 13.2519 0 0 0 12.2654 0 12.2919 0 0 0 0 0 0 0 0 0 15.5067 0 11.4713 0 0 0 0 0 0 0 0 0 0 11.3534 0 0 0 0 11.0869 0 0 0 0 0 0 0 0 13.0789 0 12.6345 0 0 0 0 11.3144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4133 0 0 0 0 0 0 0 0 0 12.1416 0 0 0 12.9851 0 0 0 0 0 0 0 0 0 0 13.3295 0 0 0 12.418 0 0 12.1643 O43464 HTRA2_HUMAN "Serine protease HTRA2, mitochondrial, EC 3.4.21.108 (High temperature requirement protein A2, HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)" HTRA2 OMI PRSS25 Homo sapiens (Human) adult walking behavior [GO:0007628]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; ceramide metabolic process [GO:0006672]; execution phase of apoptosis [GO:0097194]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitochondrion organization [GO:0007005]; negative regulation of cell cycle [GO:0045786]; negative regulation of mitophagy in response to mitochondrial depolarization [GO:1904924]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; neuron development [GO:0048666]; pentacyclic triterpenoid metabolic process [GO:0019742]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of protein targeting to mitochondrion [GO:1903955]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of multicellular organism growth [GO:0040014]; response to herbicide [GO:0009635] CD40 receptor complex [GO:0035631]; chromatin [GO:0000785]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase complex [GO:1905370] CD40 receptor complex [GO:0035631]; chromatin [GO:0000785]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase complex [GO:1905370]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; unfolded protein binding [GO:0051082]; adult walking behavior [GO:0007628]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; ceramide metabolic process [GO:0006672]; execution phase of apoptosis [GO:0097194]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitochondrion organization [GO:0007005]; negative regulation of cell cycle [GO:0045786]; negative regulation of mitophagy in response to mitochondrial depolarization [GO:1904924]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; neuron development [GO:0048666]; pentacyclic triterpenoid metabolic process [GO:0019742]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of protein targeting to mitochondrion [GO:1903955]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of multicellular organism growth [GO:0040014]; response to herbicide [GO:0009635] GO:0000785; GO:0004252; GO:0005634; GO:0005739; GO:0005758; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006508; GO:0006672; GO:0007005; GO:0007568; GO:0007628; GO:0008233; GO:0008236; GO:0008630; GO:0009635; GO:0009898; GO:0010822; GO:0012501; GO:0016020; GO:0016540; GO:0019742; GO:0030163; GO:0030900; GO:0031966; GO:0034599; GO:0034605; GO:0035458; GO:0035631; GO:0040014; GO:0042802; GO:0043065; GO:0043280; GO:0045786; GO:0048666; GO:0051082; GO:0071300; GO:0071363; GO:0097194; GO:1901215; GO:1902176; GO:1903146; GO:1903955; GO:1904924; GO:1905370; GO:2001241; GO:2001269 identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; unfolded protein binding [GO:0051082] ACLTSGTPGPRAQLTAVTPDTRTR 0.9265 1.9134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5038 12.9492 0 0 0 0 0 0 0 0 14.7004 0 0 0 13.5191 13.6056 0 0 0 0 12.8705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0565 0 0 0 0 0 0 0 0 0 0 0 0 0 12.726 0 0 0 0 0 0 13.6994 0 0 0 0 13.4651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9196 0 0 0 0 0 0 0 0 0 0 11.9598 0 0 11.8581 0 13.8422 0 0 O95379 TFIP8_HUMAN "Tumor necrosis factor alpha-induced protein 8, TNF alpha-induced protein 8 (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein, NDED) (SCC-S2) (TNF-induced protein GG2-1)" TNFAIP8 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065] GO:0005654; GO:0005737; GO:0043027; GO:0043065; GO:0043066 cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027] EAEKIIKNLIK 0.92651 1.6502 0 13.1167 0 0 13.044 0 12.4404 12.3531 0 0 0 0 0 0 0 0 0 0 0 0 0 10.959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4783 0 0 0 0 0 0 12.4618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.269 0 0 0 10.4776 0 0 13.0352 0 0 0 0 10.691 0 0 0 0 0 0 0 0 11.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8575 0 13.2101 0 0 0 0 0 12.3208 12.3209 0 0 12.8589 14.5003 0 13.6968 11.5823 0 0 0 0 14.7905 13.8533 0 0 0 0 0 0 0 0 13.5524 0 0 0 9.53087 0 0 0 0 0 10.4632 0 9.82837 0 0 0 13.6366 0 0 0 0 0 13.5875 0 0 0 0 0 0 0 0 13.16 0 0 0 0 0 0 13.4182 0 0 14.6382 0 0 0 Q9BRJ9 MESP1_HUMAN "Mesoderm posterior protein 1 (Class C basic helix-loop-helix protein 5, bHLHc5)" MESP1 BHLHC5 Homo sapiens (Human) "cardiac atrium formation [GO:0003210]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell differentiation [GO:0055007]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cardiac ventricle formation [GO:0003211]; cardioblast anterior-lateral migration [GO:0003259]; cardioblast migration to the midline involved in heart field formation [GO:0060975]; embryonic heart tube morphogenesis [GO:0003143]; endothelial cell differentiation [GO:0045446]; gastrulation [GO:0007369]; gene expression [GO:0010467]; growth involved in heart morphogenesis [GO:0003241]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; lateral mesoderm development [GO:0048368]; mesoderm formation [GO:0001707]; mesodermal cell migration [GO:0008078]; negative regulation of endodermal cell fate specification [GO:0042664]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of hepatocyte differentiation [GO:0070368]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]; signal transduction involved in regulation of gene expression [GO:0023019]; sinoatrial node cell differentiation [GO:0060921]; sinus venosus morphogenesis [GO:0003236]; somite rostral/caudal axis specification [GO:0032525]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cardiac atrium formation [GO:0003210]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell differentiation [GO:0055007]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cardiac ventricle formation [GO:0003211]; cardioblast anterior-lateral migration [GO:0003259]; cardioblast migration to the midline involved in heart field formation [GO:0060975]; embryonic heart tube morphogenesis [GO:0003143]; endothelial cell differentiation [GO:0045446]; gastrulation [GO:0007369]; gene expression [GO:0010467]; growth involved in heart morphogenesis [GO:0003241]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; lateral mesoderm development [GO:0048368]; mesoderm formation [GO:0001707]; mesodermal cell migration [GO:0008078]; negative regulation of endodermal cell fate specification [GO:0042664]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of hepatocyte differentiation [GO:0070368]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]; signal transduction involved in regulation of gene expression [GO:0023019]; sinoatrial node cell differentiation [GO:0060921]; sinus venosus morphogenesis [GO:0003236]; somite rostral/caudal axis specification [GO:0032525]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001707; GO:0001947; GO:0003007; GO:0003139; GO:0003143; GO:0003210; GO:0003211; GO:0003236; GO:0003241; GO:0003259; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0007369; GO:0008078; GO:0010467; GO:0022008; GO:0023019; GO:0032525; GO:0035481; GO:0042662; GO:0042664; GO:0045446; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048368; GO:0051155; GO:0055007; GO:0060913; GO:0060921; GO:0060947; GO:0060975; GO:0070368; GO:0090082 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GARSSRLGSGQR 0.92653 2.0448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0A6YYK1 TVA81_HUMAN T cell receptor alpha variable 8-1 TRAV8-1 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 GFEAEFIKSKFSFNLR 0.92654 1.9645 0 0 0 0 13.7009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3304 0 0 0 0 0 0 0 0 0 0 11.1112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2987 0 0 11.4724 0 0 0 0 0 0 0 13.4742 0 0 0 12.2988 0 0 0 15.7223 0 0 13.4031 0 0 0 0 0 0 0 0 0 13.1927 0 0 0 0 0 0 0 0 11.0475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1988 0 0 0 14.1709 O75676 KS6A4_HUMAN "Ribosomal protein S6 kinase alpha-4, S6K-alpha-4, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B, RSKB)" RPS6KA4 MSK2 Homo sapiens (Human) "histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-S28 specific) [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000287; GO:0001818; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0006954; GO:0016572; GO:0018105; GO:0032793; GO:0033129; GO:0035066; GO:0035175; GO:0035556; GO:0043687; GO:0044022; GO:0045944; GO:0051092; GO:0070498; GO:0106310 ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-S28 specific) [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711] EGFFLKSVENAPLAKR 0.92655 1.6498 0 0 0 0 11.1105 0 10.3524 0 13.9536 0 0 0 13.8205 14.9959 0 0 0 0 0 11.2687 0 10.8323 0 0 10.6259 0 13.2867 0 0 0 0 14.8791 0 14.549 0 13.5721 0 0 0 0 0 0 0 0 13.5294 0 0 0 0 0 10.0136 12.9312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0228 12.4844 13.2095 0 0 0 0 0 0 0 0 0 13.1234 0 11.9628 11.574 12.0885 0 0 14.1536 0 0 0 0 0 11.7249 0 0 0 0 0 14.3243 0 0 0 0 0 18.5806 0 0 0 14.3727 0 0 10.3618 0 0 15.4211 0 0 0 0 10.6256 14.7401 0 0 0 0 11.3689 0 0 11.4172 0 0 0 13.4544 0 0 14.8928 11.2291 0 11.6585 9.85702 11.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8977 0 0 14.6328 0 0 10.1787 0 11.4456 13.2131 0 14.3021 0 14.0609 0 0 O60568 PLOD3_HUMAN "Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3, EC 1.14.11.4 (Lysyl hydroxylase 3, LH3); Procollagen glycosyltransferase, EC 2.4.1.50, EC 2.4.1.66 (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase) ]" PLOD3 Homo sapiens (Human) basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311] GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032963; GO:0033823; GO:0042311; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070062; GO:0070831 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475] ARAVMNFVVRYR 0.92656 1.1015 0 0 0 0 0 0 0 0 0 0 0 0 11.2875 0 10.9679 0 0 10.748 0 10.9169 0 0 0 0 0 12.354 11.3615 0 0 0 13.3941 13.313 13.852 0 11.5242 0 0 0 0 12.1711 0 12.2267 12.1462 0 0 0 0 12.0341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2654 0 12.1938 0 12.3619 0 0 0 11.3404 12.2945 0 0 0 14.2783 0 15.5302 0 0 11.9286 0 14.1994 0 0 13.5297 14.1312 14.7374 14.5154 0 0 0 12.5122 13.9844 0 0 0 0 13.9119 13.1016 0 0 0 0 0 0 13.3315 0 0 0 0 0 0 0 12.731 10.6663 0 0 0 0 13.4213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1631 0 0 13.7945 0 0 0 0 0 0 13.6448 0 0 14.6201 0 13.9794 0 0 0 12.6415 12.434 0 0 0 0 14.1839 0 0 0 0 0 14.0586 0 0 0 0 Q9HCT0 FGF22_HUMAN "Fibroblast growth factor 22, FGF-22" FGF22 UNQ2500/PRO5800 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334] GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0030154; GO:0030334 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] GQPMFLALDRR 0.92656 1.6407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1007 13.0878 0 0 13.9186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5557 0 0 0 0 0 0 0 15.8102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42575 CASP2_HUMAN "Caspase-2, CASP-2, EC 3.4.22.55 (Neural precursor cell expressed developmentally down-regulated protein 2, NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12 ]" CASP2 ICH1 NEDD2 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; release of cytochrome c from mitochondria [GO:0001836]" caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase complex [GO:1905369]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] "caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase complex [GO:1905369]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; release of cytochrome c from mitochondria [GO:0001836]" GO:0001554; GO:0001836; GO:0003407; GO:0004197; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007420; GO:0007568; GO:0008303; GO:0008630; GO:0016020; GO:0016485; GO:0019899; GO:0019904; GO:0035234; GO:0042802; GO:0043065; GO:0043066; GO:0043525; GO:0060546; GO:0071260; GO:0097153; GO:0097190; GO:0097192; GO:0097194; GO:0097199; GO:0097200; GO:1905369; GO:2001235 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] EMSEYCSTLCR 0.92658 2.2341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5706 0 0 0 0 0 0 0 0 0 0 0 0 10.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1648 0 12.4275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1967 0 0 0 0 0 0 0 13.4757 0 0 0 11.5657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8077 0 0 0 0 0 0 0 0 0 O75381 PEX14_HUMAN Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14) PEX14 Homo sapiens (Human) "microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein-containing complex assembly [GO:0065003]" cytosol [GO:0005829]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein-containing complex assembly [GO:0065003]" GO:0001650; GO:0003714; GO:0005102; GO:0005634; GO:0005777; GO:0005778; GO:0005829; GO:0007031; GO:0008017; GO:0016020; GO:0016021; GO:0016558; GO:0016560; GO:0016561; GO:0032091; GO:0032991; GO:0034453; GO:0036250; GO:0042802; GO:0043433; GO:0044721; GO:0045892; GO:0047485; GO:0048487; GO:0065003; GO:1990429 beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] IPSWQIPVK 0.92659 1.6403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5487 0 0 11.6361 0 11.4208 0 12.8747 0 0 0 0 11.1095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0715 0 0 0 0 0 0 0 0 0 0 0 13.4971 0 0 0 0 0 0 0 0 0 0 13.2038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4991 0 0 0 0 0 12.2185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6103 12.6357 0 0 0 12.3136 0 0 0 0 0 0 0 0 0 P12645 BMP3_HUMAN "Bone morphogenetic protein 3, BMP-3 (Bone morphogenetic protein 3A, BMP-3A) (Osteogenin)" BMP3 BMP3A Homo sapiens (Human) cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] GO:0001501; GO:0001649; GO:0005102; GO:0005125; GO:0005615; GO:0007267; GO:0008083; GO:0010862; GO:0051216; GO:0060395; GO:0070062; GO:0070700 BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102] AVGVVPGIPEPCCVPEK 0.92659 2.0295 0 0 0 0 0 0 0 0 0 0 13.1619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.213 11.6439 12.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.799 0 0 11.1541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N976 YG039_HUMAN Putative uncharacterized protein FLJ38264 Homo sapiens (Human) RAQIVSTPPSPLAALR 0.92661 1.1008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9019 13.6424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54852 EMP3_HUMAN "Epithelial membrane protein 3, EMP-3 (Hematopoietic neural membrane protein 1, HNMP-1) (Protein YMP)" EMP3 YMP Homo sapiens (Human) bleb assembly [GO:0032060]; cell death [GO:0008219] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bleb assembly [GO:0032060]; cell death [GO:0008219] GO:0005886; GO:0008219; GO:0016021; GO:0032060 ESLNLWYDCTWNNDTK 0.92663 2.2339 12.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.709 0 0 0 0 0 0 11.8089 0 0 11.9746 0 0 15.9045 0 12.4627 0 0 0 0 0 0 0 0 11.1518 0 0 0 0 0 0 0 0 0 11.0216 0 0 0 0 0 0 0 0 0 0 0 11.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0176 0 0 0 0 0 0 14.8118 0 0 0 0 0 0 0 0 0 0 0 0 11.9867 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NF99 ZN397_HUMAN Zinc finger protein 397 (Zinc finger and SCAN domain-containing protein 15) (Zinc finger protein 47) ZNF397 ZNF47 ZSCAN15 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0015630; GO:0042803; GO:0045892; GO:0046872; GO:0046982 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDVCGHSFKQHSSLTQHQR 0.92664 1.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5837 0 0 0 0 0 0 Q7RTS7 K2C74_HUMAN "Keratin, type II cytoskeletal 74 (Cytokeratin-74, CK-74) (Keratin-5c, K5C) (Keratin-74, K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)" KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 Homo sapiens (Human) intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; keratin filament binding [GO:1990254]; structural constituent of skin epidermis [GO:0030280]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005737; GO:0005829; GO:0030280; GO:0031424; GO:0045095; GO:0045104; GO:0045109; GO:0070062; GO:1990254 keratin filament binding [GO:1990254]; structural constituent of skin epidermis [GO:0030280] AQEREQIKVLNDK 0.92665 1.6475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8064 0 0 0 10.1518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.531 0 0 0 13.2447 13.807 0 0 13.5857 11.6991 14.5739 12.7969 13.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3062 0 0 0 0 0 13.2088 0 0 0 13.9479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8124 0 0 0 0 0 0 0 11.7363 11.9486 12.7141 0 0 0 0 0 0 11.9696 11.751 0 0 0 13.6389 0 0 Q8NBZ9 NEAS1_HUMAN Putative uncharacterized protein NEXN-AS1 (NEXN antisense RNA 1) NEXN-AS1 C1orf118 Homo sapiens (Human) MVWRFQKHIGK 0.92666 1.1005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9081 0 0 0 0 0 0 0 0 12.8597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NEK1 ARRD5_HUMAN Arrestin domain-containing protein 5 ARRDC5 Homo sapiens (Human) protein transport [GO:0015031] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; protein transport [GO:0015031] GO:0005737; GO:0015031; GO:0031625; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625] IYLAGSSIKGQVILTLNSTLVDPIVK 0.92668 1.6472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZB0 CI130_HUMAN Putative uncharacterized protein ERCC6L2-AS1 (ERCC6L2 antisense RNA 1) (Nasopharyngeal carcinoma-associated gene 12 protein) ERCC6L2-AS1 C9orf130 LINC00476 NAG12 Homo sapiens (Human) EGDVRSGGRAR 0.92672 2.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7637 0 0 13.4773 0 0 0 0 0 0 0 12.9378 0 0 0 0 0 0 12.8687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1741 13.9189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWF6 DNJB3_HUMAN DnaJ homolog subfamily B member 3 DNAJB3 HCG3 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077] GO:0005634; GO:0005737; GO:0044183; GO:0051082; GO:0051087; GO:0061077 chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] KLALKWHPDK 0.92673 1.1004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6729 0 0 0 12.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5X7 IF4E3_HUMAN "Eukaryotic translation initiation factor 4E type 3, eIF-4E type 3, eIF-4E3, eIF4E type 3, eIF4E-3" EIF4E3 Homo sapiens (Human) cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743] GO:0000340; GO:0003743; GO:0005829; GO:0005845; GO:0016281 RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743] DREDVVQVWNVNASLVGEATVLEKIYELLPHITFK 0.92674 2.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0424 0 0 12.1875 0 0 0 0 0 0 0 0 0 11.6508 0 0 0 11.4747 12.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0663 0 0 0 0 0 12.3309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6067 0 0 0 0 0 0 0 Q9NYY1 IL20_HUMAN "Interleukin-20, IL-20 (Cytokine Zcyto10)" IL20 ZCYTO10 UNQ852/PRO1801 Homo sapiens (Human) osteoclast differentiation [GO:0030316]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of inflammatory response [GO:0050727] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-20 receptor binding [GO:0045517]; interleukin-22 receptor binding [GO:0045518]; osteoclast differentiation [GO:0030316]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of inflammatory response [GO:0050727] GO:0005125; GO:0005576; GO:0005615; GO:0030316; GO:0042531; GO:0045517; GO:0045518; GO:0045606; GO:0045618; GO:0045672; GO:0050727 cytokine activity [GO:0005125]; interleukin-20 receptor binding [GO:0045517]; interleukin-22 receptor binding [GO:0045518] CCLLRHLLR 0.92675 1.6464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6432 0 0 0 0 0 0 0 0 0 0 11.9049 0 0 0 0 0 0 0 0 0 0 11.3838 0 0 0 0 0 0 0 11.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3539 0 0 0 0 11.4323 0 Q8NCS4 TM35B_HUMAN Transmembrane protein 35B (ZMYM6 neighbor protein) TMEM35B ZMYM6NB Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALLLSVLRVLLGGFFALVGLAK 0.92678 2.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.315 12.2672 12.401 0 0 0 12.1881 0 15.7424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8036 0 0 17.3728 0 0 0 14.7286 0 0 0 16.3242 14.4852 0 0 0 14.5712 13.5984 14.3278 13.8267 0 0 13.037 13.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0161 0 0 0 0 0 0 0 0 0 0 11.8516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5653 0 0 0 0 0 14.7148 0 0 0 0 0 0 0 0 0 0 0 0 13.7852 0 12.6289 0 0 Q9GZU8 PIP30_HUMAN PSME3-interacting protein (NEFA-interacting nuclear protein NIP30) (PA28G-interacting protein) PSME3IP1 C16orf94 FAM192A NIP30 PIP30 CDA018 CDA10 Homo sapiens (Human) negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein binding [GO:0032091] GO:0005634; GO:0032091; GO:1901799 FVSEAELDERRK 0.92678 2.2069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0095 0 0 0 0 0 0 0 0 11.7174 0 0 0 0 0 0 0 0 11.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5296 0 12.6022 12.197 12.6405 13.0839 0 0 12.9473 0 0 0 0 14.6037 12.8674 0 0 13.4911 13.2864 13.2682 13.2824 0 0 0 0 13.2347 13.2845 13.7128 12.9553 0 0 0 0 0 0 12.9896 13.1728 13.8579 13.6062 0 12.3097 11.7611 0 0 0 0 0 0 0 13.6233 0 0 0 13.4243 12.6462 12.9023 0 13.9463 0 14.003 13.3788 0 0 0 10.574 0 0 12.7268 0 12.4797 13.2948 11.5501 0 0 0 0 0 0 0 0 0 0 0 11.5336 0 11.259 0 0 0 0 0 0 0 13.4597 0 0 12.0759 0 0 0 12.37 13.3773 0 0 0 0 0 0 Q16254 E2F4_HUMAN "Transcription factor E2F4, E2F-4" E2F4 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell volume homeostasis [GO:0006884]; centriole assembly [GO:0098534]; epithelial cell development [GO:0002064]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" GO:0000083; GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0002064; GO:0003677; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0006884; GO:0008015; GO:0009887; GO:0019904; GO:0042127; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251; GO:1990837; GO:1990841 "DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CFAGDTLLAIRAPSGTSLEVPIPEGLNGQKK 0.9268 2.0389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1808 0 0 0 11.4899 0 0 0 0 0 0 11.3351 0 0 0 0 0 0 0 13.3123 0 0 0 0 0 0 0 0 0 0 0 12.4879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60667 FAIM3_HUMAN Fas apoptotic inhibitory molecule 3 (IgM Fc fragment receptor) (Regulator of Fas-induced apoptosis Toso) FCMR FAIM3 TOSO Homo sapiens (Human) cellular defense response [GO:0006968]; immune system process [GO:0002376]; negative regulation of apoptotic process [GO:0043066] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; cellular defense response [GO:0006968]; immune system process [GO:0002376]; negative regulation of apoptotic process [GO:0043066] GO:0002376; GO:0004888; GO:0005576; GO:0005886; GO:0006968; GO:0016021; GO:0043066 transmembrane signaling receptor activity [GO:0004888] DFWLWPLYFLPVSGALRILPEVK 0.92681 2.3448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2122 0 0 0 0 0 11.9733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2079 0 0 0 0 0 0 0 13.5327 0 0 0 0 13.3637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5516 0 0 0 0 13.1765 0 0 0 0 0 0 0 0 0 0 0 12.6373 0 0 13.1312 15.0543 0 0 13.36 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92538 GBF1_HUMAN "Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1, BFA-resistant GEF 1" GBF1 KIAA0248 Homo sapiens (Human) "cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; cilium assembly [GO:0060271]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] "cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; cilium assembly [GO:0060271]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0002263; GO:0005085; GO:0005547; GO:0005793; GO:0005794; GO:0005801; GO:0005802; GO:0005811; GO:0005829; GO:0006888; GO:0006890; GO:0006892; GO:0006895; GO:0007030; GO:0007346; GO:0015031; GO:0016020; GO:0030593; GO:0031252; GO:0032012; GO:0034067; GO:0042147; GO:0048205; GO:0060271; GO:0061162; GO:0070973; GO:0080025; GO:0090166; GO:0097111; GO:0098586; GO:1903409; GO:1903420; GO:2000008 "guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]" ALLVHDLQKLDALEWESCFNKVLFPLLTK 0.92681 1.0991 0 0 14.6686 0 0 0 0 0 0 0 0 0 0 0 13.4998 0 0 0 13.5729 0 0 0 0 0 11.9516 0 0 12.5218 0 0 0 0 0 0 12.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7953 0 13.6319 13.8844 13.2079 13.053 11.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2116 11.1506 0 0 11.9436 0 13.7548 13.5825 0 0 0 0 11.5452 0 16.0865 13.6084 16.4751 0 10.582 0 0 11.5765 12.339 0 14.7151 0 0 0 0 13.4822 12.5305 0 11.9263 13.1205 16.0585 12.4764 0 12.8707 13.1024 0 10.8387 0 16.5008 0 13.6472 12.6244 15.2701 0 0 0 13.3467 0 14.2002 0 0 13.9199 0 0 0 0 0 0 0 0 0 0 13.3636 0 0 0 0 0 0 0 0 12.4055 0 0 0 0 0 0 0 0 14.1312 0 0 0 14.1264 14.2824 0 14.7557 0 14.7258 0 14.9362 0 14.2631 14.1892 14.5729 14.9204 14.544 0 15.1217 13.2886 14.5866 14.1115 0 14.4301 0 0 Q9NXH8 TOR4A_HUMAN Torsin-4A (Torsin family 4 member A) TOR4A C9orf167 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; platelet alpha granule lumen [GO:0031093] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005576; GO:0005635; GO:0005788; GO:0016021; GO:0016887; GO:0031093 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ASLLAVLSREHPLWQAAAIVPFLLLDKR 0.92682 1.8645 0 0 0 0 0 0 0 0 0 12.0573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5673 11.7468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2319 0 0 0 0 14.4771 0 14.7825 0 0 0 0 14.0282 0 0 0 13.9706 13.8241 0 14.2866 14.0566 13.597 0 0 0 13.6407 13.964 0 14.3364 0 0 0 0 0 0 12.9589 0 0 0 13.5812 13.8792 13.8047 0 0 0 13.413 0 14.1554 0 0 0 0 0 13.4842 0 13.0237 0 0 11.7593 0 12.9021 0 0 0 0 13.7733 0 0 0 12.9601 0 0 0 0 0 0 0 0 0 15.1132 0 0 0 0 0 0 0 0 11.2007 0 0 0 0 0 0 0 0 14.74 14.9031 16.0159 14.6694 0 0 0 0 0 Q86TM6 SYVN1_HUMAN "E3 ubiquitin-protein ligase synoviolin, EC 2.3.2.27 (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1)" SYVN1 HRD1 KIAA1810 Homo sapiens (Human) "endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790] "cytoplasm [GO:0005737]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000836; GO:0000839; GO:0002327; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005790; GO:0006511; GO:0016020; GO:0016567; GO:0030176; GO:0030433; GO:0030970; GO:0036503; GO:0036513; GO:0044322; GO:0046872; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070936; GO:0140297; GO:1902236; GO:1904380; GO:1990381 ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082] GASVQLVFGFEYAILMTMVLTIFIK 0.92683 2.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8781 0 0 0 0 0 0 0 0 0 12.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51003 PAPOA_HUMAN "Poly(A) polymerase alpha, PAP-alpha, EC 2.7.7.19 (Polynucleotide adenylyltransferase alpha)" PAPOLA PAP Homo sapiens (Human) mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; regulation of mRNA 3'-end processing [GO:0031440]; RNA polyadenylation [GO:0043631] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; regulation of mRNA 3'-end processing [GO:0031440]; RNA polyadenylation [GO:0043631] GO:0000287; GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006378; GO:0030145; GO:0031124; GO:0031440; GO:0043631 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723] IAAMHVK 0.92684 1.9594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5271 0 0 0 0 0 0 12.9176 0 0 13.7117 0 0 0 0 0 0 0 12.8417 0 0 0 10.4099 0 0 0 0 0 0 0 0 0 11.5514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.805 0 0 0 14.5005 0 13.3846 0 12.1779 0 0 0 0 0 0 0 0 13.8504 0 13.2331 0 0 0 14.0012 13.4271 0 15.1294 16.2466 0 0 0 13.0728 15.0477 14.175 0 0 0 15.2429 0 0 0 13.6973 0 13.9331 12.4413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7899 0 0 14.9288 14.7072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6547 0 0 0 0 0 0 0 0 0 0 0 12.0894 0 0 0 15.6841 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RTX5 SYTC2_HUMAN "Threonine--tRNA ligase 2, cytoplasmic, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase protein 3)" TARS3 TARSL2 Homo sapiens (Human) threonyl-tRNA aminoacylation [GO:0006435] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435] GO:0004829; GO:0005524; GO:0005634; GO:0005737; GO:0006435; GO:0042802 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829] AIIKEKQPFER 0.92686 1.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2413 0 0 0 0 0 12.4645 0 0 0 0 0 0 0 10.2907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7989 13.8218 12.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6652 12.8748 12.82 0 0 0 13.1073 0 12.8589 0 14.1411 0 0 0 0 0 0 0 13.0933 0 0 12.7742 12.5629 0 14.0976 0 12.4156 0 0 0 0 0 14.8888 0 0 11.2229 0 0 0 13.9825 0 0 0 0 13.0687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14916 NPT1_HUMAN "Sodium-dependent phosphate transport protein 1 (Na(+)/PI cotransporter 1) (Na/Pi-4) (Renal Na(+)-dependent phosphate cotransporter 1) (Renal sodium-dependent phosphate transport protein 1, Renal sodium-phosphate transport protein 1) (Sodium/phosphate cotransporter 1) (Solute carrier family 17 member 1)" SLC17A1 NPT1 Homo sapiens (Human) anion transport [GO:0006820]; ion transport [GO:0006811]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; urate metabolic process [GO:0046415]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphate ion transmembrane transporter activity [GO:0015114]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; ion transport [GO:0006811]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; urate metabolic process [GO:0046415]; urate transport [GO:0015747] GO:0005436; GO:0005764; GO:0005886; GO:0005887; GO:0006811; GO:0006817; GO:0006820; GO:0015114; GO:0015136; GO:0015739; GO:0015747; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0046415 phosphate ion transmembrane transporter activity [GO:0015114]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857] ACSTLTGMIGGLIASTLTGLILK 0.92686 1.1019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7359 14.7274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P03886 NU1M_HUMAN "NADH-ubiquinone oxidoreductase chain 1, EC 7.1.1.2 (NADH dehydrogenase subunit 1)" MT-ND1 MTND1 NADH1 ND1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] KILGYMQLR 0.92688 2.2053 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.241 13.7631 14.4817 0 0 0 0 0 17.2206 0 16.9629 0 17.085 0 0 0 0 0 0 0 0 0 15.3009 0 0 0 16.1437 0 15.319 0 0 0 16.7349 0 16.6784 0 0 0 15.0384 0 0 0 15.8166 15.7321 0 0 15.6447 0 15.3327 0 0 0 14.8528 0 0 0 0 14.6046 0 0 0 0 0 14.7891 14.4444 0 0 0 0 0 14.0613 0 0 0 15.2394 0 15.2527 0 0 0 0 0 0 0 0 13.6014 0 0 0 0 0 14.6523 14.632 0 14.1763 0 0 0 0 15.6287 P17516 AK1C4_HUMAN "Aldo-keto reductase family 1 member C4, EC 1.1.1.-, EC 1.1.1.209, EC 1.1.1.210, EC 1.1.1.51, EC 1.1.1.53, EC 1.1.1.62 (3-alpha-hydroxysteroid dehydrogenase type I, 3-alpha-HSD1, EC 1.1.1.357) (3alpha-hydroxysteroid 3-dehydrogenase) (Chlordecone reductase, CDR, EC 1.1.1.225) (Dihydrodiol dehydrogenase 4, DD-4, DD4) (HAKRA)" AKR1C4 CHDR Homo sapiens (Human) androgen metabolic process [GO:0008209]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; cellular response to jasmonic acid stimulus [GO:0071395]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; bile acid transmembrane transporter activity [GO:0015125]; chlordecone reductase activity [GO:0047743]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; electron transfer activity [GO:0009055]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; retinal dehydrogenase activity [GO:0001758]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; cellular response to jasmonic acid stimulus [GO:0071395]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]" GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0005737; GO:0005829; GO:0006693; GO:0006699; GO:0008202; GO:0008209; GO:0009055; GO:0015125; GO:0015721; GO:0016229; GO:0016655; GO:0032052; GO:0035410; GO:0042448; GO:0044594; GO:0044597; GO:0044598; GO:0047023; GO:0047024; GO:0047035; GO:0047044; GO:0047045; GO:0047086; GO:0047743; GO:0070062; GO:0071395 "17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; bile acid transmembrane transporter activity [GO:0015125]; chlordecone reductase activity [GO:0047743]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; electron transfer activity [GO:0009055]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; retinal dehydrogenase activity [GO:0001758]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" HKQTPALIALR 0.9269 1.8625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2324 0 0 0 0 0 0 12.2817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3678 0 0 0 0 0 0 0 0 12.9726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4285 12.3069 12.5829 0 12.504 0 0 0 0 13.3691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5444 13.8988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8502 0 0 0 0 0 0 P09758 TACD2_HUMAN Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1) TACSTD2 GA733-1 M1S1 TROP2 Homo sapiens (Human) negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell motility [GO:2000146]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of stem cell differentiation [GO:2000738]; regulation of epithelial cell proliferation [GO:0050678]; response to stimulus [GO:0050896]; ureteric bud morphogenesis [GO:0060675]; visual perception [GO:0007601] basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nucleus [GO:0005634] basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell motility [GO:2000146]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of stem cell differentiation [GO:2000738]; regulation of epithelial cell proliferation [GO:0050678]; response to stimulus [GO:0050896]; ureteric bud morphogenesis [GO:0060675]; visual perception [GO:0007601] GO:0005615; GO:0005634; GO:0005829; GO:0007601; GO:0009925; GO:0010633; GO:0016020; GO:0016021; GO:0016328; GO:0050678; GO:0050896; GO:0051497; GO:0060675; GO:0070062; GO:0090191; GO:1900025; GO:1900028; GO:2000146; GO:2000738 FSMKRLTAGLIAVIVVVVVALVAGMAVLVITNR 0.92692 1.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2874 0 0 0 0 0 0 0 0 11.8521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6656 0 0 0 0 14.0631 0 0 0 13.4799 0 0 14.0116 0 12.8746 0 13.328 0 0 0 13.3994 0 14.2315 0 13.9676 13.9272 13.2115 0 0 0 0 0 0 13.9944 11.4088 14.0524 0 0 13.2436 13.5928 13.5098 0 10.4353 13.3596 14.8368 12.7244 0 0 13.2872 0 0 0 12.3137 0 12.8753 0 0 0 0 12.7025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0823 0 0 0 0 0 0 0 0 0 0 0 0 11.9846 0 12.7909 0 0 0 0 P19438 TNR1A_HUMAN "Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1, TNF-R1) (Tumor necrosis factor receptor type I, TNF-RI, TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1, TBPI ]" TNFRSF1A TNFAR TNFR1 Homo sapiens (Human) aortic valve development [GO:0003176]; cellular response to mechanical stimulus [GO:0071260]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin metabolic process [GO:0006693]; protein localization to plasma membrane [GO:0072659]; pulmonary valve development [GO:0003177]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; transcription by RNA polymerase II [GO:0006366]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor activity [GO:0005031]; aortic valve development [GO:0003176]; cellular response to mechanical stimulus [GO:0071260]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin metabolic process [GO:0006693]; protein localization to plasma membrane [GO:0072659]; pulmonary valve development [GO:0003177]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; transcription by RNA polymerase II [GO:0006366]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0000139; GO:0002947; GO:0003176; GO:0003177; GO:0003332; GO:0005031; GO:0005576; GO:0005615; GO:0005739; GO:0005886; GO:0005887; GO:0006366; GO:0006693; GO:0006954; GO:0008625; GO:0008630; GO:0009986; GO:0010614; GO:0010803; GO:0016020; GO:0019221; GO:0033209; GO:0042531; GO:0042742; GO:0043120; GO:0043123; GO:0043235; GO:0045121; GO:0045944; GO:0050728; GO:0050729; GO:0071260; GO:0072659; GO:1902339; GO:1903140 tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor activity [GO:0005031] CRKEMGQVEISSCTVDR 0.92692 2.0795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1149 0 0 0 0 0 0 0 0 0 0 10.7217 0 0 11.2926 11.0674 0 0 0 11.1553 0 0 0 0 0 0 0 0 0 0 11.0815 11.0969 11.1364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1411 13.1132 0 0 12.7607 0 12.1876 0 0 13.8308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.261 0 15.6992 0 0 0 0 0 0 13.4698 15.1592 16.6422 16.916 0 15.2417 0 0 0 11.4534 12.8086 0 0 0 0 18.5957 12.0832 0 0 0 0 18.2164 0 0 0 0 0 0 18.1328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2071 0 0 0 0 0 13.1198 0 11.6653 0 0 0 0 0 10.5641 0 0 0 O75197 LRP5_HUMAN "Low-density lipoprotein receptor-related protein 5, LRP-5 (Low-density lipoprotein receptor-related protein 7, LRP-7)" LRP5 LR3 LRP7 Homo sapiens (Human) "adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; osteoblast proliferation [GO:0033687]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]" endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; osteoblast proliferation [GO:0033687]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019]" GO:0001702; GO:0002053; GO:0002076; GO:0005783; GO:0005886; GO:0006007; GO:0006897; GO:0008078; GO:0008203; GO:0008217; GO:0008284; GO:0009952; GO:0015026; GO:0016021; GO:0017147; GO:0033687; GO:0033690; GO:0035019; GO:0035426; GO:0042074; GO:0042632; GO:0042733; GO:0042813; GO:0042981; GO:0043235; GO:0045600; GO:0045668; GO:0045669; GO:0045840; GO:0045893; GO:0045944; GO:0046849; GO:0048539; GO:0051091; GO:0060033; GO:0060042; GO:0060070; GO:0060349; GO:0060444; GO:0060612; GO:0060764; GO:0061178; GO:0061304; GO:0071901; GO:0071936; GO:0110135; GO:1902262; GO:1904928; GO:1990851; GO:1990909 coreceptor activity [GO:0015026]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] AKDDGTQPFVLTSLSQGQNPDR 0.92694 1.862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6023 0 0 0 12.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7306 0 0 0 21.0026 14.5702 11.6158 0 0 13.8636 21.8917 21.5044 0 0 0 15.048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2097 19.5987 0 19.6134 0 0 0 0 0 0 0 0 0 0 0 0 11.3006 12.2438 0 0 0 0 0 0 0 0 0 0 18.3728 11.9559 0 0 0 12.3998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9848 0 0 0 0 0 0 0 0 11.123 Q14563 SEM3A_HUMAN "Semaphorin-3A (Semaphorin III, Sema III)" SEMA3A SEMAD Homo sapiens (Human) apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215]; apoptotic process [GO:0006915]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491] GO:0001755; GO:0001764; GO:0005576; GO:0005615; GO:0005887; GO:0006915; GO:0007411; GO:0008045; GO:0010977; GO:0021675; GO:0021772; GO:0030215; GO:0030335; GO:0030424; GO:0030425; GO:0038191; GO:0045499; GO:0046330; GO:0048485; GO:0048841; GO:0048843; GO:0048846; GO:0048880; GO:0050919; GO:0060385; GO:0061549; GO:0071526; GO:0097490; GO:0097491; GO:0150020; GO:1901166; GO:1902285; GO:2001224 chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215] ACAECCLARDPYCAWDGSACSR 0.92697 2.0497 0 0 0 0 0 14.7424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9111 0 0 0 0 0 13.3817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J237 TVA82_HUMAN T cell receptor alpha variable 8-2 TRAV8-2 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 GINGFEAEFKK 0.92698 1.992 0 0 0 0 0 0 0 0 0 13.3681 0 0 0 0 0 0 0 0 15.3883 0 0 0 0 0 0 0 14.9355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6521 0 0 0 0 0 0 12.8162 13.2923 14.531 15.6657 0 14.0403 14.6847 13.6131 12.9492 0 0 0 0 16.3244 0 14.3355 0 15.5825 13.6348 0 0 13.6148 0 16.0763 16.406 0 0 0 0 14.0353 0 13.0608 0 0 0 0 0 13.6686 0 0 0 0 0 0 0 0 0 0 14.9741 13.2509 0 0 15.7549 12.9576 15.871 0 0 16.1041 0 13.5255 0 0 14.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 13.159 13.4907 0 0 0 0 0 12.601 0 0 0 0 0 0 12.5593 0 12.6002 0 0 0 0 0 0 0 0 0 0 0 0 0 O60762 DPM1_HUMAN "Dolichol-phosphate mannosyltransferase subunit 1, EC 2.4.1.83 (Dolichol-phosphate mannose synthase subunit 1, DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1, MPD synthase subunit 1)" DPM1 Homo sapiens (Human) dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269] dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634] dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537]; dolichol metabolic process [GO:0019348]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269] GO:0004169; GO:0004582; GO:0005537; GO:0005634; GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0019348; GO:0019673; GO:0033185; GO:0035268; GO:0035269; GO:0043178 alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537] CVSKGYVFQMEMIVRAR 0.92698 1.9138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0477 0 0 0 0 0 0 0 0 0 0 0 12.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00748 EST2_HUMAN "Cocaine esterase, EC 3.1.1.84 (Carboxylesterase 2, CE-2, hCE-2, EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2, EC 3.1.1.56)" CES2 ICE Homo sapiens (Human) catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805] GO:0005783; GO:0005788; GO:0006693; GO:0006805; GO:0009056; GO:0043231; GO:0047374; GO:0052689; GO:0080030 carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374] ADHGDELPFVFRSFFGGNYIKFTEEEEQLSR 0.92699 2.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1935 0 13.7657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9695 0 13.4977 14.4908 0 14.7174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0179 0 0 13.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQS3 NECT3_HUMAN Nectin-3 (CDw113) (Nectin cell adhesion molecule 3) (Poliovirus receptor-related protein 3) (CD antigen CD113) NECTIN3 PRR3 PVRL3 Homo sapiens (Human) establishment of protein localization to plasma membrane [GO:0061951]; fertilization [GO:0009566]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; retina morphogenesis in camera-type eye [GO:0060042]; spermatid development [GO:0007286] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; establishment of protein localization to plasma membrane [GO:0061951]; fertilization [GO:0009566]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; retina morphogenesis in camera-type eye [GO:0060042]; spermatid development [GO:0007286] GO:0002089; GO:0005886; GO:0005911; GO:0005912; GO:0007156; GO:0007157; GO:0007286; GO:0009566; GO:0042802; GO:0042803; GO:0043296; GO:0044291; GO:0050839; GO:0060042; GO:0061951; GO:0098686; GO:0099061; GO:1902414 cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] FERPMDYYEDLKMGMK 0.92699 1.6411 0 0 0 0 0 15.6908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5S9 TM144_HUMAN Transmembrane protein 144 TMEM144 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; carbohydrate transmembrane transporter activity [GO:0015144] GO:0015144; GO:0016021 carbohydrate transmembrane transporter activity [GO:0015144] KFDTGDGMFLQWVLCAAIWLVALVVNLILHCPK 0.92702 1.9914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L11 LCFC1_HUMAN Sperm-egg fusion protein LLCFC1 (LLLL and CFNLAS motif-containing protein 1) (MSSP-binding protein CTM-1) (Sperm-oocyte fusion required protein 1) LLCFC1 C7orf34 SOF1 Homo sapiens (Human) fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] extracellular region [GO:0005576] extracellular region [GO:0005576]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] GO:0005576; GO:0007342 AVFLVPILLLLQVK 0.92702 1.9135 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2272 0 0 0 0 0 0 0 0 0 0 11.1187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7684 0 0 0 0 0 0 0 0 0 14.3525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3482 0 0 0 0 0 Q9C0F3 ZN436_HUMAN Zinc finger protein 436 ZNF436 KIAA1710 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DVMQENYGNVVSLDFEIR 0.92702 3.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98513 0 0 0 0 0 0 0 0 0 0 0 0 10.8941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2221 12.6075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3341 0 0 0 0 0 12.6738 0 0 0 0 0 0 13.8039 0 13.2438 0 0 0 0 0 0 0 12.9798 0 0 0 0 0 0 0 0 0 12.5839 0 0 0 11.8898 0 0 0 0 0 0 0 0 0 0 11.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7666 0 0 11.7314 0 Q9H813 PACC1_HUMAN "Proton-activated chloride channel, PAC, hPAC (Acid-sensitive outwardly-rectifying anion channel, ASOR) (Proton-activated outwardly rectifying anion channel, PAORAC) (Transmembrane protein 206, hTMEM206)" PACC1 C1orf75 TMEM206 Homo sapiens (Human) chloride transport [GO:0006821] cell surface [GO:0009986]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; pH-gated chloride channel activity [GO:0061797]; chloride transport [GO:0006821] GO:0005887; GO:0006821; GO:0009986; GO:0034707; GO:0061797 pH-gated chloride channel activity [GO:0061797] EEDGREAVEFRQETSVVNYIDQR 0.92702 2.0777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYG5 PAR6B_HUMAN "Partitioning defective 6 homolog beta, PAR-6 beta, PAR-6B" PARD6B PAR6B Homo sapiens (Human) axonogenesis [GO:0007409]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cell-cell junction assembly [GO:0007043]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; protein-containing complex assembly [GO:0065003]; regulation of cell migration [GO:0030334]; regulation of cellular localization [GO:0060341] GO:0005080; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007043; GO:0007098; GO:0007163; GO:0007409; GO:0016324; GO:0030334; GO:0032991; GO:0051301; GO:0060341; GO:0065003; GO:0070062; GO:0070160 protein kinase C binding [GO:0005080] KKPHIVISMPQDFR 0.92706 2.0465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8723 0 11.6831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4103 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6207 0 0 0 0 12.5599 0 0 0 0 0 0 0 0 0 0 0 12.1577 0 0 0 0 0 0 0 0 0 0 13.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0571 0 0 0 0 0 0 0 0 0 0 Q13496 MTM1_HUMAN "Myotubularin (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTM1 CG2 Homo sapiens (Human) autophagosome assembly [GO:0000045]; endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]; skeletal muscle tissue growth [GO:0048630]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; I band [GO:0031674]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; autophagosome assembly [GO:0000045]; endosome to lysosome transport [GO:0008333]; intermediate filament organization [GO:0045109]; mitochondrion distribution [GO:0048311]; mitochondrion morphogenesis [GO:0070584]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of skeletal muscle tissue growth [GO:0048633]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein transport [GO:0015031]; regulation of vacuole organization [GO:0044088]; skeletal muscle tissue growth [GO:0048630]; TOR signaling [GO:0031929]" GO:0000045; GO:0001726; GO:0004438; GO:0004721; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008333; GO:0015031; GO:0019215; GO:0030175; GO:0031674; GO:0031929; GO:0032007; GO:0032435; GO:0035091; GO:0043161; GO:0043491; GO:0044088; GO:0045109; GO:0046716; GO:0046856; GO:0048311; GO:0048630; GO:0048633; GO:0051898; GO:0052629; GO:0070584; GO:1902902 "intermediate filament binding [GO:0019215]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]" FKNPFYTKEINR 0.92707 2.0326 0 0 0 0 0 0 0 0 0 10.5173 0 0 10.4857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3165 0 0 0 0 0 0 0 0 0 0 0 12.7437 0 0 0 12.8875 0 0 0 0 13.4691 12.9084 13.6998 0 0 0 12.7506 0 0 0 0 0 13.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9197 0 0 0 0 0 0 0 Q8N8Q3 ENDOV_HUMAN "Endonuclease V, hEndoV, EC 3.1.26.- (Inosine-specific endoribonuclease)" ENDOV Homo sapiens (Human) DNA repair [GO:0006281] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; magnesium ion binding [GO:0000287]; single-stranded RNA binding [GO:0003727]; DNA repair [GO:0006281]" GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0010494; GO:0016888; GO:0016891 "DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; magnesium ion binding [GO:0000287]; single-stranded RNA binding [GO:0003727]" MALEAAGGPPEETLSLWK 0.92707 1.6605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60174 TPIS_HUMAN "Triosephosphate isomerase, TIM, EC 5.3.1.1 (Methylglyoxal synthase, EC 4.2.3.3) (Triose-phosphate isomerase)" TPI1 TPI Homo sapiens (Human) canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242] GO:0004807; GO:0005615; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0008929; GO:0019242; GO:0019563; GO:0031625; GO:0042803; GO:0046166; GO:0061621; GO:0070062 methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625] DWSKVVLAYEPVWAIGTGKTATPQQAQEVHEK 0.9271 2.3354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.237 13.1065 0 0 0 0 0 0 0 0 0 12.9979 0 0 0 0 0 0 0 0 0 0 0 Q16635 TAZ_HUMAN "Tafazzin, Taz, EC 2.3.1.- (Protein G4.5)" TAFAZZIN EFE2 G4.5 TAZ Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; cardiac muscle tissue development [GO:0048738]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; cardiolipin metabolic process [GO:0032048]; cristae formation [GO:0042407]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hemopoiesis [GO:0030097]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; muscle contraction [GO:0006936]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cardiolipin metabolic process [GO:1900210]; skeletal muscle tissue development [GO:0007519]; spermatocyte division [GO:0048137] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; O-acyltransferase activity [GO:0008374]; cardiac muscle contraction [GO:0060048]; cardiac muscle tissue development [GO:0048738]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; cardiolipin metabolic process [GO:0032048]; cristae formation [GO:0042407]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hemopoiesis [GO:0030097]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; muscle contraction [GO:0006936]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cardiolipin metabolic process [GO:1900210]; skeletal muscle tissue development [GO:0007519]; spermatocyte division [GO:0048137] GO:0000423; GO:0003007; GO:0003841; GO:0005739; GO:0005741; GO:0005743; GO:0006936; GO:0007005; GO:0007007; GO:0007507; GO:0007519; GO:0008374; GO:0030097; GO:0031966; GO:0032048; GO:0032049; GO:0032981; GO:0035965; GO:0042407; GO:0042775; GO:0047184; GO:0048137; GO:0048738; GO:0060048; GO:1900210; GO:2001171 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; O-acyltransferase activity [GO:0008374] ITVLIGKPFSALPVLER 0.9271 2.2388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2X7 GIT1_HUMAN "ARF GTPase-activating protein GIT1, ARF GAP GIT1 (Cool-associated and tyrosine-phosphorylated protein 1, CAT-1, CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1)" GIT1 Homo sapiens (Human) brain development [GO:0007420]; cell redox homeostasis [GO:0045454]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; intramembranous ossification [GO:0001957]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of interleukin-1 beta production [GO:0032691]; neuron development [GO:0048666]; positive regulation of microtubule nucleation [GO:0090063]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465] calyx of Held [GO:0044305]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202] calyx of Held [GO:0044305]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; brain development [GO:0007420]; cell redox homeostasis [GO:0045454]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; intramembranous ossification [GO:0001957]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of interleukin-1 beta production [GO:0032691]; neuron development [GO:0048666]; positive regulation of microtubule nucleation [GO:0090063]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465] GO:0001957; GO:0005096; GO:0005739; GO:0005813; GO:0005829; GO:0005925; GO:0007420; GO:0007626; GO:0008277; GO:0014069; GO:0016020; GO:0030027; GO:0031267; GO:0032012; GO:0032465; GO:0032691; GO:0036465; GO:0043005; GO:0043015; GO:0044305; GO:0044877; GO:0045202; GO:0045454; GO:0045820; GO:0046872; GO:0048013; GO:0048666; GO:0061743; GO:0071222; GO:0090063; GO:0097431; GO:0098794; GO:0099171; GO:0106015; GO:2000300 gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] AAKQLVTITTR 0.92712 2.0316 0 0 0 11.8818 11.7827 0 0 0 0 0 0 0 0 0 0 0 0 13.1574 0 0 12.6312 0 0 0 0 0 0 0 0 0 10.9622 0 0 0 0 0 0 0 0 0 9.96217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3265 0 0 13.1178 11.4069 0 0 0 0 12.7041 0 12.171 12.3961 0 0 0 12.9775 13.426 0 0 12.7528 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2239 0 0 0 0 0 12.7094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5244 0 13.968 0 0 0 0 0 0 0 0 0 0 0 0 12.0042 12.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q495B1 AKD1A_HUMAN Ankyrin repeat and death domain-containing protein 1A ANKDD1A Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 DGLTLLHCAAQKGHVPVLAFIMEDLEDVALDHVDKLGR 0.92713 2.1696 0 0 0 0 0 0 0 0 13.101 13.2136 13.1976 0 13.1257 13.2513 13.0947 0 0 0 0 0 0 0 0 0 0 0 0 13.2019 13.4135 0 13.242 13.3376 12.3351 0 13.1057 13.1024 13.2686 13.294 0 0 12.5291 12.6146 0 0 0 0 0 0 12.4742 0 0 0 0 0 0 0 12.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.23 0 0 0 0 0 0 0 0 0 0 0 15.8994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6702 0 0 0 0 0 0 0 0 0 14.4949 14.7394 0 0 14.7677 14.6166 0 14.6269 0 0 14.4879 0 14.4866 0 0 0 0 0 0 0 0 0 0 P49190 PTH2R_HUMAN "Parathyroid hormone 2 receptor, PTH2 receptor" PTH2R PTHR2 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cold-induced thermogenesis [GO:0120162] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cold-induced thermogenesis [GO:0120162] GO:0004991; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007188; GO:0008528; GO:0017046; GO:0120162 G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046] HCNPNGTWDFMHSLNKTWANYSDCLR 0.92714 2.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5818 0 0 0 0 0 0 12.4808 0 0 0 0 0 0 0 0 11.7389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7898 0 0 0 0 0 Q06136 KDSR_HUMAN "3-ketodihydrosphingosine reductase, KDS reductase, EC 1.1.1.102 (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1, FVT-1) (Short chain dehydrogenase/reductase family 35C member 1)" KDSR FVT1 SDR35C1 Homo sapiens (Human) 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-dehydrosphinganine reductase activity [GO:0047560]; 3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148] GO:0005615; GO:0005783; GO:0005789; GO:0006666; GO:0016020; GO:0016021; GO:0030148; GO:0047560 3-dehydrosphinganine reductase activity [GO:0047560] AVITTMKERR 0.92714 1.1025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6026 0 0 0 0 0 0 0 0 12.7073 11.9221 12.8887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2794 0 12.3735 0 0 0 0 0 12.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7705 0 0 0 0 0 0 0 0 0 Q9Y646 CBPQ_HUMAN "Carboxypeptidase Q, EC 3.4.17.- (Lysosomal dipeptidase) (Plasma glutamate carboxypeptidase)" CPQ LCH1 PGCP Homo sapiens (Human) peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246] GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0043231; GO:0046872; GO:0070062; GO:0070573 carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803] AIINLAVYGK 0.92715 2.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8872 0 11.5712 0 0 0 0 0 0 0 11.5063 0 14.085 0 0 11.0327 0 0 0 14.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3666 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9779 0 0 0 0 0 14.8488 0 0 0 0 0 0 0 0 11.3852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MXT2 MAGBH_HUMAN Melanoma-associated antigen B17 MAGEB17 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 MKVLEFVAKLNDTVASTYK 0.92716 2.0297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1641 10.3886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60939 SCN2B_HUMAN Sodium channel subunit beta-2 SCN2B UNQ326/PRO386 Homo sapiens (Human) cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; gene expression [GO:0010467]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; nervous system development [GO:0007399]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; response to heat [GO:0009408]; response to pyrethroid [GO:0046684]; sodium ion transmembrane transport [GO:0035725] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated sodium channel complex [GO:0001518] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated sodium channel complex [GO:0001518]; sodium channel regulator activity [GO:0017080]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; gene expression [GO:0010467]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; nervous system development [GO:0007399]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; response to heat [GO:0009408]; response to pyrethroid [GO:0046684]; sodium ion transmembrane transport [GO:0035725] GO:0001518; GO:0005886; GO:0007268; GO:0007399; GO:0009408; GO:0010467; GO:0017080; GO:0035725; GO:0045202; GO:0046684; GO:0060048; GO:0060371; GO:0086002; GO:0086006; GO:0086012; GO:0086091; GO:1902282; GO:2000649 sodium channel regulator activity [GO:0017080]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006] DSTVAVIVGASVGGFLAVVILVLMVVK 0.92716 1.1021 0 0 0 0 0 0 0 0 0 0 12.8699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0U1RQI7 KLF18_HUMAN Kruppel-like factor 18 KLF18 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" NPEVSRPYVCTYEDCK 0.92717 3.5595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8622 0 12.0708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2264 0 12.4064 0 0 0 0 0 0 11.7463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7138 0 0 0 0 0 0 0 0 0 12.9209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0914 0 0 0 0 0 0 11.6935 0 0 0 0 0 0 13.6904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NM36 LRC30_HUMAN Leucine-rich repeat-containing protein 30 LRRC30 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] GO:0004722; GO:0005737; GO:0007165; GO:0043231 protein serine/threonine phosphatase activity [GO:0004722] LTRIVVLNLCGNRLK 0.92724 1.0998 0 0 0 0 0 0 0 0 0 0 12.8834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8292 15.1315 13.2421 0 0 0 0 12.0816 0 0 0 0 0 0 0 0 0 0 0 0 12.5748 0 0 0 0 0 0 0 0 0 0 13.1803 0 0 0 0 0 0 0 0 0 0 12.5101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4813 P10244 MYBB_HUMAN "Myb-related protein B, B-Myb (Myb-like protein 2)" MYBL2 BMYB Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]" Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to leukemia inhibitory factor [GO:1990830]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006355; GO:0031523; GO:0043525; GO:0045944; GO:0090307; GO:1990830; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DQLFMQEKAR 0.92726 2.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6994 15.204 0 0 12.5521 0 16.9916 0 0 0 0 0 0 0 0 0 13.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8457 0 0 0 0 12.4834 0 12.1897 0 0 0 0 12.6474 0 0 0 0 0 0 0 0 11.3617 0 0 0 0 0 15.9438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1768 0 0 0 0 0 0 0 0 0 0 13.854 0 0 0 0 0 0 0 0 0 Q04941 PLP2_HUMAN Proteolipid protein 2 (Differentiation-dependent protein A4) (Intestinal membrane A4 protein) PLP2 A4 Homo sapiens (Human) chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; ion transport [GO:0006811] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemokine binding [GO:0019956]; ion transmembrane transporter activity [GO:0015075]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; ion transport [GO:0006811] GO:0005783; GO:0005789; GO:0005886; GO:0006811; GO:0006935; GO:0015075; GO:0016020; GO:0016021; GO:0019221; GO:0019956 chemokine binding [GO:0019956]; ion transmembrane transporter activity [GO:0015075] LSAPGCWAACTNFSRTRK 0.92726 2.2342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4633 0 0 0 0 14.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3726 0 0 0 0 13.1982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.77 0 0 13.3744 13.256 13.0608 13.2302 0 13.1801 0 0 0 0 0 0 0 12.0959 0 0 11.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4438 0 0 0 0 12.2339 0 0 0 0 0 12.5361 0 0 0 0 0 0 0 0 0 0 Q15181 IPYR_HUMAN "Inorganic pyrophosphatase, EC 3.6.1.1 (Pyrophosphate phospho-hydrolase, PPase)" PPA1 IOPPP PP Homo sapiens (Human) phosphate-containing compound metabolic process [GO:0006796] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796] GO:0000287; GO:0004427; GO:0005737; GO:0005829; GO:0006796; GO:0070062 inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287] PENEFAFNAEFK 0.92726 1.0996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.31082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9881 0 0 0 10.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53H76 PLA1A_HUMAN "Phospholipase A1 member A, EC 3.1.1.111 (Phosphatidylserine-specific phospholipase A1, PS-PLA1)" PLA1A NMD PSPLA1 Homo sapiens (Human) lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phosphatidylserine metabolic process [GO:0006658] acrosomal membrane [GO:0002080]; extracellular region [GO:0005576]; extracellular space [GO:0005615] acrosomal membrane [GO:0002080]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phosphatidylserine metabolic process [GO:0006658] GO:0002080; GO:0005576; GO:0005615; GO:0006629; GO:0006658; GO:0008970; GO:0016042; GO:0016298; GO:0036150; GO:0052739 lipase activity [GO:0016298]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970] IGLVEQGGVKIEPLPKEVK 0.92727 2.278 15.7695 14.0119 13.1918 0 0 0 13.8703 16.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4932 0 14.6415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8881 13.244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1857 0 0 0 0 0 13.2042 0 14.8771 0 0 0 19.5777 0 15.0869 0 0 0 16.9468 0 0 14.0934 0 0 14.4827 0 0 0 12.0327 0 0 0 13.9947 0 0 0 0 19.4918 14.0181 13.051 0 0 0 0 0 0 0 0 0 0 0 11.9618 0 14.3828 19.4537 16.8493 0 0 0 14.1065 0 13.5735 0 0 0 18.9162 0 0 0 0 0 0 0 0 0 15.6605 0 12.8259 0 0 14.344 0 11.1655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FN9 DTD2_HUMAN "D-aminoacyl-tRNA deacylase 2, EC 3.1.1.96 (Animalia-specific tRNA deacylase, ATD) (D-tyrosyl-tRNA(Tyr) deacylase 2) (L-alanyl-tRNA deacylase)" DTD2 C14orf126 Homo sapiens (Human) aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; Ala-tRNA(Thr) hydrolase activity [GO:0106105]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399] GO:0000049; GO:0005737; GO:0006399; GO:0051500; GO:0106074; GO:0106105 Ala-tRNA(Thr) hydrolase activity [GO:0106105]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049] LQIRPADGDVAAQWVEVQRGLVIYVCFFK 0.92727 2.0543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3276 0 0 0 13.8603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5024 0 0 0 15.5985 0 0 0 0 15.4059 14.7641 0 15.2995 0 0 0 0 0 14.8667 0 0 0 0 14.8597 0 0 0 14.732 0 0 14.5004 0 0 0 0 0 0 0 0 0 0 0 0 14.4403 0 0 0 0 0 0 0 11.5341 0 0 0 0 11.51 0 12.7741 0 0 0 0 12.8403 0 0 0 0 0 0 O75022 LIRB3_HUMAN "Leukocyte immunoglobulin-like receptor subfamily B member 3, LIR-3, Leukocyte immunoglobulin-like receptor 3 (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5, ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a)" LILRB3 ILT5 LIR3 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; negative regulation of osteoclast differentiation [GO:0045671] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; negative regulation of osteoclast differentiation [GO:0045671] GO:0002250; GO:0004888; GO:0005886; GO:0005887; GO:0006952; GO:0007166; GO:0019221; GO:0030667; GO:0032396; GO:0038023; GO:0045671 inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] SMYGAHK 0.92729 2.2111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7048 0 0 0 11.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9048 0 0 0 0 0 0 11.1561 0 11.4366 0 0 0 0 0 0 13.2317 0 12.7941 0 0 0 0 0 0 12.3012 0 0 0 0 0 0 12.3661 0 0 0 0 0 0 0 13.1581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9915 P24530 EDNRB_HUMAN "Endothelin receptor type B, ET-B, ET-BR (Endothelin receptor non-selective type)" EDNRB ETRB Homo sapiens (Human) aging [GO:0007568]; aldosterone metabolic process [GO:0032341]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; cGMP-mediated signaling [GO:0019934]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; enteric nervous system development [GO:0048484]; enteric smooth muscle cell differentiation [GO:0035645]; epithelial fluid transport [GO:0042045]; establishment of endothelial barrier [GO:0061028]; gene expression [GO:0010467]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron maturation [GO:0014043]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuroblast migration [GO:0097402]; peripheral nervous system development [GO:0007422]; pharynx development [GO:0060465]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; podocyte differentiation [GO:0072112]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of penile erection [GO:0060406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; posterior midgut development [GO:0007497]; protein transmembrane transport [GO:0071806]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fever generation [GO:0031620]; regulation of heart rate [GO:0002027]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; renal albumin absorption [GO:0097018]; renal sodium excretion [GO:0035812]; renal sodium ion absorption [GO:0070294]; renin secretion into blood stream [GO:0002001]; response to endothelin [GO:1990839]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to sodium phosphate [GO:1904383]; sensory perception of pain [GO:0019233]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311]; vein smooth muscle contraction [GO:0014826] integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; endothelin receptor activity [GO:0004962]; peptide hormone binding [GO:0017046]; type 1 angiotensin receptor binding [GO:0031702]; aging [GO:0007568]; aldosterone metabolic process [GO:0032341]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; cGMP-mediated signaling [GO:0019934]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; enteric nervous system development [GO:0048484]; enteric smooth muscle cell differentiation [GO:0035645]; epithelial fluid transport [GO:0042045]; establishment of endothelial barrier [GO:0061028]; gene expression [GO:0010467]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron maturation [GO:0014043]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuroblast migration [GO:0097402]; peripheral nervous system development [GO:0007422]; pharynx development [GO:0060465]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; podocyte differentiation [GO:0072112]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of penile erection [GO:0060406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; posterior midgut development [GO:0007497]; protein transmembrane transport [GO:0071806]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fever generation [GO:0031620]; regulation of heart rate [GO:0002027]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; renal albumin absorption [GO:0097018]; renal sodium excretion [GO:0035812]; renal sodium ion absorption [GO:0070294]; renin secretion into blood stream [GO:0002001]; response to endothelin [GO:1990839]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to sodium phosphate [GO:1904383]; sensory perception of pain [GO:0019233]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311]; vein smooth muscle contraction [GO:0014826] GO:0000122; GO:0001755; GO:0001934; GO:0002001; GO:0002027; GO:0004962; GO:0005886; GO:0005887; GO:0006885; GO:0007166; GO:0007194; GO:0007200; GO:0007204; GO:0007249; GO:0007399; GO:0007422; GO:0007497; GO:0007568; GO:0008284; GO:0010467; GO:0014043; GO:0014070; GO:0014826; GO:0017046; GO:0019233; GO:0019722; GO:0019934; GO:0030202; GO:0030318; GO:0031620; GO:0031702; GO:0031965; GO:0032341; GO:0035645; GO:0035810; GO:0035812; GO:0035815; GO:0042045; GO:0042310; GO:0042311; GO:0043066; GO:0045121; GO:0048066; GO:0048246; GO:0048265; GO:0048484; GO:0050678; GO:0051248; GO:0051930; GO:0060070; GO:0060406; GO:0060465; GO:0061028; GO:0070294; GO:0070588; GO:0071222; GO:0071806; GO:0072112; GO:0086100; GO:0097018; GO:0097402; GO:1904383; GO:1990839 endothelin receptor activity [GO:0004962]; peptide hormone binding [GO:0017046]; type 1 angiotensin receptor binding [GO:0031702] ALVALVLACGLSRIWGEER 0.9273 1.9616 0 0 0 0 0 0 0 0 0 0 0 0 12.3726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7119 0 0 10.0925 0 0 0 0 0 0 0 0 11.7195 0 0 10.9103 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4955 0 0 13.2658 0 14.8174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5361 0 0 0 13.1082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4647 0 0 0 0 0 0 0 0 0 15.1195 0 0 0 14.1405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7654 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2917 0 0 0 P13762 DRB4_HUMAN "HLA class II histocompatibility antigen, DR beta 4 chain (MHC class II antigen DRB4)" HLA-DRB4 Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] GO:0000139; GO:0002250; GO:0002503; GO:0005765; GO:0005886; GO:0012507; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0031902; GO:0032588; GO:0042613; GO:0050870; GO:0071556 MHC class II protein complex binding [GO:0023026] RAEVDTYCR 0.92732 1.8646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75157 T22D2_HUMAN TSC22 domain family protein 2 (TSC22-related-inducible leucine zipper protein 4) TSC22D2 KIAA0669 TILZ4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] regulation of transcription by RNA polymerase II [GO:0006357] GO:0006357 DSDSSVLTR 0.92733 2.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9671 0 0 0 0 11.5265 0 0 0 0 0 0 0 9.88364 0 0 0 0 12.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9748 0 0 0 0 0 0 0 0 0 0 P58401 NRX2B_HUMAN Neurexin-2-beta (Neurexin II-beta) NRXN2 Homo sapiens (Human) neuron cell-cell adhesion [GO:0007158]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; neuron cell-cell adhesion [GO:0007158]; signal transduction [GO:0007165] GO:0004888; GO:0005886; GO:0007158; GO:0007165; GO:0016021; GO:0050839; GO:0097109 cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888] EKAPAAPK 0.92734 1.6514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.77 0 0 0 0 0 0 0 0 12.1781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBI6 CP4FB_HUMAN "Cytochrome P450 4F11, CYPIVF11, EC 1.14.14.1 (3-hydroxy fatty acids omega-hydroxylase CYP4F11) (Docosahexaenoic acid omega-hydroxylase, EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase, EC 1.14.14.80) (Phylloquinone omega-hydroxylase CYP4F11, EC 1.14.14.78)" CYP4F11 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377]" GO:0004497; GO:0005504; GO:0005506; GO:0005789; GO:0006631; GO:0007596; GO:0008391; GO:0016021; GO:0016709; GO:0019369; GO:0020037; GO:0031408; GO:0036101; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0070330; GO:0097267; GO:0102033 "arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]" ILPTHTEPRRK 0.92734 2.2638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4027 0 0 0 12.766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ75 ROBO4_HUMAN Roundabout homolog 4 (Magic roundabout) ROBO4 UNQ421/PRO3674 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334] axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; establishment of endothelial barrier [GO:0061028]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334] GO:0001525; GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0030334; GO:0030424; GO:0038023; GO:0061028; GO:0070062; GO:0070593; GO:0098632 cell-cell adhesion mediator activity [GO:0098632]; signaling receptor activity [GO:0038023] ARGPDSNVLLLRLPEK 0.92735 1.6428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0235 0 13.5513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75312 ZPR1_HUMAN Zinc finger protein ZPR1 (Zinc finger protein 259) ZPR1 ZNF259 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834] axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834] GO:0000226; GO:0001833; GO:0001834; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0007165; GO:0008270; GO:0008283; GO:0008380; GO:0010628; GO:0015030; GO:0021510; GO:0030424; GO:0030426; GO:0030576; GO:0030971; GO:0031369; GO:0031641; GO:0033120; GO:0042023; GO:0042307; GO:0043025; GO:0043204; GO:0045787; GO:0045927; GO:0048471; GO:0061564; GO:0071364; GO:0071931; GO:0097504; GO:1902742; GO:1990261; GO:2000672 receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270] AHFIMDDPAGNSYLQNVYAPEDDPEMKVER 0.92736 2.0532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.542 0 12.1811 0 0 0 0 14.7245 0 13.0882 0 0 0 12.3571 13.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF64 GIPC3_HUMAN PDZ domain-containing protein GIPC3 GIPC3 C19orf64 Homo sapiens (Human) LRSGGAATVEEAPSEFEEEASR 0.92737 2.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28221 5HT1D_HUMAN "5-hydroxytryptamine receptor 1D, 5-HT-1D, 5-HT1D (Serotonin 1D alpha receptor, 5-HT-1D-alpha) (Serotonin receptor 1D)" HTR1D HTR1DA HTRL Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intestine smooth muscle contraction [GO:0014827]; regulation of behavior [GO:0050795]; regulation of locomotion [GO:0040012]; vasoconstriction [GO:0042310]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intestine smooth muscle contraction [GO:0014827]; regulation of behavior [GO:0050795]; regulation of locomotion [GO:0040012]; vasoconstriction [GO:0042310]" GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007268; GO:0014827; GO:0030425; GO:0030594; GO:0040012; GO:0042310; GO:0045202; GO:0050795; GO:0051378 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] ILGIILGAFIICWLPFFVVSLVLPICR 0.92739 1.103 0 0 0 0 0 0 10.6111 0 0 10.8469 0 0 0 0 0 0 0 0 0 0 12.9054 0 13.4481 0 0 0 0 13.8378 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6658 0 0 0 0 0 0 0 0 0 0 0 14.3191 0 11.5533 14.6533 0 0 17.7556 0 0 14.5525 0 14.3054 0 0 14.86 0 0 0 0 0 0 0 0 14.2795 0 0 14.5667 0 0 15.0206 0 0 0 0 10.6646 0 0 0 14.2969 0 0 0 0 0 0 14.5254 0 0 0 0 14.7194 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7696 0 0 0 0 0 0 0 14.4362 14.6965 14.9332 13.6961 0 14.1658 0 14.5058 0 0 13.3122 0 0 0 0 0 0 0 0 14.2254 0 0 0 0 0 0 Q9Y576 ASB1_HUMAN "Ankyrin repeat and SOCS box protein 1, ASB-1" ASB1 KIAA1146 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; male genitalia development [GO:0030539]; negative regulation of cytokine production [GO:0001818]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; intracellular signal transduction [GO:0035556]; male genitalia development [GO:0030539]; negative regulation of cytokine production [GO:0001818]; protein ubiquitination [GO:0016567] GO:0000151; GO:0001818; GO:0005829; GO:0016567; GO:0030539; GO:0035556 LHLIPSLPLPDPIK 0.92739 1.9594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9123 0 0 0 0 0 0 10.3992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.051 0 0 0 0 0 0 0 0 0 0 0 0 12.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 P42081 CD86_HUMAN T-lymphocyte activation antigen CD86 (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD antigen CD86) CD86 CD28LG2 Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription, DNA-templated [GO:0045893]; T cell costimulation [GO:0031295]" cell surface [GO:0009986]; centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription, DNA-templated [GO:0045893]; T cell costimulation [GO:0031295]" GO:0001618; GO:0002250; GO:0002639; GO:0005886; GO:0006955; GO:0007166; GO:0007202; GO:0008284; GO:0009897; GO:0009986; GO:0015026; GO:0016021; GO:0023035; GO:0031295; GO:0032743; GO:0032753; GO:0032761; GO:0034451; GO:0038023; GO:0042102; GO:0042113; GO:0042130; GO:0045630; GO:0045893; GO:0070062; GO:0071222; GO:1901224; GO:1990051 coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] KMSVLLRTK 0.92744 2.2747 0 0 0 0 0 0 0 0 0 0 10.9297 0 0 0 0 0 0 0 0 0 0 0 0 12.413 0 0 0 0 0 0 0 0 10.1775 0 0 0 0 0 0 0 12.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7601 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9687 0 0 0 0 0 0 12.7223 12.2689 0 0 0 0 0 0 0 0 0 0 0 0 10.5865 0 0 0 0 0 0 0 0 0 0 0 0 15.8654 0 0 12.6173 0 0 0 0 0 10.2497 0 0 0 0 0 0 0 0 0 0 12.2782 0 0 12.1324 0 0 0 11.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0176 0 14.6708 0 0 0 0 0 0 Q5T6L9 EMARD_HUMAN "Endoplasmic reticulum membrane-associated RNA degradation protein, ER membrane-associated RNA degradation protein" ERMARD C6orf70 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 ETTNQLLAFSLVLLLRFVDDCLLSVFK 0.92744 2.2077 0 0 0 0 0 0 0 0 13.4513 14.9803 15.894 15.0983 15.578 15.4737 15.3724 15.2858 15.3179 13.3058 0 13.1645 13.4159 0 0 0 14.8422 0 13.0753 15.1164 15.184 13.5863 14.3892 14.6284 14.0683 0 13.2555 12.8898 14.2314 13.0349 0 12.9968 12.5258 14.6115 14.4819 12.9885 0 0 0 13.4599 12.6412 14.5278 0 0 0 0 0 0 16.1152 0 0 0 13.0925 13.8284 0 0 0 0 0 0 0 0 0 0 0 12.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0968 0 0 0 0 0 0 0 10.4073 0 10.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6468 0 0 15.1887 18.4178 16.1613 0 15.2028 15.3762 0 15.9274 14.4112 15.212 0 0 0 0 14.9651 0 17.7688 0 0 P51690 ARSL_HUMAN "Arylsulfatase L, EC 3.1.6.1 (Arylsulfatase E, ASE)" ARSL ARSE Homo sapiens (Human) skeletal system development [GO:0001501] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; skeletal system development [GO:0001501] GO:0001501; GO:0004065; GO:0005788; GO:0005794; GO:0005795; GO:0046872; GO:0070062 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] LNFLFQVLALVALTLVAGK 0.92745 2.1985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3983 0 0 0 0 0 0 13.1696 0 0 14.2643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5618 0 0 0 0 0 0 0 0 0 0 0 14.4304 0 0 14.3729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51693 APLP1_HUMAN "Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1, APLP, APLP-1) [Cleaved into: C30 ]" APLP1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; mRNA polyadenylation [GO:0006378]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399]; regulation of translation [GO:0006417] basement membrane [GO:0005604]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; alpha-2B adrenergic receptor binding [GO:0031695]; alpha-2C adrenergic receptor binding [GO:0031696]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to norepinephrine stimulus [GO:0071874]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; mRNA polyadenylation [GO:0006378]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; nervous system development [GO:0007399]; regulation of translation [GO:0006417] GO:0005604; GO:0005654; GO:0005794; GO:0005886; GO:0006378; GO:0006417; GO:0006897; GO:0006915; GO:0007155; GO:0007399; GO:0007409; GO:0007417; GO:0008201; GO:0009887; GO:0016021; GO:0030198; GO:0030900; GO:0031694; GO:0031695; GO:0031696; GO:0042802; GO:0046914; GO:0048471; GO:0071874; GO:0106072 alpha-2A adrenergic receptor binding [GO:0031694]; alpha-2B adrenergic receptor binding [GO:0031695]; alpha-2C adrenergic receptor binding [GO:0031696]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914] EAVSGLLIMGAGGGSLIVLSMLLLR 0.92745 3.5582 0 0 0 0 0 0 0 0 0 0 0 0 11.4901 0 0 0 0 0 11.0936 0 0 13.2767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1953 0 0 0 0 0 0 0 0 0 0 0 17.4375 0 0 15.9648 15.6984 15.3919 15.2612 16.7676 12.0815 0 0 11.2121 0 0 12.1102 0 0 0 0 0 0 0 0 0 13.5682 0 0 17.0312 14.2111 11.7231 0 14.0289 0 0 13.5588 0 0 0 0 0 0 0 0 0 0 10.8825 0 0 0 0 12.6607 0 0 0 13.3188 0 13.8592 0 0 12.5823 0 11.5811 0 0 0 0 15.3853 0 0 15.5924 12.814 14.6357 12.8402 0 0 13.0094 16.9424 0 0 13.216 0 0 0 0 0 12.9162 0 0 0 0 0 15.2486 0 13.7929 0 11.3855 0 0 0 0 18.7791 0 0 17.1667 0 0 0 0 0 0 0 0 0 0 0 11.5531 0 0 0 0 12.9787 0 P78383 S35B1_HUMAN "Solute carrier family 35 member B1 (ATP/ADP exchanger ER, AXER) (Endoplasmic reticulum ATP/ADP translocase) (UDP-galactose transporter-related protein 1, UGTrel1)" SLC35B1 UGTREL1 Homo sapiens (Human) UDP-galactose transmembrane transport [GO:0072334] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; ATP:ADP antiporter activity [GO:0005471]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460]; UDP-galactose transmembrane transport [GO:0072334] GO:0005459; GO:0005460; GO:0005471; GO:0005789; GO:0022857; GO:0030173; GO:0030176; GO:0043231; GO:0072334 ATP:ADP antiporter activity [GO:0005471]; transmembrane transporter activity [GO:0022857]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460] FGKGAKK 0.92747 1.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6304 0 0 0 0 0 0 0 10.6122 0 13.7755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0998 0 0 0 0 0 0 0 15.3051 0 0 0 0 0 13.5232 0 0 0 0 0 0 0 14.358 0 0 0 0 0 0 0 14.358 0 10.6674 0 0 0 0 14.7842 13.9043 0 14.4016 0 0 13.5392 0 0 0 0 0 0 0 12.8626 0 0 0 0 0 14.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0946 0 0 0 0 0 0 0 0 0 14.4022 0 Q14003 KCNC3_HUMAN Potassium voltage-gated channel subfamily C member 3 (KSHIIID) (Voltage-gated potassium channel subunit Kv3.3) KCNC3 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765] anchoring junction [GO:0070161]; axon [GO:0030424]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; axon [GO:0030424]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005856; GO:0005886; GO:0005938; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032591; GO:0032809; GO:0034765; GO:0042734; GO:0043204; GO:0045211; GO:0051260; GO:0051262; GO:0070161; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] AAKDVLGFLRVVR 0.92747 1.6616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6306 0 12.0031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2868 0 15.6186 0 0 0 14.3514 11.8848 0 0 0 15.207 0 0 0 0 12.0847 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9296 0 0 13.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6272 12.1891 0 0 0 0 Q8TAL6 FIBIN_HUMAN Fin bud initiation factor homolog FIBIN PSEC0235 Homo sapiens (Human) protein kinase C signaling [GO:0070528]; response to dexamethasone [GO:0071548]; response to manganese ion [GO:0010042] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; protein homodimerization activity [GO:0042803]; protein kinase C signaling [GO:0070528]; response to dexamethasone [GO:0071548]; response to manganese ion [GO:0010042] GO:0005576; GO:0005783; GO:0005794; GO:0010042; GO:0042803; GO:0070528; GO:0071548 protein homodimerization activity [GO:0042803] RCSQGEGSQVGSLLSLTLREEFTVLGR 0.92747 1.1001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8308 0 0 0 11.6003 0 0 11.5808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6324 0 11.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7008 0 0 11.5085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5324 0 0 0 0 0 0 0 0 0 0 0 0 A2A3L6 TTC24_HUMAN "Tetratricopeptide repeat protein 24, TPR repeat protein 24" TTC24 Homo sapiens (Human) AHLPFVGPGPPR 0.9275 1.6608 13.1795 0 0 0 0 0 14.748 0 12.4756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8306 14.2971 13.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5423 14.5275 14.5741 14.6324 14.376 16.4336 14.5845 0 0 0 0 0 0 0 0 14.8272 0 15.3806 0 0 0 0 0 0 15.3931 14.9405 0 0 14.4595 0 15.2517 0 0 0 0 0 0 13.0654 13.9858 0 0 0 14.8987 14.6914 0 14.2533 14.4349 0 14.2471 0 0 14.0062 0 14.6573 14.4957 0 0 13.1013 0 13.5092 0 0 0 17.376 14.4047 12.4262 15.099 15.0968 0 0 14.1201 0 0 14.2998 0 0 0 15.3698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1408 0 0 0 0 0 0 Q14406 CSHL_HUMAN "Chorionic somatomammotropin hormone-like 1, Chorionic somatomammotropin-like (Lactogen-like)" CSHL1 CSHP1 CSL Homo sapiens (Human) animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667] extracellular space [GO:0005615]; vesicle [GO:0031982] extracellular space [GO:0005615]; vesicle [GO:0031982]; growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]; animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667] GO:0005131; GO:0005179; GO:0005615; GO:0008083; GO:0031667; GO:0031982; GO:0042531; GO:0045927; GO:0046427; GO:0046872; GO:0048513; GO:0060396 growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872] MVQCRSVEGSCGF 0.92751 1.9143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2143 0 0 0 0 0 0 0 0 0 0 0 12.6945 0 0 11.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8442 0 0 0 0 0 0 0 0 0 0 0 0 0 P00846 ATP6_HUMAN ATP synthase subunit a (F-ATPase protein 6) MT-ATP6 ATP6 ATPASE6 MTATP6 Homo sapiens (Human) aging [GO:0007568]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to hyperoxia [GO:0055093] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton transmembrane transporter activity [GO:0015078]; aging [GO:0007568]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to hyperoxia [GO:0055093]" GO:0005743; GO:0005753; GO:0007568; GO:0015078; GO:0015986; GO:0016021; GO:0042776; GO:0045263; GO:0055093 proton transmembrane transporter activity [GO:0015078] LITTQQWLIK 0.92752 2.0798 0 0 0 0 0 0 0 0 0 0 12.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0467 0 15.1349 0 0 0 0 0 12.5104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4584 0 0 0 0 0 13.5723 0 12.2613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 P45877 PPIC_HUMAN "Peptidyl-prolyl cis-trans isomerase C, PPIase C, EC 5.2.1.8 (Cyclophilin C) (Rotamase C)" PPIC CYPC Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018; GO:0043231; GO:0070062 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] DVGRIVIGLFGKVVPK 0.92752 1.0984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5674 0 0 0 0 0 11.0183 0 0 0 0 0 0 0 0 0 0 0 10.3775 O60551 NMT2_HUMAN "Glycylpeptide N-tetradecanoyltransferase 2, EC 2.3.1.97 (Myristoyl-CoA:protein N-myristoyltransferase 2, NMT 2) (Peptide N-myristoyltransferase 2) (Protein-lysine myristoyltransferase NMT2, EC 2.3.1.-) (Type II N-myristoyltransferase)" NMT2 Homo sapiens (Human) intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400] GO:0004379; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0018008; GO:0018030; GO:0019898; GO:0022400; GO:0043657; GO:0075733 glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030] IQQPSKNPSVPMQKLQDIQR 0.92754 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.343 0 11.9348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5484 0 0 0 0 0 0 10.9656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7768 0 0 0 0 0 0 13.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.098 13.0162 0 0 13.0284 0 0 12.4344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6782 0 0 0 0 0 0 0 0 0 0 0 P51522 ZNF83_HUMAN Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1) ZNF83 ZNF816B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNECGKVFHNMSHLAQHR 0.92755 2.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4832 0 10.4465 0 11.5943 0 0 0 0 0 0 0 0 0 14.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1738 0 0 0 0 0 0 12.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRC1 ST7_HUMAN Suppressor of tumorigenicity 7 protein (Protein FAM4A1) (Protein HELG) ST7 FAM4A1 HELG RAY1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; regulation of cell differentiation [GO:0045595] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; extracellular matrix organization [GO:0030198]; regulation of cell differentiation [GO:0045595] GO:0016021; GO:0030198; GO:0045595 DWNCKSIFMRVEDELEIPPAPQSQHFQN 0.92755 2.3453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7299 0 0 0 0 0 0 0 0 12.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8815 0 0 0 0 12.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBM8 PCYXL_HUMAN "Prenylcysteine oxidase-like, EC 1.8.3.-" PCYOX1L PSEC0105 Homo sapiens (Human) prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; prenylcysteine oxidase activity [GO:0001735]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] GO:0001735; GO:0005576; GO:0016020; GO:0030327; GO:0030328; GO:0031093 prenylcysteine oxidase activity [GO:0001735] DLMHKVKTEL 0.92762 2.2443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8972 0 13.8869 0 0 0 0 0 0 0 0 0 16.7688 0 0 0 0 0 0 0 13.5805 0 0 0 0 16.6781 16.453 0 12.5977 0 0 0 0 13.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6977 0 0 0 0 0 12.2005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0951 0 0 0 0 0 0 0 12.0099 0 0 0 0 0 0 0 0 0 0 0 12.5432 0 0 0 0 0 0 0 0 0 0 0 0 Q96HM7 PED1B_HUMAN PC-esterase domain-containing protein 1B (Protein FAM113B) PCED1B FAM113B Homo sapiens (Human) AVYKDLVLLLQK 0.92764 2.0474 0 0 0 10.7393 0 0 0 0 0 0 0 0 0 10.0268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7858 0 0 0 14.6759 0 0 11.1451 0 0 11.2544 0 0 0 0 13.5852 0 0 12.6884 0 0 0 0 14.5699 0 0 16.5705 0 0 0 0 0 10.5897 0 0 0 0 12.6561 0 0 0 0 0 0 0 0 0 0 0 0 0 P48039 MTR1A_HUMAN "Melatonin receptor type 1A, Mel-1A-R, Mel1a receptor" MTNR1A Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; mating behavior [GO:0007617]" GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007193; GO:0007617; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0097159 G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melatonin receptor activity [GO:0008502]; organic cyclic compound binding [GO:0097159] EYRRIIVSLCTAR 0.92768 1.8575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7997 P52849 NDST2_HUMAN "Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2, EC 2.8.2.8 (Glucosaminyl N-deacetylase/N-sulfotransferase 2, NDST-2) (N-heparan sulfate sulfotransferase 2, N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2, EC 3.-.-.-; Heparan sulfate N-sulfotransferase 2, EC 2.8.2.- ]" NDST2 HSST2 Homo sapiens (Human) "glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mast cell mediated immunity [GO:0002448]; regulation of angiotensin levels in blood [GO:0002002]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mast cell mediated immunity [GO:0002448]; regulation of angiotensin levels in blood [GO:0002002]" GO:0000139; GO:0002002; GO:0002448; GO:0005794; GO:0006024; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0050119; GO:0102140 [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119] DYQVNPSAPLLHLTR 0.9277 2.2051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8042 0 0 0 0 0 0 0 0 0 10.9625 0 0 0 0 0 0 0 0 0 11.5243 0 0 11.0511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2088 0 0 13.1124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWB4 PRS55_HUMAN "Serine protease 55, EC 3.4.21.- (Testis serine protease 1, T-SP1)" PRSS55 TSP1 UNQ9391/PRO34284 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; flagellated sperm motility [GO:0030317]; proteolysis [GO:0006508] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; binding of sperm to zona pellucida [GO:0007339]; flagellated sperm motility [GO:0030317]; proteolysis [GO:0006508] GO:0001669; GO:0004252; GO:0005829; GO:0005886; GO:0006508; GO:0007339; GO:0030317; GO:0031225 serine-type endopeptidase activity [GO:0004252] LLFSVLLLLSLVTGTQLGPR 0.9277 2.0773 0 0 0 0 0 11.4735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5781 0 0 0 0 0 Q9H2U2 IPYR2_HUMAN "Inorganic pyrophosphatase 2, mitochondrial, EC 3.6.1.1 (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2, PPase 2)" PPA2 HSPC124 Homo sapiens (Human) diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722]; diphosphate metabolic process [GO:0071344]; phosphate-containing compound metabolic process [GO:0006796]; regulation of mitochondrial membrane potential [GO:0051881] GO:0000287; GO:0004427; GO:0004722; GO:0005739; GO:0005759; GO:0005829; GO:0006796; GO:0051881; GO:0071344 inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; protein serine/threonine phosphatase activity [GO:0004722] ILGILALIDEGETDWK 0.9277 2.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8674 0 0 11.8032 0 0 0 0 0 0 0 0 0 0 0 0 12.4079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5781 0 0 0 0 0 0 0 0 0 0 14.0104 0 0 0 0 0 0 0 0 0 0 0 0 13.252 0 13.2779 0 0 12.9276 0 0 0 0 0 0 0 0 0 12.997 0 12.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7418 0 0 0 0 0 0 0 Q9NPA3 M1IP1_HUMAN "Mid1-interacting protein 1 (Gastrulation-specific G12-like protein) (Mid1-interacting G12-like protein) (Protein STRAIT11499) (Spot 14-related protein, S14R, Spot 14-R)" MID1IP1 MIG12 Homo sapiens (Human) lipid metabolic process [GO:0006629]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of ligase activity [GO:0051351]; protein polymerization [GO:0051258]; regulation of lipid biosynthetic process [GO:0046890] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; lipid metabolic process [GO:0006629]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of ligase activity [GO:0051351]; protein polymerization [GO:0051258]; regulation of lipid biosynthetic process [GO:0046890] GO:0005634; GO:0005829; GO:0005874; GO:0006629; GO:0007026; GO:0008022; GO:0015630; GO:0042802; GO:0045723; GO:0046890; GO:0051258; GO:0051351 identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022] LTRKANILTNR 0.9277 1.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H161 ALX4_HUMAN Homeobox protein aristaless-like 4 ALX4 KIAA1788 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; digestive tract development [GO:0048565]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal system morphogenesis [GO:0048704]; hair follicle development [GO:0001942]; muscle organ development [GO:0007517]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; digestive tract development [GO:0048565]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal system morphogenesis [GO:0048704]; hair follicle development [GO:0001942]; muscle organ development [GO:0007517]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001501; GO:0001942; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007517; GO:0009791; GO:0009952; GO:0035115; GO:0035116; GO:0042733; GO:0042981; GO:0048565; GO:0048704; GO:0060021; GO:0071837; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" RERFGQMQQVR 0.92774 2.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX04 CA109_HUMAN Ribosome biogenesis protein C1orf109 C1orf109 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosomal large subunit biogenesis [GO:0042273] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0042273 MTQDRPLLAVQEALKK 0.92774 2.0857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0911 0 0 0 0 13.9065 13.5044 13.9505 15.1959 15.284 13.9727 0 0 0 14.2011 13.8526 0 0 0 0 0 0 0 13.4717 0 0 13.245 0 0 0 0 0 0 0 0 0 0 13.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4675 0 0 0 13.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVK8 NUD18_HUMAN "8-oxo-dGDP phosphatase NUDT18, EC 3.6.1.58 (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (MutT homolog 3) (Nucleoside diphosphate-linked moiety X motif 18, Nudix motif 18)" NUDT18 MTH3 Homo sapiens (Human) dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule metabolic process [GO:0055086] cytosol [GO:0005829] cytosol [GO:0005829]; 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287]; dADP catabolic process [GO:0046057]; dGDP catabolic process [GO:0046067]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule metabolic process [GO:0055086] GO:0000287; GO:0005829; GO:0044715; GO:0044716; GO:0044717; GO:0046057; GO:0046067; GO:0046712; GO:0055086 8-hydroxy-dADP phosphatase activity [GO:0044717]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; magnesium ion binding [GO:0000287] ECRGSWYLPAGR 0.92778 2.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9045 0 0 0 0 0 0 0 12.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9477 0 0 0 0 0 0 0 0 13.4226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2126 0 0 0 0 0 0 0 0 0 0 0 0 12.9482 0 0 0 0 0 0 0 0 0 0 0 12.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2723 0 13.7222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3604 0 0 Q9BYQ0 KRA98_HUMAN Keratin-associated protein 9-8 (Keratin-associated protein 9.8) (Ultrahigh sulfur keratin-associated protein 9.8) KRTAP9-8 KAP9.8 KRTAP9.8 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTHCCSPCCQPTCCR 0.92778 2.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 11.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1233 0 0 0 0 0 10.805 0 0 0 11.3022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2201 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7352 0 0 0 0 0 0 0 0 0 0 0 10.7586 0 0 12.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8837 0 0 0 0 10.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9261 0 0 0 0 0 0 Q5JZY3 EPHAA_HUMAN "Ephrin type-A receptor 10, EC 2.7.10.1" EPHA10 Homo sapiens (Human) axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0016021; GO:0033674; GO:0043005; GO:0043235 ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] CGREGPAGACEPCGPR 0.9278 2.0745 0 0 0 0 0 0 0 0 0 0 0 10.3704 0 0 0 0 0 10.9581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3491 0 0 0 11.8804 0 0 12.1168 0 0 0 0 17.7743 0 0 0 0 0 0 16.8523 14.8041 0 0 0 15.1137 0 12.9328 0 0 0 0 0 0 12.7612 13.5975 0 13.4185 14.1681 13.5904 0 14.1236 0 0 13.0426 0 12.0517 0 0 0 0 14.4024 0 0 0 0 13.6061 0 0 12.3983 14.103 12.929 14.9036 14.1489 15.9057 11.5058 0 0 0 0 0 0 0 0 0 0 0 0 14.0348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5648 0 12.817 0 0 0 0 0 13.2521 0 0 0 0 0 0 12.3006 12.1686 0 14.45 0 13.9992 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXY8 BEX2_HUMAN "Protein BEX2 (Brain-expressed X-linked protein 2, hBex2)" BEX2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165] GO:0005102; GO:0005634; GO:0005737; GO:0006915; GO:0007049; GO:0007165; GO:0042981; GO:0051726 signaling receptor binding [GO:0005102] FRVRQPILQYR 0.92784 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8305 0 12.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4822 14.4836 0 13.9277 0 0 0 10.9453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60412 KR10B_HUMAN Keratin-associated protein 10-11 (High sulfur keratin-associated protein 10.11) (Keratin-associated protein 10.11) (Keratin-associated protein 18-11) (Keratin-associated protein 18.11) KRTAP10-11 KAP10.11 KAP18-11 KRTAP10.11 KRTAP18-11 KRTAP18.11 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 ASSSRCQQPSCQPACCTTSCCR 0.92785 2.0545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1089 0 0 0 0 0 0 0 0 0 0 0 0 10.0707 0 0 0 0 0 0 0 0 0 0 0 0 10.8844 0 0 0 0 0 0 10.5338 0 0 0 0 0 0 0 0 0 0 0 0 12.0288 0 0 0 0 0 10.3605 0 0 0 0 0 0 0 0 0 0 11.8974 0 0 0 15.0768 14.6149 0 0 0 14.5578 0 0 0 0 0 0 0 11.5306 0 0 0 0 10.9401 0 0 12.5849 0 0 0 0 0 0 11.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1041 0 0 0 0 Q96JF0 SIAT2_HUMAN "Beta-galactoside alpha-2,6-sialyltransferase 2, Alpha 2,6-ST 2, EC 2.4.99.1 (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 2) (ST6Gal II, ST6GalII, hST6Gal II) (Sialyltransferase 2)" ST6GAL2 KIAA1877 SIAT2 Homo sapiens (Human) oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; sialylation [GO:0097503] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; sialylation [GO:0097503]" GO:0000139; GO:0003835; GO:0005794; GO:0006486; GO:0009311; GO:0016021; GO:0032580; GO:0097503 "beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]" GYEKDVGNKTTIR 0.92785 1.9617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7353 0 0 0 0 0 0 0 0 0 11.4487 11.0168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NJR5 SPDL3_HUMAN Putative speedy protein-like protein 3 Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0019901; GO:0045737 protein kinase binding [GO:0019901] EWSDESEEEPEK 0.92787 2.2833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7261 12.6808 0 11.8326 0 0 0 0 0 0 0 0 0 11.6097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4888 11.9152 11.0729 11.6143 0 0 11.164 0 0 14.0426 0 14.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7245 12.8988 0 0 0 0 0 0 O95429 BAG4_HUMAN "BAG family molecular chaperone regulator 4, BAG-4 (Bcl-2-associated athanogene 4) (Silencer of death domains)" BAG4 SODD Homo sapiens (Human) "cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:2001145]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; ruffle assembly [GO:0097178]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:2001145]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; ruffle assembly [GO:0097178]" GO:0000774; GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0010763; GO:0016020; GO:0030838; GO:0031625; GO:0033138; GO:0043066; GO:0045785; GO:0050821; GO:0051087; GO:0051496; GO:0051897; GO:0071356; GO:0071364; GO:0072659; GO:0097178; GO:1903215; GO:2001145 adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625] DSSYPYSQSDQSMNR 0.92788 2.1592 0 0 0 0 0 0 0 0 11.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7588 0 12.7038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4446 0 12.8802 0 0 0 0 13.1967 0 13.2906 0 0 0 12.4958 13.0274 13.3315 13.0835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1873 0 0 12.9575 0 12.7402 0 12.8867 0 12.6953 12.9482 13.0687 0 12.6982 0 0 0 0 12.5156 0 0 13.6073 13.7461 0 0 0 0 10.7421 0 0 0 0 0 0 0 0 14.3009 0 0 15.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N104 D106A_HUMAN "Beta-defensin 106 (Beta-defensin 6, BD-6, DEFB-6) (Defensin, beta 106)" DEFB106A BD6 DEFB106 DEFB6; DEFB106B Homo sapiens (Human) antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634] extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634]; CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] GO:0001530; GO:0005634; GO:0008201; GO:0019898; GO:0031727; GO:0045087; GO:0050829; GO:0050830; GO:0061760; GO:1990742 CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530] RTFLFLFAVLFFLTPAK 0.92789 1.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UY8 NT5D3_HUMAN "5'-nucleotidase domain-containing protein 3, EC 3.1.3.- (GRP94-neighboring nucleotidase)" NT5DC3 GNN TU12B1-TY Homo sapiens (Human) cytosol [GO:0005829]; receptor complex [GO:0043235] cytosol [GO:0005829]; receptor complex [GO:0043235]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] GO:0005829; GO:0008253; GO:0043235; GO:0046872 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] AVLAKLADHGK 0.9279 1.6619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2437 13.393 0 0 0 0 10.4674 0 0 0 0 0 0 0 0 14.0654 0 0 0 0 12.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9576 12.9391 12.753 11.9986 0 0 0 0 0 14.2877 0 0 14.0047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.566 0 0 0 0 12.8557 13.844 0 12.9699 12.6851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2439 12.8959 12.9257 0 0 0 0 0 0 0 0 0 0 0 0 12.7055 0 0 0 0 12.5873 0 0 0 0 0 0 0 0 0 0 0 12.461 0 0 0 0 12.5625 0 0 P01034 CYTC_HUMAN Cystatin-C (Cystatin-3) (Gamma-trace) (Neuroendocrine basic polypeptide) (Post-gamma-globulin) CST3 Homo sapiens (Human) defense response [GO:0006952]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of collagen catabolic process [GO:0010711]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of elastin catabolic process [GO:0060311]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; regulation of tissue remodeling [GO:0034103]; supramolecular fiber organization [GO:0097435] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; tertiary granule lumen [GO:1904724]; vesicle [GO:0031982] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; tertiary granule lumen [GO:1904724]; vesicle [GO:0031982]; amyloid-beta binding [GO:0001540]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; identical protein binding [GO:0042802]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; defense response [GO:0006952]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of collagen catabolic process [GO:0010711]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of elastin catabolic process [GO:0060311]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; regulation of tissue remodeling [GO:0034103]; supramolecular fiber organization [GO:0097435] GO:0001540; GO:0002020; GO:0004866; GO:0004869; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005794; GO:0005886; GO:0006952; GO:0010466; GO:0010711; GO:0010716; GO:0030414; GO:0031982; GO:0034103; GO:0042802; GO:0045861; GO:0060311; GO:0060313; GO:0070062; GO:0097435; GO:1904724; GO:1904813; GO:2000117 amyloid-beta binding [GO:0001540]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; identical protein binding [GO:0042802]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020] AGPLRAPLLLLAILAVALAVSPAAGSSPGK 0.92791 1.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8438 0 0 0 14.4964 0 0 0 0 0 0 0 14.2241 14.4067 0 14.2564 14.0972 0 14.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43390 HNRPR_HUMAN "Heterogeneous nuclear ribonucleoprotein R, hnRNP R" HNRNPR HNRPR Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005783; GO:0006397; GO:0071013; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723] EEEEPMDTSSVTHTEHYK 0.92794 1.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6437 0 0 0 0 0 0 0 0 11.7309 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1338 0 0 0 0 0 0 0 0 0 12.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5974 0 11.676 0 0 0 0 0 0 13.098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5605 11.4371 0 0 0 0 0 0 0 0 0 0 14.4491 0 0 0 11.4967 0 Q9H693 CP095_HUMAN Uncharacterized protein C16orf95 C16orf95 Homo sapiens (Human) KQHPCWMHAAGTTAGGSAVMSACCPSSSSSR 0.92795 1.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L5D6 GET4_HUMAN "Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit, TRC35)" GET4 C7orf20 CEE TRC35 CGI-20 Homo sapiens (Human) cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] BAT3 complex [GO:0071818]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; cytoplasmic sequestering of protein [GO:0051220]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0006620; GO:0031647; GO:0045048; GO:0051087; GO:0051220; GO:0071816; GO:0071818; GO:1904378 chaperone binding [GO:0051087] ASVEKGDYYEAHQMYRTLFFR 0.92796 1.1147 0 0 0 0 0 0 10.3317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4522 0 0 0 0 13.4788 0 0 0 0 0 0 0 0 0 0 13.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9025 0 0 0 0 0 P43308 SSRB_HUMAN "Translocon-associated protein subunit beta, TRAP-beta (Signal sequence receptor subunit beta, SSR-beta)" SSR2 TRAPB HSD25 Homo sapiens (Human) cotranslational protein targeting to membrane [GO:0006613] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613] GO:0005783; GO:0005789; GO:0006613; GO:0016021 RFSPHFLDWAAFGVMTLPSIGIPLLLWYSSK 0.92797 1.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8944 12.0904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYB9 ABI2_HUMAN "Abl interactor 2 (Abelson interactor 2, Abi-2) (Abl-binding protein 3, AblBP3) (Arg-binding protein 1, ArgBP1)" ABI2 ARGBPIA Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; lens fiber cell morphogenesis [GO:0070309]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; zonula adherens assembly [GO:0045186] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; SCAR complex [GO:0031209] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; SCAR complex [GO:0031209]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; proline-rich region binding [GO:0070064]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625]; actin polymerization or depolymerization [GO:0008154]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; lens fiber cell morphogenesis [GO:0070309]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; zonula adherens assembly [GO:0045186] GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005912; GO:0007010; GO:0007399; GO:0008093; GO:0008154; GO:0010592; GO:0016477; GO:0016601; GO:0017124; GO:0018108; GO:0019900; GO:0030027; GO:0031209; GO:0031625; GO:0032433; GO:0035591; GO:0042802; GO:0043197; GO:0045186; GO:0061001; GO:0070064; GO:0070309; GO:2000601 cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; proline-rich region binding [GO:0070064]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625] DKEDELSFQEGAIIYVIKK 0.92797 2.2937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7453 0 0 0 0 16.4673 0 0 0 0 14.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6891 0 0 11.7096 0 0 0 0 0 0 0 0 0 0 0 11.2337 0 0 0 0 0 15.8844 0 11.2766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q30KR1 DB109_HUMAN "Putative beta-defensin 109B (Defensin, beta 109, pseudogene 1B) (Defensin, beta 109B)" DEFB109B DEFB109P1B Homo sapiens (Human) cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742] extracellular space [GO:0005615] extracellular space [GO:0005615]; CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]; cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742] GO:0005615; GO:0031731; GO:0042056; GO:0042742; GO:0060326 CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056] LHLLLLILLLFSILLSPVR 0.92798 2.2799 0 0 0 0 0 0 0 0 10.4736 0 0 0 0 0 0 0 10.2439 0 0 0 0 0 0 0 0 11.0702 0 0 0 0 12.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5416 0 0 0 0 13.9427 11.3106 0 14.6868 0 0 11.3648 0 0 0 0 0 12.2814 0 0 0 0 0 0 0 0 0 0 0 11.8725 14.7237 0 0 0 11.6521 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2561 0 0 0 0 0 0 0 0 0 10.4703 0 0 0 0 0 0 0 0 0 0 0 0 12.3217 0 0 0 0 12.4798 0 0 0 14.3184 0 0 0 0 12.1179 0 0 13.1569 0 0 0 0 0 0 0 0 0 11.5729 0 0 0 13.3867 0 0 0 0 0 0 0 0 0 0 0 I0J062 PANO1_HUMAN Proapoptotic nucleolar protein 1 PANO1 PANO Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of apoptotic process [GO:0043065]; regulation of protein stability [GO:0031647] nucleolus [GO:0005730] nucleolus [GO:0005730]; apoptotic process [GO:0006915]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of apoptotic process [GO:0043065]; regulation of protein stability [GO:0031647] GO:0005730; GO:0006915; GO:0031647; GO:0032435; GO:0043065 LPAPRSAST 0.92799 1.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.028 0 14.3969 0 14.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5707 0 0 0 0 0 0 0 15.4866 0 0 14.6407 14.8861 0 15.3014 14.6813 0 0 0 14.3855 0 0 0 0 14.825 14.8483 14.9213 0 0 14.6353 0 14.65 14.7613 15.1646 14.8195 0 14.832 0 14.802 14.5518 0 0 14.5752 0 0 14.56 0 0 0 0 0 14.7454 0 14.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.935 0 13.9194 0 0 12.8244 0 0 0 Q86SX3 TEDC1_HUMAN Tubulin epsilon and delta complex protein 1 TEDC1 C14orf80 Homo sapiens (Human) positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0005737; GO:0005814; GO:0005929; GO:0045880 ALLRTLERENQR 0.928 1.9162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5849 0 12.871 0 0 0 0 13.4553 0 14.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4026 11.9032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2686 0 0 0 0 13.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GT9 XAGE2_HUMAN "X antigen family member 2, XAGE-2 (Cancer/testis antigen 12.2, CT12.2) (G antigen family D member 3)" XAGE2 GAGED3 XAGE2B Homo sapiens (Human) GKILPKAEHFK 0.928 1.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1I8 CAAS1_HUMAN Putative uncharacterized protein encoded by CACTIN-AS1 (Cactin antisense RNA 1) CACTIN-AS1 C19orf29-AS1 C19orf29OS Homo sapiens (Human) MNEGTPQCACR 0.92802 2.0822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7945 0 0 0 0 0 0 0 0 12.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9721 12.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2833 0 0 0 0 0 0 0 14.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9181 11.2494 0 0 0 Q1A5X6 IQCJ_HUMAN IQ domain-containing protein J IQCJ Homo sapiens (Human) AWREYLQR 0.92807 2.0818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8133 0 12.6096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3633 0 0 0 0 0 0 0 15.1941 0 0 0 0 13.5274 0 0 0 0 0 0 0 0 13.5167 0 13.2313 0 12.832 0 0 0 13.9631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFZ4 NLGN2_HUMAN Neuroligin-2 NLGN2 KIAA1366 Homo sapiens (Human) "brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to cell surface [GO:0034394]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic transmission, GABAergic [GO:0051932]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]" "anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]" "anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dopaminergic synapse [GO:0098691]; excitatory synapse [GO:0060076]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; inhibitory synapse assembly [GO:1904862]; insulin metabolic process [GO:1901142]; jump response [GO:0007630]; locomotory exploration behavior [GO:0035641]; modulation of chemical synaptic transmission [GO:0050804]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of t-SNARE clustering [GO:1904034]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to cell surface [GO:0034394]; protein localization to synapse [GO:0035418]; regulation of AMPA receptor activity [GO:2000311]; regulation of presynapse assembly [GO:1905606]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic transmission, GABAergic [GO:0051932]; synaptic vesicle endocytosis [GO:0048488]; terminal button organization [GO:0072553]; thigmotaxis [GO:0001966]" GO:0001966; GO:0002087; GO:0005737; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007416; GO:0007420; GO:0007630; GO:0008284; GO:0009986; GO:0016020; GO:0019233; GO:0032024; GO:0032230; GO:0034394; GO:0035176; GO:0035418; GO:0035641; GO:0038023; GO:0042043; GO:0042734; GO:0042802; GO:0043198; GO:0045202; GO:0045211; GO:0045217; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0050885; GO:0051932; GO:0051965; GO:0051968; GO:0060076; GO:0060077; GO:0060999; GO:0070161; GO:0072553; GO:0072578; GO:0089717; GO:0097104; GO:0097105; GO:0097116; GO:0097119; GO:0097151; GO:0097470; GO:0098609; GO:0098690; GO:0098691; GO:0098983; GO:0099054; GO:0099055; GO:0099060; GO:1901142; GO:1902474; GO:1904034; GO:1904862; GO:1905606; GO:2000311; GO:2000463; GO:2000809 cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; signaling receptor activity [GO:0038023] DVLRETIK 0.9281 5.3505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0885 0 0 0 0 12.3744 0 15.7709 0 0 0 0 0 14.2196 0 0 0 0 0 0 12.133 11.9227 0 0 0 0 10.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4573 0 0 0 13.154 0 14.0201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RQ1 ERGI2_HUMAN Endoplasmic reticulum-Golgi intermediate compartment protein 2 ERGIC2 ERV41 PTX1 CDA14 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" "COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; retrograte transporter complex, Golgi to ER [GO:0061852]; transporter complex [GO:1990351]" "COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; retrograte transporter complex, Golgi to ER [GO:0061852]; transporter complex [GO:1990351]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0006888; GO:0006890; GO:0016020; GO:0016021; GO:0030134; GO:0033116; GO:0043231; GO:0061852; GO:1990351 EDDSSQSPNACR 0.92811 2.199 11.483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4227 12.6514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8125 0 0 0 0 0 14.121 0 0 0 0 0 0 0 10.2778 0 0 0 0 0 0 0 0 0 0 14.6362 0 0 0 0 0 0 Q9H2X0 CHRD_HUMAN Chordin CHRD UNQ217/PRO243 Homo sapiens (Human) BMP signaling pathway involved in spinal cord dorsal/ventral patterning [GO:0021919]; dorsal/ventral pattern formation [GO:0009953]; floor plate development [GO:0033504]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of cell adhesion [GO:0045785]; positive regulation of mesenchymal cell proliferation [GO:0002053]; skeletal system development [GO:0001501] extracellular space [GO:0005615] extracellular space [GO:0005615]; BMP binding [GO:0036122]; cytokine binding [GO:0019955]; BMP signaling pathway involved in spinal cord dorsal/ventral patterning [GO:0021919]; dorsal/ventral pattern formation [GO:0009953]; floor plate development [GO:0033504]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of cell adhesion [GO:0045785]; positive regulation of mesenchymal cell proliferation [GO:0002053]; skeletal system development [GO:0001501] GO:0001501; GO:0002053; GO:0005615; GO:0009953; GO:0019955; GO:0021919; GO:0030336; GO:0030514; GO:0033504; GO:0036122; GO:0045668; GO:0045785 BMP binding [GO:0036122]; cytokine binding [GO:0019955] AVPRLSLRLLR 0.92811 2.0811 0 0 0 0 0 0 0 0 0 0 0 11.8207 0 14.0513 0 11.4516 0 0 12.1828 13.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6561 0 0 0 0 11.9572 0 0 0 0 0 11.4804 0 0 0 0 0 0 13.1636 12.9546 12.957 13.0881 0 0 0 15.3651 0 0 11.5883 11.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.444 0 0 15.128 0 0 0 0 13.5663 0 10.8757 11.4024 0 11.9555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9518 0 14.2994 0 14.1454 0 0 0 0 0 0 0 12.1899 13.4359 0 0 0 0 0 0 13.2407 0 0 0 0 16.1387 14.4658 0 0 13.8829 0 0 0 0 0 0 13.9476 0 0 0 13.8075 0 10.1468 0 0 0 0 0 0 0 0 11.9621 0 0 14.4694 0 14.3965 0 14.5568 0 0 0 0 14.41 0 0 13.3405 0 14.3014 0 0 0 0 P14314 GLU2B_HUMAN "Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain, PKCSH)" PRKCSH G19P1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491] GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219 calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325] FSAMKYEQGTGCWQGPNR 0.92812 2.0508 13.0955 0 13.6148 0 0 12.3331 0 0 0 0 14.6085 0 0 0 0 12.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8094 0 0 0 0 0 0 0 0 0 0 13.8163 0 0 0 0 0 0 13.4295 0 0 0 0 13.5288 0 0 0 14.1748 14.8804 0 0 15.0522 12.8057 0 0 0 11.9146 0 0 0 0 0 0 0 0 0 12.1046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0641 0 0 0 0 12.3492 0 0 0 0 0 0 12.7568 0 0 0 0 13.9633 0 0 12.4976 0 0 0 0 0 0 0 0 0 0 0 0 13.003 11.97 0 0 0 0 0 11.6265 0 0 0 0 P15313 VATB1_HUMAN "V-type proton ATPase subunit B, kidney isoform, V-ATPase subunit B 1 (Endomembrane proton pump 58 kDa subunit) (Vacuolar proton pump subunit B 1)" ATP6V1B1 ATP6B1 VATB VPP3 Homo sapiens (Human) adult behavior [GO:0030534]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; chloride ion homeostasis [GO:0055064]; inner ear morphogenesis [GO:0042472]; olfactory behavior [GO:0042048]; ossification [GO:0001503]; pH reduction [GO:0045851]; potassium ion homeostasis [GO:0055075]; prostaglandin metabolic process [GO:0006693]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of pH [GO:0006885]; renal sodium excretion [GO:0035812]; renal sodium ion transport [GO:0003096]; renal tubular secretion [GO:0097254]; renal water homeostasis [GO:0003091]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; adult behavior [GO:0030534]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; chloride ion homeostasis [GO:0055064]; inner ear morphogenesis [GO:0042472]; olfactory behavior [GO:0042048]; ossification [GO:0001503]; pH reduction [GO:0045851]; potassium ion homeostasis [GO:0055075]; prostaglandin metabolic process [GO:0006693]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of pH [GO:0006885]; renal sodium excretion [GO:0035812]; renal sodium ion transport [GO:0003096]; renal tubular secretion [GO:0097254]; renal water homeostasis [GO:0003091]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]" GO:0000221; GO:0001503; GO:0003091; GO:0003096; GO:0005524; GO:0005737; GO:0005829; GO:0005902; GO:0006693; GO:0006885; GO:0007035; GO:0007605; GO:0010468; GO:0015078; GO:0016241; GO:0016323; GO:0016324; GO:0016328; GO:0016471; GO:0030534; GO:0035812; GO:0042048; GO:0042472; GO:0044877; GO:0045851; GO:0046034; GO:0046961; GO:0055064; GO:0055074; GO:0055075; GO:0070062; GO:0070072; GO:0097254; GO:0098850; GO:1902600 "ATP binding [GO:0005524]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" LLRIFPKEMLK 0.92814 2.2747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9569 0 0 0 0 0 0 0 11.3064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2886 0 0 0 0 0 0 0 0 Q8IWE2 NXP20_HUMAN Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1) FAM114A1 NOXP20 Homo sapiens (Human) cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] GO:0005654; GO:0005794; GO:0005829 GMLSAITNVVQNTGKSVLTGGLDALEFIGK 0.92814 1.8591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9447 0 0 0 0 0 0 0 0 0 0 12.4575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9797 0 12.0643 0 0 0 0 0 0 0 0 0 0 11.1204 14.3115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SQQ9 VAX1_HUMAN Ventral anterior homeobox 1 VAX1 Homo sapiens (Human) astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; central nervous system development [GO:0007417]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast proliferation [GO:0007405]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]; astrocyte differentiation [GO:0048708]; axon guidance [GO:0007411]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; central nervous system development [GO:0007417]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast proliferation [GO:0007405]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle cell differentiation [GO:0035914]" GO:0000785; GO:0000978; GO:0000981; GO:0001162; GO:0001227; GO:0001764; GO:0005634; GO:0006357; GO:0007405; GO:0007406; GO:0007411; GO:0007417; GO:0007420; GO:0030182; GO:0031490; GO:0035914; GO:0043010; GO:0048708; GO:0060021; GO:0060563; GO:1990837 "chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]" CHSDAEAARVSKNAHK 0.92818 1.0983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1731 0 0 0 0 0 0 13.8412 0 0 0 0 0 0 0 13.7478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8928 0 0 0 0 0 13.8318 0 0 0 0 13.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXS1 IDI2_HUMAN "Isopentenyl-diphosphate delta-isomerase 2, EC 5.3.3.2 (Isopentenyl pyrophosphate isomerase 2, IPP isomerase 2, IPPI2)" IDI2 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]; isopentenyl diphosphate metabolic process [GO:0046490]; isoprenoid biosynthetic process [GO:0008299] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisome [GO:0005777]; isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]; isopentenyl diphosphate metabolic process [GO:0046490]; isoprenoid biosynthetic process [GO:0008299] GO:0004452; GO:0005737; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0009240; GO:0043231; GO:0046490; GO:0046872; GO:0050992 isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872] SDINLDWVDR 0.92819 1.1172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5535 0 0 0 13.6788 14.0668 0 13.2237 0 14.5421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q10567 AP1B1_HUMAN AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit) AP1B1 ADTB1 BAM22 CLAPB2 Homo sapiens (Human) basolateral protein secretion [GO:0110010]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; basolateral protein secretion [GO:0110010]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0001822; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0007368; GO:0007507; GO:0016192; GO:0019901; GO:0030121; GO:0030276; GO:0030659; GO:0032588; GO:0043231; GO:0060155; GO:0110010; GO:1903232 clathrin binding [GO:0030276]; protein kinase binding [GO:0019901] CAIKVEQSAER 0.9282 1.6636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1378 14.2347 11.4904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6844 11.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3202 0 0 13.5011 0 0 12.3854 0 0 0 0 0 0 0 0 13.9628 0 0 0 0 0 0 0 0 0 0 12.6777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5253 0 0 14.0387 0 0 0 0 0 Q8N808 S35G3_HUMAN Solute carrier family 35 member G3 (Acyl-malonyl-condensing enzyme 1) (Transmembrane protein 21A) SLC35G3 AMAC1 TMEM21A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CLFHLPIALLLK 0.9282 2.0887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6143 12.9616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6316 0 0 0 0 0 0 0 13.2958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WR0 CCD25_HUMAN Coiled-coil domain-containing protein 25 CCDC25 Homo sapiens (Human) positive regulation of cell motility [GO:2000147] endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887] endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; DNA binding [GO:0003677]; positive regulation of cell motility [GO:2000147] GO:0003677; GO:0005887; GO:0012505; GO:2000147 DNA binding [GO:0003677] EMDELRSYSSLMK 0.92823 2.3608 16.078 15.5502 13.0579 0 0 0 0 14.2811 15.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.057 0 0 0 14.8856 0 0 0 10.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72756 0 0 0 0 0 0 15.4847 0 16.0571 16.0272 16.1422 15.8919 15.8743 0 18.7819 18.8767 18.8635 17.1816 0 18.0922 12.6428 16.789 0 12.1086 0 0 0 0 12.8413 0 13.7602 0 13.157 11.9084 0 14.9712 13.8888 0 0 0 12.1177 0 0 14.6445 0 12.2851 12.3575 12.3317 12.7822 15.4069 0 0 13.0815 13.3986 0 0 13.426 13.8426 14.5993 12.4955 12.7196 13.8257 14.6179 13.1302 0 0 0 0 0 18.0399 12.8349 13.919 0 15.6124 13.4824 0 0 0 0 12.977 0 14.947 14.0334 12.1484 0 0 0 0 0 0 0 0 13.6225 11.7463 13.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7686 13.6436 14.0984 0 0 0 0 0 0 Q9H446 RWDD1_HUMAN RWD domain-containing protein 1 (DRG family-regulatory protein 2) RWDD1 DFRP2 CGI-24 PTD013 Homo sapiens (Human) androgen receptor signaling pathway [GO:0030521]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825] cytoplasm [GO:0005737]; polysome [GO:0005844] cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825] GO:0002181; GO:0005737; GO:0005844; GO:0030521; GO:0034599; GO:0071394; GO:2000825 FDAELLEIKKK 0.92827 1.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7824 0 0 0 0 0 13.6278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZE3 PACE1_HUMAN Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3) SCYL3 PACE1 Homo sapiens (Human) cell migration [GO:0016477]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; spinal cord motor neuron differentiation [GO:0021522] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; cell migration [GO:0016477]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; spinal cord motor neuron differentiation [GO:0021522] GO:0000139; GO:0005524; GO:0005737; GO:0005794; GO:0006468; GO:0006954; GO:0008104; GO:0016477; GO:0021522; GO:0030027; GO:0042802; GO:0048666 ATP binding [GO:0005524]; identical protein binding [GO:0042802] AAKHLKTLR 0.92829 2.3457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2648 0 0 11.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1489 0 14.7378 0 0 0 0 0 0 0 13.6355 12.8498 0 0 0 0 0 0 0 0 0 0 0 0 12.458 14.0377 10.0322 0 0 13.9447 13.7973 0 13.6222 0 0 0 0 0 0 12.9787 0 0 12.567 12.1958 0 13.7492 13.8608 12.1592 0 0 0 0 12.9497 0 14.0875 0 12.1869 0 0 0 0 0 13.3142 0 12.7133 0 0 14.0205 0 0 13.6834 12.0952 0 13.4094 14.1166 0 12.1259 0 14.1329 12.8073 15.0882 0 12.7417 12.6201 12.591 0 13.0173 0 13.8375 0 14.7007 0 0 12.3156 0 0 0 0 13.3347 0 12.2816 0 12.8812 0 11.4802 12.141 14.224 13.9514 0 12.4076 15.4903 13.7997 10.8115 0 0 14.1787 0 0 13.6747 13.7751 0 0 0 0 0 0 11.8333 0 13.2773 0 0 0 0 0 0 P82675 RT05_HUMAN "28S ribosomal protein S5, mitochondrial, MRP-S5, S5mt (Mitochondrial small ribosomal subunit protein uS5m)" MRPS5 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ERGWSGNSWGGISLGPPDPGPCGETYEDFDTRILEVR 0.9283 1.6623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9548 13.5745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0997 0 0 0 0 0 0 0 12.7796 0 0 0 0 0 0 0 0 11.9629 0 0 0 0 0 0 0 0 0 0 0 12.2889 0 12.9845 0 0 Q8IXM2 BAP18_HUMAN Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa) BAP18 C17orf49 Homo sapiens (Human) chromatin organization [GO:0006325] cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589] cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325] GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0016589; GO:0042802; GO:0071339 DNA binding [GO:0003677]; identical protein binding [GO:0042802] TVAQIKATVKR 0.9283 1.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9076 11.8813 12.4044 0 0 0 0 0 11.7846 0 0 0 0 0 0 12.1632 0 0 Q8N4P2 TT30B_HUMAN "Tetratricopeptide repeat protein 30B, TPR repeat protein 30B" TTC30B Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073] axonemal microtubule [GO:0005879]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] axonemal microtubule [GO:0005879]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073] GO:0005879; GO:0005929; GO:0030992; GO:0035720; GO:0042073; GO:0060271; GO:0097542; GO:0120170 intraciliary transport particle B binding [GO:0120170] EEEQLSYDDPDKK 0.92834 2.0863 0 0 0 0 0 0 0 0 10.0769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9539 0 0 0 0 0 0 0 11.1139 0 0 11.2856 0 0 0 0 0 0 11.5109 0 11.4289 0 0 Q9NQ34 TMM9B_HUMAN Transmembrane protein 9B TMEM9B C11orf15 UNQ712/PRO1375 Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005765; GO:0016021; GO:0031901; GO:0043123 CECKYEERSSVTIK 0.92837 2.1606 0 0 0 0 0 0 0 0 0 0 10.8033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7272 0 11.3455 0 0 0 0 0 0 0 0 0 0 13.2889 0 0 12.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7911 0 0 0 0 0 0 0 0 12.0214 P98082 DAB2_HUMAN "Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2, DOC-2) (Differentially-expressed protein 2)" DAB2 DOC2 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to transforming growth factor beta stimulus [GO:0071560]; clathrin coat assembly [GO:0048268]; leading edge cell differentiation [GO:0035026]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cell migration [GO:0030335]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of endocytosis [GO:0045807]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]; response to salt [GO:1902074]; response to steroid hormone [GO:0048545]; Wnt signaling pathway [GO:0016055]" clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; SMAD binding [GO:0046332]; apoptotic process [GO:0006915]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to transforming growth factor beta stimulus [GO:0071560]; clathrin coat assembly [GO:0048268]; leading edge cell differentiation [GO:0035026]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cell migration [GO:0030335]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of endocytosis [GO:0045807]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]; response to salt [GO:1902074]; response to steroid hormone [GO:0048545]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0001650; GO:0001934; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0005925; GO:0006898; GO:0006915; GO:0008022; GO:0010718; GO:0010862; GO:0010977; GO:0015031; GO:0016055; GO:0030136; GO:0030308; GO:0030335; GO:0030511; GO:0030665; GO:0032091; GO:0032349; GO:0032436; GO:0035026; GO:0035615; GO:0038024; GO:0043066; GO:0043231; GO:0045807; GO:0045944; GO:0046332; GO:0048268; GO:0048471; GO:0048545; GO:0050680; GO:0050750; GO:0060391; GO:0060766; GO:0070373; GO:0071364; GO:0071560; GO:0090090; GO:1900026; GO:1902074; GO:1903077; GO:2000096; GO:2000298; GO:2000370; GO:2000643; GO:2000860 cargo receptor activity [GO:0038024]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; SMAD binding [GO:0046332] LIGIDDVPDARGDK 0.9284 1.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1327 0 0 0 0 0 Q02246 CNTN2_HUMAN "Contactin-2 (Axonal glycoprotein TAG-1) (Axonin-1) (Transient axonal glycoprotein 1, TAX-1)" CNTN2 AXT TAG1 TAX1 Homo sapiens (Human) adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cerebral cortex GABAergic interneuron migration [GO:0021853]; clustering of voltage-gated potassium channels [GO:0045163]; dendrite self-avoidance [GO:0070593]; establishment of localization in cell [GO:0051649]; establishment of protein localization to juxtaparanode region of axon [GO:0071206]; fat cell differentiation [GO:0045444]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; learning [GO:0007612]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; positive regulation of protein processing [GO:0010954]; presynaptic membrane organization [GO:0097090]; protein localization to juxtaparanode region of axon [GO:0071205]; protein processing [GO:0016485]; receptor internalization [GO:0031623]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of astrocyte differentiation [GO:0048710]; regulation of axon diameter [GO:0031133]; regulation of cell morphogenesis involved in differentiation [GO:0010769]; regulation of neuronal synaptic plasticity [GO:0048168] anchored component of postsynaptic membrane [GO:0099025]; axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; juxtaparanode region of axon [GO:0044224]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchored component of postsynaptic membrane [GO:0099025]; axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; juxtaparanode region of axon [GO:0044224]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cerebral cortex GABAergic interneuron migration [GO:0021853]; clustering of voltage-gated potassium channels [GO:0045163]; dendrite self-avoidance [GO:0070593]; establishment of localization in cell [GO:0051649]; establishment of protein localization to juxtaparanode region of axon [GO:0071206]; fat cell differentiation [GO:0045444]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; learning [GO:0007612]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; positive regulation of protein processing [GO:0010954]; presynaptic membrane organization [GO:0097090]; protein localization to juxtaparanode region of axon [GO:0071205]; protein processing [GO:0016485]; receptor internalization [GO:0031623]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of astrocyte differentiation [GO:0048710]; regulation of axon diameter [GO:0031133]; regulation of cell morphogenesis involved in differentiation [GO:0010769]; regulation of neuronal synaptic plasticity [GO:0048168] GO:0000226; GO:0001973; GO:0002023; GO:0005886; GO:0007155; GO:0007156; GO:0007411; GO:0007413; GO:0007612; GO:0007628; GO:0009986; GO:0010769; GO:0010954; GO:0016485; GO:0021853; GO:0022010; GO:0030246; GO:0030424; GO:0031133; GO:0031623; GO:0033268; GO:0042802; GO:0043025; GO:0043194; GO:0043209; GO:0043621; GO:0044224; GO:0045163; GO:0045202; GO:0045444; GO:0045665; GO:0048168; GO:0048710; GO:0051649; GO:0060168; GO:0070593; GO:0071205; GO:0071206; GO:0097090; GO:0098632; GO:0099025 carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; protein self-association [GO:0043621] AAPKAVVLWSK 0.92841 1.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0456 13.3838 0 0 12.3618 0 0 0 0 0 0 0 0 0 0 0 Q9UKP3 ITBP2_HUMAN Integrin beta-1-binding protein 2 (Melusin) ITGB1BP2 MSTP015 Homo sapiens (Human) muscle organ development [GO:0007517]; signal transduction [GO:0007165] Z disc [GO:0030018] Z disc [GO:0030018]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; muscle organ development [GO:0007517]; signal transduction [GO:0007165] GO:0005178; GO:0005509; GO:0007165; GO:0007517; GO:0008270; GO:0017124; GO:0030018 calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270] AGVVLEMDEEESDDSDDDLSWTEEEEEEEAMGE 0.92841 2.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3617 13.7967 13.9615 0 0 12.6983 0 0 0 0 0 0 0 0 0 0 0 10.9413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4334 0 0 10.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42261 GRIA1_HUMAN "Glutamate receptor 1, GluR-1 (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1, GluA1)" GRIA1 GLUH1 GLUR1 Homo sapiens (Human) cellular response to ammonium ion [GO:0071242]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; axonal spine [GO:0044308]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; axonal spine [GO:0044308]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; perisynaptic space [GO:0099544]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to ammonium ion [GO:0071242]; chemical synaptic transmission [GO:0007268]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] GO:0001540; GO:0004971; GO:0005789; GO:0005886; GO:0007165; GO:0007268; GO:0007616; GO:0008066; GO:0009986; GO:0012507; GO:0014069; GO:0015276; GO:0030165; GO:0030425; GO:0030666; GO:0030672; GO:0031623; GO:0031901; GO:0032281; GO:0032591; GO:0033116; GO:0038023; GO:0043025; GO:0043197; GO:0044308; GO:0044309; GO:0055037; GO:0055038; GO:0060076; GO:0060292; GO:0070161; GO:0071242; GO:0097060; GO:0098793; GO:0098978; GO:0099061; GO:0099544; GO:0099583; GO:1904315 AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate receptor activity [GO:0008066]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; PDZ domain binding [GO:0030165]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] FVYIYDADRGLSVLQKVLDTAAEK 0.92844 2.0545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2008 0 0 0 0 0 12.5646 0 Q9GZT5 WN10A_HUMAN Protein Wnt-10a WNT10A Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; skin development [GO:0043588]; tongue development [GO:0043586] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; skin development [GO:0043588]; tongue development [GO:0043586] GO:0001942; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0010628; GO:0014033; GO:0030182; GO:0031069; GO:0042476; GO:0042487; GO:0043586; GO:0043588; GO:0045165; GO:0048018; GO:0048730; GO:0048733; GO:0060070; GO:0071560 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] ACGCDASR 0.92845 1.1199 11.7752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5916 0 0 0 0 13.58 13.8043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 0 12.3644 0 0 13.2407 0 0 11.626 13.6555 11.0733 0 0 0 0 0 0 0 0 0 0 0 0 11.641 0 0 0 0 13.0638 0 0 0 0 11.5604 0 10.6571 0 0 0 0 0 0 0 0 0 11.0221 0 0 0 0 0 0 0 0 0 11.8447 0 12.4596 0 0 0 0 12.0007 0 0 0 0 0 12.5098 0 0 0 0 0 12.2349 14.5525 0 13.5653 0 0 0 0 0 0 0 0 0 12.6672 0 0 0 0 0 0 11.8144 0 0 0 0 0 0 0 12.0629 14.011 10.358 0 0 Q96FV2 SCRN2_HUMAN Secernin-2 SCRN2 Homo sapiens (Human) proteolysis [GO:0006508] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508] GO:0006508; GO:0016805; GO:0070004; GO:0070062 cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805] ASSSPDSPCSCDCFVSVPPASAIPAVIFAKNSDRPR 0.92846 1.1063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7202 0 0 0 0 0 0 0 12.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2222 0 0 0 0 0 0 10.5921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49006 MRP_HUMAN "MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate, Mac-MARCKS, MacMARCKS)" MARCKSL1 MLP MRP Homo sapiens (Human) actin filament organization [GO:0007015]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; actin filament organization [GO:0007015]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284] GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0007015; GO:0007417; GO:0008283; GO:0008284; GO:0051015; GO:0070062 actin filament binding [GO:0051015]; calmodulin binding [GO:0005516] KEGGGDSSASSPTEEEQEQGEIGACSDEGTAQEGK 0.92847 2.2044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6714 0 0 0 0 0 0 0 0 0 0 0 14.906 0 0 0 0 0 0 14.6008 0 0 16.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JJ37 BTBDJ_HUMAN BTB/POZ domain-containing protein 19 BTBD19 Homo sapiens (Human) GDEARGAPCRR 0.92849 1.927 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9936 12.1323 0 0 12.2479 14.1025 0 0 0 0 12.8408 0 0 0 0 14.3892 11.9602 0 0 0 0 0 12.0051 12.079 0 0 0 0 0 0 0 0 0 0 0 12.0122 0 0 0 0 0 11.3222 0 0 0 11.9892 13.0216 0 11.9935 0 0 0 0 0 0 11.7702 0 0 0 0 0 11.7899 12.3681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4228 0 0 0 0 0 0 0 0 Q63HM2 PCX4_HUMAN "Pecanex-like protein 4 (Hepatitis C virus F protein-binding protein 2, HCV F protein-binding protein 2) (Pecanex homolog protein 4)" PCNX4 C14orf135 FBP2 PCNXL4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AFRYTLKLMIDK 0.92849 1.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60462 NRP2_HUMAN Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2) NRP2 VEGF165R2 Homo sapiens (Human) angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649] GO:0001525; GO:0001938; GO:0002116; GO:0003148; GO:0005021; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0008201; GO:0010595; GO:0016020; GO:0016021; GO:0017154; GO:0019838; GO:0019955; GO:0021612; GO:0021649; GO:0021675; GO:0021828; GO:0030424; GO:0036486; GO:0038023; GO:0042802; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099055; GO:0099175; GO:1901166; GO:1902285; GO:1903375; GO:1904835; GO:1990830 cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor receptor activity [GO:0005021] EDQGGEWKHGR 0.92853 2.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0649 0 0 11.2673 0 0 0 0 0 0 0 0 0 13.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.241 0 0 0 0 0 0 0 0 0 0 13.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9005 0 0 0 0 0 11.6697 0 0 13.2551 0 0 0 0 0 11.0378 0 0 12.0775 0 13.0989 0 0 0 0 0 0 0 0 11.7965 0 0 0 0 0 0 0 0 0 11.7174 0 0 0 0 0 0 0 0 0 0 0 0 10.1055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61513 RL37A_HUMAN 60S ribosomal protein L37a (Large ribosomal subunit protein eL43) RPL37A Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0046872; GO:0070062 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] KVGIVGKYGTR 0.92853 1.9165 12.0772 0 0 0 0 0 0 0 0 0 10.2182 0 0 0 0 0 15.0452 0 0 0 0 0 12.8707 0 15.2664 0 0 0 0 0 0 0 0 0 0 15.3979 0 0 0 15.7751 0 18.0166 0 0 0 0 0 0 12.9998 11.457 13.5621 0 0 0 0 0 0 0 0 18.1694 0 0 16.8416 16.8605 16.8489 16.9062 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8542 0 0 0 0 0 0 0 0 0 12.4983 0 0 0 0 0 0 0 0 11.4614 0 0 13.3185 11.8146 0 0 0 0 11.7499 0 0 0 13.3405 0 0 0 0 0 13.0441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6617 0 0 0 0 0 0 0 0 0 0 0 0 12.9458 0 0 0 0 0 13.3999 0 0 0 0 0 0 12.5162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3014 17.0382 0 11.5956 0 0 P00156 CYB_HUMAN Cytochrome b (Complex III subunit 3) (Complex III subunit III) (Cytochrome b-c1 complex subunit 3) (Ubiquinol-cytochrome-c reductase complex cytochrome b subunit) MT-CYB COB CYTB MTCYB Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739] "integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0031305; GO:0045333; GO:0046872 metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121] LGGVLALLLSILILAMIPILHMSK 0.92861 1.9263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1122 0 0 0 0 0 0 0 0 0 10.4732 0 0 10.1964 0 0 0 11.3118 0 0 0 0 14.8042 0 14.5319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6956 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06587 RING1_HUMAN "E3 ubiquitin-protein ligase RING1, EC 2.3.2.27 (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (Really interesting new gene 1 protein)" RING1 RNF1 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; chromatin organization [GO:0006325]; histone H2A monoubiquitination [GO:0035518]; negative regulation of transcription, DNA-templated [GO:0045892]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activator activity [GO:0097027]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; chromatin organization [GO:0006325]; histone H2A monoubiquitination [GO:0035518]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0000151; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0009952; GO:0016607; GO:0031519; GO:0035102; GO:0035518; GO:0045892; GO:0046872; GO:0048593; GO:0061630; GO:0097027 chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activator activity [GO:0097027] ECLHRFCSDCIVTALR 0.92861 1.8601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.213 0 0 10.224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2I2 NTNG1_HUMAN Netrin-G1 (Laminet-1) NTNG1 KIAA0976 LMNT1 UNQ571/PRO1133 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888] anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888] GO:0005576; GO:0005886; GO:0007409; GO:0009887; GO:0009888; GO:0010975; GO:0016477; GO:0034446; GO:0043256; GO:0046658; GO:0050804; GO:0050839; GO:0070831; GO:0098632; GO:0098685; GO:0098978; GO:0099029; GO:0099560; GO:0150011; GO:2001222 cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632] CNGSGFCECK 0.92862 2.0832 0 0 0 0 0 0 0 0 11.8414 0 13.0872 0 0 0 0 0 0 0 0 0 0 12.8354 0 0 0 0 0 0 0 0 0 0 13.3685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8533 0 0 0 0 0 0 0 14.2759 14.0778 13.9135 15.6062 14.3052 0 0 14.2136 0 14.5201 0 0 0 14.06 0 0 14.3684 14.127 13.9624 14.635 14.2854 14.265 14.3281 0 14.3878 14.1341 14.3531 14.4722 0 0 18.5296 14.3538 14.291 14.2987 0 18.4416 0 0 0 0 14.452 11.704 0 14.9631 0 14.894 0 0 12.1536 14.5068 0 14.713 14.2628 14.4162 0 0 0 14.5055 0 14.7474 0 14.6703 0 0 0 15.0684 0 0 14.7455 14.6668 0 0 0 0 0 0 14.6901 0 0 0 18.5344 0 0 0 0 0 0 0 0 0 0 16.0663 0 0 0 0 0 18.5156 0 0 14.6109 0 0 0 0 0 Q13536 CROC4_HUMAN Protein CROC-4 (Contingent replication of cDNA 4) (MIR9-1 host gene) MIR9-1HG C1orf61 CROC4 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005634; GO:0045944 CTERCLCVLPLR 0.92864 1.664 11.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.071 0 0 14.9589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2442 Q9BY67 CADM1_HUMAN "Cell adhesion molecule 1 (Immunoglobulin superfamily member 4, IgSF4) (Nectin-like protein 2, NECL-2) (Spermatogenic immunoglobulin superfamily, SgIgSF) (Synaptic cell adhesion molecule, SynCAM) (Tumor suppressor in lung cancer 1, TSLC-1)" CADM1 IGSF4 IGSF4A NECL2 SYNCAM TSLC1 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; liver development [GO:0001889]; positive regulation of cytokine production [GO:0001819]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271] basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune system process [GO:0002376]; liver development [GO:0001889]; positive regulation of cytokine production [GO:0001819]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; spermatogenesis [GO:0007283]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271] GO:0001819; GO:0001889; GO:0002376; GO:0005102; GO:0005886; GO:0005911; GO:0006915; GO:0007156; GO:0007157; GO:0007283; GO:0007420; GO:0008037; GO:0014069; GO:0016021; GO:0016323; GO:0030154; GO:0030165; GO:0042271; GO:0042803; GO:0043005; GO:0045202; GO:0045954; GO:0050839; GO:0051606 cell adhesion molecule binding [GO:0050839]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] AVDHAVIGGVVAVVVFAMLCLLIILGRYFAR 0.92865 1.9257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0826 0 0 0 0 0 0 12.9239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0393 0 13.7687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ31 AKIP1_HUMAN A-kinase-interacting protein 1 (Breast cancer-associated gene 3 protein) (PKA-interacting protein) (Proline-rich protein BCA3) AKIP1 BCA3 C11orf17 Homo sapiens (Human) regulation of NIK/NF-kappaB signaling [GO:1901222]; substrate adhesion-dependent cell spreading [GO:0034446] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; regulation of NIK/NF-kappaB signaling [GO:1901222]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0005654; GO:0034446; GO:1901222 SARLALEVLERAK 0.92865 1.8594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8237 0 0 0 0 0 0 12.8125 0 0 0 0 0 0 0 0 0 0 0 0 12.1006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4044 0 0 Q16651 PRSS8_HUMAN "Prostasin, EC 3.4.21.- (Channel-activating protease 1, CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain ]" PRSS8 Homo sapiens (Human) positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0010765; GO:0016021; GO:0017080; GO:0070062 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sodium channel regulator activity [GO:0017080] AQKGVLGPGQLGAVAILLYLGLLR 0.92869 1.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.194 0 0 0 0 0 0 11.2397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4761 Q3LI72 KR195_HUMAN Keratin-associated protein 19-5 KRTAP19-5 KAP19.5 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 SCRPSCYGGYGFSGFY 0.92871 1.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5578 0 0 0 0 11.1577 0 0 0 0 0 0 0 0 0 0 11.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6326 0 0 12.4592 0 0 12.9091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9732 0 12.7875 0 12.0507 0 12.7984 0 0 0 0 0 0 0 0 0 12.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3539 0 0 0 0 0 0 12.2562 0 0 0 0 0 0 0 0 0 12.3777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T9L3 WLS_HUMAN "Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog, EVI) (Putative NF-kappa-B-activating protein 373)" WLS C1orf139 GPR177 UNQ85/PRO18667 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; cementum mineralization [GO:0071529]; exocrine pancreas development [GO:0031017]; hindbrain development [GO:0030902]; intracellular protein transport [GO:0006886]; mesoderm formation [GO:0001707]; midbrain development [GO:0030901]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of organelle membrane [GO:0031301]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of organelle membrane [GO:0031301]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]; anterior/posterior axis specification [GO:0009948]; cementum mineralization [GO:0071529]; exocrine pancreas development [GO:0031017]; hindbrain development [GO:0030902]; intracellular protein transport [GO:0006886]; mesoderm formation [GO:0001707]; midbrain development [GO:0030901]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] GO:0000139; GO:0001707; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0009948; GO:0012505; GO:0016055; GO:0017147; GO:0030177; GO:0030666; GO:0030901; GO:0030902; GO:0031017; GO:0031301; GO:0031410; GO:0031901; GO:0042802; GO:0043123; GO:0061355; GO:0061357; GO:0070062; GO:0071529; GO:0090263 identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147] INVGIGEIKDIR 0.92871 2.0509 0 0 0 0 0 17.2767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00744 WN10B_HUMAN Protein Wnt-10b (Protein Wnt-12) WNT10B WNT12 Homo sapiens (Human) bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; epithelial cell differentiation [GO:0030855]; fat cell differentiation [GO:0045444]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast development [GO:0048627]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; epithelial cell differentiation [GO:0030855]; fat cell differentiation [GO:0045444]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast development [GO:0048627]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366] GO:0000086; GO:0000122; GO:0001649; GO:0002062; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0006366; GO:0006629; GO:0007224; GO:0010971; GO:0014835; GO:0030182; GO:0030217; GO:0030501; GO:0030855; GO:0030858; GO:0032434; GO:0043065; GO:0045165; GO:0045444; GO:0045582; GO:0045599; GO:0045669; GO:0045899; GO:0048018; GO:0048627; GO:0048641; GO:0048741; GO:0050680; GO:0050821; GO:0050909; GO:0051091; GO:0051885; GO:0060070; GO:0060346; GO:0061196; GO:0071300; GO:0071320; GO:0071374; GO:0071425; GO:0090263; GO:0120163; GO:1902035 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] ACNKTSRLLDGCGSLCCGR 0.92874 1.1205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.68024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.631 12.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75964 ATP5L_HUMAN "ATP synthase subunit g, mitochondrial, ATPase subunit g (ATP synthase membrane subunit g)" ATP5MG ATP5L Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776 proton transmembrane transporter activity [GO:0015078] KIVNSAQTGSFK 0.92874 1.6625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15653 IKBB_HUMAN "NF-kappa-B inhibitor beta, NF-kappa-BIB (I-kappa-B-beta, IkB-B, IkB-beta, IkappaBbeta) (Thyroid receptor-interacting protein 9, TR-interacting protein 9, TRIP-9)" NFKBIB IKBB TRIP9 Homo sapiens (Human) "cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; inflammatory response [GO:0006954]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; inflammatory response [GO:0006954]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" GO:0003713; GO:0005634; GO:0005829; GO:0006351; GO:0006954; GO:0007165; GO:0007253; GO:0043122; GO:0071222 transcription coactivator activity [GO:0003713] PNPILARLLR 0.92876 1.1064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6N3 CLCA3_HUMAN "Calcium-activated chloride channel regulator family member 3, Calcium-activated chloride channel family member 3, hCLCA3" CLCA3P CLCA3 Homo sapiens (Human) ion transmembrane transport [GO:0034220]; regulation of ion transmembrane transport [GO:0034765] chloride channel complex [GO:0034707]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; chloride channel activity [GO:0005254]; metalloendopeptidase activity [GO:0004222]; voltage-gated ion channel activity [GO:0005244]; ion transmembrane transport [GO:0034220]; regulation of ion transmembrane transport [GO:0034765] GO:0004222; GO:0005244; GO:0005254; GO:0005262; GO:0005615; GO:0005886; GO:0034220; GO:0034707; GO:0034765 calcium channel activity [GO:0005262]; chloride channel activity [GO:0005254]; metalloendopeptidase activity [GO:0004222]; voltage-gated ion channel activity [GO:0005244] MVFSLKVILFLSLLLSPVLK 0.92876 1.1203 0 0 0 0 0 0 0 0 0 0 11.9798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3654 0 11.8482 0 0 0 12.0944 0 0 11.5643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5233 0 0 0 0 0 0 0 0 0 0 13.5878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3246 0 0 0 0 0 0 0 13.6484 P51575 P2RX1_HUMAN "P2X purinoceptor 1, P2X1 (ATP receptor) (Purinergic receptor)" P2RX1 P2X1 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; insemination [GO:0007320]; ion transport [GO:0006811]; neuronal action potential [GO:0019228]; platelet activation [GO:0030168]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; regulation of blood pressure [GO:0008217]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to ATP [GO:0033198]; serotonin secretion by platelet [GO:0002554]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]" external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579] "external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; cation channel activity [GO:0005261]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; purinergic nucleotide receptor activity [GO:0001614]; suramin binding [GO:0043924]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; insemination [GO:0007320]; ion transport [GO:0006811]; neuronal action potential [GO:0019228]; platelet activation [GO:0030168]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; regulation of blood pressure [GO:0008217]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to ATP [GO:0033198]; serotonin secretion by platelet [GO:0002554]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]" GO:0001614; GO:0002554; GO:0003056; GO:0004931; GO:0005261; GO:0005524; GO:0005639; GO:0005886; GO:0005887; GO:0006811; GO:0006915; GO:0006919; GO:0007165; GO:0007320; GO:0008217; GO:0009897; GO:0019228; GO:0030168; GO:0030667; GO:0032991; GO:0033198; GO:0035249; GO:0035579; GO:0042802; GO:0043005; GO:0043924; GO:0044877; GO:0045121; GO:0046513; GO:0098978; GO:0099055; GO:0099059; GO:0099509; GO:1905665; GO:2000300 ATP binding [GO:0005524]; cation channel activity [GO:0005261]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; purinergic nucleotide receptor activity [GO:0001614]; suramin binding [GO:0043924] KVGVIFRLIQLVVLVYVIGWVFLYEK 0.92877 2.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8115 0 0 12.673 13.7379 13.9051 0 0 14.002 0 0 0 0 0 0 0 0 13.1689 0 0 0 0 13.3643 0 0 0 0 0 0 0 13.3051 0 0 0 0 0 13.4303 0 0 0 0 0 0 0 0 0 0 0 0 12.9357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1178 0 0 0 0 Q8NDZ0 BEND2_HUMAN BEN domain-containing protein 2 BEND2 CXorf20 Homo sapiens (Human) DNA binding [GO:0003677] GO:0003677 DNA binding [GO:0003677] DGGEGCSWMFQPMNNSKMREK 0.92877 2.1991 0 0 12.3374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3374 0 0 0 0 0 0 13.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2694 0 13.1995 0 0 0 0 12.2434 0 0 0 0 0 0 0 0 0 0 0 15.2419 0 0 10.7168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7197 0 0 14.6883 0 0 0 0 17.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3K2 GHITM_HUMAN "Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1, MICS1) (Transmembrane BAX inhibitor motif-containing protein 5)" GHITM DERP2 MICS1 TMBIM5 My021 UNQ244/PRO281 Homo sapiens (Human) apoptotic process [GO:0006915]; inner mitochondrial membrane organization [GO:0007007]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448] extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; inner mitochondrial membrane organization [GO:0007007]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448] GO:0005739; GO:0006915; GO:0007007; GO:0016020; GO:0031305; GO:0070062; GO:0090201; GO:1905448 AVIWPQYVKDR 0.9288 2.0903 0 0 0 0 0 0 0 0 0 15.5372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9088 0 0 0 14.1304 0 0 0 10.4187 10.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2446 0 16.0682 15.9124 0 15.1269 0 14.6609 16.077 14.9428 0 0 16.0685 0 15.8897 15.6213 0 0 0 12.6538 0 0 0 0 13.666 0 0 0 0 0 0 13.7217 13.269 13.6407 0 0 0 0 0 0 0 0 0 0 13.4079 12.6373 0 12.5858 0 0 0 0 12.9273 0 0 0 0 0 0 12.8079 12.74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2197 0 0 12.4062 0 0 0 0 A0A1B0GX68 TVB2_HUMAN T cell receptor beta variable 2 TRBV2 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 LEDSAMYFCASSE 0.92881 1.1179 0 0 0 0 0 0 0 0 12.6946 0 0 0 12.8221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.971 0 0 0 0 0 0 0 12.6271 0 0 13.1286 0 0 0 0 14.5283 14.4711 0 12.9536 0 0 0 0 0 0 0 0 12.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.232 0 0 0 0 0 0 0 0 0 0 0 12.5304 0 0 0 0 0 0 0 0 0 0 12.6623 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8718 0 0 0 0 0 0 0 0 0 0 11.8594 0 0 0 0 0 0 0 Q8NES3 LFNG_HUMAN "Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe, EC 2.4.1.222 (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)" LFNG Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; compartment pattern specification [GO:0007386]; marginal zone B cell differentiation [GO:0002315]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; ovarian follicle development [GO:0001541]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; somitogenesis [GO:0001756]; T cell differentiation [GO:0030217] extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]; animal organ morphogenesis [GO:0009887]; compartment pattern specification [GO:0007386]; marginal zone B cell differentiation [GO:0002315]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; ovarian follicle development [GO:0001541]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; somitogenesis [GO:0001756]; T cell differentiation [GO:0030217] GO:0000139; GO:0001541; GO:0001756; GO:0002315; GO:0005576; GO:0007386; GO:0008375; GO:0008593; GO:0009887; GO:0014807; GO:0030173; GO:0030217; GO:0032092; GO:0033829; GO:0045747; GO:0046872; GO:0051446; GO:1902367; GO:1903561 acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] ALRSLAGPAGAAPAPGLGAAAAAPGALVR 0.92885 3.5647 0 0 0 0 0 0 0 0 0 13.4468 14.5019 12.9873 14.4573 13.9951 14.1852 13.9799 13.2149 13.4298 13.4055 15.7684 14.2818 0 0 0 14.1177 12.7771 14.1651 14.3576 14.0876 13.9397 13.5521 13.3676 0 0 0 0 0 0 14.8101 0 13.4259 12.4109 0 11.6545 12.8919 13.327 0 0 14.6821 0 12.7449 12.6773 0 13.827 13.423 12.0764 0 0 0 0 0 0 0 0 0 13.6497 0 0 0 0 0 0 0 0 0 0 0 0 13.367 14.2958 13.8378 0 17.2911 16.9906 17.422 16.8101 17.042 0 15.4734 0 0 0 12.2746 16.8671 16.7428 13.1422 16.6315 0 0 16.0954 16.1632 15.5911 0 14.7692 0 0 0 0 0 11.3953 0 0 16.6271 0 0 0 0 14.4804 14.37 0 0 0 0 0 15.8346 0 0 15.5657 15.2886 14.5087 0 10.7282 0 0 0 0 0 0 14.4977 0 0 13.6193 13.7042 0 0 0 0 16.2712 0 0 0 0 0 0 13.4201 0 14.5391 16.0261 16.4807 16.6566 15.6309 16.4058 14.1002 15.379 15.6084 14.6823 15.4301 15.5291 16.4227 14.8879 15.1658 0 14.9567 10.7631 0 14.5001 0 14.521 0 0 Q9NU39 FX4L1_HUMAN "Forkhead box protein D4-like 1, FOXD4-like 1" FOXD4L1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" APVGRVGAAAVSGGGRGL 0.92885 1.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5217 0 0 14.3955 0 0 0 0 0 0 0 0 0 0 0 0 P17023 ZNF19_HUMAN Zinc finger protein 19 (Zinc finger protein KOX12) ZNF19 KOX12 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AQYQEMVTFEDVAVHFTKTEWTGLSPAQR 0.92887 1.9538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4846 0 0 0 0 0 0 0 0 0 0 0 11.5434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4469 P16499 PDE6A_HUMAN "Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha, GMP-PDE alpha, EC 3.1.4.35 (PDE V-B1)" PDE6A PDEA Homo sapiens (Human) retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601] photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] "photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]" GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0042622; GO:0046872; GO:0047555; GO:0060041; GO:0097381 "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" FHFSDLPLTELELVKCGIQMYYELK 0.9289 2.2908 0 0 0 0 0 0 0 0 0 11.1446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1058 0 0 0 12.8511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0698 0 0 0 0 0 12.4568 0 0 0 0 0 0 0 0 0 0 0 14.4459 10.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4941 0 0 0 0 0 0 0 0 11.6371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7676 0 0 0 11.0164 0 0 P51688 SPHM_HUMAN "N-sulphoglucosamine sulphohydrolase, EC 3.10.1.1 (Sulfoglucosamine sulfamidase) (Sulphamidase)" SGSH HSS Homo sapiens (Human) glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200] GO:0005539; GO:0005764; GO:0006027; GO:0008449; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0070062 glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250] FGNGESGMGR 0.9289 1.9179 0 0 0 13.9846 14.2068 0 14.0928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7716 0 0 0 0 13.2753 0 0 0 14.86 0 16.2318 14.8446 14.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2696 0 0 0 0 0 P21941 MATN1_HUMAN Cartilage matrix protein (Matrilin-1) MATN1 CMP CRTM Homo sapiens (Human) extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; protein-containing complex assembly [GO:0065003]; regulation of bone mineralization [GO:0030500] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; protein-containing complex assembly [GO:0065003]; regulation of bone mineralization [GO:0030500] GO:0003429; GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0030500; GO:0031012; GO:0062023; GO:0065003 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] AHVSKAALLQAVRR 0.92894 1.9178 0 0 0 0 0 0 0 0 0 0 12.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4056 0 0 0 11.4598 0 0 0 0 0 0 11.8429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1722 0 0 0 0 0 13.27 0 0 0 0 0 13.2298 0 0 0 0 0 0 0 0 13.0297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4589 13.4436 13.3178 0 0 0 0 0 0 11.4607 0 0 0 0 0 0 0 0 0 0 0 13.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7854 0 0 0 13.1217 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBD1 RC3H2_HUMAN "Roquin-2, EC 2.3.2.27 (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING finger protein 164) (RING-type E3 ubiquitin transferase Roquin-2)" RC3H2 MNAB RNF164 Homo sapiens (Human) "B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]" cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932] "cell surface [GO:0009986]; cytoplasmic stress granule [GO:0010494]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; P-body [GO:0000932]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; B cell homeostasis [GO:0001782]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymph node development [GO:0048535]; multicellular organism growth [GO:0035264]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-embryonic development [GO:0009791]; protein polyubiquitination [GO:0000209]; regulation of miRNA metabolic process [GO:2000628]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000209; GO:0000288; GO:0000932; GO:0001782; GO:0003677; GO:0003723; GO:0003725; GO:0003729; GO:0006511; GO:0009791; GO:0009986; GO:0010494; GO:0016020; GO:0035264; GO:0035613; GO:0042098; GO:0043029; GO:0043231; GO:0046872; GO:0048286; GO:0048535; GO:0048536; GO:0050852; GO:0060173; GO:0061470; GO:0061630; GO:1901224; GO:2000320; GO:2000628 DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630] CVEDLALYLK 0.92894 2.0863 0 0 0 0 0 0 0 0 0 0 12.8462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6026 0 0 0 0 0 0 0 12.6349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.116 0 0 0 0 0 0 0 12.8011 0 0 0 0 0 0 0 13.0627 0 0 0 0 0 0 0 0 0 0 0 9.80808 0 0 15.3801 0 0 0 0 0 0 12.4903 0 0 0 0 0 0 0 0 0 13.0885 0 0 0 0 0 12.4754 12.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2786 12.9245 0 0 0 0 0 0 0 10.9005 0 11.0658 0 0 0 0 0 0 14.479 0 0 0 0 0 0 P78357 CNTP1_HUMAN "Contactin-associated protein 1, Caspr, Caspr1 (Neurexin IV) (Neurexin-4) (p190)" CNTNAP1 CASPR NRXN4 Homo sapiens (Human) "axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; signal transduction [GO:0007165]" integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone membrane [GO:0048787] "integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; presynaptic active zone membrane [GO:0048787]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; signal transduction [GO:0007165]" GO:0002175; GO:0005887; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016021; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048787; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0097106; GO:0098529; GO:1990227 SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023] AAHEYHPGSK 0.92897 1.1227 9.78625 0 0 0 0 0 0 0 0 0 0 10.9011 0 0 0 0 0 0 11.58 11.9786 0 0 12.3625 12.875 0 0 0 0 14.2033 0 0 0 12.1093 0 0 0 0 0 0 0 0 0 0 0 11.9861 0 0 0 11.2841 0 0 0 0 11.5464 0 0 0 0 0 0 0 0 0 0 0 0 13.5483 13.3408 13.6738 13.7835 0 13.9863 0 0 13.4023 13.4342 0 0 13.2091 14.1232 0 13.4815 0 0 0 0 12.3058 0 0 0 13.0024 0 0 0 0 0 0 0 0 0 0 14.4571 0 10.6544 0 0 0 0 18.1485 0 13.6119 0 0 12.7846 13.1263 0 12.9982 0 13.6511 0 0 14.4815 0 0 12.8508 13.2376 13.3451 0 0 0 11.6195 0 0 0 0 12.8481 0 0 0 14.2999 0 0 0 13.7991 14.0642 0 0 0 0 12.5534 0 13.3813 0 0 14.1942 0 0 0 0 0 0 0 0 0 0 12.9963 0 0 0 0 0 0 11.2488 13.0976 0 0 0 0 0 0 Q9P0K8 FOXJ2_HUMAN Forkhead box protein J2 (Fork head homologous X) FOXJ2 FHX Homo sapiens (Human) "cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell differentiation [GO:0110059]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell differentiation [GO:0110059]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0006357; GO:0007141; GO:0007283; GO:0016525; GO:0030154; GO:0042802; GO:0043565; GO:0045893; GO:0045944; GO:0110059; GO:1904707; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" MVNRLNWSSIEQSQFSELMESLRQAEQK 0.929 1.1219 0 0 0 0 0 0 0 0 0 0 0 12.1284 0 0 0 0 0 0 0 0 0 0 11.4613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8226 0 0 0 0 0 0 0 12.8502 0 12.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6035 0 0 12.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13861 KAP2_HUMAN cAMP-dependent protein kinase type II-alpha regulatory subunit PRKAR2A PKR2 PRKAR2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480] GO:0004862; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005952; GO:0008603; GO:0016020; GO:0019904; GO:0030552; GO:0031588; GO:0031625; GO:0032991; GO:0034236; GO:0035556; GO:0044853; GO:0070062; GO:0097546; GO:2000480 cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625] DGGNQEVEIARCHK 0.92902 2.0547 0 0 0 0 0 0 0 0 10.5999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EV8 DTBP1_HUMAN "Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8, BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein, HPS7 protein)" DTNBP1 BLOC1S8 My031 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; brain development [GO:0007420]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506]; regulation of synaptic vesicle exocytosis [GO:2000300]; retina development in camera-type eye [GO:0060041] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]; actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; brain development [GO:0007420]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506]; regulation of synaptic vesicle exocytosis [GO:2000300]; retina development in camera-type eye [GO:0060041] GO:0001934; GO:0001956; GO:0002092; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006469; GO:0007420; GO:0007596; GO:0008089; GO:0010008; GO:0010628; GO:0014059; GO:0014069; GO:0015630; GO:0016528; GO:0030424; GO:0030426; GO:0030496; GO:0030672; GO:0031083; GO:0031175; GO:0031532; GO:0032091; GO:0032438; GO:0033162; GO:0042383; GO:0043005; GO:0043025; GO:0043197; GO:0043506; GO:0045211; GO:0048490; GO:0048812; GO:0048813; GO:0060041; GO:0060155; GO:0060159; GO:0061002; GO:0061646; GO:0070161; GO:0071901; GO:0098685; GO:0098686; GO:0098978; GO:1901215; GO:1904115; GO:2000300 EATPDGGEDSDS 0.92902 1.9171 0 0 0 12.3546 0 0 0 11.0769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1707 0 11.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3458 0 11.3231 0 0 0 0 0 0 0 11.4766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5508 13.3891 0 0 12.2556 0 0 0 0 0 0 10.5185 0 0 0 0 0 P78367 NKX32_HUMAN Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B) NKX3-2 BAPX1 NKX3B Homo sapiens (Human) animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ formation [GO:0048645]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; intestinal epithelial cell development [GO:0060576]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0007368; GO:0030154; GO:0031016; GO:0032331; GO:0042474; GO:0043066; GO:0048536; GO:0048645; GO:0048705; GO:0048706; GO:0060576; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" FNHQRYLSGPER 0.92903 2.3467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4717 0 0 0 13.768 0 0 0 0 0 0 11.752 Q13155 AIMP2_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1) AIMP2 JTV1 PRO0992 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of neuron death [GO:1901216]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of neuron death [GO:1901216]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510] GO:0005634; GO:0005829; GO:0006412; GO:0006915; GO:0008285; GO:0016020; GO:0016567; GO:0017101; GO:0031398; GO:0060090; GO:0060510; GO:0065003; GO:1901216; GO:1903632 molecular adaptor activity [GO:0060090] KQPRQDYQLGFTLIWK 0.92904 1.6645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5886 0 0 0 0 0 0 0 13.0158 0 0 0 0 0 0 0 0 0 0 11.1137 0 0 13.0753 0 13.9421 0 0 0 0 0 0 12.7026 0 0 0 0 12.9015 0 13.0706 14.2265 0 0 0 0 0 0 0 0 0 0 13.7651 0 0 0 0 0 0 13.0528 0 0 0 0 0 0 0 0 0 0 0 0 13.3024 0 0 13.3019 0 0 0 0 12.5087 13.1083 0 0 0 0 0 0 15.0883 14.8007 13.8826 14.7356 0 0 0 0 13.2346 0 0 0 0 0 0 0 0 14.7834 0 0 Q7LG56 RIR2B_HUMAN "Ribonucleoside-diphosphate reductase subunit M2 B, EC 1.17.4.1 (TP53-inducible ribonucleotide reductase M2 B) (p53-inducible ribonucleotide reductase small subunit 2-like protein, p53R2)" RRM2B P53R2 Homo sapiens (Human) 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleoside triphosphate metabolic process [GO:0009200]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; kidney development [GO:0001822]; mitochondrial DNA replication [GO:0006264]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; renal system process [GO:0003014]; response to amine [GO:0014075]; response to oxidative stress [GO:0006979]; ribonucleoside diphosphate metabolic process [GO:0009185] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleoside triphosphate metabolic process [GO:0009200]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; kidney development [GO:0001822]; mitochondrial DNA replication [GO:0006264]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; renal system process [GO:0003014]; response to amine [GO:0014075]; response to oxidative stress [GO:0006979]; ribonucleoside diphosphate metabolic process [GO:0009185]" GO:0000731; GO:0001822; GO:0003014; GO:0004748; GO:0005654; GO:0005739; GO:0005829; GO:0006264; GO:0006281; GO:0006979; GO:0009185; GO:0009200; GO:0009263; GO:0009265; GO:0010971; GO:0014075; GO:0042802; GO:0046872; GO:0070318; GO:1902254 "identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]" STFGERVVAFAAVEGVFFSGSFAAIFWLKK 0.92904 1.1069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1326 0 0 0 0 0 0 13.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P33260 CP2CI_HUMAN "Cytochrome P450 2C18, EC 1.14.14.1 (CYPIIC18) (Cytochrome P450-6b/29c)" CYP2C18 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0005886; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0008401; GO:0016712; GO:0019373; GO:0019825; GO:0020037; GO:0042572; GO:0042573; GO:0043231; GO:0043651; GO:0070330; GO:0071614 "arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]" EFPNPEMFDPGHFLDKSGNFKK 0.92907 1.9481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36543 VATE1_HUMAN "V-type proton ATPase subunit E 1, V-ATPase subunit E 1 (V-ATPase 31 kDa subunit, p31) (Vacuolar proton pump subunit E 1)" ATP6V1E1 ATP6E ATP6E2 Homo sapiens (Human) proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241] "anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; proton-transporting two-sector ATPase complex [GO:0016469]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; proton-transporting two-sector ATPase complex [GO:0016469]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]" GO:0000221; GO:0005765; GO:0005768; GO:0005829; GO:0005902; GO:0016241; GO:0016324; GO:0016469; GO:0030665; GO:0030672; GO:0046961; GO:0051117; GO:0070062; GO:0070161; GO:1902600 "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" DTTRYQVLLDGLVLQGLYQLLEPR 0.92907 2.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4914 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49427 UB2R1_HUMAN "Ubiquitin-conjugating enzyme E2 R1, EC 2.3.2.23 ((E3-independent) E2 ubiquitin-conjugating enzyme R1, EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (Ubiquitin-conjugating enzyme E2-CDC34) (Ubiquitin-protein ligase R1)" CDC34 UBCH3 UBE2R1 Homo sapiens (Human) cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000082; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006270; GO:0006511; GO:0016567; GO:0016607; GO:0035458; GO:0036211; GO:0043161; GO:0043525; GO:0043951; GO:0061631; GO:0070848; GO:0070936; GO:0090261 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] ARLKFPIDYPYSPPAFR 0.92907 1.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5641 0 0 0 0 0 0 0 0 0 13.9262 0 0 0 0 0 0 0 0 0 0 0 12.1811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5221 0 0 14.2413 0 0 0 0 0 0 Q6DKK2 TTC19_HUMAN "Tetratricopeptide repeat protein 19, mitochondrial, TPR repeat protein 19" TTC19 Homo sapiens (Human) mitochondrial respiratory chain complex III assembly [GO:0034551]; mitotic cytokinesis [GO:0000281] centrosome [GO:0005813]; midbody [GO:0030496]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469] centrosome [GO:0005813]; midbody [GO:0030496]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitotic cytokinesis [GO:0000281] GO:0000281; GO:0005739; GO:0005743; GO:0005813; GO:0030496; GO:0034551; GO:0070469 EIYQEALKQAKLK 0.92911 1.9264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7283 0 0 0 0 12.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2755 0 0 0 0 13.9242 11.716 0 0 12.8234 0 0 12.0548 0 0 0 12.552 0 0 0 0 0 0 0 0 0 0 0 10.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0291 0 0 0 0 0 0 0 P0DMW2 PYDC4_HUMAN NLR family pyrin domain-containing protein 2B (Pyrin domain-containing protein 2-like protein POP4) (Pyrin-only protein 4) NLRP2B CLRX.1 NLRP2P NOD24 POP4 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of cell cycle [GO:0045786]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of apoptotic process [GO:0043065]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; innate immune response [GO:0045087]; negative regulation of cell cycle [GO:0045786]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of apoptotic process [GO:0043065]; regulation of inflammatory response [GO:0050727] GO:0005634; GO:0005737; GO:0010804; GO:0032088; GO:0033137; GO:0034122; GO:0043065; GO:0043231; GO:0045087; GO:0045786; GO:0050727 FKSLIRTVSLGNELQK 0.92912 2.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5085 0 0 0 0 0 0 11.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5928 0 0 0 0 0 0 13.0819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WT1 TT30A_HUMAN "Tetratricopeptide repeat protein 30A, TPR repeat protein 30A" TTC30A Homo sapiens (Human) intraciliary transport [GO:0042073] axonemal microtubule [GO:0005879]; intraciliary transport particle B [GO:0030992] axonemal microtubule [GO:0005879]; intraciliary transport particle B [GO:0030992]; intraciliary transport particle B binding [GO:0120170]; intraciliary transport [GO:0042073] GO:0005879; GO:0030992; GO:0042073; GO:0120170 intraciliary transport particle B binding [GO:0120170] AGLSGAQIPDGEFTALVYRLIRDAR 0.92912 2.0728 0 0 0 0 0 0 0 0 0 0 0 11.9005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.849 0 0 0 0 0 0 0 0 12.5761 0 12.5232 0 0 0 0 0 13.0306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6023 0 0 0 0 0 0 0 0 0 0 0 0 Q9C040 TRIM2_HUMAN "Tripartite motif-containing protein 2, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2)" TRIM2 KIAA0517 RNF86 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523] GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ASIVDDIHSTFDELQK 0.92915 1.1051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0001 0 0 11.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3718 0 12.448 0 0 13.9541 0 0 0 0 0 0 0 12.0848 0 0 0 10.6552 0 0 0 13.5075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5I2 PCDAA_HUMAN "Protocadherin alpha-10, PCDH-alpha-10" PCDHA10 CNRS8 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005576; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DKDKFPVLVLR 0.92916 2.1593 0 0 0 0 0 0 0 0 0 13.3298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1484 0 0 0 12.047 0 0 0 13.0234 0 0 12.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4207 0 0 0 0 12.5055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9494 0 0 0 0 0 0 0 0 0 0 0 P82251 BAT1_HUMAN "b(0,+)-type amino acid transporter 1, b(0,+)AT1 (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)" SLC7A9 BAT1 Homo sapiens (Human) L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003] GO:0005886; GO:0005887; GO:0015175; GO:0015179; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0065003 L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605] LGSYVQNIFTAAKLVIVAIIIISGLVLLAQGNTK 0.92919 1.934 0 0 0 0 0 0 0 0 0 0 0 0 13.5413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.266 0 10.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.497 0 0 0 11.3653 0 10.8697 15.2478 0 0 0 0 0 0 0 11.168 0 0 0 0 0 0 0 0 0 15.325 11.8322 0 0 0 0 0 0 0 0 0 0 12.5943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5647 0 12.1311 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8394 0 0 0 0 0 0 11.926 0 0 0 0 0 0 0 0 0 9.51765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5813 0 0 10.8725 0 Q9UPQ8 DOLK_HUMAN "Dolichol kinase, EC 2.7.1.108 (Transmembrane protein 15)" DOLK KIAA1094 TMEM15 UNQ2422/PRO4980 Homo sapiens (Human) dolichyl diphosphate biosynthetic process [GO:0006489]; dolichyl monophosphate biosynthetic process [GO:0043048]; phosphorylation [GO:0016310] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; dolichol kinase activity [GO:0004168]; dolichyl diphosphate biosynthetic process [GO:0006489]; dolichyl monophosphate biosynthetic process [GO:0043048]; phosphorylation [GO:0016310] GO:0004168; GO:0005789; GO:0006489; GO:0016310; GO:0030176; GO:0043048 dolichol kinase activity [GO:0004168] LIRRNPLLWLLQFLFQTDTR 0.92921 2.0835 0 0 0 10.9052 0 0 12.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.549 0 0 0 0 0 0 0 0 11.4799 0 0 0 0 0 0 0 0 0 11.2825 0 14.6988 0 0 0 14.9093 15.2316 14.2075 0 0 0 0 0 12.8852 0 0 0 0 0 0 0 0 0 15.159 14.1319 0 0 14.3547 0 13.0432 0 0 0 14.748 0 0 0 0 0 0 0 0 0 0 0 14.4654 0 0 0 0 0 0 0 0 0 13.4878 0 0 0 0 0 0 0 0 12.7958 0 0 0 0 0 0 13.4549 13.6313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0938 0 0 0 0 0 0 0 0 0 14.9059 12.8243 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCW5 NNRE_HUMAN "NAD(P)H-hydrate epimerase, EC 5.1.99.6 (Apolipoprotein A-I-binding protein, AI-BP) (NAD(P)HX epimerase) (YjeF N-terminal domain-containing protein 1, YjeF_N1)" NAXE AIBP APOA1BP YJEFN1 Homo sapiens (Human) lipid transport [GO:0006869]; membrane raft distribution [GO:0031580]; negative regulation of angiogenesis [GO:0016525]; nicotinamide nucleotide metabolic process [GO:0046496]; regulation of cholesterol efflux [GO:0010874]; sprouting angiogenesis [GO:0002040] cell body [GO:0044297]; cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cell body [GO:0044297]; cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166]; lipid transport [GO:0006869]; membrane raft distribution [GO:0031580]; negative regulation of angiogenesis [GO:0016525]; nicotinamide nucleotide metabolic process [GO:0046496]; regulation of cholesterol efflux [GO:0010874]; sprouting angiogenesis [GO:0002040] GO:0000166; GO:0002040; GO:0005576; GO:0005615; GO:0005739; GO:0005759; GO:0005929; GO:0006869; GO:0010874; GO:0016525; GO:0031580; GO:0042802; GO:0044297; GO:0046496; GO:0046872; GO:0052856; GO:0052857; GO:0070062 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166] ALLGLGLLVAGSRVPRIK 0.92922 2.1787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3315 0 0 0 0 0 0 0 0 0 11.3622 0 0 0 0 0 0 0 14.8781 0 0 0 0 0 0 0 12.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0083 0 0 0 0 10.832 0 0 0 0 0 9.64478 12.7102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.428 13.9278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9951 0 0 0 0 0 0 0 14.9269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9769 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7915 0 0 Q86YV6 MYLK4_HUMAN "Myosin light chain kinase family member 4, EC 2.7.11.1 (Sugen kinase 85, SgK085)" MYLK4 SGK085 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468] GO:0004687; GO:0005524; GO:0006468; GO:0106310 ATP binding [GO:0005524]; myosin light chain kinase activity [GO:0004687]; protein serine kinase activity [GO:0106310] CEETATGLKLAAKIIK 0.92924 2.2029 0 0 0 0 9.65216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7654 14.128 0 0 0 13.7965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7549 0 0 0 12.1602 0 0 0 0 0 0 0 14.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.998 0 12.8084 13.0584 0 0 0 0 13.9241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAD4 WDR41_HUMAN WD repeat-containing protein 41 WDR41 MSTP048 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; positive regulation of GTPase activity [GO:0043547]; regulation of autophagy [GO:0010506] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosomal membrane [GO:0005765] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; positive regulation of GTPase activity [GO:0043547]; regulation of autophagy [GO:0010506] GO:0005737; GO:0005765; GO:0006914; GO:0010506; GO:0032045; GO:0043547; GO:0045920; GO:0050777 GLYVYSLQMK 0.92928 2.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4994 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7813 0 15.7454 0 0 0 0 0 0 0 0 0 11.9554 0 0 0 17.4956 16.9696 16.6396 0 0 0 0 0 0 0 0 14.4825 0 0 0 0 0 0 0 0 0 0 14.8821 0 0 0 0 0 14.6074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2924 0 0 Q8WXF8 DEDD2_HUMAN DNA-binding death effector domain-containing protein 2 (DED-containing protein FLAME-3) (FADD-like anti-apoptotic molecule 3) DEDD2 FLAME3 PSEC0004 Homo sapiens (Human) "apoptotic nuclear changes [GO:0030262]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; signaling receptor complex adaptor activity [GO:0030159]; apoptotic nuclear changes [GO:0030262]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]" GO:0003677; GO:0005654; GO:0005730; GO:0006396; GO:0008625; GO:0016075; GO:0019725; GO:0030159; GO:0030262; GO:0035556; GO:0045892; GO:2001238 DNA binding [GO:0003677]; signaling receptor complex adaptor activity [GO:0030159] LLGQLLRVLARHDLLPHLAR 0.92929 2.0512 0 0 0 0 13.7097 0 0 0 15.7153 0 14.9267 14.8712 14.7017 0 0 13.812 0 0 0 0 0 14.1688 13.2926 14.3891 0 0 0 0 0 12.432 14.002 0 13.74 10.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7957 13.6281 13.5335 13.158 0 0 13.0694 0 0 13.0207 14.5882 14.1159 0 0 14.4667 15.5753 0 0 15.3515 15.0311 15.737 18.8195 15.1715 15.1557 15.9906 0 14.0768 14.0108 13.9817 14.1802 14.475 13.6914 13.8236 15.8996 14.7367 14.7391 15.6337 15.3534 15.0845 0 14.9668 0 14.8593 14.5062 15.7528 19.3445 15.032 19.0174 14.9943 14.4587 16.476 16.196 16.8233 16.5775 15.8638 0 15.688 16.0173 16.0732 16.5386 15.2399 16.4739 14.0532 0 16.2136 15.4165 15.9932 0 15.921 16.0016 16.1644 16.0688 15.7303 16.0959 14.3046 15.2067 15.5342 16.084 14.1645 0 15.4267 15.3375 15.5483 14.4523 15.5593 16.0975 15.4206 16.204 14.1364 14.3057 15.9901 15.2107 0 0 14.7244 15.4544 19.3328 0 14.8335 15.322 0 0 0 0 0 0 0 0 0 12.9254 0 15.5467 0 0 0 15.1796 15.0514 14.6251 14.5305 16.071 0 0 0 0 P10745 RET3_HUMAN "Retinol-binding protein 3 (Interphotoreceptor retinoid-binding protein, IRBP) (Interstitial retinol-binding protein)" RBP3 Homo sapiens (Human) lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601] cone matrix sheath [GO:0090658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] cone matrix sheath [GO:0090658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; serine-type peptidase activity [GO:0008236]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601] GO:0001523; GO:0005501; GO:0005576; GO:0005615; GO:0006508; GO:0006629; GO:0007601; GO:0008236; GO:0016918; GO:0019841; GO:0090658; GO:1903561 retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; serine-type peptidase activity [GO:0008236] AWDLAGVEPDITVPMSEALSIAQDIVALR 0.92929 2.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.706 0 0 0 0 11.9113 0 11.8761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.141 0 0 0 12.1452 0 0 0 0 0 13.4587 0 0 15.3139 0 18.5114 0 18.124 13.0871 0 0 0 0 0 19.1096 0 0 0 0 0 0 0 14.4017 0 0 0 0 0 0 0 0 0 0 18.3789 0 15.1196 0 14.3196 0 0 18.4933 12.6497 0 0 0 0 0 0 12.7275 0 13.0178 19.0577 12.5338 13.7781 12.613 0 13.6246 14.3133 14.4988 0 0 0 12.6682 0 0 0 0 0 0 0 0 0 0 0 12.4899 0 0 0 14.7053 0 0 0 0 0 0 0 0 0 0 12.1278 0 0 19.0036 19.0351 0 0 0 0 0 0 0 Q5T8D3 ACBD5_HUMAN Acyl-CoA-binding domain-containing protein 5 ACBD5 KIAA1996 Homo sapiens (Human) autophagy of peroxisome [GO:0030242]; fatty acid metabolic process [GO:0006631] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; autophagy of peroxisome [GO:0030242]; fatty acid metabolic process [GO:0006631] GO:0000062; GO:0005654; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006631; GO:0008289; GO:0016020; GO:0016021; GO:0030242 fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289] AESSDSGAESEEEEAQEEVKGAEQSDNDKK 0.92929 4.9614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8164 0 11.2522 0 0 0 0 0 0 0 0 0 10.1401 11.1096 0 0 0 0 0 0 0 0 0 0 0 0 14.908 0 0 0 0 0 0 0 0 14.0826 14.5195 0 0 0 0 0 0 0 11.4014 0 0 12.7678 0 0 0 0 0 0 0 0 0 0 11.3025 0 0 14.0535 0 0 0 0 0 12.7837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.281 0 0 0 12.4052 0 0 0 0 0 0 0 14.6025 14.4116 0 0 0 13.8707 0 0 0 11.2569 0 0 0 0 11.665 0 0 0 0 0 0 0 0 0 0 0 0 14.3176 0 14.29 0 0 0 0 0 0 Q5VY09 IER5_HUMAN Immediate early response gene 5 protein IER5 PP4583 SBBI48 Homo sapiens (Human) cellular response to heat [GO:0034605]; positive regulation of cellular response to heat [GO:1900036]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cellular response to heat [GO:0034605]; positive regulation of cellular response to heat [GO:1900036]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0034605; GO:0042127; GO:0042802; GO:0045944; GO:1900036 identical protein binding [GO:0042802] AACCCAPQPAEDEPPAPPAVCPR 0.92929 2.2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1457 0 0 0 0 0 0 0 0 10.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7509 0 0 0 0 0 11.5647 0 0 14.6909 0 0 0 0 0 0 12.3914 0 0 10.8062 0 0 0 0 0 0 0 0 11.7019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1914 0 0 0 10.9479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PK11 CLRN2_HUMAN Clarin-2 CLRN2 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171] integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] GO:0007605; GO:0016021; GO:0032421; GO:0060088; GO:0060171; GO:0120045 AWYGLASLLSFSSFILIIVALVVPHWLSGK 0.92932 1.9438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3587 11.6426 0 0 0 12.0279 0 10.1765 0 0 0 0 0 12.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3295 0 0 P48651 PTSS1_HUMAN "Phosphatidylserine synthase 1, PSS-1, PtdSer synthase 1, EC 2.7.8.29 (Serine-exchange enzyme I)" PTDSS1 KIAA0024 PSSA Homo sapiens (Human) phosphatidylserine biosynthetic process [GO:0006659] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; L-serine-phosphatidylcholine phosphatidyltransferase activity [GO:0106258]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659] GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740; GO:0106245; GO:0106258 L-serine-phosphatidylcholine phosphatidyltransferase activity [GO:0106258]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740] DIHTTTGKIKR 0.92932 2.1774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4388 0 0 0 0 0 13.9272 0 0 0 0 0 0 0 0 0 0 0 0 Q6NW34 NEPRO_HUMAN Nucleolus and neural progenitor protein NEPRO C3orf17 Homo sapiens (Human) negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747] nucleolus [GO:0005730]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleus [GO:0005634]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747] GO:0005634; GO:0005730; GO:0045665; GO:0045747 AQAIFLGNKLLK 0.92932 2.3562 0 0 0 0 0 0 0 0 13.0034 0 0 0 0 0 0 0 12.7769 0 0 0 0 0 0 0 11.7787 0 0 0 0 0 0 0 0 0 0 13.7448 0 0 11.5762 0 0 14.1056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4664 0 0 0 0 0 13.085 0 14.3697 0 13.6703 13.7768 0 14.604 11.6847 0 14.0208 0 0 0 0 14.2274 13.5908 0 0 0 12.2663 0 0 0 0 13.0793 0 0 0 0 12.5183 0 0 12.9053 0 0 0 0 10.9664 0 0 13.6179 0 0 0 0 13.9637 0 0 0 0 14.0598 0 0 0 0 12.9311 0 0 0 0 0 13.5806 13.9521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2287 0 0 0 11.5118 0 0 12.9236 0 0 0 0 0 0 0 0 10.4233 13.4594 12.562 0 0 0 12.9245 0 13.1881 0 Q5H9R7 PP6R3_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 Homo sapiens (Human) regulation of phosphoprotein phosphatase activity [GO:0043666] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666] GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0019888; GO:0019903; GO:0043666 protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] AECLEDLVSFIIEEPPQDMDEK 0.92934 2.2012 0 12.0713 0 11.2409 0 0 0 0 0 0 0 0 0 0 12.2839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9792 12.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.349 0 0 0 0 0 0 0 12.5959 0 0 0 0 0 0 0 0 15.5691 0 0 14.108 0 0 0 9.44 0 0 12.909 0 0 0 0 0 13.4431 0 0 0 0 15.9952 0 0 0 13.8683 0 0 0 0 0 0 12.2556 0 0 14.8695 0 13.5388 0 0 0 14.117 0 0 13.3389 0 14.3619 0 0 0 0 15.076 0 0 13.5371 0 0 14.6504 0 0 13.5353 0 13.9781 0 0 0 0 0 0 0 13.4882 0 14.3019 0 0 0 0 13.2454 13.4639 0 0 0 0 0 0 0 13.0785 14.0107 0 0 0 0 13.6446 0 0 0 0 Q8IXR5 F178B_HUMAN Protein FAM178B FAM178B HSPC234 Homo sapiens (Human) HLWCPSLQEVR 0.92936 2.1574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q24JQ0 TM241_HUMAN Transmembrane protein 241 TMEM241 C18orf45 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297] GO:0005794; GO:0015297; GO:0016021 antiporter activity [GO:0015297] LAIPVFLTLHNVAEVIICGYQKCFQK 0.92939 1.8539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9842 0 10.6078 0 0 0 0 0 0 0 18.9464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5186 0 0 0 0 0 0 18.3558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7274 0 0 0 0 0 0 13.9123 0 0 0 17.8522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A286YF18 SMI44_HUMAN Small integral membrane protein 44 SMIM44 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LPRYVLYLLLAALVVVAVAYAIVGHLIK 0.9294 1.9431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8627 0 0 0 0 0 0 0 0 15.498 14.8899 0 14.0455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6008 0 13.6992 0 0 13.1246 0 0 0 12.6661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2892 11.9848 0 0 0 0 0 0 11.8114 0 Q96P56 CTSR2_HUMAN "Cation channel sperm-associated protein 2, CatSper2" CATSPER2 Homo sapiens (Human) fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sperm capacitation [GO:0048240] CatSper complex [GO:0036128]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] CatSper complex [GO:0036128]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; voltage-gated ion channel activity [GO:0005244]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sperm capacitation [GO:0048240] GO:0005227; GO:0005244; GO:0005262; GO:0005886; GO:0009566; GO:0030317; GO:0031514; GO:0034765; GO:0036128; GO:0048240 calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; voltage-gated ion channel activity [GO:0005244] ADMFKRQIIQR 0.9294 2.0904 13.7096 0 13.8431 0 13.8927 0 0 0 0 0 0 12.3488 0 0 0 0 10.9127 0 0 0 0 0 0 0 11.0317 0 0 0 10.6255 12.2497 0 0 12.1279 0 0 0 11.9307 0 0 10.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1533 0 11.0579 0 0 0 0 0 0 13.6005 0 11.3282 0 0 0 0 0 0 0 0 9.07615 0 0 0 11.4358 0 0 0 0 12.2865 0 13.6025 0 0 0 0 0 0 0 12.827 0 0 0 10.1703 0 13.4494 0 0 0 0 0 12.3034 0 14.6607 0 0 0 0 0 0 0 13.4603 0 0 0 0 0 0 12.8511 0 0 12.9083 0 0 0 0 0 11.1647 0 0 0 0 0 0 13.4005 0 0 0 0 10.3832 0 12.809 0 13.5591 0 11.6336 0 0 0 12.9939 14.7078 0 13.3971 14.2455 0 0 0 0 13.5838 0 0 12.3591 0 Q8WVF1 OSCP1_HUMAN "Protein OSCP1, hOSCP1 (Organic solute transport protein 1) (Oxidored-nitro domain-containing protein 1)" OSCP1 C1orf102 NOR1 Homo sapiens (Human) xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] GO:0005737; GO:0005886; GO:0009925; GO:0022857; GO:1990961 transmembrane transporter activity [GO:0022857] FMEELFKPQELYSKK 0.92942 2.1752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60784 TOM1_HUMAN Target of Myb protein 1 TOM1 Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; signal transduction [GO:0007165] azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; signal transduction [GO:0007165] GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0015031; GO:0016020; GO:0016197; GO:0030276; GO:0035091; GO:0035577; GO:0035579; GO:0043130; GO:0070062 clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130] FHVLVASQDFVESVLVRTILPK 0.92943 2.0573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8533 12.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2731 0 0 0 0 0 15.7156 0 14.1699 11.9285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6222 0 13.2359 0 0 0 11.5019 0 0 0 0 0 0 0 0 11.8604 0 0 13.6851 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8918 0 0 0 0 0 0 0 P60509 ERB1_HUMAN "Endogenous retrovirus group PABLB member 1 Env polyprotein (Endogenous retrovirus group PABLB member 1) (Envelope polyprotein) (HERV-R(b) Env protein) (HERV-R(b)_3p24.3 provirus ancestral Env polyprotein) [Includes: Surface protein domain, SU; Transmembrane protein domain, TM ]" ERVPABLB-1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 DKVIAFAIPLLDTKVFVQTSR 0.92943 1.9185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4946 14.3233 0 0 0 0 0 0 0 0 0 14.934 0 0 0 0 0 0 0 0 0 0 12.6462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16659 MK06_HUMAN "Mitogen-activated protein kinase 6, MAP kinase 6, MAPK 6, EC 2.7.11.24 (Extracellular signal-regulated kinase 3, ERK-3) (MAP kinase isoform p97, p97-MAPK)" MAPK6 ERK3 PRKM6 Homo sapiens (Human) cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0007165; GO:0019901; GO:0032156; GO:0032991; GO:0035556; GO:0046982; GO:0060999; GO:0106310 ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] IVLTDPQSVKHALREIK 0.92944 2.1994 0 0 13.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.017 13.874 0 13.4789 0 0 0 0 11.7768 0 0 0 0 0 0 13.6108 0 0 0 0 0 0 0 12.1853 14.2057 0 0 0 0 0 0 0 11.8048 12.2429 0 13.0917 0 0 0 0 0 12.7747 0 0 0 0 0 13.5768 0 0 0 0 0 12.1625 0 0 0 0 13.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.787 0 0 0 0 0 0 0 12.3631 0 0 0 0 0 0 0 0 0 11.1968 0 12.0567 0 0 0 12.2355 0 11.9766 0 Q6ZRG5 YQ015_HUMAN Putative uncharacterized protein FLJ43944 Homo sapiens (Human) MMRWNFSPEDLSSIFR 0.92945 1.0698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CI26 TR49C_HUMAN Tripartite motif-containing protein 49C (Tripartite motif-containing protein 49-like protein 2) TRIM49C TRIM49L2 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] MAHRMEILRGMYEELNEMCHK 0.92948 1.9295 0 0 0 0 0 0 0 0 0 11.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8298 0 0 0 0 0 0 0 0 0 9.79323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0157 12.6811 0 0 0 0 12.0046 0 0 0 0 0 12.3966 0 0 0 0 0 13.8351 0 0 0 0 0 0 0 0 0 13.4517 0 0 0 0 11.2671 0 0 0 0 0 0 0 0 11.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0051 0 0 0 0 0 0 0 0 0 0 0 11.1466 0 0 11.7462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6I3 EPN1_HUMAN Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1) EPN1 Homo sapiens (Human) embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; Notch signaling pathway [GO:0007219] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; Notch signaling pathway [GO:0007219] GO:0001701; GO:0005543; GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0007219; GO:0007565; GO:0030125; GO:0030276; GO:0048568; GO:1903671 clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] MSTSSLRRQMK 0.92948 1.6647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.195 0 0 0 0 0 0 0 0 0 12.994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5I7 CLD16_HUMAN "Claudin-16 (Paracellin-1, PCLN-1)" CLDN16 PCLN1 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular metal ion homeostasis [GO:0006875]; intercellular transport [GO:0010496]; metal ion transport [GO:0030001] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular metal ion homeostasis [GO:0006875]; intercellular transport [GO:0010496]; metal ion transport [GO:0030001] GO:0005198; GO:0005886; GO:0005923; GO:0006875; GO:0007155; GO:0010496; GO:0015095; GO:0016021; GO:0016338; GO:0030001; GO:0042802; GO:0070830 identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; structural molecule activity [GO:0005198] ALMITADILAGFGFLTLLLGLDCVKFLPDEPYIKVR 0.9295 2.3688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7473 15.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9032 0 0 0 0 14.973 0 0 P78382 S35A1_HUMAN "CMP-sialic acid transporter, CMP-SA-Tr, CMP-Sia-Tr (Solute carrier family 35 member A1)" SLC35A1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; protein modification process [GO:0036211] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456]; UDP-galactose transmembrane transporter activity [GO:0005459]; carbohydrate metabolic process [GO:0005975]; carbohydrate transport [GO:0008643]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; protein modification process [GO:0036211] GO:0000139; GO:0005456; GO:0005459; GO:0005794; GO:0005887; GO:0005975; GO:0008643; GO:0015297; GO:0015782; GO:0016021; GO:0030173; GO:0036211 antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456]; UDP-galactose transmembrane transporter activity [GO:0005459] AAPRDNVTLLFKLYCLAVMTLMAAVYTIALR 0.92952 2.0645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0174 12.2213 0 0 11.9541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1237 11.2702 11.0303 10.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4637 0 0 0 0 0 0 0 0 0 0 0 12.7614 0 0 0 0 0 0 0 11.9424 0 0 0 0 0 0 0 0 0 12.7148 0 0 0 0 12.5634 0 0 0 0 0 12.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1362 12.4494 0 0 0 0 0 0 0 0 0 0 0 0 Q16621 NFE2_HUMAN "Transcription factor NF-E2 45 kDa subunit (Leucine zipper protein NF-E2) (Nuclear factor, erythroid-derived 2 45 kDa subunit) (p45 NF-E2)" NFE2 Homo sapiens (Human) "hemostasis [GO:0007599]; integrated stress response signaling [GO:0140467]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; WW domain binding [GO:0050699]; hemostasis [GO:0007599]; integrated stress response signaling [GO:0140467]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006357; GO:0007599; GO:0016605; GO:0032993; GO:0042802; GO:0043565; GO:0045893; GO:0047485; GO:0050699; GO:0090575; GO:0140467; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; WW domain binding [GO:0050699]" RKLETIVQLER 0.92955 1.097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Z7 COL10_HUMAN "Collectin-10 (Collectin liver protein 1, CL-L1) (Collectin-34, CL-34)" COLEC10 CLL1 UNQ366/PRO702 Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; serine-type endopeptidase complex [GO:1905370] "collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; serine-type endopeptidase complex [GO:1905370]; chemoattractant activity [GO:0042056]; mannose binding [GO:0005537]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" GO:0001867; GO:0002752; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0005794; GO:0006508; GO:0009897; GO:0042056; GO:1903028; GO:1904888; GO:1905370 chemoattractant activity [GO:0042056]; mannose binding [GO:0005537] NVIAGIRETEEK 0.92957 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43612 OREX_HUMAN "Orexin (Hypocretin, Hcrt) [Cleaved into: Orexin-A (Hypocretin-1, Hcrt1); Orexin-B (Hypocretin-2, Hcrt2) ]" HCRT OX PPORX PPOX Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659] GO:0001659; GO:0005184; GO:0005576; GO:0005791; GO:0007200; GO:0007204; GO:0007205; GO:0007218; GO:0007268; GO:0008021; GO:0008156; GO:0030141; GO:0030431; GO:0031771; GO:0031772; GO:0042594; GO:0042755; GO:0043267; GO:0046928; GO:0048471; GO:0051928; GO:0051970; GO:0051971; GO:0060079; GO:0070161; GO:0098794; GO:0120162 neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772] SGPPGLQGRLQR 0.9296 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7662 14.0325 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2146 0 0 0 0 0 11.4861 12.2915 13.2969 12.0674 0 0 0 0 0 0 0 0 0 13.2742 0 0 0 0 Q15828 CYTM_HUMAN Cystatin-M (Cystatin-6) (Cystatin-E) CST6 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; epidermis development [GO:0008544] cornified envelope [GO:0001533]; extracellular exosome [GO:0070062] cornified envelope [GO:0001533]; extracellular exosome [GO:0070062]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; anatomical structure morphogenesis [GO:0009653]; epidermis development [GO:0008544] GO:0001533; GO:0004869; GO:0008544; GO:0009653; GO:0070062 cysteine-type endopeptidase inhibitor activity [GO:0004869] ARSNLPLALGLALVAFCLLALPR 0.9296 2.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0481 0 0 14.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5529 0 0 0 0 P24390 ERD21_HUMAN "ER lumen protein-retaining receptor 1 (KDEL endoplasmic reticulum protein retention receptor 1, KDEL receptor 1) (Putative MAPK-activating protein PM23)" KDELR1 ERD2.1 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]" cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]" GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005793; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030133; GO:0030217; GO:0030663; GO:0033116; GO:0046923; GO:0070231 ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046] FLGDLSHLLAIILLLLK 0.92961 2.2913 0 0 0 0 12.2662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5656 0 0 0 12.9784 0 0 0 0 11.7658 0 0 0 0 0 11.0239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0995 12.191 0 0 0 0 0 0 0 0 0 11.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24855 DNAS1_HUMAN "Deoxyribonuclease-1, EC 3.1.21.1 (Deoxyribonuclease I, DNase I) (Dornase alfa)" DNASE1 DNL1 DRNI Homo sapiens (Human) "apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; zymogen granule [GO:0042588]; actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]" GO:0000737; GO:0002283; GO:0002673; GO:0003677; GO:0003779; GO:0004530; GO:0005576; GO:0005634; GO:0005635; GO:0006308; GO:0006915; GO:0042588; GO:0070062; GO:0070948 actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677] GMKLLGALLALAALLQGAVSLK 0.92962 1.9484 0 0 0 0 0 0 0 0 13.3614 12.2693 0 0 0 13.2971 0 0 0 12.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8837 0 12.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4034 0 0 0 0 0 0 0 0 0 0 0 13.3188 0 0 0 0 13.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9373 0 0 0 0 0 0 0 0 0 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTI0 YK032_HUMAN Putative uncharacterized protein FLJ44636 Homo sapiens (Human) ILSGKGSGGSAR 0.92962 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7N1 F86B1_HUMAN "Putative protein N-methyltransferase FAM86B1, EC 2.1.1.-" FAM86B1 Homo sapiens (Human) methylation [GO:0032259] methyltransferase activity [GO:0008168]; methylation [GO:0032259] GO:0008168; GO:0032259 methyltransferase activity [GO:0008168] DSSDSELLR 0.92963 1.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5256 0 0 0 0 0 0 0 0 0 10.9811 0 0 0 0 0 0 0 0 0 0 0 10.9069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LI62 KR204_HUMAN Putative keratin-associated protein 20-4 KRTAP20-4 KAP20.4 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CRHGCHSSYSAR 0.92964 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28328 PEX2_HUMAN "Peroxisome biogenesis factor 2 (35 kDa peroxisomal membrane protein) (Peroxin-2) (Peroxisomal membrane protein 3) (Peroxisome assembly factor 1, PAF-1) (RING finger protein 72)" PEX2 PAF1 PMP3 PMP35 PXMP3 RNF72 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome organization [GO:0007031]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; very long-chain fatty acid metabolic process [GO:0000038] Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778] Cdc73/Paf1 complex [GO:0016593]; cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; metal ion binding [GO:0046872]; fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome organization [GO:0007031]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0000122; GO:0005778; GO:0005779; GO:0005829; GO:0006635; GO:0007031; GO:0016020; GO:0016558; GO:0016593; GO:0031648; GO:0046872; GO:0048147; GO:0050680 metal ion binding [GO:0046872] ECALCGEWPTMPHTIGCEHIFCYFCAK 0.92965 4.9532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6017 0 0 0 0 0 10.6325 0 0 0 12.9118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.786 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5313 0 0 10.9202 0 0 0 0 0 0 0 0 0 0 0 12.9477 0 0 0 0 0 0 0 0 0 0 0 11.991 0 0 11.5289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDG2 ACTT1_HUMAN "Actin-related protein T1, ARP-T1" ACTRT1 ARPT1 HSD27 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003682; GO:0005634; GO:0005737; GO:0005856; GO:0006355; GO:0008589; GO:0045892 chromatin binding [GO:0003682] EYGTSVVQRR 0.92969 1.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NDL7 MT21E_HUMAN "Putative methyltransferase-like protein 21E pseudogene, EC 2.1.1.-" METTL21EP METTL21CP1 Homo sapiens (Human) peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023] GO:0005737; GO:0005829; GO:0016279; GO:0018022; GO:0018023 protein-lysine N-methyltransferase activity [GO:0016279] FKELFDLEEISSFPSLNIKLYK 0.92971 1.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVJ8 APRG1_HUMAN APRG1 tumor suppressor candidate (AP20 region protein 1) APRG1 C3orf35 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GITALDGLKRGR 0.92971 2.1712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4354 13.0626 13.9768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4S7 PAQR4_HUMAN Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV) PAQR4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023] GO:0016021; GO:0038023 signaling receptor activity [GO:0038023] LRAFGWQAAARLLVFGAR 0.92971 1.0708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6352 0 0 0 0 0 0 0 0 P58182 O12D2_HUMAN Olfactory receptor 12D2 (Hs6M1-20) (Olfactory receptor OR6-28) OR12D2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IVAIMYTVVTPVLNPLIYTLRNK 0.92973 1.0699 0 0 0 0 0 0 0 0 12.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9045 0 0 0 0 10.9002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HYA8 MKS3_HUMAN Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67) TMEM67 MKS3 Homo sapiens (Human) cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433] centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038] centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; filamin binding [GO:0031005]; unfolded protein binding [GO:0051082]; cilium assembly [GO:0060271]; negative regulation of centrosome duplication [GO:0010826]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005789; GO:0005813; GO:0010826; GO:0016021; GO:0030433; GO:0030659; GO:0031005; GO:0035869; GO:0036038; GO:0051082; GO:0060170; GO:0060271 filamin binding [GO:0031005]; unfolded protein binding [GO:0051082] ALQFLHK 0.92973 2.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8038 0 0 13.6242 0 0 0 0 0 0 0 0 0 13.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.026 10.9707 0 0 11.545 0 0 0 0 0 14.2972 12.2063 0 Q7Z6J9 SEN54_HUMAN "tRNA-splicing endonuclease subunit Sen54 (SEN54 homolog, HsSEN54) (tRNA-intron endonuclease Sen54)" TSEN54 SEN54 Homo sapiens (Human) "mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" GO:0000214; GO:0000379; GO:0005654; GO:0005730; GO:0006388; GO:0006397 DFLPDGSAAQAERLRR 0.92973 1.9341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1107 0 0 0 0 11.0347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2427 0 0 0 0 0 0 0 0 13.8699 0 11.6077 0 0 0 0 0 0 0 0 0 15.6611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4389 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4292 0 0 0 0 0 0 0 0 0 0 0 14.058 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWU9 TPH2_HUMAN "Tryptophan 5-hydroxylase 2, EC 1.14.16.4 (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2)" TPH2 NTPH Homo sapiens (Human) aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427] cytosol [GO:0005829]; neuron projection [GO:0043005] cytosol [GO:0005829]; neuron projection [GO:0043005]; iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510]; aromatic amino acid family metabolic process [GO:0009072]; cellular response to lithium ion [GO:0071285]; circadian rhythm [GO:0007623]; response to activity [GO:0014823]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to nutrient levels [GO:0031667]; serotonin biosynthetic process [GO:0042427] GO:0004510; GO:0005506; GO:0005829; GO:0007623; GO:0009072; GO:0014823; GO:0031667; GO:0042427; GO:0043005; GO:0043627; GO:0051384; GO:0051592; GO:0071285 iron ion binding [GO:0005506]; tryptophan 5-monooxygenase activity [GO:0004510] LYPTHACREYLK 0.92973 2.1405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8558 0 0 12.3554 0 0 0 0 0 0 12.1248 0 0 0 0 0 0 0 0 0 0 11.4378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1543 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9791 15.2753 0 0 0 0 0 0 0 13.3408 0 0 0 0 0 0 0 0 0 O60830 TI17B_HUMAN Mitochondrial import inner membrane translocase subunit Tim17-B TIMM17B TIM17B JM3 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; protein transmembrane transporter activity [GO:0008320]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] GO:0005743; GO:0005744; GO:0006626; GO:0006886; GO:0008320; GO:0030150; GO:0031305 protein transmembrane transporter activity [GO:0008320] EPCPWRIVDDCGGAFTMGVIGGGVFQAIKGFR 0.92974 1.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6117 0 11.3515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55899 FCGRN_HUMAN "IgG receptor FcRn large subunit p51, FcRn (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor)" FCGRT FCRN Homo sapiens (Human) IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor [GO:0002416] endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; beta-2-microglobulin binding [GO:0030881]; IgG binding [GO:0019864]; IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor [GO:0002416] GO:0002416; GO:0005615; GO:0009897; GO:0010008; GO:0016021; GO:0019864; GO:0030881 beta-2-microglobulin binding [GO:0030881]; IgG binding [GO:0019864] IKEKLFLEAFK 0.92977 2.288 0 0 0 0 0 0 0 0 0 0 11.5872 0 0 0 11.3466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6869 0 0 0 0 0 0 0 0 0 12.5959 0 0 0 0 0 15.3752 0 0 0 14.3635 0 15.0784 14.0223 14.0293 0 14.0067 0 0 0 0 13.6764 0 0 16.1094 15.274 14.2296 14.9981 15.8063 0 15.5709 14.5777 14.8316 12.984 13.4897 0 0 14.6488 13.7037 0 14.6058 0 12.7565 14.632 0 0 0 0 0 0 0 14.5329 14.9452 0 0 14.6224 0 14.1102 0 0 0 0 13.8253 0 0 0 12.3898 0 0 12.9573 0 0 0 0 0 0 0 0 0 0 0 11.3512 11.9354 0 0 0 0 0 0 0 0 0 11.903 0 0 0 0 0 13.3569 11.9789 0 0 0 0 P60893 GPR85_HUMAN Probable G-protein coupled receptor 85 (Super conserved receptor expressed in brain 2) GPR85 SREB2 Homo sapiens (Human) signal transduction [GO:0007165] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; signal transduction [GO:0007165] GO:0004930; GO:0005783; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930] ANDSLGFMLLLALILLATQLVYLK 0.92977 2.3482 0 0 0 0 0 0 0 12.6418 0 0 0 0 0 11.3719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.084 0 0 10.058 0 11.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8235 0 0 0 11.4666 0 0 0 0 0 0 0 0 0 0 10.9986 0 13.3927 0 0 0 0 0 0 13.5339 0 0 12.993 13.5984 0 10.8358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5575 13.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGL7 OR4P4_HUMAN Olfactory receptor 4P4 (Olfactory receptor 4P3) OR4P4 OR4P3P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] PLHYTIIMSRQK 0.92978 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0719 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHI7 S23A1_HUMAN "Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1, hSVCT1) (Yolk sac permease-like molecule 3)" SLC23A1 SVCT1 YSPL3 Homo sapiens (Human) brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081]; brain development [GO:0007420]; dehydroascorbic acid transport [GO:0070837]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; lung development [GO:0030324]; nucleobase transport [GO:0015851]; response to toxic substance [GO:0009636]; sodium ion transport [GO:0006814] GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006814; GO:0007420; GO:0008520; GO:0009636; GO:0009925; GO:0015081; GO:0015205; GO:0015229; GO:0015851; GO:0015882; GO:0016324; GO:0019852; GO:0030324; GO:0033300; GO:0043229; GO:0070062; GO:0070837 dehydroascorbic acid transmembrane transporter activity [GO:0033300]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; nucleobase transmembrane transporter activity [GO:0015205]; sodium ion transmembrane transporter activity [GO:0015081] AYGFQARTDAR 0.92978 1.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.42549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6721 0 0 13.372 0 0 0 0 12.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6DD88 ATLA3_HUMAN "Atlastin-3, EC 3.6.5.-" ATL3 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; protein homooligomerization [GO:0051260] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; protein homooligomerization [GO:0051260] GO:0003924; GO:0005525; GO:0005783; GO:0007029; GO:0007030; GO:0016020; GO:0016021; GO:0042802; GO:0051260; GO:0071782; GO:0098826; GO:1903373 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] GKSFILDFMLRYLYSQK 0.92979 1.0761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7647 0 0 11.9841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2I9 STK40_HUMAN "Serine/threonine-protein kinase 40, EC 2.7.11.1 (SINK-homologous serine/threonine-protein kinase) (Sugen kinase 495, SgK495)" STK40 SGK495 SHIK Homo sapiens (Human) glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016] GO:0003016; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006468; GO:0010468; GO:0035264; GO:0043066; GO:0043408; GO:0048286; GO:0060425; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ITITNFCLGKHLVSEGDLLKDQR 0.92981 2.0835 0 0 0 0 0 0 0 0 0 0 0 10.6965 0 0 0 0 0 0 11.2953 0 0 0 0 0 0 0 0 0 0 0 0 11.9753 0 0 0 0 0 0 11.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.498 0 0 0 0 10.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1E5 TMX4_HUMAN Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13) TMX4 KIAA1162 TXNDC13 PSEC0095 UNQ475/PRO938 Homo sapiens (Human) endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; disulfide oxidoreductase activity [GO:0015036] GO:0005637; GO:0012505; GO:0015036; GO:0016021 disulfide oxidoreductase activity [GO:0015036] DSLVDDEEEKEDLGDEDEAEEEEEEDNLAAGVDEER 0.92982 2.1796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8598 0 0 0 0 0 0 0 0 0 12.6253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9778 0 0 0 0 0 0 11.2131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2868 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7373 0 13.6774 0 0 0 12.0819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PI77 BHLH9_HUMAN "Protein BHLHb9, bHLHb9 (Transcription regulator of 60 kDa, p60TRP)" BHLHB9 KIAA1701 Homo sapiens (Human) learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neurogenesis [GO:0050769]; positive regulation of synapse assembly [GO:0051965] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neurogenesis [GO:0050769]; positive regulation of synapse assembly [GO:0051965] GO:0005634; GO:0005829; GO:0007611; GO:0042803; GO:0043524; GO:0050769; GO:0051965; GO:0061003; GO:0070062 protein homodimerization activity [GO:0042803] ALAALKLIFNQK 0.92984 1.0877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0759 0 0 0 0 0 0 0 0 0 0 0 12.5971 0 0 0 0 0 0 0 11.8666 11.0442 0 0 0 0 0 0 0 0 13.9761 0 0 0 13.0779 0 0 0 0 16.3138 0 0 0 0 13.0342 0 0 0 12.2376 0 0 14.7294 0 0 12.8952 0 0 12.9821 0 0 0 16.2317 12.2749 0 0 0 12.074 0 0 0 0 12.5525 0 12.5503 11.6584 0 0 13.477 16.5214 0 12.9355 0 0 12.5141 0 15.5557 0 0 0 0 17.2796 15.472 11.5595 14.6917 0 0 0 15.632 13.6856 0 0 11.1294 0 0 0 0 9.93624 0 0 0 0 0 0 12.1869 15.1924 0 0 0 0 0 0 0 12.8988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2781 0 0 9.76967 15.22 0 0 0 14.3168 0 12.9821 10.176 Q05315 LEG10_HUMAN "Galectin-10, Gal-10 (Charcot-Leyden crystal protein, CLC) (Eosinophil lysophospholipase) (Lysolecithin acylhydrolase)" CLC LGALS10 LGALS10A Homo sapiens (Human) regulation of activated T cell proliferation [GO:0046006]; regulation of T cell anergy [GO:0002667]; regulation of T cell cytokine production [GO:0002724]; T cell apoptotic process [GO:0070231] collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829] collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; carbohydrate binding [GO:0030246]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; identical protein binding [GO:0042802]; regulation of activated T cell proliferation [GO:0046006]; regulation of T cell anergy [GO:0002667]; regulation of T cell cytokine production [GO:0002724]; T cell apoptotic process [GO:0070231] GO:0002667; GO:0002724; GO:0005829; GO:0030246; GO:0042802; GO:0046006; GO:0062023; GO:0070231; GO:0097153 carbohydrate binding [GO:0030246]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; identical protein binding [GO:0042802] MVQVWRDISLTK 0.92985 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5523 0 0 0 0 0 0 0 13.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNR0 TMM91_HUMAN "Transmembrane protein 91 (Dispanin subfamily C member 3, DSPC3)" TMEM91 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244; GO:0016020; GO:0016021; GO:0043231 GDIQGAGAASRR 0.92987 1.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.215 0 0 0 0 0 0 0 0 11.8713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6873 0 0 14.7784 0 14.4222 14.4466 14.5062 0 0 0 0 0 0 0 0 13.5056 11.5403 0 0 0 0 0 0 0 14.1837 0 0 0 0 0 0 0 0 0 0 0 0 10.8854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5967 0 0 0 0 0 11.1393 0 O95393 BMP10_HUMAN "Bone morphogenetic protein 10, BMP-10" BMP10 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433]; activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]" GO:0001822; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010628; GO:0010862; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0045214; GO:0045893; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060389; GO:0060395; GO:0061036; GO:1903242; GO:2000138 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433] FKYEGMAVSECGCR 0.92988 2.0594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1514 12.3561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65868 0 0 0 0 0 0 0 0 0 0 0 0 0 11.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3563 0 0 0 13.561 0 0 0 0 0 0 0 0 0 0 0 0 12.7273 0 13.8563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4844 0 0 13.9402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5916 13.633 0 0 0 0 0 0 0 0 0 0 0 13.1702 0 0 14.0097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HH4 TM169_HUMAN Transmembrane protein 169 TMEM169 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 YVTLTGTITRGK 0.92988 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9542 0 0 0 0 0 0 0 0 0 10.9416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6761 13.0428 0 0 0 0 14.5796 0 Q3SYB3 FX4L6_HUMAN "Forkhead box protein D4-like 6, FOXD4-like 6" FOXD4L6 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CWAGTCR 0.92992 1.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3088 0 0 0 0 0 0 0 12.3589 0 0 0 0 0 12.2942 0 0 0 0 0 0 12.3733 0 0 13.7345 0 0 0 0 0 0 0 0 0 0 11.1055 13.8981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5463 0 0 12.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4036 0 0 0 0 0 11.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7583 0 0 0 0 0 0 0 0 0 0 0 Q3ZM63 ETDA_HUMAN Embryonic testis differentiation protein homolog A ETDA Homo sapiens (Human) EPALNIK 0.92992 2.0921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.183 0 0 0 0 0 0 0 0 0 0 0 0 13.3235 0 0 0 0 0 0 12.2857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9312 0 0 0 0 0 14.0091 0 0 0 0 0 0 0 0 0 0 0 0 13.5735 0 0 16.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5794 0 0 0 0 0 Q96AM1 MRGRF_HUMAN "Mas-related G-protein coupled receptor member F, Mas-related gene F protein (G-protein coupled receptor 140) (G-protein coupled receptor 168)" MRGPRF GPR140 GPR168 MRGF PSEC0142 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0016021; GO:0031965 G protein-coupled receptor activity [GO:0004930] DKSQRLWEPLR 0.92992 2.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DT0 LEG12_HUMAN "Galectin-12, Gal-12 (Galectin-related inhibitor of proliferation)" LGALS12 GRIP1 Homo sapiens (Human) intrinsic apoptotic signaling pathway [GO:0097193]; lymphatic endothelial cell migration [GO:1904977]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid catabolic process [GO:0050994] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; integrin binding [GO:0005178]; lactose binding [GO:0030395]; intrinsic apoptotic signaling pathway [GO:0097193]; lymphatic endothelial cell migration [GO:1904977]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid catabolic process [GO:0050994] GO:0005178; GO:0005634; GO:0005737; GO:0005739; GO:0030246; GO:0030395; GO:0045598; GO:0050994; GO:0097193; GO:1904977 carbohydrate binding [GO:0030246]; integrin binding [GO:0005178]; lactose binding [GO:0030395] EARWPHLALR 0.92992 1.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3488 0 0 0 11.4802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4336 0 0 14.8656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3472 0 0 0 0 0 0 0 0 Q8WY64 MYLIP_HUMAN "E3 ubiquitin-protein ligase MYLIP, EC 2.3.2.27 (Inducible degrader of the LDL-receptor, Idol) (Myosin regulatory light chain interacting protein, MIR) (RING-type E3 ubiquitin transferase MYLIP)" MYLIP BZF1 IDOL BM-023 PP5242 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005829; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0046872; GO:0061630 cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ANGEDCLNQVCR 0.92995 2.3582 0 0 0 0 0 0 0 0 11.3018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4244 0 0 0 0 13.4658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4304 0 0 0 0 11.8509 0 0 0 0 10.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T215 TPC3L_HUMAN "Trafficking protein particle complex subunit 3-like protein, TRAPPC3-like protein (BET3-like protein)" TRAPPC3L BET3L Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891] cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008] cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891] GO:0005783; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106 DYEKDEDVNQYLDKMGYGIGTR 0.92996 2.0916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0336 0 12.9301 0 0 0 0 0 0 0 0 13.9752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JUK3 KCNT1_HUMAN Potassium channel subfamily T member 1 (KCa4.1) KCNT1 KIAA1422 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271] GO:0005228; GO:0005886; GO:0015271; GO:0016021 intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271] AKLPRSPSEGK 0.92997 1.9192 0 0 0 0 0 0 0 0 0 14.7867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7234 0 12.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0779 0 11.3342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2753 0 0 0 13.8942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5283 0 0 0 0 0 0 0 Q6U7Q0 ZN322_HUMAN Zinc finger protein 322 (Zinc finger protein 322A) (Zinc finger protein 388) (Zinc finger protein 489) ZNF322 ZNF322A ZNF388 ZNF489 Homo sapiens (Human) positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005654; GO:0005813; GO:0005829; GO:0006357; GO:0046872; GO:1902459 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IFIHMHEIIQIDGHIYQCLECK 0.92997 2.1776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.09 0 0 0 0 0 0 0 0 11.1692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.419 11.0462 13.1963 0 11.1642 0 0 0 0 0 0 0 0 0 0 0 14.0221 0 0 0 0 0 0 0 0 0 0 0 12.8883 0 0 0 13.5031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 E5RJ46 CH087_HUMAN Putative uncharacterized protein LINC02906 (Long intergenic non-protein coding RNA 2906) LINC02906 C8orf87 Homo sapiens (Human) PLPHSQESQHGSATSKK 0.93 1.0709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVK6 TMED9_HUMAN "Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2, p24alpha2) (p25)" TMED9 GP25L2 Homo sapiens (Human) COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; syntaxin binding [GO:0019905]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638] GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0008021; GO:0010638; GO:0016021; GO:0019905; GO:0030133; GO:0030134; GO:0030140; GO:0033116; GO:0048205; GO:0070062 syntaxin binding [GO:0019905] AVELGVLLVR 0.93 1.1125 0 0 0 10.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8958 15.7501 0 0 15.6856 0 0 0 0 0 0 0 0 0 0 0 0 12.198 0 0 0 0 0 12.8578 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8125 0 0 0 0 0 0 0 0 0 0 13.5552 12.8212 0 0 12.2849 0 0 0 0 13.1755 0 0 0 0 0 0 0 0 0 0 0 Q96G79 S35A4_HUMAN Probable UDP-sugar transporter protein SLC35A4 (Solute carrier family 35 member A4) SLC35A4 Homo sapiens (Human) carbohydrate transport [GO:0008643] Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173] Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; carbohydrate transport [GO:0008643] GO:0005794; GO:0008643; GO:0015165; GO:0030173 pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165] HGSSITRLFVVSCSLVVNAVLSAVLLR 0.93001 2.1346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0053 0 0 0 0 0 0 0 0 0 11.8748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8683 0 0 0 0 0 0 0 0 0 0 0 12.1846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7693 0 0 0 0 0 Q9BUY5 ZN426_HUMAN Zinc finger protein 426 ZNF426 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ELCDCEQCGEVFSEHSCLK 0.93001 1.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19835 CEL_HUMAN "Bile salt-activated lipase, BAL, EC 3.1.1.13, EC 3.1.1.3, EC 3.1.1.6 (Bile salt-stimulated lipase, BSSL) (Bucelipase) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase)" CEL BAL Homo sapiens (Human) ceramide catabolic process [GO:0046514]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; pancreatic juice secretion [GO:0030157] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; presynapse [GO:0098793] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; presynapse [GO:0098793]; acetylesterase activity [GO:0008126]; catalytic activity [GO:0003824]; heparin binding [GO:0008201]; hydrolase activity [GO:0016787]; retinyl-palmitate esterase activity [GO:0050253]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; ceramide catabolic process [GO:0046514]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; pancreatic juice secretion [GO:0030157] GO:0003824; GO:0004771; GO:0004806; GO:0005576; GO:0005615; GO:0005737; GO:0006629; GO:0008126; GO:0008201; GO:0016787; GO:0030157; GO:0030299; GO:0046514; GO:0050253; GO:0070062; GO:0098793 acetylesterase activity [GO:0008126]; catalytic activity [GO:0003824]; heparin binding [GO:0008201]; hydrolase activity [GO:0016787]; retinyl-palmitate esterase activity [GO:0050253]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806] KVAEKVGCPVGDAAR 0.93003 2.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9577 0 11.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9726 0 0 0 0 0 0 Q9HAW9 UD18_HUMAN "UDP-glucuronosyltransferase 1A8, UGT1A8, EC 2.4.1.17 (UDP-glucuronosyltransferase 1-8, UDPGT 1-8, UGT1*8, UGT1-08, UGT1.8) (UDP-glucuronosyltransferase 1-H, UGT-1H, UGT1H)" UGT1A8 GNT1 UGT1 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; coumarin metabolic process [GO:0009804]; fatty acid metabolic process [GO:0006631]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; fatty acid binding [GO:0005504]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; cellular glucuronidation [GO:0052695]; coumarin metabolic process [GO:0009804]; fatty acid metabolic process [GO:0006631]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] GO:0001889; GO:0001972; GO:0004857; GO:0005496; GO:0005504; GO:0005783; GO:0005789; GO:0006631; GO:0006805; GO:0008202; GO:0009804; GO:0015020; GO:0016021; GO:0019899; GO:0042573; GO:0042803; GO:0045922; GO:0045939; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:1904224; GO:2001030 enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; fatty acid binding [GO:0005504]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496] AQVRSLFSLFLSSSNGFFNLFFSHCRSLFNDR 0.93003 1.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEM8 CBPC3_HUMAN "Cytosolic carboxypeptidase 3, EC 3.4.17.- (ATP/GTP-binding protein-like 3) (Protein deglutamylase CCP3)" AGBL3 CCP3 Homo sapiens (Human) protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytosol [GO:0005829] cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] GO:0004181; GO:0005829; GO:0006508; GO:0008270; GO:0035610 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] EDYSDRTISDEDESDEDMFMK 0.93006 2.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2666 0 0 0 12.902 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2389 14.0437 0 0 0 0 0 0 11.8306 0 0 0 0 0 9.78105 0 10.7408 11.0776 0 0 0 14.0794 0 13.7259 13.9697 0 0 13.5779 0 0 0 13.8555 0 0 0 0 13.1377 0 13.9264 12.5297 0 0 0 0 0 0 13.5156 0 0 0 0 14.0776 0 13.4022 10.5473 10.3539 11.2584 13.5367 0 13.6528 13.0623 0 0 0 0 0 12.5136 13.7338 0 0 0 0 11.7379 13.63 0 0 13.1919 0 0 0 0 0 0 0 0 0 13.9523 11.8284 0 11.8845 0 0 0 15.9195 0 0 10.207 0 10.706 0 0 0 0 13.8957 13.2112 9.86262 0 0 15.3814 0 0 Q8N769 CN178_HUMAN Uncharacterized protein C14orf178 C14orf178 Homo sapiens (Human) DSTFLRHLESDR 0.93007 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L5Y1 ENOF1_HUMAN "Mitochondrial enolase superfamily member 1, EC 4.2.1.68 (Antisense RNA to thymidylate synthase, rTS) (L-fuconate dehydratase)" ENOSF1 RTS TYMSAS Homo sapiens (Human) carbohydrate catabolic process [GO:0016052]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; hydro-lyase activity [GO:0016836]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; carbohydrate catabolic process [GO:0016052]; cellular amino acid catabolic process [GO:0009063]; cellular carbohydrate catabolic process [GO:0044275] GO:0000287; GO:0005739; GO:0009063; GO:0016052; GO:0016836; GO:0016853; GO:0044275; GO:0050023 hydro-lyase activity [GO:0016836]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287] PVWKLLVDMDPR 0.93009 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7659 0 0 0 0 0 0 0 0 0 0 Q7KZN9 COX15_HUMAN Cytochrome c oxidase assembly protein COX15 homolog COX15 Homo sapiens (Human) "cellular respiration [GO:0045333]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]; respiratory gaseous exchange by respiratory system [GO:0007585]" cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cellular respiration [GO:0045333]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; proton transmembrane transport [GO:1902600]; respiratory chain complex IV assembly [GO:0008535]; respiratory gaseous exchange by respiratory system [GO:0007585]" GO:0004129; GO:0005654; GO:0005739; GO:0005743; GO:0005746; GO:0006123; GO:0006783; GO:0006784; GO:0007585; GO:0008535; GO:0016021; GO:0016627; GO:0016653; GO:0020037; GO:0045333; GO:0060090; GO:0070069; GO:1902600 "cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]" GRQYLPLLAPRAAPR 0.9301 2.2005 0 0 0 0 0 0 10.0025 0 0 0 0 0 0 11.9114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2369 0 0 0 0 14.2164 0 0 0 0 0 0 0 0 14.9798 0 0 13.6886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8214 0 0 0 0 0 0 0 0 0 0 0 0 12.8857 0 0 0 0 0 0 12.1559 0 0 0 12.7724 0 0 0 0 0 0 14.5587 0 0 0 0 14.1854 0 0 0 0 0 0 0 12.2421 0 0 0 11.7148 0 13.8772 0 0 0 0 0 0 0 0 0 0 12.8864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6I3 LVK55_HUMAN Probable non-functional immunoglobulin lambda variable 11-55 IGLV11-55 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 LPCTLSSDLSVGGKNMFWYQQKLGSSPR 0.93011 1.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6791 12.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51809 VAMP7_HUMAN "Vesicle-associated membrane protein 7, VAMP-7 (Synaptobrevin-like protein 1) (Tetanus-insensitive VAMP, Ti-VAMP)" VAMP7 SYBL1 Homo sapiens (Human) "calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]" anchoring junction [GO:0070161]; azurophil granule membrane [GO:0035577]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] "anchoring junction [GO:0070161]; azurophil granule membrane [GO:0035577]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0005484; GO:0005737; GO:0005765; GO:0005789; GO:0005802; GO:0005886; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008333; GO:0015031; GO:0016020; GO:0016021; GO:0016192; GO:0017156; GO:0030027; GO:0030141; GO:0030658; GO:0030667; GO:0030669; GO:0030670; GO:0031091; GO:0031143; GO:0031201; GO:0031902; GO:0035577; GO:0043005; GO:0043231; GO:0043308; GO:0043312; GO:0043320; GO:0045202; GO:0045335; GO:0070062; GO:0070161; GO:1903595 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] AFNFLNEIK 0.93011 2.0651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5302 0 14.1528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92581 SL9A6_HUMAN "Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6, NHE-6) (Solute carrier family 9 member 6)" SLC9A6 KIAA0267 NHE6 Homo sapiens (Human) axon extension [GO:0048675]; dendrite extension [GO:0097484]; ion transport [GO:0006811]; neuron projection morphogenesis [GO:0048812]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; ion transport [GO:0006811]; neuron projection morphogenesis [GO:0048812]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] GO:0005789; GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0031901; GO:0043231; GO:0048675; GO:0048812; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0097484; GO:0098719 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] AANIYPLSLLLNLGRR 0.93011 1.0879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6258 12.4484 0 0 12.0702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NND4 O2AT4_HUMAN Olfactory receptor 2AT4 (Olfactory receptor OR11-265) OR2AT4 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021; GO:0070374 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DVKAAITKIMSQDPGCDR 0.93014 1.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWF8 CAPSL_HUMAN Calcyphosin-like protein CAPSL Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509] GO:0005509; GO:0005737 calcium ion binding [GO:0005509] LTTATDPIERLR 0.93016 1.107 0 0 0 0 0 0 0 0 10.7668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3807 0 0 0 11.0776 0 0 0 0 0 0 0 0 0 0 0 Q8NCG5 CHST4_HUMAN "Carbohydrate sulfotransferase 4, EC 2.8.2.- (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3, GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase, HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase, LSST) (N-acetylglucosamine 6-O-sulfotransferase 2, GlcNAc6ST-2, Gn6st-2)" CHST4 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; N-acetylglucosamine metabolic process [GO:0006044]; O-glycan processing [GO:0016266]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; N-acetylglucosamine metabolic process [GO:0006044]; O-glycan processing [GO:0016266]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0006954; GO:0006955; GO:0007155; GO:0007267; GO:0008146; GO:0016021; GO:0016266; GO:0031228; GO:1903238 N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] AHCRLLCSQQPFEVVEK 0.93017 2.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1687 0 12.8101 0 0 0 11.2037 0 0 0 0 0 0 0 0 13.9142 0 0 0 0 15.3407 0 15.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1558 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXU5 ARL15_HUMAN "ADP-ribosylation factor-like protein 15 (ADP-ribosylation factor-related protein 2, ARF-related protein 2)" ARL15 ARFRP2 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924] KYFELEPLAR 0.93017 1.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0336 0 0 0 0 0 0 0 0 0 0 10.6732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GVZ2 F240B_HUMAN Protein FAM240B FAM240B Homo sapiens (Human) MNNQYIRREVFCCGTCHELK 0.93019 2.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9377 11.8998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE02 ELP5_HUMAN Elongator complex protein 5 (Dermal papilla-derived protein 6) (S-phase 2 protein) ELP5 C17orf81 DERP6 HSPC002 MSTP071 Homo sapiens (Human) positive regulation of cell migration [GO:0030335]; regulation of translation [GO:0006417]; tRNA modification [GO:0006400]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; regulation of translation [GO:0006417]; tRNA modification [GO:0006400]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006400; GO:0006417; GO:0030335; GO:0033588 TPSEGARAGTGR 0.93019 1.1108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4598 0 13.724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0295 13.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8061 0 0 0 13.2005 13.3159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9816 0 12.7351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8906 12.5512 0 0 0 0 0 0 0 Q9NZD2 GLTP_HUMAN "Glycolipid transfer protein, GLTP" GLTP Homo sapiens (Human) ceramide transport [GO:0035627]; glycosphingolipid metabolic process [GO:0006687]; intermembrane lipid transfer [GO:0120009] cytosol [GO:0005829] cytosol [GO:0005829]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; ceramide transport [GO:0035627]; glycosphingolipid metabolic process [GO:0006687]; intermembrane lipid transfer [GO:0120009] GO:0005829; GO:0006687; GO:0008289; GO:0017089; GO:0035627; GO:0042802; GO:0051861; GO:0120009; GO:0120013; GO:1902387; GO:1902388 ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transfer activity [GO:0120013] ALLAEHLLK 0.93019 1.0938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0831 0 14.1734 0 0 0 0 0 0 0 0 14.9917 0 0 15.5267 0 0 0 15.6852 0 0 14.5588 0 0 0 0 0 14.7737 12.941 14.1268 0 0 0 14.8376 14.8124 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8776 0 0 0 0 0 0 0 0 0 0 15.2274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0771 0 13.126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8522 0 O43734 CIKS_HUMAN "E3 ubiquitin ligase TRAF3IP2, EC 2.3.2.27 (Adapter protein CIKS) (Connection to IKK and SAPK/JNK) (E3 ubiquitin-protein ligase CIKS) (Nuclear factor NF-kappa-B activator 1, ACT1) (TRAF3-interacting protein 2)" TRAF3IP2 C6orf2 C6orf4 C6orf5 C6orf6 Homo sapiens (Human) B cell affinity maturation [GO:0002344]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; CD40 signaling pathway [GO:0023035]; eosinophil homeostasis [GO:1990959]; eosinophil mediated immunity [GO:0002447]; establishment of T cell polarity [GO:0001768]; heart development [GO:0007507]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; leukocyte activation involved in inflammatory response [GO:0002269]; lymph node development [GO:0048535]; mRNA stabilization [GO:0048255]; mucus secretion [GO:0070254]; neutrophil activation [GO:0042119]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein import into nucleus [GO:0006606]; protein K63-linked ubiquitination [GO:0070534]; protein localization to P-body [GO:0110012]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; skin development [GO:0043588]; spleen development [GO:0048536]; T cell differentiation [GO:0030217]; T-helper 17 type immune response [GO:0072538]; transitional two stage B cell differentiation [GO:0002334]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type 2 immune response [GO:0042092] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630]; B cell affinity maturation [GO:0002344]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; CD40 signaling pathway [GO:0023035]; eosinophil homeostasis [GO:1990959]; eosinophil mediated immunity [GO:0002447]; establishment of T cell polarity [GO:0001768]; heart development [GO:0007507]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; leukocyte activation involved in inflammatory response [GO:0002269]; lymph node development [GO:0048535]; mRNA stabilization [GO:0048255]; mucus secretion [GO:0070254]; neutrophil activation [GO:0042119]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein import into nucleus [GO:0006606]; protein K63-linked ubiquitination [GO:0070534]; protein localization to P-body [GO:0110012]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; skin development [GO:0043588]; spleen development [GO:0048536]; T cell differentiation [GO:0030217]; T-helper 17 type immune response [GO:0072538]; transitional two stage B cell differentiation [GO:0002334]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type 2 immune response [GO:0042092] GO:0001768; GO:0001782; GO:0001783; GO:0001822; GO:0002230; GO:0002269; GO:0002334; GO:0002344; GO:0002447; GO:0005102; GO:0005634; GO:0006606; GO:0006954; GO:0006959; GO:0007507; GO:0009410; GO:0023019; GO:0023035; GO:0030217; GO:0031410; GO:0033209; GO:0035556; GO:0038173; GO:0042092; GO:0042119; GO:0043123; GO:0043588; GO:0048255; GO:0048535; GO:0048536; GO:0061630; GO:0070254; GO:0070534; GO:0072538; GO:0097400; GO:0110012; GO:1990959 signaling receptor binding [GO:0005102]; ubiquitin protein ligase activity [GO:0061630] FIPVLFPNAKKEHVPTWLQNTHVYSWPK 0.9302 2.0643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5531 12.84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8135 13.1531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3567 0 0 0 0 0 0 12.524 0 0 0 0 0 0 14.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5Z0 AADAT_HUMAN "Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial, KAT/AadAT (2-aminoadipate aminotransferase) (2-aminoadipate transaminase, EC 2.6.1.39) (Alpha-aminoadipate aminotransferase, AadAT) (Glycine transaminase AADAT, EC 2.6.1.4) (Kynurenine aminotransferase II) (Kynurenine--glyoxylate transaminase AADAT, EC 2.6.1.63) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2, EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II) (Methionine--glyoxylate transaminase AADAT, EC 2.6.1.73)" AADAT KAT2 KYAT2 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; 2-aminoadipate transaminase activity [GO:0047536]; glycine:2-oxoglutarate aminotransferase activity [GO:0047958]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; methionine-glyoxylate transaminase activity [GO:0050094]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512] GO:0005759; GO:0006103; GO:0006536; GO:0008483; GO:0009058; GO:0016212; GO:0030170; GO:0033512; GO:0042803; GO:0047315; GO:0047536; GO:0047958; GO:0050094; GO:0070189; GO:1901605 2-aminoadipate transaminase activity [GO:0047536]; glycine:2-oxoglutarate aminotransferase activity [GO:0047958]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; methionine-glyoxylate transaminase activity [GO:0050094]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] KEIYELARK 0.9302 1.0724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14994 SYN3_HUMAN Synapsin-3 (Synapsin III) SYN3 Homo sapiens (Human) "neurotransmitter secretion [GO:0007269]; regulation of synaptic transmission, GABAergic [GO:0032228]; synaptic vesicle clustering [GO:0097091]" anchoring junction [GO:0070161]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; neurotransmitter secretion [GO:0007269]; regulation of synaptic transmission, GABAergic [GO:0032228]; synaptic vesicle clustering [GO:0097091]" GO:0005524; GO:0007269; GO:0008021; GO:0014069; GO:0030672; GO:0032228; GO:0070161; GO:0097091; GO:0098850; GO:0098978 ATP binding [GO:0005524] AYMRTSISGNWK 0.93022 1.072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9386 14.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9586 0 0 10.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.18001 0 0 17.287 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1736 0 0 P06732 KCRM_HUMAN "Creatine kinase M-type, EC 2.7.3.2 (Creatine kinase M chain) (Creatine phosphokinase M-type, CPK-M) (M-CK)" CKM CKMM Homo sapiens (Human) phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310] cytosol [GO:0005829]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular space [GO:0005615]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310] GO:0004111; GO:0005524; GO:0005615; GO:0005829; GO:0016301; GO:0016310; GO:0046314 ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301] FCVGLQKIEEIFK 0.93023 1.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32249 GP183_HUMAN "G-protein coupled receptor 183 (Epstein-Barr virus-induced G-protein coupled receptor 2, EBI2, EBV-induced G-protein coupled receptor 2, hEBI2)" GPR183 EBI2 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; dendritic cell chemotaxis [GO:0002407]; dendritic cell homeostasis [GO:0036145]; G protein-coupled receptor signaling pathway [GO:0007186]; humoral immune response [GO:0006959]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; mature B cell differentiation involved in immune response [GO:0002313]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of astrocyte chemotaxis [GO:2000458]; T cell chemotaxis [GO:0010818]; T follicular helper cell differentiation [GO:0061470] GO:0002250; GO:0002312; GO:0002313; GO:0002407; GO:0004930; GO:0005886; GO:0005887; GO:0006955; GO:0006959; GO:0007186; GO:0008142; GO:0010818; GO:0030316; GO:0030595; GO:0030890; GO:0036145; GO:0061470; GO:0070374; GO:2000458 G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142] FIAVVHPLR 0.93023 1.9365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8239 0 0 0 0 0 0 0 0 0 0 0 13.0465 0 0 0 0 0 0 0 0 0 0 12.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5844 0 0 0 13.5157 0 0 0 0 0 0 0 0 0 0 13.0426 0 0 0 0 0 0 13.5042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95744 PM2P2_HUMAN Putative postmeiotic segregation increased 2-like protein 2 (Postmeiotic segregation increased 2-like protein 14) (Postmeiotic segregation increased protein 4) (Putative postmeiotic segregation increased 2 pseudogene 2) PMS2P2 PMS2L14 PMS2L2 PMS4 Homo sapiens (Human) mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446] mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389] mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446] GO:0006298; GO:0016446; GO:0016887; GO:0032300; GO:0032389; GO:0140664 ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664] ACFPFAFCRDCQFLEGSPAMLPVQPAKLTVTGELR 0.93025 2.3692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7373 13.6987 11.8199 11.4177 11.4359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEM0 MCPH1_HUMAN Microcephalin MCPH1 Homo sapiens (Human) bone development [GO:0060348]; cerebral cortex development [GO:0021987]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; regulation of centrosome cycle [GO:0046605]; regulation of chromosome condensation [GO:0060623]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; bone development [GO:0060348]; cerebral cortex development [GO:0021987]; establishment of mitotic spindle orientation [GO:0000132]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; regulation of centrosome cycle [GO:0046605]; regulation of chromosome condensation [GO:0060623]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549] GO:0000122; GO:0000132; GO:0000278; GO:0005654; GO:0005737; GO:0005815; GO:0021987; GO:0042802; GO:0043549; GO:0046605; GO:0050727; GO:0060348; GO:0060623; GO:0071539; GO:0097150 identical protein binding [GO:0042802] DFNFKTPENDKR 0.93026 1.0717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3581 0 0 0 0 0 0 0 0 12.7024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01705 LV223_HUMAN Immunoglobulin lambda variable 2-23 (Ig lambda chain V-II region NEI) IGLV2-23 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814 antigen binding [GO:0003823] APKLMIYEGSKR 0.93028 1.1091 0 0 0 0 0 0 0 0 12.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9986 0 0 0 0 0 0 0 0 0 15.0629 0 0 0 0 0 0 13.9384 0 0 0 0 0 0 0 0 0 0 0 15.1502 0 14.4008 0 13.5515 0 0 0 0 0 13.5628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3081 0 0 0 0 0 0 0 0 12.7109 0 0 11.8949 0 0 0 0 13.6585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3839 0 0 0 0 0 Q9HBZ2 ARNT2_HUMAN "Aryl hydrocarbon receptor nuclear translocator 2, ARNT protein 2 (Class E basic helix-loop-helix protein 1, bHLHe1)" ARNT2 BHLHE1 KIAA0307 Homo sapiens (Human) "brain development [GO:0007420]; central nervous system development [GO:0007417]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; central nervous system development [GO:0007417]; in utero embryonic development [GO:0001701]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0017162; GO:0034751; GO:0045893; GO:0045944; GO:0046982; GO:1990837 "aryl hydrocarbon receptor binding [GO:0017162]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EGQQSSMR 0.93029 1.9476 13.464 15.3637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WU49 CG033_HUMAN Uncharacterized protein C7orf33 C7orf33 Homo sapiens (Human) HKKPNPHQNMNR 0.9303 1.1091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2866 0 0 0 0 0 0 13.587 0 0 0 0 0 0 0 0 P51681 CCR5_HUMAN "C-C chemokine receptor type 5, C-C CKR-5, CC-CKR-5, CCR-5, CCR5 (CHEMR13) (HIV-1 fusion coreceptor) (CD antigen CD195)" CCR5 CMKBR5 Homo sapiens (Human) calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to cholesterol [GO:0070723]; signaling [GO:0023052] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine receptor activity [GO:0004950]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; phosphatidylinositol phospholipase C activity [GO:0004435]; virus receptor activity [GO:0001618]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to cholesterol [GO:0070723]; signaling [GO:0023052] GO:0000165; GO:0001618; GO:0002407; GO:0003779; GO:0004435; GO:0004950; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0006816; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007166; GO:0007186; GO:0007204; GO:0007267; GO:0009897; GO:0009986; GO:0014808; GO:0015026; GO:0016493; GO:0019722; GO:0019957; GO:0023052; GO:0042802; GO:0060326; GO:0070723; GO:0071222; GO:0071791 actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine receptor activity [GO:0004950]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; phosphatidylinositol phospholipase C activity [GO:0004435]; virus receptor activity [GO:0001618] FCKCCSIFQQEAPER 0.93035 1.1119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8892 0 0 13.0947 0 0 12.7551 0 12.7622 0 0 0 0 0 0 12.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4575 12.5585 0 0 0 0 11.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N967 LRTM2_HUMAN Leucine-rich repeat and transmembrane domain-containing protein 2 LRTM2 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; positive regulation of synapse assembly [GO:0051965] GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050919; GO:0051965 heparin binding [GO:0008201]; Roundabout binding [GO:0048495] HWMEWFSYRGGR 0.93035 1.6648 0 0 0 0 0 0 0 0 0 0 0 12.186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1381 0 0 0 0 0 0 13.0653 0 0 0 0 0 13.0421 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2826 0 0 0 0 0 0 0 0 0 0 15.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23280 CAH6_HUMAN "Carbonic anhydrase 6, EC 4.2.1.1 (Carbonate dehydratase VI) (Carbonic anhydrase VI, CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase)" CA6 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; one-carbon metabolic process [GO:0006730] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; one-carbon metabolic process [GO:0006730] GO:0001580; GO:0004089; GO:0005576; GO:0005615; GO:0005829; GO:0006730; GO:0008270; GO:0016836; GO:0070062 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] IEEILDYLRR 0.93036 2.1406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3598 0 0 0 0 14.8022 0 0 0 0 0 0 0 0 0 0 0 13.6743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZN7 ROGDI_HUMAN Protein rogdi homolog ROGDI Homo sapiens (Human) brain development [GO:0007420]; hemopoiesis [GO:0030097]; neurogenesis [GO:0022008]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284] anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; brain development [GO:0007420]; hemopoiesis [GO:0030097]; neurogenesis [GO:0022008]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284] GO:0005635; GO:0007420; GO:0008021; GO:0008284; GO:0022008; GO:0030097; GO:0030424; GO:0030425; GO:0042475; GO:0043204; GO:0043291; GO:0070161 LQQIQDARNHVSQAIYLLTSRDQSYQFK 0.93036 2.1718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5865 0 0 10.2323 0 0 0 0 13.3276 0 12.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6467 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6531 0 0 0 10.1147 0 13.1338 12.9722 0 0 0 0 0 0 0 13.7311 12.7918 0 0 0 0 10.5855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6309 0 0 0 0 0 0 12.5862 12.4247 0 0 0 0 0 0 0 9.47224 P28347 TEAD1_HUMAN "Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1, TEAD-1) (Transcription factor 13, TCF-13)" TEAD1 TCF13 TEF1 Homo sapiens (Human) "embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0003677; GO:0003700; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" IILSDEGK 0.93037 1.0762 0 0 0 0 10.3447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47898 5HT5A_HUMAN "5-hydroxytryptamine receptor 5A, 5-HT-5, 5-HT-5A, 5-HT5A (Serotonin receptor 5A)" HTR5A Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hippocampus development [GO:0021766]; response to estradiol [GO:0032355]" dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] "dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hippocampus development [GO:0021766]; response to estradiol [GO:0032355]" GO:0004993; GO:0005791; GO:0005794; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007189; GO:0007198; GO:0007268; GO:0021766; GO:0030425; GO:0030594; GO:0032355; GO:0043204; GO:0051378; GO:0099060 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] NYNSAFKNFFSR 0.93037 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5209 0 0 0 0 0 0 0 0 0 0 P14652 HXB2_HUMAN Homeobox protein Hox-B2 (Homeobox protein Hox-2.8) (Homeobox protein Hox-2H) (K8) HOXB2 HOX2H Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; facial nerve structural organization [GO:0021612]; morphogenesis of an epithelial sheet [GO:0002011]; nervous system development [GO:0007399]; neural nucleus development [GO:0048857]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 3 development [GO:0021569]; rhombomere 4 development [GO:0021570] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; facial nerve structural organization [GO:0021612]; morphogenesis of an epithelial sheet [GO:0002011]; nervous system development [GO:0007399]; neural nucleus development [GO:0048857]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 3 development [GO:0021569]; rhombomere 4 development [GO:0021570]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002011; GO:0005634; GO:0005654; GO:0006357; GO:0007399; GO:0009952; GO:0009953; GO:0021569; GO:0021570; GO:0021612; GO:0043565; GO:0045944; GO:0048704; GO:0048857; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ESTLIPPPPPFEQTFPSLQPGASTLQRPRSQK 0.93038 1.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.747 0 0 12.2876 0 0 12.1175 0 0 0 0 0 0 0 0 0 0 0 0 11.7672 0 0 0 0 0 0 0 12.2874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX40 TM107_HUMAN Transmembrane protein 107 TMEM107 DC20 UNQ638/PRO1268 Homo sapiens (Human) cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; detection of nodal flow [GO:0003127]; embryonic digit morphogenesis [GO:0042733]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; detection of nodal flow [GO:0003127]; embryonic digit morphogenesis [GO:0042733]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021] GO:0003127; GO:0010468; GO:0016021; GO:0021532; GO:0035869; GO:0036038; GO:0042733; GO:0060021; GO:0060271; GO:0097094; GO:1904491; GO:1905515 GRVSGLVPSRFLTLLAHLVVVITLFWSR 0.93038 1.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8538 0 0 0 0 0 0 14.514 0 0 0 0 0 0 0 14.7566 0 0 0 0 0 14.5044 0 0 0 0 13.6945 0 0 13.9679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7646 0 13.9613 0 0 14.3699 0 0 0 0 0 0 0 0 0 0 13.7678 0 0 14.0513 0 0 0 0 0 13.7876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43826 G6PT1_HUMAN "Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein, TRG-19)" SLC37A4 G6PT G6PT1 PRO0685 TRG19 Homo sapiens (Human) carbohydrate transport [GO:0008643]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152]; carbohydrate transport [GO:0008643]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435] GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0008643; GO:0015152; GO:0015760; GO:0016020; GO:0016021; GO:0030176; GO:0035435; GO:0042593; GO:0061513 glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152] AAQGYGYYRTVIFSAMFGGYSLYYFNRK 0.9304 1.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXI6 RN186_HUMAN "E3 ubiquitin-protein ligase RNF186, EC 2.3.2.27 (RING finger protein 186)" RNF186 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585] GO:0004842; GO:0005789; GO:0016021; GO:0035519; GO:0043161; GO:0046872; GO:0051865; GO:0061630; GO:0070059; GO:0070534; GO:0070585 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] RLAAHLLLLALLIILIGPFIYPGVLR 0.93043 1.0753 0 0 0 12.2695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0C4DH42 HV366_HUMAN Immunoglobulin heavy variable 3-66 IGHV3-66 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] QAPGKGLEWVSVIYSCGSTYYADSVKGR 0.93044 1.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6055 0 0 0 0 0 0 11.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQG0 POK11_HUMAN "Endogenous retrovirus group K member 11 Pol protein (HERV-K_3q27.2 provirus ancestral Pol protein) [Includes: Reverse transcriptase, RT, EC 2.7.7.49; Ribonuclease H, RNase H, EC 3.1.26.4; Integrase, IN ]" ERVK-11 Homo sapiens (Human) DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] GO:0003677; GO:0003964; GO:0004523; GO:0006281; GO:0006310; GO:0008270; GO:0015074; GO:0035613 DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] AAYTGPK 0.93044 1.0944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3028 0 0 0 0 0 11.555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK17 KCND3_HUMAN Potassium voltage-gated channel subfamily D member 3 (Voltage-gated potassium channel subunit Kv4.3) KCND3 Homo sapiens (Human) membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; ventricular cardiac muscle cell membrane repolarization [GO:0099625] dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076] dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; ventricular cardiac muscle cell membrane repolarization [GO:0099625] GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0008076; GO:0014069; GO:0016021; GO:0034765; GO:0042383; GO:0043025; GO:0043197; GO:0044325; GO:0045211; GO:0046872; GO:0051260; GO:0071805; GO:0086009; GO:0086013; GO:0086091; GO:0097623; GO:0098915; GO:0098982; GO:0099060; GO:0099625 A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] EFFFNEDTKEYFFDRDPEVFR 0.93045 1.0975 0 0 0 14.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0363 0 0 0 0 11.7974 0 0 0 0 0 0 0 0 0 0 0 0 14.0233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9401 0 0 15.226 0 0 0 0 0 0 0 0 0 0 14.6794 0 10.7827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60235 TM11D_HUMAN "Transmembrane protease serine 11D, EC 3.4.21.- (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain ]" TMPRSS11D HAT Homo sapiens (Human) proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585] GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0007585; GO:0008233; GO:0070062 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] TLSGRIESLITK 0.93046 1.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12318 FCG2A_HUMAN "Low affinity immunoglobulin gamma Fc region receptor II-a, IgG Fc receptor II-a (CDw32) (Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a) (CD antigen CD32)" FCGR2A CD32 FCG2 FCGR2A1 IGFR2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; immune system process [GO:0002376]; regulation of immune response [GO:0050776] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; immune system process [GO:0002376]; regulation of immune response [GO:0050776] GO:0002376; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0007166; GO:0019864; GO:0030667; GO:0050776 IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888] APTDDDK 0.93046 1.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1286 0 0 0 0 0 0 0 0 0 0 10.7992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5643 0 0 0 0 0 0 12.668 0 0 0 0 0 13.5261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19957 ELAF_HUMAN "Elafin (Elastase-specific inhibitor, ESI) (Peptidase inhibitor 3, PI-3) (Protease inhibitor WAP3) (Skin-derived antileukoproteinase, SKALP) (WAP four-disulfide core domain protein 14)" PI3 WAP3 WFDC14 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; copulation [GO:0007620]; innate immune response [GO:0045087]; peptide cross-linking [GO:0018149] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; structural constituent of skin epidermis [GO:0030280]; antibacterial humoral response [GO:0019731]; copulation [GO:0007620]; innate immune response [GO:0045087]; peptide cross-linking [GO:0018149] GO:0001533; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0007620; GO:0018149; GO:0019731; GO:0030280; GO:0031012; GO:0045087 endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; structural constituent of skin epidermis [GO:0030280] ASSFLIVVVFLIAGTLVLEAAVTGVPVKGQDTVK 0.93046 1.9204 0 0 0 0 0 0 0 0 0 0 11.5626 0 0 0 11.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3838 0 0 14.8115 9.62675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3298 13.8796 0 0 0 0 0 0 0 13.0201 0 0 0 0 0 0 16.8911 0 0 0 0 0 0 0 10.9692 0 0 0 0 11.2389 12.82 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3981 0 0 0 0 14.3595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1725 0 0 0 0 0 0 0 0 0 12.448 0 0 0 0 0 0 0 11.3336 0 0 0 0 0 0 0 11.6966 0 0 0 0 0 0 15.7925 0 0 0 0 0 0 0 0 0 Q96EU7 C1GLC_HUMAN "C1GALT1-specific chaperone 1 (C38H2-like protein 1, C38H2-L1) (Core 1 beta1,3-galactosyltransferase 2, C1Gal-T2, C1GalT2, Core 1 beta3-Gal-T2) (Core 1 beta3-galactosyltransferase-specific molecular chaperone)" C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Homo sapiens (Human) "O-glycan processing, core 1 [GO:0016267]; platelet activation [GO:0030168]; platelet morphogenesis [GO:0036344]; protein O-linked glycosylation [GO:0006493]" extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; O-glycan processing, core 1 [GO:0016267]; platelet activation [GO:0030168]; platelet morphogenesis [GO:0036344]; protein O-linked glycosylation [GO:0006493]" GO:0000139; GO:0006493; GO:0016021; GO:0016263; GO:0016267; GO:0030168; GO:0036344; GO:0070062 glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263] VFESINMDTNDMWLMMRK 0.93046 1.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5534 0 0 0 0 0 0 0 0 0 13.1912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2B9 IPKG_HUMAN "cAMP-dependent protein kinase inhibitor gamma, PKI-gamma" PKIG Homo sapiens (Human) negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0004862; GO:0005634; GO:0005737; GO:0042308; GO:2000480 cAMP-dependent protein kinase inhibitor activity [GO:0004862] MEVESSYSDFISCDR 0.93046 1.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0871 0 0 0 0 0 0 0 0 0 0 Q9BXS0 COPA1_HUMAN "Collagen alpha-1(XXV) chain (Alzheimer disease amyloid-associated protein, AMY) (CLAC-P) [Cleaved into: Collagen-like Alzheimer amyloid plaque component, CLAC ]" COL25A1 Homo sapiens (Human) collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] GO:0001540; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0005886; GO:0005887; GO:0008201; GO:0016021; GO:0042802; GO:0062023 amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] GEQGDQGPR 0.93047 1.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2342 0 0 0 0 0 13.4731 13.9888 12.7022 0 0 0 11.3236 0 0 11.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01920 DQB1_HUMAN "HLA class II histocompatibility antigen, DQ beta 1 chain (MHC class II antigen DQB1)" HLA-DQB1 HLA-DQB Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; humoral immune response [GO:0006959]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; humoral immune response [GO:0006959]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852] GO:0000139; GO:0002250; GO:0002503; GO:0005765; GO:0005886; GO:0006955; GO:0006959; GO:0010008; GO:0012507; GO:0016020; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0032395; GO:0032588; GO:0042605; GO:0042613; GO:0050852; GO:0050870; GO:0071556 MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605] DSPEDFVYQFKAMCYFTNGTER 0.93048 2.2882 0 0 0 0 0 0 12.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4317 0 0 0 0 0 0 0 P07360 CO8G_HUMAN Complement component C8 gamma chain C8G Homo sapiens (Human) "complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]" blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement binding [GO:0001848]; retinol binding [GO:0019841]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]" GO:0001848; GO:0005576; GO:0005579; GO:0005886; GO:0006957; GO:0006958; GO:0019835; GO:0019841; GO:0050778; GO:0070062; GO:0072562 complement binding [GO:0001848]; retinol binding [GO:0019841] LPPGTATLLTLLLAAGSLGQK 0.93048 1.0943 11.1758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3161 0 13.2087 0 14.7992 0 0 0 0 0 13.8022 0 0 0 14.789 0 0 0 12.4079 0 14.1455 0 0 0 0 0 0 0 0 0 15.2814 0 14.6148 0 15.3121 0 0 14.8193 13.834 0 0 0 0 0 0 0 0 0 0 0 0 14.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.845 0 0 0 0 13.486 0 0 0 0 0 15.038 15.0372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3788 0 0 0 0 0 0 0 P0C8F1 PATE4_HUMAN "Prostate and testis expressed protein 4 (PATE-like protein B, PATE-B)" PATE4 Homo sapiens (Human) regulation of neurotransmitter receptor activity [GO:0099601] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; acetylcholine receptor regulator activity [GO:0030548]; regulation of neurotransmitter receptor activity [GO:0099601] GO:0001669; GO:0005615; GO:0030548; GO:0099601 acetylcholine receptor regulator activity [GO:0030548] MRKMNTLLLVSLSFLYLK 0.93048 1.072 0 0 0 0 0 0 0 12.2191 0 14.0278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9682 0 0 0 0 0 0 0 0 0 13.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVC6 MED17_HUMAN "Mediator of RNA polymerase II transcription subunit 17 (Activator-recruited cofactor 77 kDa component, ARC77) (Cofactor required for Sp1 transcriptional activation subunit 6, CRSP complex subunit 6) (Mediator complex subunit 17) (Thyroid hormone receptor-associated protein complex 80 kDa component, Trap80) (Transcriptional coactivator CRSP77) (Vitamin D3 receptor-interacting protein complex 80 kDa component, DRIP80)" MED17 ARC77 CRSP6 DRIP77 DRIP80 TRAP80 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000151; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006367; GO:0016020; GO:0016592; GO:0030374; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0051123; GO:0060261; GO:0061630; GO:0070847 nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] KKSLAGAAQILLK 0.93048 2.3627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4814 0 0 0 0 0 0 12.8532 0 0 0 0 0 0 0 0 0 0 0 0 13.1638 13.1582 0 0 0 0 0 0 0 0 0 12.6452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75309 CAD16_HUMAN "Cadherin-16 (Kidney-specific cadherin, Ksp-cadherin)" CDH16 UNQ695/PRO1340 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0016323; GO:0016339; GO:0070062 calcium ion binding [GO:0005509] ARLSRGTR 0.93049 1.1109 0 0 0 0 0 11.7937 0 0 0 0 0 0 0 0 0 0 0 0 11.1589 0 0 0 0 0 0 0 0 0 0 9.45127 0 0 0 0 0 0 10.8343 0 14.4959 0 10.5099 11.3419 0 11.7777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5164 0 0 0 0 0 0 11.4501 0 10.9085 0 0 0 0 10.3074 0 0 0 0 0 0 0 16.6712 0 0 12.6902 10.4358 0 0 0 13.4606 0 0 16.4271 0 0 0 0 0 11.5516 11.241 0 0 0 0 0 10.7065 9.77418 0 0 0 0 0 0 0 0 0 0 0 0 10.2938 0 0 0 0 0 0 11.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.292 9.78519 Q8IUH5 ZDH17_HUMAN "Palmitoyltransferase ZDHHC17, EC 2.3.1.225 (Acyltransferase ZDHHC17, EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17, DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14, HIP-14) (Huntingtin-interacting protein 3, HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17)" ZDHHC17 HIP14 HIP3 HYPH KIAA0946 HSPC294 Homo sapiens (Human) axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386] aggresome [GO:0016235]; anchoring junction [GO:0070161]; cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734] aggresome [GO:0016235]; anchoring junction [GO:0070161]; cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; signaling receptor binding [GO:0005102]; axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386] GO:0000139; GO:0005102; GO:0005794; GO:0007409; GO:0015095; GO:0016021; GO:0016235; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0042995; GO:0043123; GO:0043231; GO:0051386; GO:0070161; GO:0070372; GO:0140439 identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; signaling receptor binding [GO:0005102] PQSHYNHGYGEPLGR 0.9305 1.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y547 IFT25_HUMAN "Intraflagellar transport protein 25 homolog (Heat shock protein beta-11, Hspb11) (Placental protein 25, PP25)" HSPB11 C1orf41 IFT25 HSPC034 Homo sapiens (Human) cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] GO:0001501; GO:0001822; GO:0005813; GO:0005929; GO:0007224; GO:0007283; GO:0007507; GO:0015031; GO:0030154; GO:0030324; GO:0030992; GO:0035720; GO:0046872; GO:0060271; GO:0070986; GO:0097542 metal ion binding [GO:0046872] IEKSTSKEPVDFEQWIEK 0.9305 1.072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0069 0 0 0 0 12.9506 11.7825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1482 17.7111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJW9 SRTD3_HUMAN "SERTA domain-containing protein 3 (Replication protein-binding trans-activator, RPA-binding trans-activator)" SERTAD3 RBT1 Homo sapiens (Human) "negative regulation of cell growth [GO:0030308]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; negative regulation of cell growth [GO:0030308]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355; GO:0030308; GO:0045893 APSLRRHVLIHNTLQQLQAALR 0.93051 2.3482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.106 0 0 0 0 Q14CZ0 TAPR1_HUMAN Telomere attrition and p53 response 1 protein TAPR1 C16orf72 Homo sapiens (Human) negative regulation of signal transduction by p53 class mediator [GO:1901797] negative regulation of signal transduction by p53 class mediator [GO:1901797] GO:1901797 KEEGEAEIQEHGPEHWFSKWER 0.93052 2.0921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9752 0 0 0 0 0 0 0 12.8965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2897 0 0 12.3163 0 0 0 12.8024 0 0 0 0 0 0 12.904 0 13.5115 0 0 0 13.8537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8044 0 0 13.0769 A0A5B7 TVB29_HUMAN T cell receptor beta variable 29-1 TRBV29-1 TCRBV4S1A1T Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 LSLLLLLLGLGSVFSAVISQK 0.93055 2.1376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8423 0 0 0 11.9953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0091 0 0 11.9638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0755 0 0 0 0 0 0 0 0 0 12.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01094 E2F1_HUMAN "Transcription factor E2F1, E2F-1 (PBR3) (Retinoblastoma-associated protein 1, RBAP-1) (Retinoblastoma-binding protein 3, RBBP-3) (pRB-binding protein E2F-1)" E2F1 RBBP3 Homo sapiens (Human) "anoikis [GO:0043276]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; forebrain development [GO:0030900]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell apoptotic process [GO:1990086]; mRNA stabilization [GO:0048255]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rb-E2F complex [GO:0035189]; RNA polymerase II transcription regulator complex [GO:0090575] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Rb-E2F complex [GO:0035189]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anoikis [GO:0043276]; cellular response to fatty acid [GO:0071398]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; forebrain development [GO:0030900]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell apoptotic process [GO:1990086]; mRNA stabilization [GO:0048255]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" GO:0000077; GO:0000082; GO:0000083; GO:0000122; GO:0000228; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006351; GO:0006355; GO:0006357; GO:0007283; GO:0008630; GO:0010628; GO:0019901; GO:0030900; GO:0032991; GO:0035189; GO:0043065; GO:0043276; GO:0043392; GO:0043433; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048146; GO:0048255; GO:0060252; GO:0070345; GO:0071398; GO:0071456; GO:0071466; GO:0071930; GO:0072332; GO:0090575; GO:0140297; GO:1990086; GO:1990090; GO:1990837; GO:2000045 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" RIYDITNVLEGIQLIAKK 0.93055 1.072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7902 0 0 0 P43080 GUC1A_HUMAN "Guanylyl cyclase-activating protein 1, GCAP 1 (Guanylate cyclase activator 1A)" GUCA1A C6orf131 GCAP GCAP1 GUCA1 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; phototransduction [GO:0007602]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of guanylate cyclase activity [GO:0031284]; signal transduction [GO:0007165]; visual perception [GO:0007601] cone photoreceptor outer segment [GO:0120199]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917] cone photoreceptor outer segment [GO:0120199]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; guanylate cyclase regulator activity [GO:0030249]; cellular response to calcium ion [GO:0071277]; phototransduction [GO:0007602]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of guanylate cyclase activity [GO:0031284]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0001917; GO:0005509; GO:0007165; GO:0007601; GO:0007602; GO:0008048; GO:0010753; GO:0030249; GO:0031284; GO:0071277; GO:0097381; GO:0120199 calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; guanylate cyclase regulator activity [GO:0030249] DGYIDFMEYVAALSLVLKGK 0.93059 1.0766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UB9 TM135_HUMAN "Transmembrane protein 135 (Peroxisomal membrane protein 52, PMP52)" TMEM135 Homo sapiens (Human) peroxisome organization [GO:0007031]; regulation of mitochondrial fission [GO:0090140]; response to cold [GO:0009409]; response to food [GO:0032094] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; peroxisome organization [GO:0007031]; regulation of mitochondrial fission [GO:0090140]; response to cold [GO:0009409]; response to food [GO:0032094] GO:0005777; GO:0005778; GO:0005811; GO:0007031; GO:0009409; GO:0016021; GO:0031966; GO:0032094; GO:0090140 FVDSICKHGPR 0.9306 2.0577 0 0 0 0 0 0 0 0 0 0 0 11.7342 0 12.549 0 0 0 0 10.0713 0 0 0 0 0 13.0088 0 0 0 0 0 0 0 0 10.8311 0 0 0 0 0 0 0 0 14.1049 0 0 12.0989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2871 0 0 0 13.2127 14.3746 0 0 0 0 0 0 0 0 0 13.1088 0 13.0645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4938 0 0 0 0 15.7449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6477 0 0 0 0 0 0 0 0 0 0 0 Q8NC01 CLC1A_HUMAN "C-type lectin domain family 1 member A (C-type lectin-like receptor 1, CLEC-1)" CLEC1A CLEC1 UNQ569/PRO1131 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; signal transduction [GO:0007165] GO:0004888; GO:0005887; GO:0007165; GO:0007166; GO:0030246 carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888] CSPCTEQWKWHGDNCYQFYK 0.9306 1.0926 0 0 0 0 0 0 11.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8988 0 0 0 0 0 0 0 13.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTS1 ABHD5_HUMAN "1-acylglycerol-3-phosphate O-acyltransferase ABHD5, EC 2.3.1.51 (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58)" ABHD5 NCIE2 CGI-58 Homo sapiens (Human) cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of triglyceride catabolic process [GO:0010898] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171]; cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of triglyceride catabolic process [GO:0010898] GO:0003841; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006631; GO:0006654; GO:0010891; GO:0010898; GO:0030154; GO:0042171; GO:0043231; GO:0051006; GO:0052689; GO:0055088 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171] KYSSMFEDDTVTEYIYHCNVQTPSGETAFK 0.9306 1.096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2618 0 0 0 0 0 0 0 0 0 0 0 0 12.5504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1868 0 A0A0G2JMI3 HV692_HUMAN Immunoglobulin heavy variable 1-69-2 IGHV1-69-2 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] ILLLVAAATGTHAEVQLVQSGAEVKKPGATVK 0.93061 1.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N66 MBOA7_HUMAN "Lysophospholipid acyltransferase 7, LPLAT 7, EC 2.3.1.- (1-acylglycerophosphatidylinositol O-acyltransferase) (Bladder and breast carcinoma-overexpressed gene 1 protein) (Leukocyte receptor cluster member 4) (Lysophosphatidylinositol acyltransferase, LPIAT, Lyso-PI acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 7, O-acyltransferase domain-containing protein 7, h-mboa-7)" MBOAT7 BB1 LENG4 OACT7 Homo sapiens (Human) layer formation in cerebral cortex [GO:0021819]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]; ventricular system development [GO:0021591] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374]; layer formation in cerebral cortex [GO:0021819]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]; ventricular system development [GO:0021591] GO:0003841; GO:0005783; GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0016021; GO:0016746; GO:0021591; GO:0021819; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0047144; GO:0071617; GO:0090207 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374] AASLEYDYETIRNIDCYSTDFCVRVR 0.93062 2.067 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7416 0 0 0 13.7393 0 0 13.1298 0 0 0 0 14.4664 0 0 0 0 0 0 14.5991 12.5217 0 0 0 0 0 12.9363 0 0 0 0 0 0 11.8853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0189 Q9NVG8 TBC13_HUMAN TBC1 domain family member 13 TBC1D13 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886] GO:0005096; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0090630 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] EPSIALEKLR 0.93063 1.0882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4041 12.9888 0 0 0 0 0 0 0 13.7275 13.8483 0 13.1244 0 13.3394 0 0 0 0 0 0 10.6876 11.8061 11.3709 0 0 0 0 12.8056 0 0 0 0 0 0 0 0 0 11.1583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7032 0 0 0 0 0 0 0 0 0 0 0 14.7074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BM9 ARL8A_HUMAN ADP-ribosylation factor-like protein 8A (ADP-ribosylation factor-like protein 10B) (Novel small G protein indispensable for equal chromosome segregation 2) ARL8A ARL10B GIE2 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein transport [GO:0015031] anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; synapse [GO:0045202]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein transport [GO:0015031] GO:0003924; GO:0005525; GO:0005737; GO:0005765; GO:0005886; GO:0007049; GO:0007059; GO:0008089; GO:0015031; GO:0016020; GO:0030496; GO:0031902; GO:0035577; GO:0043014; GO:0045202; GO:0048487; GO:0051233; GO:0051301; GO:0070062; GO:0070161; GO:0101003; GO:1904115 alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] IALFNKLLDWFKALFWK 0.93064 1.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H081 MIS12_HUMAN Protein MIS12 homolog MIS12 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070]; protein localization to kinetochore [GO:0034501] cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear MIS12/MIND complex [GO:0000818]; nucleus [GO:0005634] cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear MIS12/MIND complex [GO:0000818]; nucleus [GO:0005634]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070]; protein localization to kinetochore [GO:0034501] GO:0000070; GO:0000444; GO:0000776; GO:0000818; GO:0005634; GO:0005829; GO:0007059; GO:0031617; GO:0034501; GO:0051301; GO:0051315; GO:0051382 DHGTSDFRESLVSLVQNSRK 0.93064 1.0911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3769 0 0 0 0 0 0 0 0 0 0 0 0 0 12.685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJV8 PURG_HUMAN "Purine-rich element-binding protein gamma, Purine-rich element-binding protein G" PURG Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0003723; GO:0005634; GO:0006357; GO:0032422 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" FGENFIKYEEEMRK 0.93065 1.0595 11.4319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9142 0 0 0 0 0 0 12.7769 12.8468 0 0 12.5699 0 0 0 0 0 0 0 12.0027 0 13.208 0 0 0 0 12.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.813 0 0 0 12.6233 0 0 0 0 0 0 11.6851 0 0 0 0 0 0 0 0 13.7646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VU69 CP141_HUMAN Cilia- and flagella-associated protein 141 CFAP141 C1orf189 Homo sapiens (Human) axonemal microtubule [GO:0005879] axonemal microtubule [GO:0005879] GO:0005879 KQLLMVRQAALHQLFEK 0.93066 1.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B1APH4 ZN487_HUMAN Putative zinc finger protein 487 (KRAB domain only protein 1) ZNF487 KRBO1 ZNF487P Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DKTYECNECGKNFCEK 0.93067 1.1081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2239 0 0 0 0 0 0 13.4558 0 12.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95295 SNAPN_HUMAN "SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7, BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein, SNAP-associated protein)" SNAPIN BLOC1S7 SNAP25BP SNAPAP Homo sapiens (Human) anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; organelle transport along microtubule [GO:0072384]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; protein-containing complex localization [GO:0031503]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; regulation of protein binding [GO:0043393]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; Golgi membrane [GO:0000139]; manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; Golgi membrane [GO:0000139]; manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNARE binding [GO:0000149]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; organelle transport along microtubule [GO:0072384]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; protein-containing complex localization [GO:0031503]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]; regulation of protein binding [GO:0043393]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553] GO:0000139; GO:0000149; GO:0001669; GO:0002177; GO:0006886; GO:0007040; GO:0007042; GO:0007269; GO:0008021; GO:0008089; GO:0008090; GO:0008333; GO:0010977; GO:0016079; GO:0016188; GO:0030141; GO:0030672; GO:0031083; GO:0031175; GO:0031503; GO:0031629; GO:0032418; GO:0032438; GO:0043393; GO:0045202; GO:0048471; GO:0048489; GO:0048490; GO:0051036; GO:0051604; GO:0062196; GO:0070050; GO:0070161; GO:0072384; GO:0072553; GO:0097352; GO:0098574; GO:0099078; GO:1902774; GO:1902824; GO:1904115; GO:2000300 SNARE binding [GO:0000149] RVVLVNNILQNAQERLR 0.93069 1.0946 0 0 0 12.3831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5648 0 0 0 0 0 0 0 0 13.3734 12.6601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5632 0 12.7071 0 0 0 0 0 0 13.4074 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8112 0 0 0 0 0 0 0 0 0 0 0 Q9H0Q3 FXYD6_HUMAN FXYD domain-containing ion transport regulator 6 (Phosphohippolin) FXYD6 UNQ521/PRO1056 Homo sapiens (Human) ion transport [GO:0006811]; regulation of ion transport [GO:0043269] glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886] glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; ion channel regulator activity [GO:0099106]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269] GO:0005886; GO:0006811; GO:0043269; GO:0098978; GO:0099055; GO:0099056; GO:0099106 ion channel regulator activity [GO:0099106] ELVLVFLCSLLAPMVLASAAEK 0.9307 2.3584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8093 0 0 0 0 0 0 A0A087WSY4 HV432_HUMAN Immunoglobulin heavy variable 4-30-2 IGHV4-30-2 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] MKHLWFFLLLVAAPRWVLSQLQLQESGSGLVK 0.93071 1.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NHX0 CAST2_HUMAN Cytosolic arginine sensor for mTORC1 subunit 2 (Cellular arginine sensor for mTORC1 protein 2) (GATS-like protein 2) CASTOR2 GATSL1 GATSL2 Homo sapiens (Human) cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] cytosol [GO:0005829] cytosol [GO:0005829]; identical protein binding [GO:0042802]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] GO:0005829; GO:0042802; GO:1902531; GO:1903577; GO:1904262 identical protein binding [GO:0042802] FDHALVPEENINGVISALKVSQAEKH 0.93071 1.0899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5517 0 0 0 0 0 0 0 0 0 0 0 13.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8576 0 0 0 0 0 0 P0C854 CECR9_HUMAN Putative cat eye syndrome critical region protein 9 CECR9 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 IPQPLLPAYILLMLPSLVVDMALPSSRLLRSIK 0.93071 2.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6221 0 0 0 14.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8668 0 0 0 0 0 Q8N1B4 VPS52_HUMAN Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein) VPS52 SACM2L Homo sapiens (Human) "ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000938; GO:0005794; GO:0005829; GO:0006896; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0032588; GO:0042147; GO:0048471; GO:0048611; GO:0055037; GO:1990745 syntaxin binding [GO:0019905] AELINIHHLMVELKK 0.93071 1.9501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.821 0 12.478 0 0 0 0 0 13.1518 12.8312 0 0 0 16.1279 0 0 0 11.0037 0 0 11.4319 12.4271 0 0 0 0 0 12.0572 0 0 12.9404 0 0 0 0 0 0 0 0 0 0 13.3082 0 0 13.7752 13.3538 11.1797 0 0 0 0 0 0 0 12.2136 11.5677 0 0 0 0 0 0 0 0 0 10.9942 0 12.2226 0 12.1441 0 0 0 12.2444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9802 0 0 0 0 0 0 0 P04732 MT1E_HUMAN "Metallothionein-1E, MT-1E (Metallothionein-IE, MT-IE)" MT1E Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010273; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCVCKGASEKCSCCA 0.93073 2.0564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0682 0 0 0 0 0 0 0 0 11.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60682 MUSC_HUMAN "Musculin (Activated B-cell factor 1, ABF-1) (Class A basic helix-loop-helix protein 22, bHLHa22)" MSC ABF1 BHLHA22 Homo sapiens (Human) "branchiomeric skeletal muscle development [GO:0014707]; cardiac conduction system development [GO:0003161]; cellular response to leukemia inhibitory factor [GO:1990830]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; branchiomeric skeletal muscle development [GO:0014707]; cardiac conduction system development [GO:0003161]; cellular response to leukemia inhibitory factor [GO:1990830]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003161; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007519; GO:0014707; GO:0032502; GO:0046983; GO:0060021; GO:0060539; GO:1990830; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ARMRVLSK 0.93075 1.1114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0A6YYJ7 TVA83_HUMAN T cell receptor alpha variable 8-3 TRAV8-3 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 LLELIPLLGIHFVLR 0.93077 2.0558 0 0 0 0 14.1241 0 0 0 0 0 0 0 13.2273 0 0 0 13.4965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7063 0 0 0 13.6587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0445 0 0 0 0 0 0 0 13.4709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SJ2 AMGO2_HUMAN "Amphoterin-induced protein 2 (AMIGO-2) (Alivin-1) (Differentially expressed in gastric adenocarcinomas, DEGA)" AMIGO2 ALI1 Homo sapiens (Human) brain development [GO:0007420]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; positive regulation of synapse assembly [GO:0051965] integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; brain development [GO:0007420]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of apoptotic process [GO:0043066]; negative regulation of programmed cell death [GO:0043069]; positive regulation of synapse assembly [GO:0051965] GO:0005634; GO:0005886; GO:0007156; GO:0007157; GO:0007420; GO:0016021; GO:0043066; GO:0043069; GO:0051965 CLDLSSNKLKTVK 0.93077 2.1551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9733 0 0 0 12.2654 0 13.752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q496M5 PLK5_HUMAN "Inactive serine/threonine-protein kinase PLK5 (Polo-like kinase 5, PLK-5)" PLK5 PLK5P FG060302 Homo sapiens (Human) cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; defense response to tumor cell [GO:0002357]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; positive regulation of neuron projection development [GO:0010976]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; defense response to tumor cell [GO:0002357]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; positive regulation of neuron projection development [GO:0010976]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] GO:0000278; GO:0000922; GO:0002357; GO:0004672; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0010976; GO:0030154; GO:0032465; GO:0042981; GO:0044819; GO:0051301; GO:0071363; GO:0090166; GO:2000045 ATP binding [GO:0005524]; protein kinase activity [GO:0004672] EGTLPTPVPPAGPGLCLLR 0.93079 1.6652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6S8J3 POTEE_HUMAN "POTE ankyrin domain family member E (ANKRD26-like family C member 1A) (Prostate, ovary, testis-expressed protein on chromosome 2, POTE-2)" POTEE A26C1A POTE2 Homo sapiens (Human) retina homeostasis [GO:0001895]; substantia nigra development [GO:0021762] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; retina homeostasis [GO:0001895]; substantia nigra development [GO:0021762] GO:0001895; GO:0005615; GO:0021762; GO:0070062; GO:0072562 EAQSKRGILTLK 0.9308 2.145 0 0 0 0 0 0 0 0 12.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9727 0 0 0 12.2833 0 13.2708 0 0 0 0 0 0 0 0 0 12.7586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2907 0 0 0 13.9921 0 14.1133 0 0 0 0 0 0 0 11.0291 13.2672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7365 0 Q06945 SOX4_HUMAN Transcription factor SOX-4 SOX4 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cellular response to glucose stimulus [GO:0071333]; endocrine pancreas development [GO:0031018]; gene expression [GO:0010467]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hematopoietic stem cell homeostasis [GO:0061484]; kidney morphogenesis [GO:0060993]; limb bud formation [GO:0060174]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein ubiquitination [GO:0031397]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; spinal cord motor neuron differentiation [GO:0021522]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; ascending aorta morphogenesis [GO:0035910]; atrial septum primum morphogenesis [GO:0003289]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; cellular response to glucose stimulus [GO:0071333]; endocrine pancreas development [GO:0031018]; gene expression [GO:0010467]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hematopoietic stem cell homeostasis [GO:0061484]; kidney morphogenesis [GO:0060993]; limb bud formation [GO:0060174]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein ubiquitination [GO:0031397]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; noradrenergic neuron differentiation [GO:0003357]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of N-terminal peptidyl-lysine acetylation [GO:2000761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein stabilization [GO:0050821]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; spinal cord motor neuron differentiation [GO:0021522]; sympathetic nervous system development [GO:0048485]; T cell differentiation [GO:0030217]; ventricular septum morphogenesis [GO:0060412]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001841; GO:0002328; GO:0003183; GO:0003211; GO:0003215; GO:0003289; GO:0003357; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0006355; GO:0007507; GO:0008284; GO:0008285; GO:0009653; GO:0010467; GO:0014009; GO:0021510; GO:0021522; GO:0021782; GO:0030154; GO:0030217; GO:0031018; GO:0031397; GO:0031647; GO:0032024; GO:0035019; GO:0035198; GO:0035910; GO:0042593; GO:0043065; GO:0043516; GO:0045588; GO:0045663; GO:0045727; GO:0045893; GO:0045944; GO:0048485; GO:0050821; GO:0060174; GO:0060412; GO:0060548; GO:0060563; GO:0060993; GO:0061484; GO:0071333; GO:0090263; GO:1990837; GO:2000761 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" HMADYPDYKYR 0.93081 2.3569 11.1452 0 0 0 13.2698 0 0 13.0913 0 0 0 0 0 0 0 12.4651 12.9572 0 15.4765 12.6891 12.733 0 12.6758 13.5899 12.9208 0 12.7652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7128 12.1777 0 13.0268 0 0 0 0 0 13.2864 0 13.8312 10.1992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4153 0 0 0 0 0 0 0 0 0 15.6094 0 0 0 0 0 0 0 14.6429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4543 0 0 0 18.5146 0 0 0 18.4642 0 0 0 0 0 0 0 14.8437 0 0 0 10.5652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9113 P01185 NEU2_HUMAN Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin ] AVP ARVP VP Homo sapiens (Human) cell-cell signaling [GO:0007267]; ERK1 and ERK2 cascade [GO:0070371]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; hyperosmotic salinity response [GO:0042538]; locomotory behavior [GO:0007626]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of female receptivity [GO:0007621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; protein kinase C signaling [GO:0070528]; regulation of renal sodium excretion [GO:0035813]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vasoconstriction [GO:0042310]; viral entry into host cell [GO:0046718]; water transport [GO:0006833] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; V1A vasopressin receptor binding [GO:0031894]; V1B vasopressin receptor binding [GO:0031895]; cell-cell signaling [GO:0007267]; ERK1 and ERK2 cascade [GO:0070371]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; hyperosmotic salinity response [GO:0042538]; locomotory behavior [GO:0007626]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of female receptivity [GO:0007621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; protein kinase C signaling [GO:0070528]; regulation of renal sodium excretion [GO:0035813]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vasoconstriction [GO:0042310]; viral entry into host cell [GO:0046718]; water transport [GO:0006833] GO:0002125; GO:0003084; GO:0004672; GO:0005102; GO:0005184; GO:0005185; GO:0005576; GO:0005615; GO:0005829; GO:0006091; GO:0006833; GO:0007165; GO:0007204; GO:0007267; GO:0007621; GO:0007625; GO:0007626; GO:0008284; GO:0010628; GO:0014049; GO:0030141; GO:0030307; GO:0030425; GO:0030669; GO:0031394; GO:0031894; GO:0031895; GO:0032849; GO:0033138; GO:0033574; GO:0035094; GO:0035176; GO:0035813; GO:0042310; GO:0042538; GO:0042711; GO:0043027; GO:0043066; GO:0043084; GO:0043154; GO:0045471; GO:0045907; GO:0046718; GO:0050891; GO:0051970; GO:0070371; GO:0070528; GO:0090201 cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; V1A vasopressin receptor binding [GO:0031894]; V1B vasopressin receptor binding [GO:0031895] ACGSGGRCAAFGVCCNDESCVTEPECR 0.93082 2.1544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6339 0 0 0 0 0 0 0 0 0 10.6109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49AS3 L37A5_HUMAN Putative protein LRRC37A5P (Leucine-rich repeat-containing 37 member A5 pseudogene) LRRC37A5P C9orf29 Homo sapiens (Human) LISRTGLLMKLLSEQQELR 0.93083 2.1333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5453 0 0 0 0 0 0 0 0 0 13.0377 0 0 0 0 0 0 0 13.5612 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1744 0 0 0 0 0 0 0 0 0 0 0 Q8WW22 DNJA4_HUMAN DnaJ homolog subfamily A member 4 DNAJA4 Homo sapiens (Human) negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of gene expression [GO:0010628]; protein refolding [GO:0042026]; response to heat [GO:0009408] GO:0005524; GO:0005737; GO:0005829; GO:0009408; GO:0010596; GO:0010628; GO:0016020; GO:0030544; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0090084 ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] APLEKGILIIQFLVIFPEK 0.93087 1.0735 10.9694 0 0 0 0 0 0 0 0 0 0 0 12.3098 0 0 0 0 0 0 0 0 0 0 0 11.2116 0 0 0 0 0 0 0 10.2135 0 0 0 0 0 11.4655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7308 0 0 0 0 0 0 0 0 11.0522 0 15.0592 0 0 0 0 14.2731 0 0 0 0 14.8042 14.0639 0 13.4035 13.7079 0 0 0 0 0 0 0 0 10.7688 11.2401 0 0 0 0 0 0 0 0 13.689 0 0 0 13.5534 0 0 12.7246 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4465 0 0 0 0 0 13.0742 0 0 10.6331 0 11.7681 0 0 0 0 0 0 0 0 12.0717 0 0 0 0 0 0 0 0 0 0 0 Q9H0E2 TOLIP_HUMAN Toll-interacting protein TOLLIP Homo sapiens (Human) autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] "azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; leukocyte activation [GO:0045321]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0005150; GO:0005576; GO:0005737; GO:0005829; GO:0006511; GO:0006914; GO:0006954; GO:0007165; GO:0016310; GO:0016604; GO:0019900; GO:0030855; GO:0031624; GO:0031625; GO:0032183; GO:0032991; GO:0033235; GO:0035325; GO:0035578; GO:0035580; GO:0036010; GO:0043130; GO:0045087; GO:0045321; GO:0048471; GO:0070062; GO:0070498 "interleukin-1, type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]" LNITVVQAKLAK 0.93087 1.0675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6ZKI3 RTL8C_HUMAN Retrotransposon Gag-like protein 8C (Mammalian retrotransposon derived protein 8C) RTL8C CXX1 FAM127A MAR8 MAR8C MART8 Homo sapiens (Human) ALLALPIRPATRR 0.93088 1.0769 10.3005 0 0 14.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1845 0 0 0 0 0 0 11.6966 0 0 0 0 0 0 10.684 0 0 0 0 0 0 0 11.8987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4572 12.3027 0 12.4279 13.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4603 0 0 0 0 0 0 0 0 0 0 0 0 12.5562 13.0197 12.2188 12.1434 0 0 12.3498 12.1067 0 12.4016 0 0 12.3397 0 0 0 0 12.3687 0 0 0 12.7713 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1679 0 12.248 0 0 0 0 0 0 13.2983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2401 11.3889 0 0 0 0 0 0 10.6257 P36873 PP1G_HUMAN "Serine/threonine-protein phosphatase PP1-gamma catalytic subunit, PP-1G, EC 3.1.3.16 (Protein phosphatase 1C catalytic subunit)" PPP1CC Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; protein-containing complex [GO:0032991]; PTW/PP1 phosphatase complex [GO:0072357] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; protein-containing complex [GO:0032991]; PTW/PP1 phosphatase complex [GO:0072357]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822] GO:0000164; GO:0000165; GO:0000776; GO:0003723; GO:0004721; GO:0004722; GO:0005521; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0005925; GO:0005977; GO:0006470; GO:0007049; GO:0008022; GO:0008157; GO:0016607; GO:0016791; GO:0017018; GO:0019901; GO:0019904; GO:0030182; GO:0030496; GO:0032154; GO:0032922; GO:0032991; GO:0042752; GO:0043153; GO:0043197; GO:0044877; GO:0046822; GO:0046872; GO:0047485; GO:0051301; GO:0060252; GO:0072357; GO:0098793; GO:0098978 lamin binding [GO:0005521]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723] AHQVVEDGYEFFAKR 0.93089 1.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2775 13.8945 0 0 0 0 0 0 0 0 0 14.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1349 0 0 0 0 0 0 0 0 0 0 0 Q9H204 MED28_HUMAN "Mediator of RNA polymerase II transcription subunit 28 (Endothelial-derived protein 1) (Mediator complex subunit 28) (Merlin and Grb2-interacting cytoskeletal protein, Magicin) (Tumor angiogenesis marker EG-1)" MED28 EG1 FKSG20 Homo sapiens (Human) negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] core mediator complex [GO:0070847]; cortical actin cytoskeleton [GO:0030864]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] core mediator complex [GO:0070847]; cortical actin cytoskeleton [GO:0030864]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] GO:0003779; GO:0005634; GO:0005654; GO:0016020; GO:0016592; GO:0030864; GO:0032968; GO:0035019; GO:0051123; GO:0051151; GO:0060261; GO:0070847 actin binding [GO:0003779] DALVQKHLTKLR 0.93089 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NFZ4 FA24A_HUMAN Protein FAM24A FAM24A Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 IMIGIGSSLLVAAMVLLSVVFCLYFKVAKALK 0.9309 1.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYJ8 TAB2_HUMAN "TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2, TAB-2) (TGF-beta-activated kinase 1-binding protein 2)" TAB2 KIAA0733 MAP3K7IP2 Homo sapiens (Human) heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496] cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; heart development [GO:0007507]; negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496] GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0007507; GO:0008270; GO:0010008; GO:0010507; GO:0032496; GO:0043123; GO:0043130; GO:0045860; GO:0070530 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] KNQIEIK 0.93091 2.1735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7401 0 0 0 0 0 0 0 0 10.7199 0 0 0 16.3871 0 0 0 0 0 0 0 0 0 0 0 0 13.7609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZP65 BICL1_HUMAN "BICD family-like cargo adapter 1 (Bicaudal D-related protein 1, BICD-related protein 1, BICDR-1) (Coiled-coil domain-containing protein 64A, CCDC64A)" BICDL1 BICDR1 CCDC64 Homo sapiens (Human) Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496] centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynactin binding [GO:0034452]; small GTPase binding [GO:0031267]; Golgi to secretory granule transport [GO:0055107]; neuron projection development [GO:0031175]; vesicle transport along microtubule [GO:0047496] GO:0005737; GO:0005813; GO:0031175; GO:0031267; GO:0034452; GO:0047496; GO:0055107 dynactin binding [GO:0034452]; small GTPase binding [GO:0031267] ALLERNQDMSRQYEQMHK 0.93093 1.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4771 0 0 0 0 0 0 0 0 11.3847 0 0 0 0 0 11.7878 0 0 0 0 0 0 0 14.3181 0 11.3964 0 0 0 0 0 0 0 0 11.3255 0 0 0 0 11.5753 0 0 0 11.0308 10.8192 0 0 0 0 0 0 0 11.5299 0 0 0 0 0 10.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8103 0 0 0 0 0 14.2766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PI73 LIRA6_HUMAN "Leukocyte immunoglobulin-like receptor subfamily A member 6 (Immunoglobulin-like transcript 8, ILT-8) (Leukocyte Ig-like receptor)" LILRA6 ILT8 Homo sapiens (Human) adaptive immune response [GO:0002250]; cytokine-mediated signaling pathway [GO:0019221] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inhibitory MHC class I receptor activity [GO:0032396]; adaptive immune response [GO:0002250]; cytokine-mediated signaling pathway [GO:0019221] GO:0002250; GO:0005886; GO:0016021; GO:0019221; GO:0032396 inhibitory MHC class I receptor activity [GO:0032396] FSIPSMTQHHAGRYR 0.93094 1.0912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2445 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6463 0 13.153 0 15.0155 0 0 0 0 0 0 0 13.9249 0 0 0 0 0 0 14.8425 0 0 0 13.7455 0 0 0 0 0 0 0 0 13.9003 14.803 0 0 0 0 14.4904 0 0 0 0 0 0 0 12.2909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5824 0 0 0 0 0 0 0 P22732 GTR5_HUMAN "Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine, GLUT-5)" SLC2A5 GLUT5 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; intestinal hexose absorption [GO:0106001]; monosaccharide transmembrane transport [GO:0015749]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; specific granule membrane [GO:0035579] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; specific granule membrane [GO:0035579]; fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; carbohydrate metabolic process [GO:0005975]; cellular response to fructose stimulus [GO:0071332]; fructose import across plasma membrane [GO:1990539]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; intestinal hexose absorption [GO:0106001]; monosaccharide transmembrane transport [GO:0015749]; regulation of systemic arterial blood pressure mediated by a chemical signal [GO:0003044]; response to fructose [GO:0009750] GO:0003044; GO:0005353; GO:0005355; GO:0005886; GO:0005887; GO:0005975; GO:0009750; GO:0015149; GO:0015749; GO:0015755; GO:0016020; GO:0016324; GO:0035579; GO:0042383; GO:0070061; GO:0070062; GO:0071332; GO:0106001; GO:1904659; GO:1990539 fructose binding [GO:0070061]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149] AAGFISVLKLFR 0.93096 2.1732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5675 0 0 0 0 0 13.6437 0 0 0 0 0 0 0 0 0 0 0 0 12.7774 0 0 0 0 0 0 12.383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9257 0 0 0 13.9643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3678 0 0 0 0 0 13.4001 0 0 0 14.715 0 0 0 0 0 0 0 0 0 0 0 0 13.026 0 0 13.1709 0 0 0 13.7196 0 0 0 0 0 0 0 14.0304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0286 0 0 0 0 0 0 0 0 0 0 A0PJX8 TMM82_HUMAN Transmembrane protein 82 TMEM82 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AQWASLETVHLAGLALFLTVVGSR 0.93097 1.9321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92793 CBP_HUMAN "CREB-binding protein (Histone lysine acetyltransferase CREBBP, EC 2.3.1.48) (Protein-lysine acetyltransferase CREBBP, EC 2.3.1.-)" CREBBP CBP Homo sapiens (Human) "cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; histone acetylation [GO:0016573]; histone glutamine methylation [GO:1990258]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]" GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006473; GO:0007165; GO:0008270; GO:0008589; GO:0016407; GO:0016573; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0034212; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0045893; GO:0045944; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0140297; GO:1900034; GO:1990258 acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] AFAERIIHDYK 0.93098 2.3522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1124 0 16.8852 0 0 0 14.6516 0 0 0 0 0 0 15.0365 14.1806 15.4502 0 0 0 0 15.027 14.4821 0 0 0 14.5447 0 15.6146 14.6633 0 14.3311 0 14.7157 0 15.138 14.1124 13.8554 0 14.2206 0 0 0 14.8592 0 0 0 14.3813 0 13.6047 0 0 0 0 0 0 0 13.547 0 0 0 0 13.9745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7416 14.4821 0 0 0 0 0 Q9NXV2 KCTD5_HUMAN BTB/POZ domain-containing protein KCTD5 KCTD5 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] GO:0005634; GO:0005737; GO:0005829; GO:0031463; GO:0042802; GO:0043161; GO:0044877; GO:0051260; GO:0097602 cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] RCSAGLGALAQRPGSVSK 0.93098 1.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5012 0 0 12.4335 12.6904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2768 0 0 0 0 0 0 0 0 0 Q6PRD7 CEMP1_HUMAN "Cementoblastoma-derived protein 1 (Cementum protein 1) (Cementum protein 23, CP-23)" CEMP1 Homo sapiens (Human) biomineral tissue development [GO:0031214]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; odontogenesis [GO:0042476] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; hydroxyapatite binding [GO:0046848]; biomineral tissue development [GO:0031214]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; odontogenesis [GO:0042476] GO:0005634; GO:0005654; GO:0005737; GO:0008283; GO:0030154; GO:0031214; GO:0042476; GO:0046848 hydroxyapatite binding [GO:0046848] IHIRRLLSWAAPGACGLR 0.93099 1.9206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2916 0 0 0 0 0 0 0 11.9706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N100 ATOH7_HUMAN "Transcription factor ATOH7 (Atonal bHLH transcription factor 7) (Class A basic helix-loop-helix protein 13, bHLHa13) (Protein atonal homolog 7)" ATOH7 ATH5 BHLHA13 Homo sapiens (Human) circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; optic nerve development [GO:0021554]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to auditory stimulus [GO:0010996] axon [GO:0030424]; chromatin [GO:0000785]; nucleus [GO:0005634]; perikaryon [GO:0043204] "axon [GO:0030424]; chromatin [GO:0000785]; nucleus [GO:0005634]; perikaryon [GO:0043204]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; optic nerve development [GO:0021554]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to auditory stimulus [GO:0010996]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003407; GO:0005634; GO:0006357; GO:0007623; GO:0010996; GO:0021554; GO:0030182; GO:0030424; GO:0043153; GO:0043204; GO:0045944; GO:0046983; GO:1902336; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" RVVPQWGQDKK 0.931 1.0899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D161 F221A_HUMAN Protein FAM221A FAM221A C7orf46 Homo sapiens (Human) AYLYVPLNGSQPIRCR 0.93101 2.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0091 0 0 0 0 0 0 0 0 0 12.6009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUI1 C144L_HUMAN Putative coiled-coil domain-containing protein 144 N-terminal-like CCDC144NL Homo sapiens (Human) GGAGGSPKPAVYATRK 0.93101 1.0623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6868 0 0 0 0 0 0 0 0 0 0 0 Q8IW75 SPA12_HUMAN "Serpin A12 (OL-64) (Visceral adipose tissue-derived serine protease inhibitor, Vaspin) (Visceral adipose-specific serpin)" SERPINA12 Homo sapiens (Human) gluconeogenesis [GO:0006094]; lipid biosynthetic process [GO:0008610]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of lipid biosynthetic process [GO:0051055]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cholesterol metabolic process [GO:0090181]; regulation of triglyceride metabolic process [GO:0090207] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; gluconeogenesis [GO:0006094]; lipid biosynthetic process [GO:0008610]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of lipid biosynthetic process [GO:0051055]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cholesterol metabolic process [GO:0090181]; regulation of triglyceride metabolic process [GO:0090207] GO:0004867; GO:0005615; GO:0005886; GO:0006094; GO:0008610; GO:0010951; GO:0014065; GO:0014068; GO:0045721; GO:0046628; GO:0051055; GO:0090181; GO:0090207 serine-type endopeptidase inhibitor activity [GO:0004867] DLHEGFHYIIHELTQK 0.93101 2.1725 0 0 0 0 0 0 0 0 0 11.7564 13.6046 0 12.0755 12.0037 0 13.4255 0 0 0 0 0 0 0 0 0 0 0 11.1343 0 0 0 0 0 0 0 0 0 0 11.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0466 0 11.216 0 0 0 0 12.3293 13.2227 15.1233 0 15.4718 0 13.5358 0 0 0 0 0 0 0 0 14.4598 0 15.048 14.7111 15.6832 0 15.1937 0 12.0053 0 0 12.41 0 12.3676 0 0 17.1707 13.1265 0 12.6626 0 0 0 13.9624 0 0 0 0 0 0 0 0 0 12.1965 11.373 12.6468 14.4795 12.121 0 13.4916 14.7192 0 0 0 12.5799 0 0 0 11.736 0 11.1661 0 0 12.1954 12.3481 0 0 0 0 0 0 0 12.2137 0 0 0 12.0064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0923 0 0 0 0 0 0 0 P35232 PHB1_HUMAN Prohibitin 1 PHB1 PHB Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of transcription, DNA-templated [GO:0006355]; RIG-I signaling pathway [GO:0039529]; signal transduction [GO:0007165]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; proteinase activated receptor binding [GO:0031871]; transcription corepressor activity [GO:0003714]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; histone deacetylation [GO:0016575]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of cell death [GO:0010942]; positive regulation of complement activation [GO:0045917]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of transcription, DNA-templated [GO:0006355]; RIG-I signaling pathway [GO:0039529]; signal transduction [GO:0007165]; T-helper 17 type immune response [GO:0072538]; viral entry into host cell [GO:0046718]" GO:0000122; GO:0001649; GO:0001850; GO:0001851; GO:0002639; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005769; GO:0005886; GO:0005887; GO:0006355; GO:0007005; GO:0007165; GO:0007202; GO:0008022; GO:0008285; GO:0009986; GO:0010628; GO:0010942; GO:0010944; GO:0016020; GO:0016575; GO:0019899; GO:0023035; GO:0030308; GO:0031871; GO:0032740; GO:0035632; GO:0039529; GO:0042113; GO:0042177; GO:0042826; GO:0042981; GO:0044830; GO:0045745; GO:0045892; GO:0045893; GO:0045917; GO:0046718; GO:0046982; GO:0048661; GO:0050821; GO:0050847; GO:0051897; GO:0060766; GO:0070062; GO:0070373; GO:0070374; GO:0071354; GO:0071897; GO:0072538; GO:0140374; GO:1901224; GO:1990051; GO:2000323 complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; proteinase activated receptor binding [GO:0031871]; transcription corepressor activity [GO:0003714] DLQNVNITLRILFRPVASQLPR 0.93103 2.3508 0 0 0 0 0 0 0 0 0 0 13.4538 0 0 0 0 10.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5008 0 0 0 0 0 0 0 12.4433 0 0 14.0379 0 11.4434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5622 0 0 0 11.5467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0073 0 0 0 0 0 0 0 0 15.0543 0 0 0 0 0 11.9241 0 0 0 0 0 0 0 P63104 1433Z_HUMAN "14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1, KCIP-1)" YWHAZ Homo sapiens (Human) angiogenesis [GO:0001525]; ERK1 and ERK2 cascade [GO:0070371]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; lung development [GO:0030324]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of synapse maturation [GO:0090128]; respiratory system process [GO:0003016]; signal transduction [GO:0007165]; synaptic target recognition [GO:0008039]; tube formation [GO:0035148] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; vesicle [GO:0031982] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; angiogenesis [GO:0001525]; ERK1 and ERK2 cascade [GO:0070371]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; lung development [GO:0030324]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of synapse maturation [GO:0090128]; respiratory system process [GO:0003016]; signal transduction [GO:0007165]; synaptic target recognition [GO:0008039]; tube formation [GO:0035148] GO:0000122; GO:0001525; GO:0003016; GO:0003723; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006468; GO:0006605; GO:0007165; GO:0008039; GO:0008104; GO:0019901; GO:0019904; GO:0030324; GO:0031625; GO:0031982; GO:0035148; GO:0042470; GO:0042802; GO:0043066; GO:0044325; GO:0045296; GO:0051683; GO:0070062; GO:0070371; GO:0070372; GO:0072562; GO:0090128; GO:0090168; GO:0098686; GO:0098978; GO:0140297 cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] DICNDVLSLLEKFLIPNASQAESKVFYLK 0.93103 1.1115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.66 0 0 0 0 0 0 0 0 0 14.1311 13.9876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FL8 S47A1_HUMAN "Multidrug and toxin extrusion protein 1, MATE-1, hMATE-1 (Solute carrier family 47 member 1)" SLC47A1 MATE1 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; amide transmembrane transporter activity [GO:0042887]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; amino acid import across plasma membrane [GO:0089718]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; organic cation transport [GO:0015695]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] GO:0005886; GO:0015179; GO:0015299; GO:0015695; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031982; GO:0042887; GO:0042908; GO:0042910; GO:0055085; GO:0061459; GO:0089718; GO:0097638; GO:1902475; GO:1990961 amide transmembrane transporter activity [GO:0042887]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; solute:proton antiporter activity [GO:0015299]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910] ALLVLAGPAFLVQLMVFLISFISSVFCGHLGK 0.93103 5.4296 0 0 0 0 0 0 0 0 11.6095 0 0 0 0 0 0 0 0 0 0 13.6521 0 0 0 0 0 13.9786 14.3525 14.0988 0 10.197 13.7491 0 0 0 0 0 0 0 11.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5333 9.75871 0 0 0 11.745 0 0 0 0 13.9527 0 11.9218 0 13.9537 0 0 0 0 14.6818 14.9742 0 14.2807 12.2179 14.6618 0 11.8336 14.9783 11.1401 0 12.1511 0 0 15.3363 11.5792 14.0442 0 15.1996 0 13.4363 0 14.1884 11.3365 13.153 0 0 11.6815 0 11.9798 11.2475 0 0 12.9425 0 0 0 0 13.0562 0 0 11.2498 0 13.9456 10.8992 0 11.6514 11.1113 0 13.5077 0 14.4437 14.3682 0 0 13.4466 15.468 0 12.6124 0 11.754 0 0 0 10.8532 13.9221 0 0 12.576 11.4158 0 0 11.5261 0 0 12.1045 0 10.8061 0 0 11.0456 0 15.5699 0 0 13.5571 0 12.5993 0 10.6194 0 0 0 11.4015 Q99856 ARI3A_HUMAN "AT-rich interactive domain-containing protein 3A, ARID domain-containing protein 3A (B-cell regulator of IgH transcription, Bright) (Dead ringer-like protein 1) (E2F-binding protein 1)" ARID3A DRIL1 DRIL3 DRX E2FBP1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0003682; GO:0003712; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0042802; GO:0045121; GO:0045944 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712] AQPPQAFRGDGVPRVLGGQER 0.93105 1.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1177 0 0 0 0 0 0 0 0 0 0 0 0 0 11.504 0 14.4745 0 0 0 0 0 0 14.4863 0 0 0 0 0 0 12.9208 13.7632 13.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11215 ITAM_HUMAN Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b) ITGAM CD11B CR3A Homo sapiens (Human) "amyloid-beta clearance [GO:0097242]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-matrix adhesion [GO:0007160]; complement-mediated synapse pruning [GO:0150062]; ectodermal cell differentiation [GO:0010668]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; phagocytosis, engulfment [GO:0006911]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898]; vertebrate eye-specific patterning [GO:0150064]" cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integrin alphaM-beta2 complex [GO:0034688]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] "cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integrin alphaM-beta2 complex [GO:0034688]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; amyloid-beta clearance [GO:0097242]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-matrix adhesion [GO:0007160]; complement-mediated synapse pruning [GO:0150062]; ectodermal cell differentiation [GO:0010668]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; phagocytosis, engulfment [GO:0006911]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898]; vertebrate eye-specific patterning [GO:0150064]" GO:0001540; GO:0001774; GO:0001851; GO:0005178; GO:0005615; GO:0005886; GO:0006898; GO:0006911; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0010668; GO:0030900; GO:0031072; GO:0032930; GO:0033627; GO:0034688; GO:0035579; GO:0038024; GO:0043315; GO:0044853; GO:0045087; GO:0045963; GO:0046872; GO:0070062; GO:0070821; GO:0090314; GO:0097190; GO:0097242; GO:0098609; GO:0098742; GO:0110090; GO:0150062; GO:0150064; GO:1901216; GO:1904151; GO:1905114; GO:2000363 amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; integrin binding [GO:0005178]; metal ion binding [GO:0046872] ASLGNKLLLKANVTSENNMPR 0.93106 2.0597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7878 0 0 0 0 0 0 0 0 10.7067 0 0 0 13.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5053 0 0 0 0 0 0 11.1343 0 10.7368 0 0 12.9922 0 0 0 0 0 0 12.6312 0 14.702 0 12.4426 0 0 0 10.8174 0 0 0 0 0 0 0 0 13.0567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9833 0 0 0 12.8256 0 0 0 0 11.7914 11.1248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4817 0 11.979 0 0 0 0 0 0 0 0 0 0 0 0 13.4732 0 0 0 0 0 0 0 0 14.3925 0 0 0 0 Q15819 UB2V2_HUMAN "Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1, EDAF-1) (Enterocyte differentiation-promoting factor 1, EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein)" UBE2V2 MMS2 UEV2 Homo sapiens (Human) DNA double-strand break processing [GO:0000729]; error-free postreplication DNA repair [GO:0042275]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA repair [GO:0006282] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; DNA double-strand break processing [GO:0000729]; error-free postreplication DNA repair [GO:0042275]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA repair [GO:0006282] GO:0000209; GO:0000729; GO:0005634; GO:0005654; GO:0005737; GO:0006282; GO:0006301; GO:0016567; GO:0031372; GO:0042275; GO:0070062; GO:0070534; GO:1902523; GO:2000781 VVLQELR 0.93106 1.1115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4QY38 DB134_HUMAN "Beta-defensin 134 (Defensin, beta 134)" DEFB134 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 NGICRLECYESEMLVAYCMFQLECCVKGNPAP 0.93109 1.0895 0 0 0 0 0 0 0 0 0 0 0 0 12.9589 0 0 0 0 0 0 0 11.0124 11.5561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7033 0 0 0 0 0 0 O43255 SIAH2_HUMAN "E3 ubiquitin-protein ligase SIAH2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2, Siah-2, hSiah2)" SIAH2 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; regulation of protein ubiquitination [GO:0031396]; rhythmic process [GO:0048511]; small GTPase mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; transcription corepressor activity [GO:0003714]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of circadian rhythm [GO:0042752]; regulation of protein ubiquitination [GO:0031396]; rhythmic process [GO:0048511]; small GTPase mediated signal transduction [GO:0007264]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0003714; GO:0004842; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006915; GO:0007049; GO:0007264; GO:0008270; GO:0031396; GO:0031624; GO:0042752; GO:0043005; GO:0043025; GO:0043066; GO:0043154; GO:0043161; GO:0043231; GO:0048511; GO:0060070; GO:0061630; GO:0090090; GO:1990000; GO:2001237 transcription corepressor activity [GO:0003714]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] KQAENFAYR 0.93112 2.0924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ68 FR8P1_HUMAN Putative FERM domain-containing protein FRMD8P1 (FERM domain-containing 8 pseudogene 1) FRMD8P1 FKSG43 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090] cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090] GO:0005856; GO:0005886; GO:0090090 EVLKLPDIALDVFALWLVSPLLEVQLKPK 0.93112 1.0618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1992 0 0 12.6107 0 0 0 0 0 0 0 0 0 0 0 0 13.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50583 AP4A_HUMAN "Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical], EC 3.6.1.17 (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase, Ap4A hydrolase, Ap4Aase, Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2, Nudix motif 2)" NUDT2 APAH1 Homo sapiens (Human) AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; cellular response to oxidative stress [GO:0034599]; nucleobase-containing compound metabolic process [GO:0006139] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [GO:0008803]; GTP binding [GO:0005525]; AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; cellular response to oxidative stress [GO:0034599]; nucleobase-containing compound metabolic process [GO:0006139] GO:0004081; GO:0005525; GO:0005759; GO:0006139; GO:0006167; GO:0006754; GO:0006915; GO:0008803; GO:0034599 bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [GO:0008803]; GTP binding [GO:0005525] ALRACGLIIFRR 0.93113 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62318 SMD3_HUMAN "Small nuclear ribonucleoprotein Sm D3, Sm-D3 (snRNP core protein D3)" SNRPD3 Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683] "catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U7 snRNA binding [GO:0071209]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005829; GO:0006479; GO:0008380; GO:0016604; GO:0019899; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0070034; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0071208; GO:0071209; GO:0097526; GO:1903241 enzyme binding [GO:0019899]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U7 snRNA binding [GO:0071209] IRFLILPDMLK 0.93113 1.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5U5R9 HECD2_HUMAN "Probable E3 ubiquitin-protein ligase HECTD2, EC 2.3.2.26 (HECT domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECTD2)" HECTD2 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630] GO:0005829; GO:0061630 ubiquitin protein ligase activity [GO:0061630] APVLPEPILPIQPK 0.93113 2.1381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8951 0 0 12.5257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2703 0 0 0 0 0 0 0 0 0 13.3613 12.6155 12.6699 12.7467 0 0 13.2039 0 0 0 0 0 0 0 0 12.5289 0 0 0 0 0 0 12.0162 0 0 0 0 0 0 0 0 12.1851 0 0 0 0 0 0 0 0 0 12.7277 14.7082 0 15.2282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.247 P0CW21 SPGOS_HUMAN Putative uncharacterized protein SPART-AS1 (SPART antisense RNA 1) (SPG20 antisense RNA 1) (SPG20 opposite strand transcript protein) SPART-AS1 C13orf43 SPG20-AS1 SPG20OS Homo sapiens (Human) KDIGHLQHLAQRLQWNR 0.93115 1.0776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60831 PRAF2_HUMAN PRA1 family protein 2 PRAF2 JM4 Homo sapiens (Human) L-glutamate transmembrane transport [GO:0015813]; protein transport [GO:0015031] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; L-glutamate transmembrane transport [GO:0015813]; protein transport [GO:0015031] GO:0010008; GO:0015031; GO:0015813; GO:0016020; GO:0016021 PLHTLLSALVVAVALGVLVWAAETRAAVRR 0.93116 1.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0705 0 0 0 0 12.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95219 SNX4_HUMAN Sorting nexin-4 SNX4 Homo sapiens (Human) endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031] GO:0005154; GO:0005158; GO:0005737; GO:0005769; GO:0005868; GO:0005886; GO:0015031; GO:0016020; GO:0031201; GO:0031901; GO:0032266; GO:0032456; GO:0032991; GO:0035091; GO:1903595; GO:1990459; GO:1990460; GO:2000786 epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459] EALISYAVMQISMCKKGIQVWTNAK 0.93117 1.0772 0 0 0 0 0 0 0 0 0 0 11.4812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0727 0 0 0 0 14.0411 0 0 0 0 0 12.6745 0 0 0 14.2302 14.4308 0 13.9353 12.4625 14.0428 13.0067 13.2433 0 0 0 14.5214 14.0516 0 13.184 13.9759 13.8948 0 0 0 0 0 13.7869 0 0 13.7634 0 0 0 0 0 0 14.4194 12.0951 13.8626 12.5325 0 0 0 13.5182 0 0 0 0 0 0 0 11.3199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2122 15.6703 0 0 0 0 0 0 Q16082 HSPB2_HUMAN "Heat shock protein beta-2, HspB2 (DMPK-binding protein, MKBP)" HSPB2 Homo sapiens (Human) protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; somatic muscle development [GO:0007525] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; somatic muscle development [GO:0007525] GO:0005212; GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0007525; GO:0008047; GO:0009408; GO:0042026; GO:0051082 enzyme activator activity [GO:0008047]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082] HGFVSREFCR 0.93117 1.0867 0 0 0 0 0 0 0 0 11.2454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99909 SSX3_HUMAN "Protein SSX3 (Cancer/testis antigen 5.3, CT5.3)" SSX3 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 QLCPPGK 0.93117 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0475 0 0 0 0 0 0 0 0 0 0 10.8625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.456 0 0 0 0 Q9BUB5 MKNK1_HUMAN "MAP kinase-interacting serine/threonine-protein kinase 1, EC 2.7.11.1 (MAP kinase signal-integrating kinase 1, MAPK signal-integrating kinase 1, Mnk1)" MKNK1 MNK1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417] GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0006468; GO:0009931; GO:0018105; GO:0035556; GO:0046777; GO:0046872; GO:0106310 ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EVETLYQCQGNKNILELIEFFEDDTR 0.93117 2.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.663 14.0507 0 0 0 0 0 0 0 0 11.3306 0 0 0 0 0 0 0 0 0 0 0 0 12.2805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4252 0 0 0 0 0 0 11.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7197 0 0 0 0 0 0 13.2652 0 0 0 0 0 P38117 ETFB_HUMAN "Electron transfer flavoprotein subunit beta, Beta-ETF" ETFB FP585 Homo sapiens (Human) cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251 electron transfer activity [GO:0009055] EKVDLVLLGK 0.93118 1.0966 0 0 0 0 0 0 0 0 0 0 11.1232 0 0 0 0 0 0 13.0439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8835 0 0 0 0 11.1625 0 0 11.2518 0 0 0 16.0624 0 11.5638 0 0 0 14.8573 0 0 0 0 0 0 0 0 0 12.7603 0 0 0 0 13.3969 0 14.3686 0 0 0 0 0 0 0 0 0 0 0 14.6561 0 0 0 0 0 14.5895 0 11.2098 0 0 0 0 14.7969 0 0 0 0 0 0 0 0 0 0 14.7174 0 0 0 0 0 11.5586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4833 0 0 0 0 11.9795 0 P12268 IMDH2_HUMAN "Inosine-5'-monophosphate dehydrogenase 2, IMP dehydrogenase 2, IMPD 2, IMPDH 2, EC 1.1.1.205 (Inosine-5'-monophosphate dehydrogenase type II, IMP dehydrogenase II, IMPDH-II)" IMPDH2 IMPD2 Homo sapiens (Human) 'de novo' XMP biosynthetic process [GO:0097294]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; retina development in camera-type eye [GO:0060041] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; 'de novo' XMP biosynthetic process [GO:0097294]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; retina development in camera-type eye [GO:0060041] GO:0000166; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005778; GO:0005829; GO:0006177; GO:0006183; GO:0007623; GO:0016020; GO:0034774; GO:0042802; GO:0046651; GO:0046872; GO:0060041; GO:0070062; GO:0071353; GO:0097294; GO:1904813 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723] ALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKK 0.9312 1.9413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.364 0 0 0 11.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40126 TYRP2_HUMAN "L-dopachrome tautomerase, DCT, DT, EC 5.3.3.12 (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2, TRP-2, TRP2)" DCT TYRP2 Homo sapiens (Human) cell development [GO:0048468]; developmental pigmentation [GO:0048066]; epidermis development [GO:0008544]; melanin biosynthetic process from tyrosine [GO:0006583]; positive regulation of neuroblast proliferation [GO:0002052]; response to blue light [GO:0009637]; ventricular zone neuroblast division [GO:0021847] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; dopachrome isomerase activity [GO:0004167]; oxidoreductase activity [GO:0016491]; cell development [GO:0048468]; developmental pigmentation [GO:0048066]; epidermis development [GO:0008544]; melanin biosynthetic process from tyrosine [GO:0006583]; positive regulation of neuroblast proliferation [GO:0002052]; response to blue light [GO:0009637]; ventricular zone neuroblast division [GO:0021847] GO:0002052; GO:0004167; GO:0005507; GO:0005829; GO:0005886; GO:0006583; GO:0008544; GO:0009637; GO:0016021; GO:0016491; GO:0021847; GO:0033162; GO:0042470; GO:0043231; GO:0048066; GO:0048468 copper ion binding [GO:0005507]; dopachrome isomerase activity [GO:0004167]; oxidoreductase activity [GO:0016491] CTGNFAGYNCGDCKFGWTGPNCER 0.9312 2.3485 0 0 0 0 0 0 0 0 0 0 0 12.5387 0 0 0 0 14.5567 0 0 0 11.1191 0 13.2536 0 0 0 0 0 0 0 13.6676 0 0 0 0 0 12.9928 0 12.5938 0 0 0 12.8437 0 0 0 0 0 0 0 0 0 0 0 12.2262 0 12.2078 14.3726 14.0212 13.2498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5416 0 0 12.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0544 0 0 13.345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1936 12.8385 13.6773 12.6008 12.7209 12.3641 0 12.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3737 0 0 0 Q9BWK5 CYREN_HUMAN "Cell cycle regulator of non-homologous end joining, Cell cycle regulator of NHEJ (Modulator of retrovirus infection homolog)" CYREN C7orf49 MRI Homo sapiens (Human) double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] GO:0005634; GO:0005737; GO:0006303; GO:0033152; GO:0035861; GO:2001033 MRMAAVPVAAAR 0.9312 1.0964 0 0 0 0 0 0 0 0 0 0 0 12.5638 0 0 12.1784 0 0 12.5723 0 0 0 12.2553 0 0 0 0 0 0 0 0 0 0 13.1612 0 0 0 0 0 0 13.4101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2437 13.1811 15.984 0 14.6009 0 0 0 0 0 15.6631 0 0 0 0 0 15.7231 0 0 0 0 P62508 ERR3_HUMAN Estrogen-related receptor gamma (ERR gamma-2) (Estrogen receptor-related protein 3) (Nuclear receptor subfamily 3 group B member 3) ESRRG ERR3 ERRG2 KIAA0832 NR3B3 Homo sapiens (Human) "positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003707; GO:0004879; GO:0005496; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0034056; GO:0042802; GO:0045944; GO:0048384; GO:0050682; GO:0120162; GO:1990837 "AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]" LAGLLDLNNAILQLVKK 0.93121 2.0676 0 0 0 0 14.6626 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19526 FUT1_HUMAN "Galactoside alpha-(1,2)-fucosyltransferase 1 (Alpha(1,2)FT 1) (Blood group H alpha 2-fucosyltransferase) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1) (Type 1 galactoside alpha-(1,2)-fucosyltransferase FUT1, EC 2.4.1.69) (Type 2 galactoside alpha-(1,2)-fucosyltransferase FUT1, EC 2.4.1.344)" FUT1 H HSC Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; lipid metabolic process [GO:0006629]; olfactory bulb development [GO:0021772]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of sprouting angiogenesis [GO:1903672]; protein glycosylation [GO:0006486]; regulation of cell adhesion [GO:0030155]; regulation of endothelial cell proliferation [GO:0001936] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; alpha-(1,2)-fucosyltransferase activity [GO:0031127]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; lipid metabolic process [GO:0006629]; olfactory bulb development [GO:0021772]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of sprouting angiogenesis [GO:1903672]; protein glycosylation [GO:0006486]; regulation of cell adhesion [GO:0030155]; regulation of endothelial cell proliferation [GO:0001936]" GO:0000139; GO:0001936; GO:0001954; GO:0005794; GO:0005887; GO:0005975; GO:0006486; GO:0006629; GO:0008107; GO:0008417; GO:0009312; GO:0010595; GO:0016020; GO:0021772; GO:0030155; GO:0031127; GO:0032580; GO:0036065; GO:0042355; GO:1903672; GO:1904906 "alpha-(1,2)-fucosyltransferase activity [GO:0031127]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]" RAFILPAMHAALAPVFRITLPVLAPEVDSR 0.93122 1.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSG1 RN165_HUMAN "E3 ubiquitin-protein ligase RNF165, EC 2.3.2.27 (RING finger protein 165)" RNF165 Homo sapiens (Human) forelimb morphogenesis [GO:0035136]; innervation [GO:0060384]; motor neuron axon guidance [GO:0008045]; multicellular organism aging [GO:0010259]; muscle structure development [GO:0061061]; positive regulation of BMP signaling pathway [GO:0030513]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209] nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; forelimb morphogenesis [GO:0035136]; innervation [GO:0060384]; motor neuron axon guidance [GO:0008045]; multicellular organism aging [GO:0010259]; muscle structure development [GO:0061061]; positive regulation of BMP signaling pathway [GO:0030513]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005634; GO:0008045; GO:0008270; GO:0010259; GO:0030163; GO:0030513; GO:0032991; GO:0035136; GO:0060384; GO:0061061; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CTICLSMLEDGEDVR 0.93123 1.6655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.88509 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.836 0 0 0 0 0 0 0 0 12.5138 12.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7344 0 0 0 0 0 0 12.5631 0 0 0 0 0 0 0 0 0 11.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8851 0 0 0 0 Q9H9L4 KANL2_HUMAN KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog) KANSL2 C12orf41 NSL2 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" GO:0000123; GO:0005654; GO:0005829; GO:0005886; GO:0006325; GO:0015629; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0051571; GO:1900095 GDPDSEADSIDSDQEDPLK 0.93123 2.3638 14.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6687 0 0 0 0 14.3686 0 0 0 0 0 0 0 11.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6051 0 14.3989 0 0 0 0 0 0 0 0 0 0 13.6294 0 0 0 0 0 0 14.0744 0 0 0 0 13.6602 0 0 0 0 0 13.5585 0 0 0 0 0 0 15.3803 0 0 0 0 0 0 0 0 0 14.6909 0 0 0 0 13.1994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1621 0 0 0 14.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2226 0 0 0 13.7666 0 0 0 Q9UBF6 RBX2_HUMAN "RING-box protein 2, Rbx2 (CKII beta-binding protein 1, CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein)" RNF7 RBX2 ROC2 SAG Homo sapiens (Human) post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; response to redox state [GO:0051775]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0019788; GO:0031461; GO:0031466; GO:0043687; GO:0045116; GO:0051775; GO:0061630; GO:0061663; GO:0097602 copper ion binding [GO:0005507]; cullin family protein binding [GO:0097602]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ADVEDGEETCALASHSGSSGSK 0.93125 2.3483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8709 0 0 0 0 0 0 0 0 0 11.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZY2 FA30A_HUMAN Putative uncharacterized protein FAM30A FAM30A C14orf110 KIAA0125 HSPC053 Homo sapiens (Human) GTLQGAALRSR 0.93126 1.9502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90515 0 0 0 0 0 0 0 0 0 0 0 10.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3805 0 0 12.6528 0 0 0 0 0 0 0 0 0 0 0 0 10.4891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3385 0 Q7Z3B1 NEGR1_HUMAN Neuronal growth regulator 1 (IgLON family member 4) NEGR1 IGLON4 UNQ2433/PRO4993 Homo sapiens (Human) brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; feeding behavior [GO:0007631]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; positive regulation of neuron projection development [GO:0010976]; regulation of synapse assembly [GO:0051963] anchored component of membrane [GO:0031225]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; feeding behavior [GO:0007631]; locomotory behavior [GO:0007626]; neuron projection development [GO:0031175]; positive regulation of neuron projection development [GO:0010976]; regulation of synapse assembly [GO:0051963] GO:0005576; GO:0005886; GO:0007420; GO:0007626; GO:0007631; GO:0010976; GO:0030425; GO:0031175; GO:0031225; GO:0043025; GO:0051963; GO:0098609 CEGAGVPPPAFEWYKGEK 0.93127 1.0589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20226 TBP_HUMAN TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit) TBP GTF2D1 TF2D TFIID Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase II promoter [GO:0006367]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; female germ cell nucleus [GO:0001674]; female pronucleus [GO:0001939]; male germ cell nucleus [GO:0001673]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase transcription factor SL1 complex [GO:0005668]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; female germ cell nucleus [GO:0001674]; female pronucleus [GO:0001939]; male germ cell nucleus [GO:0001673]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase transcription factor SL1 complex [GO:0005668]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; aryl hydrocarbon receptor binding [GO:0017162]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; TFIIB-class transcription factor binding [GO:0001093]; transcription cis-regulatory region binding [GO:0000976]; DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000979; GO:0000995; GO:0001046; GO:0001091; GO:0001093; GO:0001673; GO:0001674; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005668; GO:0005669; GO:0005672; GO:0005737; GO:0006352; GO:0006366; GO:0006367; GO:0006383; GO:0006468; GO:0016251; GO:0017162; GO:0019899; GO:0032991; GO:0042789; GO:0051123; GO:0060261; GO:0097550; GO:0140223; GO:0140297 aryl hydrocarbon receptor binding [GO:0017162]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; TFIIB-class transcription factor binding [GO:0001093]; transcription cis-regulatory region binding [GO:0000976] AEIYEAFENIYPILKGFR 0.93129 1.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ92 OR5P2_HUMAN Olfactory receptor 5P2 (Olfactory receptor-like protein JCG3) OR5P2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ILSHDACYFSR 0.9313 1.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8383 0 0 0 0 0 0 0 0 0 12.9691 13.121 0 0 0 13.6671 0 0 0 0 13.8256 13.0459 0 0 0 0 0 0 0 0 13.0327 12.6335 12.8237 13.0631 0 0 0 0 0 0 0 0 12.4692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8225 0 0 0 0 12.9081 0 0 0 0 0 0 13.0011 0 0 0 0 0 0 0 12.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8115 0 0 0 0 0 0 0 0 13.3278 0 O14656 TOR1A_HUMAN "Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A, EC 3.6.4.-) (Torsin family 1 member A)" TOR1A DQ2 DYT1 TA TORA Homo sapiens (Human) "cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ER-associated misfolded protein catabolic process [GO:0071712]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]" anchoring junction [GO:0070161]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021] "anchoring junction [GO:0070161]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082]; cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ER-associated misfolded protein catabolic process [GO:0071712]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; organelle organization [GO:0006996]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; response to oxidative stress [GO:0006979]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]" GO:0000338; GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0005829; GO:0005856; GO:0006979; GO:0006996; GO:0006998; GO:0007155; GO:0008021; GO:0008092; GO:0016020; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0042406; GO:0042802; GO:0043231; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051082; GO:0051085; GO:0051584; GO:0051787; GO:0061077; GO:0070062; GO:0070161; GO:0071712; GO:0071763; GO:0140662; GO:1900244; GO:2000008 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082] GCKTVFTKLDYYYDD 0.93132 1.9379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN19 DAPP1_HUMAN "Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide, hDAPP1 (B lymphocyte adapter protein Bam32) (B-cell adapter molecule of 32 kDa)" DAPP1 BAM32 HSPC066 Homo sapiens (Human) protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phospholipid binding [GO:0005543]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]" GO:0005543; GO:0005547; GO:0005829; GO:0005886; GO:0006470; GO:0007165; GO:0043325 "phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phospholipid binding [GO:0005543]" DFVKHFANQPLIGSETGTLMVLK 0.93133 1.0688 0 12.1577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HP8 T176A_HUMAN Transmembrane protein 176A (Hepatocellular carcinoma-associated antigen 112) TMEM176A HCA112 Homo sapiens (Human) negative regulation of dendritic cell differentiation [GO:2001199] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; negative regulation of dendritic cell differentiation [GO:2001199] GO:0016021; GO:2001199 RLHLCTSFMDMLKALFR 0.93134 1.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2019 11.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969F1 TF3C6_HUMAN "General transcription factor 3C polypeptide 6 (Transcription factor IIIC 35 kDa subunit, TFIIIC 35 kDa subunit, TFIIIC35) (Transcription factor IIIC subunit 6)" GTF3C6 C6orf51 CDA020 NPD020 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0006383; GO:0016604; GO:0042791; GO:0042797 DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] KLSMTRTLLTEK 0.93136 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.253 0 12.9073 0 0 0 0 0 0 0 0 0 0 0 12.4921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52434 RPAB3_HUMAN "DNA-directed RNA polymerases I, II, and III subunit RPABC3, RNA polymerases I, II, and III subunit ABC3 (DNA-directed RNA polymerase II subunit H) (DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide) (RPB17) (RPB8 homolog, hRPB8)" POLR2H Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; single-stranded DNA binding [GO:0003697]; transcription by RNA polymerase II [GO:0006366]" GO:0003697; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006366; GO:0032993 single-stranded DNA binding [GO:0003697] DIDPEGKKFDR 0.93137 1.0682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5937 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4631 0 0 A0A1B0GX51 TVB78_HUMAN T cell receptor beta variable 7-8 TRBV7-8 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 FFAERPEGSVSTLKIQR 0.93138 1.0777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3599 0 0 0 0 0 0 0 0 0 0 Q9H2A7 CXL16_HUMAN "C-X-C motif chemokine 16 (Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein, SR-PSOX) (Small-inducible cytokine B16) (Transmembrane chemokine CXCL16)" CXCL16 SCYB16 SRPSOX UNQ2759/PRO6714 Homo sapiens (Human) chemotaxis [GO:0006935]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; receptor-mediated endocytosis [GO:0006898]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; T cell chemotaxis [GO:0010818] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemokine activity [GO:0008009]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; chemotaxis [GO:0006935]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; receptor-mediated endocytosis [GO:0006898]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; T cell chemotaxis [GO:0010818] GO:0005041; GO:0005044; GO:0005576; GO:0005615; GO:0005886; GO:0006898; GO:0006935; GO:0008009; GO:0010818; GO:0016020; GO:0016021; GO:0030307; GO:0030335; GO:0034097; GO:0034341; GO:0034612 chemokine activity [GO:0008009]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044] TSATVPVLCLLAIIFILTAALSYVLCKRR 0.93138 1.0618 0 0 0 0 0 0 0 0 0 0 12.0123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8318 0 0 0 0 0 0 0 0 0 0 11.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6103 0 0 0 0 0 11.7426 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY12 GAR1_HUMAN H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1) GAR1 NOLA1 Homo sapiens (Human) snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004] "box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; chromosome, telomeric region [GO:0000781]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]" "box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; chromosome, telomeric region [GO:0000781]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004]" GO:0000454; GO:0000781; GO:0001650; GO:0003723; GO:0005654; GO:0005697; GO:0007004; GO:0031429; GO:0034513; GO:0070034; GO:0072589; GO:0090661 box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] SFRGGGRGGFNR 0.93138 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H334 FOXP1_HUMAN "Forkhead box protein P1 (Mac-1-regulated forkhead, MFH)" FOXP1 HSPC215 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell activation [GO:0042118]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 beta production [GO:0032651]; regulation of interleukin-12 production [GO:0032655]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; response to testosterone [GO:0033574]; striatum development [GO:0021756]; T follicular helper cell differentiation [GO:0061470]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to tumor necrosis factor [GO:0071356]; endothelial cell activation [GO:0042118]; macrophage activation [GO:0042116]; monocyte activation [GO:0042117]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of defense response to bacterium [GO:1900424]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 beta production [GO:0032651]; regulation of interleukin-12 production [GO:0032655]; regulation of macrophage colony-stimulating factor production [GO:1901256]; regulation of monocyte differentiation [GO:0045655]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tumor necrosis factor production [GO:0032680]; response to lipopolysaccharide [GO:0032496]; response to testosterone [GO:0033574]; striatum development [GO:0021756]; T follicular helper cell differentiation [GO:0061470]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001227; GO:0002903; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006974; GO:0010468; GO:0010595; GO:0010629; GO:0021756; GO:0030316; GO:0032496; GO:0032651; GO:0032655; GO:0032680; GO:0032745; GO:0033574; GO:0036035; GO:0042116; GO:0042117; GO:0042118; GO:0042802; GO:0043621; GO:0045655; GO:0045892; GO:0046872; GO:0048661; GO:0050681; GO:0050727; GO:0050861; GO:0060766; GO:0061052; GO:0061470; GO:0071356; GO:1900424; GO:1901256; GO:1901509; GO:1905206; GO:1990837; GO:2000341 "core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" HNLSLHKCFVRVENVK 0.93139 1.0895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBK3 SUMF1_HUMAN "Formylglycine-generating enzyme, FGE, EC 1.8.3.7 (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1)" SUMF1 PSEC0152 UNQ3037/PRO9852 Homo sapiens (Human) glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491]; glycosphingolipid metabolic process [GO:0006687]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158] GO:0005783; GO:0005788; GO:0006687; GO:0016491; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135 cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491] FGDSFVFEGMLSEQVK 0.93141 1.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75896 TUSC2_HUMAN "Tumor suppressor candidate 2 (Fusion 1 protein, Fus-1 protein) (PDGFA-associated protein 2)" TUSC2 C3orf11 FUS1 LGCC PDAP2 Homo sapiens (Human) cell cycle [GO:0007049]; cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; cell cycle [GO:0007049]; cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377] GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0007049; GO:0032700; GO:0032733; GO:0048469; GO:0051881; GO:0070945; GO:2000377 MGASGSK 0.93142 1.0776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8296 0 0 0 13.3109 0 0 13.6215 12.8589 0 13.8264 0 0 0 0 0 0 0 13.4089 0 0 0 0 0 0 0 0 13.4924 0 10.8178 0 0 0 0 0 0 0 0 0 0 0 0 12.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75388 GPR32_HUMAN Probable G-protein coupled receptor 32 GPR32 Homo sapiens (Human) complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007200; GO:0007204 complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982] ASWLAFGVWLLAAALCSAHLK 0.93143 2.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5561 13.6081 0 0 14.4072 0 0 0 0 0 0 14.2785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16820 MEP1B_HUMAN "Meprin A subunit beta, EC 3.4.24.63 (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta)" MEP1B Homo sapiens (Human) inflammatory response [GO:0006954]; proteolysis [GO:0006508]; toxin transport [GO:1901998] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; proteolysis [GO:0006508]; toxin transport [GO:1901998] GO:0004222; GO:0005576; GO:0005887; GO:0006508; GO:0006954; GO:0008270; GO:0017090; GO:0042802; GO:1901998 identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] CQSGEDWWYMGERCEKR 0.93144 1.0776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0079 0 0 0 0 0 0 0 12.9469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SE0 ABHD1_HUMAN "Protein ABHD1, EC 3.1.1.- (Alpha/beta hydrolase domain-containing protein 1, Abhydrolase domain-containing protein 1) (Lung alpha/beta hydrolase 1)" ABHD1 LABH1 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793] GO:0008126; GO:0016021; GO:0034338; GO:0044255; GO:0047372; GO:0051792; GO:0051793 acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338] QFDERYTSVAFGYQDCVTYYK 0.93144 1.0872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29466 CASP1_HUMAN "Caspase-1, CASP-1, EC 3.4.22.36 (Interleukin-1 beta convertase, IL-1BC) (Interleukin-1 beta-converting enzyme, ICE, IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10 ]" CASP1 IL1BC IL1BCE Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cytokine precursor processing [GO:0140447]; defense response to virus [GO:0051607]; icosanoid biosynthetic process [GO:0046456]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; signaling receptor ligand precursor processing [GO:0140448] AIM2 inflammasome complex [GO:0097169]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557]; microtubule [GO:0005874]; NLRP1 inflammasome complex [GO:0072558]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991] AIM2 inflammasome complex [GO:0097169]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557]; microtubule [GO:0005874]; NLRP1 inflammasome complex [GO:0072558]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic substance [GO:0071310]; cytokine precursor processing [GO:0140447]; defense response to virus [GO:0051607]; icosanoid biosynthetic process [GO:0046456]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; signaling receptor ligand precursor processing [GO:0140448] GO:0002221; GO:0004175; GO:0004197; GO:0005615; GO:0005730; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0006915; GO:0007165; GO:0007231; GO:0008303; GO:0008656; GO:0016540; GO:0019900; GO:0032731; GO:0032991; GO:0042802; GO:0042981; GO:0043123; GO:0043280; GO:0046456; GO:0050700; GO:0050727; GO:0050729; GO:0051607; GO:0061702; GO:0070269; GO:0071222; GO:0071260; GO:0071310; GO:0071346; GO:0072557; GO:0072558; GO:0072559; GO:0097169; GO:0097179; GO:0097199; GO:0140447; GO:0140448; GO:1903265 CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase binding [GO:0019900] LIEHMQEYACSCDVEEIFRK 0.93145 1.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8487 0 0 0 0 0 Q9BRQ4 CF300_HUMAN Cilia- and flagella-associated protein 300 CFAP300 C11orf70 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] GO:0005737; GO:0005856; GO:0031514 CLDSFCDPFLISDELRR 0.93145 2.1334 0 0 0 0 0 0 0 11.2044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5767 14.1447 18.1377 0 0 14.9283 15.1262 15.1819 15.5613 14.4659 15.7949 0 0 0 0 0 0 0 0 0 14.5026 0 0 P0C7U0 ELFN1_HUMAN Protein ELFN1 (Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1) (Protein phosphatase 1 regulatory subunit 28) ELFN1 PPP1R28 Homo sapiens (Human) synapse organization [GO:0050808] dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] dendrite [GO:0030425]; excitatory synapse [GO:0060076]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; protein phosphatase inhibitor activity [GO:0004864]; synapse organization [GO:0050808] GO:0004864; GO:0005615; GO:0016021; GO:0030425; GO:0031012; GO:0050808; GO:0060076 protein phosphatase inhibitor activity [GO:0004864] AAAAEAK 0.93146 1.056 0 0 0 0 0 0 0 0 0 0 0 13.8391 0 12.6552 12.4341 0 0 0 11.916 0 12.5338 0 0 0 0 0 12.9879 0 0 0 0 0 0 0 0 0 12.4931 0 0 0 0 0 0 0 0 14.3785 0 13.1397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4442 0 0 13.2016 0 13.6778 14.1489 0 0 0 0 0 14.3527 0 14.4946 0 0 0 0 13.8558 0 0 0 13.3214 0 0 0 0 13.2851 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.166 0 0 0 0 0 14.1761 0 0 0 0 13.2567 0 0 0 0 Q9BTC8 MTA3_HUMAN Metastasis-associated protein MTA3 MTA3 KIAA1266 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; G2/M transition of mitotic cell cycle [GO:0000086]; granulosa cell proliferation [GO:1990739]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; G2/M transition of mitotic cell cycle [GO:0000086]; granulosa cell proliferation [GO:1990739]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" GO:0000086; GO:0000122; GO:0003682; GO:0003713; GO:0003714; GO:0005654; GO:0005737; GO:0006338; GO:0010971; GO:0016575; GO:0016581; GO:0042659; GO:0042826; GO:0043231; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0120325; GO:1904197; GO:1990739; GO:2000736 chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] ACESCYATQSHQWYSWGPPNMQCR 0.93146 1.0868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6029 0 0 0 12.0348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1152 0 12.8569 14.0271 13.5897 14.7399 0 0 0 0 0 0 0 0 0 0 0 0 14.2516 0 0 0 0 0 0 0 0 14.1348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0343 0 0 0 0 0 0 0 P35325 SPR2B_HUMAN "Small proline-rich protein 2B, SPR-2B" SPRR2B Homo sapiens (Human) epidermis development [GO:0008544]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216] cornified envelope [GO:0001533]; cytosol [GO:0005829] cornified envelope [GO:0001533]; cytosol [GO:0005829]; epidermis development [GO:0008544]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216] GO:0001533; GO:0005829; GO:0008544; GO:0030216; GO:0031424 CPQPCPPQQCQQKYPPVTPSPPCQPKYPPK 0.93149 1.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2473 0 0 0 0 0 0 0 Q6UW88 EPGN_HUMAN "Epigen (Epithelial mitogen, EPG)" EPGN UNQ3072/PRO9904 Homo sapiens (Human) angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; MAPK cascade [GO:0000165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840] clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; MAPK cascade [GO:0000165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840] GO:0000165; GO:0001525; GO:0005154; GO:0005576; GO:0005615; GO:0005887; GO:0007173; GO:0008083; GO:0008284; GO:0030297; GO:0030669; GO:0043406; GO:0045741; GO:0045840; GO:0050679 epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] SPYNVCSGERR 0.93152 1.0889 0 0 0 0 0 0 0 0 0 0 0 0 11.1562 0 0 0 0 0 11.6378 0 0 0 0 0 13.0786 0 0 14.0952 0 14.2318 0 0 0 0 0 15.0612 0 11.1406 0 0 0 0 0 0 14.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7363 0 0 0 0 Q9BW60 ELOV1_HUMAN "Elongation of very long chain fatty acids protein 1, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1, ELOVL FA elongase 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3-oxoacyl-CoA synthase 1)" ELOVL1 SSC1 CGI-88 Homo sapiens (Human) "alpha-linolenic acid metabolic process [GO:0036109]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; alpha-linolenic acid metabolic process [GO:0036109]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0016020; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042761; GO:0043651; GO:0046513; GO:0061436; GO:0102336; GO:0102337; GO:0102338; GO:0102756 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756] EAVVNLYQEVMKHADPR 0.93152 1.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0331 0 0 0 0 0 14.3151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8854 0 0 0 0 0 0 0 0 0 0 0 13.4355 0 0 0 0 0 0 0 0 0 P55822 SH3BG_HUMAN "SH3 domain-binding glutamic acid-rich protein, SH3BGR protein (21-glutamic acid-rich protein, 21-GARP)" SH3BGR Homo sapiens (Human) protein-containing complex assembly [GO:0065003] cytosol [GO:0005829] cytosol [GO:0005829]; SH3 domain binding [GO:0017124]; protein-containing complex assembly [GO:0065003] GO:0005829; GO:0017124; GO:0065003 SH3 domain binding [GO:0017124] NEEEGETATEETEEIAMEGAEGEAEEEEETAEGEEPGEDEDS 0.93156 1.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEE9 SAP25_HUMAN Histone deacetylase complex subunit SAP25 (25 kDa Sin3-associated polypeptide) (Sin3 corepressor complex subunit SAP25) SAP25 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0005737; GO:0006355 LLPPPPIMSARVLPRPSPSR 0.93156 1.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3453 0 0 0 0 0 0 0 0 0 0 13.1433 0 0 0 0 0 0 0 0 0 0 0 11.4336 0 14.0187 0 0 0 0 0 0 0 0 0 0 0 0 14.0393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1165 0 0 0 0 Q96S90 LYSM1_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 1 LYSMD1 SB145 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 LYTNDSIFLKKTLYIPILTEPR 0.93157 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J268 TVA4_HUMAN T cell receptor alpha variable 4 TRAV4 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 MRQVARVIVFLTLSTLSLAK 0.9316 1.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C004 SPY4_HUMAN "Protein sprouty homolog 4, Spry-4" SPRY4 Homo sapiens (Human) animal organ development [GO:0048513]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587]; protein kinase inhibitor activity [GO:0004860]; animal organ development [GO:0048513]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025] GO:0004860; GO:0005737; GO:0005829; GO:0005925; GO:0032587; GO:0040037; GO:0043407; GO:0046580; GO:0048513; GO:0070373; GO:1900025; GO:1990830 protein kinase inhibitor activity [GO:0004860] AVRIQPKVVHCQPLDLK 0.93161 1.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6227 0 0 12.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1943 0 0 0 0 0 0 0 0 13.2585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06681 CO2_HUMAN "Complement C2, EC 3.4.21.43 (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment ]" C2 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]" classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]" GO:0004252; GO:0005576; GO:0005601; GO:0005615; GO:0005886; GO:0006508; GO:0006956; GO:0006958; GO:0009617; GO:0045087; GO:0046872; GO:0050778; GO:0070062; GO:1903028; GO:2000427 metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] DFHINLFRMQPWLR 0.93162 2.1418 0 0 0 11.8729 0 0 0 0 0 0 0 0 0 0 13.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2547 14.084 0 0 0 0 0 0 0 0 0 16.1754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18146 EGR1_HUMAN "Early growth response protein 1, EGR-1 (AT225) (Nerve growth factor-induced protein A, NGFI-A) (Transcription factor ETR103) (Transcription factor Zif268) (Zinc finger protein 225) (Zinc finger protein Krox-24)" EGR1 KROX24 ZNF225 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cellular response to gamma radiation [GO:0071480]; cellular response to heparin [GO:0071504]; cellular response to interleukin-8 [GO:0098759]; cellular response to mycophenolic acid [GO:0071506]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; estrous cycle [GO:0044849]; glomerular mesangial cell proliferation [GO:0072110]; interleukin-1-mediated signaling pathway [GO:0070498]; locomotor rhythm [GO:0045475]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular metanephric mesangial cell proliferation [GO:0072303]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of protein sumoylation [GO:0033233]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; T cell differentiation [GO:0030217]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; cellular response to gamma radiation [GO:0071480]; cellular response to heparin [GO:0071504]; cellular response to interleukin-8 [GO:0098759]; cellular response to mycophenolic acid [GO:0071506]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; estrous cycle [GO:0044849]; glomerular mesangial cell proliferation [GO:0072110]; interleukin-1-mediated signaling pathway [GO:0070498]; locomotor rhythm [GO:0045475]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular metanephric mesangial cell proliferation [GO:0072303]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of protein sumoylation [GO:0033233]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to ischemia [GO:0002931]; skeletal muscle cell differentiation [GO:0035914]; T cell differentiation [GO:0030217]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0002931; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0008270; GO:0009749; GO:0010385; GO:0010628; GO:0030217; GO:0030509; GO:0032722; GO:0032731; GO:0032868; GO:0032922; GO:0033233; GO:0035035; GO:0035914; GO:0042981; GO:0043565; GO:0044729; GO:0044849; GO:0045475; GO:0045893; GO:0045944; GO:0046886; GO:0060086; GO:0061418; GO:0070498; GO:0071480; GO:0071504; GO:0071506; GO:0072110; GO:0072303; GO:0090090; GO:0098759; GO:1901216; GO:1902895; GO:1902949; GO:1990837; GO:1990841; GO:2000182 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; histone acetyltransferase binding [GO:0035035]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" ALNTSYQSQLIKPSRMR 0.93163 1.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1373 0 13.364 12.8582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2778 0 12.7158 0 14.2589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7971 0 0 0 0 13.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP70 AMBN_HUMAN Ameloblastin AMBN Homo sapiens (Human) biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of cell population proliferation [GO:0042127] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; growth factor activity [GO:0008083]; structural constituent of tooth enamel [GO:0030345]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of cell population proliferation [GO:0042127] GO:0005576; GO:0005788; GO:0007155; GO:0008083; GO:0030345; GO:0031214; GO:0042127; GO:0042475 growth factor activity [GO:0008083]; structural constituent of tooth enamel [GO:0030345] MSASKIPLFKMK 0.93164 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1032 0 0 0 14.678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14242 SELPL_HUMAN "P-selectin glycoprotein ligand 1, PSGL-1 (Selectin P ligand) (CD antigen CD162)" SELPLG Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; hemopoiesis [GO:0030097]; leukocyte adhesive activation [GO:0050902]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; uropod [GO:0001931] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; uropod [GO:0001931]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; hemopoiesis [GO:0030097]; leukocyte adhesive activation [GO:0050902]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901] GO:0001618; GO:0001931; GO:0005102; GO:0005886; GO:0005887; GO:0007155; GO:0016020; GO:0016021; GO:0030097; GO:0044853; GO:0050900; GO:0050901; GO:0050902; GO:0071354 signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618] ALGPLLARDRR 0.93165 2.0597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5305 0 0 0 14.874 0 0 0 0 0 0 13.9233 0 0 0 0 0 0 0 0 0 14.6182 0 0 0 0 0 0 0 0 0 13.8474 0 0 0 0 0 0 13.0817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1463 0 0 0 0 0 0 0 Q9NR33 DPOE4_HUMAN DNA polymerase epsilon subunit 4 (DNA polymerase II subunit 4) (DNA polymerase epsilon subunit p12) POLE4 Homo sapiens (Human) DNA-templated DNA replication [GO:0006261] ATAC complex [GO:0140672]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATAC complex [GO:0140672]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; DNA-templated DNA replication [GO:0006261] GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0008622; GO:0046982; GO:0140672 DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982] AAELFVETIAKDAYCCAQQGKR 0.93166 1.0683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4943 0 0 0 0 0 0 0 11.4863 0 0 0 0 0 0 0 0 12.0493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8357 13.9452 0 0 0 0 0 0 0 0 14.2023 0 0 0 0 0 0 0 0 0 0 14.7946 14.3649 0 0 0 0 0 0 12.4014 15.1669 0 0 15.0701 0 0 0 0 0 13.7881 14.4376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0132 0 0 0 0 0 0 0 0 0 0 0 0 14.3113 0 0 0 0 0 13.9781 0 0 0 0 0 Q15013 MD2BP_HUMAN MAD2L1-binding protein (Caught by MAD2 protein) (p31(comet)) MAD2L1BP CMT2 KIAA0110 Homo sapiens (Human) deactivation of mitotic spindle assembly checkpoint [GO:1902426]; regulation of exit from mitosis [GO:0007096] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; regulation of exit from mitosis [GO:0007096] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0007096; GO:0031965; GO:1902426 TLVPRVLILLGGNALSPK 0.93167 1.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5L3 C1QL2_HUMAN "Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10, C1q/TNF-related protein 10)" C1QL2 CTRP10 Homo sapiens (Human) collagen trimer [GO:0005581]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802] GO:0005581; GO:0005615; GO:0042802 identical protein binding [GO:0042802] ALGLLIAVPLLLQAAPR 0.93167 1.6659 0 11.8311 0 0 0 0 11.7005 0 14.7182 0 0 0 0 0 0 0 11.1406 0 0 0 10.5441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3323 0 0 9.59531 0 0 0 0 0 0 0 11.4589 0 0 0 0 0 0 0 0 0 0 11.946 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7226 0 0 0 0 0 0 11.9373 0 0 0 0 0 0 0 12.5784 0 0 0 12.5533 12.8361 0 0 0 0 12.863 0 0 0 0 0 0 0 12.6895 10.823 0 0 0 12.7461 11.1412 0 0 11.589 12.2837 12.6669 12.6237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6515 0 0 11.9195 0 0 0 0 0 0 0 0 0 0 10.1224 12.8963 0 A0PG75 PLS5_HUMAN Phospholipid scramblase family member 5 PLSCR5 Homo sapiens (Human) plasma membrane phospholipid scrambling [GO:0017121] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121] GO:0005886; GO:0017121; GO:0017128 phospholipid scramblase activity [GO:0017128] DAQNQRR 0.9317 1.0679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7863 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR28 DBLOH_HUMAN "Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase, Smac)" DIABLO SMAC Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065] GO:0005739; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0008625; GO:0008631; GO:0008635; GO:0009898; GO:0035631; GO:0043065; GO:0051402; GO:0097193 MAALKSWLSRSVTSFFR 0.93171 1.0776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5U5Q3 MEX3C_HUMAN "RNA-binding E3 ubiquitin-protein ligase MEX3C, EC 2.3.2.27 (RING finger and KH domain-containing protein 2) (RING finger protein 194) (RING-type E3 ubiquitin transferase MEX3C)" MEX3C RKHD2 RNF194 BM-013 Homo sapiens (Human) chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; chondrocyte hypertrophy [GO:0003415]; energy homeostasis [GO:0097009]; regulation of fat cell differentiation [GO:0045598] GO:0003415; GO:0003723; GO:0005634; GO:0005737; GO:0045598; GO:0046872; GO:0061630; GO:0097009 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] RTPSCPVCQTAVTQAIQIHS 0.93175 1.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4702 0 0 0 0 0 13.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00222 GRM8_HUMAN "Metabotropic glutamate receptor 8, mGluR8" GRM8 GPRC1H MGLUR8 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]" GO:0001640; GO:0001642; GO:0004930; GO:0005886; GO:0005887; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642] GVPETFNEAK 0.93176 2.3717 0 0 0 0 13.7197 0 0 0 0 0 10.7498 0 0 13.5834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9443 0 0 0 0 0 0 13.2184 13.4743 0 0 0 0 0 0 0 0 15.6075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5708 0 12.9139 0 0 0 0 0 12.667 0 0 0 0 0 0 0 0 0 13.2213 0 0 0 0 14.856 0 0 0 0 0 0 0 0 0 0 0 12.3507 0 0 14.411 0 0 0 0 14.9178 0 0 13.7514 0 0 12.6708 0 0 0 12.4959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4498 0 0 0 12.9807 0 0 0 0 0 13.7155 13.2074 0 0 0 11.266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9643 Q9NS82 AAA1_HUMAN "Asc-type amino acid transporter 1, Asc-1 (Solute carrier family 7 member 10)" SLC7A10 ASC1 Homo sapiens (Human) amino acid transport [GO:0006865]; D-alanine transport [GO:0042941]; D-serine transport [GO:0042942]; neutral amino acid transport [GO:0015804] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-serine transmembrane transporter activity [GO:0015194]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transport [GO:0006865]; D-alanine transport [GO:0042941]; D-serine transport [GO:0042942]; neutral amino acid transport [GO:0015804] GO:0005886; GO:0005887; GO:0006865; GO:0015175; GO:0015179; GO:0015194; GO:0015804; GO:0016020; GO:0042941; GO:0042942 L-amino acid transmembrane transporter activity [GO:0015179]; L-serine transmembrane transporter activity [GO:0015194]; neutral amino acid transmembrane transporter activity [GO:0015175] VALKKEIGLLSACTIIIGNIIGSGIFISPK 0.93177 1.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8075 0 0 0 0 0 0 12.0983 0 0 0 0 0 0 0 0 0 0 0 13.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43914 TYOBP_HUMAN "TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein, KAR-associated protein)" TYROBP DAP12 KARAP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; apoptotic cell clearance [GO:0043277]; apoptotic signaling pathway [GO:0097190]; cellular defense response [GO:0006968]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; microglial cell activation involved in immune response [GO:0002282]; myeloid leukocyte activation [GO:0002274]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of transforming growth factor beta1 production [GO:0032911]; neutrophil activation involved in immune response [GO:0002283]; osteoclast differentiation [GO:0030316]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast development [GO:2001206]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; protein stabilization [GO:0050821]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stimulatory killer cell immunoglobulin-like receptor signaling pathway [GO:0002222] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; apoptotic cell clearance [GO:0043277]; apoptotic signaling pathway [GO:0097190]; cellular defense response [GO:0006968]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; microglial cell activation involved in immune response [GO:0002282]; myeloid leukocyte activation [GO:0002274]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of transforming growth factor beta1 production [GO:0032911]; neutrophil activation involved in immune response [GO:0002283]; osteoclast differentiation [GO:0030316]; positive regulation of gene expression [GO:0010628]; positive regulation of hippocampal neuron apoptotic process [GO:0110090]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast development [GO:2001206]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; protein stabilization [GO:0050821]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stimulatory killer cell immunoglobulin-like receptor signaling pathway [GO:0002222] GO:0002222; GO:0002223; GO:0002274; GO:0002282; GO:0002283; GO:0005102; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0010628; GO:0016021; GO:0030036; GO:0030316; GO:0030667; GO:0030889; GO:0030900; GO:0032693; GO:0032731; GO:0032755; GO:0032760; GO:0032816; GO:0032911; GO:0032930; GO:0034241; GO:0035556; GO:0042802; GO:0042803; GO:0043277; GO:0046872; GO:0048678; GO:0050821; GO:0097190; GO:0110090; GO:1900272; GO:1901216; GO:1902685; GO:1904151; GO:2000010; GO:2001206 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] GGLEPCSRLLLLPLLLAVSGLR 0.93178 1.0617 0 0 0 0 0 0 0 0 13.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PK05 TMM72_HUMAN Transmembrane protein 72 (Kidney-specific secretory protein of 37 kDa) TMEM72 C10orf127 KSP37 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 KQVHFEDNLVR 0.93181 1.0889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7149 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3935 0 0 0 0 0 A0A0B4J240 TVA10_HUMAN T cell receptor alpha variable 10 TRAV10 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 KHLTTFLVILWLYFYR 0.93182 1.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7805 0 0 0 0 0 0 13.1196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0177 0 13.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVK2 SNR27_HUMAN "U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein, U4/U6.U5 snRNP 27 kDa protein, U4/U6.U5-27K (Nucleic acid-binding protein RY-1) (U4/U6.U5 tri-snRNP-associated 27 kDa protein, 27K) (U4/U6.U5 tri-snRNP-associated protein 3)" SNRNP27 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; nucleic acid binding [GO:0003676]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003676; GO:0005634; GO:0005654; GO:0046540 nucleic acid binding [GO:0003676] MGRSRSR 0.93183 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2201 0 0 0 0 0 0 0 0 0 0 0 0 0 11.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1058 0 0 0 O95096 NKX22_HUMAN Homeobox protein Nkx-2.2 (Homeobox protein NK-2 homolog B) NKX2-2 NKX2.2 NKX2B Homo sapiens (Human) astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; negative regulation of neuron differentiation [GO:0045665]; neuroendocrine cell differentiation [GO:0061101]; neuron fate specification [GO:0048665]; oligodendrocyte development [GO:0014003]; optic nerve development [GO:0021554]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell fate commitment [GO:0003327]; ventral spinal cord interneuron fate determination [GO:0060580] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; negative regulation of neuron differentiation [GO:0045665]; neuroendocrine cell differentiation [GO:0061101]; neuron fate specification [GO:0048665]; oligodendrocyte development [GO:0014003]; optic nerve development [GO:0021554]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell fate commitment [GO:0003327]; ventral spinal cord interneuron fate determination [GO:0060580]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003323; GO:0003326; GO:0003327; GO:0003329; GO:0005634; GO:0005654; GO:0006357; GO:0007224; GO:0007420; GO:0009749; GO:0010628; GO:0014003; GO:0021522; GO:0021530; GO:0021554; GO:0030154; GO:0030858; GO:0032570; GO:0045665; GO:0045666; GO:0048565; GO:0048665; GO:0048708; GO:0048714; GO:0060580; GO:0061101 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EHLASLIRLTPTQVKIWFQNHR 0.93185 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.638 0 0 0 0 0 0 11.4099 0 0 0 0 0 0 0 Q56P42 PYDC2_HUMAN "Pyrin domain-containing protein 2 (Pyrin-only protein 2) (cellular POP2, cPOP2)" PYDC2 POP2 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of inflammatory response [GO:0050727] GO:0005634; GO:0005737; GO:0006954; GO:0010804; GO:0032088; GO:0032691; GO:0043231; GO:0045087; GO:0050727; GO:0050728; GO:1900226; GO:1901223 ASSAELDFNLQALLEQLSQDELSKFKSLIR 0.93185 1.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60809 PRA10_HUMAN PRAME family member 10 PRAMEF10 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 DCRIQDPQLR 0.93186 1.9381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0173 0 0 0 0 0 0 0 0 0 10.4674 0 0 11.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8882 0 0 0 0 0 11.9649 0 0 0 0 0 0 13.7732 0 0 12.2037 0 0 11.8569 0 0 0 0 0 0 12.4737 11.2712 0 12.5762 0 0 0 0 12.6222 0 13.9632 0 0 Q8TEC5 SH3R2_HUMAN "E3 ubiquitin-protein ligase SH3RF2, EC 2.3.2.27 (Heart protein phosphatase 1-binding protein, HEPP1) (POSH-eliminating RING protein) (Protein phosphatase 1 regulatory subunit 39) (RING finger protein 158) (RING-type E3 ubiquitin transferase SH3RF2) (SH3 domain-containing RING finger protein 2)" SH3RF2 POSH3 POSHER PPP1R39 RNF158 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] GO:0004864; GO:0005634; GO:0005654; GO:0008157; GO:0016567; GO:0019902; GO:0030335; GO:0031397; GO:0032436; GO:0043066; GO:0046329; GO:0046330; GO:0046872; GO:0051865; GO:0061630 metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; ubiquitin protein ligase activity [GO:0061630] FNKGDIILLRR 0.93189 2.3496 0 0 0 0 0 0 0 0 0 0 0 13.3226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3641 12.1391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3787 0 0 0 13.3973 12.7697 12.4859 0 12.5008 12.0468 12.4458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9503 0 0 0 0 0 11.7999 0 0 0 0 0 11.935 0 0 0 12.3858 0 0 0 0 0 12.0585 0 0 0 0 0 11.8881 0 0 0 0 0 0 0 0 0 0 12.3951 0 0 11.7461 0 0 0 0 0 0 0 12.7347 12.7257 0 0 0 0 0 0 0 0 0 0 14.3698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04280 PRP1_HUMAN "Basic salivary proline-rich protein 1, Salivary proline-rich protein [Cleaved into: Proline-rich peptide II-2; Basic peptide IB-6; Peptide P-H ]" PRB1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 PPQGGRPSRPPQ 0.93192 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TAA8 TXIP1_HUMAN "Translin-associated factor X-interacting protein 1, Trax-interacting protein 1" TSNAXIP1 TXI1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005737; GO:0007283; GO:0030154; GO:0048471 DAWKERLAEEQK 0.93193 1.0623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8577 0 0 0 0 0 0 10.9266 0 0 0 0 0 0 0 0 11.7843 0 0 0 0 0 0 0 14.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1777 11.9169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NKF2 ARI3C_HUMAN "AT-rich interactive domain-containing protein 3C, ARID domain-containing protein 3C" ARID3C Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0045121; GO:0045944 chromatin binding [GO:0003682]; DNA binding [GO:0003677] GTPVNRVPIMAKQVLDLYALFR 0.93194 5.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3796 12.4167 0 0 0 0 16.0827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6152 0 0 12.0268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3596 0 Q96A09 TET5B_HUMAN "Terminal nucleotidyltransferase 5B, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46B)" TENT5B FAM46B Homo sapiens (Human) mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of translation [GO:0045727] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of translation [GO:0045727] GO:0004652; GO:0005634; GO:0005737; GO:0008285; GO:0043066; GO:0045727; GO:0045786; GO:0048255; GO:1990817 polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817] FFIDFPDLVEQR 0.93197 1.0567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYN0 SRXN1_HUMAN "Sulfiredoxin-1, EC 1.8.98.2" SRXN1 C20orf139 SRX SRX1 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; sulfiredoxin activity [GO:0032542]; cellular response to oxidative stress [GO:0034599]; response to oxidative stress [GO:0006979]" GO:0005524; GO:0005737; GO:0005829; GO:0006979; GO:0016667; GO:0032542; GO:0034599 "ATP binding [GO:0005524]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; sulfiredoxin activity [GO:0032542]" IAAVHNVPLSVLIRPLPSVLDPAK 0.93197 1.0816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9443 0 0 0 0 0 0 0 0 0 0 0 13.89 0 0 13.2296 0 14.1893 0 0 0 13.6428 0 0 0 0 0 0 0 0 0 13.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3664 0 0 0 0 0 0 12.7498 0 0 12.3141 0 0 0 0 Q9H2T7 RBP17_HUMAN Ran-binding protein 17 RANBP17 Homo sapiens (Human) mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] GO:0005049; GO:0005525; GO:0005643; GO:0005737; GO:0006606; GO:0006611; GO:0031267; GO:0051028 GTP binding [GO:0005525]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] AKYLGNLIKGVK 0.93198 2.3641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0279 0 0 0 11.6786 0 13.8799 0 13.1359 0 0 0 12.0484 0 0 0 0 11.019 0 0 0 0 15.1672 15.1551 14.6797 0 0 16.8179 0 0 0 0 0 0 0 0 13.4218 14.4355 0 0 0 13.4396 0 0 0 13.5537 0 0 0 0 14.7317 0 0 0 0 0 11.7712 0 0 0 0 14.8622 0 0 0 0 13.8823 14.6622 0 0 0 0 0 0 0 0 0 0 0 0 14.845 0 0 13.5327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1808 0 14.6413 0 14.3 0 0 0 0 0 0 Q9UGB7 MIOX_HUMAN "Inositol oxygenase, EC 1.13.99.1 (Aldehyde reductase-like 6) (Kidney-specific protein 32) (Myo-inositol oxygenase, MI oxygenase) (Renal-specific oxidoreductase)" MIOX ALDRL6 KSP32 RSOR Homo sapiens (Human) inositol catabolic process [GO:0019310] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701]; inositol catabolic process [GO:0019310]" GO:0004033; GO:0005737; GO:0005829; GO:0008199; GO:0016234; GO:0016651; GO:0016701; GO:0019310; GO:0050113 "aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701]" FDLYTKCPDLPDVDK 0.93206 1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9957 0 0 0 0 0 0 0 0 0 0 0 0 13.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYR3 KRA44_HUMAN Keratin-associated protein 4-4 (Keratin-associated protein 4-13) (Keratin-associated protein 4.13) (Keratin-associated protein 4.4) (Ultrahigh sulfur keratin-associated protein 4.13) (Ultrahigh sulfur keratin-associated protein 4.4) KRTAP4-4 KAP4.13 KAP4.4 KRTAP4-13 KRTAP4.13 KRTAP4.4 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MVNSCCGSVCSDQGCGLENCCR 0.93207 4.0588 14.7767 11.2337 0 0 10.5873 0 0 0 0 11.0137 0 0 0 0 13.0851 0 0 0 0 0 12.0639 0 0 0 0 0 10.7692 13.5745 12.3673 13.5348 12.7535 12.6064 0 11.7754 11.404 0 0 0 0 12.5583 11.0703 0 0 0 0 10.4859 0 0 0 13.5119 0 10.6385 13.4332 13.4186 0 0 11.3926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2649 0 12.4913 12.4225 0 13.9854 13.5831 13.687 0 15.3581 0 13.1755 0 12.443 11.3833 11.5222 12.1264 0 12.2182 11.3462 0 0 0 0 0 13.2431 14.9908 14.297 0 11.5971 12.2703 14.0372 0 11.9257 0 12.5623 0 13.8 0 0 13.4294 0 0 12.535 0 13.6563 0 0 0 11.9497 10.938 0 11.4938 13.0592 0 0 0 0 12.0396 14.311 13.0662 12.0643 12.0077 0 0 0 0 12.5882 0 0 0 13.4274 13.1974 0 0 11.3754 0 0 0 0 12.218 0 0 12.8031 0 11.8541 0 0 0 13.4299 0 0 0 0 12.3767 10.2398 13.4699 0 0 0 0 11.301 12.2556 0 A5X5Y0 5HT3E_HUMAN "5-hydroxytryptamine receptor 3E, 5-HT3-E, 5-HT3E (Serotonin receptor 3E)" HTR3E Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0098662; GO:1904315; GO:1904602 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] AQREHEAQKQHSVELWLQFSHAMDAMLFR 0.9321 1.0785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2101 0 0 0 0 0 0 0 0 0 0 14.4538 0 0 0 0 14.9242 15.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MX0 CKLF3_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 3 (Chemokine-like factor superfamily member 3) CMTM3 CKLFSF3 Homo sapiens (Human) blastocyst hatching [GO:0001835]; chemotaxis [GO:0006935]; positive regulation of B cell receptor signaling pathway [GO:0050861] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; cytokine activity [GO:0005125]; blastocyst hatching [GO:0001835]; chemotaxis [GO:0006935]; positive regulation of B cell receptor signaling pathway [GO:0050861] GO:0001835; GO:0005125; GO:0005615; GO:0005829; GO:0006935; GO:0016021; GO:0031410; GO:0031965; GO:0050861 cytokine activity [GO:0005125] ALLPARAFLCSLK 0.93215 1.0783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1432 0 0 0 11.7113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6727 0 0 0 0 0 12.7574 0 0 0 0 12.8097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6925 0 Q9Y6E7 SIR4_HUMAN "NAD-dependent protein lipoamidase sirtuin-4, mitochondrial, EC 2.3.1.- (NAD-dependent ADP-ribosyltransferase sirtuin-4, EC 2.4.2.-) (NAD-dependent protein biotinylase sirtuin-4, EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-4, EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4)" SIRT4 SIR2L4 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; glutamine metabolic process [GO:0006541]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; deacetylase activity [GO:0019213]; lipoamidase activity [GO:0061690]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein biotinidase activity [GO:0106420]; NAD-dependent protein lipoamidase activity [GO:0106419]; protein lysine deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; glutamine metabolic process [GO:0006541]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350] GO:0000820; GO:0003950; GO:0005739; GO:0005743; GO:0005759; GO:0006471; GO:0006476; GO:0006541; GO:0006974; GO:0007005; GO:0008270; GO:0010667; GO:0019213; GO:0033558; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0061690; GO:0070403; GO:0071456; GO:0072350; GO:0106419; GO:0106420; GO:1903217; GO:1904182 deacetylase activity [GO:0019213]; lipoamidase activity [GO:0061690]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein biotinidase activity [GO:0106420]; NAD-dependent protein lipoamidase activity [GO:0106419]; protein lysine deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270] KLPIAILNIGPTR 0.93216 2.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.749 0 0 12.6023 0 0 0 0 0 0 0 0 13.1539 13.7275 0 0 13.3938 0 0 0 0 0 0 0 0 0 13.3174 0 13.8124 0 0 0 0 0 0 0 13.5841 0 0 0 13.0197 12.5316 13.1192 0 0 0 13.2314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2738 0 0 0 0 0 0 0 0 Q2QL34 MP17L_HUMAN "Mpv17-like protein (M-LP homolog, M-LPH)" MPV17L Homo sapiens (Human) negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; reactive oxygen species metabolic process [GO:0072593] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; reactive oxygen species metabolic process [GO:0072593] GO:0005737; GO:0005739; GO:0005777; GO:0005778; GO:0010730; GO:0016021; GO:0043231; GO:0072593; GO:1901029 LQGREANWRQTR 0.93218 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2799 0 0 0 0 0 0 0 0 0 0 12.472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VXF1 F74A3_HUMAN Putative protein FAM74A3 FAM74A3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RRAESSEAVPEK 0.9322 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3004 19.2766 19.3053 0 0 0 0 0 0 0 0 0 0 0 19.1254 0 0 0 19.0896 0 0 18.8927 19.081 0 0 0 0 0 0 0 0 19.2698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8831 0 0 0 0 0 0 0 Q5VVB8 TM244_HUMAN Transmembrane protein 244 TMEM244 C6orf191 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALQVRVAPSKVVLQK 0.93224 2.0605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7566 0 0 12.6691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02818 OSTCN_HUMAN "Osteocalcin (Bone Gla protein, BGP) (Gamma-carboxyglutamic acid-containing protein)" BGLAP Homo sapiens (Human) aging [GO:0007568]; bone development [GO:0060348]; bone mineralization [GO:0030282]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; cellular response to vitamin D [GO:0071305]; odontogenesis [GO:0042476]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of osteoclast differentiation [GO:0045670]; response to activity [GO:0014823]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to gravity [GO:0009629]; response to hydroxyisoflavone [GO:0033594]; response to mechanical stimulus [GO:0009612]; response to testosterone [GO:0033574]; response to vitamin D [GO:0033280]; response to vitamin K [GO:0032571]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; skeletal system development [GO:0001501]; stem cell differentiation [GO:0048863] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; perikaryon [GO:0043204]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; perikaryon [GO:0043204]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; hydroxyapatite binding [GO:0046848]; structural constituent of bone [GO:0008147]; structural molecule activity [GO:0005198]; aging [GO:0007568]; bone development [GO:0060348]; bone mineralization [GO:0030282]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; cellular response to vitamin D [GO:0071305]; odontogenesis [GO:0042476]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of osteoclast differentiation [GO:0045670]; response to activity [GO:0014823]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to gravity [GO:0009629]; response to hydroxyisoflavone [GO:0033594]; response to mechanical stimulus [GO:0009612]; response to testosterone [GO:0033574]; response to vitamin D [GO:0033280]; response to vitamin K [GO:0032571]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; skeletal system development [GO:0001501]; stem cell differentiation [GO:0048863] GO:0001501; GO:0001649; GO:0002076; GO:0005198; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005791; GO:0005796; GO:0007155; GO:0007568; GO:0008147; GO:0009410; GO:0009612; GO:0009629; GO:0010043; GO:0014823; GO:0030282; GO:0030425; GO:0030500; GO:0031982; GO:0032571; GO:0033280; GO:0033574; GO:0033594; GO:0042476; GO:0043204; GO:0043627; GO:0045124; GO:0045471; GO:0045670; GO:0046848; GO:0048863; GO:0051384; GO:0060348; GO:0071305; GO:0071363; GO:1900076 calcium ion binding [GO:0005509]; hydroxyapatite binding [GO:0046848]; structural constituent of bone [GO:0008147]; structural molecule activity [GO:0005198] RALTLLALLALAALCIAGQAGAK 0.93225 1.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0861 11.8516 0 0 0 11.6378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92556 ELMO1_HUMAN Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament-based process [GO:0030029]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of catalytic activity [GO:0050790]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; actin filament-based process [GO:0030029]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of catalytic activity [GO:0050790]" GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016477; GO:0016601; GO:0017124; GO:0030029; GO:0030036; GO:0032045; GO:0048870; GO:0050790 SH3 domain binding [GO:0017124] DIIFELRR 0.93225 4.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1128 0 0 0 0 0 0 0 0 0 0 15.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4003 0 0 0 0 0 13.5291 0 0 0 0 0 0 12.2785 19.006 0 0 0 0 11.7194 0 0 15.1707 0 0 0 0 0 0 14.4154 0 0 0 13.6552 0 14.5361 0 0 0 0 0 13.005 0 0 0 0 14.9911 15.3231 13.556 0 0 0 0 0 13.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8597 0 0 0 0 0 0 13.0274 12.994 0 0 0 0 0 0 0 0 0 0 0 0 15.695 Q9NVX0 HAUS2_HUMAN "HAUS augmin-like complex subunit 2 (Centrosomal protein of 27 kDa, Cep27)" HAUS2 C15orf25 CEP27 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule nucleation [GO:0007020]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule nucleation [GO:0007020]; spindle assembly [GO:0051225] GO:0005813; GO:0005829; GO:0007020; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:1990498 TVSCFVNFTRLQQITNIQAEIYQK 0.93227 1.0816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5831 0 0 0 10.9111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3854 10.4013 0 0 0 0 0 0 0 9.23829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMI3 GLDN_HUMAN Gliomedin [Cleaved into: Gliomedin shedded ectodomain ] GLDN COLM UNQ9339/PRO34011 Homo sapiens (Human) clustering of voltage-gated sodium channels [GO:0045162]; microvillus organization [GO:0032528]; signal transduction [GO:0007165] axon [GO:0030424]; cell surface [GO:0009986]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; cell surface [GO:0009986]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; clustering of voltage-gated sodium channels [GO:0045162]; microvillus organization [GO:0032528]; signal transduction [GO:0007165] GO:0005581; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0016021; GO:0030424; GO:0032528; GO:0045162; GO:0086080 protein binding involved in heterotypic cell-cell adhesion [GO:0086080] EDSALRSFLAELSRAPR 0.93231 1.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIL9 CRAS1_HUMAN Putative uncharacterized protein CRYM-AS1 (CRYM antisense RNA 1) (CRYM antisense gene protein 1) CRYM-AS1 NCRNA00169 Homo sapiens (Human) lipid transport [GO:0006869] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ABC-type transporter activity [GO:0140359]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869] GO:0005319; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0140359 ABC-type transporter activity [GO:0140359]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] RCIALVVEMVLTFLFSAALLATRSVITINK 0.93232 1.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0142 14.4653 0 0 0 0 0 0 0 15.5113 0 14.701 0 0 14.2326 15.4988 0 0 0 15.1806 15.4235 15.0826 0 14.1767 0 0 0 14.3457 0 13.9175 14.0836 0 0 0 0 0 0 0 0 15.394 0 0 0 0 0 0 0 13.6215 0 14.2624 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRR5 UBQL4_HUMAN "Ubiquilin-4 (Ataxin-1 interacting ubiquitin-like protein, A1Up) (Ataxin-1 ubiquitin-like-interacting protein A1U) (Connexin43-interacting protein of 75 kDa, CIP75)" UBQLN4 C1orf6 CIP75 UBIN Homo sapiens (Human) autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005789; GO:0005829; GO:0006281; GO:0006511; GO:0006914; GO:0006974; GO:0031410; GO:0031593; GO:0032434; GO:0032991; GO:0036435; GO:0042802; GO:0048471; GO:0090734; GO:1901097; GO:2000042 identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593] AEPSGAETRPPIRVTVK 0.93233 1.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15256 PTPRR_HUMAN "Receptor-type tyrosine-protein phosphatase R, R-PTP-R, EC 3.1.3.48 (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1)" PTPRR ECPTP PTPRQ Homo sapiens (Human) ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; ERBB2 signaling pathway [GO:0038128]; in utero embryonic development [GO:0001701]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] GO:0001701; GO:0004725; GO:0005001; GO:0005615; GO:0005829; GO:0005886; GO:0006470; GO:0007165; GO:0010633; GO:0016021; GO:0019901; GO:0030054; GO:0035335; GO:0038128; GO:0048471; GO:0070373 protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] EKVAMEYLQSASR 0.93234 2.0925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6512 0 0 0 0 0 11.789 0 0 0 0 11.3303 14.8937 0 0 14.7443 0 0 0 0 0 0 0 15.419 0 0 0 0 0 0 12.8919 0 0 0 0 0 0 0 0 0 0 0 0 12.8516 14.7282 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9495 14.4754 0 13.2279 0 0 0 14.3535 0 0 0 0 0 0 14.2568 18.1715 0 14.1848 15.1327 15.0044 0 0 0 0 12.3108 14.2293 0 15.903 0 14.995 0 0 0 15.5355 14.9289 0 14.1816 12.9058 0 0 0 0 0 0 0 0 0 0 0 0 13.6325 0 0 0 0 0 0 0 0 Q9UBP8 KAAG1_HUMAN Kidney-associated antigen 1 (RU2 antisense gene protein) KAAG1 RU2AS Homo sapiens (Human) immune response [GO:0006955] immune response [GO:0006955] GO:0006955 TQGAGSPPETNEKLTNPQVKEK 0.93237 1.0628 0 0 0 0 0 0 0 0 0 10.7449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YU5 BWNIN_HUMAN Protein BRAWNIN BRAWNIN BR C12orf73 Homo sapiens (Human) mitochondrial respiratory chain complex III assembly [GO:0034551] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex III assembly [GO:0034551] GO:0005739; GO:0005743; GO:0016021; GO:0034551 RGELKTELLGLK 0.93244 1.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2I3 FAH2B_HUMAN "Fumarylacetoacetate hydrolase domain-containing protein 2B, EC 3.-.-.-" FAHD2B Homo sapiens (Human) hydro-lyase activity [GO:0016836]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] GO:0016787; GO:0016836; GO:0046872 hydro-lyase activity [GO:0016836]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] RRLLTALLQAQK 0.93246 1.06 0 0 0 0 0 0 0 0 12.7678 0 0 0 0 0 11.6452 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2778 0 0 0 0 0 0 13.2147 0 0 0 0 0 0 0 0 0 0 9.59184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7324 0 0 0 0 0 12.3052 11.2969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99653 CHP1_HUMAN Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22) CHP1 CHP Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860]; cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; potassium ion transport [GO:0006813]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453]; regulation of neuron death [GO:1901214]; small GTPase mediated signal transduction [GO:0007264] GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0005925; GO:0006469; GO:0006611; GO:0006813; GO:0007264; GO:0008017; GO:0010923; GO:0015459; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0048306; GO:0050821; GO:0051222; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070062; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1901214 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; potassium channel regulator activity [GO:0015459]; protein kinase inhibitor activity [GO:0004860] IINAFFPEGEDQVNFR 0.93248 1.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2405 0 0 0 0 0 12.7937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQL6 HDAC5_HUMAN "Histone deacetylase 5, HD5, EC 3.5.1.98 (Antigen NY-CO-9)" HDAC5 KIAA0600 Homo sapiens (Human) "B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of myotube differentiation [GO:0010830]; regulation of protein binding [GO:0043393]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor binding [GO:0001222]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of myotube differentiation [GO:0010830]; regulation of protein binding [GO:0043393]" GO:0000118; GO:0000122; GO:0000978; GO:0001222; GO:0004407; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006338; GO:0006476; GO:0006954; GO:0010830; GO:0010832; GO:0016575; GO:0016607; GO:0030183; GO:0031507; GO:0032869; GO:0033558; GO:0040029; GO:0042113; GO:0042802; GO:0042826; GO:0043393; GO:0045892; GO:0045944; GO:0046872; GO:0051091; GO:0061629; GO:0090051; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor binding [GO:0001222] EGSTESESTQEDLEEEDEEDDGEEEEDCIQVK 0.93248 1.0577 0 0 0 0 0 0 0 0 12.5244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6048 0 0 0 0 0 0 0 0 0 0 0 12.0901 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3953 0 0 0 0 0 0 0 0 13.4549 0 0 0 14.4792 0 0 12.1253 0 0 0 0 0 0 0 0 0 0 0 0 11.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4365 0 12.8005 12.1875 0 13.0128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VYS4 MEDAG_HUMAN "Mesenteric estrogen-dependent adipogenesis protein (Activated in W/Wv mouse stomach 3 homolog, hAWMS3) (Mesenteric estrogen-dependent adipose 4, MEDA-4)" MEDAG AWMS3 C13orf33 MEDA4 Homo sapiens (Human) positive regulation of fat cell differentiation [GO:0045600] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; positive regulation of fat cell differentiation [GO:0045600] GO:0005737; GO:0045600 ETILSKPMLFFINVQTKK 0.93249 1.055 0 0 0 0 0 0 0 0 13.9255 0 0 0 12.2682 0 0 0 13.2568 0 0 12.428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9451 0 0 0 0 15.066 0 0 0 0 0 0 0 0 0 0 0 0 Q1ED39 KNOP1_HUMAN Lysine-rich nucleolar protein 1 (Protein FAM191A) (Testis-specific gene 118 protein) KNOP1 C16orf88 FAM191A TSG118 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730]; RNA binding [GO:0003723] GO:0003723; GO:0005730 RNA binding [GO:0003723] LKFLRLMGGFK 0.93252 2.3723 10.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6371 0 0 0 0 0 0 0 0 0 0 0 0 11.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.196 0 12.7081 0 0 0 0 0 0 0 0 0 12.0207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZD4 DCP1B_HUMAN "mRNA-decapping enzyme 1B, EC 3.6.1.62" DCP1B Homo sapiens (Human) "deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of catalytic activity [GO:0043085]" GO:0000184; GO:0000290; GO:0000932; GO:0003729; GO:0005634; GO:0005829; GO:0008047; GO:0016020; GO:0016787; GO:0031087; GO:0043085; GO:0043231 enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729] GRDISLAALQRHDPYINR 0.93252 1.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54707 AT12A_HUMAN "Potassium-transporting ATPase alpha chain 2 (HK alpha 2) (Non-gastric H(+)/K(+) ATPase subunit alpha, EC 7.2.2.19) (Non-gastric Na(+)/K(+) ATPase subunit alpha, EC 7.2.2.13) (Proton pump) (Sodium pump)" ATP12A ATP1AL1 Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sodium ion export across plasma membrane [GO:0036376] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; potassium:proton exchanging ATPase complex [GO:0005889] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; potassium:proton exchanging ATPase complex [GO:0005889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; sodium ion export across plasma membrane [GO:0036376] GO:0005391; GO:0005524; GO:0005829; GO:0005886; GO:0005889; GO:0006883; GO:0006885; GO:0008900; GO:0015629; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030007; GO:0036376; GO:0046872; GO:1902600; GO:1990573 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391] CSTIMINGEEHPLDK 0.93254 3.5699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.248 0 0 0 0 0 12.3605 0 0 0 0 0 0 0 0 0 0 0 13.8791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5048 0 0 0 12.8409 0 0 0 0 0 12.8189 0 0 0 0 0 0 12.3236 12.7966 0 12.6359 0 0 0 0 0 0 Q9BR11 ZSWM1_HUMAN Zinc finger SWIM domain-containing protein 1 ZSWIM1 C20orf162 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; zinc ion binding [GO:0008270] GO:0005634; GO:0008270 zinc ion binding [GO:0008270] EDTEGLAQMFQVFKKFNPAWER 0.93255 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1561 0 0 0 0 0 0 0 0 11.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0758 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQA5 TRPV5_HUMAN "Transient receptor potential cation channel subfamily V member 5, TrpV5 (Calcium transport protein 2, CaT2) (Epithelial calcium channel 1, ECaC, ECaC1) (Osm-9-like TRP channel 3, OTRPC3)" TRPV5 ECAC1 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809] GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0016324; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0070588; GO:0098703 calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872] ILESPLLRASKENDLSVLR 0.93255 1.6661 0 0 0 10.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2283 0 0 14.2447 14.1357 13.1118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SL1 DIRC2_HUMAN Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2) SLC49A4 DIRC2 Homo sapiens (Human) integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765] GO:0005765; GO:0016021; GO:0043231 GLRITVLLTSFLMVLGTGLRCIPISDLILK 0.9326 1.0569 0 0 0 0 0 0 0 0 13.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2V0 CDIN1_HUMAN CDAN1-interacting nuclease 1 (Protein HH114) CDIN1 C15orf41 Homo sapiens (Human) erythrocyte differentiation [GO:0030218] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; erythrocyte differentiation [GO:0030218] GO:0005634; GO:0005737; GO:0030218 AQYDEIAQCLVSVPPTRQSLRK 0.93265 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0958 0 11.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6956 0 0 0 0 0 0 11.856 0 0 0 0 0 0 12.1999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J1U7 HV601_HUMAN Immunoglobulin heavy variable 6-1 IGHV6-1 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] GLEWLGRTYYRSK 0.93268 1.8501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4542 15.2358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2356 0 12.9928 0 0 0 0 12.4668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5385 0 0 0 0 0 0 0 0 0 0 0 0 O43708 MAAI_HUMAN "Maleylacetoacetate isomerase, MAAI, EC 5.2.1.2 (GSTZ1-1) (Glutathione S-transferase zeta 1, EC 2.5.1.18)" GSTZ1 MAAI Homo sapiens (Human) glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005829; GO:0006559; GO:0006572; GO:0006749; GO:0016034; GO:0042802; GO:0042803 glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; maleylacetoacetate isomerase activity [GO:0016034]; protein homodimerization activity [GO:0042803] IALALKGIDYKTVPINLIK 0.93268 2.0968 0 0 14.6211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ89 F110A_HUMAN Protein FAM110A FAM110A C20orf55 F10 Homo sapiens (Human) cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922] GO:0000922; GO:0005737; GO:0005815 LRTRVPGYLLR 0.9327 2.1461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7358 0 0 0 0 0 0 0 0 0 0 14.6919 0 0 0 0 0 0 0 0 0 13.5148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MA1 DMRTB_HUMAN Doublesex- and mab-3-related transcription factor B1 DMRTB1 Homo sapiens (Human) germ cell development [GO:0007281]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; germ cell development [GO:0007281]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007281; GO:0007548; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CYLISERQKIMAAQK 0.93277 2.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.662 11.6367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43488 ARK72_HUMAN "Aflatoxin B1 aldehyde reductase member 2, EC 1.1.1.n11 (AFB1 aldehyde reductase 1, AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase, SSA reductase)" AKR7A2 AFAR AFAR1 AKR7 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular aldehyde metabolic process [GO:0006081]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; electron transfer activity [GO:0009055]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]; carbohydrate metabolic process [GO:0005975]; cellular aldehyde metabolic process [GO:0006081]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629]" GO:0004032; GO:0004033; GO:0005737; GO:0005794; GO:0005829; GO:0005975; GO:0006081; GO:0006629; GO:0009055; GO:0019119; GO:0044597; GO:0044598; GO:0070062 "alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; electron transfer activity [GO:0009055]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]" QPVGRFFGNSWAETYRNR 0.9328 1.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8306 0 0 0 0 0 0 0 0 0 Q96FF9 CDCA5_HUMAN Sororin (Cell division cycle-associated protein 5) (p35) CDCA5 Homo sapiens (Human) cell division [GO:0051301]; double-strand break repair [GO:0006302]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of exit from mitosis [GO:0031536]; regulation of cohesin loading [GO:0071922] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; protein-containing complex binding [GO:0044877]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of exit from mitosis [GO:0031536]; regulation of cohesin loading [GO:0071922]" GO:0000278; GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006302; GO:0007064; GO:0007076; GO:0007080; GO:0031536; GO:0044877; GO:0051301; GO:0071922 chromatin binding [GO:0003682]; protein-containing complex binding [GO:0044877] APSPTKPLRR 0.93281 1.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8165 12.7377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9526 0 0 13.3083 0 0 0 13.6407 0 0 14.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12765 SCRN1_HUMAN Secernin-1 SCRN1 KIAA0193 Homo sapiens (Human) exocytosis [GO:0006887]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887]; proteolysis [GO:0006508] GO:0005634; GO:0005737; GO:0006508; GO:0006887; GO:0016805; GO:0031965; GO:0070004 cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805] AHEWARAIIESDQEQGR 0.93282 1.0547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5466 0 0 0 0 0 0 0 0 0 0 13.5487 0 0 0 0 0 0 0 0 0 0 0 0 11.6574 0 0 0 0 0 0 0 0 0 14.4969 0 0 0 0 0 0 0 0 0 0 P78385 KRT83_HUMAN "Keratin, type II cuticular Hb3 (Hair keratin K2.10) (Keratin-83, K83) (Type II hair keratin Hb3) (Type-II keratin Kb23)" KRT83 KRTHB3 Homo sapiens (Human) aging [GO:0007568]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular space [GO:0005615]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; aging [GO:0007568]; epidermis development [GO:0008544]; hair cycle [GO:0042633]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005615; GO:0005829; GO:0007568; GO:0008544; GO:0030280; GO:0031424; GO:0042633; GO:0045095; GO:0045109 structural constituent of skin epidermis [GO:0030280] FLEQQNK 0.93283 1.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5923 0 13.1757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6F1 CLD19_HUMAN Claudin-19 CLDN19 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; neuronal action potential propagation [GO:0019227]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transepithelial transport [GO:0150111]; response to stimulus [GO:0050896]; visual perception [GO:0007601] apical junction complex [GO:0043296]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical junction complex [GO:0043296]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; actin cytoskeleton reorganization [GO:0031532]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; neuronal action potential propagation [GO:0019227]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transepithelial transport [GO:0150111]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0001934; GO:0005198; GO:0005634; GO:0005886; GO:0005923; GO:0007155; GO:0007601; GO:0008285; GO:0010628; GO:0010629; GO:0016021; GO:0016323; GO:0016338; GO:0019227; GO:0030336; GO:0031532; GO:0042802; GO:0043296; GO:0048471; GO:0050896; GO:0061045; GO:0070830; GO:0150111; GO:1901890 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] ALMVVAVLLGFVAMVLSVVGMKCTR 0.93283 2.0607 0 0 0 0 0 0 0 0 0 0 0 13.3533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0575 15.0557 0 0 0 0 0 0 0 0 0 14.0242 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0941 0 0 0 0 Q96QK8 SIM14_HUMAN Small integral membrane protein 14 SMIM14 C4orf34 Homo sapiens (Human) blastocyst hatching [GO:0001835] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; blastocyst hatching [GO:0001835] GO:0001835; GO:0005783; GO:0005789; GO:0016021 AEGGFDPCECVCSHEHAMRR 0.93283 1.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2798 0 0 0 0 0 11.4836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0203 0 0 0 0 12.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40225 TPO_HUMAN "Thrombopoietin (C-mpl ligand, ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor, MGDF) (Myeloproliferative leukemia virus oncogene ligand)" THPO MGDF Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to lipopolysaccharide [GO:0071222]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; receptor signaling pathway via STAT [GO:0097696]; thrombopoietin-mediated signaling pathway [GO:0038163] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; cell population proliferation [GO:0008283]; cellular response to lipopolysaccharide [GO:0071222]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; receptor signaling pathway via STAT [GO:0097696]; thrombopoietin-mediated signaling pathway [GO:0038163] GO:0001934; GO:0005102; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0008083; GO:0008283; GO:0008284; GO:0030219; GO:0035855; GO:0038163; GO:0043410; GO:0045654; GO:0051897; GO:0070374; GO:0071222; GO:0097696; GO:1902035 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102] LLLGALQSLLGTQLPPQGRTTAHK 0.93285 1.0816 0 0 0 0 0 10.3853 0 0 0 0 0 0 0 0 11.8193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9248 0 0 0 13.1371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2051 0 0 0 0 0 12.6152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2767 0 0 0 0 0 0 P20036 DPA1_HUMAN "HLA class II histocompatibility antigen, DP alpha 1 chain (DP(W3)) (DP(W4)) (HLA-SB alpha chain) (MHC class II DP3-alpha) (MHC class II DPA1)" HLA-DPA1 HLA-DP1A HLASB Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to interferon-gamma [GO:0071346]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to interferon-gamma [GO:0071346]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102] GO:0000139; GO:0002250; GO:0002503; GO:0005765; GO:0005886; GO:0005887; GO:0006955; GO:0009986; GO:0010008; GO:0012507; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0032395; GO:0032588; GO:0032729; GO:0042102; GO:0042605; GO:0042613; GO:0043231; GO:0050870; GO:0071346; GO:0071556 MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605] AVILRALSLAFLLSLRGAGAIK 0.93286 2.0945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.758 0 0 0 0 0 0 0 0 0 15.5898 14.3325 0 0 0 0 0 0 0 16.3979 0 0 0 0 14.9139 0 0 16.556 0 0 0 14.7445 0 0 0 0 15.5326 0 15.5444 14.0202 0 0 0 0 16.04 0 16.0615 0 0 14.7458 0 14.4545 0 0 0 0 0 0 0 0 0 0 14.9043 0 15.0271 0 0 14.9461 16.7638 0 0 0 0 0 0 0 0 0 14.4334 0 0 0 0 0 15.9136 0 14.5106 0 0 15.2353 0 0 14.166 0 0 0 0 14.7397 0 15.8601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5065 0 0 0 0 0 14.5829 0 O60739 EIF1B_HUMAN "Eukaryotic translation initiation factor 1b, eIF1b (Protein translation factor SUI1 homolog GC20)" EIF1B Homo sapiens (Human) regulation of translational initiation [GO:0006446] eukaryotic 43S preinitiation complex [GO:0016282] eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446] GO:0003723; GO:0003743; GO:0006446; GO:0016282; GO:0043024 ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GDDLLPAGTEDYIHIRIQQRNGR 0.93287 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRQ2 PLS4_HUMAN "Phospholipid scramblase 4, PL scramblase 4 (Ca(2+)-dependent phospholipid scramblase 4) (Cell growth-inhibiting gene 43 protein) (TRA1)" PLSCR4 GIG43 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; plasma membrane phospholipid scrambling [GO:0017121] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; enzyme binding [GO:0019899]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; cellular response to lipopolysaccharide [GO:0071222]; plasma membrane phospholipid scrambling [GO:0017121] GO:0005509; GO:0005886; GO:0016021; GO:0017121; GO:0017124; GO:0017128; GO:0019899; GO:0042609; GO:0071222 calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; enzyme binding [GO:0019899]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124] CTCCCFCCPSAR 0.93287 1.0853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3515 0 10.7045 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9279 0 0 0 10.9732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUX7 LHPL2_HUMAN LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein) LHFPL2 KIAA0206 Homo sapiens (Human) development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338] GO:0005886; GO:0007338; GO:0016020; GO:0016021; GO:0031092; GO:0046545; GO:0046546; GO:1905516 SRGGVEPAGPGGGSPEPYHPTLGIYARCIR 0.93288 1.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5237 0 0 0 0 0 0 0 0 0 0 11.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K0S8 ME3L2_HUMAN Putative homeobox protein Meis3-like 2 MEIS3P2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0005634; GO:0006357; GO:0007420; GO:0008284; GO:0009880; GO:0009887; GO:0045944 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KRGIFPK 0.93289 1.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53367 ARFP1_HUMAN Arfaptin-1 (ADP-ribosylation factor-interacting protein 1) ARFIP1 Homo sapiens (Human) "intracellular protein transport [GO:0006886]; negative regulation of retrograde transport, endosome to Golgi [GO:1905280]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein secretion [GO:0050708]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; intracellular protein transport [GO:0006886]; negative regulation of retrograde transport, endosome to Golgi [GO:1905280]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein secretion [GO:0050708]" GO:0000139; GO:0005543; GO:0005829; GO:0006886; GO:0019904; GO:0032588; GO:0034315; GO:0050708; GO:0070273; GO:1905280 phosphatidylinositol-4-phosphate binding [GO:0070273]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904] SGPVILADEIKNPAMEKLELVR 0.93289 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8669 14.2173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0185 13.3542 13.4555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN76 S6A14_HUMAN Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14) SLC6A14 Homo sapiens (Human) alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; response to toxic substance [GO:0009636]; sodium ion transmembrane transport [GO:0035725] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293]; alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; response to toxic substance [GO:0009636]; sodium ion transmembrane transport [GO:0035725] GO:0003333; GO:0005886; GO:0005887; GO:0006865; GO:0009636; GO:0015171; GO:0015293; GO:0016021; GO:0022858; GO:0031982; GO:0032328; GO:0035725; GO:0070062; GO:0089718 alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; symporter activity [GO:0015293] NCSSWSDKNCSRSPIVTHCNVSTVNK 0.93292 1.6681 0 0 0 0 0 10.6292 0 0 0 0 0 12.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 11.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0621 0 0 10.7479 0 0 13.4906 0 0 0 0 0 0 0 0 0 0 0 0 14.1801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7889 0 0 0 0 0 0 0 13.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVG9 HUNIN_HUMAN "Humanin (Humanin mitochondrial, HNM)" MT-RNR2 HN Homo sapiens (Human) apoptotic process [GO:0006915]; cellular iron ion homeostasis [GO:0006879]; cellular response to amyloid-beta [GO:1904646]; leukocyte chemotaxis [GO:0030595]; mitochondrion organization [GO:0007005]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of response to oxidative stress [GO:1902883]; supramolecular fiber organization [GO:0097435] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; cellular iron ion homeostasis [GO:0006879]; cellular response to amyloid-beta [GO:1904646]; leukocyte chemotaxis [GO:0030595]; mitochondrion organization [GO:0007005]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of response to oxidative stress [GO:1902883]; supramolecular fiber organization [GO:0097435] GO:0001664; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0006879; GO:0006915; GO:0007005; GO:0030595; GO:0032692; GO:0032701; GO:0036126; GO:0042802; GO:0043066; GO:0043524; GO:0043621; GO:0048019; GO:0048471; GO:0050728; GO:0097225; GO:0097435; GO:0150079; GO:1900118; GO:1900226; GO:1901215; GO:1902883; GO:1904646; GO:1905907 G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102] MAPRGFSCLLLLTSEIDLPVKR 0.93293 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9F8 ZN454_HUMAN Zinc finger protein 454 ZNF454 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFHQSTHLIHHQR 0.93294 2.0925 0 0 0 0 0 0 0 0 12.4097 0 0 0 0 0 0 0 0 0 12.4318 0 12.7115 0 0 0 0 0 0 0 0 0 0 12.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9614 0 0 0 0 0 0 0 0 0 12.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1648 0 0 0 0 0 0 0 0 0 0 0 0 13.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 E9PRG8 CK098_HUMAN Uncharacterized protein C11orf98 C11orf98 Homo sapiens (Human) HRVVGAVIDQGLITRHHLK 0.93298 2.1266 0 0 0 0 0 0 0 11.5233 14.1202 0 0 0 0 0 0 15.4276 0 0 14.3683 0 0 0 0 0 14.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3081 0 0 0 0 0 0 11.2771 0 0 0 0 0 12.7537 0 0 0 0 0 0 0 0 14.2022 0 0 0 12.7666 12.5435 12.3571 11.7841 12.9691 0 0 0 0 15.2463 0 11.3247 12.1536 0 15.0765 16.3247 0 11.6774 21.636 17.1308 17.867 13.1044 16.642 14.6016 14.8957 16.5087 16.8875 17.2844 14.4713 15.5249 0 0 11.8777 15.2129 0 13.6704 14.71 17.1565 15.8863 13.7853 14.8226 14.0025 14.0104 15.6187 0 14.7222 14.7537 0 0 14.6834 0 15.548 0 15.1494 15.3636 13.7622 0 14.7425 13.2194 0 15.2403 0 13.5338 15.0929 0 14.8453 15.6526 14.5445 13.4221 14.2418 14.5179 15.0041 14.3308 0 15.6259 11.7674 13.3983 14.8537 15.4157 14.341 0 0 0 0 0 0 0 13.22 12.4869 11.907 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6099 0 13.0752 0 13.3811 0 15.963 0 0 0 0 Q7Z5M8 AB12B_HUMAN "Protein ABHD12B, EC 3.-.-.- (Abhydrolase domain-containing protein 12B) (Alpha/beta hydrolase domain-containing protein 12B)" ABHD12B C14orf29 Homo sapiens (Human) monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] GO:0004622; GO:0005789; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651 acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474] LVKVLSDGGFHVLSVDYR 0.93299 1.6662 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4107 0 0 0 0 0 0 12.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0771 0 12.3956 12.2348 12.7247 14.1678 13.1811 0 0 0 0 0 0 0 0 0 0 0 12.9647 0 0 0 0 Q8IZF2 AGRF5_HUMAN Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116) ADGRF5 GPR116 KIAA0758 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; energy reserve metabolic process [GO:0006112]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular filtration [GO:0003094]; glucose homeostasis [GO:0042593]; macrophage activation [GO:0042116]; negative regulation of macrophage activation [GO:0043031]; pharyngeal arch artery morphogenesis [GO:0061626]; phospholipid biosynthetic process [GO:0008654]; positive regulation of phospholipid biosynthetic process [GO:0071073]; regulation of lipid metabolic process [GO:0019216]; surfactant homeostasis [GO:0043129] apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; energy reserve metabolic process [GO:0006112]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular filtration [GO:0003094]; glucose homeostasis [GO:0042593]; macrophage activation [GO:0042116]; negative regulation of macrophage activation [GO:0043031]; pharyngeal arch artery morphogenesis [GO:0061626]; phospholipid biosynthetic process [GO:0008654]; positive regulation of phospholipid biosynthetic process [GO:0071073]; regulation of lipid metabolic process [GO:0019216]; surfactant homeostasis [GO:0043129] GO:0003094; GO:0004930; GO:0005886; GO:0006112; GO:0007166; GO:0007186; GO:0007189; GO:0008654; GO:0009986; GO:0016021; GO:0019216; GO:0031410; GO:0042116; GO:0042593; GO:0043031; GO:0043129; GO:0045177; GO:0045444; GO:0048821; GO:0061626; GO:0071073 G protein-coupled receptor activity [GO:0004930] ALLAFAIPALIIVVVNITITIVVITK 0.93299 4.9951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7194 0 0 0 11.2593 0 11.2108 0 0 12.2462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5791 0 0 0 0 0 0 0 13.7661 0 0 0 0 0 0 11.8686 0 0 0 0 0 0 0 0 0 11.9738 0 0 12.7692 0 0 0 11.2497 0 0 0 0 0 0 0 0 13.3622 0 0 0 0 0 11.2965 0 0 0 0 0 0 11.3795 0 0 0 0 0 0 0 14.0863 0 0 0 0 11.2695 0 0 0 Q5T8I3 F102B_HUMAN Protein FAM102B FAM102B Homo sapiens (Human) KGGETLKVHLGIADLSAK 0.93304 1.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.238 14.1125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8415 14.2981 0 0 0 0 0 A0A577 TVB41_HUMAN T cell receptor beta variable 4-1 TRBV4-1 TCRBV7S1A1N2T Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 CEQHMGHRAMYWYKQK 0.93305 1.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UDW3 ZMAT5_HUMAN "Zinc finger matrin-type protein 5 (U11/U12 small nuclear ribonucleoprotein 20 kDa protein, U11/U12 snRNP 20 kDa protein, U11/U12-20K)" ZMAT5 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689] nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0005654; GO:0005689; GO:0006397; GO:0008270; GO:0008380 zinc ion binding [GO:0008270] HLNGLQHLKAKK 0.93307 2.1026 11.926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4667 0 0 14.4209 0 16.1509 0 0 15.9196 0 0 0 0 0 0 0 12.0134 0 0 0 0 0 0 0 12.6496 0 0 0 12.1528 12.968 13.5079 0 0 12.7259 0 0 0 11.3811 12.9856 15.0705 11.5837 0 0 12.7091 0 0 0 0 0 0 16.6194 0 0 12.6386 13.9416 14.297 0 0 12.8293 0 0 0 0 0 0 0 0 0 16.2814 16.275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9733 0 0 0 0 0 14.7828 0 O75310 UDB11_HUMAN "UDP-glucuronosyltransferase 2B11, UDPGT 2B11, EC 2.4.1.17" UGT2B11 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] GO:0005789; GO:0006805; GO:0008210; GO:0015020; GO:0016021; GO:0052695; GO:0052697 glucuronosyltransferase activity [GO:0015020] AKGAAVR 0.93308 1.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LI64 KRA61_HUMAN Keratin-associated protein 6-1 KRTAP6-1 C21orf103 KAP6.1 Homo sapiens (Human) keratinization [GO:0031424] cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882]; keratinization [GO:0031424] GO:0005829; GO:0005882; GO:0031424 CGSYYGNYYGTPGYGFCGYGGLGYGYGGLGCGYGSCCGCGFR 0.93311 2.1004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3468 0 11.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 P17987 TCPA_HUMAN "T-complex protein 1 subunit alpha, TCP-1-alpha (CCT-alpha)" TCP1 CCT1 CCTA Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]; tubulin complex assembly [GO:0007021] acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199] acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]; tubulin complex assembly [GO:0007021] GO:0000242; GO:0000792; GO:0001669; GO:0002199; GO:0003723; GO:0005524; GO:0005794; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007021; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044053; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:0140662; GO:1901998; GO:1904851; GO:1904871; GO:1904874; GO:2000109 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] DNKQAGVFEPTIVK 0.93312 1.0828 0 0 0 0 0 0 0 0 11.8953 11.5594 0 0 0 0 0 0 0 0 0 0 0 0 13.0219 0 0 9.39898 0 0 0 0 0 0 12.5751 0 0 0 0 10.8949 0 0 0 0 0 0 0 0 9.6024 11.1297 0 0 0 13.2929 0 0 0 0 10.7087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8119 0 0 0 0 11.9983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1997 0 15.8786 0 0 14.6828 0 0 0 0 14.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.218 0 0 14.6549 0 15.1029 0 0 0 14.3936 0 11.1733 0 11.9228 14.6467 0 14.5233 0 0 0 0 0 0 0 0 0 13.155 0 0 13.9446 0 12.8339 14.0683 0 13.928 0 13.647 15.4155 14.6789 14.5671 0 13.5868 0 0 0 0 Q8N6I1 EID2_HUMAN "EP300-interacting inhibitor of differentiation 2, EID-2 (CREBBP/EP300 inhibitor 2) (EID-1-like inhibitor of differentiation 2)" EID2 CRI2 Homo sapiens (Human) "cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of cell population proliferation [GO:0042127]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; SMAD protein complex assembly [GO:0007183]; transforming growth factor beta receptor complex assembly [GO:0007181]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of cell population proliferation [GO:0042127]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; SMAD protein complex assembly [GO:0007183]; transforming growth factor beta receptor complex assembly [GO:0007181]" GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0007181; GO:0007183; GO:0007517; GO:0017015; GO:0030154; GO:0030512; GO:0042127; GO:0045892; GO:0046332 SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714] GAPVAAAALARAAAAGRESPAAAAAR 0.93312 1.0859 0 0 0 0 0 0 0 0 0 0 0 12.8344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3777 0 0 15.492 0 0 0 0 0 15.4972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2285 12.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7027 0 0 0 0 0 0 Q8N8I0 SAM12_HUMAN "Sterile alpha motif domain-containing protein 12, SAM domain-containing protein 12" SAMD12 Homo sapiens (Human) transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasmic side of plasma membrane [GO:0009898] cytoplasmic side of plasma membrane [GO:0009898]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0007169; GO:0009898 TTLLLGQTGVRENLLLFLHRISIIENSIQI 0.93316 1.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y226 S22AD_HUMAN "Solute carrier family 22 member 13 (Organic cation transporter-like 3, ORCTL-3)" SLC22A13 OCTL1 ORCTL3 Homo sapiens (Human) NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nicotinate transmembrane transporter activity [GO:0090416]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fatty acid metabolic process [GO:0045922]; nicotinate transport [GO:2001142]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; urate transport [GO:0015747] GO:0002854; GO:0005783; GO:0005794; GO:0005886; GO:0015747; GO:0016021; GO:0016324; GO:0034356; GO:0045922; GO:0070062; GO:0090416; GO:2001142 nicotinate transmembrane transporter activity [GO:0090416] ATILAQLLLFTLIGLATAFVPSFELYMALR 0.93317 1.0857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14983 AT2A1_HUMAN "Sarcoplasmic/endoplasmic reticulum calcium ATPase 1, SERCA1, SR Ca(2+)-ATPase 1, EC 7.2.2.10 (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)" ATP2A1 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; calcium ion import [GO:0070509]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; maintenance of mitochondrion location [GO:0051659]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of calcium ion import into sarcoplasmic reticulum [GO:1902082]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cardiac conduction [GO:1903779]; regulation of striated muscle contraction [GO:0006942]; relaxation of skeletal muscle [GO:0090076]; response to endoplasmic reticulum stress [GO:0034976] calcium channel complex [GO:0034704]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017] calcium channel complex [GO:0034704]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; H zone [GO:0031673]; I band [GO:0031674]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium-dependent ATPase activity [GO:0030899]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; calcium ion import [GO:0070509]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; maintenance of mitochondrion location [GO:0051659]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of striated muscle contraction [GO:0045988]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of calcium ion import into sarcoplasmic reticulum [GO:1902082]; positive regulation of cardiac muscle cell contraction [GO:0106134]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of fast-twitch skeletal muscle fiber contraction [GO:0031448]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cardiac conduction [GO:1903779]; regulation of striated muscle contraction [GO:0006942]; relaxation of skeletal muscle [GO:0090076]; response to endoplasmic reticulum stress [GO:0034976] GO:0005388; GO:0005509; GO:0005524; GO:0005739; GO:0005789; GO:0005793; GO:0006816; GO:0006874; GO:0006942; GO:0008637; GO:0015662; GO:0016020; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031095; GO:0031448; GO:0031673; GO:0031674; GO:0032470; GO:0032471; GO:0033017; GO:0034220; GO:0034704; GO:0034976; GO:0042803; GO:0045988; GO:0048471; GO:0051561; GO:0051659; GO:0070059; GO:0070509; GO:0070588; GO:0090076; GO:0106134; GO:1901896; GO:1902082; GO:1903779; GO:1990036 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; calcium-dependent ATPase activity [GO:0030899]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; protein homodimerization activity [GO:0042803] AIYNNMK 0.9332 2.1095 0 0 11.0936 0 0 0 0 0 0 0 0 0 11.7273 0 0 0 0 0 0 0 0 0 0 0 0 0 10.754 10.6819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.154 13.1938 0 0 11.5954 0 0 0 0 0 14.6575 0 0 0 0 0 0 0 14.8007 0 0 0 0 0 0 0 14.3035 12.9069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6101 0 0 0 14.3206 12.9898 0 0 13.1433 0 12.3555 0 0 0 13.2198 0 12.9278 0 12.1703 0 12.0629 0 11.4399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6422 13.2025 0 12.3161 0 0 0 0 0 P50219 MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9) MNX1 HLXB9 Homo sapiens (Human) central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; neuron projection morphogenesis [GO:0048812]; spinal cord motor neuron cell fate specification [GO:0021520] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; neuron projection morphogenesis [GO:0048812]; spinal cord motor neuron cell fate specification [GO:0021520]" GO:0000785; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007417; GO:0021520; GO:0031018; GO:0048812; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GGGGGAGK 0.93321 1.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30954 O10J1_HUMAN Olfactory receptor 10J1 (Olfactory receptor OR1-26) (Olfactory receptor-like protein HGMP07J) OR10J1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; single fertilization [GO:0007338] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; single fertilization [GO:0007338] GO:0004930; GO:0004984; GO:0005549; GO:0005887; GO:0007186; GO:0007338; GO:0007606; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IASVEGRKK 0.93322 2.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7818 12.5402 0 0 0 0 0 0 0 0 0 0 13.8576 0 0 0 0 0 0 13.9731 0 0 0 0 11.6941 0 0 12.561 14.0461 10.5469 0 0 0 0 0 0 0 0 0 0 0 0 13.6659 0 0 0 0 0 0 0 0 0 0 0 11.3034 0 12.7032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1242 0 0 0 0 0 0 Q15173 2A5B_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform (PP2A B subunit isoform B'-beta) (PP2A B subunit isoform B56-beta) (PP2A B subunit isoform PR61-beta) (PP2A B subunit isoform R5-beta) PPP2R5B Homo sapiens (Human) cellular response to growth factor stimulus [GO:0071363]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of protein autophosphorylation [GO:0031952]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; cellular response to growth factor stimulus [GO:0071363]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of protein autophosphorylation [GO:0031952]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165] GO:0000159; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007165; GO:0010469; GO:0010976; GO:0019888; GO:0031334; GO:0031952; GO:0045944; GO:0050730; GO:0051091; GO:0051388; GO:0070317; GO:0071363; GO:0072542 protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] EREYLKTILHR 0.93327 1.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8137 0 0 10.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1161 11.6018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01650 LAT1_HUMAN "Large neutral amino acids transporter small subunit 1 (4F2 light chain, 4F2 LC, 4F2LC) (CD98 light chain) (Integral membrane protein E16, E16) (L-type amino acid transporter 1, hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)" SLC7A5 CD98LC LAT1 MPE16 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; liver regeneration [GO:0097421]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; odontogenesis [GO:0042476]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of leucine import across plasma membrane [GO:1905534]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908] amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-leucine import across plasma membrane [GO:1903801]; L-tryptophan transmembrane transport [GO:1904556]; leucine import across plasma membrane [GO:0098713]; liver regeneration [GO:0097421]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; odontogenesis [GO:0042476]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of leucine import across plasma membrane [GO:1905534]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908] GO:0002720; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010507; GO:0010629; GO:0014850; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015297; GO:0015349; GO:0015804; GO:0015818; GO:0015823; GO:0015829; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0031528; GO:0032729; GO:0032740; GO:0032753; GO:0042149; GO:0042476; GO:0042605; GO:0042908; GO:0043231; GO:0055093; GO:0060252; GO:0070062; GO:0070327; GO:0071222; GO:0089718; GO:0097421; GO:0098591; GO:0098713; GO:0150104; GO:1903577; GO:1903801; GO:1904556; GO:1905460; GO:1905534; GO:1990184 amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349] AGAGPKRR 0.93328 2.3729 0 0 0 0 0 0 12.962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2589 0 0 15.7258 14.9779 15.3802 14.1874 15.0911 0 0 0 0 0 0 0 0 0 12.4321 0 12.7818 0 11.9248 0 0 0 14.006 0 0 0 0 0 11.456 0 0 0 0 0 0 14.3918 0 0 0 0 0 0 10.0422 12.7967 0 0 13.1216 12.2197 0 11.7377 0 0 0 0 0 0 0 0 0 0 0 10.3339 0 0 0 0 11.5517 12.2366 13.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36268 GGT2_HUMAN "Inactive glutathione hydrolase 2 (Gamma-glutamyltransferase 2 pseudogene) (Inactive gamma-glutamyltranspeptidase 2, GGT 2)" GGT2P GGT2 Homo sapiens (Human) glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727] GO:0002682; GO:0005783; GO:0005886; GO:0006751; GO:0031179; GO:0048471; GO:0050727; GO:0070062; GO:1901750 GGEPAGY 0.93329 1.0552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4163 0 0 0 0 0 Q8IZN7 D107A_HUMAN "Beta-defensin 107 (Beta-defensin 7, BD-7, DEFB-7) (Defensin, beta 107)" DEFB107A DEFB107 DEFB7; DEFB107B Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; lipid binding [GO:0008289]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0008289; GO:0042742; GO:0045087 lipid binding [GO:0008289] IFVFILAALILLAQIFQAR 0.93329 2.0968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3526 0 0 0 0 0 0 0 0 13.7081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4899 14.0122 12.5046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8448 0 0 0 0 0 0 0 13.9259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1733 0 0 0 0 0 12.1411 12.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7402 0 0 0 0 0 0 0 0 0 10.7563 0 0 0 0 0 0 0 0 0 0 13.0845 10.1326 0 0 0 0 0 Q13651 I10R1_HUMAN "Interleukin-10 receptor subunit alpha, IL-10 receptor subunit alpha, IL-10R subunit alpha, IL-10RA (CDw210a) (Interleukin-10 receptor subunit 1, IL-10R subunit 1, IL-10R1) (CD antigen CD210)" IL10RA IL10R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; negative regulation of autophagy [GO:0010507]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of synapse organization [GO:0050807]; response to lipopolysaccharide [GO:0032496]; ubiquitin-dependent endocytosis [GO:0070086] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interleukin-10 binding [GO:0019969]; interleukin-10 receptor activity [GO:0004920]; signaling receptor activity [GO:0038023]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of autophagy [GO:0010507]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of synapse organization [GO:0050807]; response to lipopolysaccharide [GO:0032496]; ubiquitin-dependent endocytosis [GO:0070086] GO:0004896; GO:0004920; GO:0005829; GO:0005886; GO:0005887; GO:0010507; GO:0019221; GO:0019969; GO:0032496; GO:0038023; GO:0046427; GO:0050807; GO:0070086 cytokine receptor activity [GO:0004896]; interleukin-10 binding [GO:0019969]; interleukin-10 receptor activity [GO:0004920]; signaling receptor activity [GO:0038023] KVKHENFSLLTSGEVGEFCVQVK 0.9333 1.8475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2536 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.738 0 0 0 0 0 0 0 0 0 0 0 0 13.554 0 0 0 0 0 0 0 13.0518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7581 0 0 0 0 0 0 0 15.4218 0 0 0 0 13.5142 0 0 0 0 0 0 0 0 0 0 12.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1063 0 0 0 0 0 0 0 0 Q15262 PTPRK_HUMAN "Receptor-type tyrosine-protein phosphatase kappa, Protein-tyrosine phosphatase kappa, R-PTP-kappa, EC 3.1.3.48" PTPRK PTPK Homo sapiens (Human) "cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]" adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription, DNA-templated [GO:0045892]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007155; GO:0007165; GO:0007179; GO:0008013; GO:0008285; GO:0009986; GO:0010839; GO:0016021; GO:0016477; GO:0019901; GO:0030054; GO:0030336; GO:0031256; GO:0034394; GO:0034614; GO:0034644; GO:0043231; GO:0045295; GO:0045786; GO:0045892; GO:0048041 beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] ETKTQCVR 0.93333 4.879 0 0 0 0 0 0 14.2011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2811 0 0 0 12.1968 0 10.4067 12.8741 0 0 0 0 0 0 0 13.6099 12.553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4131 0 0 0 0 0 14.1365 0 10.9986 12.9854 14.9386 12.1095 12.9009 11.7465 12.5517 15.4115 0 14.6616 0 15.1668 14.0257 0 12.8662 0 0 17.9565 13.9812 17.1851 12.7902 16.8645 17.8173 0 0 0 11.7263 0 15.0589 12.2474 0 0 12.4695 14.2024 14.2516 11.4259 0 0 13.5644 12.5062 12.5666 0 0 13.4288 14.8318 0 0 13.6588 14.6121 0 14.5023 0 0 0 0 0 12.9508 15.2052 13.9186 12.7087 0 12.1854 12.8272 0 0 12.4248 12.4765 0 0 13.3707 13.8315 12.2764 0 0 9.90959 12.2106 0 10.6421 10.9241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8097 0 13.0703 0 12.5983 0 15.3913 12.1859 12.8279 0 13.5399 0 0 14.6674 12.5198 Q15543 TAF13_HUMAN "Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit, TAF(II)18, TAFII-18, TAFII18)" TAF13 TAF2K TAFII18 Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; DNA-templated transcription, initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006352; GO:0006366; GO:0006367; GO:0006468; GO:0008022; GO:0016251; GO:0017025; GO:0042789; GO:0046982; GO:0051123; GO:0060261 DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025] DLLTMNEELKR 0.93333 2.1463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3018 0 0 0 0 0 0 0 0 0 0 0 0 13.5044 0 0 0 0 0 15.2842 0 0 0 0 13.6726 0 0 0 0 0 0 0 0 0 0 0 13.352 0 0 0 0 0 0 13.1906 0 0 0 0 0 0 0 0 13.0648 0 13.1974 0 0 0 0 12.9186 0 0 0 0 0 0 0 0 0 0 0 14.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVU9 CBCO1_HUMAN Ciliary-associated calcium-binding coiled-coil protein 1 CABCOCO1 C10orf107 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; calcium ion binding [GO:0005509] GO:0005509; GO:0005737; GO:0005813; GO:0036126 calcium ion binding [GO:0005509] LQIQEEAFNARIEKLK 0.93333 1.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8249 0 0 13.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7048 0 14.5712 13.8426 0 13.9018 0 0 0 0 13.0891 0 0 0 0 0 0 0 14.8132 0 0 Q96LZ3 CANB2_HUMAN "Calcineurin subunit B type 2 (Calcineurin B-like protein, CBLP) (Calcineurin BII, CNBII) (PPP3R1-like) (Protein phosphatase 2B regulatory subunit 2) (Protein phosphatase 3 regulatory subunit B beta isoform)" PPP3R2 CBLP PPP3RL Homo sapiens (Human) calcineurin-mediated signaling [GO:0097720]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; penetration of zona pellucida [GO:0007341]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470] calcineurin complex [GO:0005955]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; protein serine/threonine phosphatase complex [GO:0008287]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226] calcineurin complex [GO:0005955]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; protein serine/threonine phosphatase complex [GO:0008287]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902]; calcineurin-mediated signaling [GO:0097720]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; penetration of zona pellucida [GO:0007341]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470] GO:0005509; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0007341; GO:0008287; GO:0008597; GO:0019902; GO:0070886; GO:0097225; GO:0097226; GO:0097720; GO:1901386; GO:1901387; GO:1905665; GO:1905949 calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902] GNEASYPAEMCSHFDNDEIK 0.93333 1.8472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8813 0 0 0 0 0 0 0 13.8074 14.0941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95049 ZO3_HUMAN Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3) TJP3 ZO3 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105] GO:0005634; GO:0005654; GO:0005886; GO:0005923; GO:0030054; GO:0035633; GO:0045216; GO:0050839; GO:0090557; GO:0098609; GO:0150105; GO:1905605 cell adhesion molecule binding [GO:0050839] DLREQERGIIPNQSR 0.93336 1.6682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8462 14.1421 13.6868 0 10.7548 11.709 0 0 0 0 0 0 0 0 0 0 0 0 14.3238 0 0 0 0 0 0 0 0 14.4304 0 0 0 0 0 0 0 0 14.4355 0 0 0 0 0 12.1848 0 11.4385 12.5489 12.8506 0 0 0 0 0 0 12.3353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1132 0 11.2127 0 14.258 0 0 0 13.4876 0 12.592 0 14.9676 16.5075 0 0 0 0 0 0 0 11.8524 0 Q8N1B3 CCNQ_HUMAN Cyclin-Q (CDK10-activating cyclin) (Cyclin-M) (Cyclin-related protein FAM58A) CCNQ FAM58A Homo sapiens (Human) regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of transcription by RNA polymerase II [GO:0006357] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000307; GO:0005634; GO:0006357; GO:0016538; GO:1902749 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] DSIVQCELLMLRVLRFQVSFQHPHK 0.93337 1.8463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5882 0 0 0 0 0 0 0 0 0 0 0 11.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0189 12.1677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43447 PPIH_HUMAN "Peptidyl-prolyl cis-trans isomerase H, PPIase H, EC 5.2.1.8 (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H, CypH) (U-snRNP-associated cyclophilin SnuCyp-20, USA-CYP)" PPIH CYP20 CYPH Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex assembly [GO:0065003]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex assembly [GO:0065003]" GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0005681; GO:0005737; GO:0006457; GO:0016018; GO:0016607; GO:0043021; GO:0043231; GO:0045070; GO:0046540; GO:0065003; GO:0071001 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021] GPFADENFKLR 0.93338 2.1074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1054 0 0 0 0 0 0 0 0 0 0 13.8318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47712 PA24A_HUMAN "Cytosolic phospholipase A2, cPLA2 (Phospholipase A2 group IVA) [Includes: Phospholipase A2, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase, EC 3.1.1.5 ]" PLA2G4A CPLA2 PLA2G4 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; establishment of localization in cell [GO:0051649]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; establishment of localization in cell [GO:0051649]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475]; icosanoid metabolic process [GO:0006690]; leukotriene biosynthetic process [GO:0019370]; monoacylglycerol biosynthetic process [GO:0006640]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylglycerol catabolic process [GO:0034478]; platelet activating factor biosynthetic process [GO:0006663]; positive regulation of macrophage activation [GO:0043032]; positive regulation of platelet activation [GO:0010572]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of T-helper 1 type immune response [GO:0002827]; prostaglandin biosynthetic process [GO:0001516]; regulation of cell population proliferation [GO:0042127] GO:0000139; GO:0001516; GO:0002827; GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006071; GO:0006640; GO:0006663; GO:0006690; GO:0008374; GO:0010314; GO:0010572; GO:0019369; GO:0019370; GO:0032266; GO:0032308; GO:0034478; GO:0034638; GO:0036151; GO:0042127; GO:0043032; GO:0043231; GO:0046475; GO:0047498; GO:0047499; GO:0050482; GO:0051649; GO:0070273; GO:0071236; GO:0102545; GO:1902387 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; ceramide 1-phosphate binding [GO:1902387]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A2 activity [GO:0004623] ETEEEKEIADFDIFDDPESPFSTFNFQYPNQAFKR 0.93338 2.0954 0 0 0 0 0 0 0 13.0057 0 0 0 0 0 0 0 0 0 0 0 0 10.4974 0 0 0 0 0 0 0 0 0 0 0 10.7251 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1847 0 13.6313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.173 0 0 0 0 0 0 0 0 0 13.2626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6347 0 0 0 0 0 0 0 0 12.7753 0 0 0 0 12.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4605 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXS0 CL19A_HUMAN C-type lectin domain family 19 member A CLEC19A UNQ5810/PRO19627 Homo sapiens (Human) external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; carbohydrate binding [GO:0030246] GO:0005576; GO:0009897; GO:0030246 carbohydrate binding [GO:0030246] GHCYRFFPLNKTWAEADLYCSEFSVGR 0.93338 1.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3405 0 0 0 0 0 0 0 P0C7N8 OR9G9_HUMAN Olfactory receptor 9G9 OR9G9 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EALKKLLP 0.93341 1.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.759 0 0 0 0 0 0 13.247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8195 0 0 0 12.3888 0 0 0 0 P35212 CXA4_HUMAN "Gap junction alpha-4 protein (Connexin-37, Cx37)" GJA4 Homo sapiens (Human) blood vessel development [GO:0001568]; calcium ion transport [GO:0006816]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; endothelium development [GO:0003158]; response to pain [GO:0048265] connexin complex [GO:0005922]; gap junction [GO:0005921]; integral component of plasma membrane [GO:0005887] connexin complex [GO:0005922]; gap junction [GO:0005921]; integral component of plasma membrane [GO:0005887]; gap junction channel activity [GO:0005243]; blood vessel development [GO:0001568]; calcium ion transport [GO:0006816]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; endothelium development [GO:0003158]; response to pain [GO:0048265] GO:0001568; GO:0003158; GO:0005243; GO:0005887; GO:0005921; GO:0005922; GO:0006816; GO:0007043; GO:0007267; GO:0048265 gap junction channel activity [GO:0005243] EERLRQK 0.93341 1.8461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8138 0 0 0 0 0 0 0 10.8933 0 0 0 0 0 0 0 0 10.567 0 0 0 0 14.0176 0 0 11.6931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4L9 PPR42_HUMAN Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67) PPP1R42 LRRC67 Homo sapiens (Human) positive regulation of protein dephosphorylation [GO:0035307] centrosome [GO:0005813]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; protein phosphatase type 1 complex [GO:0000164] centrosome [GO:0005813]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; protein phosphatase type 1 complex [GO:0000164]; actin binding [GO:0003779]; dynein complex binding [GO:0070840]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; tubulin binding [GO:0015631]; positive regulation of protein dephosphorylation [GO:0035307] GO:0000164; GO:0002177; GO:0003779; GO:0004865; GO:0005813; GO:0005815; GO:0015630; GO:0015631; GO:0035307; GO:0070840 actin binding [GO:0003779]; dynein complex binding [GO:0070840]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; tubulin binding [GO:0015631] LEKLYLGGNYIAVIEGLEGLGELR 0.93342 2.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7271 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUI4 S29P2_HUMAN Putative protein SNX29P2 (RUN domain-containing protein 2C) (Sorting nexin 29 protein pseudogene 2) SNX29P2 RUNDC2C Homo sapiens (Human) DLNGQSK 0.93345 1.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVC3 S38A7_HUMAN Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7) SLC38A7 SNAT7 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814] GO:0003333; GO:0005290; GO:0005313; GO:0006814; GO:0015179; GO:0015180; GO:0015182; GO:0015183; GO:0015186; GO:0015190; GO:0015191; GO:0015194; GO:0016021; GO:0030424; GO:0043025 L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-leucine transmembrane transporter activity [GO:0015190]; L-methionine transmembrane transporter activity [GO:0015191]; L-serine transmembrane transporter activity [GO:0015194] RRVLQTLVWFLLTLLLALFIPDIGK 0.93351 2.1049 0 0 0 0 0 0 12.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.088 0 0 0 0 0 14.5067 0 0 0 14.7476 0 0 0 0 0 0 0 0 0 13.5525 0 0 0 0 0 0 0 0 0 0 0 13.8051 0 0 0 13.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.424 10.8586 0 0 0 0 0 0 0 0 0 0 0 13.7861 0 0 O60383 GDF9_HUMAN "Growth/differentiation factor 9, GDF-9" GDF9 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of progesterone secretion [GO:2000870]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]; BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of progesterone secretion [GO:2000870]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0005125; GO:0005615; GO:0007179; GO:0007292; GO:0008083; GO:0008284; GO:0010862; GO:0030509; GO:0060395; GO:0070698; GO:2000870 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698] RSIHMSINFTCMK 0.93355 1.8423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9884 0 0 0 0 0 0 15.3163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9625 0 0 0 0 0 0 0 0 0 0 0 0 P32239 GASR_HUMAN "Gastrin/cholecystokinin type B receptor, CCK-B receptor, CCK-BR (Cholecystokinin-2 receptor, CCK2-R)" CCKBR CCKRB Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cholecystokinin signaling pathway [GO:0038188]; digestive tract development [GO:0048565]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; gland development [GO:0048732]; pH reduction [GO:0045851]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; gastrin receptor activity [GO:0015054]; peptide hormone binding [GO:0017046]; type B gastrin/cholecystokinin receptor binding [GO:0031741]; cell surface receptor signaling pathway [GO:0007166]; cholecystokinin signaling pathway [GO:0038188]; digestive tract development [GO:0048565]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric acid secretion [GO:0001696]; gland development [GO:0048732]; pH reduction [GO:0045851]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0001696; GO:0004930; GO:0004951; GO:0005886; GO:0007166; GO:0007186; GO:0007200; GO:0007204; GO:0008284; GO:0015054; GO:0016021; GO:0017046; GO:0031741; GO:0038188; GO:0045851; GO:0046935; GO:0048565; GO:0048732 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; gastrin receptor activity [GO:0015054]; peptide hormone binding [GO:0017046]; type B gastrin/cholecystokinin receptor binding [GO:0031741] ALSGAPISFIHLLSYASACVNPLVYCFMHRRFR 0.93356 2.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6707 0 0 0 0 0 0 0 12.2825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2615 0 0 0 0 0 13.4215 0 12.0999 0 12.4922 0 0 11.843 0 0 0 0 0 0 11.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1736 14.2609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4512 11.3053 0 0 0 0 0 0 0 0 0 0 0 Q9UJY5 GGA1_HUMAN "ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)" GGA1 Homo sapiens (Human) "Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]" cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]; toxin transport [GO:1901998]" GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006893; GO:0008104; GO:0010008; GO:0016020; GO:0030163; GO:0031267; GO:0031901; GO:0032991; GO:0034394; GO:0035091; GO:0042147; GO:0043001; GO:0043130; GO:0043231; GO:0045732; GO:1901998; GO:1903441 phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130] EPAMEPETLEAR 0.9336 2.1042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9132 0 0 0 0 0 0 0 14.3829 0 0 0 0 0 0 0 0 0 0 0 11.632 0 0 0 0 0 0 0 0 12.7792 0 0 0 0 0 0 0 0 0 0 0 0 12.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8256 11.1606 0 0 0 0 0 0 0 0 0 11.9658 0 0 0 0 0 0 0 0 0 0 0 0 A6NKU9 SPDE3_HUMAN Speedy protein E3 SPDYE3 Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0019901; GO:0045737 protein kinase binding [GO:0019901] CRAWVSPEELEEIQAYDPEHWVWARDR 0.93367 1.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95363 SYFM_HUMAN "Phenylalanine--tRNA ligase, mitochondrial, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase, PheRS)" FARS2 FARS1 HSPC320 Homo sapiens (Human) phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA processing [GO:0008033] GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006418; GO:0006432; GO:0008033 ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049] KGDNYYLNRTHMLR 0.93368 2.1026 0 0 0 0 0 0 0 0 14.7591 0 0 0 0 14.4907 13.7541 0 0 0 0 0 0 0 0 0 0 0 0 14.0265 0 0 0 13.5688 0 0 0 0 0 0 15.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6757 0 0 11.9691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5795 0 0 0 0 0 0 0 0 15.5126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3081 15.2305 15.5403 0 14.9986 10.8568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS26 SPNXA_HUMAN "Sperm protein associated with the nucleus on the X chromosome A (Cancer/testis antigen 11.1, CT11.1) (Nuclear-associated protein SPAN-Xa, SPAN-X, SPANX-A) (SPANX family member A)" SPANXA1 SPANXA; SPANXA2 Homo sapiens (Human) spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0007283 MKTSESSTILVVR 0.93368 1.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0122 0 11.8803 0 0 0 0 11.4896 0 0 0 0 12.2067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2941 0 12.1728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NNZ2 TBB8B_HUMAN Tubulin beta 8B TUBB8B Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0015630; GO:0045171; GO:0070062; GO:0072686 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200] AVLVDLEPGTMDSVHSGPFGQVFR 0.93371 1.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5911 0 0 0 14.5875 0 0 0 0 0 0 0 0 0 0 11.332 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9527 0 0 0 14.0249 0 0 10.9125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTN3 S35D1_HUMAN "UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, UDP-GlcA/UDP-GalNAc transporter (Solute carrier family 35 member D1) (UDP-galactose transporter-related protein 7, UGTrel7)" SLC35D1 KIAA0260 UGTREL7 Homo sapiens (Human) carbohydrate transport [GO:0008643] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643] GO:0005461; GO:0005462; GO:0005463; GO:0005789; GO:0005794; GO:0008643; GO:0015297; GO:0016021 antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] KLNLPMFTVLR 0.93373 1.0544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30520 PURA2_HUMAN "Adenylosuccinate synthetase isozyme 2, AMPSase 2, AdSS 2, EC 6.3.4.4 (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme, L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)" ADSS2 ADSS Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; AMP biosynthetic process [GO:0006167]; aspartate metabolic process [GO:0006531]; cellular response to electrical stimulus [GO:0071257]; immune system process [GO:0002376]; IMP metabolic process [GO:0046040]; response to ammonium ion [GO:0060359]; response to purine-containing compound [GO:0014074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; 'de novo' AMP biosynthetic process [GO:0044208]; AMP biosynthetic process [GO:0006167]; aspartate metabolic process [GO:0006531]; cellular response to electrical stimulus [GO:0071257]; immune system process [GO:0002376]; IMP metabolic process [GO:0046040]; response to ammonium ion [GO:0060359]; response to purine-containing compound [GO:0014074] GO:0000287; GO:0002376; GO:0004019; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006167; GO:0006531; GO:0014074; GO:0042301; GO:0044208; GO:0046040; GO:0060359; GO:0070062; GO:0071257 adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301] MCDLVSDFDGFSERFKVLANQYK 0.93374 2.1498 0 0 0 0 0 0 0 0 0 11.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.517 0 0 0 0 0 0 0 0 0 0 11.8578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94898 LRIG2_HUMAN "Leucine-rich repeats and immunoglobulin-like domains protein 2, LIG-2" LRIG2 KIAA0806 LIG2 Homo sapiens (Human) innervation [GO:0060384]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; innervation [GO:0060384]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605] GO:0005102; GO:0005615; GO:0005737; GO:0005886; GO:0006509; GO:0007605; GO:0010640; GO:0016021; GO:0030426; GO:0031012; GO:0034394; GO:0048681; GO:0051045; GO:0060384; GO:0097708; GO:2000010; GO:2001222 signaling receptor binding [GO:0005102] EPDCSASSMSCHR 0.93379 2.6241 0 10.5022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8921 11.8922 0 0 0 0 0 12.3953 0 0 12.2018 18.1115 0 13.7991 0 0 0 10.8362 0 0 0 0 0 0 0 0 0 0 0 0 12.6564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9P8 L2HDH_HUMAN "L-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.2 (Duranin)" L2HGDH C14orf160 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; small molecule metabolic process [GO:0044281] integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545]; 2-oxoglutarate metabolic process [GO:0006103]; small molecule metabolic process [GO:0044281] GO:0003973; GO:0005739; GO:0005743; GO:0006103; GO:0016021; GO:0031305; GO:0044281; GO:0047545 (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545] ALILRHPSLSIGVLEK 0.93382 2.1102 0 0 0 0 0 0 0 0 0 13.1993 0 0 0 0 0 0 12.3459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5216 0 0 0 0 0 0 0 0 0 0 13.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6076 0 0 0 15.0541 0 12.4928 15.0705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B4DH59 NBPFP_HUMAN Neuroblastoma breakpoint family member 26 NBPF26 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DQEEEEDQGPPCPR 0.93384 1.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.735 Q9BYE9 CDHR2_HUMAN "Cadherin-related family member 2 (Protocadherin LKC, PC-LKC) (Protocadherin-24)" CDHR2 PCDH24 PCLKC Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; regulation of microvillus length [GO:0032532] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; microvillus membrane [GO:0031528]; spanning component of plasma membrane [GO:0044214] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; microvillus membrane [GO:0031528]; spanning component of plasma membrane [GO:0044214]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; regulation of microvillus length [GO:0032532] GO:0005509; GO:0005903; GO:0007156; GO:0016324; GO:0030855; GO:0031526; GO:0031528; GO:0032532; GO:0044214; GO:0044331; GO:0050839; GO:0060243; GO:0070062; GO:0070161; GO:0090675; GO:0098609 calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] ANPMLNLPNK 0.93384 1.0663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8036 0 0 0 0 0 0 0 11.7719 0 14.0979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8517 0 0 0 0 0 0 0 0 0 0 0 10.9952 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4842 0 0 0 0 0 0 0 0 0 0 0 0 13.0704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.75 0 0 0 0 0 0 Q9NVT9 ARMC1_HUMAN Armadillo repeat-containing protein 1 ARMC1 ARCP Homo sapiens (Human) intracellular distribution of mitochondria [GO:0048312] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; intracellular distribution of mitochondria [GO:0048312] GO:0005739; GO:0005741; GO:0005829; GO:0046872; GO:0048312 metal ion binding [GO:0046872] IKGVISFTFQMAVQRCVVR 0.93386 1.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6XPS3 TPTE2_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2, EC 3.1.3.67 (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)" TPTE2 TPIP Homo sapiens (Human) cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; protein tyrosine phosphatase activity [GO:0004725]; cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896]" GO:0000139; GO:0004725; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0008285; GO:0014065; GO:0016021; GO:0016311; GO:0016314; GO:0042995; GO:0046856; GO:0048870; GO:0051800; GO:0051896 "phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; protein tyrosine phosphatase activity [GO:0004725]" FLDKKHR 0.93388 2.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2291 0 13.5799 0 0 0 10.8238 0 0 0 0 0 0 0 0 0 12.9724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8567 0 0 0 15.8392 0 0 0 12.3269 0 0 0 0 13.6367 0 13.3624 11.7649 0 0 11.2359 11.9261 0 0 14.4291 0 0 0 14.4822 13.2135 0 15.3946 0 11.5342 0 0 0 0 0 0 11.4561 14.2235 0 0 0 0 0 0 0 0 13.0229 0 0 12.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7063 0 11.7621 0 13.2946 0 0 11.4656 0 0 0 0 0 14.1456 14.7045 0 0 0 11.4947 13.0311 0 0 0 0 0 0 0 18.1433 0 0 0 0 0 12.658 0 0 14.9292 0 0 0 0 0 0 18.3229 0 0 Q5XLA6 CAR17_HUMAN Caspase recruitment domain-containing protein 17 (Caspase-1 inhibitor INCA) (Inhibitory caspase recruitment domain protein) CARD17 INCA Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; negative regulation of interleukin-1 beta production [GO:0032691]; regulation of apoptotic process [GO:0042981] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of interleukin-1 beta production [GO:0032691]; regulation of apoptotic process [GO:0042981] GO:0004869; GO:0005737; GO:0032691; GO:0032991; GO:0042802; GO:0042981; GO:0071222; GO:0089720 caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802] ARALLDSVIRK 0.9339 1.064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2276 0 0 0 0 0 11.8417 0 0 0 0 0 11.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99687 MEIS3_HUMAN Homeobox protein Meis3 (Meis1-related protein 2) MEIS3 MRG2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003682; GO:0005634; GO:0006357; GO:0007420; GO:0008284; GO:0009880; GO:0009887; GO:0043565; GO:0045944; GO:0051897; GO:1990837; GO:2001234 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AWLFQHLSHPYPSEEQKK 0.9339 2.097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0044 0 0 0 0 0 0 0 0 11.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2858 0 0 0 0 0 0 0 0 0 0 0 10.9725 0 10.7325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXR3 POK6_HUMAN "Endogenous retrovirus group K member 6 Pol protein (HERV-K(C7) Pol protein) (HERV-K(HML-2.HOM) Pol protein) (HERV-K108 Pol protein) (HERV-K_7p22.1 provirus ancestral Pol protein) [Includes: Reverse transcriptase, RT, EC 2.7.7.49; Ribonuclease H, RNase H, EC 3.1.26.4; Integrase, IN ]" ERVK-6 ERVK6 Homo sapiens (Human) DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] GO:0003677; GO:0003964; GO:0004523; GO:0006281; GO:0006310; GO:0008270; GO:0015074; GO:0035613 DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] AAYTGPK 0.93392 1.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5769 12.6194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4W6 COE3_HUMAN "Transcription factor COE3 (Early B-cell factor 3, EBF-3) (Olf-1/EBF-like 2, O/E-2, OE-2)" EBF3 COE3 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0045893; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EVLLKRAADLVEALYGMPHNNQEIILK 0.93392 1.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95409 ZIC2_HUMAN Zinc finger protein ZIC 2 (Zinc finger protein of the cerebellum 2) ZIC2 Homo sapiens (Human) "brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007417; GO:0007420; GO:0007601; GO:0016604; GO:0030154; GO:0031490; GO:0045892; GO:0045893; GO:0046872; GO:0051091 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LVNHIRVHTGEK 0.93397 1.0493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62750 RL23A_HUMAN 60S ribosomal protein L23a (Large ribosomal subunit protein uL23) RPL23A Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0019843; GO:0022625; GO:0022626; GO:0045296; GO:0070062; GO:1904841 cadherin binding [GO:0045296]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841] HQIKQAVKK 0.93397 2.1468 0 11.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3419 0 0 14.5908 0 0 14.472 0 14.4292 14.7129 14.9196 15.0571 13.6746 15.7253 14.3969 13.7029 0 0 0 0 0 13.1817 0 14.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7405 0 0 0 0 0 0 0 0 0 13.6363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969I6 S38A4_HUMAN Sodium-coupled neutral amino acid transporter 4 (Amino acid transporter A3) (Na(+)-coupled neutral amino acid transporter 4) (Solute carrier family 38 member 4) (System A amino acid transporter 3) (System N amino acid transporter 3) SLC38A4 ATA3 NAT3 SNAT4 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; sodium ion transport [GO:0006814] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; symporter activity [GO:0015293]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; sodium ion transport [GO:0006814] GO:0003333; GO:0005886; GO:0005887; GO:0006814; GO:0006865; GO:0015171; GO:0015179; GO:0015293 amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; symporter activity [GO:0015293] HFLIAAVLIALNNVLVILVPTIK 0.93399 2.1079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6477 0 0 13.7875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.734 0 0 0 14.9644 15.1355 0 0 0 12.2802 0 0 0 0 0 0 0 13.1978 0 0 14.3078 12.765 14.5473 0 14.1658 0 0 0 0 15.1455 0 0 13.949 12.8307 0 12.467 0 13.1549 13.4484 14.0598 0 0 0 0 0 0 0 0 0 13.8756 0 0 0 13.6482 0 0 0 0 14.4908 0 13.7233 0 0 0 0 14.2172 0 0 0 0 0 11.9195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1207 13.0353 0 0 0 0 0 0 Q9H173 SIL1_HUMAN "Nucleotide exchange factor SIL1 (BiP-associated protein, BAP)" SIL1 UNQ545/PRO836 Homo sapiens (Human) cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457] GO:0000774; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0006613; GO:0006886; GO:0042802; GO:0051082 adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082] KKVLFALCSLLR 0.93399 2.3747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9821 14.3047 0 0 15.1691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1205 0 0 0 0 0 0 14.0714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75808 CAN15_HUMAN "Calpain-15, EC 3.4.22.- (Small optic lobes homolog)" CAPN15 SOLH Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; proteolysis [GO:0006508] GO:0004198; GO:0005737; GO:0006508; GO:0046872 calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872] DEEEKEEQEEEEGAAEPRGGWACPR 0.93401 1.7024 0 0 0 0 0 0 0 0 0 0 0 15.6723 0 14.2675 14.0408 13.6931 13.5694 13.0432 13.3096 16.2189 0 0 14.5439 0 13.4557 0 0 12.4148 0 0 0 14.9313 10.1782 13.977 15.7352 15.3698 16.5392 0 16.6079 12.7908 0 14.081 0 0 0 0 0 0 0 0 0 16.0988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0544 13.9102 13.5982 13.7285 14.0458 13.5961 12.9843 0 0 13.5205 13.5676 0 0 17.7492 17.9509 0 18.0542 18.1439 0 12.8453 0 0 13.4132 13.5287 12.4451 13.7048 0 18.0358 0 14.0063 0 0 13.3973 0 13.4718 13.7445 0 0 12.9933 12.9645 14.5319 17.3174 18.6576 0 17.8106 13.1106 12.5701 0 12.7722 11.9688 0 0 14.1172 13.3454 13.6801 17.5708 13.4642 13.285 0 0 12.7976 0 14.3647 13.2458 11.7314 18.3519 18.3905 16.9217 14.1155 16.8704 16.8837 11.8969 16.7184 0 0 0 13.0628 0 0 0 12.7508 0 14.1225 0 0 0 0 16.6809 0 16.155 16.1683 17.1149 17.1445 0 0 13.3355 14.7928 0 12.9674 14.2876 0 0 0 0 0 0 P42765 THIM_HUMAN "3-ketoacyl-CoA thiolase, mitochondrial, EC 2.3.1.16 (Acetyl-CoA acetyltransferase, EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial, EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)" ACAA2 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723]; cellular response to hypoxia [GO:0071456]; cholesterol biosynthetic process [GO:0006695]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] GO:0003723; GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006635; GO:0006695; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109 acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; RNA binding [GO:0003723] AANDAGYFNDEMAPIEVK 0.93405 1.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0472 16.715 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5638 0 0 0 0 0 0 0 0 0 0 13.0762 13.9955 0 0 0 13.4157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.58192 0 0 0 0 0 0 0 0 0 Q8N0U2 TMM61_HUMAN Transmembrane protein 61 TMEM61 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DLYYLTVESSEKESCRTPK 0.93405 1.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TGL8 PXDC1_HUMAN PX domain-containing protein 1 PXDC1 C6orf145 Homo sapiens (Human) phosphatidylinositol binding [GO:0035091] GO:0035091 phosphatidylinositol binding [GO:0035091] SVLYLHRSLADLGR 0.93409 1.0665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4354 0 0 0 0 0 0 0 0 0 0 12.2063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.857 0 0 0 0 0 0 11.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD20 GTR12_HUMAN "Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12, GLUT-12)" SLC2A12 GLUT12 Homo sapiens (Human) circulatory system development [GO:0072359]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; transmembrane transport [GO:0055085] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; circulatory system development [GO:0072359]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; transmembrane transport [GO:0055085] GO:0005355; GO:0005886; GO:0008645; GO:0012505; GO:0015293; GO:0016020; GO:0016021; GO:0048471; GO:0055056; GO:0055085; GO:0072359; GO:1904659 D-glucose transmembrane transporter activity [GO:0055056]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293] DEYQYSFWDLFR 0.93409 1.6726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRP1 PDD2L_HUMAN Programmed cell death protein 2-like PDCD2L Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; apoptotic process [GO:0006915]; cell cycle [GO:0007049] GO:0005737; GO:0006915; GO:0007049; GO:0016020 DAPVHGSPTGPGAWTASK 0.93411 1.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4252 0 0 0 0 0 13.6902 0 0 0 0 0 0 0 0 0 14.3811 0 0 13.0309 13.1899 0 0 0 0 0 0 0 13.0107 14.1698 0 0 0 0 0 15.321 0 0 13.7248 0 0 0 0 12.9776 0 14.3771 0 0 0 0 13.9936 15.1127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95208 EPN2_HUMAN Epsin-2 (EPS-15-interacting protein 2) EPN2 KIAA1065 Homo sapiens (Human) endocytosis [GO:0006897]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of Notch signaling pathway [GO:0045747] clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] clathrin coat of endocytic vesicle [GO:0030128]; clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of Notch signaling pathway [GO:0045747] GO:0005543; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0030125; GO:0030128; GO:0030276; GO:0030948; GO:0043231; GO:0045296; GO:0045747; GO:1903671 cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] QLVALLKDEER 0.93412 1.8303 0 0 0 0 0 0 0 0 0 10.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7001 0 0 0 12.3094 0 0 0 0 0 0 0 13.2633 0 0 0 0 0 0 0 0 0 0 0 0 12.2253 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYD3 RM04_HUMAN "39S ribosomal protein L4, mitochondrial, L4mt, MRP-L4 (Mitochondrial large ribosomal subunit protein uL4m)" MRPL4 CDABP0091 CGI-28 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] HQTLVLTLPTVAFLEDKLLWQDSRYR 0.93413 1.0664 0 0 0 0 0 0 15.0146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9283 0 0 0 0 0 0 0 0 0 0 9.60923 0 0 0 0 0 0 0 0 0 0 0 12.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0572 0 14.7853 0 0 14.98 14.7159 12.1128 0 0 14.5327 0 0 0 0 0 0 0 0 0 0 0 0 13.3204 0 0 0 0 0 0 0 0 0 0 0 0 14.2625 0 0 0 0 0 0 0 0 0 0 0 0 14.8062 0 14.2214 11.2888 14.8405 0 0 13.9395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVR7 TBCC1_HUMAN TBCC domain-containing protein 1 TBCCD1 Homo sapiens (Human) maintenance of centrosome location [GO:0051661]; maintenance of Golgi location [GO:0051684]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; spindle pole centrosome [GO:0031616] cytoplasm [GO:0005737]; spindle pole centrosome [GO:0031616]; maintenance of centrosome location [GO:0051661]; maintenance of Golgi location [GO:0051684]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360] GO:0005737; GO:0008360; GO:0030334; GO:0031616; GO:0051661; GO:0051684 EQKIQIWQKTVK 0.93414 1.6997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6004 13.8918 0 0 0 0 0 0 0 0 0 0 12.646 0 0 0 0 12.527 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0447 0 11.8632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1364 0 Q14050 CO9A3_HUMAN Collagen alpha-3(IX) chain COL9A3 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; female gonad development [GO:0008585]; male gonad development [GO:0008584] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; female gonad development [GO:0008585]; male gonad development [GO:0008584] GO:0005201; GO:0005576; GO:0005594; GO:0005604; GO:0005615; GO:0005788; GO:0008584; GO:0008585; GO:0030020; GO:0030198; GO:0031012; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] GFQGQKGSMGDPGLPGPQGLR 0.93415 1.6708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1072 0 0 0 0 0 0 0 0 0 0 0 0 0 P78352 DLG4_HUMAN "Disks large homolog 4 (Postsynaptic density protein 95, PSD-95) (Synapse-associated protein 90, SAP-90, SAP90)" DLG4 PSD95 Homo sapiens (Human) AMPA glutamate receptor clustering [GO:0097113]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; dendritic spine morphogenesis [GO:0060997]; establishment of protein localization [GO:0045184]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; learning [GO:0007612]; locomotory exploration behavior [GO:0035641]; negative regulation of receptor internalization [GO:0002091]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic transmission [GO:0050806]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of grooming behavior [GO:2000821]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic vesicle maturation [GO:0016188]; vocalization behavior [GO:0071625] adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cerebellar mossy fiber [GO:0044300]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; excitatory synapse [GO:0060076]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; voltage-gated potassium channel complex [GO:0008076] adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cerebellar mossy fiber [GO:0044300]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; excitatory synapse [GO:0060076]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; voltage-gated potassium channel complex [GO:0008076]; acetylcholine receptor binding [GO:0033130]; beta-1 adrenergic receptor binding [GO:0031697]; beta-2 adrenergic receptor binding [GO:0031698]; D1 dopamine receptor binding [GO:0031748]; frizzled binding [GO:0005109]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; neuroligin family protein binding [GO:0097109]; P2Y1 nucleotide receptor binding [GO:0031812]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; structural constituent of postsynaptic density [GO:0098919]; AMPA glutamate receptor clustering [GO:0097113]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; dendritic spine morphogenesis [GO:0060997]; establishment of protein localization [GO:0045184]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; learning [GO:0007612]; locomotory exploration behavior [GO:0035641]; negative regulation of receptor internalization [GO:0002091]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of synaptic transmission [GO:0050806]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of grooming behavior [GO:2000821]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic vesicle maturation [GO:0016188]; vocalization behavior [GO:0071625] GO:0002091; GO:0005109; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005912; GO:0007165; GO:0007204; GO:0007268; GO:0007399; GO:0007612; GO:0008021; GO:0008022; GO:0008076; GO:0014069; GO:0016188; GO:0019865; GO:0019894; GO:0019900; GO:0019901; GO:0019903; GO:0030054; GO:0030165; GO:0030666; GO:0030863; GO:0031234; GO:0031594; GO:0031697; GO:0031698; GO:0031748; GO:0031812; GO:0032281; GO:0032839; GO:0033130; GO:0035176; GO:0035255; GO:0035418; GO:0035641; GO:0035865; GO:0043005; GO:0043113; GO:0043197; GO:0044224; GO:0044300; GO:0044306; GO:0044309; GO:0044877; GO:0045184; GO:0045197; GO:0045202; GO:0045211; GO:0048169; GO:0050806; GO:0050885; GO:0060076; GO:0060997; GO:0061098; GO:0065003; GO:0071625; GO:0097060; GO:0097109; GO:0097110; GO:0097113; GO:0097120; GO:0098609; GO:0098839; GO:0098919; GO:0098970; GO:0098978; GO:0099031; GO:0099645; GO:0150012; GO:1904719; GO:2000310; GO:2000463; GO:2000821 acetylcholine receptor binding [GO:0033130]; beta-1 adrenergic receptor binding [GO:0031697]; beta-2 adrenergic receptor binding [GO:0031698]; D1 dopamine receptor binding [GO:0031748]; frizzled binding [GO:0005109]; immunoglobulin binding [GO:0019865]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; neuroligin family protein binding [GO:0097109]; P2Y1 nucleotide receptor binding [GO:0031812]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; structural constituent of postsynaptic density [GO:0098919] DWGSSSGSQGR 0.93416 1.8407 0 0 0 0 0 0 11.3215 0 0 0 0 0 0 0 0 14.495 0 14.218 13.7046 0 0 0 14.2101 13.4152 14.1048 0 15.4317 13.2538 0 0 0 0 0 0 0 0 0 0 0 0 14.3022 0 14.3202 0 14.3899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1592 0 0 0 0 13.0578 0 13.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7976 0 14.7236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9803 0 0 0 0 0 14.8321 0 0 14.5783 0 0 0 0 0 0 0 Q16619 CTF1_HUMAN "Cardiotrophin-1, CT-1" CTF1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; leukemia inhibitory factor signaling pathway [GO:0048861]; muscle organ development [GO:0007517]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; leukemia inhibitory factor receptor binding [GO:0005146]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; leukemia inhibitory factor signaling pathway [GO:0048861]; muscle organ development [GO:0007517]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] GO:0005125; GO:0005146; GO:0005576; GO:0005615; GO:0007166; GO:0007267; GO:0007517; GO:0008284; GO:0030182; GO:0042531; GO:0048666; GO:0048861 cytokine activity [GO:0005125]; leukemia inhibitory factor receptor binding [GO:0005146] RQAELNPRAPR 0.93418 1.064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06643 TNFC_HUMAN "Lymphotoxin-beta, LT-beta (Tumor necrosis factor C, TNF-C) (Tumor necrosis factor ligand superfamily member 3)" LTB TNFC TNFSF3 Homo sapiens (Human) cell-cell signaling [GO:0007267]; gene expression [GO:0010467]; immune response [GO:0006955]; lymph node development [GO:0048535]; positive regulation of interleukin-12 production [GO:0032735]; signal transduction [GO:0007165]; skin development [GO:0043588] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; cell-cell signaling [GO:0007267]; gene expression [GO:0010467]; immune response [GO:0006955]; lymph node development [GO:0048535]; positive regulation of interleukin-12 production [GO:0032735]; signal transduction [GO:0007165]; skin development [GO:0043588] GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006955; GO:0007165; GO:0007267; GO:0010467; GO:0016021; GO:0032735; GO:0043588; GO:0048535 cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] RGERVYVNISHPDMVDFAR 0.93419 1.8282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTX5 ECHD1_HUMAN "Ethylmalonyl-CoA decarboxylase, EC 4.1.1.94 (Enoyl-CoA hydratase domain-containing protein 1) (Methylmalonyl-CoA decarboxylase, MMCD)" ECHDC1 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635] cytosol [GO:0005829] cytosol [GO:0005829]; carboxy-lyase activity [GO:0016831]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635] GO:0004300; GO:0005829; GO:0006635; GO:0016831 carboxy-lyase activity [GO:0016831]; enoyl-CoA hydratase activity [GO:0004300] LVEIIGSRQALKVLSGALK 0.93419 1.0658 0 0 0 0 14.2136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56270 MAZ_HUMAN "Myc-associated zinc finger protein, MAZI (Pur-1) (Purine-binding transcription factor) (Serum amyloid A-activating factor-1, SAF-1) (Transcription factor Zif87) (ZF87) (Zinc finger protein 801)" MAZ ZNF801 Homo sapiens (Human) "negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000122; GO:0000978; GO:0000981; GO:0003700; GO:0003723; GO:0005634; GO:0006357; GO:0006367; GO:0006369; GO:0008284; GO:0010628; GO:0014068; GO:0030335; GO:0045893; GO:0046872; GO:0051897; GO:2001234 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DVYHLNR 0.9342 1.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5FYA8 ARSH_HUMAN "Arylsulfatase H, ASH, EC 3.1.6.-" ARSH Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021] endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005788; GO:0016021; GO:0046872 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] EALAFIERYKR 0.93421 5.3685 0 0 0 11.5361 0 0 0 0 10.5728 0 0 0 0 0 0 0 10.3939 0 0 0 0 0 0 0 0 0 0 0 0 11.8617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4441 0 0 0 0 10.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 11.549 12.06 0 0 0 0 0 13.6313 0 0 13.9376 12.5964 0 0 16.9127 0 0 0 16.3991 0 0 0 14.5643 0 11.6265 12.3035 11.4182 0 0 0 12.3097 0 0 0 0 0 0 0 16.1426 0 0 0 0 12.5189 13.3669 0 0 0 0 0 0 0 15.3296 12.9086 14.7081 0 0 12.4021 0 12.7488 0 0 0 0 12.3632 12.5581 0 0 0 0 0 12.3467 0 11.7651 0 0 0 0 0 0 13.3658 0 12.0871 0 13.9585 0 0 0 0 0 0 0 12.1824 0 0 0 0 0 0 0 0 11.7412 11.9421 0 0 0 0 0 0 Q8N5S3 CB073_HUMAN Uncharacterized protein C2orf73 C2orf73 Homo sapiens (Human) GAEVLLNTPGSR 0.93421 2.1043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4546 0 0 0 0 9.55034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9209 0 0 0 18.194 0 0 0 11.43 0 0 0 12.3359 0 0 17.7855 0 0 0 12.2841 0 17.6753 0 0 0 0 0 0 0 0 0 0 0 17.5308 17.5569 17.4786 0 17.5111 0 17.4225 17.4679 0 0 0 0 17.507 17.5281 0 0 0 17.4783 0 0 0 0 17.3782 0 0 0 0 0 0 0 17.4508 0 17.4439 0 0 0 0 17.4127 0 0 0 0 17.2847 13.5189 0 0 17.4539 0 0 0 0 0 0 11.1522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8099 0 10.249 0 0 0 0 0 Q9H6X4 TM134_HUMAN Transmembrane protein 134 TMEM134 Homo sapiens (Human) cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] GO:0005829; GO:0016021; GO:0048471 SYNTCCSWTQHPLIQKNRR 0.93423 1.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3015 0 0 12.5908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9943 0 0 0 0 0 12.9357 0 0 0 0 0 0 12.7164 0 0 12.9407 0 0 0 0 0 12.7434 0 0 0 0 13.1112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J2E0 TVBL4_HUMAN T cell receptor beta variable 12-4 TRBV12-4 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 GSWTLCCVSLCILVAK 0.93424 1.0494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60507 EFC1_HUMAN "Endogenous retrovirus group FC1 Env polyprotein (Envelope polyprotein) (Fc1env) (HERV-F(c)1_Xq21.33 provirus ancestral Env polyprotein) (HERV-Fc1env) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERVFC1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ARPSPLCLLLLLTLLTPIVPSNSLLTEPPFR 0.93425 2.6334 0 0 0 10.2778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0368 0 0 0 0 0 0 0 12.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0756 0 0 0 0 0 0 0 0 0 0 0 15.1035 0 0 0 11.2532 0 12.7808 13.5052 0 0 0 0 13.5697 12.3159 0 0 0 0 0 11.2755 0 0 Q9H1K4 GHC2_HUMAN "Mitochondrial glutamate carrier 2, GC-2 (Glutamate/H(+) symporter 2) (Solute carrier family 25 member 18)" SLC25A18 GC2 Homo sapiens (Human) aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490] GO:0005280; GO:0005313; GO:0005743; GO:0006811; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0043490 amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857] GAAVNLTLVTPEKAIK 0.93428 1.0493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P45844 ABCG1_HUMAN "ATP-binding cassette sub-family G member 1, EC 7.6.2.- (ATP-binding cassette transporter 8) (White protein homolog)" ABCG1 ABC8 WHT1 Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol metabolic process [GO:0090181]; response to lipid [GO:0033993]; response to organic substance [GO:0010033]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ABC-type sterol transporter activity [GO:0034041]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534]; amyloid precursor protein catabolic process [GO:0042987]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; glycoprotein transport [GO:0034436]; high-density lipoprotein particle remodeling [GO:0034375]; intracellular cholesterol transport [GO:0032367]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol metabolic process [GO:0090181]; response to lipid [GO:0033993]; response to organic substance [GO:0010033]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085] GO:0000139; GO:0005524; GO:0005543; GO:0005739; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0008203; GO:0009897; GO:0010033; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016020; GO:0016021; GO:0019534; GO:0032367; GO:0033344; GO:0033700; GO:0033993; GO:0034041; GO:0034374; GO:0034375; GO:0034436; GO:0042626; GO:0042632; GO:0042803; GO:0042987; GO:0043531; GO:0043691; GO:0045542; GO:0046982; GO:0050714; GO:0055037; GO:0055085; GO:0055091; GO:0071403; GO:0090181; GO:0090554; GO:0120020; GO:0140328; GO:1902004 ABC-type sterol transporter activity [GO:0034041]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; toxin transmembrane transporter activity [GO:0019534] AVREGMCDSDHK 0.93429 2.1522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.571 0 0 0 12.7264 0 13.6498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2P2 ANM9_HUMAN "Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10, EC 2.1.1.320)" PRMT9 PRMT10 Homo sapiens (Human) mRNA processing [GO:0006397]; peptidyl-arginine methylation [GO:0018216] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; mRNA processing [GO:0006397]; peptidyl-arginine methylation [GO:0018216] GO:0005737; GO:0006397; GO:0016274; GO:0018216; GO:0035241; GO:0035243 protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243] AVCLGSKSVLDIGAGTGILSMFAKK 0.9343 2.1029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6206 0 0 0 0 0 0 0 0 0 10.8263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3835 0 0 0 0 11.6931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4615 13.0855 0 0 0 0 0 0 0 0 0 0 0 0 12.4701 0 0 0 0 0 0 0 11.0135 0 12.333 0 0 0 0 0 12.909 0 0 0 11.9769 0 11.7198 0 0 0 0 0 0 0 0 0 0 0 0 13.8943 0 0 0 0 0 0 0 0 13.454 0 0 0 0 0 12.2971 0 0 0 0 12.2076 0 0 0 0 0 Q9Y5F0 PCDBD_HUMAN "Protocadherin beta-13, PCDH-beta-13" PCDHB13 UNQ332/PRO531 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; postsynaptic membrane [GO:0045211] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; postsynaptic membrane [GO:0045211]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0032391; GO:0045211; GO:0097381 calcium ion binding [GO:0005509] INPLTGEIELKK 0.9343 1.0493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7D7 WDR26_HUMAN WD repeat-containing protein 26 (CUL4- and DDB1-associated WDR protein 2) (Myocardial ischemic preconditioning up-regulated protein 2) WDR26 CDW2 MIP2 PRO0852 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0034657; GO:0043161 DTTVIIWQVDPDTHLLKLLK 0.93433 4.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8626 0 0 0 0 0 0 0 0 0 0 12.6664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0749 0 0 0 11.5945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3191 0 0 0 0 0 0 0 0 12.5431 0 0 0 12.9553 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9469 0 0 Q9H6L2 TM231_HUMAN Transmembrane protein 231 TMEM231 UNQ870/PRO1886 Homo sapiens (Human) camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944] ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038] ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224]; vasculature development [GO:0001944] GO:0001701; GO:0001944; GO:0007224; GO:0016021; GO:0032880; GO:0035869; GO:0036038; GO:0042733; GO:0043010; GO:0060170; GO:0060271; GO:0060563 IKIFVFQNQVVTTIPVTVTPRGDLCK 0.93434 2.1508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5Z0 BACE2_HUMAN "Beta-secretase 2, EC 3.4.23.45 (Aspartic-like protease 56 kDa) (Aspartyl protease 1, ASP1, Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2, Beta-site APP cleaving enzyme 2) (Down region aspartic protease, DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase)" BACE2 AEPLC ALP56 ASP21 CDA13 UNQ418/PRO852 Homo sapiens (Human) amyloid-beta metabolic process [GO:0050435]; glucose homeostasis [GO:0042593]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; peptide hormone processing [GO:0016486]; proteolysis [GO:0006508] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; aspartic-type endopeptidase activity [GO:0004190]; amyloid-beta metabolic process [GO:0050435]; glucose homeostasis [GO:0042593]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; peptide hormone processing [GO:0016486]; proteolysis [GO:0006508] GO:0004190; GO:0005768; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0016021; GO:0016486; GO:0042593; GO:0042985; GO:0050435 aspartic-type endopeptidase activity [GO:0004190] ALLLPLLAQWLLR 0.93439 3.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9481 0 0 0 0 0 0 0 0 0 0 0 13.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2708 0 0 0 0 0 0 13.1403 0 0 0 12.7971 0 0 0 0 0 12.4715 0 0 0 0 0 0 0 13.7215 0 0 0 0 14.032 11.3025 0 0 0 0 0 14.1683 0 0 0 0 0 0 0 13.3817 15.0638 13.6961 0 14.6179 0 0 0 13.229 13.7179 13.7382 0 0 0 0 13.9379 11.8647 0 0 0 0 0 0 0 0 13.4014 0 13.193 0 0 0 0 0 0 0 0 0 0 13.2573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ73 RFFL_HUMAN "E3 ubiquitin-protein ligase rififylin, EC 2.3.2.27 (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2, CARP-2) (FYVE-RING finger protein Sakura, Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like) (RING-type E3 ubiquitin transferase rififylin)" RFFL RNF189 RNF34L Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of TOR signaling [GO:0032006]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of TOR signaling [GO:0032006]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0002020; GO:0002039; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0010008; GO:0010762; GO:0010804; GO:0016020; GO:0019901; GO:0031625; GO:0032006; GO:0043161; GO:0046872; GO:0055038; GO:0061630; GO:0070936; GO:1901796; GO:1901797; GO:1902042; GO:2001271 metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] KNFCMTCSSQVGNGPR 0.93441 1.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.992 0 15.7081 0 0 0 0 0 0 14.6096 0 0 0 0 0 0 0 14.6278 16.1061 0 0 14.5339 0 0 0 14.6169 0 0 0 14.1 0 0 0 0 0 13.367 14.0604 14.8974 0 0 0 0 0 0 0 0 13.5387 0 0 0 0 0 0 0 0 0 0 0 13.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1374 0 0 P48023 TNFL6_HUMAN "Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand, APTL) (CD95 ligand, CD95-L) (Fas antigen ligand, Fas ligand, FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand, sFasL); ADAM10-processed FasL form, APL; FasL intracellular domain, FasL ICD (SPPL2A-processed FasL form, SPA) ]" FASLG APT1LG1 CD95L FASL TNFSF6 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell-cell signaling [GO:0007267]; cellular chloride ion homeostasis [GO:0030644]; cellular response to interferon-gamma [GO:0071346]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory cell apoptotic process [GO:0006925]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylserine exposure on apoptotic cell surface [GO:1905782]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231] caveola [GO:0005901]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell-cell signaling [GO:0007267]; cellular chloride ion homeostasis [GO:0030644]; cellular response to interferon-gamma [GO:0071346]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory cell apoptotic process [GO:0006925]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylserine exposure on apoptotic cell surface [GO:1905782]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231] GO:0000122; GO:0005102; GO:0005123; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0005887; GO:0005901; GO:0006915; GO:0006919; GO:0006925; GO:0007165; GO:0007267; GO:0008284; GO:0008625; GO:0009897; GO:0016525; GO:0030644; GO:0032496; GO:0043065; GO:0043123; GO:0043202; GO:0043525; GO:0045742; GO:0046666; GO:0048388; GO:0048471; GO:0060205; GO:0070062; GO:0070231; GO:0070266; GO:0070848; GO:0071346; GO:0097190; GO:0097191; GO:0097527; GO:1903514; GO:1905782; GO:2000353 cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] ELRKVAHLTGK 0.93443 1.7037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2418 0 0 0 12.5494 0 0 0 0 0 0 0 0 0 0 0 0 11.9786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7905 0 0 0 13.8365 0 0 0 0 0 0 0 13.0309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2694 0 0 0 0 0 0 0 0 0 14.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4883 0 15.4065 0 0 0 0 0 0 O15547 P2RX6_HUMAN "P2X purinoceptor 6, P2X6 (ATP receptor) (P2XM) (Purinergic receptor) (Purinergic receptor P2X-like 1)" P2RX6 P2RXL1 P2X6 Homo sapiens (Human) muscle contraction [GO:0006936]; response to ATP [GO:0033198]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235] cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; channel activity [GO:0015267]; extracellularly ATP-gated cation channel activity [GO:0004931]; protein-containing complex binding [GO:0044877]; purinergic nucleotide receptor activity [GO:0001614]; transmembrane signaling receptor activity [GO:0004888]; muscle contraction [GO:0006936]; response to ATP [GO:0033198]; signal transduction [GO:0007165] GO:0001614; GO:0004888; GO:0004931; GO:0005524; GO:0005639; GO:0005737; GO:0005886; GO:0005887; GO:0006936; GO:0007165; GO:0014069; GO:0015267; GO:0030054; GO:0033198; GO:0043025; GO:0043197; GO:0043235; GO:0044877; GO:0098688; GO:0098978; GO:0099060 ATP binding [GO:0005524]; channel activity [GO:0015267]; extracellularly ATP-gated cation channel activity [GO:0004931]; protein-containing complex binding [GO:0044877]; purinergic nucleotide receptor activity [GO:0001614]; transmembrane signaling receptor activity [GO:0004888] GYQERDLEPQFSIITKLK 0.93444 2.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5914 0 0 0 0 0 14.5014 14.481 14.3197 14.3292 0 14.2477 0 15.0684 0 14.3077 0 0 0 14.2017 0 0 14.0836 0 14.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1732 0 0 0 0 0 0 0 12.7962 0 0 0 11.5882 14.14 0 0 0 0 0 0 0 12.8224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6329 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6792 0 0 0 0 14.8674 0 0 12.1625 0 14.5205 0 13.6647 0 0 0 0 12.1614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J01 THOC3_HUMAN "THO complex subunit 3, Tho3 (TEX1 homolog) (hTREX45)" THOC3 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] GO:0000346; GO:0000445; GO:0003723; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0046784 RNA binding [GO:0003723] THRSKAEEQFK 0.93446 1.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KN9 CXD4_HUMAN "Gap junction delta-4 protein (Connexin-40.1, Cx40.1)" GJD4 CX40.1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014717] connexin complex [GO:0005922]; integral component of membrane [GO:0016021] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014717] GO:0005243; GO:0005922; GO:0007267; GO:0014717; GO:0016021 gap junction channel activity [GO:0005243] LWFVLTMLLRMLVIVLAGR 0.93446 1.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRA2 TXD17_HUMAN "Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein, TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5)" TXNDC17 TXNL5 Homo sapiens (Human) tumor necrosis factor-mediated signaling pathway [GO:0033209] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxidase activity [GO:0004601]; protein-disulfide reductase (NAD(P)) activity [GO:0047134]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0004601; GO:0005829; GO:0033209; GO:0047134; GO:0070062 peroxidase activity [GO:0004601]; protein-disulfide reductase (NAD(P)) activity [GO:0047134] AVEQHNGKTIFAYFTGSK 0.93447 1.7031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VG73 YC023_HUMAN Putative uncharacterized protein LOC152225 Homo sapiens (Human) NNSFNKEDRMSSDTMVGSCDR 0.93449 1.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7074 0 0 0 14.6207 0 0 0 0 0 14.2669 0 0 0 14.3301 0 0 14.3981 14.4987 0 13.9199 14.1176 0 0 0 14.9827 14.3417 0 0 14.1439 0 0 0 0 0 0 0 14.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19652 A1AG2_HUMAN "Alpha-1-acid glycoprotein 2, AGP 2 (Orosomucoid-2, OMD 2)" ORM2 AGP2 Homo sapiens (Human) acute-phase response [GO:0006953]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune system process [GO:0002682] azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580] azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; acute-phase response [GO:0006953]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune system process [GO:0002682] GO:0002682; GO:0005576; GO:0005615; GO:0006953; GO:0031093; GO:0032731; GO:0032732; GO:0032760; GO:0035578; GO:0035580; GO:0062023; GO:0070062; GO:0072562 DKCEPLEK 0.93451 1.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7Q2 CEAS1_HUMAN Putative uncharacterized protein CELF2-AS1 (CELF2 antisense RNA 1) (CELF2 antisense gene protein 1) CELF2-AS1 C10orf31 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GGQHRTTMMPCLLRVGVFR 0.93451 1.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5N5 N6MT1_HUMAN "Methyltransferase N6AMT1 (HemK methyltransferase family member 2, M.HsaHemK2P) (Lysine N-methyltransferase 9, EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1, EC 2.1.1.-) (Protein N(5)-glutamine methyltransferase, EC 2.1.1.-)" N6AMT1 C21orf127 HEMK2 KMT9 PRED28 Homo sapiens (Human) arsonoacetate metabolic process [GO:0018872]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; histone lysine methylation [GO:0034968]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404] cytosol [GO:0005829]; eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; eRF1 methyltransferase complex [GO:0035657]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone-lysine N-methyltransferase activity [GO:0018024]; methylarsonite methyltransferase activity [GO:0030792]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; arsonoacetate metabolic process [GO:0018872]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; histone lysine methylation [GO:0034968]; methylation [GO:0032259]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404] GO:0003676; GO:0005634; GO:0005829; GO:0006325; GO:0008276; GO:0008757; GO:0009007; GO:0009404; GO:0018024; GO:0018364; GO:0018872; GO:0030307; GO:0030792; GO:0032259; GO:0032775; GO:0032991; GO:0034968; GO:0035657; GO:0036009; GO:1904047 histone-lysine N-methyltransferase activity [GO:0018024]; methylarsonite methyltransferase activity [GO:0030792]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007] CNKVHIQPVITDLVKGLLPR 0.93451 2.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8495 0 0 0 0 0 0 13.5536 13.6172 0 0 0 0 0 11.072 0 0 0 0 0 0 0 14.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7793 0 0 Q5GH72 XKR7_HUMAN XK-related protein 7 XKR7 C20orf159 XRG7 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742 AGTPTPPVFQVR 0.93452 4.1709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6313 12.2848 0 0 0 0 12.5017 0 12.944 0 0 0 0 14.5477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9935 0 0 0 0 0 0 0 11.6856 0 0 0 0 0 13.6549 14.4452 0 0 0 0 0 0 0 0 0 14.7733 0 13.7263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87072 0 0 0 0 0 0 0 0 0 0 0 13.9259 0 13.8706 0 0 0 0 0 0 0 13.9493 12.1063 0 0 0 0 Q6JEL2 KLH10_HUMAN Kelch-like protein 10 KLHL10 Homo sapiens (Human) cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; fertilization [GO:0009566]; homeostasis of number of cells within a tissue [GO:0048873]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567]; spermatid development [GO:0007286] GO:0000902; GO:0005737; GO:0007286; GO:0008584; GO:0009566; GO:0016567; GO:0048808; GO:0048873 KTWHQVAPMHSRR 0.93452 1.0496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3269 0 0 0 0 10.8306 0 11.0077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A49 SYAP1_HUMAN "Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein, BSTA)" SYAP1 PRO3113 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203] GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0031234; GO:0032869; GO:0036120; GO:0038203; GO:0042734; GO:0043204; GO:0045202; GO:0045211; GO:0045600; GO:0048172; GO:0048471; GO:0070062; GO:0070161; GO:0071364; GO:0071902; GO:1990314 EIEKMLQEEN 0.93452 2.1487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7548 0 0 0 0 0 0 0 13.2555 13.6282 14.5158 0 14.8374 15.5437 14.1225 13.6702 14.7799 13.9796 13.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.913 12.2129 0 0 0 0 11.4054 0 0 0 0 0 13.5476 0 0 0 0 0 12.2275 0 12.8286 12.4002 0 0 0 0 0 0 0 0 0 0 10.505 0 0 0 0 13.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06432 CCG1_HUMAN "Voltage-dependent calcium channel gamma-1 subunit (Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma)" CACNG1 CACNLG Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; establishment of localization in cell [GO:0051649]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; sarcoplasmic reticulum calcium ion transport [GO:0070296] integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcolemma [GO:0042383]; T-tubule [GO:0030315] integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport [GO:0070588]; establishment of localization in cell [GO:0051649]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; sarcoplasmic reticulum calcium ion transport [GO:0070296] GO:0005245; GO:0005246; GO:0005887; GO:0030315; GO:0042383; GO:0045933; GO:0051649; GO:0070296; GO:0070588; GO:1902514; GO:1990454 calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245] EYSISAAAIAIFSLGFIILGSLCVLLSLGKK 0.93454 1.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6797 0 0 0 0 0 0 0 0 0 0 0 0 11.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.558 0 0 0 0 12.2825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9096 0 0 0 0 0 0 12.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXN7 TO20L_HUMAN TOMM20-like protein 1 TOMM20L UNQ9438/PRO34772 Homo sapiens (Human) protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031] integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742] integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion targeting sequence binding [GO:0030943]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031] GO:0005742; GO:0016031; GO:0030150; GO:0030943; GO:0031307 mitochondrion targeting sequence binding [GO:0030943] RAEPQKAEEQGTQLWDPTK 0.93455 1.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5796 0 13.033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2P1 NYNRI_HUMAN Protein NYNRIN (NYN domain and retroviral integrase catalytic domain-containing protein) (Protein cousin of GIN1) NYNRIN CGIN1 KIAA1305 Homo sapiens (Human) "DNA integration [GO:0015074]; DNA repair [GO:0006281]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasmic ribonucleoprotein granule [GO:0036464]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]; DNA integration [GO:0015074]; DNA repair [GO:0006281]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" GO:0003729; GO:0004521; GO:0005634; GO:0006281; GO:0015074; GO:0016021; GO:0036464; GO:0090502 endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729] ALKEFIFLHGKK 0.93456 1.8442 0 0 11.5521 0 0 0 0 12.5475 0 14.2655 0 14.2241 13.7967 0 0 0 13.9973 11.8616 0 10.7822 14.1222 0 16.0498 0 13.1264 0 13.0988 13.1103 0 0 0 0 0 11.1277 0 0 0 0 13.1202 0 0 0 0 0 0 0 11.6961 0 11.6622 0 0 0 0 17.7879 0 0 10.6574 0 0 0 0 0 0 15.3088 0 0 0 0 0 11.5166 0 12.5266 0 0 0 10.4165 0 0 9.86127 0 0 0 14.0336 0 0 0 15.2154 0 0 13.4398 0 13.3787 19.9061 14.8783 0 15.1805 14.5844 0 16.9856 15.1977 15.4252 0 0 0 12.6057 0 12.7075 0 13.3665 12.2114 0 14.4051 11.6257 0 0 15.8017 0 13.8081 13.7502 0 14.7262 13.3961 0 14.0405 13.0328 0 0 0 0 14.4773 14.6428 0 0 0 0 0 0 0 0 0 12.79 0 0 0 19.4523 13.6649 0 0 12.8863 0 15.1574 15.3235 12.7764 0 0 0 15.2495 0 0 10.5967 0 0 0 11.7457 0 0 13.6455 13.3545 0 0 10.773 0 14.5109 14.8012 15.2127 0 0 0 13.5622 0 Q6SJ96 TBPL2_HUMAN "TATA box-binding protein-like 2, TBP-like 2 (TATA box-binding protein-related factor 3, TBP-related factor 3)" TBPL2 TBP2 TRF3 Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]" cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; nucleus [GO:0005634]; DNA binding [GO:0003677]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA-templated transcription, initiation [GO:0006352]" GO:0001674; GO:0003677; GO:0005634; GO:0005737; GO:0006352; GO:0016251; GO:0140223 DNA binding [GO:0003677]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II general transcription initiation factor activity [GO:0016251] FAAVIMR 0.93456 1.7018 0 0 0 0 0 0 0 0 0 0 10.7053 13.2189 0 0 0 13.6511 0 0 0 0 10.3052 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8455 0 0 0 13.7581 0 0 0 13.8361 0 0 0 0 0 0 12.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2172 0 11.3737 13.3637 0 0 0 0 0 0 0 0 0 12.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4385 0 0 12.7229 0 0 0 0 0 0 0 13.0365 0 0 0 14.7098 0 0 0 0 15.6569 0 0 0 0 0 0 0 0 13.0422 0 12.1487 0 0 0 0 0 0 13.1366 0 0 0 0 0 0 0 0 0 0 0 14.0882 0 0 14.2095 0 0 12.97 14.0218 0 0 0 0 12.3738 0 0 0 0 16.6208 0 0 0 0 10.6528 0 14.8149 0 0 0 0 0 14.2991 0 0 Q9Y5P1 O51B2_HUMAN Olfactory receptor 51B2 (Odorant receptor HOR5'beta3) (Olfactory receptor 51B1) OR51B2 OR51B1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FGKNVPEVVHIIMSYIYFLFPPLMNPVIYSIKTK 0.93456 2.6864 12.3597 9.56485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8065 0 0 16.0705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9545 0 0 0 0 14.4977 0 15.0172 0 0 0 0 0 0 15.5106 14.1198 0 0 0 0 0 13.7611 13.249 14.2524 13.0562 0 0 0 0 0 14.3287 0 0 0 14.672 0 0 15.0247 0 0 0 0 0 0 0 0 0 0 0 0 14.5855 0 0 0 0 0 14.0039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8044 0 O95081 AGFG2_HUMAN "Arf-GAP domain and FG repeat-containing protein 2 (HIV-1 Rev-binding protein-like protein) (Rev/Rex activation domain-binding protein related, RAB-R)" AGFG2 HRBL RABR Homo sapiens (Human) cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005737; GO:0016020; GO:0046872 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] VRELGGCSQAGNRHCFECAQR 0.93459 1.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2P5 S27A5_HUMAN "Long-chain fatty acid transport protein 5, FATP-5, Fatty acid transport protein 5 (Bile acid-CoA ligase, BA-CoA ligase, BAL) (Bile acyl-CoA synthetase, BACS, EC 6.2.1.7) (Cholate--CoA ligase) (Fatty-acid-coenzyme A ligase, very long-chain 3) (Long-chain-fatty-acid--CoA ligase, EC 6.2.1.3) (Solute carrier family 27 member 5) (Very long-chain acyl-CoA synthetase homolog 2, VLCS-H2, VLCSH2, EC 6.2.1.-) (Very long-chain acyl-CoA synthetase-related protein, VLACS-related, VLACSR)" SLC27A5 ACSB ACSVL6 FACVL3 FATP5 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; establishment of localization in cell [GO:0051649]; ketone body biosynthetic process [GO:0046951]; long-chain fatty acid import across plasma membrane [GO:0015911]; triglyceride mobilization [GO:0006642]; very long-chain fatty acid metabolic process [GO:0000038] basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein-containing complex [GO:0032991] basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; establishment of localization in cell [GO:0051649]; ketone body biosynthetic process [GO:0046951]; long-chain fatty acid import across plasma membrane [GO:0015911]; triglyceride mobilization [GO:0006642]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0004467; GO:0005324; GO:0005524; GO:0005783; GO:0005789; GO:0006642; GO:0006699; GO:0009925; GO:0015245; GO:0015721; GO:0015911; GO:0016491; GO:0030176; GO:0031957; GO:0032991; GO:0044877; GO:0046951; GO:0047747; GO:0051649 ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oxidoreductase activity [GO:0016491]; protein-containing complex binding [GO:0044877]; very long-chain fatty acid-CoA ligase activity [GO:0031957] GVRQQLALLLLLLLLLWGLGQPVWPVAVALTLR 0.9346 4.0595 11.4511 0 0 15.4074 0 0 0 0 0 13.6078 0 0 0 12.8788 0 15.0121 15.4516 14.9465 16.0523 15.5463 15.6322 12.1806 13.0152 0 15.3067 15.7309 13.1506 16.1788 15.7235 15.4632 0 15.175 0 0 0 0 0 0 13.6627 0 15.3071 15.2416 15.217 15.5634 15.8094 15.2485 15.4211 15.3675 15.3373 15.1296 15.1674 0 0 14.6829 14.5036 14.8146 12.3384 12.4966 13.9337 11.2954 12.8785 12.1358 12.2904 12.5917 13.068 13.2663 0 0 0 0 0 10.5253 12.9969 0 12.4489 0 14.2901 13.3892 12.3585 14.2659 14.9109 14.1883 0 0 0 15.0015 14.1581 16.0964 0 0 0 13.9783 15.9265 14.7754 0 13.2207 12.9618 16.6744 17.4406 15.9245 14.0958 17.4537 14.311 16.9977 13.8522 16.3521 14.0983 16.5049 17.2687 16.3417 16.0846 16.3359 12.2735 14.1954 0 15.8767 15.9804 16.5679 16.0229 14.4091 11.923 13.1109 15.9801 16.6966 16.3206 15.9075 11.2161 15.7408 14.0084 14.5002 0 14.0377 0 0 15.1475 15.2377 15.5717 15.4743 16.1504 0 14.3946 13.2526 15.4216 15.248 15.2601 15.4598 15.606 11.065 0 0 15.3295 14.2625 0 16.2133 16.1614 13.9431 15.6562 0 0 0 12.1614 0 0 0 13.87 14.634 0 0 14.1963 0 0 0 15.0603 15.5245 14.1935 0 0 0 15.573 0 Q8TB37 NUBPL_HUMAN Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1) NUBPL C14orf127 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584]" GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0070584; GO:0140663 "4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; metal ion binding [GO:0046872]" AYLRIAVEVVRR 0.9346 2.1475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.049 0 0 0 0 0 0 12.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4692 14.4855 0 0 0 0 0 0 0 0 14.4091 0 0 0 0 0 15.3909 0 0 0 0 14.0936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1509 0 0 0 13.5528 13.141 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0082 0 0 0 0 0 0 0 O00299 CLIC1_HUMAN "Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27, NCC27) (Regulatory nuclear chloride ion channel protein, hRNCC)" CLIC1 G6 NCC27 Homo sapiens (Human) chloride transport [GO:0006821]; glutathione metabolic process [GO:0006749]; platelet aggregation [GO:0070527]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell cycle [GO:0051726]; regulation of ion transmembrane transport [GO:0034765]; regulation of mitochondrial membrane potential [GO:0051881]; signal transduction [GO:0007165] blood microparticle [GO:0072562]; brush border [GO:0005903]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] blood microparticle [GO:0072562]; brush border [GO:0005903]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; chloride transport [GO:0006821]; glutathione metabolic process [GO:0006749]; platelet aggregation [GO:0070527]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell cycle [GO:0051726]; regulation of ion transmembrane transport [GO:0034765]; regulation of mitochondrial membrane potential [GO:0051881]; signal transduction [GO:0007165] GO:0005244; GO:0005254; GO:0005615; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005886; GO:0005903; GO:0006749; GO:0006821; GO:0007165; GO:0016020; GO:0031965; GO:0031982; GO:0034707; GO:0034765; GO:0045296; GO:0045669; GO:0048471; GO:0051726; GO:0051881; GO:0070062; GO:0070527; GO:0072562 cadherin binding [GO:0045296]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244] GFTIPEAFRGVHRYLSNAYAR 0.93461 1.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16553 LY6E_HUMAN "Lymphocyte antigen 6E, Ly-6E (Retinoic acid-induced gene E protein, RIG-E) (Stem cell antigen 2, SCA-2) (Thymic shared antigen 1, TSA-1)" LY6E 9804 RIGE SCA2 TSA1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; negative regulation of viral entry into host cell [GO:0046597] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acetylcholine receptor inhibitor activity [GO:0030550]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of viral entry into host cell [GO:0046597] GO:0005576; GO:0005886; GO:0007166; GO:0030550; GO:0031225; GO:0046597 acetylcholine receptor inhibitor activity [GO:0030550] ASVTLLGAGLLLSLLPALLR 0.93462 1.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5335 0 12.6595 11.8449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6989 0 0 0 0 12.2533 13.2814 11.6237 0 0 0 12.9054 0 12.4314 0 0 12.6687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.757 11.9824 0 12.3442 0 12.3115 13.8789 0 12.2223 0 0 0 0 0 14.6306 0 0 0 14.0423 11.1562 0 0 0 11.7421 0 0 0 0 0 12.0381 Q6UWP7 LCLT1_HUMAN "Lysocardiolipin acyltransferase 1, EC 2.3.1.- (1-acylglycerol-3-phosphate O-acyltransferase 8, 1-AGP acyltransferase 8, 1-AGPAT 8, EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1)" LCLAT1 AGPAT8 ALCAT1 LYCAT UNQ1849/PRO3579 Homo sapiens (Human) cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; O-acyltransferase activity [GO:0008374]; cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149] GO:0003841; GO:0005783; GO:0005789; GO:0005829; GO:0006654; GO:0008374; GO:0012505; GO:0016020; GO:0016021; GO:0016024; GO:0016746; GO:0035965; GO:0036149 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; O-acyltransferase activity [GO:0008374] YPIDTLPTSKEDLQLWCHKR 0.93462 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.773 0 0 0 0 13.1135 0 13.2148 12.0784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEX9 DR9C7_HUMAN "Short-chain dehydrogenase/reductase family 9C member 7, EC 1.1.1.- (Orphan short-chain dehydrogenase/reductase, SDR-O) (RDH-S)" SDR9C7 RDHS SDRO Homo sapiens (Human) retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] GO:0004745; GO:0005737; GO:0008202; GO:0016229; GO:0016491; GO:0042572; GO:0043231 NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229] ELYYFGVKVCIIEPGNYRTAILGK 0.93463 2.6861 0 0 0 0 0 0 0 0 0 0 0 0 10.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6846 0 0 0 0 0 0 0 0 11.6034 0 0 0 0 0 0 0 0 11.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZN2 TGIF2_HUMAN "Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2, TGFB-induced factor 2)" TGIF2 Homo sapiens (Human) "amacrine cell differentiation [GO:0035881]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of amacrine cell differentiation [GO:1902871]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; amacrine cell differentiation [GO:0035881]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway [GO:0038092]; positive regulation of amacrine cell differentiation [GO:1902871]; regulation of gastrulation [GO:0010470]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0010470; GO:0035881; GO:0038092; GO:1902871; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LLPDMLR 0.93464 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6481 0 0 14.6463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUA7 TB22A_HUMAN TBC1 domain family member 22A TBC1D22A C22orf4 Homo sapiens (Human) activation of GTPase activity [GO:0090630] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0042803; GO:0071889; GO:0090630 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803] MASDGAR 0.93466 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92609 TBCD5_HUMAN TBC1 domain family member 5 TBC1D5 KIAA0210 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]" autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904] "autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]; AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:0090630; GO:1905394 AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394] DSFFSNISRSR 0.93466 1.6992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5381 0 0 0 0 0 0 16.4438 13.4988 0 10.3941 0 0 0 0 13.7302 0 0 0 0 0 0 0 0 12.7533 0 0 0 0 13.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7752 0 0 0 0 0 0 0 0 0 0 12.0673 0 0 0 0 12.7376 0 0 0 0 0 0 P02771 FETA_HUMAN Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin) AFP HPAFP Homo sapiens (Human) ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448]; SMAD protein signal transduction [GO:0060395] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; fatty acid binding [GO:0005504]; zinc ion binding [GO:0008270]; ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448]; SMAD protein signal transduction [GO:0060395] GO:0001542; GO:0005504; GO:0005615; GO:0005737; GO:0005788; GO:0008270; GO:0042448; GO:0060395 fatty acid binding [GO:0005504]; zinc ion binding [GO:0008270] ETFMNKFIYEIAR 0.93469 2.3759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3221 10.6813 0 0 0 0 0 0 0 0 13.4544 0 13.4507 0 0 0 0 0 0 0 0 0 13.9186 0 0 0 0 0 12.9614 11.9823 0 0 0 0 0 0 13.7833 13.1393 12.9889 13.6472 0 0 0 0 13.0114 0 0 0 0 0 0 12.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0402 0 0 0 0 14.2281 0 0 0 0 0 0 10.932 0 0 0 11.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7022 12.3999 0 0 0 12.6145 12.7325 0 0 0 0 0 Q5MJ70 SPDYA_HUMAN "Speedy protein A (Rapid inducer of G2/M progression in oocytes A, RINGO A, hSpy/Ringo A) (Speedy-1, Spy1)" SPDYA SPDY1 SPY1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein kinase activity [GO:0045860] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; cellular response to DNA damage stimulus [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; male meiotic nuclear division [GO:0007140]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein kinase activity [GO:0045860] GO:0000082; GO:0005634; GO:0005654; GO:0006974; GO:0007140; GO:0008284; GO:0019901; GO:0030295; GO:0045737; GO:0045860 protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] SVHHSGAVRNYNRDEVQLPR 0.93469 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEQ5 CA162_HUMAN Transmembrane protein C1orf162 C1orf162 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 HLILAFCAGVLLTLLLIAFIFLIIK 0.93469 2.6856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6253 10.7371 0 0 0 0 12.5582 12.9184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.588 0 0 0 0 0 0 0 0 0 0 0 0 10.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9181 0 0 0 0 13.3577 12.0622 0 0 0 0 0 0 0 0 0 12.0843 0 0 0 0 0 0 0 0 0 0 11.0456 11.2554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5L4 TIM13_HUMAN Mitochondrial import inner membrane translocase subunit Tim13 TIMM13 TIM13B TIMM13A TIMM13B Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; zinc ion binding [GO:0008270]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605] GO:0001650; GO:0005739; GO:0005743; GO:0005758; GO:0006626; GO:0007605; GO:0008270; GO:0042719; GO:0045039 zinc ion binding [GO:0008270] KCIGKPGGSLDNSEQK 0.93469 1.0653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5066 0 0 0 Q96BS2 CHP3_HUMAN "Calcineurin B homologous protein 3 (Tescalcin, TSC)" TESC CHP3 Homo sapiens (Human) "cellular response to retinoic acid [GO:0071300]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of cell adhesion mediated by integrin [GO:0033628]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase inhibitor activity [GO:0019212]; protein homodimerization activity [GO:0042803]; protein kinase inhibitor activity [GO:0004860]; cellular response to retinoic acid [GO:0071300]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of cell adhesion mediated by integrin [GO:0033628]" GO:0000287; GO:0001726; GO:0004860; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0008584; GO:0010628; GO:0015031; GO:0019212; GO:0030027; GO:0030219; GO:0030854; GO:0032417; GO:0032587; GO:0033628; GO:0042803; GO:0045654; GO:0045893; GO:0050821; GO:0051604; GO:0071300; GO:0072659 calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase inhibitor activity [GO:0019212]; protein homodimerization activity [GO:0042803]; protein kinase inhibitor activity [GO:0004860] TGFSSDQIEQLHRRFK 0.93473 1.0501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8076 0 0 0 0 0 0 13.4131 0 0 0 0 0 0 0 0 0 0 Q96IR2 ZN845_HUMAN Zinc finger protein 845 ZNF845 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECDEAFSFK 0.93474 1.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12805 FBLN3_HUMAN "EGF-containing fibulin-like extracellular matrix protein 1 (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3, FIBL-3)" EFEMP1 FBLN3 FBNL Homo sapiens (Human) "camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; peptidyl-tyrosine phosphorylation [GO:0018108]; post-embryonic eye morphogenesis [GO:0048050]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; epidermal growth factor receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; peptidyl-tyrosine phosphorylation [GO:0018108]; post-embryonic eye morphogenesis [GO:0048050]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" GO:0005006; GO:0005154; GO:0005509; GO:0005576; GO:0005615; GO:0006355; GO:0007173; GO:0007601; GO:0008083; GO:0018108; GO:0031012; GO:0032331; GO:0043010; GO:0048048; GO:0048050; GO:0062023; GO:0070062 calcium ion binding [GO:0005509]; epidermal growth factor receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083] ELPQSIVYKYMSIR 0.93475 2.3755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2175 0 0 0 0 13.2204 0 0 0 0 0 0 0 0 0 0 0 0 12.8243 0 0 0 0 0 0 0 12.2163 0 0 0 0 0 0 11.5025 0 0 0 0 0 11.9349 0 0 0 0 0 0 0 12.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2304 0 0 0 0 0 0 0 0 0 0 11.1456 0 0 0 0 0 0 0 0 0 13.1477 0 0 0 0 0 0 0 0 Q9GZN6 S6A16_HUMAN Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 (Solute carrier family 6 member 16) SLC6A16 NTT5 Homo sapiens (Human) neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; organic substance transport [GO:0071702]; sodium ion transmembrane transport [GO:0035725] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; organic substance transport [GO:0071702]; sodium ion transmembrane transport [GO:0035725] GO:0005326; GO:0005887; GO:0006836; GO:0015293; GO:0035725; GO:0071702; GO:0071705 neurotransmitter transmembrane transporter activity [GO:0005326]; symporter activity [GO:0015293] CPLTMNSSGFDPECER 0.93475 2.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2998 0 12.8957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EC8 YIPF6_HUMAN Protein YIPF6 (YIP1 family member 6) YIPF6 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal epithelial cell development [GO:0060576] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intestinal epithelial cell development [GO:0060576] GO:0000138; GO:0000139; GO:0005783; GO:0005797; GO:0005801; GO:0005802; GO:0006888; GO:0016021; GO:0030134; GO:0042802; GO:0060576 identical protein binding [GO:0042802] SRIREFDSSTLNESVR 0.93476 1.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32971 TNFL8_HUMAN "Tumor necrosis factor ligand superfamily member 8 (CD30 ligand, CD30-L) (CD antigen CD153)" TNFSF8 CD30L CD30LG Homo sapiens (Human) "CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]" extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]" GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0007267; GO:0042129; GO:0043374; GO:0045944; GO:0050830 cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] LELLINKHIKK 0.93477 1.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14106 TOB2_HUMAN Protein Tob2 (Protein Tob4) (Transducer of erbB-2 2) TOB2 KIAA1663 TOB4 TROB2 Homo sapiens (Human) female gamete generation [GO:0007292]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; osteoclast differentiation [GO:0030316]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; nuclear vitamin D receptor binding [GO:0042809]; transcription corepressor activity [GO:0003714]; female gamete generation [GO:0007292]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoclast differentiation [GO:0045671]; osteoclast differentiation [GO:0030316]; positive regulation of ossification [GO:0045778]; regulation of gene expression [GO:0010468] GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0007292; GO:0008285; GO:0010468; GO:0030316; GO:0042809; GO:0045671; GO:0045778 nuclear vitamin D receptor binding [GO:0042809]; transcription corepressor activity [GO:0003714] QLEIKVALNFIISYLYNKLPR 0.93478 1.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60262 GBG7_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 GNG7 GNGT7 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0005834; GO:0005886; GO:0007186; GO:0008277; GO:0031681; GO:0070062 G-protein beta-subunit binding [GO:0031681] IEAGIERIKVSK 0.93479 1.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8896 0 11.8677 0 0 0 0 12.7673 0 0 0 0 0 12.0347 0 12.9865 0 11.4871 0 0 0 0 0 0 0 0 11.3656 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2095 13.102 0 0 0 0 11.1181 0 12.3405 0 13.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EH8 NEUL3_HUMAN "E3 ubiquitin-protein ligase NEURL3, EC 2.3.2.27 (Lung-inducible neuralized-related C3CH4 RING domain protein) (Neuralized-like protein 3) (RING-type E3 ubiquitin transferase NEURL3)" NEURL3 LINCR Homo sapiens (Human) metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] ATPGEECAICFYHAANTRLVPCGHTYFCR 0.93479 1.8244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0712 0 0 0 0 0 10.3967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5069 0 0 0 0 0 0 14.7648 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0118 0 0 0 0 13.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5605 0 0 0 0 0 0 0 12.8425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1523 0 0 0 0 0 11.1156 0 0 0 0 0 Q9H1U9 S2551_HUMAN Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51) SLC25A51 MCART1 Homo sapiens (Human) aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549]; mitochondrial transmembrane transport [GO:1990542] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD transmembrane transporter activity [GO:0051724]; aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549]; mitochondrial transmembrane transport [GO:1990542] GO:0005739; GO:0005743; GO:0016021; GO:0019646; GO:0051724; GO:1990542; GO:1990549 NAD transmembrane transporter activity [GO:0051724] DGFRNLYR 0.9348 1.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCI5 PIFO_HUMAN Protein pitchfork PIFO C1orf88 Homo sapiens (Human) cilium organization [GO:0044782]; embryonic heart tube left/right pattern formation [GO:0060971]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344] ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; gamma-tubulin binding [GO:0043015]; kinesin binding [GO:0019894]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cilium organization [GO:0044782]; embryonic heart tube left/right pattern formation [GO:0060971]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344] GO:0005634; GO:0005802; GO:0008092; GO:0019894; GO:0019901; GO:0031267; GO:0031344; GO:0031410; GO:0033674; GO:0036064; GO:0043015; GO:0044782; GO:0048487; GO:0060971 beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; gamma-tubulin binding [GO:0043015]; kinesin binding [GO:0019894]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] DTYYPSPGAYNPEKKPPPK 0.93481 1.8399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8703 0 0 0 0 0 0 0 0 0 0 12.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8199 14.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.123 0 0 0 0 0 0 0 0 0 0 11.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8877 Q96G75 RMD5B_HUMAN "E3 ubiquitin-protein transferase RMND5B, EC 2.3.2.27 (Protein RMD5 homolog B)" RMND5B UNQ2508/PRO5996 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0005634; GO:0005737; GO:0005829; GO:0034657; GO:0043161; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] DELPIEIELGMK 0.93484 1.8387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7836 0 0 0 0 0 14.5318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUM4 T106B_HUMAN Transmembrane protein 106B TMEM106B Homo sapiens (Human) dendrite morphogenesis [GO:0048813]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neuron cellular homeostasis [GO:0070050]; positive regulation of dendrite development [GO:1900006]; positive regulation of hydrolase activity [GO:0051345]; regulation of lysosome organization [GO:1905671] endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATPase binding [GO:0051117]; dendrite morphogenesis [GO:0048813]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neuron cellular homeostasis [GO:0070050]; positive regulation of dendrite development [GO:1900006]; positive regulation of hydrolase activity [GO:0051345]; regulation of lysosome organization [GO:1905671] GO:0005764; GO:0005765; GO:0005768; GO:0007040; GO:0007041; GO:0007042; GO:0016021; GO:0031902; GO:0032418; GO:0048813; GO:0051117; GO:0051345; GO:0070050; GO:1900006; GO:1905146; GO:1905671 ATPase binding [GO:0051117] IPRGQENQLVALIPYSDQRLR 0.93486 1.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5624 14.1842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60499 STX10_HUMAN "Syntaxin-10, Syn10" STX10 SYN10 Homo sapiens (Human) "Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982] "cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]" GO:0000139; GO:0000149; GO:0005484; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0019905; GO:0030285; GO:0031201; GO:0031982; GO:0032588; GO:0032880; GO:0042147; GO:0048193; GO:0048278; GO:0048471 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] RQWCAIAVLVGVLLLVLILLFSL 0.93489 1.7038 0 0 0 0 0 0 0 0 0 0 0 10.3499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9946 0 0 0 0 0 0 0 0 0 12.5895 0 0 0 12.0459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0886 0 0 0 0 0 13.6234 0 0 12.5723 0 0 0 0 12.5495 0 12.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1647 0 0 11.3453 0 0 0 0 0 0 0 0 12.6027 0 0 0 0 0 0 P63136 POK25_HUMAN "Endogenous retrovirus group K member 25 Pol protein (HERV-K_11q22.1 provirus ancestral Pol protein) [Includes: Reverse transcriptase, RT, EC 2.7.7.49; Ribonuclease H, RNase H, EC 3.1.26.4; Integrase, IN ]" ERVK-25 Homo sapiens (Human) DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] GO:0003677; GO:0003964; GO:0004523; GO:0006281; GO:0006310; GO:0008270; GO:0015074; GO:0035613 DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] AAYTGPK 0.93489 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01589 IL2RA_HUMAN "Interleukin-2 receptor subunit alpha, IL-2 receptor subunit alpha, IL-2-RA, IL-2R subunit alpha, IL2-RA (TAC antigen) (p55) (CD antigen CD25)" IL2RA Homo sapiens (Human) "activated T cell proliferation [GO:0050798]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell proliferation [GO:0042130]; Notch signaling pathway [GO:0007219]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of T cell differentiation [GO:0045582]; regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000561]; regulation of T cell homeostatic proliferation [GO:0046013]; regulation of T cell tolerance induction [GO:0002664]" external side of plasma membrane [GO:0009897]; interleukin-2 receptor complex [GO:0005893]; plasma membrane [GO:0005886] "external side of plasma membrane [GO:0009897]; interleukin-2 receptor complex [GO:0005893]; plasma membrane [GO:0005886]; interleukin-2 binding [GO:0019976]; interleukin-2 receptor activity [GO:0004911]; activated T cell proliferation [GO:0050798]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell proliferation [GO:0042130]; Notch signaling pathway [GO:0007219]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of T cell differentiation [GO:0045582]; regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000561]; regulation of T cell homeostatic proliferation [GO:0046013]; regulation of T cell tolerance induction [GO:0002664]" GO:0002437; GO:0002664; GO:0004911; GO:0005886; GO:0005893; GO:0006915; GO:0006924; GO:0006954; GO:0006955; GO:0007166; GO:0007219; GO:0009897; GO:0019976; GO:0042104; GO:0042130; GO:0045582; GO:0046013; GO:0050728; GO:0050798; GO:2000561 interleukin-2 binding [GO:0019976]; interleukin-2 receptor activity [GO:0004911] ALHRGPAESVCK 0.93491 1.0657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H3BPF8 GOG8S_HUMAN Golgin subfamily A member 8S GOLGA8S Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 ARTEWKLEQSMR 0.93493 1.0655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGZ0 O2AJ1_HUMAN Olfactory receptor 2AJ1 OR2AJ1 OR2AJ1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FLAIFYTILTPTLNPFIYSFRNKDVLAVMK 0.93496 2.6798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8491 0 0 0 0 0 0 0 11.7642 0 0 0 0 0 0 0 0 12.7314 0 0 0 12.1594 0 0 12.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5575 0 11.2711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.702 11.5812 0 0 0 0 0 Q6MZQ0 PRR5L_HUMAN "Proline-rich protein 5-like (Protein observed with Rictor-2, Protor-2)" PRR5L PROTOR2 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of fibroblast migration [GO:0010762]; TORC2 signaling [GO:0038203] TORC2 complex [GO:0031932] TORC2 complex [GO:0031932]; ubiquitin protein ligase binding [GO:0031625]; cellular response to oxidative stress [GO:0034599]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of fibroblast migration [GO:0010762]; TORC2 signaling [GO:0038203] GO:0001933; GO:0001934; GO:0006468; GO:0009968; GO:0010762; GO:0014065; GO:0014068; GO:0031625; GO:0031932; GO:0034599; GO:0038203; GO:0061014; GO:0090316 ubiquitin protein ligase binding [GO:0031625] QISLLGFRDLVLLKVK 0.93497 1.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2758 0 0 0 0 0 0 0 12.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2279 0 0 0 0 0 12.7959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8602 0 0 0 0 0 Q9UK22 FBX2_HUMAN F-box only protein 2 FBXO2 FBX2 Homo sapiens (Human) glycoprotein catabolic process [GO:0006516]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005]; amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; ubiquitin-protein transferase activity [GO:0004842]; glycoprotein catabolic process [GO:0006516]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of protein ubiquitination [GO:0031396]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0001540; GO:0004842; GO:0005737; GO:0005783; GO:0005829; GO:0006508; GO:0006516; GO:0016020; GO:0016567; GO:0019005; GO:0030246; GO:0030433; GO:0031146; GO:0031396; GO:0036211; GO:0043197 amyloid-beta binding [GO:0001540]; carbohydrate binding [GO:0030246]; ubiquitin-protein transferase activity [GO:0004842] LVCLRWKELVDGAPLWLLK 0.93498 1.6735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.956 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2957 P61587 RND3_HUMAN Rho-related GTP-binding protein RhoE (Protein MemB) (Rho family GTPase 3) (Rho-related GTP-binding protein Rho8) (Rnd3) RND3 ARHE RHO8 RHOE Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] GO:0000139; GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007015; GO:0007155; GO:0007163; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030036; GO:0030865; GO:0031410; GO:0032956; GO:0042995 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] WKGEIQEFCPNTKMLLVGCK 0.935 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUF1 CBWD2_HUMAN COBW domain-containing protein 2 (Cobalamin synthase W domain-containing protein 2) CBWD2 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524] GO:0005524; GO:0005737 ATP binding [GO:0005524] IPVTIITGYLGAGKTTLLNYILTEQHSK 0.935 1.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYH8 ING5_HUMAN Inhibitor of growth protein 5 (p28ING5) ING5 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; fibroblast proliferation [GO:0048144]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; apoptotic signaling pathway [GO:0097190]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; fibroblast proliferation [GO:0048144]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000123; GO:0001558; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006275; GO:0006325; GO:0006355; GO:0006473; GO:0008285; GO:0016570; GO:0035064; GO:0043065; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045893; GO:0045926; GO:0046872; GO:0048144; GO:0048147; GO:0050793; GO:0051726; GO:0070776; GO:0097190; GO:1903706; GO:2000278; GO:2001235 chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] CKEYSDDKVQLAMQTYEMVDK 0.935 1.6932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5453 0 0 0 0 0 0 0 0 0 11.9273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20749 BCL3_HUMAN "B-cell lymphoma 3 protein, BCL-3 (Proto-oncogene BCL3)" BCL3 BCL4 D19S37 Homo sapiens (Human) "antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]" Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]" GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222 DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] AAGLPGAALPLRKR 0.93501 1.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6694 12.3283 0 0 0 0 0 0 0 0 0 14.9553 0 0 0 0 0 0 0 0 14.0443 0 0 15.0494 14.4169 0 0 0 0 0 0 0 0 16.0056 0 0 0 0 0 0 0 0 0 0 13.9484 15.7205 0 0 0 0 0 0 15.4185 0 0 0 0 15.0434 15.0994 13.8355 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5518 0 14.7525 0 0 0 0 0 0 0 13.9951 0 0 0 0 14.6937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TZJ5 S31A1_HUMAN Spermatogenesis-associated protein 31A1 (Protein FAM75A1) SPATA31A1 C9orf36 FAM75A1 FAM75A2 SPATA31A2 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 AGETREAVPQCR 0.93501 1.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6313 0 0 0 0 0 0 11.7722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49915 GUAA_HUMAN "GMP synthase [glutamine-hydrolyzing], EC 6.3.5.2 (GMP synthetase) (Glutamine amidotransferase)" GMPS Homo sapiens (Human) glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168] GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0006541; GO:0009113; GO:0009168; GO:0016462 ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462] PDLIESASLVASGKAELIK 0.93506 2.1111 0 0 0 0 0 0 0 0 0 0 11.1007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2244 12.3873 12.0325 0 0 0 0 0 0 0 0 11.9992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2253 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12018 VPREB_HUMAN "Immunoglobulin iota chain (CD179 antigen-like family member A) (Protein VPreB1) (V(pre)B protein, VpreB protein) (CD antigen CD179a)" VPREB1 VPREB Homo sapiens (Human) immune response [GO:0006955] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immune response [GO:0006955] GO:0005576; GO:0005615; GO:0005783; GO:0006955 YFSQSDKSQGPQVPPRFSGSK 0.93509 1.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55774 CCL18_HUMAN "C-C motif chemokine 18 (Alternative macrophage activation-associated CC chemokine 1, AMAC-1) (CC chemokine PARC) (Dendritic cell chemokine 1, DC-CK1) (Macrophage inflammatory protein 4, MIP-4) (Pulmonary and activation-regulated chemokine) (Small-inducible cytokine A18) [Cleaved into: CCL18(1-68); CCL18(3-69); CCL18(4-69) ]" CCL18 AMAC1 DCCK1 MIP4 PARC SCYA18 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] extracellular space [GO:0005615] extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] GO:0002548; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007154; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0030593; GO:0031640; GO:0043547; GO:0048020; GO:0048247; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009] GLAAALLVLVCTMALCSCAQVGTNK 0.93512 2.1226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3463 13.2078 0 0 13.219 13.1752 0 0 0 0 13.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3963 14.1883 0 0 Q8TBM8 DJB14_HUMAN DnaJ homolog subfamily B member 14 DNAJB14 UNQ9427/PRO34683 Homo sapiens (Human) cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0030433; GO:0030544; GO:0031965; GO:0051085; GO:0065003; GO:0071218 Hsp70 protein binding [GO:0030544] AEKLYPLPSAR 0.93512 1.8321 0 0 0 0 0 0 0 0 0 0 0 11.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5615 0 0 0 0 0 0 0 0 0 12.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6973 0 0 0 0 0 0 0 0 12.2467 0 Q9HD43 PTPRH_HUMAN "Receptor-type tyrosine-protein phosphatase H, R-PTP-H, EC 3.1.3.48 (Stomach cancer-associated protein tyrosine phosphatase 1, SAP-1) (Transmembrane-type protein-tyrosine phosphatase type H)" PTPRH SAP1 Homo sapiens (Human) apoptotic process [GO:0006915]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; apoptotic process [GO:0006915]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005001; GO:0005737; GO:0005887; GO:0006470; GO:0006915; GO:0016324; GO:0031528; GO:0045296; GO:1990264 cadherin binding [GO:0045296]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] EVPYEDVENLIYENVAAIQAHKLEV 0.93517 1.6983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.911 12.3117 0 0 0 0 0 0 0 0 0 0 0 0 11.9133 0 0 13.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2675 0 12.9781 0 0 0 13.5672 13.7357 0 0 0 0 0 9.84375 0 0 0 0 0 12.7007 0 11.0666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y248 PSF2_HUMAN DNA replication complex GINS protein PSF2 (GINS complex subunit 2) GINS2 PSF2 CGI-122 DC5 HSPC037 Homo sapiens (Human) DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0000727; GO:0000811; GO:0005634; GO:0005654; GO:0006268; GO:0071162; GO:1900264; GO:1903934 CRLLPPEWMDVEK 0.9352 2.1205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4415 12.5074 0 0 13.7061 14.3063 14.5153 0 0 0 16.3436 0 0 0 0 0 0 0 0 0 0 0 0 0 16.628 0 0 13.4553 0 0 0 0 16.2989 16.2153 0 0 0 0 0 0 0 0 0 16.8605 0 0 13.2236 0 0 0 0 12.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8062 0 0 0 0 0 0 0 0 0 0 0 17.5034 0 14.5174 0 0 0 0 0 Q9H898 ZMAT4_HUMAN Zinc finger matrin-type protein 4 ZMAT4 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0008270; GO:0042802 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] HKKNAAR 0.93524 1.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3702 0 0 0 0 13.9863 0 0 0 14.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0089 14.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4226 9.43277 0 0 13.8396 0 0 0 0 11.5575 13.9382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7423 0 0 0 0 0 0 0 0 15.7857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1373 0 0 0 0 0 0 0 0 0 18.338 0 0 0 0 0 0 0 0 0 0 0 0 16.0474 0 0 15.4888 0 0 0 0 0 0 0 O95997 PTTG1_HUMAN "Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein, Tumor-transforming protein 1, hPTTG)" PTTG1 EAP1 PTTG TUTR1 Homo sapiens (Human) cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; SH3 domain binding [GO:0017124]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816]; spermatogenesis [GO:0007283] GO:0004869; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0007283; GO:0017124; GO:0045143; GO:0051276; GO:0051301; GO:2000816 cysteine-type endopeptidase inhibitor activity [GO:0004869]; SH3 domain binding [GO:0017124] DGLKLGSGPSIK 0.93526 1.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2907 0 0 0 0 15.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG42 F157B_HUMAN Putative protein FAM157B FAM157B Homo sapiens (Human) IQISLWPRK 0.93527 1.049 0 0 0 0 0 0 0 0 0 12.3698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5932 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2862 0 0 0 0 0 0 Q969X1 LFG3_HUMAN Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1) TMBIM1 LFG3 RECS1 PP1201 PSEC0158 Homo sapiens (Human) negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of blood vessel remodeling [GO:2000504] endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; death receptor binding [GO:0005123]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of blood vessel remodeling [GO:2000504] GO:0005123; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0010008; GO:0016020; GO:0016021; GO:0035579; GO:0043086; GO:0043231; GO:0070062; GO:1902042; GO:1902045; GO:1903077; GO:2000504; GO:2001234 death receptor binding [GO:0005123] AVIIAMIITAVVSISVTIFCFQTK 0.93528 1.8404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZD0 SAM14_HUMAN "Sterile alpha motif domain-containing protein 14, SAM domain-containing protein 14" SAMD14 Homo sapiens (Human) actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; neuron projection development [GO:0031175] GO:0005737; GO:0007015; GO:0014069; GO:0015629; GO:0019722; GO:0030425; GO:0031175; GO:0051015 actin filament binding [GO:0051015] AEPHSEDDSR 0.93529 2.6316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1081 10.809 0 0 0 11.4101 0 0 0 14.639 10.5637 11.87 10.9487 0 0 10.6787 0 0 0 0 0 0 0 0 0 0 0 11.9646 0 0 0 12.9777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1469 11.6653 0 0 0 0 0 0 0 16.0671 0 0 14.3844 0 0 0 0 0 0 12.5141 0 0 0 0 0 0 0 12.1104 0 15.3153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4652 0 0 0 0 0 0 12.5279 0 0 0 0 0 0 12.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2049 0 0 0 0 0 0 0 12.6936 0 0 0 0 0 0 0 12.9906 0 16.8659 0 0 0 0 0 P58512 CU067_HUMAN Uncharacterized protein encoded by LINC01547 LINC01547 C21orf67 C21orf69 Homo sapiens (Human) endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783] GO:0005783 GCCRGCASFSPFPAPRCPSER 0.93534 1.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0258 0 11.4008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7702 0 0 0 0 0 0 0 0 0 0 0 0 13.5212 0 0 0 0 0 15.0054 0 0 0 14.0285 0 0 13.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KX2 CAZA3_HUMAN "F-actin-capping protein subunit alpha-3 (CapZ alpha-3, CP-alpha-3) (Germ cell-specific protein 3)" CAPZA3 CAPAA3 GSG3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016] cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634] cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016] GO:0005634; GO:0005829; GO:0008290; GO:0016020; GO:0030036; GO:0030863; GO:0051015; GO:0051016 actin filament binding [GO:0051015] DLPVTRTLIDWHRILSDLNLVMYPK 0.93534 1.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PJ5 FCRL4_HUMAN "Fc receptor-like protein 4, FcR-like protein 4, FcRL4 (Fc receptor homolog 4, FcRH4) (IFGP family protein 2, hIFGP2) (Immune receptor translocation-associated protein 1) (CD antigen CD307d)" FCRL4 FCRH4 IFGP2 IRTA1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0004888; GO:0005887; GO:0007166; GO:0009986 transmembrane signaling receptor activity [GO:0004888] GERVTLTCNGFQFYATEK 0.93536 1.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3C1V1 CK091_HUMAN Uncharacterized protein C11orf91 C11orf91 Homo sapiens (Human) GISSSPLSDFNIWKKLFVPLK 0.93538 2.1182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2987 0 0 0 10.7217 12.3219 0 0 0 0 0 0 0 0 0 0 0 12.1341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JB2 COG3_HUMAN "Conserved oligomeric Golgi complex subunit 3, COG complex subunit 3 (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94)" COG3 SEC34 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] "cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0005829; GO:0005886; GO:0006486; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0007030; GO:0017119; GO:0032580; GO:0032588; GO:0033365; GO:0050821; GO:0070085 ELLLGPSIACTVAELTSQNNR 0.93539 4.1017 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3737 0 0 0 0 0 0 0 0 0 0 0 12.0841 0 0 0 0 0 0 0 0 0 0 0 14.2448 0 0 13.6003 0 0 0 0 0 13.6964 13.6102 0 0 0 12.1494 0 0 0 0 13.309 0 0 12.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4286 0 13.8309 0 15.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.701 0 0 0 0 0 0 0 0 13.2329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3239 0 0 0 0 0 0 0 13.1387 0 0 0 0 13.662 0 Q13326 SGCG_HUMAN "Gamma-sarcoglycan, Gamma-SG (35 kDa dystrophin-associated glycoprotein, 35DAG)" SGCG Homo sapiens (Human) cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; muscle organ development [GO:0007517] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; muscle organ development [GO:0007517] GO:0005737; GO:0005856; GO:0005886; GO:0007517; GO:0016012; GO:0016021; GO:0042383; GO:0048738; GO:0060047 CLYLFVLLLLIILVVNLALTIWILK 0.93542 1.6737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WS3 OOSP2_HUMAN Oocyte-secreted protein 2 (Placenta-specific 1-like protein) (Protein TMEM122) OOSP2 PLAC1L TMEM122 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 IHTYVYEFIYLVRDCGIRTR 0.93544 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5939 0 0 15.1539 0 0 0 0 0 0 14.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 14.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NJ3 ZN285_HUMAN Zinc finger protein 285 (Zinc finger protein 285A) ZNF285 ZNF285A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AQHDDSLSWTSCDHHESQECK 0.93545 1.6934 0 0 0 0 0 0 0 0 0 0 0 0 12.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9436 0 0 0 0 11.5992 0 0 0 0 0 0 0 0 12.3472 11.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1695 0 0 0 0 0 12.9505 0 0 0 0 12.7431 0 11.3422 0 12.5834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5953 0 0 0 0 0 12.5215 0 0 0 0 0 0 0 0 0 Q8N715 CC185_HUMAN Coiled-coil domain-containing protein 185 CCDC185 C1orf65 Homo sapiens (Human) AQAEHRK 0.93546 2.376 0 0 0 0 12.7765 10.2052 0 0 0 0 0 0 0 0 0 0 0 12.7227 12.9959 0 13.2788 0 12.4743 0 12.1423 0 0 0 0 0 13.3903 10.6431 0 0 0 0 0 0 0 0 0 0 0 0 13.2474 10.7305 0 12.314 0 11.0237 0 0 0 14.7007 12.9283 0 11.2886 16.8881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5779 0 0 0 13.9773 12.7378 0 0 0 0 13.7043 14.0788 0 0 0 0 0 0 0 0 11.4083 13.8012 0 0 0 0 0 14.4153 12.7245 14.0231 0 0 0 0 0 11.634 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8382 12.8883 12.9685 0 0 0 12.4041 14.6093 0 12.9829 0 0 0 0 0 13.2968 0 14.2755 0 0 12.3649 14.5412 0 14.4409 0 0 0 0 0 13.1152 0 14.5401 13.9572 14.5767 14.1447 13.7159 14.3879 0 14.4418 14.4725 14.2236 15.5753 0 0 0 0 0 0 14.1943 0 13.7508 14.4908 0 0 0 0 Q96HH6 TMM19_HUMAN Transmembrane protein 19 TMEM19 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 PISPWRWLFSVVVPVLIVSNGLKK 0.93552 2.687 0 0 0 0 0 0 0 0 0 0 0 13.1772 0 0 0 0 0 0 0 0 0 12.1479 0 0 0 0 11.368 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6349 0 0 0 11.9251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX38 ABITM_HUMAN Protein Abitram (Actin-binding transcription modulator) (Protein Simiate) ABITRAM C9orf6 FAM206A Homo sapiens (Human) dendrite morphogenesis [GO:0048813]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489] dendrite [GO:0030425]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634] dendrite [GO:0030425]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; dendrite morphogenesis [GO:0048813]; regulation of actin filament polymerization [GO:0030833]; regulation of filopodium assembly [GO:0051489] GO:0003785; GO:0005634; GO:0016607; GO:0030027; GO:0030425; GO:0030426; GO:0030833; GO:0032433; GO:0048813; GO:0051015; GO:0051489 actin filament binding [GO:0051015]; actin monomer binding [GO:0003785] TIKSISYQISTNCSRLQNK 0.93554 1.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969G9 NKD1_HUMAN "Protein naked cuticle homolog 1, Naked-1, hNkd, hNkd1" NKD1 NKD PP7246 Homo sapiens (Human) "eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of convergent extension involved in axis elongation [GO:1901233]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of non-canonical Wnt signaling pathway via JNK cascade [GO:1901231]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; Wnt signaling pathway [GO:0016055]" cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159] "cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; PDZ domain binding [GO:0030165]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of convergent extension involved in axis elongation [GO:1901233]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of non-canonical Wnt signaling pathway via JNK cascade [GO:1901231]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; Wnt signaling pathway [GO:0016055]" GO:0000159; GO:0001754; GO:0005509; GO:0005737; GO:0005886; GO:0007525; GO:0016055; GO:0030165; GO:0030178; GO:0045732; GO:0090090; GO:0090249; GO:1901231; GO:1901233; GO:2000096 calcium ion binding [GO:0005509]; PDZ domain binding [GO:0030165] ESPEGDSFAVSAAWARK 0.93557 4.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3832 0 0 0 0 0 0 0 0 13.2876 0 0 0 14.7233 0 0 0 0 15.6983 0 0 0 11.5882 0 0 0 0 13.5618 0 0 0 11.9876 0 0 0 0 0 14.4312 0 13.9142 0 0 0 0 10.9417 0 0 0 0 0 0 0 0 0 0 14.4413 0 0 13.2592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5619 0 0 0 0 13.2448 0 0 0 0 0 Q8TAG6 VEXIN_HUMAN Vexin VXN C8orf46 Homo sapiens (Human) neurogenesis [GO:0022008]; neuron differentiation [GO:0030182] nucleus [GO:0005634]; plasma membrane [GO:0005886] nucleus [GO:0005634]; plasma membrane [GO:0005886]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182] GO:0005634; GO:0005886; GO:0022008; GO:0030182 AYGKSLIPPVPRISVK 0.93559 1.047 0 0 0 0 0 0 0 0 0 0 0 12.5592 0 0 0 12.8647 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9479 0 0 0 0 0 0 0 0 12.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09603 CSF1_HUMAN "Macrophage colony-stimulating factor 1, CSF-1, M-CSF, MCSF (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1 ]" CSF1 Homo sapiens (Human) branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; macrophage homeostasis [GO:0061519]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; monocyte differentiation [GO:0030224]; monocyte homeostasis [GO:0035702]; myeloid leukocyte migration [GO:0097529]; negative regulation of neuron death [GO:1901215]; neutrophil homeostasis [GO:0001780]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803]; branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; macrophage homeostasis [GO:0061519]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; monocyte differentiation [GO:0030224]; monocyte homeostasis [GO:0035702]; myeloid leukocyte migration [GO:0097529]; negative regulation of neuron death [GO:1901215]; neutrophil homeostasis [GO:0001780]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001503; GO:0001780; GO:0001954; GO:0002158; GO:0002931; GO:0003006; GO:0005125; GO:0005157; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006954; GO:0007169; GO:0007265; GO:0008083; GO:0008284; GO:0010628; GO:0010743; GO:0010744; GO:0010759; GO:0016020; GO:0016021; GO:0016604; GO:0030224; GO:0030225; GO:0030278; GO:0030316; GO:0030335; GO:0032946; GO:0035702; GO:0038145; GO:0040018; GO:0042117; GO:0042476; GO:0042488; GO:0042802; GO:0042803; GO:0045087; GO:0045651; GO:0045657; GO:0045672; GO:0045860; GO:0046579; GO:0048471; GO:0048873; GO:0051247; GO:0060444; GO:0060611; GO:0060763; GO:0061518; GO:0061519; GO:0097529; GO:1901215; GO:1902228; GO:1904141; GO:1905523; GO:1990682 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803] SCFTKDYEEHDKACVR 0.9356 1.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55809 SCOT1_HUMAN "Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial, SCOT, EC 2.8.3.5 (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase, SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)" OXCT1 OXCT SCOT Homo sapiens (Human) adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; lipid metabolic process [GO:0006629]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; lipid metabolic process [GO:0006629]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410] GO:0005739; GO:0005759; GO:0006629; GO:0007420; GO:0007507; GO:0007584; GO:0008260; GO:0008410; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046950; GO:0046952; GO:0060612 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; identical protein binding [GO:0042802] GLTAVSNNAGVDNFGLGLLLRSKQIK 0.93561 1.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGI3 O56B1_HUMAN Olfactory receptor 56B1 (Olfactory receptor OR11-65) OR56B1 OR56B1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAFQKVLFALTKEIR 0.93561 2.6252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7793 0 0 0 0 13.2274 0 12.3293 0 0 0 0 0 12.6397 0 0 12.5004 0 0 0 0 0 0 12.2712 0 0 0 0 0 0 13.532 0 12.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6567 0 0 11.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVR5 KTU_HUMAN "Protein kintoun (Dynein assembly factor 2, axonemal)" DNAAF2 C14orf104 KTU Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of left/right asymmetry [GO:0061966]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]; protein stabilization [GO:0050821]; response to retinoic acid [GO:0032526] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of left/right asymmetry [GO:0061966]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]; protein stabilization [GO:0050821]; response to retinoic acid [GO:0032526] GO:0001701; GO:0003351; GO:0005576; GO:0005737; GO:0005829; GO:0032526; GO:0036158; GO:0036159; GO:0050821; GO:0051649; GO:0060285; GO:0061966; GO:0070286; GO:0101031; GO:0120293 ETLTLLIQVPR 0.93561 3.4992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9184 0 14.0275 14.8035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0857 0 0 0 0 0 0 0 0 13.7238 0 0 0 14.3715 0 0 0 0 0 0 0 0 14.4431 0 13.248 0 0 0 0 0 0 10.0771 0 0 0 0 0 0 13.3933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2372 0 0 0 0 0 13.3218 Q9UGM6 SYWM_HUMAN "Tryptophan--tRNA ligase, mitochondrial, EC 6.1.1.2 ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase, TrpRS)" WARS2 Homo sapiens (Human) mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; positive regulation of angiogenesis [GO:0045766]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]; vasculogenesis [GO:0001570] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; positive regulation of angiogenesis [GO:0045766]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436]; vasculogenesis [GO:0001570] GO:0001570; GO:0004830; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0006418; GO:0006436; GO:0045766; GO:0070183 ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830] DHLEKVLQIGSAKAK 0.93562 1.8325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5584 0 0 0 0 0 0 0 0 0 0 15.5725 15.9721 0 15.3205 0 15.5994 15.4158 15.2207 15.1144 0 15.0007 0 0 15.1675 0 0 0 0 0 0 0 14.3439 13.6251 0 0 0 0 0 14.9525 0 0 14.2177 0 0 13.0857 0 12.5191 0 0 13.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9656 0 12.8045 12.4545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7045 0 0 0 0 0 0 11.2083 0 Q9NPC1 LT4R2_HUMAN "Leukotriene B4 receptor 2, LTB4-R 2, LTB4-R2 (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2)" LTB4R2 BLT2R BLTR2 Homo sapiens (Human) chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; keratinocyte migration [GO:0051546]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; keratinocyte migration [GO:0051546]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218] GO:0001632; GO:0004974; GO:0005654; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0007194; GO:0007218; GO:0008528; GO:0016020; GO:0051546 G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974] GRPLAATLVLHLALADGAVLLLTPLFVAFLTR 0.93564 2.6445 0 0 0 0 0 0 10.4613 0 0 0 0 0 0 0 11.8075 0 0 0 0 0 0 0 0 0 0 0 0 11.6468 0 0 0 0 0 0 0 0 0 0 11.3812 0 0 0 0 0 0 10.6722 0 0 11.019 0 0 11.322 0 0 0 0 10.8108 10.9301 0 0 10.4646 0 0 0 0 0 0 0 15.3484 0 0 0 14.711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.171 0 0 14.9233 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4584 13.0273 0 10.3636 13.2939 0 0 0 13.0869 0 0 0 0 0 0 0 0 0 0 13.2607 0 0 0 0 0 0 0 0 0 0 12.1355 0 0 0 0 0 0 10.4888 0 0 0 0 13.2217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0552 0 0 0 0 0 0 0 0 0 0 0 0 Q5YKI7 GGNB1_HUMAN Putative gametogenetin-binding protein 1 GGNBP1 Homo sapiens (Human) cell differentiation [GO:0030154]; mitochondrial fission [GO:0000266]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; cell differentiation [GO:0030154]; mitochondrial fission [GO:0000266]; spermatogenesis [GO:0007283] GO:0000266; GO:0005737; GO:0005794; GO:0007283; GO:0016020; GO:0030154 RLRHLPSPISVAQCLLLEEK 0.93567 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02410 APBA1_HUMAN "Amyloid-beta A4 precursor protein-binding family A member 1 (Adapter protein X11alpha) (Neuron-specific X11 protein) (Neuronal Munc18-1-interacting protein 1, Mint-1)" APBA1 MINT1 X11 Homo sapiens (Human) axo-dendritic transport [GO:0008088]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of synaptic vesicle exocytosis [GO:2000300] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; amyloid-beta binding [GO:0001540]; axo-dendritic transport [GO:0008088]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of synaptic vesicle exocytosis [GO:2000300] GO:0001540; GO:0001701; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007155; GO:0007268; GO:0007399; GO:0007626; GO:0008021; GO:0008088; GO:0010468; GO:0014047; GO:0014051; GO:0035264; GO:0043197; GO:0048471; GO:0048787; GO:0065003; GO:0098685; GO:0098978; GO:2000300 amyloid-beta binding [GO:0001540] CPPVTTVLIRR 0.93568 2.1114 0 0 0 0 0 0 0 0 0 12.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6329 0 0 0 15.8886 0 0 0 14.317 0 16.6704 13.4348 0 0 0 0 0 0 0 14.7906 0 0 0 0 0 0 0 0 0 0 0 12.9186 0 0 0 12.8136 15.1658 0 0 0 13.2523 0 14.2886 14.0012 13.8237 0 0 0 0 0 0 0 12.8668 0 0 13.176 0 0 0 0 0 0 0 13.834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1522 0 11.6688 0 0 0 0 0 0 Q9NR00 TCIM_HUMAN "Transcriptional and immune response regulator (Thyroid cancer protein 1, TC-1)" TCIM C8orf4 TC1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; endothelial cell activation involved in immune response [GO:0002264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C activity [GO:1900020]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of hemopoiesis [GO:1903706] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Notch binding [GO:0005112]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; endothelial cell activation involved in immune response [GO:0002264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C activity [GO:1900020]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of hemopoiesis [GO:1903706] GO:0002264; GO:0005112; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0010739; GO:0016607; GO:0034605; GO:0043066; GO:0043620; GO:0045746; GO:1900020; GO:1901224; GO:1902806; GO:1903706 Notch binding [GO:0005112] KAVGNIFENTDQESLERLFR 0.93569 1.0502 0 0 0 0 0 0 0 0 0 0 15.0733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2475 0 13.6382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3399 0 0 0 0 0 Q9BTM9 URM1_HUMAN Ubiquitin-related modifier 1 URM1 C9orf74 Homo sapiens (Human) protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; protein tag [GO:0031386]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0005634; GO:0005829; GO:0031386; GO:0032447; GO:0034227; GO:0097163 protein tag [GO:0031386]; sulfur carrier activity [GO:0097163] HRVTLPGQEEPWDIRNLLIWIK 0.93574 2.1228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4332 0 0 0 0 0 0 0 0 13.2405 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7989 0 0 0 14.9085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2101 0 12.6228 0 0 0 0 0 13.3531 0 0 0 0 0 0 0 13.37 0 A6NHL2 TBAL3_HUMAN Tubulin alpha chain-like 3 TUBAL3 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200] DYEEVAQSF 0.9358 1.0478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8612 0 0 0 0 0 0 0 12.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4397 0 0 12.1346 0 0 0 0 0 0 0 0 Q9UJJ9 GNPTG_HUMAN N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma) GNPTG C16orf27 GNPTAG CAB56184 LP2537 Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; N-glycan processing to lysosome [GO:0016256] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex [GO:0070622] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex [GO:0070622]; protein homodimerization activity [GO:0042803]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; N-glycan processing to lysosome [GO:0016256] GO:0000139; GO:0003976; GO:0005794; GO:0016256; GO:0042803; GO:0046835; GO:0070062; GO:0070622 protein homodimerization activity [GO:0042803]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] AHKELSKEIK 0.9358 1.7051 0 0 11.666 0 0 10.0602 0 0 10.0395 0 0 0 0 0 0 11.537 0 0 0 11.6172 0 0 0 0 0 0 12.245 12.7785 11.4756 0 0 0 0 11.8634 0 0 0 0 10.5578 0 0 0 0 0 0 0 0 12.5054 0 0 0 0 0 0 9.69615 0 0 0 0 0 0 0 0 0 0 9.65267 12.0209 12.672 0 0 0 0 0 0 13.1715 0 13.1882 0 15.6972 0 15.8228 0 0 0 0 0 16.0773 12.1418 0 0 13.4073 11.2576 0 0 0 0 0 12.1848 0 0 0 0 0 0 0 0 0 0 12.7642 0 0 0 0 0 0 12.0299 0 0 12.758 13.3509 0 0 17.0412 0 12.742 12.2402 13.0325 17.3712 0 0 0 0 12.5073 0 12.0871 0 0 0 12.3915 0 12.2199 0 12.1933 16.9145 0 0 0 0 0 0 0 0 12.0267 0 10.233 0 0 0 12.8601 0 0 12.3174 14.4804 0 0 0 0 0 0 12.1109 0 0 0 0 12.2856 13.0861 16.2528 0 0 11.0973 Q93062 RBPMS_HUMAN "RNA-binding protein with multiple splicing, RBP-MS (Heart and RRM expressed sequence, Hermes)" RBPMS HERMES Homo sapiens (Human) positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to oxidative stress [GO:0006979]; RNA processing [GO:0006396] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to oxidative stress [GO:0006979]; RNA processing [GO:0006396] GO:0000932; GO:0003713; GO:0003723; GO:0003729; GO:0005654; GO:0005829; GO:0006396; GO:0006979; GO:0008143; GO:0010494; GO:0010862; GO:0042803; GO:0060391 mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] ELYLLFRPFK 0.93581 1.6945 11.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0327 0 0 0 0 0 0 0 0 10.8409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2113 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14994 NR1I3_HUMAN "Nuclear receptor subfamily 1 group I member 3 (Constitutive activator of retinoid response, Constitutive active response) (Constitutive androstane receptor, CAR) (Orphan nuclear receptor MB67)" NR1I3 CAR Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0008270; GO:0030154; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" ASREDELRNCVVCGDQATGYHFNALTCEGCK 0.93582 1.0475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09564 CD7_HUMAN T-cell antigen CD7 (GP40) (T-cell leukemia antigen) (T-cell surface antigen Leu-9) (TP41) (CD antigen CD7) CD7 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955]; T cell activation [GO:0042110]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; immune response [GO:0006955]; T cell activation [GO:0042110]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0002250; GO:0005886; GO:0006955; GO:0007169; GO:0016020; GO:0016021; GO:0038023; GO:0042110 signaling receptor activity [GO:0038023] AGPPRLLLLPLLLALAR 0.93583 2.1209 0 0 12.516 0 0 0 0 12.2777 0 0 0 0 0 0 0 0 0 14.0401 0 0 0 0 0 0 0 0 0 12.7842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0955 0 0 0 0 0 13.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1567 0 0 0 0 12.0878 13.042 0 0 14.9618 0 0 13.1428 0 0 0 0 0 0 13.9951 11.2375 0 14.152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0781 0 0 0 0 0 0 0 0 0 0 0 0 0 15.788 0 0 13.3825 0 0 0 0 0 0 11.2801 0 0 12.6435 0 0 12.3933 0 0 0 0 0 0 0 0 0 13.2548 10.6894 0 0 0 12.4787 0 0 0 0 Q99674 CGRE1_HUMAN Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin) CGREF1 CGR11 Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285] GO:0005509; GO:0005576; GO:0007049; GO:0007155; GO:0008285 calcium ion binding [GO:0005509] LPLTMTVLILLLLPTGQAAPK 0.93584 1.8121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3305 0 0 12.4467 0 0 0 0 0 0 13.1221 0 0 0 13.2631 14.7873 13.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0983 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKD1 GMEB2_HUMAN "Glucocorticoid modulatory element-binding protein 2, GMEB-2 (DNA-binding protein p79PIF) (Parvovirus initiation factor p79, PIF p79)" GMEB2 KIAA1269 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0042802; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DAVLLNNIVQNFGMLDLVKKVLASHK 0.93584 1.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2772 0 10.6209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.96 0 0 0 0 12.0917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0153 0 0 0 0 Q9H2D1 MFTC_HUMAN Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32) SLC25A32 MFT MFTC Homo sapiens (Human) folate import into mitochondrion [GO:1904947]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; mitochondrial FAD transmembrane transport [GO:1990548]; mitochondrial transport [GO:0006839]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; transmembrane transporter activity [GO:0022857]; folate import into mitochondrion [GO:1904947]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; mitochondrial FAD transmembrane transport [GO:1990548]; mitochondrial transport [GO:0006839]; transmembrane transport [GO:0055085] GO:0005739; GO:0005743; GO:0006839; GO:0008517; GO:0015230; GO:0015884; GO:0016021; GO:0022857; GO:0046655; GO:0055085; GO:1904947; GO:1990548 FAD transmembrane transporter activity [GO:0015230]; folic acid transmembrane transporter activity [GO:0008517]; transmembrane transporter activity [GO:0022857] VTPACCITFVVYENVSHFLLDLREKR 0.93586 1.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2997 0 0 12.4205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0988 0 0 0 11.6199 0 0 0 0 0 0 0 0 0 P08571 CD14_HUMAN "Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form ]" CD14 Homo sapiens (Human) apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; phagocytosis [GO:0006909]; positive regulation of endocytosis [GO:0045807]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; receptor-mediated endocytosis [GO:0006898]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to magnesium ion [GO:0032026]; response to tumor necrosis factor [GO:0034612]; toll-like receptor 4 signaling pathway [GO:0034142] anchored component of external side of plasma membrane [GO:0031362]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lipopolysaccharide receptor complex [GO:0046696]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] anchored component of external side of plasma membrane [GO:0031362]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lipopolysaccharide receptor complex [GO:0046696]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; opsonin receptor activity [GO:0001847]; peptidoglycan immune receptor activity [GO:0016019]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; phagocytosis [GO:0006909]; positive regulation of endocytosis [GO:0045807]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; receptor-mediated endocytosis [GO:0006898]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to magnesium ion [GO:0032026]; response to tumor necrosis factor [GO:0034612]; toll-like receptor 4 signaling pathway [GO:0034142] GO:0001530; GO:0001847; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0006898; GO:0006909; GO:0006915; GO:0006954; GO:0007166; GO:0009408; GO:0009897; GO:0010008; GO:0016019; GO:0030667; GO:0031362; GO:0031663; GO:0031666; GO:0032026; GO:0032481; GO:0032729; GO:0032757; GO:0032760; GO:0034142; GO:0034145; GO:0034612; GO:0045087; GO:0045121; GO:0045471; GO:0045807; GO:0046696; GO:0051602; GO:0070062; GO:0070891; GO:0071219; GO:0071222; GO:0071223; GO:0071723; GO:0071726; GO:0071727; GO:1901224 lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; opsonin receptor activity [GO:0001847]; peptidoglycan immune receptor activity [GO:0016019] LTVGAAQVPAQLLVGALRVLAYSRLK 0.93588 1.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8841 0 0 0 0 0 13.445 0 0 0 0 0 0 0 0 0 0 0 13.2608 0 0 0 0 0 0 0 13.5427 0 0 0 0 0 0 0 0 0 0 0 13.6923 0 12.9955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N766 EMC1_HUMAN ER membrane protein complex subunit 1 EMC1 KIAA0090 PSEC0263 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005789; GO:0016021; GO:0030176; GO:0032991; GO:0045050; GO:0071816; GO:0072546 DLTTELSWELTIPPEVQR 0.93591 2.6802 12.1332 0 0 0 0 0 0 0 0 0 0 0 12.8116 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5488 0 0 0 0 0 0 0 0 0 0 0 0 11.5859 0 0 0 13.5779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0567 0 13.7135 0 10.0618 0 0 0 13.519 0 0 0 0 13.4349 0 0 10.639 0 0 13.3684 0 0 0 0 10.5177 16.358 12.1775 0 0 14.4114 14.9938 10.156 0 0 11.0984 0 0 0 0 12.0497 0 0 0 0 0 0 14.7035 12.3434 0 0 12.6013 13.1026 0 0 0 0 0 0 0 12.526 0 12.5758 0 0 0 0 0 12.6419 0 0 0 0 0 0 11.8982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8435 0 0 0 0 0 0 0 0 0 11.702 0 0 0 0 0 0 0 0 0 0 Q9UK05 GDF2_HUMAN "Growth/differentiation factor 2, GDF-2 (Bone morphogenetic protein 9, BMP-9)" GDF2 BMP9 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA replication [GO:0008156]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA replication [GO:0008156]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]" GO:0001503; GO:0001525; GO:0001569; GO:0001570; GO:0001649; GO:0001937; GO:0001938; GO:0005125; GO:0005576; GO:0005615; GO:0006366; GO:0006879; GO:0008083; GO:0008156; GO:0010596; GO:0010862; GO:0016525; GO:0030308; GO:0030509; GO:0030513; GO:0032757; GO:0032924; GO:0043537; GO:0045603; GO:0045766; GO:0045893; GO:0045944; GO:0048514; GO:0051216; GO:0060389; GO:0060395; GO:0061036; GO:0070062; GO:0071773; GO:2000279 cytokine activity [GO:0005125]; growth factor activity [GO:0008083] HAIVQTLVHLKFPTK 0.93591 2.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1596 0 0 0 0 0 12.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12988 HSPB3_HUMAN "Heat shock protein beta-3, HspB3 (Heat shock 17 kDa protein, HSP 17) (Protein 3)" HSPB3 HSP27 HSPL27 Homo sapiens (Human) response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; response to unfolded protein [GO:0006986] GO:0005634; GO:0005737; GO:0006986; GO:0016607 AKIILRHLIEIPVR 0.93593 1.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1602 0 0 0 0 0 0 0 11.3838 0 0 0 0 0 0 11.4487 0 0 0 0 12.0584 0 0 0 0 0 0 0 10.3801 0 0 0 0 0 11.5792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6DN72 FCRL6_HUMAN "Fc receptor-like protein 6, FcR-like protein 6, FcRL6 (Fc receptor homolog 6, FcRH6) (IFGP6)" FCRL6 FCRH6 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class II protein binding [GO:0042289]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166] GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0009897; GO:0019902; GO:0019903; GO:0042289 MHC class II protein binding [GO:0042289]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; transmembrane signaling receptor activity [GO:0004888] EGDSGLYWCEVAPEGGQVQK 0.936 2.1184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQE3 TBA1C_HUMAN Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain ] TUBA1C TUBA6 Homo sapiens (Human) cell division [GO:0051301]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; vesicle [GO:0031982]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000278; GO:0005198; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0015630; GO:0030705; GO:0031982; GO:0051301 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] CDPRHGK 0.93602 1.8358 0 0 0 0 0 0 0 0 0 0 0 9.72523 0 0 0 0 0 0 0 0 0 0 0 14.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4467 0 0 11.5433 0 0 0 0 0 0 0 10.3065 12.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2227 0 0 13.4406 0 0 0 10.774 0 0 0 0 0 14.2612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y639 NPTN_HUMAN "Neuroplastin (Stromal cell-derived receptor 1, SDR-1)" NPTN SDFR1 SDR1 Homo sapiens (Human) "axon guidance [GO:0007411]; cellular calcium ion homeostasis [GO:0006874]; dendrite self-avoidance [GO:0070593]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; long-term synaptic potentiation [GO:0060291]; negative regulation of cytokine production [GO:0001818]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization [GO:1903829]; positive regulation of protein phosphorylation [GO:0001934]; regulation of receptor localization to synapse [GO:1902683]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; visual learning [GO:0008542]" anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; inhibitory synapse [GO:0060077]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685] "anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; inhibitory synapse [GO:0060077]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; transmembrane transporter binding [GO:0044325]; type 1 fibroblast growth factor receptor binding [GO:0005105]; axon guidance [GO:0007411]; cellular calcium ion homeostasis [GO:0006874]; dendrite self-avoidance [GO:0070593]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; long-term synaptic potentiation [GO:0060291]; negative regulation of cytokine production [GO:0001818]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization [GO:1903829]; positive regulation of protein phosphorylation [GO:0001934]; regulation of receptor localization to synapse [GO:1902683]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; visual learning [GO:0008542]" GO:0001772; GO:0001818; GO:0001934; GO:0005105; GO:0005886; GO:0006874; GO:0007156; GO:0007204; GO:0007411; GO:0008542; GO:0009986; GO:0010976; GO:0030424; GO:0030425; GO:0042734; GO:0044325; GO:0045743; GO:0048170; GO:0050839; GO:0060077; GO:0060291; GO:0070161; GO:0070374; GO:0070593; GO:0098632; GO:0098685; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:0099557; GO:1900273; GO:1902683; GO:1903829; GO:1904861 cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; transmembrane transporter binding [GO:0044325]; type 1 fibroblast growth factor receptor binding [GO:0005105] NASNMEYRINK 0.93602 2.6366 0 0 0 0 0 0 0 0 0 0 11.2403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5315 0 0 0 0 0 12.5573 0 12.6544 15.1471 0 0 0 11.917 14.9175 15.5154 14.3344 13.6886 16.0911 0 13.5013 12.2996 0 12.2081 0 0 0 13.909 0 0 0 0 0 0 12.8938 0 0 0 11.6691 0 0 0 0 12.9738 0 0 0 0 0 0 13.8115 0 0 11.97 0 13.037 0 0 12.5144 0 0 0 0 0 0 0 0 0 0 0 12.8649 12.3351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0794 0 0 0 0 0 0 0 0 0 0 0 0 12.7526 0 0 P13498 CY24A_HUMAN "Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox, p22phox)" CYBA Homo sapiens (Human) cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; establishment of localization in cell [GO:0051649]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; specific granule membrane [GO:0035579]; stress fiber [GO:0001725]; tertiary granule membrane [GO:0070821] apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; specific granule membrane [GO:0035579]; stress fiber [GO:0001725]; tertiary granule membrane [GO:0070821]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; establishment of localization in cell [GO:0051649]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] GO:0001666; GO:0001725; GO:0001938; GO:0003106; GO:0005634; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006801; GO:0006954; GO:0009055; GO:0009410; GO:0014823; GO:0014895; GO:0016020; GO:0016175; GO:0016324; GO:0017004; GO:0017124; GO:0020037; GO:0030141; GO:0030307; GO:0030425; GO:0030670; GO:0031667; GO:0032755; GO:0032760; GO:0032930; GO:0033864; GO:0034137; GO:0035579; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0046872; GO:0046982; GO:0048661; GO:0050665; GO:0050766; GO:0051279; GO:0051649; GO:0070254; GO:0070257; GO:0070555; GO:0070821; GO:0071260; GO:0071333; GO:0071356; GO:0071407; GO:0071480; GO:0097038; GO:1900426; GO:1903428; GO:1904044; GO:1904385; GO:1904845 electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] AVLHLLLSVPAGFLLATILGTACLAIASGIYLLAAVR 0.93606 1.8342 0 0 0 0 0 0 10.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8423 0 0 0 12.3505 0 0 13.6669 14.7951 14.8733 14.5861 0 0 0 13.7169 0 0 0 0 0 0 0 0 0 12.4034 0 0 0 0 0 15.051 0 0 0 13.1144 0 0 0 0 0 13.2227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2674 0 13.4529 0 0 12.8085 0 0 0 0 0 0 11.7372 0 0 11.6474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7 0 0 0 0 0 P15529 MCP_HUMAN Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD antigen CD46) CD46 MCP MIC10 Homo sapiens (Human) "adaptive immune response [GO:0002250]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of Notch signaling pathway [GO:0008593]; sequestering of extracellular ligand from receptor [GO:0035581]; single fertilization [GO:0007338]; T cell mediated immunity [GO:0002456]" cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; inner acrosomal membrane [GO:0002079]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; inner acrosomal membrane [GO:0002079]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of Notch signaling pathway [GO:0008593]; sequestering of extracellular ligand from receptor [GO:0035581]; single fertilization [GO:0007338]; T cell mediated immunity [GO:0002456]" GO:0001618; GO:0002079; GO:0002250; GO:0002456; GO:0005886; GO:0005887; GO:0005925; GO:0006958; GO:0007338; GO:0008593; GO:0009986; GO:0010628; GO:0010629; GO:0032733; GO:0035581; GO:0038023; GO:0042102; GO:0043382; GO:0045087; GO:0045296; GO:0045591; GO:0045959; GO:0070062; GO:0071636 cadherin binding [GO:0045296]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] PPICEKVLCTPPPKIK 0.93607 1.0479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y606 PUS1_HUMAN "Pseudouridylate synthase 1 homolog, EC 5.4.99.- (tRNA pseudouridine synthase 1, EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)" PUS1 PP8985 Homo sapiens (Human) mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] GO:0000049; GO:0002153; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0031119; GO:0070902; GO:0106029; GO:1990481 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029] FGNDGLHEPLDWAQEEGK 0.93609 2.6347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.063 0 13.7826 0 0 0 0 0 0 0 0 13.2198 0 0 0 0 0 0 0 0 0 0 0 14.9708 0 0 0 9.65768 0 0 0 0 0 15.647 0 0 0 0 0 0 12.4707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7684 14.0892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40305 IFI27_HUMAN "Interferon alpha-inducible protein 27, mitochondrial, p27 (Interferon alpha-induced 11.5 kDa protein) (Interferon-stimulated gene 12a protein, ISG12(a), ISG12A)" IFI27 Homo sapiens (Human) apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; innate immune response [GO:0045087]; modulation by host of viral genome replication [GO:0044827]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein export from nucleus [GO:0046825]; type I interferon signaling pathway [GO:0060337] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; innate immune response [GO:0045087]; modulation by host of viral genome replication [GO:0044827]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of protein export from nucleus [GO:0046825]; type I interferon signaling pathway [GO:0060337] GO:0000122; GO:0005521; GO:0005635; GO:0005637; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0042802; GO:0043161; GO:0044827; GO:0045087; GO:0046825; GO:0051607; GO:0060337; GO:0061629; GO:0070936; GO:0097190; GO:0097191 identical protein binding [GO:0042802]; lamin binding [GO:0005521]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] FILGSIGSAIAAVIAR 0.93612 1.8326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2314 0 0 0 0 13.8488 0 0 0 0 0 0 0 0 0 0 Q14494 NF2L1_HUMAN "Endoplasmic reticulum membrane sensor NFE2L1 (Locus control region-factor 1, LCR-F1) (Nuclear factor erythroid 2-related factor 1, NF-E2-related factor 1, NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) (Protein NRF1, p120 form) (Transcription factor 11, TCF-11) [Cleaved into: Transcription factor NRF1 (Protein NRF1, p110 form) ]" NFE2L1 HBZ17 NRF1 TCF11 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell redox homeostasis [GO:0045454]; cellular response to cholesterol [GO:0071397]; cellular response to oxidative stress [GO:0034599]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; heme biosynthetic process [GO:0006783]; integrated stress response signaling [GO:0140467]; lipid homeostasis [GO:0055088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of odontoblast differentiation [GO:1901329]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cholesterol binding [GO:0015485]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell redox homeostasis [GO:0045454]; cellular response to cholesterol [GO:0071397]; cellular response to oxidative stress [GO:0034599]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; heme biosynthetic process [GO:0006783]; integrated stress response signaling [GO:0140467]; lipid homeostasis [GO:0055088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of odontoblast differentiation [GO:1901329]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0006357; GO:0006783; GO:0008203; GO:0008289; GO:0009653; GO:0015485; GO:0016021; GO:0030176; GO:0034599; GO:0036003; GO:0042632; GO:0042802; GO:0045454; GO:0046982; GO:0055088; GO:0071397; GO:0090575; GO:0097201; GO:0140467; GO:1901329 "cholesterol binding [GO:0015485]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KYLTEGLLQFTILLSLIGVR 0.93613 2.6575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1047 0 0 0 0 0 0 0 0 0 0 0 0 12.8629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2F5 EPC1_HUMAN Enhancer of polycomb homolog 1 EPC1 Homo sapiens (Human) "cell differentiation [GO:0030154]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; chromatin-protein adaptor [GO:0140463]; cell differentiation [GO:0030154]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" GO:0000122; GO:0000724; GO:0000786; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006357; GO:0007283; GO:0016573; GO:0030154; GO:0031965; GO:0032777; GO:0035267; GO:0040008; GO:0042981; GO:0043231; GO:0043967; GO:0043968; GO:0045814; GO:0045892; GO:0045893; GO:0045944; GO:0051726; GO:0140463; GO:1905168; GO:2000779 chromatin-protein adaptor [GO:0140463] GPSLIPSVKQEK 0.93613 2.1146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6567 0 0 0 0 0 0 0 0 12.1699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2625 0 0 0 14.3887 0 14.162 0 0 0 0 13.2992 0 0 0 0 0 0 0 0 0 0 0 P26651 TTP_HUMAN "mRNA decay activator protein ZFP36 (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Tristetraprolin) (Zinc finger protein 36, Zfp-36)" ZFP36 G0S24 NUP475 RNF162A TIS11A TTP Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; hematopoietic stem cell differentiation [GO:0060218]; MAPK cascade [GO:0000165]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; mRNA transport [GO:0051028]; myeloid cell differentiation [GO:0030099]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of polynucleotide adenylyltransferase activity [GO:1904246]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral transcription [GO:0032897]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; p38MAPK cascade [GO:0038066]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to starvation [GO:0042594]; response to wounding [GO:0009611]" CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] "CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; 14-3-3 protein binding [GO:0071889]; C-C chemokine binding [GO:0019957]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; hematopoietic stem cell differentiation [GO:0060218]; MAPK cascade [GO:0000165]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; mRNA transport [GO:0051028]; myeloid cell differentiation [GO:0030099]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of polynucleotide adenylyltransferase activity [GO:1904246]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral transcription [GO:0032897]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; p38MAPK cascade [GO:0038066]; positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA [GO:1901835]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to starvation [GO:0042594]; response to wounding [GO:0009611]" GO:0000122; GO:0000165; GO:0000288; GO:0000289; GO:0000932; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0009611; GO:0010494; GO:0010837; GO:0019899; GO:0019901; GO:0019957; GO:0030014; GO:0030099; GO:0031072; GO:0031086; GO:0032680; GO:0032703; GO:0032897; GO:0035278; GO:0035925; GO:0038066; GO:0042594; GO:0043488; GO:0044344; GO:0044877; GO:0045600; GO:0045616; GO:0045647; GO:0046872; GO:0050728; GO:0051028; GO:0060213; GO:0060218; GO:0061158; GO:0070063; GO:0070935; GO:0071222; GO:0071356; GO:0071364; GO:0071385; GO:0071889; GO:0097011; GO:1900153; GO:1901835; GO:1902037; GO:1902172; GO:1904246; GO:1904582; GO:1990904; GO:2000637 14-3-3 protein binding [GO:0071889]; C-C chemokine binding [GO:0019957]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063] HPKYKTELCHK 0.93615 1.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13866 SC5A1_HUMAN "Sodium/glucose cotransporter 1, Na(+)/glucose cotransporter 1 (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1)" SLC5A1 NAGT SGLT1 Homo sapiens (Human) alpha-glucoside transport [GO:0000017]; fucose transmembrane transport [GO:0015756]; galactose transmembrane transport [GO:0015757]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; intestinal D-glucose absorption [GO:0001951]; intestinal hexose absorption [GO:0106001]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; renal glucose absorption [GO:0035623]; response to inorganic substance [GO:0010035]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]; transepithelial water transport [GO:0035377]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular organelle [GO:0043229]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; alpha-glucoside transmembrane transporter activity [GO:0015151]; D-glucose transmembrane transporter activity [GO:0055056]; fucose transmembrane transporter activity [GO:0015150]; galactose transmembrane transporter activity [GO:0005354]; galactose:sodium symporter activity [GO:0015371]; glucose transmembrane transporter activity [GO:0005355]; glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; water transmembrane transporter activity [GO:0005372]; alpha-glucoside transport [GO:0000017]; fucose transmembrane transport [GO:0015756]; galactose transmembrane transport [GO:0015757]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; intestinal D-glucose absorption [GO:0001951]; intestinal hexose absorption [GO:0106001]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; renal glucose absorption [GO:0035623]; response to inorganic substance [GO:0010035]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814]; transepithelial water transport [GO:0035377]; transport across blood-brain barrier [GO:0150104] GO:0000017; GO:0001951; GO:0005354; GO:0005355; GO:0005367; GO:0005372; GO:0005412; GO:0005769; GO:0005886; GO:0005887; GO:0006814; GO:0010035; GO:0015146; GO:0015150; GO:0015151; GO:0015371; GO:0015750; GO:0015756; GO:0015757; GO:0015798; GO:0016021; GO:0016324; GO:0031526; GO:0035377; GO:0035623; GO:0043229; GO:0048471; GO:0055056; GO:0070062; GO:0097708; GO:0098708; GO:0098719; GO:0106001; GO:0150104; GO:1904659 alpha-glucoside transmembrane transporter activity [GO:0015151]; D-glucose transmembrane transporter activity [GO:0055056]; fucose transmembrane transporter activity [GO:0015150]; galactose transmembrane transporter activity [GO:0005354]; galactose:sodium symporter activity [GO:0015371]; glucose transmembrane transporter activity [GO:0005355]; glucose:sodium symporter activity [GO:0005412]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; water transmembrane transporter activity [GO:0005372] CYTPRADSFHIFR 0.93617 2.1145 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4364 0 0 0 11.8849 0 0 0 0 0 0 0 11.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.43 0 0 0 0 11.3034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEB9 RHBL4_HUMAN "Rhomboid-related protein 4, RRP4, EC 3.4.21.105 (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4)" RHBDD1 RHBDL4 HSD-50 HSD50 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial membrane [GO:0031966]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]" GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0030176; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211 endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] PLYSSCLSVEKCYQQKDWQR 0.93618 1.0502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3858 0 0 11.5575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04843 RPN1_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I, RPN-I) (Ribophorin-1)" RPN1 Homo sapiens (Human) protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] GO:0003723; GO:0005783; GO:0005789; GO:0005791; GO:0005829; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0036211; GO:0042470 RNA binding [GO:0003723] APDELHYTYLDTFGRPVIVAYK 0.93619 2.655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7667 0 0 0 0 0 0 0 0 0 0 0 11.7466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4658 0 0 0 0 0 0 0 Q12918 KLRB1_HUMAN "Killer cell lectin-like receptor subfamily B member 1 (C-type lectin domain family 5 member B) (HNKR-P1a, NKR-P1A) (Natural killer cell surface protein P1A) (CD antigen CD161)" KLRB1 CLEC5B NKRP1A Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; regulation of natural killer cell mediated cytotoxicity [GO:0042269] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; regulation of natural killer cell mediated cytotoxicity [GO:0042269] GO:0004888; GO:0005886; GO:0007166; GO:0009986; GO:0016021; GO:0030246; GO:0038023; GO:0042269 carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] ENSCISISQTSVYSEYCSTEIR 0.93619 1.6765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7876 0 0 0 0 0 0 12.5165 0 0 0 0 0 12.7462 0 0 12.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4981 13.4112 11.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5614 0 0 0 0 0 0 0 13.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4295 Q86XW9 TXND6_HUMAN "Thioredoxin domain-containing protein 6 (Thioredoxin-like protein 2, Txl-2)" NME9 TXL2 TXNDC6 Homo sapiens (Human) CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] cell projection [GO:0042995]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293] cell projection [GO:0042995]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] GO:0004550; GO:0005856; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0042995; GO:0120293 nucleoside diphosphate kinase activity [GO:0004550] DEALSDEDECVSHGKNNGEDEDMVSSER 0.93619 1.7074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5758 0 0 0 0 0 0 0 Q8N196 SIX5_HUMAN Homeobox protein SIX5 (DM locus-associated homeodomain protein) (Sine oculis homeobox homolog 5) SIX5 DMAHP Homo sapiens (Human) "lens development in camera-type eye [GO:0002088]; Leydig cell proliferation [GO:0160024]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; lens development in camera-type eye [GO:0002088]; Leydig cell proliferation [GO:0160024]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002088; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007286; GO:0045892; GO:0160024; GO:1902723 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LLESRPFPAAHHAFLQDLYLRAR 0.93621 2.1128 0 0 11.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0522 0 0 0 0 0 0 0 0 0 0 0 0 12.8544 0 0 0 0 0 12.6851 12.8296 0 0 14.148 0 0 0 0 0 0 0 0 0 0 0 0 13.0533 0 0 0 0 0 0 13.7682 0 13.5467 0 0 0 0 0 0 0 13.5371 0 0 13.5209 0 0 13.2743 0 0 0 0 0 0 13.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5193 0 0 0 0 0 0 0 P11310 ACADM_HUMAN "Medium-chain specific acyl-CoA dehydrogenase, mitochondrial, MCAD, EC 1.3.8.7 (Medium chain acyl-CoA dehydrogenase, MCADH)" ACADM Homo sapiens (Human) "cardiac muscle cell differentiation [GO:0055007]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; glycogen biosynthetic process [GO:0005978]; liver development [GO:0001889]; medium-chain fatty acid catabolic process [GO:0051793]; medium-chain fatty acid metabolic process [GO:0051791]; post-embryonic development [GO:0009791]; regulation of gluconeogenesis [GO:0006111]; response to cold [GO:0009409]; response to starvation [GO:0042594]" axon [GO:0030424]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "axon [GO:0030424]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; cardiac muscle cell differentiation [GO:0055007]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; glycogen biosynthetic process [GO:0005978]; liver development [GO:0001889]; medium-chain fatty acid catabolic process [GO:0051793]; medium-chain fatty acid metabolic process [GO:0051791]; post-embryonic development [GO:0009791]; regulation of gluconeogenesis [GO:0006111]; response to cold [GO:0009409]; response to starvation [GO:0042594]" GO:0001889; GO:0003995; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005978; GO:0006111; GO:0006635; GO:0009409; GO:0009791; GO:0019254; GO:0030424; GO:0031966; GO:0033539; GO:0042594; GO:0042802; GO:0045329; GO:0050660; GO:0051791; GO:0051793; GO:0055007; GO:0070991 acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991] KGDEYIINGQK 0.93622 2.3763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q52LG2 KR132_HUMAN Keratin-associated protein 13-2 KRTAP13-2 KAP13.2 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 MSYNCCSGNFSSR 0.93622 1.7073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3726 0 0 0 0 11.2536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0741 0 0 0 11.6764 0 0 0 12.9866 15.4365 0 0 0 0 0 0 0 0 14.1088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3265 0 0 0 13.7634 13.7497 0 13.7685 0 0 0 0 0 0 P39210 MPV17_HUMAN Protein Mpv17 MPV17 Homo sapiens (Human) cellular response to reactive oxygen species [GO:0034614]; glomerular basement membrane development [GO:0032836]; homeostatic process [GO:0042592]; inner ear development [GO:0048839]; mitochondrial genome maintenance [GO:0000002]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of reactive oxygen species metabolic process [GO:2000377] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; channel activity [GO:0015267]; cellular response to reactive oxygen species [GO:0034614]; glomerular basement membrane development [GO:0032836]; homeostatic process [GO:0042592]; inner ear development [GO:0048839]; mitochondrial genome maintenance [GO:0000002]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of reactive oxygen species metabolic process [GO:2000377] GO:0000002; GO:0005737; GO:0005739; GO:0005743; GO:0005777; GO:0005778; GO:0005829; GO:0015267; GO:0016021; GO:0032836; GO:0034614; GO:0042592; GO:0048839; GO:1901858; GO:2000377 channel activity [GO:0015267] VLDRFIPGTTKVDALK 0.93624 1.0468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NEF3 GG6L4_HUMAN Golgin subfamily A member 6-like protein 4 GOLGA6L4 Homo sapiens (Human) ELESVGRQLQAEVENNQMLSLLNR 0.93625 3.5737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.21 0 0 0 0 13.4066 0 0 0 0 0 0 0 0 0 0 0 12.8322 0 14.5965 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6411 0 0 0 13.3212 13.217 0 14.7455 0 0 0 0 13.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2V7 SPNS1_HUMAN Protein spinster homolog 1 (HSpin1) (Spinster-like protein 1) SPNS1 SPIN1 PP20300 Homo sapiens (Human) lipid transport [GO:0006869] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; lipid transport [GO:0006869] GO:0005743; GO:0005765; GO:0006869; GO:0016020; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] STRVPVASVLI 0.93625 2.1122 0 0 0 14.3808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7389 0 12.6052 0 10.4827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8916 0 0 14.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2558 0 15.391 0 13.6005 11.5074 0 12.3514 15.7963 14.1944 0 0 0 0 0 0 0 0 0 0 12.6517 0 14.3794 14.5032 15.3487 0 13.4221 0 0 0 0 0 0 0 12.8924 0 0 0 0 0 13.477 0 0 0 0 13.084 14.2238 14.0899 14.5135 14.3083 0 0 14.1791 0 0 0 0 0 0 0 0 0 14.8095 0 13.0301 13.1383 0 14.743 14.2585 0 0 0 14.3209 0 0 0 0 0 0 0 0 0 0 0 0 14.0203 0 0 0 0 0 0 0 12.9873 0 0 0 0 0 0 12.7229 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZS1 FOXP3_HUMAN "Forkhead box protein P3 (Scurfin) [Cleaved into: Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form ]" FOXP3 IPEX JM2 Homo sapiens (Human) "B cell homeostasis [GO:0001782]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment [GO:0002362]; chromatin remodeling [GO:0006338]; establishment of endothelial blood-brain barrier [GO:0014045]; histone acetylation [GO:0016573]; immature T cell proliferation in thymus [GO:0033080]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; myeloid cell homeostasis [GO:0002262]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of cytokine production [GO:0001818]; negative regulation of defense response to virus [GO:0050687]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of immune response [GO:0050777]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of histone acetylation [GO:0035066]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peripheral T cell tolerance induction [GO:0002851]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell anergy [GO:0002669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of T cell anergy [GO:0002667]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; response to rapamycin [GO:1901355]; response to virus [GO:0009615]; T cell activation [GO:0042110]; T cell anergy [GO:0002870]; T cell homeostasis [GO:0043029]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852]; tolerance induction to self antigen [GO:0002513]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta1 production [GO:0032905]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; NFAT protein binding [GO:0051525]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; B cell homeostasis [GO:0001782]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment [GO:0002362]; chromatin remodeling [GO:0006338]; establishment of endothelial blood-brain barrier [GO:0014045]; histone acetylation [GO:0016573]; immature T cell proliferation in thymus [GO:0033080]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; myeloid cell homeostasis [GO:0002262]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of cytokine production [GO:0001818]; negative regulation of defense response to virus [GO:0050687]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of immune response [GO:0050777]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of histone acetylation [GO:0035066]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peripheral T cell tolerance induction [GO:0002851]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell anergy [GO:0002669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of T cell anergy [GO:0002667]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; response to rapamycin [GO:1901355]; response to virus [GO:0009615]; T cell activation [GO:0042110]; T cell anergy [GO:0002870]; T cell homeostasis [GO:0043029]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852]; tolerance induction to self antigen [GO:0002513]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta1 production [GO:0032905]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001782; GO:0001818; GO:0002262; GO:0002362; GO:0002456; GO:0002513; GO:0002667; GO:0002669; GO:0002677; GO:0002725; GO:0002851; GO:0002870; GO:0003677; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0006366; GO:0006954; GO:0008285; GO:0009314; GO:0009615; GO:0014045; GO:0016573; GO:0031064; GO:0032088; GO:0032496; GO:0032689; GO:0032693; GO:0032700; GO:0032703; GO:0032713; GO:0032714; GO:0032715; GO:0032720; GO:0032753; GO:0032792; GO:0032831; GO:0032905; GO:0032914; GO:0032991; GO:0033080; GO:0033092; GO:0035035; GO:0035066; GO:0035067; GO:0035739; GO:0042110; GO:0042130; GO:0042803; GO:0042826; GO:0043029; GO:0043433; GO:0043565; GO:0045591; GO:0045892; GO:0045893; GO:0045944; GO:0046007; GO:0046872; GO:0048289; GO:0048294; GO:0048302; GO:0050687; GO:0050777; GO:0050852; GO:0051059; GO:0051525; GO:1901355; GO:1990837; GO:2000320; GO:2000562 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; NFAT protein binding [GO:0051525]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]" FHNMRPPFTYATLIRWAILEAPEK 0.93626 1.6947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M32 KAD7_HUMAN "Adenylate kinase 7, AK 7, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 7)" AK7 Homo sapiens (Human) cell projection organization [GO:0030030]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; cell projection organization [GO:0030030]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0009142; GO:0030030; GO:0031514 adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550] ALDPEDSEVPFTEEDYR 0.93627 4.9384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2652 10.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6054 14.2707 0 0 13.4615 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4556 0 13.5479 0 0 0 13.4593 13.9232 12.6897 0 0 0 0 0 0 14.2564 0 0 0 0 0 15.604 0 0 0 0 0 14.9413 0 0 0 0 0 0 0 0 0 0 0 11.52 0 0 0 0 0 0 0 0 13.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5706 0 0 0 0 Q99944 EGFL8_HUMAN "Epidermal growth factor-like protein 8, EGF-like protein 8 (Vascular endothelial statin-2, VE-statin-2)" EGFL8 C6orf8 NG3 UNQ8752/PRO29920 Homo sapiens (Human) anatomical structure development [GO:0048856] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856] GO:0005102; GO:0005509; GO:0005576; GO:0009986; GO:0048856 calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102] RHPGALTCEAICAK 0.93627 1.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2582 0 0 0 0 16.1426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4317 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969V6 MRTFA_HUMAN "Myocardin-related transcription factor A, MRTF-A (MKL/myocardin-like protein 1) (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein)" MRTFA KIAA1438 MAL MKL1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription via serum response element binding [GO:0010735]; smooth muscle cell differentiation [GO:0051145]; wound healing, spreading of cells [GO:0044319]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription via serum response element binding [GO:0010735]; smooth muscle cell differentiation [GO:0051145]; wound healing, spreading of cells [GO:0044319]" GO:0003713; GO:0003779; GO:0003785; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010735; GO:0030036; GO:0043522; GO:0044319; GO:0045944; GO:0051145; GO:1902895 actin binding [GO:0003779]; actin monomer binding [GO:0003785]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713] EPPGYEEAMSQQPK 0.93628 2.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7824 12.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2209 0 0 0 12.7802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8026 0 P51553 IDH3G_HUMAN "Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)" IDH3G Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] GO:0000287; GO:0004449; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0005962; GO:0005975; GO:0006099; GO:0006102; GO:0051287 ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] ALKVATVAGSAAKAVLGPALLCR 0.93631 1.6741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6399 15.7123 15.7572 12.7304 13.5458 0 14.5634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6009 0 0 14.7318 13.4143 13.7645 0 15.1039 0 13.4745 15.8093 14.5909 0 0 0 0 0 0 0 14.8172 14.0831 0 13.9764 14.749 13.9034 16.0197 0 16.5761 0 16.1143 14.8675 0 14.6828 15.1075 15.6462 0 16.096 15.891 15.736 0 0 16.8913 16.2399 15.8725 15.5966 0 0 15.2748 0 14.8575 0 0 0 13.9822 12.9249 14.5473 14.4561 15.5432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9668 0 0 14.408 0 15.3079 0 0 0 P62136 PP1A_HUMAN "Serine/threonine-protein phosphatase PP1-alpha catalytic subunit, PP-1A, EC 3.1.3.16" PPP1CA PPP1A Homo sapiens (Human) beta-catenin destruction complex disassembly [GO:1904886]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; negative regulation of protein binding [GO:0032091]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of translational initiation by eIF2 alpha dephosphorylation [GO:0036496]; response to lead ion [GO:0010288] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; ribonucleoprotein complex binding [GO:0043021]; beta-catenin destruction complex disassembly [GO:1904886]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; negative regulation of protein binding [GO:0032091]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of translational initiation by eIF2 alpha dephosphorylation [GO:0036496]; response to lead ion [GO:0010288] GO:0000164; GO:0004721; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005977; GO:0005979; GO:0005981; GO:0006470; GO:0007049; GO:0008157; GO:0010288; GO:0016311; GO:0016791; GO:0017018; GO:0030324; GO:0032091; GO:0032922; GO:0035970; GO:0036496; GO:0042587; GO:0042752; GO:0043021; GO:0043153; GO:0043197; GO:0043204; GO:0046872; GO:0048754; GO:0051301; GO:0060828; GO:0070062; GO:0070262; GO:0072357; GO:0098641; GO:0098793; GO:0098978; GO:1904886; GO:2001241 cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; ribonucleoprotein complex binding [GO:0043021] AHQVVEDGYEFFAKR 0.93633 1.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q685J3 MUC17_HUMAN "Mucin-17, MUC-17 (Small intestinal mucin-3, MUC-3)" MUC17 MUC3 Homo sapiens (Human) cellular homeostasis [GO:0019725] apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent, lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]; cellular homeostasis [GO:0019725]" GO:0005576; GO:0005796; GO:0005886; GO:0009897; GO:0016021; GO:0016324; GO:0019725; GO:0030165; GO:0030197; GO:0062023 "extracellular matrix constituent, lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]" LGSVVVEHDVLLRTKYTPEYK 0.93634 1.8128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4997 0 0 0 0 0 0 0 0 0 0 0 13.6942 0 15.7125 0 0 0 0 0 0 0 0 0 13.1544 0 0 0 13.6315 13.7808 0 0 0 0 0 0 0 13.2013 0 0 0 0 0 0 0 13.2992 0 0 0 0 0 0 0 0 0 0 13.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1018 0 0 0 0 13.7936 0 0 0 12.3233 0 0 12.2469 0 0 12.411 0 0 0 0 0 0 0 P49286 MTR1B_HUMAN "Melatonin receptor type 1B, Mel-1B-R, Mel1b receptor" MTNR1B Homo sapiens (Human) "camera-type eye development [GO:0043010]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]; camera-type eye development [GO:0043010]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose homeostasis [GO:0042593]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transmission of nerve impulse [GO:0051970]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; regulation of neuronal action potential [GO:0098908]" GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007268; GO:0008502; GO:0010754; GO:0042593; GO:0043010; GO:0043524; GO:0045202; GO:0045906; GO:0046010; GO:0046676; GO:0050796; GO:0051481; GO:0051970; GO:0051971; GO:0098908; GO:1902260 G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502] HCIQDASK 0.93635 1.6938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2676 0 0 0 0 0 0 0 0 0 0 0 12.06 0 11.9797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1072 11.4937 11.7886 0 0 0 0 0 0 12.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9237 0 0 0 12.1203 10.9553 0 0 0 12.1629 0 0 12.4819 0 0 0 0 0 14.8364 16.3099 14.7338 14.9715 15.4865 15.4159 0 0 15.2958 16.3921 0 14.9704 14.8956 15.0923 0 13.2778 13.0313 13.5653 0 13.7029 15.2902 14.8342 13.0402 0 11.3401 0 14.1171 13.3677 0 14.132 13.3257 14.8772 0 12.6561 14.2023 0 0 13.1855 0 14.222 0 12.385 0 0 13.4393 0 12.1727 0 0 0 0 11.2585 0 12.4838 0 0 0 12.8147 12.6786 11.7646 12.2517 0 0 0 0 0 0 0 0 0 0 0 12.1558 0 11.677 0 0 0 0 11.9847 0 0 0 0 12.0792 0 0 0 0 0 0 0 11.6909 0 0 12.0544 Q8IY95 TM192_HUMAN Transmembrane protein 192 TMEM192 Homo sapiens (Human) endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803] GO:0005654; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0016021; GO:0042803; GO:0048471 protein homodimerization activity [GO:0042803] IRNRGYNLIYR 0.93637 2.1235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8924 0 0 13.6001 0 12.4573 0 0 0 0 0 0 0 0 12.8254 0 0 11.9079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5704 0 0 0 0 0 0 0 0 P08700 IL3_HUMAN "Interleukin-3, IL-3 (Hematopoietic growth factor) (Mast cell growth factor, MCGF) (Multipotential colony-stimulating factor) (P-cell-stimulating factor)" IL3 Homo sapiens (Human) cell-cell signaling [GO:0007267]; embryonic hemopoiesis [GO:0035162]; immune response [GO:0006955]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-3 receptor binding [GO:0005135]; cell-cell signaling [GO:0007267]; embryonic hemopoiesis [GO:0035162]; immune response [GO:0006955]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] GO:0005125; GO:0005135; GO:0005576; GO:0005615; GO:0006955; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0035162; GO:0042531; GO:0050731 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-3 receptor binding [GO:0005135] LPVLLLLQLLVR 0.93641 2.6892 0 0 0 0 11.1165 0 0 0 0 12.2777 12.0719 0 12.0013 0 12.8627 0 10.8592 0 10.5031 0 0 0 0 0 0 0 0 0 0 0 14.1849 0 0 12.5986 12.4661 12.0832 0 9.69664 12.4863 11.6118 10.6804 0 0 0 0 0 9.68278 0 0 0 9.99817 0 0 0 12.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6479 12.4133 0 0 0 0 11.3244 0 14.1367 12.7905 0 12.9776 14.5142 15.3869 0 0 0 15.0162 13.2572 14.7931 14.6411 15.1694 14.7809 0 0 14.9062 14.8759 14.8401 0 9.57962 0 0 0 0 0 14.4774 0 0 12.9978 0 0 0 12.3406 0 14.1686 0 0 0 14.0231 13.4951 13.5015 0 0 14.0526 0 14.9542 14.7007 0 14.8764 11.7794 11.0038 15.0093 0 12.7452 0 0 13.4893 13.8801 10.4013 0 14.1481 12.9383 0 0 0 0 0 12.763 0 10.5507 0 0 0 0 11.6356 13.4182 12.7694 13.8128 0 0 11.3179 13.6758 0 12.8188 0 12.7147 0 12.7554 13.7913 0 13.3704 0 0 0 13.1946 13.5094 0 13.1477 13.0531 14.2609 Q5JTJ3 COA6_HUMAN Cytochrome c oxidase assembly factor 6 homolog COA6 C1orf31 Homo sapiens (Human) mitochondrial ATP synthesis coupled electron transport [GO:0042775]; plasma membrane ATP synthesis coupled electron transport [GO:0042774]; respiratory chain complex IV assembly [GO:0008535] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; respiratory chain complex IV [GO:0045277] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; respiratory chain complex IV [GO:0045277]; copper ion binding [GO:0005507]; RNA binding [GO:0003723]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; plasma membrane ATP synthesis coupled electron transport [GO:0042774]; respiratory chain complex IV assembly [GO:0008535] GO:0003723; GO:0005507; GO:0005654; GO:0005739; GO:0005758; GO:0005886; GO:0008535; GO:0042774; GO:0042775; GO:0045277 copper ion binding [GO:0005507]; RNA binding [GO:0003723] CLDENLEDASQCK 0.93642 1.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60981 DEST_HUMAN "Destrin (Actin-depolymerizing factor, ADF)" DSTN ACTDP DSN Homo sapiens (Human) actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; positive regulation of actin filament depolymerization [GO:0030836] actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; positive regulation of actin filament depolymerization [GO:0030836] GO:0005737; GO:0008154; GO:0015629; GO:0030042; GO:0030043; GO:0030836; GO:0030864; GO:0051014; GO:0051015; GO:0070062 actin filament binding [GO:0051015] KKAVIFCLSADK 0.93643 1.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P33552 CKS2_HUMAN "Cyclin-dependent kinases regulatory subunit 2, CKS-2" CKS2 Homo sapiens (Human) cell division [GO:0051301]; fibroblast proliferation [GO:0048144]; meiosis I [GO:0007127]; mitotic cell cycle phase transition [GO:0044772]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell division [GO:0051301]; fibroblast proliferation [GO:0048144]; meiosis I [GO:0007127]; mitotic cell cycle phase transition [GO:0044772]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000307; GO:0003682; GO:0006357; GO:0007127; GO:0007346; GO:0019005; GO:0019901; GO:0042393; GO:0043130; GO:0044772; GO:0048144; GO:0051301; GO:0061575 chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130] HVMLPRELSKQVPK 0.93646 2.6257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7516 14.6258 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9476 0 0 0 0 0 0 0 0 11.5419 0 0 0 0 0 0 0 0 14.4318 0 0 0 0 0 0 0 0 0 14.6118 0 0 0 0 15.519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0E2 XPO4_HUMAN "Exportin-4, Exp4" XPO4 KIAA1721 Homo sapiens (Human) positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611] GO:0005049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0046827 nuclear export signal receptor activity [GO:0005049] AMNLYEACLTLLQVYSKNNLGR 0.93648 2.6879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4413 11.6795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4264 0 0 0 0 13.0613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04118 COL_HUMAN Colipase CLPS Homo sapiens (Human) digestion [GO:0007586]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; response to bacterium [GO:0009617]; response to food [GO:0032094] extracellular region [GO:0005576] extracellular region [GO:0005576]; enzyme activator activity [GO:0008047]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; response to bacterium [GO:0009617]; response to food [GO:0032094] GO:0005576; GO:0006629; GO:0007586; GO:0008047; GO:0009617; GO:0016042; GO:0032094 enzyme activator activity [GO:0008047] CPCERGLTCEGDK 0.93651 2.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8364 13.7014 13.7346 14.0783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4186 0 0 0 0 0 12.3592 0 0 0 13.5523 0 0 0 0 0 11.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0359 11.9944 0 0 10.788 12.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22760 AAAD_HUMAN "Arylacetamide deacetylase, EC 3.1.1.3" AADAC DAC Homo sapiens (Human) lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; catalytic activity [GO:0003824]; deacetylase activity [GO:0019213]; lipase activity [GO:0016298]; serine hydrolase activity [GO:0017171]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898]; xenobiotic metabolic process [GO:0006805] GO:0003824; GO:0004806; GO:0005789; GO:0006629; GO:0006805; GO:0010898; GO:0016021; GO:0016298; GO:0017171; GO:0019213 catalytic activity [GO:0003824]; deacetylase activity [GO:0019213]; lipase activity [GO:0016298]; serine hydrolase activity [GO:0017171]; triglyceride lipase activity [GO:0004806] LRNTGVQVTHNHVEDGFHGAFSFLGLKISHR 0.93651 1.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5307 0 0 0 0 11.6239 0 0 0 0 12.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4585 0 0 0 18.0639 0 0 15.6922 14.6548 0 0 15.1961 14.973 14.9058 0 14.3315 0 13.8054 14.9371 13.987 0 0 0 14.2169 14.3511 0 13.7249 0 13.6409 0 14.8799 14.5854 14.9376 0 0 14.0566 14.0073 14.3965 13.8831 13.6607 13.7023 13.6407 17.3904 16.2603 0 0 0 13.5628 0 14.8741 0 0 13.5634 0 13.8698 0 0 16.9654 13.7586 14.6075 13.7084 0 14.6544 13.6433 13.518 13.6046 14.3867 0 0 0 0 0 14.7247 14.3682 0 0 0 0 14.1853 0 0 0 0 0 13.372 0 0 14.0781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6058 0 14.7585 13.2068 0 0 0 0 0 Q9HBL8 NMRL1_HUMAN NmrA-like family domain-containing protein 1 NMRAL1 HSCARG Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802] GO:0005654; GO:0005829; GO:0042802; GO:0048471 identical protein binding [GO:0042802] DLANMFRFYALRPDR 0.93652 2.6254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8621 0 13.8207 0 14.3288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5842 15.8932 0 0 0 0 0 0 0 16.6041 0 0 0 0 0 0 0 16.2132 16.2204 0 0 11.367 0 0 15.93 0 0 0 0 0 0 0 10.6898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6GMV1 ALG1L_HUMAN "Putative glycosyltransferase ALG1-like, EC 2.4.1.-" ALG1L Homo sapiens (Human) protein glycosylation [GO:0006486] endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783]; mannosyltransferase activity [GO:0000030]; protein glycosylation [GO:0006486] GO:0000030; GO:0005783; GO:0006486 mannosyltransferase activity [GO:0000030] DPCCPSR 0.93656 1.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55021 0 0 0 0 0 0 0 0 0 0 0 11.5797 0 0 0 0 0 0 0 10.628 0 0 0 11.6903 0 0 0 0 0 15.0374 0 0 0 0 13.9188 0 0 0 10.9625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5306 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5208 0 0 0 11.598 0 0 0 0 0 0 0 0 0 10.0285 0 0 0 0 0 0 0 0 10.644 10.0098 0 0 0 0 0 12.5722 0 0 0 0 10.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11488 GNAT1_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-1 (Transducin alpha-1 chain) GNAT1 GNATR Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell population proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; phototransduction, visible light [GO:0007603]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; response to light intensity [GO:0009642]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of umami taste [GO:0050917]; signal transduction [GO:0007165]; visual perception [GO:0007601]" apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; acyl binding [GO:0000035]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell population proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; phototransduction, visible light [GO:0007603]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; response to light intensity [GO:0009642]; response to light stimulus [GO:0009416]; retina development in camera-type eye [GO:0060041]; rhodopsin mediated signaling pathway [GO:0016056]; sensory perception of umami taste [GO:0050917]; signal transduction [GO:0007165]; visual perception [GO:0007601]" GO:0000035; GO:0001580; GO:0001664; GO:0001750; GO:0001917; GO:0001973; GO:0003924; GO:0005525; GO:0005829; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0007193; GO:0007601; GO:0007603; GO:0008283; GO:0009416; GO:0009642; GO:0016020; GO:0016056; GO:0016324; GO:0019003; GO:0019901; GO:0022400; GO:0031683; GO:0032391; GO:0042462; GO:0042622; GO:0043025; GO:0046872; GO:0050908; GO:0050917; GO:0051343; GO:0051344; GO:0060041; GO:0071257; GO:0097381 acyl binding [GO:0000035]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901] DLNFRMFDVGGQRSER 0.93657 0.9424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0893 0 15.4483 0 0 0 0 0 0 Q8NGZ2 O14K1_HUMAN Olfactory receptor 14K1 (Olfactory receptor 5AY1) (Olfactory receptor OR1-39) OR14K1 OR5AY1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] LHALLFSLIYLTAVLMNLVIILLMILDHR 0.93658 1.0461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8403 0 0 0 0 0 0 O43692 PI15_HUMAN "Peptidase inhibitor 15, PI-15 (25 kDa trypsin inhibitor, p25TI) (Cysteine-rich secretory protein 8, CRISP-8) (SugarCrisp)" PI15 CRISP8 P25TI Homo sapiens (Human) negative regulation of peptidase activity [GO:0010466] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of peptidase activity [GO:0010466] GO:0005615; GO:0010466; GO:0030414; GO:0070062 peptidase inhibitor activity [GO:0030414] RAVYLVCNYAPKGNWIGEAPYK 0.9366 1.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7013 0 0 0 0 0 0 Q495M3 S36A2_HUMAN "Proton-coupled amino acid transporter 2, Proton/amino acid transporter 2 (Solute carrier family 36 member 2) (Transmembrane domain rich protein 1, Tramdorin-1)" SLC36A2 PAT2 TRAMD1 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600] GO:0003333; GO:0005280; GO:0005297; GO:0005789; GO:0005886; GO:0006811; GO:0006865; GO:0015171; GO:0015179; GO:0015180; GO:0015187; GO:0015193; GO:0015808; GO:0015816; GO:0015824; GO:0016021; GO:0035524; GO:0055038; GO:0070062; GO:1902600 amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297] GITVFQALIHLVK 0.93662 2.1184 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9839 13.9839 0 0 14.5649 13.2304 0 14.4516 0 16.5039 0 13.2433 0 0 13.6426 0 0 0 0 0 12.603 0 0 0 0 0 0 0 0 0 13.545 0 0 12.7476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3696 0 0 0 0 0 0 0 15.2128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9929 0 0 0 0 0 0 14.7898 0 0 0 0 12.89 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7092 0 0 0 13.63 0 0 0 0 15.3355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1Q7 PED1A_HUMAN PC-esterase domain-containing protein 1A (Protein FAM113A) (Sarcoma antigen NY-SAR-23) PCED1A C20orf81 FAM113A Homo sapiens (Human) transferase activity [GO:0016740] GO:0016740 transferase activity [GO:0016740] AVYKDLVLLLQK 0.93663 1.8326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4819 0 0 0 0 0 P53677 AP3M2_HUMAN AP-3 complex subunit mu-2 (Adaptor-related protein complex 3 subunit mu-2) (Clathrin assembly protein assembly protein complex 3 mu-2 medium chain) (Clathrin coat assembly protein AP47 homolog 2) (Clathrin coat-associated protein AP47 homolog 2) (Golgi adaptor AP-1 47 kDa protein homolog 2) (HA1 47 kDa subunit homolog 2) (Mu3B-adaptin) (P47B) AP3M2 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793] "AP-3 adaptor complex [GO:0030123]; AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" GO:0005769; GO:0005794; GO:0006886; GO:0006897; GO:0008089; GO:0016183; GO:0016192; GO:0030119; GO:0030123; GO:0030131; GO:0030659; GO:0031410; GO:0035654; GO:0036465; GO:0046907; GO:0048490; GO:0098793; GO:1904115 AGKFQVR 0.93664 1.6768 0 0 0 0 0 0 0 0 12.4602 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0815 0 0 0 12.4546 0 0 0 12.0871 12.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2497 0 0 0 0 12.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6573 0 0 0 0 0 0 Q13516 OLIG2_HUMAN "Oligodendrocyte transcription factor 2, Oligo2 (Class B basic helix-loop-helix protein 1, bHLHb1) (Class E basic helix-loop-helix protein 19, bHLHe19) (Protein kinase C-binding protein 2) (Protein kinase C-binding protein RACK17)" OLIG2 BHLHB1 BHLHE19 PRKCBP2 RACK17 Homo sapiens (Human) myelination [GO:0042552]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; thalamus development [GO:0021794] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; myelination [GO:0042552]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron differentiation [GO:0021522]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; thalamus development [GO:0021794]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0021522; GO:0021530; GO:0021794; GO:0030182; GO:0042552; GO:0042802; GO:0045665; GO:0046983; GO:0048663; GO:0048714; GO:0071837; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" IATLLLARNYILMLTNSLEEMK 0.93672 1.7784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY30 BTG4_HUMAN Protein BTG4 (BTG family member 4) (Protein PC3b) BTG4 PC3B Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; neuron differentiation [GO:0030182]; regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; neuron differentiation [GO:0030182]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005737; GO:0008285; GO:0030182; GO:0045930; GO:0051726 ASSDVSSGTSCDEESCSK 0.93673 1.6755 0 0 0 12.8939 0 0 0 0 14.6213 14.7633 14.7415 14.6083 14.3554 14.9206 15.3522 14.1814 14.0619 14.5501 0 14.446 0 0 0 0 13.479 0 0 13.5234 14.5752 13.2674 13.1897 14.2364 15.0296 12.9454 13.1785 0 14.1723 12.3682 14.7323 14.3887 12.8822 17.215 14.6617 17.1534 13.4273 13.0697 12.9333 0 12.9527 0 0 17.2882 12.6685 13.0883 14.1218 13.1943 13.9155 11.6481 0 0 0 0 11.6468 0 0 0 0 0 0 0 0 0 0 0 13.5969 0 0 13.8448 0 0 0 0 0 0 13.6799 0 0 13.6608 0 18.0492 0 14.7009 0 13.5525 16.8068 0 0 0 0 15.2768 0 0 0 0 0 0 0 0 0 13.8296 0 0 0 13.3254 19.7442 0 0 14.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.48 0 0 0 0 0 0 0 0 15.1707 0 12.2251 0 0 0 0 0 0 14.8342 15.471 15.2705 14.9527 16.0633 0 16.5057 15.2006 15.0918 16.4934 14.9915 16.0351 0 14.9558 16.3794 19.5815 0 0 0 16.9085 19.7156 15.0258 0 0 Q8TE04 PANK1_HUMAN "Pantothenate kinase 1, hPanK, hPanK1, EC 2.7.1.33 (Pantothenic acid kinase 1)" PANK1 PANK Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; recycling endosome [GO:0055037] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310] GO:0004594; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0015937; GO:0016310; GO:0030136; GO:0042803; GO:0055037; GO:1905502 acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803] HPQAPALRLLNRK 0.93674 1.8149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4069 0 0 0 0 0 0 0 0 0 0 0 16.2528 0 0 0 0 0 0 13.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7541 0 0 0 0 0 0 0 0 13.6175 0 0 0 0 13.8747 0 11.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5174 0 13.357 0 0 0 0 0 0 Q495X7 TRI60_HUMAN Tripartite motif-containing protein 60 (RING finger protein 129) (RING finger protein 33) TRIM60 RNF129 RNF33 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DLEILCTQCSFSTKHQKHYICPIK 0.93675 1.7779 0 0 0 0 0 0 0 0 13.6472 0 0 0 0 0 0 14.3939 0 13.6111 0 0 0 0 14.9406 0 0 0 0 0 0 14.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8781 14.4071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8509 0 0 0 0 14.0532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.668 0 0 0 0 0 0 14.1836 0 0 0 0 0 0 0 0 0 0 0 14.6996 0 0 Q6VVX0 CP2R1_HUMAN "Vitamin D 25-hydroxylase, EC 1.14.14.24 (Cytochrome P450 2R1)" CYP2R1 Homo sapiens (Human) calcitriol biosynthetic process from calciol [GO:0036378]; organic acid metabolic process [GO:0006082]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; D3 vitamins binding [GO:1902271]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; protein homodimerization activity [GO:0042803]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; calcitriol biosynthetic process from calciol [GO:0036378]; organic acid metabolic process [GO:0006082]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]" GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006766; GO:0006805; GO:0008395; GO:0016712; GO:0020037; GO:0030343; GO:0036378; GO:0042359; GO:0042803; GO:0043231; GO:1902271 "D3 vitamins binding [GO:1902271]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; protein homodimerization activity [GO:0042803]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]" AEEGAAALGGALFLLLFALGVRQLLK 0.93677 1.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8351 11.3858 0 0 0 0 0 0 0 0 0 0 0 0 P52797 EFNA3_HUMAN "Ephrin-A3 (EFL-2) (EHK1 ligand, EHK1-L) (EPH-related receptor tyrosine kinase ligand 3, LERK-3)" EFNA3 EFL2 EPLG3 LERK3 Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of angiogenesis [GO:0016525]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; regulation of neuron differentiation [GO:0045664] anchored component of membrane [GO:0031225]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of angiogenesis [GO:0016525]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; regulation of neuron differentiation [GO:0045664] GO:0005005; GO:0005886; GO:0007267; GO:0007411; GO:0016525; GO:0031225; GO:0031226; GO:0045664; GO:0046875; GO:0048013; GO:1902961 ephrin receptor binding [GO:0046875]; transmembrane-ephrin receptor activity [GO:0005005] AAAPLLLLLLLVPVPLLPLLAQGPGGALGNR 0.93678 2.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54855 UDB15_HUMAN "UDP-glucuronosyltransferase 2B15, UDPGT 2B15, UGT2B15, EC 2.4.1.17 (HLUG4) (UDP-glucuronosyltransferase 2B8, UDPGT 2B8) (UDPGTh-3)" UGT2B15 UGT2B8 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0015020; GO:0016021; GO:0052695 glucuronosyltransferase activity [GO:0015020] ILDRWIYGVSK 0.9368 1.8132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7983 0 0 0 0 0 0 0 0 0 12.5055 0 12.9465 0 0 0 0 0 0 0 13.1744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2M5 KLH20_HUMAN Kelch-like protein 20 (Kelch-like ECT2-interacting protein) (Kelch-like protein X) KLHL20 KLEIP KLHLX Homo sapiens (Human) cytoskeleton organization [GO:0007010]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; response to interferon-alpha [GO:0035455] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842]; cytoskeleton organization [GO:0007010]; Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; response to interferon-alpha [GO:0035455] GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0007010; GO:0015031; GO:0015629; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0035455; GO:0043066; GO:0043161; GO:0048471; GO:1990390 actin binding [GO:0003779]; interferon-gamma binding [GO:0019964]; ubiquitin-protein transferase activity [GO:0004842] AMFTGELAESRQTEVVIR 0.9368 2.682 0 0 0 0 0 0 0 0 0 0 0 0 0 13.765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3385 0 0 0 0 0 12.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2765 0 0 0 0 0 0 12.5474 0 0 0 0 0 0 0 0 0 0 14.3461 0 13.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5421 0 0 0 0 0 0 0 0 10.9414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4189 0 0 0 P22894 MMP8_HUMAN "Neutrophil collagenase, EC 3.4.24.34 (Matrix metalloproteinase-8, MMP-8) (PMNL collagenase, PMNL-CL)" MMP8 CLG1 Homo sapiens (Human) collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of tumor necrosis factor production [GO:0032760]; proteolysis [GO:0006508]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of tumor necrosis factor production [GO:0032760]; proteolysis [GO:0006508]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077] GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008270; GO:0010628; GO:0010629; GO:0022617; GO:0030198; GO:0030574; GO:0032693; GO:0032755; GO:0032760; GO:0035580; GO:0035987; GO:0043388; GO:0043410; GO:0045429; GO:0046330; GO:0062023; GO:0150077; GO:0150078; GO:1901224; GO:1903428; GO:1903978; GO:1903980; GO:1904724 endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] FSLKTLPFLLLLHVQISK 0.93681 0.94242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2593 12.7375 0 0 0 0 12.129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1157 11.2525 12.339 0 0 11.0639 0 15.4955 14.6349 0 0 0 0 0 0 0 14.0097 0 13.5507 0 0 14.7622 0 0 0 0 0 14.5247 13.8723 13.8658 0 0 0 0 0 0 0 13.4479 0 12.6513 0 0 0 0 0 13.3205 0 0 0 0 0 0 0 0 0 13.719 0 0 0 0 13.167 0 0 0 13.2502 0 0 0 13.1966 0 0 0 13.2801 0 0 0 13.3655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16572 VACHT_HUMAN "Vesicular acetylcholine transporter, VAChT (Solute carrier family 18 member 3)" SLC18A3 VACHT Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195] AP-1 adaptor complex [GO:0030121]; AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; acetylcholine transmembrane transporter activity [GO:0005277]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] GO:0005277; GO:0005886; GO:0006836; GO:0007268; GO:0016021; GO:0022857; GO:0030121; GO:0030122; GO:0030669; GO:0043195; GO:0060201 acetylcholine transmembrane transporter activity [GO:0005277]; transmembrane transporter activity [GO:0022857] HTMAASEWEMGMAWLPAFVPHVLGVYLTVR 0.93686 2.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3958 0 0 0 11.3972 12.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.592 0 0 0 0 12.5742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5775 0 0 12.5276 0 0 0 0 0 0 0 12.1831 0 0 0 0 0 0 0 0 0 0 0 0 0 P46734 MP2K3_HUMAN "Dual specificity mitogen-activated protein kinase kinase 3, MAP kinase kinase 3, MAPKK 3, EC 2.7.12.2 (MAPK/ERK kinase 3, MEK 3) (Stress-activated protein kinase kinase 2, SAPK kinase 2, SAPKK-2, SAPKK2)" MAP2K3 MEK3 MKK3 PRKMK3 SKK2 Homo sapiens (Human) "cardiac muscle contraction [GO:0060048]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular senescence [GO:0090398]; heart development [GO:0007507]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cardiac muscle contraction [GO:0060048]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular senescence [GO:0090398]; heart development [GO:0007507]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of hippo signaling [GO:0035331]; p38MAPK cascade [GO:0038066]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]" GO:0000165; GO:0001817; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0006954; GO:0007165; GO:0007507; GO:0016020; GO:0019901; GO:0035331; GO:0035924; GO:0038066; GO:0043410; GO:0043536; GO:0045860; GO:0045893; GO:0051770; GO:0060048; GO:0071222; GO:0072709; GO:0090398; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] DLRISCMSKPPAPNPTPPR 0.93689 2.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.553 0 0 0 0 0 0 0 0 0 0 13.9073 0 0 0 0 0 0 0 0 14.9632 0 0 Q32P41 TRM5_HUMAN "tRNA (guanine(37)-N1)-methyltransferase, EC 2.1.1.228 (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog)" TRMT5 KIAA1393 TRM5 Homo sapiens (Human) mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] GO:0002939; GO:0005634; GO:0005737; GO:0005759; GO:0008175; GO:0009019; GO:0030488; GO:0052906; GO:0070901 tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175] ERKPSVHVVMNLPAK 0.93689 4.904 0 0 0 0 0 0 12.6683 0 11.1149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPY3 DICER_HUMAN "Endoribonuclease Dicer, EC 3.1.26.3 (Helicase with RNase motif, Helicase MOI)" DICER1 DICER HERNA KIAA0928 Homo sapiens (Human) "apoptotic DNA fragmentation [GO:0006309]; global gene silencing by mRNA cleavage [GO:0098795]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; negative regulation of gene expression [GO:0010629]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; siRNA processing [GO:0030422]; tRNA catabolic process [GO:0016078]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; apoptotic DNA fragmentation [GO:0006309]; global gene silencing by mRNA cleavage [GO:0098795]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; negative regulation of gene expression [GO:0010629]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; nerve development [GO:0021675]; neuron projection morphogenesis [GO:0048812]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; siRNA processing [GO:0030422]; tRNA catabolic process [GO:0016078]" GO:0000122; GO:0003677; GO:0003723; GO:0003725; GO:0004386; GO:0004521; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006309; GO:0010586; GO:0010626; GO:0010629; GO:0014040; GO:0016078; GO:0016442; GO:0019904; GO:0021675; GO:0030422; GO:0031054; GO:0031643; GO:0032290; GO:0032720; GO:0035196; GO:0035197; GO:0038061; GO:0046872; GO:0048471; GO:0048812; GO:0070062; GO:0070578; GO:0070883; GO:0070922; GO:0090501; GO:0090502; GO:0098795 ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; protein domain specific binding [GO:0019904]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; siRNA binding [GO:0035197] AAQLFLCSLGLKVLPVIK 0.93691 1.0521 0 0 0 0 0 0 0 0 14.2674 0 0 12.9783 10.8586 0 12.5837 0 0 13.0529 0 13.1685 0 0 0 12.6334 16.1987 12.7053 13.0844 0 0 16.2221 0 0 0 0 0 0 0 0 14.8261 0 0 0 0 16.6957 0 0 0 0 0 0 12.7569 0 15.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5413 0 0 0 0 17.2274 0 0 13.7747 13.5507 13.3593 13.977 13.7493 14.6893 14.4063 0 14.1729 0 0 12.7542 14.4014 13.2422 14.499 12.1374 14.73 14.5445 14.9093 12.496 13.5324 12.5928 12.2759 0 0 0 13.8646 14.3757 14.4909 0 15.2476 12.4369 14.6982 15.368 15.5049 13.8424 14.4684 13.8381 14.1522 17.7954 0 17.7533 17.4825 0 0 17.7163 0 14.6504 0 0 14.1439 14.4524 14.2345 14.4003 0 0 18.3386 14.4008 0 14.2013 0 17.5932 17.5224 10.198 14.9871 13.7692 17.7357 0 0 17.6612 14.2603 0 17.7782 0 0 0 0 14.2014 0 0 0 14.8789 15.044 13.8673 0 0 13.8391 13.9785 0 13.3908 0 13.5762 13.0868 0 0 0 0 12.6742 14.4222 14.9443 17.5962 12.4981 15.3079 0 14.3026 11.5718 Q9H521 YM006_HUMAN Putative uncharacterized protein LOC645739 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107] actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein serine/threonine kinase activity [GO:0004674]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107] GO:0004674; GO:0005737; GO:0005856; GO:0016477; GO:0018107; GO:0031032; GO:0042641 protein serine/threonine kinase activity [GO:0004674] MVWQENEDLRK 0.93693 1.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N138 ORML3_HUMAN ORM1-like protein 3 ORMDL3 Homo sapiens (Human) cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; motor behavior [GO:0061744]; myelination [GO:0042552]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; negative regulation of serine C-palmitoyltransferase activity [GO:1904221]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; sphingomyelin biosynthetic process [GO:0006686] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; SPOTS complex [GO:0035339] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; motor behavior [GO:0061744]; myelination [GO:0042552]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; negative regulation of serine C-palmitoyltransferase activity [GO:1904221]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; sphingomyelin biosynthetic process [GO:0006686] GO:0002903; GO:0005783; GO:0005886; GO:0006672; GO:0006686; GO:0006940; GO:0010508; GO:0016021; GO:0030667; GO:0035339; GO:0035579; GO:0042552; GO:0061744; GO:0090156; GO:1900060; GO:1900182; GO:1904221 LPQLHGVRIFGINKY 0.93694 1.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JJ3 ELMO2_HUMAN "Engulfment and cell motility protein 2 (Protein ced-12 homolog A, hCed-12A)" ELMO2 CED12A KIAA1834 Homo sapiens (Human) actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] GO:0005829; GO:0006909; GO:0006915; GO:0007015; GO:0016020; GO:0017124; GO:0030971; GO:0048870; GO:0060326; GO:0098609 receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124] AFEELFGICIQLLNK 0.93694 1.81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3184 0 0 0 12.1064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0899 0 0 0 0 0 0 0 0 0 0 0 0 14.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0733 0 0 13.0606 0 0 13.5404 12.6871 0 0 0 0 13.5971 0 12.4485 17.5801 12.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX07 TSAP1_HUMAN tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1) TRNAU1AP SECP43 TRSPAP1 Homo sapiens (Human) selenocysteine incorporation [GO:0001514] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514] GO:0000049; GO:0001514; GO:0003723; GO:0005634; GO:0005737 RNA binding [GO:0003723]; tRNA binding [GO:0000049] EFMEQSEELYDALMDCHWQPLDTVSSEIPAMM 0.93694 2.3777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.843 0 0 13.7988 14.8794 14.529 0 0 0 13.7214 13.4202 0 0 0 0 0 0 0 0 12.9109 0 0 0 13.4184 13.095 0 0 0 12.8246 0 0 13.7638 0 12.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1968 12.3227 0 0 0 0 0 0 0 12.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0885 0 0 0 0 0 0 0 0 0 0 P40198 CEAM3_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 3 (Carcinoembryonic antigen CGM1) (CD antigen CD66d) CEACAM3 CD66D CGM1 Homo sapiens (Human) regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; protein tyrosine kinase binding [GO:1990782]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] GO:0002682; GO:0005886; GO:0007165; GO:0009986; GO:0016021; GO:0035579; GO:1990782 protein tyrosine kinase binding [GO:1990782] EVLLLVHNLPQHLFGYSWYK 0.93695 1.0506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVE7 GOT1A_HUMAN Vesicle transport protein GOT1A (Golgi transport 1 homolog A) (hGOT1b) GOLT1A GOT1B Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; trans-Golgi network [GO:0005802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000137; GO:0000139; GO:0005635; GO:0005783; GO:0005802; GO:0005829; GO:0006888; GO:0015031; GO:0016020; GO:0016021; GO:0042147 GTSFLLGGVVIVLLR 0.93695 2.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4026 0 0 0 0 0 13.2555 0 0 10.5445 13.7387 13.2187 13.6611 0 0 0 16.2678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9889 0 0 0 0 0 0 0 11.0579 0 10.7981 0 0 14.3544 0 0 0 0 0 0 0 13.9727 13.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3699 0 0 0 12.3367 0 12.6581 0 0 0 0 0 0 0 0 0 0 9.92803 12.6877 0 0 0 0 14.1403 0 0 0 Q6UX41 BTNL8_HUMAN Butyrophilin-like protein 8 BTNL8 UNQ702/PRO1347 Homo sapiens (Human) adaptive immune response [GO:0002250]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0002250; GO:0005102; GO:0005886; GO:0009897; GO:0016021; GO:0050852 signaling receptor binding [GO:0005102] APQEVPHSEKR 0.93696 1.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ31 KCNS3_HUMAN Potassium voltage-gated channel subfamily S member 3 (Delayed-rectifier K(+) channel alpha subunit 3) (Voltage-gated potassium channel subunit Kv9.3) KCNS3 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005794; GO:0005829; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0016021; GO:0034765; GO:0051260; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249] ELEKFDTLRFGQLR 0.93699 2.3763 0 0 10.9783 0 0 0 0 0 0 0 0 0 12.2211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2734 0 0 0 0 O75830 SPI2_HUMAN "Serpin I2 (Myoepithelium-derived serine protease inhibitor) (Pancpin) (Pancreas-specific protein TSA2004) (Peptidase inhibitor 14, PI-14)" SERPINI2 MEPI PI14 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; regulation of cell adhesion [GO:0030155] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; regulation of cell adhesion [GO:0030155] GO:0004867; GO:0005615; GO:0010951; GO:0030155; GO:0070062 serine-type endopeptidase inhibitor activity [GO:0004867] SFFSAISEKK 0.93704 1.0006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7466 15.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVQ1 CANT1_HUMAN "Soluble calcium-activated nucleotidase 1, SCAN-1, EC 3.6.1.6 (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107)" CANT1 SHAPY Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteoglycan biosynthetic process [GO:0030166] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteoglycan biosynthetic process [GO:0030166] GO:0004382; GO:0005509; GO:0005576; GO:0005789; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030166; GO:0032580; GO:0035580; GO:0042803; GO:0043123; GO:0043262; GO:0045134; GO:0070062; GO:1904724; GO:1904813 adenosine-diphosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; guanosine-diphosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; uridine-diphosphatase activity [GO:0045134] AQEENTWFSYLK 0.93704 0.94395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P68871 HBB_HUMAN Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin ] HBB Homo sapiens (Human) carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; platelet aggregation [GO:0070527]; positive regulation of cell death [GO:0010942]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of blood pressure [GO:0008217]; renal absorption [GO:0070293]; response to hydrogen peroxide [GO:0042542] blood microparticle [GO:0072562]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; tertiary granule lumen [GO:1904724] blood microparticle [GO:0072562]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; tertiary granule lumen [GO:1904724]; heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; hemoglobin binding [GO:0030492]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; platelet aggregation [GO:0070527]; positive regulation of cell death [GO:0010942]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of blood pressure [GO:0008217]; renal absorption [GO:0070293]; response to hydrogen peroxide [GO:0042542] GO:0005344; GO:0005576; GO:0005615; GO:0005829; GO:0005833; GO:0008217; GO:0010942; GO:0015670; GO:0015671; GO:0019825; GO:0020037; GO:0030185; GO:0030492; GO:0031721; GO:0031838; GO:0042542; GO:0042744; GO:0043177; GO:0045429; GO:0046872; GO:0070062; GO:0070293; GO:0070527; GO:0071682; GO:0072562; GO:0098869; GO:1904724; GO:1904813 heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; hemoglobin binding [GO:0030492]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] LHVDPENFR 0.93706 2.6582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4995 0 0 0 0 0 0 0 0 0 13.6466 0 0 0 0 0 0 0 14.2643 14.7778 13.4844 0 0 0 0 0 0 0 0 11.7598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1412 0 0 0 0 0 0 0 0 0 0 13.2389 12.9163 0 0 0 0 0 0 0 13.4878 0 0 17.4691 12.806 13.5494 0 0 0 0 0 0 0 0 0 11.535 13.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4797 0 0 0 0 0 0 0 0 0 Q9Y3D3 RT16_HUMAN "28S ribosomal protein S16, mitochondrial, MRP-S16, S16mt (Mitochondrial small ribosomal subunit protein bS16m)" MRPS16 RPMS16 CGI-132 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit [GO:0015935] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0005829; GO:0006412; GO:0015935; GO:0032543 structural constituent of ribosome [GO:0003735] MVHLTTLLCK 0.93706 0.94306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0226 0 P15923 TFE2_HUMAN "Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21, bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3, TCF-3) (Transcription factor ITF-1)" TCF3 BHLHB21 E2A ITF1 Homo sapiens (Human) "B cell differentiation [GO:0030183]; B cell lineage commitment [GO:0002326]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; vitamin D response element binding [GO:0070644]; B cell differentiation [GO:0030183]; B cell lineage commitment [GO:0002326]; immunoglobulin V(D)J recombination [GO:0033152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000791; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0002326; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007399; GO:0030183; GO:0030890; GO:0031435; GO:0032991; GO:0033152; GO:0042803; GO:0043425; GO:0045666; GO:0045787; GO:0045893; GO:0045944; GO:0046982; GO:0051091; GO:0061629; GO:0070644; GO:0070888; GO:0090575; GO:0140297; GO:2000045 "bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; vitamin D response element binding [GO:0070644]" DINEAFKELGR 0.9371 1.7083 0 0 0 0 0 0 0 0 0 0 0 0 13.5057 0 11.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1948 0 0 0 0 0 0 0 11.5087 0 0 0 0 0 10.9526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9831 0 12.5899 0 0 0 0 0 0 0 0 0 0 0 13.4221 0 0 11.5403 0 13.0351 12.7652 12.7297 0 0 0 11.5735 0 0 11.1376 0 11.1515 0 11.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4435 0 0 0 0 0 0 0 12.3651 11.3284 0 0 0 0 0 0 0 0 11.3778 0 14.4659 11.9966 0 0 12.4935 0 12.4681 0 0 0 0 14.4706 0 0 0 0 O43156 TTI1_HUMAN TELO2-interacting protein 1 homolog (Protein SMG10) TTI1 KIAA0406 SMG10 Homo sapiens (Human) chromatin remodeling [GO:0006338]; positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006] ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078] ASTRA complex [GO:0070209]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078]; chromatin remodeling [GO:0006338]; positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006] GO:0005634; GO:0005737; GO:0006338; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0070209; GO:0110078; GO:2000003 DAPLAVLRAFKVLR 0.93711 0.99889 0 11.8101 0 0 0 0 11.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8276 0 0 12.5476 0 12.4519 0 0 0 13.5793 0 0 0 0 13.6547 0 13.2103 0 0 14.2878 0 0 0 0 0 0 13.557 13.0937 0 0 0 0 12.7209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1617 12.9977 0 0 0 0 0 0 0 0 0 0 0 0 14.0617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0713 0 0 0 10.0622 0 0 0 0 11.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGZ6 OR6F1_HUMAN Olfactory receptor 6F1 (Olfactory receptor OR1-38) OR6F1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVHVLNTVVTPVLNPFIYTLRNK 0.93711 1.6888 0 0 0 0 0 0 0 0 0 0 13.1453 0 0 0 0 0 13.6077 0 0 0 0 0 0 0 14.3235 12.6399 14.7761 14.411 0 14.1977 13.9644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1255 0 0 0 0 0 0 0 0 0 10.2984 0 0 0 0 0 0 0 10.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6129 0 0 0 0 0 0 12.3491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRU3 CNNM1_HUMAN Metal transporter CNNM1 (Ancient conserved domain-containing protein 1) (Cyclin-M1) CNNM1 ACDP1 Homo sapiens (Human) ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960] GO:0005886; GO:0006811; GO:0010960; GO:0016021; GO:0022857; GO:0043231 transmembrane transporter activity [GO:0022857] ALGALLLLALSALFSGLRLSLLSLDPVELR 0.93713 4.1807 0 0 0 0 0 0 0 0 0 0 9.75459 0 0 11.632 0 12.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6225 0 13.4599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76893 0 0 0 0 0 13.924 0 0 12.3029 0 0 15.6466 0 0 13.717 0 0 0 0 0 0 0 15.1608 0 14.6689 13.5961 0 13.1055 0 0 13.7396 13.3424 0 0 13.8716 12.8985 0 0 0 0 0 14.0994 0 12.0295 12.5462 13.2917 13.0567 0 0 14.3995 13.0994 0 0 14.3868 0 16.9839 13.1098 15.0162 13.8 0 0 15.0056 0 14.6546 0 0 0 13.0609 0 0 14.335 0 16.5686 0 14.1058 14.0766 0 14.3756 0 13.28 0 13.5083 10.9352 0 0 15.0596 0 12.9009 0 0 0 12.5775 12.6638 12.6487 0 0 0 0 0 0 0 0 0 0 0 12.2644 10.7255 12.6532 0 12.4276 13.1098 0 12.7852 15.0372 10.4576 0 0 Q96NI6 LRFN5_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 5 LRFN5 C14orf146 SALM5 Homo sapiens (Human) negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061] cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] GO:0009986; GO:0043031; GO:0050728; GO:0098978; GO:0098982; GO:0099061; GO:0099560; GO:1905606 EKILFYLFLIGIAVK 0.93716 4.0624 12.6503 0 0 10.2193 0 0 0 0 0 0 0 0 13.1062 0 12.1829 0 0 0 0 0 12.126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.892 12.2185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.815 13.8202 0 0 0 0 0 13.7541 0 0 13.7676 0 13.5232 0 0 0 0 14.0735 0 15.0065 15.7569 16.0615 0 0 0 0 13.4055 0 0 13.4682 13.6909 12.7815 14.1127 0 0 0 0 0 0 11.9914 13.8618 0 0 0 0 0 0 0 0 0 0 0 0 13.2276 0 12.2569 0 0 0 16.2264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3198 0 0 0 0 0 0 P19623 SPEE_HUMAN "Spermidine synthase, SPDSY, EC 2.5.1.16 (Putrescine aminopropyltransferase)" SRM SPS1 SRML1 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295] cytosol [GO:0005829] cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295] GO:0004766; GO:0005829; GO:0006595; GO:0006596; GO:0008295; GO:0042802; GO:0042803; GO:1990830 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766] KVLIIGGGDGGVLR 0.93718 1.7795 0 0 0 0 0 0 0 0 0 11.7755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5778 0 0 0 0 0 0 0 0 0 0 0 12.938 0 13.6735 0 0 0 0 0 0 0 14.0065 0 0 0 0 0 0 0 0 0 0 0 13.5155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9997 0 0 0 0 0 13.3814 13.9073 13.7676 0 0 0 0 0 0 0 0 0 13.8277 0 0 13.2988 0 13.3127 0 13.9802 14.8262 0 0 0 0 0 0 0 0 9.59031 14.1754 13.2291 0 0 0 0 13.9944 13.167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNQ0 ABCG2_HUMAN "Broad substrate specificity ATP-binding cassette transporter ABCG2, EC 7.6.2.2 (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)" ABCG2 ABCP BCRP BCRP1 MXR Homo sapiens (Human) biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; export across plasma membrane [GO:0140115]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate metabolic process [GO:0046415]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; external side of apical plasma membrane [GO:0098591]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]; biotin transport [GO:0015878]; cellular detoxification [GO:1990748]; export across plasma membrane [GO:0140115]; lipid transport [GO:0006869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate metabolic process [GO:0046415]; xenobiotic transport across blood-brain barrier [GO:1990962] GO:0005524; GO:0005654; GO:0005886; GO:0006869; GO:0008514; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015711; GO:0015878; GO:0016020; GO:0016021; GO:0016324; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0042802; GO:0042803; GO:0042910; GO:0045121; GO:0046415; GO:0055085; GO:0070633; GO:0097744; GO:0098591; GO:0140115; GO:0150104; GO:1990748; GO:1990962 ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; identical protein binding [GO:0042802]; organic anion transmembrane transporter activity [GO:0008514]; protein homodimerization activity [GO:0042803]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] ATEIIEPSK 0.9372 1.8167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3435 0 0 0 0 0 0 11.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7439 0 0 0 0 0 0 0 14.8186 0 0 0 0 0 11.4098 0 14.9726 0 0 0 0 0 0 0 13.9053 0 0 0 13.2432 0 11.7611 0 0 14.3151 14.1439 14.7346 0 13.0585 0 0 0 0 0 13.0927 0 0 0 0 0 0 12.2846 0 0 0 0 12.9614 13.3044 13.7587 0 0 12.9664 14.167 0 13.2057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1887 0 0 0 0 0 0 0 0 0 0 A6NGB7 TM221_HUMAN Transmembrane protein 221 TMEM221 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TLSAGLGHWDGVTHEMR 0.93721 1.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4567 11.0556 0 11.4678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75840 KLF7_HUMAN Krueppel-like factor 7 (Ubiquitous krueppel-like factor) KLF7 UKLF Homo sapiens (Human) axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; dendrite morphogenesis [GO:0048813]; glucose homeostasis [GO:0042593]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007409; GO:0007411; GO:0008270; GO:0042593; GO:0045604; GO:0045944; GO:0048813; GO:0061179; GO:1904178 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CNHCDRCFSR 0.93722 1.0509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QD8 S38A2_HUMAN Sodium-coupled neutral amino acid transporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2) SLC38A2 ATA2 KIAA1382 SAT2 SNAT2 Homo sapiens (Human) alanine transport [GO:0032328]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; cellular response to amino acid starvation [GO:0034198]; cellular response to arsenite(3-) [GO:1903841]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glutamine transport [GO:0006868]; glycine betaine transport [GO:0031460]; L-serine transport [GO:0015825]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA splicing [GO:0033120]; regulation of cellular response to stress [GO:0080135]; response to muscle activity [GO:0014850]; transport across blood-brain barrier [GO:0150104] axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; neutral amino acid:sodium symporter activity [GO:0005295]; alanine transport [GO:0032328]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; cellular response to amino acid starvation [GO:0034198]; cellular response to arsenite(3-) [GO:1903841]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glutamine transport [GO:0006868]; glycine betaine transport [GO:0031460]; L-serine transport [GO:0015825]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA splicing [GO:0033120]; regulation of cellular response to stress [GO:0080135]; response to muscle activity [GO:0014850]; transport across blood-brain barrier [GO:0150104] GO:0003333; GO:0005295; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006836; GO:0006865; GO:0006868; GO:0007565; GO:0010628; GO:0014850; GO:0015171; GO:0015179; GO:0015186; GO:0015194; GO:0015804; GO:0015825; GO:0021987; GO:0030424; GO:0030425; GO:0031460; GO:0032328; GO:0033120; GO:0034198; GO:0042383; GO:0043025; GO:0071260; GO:0080135; GO:0150104; GO:1903841 amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; neutral amino acid:sodium symporter activity [GO:0005295] AFGLVGK 0.93723 1.8154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9194 0 0 11.7112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2096 11.083 0 0 0 0 0 0 11.7565 0 0 0 12.0134 12.5126 11.9631 0 0 11.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6238 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0537 13.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KNT9 TMM95_HUMAN Sperm-egg fusion protein TMEM95 (Transmembrane protein 95) TMEM95 UNQ9390/PRO34281 Homo sapiens (Human) fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; sperm plasma membrane [GO:0097524] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; sperm plasma membrane [GO:0097524]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] GO:0002080; GO:0007342; GO:0016021; GO:0097524 LARLCSQMEARQK 0.93725 1.0459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1731 0 0 0 11.505 0 0 0 0 0 0 0 0 0 0 P35575 G6PC1_HUMAN "Glucose-6-phosphatase catalytic subunit 1, EC 3.1.3.9 (Glucose-6-phosphatase, G-6-Pase, G6Pase) (Glucose-6-phosphatase alpha, G6Pase-alpha)" G6PC1 G6PC G6PT Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose-6-phosphate transport [GO:0015760]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; multicellular organism growth [GO:0035264]; regulation of gene expression [GO:0010468]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; urate metabolic process [GO:0046415] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; phosphate ion binding [GO:0042301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; cholesterol homeostasis [GO:0042632]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose-6-phosphate transport [GO:0015760]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; multicellular organism growth [GO:0035264]; regulation of gene expression [GO:0010468]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; urate metabolic process [GO:0046415]" GO:0004346; GO:0005789; GO:0005977; GO:0005980; GO:0006094; GO:0006641; GO:0008202; GO:0010468; GO:0015760; GO:0016020; GO:0016021; GO:0016773; GO:0030176; GO:0035264; GO:0042301; GO:0042593; GO:0042632; GO:0046415; GO:0051156 "glucose-6-phosphatase activity [GO:0004346]; phosphate ion binding [GO:0042301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" GKLSKWLPFR 0.93728 1.7667 0 0 0 0 0 0 12.867 0 0 0 0 0 0 0 0 0 0 0 14.1084 0 0 14.4637 0 0 0 0 0 0 0 0 0 12.8934 0 0 0 0 0 0 0 0 0 0 0 0 14.5578 10.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.765 0 0 0 0 0 0 0 0 0 0 0 0 12.1403 12.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1026 0 0 0 0 0 0 0 0 0 0 Q9BZK3 NACP4_HUMAN "Putative nascent polypeptide-associated complex subunit alpha-like protein (Alpha-NAC pseudogene 1) (NAC-alpha pseudogene 1) (NACA family member 4, pseudogene)" NACA4P NACAP1 FKSG17 Homo sapiens (Human) protein targeting to membrane [GO:0006612] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; unfolded protein binding [GO:0051082]; protein targeting to membrane [GO:0006612] GO:0005737; GO:0005854; GO:0006612; GO:0051082 unfolded protein binding [GO:0051082] LGLQQVTGVTRVTIRK 0.93728 1.0453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087WT02 TVA92_HUMAN T cell receptor alpha variable 9-2 TRAV9-2 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0006955; GO:0042101 MNYSPGLVSLILLLLGR 0.93729 1.0007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99467 CD180_HUMAN CD180 antigen (Lymphocyte antigen 64) (Radioprotective 105 kDa protein) (CD antigen CD180) CD180 LY64 RP105 Homo sapiens (Human) B cell proliferation involved in immune response [GO:0002322]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; B cell proliferation involved in immune response [GO:0002322]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666] GO:0002322; GO:0005615; GO:0005654; GO:0005730; GO:0005886; GO:0006954; GO:0016021; GO:0031012; GO:0031663; GO:0031666; GO:0045087; GO:0071222; GO:0072686 LHLGVGCLEK 0.93729 0.94501 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2844 13.8905 0 0 13.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7551 0 11.9621 0 0 0 0 0 0 0 0 0 0 0 12.3136 13.1116 0 0 0 0 0 0 0 15.6465 0 0 0 0 0 0 0 0 11.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.708 0 0 0 0 0 0 0 0 12.9099 11.6959 0 0 0 0 0 0 O95201 ZN205_HUMAN Zinc finger protein 205 (Zinc finger protein 210) ZNF205 ZNF210 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" mitochondrion [GO:0005739]; nucleus [GO:0005634] "mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005739; GO:0006355; GO:0006357; GO:0008270; GO:0010729; GO:1901030 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" EKALFLPGGALPSPRIPVLSR 0.93731 2.6477 0 0 0 0 0 0 0 0 0 11.6245 11.1543 0 11.2288 0 0 0 0 0 0 0 10.7597 0 0 0 0 0 0 0 11.6974 0 12.5851 11.0253 11.6167 0 0 0 0 0 0 0 0 0 11.3855 0 0 0 0 0 0 10.7369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0264 0 0 0 0 0 0 0 0 0 0 0 0 0 12.542 0 0 0 0 0 0 0 0 0 0 12.3854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0063 12.8623 12.5806 0 12.2744 12.3382 0 0 0 0 11.992 0 0 10.7141 0 0 0 0 0 11.8501 0 0 0 0 Q8NH94 OR1L1_HUMAN "Olfactory receptor 1L1 (Olfactory receptor 1L2) (Olfactory receptor 9-C, OR9-C) (Olfactory receptor OR9-27)" OR1L1 OR1L2 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ILITVLKIPSAAGK 0.93732 2.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5007 14.2708 0 0 0 0 0 0 0 0 0 0 0 10.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7439 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3234 0 0 0 0 0 0 0 0 0 0 11.1348 0 0 0 0 0 0 0 Q13145 BAMBI_HUMAN BMP and activin membrane-bound inhibitor homolog (Non-metastatic gene A protein) (Putative transmembrane protein NMA) BAMBI NMA Homo sapiens (Human) "cell migration [GO:0016477]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]" cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; type II transforming growth factor beta receptor binding [GO:0005114]; cell migration [GO:0016477]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell shape [GO:0008360]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0005109; GO:0005114; GO:0005737; GO:0005886; GO:0007179; GO:0008284; GO:0008360; GO:0010718; GO:0016021; GO:0016477; GO:0030512; GO:0030514; GO:0032092; GO:0045668; GO:0045893; GO:0090263 frizzled binding [GO:0005109]; type II transforming growth factor beta receptor binding [GO:0005114] AAVIAVPIAGGLILVLLIMLALR 0.93734 1.7652 0 0 0 0 0 0 0 0 0 11.1154 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.47105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5423 15.0402 15.029 0 13.5552 14.8289 15.0158 0 14.9636 15.6176 14.8696 0 14.4219 14.2421 0 15.343 14.5462 13.6917 0 13.2535 0 0 13.8472 14.8864 0 0 0 13.1397 0 0 14.0679 14.5069 0 14.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7212 0 0 12.6533 12.8357 0 0 0 0 0 0 0 11.4875 0 0 0 0 0 0 0 0 0 0 0 0 11.309 0 0 0 0 0 0 0 0 0 0 0 12.6767 0 0 0 0 0 0 0 0 Q8WU67 ABHD3_HUMAN "Phospholipase ABHD3, EC 3.1.1.32, EC 3.1.1.4 (Abhydrolase domain-containing protein 3)" ABHD3 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470] GO:0004623; GO:0005886; GO:0006656; GO:0008126; GO:0008970; GO:0016021; GO:0034338; GO:0044255; GO:0046470; GO:0047372; GO:0051792; GO:0051793; GO:0052739; GO:0052740 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; short-chain carboxylesterase activity [GO:0034338] PLNWLLFNYYLTTCLQSSVNK 0.93736 0.99891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW19 APLF_HUMAN "Aprataxin and PNK-like factor, EC 3.1.-.- (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1)" APLF C2orf13 PALF XIP1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA ligation [GO:0051106]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of DNA ligation [GO:0051106]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012] GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006974; GO:0008408; GO:0035861; GO:0045191; GO:0046872; GO:0051106 3'-5' exonuclease activity [GO:0008408]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166] MSGGFELQPRDGGPR 0.93737 2.6893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6353 0 0 11.4648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5564 0 0 0 0 0 0 0 0 0 0 0 12.9992 0 0 0 0 0 11.753 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95273 CCDB1_HUMAN Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid) CCNDBP1 DIP1 GCIP HHM Homo sapiens (Human) cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0016604; GO:0051726 DQGITLRKLVR 0.93738 3.5409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5664 14.5226 0 0 0 0 0 0 0 0 0 0 0 13.5649 0 0 14.3013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6236 0 13.1269 0 0 0 0 0 0 0 0 0 12.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.501 0 0 0 0 0 0 0 Q9H0U3 MAGT1_HUMAN "Magnesium transporter protein 1, MagT1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit MAGT1, Oligosaccharyl transferase subunit MAGT1) (Implantation-associated protein, IAP)" MAGT1 IAG2 PSEC0084 UNQ628/PRO1244 Homo sapiens (Human) cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085] GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0016020; GO:0018279; GO:0035577; GO:0050890; GO:0055085 magnesium ion transmembrane transporter activity [GO:0015095] FWCVSVTMVVALLIVCDVPSASAQR 0.93738 3.5012 0 0 0 0 0 0 0 11.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3388 12.088 0 0 0 0 0 0 0 0 0 0 11.2678 0 0 0 0 0 0 0 0 0 0 0 14.6279 0 16.264 14.528 0 14.5364 0 0 0 0 0 0 14.2504 0 13.9162 0 0 0 13.6163 0 0 0 0 13.3393 0 0 0 0 0 0 0 0 0 0 0 0 13.646 12.7874 0 0 0 13.3122 0 0 0 0 0 0 0 0 0 0 12.8467 0 0 0 0 13.5696 0 0 0 0 0 0 10.9411 0 0 0 0 0 12.1655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.646 0 0 0 0 0 Q9Y5W5 WIF1_HUMAN "Wnt inhibitory factor 1, WIF-1" WIF1 UNQ191/PRO217 Homo sapiens (Human) anatomical structure development [GO:0048856]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0005102; GO:0005576; GO:0007165; GO:0009986; GO:0016055; GO:0017147; GO:0030178; GO:0045600; GO:0048856 signaling receptor binding [GO:0005102]; Wnt-protein binding [GO:0017147] ANCSTTCFNGGTCFYPGK 0.93738 2.6265 0 0 0 0 0 0 0 0 0 0 0 0 12.3844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5993 0 0 13.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1355 0 0 0 0 0 0 0 13.4519 0 0 0 0 13.3348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2761 0 0 13.705 14.5433 0 0 13.6137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J266 TVA41_HUMAN T cell receptor alpha variable 41 TRAV41 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 HGRLIATINIQEK 0.93741 0.99847 0 0 0 0 0 10.5657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6353 0 0 0 0 0 0 0 0 0 0 0 0 14.1736 0 0 0 0 0 0 0 13.5101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBF6 AVL9_HUMAN Late secretory pathway protein AVL9 homolog AVL9 KIAA0241 Homo sapiens (Human) cell migration [GO:0016477] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; cell migration [GO:0016477] GO:0005737; GO:0016021; GO:0016477; GO:0055037 DLVLHFR 0.93744 2.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7249 0 0 0 12.4305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23.5892 0 0 10.2226 11.898 10.3202 0 0 15.5382 0 0 14.045 0 0 15.273 0 15.157 0 13.4972 0 11.1408 15.3408 0 0 0 0 11.041 0 0 0 0 0 0 0 0 0 0 0 11.5342 0 0 15.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9759 0 15.0851 0 0 0 13.7736 0 0 0 0 0 0 0 13.6338 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0007 0 0 0 0 0 0 0 0 0 0 0 14.1564 13.9273 14.2777 0 0 0 0 0 0 0 0 10.6146 13.3541 0 0 O94868 FCSD2_HUMAN "F-BAR and double SH3 domains protein 2 (Carom) (Protein nervous wreck 1, NWK1) (SH3 multiple domains protein 3)" FCHSD2 KIAA0769 SH3MD3 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833] anchoring junction [GO:0070161]; clathrin-coated pit [GO:0005905]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stereocilium shaft [GO:0120043] "anchoring junction [GO:0070161]; clathrin-coated pit [GO:0005905]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stereocilium shaft [GO:0120043]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]" GO:0005547; GO:0005886; GO:0005905; GO:0007274; GO:0015031; GO:0030833; GO:0030838; GO:0031594; GO:0043325; GO:0055037; GO:0061024; GO:0070161; GO:0072583; GO:0120043; GO:2000601 "phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]" AELEQKIDEAR 0.93746 1.0437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0465 14.6678 13.212 14.5254 13.6215 12.8727 0 0 0 0 0 0 0 0 0 0 0 13.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7936 0 0 0 0 0 0 0 0 0 12.1214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01258 CALC_HUMAN "Calcitonin [Cleaved into: Calcitonin; Katacalcin (Calcitonin carboxyl-terminal peptide, CCP) (PDN-21) ]" CALCA CALC1 Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; ossification [GO:0001503]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265]; smooth muscle contraction [GO:0006939]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; ossification [GO:0001503]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265]; smooth muscle contraction [GO:0006939]" GO:0001503; GO:0001984; GO:0002548; GO:0005179; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006939; GO:0006954; GO:0007189; GO:0007190; GO:0007204; GO:0007218; GO:0007566; GO:0007568; GO:0007631; GO:0008016; GO:0009408; GO:0030279; GO:0031716; GO:0032147; GO:0042802; GO:0043025; GO:0043195; GO:0045779; GO:0045892; GO:0045986; GO:0048265; GO:0050965; GO:0051480; GO:0051482; GO:0071356; GO:1990090 calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802] DMSSDLERDHRPHVSMPQNAN 0.9375 1.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWQ2 HPSE2_HUMAN "Inactive heparanase-2, Hpa2" HPSE2 HPA2 Homo sapiens (Human) cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cell population proliferation [GO:0008284] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparan sulfate proteoglycan binding [GO:0043395]; heparanase activity [GO:0030305]; cell population proliferation [GO:0008283]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cell population proliferation [GO:0008284] GO:0005615; GO:0005886; GO:0006027; GO:0008283; GO:0008284; GO:0030198; GO:0030305; GO:0031012; GO:0043395 heparan sulfate proteoglycan binding [GO:0043395]; heparanase activity [GO:0030305] AAGLKEKTLILLDVSTK 0.9375 3.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3252 0 0 0 0 0 0 12.8159 0 0 0 0 0 0 11.0753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6793 0 0 11.663 0 0 13.6524 0 14.3496 14.6616 0 0 0 0 0 12.9418 0 0 0 11.3069 13.311 0 0 0 0 0 0 13.5768 0 0 0 14.6069 0 0 0 0 0 13.4775 0 12.9531 0 0 0 0 0 0 0 0 0 13.7749 0 0 0 0 11.9251 0 14.2874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.011 0 0 0 0 13.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7728 0 0 0 13.5369 0 0 12.4358 0 11.0604 Q9UKT7 FBXL3_HUMAN F-box/LRR-repeat protein 3 (F-box and leucine-rich repeat protein 3A) (F-box/LRR-repeat protein 3A) FBXL3 FBL3A FBXL3A Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0000151; GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0016604; GO:0019005; GO:0031146; GO:0031648; GO:0042752; GO:0043153; GO:0048511; GO:0051726 ubiquitin-protein transferase activity [GO:0004842] RHSNHLQYVSFK 0.9375 1.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05000 IFNW1_HUMAN Interferon omega-1 (Interferon alpha-II-1) IFNW1 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of cell cycle [GO:0051726]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of cell cycle [GO:0051726]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005615; GO:0006959; GO:0009615; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0051726; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132] NTLVLLHQMRR 0.93752 1.0427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0647 0 0 0 0 0 0 13.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4485 0 0 0 0 0 Q9BVM4 GGACT_HUMAN "Gamma-glutamylaminecyclotransferase, GGACT, EC 4.3.2.8 (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase)" GGACT A2LD1 Homo sapiens (Human) cellular modified amino acid catabolic process [GO:0042219] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; gamma-glutamylaminecyclotransferase activity [GO:0061929]; cellular modified amino acid catabolic process [GO:0042219] GO:0005829; GO:0042219; GO:0061929; GO:0070062 gamma-glutamylaminecyclotransferase activity [GO:0061929] MALVFVYGTLKR 0.93752 1.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.598 0 0 0 0 0 0 0 0 0 0 0 0 11.4681 0 13.0236 12.2747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6863 0 0 0 0 0 0 0 O15118 NPC1_HUMAN NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein) NPC1 Homo sapiens (Human) adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; viral entry into host cell [GO:0046718] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of cell death [GO:0060548]; negative regulation of macroautophagy [GO:0016242]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; viral entry into host cell [GO:0046718] GO:0001618; GO:0004888; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0015248; GO:0015485; GO:0015918; GO:0016020; GO:0016021; GO:0016236; GO:0016242; GO:0030299; GO:0030301; GO:0031579; GO:0031902; GO:0032367; GO:0032934; GO:0033344; GO:0038023; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0060548; GO:0070062; GO:0071383; GO:0071404; GO:0090150; GO:1905103 cholesterol binding [GO:0015485]; signaling receptor activity [GO:0038023]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] AEEALAHMGSSVFSGITLTKFGGIVVLAFAK 0.93753 1.7091 0 0 0 0 0 0 0 0 17.7588 0 0 0 13.3959 13.759 0 11.5282 0 0 0 0 0 9.47054 0 13.2839 0 0 0 0 13.1564 12.7267 0 0 16.3602 0 0 0 10.2211 0 0 12.8989 0 0 0 0 0 0 13.6852 13.8617 13.7278 13.2179 0 13.3362 13.1242 0 12.6431 0 12.572 10.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3552 0 0 0 11.3415 0 12.1847 0 13.1365 13.6659 12.92 12.9168 0 0 0 12.789 0 12.9269 12.2725 12.3817 0 12.836 0 14.0391 0 0 0 11.9999 11.3914 11.3458 0 0 0 0 0 11.5864 0 0 0 0 0 0 0 0 13.0098 0 0 0 12.2632 0 0 0 11.4354 0 0 0 0 0 0 14.5379 0 0 0 0 0 0 0 0 0 0 13.9427 0 0 0 0 0 0 0 0 0 0 0 0 11.3507 0 0 0 0 14.6622 14.9136 11.644 0 0 0 0 14.4261 0 0 0 0 0 0 0 0 0 0 P62312 LSM6_HUMAN U6 snRNA-associated Sm-like protein LSm6 LSM6 Homo sapiens (Human) "maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]" GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005730; GO:0005732; GO:0005737; GO:0005829; GO:0006402; GO:0008033; GO:0008380; GO:0030490; GO:0030532; GO:0046540; GO:0046982; GO:0071005; GO:0120115 protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] GNNVLYISTQKR 0.93753 1.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4251 0 Q15629 TRAM1_HUMAN "Translocating chain-associated membrane protein 1, Protein TRAM1" TRAM1 TRAM Homo sapiens (Human) "cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" GO:0005783; GO:0006613; GO:0006616; GO:0006986; GO:0016021; GO:0030176; GO:0038023; GO:0045048 signaling receptor activity [GO:0038023] FFYISQLAYWLHAFPELYFQK 0.93753 1.6899 0 0 0 0 0 0 0 0 0 10.8491 0 0 0 0 0 0 0 0 15.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3359 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9463 0 0 0 0 14.7612 13.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2845 0 0 0 0 0 0 12.1396 0 0 0 0 0 0 0 10.0542 0 10.5958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY65 TBA8_HUMAN Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2) TUBA8 TUBAL2 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0015630 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200] AYHEQLSVAEITSSCFEPNSQMVKCDPR 0.93753 1.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9964 0 13.0579 0 0 0 12.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7302 0 0 0 0 0 0 0 10.4201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2302 15.5109 15.7325 0 15.4954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZL8 PELP1_HUMAN "Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)" PELP1 HMX3 MNAR Homo sapiens (Human) cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATPase binding [GO:0051117]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364] GO:0000791; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0016020; GO:0032183; GO:0045944; GO:0047485; GO:0051117; GO:0071339; GO:0071391 ATPase binding [GO:0051117]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SUMO binding [GO:0032183] ACMTYFPRACGSLKGK 0.93755 2.3836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0379 0 12.9488 0 0 0 0 0 0 0 18.3016 0 0 0 0 0 0 0 0 0 0 0 13.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1272 0 0 0 0 14.5897 0 0 0 0 13.0179 0 0 0 0 0 14.4942 0 0 0 0 0 0 0 0 0 0 11.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9582 0 0 0 0 0 0 0 0 0 0 11.7362 0 O00358 FOXE1_HUMAN "Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5, HFKL5) (Thyroid transcription factor 2, TTF-2)" FOXE1 FKHL15 FOXE2 TITF2 TTF2 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cranial skeletal system development [GO:1904888]; embryonic organ morphogenesis [GO:0048562]; hair follicle morphogenesis [GO:0031069]; hard palate development [GO:0060022]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cranial skeletal system development [GO:1904888]; embryonic organ morphogenesis [GO:0048562]; hair follicle morphogenesis [GO:0031069]; hard palate development [GO:0060022]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pharynx development [GO:0060465]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0006590; GO:0009653; GO:0016477; GO:0030154; GO:0030878; GO:0031069; GO:0043565; GO:0045892; GO:0045893; GO:0048538; GO:0048562; GO:0060022; GO:0060023; GO:0060465; GO:1904888; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" FPFYRDNPK 0.93756 1.6891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6178 11.5489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3812 0 0 0 0 0 0 0 0 0 14.009 0 14.1783 14.0711 0 14.2383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1477 0 10.8242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP97 DLRB1_HUMAN "Dynein light chain roadblock-type 1 (Bithoraxoid-like protein, BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)" DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162 Homo sapiens (Human) microtubule-based movement [GO:0007018]; visual behavior [GO:0007632] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; visual behavior [GO:0007632] GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0007632; GO:0016020; GO:0030286; GO:0045505; GO:0097542 dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777] LQSQKGVQGIIVVNTEGIPIK 0.93756 1.7086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1398 0 0 14.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8959 0 12.2446 0 P20849 CO9A1_HUMAN Collagen alpha-1(IX) chain COL9A1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198] GO:0005201; GO:0005576; GO:0005594; GO:0005604; GO:0005615; GO:0005788; GO:0009887; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] APTDQHIKQVCMR 0.93761 2.5233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2943 0 0 0 0 0 0 15.8871 0 0 0 0 0 0 0 11.872 0 0 0 12.253 0 0 0 0 0 12.2033 0 13.3502 0 0 0 12.0567 0 0 0 0 0 0 0 0 0 0 0 12.6532 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7115 12.6799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A096LP01 SIM26_HUMAN Small integral membrane protein 26 SMIM26 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GFYVETVVTYK 0.93762 1.6877 0 0 0 0 0 0 0 0 14.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGY7 O10J6_HUMAN Putative olfactory receptor 10J6 OR10J6P OR10J6 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004984; GO:0004993; GO:0005887; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984] LFVILVPMGLVFISYVLIISTVLK 0.93762 0.99954 14.1355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7659 0 14.4813 0 0 0 0 0 14.3792 0 0 0 14.3693 0 0 0 0 0 0 0 0 0 0 12.5331 12.9249 12.7142 0 0 14.8249 0 0 0 0 0 0 0 0 0 0 13.3648 0 0 0 0 0 0 0 0 0 0 13.5369 0 0 12.8131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8689 0 0 0 0 0 0 0 0 0 Q8IXB3 TARG1_HUMAN "Trafficking regulator of GLUT4 1 (Dispanin subfamily B member 1, DSPB1) (Interferon-induced transmembrane domain-containing protein D3) (Protein located at seventeen-p-thirteen point three 1) (Tumor suppressor candidate 5)" TRARG1 IFITMD3 LOST1 TUSC5 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; endosome to plasma membrane protein transport [GO:0099638]; glucose import in response to insulin stimulus [GO:0044381]; protein localization to plasma membrane [GO:0072659]; vesicle fusion to plasma membrane [GO:0099500] cytoplasmic vesicle membrane [GO:0030659]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cellular response to insulin stimulus [GO:0032869]; endosome to plasma membrane protein transport [GO:0099638]; glucose import in response to insulin stimulus [GO:0044381]; protein localization to plasma membrane [GO:0072659]; vesicle fusion to plasma membrane [GO:0099500] GO:0005886; GO:0012505; GO:0016020; GO:0016021; GO:0030659; GO:0032869; GO:0044381; GO:0048471; GO:0072659; GO:0099500; GO:0099638 LARLLSITLIIMGIVIIMVAVTVNFTVQK 0.93763 1.7807 0 0 0 0 0 0 0 0 0 0 0 14.3143 13.5215 0 0 14.1437 12.0327 0 0 0 13.8384 0 13.3177 0 14.9684 0 0 0 12.1926 0 0 0 0 0 0 0 0 0 13.3058 0 0 0 0 0 0 13.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5108 12.2867 0 0 0 15.3346 0 14.8961 16.0156 0 16.0639 0 15.3823 15.6269 15.4419 0 13.6505 0 15.1179 0 0 0 0 0 0 0 0 0 13.859 0 0 0 0 0 0 14.9155 0 0 0 0 0 0 0 0 0 0 0 13.59 0 0 13.3819 0 0 0 0 0 0 0 0 0 0 0 12.4068 0 0 0 0 0 0 13.9052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2Y6 TMM98_HUMAN Transmembrane protein 98 (Protein TADA1) TMEM98 UNQ536/PRO1079 Homo sapiens (Human) negative regulation of myelination [GO:0031642]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein processing [GO:0010955]; T-helper 1 cell differentiation [GO:0045063] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of myelination [GO:0031642]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein processing [GO:0010955]; T-helper 1 cell differentiation [GO:0045063] GO:0005615; GO:0005783; GO:0005789; GO:0005886; GO:0010955; GO:0016021; GO:0031642; GO:0045063; GO:0048715; GO:0070062; GO:1900181 ETVVIVAIGVLATIFLASFAALVLVCR 0.93765 2.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5617 0 A6NDP7 MADL2_HUMAN Myeloid-associated differentiation marker-like protein 2 MYADML2 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] GO:0005737; GO:0016021 ECSPEPAGCAARDFR 0.93766 1.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5H6 PCDA8_HUMAN "Protocadherin alpha-8, PCDH-alpha-8" PCDHA8 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] HRDLLEVSLQNGILFVNSR 0.93766 1.7802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.62 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5432 A6NCM1 IQCAL_HUMAN IQ and AAA domain-containing protein 1-like (IQ and AAA domain-containing protein 1 pseudogene 1) IQCA1L IQCA1P1 Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ADLCENHCLDR 0.93767 2.5215 0 11.7578 0 0 0 0 0 0 0 0 0 0 0 12.3782 0 0 13.0908 0 0 0 0 0 0 0 0 0 0 0 9.91645 0 13.5438 0 12.3269 0 0 0 0 0 0 0 0 12.6814 0 0 0 0 16.4305 0 0 0 0 0 0 12.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4282 14.9556 0 0 0 0 0 0 0 0 0 0 14.5532 17.36 17.5276 17.2669 17.2714 18.1684 16.9194 0 0 0 0 0 16.8642 0 14.904 17.178 17.0102 15.2202 0 0 0 0 0 0 13.8273 0 0 13.26 0 0 15.853 0 12.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.576 0 0 0 13.4738 0 13.4366 0 0 0 12.0714 0 0 13.0346 0 0 13.4672 0 11.4823 0 0 13.5027 13.5474 0 12.5053 0 Q6ICL7 S35E4_HUMAN Solute carrier family 35 member E4 SLC35E4 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297] GO:0005794; GO:0015297; GO:0016021 antiporter activity [GO:0015297] CRCPPEHHDGRMTSAEVGAAAGGAQAAGPPEWPPGSPQALR 0.93767 0.99851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13051 UNG_HUMAN "Uracil-DNA glycosylase, UDG, EC 3.2.2.27" UNG DGU UNG1 UNG15 Homo sapiens (Human) "base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]" mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]" GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0016446; GO:0043024; GO:0043066; GO:0045008; GO:0045190; GO:0097510 damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844] KHYTVYPPPHQVFTWTQMCDIKDVK 0.9377 1.8167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15475 SIX1_HUMAN Homeobox protein SIX1 (Sine oculis homeobox homolog 1) SIX1 Homo sapiens (Human) "aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cochlea morphogenesis [GO:0090103]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; endothelin receptor signaling pathway [GO:0086100]; epithelial cell differentiation [GO:0030855]; facial nerve morphogenesis [GO:0021610]; fungiform papilla morphogenesis [GO:0061197]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal cell proliferation involved in ureter development [GO:0072198]; mesonephric tubule formation [GO:0072172]; metanephric mesenchyme development [GO:0072075]; middle ear morphogenesis [GO:0042474]; myoblast migration [GO:0051451]; myoblast proliferation [GO:0051450]; myotome development [GO:0061055]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; olfactory placode formation [GO:0030910]; organ induction [GO:0001759]; otic vesicle development [GO:0071599]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization [GO:0032880]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trigeminal ganglion development [GO:0061551]; ureter smooth muscle cell differentiation [GO:0072193]; ureteric bud development [GO:0001657]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cochlea morphogenesis [GO:0090103]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic skeletal system morphogenesis [GO:0048704]; endothelin receptor signaling pathway [GO:0086100]; epithelial cell differentiation [GO:0030855]; facial nerve morphogenesis [GO:0021610]; fungiform papilla morphogenesis [GO:0061197]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal cell proliferation involved in ureter development [GO:0072198]; mesonephric tubule formation [GO:0072172]; metanephric mesenchyme development [GO:0072075]; middle ear morphogenesis [GO:0042474]; myoblast migration [GO:0051451]; myoblast proliferation [GO:0051450]; myotome development [GO:0061055]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; olfactory placode formation [GO:0030910]; organ induction [GO:0001759]; otic vesicle development [GO:0071599]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization [GO:0032880]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trigeminal ganglion development [GO:0061551]; ureter smooth muscle cell differentiation [GO:0072193]; ureteric bud development [GO:0001657]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001657; GO:0001658; GO:0001759; GO:0001822; GO:0003151; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0006915; GO:0007219; GO:0007389; GO:0007519; GO:0007605; GO:0008582; GO:0010467; GO:0014033; GO:0014842; GO:0014857; GO:0021610; GO:0030855; GO:0030878; GO:0030910; GO:0032880; GO:0034504; GO:0035909; GO:0042472; GO:0042474; GO:0043524; GO:0043565; GO:0045664; GO:0045893; GO:0045944; GO:0048538; GO:0048665; GO:0048699; GO:0048701; GO:0048704; GO:0048741; GO:0048839; GO:0050678; GO:0051450; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0071599; GO:0072075; GO:0072095; GO:0072107; GO:0072172; GO:0072193; GO:0072198; GO:0072513; GO:0086100; GO:0090103; GO:0090190; GO:0090336; GO:1905243; GO:1990837; GO:2000288; GO:2000729; GO:2001014 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]" PLGAVGK 0.93773 1.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNA3 A4GCT_HUMAN "Alpha-1,4-N-acetylglucosaminyltransferase, Alpha4GnT, EC 2.4.1.-" A4GNT Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; epithelial cell proliferation [GO:0050673]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; hexosyltransferase activity [GO:0016758]; carbohydrate metabolic process [GO:0005975]; epithelial cell proliferation [GO:0050673]; glycoprotein biosynthetic process [GO:0009101]; negative regulation of epithelial cell proliferation [GO:0050680]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0005975; GO:0006493; GO:0008375; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016758; GO:0050673; GO:0050680 acetylglucosaminyltransferase activity [GO:0008375]; hexosyltransferase activity [GO:0016758] GSNTLVENLYRK 0.93776 1.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2494 0 15.0011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4157 0 0 14.1643 0 0 0 0 0 0 0 13.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYJ1 LOXE3_HUMAN "Hydroperoxide isomerase ALOXE3 (Epidermis-type lipoxygenase 3, Epidermal LOX-3, e-LOX-3, eLOX-3) (Hydroperoxy dehydratase ALOXE3) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152) (Hydroperoxy icosatetraenoate isomerase, EC 5.4.4.7)" ALOXE3 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665] cytosol [GO:0005829] "cytosol [GO:0005829]; hepoxilin A3 synthase activity [GO:0051120]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; intramolecular transferase activity, transferring hydroxy groups [GO:0050486]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipoxygenase pathway [GO:0019372]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; sensory perception of pain [GO:0019233]; sphingolipid metabolic process [GO:0006665]" GO:0005506; GO:0005829; GO:0006665; GO:0016702; GO:0019233; GO:0019369; GO:0019372; GO:0035357; GO:0043651; GO:0045444; GO:0046513; GO:0050486; GO:0051120; GO:0051122; GO:0061436; GO:0106255; GO:0106256 "hepoxilin A3 synthase activity [GO:0051120]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; intramolecular transferase activity, transferring hydroxy groups [GO:0050486]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]" ARGVLAIPNYHYR 0.93778 0.9453 14.1057 0 13.6428 0 0 0 0 0 0 11.3526 0 0 0 0 0 0 9.57412 0 0 0 0 10.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92444 0 0 0 0 0 0 0 0 0 0 10.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1219 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13163 MP2K5_HUMAN "Dual specificity mitogen-activated protein kinase kinase 5, MAP kinase kinase 5, MAPKK 5, EC 2.7.12.2 (MAPK/ERK kinase 5, MEK 5)" MAP2K5 MEK5 MKK5 PRKMK5 Homo sapiens (Human) cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819] cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] GO:0000122; GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0007165; GO:0007507; GO:0030307; GO:0032088; GO:0032717; GO:0034115; GO:0043154; GO:0043406; GO:0045944; GO:0046872; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0071499; GO:0090051; GO:0106310; GO:2000342; GO:2001240 ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] AYHVPSGKILAVKVILLDITLELQK 0.93781 2.6384 0 0 0 12.9581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0491 0 15.0294 0 0 15.0294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.051 0 0 0 0 0 0 14.1391 0 0 0 0 0 14.3154 0 0 0 0 0 0 0 13.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H246 CA021_HUMAN Uncharacterized protein C1orf21 (Cell proliferation-inducing gene 13 protein) C1orf21 PIG13 Homo sapiens (Human) LKTNKEVPGLVHQPR 0.93781 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7455 0 0 0 14.8883 0 0 14.3048 14.6588 0 0 12.0775 0 0 0 0 0 0 0 0 0 P12544 GRAA_HUMAN "Granzyme A, EC 3.4.21.78 (CTL tryptase) (Cytotoxic T-lymphocyte proteinase 1) (Fragmentin-1) (Granzyme-1) (Hanukkah factor, H factor, HF)" GZMA CTLA3 HFSP Homo sapiens (Human) apoptotic process [GO:0006915]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; response to bacterium [GO:0009617] extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634] extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; response to bacterium [GO:0009617] GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0006915; GO:0006955; GO:0009617; GO:0019835; GO:0032078; GO:0042803; GO:0043065; GO:0043392; GO:0051354; GO:0051603; GO:0070269; GO:0140507; GO:1902483 protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252] CGDPRGPGVYILLSKK 0.93782 4.996 0 0 0 10.808 0 0 0 0 0 0 13.4676 0 0 0 0 11.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7048 0 0 0 0 0 0 13.1544 0 0 0 0 12.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4272 0 11.165 0 0 0 0 0 13.7357 0 13.4294 0 0 0 15.4261 0 0 13.8754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8336 0 15.0084 0 0 0 0 0 0 12.5496 0 0 12.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0488 0 0 13.8186 0 0 0 0 0 0 0 0 12.961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7562 0 0 0 0 0 0 Q9BZD2 S29A3_HUMAN "Equilibrative nucleoside transporter 3, hENT3 (Solute carrier family 29 member 3)" SLC29A3 ENT3 UNQ717/PRO1380 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; nucleoside transmembrane transporter activity [GO:0005337] GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0016021; GO:0031902; GO:0043231 nucleoside transmembrane transporter activity [GO:0005337] ALPGFVLLRTCLIPLFVLCNYQPRVHLK 0.93782 1.7653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2137 0 0 0 0 13.7894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4152 0 0 0 0 0 12.6844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8563 0 0 0 0 0 13.9516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1916 0 0 0 0 0 0 0 0 0 13.0254 0 0 0 0 0 0 0 0 13.0028 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1477 0 0 0 0 13.9233 0 0 0 0 0 0 0 0 0 13.4674 0 0 0 0 13.5057 0 0 0 13.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1887 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJL9 ZF69B_HUMAN Zinc finger protein 69 homolog B (Zinc finger protein 643) ZFP69B ZNF643 Homo sapiens (Human) Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; Golgi organization [GO:0007030]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0006357; GO:0007030; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DISGVPSSDLK 0.93783 1.6807 0 0 0 0 0 0 0 0 14.6233 0 0 0 0 12.2678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6418 0 0 0 13.1054 0 0 13.5237 0 0 0 0 0 0 13.999 13.5741 0 13.4759 0 0 13.9758 14.1078 0 0 0 0 14.3428 0 0 0 14.5997 0 0 0 0 14.231 0 0 0 0 0 0 0 0 0 13.6196 0 0 0 0 13.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T75 DSCR8_HUMAN "Down syndrome critical region protein 8 (Cancer/testis antigen 25, CT25) (DCR1-24.0) (Malignant melanoma-associated protein 1, MMA-1) (Protein MTAG2)" DSCR8 C21orf65 MTAG2 Homo sapiens (Human) EPGPNFVTVRK 0.93784 1.042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0A0MS01 TVG10_HUMAN Probable non-functional T cell receptor gamma variable 10 TRGV10 Homo sapiens (Human) adaptive immune response [GO:0002250] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0009897; GO:0042101 EDMAVYYCAAWD 0.93786 1.0418 12.6375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.849 13.1599 12.9721 14.831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6839 0 0 0 14.534 13.9102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4686 14.5796 0 0 0 0 0 P41271 NBL1_HUMAN Neuroblastoma suppressor of tumorigenicity 1 (DAN domain family member 1) (Protein N03) (Zinc finger protein DAN) NBL1 DAN DAND1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of monocyte chemotaxis [GO:0090027]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582] extracellular space [GO:0005615] extracellular space [GO:0005615]; BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of monocyte chemotaxis [GO:0090027]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582] GO:0005615; GO:0007399; GO:0009887; GO:0016015; GO:0030514; GO:0035582; GO:0036122; GO:0038098; GO:0042802; GO:0045666; GO:0048018; GO:0048263; GO:0048812; GO:0090027 BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018] MLRVLVGAVLPAMLLAAPPPINKLALFPDK 0.93787 2.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6876 0 0 0 0 0 0 12.0325 13.1683 0 0 0 0 0 0 0 12.3007 0 0 0 0 0 12.6601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3479 12.5915 0 0 0 0 0 12.6846 0 0 0 0 0 0 12.6666 0 0 0 0 0 0 0 0 0 12.9059 12.3367 0 0 0 0 0 0 0 0 12.6886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SW96 ARH_HUMAN Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein) LDLRAP1 ARH Homo sapiens (Human) amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076] axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] "axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076]" GO:0001540; GO:0001784; GO:0005546; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0006898; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0030301; GO:0030424; GO:0030669; GO:0031623; GO:0034383; GO:0035591; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0043393; GO:0048260; GO:0050750; GO:0055037; GO:0071345; GO:0090118; GO:0090205; GO:1903076; GO:1904707; GO:1905581; GO:1905602 "amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]" ALIRSPSLAKQSWGGGGR 0.93788 2.6602 12.7607 0 0 0 0 0 0 0 13.9354 0 14.1766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4363 0 0 13.2562 0 0 0 0 0 0 0 0 0 13.6853 0 0 0 0 0 0 0 0 14.2761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3802 0 14.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D126 ISPD_HUMAN "D-ribitol-5-phosphate cytidylyltransferase, EC 2.7.7.40 (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein, hISPD)" CRPPA ISPD Homo sapiens (Human) axon guidance [GO:0007411]; isoprenoid biosynthetic process [GO:0008299]; protein O-linked mannosylation [GO:0035269] cytosol [GO:0005829] cytosol [GO:0005829]; cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; isoprenoid biosynthetic process [GO:0008299]; protein O-linked mannosylation [GO:0035269] GO:0005829; GO:0007411; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0070567 cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803] ALAEDQINSKLSK 0.93789 1.7756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5759 0 0 0 0 0 12.7744 12.1393 0 0 0 0 13.3722 0 0 0 0 0 0 0 14.3279 0 0 0 0 0 0 0 0 0 0 0 14.206 0 13.1333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9028 0 0 0 14.9978 0 0 0 0 13.4348 0 13.0723 0 0 0 0 0 13.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30411 BKRB2_HUMAN "B2 bradykinin receptor, B2R, BK-2 receptor" BDKRB2 BKR2 Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; blood circulation [GO:0008015]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1990127]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1902239]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of vascular permeability [GO:0043114]; regulation of vasoconstriction [GO:0019229]; response to salt stress [GO:0009651]; smooth muscle contraction [GO:0006939]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; bradykinin receptor activity [GO:0004947]; G protein-coupled receptor activity [GO:0004930]; phosphatidylinositol phospholipase C activity [GO:0004435]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; type 1 angiotensin receptor binding [GO:0031702]; arachidonic acid secretion [GO:0050482]; blood circulation [GO:0008015]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1990127]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1902239]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of vascular permeability [GO:0043114]; regulation of vasoconstriction [GO:0019229]; response to salt stress [GO:0009651]; smooth muscle contraction [GO:0006939]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasoconstriction [GO:0042310]; vasodilation [GO:0042311] GO:0002020; GO:0004435; GO:0004930; GO:0004947; GO:0005768; GO:0005794; GO:0005886; GO:0005887; GO:0006939; GO:0006954; GO:0007166; GO:0007169; GO:0007186; GO:0007204; GO:0008015; GO:0009651; GO:0019229; GO:0031702; GO:0033137; GO:0042310; GO:0042311; GO:0043114; GO:0043231; GO:0046982; GO:0050482; GO:1902239; GO:1990127 bradykinin receptor activity [GO:0004947]; G protein-coupled receptor activity [GO:0004930]; phosphatidylinositol phospholipase C activity [GO:0004435]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; type 1 angiotensin receptor binding [GO:0031702] ATVLVLVVLLLFIICWLPFQISTFLDTLHR 0.93793 1.0372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8945 0 0 0 0 14.5804 0 0 0 0 0 0 0 13.4829 0 0 0 0 0 0 0 0 0 0 0 0 0 13.514 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1343 0 0 0 0 0 0 0 0 0 12.8202 0 0 0 0 0 0 0 0 0 13.6481 0 13.4737 13.9016 0 0 0 0 0 0 0 0 0 0 0 14.4784 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6111 0 0 0 0 0 0 12.95 0 0 0 0 0 0 0 P49458 SRP09_HUMAN "Signal recognition particle 9 kDa protein, SRP9" SRP9 Homo sapiens (Human) negative regulation of translational elongation [GO:0045900]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614] "cytosol [GO:0005829]; signal recognition particle receptor complex [GO:0005785]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytosol [GO:0005829]; signal recognition particle receptor complex [GO:0005785]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; negative regulation of translational elongation [GO:0045900]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]" GO:0003723; GO:0005047; GO:0005785; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0045900 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047] PQYQTWEEFSRAAEK 0.93793 1.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2162 0 0 0 0 0 0 0 0 0 0 0 12.0829 0 0 0 0 0 0 0 0 0 0 0 Q9UPY6 WASF3_HUMAN "Actin-binding protein WASF3 (Protein WAVE-3) (Verprolin homology domain-containing protein 3) (Wiskott-Aldrich syndrome protein family member 3, WASP family protein member 3)" WASF3 KIAA0900 SCAR3 WAVE3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360] GO:0003779; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0030041; GO:0031209; GO:0031643; GO:0034237; GO:0065003; GO:0070062; GO:0071933; GO:0097386; GO:0098794; GO:0098885; GO:0098978; GO:2000601 actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A regulatory subunit binding [GO:0034237] IAVEYSDSDDDSEFDENDWSD 0.93794 2.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7158 14.4607 14.8045 14.3173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00584 RNT2_HUMAN "Ribonuclease T2, EC 4.6.1.19 (Ribonuclease 6)" RNASET2 RNASE6PL Homo sapiens (Human) innate immune response [GO:0045087]; RNA catabolic process [GO:0006401] azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758] azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; endoribonuclease activity [GO:0004521]; ribonuclease activity [GO:0004540]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723]; innate immune response [GO:0045087]; RNA catabolic process [GO:0006401] GO:0003723; GO:0004521; GO:0004540; GO:0005576; GO:0005615; GO:0005758; GO:0005764; GO:0005788; GO:0006401; GO:0033897; GO:0035578; GO:0043202; GO:0045087; GO:0070062 endoribonuclease activity [GO:0004521]; ribonuclease activity [GO:0004540]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723] IQNDCRDPPDYWTIHGLWPDKSEGCNR 0.93795 1.6787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6996 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5045 0 0 0 0 O60224 SSX4_HUMAN "Protein SSX4 (Cancer/testis antigen 5.4, CT5.4)" SSX4 SSX4A; SSX4B Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 AFDDIAKYFSKK 0.93799 1.7091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7553 0 0 0 0 0 14.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2C9 UMAS1_HUMAN Uncharacterized protein UMODL1-AS1 (UMODL1 antisense RNA 1) (UMODL1 antisense gene protein 1) UMODL1-AS1 C21orf128 Homo sapiens (Human) KRQQQTSINVFTTIK 0.93799 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2024 0 0 0 12.4887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0642 0 0 0 0 12.4734 0 0 0 0 0 12.4976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16930 FAAA_HUMAN "Fumarylacetoacetase, FAA, EC 3.7.1.2 (Beta-diketonase) (Fumarylacetoacetate hydrolase)" FAH Homo sapiens (Human) arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; lipid metabolic process [GO:0006629]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; lipid metabolic process [GO:0006629]; tyrosine catabolic process [GO:0006572] GO:0004334; GO:0005829; GO:0006527; GO:0006559; GO:0006572; GO:0006629; GO:0046872; GO:0070062; GO:1902000 fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872] IGFGQCAGKVLPALLPS 0.938 2.6586 0 0 0 0 0 0 0 0 0 0 15.9036 0 0 0 0 14.2354 0 0 0 0 10.9847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9064 0 0 0 0 0 0 0 0 15.3917 0 0 0 0 0 0 0 0 15.4243 0 0 0 0 14.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.68 0 0 0 0 15.2126 0 0 0 0 0 0 0 12.7923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6873 13.0122 0 0 0 0 0 0 Q9H871 RMD5A_HUMAN "E3 ubiquitin-protein transferase RMND5A, EC 2.3.2.27 (P44CTLH) (Protein RMD5 homolog A)" RMND5A Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0034657; GO:0043161; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] EMLIAQNSSLEFKLHRLYFISLLMGGTTNQR 0.938 1.0409 0 0 0 0 0 0 0 0 0 0 0 12.5257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9704 0 12.5765 0 0 11.8624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBS3 DNJB9_HUMAN "DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4, ER-resident protein ERdj4, ERdj4) (Microvascular endothelial differentiation gene 1 protein, Mdg-1)" DNAJB9 MDG1 UNQ743/PRO1471 Homo sapiens (Human) B cell differentiation [GO:0030183]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; positive regulation of immunoglobulin production [GO:0002639]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; positive regulation of immunoglobulin production [GO:0002639]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0002639; GO:0005730; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0006986; GO:0030183; GO:0030433; GO:0030544; GO:0034976; GO:0051087; GO:0051787; GO:0070062; GO:1903895 chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787] SYYDILGVPKSASER 0.938 1.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5286 0 0 0 0 0 0 0 15.1854 0 14.507 15.4278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MYZ0 MIY4B_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2) MINDY4B C3orf76 FAM188B2 Homo sapiens (Human) cysteine-type deubiquitinase activity [GO:0004843]; Lys48-specific deubiquitinase activity [GO:1990380] GO:0004843; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; Lys48-specific deubiquitinase activity [GO:1990380] FHDPSSELAFTLEVGK 0.93801 0.98947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0002 12.3397 0 0 0 12.9419 13.6486 13.4861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9939 0 0 0 0 0 0 0 12.3131 13.9081 12.9749 0 0 0 0 0 0 0 12.9939 12.9315 0 0 0 0 0 0 0 0 0 11.8797 13.8192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0425 0 0 0 0 0 0 11.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0035 0 0 0 0 0 0 Q14119 VEZF1_HUMAN Vascular endothelial zinc finger 1 (Putative transcription factor DB1) (Zinc finger protein 161) VEZF1 DB1 ZNF161 Homo sapiens (Human) angiogenesis [GO:0001525]; cellular defense response [GO:0006968]; endothelial cell development [GO:0001885]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; angiogenesis [GO:0001525]; cellular defense response [GO:0006968]; endothelial cell development [GO:0001885]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0001228; GO:0001525; GO:0001885; GO:0005634; GO:0005654; GO:0006357; GO:0006968; GO:0045603; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DSYHLRRHESCHTGIK 0.93801 4.0455 0 0 0 0 0 0 0 0 11.8812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8589 0 0 0 14.4958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7285 0 0 0 0 0 0 0 0 0 0 0 12.5724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0843 0 0 0 13.3285 0 0 Q9H8P0 PORED_HUMAN "Polyprenol reductase, EC 1.3.1.94 (3-oxo-5-alpha-steroid 4-dehydrogenase 3, EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3, S5AR 3, SR type 3)" SRD5A3 SRD5A2L Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; dolichol biosynthetic process [GO:0019408]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol catabolic process [GO:0016095] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; cholestenone 5-alpha-reductase activity [GO:0047751]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenol reductase activity [GO:0102389]; androgen biosynthetic process [GO:0006702]; dolichol biosynthetic process [GO:0019408]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol catabolic process [GO:0016095]" GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0006489; GO:0006702; GO:0016021; GO:0016095; GO:0016628; GO:0019348; GO:0019408; GO:0047751; GO:0102389 "3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; cholestenone 5-alpha-reductase activity [GO:0047751]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenol reductase activity [GO:0102389]" APWAEAEHSALNPLR 0.93801 1.0015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9023 0 0 0 0 0 0 0 0 0 13.4778 0 0 0 0 0 13.7366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6243 0 0 0 0 0 0 0 13.2087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02724 GLPA_HUMAN Glycophorin-A (MN sialoglycoprotein) (PAS-2) (Sialoglycoprotein alpha) (CD antigen CD235a) GYPA GPA Homo sapiens (Human) cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; virus receptor activity [GO:0001618] GO:0001618; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0016020; GO:0042802 identical protein binding [GO:0042802]; virus receptor activity [GO:0001618] VQLAHHFSEPEITLIIFGVMAGVIGTILLISYGIRRLIK 0.93802 0.94538 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2535 0 15.0659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6L8G5 KR510_HUMAN Keratin-associated protein 5-10 (Keratin-associated protein 5.10) (Ultrahigh sulfur keratin-associated protein 5.10) KRTAP5-10 KAP5.10 KRTAP5.10 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GDCGSCGGSKGGCGSCGGSK 0.93803 4.1056 0 0 0 0 0 0 0 0 10.4295 0 0 0 0 11.7954 0 0 0 0 0 0 0 0 0 0 0 13.3378 13.8542 0 0 0 0 0 0 11.9665 0 10.3542 0 12.5076 0 12.2237 13.7356 0 0 0 0 13.7522 0 12.5448 0 12.0651 0 0 0 0 0 0 9.94483 0 0 0 0 0 0 0 0 0 0 0 11.9132 0 11.4478 0 0 0 0 11.9044 0 0 11.2577 0 0 12.2997 13.259 0 0 0 0 0 0 0 12.6942 11.504 11.9626 13.9679 11.6797 0 0 0 0 11.8979 12.8302 13.614 11.8333 12.7739 0 0 0 0 12.5504 0 10.9429 0 0 0 0 0 0 0 0 0 0 0 11.434 12.2372 0 11.9685 13.3939 0 12.0186 0 0 0 0 0 0 0 0 0 0 0 11.9815 0 0 0 0 0 0 0 0 11.2984 0 0 12.0432 11.8652 11.5118 0 0 0 0 0 0 0 0 14.325 0 0 0 13.8282 13.7572 12.7867 13.6746 0 12.0496 0 0 0 0 0 0 0 Q86TE4 LUZP2_HUMAN Leucine zipper protein 2 LUZP2 UNQ2566/PRO6246 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AEKHQATINFLK 0.93803 1.8092 0 0 0 0 0 0 0 0 0 0 0 0 12.2619 0 0 0 0 11.1888 0 11.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2283 0 0 0 0 0 0 0 0 0 0 0 15.0301 0 14.5142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7824 0 0 12.1864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5332 0 0 0 0 Q9HCJ2 LRC4C_HUMAN "Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand, NGL-1)" LRRC4C KIAA1580 NGL1 UNQ292/PRO331 Homo sapiens (Human) modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560] anchoring junction [GO:0070161]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]; modulation of chemical synaptic transmission [GO:0050804]; regulation of axonogenesis [GO:0050770]; synaptic membrane adhesion [GO:0099560] GO:0005615; GO:0005886; GO:0016020; GO:0016021; GO:0050770; GO:0050804; GO:0050839; GO:0070161; GO:0098632; GO:0098685; GO:0098978; GO:0099061; GO:0099560 cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632] ALFDPLLVVLLALQLLVVAGLVR 0.93803 0.99282 0 0 0 0 0 0 0 0 14.1738 0 11.4278 14.2171 13.3022 0 0 13.3877 13.3961 13.0007 0 13.762 0 0 0 12.2867 0 0 14.2464 13.9105 0 0 11.7597 0 0 0 0 0 0 0 0 0 13.8694 0 0 14.1058 14.0951 13.8629 13.2946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7803 0 12.2853 13.7148 0 0 0 0 0 0 13.6472 0 0 0 0 14.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2314 0 0 0 0 0 0 0 0 12.6451 0 0 0 0 12.5252 12.7316 0 0 0 0 0 0 0 12.6021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4185 0 0 0 12.1521 12.5034 0 0 0 12.5117 0 0 0 0 12.9317 0 0 0 12.1842 P52655 TF2AA_HUMAN "Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit, TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit) ]" GTF2A1 TF2A1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366] GO:0000979; GO:0001091; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0016251; GO:0017025; GO:0045944; GO:0046982; GO:0051123; GO:0060261; GO:0061629; GO:0097550 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025] WKFHLKDGIMNLNGR 0.93806 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0009 0 0 0 12.4011 0 0 0 0 0 0 0 0 0 0 0 Q6ZS02 DMP46_HUMAN Putative GED domain-containing protein DNM1P46 (DNM1 pseudogene 46) DNM1P46 C15orf51 Homo sapiens (Human) GTPase activity [GO:0003924] GO:0003924 GTPase activity [GO:0003924] DAASQSCCPTCTR 0.93806 1.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4598 0 0 0 0 11.3817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31371 FGF9_HUMAN "Fibroblast growth factor 9, FGF-9 (Glia-activating factor, GAF) (Heparin-binding growth factor 9, HBGF-9)" FGF9 Homo sapiens (Human) activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; mesenchymal cell proliferation [GO:0010463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reproductive process [GO:2000243]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein import into nucleus [GO:0006606]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; Sertoli cell proliferation [GO:0060011]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; mesenchymal cell proliferation [GO:0010463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reproductive process [GO:2000243]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein import into nucleus [GO:0006606]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; Sertoli cell proliferation [GO:0060011]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0000122; GO:0001525; GO:0001649; GO:0001654; GO:0001934; GO:0002053; GO:0002062; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0006606; GO:0007165; GO:0007224; GO:0007267; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0010463; GO:0010628; GO:0021762; GO:0030154; GO:0030178; GO:0030238; GO:0030324; GO:0030326; GO:0030334; GO:0030949; GO:0032924; GO:0032927; GO:0042472; GO:0045880; GO:0048010; GO:0048505; GO:0048566; GO:0048706; GO:0050679; GO:0051781; GO:0060011; GO:0060038; GO:0060045; GO:0060070; GO:0060484; GO:0072089; GO:0090263; GO:1904707; GO:1904754; GO:1905931; GO:2000243; GO:2000648 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201] EQFEENWYNTYSSNLYK 0.93807 1.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7701 0 0 0 0 0 10.6445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19544 WT1_HUMAN Wilms tumor protein (WT33) WT1 Homo sapiens (Human) "adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerular basement membrane development [GO:0032836]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal to epithelial transition [GO:0060231]; metanephric epithelium development [GO:0072207]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; podocyte differentiation [GO:0072112]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA methylation [GO:1905643]; positive regulation of gene expression [GO:0010628]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerular basement membrane development [GO:0032836]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal to epithelial transition [GO:0060231]; metanephric epithelium development [GO:0072207]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of female gonad development [GO:2000195]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; podocyte differentiation [GO:0072112]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA methylation [GO:1905643]; positive regulation of gene expression [GO:0010628]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001657; GO:0001658; GO:0001822; GO:0003156; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007281; GO:0007356; GO:0007507; GO:0007530; GO:0008270; GO:0008285; GO:0008380; GO:0008406; GO:0008584; GO:0009888; GO:0010385; GO:0010628; GO:0016607; GO:0017148; GO:0030308; GO:0030325; GO:0030539; GO:0030855; GO:0032835; GO:0032836; GO:0035802; GO:0043010; GO:0043065; GO:0043066; GO:0043565; GO:0044729; GO:0045892; GO:0045893; GO:0045944; GO:0060231; GO:0060421; GO:0060539; GO:0060923; GO:0061032; GO:0070742; GO:0071320; GO:0071371; GO:0072075; GO:0072112; GO:0072166; GO:0072207; GO:0072284; GO:0072302; GO:1902895; GO:1905643; GO:2000020; GO:2000195; GO:2001076 "C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" RVPGVAPTLVR 0.93809 1.0399 0 0 0 0 14.9137 14.0682 13.9493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J262 TVA86_HUMAN T cell receptor alpha variable 8-6 TRAV8-6 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 MLLLLVPAFQVIFTLGGTR 0.93812 1.0393 0 0 0 0 0 0 0 0 0 0 0 9.91809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9295 0 0 0 0 14.5086 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7783 14.7847 0 0 14.488 14.7395 0 0 0 0 0 0 0 14.5944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75832 PSD10_HUMAN 26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK)) PSMD10 Homo sapiens (Human) "apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome regulatory particle assembly [GO:0070682]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome regulatory particle assembly [GO:0070682]" GO:0000122; GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007253; GO:0008134; GO:0030307; GO:0031398; GO:0032088; GO:0032436; GO:0043066; GO:0043409; GO:0043518; GO:0045111; GO:0045737; GO:0070682; GO:0090201 transcription factor binding [GO:0008134] DHYEATAMHRAAAK 0.93812 1.7809 0 0 0 0 0 0 0 16.1081 0 14.0689 11.8247 0 0 11.5635 0 0 0 9.99647 0 0 0 0 11.6396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8296 0 9.82744 0 0 0 0 0 0 0 0 0 0 0 10.9773 0 0 0 0 0 0 10.1699 0 0 0 0 0 10.7841 13.1117 0 12.5679 0 0 15.4695 0 0 11.9973 0 11.3016 0 13.5691 0 0 13.0969 0 0 13.8016 13.0366 14.758 12.4112 0 13.2935 0 0 0 0 12.2168 0 0 0 12.5678 0 0 12.4285 0 0 13.4898 0 0 0 0 0 0 0 0 0 0 0 0 12.1601 12.3152 13.0016 0 12.0337 0 12.0768 0 0 0 0 0 12.4275 0 0 12.4378 0 0 0 0 0 0 14.0181 0 0 12.7961 0 0 12.9797 0 11.2457 0 13.273 11.9869 0 0 0 0 0 0 0 0 0 0 0 0 12.8539 0 0 12.2271 12.1503 12.6371 0 0 10.9811 0 12.9665 0 O94842 TOX4_HUMAN TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1) TOX4 C14orf92 KIAA0737 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] chromatin [GO:0000785]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; chromatin DNA binding [GO:0031490]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000785; GO:0005634; GO:0006357; GO:0031490; GO:0072357 chromatin DNA binding [GO:0031490] DWDNEYCSNECVVK 0.93812 2.3876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8539 0 0 11.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5352 0 13.759 0 13.7037 13.7866 0 0 0 0 14.2556 0 14.7008 0 13.7351 0 0 0 14.4933 13.9512 13.7512 0 14.2469 0 0 0 0 0 0 13.9101 13.7133 0 0 14.3318 13.3947 13.0995 0 0 13.8908 0 0 0 12.6762 12.8844 0 0 0 0 0 0 12.9892 0 13.3922 13.5361 0 0 11.541 13.5203 0 13.4812 14.2845 0 0 13.1768 0 0 0 13.2157 13.2543 0 0 0 0 0 0 0 0 0 0 11.0257 0 0 0 0 0 0 0 0 0 0 0 11.9665 0 0 0 0 12.4456 0 0 0 0 0 0 0 0 0 Q13131 AAPK1_HUMAN "5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK subunit alpha-1, EC 2.7.11.1 (Acetyl-CoA carboxylase kinase, ACACA kinase, EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase, HMGCR kinase, EC 2.7.11.31) (Tau-protein kinase PRKAA1, EC 2.7.11.26)" PRKAA1 AMPK1 Homo sapiens (Human) autophagy [GO:0006914]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to calcium ion [GO:0071277]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; autophagy [GO:0006914]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to calcium ion [GO:0071277]; cellular response to ethanol [GO:0071361]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to organonitrogen compound [GO:0071417]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; cold acclimation [GO:0009631]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; motor behavior [GO:0061744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of glucosylceramide biosynthetic process [GO:0046318]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; neuron cellular homeostasis [GO:0070050]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of mitochondrial transcription [GO:1903109]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of skeletal muscle tissue development [GO:0048643]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bile acid secretion [GO:0120188]; regulation of circadian rhythm [GO:0042752]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of stress granule assembly [GO:0062028]; regulation of vesicle-mediated transport [GO:0060627]; response to 17alpha-ethynylestradiol [GO:1904486]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to camptothecin [GO:1901563]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0001666; GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008022; GO:0008284; GO:0008610; GO:0009411; GO:0009631; GO:0010332; GO:0010508; GO:0010628; GO:0010629; GO:0014823; GO:0015721; GO:0016055; GO:0016324; GO:0016607; GO:0019395; GO:0030424; GO:0030425; GO:0031000; GO:0031588; GO:0031669; GO:0032007; GO:0033135; GO:0034599; GO:0035174; GO:0035556; GO:0038183; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0044877; GO:0045542; GO:0045821; GO:0046318; GO:0046627; GO:0046872; GO:0047322; GO:0048156; GO:0048511; GO:0048643; GO:0050321; GO:0050405; GO:0050995; GO:0055089; GO:0060627; GO:0061744; GO:0061762; GO:0062028; GO:0070050; GO:0070301; GO:0070507; GO:0071277; GO:0071333; GO:0071361; GO:0071380; GO:0071417; GO:0071456; GO:0071466; GO:0097009; GO:0106310; GO:0120188; GO:1901563; GO:1903109; GO:1903829; GO:1903944; GO:1903955; GO:1904428; GO:1904486; GO:1905691; GO:1990044; GO:2000758 [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] ATIKDIR 0.93812 3.5827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8115 0 0 0 0 0 0 0 0 0 0 0 0 9.54919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1515 0 0 0 0 13.2971 0 0 0 0 0 0 0 0 0 0 0 0 11.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9477 0 0 0 13.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1102 0 0 0 0 Q8N859 ZN713_HUMAN Zinc finger protein 713 ZNF713 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ITSLTEHHR 0.93813 1.8194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5Y4 PD2R2_HUMAN Prostaglandin D2 receptor 2 (Chemoattractant receptor-homologous molecule expressed on Th2 cells) (G-protein coupled receptor 44) (CD antigen CD294) PTGDR2 CRTH2 DL1R GPR44 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; calcium-mediated signaling [GO:0019722]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; negative regulation of male germ cell proliferation [GO:2000255]; neuropeptide signaling pathway [GO:0007218]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; prostaglandin D receptor activity [GO:0004956]; prostaglandin F receptor activity [GO:0004958]; prostaglandin J receptor activity [GO:0001785]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; calcium-mediated signaling [GO:0019722]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; negative regulation of male germ cell proliferation [GO:2000255]; neuropeptide signaling pathway [GO:0007218]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745] GO:0001785; GO:0004930; GO:0004956; GO:0004958; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0007186; GO:0007193; GO:0007218; GO:0019722; GO:0042277; GO:0042923; GO:0043005; GO:0045745; GO:2000255 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; prostaglandin D receptor activity [GO:0004956]; prostaglandin F receptor activity [GO:0004958]; prostaglandin J receptor activity [GO:0001785] ALSSTSS 0.93813 1.6863 0 0 0 0 0 0 0 0 17.8874 16.9619 16.4123 12.623 16.4418 16.46 13.9229 14.0323 0 0 0 0 0 0 0 0 0 0 0 0 13.5468 0 15.7916 14.5321 16.6259 17.4042 16.4391 16.8091 17.3257 16.555 16.6331 16.325 0 0 0 0 12.8843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6894 0 0 0 0 14.5358 0 0 0 0 0 0 0 0 0 0 0 0 13.7456 0 0 0 0 0 0 0 0 0 14.6284 0 0 0 13.3887 12.1552 0 0 0 0 0 0 0 12.9402 0 0 0 0 12.4741 0 0 0 0 0 0 0 0 12.5573 0 0 0 0 0 0 0 0 14.2837 0 0 0 12.1845 0 0 0 0 0 17.3245 17.1949 17.0828 17.1001 17.2757 14.4435 17.3306 17.0285 17.1613 17.0301 17.29 14.4785 14.1629 17.0225 0 0 0 0 0 0 17.0435 0 11.1908 O76090 BEST1_HUMAN Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2) BEST1 VMD2 Homo sapiens (Human) chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; chloride transport [GO:0006821]; detection of light stimulus involved in visual perception [GO:0050908]; ion transmembrane transport [GO:0034220]; regulation of calcium ion transport [GO:0051924]; transepithelial chloride transport [GO:0030321]; visual perception [GO:0007601] GO:0005229; GO:0005254; GO:0005829; GO:0005886; GO:0006821; GO:0007601; GO:0009925; GO:0015106; GO:0016020; GO:0016021; GO:0016323; GO:0030321; GO:0034220; GO:0034707; GO:0042802; GO:0050908; GO:0051924 bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229] DHMDPYWALENR 0.93814 2.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9907 0 13.8837 0 10.6985 0 0 0 0 0 0 12.0928 0 0 0 0 0 0 0 0 0 0 0 13.4168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3038 0 0 0 0 0 13.8048 0 14.93 0 0 0 0 0 0 0 0 12.7006 0 0 0 0 0 0 0 0 0 0 17.5218 0 0 14.0042 12.2334 0 0 0 0 0 0 0 0 12.1791 0 0 0 0 0 0 0 13.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2715 0 13.8115 0 0 0 0 0 0 0 14.2372 0 0 14.3062 0 0 0 0 0 0 0 16.9904 0 0 0 0 17.1786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGN5 O10G8_HUMAN Olfactory receptor 10G8 (Olfactory receptor OR11-282) OR10G8 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVDGVVAVFYTVLTPLLNPVVYTLRNKEVK 0.93816 1.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95800 GPR75_HUMAN Probable G-protein coupled receptor 75 GPR75 Homo sapiens (Human) chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron death [GO:1901214] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of neuron death [GO:1901214] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0016493; GO:0070098; GO:1901214 C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930] MVLGKQPNR 0.93817 1.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1694 11.5405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1368 0 0 0 0 0 0 0 0 0 0 0 P32302 CXCR5_HUMAN "C-X-C chemokine receptor type 5, CXC-R5, CXCR-5 (Burkitt lymphoma receptor 1) (Monocyte-derived receptor 15, MDR-15) (CD antigen CD185)" CXCR5 BLR1 MDR15 Homo sapiens (Human) B cell activation [GO:0042113]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; lymph node development [GO:0048535]; positive regulation of cytokinesis [GO:0032467]; positive regulation of cytosolic calcium ion concentration [GO:0007204] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; B cell activation [GO:0042113]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukocyte chemotaxis [GO:0030595]; lymph node development [GO:0048535]; positive regulation of cytokinesis [GO:0032467]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0004930; GO:0005886; GO:0005887; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0030595; GO:0032467; GO:0042113; GO:0048535; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930] AVFVPVAYSLIFLLGVIGNVLVLVILER 0.93817 4.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2991 11.7593 0 0 11.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7838 0 0 0 13.9421 0 0 0 0 0 14.5272 13.4578 0 14.3877 0 14.417 0 0 0 13.8496 0 11.8844 13.4014 0 0 0 0 0 0 13.8131 0 0 0 0 0 0 0 0 12.5493 0 10.1301 0 0 0 0 0 0 0 13.1216 0 0 0 0 0 0 0 0 0 0 12.1469 0 0 0 10.8471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8299 0 0 0 0 0 12.8916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13385 TDGF1_HUMAN "Teratocarcinoma-derived growth factor 1 (Cripto-1 growth factor, CRGF) (Epidermal growth factor-like cripto protein CR1)" TDGF1 CRIPTO Homo sapiens (Human) "anatomical structure development [GO:0048856]; anterior/posterior axis specification, embryo [GO:0008595]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-6 [GO:0071354]; cellular response to tumor necrosis factor [GO:0071356]; determination of left/right symmetry [GO:0007368]; embryo development ending in birth or egg hatching [GO:0009792]; heart development [GO:0007507]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of apoptotic process [GO:0043066]; nodal signaling pathway [GO:0038092]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of signal transduction [GO:0009966]" anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; activin receptor binding [GO:0070697]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; anterior/posterior axis specification, embryo [GO:0008595]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-6 [GO:0071354]; cellular response to tumor necrosis factor [GO:0071356]; determination of left/right symmetry [GO:0007368]; embryo development ending in birth or egg hatching [GO:0009792]; heart development [GO:0007507]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of apoptotic process [GO:0043066]; nodal signaling pathway [GO:0038092]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of signal transduction [GO:0009966]" GO:0001568; GO:0001763; GO:0002042; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0007368; GO:0007507; GO:0008083; GO:0008284; GO:0008595; GO:0009792; GO:0009952; GO:0009966; GO:0009986; GO:0010595; GO:0016324; GO:0018105; GO:0019897; GO:0030154; GO:0030335; GO:0030879; GO:0031225; GO:0035729; GO:0038092; GO:0038100; GO:0043066; GO:0043406; GO:0043410; GO:0044344; GO:0045121; GO:0048856; GO:0050731; GO:0070697; GO:0071346; GO:0071354; GO:0071356; GO:0071364 activin receptor binding [GO:0070697]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102] NCEHDVR 0.93818 1.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7943 12.9717 0 0 0 0 12.0433 0 0 0 11.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 0 0 0 0 0 0 0 12.9208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9442 0 11.6921 0 0 0 0 0 0 0 12.2777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0347 0 12.3865 0 0 0 0 0 0 0 0 11.8111 0 0 P46091 CML2_HUMAN Chemerin-like receptor 2 (Chemerin chemokine-like receptor 2) (Chemokine-like receptor 2) (G-protein coupled receptor 1) CMKLR2 GPR1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; neuropeptide signaling pathway [GO:0007218] GO:0004930; GO:0005654; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0042277; GO:0042593; GO:0042923; GO:0043005; GO:0043231; GO:0097003; GO:0097004 adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277] MEDLEETLFEEFENYSYDLDYYSLESDLEEK 0.93818 1.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0007 0 11.7089 0 0 14.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8827 0 0 0 11.9035 0 0 0 0 12.8215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.964 0 0 0 0 0 0 0 0 12.7743 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4462 11.6819 0 0 0 0 0 0 0 0 0 P03928 ATP8_HUMAN ATP synthase protein 8 (A6L) (F-ATPase subunit 8) MT-ATP8 ATP8 ATPASE8 MTATP8 Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton transmembrane transporter activity [GO:0015078]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0000276; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0016021; GO:0042776 proton transmembrane transporter activity [GO:0015078] MPQLNTTVWPTMITPMLLTLFLITQLK 0.93819 1.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0805 0 0 0 12.6153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9638 0 0 0 11.7264 0 11.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWW4 SSBP3_HUMAN Single-stranded DNA-binding protein 3 (Sequence-specific single-stranded-DNA-binding protein) SSBP3 SSDP SSDP1 Homo sapiens (Human) head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; mesendoderm development [GO:0048382]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; head morphogenesis [GO:0060323]; hematopoietic progenitor cell differentiation [GO:0002244]; mesendoderm development [GO:0048382]; midbrain-hindbrain boundary initiation [GO:0021547]; positive regulation of anterior head development [GO:2000744]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prechordal plate formation [GO:0021501]; protein-containing complex assembly [GO:0065003] GO:0002244; GO:0003697; GO:0003713; GO:0005634; GO:0005667; GO:0008284; GO:0021501; GO:0021547; GO:0045944; GO:0048382; GO:0060323; GO:0065003; GO:2000744 single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] GMGPMGPGPQNYGSGMR 0.93819 0.94771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8922 0 0 0 0 0 0 0 0 0 0 0 Q04741 EMX1_HUMAN Homeobox protein EMX1 (Empty spiracles homolog 1) (Empty spiracles-like protein 1) EMX1 Homo sapiens (Human) brain development [GO:0007420]; brain morphogenesis [GO:0048854]; central nervous system development [GO:0007417]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron projection extension [GO:1990138]; post-embryonic development [GO:0009791]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410] chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] "chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; central nervous system development [GO:0007417]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; neuron projection extension [GO:1990138]; post-embryonic development [GO:0009791]; radial glial cell differentiation [GO:0060019]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]" GO:0000785; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0006357; GO:0007417; GO:0007420; GO:0009410; GO:0009791; GO:0021796; GO:0021895; GO:0030182; GO:0048854; GO:0048872; GO:0060019; GO:0060563; GO:0070445; GO:1990138; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DPLHFYPWVLRNR 0.9382 1.8174 10.1911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.1009 0 0 0 0 0 0 0 0 15.6076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7533 0 0 0 10.2709 0 0 0 0 0 0 0 0 0 0 12.7491 0 0 0 0 0 0 0 0 0 0 12.5709 0 0 0 0 0 13.5539 0 0 0 0 0 0 12.79 0 0 0 0 0 0 0 0 0 12.5467 10.7812 12.3237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9575 0 0 0 0 0 0 0 0 0 0 0 13.072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3313 0 0 0 0 0 0 0 14.1961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3499 0 Q5MJ10 SPXN2_HUMAN "Sperm protein associated with the nucleus on the X chromosome N2 (Nuclear-associated protein SPAN-Xn2, SPANX-N2) (SPANX family member N2)" SPANXN2 Homo sapiens (Human) EQPTSSTNGEK 0.9382 1.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4491 0 0 0 0 0 12.4705 11.9475 0 0 0 0 0 0 0 11.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9475 11.3351 0 0 0 0 0 0 11.0562 0 0 0 11.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXZ4 UNC5D_HUMAN Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D) UNC5D KIAA1777 UNC5H4 UNQ6012/PRO34692 Homo sapiens (Human) apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; pyramidal neuron differentiation [GO:0021859]; regulation of neuron migration [GO:2001222] GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0016021; GO:0021859; GO:0098742; GO:2001222 netrin receptor activity [GO:0005042] AEYHGKNHSR 0.93821 2.6934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7938 0 0 0 0 0 0 0 0 0 9.98456 0 0 0 18.2326 0 0 13.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0203 12.3041 0 13.3008 11.7668 0 0 0 0 0 0 0 14.0644 0 0 0 0 0 13.1202 0 0 12.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1885 0 13.3487 0 0 0 0 11.3192 0 12.0884 0 0 0 0 0 0 11.8137 12.0644 0 14.3355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5439 12.2763 0 0 0 0 0 0 0 0 11.682 0 0 0 0 0 0 0 0 0 0 0 11.062 0 0 0 A1A5D9 BICL2_HUMAN "BICD family-like cargo adapter 2 (Bicaudal D-related protein 2, BICD-related protein 2, BICDR-2) (Coiled-coil domain-containing protein 64B)" BICDL2 BICDR2 CCDC64B Homo sapiens (Human) Golgi to secretory granule transport [GO:0055107]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; small GTPase binding [GO:0031267]; Golgi to secretory granule transport [GO:0055107]; vesicle transport along microtubule [GO:0047496] GO:0005737; GO:0031267; GO:0047496; GO:0055107 small GTPase binding [GO:0031267] EERLQQENHELR 0.93822 1.6843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IBW4 CNDH2_HUMAN "Condensin-2 complex subunit H2 (Chromosome-associated protein H2, hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2)" NCAPH2 CAPH2 Homo sapiens (Human) female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077] cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077] GO:0000794; GO:0000796; GO:0003682; GO:0005634; GO:0005654; GO:0007076; GO:0010032; GO:0016020; GO:0030054; GO:0033077; GO:0045171; GO:0051306; GO:0051309; GO:0051984; GO:1905820 chromatin binding [GO:0003682] DWEDTVQPLLQEQEQHVPFDIHTYGDQLVSR 0.93822 3.522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5267 0 0 0 0 0 0 0 0 0 0 12.913 0 0 12.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4166 0 0 0 0 0 12.7438 0 0 12.6414 0 14.6523 0 0 0 0 0 0 0 0 0 10.3494 14.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3814 0 0 0 0 0 0 0 0 0 8.90313 0 0 0 0 0 0 0 0 0 Q9Y2D1 ATF5_HUMAN "Cyclic AMP-dependent transcription factor ATF-5, cAMP-dependent transcription factor ATF-5 (Activating transcription factor 5) (Transcription factor ATFx)" ATF5 ATFX Homo sapiens (Human) "cerebellar granule cell precursor proliferation [GO:0021930]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron development [GO:0021891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of centrosome cycle [GO:0046605]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]; cerebellar granule cell precursor proliferation [GO:0021930]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron development [GO:0021891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; regulation of centrosome cycle [GO:0046605]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006355; GO:0006357; GO:0007623; GO:0008285; GO:0009791; GO:0015631; GO:0019900; GO:0021891; GO:0021930; GO:0035264; GO:0043066; GO:0043565; GO:0045444; GO:0045892; GO:0045893; GO:0045944; GO:0046605; GO:0090575; GO:1902750 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]" LAPYPHPATTRGDRK 0.93822 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05940 VMAT2_HUMAN "Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2, VAT2)" SLC18A2 SVMT VMAT2 Homo sapiens (Human) aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]; sequestering of neurotransmitter [GO:0042137] centrosome [GO:0005813]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] centrosome [GO:0005813]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; transmembrane transporter activity [GO:0022857]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; locomotory behavior [GO:0007626]; monoamine transport [GO:0015844]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]; sequestering of neurotransmitter [GO:0042137] GO:0001975; GO:0005335; GO:0005813; GO:0005886; GO:0005887; GO:0006836; GO:0007268; GO:0007626; GO:0008021; GO:0008504; GO:0009636; GO:0009791; GO:0015842; GO:0015844; GO:0015872; GO:0016020; GO:0022857; GO:0030672; GO:0042137; GO:0043195; GO:0043231; GO:0070083; GO:0098691; GO:0098700; GO:1903427 monoamine transmembrane transporter activity [GO:0008504]; serotonin:sodium symporter activity [GO:0005335]; transmembrane transporter activity [GO:0022857] MYTQNNIQSYPIGEDEESESD 0.93823 0.98966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.339 0 13.063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95238 SPDEF_HUMAN "SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor, Prostate-specific Ets) (Prostate-derived Ets factor)" SPDEF PDEF PSE Homo sapiens (Human) cell differentiation [GO:0030154]; epithelial cell fate commitment [GO:0072148]; glandular epithelial cell development [GO:0002068]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; epithelial cell fate commitment [GO:0072148]; glandular epithelial cell development [GO:0002068]; intestinal epithelial cell development [GO:0060576]; lung goblet cell differentiation [GO:0060480]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000981; GO:0002068; GO:0005634; GO:0006357; GO:0006366; GO:0010454; GO:0010455; GO:0030154; GO:0043065; GO:0043565; GO:0045944; GO:0060480; GO:0060576; GO:0072148; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ELLLKPHSYGRFIR 0.93824 1.7673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0R4 HDHD2_HUMAN Haloacid dehalogenase-like hydrolase domain-containing protein 2 HDHD2 Homo sapiens (Human) dephosphorylation [GO:0016311] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311] GO:0016311; GO:0016791; GO:0019899; GO:0046872; GO:0070062 enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791] GTGCEPEEAVMIGDDCR 0.93824 0.94671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7645 11.5552 12.8385 0 0 0 0 0 0 12.3647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0616 0 0 0 0 0 0 0 0 0 12.763 13.0415 0 0 0 0 0 0 0 0 0 0 0 0 0 12.125 13.7988 13.4667 12.5237 12.9142 0 0 0 12.1397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0443 0 0 0 0 0 0 13.1595 0 14.2777 0 0 0 14.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K855 EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 EFCAB7 KIAA1799 Homo sapiens (Human) positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944] ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797] ciliary membrane [GO:0060170]; cilium [GO:0005929]; extrinsic component of membrane [GO:0019898]; plasma membrane protein complex [GO:0098797]; calcium ion binding [GO:0005509]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005509; GO:0005929; GO:0019898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:1903569 calcium ion binding [GO:0005509] AELLKSFK 0.93825 0.94643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.673 0 0 11.8394 0 0 0 0 0 0 0 0 0 13.9202 11.1201 13.4305 0 0 0 0 0 0 0 0 0 0 11.5366 0 0 0 0 0 12.4375 0 0 0 0 0 14.3582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.986 0 0 0 0 0 9.53142 0 13.4985 0 0 0 0 0 0 14.0787 0 0 0 0 10.7878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXI6 TB10A_HUMAN "TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa, EPI64 protein) (Rab27A-GAP-alpha)" TBC1D10A EPI64 TBC1D10 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of GTPase activity [GO:0090630]; positive regulation of proteolysis [GO:0045862]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0005902; GO:0030165; GO:0042147; GO:0045296; GO:0045862; GO:0070062; GO:0090630; GO:0097202 cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165] EHLIQLRRWQETR 0.93825 2.6483 0 0 10.6775 0 0 0 0 0 0 0 12.8465 0 0 0 0 0 0 0 0 0 12.4776 0 0 0 0 0 0 0 0 0 10.7957 0 0 0 0 14.3581 0 0 0 0 0 0 10.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6428 0 10.2637 0 0 0 0 0 0 11.1288 0 12.8422 0 0 0 10.5976 0 0 0 0 13.0205 0 0 13.7214 0 0 0 0 12.4684 0 12.6606 0 0 0 0 0 0 0 0 0 0 0 0 14.1227 0 0 12.903 0 0 11.945 11.9404 0 0 0 0 0 0 13.0066 0 12.3163 0 0 0 0 17.5011 14.6729 0 11.8436 10.4158 14.6329 14.2093 0 0 0 0 0 0 0 0 9.94875 0 0 0 13.7678 11.8129 14.5024 14.185 12.5587 13.4851 0 12.5432 0 0 0 12.5812 0 0 14.0235 0 0 0 0 0 0 0 0 11.8277 0 0 0 11.7827 10.674 0 0 10.4364 14.4737 0 0 12.1517 0 0 0 P62683 GAK21_HUMAN "Endogenous retrovirus group K member 21 Gag polyprotein (HERV-K_12q14.1 provirus ancestral Gag polyprotein, Gag polyprotein)" ERVK-21 Homo sapiens (Human) viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032] GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032 nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] GPELVGPSESK 0.93826 0.98949 0 0 0 0 0 0 0 0 0 0 12.3611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8581 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6L8G4 KR511_HUMAN Keratin-associated protein 5-11 (Keratin-associated protein 5.11) (Ultrahigh sulfur keratin-associated protein 5.11) KRTAP5-11 KAP5.11 KRTAP5.11 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GGCGSCGCSQSNCCK 0.93827 2.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1857 0 0 0 0 0 0 0 0 0 0 0 10.8707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6089 0 0 0 0 12.8738 0 0 0 0 0 0 12.2098 0 0 0 11.8016 0 0 0 0 13.0295 13.5616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0259 11.9173 0 0 0 12.3916 0 0 12.2002 12.0204 0 0 0 0 0 0 11.9399 0 0 11.8138 0 0 0 0 0 12.602 0 0 0 0 0 0 0 0 0 0 0 12.2685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSF0 SMAKA_HUMAN "Small membrane A-kinase anchor protein, Small membrane AKAP, smAKAP" C2orf88 Homo sapiens (Human) plasma membrane [GO:0005886] plasma membrane [GO:0005886]; protein kinase A regulatory subunit binding [GO:0034237] GO:0005886; GO:0034237 protein kinase A regulatory subunit binding [GO:0034237] QHESEEPFMPEERCLPRMASPVNVK 0.93827 1.0409 0 0 0 0 0 0 0 0 0 0 0 10.5719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2562 0 0 0 0 0 0 10.599 0 0 0 0 0 0 Q9Y5P6 GMPPB_HUMAN "Mannose-1-phosphate guanyltransferase beta, EC 2.7.7.13 (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta)" GMPPB Homo sapiens (Human) GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; nucleotidyltransferase activity [GO:0016779]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486] GO:0004475; GO:0005525; GO:0005737; GO:0006486; GO:0009298; GO:0016779 GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; nucleotidyltransferase activity [GO:0016779] IRSHSWLESCIVGWR 0.93827 1.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7635 0 0 0 0 0 0 0 0 0 0 10.2613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IK0 TM101_HUMAN Transmembrane protein 101 (Putative NF-kappa-B-activating protein 130) TMEM101 Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0016021; GO:0043123 PDIPVPYLYFDMGAAVLCASFMSFGVK 0.93828 0.99306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.424 0 0 0 0 0 0 12.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0011 0 0 0 0 0 0 0 0 0 11.225 0 0 0 10.4832 Q9Y6G1 TM14A_HUMAN Transmembrane protein 14A TMEM14A C6orf73 PTD011 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; regulation of heme biosynthetic process [GO:0070453] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; regulation of heme biosynthetic process [GO:0070453] GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0043066; GO:0070453; GO:1901029 IMPAGLVAGLSLMMILRLVLLLL 0.93828 1.6821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9683 0 0 0 0 0 0 0 0 0 14.5193 0 0 0 0 0 0 A6NEL3 F86C2_HUMAN "Putative protein FAM86C2P, EC 2.1.1.-" FAM86C2P Homo sapiens (Human) methylation [GO:0032259] methyltransferase activity [GO:0008168]; methylation [GO:0032259] GO:0008168; GO:0032259 methyltransferase activity [GO:0008168] ALRSFPWQSLEAKLR 0.93829 0.94715 0 0 0 0 0 0 0 0 12.4835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75333 TBX10_HUMAN "T-box transcription factor TBX10, T-box protein 10" TBX10 TBX7 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0005634; GO:0006357; GO:0009653; GO:0045893 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" TPAWLHHQLLPPPEVLLAPATYR 0.93829 0.98895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1286 0 0 0 0 0 0 0 0 0 Q15485 FCN2_HUMAN Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35) FCN2 FCNL Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370] "blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; identical protein binding [GO:0042802]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0042802; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065 antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; identical protein binding [GO:0042802]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] PLTVLCDMDTDGGGWTVFQRR 0.9383 1.0404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6054 0 0 0 0 0 0 11.4285 0 0 0 0 0 0 11.9458 0 0 0 11.4521 0 0 0 0 0 0 0 0 0 0 0 11.3189 0 0 0 0 0 0 12.5151 0 0 0 0 0 0 0 0 12.7913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5232 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4H3 HDDC2_HUMAN "5'-deoxynucleotidase HDDC2, EC 3.1.3.89 (HD domain-containing protein 2) (Hepatitis C virus NS5A-transactivated protein 2, HCV NS5A-transactivated protein 2)" HDDC2 C6orf74 NS5ATP2 CGI-130 Homo sapiens (Human) 5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872] GO:0002953; GO:0046872 5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872] QLDQCEMILQASEYEDLEHK 0.93831 0.92942 0 0 0 0 0 0 0 0 0 0 11.2146 0 0 0 0 10.6974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7474 13.5479 0 0 0 13.0229 0 0 0 0 0 0 12.4143 0 12.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8337 12.1837 0 0 0 12.0184 0 12.6469 12.9808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7857 0 0 0 0 11.0484 0 0 0 0 0 0 0 0 0 0 11.5988 0 0 0 0 0 0 0 0 0 0 P02656 APOC3_HUMAN "Apolipoprotein C-III, Apo-CIII, ApoC-III (Apolipoprotein C3)" APOC3 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of cholesterol import [GO:0060621]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of high-density lipoprotein particle clearance [GO:0010987]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of triglyceride catabolic process [GO:0010897]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; phospholipid efflux [GO:0033700]; regulation of Cdc42 protein signal transduction [GO:0032489]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379] chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate-density lipoprotein particle [GO:0034363]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361] chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate-density lipoprotein particle [GO:0034363]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; cholesterol binding [GO:0015485]; enzyme regulator activity [GO:0030234]; high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; phospholipid binding [GO:0005543]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of cholesterol import [GO:0060621]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of high-density lipoprotein particle clearance [GO:0010987]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of triglyceride catabolic process [GO:0010897]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; phospholipid efflux [GO:0033700]; regulation of Cdc42 protein signal transduction [GO:0032489]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0005543; GO:0005576; GO:0005615; GO:0005769; GO:0006641; GO:0007186; GO:0010897; GO:0010903; GO:0010916; GO:0010987; GO:0010989; GO:0015485; GO:0019433; GO:0030234; GO:0032489; GO:0033344; GO:0033700; GO:0034361; GO:0034363; GO:0034366; GO:0034375; GO:0034379; GO:0034382; GO:0042157; GO:0042627; GO:0042632; GO:0043691; GO:0045717; GO:0045833; GO:0048261; GO:0050995; GO:0051005; GO:0055102; GO:0060621; GO:0062023; GO:0070062; GO:0070328; GO:0070653 cholesterol binding [GO:0015485]; enzyme regulator activity [GO:0030234]; high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; phospholipid binding [GO:0005543] MQPRVLLVVALLALLASAR 0.93832 0.99197 0 0 10.3185 0 0 0 0 0 0 0 0 0 0 0 11.4658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7007 0 0 0 0 0 0 0 10.4121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6265 0 0 0 0 0 0 0 0 0 0 0 9.44047 0 0 0 12.5165 0 0 0 0 0 0 0 0 0 0 11.9206 0 11.7495 0 0 0 0 0 0 12.4164 0 0 0 0 0 0 0 13.9243 0 0 0 13.4201 0 0 0 0 0 11.2269 13.6793 0 0 0 0 0 11.1741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H341 O51M1_HUMAN Olfactory receptor 51M1 (Odorant receptor HOR5'beta7) (Olfactory receptor OR11-40) OR51M1 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AGLIVIFRGPVATIPIVLLLK 0.93832 2.3842 0 0 0 0 0 0 0 0 12.4562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9359 0 0 0 0 0 0 10.53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1856 13.9644 0 0 0 0 11.8098 0 0 0 0 0 0 0 13.1381 0 0 0 0 0 0 0 0 0 0 0 12.469 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2968 12.5173 0 0 0 0 0 0 0 0 13.1769 0 0 0 0 12.3304 0 0 12.6848 0 0 11.7194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5095 0 0 0 12.1896 0 0 0 11.6444 0 0 0 0 0 0 0 0 Q9BTL3 RAMAC_HUMAN "RNA guanine-N7 methyltransferase activating subunit (Protein FAM103A1) (RNA guanine-7 methyltransferase activating subunit) (RNMT-activating mRNA cap methyltransferase subunit) (RNMT-activating mini protein, RAM)" RAMAC C15orf18 FAM103A1 RAMMET Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031]; RNA 5'-cap (guanine-N7)-methylation [GO:0106005] mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleus [GO:0005634] mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex [GO:0036031]; RNA 5'-cap (guanine-N7)-methylation [GO:0106005] GO:0003723; GO:0005634; GO:0005845; GO:0006370; GO:0008047; GO:0031533; GO:0032259; GO:0036031; GO:0106005 enzyme activator activity [GO:0008047]; RNA binding [GO:0003723] FEEMFASRFTENDKEYQEYLK 0.93833 0.98738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43172 PRP4_HUMAN "U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog, hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4)" PRPF4 PRP4 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0008380; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0046540; GO:0071001; GO:0071005; GO:0097525 U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070] NILSVVGTDALKKTK 0.93834 0.99688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.12 0 0 P78386 KRT85_HUMAN "Keratin, type II cuticular Hb5 (Hair keratin K2.12) (Keratin-85, K85) (Type II hair keratin Hb5) (Type-II keratin Kb25)" KRT85 KRTHB5 Homo sapiens (Human) epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular space [GO:0005615]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; structural molecule activity [GO:0005198]; epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005198; GO:0005615; GO:0005829; GO:0008544; GO:0030280; GO:0031424; GO:0045095; GO:0045109 structural constituent of skin epidermis [GO:0030280]; structural molecule activity [GO:0005198] FLEQQNK 0.93834 3.5147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1443 O00754 MA2B1_HUMAN "Lysosomal alpha-mannosidase, Laman, EC 3.2.1.24 (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide ]" MAN2B1 LAMAN MANB Homo sapiens (Human) learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]; protein modification process [GO:0036211] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517]; protein modification process [GO:0036211] GO:0004559; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006013; GO:0006517; GO:0007611; GO:0030246; GO:0035578; GO:0036211; GO:0043202; GO:0043231; GO:0046872; GO:0070062 alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] DHFTFCQQLNISICPLSQTAARFQVIVYNPLGRK 0.93836 0.92701 0 0 0 0 0 0 12.2843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.255 0 0 0 0 12.7234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5845 0 0 0 0 0 0 14.1896 0 0 0 0 0 0 0 0 0 0 0 0 13.5333 0 0 0 13.0085 0 0 12.6442 0 0 0 11.7453 0 0 0 0 0 12.269 0 0 10.9125 0 0 0 0 0 0 0 0 0 13.279 0 0 0 0 12.9281 13.6058 0 12.8818 0 12.6987 0 0 0 0 13.4607 0 0 0 0 0 0 13.6909 0 0 0 12.1332 12.1749 14.1362 0 0 0 18.4314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.029 0 0 0 P43364 MAGAB_HUMAN "Melanoma-associated antigen 11 (Cancer/testis antigen 1.11, CT1.11) (MAGE-11 antigen)" MAGEA11 MAGE11 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0042826 histone deacetylase binding [GO:0042826] AHAETSK 0.93836 1.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6444 0 13.0752 0 0 0 0 0 0 0 0 0 0 0 14.8523 0 0 0 0 0 0 0 0 0 0 0 0 14.4346 0 0 0 0 0 0 0 0 0 0 0 0 12.1482 0 0 0 0 13.1187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZT77 ZN826_HUMAN Putative zinc finger protein 826 ZNF826P ZNF826 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" PSTIFHTLLYIRQFILERNAINGIK 0.93837 0.99118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0261 0 0 0 0 13.5539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6108 0 Q9H2A3 NGN2_HUMAN "Neurogenin-2, NGN-2 (Class A basic helix-loop-helix protein 8, bHLHa8) (Protein atonal homolog 4)" NEUROG2 ATOH4 BHLHA8 NGN2 Homo sapiens (Human) neuron differentiation [GO:0030182]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; neuron differentiation [GO:0030182]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0046983; GO:0051091; GO:0070888; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GAEAGQGARGGVAAGAEGCR 0.93837 0.98315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ42 GP160_HUMAN "Probable G-protein coupled receptor 160 (G-protein coupled receptor GPCR1, hGPCR1)" GPR160 GPCR150 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021; GO:0043235 G protein-coupled receptor activity [GO:0004930] IFLSKLIVCFLSTWLPFVLLQVIIVLLK 0.93837 2.6467 0 0 0 0 0 0 0 0 11.9421 0 0 0 0 0 10.7879 0 0 17.1173 0 16.2154 16.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9024 0 14.1254 12.1415 10.9373 0 0 16.8274 16.6957 16.8647 17.3728 17.359 17.0089 14.5548 0 0 16.9557 0 16.1269 0 0 16.5875 0 0 0 10.8576 11.4555 11.2264 11.7146 0 0 0 0 11.0714 0 0 0 0 12.8805 0 13.4151 0 0 12.7371 0 0 0 0 13.594 13.2996 0 0 0 15.1271 13.8671 14.7447 14.4385 0 14.1662 0 0 0 13.0025 15.8553 0 0 0 0 0 0 0 0 13.7259 0 14.9378 13.6506 13.2774 0 12.9224 13.1092 0 13.2923 12.9553 0 0 0 13.3512 0 13.4832 0 11.719 0 0 0 12.719 0 0 0 0 0 0 13.9004 0 14.0922 0 0 0 0 0 0 0 0 0 0 11.1643 0 0 0 0 0 0 0 0 0 0 0 12.7273 0 14.4556 0 0 0 0 0 0 0 14.5465 0 0 0 0 0 0 0 0 Q14331 FRG1_HUMAN Protein FRG1 (FSHD region gene 1 protein) FRG1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; rRNA processing [GO:0006364]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; rRNA processing [GO:0006364]" GO:0000398; GO:0003723; GO:0005730; GO:0006364; GO:0007517; GO:0015030; GO:0030018; GO:0051015; GO:0055120; GO:0071013 actin filament binding [GO:0051015]; RNA binding [GO:0003723] DGFLHETLLDRR 0.93838 0.92674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1255 0 0 0 0 0 0 0 0 11.4296 0 0 0 13.6317 0 0 0 10.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KT7 S35G5_HUMAN Solute carrier family 35 member G5 (Acyl-malonyl-condensing enzyme 1-like protein 2) SLC35G5 AMAC AMAC1L2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CLFHLPIALLLK 0.93838 0.99118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.361 0 0 0 0 0 0 0 0 0 13.63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8267 0 11.644 0 0 0 0 0 0 0 0 0 0 0 0 14.7687 0 0 0 0 0 0 14.0856 0 0 0 0 0 0 0 0 0 13.9776 0 0 0 0 0 0 0 0 0 0 14.6921 0 0 0 0 0 0 0 0 13.537 13.4597 0 14.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0972 0 13.3979 0 0 0 0 0 0 0 0 Q969D9 TSLP_HUMAN Thymic stromal lymphopoietin TSLP Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531] GO:0001961; GO:0005125; GO:0005139; GO:0005576; GO:0005615; GO:0008284; GO:0032722; GO:0032733; GO:0032736; GO:0032754; GO:0032755; GO:0033005; GO:0042531; GO:0043066; GO:0050729; GO:0050829; GO:0050832; GO:0061844; GO:0071654; GO:0071657; GO:1904894 cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139] FPFALLYVLSVSFRK 0.9384 0.9862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5462 0 0 0 0 0 0 11.9429 0 0 11.3106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXJ5 C1QT2_HUMAN Complement C1q tumor necrosis factor-related protein 2 C1QTNF2 CTRP2 UNQ6349/PRO21054 Homo sapiens (Human) regulation of lipid metabolic process [GO:0019216] collagen trimer [GO:0005581]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; extracellular region [GO:0005576]; regulation of lipid metabolic process [GO:0019216] GO:0005576; GO:0005581; GO:0019216 AGPRGPKGVNGTPGK 0.9384 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5403 0 13.5706 0 0 14.8156 0 13.5857 14.9958 0 0 0 0 13.9187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8554 0 0 0 0 14.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUH8 SPP2C_HUMAN "Signal peptide peptidase-like 2C, SPP-like 2C, SPPL2c, EC 3.4.23.- (Intramembrane protease 5, IMP-5)" SPPL2C IMP5 Homo sapiens (Human) membrane protein proteolysis [GO:0033619] endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765] "endoplasmic reticulum membrane [GO:0005789]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]" GO:0005765; GO:0005789; GO:0030660; GO:0033619; GO:0042500; GO:0042803; GO:0071458; GO:0071556 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]" LPMVLKVPRLR 0.93841 0.93675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6182 0 0 12.1324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2584 0 0 0 12.4245 0 0 0 0 0 0 0 0 0 0 Q13275 SEM3F_HUMAN "Semaphorin-3F (Sema III/F) (Semaphorin IV, Sema IV)" SEMA3F Homo sapiens (Human) axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486] GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0021612; GO:0021637; GO:0021675; GO:0021785; GO:0030215; GO:0030335; GO:0036486; GO:0045499; GO:0048843; GO:0048846; GO:0050919; GO:0061549; GO:0071526; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1902285; GO:1902287 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] CQAYGAACADCCLARDPYCAWDGQACSR 0.93842 0.98136 0 0 0 10.3429 0 0 0 0 13.5788 0 14.0205 10.948 0 0 13.7757 0 0 0 0 0 0 0 13.8821 0 0 0 0 14.3458 14.1947 14.3621 0 0 0 0 0 0 0 0 12.7289 13.9972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7807 0 11.3661 0 14.4075 13.8081 0 14.9065 11.6352 13.187 13.1566 0 0 0 0 15.312 0 14.8796 13.3659 14.0509 13.6752 15.538 13.2386 13.1061 13.6475 15.1846 0 13.9141 0 12.9799 14.119 0 0 0 11.4029 0 11.4098 12.7477 12.8617 14.736 0 0 14.3287 14.8915 0 13.5304 0 0 0 0 13.5344 0 0 0 0 0 0 0 14.1207 12.9581 13.0828 0 0 13.0831 14.3548 13.3836 13.6673 0 0 0 0 13.6262 0 0 13.4462 0 0 0 0 0 0 0 11.2916 0 12.1196 0 0 0 0 0 13.3426 14.0289 0 0 13.2945 13.3081 0 0 0 0 0 13.3563 0 0 0 0 13.3468 0 0 0 Q8WUU8 TM174_HUMAN Transmembrane protein 174 TMEM174 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 FKMLSCQLCKESEER 0.93842 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8992 0 11.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5394 14.2232 14.1802 0 0 13.1614 0 0 0 0 0 0 0 0 Q02985 FHR3_HUMAN "Complement factor H-related protein 3, FHR-3 (DOWN16) (H factor-like protein 3)" CFHR3 CFHL3 FHR3 Homo sapiens (Human) complement activation [GO:0006956] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; complement component C3b binding [GO:0001851]; complement activation [GO:0006956] GO:0001851; GO:0005615; GO:0006956; GO:0070062; GO:0072562 complement component C3b binding [GO:0001851] CGPPPPISNGDTTSFLLK 0.93843 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX77 ENK13_HUMAN "Endogenous retrovirus group K member 13-1 Env polyprotein (Envelope polyprotein) (HERV-K_16p13.3 provirus ancestral Env polyprotein) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERVK13-1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198] GO:0005198; GO:0005886; GO:0016021 structural molecule activity [GO:0005198] GHYWQDCSSK 0.93843 3.4853 0 0 0 0 0 0 0 0 11.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5288 0 0 0 0 0 0 0 0 0 0 0 0 15.5096 0 0 0 0 0 0 14.6105 0 0 0 14.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9008 0 10.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9681 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3C8 UFC1_HUMAN "Ubiquitin-fold modifier-conjugating enzyme 1, Ufm1-conjugating enzyme 1" UFC1 CGI-126 HSPC155 Homo sapiens (Human) brain development [GO:0007420]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; UFM1 conjugating enzyme activity [GO:0061657]; UFM1 transferase activity [GO:0071568]; brain development [GO:0007420]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] GO:0007420; GO:0034976; GO:0061657; GO:0061709; GO:0070062; GO:0071568; GO:0071569; GO:1990592 UFM1 conjugating enzyme activity [GO:0061657]; UFM1 transferase activity [GO:0071568] ADEATRR 0.93843 0.99113 0 0 0 0 0 0 0 12.1861 0 12.9535 12.9218 0 0 12.5462 11.3726 0 9.57826 0 0 0 0 0 0 0 0 0 0 0 12.3735 0 12.9094 0 12.3481 0 11.5047 12.2677 12.9925 12.4971 12.7814 12.9098 0 0 0 0 0 0 0 0 0 11.2123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4279 0 0 12.7173 12.9354 0 12.3297 0 0 0 0 0 0 0 0 0 12.3849 11.7489 0 13.5264 12.6114 13.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1293 12.9221 12.6645 0 0 0 0 12.5641 0 0 14.1677 0 13.5423 15.1868 0 0 0 0 0 11.3893 11.5256 0 0 14.3872 0 0 0 14.8236 11.9514 14.5367 13.4662 14.2825 12.6482 0 12.428 0 0 0 0 0 13.8904 0 0 0 0 Q5T753 LCE1E_HUMAN Late cornified envelope protein 1E (Late envelope protein 5) LCE1E LEP5 Homo sapiens (Human) keratinization [GO:0031424] identical protein binding [GO:0042802]; keratinization [GO:0031424] GO:0031424; GO:0042802 identical protein binding [GO:0042802] CPTPKCPPK 0.93844 0.94875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3F1 GP155_HUMAN Integral membrane protein GPR155 (G-protein coupled receptor PGR22) GPR155 PGR22 Homo sapiens (Human) cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; cognition [GO:0050890]; intracellular signal transduction [GO:0035556]; transmembrane transport [GO:0055085] GO:0016021; GO:0035556; GO:0050890; GO:0055085; GO:0070062 FALPALLFK 0.93844 1.0383 0 0 0 0 0 0 0 0 13.6167 0 0 0 0 16.3278 0 0 0 11.5651 0 0 0 13.1454 0 0 13.1424 0 0 0 0 0 12.9959 0 0 11.5727 15.6838 0 0 13.0422 0 0 0 11.2911 0 0 0 11.0974 0 0 0 0 0 0 0 0 0 0 0 0 11.6826 0 0 0 0 0 0 0 14.319 0 0 15.097 0 0 14.521 0 11.07 14.8612 14.172 0 13.6767 11.3164 0 0 0 0 14.6473 10.0221 14.0295 0 11.8458 14.6411 14.4119 13.5948 0 12.7373 15.2435 15.3344 0 14.0734 0 0 14.3451 0 14.1163 0 14.0326 15.2281 0 0 0 0 12.9246 14.5603 0 0 0 9.92193 0 0 0 0 0 0 14.2824 0 0 10.0388 0 15.3284 0 13.269 0 0 14.1668 0 0 9.78051 14.8167 0 13.0255 14.0861 0 0 0 12.9573 14.8655 14.1592 14.3622 0 12.8711 0 0 0 12.3392 0 0 0 14.365 0 0 0 14.4683 0 0 14.8194 14.8585 0 0 0 13.3022 14.3638 12.2088 0 14.8778 0 0 0 15.3483 0 13.0588 14.4919 K9M1U5 IFNL4_HUMAN "Interferon lambda-4, IFN-lambda-4" IFNL4 Homo sapiens (Human) cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007260; GO:0038196; GO:0045087; GO:0050778; GO:0051607; GO:0098586 cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102] DRYEEEALSWGQR 0.93845 0.99554 0 0 0 0 11.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7T2 OR2T7_HUMAN Olfactory receptor 2T7 (OST723) (olfactory receptor OR1-44) OR2T7 OR2T7P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IILIHIDSR 0.93845 0.94715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3127 0 0 0 0 P49593 PPM1F_HUMAN "Protein phosphatase 1F, EC 3.1.3.16 (Ca(2+)/calmodulin-dependent protein kinase phosphatase, CaM-kinase phosphatase, CaMKPase) (Partner of PIX 2) (Protein fem-2 homolog, hFem-2)" PPM1F KIAA0015 POPX2 Homo sapiens (Human) "cellular response to xenobiotic stimulus [GO:0071466]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]; regulation of protein localization [GO:0032880]" cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to xenobiotic stimulus [GO:0071466]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470]; regulation of protein localization [GO:0032880]" GO:0004722; GO:0005634; GO:0005829; GO:0006469; GO:0006470; GO:0008138; GO:0010628; GO:0010634; GO:0010811; GO:0017018; GO:0030335; GO:0032880; GO:0032991; GO:0033137; GO:0033192; GO:0035970; GO:0043280; GO:0044387; GO:0045892; GO:0045927; GO:0046872; GO:0048471; GO:0050921; GO:0051224; GO:0051496; GO:0051894; GO:0070262; GO:0071466; GO:0097193; GO:2000048 calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] EEEEEEEDDDEEEK 0.93845 0.93495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3422 0 0 0 0 0 0 0 0 0 11.8383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0397 0 0 0 11.7761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2256 11.3777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0085 0 0 0 0 0 0 0 0 12.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63027 VAMP2_HUMAN "Vesicle-associated membrane protein 2, VAMP-2 (Synaptobrevin-2)" VAMP2 SYB2 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; long-term synaptic potentiation [GO:0060291]; membrane fusion [GO:0061025]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; regulation of vesicle-mediated transport [GO:0060627]; response to glucose [GO:0009749]; SNARE complex assembly [GO:0035493]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; zymogen granule membrane [GO:0042589] anchoring junction [GO:0070161]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; phospholipid binding [GO:0005543]; protein self-association [GO:0043621]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to insulin stimulus [GO:0032869]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; long-term synaptic potentiation [GO:0060291]; membrane fusion [GO:0061025]; positive regulation of intracellular protein transport [GO:0090316]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of exocytosis [GO:0017157]; regulation of vesicle-mediated transport [GO:0060627]; response to glucose [GO:0009749]; SNARE complex assembly [GO:0035493]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0005484; GO:0005516; GO:0005543; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006887; GO:0006906; GO:0008021; GO:0009749; GO:0015031; GO:0016020; GO:0016079; GO:0016192; GO:0017075; GO:0017156; GO:0017157; GO:0019905; GO:0030136; GO:0030141; GO:0030667; GO:0030669; GO:0030672; GO:0031201; GO:0031410; GO:0031982; GO:0032869; GO:0035493; GO:0042589; GO:0043001; GO:0043005; GO:0043231; GO:0043308; GO:0043621; GO:0044306; GO:0045202; GO:0048306; GO:0048471; GO:0048488; GO:0060203; GO:0060291; GO:0060627; GO:0061025; GO:0061202; GO:0065003; GO:0070032; GO:0070033; GO:0070044; GO:0070083; GO:0070161; GO:0090316; GO:1902259 calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; phospholipid binding [GO:0005543]; protein self-association [GO:0043621]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] MMIILGVICAIILIIIIVYFST 0.93845 1.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SQH8 CF136_HUMAN Uncharacterized protein C6orf136 C6orf136 Homo sapiens (Human) LGPCLRAYQAR 0.93845 1.717 0 0 0 0 0 0 0 0 11.8225 0 0 0 0 0 13.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8661 14.474 0 0 0 0 0 0 0 0 0 0 13.1521 0 0 0 0 0 0 0 0 0 0 0 13.537 0 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3735 0 0 0 13.8567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0K0K1G6 TVBJ3_HUMAN T cell receptor beta variable 10-3 TRBV10-3 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 CHQTENHRYMYWYR 0.93846 0.93327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0449 0 0 10.7095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.832 0 13.3365 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6309 0 0 0 0 0 0 0 0 0 0 12.8829 12.625 13.5664 0 0 13.9573 13.9351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVZ9 KBTB7_HUMAN Kelch repeat and BTB domain-containing protein 7 KBTBD7 Homo sapiens (Human) negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleus [GO:0005634] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020] GO:0005634; GO:0005829; GO:0009968; GO:0031463; GO:0035020; GO:0043161; GO:0070936 DPITGVKLK 0.93846 2.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3929 12.9747 13.1219 0 0 0 0 11.4108 0 0 0 0 0 0 0 0 0 0 0 0 14.3894 14.0797 0 0 0 0 0 0 0 0 0 0 0 15.0464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5511 0 0 0 0 0 0 0 0 0 0 0 13.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1455 0 0 0 0 0 0 Q0P6H9 TMM62_HUMAN Transmembrane protein 62 TMEM62 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787] GO:0016021; GO:0016787 hydrolase activity [GO:0016787] AAVLALRVVAGLAAAALVAMLLEHYGLAGQPSPLPR 0.93847 0.92337 0 0 0 0 11.5332 0 0 0 12.7182 0 0 12.759 0 0 12.3686 0 13.1352 0 0 0 0 0 0 0 0 0 0 0 12.46 0 0 0 0 12.1854 0 13.1735 13.1729 13.1047 0 0 12.4467 0 0 12.9456 12.8917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9743 0 0 0 0 0 11.1991 0 0 0 0 0 0 0 0 0 0 10.8492 0 13.4029 0 0 0 0 0 0 12.6612 0 0 0 0 0 0 0 0 0 0 0 0 13.9332 13.2688 0 14.1267 14.4246 13.8548 14.1392 14.5266 14.8809 0 15.4406 13.7677 13.2138 0 0 0 0 16.3307 0 0 0 0 0 Q7L775 EPMIP_HUMAN EPM2A-interacting protein 1 (Laforin-interacting protein) EPM2AIP1 KIAA0766 My007 Homo sapiens (Human) glycogen biosynthetic process [GO:0005978]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; glycogen biosynthetic process [GO:0005978]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868] GO:0005634; GO:0005978; GO:0032868; GO:0042802; GO:0045725; GO:0098554; GO:2000467 identical protein binding [GO:0042802] AARAGLGLCR 0.93847 0.99519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0448 0 0 0 0 0 0 12.7979 0 0 18.0822 0 18.0901 0 0 0 0 11.4178 0 0 0 0 0 0 12.7835 0 13.8527 0 0 0 0 0 0 15.3967 0 14.4761 0 14.178 0 0 0 0 0 0 0 0 0 0 0 0 12.7145 0 0 0 13.7039 13.3883 0 0 0 0 0 0 12.7687 0 0 0 0 13.2978 0 0 0 13.6938 0 0 12.3131 0 0 0 0 0 0 0 0 0 0 12.5448 0 0 0 0 0 0 0 0 12.9586 0 0 14.7403 0 0 0 0 0 0 0 0 O60936 NOL3_HUMAN "Nucleolar protein 3 (Apoptosis repressor with CARD) (Muscle-enriched cytoplasmic protein, Myp) (Nucleolar protein of 30 kDa, Nop30)" NOL3 ARC NOP Homo sapiens (Human) blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; intrinsic apoptotic signaling pathway [GO:0097193]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein complex oligomerization [GO:0051259]; regulation of NIK/NF-kappaB signaling [GO:1901222]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to hypoxia [GO:0001666]; response to injury involved in regulation of muscle adaptation [GO:0014876]; response to ischemia [GO:0002931]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; sarcoplasmic reticulum [GO:0016529] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; intrinsic apoptotic signaling pathway [GO:0097193]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein complex oligomerization [GO:0051259]; regulation of NIK/NF-kappaB signaling [GO:1901222]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to hypoxia [GO:0001666]; response to injury involved in regulation of muscle adaptation [GO:0014876]; response to ischemia [GO:0002931]; RNA splicing [GO:0008380] GO:0001666; GO:0001974; GO:0002931; GO:0003723; GO:0005123; GO:0005509; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006376; GO:0008380; GO:0010659; GO:0010667; GO:0010804; GO:0014736; GO:0014808; GO:0014876; GO:0016020; GO:0016529; GO:0035877; GO:0042802; GO:0043027; GO:0043066; GO:0051259; GO:0060547; GO:0089720; GO:0090201; GO:0097193; GO:1901222; GO:1902109; GO:1902176; GO:1903298; GO:1990001; GO:2001237; GO:2001243 calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] LLLLVQGKGEAACQELLRCAQR 0.93848 0.94674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T2T1 MPP7_HUMAN MAGUK p55 subfamily member 7 MPP7 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591]; bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896] GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0016328; GO:0019904; GO:0030010; GO:0030054; GO:0031334; GO:0035591; GO:0045296; GO:0060090; GO:0070830; GO:0071896; GO:0097025 cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591] ELLKLLSK 0.93848 0.99011 0 0 0 0 0 0 0 0 0 12.4978 0 12.1211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9284 0 0 0 11.5261 0 0 0 11.8256 0 0 12.3149 0 0 0 0 0 0 0 0 11.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3068 0 0 13.7009 0 0 0 0 0 0 0 0 13.2351 13.3738 0 13.7576 0 13.0974 13.1915 0 0 11.0129 0 0 0 0 0 0 0 0 0 0 0 0 11.4703 0 0 0 13.3464 13.9063 13.2581 13.4419 0 0 14.4585 0 0 0 0 0 0 0 0 13.5098 0 0 0 0 0 0 14.9901 0 0 0 14.5259 13.34 14.0435 12.7347 0 13.0553 0 19.5914 0 0 10.5853 11.6329 0 0 0 0 0 0 0 0 10.8554 0 0 0 12.5803 11.5592 0 0 0 0 0 11.8158 0 0 0 0 12.6875 0 0 0 Q8WXS5 CCG8_HUMAN "Voltage-dependent calcium channel gamma-8 subunit (Neuronal voltage-gated calcium channel gamma-8 subunit) (Transmembrane AMPAR regulatory protein gamma-8, TARP gamma-8)" CACNG8 CACNG6 Homo sapiens (Human) "calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]" AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891] "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; endocytic vesicle membrane [GO:0030666]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]" GO:0005245; GO:0005246; GO:0005886; GO:0005891; GO:0006816; GO:0014069; GO:0016247; GO:0019226; GO:0030666; GO:0032281; GO:0051968; GO:0070161; GO:0098839; GO:0098943; GO:0098970; GO:0099590; GO:1990454; GO:2000311 calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245] AGGGAGGSGGSGPSAILRLPSYRFR 0.93848 1.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1839 0 0 0 0 0 0 Q96IJ6 GMPPA_HUMAN "Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A, GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)" GMPPA Homo sapiens (Human) biosynthetic process [GO:0009058] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058] GO:0005737; GO:0009058; GO:0016779; GO:0070062 nucleotidyltransferase activity [GO:0016779] IPAEVLILNSIVLPHKELSR 0.93848 1.7165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3307 0 P19875 CXCL2_HUMAN "C-X-C motif chemokine 2 (Growth-regulated protein beta, Gro-beta) (Macrophage inflammatory protein 2-alpha, MIP2-alpha) [Cleaved into: GRO-beta(5-73) (GRO-beta-T) (Hematopoietic synergistic factor, HSF) (SB-251353) ]" CXCL2 GRO2 GROB MIP2A SCYB2 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; response to molecule of bacterial origin [GO:0002237] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; response to molecule of bacterial origin [GO:0002237] GO:0002237; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0008009; GO:0030593; GO:0031640; GO:0045236; GO:0061844; GO:0070098; GO:0071222 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236] LLRVALLLLLLVAASR 0.9385 1.0409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7185 13.6976 0 0 0 13.7122 13.7528 13.6708 0 13.1511 0 0 0 0 0 0 0 0 12.9612 0 0 0 13.5302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4KMG0 CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes CDON CDO Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; embryonic body morphogenesis [GO:0010172]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; lens development in camera-type eye [GO:0002088]; myoblast fusion [GO:0007520]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of protein binding [GO:0043393]; skeletal muscle satellite cell differentiation [GO:0014816]; smoothened signaling pathway [GO:0007224] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anterior/posterior pattern specification [GO:0009952]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; embryonic body morphogenesis [GO:0010172]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; lens development in camera-type eye [GO:0002088]; myoblast fusion [GO:0007520]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of protein binding [GO:0043393]; skeletal muscle satellite cell differentiation [GO:0014816]; smoothened signaling pathway [GO:0007224] GO:0001708; GO:0001934; GO:0002088; GO:0005886; GO:0005887; GO:0006468; GO:0007155; GO:0007224; GO:0007399; GO:0007520; GO:0009952; GO:0010172; GO:0014816; GO:0021987; GO:0030182; GO:0043393; GO:0043410; GO:0045663; GO:0045666; GO:0045944; GO:0048643; GO:0051057; GO:0060059; GO:0061351; GO:0098609; GO:2000179 IPDHLQLAK 0.9385 0.99408 0 0 0 0 0 0 0 0 0 12.6936 0 12.2055 12.0989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6727 0 9.59059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1863 0 0 0 0 0 0 0 0 12.8502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8822 0 0 16.3217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9776 0 0 0 0 O00241 SIRB1_HUMAN "Signal-regulatory protein beta-1, SIRP-beta-1 (CD172 antigen-like family member B) (CD antigen CD172b)" SIRPB1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T cell activation [GO:0050870]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T cell activation [GO:0050870]; signal transduction [GO:0007165] GO:0005886; GO:0005887; GO:0007165; GO:0007166; GO:0009986; GO:0030667; GO:0050766; GO:0050870 SGAGTELSVRAKPSAPVVSGPAVR 0.93853 0.98481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NNH2 F90AR_HUMAN Protein FAM90A27P FAM90A27P Homo sapiens (Human) EPAEDCLFLRHPTMPLPVHTTKK 0.93854 0.99324 0 0 0 0 0 0 0 0 0 14.2427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1957 0 0 0 0 13.8311 0 0 0 0 0 0 0 0 13.2286 0 0 0 0 0 0 13.6821 0 13.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.19 0 0 0 0 14.9347 0 0 14.5333 0 0 0 0 0 0 0 0 0 0 0 0 Q3ZCQ2 AX2R_HUMAN "Annexin-2 receptor (Annexin II receptor, AXIIR)" ANXA2R AX2R C5orf39 Homo sapiens (Human) signaling receptor activity [GO:0038023] GO:0038023 signaling receptor activity [GO:0038023] RHPPALQPWRHLPGFSDCLEWILR 0.93854 0.98481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUZ5 AT2L2_HUMAN "5-phosphohydroxy-L-lysine phospho-lyase, EC 4.2.3.134 (Alanine--glyoxylate aminotransferase 2-like 2)" PHYKPL AGXT2L2 PP9286 Homo sapiens (Human) mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] GO:0005759; GO:0008483; GO:0016829; GO:0030170; GO:0042802 identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] IKHPIVGDVRGVGLFIGVDLIK 0.93854 0.93014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCH3 CPNE5_HUMAN Copine-5 (Copine V) CPNE5 KIAA1599 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] GO:0005544; GO:0005886; GO:0030154; GO:0043005; GO:0043204; GO:0046872; GO:0070062; GO:0071277; GO:1903861 calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] DFFGKSDPFLVFYR 0.93854 1.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.595 0 0 0 0 0 0 0 0 0 Q9BXK1 KLF16_HUMAN "Krueppel-like factor 16 (Basic transcription element-binding protein 4, BTE-binding protein 4) (Novel Sp1-like zinc finger transcription factor 2) (Transcription factor BTEB4) (Transcription factor NSLP2)" KLF16 BTEB4 NSLP2 Homo sapiens (Human) dopamine receptor signaling pathway [GO:0007212]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; dopamine receptor signaling pathway [GO:0007212]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007212; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" PFACDWQGCDK 0.93857 1.7813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGN4 PRA25_HUMAN PRAME family member 25 PRAMEF25 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 AELMKRVR 0.93859 0.99688 0 0 0 0 0 0 0 0 0 10.8039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXK5 LRRN1_HUMAN "Leucine-rich repeat neuronal protein 1 (Neuronal leucine-rich repeat protein 1, NLRR-1)" LRRN1 KIAA1497 Nbla10449 UNQ693/PRO1338 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965] GO:0005615; GO:0016021; GO:0031012; GO:0051965 LVKVPQLALQKVPNLK 0.93859 0.92885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.316 0 0 11.835 0 0 0 0 0 0 0 0 0 0 0 0 13.2576 0 0 0 0 0 0 0 0 0 0 0 0 15.7691 0 0 0 0 0 0 0 0 0 0 0 13.5569 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.324 0 0 0 Q8TCH9 YV004_HUMAN Putative uncharacterized protein FLJ23865 Homo sapiens (Human) LVLPPPPQVLPLLSPARGRIQFSGR 0.9386 0.99118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48060 GLIP1_HUMAN "Glioma pathogenesis-related protein 1, GliPR 1 (Protein RTVP-1)" GLIPR1 GLIPR RTVP1 Homo sapiens (Human) azurophil granule membrane [GO:0035577]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] GO:0005615; GO:0005886; GO:0016020; GO:0016021; GO:0035577 AWASNCQFSHNTR 0.93863 1.7708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3669 0 12.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50402 EMD_HUMAN Emerin EMD EDMD STA Homo sapiens (Human) cellular response to growth factor stimulus [GO:0071363]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast proliferation [GO:0048147]; nuclear membrane organization [GO:0071763]; positive regulation of protein export from nucleus [GO:0046827]; regulation of canonical Wnt signaling pathway [GO:0060828]; skeletal muscle cell differentiation [GO:0035914] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; spindle [GO:0005819] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; actin binding [GO:0003779]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; cellular response to growth factor stimulus [GO:0071363]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast proliferation [GO:0048147]; nuclear membrane organization [GO:0071763]; positive regulation of protein export from nucleus [GO:0046827]; regulation of canonical Wnt signaling pathway [GO:0060828]; skeletal muscle cell differentiation [GO:0035914] GO:0003779; GO:0005635; GO:0005637; GO:0005640; GO:0005654; GO:0005737; GO:0005783; GO:0005819; GO:0005829; GO:0005874; GO:0006936; GO:0007517; GO:0016020; GO:0016021; GO:0031965; GO:0035914; GO:0045296; GO:0046827; GO:0048147; GO:0048487; GO:0060828; GO:0071363; GO:0071763; GO:0090090 actin binding [GO:0003779]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296] ERPMYGRDSAYQSITHYR 0.93863 0.98695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2781 0 0 0 0 0 13.1012 0 0 0 0 0 0 0 0 0 0 0 11.4185 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGS1 OR1J4_HUMAN Olfactory receptor 1J4 (HTPCRX01) (Olfactory receptor OR9-21) OR1J4 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GALERLFNRATVLSQ 0.93863 0.99688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H147 TDIF1_HUMAN "Deoxynucleotidyltransferase terminal-interacting protein 1 (Terminal deoxynucleotidyltransferase-interacting factor 1, TdIF1, TdT-interacting factor 1)" DNTTIP1 C20orf167 TDIF1 Homo sapiens (Human) chromosome [GO:0005694]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803] GO:0000118; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0031491; GO:0042803 DNA binding [GO:0003677]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803] GPSGAER 0.93863 2.5196 0 0 0 0 12.726 0 0 0 13.1103 0 0 0 0 0 0 14.0604 0 0 13.9912 13.952 0 0 0 0 0 13.8684 14.2609 0 14.1198 14.0719 13.9787 0 0 0 0 0 0 0 0 0 13.5025 0 0 0 13.5013 0 11.2377 13.8637 12.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0153 0 0 0 0 0 0 0 0 13.1109 0 0 12.75 12.8506 0 0 0 0 12.9179 0 0 15.7416 0 0 0 15.4922 14.2987 0 18.4296 0 0 0 0 0 0 0 15.012 0 0 12.6022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4358 15.6707 13.4814 18.9817 0 0 14.9126 0 0 0 13.7929 0 0 0 12.2585 12.275 0 0 0 0 14.1759 15.5332 0 14.3228 12.9529 12.1633 0 13.8277 0 0 14.2884 13.2568 12.8219 13.1438 15.2327 19.3742 15.247 0 13.3153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.239 0 13.5126 0 0 0 0 0 Q9P0J7 KCMF1_HUMAN "E3 ubiquitin-protein ligase KCMF1, EC 2.3.2.27 (FGF-induced in gastric cancer) (Potassium channel modulatory factor, PCMF) (RING-type E3 ubiquitin transferase KCMF1) (ZZ-type zinc finger-containing protein 1)" KCMF1 FIGC ZZZ1 Homo sapiens (Human) synaptic signaling [GO:0099536] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; synaptic signaling [GO:0099536] GO:0005576; GO:0005829; GO:0005886; GO:0008270; GO:0045202; GO:0061630; GO:0099536; GO:1904813 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] HEGVSCDACLK 0.93863 3.442 0 0 0 0 0 0 0 0 0 0 12.8171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6821 0 0 12.4748 14.3233 0 13.2203 12.6775 0 0 12.9045 12.7938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16600 ZN239_HUMAN Zinc finger protein 239 (Zinc finger protein HOK-2) (Zinc finger protein MOK-2) ZNF239 HOK2 MOK2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003723; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GFTRSSSLLIHHAVHTGEKPYK 0.93864 1.7147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.43277 0 0 0 0 0 0 14.7531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0092 0 0 0 0 13.0001 0 16.8991 0 0 0 0 0 0 0 0 0 0 0 0 15.055 0 0 0 0 0 0 0 0 0 0 16.6403 0 14.913 15.0489 0 0 0 0 0 0 0 0 0 0 12.0692 0 0 0 0 0 16.6381 0 16.0635 0 0 0 0 0 0 0 0 0 0 0 0 12.9929 0 0 0 0 0 0 0 0 14.1599 0 0 0 0 0 0 13.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51148 RAB5C_HUMAN "Ras-related protein Rab-5C, EC 3.6.5.2 (L1880) (RAB5L)" RAB5C RABL Homo sapiens (Human) endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100] azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; regulation of endocytosis [GO:0030100] GO:0003924; GO:0003925; GO:0005525; GO:0005765; GO:0005768; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0019003; GO:0030100; GO:0030139; GO:0031901; GO:0035577; GO:0042470; GO:0048227; GO:0070062 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] LVLLGESAVGKSSLVLR 0.93865 0.9862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2207 0 0 0 13.8837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DV60 LCE7A_HUMAN Late cornified envelope protein 7A LCE7A Homo sapiens (Human) keratinization [GO:0031424] keratinization [GO:0031424] GO:0031424 CSTCYSSGDCS 0.93866 1.7688 0 0 0 0 0 0 0 0 0 12.5066 12.2329 0 0 0 13.1893 0 0 10.7379 0 0 0 0 0 0 0 0 0 0 0 10.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2438 14.9755 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70039 0 0 0 11.0506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9482 0 0 10.2853 0 0 0 0 0 0 12.1212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2815 P59538 T2R31_HUMAN "Taste receptor type 2 member 31, T2R31 (Taste receptor type 2 member 44, T2R44) (Taste receptor type 2 member 53, T2R53)" TAS2R31 TAS2R44 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] FSYPSIHPFILIWGNKKLK 0.93866 0.99687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7929 0 0 0 0 13.1833 13.4659 0 0 0 0 12.3694 0 0 0 0 12.8737 0 12.9629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMS0 NFU1_HUMAN "NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)" NFU1 HIRIP5 CGI-33 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]" GO:0005506; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016226; GO:0051539; GO:0097428 "4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]" FIPGKPVLETR 0.93867 1.7137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A597 TVB55_HUMAN T cell receptor beta variable 5-5 TRBV5-5 TCRBV5S3A2T Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 MGPGLLCWVLLCLLGAGPVDAGVTQSPTHLIKTRGQQVTLR 0.93868 0.98175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1298 0 0 12.9482 11.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV31 TM139_HUMAN Transmembrane protein 139 TMEM139 UNQ1932/PRO4407 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PLLLLCCASFLLGLALLGIK 0.93868 0.94889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17931 LEG3_HUMAN "Galectin-3, Gal-3 (35 kDa lectin) (Carbohydrate-binding protein 35, CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein, GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen)" LGALS3 MAC2 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380] GO:0001772; GO:0002548; GO:0003723; GO:0004864; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005743; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0009986; GO:0016020; GO:0019863; GO:0019903; GO:0030246; GO:0030593; GO:0030667; GO:0030855; GO:0031334; GO:0031640; GO:0042056; GO:0042129; GO:0043236; GO:0045087; GO:0045806; GO:0048245; GO:0048246; GO:0050860; GO:0050918; GO:0061844; GO:0062023; GO:0070062; GO:0070232; GO:0070492; GO:0071674; GO:0071677; GO:0090280; GO:0101003; GO:1902041; GO:1903078; GO:1903614; GO:2000521; GO:2001189; GO:2001237 carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723] IALDFQRGNDVAFHFNPRFNENNR 0.93869 0.93555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5512 0 0 0 0 0 0 0 0 0 0 0 14.1282 14.3755 0 0 0 0 13.0711 0 0 0 0 14.05 0 17.3044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5628 11.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02080 MEF2B_HUMAN Myocyte-specific enhancer factor 2B (RSRFR2) (Serum response factor-like protein 2) MEF2B XMEF2 Homo sapiens (Human) cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0007517; GO:0030054; GO:0030154; GO:0042826; GO:0045944; GO:0046983; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" KIQISRILDQR 0.9387 1.8182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6988 11.8881 12.9122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Y0 NS1BP_HUMAN "Influenza virus NS1A-binding protein, NS1-BP, NS1-binding protein (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39)" IVNS1ABP ARA3 FLARA3 KIAA0850 KLHL39 NS1 NS1BP HSPC068 Homo sapiens (Human) intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383] GO:0005654; GO:0005667; GO:0005681; GO:0005829; GO:0005856; GO:0006383; GO:0008380; GO:0009615; GO:0031397; GO:0097193; GO:2001243 AVLACCSPYLFEIFNSDSDPHGISHVK 0.9387 1.7131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06744 G6PI_HUMAN "Glucose-6-phosphate isomerase, GPI, EC 5.3.1.9 (Autocrine motility factor, AMF) (Neuroleukin, NLK) (Phosphoglucose isomerase, PGI) (Phosphohexose isomerase, PHI) (Sperm antigen 36, SA-36)" GPI Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574] ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; carbohydrate derivative binding [GO:0097367]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574] GO:0001701; GO:0001707; GO:0002639; GO:0004347; GO:0005125; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0006094; GO:0006096; GO:0006959; GO:0007599; GO:0007611; GO:0008083; GO:0010595; GO:0016020; GO:0031625; GO:0032355; GO:0032570; GO:0033574; GO:0034101; GO:0034774; GO:0035902; GO:0035994; GO:0042593; GO:0043005; GO:0043154; GO:0043278; GO:0043524; GO:0046686; GO:0048029; GO:0051156; GO:0060170; GO:0070062; GO:0097367; GO:1904813 carbohydrate derivative binding [GO:0097367]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625] ILLANFLAQTEALMR 0.93871 0.99559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8292 0 0 0 0 13.0399 0 13.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 13.04 0 0 0 0 0 0 0 0 13.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6496 0 0 0 0 0 0 12.1654 0 0 0 0 0 0 12.2936 0 0 0 0 0 0 0 0 12.4107 13.939 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3713 0 0 0 0 0 0 13.4723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PH6 DB118_HUMAN "Defensin beta 118 (Beta-defensin 18, DEFB-18) (Epididymal secretory protein 13.6, ESP13.6)" DEFB118 C20orf63 DEFB18 ESC42 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-matrix adhesion [GO:0007160]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation of cell adhesion [GO:0007162]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; spermatogenesis [GO:0007283] extracellular region [GO:0005576] extracellular region [GO:0005576]; lipopolysaccharide binding [GO:0001530]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-matrix adhesion [GO:0007160]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation of cell adhesion [GO:0007162]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; spermatogenesis [GO:0007283] GO:0001530; GO:0005576; GO:0007160; GO:0007162; GO:0007283; GO:0031640; GO:0031665; GO:0042742; GO:0045087; GO:0050829; GO:0050830; GO:0051673; GO:0061844 lipopolysaccharide binding [GO:0001530] KCWNRSGHCR 0.93871 1.0386 0 0 11.5071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0646 0 0 0 0 0 0 15.0161 15.0401 0 0 15.0168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7128 0 0 11.8136 0 0 0 11.178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAA6 CO053_HUMAN Putative uncharacterized protein encoded by LINC02694 LINC02694 C15orf53 Homo sapiens (Human) CVCGGCYLGKSTR 0.93872 0.92339 0 12.3468 0 0 0 0 0 11.1383 0 11.9527 9.84138 0 0 0 0 0 0 0 0 0 0 18.4616 0 18.4881 0 0 0 0 0 0 0 10.2776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7757 0 0 10.8647 0 0 0 0 0 10.3961 13.7545 0 14.3169 14.5306 0 0 0 0 0 0 0 0 0 0 19.55 0 19.6533 19.689 19.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.589 0 0 0 0 12.5858 12.5639 0 0 19.503 0 0 12.879 13.0529 12.9301 0 12.6574 19.5153 0 0 0 0 19.5592 19.547 13.4741 19.5036 0 19.5205 0 0 19.5174 0 19.589 0 0 0 0 0 0 0 0 12.4263 0 0 0 13.3224 0 0 0 12.2974 0 0 11.823 0 13.3571 0 11.83 0 0 0 0 0 0 0 0 0 11.9999 0 0 0 0 0 0 12.6845 0 0 0 0 0 P25311 ZA2G_HUMAN "Zinc-alpha-2-glycoprotein, Zn-alpha-2-GP, Zn-alpha-2-glycoprotein" AZGP1 ZAG ZNGP1 Homo sapiens (Human) antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; cell adhesion [GO:0007155]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of cell population proliferation [GO:0008285]; retina homeostasis [GO:0001895] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein transmembrane transporter activity [GO:0008320]; ribonuclease activity [GO:0004540]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; cell adhesion [GO:0007155]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of cell population proliferation [GO:0008285]; retina homeostasis [GO:0001895] GO:0001580; GO:0001895; GO:0002476; GO:0004540; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0008285; GO:0008320; GO:0009897; GO:0062023; GO:0070062 protein transmembrane transporter activity [GO:0008320]; ribonuclease activity [GO:0004540] MVPVLLSLLLLLGPAVPQENQDGR 0.93873 1.7126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3106 0 0 11.9832 0 14.9132 0 15.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30203 CD6_HUMAN T-cell differentiation antigen CD6 (T12) (TP120) (CD antigen CD6) [Cleaved into: Soluble CD6 ] CD6 Homo sapiens (Human) acute inflammatory response to antigenic stimulus [GO:0002438]; adaptive immune response [GO:0002250]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immunological synapse formation [GO:0001771]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell proliferation [GO:0042102]; response to lipopolysaccharide [GO:0032496] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; spanning component of plasma membrane [GO:0044214] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; spanning component of plasma membrane [GO:0044214]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; protein kinase binding [GO:0019901]; scavenger receptor activity [GO:0005044]; acute inflammatory response to antigenic stimulus [GO:0002438]; adaptive immune response [GO:0002250]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immunological synapse formation [GO:0001771]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell proliferation [GO:0042102]; response to lipopolysaccharide [GO:0032496] GO:0001530; GO:0001771; GO:0001772; GO:0001934; GO:0002250; GO:0002438; GO:0005044; GO:0005576; GO:0005887; GO:0007157; GO:0009897; GO:0019901; GO:0031226; GO:0031663; GO:0032496; GO:0042102; GO:0042802; GO:0044214; GO:0045087; GO:0070891; GO:1900017 identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; protein kinase binding [GO:0019901]; scavenger receptor activity [GO:0005044] ELMLLIPSIVLGILLLGSLIFIAFILLR 0.93873 0.94711 0 0 0 0 0 10.3057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9365 13.2903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2376 10.8865 12.7942 0 11.9459 11.9508 0 12.7685 0 0 0 14.5137 0 0 12.7116 0 0 11.1951 12.1325 0 0 0 0 0 13.5646 0 11.8075 0 15.1067 14.3703 15.5776 0 15.3594 13.7993 0 0 0 0 0 0 14.2379 0 0 0 12.7231 0 0 0 12.2423 0 0 13.6219 0 0 0 0 0 0 14.0661 0 0 0 0 13.3371 0 11.903 0 0 0 13.68 12.6403 0 0 0 0 12.4378 12.9832 12.589 0 0 0 0 0 0 0 12.108 13.6299 0 0 14.9911 0 0 0 14.7395 0 0 0 0 0 14.592 11.2074 0 0 0 0 0 0 0 13.9971 11.1239 0 0 11.7461 0 A5PLL1 AN34B_HUMAN Ankyrin repeat domain-containing protein 34B ANKRD34B Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 AKGKEVIIITTAK 0.93874 0.99034 12.9303 0 0 0 10.166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7603 0 0 0 0 0 0 0 15.8163 0 0 0 0 0 0 0 0 0 14.2628 0 13.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3001 0 0 12.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2876 0 0 0 0 0 0 0 0 0 0 0 0 17.2968 17.278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0505 0 Q6UWF9 F180A_HUMAN Protein FAM180A FAM180A UNQ1940/PRO4423 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MHWKMLLLLLLYYNAEASMCHRWSR 0.93874 0.91336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYZ8 REG4_HUMAN "Regenerating islet-derived protein 4, REG-4 (Gastrointestinal secretory protein) (REG-like protein) (Regenerating islet-derived protein IV, Reg IV)" REG4 GISP RELP Homo sapiens (Human) response to bacterium [GO:0009617] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; mannan binding [GO:2001065]; signaling receptor activity [GO:0038023]; response to bacterium [GO:0009617] GO:0005576; GO:0005737; GO:0008201; GO:0009617; GO:0038023; GO:2001065 heparin binding [GO:0008201]; mannan binding [GO:2001065]; signaling receptor activity [GO:0038023] ASRSMRLLLLLSCLAK 0.93874 2.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3412 12.5566 11.8505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2561 12.8931 0 0 0 0 13.0265 0 0 12.9384 0 0 0 0 0 0 13.8939 0 12.9284 13.1798 13.64 12.9223 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75771 RA51D_HUMAN DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD) RAD51D RAD51L3 Homo sapiens (Human) DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; strand invasion [GO:0042148]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]" GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007131; GO:0008094; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051726; GO:0140664 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]" MGVLRVGLCPGLTEEMIQLLRSHR 0.93875 1.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3378 0 0 0 0 0 0 0 0 0 0 Q8TBR7 TLC3A_HUMAN TLC domain-containing protein 3A (Protein CT120) (Protein FAM57A) TLCD3A FAM57A Homo sapiens (Human) lipid homeostasis [GO:0055088] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid homeostasis [GO:0055088] GO:0005783; GO:0005886; GO:0016021; GO:0055088 ILLFPFMYWSYGR 0.93876 0.99423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8398 0 0 0 0 0 0 0 0 0 0 0 0 14.4402 14.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00519 FAAH1_HUMAN "Fatty-acid amide hydrolase 1, EC 3.5.1.99 (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase, EC 3.1.1.-) (Oleamide hydrolase 1)" FAAH FAAH1 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907] cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090] cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; identical protein binding [GO:0042802]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; fatty acid catabolic process [GO:0009062]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907] GO:0004040; GO:0005543; GO:0005789; GO:0005856; GO:0009062; GO:0016021; GO:0017064; GO:0019369; GO:0031090; GO:0042802; GO:0045907; GO:0047372; GO:0052651; GO:0102077; GO:0103073 acylglycerol lipase activity [GO:0047372]; amidase activity [GO:0004040]; anandamide amidohydrolase activity [GO:0103073]; fatty acid amide hydrolase activity [GO:0017064]; identical protein binding [GO:0042802]; oleamide hydrolase activity [GO:0102077]; phospholipid binding [GO:0005543] EVERLMTPEKQSS 0.93879 0.9933 0 0 0 0 0 0 0 0 0 13.8241 0 0 0 0 0 0 0 0 0 0 0 0 0 16.164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1565 0 0 0 0 0 0 0 14.9028 0 0 0 0 0 0 12.1614 0 0 0 0 0 14.0752 0 0 0 0 0 12.589 13.63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.25096 0 0 0 0 0 13.2028 11.6852 0 0 0 0 0 0 0 0 0 0 11.641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5389 0 0 0 0 0 0 0 0 0 13.7839 0 0 11.258 0 0 0 0 0 0 11.1662 0 0 Q9H9B4 SFXN1_HUMAN Sideroflexin-1 SFXN1 Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-alanine transport [GO:0015808]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; L-alanine transmembrane transporter activity [GO:0015180]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-alanine transport [GO:0015808]; L-serine transport [GO:0015825]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300] GO:0005739; GO:0006730; GO:0006826; GO:0015180; GO:0015194; GO:0015808; GO:0015825; GO:0022857; GO:0022889; GO:0030218; GO:0031305; GO:0140300; GO:1990542 L-alanine transmembrane transporter activity [GO:0015180]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857] ELKVGIPVTDENGNRLGESANAAK 0.93879 1.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0N7 F229B_HUMAN Protein FAM229B FAM229B C6orf225 Homo sapiens (Human) RCPGSHCLTITDVPVTVYATTR 0.9388 1.037 0 0 0 0 0 0 0 0 0 0 0 12.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2811 0 0 0 0 0 13.8159 0 12.7767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3285 0 0 0 0 0 0 Q5VZR4 MF14C_HUMAN Hippocampus abundant transcript-like protein 2 (Major facilitator superfamily domain-containing 14C) MFSD14C HIATL2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] GLLSFLSAPLIGALSDVWGRK 0.93881 1.6797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86Y91 KI18B_HUMAN Kinesin-like protein KIF18B KIF18B Homo sapiens (Human) cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302] astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] astral microtubule [GO:0000235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule end [GO:1990752]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of cell division [GO:0051302] GO:0000070; GO:0000235; GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0008574; GO:0016604; GO:0016887; GO:0019894; GO:0035371; GO:0051301; GO:0051302; GO:0061673; GO:1990023; GO:1990752 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] AKEIRLSLK 0.93881 3.3841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6689 0 0 0 0 10.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8088 0 11.0183 12.0525 13.5663 13.0212 13.3707 12.3773 0 13.3048 11.9432 13.1636 0 0 0 0 12.7083 11.3674 12.028 0 0 0 0 12.6327 0 14.3231 0 0 0 0 0 0 0 0 0 0 0 0 14.5815 0 0 0 0 0 0 12.6456 0 0 12.9053 0 0 0 12.1089 0 0 12.1701 0 0 0 0 0 13.7021 0 0 0 0 0 11.9638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9576 0 0 0 0 13.3824 12.6462 0 0 0 0 0 0 0 0 13.5201 13.3508 0 10.2755 0 0 0 0 10.8144 Q15750 TAB1_HUMAN "TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1, TAK1-binding protein 1)" TAB1 MAP3K7IP1 Homo sapiens (Human) aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; kinase activator activity [GO:0019209]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001701; GO:0003007; GO:0003279; GO:0004722; GO:0005634; GO:0005829; GO:0007179; GO:0008047; GO:0010008; GO:0016607; GO:0019209; GO:0030324; GO:0032991; GO:0035904; GO:0043406; GO:0044877; GO:0048273; GO:0060976; GO:0071902 enzyme activator activity [GO:0008047]; kinase activator activity [GO:0019209]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877] ARFCPRHEDMTLLVR 0.93882 2.6602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4355 0 0 0 0 0 12.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2113 11.5561 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX46 ALKL2_HUMAN "ALK and LTK ligand 2 (Augmentor alpha, AUG-alpha)" ALKAL2 FAM150B UNQ542/PRO1097 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976] extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976] GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0010976; GO:0030298; GO:0030971; GO:0070374; GO:0070378 cytokine activity [GO:0005125]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971] DCALGRAEAAGLGPSPEQR 0.93883 1.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.792 0 0 0 0 0 0 0 0 0 0 0 0 14.1914 14.3762 13.9899 0 13.6263 10.2411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8493 0 10.7317 0 11.7676 14.2907 0 0 0 0 11.8642 0 0 0 0 0 0 11.4828 0 0 0 0 0 0 0 0 0 12.2607 0 0 0 11.1249 0 12.6523 0 12.0906 0 0 0 0 0 10.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5593 0 0 0 0 0 0 0 15.5403 0 0 0 0 0 14.4812 0 0 14.7718 0 0 0 0 0 0 0 12.0512 0 Q9Y257 KCNK6_HUMAN Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence) KCNK6 TOSS TWIK2 Homo sapiens (Human) negative regulation of systemic arterial blood pressure [GO:0003085]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; negative regulation of systemic arterial blood pressure [GO:0003085]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322] GO:0003085; GO:0005242; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0015271; GO:0022841; GO:0030322; GO:0034765; GO:0060075; GO:0071805 inward rectifier potassium channel activity [GO:0005242]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841] LRAELETLRAQLLQR 0.93883 0.99688 0 0 12.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13261 I15RA_HUMAN "Interleukin-15 receptor subunit alpha, IL-15 receptor subunit alpha, IL-15R-alpha, IL-15RA (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha, sIL-15 receptor subunit alpha, sIL-15R-alpha, sIL-15RA ]" IL15RA Homo sapiens (Human) interleukin-15-mediated signaling pathway [GO:0035723]; natural killer cell differentiation [GO:0001779]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phagocytosis [GO:0050766] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; protein kinase binding [GO:0019901]; interleukin-15-mediated signaling pathway [GO:0035723]; natural killer cell differentiation [GO:0001779]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phagocytosis [GO:0050766] GO:0000139; GO:0001779; GO:0004896; GO:0005615; GO:0005768; GO:0005789; GO:0005886; GO:0009986; GO:0016021; GO:0019901; GO:0030659; GO:0031965; GO:0032825; GO:0035723; GO:0042010; GO:0050766 cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; protein kinase binding [GO:0019901] GCRTLGLPALLLLLLLR 0.93884 1.6791 0 0 0 0 0 0 0 0 0 0 11.1879 15.6444 0 13.9676 0 0 0 15.6224 13.4524 0 0 9.9042 14.7887 0 0 0 0 14.2321 10.9001 0 0 0 11.1277 0 0 14.6958 16.8663 15.4538 0 0 0 0 0 0 14.7958 0 0 0 0 0 0 0 0 0 0 0 15.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4077 0 0 15.6259 0 0 0 21.2723 23.3732 17.2494 17.0001 16.9958 17.0257 16.9092 17.1433 0 16.9583 16.3081 16.6605 0 16.7974 16.901 0 17.0182 0 0 15.3586 0 16.0954 19.3818 19.9685 17.8148 17.4339 18.2948 0 19.3357 0 15.9184 0 0 0 14.9978 0 0 0 15.5425 0 20.2329 18.5039 0 18.1008 18.0454 18.636 17.4099 17.9904 17.1566 20.797 0 19.6816 20.1597 20.2101 0 0 15.7556 19.011 19.4266 0 0 10.9953 0 19.4429 15.7913 0 19.9511 20.3319 0 20.9618 0 17.9999 0 20.122 19.9149 20.9233 11.6637 0 15.3341 0 0 0 0 0 14.8898 0 15.6036 0 0 16.2549 0 17.8507 14.6736 14.868 0 0 16.0055 14.4383 0 0 Q96F10 SAT2_HUMAN "Thialysine N-epsilon-acetyltransferase, EC 2.3.1.- (Diamine acetyltransferase 2, EC 2.3.1.57) (Spermidine/spermine N(1)-acetyltransferase 2, SSAT-2)" SAT2 SSAT2 Homo sapiens (Human) nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; nor-spermidine metabolic process [GO:0046204]; putrescine acetylation [GO:0032920]; spermidine acetylation [GO:0032918]; spermine acetylation [GO:0032919] GO:0004145; GO:0005737; GO:0008080; GO:0019809; GO:0032918; GO:0032919; GO:0032920; GO:0042802; GO:0046204; GO:0070062 diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809] KVAEVALDKGCSQFR 0.93885 0.99688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5572 0 0 0 0 0 13.4214 0 0 0 0 0 0 0 0 12.9431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6145 0 0 0 0 0 0 12.5776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00748 FA12_HUMAN "Coagulation factor XII, EC 3.4.21.38 (Hageman factor, HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2) ]" F12 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]" collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase complex [GO:1905370] "collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; Factor XII activation [GO:0002542]; fibrinolysis [GO:0042730]; innate immune response [GO:0045087]; plasma kallikrein-kinin cascade [GO:0002353]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibrinolysis [GO:0051919]; positive regulation of plasminogen activation [GO:0010756]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to misfolded protein [GO:0051788]; zymogen activation [GO:0031638]" GO:0002353; GO:0002542; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005791; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0010756; GO:0016485; GO:0016540; GO:0030194; GO:0031638; GO:0042730; GO:0045087; GO:0051787; GO:0051788; GO:0051919; GO:0062023; GO:0070062; GO:1905370 calcium ion binding [GO:0005509]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252] CFEPQLLRFFHK 0.93887 0.90909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7819 0 0 0 0 0 0 0 0 13.3559 0 11.1029 0 0 0 0 0 0 0 0 12.7188 0 0 12.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5143 0 0 0 0 0 13.2322 0 0 13.0634 11.9764 0 0 0 0 0 11.8889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H115 SNAB_HUMAN "Beta-soluble NSF attachment protein, SNAP-beta (N-ethylmaleimide-sensitive factor attachment protein beta)" NAPB SNAPB Homo sapiens (Human) "intracellular protein transport [GO:0006886]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]" extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044] "extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]" GO:0005483; GO:0006886; GO:0010807; GO:0019905; GO:0031201; GO:0035249; GO:0035494; GO:0070044; GO:0070062; GO:0098978 soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905] HDSATSFVDAGNAYKKADPQEAINCLNAAIDIYTDMGR 0.93887 0.95057 0 0 0 0 0 0 0 0 0 0 0 10.6286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4557 0 0 0 0 0 0 0 0 0 12.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2368 0 0 0 0 0 0 0 0 0 0 0 0 12.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51679 CCR4_HUMAN "C-C chemokine receptor type 4, C-C CKR-4, CC-CKR-4, CCR-4, CCR4 (K5-5) (CD antigen CD194)" CCR4 CMKBR4 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interneuron migration [GO:1904936]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of positive chemotaxis [GO:0050927]; response to antibiotic [GO:0046677]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]; tolerance induction [GO:0002507] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interneuron migration [GO:1904936]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of positive chemotaxis [GO:0050927]; response to antibiotic [GO:0046677]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]; tolerance induction [GO:0002507] GO:0002507; GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007204; GO:0009314; GO:0009617; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0043025; GO:0046677; GO:0048872; GO:0050927; GO:0060326; GO:1904936 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950] MISWMYLVGFYSGIFFVMLMSIDRYLAIVHAVFSLRAR 0.93888 0.9176 0 0 0 0 0 0 0 0 0 0 0 11.8317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2281 11.9982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25774 CATS_HUMAN "Cathepsin S, EC 3.4.22.27" CTSS Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; positive regulation of cation channel activity [GO:2001259]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]; toll-like receptor signaling pathway [GO:0002224] collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; endolysosome lumen [GO:0036021]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; tertiary granule lumen [GO:1904724]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]; serine-type endopeptidase activity [GO:0004252]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen [GO:0048002]; basement membrane disassembly [GO:0034769]; cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; positive regulation of cation channel activity [GO:2001259]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to acidic pH [GO:0010447]; toll-like receptor signaling pathway [GO:0002224] GO:0001968; GO:0002224; GO:0002250; GO:0004197; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0006955; GO:0010447; GO:0016485; GO:0019882; GO:0019886; GO:0022617; GO:0030574; GO:0034769; GO:0036021; GO:0043202; GO:0043231; GO:0043236; GO:0043394; GO:0045335; GO:0048002; GO:0051603; GO:0062023; GO:0097067; GO:1904724; GO:1904813; GO:2001259 collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]; serine-type endopeptidase activity [GO:0004252] DPTLDHHWHLWK 0.93889 2.3878 0 0 18.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4163 0 0 0 0 0 0 13.8535 0 0 15.2347 15.7017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9484 14.6758 14.5978 14.6482 0 0 0 0 0 0 0 0 0 Q6ZMV8 ZN730_HUMAN Putative zinc finger protein 730 ZNF730 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGKAFNWFSHFTTHK 0.9389 1.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7199 0 0 0 0 0 15.0356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2E5 CE064_HUMAN Uncharacterized protein C5orf64 C5orf64 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 KLISFQPPQLGRTNMHYSK 0.93891 1.7095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3819 0 0 0 0 0 0 0 0 0 0 10.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5X3 SNX5_HUMAN Sorting nexin-5 SNX5 Homo sapiens (Human) "intracellular protein transport [GO:0006886]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]" "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; pinocytosis [GO:0006907]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0001726; GO:0001891; GO:0005768; GO:0005829; GO:0006886; GO:0006907; GO:0016241; GO:0030904; GO:0030905; GO:0031234; GO:0031313; GO:0031901; GO:0034452; GO:0035091; GO:0042147; GO:0043231; GO:0045296; GO:0045893; GO:0046628; GO:0048471; GO:0070685; GO:0097422 cadherin binding [GO:0045296]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091] LTELLRYYMLNIEAAKDLLYR 0.93891 0.92527 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1116 14.774 0 14.926 0 14.8415 15.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4681 0 0 0 0 0 0 0 0 0 0 0 0 16.0924 0 0 16.4225 0 0 0 16.6402 0 0 0 0 0 0 0 15.5931 0 0 0 0 P61244 MAX_HUMAN "Protein max (Class D basic helix-loop-helix protein 4, bHLHd4) (Myc-associated factor X)" MAX BHLHD4 Homo sapiens (Human) "cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Mad-Max complex [GO:0070443]; MLL1 complex [GO:0071339]; Myc-Max complex [GO:0071943]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Mad-Max complex [GO:0070443]; MLL1 complex [GO:0071339]; Myc-Max complex [GO:0071943]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to axon injury [GO:0048678]; response to insulin [GO:0032868]; retina development in camera-type eye [GO:0060041]" GO:0000122; GO:0000785; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0009267; GO:0010629; GO:0016605; GO:0030425; GO:0032868; GO:0032993; GO:0042802; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0048678; GO:0051402; GO:0060041; GO:0065003; GO:0070443; GO:0070888; GO:0071339; GO:0071375; GO:0071943; GO:0090575; GO:0140297; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; sequence-specific double-stranded DNA binding [GO:1990837]" DSVPSLQGEK 0.93892 1.0088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7841 11.957 0 12.5903 13.4307 0 11.2267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13046 PSG7_HUMAN "Putative pregnancy-specific beta-1-glycoprotein 7, PS-beta-G-7, PSBG-7, Pregnancy-specific glycoprotein 7" PSG7 Homo sapiens (Human) female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] GO:0002682; GO:0005576; GO:0005886; GO:0007165; GO:0007565; GO:0009986; GO:1990782 protein tyrosine kinase binding [GO:1990782] IENRILILPSVTRNETGPYQCEIR 0.93892 1.7176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9796 0 0 11.0918 0 0 0 11.4389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PD4 IL17F_HUMAN "Interleukin-17F, IL-17F (Cytokine ML-1)" IL17F Homo sapiens (Human) adaptive immune response [GO:0002250]; cartilage development [GO:0051216]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; negative regulation of angiogenesis [GO:0016525]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of granulocyte macrophage colony-stimulating factor production [GO:0032645]; regulation of interleukin-2 production [GO:0032663]; regulation of interleukin-6 production [GO:0032675]; regulation of interleukin-8 production [GO:0032677]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor binding [GO:0005126]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; adaptive immune response [GO:0002250]; cartilage development [GO:0051216]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; negative regulation of angiogenesis [GO:0016525]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of granulocyte macrophage colony-stimulating factor production [GO:0032645]; regulation of interleukin-2 production [GO:0032663]; regulation of interleukin-6 production [GO:0032675]; regulation of interleukin-8 production [GO:0032677]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] GO:0001819; GO:0002225; GO:0002250; GO:0005125; GO:0005126; GO:0005576; GO:0005615; GO:0006954; GO:0016525; GO:0017015; GO:0019955; GO:0032645; GO:0032663; GO:0032675; GO:0032677; GO:0032755; GO:0032761; GO:0042803; GO:0045087; GO:0045944; GO:0046982; GO:0050829; GO:0050830; GO:0051216; GO:0097400; GO:1900017; GO:2000340 cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor binding [GO:0005126]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] EDISMNSVPIQQETLVVRR 0.93892 3.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZD6 TMG4_HUMAN "Transmembrane gamma-carboxyglutamic acid protein 4 (Proline-rich gamma-carboxyglutamic acid protein 4, Proline-rich Gla protein 4)" PRRG4 PRGP4 TMG4 Homo sapiens (Human) endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; WW domain binding [GO:0050699] GO:0005509; GO:0005576; GO:0005886; GO:0016021; GO:0033116; GO:0050699 calcium ion binding [GO:0005509]; WW domain binding [GO:0050699] CNRLQHPCSSAVYER 0.93892 0.9491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1645 0 0 0 0 0 0 0 0 0 0 0 0 10.9352 0 0 11.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7622 0 0 0 0 0 0 12.2128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ90 ANO2_HUMAN Anoctamin-2 (Transmembrane protein 16B) ANO2 C12orf3 TMEM16B Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] chloride channel complex [GO:0034707]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005229; GO:0005254; GO:0005654; GO:0005886; GO:0034220; GO:0034707; GO:0046983; GO:0055085; GO:1902476 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] AASSAPSGQSQLGSMMSSGSQHTNV 0.93892 0.91626 0 12.2936 12.0187 13.0928 0 0 0 0 11.6752 12.3108 0 11.9148 12.6403 11.2723 0 0 0 13.2133 0 0 0 12.3859 0 13.2261 0 0 0 12.5613 13.7257 12.7113 0 13.5321 12.5276 12.4713 12.6406 12.2365 11.9206 12.7045 0 12.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 10.581 10.2754 0 9.17946 0 0 0 0 0 0 0 0 0 11.9091 14.4394 11.54 10.7326 0 0 12.7578 10.9816 12.5601 12.9323 14.7881 10.8052 15.3792 14.6437 12.2512 14.924 12.9617 15.2182 14.6698 15.0919 10.6473 15.3769 15.1958 13.843 13.6517 0 13.2605 14.7505 0 13.5775 15.0197 0 14.3779 13.9741 11.255 0 12.2929 12.4069 0 12.2646 13.6227 12.6321 12.8432 12.495 12.4874 0 13.5353 11.4885 0 13.5687 13.5276 0 0 12.3853 0 13.2821 12.41 12.8053 0 14.224 0 0 0 11.5499 0 0 0 11.9525 13.8386 0 0 0 15.6829 0 13.874 10.8633 13.1981 0 0 11.8064 0 0 0 0 0 14.3807 11.6049 0 0 11.8672 13.2105 12.1211 11.7507 0 0 11.1306 0 0 0 0 11.9427 11.8827 11.0566 12.8803 12.3166 11.3479 0 0 0 12.6533 0 0 11.976 0 Q96F85 CNRP1_HUMAN "CB1 cannabinoid receptor-interacting protein 1, CRIP-1" CNRIP1 C2orf32 Homo sapiens (Human) negative regulation of signaling receptor activity [GO:2000272]; regulation of signaling receptor activity [GO:0010469] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; type 1 cannabinoid receptor binding [GO:0031718]; negative regulation of signaling receptor activity [GO:2000272]; regulation of signaling receptor activity [GO:0010469] GO:0005737; GO:0005886; GO:0008022; GO:0010469; GO:0031718; GO:2000272 protein C-terminus binding [GO:0008022]; type 1 cannabinoid receptor binding [GO:0031718] IKPSTLQVENISIGGVLVPLELK 0.93893 0.92479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7794 11.2695 0 0 0 0 0 11.728 0 0 0 0 0 0 0 0 0 0 0 12.5484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2035 0 0 0 0 0 0 0 0 0 0 0 0 13.3712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8063 0 0 0 0 0 0 0 12.9826 0 0 0 0 0 0 0 0 Q14592 ZN460_HUMAN Zinc finger protein 460 (Zinc finger protein 272) (Zinc finger protein HZF8) ZNF460 ZNF272 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFTYRSNFVLHNK 0.93895 0.9853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8012 0 0 0 0 10.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0578 0 0 0 0 0 0 0 0 0 0 0 0 12.4985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8707 0 0 0 12.0334 0 0 0 0 0 0 0 0 0 Q8NI38 IKBD_HUMAN "NF-kappa-B inhibitor delta, NFKB inhibitor delta (I-kappa-B-delta, IkB-delta, IkappaBdelta) (IkappaBNS) (T-cell activation NFKB-like protein) (TA-NFKBH)" NFKBID IKBNS Homo sapiens (Human) inflammatory response [GO:0006954]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852] nucleus [GO:0005634] nucleus [GO:0005634]; inflammatory response [GO:0006954]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; regulation of gene expression [GO:0010468]; T cell receptor signaling pathway [GO:0050852] GO:0005634; GO:0006954; GO:0010468; GO:0050852; GO:2000321 PGPGPEGLRQLLK 0.93895 0.92395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBV4 PLPP7_HUMAN Inactive phospholipid phosphatase 7 (Phosphatidic acid phosphatase type 2 domain-containing protein 3) PLPP7 C9orf67 PPAPDC3 Homo sapiens (Human) negative regulation of myotube differentiation [GO:0010832] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; negative regulation of myotube differentiation [GO:0010832] GO:0005635; GO:0005789; GO:0010832; GO:0016020; GO:0016021; GO:0042392 sphingosine-1-phosphate phosphatase activity [GO:0042392] AEFLSLNQPPKGGPEPR 0.93896 0.99602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3838 0 0 0 12.9175 0 11.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8435 0 0 0 0 0 0 0 0 0 0 12.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTI7 INKA2_HUMAN "PAK4-inhibitor INKA2 (Induced in neural crest by AP2-alpha protein-related homolog, HInca-r) (Inka box actin regulator 2)" INKA2 C1orf183 FAM212B Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291] GO:0005634; GO:0005654; GO:0019901; GO:0030291 protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291] EVGDGLQDQMNCMMGALQELK 0.93897 0.91374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9813 0 0 0 0 0 0 0 15.3389 0 0 0 0 0 0 0 0 0 17.4904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8744 17.5001 0 16.1333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14565 DMC1_HUMAN Meiotic recombination protein DMC1/LIM15 homolog DMC1 DMC1H LIM15 Homo sapiens (Human) chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148] "chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]" "chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; strand invasion [GO:0042148]" GO:0000150; GO:0000730; GO:0000781; GO:0000794; GO:0001541; GO:0001556; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006312; GO:0007129; GO:0007131; GO:0007141; GO:0007283; GO:0007286; GO:0007292; GO:0008094; GO:0042148; GO:0042802; GO:0051321; GO:0070192; GO:0140664 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]" LLIIDSIMALFRVDFSGRGELAER 0.93898 0.98481 0 0 0 0 11.5244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4424 0 0 0 0 13.4235 0 0 0 14.0591 0 12.902 0 0 0 0 0 0 0 0 14.1059 0 0 0 0 0 0 0 12.9717 0 0 0 13.7709 0 0 0 14.0666 13.6851 0 13.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6333 13.0354 13.9571 0 0 13.8806 0 0 13.3151 13.1839 0 0 0 0 0 0 0 12.5138 13.3989 0 13.7973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5298 0 0 0 0 P0C7T3 O56A5_HUMAN Olfactory receptor 56A5 OR56A5 OR56A5P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAIFVVARNGLLTMPIPILSSRLR 0.93899 1.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32321 DCTD_HUMAN "Deoxycytidylate deaminase, EC 3.5.4.12 (dCMP deaminase)" DCTD Homo sapiens (Human) dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; pyrimidine nucleotide metabolic process [GO:0006220] cytosol [GO:0005829] cytosol [GO:0005829]; dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; pyrimidine nucleotide metabolic process [GO:0006220] GO:0004132; GO:0005829; GO:0006220; GO:0006226; GO:0006231; GO:0008270; GO:0042802 dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] LIIQAGIKEVIFMSDK 0.93899 2.3858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0514 12.6988 12.566 0 12.8873 0 0 0 12.5665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKR3 KLK13_HUMAN "Kallikrein-13, EC 3.4.21.- (Kallikrein-like protein 4, KLK-L4)" KLK13 KLKL4 Homo sapiens (Human) protein processing [GO:0016485]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; hydrolase activity [GO:0016787]; serine-type endopeptidase activity [GO:0004252]; protein processing [GO:0016485]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0006508; GO:0016485; GO:0016787; GO:0030141 hydrolase activity [GO:0016787]; serine-type endopeptidase activity [GO:0004252] DSCEGDSGGPLVCNR 0.93899 0.9906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3123 0 0 0 0 0 0 12.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JYT7 K1755_HUMAN Uncharacterized protein KIAA1755 KIAA1755 Homo sapiens (Human) AKGLAVLIDARR 0.93902 3.3779 0 0 0 0 0 0 0 0 12.73 0 0 14.7407 14.0785 14.16 13.6473 0 14.6002 0 11.7384 13.8256 13.9347 0 0 0 12.5898 11.1396 13.8085 14.4114 0 13.9873 0 15.0846 13.8245 13.761 13.1388 11.9503 15.2214 15.3315 12.8371 15.1133 13.3211 0 0 15.1227 13.2179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8165 0 0 0 0 13.2301 0 0 0 0 0 0 0 12.362 0 0 0 0 0 0 0 0 0 0 0 0 13.4599 0 0 0 0 13.6295 0 0 0 0 12.1316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4164 0 0 0 12.6227 0 0 0 0 0 0 12.341 0 13.7575 0 0 0 0 0 0 12.4203 0 0 0 0 0 0 14.7366 0 13.9083 14.6229 0 0 14.7634 0 14.4789 0 16.7914 14.7419 14.6826 0 14.1265 0 12.6244 0 0 0 0 0 Q9UBS0 KS6B2_HUMAN "Ribosomal protein S6 kinase beta-2, S6K-beta-2, S6K2, EC 2.7.11.1 (70 kDa ribosomal protein S6 kinase 2, P70S6K2, p70-S6K 2) (S6 kinase-related kinase, SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta, S6K-beta, p70 S6 kinase beta, p70 S6K-beta, p70 S6KB, p70-beta)" RPS6KB2 STK14B Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; translation [GO:0006412] GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006412; GO:0007165; GO:0018105; GO:0031929; GO:0042277; GO:0043491; GO:0045948; GO:0106310 ATP binding [GO:0005524]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711] HPFIVELAYAFQTGGKLYLILECLSGGELFTHLER 0.93903 0.9306 13.4017 13.7312 0 0 0 0 11.897 0 0 0 0 0 0 13.9021 13.2369 0 0 0 13.9516 0 0 15.4354 0 15.1124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5955 15.7077 15.6449 16.1913 15.9709 0 15.933 16.1182 15.5947 15.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6914 0 13.7379 14.2387 0 0 15.5067 14.2936 15.2955 13.9753 14.0425 13.5269 14.4659 14.1271 0 0 0 0 13.2032 13.6372 11.1579 0 0 0 13.2543 13.2726 13.6502 0 0 0 14.129 0 15.2579 13.8336 0 13.9817 15.1388 14.9211 13.2545 13.9595 14.1314 0 0 0 0 0 0 13.2538 13.6385 0 16.1292 0 0 0 14.3599 0 0 0 13.4585 0 0 0 0 13.8531 0 0 0 0 0 0 0 0 0 0 12.8144 0 14.6742 0 13.6154 0 0 0 13.891 0 P08174 DAF_HUMAN Complement decay-accelerating factor (CD antigen CD55) CD55 CR DAF Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of T cell cytokine production [GO:0002726]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; respiratory burst [GO:0045730]; T cell mediated immunity [GO:0002456]" anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle [GO:0030133] "anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle [GO:0030133]; lipid binding [GO:0008289]; virus receptor activity [GO:0001618]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of T cell cytokine production [GO:0002726]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; respiratory burst [GO:0045730]; T cell mediated immunity [GO:0002456]" GO:0000139; GO:0001618; GO:0002456; GO:0002726; GO:0005576; GO:0005886; GO:0006958; GO:0007204; GO:0008289; GO:0009986; GO:0030133; GO:0030449; GO:0030667; GO:0031225; GO:0031664; GO:0033116; GO:0045087; GO:0045121; GO:0045730; GO:0045916; GO:0045959; GO:0070062; GO:0101003; GO:1903659; GO:2000516; GO:2000563 lipid binding [GO:0008289]; virus receptor activity [GO:0001618] GKSLTSKVPPTVQK 0.93904 2.3846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5229 0 10.839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LR4 TAFA4_HUMAN Chemokine-like protein TAFA-4 TAFA4 FAM19A4 Homo sapiens (Human) macrophage chemotaxis [GO:0048246]; phagocytosis [GO:0006909]; regulation of membrane potential [GO:0042391]; regulation of sensory perception of pain [GO:0051930]; regulation of signaling receptor activity [GO:0010469]; superoxide anion generation [GO:0042554] extracellular space [GO:0005615] extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; macrophage chemotaxis [GO:0048246]; phagocytosis [GO:0006909]; regulation of membrane potential [GO:0042391]; regulation of sensory perception of pain [GO:0051930]; regulation of signaling receptor activity [GO:0010469]; superoxide anion generation [GO:0042554] GO:0005615; GO:0006909; GO:0010469; GO:0042391; GO:0042554; GO:0048018; GO:0048246; GO:0051930 receptor ligand activity [GO:0048018] MRVCAKSVLLSHWLFLAYVLMVCCK 0.93904 1.0409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8345 0 0 12.7542 0 0 0 13.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99878 H2A1J_HUMAN Histone H2A type 1-J (Histone H2A/e) H2AC14 H2AFE HIST1H2AJ Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AGLQFPVGR 0.93904 1.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0703 0 0 0 0 0 0 0 Q96DB9 FXYD5_HUMAN FXYD domain-containing ion transport regulator 5 (Dysadherin) FXYD5 DYSAD IWU1 HSPC113 UNQ2561/PRO6241 Homo sapiens (Human) ion transport [GO:0006811]; microvillus assembly [GO:0030033]; negative regulation of calcium-dependent cell-cell adhesion [GO:0046588]; regulation of ion transport [GO:0043269] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; ion channel regulator activity [GO:0099106]; ion transport [GO:0006811]; microvillus assembly [GO:0030033]; negative regulation of calcium-dependent cell-cell adhesion [GO:0046588]; regulation of ion transport [GO:0043269] GO:0003779; GO:0006811; GO:0016021; GO:0030033; GO:0043269; GO:0045296; GO:0046588; GO:0099106 actin binding [GO:0003779]; cadherin binding [GO:0045296]; ion channel regulator activity [GO:0099106] GLLVAAVLFITGIIILTSGKCR 0.93905 3.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 13.829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8947 0 0 0 0 0 12.2892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0807 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8279 0 14.3956 11.7527 15.3882 0 0 14.3889 0 14.989 12.1931 0 0 0 0 13.1255 0 0 0 0 13.2821 0 0 14.384 0 0 0 0 0 0 0 0 0 0 0 0 13.9893 0 0 0 0 14.3545 13.9449 0 0 0 12.7052 0 0 0 0 13.4378 11.7096 0 0 0 0 0 0 13.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6D3 XKR8_HUMAN "XK-related protein 8, hXkr8 [Cleaved into: XK-related protein 8, processed form ]" XKR8 XRG8 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; establishment of localization in cell [GO:0051649]; neutrophil clearance [GO:0097350]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of myoblast differentiation [GO:0045663]; tolerance induction to self antigen [GO:0002513] integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; establishment of localization in cell [GO:0051649]; neutrophil clearance [GO:0097350]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of myoblast differentiation [GO:0045663]; tolerance induction to self antigen [GO:0002513] GO:0002513; GO:0005886; GO:0016020; GO:0016021; GO:0017128; GO:0043652; GO:0045663; GO:0048471; GO:0051649; GO:0070782; GO:0097350; GO:1902742 phospholipid scramblase activity [GO:0017128] ALRTCLPSK 0.93905 1.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NB3 ZN830_HUMAN Zinc finger protein 830 (Coiled-coil domain-containing protein 16) ZNF830 CCDC16 Homo sapiens (Human) blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; replication fork protection [GO:0048478]; RNA splicing [GO:0008380] chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; blastocyst growth [GO:0001832]; cell division [GO:0051301]; chromosome organization [GO:0051276]; intestinal epithelial structure maintenance [GO:0060729]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic DNA replication checkpoint signaling [GO:0033314]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; nuclear DNA replication [GO:0033260]; ovarian follicle development [GO:0001541]; preantral ovarian follicle growth [GO:0001546]; replication fork protection [GO:0048478]; RNA splicing [GO:0008380] GO:0001541; GO:0001546; GO:0001832; GO:0003676; GO:0005634; GO:0005654; GO:0005681; GO:0005694; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0033260; GO:0033314; GO:0043066; GO:0044773; GO:0048478; GO:0051276; GO:0051301; GO:0060729 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] ATLVPQVQPSTSAWTTNFDKIGKEFIR 0.93906 4.0799 0 0 0 0 0 0 0 0 0 0 0 14.4162 0 0 0 0 0 0 0 0 0 0 0 0 12.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2799 0 0 0 0 0 0 0 0 10.4598 0 0 0 0 0 0 14.6966 0 0 0 0 0 0 0 0 0 0 12.7833 15.6659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1779 0 0 0 0 0 0 0 0 0 11.867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0909 0 0 0 0 0 16.1659 0 0 0 10.5108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00604 NDP_HUMAN Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein) NDP EVR2 Homo sapiens (Human) "decidualization [GO:0046697]; extracellular matrix-cell signaling [GO:0035426]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuole organization [GO:0007033]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein homodimerization activity [GO:0042803]; decidualization [GO:0046697]; extracellular matrix-cell signaling [GO:0035426]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuole organization [GO:0007033]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]" GO:0005109; GO:0005125; GO:0005615; GO:0007033; GO:0007399; GO:0007601; GO:0009986; GO:0016055; GO:0031012; GO:0035426; GO:0042803; GO:0045893; GO:0046697; GO:0051091; GO:0061299; GO:0062023; GO:0110135 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein homodimerization activity [GO:0042803] LTATYRYILSCHCEECNS 0.9391 1.7148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TAQ9 DCAF8_HUMAN DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A) DCAF8 H326 WDR42A Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016567; GO:0080008 GTDTESSGEDKDSDSMEDTGHYSINDENR 0.9391 0.95174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2203 0 0 0 0 0 0 0 0 0 0 12.2992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7053 0 0 0 12.5172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1427 0 0 0 0 0 0 13.1755 0 0 0 0 12.4558 12.6765 0 0 0 0 0 0 0 0 0 0 13.7729 0 0 0 0 0 0 0 0 0 0 12.3933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZU3 SYCP3_HUMAN "Synaptonemal complex protein 3, SCP-3" SYCP3 SCP3 Homo sapiens (Human) "cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" "chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]" "chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" GO:0000775; GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0007141; GO:0007286; GO:0035093; GO:0051301; GO:0051321 DNA binding [GO:0003677] DLSGSEEDVIEGK 0.93911 0.90955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9873 0 0 0 0 0 14.4156 14.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0128 0 0 0 12.9791 0 0 0 0 13.0274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUR5 MIC26_HUMAN MICOS complex subunit MIC26 (Apolipoprotein O) (MICOS complex subunit MIC23) (Protein FAM121B) APOO FAM121B MIC23 MIC26 My025 UNQ1866/PRO4302 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; lipid transport [GO:0006869] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; high-density lipoprotein particle [GO:0034364]; integral component of mitochondrial inner membrane [GO:0031305]; low-density lipoprotein particle [GO:0034362]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; very-low-density lipoprotein particle [GO:0034361] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; high-density lipoprotein particle [GO:0034364]; integral component of mitochondrial inner membrane [GO:0031305]; low-density lipoprotein particle [GO:0034362]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; very-low-density lipoprotein particle [GO:0034361]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; lipid transport [GO:0006869] GO:0000139; GO:0001401; GO:0005576; GO:0005615; GO:0005739; GO:0005743; GO:0005789; GO:0005829; GO:0006869; GO:0007007; GO:0031305; GO:0034361; GO:0034362; GO:0034364; GO:0042407; GO:0044284; GO:0061617; GO:0140275 FKVIQRSVGPASLSLLTFK 0.93911 1.7711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9503 0 0 11.8729 10.5891 10.3888 0 0 0 0 0 0 0 0 0 0 0 0 11.1862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1699 0 0 12.8851 0 0 0 0 0 0 0 0 12.3908 10.9423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6A0 DEN2D_HUMAN DENN domain-containing protein 2D DENND2D Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005654; GO:0005829 guanyl-nucleotide exchange factor activity [GO:0005085] DILPPKLQDDILDSLGQGINELK 0.93911 1.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.548 11.8637 0 14.019 0 0 0 0 10.6182 0 0 0 0 0 0 0 0 16.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3446 0 0 0 0 0 0 0 0 13.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7048 0 14.6294 0 0 0 0 12.3959 0 0 13.3571 0 0 0 0 10.1281 0 0 0 0 0 10.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ71 CLC4K_HUMAN C-type lectin domain family 4 member K (Langerin) (CD antigen CD207) CD207 CLEC4K Homo sapiens (Human) defense response to virus [GO:0051607] clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; defense response to virus [GO:0051607] GO:0005537; GO:0005886; GO:0009897; GO:0016021; GO:0030139; GO:0030246; GO:0030669; GO:0031901; GO:0051607 carbohydrate binding [GO:0030246]; mannose binding [GO:0005537] AALICLTLVLVASVLLQAVLYPR 0.93911 0.95124 0 0 0 0 0 0 0 0 0 12.6479 0 0 14.924 0 0 0 0 0 0 12.5351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2972 0 0 0 0 0 0 0 0 0 0 11.5892 0 14.3877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4372 13.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6936 0 0 12.8778 P78413 IRX4_HUMAN Iroquois-class homeodomain protein IRX-4 (Homeodomain protein IRXA3) (Iroquois homeobox protein 4) IRX4 IRXA3 Homo sapiens (Human) cell development [GO:0048468]; establishment of animal organ orientation [GO:0048561]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; establishment of animal organ orientation [GO:0048561]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007507; GO:0030182; GO:0048468; GO:0048561 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HSTLNQAWATAKGALLDPGPLGRSLGAGANVLTAPLAR 0.93912 0.9176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8Q1 C56D1_HUMAN "Probable transmembrane reductase CYB561D1, EC 7.2.1.3 (Cytochrome b561 domain-containing protein 1)" CYB561D1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575] GO:0016021; GO:0016491; GO:0020037; GO:0046872; GO:0140571; GO:0140575 heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575] GAAWYLCLALPVYPALVIMHQISRSYLPR 0.93912 1.0052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0191 0 0 0 0 16.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2553 0 0 11.4524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63252 KCNJ2_HUMAN "Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1, IRK-1, hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)" KCNJ2 IRK1 Homo sapiens (Human) cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane repolarization [GO:0060306]; regulation of resting membrane potential [GO:0060075]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076] dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076] "dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intrinsic component of membrane [GO:0031224]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; magnesium ion transport [GO:0015693]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane repolarization [GO:0060306]; regulation of resting membrane potential [GO:0060075]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076]" GO:0005242; GO:0005546; GO:0005790; GO:0005791; GO:0005794; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0030007; GO:0030315; GO:0031224; GO:0034765; GO:0042802; GO:0043025; GO:0043197; GO:0051289; GO:0055119; GO:0060075; GO:0060306; GO:0071260; GO:0071805; GO:0086002; GO:0086004; GO:0086008; GO:0086011; GO:0086012; GO:0086013; GO:0086091; GO:0090076; GO:1901381; GO:1990573 "identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]" KSHLVEAHVRAQLLK 0.93915 2.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8066 0 0 0 0 0 0 0 0 0 12.9817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9425 0 0 0 Q9NYV6 RRN3_HUMAN "RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA, TIF-IA)" RRN3 TIFIA Homo sapiens (Human) "cytoplasm organization [GO:0007028]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; cytoplasm organization [GO:0007028]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation from RNA polymerase I promoter [GO:0006361]" GO:0001042; GO:0001164; GO:0001181; GO:0001701; GO:0005634; GO:0005654; GO:0005730; GO:0006361; GO:0007000; GO:0007028; GO:0042254; GO:0045893; GO:0048144; GO:0048872; GO:0072332; GO:1902254; GO:2000142 RNA polymerase I core binding [GO:0001042]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] ALENDFFNSPPR 0.93915 2.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3 0 12.1842 0 13.8406 0 0 0 0 12.5844 0 0 0 0 0 13.3117 0 12.5713 0 0 0 0 0 0 0 0 0 0 0 12.2119 0 0 12.5034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8144 13.015 0 0 14.9516 0 12.6255 0 0 0 0 0 0 0 0 0 0 12.748 0 0 0 0 12.7753 0 0 14.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9876 0 0 0 0 11.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8036 0 0 0 0 0 0 0 0 12.8384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25101 EDNRA_HUMAN "Endothelin-1 receptor (Endothelin receptor type A, ET-A, ETA-R, hET-AR)" EDNRA ETA ETRA Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organism aging [GO:0010259]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; podocyte apoptotic process [GO:1903210]; podocyte differentiation [GO:0072112]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; endothelin receptor activity [GO:0004962]; phosphatidylinositol phospholipase C activity [GO:0004435]; activation of adenylate cyclase activity [GO:0007190]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; artery smooth muscle contraction [GO:0014824]; atrial cardiac muscle tissue development [GO:0003228]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; canonical Wnt signaling pathway [GO:0060070]; cardiac chamber formation [GO:0003207]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell population proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to oxidative stress [GO:0034599]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic heart tube development [GO:0035050]; embryonic skeletal system development [GO:0048706]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; enteric nervous system development [GO:0048484]; establishment of endothelial barrier [GO:0061028]; face development [GO:0060324]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; heparin metabolic process [GO:0030202]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; mesenchymal cell apoptotic process [GO:0097152]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; multicellular organism aging [GO:0010259]; neural crest cell fate commitment [GO:0014034]; neuromuscular process [GO:0050905]; neuron remodeling [GO:0016322]; noradrenergic neuron differentiation [GO:0003357]; norepinephrine metabolic process [GO:0042415]; pharyngeal arch artery morphogenesis [GO:0061626]; podocyte apoptotic process [GO:1903210]; podocyte differentiation [GO:0072112]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; protein transmembrane transport [GO:0071806]; regulation of blood pressure [GO:0008217]; regulation of glucose transmembrane transport [GO:0010827]; regulation of heart rate [GO:0002027]; regulation of protein localization to cell leading edge [GO:1905871]; renal albumin absorption [GO:0097018]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to acetylcholine [GO:1905144]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; vascular associated smooth muscle cell development [GO:0097084]; vasoconstriction [GO:0042310] GO:0000278; GO:0001569; GO:0001666; GO:0001701; GO:0001974; GO:0001975; GO:0002027; GO:0003094; GO:0003207; GO:0003220; GO:0003228; GO:0003253; GO:0003357; GO:0004435; GO:0004962; GO:0005886; GO:0005887; GO:0006468; GO:0006874; GO:0006939; GO:0007005; GO:0007165; GO:0007186; GO:0007190; GO:0007193; GO:0007202; GO:0007204; GO:0007249; GO:0007585; GO:0008217; GO:0008283; GO:0009611; GO:0010259; GO:0010467; GO:0010737; GO:0010827; GO:0014034; GO:0014824; GO:0016322; GO:0030202; GO:0030878; GO:0034599; GO:0035050; GO:0035904; GO:0042310; GO:0042415; GO:0042474; GO:0044751; GO:0048066; GO:0048484; GO:0048485; GO:0048675; GO:0048706; GO:0050905; GO:0055078; GO:0060070; GO:0060324; GO:0060385; GO:0061028; GO:0061626; GO:0070294; GO:0070588; GO:0071372; GO:0071373; GO:0071806; GO:0072011; GO:0072112; GO:0086100; GO:0086101; GO:0097018; GO:0097084; GO:0097152; GO:0097492; GO:1902287; GO:1903210; GO:1903537; GO:1904888; GO:1905144; GO:1905871; GO:2001259 endothelin receptor activity [GO:0004962]; phosphatidylinositol phospholipase C activity [GO:0004435] FKNCFQSCLCCCCYQSK 0.93916 3.5013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2354 0 0 14.4314 14.8201 0 0 0 0 14.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7711 13.2014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2297 0 0 0 0 0 0 0 0 12.7419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4902 0 0 0 0 0 0 0 0 11.9913 0 0 0 0 0 12.4402 18.4549 12.1653 0 0 19.4922 0 0 0 0 0 0 0 0 0 0 0 O76000 OR2B3_HUMAN "Putative olfactory receptor 2B3 (Hs6M1-1) (Olfactory receptor OR6-14, OR6-4, Olfactory receptor 6-4)" OR2B3 OR2B3P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EAFKRLMPR 0.93917 0.91628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2435 0 0 0 0 0 10.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.673 0 0 0 0 0 0 12.0442 11.6685 0 0 0 0 0 0 11.8417 0 0 0 0 0 11.1669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5164 10.9789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4397 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3067 0 0 0 0 0 10.7122 11.0911 0 0 0 Q99807 COQ7_HUMAN "5-demethoxyubiquinone hydroxylase, mitochondrial, DMQ hydroxylase, EC 1.14.99.60 (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)" COQ7 Homo sapiens (Human) determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744] chromosome [GO:0005694]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142] "chromosome [GO:0005694]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142]; 3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744]" GO:0000122; GO:0003682; GO:0005634; GO:0005694; GO:0005739; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0016709; GO:0031314; GO:0045944; GO:0046872; GO:0110142; GO:2000377 "3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]" IYAGQMAVLGRTSVGPVIQKMWDQEK 0.9392 0.91457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6931 0 0 10.1911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2345 0 0 13.675 0 0 12.6361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14832 GRM3_HUMAN "Metabotropic glutamate receptor 3, mGluR3" GRM3 GPRC1C MGLUR3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]" astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission, glutamatergic [GO:0051966]" GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014069; GO:0030424; GO:0043197; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099055; GO:0099056 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] DDYLLPGVK 0.93921 0.91378 0 0 11.8882 0 0 0 0 0 0 0 0 0 13.3794 0 0 0 0 0 12.915 0 14.4883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8184 0 0 0 11.3933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2309 14.2125 0 0 0 0 14.5186 0 0 0 0 12.9676 13.8663 0 0 0 0 13.5922 0 0 0 0 0 12.8497 0 12.8876 0 0 13.065 0 12.9104 0 0 0 0 0 0 0 0 12.7836 0 0 0 12.8716 0 0 0 0 0 14.5986 0 0 0 13.1383 0 0 0 0 15.1736 0 14.7833 14.2606 14.8438 14.0092 0 0 0 0 0 0 15.8723 0 0 0 11.5723 12.5804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4223 0 0 0 0 0 13.7547 0 Q8N945 PRLD2_HUMAN PRELI domain-containing protein 2 PRELID2 Homo sapiens (Human) phospholipid transport [GO:0015914] mitochondrial intermembrane space [GO:0005758] mitochondrial intermembrane space [GO:0005758]; phosphatidic acid transfer activity [GO:1990050]; phospholipid transport [GO:0015914] GO:0005758; GO:0015914; GO:1990050 phosphatidic acid transfer activity [GO:1990050] ISITGVGFLNCVLETFASTFLRQGAQK 0.93926 2.524 0 0 0 0 0 0 0 0 0 0 0 13.264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.997 11.0109 0 0 0 0 0 0 13.0613 12.4983 0 0 0 0 0 0 0 0 10.7947 0 0 0 0 0 0 13.36 0 0 0 13.8346 0 15.157 0 0 0 0 0 0 13.9958 0 0 0 0 0 14.8999 13.2894 14.8045 0 0 0 0 0 0 0 0 0 12.9287 0 0 14.4064 0 13.0452 0 0 0 0 0 0 0 0 0 14.2458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3422 0 0 0 0 0 0 13.7974 0 13.6634 0 0 0 0 13.6119 0 13.6611 0 0 0 0 0 0 0 Q969R8 ITFG2_HUMAN KICSTOR complex protein ITFG2 (Integrin-alpha FG-GAP repeat-containing protein 2) ITFG2 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]; regulation of TOR signaling [GO:0032006] cytosol [GO:0005829]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; germinal center B cell differentiation [GO:0002314]; negative regulation of TORC1 signaling [GO:1904262]; regulation of TOR signaling [GO:0032006] GO:0002314; GO:0005654; GO:0005765; GO:0005829; GO:0032006; GO:0034198; GO:0042149; GO:0140007; GO:1904262 DVVLHQTSGRIHNKNVSTHLIGNIK 0.93926 1.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14772 FPGT_HUMAN "Fucose-1-phosphate guanylyltransferase, EC 2.7.7.30 (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase)" FPGT GFPP Homo sapiens (Human) fucose metabolic process [GO:0006004] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525]; fucose metabolic process [GO:0006004] GO:0003824; GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0047341 catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525] HRDLEYRSCHR 0.93927 0.92206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.27 11.2535 Q9BRT9 SLD5_HUMAN "DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed ]" GINS4 SLD5 Homo sapiens (Human) DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] CMG complex [GO:0071162]; cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] CMG complex [GO:0071162]; cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0000727; GO:0000811; GO:0001833; GO:0005634; GO:0005654; GO:0005737; GO:0006268; GO:0071162; GO:1900264; GO:1903934 ERQENILVEPDTDEQRDYVIDLEK 0.93927 0.98481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4169 0 0 0 0 0 0 0 0 0 13.6823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3296 0 0 0 0 14.0042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9573 0 14.8832 0 0 0 0 0 Q86UW8 HPLN4_HUMAN Hyaluronan and proteoglycan link protein 4 (Brain link protein 2) HAPLN4 BRAL2 KIAA1926 Homo sapiens (Human) "cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; inhibitory synapse assembly [GO:1904862]; skeletal system development [GO:0001501]; synaptic transmission, GABAergic [GO:0051932]" extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; perineuronal net [GO:0072534]; synapse [GO:0045202] "extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; perineuronal net [GO:0072534]; synapse [GO:0045202]; hyaluronic acid binding [GO:0005540]; structural constituent of synapse-associated extracellular matrix [GO:0150043]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; inhibitory synapse assembly [GO:1904862]; skeletal system development [GO:0001501]; synaptic transmission, GABAergic [GO:0051932]" GO:0001501; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0031012; GO:0045202; GO:0051932; GO:0072534; GO:0150043; GO:1904862 hyaluronic acid binding [GO:0005540]; structural constituent of synapse-associated extracellular matrix [GO:0150043] DGLDWCNAGWLR 0.93928 0.93063 0 0 0 0 0 0 0 11.3286 0 0 0 0 10.9953 0 11.6654 0 0 0 0 12.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7291 0 0 0 0 0 0 0 0 0 12.3649 0 0 0 0 12.0082 0 0 0 11.5954 0 0 0 0 0 0 0 0 12.5889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2365 0 0 0 14.1951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6882 0 0 0 0 11.4182 0 0 0 0 Q969G6 RIFK_HUMAN "Riboflavin kinase, EC 2.7.1.26 (ATP:riboflavin 5'-phosphotransferase) (Flavokinase)" RFK Homo sapiens (Human) apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; phosphorylation [GO:0016310]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; phosphorylation [GO:0016310]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771] GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0016310; GO:0033864; GO:0046872; GO:0072593 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531] MRHLPYFCR 0.93928 0.92131 0 0 13.6817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6SPF0 SAMD1_HUMAN "Sterile alpha motif domain-containing protein 1, SAM domain-containing protein 1 (Atherin)" SAMD1 Homo sapiens (Human) "chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634] "chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle binding [GO:0030169]; chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" GO:0000122; GO:0003682; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0030169; GO:0034439; GO:0042393; GO:0045892; GO:0051260; GO:0090077; GO:0090308 chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle binding [GO:0030169] APPAASARPSR 0.93929 1.7185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4285 Q5T160 SYRM_HUMAN "Probable arginine--tRNA ligase, mitochondrial, EC 6.1.1.19 (Arginyl-tRNA synthetase, ArgRS)" RARS2 RARSL Homo sapiens (Human) arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; arginyl-tRNA aminoacylation [GO:0006420]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] GO:0003723; GO:0004814; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006420; GO:0032543 arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; RNA binding [GO:0003723] DSPPEVAGARLHLFKAVR 0.9393 0.92049 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5652 0 0 0 0 0 0 0 0 0 0 0 0 10.3016 0 0 0 0 0 0 0 0 0 0 0 0 13.2971 13.6306 14.8311 13.1299 0 0 0 0 12.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7386 12.2487 0 0 0 0 0 0 0 12.4829 12.3106 0 0 0 0 0 13.7943 0 0 0 0 11.8876 0 0 15.7233 0 0 0 0 0 14.0191 0 0 0 0 0 11.9796 0 11.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2239 0 14.7316 0 11.5904 0 0 0 0 0 0 0 0 13.2963 12.6871 0 0 0 0 0 P82664 RT10_HUMAN "28S ribosomal protein S10, mitochondrial, MRP-S10, S10mt (Mitochondrial small ribosomal subunit protein uS10m)" MRPS10 MSTP040 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005763; GO:0032543 ELGISIKVHEPPR 0.93931 2.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5787 12.5839 12.2122 0 12.6517 0 12.1399 0 0 0 0 0 13.0373 0 0 14.1634 12.359 13.5759 13.7322 14.7337 0 0 0 13.1014 13.0132 0 0 12.8285 0 0 0 0 0 0 0 0 15.1436 0 13.5252 0 0 13.6897 13.7315 13.5838 0 0 0 14.3999 12.5406 0 0 14.3439 0 14.351 13.792 12.8186 0 0 12.9084 0 0 0 13.7234 14.3771 14.2439 0 0 0 0 0 0 12.4537 0 0 12.5265 11.7827 0 13.8788 0 13.6339 0 0 0 0 0 0 0 0 12.0699 0 0 0 0 0 11.2279 13.1806 0 12.992 0 0 0 0 0 12.4327 Q9HBV2 SACA1_HUMAN Sperm acrosome membrane-associated protein 1 (Sperm acrosomal membrane-associated protein 32) SPACA1 SAMP32 Homo sapiens (Human) acrosome assembly [GO:0001675] acrosomal membrane [GO:0002080]; inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021] acrosomal membrane [GO:0002080]; inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021]; acrosome assembly [GO:0001675] GO:0001675; GO:0002079; GO:0002080; GO:0016021 DSTSLDQLPTEMPGEDDALSEWNE 0.93934 3.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8723 0 0 0 0 0 0 0 0 0 0 0 0 12.5783 0 0 0 0 0 12.6624 0 0 0 0 0 0 0 0 0 14.044 0 0 0 0 0 0 0 13.6757 0 12.9274 0 14.2644 0 0 13.3978 10.4902 0 0 12.3065 0 0 0 0 0 13.292 0 0 0 0 0 12.9352 0 0 0 15.1064 12.9592 0 0 0 0 0 0 0 0 0 0 0 14.8481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWV2 SPAT9_HUMAN Spermatogenesis-associated protein 9 (Testis development protein NYD-SP16) SPATA9 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 EVNAPRQPLYNIQVR 0.93935 0.91848 0 0 0 0 0 0 0 0 0 18.0237 0 14.4152 14.6523 14.3324 14.6175 0 14.4421 12.209 15.1551 12.7378 0 0 0 14.3489 0 0 15.3347 15.0467 14.8264 0 14.8578 14.6213 0 13.6176 0 0 0 0 14.6269 14.8162 0 0 0 0 0 15.1791 0 0 19.0804 0 19.0756 0 0 0 0 0 0 0 0 0 0 0 14.1253 0 0 0 0 0 0 0 0 0 0 0 0 0 13.245 0 0 0 0 0 0 0 0 0 12.89 0 0 0 15.4026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5864 0 0 0 0 0 0 0 0 0 0 0 15.4853 0 0 0 0 0 0 0 0 12.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1602 0 0 0 0 0 0 0 0 0 0 15.8633 19.3663 15.7833 0 15.98 0 16.1433 16.2381 16.0439 0 0 15.5095 0 0 13.941 0 0 0 0 0 0 0 P63208 SKP1_HUMAN "S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19, p19A) (Organ of Corti protein 2, OCP-2) (Organ of Corti protein II, OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1)" SKP1 EMC19 OCP2 SKP1A TCEB1L Homo sapiens (Human) histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; histone H2A monoubiquitination [GO:0035518]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0008013; GO:0016567; GO:0019005; GO:0019904; GO:0031146; GO:0031467; GO:0035518; GO:0051457; GO:0070936; GO:0097602; GO:1904668; GO:1990444; GO:1990756 beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; protein domain specific binding [GO:0019904]; ubiquitin ligase-substrate adaptor activity [GO:1990756] KVIQWCTHHK 0.93936 0.91807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5333 13.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A494C0N9 F246B_HUMAN Protein FAM246B FAM246B Homo sapiens (Human) AAPRGPTLLRTLGTVSALVAASR 0.93938 1.7176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14714 SSPN_HUMAN Sarcospan (K-ras oncogene-associated protein) (Kirsten-ras-associated protein) SSPN KRAG Homo sapiens (Human) cell adhesion [GO:0007155]; muscle contraction [GO:0006936] anchoring junction [GO:0070161]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133] anchoring junction [GO:0070161]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of plasma membrane [GO:0005887]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133]; cell adhesion [GO:0007155]; muscle contraction [GO:0006936] GO:0005887; GO:0006936; GO:0007155; GO:0016010; GO:0030133; GO:0042383; GO:0045211; GO:0070161 ECGEEEPRTCCGCR 0.93938 1.0052 0 0 0 0 0 0 0 0 0 0 0 14.4955 0 0 0 11.86 0 0 12.6611 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8695 0 0 0 0 0 0 0 0 0 0 11.398 0 0 0 0 12.731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91458 0 0 0 0 14.6739 0 0 0 0 0 0 0 0 0 0 13.8222 0 14.2905 0 12.8556 13.3987 0 0 13.372 13.1783 0 0 0 0 15.2022 0 0 0 12.7204 0 0 0 12.3111 0 0 0 0 0 14.0411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3611 12.4101 0 0 0 0 0 0 0 0 0 13.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7571 0 0 0 0 0 0 0 P38919 IF4A3_HUMAN "Eukaryotic initiation factor 4A-III, eIF-4A-III, eIF4A-III, EC 3.6.4.13 (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic initiation factor 4A-like NUK-34) (Eukaryotic translation initiation factor 4A isoform 3) (Nuclear matrix protein 265, NMP 265, hNMP 265) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed ]" EIF4A3 DDX48 KIAA0111 Homo sapiens (Human) "associative learning [GO:0008306]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to selenite ion [GO:0072715]; embryonic cranial skeleton morphogenesis [GO:0048701]; exploration behavior [GO:0035640]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of selenocysteine insertion sequence binding [GO:1904574]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to organic cyclic compound [GO:0014070]; rRNA processing [GO:0006364]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; U2-type catalytic step 1 spliceosome [GO:0071006] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; U2-type catalytic step 1 spliceosome [GO:0071006]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368]; translation regulator activity [GO:0045182]; associative learning [GO:0008306]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to selenite ion [GO:0072715]; embryonic cranial skeleton morphogenesis [GO:0048701]; exploration behavior [GO:0035640]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of selenocysteine incorporation [GO:1904570]; negative regulation of selenocysteine insertion sequence binding [GO:1904574]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to organic cyclic compound [GO:0014070]; rRNA processing [GO:0006364]" GO:0000184; GO:0000398; GO:0003723; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006406; GO:0008143; GO:0008306; GO:0014070; GO:0016020; GO:0016607; GO:0016887; GO:0017148; GO:0030425; GO:0035145; GO:0035368; GO:0035613; GO:0035640; GO:0043021; GO:0043025; GO:0045182; GO:0045727; GO:0048701; GO:0071006; GO:0071013; GO:0072715; GO:0090394; GO:0098978; GO:0099524; GO:0099578; GO:1904570; GO:1904574; GO:1990416; GO:2000622 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; selenocysteine insertion sequence binding [GO:0035368]; translation regulator activity [GO:0045182] FDTLCDLYDTLTITQAVIFCNTKR 0.93939 2.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.146 0 0 0 15.4754 0 0 15.0823 14.0969 0 0 0 0 0 0 14.7896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6416 0 0 0 0 0 0 0 P21452 NK2R_HUMAN "Substance-K receptor, SKR (NK-2 receptor, NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2)" TACR2 NK2R NKNAR TAC2R Homo sapiens (Human) "intestine smooth muscle contraction [GO:0014827]; muscle contraction [GO:0006936]; negative regulation of luteinizing hormone secretion [GO:0033685]; operant conditioning [GO:0035106]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; prolactin secretion [GO:0070459]; response to electrical stimulus [GO:0051602]; tachykinin receptor signaling pathway [GO:0007217]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; substance K receptor activity [GO:0016497]; tachykinin receptor activity [GO:0004995]; intestine smooth muscle contraction [GO:0014827]; muscle contraction [GO:0006936]; negative regulation of luteinizing hormone secretion [GO:0033685]; operant conditioning [GO:0035106]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of uterine smooth muscle contraction [GO:0070474]; positive regulation of vascular permeability [GO:0043117]; prolactin secretion [GO:0070459]; response to electrical stimulus [GO:0051602]; tachykinin receptor signaling pathway [GO:0007217]" GO:0004995; GO:0005886; GO:0005887; GO:0006936; GO:0007217; GO:0014057; GO:0014827; GO:0016497; GO:0033685; GO:0035106; GO:0036126; GO:0043117; GO:0045987; GO:0051602; GO:0061827; GO:0070459; GO:0070474; GO:0097225; GO:1902093 substance K receptor activity [GO:0016497]; tachykinin receptor activity [GO:0004995] TLLLYHLVVIALIYFLPLAVMFVAYSVIGLTLWRR 0.93942 1.0096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.463 0 13.3457 0 0 0 0 0 0 0 0 12.0819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9N8 EIF1A_HUMAN Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein) (Haponin) EIF1AD Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GO:0003723; GO:0003743; GO:0005634; GO:0005654; GO:0005829; GO:0043231 RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] RQYHESEEESEEEEAA 0.93942 1.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13287 NMI_HUMAN "N-myc-interactor, Nmi (N-myc and STAT interactor)" NMI Homo sapiens (Human) interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein K48-linked ubiquitination [GO:0070936]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein K48-linked ubiquitination [GO:0070936]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142]; transcription by RNA polymerase II [GO:0006366] GO:0002281; GO:0003712; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007259; GO:0008285; GO:0009615; GO:0016020; GO:0032687; GO:0032688; GO:0034142; GO:0042802; GO:0045089; GO:0045824; GO:0050729; GO:0060333; GO:0070936; GO:1901223; GO:1901224; GO:1902524 identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712] EDQMRDK 0.93943 1.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7559 0 0 0 11.8809 0 0 0 0 0 11.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3633 0 0 0 0 Q9UHE8 STEA1_HUMAN "Metalloreductase STEAP1, EC 1.16.1.- (Six-transmembrane epithelial antigen of prostate 1)" STEAP1 PRSS24 STEAP Homo sapiens (Human) ion transport [GO:0006811]; iron ion homeostasis [GO:0055072] cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072] GO:0005768; GO:0005886; GO:0005887; GO:0005911; GO:0006811; GO:0010008; GO:0016020; GO:0016491; GO:0046872; GO:0055072 metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491] LGIVSLLLGTIHALIFAWNK 0.93946 1.0025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84942 0 0 0 0 0 0 0 0 0 0 0 11.4217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5685 0 12.107 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6081 0 Q9UK23 NAGPA_HUMAN "N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase, EC 3.1.4.45 (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase)" NAGPA Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; lysosome organization [GO:0007040]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944]; carbohydrate metabolic process [GO:0005975]; lysosome organization [GO:0007040]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299] GO:0003944; GO:0005975; GO:0006486; GO:0006622; GO:0007040; GO:0016021; GO:0032580; GO:0033299; GO:0036211 N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944] AGELSFFTRTAWLALTLALAFLLLISTAANLSLLLSR 0.93947 1.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2651 0 0 10.0932 0 0 9.77924 0 0 0 0 0 0 0 0 0 0 0 12.1361 0 0 0 0 16.6957 0 0 0 0 0 0 0 0 0 0 0 10.7109 0 0 0 0 0 0 0 0 0 0 9.72627 0 0 0 0 0 0 0 0 0 0 12.2941 0 0 0 0 14.4767 0 13.8201 0 0 11.5496 0 0 0 0 13.1813 0 0 0 0 0 0 0 12.2329 12.4779 0 0 0 0 0 0 0 11.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2003 0 0 0 0 0 0 14.3985 0 0 0 0 0 0 0 0 0 9.2861 0 0 0 10.3861 0 Q96I76 GPTC3_HUMAN G patch domain-containing protein 3 GPATCH3 GPATC3 Homo sapiens (Human) "negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032480; GO:0039536; GO:0045893 nucleic acid binding [GO:0003676] EEEEESHSDEDDDR 0.93948 1.0023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7771 10.9687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7868 15.0936 13.7332 0 0 14.6795 13.6485 0 0 13.076 0 0 0 0 0 0 0 0 0 13.3142 0 0 0 0 0 0 0 11.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1982 0 0 0 0 0 0 14.19 0 0 0 0 0 0 0 0 0 14.8314 14.2854 0 0 0 0 0 0 13.9789 13.7099 0 0 14.3064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3914 0 0 0 0 0 10.7156 12.6177 A0A0B4J279 TVA21_HUMAN T cell receptor alpha variable 21 TRAV21 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 QDPGKGLTSLLLIQSSQREQTSGR 0.93951 1.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01064 PDE1B_HUMAN "Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B, Cam-PDE 1B, EC 3.1.4.17 (63 kDa Cam-PDE)" PDE1B PDES1B Homo sapiens (Human) cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; locomotory behavior [GO:0007626]; monocyte differentiation [GO:0030224]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter levels [GO:0001505]; response to amphetamine [GO:0001975]; serotonin metabolic process [GO:0042428]; signal transduction [GO:0007165]; visual learning [GO:0008542] cytosol [GO:0005829]; neuronal cell body [GO:0043025] "cytosol [GO:0005829]; neuronal cell body [GO:0043025]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; locomotory behavior [GO:0007626]; monocyte differentiation [GO:0030224]; regulation of dopamine metabolic process [GO:0042053]; regulation of neurotransmitter levels [GO:0001505]; response to amphetamine [GO:0001975]; serotonin metabolic process [GO:0042428]; signal transduction [GO:0007165]; visual learning [GO:0008542]" GO:0001505; GO:0001975; GO:0004114; GO:0004115; GO:0004117; GO:0005516; GO:0005829; GO:0007165; GO:0007626; GO:0008542; GO:0030224; GO:0036006; GO:0042053; GO:0042428; GO:0043025; GO:0046872; GO:0047555; GO:0048101; GO:0097011 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]" FRSIVHAVQAGIFVERMFR 0.93951 3.4937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4584 0 0 0 0 0 0 0 0 0 0 0 0 13.5905 0 0 0 16.6584 0 14.8821 0 0 0 0 0 0 16.0455 0 0 0 0 0 0 0 0 12.3357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1972 0 14.2272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5663 0 P18510 IL1RA_HUMAN "Interleukin-1 receptor antagonist protein, IL-1RN, IL-1ra, IRAP (ICIL-1RA) (IL1 inhibitor) (Anakinra)" IL1RN IL1F3 IL1RA Homo sapiens (Human) acute-phase response [GO:0006953]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; insulin secretion [GO:0030073]; lipid metabolic process [GO:0006629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; response to glucocorticoid [GO:0051384] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]; interleukin-1 type I receptor antagonist activity [GO:0045352]; interleukin-1 type II receptor antagonist activity [GO:0045353]; interleukin-1, type I receptor binding [GO:0005150]; interleukin-1, type II receptor binding [GO:0005151]; acute-phase response [GO:0006953]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; insulin secretion [GO:0030073]; lipid metabolic process [GO:0006629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; response to glucocorticoid [GO:0051384]" GO:0002437; GO:0005125; GO:0005149; GO:0005150; GO:0005151; GO:0005152; GO:0005615; GO:0005737; GO:0005886; GO:0006629; GO:0006953; GO:0006954; GO:0006955; GO:0030073; GO:0034115; GO:0045352; GO:0045353; GO:0051384; GO:0070062; GO:2000660 "cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]; interleukin-1 type I receptor antagonist activity [GO:0045352]; interleukin-1 type II receptor antagonist activity [GO:0045353]; interleukin-1, type I receptor binding [GO:0005150]; interleukin-1, type II receptor binding [GO:0005151]" GLRSHLITLLLFLFHSETICRPSGR 0.93952 1.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50281 MMP14_HUMAN "Matrix metalloproteinase-14, MMP-14, EC 3.4.24.80 (MMP-X1) (Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1) (Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP)" MMP14 Homo sapiens (Human) angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; cell motility [GO:0048870]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; macropinosome [GO:0044354]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; astrocyte cell migration [GO:0043615]; branching morphogenesis of an epithelial tube [GO:0048754]; cell motility [GO:0048870]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; endodermal cell differentiation [GO:0035987]; endothelial cell proliferation [GO:0001935]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; head development [GO:0060322]; lung development [GO:0030324]; male gonad development [GO:0008584]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Notch signaling pathway [GO:0045746]; ovarian follicle development [GO:0001541]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of macrophage migration [GO:1905523]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein localization to plasma membrane [GO:1903076]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to odorant [GO:1990834]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501]; tissue remodeling [GO:0048771]; zymogen activation [GO:0031638] GO:0001501; GO:0001525; GO:0001541; GO:0001666; GO:0001935; GO:0001958; GO:0004175; GO:0004222; GO:0004252; GO:0005178; GO:0005615; GO:0005634; GO:0005796; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006508; GO:0006979; GO:0008270; GO:0008584; GO:0009612; GO:0010831; GO:0010954; GO:0014070; GO:0016485; GO:0022617; GO:0030198; GO:0030307; GO:0030324; GO:0030335; GO:0030574; GO:0031012; GO:0031410; GO:0031638; GO:0035987; GO:0035988; GO:0042470; GO:0043615; GO:0043627; GO:0044354; GO:0045111; GO:0045579; GO:0045746; GO:0048701; GO:0048754; GO:0048771; GO:0048870; GO:0051895; GO:0060322; GO:0070006; GO:0097094; GO:1903076; GO:1905523; GO:1990834 endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] ADADTMKAMR 0.93952 0.93103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8572 13.0422 14.4895 0 14.2406 14.7066 14.4284 14.0947 13.6912 13.5702 13.3914 13.365 12.1277 13.4603 0 0 11.3796 0 0 0 0 0 11.4712 0 0 0 0 11.3828 0 11.93 13.2358 14.5847 0 0 0 10.1665 0 0 0 0 0 14.9433 0 0 12.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.67 12.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0414 0 0 11.7106 0 0 0 12.2658 0 0 0 0 11.4859 0 13.2765 0 0 11.0922 0 0 0 0 0 0 0 0 12.3654 0 0 12.4306 0 0 0 12.7566 0 0 0 0 13.7503 13.3933 13.536 0 0 0 12.0747 0 0 Q5EBL2 ZN628_HUMAN Zinc finger protein 628 ZNF628 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0007283; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LHSGERPYACGECGKAFR 0.93953 1.7722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3008 0 0 0 0 0 13.0349 0 0 0 0 0 0 10.0399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9551 0 0 0 0 0 0 16.0416 12.0027 0 0 0 0 0 0 0 0 11.0861 0 0 10.1893 11.508 0 0 0 0 0 0 0 0 0 0 0 0 11.5527 0 0 0 0 0 0 0 0 0 10.1501 14.8361 0 0 Q6BAA4 FCRLB_HUMAN "Fc receptor-like B (Fc receptor homolog expressed in B-cells protein 2, FREB-2) (Fc receptor-like and mucin-like protein 2) (Fc receptor-like protein 2) (Fc receptor-related protein Y, FcRY)" FCRLB FCRL2 FCRLM2 FCRY FREB2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; negative regulation of immune response [GO:0050777] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of immune response [GO:0050777] GO:0004888; GO:0005737; GO:0005783; GO:0005887; GO:0007166; GO:0050777 transmembrane signaling receptor activity [GO:0004888] ASDSGRYQCSGTMR 0.93955 1.783 0 0 0 0 14.2074 13.5114 14.0488 13.6601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2602 14.4998 0 13.4046 0 0 0 0 0 0 0 0 0 0 13.8342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1945 0 0 0 0 13.8775 0 0 0 0 0 0 0 0 0 0 0 0 0 15.188 0 13.178 0 0 0 13.0971 0 0 0 A5D6W6 FITM1_HUMAN Fat storage-inducing transmembrane protein 1 (Fat-inducing protein 1) FITM1 FIT1 Homo sapiens (Human) lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890] GO:0005789; GO:0008654; GO:0010890; GO:0017129; GO:0019915; GO:0019992; GO:0030176; GO:0034389; GO:0140042 diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129] HLSRLVVGAAVWR 0.93957 0.9203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21583 SCF_HUMAN "Kit ligand (Mast cell growth factor, MGF) (Stem cell factor, SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand, sKITLG ]" KITLG MGF SCF Homo sapiens (Human) cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hematopoietic progenitor cell differentiation [GO:0002244]; male gonad development [GO:0008584]; mast cell apoptotic process [GO:0033024]; mast cell migration [GO:0097531]; mast cell proliferation [GO:0070662]; melanocyte migration [GO:0097324]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of T cell proliferation [GO:0042102]; Ras protein signal transduction [GO:0007265]; T cell proliferation [GO:0042098] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173]; cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hematopoietic progenitor cell differentiation [GO:0002244]; male gonad development [GO:0008584]; mast cell apoptotic process [GO:0033024]; mast cell migration [GO:0097531]; mast cell proliferation [GO:0070662]; melanocyte migration [GO:0097324]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of T cell proliferation [GO:0042102]; Ras protein signal transduction [GO:0007265]; T cell proliferation [GO:0042098] GO:0001541; GO:0001755; GO:0002244; GO:0002573; GO:0002687; GO:0002763; GO:0005125; GO:0005173; GO:0005576; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0007155; GO:0007265; GO:0008083; GO:0008284; GO:0008584; GO:0016021; GO:0018108; GO:0030027; GO:0030175; GO:0033024; GO:0033026; GO:0035162; GO:0035234; GO:0042098; GO:0042102; GO:0043406; GO:0045636; GO:0046579; GO:0050731; GO:0070662; GO:0070668; GO:0097192; GO:0097324; GO:0097531; GO:1901534; GO:1902035 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173] DSRVSVTKPFMLPPVAASSLR 0.93957 1.7214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7231 0 0 0 0 0 0 0 0 0 0 0 0 14.9037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96D96 HVCN1_HUMAN "Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1, HV1) (Voltage sensor domain-only protein)" HVCN1 VSOP UNQ578/PRO1140 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; positive regulation of superoxide anion generation [GO:0032930]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; identical protein binding [GO:0042802]; voltage-gated cation channel activity [GO:0022843]; voltage-gated proton channel activity [GO:0030171]; cell redox homeostasis [GO:0045454]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; positive regulation of superoxide anion generation [GO:0032930]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043] GO:0005886; GO:0005887; GO:0009268; GO:0010043; GO:0016021; GO:0016324; GO:0022843; GO:0030171; GO:0030667; GO:0030670; GO:0032930; GO:0034765; GO:0035579; GO:0042802; GO:0045454; GO:0051453; GO:0071294; GO:0071467; GO:1902600 identical protein binding [GO:0042802]; voltage-gated cation channel activity [GO:0022843]; voltage-gated proton channel activity [GO:0030171] FLRHFTVVGDDYHAWNINYKK 0.93957 3.5336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9698 0 12.5981 0 13.2256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9353 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7749 10.3908 0 0 0 0 0 0 0 0 0 13.0305 0 0 0 0 0 0 0 0 0 0 0 0 10.3079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7943 0 0 0 0 0 0 0 0 12.6488 0 0 0 0 10.4819 0 0 0 0 0 0 0 0 15.8264 O00144 FZD9_HUMAN "Frizzled-9, Fz-9, hFz9 (FzE6) (CD antigen CD349)" FZD9 FZD3 Homo sapiens (Human) B cell differentiation [GO:0030183]; bone regeneration [GO:1990523]; canonical Wnt signaling pathway [GO:0060070]; learning or memory [GO:0007611]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904394]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; postsynapse organization [GO:0099173]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; release of cytochrome c from mitochondria [GO:0001836] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; filopodium membrane [GO:0031527]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; B cell differentiation [GO:0030183]; bone regeneration [GO:1990523]; canonical Wnt signaling pathway [GO:0060070]; learning or memory [GO:0007611]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904394]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; postsynapse organization [GO:0099173]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; release of cytochrome c from mitochondria [GO:0001836] GO:0001503; GO:0001836; GO:0004930; GO:0005737; GO:0005789; GO:0005794; GO:0005886; GO:0007399; GO:0007405; GO:0007611; GO:0009986; GO:0016021; GO:0017147; GO:0030183; GO:0030501; GO:0031527; GO:0031966; GO:0042803; GO:0042813; GO:0043065; GO:0043524; GO:0046982; GO:0048471; GO:0051480; GO:0051726; GO:0051902; GO:0060070; GO:0060546; GO:0090263; GO:0098794; GO:0098978; GO:0099173; GO:0099566; GO:1901029; GO:1904393; GO:1904394; GO:1990523; GO:2000179 G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] APGSYGR 0.93958 3.6324 0 0 16.811 14.8618 13.3224 15.3006 10.4793 12.9837 0 0 0 0 0 0 12.3959 14.8584 0 17.1133 18.3714 18.3135 15.4152 0 18.3101 14.6695 18.0322 15.6018 0 0 0 0 0 0 0 0 0 0 0 16.8094 0 0 0 0 0 11.6256 10.5366 0 0 12.719 13.1917 12.8317 12.7754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3799 0 0 0 18.1674 18.1254 0 18.0954 0 18.0281 12.1575 13.1042 14.5901 0 15.013 13.4007 14.0231 13.6019 14.2025 15.1293 14.9821 15.0571 15.5168 14.7382 15.0301 14.3953 13.4235 12.9307 13.6359 0 0 15.091 18.4167 14.5022 17.3775 17.3449 16.963 18.6935 14.7611 15.4442 13.8331 18.2387 12.7402 18.1751 12.4862 18.1428 0 12.8845 0 0 0 18.3331 12.4978 14.0948 14.6653 13.2416 14.8072 14.3249 0 18.4493 13.5688 14.1906 18.4938 11.4245 18.3778 12.6822 14.3498 0 16.5435 18.4632 18.6466 13.8388 0 13.9282 0 14.4821 18.6057 11.9341 13.354 12.2578 0 0 14.0218 18.7307 18.7267 18.8532 18.8472 18.8061 0 0 0 0 0 0 0 0 12.6894 13.9661 0 0 13.4294 0 0 18.5221 18.4091 12.2693 0 0 0 0 0 14.3132 Q3SXM5 HSDL1_HUMAN Inactive hydroxysteroid dehydrogenase-like protein 1 (Short chain dehydrogenase/reductase family 12C member 3) HSDL1 SDR12C3 Homo sapiens (Human) intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] GO:0005739; GO:0043231; GO:0045111 DIADTYKVETDIIVADFSSGREIYLPIR 0.93959 0.95245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6567 0 0 0 0 0 0 0 12.7139 0 0 0 0 0 0 0 0 0 0 0 0 12.4391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4785 0 0 0 0 0 0 13.3232 0 0 0 0 0 0 13.8803 0 0 13.6938 0 0 0 0 0 14.0414 0 0 0 0 13.3814 0 0 0 0 0 0 0 0 15.3187 0 13.3648 0 0 13.6026 0 0 0 0 13.4198 13.474 0 12.9715 0 0 0 0 0 0 0 0 15.6286 14.6265 0 14.7228 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2458 0 0 16.2225 15.0963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZJ6 GPR63_HUMAN Probable G-protein coupled receptor 63 (PSP24-2) (PSP24-beta) GPR63 PSP24B Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007186; GO:0016021; GO:0043235 G protein-coupled receptor activity [GO:0004930] FHDACLDMMPKSFKFLPQLPGHTK 0.93959 0.91864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8874 0 0 0 0 0 0 11.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LP2 FA81B_HUMAN Protein FAM81B FAM81B Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 IKEDISACLQGTHGFRK 0.9396 1.7926 0 14.0077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1585 0 0 0 10.4184 14.7367 0 0 0 0 0 0 20.1307 19.2566 15.5885 0 14.1303 18.7644 15.6839 15.2046 15.7578 0 0 0 0 14.2218 13.7005 0 0 0 14.3997 14.3229 13.8569 0 0 0 0 0 0 14.6239 14.4457 13.1776 13.6641 0 0 12.1259 0 0 0 0 0 0 0 0 0 0 0 13.2764 0 0 0 0 0 0 0 0 0 0 0 0 13.7624 0 0 0 0 14.0175 0 0 13.2859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYW4 TA2R5_HUMAN "Taste receptor type 2 member 5, T2R5" TAS2R5 Homo sapiens (Human) chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0007635; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] TVCARRCWGP 0.9396 0.90962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2809 0 0 0 11.4514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2365 12.7113 0 0 0 0 0 0 12.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7593 0 0 0 0 13.1026 0 0 0 0 13.0774 0 0 11.783 0 0 0 0 0 13.2678 0 0 0 0 0 0 0 0 0 0 0 12.1762 0 0 0 0 0 0 0 0 0 0 0 0 12.0286 0 0 0 0 0 0 0 0 0 11.7295 12.3944 0 0 0 0 Q7L190 DPPA4_HUMAN Developmental pluripotency-associated protein 4 DPPA4 Homo sapiens (Human) lung-associated mesenchyme development [GO:0060484]; system development [GO:0048731] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lung-associated mesenchyme development [GO:0060484]; system development [GO:0048731] GO:0003682; GO:0005634; GO:0005654; GO:0048731; GO:0060484 chromatin binding [GO:0003682] IPIPPLPSK 0.93964 1.0055 0 0 0 11.6837 11.2451 13.6432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6421 0 17.2087 0 12.3911 0 0 0 0 13.5008 0 0 0 0 0 0 0 0 0 12.6169 0 0 12.6259 0 0 0 0 0 0 0 15.1654 0 9.99548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3461 12.221 0 12.444 0 0 0 0 0 0 11.7171 15.1079 14.3278 0 0 0 0 14.7919 0 0 15.9134 0 0 0 0 18.5339 0 16.0128 0 11.4682 0 0 0 0 0 0 17.0643 0 15.4456 15.5822 0 16.3431 16.9624 0 0 16.0032 0 15.1581 0 0 0 17.0172 0 15.0654 12.198 0 15.7327 13.5643 16.2962 0 15.3135 15.4527 14.1955 0 14.7522 14.1461 13.3939 11.6349 0 0 0 15.9728 12.1919 0 0 13.3329 13.6369 0 0 13.508 12.3299 0 0 13.1841 0 0 16.7996 0 15.8095 0 0 0 0 0 0 0 0 0 0 0 0 10.1424 10.9942 0 13.7885 0 18.8809 0 0 0 0 14.7916 0 Q8N695 SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) SLC5A8 AIT SMCT SMCT1 Homo sapiens (Human) apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; propanoate transport [GO:0015730]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic acid:sodium symporter activity [GO:0005343]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; symporter activity [GO:0015293]; apoptotic process [GO:0006915]; ion transport [GO:0006811]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; propanoate transport [GO:0015730]; sodium ion transport [GO:0006814] GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006915; GO:0008028; GO:0015129; GO:0015293; GO:0015552; GO:0015730; GO:0016021; GO:0016324; GO:0022803; GO:0034356; GO:0070062; GO:0140161 lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic acid:sodium symporter activity [GO:0005343]; passive transmembrane transporter activity [GO:0022803]; propionate transmembrane transporter activity [GO:0015552]; symporter activity [GO:0015293] KQNLDPRYILTK 0.93966 1.0102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MT1 RN145_HUMAN "RING finger protein 145, EC 2.3.2.27" RNF145 Homo sapiens (Human) endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005783; GO:0005789; GO:0008270; GO:0012505; GO:0016021; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AQLGWKSFLLRR 0.93967 2.3881 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6933 0 0 0 12.0313 0 11.8464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0171 14.0546 0 17.3939 0 0 0 0 13.2044 13.2542 0 13.0616 0 0 13.7708 13.3868 0 13.19 0 0 13.3308 14.7928 0 0 13.6468 0 0 13.67 13.1806 13.5199 0 0 12.6133 0 0 0 0 14.9478 0 13.6055 13.8411 0 13.5969 0 0 0 0 0 0 13.5404 13.9171 0 0 0 0 0 13.7858 0 13.4138 13.5847 0 13.4696 0 0 0 0 0 14.0663 13.841 14.0042 0 13.6482 0 0 0 0 0 14.0827 14.022 14.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4688 0 0 0 0 0 0 0 13.6982 0 0 0 0 0 0 P08397 HEM3_HUMAN "Porphobilinogen deaminase, PBG-D, EC 2.5.1.61 (Hydroxymethylbilane synthase, HMBS) (Pre-uroporphyrinogen synthase)" HMBS PBGD UPS Homo sapiens (Human) heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782] GO:0004418; GO:0005737; GO:0005829; GO:0006782; GO:0006783; GO:0018160 hydroxymethylbilane synthase activity [GO:0004418] GPQLAAQNLGISLANLLLSKGAKNILDVAR 0.9397 1.0037 0 0 0 0 0 0 0 0 13.6375 12.5585 12.3291 12.6264 12.7851 11.8925 12.4995 0 0 0 11.7006 0 13.7556 0 0 0 0 12.3186 0 0 0 12.3167 0 0 0 0 0 0 0 12.6129 0 11.47 0 0 0 11.4792 0 0 0 0 0 0 0 11.7196 16.7336 0 0 0 0 15.961 0 0 0 0 0 14.4522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6603 0 13.4833 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2712 0 0 0 14.1081 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8305 0 0 0 0 0 0 0 13.7268 10.7813 17.7505 12.1284 0 0 0 0 0 17.0964 0 0 0 0 12.5276 0 0 0 0 17.0148 0 0 0 0 Q96MA6 KAD8_HUMAN "Adenylate kinase 8, AK 8, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 8)" AK8 C9orf98 Homo sapiens (Human) nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; ventricular system development [GO:0021591] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; sperm flagellum [GO:0036126] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; sperm flagellum [GO:0036126]; adenylate kinase activity [GO:0004017]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; ventricular system development [GO:0021591] GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0005930; GO:0006165; GO:0009142; GO:0016208; GO:0021591; GO:0036126; GO:0097729 adenylate kinase activity [GO:0004017]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550] HVIVLSAPDTVLIERNLGKR 0.9397 3.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9742 11.2372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4434 0 0 0 0 0 0 14.9979 0 12.456 0 0 0 0 0 0 0 0 0 0 11.7733 12.8178 0 0 0 0 0 0 0 12.853 0 0 0 0 14.8667 0 12.9584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5313 0 12.9274 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T754 LCE1F_HUMAN Late cornified envelope protein 1F (Late envelope protein 6) LCE1F LEP6 Homo sapiens (Human) keratinization [GO:0031424] identical protein binding [GO:0042802]; keratinization [GO:0031424] GO:0031424; GO:0042802 identical protein binding [GO:0042802] CPPVSSCCSVSSGGCCGSSSGGCCSSGGGGCCSSGGGGCCLSHHR 0.93971 3.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4918 0 0 12.7048 0 0 11.2354 0 0 0 0 0 11.8544 0 11.4778 0 10.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1372 0 0 0 0 11.8058 0 0 0 10.444 0 11.8078 11.1603 14.8574 0 15.0407 0 0 13.7991 0 0 0 0 12.2372 0 0 15.369 13.1663 0 0 12.3679 0 0 13.3537 0 0 0 0 0 0 14.3652 0 0 0 11.0866 11.6641 12.9307 0 12.634 13.8853 0 0 0 0 0 12.3691 13.2378 0 0 0 13.894 0 0 0 0 0 0 12.7152 0 15.6464 0 14.8236 0 0 11.394 0 0 0 0 0 0 12.2126 12.2623 0 11.3075 0 0 0 0 0 12.8397 0 0 0 0 12.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 P12829 MYL4_HUMAN "Myosin light chain 4 (Myosin light chain 1, embryonic muscle/atrial isoform) (Myosin light chain alkali GT-1 isoform)" MYL4 MLC1 PRO1957 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of the force of heart contraction [GO:0002026] A band [GO:0031672]; cytosol [GO:0005829]; myosin II complex [GO:0016460] A band [GO:0031672]; cytosol [GO:0005829]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; calcium ion binding [GO:0005509]; myosin II heavy chain binding [GO:0032038]; cardiac muscle contraction [GO:0060048]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of the force of heart contraction [GO:0002026] GO:0002026; GO:0003785; GO:0005509; GO:0005829; GO:0016460; GO:0031672; GO:0032038; GO:0032781; GO:0051015; GO:0060048 actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; calcium ion binding [GO:0005509]; myosin II heavy chain binding [GO:0032038] ALGQNPTNAEVLRVLGKPK 0.93972 1.0034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12836 ZP4_HUMAN "Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4, Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4 ]" ZP4 ZPB Homo sapiens (Human) acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804]; acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468] GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0016021; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360 acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804] GDCEGLGCCYSSEEVNSCYYGNTVTLHCTR 0.93975 2.6179 0 0 0 0 0 0 13.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 11.635 0 0 0 0 11.5195 0 0 13.0123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3339 10.3036 0 0 0 0 12.154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3989 0 0 14.9788 0 14.4778 14.3455 14.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5707 0 12.6267 0 0 0 0 0 13.3754 0 0 0 0 0 0 0 13.9653 0 0 0 0 10.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2437 0 0 12.6877 13.3925 13.3428 13.163 12.6426 13.7474 9.58708 0 0 0 0 0 0 13.4436 0 0 14.3044 0 14.3722 0 14.0138 0 0 Q659A1 ICE2_HUMAN Little elongation complex subunit 2 (Interactor of little elongator complex ELL subunit 2) (NMDA receptor-regulated protein 2) ICE2 BRCC1 NARG2 UNQ3101/PRO10100 Homo sapiens (Human) positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] GO:0000791; GO:0005654; GO:0005829; GO:0008023; GO:0015030; GO:0016604; GO:0035363; GO:0042795; GO:0042796; GO:0045945 CAQDYNMLSDDARLFTEKILR 0.93976 2.6606 0 13.7027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2738 0 0 0 0 0 0 0 0 0 13.9931 0 0 14.6241 0 13.4007 0 0 0 14.4372 0 0 0 14.2381 0 14.7454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2141 0 0 0 0 14.6455 14.4803 0 0 12.6705 14.2268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6709 0 0 0 15.4535 14.1702 0 0 0 0 0 13.2437 0 0 13.6372 0 0 14.1592 17.378 0 0 12.7278 15.049 0 14.5485 15.0883 14.492 14.2164 13.8738 0 0 12.922 13.7585 14.964 0 0 12.7537 17.3356 0 14.9019 16.0758 15.9223 0 0 13.2389 14.5157 0 0 13.7421 0 0 0 0 0 11.962 0 0 13.3523 0 0 0 0 0 0 0 0 0 0 0 12.5839 0 14.1583 0 0 12.9338 0 14.6703 0 0 0 0 0 Q8TAK6 OLIG1_HUMAN "Oligodendrocyte transcription factor 1, Oligo1 (Class B basic helix-loop-helix protein 6, bHLHb6) (Class E basic helix-loop-helix protein 21, bHLHe21)" OLIG1 BHLHB6 BHLHE21 Homo sapiens (Human) neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte development [GO:0014003]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; oligodendrocyte development [GO:0014003]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0014003; GO:0030182; GO:0046983; GO:0048663 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAREKPEAPAEPPGPGPGSGAHPGGSAR 0.93977 2.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0283 0 0 0 0 12.3664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9833 0 0 0 0 0 0 0 0 0 0 10.9936 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2951 0 0 0 0 0 0 0 0 0 0 0 12.0219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2911 0 O00341 EAA5_HUMAN Excitatory amino acid transporter 5 (Retinal glutamate transporter) (Solute carrier family 1 member 7) SLC1A7 EAAT5 Homo sapiens (Human) dicarboxylic acid transport [GO:0006835]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; neutral amino acid transmembrane transporter activity [GO:0015175]; dicarboxylic acid transport [GO:0006835]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504] GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0006811; GO:0006835; GO:0006836; GO:0015175; GO:0015501; GO:0015813; GO:0016021; GO:0098793; GO:0098810 glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; neutral amino acid transmembrane transporter activity [GO:0015175] KNPIVFIRGILQALLIALATSSSSATLPITFK 0.93979 1.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7117 0 0 0 0 0 0 14.9925 14.2106 14.9283 14.519 14.3311 0 0 14.8055 14.51 0 0 0 0 13.7471 0 0 14.5372 12.6626 0 0 0 14.1134 0 0 0 0 0 0 0 0 0 0 13.4075 0 0 13.4578 0 0 0 0 0 13.3045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5115 0 0 0 0 12.3495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7108 0 0 0 0 0 0 12.8521 0 0 0 0 0 0 Q9BT04 FUZZY_HUMAN Protein fuzzy homolog FUZ FY Homo sapiens (Human) cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; intraciliary transport [GO:0042073]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314]; negative regulation of neural crest formation [GO:0090301]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; protein transport [GO:0015031]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; intraciliary transport [GO:0042073]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314]; negative regulation of neural crest formation [GO:0090301]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; protein transport [GO:0015031]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192] GO:0001736; GO:0001843; GO:0001942; GO:0005737; GO:0005856; GO:0005929; GO:0008285; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0021915; GO:0030336; GO:0042073; GO:0045724; GO:0048704; GO:0060271; GO:0070062; GO:0090090; GO:0090301; GO:1902017; GO:1905515; GO:2000314 ACLPLGPR 0.93982 1.7886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8041 0 0 14.1967 13.2569 0 0 14.4538 14.5204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5161 11.8635 0 0 0 0 0 0 0 12.3488 13.1683 11.8537 0 0 0 0 0 0 12.4051 0 14.7342 0 0 0 0 0 0 0 14.5267 0 0 0 0 0 0 0 0 0 11.9609 0 0 0 0 0 0 0 13.8388 0 0 0 0 12.3309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9189 10.3486 0 0 0 0 0 0 Q9HBU1 BARX1_HUMAN Homeobox protein BarH-like 1 BARX1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; digestive system development [GO:0055123]; endothelial cell differentiation [GO:0045446]; negative regulation of Wnt signaling pathway [GO:0030178]; regulation of transcription by RNA polymerase II [GO:0006357]; spleen development [GO:0048536]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; anterior/posterior pattern specification [GO:0009952]; digestive system development [GO:0055123]; endothelial cell differentiation [GO:0045446]; negative regulation of Wnt signaling pathway [GO:0030178]; regulation of transcription by RNA polymerase II [GO:0006357]; spleen development [GO:0048536]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0009952; GO:0016055; GO:0030178; GO:0045446; GO:0048536; GO:0055123 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" FGVQALLAARPFHSHLAVLK 0.93982 1.7099 0 0 0 0 0 0 0 0 0 10.9759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQH7 XPP3_HUMAN "Xaa-Pro aminopeptidase 3, X-Pro aminopeptidase 3, EC 3.4.11.9 (Aminopeptidase P3, APP3)" XPNPEP3 Homo sapiens (Human) glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508] GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0008233; GO:0016485; GO:0030145; GO:0042803; GO:0070006 aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803] DPSRELWDGPR 0.93982 0.91077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5689 0 0 0 0 0 0 0 0 0 14.4909 0 11.0868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4133 0 0 0 0 0 13.9072 12.5919 0 0 0 14.4924 13.5456 14.5028 12.5798 0 0 13.5923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2374 14.4658 0 0 0 0 12.5975 15.3621 0 0 0 12.475 14.4088 0 12.7694 13.6673 0 14.3576 0 13.5441 0 0 0 0 13.8485 0 0 13.7261 14.9893 0 0 14.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4579 0 0 0 0 0 0 0 13.4742 0 0 13.7818 0 0 0 0 0 0 13.4381 0 0 0 0 0 0 Q6QEF8 CORO6_HUMAN "Coronin-6 (Coronin-like protein E, Clipin-E)" CORO6 PP1009 PP1782 PP1881 Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477] actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cell migration [GO:0016477] GO:0007015; GO:0016477; GO:0051015 actin filament binding [GO:0051015] CEPIIMTVPR 0.93984 0.90982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3684 13.0986 0 12.9161 0 0 0 0 0 0 0 0 0 13.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXV1 IZUM2_HUMAN Izumo sperm-egg fusion protein 2 IZUMO2 C19orf41 SCRL UNQ6978/PRO21961 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ACNPKLCR 0.93984 0.95307 0 0 0 12.9684 13.5657 0 0 0 0 0 12.7751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7933 0 12.4756 0 0 0 0 0 0 0 0 12.4121 0 0 0 0 0 0 0 0 0 0 13.383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.807 0 0 0 0 12.3492 0 0 0 0 0 0 0 0 12.7069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5957 0 0 0 0 0 A6BM72 MEG11_HUMAN "Multiple epidermal growth factor-like domains protein 11, Multiple EGF-like domains protein 11" MEGF11 KIAA1781 UNQ1949/PRO4432 Homo sapiens (Human) homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842] GO:0010842; GO:0016021; GO:0016323; GO:0034109 HSVGAVTGIMLLLFLIVVLLGLFAWHRRR 0.93988 2.4904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4153 13.6199 13.4976 0 0 13.6888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9487 0 0 0 0 0 0 0 0 0 0 13.4642 0 11.7461 0 0 0 0 0 10.6736 0 0 0 0 0 0 0 14.4909 12.0476 0 0 13.6254 0 0 12.0703 11.5393 0 13.7991 0 0 0 12.5837 12.958 0 11.8252 0 0 0 0 14.8644 12.2272 0 0 0 0 0 0 0 0 12.252 0 0 13.6746 11.8473 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0183 11.8377 13.3393 0 0 0 0 0 0 10.8315 O15232 MATN3_HUMAN Matrilin-3 MATN3 Homo sapiens (Human) cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; cartilage development [GO:0051216]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] GO:0001501; GO:0005201; GO:0005509; GO:0005576; GO:0005788; GO:0030198; GO:0031012; GO:0051216; GO:0062023; GO:0120216 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] CALGTHGCQHICVNDRTGSHHCECYEGYTLNADKK 0.93988 3.5849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7639 12.7915 0 0 0 0 0 0 0 0 0 0 0 0 11.4833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3563 11.0857 13.9263 12.0504 0 0 0 0 0 0 0 12.3106 0 0 0 0 0 14.4865 14.276 0 0 0 12.8874 14.5643 0 0 0 0 0 14.5795 15.6661 14.1587 0 0 0 0 0 0 14.496 0 0 0 0 0 0 0 13.4282 0 0 0 0 0 0 14.6919 0 0 11.4608 14.8915 0 0 0 0 0 0 14.5923 0 0 0 0 0 0 0 15.1474 0 0 0 11.4235 0 0 0 0 10.744 0 0 0 14.0464 0 0 11.5983 0 0 0 0 0 0 0 0 0 0 0 0 Q05952 STP2_HUMAN "Nuclear transition protein 2, TP-2, TP2" TNP2 Homo sapiens (Human) "acrosome reaction [GO:0007340]; penetration of zona pellucida [GO:0007341]; positive regulation of protein processing [GO:0010954]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" nucleosome [GO:0000786]; nucleus [GO:0005634] "nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; penetration of zona pellucida [GO:0007341]; positive regulation of protein processing [GO:0010954]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" GO:0000786; GO:0003677; GO:0005634; GO:0007283; GO:0007340; GO:0007341; GO:0008270; GO:0010954; GO:0035093 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] PTILHCRCPKNR 0.93989 1.0102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7P2 LCE1A_HUMAN Late cornified envelope protein 1A (Late envelope protein 1) LCE1A LEP1 Homo sapiens (Human) keratinization [GO:0031424] cytosol [GO:0005829] cytosol [GO:0005829]; keratinization [GO:0031424] GO:0005829; GO:0031424 CPPVSSCCSVSSGGCCGSSSGGGCSSGGGGCCLSHHR 0.93989 3.4502 0 0 0 11.2295 0 0 0 0 13.3599 13.6188 14.7814 0 0 0 0 0 0 0 0 10.8697 0 0 0 0 11.1068 11.6761 0 13.4457 0 0 0 13.0214 0 0 0 0 13.4285 0 13.6671 0 13.0061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3909 0 0 0 0 11.4767 0 12.7213 12.4577 0 0 0 0 0 13.5669 0 0 13.1439 0 0 0 0 0 11.6579 11.7498 0 0 0 0 0 0 0 0 0 11.9849 13.6162 0 0 0 0 0 12.508 0 0 0 0 12.9245 0 12.2571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.077 13.887 12.5476 0 0 0 0 0 0 12.9452 0 0 0 0 12.4296 0 0 0 12.5981 13.4986 0 0 0 12.894 0 0 0 0 0 0 0 14.0252 0 0 12.3182 0 13.0894 11.3319 0 0 0 0 0 0 Q6JVE5 LCN12_HUMAN Epididymal-specific lipocalin-12 LCN12 Homo sapiens (Human) extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; retinoic acid binding [GO:0001972] GO:0001972; GO:0005576; GO:0005615 retinoic acid binding [GO:0001972] HTSRLAVLRISLLGR 0.93992 0.90729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7444 0 0 0 0 0 0 0 0 0 12.6054 13.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22607 FGFR3_HUMAN "Fibroblast growth factor receptor 3, FGFR-3, EC 2.7.10.1 (CD antigen CD333)" FGFR3 JTK4 Homo sapiens (Human) bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0000165; GO:0001501; GO:0001958; GO:0002062; GO:0003416; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0007267; GO:0008284; GO:0008543; GO:0009986; GO:0010518; GO:0017134; GO:0018108; GO:0030133; GO:0030282; GO:0033674; GO:0035988; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048640; GO:0060349; GO:0070374; GO:0070977; GO:1902178 ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] AAKPVTVAVK 0.93993 0.90701 0 0 0 0 0 0 0 0 0 10.7206 0 0 11.3579 0 0 14.9208 0 0 0 0 0 0 0 0 0 14.1312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5241 0 0 13.4271 0 0 0 0 0 0 12.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3181 0 0 0 0 0 0 0 0 15.7575 0 0 0 15.494 0 16.2185 15.1977 14.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2591 0 12.6712 0 12.8117 13.2999 12.3247 10.4378 0 0 0 0 0 0 11.2731 0 0 0 0 0 0 0 0 0 0 11.747 0 0 12.1073 0 0 10.722 0 11.796 0 0 0 0 0 0 0 11.13 0 0 11.3612 0 0 0 0 0 0 0 0 0 0 0 12.1255 0 0 0 0 0 0 0 0 Q9NVE4 CCD87_HUMAN Coiled-coil domain-containing protein 87 CCDC87 Homo sapiens (Human) cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] cell differentiation [GO:0030154]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] GO:0007283; GO:0007338; GO:0030154; GO:1905516; GO:2000344 ARLRQLPSLVNAWER 0.93994 4.1864 0 0 0 12.1484 0 0 0 0 0 0 0 0 0 12.9245 0 0 0 0 0 0 0 0 0 14.2995 15.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6587 16.7743 0 15.7509 13.0406 0 0 0 0 19.1778 18.3627 13.8767 12.6043 23.0906 14.9863 13.7617 13.7593 0 0 14.7949 12.8459 13.0335 15.3874 19.1375 16.9809 17.0407 11.9015 0 0 11.389 12.9217 12.8612 19.7493 19.7187 19.6335 0 14.627 0 18.8992 0 18.5281 0 0 0 20.3096 0 13.4264 0 12.9454 15.8238 0 20.0575 0 0 13.6613 0 0 13.0243 0 20.089 0 0 20.2161 0 16.0311 14.3628 14.3081 12.4215 19.2536 14.3405 19.5996 0 20.1186 0 12.1225 0 0 15.0221 0 12.3035 0 0 0 20.0576 19.1836 19.6774 0 0 0 14.6051 0 0 0 0 0 0 0 0 13.9939 0 0 14.9391 0 0 0 0 0 0 14.7119 0 Q9H6E4 CC134_HUMAN Coiled-coil domain-containing protein 134 CCDC134 Homo sapiens (Human) angiogenesis [GO:0001525]; embryonic hemopoiesis [GO:0035162]; embryonic liver development [GO:1990402]; placenta development [GO:0001890]; ventricular system development [GO:0021591] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634]; angiogenesis [GO:0001525]; embryonic hemopoiesis [GO:0035162]; embryonic liver development [GO:1990402]; placenta development [GO:0001890]; ventricular system development [GO:0021591] GO:0001525; GO:0001890; GO:0005576; GO:0005634; GO:0005783; GO:0016020; GO:0021591; GO:0035162; GO:1990402 EIRKGPR 0.93996 1.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9451 0 13.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5907 0 0 0 14.4028 0 0 0 0 0 10.8213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4349 13.1731 0 0 0 0 0 13.845 0 0 0 0 0 0 0 0 14.2321 P51685 CCR8_HUMAN "C-C chemokine receptor type 8, C-C CKR-8, CC-CKR-8, CCR-8 (CC chemokine receptor CHEMR1) (CMKBRL2) (Chemokine receptor-like 1, CKR-L1) (GPR-CY6, GPRCY6) (TER1) (CD antigen CDw198)" CCR8 CKRL1 CMKBR8 CMKBRL2 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; coreceptor activity [GO:0015026]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0007155; GO:0007186; GO:0007204; GO:0009897; GO:0015026; GO:0016493; GO:0019722; GO:0019957; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; coreceptor activity [GO:0015026] ESCEKSSSCQQHSSR 0.93997 1.7614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.58 0 0 0 0 0 0 0 0 0 0 14.2836 0 0 13.7491 11.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969Q1 TRI63_HUMAN "E3 ubiquitin-protein ligase TRIM63, EC 2.3.2.27 (Iris RING finger protein) (Muscle-specific RING finger protein 1, MuRF-1, MuRF1) (RING finger protein 28) (RING-type E3 ubiquitin transferase TRIM63) (Striated muscle RING zinc finger protein) (Tripartite motif-containing protein 63)" TRIM63 IRF MURF1 RNF28 SMRZ Homo sapiens (Human) muscle contraction [GO:0006936]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein ubiquitination [GO:0016567]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to glucocorticoid [GO:0051384]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732] cytoplasm [GO:0005737]; M band [GO:0031430]; microtubule [GO:0005874]; nucleus [GO:0005634]; Z disc [GO:0030018] cytoplasm [GO:0005737]; M band [GO:0031430]; microtubule [GO:0005874]; nucleus [GO:0005634]; Z disc [GO:0030018]; titin binding [GO:0031432]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; muscle contraction [GO:0006936]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein ubiquitination [GO:0016567]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to glucocorticoid [GO:0051384]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732] GO:0005634; GO:0005737; GO:0005874; GO:0006936; GO:0007165; GO:0008270; GO:0010614; GO:0014732; GO:0014878; GO:0016567; GO:0030018; GO:0031430; GO:0031432; GO:0051384; GO:0061630; GO:0070555 titin binding [GO:0031432]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CANDIFQAANPYWTSR 0.93997 1.7985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.157 0 0 12.9175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6999 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2977 0 0 13.8523 0 0 0 0 0 0 0 12.8221 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7607 0 11.6888 0 0 0 0 13.2734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N394 TMTC2_HUMAN "Protein O-mannosyl-transferase TMTC2, EC 2.4.1.109 (Transmembrane and TPR repeat-containing protein 2)" TMTC2 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269] GO:0000030; GO:0004169; GO:0005783; GO:0005789; GO:0016021; GO:0035269; GO:0055074 dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] KNLSLFLSISLLIFWGSSLLGARLYWMGNK 0.94 3.5829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8015 0 0 0 0 0 0 10.3359 12.6138 0 0 0 0 0 0 0 0 0 0 10.6093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2031 0 0 0 0 0 0 0 0 12.9556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8746 0 0 10.0466 0 0 12.6021 0 0 0 0 12.5113 0 0 0 0 14.3157 10.6267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2667 0 0 0 0 Q8TDD5 MCLN3_HUMAN "Mucolipin-3 (Transient receptor potential channel mucolipin 3, TRPML3)" MCOLN3 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626] autophagosome membrane [GO:0000421]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] autophagosome membrane [GO:0000421]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; calcium ion transmembrane transport [GO:0070588]; inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626] GO:0000421; GO:0005262; GO:0005765; GO:0005886; GO:0007626; GO:0008289; GO:0016020; GO:0016021; GO:0031901; GO:0031902; GO:0042491; GO:0070588; GO:0072345 calcium channel activity [GO:0005262]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345] FCCCAAMIYLGYCFCGWIVLGPYHDKFR 0.94 3.4485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5641 0 13.106 0 0 0 11.9886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8655 10.9228 0 0 13.5817 0 0 0 0 13.911 0 11.9621 0 0 0 13.9183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4478 0 0 0 0 0 0 0 0 0 15.1195 0 0 0 0 15.4252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7095 0 0 0 0 0 0 Q68CQ7 GL8D1_HUMAN "Glycosyltransferase 8 domain-containing protein 1, EC 2.4.1.-" GLT8D1 GALA4A AD-017 MSTP137 UNQ572/PRO1134 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycosyltransferase activity [GO:0016757] GO:0005794; GO:0016020; GO:0016021; GO:0016757 glycosyltransferase activity [GO:0016757] AAKLLHWNGHLK 0.94002 2.5103 0 0 0 0 0 0 0 0 0 0 0 0 11.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7724 0 0 0 0 0 14.9421 11.7554 0 0 0 0 12.036 0 11.6834 11.7468 0 0 0 0 0 0 13.6672 11.5954 0 0 0 0 0 11.4093 11.5146 0 0 0 12.2337 12.1584 0 0 0 0 12.8923 12.1243 0 0 0 13.0493 11.9667 11.4396 0 0 0 0 13.1609 0 0 0 0 0 0 0 0 0 0 0 11.3538 0 0 12.6772 0 11.8614 0 0 0 0 12.1482 0 0 0 0 0 0 0 0 0 0 0 0 12.0028 0 0 0 11.3667 0 0 0 0 0 0 0 0 0 12.4925 0 0 0 0 0 0 0 0 0 0 15.0884 P30989 NTR1_HUMAN "Neurotensin receptor type 1, NT-R-1, NTR1 (High-affinity levocabastine-insensitive neurotensin receptor) (NTRH)" NTSR1 NTRR Homo sapiens (Human) adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate catabolic process [GO:0071545]; L-glutamate import across plasma membrane [GO:0098712]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of action potential [GO:0098900]; regulation of membrane depolarization [GO:0003254]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of sensory perception of pain [GO:0051930]; response to lipid [GO:0033993]; temperature homeostasis [GO:0001659] cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; terminal bouton [GO:0043195] cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; terminal bouton [GO:0043195]; G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate catabolic process [GO:0071545]; L-glutamate import across plasma membrane [GO:0098712]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of action potential [GO:0098900]; regulation of membrane depolarization [GO:0003254]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of sensory perception of pain [GO:0051930]; response to lipid [GO:0033993]; temperature homeostasis [GO:0001659] GO:0001659; GO:0003085; GO:0003254; GO:0004930; GO:0005739; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0007268; GO:0007612; GO:0008344; GO:0009898; GO:0009986; GO:0010628; GO:0014049; GO:0014054; GO:0016492; GO:0032280; GO:0033993; GO:0042802; GO:0043065; GO:0043066; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0043576; GO:0044877; GO:0045121; GO:0047485; GO:0050965; GO:0051092; GO:0051280; GO:0051281; GO:0051930; GO:0060732; GO:0070779; GO:0071545; GO:0090238; GO:0097151; GO:0098712; GO:0098900; GO:2001259 G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877] AVVIAFVVCWLPYHVRR 0.94004 3.5221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4423 0 0 0 0 15.8864 0 0 0 0 0 0 14.6521 14.4585 14.1202 15.2581 15.0898 13.0181 0 0 0 0 13.9501 0 0 0 0 0 12.4122 0 0 0 0 14.4331 0 0 0 0 0 0 15.0368 0 0 0 0 0 13.0967 0 0 14.3533 0 12.8477 0 0 0 0 0 14.0504 0 0 0 0 0 0 14.1312 0 0 0 0 0 0 0 0 0 0 12.3247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9444 0 0 0 0 0 0 13.6989 0 Q04837 SSBP_HUMAN "Single-stranded DNA-binding protein, mitochondrial, Mt-SSB, MtSSB (PWP1-interacting protein 17)" SSBP1 SSBP Homo sapiens (Human) DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrion morphogenesis [GO:0070584]; positive regulation of DNA helicase activity [GO:1905776]; positive regulation of helicase activity [GO:0051096]; positive regulation of mitochondrial DNA replication [GO:0090297]; protein homotetramerization [GO:0051289] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoid [GO:0009295]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoid [GO:0009295]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrion morphogenesis [GO:0070584]; positive regulation of DNA helicase activity [GO:1905776]; positive regulation of helicase activity [GO:0051096]; positive regulation of mitochondrial DNA replication [GO:0090297]; protein homotetramerization [GO:0051289] GO:0003682; GO:0003697; GO:0003723; GO:0005634; GO:0005739; GO:0005759; GO:0006264; GO:0006268; GO:0009295; GO:0042645; GO:0042802; GO:0042803; GO:0051096; GO:0051289; GO:0070062; GO:0070584; GO:0090297; GO:1905776 chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] IDYGEYMDKNNVRR 0.94004 1.7834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5991 0 15.3685 15.1484 13.6669 15.3518 12.035 0 15.0784 12.2592 0 0 0 0 0 0 0 12.3068 0 14.0331 0 0 0 0 0 0 0 0 0 0 12.4845 0 0 13.4019 0 0 0 12.573 15.5455 0 0 0 13.2728 15.0215 0 0 0 0 0 0 0 13.1293 13.0355 0 13.0756 0 0 14.9176 0 14.1811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4415 0 0 0 0 0 0 0 Q8TEY7 UBP33_HUMAN "Ubiquitin carboxyl-terminal hydrolase 33, EC 3.4.19.12 (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) (VHL-interacting deubiquitinating enzyme 1, hVDU1)" USP33 KIAA1097 VDU1 Homo sapiens (Human) axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001664; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005925; GO:0006511; GO:0006897; GO:0007411; GO:0008270; GO:0008277; GO:0009267; GO:0010506; GO:0016477; GO:0016579; GO:0030891; GO:0031267; GO:0032091; GO:0032092; GO:0043025; GO:0048471; GO:0050821; GO:0051298; GO:0070536; GO:0071108 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] EDSPATFYCISMQWFR 0.94004 1.7215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5612 0 0 0 0 0 0 0 11.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5429 12.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0378 0 0 0 0 0 0 0 0 0 0 0 11.366 0 0 0 0 0 0 0 0 11.5136 0 0 0 0 0 0 Q6UWY2 PRS57_HUMAN "Serine protease 57, EC 3.4.21.- (Neutrophil serine protease 4, NSP4) (Serine protease 1-like protein 1)" PRSS57 PRSSL1 UNQ782/PRO1599 Homo sapiens (Human) proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular space [GO:0005615] azurophil granule lumen [GO:0035578]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508; GO:0008201; GO:0008236; GO:0035578 heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] ARWVVSAAHCFSHR 0.94005 0.91137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4IF30 S35F4_HUMAN Solute carrier family 35 member F4 SLC35F4 C14orf36 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] ARCLSCTSMVLK 0.94007 2.5097 0 0 0 0 0 0 0 0 0 0 14.3447 0 0 0 0 0 0 0 0 0 0 14.0009 0 0 0 0 0 0 11.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1862 0 0 13.1552 0 13.6247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.739 13.5684 0 0 0 12.7678 12.1349 13.4272 12.8115 13.3814 0 0 0 0 0 14.5014 0 0 0 14.704 0 0 12.1097 11.7857 0 0 0 0 0 0 0 11.0539 0 0 0 0 0 0 13.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2061 0 12.8772 14.1396 0 0 12.9646 0 0 O75888 TNF13_HUMAN "Tumor necrosis factor ligand superfamily member 13 (A proliferation-inducing ligand, APRIL) (TNF- and APOL-related leukocyte expressed ligand 2, TALL-2) (TNF-related death ligand 1, TRDL-1) (CD antigen CD256)" TNFSF13 APRIL TALL2 ZTNF2 UNQ383/PRO715 Homo sapiens (Human) immune response [GO:0006955]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; immune response [GO:0006955]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; signal transduction [GO:0007165] GO:0005102; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006955; GO:0007165; GO:0008284; GO:0016020; GO:0048018; GO:0048298; GO:0070062 cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] GRGLQAQGYGVR 0.94007 0.91083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41231 P2RY2_HUMAN "P2Y purinoceptor 2, P2Y2 (ATP receptor) (P2U purinoceptor 1, P2U1) (P2U receptor 1) (Purinergic receptor)" P2RY2 P2RU1 Homo sapiens (Human) blood vessel diameter maintenance [GO:0097746]; cellular ion homeostasis [GO:0006873]; cellular response to ATP [GO:0071318]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of mucus secretion [GO:0070257] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; A1 adenosine receptor binding [GO:0031686]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UTP receptor activity [GO:0045030]; signaling receptor activity [GO:0038023]; blood vessel diameter maintenance [GO:0097746]; cellular ion homeostasis [GO:0006873]; cellular response to ATP [GO:0071318]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of mucus secretion [GO:0070257] GO:0005886; GO:0005887; GO:0006873; GO:0007186; GO:0007200; GO:0031686; GO:0038023; GO:0045028; GO:0045030; GO:0070257; GO:0071318; GO:0097746 A1 adenosine receptor binding [GO:0031686]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UTP receptor activity [GO:0045030]; signaling receptor activity [GO:0038023] FARDAKPPTGPSPATPAR 0.94008 2.6965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1162 0 12.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15503 INSI1_HUMAN "Insulin-induced gene 1 protein, INSIG-1" INSIG1 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; cellular response to sterol [GO:0036315]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; cranial suture morphogenesis [GO:0060363]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of cargo loading into COPII-coated vesicle [GO:1901303]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein exit from endoplasmic reticulum [GO:0070862]; negative regulation of steroid biosynthetic process [GO:0010894]; roof of mouth development [GO:0060021]; SREBP signaling pathway [GO:0032933]; SREBP-SCAP complex retention in endoplasmic reticulum [GO:0036316]; sterol biosynthetic process [GO:0016126]; triglyceride metabolic process [GO:0006641] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SREBP-SCAP-Insig complex [GO:0032937] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SREBP-SCAP-Insig complex [GO:0032937]; oxysterol binding [GO:0008142]; cellular response to insulin stimulus [GO:0032869]; cellular response to sterol [GO:0036315]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; cranial suture morphogenesis [GO:0060363]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of cargo loading into COPII-coated vesicle [GO:1901303]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein exit from endoplasmic reticulum [GO:0070862]; negative regulation of steroid biosynthetic process [GO:0010894]; roof of mouth development [GO:0060021]; SREBP signaling pathway [GO:0032933]; SREBP-SCAP complex retention in endoplasmic reticulum [GO:0036316]; sterol biosynthetic process [GO:0016126]; triglyceride metabolic process [GO:0006641] GO:0005783; GO:0005789; GO:0006641; GO:0006695; GO:0008142; GO:0010894; GO:0016126; GO:0032869; GO:0032933; GO:0032937; GO:0036315; GO:0036316; GO:0042472; GO:0042474; GO:0042632; GO:0045599; GO:0045717; GO:0060021; GO:0060363; GO:0070862; GO:1901303 oxysterol binding [GO:0008142] CIAVFVGINHASAK 0.94009 0.9539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0607 0 0 0 0 0 0 0 0 0 0 0 0 10.9042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3561 11.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1216 0 0 0 0 0 0 11.9376 0 0 0 13.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P286 PAK5_HUMAN "Serine/threonine-protein kinase PAK 5, EC 2.7.11.1 (p21-activated kinase 5, PAK-5) (p21-activated kinase 7, PAK-7)" PAK5 KIAA1264 PAK7 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] GO:0001558; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007010; GO:0007165; GO:0007612; GO:0007613; GO:0007626; GO:0008283; GO:0016477; GO:0035556; GO:0043408; GO:0045202; GO:0106310; GO:2001237 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALSYLHNQGVIHRDIK 0.94011 2.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8543 0 12.9335 0 0 0 0 0 0 0 0 12.5641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8122 12.8549 0 0 0 0 0 0 0 0 0 16.092 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVJ7 DUS23_HUMAN "Dual specificity protein phosphatase 23, EC 3.1.3.16, EC 3.1.3.48 (Low molecular mass dual specificity phosphatase 3, LDP-3) (VH1-like phosphatase Z)" DUSP23 LDP3 VHZ Homo sapiens (Human) dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0016311; GO:0016791; GO:0017018 myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GEAVGVHCALGFGR 0.94013 1.7196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUQ2 PLCE_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 5, 1-AGP acyltransferase 5, 1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon, LPAAT-epsilon)" AGPAT5 Homo sapiens (Human) acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730] endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016021; GO:0016024; GO:0016746 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] GLAVLKHVLTPR 0.94016 1.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8422 16.1164 0 0 0 0 17.0255 0 0 0 0 0 0 0 0 0 0 13.3838 0 0 0 0 0 0 0 0 0 0 0 13.3978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9188 0 13.7394 13.3035 0 0 0 14.3034 0 0 0 0 0 16.5803 0 0 0 0 0 0 0 14.0581 13.7687 0 0 0 0 0 0 0 0 0 17.7603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P85298 RHG08_HUMAN Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8) ARHGAP8 Homo sapiens (Human) negative regulation of endocytic recycling [GO:2001136]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of endocytic recycling [GO:2001136]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0051056; GO:0070374; GO:2001136 GTPase activator activity [GO:0005096] AAPLQEAVPRTQATGLTKPTLPPSPLMAAR 0.94019 1.7189 0 0 0 0 0 0 0 10.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7925 0 0 0 0 0 0 0 0 0 13.6184 0 0 0 0 0 0 14.8273 0 0 0 13.9619 0 0 13.5591 0 0 0 0 11.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5115 0 0 0 0 0 0 0 0 0 0 0 0 Q3KNW5 SOAT_HUMAN "Sodium-dependent organic anion transporter, SOAT (Solute carrier family 10 member 6, SLC10A6)" SLC10A6 SOAT Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250]; bile acid and bile salt transport [GO:0015721]; sodium-dependent organic anion transport [GO:0043251]; transmembrane transport [GO:0055085] GO:0005886; GO:0008508; GO:0015721; GO:0016021; GO:0043250; GO:0043251; GO:0055085 bile acid:sodium symporter activity [GO:0008508]; sodium-dependent organic anion transmembrane transporter activity [GO:0043250] IGAVVGGVLLLVVAVAGVVLAK 0.94019 3.4864 0 0 0 0 0 10.4649 0 0 0 0 0 0 0 0 0 0 12.0089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.326 10.6514 0 0 0 11.6672 0 0 0 0 11.5644 0 0 0 0 0 0 0 12.3053 0 11.3447 0 0 0 0 0 0 0 0 0 0 0 0 10.5559 0 0 0 0 17.8448 0 0 16.9306 0 0 0 14.963 14.4099 0 13.9787 15.1234 0 0 0 0 14.0996 0 0 0 0 0 13.0974 0 14.6206 13.9509 0 0 0 14.1385 14.5364 13.426 0 14.5449 14.0998 14.3251 0 14.8564 13.6234 14.5098 14.3857 0 0 0 0 13.3073 0 0 14.2476 14.5848 0 12.8818 14.719 0 13.1465 0 13.8307 0 15.0329 0 0 0 15.3294 0 13.6704 14.0076 13.8743 13.6852 0 14.7298 13.3688 0 0 11.365 14.7141 0 0 11.3989 0 0 12.1192 0 0 0 0 0 0 0 0 0 12.9335 0 0 0 0 0 13.6229 0 0 0 13.9014 12.5949 0 0 0 11.8055 0 0 0 Q53FE4 CD017_HUMAN Uncharacterized protein C4orf17 C4orf17 Homo sapiens (Human) ACSTPGSCSSGMTSTK 0.94019 3.8496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7397 0 0 0 0 0 0 0 0 0 0 0 0 12.8151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4679 13.5767 0 0 0 0 0 0 0 0 14.6976 0 0 0 0 0 12.805 0 0 0 0 0 0 12.4795 0 0 0 14.7749 0 0 0 0 0 0 14.4495 14.1522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MIW9 MUCL3_HUMAN Mucin-like protein 3 (Diffuse panbronchiolitis critical region protein 1) MUCL3 C6orf37 DPCR1 PBLT Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005737; GO:0005886; GO:0016021 KHITPAPKSK 0.94022 1.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8975 0 0 0 0 0 0 0 12.8911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6485 0 0 0 0 0 14.3369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3567 0 Q9NX52 RHBL2_HUMAN "Rhomboid-related protein 2, RRP2, EC 3.4.21.105 (Rhomboid-like protein 2) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment, NTF; Rhomboid-related protein 2, C-terminal fragment, CTF ]" RHBDL2 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005886; GO:0006508; GO:0016021 serine-type endopeptidase activity [GO:0004252] DPRFWIAIAAYLACVLFAVFFNIFLSPAN 0.94022 3.4451 0 0 0 0 0 0 0 11.9401 0 0 0 0 0 13.7521 0 14.0917 0 0 0 0 13.1624 0 0 0 0 0 0 0 0 12.841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9978 11.942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.106 0 0 0 14.0178 0 0 0 0 0 13.6364 0 0 0 0 0 0 0 12.5326 13.5806 13.6582 11.1758 0 0 13.9151 0 13.414 0 0 0 11.537 0 0 0 0 0 0 11.4791 0 0 0 0 0 12.1615 12.3712 0 0 0 0 0 11.6015 0 0 13.3444 0 14.0521 0 0 14.6679 14.0523 13.0488 12.9342 13.6656 0 0 0 0 12.9759 13.2101 0 0 0 0 0 0 0 0 14.2661 15.139 0 11.6762 0 0 0 0 0 0 11.8763 0 0 0 12.1502 13.0283 0 0 0 11.7396 0 0 0 0 0 0 0 13.858 0 Q9P2R3 ANFY1_HUMAN "Rabankyrin-5, Rank-5 (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif)" ANKFY1 ANKHZN KIAA1255 Homo sapiens (Human) "endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020] "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; macropinosome [GO:0044354]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005765; GO:0005768; GO:0005769; GO:0005829; GO:0006897; GO:0010008; GO:0016020; GO:0016197; GO:0031267; GO:0034058; GO:0042147; GO:0043231; GO:0044354; GO:0046872; GO:0048549; GO:0070062; GO:0090160; GO:1901981 metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267] EIPIIKFDLNKPVR 0.94023 2.5056 0 0 0 0 0 0 0 0 14.513 14.5788 0 14.3161 14.1405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4824 0 0 0 0 0 0 11.8602 0 0 0 13.1354 14.2309 13.0929 0 14.8755 14.2376 13.4132 12.4411 13.7281 0 0 0 0 0 0 12.9175 0 0 0 0 14.3826 0 12.7453 14.7013 0 0 0 0 13.9121 12.6125 0 0 0 0 0 13.0841 12.8412 0 0 0 0 13.9014 13.5209 0 0 13.1656 0 13.7778 0 12.466 0 0 13.2332 0 0 0 0 0 0 0 0 0 0 12.3051 0 0 0 13.0962 0 0 0 0 0 13.3701 0 13.4464 13.7002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15399 NMDE4_HUMAN "Glutamate receptor ionotropic, NMDA 2D, GluN2D (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D, NMDAR2D, NR2D)" GRIN2D GluN2D NMDAR2D Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211] "anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic plasticity [GO:0048167]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]" GO:0001964; GO:0004970; GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007420; GO:0008344; GO:0015276; GO:0016595; GO:0017146; GO:0022849; GO:0035249; GO:0038023; GO:0042165; GO:0045211; GO:0048167; GO:0048168; GO:0051930; GO:0051968; GO:0060079; GO:0060291; GO:0070161; GO:0097553; GO:0098686; GO:0098839; GO:0098976; GO:0098978; GO:0099061; GO:1904062; GO:1904315; GO:2000463 glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ASVDRWRR 0.94025 1.7116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5708 0 0 13.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2759 0 0 0 0 0 0 0 0 0 15.9911 11.9791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0595 0 0 0 14.4085 0 0 15.014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1517 0 15.5782 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTW4 NPRL2_HUMAN "GATOR complex protein NPRL2 (Gene 21 protein, G21 protein) (Nitrogen permease regulator 2-like protein, NPR2-like protein) (Tumor suppressor candidate 4)" NPRL2 TUSC4 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; cellular response to amino acid starvation [GO:0034198]; negative regulation of kinase activity [GO:0033673]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GO:0004672; GO:0005096; GO:0005765; GO:0005774; GO:0010508; GO:0032007; GO:0033673; GO:0034198; GO:1904262; GO:1990130 GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672] ELFDTVQVYIITK 0.94025 3.3927 0 0 0 0 0 0 0 0 0 13.5317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.702 0 0 12.3255 0 0 0 0 0 0 12.4037 0 0 0 0 0 0 0 0 10.9129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3259 0 0 0 0 0 13.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCJ5 SPRY3_HUMAN SPRY domain-containing protein 3 SPRYD3 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010] GO:0005737; GO:0007010; GO:0007166 MDDLNLHYRFLNWRR 0.94027 0.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54098 DPOG1_HUMAN "DNA polymerase subunit gamma-1, EC 2.7.7.7 (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha)" POLG MDP1 POLG1 POLGA Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA metabolic process [GO:0006259]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]" gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] "gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; base-excision repair, gap-filling [GO:0006287]; DNA metabolic process [GO:0006259]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]" GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005739; GO:0005759; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0008408; GO:0032991; GO:0042645 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020] ACLQKLKGTTELLPK 0.94031 1.7891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3185 0 0 0 0 0 0 0 0 0 0 10.4857 0 0 0 0 0 0 12.5839 0 12.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3632 0 12.7704 0 0 13.2078 13.7466 13.4645 13.5812 13.3903 0 0 0 0 13.141 0 12.6952 12.9711 0 0 0 14.8474 13.5947 12.2086 14.9959 0 14.9116 0 12.8824 13.0349 0 11.0256 0 0 14.4985 0 0 0 0 0 0 0 0 0 13.1354 13.492 13.6336 11.1959 13.1292 0 13.2359 0 13.2276 10.7699 0 0 10.8364 0 0 0 0 0 0 12.6383 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6077 0 0 0 0 0 12.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8172 0 0 0 0 P21462 FPR1_HUMAN "fMet-Leu-Phe receptor, fMLP receptor (N-formyl peptide receptor, FPR) (N-formylpeptide chemoattractant receptor)" FPR1 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; nitric oxide mediated signal transduction [GO:0007263]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165] azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; N-formyl peptide receptor activity [GO:0004982]; RAGE receptor binding [GO:0050786]; scavenger receptor binding [GO:0005124]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; nitric oxide mediated signal transduction [GO:0007263]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165] GO:0001664; GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005124; GO:0005737; GO:0005886; GO:0006935; GO:0006954; GO:0007165; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007263; GO:0016021; GO:0030667; GO:0035577; GO:0050786; GO:0101003 complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; N-formyl peptide receptor activity [GO:0004982]; RAGE receptor binding [GO:0050786]; scavenger receptor binding [GO:0005124] INVAVAMLTVRGIIR 0.94033 3.8463 0 0 0 0 0 0 0 0 0 0 10.7691 0 0 0 0 12.8979 0 0 0 0 0 11.4027 0 0 0 11.7737 0 0 0 0 0 0 0 0 0 0 0 0 13.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4358 15.9905 0 0 0 0 0 0 0 12.829 11.9349 0 17.3911 0 0 0 0 0 0 0 11.9099 0 0 0 0 14.3865 0 0 0 15.2147 0 0 0 11.5632 0 0 14.8508 11.7635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5897 0 0 0 0 0 0 0 0 0 0 12.7942 0 0 0 0 0 0 0 12.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6205 11.6602 0 0 0 0 Q96MU7 YTDC1_HUMAN "YTH domain-containing protein 1 (Splicing factor YT521, YT521-B)" YTHDC1 KIAA1966 YT521 Homo sapiens (Human) "dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]" GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0110104; GO:1990247 mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723] ASRSSQSSK 0.94033 3.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9481 0 0 0 0 0 0 0 0 11.354 0 0 12.4028 0 11.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4794 12.6045 0 14.0207 0 0 0 0 0 0 0 0 13.9308 0 0 0 0 12.8687 12.4203 12.3422 0 0 11.2889 0 14.8459 14.2117 0 12.0174 0 12.417 0 0 0 0 12.5821 0 0 0 0 0 0 0 0 13.4114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1804 0 0 0 0 0 0 0 0 12.1958 0 10.6736 0 13.4165 0 0 0 0 0 0 0 0 0 0 12.4537 0 0 0 Q9UKS7 IKZF2_HUMAN Zinc finger protein Helios (Ikaros family zinc finger protein 2) IKZF2 HELIOS ZNFN1A2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] DPLECNICGYR 0.94034 0.95423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3171 0 0 16.5601 16.5804 0 0 0 17.1535 0 0 0 0 0 0 0 17.0199 18.19 17.9937 17.4375 0 15.9773 15.7243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4993 13.3019 0 0 0 0 0 0 0 0 11.7352 0 0 0 0 0 0 0 0 0 13.5092 0 0 0 0 14.1115 0 13.14 0 0 0 0 15.5202 14.7478 0 0 0 0 0 0 0 13.5481 13.9639 0 0 0 0 13.6359 0 0 0 0 0 0 0 0 13.2421 0 0 0 0 0 0 0 0 10.7596 0 0 0 0 0 0 0 0 0 0 19.6789 19.3904 0 0 0 10.8579 0 0 0 0 0 0 12.0167 0 13.3143 0 0 0 0 0 0 0 0 0 Q13630 FCL_HUMAN "GDP-L-fucose synthase, EC 1.1.1.271 (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)" GFUS SDR4E1 TSTA3 Homo sapiens (Human) 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]" GO:0005829; GO:0007159; GO:0009055; GO:0010595; GO:0019673; GO:0042351; GO:0042356; GO:0042802; GO:0047918; GO:0050577; GO:0070062; GO:1904906 "electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]" ETCAWFTDNYEQAR 0.94037 0.96368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6944 0 0 0 0 0 0 0 0 0 0 0 0 13.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA82 LCE2D_HUMAN Late cornified envelope protein 2D (Late envelope protein 12) (Small proline-rich-like epidermal differentiation complex protein 1A) LCE2D LEP12 SPRL1A Homo sapiens (Human) keratinization [GO:0031424] keratinization [GO:0031424] GO:0031424 HQSPDCCESEPSGASGCCHSSGGCC 0.94037 1.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1856 0 0 12.7402 0 0 0 0 13.5515 0 14.3354 0 0 13.3354 0 0 0 0 0 0 11.6783 0 0 0 0 0 0 0 0 0 0 0 11.6121 0 0 0 0 14.6048 0 0 0 0 0 0 0 12.5391 0 0 0 0 0 0 0 0 0 0 0 13.4368 0 13.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3807 0 11.855 0 0 0 0 0 0 12.7621 P50613 CDK7_HUMAN "Cyclin-dependent kinase 7, EC 2.7.11.22, EC 2.7.11.23 (39 kDa protein kinase, p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)" CDK7 CAK CAK1 CDKN7 MO15 STK1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] "CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000079; GO:0000439; GO:0001650; GO:0001673; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0006468; GO:0007049; GO:0008022; GO:0008094; GO:0008353; GO:0019907; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0051726; GO:0070516; GO:0070816; GO:0070985; GO:0106310; GO:2000045 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]" AYTHQVVTRWYRAPELLFGAR 0.94038 3.5118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8201 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4413 0 0 0 0 12.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8685 0 0 16.3884 12.9158 11.0712 0 0 0 12.2883 0 0 0 0 0 0 0 0 0 0 0 0 13.3232 11.3947 0 Q96RJ0 TAAR1_HUMAN "Trace amine-associated receptor 1, TaR-1, Trace amine receptor 1" TAAR1 TA1 TAR1 TRAR1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594] ASLYSLMVLIILTTLVGNLIVIVSISHFK 0.94038 1.7869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.933 0 0 0 0 11.2875 0 0 0 0 0 Q86XP6 GKN2_HUMAN Gastrokine-2 (Blottin) (Down-regulated in gastric cancer) (Trefoil factor interactions(z) 1) GKN2 BLOT GDDR TFIZ1 UNQ465/PRO813 Homo sapiens (Human) regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617] basal part of cell [GO:0045178]; extracellular space [GO:0005615] basal part of cell [GO:0045178]; extracellular space [GO:0005615]; regulation of cell population proliferation [GO:0042127]; response to bacterium [GO:0009617] GO:0005615; GO:0009617; GO:0042127; GO:0045178 HGYIASRVLSRR 0.94039 1.0102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59020 DSCR9_HUMAN Down syndrome critical region protein 9 DSCR9 Homo sapiens (Human) KQEGTENTSICCR 0.9404 1.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86U10 LPP60_HUMAN "60 kDa lysophospholipase, LysoLP, EC 3.1.1.5 (Lysophospholipase-transacylase) [Includes: L-asparaginase, EC 3.5.1.1 (L-asparagine amidohydrolase); 1-alkyl-2-acetylglycerophosphocholine esterase, EC 3.1.1.47 (Platelet-activating factor acetylhydrolase, PAF acetylhydrolase) ]" ASPG C14orf76 Homo sapiens (Human) aspartate family amino acid metabolic process [GO:0009066]; lipid catabolic process [GO:0016042] cytosol [GO:0005829] "cytosol [GO:0005829]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; asparaginase activity [GO:0004067]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; aspartate family amino acid metabolic process [GO:0009066]; lipid catabolic process [GO:0016042]" GO:0003847; GO:0004067; GO:0004622; GO:0005829; GO:0009066; GO:0016042; GO:0016747; GO:0102545 "1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; asparaginase activity [GO:0004067]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]" DTDGFSPLLLAVRGRHPGVIGLLR 0.9404 2.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UUV9 CRTC1_HUMAN "CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1) (Transducer of regulated cAMP response element-binding protein 1, TORC-1, Transducer of CREB protein 1)" CRTC1 KIAA0616 MECT1 TORC1 WAMTP1 Homo sapiens (Human) energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0014069; GO:0016604; GO:0030425; GO:0032793; GO:0043025; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0097009; GO:0098978; GO:0099527; GO:1900006; GO:1900273; GO:1902631 cAMP response element binding protein binding [GO:0008140] HHGLVDRVYRER 0.94041 1.0102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H313 TTYH1_HUMAN "Protein tweety homolog 1, hTTY1" TTYH1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chloride transport [GO:0006821]; filopodium assembly [GO:0046847]; ion transmembrane transport [GO:0034220]; iron ion transport [GO:0006826]; mitotic cell cycle [GO:0000278] chloride channel complex [GO:0034707]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202] chloride channel complex [GO:0034707]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iron ion transmembrane transporter activity [GO:0005381]; volume-sensitive chloride channel activity [GO:0072320]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; chloride transport [GO:0006821]; filopodium assembly [GO:0046847]; ion transmembrane transport [GO:0034220]; iron ion transport [GO:0006826]; mitotic cell cycle [GO:0000278] GO:0000278; GO:0005229; GO:0005254; GO:0005381; GO:0005509; GO:0005886; GO:0006821; GO:0006826; GO:0016021; GO:0030868; GO:0031527; GO:0031589; GO:0032433; GO:0034220; GO:0034707; GO:0045202; GO:0046847; GO:0072320; GO:0098609 calcium ion binding [GO:0005509]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; iron ion transmembrane transporter activity [GO:0005381]; volume-sensitive chloride channel activity [GO:0072320] AWALFPPSDDYDDTDDDDPFNPQESK 0.94041 3.4841 0 0 0 0 11.8019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9242 0 0 13.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9765 0 0 15.0925 0 15.1803 0 12.808 0 12.3727 11.8042 0 12.3809 0 0 13.731 0 0 0 0 13.2014 13.8987 0 0 14.3349 0 13.7823 11.8456 13.7918 0 13.8443 0 0 0 0 0 0 0 0 13.4621 0 0 0 0 0 0 0 0 0 0 13.7964 13.1074 0 0 0 0 0 0 0 0 0 0 10.916 0 0 0 12.9811 0 12.9817 0 0 0 11.3124 0 0 0 0 0 0 0 12.2789 0 0 0 14.668 0 0 12.2075 11.7553 11.9985 0 0 0 0 0 0 0 0 0 13.0608 Q9NWV4 CZIB_HUMAN CXXC motif containing zinc binding protein (UPF0587 protein C1orf123) CZIB C1orf123 Homo sapiens (Human) zinc ion binding [GO:0008270] GO:0008270 zinc ion binding [GO:0008270] CGNCGEISDK 0.94041 0.96068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1404 0 0 0 0 0 0 0 0 Q5TFQ8 SIRBL_HUMAN "Signal-regulatory protein beta-1 isoform 3, SIRP-beta-1 isoform 3" SIRPB1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 VLLVVGVSVIYVYWK 0.94043 0.96013 0 0 0 0 0 0 0 0 0 0 0 0 0 14.457 0 0 12.3734 0 14.2515 0 0 0 0 0 0 0 0 15.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.823 0 12.8096 0 0 14.7985 0 0 14.1167 12.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7352 0 0 0 16.0475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04216 THY1_HUMAN Thy-1 membrane glycoprotein (CDw90) (Thy-1 antigen) (CD antigen CD90) THY1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron projection regeneration [GO:0070571]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of T cell activation [GO:0050870]; protein autophosphorylation [GO:0046777]; receptor clustering [GO:0043113]; regulation of cell-matrix adhesion [GO:0001952]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]; retinal cone cell development [GO:0046549]; T cell receptor signaling pathway [GO:0050852] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; GTPase activator activity [GO:0005096]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron projection regeneration [GO:0070571]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of T cell activation [GO:0050870]; protein autophosphorylation [GO:0046777]; receptor clustering [GO:0043113]; regulation of cell-matrix adhesion [GO:0001952]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298]; retinal cone cell development [GO:0046549]; T cell receptor signaling pathway [GO:0050852] GO:0001525; GO:0001952; GO:0002693; GO:0005096; GO:0005178; GO:0005576; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0007010; GO:0007229; GO:0007267; GO:0009897; GO:0009986; GO:0016324; GO:0019901; GO:0030336; GO:0030425; GO:0030426; GO:0030673; GO:0031362; GO:0032590; GO:0032809; GO:0034116; GO:0034235; GO:0043113; GO:0043547; GO:0045121; GO:0046549; GO:0046777; GO:0048041; GO:0050771; GO:0050852; GO:0050860; GO:0050870; GO:0051281; GO:0051894; GO:0061099; GO:0070062; GO:0070571; GO:0098609; GO:2000298 GPI anchor binding [GO:0034235]; GTPase activator activity [GO:0005096]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901] DKLVKCEGISLLAQNTSWLLLLLLSLSLLQATDFMSL 0.94044 1.7338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6JVE6 LCN10_HUMAN Epididymal-specific lipocalin-10 LCN10 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; small molecule binding [GO:0036094] GO:0005576; GO:0036094 small molecule binding [GO:0036094] AAVILPK 0.94045 1.7243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4482 0 0 0 0 0 12.6032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3213 0 0 0 11.8827 0 0 0 0 0 0 0 0 0 0 0 0 13.7704 13.5521 11.3677 0 0 0 0 13.1744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4437 0 12.6449 13.3935 12.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9789 0 13.1137 0 0 11.1893 11.7193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AA3 RFT1_HUMAN Protein RFT1 homolog RFT1 Homo sapiens (Human) carbohydrate transport [GO:0008643]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; glycolipid translocation [GO:0034203] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glycolipid floppase activity [GO:0034202]; carbohydrate transport [GO:0008643]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; glycolipid translocation [GO:0034203] GO:0005789; GO:0006488; GO:0008643; GO:0016021; GO:0034202; GO:0034203 glycolipid floppase activity [GO:0034202] ACLSGGTQR 0.94045 0.97533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4017 0 12.7307 0 12.4435 0 0 12.3018 0 0 0 0 0 0 0 12.8304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8839 13.0432 0 15.3296 13.9424 13.0459 13.1699 0 14.1948 12.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.721 0 0 0 0 13.0894 12.8077 0 0 12.9741 0 0 0 0 0 0 0 0 0 14.1295 0 0 0 13.0336 0 0 13.5105 0 0 15.4475 0 0 0 13.1598 0 0 0 0 14.6249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0892 13.9633 0 0 0 12.5556 0 0 0 0 0 0 0 0 0 0 13.6758 0 0 0 12.4325 10.6314 0 0 0 0 O95819 M4K4_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 4, EC 2.7.11.1 (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4, MEK kinase kinase 4, MEKKK 4) (Nck-interacting kinase)" MAP4K4 HGK KIAA0687 NIK Homo sapiens (Human) intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; focal adhesion [GO:0005925] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; neuron projection morphogenesis [GO:0048812]; positive regulation of ARF protein signal transduction [GO:0032014]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of GTPase activity [GO:0043547]; positive regulation of keratinocyte migration [GO:0051549]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408] GO:0000165; GO:0001953; GO:0004111; GO:0004674; GO:0005524; GO:0005737; GO:0005925; GO:0006468; GO:0008017; GO:0030335; GO:0032014; GO:0035556; GO:0043066; GO:0043408; GO:0043547; GO:0046328; GO:0048812; GO:0051549; GO:0051894; GO:0106310; GO:0120183 ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DETEYEYSGSEEEEEEVPEQEGEPSSIVNVPGESTLR 0.94046 3.3843 0 0 0 0 0 0 0 0 0 0 0 14.5051 0 0 11.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6879 0 0 0 0 0 12.179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8618 0 12.7443 0 12.6853 12.6705 0 0 11.8071 0 13.3108 0 0 0 13.4248 0 13.7402 0 0 0 0 0 0 13.9909 0 0 0 12.0321 0 0 10.8223 0 0 0 0 0 13.3019 0 0 0 13.4656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1541 0 0 0 12.598 0 0 13.8736 0 0 0 0 0 0 0 0 11.9938 0 0 13.3923 12.7274 12.8069 0 0 0 0 0 0 14.3303 0 0 0 0 0 0 0 0 12.6595 0 0 12.0073 0 0 0 P54315 LIPR1_HUMAN "Inactive pancreatic lipase-related protein 1, PL-RP1" PNLIPRP1 PLRP1 Homo sapiens (Human) lipid metabolic process [GO:0006629] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629] GO:0004806; GO:0005509; GO:0005576; GO:0006629 calcium ion binding [GO:0005509]; triglyceride lipase activity [GO:0004806] EVCYEDLGCFSDTEPWGGTAIR 0.94046 1.7988 0 0 0 0 0 0 0 0 0 10.8667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.767 0 11.5231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99735 MGST2_HUMAN "Microsomal glutathione S-transferase 2, Microsomal GST-2, EC 2.5.1.18 (Glutathione peroxidase MGST2, EC 1.11.1.-) (Leukotriene C4 synthase MGST2, EC 4.4.1.20) (Microsomal glutathione S-transferase II, Microsomal GST-II)" MGST2 GST2 Homo sapiens (Human) glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729] GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006629; GO:0006750; GO:0008047; GO:0016020; GO:0016021; GO:0019370; GO:0042802; GO:0043231; GO:0043295; GO:0046466; GO:0050729 enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464] LSLGILALLTLLGALGIANSFLDEYLDLNIAKKLR 0.94046 0.90689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1709 0 0 0 0 0 0 12.8646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6Y1 PCD20_HUMAN Protocadherin-20 (Protocadherin-13) PCDH20 PCDH13 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0003723; GO:0005509; GO:0005887; GO:0007155; GO:0007156 calcium ion binding [GO:0005509]; RNA binding [GO:0003723] DLFHLDENTGVIK 0.94048 3.8425 0 0 0 0 0 0 0 0 0 0 11.2883 0 0 0 0 0 0 0 0 0 0 12.5457 0 12.6911 0 0 11.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4624 0 0 0 12.7689 0 0 0 13.9966 0 16.0312 15.7473 0 16.0135 0 14.8612 15.2223 0 0 0 0 0 13.971 14.6439 11.7838 0 14.481 0 0 0 0 0 0 12.0295 0 0 0 0 0 0 14.1463 0 13.6722 0 0 11.7843 0 0 0 0 0 0 14.1759 0 0 0 13.7824 0 0 0 12.3659 0 0 0 0 12.1732 0 0 13.4878 0 0 0 0 0 12.2138 13.3527 12.822 0 0 0 0 0 11.9792 0 11.2004 13.5572 0 0 0 13.0616 0 0 0 0 0 0 0 0 0 0 13.6148 0 0 0 0 13.812 0 13.8522 Q9Y2G5 OFUT2_HUMAN "GDP-fucose protein O-fucosyltransferase 2, EC 2.4.1.221 (Peptide-O-fucosyltransferase 2, O-FucT-2)" POFUT2 C21orf80 FUT13 KIAA0958 Homo sapiens (Human) fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046] GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0010468; GO:0010717; GO:0036066; GO:0046922; GO:0051046; GO:1903334 peptide-O-fucosyltransferase activity [GO:0046922] DVYIRIASLLKTLLK 0.94048 0.97508 0 0 0 0 0 0 0 0 0 0 0 0 17.3197 14.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0557 13.6601 0 0 13.9425 14.067 0 0 0 0 13.6697 13.8711 0 0 0 0 0 0 14.5516 0 13.7514 0 0 0 0 0 0 0 0 0 13.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08575 PTPRC_HUMAN "Receptor-type tyrosine-protein phosphatase C, EC 3.1.3.48 (Leukocyte common antigen, L-CA) (T200) (CD antigen CD45)" PTPRC CD45 Homo sapiens (Human) alpha-beta T cell proliferation [GO:0046633]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; extrinsic apoptotic signaling pathway [GO:0097191]; gamma-delta T cell differentiation [GO:0042492]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte cell-cell adhesion [GO:0007159]; MAPK cascade [GO:0000165]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852] bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] bleb [GO:0032059]; cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane microdomain [GO:0098857]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; alpha-beta T cell proliferation [GO:0046633]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; bone marrow development [GO:0048539]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell cycle phase transition [GO:0044770]; cell surface receptor signaling pathway [GO:0007166]; cellular response to extracellular stimulus [GO:0031668]; defense response to virus [GO:0051607]; dephosphorylation [GO:0016311]; DN2 thymocyte differentiation [GO:1904155]; extrinsic apoptotic signaling pathway [GO:0097191]; gamma-delta T cell differentiation [GO:0042492]; hematopoietic progenitor cell differentiation [GO:0002244]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte cell-cell adhesion [GO:0007159]; MAPK cascade [GO:0000165]; natural killer cell differentiation [GO:0001779]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; plasma membrane raft distribution [GO:0044855]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of antigen receptor-mediated signaling pathway [GO:0050857]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of hematopoietic stem cell migration [GO:2000473]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of interleukin-8 production [GO:0032677]; regulation of phagocytosis [GO:0050764]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; release of sequestered calcium ion into cytosol [GO:0051209]; response to gamma radiation [GO:0010332]; stem cell development [GO:0048864]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852] GO:0000165; GO:0001779; GO:0001915; GO:0001916; GO:0001960; GO:0002244; GO:0002639; GO:0002925; GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0006469; GO:0006470; GO:0006933; GO:0007159; GO:0007166; GO:0008201; GO:0009897; GO:0009898; GO:0009986; GO:0010332; GO:0010468; GO:0016020; GO:0016021; GO:0016311; GO:0018108; GO:0019901; GO:0030183; GO:0030217; GO:0030506; GO:0030507; GO:0030667; GO:0030890; GO:0031668; GO:0031953; GO:0032059; GO:0032677; GO:0032703; GO:0032743; GO:0032760; GO:0034113; GO:0035584; GO:0042100; GO:0042102; GO:0042110; GO:0042492; GO:0043395; GO:0043406; GO:0043410; GO:0044770; GO:0044855; GO:0045059; GO:0045060; GO:0045121; GO:0045588; GO:0045860; GO:0046425; GO:0046633; GO:0046641; GO:0046777; GO:0048304; GO:0048539; GO:0048864; GO:0050731; GO:0050764; GO:0050852; GO:0050853; GO:0050857; GO:0051209; GO:0051607; GO:0051726; GO:0061097; GO:0061099; GO:0070062; GO:0070373; GO:0070374; GO:0097191; GO:0098857; GO:1903615; GO:1903979; GO:1904155; GO:1905451; GO:2000473; GO:2000648; GO:2001238 ankyrin binding [GO:0030506]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] ALIAFLAFLIIVTSIALLVVLYK 0.9405 3.5108 12.8205 11.9724 13.8348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8304 0 0 11.377 0 0 0 0 0 0 12.4189 0 0 0 0 0 11.076 0 0 0 0 11.3468 0 0 0 0 0 0 11.6656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4719 11.2531 0 0 0 12.9459 0 14.2198 13.9693 13.7201 10.7733 14.4382 0 15.0053 13.9953 14.0227 0 0 0 0 13.7084 0 0 12.4466 11.801 13.4831 0 0 12.8659 0 14.3843 0 0 0 0 0 13.4941 15.0833 0 12.2973 13.0728 0 0 0 0 12.3123 0 0 0 13.2873 13.6033 14.6087 13.7295 0 12.2898 0 13.1265 12.8481 0 12.7171 0 12.2504 0 11.6353 13.9546 0 0 0 13.3129 13.4916 0 13.3453 14.9093 13.4027 13.7394 0 0 0 12.4216 0 0 0 0 13.6051 11.7666 0 0 0 0 11.1145 14.8007 13.6693 14.6573 0 0 0 0 13.953 0 0 15.0047 0 0 0 0 14.4635 14.1555 12.1047 0 0 15.0308 0 0 K7EIQ3 CS082_HUMAN Uncharacterized protein ZNF561-AS1 (ZNF561 antisense RNA 1) (ZNF561 antisense gene protein 1) ZNF561-AS1 C19orf82 Homo sapiens (Human) AFIGRAQWLTPVIPALWEAKGLTLLSR 0.94051 1.7602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.96 0 0 0 0 0 0 13.3157 0 0 0 0 0 13.5595 0 13.3146 0 0 0 0 0 13.4432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9883 0 0 12.8816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63173 RL38_HUMAN 60S ribosomal protein L38 (Large ribosomal subunit protein eL38) RPL38 Homo sapiens (Human) 90S preribosome assembly [GO:0034463]; axial mesoderm development [GO:0048318]; cytoplasmic translation [GO:0002181]; middle ear morphogenesis [GO:0042474]; ossification [GO:0001503]; regulation of translation [GO:0006417]; ribonucleoprotein complex assembly [GO:0022618]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; eukaryotic 80S initiation complex [GO:0033291]; focal adhesion [GO:0005925]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; eukaryotic 80S initiation complex [GO:0033291]; focal adhesion [GO:0005925]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; 90S preribosome assembly [GO:0034463]; axial mesoderm development [GO:0048318]; cytoplasmic translation [GO:0002181]; middle ear morphogenesis [GO:0042474]; ossification [GO:0001503]; regulation of translation [GO:0006417]; ribonucleoprotein complex assembly [GO:0022618]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; translation [GO:0006412] GO:0001501; GO:0001503; GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0006417; GO:0007605; GO:0014069; GO:0022618; GO:0022625; GO:0022626; GO:0033291; GO:0034463; GO:0042474; GO:0042788; GO:0048318 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AEKLKQSLPPGLAVK 0.94051 1.7217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3949 0 0 16.0983 13.9269 0 0 13.1701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVV4 PAPD1_HUMAN "Poly(A) RNA polymerase, mitochondrial, PAP, EC 2.7.7.19 (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1, TUTase 1) (mtPAP)" MTPAP PAPD1 Homo sapiens (Human) histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; UTP binding [GO:0002134]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] GO:0000287; GO:0002134; GO:0003723; GO:0004652; GO:0005524; GO:0005654; GO:0005739; GO:0006378; GO:0016779; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; protein homodimerization activity [GO:0042803]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; UTP binding [GO:0002134] CVIEGNNCTFVRDLSRIK 0.94053 2.5348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7181 0 0 0 0 0 0 0 0 0 12.0686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1011 0 0 0 0 0 0 0 0 0 0 0 0 17.2448 0 0 0 12.5009 0 0 0 0 0 11.6311 0 0 12.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4748 Q9NXW2 DJB12_HUMAN DnaJ homolog subfamily B member 12 DNAJB12 Homo sapiens (Human) cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; protein-containing complex assembly [GO:0065003]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005783; GO:0005789; GO:0016020; GO:0030176; GO:0030433; GO:0030544; GO:0031965; GO:0036503; GO:0051085; GO:0065003; GO:0071218 Hsp70 protein binding [GO:0030544] ALRFLEKAQR 0.94053 1.7959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2239 0 13.8938 0 0 0 0 0 0 0 0 0 0 0 14.0954 0 0 0 0 0 0 14.2359 0 0 F8VTS6 RFAL1_HUMAN Ret finger protein-like 4A-like protein 1 RFPL4AL1 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000785; GO:0004842; GO:0005654; GO:0045893; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] ALVSIIKELEPK 0.94054 1.7594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6149 12.5882 0 0 0 11.9843 0 11.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3662 0 0 0 0 0 10.7231 0 0 0 0 0 0 0 0 0 0 0 0 11.8771 0 0 0 0 0 13.4327 0 0 0 0 0 0 0 0 12.1292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15303 GRM6_HUMAN "Metabotropic glutamate receptor 6, mGluR6" GRM6 GPRC1F MGLUR6 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; detection of light stimulus involved in visual perception [GO:0050908]; detection of visible light [GO:0009584]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; locomotory behavior [GO:0007626]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; regulation of synaptic transmission, glutamatergic [GO:0051966]; retina development in camera-type eye [GO:0060041]" dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; new growing cell tip [GO:0035841]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; new growing cell tip [GO:0035841]; plasma membrane [GO:0005886]; synapse [GO:0045202]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; protein homodimerization activity [GO:0042803]; chemical synaptic transmission [GO:0007268]; detection of light stimulus involved in visual perception [GO:0050908]; detection of visible light [GO:0009584]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; locomotory behavior [GO:0007626]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; regulation of synaptic transmission, glutamatergic [GO:0051966]; retina development in camera-type eye [GO:0060041]" GO:0000139; GO:0001640; GO:0004930; GO:0005789; GO:0005886; GO:0005887; GO:0007216; GO:0007268; GO:0007626; GO:0008066; GO:0009584; GO:0030425; GO:0035841; GO:0042803; GO:0045202; GO:0050908; GO:0051966; GO:0060041; GO:1905665 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; protein homodimerization activity [GO:0042803] GVPETFNEAK 0.94054 2.5163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2672 11.9125 0 14.8442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.418 14.315 0 14.1487 0 0 0 13.2126 0 0 13.551 0 11.8942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29376 LTK_HUMAN "Leukocyte tyrosine kinase receptor, EC 2.7.10.1 (Protein tyrosine kinase 1)" LTK TYK1 Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to retinoic acid [GO:0071300]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell population proliferation [GO:0008283]; cellular response to retinoic acid [GO:0071300]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004672; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0007169; GO:0008283; GO:0010666; GO:0010976; GO:0014065; GO:0016020; GO:0030298; GO:0033674; GO:0038083; GO:0042127; GO:0043066; GO:0043235; GO:0045664; GO:0071300 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GCPGPVYRIMTQCWQHEPELR 0.94054 3.4375 0 0 0 0 0 0 0 0 0 0 0 9.99972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2955 0 0 0 0 0 0 0 0 0 11.8724 0 0 0 0 0 0 0 0 0 0 0 13.3198 0 0 0 0 13.4392 0 0 0 0 0 0 0 0 0 0 0 12.0702 0 0 0 0 0 0 0 0 0 10.8688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4534 0 0 0 0 0 0 0 0 11.3924 0 0 0 0 0 0 0 0 0 11.4732 0 0 0 0 0 0 0 0 0 0 Q12866 MERTK_HUMAN "Tyrosine-protein kinase Mer, EC 2.7.10.1 (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK)" MERTK MER Homo sapiens (Human) cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; establishment of localization in cell [GO:0051649]; natural killer cell differentiation [GO:0001779]; negative regulation of cytokine production [GO:0001818]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of lymphocyte activation [GO:0051250]; nervous system development [GO:0007399]; neutrophil clearance [GO:0097350]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of kinase activity [GO:0033674]; positive regulation of phagocytosis [GO:0050766]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; retina development in camera-type eye [GO:0060041]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; establishment of localization in cell [GO:0051649]; natural killer cell differentiation [GO:0001779]; negative regulation of cytokine production [GO:0001818]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of lymphocyte activation [GO:0051250]; nervous system development [GO:0007399]; neutrophil clearance [GO:0097350]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of kinase activity [GO:0033674]; positive regulation of phagocytosis [GO:0050766]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; retina development in camera-type eye [GO:0060041]; secretion by cell [GO:0032940]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068] GO:0001750; GO:0001779; GO:0001818; GO:0004714; GO:0005524; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006468; GO:0006909; GO:0007166; GO:0007169; GO:0007267; GO:0007283; GO:0007399; GO:0016477; GO:0030168; GO:0032940; GO:0033674; GO:0034446; GO:0043235; GO:0043491; GO:0050766; GO:0051250; GO:0051649; GO:0060041; GO:0060068; GO:0097350; GO:2000107 ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] ARISVQVHNATCTVRIAAVTR 0.94054 4.0458 0 0 0 14.6676 14.8831 0 0 0 0 14.8819 0 0 0 0 0 0 0 10.06 0 0 0 0 0 0 0 0 0 10.8377 0 0 0 0 0 14.7135 14.7884 0 14.2042 0 0 0 8.90081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8123 0 0 0 12.1768 0 0 15.425 15.1374 16.2351 15.8535 15.5226 15.5176 15.2331 0 0 15.2744 15.3578 15.14 14.3405 14.8915 0 0 0 15.3451 15.3072 14.8257 15.1579 0 13.671 15.3557 15.1321 16.1154 14.3317 14.6746 14.126 0 0 14.729 15.1505 15.2599 15.1307 0 14.7436 14.5382 14.4915 0 14.7541 0 0 0 14.9936 15.0039 14.7066 15.946 16.9008 0 15.0107 14.0003 0 14.496 15.473 10.4038 0 14.5986 0 0 0 0 13.9617 0 0 14.8301 0 0 0 0 12.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6517 0 13.5709 0 0 0 0 0 P53701 CCHL_HUMAN "Holocytochrome c-type synthase, EC 4.4.1.17 (Cytochrome c-type heme lyase)" HCCS CCHL Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cytochrome c-heme linkage [GO:0018063] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cytochrome c-heme linkage [GO:0018063] GO:0004408; GO:0005739; GO:0005743; GO:0005829; GO:0009887; GO:0016020; GO:0018063; GO:0020037; GO:0046872 heme binding [GO:0020037]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872] ARIRSWMGYELPFDR 0.94057 0.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2082 0 0 0 0 0 0 13.5405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PJ21 SPSB3_HUMAN "SPRY domain-containing SOCS box protein 3, SSB-3" SPSB3 C16orf31 SSB3 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0019005; GO:0043161 QLRPDSGDTLEGLPLPPGLKQVLHNK 0.94057 1.0362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6QHF9 PAOX_HUMAN "Peroxisomal N(1)-acetyl-spermine/spermidine oxidase, EC 1.5.3.13 (Polyamine oxidase)" PAOX PAO UNQ1923/PRO4398 Homo sapiens (Human) polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782] "cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; positive regulation of spermidine biosynthetic process [GO:1901307]; putrescine biosynthetic process [GO:0009446]; putrescine catabolic process [GO:0009447]; spermidine catabolic process [GO:0046203]; spermine catabolic process [GO:0046208]" GO:0005782; GO:0005829; GO:0006598; GO:0009446; GO:0009447; GO:0016491; GO:0046203; GO:0046208; GO:0046592; GO:0052899; GO:0052901; GO:0052902; GO:0052903; GO:0052904; GO:1901307 "N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052899]; N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052904]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity [GO:0052902]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]" EIGQHVAGWTEDEETR 0.94057 0.95524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PX1 RN157_HUMAN "E3 ubiquitin ligase RNF157, EC 2.3.2.27 (RING finger protein 157) (RING-type E3 ubiquitin transferase RNF157)" RNF157 KIAA1917 Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of dendrite extension [GO:1903861]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] cell body [GO:0044297]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell body [GO:0044297]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endosome to lysosome transport [GO:0008333]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of dendrite extension [GO:1903861]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0008333; GO:0016567; GO:0043066; GO:0043951; GO:0044297; GO:0045744; GO:0046872; GO:0051865; GO:0061630; GO:1903861 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] ALLQIRAMRK 0.94057 1.7576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.228 0 0 0 0 0 0 0 0 0 12.0066 0 0 0 0 0 12.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5259 0 0 0 0 0 0 0 0 0 0 11.5578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60760 HPGDS_HUMAN "Hematopoietic prostaglandin D synthase, H-PGDS, EC 5.3.99.2 (GST class-sigma) (Glutathione S-transferase, EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase)" HPGDS GSTS PGDS PTGDS2 Homo sapiens (Human) glutathione metabolic process [GO:0006749]; locomotory behavior [GO:0007626]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; locomotory behavior [GO:0007626]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693]; signal transduction [GO:0007165] GO:0000287; GO:0001516; GO:0004364; GO:0004667; GO:0005509; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0006749; GO:0007165; GO:0007626; GO:0042803; GO:0043231; GO:2000255 calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803] PDLLDNHPRLVTLRK 0.94059 1.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6926 0 0 0 0 0 0 0 0 13.7821 0 14.108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3604 0 P78363 ABCA4_HUMAN "Retinal-specific phospholipid-transporting ATPase ABCA4, EC 7.6.2.1 (ATP-binding cassette sub-family A member 4) (RIM ABC transporter, RIM proteinv, RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein)" ABCA4 ABCR Homo sapiens (Human) "lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]" cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; rod photoreceptor disc membrane [GO:0120202] "cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; rod photoreceptor disc membrane [GO:0120202]; 11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501]; retinol transmembrane transporter activity [GO:0034632]; lipid transport [GO:0006869]; phospholipid transfer to membrane [GO:0006649]; phospholipid translocation [GO:0045332]; photoreceptor cell maintenance [GO:0045494]; phototransduction, visible light [GO:0007603]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; transmembrane transport [GO:0055085]; visual perception [GO:0007601]" GO:0001523; GO:0001750; GO:0003924; GO:0005319; GO:0005501; GO:0005502; GO:0005503; GO:0005524; GO:0005548; GO:0005783; GO:0005887; GO:0006649; GO:0006869; GO:0007601; GO:0007603; GO:0016020; GO:0016887; GO:0031410; GO:0034632; GO:0042574; GO:0042626; GO:0043231; GO:0045332; GO:0045494; GO:0055085; GO:0090555; GO:0097381; GO:0120202; GO:0140326; GO:0140327; GO:0140347; GO:0140359 11-cis retinal binding [GO:0005502]; ABC-type transporter activity [GO:0140359]; all-trans retinal binding [GO:0005503]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled transmembrane transporter activity [GO:0042626]; flippase activity [GO:0140327]; GTPase activity [GO:0003924]; lipid transporter activity [GO:0005319]; N-retinylidene-phosphatidylethanolamine flippase activity [GO:0140347]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; retinoid binding [GO:0005501]; retinol transmembrane transporter activity [GO:0034632] FGDGYIVTMKIKSPK 0.94059 4.9424 0 0 0 0 12.1556 0 0 0 0 0 0 0 11.7603 0 0 0 0 0 0 10.1762 0 0 0 0 0 0 11.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1944 0 13.0314 0 0 0 0 0 0 0 0 0 17.4625 13.6482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6325 0 11.703 0 0 0 0 0 0 0 0 0 14.618 0 0 0 0 0 12.8273 0 14.7785 13.17 13.6932 14.8556 0 11.6626 14.5663 13.596 0 0 0 0 0 0 0 14.446 0 0 Q96AB3 ISOC2_HUMAN Isochorismatase domain-containing protein 2 ISOC2 Homo sapiens (Human) protein destabilization [GO:0031648] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein destabilization [GO:0031648] GO:0005634; GO:0005737; GO:0031648 MAAARPSLGRVLPGSSVLFLCDMQEK 0.94059 1.0362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15018 LIF_HUMAN "Leukemia inhibitory factor, LIF (Differentiation-stimulating factor, D factor) (Melanoma-derived LPL inhibitor, MLPLI) (Emfilermin)" LIF HILDA Homo sapiens (Human) blood vessel remodeling [GO:0001974]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fibroblast proliferation [GO:0048144]; immune response [GO:0006955]; leukemia inhibitory factor signaling pathway [GO:0048861]; lung alveolus development [GO:0048286]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; macrophage differentiation [GO:0030225]; meiotic nuclear division [GO:0140013]; muscle organ morphogenesis [GO:0048644]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of hormone secretion [GO:0046888]; negative regulation of meiotic nuclear division [GO:0045835]; neuron development [GO:0048666]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 acetylation [GO:1901676]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell differentiation [GO:0045595]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; stem cell differentiation [GO:0048863]; trophoblast giant cell differentiation [GO:0060707]; tyrosine phosphorylation of STAT protein [GO:0007260] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; leukemia inhibitory factor receptor binding [GO:0005146]; signaling receptor binding [GO:0005102]; blood vessel remodeling [GO:0001974]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fibroblast proliferation [GO:0048144]; immune response [GO:0006955]; leukemia inhibitory factor signaling pathway [GO:0048861]; lung alveolus development [GO:0048286]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; macrophage differentiation [GO:0030225]; meiotic nuclear division [GO:0140013]; muscle organ morphogenesis [GO:0048644]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of hormone secretion [GO:0046888]; negative regulation of meiotic nuclear division [GO:0045835]; neuron development [GO:0048666]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 acetylation [GO:1901676]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell differentiation [GO:0045595]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; stem cell differentiation [GO:0048863]; trophoblast giant cell differentiation [GO:0060707]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0001974; GO:0005102; GO:0005125; GO:0005146; GO:0005576; GO:0005615; GO:0005829; GO:0006955; GO:0007260; GO:0007566; GO:0008083; GO:0008284; GO:0008285; GO:0010628; GO:0030225; GO:0033138; GO:0033141; GO:0033630; GO:0035019; GO:0042531; GO:0043410; GO:0045595; GO:0045651; GO:0045835; GO:0045944; GO:0046697; GO:0046888; GO:0048144; GO:0048146; GO:0048286; GO:0048644; GO:0048666; GO:0048711; GO:0048861; GO:0048863; GO:0050731; GO:0060426; GO:0060463; GO:0060707; GO:0060708; GO:0070373; GO:0072108; GO:0072307; GO:0140013; GO:1900182; GO:1901676; GO:1903025 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; leukemia inhibitory factor receptor binding [GO:0005146]; signaling receptor binding [GO:0005102] KVLAAGVVPLLLVLHWK 0.9406 2.4957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9884 10.6366 0 0 0 0 0 0 0 0 0 0 12.8338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.612 0 0 12.5925 0 0 0 0 0 0 13.1694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7663 0 0 0 0 0 0 0 0 0 0 0 0 13.2116 0 13.2253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29033 CXB2_HUMAN "Gap junction beta-2 protein (Connexin-26, Cx26)" GJB2 Homo sapiens (Human) aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oxidative stress [GO:0034599]; decidualization [GO:0046697]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; gap junction-mediated intercellular transport [GO:1990349]; inner ear development [GO:0048839]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; sensory perception of sound [GO:0007605]; transmembrane transport [GO:0055085] astrocyte projection [GO:0097449]; cell body [GO:0044297]; connexin complex [GO:0005922]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; gap junction [GO:0005921]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] astrocyte projection [GO:0097449]; cell body [GO:0044297]; connexin complex [GO:0005922]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; gap junction [GO:0005921]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763]; identical protein binding [GO:0042802]; aging [GO:0007568]; cell-cell signaling [GO:0007267]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oxidative stress [GO:0034599]; decidualization [GO:0046697]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; gap junction-mediated intercellular transport [GO:1990349]; inner ear development [GO:0048839]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to human chorionic gonadotropin [GO:0044752]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; sensory perception of sound [GO:0007605]; transmembrane transport [GO:0055085] GO:0002931; GO:0005243; GO:0005509; GO:0005793; GO:0005829; GO:0005886; GO:0005887; GO:0005921; GO:0005922; GO:0007267; GO:0007568; GO:0007605; GO:0016264; GO:0016328; GO:0032355; GO:0032496; GO:0032526; GO:0032570; GO:0034599; GO:0042802; GO:0044297; GO:0044752; GO:0046677; GO:0046697; GO:0048471; GO:0048839; GO:0055085; GO:0071377; GO:0071549; GO:0097449; GO:1903763; GO:1905867; GO:1990349 calcium ion binding [GO:0005509]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763]; identical protein binding [GO:0042802] HSTSIGKIWLTVLFIFRIMILVVAAK 0.94062 1.0362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4845 0 0 11.8689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1426 0 0 0 0 0 0 0 Q12849 GRSF1_HUMAN "G-rich sequence factor 1, GRSF-1" GRSF1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; morphogenesis of embryonic epithelium [GO:0016331]; mRNA polyadenylation [GO:0006378]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; regulation of RNA splicing [GO:0043484]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770] cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; anterior/posterior pattern specification [GO:0009952]; morphogenesis of embryonic epithelium [GO:0016331]; mRNA polyadenylation [GO:0006378]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; regulation of RNA splicing [GO:0043484]; tRNA processing [GO:0008033] GO:0000962; GO:0003723; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0006378; GO:0008033; GO:0009952; GO:0016331; GO:0035770; GO:0042645; GO:0043484; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723] ASLLPQSLAAAAAVPTR 0.94062 0.9637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3754 0 0 0 0 0 0 0 13.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAA5 GRPE2_HUMAN "GrpE protein homolog 2, mitochondrial (Mt-GrpE#2)" GRPEL2 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150] "mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]" "mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]" GO:0000774; GO:0001405; GO:0005739; GO:0005743; GO:0005744; GO:0006457; GO:0006886; GO:0030150; GO:0042803; GO:0051082; GO:0051087 adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082] DLVEVADILEK 0.94062 3.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0946 0 0 0 0 0 0 0 0 11.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5967 0 0 0 10.8678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8359 13.5412 0 0 0 12.9427 0 13.0156 0 0 0 0 0 12.9815 13.2011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3314 0 13.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DV79 SPD18_HUMAN Speedy protein E18 SPDYE18 Homo sapiens (Human) EWSDESEEEPEK 0.94065 1.0102 0 0 0 0 0 0 0 0 0 0 0 0 14.0518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2509 0 0 0 14.0026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DT6 ATG4C_HUMAN "Cysteine protease ATG4C, EC 3.4.22.- (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3, Autophagin-3) (Autophagy-related protein 4 homolog C, HsAPG4C)" ATG4C APG4C AUTL1 AUTL3 Homo sapiens (Human) autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; autophagy [GO:0006914]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508] GO:0004197; GO:0005737; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0051697 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] AVIILVPVR 0.94065 1.7192 0 0 0 0 0 0 0 0 13.5369 0 0 13.3256 13.3938 13.3534 10.3794 13.769 0 0 0 14.2496 0 0 0 0 13.2433 0 0 12.6638 13.9487 13.3999 14.1108 0 0 13.0887 0 12.6674 0 13.0287 0 0 13.6509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.497 0 0 0 0 0 0 0 0 0 0 0 0 14.3098 0 0 0 0 0 0 0 0 13.3938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1094 0 0 0 0 0 0 13.4398 0 0 0 0 0 0 0 0 0 0 13.4851 0 0 0 0 0 0 0 0 12.641 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9402 0 0 0 0 0 0 0 0 12.2132 0 11.6286 0 0 0 0 0 0 12.2546 0 13.5365 O43556 SGCE_HUMAN "Epsilon-sarcoglycan, Epsilon-SG" SGCE ESG UNQ433/PRO840 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; muscle organ development [GO:0007517] cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dystrophin-associated glycoprotein complex [GO:0016010]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dystrophin-associated glycoprotein complex [GO:0016010]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cell-matrix adhesion [GO:0007160]; muscle organ development [GO:0007517] GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0007160; GO:0007517; GO:0016010; GO:0016012; GO:0032590; GO:0042383 SRDYYTDFLITLAVPSAVALVLFLILAYIMCCRR 0.94067 0.97273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0926 0 0 0 0 0 0 12.9066 0 0 0 13.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNB7 ALKMO_HUMAN "Alkylglycerol monooxygenase, EC 1.14.16.5 (Transmembrane protein 195)" AGMO TMEM195 Homo sapiens (Human) ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; ether lipid metabolic process [GO:0046485]; membrane lipid metabolic process [GO:0006643]; triglyceride biosynthetic process [GO:0019432] GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0016021; GO:0019432; GO:0046485; GO:0050479 glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506] AAIMETLRCLMFLMLYR 0.94068 4.1079 0 0 0 0 0 0 11.5096 0 0 0 0 0 10.4409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6861 0 12.5873 14.6046 0 12.394 0 11.6339 0 0 0 0 0 15.5022 0 0 0 0 12.3955 0 0 0 0 0 0 13.0542 12.0137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3112 0 0 14.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5905 0 0 0 0 0 0 0 0 12.2185 0 0 0 0 0 0 0 0 0 0 0 0 Q52M58 CN177_HUMAN Testis-specific protein LINC02914 (Long intergenic non-protein coding RNA 2914) LINC02914 C14orf177 Homo sapiens (Human) cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634] cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634] GO:0005634; GO:0005737; GO:0031514 ARCCGECSTCFCTEEK 0.9407 0.97534 0 0 12.7569 0 11.7008 12.7524 0 0 0 0 0 0 0 0 0 0 10.0799 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4205 0 0 0 11.3171 11.3499 0 0 9.98925 11.9164 0 0 0 0 0 0 11.2043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.012 0 10.7827 0 12.6562 0 0 12.5721 0 0 10.8579 13.7444 0 0 12.9097 0 0 0 0 0 12.4789 0 12.1713 0 0 0 0 0 0 12.4923 0 12.8025 0 0 13.823 14.5613 0 0 0 12.739 0 11.8578 0 0 12.9983 0 0 0 13.4935 0 11.9416 0 0 0 13.0612 0 12.7343 10.9518 0 12.5162 0 0 0 0 0 0 0 0 11.8844 0 13.333 0 0 12.3593 0 0 0 13.5946 0 0 0 13.5742 10.5968 0 13.0398 0 0 0 11.1988 0 0 11.3078 0 0 0 0 0 10.7862 0 0 11.787 0 0 0 0 0 0 0 0 0 0 Q6UWW8 EST3_HUMAN "Carboxylesterase 3, EC 3.1.1.1 (Liver carboxylesterase 31 homolog)" CES3 UNQ869/PRO1887 Homo sapiens (Human) low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805] GO:0005788; GO:0005829; GO:0006805; GO:0034383; GO:0052689; GO:0070062; GO:0080030 carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030] EGEELVLSKKLK 0.94071 1.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C073 F117A_HUMAN Protein FAM117A (C/EBP-induced protein) FAM117A Homo sapiens (Human) EISKLKQQLQR 0.94071 2.4918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.244 0 0 0 13.5183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8999 0 0 0 0 0 0 0 12.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9294 Q8NGI0 O52N2_HUMAN Olfactory receptor 52N2 (Olfactory receptor OR11-57) OR52N2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NVMLIIPFTLLTKR 0.94073 0.95898 0 0 0 0 0 0 0 0 0 0 10.7214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7944 0 0 0 0 0 0 0 12.7287 12.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2245 14.1715 0 0 0 0 0 13.0955 0 0 0 13.401 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5915 0 0 0 0 0 O14493 CLD4_HUMAN "Claudin-4 (Clostridium perfringens enterotoxin receptor, CPE-R, CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein)" CLDN4 CPER CPETR1 WBSCR8 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; circadian rhythm [GO:0007623]; establishment of skin barrier [GO:0061436]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; renal absorption [GO:0070293]; response to progesterone [GO:0032570] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basal plasma membrane [GO:0009925]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basal plasma membrane [GO:0009925]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; circadian rhythm [GO:0007623]; establishment of skin barrier [GO:0061436]; female pregnancy [GO:0007565]; positive regulation of cell migration [GO:0030335]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; renal absorption [GO:0070293]; response to progesterone [GO:0032570] GO:0004888; GO:0005198; GO:0005254; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007155; GO:0007565; GO:0007623; GO:0009925; GO:0016324; GO:0016327; GO:0016328; GO:0016338; GO:0022604; GO:0030335; GO:0032570; GO:0034707; GO:0042802; GO:0061436; GO:0070160; GO:0070293; GO:0070830; GO:0090303; GO:1905050 chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888] ALVIISIIVAALGVLLSVVGGKCTNCLEDESAKAK 0.94074 0.90689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B1ATL7 PRR32_HUMAN Proline-rich protein 32 PRR32 CXorf64 Homo sapiens (Human) IACRGKLAHVSFPLR 0.94075 0.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89315 0 0 0 0 0 0 0 10.1876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEB7 RN128_HUMAN "E3 ubiquitin-protein ligase RNF128, EC 2.3.2.27 (Gene related to anergy in lymphocytes protein, GRAIL) (RING finger protein 128) (RING-type E3 ubiquitin transferase RNF128)" RNF128 Homo sapiens (Human) negative regulation of cytokine production [GO:0001818]; positive regulation of protein catabolic process in the vacuole [GO:1904352]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of cytokine production [GO:0001818]; positive regulation of protein catabolic process in the vacuole [GO:1904352]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001818; GO:0005737; GO:0005770; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0006511; GO:0016021; GO:0031647; GO:0046872; GO:0048471; GO:0061462; GO:0061630; GO:1904352 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AIGRLQLRTLK 0.94077 1.8038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3096 0 0 0 0 0 0 13.0644 0 13.0981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0618 14.7484 0 0 0 0 11.9827 0 14.2496 0 13.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1384 13.3641 0 0 0 0 0 0 0 0 0 0 0 13.2251 0 0 0 14.7996 0 0 0 0 0 0 0 0 0 0 0 0 13.974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60575 ISK4_HUMAN Serine protease inhibitor Kazal-type 4 (Peptide PEC-60 homolog) SPINK4 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576 serine-type endopeptidase inhibitor activity [GO:0004867] AVRQWVIALALAALLVVDR 0.94078 1.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4686 0 15.2871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7048 0 0 0 0 0 0 0 0 0 0 0 0 13.1848 13.6294 0 13.933 0 0 0 13.9928 0 0 0 0 13.9266 0 14.2612 0 0 0 0 14.3277 0 14.3421 0 0 0 0 0 13.8524 0 13.5238 0 0 15.7572 0 0 0 0 13.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8835 0 0 0 0 0 0 0 0 0 14.8567 0 Q5H9B9 BM2KL_HUMAN Putative BMP-2-inducible kinase-like protein BMP2KL Homo sapiens (Human) AKYSDMSPVYR 0.9408 1.7276 0 0 0 0 0 0 0 0 0 0 0 11.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2VIR3 IF2GL_HUMAN "Eukaryotic translation initiation factor 2 subunit 3B, EC 3.6.5.3 (Eukaryotic translation initiation factor 2 subunit gamma A, eIF-2-gamma A, eIF-2gA)" EIF2S3B Homo sapiens (Human) formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903] eukaryotic translation initiation factor 2 complex [GO:0005850] eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational fidelity [GO:0045903] GO:0000049; GO:0001731; GO:0003743; GO:0003924; GO:0005525; GO:0005850; GO:0045903 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] HILILQNKIDLVKER 0.94081 1.7892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4892 0 0 0 10.499 0 14.6436 0 0 13.6255 16.1673 0 0 0 0 0 0 0 0 0 12.0662 0 11.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1692 0 10.5224 0 0 0 0 0 12.4047 0 0 0 0 0 0 0 0 0 0 0 12.6455 0 0 0 0 0 0 0 12.3446 12.9046 0 0 0 0 0 0 12.6644 0 0 0 0 13.2143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C2W1 FBSP1_HUMAN "F-box/SPRY domain-containing protein 1 (F-box only protein 45, hFbxo45)" FBXO45 FBX45 Homo sapiens (Human) anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511] anchoring junction [GO:0070161]; cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202] anchoring junction [GO:0070161]; cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; SCF ubiquitin ligase complex [GO:0019005]; synapse [GO:0045202]; anterior commissure morphogenesis [GO:0021960]; cellular response to DNA damage stimulus [GO:0006974]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; corticospinal tract morphogenesis [GO:0021957]; neuron migration [GO:0001764]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; synapse assembly involved in innervation [GO:0060386]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001764; GO:0006511; GO:0006974; GO:0014069; GO:0016567; GO:0019005; GO:0021799; GO:0021800; GO:0021957; GO:0021960; GO:0042734; GO:0042995; GO:0043161; GO:0045202; GO:0045211; GO:0060386; GO:0070161; GO:0098978; GO:0099523; GO:0099524 IRAFQHAFSTNDCSR 0.94082 0.95527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3127 0 0 0 0 0 0 0 0 0 11.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6435 0 0 0 0 0 0 0 0 0 0 15.4718 0 0 0 0 0 0 0 0 0 0 12.3552 0 11.8396 0 0 0 0 0 0 O60220 TIM8A_HUMAN Mitochondrial import inner membrane translocase subunit Tim8 A (Deafness dystonia protein 1) (X-linked deafness dystonia protein) TIMM8A DDP DDP1 TIM8A Homo sapiens (Human) nervous system development [GO:0007399]; protein insertion into mitochondrial inner membrane [GO:0045039] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; protein insertion into mitochondrial inner membrane [GO:0045039] GO:0005739; GO:0005743; GO:0005758; GO:0007399; GO:0008270; GO:0042719; GO:0042802; GO:0045039 identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] FIDTSQFILNRLEQTQK 0.94083 1.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.567 0 12.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7196 12.6192 0 0 14.1317 0 0 0 0 13.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8362 0 P07998 RNAS1_HUMAN "Ribonuclease pancreatic, EC 4.6.1.18 (HP-RNase) (RIB-1) (RNase UpI-1) (Ribonuclease 1, RNase 1) (Ribonuclease A, RNase A)" RNASE1 RIB1 RNS1 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830]; RNA phosphodiester bond hydrolysis [GO:0090501] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540]; defense response to Gram-positive bacterium [GO:0050830]; RNA phosphodiester bond hydrolysis [GO:0090501] GO:0003676; GO:0004522; GO:0004540; GO:0016829; GO:0050830; GO:0070062; GO:0090501 lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540] ALEKSLVRLLLLVLILLVLGWVQPSLGK 0.94083 4.1614 0 0 0 0 0 0 0 0 0 0 11.0136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1652 0 0 10.9109 0 10.6824 0 0 0 0 10.8404 11.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2388 14.1596 13.7528 14.3396 0 12.7764 0 0 0 14.066 0 0 13.2458 13.499 0 14.7853 13.0171 14.516 13.8156 14.3969 13.6917 0 13.9672 12.4647 13.7402 13.735 0 0 14.0378 0 0 0 0 10.6784 0 0 0 11.2353 0 0 0 11.3944 12.4749 12.2051 10.6579 0 13.2641 12.5201 13.3645 13.5393 13.6435 0 12.976 0 0 14.3257 13.1409 0 12.4345 13.425 13.9419 0 12.9023 12.9071 11.9057 0 12.7939 12.8295 13.0598 13.1006 0 0 13.0232 0 12.7486 12.6537 12.4546 0 12.7457 0 0 0 9.69728 0 11.7492 0 0 0 0 0 10.9127 13.1127 12.5296 11.8039 0 12.2069 11.9276 0 11.8547 0 12.0077 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4E8 UBP15_HUMAN "Ubiquitin carboxyl-terminal hydrolase 15, EC 3.4.19.12 (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4)" USP15 KIAA0529 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K27-linked deubiquitination [GO:1990167]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K27-linked deubiquitination [GO:1990167]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005160; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0007179; GO:0016579; GO:0016604; GO:0030509; GO:0035520; GO:0035616; GO:0042802; GO:0046332; GO:0060389; GO:0061649; GO:1900246; GO:1905035; GO:1990167; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin modification-dependent histone binding [GO:0061649] AEGGAADLDTQRSDIATLLK 0.94084 3.5049 0 0 0 0 0 0 0 0 14.2285 0 0 0 0 12.6218 0 0 0 11.6733 0 0 0 0 0 12.1589 0 0 0 13.3829 14.0871 12.3365 0 13.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0894 0 14.5881 0 0 0 0 0 0 0 13.5889 0 0 0 14.1727 0 0 0 13.2979 14.013 14.5822 0 0 14.2519 0 0 15.401 0 12.9122 16.1546 0 14.5445 0 15.5322 14.8908 0 0 14.6806 0 0 0 13.284 0 0 0 15.8736 0 0 15.168 12.848 0 14.258 13.2084 0 0 12.9524 0 0 0 14.6244 0 0 12.6828 14.4803 0 13.692 0 0 14.7037 0 0 0 0 14.6681 0 15.4069 0 0 0 0 14.8689 0 14.4845 0 0 0 15.7718 0 0 14.0258 15.1638 0 0 14.2983 0 0 0 0 0 13.9383 13.3899 0 13.9433 0 0 0 0 0 0 13.5229 0 12.4302 0 0 13.917 0 P13994 YJU2B_HUMAN Probable splicing factor YJU2B (Coiled-coil domain-containing protein 130) YJU2B CCDC130 SB115 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]" post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684] "post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]" GO:0000398; GO:0005684; GO:0008380; GO:0009615; GO:0071014 AIQEEEERDQALQAKASLTIPLVPETEDDR 0.94086 0.96387 0 0 0 0 0 0 0 0 0 0 0 14.7257 0 13.8274 0 0 0 0 0 0 0 0 12.5055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4074 0 0 0 0 0 0 0 0 0 0 9.80143 0 0 0 0 13.1965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4 0 15.5753 0 0 0 0 11.8442 0 14.1278 12.5534 0 0 0 0 0 0 0 0 0 Q6NVH7 SWAP1_HUMAN "ATPase SWSAP1 (SWIM-type zinc finger 7-associated protein 1) (SWS1-associated protein 1) (ZSWIM7-associated protein 1, ZSWIM7AP1)" SWSAP1 C19orf39 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; protein stabilization [GO:0050821] nucleus [GO:0005634]; Shu complex [GO:0097196] nucleus [GO:0005634]; Shu complex [GO:0097196]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; protein stabilization [GO:0050821] GO:0000724; GO:0003697; GO:0005634; GO:0016887; GO:0050821; GO:0097196 ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697] IRFQYPPSTRELFR 0.94086 2.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.249 0 0 0 12.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7822 0 0 0 0 0 0 0 0 0 0 0 0 Q96NU0 CNT3B_HUMAN Contactin-associated protein-like 3B (Cell recognition molecule Caspr3b) CNTNAP3B CASPR3B Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155] GO:0005886; GO:0007155; GO:0016021 CEQRLALR 0.94087 1.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9376 14.1175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4421 0 0 0 0 14.0402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0442 0 0 0 12.0865 0 0 0 0 0 0 0 0 0 0 0 0 12.3609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYU1 PBX4_HUMAN Pre-B-cell leukemia transcription factor 4 (Homeobox protein PBX4) PBX4 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741] "chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001654; GO:0001741; GO:0005634; GO:0006357; GO:0007420; GO:0009887; GO:0043565; GO:0045893; GO:0048568; GO:0048666 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" HALNCHR 0.94089 0.97273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13572 ITPK1_HUMAN "Inositol-tetrakisphosphate 1-kinase, EC 2.7.1.134 (Inositol 1,3,4-trisphosphate 5/6-kinase, Inositol-triphosphate 5/6-kinase, Ins(1,3,4)P(3) 5/6-kinase, EC 2.7.1.159)" ITPK1 Homo sapiens (Human) blood coagulation [GO:0007596]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; cytosol [GO:0005829] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; ATP binding [GO:0005524]; catalytic activity [GO:0003824]; hydrolase activity [GO:0016787]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; blood coagulation [GO:0007596]; inositol phosphorylation [GO:0052746]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube development [GO:0021915]; signal transduction [GO:0007165]" GO:0000287; GO:0000825; GO:0003824; GO:0005524; GO:0005829; GO:0007165; GO:0007596; GO:0016324; GO:0016787; GO:0016853; GO:0021915; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052746; GO:0070266 "ATP binding [GO:0005524]; catalytic activity [GO:0003824]; hydrolase activity [GO:0016787]; inositol tetrakisphosphate 1-kinase activity [GO:0047325]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]" KRGMEVVQLNLSR 0.9409 1.011 0 0 0 0 0 0 0 0 13.3294 14.2198 14.8637 13.705 14.7157 12.4743 14.2789 12.608 0 11.7837 11.6962 0 11.8128 0 0 0 0 0 0 0 0 13.6273 13.5839 13.2818 13.5411 12.7176 11.8589 13.1063 12.3689 11.9236 13.1196 0 0 0 12.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2675 0 0 0 0 0 0 0 0 13.8679 15.272 12.5806 14.7947 15.3779 15.4469 15.5097 13.3906 15.3619 13.7756 14.8064 0 14.0297 14.0045 13.4391 0 0 0 0 14.1389 0 0 0 0 Q53GT1 KLH22_HUMAN Kelch-like protein 22 KLHL22 Homo sapiens (Human) cell division [GO:0051301]; cellular response to leucine [GO:0071233]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; 14-3-3 protein binding [GO:0071889]; cell division [GO:0051301]; cellular response to leucine [GO:0071233]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513] GO:0000070; GO:0005634; GO:0005737; GO:0005764; GO:0005813; GO:0005827; GO:0005829; GO:0006513; GO:0007094; GO:0010507; GO:0015630; GO:0030307; GO:0031463; GO:0043161; GO:0043231; GO:0045171; GO:0051301; GO:0071233; GO:0071889; GO:0072686; GO:1904263 14-3-3 protein binding [GO:0071889] GTPDRSQADPDFASEVMSVSDWEEFDNSSED 0.94091 1.7517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8311 0 0 0 0 0 0 0 0 0 0 0 0 12.9544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8739 0 0 0 0 0 0 12.1134 0 0 0 11.7805 0 13.0383 0 0 0 0 0 12.5931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.098 Q6UW68 TM205_HUMAN Transmembrane protein 205 TMEM205 UNQ501/PRO1018 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GLGGEVPGSHQGPDPYRQLREK 0.94091 1.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UM44 HHLA2_HUMAN HERV-H LTR-associating protein 2 (Human endogenous retrovirus-H long terminal repeat-associating protein 2) HHLA2 Homo sapiens (Human) positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cytokine production [GO:0001819]; regulation of cytokine production [GO:0001817]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cytokine production [GO:0001819]; regulation of cytokine production [GO:0001817]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0001819; GO:0005102; GO:0009897; GO:0016021; GO:0031295; GO:0042104; GO:0050852 signaling receptor binding [GO:0005102] TSLFYNEIQNGNASLFFR 0.94091 1.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9675 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8725 0 0 0 0 0 0 0 0 0 0 0 0 0 12.911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92870 APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1) APBB2 FE65L FE65L1 Homo sapiens (Human) "intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808]" cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202] "cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808]" GO:0000122; GO:0001540; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0016020; GO:0030027; GO:0030426; GO:0035556; GO:0036438; GO:0045202; GO:0045944; GO:0050808; GO:1901988 amyloid-beta binding [GO:0001540] ANVNLDVPLQVDFPTPKTELVQK 0.94092 0.97675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7316 12.6784 12.8294 0 12.7737 0 0 11.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1055 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2454 0 0 0 0 0 19.2263 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4965 0 0 0 0 Q9BT30 ALKB7_HUMAN "Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial, EC 1.14.11.- (Alkylated DNA repair protein alkB homolog 7) (Spermatogenesis cell proliferation-related protein) (Spermatogenesis-associated protein 11)" ALKBH7 ABH7 SPATA11 UNQ6002/PRO34564 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445] GO:0005739; GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0046872; GO:0051213; GO:1902445 dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872] ETEKSRWSEASR 0.94092 1.0102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15782 CH3L2_HUMAN Chitinase-3-like protein 2 (Chondrocyte protein 39) (YKL-39) CHI3L2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; hydrolase activity [GO:0016787]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032] GO:0005576; GO:0005615; GO:0005975; GO:0006032; GO:0008061; GO:0016787; GO:0030246 carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; hydrolase activity [GO:0016787] FTPENIDPFLCSHLIYSFASIENNKVIIK 0.94094 0.97618 0 0 0 0 0 0 0 0 0 0 0 0 12.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4718 0 0 11.652 0 0 0 0 0 0 15.1375 12.019 0 11.8158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3608 0 0 0 0 0 0 0 0 0 Q15007 FL2D_HUMAN "Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog, hFL(2)D) (WT1-associated protein) (Wilms tumor 1-associating protein)" WTAP KIAA0105 Homo sapiens (Human) "cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007049; GO:0008380; GO:0016607; GO:0031965; GO:0036396; GO:0042802; GO:0080009 identical protein binding [GO:0042802] EGNTTEDDFPSSPGNGNKSSNSSEER 0.94096 1.7993 0 0 0 11.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y484 WIPI4_HUMAN "WD repeat domain phosphoinositide-interacting protein 4, WIPI-4 (WD repeat-containing protein 45)" WDR45 WDRX1 WDRXI4 WIPI4 JM5 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] "cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]" GO:0000045; GO:0000407; GO:0000422; GO:0005829; GO:0006497; GO:0006914; GO:0009267; GO:0019898; GO:0019901; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0080025; GO:1901981; GO:2000786 "phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]" DSKEKLVLEFTFTK 0.94096 0.97607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6L6 SO1B1_HUMAN "Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1, LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2, OATP-2) (Solute carrier family 21 member 6)" SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] GO:0005886; GO:0005887; GO:0015125; GO:0015347; GO:0015349; GO:0015711; GO:0015721; GO:0016020; GO:0016323; GO:0042167; GO:0043252 bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] DDACTRK 0.94096 1.7845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1529 0 0 0 0 0 0 0 0 0 0 0 0 13.1021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3204 0 12.5621 17.963 13.2468 0 13.7621 13.7891 13.7205 0 0 13.6432 13.8578 0 0 12.9385 0 18.1264 0 18.0205 18.0752 0 14.2346 0 0 17.9098 0 13.7448 14.0318 13.7064 0 17.9471 17.9416 0 17.7867 0 19.1549 0 0 0 0 0 0 12.0726 0 0 0 0 0 0 0 0 14.7894 0 0 0 0 0 0 0 0 0 0 0 0 12.6439 0 0 0 0 0 12.356 0 0 0 0 0 0 17.9333 0 0 0 0 0 0 0 12.7353 0 0 0 13.4276 0 0 14.3612 0 0 0 0 0 0 0 0 0 0 Q3SYF9 KR197_HUMAN Keratin-associated protein 19-7 KRTAP19-7 KAP19.7 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 LGYGCGYGGYRYSCCHPSCYGGYWSSGFY 0.94097 1.7328 0 0 0 0 0 0 0 0 13.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5687 0 0 0 13.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7109 0 0 0 0 0 0 13.5402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN86 G3BP2_HUMAN "Ras GTPase-activating protein-binding protein 2, G3BP-2 (GAP SH3 domain-binding protein 2)" G3BP2 KIAA0660 Homo sapiens (Human) cytoplasmic sequestering of NF-kappaB [GO:0007253]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor complex adaptor activity [GO:0030159]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of stress granule assembly [GO:0062029]; protein homooligomerization [GO:0051260]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063] GO:0003723; GO:0003729; GO:0005737; GO:0005829; GO:0007253; GO:0007265; GO:0010494; GO:0030159; GO:0034063; GO:0045087; GO:0051028; GO:0051260; GO:0062029; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor complex adaptor activity [GO:0030159] FYVHNDMFR 0.94097 1.7221 0 0 0 0 0 0 0 0 0 0 0 14.9834 0 0 0 0 0 0 0 0 0 0 0 0 11.2424 0 0 0 0 0 0 0 13.6234 0 13.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7688 0 0 0 0 0 0 0 0 0 0 12.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98095 FBLN2_HUMAN "Fibulin-2, FIBL-2" FBLN2 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005201; GO:0005509; GO:0005576; GO:0010811; GO:0030023; GO:0030198; GO:0031012; GO:0050840; GO:0062023; GO:1903561 calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201] CGEGQVCHNLPGSYR 0.94099 1.7844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7539 0 0 0 0 0 0 0 0 0 0 10.2557 0 13.1299 0 14.3693 0 0 0 0 0 0 0 0 0 0 0 14.8302 0 0 0 0 0 0 0 0 0 0 11.6505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4223 0 0 0 0 0 0 0 19.1685 0 19.1071 0 0 19.0694 18.9485 0 0 12.0712 0 0 0 0 0 0 0 0 0 18.6174 0 0 17.5084 Q5T9Z0 TEDM1_HUMAN "Transmembrane epididymal protein 1 (Human epididymis-specific protein 9, He9)" TEDDM1 HE9 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EWQHLTMFILLTLNGCVDFMSKNVLPQR 0.94099 0.97183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5896 0 0 13.8518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEX6 WFD11_HUMAN Protein WFDC11 WFDC11 WAP11 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] GO:0004867; GO:0005615; GO:0019731; GO:0045087 serine-type endopeptidase inhibitor activity [GO:0004867] KELLLEECWGKPNVK 0.941 0.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96D03 DDT4L_HUMAN "DNA damage-inducible transcript 4-like protein (HIF-1 responsive protein RTP801-like) (Protein regulated in development and DNA damage response 2, REDD-2)" DDIT4L REDD2 RTP801L Homo sapiens (Human) negative regulation of signal transduction [GO:0009968] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; negative regulation of signal transduction [GO:0009968] GO:0005737; GO:0009968 GRFSSGFRR 0.94101 0.95821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74477 0 0 0 0 0 0 12.9605 12.2876 0 12.1175 0 0 0 0 10.791 0 0 14.1716 14.0236 0 0 0 0 12.7568 0 13.2434 0 0 0 0 0 13.0971 0 0 12.7388 0 0 0 0 13.7536 0 0 0 14.157 0 11.0506 0 0 13.2444 0 14.0807 13.4898 0 13.8753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1432 0 0 0 0 0 10.2542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15717 ELAV1_HUMAN "ELAV-like protein 1 (Hu-antigen R, HuR)" ELAVL1 HUR Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA stabilization [GO:0048255]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; positive regulation of translation [GO:0045727]; post-transcriptional gene silencing [GO:0016441]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of stem cell population maintenance [GO:2000036] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; sarcoplasm [GO:0016528] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; sarcoplasm [GO:0016528]; double-stranded RNA binding [GO:0003725]; lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA stabilization [GO:0048255]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; positive regulation of translation [GO:0045727]; post-transcriptional gene silencing [GO:0016441]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of stem cell population maintenance [GO:2000036] GO:0000932; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006606; GO:0010494; GO:0016020; GO:0016441; GO:0016528; GO:0019901; GO:0031410; GO:0035198; GO:0035925; GO:0042803; GO:0045727; GO:0048255; GO:0051260; GO:0060965; GO:0070935; GO:0098794; GO:0098978; GO:0106222; GO:1990904; GO:2000036 double-stranded RNA binding [GO:0003725]; lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] GVAFIRFDKR 0.94102 1.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7728 12.9266 13.73 13.3558 0 12.361 0 0 0 0 0 0 12.4712 14.2359 0 0 0 0 0 0 0 0 0 0 11.7192 12.8751 0 0 0 0 0 0 0 13.5008 13.8247 0 0 14.8639 0 13.9764 0 0 0 13.6691 0 0 0 0 0 13.9229 0 0 14.3061 13.9942 0 0 14.1094 0 0 14.1775 0 0 14.2415 13.8177 0 0 0 0 0 0 0 15.5918 0 0 0 0 0 13.3465 0 0 0 0 10.6499 10.7447 0 0 0 0 0 11.5504 0 0 0 0 0 0 0 10.0176 11.0104 0 0 0 0 0 12.9954 0 0 0 0 0 0 0 0 Q9H0A3 T191A_HUMAN Transmembrane protein 191A TMEM191A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IIILKRTSLPTVSPSNER 0.94102 2.5084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7168 0 0 0 0 13.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.035 0 0 10.0921 0 0 0 0 0 11.8837 0 0 0 13.9408 0 0 13.2474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8264 0 0 0 0 0 0 12.8604 0 0 0 0 0 0 0 0 0 11.6124 0 0 0 0 0 Q7Z398 ZN550_HUMAN Zinc finger protein 550 ZNF550 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFRCSSELIQHQR 0.94103 3.8886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0019 0 0 0 0 0 12.4257 0 16.3462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P202 WHRN_HUMAN Whirlin (Autosomal recessive deafness type 31 protein) WHRN DFNB31 KIAA1526 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; anchoring junction [GO:0070161]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696] actin filament [GO:0005884]; anchoring junction [GO:0070161]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696]; identical protein binding [GO:0042802]; auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:0070161; GO:1990075; GO:1990227; GO:1990696 identical protein binding [GO:0042802] DYIDFLVTEFNVML 0.94105 2.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8761 0 0 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.795 0 0 0 0 0 0 9.55403 0 0 0 0 0 0 0 0 0 0 0 19.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9984 0 0 0 0 0 P48145 NPBW1_HUMAN Neuropeptides B/W receptor type 1 (G-protein coupled receptor 7) NPBWR1 GPR7 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of metabolic process [GO:0019222] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of metabolic process [GO:0019222] GO:0004930; GO:0004985; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0007268; GO:0008188; GO:0016021; GO:0019222; GO:0042277; GO:0042923; GO:0043005; GO:0045202 G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277] AVSLAVWGIVTLVVLPFAVFAR 0.94107 0.95557 0 0 0 0 10.9282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3074 0 0 0 0 0 0 0 12.0528 0 0 12.5487 0 0 10.7438 0 0 0 0 0 11.3377 0 0 0 0 0 0 0 0 0 0 13.1892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7872 0 0 0 0 0 0 0 0 0 0 Q9BZX2 UCK2_HUMAN "Uridine-cytidine kinase 2, UCK 2, EC 2.7.1.48 (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2)" UCK2 UMPK Homo sapiens (Human) CTP salvage [GO:0044211]; phosphorylation [GO:0016310]; UMP salvage [GO:0044206] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; identical protein binding [GO:0042802]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; phosphorylation [GO:0016310]; UMP salvage [GO:0044206] GO:0004849; GO:0005524; GO:0005737; GO:0005829; GO:0016310; GO:0042802; GO:0043771; GO:0044206; GO:0044211 ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; identical protein binding [GO:0042802]; uridine kinase activity [GO:0004849] GRDLEQILSQYITFVK 0.94107 2.507 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9547 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8682 0 0 0 0 0 0 0 0 0 0 0 14.9457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0019 13.0183 0 0 0 0 0 0 0 0 0 0 13.4588 0 0 0 0 0 0 0 0 0 0 0 0 10.9363 0 0 0 0 0 0 0 0 0 0 Q9Y320 TMX2_HUMAN Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14) TMX2 TXNDC14 CGI-31 My009 PIG26 PSEC0045 UNQ237/PRO270 Homo sapiens (Human) brain development [GO:0007420] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane-bounded organelle [GO:0043227]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane-bounded organelle [GO:0043227]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; brain development [GO:0007420] GO:0005739; GO:0005789; GO:0007420; GO:0015036; GO:0016021; GO:0031966; GO:0042802; GO:0043227; GO:0044233 disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802] AVLAPLIALVYSVPR 0.94108 1.7944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2063 11.5745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3813 0 0 0 0 0 0 0 0 10.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9508 0 0 17.5388 14.7631 10.6726 15.1066 18.0016 19.4319 13.3181 0 0 13.6722 0 0 14.2136 9.10297 0 0 11.489 0 0 17.2737 16.4017 17.056 15.6118 13.3741 12.1047 0 0 0 0 0 12.8725 0 0 0 0 0 0 0 0 0 12.4215 0 15.4343 0 0 0 0 0 0 0 0 12.5749 0 0 13.3031 0 0 0 0 0 0 0 0 14.4992 0 0 0 0 0 0 0 0 0 0 0 0 0 14.604 0 0 13.6324 0 0 0 0 0 11.4404 Q86U28 ISCA2_HUMAN "Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1)" ISCA2 HBLD1 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]" GO:0005506; GO:0005739; GO:0005759; GO:0016226; GO:0051537; GO:0051539; GO:0106035 "2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]" FSLDTVINPDDR 0.94114 1.0122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0286 0 0 0 13.6239 0 0 0 11.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1L4 CP4Z2_HUMAN Putative inactive cytochrome P450 family member 4Z2 CYP4Z2P Homo sapiens (Human) integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" GO:0004497; GO:0005506; GO:0016021; GO:0016705; GO:0020037 "heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" AMHLFPAPPAHWFYGHKESYPVKEFEVYPELMEK 0.94114 0.97273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SI1 KCD15_HUMAN BTB/POZ domain-containing protein KCTD15 (Potassium channel tetramerization domain-containing protein 15) KCTD15 Homo sapiens (Human) protein homooligomerization [GO:0051260] nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homooligomerization [GO:0051260] GO:0005634; GO:0042802; GO:0051260 identical protein binding [GO:0042802] DFSLLYEEARYYQLQPMVR 0.94116 1.0117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0692 0 0 0 0 0 0 0 0 12.4138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2577 0 14.1727 0 0 0 0 0 0 0 0 12.3955 0 0 0 0 0 0 0 12.9704 0 0 0 12.9237 0 0 13.8306 0 0 0 14.1812 0 0 0 0 13.4436 0 0 0 0 0 0 13.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95870 ABHGA_HUMAN "Phosphatidylserine lipase ABHD16A, EC 3.1.-.- (Alpha/beta hydrolase domain-containing protein 16A, Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5, hBAT5) (Monoacylglycerol lipase ABHD16A, EC 3.1.1.23) (Protein G5)" ABHD16A BAT5 G5 NG26 PP199 Homo sapiens (Human) monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344] GO:0004620; GO:0006660; GO:0008474; GO:0016020; GO:0016021; GO:0047372; GO:0052651; GO:1905344 acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620] GNDLLLKLLQHR 0.94118 2.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6421 11.7718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4385 0 P22891 PROZ_HUMAN Vitamin K-dependent protein Z PROZ Homo sapiens (Human) blood coagulation [GO:0007596]; proteolysis [GO:0006508] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; proteolysis [GO:0006508] GO:0004252; GO:0005509; GO:0005615; GO:0005788; GO:0005796; GO:0006508; GO:0007596; GO:0070062 calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252] APDLQDLPWQVKLTNSEGK 0.94118 2.565 0 0 0 0 0 0 0 0 0 13.8171 0 14.0981 0 14.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4342 0 14.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1718 0 0 0 0 0 0 0 10.825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3416 0 0 0 0 13.2958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8408 0 0 0 0 0 0 0 12.0053 9.74901 0 0 Q5SRN2 TSBP1_HUMAN Testis-expressed basic protein 1 (Uncharacterized protein C6orf10) TSBP1 C6orf10 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 ERDAEKDPNK 0.94118 3.4622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4476 10.6199 0 0 0 0 0 0 0 11.8878 0 0 0 0 0 0 0 0 10.8496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4027 11.7214 11.1056 0 0 0 11.4274 13.8878 0 0 0 0 0 0 0 0 0 0 12.5036 0 0 0 0 0 0 14.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6736 12.5372 0 0 0 0 11.4283 11.0056 0 11.9899 0 0 0 0 0 0 10.8967 0 0 0 0 0 13.1873 0 0 0 0 0 12.5332 0 14.4314 0 0 13.0069 0 12.7195 0 11.179 0 15.4878 0 0 0 0 0 0 0 0 0 0 0 0 0 12.344 11.9848 0 0 11.8298 0 0 0 11.7243 0 0 0 Q6UX34 SNORC_HUMAN Protein SNORC (Secondary ossification center-associated regulator of chondrocyte maturation protein) SNORC C2orf82 UNQ830/PRO1757 Homo sapiens (Human) cartilage development [GO:0051216] cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; cartilage development [GO:0051216] GO:0005576; GO:0005737; GO:0016021; GO:0051216; GO:0062023; GO:0071944 LDQGGGSLGPGAIAAIVIAALLATCVVLALVVVALRK 0.94118 0.97678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3979 0 13.742 0 0 13.8276 0 13.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9423 0 0 0 12.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9829 0 0 0 0 0 0 0 Q8NAN2 MIGA1_HUMAN Mitoguardin 1 (Protein FAM73A) MIGA1 FAM73A Homo sapiens (Human) mitochondrial fusion [GO:0008053] integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of plasma membrane [GO:0005887]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; mitochondrial fusion [GO:0008053] GO:0005739; GO:0005741; GO:0005887; GO:0008053; GO:0042803; GO:0046982 protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] FSPVAKKLFVVTAVSAISVIFLAHHFK 0.94118 4.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6861 0 0 0 0 12.9631 0 0 12.8808 0 0 12.6913 12.0686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0717 0 0 0 0 0 0 0 0 0 13.7145 14.3315 0 0 0 0 0 0 0 0 13.9573 0 0 0 13.649 0 12.9016 12.8268 0 0 0 0 0 0 0 0 12.9611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.318 0 0 0 0 0 0 0 0 0 0 0 12.8295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBP5 F174A_HUMAN "Membrane protein FAM174A (Hepatitis C virus NS5A-transactivated protein 6, HCV NS5A-transactivated protein 6) (Transmembrane protein 157)" FAM174A NS5ATP6 TMEM157 UNQ1912/PRO4371 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALTVLMVVSGAVLVYFVVR 0.94118 3.5965 0 0 0 0 0 0 0 0 0 0 0 12.1173 14.6776 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4254 0 12.9502 12.7433 0 12.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.663 0 0 0 0 0 0 0 14.7138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0454 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUP2 FBLI1_HUMAN "Filamin-binding LIM protein 1, FBLP-1 (Migfilin) (Mitogen-inducible 2-interacting protein, MIG2-interacting protein)" FBLIM1 FBLP1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; regulation of cell shape [GO:0008360]; regulation of integrin activation [GO:0033623] cell junction [GO:0030054]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; focal adhesion [GO:0005925]; stress fiber [GO:0001725] cell junction [GO:0030054]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; focal adhesion [GO:0005925]; stress fiber [GO:0001725]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]; regulation of cell shape [GO:0008360]; regulation of integrin activation [GO:0033623] GO:0001650; GO:0001725; GO:0005737; GO:0005829; GO:0005925; GO:0008360; GO:0030054; GO:0031005; GO:0033623; GO:0046872; GO:0071944; GO:0098609 filamin binding [GO:0031005]; metal ion binding [GO:0046872] CEDCRILLSVEPTDQGCYPLNNHLFCK 0.94118 1.7551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1175 0 11.3134 0 0 0 0 0 0 0 12.8774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7445 0 0 0 0 0 0 0 0 0 0 0 0 Q96PB1 CASD1_HUMAN "N-acetylneuraminate 9-O-acetyltransferase, EC 2.3.1.45 (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase, SOAT)" CASD1 C7orf12 Nbla04196 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] integral component of Golgi membrane [GO:0030173] integral component of Golgi membrane [GO:0030173]; N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186]; carbohydrate metabolic process [GO:0005975] GO:0005975; GO:0030173; GO:0047186 N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity [GO:0047186] IINPQFKEEGNK 0.94118 3.3707 0 0 0 11.9823 0 0 0 0 14.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4822 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0742 0 0 0 0 0 0 0 0 0 0 0 13.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0072 12.3717 0 0 0 13.4018 0 0 0 0 10.8855 0 0 0 0 13.8921 0 0 12.8317 14.1407 0 15.1504 13.9767 0 14.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087WTH1 TM265_HUMAN Transmembrane protein 265 TMEM265 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 KLILASFAVWLAVLILGPLLLWLLSYAIAQAE 0.94121 1.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZE8 RM35_HUMAN "39S ribosomal protein L35, mitochondrial, L35mt, MRP-L35 (Mitochondrial large ribosomal subunit protein bL35m)" MRPL35 BM-007 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 structural constituent of ribosome [GO:0003735] PLNILASSTYR 0.94121 0.89998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.747 0 0 0 0 0 0 0 0 11.7417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6258 0 0 0 0 0 12.5882 13.1043 0 12.0376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14880 MGST3_HUMAN "Microsomal glutathione S-transferase 3, Microsomal GST-3 (Glutathione peroxidase MGST3, EC 1.11.1.-) (LTC4 synthase MGST3, EC 4.4.1.20) (Microsomal glutathione S-transferase III, Microsomal GST-III)" MGST3 Homo sapiens (Human) leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; transferase activity [GO:0016740]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629] GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0006629; GO:0016020; GO:0016021; GO:0016740; GO:0019370; GO:0042802; GO:0043231 glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; transferase activity [GO:0016740] IASGLGLAWIVGR 0.94122 0.89876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0837 13.9085 14.1645 0 15.6122 0 0 0 13.989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGP8 SEC63_HUMAN Translocation protein SEC63 homolog SEC63 SEC63L Homo sapiens (Human) "liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein targeting to membrane [GO:0006612]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]" endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; protein transmembrane transporter activity [GO:0008320]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein targeting to membrane [GO:0006612]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]" GO:0001889; GO:0003723; GO:0005783; GO:0006612; GO:0006614; GO:0006620; GO:0006807; GO:0008320; GO:0010259; GO:0016020; GO:0016021; GO:0031204; GO:0031207; GO:0038023 protein transmembrane transporter activity [GO:0008320]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023] ARVLLLSHLARMK 0.94124 0.97234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4374 0 0 0 0 0 13.8173 13.987 0 0 0 0 10.619 10.1635 0 10.809 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83638 0 0 0 0 0 0 10.702 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3703 12.7279 0 0 15.4392 0 12.7171 0 15.1588 0 11.1648 15.554 14.8053 13.8263 13.7903 0 17.0304 17.4876 16.7668 17.4693 17.6674 16.9158 15.7652 17.1319 16.8265 16.2514 15.1709 15.9915 14.8415 16.0085 15.1495 14.809 15.1791 15.0807 14.6713 12.9539 15.6816 12.8829 0 15.1057 15.6238 0 0 12.8846 15.1242 0 14.2723 16.2939 15.779 15.5807 0 0 12.7738 12.9591 14.5905 14.6262 14.7015 14.8154 14.9296 13.1888 13.8222 12.0368 14.2476 14.5502 13.7302 15.239 12.9193 14.1467 0 0 14.7558 0 13.3449 0 13.7651 0 11.1073 0 15.4438 12.903 0 13.6884 0 13.252 0 0 0 12.5449 0 13.1488 0 10.5256 0 0 0 13.0513 11.2404 12.6929 13.9038 0 13.3468 11.7704 0 0 0 0 13.4625 14.4858 12.1825 11.6026 0 0 14.9161 12.0583 A6NJV1 F166C_HUMAN Protein FAM166C (Family with sequence similarity 166 member C) FAM166C C2orf70 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 FNLDSHRSTELTNFYQMVQQHR 0.94124 1.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M3V2 SWAHA_HUMAN Ankyrin repeat domain-containing protein SOWAHA (Ankyrin repeat domain-containing protein 43) (Protein sosondowah homolog A) SOWAHA ANKRD43 Homo sapiens (Human) DRFKQFVNNVAVVK 0.94124 2.6707 0 0 0 0 0 0 0 0 0 0 0 9.69542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2968 0 0 0 0 11.3218 12.0399 0 0 0 0 0 0 12.5447 0 13.5513 0 13.4912 13.1817 13.6844 0 0 12.2147 12.0639 0 0 0 11.9288 0 0 0 0 0 0 11.4959 14.3973 0 0 0 0 0 0 0 14.0968 0 14.1917 0 13.68 12.6343 13.0562 14.3951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2581 0 13.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.699 0 0 0 0 14.3426 0 0 0 0 0 0 0 0 13.4022 0 0 0 0 0 Q9Y6C7 L3R2A_HUMAN Putative uncharacterized protein encoded by LINC00312 (Loss of heterozygosity 3 chromosomal region 2 gene A protein) LINC00312 LOH3CR2A NCRNA00312 NAG7 Homo sapiens (Human) RQANQANKLSMMLLR 0.94125 0.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6153 Q71RH2 TLC3B_HUMAN "Ceramide synthase, EC 2.3.1.- (Protein FAM57B) (TLC domain-containing protein 3B)" TLCD3B FAM57B FP1188 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; negative regulation of fat cell differentiation [GO:0045599] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; negative regulation of fat cell differentiation [GO:0045599] GO:0000139; GO:0005783; GO:0005789; GO:0016021; GO:0045599; GO:0046513; GO:0050291; GO:0055088 sphingosine N-acyltransferase activity [GO:0050291] HQVKGHGGDDGAAR 0.94126 1.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3796 0 0 0 0 0 0 0 15.6071 0 0 13.424 0 0 0 0 0 11.8068 0 0 12.1316 0 0 0 11.9433 0 0 0 0 12.0372 0 0 0 0 0 11.8454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3711 0 0 0 0 0 0 0 0 0 0 13.1873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4132 0 0 0 0 0 0 0 0 0 P03973 SLPI_HUMAN "Antileukoproteinase, ALP (BLPI) (HUSI-1) (Mucus proteinase inhibitor, MPI) (Protease inhibitor WAP4) (Secretory leukocyte protease inhibitor) (Seminal proteinase inhibitor) (WAP four-disulfide core domain protein 4)" SLPI WAP4 WFDC4 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; immune response [GO:0006955]; innate immune response [GO:0045087]; modulation of process of another organism [GO:0035821]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; response to lipopolysaccharide [GO:0032496] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; specific granule lumen [GO:0035580] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; specific granule lumen [GO:0035580]; DNA binding [GO:0003677]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; immune response [GO:0006955]; innate immune response [GO:0045087]; modulation of process of another organism [GO:0035821]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; response to lipopolysaccharide [GO:0032496] GO:0003677; GO:0003729; GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0005794; GO:0006955; GO:0019731; GO:0019899; GO:0032091; GO:0032496; GO:0035580; GO:0035821; GO:0045071; GO:0045087; GO:0062023; GO:0070062 DNA binding [GO:0003677]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; serine-type endopeptidase inhibitor activity [GO:0004867] CCMGMCGK 0.94127 1.7897 0 0 0 0 0 0 0 0 0 15.3356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3538 0 0 0 0 0 0 0 12.6441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5601 0 0 0 0 0 0 0 0 11.2006 0 0 13.2214 0 0 0 13.7499 0 0 0 11.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.009 0 0 0 0 Q96BW1 UPP_HUMAN Uracil phosphoribosyltransferase homolog UPRT Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525] GO:0005525; GO:0005654; GO:0005737; GO:0005829; GO:0043231 GTP binding [GO:0005525] GNCGVSIMRSGEAMEQGLRDCCR 0.94127 1.8043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VT40 FA78B_HUMAN Protein FAM78B FAM78B Homo sapiens (Human) EKIILQTIK 0.94128 3.4614 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5536 0 11.3619 0 0 0 0 12.5839 0 14.3062 13.0192 0 0 0 0 0 0 13.7632 13.0846 13.2698 0 0 0 0 0 0 0 0 12.2575 0 0 0 0 0 0 0 0 0 0 0 12.988 0 13.1819 0 12.3192 0 13.2379 0 12.7641 0 13.6079 0 14.1637 0 0 0 0 0 0 0 0 0 0 10.9942 0 12.1277 0 0 11.2768 12.7276 0 0 0 14.6982 0 0 0 12.3093 0 0 0 0 0 0 0 0 12.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC27 ADA32_HUMAN "Disintegrin and metalloproteinase domain-containing protein 32, ADAM 32" ADAM32 UNQ5982/PRO21340 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; proteolysis [GO:0006508] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; proteolysis [GO:0006508] GO:0004222; GO:0006508; GO:0007155; GO:0007339; GO:0016021 metalloendopeptidase activity [GO:0004222] CYKGLCCKDCQILQSGVECR 0.94129 2.5615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.272 0 0 0 11.4982 0 0 11.7509 0 0 0 10.8921 0 12.5958 14.1822 0 14.686 0 0 0 0 0 11.5681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.577 0 0 0 0 0 0 0 11.5192 0 0 0 15.3566 0 0 0 0 12.5156 12.7442 0 14.7827 13.8611 0 0 0 12.174 0 0 0 0 0 13.5157 12.2259 0 0 0 0 0 13.061 0 0 13.1535 0 0 11.8446 0 0 0 0 15.3941 0 0 0 0 15.9637 11.9943 0 0 0 0 0 11.9862 15.4965 0 0 0 0 0 0 0 0 0 0 0 15.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6945 0 0 0 0 0 0 0 0 Q8NGJ9 O51T1_HUMAN Olfactory receptor 51T1 (Olfactory receptor OR11-26) OR51T1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GLRGRWD 0.94132 0.96882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6207 0 0 0 14.0896 0 11.4362 0 0 0 0 0 0 0 0 0 0 0 14.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1693 0 0 0 0 0 0 0 0 0 0 12.1199 0 0 0 0 0 0 0 0 0 Q9NSD5 S6A13_HUMAN "Sodium- and chloride-dependent GABA transporter 2, GAT-2 (Solute carrier family 6 member 13)" SLC6A13 GAT2 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; monocarboxylic acid transport [GO:0015718]; nitrogen compound transport [GO:0071705]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]; amino acid import across plasma membrane [GO:0089718]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; monocarboxylic acid transport [GO:0015718]; nitrogen compound transport [GO:0071705]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]; transport across blood-brain barrier [GO:0150104] GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0005887; GO:0008028; GO:0010940; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0035725; GO:0043005; GO:0051936; GO:0051939; GO:0070062; GO:0071705; GO:0089718; GO:0098793; GO:0150104 amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369] ERIRQLMCPAEDLPQR 0.94132 0.95582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8369 0 10.7781 0 0 0 10.7268 0 0 0 0 0 12.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.319 0 0 0 0 0 0 12.8709 0 0 0 0 0 0 0 0 11.9537 0 12.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4747 0 0 0 0 0 11.4031 0 0 0 0 0 0 0 0 0 13.0252 0 0 0 0 0 0 0 0 13.8268 0 0 0 0 0 0 0 0 0 Q13316 DMP1_HUMAN "Dentin matrix acidic phosphoprotein 1, DMP-1, Dentin matrix protein 1" DMP1 Homo sapiens (Human) biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173] GO:0001503; GO:0005178; GO:0005509; GO:0005576; GO:0005634; GO:0005788; GO:0010811; GO:0030198; GO:0031012; GO:0031214; GO:0050840; GO:0070173 calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178] DDDEDDSGDDTFGDDDSGPGPK 0.94133 4.0267 0 0 0 0 0 0 0 0 15.1742 14.8984 14.5761 0 14.5226 0 0 0 0 0 0 11.1782 0 0 12.2835 0 14.1085 0 0 0 0 15.0517 0 14.1869 0 0 0 0 0 0 0 11.4783 0 12.3797 0 14.5842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1928 0 0 0 0 0 0 14.7646 0 0 0 0 0 0 11.5159 13.1021 13.6845 0 11.6749 0 0 12.6011 0 13.324 0 0 0 0 14.055 11.9079 13.2928 0 0 12.6422 14.3929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8214 0 0 0 0 0 13.5037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9275 0 0 0 13.1593 0 0 0 0 0 0 0 0 12.4038 11.85 0 0 0 0 0 0 0 0 0 0 11.8107 0 0 0 0 0 0 12.9138 0 0 0 0 0 0 Q14376 GALE_HUMAN "UDP-glucose 4-epimerase, EC 5.1.3.2 (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase, UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase, UDP-GlcNAc 4-epimerase, EC 5.1.3.7) (UDP-galactose 4-epimerase)" GALE Homo sapiens (Human) galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499] cytosol [GO:0005829] cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499] GO:0003974; GO:0003978; GO:0005829; GO:0019388; GO:0033499; GO:0042802; GO:0042803 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974] PLDYYRVNLTGTIQLLEIMKAHGVK 0.94133 0.97344 0 0 0 0 0 0 0 0 0 0 0 0 10.8782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1326 12.3157 0 0 0 0 0 0 0 0 13.4407 0 13.1744 16.2711 16.14 0 0 0 0 0 0 0 0 0 14.4003 0 16.3115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2446 0 0 0 0 0 0 0 0 0 0 0 9.87238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LIE5 ADPRM_HUMAN "Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase, EC 3.6.1.13, EC 3.6.1.16, EC 3.6.1.53 (ADPRibase-Mn) (CDP-choline phosphohydrolase)" ADPRM C17orf48 MDS006 Nbla03831 Homo sapiens (Human) cytosol [GO:0005829] "cytosol [GO:0005829]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]" GO:0005829; GO:0008663; GO:0030145; GO:0047631; GO:0047734 "2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]" FLEDQIVHHPETMPSEDYYAYHFVPFPKFR 0.94133 1.7527 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9242 0 0 0 0 0 0 0 0 0 0 11.8892 0 0 0 0 0 0 0 0 0 0 0 12.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6V9 TEX9_HUMAN Testis-expressed protein 9 TEX9 Homo sapiens (Human) DIANEEHKK 0.94133 2.5009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9931 0 0 0 0 0 14.1257 0 0 0 14.0841 14.1874 0 0 14.204 0 0 0 0 0 0 0 13.6931 0 13.5594 14.5778 0 0 0 13.6761 0 0 0 0 0 0 13.6122 14.5618 0 0 0 0 0 0 0 14.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3136 0 0 0 9.3213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQZ7 ENTP7_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 7, NTPDase 7, EC 3.6.1.15 (Lysosomal apyrase-like protein 1)" ENTPD7 LALP1 Homo sapiens (Human) CTP catabolic process [GO:0006254]; GTP metabolic process [GO:0046039]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; regulation of immune response [GO:0050776]; T-helper 17 cell differentiation [GO:0072539]; UDP catabolic process [GO:0006256]; UTP catabolic process [GO:0046052] cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasmic vesicle membrane [GO:0030659]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; CTPase activity [GO:0043273]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; metal ion binding [GO:0046872]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; CTP catabolic process [GO:0006254]; GTP metabolic process [GO:0046039]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; regulation of immune response [GO:0050776]; T-helper 17 cell differentiation [GO:0072539]; UDP catabolic process [GO:0006256]; UTP catabolic process [GO:0046052] GO:0003924; GO:0004382; GO:0005794; GO:0006254; GO:0006256; GO:0009134; GO:0016020; GO:0016021; GO:0017110; GO:0017111; GO:0030659; GO:0030666; GO:0034656; GO:0043273; GO:0045134; GO:0046039; GO:0046052; GO:0046872; GO:0050776; GO:0072539 CTPase activity [GO:0043273]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; metal ion binding [GO:0046872]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134] AAQDYCGMAWSVLTQR 0.94134 4.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3177 0 0 0 0 0 0 0 0 0 0 12.6863 0 0 0 0 0 0 12.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1262 0 0 0 0 0 10.6475 0 10.2348 14.0363 0 0 0 0 0 0 0 14.4354 0 0 0 12.1908 13.3644 0 0 0 0 0 12.5127 0 0 0 0 0 11.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1947 0 0 0 0 0 0 0 0 0 0 12.0665 0 0 14.8527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GVM5 ETDC_HUMAN Embryonic testis differentiation protein homolog C ETDC Homo sapiens (Human) NVQVFLINRQLGRNR 0.94135 0.97333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6257 0 0 0 0 0 0 11.7069 0 0 11.7515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75607 NPM3_HUMAN Nucleoplasmin-3 NPM3 Homo sapiens (Human) chromatin remodeling [GO:0006338]; rRNA processing [GO:0006364]; rRNA transcription [GO:0009303] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; rRNA processing [GO:0006364]; rRNA transcription [GO:0009303] GO:0003682; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006364; GO:0009303; GO:0015629; GO:0042393 chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723] DECNVVEVVAR 0.94135 1.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0508 12.8507 12.5539 0 0 0 0 0 0 12.4357 0 12.7275 0 0 0 0 0 0 0 0 0 0 12.1213 0 0 0 0 0 0 0 0 0 0 0 0 11.7396 0 0 0 0 0 0 0 0 0 0 11.999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VX71 SUSD4_HUMAN Sushi domain-containing protein 4 SUSD4 UNQ196/PRO222 Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]" extracellular region [GO:0005576]; integral component of membrane [GO:0016021] "extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]" GO:0005576; GO:0006958; GO:0016021; GO:0030449; GO:0045087; GO:0045957; GO:0045959 IVAFTATSVLLVLLLVILAR 0.94138 1.7253 0 0 0 0 0 0 0 0 12.9084 0 0 12.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0799 0 0 0 0 0 0 0 0 0 0 13.1724 0 0 0 0 0 0 0 0 0 0 14.5755 0 0 0 0 0 0 14.3387 0 0 0 0 0 13.1788 13.2541 0 13.1904 0 0 12.77 0 0 0 0 12.5859 0 13.9836 0 0 0 12.684 0 0 0 0 0 0 12.6777 12.8629 0 12.5384 0 0 0 0 0 13.8056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4172 0 0 0 0 0 0 0 0 12.1457 11.0365 0 0 0 0 0 0 0 0 0 0 12.8152 12.4976 0 Q56A73 SPIN4_HUMAN Spindlin-4 SPIN4 Homo sapiens (Human) "gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; methylated histone binding [GO:0035064]; gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005654; GO:0005829; GO:0006355; GO:0007276; GO:0035064 methylated histone binding [GO:0035064] GTVLEQVSVKPTLYIIKYDGK 0.94139 1.7518 0 0 0 0 0 0 0 0 0 0 12.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5567 0 0 0 0 11.3531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6458 0 0 12.2011 14.5457 14.4826 0 0 0 0 14.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2249 0 0 0 0 0 14.1867 0 0 0 0 0 0 0 0 13.6563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EA4 SPDLY_HUMAN "Protein Spindly, hSpindly (Arsenite-related gene 1 protein) (Coiled-coil domain-containing protein 99) (Rhabdomyosarcoma antigen MU-RMS-40.4A) (Spindle apparatus coiled-coil domain-containing protein 1)" SPDL1 CCDC99 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]; enzyme binding [GO:0019899]; kinetochore binding [GO:0043515]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0005815; GO:0005829; GO:0007080; GO:0007094; GO:0016477; GO:0019899; GO:0034501; GO:0043515; GO:0051301 enzyme binding [GO:0019899]; kinetochore binding [GO:0043515] CLQLSESENMKLRAK 0.94139 2.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5N1 HRH3_HUMAN "Histamine H3 receptor, H3R, HH3R (G-protein coupled receptor 97)" HRH3 GPCR97 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of serotonin secretion [GO:0014063]; neurotransmitter secretion [GO:0007269]; regulation of norepinephrine secretion [GO:0014061]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of serotonin secretion [GO:0014063]; neurotransmitter secretion [GO:0007269]; regulation of norepinephrine secretion [GO:0014061]" GO:0004969; GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007197; GO:0007268; GO:0007269; GO:0014050; GO:0014061; GO:0014063; GO:0016907; GO:0030425; GO:0030594; GO:0045202; GO:0050890; GO:0098793 G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] GLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTR 0.9414 0.97273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1858 0 15.0674 0 0 0 0 0 0 P07951 TPM2_HUMAN Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2) TPM2 TMSB Homo sapiens (Human) actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; regulation of ATP-dependent activity [GO:0043462] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; regulation of ATP-dependent activity [GO:0043462] GO:0003779; GO:0005829; GO:0005862; GO:0005884; GO:0006936; GO:0007015; GO:0008307; GO:0015629; GO:0042802; GO:0042803; GO:0043462; GO:0046982; GO:0051015 actin binding [GO:0003779]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307] ATDAEADVASLNRRIQLVEEELDR 0.94141 1.0128 0 0 0 0 0 0 0 0 0 0 0 0 0 11.254 0 0 0 0 0 0 0 0 0 0 0 0 0 9.73234 0 11.4095 0 0 0 0 0 0 0 0 0 0 10.6231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8815 0 0 0 0 0 0 0 0 0 0 0 0 10.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9809 0 0 0 0 0 0 0 0 0 0 0 0 0 P30039 PBLD_HUMAN "Phenazine biosynthesis-like domain-containing protein, EC 5.1.-.- (MAWD-binding protein, MAWDBP) (Unknown protein 32 from 2D-page of liver tissue)" PBLD MAWBP Homo sapiens (Human) biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] GO:0005737; GO:0009058; GO:0016853; GO:0030277; GO:0030512; GO:0042802; GO:0060392; GO:0070062 identical protein binding [GO:0042802]; isomerase activity [GO:0016853] EMHAFQCSHRGGELGISLRPDGR 0.94141 3.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7584 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8342 0 0 0 13.5015 0 0 0 0 0 0 0 0 13.3472 0 0 0 0 0 0 0 11.8513 0 0 13.3961 10.9783 0 0 0 12.5294 0 0 10.6288 0 12.9976 0 13.8908 15.3066 0 0 0 0 14.471 0 0 0 0 0 0 0 0 0 0 12.7112 12.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.575 0 14.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VNC0 AT135_HUMAN "Probable cation-transporting ATPase 13A5, EC 7.2.2.- (P5-ATPase isoform 5)" ATP13A5 UNQ488/PRO1004 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type transmembrane transporter activity [GO:0140358]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005524; GO:0005886; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0034220; GO:0046872; GO:0055085; GO:0140358 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type transmembrane transporter activity [GO:0140358] CHSLEDYRK 0.94141 0.97718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0175 0 0 0 0 11.5861 0 0 0 13.2953 0 0 0 0 0 0 0 12.2985 0 0 0 0 0 0 0 11.847 0 0 0 0 0 0 0 0 12.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4344 0 0 0 0 12.7442 0 0 12.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2152 0 0 0 11.7206 0 0 0 0 0 0 0 0 0 0 0 12.4955 0 0 0 0 0 0 0 0 0 0 0 0 Q6J4K2 NCLX_HUMAN "Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)" SLC8B1 NCKX6 NCLX SLC24A6 Homo sapiens (Human) calcium export from the mitochondrion [GO:0099093]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; glucose homeostasis [GO:0042593]; ion transport [GO:0006811]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896] integral component of mitochondrial membrane [GO:0032592]; membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] integral component of mitochondrial membrane [GO:0032592]; membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; calcium:cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; cation transmembrane transporter activity [GO:0008324]; protein homodimerization activity [GO:0042803]; calcium export from the mitochondrion [GO:0099093]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; glucose homeostasis [GO:0042593]; ion transport [GO:0006811]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896] GO:0005432; GO:0005743; GO:0005886; GO:0006811; GO:0006812; GO:0006851; GO:0006874; GO:0008324; GO:0015368; GO:0016020; GO:0030061; GO:0032592; GO:0042383; GO:0042593; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256 calcium:cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; cation transmembrane transporter activity [GO:0008324]; protein homodimerization activity [GO:0042803] ALKVFKLPVEFLLLLTVPVVDPDK 0.94144 2.4961 0 0 0 0 0 0 0 0 0 0 0 11.8836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8073 0 0 0 0 0 11.8811 0 10.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1991 0 0 0 0 P50479 PDLI4_HUMAN PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein) PDLIM4 RIL Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; muscle structure development [GO:0061061] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; recycling endosome lumen [GO:0034777]; recycling endosome membrane [GO:0055038]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; excitatory chemical synaptic transmission [GO:0098976]; heart development [GO:0007507]; muscle structure development [GO:0061061] GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0005912; GO:0007507; GO:0019903; GO:0030018; GO:0030027; GO:0030036; GO:0031532; GO:0031901; GO:0031905; GO:0031941; GO:0034777; GO:0042803; GO:0043197; GO:0045211; GO:0046872; GO:0048471; GO:0051371; GO:0051393; GO:0055038; GO:0061061; GO:0098976 actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903] PEGRSWPSAPDDSK 0.94145 0.90051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8808 0 Q5SQ80 A20A2_HUMAN Putative ankyrin repeat domain-containing protein 20A2 (Ankyrin repeat domain-containing protein 20A2 pseudogene) ANKRD20A2P ANKRD20A2 Homo sapiens (Human) DSELQKIHRAAVK 0.94145 1.7848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0GE19 NTCP7_HUMAN Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) SLC10A7 C4orf13 P7 PSEC0051 Homo sapiens (Human) bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; glycoprotein transport [GO:0034436]; Golgi vesicle transport [GO:0048193]; heparin biosynthetic process [GO:0030210]; sodium ion transport [GO:0006814] cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; bile acid transmembrane transporter activity [GO:0015125]; symporter activity [GO:0015293]; bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; glycoprotein transport [GO:0034436]; Golgi vesicle transport [GO:0048193]; heparin biosynthetic process [GO:0030210]; sodium ion transport [GO:0006814] GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005797; GO:0005801; GO:0005802; GO:0005886; GO:0006814; GO:0006874; GO:0015125; GO:0015293; GO:0016021; GO:0030210; GO:0031226; GO:0034436; GO:0048193; GO:0060348 bile acid transmembrane transporter activity [GO:0015125]; symporter activity [GO:0015293] IVFAGHEHLSLISVPLLIYHPAQILLGSVLVPTIK 0.94149 0.9643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0884 0 0 0 0 0 0 0 0 0 0 0 0 0 12.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8336 0 0 11.1035 12.0753 0 0 11.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9761 0 0 0 12.5044 0 0 12.2118 12.9534 0 0 0 0 0 0 0 0 0 0 11.6077 0 0 0 12.0261 0 11.623 0 0 0 0 0 0 0 0 0 0 Q8TEU7 RPGF6_HUMAN "Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2, PDZ-GEF2) (RA-GEF-2)" RAPGEF6 PDZGEF2 Homo sapiens (Human) microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087] GO:0005085; GO:0005813; GO:0005829; GO:0005886; GO:0007265; GO:0016324; GO:0030033; GO:0030139; GO:0030742; GO:0031267; GO:0043087; GO:0043547; GO:0070300; GO:0072659 GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267] EIRQVVR 0.94149 0.89838 0 0 0 0 0 0 0 12.5886 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5971 0 13.0139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1117 0 0 10.8498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0518 13.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3508 12.8012 12.6705 0 0 0 0 0 0 0 0 14.7368 14.7549 0 0 0 0 0 0 15.071 0 0 0 14.4604 14.7451 0 0 14.8034 12.6568 0 15.5343 0 0 0 0 0 0 0 0 11.6806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8261 0 P61570 ENK25_HUMAN "Endogenous retrovirus group K member 25 Env polyprotein (Envelope polyprotein) (HERV-K_11q22.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERVK-25 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198] GO:0005198; GO:0005886; GO:0016021 structural molecule activity [GO:0005198] CPAKPEEEGMMINISIGYR 0.9415 0.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10266 POK10_HUMAN "Endogenous retrovirus group K member 10 Pol protein (HERV-K10 Pol protein) (HERV-K107 Pol protein) (HERV-K_5q33.3 provirus ancestral Pol protein) [Includes: Reverse transcriptase, RT, EC 2.7.7.49; Ribonuclease H, RNase H, EC 3.1.26.4; Integrase, IN ]" ERVK-10 Homo sapiens (Human) DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] GO:0003677; GO:0003964; GO:0004523; GO:0006281; GO:0006310; GO:0008270; GO:0015074; GO:0035613 DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] AAYTGPK 0.94151 1.0353 0 0 0 0 0 0 0 0 0 0 13.9696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWS6 F118A_HUMAN Protein FAM118A FAM118A C22orf8 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; identical protein binding [GO:0042802] GO:0016021; GO:0042802 identical protein binding [GO:0042802] DLLVVAHDLIRK 0.94152 0.89741 9.48989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8486 0 0 0 0 0 0 0 0 14.4392 0 0 0 0 0 0 0 0 13.5552 0 0 14.6394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1474 0 0 0 0 0 0 0 A6NCL2 LRCL1_HUMAN Leucine-rich colipase-like protein 1 LRCOL1 Homo sapiens (Human) digestion [GO:0007586]; lipid catabolic process [GO:0016042]; response to food [GO:0032094] extracellular region [GO:0005576] extracellular region [GO:0005576]; enzyme activator activity [GO:0008047]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; response to food [GO:0032094] GO:0005576; GO:0007586; GO:0008047; GO:0016042; GO:0032094 enzyme activator activity [GO:0008047] CSHDSECQSSCCVR 0.94153 3.5878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6061 0 0 11.1689 0 13.1821 0 0 0 0 11.4523 0 0 0 0 10.5299 0 0 10.613 0 0 0 0 13.5513 0 0 12.0303 0 12.2407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6197 0 0 0 0 0 10.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3694 0 0 12.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43772 MCAT_HUMAN "Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase, CAC, CACT) (Solute carrier family 25 member 20)" SLC25A20 CAC CACT Homo sapiens (Human) carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; acyl carnitine transmembrane transporter activity [GO:0015227]; transmembrane transporter activity [GO:0022857]; carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839] GO:0001701; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006853; GO:0015227; GO:0016021; GO:0022857; GO:1902603 acyl carnitine transmembrane transporter activity [GO:0015227]; transmembrane transporter activity [GO:0022857] ILVAGGIAGIFNWAVAIPPDVLKSRFQTAPPGK 0.94153 1.7319 0 0 11.0831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2802 0 0 0 0 10.3466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8237 0 0 0 P34995 PE2R1_HUMAN "Prostaglandin E2 receptor EP1 subtype, PGE receptor EP1 subtype, PGE2 receptor EP1 subtype (Prostanoid EP1 receptor)" PTGER1 Homo sapiens (Human) adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; D1 dopamine receptor binding [GO:0031748]; prostaglandin E receptor activity [GO:0004957]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496] GO:0004957; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007189; GO:0007191; GO:0007204; GO:0031748; GO:0032496 D1 dopamine receptor binding [GO:0031748]; prostaglandin E receptor activity [GO:0004957] ARLALAAVAAVALAVALLPLAR 0.94154 3.6328 0 0 0 0 0 0 0 11.8731 0 11.6392 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5791 13.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3401 0 0 0 12.1288 0 0 0 0 0 0 14.9514 0 0 0 13.3791 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0005 0 0 12.2779 0 0 0 11.5247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3711 0 0 11.1018 0 Q9H0R3 TM222_HUMAN Transmembrane protein 222 TMEM222 C1orf160 Homo sapiens (Human) dendrite [GO:0030425]; integral component of membrane [GO:0016021] dendrite [GO:0030425]; integral component of membrane [GO:0016021] GO:0016021; GO:0030425 TWLPFILLLGIILTVSLVFNLR 0.94155 0.96992 0 0 0 0 13.8226 0 13.9542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LP6 CL042_HUMAN Uncharacterized protein C12orf42 C12orf42 Homo sapiens (Human) CSVSTVSFDEESYEEFR 0.94156 2.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9182 0 0 0 13.0145 0 0 0 0 14.1713 0 0 0 0 0 0 0 0 0 0 0 0 11.9856 12.2509 0 0 0 0 0 0 0 14.7291 14.8281 0 0 0 0 0 0 13.1859 0 12.9075 0 0 11.8743 0 0 0 10.7345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5664 0 0 0 11.7644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1577 0 Q8N4A0 GALT4_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 4, EC 2.4.1.41 (Polypeptide GalNAc transferase 4, GalNAc-T4, pp-GaNTase 4) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4)" GALNT4 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] GO:0000139; GO:0004653; GO:0006493; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0048471; GO:0070062 carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] AAEVWMDEYKEHFYNR 0.94157 0.9689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4908 0 0 0 0 0 13.9377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9257 10.6077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6947 14.4529 14.3829 0 0 0 0 0 0 0 0 14.0919 13.6713 12.7653 0 0 0 0 0 15.0668 0 0 0 0 Q9BXK5 B2L13_HUMAN "Bcl-2-like protein 13, Bcl2-L-13 (Bcl-rambo) (Protein Mil1)" BCL2L13 MIL1 CD003 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981] GO:0005634; GO:0005739; GO:0006915; GO:0006919; GO:0008656; GO:0016021; GO:0031966; GO:0042981 cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656] EPLHKALQMLLSQPVTYQAFR 0.94161 3.4511 0 0 0 0 0 0 0 0 0 0 12.6138 0 0 0 13.5338 13.7463 11.6305 0 0 0 12.5338 0 0 13.9254 12.3981 11.9169 13.9214 0 0 0 0 0 0 13.9102 13.082 0 13.3489 13.0233 0 0 12.5581 0 0 12.0813 0 0 0 0 0 0 0 0 0 10.4547 0 11.5767 0 0 0 0 0 0 0 0 0 0 0 0 0 14.332 0 0 0 0 0 0 0 0 0 0 0 15.0104 0 0 0 13.8657 0 0 0 0 0 13.8941 0 0 0 0 0 0 0 12.4621 13.6296 0 0 0 0 12.4274 12.7356 0 0 0 0 13.1012 0 0 0 0 0 0 0 0 13.1789 0 0 0 0 0 0 14.0664 0 0 12.5854 14.9657 0 14.1419 0 0 13.5722 13.7507 14.6385 0 0 0 0 0 0 0 0 13.3103 0 0 0 0 0 0 0 0 14.4045 0 0 12.8986 14.0845 0 0 12.6839 0 13.4298 0 14.6893 0 13.625 13.366 0 0 0 0 13.7749 0 0 0 0 Q9QC07 POK18_HUMAN "Endogenous retrovirus group K member 18 Pol protein (HERV-K(C1a) Pol protein) (HERV-K110 Pol protein) (HERV-K18 Pol protein) (HERV-K_1q23.3 provirus ancestral Pol protein) [Includes: Reverse transcriptase, EC 2.7.7.49; Ribonuclease H, RNase H, EC 3.1.26.4 ]" ERVK-18 Homo sapiens (Human) DNA integration [GO:0015074]; DNA repair [GO:0006281] DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA repair [GO:0006281] GO:0003677; GO:0003964; GO:0004523; GO:0006281; GO:0008270; GO:0015074; GO:0035613 DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] FQWKVLPQGMLNSPTICQTFVGR 0.94162 1.7305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.018 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7508 0 0 12.7289 13.3253 0 0 0 0 0 0 12.3519 0 0 0 14.4777 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4735 0 0 0 13.7674 0 0 0 0 0 0 0 0 0 13.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.416 0 0 0 0 0 0 0 0 0 0 0 0 10.7908 0 0 0 0 0 0 0 13.5605 0 A0A0B4J245 TVAL1_HUMAN T cell receptor alpha variable 12-1 TRAV12-1 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101; GO:0042605 peptide antigen binding [GO:0042605] ISLRVLLVILWLQLSWVWSQR 0.94163 1.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.11 0 0 0 0 0 0 0 Q86WG3 ATCAY_HUMAN "Caytaxin (Ataxia cayman type protein) (BNIP-2-homology, BNIP-H)" ATCAY KIAA1872 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrion distribution [GO:0048311]; negative regulation of glutamate metabolic process [GO:2000212]; neuron projection development [GO:0031175]; regulation of protein localization [GO:0032880] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; neuron projection [GO:0043005]; presynapse [GO:0098793]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; neuron projection [GO:0043005]; presynapse [GO:0098793]; synapse [GO:0045202]; kinesin binding [GO:0019894]; apoptotic process [GO:0006915]; mitochondrion distribution [GO:0048311]; negative regulation of glutamate metabolic process [GO:2000212]; neuron projection development [GO:0031175]; regulation of protein localization [GO:0032880] GO:0005737; GO:0006915; GO:0019894; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0031966; GO:0032880; GO:0043005; GO:0045202; GO:0048311; GO:0070161; GO:0098793; GO:2000212 kinesin binding [GO:0019894] CYQMIDRR 0.94163 0.97294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8243 0 0 0 0 0 0 0 0 0 0 0 13.3188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.119 0 0 0 14.842 0 14.2956 0 0 12.3306 14.7922 0 0 0 0 0 12.8832 0 0 11.823 0 0 0 0 15.7089 0 0 0 0 0 0 0 0 0 0 0 0 12.0074 12.931 14.4475 13.2079 13.1634 14.4601 0 15.4987 0 0 0 0 0 14.3297 13.2017 0 0 0 0 13.0113 0 0 0 0 0 0 0 14.1137 0 0 0 0 0 0 0 0 0 0 0 0 12.9663 0 0 15.6522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1XBS5 CBAR1_HUMAN CBY1-interacting BAR domain-containing protein 1 CIBAR1 FAM92A FAM92A1 Homo sapiens (Human) cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; limb morphogenesis [GO:0035108]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; limb morphogenesis [GO:0035108]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0005543; GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0007007; GO:0019898; GO:0030061; GO:0035108; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0061024; GO:0097546; GO:0097749 phospholipid binding [GO:0005543] DIKTIFSEFITIEMLFHGK 0.94165 1.7304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9366 0 0 0 0 0 0 0 0 0 Q9NRR1 CYTL1_HUMAN Cytokine-like protein 1 (Protein C17) CYTL1 C4orf4 UNQ1942/PRO4425 Homo sapiens (Human) cartilage homeostasis [GO:1990079]; chondrocyte differentiation [GO:0002062]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; inner ear development [GO:0048839]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366] extracellular space [GO:0005615] extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; cartilage homeostasis [GO:1990079]; chondrocyte differentiation [GO:0002062]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; inner ear development [GO:0048839]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366] GO:0002062; GO:0005102; GO:0005615; GO:0006366; GO:0007165; GO:0045944; GO:0048839; GO:0050650; GO:0051091; GO:1990079 signaling receptor binding [GO:0005102] MRTPGPLPVLLLLLAGAPAAR 0.94165 2.6622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2314 0 0 0 0 0 0 0 0 0 0 10.5891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2649 0 0 0 0 0 0 13.6808 0 0 0 13.3845 12.3547 0 0 0 0 0 0 0 13.2534 0 0 0 0 0 13.9343 0 0 0 0 0 0 0 0 11.7056 0 12.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5855 0 0 0 11.2468 0 0 0 0 0 0 0 0 0 0 0 0 12.2507 0 0 0 0 13.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1621 0 0 0 Q01151 CD83_HUMAN "CD83 antigen, hCD83 (B-cell activation protein) (Cell surface protein HB15) (CD antigen CD83)" CD83 Homo sapiens (Human) "CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response [GO:0006952]; humoral immune response [GO:0006959]; negative regulation of interleukin-4 production [GO:0032713]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]" external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response [GO:0006952]; humoral immune response [GO:0006959]; negative regulation of interleukin-4 production [GO:0032713]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; response to organic cyclic compound [GO:0014070]; signal transduction [GO:0007165]" GO:0005886; GO:0005887; GO:0006952; GO:0006959; GO:0007165; GO:0009897; GO:0014070; GO:0032713; GO:0032733; GO:0032743; GO:0043367; GO:0043372 AEIVLLLALVIFYLTLIIFTCK 0.94167 0.97796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3468 0 0 0 0 0 0 14.3506 0 0 0 0 10.5651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4514 0 0 0 0 0 0 0 0 0 0 0 Q14568 HS902_HUMAN Heat shock protein HSP 90-alpha A2 (Heat shock 90 kDa protein 1 alpha-like 3) (Heat shock protein HSP 90-alpha A2 pseudogene) HSP90AA2P HSP90AA2 HSPCAL3 Homo sapiens (Human) protein folding [GO:0006457] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0019899; GO:0051082; GO:0070062 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082] ECDKEVSDDETEEKEDK 0.94167 4.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4608 0 0 0 0 0 0 0 0 0 0 11.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7961 0 12.7099 0 0 0 13.0774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8337 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4819 0 0 0 14.2608 Q8NGP6 OR5M8_HUMAN Olfactory receptor 5M8 (Olfactory receptor OR11-194) OR5M8 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] EALIKELSMKIYFS 0.94167 1.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6873 0 0 0 0 12.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8146 0 0 0 11.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3439 0 0 0 0 0 0 0 0 0 0 0 Q14802 FXYD3_HUMAN FXYD domain-containing ion transport regulator 3 (Chloride conductance inducer protein Mat-8) (Mammary tumor 8 kDa protein) (Phospholemman-like) (Sodium/potassium-transporting ATPase subunit FXYD3) FXYD3 MAT8 PLML Homo sapiens (Human) chloride transport [GO:0006821]; potassium ion transport [GO:0006813]; regulation of catalytic activity [GO:0050790]; regulation of ion transport [GO:0043269]; sodium ion transport [GO:0006814] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; chloride channel activity [GO:0005254]; ion channel regulator activity [GO:0099106]; chloride transport [GO:0006821]; potassium ion transport [GO:0006813]; regulation of catalytic activity [GO:0050790]; regulation of ion transport [GO:0043269]; sodium ion transport [GO:0006814] GO:0005254; GO:0005789; GO:0005886; GO:0005887; GO:0006813; GO:0006814; GO:0006821; GO:0043269; GO:0050790; GO:0051117; GO:0070062; GO:0099106 ATPase binding [GO:0051117]; chloride channel activity [GO:0005254]; ion channel regulator activity [GO:0099106] NSPFYYDWHSLQVGGLICAGVLCAMGIIIVMSAKCKCK 0.94168 0.90084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25089 FPR3_HUMAN "N-formyl peptide receptor 3 (FMLP-related receptor II, FMLP-R-II) (Formyl peptide receptor-like 2)" FPR3 FPRH1 FPRL2 Homo sapiens (Human) chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165] GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005886; GO:0006935; GO:0006954; GO:0007165; GO:0007200; GO:0007204; GO:0016021 complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982] PLRVFAAVVASFFICWFPYELIGILMAVWLKEMLLNGK 0.94169 0.90084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6U736 OPN5_HUMAN Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin) (Transmembrane protein 13) OPN5 GPR136 PGR12 TMEM13 Homo sapiens (Human) "cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; visual perception [GO:0007601]" cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; entrainment of circadian clock by photoperiod [GO:0043153]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; phototransduction [GO:0007602]; phototransduction, UV [GO:0007604]; visual perception [GO:0007601]" GO:0005502; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0007604; GO:0008020; GO:0043153; GO:0071482; GO:0071492; GO:1990384 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020] LHTVTTVRK 0.94169 0.9659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75056 SDC3_HUMAN "Syndecan-3, SYND3" SDC3 KIAA0468 Homo sapiens (Human) cell migration [GO:0016477] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; microspike [GO:0044393]; plasma membrane [GO:0005886] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; microspike [GO:0044393]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; cell migration [GO:0016477] GO:0005796; GO:0005886; GO:0009986; GO:0016020; GO:0016021; GO:0016477; GO:0042802; GO:0043202; GO:0044393; GO:0062023 identical protein binding [GO:0042802] AAGAQRWRSENFER 0.9417 2.5109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5443 0 0 0 0 0 0 0 0 0 0 11.6484 0 0 0 0 0 0 11.1554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4398 0 0 0 12.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3602 0 0 0 14.1585 13.1877 12.1778 0 11.6558 0 0 0 0 0 0 12.346 13.4402 0 13.7872 0 11.1294 0 0 0 10.9115 12.5115 0 10.9136 0 0 0 0 0 0 11.7986 0 0 0 0 0 11.0375 0 0 0 0 12.9477 11.1026 0 0 0 0 0 0 0 0 0 0 12.0961 0 0 0 0 0 0 13.7463 0 11.7633 0 0 13.3283 12.985 13.873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5U9 IR3IP_HUMAN Immediate early response 3-interacting protein 1 IER3IP1 HSPC039 Homo sapiens (Human) brain development [GO:0007420]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; organ growth [GO:0035265]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of fibroblast apoptotic process [GO:2000269] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; brain development [GO:0007420]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; organ growth [GO:0035265]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of fibroblast apoptotic process [GO:2000269] GO:0003331; GO:0005783; GO:0005789; GO:0005794; GO:0006888; GO:0007420; GO:0015031; GO:0016020; GO:0030134; GO:0030173; GO:0035265; GO:0050714; GO:2000269 SVRTVMRVPLIIVNSIAIVLLLLFG 0.94171 2.5275 0 0 0 0 0 0 0 0 0 0 0 0 14.2458 0 11.7921 0 13.3001 0 14.2945 11.716 0 0 13.6568 0 15.4705 14.649 0 0 14.226 14.3778 0 0 0 0 0 0 12.009 12.2558 0 0 0 0 12.648 0 0 0 0 0 0 0 0 11.9898 0 0 0 0 0 0 0 10.3056 0 0 0 0 0 0 15.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2933 15.8838 0 13.894 0 15.9187 0 0 0 0 0 0 0 0 0 0 0 13.0662 0 11.3804 0 0 0 0 0 12.3437 0 12.2943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3509 0 14.6787 0 0 14.6227 15.2092 0 0 0 10.6222 10.8768 0 0 10.9625 0 0 0 0 0 0 0 0 0 0 13.6592 0 10.5089 14.5204 0 0 0 14.3909 0 0 0 15.3317 0 0 10.8036 0 14.9514 15.1773 13.9687 0 14.6635 13.5793 0 14.6225 10.7905 0 0 0 14.8709 0 13.7661 0 10.1836 Q8IU99 CAHM1_HUMAN Calcium homeostasis modulator protein 1 (Protein FAM26C) CALHM1 FAM26C Homo sapiens (Human) ATP transport [GO:0015867]; cation transport [GO:0006812]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; response to stimulus [GO:0050896]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated ion channel activity [GO:0005244]; ATP transport [GO:0015867]; cation transport [GO:0006812]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; response to stimulus [GO:0050896]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] GO:0005227; GO:0005244; GO:0005245; GO:0005261; GO:0005789; GO:0005887; GO:0006812; GO:0015867; GO:0016323; GO:0034765; GO:0042802; GO:0050896; GO:0050913; GO:0050916; GO:0050917; GO:0051260; GO:0051291 calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated ion channel activity [GO:0005244] ALIAPVVWVAVTLLDGK 0.94173 1.7285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UEU0 VTI1B_HUMAN Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1) VTI1B VTI1 VTI1L VTI1L1 VTI2 Homo sapiens (Human) "Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane fusion [GO:0061025]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]" cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane fusion [GO:0061025]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0005484; GO:0005576; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006891; GO:0006896; GO:0006904; GO:0006906; GO:0008021; GO:0012507; GO:0016021; GO:0016192; GO:0016236; GO:0019869; GO:0031093; GO:0031201; GO:0031901; GO:0031902; GO:0031982; GO:0042147; GO:0043025; GO:0043231; GO:0048280; GO:0048471; GO:0055037; GO:0055038; GO:0061025; GO:1903076 chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] ILRSMSRK 0.94173 3.4904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5768 0 0 0 12.2367 12.8685 0 0 0 0 14.0946 0 0 0 0 13.9598 10.9973 0 14.0739 0 0 13.4363 0 0 0 12.4985 0 13.6512 0 0 12.3555 0 0 12.9087 13.426 0 14.3923 0 0 13.5458 0 0 0 0 16.1571 0 0 0 0 0 0 12.7107 12.759 0 0 0 0 0 0 0 0 0 0 0 0 10.6501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY45 AMN1_HUMAN Protein AMN1 homolog AMN1 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] SCF ubiquitin ligase complex [GO:0019005] SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0019005; GO:0031146 PLPPNIKDRLIK 0.94174 0.9643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6745 0 0 0 0 0 14.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13488 VPP3_HUMAN "V-type proton ATPase 116 kDa subunit a 3, V-ATPase 116 kDa subunit a 3 (Osteoclastic proton pump 116 kDa subunit, OC-116 kDa, OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein, TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3)" TCIRG1 ATP6N1C ATP6V0A3 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; establishment of cell polarity [GO:0030010]; establishment of vesicle localization [GO:0051650]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; lysosomal lumen acidification [GO:0007042]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; pH reduction [GO:0045851]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; protein localization to organelle [GO:0033365]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; ruffle organization [GO:0031529]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; vacuolar acidification [GO:0007035] "apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular calcium ion homeostasis [GO:0006874]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; establishment of cell polarity [GO:0030010]; establishment of vesicle localization [GO:0051650]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; lysosomal lumen acidification [GO:0007042]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; pH reduction [GO:0045851]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; protein localization to organelle [GO:0033365]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; ruffle organization [GO:0031529]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; vacuolar acidification [GO:0007035]" GO:0000045; GO:0000220; GO:0001503; GO:0002158; GO:0005634; GO:0005765; GO:0005770; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0006954; GO:0006968; GO:0007035; GO:0007039; GO:0007042; GO:0008284; GO:0010008; GO:0010155; GO:0010272; GO:0010467; GO:0010468; GO:0016064; GO:0016236; GO:0016324; GO:0016471; GO:0021554; GO:0030010; GO:0030183; GO:0030217; GO:0030316; GO:0030670; GO:0031529; GO:0033176; GO:0033365; GO:0035709; GO:0035711; GO:0043029; GO:0044691; GO:0045453; GO:0045667; GO:0045851; GO:0046961; GO:0050796; GO:0051117; GO:0051650; GO:0060041; GO:0061484; GO:0070166; GO:0071345; GO:0090383; GO:0097188; GO:0101003; GO:1902600 "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" ACRGFLIASFR 0.94175 3.5235 0 0 0 0 0 0 0 0 0 12.3703 12.5716 12.5971 11.9192 0 12.1391 0 0 12.029 0 0 0 11.3103 0 0 0 0 11.8515 0 0 0 0 0 0 0 0 11.6995 0 0 0 0 0 0 0 0 0 12.1097 0 0 0 0 0 0 13.8515 13.2869 12.5494 0 0 0 0 0 0 0 0 0 0 11.398 0 13.65 0 0 13.0957 0 0 13.0504 0 12.528 0 0 11.431 0 12.1448 0 0 0 0 14.3126 0 0 0 0 14.2095 0 0 13.5103 0 11.877 14.7211 0 11.8904 0 13.1978 0 13.4089 0 0 0 12.9765 0 0 0 0 0 12.7886 14.2037 0 0 0 12.1275 13.3607 0 16.0058 0 12.1556 0 0 0 15.7149 0 0 0 0 0 0 0 0 0 0 12.5653 13.4861 0 0 0 0 0 14.7621 0 0 13.7974 11.2967 0 0 0 0 0 13.7347 0 13.3408 13.621 0 0 0 0 0 13.5602 13.7765 11.2216 0 0 0 13.6437 14.1744 0 11.7531 11.6806 0 14.3371 0 13.8471 0 0 Q9BTV4 TMM43_HUMAN Transmembrane protein 43 (Protein LUMA) TMEM43 UNQ2564/PRO6244 Homo sapiens (Human) innate immune response [GO:0045087]; nuclear membrane organization [GO:0071763] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; innate immune response [GO:0045087]; nuclear membrane organization [GO:0071763] GO:0005639; GO:0005788; GO:0005789; GO:0005794; GO:0042802; GO:0043621; GO:0045087; GO:0071763 identical protein binding [GO:0042802]; protein self-association [GO:0043621] GDFFYHSENPK 0.94177 3.5862 11.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4019 0 0 0 0 0 0 13.0474 0 0 0 0 0 0 0 0 0 0 0 12.5433 0 0 13.8543 9.63789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8101 0 0 17.4212 0 12.8709 18.0092 0 0 0 0 0 0 13.7056 0 18.8516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.783 0 0 0 0 0 11.2411 0 0 12.9258 0 0 0 0 0 0 0 0 0 0 0 10.8619 0 0 0 17.4454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4231 0 0 0 0 0 14.2213 0 0 0 0 0 11.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2V7 COG6_HUMAN "Conserved oligomeric Golgi complex subunit 6, COG complex subunit 6 (Component of oligomeric Golgi complex 6)" COG6 KIAA1134 Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588] "Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" GO:0000139; GO:0000301; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0070085 EELESISEDVQAMSNCCQDMTSRLQAAKEQTQDLIVK 0.94177 0.89763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9794 0 0 0 12.7524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9406 Q9Y2A4 ZN443_HUMAN Zinc finger protein 443 (Krueppel-type zinc finger protein ZK1) ZNF443 Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0006915; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CRMLERFVESK 0.9418 3.4016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.684 0 0 11.5467 0 0 0 15.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1609 0 0 0 0 0 0 0 12.8345 13.0493 0 0 0 0 0 0 11.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6184 0 0 0 0 0 0 0 0 0 0 11.8701 0 0 0 0 0 0 Q9ULK6 RN150_HUMAN RING finger protein 150 RNF150 KIAA1214 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005737; GO:0006511; GO:0016021; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] KAISKLQIR 0.94181 0.90533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7989 17.7402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1812 0 0 0 0 0 9.53058 0 0 0 0 0 0 0 0 0 0 0 0 0 11.788 0 0 0 0 0 0 0 0 0 0 0 0 12.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08910 ABHD2_HUMAN "Monoacylglycerol lipase ABHD2, EC 3.1.1.23 (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase, EC 3.1.1.6) (Lung alpha/beta hydrolase 2) (Progesterone-sensitive lipase, EC 3.1.1.79) (Protein PHPS1-2)" ABHD2 LABH2 Homo sapiens (Human) acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; hormone binding [GO:0042562]; hormone-sensitive lipase activity [GO:0033878]; nuclear steroid receptor activity [GO:0003707]; short-chain carboxylesterase activity [GO:0034338]; triglyceride lipase activity [GO:0004806]; acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401] GO:0001669; GO:0003707; GO:0004806; GO:0007340; GO:0008126; GO:0009611; GO:0014909; GO:0014912; GO:0016021; GO:0032570; GO:0033878; GO:0034338; GO:0036126; GO:0042562; GO:0043401; GO:0044255; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524 acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; hormone binding [GO:0042562]; hormone-sensitive lipase activity [GO:0033878]; nuclear steroid receptor activity [GO:0003707]; short-chain carboxylesterase activity [GO:0034338]; triglyceride lipase activity [GO:0004806] EYYEEESCMR 0.94184 0.97363 0 0 9.24572 0 0 0 0 0 0 15.18 0 0 0 0 14.8039 0 0 0 0 0 0 0 0 13.2399 0 0 0 0 15.1479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9963 0 0 0 0 0 0 0 0 0 0 0 0 11.0332 0 0 0 0 13.0222 0 0 0 0 0 0 0 0 0 10.9547 0 0 0 0 0 0 0 0 0 0 11.5555 0 0 0 12.8053 0 0 0 13.7224 0 0 15.8698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9576 0 0 0 12.354 0 0 0 0 0 0 0 0 0 0 0 0 14.4506 14.7263 0 0 0 0 0 0 0 0 0 0 11.7752 0 0 10.9776 0 0 0 0 P27037 AVR2A_HUMAN "Activin receptor type-2A, EC 2.7.11.30 (Activin receptor type IIA, ACTR-IIA, ACTRIIA)" ACVR2A ACVR2 Homo sapiens (Human) activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesoderm development [GO:0007498]; odontogenesis of dentin-containing tooth [GO:0042475]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; sperm ejaculation [GO:0042713]; spermatogenesis [GO:0007283]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic skeletal system development [GO:0048706]; gastrulation with mouth forming second [GO:0001702]; mesoderm development [GO:0007498]; odontogenesis of dentin-containing tooth [GO:0042475]; penile erection [GO:0043084]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of nitric-oxide synthase activity [GO:0050999]; Sertoli cell proliferation [GO:0060011]; sperm ejaculation [GO:0042713]; spermatogenesis [GO:0007283]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] GO:0001702; GO:0001934; GO:0004674; GO:0004675; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006468; GO:0007178; GO:0007283; GO:0007368; GO:0007498; GO:0009952; GO:0009986; GO:0010862; GO:0015026; GO:0019838; GO:0030165; GO:0030501; GO:0030509; GO:0032924; GO:0032927; GO:0034673; GO:0034711; GO:0042475; GO:0042713; GO:0043084; GO:0043235; GO:0043621; GO:0045648; GO:0045669; GO:0045944; GO:0046872; GO:0048179; GO:0048185; GO:0048706; GO:0050999; GO:0060011; GO:0071363; GO:0071773; GO:0098821 activin binding [GO:0048185]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675] HAGMAMLCETIEECWDHDAEAR 0.94184 3.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4442 0 0 0 0 11.4835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40189 IL6RB_HUMAN "Interleukin-6 receptor subunit beta, IL-6 receptor subunit beta, IL-6R subunit beta, IL-6R-beta, IL-6RB (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130, gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)" IL6ST Homo sapiens (Human) ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; glycogen metabolic process [GO:0005977]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; leukemia inhibitory factor signaling pathway [GO:0048861]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of neuron apoptotic process [GO:0043524]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; response to cytokine [GO:0034097] ciliary neurotrophic factor receptor complex [GO:0070110]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ciliary neurotrophic factor receptor complex [GO:0070110]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor activity [GO:0004897]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-27 receptor activity [GO:0045509]; scaffold protein binding [GO:0097110]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; glycogen metabolic process [GO:0005977]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; leukemia inhibitory factor signaling pathway [GO:0048861]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of neuron apoptotic process [GO:0043524]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; response to cytokine [GO:0034097] GO:0002675; GO:0002821; GO:0004896; GO:0004897; GO:0004921; GO:0005127; GO:0005576; GO:0005615; GO:0005886; GO:0005896; GO:0005900; GO:0005977; GO:0008284; GO:0009897; GO:0010575; GO:0010613; GO:0016020; GO:0019221; GO:0019838; GO:0019955; GO:0019970; GO:0030425; GO:0034097; GO:0038165; GO:0042102; GO:0042531; GO:0042802; GO:0043025; GO:0043066; GO:0043235; GO:0043524; GO:0045121; GO:0045509; GO:0045669; GO:0045747; GO:0048711; GO:0048861; GO:0060576; GO:0070062; GO:0070102; GO:0070104; GO:0070106; GO:0070110; GO:0070120; GO:0097110; GO:1901731 ciliary neurotrophic factor receptor activity [GO:0004897]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-27 receptor activity [GO:0045509]; scaffold protein binding [GO:0097110] EDGKGYWSDWSEEASGITYEDRPSK 0.94185 0.89463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.701 0 0 0 13.9259 0 0 0 0 14.091 0 0 0 0 0 0 13.2851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CG8 CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 CTHRC1 UNQ762/PRO1550 Homo sapiens (Human) "cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasm [GO:0016528] "collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasm [GO:0016528]; frizzled binding [GO:0005109]; Wnt-protein binding [GO:0017147]; cell migration [GO:0016477]; cochlea morphogenesis [GO:0090103]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein binding [GO:0032092]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001649; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0016477; GO:0016528; GO:0017147; GO:0032092; GO:0033687; GO:0033690; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177 frizzled binding [GO:0005109]; Wnt-protein binding [GO:0017147] GLLLLLLLQLPAPSSASEIPK 0.94185 1.7254 0 0 0 0 0 0 0 0 0 0 11.7039 0 0 0 11.6968 0 0 0 0 0 0 0 0 0 15.1126 0 0 0 0 0 0 0 11.4443 0 0 0 0 10.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.19229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8704 0 0 0 12.6518 0 0 0 0 15.1169 15.1411 0 0 0 15.291 0 0 0 0 0 0 0 0 15.2239 15.3042 0 0 0 0 0 0 0 15.3439 0 0 0 0 0 12.4112 0 0 0 0 0 0 0 11.9615 15.4373 0 0 0 0 0 0 0 15.3757 15.5953 0 10.8163 0 0 0 16.0227 0 0 0 0 0 12.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8317 0 0 0 0 0 0 11.7556 Q9H069 DRC3_HUMAN Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48) DRC3 LRRC48 Homo sapiens (Human) axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126] GO:0005737; GO:0005929; GO:0005930; GO:0036126 EELELPNIEK 0.94186 3.523 0 0 0 0 0 0 0 0 0 0 0 0 12.7753 0 0 0 0 0 0 0 0 0 0 0 0 10.643 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2761 0 0 0 0 0 0 0 12.5256 0 0 0 0 0 12.9963 0 0 0 0 0 0 0 0 0 11.7251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.919 0 11.7052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3856 0 0 0 0 0 10.4299 14.0218 0 0 0 13.28 0 0 0 0 0 0 0 0 0 0 0 0 P41223 BUD31_HUMAN Protein BUD31 homolog (Protein EDG-2) (Protein G10 homolog) BUD31 EDG2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of androgen receptor activity [GO:2000825]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of androgen receptor activity [GO:2000825]" GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0016922; GO:0030374; GO:0071007; GO:2000825 nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374] DTNFGTNCICR 0.94187 1.7519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88695 11.0072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6923 0 0 0 0 0 0 0 0 0 0 14.7826 14.7666 0 12.9523 0 14.1132 12.4057 0 14.088 13.141 0 0 0 0 0 0 0 0 13.2935 0 0 0 0 0 0 0 0 0 0 12.2254 0 0 0 0 0 0 0 0 0 0 15.9503 11.9306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7334 0 Q53EL9 SEZ6_HUMAN "Seizure protein 6 homolog, SEZ-6, hSEZ-6" SEZ6 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer development [GO:0021680]; excitatory postsynaptic potential [GO:0060079]; regulation of dendrite development [GO:0050773]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] apical dendrite [GO:0097440]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical dendrite [GO:0097440]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer development [GO:0021680]; excitatory postsynaptic potential [GO:0060079]; regulation of dendrite development [GO:0050773]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] GO:0005783; GO:0005886; GO:0008344; GO:0016021; GO:0021680; GO:0043025; GO:0043197; GO:0043198; GO:0048471; GO:0050773; GO:0060074; GO:0060079; GO:0090036; GO:0097440 GQDCIWGVHVEEDKRIMLDIR 0.94188 0.96811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.954 0 0 0 12.5025 0 0 0 0 0 11.3435 0 0 0 0 0 0 11.5507 0 0 0 0 0 0 0 0 0 0 0 P01732 CD8A_HUMAN T-cell surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen T8/Leu-2) (CD antigen CD8a) CD8A MAL Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell surface receptor signaling pathway [GO:0007166]; cytotoxic T cell differentiation [GO:0045065]; immune response [GO:0006955]; T cell activation [GO:0042110]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; T cell receptor complex [GO:0042101] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; T cell receptor complex [GO:0042101]; coreceptor activity [GO:0015026]; MHC class I protein binding [GO:0042288]; MHC class I protein complex binding [GO:0023024]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell surface receptor signaling pathway [GO:0007166]; cytotoxic T cell differentiation [GO:0045065]; immune response [GO:0006955]; T cell activation [GO:0042110]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0002250; GO:0002456; GO:0005576; GO:0005886; GO:0005887; GO:0006955; GO:0007166; GO:0007169; GO:0009897; GO:0015026; GO:0019882; GO:0023024; GO:0042101; GO:0042110; GO:0042288; GO:0043235; GO:0044853; GO:0045065; GO:0050852 coreceptor activity [GO:0015026]; MHC class I protein binding [GO:0042288]; MHC class I protein complex binding [GO:0023024] ALPVTALLLPLALLLHAAR 0.9419 0.96791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6032 0 0 0 14.2736 0 0 0 0 0 14.1261 0 0 0 13.3662 14.6558 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0444 0 0 0 0 0 0 0 0 0 0 13.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW40 CC103_HUMAN Coiled-coil domain-containing protein 103 CCDC103 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; protein homodimerization activity [GO:0042803]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] GO:0001947; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036158; GO:0036159; GO:0042803; GO:0060287; GO:0070286; GO:0071907 protein homodimerization activity [GO:0042803] FTLNLSLLSR 0.9419 0.89338 0 0 0 0 0 0 0 0 0 0 0 11.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C019 TRI15_HUMAN Tripartite motif-containing protein 15 (RING finger protein 93) (Zinc finger protein 178) (Zinc finger protein B7) TRIM15 RNF93 ZNF178 ZNFB7 Homo sapiens (Human) innate immune response [GO:0045087]; mesodermal cell fate determination [GO:0007500]; negative regulation of intracellular transport of viral material [GO:1901253]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; mesodermal cell fate determination [GO:0007500]; negative regulation of intracellular transport of viral material [GO:1901253]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790] GO:0003713; GO:0005737; GO:0007500; GO:0008270; GO:0010468; GO:0016567; GO:0032481; GO:0044790; GO:0045087; GO:0051091; GO:0051092; GO:0061630; GO:1900246; GO:1901253 transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DFHRKILTLPEMMR 0.9419 3.3983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7197 0 12.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1817 13.8968 0 14.2935 0 0 14.0695 0 13.3383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06132 DCUP_HUMAN "Uroporphyrinogen decarboxylase, UPD, URO-D, EC 4.1.1.37" UROD Homo sapiens (Human) heme biosynthetic process [GO:0006783]; porphyrin-containing compound catabolic process [GO:0006787]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound catabolic process [GO:0006787]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782] GO:0004853; GO:0005654; GO:0005829; GO:0006778; GO:0006782; GO:0006783; GO:0006787 uroporphyrinogen decarboxylase activity [GO:0004853] AAWGEETDYTPVWCMR 0.94191 1.0153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5311 0 0 0 0 12.459 0 0 0 0 14.6945 0 0 0 0 0 0 0 12.9398 0 0 Q5VXM1 CDCP2_HUMAN CUB domain-containing protein 2 CDCP2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 CHWTIRLPPGYQVK 0.94191 0.89292 0 0 0 9.84152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2699 0 Q8TEX9 IPO4_HUMAN "Importin-4, Imp4 (Importin-4b, Imp4b) (Ran-binding protein 4, RanBP4)" IPO4 IMP4B RANBP4 Homo sapiens (Human) DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; protein import into nucleus [GO:0006606] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; protein import into nucleus [GO:0006606] GO:0000785; GO:0005634; GO:0005737; GO:0006335; GO:0006336; GO:0006606; GO:0008139; GO:0016020; GO:0031267; GO:0032991; GO:0061608 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; small GTPase binding [GO:0031267] EVMPLLLAYLK 0.94192 3.4452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5675 0 0 0 13.3906 0 0 0 0 0 0 11.252 0 0 0 0 0 0 0 0 0 13.0024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7883 0 0 0 13.3965 0 0 0 0 0 0 0 0 13.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6035 0 12.9414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4083 0 0 12.3168 0 0 0 0 0 0 12.7263 0 0 12.1988 0 0 0 0 0 0 0 0 0 0 O14669 TMG2_HUMAN "Transmembrane gamma-carboxyglutamic acid protein 2 (Proline-rich gamma-carboxyglutamic acid protein 2, Proline-rich Gla protein 2)" PRRG2 PRGP2 TMG2 Homo sapiens (Human) extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509] GO:0005509; GO:0005615; GO:0005886; GO:0005887 calcium ion binding [GO:0005509] ECLEERCSWEEAR 0.94194 0.96594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06418 TYRO3_HUMAN "Tyrosine-protein kinase receptor TYRO3, EC 2.7.10.1 (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF)" TYRO3 BYK DTK RSE SKY TIF Homo sapiens (Human) apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of kinase activity [GO:0033674]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; receptor complex [GO:0043235] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of kinase activity [GO:0033674]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068] GO:0001618; GO:0001764; GO:0001779; GO:0004713; GO:0004714; GO:0005524; GO:0005634; GO:0005635; GO:0005789; GO:0005887; GO:0006909; GO:0007155; GO:0007165; GO:0007169; GO:0007218; GO:0007283; GO:0007399; GO:0009986; GO:0014065; GO:0016477; GO:0021885; GO:0030168; GO:0032940; GO:0033674; GO:0034122; GO:0034446; GO:0042698; GO:0043235; GO:0043277; GO:0043491; GO:0043524; GO:0043548; GO:0045824; GO:0046777; GO:0050728; GO:0051250; GO:0051402; GO:0051649; GO:0060068; GO:0070050; GO:0070527; GO:1903902 ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618] DQPYSGAGDGSGMGAVGGTPSDCR 0.94195 3.4865 0 0 0 0 11.4616 13.7502 0 0 0 11.1224 0 0 0 0 0 0 13.0529 0 12.8701 0 0 0 0 0 12.4151 11.9409 12.455 0 12.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9775 12.7584 0 14.8587 0 0 11.6871 0 0 0 0 14.1491 14.1586 0 0 12.5655 0 0 13.4597 0 13.2201 0 0 0 0 0 13.8022 0 0 0 0 0 12.6612 0 0 13.0346 0 0 0 0 0 0 0 0 0 0 0 10.0507 0 13.3204 0 14.431 0 12.5196 0 0 0 0 0 0 0 11.2479 12.6405 0 0 0 0 0 0 12.0185 0 0 0 0 0 0 0 0 0 0 12.6631 0 0 0 0 0 0 0 13.0283 12.1442 0 0 0 0 0 0 12.0744 0 0 0 0 0 0 9.94544 13.0549 0 Q6W5P4 NPSR1_HUMAN Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) NPSR1 GPR154 GPRA PGR14 Homo sapiens (Human) eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000]; eating behavior [GO:0042755]; negative regulation of defecation [GO:2000293]; negative regulation of eating behavior [GO:1903999]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; righting reflex [GO:0060013] GO:0005000; GO:0005737; GO:0005886; GO:0005887; GO:0007218; GO:0008188; GO:0042755; GO:0051281; GO:0060013; GO:0070374; GO:1903999; GO:2000293 neuropeptide receptor activity [GO:0008188]; vasopressin receptor activity [GO:0005000] QARVLIVIAWSLSFLFSIPTLIIFGKR 0.94195 4.0055 0 0 0 0 0 0 0 0 12.9461 12.0426 10.8507 10.2765 12.2513 0 0 0 0 0 0 0 0 0 0 0 12.2268 11.6719 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0051 0 0 0 0 0 0 0 0 0 0 0 11.8275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1064 0 12.3975 13.5517 13.0596 0 14.4821 0 0 12.2446 0 0 13.4747 12.8214 13.6099 0 0 11.1154 12.7721 0 0 0 0 14.1657 14.9194 12.9822 13.9105 0 0 0 0 13.4544 0 14.9119 0 0 14.2657 12.9695 13.5093 0 0 13.6518 13.192 13.2362 0 0 0 0 13.3038 13.4556 0 0 0 0 0 0 0 0 0 13.309 0 14.9651 12.5897 0 0 13.2119 0 13.2194 0 0 0 0 12.0319 0 14.1033 12.0714 12.8874 0 0 0 0 12.9475 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3871 0 0 0 0 0 Q13685 AAMP_HUMAN Angio-associated migratory cell protein AAMP Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909] cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; smooth muscle cell migration [GO:0014909] GO:0001525; GO:0005829; GO:0005886; GO:0008201; GO:0009986; GO:0010595; GO:0014909; GO:0015630; GO:0030154; GO:0045171 heparin binding [GO:0008201] APVLLAGTADGNTWMWKVPNGDCK 0.942 1.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9838 0 11.8797 0 12.8439 0 0 0 0 0 0 0 0 17.1453 0 0 0 13.4479 13.7833 0 0 0 0 0 0 0 14.556 14.1747 14.2012 0 0 0 0 0 0 0 14.0571 10.9015 0 0 0 0 13.5607 0 14.243 14.313 13.9072 0 0 0 0 0 0 0 0 0 0 10.086 0 0 0 0 13.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2437 14.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00451 GFRA2_HUMAN "GDNF family receptor alpha-2, GDNF receptor alpha-2, GDNFR-alpha-2, GFR-alpha-2 (GDNF receptor beta, GDNFR-beta) (Neurturin receptor alpha, NRTNR-alpha, NTNR-alpha) (RET ligand 2) (TGF-beta-related neurotrophic factor receptor 2)" GFRA2 GDNFRB RETL2 TRNR2 Homo sapiens (Human) nervous system development [GO:0007399]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; nervous system development [GO:0007399]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005886; GO:0007169; GO:0007399; GO:0009897; GO:0016167; GO:0019898; GO:0031225; GO:0038023; GO:0043235 glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023] ECQAALEVLQESPLYDCRCKR 0.94203 4.8942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2798 0 0 0 0 0 0 13.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9612 0 0 0 0 12.7814 0 13.2166 0 0 0 0 0 0 0 0 0 12.2237 0 0 0 0 0 0 0 0 0 0 0 0 13.9484 0 0 0 0 0 0 0 0 0 0 0 0 18.4476 0 12.3073 0 0 0 13.2094 0 0 0 0 0 0 0 0 0 0 0 0 11.6517 0 0 0 12.4896 0 0 0 0 0 0 0 0 0 11.8754 0 0 0 0 0 0 13.7933 0 0 0 Q9NSK0 KLC4_HUMAN "Kinesin light chain 4, KLC 4 (Kinesin-like protein 8)" KLC4 KNSL8 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; kinesin binding [GO:0019894]; microtubule-based movement [GO:0007018] GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0019894 kinesin binding [GO:0019894] DEPAGHR 0.94203 2.697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7967 0 0 0 0 0 12.2342 0 0 0 0 0 0 12.1297 0 0 0 0 0 0 0 0 0 12.6215 0 0 0 0 12.7731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.745 0 0 0 12.4249 0 0 11.4551 0 0 0 0 13.111 0 12.4112 0 0 0 0 0 12.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6597 0 12.4527 0 13.2157 12.2288 0 12.1876 0 12.6267 0 0 0 0 0 13.0621 0 0 0 0 0 0 0 0 0 0 11.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0493 0 12.7547 0 0 P82912 RT11_HUMAN "28S ribosomal protein S11, mitochondrial, MRP-S11, S11mt (Cervical cancer proto-oncogene 2 protein, HCC-2) (Mitochondrial small ribosomal subunit protein uS11m)" MRPS11 RPMS11 HCC2 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] "cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" GO:0000028; GO:0000462; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0022627; GO:0032543; GO:0048027; GO:0070181 mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735] AKQKGVIHIR 0.94206 0.90578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.244 0 0 0 0 0 0 0 0 0 0 0 11.7607 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8567 0 10.7142 0 0 0 0 0 0 0 0 0 10.5142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8032 Q8NBX0 SCPDL_HUMAN "Saccharopine dehydrogenase-like oxidoreductase, EC 1.-.-.-" SCCPDH CGI-49 Homo sapiens (Human) glycolipid biosynthetic process [GO:0009247] extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247] GO:0005576; GO:0005634; GO:0005739; GO:0005811; GO:0009247; GO:0016020; GO:0016491; GO:0030496; GO:0031093 oxidoreductase activity [GO:0016491] FGIGRQLLIK 0.94206 2.5656 0 0 0 0 0 0 0 0 13.4733 0 0 0 0 12.1491 13.241 13.2972 12.4144 12.7907 0 0 0 0 11.2881 0 0 0 0 13.8629 0 11.9452 0 12.2371 0 13.068 13.7556 11.3679 12.7205 11.3376 13.125 0 0 0 0 0 11.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9721 0 0 0 0 0 0 0 0 0 11.6852 0 13.201 12.1605 0 0 0 12.6696 12.9163 13.6294 0 0 0 13.2515 0 12.9257 0 12.8287 0 0 14.2519 0 0 0 0 0 12.999 13.181 12.0454 0 0 0 13.1245 0 0 13.0609 13.1736 0 0 0 0 12.738 12.2664 0 13.5968 0 13.5103 0 0 12.9107 13.6512 0 12.1696 0 10.7131 0 0 0 0 0 0 13.1497 0 0 0 13.1704 12.3392 0 0 0 0 0 13.1825 0 0 0 0 13.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5QGZ9 CL12A_HUMAN "C-type lectin domain family 12 member A (C-type lectin-like molecule 1, CLL-1) (Dendritic cell-associated lectin 2, DCAL-2) (Myeloid inhibitory C-type lectin-like receptor, MICL) (CD antigen CD371)" CLEC12A CLL1 DCAL2 MICL Homo sapiens (Human) signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; signaling receptor regulator activity [GO:0030545]; transmembrane signaling receptor activity [GO:0004888]; signal transduction [GO:0007165] GO:0004888; GO:0005886; GO:0005887; GO:0007165; GO:0030246; GO:0030545; GO:0035579; GO:0070821 carbohydrate binding [GO:0030246]; signaling receptor regulator activity [GO:0030545]; transmembrane signaling receptor activity [GO:0004888] MANPVQLGSTYFREA 0.94208 0.89492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0028 0 0 0 12.4385 0 11.7589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUW8 TYDP1_HUMAN "Tyrosyl-DNA phosphodiesterase 1, Tyr-DNA phosphodiesterase 1, EC 3.1.4.-" TDP1 Homo sapiens (Human) DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012] GO:0000012; GO:0003690; GO:0003697; GO:0004527; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006302; GO:0017005; GO:0043231 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697] TYMRPSPDFSK 0.94209 1.7309 0 0 0 0 0 0 0 0 0 13.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6175 0 0 0 0 0 0 0 0 13.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.105 0 0 0 0 0 0 0 0 13.6901 12.7037 0 0 12.9697 0 14.2487 0 14.0335 12.9898 12.8162 0 0 0 0 0 0 0 0 12.7537 0 0 0 0 Q8WX39 LCN9_HUMAN Epididymal-specific lipocalin-9 (MUP-like lipocalin) LCN9 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; small molecule binding [GO:0036094] GO:0005615; GO:0036094 small molecule binding [GO:0036094] NGTETHTLALYETCEK 0.9421 0.89476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0757 13.3252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7P3 LCE1B_HUMAN Late cornified envelope protein 1B (Late envelope protein 2) (Small proline-rich-like epidermal differentiation complex protein 2A) LCE1B LEP2 SPRL2A Homo sapiens (Human) keratinization [GO:0031424] identical protein binding [GO:0042802]; keratinization [GO:0031424] GO:0031424; GO:0042802 identical protein binding [GO:0042802] MSCQQNQQQCQPPPK 0.94211 3.3844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0228 10.5189 0 0 0 0 12.7892 0 0 0 0 0 0 0 0 0 12.3446 0 12.6312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2923 0 15.4425 0 0 0 0 0 0 0 0 14.8759 0 0 0 0 0 0 0 0 14.594 0 0 0 0 13.9249 13.2067 0 0 0 11.6344 11.8813 0 0 0 0 0 13.188 0 0 0 0 0 14.3439 0 0 0 14.0588 0 0 0 0 0 0 0 0 0 11.4214 0 0 11.143 0 0 0 0 0 0 0 14.1171 0 0 0 0 15.2564 0 13.2752 0 0 0 0 0 0 0 0 10.9879 0 0 0 0 0 0 0 0 0 0 13.6141 0 0 0 0 0 0 13.4828 0 0 0 0 13.8382 0 0 0 Q9BWX1 PHF7_HUMAN PHD finger protein 7 (Testis development protein NYD-SP6) PHF7 Homo sapiens (Human) cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872] GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016607; GO:0046872 metal ion binding [GO:0046872] KWECEECSPAAATDYIPENSGDIPCCSSTFHPEEHFCR 0.94211 1.0159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2829 0 0 0 14.4129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.188 0 0 0 0 0 0 15.6093 15.6521 0 14.1111 0 0 0 0 14.5884 0 0 0 14.2802 0 0 0 0 14.2107 0 13.9971 0 13.7592 0 0 0 0 0 0 0 0 0 0 0 14.2984 0 0 0 13.8224 0 0 0 0 0 0 0 0 0 11.6764 0 0 0 0 0 11.2122 0 0 0 0 0 0 0 0 0 0 13.1733 0 0 0 0 0 14.0123 13.5867 0 Q16611 BAK_HUMAN "Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK) (Bcl-2-like protein 7, Bcl2-L-7)" BAK1 BAK BCL2L7 CDN1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068] BAK complex [GO:0097145]; Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930] BAK complex [GO:0097145]; Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; BH domain binding [GO:0051400]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068] GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006915; GO:0007420; GO:0007568; GO:0008053; GO:0008285; GO:0008630; GO:0008635; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0014070; GO:0018105; GO:0031018; GO:0031072; GO:0031100; GO:0031307; GO:0031334; GO:0032469; GO:0032471; GO:0033137; GO:0034620; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0050673; GO:0051087; GO:0051400; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097136; GO:0097145; GO:0097190; GO:0097192; GO:0097202; GO:1900103; GO:1901029; GO:1901030; GO:1902262; GO:1903896 BH domain binding [GO:0051400]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325] FVVDFMLHHCIARWIAQR 0.94213 0.89445 0 0 0 0 0 0 0 0 13.0277 0 0 0 0 0 0 0 11.9714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0C4DH30 HV316_HUMAN Probable non-functional immunoglobulin heavy variable 3-16 IGHV3-16 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] RAEDMAVYYCVR 0.94214 1.0154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9I0 SYT2_HUMAN "Synaptotagmin-2 (Synaptotagmin II, SytII)" SYT2 Homo sapiens (Human) calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0030424; GO:0030669; GO:0030672; GO:0031045; GO:0042584; GO:0043533; GO:0048488; GO:0048791; GO:0070161; GO:0070382; GO:0071277; GO:1903861 "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" TLNPYFNESFSFEIPFEQIQKVQVVVTVLDYDKLGK 0.94216 0.90097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXH8 CAD26_HUMAN Cadherin-like protein 26 (Cadherin-like protein VR20) CDH26 Homo sapiens (Human) "CD4-positive, alpha-beta T cell activation [GO:0035710]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]" catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] "catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]" GO:0005178; GO:0005509; GO:0005886; GO:0007156; GO:0008013; GO:0015630; GO:0016021; GO:0016342; GO:0035710; GO:0045294; GO:0045296; GO:0070097; GO:0098742 alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; integrin binding [GO:0005178] HPSLLLLLVLLLWLLQVSIIDSVQQETDDLTK 0.94217 2.5018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3791 0 0 0 0 0 0 0 0 0 0 0 13.0934 13.8788 0 0 0 0 0 13.5825 0 0 13.1958 0 0 0 0 0 0 0 0 0 12.5549 12.1853 0 0 0 0 11.8872 0 13.5765 13.9688 13.1108 0 0 0 0 13.6354 13.597 0 0 0 0 0 13.1573 0 13.4095 0 0 0 12.7479 0 13.3032 0 0 11.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8498 0 0 10.5084 0 0 12.6161 0 0 0 0 0 0 0 0 0 0 0 12.5588 0 0 0 0 0 0 0 0 0 11.828 0 O43819 SCO2_HUMAN "Protein SCO2 homolog, mitochondrial" SCO2 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; eye development [GO:0001654]; in utero embryonic development [GO:0001701]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; muscle system process [GO:0003012]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myofibril [GO:0030016] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035]; cellular copper ion homeostasis [GO:0006878]; eye development [GO:0001654]; in utero embryonic development [GO:0001701]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; muscle system process [GO:0003012]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823] GO:0001654; GO:0001701; GO:0003012; GO:0005507; GO:0005739; GO:0005759; GO:0006878; GO:0014823; GO:0015035; GO:0016531; GO:0022904; GO:0030016; GO:0031305; GO:0033617 copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035] LLLTRSPTAWHRLSQLK 0.94218 0.892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVN8 UB2Q2_HUMAN "Ubiquitin-conjugating enzyme E2 Q2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme Q2) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2)" UBE2Q2 Homo sapiens (Human) protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0061631; GO:0070936 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] DIYRSQSYK 0.94218 0.96704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8167 0 0 0 12.7494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.685 0 0 0 0 0 0 0 13.6622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16559 TAL2_HUMAN "T-cell acute lymphocytic leukemia protein 2, TAL-2 (Class A basic helix-loop-helix protein 19, bHLHa19)" TAL2 BHLHA19 Homo sapiens (Human) midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; thalamus development [GO:0021794] chromatin [GO:0000785] "chromatin [GO:0000785]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; thalamus development [GO:0021794]" GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0006357; GO:0009791; GO:0021794; GO:0030901; GO:0035264; GO:0046983 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LIPTHPPDK 0.94219 0.96679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00888 PSG4_HUMAN "Pregnancy-specific beta-1-glycoprotein 4, PS-beta-G-4, PSBG-4, Pregnancy-specific glycoprotein 4 (Pregnancy-specific beta-1-glycoprotein 9, PS-beta-G-9, PSBG-9, Pregnancy-specific glycoprotein 9)" PSG4 CGM4 PSG9 Homo sapiens (Human) female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] GO:0002682; GO:0005576; GO:0005886; GO:0007165; GO:0007565; GO:0009986; GO:1990782 protein tyrosine kinase binding [GO:1990782] ILILPNVTR 0.9422 0.89179 0 0 0 0 0 0 0 0 0 0 0 0 11.1518 0 0 0 0 11.9186 0 0 0 0 0 0 11.9292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.234 0 0 13.2217 0 12.0316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9111 0 0 0 0 0 0 12.9828 0 0 0 0 13.1355 11.7033 0 0 0 0 0 0 0 13.7016 0 0 0 0 0 0 0 0 0 0 0 0 14.3575 0 0 0 0 0 0 0 0 0 11.1476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3025 13.1693 12.3746 0 0 0 0 0 0 0 0 12.9283 0 0 0 10.8149 Q96FQ6 S10AG_HUMAN Protein S100-A16 (Aging-associated gene 13 protein) (Protein S100-F) (S100 calcium-binding protein A16) S100A16 S100F AAG13 Homo sapiens (Human) response to calcium ion [GO:0051592] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; response to calcium ion [GO:0051592] GO:0003723; GO:0005509; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0042803; GO:0048306; GO:0051592; GO:0070062 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] ISFDEYWTLIGGITGPIAK 0.94224 1.7381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3628 13.1889 13.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5331 0 0 0 0 0 0 0 0 10.602 0 0 0 0 0 0 0 0 0 13.4188 0 D6R901 U17LL_HUMAN "Ubiquitin carboxyl-terminal hydrolase 17-like protein 21, EC 3.4.19.12" USP17L21 Homo sapiens (Human) protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0042981 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] AQEGQWYK 0.94225 2.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8431 0 0 0 0 0 0 0 0 0 11.6691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9086 14.9516 0 15.0334 0 15.2118 12.004 19.6928 14.9169 0 0 0 0 0 14.4073 0 0 0 0 0 0 0 0 0 0 15.3265 16.3694 0 0 15.4664 0 15.5397 0 0 15.4178 0 0 0 0 0 0 0 12.3261 0 15.2044 0 0 0 0 0 11.7031 0 0 0 15.5154 0 15.225 0 0 15.0264 0 14.9936 0 0 0 0 15.3803 0 0 0 0 12.9997 0 0 0 0 0 12.7375 14.1724 0 15.1971 0 0 0 0 0 0 0 0 0 0 0 10.7093 0 0 0 0 12.5078 15.4682 0 0 0 0 0 0 P07225 PROS_HUMAN Vitamin K-dependent protein S PROS1 PROS Homo sapiens (Human) blood coagulation [GO:0007596]; fibrinolysis [GO:0042730] blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093] blood microparticle [GO:0072562]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; endopeptidase inhibitor activity [GO:0004866]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730] GO:0000139; GO:0004866; GO:0005509; GO:0005576; GO:0005615; GO:0005789; GO:0005796; GO:0005886; GO:0007596; GO:0031093; GO:0042730; GO:0070062; GO:0072562 calcium ion binding [GO:0005509]; endopeptidase inhibitor activity [GO:0004866] DPSNINGGCSQICDNTPGSYHCSCKNGFVMLSNK 0.94226 1.7541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8947 10.7612 0 0 0 0 11.2138 0 0 0 0 0 0 0 13.0258 14.2544 0 0 0 0 0 12.0628 0 0 0 0 0 0 13.8949 0 0 14.6934 13.5558 0 0 0 11.1394 0 0 0 0 12.4187 0 0 13.5386 0 0 13.8144 0 0 0 0 12.5282 0 0 0 0 0 13.7232 13.4873 0 0 14.3714 0 0 0 12.8413 0 0 0 12.6233 0 13.0864 0 0 0 0 0 0 0 0 0 0 0 0 17.59 0 0 0 0 0 13.6174 0 0 0 0 0 0 11.4902 0 0 0 0 0 0 0 0 0 Q96MD2 KICS2_HUMAN KICSTOR subunit 2 (KICSTOR complex protein C12orf66) KICS2 C12orf66 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462] intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462] GO:0005764; GO:0005765; GO:0034198; GO:0042149; GO:0045171; GO:0061462; GO:0140007; GO:1904262 AVQPPHLFLWLMKLKNMLLAK 0.94226 3.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2072 0 12.1073 0 0 0 0 0 0 0 0 0 0 10.9891 0 0 0 0 0 0 0 0 0 14.0192 0 0 14.6329 0 0 0 13.5944 14.7089 0 0 14.3954 13.8744 13.9081 0 0 0 0 14.0411 0 0 0 0 13.7763 12.8836 0 0 0 0 0 0 0 11.2531 11.231 0 13.5062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TGY1 TMCO4_HUMAN Transmembrane and coiled-coil domain-containing protein 4 TMCO4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EEESEMAEASR 0.94227 1.7374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LA6 FCRL1_HUMAN "Fc receptor-like protein 1, FcR-like protein 1, FcRL1 (Fc receptor homolog 1, FcRH1) (IFGP family protein 1, hIFGP1) (Immune receptor translocation-associated protein 5) (CD antigen CD307a)" FCRL1 FCRH1 IFGP1 IRTA5 Homo sapiens (Human) B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; coreceptor activity [GO:0015026]; transmembrane signaling receptor activity [GO:0004888]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166] GO:0004888; GO:0005887; GO:0007166; GO:0009986; GO:0015026; GO:0042113 coreceptor activity [GO:0015026]; transmembrane signaling receptor activity [GO:0004888] ANITDVDYEDAM 0.94227 2.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8964 13.2647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1743 14.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y661 HS3S4_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 4, EC 2.8.2.23 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4, 3-OST-4, Heparan sulfate 3-O-sulfotransferase 4, h3-OST-4)" HS3ST4 3OST4 Homo sapiens (Human) heparan sulfate proteoglycan metabolic process [GO:0030201] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; heparan sulfate proteoglycan metabolic process [GO:0030201] GO:0000139; GO:0008467; GO:0016021; GO:0030201 [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467] DIKLIVVVR 0.94227 2.4989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4625 11.8269 0 11.2858 11.8292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y264 ANGP4_HUMAN "Angiopoietin-4, ANG-4 (Angiopoietin-3, ANG-3)" ANGPT4 ANG3 ANG4 Homo sapiens (Human) angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] GO:0001525; GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007219; GO:0010595; GO:0016525; GO:0030297; GO:0030971; GO:0043066; GO:0043536; GO:0043537; GO:0045766; GO:0050731; GO:0062023; GO:0071456 receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] ESLANPLHLGKLPTQQVKQLEQALQNNTQWLK 0.94229 1.7531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.69 0 0 0 0 0 0 0 0 10.8242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B1AK76 SNUFL_HUMAN Putative SNURF-like protein SNURFL CXorf19 Homo sapiens (Human) nuclear speck [GO:0016607] nuclear speck [GO:0016607] GO:0016607 DHLHLRWTTEQHMPEVEVQVKYR 0.94231 3.8648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8516 12.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3832 0 0 12.3843 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3753 0 0 0 0 10.7231 0 0 0 0 12.9483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1467 0 0 0 O00712 NFIB_HUMAN "Nuclear factor 1 B-type, NF1-B, Nuclear factor 1/B (CCAAT-box-binding transcription factor, CTF) (Nuclear factor I/B, NF-I/B, NFI-B) (TGGCA-binding protein)" NFIB Homo sapiens (Human) "anterior commissure morphogenesis [GO:0021960]; brain development [GO:0007420]; cell differentiation involved in salivary gland development [GO:0060689]; chondrocyte differentiation [GO:0002062]; club cell differentiation [GO:0060486]; commissural neuron axon guidance [GO:0071679]; DNA replication [GO:0006260]; glandular epithelial cell differentiation [GO:0002067]; glial cell differentiation [GO:0010001]; hindbrain development [GO:0030902]; lung ciliated cell differentiation [GO:0061141]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell proliferation involved in lung morphogenesis [GO:2000795]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; regulation of transcription by RNA polymerase II [GO:0006357]; response to bacterium [GO:0009617]; salivary gland cavitation [GO:0060662]; stem cell proliferation [GO:0072089]; type I pneumocyte differentiation [GO:0060509]; type II pneumocyte differentiation [GO:0060510]" cerebellar mossy fiber [GO:0044300]; chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cerebellar mossy fiber [GO:0044300]; chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulator inhibitor activity [GO:0140416]; anterior commissure morphogenesis [GO:0021960]; brain development [GO:0007420]; cell differentiation involved in salivary gland development [GO:0060689]; chondrocyte differentiation [GO:0002062]; club cell differentiation [GO:0060486]; commissural neuron axon guidance [GO:0071679]; DNA replication [GO:0006260]; glandular epithelial cell differentiation [GO:0002067]; glial cell differentiation [GO:0010001]; hindbrain development [GO:0030902]; lung ciliated cell differentiation [GO:0061141]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell proliferation involved in lung morphogenesis [GO:2000795]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; regulation of transcription by RNA polymerase II [GO:0006357]; response to bacterium [GO:0009617]; salivary gland cavitation [GO:0060662]; stem cell proliferation [GO:0072089]; type I pneumocyte differentiation [GO:0060509]; type II pneumocyte differentiation [GO:0060510]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0002062; GO:0002067; GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0007420; GO:0009617; GO:0010001; GO:0021740; GO:0021960; GO:0030902; GO:0043392; GO:0044300; GO:0045893; GO:0045944; GO:0060486; GO:0060509; GO:0060510; GO:0060662; GO:0060689; GO:0061141; GO:0071679; GO:0072089; GO:0140416; GO:1902894; GO:1990837; GO:2000647; GO:2000791; GO:2000795 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulator inhibitor activity [GO:0140416]" DELLSEKPEIK 0.94231 4.0664 14.5982 16.1574 15.3907 0 13.8287 13.4852 16.2748 15.7905 0 11.0554 0 0 0 0 0 0 12.2963 11.9788 12.0229 12.4459 16.7224 19.1359 17.2286 18.8122 11.411 0 11.3075 0 12.1798 12.7383 10.6965 0 0 0 0 0 0 0 0 12.7373 0 0 0 0 10.9646 11.2133 0 0 0 12.0157 12.2632 0 14.0047 11.1186 0 11.4719 0 0 11.2204 0 12.1715 0 0 0 0 0 15.4556 15.5577 15.401 16.0571 16.0272 16.1422 16.0015 15.6257 15.9544 18.874 14.7624 18.92 18.724 17.7041 18.995 22.146 22.1524 21.8597 21.6881 21.62 21.676 18.9086 19.0311 20.0757 18.8222 20.0812 19.3163 19.0921 19.1702 19.3758 21.9765 18.0627 22.123 19.2776 18.568 18.359 18.0786 19.0235 19.0316 18.7653 18.8864 18.9504 18.7581 19.7442 19.3918 19.3216 20.3144 19.2324 18.9393 15.9459 18.5232 16.0058 20.1304 19.2175 19.2199 18.5522 19.5189 19.9388 19.9048 18.9108 19.4951 19.3085 18.9801 18.2652 18.3494 19.3963 18.8827 18.642 18.5978 19.5902 15.9247 18.982 18.8611 18.2429 19.6125 19.6269 19.0912 18.8721 18.9904 18.4777 18.1163 14.1633 0 0 18.9984 18.9107 18.8471 18.8869 18.8003 19.4816 14.176 13.8403 14.3403 12.0704 14.309 15.6241 14.9065 14.9666 13.2955 13.5248 0 14.8264 12.2347 11.7522 0 20.0386 20.1017 16.1376 15.8855 15.6461 0 14.02 0 0 P07202 PERT_HUMAN "Thyroid peroxidase, TPO, EC 1.11.1.8" TPO Homo sapiens (Human) embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590] cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]; embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590] GO:0004447; GO:0004601; GO:0005509; GO:0005615; GO:0005886; GO:0005887; GO:0006590; GO:0006979; GO:0009986; GO:0020037; GO:0035162; GO:0042446; GO:0042744 calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601] DHPRWGASNTALAR 0.94231 4.8915 0 0 0 0 0 0 0 0 0 0 0 12.9246 12.9579 0 0 0 0 0 0 0 0 11.6008 0 0 0 0 13.3369 0 0 0 13.2392 0 13.5968 0 12.5763 0 0 0 13.0448 0 0 0 12.8561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2519 0 0 0 0 0 0 14.5087 0 0 0 0 13.9676 0 13.2194 0 0 14.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2331 0 0 0 12.4482 0 12.2747 0 0 0 0 0 0 0 0 0 0 11.138 0 0 0 0 0 0 0 0 0 0 0 0 13.6819 0 0 0 0 12.9983 0 0 0 0 13.2009 11.5973 0 0 0 12.423 0 0 Q8N6M3 FITM2_HUMAN "Acyl-coenzyme A diphosphatase FITM2, EC 3.6.1.- (Fat storage-inducing transmembrane protein 2) (Fat-inducing protein 2)" FITM2 C20orf142 FIT2 Homo sapiens (Human) cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; fatty-acyl-CoA catabolic process [GO:0036115]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; CoA pyrophosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129]; cellular triglyceride homeostasis [GO:0035356]; cytoskeleton organization [GO:0007010]; fatty-acyl-CoA catabolic process [GO:0036115]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of cell morphogenesis [GO:0022604]; regulation of triglyceride biosynthetic process [GO:0010866]; sequestering of triglyceride [GO:0030730] GO:0005789; GO:0007010; GO:0008654; GO:0010866; GO:0010890; GO:0010945; GO:0017129; GO:0019915; GO:0019992; GO:0022604; GO:0030176; GO:0030730; GO:0034389; GO:0035356; GO:0036115; GO:0055088; GO:0140042 CoA pyrophosphatase activity [GO:0010945]; diacylglycerol binding [GO:0019992]; triglyceride binding [GO:0017129] ELSPLPESYLSNKRNVLNVYFVK 0.94231 1.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5353 0 0 12.8891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4886 0 0 0 0 0 Q03518 TAP1_HUMAN "Antigen peptide transporter 1, APT1, EC 7.4.2.- (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1, PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein, RING4)" TAP1 ABCB2 PSF1 RING4 Y3 Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cytosol to endoplasmic reticulum transport [GO:0046967]; defense response [GO:0006952]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]" centriolar satellite [GO:0034451]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825] "centriolar satellite [GO:0034451]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]; ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; peptide transmembrane transporter activity [GO:1904680]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cytosol to endoplasmic reticulum transport [GO:0046967]; defense response [GO:0006952]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085]" GO:0002250; GO:0002479; GO:0005524; GO:0005783; GO:0005789; GO:0006952; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016020; GO:0016021; GO:0019885; GO:0023029; GO:0030176; GO:0030670; GO:0033116; GO:0034451; GO:0042288; GO:0042605; GO:0042626; GO:0042803; GO:0042824; GO:0042825; GO:0043531; GO:0046872; GO:0046967; GO:0046978; GO:0046979; GO:0055085; GO:1904680 ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; peptide transmembrane transporter activity [GO:1904680]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979] IFSLLVPTALPLLR 0.94232 0.89557 0 0 0 0 0 0 0 10.8022 0 12.3473 0 0 0 13.9547 0 0 12.7577 0 0 0 0 0 0 0 0 12.1581 0 0 0 0 0 12.5556 0 0 0 0 0 12.6539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6674 13.7345 0 0 0 0 0 0 0 0 13.4665 0 13.5445 0 0 0 0 0 0 0 13.172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9414 0 0 13.3652 0 0 12.9775 0 0 0 0 0 0 0 0 13.2059 0 0 0 0 11.6947 12.8913 0 0 0 0 0 0 0 0 12.9475 0 0 0 13.4389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5764 P19013 K2C4_HUMAN "Keratin, type II cytoskeletal 4 (Cytokeratin-4, CK-4) (Keratin-4, K4) (Type-II keratin Kb4)" KRT4 CYK4 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; negative regulation of epithelial cell proliferation [GO:0050680] cell surface [GO:0009986]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634] cell surface [GO:0009986]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]; structural constituent of skin epidermis [GO:0030280]; cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; negative regulation of epithelial cell proliferation [GO:0050680] GO:0005634; GO:0005829; GO:0005882; GO:0007010; GO:0009986; GO:0030280; GO:0030855; GO:0031424; GO:0045095; GO:0045109; GO:0045111; GO:0050680 structural constituent of skin epidermis [GO:0030280] AQYEEIAQR 0.94236 3.9155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9252 0 0 0 0 0 0 0 0 11.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4889 Q9BYR4 KRA43_HUMAN Keratin-associated protein 4-3 (Keratin-associated protein 4.3) (Ultrahigh sulfur keratin-associated protein 4.3) KRTAP4-3 KAP4.3 KRTAP4.3 Homo sapiens (Human) aging [GO:0007568]; hair cycle [GO:0042633] cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; aging [GO:0007568]; hair cycle [GO:0042633] GO:0005829; GO:0007568; GO:0042633; GO:0045095 CPFSCPTTCCRTTCFHPICCGSSCC 0.94236 4.1261 0 13.5344 0 0 0 0 0 0 11.1411 0 0 0 10.4298 12.5431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.445 12.6646 0 0 0 11.1626 11.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4478 0 0 0 0 0 0 0 10.2082 0 0 0 14.4075 0 0 12.7664 11.4386 14.4754 11.8367 11.6852 12.1625 0 0 11.1926 13.8932 0 0 14.8141 0 0 11.6136 11.2599 0 0 14.4075 0 13.248 12.4945 0 0 0 0 0 12.3485 13.4114 0 0 0 0 0 0 11.3676 12.3942 0 0 12.801 0 12.4926 11.5661 0 0 14.4495 0 0 12.7034 13.7999 0 0 0 0 0 9.89957 0 0 0 12.996 0 0 0 0 0 0 0 13.9707 0 0 0 11.4763 11.2516 0 0 0 12.1902 0 12.0901 0 11.8442 13.2715 0 0 0 10.796 0 11.7625 0 0 0 0 0 0 0 Q9ULP0 NDRG4_HUMAN "Protein NDRG4 (Brain development-related molecule 1) (N-myc downstream-regulated gene 4 protein) (Vascular smooth muscle cell-associated protein 8, SMAP-8)" NDRG4 BDM1 KIAA1180 Homo sapiens (Human) brain development [GO:0007420]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell migration involved in heart development [GO:0060973]; embryonic heart tube development [GO:0035050]; heart looping [GO:0001947]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron projection development [GO:0010976]; regulation of endocytic recycling [GO:2001135]; signal transduction [GO:0007165]; vesicle docking [GO:0048278]; visual learning [GO:0008542] basolateral plasma membrane [GO:0016323]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739] basolateral plasma membrane [GO:0016323]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; brain development [GO:0007420]; cardiac muscle cell proliferation [GO:0060038]; cell differentiation [GO:0030154]; cell migration involved in heart development [GO:0060973]; embryonic heart tube development [GO:0035050]; heart looping [GO:0001947]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron projection development [GO:0010976]; regulation of endocytic recycling [GO:2001135]; signal transduction [GO:0007165]; vesicle docking [GO:0048278]; visual learning [GO:0008542] GO:0001947; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0007165; GO:0007420; GO:0008542; GO:0010642; GO:0010976; GO:0014912; GO:0016323; GO:0030154; GO:0031253; GO:0035050; GO:0048278; GO:0048662; GO:0060038; GO:0060973; GO:0070374; GO:2001135 LSGGAVPSASMTRLAR 0.94236 1.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UF1 TSN33_HUMAN "Tetraspanin-33, Tspan-33 (Penumbra, hPen) (Proerythroblast new membrane)" TSPAN33 PEN Homo sapiens (Human) pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] adherens junction [GO:0005912]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197] adherens junction [GO:0005912]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] GO:0005788; GO:0005886; GO:0005887; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197 enzyme binding [GO:0019899] DWSQNMYFNCSEDNPSRER 0.94237 1.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2655 0 0 0 0 0 0 0 0 0 12.8805 0 0 0 0 0 0 11.4994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1189 0 0 0 15.836 0 0 0 0 12.0216 0 0 0 0 0 0 0 14.0375 0 0 0 0 0 14.7582 0 0 0 0 0 0 0 0 0 0 0 0 14.6774 14.5709 0 0 0 0 14.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6944 0 0 0 0 0 0 0 0 0 0 0 0 12.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2L4 TMM60_HUMAN Transmembrane protein 60 TMEM60 C7orf35 DC32 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 APWNWFLIFIPVWIFDTILLVLLIVKMAGR 0.94239 2.5149 0 0 0 0 0 0 0 0 0 0 10.0835 0 0 0 0 0 12.9817 0 13.2529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2347 0 0 0 0 0 0 0 0 0 13.5406 0 0 0 0 13.2512 0 0 0 0 0 0 0 0 0 0 0 13.9574 0 0 0 0 0 0 0 0 0 13.8106 0 0 14.7372 0 0 0 14.0274 14.5567 0 0 0 0 0 0 0 0 0 0 13.5205 0 0 12.0617 14.1818 13.9775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4215 0 Q5TAG4 NBPFC_HUMAN Neuroblastoma breakpoint family member 12 (Chromosome 1 amplified sequence 1) NBPF12 COAS1 KIAA1245 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DQEEEEDQGPPCPR 0.9424 0.90097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0486 19.8835 0 0 0 19.3835 0 0 0 0 0 0 0 19.7399 19.5695 19.704 0 0 0 0 0 0 19.1707 18.9229 0 0 0 18.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3728 0 0 0 0 19.1972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q95460 HMR1_HUMAN "Major histocompatibility complex class I-related gene protein, MHC class I-related gene protein (Class I histocompatibility antigen-like protein)" MR1 Homo sapiens (Human) antigen processing and presentation of exogenous antigen [GO:0019884]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; T cell differentiation in thymus [GO:0033077] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; MHC class I protein complex [GO:0042612]; plasma membrane [GO:0005886] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; MHC class I protein complex [GO:0042612]; plasma membrane [GO:0005886]; beta-2-microglobulin binding [GO:0030881]; MHC class I receptor activity [GO:0032393]; T cell receptor binding [GO:0042608]; antigen processing and presentation of exogenous antigen [GO:0019884]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity directed against tumor cell target [GO:0002854]; T cell differentiation in thymus [GO:0033077] GO:0000139; GO:0002474; GO:0002854; GO:0005615; GO:0005783; GO:0005789; GO:0005886; GO:0006955; GO:0009897; GO:0016021; GO:0019884; GO:0030881; GO:0031901; GO:0031902; GO:0032393; GO:0033077; GO:0042608; GO:0042612; GO:0045087; GO:0050829; GO:0050830 beta-2-microglobulin binding [GO:0030881]; MHC class I receptor activity [GO:0032393]; T cell receptor binding [GO:0042608] AVSGSIVLVIVLAGVGVLVWR 0.94243 2.5582 0 0 0 0 0 0 0 0 13.6902 13.4511 13.5116 16.8235 16.6718 13.5503 0 12.4517 0 0 0 0 0 0 0 0 0 0 0 12.5747 12.4405 12.2547 12.2784 13.8359 12.4959 12.1956 13.2945 12.6315 13.3361 13.4282 14.3786 12.1124 13.2068 0 14.1489 12.5036 12.2894 0 12.269 12.3321 12.1805 16.4865 13.8586 0 0 0 0 16.9591 13.3181 14.0047 11.7882 11.9336 12.8661 12.4414 12.5621 0 11.748 0 0 10.9749 0 0 0 0 0 0 0 0 11.4051 0 11.6193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.634 0 11.6908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1548 0 0 15.8641 0 0 0 0 0 0 0 0 0 15.6898 15.8409 18.9167 15.4969 15.3995 14.9109 15.7986 14.9088 14.6074 15.7564 15.6185 16.1109 15.5626 0 0 0 0 0 0 0 14.418 0 0 Q8NGI1 O56B2_HUMAN Putative olfactory receptor 56B2 OR56B2P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] HYCSQNQIEHCLCSNLGVTSLSCDDR 0.94245 2.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5296 0 0 0 0 0 0 0 0 0 0 10.525 0 0 0 0 0 0 0 0 0 14.5601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGL9 OR4CG_HUMAN Olfactory receptor 4C16 (Olfactory receptor OR11-135) OR4C16 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IVFVIFLR 0.94246 1.7506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4272 0 0 0 0 0 13.2504 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7005 0 0 0 11.9239 0 0 0 0 0 0 14.2208 0 0 0 0 0 0 0 0 0 13.2821 13.7142 0 0 0 0 0 0 0 0 13.7534 0 0 0 0 0 0 0 0 0 0 12.8257 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3271 0 0 10.2695 12.4857 0 0 0 0 13.3715 0 0 0 0 0 12.0494 0 11.4986 0 0 0 0 0 0 0 0 0 0 0 11.847 0 0 0 11.8867 0 0 11.5175 O15270 SPTC2_HUMAN "Serine palmitoyltransferase 2, EC 2.3.1.50 (Long chain base biosynthesis protein 2, LCB 2) (Long chain base biosynthesis protein 2a, LCB2a) (Serine-palmitoyl-CoA transferase 2, SPT 2)" SPTLC2 KIAA0526 LCB2 Homo sapiens (Human) adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] GO:0004758; GO:0005789; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504 pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] DFVSLYQDFENFYTR 0.94247 2.5324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8709 10.3677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8084 0 0 0 11.2753 0 0 0 0 0 0 0 0 0 0 0 0 11.1528 12.6229 0 0 0 0 0 0 0 0 0 13.3238 0 0 0 0 0 12.8964 0 0 0 10.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.269 0 0 0 0 0 13.3787 0 11.7619 0 0 0 12.87 0 0 0 0 0 0 0 0 0 Q9NSY0 NRBP2_HUMAN "Nuclear receptor-binding protein 2 (Transformation-related gene 16 protein, TRG-16)" NRBP2 PP9320 TRG16 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular signal transduction [GO:0035556]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; endomembrane system [GO:0012505] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular signal transduction [GO:0035556]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006888; GO:0012505; GO:0016242; GO:0030182; GO:0035556; GO:0043524 ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] AMDLHAVLAELPRPRR 0.94247 0.89107 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6088 0 12.9879 0 0 0 0 0 0 12.4805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2958 0 0 0 15.6968 15.3052 0 0 14.946 14.7902 16.3582 15.7356 15.5986 14.984 15.6496 15.8054 15.427 0 15.3188 15.5803 14.7464 14.0227 13.9295 0 0 0 14.126 14.2252 0 0 0 13.7479 0 0 14.4781 0 0 0 0 0 0 0 0 13.1626 0 13.7062 13.4684 0 14.6732 12.2093 0 0 13.202 0 12.9974 0 0 0 0 0 0 0 0 0 0 0 0 13.3346 13.2672 0 13.6473 0 0 0 9.93261 0 0 0 0 11.601 0 0 0 0 0 0 0 0 0 0 13.5602 0 0 0 0 0 0 0 0 0 0 0 Q02978 M2OM_HUMAN "Mitochondrial 2-oxoglutarate/malate carrier protein, OGCP, alpha-oxoglutarate carrier (Solute carrier family 25 member 11, SLC25A11)" SLC25A11 SLC20A4 Homo sapiens (Human) malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]; malate transmembrane transport [GO:0071423]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005887; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015367; GO:0015709; GO:0015729; GO:0022857; GO:0035435; GO:0071422; GO:0071423 antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857] AEGLRGIYTGLSAGLLR 0.94248 2.6668 0 0 0 11.085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1817 0 0 0 0 0 0 0 13.9084 0 14.2526 0 0 0 0 14.5436 0 10.8969 13.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2009 0 0 P12110 CO6A2_HUMAN Collagen alpha-2(VI) chain COL6A2 Homo sapiens (Human) cell adhesion [GO:0007155]; response to glucose [GO:0009749] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; response to glucose [GO:0009749] GO:0005518; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0007155; GO:0009749; GO:0030020; GO:0032991; GO:0042383; GO:0062023; GO:0070062; GO:1903561 collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] ETCGCCDCEK 0.94251 0.88516 0 0 0 0 0 0 0 0 0 0 12.5341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16662 UD2B7_HUMAN "UDP-glucuronosyltransferase 2B7, UDPGT 2B7, UGT2B7, EC 2.4.1.17 (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9, UDPGT 2B9) (UDPGTh-2)" UGT2B7 UGTB2B9 Homo sapiens (Human) androgen metabolic process [GO:0008209]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; androgen metabolic process [GO:0008209]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629] GO:0005789; GO:0006629; GO:0008209; GO:0008210; GO:0015020; GO:0016020; GO:0016021; GO:0052695 glucuronosyltransferase activity [GO:0015020] CCLFCFWKFAR 0.94251 1.7414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9539 0 13.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8532 0 0 0 0 0 0 0 0 0 15.3629 0 0 0 0 0 0 15.1178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6048 0 0 0 0 0 0 0 A0A286YF77 SCGR6_HUMAN Small cysteine and glycine repeat-containing protein 6 (Keratin-associated protein 28-6) SCYGR6 KRTAP28-6 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CYRVGCCSSCCPCCR 0.94252 2.5305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6866 0 0 0 9.88798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3058 0 0 0 0 0 0 0 0 0 0 13.4959 14.1426 0 0 0 0 0 0 0 9.72554 0 0 0 0 0 0 0 12.496 14.3318 0 0 0 13.0963 0 11.0089 0 0 0 0 0 10.9245 0 0 0 0 12.0768 0 14.6927 0 0 0 0 0 0 0 11.6388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2772 0 0 0 0 10.5187 0 11.1467 0 0 13.54 0 0 0 12.0926 0 12.1564 0 0 0 0 0 0 13.5191 0 0 0 0 0 0 12.119 0 0 0 0 10.2852 11.1727 0 0 0 Q92611 EDEM1_HUMAN ER degradation-enhancing alpha-mannosidase-like protein 1 EDEM1 EDEM KIAA0212 Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein targeting to ER [GO:0045047]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]" aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176] "aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein targeting to ER [GO:0045047]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]" GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006986; GO:0016235; GO:0030176; GO:0030433; GO:0036510; GO:0044322; GO:0045047; GO:0051787; GO:0097466; GO:1904154; GO:1904380; GO:1904382 "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]" ALVLGLVLLR 0.94255 2.5112 0 0 0 0 0 0 10.2377 0 0 12.0165 12.1069 0 11.75 11.4496 10.5094 11.776 12.9777 11.4012 0 12.1609 12.878 0 12.36 0 0 12.3619 12.0681 12.3402 11.6356 12.2044 0 12.5641 0 13.544 0 0 14.3444 0 0 13.4278 0 0 12.09 0 11.4569 0 0 0 10.9498 0 0 0 0 0 0 10.3996 0 0 0 0 0 0 0 0 0 0 0 13.4293 13.9432 0 13.1773 13.6347 0 0 0 0 0 0 0 0 12.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7874 0 0 0 0 0 0 0 0 12.6307 0 0 0 0 0 0 0 0 0 12.8086 14.2901 0 12.3504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5024 0 0 0 0 11.7474 0 0 0 0 0 0 0 O60656 UD19_HUMAN "UDP-glucuronosyltransferase 1A9, UGT1A9, EC 2.4.1.17 (UDP-glucuronosyltransferase 1-9, UDPGT 1-9, UGT1*9, UGT1-09, UGT1.9) (UDP-glucuronosyltransferase 1-I, UGT-1I, UGT1I) (lugP4)" UGT1A9 GNT1 UGT1 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] GO:0001889; GO:0001972; GO:0004857; GO:0005783; GO:0005789; GO:0006805; GO:0015020; GO:0016021; GO:0019899; GO:0042573; GO:0042803; GO:0045922; GO:0046982; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:1904224; GO:2001030 enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972] ERVRNHIMHLEEHLLCHR 0.94256 0.89586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4567 0 0 0 0 11.147 0 0 0 0 0 0 0 0 0 0 0 11.9811 0 0 0 0 11.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6597 0 0 0 0 12.3295 0 0 0 0 0 0 0 0 12.3251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1069 0 18.4679 Q9H3V2 MS4A5_HUMAN Membrane-spanning 4-domains subfamily A member 5 (CD20 antigen-like 2) (Testis-expressed transmembrane protein 4) MS4A5 CD20L2 TETM4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ILGTIQILFGIMTFSFGVIFLFTLLKPYPR 0.94256 1.731 0 0 0 0 10.8097 0 0 13.4366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2802 0 0 0 0 0 0 12.0061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9839 0 0 0 0 0 0 0 0 0 15.5803 12.2786 0 0 0 0 0 0 0 15.8454 13.2097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7299 0 0 0 0 0 0 0 0 P52758 RIDA_HUMAN "2-iminobutanoate/2-iminopropanoate deaminase, EC 3.5.99.10 (14.5 kDa translational inhibitor protein, hp14.5, p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog)" RIDA HRSP12 Homo sapiens (Human) brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; 2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074]" GO:0001822; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0006629; GO:0007420; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0030324; GO:0033993; GO:0036041; GO:0042802; GO:0046914; GO:0050680; GO:0061157; GO:0070062; GO:0070314; GO:0120242; GO:0120243; GO:1901565; GO:1902074 "2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; endoribonuclease activity, producing 3'-phosphomonoesters [GO:0016892]; identical protein binding [GO:0042802]; long-chain fatty acid binding [GO:0036041]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]" RVISTAKAPGAIGPYSQAVLVDR 0.94257 1.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4093 0 0 0 14.9744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6M3 MILR1_HUMAN "Allergin-1 (Allergy inhibitory receptor 1) (Mast cell antigen 32, MCA-32) (Mast cell immunoglobulin-like receptor 1)" MILR1 C17orf60 MCA32 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; mast cell degranulation [GO:0043303]; negative regulation of mast cell activation [GO:0033004] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; mast cell degranulation [GO:0043303]; negative regulation of mast cell activation [GO:0033004] GO:0004888; GO:0005887; GO:0007166; GO:0033004; GO:0043303; GO:0098742 transmembrane signaling receptor activity [GO:0004888] EQEACDSYK 0.94257 2.418 0 0 0 0 0 0 0 0 0 0 0 10.7293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7062 0 0 0 0 11.8898 0 0 0 0 0 0 0 0 0 0 13.7204 0 12.5843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3691 0 0 0 0 0 0 0 0 0 12.6437 0 13.5905 0 0 0 0 0 0 12.5944 0 0 0 11.5366 10.7722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV15 T255B_HUMAN Transmembrane protein 255B (Protein FAM70B) TMEM255B FAM70B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 KKTSLWFVGSLLLVSVLIVTVGLAATTR 0.94257 2.5282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14004 CDK13_HUMAN "Cyclin-dependent kinase 13, EC 2.7.11.22, EC 2.7.11.23 (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13, hCDK13) (Cholinesterase-related cell division controller)" CDK13 CDC2L CDC2L5 CHED KIAA1791 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of signal transduction [GO:0009966]; transcription elongation from RNA polymerase II promoter [GO:0006368]" cyclin K-CDK13 complex [GO:0002945]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cyclin K-CDK13 complex [GO:0002945]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of signal transduction [GO:0009966]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000307; GO:0000380; GO:0002945; GO:0003723; GO:0004672; GO:0004693; GO:0005524; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006368; GO:0006468; GO:0008024; GO:0008353; GO:0009966; GO:0016607; GO:0019901; GO:0019908; GO:0030097; GO:0030332; GO:0032968; GO:0070816; GO:0106310; GO:1904813; GO:2000737 ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] AAEAAAK 0.94259 3.4747 0 0 0 0 0 0 0 0 13.8134 0 13.2573 0 13.497 0 0 0 0 11.8048 10.1193 0 0 0 0 0 0 0 0 11.7777 0 13.3869 13.4694 13.7816 14.0021 14.9134 14.1426 14.2496 13.7466 15.0914 13.8472 0 0 0 13.3943 0 0 13.9203 0 0 13.3697 13.8765 14.7029 12.9071 12.8466 13.7426 13.7676 12.82 12.4567 0 0 0 0 0 10.98 0 10.7883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4017 12.3778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0796 0 0 0 0 0 0 0 0 0 12.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8045 0 0 0 15.0148 0 0 0 0 14.1993 15.1204 16.1486 14.9966 0 0 0 13.6102 14.7299 13.559 14.8577 0 15.4944 0 14.6496 0 15.2994 14.188 0 10.8288 0 15.3831 0 0 Q8IV01 SYT12_HUMAN "Synaptotagmin-12 (Synaptotagmin XII, SytXII)" SYT12 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; long-term synaptic potentiation [GO:0060291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; spontaneous exocytosis of neurotransmitter [GO:0048792]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; long-term synaptic potentiation [GO:0060291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of neurotransmitter secretion [GO:0046928]; spontaneous exocytosis of neurotransmitter [GO:0048792]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0046928; GO:0048792; GO:0060291; GO:0070161; GO:0070382; GO:0071277; GO:0098686 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] ELDLAPYGTLR 0.94259 2.5537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0124 0 0 0 0 15.0527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BN6 F149B_HUMAN Primary cilium assembly protein FAM149B1 FAM149B1 KIAA0974 Homo sapiens (Human) cilium assembly [GO:0060271]; protein localization to cilium [GO:0061512] cilium [GO:0005929] cilium [GO:0005929]; cilium assembly [GO:0060271]; protein localization to cilium [GO:0061512] GO:0005929; GO:0060271; GO:0061512 DSTIFGIRGKK 0.9426 2.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0898 0 0 0 0 0 0 0 0 0 0 0 0 13.919 0 0 0 0 13.7465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TF58 IFFO2_HUMAN Intermediate filament family orphan 2 IFFO2 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 AELVVFK 0.94261 3.3749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1094 0 0 0 14.1769 0 0 0 0 0 13.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3294 0 A0A0C4DH27 TRGV8_HUMAN T cell receptor gamma variable 8 TRGV8 TCRGV8 Homo sapiens (Human) adaptive immune response [GO:0002250]; innate immune response [GO:0045087] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087] GO:0002250; GO:0009897; GO:0042101; GO:0045087 DSGVYYCATWDR 0.94262 1.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6L8G9 KRA56_HUMAN Keratin-associated protein 5-6 (Keratin-associated protein 5.6) (Ultrahigh sulfur keratin-associated protein 5.6) KRTAP5-6 KAP5.6 KRTAP5.6 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GCCGSCGGSKGGCGSCGGSKGGCGSCGCSQCSCCK 0.94262 2.4178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.567 0 0 0 12.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8949 0 0 0 0 10.8963 0 0 11.246 0 0 0 0 12.9698 0 0 0 0 0 13.4494 0 0 0 0 0 0 0 0 11.3695 12.7531 0 0 0 0 0 0 12.2895 0 0 0 0 0 0 0 11.1918 9.88258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1867 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0906 0 0 0 0 0 0 0 0 0 0 0 12.4711 0 0 12.4584 0 0 0 0 0 0 Q9BZM2 PA2GF_HUMAN "Group IIF secretory phospholipase A2, GIIF sPLA2, sPLA2-IIF, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase 2F)" PLA2G2F Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; innate immune response [GO:0045087]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644] cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; innate immune response [GO:0045087]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644] GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005829; GO:0005886; GO:0006644; GO:0016042; GO:0019369; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0042130; GO:0045087; GO:0047498; GO:0050482 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543] KFFTVAILAGSVLSTAHGSLLNLK 0.94264 0.90118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1965 0 11.9632 0 0 0 0 10.9462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19086 GNAZ_HUMAN Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha) GNAZ Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled serotonin receptor signaling pathway [GO:0098664] cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; heterotrimeric G-protein complex [GO:0005834]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; heterotrimeric G-protein complex [GO:0005834]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled serotonin receptor signaling pathway [GO:0098664] GO:0001664; GO:0003924; GO:0005525; GO:0005635; GO:0005783; GO:0005829; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007193; GO:0030425; GO:0031683; GO:0031821; GO:0044297; GO:0046872; GO:0098664 G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] EIKLLLLGTSNSGK 0.94265 2.5532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1213 0 0 14.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.363 0 0 0 0 0 0 0 14.6192 0 0 0 0 0 0 0 0 0 13.9409 0 0 0 0 0 0 0 11.4852 0 11.8322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3B7S5 SMI21_HUMAN Small integral membrane protein 21 SMIM21 C18orf62 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FFTLLVLFHVMVLLRNHSRIQGVSEDWK 0.94266 2.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5616 14.7944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZA9 IRGQ_HUMAN Immunity-related GTPase family Q protein IRGQ IRGQ1 FKSG27 Homo sapiens (Human) GTP binding [GO:0005525] GO:0005525 GTP binding [GO:0005525] ADAEAVLAPPEPAQ 0.9427 2.5496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3191 0 0 0 0 0 0 0 0 0 0 0 0 14.8345 13.5683 0 0 0 0 0 0 0 0 0 14.0928 13.8806 0 0 0 13.5221 13.3522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWR8 MCUB_HUMAN "Calcium uniporter regulatory subunit MCUb, mitochondrial, MCUb (Coiled-coil domain-containing protein 109B)" MCUB CCDC109B Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851] calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246] calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]; calcium channel inhibitor activity [GO:0019855]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851] GO:0005654; GO:0005739; GO:0005743; GO:0006851; GO:0019855; GO:0031224; GO:0031305; GO:0034704; GO:0036444; GO:0043231; GO:0051560; GO:1990246 calcium channel inhibitor activity [GO:0019855] EHHLLEKIDHLK 0.9427 3.4739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1531 0 0 0 12.914 12.7733 0 0 0 0 0 0 0 0 0 0 12.8282 12.9724 0 0 0 0 13.2602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.887 0 12.2561 0 0 0 0 0 0 12.0209 0 0 0 12.966 0 0 0 0 0 0 14.0371 13.6996 13.3163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.867 0 0 0 0 0 12.6155 0 Q6PP77 XKR2_HUMAN "XK-related protein 2 (Membrane protein XPLAC) (X Kell blood group-related, X-linked)" XKRX XKR2 XPLAC XRG2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 AVPFLVLNFLIILFEPWIK 0.94271 4.9986 0 0 0 12.4041 0 0 0 0 13.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9712 0 13.2405 0 0 0 0 0 0 13.4018 0 0 0 0 13.6643 0 0 0 12.5706 0 0 0 0 0 0 0 12.9529 0 0 13.9751 0 13.5043 11.9546 13.8621 0 0 11.8431 10.783 12.9599 12.3992 0 0 0 0 0 0 0 12.5136 0 0 0 0 15.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9767 0 0 0 0 0 0 0 0 0 0 0 0 10.0445 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7247 0 0 14.6187 H3BTG2 TEX46_HUMAN Testis-expressed protein 46 TEX46 C1orf234 Homo sapiens (Human) LTLPEPQQDEILQRLLFSEMKMK 0.94274 1.7543 0 0 0 0 0 0 0 0 13.0229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1106 0 14.2069 0 0 0 13.7844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.947 0 13.4761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L92 SNX27_HUMAN Sorting nexin-27 SNX27 KIAA0488 My014 Homo sapiens (Human) endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; establishment of natural killer cell polarity [GO:0001770]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; establishment of natural killer cell polarity [GO:0001770]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165] GO:0001770; GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0031901; GO:0032266; GO:0032456; GO:0035091 phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] AEEKSYQLQKLYEQR 0.94274 0.89077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3914 0 0 0 0 0 0 0 0 0 12.1381 0 0 0 0 10.6647 0 0 13.1256 0 0 12.9045 0 0 0 11.4815 0 0 14.6756 0 0 0 0 0 0 0 0 0 0 0 13.4451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4862 A1L162 ERIC2_HUMAN Glutamate-rich protein 2 ERICH2 Homo sapiens (Human) GESDEELSDESSDEGEDGS 0.9428 3.4695 0 11.1517 0 11.301 0 10.9039 0 0 11.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1561 0 0 0 0 0 0 0 0 11.3348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9919 0 0 0 0 0 0 0 10.7648 0 0 0 0 0 0 0 0 12.3241 13.6591 0 0 0 0 0 0 0 0 10.1055 0 0 0 0 0 0 0 11.1928 10.8703 0 0 0 0 0 0 11.1186 0 0 0 0 0 0 0 0 0 11.9441 0 0 0 0 0 12.0824 0 11.1904 0 0 0 0 0 0 12.0127 0 0 11.1621 0 0 0 0 0 0 0 14.433 0 0 0 0 0 0 0 0 0 0 0 14.1361 14.3628 0 0 0 11.5903 0 0 0 10.8842 0 Q8TF08 CX7B2_HUMAN "Cytochrome c oxidase subunit 7B2, mitochondrial (Cytochrome c oxidase polypeptide VIIb2)" COX7B2 Homo sapiens (Human) oxidative phosphorylation [GO:0006119] integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277] integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; oxidative phosphorylation [GO:0006119] GO:0004129; GO:0005739; GO:0005746; GO:0006119; GO:0016021; GO:0045277 cytochrome-c oxidase activity [GO:0004129] MFPLARNALSSLKIQSILQSMAR 0.9428 1.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95258 UCP5_HUMAN "Brain mitochondrial carrier protein 1, BMCP-1 (Mitochondrial uncoupling protein 5, UCP 5) (Solute carrier family 25 member 14)" SLC25A14 BMCP1 UCP5 UNQ791/PRO1682 Homo sapiens (Human) aerobic respiration [GO:0009060]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]; aerobic respiration [GO:0009060]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] GO:0005739; GO:0005743; GO:0005887; GO:0006839; GO:0008272; GO:0009060; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0022857; GO:0035435; GO:0071422; GO:0071423 antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857] FATAAVIVSGHQKSTTVSHEMSGLNWK 0.94291 3.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.666 0 0 0 0 0 0 0 10.3406 0 0 0 0 0 0 0 0 0 0 11.3592 0 0 0 16.2924 0 0 0 0 11.3508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0769 0 0 0 0 0 11.9243 11.1265 0 0 0 14.7282 0 0 0 0 0 0 0 0 0 0 0 0 11.0937 0 0 0 0 0 0 0 12.5892 0 0 0 11.2466 0 0 13.8565 0 0 0 12.7235 0 0 0 0 0 0 0 Q96KN2 CNDP1_HUMAN "Beta-Ala-His dipeptidase, EC 3.4.13.20 (CNDP dipeptidase 1) (Carnosine dipeptidase 1) (Glutamate carboxypeptidase-like protein 2) (Serum carnosinase)" CNDP1 CN1 CPGL2 UNQ1915/PRO4380 Homo sapiens (Human) proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268] cytosol [GO:0005829]; extracellular region [GO:0005576] cytosol [GO:0005829]; extracellular region [GO:0005576]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268] GO:0004180; GO:0005576; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0032268; GO:0046872; GO:0070573 carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233] LGRMAASLLAVLLLLLER 0.94296 1.7418 0 0 13.8033 0 13.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0965 0 0 13.1842 13.3537 13.9451 12.3891 0 0 0 13.1373 0 0 12.6009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9182 0 0 0 0 0 12.1848 0 0 0 0 0 Q9NXS3 KLH28_HUMAN Kelch-like protein 28 (BTB/POZ domain-containing protein 5) KLHL28 BTBD5 Homo sapiens (Human) FAETYGCR 0.94297 3.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4064 0 0 0 0 14.0739 0 13.6229 0 0 0 0 0 12.9458 0 0 0 0 0 12.4327 0 0 0 0 0 0 13.0009 0 11.8629 0 0 0 9.67205 0 0 0 12.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1295 10.2321 0 0 0 12.5336 12.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95445 APOM_HUMAN "Apolipoprotein M, Apo-M, ApoM (Protein G3a)" APOM G3A NG20 HSPC336 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of plasma lipoprotein oxidation [GO:0034445]; reverse cholesterol transport [GO:0043691] discoidal high-density lipoprotein particle [GO:0034365]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361] discoidal high-density lipoprotein particle [GO:0034365]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; antioxidant activity [GO:0016209]; lipid transporter activity [GO:0005319]; phospholipid binding [GO:0005543]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of plasma lipoprotein oxidation [GO:0034445]; reverse cholesterol transport [GO:0043691] GO:0005319; GO:0005543; GO:0005576; GO:0016209; GO:0033344; GO:0034361; GO:0034362; GO:0034364; GO:0034365; GO:0034366; GO:0034375; GO:0034380; GO:0034384; GO:0034445; GO:0042157; GO:0042632; GO:0043691 antioxidant activity [GO:0016209]; lipid transporter activity [GO:0005319]; phospholipid binding [GO:0005543] ATIRMKDGLCVPR 0.94299 0.88534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L0X0 TRIL_HUMAN TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644) TRIL KIAA0644 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; lipopolysaccharide binding [GO:0001530]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of cytokine production involved in immune response [GO:0002718]; toll-like receptor 4 signaling pathway [GO:0034142] GO:0001530; GO:0002718; GO:0005615; GO:0006954; GO:0031012; GO:0034142; GO:0045087; GO:0046696 lipopolysaccharide binding [GO:0001530] FLGKNAFAQLGKLR 0.94301 2.6979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3183 0 0 12.0106 0 11.3712 0 0 0 0 0 0 0 0 0 0 0 15.1424 14.159 0 0 0 0 0 0 0 0 0 0 14.1192 14.9785 0 0 0 0 0 0 0 0 0 0 14.2362 0 0 0 13.9949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0783 0 0 0 0 0 0 Q9UNS2 CSN3_HUMAN "COP9 signalosome complex subunit 3, SGN3, Signalosome subunit 3 (JAB1-containing signalosome subunit 3)" COPS3 CSN3 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902162]; regulation of protein neddylation [GO:2000434]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; in utero embryonic development [GO:0001701]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902162]; regulation of protein neddylation [GO:2000434]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000338; GO:0001701; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0007165; GO:0008180; GO:0009416; GO:0045116; GO:0048471; GO:1902162; GO:2000434 HFLCYYYYGGMIYTGLKNFER 0.94301 3.363 0 0 0 0 0 0 0 0 12.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4886 13.1081 0 0 0 0 0 0 0 0 13.7619 0 0 10.3052 15.9074 11.725 0 0 0 0 0 0 10.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0408 14.4431 13.6382 12.6177 0 0 0 0 0 0 0 0 0 0 0 10.9683 0 0 0 0 0 0 0 0 0 0 0 0 12.4103 14.4928 0 0 0 0 0 10.4069 0 0 0 0 11.071 11.8793 0 0 0 0 0 0 0 0 0 0 12.4577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4213 0 0 0 0 0 0 0 0 14.5989 0 0 0 0 0 13.7713 0 0 0 0 0 0 0 0 11.4921 0 0 0 0 0 0 15.5631 Q9BS18 APC13_HUMAN "Anaphase-promoting complex subunit 13, APC13 (Cyclosome subunit 13)" ANAPC13 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680] anaphase-promoting complex [GO:0005680]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005680; GO:0007049; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0070979 ILDLIDDAWREDK 0.94305 0.88332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D0Y5 CG077_HUMAN Uncharacterized protein C7orf77 C7orf77 Homo sapiens (Human) TTVKEQNACLTHPDRSAMAGLLL 0.94306 1.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75154 RFIP3_HUMAN "Rab11 family-interacting protein 3, FIP3-Rab11, Rab11-FIP3 (Arfophilin-1) (EF hands-containing Rab-interacting protein, Eferin) (MU-MB-17.148)" RAB11FIP3 ARFO1 KIAA0665 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; negative regulation of adiponectin secretion [GO:0070164]; protein localization to cilium [GO:0061512]; regulation of cytokinesis [GO:0032465]; vesicle-mediated transport [GO:0016192] GO:0005509; GO:0005654; GO:0005739; GO:0005768; GO:0005813; GO:0005829; GO:0007049; GO:0016192; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0034451; GO:0042803; GO:0043231; GO:0045171; GO:0051301; GO:0051959; GO:0055037; GO:0055038; GO:0061512; GO:0070164 calcium ion binding [GO:0005509]; dynein light intermediate chain binding [GO:0051959]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] ACEMVLEETRR 0.94307 2.5396 0 0 0 0 0 0 0 0 11.2772 0 10.9537 0 0 0 0 0 0 0 0 0 11.4153 0 0 0 0 0 0 0 0 0 9.38502 0 0 0 0 0 0 0 0 0 0 0 0 13.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3918 0 0 0 0 14.352 0 0 12.3179 0 12.7012 12.7356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QR1 SG3A1_HUMAN "Secretoglobin family 3A member 1 (Cytokine HIN-1) (High in normal 1) (Pneumo secretory protein 2, PnSP-2) (Uteroglobin-related protein 2)" SCGB3A1 HIN1 PNSP2 UGRP2 UNQ629/PRO1245 Homo sapiens (Human) negative regulation of cell growth [GO:0030308]; positive regulation of myoblast fusion [GO:1901741]; regulation of cell population proliferation [GO:0042127] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; negative regulation of cell growth [GO:0030308]; positive regulation of myoblast fusion [GO:1901741]; regulation of cell population proliferation [GO:0042127] GO:0005125; GO:0005615; GO:0030308; GO:0042127; GO:0070062; GO:1901741 cytokine activity [GO:0005125] ALKALLGALTVFG 0.94309 0.88332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28223 5HT2A_HUMAN "5-hydroxytryptamine receptor 2A, 5-HT-2, 5-HT-2A (Serotonin receptor 2A)" HTR2A HTR2 Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; aging [GO:0007568]; artery smooth muscle contraction [GO:0014824]; behavioral response to cocaine [GO:0048148]; cell death [GO:0008219]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; glycolytic process [GO:0006096]; memory [GO:0007613]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cytoskeleton [GO:0044380]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; serotonin receptor signaling pathway [GO:0007210]; sleep [GO:0030431]; temperature homeostasis [GO:0001659]; urinary bladder smooth muscle contraction [GO:0014832]" anchoring junction [GO:0070161]; axon [GO:0030424]; caveola [GO:0005901]; cell body fiber [GO:0070852]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; G protein-coupled serotonin receptor complex [GO:0098666]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] "anchoring junction [GO:0070161]; axon [GO:0030424]; caveola [GO:0005901]; cell body fiber [GO:0070852]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; G protein-coupled serotonin receptor complex [GO:0098666]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; serotonin binding [GO:0051378]; virus receptor activity [GO:0001618]; activation of phospholipase C activity [GO:0007202]; aging [GO:0007568]; artery smooth muscle contraction [GO:0014824]; behavioral response to cocaine [GO:0048148]; cell death [GO:0008219]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; glycolytic process [GO:0006096]; memory [GO:0007613]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cytoskeleton [GO:0044380]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; serotonin receptor signaling pathway [GO:0007210]; sleep [GO:0030431]; temperature homeostasis [GO:0001659]; urinary bladder smooth muscle contraction [GO:0014832]" GO:0001587; GO:0001618; GO:0001659; GO:0004993; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006096; GO:0006874; GO:0007187; GO:0007200; GO:0007202; GO:0007204; GO:0007208; GO:0007210; GO:0007268; GO:0007568; GO:0007613; GO:0008219; GO:0008284; GO:0009410; GO:0010513; GO:0014059; GO:0014065; GO:0014824; GO:0014832; GO:0018108; GO:0030424; GO:0030425; GO:0030431; GO:0030594; GO:0031410; GO:0042802; GO:0043025; GO:0043198; GO:0043267; GO:0043406; GO:0044380; GO:0044877; GO:0045600; GO:0045821; GO:0045907; GO:0048148; GO:0050731; GO:0050965; GO:0050966; GO:0051209; GO:0051378; GO:0051967; GO:0070161; GO:0070374; GO:0070852; GO:0071886; GO:0098664; GO:0098666; GO:0098978; GO:0099055; GO:0099056; GO:2000300 "1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; serotonin binding [GO:0051378]; virus receptor activity [GO:0001618]" KPLQLILVNTIPALAYK 0.94312 2.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3741 0 0 0 0 0 0 0 16.3895 0 12.5785 0 0 0 0 11.8269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4834 12.142 0 0 0 0 0 0 0 0 0 0 0 10.7967 0 0 12.9304 0 0 0 0 0 0 0 0 0 0 0 0 12.6823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6091 0 0 0 Q7Z3J2 VP35L_HUMAN VPS35 endosomal protein-sorting factor-like (Esophageal cancer-associated protein) VPS35L C16orf62 101F10.2 Homo sapiens (Human) endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] GO:0005768; GO:0005886; GO:0006893; GO:0015031; GO:0016021; GO:0032456; GO:0101003 AYLCRVGMEVAPHLK 0.94313 3.8301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1647 0 0 0 11.9264 0 0 10.7238 12.4225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7571 0 0 0 0 15.6247 0 15.6105 0 0 0 0 0 0 16.0937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8022 0 0 0 11.9645 0 0 0 0 0 0 0 13.4335 0 0 0 0 0 0 0 0 0 0 0 0 12.6989 0 0 0 13.1394 11.8262 0 0 0 0 0 0 0 0 0 13.2094 0 0 0 0 0 0 11.8429 12.8819 12.5488 0 11.3288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6157 0 0 0 0 14.0841 0 0 0 0 0 0 0 0 13.0734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7975 17.6089 Q6UX15 LAYN_HUMAN Layilin LAYN UNQ208/PRO234 Homo sapiens (Human) cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; ruffle [GO:0001726] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; ruffle [GO:0001726]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540] GO:0001726; GO:0005540; GO:0005925; GO:0009986; GO:0016021; GO:0030246 carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540] CNMKNNFICKYSDEK 0.94316 1.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9466 0 0 0 0 0 0 0 0 10.4974 0 0 0 0 0 0 0 0 0 12.761 13.2815 0 0 0 0 0 0 0 0 0 11.8076 0 0 0 0 0 0 0 0 0 13.5738 0 0 0 0 0 13.4051 0 0 13.3089 13.5111 0 0 0 14.5079 0 0 13.3092 0 0 0 0 0 0 13.6741 13.2706 0 0 0 0 0 14.1843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0192 0 0 0 0 11.8297 0 0 0 0 0 0 0 0 0 0 0 0 13.5794 0 0 0 13.774 0 0 0 0 0 0 11.431 0 13.1351 0 0 0 0 0 13.8675 0 0 0 0 0 0 0 0 0 13.2749 0 0 0 0 13.2598 0 0 0 0 0 0 0 0 0 13.4467 0 0 0 0 0 A2VDF0 FUCM_HUMAN "Fucose mutarotase, EC 5.1.3.29" FUOM C10orf125 Homo sapiens (Human) fucose metabolic process [GO:0006004]; fucosylation [GO:0036065] cytosol [GO:0005829] "cytosol [GO:0005829]; fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]" GO:0005829; GO:0006004; GO:0016857; GO:0036065; GO:0036373; GO:0042806 "fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]" AFAVVATGETALYGNLILRKGVLALNPLL 0.94321 3.8931 0 11.0858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2837 0 0 0 0 13.0265 0 0 13.6952 0 0 0 0 0 0 0 0 0 11.7026 0 0 0 0 0 0 0 0 0 12.546 0 0 0 0 0 0 0 0 0 0 12.6041 0 0 0 0 0 0 0 0 0 0 0 0 0 11.807 0 0 0 10.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4QPB2 LRP5L_HUMAN "Low-density lipoprotein receptor-related protein 5-like protein, LRP-5-like" LRP5L Homo sapiens (Human) adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cholesterol homeostasis [GO:0042632]; gastrulation with mouth forming second [GO:0001702]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retinal blood vessel morphogenesis [GO:0061304] coreceptor activity [GO:0015026]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cholesterol homeostasis [GO:0042632]; gastrulation with mouth forming second [GO:0001702]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retinal blood vessel morphogenesis [GO:0061304] GO:0001702; GO:0002076; GO:0009952; GO:0015026; GO:0042632; GO:0045944; GO:0046849; GO:0048539; GO:0060349; GO:0060444; GO:0060612; GO:0061178; GO:0061304 coreceptor activity [GO:0015026] QTLLKDKLPHIFR 0.94323 0.88534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9E0 F133A_HUMAN Protein FAM133A FAM133A Homo sapiens (Human) LLSGNESSSKKR 0.94326 3.4144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0485 0 0 13.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2141 0 0 12.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8677 0 0 0 11.5669 0 0 12.4606 0 0 0 0 0 Q93070 NAR4_HUMAN "Ecto-ADP-ribosyltransferase 4, EC 2.4.2.31 (ADP-ribosyltransferase C2 and C3 toxin-like 4, ARTC4) (Dombrock blood group carrier molecule) (Mono(ADP-ribosyl)transferase 4) (NAD(P)(+)--arginine ADP-ribosyltransferase 4) (CD antigen CD297)" ART4 DO DOK1 Homo sapiens (Human) arginine metabolic process [GO:0006525]; peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; arginine metabolic process [GO:0006525]; peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] GO:0003950; GO:0005576; GO:0005886; GO:0006471; GO:0006525; GO:0016020; GO:0018120; GO:0031225; GO:0106274 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274] ASSKKCIPDPIAIASLSFLTSVIIFSK 0.94326 3.8261 0 0 0 9.79433 0 0 0 0 0 0 0 11.3102 0 0 0 0 10.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 0 13.4661 13.1133 0 13.8964 0 0 0 0 14.3485 13.4689 0 0 0 13.6226 0 13.0885 0 13.0552 0 0 0 0 13.2539 13.0557 0 0 0 0 0 0 13.2101 13.157 0 12.8105 0 0 0 12.5597 0 0 13.016 13.7921 13.119 0 12.9343 0 0 0 0 0 0 0 12.5519 0 13.5584 0 0 0 10.6777 0 0 0 0 12.4552 0 13.0213 0 0 12.5722 0 0 0 0 12.5731 0 0 0 0 0 0 13.0269 0 0 0 0 0 12.5052 0 0 0 11.931 0 12.4539 0 0 0 0 P15153 RAC2_HUMAN Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2) RAC2 Homo sapiens (Human) actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; mast cell proliferation [GO:0070662]; motor neuron axon guidance [GO:0008045]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]; respiratory burst [GO:0045730]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; NADPH oxidase complex [GO:0043020]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; NADPH oxidase complex [GO:0043020]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; mast cell proliferation [GO:0070662]; motor neuron axon guidance [GO:0008045]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of T cell proliferation [GO:0042129]; respiratory burst [GO:0045730]; signal transduction [GO:0007165] GO:0003924; GO:0005525; GO:0005635; GO:0005741; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007015; GO:0007163; GO:0007165; GO:0007186; GO:0008045; GO:0008360; GO:0010310; GO:0010592; GO:0010810; GO:0016601; GO:0019887; GO:0019901; GO:0030027; GO:0030031; GO:0030670; GO:0030865; GO:0031410; GO:0032956; GO:0042129; GO:0042995; GO:0043020; GO:0043304; GO:0043652; GO:0045730; GO:0060263; GO:0060753; GO:0070062; GO:0070662; GO:0070668; GO:0071593; GO:0090023; GO:1902622; GO:1903955 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] WFPEVRHHCPSTPIILVGTKLDLR 0.94328 1.0345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16615 AT2A2_HUMAN "Sarcoplasmic/endoplasmic reticulum calcium ATPase 2, SERCA2, SR Ca(2+)-ATPase 2, EC 7.2.2.10 (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)" ATP2A2 ATP2B Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epidermis development [GO:0008544]; ER-nucleus signaling pathway [GO:0006984]; ion transmembrane transport [GO:0034220]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; neuron cellular homeostasis [GO:0070050]; organelle localization by membrane tethering [GO:0140056]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of heart rate [GO:0010460]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to endoplasmic reticulum stress [GO:0034976]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; transition between fast and slow fiber [GO:0014883] calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; platelet dense tubular network membrane [GO:0031095]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017] calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; platelet dense tubular network membrane [GO:0031095]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; P-type ion transporter activity [GO:0015662]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]; transmembrane transporter binding [GO:0044325]; autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epidermis development [GO:0008544]; ER-nucleus signaling pathway [GO:0006984]; ion transmembrane transport [GO:0034220]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; neuron cellular homeostasis [GO:0070050]; organelle localization by membrane tethering [GO:0140056]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of heart rate [GO:0010460]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to endoplasmic reticulum stress [GO:0034976]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; transition between fast and slow fiber [GO:0014883] GO:0000045; GO:0002026; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005789; GO:0005887; GO:0006874; GO:0006984; GO:0007155; GO:0008022; GO:0008544; GO:0010460; GO:0010882; GO:0014801; GO:0014883; GO:0014898; GO:0015662; GO:0016020; GO:0016021; GO:0016240; GO:0016529; GO:0016887; GO:0019899; GO:0031095; GO:0032469; GO:0032470; GO:0033017; GO:0033292; GO:0034220; GO:0034599; GO:0034976; GO:0044325; GO:0044548; GO:0045822; GO:0055119; GO:0070050; GO:0070296; GO:0070588; GO:0086036; GO:0086039; GO:0090534; GO:0097470; GO:0098909; GO:0140056; GO:1900121; GO:1903233; GO:1903515; GO:1903779; GO:1990036; GO:1990456 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; P-type ion transporter activity [GO:0015662]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]; transmembrane transporter binding [GO:0044325] AIYNNMK 0.94331 2.5589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5922 0 0 0 0 0 0 12.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06734 FCER2_HUMAN Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form ] FCER2 CD23A CLEC4J FCE2 IGEBF Homo sapiens (Human) positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770] GO:0002925; GO:0005178; GO:0005886; GO:0005887; GO:0009897; GO:0019863; GO:0030246; GO:0046872; GO:0051000; GO:0051712; GO:0051770; GO:0070062 carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872] QWVHARYACDDMEGQLVSIHSPEEQDFLTK 0.94332 2.422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1603 0 0 0 0 0 0 0 10.7998 13.9357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5694 0 0 0 0 0 0 0 0 0 11.6102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9706 0 0 0 Q8TC07 TBC15_HUMAN "TBC1 domain family member 15 (GTPase-activating protein RAB7, GAP for RAB7, Rab7-GAP)" TBC1D15 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of GTPase activity [GO:0043087] GO:0005096; GO:0005576; GO:0005737; GO:0043087; GO:0090630 GTPase activator activity [GO:0005096] FLLGYFPWDSTK 0.94332 2.6687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4994 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5804 0 13.006 14.4789 0 0 10.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4521 0 0 0 0 0 0 13.6079 13.2258 0 0 0 0 0 0 13.7963 14.4302 13.5167 0 0 0 0 11.6926 13.1346 13.6327 0 13.6372 12.9815 0 0 0 0 0 0 13.3716 0 13.5173 0 0 0 0 0 13.2426 13.1229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3833 0 0 0 0 0 0 0 P49771 FLT3L_HUMAN "Fms-related tyrosine kinase 3 ligand, Flt3 ligand, Flt3L (SL cytokine)" FLT3LG Homo sapiens (Human) embryonic hemopoiesis [GO:0035162]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; embryonic hemopoiesis [GO:0035162]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165] GO:0005102; GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0007165; GO:0008284; GO:0009986; GO:0016020; GO:0016021; GO:0030971; GO:0035162 cytokine activity [GO:0005125]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] RTPRPGEQVPPVPSPQDLLLVEH 0.94333 1.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA77 LCE3B_HUMAN Late cornified envelope protein 3B (Late envelope protein 14) LCE3B LEP14 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; keratinization [GO:0031424]; killing of cells of another organism [GO:0031640] defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; keratinization [GO:0031424]; killing of cells of another organism [GO:0031640] GO:0031424; GO:0031640; GO:0050829; GO:0050830 GSGQQDGASDCGYGSGGCC 0.94333 3.4526 0 0 0 13.9474 0 0 11.4172 0 0 10.1746 0 0 14.9309 16.6713 0 0 0 0 0 0 12.3306 0 0 0 0 0 14.3251 0 0 0 0 0 0 0 0 0 13.3632 0 0 0 0 0 13.8091 0 0 11.9486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1939 0 0 13.7575 0 0 12.5127 0 13.1618 12.2604 10.929 0 0 12.9425 14.1841 0 14.2317 0 0 0 11.2641 0 11.6926 0 0 11.9863 0 11.9841 0 11.9483 0 11.7762 0 0 0 0 12.1265 0 0 0 11.8973 0 0 0 12.0992 13.4903 0 11.4647 0 0 12.1797 8.72233 0 11.9301 12.5204 11.4305 11.8208 0 12.0896 15.4265 12.3047 0 12.1738 14.3451 0 12.0874 0 12.0151 0 0 11.5972 14.1898 0 0 13.5541 9.61104 11.3269 0 0 0 12.4628 0 0 12.7895 11.7551 0 0 10.9116 0 0 10.9996 0 0 0 0 11.3073 0 0 0 15.2728 12.4262 14.3252 11.7502 0 0 0 11.4091 0 0 0 P10912 GHR_HUMAN "Growth hormone receptor, GH receptor (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein, GH-binding protein, GHBP (Serum-binding protein) ]" GHR Homo sapiens (Human) activation of Janus kinase activity [GO:0042976]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cytokine-mediated signaling pathway [GO:0019221]; endocytosis [GO:0006897]; growth hormone receptor signaling pathway [GO:0060396]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of neuron death [GO:1901215]; positive regulation of cell differentiation [GO:0045597]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor internalization [GO:0031623]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of multicellular organism growth [GO:0040014]; response to cycloheximide [GO:0046898]; response to estradiol [GO:0032355]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to gravity [GO:0009629]; response to interleukin-1 [GO:0070555]; response to morphine [GO:0043278]; taurine metabolic process [GO:0019530] cell surface [GO:0009986]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth hormone receptor complex [GO:0070195]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth hormone receptor complex [GO:0070195]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; growth hormone receptor activity [GO:0004903]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; proline-rich region binding [GO:0070064]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH2 domain binding [GO:0042169]; activation of Janus kinase activity [GO:0042976]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cytokine-mediated signaling pathway [GO:0019221]; endocytosis [GO:0006897]; growth hormone receptor signaling pathway [GO:0060396]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of neuron death [GO:1901215]; positive regulation of cell differentiation [GO:0045597]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor internalization [GO:0031623]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of multicellular organism growth [GO:0040014]; response to cycloheximide [GO:0046898]; response to estradiol [GO:0032355]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to gravity [GO:0009629]; response to interleukin-1 [GO:0070555]; response to morphine [GO:0043278]; taurine metabolic process [GO:0019530] GO:0004896; GO:0004903; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0005887; GO:0006897; GO:0007259; GO:0009629; GO:0009755; GO:0009897; GO:0009986; GO:0016021; GO:0017046; GO:0019221; GO:0019530; GO:0019838; GO:0019901; GO:0019903; GO:0019955; GO:0031623; GO:0032094; GO:0032355; GO:0032869; GO:0032870; GO:0036464; GO:0040014; GO:0040018; GO:0042169; GO:0042445; GO:0042531; GO:0042802; GO:0042803; GO:0042976; GO:0043025; GO:0043235; GO:0043278; GO:0043406; GO:0045597; GO:0046427; GO:0046898; GO:0048009; GO:0050731; GO:0051384; GO:0060351; GO:0060396; GO:0070064; GO:0070195; GO:0070555; GO:1901215 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; growth hormone receptor activity [GO:0004903]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; proline-rich region binding [GO:0070064]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH2 domain binding [GO:0042169] IKGIDPDLLK 0.94334 4.1084 0 0 0 0 0 0 14.8118 0 0 0 0 12.323 11.9148 0 0 0 0 0 11.8598 0 0 0 0 0 0 0 0 0 12.3044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5422 13.9099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8837 0 0 11.7767 0 0 0 12.457 0 0 0 0 0 0 0 13.2851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2489 13.9236 0 0 0 13.9223 15.0949 0 0 0 0 0 0 14.7104 13.4945 13.6869 0 15.1252 15.4127 0 0 0 0 0 0 0 0 10.3323 0 0 12.6087 0 0 0 0 10.2366 0 0 0 0 0 0 0 0 0 0 0 0 12.0866 0 13.4071 0 0 0 0 0 0 0 0 0 0 12.8845 14.846 0 0 0 0 0 0 0 12.1004 0 0 0 0 0 Q9BYR9 KRA24_HUMAN Keratin-associated protein 2-4 (High sulfur keratin-associated protein 2.4) (Keratin-associated protein 2.4) KRTAP2-4 KAP2.4 KRTAP2.4 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTGSCCGSTLSSLSYGGGCCQPCCCR 0.94335 3.8898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0733 0 0 0 0 13.3787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2614 0 0 0 0 0 0 11.9465 0 0 0 0 0 0 0 0 0 0 10.4806 0 0 0 0 0 12.8937 0 0 0 0 13.8906 0 12.1862 0 0 0 0 0 13.2063 0 0 0 0 0 0 0 0 0 0 11.5844 0 0 11.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0406 0 0 0 0 0 0 0 0 0 13.8389 0 0 0 0 0 0 0 11.5017 12.2017 0 0 0 0 0 B2RPK0 HGB1A_HUMAN "Putative high mobility group protein B1-like 1 (High mobility group protein B1 pseudogene 1) (Putative high mobility group protein 1-like 1, HMG-1L1)" HMGB1P1 HMG1L1 HMGB1L1 Homo sapiens (Human) positive regulation of response to stimulus [GO:0048584]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; positive regulation of response to stimulus [GO:0048584]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0005634; GO:0005694; GO:0006357; GO:0008301; GO:0048584 "DNA binding, bending [GO:0008301]" EEEEDEEDEEDEEEEDEEDEEDDDDE 0.94336 3.4117 0 0 0 0 0 0 0 0 0 0 0 0 13.7087 0 0 0 0 0 0 0 0 0 0 0 11.4034 0 0 0 10.9884 0 0 0 0 0 11.9263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1193 0 0 0 0 12.3795 12.7539 0 0 0 0 0 0 0 12.574 0 0 0 0 0 0 0 0 0 0 12.6406 0 0 0 0 0 0 0 0 0 12.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5273 12.646 0 0 11.5157 0 0 0 0 0 0 0 0 9.64254 0 0 0 11.5447 12.7414 0 12.4759 12.9521 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5731 0 0 0 0 0 11.6106 0 0 0 0 0 0 0 11.5875 0 0 0 0 0 0 11.4329 0 14.0848 0 0 12.5515 Q86TG7 PEG10_HUMAN "Retrotransposon-derived protein PEG10 (Embryonal carcinoma differentiation-regulated protein) (Mammalian retrotransposon-derived protein 2) (Myelin expression factor 3-like protein 1, MEF3-like protein 1) (Paternally expressed gene 10 protein) (Retrotransposon gag domain-containing protein 3) (Retrotransposon-derived gag-like polyprotein) (Ty3/Gypsy-like protein)" PEG10 EDR KIAA1051e MAR2 MART2 MEF3L1 RGAG3 Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein homooligomerization [GO:0051260]; vesicle-mediated intercellular transport [GO:0110077] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein homooligomerization [GO:0051260]; vesicle-mediated intercellular transport [GO:0110077] GO:0003677; GO:0003723; GO:0003729; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0008270; GO:0016020; GO:0030154; GO:0030512; GO:0051028; GO:0051260; GO:0110077; GO:1903561 DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DELSEEINNLR 0.94338 2.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5871 0 10.1215 0 11.7247 0 0 0 11.3164 0 11.5695 14.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8756 0 14.7845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0935 0 0 0 0 0 0 0 0 14.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5266 0 0 0 0 0 14.8816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5892 0 0 0 0 0 13.5947 14.2504 0 0 0 12.2514 0 0 0 0 0 0 0 0 12.7429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5954 0 0 14.998 0 0 0 0 0 P49888 ST1E1_HUMAN "Sulfotransferase 1E1, ST1E1, EC 2.8.2.4 (EST-1) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)" SULT1E1 STE Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] GO:0004062; GO:0004304; GO:0005496; GO:0005737; GO:0005829; GO:0006068; GO:0006711; GO:0008146; GO:0008202; GO:0008210; GO:0031965; GO:0045600; GO:0047894; GO:0050294; GO:0050427; GO:0051923 aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146] DCKIIYLCRNAK 0.9434 2.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.32396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5325 0 0 0 0 0 0 0 14.7678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7701 0 0 0 0 0 0 0 0 0 10.1692 0 0 0 0 0 0 0 0 12.7922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57729 RAB38_HUMAN Ras-related protein Rab-38 (Melanoma antigen NY-MEL-1) RAB38 Homo sapiens (Human) endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0007005; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:2001247 AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] FGNMTRVYYREAMGAFIVFDVTR 0.9434 3.8202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.66 0 0 0 0 13.8294 0 0 0 0 0 0 14.5768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6963 14.2786 0 0 0 0 0 0 0 0 0 0 13.2718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2654 0 0 0 0 0 0 0 Q10589 BST2_HUMAN "Bone marrow stromal antigen 2, BST-2 (HM1.24 antigen) (Tetherin) (CD antigen CD317)" BST2 Homo sapiens (Human) B cell activation [GO:0042113]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of intracellular transport of viral material [GO:1901253]; negative regulation of plasmacytoid dendritic cell cytokine production [GO:0002737]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of actin cytoskeleton organization [GO:0032956]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metalloendopeptidase inhibitor activity [GO:0008191]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of intracellular transport of viral material [GO:1901253]; negative regulation of plasmacytoid dendritic cell cytokine production [GO:0002737]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of actin cytoskeleton organization [GO:0032956]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615] GO:0002737; GO:0003723; GO:0005771; GO:0005794; GO:0005886; GO:0008191; GO:0009615; GO:0009986; GO:0016020; GO:0016021; GO:0016324; GO:0030308; GO:0030336; GO:0031225; GO:0032956; GO:0034341; GO:0035455; GO:0035456; GO:0035577; GO:0042113; GO:0042802; GO:0042803; GO:0043123; GO:0043231; GO:0045071; GO:0045087; GO:0045121; GO:0051607; GO:0070062; GO:0070665; GO:1901253 identical protein binding [GO:0042802]; metalloendopeptidase inhibitor activity [GO:0008191]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] CKLLLGIGILVLLIIVILGVPLIIFTIK 0.9434 4.8634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4967 13.2961 0 11.1554 0 0 0 0 0 0 0 12.5881 0 13.5812 0 0 0 0 0 0 11.7007 0 0 0 0 13.8313 0 0 0 0 0 0 0 0 11.4987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3513 14.2399 0 0 0 0 0 0 14.6638 15.1213 0 0 0 14.3273 0 15.2806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2016 0 0 11.9734 13.3767 0 0 14.8124 0 0 0 0 0 15.3192 15.7585 0 0 0 0 13.4305 0 0 14.3432 14.9046 0 0 9.73743 0 13.6855 0 14.7236 14.1025 0 13.2736 11.777 0 12.2582 14.9236 0 13.5908 15.2189 14.0986 0 0 13.844 0 13.654 11.7738 14.1154 0 14.2534 0 0 0 0 0 0 17.0678 14.0095 0 9.94935 12.6535 0 0 0 0 13.1766 0 0 0 0 13.5774 0 0 13.1243 0 0 0 0 0 0 0 0 0 Q8TAP6 CEP76_HUMAN "Centrosomal protein of 76 kDa, Cep76" CEP76 C18orf9 Homo sapiens (Human) regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; regulation of centriole replication [GO:0046599] GO:0005813; GO:0005814; GO:0005829; GO:0032991; GO:0046599 EELAPDQQHLSTEDLIKALR 0.9434 2.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9732 0 0 0 0 0 0 0 0 0 0 12.1579 0 0 0 13.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6989 0 0 0 14.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5355 12.3208 0 0 15.4839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 15.2092 14.6319 0 0 0 0 0 0 0 0 12.2223 0 0 11.6893 0 13.1808 12.4816 0 0 0 0 P57052 RBM11_HUMAN Splicing regulator RBM11 (RNA-binding motif protein 11) RBM11 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0008266; GO:0008380; GO:0016607; GO:0030154; GO:0034599; GO:0042803 poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727] EEILYELFLQAGPLTKVTICKDR 0.94343 2.3952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5296 0 0 0 0 0 0 0 0 0 0 0 11.3618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWI4 SHSA2_HUMAN Protein shisa-2 homolog (Transmembrane protein 46) SHISA2 C13orf13 TMEM46 UNQ9166/PRO28631 Homo sapiens (Human) negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Wnt signaling pathway [GO:0030178] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Wnt signaling pathway [GO:0030178] GO:0005783; GO:0005789; GO:0016021; GO:0030178; GO:0040037 FDGGDATICCGSCALR 0.94343 1.7418 11.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4714 0 0 12.6438 0 0 0 0 0 0 12.2572 0 0 0 12.6301 0 10.6864 0 0 0 0 0 12.3385 12.6849 0 0 0 12.6009 0 0 0 0 12.5897 0 0 12.1915 0 11.4402 0 0 0 0 0 0 0 0 Q86VI3 IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 IQGAP3 Homo sapiens (Human) cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; gene expression [GO:0010467]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; small GTPase binding [GO:0031267]; cellular response to organic substance [GO:0071310]; ERK1 and ERK2 cascade [GO:0070371]; G1/S transition of mitotic cell cycle [GO:0000082]; gene expression [GO:0010467]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087] GO:0000082; GO:0001934; GO:0005096; GO:0005516; GO:0005829; GO:0005911; GO:0006468; GO:0007265; GO:0008361; GO:0010467; GO:0010628; GO:0010629; GO:0016328; GO:0031267; GO:0032956; GO:0033598; GO:0033601; GO:0043087; GO:0043410; GO:0051015; GO:0070371; GO:0070856; GO:0071310 actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; myosin VI light chain binding [GO:0070856]; small GTPase binding [GO:0031267] ALQDPALALR 0.94345 2.5719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7671 11.9072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.526 0 14.4887 0 13.848 13.454 13.3884 14.0001 18.451 18.2614 0 0 13.1389 18.2695 0 0 13.003 11.9316 0 0 18.0922 0 0 12.0119 17.7141 17.0296 16.8164 16.8239 15.3444 15.0508 0 12.2699 16.2999 16.9357 15.7184 16.1624 15.4272 0 0 15.0669 16.8681 0 15.6825 16.3618 16.1785 15.9582 15.0871 16.0544 16.0479 16.3003 17.2033 0 15.7595 0 15.9587 16.3987 0 0 14.3914 14.1664 0 15.3109 15.7148 14.7941 14.839 15.0818 15.1676 15.6529 15.4084 14.4282 15.3673 13.8484 14.3453 0 0 0 0 0 0 0 13.1173 0 15.2612 13.5607 14.3973 14.2941 14.0813 13.4843 13.9662 13.5365 14.1761 13.6863 14.1803 14.3583 11.7806 0 0 16.0241 15.7502 15.2073 0 0 0 13.2899 0 11.8667 Q1EHB4 SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12) SLC5A12 SMCT2 Homo sapiens (Human) ion transport [GO:0006811]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293]; ion transport [GO:0006811]; sodium ion transport [GO:0006814] GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0016021; GO:0016324; GO:0070062 lactate transmembrane transporter activity [GO:0015129]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293] CISCKTEKHAK 0.94347 0.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8511 0 0 0 0 0 0 0 0 12.8172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0936 13.6704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BPW8 NIPS1_HUMAN "Protein NipSnap homolog 1, NipSnap1" NIPSNAP1 Homo sapiens (Human) sensory perception of pain [GO:0019233] mitochondrion [GO:0005739]; synaptic membrane [GO:0097060] mitochondrion [GO:0005739]; synaptic membrane [GO:0097060]; neurotransmitter binding [GO:0042165]; sensory perception of pain [GO:0019233] GO:0005739; GO:0019233; GO:0042165; GO:0097060 neurotransmitter binding [GO:0042165] DAHSTLLSKK 0.94347 2.5547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3808 0 0 12.4995 0 0 0 0 0 0 0 0 12.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0562 0 0 0 0 0 0 11.774 10.9743 0 0 0 0 0 0 0 0 0 0 0 0 11.8486 0 11.1018 0 0 0 0 0 0 14.0223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0452 0 0 0 0 13.1446 0 13.4219 0 14.1675 0 0 0 12.6349 0 0 0 0 0 0 P12004 PCNA_HUMAN "Proliferating cell nuclear antigen, PCNA (Cyclin)" PCNA Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]" "centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]" "centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]" GO:0000122; GO:0000307; GO:0000701; GO:0000781; GO:0000785; GO:0001673; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0007507; GO:0008022; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990 chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971] FEARLVQGSILKK 0.94351 2.4832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7446 13.4723 13.6259 12.9931 13.3129 14.3851 13.0456 0 14.1227 0 14.4299 13.1921 15.1039 0 0 0 0 0 0 0 0 0 0 0 0 13.7004 14.3525 13.6676 0 0 0 15.0159 0 0 13.7799 12.7935 13.2075 0 0 0 15.1531 0 0 14.4082 15.615 16.4059 14.192 0 0 13.6533 14.0255 15.5484 15.31 15.8341 11.6094 14.0747 13.7994 13.9236 13.4205 0 0 13.7029 15.3895 14.9272 15.1123 15.3405 13.6639 0 0 12.6078 12.8084 0 0 0 0 0 0 12.2187 0 13.2232 0 14.7606 11.0654 0 0 0 0 0 0 0 0 12.8279 0 0 0 0 0 13.7293 0 0 0 0 0 0 0 0 Q9UHP3 UBP25_HUMAN "Ubiquitin carboxyl-terminal hydrolase 25, EC 3.4.19.12 (Deubiquitinating enzyme 25) (USP on chromosome 21) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25)" USP25 USP21 Homo sapiens (Human) negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein modification process [GO:0036211]; proteolysis [GO:0006508]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; SUMO binding [GO:0032183]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein peptidase activity [GO:0019783]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein modification process [GO:0036211]; proteolysis [GO:0006508]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006508; GO:0006511; GO:0008233; GO:0016579; GO:0019783; GO:0031625; GO:0032183; GO:0036211; GO:0043130; GO:0051117; GO:0070536; GO:0071108; GO:1904293 ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; SUMO binding [GO:0032183]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein peptidase activity [GO:0019783] AQFLIQEEFNK 0.94351 3.6338 0 0 0 0 0 0 0 0 11.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1312 0 0 0 0 0 0 0 0 0 12.312 0 13.8113 13.8402 0 0 14.1726 0 13.5985 0 0 13.1951 0 0 0 12.8662 12.8706 13.9606 14.1093 13.9931 0 0 11.828 13.2617 14.5485 13.381 0 0 12.3668 0 13.9899 0 12.2706 12.9593 0 0 0 0 0 15.0079 13.7635 0 0 10.3931 0 0 12.6545 13.9629 0 0 14.4018 0 15.4476 13.6008 13.5646 0 0 0 13.58 13.7432 0 0 13.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7 0 0 0 10.0305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C1Z6 TFPT_HUMAN TCF3 fusion partner (INO80 complex subunit F) (Protein FB1) TFPT INO80F Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" actin filament [GO:0005884]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin filament [GO:0005884]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" GO:0000723; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005884; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0008584; GO:0019901; GO:0031011; GO:0033044; GO:0043065; GO:0044877; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0097190; GO:1904507 DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] EIEQVNERVLNRLHQVQR 0.94352 0.8894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7999 0 0 0 0 0 0 0 0 0 0 11.8895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5804 0 16.2753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4733 Q3SYA9 P12L1_HUMAN Putative POM121-like protein 1 POM121L1P POM121L1 Homo sapiens (Human) AISDCRPSR 0.94352 2.3934 17.0904 16.3189 17.4122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4689 0 0 0 12.5226 0 13.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0466 18.7003 0 0 0 15.8528 0 0 0 0 16.8753 0 0 0 0 0 0 14.9184 10.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3344 0 13.432 12.7391 12.7892 0 12.9174 0 0 0 0 13.1265 12.8154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5049 0 14.4984 0 0 0 0 0 Q16658 FSCN1_HUMAN Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534] GO:0001725; GO:0001726; GO:0002102; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005902; GO:0005911; GO:0005938; GO:0007043; GO:0007163; GO:0010592; GO:0015629; GO:0016477; GO:0030027; GO:0030035; GO:0030036; GO:0030046; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0032534; GO:0032956; GO:0035089; GO:0044393; GO:0045296; GO:0048870; GO:0051015; GO:0051017; GO:0051491; GO:0070062; GO:0071803; GO:0090091 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] DVPWGVDSLITLAFQDQRYSVQTADHRFLR 0.94355 2.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8991 0 0 13.5539 13.806 13.3689 13.8134 13.2871 0 0 0 0 0 0 12.5312 0 0 0 0 0 0 0 0 0 0 0 13.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQR0 SCML2_HUMAN Sex comb on midleg-like protein 2 SCML2 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634]; PcG protein complex [GO:0031519] "nucleus [GO:0005634]; PcG protein complex [GO:0031519]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; anatomical structure morphogenesis [GO:0009653]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0009653; GO:0031519; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393] GDEVHITFDGWSGAFDYWCKYDSR 0.94358 3.5253 0 0 0 0 0 0 0 0 0 0 12.5352 0 0 0 0 0 0 0 0 0 11.1077 0 0 0 0 0 0 0 0 0 0 0 0 10.4505 15.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0305 13.9644 0 0 0 0 0 0 15.4208 0 0 15.6524 14.7586 14.7014 0 14.1492 0 0 0 14.6001 0 14.061 0 0 13.8888 13.6702 0 14.3629 0 0 0 0 12.9943 0 14.3742 14.0262 13.4992 0 0 0 0 0 0 0 13.8638 0 0 0 0 0 14.3672 0 0 0 0 0 0 0 13.5332 13.3489 0 14.164 0 13.519 13.8419 13.2869 0 13.6954 0 12.496 0 0 0 0 0 0 0 0 0 19.0699 0 17.1591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1719 Q6H8Q1 ABLM2_HUMAN "Actin-binding LIM protein 2, abLIM-2 (Actin-binding LIM protein family member 2)" ABLIM2 KIAA1808 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; lamellipodium assembly [GO:0030032]; transcription, DNA-templated [GO:0006351]" GO:0005737; GO:0006351; GO:0015629; GO:0030032; GO:0030036; GO:0046872; GO:0051015 actin filament binding [GO:0051015]; metal ion binding [GO:0046872] CDSCEKYITGR 0.94359 0.88907 0 0 11.9954 12.6542 0 0 0 11.7198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4017 11.9514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULM3 YETS2_HUMAN YEATS domain-containing protein 2 YEATS2 KIAA1197 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; NuA4 histone acetyltransferase complex [GO:0035267] "ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; NuA4 histone acetyltransferase complex [GO:0035267]; histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" GO:0000122; GO:0006338; GO:0006355; GO:0006357; GO:0016573; GO:0017025; GO:0031063; GO:0035267; GO:0042393; GO:0043966; GO:0044154; GO:0045892; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140030; GO:0140672 histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025] AQVTAAGPQK 0.94359 1.0331 0 9.84147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8057 0 0 0 0 0 0 0 0 0 0 0 11.5398 18.9464 0 17.9815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8438 0 0 0 0 0 12.9469 0 0 15.3798 15.5571 0 0 0 0 0 0 0 0 0 0 0 0 13.7138 0 14.1093 0 0 0 0 0 0 0 15.1315 0 0 16.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2134 0 0 0 0 0 0 0 0 0 13.8906 0 0 0 0 0 0 13.5584 0 0 0 0 0 0 0 0 12.0765 0 0 0 0 0 12.4404 0 12.4149 0 0 0 0 0 0 0 Q5MNZ6 WIPI3_HUMAN "WD repeat domain phosphoinositide-interacting protein 3, WIPI-3 (WD repeat-containing protein 45-like, WDR45-like protein) (WD repeat-containing protein 45B) (WIPI49-like protein)" WDR45B WDR45L WIPI3 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] "cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]" GO:0000045; GO:0000407; GO:0000422; GO:0005764; GO:0005829; GO:0006497; GO:0009267; GO:0019898; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0062078; GO:0080025 "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]" IATASEKGTLIR 0.94361 0.88846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3938 0 0 0 0 0 14.1853 0 0 0 0 0 0 0 0 11.1197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PU9 ODF3A_HUMAN Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3) (Sperm tail protein SHIPPO 1) (Transcript induced in spermiogenesis protein 50) ODF3 SHIPPO1 TISP50 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; outer dense fiber [GO:0001520] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; outer dense fiber [GO:0001520]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0001520; GO:0005737; GO:0005856; GO:0007283; GO:0030154 HTPTKLRAPAYSFR 0.94361 0.88182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6435 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1507 0 Q5SWX8 ODR4_HUMAN "Protein odr-4 homolog, hODR-4 (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1)" ODR4 C1orf27 TTG1 TTG1A Homo sapiens (Human) protein localization [GO:0008104] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein localization [GO:0008104] GO:0008104; GO:0016021 DEDCDLLEGQK 0.94362 1.0237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8975 0 0 0 0 0 0 0 0 0 0 0 13.014 0 0 0 0 0 0 0 0 0 0 0 13.0761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0JP26 POTB3_HUMAN POTE ankyrin domain family member B3 POTEB3 Homo sapiens (Human) CCHHCFPCCR 0.94363 1.7397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6197 0 0 0 0 0 0 0 0 0 0 0 0 13.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q30KQ9 DB110_HUMAN "Beta-defensin 110 (Beta-defensin 10, DEFB-10) (Beta-defensin 11, DEFB-11) (Beta-defensin 111) (Defensin, beta 110) (Defensin, beta 111)" DEFB110 DEFB10 DEFB11 DEFB111 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 IAYCIRPGTHCCLQQ 0.94366 4.8546 0 0 11.4382 0 0 0 0 0 0 0 14.4624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7296 0 11.4324 0 0 0 0 15.3483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2359 0 0 0 0 0 0 0 0 0 0 0 0 13.2175 0 13.8846 0 0 0 0 0 0 0 0 14.6035 0 16.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6234 0 0 0 0 0 15.0995 0 0 0 0 0 15.1163 14.8608 11.5491 0 13.0554 0 0 0 0 0 0 0 0 0 0 0 14.2162 0 0 16.527 17.2523 0 14.3684 0 0 0 0 0 0 16.4738 0 0 0 0 15.2761 0 16.6376 15.332 11.7901 0 0 0 0 0 0 14.3928 15.6978 0 0 14.7053 14.1618 0 0 12.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7354 15.1648 0 0 0 0 0 Q9UEW3 MARCO_HUMAN Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2) MARCO SCARA2 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amyloid-beta clearance [GO:0097242]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; receptor-mediated endocytosis [GO:0006898]" collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; G protein-coupled receptor binding [GO:0001664]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; amyloid-beta clearance [GO:0097242]; apoptotic cell clearance [GO:0043277]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; receptor-mediated endocytosis [GO:0006898]" GO:0001540; GO:0001664; GO:0001934; GO:0004888; GO:0005044; GO:0005581; GO:0005737; GO:0005886; GO:0005887; GO:0006897; GO:0006898; GO:0006911; GO:0007166; GO:0007193; GO:0030666; GO:0038024; GO:0038187; GO:0043277; GO:0045087; GO:0070374; GO:0097242 amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; G protein-coupled receptor binding [GO:0001664]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888] GDQGVKGSSGEQGVKGEK 0.94366 3.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5623 14.3143 0 0 0 15.1172 0 0 0 0 0 0 0 0 0 14.8677 0 0 0 0 0 0 0 0 14.3078 0 0 0 0 0 0 0 0 0 0 11.7591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04259 K2C6B_HUMAN "Keratin, type II cytoskeletal 6B (Cytokeratin-6B, CK-6B) (Keratin-6B, K6B) (Type-II keratin Kb10)" KRT6B K6B KRTL1 Homo sapiens (Human) ectoderm development [GO:0007398]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]; ectoderm development [GO:0007398]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005200; GO:0005829; GO:0007398; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0070062 structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280] AQYEEIAQR 0.94367 1.0228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BU40 CRDL1_HUMAN Chordin-like protein 1 (Neuralin-1) (Neurogenesin-1) (Ventroptin) CHRDL1 NRLN1 Homo sapiens (Human) AMPA glutamate receptor clustering [GO:0097113]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; embryonic axis specification [GO:0000578]; excitatory chemical synaptic transmission [GO:0098976]; eye development [GO:0001654]; negative regulation of BMP signaling pathway [GO:0030514]; ossification [GO:0001503]; regulation of synaptic plasticity [GO:0048167]; synapse maturation [GO:0060074] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; transforming growth factor beta binding [GO:0050431]; AMPA glutamate receptor clustering [GO:0097113]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; embryonic axis specification [GO:0000578]; excitatory chemical synaptic transmission [GO:0098976]; eye development [GO:0001654]; negative regulation of BMP signaling pathway [GO:0030514]; ossification [GO:0001503]; regulation of synaptic plasticity [GO:0048167]; synapse maturation [GO:0060074] GO:0000578; GO:0001503; GO:0001654; GO:0005576; GO:0005788; GO:0005886; GO:0030154; GO:0030509; GO:0030514; GO:0036122; GO:0045202; GO:0048167; GO:0050431; GO:0060074; GO:0097113; GO:0098976 BMP binding [GO:0036122]; transforming growth factor beta binding [GO:0050431] GYFCGEETMPVYESVFMEDGETTR 0.94382 2.5657 0 0 0 0 0 0 0 0 14.6824 0 0 0 13.4511 0 0 0 12.2034 0 0 13.0012 0 0 0 0 13.1487 0 12.8504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6226 0 0 12.9455 12.1996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7616 0 0 0 13.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7586 0 0 12.9 0 0 0 0 0 12.8804 0 0 0 0 0 0 0 15.3245 15.1811 0 0 0 0 0 13.4566 0 0 0 13.7307 13.2152 0 0 0 0 0 0 15.2128 14.5798 0 0 0 0 0 0 0 15.024 0 0 0 14.4947 14.1717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5941 Q9BU23 LMF2_HUMAN Lipase maturation factor 2 (Transmembrane protein 112B) (Transmembrane protein 153) LMF2 TMEM112B TMEM153 Homo sapiens (Human) protein maturation [GO:0051604] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein maturation [GO:0051604] GO:0005789; GO:0016020; GO:0016021; GO:0051604 DSGAASEQATAAPNPCSSSSR 0.94383 0.88912 0 0 0 0 12.4479 0 0 0 0 0 14.4529 0 0 0 0 0 0 0 0 12.3663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3389 0 0 0 0 0 0 12.866 0 0 0 0 0 12.4367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0273 0 0 0 0 0 14.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0896 0 0 0 0 0 0 14.0405 0 0 0 0 0 0 13.4906 0 0 0 0 0 0 0 0 0 0 0 0 13.0933 13.5505 0 0 13.0293 0 0 0 11.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7845 0 0 0 0 Q9NPB9 ACKR4_HUMAN "Atypical chemokine receptor 4 (C-C chemokine receptor type 11, C-C CKR-11, CC-CKR-11, CCR-11) (CC chemokine receptor-like 1, CCRL1) (CCX CKR)" ACKR4 CCBP2 CCR11 CCRL1 VSHK1 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0004950; GO:0005044; GO:0005769; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0055037; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; scavenger receptor activity [GO:0005044] ISRPLKVLLTVVIVFIVTQLPYNIVK 0.94383 2.7724 0 0 0 0 11.8366 0 12.949 0 0 0 0 0 0 0 0 0 12.2003 0 0 0 0 0 0 12.8095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7168 0 0 0 0 0 0 0 0 13.0783 12.673 13.2768 12.8914 0 0 13.1642 15.6626 14.5945 14.2787 0 15.4518 15.3229 0 15.0929 15.0673 15.0234 14.3122 13.7398 15.5612 14.1911 0 0 14.5439 0 14.2802 14.5217 13.2166 0 13.5843 0 13.6256 11.9384 12.842 0 11.7416 0 14.2335 0 13.8495 15.018 12.8665 0 0 13.8388 12.6404 0 0 13.2774 12.923 0 13.0883 13.0133 0 13.4611 0 0 12.715 0 13.1804 14.0599 0 0 0 0 13.871 0 0 0 0 0 14.3408 0 0 0 12.0108 12.996 0 0 14.456 0 0 0 0 12.5362 0 10.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0302 0 O15389 SIGL5_HUMAN "Sialic acid-binding Ig-like lectin 5, Siglec-5 (CD33 antigen-like 2) (Obesity-binding protein 2, OB-BP2, OB-binding protein 2) (CD antigen CD170)" SIGLEC5 CD33L2 OBBP2 Homo sapiens (Human) cell adhesion [GO:0007155] ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0030667; GO:0033691; GO:0070821; GO:0101003 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] PEDHGTNLTCQMKRQGAQVTTER 0.94385 1.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75679 RFPL3_HUMAN Ret finger protein-like 3 RFPL3 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0045893; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] CINSLQKEPHGEDLLCCCCSMVSQRNK 0.94385 4.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7331 13.9797 0 0 0 0 0 0 12.3012 0 0 0 0 0 0 0 0 0 12.3407 13.9204 12.2575 0 0 0 0 0 13.4888 12.5321 0 0 0 13.0672 0 0 0 0 12.5655 0 0 0 0 0 0 0 0 0 0 0 0 11.648 0 0 0 0 0 0 0 11.7395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3375 0 0 11.1277 0 0 0 0 0 0 0 11.1375 11.1692 0 0 10.9154 0 0 11.3808 0 0 0 0 0 0 0 Q8TAF8 LHPL5_HUMAN LHFPL tetraspan subfamily member 5 protein (Lipoma HMGIC fusion partner-like 5 protein) (Tetraspan membrane protein of hair cell stereocilia) LHFPL5 TMHS Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; ion transport [GO:0006811]; sensory perception of sound [GO:0007605] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium tip [GO:0032426] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium tip [GO:0032426]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; ion transport [GO:0006811]; sensory perception of sound [GO:0007605] GO:0005886; GO:0006811; GO:0007605; GO:0016020; GO:0016021; GO:0016324; GO:0032426; GO:0050910; GO:0050974; GO:0060088 WAFMLAILSIGDALILSFLAFVLGYR 0.94386 1.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2193 0 0 0 12.9603 0 0 0 0 0 13.0898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2979 0 0 14.6014 0 14.5163 0 0 0 0 0 0 0 0 0 0 14.9669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95343 SIX3_HUMAN Homeobox protein SIX3 (Sine oculis homeobox homolog 3) SIX3 Homo sapiens (Human) "apoptotic process involved in development [GO:1902742]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; epithelial cell maturation [GO:0002070]; eye development [GO:0001654]; forebrain dorsal/ventral pattern formation [GO:0021798]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lens fiber cell differentiation [GO:0070306]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast differentiation [GO:0014016]; neuroblast migration [GO:0097402]; optic vesicle morphogenesis [GO:0003404]; pituitary gland development [GO:0021983]; proximal/distal axis specification [GO:0009946]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell population proliferation [GO:0042127]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neural retina development [GO:0061074]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; apoptotic process involved in development [GO:1902742]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; epithelial cell maturation [GO:0002070]; eye development [GO:0001654]; forebrain dorsal/ventral pattern formation [GO:0021798]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lens fiber cell differentiation [GO:0070306]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast differentiation [GO:0014016]; neuroblast migration [GO:0097402]; optic vesicle morphogenesis [GO:0003404]; pituitary gland development [GO:0021983]; proximal/distal axis specification [GO:0009946]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell population proliferation [GO:0042127]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neural retina development [GO:0061074]; regulation of neuroblast proliferation [GO:1902692]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; visual perception [GO:0007601]" GO:0000785; GO:0000978; GO:0000981; GO:0001222; GO:0001228; GO:0001654; GO:0002070; GO:0002088; GO:0003404; GO:0005634; GO:0005667; GO:0006357; GO:0007420; GO:0007601; GO:0009946; GO:0014016; GO:0021537; GO:0021798; GO:0021846; GO:0021978; GO:0021983; GO:0042127; GO:0045665; GO:0045892; GO:0061074; GO:0070306; GO:0097402; GO:1901987; GO:1902692; GO:1902742; GO:1990086; GO:1990837; GO:2000177 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]" FLWSLPVAPGACEAINKHESILR 0.94388 0.88772 0 0 0 0 0 11.3353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2021 0 0 0 0 0 0 15.7984 12.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0918 0 0 0 0 0 0 0 11.5796 0 0 12.9607 0 0 11.2481 0 10.7388 13.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4999 0 0 0 0 0 0 0 0 12.4765 0 0 0 13.4226 0 12.5933 0 13.1591 0 0 0 0 10.8135 0 0 0 P01909 DQA1_HUMAN "HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)" HLA-DQA1 Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] GO:0000139; GO:0002250; GO:0002503; GO:0005765; GO:0005886; GO:0005887; GO:0006955; GO:0010008; GO:0012507; GO:0016020; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0032395; GO:0032588; GO:0042605; GO:0042613; GO:0050870; GO:0071556 MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605] FDPQFALTNIAVLKHNLNSLIK 0.94388 2.5414 0 0 11.2838 0 13.5259 0 0 0 0 0 0 14.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2175 0 0 0 0 0 14.2635 0 14.9191 0 0 0 14.2407 0 0 0 0 13.4446 0 0 0 0 15.5823 0 0 0 15.6621 0 0 13.3505 0 0 0 0 0 0 0 0 0 13.8985 0 15.5012 0 0 14.6378 0 0 14.4689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.838 0 0 0 0 0 0 0 0 0 0 0 11.7476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61582 NP7_HUMAN Endogenous retrovirus group K member 7 Np9 protein (HERV-K(III) Np9 protein) (HERV-K102 Np9 protein) (HERV-K_1q22 provirus Np9 protein) ERVK-7 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 QERSDCYCVCVER 0.94388 0.88097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.334 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZV1 ANKR2_HUMAN "Ankyrin repeat domain-containing protein 2 (Skeletal muscle ankyrin repeat protein, hArpp)" ANKRD2 ARPP Homo sapiens (Human) muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619] cytosol [GO:0005829]; euchromatin [GO:0000791]; I band [GO:0031674]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; PML body [GO:0016605] cytosol [GO:0005829]; euchromatin [GO:0000791]; I band [GO:0031674]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; PML body [GO:0016605]; protein kinase B binding [GO:0043422]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619] GO:0000122; GO:0000791; GO:0005634; GO:0005829; GO:0006357; GO:0006936; GO:0007517; GO:0008307; GO:0016605; GO:0031674; GO:0043231; GO:0043422; GO:0043619; GO:0045662; GO:0061629 protein kinase B binding [GO:0043422]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; structural constituent of muscle [GO:0008307] DKLLSTPLHVAVR 0.94388 1.0238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9315 0 0 0 0 14.3775 0 0 0 0 0 0 0 0 0 0 0 0 0 P15309 PPAP_HUMAN "Prostatic acid phosphatase, PAP, EC 3.1.3.2 (5'-nucleotidase, 5'-NT, EC 3.1.3.5) (Acid phosphatase 3) (Ecto-5'-nucleotidase) (Protein tyrosine phosphatase ACP3, EC 3.1.3.48) (Thiamine monophosphatase, TMPase) [Cleaved into: PAPf39 ]" ACP3 ACPP Homo sapiens (Human) adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; nucleotide metabolic process [GO:0009117]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; purine nucleobase metabolic process [GO:0006144]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772] acid phosphatase complex [GO:1904097]; azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; phosphatidylinositol phosphate phosphatase complex [GO:1904144]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] acid phosphatase complex [GO:1904097]; azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; phosphatidylinositol phosphate phosphatase complex [GO:1904144]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; identical protein binding [GO:0042802]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; thiamine phosphate phosphatase activity [GO:0042131]; XMP 5'-nucleosidase activity [GO:0106411]; adenosine metabolic process [GO:0046085]; dephosphorylation [GO:0016311]; lipid metabolic process [GO:0006629]; lysosome organization [GO:0007040]; nucleotide metabolic process [GO:0009117]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; purine nucleobase metabolic process [GO:0006144]; regulation of sensory perception of pain [GO:0051930]; thiamine metabolic process [GO:0006772] GO:0003993; GO:0004725; GO:0005615; GO:0005634; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006144; GO:0006629; GO:0006772; GO:0007040; GO:0008253; GO:0009117; GO:0012506; GO:0016021; GO:0016311; GO:0016791; GO:0030175; GO:0035577; GO:0042131; GO:0042802; GO:0042803; GO:0046085; GO:0051930; GO:0052642; GO:0060168; GO:0070062; GO:0106411; GO:1904097; GO:1904144 5'-nucleotidase activity [GO:0008253]; acid phosphatase activity [GO:0003993]; identical protein binding [GO:0042802]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; thiamine phosphate phosphatase activity [GO:0042131]; XMP 5'-nucleosidase activity [GO:0106411] AAPLLLARAASLSLGFLFLLFFWLDRSVLAK 0.94389 0.88742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7943 0 11.7945 0 0 0 0 14.3727 0 0 0 0 14.4387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4603 0 0 0 14.032 0 0 0 0 0 0 0 0 0 0 13.495 14.7094 0 0 0 0 0 0 0 0 0 0 13.8299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49821 NDUV1_HUMAN "NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial, EC 7.1.1.2 (Complex I-51kD, CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)" NDUFV1 UQOR1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005739; GO:0005743; GO:0005747; GO:0005829; GO:0006120; GO:0008137; GO:0009060; GO:0010181; GO:0042775; GO:0042776; GO:0046872; GO:0051287; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]" EGVDWMNKVMAR 0.94389 0.88049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8396 11.929 0 0 0 0 13.8501 11.4892 10.8647 0 0 0 0 0 12.9799 0 0 0 0 0 13.0723 0 0 0 0 0 0 13.3239 0 12.1692 0 0 0 0 0 0 0 11.5584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8213 0 13.2359 0 12.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNM6 TEX43_HUMAN Testis-expressed protein 43 TEX43 C5orf48 Homo sapiens (Human) flagellated sperm motility [GO:0030317] flagellated sperm motility [GO:0030317] GO:0030317 KVVFQKGPPEIK 0.9439 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4F0 BPIB2_HUMAN "BPI fold-containing family B member 2 (Bactericidal/permeability-increasing protein-like 1, BPI-like 1) (Long palate, lung and nasal epithelium carcinoma-associated protein 2) (RYSR)" BPIFB2 BPIL1 C20orf184 LPLUNC2 UNQ2489/PRO5776 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lipid binding [GO:0008289] GO:0005576; GO:0005788; GO:0008289; GO:0070062 lipid binding [GO:0008289] ILNVHVPRLHLK 0.9439 3.8815 0 0 0 0 0 10.8965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0199 0 14.5157 0 0 0 14.464 13.8279 14.4223 15.3858 14.3931 0 13.9345 14.4104 13.9259 0 14.0199 0 0 0 0 14.7127 0 14.2383 0 0 0 0 0 14.1084 13.8783 13.6558 0 0 0 0 0 0 0 13.2925 13.8175 0 0 0 0 0 0 0 0 12.4611 0 0 0 0 0 0 0 13.1647 0 0 0 0 0 0 12.4878 0 0 0 0 0 0 0 0 0 14.8697 0 0 13.0931 0 12.2718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTY9 PRS41_HUMAN "Serine protease 41, EC 3.4.21.- (Testis serine protease 1, TESSP-1)" PRSS41 TESSP1 Homo sapiens (Human) proteolysis [GO:0006508] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0017080; GO:0031225; GO:0043229 serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080] GALLLALLLARAGLGK 0.94391 1.742 14.0643 14.7559 10.5726 0 0 0 0 11.7055 0 0 10.5362 0 0 0 0 0 0 0 11.1517 13.9436 0 13.2822 13.9748 12.7955 0 13.9595 12.9495 0 0 0 0 0 0 0 0 0 0 0 0 0 14.606 0 0 0 0 0 0 0 0 0 12.9825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5092 0 15.6056 0 14.0636 0 0 0 16.3369 13.0127 16.2065 0 15.3642 15.5676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5134 0 0 0 0 14.2971 0 0 0 0 0 0 0 0 0 0 0 12.4513 12.8444 0 0 0 0 0 0 0 0 0 0 13.5794 0 0 0 12.2034 0 0 0 0 0 0 11.4737 0 0 0 Q8N9K5 ZN565_HUMAN Zinc finger protein 565 ZNF565 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ADWECEGQFERQVNEECYFK 0.94391 0.87892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6037 0 0 0 0 0 0 0 0 13.3319 0 12.6099 12.7095 0 0 12.2357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2335 0 0 0 0 11.9711 0 0 0 0 0 12.5104 0 0 0 0 0 0 0 0 13.3552 0 0 0 0 12.8959 0 0 13.0699 0 12.9037 13.4657 0 13.4574 13.002 0 0 0 0 0 12.7341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9585 0 0 0 0 0 0 0 0 0 0 0 0 12.5056 0 P16519 NEC2_HUMAN "Neuroendocrine convertase 2, NEC 2, EC 3.4.21.94 (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2, PC2)" PCSK2 NEC2 Homo sapiens (Human) enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508] dendrite [GO:0030425]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] dendrite [GO:0030425]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; enkephalin processing [GO:0034230]; insulin processing [GO:0030070]; islet amyloid polypeptide processing [GO:0034231]; nervous system development [GO:0007399]; peptide hormone processing [GO:0016486]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0005654; GO:0006508; GO:0007399; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0030070; GO:0030133; GO:0030141; GO:0030425; GO:0034230; GO:0034231; GO:0043005; GO:0043204; GO:0043231 serine-type endopeptidase activity [GO:0004252] AAAGFLFCVMVFASAERPVFTNHFLVELHK 0.94393 1.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5588 0 11.907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0679 0 0 0 0 0 0 0 0 0 0 13.3443 0 14.4791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0902 0 0 0 13.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4284 0 0 0 0 0 Q7Z417 NUFP2_HUMAN "FMR1-interacting protein NUFIP2 (82 kDa FMRP-interacting protein, 82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2) (Nuclear FMR1-interacting protein 2)" NUFIP2 KIAA1321 PIG1 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0016604; GO:0042788 RNA binding [GO:0003723] EMESIWNLQKQDPK 0.94395 4.1538 0 12.6619 0 0 11.4554 13.9997 15.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3105 14.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7315 11.9579 14.2646 0 0 0 0 0 0 13.1612 14.4229 13.1929 19.4238 0 13.9581 14.5696 14.0974 18.716 14.7607 14.7427 18.3914 17.3873 0 0 18.5647 16.0735 0 0 15.3905 15.3124 13.5735 14.6422 12.1219 12.6976 0 12.2869 12.5346 17.6634 13.7521 17.7263 14.6753 14.6222 15.2732 0 15.3311 13.5891 12.4084 14.0865 12.6734 15.925 12.7389 0 14.7061 14.1614 18.233 13.7292 0 17.6768 0 0 12.3622 14.6338 0 19.0131 14.2541 12.8057 0 0 0 0 0 0 0 0 0 0 0 15.6366 0 19.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6196 12.3538 13.0385 0 0 0 0 0 Q8NH92 OR1S1_HUMAN Olfactory receptor 1S1 (Olfactory receptor OR11-232) OR1S1 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVLRVSSTQGK 0.94395 0.88638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4963 0 0 11.5321 0 0 0 0 0 0 0 0 10.5549 0 0 0 0 0 0 0 0 0 11.674 0 0 12.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2794 0 0 0 0 0 0 0 0 0 0 0 0 13.6179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8867 12.886 0 0 0 0 0 Q9GZX9 TWSG1_HUMAN Twisted gastrulation protein homolog 1 TWSG1 TSG PSEC0250 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; chondrocyte differentiation [GO:0002062]; forebrain development [GO:0030900]; hemopoiesis [GO:0030097]; mesoderm formation [GO:0001707]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of CD4-positive, alpha-beta T cell activation [GO:2000515]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of cytokine production [GO:0001818]; negative regulation of osteoblast differentiation [GO:0045668]; ossification [GO:0001503]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of BMP signaling pathway [GO:0030510]; salivary gland morphogenesis [GO:0007435]; transforming growth factor beta receptor signaling pathway [GO:0007179]" extracellular space [GO:0005615] "extracellular space [GO:0005615]; heparin binding [GO:0008201]; transforming growth factor beta binding [GO:0050431]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; chondrocyte differentiation [GO:0002062]; forebrain development [GO:0030900]; hemopoiesis [GO:0030097]; mesoderm formation [GO:0001707]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of CD4-positive, alpha-beta T cell activation [GO:2000515]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of cytokine production [GO:0001818]; negative regulation of osteoblast differentiation [GO:0045668]; ossification [GO:0001503]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of BMP signaling pathway [GO:0030510]; salivary gland morphogenesis [GO:0007435]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0001503; GO:0001707; GO:0001818; GO:0002062; GO:0005615; GO:0007179; GO:0007435; GO:0008201; GO:0010862; GO:0030097; GO:0030509; GO:0030510; GO:0030513; GO:0030514; GO:0030900; GO:0043010; GO:0045668; GO:0050431; GO:2000515; GO:2000562 heparin binding [GO:0008201]; transforming growth factor beta binding [GO:0050431] CLIQELCQCRPGEGNCSCCK 0.94398 2.6986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5657 0 0 0 0 0 11.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4723 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SSG8 MUC21_HUMAN "Mucin-21, MUC-21 (Epiglycanin)" MUC21 C6orf205 UNQ697/PRO1342 Homo sapiens (Human) negative regulation of cell-cell adhesion [GO:0022408] Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of cell-cell adhesion [GO:0022408] GO:0005796; GO:0005886; GO:0016021; GO:0022408 PGGSLVPWEIFLITLVSVVAAVGLFAGLFFCVRNSLSLR 0.94402 2.424 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8797 0 0 0 10.9664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9458 0 10.9334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6909 0 0 0 0 0 0 0 0 0 14.4794 0 14.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1973 0 10.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TEC3 ZN697_HUMAN Zinc finger protein 697 ZNF697 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EDDDESAGENR 0.94404 3.8801 0 0 0 0 0 12.6114 0 0 0 11.4725 11.5616 0 0 0 0 0 0 0 0 12.6802 0 0 0 0 11.6143 0 0 0 0 0 0 0 0 12.4399 12.6391 0 0 0 0 0 0 0 0 11.833 0 0 0 11.5429 0 0 0 0 0 0 0 11.2309 0 0 0 0 0 0 0 0 0 0 0 11.8291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4067 11.4741 0 0 0 0 11.4503 0 13.633 0 0 0 0 0 0 0 15.2011 12.6498 13.7977 0 0 0 0 0 0 0 0 0 0 0 12.5468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3794 0 12.5579 0 0 0 0 0 0 0 0 13.4645 13.0685 0 0 0 0 12.7338 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 0 0 0 0 0 0 0 0 0 0 0 0 14.6569 0 0 Q5ZPR3 CD276_HUMAN "CD276 antigen (4Ig-B7-H3) (B7 homolog 3, B7-H3) (Costimulatory molecule) (CD antigen CD276)" CD276 B7H3 PSEC0249 UNQ309/PRO352 Homo sapiens (Human) positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0005102; GO:0009897; GO:0016021; GO:0032729; GO:0042102; GO:0042110; GO:0050776; GO:0050852 signaling receptor binding [GO:0005102] KIKQSCEEENAGAEDQDGEGEGSK 0.94407 1.0257 0 0 0 0 0 0 0 0 0 0 0 0 9.8716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.191 0 0 10.1955 0 0 0 12.6964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2585 0 0 0 0 0 0 12.0338 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5821 10.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P9F5 TRI40_HUMAN "E3 ubiquitin ligase TRIM40, EC 2.3.2.27 (Probable E3 NEDD8-protein ligase) (RING finger protein 35)" TRIM40 RNF35 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of cell growth [GO:0030308]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein localization to nucleus [GO:1900181]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385] cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of cell growth [GO:0030308]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein localization to nucleus [GO:1900181]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0008385; GO:0010468; GO:0016567; GO:0030308; GO:0032088; GO:0042177; GO:0045087; GO:0045116; GO:0061630; GO:1900181; GO:1901223 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GVSELLLQPPQKL 0.94408 0.88923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q309B1 TR16L_HUMAN Tripartite motif-containing protein 16-like protein (Tripartite motif-containing protein 70) TRIM16L TRIM70 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 FLHWRQVLSQQSLYLHR 0.94411 1.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9Q2 SR1IP_HUMAN "Protein SREK1IP1 (SFRS12-interacting protein 1) (SREK1-interacting protein 1) (Splicing regulatory protein of 18 kDa, p18SRP)" SREK1IP1 P18SRP SFRS12IP1 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003676; GO:0006397; GO:0008270; GO:0008380 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] LQALQEKRINEEEEK 0.94412 2.4226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9252 0 0 0 0 12.1283 0 0 0 13.7215 0 10.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4607 0 0 0 0 0 0 0 0 0 0 0 10.7239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8008 0 0 0 0 0 0 0 0 Q16633 OBF1_HUMAN POU domain class 2-associating factor 1 (B-cell-specific coactivator OBF-1) (BOB-1) (OCA-B) (OCT-binding factor 1) POU2AF1 BOB1 OBF1 Homo sapiens (Human) cellular response to virus [GO:0098586]; germinal center B cell differentiation [GO:0002314]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944] RNA polymerase II transcription regulator complex [GO:0090575] RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cellular response to virus [GO:0098586]; germinal center B cell differentiation [GO:0002314]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0002314; GO:0003677; GO:0003712; GO:0003713; GO:0006959; GO:0032755; GO:0045944; GO:0090575; GO:0098586 DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] PYQGVRVKEPVK 0.94413 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXY8 PPIL6_HUMAN "Probable inactive peptidyl-prolyl cis-trans isomerase-like 6, PPIase (Cyclophilin-like protein PPIL6) (Rotamase PPIL6)" PPIL6 Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] GO:0000413; GO:0005737; GO:0006457 FEDPILVPLQEFAWHQYLQEKK 0.94413 2.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6085 0 0 0 16.033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8863 0 0 0 0 13.3281 0 0 0 0 0 18.2326 0 0 0 0 0 18.9464 0 0 0 0 18.6685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9755 0 0 0 0 0 0 0 0 19.0026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4219 0 0 0 0 11.0628 0 18.1119 18.0496 17.8522 0 17.1218 0 0 0 0 0 13.8779 0 0 0 0 0 0 13.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXI3 5NT1A_HUMAN "Cytosolic 5'-nucleotidase 1A, cN1A, EC 3.1.3.5 (Cytosolic 5'-nucleotidase IA, cN-I, cN-IA)" NT5C1A Homo sapiens (Human) adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; dGMP catabolic process [GO:0046055]; IMP catabolic process [GO:0006204]; nucleoside metabolic process [GO:0009116] cytosol [GO:0005829] cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; IMP 5'-nucleotidase activity [GO:0050483]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; XMP 5'-nucleosidase activity [GO:0106411]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; dGMP catabolic process [GO:0046055]; IMP catabolic process [GO:0006204]; nucleoside metabolic process [GO:0009116] GO:0000166; GO:0000255; GO:0000287; GO:0005829; GO:0006196; GO:0006204; GO:0008253; GO:0009116; GO:0046055; GO:0046059; GO:0046085; GO:0050483; GO:0106411 5'-nucleotidase activity [GO:0008253]; IMP 5'-nucleotidase activity [GO:0050483]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; XMP 5'-nucleosidase activity [GO:0106411] PLAQGPLK 0.94413 1.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q687X5 STEA4_HUMAN "Metalloreductase STEAP4, EC 1.16.1.9 (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)" STEAP4 STAMP2 TNFAIP9 Homo sapiens (Human) copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron import into cell [GO:0033212]; protein homotrimerization [GO:0070207] early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; fat cell differentiation [GO:0045444]; iron import into cell [GO:0033212]; protein homotrimerization [GO:0070207] GO:0000139; GO:0005654; GO:0005768; GO:0005886; GO:0008823; GO:0009055; GO:0015677; GO:0016021; GO:0020037; GO:0031901; GO:0033212; GO:0045444; GO:0046872; GO:0052851; GO:0070062; GO:0070207; GO:0071949 cupric reductase activity [GO:0008823]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ferric-chelate reductase (NADPH) activity [GO:0052851]; heme binding [GO:0020037]; metal ion binding [GO:0046872] KQLGLVALGFAFLHVLYTLVIPIR 0.94415 1.0239 0 0 0 0 0 12.8703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8028 0 0 0 0 0 0 11.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2259 13.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7709 0 0 12.488 12.698 0 0 0 0 0 12.5923 9.76903 0 0 0 0 14.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXU6 S35F2_HUMAN Solute carrier family 35 member F2 SLC35F2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] IKGKLFTWNILK 0.94416 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N108 MIER1_HUMAN "Mesoderm induction early response protein 1, Early response 1, Er1, Mi-er1, hMi-er1" MIER1 KIAA1610 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0016575; GO:0017053; GO:0032991; GO:0042826; GO:0043123 histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714] AAREELSVWTEEECR 0.94417 3.8765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1339 0 12.282 0 0 0 0 0 0 0 10.6826 0 0 0 0 11.4578 0 0 0 0 0 0 0 0 0 11.3924 11.2498 0 0 0 0 0 0 0 0 0 0 10.5927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8593 11.9963 0 11.8848 0 0 0 0 0 0 0 0 0 11.8548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5207 0 0 0 0 0 0 0 0 0 11.3984 0 0 0 12.2584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3841 0 0 0 0 0 0 0 0 12.1735 0 0 0 0 0 0 0 0 0 0 14.5358 13.8784 0 14.7049 0 0 0 0 11.7504 16.1116 0 0 12.864 0 0 0 0 0 11.9848 0 0 0 Q9UJ37 SIA7B_HUMAN "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2, EC 2.4.99.3 (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II, ST6GalNAcII) (SThM) (Sialyltransferase 7B, SIAT7-B)" ST6GALNAC2 SIAT7B SIATL1 STHM Homo sapiens (Human) O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; transferase activity [GO:0016740]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein sialylation [GO:1990743]; viral protein processing [GO:0019082]" GO:0000139; GO:0001665; GO:0006486; GO:0006493; GO:0008373; GO:0016021; GO:0016266; GO:0016740; GO:0019082; GO:1990743 "alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; transferase activity [GO:0016740]" ASNSWTGKGQACRHLLHLAIQR 0.94417 2.3967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8088 0 0 0 0 0 0 10.4254 0 0 13.2525 0 0 0 0 0 0 0 0 0 0 12.3316 0 0 0 0 0 0 0 18.0171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTQ9 CXB4_HUMAN "Gap junction beta-4 protein (Connexin-30.3, Cx30.3)" GJB4 Homo sapiens (Human) cell-cell signaling [GO:0007267]; gap junction-mediated intercellular transport [GO:1990349]; olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608] cell junction [GO:0030054]; connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; gap junction-mediated intercellular transport [GO:1990349]; olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608] GO:0005243; GO:0005654; GO:0005730; GO:0005887; GO:0005922; GO:0007267; GO:0007608; GO:0030054; GO:0042048; GO:1990349 gap junction channel activity [GO:0005243] AGSAPVDAGGYP 0.94418 2.5761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7063 0 0 0 0 0 0 11.7941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5791 0 0 0 0 0 12.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6868 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9121 0 0 0 0 0 0 0 0 0 0 0 0 10.4743 0 0 0 0 13.0083 0 0 0 0 0 0 0 0 0 0 0 0 13.8718 0 0 0 0 0 13.9472 0 12.9422 0 13.0302 0 0 0 0 0 0 0 0 0 0 0 0 0 O00425 IF2B3_HUMAN "Insulin-like growth factor 2 mRNA-binding protein 3, IGF2 mRNA-binding protein 3, IMP-3 (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer, hKOC) (VICKZ family member 3)" IGF2BP3 IMP3 KOC1 VICKZ3 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; translation [GO:0006412] GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0007399; GO:0009653; GO:0010468; GO:0010494; GO:0017148; GO:0045182; GO:0048027; GO:0051028; GO:0051252; GO:0070934; GO:1990247 mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] AIEALSGKIELHGKPIEVEHSVPK 0.94419 0.88652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4KMQ2 ANO6_HUMAN "Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel, SCAN channel) (Transmembrane protein 16F)" ANO6 TMEM16F Homo sapiens (Human) "activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]" cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] "cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; dendritic cell chemotaxis [GO:0002407]; ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]" GO:0002407; GO:0002543; GO:0005227; GO:0005229; GO:0005244; GO:0005247; GO:0005254; GO:0005829; GO:0005886; GO:0006812; GO:0006821; GO:0007596; GO:0009986; GO:0016020; GO:0017121; GO:0017128; GO:0030501; GO:0032060; GO:0034220; GO:0034707; GO:0034767; GO:0035579; GO:0035590; GO:0035725; GO:0043065; GO:0045794; GO:0046872; GO:0046931; GO:0046983; GO:0055085; GO:0060100; GO:0061589; GO:0061590; GO:0070062; GO:0070588; GO:0070821; GO:0090026; GO:0097045; GO:1902476; GO:1903766; GO:2000353 calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244] FGINRLVNSGIYK 0.94419 0.87801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7504 13.7288 0 12.9532 13.3269 11.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.419 12.372 0 0 0 0 14.9528 12.4973 13.8511 0 0 0 0 0 13.2599 0 0 0 0 0 12.4041 0 0 0 0 0 0 0 12.0493 0 0 11.8449 12.231 0 12.2895 10.8626 0 0 0 0 0 0 0 0 13.2663 0 0 0 0 0 0 0 0 12.4956 0 0 10.3797 0 0 0 0 12.9899 0 13.0912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1929 0 0 0 0 0 0 Q5TGI0 FAXC_HUMAN Failed axon connections homolog FAXC C6orf168 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] GO:0005737; GO:0016021 AISRAVTKMVEEHFYWTLAYCQWVDNLNETR 0.94419 3.8102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2492 0 0 11.1401 0 0 0 0 0 0 0 0 Q9NR64 KLHL1_HUMAN Kelch-like protein 1 KLHL1 KIAA1490 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; adult walking behavior [GO:0007628]; cerebellar Purkinje cell layer development [GO:0021680]; dendrite development [GO:0016358] GO:0003779; GO:0005737; GO:0005856; GO:0007628; GO:0016358; GO:0021680; GO:0030036; GO:0030425; GO:0043025 actin binding [GO:0003779] DGSSCLSSMEYYDPHTNK 0.94419 2.5589 0 0 0 0 0 0 0 0 0 12.2929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9379 0 0 0 0 15.1413 0 12.1309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4427 0 0 0 0 0 0 0 10.8456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99615 DNJC7_HUMAN "DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2, TPR repeat protein 2)" DNAJC7 TPR2 TTC2 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034] GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034 ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072] ALEFAPACHR 0.9442 2.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.146 0 0 0 0 0 0 11.8911 15.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8454 0 0 0 0 0 0 0 0 0 10.5112 0 0 11.078 14.8164 0 11.7356 0 0 0 12.3765 0 12.777 0 12.776 0 12.7709 13.4885 12.8797 0 0 0 0 0 0 0 0 0 0 12.538 0 0 0 10.1201 0 0 0 0 0 0 0 0 0 0 12.9542 0 0 0 12.3483 0 0 0 0 0 0 0 0 0 11.905 17.9727 10.7532 0 13.026 0 0 0 0 14.5273 0 0 0 0 0 0 0 0 0 13.1744 0 0 0 12.5175 0 0 9.47318 0 0 0 0 0 0 0 0 10.567 0 0 0 0 0 0 13.0997 0 0 Q15723 ELF2_HUMAN ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor) ELF2 NERF Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016604; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AASSVRSGKNSSPINCSR 0.94423 2.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7857 0 0 0 0 0 19.9401 0 0 11.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NC51 T150B_HUMAN Modulator of macroautophagy TMEM150B (Protein DRAM-3) (Transmembrane protein 150B) (Transmembrane protein 224) TMEM150B TMEM224 Homo sapiens (Human) autophagy [GO:0006914] autophagosome membrane [GO:0000421]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887] autophagosome membrane [GO:0000421]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; autophagy [GO:0006914] GO:0000421; GO:0005887; GO:0006914; GO:0010008 NQRPTHLAGAFLAFILGNVYFWLQLLLWR 0.94424 3.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8927 0 0 0 0 0 0 0 0 0 0 0 0 12.9297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.833 0 0 13.8709 0 0 0 0 0 0 0 0 0 0 0 0 12.5417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41440 S19A1_HUMAN "Reduced folate transporter, FOLT (Cyclic dinucleotide:anion antiporter SLC19A1) (Folate:anion antiporter SLC19A1) (Intestinal folate carrier 1, IFC-1) (Placental folate transporter) (Reduced folate carrier protein, RFC, hRFC) (Reduced folate transporter 1, RFT-1) (Solute carrier family 19 member 1, hSLC19A1)" SLC19A1 FLOT1 RFC1 Homo sapiens (Human) cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; female pregnancy [GO:0007565]; folate import across plasma membrane [GO:1904447]; folate transmembrane transport [GO:0098838]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; methotrexate transport [GO:0051958]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; 2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; folate:anion antiporter activity [GO:0008518]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; methotrexate transmembrane transporter activity [GO:0015350]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; female pregnancy [GO:0007565]; folate import across plasma membrane [GO:1904447]; folate transmembrane transport [GO:0098838]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; methotrexate transport [GO:0051958]; organic anion transport [GO:0015711]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic transmembrane transport [GO:0006855]" GO:0005542; GO:0005886; GO:0005887; GO:0006855; GO:0007565; GO:0008514; GO:0008517; GO:0008518; GO:0015350; GO:0015711; GO:0015884; GO:0016323; GO:0016324; GO:0031526; GO:0042910; GO:0046655; GO:0051958; GO:0055085; GO:0061507; GO:0098838; GO:0140360; GO:0140361; GO:0150104; GO:1904447 "2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; folate:anion antiporter activity [GO:0008518]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; methotrexate transmembrane transporter activity [GO:0015350]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]" AAVLLGVFTSSVLGQLLVTVGR 0.94425 2.8094 11.0975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7414 11.9041 0 0 0 11.7921 0 0 0 0 0 0 0 0 13.8597 13.0562 13.5625 0 0 10.1736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4241 0 0 0 0 0 0 14.4703 0 0 12.9575 0 15.2374 0 14.5106 15.2429 0 0 14.0464 14.5731 0 14.5097 15.4936 0 0 0 14.5662 14.0557 0 0 0 0 14.3002 0 0 0 0 0 14.0613 14.2486 14.8524 0 0 0 0 0 0 0 0 0 14.1606 0 14.1468 14.3382 14.4701 14.3628 0 12.7224 0 0 0 12.841 0 14.5497 0 0 0 0 0 0 0 0 0 12.4366 0 0 0 12.5593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1163 0 0 15.7418 Q9H3Y0 CRSPL_HUMAN Peptidase inhibitor R3HDML (Cysteine-rich secretory protein R3HDML) R3HDML Homo sapiens (Human) negative regulation of peptidase activity [GO:0010466] extracellular space [GO:0005615] extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of peptidase activity [GO:0010466] GO:0005615; GO:0010466; GO:0030414 peptidase inhibitor activity [GO:0030414] LLSGLEVPRYRR 0.94427 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6146 0 0 0 0 0 0 0 0 0 0 13.593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23219 PGH1_HUMAN "Prostaglandin G/H synthase 1, EC 1.14.99.1 (Cyclooxygenase-1, COX-1) (Prostaglandin H2 synthase 1, PGH synthase 1, PGHS-1, PHS 1) (Prostaglandin-endoperoxide synthase 1)" PTGS1 COX1 Homo sapiens (Human) cyclooxygenase pathway [GO:0019371]; inflammatory response [GO:0006954]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; cyclooxygenase pathway [GO:0019371]; inflammatory response [GO:0006954]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; response to oxidative stress [GO:0006979]" GO:0001516; GO:0001750; GO:0004601; GO:0004666; GO:0005737; GO:0005789; GO:0005794; GO:0006954; GO:0006979; GO:0008217; GO:0016702; GO:0019371; GO:0020037; GO:0042127; GO:0043005; GO:0043231; GO:0046872; GO:0070062 "heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]" FDPELLFGVQFQYRNR 0.94429 4.0857 0 0 0 0 0 0 0 0 0 11.5668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7355 0 0 0 0 0 0 0 0 0 0 11.7742 0 0 0 0 13.0154 0 0 0 12.9709 0 0 0 0 12.2958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5093 0 0 0 14.7927 0 11.5867 0 12.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4385 0 0 13.5143 11.5567 11.8609 0 12.9941 0 0 0 0 0 0 0 0 0 10.4283 0 0 0 0 0 0 13.8829 0 0 0 0 13.3876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1988 0 0 0 13.4992 0 Q86WD7 SPA9_HUMAN Serpin A9 (Centerin) (Germinal center B-cell-expressed transcript 1 protein) SERPINA9 GCET1 SERPINA11 UNQ692/PRO1337 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0005737; GO:0010951; GO:0016020 serine-type endopeptidase inhibitor activity [GO:0004867] LYEAEVFSTDFSNPSIAQAR 0.94429 2.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75807 PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A (Growth arrest and DNA damage-inducible protein GADD34) (Myeloid differentiation primary response protein MyD116 homolog) PPP1R15A GADD34 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation [GO:1903917]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of translational initiation in response to stress [GO:0032058]; protein localization to endoplasmic reticulum [GO:0070972]; regulation of cell cycle [GO:0051726]; regulation of translational initiation by eIF2 alpha dephosphorylation [GO:0036496]; response to endoplasmic reticulum stress [GO:0034976] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein phosphatase type 1 complex [GO:0000164] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein phosphatase type 1 complex [GO:0000164]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation [GO:1903917]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of translational initiation in response to stress [GO:0032058]; protein localization to endoplasmic reticulum [GO:0070972]; regulation of cell cycle [GO:0051726]; regulation of translational initiation by eIF2 alpha dephosphorylation [GO:0036496]; response to endoplasmic reticulum stress [GO:0034976] GO:0000164; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006915; GO:0006974; GO:0008157; GO:0016020; GO:0019888; GO:0019901; GO:0032058; GO:0032515; GO:0032516; GO:0034976; GO:0035308; GO:0036496; GO:0051726; GO:0070059; GO:0070972; GO:0072542; GO:1902310; GO:1903898; GO:1903917 protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] ECCPAVEEEDDEEAVKKEAHR 0.9443 3.9264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1102 0 0 11.4175 0 0 13.9288 0 0 0 0 0 0 0 15.1536 0 0 0 15.149 0 0 0 13.8865 13.425 0 0 14.6977 0 0 0 13.007 0 13.9966 0 0 0 0 0 13.6577 0 0 15.1425 0 0 0 0 0 13.9056 0 0 0 13.7629 0 14.3246 0 0 11.4486 0 14.1482 0 12.9753 0 14.4216 14.2961 14.351 0 0 14.3348 14.0276 0 0 0 14.5356 0 0 0 0 14.4033 0 0 0 0 0 0 10.7947 0 0 11.9337 0 0 11.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0673 0 0 0 0 0 0 0 Q4V348 Z658B_HUMAN Zinc finger protein 658B ZNF658B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AALIVHQR 0.9443 1.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7B0 FLIP1_HUMAN "Filamin-A-interacting protein 1, FILIP" FILIP1 KIAA1275 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] GO:0005730; GO:0005829; GO:0005886; GO:0015629 AETQSMKIELK 0.9443 4.0124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5972 0 0 0 14.474 0 0 0 0 0 13.7432 0 0 0 0 13.641 0 12.6688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1974 0 0 0 10.7126 0 0 0 0 13.8481 0 0 0 0 0 0 0 11.8539 0 13.2135 0 13.1977 0 0 0 13.3759 13.0091 13.9177 11.1381 0 0 12.758 12.9854 0 13.3259 13.1137 13.1682 12.8359 0 13.2737 12.666 12.1366 0 0 0 0 0 0 0 15.4598 0 0 12.2055 0 0 11.8183 14.995 0 0 13.0151 12.972 0 13.9026 13.6895 14.4112 13.1806 0 14.3105 0 0 0 13.6397 0 0 0 0 12.7945 0 15.013 0 11.6038 11.3771 0 0 0 0 0 0 0 0 11.3601 0 12.2912 14.3161 0 0 0 13.2894 13.9121 0 0 0 0 0 0 0 Q969S6 TM203_HUMAN Transmembrane protein 203 TMEM203 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; spermatogenesis [GO:0007283] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cellular calcium ion homeostasis [GO:0006874]; spermatogenesis [GO:0007283] GO:0005783; GO:0005789; GO:0006874; GO:0007283; GO:0016021 LFWVLTVLSLK 0.9443 1.7434 0 0 0 13.0395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7012 0 0 0 0 0 13.6498 0 0 0 0 0 0 11.1977 0 0 0 12.4812 0 0 0 0 12.4632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7078 0 0 0 0 0 0 14.0587 0 0 0 0 0 P05538 DQB2_HUMAN "HLA class II histocompatibility antigen, DQ beta 2 chain (HLA class II histocompatibility antigen, DX beta chain) (MHC class II antigen DQB2)" HLA-DQB2 HLA-DXB Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; immune response [GO:0006955]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] GO:0000139; GO:0002250; GO:0002503; GO:0005765; GO:0005886; GO:0006955; GO:0010008; GO:0012507; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0032395; GO:0032588; GO:0042613; GO:0050870; GO:0071556 MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395] GQKGPRGPPPAGLLH 0.94431 3.8714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1699 0 14.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0927 0 0 0 0 0 0 0 0 0 13.1828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7005 0 0 0 0 0 Q8NBH2 KY_HUMAN "Kyphoscoliosis peptidase, EC 3.4.-.-" KY Homo sapiens (Human) muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]; peptidase activity [GO:0008233]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; proteolysis [GO:0006508] GO:0005737; GO:0005856; GO:0006508; GO:0007517; GO:0007528; GO:0008233; GO:0030018 peptidase activity [GO:0008233] LHGIAKVLVK 0.94431 2.3938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7566 0 13.0667 0 0 0 0 0 0 0 0 0 0 11.8279 0 0 0 0 0 0 11.1989 0 14.1632 0 0 0 14.1141 0 0 0 0 0 13.6946 0 0 12.2262 0 0 0 0 0 14.1159 0 0 0 0 13.5983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.879 13.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3657 Q9UKB3 DJC12_HUMAN DnaJ homolog subfamily C member 12 (J domain-containing protein 1) DNAJC12 JDP1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 GKKDLMLEESDK 0.94432 1.0263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3921 0 11.5918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.4682 0 11.6551 0 12.1192 0 0 0 0 0 0 0 0 0 0 0 0 13.2658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DV4 RM38_HUMAN "39S ribosomal protein L38, mitochondrial, L38mt, MRP-L38 (Mitochondrial large ribosomal subunit protein mL38)" MRPL38 HSPC262 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005762; GO:0032543 EKIDIGLPPPKVSR 0.94433 1.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8545 0 0 0 O00189 AP4M1_HUMAN "AP-4 complex subunit mu-1 (AP-4 adaptor complex mu subunit) (Adaptor-related protein complex 4 subunit mu-1) (Mu subunit of AP-4) (Mu-adaptin-related protein 2, mu-ARP2) (Mu4-adaptin, mu4)" AP4M1 MUARP2 Homo sapiens (Human) autophagosome assembly [GO:0000045]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome lumen [GO:0031904]; extracellular exosome [GO:0070062]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome lumen [GO:0031904]; extracellular exosome [GO:0070062]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; protein domain specific binding [GO:0019904]; protein transmembrane transporter activity [GO:0008320]; autophagosome assembly [GO:0000045]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192] GO:0000045; GO:0005769; GO:0005802; GO:0005829; GO:0006605; GO:0006622; GO:0006886; GO:0006892; GO:0006895; GO:0008104; GO:0008320; GO:0016192; GO:0019904; GO:0030124; GO:0030131; GO:0031410; GO:0031904; GO:0032588; GO:0070062; GO:0090160; GO:1903361 protein domain specific binding [GO:0019904]; protein transmembrane transporter activity [GO:0008320] HLSHSDAYVIR 0.94434 1.0258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0449 0 0 12.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.569 16.8543 0 0 0 0 0 0 0 0 0 0 0 0 13.6241 11.4957 0 0 0 0 0 0 0 0 0 0 12.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8952 0 0 0 11.9144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0761 0 12.7346 0 0 0 0 0 0 0 0 0 12.9339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7051 0 P21912 SDHB_HUMAN "Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial, EC 1.3.5.1 (Iron-sulfur subunit of complex II, Ip)" SDHB SDH SDH1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]" "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]" "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]" GO:0005654; GO:0005739; GO:0005743; GO:0005749; GO:0005886; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0009060; GO:0022904; GO:0031966; GO:0042776; GO:0046872; GO:0048039; GO:0051537; GO:0051538; GO:0051539 "2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]" CGPMVLDALIKIKNEVDSTLTFR 0.94434 3.4748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5992 0 0 0 0 0 0 0 0 0 0 0 0 12.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5605 0 0 10.956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9457 0 0 0 0 0 13.2327 0 11.2551 0 0 0 13.3146 0 0 0 10.5097 0 0 0 0 0 0 0 0 0 0 13.5768 0 0 0 0 0 0 18.4331 0 14.3604 0 0 0 11.1861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0492 0 0 0 0 0 0 0 0 0 0 0 15.5584 15.5494 0 0 0 0 0 0 0 0 0 0 0 10.348 0 0 0 0 0 0 0 12.0057 0 0 12.2095 0 0 0 9.97284 Q03395 ROM1_HUMAN "Rod outer segment membrane protein 1, ROSP1 (Tetraspanin-23, Tspan-23)" ROM1 TSPAN23 Homo sapiens (Human) camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell outer segment organization [GO:0035845]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to photoreceptor outer segment [GO:1903546]; regulation of gene expression [GO:0010468]; retina vasculature development in camera-type eye [GO:0061298]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622] integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622]; protein homodimerization activity [GO:0042803]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell outer segment organization [GO:0035845]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to photoreceptor outer segment [GO:1903546]; regulation of gene expression [GO:0010468]; retina vasculature development in camera-type eye [GO:0061298]; visual perception [GO:0007601] GO:0005887; GO:0007155; GO:0007601; GO:0010468; GO:0035845; GO:0042622; GO:0042803; GO:0050908; GO:0051260; GO:0051291; GO:0060219; GO:0061298; GO:1903546 protein homodimerization activity [GO:0042803] APVLPLVLPLQPR 0.94434 1.0194 0 0 0 0 0 0 0 0 0 0 12.5391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6165 0 0 0 0 0 0 0 9.81506 0 11.3822 0 0 0 0 0 0 0 0 0 0 0 0 13.7323 0 0 0 0 0 10.4296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3294 0 0 0 12.0276 0 0 0 0 0 13.8919 12.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5661 0 15.2114 0 0 0 0 0 0 0 11.2349 0 0 0 0 13.6037 0 0 13.8533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5597 0 0 0 0 0 0 0 0 0 11.8181 0 0 0 0 0 0 12.4409 0 0 0 0 0 0 0 0 14.2755 0 0 0 0 0 0 0 0 0 0 Q07352 TISB_HUMAN "mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1, ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1, ZFP36-like 1)" ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; protein kinase B signaling [GO:0043491]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; response to wounding [GO:0009611]; spongiotrophoblast layer development [GO:0060712]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; 14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; protein kinase B signaling [GO:0043491]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; response to wounding [GO:0009611]; spongiotrophoblast layer development [GO:0060712]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]" GO:0000165; GO:0000288; GO:0000932; GO:0001570; GO:0003342; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006915; GO:0007507; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0014065; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0046872; GO:0048382; GO:0051028; GO:0060710; GO:0060712; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904 14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] HSVTLPSSK 0.94435 1.0184 0 0 12.0126 0 0 0 0 0 0 0 0 0 0 13.2352 0 0 0 0 0 0 11.8441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4654 0 13.3167 0 0 14.0633 0 13.1174 0 0 14.0215 0 0 0 0 13.2638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UE4 LYRIC_HUMAN "Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein, AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein)" MTDH AEG1 LYRIC Homo sapiens (Human) lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0001650; GO:0003712; GO:0003713; GO:0003723; GO:0003725; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005923; GO:0006357; GO:0010508; GO:0016021; GO:0016324; GO:0016604; GO:0031663; GO:0031965; GO:0043066; GO:0043123; GO:0045766; GO:0046581; GO:0048471; GO:0051059; GO:0051092; GO:0051897; GO:0061629 double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] EEAAAVPAAAPDDLALLKNLRSEEQK 0.94435 2.4848 0 0 0 0 0 0 0 0 0 12.5865 13.2095 0 11.4618 0 0 10.1768 0 0 0 0 0 0 0 0 0 14.3614 0 0 0 12.1506 0 0 0 0 0 0 0 13.458 0 0 0 0 12.9868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5164 0 11.1257 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1174 0 0 0 0 0 0 0 0 13.0348 0 13.4251 12.5036 0 0 0 0 0 0 0 12.2408 11.8877 0 0 0 0 0 0 0 0 0 0 0 13.1418 0 0 0 0 0 0 0 0 13.4247 0 0 0 0 0 0 0 0 0 14.773 13.0382 0 0 0 13.5895 0 0 0 0 0 0 14.5396 0 0 0 0 13.9394 13.4394 0 13.0059 11.2383 0 0 0 0 0 13.4986 0 0 12.8988 0 0 0 0 0 14.6982 0 0 Q9H354 YJ001_HUMAN Putative uncharacterized protein PRO1933 PRO1933 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 HNLRLVQLASELILIEIIPK 0.94436 1.7425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2311 0 0 13.9855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8167 0 12.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T59 CDRTF_HUMAN CMT1A duplicated region transcript 15 protein CDRT15 Homo sapiens (Human) LGRRVPAATPAPR 0.94437 1.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3313 0 0 10.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0013 11.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 P54253 ATX1_HUMAN Ataxin-1 (Spinocerebellar ataxia type 1 protein) ATXN1 ATX1 SCA1 Homo sapiens (Human) "anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; regulation of transcription, DNA-templated [GO:0006355]; RNA processing [GO:0006396]; social behavior [GO:0035176]" GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006396; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0008022; GO:0008266; GO:0016363; GO:0034046; GO:0035176; GO:0042405; GO:0042802; GO:0043621; GO:0045892; GO:0048856; GO:0051168 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621] ADGLAGSRHR 0.94438 1.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3372 11.5025 12.5626 0 17.4937 0 14.6817 0 0 0 11.8435 0 11.1325 0 0 0 0 0 13.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7973 0 0 0 0 0 0 0 0 18.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.254 0 0 0 0 0 Q15695 U2AFL_HUMAN "Putative U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 1) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 1)" ZRSR2P1 U2AF1-RS1 U2AF1L1 U2AF1P U2AF1RS1 U2AFBPL ZRSR1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] "spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0005681; GO:0030628; GO:0046872; GO:0089701 metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628] FGDRCSR 0.94438 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBZ9 TEX47_HUMAN Testis-expressed protein 47 TEX47 C7orf62 Homo sapiens (Human) GSKRPLPLEPLLFLQVPR 0.94439 1.7422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8415 0 0 0 0 0 0 14.7673 14.8532 15.0557 0 14.9702 14.9276 16.2105 15.6505 0 15.1312 15.4765 16.5503 15.8036 15.5698 0 15.5987 15.7539 14.9301 11.8405 14.6893 14.6384 14.3748 0 15.0152 14.8497 14.7371 0 15.9212 0 0 14.5599 0 15.9636 14.7852 15.4047 0 13.8857 0 0 0 14.3654 14.2968 13.0611 14.5897 0 0 12.053 0 0 0 0 0 0 14.0116 0 0 0 0 0 0 14.218 0 14.0157 0 14.8116 0 0 0 0 13.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8981 0 0 0 0 0 0 A6NGZ8 SMIM9_HUMAN Small integral membrane protein 9 SMIM9 CXorf68 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 EPQKLLIIGFLLCSLTCLLLETVASSPLPLSALGIQEKTGSK 0.9444 1.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9533 0 0 0 0 0 0 0 0 12.003 0 0 12.0968 0 0 11.3686 0 11.6289 0 12.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8898 0 0 0 0 0 Q9UJH8 METRN_HUMAN Meteorin METRN C16orf23 RJD6 Homo sapiens (Human) axonogenesis [GO:0007409]; glial cell differentiation [GO:0010001]; positive regulation of axonogenesis [GO:0050772]; radial glial cell differentiation [GO:0060019] extracellular space [GO:0005615] extracellular space [GO:0005615]; hormone activity [GO:0005179]; axonogenesis [GO:0007409]; glial cell differentiation [GO:0010001]; positive regulation of axonogenesis [GO:0050772]; radial glial cell differentiation [GO:0060019] GO:0005179; GO:0005615; GO:0007409; GO:0010001; GO:0050772; GO:0060019 hormone activity [GO:0005179] ARPGIACLRPVR 0.9444 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8761 0 0 0 0 0 0 0 0 0 0 0 11.1098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46783 RS10_HUMAN 40S ribosomal protein S10 (Small ribosomal subunit protein eS10) RPS10 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0016020; GO:0022626; GO:0022627 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EGVMVAK 0.94443 1.027 0 0 0 0 0 0 14.0393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1051 0 0 0 0 0 0 0 0 0 0 14.1417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DP74 D130A_HUMAN "Beta-defensin 130A (Beta-defensin 130) (Beta-defensin 30, DEFB-30) (Defensin, beta 130)" DEFB130A DEFB130 DEFB30 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832] cytosol [GO:0005829]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular space [GO:0005615]; CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832] GO:0005615; GO:0005829; GO:0031731; GO:0042056; GO:0042742; GO:0042832; GO:0051838; GO:0060326; GO:0061844 CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056] KLHSLISVLLLFVTLIPK 0.94444 3.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7715 0 0 0 0 10.5824 0 0 0 0 0 0 0 0 0 14.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7252 11.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5134 0 0 0 0 0 0 0 0 0 0 0 0 11.1316 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7604 0 0 0 0 0 0 0 0 0 14.0145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3911 0 11.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0157 0 0 0 0 0 0 0 0 P27824 CALX_HUMAN Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90) CANX Homo sapiens (Human) aging [GO:0007568]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; synaptic vesicle endocytosis [GO:0048488]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082] axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790] axon [GO:0030424]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic active zone membrane [GO:0099059]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; synaptic vesicle endocytosis [GO:0048488]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082] GO:0003723; GO:0005509; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005791; GO:0005840; GO:0006457; GO:0007568; GO:0009306; GO:0016020; GO:0019082; GO:0030246; GO:0030424; GO:0030433; GO:0032839; GO:0032991; GO:0034185; GO:0034975; GO:0035255; GO:0042470; GO:0043025; GO:0043197; GO:0044233; GO:0044322; GO:0048488; GO:0051082; GO:0070062; GO:0071556; GO:0072583; GO:0098978; GO:0099055; GO:0099059 apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; ionotropic glutamate receptor binding [GO:0035255]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] AKHHAISAKLNK 0.94444 2.4143 0 0 0 0 0 0 0 0 0 12.4629 0 0 0 0 0 0 0 0 0 0 0 0 10.5237 0 0 0 0 0 12.5346 0 0 0 0 0 0 0 10.0507 11.9635 0 10.5312 0 0 0 0 0 0 0 0 0 12.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7764 0 14.563 12.5641 0 0 0 0 0 0 0 0 0 0 15.6906 0 12.2878 0 10.9964 0 0 0 0 12.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8098 0 0 0 0 0 0 0 12.2793 0 0 0 0 0 0 0 0 0 0 12.3947 9.83629 0 0 11.9383 0 0 0 0 0 0 0 0 12.7919 0 12.5853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.917 11.9303 0 0 P43489 TNR4_HUMAN Tumor necrosis factor receptor superfamily member 4 (ACT35 antigen) (OX40L receptor) (TAX transcriptionally-activated glycoprotein 1 receptor) (CD antigen CD134) TNFRSF4 TXGP1L Homo sapiens (Human) "immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immunoglobulin production [GO:0002639]; T cell proliferation [GO:0042098]" cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tumor necrosis factor receptor activity [GO:0005031]; virus receptor activity [GO:0001618]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immunoglobulin production [GO:0002639]; T cell proliferation [GO:0042098]" GO:0001618; GO:0002639; GO:0005031; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0009897; GO:0009986; GO:0030890; GO:0042098; GO:0043433; GO:0045892 tumor necrosis factor receptor activity [GO:0005031]; virus receptor activity [GO:0001618] AVAAILGLGLVLGLLGPLAILLALYLLRR 0.94444 3.8013 0 0 0 0 11.7211 0 0 0 0 0 0 11.1366 0 0 0 0 0 0 0 0 0 0 0 11.467 0 12.0651 0 0 12.0234 0 0 0 0 0 0 12.2705 0 0 0 0 0 11.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3568 0 0 0 0 0 0 0 0 0 0 0 13.3977 0 0 0 10.9697 0 0 0 0 0 0 0 12.3822 0 0 12.3224 0 0 14.3117 0 11.2376 14.0873 11.9803 0 0 0 14.7938 0 0 12.2723 0 0 0 10.7254 0 0 12.6376 0 0 13.5985 0 0 0 0 0 0 0 0 0 14.4027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5394 0 0 0 0 0 0 11.1003 0 0 12.5633 0 13.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8456 0 0 0 0 0 0 0 0 0 Q63ZE4 S22AA_HUMAN Solute carrier family 22 member 10 (Organic anion transporter 5) SLC22A10 OAT5 Homo sapiens (Human) organic anion transport [GO:0015711] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; organic anion transport [GO:0015711] GO:0015711; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] ALVVILSSGALSIGQIILGGLAYVFR 0.94444 3.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.665 0 0 0 0 0 11.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4589 0 0 0 0 11.0194 0 0 0 0 12.7567 0 0 12.0193 0 0 11.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0419 Q8N7B6 PACRL_HUMAN PACRG-like protein PACRGL C4orf28 Homo sapiens (Human) AIPLLPRLIPVLKAALVHSDDEVFER 0.94444 4.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4653 0 10.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1343 0 0 0 0 0 13.3945 0 12.9264 0 0 0 0 0 0 0 0 0 0 13.792 0 0 0 0 0 0 0 12.9799 0 11.9153 0 0 11.323 0 0 0 12.0355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1848 0 0 0 0 0 Q9BR46 SCAS1_HUMAN Putative uncharacterized protein SCP2D1-AS1 (SCP2D1 antisense RNA 1) SCP2D1-AS1 C20orf78 Homo sapiens (Human) DKKDLSLDLLLTR 0.94451 1.0307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01210 PENK_HUMAN "Proenkephalin-A [Cleaved into: Synenkephalin; Met-enkephalin (Opioid growth factor, OGF); PENK(114-133); PENK(143-183); Met-enkephalin-Arg-Gly-Leu; Leu-enkephalin; PENK(237-258); Met-enkephalin-Arg-Phe ]" PENK Homo sapiens (Human) "aggressive behavior [GO:0002118]; aging [GO:0007568]; behavioral fear response [GO:0001662]; cellular response to cAMP [GO:0071320]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to virus [GO:0098586]; cellular response to vitamin D [GO:0071305]; chemical synaptic transmission [GO:0007268]; general adaptation syndrome, behavioral process [GO:0051867]; glial cell proliferation [GO:0014009]; locomotory exploration behavior [GO:0035641]; neuropeptide signaling pathway [GO:0007218]; osteoblast differentiation [GO:0001649]; positive regulation of behavioral fear response [GO:2000987]; regulation of long-term synaptic depression [GO:1900452]; response to calcium ion [GO:0051592]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic signaling via neuropeptide [GO:0099538]" axon terminus [GO:0043679]; cell body fiber [GO:0070852]; chromaffin granule lumen [GO:0034466]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synaptic vesicle lumen [GO:0034592] "axon terminus [GO:0043679]; cell body fiber [GO:0070852]; chromaffin granule lumen [GO:0034466]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synaptic vesicle lumen [GO:0034592]; neuropeptide hormone activity [GO:0005184]; opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]; aggressive behavior [GO:0002118]; aging [GO:0007568]; behavioral fear response [GO:0001662]; cellular response to cAMP [GO:0071320]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to virus [GO:0098586]; cellular response to vitamin D [GO:0071305]; chemical synaptic transmission [GO:0007268]; general adaptation syndrome, behavioral process [GO:0051867]; glial cell proliferation [GO:0014009]; locomotory exploration behavior [GO:0035641]; neuropeptide signaling pathway [GO:0007218]; osteoblast differentiation [GO:0001649]; positive regulation of behavioral fear response [GO:2000987]; regulation of long-term synaptic depression [GO:1900452]; response to calcium ion [GO:0051592]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic signaling via neuropeptide [GO:0099538]" GO:0001515; GO:0001649; GO:0001662; GO:0001666; GO:0001964; GO:0002118; GO:0005184; GO:0005576; GO:0005788; GO:0005886; GO:0007165; GO:0007218; GO:0007268; GO:0007568; GO:0007600; GO:0009314; GO:0009636; GO:0014009; GO:0019233; GO:0030425; GO:0031628; GO:0032280; GO:0032355; GO:0032496; GO:0034466; GO:0034592; GO:0034599; GO:0035094; GO:0035641; GO:0043025; GO:0043204; GO:0043278; GO:0043679; GO:0045471; GO:0051592; GO:0051867; GO:0070852; GO:0071305; GO:0071320; GO:0071560; GO:0071871; GO:0098586; GO:0099013; GO:0099538; GO:1900452; GO:2000987 neuropeptide hormone activity [GO:0005184]; opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628] AECSQDCATCSYR 0.94454 3.4224 0 0 0 0 12.6932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3046 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4285 0 0 0 0 0 0 0 0 0 0 0 13.6629 0 0 0 0 0 0 0 12.0843 0 0 0 0 0 0 0 0 0 0 0 11.937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01344 IGF2_HUMAN "Insulin-like growth factor II, IGF-II (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin ]" IGF2 PP1446 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]" GO:0000122; GO:0001649; GO:0001701; GO:0001892; GO:0001934; GO:0005158; GO:0005159; GO:0005178; GO:0005179; GO:0005576; GO:0005615; GO:0006006; GO:0006349; GO:0006355; GO:0008083; GO:0008284; GO:0008286; GO:0009887; GO:0031017; GO:0031056; GO:0031093; GO:0038028; GO:0040018; GO:0042104; GO:0043085; GO:0043410; GO:0043539; GO:0045725; GO:0045840; GO:0045944; GO:0046622; GO:0046628; GO:0048018; GO:0048633; GO:0050731; GO:0051146; GO:0051147; GO:0051148; GO:0051781; GO:0051897; GO:0060669; GO:0060720; GO:1905564; GO:2000467 growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018] RSRGIVEECCFR 0.94454 1.027 0 0 0 0 0 0 0 0 0 0 0 0 12.1418 12.041 0 0 0 0 12.1374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51164 ATP4B_HUMAN Potassium-transporting ATPase subunit beta (Gastric H(+)/K(+) ATPase subunit beta) (Proton pump beta chain) ATP4B Homo sapiens (Human) cell adhesion [GO:0007155]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; pH reduction [GO:0045851]; potassium ion import across plasma membrane [GO:1990573]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]; sodium ion export across plasma membrane [GO:0036376] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890] apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; heterocyclic compound binding [GO:1901363]; P-type potassium:proton transporter activity [GO:0008900]; cell adhesion [GO:0007155]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; pH reduction [GO:0045851]; potassium ion import across plasma membrane [GO:1990573]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243]; sodium ion export across plasma membrane [GO:0036376] GO:0001671; GO:0005886; GO:0005890; GO:0006883; GO:0007155; GO:0008900; GO:0010243; GO:0016324; GO:0030007; GO:0032496; GO:0036376; GO:0045851; GO:1901363; GO:1990573 ATPase activator activity [GO:0001671]; heterocyclic compound binding [GO:1901363]; P-type potassium:proton transporter activity [GO:0008900] APNHTKFSCK 0.94455 1.0205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99541 PLIN2_HUMAN "Perilipin-2 (Adipophilin) (Adipose differentiation-related protein, ADRP)" PLIN2 ADFP Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; long-chain fatty acid transport [GO:0015909]; positive regulation of sequestering of triglyceride [GO:0010890]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; long-chain fatty acid transport [GO:0015909]; positive regulation of sequestering of triglyceride [GO:0010890]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] GO:0005576; GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0005886; GO:0009410; GO:0010890; GO:0014070; GO:0015909; GO:0019915; GO:0042149; GO:1905691 DSVASTITGVMDKTK 0.94456 1.7404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6362 0 0 14.1991 0 0 0 0 14.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4086 0 0 0 0 0 0 0 Q6P9B9 INT5_HUMAN "Integrator complex subunit 5, Int5" INTS5 KIAA1698 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034243; GO:0034472 AHLAALDETPVAGPPHLR 0.94458 3.8665 0 0 0 0 0 0 0 0 14.4571 0 0 13.8855 14.6547 0 14.4393 0 0 0 14.5328 15.2722 0 13.5961 0 13.1507 0 0 0 11.0027 0 0 0 0 13.7519 0 0 13.9777 13.5093 14.1427 0 0 14.1286 0 0 14.0844 13.9784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0264 0 0 0 0 0 0 0 0 0 13.2942 15.4198 12.996 0 0 0 0 0 0 0 0 0 0 0 14.7041 0 0 12.1289 0 0 0 11.7968 0 0 0 0 11.4334 14.2977 0 0 15.8311 12.7048 0 0 0 0 0 13.5093 0 14.8002 0 15.0807 12.4478 14.6253 14.5143 0 14.4325 15.7092 0 0 0 12.4441 0 15.8597 0 0 0 0 0 0 13.3039 12.9703 0 0 11.6842 14.9258 0 13.9264 0 13.6319 0 11.3796 15.65 0 0 0 0 0 14.8259 0 0 0 0 0 0 11.606 14.9281 0 0 14.5552 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5L5 LENEP_HUMAN Lens epithelial cell protein LEP503 LENEP LEP503 Homo sapiens (Human) lens development in camera-type eye [GO:0002088] DNA binding [GO:0003677]; lens development in camera-type eye [GO:0002088] GO:0002088; GO:0003677 DNA binding [GO:0003677] DTGLRVPVIK 0.9446 1.0194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4663 0 0 0 0 0 12.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.368 0 P80294 MT1H_HUMAN "Metallothionein-1H, MT-1H (Metallothionein-0, MT-0) (Metallothionein-IH, MT-IH)" MT1H Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010273; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCICKGASEK 0.94464 3.4214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6191 11.8379 0 0 0 0 0 0 0 0 0 0 0 0 10.845 0 0 0 0 12.7798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3755 0 0 0 13.1336 13.8661 0 0 11.3071 13.4495 0 0 0 0 11.2256 0 0 12.4362 12.3814 0 0 14.7868 0 0 0 0 0 13.4073 0 0 0 0 0 0 0 0 0 0 0 11.5164 0 0 0 0 10.4475 0 0 0 0 0 0 11.305 0 0 0 0 0 11.5276 0 0 0 0 0 0 0 12.0665 0 0 0 0 0 0 0 0 0 0 11.0333 0 10.8076 11.8455 0 0 0 0 11.8388 0 0 0 0 0 0 14.2001 P04899 GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein) GNAI2 GNAI2B Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165] cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165] GO:0001664; GO:0001973; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005834; GO:0005886; GO:0007049; GO:0007165; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007194; GO:0007213; GO:0007214; GO:0007584; GO:0008283; GO:0008284; GO:0016020; GO:0030335; GO:0030425; GO:0030496; GO:0031683; GO:0032930; GO:0033864; GO:0035810; GO:0035815; GO:0044297; GO:0045121; GO:0045202; GO:0045955; GO:0046628; GO:0046872; GO:0050805; GO:0051301; GO:0051924; GO:0070062; GO:0070374; GO:0140199; GO:1903561; GO:1903614; GO:1904707; GO:2000179; GO:2001234 G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] EVKLLLLGAGESGK 0.94465 1.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2238 0 0 P09326 CD48_HUMAN "CD48 antigen (B-lymphocyte activation marker BLAST-1) (BCM1 surface antigen) (Leukocyte antigen MEM-102) (SLAM family member 2, SLAMF2) (Signaling lymphocytic activation molecule 2) (TCT.1) (CD antigen CD48)" CD48 BCM1 BLAST1 Homo sapiens (Human) defense response [GO:0006952]; regulation of adaptive immune response [GO:0002819]; T cell activation [GO:0042110] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; signaling receptor activity [GO:0038023]; defense response [GO:0006952]; regulation of adaptive immune response [GO:0002819]; T cell activation [GO:0042110] GO:0002819; GO:0003823; GO:0005886; GO:0006952; GO:0009897; GO:0016020; GO:0031225; GO:0031226; GO:0038023; GO:0042110; GO:0045121; GO:0070062 antigen binding [GO:0003823]; signaling receptor activity [GO:0038023] IKLQVLDPVPKPVIK 0.94465 2.5673 0 11.4446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14574 DSC3_HUMAN Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP) DSC3 CDHF3 DSC4 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; protein stabilization [GO:0050821] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; protein stabilization [GO:0050821] GO:0001533; GO:0001701; GO:0005509; GO:0005576; GO:0005737; GO:0005886; GO:0005911; GO:0007155; GO:0007156; GO:0016020; GO:0016021; GO:0030054; GO:0030057; GO:0045295; GO:0050821; GO:0098609 calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295] CNQNEDRMPSQDYVLTYNYEGRGSPAGSVGCCSEK 0.94468 2.4296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.016 13.0842 14.7254 13.0757 0 0 0 0 0 0 0 0 0 0 0 0 13.5504 12.1351 0 0 0 12.4421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4895 0 0 11.7755 11.286 0 0 0 0 0 0 0 13.2653 0 12.3243 0 0 0 12.1739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5628 0 12.1929 14.1869 0 12.0926 0 13.7444 0 0 0 0 0 0 0 0 12.1652 0 0 0 0 12.3385 0 0 0 P16150 LEUK_HUMAN "Leukosialin (GPL115) (Galactoglycoprotein, GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD antigen CD43) [Cleaved into: CD43 cytoplasmic tail, CD43-ct, CD43ct ]" SPN CD43 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; establishment or maintenance of cell polarity [GO:0007163]; immune response [GO:0006955]; leukocyte tethering or rolling [GO:0050901]; negative regulation of cell adhesion [GO:0007162]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of T cell migration [GO:2000406]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune response [GO:0050776]; regulation of T cell migration [GO:2000404]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; PML body [GO:0016605]; uropod [GO:0001931] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; PML body [GO:0016605]; uropod [GO:0001931]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; establishment or maintenance of cell polarity [GO:0007163]; immune response [GO:0006955]; leukocyte tethering or rolling [GO:0050901]; negative regulation of cell adhesion [GO:0007162]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of T cell migration [GO:2000406]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune response [GO:0050776]; regulation of T cell migration [GO:2000404]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296] GO:0001931; GO:0002296; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006935; GO:0006955; GO:0006968; GO:0007162; GO:0007163; GO:0007165; GO:0007166; GO:0009897; GO:0009986; GO:0016020; GO:0016605; GO:0030544; GO:0031072; GO:0032760; GO:0042130; GO:0042742; GO:0050776; GO:0050901; GO:0070062; GO:2000404; GO:2000406 heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; transmembrane signaling receptor activity [GO:0004888] GMLPVAVLVALLAVIVLVALLLLWR 0.9447 2.567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4852 15.2325 0 0 0 0 0 0 0 0 0 0 0 0 13.2344 10.4723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92496 FHR4_HUMAN "Complement factor H-related protein 4, FHR-4" CFHR4 CFHL4 FHR4 Homo sapiens (Human) complement activation [GO:0006956] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; complement component C3b binding [GO:0001851]; lipid transporter activity [GO:0005319]; complement activation [GO:0006956] GO:0001851; GO:0005319; GO:0005576; GO:0005615; GO:0006956 complement component C3b binding [GO:0001851]; lipid transporter activity [GO:0005319] CGPPPPISNGDTTSFLLK 0.9447 2.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9192 0 0 10.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9312 0 0 13.8114 0 0 0 0 0 0 0 0 0 0 0 12.7943 0 0 0 0 0 0 0 0 0 0 11.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2707 0 0 0 0 Q99797 MIPEP_HUMAN "Mitochondrial intermediate peptidase, MIP, EC 3.4.24.59" MIPEP MIP Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508] GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006518; GO:0006627; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] HYQTGQPLPK 0.9447 1.7472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2745 0 0 0 13.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7516 0 0 0 0 16.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0138 0 0 0 0 Q8N3J6 CADM2_HUMAN "Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D, IgSF4D) (Nectin-like protein 3, NECL-3) (Synaptic cell adhesion molecule 2, SynCAM 2)" CADM2 IGSF4D NECL3 Homo sapiens (Human) brain development [GO:0007420]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] anchoring junction [GO:0070161]; axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; synapse [GO:0045202]; brain development [GO:0007420]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005886; GO:0007156; GO:0007420; GO:0016021; GO:0030424; GO:0032809; GO:0045202; GO:0070161 ALRDNRIELVR 0.94471 2.8684 0 0 0 0 0 0 0 0 0 10.0327 11.1115 0 0 0 0 0 0 0 0 0 0 0 0 13.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4806 0 0 0 0 0 0 0 0 0 0 0 0 12.5824 0 0 0 0 0 0 0 0 0 0 14.9292 0 0 0 0 0 0 0 0 0 0 0 0 12.3174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3805 13.4219 0 0 0 0 0 12.4228 0 0 0 10.5732 0 13.9882 0 0 0 0 0 0 0 13.5142 0 14.3505 0 0 14.0724 0 0 0 0 11.3742 0 0 0 12.5589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9507 0 0 0 0 0 0 0 0 0 0 Q9NP31 SH22A_HUMAN "SH2 domain-containing protein 2A (SH2 domain-containing adapter protein) (T cell-specific adapter protein, TSAd) (VEGF receptor-associated protein)" SH2D2A SCAP TSAD VRAP Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SH3 domain binding [GO:0017124]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098] GO:0001525; GO:0005737; GO:0005829; GO:0007165; GO:0017124; GO:0030154; GO:0042098 SH3 domain binding [GO:0017124] EPSQLLRPKPPIPAK 0.94473 1.746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6374 0 0 10.2372 0 0 0 0 0 0 0 0 0 0 16.4936 0 13.2119 0 0 13.243 0 0 0 0 0 0 15.1492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4547 0 0 0 0 0 0 0 0 13.3068 0 0 0 0 0 0 0 0 0 12.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9085 0 0 0 0 0 0 Q86YP4 P66A_HUMAN "Transcriptional repressor p66-alpha, Hp66alpha (GATA zinc finger domain-containing protein 2A)" GATAD2A Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" GO:0000122; GO:0005634; GO:0005654; GO:0006306; GO:0006338; GO:0016575; GO:0016581; GO:0016607; GO:0030674; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000736 metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; sequence-specific DNA binding [GO:0043565] ALKVEHTSRLK 0.94474 3.4191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6826 0 12.7128 12.1315 12.9399 11.9993 0 0 12.5671 0 12.4054 0 0 11.5981 11.24 0 14.2733 0 0 13.3096 0 0 0 0 0 11.5508 0 0 0 12.309 13.014 0 12.6963 14.6519 0 0 0 0 0 0 0 13.3502 0 14.2448 0 0 0 0 9.33677 0 0 12.3826 0 0 0 0 0 0 0 0 9.74844 0 0 0 0 0 0 17.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2262 16.952 12.674 0 0 0 0 0 10.0557 0 0 0 0 0 0 0 0 0 0 0 10.9519 11.2256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5V2 NGEF_HUMAN Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor) NGEF Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020] cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005829; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0043087; GO:0048013; GO:0051056; GO:0061002; GO:0090630 guanyl-nucleotide exchange factor activity [GO:0005085] CRGLPFSSFLILPFQRITR 0.94474 3.9988 0 0 0 0 0 0 0 0 0 0 13.158 0 0 0 0 0 0 0 0 0 0 0 13.1878 14.1128 0 0 12.7592 0 0 0 0 0 0 0 0 12.6485 0 12.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8959 0 0 0 0 0 0 0 13.9063 13.7973 0 0 0 0 0 0 0 0 0 0 0 12.288 0 0 0 0 13.3012 12.1381 0 12.5904 0 0 0 13.2598 0 12.7042 0 0 0 14.3645 0 0 13.9247 0 0 0 0 0 0 11.7358 0 13.4733 0 13.5258 0 0 0 13.0887 0 14.6392 13.5082 0 0 14.0655 13.4255 14.837 13.456 13.3422 0 0 0 14.5694 0 0 0 0 0 0 0 0 0 11.2762 13.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0798 0 0 0 0 11.9289 0 0 0 0 0 0 11.5728 0 12.1701 P55211 CASP9_HUMAN "Caspase-9, CASP-9, EC 3.4.22.62 (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3, APAF-3) (ICE-like apoptotic protease 6, ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10 ]" CASP9 MCH6 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; epithelial cell apoptotic process [GO:1904019]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770] apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; epithelial cell apoptotic process [GO:1904019]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; platelet formation [GO:0030220]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of response to DNA damage stimulus [GO:2001020]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; signal transduction in response to DNA damage [GO:0042770] GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0007568; GO:0008047; GO:0008233; GO:0008303; GO:0008630; GO:0008635; GO:0017124; GO:0019901; GO:0030220; GO:0032025; GO:0032355; GO:0032496; GO:0032991; GO:0034349; GO:0034644; GO:0042770; GO:0042802; GO:0043065; GO:0043293; GO:0043525; GO:0044346; GO:0046677; GO:0051402; GO:0071549; GO:0071887; GO:0097153; GO:0097193; GO:0097199; GO:0097200; GO:0097202; GO:1904019; GO:2001020 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] KLFFKTS 0.94475 1.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6083 0 0 0 0 0 0 0 0 9.73767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0W7 THAP2_HUMAN THAP domain-containing protein 2 THAP2 Homo sapiens (Human) nucleolus [GO:0005730]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0005730; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] HFEASCFDLTGQTR 0.94475 2.5423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0885 14.4592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5242 0 0 0 0 0 0 0 0 0 0 12.8869 14.1031 0 0 13.724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7972 13.366 0 0 0 0 0 13.1119 0 0 0 0 0 0 0 0 0 13.4268 13.6284 0 0 0 0 0 0 0 0 0 0 13.6795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17010 ZFX_HUMAN Zinc finger X-chromosomal protein ZFX Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0001228; GO:0005654; GO:0005694; GO:0005730; GO:0006357; GO:0043035; GO:0045944; GO:0046872 "chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AIECDECGK 0.94477 2.4256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5 12.4149 12.0773 11.8121 0 0 0 0 0 0 0 0 0 0 0 0 14.1458 0 0 0 0 0 0 0 13.3515 0 0 0 0 0 12.4852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6074 0 0 Q9H1N7 S35B3_HUMAN Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (3'-phosphoadenosine 5'-phosphosulfate transporter) (PAPS transporter 2) (Solute carrier family 35 member B3) SLC35B3 C6orf196 PAPST2 CGI-19 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428] Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173] Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428] GO:0000139; GO:0022857; GO:0030173; GO:0030176; GO:0046964; GO:0050428 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857] ITMDLKFNNSRK 0.94477 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYM8 HOIL1_HUMAN "RanBP-type and C3HC4-type zinc finger-containing protein 1, EC 2.3.2.31 (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1, HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3)" RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4 Homo sapiens (Human) cytoplasmic sequestering of protein [GO:0051220]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; LUBAC complex [GO:0071797]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cytoplasmic sequestering of protein [GO:0051220]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] GO:0000151; GO:0000209; GO:0003713; GO:0004842; GO:0005829; GO:0032088; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0050852; GO:0051092; GO:0051220; GO:0060546; GO:0071797; GO:0097039; GO:0140311; GO:1901224; GO:2001238 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842] ARLAGEEEALR 0.94478 2.8674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5964 0 0 0 0 0 0 11.234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2864 0 12.735 0 0 0 0 0 0 0 0 0 0 0 0 12.8302 0 0 0 0 0 0 0 0 0 0 0 0 12.253 0 0 0 0 0 12.1776 0 0 0 0 0 0 12.7618 0 0 0 12.2422 12.1146 0 0 0 0 0 0 0 0 0 11.5129 12.2973 0 0 0 0 0 0 11.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW36 ZN695_HUMAN Zinc finger protein 695 (Zinc finger protein SBZF3) ZNF695 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNECSCFTDCK 0.94479 3.6041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4783 0 0 0 0 0 0 0 0 0 0 0 0 12.8152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2296 0 12.7764 0 0 0 0 0 11.207 0 0 0 0 0 0 14.7355 14.296 14.8956 15.8462 15.8048 15.702 14.3155 14.5993 0 15.4319 0 15.5409 13.7479 0 14.577 15.4833 14.7075 12.8024 15.2482 0 0 0 10.1684 0 0 14.4378 0 0 0 0 0 13.6397 16.0089 0 14.5164 14.5066 0 14.3788 0 0 0 14.5207 0 0 0 0 0 0 10.5084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3838 0 0 0 0 0 0 0 0 0 0 Q8WUN7 UBTD2_HUMAN "Ubiquitin domain-containing protein 2 (Dendritic cell-derived ubiquitin-like protein, DC-UbP) (Ubiquitin-like protein SB72)" UBTD2 DCUBP SB72 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 LSTGKDLKLVVR 0.94479 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4W2 LYZL2_HUMAN "Lysozyme-like protein 2, Lysozyme-2, EC 3.2.1.17" LYZL2 Homo sapiens (Human) metabolic process [GO:0008152] extracellular region [GO:0005576] extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; metabolic process [GO:0008152] GO:0003796; GO:0005576; GO:0008152 lysozyme activity [GO:0003796] DLSDWKKDCEVS 0.9448 1.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J2F2 SIK1B_HUMAN "Putative serine/threonine-protein kinase SIK1B, EC 2.7.11.1 (Salt-inducible kinase 1B)" SIK1B Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0035556; GO:0042149; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GFLGLNKIKGLAR 0.94481 2.5846 0 0 0 12.7925 11.6081 0 14.2639 0 0 0 0 0 0 0 0 0 0 0 12.3786 0 0 0 0 11.4918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5067 0 14.3394 0 13.4054 0 0 0 14.0824 0 0 18.2721 0 0 0 10.9926 0 0 17.7735 0 13.5353 0 0 0 0 0 0 15.7014 0 0 0 0 0 0 14.6816 0 0 0 0 0 0 0 0 0 12.2938 14.5992 0 16.5553 0 0 0 11.8486 0 0 0 0 0 0 0 12.3392 12.354 14.473 0 0 0 0 0 0 0 0 0 13.9067 11.0602 0 0 0 0 0 0 11.6723 0 0 0 0 0 0 0 0 0 0 0 0 0 12.97 0 0 0 13.1622 14.6514 0 0 0 0 0 0 P13284 GILT_HUMAN "Gamma-interferon-inducible lysosomal thiol reductase, EC 1.8.-.- (Gamma-interferon-inducible protein IP-30) (Legumaturain)" IFI30 GILT IP30 Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821] cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] "cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of fibroblast proliferation [GO:0048147]; protein stabilization [GO:0050821]" GO:0005576; GO:0005764; GO:0005829; GO:0016491; GO:0016667; GO:0016671; GO:0019886; GO:0030054; GO:0042590; GO:0043202; GO:0043231; GO:0048147; GO:0050821 "oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]" KPDVCPSSTSSLR 0.94482 1.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6131 0 0 0 0 0 0 0 11.2339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5855 0 Q8NH83 OR4A5_HUMAN Olfactory receptor 4A5 (Olfactory receptor OR11-111) OR4A5 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KLTIFIIGGVSVLM 0.94486 1.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60774 FMO6_HUMAN "Putative dimethylaniline monooxygenase [N-oxide-forming] 6, EC 1.14.13.8 (Dimethylaniline oxidase 6) (Flavin-containing monooxygenase 6, FMO 6)" FMO6P FMO6 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]" GO:0004497; GO:0004499; GO:0005789; GO:0016021; GO:0050660; GO:0050661 "flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]" EMMCFPDFPYPDDYPNYIHHSKLQEYIK 0.94487 2.7727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.799 0 0 0 0 0 0 0 0 0 0 0 12.4483 0 12.1662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5293 0 14.2024 0 0 0 0 0 11.9028 0 0 0 0 0 0 0 14.6228 0 12.1323 0 0 11.9773 0 10.9415 0 0 0 11.4587 0 0 0 0 0 0 13.04 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3981 0 0 0 0 0 0 0 0 0 0 0 0 0 P98172 EFNB1_HUMAN "Ephrin-B1 (EFL-3) (ELK ligand, ELK-L) (EPH-related receptor tyrosine kinase ligand 2, LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment, Ephrin-B1 CTF; Ephrin-B1 intracellular domain, Ephrin-B1 ICD ]" EFNB1 EFL3 EPLG2 LERK2 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ephrin receptor binding [GO:0046875]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098] GO:0001755; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0007411; GO:0009880; GO:0031295; GO:0042098; GO:0042102; GO:0045121; GO:0045202; GO:0046875; GO:0048013; GO:0070062 ephrin receptor binding [GO:0046875] AAALSLSTLASPKGGSGTAGTEPSDIIIPLR 0.9449 3.6019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7179 10.24 0 12.9737 0 10.7372 0 0 12.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2514 0 0 0 0 0 0 0 0 0 0 0 0 13.0609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9239 0 0 0 0 0 0 12.2128 0 0 0 0 0 0 0 0 9.64445 0 0 0 0 0 0 0 0 0 12.1784 0 0 0 0 11.4354 0 0 0 0 0 P50120 RET2_HUMAN "Retinol-binding protein 2 (Cellular retinol-binding protein II, CRBP-II)" RBP2 CRBP2 Homo sapiens (Human) epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; vitamin A metabolic process [GO:0006776] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; vitamin A metabolic process [GO:0006776] GO:0005501; GO:0005504; GO:0005634; GO:0005829; GO:0006776; GO:0008544; GO:0015908; GO:0016918; GO:0019841 fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841] ALVTWEGDVLVCVQK 0.94491 2.4009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5837 0 0 0 0 14.0909 0 0 0 0 11.0638 0 0 0 15.4545 0 0 0 0 0 0 0 11.4038 0 0 0 0 0 0 0 0 0 11.4468 0 0 0 0 0 0 0 9.80189 0 0 0 0 0 0 10.3868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6702 0 0 0 0 11.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRJ5 PAPOB_HUMAN "Poly(A) polymerase beta, PAP-beta, EC 2.7.7.19 (Polynucleotide adenylyltransferase beta) (Testis-specific poly(A) polymerase)" PAPOLB PAPT Homo sapiens (Human) mRNA polyadenylation [GO:0006378] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378] GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0006378; GO:0046872 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723] ITAMHLRR 0.94492 2.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5751 0 0 0 0 0 0 0 0 0 0 0 14.2423 0 0 0 0 0 0 0 11.9787 0 0 0 0 0 0 0 0 0 0 0 0 12.4459 0 0 0 0 0 0 0 0 0 0 0 0 12.2007 0 0 0 12.0687 0 0 0 0 0 0 0 0 0 0 0 0 11.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00170 AIP_HUMAN "AH receptor-interacting protein, AIP (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2, XAP-2) (Immunophilin homolog ARA9)" AIP XAP2 Homo sapiens (Human) negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805] aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805] GO:0003713; GO:0003755; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0006805; GO:0010738; GO:0016020; GO:0017162; GO:0022417; GO:0034751; GO:0036004; GO:0051082; GO:0051344 aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082] ARGKPMELIIGK 0.94494 3.4146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5898 0 12.3022 0 0 0 0 12.9531 13.7975 12.4935 0 0 0 0 0 13.5605 0 0 12.6338 0 0 0 0 0 0 0 0 0 0 0 0 13.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8218 0 0 0 0 0 0 0 0 12.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8616 0 0 0 0 0 11.3547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1347 0 0 0 0 0 0 0 0 O15496 PA2GX_HUMAN "Group 10 secretory phospholipase A2, EC 3.1.1.4 (Group X secretory phospholipase A2, GX sPLA2, sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10)" PLA2G10 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; defense response to virus [GO:0051607]; erythrocyte maturation [GO:0043249]; fertilization [GO:0009566]; hair follicle morphogenesis [GO:0031069]; intestinal stem cell homeostasis [GO:0036335]; low-density lipoprotein particle remodeling [GO:0034374]; lysophospholipid transport [GO:0051977]; macrophage activation [GO:0042116]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of inflammatory response [GO:0050728]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; platelet activating factor catabolic process [GO:0062234]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein metabolic process [GO:0051247]; production of molecular mediator involved in inflammatory response [GO:0002532]; prostaglandin biosynthetic process [GO:0001516]; regulation of macrophage activation [GO:0043030] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; defense response to virus [GO:0051607]; erythrocyte maturation [GO:0043249]; fertilization [GO:0009566]; hair follicle morphogenesis [GO:0031069]; intestinal stem cell homeostasis [GO:0036335]; low-density lipoprotein particle remodeling [GO:0034374]; lysophospholipid transport [GO:0051977]; macrophage activation [GO:0042116]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of inflammatory response [GO:0050728]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; platelet activating factor catabolic process [GO:0062234]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein metabolic process [GO:0051247]; production of molecular mediator involved in inflammatory response [GO:0002532]; prostaglandin biosynthetic process [GO:0001516]; regulation of macrophage activation [GO:0043030] GO:0001516; GO:0001669; GO:0002532; GO:0003847; GO:0004620; GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005764; GO:0006644; GO:0006658; GO:0007411; GO:0009566; GO:0010744; GO:0010884; GO:0019369; GO:0031069; GO:0032308; GO:0034374; GO:0034638; GO:0036335; GO:0042116; GO:0042632; GO:0043030; GO:0043249; GO:0043433; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0047498; GO:0050482; GO:0050728; GO:0051247; GO:0051607; GO:0051977; GO:0062234; GO:0090238; GO:0090370; GO:1900016; GO:1990830; GO:2000344 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; phospholipid binding [GO:0005543] DAIDWCCHGHDCCYTR 0.94495 2.398 0 0 0 0 12.927 0 0 0 15.913 16.1454 13.8274 15.9956 0 12.6828 13.6159 11.1678 13.8345 12.2608 0 13.9345 0 0 12.1521 0 13.0949 15.9624 12.4596 12.1134 12.2979 0 0 0 16.3968 16.3046 0 16.185 0 0 12.6956 0 13.1346 0 0 14.1065 12.6822 0 0 0 0 11.1862 0 0 0 12.1005 0 15.8831 11.9238 0 15.6408 15.5285 0 0 15.061 0 0 0 10.6662 10.4456 0 0 0 0 0 0 0 13.9776 13.7148 0 0 0 14.8555 14.3074 11.9679 0 0 0 0 0 13.2567 0 10.9481 0 0 0 11.2212 0 13.1858 12.7839 0 11.4362 13.8413 0 13.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2387 0 13.0355 0 0 13.2675 0 0 11.7325 0 14.3099 0 0 12.3914 0 0 0 0 0 11.9849 0 0 0 13.0313 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9294 11.8841 11.749 14.1822 11.837 13.0772 16.9311 16.5653 16.5093 10.6314 16.7878 13.6964 13.7328 16.6271 16.7641 13.1837 0 0 12.4168 0 16.9771 0 16.6369 14.9067 9.93351 P0C880 YT014_HUMAN Putative uncharacterized protein FLJ40606 Homo sapiens (Human) CACAGTASEGPRR 0.94496 2.6993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6461 0 0 0 0 0 0 0 0 13.0709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1112 0 0 0 0 0 0 0 0 0 P21266 GSTM3_HUMAN "Glutathione S-transferase Mu 3, EC 2.5.1.18 (GST class-mu 3) (GSTM3-3, hGSTM3-3)" GSTM3 GST5 Homo sapiens (Human) cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178] GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458 enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] HNMCGETEEEK 0.94497 2.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NHY2 AKD1B_HUMAN Ankyrin repeat and death domain-containing protein 1B ANKDD1B Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 IVEYLIQDLHLKDLNQPDEKGR 0.94502 2.8171 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2037 0 0 0 0 0 0 0 0 11.2292 0 0 10.9429 0 0 0 0 0 11.782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9395 0 0 0 0 0 0 0 0 0 13.1328 0 0 0 0 11.6144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2082 0 0 0 0 0 13.3584 0 0 12.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3779 0 0 11.9759 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6708 0 12.114 0 0 0 0 0 Q9GZS9 CHST5_HUMAN "Carbohydrate sulfotransferase 5, EC 2.8.2.- (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha, GST4-alpha) (Intestinal N-acetylglucosamine-6-O-sulfotransferase, I-GlcNAc6ST, Intestinal GlcNAc-6-sulfotransferase, hIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3, GlcNAc6ST-3, Gn6st-3)" CHST5 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; protein sulfation [GO:0006477]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001517; GO:0005794; GO:0005802; GO:0005975; GO:0006044; GO:0006477; GO:0006790; GO:0008146; GO:0016021; GO:0018146; GO:0031228 N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] DNGIVLGTNGK 0.94502 2.5785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9965 0 0 0 0 0 0 0 0 0 0 11.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9227 13.9785 0 0 0 0 0 0 13.7451 0 13.3123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5199 0 0 0 14.2174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8201 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9B8 RGF1A_HUMAN Ras-GEF domain-containing family member 1A RASGEF1A Homo sapiens (Human) cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265] GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0016477; GO:0043547; GO:0046579 guanyl-nucleotide exchange factor activity [GO:0005085] AMAELKAITHR 0.94505 3.4604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6387 0 0 0 0 0 0 0 0 0 0 0 0 14.3239 0 0 0 13.5916 0 0 0 0 0 0 0 0 0 0 0 13.1945 0 13.2538 0 0 0 0 0 12.879 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8698 0 0 13.0355 0 0 0 0 0 0 0 0 0 0 12.6416 0 12.5042 0 0 0 0 0 0 0 13.1226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.44 0 0 0 0 0 0 0 0 12.7303 0 0 0 0 0 0 Q9NX61 T161A_HUMAN "Transmembrane protein 161A (Adaptive response to oxidative stress protein 29, AROS-29)" TMEM161A UNQ582/PRO1152 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; positive regulation of DNA repair [GO:0045739]; response to retinoic acid [GO:0032526] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; positive regulation of DNA repair [GO:0045739]; response to retinoic acid [GO:0032526] GO:0016021; GO:0032526; GO:0034599; GO:0034644; GO:0045739; GO:1902230 AVLGVQLVVTLLTATLMHR 0.94509 1.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5498 0 0 0 0 0 9.91766 0 0 0 0 0 0 0 10.2583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2404 0 0 0 0 0 11.8959 0 11.6146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1644 0 0 0 0 12.5845 0 13.7631 12.8239 0 0 0 0 0 0 0 0 0 0 0 13.8158 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIA9 XPO7_HUMAN "Exportin-7, Exp7 (Ran-binding protein 16)" XPO7 KIAA0745 RANBP16 Homo sapiens (Human) protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611] GO:0005049; GO:0005634; GO:0005643; GO:0005737; GO:0006611; GO:0031267 nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] ETSKMITMYGNRILTLGEVPK 0.94509 4.1273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0894 0 0 0 12.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.505 0 0 0 0 0 0 0 0 0 0 0 13.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6294 13.0629 15.4554 0 0 15.4242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3304 Q9UDV6 ZN212_HUMAN Zinc finger protein 212 (Zinc finger protein C2H2-150) ZNF212 ZNFC150 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0003700; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0042802 DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] NFWILRLPPGSK 0.94513 1.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1462 0 0 0 0 0 0 11.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBQ5 DHB11_HUMAN "Estradiol 17-beta-dehydrogenase 11, EC 1.1.1.62 (17-beta-hydroxysteroid dehydrogenase 11, 17-beta-HSD 11, 17bHSD11, 17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI, 17-beta-HSD XI, 17betaHSDXI) (Cutaneous T-cell lymphoma-associated antigen HD-CL-03, CTCL-associated antigen HD-CL-03) (Dehydrogenase/reductase SDR family member 8) (Retinal short-chain dehydrogenase/reductase 2, retSDR2) (Short chain dehydrogenase/reductase family 16C member 2)" HSD17B11 DHRS8 PAN1B SDR16C2 PSEC0029 UNQ207/PRO233 Homo sapiens (Human) androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]" GO:0004303; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006703; GO:0006710; GO:0016229; GO:0016616; GO:0044594 "17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]" FLAVLKQKISVK 0.94514 3.9049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.374 0 0 0 0 0 0 0 10.9114 0 0 0 0 0 0 0 0 0 12.7896 0 10.4149 0 0 0 0 0 13.3954 15.025 0 0 14.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1042 14.1559 0 14.354 0 0 0 0 14.453 0 0 14.1406 0 0 0 0 0 0 0 0 0 0 13.8297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4157 0 0 0 12.8683 0 0 0 0 0 0 0 0 12.3393 0 0 0 0 13.3615 14.187 0 13.0948 0 12.4864 0 0 0 0 0 0 0 Q8N1M1 BEST3_HUMAN Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3) BEST3 VMD2L3 Homo sapiens (Human) negative regulation of ion transport [GO:0043271] chloride channel complex [GO:0034707]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; negative regulation of ion transport [GO:0043271] GO:0005254; GO:0005886; GO:0034707; GO:0043271 chloride channel activity [GO:0005254] KLFNHLK 0.94518 1.0277 0 0 0 15.1571 13.2701 14.7137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4058 0 0 14.0538 0 0 0 0 0 0 0 0 0 0 10.6735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1228 0 0 0 0 0 0 0 0 0 0 15.5855 0 18.8802 0 14.4257 0 14.5128 0 0 0 0 0 0 0 0 0 0 0 18.4457 0 0 0 0 0 0 0 18.9029 0 0 0 19.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1317 0 0 0 13.2246 0 0 P0CZ25 D10OS_HUMAN Uncharacterized protein DNAH10OS DNAH10OS Homo sapiens (Human) ESGGPDTCHLPCH 0.94522 0.87592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6327 0 0 0 12.1138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15315 RA51B_HUMAN "DNA repair protein RAD51 homolog 2, R51H2 (RAD51 homolog B, Rad51B) (RAD51-like protein 1)" RAD51B RAD51L1 REC2 Homo sapiens (Human) blastocyst growth [GO:0001832]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; somite development [GO:0061053] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; somite development [GO:0061053]" GO:0000724; GO:0001832; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0006281; GO:0006310; GO:0007131; GO:0008094; GO:0008284; GO:0010971; GO:0033063; GO:0061053; GO:0140664 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]" ACAPKMQTAYGIK 0.94524 2.7664 0 0 0 0 0 0 0 0 12.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2667 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5176 0 0 0 0 0 0 0 0 0 13.1233 Q9Y5E1 PCDB9_HUMAN "Protocadherin beta-9, PCDH-beta-9 (Protocadherin-3H)" PCDHB9 PCDH3H Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] EPCMLYFQILMDDPFQIYR 0.94526 3.6437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9616 0 0 0 0 0 0 0 0 11.0695 0 0 11.4143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43731 ERD23_HUMAN "ER lumen protein-retaining receptor 3 (KDEL endoplasmic reticulum protein retention receptor 3, KDEL receptor 3)" KDELR3 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030133; GO:0030663; GO:0046923 ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046] GKKLSLPMPI 0.94533 2.812 0 0 0 0 0 0 0 0 0 0 10.9391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8398 0 0 0 0 0 0 0 0 0 0 0 0 12.1037 0 0 0 0 0 0 12.3131 0 14.3073 0 10.8634 0 0 0 0 0 0 0 0 11.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6756 0 0 0 0 0 0 0 0 0 0 0 11.7171 0 0 0 0 0 0 0 0 0 12.5658 0 0 0 11.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7899 0 0 0 0 Q2PZI1 D19L1_HUMAN "Probable C-mannosyltransferase DPY19L1, EC 2.4.1.- (Dpy-19-like protein 1) (Protein dpy-19 homolog 1)" DPY19L1 GA0500 KIAA0877 Homo sapiens (Human) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] GO:0000030; GO:0005637; GO:0016020; GO:0016021; GO:0018406 mannosyltransferase activity [GO:0000030] AVFAAVLHWSHITHLFENDR 0.94534 2.9123 0 10.7039 0 0 0 0 0 0 15.6646 15.6673 0 0 0 15.2996 0 0 9.41109 0 0 0 12.2756 12.4157 0 12.4694 0 0 12.0794 0 0 15.5801 12.0083 0 0 0 0 14.9415 0 0 0 13.8629 12.006 15.5636 14.454 15.7205 0 0 0 13.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4994 0 11.9441 12.3376 0 0 0 13.8706 0 12.5819 0 14.4404 0 15.8933 11.6772 0 0 11.7884 0 13.7525 0 16.0666 16.4838 0 11.2756 14.6805 0 0 0 0 0 12.6325 10.8256 0 0 13.8911 15.042 16.9559 0 0 13.4143 0 0 15.5978 16.7765 17.5331 11.9757 15.315 11.7353 0 13.6302 0 12.7345 15.3469 0 0 14.7916 12.7059 0 13.3447 0 16.6604 0 14.6327 0 0 0 0 14.58 0 0 0 11.6346 0 14.5873 14.7322 16.1159 15.0514 13.5485 15.0093 14.5367 0 11.2896 14.2299 12.0061 0 0 14.1553 12.7026 0 0 15.0353 0 0 0 0 0 16.7379 0 0 15.2966 15.751 13.3848 0 13.1134 13.4584 14.5296 12.9186 13.1119 0 10.9912 15.1703 0 12.7847 Q8NEW0 ZNT7_HUMAN "Zinc transporter 7, ZnT-7 (Solute carrier family 30 member 7) (Znt-like transporter 2)" SLC30A7 ZNT7 ZNTL2 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; metal ion transport [GO:0030001]; sequestering of zinc ion [GO:0032119]; zinc ion import into Golgi apparatus [GO:1904257] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; metal ion transport [GO:0030001]; sequestering of zinc ion [GO:0032119]; zinc ion import into Golgi apparatus [GO:1904257] GO:0005385; GO:0005737; GO:0005794; GO:0006882; GO:0016021; GO:0030001; GO:0031410; GO:0031982; GO:0032119; GO:0046873; GO:0048471; GO:1904257 metal ion transmembrane transporter activity [GO:0046873]; zinc ion transmembrane transporter activity [GO:0005385] ESVGILMQRTPPLLENSLPQCYQR 0.94536 2.7641 0 0 0 0 0 0 0 0 0 10.3004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2098 12.9126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48544 KCNJ5_HUMAN "G protein-activated inward rectifier potassium channel 4, GIRK-4 (Cardiac inward rectifier, CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4, IRK-4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)" KCNJ5 GIRK4 Homo sapiens (Human) membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; ventricular cardiac muscle cell membrane repolarization [GO:0099625] plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; ventricular cardiac muscle cell membrane repolarization [GO:0099625] GO:0005886; GO:0006813; GO:0008076; GO:0015467; GO:0034765; GO:0086089; GO:0086091; GO:0098914; GO:0099625; GO:1902282; GO:1990573 G-protein activated inward rectifier potassium channel activity [GO:0015467]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282] NAMNQDMEIGVTPWDPKKIPK 0.94538 3.6394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.66 13.9834 13.8045 0 0 0 0 0 0 0 0 12.917 0 0 0 13.54 0 0 13.6296 13.2575 15.1615 0 15.6566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9399 14.1278 0 0 0 0 0 0 0 0 11.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01570 IFN14_HUMAN "Interferon alpha-14, IFN-alpha-14 (Interferon alpha-H, LeIF H) (Interferon lambda-2-H)" IFNA14 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132] ALPFALMMALVVLSCK 0.9454 1.0302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12986 NFX1_HUMAN "Transcriptional repressor NF-X1, EC 2.3.2.- (Nuclear transcription factor, X box-binding protein 1)" NFX1 NFX2 Homo sapiens (Human) "inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006366; GO:0006954; GO:0008270; GO:0016567; GO:0045347; GO:0051865; GO:0061630 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]" AEAPPVSGTFK 0.9454 4.119 0 0 0 0 0 0 0 0 0 0 11.1277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4609 15.8059 14.7767 15.1469 0 0 13.0607 0 0 0 0 0 0 0 0 0 14.9933 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8483 12.0811 10.8802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4111 0 0 0 0 10.7029 0 0 0 10.9896 0 0 0 0 11.1594 0 0 0 0 0 0 0 0 14.8801 0 0 0 0 0 0 0 0 0 O75343 GCYB2_HUMAN "Guanylate cyclase soluble subunit beta-2, GCS-beta-2, EC 4.6.1.2" GUCY1B2 Homo sapiens (Human) cGMP-mediated signaling [GO:0019934]; response to oxygen levels [GO:0070482] "guanylate cyclase complex, soluble [GO:0008074]" "guanylate cyclase complex, soluble [GO:0008074]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; cGMP-mediated signaling [GO:0019934]; response to oxygen levels [GO:0070482]" GO:0004383; GO:0005525; GO:0008074; GO:0019934; GO:0020037; GO:0046872; GO:0070482 GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872] EHVVFLIVQKAHRK 0.94541 2.7633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3588 0 12.0008 0 0 0 0 13.788 0 0 0 0 0 0 0 0 0 0 12.6322 11.4159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TGU0 TSPO2_HUMAN Translocator protein 2 (Peripheral-type benzodiazepine receptor-like protein 1) TSPO2 BZRPL1 Homo sapiens (Human) 5-aminolevulinic acid import across plasma membrane [GO:0140484]; enucleate erythrocyte differentiation [GO:0043353]; import across plasma membrane [GO:0098739]; intracellular cholesterol transport [GO:0032367]; lipid droplet organization [GO:0034389] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; 5-aminolevulinic acid transmembrane transporter activity [GO:0140485]; cholesterol binding [GO:0015485]; 5-aminolevulinic acid import across plasma membrane [GO:0140484]; enucleate erythrocyte differentiation [GO:0043353]; import across plasma membrane [GO:0098739]; intracellular cholesterol transport [GO:0032367]; lipid droplet organization [GO:0034389] GO:0005783; GO:0005789; GO:0005886; GO:0015485; GO:0016021; GO:0031090; GO:0032367; GO:0034389; GO:0043353; GO:0098739; GO:0140484; GO:0140485 5-aminolevulinic acid transmembrane transporter activity [GO:0140485]; cholesterol binding [GO:0015485] DHMSGWCEGPR 0.94544 2.4328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9857 0 0 0 0 0 0 0 9.97398 0 0 0 0 14.2662 0 0 0 0 12.6123 0 10.8279 0 0 0 0 0 12.3233 0 0 0 0 0 0 0 0 10.6775 0 11.4186 0 0 0 0 13.8089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 P13224 GP1BB_HUMAN "Platelet glycoprotein Ib beta chain, GP-Ib beta, GPIb-beta, GPIbB (Antigen CD42b-beta) (CD antigen CD42c)" GP1BB Homo sapiens (Human) "blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" GO:0004888; GO:0005886; GO:0005887; GO:0007155; GO:0007166; GO:0007597; GO:0010572; GO:0030168; GO:0035855; GO:0042802; GO:0051209; GO:1990779 identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888] ARAAARLSLTDPLVAER 0.94545 1.0277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8995 12.3273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12887 COX10_HUMAN "Protoheme IX farnesyltransferase, mitochondrial, EC 2.5.1.141 (Heme O synthase)" COX10 Homo sapiens (Human) aerobic respiration [GO:0009060]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; lipid metabolic process [GO:0006629]; mitochondrial fission [GO:0000266]; respiratory chain complex IV assembly [GO:0008535] cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] cytochrome complex [GO:0070069]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; aerobic respiration [GO:0009060]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; lipid metabolic process [GO:0006629]; mitochondrial fission [GO:0000266]; respiratory chain complex IV assembly [GO:0008535] GO:0000266; GO:0004311; GO:0005730; GO:0005739; GO:0005743; GO:0005829; GO:0006629; GO:0006783; GO:0006784; GO:0008495; GO:0008535; GO:0009060; GO:0016021; GO:0070069 farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495] EMKLQVYDLPGILAR 0.94545 4.2018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3462 0 0 0 0 0 0 10.8934 11.4234 0 0 0 0 0 10.9946 0 0 0 0 0 0 0 0 0 11.1243 0 0 0 0 0 0 0 0 0 0 0 0 11.3995 0 0 0 0 0 0 0 0 10.1205 0 0 0 0 10.9989 0 10.8053 0 0 12.4569 0 0 0 0 13.9403 0 0 0 9.99393 0 0 10.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8068 0 0 11.5055 12.088 0 12.0996 0 11.8531 0 0 0 0 13.2514 0 0 0 12.6218 0 0 0 0 12.2787 0 0 12.8871 0 0 0 0 0 12.401 0 0 0 0 0 12.2779 0 0 0 0 12.7928 0 12.2603 0 0 14.0782 13.1176 0 0 12.8928 0 0 0 13.461 13.1944 Q92806 KCNJ9_HUMAN "G protein-activated inward rectifier potassium channel 3, GIRK-3 (Inward rectifier K(+) channel Kir3.3) (Potassium channel, inwardly rectifying subfamily J member 9)" KCNJ9 GIRK3 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] integral component of presynaptic membrane [GO:0099056]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886] integral component of presynaptic membrane [GO:0099056]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005886; GO:0015467; GO:0034765; GO:0098688; GO:0099056; GO:1990573 G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242] DGRCNVQQGNVR 0.94547 2.4068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1565 0 0 12.5236 0 0 0 0 0 0 0 0 0 0 0 12.4562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.2225 20.0076 19.5974 0 17.9216 0 20.0817 20.2428 20.3318 20.1259 0 0 18.1922 0 0 0 0 0 0 0 0 19.1816 0 19.9232 Q9UJV3 TRIM1_HUMAN "Probable E3 ubiquitin-protein ligase MID2, EC 2.3.2.27 (Midin-2) (Midline defect 2) (Midline-2) (RING finger protein 60) (RING-type E3 ubiquitin transferase MID2) (Tripartite motif-containing protein 1)" MID2 FXY2 RNF60 TRIM1 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] GO:0003713; GO:0005737; GO:0005874; GO:0008017; GO:0008270; GO:0010508; GO:0016567; GO:0016740; GO:0019899; GO:0032897; GO:0035372; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0046597; GO:0051091; GO:0051092; GO:0051219; GO:0070062 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270] ATHPNKK 0.94548 2.9081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51124 GRAM_HUMAN "Granzyme M, EC 3.4.21.- (Met-1 serine protease, Hu-Met-1) (Met-ase) (Natural killer cell granular protease)" GZMM MET1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell death [GO:0008219]; cytolysis [GO:0019835]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; T cell mediated cytotoxicity [GO:0001913] extracellular region [GO:0005576]; membrane [GO:0016020] extracellular region [GO:0005576]; membrane [GO:0016020]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytolysis [GO:0019835]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; T cell mediated cytotoxicity [GO:0001913] GO:0001913; GO:0004252; GO:0005576; GO:0006508; GO:0006915; GO:0008219; GO:0008236; GO:0016020; GO:0019835; GO:0045087 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] LSRVLRELDLQVLDTR 0.94549 3.6339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2134 0 0 0 0 0 0 0 10.4732 0 0 0 0 0 0 12.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2186 0 0 0 0 0 0 12.4333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6894 0 12.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NNX6 CD209_HUMAN "CD209 antigen (C-type lectin domain family 4 member L) (Dendritic cell-specific ICAM-3-grabbing non-integrin 1, DC-SIGN, DC-SIGN1) (CD antigen CD209)" CD209 CLEC4L Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; B cell adhesion [GO:0097323]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; peptide antigen transport [GO:0046968]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of viral life cycle [GO:1903902]; regulation of T cell proliferation [GO:0042129]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; B cell adhesion [GO:0097323]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; peptide antigen transport [GO:0046968]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of viral life cycle [GO:1903902]; regulation of T cell proliferation [GO:0042129]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062] GO:0001618; GO:0002250; GO:0005537; GO:0005576; GO:0005737; GO:0005886; GO:0006897; GO:0007157; GO:0007159; GO:0009897; GO:0009986; GO:0009988; GO:0016020; GO:0016021; GO:0019062; GO:0019079; GO:0019882; GO:0030246; GO:0035556; GO:0042102; GO:0042129; GO:0042605; GO:0043657; GO:0045087; GO:0046718; GO:0046790; GO:0046872; GO:0046968; GO:0075733; GO:0097323; GO:1903902 carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; virion binding [GO:0046790]; virus receptor activity [GO:0001618] AAVGELPEK 0.94549 2.4308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2346 12.1062 0 0 10.4245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4702 0 0 0 0 0 0 0 10.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5728 0 0 0 0 0 0 0 0 0 0 11.1243 0 0 0 0 0 0 0 0 0 0 0 Q9Y336 SIGL9_HUMAN "Sialic acid-binding Ig-like lectin 9, Siglec-9 (CDw329) (Protein FOAP-9) (CD antigen CD329)" SIGLEC9 UNQ668/PRO1302 Homo sapiens (Human) cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166] GO:0005886; GO:0005887; GO:0007155; GO:0007166; GO:0030246; GO:0030667; GO:0033691 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] DRFHLLGDPHTK 0.94549 2.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1145 0 0 10.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8656 0 10.0572 0 0 0 0 0 0 0 0 0 10.5807 0 0 0 0 0 0 0 0 0 0 0 15.5905 0 0 12.1698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2424 0 12.1476 0 0 0 0 0 0 0 13.8016 0 13.5429 0 12.1498 0 0 13.2632 12.9379 0 12.9537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9383 14.5202 0 0 0 11.355 0 0 0 0 0 0 0 0 0 12.3414 0 0 0 12.1054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7594 0 0 0 0 0 0 0 0 0 11.0487 0 Q96CP7 TLCD1_HUMAN TLC domain-containing protein 1 (Calfacilitin) TLCD1 Homo sapiens (Human) lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035] GO:0005886; GO:0007009; GO:0016021; GO:0055088; GO:0055091; GO:0071709; GO:0097035 ALCRLPLPVHVR 0.94552 2.8052 0 0 0 0 0 12.6482 0 0 0 12.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7237 14.9211 0 0 0 0 0 0 0 0 11.7802 0 0 0 0 0 0 0 0 0 0 0 11.4312 0 0 12.5982 0 0 0 0 0 0 0 13.2046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1549 0 0 0 0 0 10.2167 0 0 12.9899 0 0 0 0 0 0 11.0005 0 0 0 0 0 0 11.8981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8695 0 0 11.0063 0 0 0 0 0 11.412 0 0 Q15125 EBP_HUMAN "3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, EC 5.3.3.5 (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase, D8-D7 sterol isomerase) (Emopamil-binding protein)" EBP Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; cholesterol metabolic process [GO:0008203]; hemopoiesis [GO:0030097]; ossification involved in bone maturation [GO:0043931]; sterol biosynthetic process [GO:0016126] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear envelope [GO:0005635] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear envelope [GO:0005635]; C-8 sterol isomerase activity [GO:0000247]; cholestenol delta-isomerase activity [GO:0047750]; identical protein binding [GO:0042802]; steroid delta-isomerase activity [GO:0004769]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; cholesterol metabolic process [GO:0008203]; hemopoiesis [GO:0030097]; ossification involved in bone maturation [GO:0043931]; sterol biosynthetic process [GO:0016126] GO:0000247; GO:0004769; GO:0005635; GO:0005783; GO:0005789; GO:0006695; GO:0008203; GO:0016126; GO:0030097; GO:0030176; GO:0031410; GO:0033489; GO:0033490; GO:0042802; GO:0043931; GO:0047750 C-8 sterol isomerase activity [GO:0000247]; cholestenol delta-isomerase activity [GO:0047750]; identical protein binding [GO:0042802]; steroid delta-isomerase activity [GO:0004769] PTWHILAGLFSVTGVLVVTTWLLSGRAAVVPLGTWRR 0.94553 0.87406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W10 CP4Z1_HUMAN "Cytochrome P450 4Z1, EC 1.14.14.1 (CYPIVZ1) (Laurate 7-monooxygenase, EC 1.14.14.130)" CYP4Z1 UNQ3060/PRO9882 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252]" GO:0005506; GO:0005789; GO:0008404; GO:0016021; GO:0019369; GO:0020037; GO:0048252; GO:0052722; GO:0070330 "arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]" GLVTLDGSKWKK 0.94554 2.9075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8899 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0366 16.4553 15.9887 0 0 0 0 15.2764 0 0 0 0 14.286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6584 0 0 12.8008 0 0 0 0 0 13.6908 0 0 13.8261 0 0 0 0 0 0 11.6037 13.9322 0 0 0 0 0 0 0 0 0 0 0 12.4275 0 0 0 0 0 0 0 0 0 12.7733 0 0 0 0 12.8659 0 0 12.7677 0 0 0 0 0 0 0 0 0 0 0 Q8NGA4 G32P1_HUMAN "Putative G-protein coupled receptor GPR32P1 (G-protein coupled 32 pseudogene) (G-protein coupled 32 pseudogene 1) (G-protein coupled receptor GPCR39, hGPCR39)" GPR32P1 Homo sapiens (Human) complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0002430; GO:0004875; GO:0004930; GO:0004982; GO:0005886; GO:0006954; GO:0007200; GO:0007204; GO:0016021 complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982] ASWLAFGVWLLAAALCSAHLK 0.94554 3.8945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9294 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6357 12.9634 14.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9884 0 14.7475 0 13.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9732 0 0 0 14.6856 0 0 0 0 0 0 0 0 0 0 15.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3245 0 0 0 0 0 0 0 0 Q5FYB1 ARSI_HUMAN "Arylsulfatase I, ASI, EC 3.1.6.-" ARSI Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005576; GO:0005788; GO:0046872 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GVKLENYYIQPICTPSR 0.94556 2.4053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9769 0 0 0 0 0 0 13.4824 0 0 0 0 0 0 0 0 0 0 14.5696 0 0 0 0 10.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8779 0 0 0 0 0 0 0 0 0 0 Q9UHG2 PCS1N_HUMAN "ProSAAS (Proprotein convertase subtilisin/kexin type 1 inhibitor, Proprotein convertase 1 inhibitor) (pro-SAAS) [Cleaved into: KEP; Big SAAS, b-SAAS; Little SAAS, l-SAAS (N-proSAAS); Big PEN-LEN, b-PEN-LEN (SAAS CT(1-49)); PEN; Little LEN, l-LEN; Big LEN, b-LEN (SAAS CT(25-40)) ]" PCSK1N Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; response to cold [GO:0009409]; response to dietary excess [GO:0002021] extracellular space [GO:0005615]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802] extracellular space [GO:0005615]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; response to cold [GO:0009409]; response to dietary excess [GO:0002021] GO:0002021; GO:0004866; GO:0004867; GO:0005102; GO:0005615; GO:0005802; GO:0007218; GO:0009409; GO:0016486; GO:0030141 endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102] AGGVGLLVLLLLGLFRPPPALCAR 0.94556 4.1157 12.6787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4374 0 0 0 0 0 0 0 0 0 0 14.2735 0 0 0 0 0 0 0 0 0 13.9506 0 0 0 0 0 0 14.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2491 0 0 0 0 0 0 0 0 0 0 12.052 0 0 0 0 0 13.9956 0 0 13.9889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8336 0 13.8082 Q8WY98 TM234_HUMAN Transmembrane protein 234 TMEM234 C1orf91 PP1065 UNQ548/PRO1105 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AASLGQVLALVLVAALWGGTQPLLK 0.94557 2.5447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5E7 PCDB2_HUMAN "Protocadherin beta-2, PCDH-beta-2" PCDHB2 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] IRDVNDHSPVFLDKEILLK 0.94557 1.7488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05195 MAD1_HUMAN "Max dimerization protein 1, Max dimerizer 1 (Protein MAD)" MXD1 MAD Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; Mad-Max complex [GO:0070443]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; Mad-Max complex [GO:0070443]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0046983; GO:0070443 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LKGLVPLGPESSRHTTLSLLTK 0.94558 2.4266 0 0 0 0 0 0 0 0 0 0 0 0 12.0096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.37 0 0 0 0 0 0 0 0 P0C7H9 U17L7_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 7 USP17L7 Homo sapiens (Human) protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0042981 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] APASKTLTLPTSAKVLILVLK 0.94561 4.6632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9069 13.8275 0 0 0 0 0 0 0 10.9155 0 0 0 0 16.2713 0 0 0 11.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7511 0 0 0 0 0 0 0 0 0 11.5756 0 0 0 12.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6662 0 0 0 0 0 14.2509 0 0 0 0 0 0 0 0 0 0 0 0 11.3904 0 0 0 0 11.049 0 0 0 0 0 0 0 0 11.339 0 0 0 0 Q9HCI7 MSL2_HUMAN "E3 ubiquitin-protein ligase MSL2, EC 2.3.2.- (E3 ubiquitin-protein transferase MSL2) (Male-specific lethal 2-like 1, MSL2-like 1) (Male-specific lethal-2 homolog, MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184)" MSL2 KIAA1585 MSL2L1 RNF184 Homo sapiens (Human) "histone H4-K16 acetylation [GO:0043984]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" MSL complex [GO:0072487]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "MSL complex [GO:0072487]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; histone H4-K16 acetylation [GO:0043984]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" GO:0005634; GO:0005654; GO:0016567; GO:0043984; GO:0045893; GO:0046872; GO:0061630; GO:0072487; GO:1900095 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] ACLDCICRGCQNSYMANGEK 0.94562 4.1999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1286 0 0 0 0 0 0 0 14.6575 0 0 0 0 0 0 13.5833 0 0 0 0 0 0 0 14.2674 0 0 0 11.2087 0 0 0 0 0 0 0 0 0 0 0 10.7857 0 0 0 10.7743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7274 0 0 0 0 0 0 0 0 0 Q9BZG8 DPH1_HUMAN "2-(3-amino-3-carboxypropyl)histidine synthase subunit 1, EC 2.5.1.108 (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (Ovarian cancer-associated gene 1 protein) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1)" DPH1 DPH2L DPH2L1 OVCA1 Homo sapiens (Human) peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] "cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]" GO:0005654; GO:0005829; GO:0017183; GO:0030054; GO:0032991; GO:0051539; GO:0090560 "2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]" ILEHLESRLR 0.94563 1.7482 0 0 0 0 14.279 13.9247 0 13.1605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9635 0 0 13.3261 0 0 0 11.6344 12.9393 13.2616 13.0739 0 0 0 0 0 13.6922 13.7417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6039 0 0 0 0 0 0 12.6837 0 0 0 0 0 0 15.1451 0 0 0 0 0 13.03 0 0 0 0 0 0 0 13.2772 0 0 12.8789 0 12.7828 12.9506 14.257 0 0 0 0 0 0 13.1162 0 0 0 0 0 15.5101 0 0 0 0 0 10.3719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.086 0 14.2522 11.234 0 12.9806 0 0 0 Q7RTX7 CTSR4_HUMAN "Cation channel sperm-associated protein 4, CatSper4" CATSPER4 Homo sapiens (Human) establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] GO:0001669; GO:0005227; GO:0005245; GO:0005886; GO:0006814; GO:0030317; GO:0034765; GO:0036128; GO:0048240; GO:0051649; GO:0097228 calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245] ALRLVHVCMAVEPLAR 0.94564 2.8017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1977 0 10.5642 0 13.9171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5174 15.5681 14.8155 14.3919 14.0394 0 0 0 11.5945 13.7933 0 0 13.052 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7149 0 0 0 0 0 12.9824 0 0 13.1548 0 0 0 12.9896 0 0 0 0 13.0947 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8334 0 0 0 14.7074 0 0 0 0 0 0 0 0 13.7369 0 0 0 0 0 0 0 13.5649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6804 0 0 0 0 12.1123 0 Q9UPZ3 HPS5_HUMAN "BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog, Ru2)" HPS5 AIBP63 KIAA1017 Homo sapiens (Human) blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155] GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232 EEDTEEEKEVTSPPPEEDRFQELK 0.94566 1.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2283 0 0 0 0 0 0 0 0 0 0 11.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1119 0 0 0 0 0 0 0 0 0 0 0 14.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6057 0 0 0 0 0 13.1481 0 0 12.8665 0 12.275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0828 0 0 0 0 0 Q9HCG1 ZN160_HUMAN "Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18, HKr18)" ZNF160 KIAA1611 Homo sapiens (Human) hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hemopoiesis [GO:0030097]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030097; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GVVTDIPPK 0.94567 1.0302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8219 0 9.74631 0 0 0 0 0 0 0 0 0 0 0 13.3228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6168 16.5809 0 0 0 0 0 0 0 15.4564 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14186 TFDP1_HUMAN "Transcription factor Dp-1 (DRTF1-polypeptide 1, DRTF1) (E2F dimerization partner 1)" TFDP1 DP1 Homo sapiens (Human) anoikis [GO:0043276]; epidermis development [GO:0008544]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rb-E2F complex [GO:0035189]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rb-E2F complex [GO:0035189]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein domain specific binding [GO:0019904]; anoikis [GO:0043276]; epidermis development [GO:0008544]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; transcription by RNA polymerase II [GO:0006366]" GO:0000083; GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0008544; GO:0019904; GO:0035189; GO:0043276; GO:0043433; GO:0045944; GO:0051091; GO:0070345; GO:0090575; GO:0140297; GO:1900087; GO:2000278 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein domain specific binding [GO:0019904]" AKDAGLIEANGELKVFIDQNLSPGK 0.9457 2.7996 0 0 0 0 0 0 0 0 0 0 0 0 13.4829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.129 0 12.7774 14.4272 14.2531 0 0 0 0 0 0 14.2598 0 0 14.2693 0 0 0 0 0 0 0 0 0 13.2862 0 0 0 0 0 0 13.39 0 0 0 0 0 0 14.5095 14.075 0 0 14.4909 0 0 0 0 0 0 0 0 0 13.7688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5699 0 0 0 13.9559 0 Q5T6X5 GPC6A_HUMAN "G-protein coupled receptor family C group 6 member A, hGPRC6A (G-protein coupled receptor GPCR33, hGPCR33)" GPRC6A Homo sapiens (Human) response to amino acid [GO:0043200] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; response to amino acid [GO:0043200] GO:0004930; GO:0005886; GO:0005887; GO:0043200 G protein-coupled receptor activity [GO:0004930] IILEAQVNVIVVFLR 0.9457 2.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4211 0 0 0 0 0 0 0 13.4123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1446 0 0 0 0 0 0 0 0 14.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9358 0 0 0 0 0 0 0 0 17.2322 0 0 0 0 11.6741 0 0 0 0 0 0 0 0 0 0 0 0 11.3887 0 0 0 13.5296 0 0 0 0 0 0 0 0 0 Q07869 PPARA_HUMAN "Peroxisome proliferator-activated receptor alpha, PPAR-alpha (Nuclear receptor subfamily 1 group C member 1)" PPARA NR1C1 PPAR Homo sapiens (Human) "behavioral response to nicotine [GO:0035095]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; circadian regulation of gene expression [GO:0032922]; enamel mineralization [GO:0070166]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; lipid localization [GO:0010876]; lipoprotein metabolic process [GO:0042157]; negative regulation of appetite [GO:0032099]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of glycolytic process [GO:0045820]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid transport [GO:2000191]; regulation of lipid metabolic process [GO:0019216]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; wound healing [GO:0042060]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; lipid binding [GO:0008289]; MDM2/MDM4 family protein binding [GO:0097371]; NFAT protein binding [GO:0051525]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; phosphatase binding [GO:0019902]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; behavioral response to nicotine [GO:0035095]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; circadian regulation of gene expression [GO:0032922]; enamel mineralization [GO:0070166]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; lipid localization [GO:0010876]; lipoprotein metabolic process [GO:0042157]; negative regulation of appetite [GO:0032099]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of glycolytic process [GO:0045820]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid transport [GO:2000191]; regulation of lipid metabolic process [GO:0019216]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; wound healing [GO:0042060]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0001228; GO:0001666; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006094; GO:0006631; GO:0007507; GO:0008270; GO:0008289; GO:0008544; GO:0009267; GO:0009755; GO:0010565; GO:0010745; GO:0010876; GO:0010887; GO:0010891; GO:0019216; GO:0019217; GO:0019902; GO:0019904; GO:0030154; GO:0030512; GO:0031624; GO:0032000; GO:0032091; GO:0032099; GO:0032868; GO:0032922; GO:0033993; GO:0035095; GO:0042060; GO:0042157; GO:0042752; GO:0043565; GO:0044877; GO:0045070; GO:0045471; GO:0045722; GO:0045776; GO:0045820; GO:0045893; GO:0045923; GO:0045944; GO:0046321; GO:0046889; GO:0050728; GO:0051525; GO:0051898; GO:0061052; GO:0061629; GO:0070166; GO:0097371; GO:0140297; GO:1900016; GO:1901215; GO:1902894; GO:1903038; GO:1903427; GO:1903944; GO:2000191; GO:2000272; GO:2001171 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; lipid binding [GO:0008289]; MDM2/MDM4 family protein binding [GO:0097371]; NFAT protein binding [GO:0051525]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; phosphatase binding [GO:0019902]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]" CQYCRFHKCLSVGMSHNAIR 0.94571 2.5859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.874 0 0 0 0 13.9818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6073 0 0 0 0 0 0 0 15.0915 0 14.5391 14.5906 15.3066 15.0038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4285 0 Q8N8C0 ZN781_HUMAN Zinc finger protein 781 ZNF781 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] DFTNVQNVGR 0.94571 4.1138 0 0 0 0 0 0 0 0 0 0 15.7494 0 0 0 0 0 0 0 0 0 0 14.3359 0 0 11.7505 13.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9047 0 0 12.4408 0 0 15.3613 12.3138 15.4299 15.4331 0 10.9936 0 11.0184 0 0 16.2179 12.3781 11.7104 0 0 0 0 0 0 10.8848 13.5132 0 0 0 0 0 12.6968 15.2696 0 0 0 0 0 0 0 0 14.4979 14.6771 0 13.0251 0 0 0 0 0 14.0522 15.4598 0 0 0 0 0 0 13.4715 0 0 0 0 0 0 15.043 0 0 15.2079 0 15.9511 0 0 0 0 13.5555 0 0 0 0 0 0 0 0 0 13.177 0 14.2911 0 0 10.2149 16.5687 0 0 0 0 0 10.6384 0 0 0 0 11.8453 0 0 0 0 0 0 15.2816 0 P51168 SCNNB_HUMAN "Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta, Beta-ENaC, ENaCB) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB)" SCNN1B Homo sapiens (Human) aldosterone metabolic process [GO:0032341]; artery smooth muscle contraction [GO:0014824]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; epithelial fluid transport [GO:0042045]; erythrocyte homeostasis [GO:0034101]; gene expression [GO:0010467]; leukocyte activation involved in inflammatory response [GO:0002269]; mucus secretion [GO:0070254]; multicellular organism growth [GO:0035264]; multicellular organismal water homeostasis [GO:0050891]; neutrophil activation involved in immune response [GO:0002283]; neutrophil-mediated killing of bacterium [GO:0070944]; potassium ion homeostasis [GO:0055075]; regulation of blood pressure [GO:0008217]; response to food [GO:0032094]; response to xenobiotic stimulus [GO:0009410]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; urea homeostasis [GO:0097274] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; aldosterone metabolic process [GO:0032341]; artery smooth muscle contraction [GO:0014824]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; epithelial fluid transport [GO:0042045]; erythrocyte homeostasis [GO:0034101]; gene expression [GO:0010467]; leukocyte activation involved in inflammatory response [GO:0002269]; mucus secretion [GO:0070254]; multicellular organism growth [GO:0035264]; multicellular organismal water homeostasis [GO:0050891]; neutrophil activation involved in immune response [GO:0002283]; neutrophil-mediated killing of bacterium [GO:0070944]; potassium ion homeostasis [GO:0055075]; regulation of blood pressure [GO:0008217]; response to food [GO:0032094]; response to xenobiotic stimulus [GO:0009410]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; urea homeostasis [GO:0097274] GO:0002269; GO:0002283; GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0008217; GO:0009410; GO:0009897; GO:0010467; GO:0014824; GO:0015280; GO:0016324; GO:0030659; GO:0032094; GO:0032341; GO:0034101; GO:0034706; GO:0035264; GO:0035725; GO:0036254; GO:0042045; GO:0050699; GO:0050891; GO:0050914; GO:0050915; GO:0055075; GO:0055078; GO:0070062; GO:0070254; GO:0070944; GO:0071468; GO:0097274; GO:0098719; GO:1904045; GO:1904117 ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699] DFPDWAHCYSDLQMSVAQR 0.94572 2.7054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5342 0 0 0 0 0 0 0 13.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.823 15.1947 0 14.3635 0 0 0 0 0 0 14.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 13.919 0 0 11.6906 0 0 0 0 0 0 0 0 0 0 10.8 0 0 0 0 0 14.1618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1786 0 12.563 0 0 0 0 0 0 0 0 0 0 13.8689 0 0 0 0 0 0 13.8704 13.8093 0 0 0 0 0 0 0 O94955 RHBT3_HUMAN "Rho-related BTB domain-containing protein 3, EC 3.6.1.-" RHOBTB3 KIAA0878 Homo sapiens (Human) "actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; male gonad development [GO:0008584]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; retrograde transport, endosome to Golgi [GO:0042147]; small GTPase mediated signal transduction [GO:0007264]" cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; male gonad development [GO:0008584]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; retrograde transport, endosome to Golgi [GO:0042147]; small GTPase mediated signal transduction [GO:0007264]" GO:0003924; GO:0005524; GO:0005525; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0008584; GO:0016477; GO:0016887; GO:0019901; GO:0030865; GO:0031267; GO:0031410; GO:0032588; GO:0032956; GO:0042147; GO:0042995; GO:0070062 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] DSGDVSNVIEKVKCILK 0.94577 0.8743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3T8 ZFY16_HUMAN Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein) ZFYVE16 KIAA0305 Homo sapiens (Human) endosomal transport [GO:0016197]; protein targeting to lysosome [GO:0006622]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]; vesicle organization [GO:0016050] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] "cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; endosomal transport [GO:0016197]; protein targeting to lysosome [GO:0006622]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165]; vesicle organization [GO:0016050]" GO:0005545; GO:0005547; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0016050; GO:0016197; GO:0030100; GO:0031901; GO:0043231; GO:0046872 "1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" ACGKVFCGVCCNRK 0.94582 2.7964 0 0 0 0 0 0 0 0 0 0 0 12.5734 0 0 0 0 0 0 0 0 0 0 0 11.3622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4392 0 0 0 0 0 0 0 0 0 0 0 12.539 0 10.9646 0 0 0 0 0 0 0 0 13.733 0 12.8532 0 0 0 0 0 0 13.1264 0 0 0 0 0 13.3405 0 0 0 0 0 0 0 0 0 0 0 0 12.999 0 13.6936 12.5408 0 0 0 0 0 13.5837 0 0 0 0 12.7131 12.4695 0 0 0 0 14.0154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9R8 SCAI_HUMAN Protein SCAI (Suppressor of cancer cell invasion protein) SCAI C9orf126 Homo sapiens (Human) "negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024]; transcription, DNA-templated [GO:0006351]" GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0016021; GO:0030336; GO:0031965; GO:0035024 transcription corepressor activity [GO:0003714] LLLTRFIFCSATMRMHK 0.94582 0.87202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2434 0 0 0 0 0 0 0 0 12.7303 0 0 0 17.263 17.5597 0 0 14.8749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3178 0 0 0 0 0 0 0 0 0 0 0 15.3295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.612 0 0 0 Q9HBM1 SPC25_HUMAN "Kinetochore protein Spc25, hSpc25" SPC25 SPBC25 AD024 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052] cytosol [GO:0005829]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleus [GO:0005634] cytosol [GO:0005829]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleus [GO:0005634]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052] GO:0000776; GO:0005634; GO:0005829; GO:0007052; GO:0007059; GO:0007094; GO:0008608; GO:0031262; GO:0031617; GO:0051301 DNLLKLIAEVK 0.94582 2.5828 0 0 0 0 0 0 0 0 11.2922 0 0 0 0 10.6544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6633 0 14.7882 0 0 0 0 0 0 16.5821 0 0 0 0 0 0 0 16.6281 0 0 0 0 0 0 0 0 10.5913 0 0 0 0 0 13.4463 13.9189 9.63374 0 13.6992 13.5622 0 0 0 12.5591 12.3485 0 13.6555 0 0 0 0 0 0 0 0 13.5201 0 0 0 12.5723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16552 IL17_HUMAN "Interleukin-17A, IL-17, IL-17A (Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8)" IL17A CTLA8 IL17 Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cell-cell signaling [GO:0007267]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cell-cell signaling [GO:0007267]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760] GO:0002225; GO:0002250; GO:0005125; GO:0005576; GO:0005615; GO:0006915; GO:0006954; GO:0006955; GO:0007219; GO:0007267; GO:0008219; GO:0009897; GO:0032731; GO:0032735; GO:0032739; GO:0032747; GO:0032755; GO:0032760; GO:0042803; GO:0045087; GO:0045672; GO:0045944; GO:0046982; GO:0050829; GO:0050830; GO:0050832; GO:0060729; GO:0071347; GO:0072537; GO:0097400; GO:0097530; GO:1900017; GO:1903348; GO:2000340 cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] MTPGKTSLVSLLLLLSLEAIVKAGITIPR 0.94585 2.8704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0099 0 0 0 0 0 10.7127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3252 0 0 0 0 0 14.5743 0 0 0 14.4434 0 0 14.9419 13.249 0 14.7237 0 0 0 14.4091 0 0 13.0679 0 0 0 0 0 0 0 13.7186 13.3838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8822 0 0 0 0 0 13.458 0 0 0 0 0 0 0 0 0 12.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGI9 OR5A2_HUMAN Olfactory receptor 5A2 (Olfactory receptor OR11-248) OR5A2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] AFSTCASHLTAVTLFYGSGFFMYMR 0.94587 2.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7514 0 0 0 0 0 0 0 0 0 0 11.8313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5233 0 0 0 14.1376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EX2 RNFT2_HUMAN RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118) RNFT2 TMEM118 Homo sapiens (Human) positive regulation of ERAD pathway [GO:1904294] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294] GO:0016021; GO:0046872; GO:0061630; GO:1904294 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] DGATSAHFQVY 0.94587 4.1123 0 0 0 0 0 0 0 0 0 0 13.346 0 0 0 0 13.2598 0 12.2777 0 0 0 0 0 0 12.8504 0 0 12.3487 0 0 0 0 0 0 0 0 0 0 0 0 11.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6595 0 13.7356 15.0273 13.9902 0 0 0 0 0 0 0 0 13.4521 0 12.9139 14.2021 0 0 0 0 0 19.7638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.528 0 15.443 0 13.022 13.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3659 0 13.6203 0 0 13.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7854 13.3935 0 0 0 0 0 0 0 P51636 CAV2_HUMAN Caveolin-2 CAV2 Homo sapiens (Human) basement membrane organization [GO:0071711]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; endoplasmic reticulum organization [GO:0007029]; endothelial cell proliferation [GO:0001935]; insulin receptor signaling pathway [GO:0008286]; mitochondrion organization [GO:0007005]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of skeletal muscle cell proliferation [GO:0014859]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation by host of viral process [GO:0044794]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitotic nuclear division [GO:0007088]; skeletal muscle cell proliferation [GO:0014856]; skeletal muscle fiber development [GO:0048741]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle organization [GO:0016050]; viral release from host cell [GO:0019076] acrosomal membrane [GO:0002080]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cytoplasmic vesicle [GO:0031410]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133] acrosomal membrane [GO:0002080]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cytoplasmic vesicle [GO:0031410]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]; D1 dopamine receptor binding [GO:0031748]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; scaffold protein binding [GO:0097110]; basement membrane organization [GO:0071711]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; endoplasmic reticulum organization [GO:0007029]; endothelial cell proliferation [GO:0001935]; insulin receptor signaling pathway [GO:0008286]; mitochondrion organization [GO:0007005]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of skeletal muscle cell proliferation [GO:0014859]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation by host of viral process [GO:0044794]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitotic nuclear division [GO:0007088]; skeletal muscle cell proliferation [GO:0014856]; skeletal muscle fiber development [GO:0048741]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle organization [GO:0016050]; viral release from host cell [GO:0019076] GO:0000139; GO:0001935; GO:0001937; GO:0001938; GO:0002080; GO:0002095; GO:0005634; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0005925; GO:0006906; GO:0007005; GO:0007029; GO:0007088; GO:0007179; GO:0008286; GO:0014856; GO:0014859; GO:0016020; GO:0016050; GO:0019065; GO:0019076; GO:0019901; GO:0030133; GO:0030154; GO:0030512; GO:0030674; GO:0031234; GO:0031410; GO:0031748; GO:0032991; GO:0042803; GO:0043410; GO:0043547; GO:0044794; GO:0045121; GO:0046982; GO:0048278; GO:0048471; GO:0048741; GO:0051480; GO:0060090; GO:0060161; GO:0070836; GO:0071711; GO:0097110 D1 dopamine receptor binding [GO:0031748]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; scaffold protein binding [GO:0097110] LGFEDVIAEPVTTHSFDKVWICSHALFEISKYVMYK 0.94589 0.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75019 LIRA1_HUMAN "Leukocyte immunoglobulin-like receptor subfamily A member 1 (CD85 antigen-like family member I) (Leukocyte immunoglobulin-like receptor 6, LIR-6) (CD antigen CD85i)" LILRA1 LIR6 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952] GO:0002250; GO:0003823; GO:0004888; GO:0005886; GO:0006952; GO:0007166; GO:0016021; GO:0019221; GO:0032396 antigen binding [GO:0003823]; inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888] TAPWITRIPQEIVKK 0.94592 2.7731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1608 0 0 0 0 12.243 0 0 13.1553 0 0 0 0 0 0 0 0 0 0 10.6906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4553 0 0 0 0 0 0 0 0 0 0 0 Q7Z4W3 KR193_HUMAN Keratin-associated protein 19-3 (GTHRP) (Glycine/tyrosine-rich protein) KRTAP19-3 KAP19.3 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 MSYYGSYYGGLGYGCGGFGGLGYGYGCGCGSFR 0.94595 2.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1094 0 0 0 0 11.804 0 0 0 0 0 0 0 0 0 0 0 10.7674 0 0 0 0 0 0 0 0 0 Q8N5M9 JAGN1_HUMAN Protein jagunal homolog 1 JAGN1 Homo sapiens (Human) cellular response to tunicamycin [GO:1904577]; defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; exocytosis [GO:0006887]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cellular response to tunicamycin [GO:1904577]; defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; exocytosis [GO:0006887]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0002446; GO:0005783; GO:0005789; GO:0006887; GO:0007029; GO:0015031; GO:0016021; GO:0016192; GO:0030223; GO:0038158; GO:0050832; GO:0061179; GO:1904577; GO:1990266 KLIYVHLVIWLLLVAK 0.94595 2.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4935 0 0 0 0 12.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9785 0 0 0 12.7476 0 11.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5391 0 0 0 0 0 0 0 0 0 Q9H346 O52D1_HUMAN Olfactory receptor 52D1 (Odorant receptor HOR5'beta14) (Olfactory receptor OR11-43) OR52D1 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IGFVGLFRSVAIVSPFIFLLR 0.94595 2.4655 0 0 0 0 13.5942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7315 0 0 13.6773 0 0 0 0 0 0 0 0 0 0 0 0 12.1933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02509 OC90_HUMAN "Otoconin-90, Oc90 (Phospholipase A2 homolog)" OC90 PLA2L Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; otolith mineralization [GO:0045299]; phosphatidylcholine metabolic process [GO:0046470] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; structural molecule activity [GO:0005198]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; otolith mineralization [GO:0045299]; phosphatidylcholine metabolic process [GO:0046470] GO:0004623; GO:0005198; GO:0005509; GO:0005576; GO:0016042; GO:0031012; GO:0045299; GO:0046470; GO:0050482 calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; structural molecule activity [GO:0005198] CVAGLCPRDFEDYGCTCR 0.94599 2.4647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1777 0 0 0 0 0 0 0 0 0 0 0 0 12.773 0 0 0 0 0 0 0 0 0 0 12.3914 15.7261 0 0 0 0 0 0 13.9028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5629 0 0 13.5298 0 0 0 14.7106 15.3167 0 0 0 0 0 0 O75925 PIAS1_HUMAN "E3 SUMO-protein ligase PIAS1, EC 2.3.2.- (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein, GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein)" PIAS1 DDXBP1 Homo sapiens (Human) fat cell differentiation [GO:0045444]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; fat cell differentiation [GO:0045444]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0007259; GO:0008270; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0031625; GO:0032436; GO:0033235; GO:0042127; GO:0045444; GO:0061665; GO:0140297 DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] IKELYRR 0.94602 4.1101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2401 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3813 0 0 0 0 0 0 0 11.8655 0 14.9458 0 0 0 0 14.96 0 0 0 13.8084 0 0 0 0 0 0 0 0 0 0 13.6952 0 14.4764 0 14.0756 0 0 13.3015 0 0 13.115 0 0 0 0 0 0 0 0 0 0 0 0 12.9612 0 12.8875 0 0 0 0 11.9025 0 0 0 0 0 0 0 0 0 0 12.8815 0 0 0 0 0 13.2604 14.5207 12.4432 0 0 14.8248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZRH7 CTSRG_HUMAN Cation channel sperm-associated auxiliary subunit gamma CATSPERG C19orf15 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005886; GO:0007283; GO:0030154; GO:0031514; GO:0036128; GO:0097228 ARPPRVLER 0.94604 3.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7635 0 14.037 13.9867 14.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3489 0 0 0 12.597 0 11.3565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3Y3 LARG2_HUMAN "Xylosyl- and glucuronyltransferase LARGE2, EC 2.4.-.- (Glycosyltransferase-like 1B) (LARGE xylosyl- and glucuronyltransferase 2) [Includes: Alpha-1,3-xylosyltransferase LARGE2, EC 2.4.2.-; Beta-1,3-glucuronyltransferase LARGE2, EC 2.4.1.- ]" LARGE2 GYLTL1B PP5656 Homo sapiens (Human) muscle cell cellular homeostasis [GO:0046716]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; muscle cell cellular homeostasis [GO:0046716]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] GO:0000139; GO:0005794; GO:0006493; GO:0015020; GO:0016021; GO:0030145; GO:0035252; GO:0035269; GO:0042285; GO:0046716 glucuronosyltransferase activity [GO:0015020]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285] GFNTGVILLRLDR 0.94604 2.8186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22736 NR4A1_HUMAN "Nuclear receptor subfamily 4 group A member 1 (Early response protein NAK1) (Nuclear hormone receptor NUR/77, Nur77) (Orphan nuclear receptor HMR) (Orphan nuclear receptor TR3) (ST-59) (Testicular receptor 3)" NR4A1 GFRP1 HMR NAK1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell chemotaxis [GO:0035767]; fat cell differentiation [GO:0045444]; negative regulation of cell cycle [GO:0045786]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neurotransmitter secretion involved in regulation of skeletal muscle contraction [GO:0014860]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to amphetamine [GO:0001975]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell chemotaxis [GO:0035767]; fat cell differentiation [GO:0045444]; negative regulation of cell cycle [GO:0045786]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; neurotransmitter secretion involved in regulation of skeletal muscle contraction [GO:0014860]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to amphetamine [GO:0001975]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001938; GO:0001975; GO:0002042; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006357; GO:0006366; GO:0006915; GO:0007165; GO:0008270; GO:0014860; GO:0031965; GO:0032496; GO:0035259; GO:0035767; GO:0035914; GO:0035924; GO:0042802; GO:0043065; GO:0043154; GO:0044344; GO:0045444; GO:0045786; GO:0045944; GO:0046982; GO:0051602; GO:0061469; GO:0071376; GO:0098793; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" CAVCGDNASCQHYGVRTCEGCK 0.94606 0.87235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8682 0 0 0 0 11.5728 10.6108 12.7856 0 0 0 0 17.2938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NT52 CGB2_HUMAN Choriogonadotropin subunit beta variant 2 CGB2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0005179; GO:0005615; GO:0005737; GO:0007186 hormone activity [GO:0005179] EPLRPRCR 0.94609 0.87068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXN2 CLC7A_HUMAN "C-type lectin domain family 7 member A (Beta-glucan receptor) (C-type lectin superfamily member 12) (Dendritic cell-associated C-type lectin 1, DC-associated C-type lectin 1, Dectin-1) (CD antigen CD369)" CLEC7A BGR CLECSF12 DECTIN1 UNQ539/PRO1082 Homo sapiens (Human) "antifungal innate immune response [GO:0061760]; carbohydrate mediated signaling [GO:0009756]; cell activation [GO:0001775]; cell recognition [GO:0008037]; cellular response to molecule of fungal origin [GO:0071226]; defense response to protozoan [GO:0042832]; detection of fungus [GO:0016046]; detection of molecule of fungal origin [GO:0032491]; detection of yeast [GO:0001879]; inflammatory response [GO:0006954]; phagocytosis, recognition [GO:0006910]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell maturation [GO:1903431]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of lymphocyte activation [GO:0051251]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of respiratory burst [GO:0060267]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of wound healing [GO:0090303]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell activation [GO:0042110]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; (1->3)-beta-D-glucan binding [GO:0001872]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC protein binding [GO:0042287]; pattern recognition receptor activity [GO:0038187]; antifungal innate immune response [GO:0061760]; carbohydrate mediated signaling [GO:0009756]; cell activation [GO:0001775]; cell recognition [GO:0008037]; cellular response to molecule of fungal origin [GO:0071226]; defense response to protozoan [GO:0042832]; detection of fungus [GO:0016046]; detection of molecule of fungal origin [GO:0032491]; detection of yeast [GO:0001879]; inflammatory response [GO:0006954]; phagocytosis, recognition [GO:0006910]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell maturation [GO:1903431]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of lymphocyte activation [GO:0051251]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of respiratory burst [GO:0060267]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of wound healing [GO:0090303]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell activation [GO:0042110]" GO:0001775; GO:0001872; GO:0001878; GO:0001879; GO:0002223; GO:0002732; GO:0005737; GO:0005886; GO:0006910; GO:0006954; GO:0008037; GO:0008284; GO:0009756; GO:0009986; GO:0010628; GO:0016021; GO:0016046; GO:0030246; GO:0030335; GO:0031334; GO:0032491; GO:0032729; GO:0032731; GO:0032733; GO:0032735; GO:0032743; GO:0032747; GO:0032755; GO:0032757; GO:0032760; GO:0032930; GO:0038187; GO:0042110; GO:0042287; GO:0042802; GO:0042832; GO:0043122; GO:0043123; GO:0043280; GO:0045429; GO:0046872; GO:0050766; GO:0050850; GO:0051091; GO:0051092; GO:0051251; GO:0051712; GO:0060267; GO:0061760; GO:0070884; GO:0071226; GO:0071639; GO:0090303; GO:1900017; GO:1903431; GO:2000318 (1->3)-beta-D-glucan binding [GO:0001872]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC protein binding [GO:0042287]; pattern recognition receptor activity [GO:0038187] GSCAASPPWRLIAVILGILCLVILVIAVVLGTMAIWR 0.94609 2.7704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.112 0 0 0 0 0 13.3455 0 0 0 0 0 0 0 11.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087X1C5 CP2D7_HUMAN "Putative cytochrome P450 2D7, EC 1.14.14.1" CYP2D7 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; organic acid metabolic process [GO:0006082]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; organic acid metabolic process [GO:0006082]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0005506; GO:0005737; GO:0005739; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0019369; GO:0020037; GO:0042178; GO:0043231; GO:0070330 "aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" EVLNAVPVLPHIPALAGK 0.9461 2.8174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1899 0 0 0 0 0 0 0 0 0 11.3684 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0842 0 0 0 0 0 11.3712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.879 0 14.8771 12.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05923 DUS2_HUMAN "Dual specificity protein phosphatase 2, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PAC-1)" DUSP2 PAC1 Homo sapiens (Human) endoderm formation [GO:0001706]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; endoderm formation [GO:0001706]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] GO:0001706; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0008330; GO:0017017; GO:0017018; GO:0031965; GO:0043409; GO:0051019 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] HVRAARPVPWNALLR 0.9461 0.86424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VDF9 HSP7E_HUMAN Heat shock 70 kDa protein 14 (HSP70-like protein 1) (Heat shock protein HSP60) HSPA14 HSP60 HSP70L1 Homo sapiens (Human) 'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' cotranslational protein folding [GO:0051083]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192] GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016020; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051083; GO:0051085; GO:0051787; GO:0140662 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] AMMKLTNSAEVAK 0.9461 0.86842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3767 0 12.3044 0 0 12.0727 0 0 0 0 0 0 0 0 0 0 0 0 12.2251 0 0 14.5091 0 0 0 12.5562 13.3221 12.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7204 0 0 12.764 0 0 0 0 0 0 0 0 0 13.0318 0 0 0 0 O75461 E2F6_HUMAN "Transcription factor E2F6, E2F-6" E2F6 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" GO:0000083; GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0046983; GO:0071339; GO:0090575 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EDSITVHIR 0.94611 2.8652 0 0 0 0 0 0 0 0 0 0 0 12.3919 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5695 0 12.9818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0397 0 13.2206 0 0 0 0 0 13.6083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZU45 CL20A_HUMAN Putative C-type lectin domain family 20 member A CLEC20A Homo sapiens (Human) carbohydrate binding [GO:0030246] GO:0030246 carbohydrate binding [GO:0030246] ALLLSFCAAALQLVSSK 0.94612 0.86804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQY6 WFDC6_HUMAN WAP four-disulfide core domain protein 6 (Putative protease inhibitor WAP6) WFDC6 C20orf171 WAP6 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576 serine-type endopeptidase inhibitor activity [GO:0004867] GLSGLLPILVPFILLGDIQEPGHAEGILGKPCPKIK 0.94613 0.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7192 0 11.4155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6295 0 0 0 0 0 0 0 0 14.6766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.049 10.5525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N19 G137A_HUMAN Integral membrane protein GPR137 (Transmembrane 7 superfamily member 1-like 1 protein) GPR137 C11orf4 GPR137A TM7SF1L1 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506] GO:0005765; GO:0006914; GO:0010506; GO:0016021; GO:0045671; GO:0045779; GO:1904263 AGHCEDEGCSWEHSR 0.94614 3.426 0 0 0 0 0 0 0 0 0 0 0 0 13.0012 0 0 0 13.0413 0 0 0 0 0 0 12.0105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6231 0 0 0 15.837 0 0 0 0 0 0 14.9823 0 15.9789 11.2224 0 0 0 15.3665 0 13.895 0 0 0 0 0 16.4067 0 0 0 15.9361 0 0 14.0231 14.7948 14.8428 14.0876 12.5615 0 0 12.9637 0 0 0 0 0 13.6164 13.1747 0 17.3607 0 0 0 0 14.3233 0 0 0 0 0 13.4223 0 0 12.0479 0 0 0 0 0 0 0 13.4215 0 0 12.6005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4647 14.741 0 0 0 0 12.6794 0 0 0 0 P03905 NU4M_HUMAN "NADH-ubiquinone oxidoreductase chain 4, EC 7.1.1.2 (NADH dehydrogenase subunit 4)" MT-ND4 MTND4 NADH4 ND4 Homo sapiens (Human) "aerobic respiration [GO:0009060]; aging [GO:0007568]; cerebellum development [GO:0021549]; electron transport coupled proton transport [GO:0015990]; in utero embryonic development [GO:0001701]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cerebellum development [GO:0021549]; electron transport coupled proton transport [GO:0015990]; in utero embryonic development [GO:0001701]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]" GO:0001666; GO:0001701; GO:0005743; GO:0005747; GO:0006120; GO:0007568; GO:0008137; GO:0009060; GO:0015990; GO:0021549; GO:0032981; GO:0035094; GO:0042776; GO:0045471; GO:0048039 NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ubiquinone binding [GO:0048039] AHVEAPIAGSMVLAAVLLKLGGYGMMRLTLILNPLTK 0.94621 3.8818 0 0 0 0 0 0 0 0 0 0 0 0 12.9274 0 0 0 0 0 0 0 0 0 0 0 11.572 11.7717 0 11.7291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1577 0 13.3382 0 0 0 0 0 0 0 12.4086 0 0 0 13.884 0 0 0 0 0 0 0 0 14.1137 0 0 0 0 0 0 12.1049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8395 0 11.4773 0 0 0 0 13.8674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8Q9 NIPA2_HUMAN Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2) NIPA2 Homo sapiens (Human) magnesium ion transport [GO:0015693] early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693] GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016020; GO:0016021 magnesium ion transmembrane transporter activity [GO:0015095] GLGIAIKELFAGKPVLR 0.94622 2.4098 0 11.7794 0 0 0 0 0 0 0 0 0 0 10.7849 0 0 0 0 0 12.0086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4007 14.8783 0 15.3321 15.0432 0 0 14.1539 0 0 0 0 11.27 0 0 0 15.0233 0 11.4767 0 14.2379 13.9533 11.5778 0 0 0 0 0 0 13.8146 0 13.8194 0 0 0 13.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7104 0 0 0 15.256 0 0 0 0 0 15.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8705 0 14.0672 0 0 15.7762 0 0 0 0 0 14.1209 0 0 0 0 0 0 16.5204 0 Q8NGV6 OR5H6_HUMAN Olfactory receptor 5H6 (Olfactory receptor OR3-11) OR5H6 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IPLFLAFLVIYLITIMGNLGLIVLIWK 0.94623 0.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS27 ZN662_HUMAN Zinc finger protein 662 ZNF662 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] CFDQNEDFDQHQK 0.94625 2.433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6359 0 0 13.5309 0 0 0 0 0 0 0 0 0 13.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7804 0 0 0 0 0 0 12.2069 12.2696 0 0 12.5502 0 0 0 0 0 0 0 0 0 0 0 0 13.3311 13.1849 13.3734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95751 LDOC1_HUMAN Protein LDOC1 (Leucine zipper protein down-regulated in cancer cells) LDOC1 BCUR1 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; negative regulation of cell population proliferation [GO:0008285]; regulation of growth hormone activity [GO:1903547] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; negative regulation of cell population proliferation [GO:0008285]; regulation of growth hormone activity [GO:1903547] GO:0001893; GO:0005634; GO:0005654; GO:0005730; GO:0008285; GO:0060137; GO:0071222; GO:0071225; GO:1903547 AFLDEMKQCFGWDDDEDDDDEEEEDDY 0.94626 3.8127 10.1349 0 0 0 0 0 0 0 0 0 0 0 11.6147 0 0 0 0 0 0 10.8305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1624 0 0 0 0 0 0 0 0 10.7438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0611 0 0 11.2552 0 0 0 11.9908 0 0 12.5556 0 0 0 0 0 0 0 0 0 12.5994 0 0 0 0 0 13.3821 0 0 0 0 10.8247 0 0 0 0 0 0 0 11.6658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5087 0 0 11.8812 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1862 0 0 0 14.4087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUH8 TM14B_HUMAN Transmembrane protein 14B TMEM14B Homo sapiens (Human) cerebral cortex development [GO:0021987]; neural precursor cell proliferation [GO:0061351]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of heme biosynthetic process [GO:0070453] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; identical protein binding [GO:0042802]; cerebral cortex development [GO:0021987]; neural precursor cell proliferation [GO:0061351]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of heme biosynthetic process [GO:0070453] GO:0016021; GO:0021987; GO:0031966; GO:0042802; GO:0061351; GO:0070453; GO:2000045 identical protein binding [GO:0042802] FMPVGLIAGASLLMAAK 0.94626 0.85982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56747 CLD6_HUMAN Claudin-6 (Skullin) CLDN6 UNQ757/PRO1488 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] GO:0001618; GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016327; GO:0016338; GO:0042802; GO:0070830 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618] ALCVIALLVALFGLLVYLAGAK 0.94627 2.7668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0109 0 0 0 0 0 0 0 0 10.6402 0 0 0 0 10.092 0 0 0 0 0 0 0 0 11.824 0 12.4024 0 0 12.5303 0 0 0 0 13.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2293 0 0 0 0 0 0 0 0 0 0 12.0589 0 12.1288 0 0 0 0 0 0 0 12.4391 0 0 13.2027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6154 0 0 0 0 0 0 0 Q8NC69 KCTD6_HUMAN BTB/POZ domain-containing protein KCTD6 (KCASH3 protein) (Potassium channel tetramerization domain-containing protein 6) KCTD6 Homo sapiens (Human) negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; M band [GO:0031430] cytosol [GO:0005829]; M band [GO:0031430]; ankyrin binding [GO:0030506]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005829; GO:0006511; GO:0016567; GO:0030506; GO:0031430; GO:0040008; GO:0042802; GO:0045879; GO:0051260; GO:0097602 ankyrin binding [GO:0030506]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] YSNPVAVIITQLTITTK 0.94633 0.86427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBP6 S2540_HUMAN Probable mitochondrial glutathione transporter SLC25A40 (Mitochondrial carrier family protein) (Solute carrier family 25 member 40) SLC25A40 MCFP Homo sapiens (Human) erythrocyte development [GO:0048821]; mitochondrial transmembrane transport [GO:1990542] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; erythrocyte development [GO:0048821]; mitochondrial transmembrane transport [GO:1990542] GO:0005739; GO:0005743; GO:0016021; GO:0048821; GO:1990542 FGAVTVISPLELIRTK 0.94633 2.5702 0 0 0 0 0 0 0 0 0 14.08 0 0 0 0 14.0651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9408 0 14.2813 0 0 0 0 0 12.1708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3291 0 11.8693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7936 0 0 0 0 0 0 13.067 0 0 0 0 0 0 0 0 0 0 0 0 12.2424 0 12.3214 0 0 12.5416 0 0 0 0 0 0 0 0 0 0 15.4276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6539 12.3964 0 0 0 13.0058 0 0 0 0 Q8N386 LRC25_HUMAN Leucine-rich repeat-containing protein 25 (Monocyte and plasmacytoid-activated protein) LRRC25 MAPA UNQ6169/PRO20174 Homo sapiens (Human) cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630] GO:0005783; GO:0005829; GO:0015630; GO:0016021 CDLDLQADCNCALESWHDIR 0.94635 2.4053 0 0 0 0 0 0 0 0 12.7168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8045 0 0 0 0 0 0 0 0 0 Q9BTZ2 DHRS4_HUMAN "Dehydrogenase/reductase SDR family member 4, EC 1.1.1.184 (NADPH-dependent carbonyl reductase, CR) (NADPH-dependent retinol dehydrogenase/reductase, NRDR, humNRDR) (Peroxisomal short-chain alcohol dehydrogenase, PSCD) (SCAD-SRL) (Short chain dehydrogenase/reductase family 25C member 2, Protein SDR25C2) (Short-chain dehydrogenase/reductase family member 4)" DHRS4 SDR25C2 UNQ851/PRO1800 Homo sapiens (Human) alcohol metabolic process [GO:0006066]; cellular ketone metabolic process [GO:0042180]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; retinal metabolic process [GO:0042574]; steroid metabolic process [GO:0008202] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 3-keto sterol reductase activity [GO:0000253]; 3beta-hydroxy-5beta-steroid dehydrogenase activity [GO:0033703]; alcohol dehydrogenase [NAD(P)+] activity [GO:0018455]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; alcohol metabolic process [GO:0006066]; cellular ketone metabolic process [GO:0042180]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; retinal metabolic process [GO:0042574]; steroid metabolic process [GO:0008202]" GO:0000253; GO:0004090; GO:0005634; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005789; GO:0005829; GO:0006066; GO:0008202; GO:0016655; GO:0018455; GO:0033703; GO:0042180; GO:0042574; GO:0042802; GO:0052650; GO:2000379 "3-keto sterol reductase activity [GO:0000253]; 3beta-hydroxy-5beta-steroid dehydrogenase activity [GO:0033703]; alcohol dehydrogenase [NAD(P)+] activity [GO:0018455]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]" ETLRIRR 0.94636 2.5953 0 12.1442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B4DXR9 ZN732_HUMAN Zinc finger protein 732 ZNF732 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRQSATLNK 0.94638 4.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8392 0 0 0 0 0 0 11.2989 0 11.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5651 0 0 0 0 0 0 0 0 0 0 0 0 11.9431 0 0 11.6599 0 0 0 0 0 0 11.1264 0 0 14.4256 0 0 0 0 0 0 11.6563 0 0 0 12.1259 0 0 0 0 0 0 0 11.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2959 0 0 0 14.8479 0 14.1162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6679 0 0 0 0 0 0 0 0 0 P78395 PRAME_HUMAN "Melanoma antigen preferentially expressed in tumors (Opa-interacting protein 4, OIP-4) (Preferentially expressed antigen of melanoma)" PRAME MAPE OIP4 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of growth [GO:0040008]" chromatin [GO:0000785]; Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nuclear retinoic acid receptor binding [GO:0042974]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of growth [GO:0040008]" GO:0000209; GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006915; GO:0008284; GO:0030154; GO:0031462; GO:0040008; GO:0042974; GO:0043066; GO:0043161; GO:0045596; GO:0045892; GO:0048387; GO:1990756 nuclear retinoic acid receptor binding [GO:0042974]; ubiquitin ligase-substrate adaptor activity [GO:1990756] ASLYSFPEPEAAQPMTK 0.94638 2.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4779 0 0 14.6261 14.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8856 0 0 0 0 0 0 P56645 PER3_HUMAN "Period circadian protein homolog 3, hPER3 (Cell growth-inhibiting gene 13 protein) (Circadian clock protein PERIOD 3)" PER3 GIG13 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; kinase binding [GO:0019900]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]" GO:0000122; GO:0000976; GO:0001222; GO:0005634; GO:0005737; GO:0019900; GO:0031625; GO:0032922; GO:0043153; GO:0045187; GO:0050821 kinase binding [GO:0019900]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] CISCTNTTSSSSEEDKQNHK 0.94639 3.8106 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9863 12.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2799 0 0 0 0 0 0 0 0 0 0 0 13.3086 0 0 12.78 14.1938 0 0 16.3848 15.6941 0 0 0 14.0639 0 0 15.5192 0 0 0 13.3904 0 0 0 0 0 14.1984 0 13.572 0 0 15.1218 0 0 0 0 0 0 0 14.2646 0 0 14.814 0 0 12.3894 15.6109 15.1592 0 15.0504 0 0 0 0 0 0 13.7224 0 0 0 0 13.2847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0853 0 0 0 0 0 13.5074 0 0 0 0 0 0 0 Q7Z3B4 NUP54_HUMAN Nucleoporin p54 (54 kDa nucleoporin) NUP54 Homo sapiens (Human) mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306] GO:0005635; GO:0005643; GO:0006605; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0036228; GO:0042306; GO:0042802; GO:0044613; GO:0044877; GO:0051028 identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056] EIKQHLKQQQEGLSHLISIIK 0.94641 2.8123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6555 0 13.9938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1669 0 13.1909 11.6854 0 0 0 0 0 0 13.0544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1985 0 0 0 0 0 14.9713 14.9774 0 0 0 0 0 0 0 12.6349 0 0 0 0 0 0 0 0 0 13.9607 0 15.612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4063 0 0 0 0 0 0 0 0 0 0 0 0 13.8414 0 0 0 14.7509 0 0 0 0 P07101 TY3H_HUMAN "Tyrosine 3-monooxygenase, EC 1.14.16.2 (Tyrosine 3-hydroxylase, TH)" TH TYH Homo sapiens (Human) "aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cellular response to alkaloid [GO:0071312]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to manganese ion [GO:0071287]; cellular response to nicotine [GO:0071316]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex development [GO:0021987]; circadian sleep/wake cycle [GO:0042745]; dopamine biosynthetic process [GO:0042416]; dopamine biosynthetic process from tyrosine [GO:0006585]; eating behavior [GO:0042755]; embryonic camera-type eye morphogenesis [GO:0048596]; epinephrine biosynthetic process [GO:0042418]; eye photoreceptor cell development [GO:0042462]; fatty acid metabolic process [GO:0006631]; glycoside metabolic process [GO:0016137]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hyaloid vascular plexus regression [GO:1990384]; isoquinoline alkaloid metabolic process [GO:0033076]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; multicellular organism aging [GO:0010259]; neurotransmitter biosynthetic process [GO:0042136]; norepinephrine biosynthetic process [GO:0042421]; phthalate metabolic process [GO:0018963]; phytoalexin metabolic process [GO:0052314]; pigmentation [GO:0043473]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to ether [GO:0045472]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to pyrethroid [GO:0046684]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]; response to zinc ion [GO:0010043]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; sphingolipid metabolic process [GO:0006665]; synaptic transmission, dopaminergic [GO:0001963]; terpene metabolic process [GO:0042214]; visual perception [GO:0007601]" anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome membrane [GO:0033162]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome membrane [GO:0033162]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; amino acid binding [GO:0016597]; dopamine binding [GO:0035240]; enzyme binding [GO:0019899]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; oxygen binding [GO:0019825]; protein domain specific binding [GO:0019904]; tetrahydrobiopterin binding [GO:0034617]; tyrosine 3-monooxygenase activity [GO:0004511]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cellular response to alkaloid [GO:0071312]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to manganese ion [GO:0071287]; cellular response to nicotine [GO:0071316]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex development [GO:0021987]; circadian sleep/wake cycle [GO:0042745]; dopamine biosynthetic process [GO:0042416]; dopamine biosynthetic process from tyrosine [GO:0006585]; eating behavior [GO:0042755]; embryonic camera-type eye morphogenesis [GO:0048596]; epinephrine biosynthetic process [GO:0042418]; eye photoreceptor cell development [GO:0042462]; fatty acid metabolic process [GO:0006631]; glycoside metabolic process [GO:0016137]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hyaloid vascular plexus regression [GO:1990384]; isoquinoline alkaloid metabolic process [GO:0033076]; learning [GO:0007612]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; multicellular organism aging [GO:0010259]; neurotransmitter biosynthetic process [GO:0042136]; norepinephrine biosynthetic process [GO:0042421]; phthalate metabolic process [GO:0018963]; phytoalexin metabolic process [GO:0052314]; pigmentation [GO:0043473]; regulation of heart contraction [GO:0008016]; response to activity [GO:0014823]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to ether [GO:0045472]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to pyrethroid [GO:0046684]; response to salt stress [GO:0009651]; response to water deprivation [GO:0009414]; response to zinc ion [GO:0010043]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; sphingolipid metabolic process [GO:0006665]; synaptic transmission, dopaminergic [GO:0001963]; terpene metabolic process [GO:0042214]; visual perception [GO:0007601]" GO:0001666; GO:0001963; GO:0001975; GO:0003007; GO:0004511; GO:0005634; GO:0005737; GO:0005739; GO:0005790; GO:0005829; GO:0006585; GO:0006631; GO:0006665; GO:0007507; GO:0007601; GO:0007605; GO:0007612; GO:0007613; GO:0007617; GO:0007626; GO:0008016; GO:0008021; GO:0008198; GO:0008199; GO:0009414; GO:0009416; GO:0009635; GO:0009651; GO:0009653; GO:0009887; GO:0009898; GO:0010043; GO:0010259; GO:0014823; GO:0015842; GO:0016137; GO:0016597; GO:0018963; GO:0019825; GO:0019899; GO:0019904; GO:0021987; GO:0030424; GO:0030425; GO:0031410; GO:0031667; GO:0032355; GO:0032496; GO:0033076; GO:0033162; GO:0034617; GO:0035176; GO:0035240; GO:0035900; GO:0035902; GO:0042136; GO:0042214; GO:0042416; GO:0042418; GO:0042421; GO:0042462; GO:0042745; GO:0042755; GO:0042802; GO:0043005; GO:0043195; GO:0043204; GO:0043434; GO:0043473; GO:0045471; GO:0045472; GO:0046684; GO:0048471; GO:0048596; GO:0051412; GO:0051602; GO:0052314; GO:0070161; GO:0071287; GO:0071312; GO:0071316; GO:0071333; GO:0071363; GO:0071466; GO:1990384 amino acid binding [GO:0016597]; dopamine binding [GO:0035240]; enzyme binding [GO:0019899]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; oxygen binding [GO:0019825]; protein domain specific binding [GO:0019904]; tetrahydrobiopterin binding [GO:0034617]; tyrosine 3-monooxygenase activity [GO:0004511] AVLNLLFSPRATKPSALSR 0.94645 2.5452 0 0 0 0 0 0 0 0 0 0 0 11.8323 0 0 0 0 0 0 12.8132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4168 0 0 0 10.1887 0 13.1173 0 0 0 0 10.4344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7464 12.2146 0 0 12.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 12.236 0 11.9564 0 13.2565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.832 0 11.8436 0 0 0 0 0 0 0 0 0 Q96A29 FUCT1_HUMAN GDP-fucose transporter 1 (Solute carrier family 35 member C1) SLC35C1 FUCT1 Homo sapiens (Human) carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457]; carbohydrate transport [GO:0008643]; GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066] GO:0000139; GO:0005457; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0030259; GO:0036066; GO:0036085; GO:0045746 antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457] LTFYNNVNACILFLPLLLLLGELQALR 0.94646 0.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9234 0 0 0 0 0 0 0 0 12.2284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4964 0 0 0 0 0 0 0 0 0 0 0 0 11.9974 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8671 0 0 0 0 0 0 12.4437 0 12.4344 0 12.3287 0 0 12.5757 0 13.3092 0 0 0 12.8976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00258 GET1_HUMAN Guided entry of tail-anchored proteins factor 1 (Congenital heart disease 5 protein) (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein) GET1 CHD5 WRB Homo sapiens (Human) protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005634; GO:0005783; GO:0005789; GO:0016021; GO:0043529; GO:0045048; GO:0050821; GO:0071816 ILLPSFSSFMSR 0.9465 0.85989 0 0 0 0 0 0 0 0 12.3264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6798 0 0 0 0 0 0 0 0 0 0 0 0 12.0894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4661 0 0 0 0 0 0 13.4916 0 0 0 13.8184 13.6302 0 14.0212 14.1128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.725 0 0 0 0 0 0 0 0 0 0 0 10.4604 0 0 0 0 0 0 0 0 12.7126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1981 0 0 0 0 0 P51589 CP2J2_HUMAN "Cytochrome P450 2J2, EC 1.14.14.- (Albendazole monooxygenase (hydroxylating), EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming), EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase, EC 5.4.4.7)" CYP2J2 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006631; GO:0006690; GO:0006805; GO:0008016; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016712; GO:0016853; GO:0019373; GO:0020037; GO:0043231; GO:0043651; GO:0070062; GO:0071614; GO:0106255; GO:0106301 "arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" KLKLFVSHMIDK 0.94652 2.9129 0 0 0 0 0 0 0 0 13.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4363 0 0 0 0 0 0 14.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3886 0 0 0 0 0 0 0 0 0 0 12.5702 0 0 0 0 14.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6585 0 0 0 0 0 0 0 0 0 0 0 11.2718 0 0 0 0 0 0 0 0 0 0 11.9503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63218 GBG5_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 GNG5 GNGT5 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; signal transduction [GO:0007165] GO:0003924; GO:0005834; GO:0005886; GO:0007165; GO:0007186; GO:0016020; GO:0030165; GO:0031681; GO:0070062; GO:0072513; GO:2000179 G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165] KVVQQLR 0.94652 0.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5533 0 0 0 0 0 0 0 13.7665 0 0 0 0 13.9178 0 0 14.1011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGQ1 OR9G4_HUMAN Olfactory receptor 9G4 (Olfactory receptor OR11-216) OR9G4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ILASCVSEDKR 0.94656 2.5888 0 0 0 0 0 0 0 0 0 14.3582 0 13.2576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.35 0 0 0 0 14.2564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9651 15.0841 15.0766 0 0 0 0 0 0 0 0 0 0 0 13.9665 0 0 0 0 P47710 CASA1_HUMAN Alpha-S1-casein [Cleaved into: Casoxin-D ] CSN1S1 CASA CSN1 Homo sapiens (Human) response to 11-deoxycorticosterone [GO:1903496]; response to dehydroepiandrosterone [GO:1903494]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; response to 11-deoxycorticosterone [GO:1903496]; response to dehydroepiandrosterone [GO:1903494]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570] GO:0005576; GO:0005615; GO:0032355; GO:0032570; GO:1903494; GO:1903496 LLILTCLVAVALAR 0.94657 0.86451 14.9983 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9406 0 0 0 0 0 0 0 0 0 0 0 0 11.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3298 0 0 0 0 0 12.3429 0 0 0 0 0 0 0 14.027 0 0 0 0 0 0 14.0391 0 0 13.3073 12.7827 0 13.2083 12.8414 0 13.8652 13.8168 0 0 0 0 0 0 14.386 0 0 0 0 0 12.7751 0 0 0 12.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8161 12.5355 0 11.088 12.1896 0 0 0 12.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5277 0 0 0 0 0 11.7325 11.6574 0 0 0 P31994 FCG2B_HUMAN "Low affinity immunoglobulin gamma Fc region receptor II-b, IgG Fc receptor II-b (CDw32) (Fc-gamma RII-b, Fc-gamma-RIIb, FcRII-b) (CD antigen CD32)" FCGR2B CD32 FCG2 IGFR2 Homo sapiens (Human) "antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to molecule of bacterial origin [GO:0071219]; cerebellum development [GO:0021549]; defense response [GO:0006952]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; follicular dendritic cell activation [GO:0002266]; immune complex clearance by monocytes and macrophages [GO:0002436]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; mature B cell differentiation involved in immune response [GO:0002313]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of antibody-dependent cellular cytotoxicity [GO:0001814]; negative regulation of B cell activation [GO:0050869]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of immune response [GO:0050777]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of macrophage activation [GO:0043031]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of phagocytosis [GO:0050765]; negative regulation of type I hypersensitivity [GO:0001811]; phagocytosis, engulfment [GO:0006911]; positive regulation of humoral immune response [GO:0002922]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron death [GO:1901216]; positive regulation of phagocytosis [GO:0050766]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; receptor-mediated endocytosis [GO:0006898]; regulation of adaptive immune response [GO:0002819]; regulation of B cell antigen processing and presentation [GO:0002622]; regulation of dendritic spine maintenance [GO:1902950]; regulation of immune complex clearance by monocytes and macrophages [GO:0090264]; regulation of immune response [GO:0050776]; regulation of innate immune response [GO:0045088]; regulation of signaling receptor activity [GO:0010469]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]" cell body [GO:0044297]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell body [GO:0044297]; dendritic spine [GO:0043197]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; IgG binding [GO:0019864]; low-affinity IgG receptor activity [GO:0019772]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to molecule of bacterial origin [GO:0071219]; cerebellum development [GO:0021549]; defense response [GO:0006952]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; follicular B cell differentiation [GO:0002316]; follicular dendritic cell activation [GO:0002266]; immune complex clearance by monocytes and macrophages [GO:0002436]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; mature B cell differentiation involved in immune response [GO:0002313]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of antibody-dependent cellular cytotoxicity [GO:0001814]; negative regulation of B cell activation [GO:0050869]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of immune response [GO:0050777]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of macrophage activation [GO:0043031]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of phagocytosis [GO:0050765]; negative regulation of type I hypersensitivity [GO:0001811]; phagocytosis, engulfment [GO:0006911]; positive regulation of humoral immune response [GO:0002922]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron death [GO:1901216]; positive regulation of phagocytosis [GO:0050766]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; receptor-mediated endocytosis [GO:0006898]; regulation of adaptive immune response [GO:0002819]; regulation of B cell antigen processing and presentation [GO:0002622]; regulation of dendritic spine maintenance [GO:1902950]; regulation of immune complex clearance by monocytes and macrophages [GO:0090264]; regulation of immune response [GO:0050776]; regulation of innate immune response [GO:0045088]; regulation of signaling receptor activity [GO:0010469]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]" GO:0001540; GO:0001811; GO:0001814; GO:0001818; GO:0002266; GO:0002313; GO:0002316; GO:0002436; GO:0002605; GO:0002622; GO:0002638; GO:0002819; GO:0002865; GO:0002922; GO:0002924; GO:0004888; GO:0005886; GO:0005887; GO:0006898; GO:0006911; GO:0006952; GO:0006954; GO:0006955; GO:0007165; GO:0007166; GO:0009617; GO:0009897; GO:0010469; GO:0016064; GO:0019772; GO:0019864; GO:0019886; GO:0021549; GO:0030889; GO:0032693; GO:0038096; GO:0043031; GO:0043197; GO:0043318; GO:0044297; GO:0044877; GO:0045088; GO:0046330; GO:0050765; GO:0050766; GO:0050776; GO:0050777; GO:0050859; GO:0050869; GO:0071219; GO:0090264; GO:1901216; GO:1902564; GO:1902950; GO:1904646; GO:1905898; GO:2001199 amyloid-beta binding [GO:0001540]; IgG binding [GO:0019864]; low-affinity IgG receptor activity [GO:0019772]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888] CHSWKDKPLVK 0.94661 3.6074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8145 0 0 0 10.6569 0 0 0 12.428 0 0 0 10.8353 0 0 0 0 0 0 0 0 0 0 0 12.781 0 0 13.1758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZW61 BBS12_HUMAN Bardet-Biedl syndrome 12 protein BBS12 C4orf24 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; fat cell differentiation [GO:0045444]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of stem cell differentiation [GO:2000737]; photoreceptor cell maintenance [GO:0045494]; stem cell differentiation [GO:0048863] cilium [GO:0005929] cilium [GO:0005929]; ATP binding [GO:0005524]; chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; fat cell differentiation [GO:0045444]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of stem cell differentiation [GO:2000737]; photoreceptor cell maintenance [GO:0045494]; stem cell differentiation [GO:0048863] GO:0005524; GO:0005929; GO:0042073; GO:0042755; GO:0045444; GO:0045494; GO:0045599; GO:0048863; GO:0051131; GO:2000737 ATP binding [GO:0005524] HFNRTDNTEGVSKPDGFQEHVTATHK 0.94661 0.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2901 0 0 0 Q99075 HBEGF_HUMAN "Proheparin-binding EGF-like growth factor [Cleaved into: Heparin-binding EGF-like growth factor, HB-EGF, HBEGF (Diphtheria toxin receptor, DT-R) ]" HBEGF DTR DTS HEGFL Homo sapiens (Human) "cell chemotaxis [GO:0060326]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB2-ERBB4 signaling pathway [GO:0038135]; muscle organ development [GO:0007517]; negative regulation of elastin biosynthetic process [GO:0051545]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of wound healing [GO:0090303]; regulation of heart contraction [GO:0008016]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]" cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cell chemotaxis [GO:0060326]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB2-ERBB4 signaling pathway [GO:0038135]; muscle organ development [GO:0007517]; negative regulation of elastin biosynthetic process [GO:0051545]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of wound healing [GO:0090303]; regulation of heart contraction [GO:0008016]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0005154; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0007165; GO:0007173; GO:0007517; GO:0008016; GO:0008083; GO:0008201; GO:0008284; GO:0009986; GO:0030297; GO:0030307; GO:0030335; GO:0030666; GO:0030669; GO:0035313; GO:0038134; GO:0038135; GO:0045741; GO:0048018; GO:0048661; GO:0051545; GO:0051549; GO:0051897; GO:0060326; GO:0090303 epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] EEHGKRK 0.94662 3.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3348 0 0 0 0 12.7936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8515 0 0 0 0 0 14.5267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.558 0 0 0 0 0 0 0 0 0 0 Q9H5Y7 SLIK6_HUMAN SLIT and NTRK-like protein 6 SLITRK6 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; auditory behavior [GO:0031223]; auditory receptor cell morphogenesis [GO:0002093]; axonogenesis [GO:0007409]; cochlea development [GO:0090102]; innervation [GO:0060384]; lens development in camera-type eye [GO:0002088]; linear vestibuloocular reflex [GO:0060007]; multicellular organism growth [GO:0035264]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synapse assembly [GO:0007416]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adult locomotory behavior [GO:0008344]; auditory behavior [GO:0031223]; auditory receptor cell morphogenesis [GO:0002093]; axonogenesis [GO:0007409]; cochlea development [GO:0090102]; innervation [GO:0060384]; lens development in camera-type eye [GO:0002088]; linear vestibuloocular reflex [GO:0060007]; multicellular organism growth [GO:0035264]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synapse assembly [GO:0007416]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601] GO:0001964; GO:0002088; GO:0002093; GO:0005886; GO:0005887; GO:0007409; GO:0007416; GO:0007601; GO:0007605; GO:0008344; GO:0009986; GO:0021562; GO:0031223; GO:0035264; GO:0051965; GO:0060007; GO:0060384; GO:0090102; GO:1905606 EGSDAKHLQR 0.94662 2.5874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7586 0 0 0 12.7706 0 0 0 0 0 0 0 0 11.9735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3844 12.7688 0 0 13.2245 0 0 0 12.7193 0 0 12.1786 0 0 14.7517 0 12.3036 13.6527 0 0 0 14.1606 0 0 0 12.6059 13.4115 0 14.097 0 11.3907 13.8654 14.2639 0 0 13.3658 0 0 12.7433 0 0 0 13.4799 12.6295 0 13.3079 0 0 0 11.5593 0 13.8139 12.5233 0 0 0 12.4991 0 0 0 12.9134 0 0 0 13.0141 0 11.8221 12.4434 0 0 0 0 0 0 0 0 0 11.7921 0 0 0 0 0 12.1015 0 14.0157 12.4955 0 0 0 0 0 0 0 0 0 0 12.3887 0 0 0 0 0 0 0 0 0 0 Q96D15 RCN3_HUMAN Reticulocalbin-3 (EF-hand calcium-binding protein RLP49) RCN3 UNQ239/PRO272 Homo sapiens (Human) collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of protein kinase B signaling [GO:0051896]; surfactant homeostasis [GO:0043129] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of protein kinase B signaling [GO:0051896]; surfactant homeostasis [GO:0043129] GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0043231; GO:0051896; GO:0055091; GO:0060428 calcium ion binding [GO:0005509] MWRPSVLLLLLLLR 0.94664 3.8044 0 0 0 13.0351 0 0 13.1939 11.9416 0 0 12.5288 0 0 12.9726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9403 14.0159 0 14.311 0 0 16.1053 16.619 14.5491 0 0 0 0 0 0 13.9504 0 0 0 0 0 0 0 0 12.2635 0 0 0 0 0 0 0 0 0 0 0 0 14.6621 0 0 0 13.4315 14.1389 0 0 0 0 0 0 0 0 0 13.4651 0 13.7321 13.3973 0 0 0 0 0 0 0 14.601 0 13.6829 0 0 0 0 0 0 0 0 14.1044 0 0 13.4642 0 13.7159 0 0 0 0 0 0 0 12.5301 14.3162 0 0 0 0 0 0 12.131 0 0 0 0 0 0 0 0 12.4891 0 0 0 0 0 0 0 0 12.7282 O14556 G3PT_HUMAN "Glyceraldehyde-3-phosphate dehydrogenase, testis-specific, EC 1.2.1.12 (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2, GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase)" GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; positive regulation of glycolytic process [GO:0045821] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; flagellated sperm motility [GO:0030317]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; positive regulation of glycolytic process [GO:0045821] GO:0004365; GO:0005634; GO:0005829; GO:0006006; GO:0006096; GO:0030317; GO:0045821; GO:0050661; GO:0051287 glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661] DIVLTNVTVVQLLR 0.94665 2.9099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6678 0 0 0 0 0 0 0 0 0 0 12.2023 12.5138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6261 Q13608 PEX6_HUMAN "Peroxisome assembly factor 2, PAF-2 (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1)" PEX6 PXAAA1 Homo sapiens (Human) "peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]" GO:0001750; GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016561; GO:0016887; GO:0044877; GO:0050821; GO:0097733 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] ALLRLLALGSGAWVR 0.94665 2.6131 0 0 0 0 0 0 0 0 0 0 0 12.6284 0 0 0 0 0 0 0 0 14.9017 0 11.6829 0 0 0 0 0 0 0 0 0 16.8251 0 12.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8353 0 0 0 0 0 0 0 0 0 0 0 0 12.2541 0 0 0 0 0 14.6425 0 14.6296 0 15.1148 0 0 14.5047 0 12.4654 14.7461 0 0 0 0 0 0 0 14.2402 0 0 0 0 0 0 0 0 0 13.7286 13.0389 14.6711 0 0 0 0 0 13.7033 12.8519 0 14.2178 0 0 0 0 0 0 14.4475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2601 0 0 14.5185 0 11.8744 0 13.0568 14.3898 14.0528 12.7637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0564 0 0 0 0 0 0 0 0 0 A0A286YF46 SCGR5_HUMAN Small cysteine and glycine repeat-containing protein 5 (Keratin-associated protein 28-5) SCYGR5 KRTAP28-5 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CYRVGCCSSCCPCCR 0.9467 3.9264 0 0 0 0 0 0 0 0 14.0561 0 11.0219 0 0 0 0 0 0 13.4731 12.7555 10.2257 0 0 11.6045 11.8969 12.4715 0 11.2079 0 13.1185 13.0252 0 0 0 0 0 0 10.2394 0 11.255 0 11.4975 0 0 11.4622 0 11.2849 0 0 12.719 0 14.8218 0 0 0 11.6753 0 10.2346 0 0 0 0 0 0 11.4535 9.64566 0 0 0 0 11.8456 0 0 0 0 14.3829 14.0723 0 12.4585 11.9228 0 13.4205 12.0952 0 0 0 0 14.7072 11.1682 0 12.0861 0 12.8425 15.7526 12.3677 12.5998 12.6987 13.8535 12.5279 12.1721 10.9398 13.4883 0 10.5476 0 0 11.8991 14.1286 10.7002 0 0 0 0 13.4498 12.004 12.2262 14.1429 13.4392 0 0 12.0117 0 11.7878 0 0 0 12.735 12.8735 0 13.3536 12.1379 0 0 14.1493 0 10.7085 0 0 12.4581 0 11.5445 14.6387 13.8159 0 0 0 0 10.1682 11.2962 0 0 14.4323 12.4875 0 0 0 11.6143 13.1271 0 12.7525 0 0 13.498 13.1703 12.4486 0 12.6032 11.6781 0 10.6294 13.3297 13.0865 0 13.4188 13.3788 11.8893 0 12.6848 12.1985 13.0585 0 Q8NH76 O56B4_HUMAN Olfactory receptor 56B4 (Olfactory receptor OR11-67) OR56B4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IPLIPVFLNVLHNVIPPALNPLACALR 0.9467 0.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11049 CD37_HUMAN "Leukocyte antigen CD37 (Tetraspanin-26, Tspan-26) (CD antigen CD37)" CD37 TSPAN26 Homo sapiens (Human) extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] GO:0001772; GO:0005887; GO:0016020; GO:0070062 CCGWHYPQDWFQVLILR 0.94671 0.86053 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2201 0 0 0 0 0 0 0 0 13.5757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD91 MAGC3_HUMAN "Melanoma-associated antigen C3 (Cancer/testis antigen 7.2, CT7.2) (Hepatocellular carcinoma-associated antigen 2) (MAGE-C3 antigen)" MAGEC3 HCA2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 AEMLTTVIKKYK 0.94671 2.7056 12.7189 0 0 0 0 13.4229 0 0 12.0592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2221 12.7469 11.6054 0 0 0 0 0 0 0 0 0 0 0 0 10.8826 0 0 0 0 0 0 11.6688 0 11.4299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4954 0 0 0 0 0 14.1877 0 0 0 0 12.5132 0 0 14.2966 0 12.414 13.092 16.1987 16.5519 17.1129 15.4144 16.2203 16.5196 14.9795 15.4086 16.5648 15.3997 15.555 15.3473 13.9712 13.6479 0 0 0 0 0 0 0 0 0 0 0 0 15.0492 0 14.9921 0 0 0 0 0 0 0 0 0 0 13.1867 0 0 0 11.2983 0 14.4072 0 13.1536 14.4616 0 0 0 0 0 0 0 0 0 0 12.967 0 0 0 12.7765 0 0 0 14.1551 0 0 0 0 0 0 0 12.768 0 0 0 0 0 0 0 12.813 0 0 0 0 14.7244 0 11.8082 12.9339 14.3993 Q9GZV3 SC5A7_HUMAN "High affinity choline transporter 1 (Hemicholinium-3-sensitive choline transporter, CHT) (Solute carrier family 5 member 7)" SLC5A7 CHT1 Homo sapiens (Human) "acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]; in utero embryonic development [GO:0001701]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; synaptic transmission, cholinergic [GO:0007271]; transmembrane transport [GO:0055085]" anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307]; acetylcholine biosynthetic process [GO:0008292]; choline transport [GO:0015871]; in utero embryonic development [GO:0001701]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; synaptic transmission, cholinergic [GO:0007271]; transmembrane transport [GO:0055085]" GO:0001701; GO:0005307; GO:0005886; GO:0006836; GO:0007271; GO:0007274; GO:0008292; GO:0015220; GO:0015871; GO:0016021; GO:0030424; GO:0030425; GO:0031594; GO:0033265; GO:0043204; GO:0045202; GO:0055085; GO:0070161 choline binding [GO:0033265]; choline transmembrane transporter activity [GO:0015220]; choline:sodium symporter activity [GO:0005307] AFHVEGLIAIIVFYLLILLVGIWAAWRTK 0.94671 2.8021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4122 0 0 0 0 0 0 14.0122 0 13.0123 0 0 13.4619 0 0 0 14.5843 0 0 0 0 0 0 0 0 0 14.1775 0 0 0 0 0 12.9748 0 0 0 0 0 0 0 12.3358 0 0 0 0 0 11.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0907 0 12.5587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJG1 MSPD1_HUMAN Motile sperm domain-containing protein 1 MOSPD1 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000122; GO:0000139; GO:0005634; GO:0005737; GO:0005789; GO:0016021; GO:0030154; GO:0045944; GO:0048471 ALGRKEVVATLLPSAK 0.94672 3.6044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P03891 NU2M_HUMAN "NADH-ubiquinone oxidoreductase chain 2, EC 7.1.1.2 (NADH dehydrogenase subunit 2)" MT-ND2 MTND2 NADH2 ND2 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; postsynaptic density [GO:0014069] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; postsynaptic density [GO:0014069]; ionotropic glutamate receptor binding [GO:0035255]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein kinase binding [GO:0019901]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]" GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0014069; GO:0019901; GO:0032981; GO:0035255; GO:0042776; GO:0072593 ionotropic glutamate receptor binding [GO:0035255]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein kinase binding [GO:0019901] LTWLTPLIPSTLLSLGGLPPLTGFLPK 0.94676 0.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8797 0 0 0 0 0 0 0 0 13.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4128 0 0 0 0 0 0 0 0 0 14.7294 14.6333 14.6496 14.6934 0 15.0307 0 0 0 0 0 14.1873 0 0 0 0 0 15.3425 0 0 0 0 14.8397 0 0 0 0 0 14.1734 0 15.4892 15.5229 0 0 0 0 0 0 0 0 0 14.7871 0 0 0 0 0 14.648 14.6023 0 0 0 0 0 0 0 15.0757 0 0 0 14.7712 0 0 0 0 0 0 0 0 13.2798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1328 0 0 13.8658 0 0 0 0 0 0 0 Q96HU1 SGSM3_HUMAN "Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein, RabGAPLP)" SGSM3 MAP RABGAPLP RUTBC3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of Rab protein signal transduction [GO:0032483] cytosol [GO:0005829]; gap junction [GO:0005921] cytosol [GO:0005829]; gap junction [GO:0005921]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of Rab protein signal transduction [GO:0032483] GO:0005096; GO:0005829; GO:0005921; GO:0007049; GO:0031267; GO:0032483; GO:0032486; GO:0043547; GO:0045732; GO:0048227; GO:0090630 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] CELRVLCCFAFSLSQDWELPAK 0.94677 2.4662 0 0 0 0 0 0 0 0 0 11.8867 0 0 0 11.491 0 0 11.8094 11.0415 0 13.7075 0 0 0 0 11.6638 0 0 0 0 0 10.3523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9374 0 12.9764 0 13.3156 13.1633 16.0564 0 15.9912 0 15.6372 0 0 0 0 0 0 0 0 0 0 15.2831 0 0 0 0 0 0 0 0 13.0448 0 0 0 0 14.5785 15.7021 0 0 13.7147 10.6636 10.95 0 0 0 11.4436 0 0 0 0 0 0 0 0 0 0 0 15.5974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2763 0 0 0 0 0 0 0 13.7511 0 0 0 0 0 0 Q460N3 PAR15_HUMAN "Protein mono-ADP-ribosyltransferase PARP15, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 7, ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15, PARP-15)" PARP15 BAL3 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0070212; GO:0070403; GO:0140289; GO:1990404 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; transcription corepressor activity [GO:0003714] CKIIIHVPGGK 0.9468 0.86514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4656 0 12.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7087 0 0 0 0 17.6695 0 0 0 0 0 0 12.3086 0 12.7306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5943 0 0 0 0 16.6707 16.2465 0 0 0 0 16.2626 0 0 0 0 0 16.6836 0 0 0 0 0 0 0 0 0 13.7629 0 0 0 0 0 0 0 0 0 0 0 16.1155 0 13.5332 13.1042 13.2277 0 13.4229 0 12.6582 16.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4225 13.7151 0 0 0 0 0 0 Q9BQS7 HEPH_HUMAN "Hephaestin, EC 1.-.-.-" HEPH KIAA0698 UNQ2562/PRO6242 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] GO:0004322; GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0008198; GO:0016021; GO:0016323; GO:0016491; GO:0048471; GO:0055072 copper ion binding [GO:0005507]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491] DMYSGLVGPLAICQKGILEPHGGR 0.9468 2.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8535 0 0 0 0 0 12.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9028 0 15.0189 0 0 0 0 0 0 0 0 13.4122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.545 0 0 0 0 0 0 0 12.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16587 ZNF74_HUMAN Zinc finger protein 74 (Zinc finger protein 520) (hZNF7) ZNF74 ZNF520 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0015629; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGECGKAFNQRTHLTR 0.94681 4.0151 0 0 0 0 0 0 11.4228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6617 0 0 0 0 0 0 0 0 0 11.3481 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9817 0 0 0 0 0 11.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z699 SPRE1_HUMAN "Sprouty-related, EVH1 domain-containing protein 1, Spred-1, hSpred1" SPRED1 Homo sapiens (Human) "negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of MAPK cascade [GO:0043408]; regulation of protein deacetylation [GO:0090311]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]" caveola [GO:0005901]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "caveola [GO:0005901]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; stem cell factor receptor binding [GO:0005173]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of MAPK cascade [GO:0043408]; regulation of protein deacetylation [GO:0090311]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]" GO:0005173; GO:0005654; GO:0005829; GO:0005886; GO:0005901; GO:0006469; GO:0010719; GO:0010801; GO:0016525; GO:0019901; GO:0019902; GO:0030291; GO:0030512; GO:0043408; GO:0043409; GO:0043517; GO:0060979; GO:0070373; GO:0090051; GO:0090311; GO:1902747 phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; stem cell factor receptor binding [GO:0005173] CGEACGCCGGK 0.94686 3.8676 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6726 0 12.9348 0 13.3176 13.9644 12.5793 0 0 11.6939 11.6012 0 0 12.2751 11.9882 12.0987 13.826 11.5841 0 0 13.3191 0 0 12.38 0 11.6361 0 0 12.8452 0 0 12.7348 0 13.3887 12.706 12.5418 12.7723 0 13.4791 13.8528 0 0 12.1174 12.4557 0 0 0 0 0 0 10.2384 0 0 15.1295 15.872 14.9825 15.4232 13.3382 0 12.9313 14.389 17.1072 17.0228 16.674 16.5377 15.8075 17.9459 18.1197 15.5325 16.3482 14.5908 15.4905 14.599 13.3127 15.3576 15.963 15.2766 16.0147 17.0567 15.1457 15.3456 15.9551 14.567 14.4169 12.1167 16.0356 16.1334 16.9177 17.4336 16.3406 16.4946 14.8514 15.7387 16.7922 16.5609 17.1712 18.1048 17.5635 14.771 17.7582 16.7811 16.5996 16.0812 16.9893 16.4151 17.9714 17.7412 17.4662 17.9209 17.3286 16.8599 17.2185 15.3231 16.3054 16.8958 15.7978 17.0605 17.7573 17.1172 17.5587 16.3593 17.6433 17.0521 16.4135 17.2949 17.3644 18.1711 16.6361 18.0752 17.1346 17.471 17.3227 17.4224 16.8567 14.3569 0 12.5594 16.8248 17.0316 15.9277 15.9127 17.204 17.0451 13.8838 0 10.8854 0 0 0 0 0 13.5012 14.8497 0 14.1672 0 0 0 16.1372 16.6484 16.2172 16.6683 0 0 0 14.1228 0 A8MVX0 ARG33_HUMAN Rho guanine nucleotide exchange factor 33 ARHGEF33 Homo sapiens (Human) cellular anatomical entity [GO:0110165] cellular anatomical entity [GO:0110165]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0110165 guanyl-nucleotide exchange factor activity [GO:0005085] APIKAER 0.94689 2.7975 0 0 0 0 0 12.5976 0 0 0 0 0 0 0 0 14.4513 11.638 0 0 12.9029 0 0 0 0 0 14.4657 14.4787 14.3635 14.323 15.1316 0 0 0 0 0 0 0 0 0 0 11.1586 14.8719 0 0 13.8904 15.2731 0 0 14.9055 14.5602 14.4998 13.9808 13.8493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.383 16.2692 16.909 17.2393 16.8742 16.3469 15.5713 13.7795 16.8565 16.3934 17.4836 15.9544 17.1682 17.3358 16.741 16.9901 16.935 17.244 17.2735 17.2909 17.4933 17.2937 17.1231 16.4903 16.9667 16.4534 17.535 17.395 16.9123 17.4827 16.0028 17.7735 17.9397 0 17.5246 16.973 16.9201 0 15.9513 17.0631 16.3802 16.8732 16.7735 14.6622 17.3063 17.3936 17.0669 16.7897 17.5432 17.6745 18.0303 16.827 17.8562 17.516 16.761 16.5884 0 15.5119 16.9456 17.9268 16.2219 15.534 17.4423 16.4875 17.2249 15.5331 16.8413 16.7837 17.4777 16.2057 16.5909 15.2276 14.9999 12.6863 15.417 0 15.6419 0 0 0 14.8288 15.2987 16.2268 0 0 0 12.8419 13.089 0 0 0 11.0712 17.2348 16.0659 0 0 0 0 15.2408 14.5294 14.9765 0 0 0 14.7661 0 Q8TF32 ZN431_HUMAN Zinc finger protein 431 ZNF431 KIAA1969 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006355; GO:0030154; GO:0043433; GO:0046872 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNESSNLTTHKMIHTGEKPYK 0.94692 3.3478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2021 0 0 0 13.8689 14.6828 13.8696 14.6573 0 14.2774 14.8595 14.2692 13.6827 0 13.7501 13.5051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9586 0 13.2884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13726 TF_HUMAN "Tissue factor, TF (Coagulation factor III) (Thromboplastin) (CD antigen CD142)" F3 Homo sapiens (Human) "activation of blood coagulation via clotting cascade [GO:0002543]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of plasma proteins involved in acute inflammatory response [GO:0002541]; blood coagulation [GO:0007596]; blood coagulation, extrinsic pathway [GO:0007598]; blood coagulation, fibrin clot formation [GO:0072378]; blood coagulation, intrinsic pathway [GO:0007597]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein kinase B signaling [GO:0051897]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to wounding [GO:0009611]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of external side of plasma membrane [GO:0031233]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; serine-type peptidase complex [GO:1905286] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of external side of plasma membrane [GO:0031233]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; serine-type peptidase complex [GO:1905286]; cytokine receptor activity [GO:0004896]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; activation of blood coagulation via clotting cascade [GO:0002543]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of plasma proteins involved in acute inflammatory response [GO:0002541]; blood coagulation [GO:0007596]; blood coagulation, extrinsic pathway [GO:0007598]; blood coagulation, fibrin clot formation [GO:0072378]; blood coagulation, intrinsic pathway [GO:0007597]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein kinase B signaling [GO:0051897]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to wounding [GO:0009611]" GO:0001938; GO:0002020; GO:0002541; GO:0002543; GO:0004896; GO:0005543; GO:0005615; GO:0005886; GO:0005887; GO:0006508; GO:0006919; GO:0007596; GO:0007597; GO:0007598; GO:0009611; GO:0009986; GO:0010628; GO:0010641; GO:0016020; GO:0016021; GO:0016485; GO:0019221; GO:0030335; GO:0031233; GO:0032757; GO:0045766; GO:0050927; GO:0051897; GO:0062023; GO:0072378; GO:1905286; GO:1905370 cytokine receptor activity [GO:0004896]; phospholipid binding [GO:0005543]; protease binding [GO:0002020] CFYTTDTECDLTDEIVK 0.94693 2.7006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4571 13.6496 0 0 0 13.2995 0 0 0 0 13.6286 0 0 13.6395 0 0 0 0 0 0 13.6922 0 0 Q9H7L9 SDS3_HUMAN Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog) SUDS3 SAP45 SDS3 Homo sapiens (Human) "apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell population maintenance [GO:1902459]; substantia nigra development [GO:0021762]" cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822] "cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell population maintenance [GO:1902459]; substantia nigra development [GO:0021762]" GO:0000122; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006915; GO:0016575; GO:0016580; GO:0016604; GO:0019899; GO:0021762; GO:0030336; GO:0030512; GO:0042826; GO:0043065; GO:0045892; GO:0070822; GO:1902455; GO:1902459 enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826] ERIRNAELFLQLETEQVER 0.94693 0.86639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6859 0 15.7995 0 0 0 0 15.9775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7187 15.9411 15.904 0 0 14.5285 15.6291 15.9788 15.0852 0 15.9323 0 0 0 0 0 15.2712 15.6076 0 0 15.7443 15.1453 0 16.277 15.451 0 15.3448 16.0899 0 0 0 0 0 0 15.0981 0 14.7394 0 10.6988 15.7143 0 0 15.1791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2917 0 14.7721 0 0 14.7003 0 0 0 0 12.4916 0 0 0 0 0 0 0 0 O95157 NXPH3_HUMAN Neurexophilin-3 NXPH3 KIAA1159 NPH3 UNQ687/PRO1327 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; neuropeptide signaling pathway [GO:0007218] GO:0005102; GO:0005576; GO:0007218 signaling receptor binding [GO:0005102] VCPDYNYHSDTPYYPSG 0.94694 0.86053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DSO2 SCGR9_HUMAN Small cysteine and glycine repeat-containing protein 9 (Keratin-associated protein 28-1 pseudogene) SCYGR9 KRTAP28p1 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CYRVGCCSSCCPCCR 0.94694 4.6279 0 0 11.2164 0 0 0 0 0 0 0 0 0 0 0 11.6735 0 0 0 12.2808 0 0 0 0 0 0 0 10.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6212 0 0 0 0 0 0 0 0 0 0 0 13.3277 0 0 10.8646 0 0 0 11.5955 0 0 0 0 13.899 0 12.5726 0 0 12.3828 0 0 0 0 0 0 0 0 0 0 0 13.3899 0 0 0 0 0 0 0 12.6134 0 0 0 11.3856 0 0 0 13.5566 0 0 0 0 13.5901 0 13.2865 0 0 12.2519 12.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.86 0 0 0 13.145 0 0 0 0 0 0 0 0 0 0 10.8563 0 0 0 0 0 0 0 0 0 0 13.3143 0 0 0 0 0 0 0 Q96D42 HAVR1_HUMAN "Hepatitis A virus cellular receptor 1, HAVcr-1 (Kidney injury molecule 1, KIM-1) (T-cell immunoglobulin and mucin domain-containing protein 1, TIMD-1) (T-cell immunoglobulin mucin receptor 1, TIM, TIM-1) (T-cell membrane protein 1) (CD antigen CD365)" HAVCR1 KIM1 TIM1 TIMD1 Homo sapiens (Human) "phagocytosis, engulfment [GO:0006911]; positive regulation of mast cell activation [GO:0033005]" cell surface [GO:0009986]; integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; phosphatidylserine binding [GO:0001786]; virus receptor activity [GO:0001618]; phagocytosis, engulfment [GO:0006911]; positive regulation of mast cell activation [GO:0033005]" GO:0001618; GO:0001786; GO:0005886; GO:0006911; GO:0009986; GO:0016021; GO:0031514; GO:0033005 phosphatidylserine binding [GO:0001786]; virus receptor activity [GO:0001618] GIYAGVCISVLVLLALLGVIIAK 0.94697 2.9302 0 0 0 0 0 12.7573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3376 0 0 0 0 0 0 0 0 0 0 11.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HE7 ERO1A_HUMAN "ERO1-like protein alpha, ERO1-L, ERO1-L-alpha, EC 1.8.4.- (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha)" ERO1A ERO1L UNQ434/PRO865 Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; insulin processing [GO:0030070]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; protein modification process [GO:0036211]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; response to temperature stimulus [GO:0009266] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; disulfide oxidoreductase activity [GO:0015036]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972]; brown fat cell differentiation [GO:0050873]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix organization [GO:0030198]; insulin processing [GO:0030070]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417]; protein modification process [GO:0036211]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; response to temperature stimulus [GO:0009266] GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005796; GO:0006457; GO:0006979; GO:0009266; GO:0015035; GO:0015036; GO:0016020; GO:0016491; GO:0016972; GO:0018401; GO:0022417; GO:0030070; GO:0030198; GO:0030425; GO:0030968; GO:0034975; GO:0034976; GO:0036211; GO:0043231; GO:0045454; GO:0050873; GO:0051085; GO:0051209; GO:0070059; GO:0071456; GO:0071949 disulfide oxidoreductase activity [GO:0015036]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972] LIANMPESGPSYEFHLTR 0.94697 0.86017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7544 12.7408 0 12.1631 11.6371 12.652 13.9991 14.1836 0 0 0 14.2673 0 0 0 0 13.4737 0 0 0 0 0 0 0 12.8653 0 0 0 0 14.7131 0 0 0 0 0 0 0 0 12.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7116 0 0 12.8058 0 0 0 0 12.5242 0 0 0 0 0 0 0 0 0 0 0 0 12.6204 0 0 12.6664 0 0 0 0 0 0 12.0528 0 0 0 0 0 0 0 0 0 0 0 0 11.9899 0 0 0 0 Q0P5P2 CQ067_HUMAN Uncharacterized protein C17orf67 C17orf67 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 KTLPVLVLSLTLLTVFSETSPILTEK 0.94699 2.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3278 0 0 0 10.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26951 IL3RA_HUMAN "Interleukin-3 receptor subunit alpha, IL-3 receptor subunit alpha, IL-3R subunit alpha, IL-3R-alpha, IL-3RA (CD antigen CD123)" IL3RA IL3R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-3 receptor activity [GO:0004912]; cytokine-mediated signaling pathway [GO:0019221] GO:0004896; GO:0004912; GO:0005886; GO:0009897; GO:0016021; GO:0019221; GO:0019955; GO:0043235 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-3 receptor activity [GO:0004912] ARERVYEFLSAWSTPQR 0.94701 2.794 12.7711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3009 0 0 0 0 0 0 0 0 0 10.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0723 0 0 0 0 12.5429 0 0 0 0 0 0 0 11.3699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.226 0 0 0 0 0 0 0 0 0 0 14.1279 0 0 0 13.3102 0 0 0 0 0 0 0 0 0 12.2061 0 0 0 0 0 0 13.2564 0 0 0 0 P17947 SPI1_HUMAN Transcription factor PU.1 (31 kDa-transforming protein) SPI1 Homo sapiens (Human) "anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; endothelial to hematopoietic transition [GO:0098508]; erythrocyte differentiation [GO:0030218]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; granulocyte differentiation [GO:0030851]; histone H3 acetylation [GO:0043966]; hypermethylation of CpG island [GO:0044027]; immature B cell differentiation [GO:0002327]; interleukin-6-mediated signaling pathway [GO:0070102]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage differentiation [GO:0030225]; myeloid dendritic cell differentiation [GO:0043011]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; pericyte cell differentiation [GO:1904238]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pro-T cell differentiation [GO:0002572]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of erythrocyte differentiation [GO:0045646]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of myeloid progenitor cell differentiation [GO:1905453]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; transforming growth factor beta receptor signaling pathway [GO:0007179]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; NFAT protein binding [GO:0051525]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; endothelial to hematopoietic transition [GO:0098508]; erythrocyte differentiation [GO:0030218]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; granulocyte differentiation [GO:0030851]; histone H3 acetylation [GO:0043966]; hypermethylation of CpG island [GO:0044027]; immature B cell differentiation [GO:0002327]; interleukin-6-mediated signaling pathway [GO:0070102]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage differentiation [GO:0030225]; myeloid dendritic cell differentiation [GO:0043011]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; pericyte cell differentiation [GO:1904238]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pro-T cell differentiation [GO:0002572]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of erythrocyte differentiation [GO:0045646]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of myeloid progenitor cell differentiation [GO:1905453]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001217; GO:0001227; GO:0001228; GO:0002314; GO:0002316; GO:0002327; GO:0002357; GO:0002572; GO:0002573; GO:0003682; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007179; GO:0010628; GO:0010629; GO:0030154; GO:0030218; GO:0030225; GO:0030851; GO:0031663; GO:0032088; GO:0035019; GO:0036462; GO:0042826; GO:0043011; GO:0043314; GO:0043966; GO:0044027; GO:0045347; GO:0045646; GO:0045814; GO:0045892; GO:0045944; GO:0051090; GO:0051525; GO:0060033; GO:0061629; GO:0070102; GO:0090241; GO:0090402; GO:0097677; GO:0098508; GO:0120186; GO:0140297; GO:0140311; GO:1900745; GO:1901223; GO:1901674; GO:1902262; GO:1902895; GO:1904151; GO:1904178; GO:1904238; GO:1905036; GO:1905453; GO:2000529 "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; NFAT protein binding [GO:0051525]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]" IRLYQFLLDLLR 0.94704 0.86537 0 0 0 0 0 0 0 0 0 0 0 0 14.6368 0 0 0 12.7419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5576 0 0 0 0 0 0 0 0 0 0 0 11.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZN1 IRPL1_HUMAN "Interleukin-1 receptor accessory protein-like 1, IL-1-RAPL-1, IL-1RAPL-1, IL1RAPL-1, EC 3.2.2.6 (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2, TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)" IL1RAPL1 OPHN4 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545] axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] "axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of exocytosis [GO:0045920]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; signal transduction [GO:0007165]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]" GO:0005102; GO:0005737; GO:0005886; GO:0007157; GO:0007165; GO:0009986; GO:0010975; GO:0016021; GO:0030182; GO:0030424; GO:0030425; GO:0045211; GO:0045920; GO:0050135; GO:0050775; GO:0051965; GO:0061809; GO:0097105; GO:0098978; GO:0099175; GO:0099545; GO:1905606 "NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor binding [GO:0005102]" APIPHLILLYATFTQSLKVVTKR 0.94704 2.9286 11.7576 13.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6091 0 0 0 0 0 0 0 0 0 11.6517 12.0355 0 12.4114 0 0 0 0 0 0 0 0 0 11.7334 0 0 12.8559 0 13.8934 0 0 0 0 12.565 0 0 0 0 0 0 0 13.5582 0 0 0 0 0 0 0 0 0 0 0 0 14.7701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4728 13.9834 14.0545 13.7706 14.2882 0 0 0 0 0 0 0 0 0 0 12.4025 0 0 0 0 0 0 0 11.744 13.222 11.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.889 12.5939 0 12.8014 0 0 0 0 0 0 12.4658 0 0 0 13.6387 13.8138 0 11.7603 0 0 0 0 0 0 0 12.829 0 0 0 0 0 13.8349 0 O43513 MED7_HUMAN "Mediator of RNA polymerase II transcription subunit 7, hMED7 (Activator-recruited cofactor 34 kDa component, ARC34) (Cofactor required for Sp1 transcriptional activation subunit 9, CRSP complex subunit 9) (Mediator complex subunit 7) (RNA polymerase transcriptional regulation mediator subunit 7 homolog) (Transcriptional coactivator CRSP33)" MED7 ARC34 CRSP9 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006367; GO:0016592; GO:0016604; GO:0032968; GO:0035019; GO:0051123; GO:0060261; GO:0061630; GO:0070847 transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630] KLNMSILINFLDLLDILIR 0.94705 2.4334 0 0 0 0 0 11.0425 0 0 0 0 0 13.028 0 0 0 0 0 0 0 0 13.3792 0 0 0 0 0 12.9625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7323 0 13.4122 0 0 0 0 0 14.1325 0 0 0 0 0 0 0 0 0 0 0 11.4305 0 12.5588 0 0 0 0 13.4917 0 0 0 0 0 0 0 0 0 0 0 10.985 0 0 0 0 0 0 0 0 0 0 0 12.9953 0 12.3669 0 0 0 0 0 0 12.8846 0 11.4345 0 13.3542 14.0094 0 0 0 0 0 0 13.6018 0 0 0 0 0 0 0 12.2964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26010 ITB7_HUMAN Integrin beta-7 (Gut homing receptor beta subunit) ITGB7 Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte tethering or rolling [GO:0050901]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell migration [GO:0072678] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha4-beta7 complex [GO:0034669]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha4-beta7 complex [GO:0034669]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte tethering or rolling [GO:0050901]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell migration [GO:0072678] GO:0001618; GO:0003366; GO:0005178; GO:0005886; GO:0005925; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009986; GO:0016020; GO:0016477; GO:0033627; GO:0034113; GO:0034446; GO:0034669; GO:0038023; GO:0043113; GO:0043235; GO:0046872; GO:0050839; GO:0050901; GO:0070062; GO:0072678 cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] ACECSGDMDSCISPEGGLCSGHGR 0.94707 2.82 16.0628 0 0 0 0 0 0 0 0 0 0 0 12.8889 0 0 0 12.5929 0 12.091 0 0 0 0 15.7533 0 11.3551 0 9.60546 0 13.578 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8846 0 10.8983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9153 13.3584 0 0 11.2237 0 15.2624 0 14.9542 14.1318 0 10.4429 0 11.2002 10.5551 0 0 0 13.2186 0 11.4995 0 0 0 0 0 0 0 12.4054 0 13.1705 0 0 0 11.4613 11.9469 11.6125 0 13.613 0 13.9516 0 14.1416 0 0 13.1674 0 0 0 0 0 0 12.9117 11.3844 0 12.122 0 0 11.2551 13.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 13.245 0 0 0 0 0 0 0 0 0 0 0 0 13.9128 0 12.7461 13.6914 0 11.478 0 0 0 0 0 0 0 11.5611 11.3472 0 0 0 0 0 12.7716 0 0 0 10.9015 0 O60243 H6ST1_HUMAN "Heparan-sulfate 6-O-sulfotransferase 1, HS6ST-1, EC 2.8.2.-" HS6ST1 HS6ST Homo sapiens (Human) "angiogenesis [GO:0001525]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; labyrinthine layer blood vessel development [GO:0060716]; lung alveolus development [GO:0048286]; neuron development [GO:0048666]" Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] "Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; sulfotransferase activity [GO:0008146]; angiogenesis [GO:0001525]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; labyrinthine layer blood vessel development [GO:0060716]; lung alveolus development [GO:0048286]; neuron development [GO:0048666]" GO:0000139; GO:0001525; GO:0005887; GO:0006024; GO:0008146; GO:0015015; GO:0017095; GO:0048286; GO:0048666; GO:0060716 heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; sulfotransferase activity [GO:0008146] LLHRAKEALPR 0.9471 2.9248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2035 0 0 0 0 15.8536 0 0 0 0 0 0 0 0 11.5205 0 0 0 0 0 0 0 0 0 13.4631 13.5702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.979 0 0 0 0 0 0 0 0 Q6P9B6 MEAK7_HUMAN "MTOR-associated protein MEAK7, MEAK7 (MTOR associated protein, eak-7 homolog) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1)" MEAK7 KIAA1609 TLDC1 Homo sapiens (Human) negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; TOR signaling [GO:0031929] GO:0005654; GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032; GO:1903204 GNKSILDADPEAQALLEISGHSR 0.94713 2.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2992 11.3172 0 0 0 0 0 0 12.5296 0 0 11.2436 0 10.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3559 0 0 0 0 0 0 0 0 12.475 12.651 0 0 0 0 0 0 0 12.0456 0 0 0 0 0 0 11.0501 0 0 12.0721 0 0 0 0 0 0 0 0 0 0 0 13.0352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4947 0 0 0 0 0 13.2803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96I82 KAZD1_HUMAN Kazal-type serine protease inhibitor domain-containing protein 1 KAZALD1 FKSG28 FKSG40 UNQ2945/PRO21184 Homo sapiens (Human) cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966] extracellular region [GO:0005576]; interstitial matrix [GO:0005614] extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; insulin-like growth factor binding [GO:0005520]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966] GO:0001503; GO:0001558; GO:0005520; GO:0005576; GO:0005614; GO:0009966; GO:0030154; GO:0030198 insulin-like growth factor binding [GO:0005520] LPPPRPAAALALPVLLLLLVVLTPPPTGAR 0.94713 2.8191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3385 0 0 0 0 0 13.6715 14.8113 0 11.0606 0 0 0 10.6624 0 0 0 12.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.888 0 0 0 0 0 0 11.2256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4731 0 0 0 0 0 0 0 0 0 0 0 0 11.6647 0 P04432 KVD39_HUMAN Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi) IGKV1D-39 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814 antigen binding [GO:0003823] DMRVPAQLLGLLLLWLR 0.94714 2.4523 0 0 0 0 0 0 0 0 0 0 0 13.1516 0 0 0 0 0 0 0 0 0 0 0 0 0 14.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8273 14.0152 0 0 12.0745 0 0 0 0 0 12.9764 0 0 0 14.0601 0 12.2189 0 0 0 0 0 0 0 0 0 0 11.6858 0 0 0 0 12.1009 12.7286 14.3487 0 12.073 0 0 12.2336 0 0 0 0 13.371 0 0 0 0 13.7777 13.9355 0 0 0 12.1984 0 0 0 11.9688 0 0 12.6743 0 0 0 0 0 12.5306 0 0 0 0 0 13.0675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3822 11.9653 0 0 0 0 0 0 0 14.1074 0 0 0 0 0 0 0 0 0 A0A1B0GTB2 TUNAR_HUMAN "Protein TUNAR, pTUNAR (Beta cell and neural cell-regulin, BNLN) (TCL1 upstream neural differentiation-associated RNA)" TUNAR Homo sapiens (Human) endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of neuron differentiation [GO:0045665]; neuron projection morphogenesis [GO:0048812]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATPase binding [GO:0051117]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of neuron differentiation [GO:0045665]; neuron projection morphogenesis [GO:0048812]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0005783; GO:0005789; GO:0016021; GO:0032469; GO:0035774; GO:0045665; GO:0048812; GO:0051117; GO:0051480 ATPase binding [GO:0051117] MVITSENDEDRGGQEK 0.94717 0.86671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96K75 ZN514_HUMAN Zinc finger protein 514 ZNF514 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHTGEKPYECSDCGR 0.94718 0.86061 0 0 0 0 0 0 0 0 0 0 16.5471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.9157 0 0 0 0 0 0 0 0 0 13.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0949 0 0 0 0 0 12.4209 0 0 0 0 0 0 12.1821 0 0 0 0 0 0 0 12.0769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6764 13.1392 0 0 13.0385 12.9454 13.0135 13.141 12.9974 0 0 0 0 0 0 0 13.0616 0 0 0 0 Q9Y2W6 TDRKH_HUMAN Tudor and KH domain-containing protein (Tudor domain-containing protein 2) TDRKH TDRD2 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] mitochondrion [GO:0005739]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547] mitochondrion [GO:0005739]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547]; RNA binding [GO:0003723]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030719; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0071546; GO:0071547 RNA binding [GO:0003723] EDMTEPGGAGEPALWK 0.94722 2.5968 0 12.2304 0 0 0 12.1821 0 10.2189 0 0 0 0 0 0 0 0 0 0 14.2454 0 0 13.1298 14.9105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.98 0 0 0 0 12.6289 0 13.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8349 0 0 0 0 0 0 12.1827 0 0 14.8048 0 0 0 0 0 15.5566 0 0 0 19.0581 0 0 0 0 0 0 0 18.8424 18.9136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5618 0 12.4148 11.2041 Q16512 PKN1_HUMAN "Serine/threonine-protein kinase N1, EC 2.7.11.13 (Protease-activated kinase 1, PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N)" PKN1 PAK1 PKN PRK1 PRKCL1 Homo sapiens (Human) B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; chromatin organization [GO:0006325]; epithelial cell migration [GO:0010631]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; chromatin organization [GO:0006325]; epithelial cell migration [GO:0010631]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-serine phosphorylation [GO:0018105]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536] GO:0001782; GO:0001783; GO:0002634; GO:0002637; GO:0003014; GO:0003682; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006325; GO:0006357; GO:0006468; GO:0006469; GO:0006972; GO:0007165; GO:0010631; GO:0018105; GO:0030374; GO:0030496; GO:0030889; GO:0031267; GO:0032154; GO:0032991; GO:0035402; GO:0035556; GO:0042393; GO:0042826; GO:0043687; GO:0048536; GO:0050681; GO:0060765; GO:0106310; GO:2000145 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone kinase activity (H3-T11 specific) [GO:0035402]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] ARELELAVFWRDQR 0.94725 3.7872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1662 0 11.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7116 12.7842 13.515 13.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6496 13.2805 0 0 0 0 0 13.247 0 0 0 0 12.6913 0 13.1163 0 12.8042 0 0 0 0 0 12.253 0 0 0 0 0 0 0 13.6702 0 0 0 0 12.8586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1278 0 0 0 0 0 0 0 0 0 0 12.3874 0 0 0 0 0 12.9759 Q8N2Y8 RUSC2_HUMAN "AP-4 complex accessory subunit RUSC2 (Interacting protein of Rab1, Iporin) (RUN and SH3 domain-containing protein 2)" RUSC2 KIAA0375 Homo sapiens (Human) cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; small GTPase binding [GO:0031267] GO:0005829; GO:0031267; GO:0031410; GO:0070062 small GTPase binding [GO:0031267] EGVVEGAEACPASEEALGR 0.94725 2.7696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5418 0 14.4116 0 0 0 10.451 0 0 0 0 10.2793 9.5789 0 0 0 0 0 0 0 0 0 0 0 0 11.9547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.35447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW93 ARHGJ_HUMAN Rho guanine nucleotide exchange factor 19 (Ephexin-2) ARHGEF19 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" cytosol [GO:0005829] "cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" GO:0005085; GO:0005096; GO:0005829; GO:0032956; GO:0042060; GO:0051056; GO:0060071; GO:0090630 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] FSVCDVVLDHCPAFRRVYLPYVTNQAYQER 0.94726 3.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8136 12.8023 0 13.2886 0 0 0 0 0 13.2824 0 14.8028 0 0 10.9208 0 0 0 13.5644 0 0 0 13.6714 0 12.1888 0 0 0 0 0 0 0 0 13.6019 0 12.0295 14.2846 0 0 0 14.396 0 14.1529 0 0 0 0 13.1992 0 13.3954 14.0019 0 0 13.1006 0 0 12.8609 14.5092 12.4776 0 0 0 0 0 0 0 0 12.5729 0 0 13.3346 0 0 0 0 0 0 0 0 0 0 0 0 12.7686 0 0 0 0 0 11.2333 0 0 0 0 0 12.5052 12.8419 0 0 0 0 0 0 0 Q96NY8 NECT4_HUMAN Nectin-4 (Ig superfamily receptor LNIR) (Nectin cell adhesion molecule 4) (Poliovirus receptor-related protein 4) [Cleaved into: Processed poliovirus receptor-related protein 4 ] NECTIN4 LNIR PRR4 PVRL4 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; virus receptor activity [GO:0001618]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0001618; GO:0005886; GO:0005912; GO:0007156; GO:0007157; GO:0016021; GO:0042802; GO:0070062 identical protein binding [GO:0042802]; virus receptor activity [GO:0001618] DNSSCSVMSEEPEGR 0.94727 2.5954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8786 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2342 0 0 0 0 0 0 0 0 11.5674 11.8986 13.9203 0 0 0 0 0 11.8135 0 0 10.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5273 0 0 0 0 0 13.111 0 0 0 0 0 0 0 0 0 0 11.8544 0 0 0 0 0 13.0731 0 0 0 P0C7T5 ATX1L_HUMAN "Ataxin-1-like (Brother of ataxin-1, Brother of ATXN1)" ATXN1L BOAT BOAT1 Homo sapiens (Human) "anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366]" dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of transcription, DNA-templated [GO:0006355]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0035176; GO:0048286; GO:0048856; GO:1902035 DNA binding [GO:0003677]; RNA binding [GO:0003723] DLPVTSEDMGR 0.94728 2.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4472 0 0 0 0 0 0 0 0 0 0 0 14.0345 0 13.5758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1706 0 13.0612 0 0 0 0 0 0 0 0 0 12.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L5Y9 MAEA_HUMAN "E3 ubiquitin-protein transferase MAEA, EC 2.3.2.27 (Cell proliferation-inducing gene 5 protein) (Erythroblast macrophage protein) (Human lung cancer oncogene 10 protein, HLC-10) (Macrophage erythroblast attacher) (P44EMLP)" MAEA EMP HLC10 PIG5 Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of mitotic cell cycle [GO:0007346] actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151] actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of mitotic cell cycle [GO:0007346] GO:0000151; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005826; GO:0005856; GO:0005887; GO:0007010; GO:0007049; GO:0007155; GO:0007346; GO:0016363; GO:0033033; GO:0034657; GO:0043161; GO:0043249; GO:0046872; GO:0048822; GO:0051301; GO:0061630 actin binding [GO:0003779]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] EDGSSKSPDCPVCSR 0.94728 2.4024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y295 DRG1_HUMAN "Developmentally-regulated GTP-binding protein 1, DRG-1 (Neural precursor cell expressed developmentally down-regulated protein 3, NEDD-3) (Translation factor GTPase DRG1, TRAFAC GTPase DRG1, EC 3.6.5.-)" DRG1 NEDD3 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; potassium ion binding [GO:0030955]; cytoplasmic translation [GO:0002181]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic spindle assembly [GO:1901673] GO:0002181; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0008017; GO:0016020; GO:0016604; GO:0030955; GO:0031116; GO:0042802; GO:1901673 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; potassium ion binding [GO:0030955] GRQVIAVARTCNLILIVLDVLK 0.94728 0.85845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5964 0 0 0 0 0 0 0 0 0 0 0 0 13.4143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6M1 RABEK_HUMAN Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40) RABEPK RAB9P40 Homo sapiens (Human) receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904] cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904] GO:0005768; GO:0005829; GO:0006898; GO:0006904; GO:0010008; GO:0030133; GO:0032588 FYDDLHCIDISDMKWQK 0.9473 0.85733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRX2 RM17_HUMAN "39S ribosomal protein L17, mitochondrial, L17mt, MRP-L17 (LYST-interacting protein 2) (Mitochondrial large ribosomal subunit protein bL17m)" MRPL17 LIP2 Homo sapiens (Human) mitochondrial translation [GO:0032543] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0015934; GO:0019904; GO:0032543 protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735] NLLTGLVRHERIEAPWAR 0.94731 2.767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8462 0 0 0 15.4878 0 0 0 0 0 0 0 0 14.3565 0 14.0973 13.8884 0 13.9371 0 0 0 0 0 14.4475 0 0 0 0 0 14.2421 0 0 0 0 0 0 18.1076 0 0 0 0 0 0 0 15.1727 0 0 14.5154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9854 0 0 0 0 0 0 14.251 0 0 0 0 0 0 0 0 0 14.156 0 0 0 0 Q86YQ8 CPNE8_HUMAN Copine-8 (Copine VIII) CPNE8 Homo sapiens (Human) cellular response to calcium ion [GO:0071277] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cellular response to calcium ion [GO:0071277] GO:0005544; GO:0005886; GO:0046872; GO:0070062; GO:0071277 calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] DFFGKSDPFLVFYR 0.94732 0.85722 0 0 0 0 0 0 0 0 0 13.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9103 0 0 0 12.8085 0 0 0 12.427 0 0 0 0 0 0 12.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2521 Q86W28 NALP8_HUMAN "NACHT, LRR and PYD domains-containing protein 8 (Nucleotide-binding oligomerization domain protein 16) (PYRIN and NACHT-containing protein 4)" NLRP8 NALP8 NOD16 PAN4 Homo sapiens (Human) regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; regulation of inflammatory response [GO:0050727] GO:0005524; GO:0005737; GO:0050727 ATP binding [GO:0005524] AVKLLCRVLR 0.94737 4.1388 0 0 11.3042 0 0 0 0 0 14.6166 10.5059 10.8123 0 0 13.7967 0 10.2138 0 14.2058 12.942 15.2331 13.5444 14.6674 15.3694 14.7162 15.6413 14.8474 15.1551 14.8668 14.4089 0 0 0 0 0 0 0 13.1293 0 0 0 0 0 0 14.7645 14.855 0 0 9.65734 10.249 11.799 13.1144 14.6726 14.0049 13.8419 13.6287 13.0008 0 12.4004 12.3016 0 0 0 0 0 0 0 14.5841 13.8728 12.3904 15.2831 14.0369 14.1977 0 13.5889 14.8283 15.6831 16.1193 15.2967 16.2763 16.0225 16.4577 0 15.1546 0 16.5246 0 15.1629 13.8553 14.758 12.1787 13.9612 14.581 14.7102 16.3531 16.479 15.5562 13.0784 0 0 15.8852 15.445 17.0335 16.7094 14.7496 0 16.4136 15.916 15.5026 15.9247 16.7458 0 0 0 0 15.528 15.0738 16.3671 15.7431 16.4874 15.5943 15.7113 14.6569 14.8333 14.8709 15.1448 15.4294 15.1462 15.4303 15.6505 14.6966 15.0475 15.9105 16 16.0396 15.9879 14.8519 15.9554 14.6194 15.8808 15.9135 15.4271 14.9808 15.0834 14.7331 15.2479 15.4464 14.1316 12.8155 0 11.7936 13.9091 13.8196 14.4989 15.0588 14.9183 0 14.3645 0 0 9.21825 10.9815 12.5149 0 0 11.55 14.4047 0 0 0 12.879 0 0 15.0874 14.6904 14.6042 0 0 0 14.403 0 Q9UHQ9 NB5R1_HUMAN "NADH-cytochrome b5 reductase 1, b5R.1, EC 1.6.2.2 (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2)" CYB5R1 NQO3A2 UNQ3049/PRO9865 Homo sapiens (Human) bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] "endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]" GO:0004128; GO:0005739; GO:0005789; GO:0005886; GO:0015701; GO:0016020; GO:0016021; GO:0016126; GO:0031092; GO:0070062; GO:0071949 "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]" FALPTAHHTLGLPVGKHIYLSTR 0.94737 2.59 0 0 0 0 0 0 0 0 0 0 11.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3322 0 0 0 0 0 0 0 11.3318 0 0 0 0 0 11.3504 0 0 0 13.0282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5069 0 0 0 0 0 0 0 12.4044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8883 0 0 0 0 0 11.8952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2643 11.8326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.249 0 0 0 0 15.5922 0 0 0 0 0 0 0 12.8096 0 0 0 0 0 0 0 0 0 0 0 0 O14569 C56D2_HUMAN "Transmembrane reductase CYB561D2, EC 7.2.1.3 (Cytochrome b561 domain-containing protein 2) (Putative tumor suppressor protein 101F6)" CYB561D2 101F6 LUCA12.2 Homo sapiens (Human) ascorbate homeostasis [GO:0140576] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575]; ascorbate homeostasis [GO:0140576] GO:0005783; GO:0005789; GO:0016021; GO:0016491; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576 heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575] ARCHWVLQLLALLCALLGLGLVILHK 0.94739 0.86202 0 0 0 0 0 0 0 0 0 0 13.5916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8176 0 0 14.3628 0 13.2567 14.368 0 0 0 0 14.0492 0 13.2623 14.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0604 0 14.6697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8461 0 0 0 0 0 0 0 0 0 14.7864 0 13.9303 0 0 0 0 0 0 0 0 0 0 0 0 P50135 HNMT_HUMAN "Histamine N-methyltransferase, HMT, EC 2.1.1.8" HNMT Homo sapiens (Human) histamine catabolic process [GO:0001695]; histamine metabolic process [GO:0001692]; histidine catabolic process [GO:0006548]; methylation [GO:0032259]; respiratory gaseous exchange by respiratory system [GO:0007585] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; histamine N-methyltransferase activity [GO:0046539]; histamine catabolic process [GO:0001695]; histamine metabolic process [GO:0001692]; histidine catabolic process [GO:0006548]; methylation [GO:0032259]; respiratory gaseous exchange by respiratory system [GO:0007585] GO:0001692; GO:0001695; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006548; GO:0007585; GO:0032259; GO:0046539; GO:0070062 histamine N-methyltransferase activity [GO:0046539] FLNHSTEHQCMQEFMDK 0.94741 0.86072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJZ1 STML2_HUMAN "Stomatin-like protein 2, mitochondrial, SLP-2 (EPB72-like protein 2) (Paraprotein target 7, Paratarg-7)" STOML2 SLP2 HSPC108 Homo sapiens (Human) "CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; lipid localization [GO:0010876]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]" cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] "cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive, alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; lipid localization [GO:0010876]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]" GO:0005102; GO:0005739; GO:0005743; GO:0005758; GO:0005856; GO:0005886; GO:0006851; GO:0006874; GO:0007005; GO:0010876; GO:0010918; GO:0019897; GO:0032743; GO:0034982; GO:0035710; GO:0042776; GO:0045121; GO:0050852; GO:0051020; GO:0051259; GO:0090297; GO:1900210; GO:1901612; GO:1990046 cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102] AARGTGALLLRGSLLASGR 0.94741 2.4709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6607 0 0 0 0 0 0 0 0 0 0 12.8288 0 0 12.7812 0 13.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8624 0 0 19.0127 0 0 0 0 0 0 0 0 0 11.3898 0 0 11.3578 0 0 0 0 0 0 0 11.5019 0 0 12.6891 0 0 14.9398 0 0 0 0 0 0 13.0568 0 0 14.6239 0 0 0 14.4748 13.9026 13.1042 0 12.8056 0 0 13.3344 0 12.5263 0 0 0 0 12.8085 0 12.6188 0 0 0 0 0 0 13.0825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5911 0 11.3835 13.2917 0 0 0 0 12.3834 Q96Q80 DERL3_HUMAN "Derlin-3 (Degradation in endoplasmic reticulum protein 3, DERtrin-3) (Der1-like protein 3)" DERL3 C22orf14 DER3 LLN2 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433]" Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176] "Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000839; GO:0005047; GO:0018279; GO:0030176; GO:0030433; GO:0030968; GO:0044877; GO:0051787; GO:1904153 misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047] AWQGLAAEFLQVPAVTR 0.94742 0.86062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1751 0 0 0 13.2994 12.6113 0 13.1765 0 0 0 12.8741 0 0 0 14.1838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13765 DOB_HUMAN "HLA class II histocompatibility antigen, DO beta chain (MHC class II antigen DOB)" HLA-DOB Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class II protein complex [GO:0042613] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class II protein complex [GO:0042613]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] GO:0002250; GO:0002503; GO:0002587; GO:0005764; GO:0005765; GO:0010008; GO:0016021; GO:0019886; GO:0023026; GO:0032395; GO:0042613; GO:0050870 MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395] HNYRLGAPFTVGRK 0.94743 2.8142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0131 0 11.6079 0 14.2303 0 0 0 13.7633 0 0 0 0 12.7844 0 0 0 12.951 0 0 0 0 0 11.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6558 14.2244 0 0 0 13.4611 0 0 0 0 0 0 0 0 0 0 0 0 13.4929 0 13.9617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0168 0 0 0 0 0 Q8IY50 S35F3_HUMAN Putative thiamine transporter SLC35F3 (Solute carrier family 35 member F3) SLC35F3 Homo sapiens (Human) thiamine transport [GO:0015888] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; thiamine transport [GO:0015888] GO:0015888; GO:0016021 AFVFLLSWIVLR 0.94747 2.5891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3933 0 0 0 0 12.3113 0 0 0 12.478 0 0 0 0 14.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4008 0 0 0 0 0 0 0 11.5399 0 0 0 0 11.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7197 0 0 0 0 0 0 0 13.5072 11.6534 0 0 0 10.5016 0 0 0 0 0 0 Q96BI1 S22AI_HUMAN "Solute carrier family 22 member 18 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein) (Efflux transporter-like protein) (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Organic cation transporter-like protein 2, ORCTL-2) (Solute carrier family 22 member 1-like) (Tumor-suppressing STF cDNA 5 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein) (p45-Beckwith-Wiedemann region 1 A, p45-BWR1A)" SLC22A18 BWR1A BWSCR1A HET IMPT1 ITM ORCTL2 SLC22A1L TSSC5 Homo sapiens (Human) organic cation transport [GO:0015695]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; solute:proton antiporter activity [GO:0015299]; symporter activity [GO:0015293]; ubiquitin protein ligase binding [GO:0031625]; organic cation transport [GO:0015695]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] GO:0005635; GO:0005737; GO:0005886; GO:0015293; GO:0015299; GO:0015695; GO:0016020; GO:0016021; GO:0016324; GO:0031625; GO:0042908; GO:1990961 solute:proton antiporter activity [GO:0015299]; symporter activity [GO:0015293]; ubiquitin protein ligase binding [GO:0031625] GARAALTLSFLAALALYLLLAAASSPALPGVYLLFASR 0.94754 0.85746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8246 0 0 0 11.9968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0408 0 0 0 0 12.5408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53396 ACLY_HUMAN "ATP-citrate synthase, EC 2.3.3.8 (ATP-citrate (pro-S-)-lyase, ACL) (Citrate cleavage enzyme)" ACLY Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107] GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0006085; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0035578; GO:0046872; GO:0070062; GO:1904813 ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872] AFDSGIIPMEFVNK 0.94757 2.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9769 0 0 0 0 0 0 0 0 0 12.6536 0 11.9071 0 0 0 10.8167 11.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7074 0 0 0 0 0 0 0 0 13.0458 0 0 0 0 0 0 0 0 0 0 11.1442 0 13.0454 0 0 16.1134 0 0 0 0 0 0 0 0 0 0 0 0 13.9987 14.1921 0 0 0 0 0 13.7062 13.9827 12.9148 0 0 13.4015 11.9234 0 0 0 0 0 12.0211 13.6874 15.443 14.525 13.5666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6615 0 0 0 0 0 0 0 0 0 0 14.3211 0 0 13.843 0 0 0 11.6732 Q5R3K3 CAHM6_HUMAN Calcium homeostasis modulator protein 6 (Protein FAM26F) CALHM6 C6orf187 FAM26F Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261] GO:0005261; GO:0005887 cation channel activity [GO:0005261] AQSQVLGWILIAVVIIILLIFTSVTR 0.94759 2.7107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7056 0 0 0 0 0 0 0 0 0 0 0 0 14.5681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8605 0 0 13.1837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.55 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRH3 TBG2_HUMAN Tubulin gamma-2 chain (Gamma-2-tubulin) TUBG2 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; spindle [GO:0005819]; spindle microtubule [GO:0005876] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052] GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000930; GO:0005198; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0015630; GO:0031122 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] EDMFKDNFDEMDR 0.94763 0.86223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1626 0 0 0 0 0 0 0 0 0 0 0 0 0 9.29395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6525 10.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21 0 0 15.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75431 MTX2_HUMAN Metaxin-2 (Mitochondrial outer membrane import complex protein 2) MTX2 Homo sapiens (Human) inner mitochondrial membrane organization [GO:0007007]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040] cytoplasm [GO:0005737]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401] cytoplasm [GO:0005737]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040] GO:0001401; GO:0005730; GO:0005737; GO:0005739; GO:0005741; GO:0006839; GO:0007005; GO:0007007; GO:0045040; GO:0140275 SLVAEAFVSQIAAAEPWPENATLYQQLK 0.94768 0.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3P2 NELFA_HUMAN "Negative elongation factor A, NELF-A (Wolf-Hirschhorn syndrome candidate 2 protein)" NELFA WHSC2 P/OKcl.15 Homo sapiens (Human) negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0051571 chromatin binding [GO:0003682] KMDTTTPLKGIPK 0.9477 2.7064 13.1598 12.6175 0 0 12.9631 12.9103 12.9431 0 12.088 12.5533 0 0 0 0 0 0 0 13.0107 0 0 0 0 0 0 0 12.568 0 0 0 0 0 11.7864 13.2005 0 0 0 12.3227 0 0 11.9886 0 0 0 0 0 0 0 10.2192 0 13.801 0 0 11.8119 0 0 0 10.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.621 0 15.2986 13.3811 0 0 14.9572 13.2978 0 0 0 12.4214 12.0908 0 0 0 0 0 0 0 0 0 0 0 14.2404 0 15.3777 0 0 0 0 0 0 0 0 0 0 0 0 15.3026 0 0 0 0 0 0 14.5301 0 0 0 0 0 0 0 0 14.5774 0 0 14.8939 11.8052 15.049 0 0 0 0 15.4944 0 12.5893 11.2262 0 0 0 0 0 14.1956 11.5418 0 0 0 0 15.6251 0 0 0 0 14.7125 17.9901 0 0 0 0 0 0 0 0 0 0 0 0 0 15.108 0 0 0 0 10.8224 Q6PG37 ZN790_HUMAN Zinc finger protein 790 ZNF790 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHLMMFRDVAVDFSQEEWECLDLEQRDLYR 0.94774 2.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8457 0 0 0 11.9435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4348 0 0 0 0 0 0 0 0 12.9862 13.2029 0 0 0 0 0 0 13.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47974 TISD_HUMAN "mRNA decay activator protein ZFP36L2 (Butyrate response factor 2) (EGF-response factor 2, ERF-2) (TPA-induced sequence 11d) (Zinc finger protein 36, C3H1 type-like 2, ZFP36-like 2)" ZFP36L2 ERF2 RNF162C TIS11D Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; definitive hemopoiesis [GO:0060216]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; mRNA catabolic process [GO:0006402]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; negative regulation of stem cell differentiation [GO:2000737]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of B cell differentiation [GO:0045577]; regulation of mRNA stability [GO:0043488]; response to wounding [GO:0009611]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; definitive hemopoiesis [GO:0060216]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; mRNA catabolic process [GO:0006402]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; negative regulation of stem cell differentiation [GO:2000737]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of B cell differentiation [GO:0045577]; regulation of mRNA stability [GO:0043488]; response to wounding [GO:0009611]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]" GO:0000288; GO:0003723; GO:0005634; GO:0005737; GO:0006402; GO:0009611; GO:0030097; GO:0033077; GO:0035019; GO:0035925; GO:0043488; GO:0044344; GO:0045577; GO:0045599; GO:0046872; GO:0048103; GO:0060216; GO:0061158; GO:0070371; GO:0071356; GO:0071364; GO:0071385; GO:0071560; GO:0097011; GO:1900153; GO:1901991; GO:2000737 metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723] CQFAHGFHELRSLTRHPK 0.94782 2.4368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7708 0 0 0 0 0 0 0 0 0 0 0 0 12.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.625 13.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3471 0 0 0 0 0 15.5631 0 0 0 0 0 0 0 14.8448 0 0 0 0 14.2357 0 0 0 0 0 0 0 0 Q8NH57 O52P1_HUMAN Olfactory receptor 52P1 OR52P1 OR52P1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FGHHVPVHIHILLANVYLLLPPALNPVVYGVK 0.94783 0.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3937 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0771 0 0 12.0944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5793 0 0 0 0 0 0 0 0 0 0 0 0 Q96ED9 HOOK2_HUMAN "Protein Hook homolog 2, h-hook2, hHK2" HOOK2 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; trans-Golgi network [GO:0005802] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; trans-Golgi network [GO:0005802]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] GO:0005737; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0006897; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0042802; GO:0043231; GO:0045022; GO:0051959; GO:0070695; GO:1905719 dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] AMEERYRR 0.94783 4.1304 0 13.5359 0 12.1208 0 11.8772 0 0 0 0 0 0 0 0 0 0 0 12.7867 0 0 12.7992 0 0 0 10.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9905 0 0 0 0 0 10.5289 0 0 0 0 0 0 10.4015 0 0 0 0 0 0 0 0 10.6236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.899 0 0 0 0 14.3127 16.6102 16.3567 0 0 0 0 15.9669 12.3599 0 14.5116 0 0 0 0 12.6321 0 14.6325 0 14.3329 0 12.4641 0 13.7973 0 0 0 0 0 0 0 14.7957 0 0 0 0 0 13.8709 0 0 13.6334 0 13.1336 0 0 14.6315 0 14.3709 0 14.4009 0 12.76 14.0788 0 12.8768 14.8412 13.5944 12.6111 12.6915 12.1995 0 0 14.4803 0 11.7676 0 0 0 0 0 0 0 0 13.0717 0 0 0 0 0 0 0 0 12.7145 12.7642 11.7348 0 0 0 0 0 0 14.0718 0 12.614 0 0 Q9H869 YYAP1_HUMAN YY1-associated protein 1 (Hepatocellular carcinoma susceptibility protein) (Hepatocellular carcinoma-associated protein 2) YY1AP1 HCCA2 YY1AP Homo sapiens (Human) "cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001650; GO:0003712; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0008283; GO:0030154; GO:0051726 transcription coregulator activity [GO:0003712] EEHRLPFWLK 0.94783 0.85145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3887 0 0 0 0 0 0 0 0 0 0 0 13.8513 0 0 12.5824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.719 13.3422 13.574 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5521 0 0 0 0 0 13.0247 0 0 0 0 12.7737 0 0 12.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSG2 INSY2_HUMAN "Inhibitory synaptic factor 2A, InSyn2" INSYN2A C10orf141 FAM196A INSYN2 Homo sapiens (Human) inhibitory postsynaptic potential [GO:0060080] anchoring junction [GO:0070161]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; postsynaptic density [GO:0014069]; inhibitory postsynaptic potential [GO:0060080] GO:0014069; GO:0060080; GO:0070161 GRPNSEEPAPPALRR 0.94784 2.776 0 0 0 0 10.8345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4021 0 0 0 0 0 0 0 0 0 0 14.2111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6014 0 0 0 0 12.8849 0 0 11.135 0 0 0 0 0 0 0 0 0 0 0 Q96B70 LENG9_HUMAN Leukocyte receptor cluster member 9 LENG9 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] ALLAPGLNAPPR 0.94785 3.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8514 0 0 0 0 0 0 0 0 0 0 12.5477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7642 0 12.8032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NFN3 RFOX3_HUMAN "RNA binding protein fox-1 homolog 3 (Fox-1 homolog C) (Neuronal nuclei antigen, NeuN antigen)" RBFOX3 Homo sapiens (Human) "mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0007399; GO:0008380 mRNA binding [GO:0003729] ILDVEIIFNER 0.94786 2.702 11.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.376 11.3087 0 0 0 12.3805 10.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0W4 NLGNX_HUMAN "Neuroligin-4, X-linked, Neuroligin X (HNLX)" NLGN4X KIAA1260 NLGN4 UNQ365/PRO701 Homo sapiens (Human) adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625] "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]" "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]" GO:0003360; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0016021; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0038023; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0048488; GO:0050804; GO:0050808; GO:0050839; GO:0060076; GO:0070161; GO:0071625; GO:0089717; GO:0090394; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099060 cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] DQLYLHIGLKPRVR 0.94786 0.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.166 0 0 0 0 13.2464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0778 0 0 0 0 13.7298 0 0 12.0785 0 0 0 P04733 MT1F_HUMAN "Metallothionein-1F, MT-1F (Metallothionein-IF, MT-IF)" MT1F PRO0376 Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010273; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCVCKGASEKCSCCD 0.94787 4.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5388 0 10.782 0 0 0 12.6743 0 0 0 0 0 0 10.3155 0 0 0 12.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2404 0 0 0 0 0 0 0 0 12.2094 14.0696 0 0 0 0 0 0 0 0 12.2934 0 13.9431 13.1575 0 0 12.6321 0 0 14.0761 0 0 10.8618 0 0 14.5948 0 0 0 11.8099 0 0 0 12.7996 13.1411 0 0 0 0 0 0 0 0 11.4163 0 0 0 0 0 0 0 11.9192 0 0 0 0 0 12.2824 13.0614 11.9227 10.7464 0 0 12.9243 0 0 0 0 0 0 0 0 13.1148 0 0 0 14.3858 0 12.7193 0 0 11.0099 0 0 0 0 0 0 10.9067 0 0 0 0 0 15.0647 0 0 0 0 0 0 Q9UPY8 MARE3_HUMAN "Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3, EBF3) (End-binding protein 3, EB3) (RP3)" MAPRE3 Homo sapiens (Human) "cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]" cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233] "cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225]" GO:0005737; GO:0005815; GO:0008017; GO:0008022; GO:0008104; GO:0015630; GO:0019901; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0042802; GO:0045737; GO:0045860; GO:0045893; GO:0048471; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:1903033; GO:1904825; GO:1905721 identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901] FFDANYDGK 0.94788 2.7574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1356 0 0 0 0 0 0 11.9938 0 0 11.592 0 0 0 0 10.8248 0 0 11.639 0 0 0 0 12.459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3I1 FBX7_HUMAN F-box only protein 7 FBXO7 FBX7 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; lymphocyte differentiation [GO:0030098]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] classical Lewy body [GO:0097414]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cytoplasmic inclusion [GO:0097409]; Lewy body core [GO:1990037]; Lewy body corona [GO:1990038]; Lewy neurite [GO:0097462]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; autophagy of mitochondrion [GO:0000422]; lymphocyte differentiation [GO:0030098]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of lymphocyte differentiation [GO:0045620]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of autophagy of mitochondrion [GO:1903599]; protein targeting to mitochondrion [GO:0006626]; protein ubiquitination [GO:0016567]; regulation of locomotion [GO:0040012]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000422; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006626; GO:0010975; GO:0016567; GO:0019005; GO:0019901; GO:0030098; GO:0031625; GO:0031647; GO:0032991; GO:0040012; GO:0043130; GO:0045620; GO:0045736; GO:0046982; GO:0097409; GO:0097414; GO:0097462; GO:1903204; GO:1903208; GO:1903599; GO:1990037; GO:1990038; GO:1990756; GO:2000134 protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] FLYLRDFRDNTVR 0.94789 3.8972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8382 0 0 0 0 0 0 12.2529 13.6302 0 0 0 0 0 0 0 0 0 0 0 11.9105 0 0 0 0 0 0 0 0 0 0 0 10.7694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2115 0 0 0 0 0 0 12.1246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7547 0 0 0 0 10.0503 0 0 10.9058 0 12.1849 11.6771 0 12.6562 0 0 0 10.8988 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57363 0 0 0 0 0 0 0 0 11.3624 0 0 0 0 0 0 0 0 0 13.7071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88883 0 0 9.76698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GWG4 SRTM2_HUMAN Serine-rich and transmembrane domain-containing 2 SERTM2 Homo sapiens (Human) integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] GO:0016021; GO:0043231 YSNLYMYVGLFLSLLAILLILLFTMLLR 0.9479 0.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2687 0 0 0 0 0 0 0 12.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q11206 SIA4C_HUMAN "CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4, Alpha 2,3-ST 4, Beta-galactoside alpha-2,3-sialyltransferase 4, EC 2.4.99.2, EC 2.4.99.4 (Alpha 2,3-sialyltransferase IV) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase, EC 2.4.99.6) (SAT-3) (ST-4) (ST3Gal IV, ST3GalIV) (ST3GalA.2) (STZ) (Sialyltransferase 4C, SIAT4-C)" ST3GAL4 CGS23 NANTA3 SIAT4C STZ Homo sapiens (Human) cognition [GO:0050890]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]; cognition [GO:0050890]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]" GO:0000139; GO:0003836; GO:0004513; GO:0005576; GO:0006486; GO:0008118; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0016020; GO:0016021; GO:0016266; GO:0018146; GO:0019082; GO:0030194; GO:0030259; GO:0032580; GO:0047288; GO:0050890; GO:0097503; GO:1903238; GO:1990743 "beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]" GFWKQPPLIWDVNPK 0.94792 2.7006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5631 0 0 0 12.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1137 0 0 0 0 0 0 0 0 0 0 13.0972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7098 0 0 0 0 Q9UI25 YP002_HUMAN Putative uncharacterized protein PRO0461 PRO0461 Homo sapiens (Human) MEEMSYGENSGTHVGSFSCSPQPSQQMK 0.94792 0.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3134 0 11.7565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHT4 YG001_HUMAN Putative uncharacterized protein PRO1854 PRO1854 Homo sapiens (Human) HHFKIHVPSQFFILITITKY 0.94795 2.774 0 0 0 0 0 0 0 0 0 0 11.3981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5314 0 13.352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1797 0 0 0 0 0 0 0 0 13.1479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.562 0 0 0 0 0 0 P0DN78 OPSG3_HUMAN "Medium-wave-sensitive opsin 3 (Green cone photoreceptor pigment) (Green-sensitive opsin, GOP) (opsin 1 cone pigments medium-wave-sensitive 3)" OPN1MW3 Homo sapiens (Human) cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750] integral component of plasma membrane [GO:0005887]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; visual perception [GO:0007601] GO:0001750; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0071482; GO:0097381 G protein-coupled photoreceptor activity [GO:0008020] AVAKQQKESESTQK 0.94796 2.4526 0 0 0 0 0 0 0 12.0526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7846 0 0 0 0 0 14.2456 12.5809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9033 12.1796 0 0 0 0 13.0479 0 0 0 0 0 0 0 11.5616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5718 0 0 0 0 0 0 0 12.9374 0 0 0 Q6TDP4 KLH17_HUMAN Kelch-like protein 17 (Actinfilin) KLHL17 AF Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; dendrite cytoplasm [GO:0032839]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; dendrite cytoplasm [GO:0032839]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; protein ubiquitination [GO:0016567] GO:0005615; GO:0007420; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031208; GO:0032839; GO:0043025; GO:0051015; GO:0060090; GO:0070161 actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; POZ domain binding [GO:0031208] AAHRYVLQHFVDVAK 0.94796 3.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1337 0 0 0 0 0 0 0 0 13.0318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8716 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3957 0 0 0 0 0 0 0 0 0 0 0 13.2351 0 0 13.4939 0 0 0 0 13.4379 0 0 0 0 11.9851 0 0 0 0 0 0 0 P14927 QCR7_HUMAN Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein) UQCRB UQBP Homo sapiens (Human) "aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]" mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750] "mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]" GO:0005743; GO:0005746; GO:0005750; GO:0006119; GO:0006122; GO:0009060; GO:0045333 EVIRERK 0.94801 2.7737 0 0 0 0 0 0 0 0 0 15.2085 0 0 0 14.7597 14.7013 0 0 0 12.8894 13.3726 13.9203 0 0 0 0 11.5023 0 0 11.1083 0 0 0 14.3051 0 0 0 14.9434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9998 0 0 17.5601 0 P02144 MYG_HUMAN Myoglobin MB Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; enucleate erythrocyte differentiation [GO:0043353]; heart development [GO:0007507]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; brown fat cell differentiation [GO:0050873]; enucleate erythrocyte differentiation [GO:0043353]; heart development [GO:0007507]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666] GO:0001666; GO:0005344; GO:0005829; GO:0007507; GO:0015671; GO:0019825; GO:0020037; GO:0043353; GO:0046872; GO:0050873; GO:0070062 heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] HGATVLTALGGILKK 0.94802 2.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2854 0 0 0 0 0 0 0 11.4177 0 0 0 11.9946 0 0 0 12.825 0 11.836 0 0 0 0 11.9526 12.4377 0 13.1241 0 0 12.2509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9038 0 0 0 14.6704 0 0 14.8912 14.2317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DMP2 SRG2B_HUMAN SLIT-ROBO Rho GTPase-activating protein 2B (SLIT-ROBO Rho GTPase activating protein 2 pseudogene 2) SRGAP2B SRGAP2P2 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; nervous system development [GO:0007399] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; negative regulation of cell migration [GO:0030336]; nervous system development [GO:0007399] GO:0005737; GO:0007399; GO:0030336 ANQQETEQFYFTVR 0.94803 2.6007 0 0 0 0 0 0 0 0 0 11.3925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1861 0 0 0 0 15.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.708 0 0 0 0 13.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04844 ACHE_HUMAN Acetylcholine receptor subunit epsilon CHRNE ACHRE Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; cation transmembrane transporter activity [GO:0008324]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" GO:0005231; GO:0005886; GO:0005887; GO:0005892; GO:0006936; GO:0007165; GO:0007268; GO:0007271; GO:0008324; GO:0015464; GO:0022848; GO:0030594; GO:0031594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:1904315 acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; cation transmembrane transporter activity [GO:0008324]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] AEELILKK 0.94805 3.9751 0 0 0 0 0 0 0 0 0 13.8264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2029 10.6263 0 11.4954 0 0 0 12.3931 0 0 10.8628 10.4282 10.5303 0 0 0 0 11.6761 9.36164 0 10.078 0 0 0 0 0 0 0 13.9727 0 0 0 0 0 0 0 0 0 0 11.7563 12.0429 13.3341 0 0 0 0 0 12.9281 0 12.4921 0 0 0 11.8481 0 0 0 0 0 14.3261 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4236 0 12.6462 0 0 14.8907 0 10.8114 0 0 0 0 0 0 0 0 0 0 11.4508 0 0 0 0 0 0 12.2394 0 0 0 0 0 0 0 11.2223 0 0 11.0268 13.6103 0 0 0 0 0 0 0 0 0 0 10.689 0 0 11.7212 12.2861 0 0 0 13.4169 11.9773 12.9195 0 0 14.2639 0 0 0 0 0 0 0 Q8TED1 GPX8_HUMAN "Probable glutathione peroxidase 8, GPx-8, GSHPx-8, EC 1.11.1.9" GPX8 UNQ847/PRO1785 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599] endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021] endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599] GO:0004601; GO:0004602; GO:0005788; GO:0016021; GO:0034599 glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601] AKVFAVLLSIVLCTVTLFLLQLK 0.94806 2.476 0 0 0 0 13.5504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7159 0 0 0 0 0 0 0 0 0 0 0 0 11.2446 0 0 12.2768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2703 0 0 0 0 0 0 0 0 0 13.83 0 0 0 0 0 0 P50991 TCPD_HUMAN "T-complex protein 1 subunit delta, TCP-1-delta (CCT-delta) (Stimulator of TAR RNA-binding)" CCT4 CCTD SRB Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199] cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] GO:0002199; GO:0003723; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0042470; GO:0042995; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:0140662; GO:1901998; GO:1904851; GO:1904871; GO:1904874 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] DIEREDIEFICK 0.94807 2.8739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6598 0 0 11.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9973 0 11.2821 0 12.1944 0 0 0 0 0 0 0 0 11.4944 12.2755 0 0 0 0 0 0 11.8228 0 0 0 0 14.6171 0 0 0 0 0 0 0 10.952 0 0 0 0 0 0 0 0 0 0 0 14.6183 0 0 0 0 0 0 12.5487 0 0 0 0 0 0 0 12.6693 0 0 0 0 0 0 0 0 10.9073 0 0 0 0 0 0 0 0 0 12.604 0 12.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60331 KR101_HUMAN Keratin-associated protein 10-1 (High sulfur keratin-associated protein 10.1) (Keratin-associated protein 10.1) (Keratin-associated protein 18-1) (Keratin-associated protein 18.1) KRTAP10-1 KAP10.1 KAP18-1 KRTAP10.1 KRTAP18-1 KRTAP18.1 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 DSSSCCQQSSCQPTCCASSSSQQSCCVPVCCK 0.94809 0.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0688 0 0 0 0 0 0 0 0 0 12.9745 11.237 0 0 0 0 0 0 0 0 0 0 Q13351 KLF1_HUMAN "Krueppel-like factor 1 (Erythroid krueppel-like transcription factor, EKLF)" KLF1 EKLF Homo sapiens (Human) "cellular response to peptide [GO:1901653]; erythrocyte differentiation [GO:0030218]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cellular response to peptide [GO:1901653]; erythrocyte differentiation [GO:0030218]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0030218; GO:0045893; GO:0046872; GO:0060135; GO:1901653 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" PYACTWEGCGWR 0.94811 2.4752 10.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.242 11.5346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.908 0 0 0 0 0 0 0 0 0 0 0 0 11.7718 0 0 0 0 0 0 0 0 0 0 0 13.4453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8585 0 0 0 0 0 0 0 0 0 0 0 0 13.0774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JT82 KLF17_HUMAN Krueppel-like factor 17 (Zinc finger protein 393) KLF17 ZNF393 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GSSEARPYCCNYENCGK 0.94813 2.5984 0 0 0 0 0 0 0 0 0 13.9279 11.8286 13.378 0 0 0 0 0 0 0 12.474 0 0 0 0 0 0 0 0 0 0 12.5757 13.3618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0639 0 0 0 0 0 13.9913 0 0 0 13.311 13.3048 0 0 0 0 14.1516 0 0 0 0 0 0 0 16.4043 0 13.8957 0 13.4888 0 0 0 12.3215 0 0 0 0 0 0 0 0 0 0 13.562 0 0 0 11.2226 0 0 13.4526 0 13.4098 0 0 13.8095 0 0 0 0 13.4553 0 0 0 0 10.8138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9055 0 0 Q9H3Z4 DNJC5_HUMAN "DnaJ homolog subfamily C member 5 (Ceroid-lipofuscinosis neuronal protein 4) (Cysteine string protein, CSP)" DNAJC5 CLN4 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; regulated exocytosis [GO:0045055]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079] anchored component of membrane [GO:0031225]; anchored component of synaptic vesicle membrane [GO:0098993]; azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; specific granule membrane [GO:0035579] anchored component of membrane [GO:0031225]; anchored component of synaptic vesicle membrane [GO:0098993]; azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; specific granule membrane [GO:0035579]; ATP-dependent protein binding [GO:0043008]; chaperone-mediated protein folding [GO:0061077]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; regulated exocytosis [GO:0045055]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079] GO:0005739; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0006887; GO:0016020; GO:0016079; GO:0031225; GO:0031594; GO:0035577; GO:0035579; GO:0042470; GO:0042584; GO:0043008; GO:0043231; GO:0043524; GO:0045055; GO:0051402; GO:0061077; GO:0061202; GO:0098693; GO:0098793; GO:0098993 ATP-dependent protein binding [GO:0043008] ALFVFCGLLTCCYCCCCLCCCFNCCCGK 0.94813 0.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7739 0 0 0 0 0 0 0 0 0 0 0 12.9327 0 0 12.322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P107 GMIP_HUMAN "GEM-interacting protein, GMIP" GMIP Homo sapiens (Human) activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046872; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] ASYELEFAKSTMK 0.94813 2.8727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0984 0 0 0 0 0 0 0 0 0 0 17.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.295 0 0 0 0 12.4328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0997 0 0 0 0 0 0 0 0 0 P28358 HXD10_HUMAN Homeobox protein Hox-D10 (Homeobox protein Hox-4D) (Homeobox protein Hox-4E) HOXD10 HOX4D HOX4E Homo sapiens (Human) adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of cell cycle [GO:0045786]; neuromuscular process [GO:0050905]; peripheral nervous system neuron development [GO:0048935]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; spinal cord motor neuron cell fate specification [GO:0021520] chromatin [GO:0000785]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of cell cycle [GO:0045786]; neuromuscular process [GO:0050905]; peripheral nervous system neuron development [GO:0048935]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; spinal cord motor neuron cell fate specification [GO:0021520]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007338; GO:0007519; GO:0008344; GO:0009952; GO:0009954; GO:0021520; GO:0030326; GO:0035136; GO:0035137; GO:0036464; GO:0045786; GO:0048704; GO:0048935; GO:0050905; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EESNCCMYSDK 0.94816 2.8214 0 10.1214 0 0 0 0 0 0 0 0 9.2662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2421 0 0 11.8628 0 0 0 13.767 0 0 0 0 0 0 0 12.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6735 0 11.1077 0 0 0 0 0 12.4617 0 0 11.6535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2237 0 0 0 0 0 0 0 0 0 11.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1621 0 0 13.0072 0 0 0 0 0 0 0 0 0 0 0 11.8798 0 12.6392 0 Q13772 NCOA4_HUMAN "Nuclear receptor coactivator 4, NCoA-4 (Androgen receptor coactivator 70 kDa protein, 70 kDa AR-activator, 70 kDa androgen receptor coactivator) (Androgen receptor-associated protein of 70 kDa) (Ret-activating protein ELE1)" NCOA4 ARA70 ELE1 RFG Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to estrogen stimulus [GO:0071391]; cellular response to testosterone stimulus [GO:0071394]; intracellular estrogen receptor signaling pathway [GO:0030520]; male gonad development [GO:0008584]; protein targeting to lysosome [GO:0006622]; response to hormone [GO:0009725] autolysosome [GO:0044754]; nucleus [GO:0005634] autolysosome [GO:0044754]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; cellular iron ion homeostasis [GO:0006879]; cellular response to estrogen stimulus [GO:0071391]; cellular response to testosterone stimulus [GO:0071394]; intracellular estrogen receptor signaling pathway [GO:0030520]; male gonad development [GO:0008584]; protein targeting to lysosome [GO:0006622]; response to hormone [GO:0009725] GO:0003713; GO:0005634; GO:0006622; GO:0006879; GO:0008584; GO:0009725; GO:0030520; GO:0044754; GO:0071391; GO:0071394 transcription coactivator activity [GO:0003713] ANEPCTSFAECVCDENCEK 0.94817 2.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8163 0 0 0 0 15.22 0 0 12.5623 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7373 0 0 0 0 0 0 0 0 0 10.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48448 AL3B2_HUMAN "Aldehyde dehydrogenase family 3 member B2, EC 1.2.1.3 (Aldehyde dehydrogenase 8)" ALDH3B2 ALDH8 Homo sapiens (Human) alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; sphingolipid biosynthetic process [GO:0030148] cytoplasm [GO:0005737]; lipid droplet [GO:0005811] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; sphingolipid biosynthetic process [GO:0030148] GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005811; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0030148; GO:0043878 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878] FTFDTFSHHR 0.9482 2.4717 0 0 0 0 0 0 12.4264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.79 12.7785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8473 0 13.5425 0 13.5296 0 13.8943 0 0 14.5655 0 0 0 14.8526 0 0 0 0 13.5283 13.4018 0 13.7469 0 0 0 0 0 0 0 0 0 0 0 12.3795 0 0 0 0 13.9478 13.5276 15.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5512 13.7258 0 13.3963 13.2861 0 0 0 12.7011 0 0 0 0 0 0 13.5289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3965 0 0 0 0 0 0 0 0 0 0 13.7372 0 0 0 Q96BT3 CENPT_HUMAN "Centromere protein T, CENP-T (Interphase centromere complex protein 22)" CENPT C16orf56 ICEN22 Homo sapiens (Human) cell division [GO:0051301]; chromosome organization [GO:0051276]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278] "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; chromosome organization [GO:0051276]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]" GO:0000278; GO:0000775; GO:0000776; GO:0003677; GO:0005654; GO:0005829; GO:0007059; GO:0016604; GO:0046982; GO:0051276; GO:0051301; GO:0051382 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] HHQFLEPAPAPGAAVLSSEPAEPLLVRHPPR 0.94821 0.85465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1913 0 0 0 0 0 0 Q6YI46 TMM64_HUMAN Transmembrane protein 64 TMEM64 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of osteoblast differentiation [GO:0045668]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of ATP-dependent activity [GO:0043462]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of osteoblast differentiation [GO:0045668]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoclast differentiation [GO:0045672]; regulation of ATP-dependent activity [GO:0043462]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0005783; GO:0016021; GO:0030316; GO:0043462; GO:0045600; GO:0045668; GO:0045672; GO:0045780; GO:0051480; GO:0090090 CCCLGSTCWCR 0.94823 2.4468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6344 0 0 0 0 0 0 0 11.9761 0 0 12.1012 0 0 0 0 0 0 0 0 16.3747 0 0 0 0 0 11.8858 12.9602 0 0 0 0 0 0 0 0 0 0 0 0 10.8003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0M4 IL17C_HUMAN "Interleukin-17C, IL-17C (Cytokine CX2)" IL17C UNQ561/PRO1122 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954] GO:0005125; GO:0005576; GO:0005615; GO:0006954; GO:0007166; GO:0007267 cytokine activity [GO:0005125] LLQSLLVLR 0.94825 0.85241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2G8 GHDC_HUMAN GH3 domain-containing protein GHDC D11LGP1E LGP1 Homo sapiens (Human) cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; acid-amino acid ligase activity [GO:0016881] GO:0005576; GO:0005635; GO:0005737; GO:0005783; GO:0016020; GO:0016881; GO:0034774; GO:0035580 acid-amino acid ligase activity [GO:0016881] ALEAGTAVELLDVFLGLETDGEELAGAIAAGNPGAPLRER 0.94828 4.7202 0 0 0 0 0 0 11.8904 0 0 0 0 0 0 0 0 0 13.0579 0 14.2634 0 0 13.275 10.2824 14.1759 0 0 14.5928 0 0 0 0 0 0 0 13.0014 0 0 0 0 10.0217 0 0 0 10.0568 0 0 11.2474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.955 14.643 15.2648 0 0 11.2845 0 0 0 0 0 0 0 0 0 14.886 0 16.4107 0 0 14.9541 13.8214 0 0 0 12.825 0 14.0791 15.1673 15.3655 12.6936 0 13.8606 0 0 0 0 0 0 0 0 0 15.1315 0 0 13.067 0 12.0545 15.2782 13.3887 14.3626 0 0 0 0 13.8636 0 0 0 14.0125 0 0 15.049 14.6369 0 12.077 11.911 0 0 14.9747 13.5238 0 15.7985 13.4764 0 0 0 0 13.1335 0 15.8233 0 0 13.8151 0 0 13.5806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7163 0 0 14.2556 0 0 0 Q6UXV4 MIC27_HUMAN MICOS complex subunit MIC27 (Apolipoprotein O-like) (Protein FAM121A) APOOL CXorf33 FAM121A MIC27 UNQ8193/PRO23204 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] extracellular region [GO:0005576]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; platelet alpha granule lumen [GO:0031093]; SAM complex [GO:0001401] extracellular region [GO:0005576]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; platelet alpha granule lumen [GO:0031093]; SAM complex [GO:0001401]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] GO:0001401; GO:0005576; GO:0005739; GO:0005743; GO:0007007; GO:0031093; GO:0042407; GO:0044284; GO:0061617; GO:0140275 GVYVFVK 0.9483 0.85157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.343 0 14.6665 18.7059 0 0 0 0 18.4777 0 0 0 0 0 0 0 0 0 0 O15427 MOT4_HUMAN "Monocarboxylate transporter 4, MCT 4 (Solute carrier family 16 member 3)" SLC16A3 MCT3 MCT4 Homo sapiens (Human) monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; RNA binding [GO:0003723]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879] GO:0003723; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0031965; GO:0035879; GO:0098688; GO:0099061 lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; RNA binding [GO:0003723]; symporter activity [GO:0015293] SIIQVYLTTGVITGLGLALNFQPSLIMLNR 0.94832 0.83983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2A3N6 PIPSL_HUMAN "Putative PIP5K1A and PSMD4-like protein, PIP5K1A-PSMD4" PIPSL PSMD4P2 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] GO:0005737; GO:0005886; GO:0016308; GO:0046854 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308] FMCNTVFKKIPLK 0.94833 4.2023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8917 0 14.0956 0 0 0 0 0 0 0 0 0 0 0 0 0 13.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88859 0 0 0 0 0 0 0 0 14.3573 0 0 14.2551 0 0 0 0 0 0 12.8989 14.3878 14.5471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7337 0 14.0784 0 0 0 13.7547 0 0 0 0 0 0 0 0 0 13.9246 14.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2624 0 0 0 0 0 0 0 0 0 0 14.3095 0 0 0 0 0 0 0 0 14.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6579 0 0 0 0 0 0 0 0 0 0 0 Q13733 AT1A4_HUMAN "Sodium/potassium-transporting ATPase subunit alpha-4, Na(+)/K(+) ATPase alpha-4 subunit, EC 7.2.2.13 (Sodium pump subunit alpha-4)" ATP1A4 ATP1AL2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transport [GO:0006811]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104] cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; photoreceptor cell cilium [GO:0097733]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm midpiece [GO:0097225] cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; photoreceptor cell cilium [GO:0097733]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm midpiece [GO:0097225]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; cell surface receptor signaling pathway [GO:0007166]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; ion transport [GO:0006811]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104] GO:0005391; GO:0005524; GO:0005886; GO:0005887; GO:0005890; GO:0006811; GO:0006813; GO:0006814; GO:0006883; GO:0007166; GO:0007283; GO:0009566; GO:0016887; GO:0019829; GO:0019900; GO:0030007; GO:0030317; GO:0030641; GO:0035725; GO:0036376; GO:0042391; GO:0042995; GO:0045121; GO:0046872; GO:0051649; GO:0071805; GO:0097225; GO:0097733; GO:0120200; GO:0150104; GO:1902600; GO:1990573 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; P-type sodium:potassium-exchanging transporter activity [GO:0005391] AIVVHGAELKDIQSKQLDQILQNHPEIVFAR 0.94834 2.4693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8926 0 0 0 0 14.3369 13.0989 0 0 0 0 11.1261 0 0 12.4946 0 0 0 12.8664 0 0 0 0 0 13.8876 0 0 0 0 0 9.76933 14.7793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0016 0 0 0 0 0 0 0 0 0 0 0 16.392 10.6522 0 0 0 0 0 11.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0752 0 0 0 0 0 0 P59541 T2R30_HUMAN "Taste receptor type 2 member 30, T2R30 (Taste receptor type 2 member 47, T2R47)" TAS2R30 TAS2R47 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] EYEGNVTWKIKLR 0.94837 2.5892 0 0 0 0 0 0 0 0 0 0 0 10.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7083 0 0 12.008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9825 0 0 0 0 0 0 0 0 0 0 0 0 12.5325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1R4 DUS1L_HUMAN "tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like, EC 1.3.1.88 (tRNA-dihydrouridine synthase 1-like)" DUS1L Homo sapiens (Human) tRNA dihydrouridine synthesis [GO:0002943] flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA dihydrouridine synthesis [GO:0002943] GO:0002943; GO:0017150; GO:0050660 flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150] DANYRKENLYCEVCPEDR 0.94837 0.85535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6Y1H2 HACD2_HUMAN "Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2, EC 4.2.1.134 (3-hydroxyacyl-CoA dehydratase 2, HACD2) (Protein-tyrosine phosphatase-like member B)" HACD2 PTPLB Homo sapiens (Human) fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] GO:0005783; GO:0005789; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0035338; GO:0042761; GO:0080023; GO:0102158; GO:0102343; GO:0102344; GO:0102345 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158] KGPGPLATAYLVIYNVVMTAGWLVIAVGLVRAYLAK 0.94838 0.85124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS67 GPR27_HUMAN Probable G-protein coupled receptor 27 (Super conserved receptor expressed in brain 1) GPR27 SREB1 Homo sapiens (Human) positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; signal transduction [GO:0007165] GO:0004930; GO:0005886; GO:0007165; GO:0016021; GO:0035774; GO:1900738 G protein-coupled receptor activity [GO:0004930] LATLSLLLCVSLAGNVLFALLIVR 0.94838 2.4688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1921 0 0 0 0 12.5055 0 0 0 0 0 0 11.4966 11.4185 0 0 0 10.806 0 0 13.9225 0 0 10.2812 0 0 0 0 0 0 0 11.2768 0 0 0 0 0 0 0 0 0 0 0 11.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76096 CYTF_HUMAN "Cystatin-F (Cystatin-7) (Cystatin-like metastasis-associated protein, CMAP) (Leukocystatin)" CST7 Homo sapiens (Human) immune response [GO:0006955]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of peptidase activity [GO:0010466]; positive regulation of myelination [GO:0031643] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; multivesicular body [GO:0005771] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protein homodimerization activity [GO:0042803]; immune response [GO:0006955]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of peptidase activity [GO:0010466]; positive regulation of myelination [GO:0031643] GO:0004866; GO:0004869; GO:0005615; GO:0005764; GO:0005768; GO:0005770; GO:0005771; GO:0005783; GO:0005794; GO:0006955; GO:0010466; GO:0030414; GO:0031410; GO:0031643; GO:0042803; GO:0097340; GO:1903979 cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protein homodimerization activity [GO:0042803] ALVQIVKGLKYMLEVEIGR 0.94841 2.4431 0 0 0 0 0 0 0 0 12.6279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2437 0 0 0 0 0 0 O75711 SCRG1_HUMAN "Scrapie-responsive protein 1 (Scrapie-responsive gene 1 protein, ScRG-1)" SCRG1 UNQ390/PRO725 Homo sapiens (Human) nervous system development [GO:0007399] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuron projection terminus [GO:0044306] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuron projection terminus [GO:0044306]; nervous system development [GO:0007399] GO:0005615; GO:0005794; GO:0007399; GO:0044306 GCEMICYCNFSELLCCPK 0.94843 2.4669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3583 0 15.8057 0 Q04721 NOTC2_HUMAN "Neurogenic locus notch homolog protein 2, Notch 2, hN2 [Cleaved into: Notch 2 extracellular truncation, N2ECD; Notch 2 intracellular domain, N2ICD ]" NOTCH2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060] GO:0000122; GO:0000139; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0046579; GO:0046849; GO:0051059; GO:0060413; GO:0060674; GO:0061073; GO:0061314; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1990705; GO:2000249; GO:2001204 calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023] AESQCLCPSGWAGAYCDVPNVSCDIAASRR 0.94845 2.4397 0 0 0 0 0 10.2985 0 0 14.8085 15.7697 0 0 15.0167 0 14.2263 0 0 0 0 10.7072 0 0 12.2806 0 12.3432 14.9996 0 0 0 0 13.624 15.8156 0 0 0 14.8584 0 11.5533 0 0 14.3837 0 0 0 10.1276 0 0 13.1547 0 0 0 14.093 14.1267 13.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0011 14.7153 0 0 11.0959 0 12.3354 9.69817 0 0 0 0 13.5895 0 0 0 12.0518 0 12.6116 0 15.3046 13.5646 12.8704 14.0687 13.2052 14.0701 12.9029 14.2244 0 14.0771 13.1212 12.9858 0 0 14.0736 0 0 11.5172 0 13.3678 0 0 0 0 0 12.7096 13.8963 0 14.3408 0 13.685 0 0 13.0125 0 14.4778 0 14.6953 11.928 0 15.0844 11.5343 13.6879 0 0 0 12.4174 12.4341 0 0 13.6958 14.5999 0 0 0 14.0445 11.1582 13.9806 14.282 15.0804 12.0586 12.7472 0 13.3772 0 0 13.9449 13.9213 12.7754 14.419 13.5069 15.0474 13.7535 0 12.8869 0 12.8726 0 11.6671 16.061 15.1273 0 12.4842 12.3762 12.8798 0 13.2207 0 13.6555 14.194 0 0 P16152 CBR1_HUMAN "Carbonyl reductase [NADPH] 1, EC 1.1.1.184 (15-hydroxyprostaglandin dehydrogenase [NADP(+)], EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1, EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase, PG-9-KR) (Prostaglandin-E(2) 9-reductase, EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)" CBR1 CBR CRN SDR21C1 Homo sapiens (Human) cyclooxygenase pathway [GO:0019371]; epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]" GO:0004090; GO:0005829; GO:0006805; GO:0008106; GO:0008211; GO:0016491; GO:0016616; GO:0016655; GO:0019371; GO:0030855; GO:0042373; GO:0047020; GO:0047021; GO:0050221; GO:0070062; GO:1903561; GO:2000379 "15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-E2 9-reductase activity [GO:0050221]" IGVTVLSRIHARK 0.94846 0.84448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9278 0 0 0 0 0 0 14.383 0 0 0 0 0 0 0 0 0 0 0 0 13.264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NCF5 KLH33_HUMAN Kelch-like protein 33 KLHL33 Homo sapiens (Human) ALLRCVR 0.94847 0.85353 0 0 0 0 0 0 0 0 0 12.7042 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7682 13.1354 12.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6017 0 0 17.1946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16562 CRIS2_HUMAN "Cysteine-rich secretory protein 2, CRISP-2 (Cancer/testis antigen 36, CT36) (Testis-specific protein TPX-1)" CRISP2 GAPDL5 TPX1 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 ALLPVLFLVTVLLPSLPAEGKDPAFTALLTTQLQVQREIVNK 0.94848 3.8129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7044 0 0 0 0 0 0 0 0 0 0 0 0 14.9896 0 0 0 0 0 0 12.1214 0 15.4515 0 11.0132 0 0 0 14.7124 0 0 0 0 0 0 0 0 0 0 13.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2948 0 0 0 0 0 0 0 P61586 RHOA_HUMAN "Transforming protein RhoA, EC 3.6.5.2 (Rho cDNA clone 12, h12)" RHOA ARH12 ARHA RHO12 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cortical cytoskeleton organization [GO:0030865]; cytoplasmic microtubule organization [GO:0031122]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; forebrain radial glial cell differentiation [GO:0021861]; GTP metabolic process [GO:0046039]; kidney development [GO:0001822]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; motor neuron apoptotic process [GO:0097049]; negative chemotaxis [GO:0050919]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; stress-activated protein kinase signaling cascade [GO:0031098]; substantia nigra development [GO:0021762]; substrate adhesion-dependent cell spreading [GO:0034446]; trabecula morphogenesis [GO:0061383]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of cells [GO:0044319]" apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; vesicle [GO:0031982] "apical junction complex [GO:0043296]; axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; vesicle [GO:0031982]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; alpha-beta T cell lineage commitment [GO:0002363]; androgen receptor signaling pathway [GO:0030521]; angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001998]; apical junction assembly [GO:0043297]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; beta selection [GO:0043366]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to chemokine [GO:1990869]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cerebral cortex cell migration [GO:0021795]; cleavage furrow formation [GO:0036089]; cortical cytoskeleton organization [GO:0030865]; cytoplasmic microtubule organization [GO:0031122]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of cell polarity [GO:0007163]; forebrain radial glial cell differentiation [GO:0021861]; GTP metabolic process [GO:0046039]; kidney development [GO:0001822]; mitotic cleavage furrow formation [GO:1903673]; mitotic spindle assembly [GO:0090307]; motor neuron apoptotic process [GO:0097049]; negative chemotaxis [GO:0050919]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell size [GO:0045792]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; odontogenesis [GO:0042476]; ossification involved in bone maturation [GO:0043931]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokinesis [GO:0032467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipase activity [GO:0060193]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell migration [GO:2000406]; positive regulation of translation [GO:0045727]; positive regulation of vascular associated smooth muscle contraction [GO:1904695]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium ion transport [GO:0051924]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of osteoblast proliferation [GO:0033688]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385]; skeletal muscle satellite cell migration [GO:1902766]; skeletal muscle tissue development [GO:0007519]; stress fiber assembly [GO:0043149]; stress-activated protein kinase signaling cascade [GO:0031098]; substantia nigra development [GO:0021762]; substrate adhesion-dependent cell spreading [GO:0034446]; trabecula morphogenesis [GO:0061383]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of cells [GO:0044319]" GO:0001666; GO:0001764; GO:0001822; GO:0001998; GO:0002363; GO:0003100; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005768; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0006357; GO:0007015; GO:0007160; GO:0007163; GO:0007266; GO:0007519; GO:0008360; GO:0009410; GO:0009612; GO:0009749; GO:0010812; GO:0010977; GO:0016477; GO:0017022; GO:0019003; GO:0019901; GO:0019904; GO:0021762; GO:0021795; GO:0021861; GO:0030027; GO:0030036; GO:0030054; GO:0030307; GO:0030334; GO:0030424; GO:0030496; GO:0030521; GO:0030667; GO:0030838; GO:0030865; GO:0031098; GO:0031122; GO:0031234; GO:0031410; GO:0031532; GO:0031982; GO:0032154; GO:0032467; GO:0032587; GO:0032956; GO:0033144; GO:0033688; GO:0034329; GO:0034446; GO:0035385; GO:0036089; GO:0038027; GO:0042476; GO:0042995; GO:0043123; GO:0043124; GO:0043149; GO:0043197; GO:0043200; GO:0043280; GO:0043296; GO:0043297; GO:0043366; GO:0043525; GO:0043542; GO:0043931; GO:0044319; GO:0045198; GO:0045471; GO:0045665; GO:0045666; GO:0045727; GO:0045792; GO:0046039; GO:0046638; GO:0048812; GO:0050773; GO:0050919; GO:0051022; GO:0051384; GO:0051496; GO:0051893; GO:0051924; GO:0060071; GO:0060193; GO:0061383; GO:0070062; GO:0070507; GO:0071222; GO:0071345; GO:0071803; GO:0071902; GO:0071944; GO:0090051; GO:0090307; GO:0090324; GO:0097049; GO:0097498; GO:0098794; GO:0098978; GO:0101003; GO:1901224; GO:1902766; GO:1903427; GO:1903673; GO:1904695; GO:1904706; GO:1904753; GO:1904996; GO:1905274; GO:1990869; GO:2000177; GO:2000406; GO:2000672 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rho GDP-dissociation inhibitor binding [GO:0051022] EVFEMATRAALQAR 0.94848 0.84281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P242 NYAP2_HUMAN Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 NYAP2 KIAA1486 Homo sapiens (Human) neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] GO:0014065; GO:0048812 AYDGLVIQNASDIARENDR 0.94849 0.8526 0 0 0 0 0 0 0 0 0 0 0 13.2435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5934 0 0 0 15.9635 0 0 0 16.1116 0 15.8024 0 0 0 0 0 0 0 0 0 0 Q16836 HCDH_HUMAN "Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial, HCDH, EC 1.1.1.35 (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)" HADH HAD HAD1 HADHSC SCHAD Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] GO:0003857; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0009410; GO:0014823; GO:0016740; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; transferase activity [GO:0016740] HPVSCKDTPGFIVNR 0.9485 0.84218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8438 13.7554 0 0 0 0 13.9623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.741 0 0 0 0 0 0 0 0 0 0 0 0 12.9872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T742 ZFAS1_HUMAN Uncharacterized protein ZNF22-AS1 (ZNF22 antisense RNA 1) ZNF22-AS1 C10orf25 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 FFLWFCFLLPPTR 0.94851 0.84114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PI1 SPRR4_HUMAN Small proline-rich protein 4 SPRR4 Homo sapiens (Human) keratinization [GO:0031424] cell cortex [GO:0005938] cell cortex [GO:0005938]; keratinization [GO:0031424] GO:0005938; GO:0031424 GTIIPAQQK 0.94851 0.85217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSA1 FGF21_HUMAN "Fibroblast growth factor 21, FGF-21" FGF21 UNQ3115/PRO10196 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell apoptotic process [GO:0072577]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron death [GO:1901215]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of cell migration [GO:0030334]; regulation of low-density lipoprotein particle clearance [GO:0010988]; response to activity [GO:0014823]; response to methionine [GO:1904640]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell apoptotic process [GO:0072577]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron death [GO:1901215]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of cell migration [GO:0030334]; regulation of low-density lipoprotein particle clearance [GO:0010988]; response to activity [GO:0014823]; response to methionine [GO:1904640]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165] GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0010898; GO:0010988; GO:0014823; GO:0030154; GO:0030334; GO:0030968; GO:0031667; GO:0046326; GO:0070374; GO:0071333; GO:0071377; GO:0071404; GO:0071466; GO:0072577; GO:0090080; GO:0120162; GO:1901215; GO:1904640; GO:1905599; GO:2000352 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] EDGTVGGAADQSPESLLQLKALKPGVIQILGVK 0.94853 0.84075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P047 CH074_HUMAN Uncharacterized protein C8orf74 C8orf74 Homo sapiens (Human) DLWIHEQQVATLTEAEAQK 0.94854 3.3496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7171 0 13.2418 0 0 0 0 0 0 0 12.4957 0 0 0 0 0 0 0 0 12.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4218 0 0 0 0 13.4519 12.8024 0 0 13.282 0 0 0 0 0 0 0 0 0 0 13.1428 13.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSR9 YJ005_HUMAN Uncharacterized protein FLJ45252 Homo sapiens (Human) DGPSSNSSFHSSEEEGTDLEGDMLDCSGSR 0.94855 0.83983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CJ92 GOG8H_HUMAN Golgin subfamily A member 8H GOLGA8H Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 ARTEWKLEQSMR 0.94856 3.6086 0 0 0 0 0 0 0 0 0 0 9.78074 0 11.4663 0 0 0 0 0 12.4466 0 0 0 0 0 11.0018 0 10.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4956 0 0 0 0 0 12.5803 0 0 15.8475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSJ6 PIMRE_HUMAN Protein PIMREG (CALM-interactor expressed in thymus and spleen) (PICALM-interacting mitotic regulator) (Regulator of chromosome segregation protein 1) PIMREG CATS FAM64A RCS1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005654; GO:0005730; GO:0007049; GO:0051301 LETPEPGQQGLQAAARSAKSALGAVSQR 0.94858 2.7108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3727 0 0 0 0 0 0 0 0 0 0 0 10.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2925 0 Q96BP2 CHCH1_HUMAN "Coiled-coil-helix-coiled-coil-helix domain-containing protein 1 (28S ribosomal protein S37, mitochondrial, MRP-S37) (Mitochondrial small ribosomal subunit protein mS37) (Nuclear protein C2360)" CHCHD1 C10orf34 MRPS37 Homo sapiens (Human) mitochondrial translation [GO:0032543] cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543] GO:0001650; GO:0003723; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0005829; GO:0032543 RNA binding [GO:0003723] EIQGFLDCAAR 0.94859 2.4381 0 0 14.8819 0 0 0 0 0 0 0 10.5285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4153 0 11.8134 0 0 0 0 14.4086 0 0 14.572 0 0 0 0 14.7928 14.738 18.3072 15.0183 0 0 0 0 0 15.956 0 0 0 0 0 14.6613 14.5182 14.2255 0 14.1651 0 0 14.1386 11.5505 12.661 13.4297 0 0 12.1117 18.1966 0 0 0 14.1887 14.2277 0 0 13.7614 12.6569 0 0 0 0 0 0 13.192 0 13.9008 12.0667 12.0363 13.741 12.5714 0 13.581 11.681 0 11.125 11.5489 0 0 0 12.6319 0 0 12.0092 13.7406 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 13.4786 0 13.4719 0 0 0 0 0 13.2023 Q9UKT5 FBX4_HUMAN F-box only protein 4 FBXO4 FBX4 Homo sapiens (Human) aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; post-transcriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; aging [GO:0007568]; cellular homeostasis [GO:0019725]; cellular response to ionizing radiation [GO:0071479]; common myeloid progenitor cell proliferation [GO:0035726]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of telomere maintenance via telomerase [GO:0032212]; post-transcriptional regulation of gene expression [GO:0010608]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of protein stability [GO:0031647]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0000723; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0007568; GO:0010608; GO:0016567; GO:0019005; GO:0019725; GO:0031146; GO:0031398; GO:0031647; GO:0031648; GO:0032212; GO:0035726; GO:0042803; GO:0048147; GO:0061630; GO:0071479; GO:1900181; GO:1902916; GO:2000001 protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AREEHTSAVNK 0.94859 2.8905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5333 13.3869 0 0 0 0 0 0 0 0 0 11.9556 0 11.2466 0 0 14.0921 0 0 0 0 14.2541 0 0 13.912 0 0 0 0 0 11.6807 0 13.8198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1291 0 0 0 0 10.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95267 GRP1_HUMAN "RAS guanyl-releasing protein 1 (Calcium and DAG-regulated guanine nucleotide exchange factor II, CalDAG-GEFII) (Ras guanyl-releasing protein)" RASGRP1 RASGRP Homo sapiens (Human) activation of GTPase activity [GO:0090630]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; mast cell degranulation [GO:0043303]; natural killer cell activation [GO:0030101]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of tumor necrosis factor production [GO:0032760]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; secretory granule localization [GO:0032252]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell proliferation [GO:0042098]; vesicle transport along microtubule [GO:0047496] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; zinc ion binding [GO:0008270]; activation of GTPase activity [GO:0090630]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; cell differentiation [GO:0030154]; inflammatory response to antigenic stimulus [GO:0002437]; mast cell degranulation [GO:0043303]; natural killer cell activation [GO:0030101]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of GTPase activity [GO:0043547]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of tumor necrosis factor production [GO:0032760]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; secretory granule localization [GO:0032252]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell proliferation [GO:0042098]; vesicle transport along microtubule [GO:0047496] GO:0000139; GO:0001934; GO:0002437; GO:0005085; GO:0005509; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0008270; GO:0008289; GO:0014066; GO:0016020; GO:0019992; GO:0030101; GO:0030154; GO:0031210; GO:0032252; GO:0032725; GO:0032729; GO:0032760; GO:0032825; GO:0033089; GO:0042098; GO:0042100; GO:0042110; GO:0042113; GO:0042802; GO:0043303; GO:0043406; GO:0043547; GO:0045954; GO:0046330; GO:0046579; GO:0047496; GO:0070372; GO:0070374; GO:0090630 calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; zinc ion binding [GO:0008270] CKDCGMNCHKQCK 0.94863 2.4369 0 0 11.346 0 0 0 0 0 0 10.7903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8157 0 0 0 0 0 0 0 0 0 14.0212 0 0 0 0 0 13.6793 0 10.4845 0 12.6005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5232 13.3061 0 0 12.9323 0 0 13.4087 12.4122 12.2753 0 0 16.2665 15.2599 15.7491 14.8946 15.0781 15.5974 15.1116 0 15.3318 15.1304 0 0 16.4726 16.4752 16.3619 17.8258 15.724 0 14.8865 15.969 14.702 15.894 0 15.3246 14.9449 0 15.815 14.5188 14.5372 0 13.9257 15.4526 10.4701 0 15.2511 0 0 14.1239 12.1891 14.2515 0 15.2665 0 14.255 0 15.3655 15.1472 13.7317 0 14.2186 14.0174 0 12.8218 0 0 0 13.2316 14.5296 0 15.8284 14.0033 0 0 0 0 12.3762 13.1857 0 0 0 0 10.9415 0 0 0 12.8798 0 0 0 0 0 0 0 0 0 0 11.3256 0 0 0 13.1813 15.3061 0 13.6 0 0 11.2935 0 0 P27487 DPP4_HUMAN "Dipeptidyl peptidase 4, EC 3.4.14.5 (ADABP) (Adenosine deaminase complexing protein 2, ADCP-2) (Dipeptidyl peptidase IV, DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form) ]" DPP4 ADCP2 CD26 Homo sapiens (Human) behavioral fear response [GO:0001662]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; glucagon processing [GO:0120116]; locomotory exploration behavior [GO:0035641]; membrane fusion [GO:0061025]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of neutrophil chemotaxis [GO:0090024]; peptide hormone processing [GO:0016486]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; psychomotor behavior [GO:0036343]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; viral entry into host cell [GO:0046718] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; chemorepellent activity [GO:0045499]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; behavioral fear response [GO:0001662]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; glucagon processing [GO:0120116]; locomotory exploration behavior [GO:0035641]; membrane fusion [GO:0061025]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of neutrophil chemotaxis [GO:0090024]; peptide hormone processing [GO:0016486]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; psychomotor behavior [GO:0036343]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; viral entry into host cell [GO:0046718] GO:0001618; GO:0001662; GO:0001666; GO:0002020; GO:0004177; GO:0004252; GO:0005102; GO:0005576; GO:0005765; GO:0005886; GO:0005925; GO:0006508; GO:0007155; GO:0008236; GO:0008239; GO:0008284; GO:0009986; GO:0010716; GO:0016020; GO:0016021; GO:0016324; GO:0016486; GO:0019065; GO:0030027; GO:0030139; GO:0031258; GO:0031295; GO:0033632; GO:0035641; GO:0036343; GO:0042110; GO:0042802; GO:0042803; GO:0043542; GO:0045121; GO:0045499; GO:0046581; GO:0046718; GO:0046813; GO:0061025; GO:0070062; GO:0090024; GO:0120116 aminopeptidase activity [GO:0004177]; chemorepellent activity [GO:0045499]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618] IEPNLPSYRITWTGK 0.94869 2.7076 0 0 0 0 0 0 0 0 0 11.4558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5927 0 0 0 0 0 0 10.9837 15.6895 0 0 12.285 0 0 13.5518 0 0 13.4315 11.382 0 0 0 0 12.4765 0 0 0 0 0 0 0 0 0 0 0 0 9.73274 0 0 0 11.9756 0 13.1657 0 0 0 0 0 11.4987 0 0 0 0 0 0 12.2817 12.4652 0 0 0 11.9991 0 0 11.5976 11.1065 0 0 0 0 0 0 0 0 12.3621 0 0 0 0 0 0 0 0 0 10.3701 12.7515 0 0 0 11.4067 0 0 11.2901 0 0 11.6494 0 0 12.1198 10.4003 11.5033 0 0 0 0 0 0 0 0 0 12.5518 0 Q01628 IFM3_HUMAN "Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b, DSPA2b) (Interferon-inducible protein 1-8U)" IFITM3 Homo sapiens (Human) defense response to virus [GO:0051607]; immune response [GO:0006955]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral transcription [GO:0032897]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; defense response to virus [GO:0051607]; immune response [GO:0006955]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral transcription [GO:0032897]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] GO:0005765; GO:0005886; GO:0006955; GO:0009615; GO:0016021; GO:0031901; GO:0031902; GO:0032897; GO:0032991; GO:0034341; GO:0035455; GO:0035456; GO:0045071; GO:0046597; GO:0048471; GO:0051607; GO:0060337 CLNIWALILGILMTILLIVIPVLIFQAYG 0.9487 0.84465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02747 C1QC_HUMAN Complement C1q subcomponent subunit C C1QC C1QG Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; synapse pruning [GO:0098883]" blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; complement component C1 complex [GO:0005602]; complement component C1q complex [GO:0062167]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; postsynapse [GO:0098794]; synapse [GO:0045202] "blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; complement component C1 complex [GO:0005602]; complement component C1q complex [GO:0062167]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; postsynapse [GO:0098794]; synapse [GO:0045202]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of macrophage differentiation [GO:0045650]; synapse pruning [GO:0098883]" GO:0005576; GO:0005581; GO:0005602; GO:0005615; GO:0006955; GO:0006958; GO:0030853; GO:0045087; GO:0045202; GO:0045650; GO:0062023; GO:0062167; GO:0072562; GO:0098794; GO:0098883 DVGPSSLPHLGLKLLLLLLLLPLR 0.94872 2.887 0 0 0 0 0 0 0 0 0 11.8115 10.8424 11.9515 12.5538 11.5132 11.3832 0 11.7085 12.3621 11.6191 11.0562 14.5728 0 0 0 14.0452 0 0 0 0 11.2915 12.1797 11.2829 13.1078 0 9.88634 0 0 12.9105 0 9.95242 10.0395 11.7975 12.2073 0 11.6941 0 11.6753 10.238 11.3877 11.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3514 14.3871 14.8078 0 15.2831 0 16.425 15.8659 15.6567 0 13.6514 15.3436 15.7262 12.714 0 14.5066 11.3207 12.6131 12.9152 0 12.9992 14.489 12.7312 15.0559 13.5916 13.9381 0 0 14.2963 13.4091 12.4419 14.1498 0 0 15.161 0 13.8685 13.8248 0 14.0277 0 0 14.7141 0 0 11.2497 13.358 0 14.6904 0 13.9917 0 0 0 10.4763 12.4599 0 13.6766 12.7738 0 14.6925 13.2519 13.9848 0 14.458 14.8146 14.2164 14.963 13.2483 12.9738 0 0 11.4887 11.7402 0 0 0 12.1063 15.1661 0 13.6224 0 14.8653 0 0 0 14.5404 14.3654 13.7432 13.1335 14.0965 14.1003 14.0482 13.8136 13.2766 13.7649 13.1966 13.4647 11.6862 0 13.1217 12.8697 11.3265 0 12.7911 0 13.3715 13.4255 0 11.2143 0 11.8575 Q9BYQ7 KRA41_HUMAN Keratin-associated protein 4-1 (Keratin-associated protein 4-10) (Keratin-associated protein 4.1) (Keratin-associated protein 4.10) (Ultrahigh sulfur keratin-associated protein 4.10) KRTAP4-1 KAP4.10 KRTAP4-10 KRTAP4.1 KRTAP4.10 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 ATCCRPSCCGSSC 0.94872 4.7029 0 0 11.3895 0 13.3486 0 0 12.6601 0 0 0 10.924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3747 0 0 0 0 0 0 0 12.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6958 0 12.2454 0 0 13.1418 0 13.0262 10.7288 0 13.7208 11.9483 14.2792 0 0 0 0 0 0 14.3917 0 12.4938 0 0 0 15.2922 0 0 14.3993 0 0 0 14.3427 15.0925 0 14.3336 12.327 13.6885 0 12.2959 0 12.0962 14.1342 12.714 0 0 0 0 11.7076 14.6151 13.8732 0 0 0 12.5007 12.1831 0 13.6491 0 0 0 12.6148 0 0 11.943 12.2067 13.4261 14.2091 12.3102 0 0 12.634 0 13.8115 0 0 0 0 12.0397 0 0 0 0 0 0 0 13.1232 0 0 0 10.876 0 0 0 11.5332 12.5954 0 0 0 0 0 0 0 0 0 0 0 13.4658 0 0 0 0 13.4301 Q9UIK5 TEFF2_HUMAN "Tomoregulin-2, TR-2 (Hyperplastic polyposis protein 1) (Transmembrane protein with EGF-like and two follistatin-like domains)" TMEFF2 HPP1 TENB2 TPEF UNQ178/PRO204 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of stress fiber assembly [GO:0051497]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; wound healing, spreading of cells [GO:0044319]" basement membrane [GO:0005604]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "basement membrane [GO:0005604]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of stress fiber assembly [GO:0051497]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; wound healing, spreading of cells [GO:0044319]" GO:0005576; GO:0005604; GO:0005886; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0030336; GO:0034446; GO:0044319; GO:0045720; GO:0051497 CDAGYTGQHCEK 0.94872 3.3437 0 0 0 0 0 0 0 0 0 0 0 0 13.514 0 0 0 12.6834 0 0 0 0 0 0 0 0 11.9401 0 11.9145 0 0 0 0 0 13.3425 15.2581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7949 0 11.2066 11.5472 0 0 0 0 0 0 0 0 13.1042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5924 0 0 0 0 0 0 0 0 13.2796 0 0 0 0 0 0 0 0 13.3096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1329 0 0 A6H8M9 CDHR4_HUMAN Cadherin-related family member 4 (Cadherin-like protein 29) CDHR4 CDH29 UNQ9392/PRO34300 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005887; GO:0007155; GO:0007156 calcium ion binding [GO:0005509] MSCQIPQEPQR 0.94874 0.84785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3824 0 0 0 0 0 0 0 0 0 0 0 12.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P68363 TBA1B_HUMAN Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain ] TUBA1B Homo sapiens (Human) cell division [GO:0051301]; cellular response to interleukin-4 [GO:0071353]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular response to interleukin-4 [GO:0071353]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000278; GO:0003725; GO:0005198; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005881; GO:0007017; GO:0015630; GO:0030705; GO:0031625; GO:0051301; GO:0071353 double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625] CDPRHGK 0.94874 0.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUS5 AP5S1_HUMAN "AP-5 complex subunit sigma-1 (Adaptor-related protein complex 5 sigma subunit, Sigma5)" AP5S1 C20orf29 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0000724; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599 LLLDHLRLLAPSTSLLLR 0.94874 2.6076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9061 12.8688 0 0 0 0 12.2259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9378 0 0 0 0 0 0 0 0 0 11.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8576 0 0 0 0 13.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8277 0 0 0 0 0 0 0 0 0 0 0 A8MT65 ZN891_HUMAN Zinc finger protein 891 ZNF891 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFNTSSHLKVHKK 0.94878 0.85171 0 0 0 0 0 0 0 0 0 12.3803 12.6026 0 0 0 11.4222 0 11.2725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1488 13.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4551 0 0 13.0689 13.5731 0 0 0 0 0 0 0 0 0 0 0 13.2717 0 0 0 0 0 12.4387 0 0 0 0 0 0 12.773 0 0 0 0 0 0 12.8216 0 0 0 0 0 0 0 0 13.3941 0 0 0 0 0 14.9873 0 0 14.8538 0 0 12.3548 13.3784 13.9775 0 0 0 0 0 0 14.1777 0 0 Q9UIU6 SIX4_HUMAN Homeobox protein SIX4 (Sine oculis homeobox homolog 4) SIX4 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; embryonic cranial skeleton morphogenesis [GO:0048701]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; embryonic cranial skeleton morphogenesis [GO:0048701]; fungiform papilla morphogenesis [GO:0061197]; generation of neurons [GO:0048699]; inner ear morphogenesis [GO:0042472]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; metanephric mesenchyme development [GO:0072075]; myoblast migration [GO:0051451]; myotome development [GO:0061055]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory placode formation [GO:0030910]; pharyngeal system development [GO:0060037]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureteric bud formation [GO:0072107]; protein localization to nucleus [GO:0034504]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of epithelial cell proliferation [GO:0050678]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue development [GO:0007519]; thymus development [GO:0048538]; tongue development [GO:0043586]; trigeminal ganglion development [GO:0061551]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007519; GO:0008582; GO:0008584; GO:0009653; GO:0030238; GO:0030910; GO:0032880; GO:0034504; GO:0042472; GO:0043066; GO:0043524; GO:0043586; GO:0045214; GO:0045892; GO:0045893; GO:0046661; GO:0048538; GO:0048699; GO:0048701; GO:0050678; GO:0051451; GO:0060037; GO:0061055; GO:0061197; GO:0061551; GO:0072075; GO:0072095; GO:0072107; GO:0090190; GO:0098528; GO:1902725; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" FLWSLPQSDLLR 0.94878 2.8857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5563 0 0 0 0 0 12.3178 0 0 0 0 11.7639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3049 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0348 0 0 0 12.077 0 0 0 0 13.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4264 0 13.5412 0 0 0 0 0 0 0 0 0 0 0 0 12.82 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1504 0 13.0131 0 0 0 0 0 0 0 0 0 0 0 0 11.7912 0 0 0 0 0 0 0 0 0 0 Q96CF2 CHM4C_HUMAN "Charged multivesicular body protein 4c (Chromatin-modifying protein 4c, CHMP4c) (SNF7 homolog associated with Alix 3) (SNF7-3, hSnf7-3) (Vacuolar protein sorting-associated protein 32-3, Vps32-3, hVps32-3)" CHMP4C SHAX3 Homo sapiens (Human) abscission [GO:0009838]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; abscission [GO:0009838]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0009838; GO:0009898; GO:0010824; GO:0015031; GO:0016236; GO:0030496; GO:0031468; GO:0032466; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042803; GO:0043162; GO:0044878; GO:0046761; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1902774; GO:1904930 protein homodimerization activity [GO:0042803] AALQALKR 0.94879 2.6056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.461 11.4677 0 0 0 18.7003 18.676 0 0 0 0 0 0 0 0 0 14.4891 14.5153 0 0 0 0 0 0 0 16.5884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4588 0 0 0 0 0 12.7284 0 0 0 0 12.6838 0 0 0 0 0 0 0 0 0 0 0 0 11.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2B4 CT2NL_HUMAN CTTNBP2 N-terminal-like protein CTTNBP2NL KIAA1433 Homo sapiens (Human) negative regulation of transmembrane transport [GO:0034763]; negative regulation of transporter activity [GO:0032410]; protein dephosphorylation [GO:0006470] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; protein phosphatase 2A binding [GO:0051721]; negative regulation of transmembrane transport [GO:0034763]; negative regulation of transporter activity [GO:0032410]; protein dephosphorylation [GO:0006470] GO:0005737; GO:0006470; GO:0015629; GO:0030027; GO:0032410; GO:0034763; GO:0051721 protein phosphatase 2A binding [GO:0051721] DLVIEALKAQHRDTFIEER 0.9488 2.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6549 0 0 0 0 0 0 0 0 0 0 0 12.2863 0 0 0 0 0 0 0 0 0 0 0 11.3486 0 0 0 0 0 0 0 0 13.7066 13.4059 14.1372 0 0 0 0 0 0 0 13.6628 0 0 10.7034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1618 12.323 12.7274 12.7576 0 0 0 0 0 0 0 0 0 0 13.3034 0 0 0 0 0 12.4102 0 0 0 0 0 0 0 0 0 0 0 11.5122 0 0 0 0 0 0 0 0 13.5059 0 13.2151 0 0 0 0 0 0 Q3Y452 TDRG1_HUMAN Testis development-related protein 1 TDRG1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 SIPVEPCPGLPAFAEVDLLSLLVPIK 0.94881 0.84695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEB7 ACRBP_HUMAN "Acrosin-binding protein (Acrosin-binding protein, 60 kDa form) (Cancer/testis antigen 23, CT23) (Cancer/testis antigen OY-TES-1) (Proacrosin-binding protein sp32) [Cleaved into: Acrosin-binding protein, mature form (Acrosin-binding protein, 32 kDa form, mature form) ]" ACRBP Homo sapiens (Human) acrosome assembly [GO:0001675]; fertilization [GO:0009566]; spermatid development [GO:0007286] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; nucleus [GO:0005634] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; nucleus [GO:0005634]; acrosome assembly [GO:0001675]; fertilization [GO:0009566]; spermatid development [GO:0007286] GO:0001669; GO:0001675; GO:0002080; GO:0005576; GO:0005634; GO:0007286; GO:0009566 CSNHVYYAK 0.94883 0.84611 0 0 0 0 0 0 10.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4291 0 0 0 0 12.5214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4634 0 12.4181 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1692 11.4572 0 0 0 0 0 0 12.854 0 Q13308 PTK7_HUMAN "Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4, CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7)" PTK7 CCK4 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; axis elongation [GO:0003401]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; convergent extension [GO:0060026]; coronary vasculature development [GO:0060976]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; kidney development [GO:0001822]; lung-associated mesenchyme development [GO:0060484]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuron projection development [GO:0010976]; protein phosphorylation [GO:0006468]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing [GO:0042060] cell-cell junction [GO:0005911]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell-cell junction [GO:0005911]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; protein kinase activity [GO:0004672]; actin cytoskeleton reorganization [GO:0031532]; axis elongation [GO:0003401]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; convergent extension [GO:0060026]; coronary vasculature development [GO:0060976]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; kidney development [GO:0001822]; lung-associated mesenchyme development [GO:0060484]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuron projection development [GO:0010976]; protein phosphorylation [GO:0006468]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]" GO:0001736; GO:0001822; GO:0003281; GO:0003401; GO:0004672; GO:0005524; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006468; GO:0007155; GO:0007165; GO:0010976; GO:0016477; GO:0031532; GO:0042060; GO:0045198; GO:0050839; GO:0060026; GO:0060484; GO:0060828; GO:0060976; GO:0071300; GO:0090103; GO:0090179; GO:0090263; GO:1904929 "ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; protein kinase activity [GO:0004672]" HTEAPLYVVDK 0.94884 2.8831 0 0 0 0 0 0 0 0 0 12.446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7616 14.8112 0 0 0 0 15.6603 0 0 0 0 0 0 0 0 0 0 0 19.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1463 12.7193 0 0 0 0 0 0 0 0 0 0 0 14.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BU76 MMTA2_HUMAN "Multiple myeloma tumor-associated protein 2, hMMTAG2" MMTAG2 C1orf35 Homo sapiens (Human) extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; RNA binding [GO:0003723] GO:0003723; GO:0005576; GO:0034774; GO:1904813 RNA binding [GO:0003723] AEDQTESSCESHRK 0.94884 2.828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4171 0 0 0 0 0 11.5703 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8983 0 0 0 0 0 10.8858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0934 0 0 0 0 0 0 0 0 Q9BYV7 BCDO2_HUMAN "Carotenoid-cleaving dioxygenase, mitochondrial, EC 1.13.11.-, EC 1.13.11.71 (B-diox-II) (Beta,beta-carotene 9',10'-oxygenase) (Beta-carotene dioxygenase 2)" BCO2 BCDO2 Homo sapiens (Human) carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll catabolic process [GO:0016124]; zeaxanthin catabolic process [GO:1901826] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; carotenoid metabolic process [GO:0016116]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; xanthophyll catabolic process [GO:0016124]; zeaxanthin catabolic process [GO:1901826]" GO:0003834; GO:0005739; GO:0005759; GO:0010436; GO:0010437; GO:0016116; GO:0016119; GO:0016121; GO:0016124; GO:0016702; GO:0042573; GO:0042574; GO:0046872; GO:0051881; GO:0062172; GO:0102076; GO:1901176; GO:1901826; GO:2000377 "9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]" EGGIEFPQIYYDR 0.94889 2.7772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5304 0 0 0 0 0 12.4272 0 0 0 0 0 0 14.1557 14.0083 0 0 0 11.842 11.9634 0 0 19.9256 0 0 0 0 12.592 0 0 0 11.6981 0 0 0 0 0 0 0 0 0 0 12.0086 0 0 0 0 0 0 0 0 0 0 12.628 0 0 0 0 0 0 0 0 13.319 0 0 0 0 0 0 0 0 13.6751 0 0 13.0782 13.0905 0 0 0 0 0 12.1397 0 0 0 0 12.4742 12.0181 0 0 0 12.1891 12.6826 13.5614 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIQ6 LCAP_HUMAN "Leucyl-cystinyl aminopeptidase, Cystinyl aminopeptidase, EC 3.4.11.3 (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase, IRAP) (Oxytocinase, OTase) (Placental leucine aminopeptidase, P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form ]" LNPEP OTASE Homo sapiens (Human) "antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]" cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]" GO:0000209; GO:0002480; GO:0004177; GO:0005576; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0007165; GO:0007267; GO:0007565; GO:0008217; GO:0008237; GO:0008270; GO:0016020; GO:0030163; GO:0030659; GO:0031905; GO:0042277; GO:0043171; GO:0048471; GO:0060395; GO:0070006; GO:0120163 aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] DRANLINNIFELAGLGKVPLK 0.94889 0.85012 0 0 12.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1685 0 0 12.4272 0 0 14.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2169 0 0 0 0 0 0 0 0 13.3938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8153 0 0 0 0 0 0 0 0 0 14.5513 0 0 0 0 0 0 14.5308 0 14.838 0 0 0 0 0 13.0774 0 14.7606 0 0 0 0 0 0 0 13.8889 0 0 14.4728 0 0 12.3879 0 0 13.9049 0 0 15.9253 0 13.9898 0 0 15.3693 13.4458 0 14.4175 14.9013 0 0 15.5083 0 13.5482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0332 0 0 12.9511 0 0 0 0 0 0 P50221 MEOX1_HUMAN Homeobox protein MOX-1 (Mesenchyme homeobox 1) MEOX1 MOX1 Homo sapiens (Human) hematopoietic stem cell differentiation [GO:0060218]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; hematopoietic stem cell differentiation [GO:0060218]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001757; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0060218; GO:0061053; GO:0061056; GO:0071837; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" KESSDNQENRGK 0.9489 0.84947 0 0 0 0 0 0 0 10.7095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5277 0 0 0 0 0 0 0 0 10.6772 0 0 0 0 0 0 0 10.9073 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5958 12.9919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21128 ENDOU_HUMAN "Uridylate-specific endoribonuclease, EC 4.6.1.- (Placental protein 11, PP11) (Protein endoU)" ENDOU Homo sapiens (Human) female pregnancy [GO:0007565]; immune response [GO:0006955]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; endoribonuclease activity [GO:0004521]; growth factor activity [GO:0008083]; lyase activity [GO:0016829]; manganese ion binding [GO:0030145]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; serine-type peptidase activity [GO:0008236]; female pregnancy [GO:0007565]; immune response [GO:0006955]; proteolysis [GO:0006508] GO:0003723; GO:0004521; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0006955; GO:0007565; GO:0008083; GO:0008236; GO:0016829; GO:0030145; GO:0030247 endoribonuclease activity [GO:0004521]; growth factor activity [GO:0008083]; lyase activity [GO:0016829]; manganese ion binding [GO:0030145]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; serine-type peptidase activity [GO:0008236] CNEKFNRDAACQCDR 0.94891 2.7591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7772 0 0 0 0 0 0 0 0 0 0 0 11.7841 0 0 0 0 0 0 0 14.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4385 0 0 0 0 0 0 0 10.7096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56202 CATW_HUMAN "Cathepsin W, EC 3.4.22.- (Lymphopain)" CTSW Homo sapiens (Human) immune response [GO:0006955]; proteolysis involved in protein catabolic process [GO:0051603] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; immune response [GO:0006955]; proteolysis involved in protein catabolic process [GO:0051603] GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0006955; GO:0008234; GO:0016020; GO:0031089; GO:0051603 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] ALTAHPSCLLALLVAGLAQGIR 0.94891 4.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8684 0 0 0 0 0 0 14.356 14.4508 14.1339 14.1236 14.9706 0 0 0 0 0 12.849 0 12.6381 0 0 0 13.9847 0 0 0 0 0 0 0 14.3879 0 12.8005 11.4688 0 0 0 14.044 0 0 0 14.379 0 0 0 0 14.6683 14.2803 14.6215 14.7983 14.8252 14.8916 13.4333 10.7023 14.6187 0 0 0 0 0 14.1547 14.5875 0 0 14.6071 14.2262 0 14.6185 14.3582 14.6919 11.824 15.7957 0 0 0 14.5421 14.256 0 14.1538 0 0 0 0 14.6134 0 12.6611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2X4 PCLI1_HUMAN "PTB-containing, cubilin and LRP1-interacting protein, P-CLI1 (Phosphotyrosine interaction domain-containing protein 1) (Protein NYGGF4)" PID1 NYGGF4 PCLI1 HMFN2073 Homo sapiens (Human) cellular response to cytokine stimulus [GO:0071345]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-6 [GO:0071354]; cellular response to leptin stimulus [GO:0044320]; cellular response to tumor necrosis factor [GO:0071356]; energy reserve metabolic process [GO:0006112]; mitochondrion morphogenesis [GO:0070584]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of glucose import [GO:0046325]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of fat cell proliferation [GO:0070346]; positive regulation of gene expression [GO:0010628]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial fusion [GO:0010635]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cellular response to cytokine stimulus [GO:0071345]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-6 [GO:0071354]; cellular response to leptin stimulus [GO:0044320]; cellular response to tumor necrosis factor [GO:0071356]; energy reserve metabolic process [GO:0006112]; mitochondrion morphogenesis [GO:0070584]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of glucose import [GO:0046325]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of fat cell proliferation [GO:0070346]; positive regulation of gene expression [GO:0010628]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial fusion [GO:0010635]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377] GO:0001933; GO:0005737; GO:0006112; GO:0010628; GO:0010635; GO:0044320; GO:0045944; GO:0046325; GO:0046627; GO:0051881; GO:0070346; GO:0070584; GO:0071345; GO:0071354; GO:0071356; GO:0071398; GO:1903077; GO:2000377; GO:2000379; GO:2001170; GO:2001171 CCSSHKTIKQAR 0.94891 2.8827 0 0 0 0 11.0137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8687 0 0 0 0 0 13.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15551 CLD3_HUMAN "Claudin-3 (Clostridium perfringens enterotoxin receptor 2, CPE-R 2, CPE-receptor 2) (Rat ventral prostate.1 protein homolog, hRVP1)" CLDN3 C7orf1 CPETR2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell junction maintenance [GO:0034331]; epithelial cell morphogenesis [GO:0003382]; establishment of endothelial blood-brain barrier [GO:0014045]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; regulation of membrane permeability [GO:0090559]; regulation of transepithelial transport [GO:0150111]; response to ethanol [GO:0045471]; response to Gram-positive bacterium [GO:0140459]; response to hypoxia [GO:0001666] apical junction complex [GO:0043296]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] apical junction complex [GO:0043296]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888]; actin cytoskeleton reorganization [GO:0031532]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell junction maintenance [GO:0034331]; epithelial cell morphogenesis [GO:0003382]; establishment of endothelial blood-brain barrier [GO:0014045]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of wound healing [GO:0090303]; regulation of cell morphogenesis [GO:0022604]; regulation of membrane permeability [GO:0090559]; regulation of transepithelial transport [GO:0150111]; response to ethanol [GO:0045471]; response to Gram-positive bacterium [GO:0140459]; response to hypoxia [GO:0001666] GO:0001666; GO:0001934; GO:0003382; GO:0004888; GO:0005198; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007155; GO:0008285; GO:0010628; GO:0010629; GO:0014045; GO:0016021; GO:0016327; GO:0016328; GO:0016338; GO:0022604; GO:0030335; GO:0030336; GO:0031532; GO:0032991; GO:0034331; GO:0035633; GO:0042802; GO:0043296; GO:0045471; GO:0061045; GO:0070160; GO:0070830; GO:0090303; GO:0090559; GO:0140459; GO:0150111; GO:1901890; GO:1903348; GO:1905050 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; transmembrane signaling receptor activity [GO:0004888] ITIVAGVLFLLAALLTLVPVSWSANTIIR 0.94893 0.84465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0654 0 0 0 12.0632 0 0 11.6955 0 0 0 0 0 13.7334 0 0 13.7698 0 13.6558 0 13.0974 13.3671 0 0 0 13.2847 0 13.2003 0 0 0 0 0 12.002 0 12.3876 0 12.5656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61599 NAA20_HUMAN "N-alpha-acetyltransferase 20, EC 2.3.1.254 (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5, NatB complex subunit NAT5) (NatB catalytic subunit)" NAA20 NAT5 Homo sapiens (Human) N-terminal peptidyl-methionine acetylation [GO:0017196] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196] GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031416 peptide alpha-N-acetyltransferase activity [GO:0004596] TTLRAFTCDDLFR 0.94894 0.84845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5R3I4 TTC38_HUMAN "Tetratricopeptide repeat protein 38, TPR repeat protein 38" TTC38 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 FSHDAYFYLGYQEQMR 0.94894 2.6009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5385 0 11.0694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.543 13.8262 13.6123 0 0 14.6786 15.2661 0 0 13.5118 15.3263 13.21 0 0 0 0 0 0 0 0 0 0 12.8949 14.1632 0 0 0 0 0 0 0 0 14.5896 0 0 0 0 0 14.2257 12.341 0 0 0 0 0 0 0 0 0 13.0642 0 0 13.0731 0 0 0 0 0 0 0 0 0 0 0 0 11.8979 0 12.146 0 0 0 13.1558 0 13.5575 0 0 0 0 0 0 0 0 13.586 0 0 14.1938 0 0 0 0 0 0 0 0 0 0 0 Q86W33 TPRA1_HUMAN Transmembrane protein adipocyte-associated 1 (Integral membrane protein GPR175) (Transmembrane protein 227) TPRA1 GPR175 TMEM227 PP6566 Homo sapiens (Human) aging [GO:0007568]; embryonic cleavage [GO:0040016]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of mitotic cell cycle phase transition [GO:1901991] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; aging [GO:0007568]; embryonic cleavage [GO:0040016]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of mitotic cell cycle phase transition [GO:1901991] GO:0004930; GO:0005886; GO:0006629; GO:0007186; GO:0007568; GO:0016021; GO:0040016; GO:1901991 G protein-coupled receptor activity [GO:0004930] ILFSYKCQVDETEEPDVHLPQPYAVAR 0.94894 4.6913 0 0 0 11.8784 0 0 0 0 14.1744 10.619 0 0 0 0 0 11.1332 0 0 0 0 0 0 13.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1541 0 14.0417 14.6505 14.884 0 14.826 0 14.8554 15.0529 0 0 12.4244 11.2345 0 0 0 0 0 15.3585 0 12.3544 0 0 0 0 14.3863 0 13.7814 13.6414 0 0 0 0 0 14.1873 0 0 0 0 0 14.3328 0 0 14.004 0 0 0 0 0 0 0 11.917 0 0 0 0 0 13.6658 13.8372 0 0 0 0 12.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5297 0 0 12.0807 0 0 0 13.4975 0 0 0 0 0 0 0 0 12.3464 0 0 0 Q5RIA9 CBWD5_HUMAN COBW domain-containing protein 5 (Cobalamin synthase W domain-containing protein 5) CBWD5 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524] GO:0005524; GO:0005737 ATP binding [GO:0005524] IPVTIITGYLGAGKTTLLNYILTEQHSK 0.94896 2.4503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8417 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2939 12.272 0 0 0 0 0 0 0 13.6458 0 12.8384 0 0 0 0 0 0 0 13.3998 0 0 0 0 0 0 0 0 0 0 13.4803 13.4693 0 0 0 0 0 0 0 13.2961 13.1178 11.3001 0 0 0 0 0 0 0 0 0 0 11.9239 0 Q8TAV3 CP2W1_HUMAN "Cytochrome P450 2W1, EC 1.14.14.- (CYPIIW1)" CYP2W1 Homo sapiens (Human) aflatoxin metabolic process [GO:0046222]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; steroid hydroxylase activity [GO:0008395]; aflatoxin metabolic process [GO:0046222]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805]" GO:0001972; GO:0004497; GO:0005503; GO:0005506; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006082; GO:0006644; GO:0006805; GO:0008395; GO:0008401; GO:0009986; GO:0016712; GO:0020037; GO:0034653; GO:0043231; GO:0046222; GO:1904768 "all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; steroid hydroxylase activity [GO:0008395]" LARTELFLLFAGLLQR 0.94903 0.84764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3271 0 0 0 0 0 0 15.4337 0 0 0 0 0 0 0 0 0 0 14.4617 0 0 0 0 0 14.8635 0 15.0452 0 0 0 0 14.127 0 0 16.2623 0 0 0 14.9995 14.7581 0 0 0 0 14.8165 0 0 13.8849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1414 0 13.1051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00291 HIP1_HUMAN "Huntingtin-interacting protein 1, HIP-1 (Huntingtin-interacting protein I, HIP-I)" HIP1 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100] clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] "clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]" GO:0005154; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0006897; GO:0006915; GO:0006919; GO:0007015; GO:0016020; GO:0030100; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0031234; GO:0032051; GO:0032266; GO:0035091; GO:0035254; GO:0035612; GO:0035615; GO:0042803; GO:0042981; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0051897; GO:0072583; GO:0080025; GO:0097190; GO:0098793; GO:0098794; GO:0098888; GO:0098890; GO:0098978; GO:0099637; GO:2000588 "actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]" DEKDHLIERLYR 0.94904 2.5993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DTU3 TRAR2_HUMAN T cell receptor alpha chain MC.7.G5 (MC.7.G5 TRA) (TR alpha chain TRAV38-2DV8*01J31*01C*01) TRA Homo sapiens (Human) detection of tumor cell [GO:0002355]; T cell mediated cytotoxicity directed against tumor cell target [GO:0002419] alpha-beta T cell receptor complex [GO:0042105]; integral component of membrane [GO:0016021] alpha-beta T cell receptor complex [GO:0042105]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; detection of tumor cell [GO:0002355]; T cell mediated cytotoxicity directed against tumor cell target [GO:0002419] GO:0002355; GO:0002419; GO:0016021; GO:0038023; GO:0042105 signaling receptor activity [GO:0038023] ILLLKVAGFNLLMTLR 0.94904 0.84717 0 0 0 0 0 0 0 0 0 0 0 9.9067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8438 0 0 0 0 0 0 15.5121 0 0 15.1251 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4738 0 0 0 0 0 0 0 0 0 0 0 0 14.9836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7556 18.3645 16.09 15.209 0 0 0 0 0 0 0 0 0 0 0 14.8181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5768 0 0 10.8944 0 10.7669 0 0 0 0 0 0 0 0 0 0 Q6ZNJ1 NBEL2_HUMAN Neurobeachin-like protein 2 NBEAL2 KIAA0540 UNQ253/PRO290 Homo sapiens (Human) platelet formation [GO:0030220]; protein localization [GO:0008104] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; protein kinase binding [GO:0019901]; platelet formation [GO:0030220]; protein localization [GO:0008104] GO:0005783; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0019901; GO:0030220; GO:0070821; GO:0101003 protein kinase binding [GO:0019901] ARLEGLRYTAVLK 0.94907 2.8247 0 0 0 0 0 0 0 0 0 13.0388 0 0 0 12.4765 0 0 15.9467 0 0 16.5873 16.5413 0 0 0 0 0 16.0282 0 12.4939 0 11.5363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4466 0 0 0 16.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1982 0 0 0 11.6954 0 0 0 0 0 14.9362 0 14.4091 11.7006 20.0438 0 19.0877 0 19.3036 19.2936 19.3152 19.1358 19.1635 19.1141 18.9896 0 19.0029 19.4206 0 0 0 0 18.9827 0 0 0 0 0 0 0 14.4351 0 13.0006 19.6628 19.7751 0 13.1975 0 0 13.1552 13.1849 0 0 11.7616 0 0 0 11.0024 0 13.4593 13.2277 14.3934 0 0 0 0 19.5282 0 19.6693 0 13.181 0 0 0 0 18.6934 0 0 0 0 0 0 0 19.4086 12.317 0 14.5357 0 0 14.3425 0 11.7381 14.1094 11.3716 0 0 13.9783 14.0466 14.0256 0 0 0 0 14.5365 19.7551 14.4493 0 0 Q9UHC9 NPCL1_HUMAN "NPC1-like intracellular cholesterol transporter 1, NPC1L1 (Niemann-Pick C1-like protein 1)" NPC1L1 Homo sapiens (Human) cellular response to sterol depletion [GO:0071501]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; cholesterol transport [GO:0030301]; intestinal cholesterol absorption [GO:0030299]; lipoprotein metabolic process [GO:0042157]; sterol transport [GO:0015918]; vitamin E metabolic process [GO:0042360]; vitamin transport [GO:0051180] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]; cholesterol binding [GO:0015485]; myosin V binding [GO:0031489]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; sterol binding [GO:0032934]; vitamin E binding [GO:0008431]; cellular response to sterol depletion [GO:0071501]; cholesterol biosynthetic process [GO:0006695]; cholesterol homeostasis [GO:0042632]; cholesterol transport [GO:0030301]; intestinal cholesterol absorption [GO:0030299]; lipoprotein metabolic process [GO:0042157]; sterol transport [GO:0015918]; vitamin E metabolic process [GO:0042360]; vitamin transport [GO:0051180] GO:0005886; GO:0006695; GO:0008431; GO:0015485; GO:0015918; GO:0016020; GO:0016324; GO:0030299; GO:0030301; GO:0030659; GO:0031267; GO:0031489; GO:0032934; GO:0042157; GO:0042360; GO:0042632; GO:0042803; GO:0044214; GO:0051180; GO:0071501 cholesterol binding [GO:0015485]; myosin V binding [GO:0031489]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; sterol binding [GO:0032934]; vitamin E binding [GO:0008431] GWLLWALLLR 0.94909 2.8785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6445 0 0 11.578 0 0 0 0 0 0 11.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1587 13.817 0 0 0 10.2043 0 0 0 0 0 0 14.5864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4759 0 0 0 0 11.9932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0475 0 0 A1L4L8 PL8L1_HUMAN PLAC8-like protein 1 PLAC8L1 Homo sapiens (Human) ICFCGLFCPMCLECDIAR 0.94911 0.83815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0849 0 0 15.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUH4 ZDH13_HUMAN "Palmitoyltransferase ZDHHC13, EC 2.3.1.225 (Huntingtin-interacting protein 14-related protein, HIP14-related protein) (Huntingtin-interacting protein HIP3RP) (Putative MAPK-activating protein PM03) (Putative NF-kappa-B-activating protein 209) (Zinc finger DHHC domain-containing protein 13, DHHC-13)" ZDHHC13 HIP14L HIP3RP Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345] endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345] GO:0000139; GO:0005783; GO:0015095; GO:0016020; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030660; GO:0043123 magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] FNPSLNVVDKIHQNTPLHWAVAAGNVNAVDK 0.94911 3.9269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3457 0 0 0 0 0 0 17.8458 0 0 0 0 0 0 0 0 0 0 0 13.1131 0 0 0 0 0 14.4182 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7341 0 0 0 0 0 0 0 0 0 0 9.64798 0 0 13.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF17 S3TC2_HUMAN SH3 domain and tetratricopeptide repeat-containing protein 2 SH3TC2 KIAA1985 PP12494 Homo sapiens (Human) peripheral nervous system myelin maintenance [GO:0032287]; regulation of ERBB signaling pathway [GO:1901184]; regulation of intracellular protein transport [GO:0033157] plasma membrane [GO:0005886]; recycling endosome [GO:0055037] plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of ERBB signaling pathway [GO:1901184]; regulation of intracellular protein transport [GO:0033157] GO:0005886; GO:0032287; GO:0033157; GO:0055037; GO:1901184 ALCLILSK 0.94915 4.687 0 0 10.7033 0 0 0 0 0 0 0 12.2427 0 0 0 0 0 0 0 0 0 0 12.7697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0467 12.7405 0 0 10.6049 0 0 11.3151 0 0 0 0 0 0 10.1275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9752 14.6073 0 14.2766 0 14.2806 0 0 0 0 0 14.3946 0 0 14.6736 14.6458 0 0 0 14.3894 14.4626 17.2468 0 12.329 14.3399 15.7362 12.0513 0 15.37 15.5251 14.3301 16.2144 14.6218 0 0 14.9405 0 0 0 14.9382 0 0 14.866 0 11.8586 0 0 0 14.1401 0 14.8825 14.1999 14.6899 0 0 0 0 13.2795 0 0 0 14.4293 0 0 0 14.7925 14.2617 14.6041 0 14.8887 0 0 0 0 0 0 14.7378 12.8965 11.6237 14.5871 13.0949 0 0 0 0 0 0 0 0 0 0 0 11.4402 13.861 0 12.2028 0 0 14.8419 0 0 14.7141 0 0 0 Q8NHB7 OR5K1_HUMAN Olfactory receptor 5K1 (HTPCRX10) (Olfactory receptor OR3-8) OR5K1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] TLLFVVFFAIYLITVVGNISLVALIFTHR 0.94916 0.84465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3N9 OR2W1_HUMAN Olfactory receptor 2W1 (Hs6M1-15) (Olfactory receptor OR6-13) OR2W1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AMNTCGSHLTVVSMFYGTIIYMYLQPGNR 0.94917 0.84465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07996 TSP1_HUMAN Thrombospondin-1 (Glycoprotein G) THBS1 TSP TSP1 Homo sapiens (Human) behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040] GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032695; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0040037; GO:0042327; GO:0042802; GO:0043032; GO:0043066; GO:0043154; GO:0043236; GO:0043394; GO:0043406; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237 calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431] CEGSSVQTRTCHIQECDK 0.94918 0.84855 0 0 0 0 0 0 0 0 0 13.4842 0 0 0 0 0 0 0 8.89833 11.7817 0 0 11.1468 0 0 0 0 0 0 0 0 0 0 0 0 10.5412 0 0 0 0 0 0 0 10.6448 0 0 0 0 0 0 12.4917 11.1914 11.3127 0 0 0 0 0 0 0 0 0 0 0 0 9.39227 0 14.1975 13.4665 15.152 11.3162 0 0 0 13.0595 0 0 0 0 11.2657 10.7813 13.4363 12.589 14.3852 14.5222 11.4932 0 13.2686 0 12.4327 15.2806 14.5571 14.8121 15.2796 13.8092 15.0081 0 11.7885 14.7764 0 0 0 10.7813 0 0 13.8212 12.2003 0 14.7855 13.5482 0 0 0 0 14.9989 0 14.6703 14.703 14.6085 0 0 0 15.2147 0 0 0 13.6852 14.1193 14.1648 15.1075 0 0 12.1291 12.5594 0 0 0 13.8698 0 0 0 0 0 13.5847 0 0 0 13.6566 13.6571 0 0 0 0 13.4495 0 13.3487 0 10.5723 0 0 0 12.2043 12.1221 0 0 12.4329 0 0 12.4812 0 12.8402 12.3649 0 12.4685 11.5683 0 0 0 0 12.3024 0 P37173 TGFR2_HUMAN "TGF-beta receptor type-2, TGFR-2, EC 2.7.11.30 (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II, TGF-beta receptor type II, TbetaR-II)" TGFBR2 Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to growth factor stimulus [GO:0071363]; common-partner SMAD protein phosphorylation [GO:0007182]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inferior endocardial cushion morphogenesis [GO:1905317]; Langerhans cell differentiation [GO:0061520]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of stem cell proliferation [GO:0072091]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; secondary palate development [GO:0062009]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]" caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021] "caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]; activin binding [GO:0048185]; activin receptor activity [GO:0017002]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type II [GO:0005026]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type I transforming growth factor beta receptor binding [GO:0034713]; type III transforming growth factor beta receptor binding [GO:0034714]; activation of protein kinase activity [GO:0032147]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to growth factor stimulus [GO:0071363]; common-partner SMAD protein phosphorylation [GO:0007182]; digestive tract development [GO:0048565]; embryo implantation [GO:0007566]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inferior endocardial cushion morphogenesis [GO:1905317]; Langerhans cell differentiation [GO:0061520]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of stem cell proliferation [GO:0072091]; response to cholesterol [GO:0070723]; response to estrogen [GO:0043627]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; secondary palate development [GO:0062009]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]" GO:0001568; GO:0001569; GO:0001570; GO:0001666; GO:0001701; GO:0001947; GO:0002053; GO:0002088; GO:0002651; GO:0002663; GO:0002666; GO:0003148; GO:0003149; GO:0003151; GO:0003181; GO:0003186; GO:0003214; GO:0003274; GO:0003430; GO:0004674; GO:0004675; GO:0005024; GO:0005026; GO:0005524; GO:0005539; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006468; GO:0006898; GO:0006915; GO:0007179; GO:0007182; GO:0007219; GO:0007224; GO:0007369; GO:0007420; GO:0007507; GO:0007566; GO:0007568; GO:0007584; GO:0008284; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0010468; GO:0010634; GO:0010718; GO:0010862; GO:0016021; GO:0017002; GO:0018105; GO:0018107; GO:0031100; GO:0031435; GO:0032147; GO:0034713; GO:0034714; GO:0035162; GO:0042060; GO:0042127; GO:0043011; GO:0043235; GO:0043415; GO:0043627; GO:0045121; GO:0045766; GO:0046332; GO:0046872; GO:0048185; GO:0048545; GO:0048565; GO:0048661; GO:0048701; GO:0050431; GO:0051138; GO:0060044; GO:0060389; GO:0060412; GO:0060434; GO:0060440; GO:0060443; GO:0060463; GO:0061520; GO:0062009; GO:0070021; GO:0070723; GO:0071363; GO:0072091; GO:1905007; GO:1905317; GO:1990086; GO:1990428; GO:2000379; GO:2000563 "activin binding [GO:0048185]; activin receptor activity [GO:0017002]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type II [GO:0005026]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type I transforming growth factor beta receptor binding [GO:0034713]; type III transforming growth factor beta receptor binding [GO:0034714]" EHPCVESMKDNVLR 0.94925 2.8223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.049 0 10.9229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5447 0 0 0 10.7664 0 0 0 0 0 0 0 0 0 0 0 10.5729 12.5983 0 13.9219 12.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3174 0 0 14.0105 0 0 0 0 0 0 12.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8742 0 0 0 0 0 0 0 0 0 0 0 0 Q3LI59 KR212_HUMAN Keratin-associated protein 21-2 KRTAP21-2 KAP21.2 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 NCCGGCGYGSGWSSGCGYGCGYGCGYGSGCR 0.94927 0.84777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6339 0 0 0 0 0 0 0 0 14.0736 0 0 0 13.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.655 11.9229 0 10.6374 0 11.0276 0 0 0 0 0 0 0 0 O95007 OR6B1_HUMAN "Olfactory receptor 6B1 (Olfactory receptor 7-3, OR7-3) (Olfactory receptor OR7-9)" OR6B1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAMFLIFLVAYILTVAENVIIILLVLQNR 0.94937 0.84465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0403 0 0 0 0 0 0 0 0 0 0 13.7809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1329 0 0 0 0 14.4053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8118 0 0 0 0 0 0 Q96LT7 CI072_HUMAN Guanine nucleotide exchange factor C9orf72 C9orf72 DENND9 DENNL72 Homo sapiens (Human) autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of GTP binding [GO:1904425]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063] anchoring junction [GO:0070161]; autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; guanyl-nucleotide exchange factor complex [GO:0032045]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynapse [GO:0098793] anchoring junction [GO:0070161]; autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; guanyl-nucleotide exchange factor complex [GO:0032045]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynapse [GO:0098793]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of GTP binding [GO:1904425]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063] GO:0000932; GO:0001933; GO:0005085; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0043231; GO:0043547; GO:0044295; GO:0044304; GO:0045920; GO:0048675; GO:0050777; GO:0070161; GO:0090543; GO:0098793; GO:0098794; GO:0110053; GO:1902774; GO:1903432; GO:1904425; GO:2000785 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] DSTGSFVLPFR 0.94937 2.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4841 0 0 0 15.3642 0 14.6207 0 0 0 0 0 0 0 0 14.2171 0 0 0 0 C9JQL5 DSA2D_HUMAN "Putative dispanin subfamily A member 2d, DSPA2d" Homo sapiens (Human) defense response to virus [GO:0051607]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; type I interferon signaling pathway [GO:0060337] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral genome replication [GO:0045071]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; type I interferon signaling pathway [GO:0060337] GO:0005886; GO:0016021; GO:0034341; GO:0035455; GO:0035456; GO:0045071; GO:0046597; GO:0051607; GO:0060337 CLNIWALILGILMTILLIIIPVLIFQAHR 0.94939 0.84465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53HC5 KLH26_HUMAN Kelch-like protein 26 KLHL26 Homo sapiens (Human) HFLQIAEEEDFLRLPLER 0.9494 2.4383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5002 0 0 0 0 0 0 0 0 0 0 11.6593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2337 0 0 0 16.2111 15.6528 0 0 14.1697 0 0 0 0 12.0261 0 0 0 0 13.5518 13.6504 0 0 0 0 0 0 0 11.9 0 12.8519 0 12.4299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3503 11.7416 0 0 0 0 13.5296 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4374 0 0 0 Q8IYI8 ZN440_HUMAN Zinc finger protein 440 ZNF440 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DVAVNFTQEEWALLDISQRKLYR 0.94941 0.84879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8312 0 0 0 0 0 0 0 0 13.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17900 SAP3_HUMAN "Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3, SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short ]" GM2A Homo sapiens (Human) ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; maintenance of location in cell [GO:0051651]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313] azurophil granule lumen [GO:0035578]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202] azurophil granule lumen [GO:0035578]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; beta-N-acetylhexosaminidase activity [GO:0004563]; lipid transporter activity [GO:0005319]; sphingolipid activator protein activity [GO:0030290]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; lipid transport [GO:0006869]; maintenance of location in cell [GO:0051651]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313] GO:0004563; GO:0005319; GO:0005576; GO:0005829; GO:0006687; GO:0006689; GO:0006869; GO:0007611; GO:0009313; GO:0009898; GO:0019915; GO:0030290; GO:0035578; GO:0043202; GO:0043231; GO:0050885; GO:0051651; GO:0070062 beta-N-acetylhexosaminidase activity [GO:0004563]; lipid transporter activity [GO:0005319]; sphingolipid activator protein activity [GO:0030290] MQSLMQAPLLIALGLLLAAPAQAHLK 0.94943 3.7908 0 0 0 0 0 0 0 0 0 12.1395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1848 0 0 0 0 0 13.4439 12.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.763 0 0 0 0 13.3962 11.4397 0 0 0 0 0 0 13.7073 13.3745 0 0 0 0 0 0 11.178 0 0 0 0 0 0 15.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2889 Q9UKV0 HDAC9_HUMAN "Histone deacetylase 9, HD9, EC 3.5.1.98 (Histone deacetylase 7B, HD7, HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR)" HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR Homo sapiens (Human) "B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; histone H4-K16 deacetylation [GO:1990678]; inflammatory response [GO:0006954]; negative regulation of cytokine production [GO:0001818]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]" cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity (H4-K16 specific) [GO:0034739]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; histone H4-K16 deacetylation [GO:1990678]; inflammatory response [GO:0006954]; negative regulation of cytokine production [GO:0001818]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]" GO:0000118; GO:0000122; GO:0001818; GO:0003714; GO:0004407; GO:0005080; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006325; GO:0006954; GO:0007507; GO:0016575; GO:0030183; GO:0032869; GO:0033558; GO:0034739; GO:0034983; GO:0035097; GO:0042113; GO:0042632; GO:0042826; GO:0045892; GO:0046872; GO:0048742; GO:0051005; GO:0051153; GO:0061629; GO:0070932; GO:0070933; GO:0090050; GO:0140297; GO:1990678 DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity (H4-K16 specific) [GO:0034739]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] APSSGNSTRSDSSACVDDTLGQVGAVK 0.94949 2.7895 0 0 0 0 12.3072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5998 0 0 0 0 0 0 13.3019 10.4481 0 0 0 0 0 0 0 12.5557 0 0 12.7367 0 0 11.461 0 0 0 10.7846 0 13.576 11.0939 0 0 0 0 0 0 0 11.6778 11.1228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q495A1 TIGIT_HUMAN T-cell immunoreceptor with Ig and ITIM domains (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3) TIGIT VSIG9 VSTM3 Homo sapiens (Human) negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; positive regulation of interleukin-10 production [GO:0032733] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; positive regulation of interleukin-10 production [GO:0032733] GO:0005102; GO:0005886; GO:0009986; GO:0016021; GO:0032695; GO:0032733; GO:0042802; GO:0050868 identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] ALRIHSVEGDLR 0.94953 2.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61925 IPKA_HUMAN "cAMP-dependent protein kinase inhibitor alpha, PKI-alpha (cAMP-dependent protein kinase inhibitor, muscle/brain isoform)" PKIA PRKACN1 Homo sapiens (Human) negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; protein kinase A catalytic subunit binding [GO:0034236]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] GO:0000122; GO:0004862; GO:0005634; GO:0005737; GO:0010389; GO:0034236; GO:0042308; GO:2000480 cAMP-dependent protein kinase inhibitor activity [GO:0004862]; protein kinase A catalytic subunit binding [GO:0034236] MTDVETTYADFIASGR 0.94955 0.83127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92574 TSC1_HUMAN Hamartin (Tuberous sclerosis 1 protein) TSC1 KIAA0243 TSC Homo sapiens (Human) activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; cardiac muscle cell differentiation [GO:0055007]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; regulation of stress fiber assembly [GO:0051492]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808] cell cortex [GO:0005938]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596] cell cortex [GO:0005938]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; cardiac muscle cell differentiation [GO:0055007]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; regulation of stress fiber assembly [GO:0051492]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808] GO:0001822; GO:0001843; GO:0001952; GO:0002250; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006407; GO:0006417; GO:0006813; GO:0007160; GO:0008283; GO:0008285; GO:0008306; GO:0008344; GO:0010977; GO:0014069; GO:0016020; GO:0016239; GO:0016242; GO:0017148; GO:0021766; GO:0021987; GO:0030027; GO:0030030; GO:0030426; GO:0030544; GO:0032007; GO:0032780; GO:0032794; GO:0032868; GO:0032991; GO:0033596; GO:0034260; GO:0042030; GO:0042552; GO:0043379; GO:0043666; GO:0044877; GO:0045792; GO:0045859; GO:0046323; GO:0047485; GO:0048471; GO:0050808; GO:0050821; GO:0051087; GO:0051492; GO:0051496; GO:0051726; GO:0051879; GO:0051894; GO:0055007; GO:0090630; GO:0090650; GO:0101031; GO:1901214; GO:1903204 ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877] AATRLSILSLLGHVIR 0.94957 2.4581 0 0 0 0 0 0 0 0 0 0 0 12.85 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1918 0 16.1453 15.9351 15.758 0 15.632 14.7455 0 0 0 0 0 0 0 0 0 0 0 11.6762 16.4317 0 0 0 16.4537 0 0 16.6622 0 0 11.3849 0 16.3908 0 0 0 16.2572 0 11.5803 16.4606 0 0 16.5808 0 0 0 0 0 16.2552 0 11.5451 11.9157 12.2024 0 16.3829 16.3359 0 16.1889 16.2265 0 0 0 11.7857 16.3978 16.3104 0 0 0 0 15.8332 0 15.8201 0 0 0 12.0518 15.4051 15.3014 0 0 0 0 13.2272 14.2521 13.943 0 0 0 12.7347 0 0 0 0 0 12.8981 0 0 0 15.7124 15.59 0 0 0 0 15.1702 0 Q9BSQ5 CCM2_HUMAN Cerebral cavernous malformations 2 protein (Malcavernin) CCM2 C7orf22 PP10187 Homo sapiens (Human) blood vessel endothelial cell differentiation [GO:0060837]; cell-cell junction organization [GO:0045216]; endothelial cell development [GO:0001885]; endothelial tube morphogenesis [GO:0061154]; endothelium development [GO:0003158]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; multicellular organism growth [GO:0035264]; pericardium development [GO:0060039]; regulation of angiogenesis [GO:0045765]; stress-activated MAPK cascade [GO:0051403]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; blood vessel endothelial cell differentiation [GO:0060837]; cell-cell junction organization [GO:0045216]; endothelial cell development [GO:0001885]; endothelial tube morphogenesis [GO:0061154]; endothelium development [GO:0003158]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; multicellular organism growth [GO:0035264]; pericardium development [GO:0060039]; regulation of angiogenesis [GO:0045765]; stress-activated MAPK cascade [GO:0051403]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845] GO:0001570; GO:0001701; GO:0001885; GO:0003158; GO:0005737; GO:0005739; GO:0007229; GO:0007507; GO:0032991; GO:0035264; GO:0045216; GO:0045765; GO:0048839; GO:0048845; GO:0051403; GO:0060039; GO:0060837; GO:0061154 KFLLLGLRPFIPEK 0.94959 0.84505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5506 0 0 0 15.8318 0 0 0 0 0 0 0 15.8085 0 11.2811 0 0 0 0 0 17.1317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4553 16.4481 0 0 0 0 0 0 0 16.5255 0 0 0 9.9969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7S2 DNJ5G_HUMAN "DnaJ homolog subfamily C member 5G (Cysteine string protein-gamma, CSP-gamma)" DNAJC5G Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020] GO:0016020 PPPEQDSGR 0.9496 0.84473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UQ28 PLET1_HUMAN Placenta-expressed transcript 1 protein PLET1 C11orf34 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell migration [GO:0030335]; wound healing, spreading of epidermal cells [GO:0035313]" anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] "anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell differentiation [GO:0030154]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell migration [GO:0030335]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0001953; GO:0005576; GO:0005886; GO:0009897; GO:0016324; GO:0030154; GO:0030335; GO:0031225; GO:0035313 ALPILSTLKLR 0.94961 2.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1403 12.5281 13.3291 0 13.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9658 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9467 0 0 0 0 0 0 0 0 Q7L9B9 EEPD1_HUMAN Endonuclease/exonuclease/phosphatase family domain-containing protein 1 EEPD1 KIAA1706 Homo sapiens (Human) DNA repair [GO:0006281]; positive regulation of cholesterol efflux [GO:0010875] anchored component of plasma membrane [GO:0046658]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of cholesterol efflux [GO:0010875] GO:0003677; GO:0005886; GO:0006281; GO:0010875; GO:0046658 DNA binding [GO:0003677] AVARSIVEYREYIGGFK 0.94961 2.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0519 0 12.4527 0 0 0 0 0 0 0 12.1454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8496 0 0 0 0 13.3372 0 13.6852 0 0 14.6707 12.4549 14.2583 15.1814 0 0 0 0 13.5349 0 0 0 0 0 0 0 0 0 0 0 0 13.9586 0 0 0 0 0 0 0 0 0 0 13.711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5559 0 0 13.0688 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUA5 SIM32_HUMAN Small integral membrane protein 32 SMIM32 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PDLPTYLLLFFLLLLSVALVVLFIGCQLR 0.94963 0.84465 0 0 0 0 0 0 0 0 0 10.9643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VWC8 HACD4_HUMAN "Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4, EC 4.2.1.134 (3-hydroxyacyl-CoA dehydratase 4, HACD4) (Protein-tyrosine phosphatase-like A domain-containing protein 2)" HACD4 PTPLAD2 Homo sapiens (Human) fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] GO:0005783; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0042761; GO:0102158; GO:0102343; GO:0102344; GO:0102345 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158] DILGIFPIKKK 0.94966 2.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2629 0 13.581 0 13.4927 11.0917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19484 TFEB_HUMAN "Transcription factor EB (Class E basic helix-loop-helix protein 35, bHLHe35)" TFEB BHLHE35 Homo sapiens (Human) "adaptive immune response [GO:0002250]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; embryonic placenta development [GO:0001892]; humoral immune response [GO:0006959]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adaptive immune response [GO:0002250]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; embryonic placenta development [GO:0001892]; humoral immune response [GO:0006959]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001892; GO:0002250; GO:0003700; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0006355; GO:0006357; GO:0006914; GO:0006959; GO:0007040; GO:0009267; GO:0010468; GO:0010508; GO:0019899; GO:0032418; GO:0034198; GO:0045893; GO:0045944; GO:0046983; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ASVDYIRRMQK 0.94968 0.83695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7595 0 0 0 0 0 0 14.3578 0 0 13.3281 14.1506 12.7347 13.994 0 0 0 0 0 0 0 0 0 0 0 0 14.0454 0 12.066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09486 SPRC_HUMAN "SPARC (Basement-membrane protein 40, BM-40) (Osteonectin, ON) (Secreted protein acidic and rich in cysteine)" SPARC ON Homo sapiens (Human) anatomical structure development [GO:0048856]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of endothelial cell migration [GO:0010595]; regulation of cell morphogenesis [GO:0022604] basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; platelet alpha granule membrane [GO:0031092] basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; platelet alpha granule membrane [GO:0031092]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; anatomical structure development [GO:0048856]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of endothelial cell migration [GO:0010595]; regulation of cell morphogenesis [GO:0022604] GO:0001937; GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005737; GO:0005886; GO:0009986; GO:0010595; GO:0016363; GO:0016525; GO:0022604; GO:0031091; GO:0031092; GO:0031093; GO:0043231; GO:0048856; GO:0050840; GO:0062023; GO:0071682 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840] DWLKNVLVTLYER 0.94969 0.83688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15758 AAAT_HUMAN "Neutral amino acid transporter B(0), ATB(0) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5)" SLC1A5 ASCT2 M7V1 RDR RDRC Homo sapiens (Human) amino acid transport [GO:0006865]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; neutral amino acid transport [GO:0015804]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104] basal plasma membrane [GO:0009925]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886] basal plasma membrane [GO:0009925]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; signaling receptor activity [GO:0038023]; symporter activity [GO:0015293]; virus receptor activity [GO:0001618]; amino acid transport [GO:0006865]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; neutral amino acid transport [GO:0015804]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104] GO:0001618; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0009925; GO:0010585; GO:0015171; GO:0015175; GO:0015183; GO:0015186; GO:0015194; GO:0015293; GO:0015804; GO:0016020; GO:0016021; GO:0038023; GO:0042470; GO:0046872; GO:0070062; GO:0070207; GO:0140009; GO:0150104; GO:1903803 amino acid transmembrane transporter activity [GO:0015171]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; signaling receptor activity [GO:0038023]; symporter activity [GO:0015293]; virus receptor activity [GO:0001618] CVEENNGVAKHISR 0.94969 2.8945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0922 0 0 0 0 0 0 0 11.595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3599 0 0 11.7603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6921 0 0 0 0 0 0 0 0 0 0 0 0 13.7797 0 0 0 11.7414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5044 0 0 0 0 0 0 0 0 0 0 13.3908 0 13.0238 Q9P0N9 TBCD7_HUMAN TBC1 domain family member 7 (Cell migration-inducing protein 23) TBC1D7 TBC7 HSPC239 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; negative regulation of TOR signaling [GO:0032007]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein ubiquitination [GO:0031398]; response to growth factor [GO:0070848] ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; TSC1-TSC2 complex [GO:0033596] ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; negative regulation of TOR signaling [GO:0032007]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein ubiquitination [GO:0031398]; response to growth factor [GO:0070848] GO:0005096; GO:0005829; GO:0031267; GO:0031398; GO:0031410; GO:0032007; GO:0033596; GO:0036064; GO:0043547; GO:0070848; GO:0090630; GO:1902018 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] ALVWKVLLGILPPHHESHAK 0.94969 2.9222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1047 0 0 0 12.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96346 0 0 0 0 0 0 0 0 0 0 0 0 15.2153 0 0 0 0 0 0 0 0 0 11.7752 0 11.5023 0 0 13.2824 11.8423 0 0 12.8627 0 0 0 0 0 12.3862 13.8658 0 0 0 11.9651 0 0 0 0 0 12.0476 0 0 0 12.2657 0 0 0 0 13.6468 0 0 0 0 0 0 0 0 11.735 0 0 0 13.1648 11.612 0 0 12.048 0 0 0 12.8057 0 11.3272 0 0 0 0 0 0 0 0 0 0 10.8994 0 0 0 0 12.2244 0 10.775 0 0 0 0 0 13.5042 0 0 0 11.5393 P01767 HV353_HUMAN Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT) IGHV3-53 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0005576; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] GLEWVSVIYSGGSTYYADSVK 0.94978 0.83133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV36 HID1_HUMAN Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog) HID1 C17orf28 DMC1 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020] GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0016020; GO:0070062; GO:0090498 ADQSRVGLMHIGVFILLLLSGER 0.94982 0.808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1959 0 0 13.7433 0 0 12.8042 0 0 0 0 0 0 0 0 0 0 0 12.9707 0 15.9399 0 0 0 0 16.0194 0 0 15.6041 0 0 0 0 0 0 0 0 0 15.6336 13.0651 0 0 0 0 0 0 0 14.4578 0 0 14.5495 0 0 0 0 15.3675 0 0 0 0 0 0 0 0 0 15.1254 0 11.9566 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5763 0 0 12.7446 0 0 0 0 0 0 11.9193 0 0 0 0 0 14.4882 0 13.8335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2254 0 13.6639 0 0 0 0 0 0 0 0 0 14.3955 14.2999 0 0 P07339 CATD_HUMAN "Cathepsin D, EC 3.4.23.5 [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain ]" CTSD CPSD Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201] collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagosome assembly [GO:0000045]; lipoprotein catabolic process [GO:0042159]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; proteolysis [GO:0006508]; regulation of establishment of protein localization [GO:0070201] GO:0000045; GO:0004190; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0006508; GO:0008233; GO:0010008; GO:0019886; GO:0035580; GO:0042159; GO:0042470; GO:0043065; GO:0043202; GO:0043280; GO:0045121; GO:0062023; GO:0070001; GO:0070062; GO:0070201; GO:1904724; GO:1904813 aspartic-type endopeptidase activity [GO:0004190]; aspartic-type peptidase activity [GO:0070001]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233] IPLHKFTSIR 0.94983 0.80784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9752 0 0 0 0 13.6154 0 15.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0R6 GSKIP_HUMAN "GSK3B-interacting protein, GSKIP (GSK3beta interaction protein)" GSKIP C14orf129 HSPC210 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of Wnt signaling pathway [GO:0030111] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; kinase regulator activity [GO:0019207]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of Wnt signaling pathway [GO:0030111] GO:0004860; GO:0005634; GO:0005737; GO:0006469; GO:0008631; GO:0019207; GO:0019901; GO:0030111; GO:0034237; GO:0051018; GO:0090263 kinase regulator activity [GO:0019207]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] CADDVAYINVETKERNR 0.94984 2.7618 0 0 0 0 0 0 0 10.0543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3176 12.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1912 14.1232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L0Y3 TM10C_HUMAN "tRNA methyltransferase 10 homolog C (HBV pre-S2 trans-regulated protein 2) (Mitochondrial ribonuclease P protein 1, Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (mRNA methyladenosine-N(1)-methyltransferase, EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase, EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase, EC 2.1.1.221)" TRMT10C MRPP1 RG9MTD1 Homo sapiens (Human) mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mRNA methylation [GO:0080009]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; identical protein binding [GO:0042802]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; RNA binding [GO:0003723]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mRNA methylation [GO:0080009]; positive regulation of mitochondrial translation [GO:0070131] GO:0000049; GO:0000964; GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0009019; GO:0016429; GO:0030678; GO:0042645; GO:0042802; GO:0043527; GO:0052905; GO:0061953; GO:0070131; GO:0070901; GO:0080009; GO:0090646; GO:0097745; GO:1990180 identical protein binding [GO:0042802]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; RNA binding [GO:0003723]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049] FLVPFTLHRKR 0.94986 2.6011 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2977 0 13.839 0 15.1971 15.2103 0 0 11.9826 0 11.1735 0 11.2321 0 13.0821 0 0 0 0 11.9076 0 0 0 0 0 0 0 0 0 0 0 12.7848 0 0 0 0 0 0 0 0 0 0 0 11.3163 12.6206 0 0 0 0 0 0 0 0 0 13.0538 12.3996 0 0 0 0 13.0456 0 0 0 0 11.475 0 13.4944 0 0 0 12.8287 0 0 0 0 14.8812 11.3367 0 10.8939 0 0 0 0 0 11.0806 0 0 0 17.4469 16.0491 0 0 0 0 0 0 0 0 0 11.1919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0D2K0 NIPA4_HUMAN Magnesium transporter NIPA4 (Ichthyin) (NIPA-like protein 4) (Non-imprinted in Prader-Willi/Angelman syndrome region protein 4) NIPAL4 ICHN NIPA4 Homo sapiens (Human) magnesium ion transport [GO:0015693] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693] GO:0015095; GO:0015693; GO:0016020; GO:0016021 magnesium ion transmembrane transporter activity [GO:0015095] DTGFIVFAVLLLVSCLILIFVIAPR 0.94987 2.9191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6887 13.9442 0 0 0 0 12.8117 0 0 0 12.6346 0 0 13.7762 0 0 0 14.9937 0 0 0 0 14.5389 0 0 0 0 0 0 14.6366 0 0 12.2087 0 0 0 0 0 0 0 0 11.9482 0 0 0 0 14.0209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.116 0 0 0 13.8985 0 0 0 0 11.2722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05BQ5 MBTD1_HUMAN MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) "chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; embryonic skeletal system development [GO:0048706]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; nucleus [GO:0005634] "NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; embryonic skeletal system development [GO:0048706]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" GO:0000724; GO:0000786; GO:0003682; GO:0005634; GO:0006325; GO:0008270; GO:0016573; GO:0035064; GO:0035267; GO:0042393; GO:0042981; GO:0043967; GO:0043968; GO:0045892; GO:0045893; GO:0048706; GO:0051726; GO:1905168; GO:2000779 chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] AKVLQKQPLVAK 0.94988 2.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7262 11.3567 0 0 0 0 0 0 0 0 0 0 11.0893 0 0 0 0 0 10.4587 0 0 0 0 0 10.8327 0 0 0 0 0 0 0 12.8181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.209 0 0 0 0 11.9062 0 12.9538 13.3587 0 0 0 13.0657 0 0 0 0 0 0 13.4003 12.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9384 0 0 11.263 0 0 15.0569 0 0 0 0 0 0 0 15.2415 0 0 12.1063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5878 0 0 0 0 0 0 12.4171 0 0 0 0 0 0 0 0 11.4524 0 0 0 Q9ULR5 PAI2B_HUMAN "Polyadenylate-binding protein-interacting protein 2B, PABP-interacting protein 2B, PAIP-2B, Poly(A)-binding protein-interacting protein 2B" PAIP2B KIAA1155 Homo sapiens (Human) negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA regulatory element binding translation repressor activity [GO:0000900]; translation repressor activity [GO:0030371]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947] GO:0000900; GO:0005737; GO:0017148; GO:0030371; GO:0045947 mRNA regulatory element binding translation repressor activity [GO:0000900]; translation repressor activity [GO:0030371] ENPFAEYMWMENEEDFNR 0.94989 0.83776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9656 0 0 0 0 0 0 12.0193 0 0 0 0 0 0 0 12.5033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52738 ZN140_HUMAN Zinc finger protein 140 ZNF140 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0043565; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" CVMLENYGHLVSLGLSISKPDVVSLLEQGK 0.9499 0.8375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4277 0 0 0 Q6VN20 RBP10_HUMAN "Ran-binding protein 10, RanBP10" RANBP10 KIAA1464 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010] GO:0000151; GO:0005634; GO:0005737; GO:0005829; GO:0007010; GO:0007166 HEDLQTDESSMDDR 0.94991 0.83703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58012 FOXL2_HUMAN Forkhead box protein L2 FOXL2 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte growth [GO:0001555]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; uterus development [GO:0060065]" chromatin [GO:0000785]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin conjugating enzyme binding [GO:0031624]; anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte growth [GO:0001555]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; uterus development [GO:0060065]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001541; GO:0001555; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0007338; GO:0009653; GO:0019101; GO:0030154; GO:0030331; GO:0031624; GO:0033686; GO:0043028; GO:0043065; GO:0043280; GO:0045892; GO:0045893; GO:0046881; GO:0048048; GO:0060014; GO:0060065; GO:0090543; GO:1990837 "cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin conjugating enzyme binding [GO:0031624]" GLAGPAASYGPYTR 0.94992 0.81342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95257 GA45G_HUMAN "Growth arrest and DNA damage-inducible protein GADD45 gamma (Cytokine-responsive protein CR6) (DNA damage-inducible transcript 2 protein, DDIT-2)" GADD45G CR6 DDIT2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005737; GO:0006915; GO:0030154; GO:0043065; GO:0046330; GO:0051726; GO:0120162; GO:1900745 GQDTVPESTARMQGAGK 0.94993 0.81299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8098 13.8297 0 14.0491 14.179 14.0569 13.7579 0 13.9553 0 0 12.1923 0 0 0 0 0 0 13.0689 0 0 0 0 0 0 0 13.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7596 0 0 0 0 0 0 0 0 0 0 0 0 C9JJH3 U17LA_HUMAN "Ubiquitin carboxyl-terminal hydrolase 17-like protein 10, EC 3.4.19.12" USP17L10 Homo sapiens (Human) protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0016579; GO:0042981 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] APASKTLTLHNSAKVLILVLK 0.94994 2.8291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4561 0 0 0 0 11.5312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7863 0 0 0 0 0 0 0 0 0 13.253 0 0 0 0 0 0 0 0 0 11.8416 0 0 0 0 12.4196 0 11.7866 0 0 0 0 0 0 0 10.4115 0 0 0 0 0 0 0 0 0 0 9.05675 0 0 0 0 0 0 0 0 0 13.9932 0 0 0 0 0 12.7842 0 10.8665 0 0 0 0 0 0 11.3038 0 0 0 0 0 0 13.6098 0 0 0 10.9492 0 0 0 0 0 14.2055 0 0 0 11.7213 0 0 12.6039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6773 0 14.5825 0 0 0 0 0 0 0 15.4052 Q96MP5 ZSWM3_HUMAN Zinc finger SWIM domain-containing protein 3 ZSWIM3 C20orf164 Homo sapiens (Human) zinc ion binding [GO:0008270] GO:0008270 zinc ion binding [GO:0008270] GMVPNTGQPEK 0.94994 2.7776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95041 0 0 0 0 0 0 0 0 0 0 0 12.6825 0 10.6723 0 0 0 0 0 0 0 0 0 12.066 0 0 0 11.9601 10.5262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3046 0 0 0 0 0 0 11.9547 0 0 14.0011 13.8121 13.7391 13.8082 13.7994 12.3831 13.7264 0 13.4265 0 12.3598 0 12.4814 0 0 0 0 0 0 0 0 0 0 0 0 12.2977 0 0 0 0 0 0 15.8782 0 0 0 0 0 15.853 15.8185 0 0 0 0 0 0 15.3537 15.2393 0 15.8285 15.5356 15.6655 0 0 0 0 0 15.1548 15.0299 0 0 0 9.837 0 0 0 14.7234 14.2696 14.1512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.849 0 0 0 15.679 0 Q9BQ48 RM34_HUMAN "39S ribosomal protein L34, mitochondrial, L34mt, MRP-L34 (Mitochondrial large ribosomal subunit protein bL34m)" MRPL34 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 structural constituent of ribosome [GO:0003735] AVLAGSLLGPTSR 0.94994 0.81261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYX4 CALY_HUMAN Neuron-specific vesicular protein calcyon CALY DRD1IP Homo sapiens (Human) anterograde axonal transport [GO:0008089]; clathrin coat assembly [GO:0048268]; dopamine receptor signaling pathway [GO:0007212]; endosomal transport [GO:0016197]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of endocytosis [GO:0045807]; positive regulation of retrograde axon cargo transport [GO:2001019]; postsynaptic neurotransmitter receptor internalization [GO:0098884] axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; postsynaptic endocytic zone [GO:0098843] axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; postsynaptic endocytic zone [GO:0098843]; clathrin light chain binding [GO:0032051]; protein-containing complex binding [GO:0044877]; anterograde axonal transport [GO:0008089]; clathrin coat assembly [GO:0048268]; dopamine receptor signaling pathway [GO:0007212]; endosomal transport [GO:0016197]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of endocytosis [GO:0045807]; positive regulation of retrograde axon cargo transport [GO:2001019]; postsynaptic neurotransmitter receptor internalization [GO:0098884] GO:0005768; GO:0005887; GO:0007212; GO:0008089; GO:0016021; GO:0016197; GO:0030659; GO:0031410; GO:0032051; GO:0044877; GO:0045807; GO:0048268; GO:0098843; GO:0098884; GO:0098978; GO:1904115; GO:1905445; GO:2001019 clathrin light chain binding [GO:0032051]; protein-containing complex binding [GO:0044877] AAGSAAPPPAQ 0.94994 2.9183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5K4E3 POLS2_HUMAN "Polyserase-2, EC 3.4.21.- (Polyserine protease 2) (Serine protease 36)" PRSS36 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005737; GO:0006508 serine-type endopeptidase activity [GO:0004252] LPQHLGLRPPLALLELSSR 0.94995 2.7592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P5S7 RNK_HUMAN "Ribonuclease kappa, RNase K, RNase kappa, EC 3.1.-.- (V-type proton ATPase subunit f, V-ATPase subunit f)" RNASEK Homo sapiens (Human) endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; vacuolar acidification [GO:0007035] "clathrin-coated vesicle membrane [GO:0030665]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "clathrin-coated vesicle membrane [GO:0030665]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; endoribonuclease activity [GO:0004521]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; vacuolar acidification [GO:0007035]" GO:0000139; GO:0000220; GO:0004521; GO:0005765; GO:0005886; GO:0006898; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016021; GO:0019065; GO:0030665; GO:0033176; GO:0048388; GO:0051452; GO:0061795; GO:1902600 endoribonuclease activity [GO:0004521] SPTPFFMASLLCCGPK 0.94995 0.83641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07492 GRP_HUMAN "Gastrin-releasing peptide, GRP [Cleaved into: Neuromedin-C (GRP-10) (GRP18-27) ]" GRP Homo sapiens (Human) mast cell degranulation [GO:0043303]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; negative regulation of voltage-gated sodium channel activity [GO:1905151]; neuropeptide signaling pathway [GO:0007218]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of respiratory gaseous exchange [GO:1903942]; psychomotor behavior [GO:0036343]; response to external biotic stimulus [GO:0043207]; signal transduction [GO:0007165]; social behavior [GO:0035176] extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774] extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; mast cell degranulation [GO:0043303]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; negative regulation of voltage-gated sodium channel activity [GO:1905151]; neuropeptide signaling pathway [GO:0007218]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of respiratory gaseous exchange [GO:1903942]; psychomotor behavior [GO:0036343]; response to external biotic stimulus [GO:0043207]; signal transduction [GO:0007165]; social behavior [GO:0035176] GO:0005102; GO:0005184; GO:0005576; GO:0005615; GO:0007165; GO:0007218; GO:0034774; GO:0035176; GO:0036343; GO:0043005; GO:0043207; GO:0043303; GO:0090277; GO:1900738; GO:1903817; GO:1903942; GO:1905151; GO:2000987 neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102] ELPLVLLALVLCLAPR 0.95 3.358 0 0 0 0 0 13.3394 0 0 0 0 0 0 0 0 0 11.0313 0 0 0 0 0 0 0 0 0 12.9035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87412 0 0 0 0 0 0 0 0 0 0 0 0 14.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4786 0 0 0 0 0 0 0 14.3717 0 0 0 0 0 0 14.0201 11.8165 0 0 13.9116 0 0 11.6441 0 13.165 0 0 0 0 13.9223 13.962 13.5749 13.6317 13.5886 0 0 0 0 13.5519 12.6932 0 0 0 0 0 0 0 14.2894 13.6267 0 0 0 0 0 12.2052 12.9688 0 0 13.5551 0 13.2482 0 0 12.3841 12.3135 13.4282 12.0812 0 0 0 0 0 0 0 0 0 0 0 0 13.5838 0 0 13.2801 13.4481 13.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3223 0 11.2366 13.3585 0 14.1852 0 0 0 0 0 Q13422 IKZF1_HUMAN DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1) IKZF1 IK1 IKAROS LYF1 ZNFN1A1 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; lymphocyte differentiation [GO:0030098]; mesoderm development [GO:0007498]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; lymphocyte differentiation [GO:0030098]; mesoderm development [GO:0007498]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005721; GO:0005829; GO:0006325; GO:0006357; GO:0007049; GO:0007498; GO:0019904; GO:0030098; GO:0030218; GO:0032991; GO:0042802; GO:0045892; GO:0046872 DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ACEMNGEECAEDLR 0.95 3.7597 0 0 0 0 0 0 0 0 0 0 0 10.0246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3203 0 0 0 14.4594 0 0 0 14.3352 0 0 0 0 12.6497 0 0 0 0 10.9244 0 0 0 0 0 0 0 0 0 0 0 13.8912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.702 0 0 0 10.7611 0 0 0 0 13.0003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.35716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWL2 SUSD1_HUMAN Sushi domain-containing protein 1 SUSD1 UNQ2438/PRO4999 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509] GO:0005509; GO:0016021 calcium ion binding [GO:0005509] INPKISYVISIK 0.95 4.6537 0 0 0 0 0 0 0 0 0 0 12.2947 0 0 0 0 10.2351 0 0 0 0 0 0 0 0 13.0895 0 0 0 0 0 0 11.0075 0 0 0 0 0 0 0 0 12.9044 0 0 0 0 0 0 0 10.7195 0 0 11.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8367 0 0 0 0 0 12.8619 0 12.9716 0 10.9398 12.4933 0 11.1484 0 0 0 0 0 0 0 0 14.2202 13.3316 12.7388 0 0 0 0 0 0 0 0 0 0 0 14.4569 0 0 12.7956 0 0 0 0 0 10.6236 0 0 0 13.3489 0 10.7782 0 0 0 0 0 0 0 0 12.5947 0 0 0 10.6684 0 0 10.7608 0 0 0 0 0 14.9057 0 10.0566 0 0 0 0 0 0 0 0 0 0 14.3262 0 13.5687 0 0 0 0 0 0 0 0 0 0 0 12.8978 0 0 0 Q9HCU9 BRMS1_HUMAN Breast cancer metastasis-suppressor 1 BRMS1 Homo sapiens (Human) "apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of anoikis [GO:2000210]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of apoptotic process [GO:0042981]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; apoptotic process [GO:0006915]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of anoikis [GO:2000210]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of apoptotic process [GO:0042981]" GO:0000122; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0016575; GO:0016580; GO:0030336; GO:0030512; GO:0032088; GO:0042826; GO:0042981; GO:0045892; GO:0051059; GO:0070822; GO:0090312; GO:1902455; GO:1902459; GO:2000210 histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059] IRIQVAGIYKGFCLDVIR 0.95 2.9176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0196 0 0 0 0 0 11.8159 12.2663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7586 11.2113 13.0899 0 0 0 0 0 0 11.496 0 12.9667 0 0 0 0 0 0 0 0 0 0 12.3948 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0494 0 12.5545 0 0 0 0 12.4 0 0 0 0 12.6826 0 0 0 0 13.9225 0 0 0 12.0154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5194 0 0 13.327 0 0 0 0 0 12.4158 0 0 0 0 0 0 0 11.7666 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3701 0 13.3636 Q9H606 PRORY_HUMAN "Proline-rich protein, Y-linked" PRORY CYorf17 Homo sapiens (Human) GTLSAPRLWSWMK 0.95005 0.80808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWM0 SMOX_HUMAN "Spermine oxidase, EC 1.5.3.16 (Polyamine oxidase 1, PAO-1, PAOh1)" SMOX C20orf16 SMO UNQ3039/PRO9854 Homo sapiens (Human) polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine biosynthetic process [GO:0006596]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]; xenobiotic metabolic process [GO:0006805] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0006598; GO:0006805; GO:0016491; GO:0031965; GO:0043231; GO:0046208; GO:0046592; GO:0052894; GO:0052895; GO:0052901 N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901] LIEMYRDLFQQGT 0.95006 2.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2537 0 0 0 0 0 14.6295 0 0 0 0 0 0 0 0 13.3232 0 0 0 0 0 13.8243 0 0 0 0 0 0 0 0 0 0 0 0 13.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3305 0 0 0 0 0 0 0 13.8542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9781 0 0 0 0 0 0 0 Q9NY26 S39A1_HUMAN "Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1, ZIP-1, hZIP1)" SLC39A1 IRT1 ZIP1 ZIRTL CGI-08 CGI-71 Homo sapiens (Human) cation transport [GO:0006812]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inorganic cation transmembrane transporter activity [GO:0022890]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385]; cation transport [GO:0006812]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; zinc ion transmembrane transport [GO:0071577] GO:0001701; GO:0005102; GO:0005385; GO:0005789; GO:0005886; GO:0006812; GO:0016020; GO:0016021; GO:0022890; GO:0048701; GO:0060173; GO:0071577 inorganic cation transmembrane transporter activity [GO:0022890]; signaling receptor binding [GO:0005102]; zinc ion transmembrane transporter activity [GO:0005385] GILAVSLSLRLLQSHLR 0.95009 3.3546 0 0 0 0 0 0 11.2642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3995 0 0 0 0 0 12.2754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9071 0 0 0 12.3829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3925 0 0 0 0 0 0 0 12.3762 0 0 0 0 0 12.6258 11.7782 0 0 0 0 0 0 0 0 0 0 0 0 14.3081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7739 0 0 10.5304 0 12.3517 0 0 0 0 0 0 0 0 10.9826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01700 LV147_HUMAN Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH) IGLV1-47 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0072562 antigen binding [GO:0003823] SEDEADYYCAAWDDSLSG 0.95012 0.83776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5272 0 10.7491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55286 CADH8_HUMAN Cadherin-8 CDH8 Homo sapiens (Human) "adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249]" adherens junction [GO:0005912]; axon terminus [GO:0043679]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060] "adherens junction [GO:0005912]; axon terminus [GO:0043679]; catenin complex [GO:0016342]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807]; response to cold [GO:0009409]; synaptic transmission, glutamatergic [GO:0035249]" GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0009409; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0035249; GO:0042802; GO:0043083; GO:0043679; GO:0045296; GO:0050807; GO:0097060; GO:0098742; GO:0098978 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] DIKPDLQFMPR 0.95013 0.80671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8789 0 0 0 0 0 0 0 0 0 0 0 12.4375 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14866 HNRPL_HUMAN "Heterogeneous nuclear ribonucleoprotein L, hnRNP L" HNRNPL HNRPL P/OKcl.14 Homo sapiens (Human) "cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to peptide [GO:1901652]; RNA processing [GO:0006396]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; response to peptide [GO:1901652]; RNA processing [GO:0006396]" GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006396; GO:0006397; GO:0007623; GO:0016020; GO:0034198; GO:0035770; GO:0043484; GO:0045727; GO:0045892; GO:0048025; GO:0048471; GO:0070062; GO:0097157; GO:1901652; GO:1902416; GO:1990715; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976] LCFSTAQHAS 0.95014 0.81346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60410 KR108_HUMAN Keratin-associated protein 10-8 (High sulfur keratin-associated protein 10.8) (Keratin-associated protein 10.8) (Keratin-associated protein 18-8) (Keratin-associated protein 18.8) KRTAP10-8 KAP10.8 KAP18-8 KRTAP10.8 KRTAP18-8 KRTAP18.8 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; identical protein binding [GO:0042802] GO:0005829; GO:0042802; GO:0045095 identical protein binding [GO:0042802] MADACCTRTYVIAASTMSVCSSDVGHVSR 0.95017 3.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2403 0 0 0 0 0 14.0685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2534 0 0 0 12.2883 0 14.5403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.603 0 0 0 0 0 0 0 0 0 0 0 0 12.2167 14.5558 0 14.4902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0978 0 0 0 0 0 Q3YBR2 TBRG1_HUMAN Transforming growth factor beta regulator 1 (Nuclear interactor of ARF and Mdm2) TBRG1 NIAM Homo sapiens (Human) cell cycle [GO:0007049]; DNA replication [GO:0006260]; negative regulation of cell population proliferation [GO:0008285]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; DNA replication [GO:0006260]; negative regulation of cell population proliferation [GO:0008285]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005654; GO:0006260; GO:0007049; GO:0008285; GO:0050821; GO:0051726; GO:1990173 LEEKFLKAK 0.95019 0.81228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.182 0 0 0 0 0 0 0 0 0 0 15.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TD94 RSH4A_HUMAN Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3) RSPH4A RSHL3 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177] axoneme [GO:0005930]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; radial spoke head [GO:0001535] axoneme [GO:0005930]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177] GO:0001534; GO:0001535; GO:0003341; GO:0005654; GO:0005730; GO:0005930; GO:0031514; GO:0035082; GO:0060294; GO:0062177; GO:0120221 CNWFNSIQKNEEEEEEEDEEK 0.95021 4.6428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.875 0 14.1336 0 0 0 0 12.6235 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0656 0 12.3882 0 0 0 0 0 0 0 0 0 0 10.5286 0 0 10.2952 0 0 0 0 13.2165 0 12.4584 0 12.2906 0 0 0 0 0 0 12.8816 0 15.3866 15.8394 15.7984 0 0 0 0 13.9711 0 0 10.7408 10.9413 0 0 0 0 0 10.4736 0 0 0 0 0 0 0 0 0 0 13.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20941 PHOS_HUMAN "Phosducin, PHD (33 kDa phototransducing protein) (Protein MEKA)" PDC Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601] cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; phospholipase inhibitor activity [GO:0004859]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0004859; GO:0005634; GO:0005829; GO:0007186; GO:0007601; GO:0007602; GO:0008277 phospholipase inhibitor activity [GO:0004859] KEILRQMSSPQSR 0.95022 0.83624 0 0 0 0 0 0 0 0 0 0 0 13.144 0 0 0 12.3188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9938 11.8611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5388 0 0 12.3404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9741 0 0 0 0 0 0 0 0 0 Q9H1F0 WF10A_HUMAN WAP four-disulfide core domain protein 10A (Putative protease inhibitor WAP10A) WFDC10A C20orf146 WAP10 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] GO:0004867; GO:0005615; GO:0019731; GO:0045087 serine-type endopeptidase inhibitor activity [GO:0004867] DCQANNICCSTYCGNVCMSIL 0.95024 0.83133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ55 MAGL2_HUMAN MAGE-like protein 2 (Necdin-like protein 1) (Protein nM15) MAGEL2 NDNL1 Homo sapiens (Human) "Arp2/3 complex-mediated actin nucleation [GO:0034314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of actin nucleation [GO:0051127]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; retrograde transport, endosome to Golgi [GO:0042147]; rhythmic process [GO:0048511]" cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nucleus [GO:0005634] "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nucleus [GO:0005634]; ubiquitin-protein transferase activity [GO:0004842]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of actin nucleation [GO:0051127]; protein K63-linked ubiquitination [GO:0070534]; regulation of circadian rhythm [GO:0042752]; retrograde transport, endosome to Golgi [GO:0042147]; rhythmic process [GO:0048511]" GO:0000122; GO:0004842; GO:0005634; GO:0005768; GO:0005769; GO:0005829; GO:0034314; GO:0042147; GO:0042752; GO:0045892; GO:0048511; GO:0051127; GO:0070534 ubiquitin-protein transferase activity [GO:0004842] AFLETSK 0.95026 3.985 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0711 11.8848 0 0 0 0 0 0 0 11.6549 0 0 0 0 12.503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1125 0 14.5726 0 14.896 0 0 14.55 0 0 0 0 0 0 0 0 0 0 0 15.0052 0 0 0 0 17.0799 0 0 15.213 0 0 12.6602 0 15.3337 0 11.2243 12.4672 15.8461 0 15.2396 15.6885 0 0 0 16.3451 0 0 16.0476 14.9061 0 15.4585 0 13.4624 12.9526 17.2427 0 0 0 0 12.0261 13.2257 0 0 15.5066 0 0 0 0 0 0 0 0 15.5654 0 0 15.3884 0 0 15.5773 0 0 0 14.2702 0 0 0 0 0 0 0 0 13.5406 0 0 0 15.6775 0 0 0 0 0 0 0 12.1573 A0A1B0GTD5 TEX49_HUMAN Testis-expressed protein 49 TEX49 Homo sapiens (Human) KVLLKTFPNQVFR 0.95032 0.80721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14872 MTF1_HUMAN Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) MTF1 Homo sapiens (Human) "cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cartilage homeostasis [GO:1990079]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cadmium ion [GO:0046686]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]" GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0006357; GO:0006979; GO:0007417; GO:0010038; GO:0035035; GO:0045944; GO:0046686; GO:0046872; GO:0071294; GO:1990079; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EKPFECDVQGCEK 0.95034 3.7485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3563 0 0 0 0 14.5155 0 0 13.9917 0 14.1403 0 0 0 0 10.9145 0 0 0 0 13.5451 0 0 12.1231 12.6117 0 0 0 0 0 0 0 0 0 14.5594 11.9122 0 13.3792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7077 0 0 0 14.2546 0 12.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4533 0 0 0 0 11.0037 0 0 11.0787 0 0 0 11.9585 0 0 0 0 0 0 0 0 0 0 O75290 Z780A_HUMAN Zinc finger protein 780A ZNF780A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRLYLQLSQHQKTHTGEK 0.95035 2.8223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0206 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2489 11.3124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3803 13.4333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8863 0 0 0 0 0 0 0 0 0 0 0 0 11.9682 0 0 0 0 0 0 0 0 15.2308 0 0 0 0 Q8WU39 MZB1_HUMAN "Marginal zone B- and B1-cell-specific protein (Mesenteric estrogen-dependent adipose 7, MEDA-7) (Plasma cell-induced resident endoplasmic reticulum protein, Plasma cell-induced resident ER protein, pERp1) (Proapoptotic caspase adapter protein)" MZB1 MEDA7 PACAP HSPC190 Homo sapiens (Human) apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; apoptotic process [GO:0006915]; integrin activation [GO:0033622]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; regulation of B cell proliferation [GO:0030888]; regulation of cell population proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626] GO:0002639; GO:0005576; GO:0005737; GO:0005788; GO:0006915; GO:0008284; GO:0030888; GO:0033622; GO:0034663; GO:0042127; GO:0046626 LHTSNSGGR 0.95035 0.80695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWU7 ITLN2_HUMAN Intelectin-2 (Endothelial lectin HL-2) ITLN2 UNQ2789/PRO7179 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492] GO:0005615; GO:0046872; GO:0070492 metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492] ADYPEGDGNWANYNTFGSAEAATSDDYK 0.95036 0.80675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8392 0 12.1893 0 0 0 0 Q9NP98 MYOZ1_HUMAN "Myozenin-1 (Calsarcin-2) (Filamin-, actinin- and telethonin-binding protein) (Protein FATZ)" MYOZ1 MYOZ Homo sapiens (Human) myofibril assembly [GO:0030239]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of skeletal muscle tissue regeneration [GO:0043417]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sarcomere organization [GO:0045214]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle tissue development [GO:0007519]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; nucleus [GO:0005634]; pseudopodium [GO:0031143]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; nucleus [GO:0005634]; pseudopodium [GO:0031143]; Z disc [GO:0030018]; actin binding [GO:0003779]; FATZ binding [GO:0051373]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; telethonin binding [GO:0031433]; myofibril assembly [GO:0030239]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of skeletal muscle tissue regeneration [GO:0043417]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sarcomere organization [GO:0045214]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle tissue development [GO:0007519]; wound healing [GO:0042060] GO:0000122; GO:0003779; GO:0004865; GO:0005634; GO:0007519; GO:0015629; GO:0030018; GO:0030239; GO:0031143; GO:0031433; GO:0042060; GO:0043417; GO:0043503; GO:0045214; GO:0051373; GO:0070885 actin binding [GO:0003779]; FATZ binding [GO:0051373]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; telethonin binding [GO:0031433] DVMLEELSLLTNRGSKMFK 0.95039 2.459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3511 0 16.2455 0 0 0 0 0 0 0 0 13.2604 11.1089 11.0986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6538 0 0 0 0 0 0 0 0 0 0 0 Q9NPY3 C1QR1_HUMAN "Complement component C1q receptor (C1q/MBL/SPA receptor, C1qR, C1qR(p), C1qRp) (CDw93) (Complement component 1 q subcomponent receptor 1) (Matrix-remodeling-associated protein 4) (CD antigen CD93)" CD93 C1QR1 MXRA4 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909] cell surface [GO:0009986]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; signaling receptor activity [GO:0038023]; cell-cell adhesion [GO:0098609]; macrophage activation [GO:0042116]; phagocytosis [GO:0006909] GO:0001849; GO:0005509; GO:0005886; GO:0006909; GO:0009986; GO:0016021; GO:0030246; GO:0030667; GO:0035579; GO:0038023; GO:0042116; GO:0070821; GO:0098609; GO:0101003 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; signaling receptor activity [GO:0038023] AMENQYSPTPGTDC 0.95041 4.6382 0 0 0 0 0 0 10.9053 0 0 0 0 0 0 0 0 0 0 0 0 12.9381 0 0 0 12.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5431 0 0 0 0 0 0 0 0 0 0 14.0845 14.6117 0 0 0 0 15.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6909 0 0 0 12.5822 14.1822 14.0004 0 0 0 14.5645 0 11.9041 0 0 0 12.7771 0 0 0 0 13.6436 0 0 0 0 0 12.8403 0 12.3394 0 0 0 0 0 0 0 0 0 0 12.6496 12.3998 0 0 0 13.9455 0 0 0 0 0 0 0 0 13.6952 0 0 0 0 0 0 0 12.2959 0 0 0 0 0 0 0 0 12.2248 0 0 0 0 12.4512 12.8453 0 0 0 0 13.0954 0 0 0 0 0 0 0 0 0 P78333 GPC5_HUMAN Glypican-5 [Cleaved into: Secreted glypican-5 ] GPC5 Homo sapiens (Human) cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; cell migration [GO:0016477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of protein localization to membrane [GO:1905475] GO:0005576; GO:0005615; GO:0005796; GO:0005886; GO:0009986; GO:0016021; GO:0016477; GO:0043202; GO:0046658; GO:0062023; GO:0090263; GO:1905475 CSFDQSKEKHGMK 0.95042 2.716 0 14.6631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5535 0 0 0 0 0 0 0 0 0 12.9845 0 0 0 0 0 0 0 0 16.2241 0 14.09 14.6509 0 0 0 0 14.8779 13.6247 0 13.6284 0 0 0 15.3123 0 14.9936 0 0 0 0 0 12.5475 15.115 0 0 0 0 13.0587 13.5445 0 0 0 0 0 0 0 0 0 0 13.2232 0 0 0 0 0 0 0 14.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4663 0 0 0 I3L3R5 CCER2_HUMAN Coiled-coil domain-containing glutamate-rich protein 2 CCER2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GPASELLLLRLLLLGAATAAPLAPR 0.95044 4.1382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4051 0 0 0 0 11.4943 0 10.1105 10.4615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5454 0 0 14.4148 11.3184 15.1571 13.0447 0 12.4912 14.1792 11.2586 15.3268 13.1972 0 12.3984 11.3426 0 13.1646 13.7202 14.6482 0 14.7037 9.64575 0 11.5153 11.1435 0 0 0 0 11.1923 12.2299 0 0 0 0 0 0 0 0 15.5522 14.087 11.8855 12.2131 14.5975 14.6672 0 0 0 0 13.1939 13.3918 0 14.7743 14.2005 12.5977 0 0 14.8853 0 0 0 0 0 13.4631 0 0 0 0 10.5841 0 0 0 0 0 0 0 0 0 0 14.1996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3587 0 12.5543 0 0 0 0 Q8NGX6 O10R2_HUMAN Olfactory receptor 10R2 (Olfactory receptor OR1-8) OR10R2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IPSAEGR 0.95045 0.83133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78396 CCNA1_HUMAN Cyclin-A1 CCNA1 Homo sapiens (Human) cell division [GO:0051301]; male meiosis I [GO:0007141]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283] cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; male meiosis I [GO:0007141]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283] GO:0000079; GO:0000307; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007141; GO:0007283; GO:0015630; GO:0016538; GO:0044772; GO:0051301; GO:0097123; GO:0097124 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] CYSGSENAFPPAGK 0.95046 0.79998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6078 0 0 0 0 0 12.2196 0 15.1839 0 0 14.2597 0 0 0 0 0 0 0 0 0 0 0 0 11.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07820 MCL1_HUMAN "Induced myeloid leukemia cell differentiation protein Mcl-1 (Bcl-2-like protein 3, Bcl2-L-3) (Bcl-2-related protein EAT/mcl1) (mcl1/EAT)" MCL1 BCL2L3 Homo sapiens (Human) cell fate determination [GO:0001709]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; regulation of apoptotic process [GO:0042981]; regulation of response to DNA damage stimulus [GO:2001020]; response to cytokine [GO:0034097] Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; BH3 domain binding [GO:0051434]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein transmembrane transporter activity [GO:0008320]; cell fate determination [GO:0001709]; cellular homeostasis [GO:0019725]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; regulation of apoptotic process [GO:0042981]; regulation of response to DNA damage stimulus [GO:2001020]; response to cytokine [GO:0034097] GO:0001709; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0008320; GO:0008630; GO:0010507; GO:0016020; GO:0016021; GO:0019725; GO:0034097; GO:0042803; GO:0042981; GO:0043065; GO:0043066; GO:0046982; GO:0051434; GO:0097136; GO:0097192; GO:1903378; GO:2000811; GO:2001020; GO:2001240; GO:2001243 BH3 domain binding [GO:0051434]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein transmembrane transporter activity [GO:0008320] NVLLAFAGVAGVGAGLAYLIR 0.95046 0.83133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGT9 OR2A1_HUMAN Olfactory receptor 2A1/2A42 (Olfactory receptor OR7-16) (Olfactory receptor OR7-19) OR2A1; OR2A42 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] HPEEQQK 0.95048 0.83133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5289 0 0 0 14.2814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10451 OSTP_HUMAN "Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1, SPP-1) (Urinary stone protein) (Uropontin)" SPP1 BNSP OPN PSEC0156 Homo sapiens (Human) "androgen catabolic process [GO:0006710]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to testosterone stimulus [GO:0071394]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; negative regulation of collateral sprouting of intact axon in response to injury [GO:0048685]; osteoblast differentiation [GO:0001649]; positive regulation of bone resorption [GO:0045780]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of transcription, DNA-templated [GO:0045893]; response to steroid hormone [GO:0048545]; response to vitamin D [GO:0033280]" cell projection [GO:0042995]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] "cell projection [GO:0042995]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; androgen catabolic process [GO:0006710]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to testosterone stimulus [GO:0071394]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; negative regulation of collateral sprouting of intact axon in response to injury [GO:0048685]; osteoblast differentiation [GO:0001649]; positive regulation of bone resorption [GO:0045780]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of transcription, DNA-templated [GO:0045893]; response to steroid hormone [GO:0048545]; response to vitamin D [GO:0033280]" GO:0001649; GO:0005125; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0006710; GO:0006954; GO:0007155; GO:0007566; GO:0031214; GO:0033280; GO:0042995; GO:0045780; GO:0045893; GO:0046697; GO:0048471; GO:0048545; GO:0048685; GO:0050840; GO:0070062; GO:0071394; GO:2000866 cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178] DSYETSQLDDQSAETHSHKQSR 0.9505 0.80829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UD1 OAF_HUMAN Out at first protein homolog (HCV NS5A-transactivated protein 13 target protein 2) OAF NS5ATP13TP2 Homo sapiens (Human) DVKVFRALILGELEK 0.95052 3.9762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3246 0 0 0 0 0 0 0 0 0 11.194 0 0 0 0 0 0 0 10.9319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2001 0 12.8828 0 0 0 0 0 0 14.0064 0 0 0 0 0 0 0 0 14.8367 13.8925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1864 0 0 0 14.1759 14.0746 0 0 13.9393 0 0 0 0 0 0 13.0433 0 0 0 0 0 0 0 0 0 0 0 0 14.1059 0 0 12.2122 0 0 Q8WTX7 CAST1_HUMAN Cytosolic arginine sensor for mTORC1 subunit 1 (Cellular arginine sensor for mTORC1 protein 1) (GATS-like protein 3) CASTOR1 GATSL3 Homo sapiens (Human) cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] cytosol [GO:0005829] cytosol [GO:0005829]; arginine binding [GO:0034618]; identical protein binding [GO:0042802]; protein sequestering activity [GO:0140311]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] GO:0005829; GO:0034618; GO:0042802; GO:0140311; GO:1902531; GO:1903577; GO:1904262 arginine binding [GO:0034618]; identical protein binding [GO:0042802]; protein sequestering activity [GO:0140311] EAASSSPEPSSITFFAFSLIEGYISIVMDAETQK 0.95052 3.6092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P39060 COIA1_HUMAN "Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin; Non-collagenous domain 1, NC1 ]" COL18A1 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; visual perception [GO:0007601] GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0007601; GO:0008285; GO:0009887; GO:0030198; GO:0031012; GO:0042802; GO:0046872; GO:0062023; GO:0070062 extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR 0.95053 2.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6665 0 0 0 0 11.6234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9277 0 0 0 14.5976 0 0 0 0 0 0 0 0 0 0 0 12.676 0 14.3573 12.7058 0 0 0 0 0 0 0 0 0 0 0 13.4755 0 0 0 0 13.7066 14.0229 15.1492 0 14.4683 0 0 0 0 0 0 0 14.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4615 0 0 0 0 0 13.6424 0 0 O00206 TLR4_HUMAN Toll-like receptor 4 (hToll) (CD antigen CD284) TLR4 Homo sapiens (Human) activation of innate immune response [GO:0002218]; astrocyte development [GO:0014002]; B cell proliferation involved in immune response [GO:0002322]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; detection of fungus [GO:0016046]; detection of lipopolysaccharide [GO:0032497]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation [GO:0042116]; MHC class II biosynthetic process [GO:0045342]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; phagocytosis [GO:0006909]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of platelet activation [GO:0010572]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of dendritic cell cytokine production [GO:0002730]; response to lipopolysaccharide [GO:0032496]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; wound healing involved in inflammatory response [GO:0002246] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; activation of innate immune response [GO:0002218]; astrocyte development [GO:0014002]; B cell proliferation involved in immune response [GO:0002322]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; detection of fungus [GO:0016046]; detection of lipopolysaccharide [GO:0032497]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation [GO:0042116]; MHC class II biosynthetic process [GO:0045342]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-23 production [GO:0032707]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide production involved in inflammatory response [GO:0002537]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; phagocytosis [GO:0006909]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of platelet activation [GO:0010572]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of dendritic cell cytokine production [GO:0002730]; response to lipopolysaccharide [GO:0032496]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; wound healing involved in inflammatory response [GO:0002246]" GO:0001530; GO:0001540; GO:0001726; GO:0001875; GO:0001891; GO:0002218; GO:0002224; GO:0002246; GO:0002322; GO:0002537; GO:0002730; GO:0002755; GO:0004888; GO:0005102; GO:0005737; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006809; GO:0006909; GO:0006954; GO:0006955; GO:0007252; GO:0007254; GO:0009897; GO:0009986; GO:0010008; GO:0010572; GO:0010628; GO:0014002; GO:0014911; GO:0016046; GO:0030890; GO:0031226; GO:0031663; GO:0032496; GO:0032497; GO:0032689; GO:0032700; GO:0032707; GO:0032715; GO:0032720; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032731; GO:0032732; GO:0032733; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034142; GO:0035666; GO:0036120; GO:0038023; GO:0042088; GO:0042116; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043406; GO:0045087; GO:0045342; GO:0045348; GO:0045429; GO:0045671; GO:0045944; GO:0046330; GO:0046696; GO:0046982; GO:0048471; GO:0048661; GO:0050135; GO:0050729; GO:0050829; GO:0051092; GO:0051770; GO:0060729; GO:0060907; GO:0061809; GO:0070371; GO:0070373; GO:0070374; GO:0070427; GO:0070430; GO:0070431; GO:0070434; GO:0071222; GO:0071223; GO:0071260; GO:0071346; GO:0120163; GO:0140052; GO:1900017; GO:1900227; GO:1901224; GO:1903223; GO:1903428; GO:1903974; GO:1904466; GO:1904646; GO:2000343 "amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]" AGIIFIVLQKVEKTLLR 0.95056 2.7901 0 0 0 0 0 0 13.0487 0 0 0 0 0 0 0 10.5999 0 11.9304 0 0 0 0 13.2058 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0223 0 0 0 0 0 0 0 10.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3403 12.2764 0 12.5657 13.9938 0 14.113 0 14.3532 14.7177 0 0 13.5593 14.0547 11.5364 0 15.3619 14.9507 0 16.5403 16.5696 13.6563 15.1786 0 14.8935 13.3287 15.3218 14.565 12.7568 14.0288 0 0 0 15.6466 14.842 0 13.3699 0 13.5171 14.4136 0 13.1508 14.366 15.1781 14.3531 11.1152 14.9157 0 15.4712 14.3316 14.6304 0 14.0192 14.2296 13.2072 13.6413 0 0 12.7525 0 0 0 14.7273 14.3371 0 13.8948 14.1547 0 12.6887 0 0 0 14.2516 13.6254 0 12.9465 12.4336 13.4828 14.0137 12.7502 0 12.13 0 0 13.7433 13.2035 0 14.5637 12.3398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9263 0 0 12.0377 13.1233 0 0 O43927 CXL13_HUMAN "C-X-C motif chemokine 13 (Angie) (B cell-attracting chemokine 1, BCA-1) (B lymphocyte chemoattractant) (CXC chemokine BLC) (Small-inducible cytokine B13)" CXCL13 BCA1 BLC SCYB13 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; B cell chemotaxis [GO:0035754]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; endothelial cell chemotaxis to fibroblast growth factor [GO:0035768]; germinal center formation [GO:0002467]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis across high endothelial venule [GO:0002518]; negative regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000545]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of integrin activation [GO:0033625]; positive regulation of T cell chemotaxis [GO:0010820]; regulation of angiogenesis [GO:0045765]; regulation of humoral immune response [GO:0002920] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR10 chemokine receptor binding [GO:0031735]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR5 chemokine receptor binding [GO:0031724]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; receptor ligand activity [GO:0048018]; activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; B cell chemotaxis [GO:0035754]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; endothelial cell chemotaxis to fibroblast growth factor [GO:0035768]; germinal center formation [GO:0002467]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis across high endothelial venule [GO:0002518]; negative regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000545]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of integrin activation [GO:0033625]; positive regulation of T cell chemotaxis [GO:0010820]; regulation of angiogenesis [GO:0045765]; regulation of humoral immune response [GO:0002920] GO:0002467; GO:0002518; GO:0002544; GO:0002920; GO:0005576; GO:0005615; GO:0006954; GO:0006955; GO:0007166; GO:0007204; GO:0007267; GO:0008009; GO:0008201; GO:0010820; GO:0017134; GO:0030593; GO:0031640; GO:0031724; GO:0031735; GO:0033625; GO:0033634; GO:0035754; GO:0035768; GO:0042742; GO:0045236; GO:0045765; GO:0048018; GO:0048248; GO:0061844; GO:0070098; GO:0071222; GO:0090630; GO:2000545 CCR10 chemokine receptor binding [GO:0031735]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR5 chemokine receptor binding [GO:0031724]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; receptor ligand activity [GO:0048018] KRSSSTLPVPVFK 0.95058 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75452 RDH16_HUMAN "Retinol dehydrogenase 16, EC 1.1.1.105, EC 1.1.1.209, EC 1.1.1.315, EC 1.1.1.53 (Human epidermal retinol dehydrogenase, hRDH-E) (Microsomal NAD(+)-dependent retinol dehydrogenase 4, RoDH-4) (Short chain dehydrogenase/reductase family 9C member 8) (Sterol/retinol dehydrogenase)" RDH16 RODH4 SDR9C8 Homo sapiens (Human) lipid metabolic process [GO:0006629]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; lipid metabolic process [GO:0006629]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]" GO:0004745; GO:0005789; GO:0006629; GO:0008202; GO:0009055; GO:0016021; GO:0016229; GO:0016491; GO:0042572; GO:0042802; GO:0043231; GO:0047023; GO:0047044 "androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]" ERQVLSHLR 0.95058 0.81458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.03138 0 0 0 0 14.402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.127 0 0 0 0 0 0 0 11.9889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3772 0 0 0 0 0 0 0 0 0 0 0 0 12.862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3564 0 0 0 0 0 0 13.0677 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC21 ZN596_HUMAN Zinc finger protein 596 ZNF596 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EITLECRVCGKTFSK 0.95058 0.80706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6B9 EPHX3_HUMAN "Epoxide hydrolase 3, EH3, EC 3.3.2.10 (Abhydrolase domain-containing protein 9)" EPHX3 ABHD9 Homo sapiens (Human) epoxide metabolic process [GO:0097176]; lipid metabolic process [GO:0006629] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; epoxide metabolic process [GO:0097176]; lipid metabolic process [GO:0006629] GO:0004301; GO:0005783; GO:0006629; GO:0016020; GO:0016021; GO:0016787; GO:0043231; GO:0097176 epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787] DTYLELGLVEAIGSR 0.95059 3.8175 0 0 0 0 0 0 0 0 0 13.1141 0 12.6566 12.4182 12.4138 12.2704 0 11.9868 12.5084 0 0 0 11.9524 0 0 0 0 0 0 13.4128 12.6498 12.6585 12.1075 13.1705 0 0 12.4048 12.1321 12.0406 0 0 0 0 12.5226 0 0 0 12.03 0 0 0 0 0 0 0 0 0 0 0 13.5025 13.423 0 14.3704 14.3788 0 13.6087 11.4095 12.9959 11.9114 0 0 0 0 0 0 0 15.2954 16.4398 0 0 15.3174 0 0 0 0 0 0 0 0 0 0 12.877 12.2419 0 12.853 0 13.6578 0 14.4557 0 0 0 0 0 0 0 0 13.7165 0 0 14.2189 14.4007 0 0 0 13.5489 0 0 15.5867 13.8895 0 13.9509 0 12.6419 0 0 12.6253 11.7344 0 0 0 14.2715 0 0 0 0 13.669 16.1544 15.4998 0 0 15.9605 15.2128 15.2695 15.492 13.551 0 0 14.7187 0 0 0 0 0 0 0 15.4434 0 15.4879 14.4717 15.6349 0 14.4344 14.4893 0 0 0 14.3576 14.8543 15.3356 14.6964 14.6121 0 0 0 0 11.6271 13.2584 0 13.7536 0 Q9H343 O51I1_HUMAN Olfactory receptor 51I1 (Odorant receptor HOR5'beta11) (Olfactory receptor OR11-39) OR51I1 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FWKSAPPVVHVMMSNVYLFVPPMLNPIIYSVKTK 0.9506 0.81374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4856 0 0 0 0 0 0 0 12.8702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15328 FOLR1_HUMAN "Folate receptor alpha, FR-alpha (Adult folate-binding protein, FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18)" FOLR1 FOLR Homo sapiens (Human) anterior neural tube closure [GO:0061713]; axon regeneration [GO:0031103]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell adhesion [GO:0007155]; cellular response to folic acid [GO:0071231]; folate import across plasma membrane [GO:1904447]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heart looping [GO:0001947]; neural crest cell migration involved in heart formation [GO:0003147]; pharyngeal arch artery morphogenesis [GO:0061626]; receptor-mediated endocytosis [GO:0006898]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; sperm-egg recognition [GO:0035036] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023]; anterior neural tube closure [GO:0061713]; axon regeneration [GO:0031103]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell adhesion [GO:0007155]; cellular response to folic acid [GO:0071231]; folate import across plasma membrane [GO:1904447]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heart looping [GO:0001947]; neural crest cell migration involved in heart formation [GO:0003147]; pharyngeal arch artery morphogenesis [GO:0061626]; receptor-mediated endocytosis [GO:0006898]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; sperm-egg recognition [GO:0035036] GO:0000139; GO:0001947; GO:0003147; GO:0003253; GO:0005542; GO:0005634; GO:0005768; GO:0005789; GO:0005886; GO:0006898; GO:0007155; GO:0007342; GO:0009986; GO:0012507; GO:0015884; GO:0016020; GO:0016323; GO:0016324; GO:0017015; GO:0030133; GO:0030136; GO:0031103; GO:0031362; GO:0031526; GO:0033116; GO:0035036; GO:0038023; GO:0046655; GO:0060828; GO:0061626; GO:0061713; GO:0061714; GO:0070062; GO:0071231; GO:1904447 folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023] DVSYLYRFNWNHCGEMAPACK 0.95062 4.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4741 0 0 0 0 11.2689 11.4864 0 0 0 0 0 0 0 0 0 0 0 11.1932 0 0 0 0 0 0 0 0 0 0 11.6745 11.2044 0 0 0 0 13.0758 0 0 13.3099 12.6589 0 12.65 0 11.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5289 0 0 0 0 0 0 0 0 0 11.7918 0 0 0 0 0 0 0 0 0 0 0 11.0064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5707 0 0 0 0 0 0 0 0 12.9924 0 0 13.8154 0 0 0 0 0 0 0 0 0 0 11.4054 0 0 0 12.4591 0 0 12.3955 0 0 0 0 0 0 0 0 0 15.4633 Q9P2X3 IMPCT_HUMAN Protein IMPACT (Imprinted and ancient gene protein homolog) IMPACT Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; GCN2-mediated signaling [GO:0140469]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; polysome [GO:0005844] cytoplasm [GO:0005737]; polysome [GO:0005844]; actin binding [GO:0003779]; ribosome binding [GO:0043022]; cellular response to acidic pH [GO:0071468]; cellular response to amino acid starvation [GO:0034198]; cellular response to benomyl [GO:0072755]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to leucine starvation [GO:1990253]; cellular response to UV-C [GO:0071494]; GCN2-mediated signaling [GO:0140469]; negative regulation of cell death [GO:0060548]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of translational initiation in response to starvation [GO:0071264]; regulation of translational initiation [GO:0006446] GO:0000122; GO:0001933; GO:0003779; GO:0005737; GO:0005844; GO:0006446; GO:0031333; GO:0031953; GO:0034198; GO:0042149; GO:0043022; GO:0045666; GO:0060548; GO:0070301; GO:0071264; GO:0071468; GO:0071494; GO:0072755; GO:0097201; GO:0140469; GO:1990138; GO:1990253 actin binding [GO:0003779]; ribosome binding [GO:0043022] LLHLMEILNVK 0.95065 0.83363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1087 0 0 0 Q9Y691 KCMB2_HUMAN "Calcium-activated potassium channel subunit beta-2 (BK channel subunit beta-2, BKbeta2, Hbeta2) (Calcium-activated potassium channel, subfamily M subunit beta-2) (Charybdotoxin receptor subunit beta-2) (Hbeta3) (K(VCA)beta-2) (Maxi K channel subunit beta-2) (Slo-beta-2)" KCNMB2 Homo sapiens (Human) action potential [GO:0001508]; detection of calcium ion [GO:0005513]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of vasoconstriction [GO:0019229] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium-activated potassium channel activity [GO:0015269]; ion channel inhibitor activity [GO:0008200]; potassium channel regulator activity [GO:0015459]; action potential [GO:0001508]; detection of calcium ion [GO:0005513]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of vasoconstriction [GO:0019229] GO:0001508; GO:0005513; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0008200; GO:0015269; GO:0015459; GO:0019228; GO:0019229 calcium-activated potassium channel activity [GO:0015269]; ion channel inhibitor activity [GO:0008200]; potassium channel regulator activity [GO:0015459] LLLYHTEETIK 0.95067 0.83348 0 0 0 0 0 0 12.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGB8 O4F15_HUMAN Olfactory receptor 4F15 (Olfactory receptor OR15-14) OR4F15 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] YLAIFDAFITPFLNPVIYTFR 0.95068 0.83133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0736 14.7855 0 0 14.2652 0 14.9956 0 0 0 0 14.4271 0 0 14.115 0 0 0 0 0 0 15.3785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1794 0 0 0 0 Q9NZJ6 COQ3_HUMAN "Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase, EC 2.1.1.64) (Polyprenyldihydroxybenzoate methyltransferase, EC 2.1.1.114)" COQ3 UG0215E05 Homo sapiens (Human) glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142] "extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142]; 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinol-10 3-O-methyltransferase activity [GO:0044596]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; decaprenyldihydroxybenzoate methyltransferase activity [GO:0044595]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; methyltransferase activity [GO:0008168]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744]" GO:0004395; GO:0005739; GO:0005743; GO:0005759; GO:0006071; GO:0006744; GO:0008168; GO:0008171; GO:0008425; GO:0008689; GO:0010795; GO:0031314; GO:0032259; GO:0044595; GO:0044596; GO:0110142 "2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinol-10 3-O-methyltransferase activity [GO:0044596]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; decaprenyldihydroxybenzoate methyltransferase activity [GO:0044595]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; methyltransferase activity [GO:0008168]; O-methyltransferase activity [GO:0008171]" PGVFNEYRTIWFKSYR 0.95069 0.80001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7218 0 0 0 0 0 0 0 0 0 0 0 0 13.2458 0 0 0 0 0 0 0 0 0 0 0 0 13.0694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGK5 O52M1_HUMAN Olfactory receptor 52M1 (Olfactory receptor OR11-11) OR52M1 OR52M1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FGQCVPPPVHTLLANFYLLIPPILNPIVYAVRTK 0.9507 3.8168 0 0 0 0 0 0 0 11.9647 0 12.0455 0 12.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.514 11.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0207 0 0 14.2473 13.2982 0 0 0 0 0 0 0 0 12.9682 0 0 13.3903 0 0 0 0 12.2737 0 0 0 0 0 12.7496 0 14.0856 0 0 0 0 13.6042 14.1053 14.6727 0 0 0 0 0 0 14.2305 0 0 0 0 0 0 0 0 13.8951 0 0 0 0 13.4728 0 0 0 0 0 14.2041 13.4984 0 13.3421 0 0 0 13.172 0 13.5261 0 13.2488 13.9285 0 0 13.2716 0 0 0 0 0 0 0 12.6394 0 0 0 12.9848 0 0 0 0 0 0 0 0 0 0 13.3472 0 0 13.1063 0 0 P0DPH8 TBA3D_HUMAN Tubulin alpha-3D chain (Alpha-tubulin 3D) [Cleaved into: Detyrosinated tubulin alpha-3D chain ] TUBA3D Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0015630 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200] CDPRHGK 0.95071 0.83311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2335 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GV85 RELD1_HUMAN Reelin domain-containing protein 1 REELD1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RMQAALVGWACTTLCLASCSSAFSHGASTVACDDMQPK 0.95073 0.809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6751 0 0 0 0 0 15.3295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4842 15.6491 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4359 0 0 0 0 15.7718 0 0 0 0 0 0 14.7088 14.893 0 16.7563 0 0 0 16.8312 14.4529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4X1 RGCC_HUMAN "Regulator of cell cycle RGCC (Response gene to complement 32 protein, RGC-32)" RGCC C13orf15 RGC32 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to hypoxia [GO:0071456]; complement activation [GO:0006956]; fibroblast activation [GO:0072537]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cytokine production [GO:0001818]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of exit from mitosis [GO:0001100]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; cell cycle [GO:0007049]; cellular response to hypoxia [GO:0071456]; complement activation [GO:0006956]; fibroblast activation [GO:0072537]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cytokine production [GO:0001818]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of exit from mitosis [GO:0001100]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001100; GO:0001818; GO:0001819; GO:0001937; GO:0003331; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0006956; GO:0007049; GO:0008285; GO:0010628; GO:0010718; GO:0016525; GO:0019901; GO:0030295; GO:0032967; GO:0043537; GO:0045737; GO:0045840; GO:0045944; GO:0051091; GO:0051496; GO:0070412; GO:0071456; GO:0072537; GO:0090272; GO:1900087; GO:1901203; GO:1901991; GO:2000048; GO:2000353; GO:2000573 protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412] HFHYEEHLERMKR 0.95075 0.83624 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8708 0 0 0 0 0 0 0 0 0 0 15.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1263 0 0 11.721 0 0 0 0 0 0 0 0 11.8044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NVV3 NIPA3_HUMAN Magnesium transporter NIPA3 (NIPA-like protein 1) (Non-imprinted in Prader-Willi/Angelman syndrome region protein 3) NIPAL1 NIPA3 NPAL1 Homo sapiens (Human) magnesium ion transport [GO:0015693] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693] GO:0015095; GO:0015693; GO:0016020; GO:0016021 magnesium ion transmembrane transporter activity [GO:0015095] DPGFISFAVIITVISLVLILIVAPKK 0.95076 0.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7418 0 0 0 0 0 0 0 0 0 0 0 0 11.1375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4763 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5406 0 0 0 Q00577 PURA_HUMAN Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha) PURA PUR1 Homo sapiens (Human) cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357] "chromosome, telomeric region [GO:0000781]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]" "chromosome, telomeric region [GO:0000781]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded telomeric DNA binding [GO:0003691]; mRNA regulatory element binding translation repressor activity [GO:0000900]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription regulator inhibitor activity [GO:0140416]; cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000781; GO:0000900; GO:0000977; GO:0000981; GO:0003691; GO:0003697; GO:0003723; GO:0005634; GO:0006268; GO:0006270; GO:0006357; GO:0007399; GO:0008284; GO:0030154; GO:0032422; GO:0032839; GO:0043025; GO:0043433; GO:0046332; GO:0046651; GO:0050673; GO:0098794; GO:0098963; GO:0098978; GO:0140297; GO:0140416 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded telomeric DNA binding [GO:0003691]; mRNA regulatory element binding translation repressor activity [GO:0000900]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription regulator inhibitor activity [GO:0140416]" ALKSEFLVR 0.95077 2.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8054 0 0 0 0 0 0 0 0 0 0 0 0 14.8421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.59034 Q9HAV7 GRPE1_HUMAN "GrpE protein homolog 1, mitochondrial (HMGE) (Mt-GrpE#1)" GRPEL1 GREPEL1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]" "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]" GO:0000774; GO:0001405; GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0006457; GO:0006886; GO:0030150; GO:0042802; GO:0042803; GO:0051082; GO:0051087 adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082] LHGRTLRPALVGVVK 0.9508 2.8961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8287 0 0 0 0 0 0 0 10.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4313 0 0 0 0 0 0 0 0 0 0 0 0 0 11.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6308 13.7528 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9667 0 14.9649 0 12.0497 O00716 E2F3_HUMAN "Transcription factor E2F3, E2F-3" E2F3 KIAA0075 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; protein import into nucleus [GO:0006606]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000082; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0006606; GO:0008284; GO:0043565; GO:0045944; GO:0046983; GO:0070345; GO:0090575; GO:1905461; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AAEVLKVQKR 0.95081 0.81469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3223 0 14.3644 0 0 13.7873 14.2633 13.76 0 0 0 0 13.8474 0 0 0 0 13.2053 0 0 0 0 0 0 0 0 14.5261 0 0 0 0 0 0 13.2587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30301 MIP_HUMAN "Lens fiber major intrinsic protein (Aquaporin-0) (MIP26, MP26)" MIP AQP0 Homo sapiens (Human) gap junction-mediated intercellular transport [GO:1990349]; lens development in camera-type eye [GO:0002088]; positive regulation of cell adhesion [GO:0045785]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; visual perception [GO:0007601]; water transport [GO:0006833] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; structural constituent of eye lens [GO:0005212]; water channel activity [GO:0015250]; gap junction-mediated intercellular transport [GO:1990349]; lens development in camera-type eye [GO:0002088]; positive regulation of cell adhesion [GO:0045785]; protein homotetramerization [GO:0051289]; response to stimulus [GO:0050896]; visual perception [GO:0007601]; water transport [GO:0006833] GO:0002088; GO:0005212; GO:0005516; GO:0005783; GO:0005886; GO:0005887; GO:0005921; GO:0006833; GO:0007601; GO:0015250; GO:0016021; GO:0016324; GO:0045785; GO:0050896; GO:0051289; GO:1990349 calmodulin binding [GO:0005516]; structural constituent of eye lens [GO:0005212]; water channel activity [GO:0015250] SISERLSVLKGAK 0.95081 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWY4 SCUB1_HUMAN "Signal peptide, CUB and EGF-like domain-containing protein 1" SCUBE1 Homo sapiens (Human) adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165] GO:0005509; GO:0005615; GO:0005886; GO:0006954; GO:0007165; GO:0007512; GO:0007596; GO:0009791; GO:0009897; GO:0009986; GO:0019897; GO:0042802; GO:0045446; GO:0045880 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] CSCPVGFTLQPDGK 0.95082 4.6319 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2924 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.643 0 0 0 0 0 14.6077 13.8748 14.8688 0 0 0 14.7462 0 0 11.5218 12.0059 0 0 0 0 0 14.0414 0 0 0 0 0 0 0 0 0 0 0 0 14.2782 13.8699 14.2986 11.4721 0 0 15.7912 0 12.4885 0 0 10.4369 0 0 0 0 14.2152 0 0 0 0 0 0 0 12.1388 0 0 0 0 0 0 0 0 14.2364 0 0 13.9738 12.0798 0 0 12.0947 0 0 12.4626 11.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6DKJ4 NXN_HUMAN "Nucleoredoxin, EC 1.8.1.8" NXN NRX Homo sapiens (Human) cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; in utero embryonic development [GO:0001701]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; in utero embryonic development [GO:0001701]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] GO:0001701; GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359 thioredoxin-disulfide reductase activity [GO:0004791] QLIQPIAEKIIAK 0.95083 0.81389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3852 0 0 0 0 0 0 0 0 15.6265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SXZ7 TTLL9_HUMAN "Probable tubulin polyglutamylase TTLL9, EC 6.3.2.- (Tubulin--tyrosine ligase-like protein 9)" TTLL9 C20orf125 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] GO:0000226; GO:0005524; GO:0005737; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0030317; GO:0031514; GO:0036064; GO:0046872; GO:0070740 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] ISHFRNHYELTR 0.95085 0.78749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9966 12.6844 0 0 0 13.3154 13.7338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9817 0 0 0 0 0 0 12.5804 0 0 11.3404 0 0 14.8459 0 0 0 0 0 12.7325 0 0 0 12.8901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0297 0 0 0 0 0 12.586 13.9708 12.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6N2 TVBT1_HUMAN T cell receptor beta variable 20-1 TRBV20-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 LLLLLLLGPGSGLGAVVSQHPSR 0.95088 0.80067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5445 0 0 0 0 0 0 14.1691 0 0 0 0 0 0 14.1357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3125 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS18 GLRX2_HUMAN "Glutaredoxin-2, mitochondrial" GLRX2 GRX2 CGI-133 Homo sapiens (Human) "aging [GO:0007568]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to superoxide [GO:0071451]; DNA protection [GO:0042262]; glutathione metabolic process [GO:0006749]; regulation of signal transduction [GO:0009966]; regulation of transcription, DNA-templated [GO:0006355]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to redox state [GO:0051775]; response to temperature stimulus [GO:0009266]" dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; arsenate reductase (glutaredoxin) activity [GO:0008794]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; glutathione oxidoreductase activity [GO:0097573]; metal ion binding [GO:0046872]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; aging [GO:0007568]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; cellular response to superoxide [GO:0071451]; DNA protection [GO:0042262]; glutathione metabolic process [GO:0006749]; regulation of signal transduction [GO:0009966]; regulation of transcription, DNA-templated [GO:0006355]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to redox state [GO:0051775]; response to temperature stimulus [GO:0009266]" GO:0003756; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006355; GO:0006749; GO:0006915; GO:0007568; GO:0008794; GO:0009055; GO:0009266; GO:0009966; GO:0010033; GO:0015035; GO:0015038; GO:0030154; GO:0030425; GO:0042262; GO:0042542; GO:0043025; GO:0043231; GO:0045454; GO:0046872; GO:0051537; GO:0051775; GO:0071451; GO:0097573 "2 iron, 2 sulfur cluster binding [GO:0051537]; arsenate reductase (glutaredoxin) activity [GO:0008794]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; glutathione oxidoreductase activity [GO:0097573]; metal ion binding [GO:0046872]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]" LLPLVHQCYLK 0.95088 0.83363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9016 10.6735 13.2778 13.1195 12.9922 0 0 0 0 0 0 0 0 0 0 0 13.3768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTT0 AN32E_HUMAN "Acidic leucine-rich nuclear phosphoprotein 32 family member E (LANP-like protein, LANP-L)" ANP32E Homo sapiens (Human) histone exchange [GO:0043486]; regulation of apoptotic process [GO:0042981] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; phosphatase inhibitor activity [GO:0019212]; histone exchange [GO:0043486]; regulation of apoptotic process [GO:0042981] GO:0000812; GO:0005634; GO:0019212; GO:0031410; GO:0042393; GO:0042981; GO:0043486; GO:0140713 histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; phosphatase inhibitor activity [GO:0019212] CPNLTYLNLSGNK 0.95089 2.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55683 0 0 0 0 0 0 0 0 0 0 15.6626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.261 0 0 0 0 0 0 0 0 0 0 0 0 13.3022 0 0 0 0 0 0 0 0 0 0 13.3102 13.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ14 GGT7_HUMAN "Glutathione hydrolase 7, EC 3.4.19.13 (Gamma-glutamyltransferase 7, GGT 7, EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) [Cleaved into: Glutathione hydrolase 7 heavy chain; Glutathione hydrolase 7 light chain ]" GGT7 GGTL3 GGTL5 Homo sapiens (Human) glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883] GO:0005886; GO:0006750; GO:0006751; GO:0016021; GO:0036374; GO:0102953; GO:0103068; GO:1901750; GO:1902883 glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068] RTNNFIIAVKDPR 0.95089 0.78651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4Z2 NGN3_HUMAN "Neurogenin-3, NGN-3 (Class A basic helix-loop-helix protein 7, bHLHa7) (Protein atonal homolog 5)" NEUROG3 ATOH5 BHLHA7 NGN3 Homo sapiens (Human) "central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; epithelial cell differentiation [GO:0030855]; forebrain development [GO:0030900]; hindbrain development [GO:0030902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite morphogenesis [GO:0048814]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]; transdifferentiation [GO:0060290]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; central nervous system development [GO:0007417]; endocrine pancreas development [GO:0031018]; epithelial cell differentiation [GO:0030855]; forebrain development [GO:0030900]; hindbrain development [GO:0030902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dendrite morphogenesis [GO:0048814]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]; transdifferentiation [GO:0060290]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005737; GO:0006357; GO:0007399; GO:0007417; GO:0007422; GO:0021510; GO:0030182; GO:0030855; GO:0030900; GO:0030902; GO:0031018; GO:0031490; GO:0045666; GO:0045893; GO:0045944; GO:0046983; GO:0048814; GO:0060290 "chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LTKIETLR 0.95091 0.80067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5245 0 0 0 0 0 0 0 0 0 10.3908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C626 OR5G3_HUMAN Olfactory receptor 5G3 (Olfactory receptor 5G6) (Olfactory receptor OR11-213) OR5G3 OR5G3P OR5G6P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] VISLFYTVVIPMVNPLIYSLR 0.95092 0.83133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49640 EVX1_HUMAN Homeobox even-skipped homolog protein 1 (EVX-1) EVX1 Homo sapiens (Human) embryo development ending in birth or egg hatching [GO:0009792]; interneuron migration [GO:1904936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord interneuron axon guidance [GO:0097377] axon [GO:0030424]; chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "axon [GO:0030424]; chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryo development ending in birth or egg hatching [GO:0009792]; interneuron migration [GO:1904936]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord interneuron axon guidance [GO:0097377]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0009792; GO:0030424; GO:0043025; GO:0045944; GO:0097377; GO:1904936; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EFYRENYVSRPR 0.95092 0.80067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A7E2F4 GOG8A_HUMAN "Golgin subfamily A member 8A (88 kDa Golgi matrix protein, GM88) (GM88 autoantigen)" GOLGA8A KIAA0855 Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005794; GO:0005801; GO:0005829; GO:0007030; GO:0032580 GLGAPLPAETAHTQPSPNDR 0.95094 0.83311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4213 0 0 0 0 0 0 0 0 0 0 0 0 13.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTR0 NLRP9_HUMAN "NACHT, LRR and PYD domains-containing protein 9 (Nucleotide-binding oligomerization domain protein 6) (PYRIN and NACHT-containing protein 12)" NLRP9 NALP9 NOD6 PAN12 Homo sapiens (Human) defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-18 production [GO:0032741]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737]; inflammasome complex [GO:0061702] cytoplasm [GO:0005737]; inflammasome complex [GO:0061702]; ATP binding [GO:0005524]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-18 production [GO:0032741]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727] GO:0005524; GO:0005737; GO:0006954; GO:0032741; GO:0045087; GO:0050727; GO:0051607; GO:0061702; GO:0070269 ATP binding [GO:0005524] ALAQPVCKLRK 0.95098 0.79761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7945 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.793 0 0 0 0 0 0 0 0 0 0 13.0292 0 0 0 0 0 0 0 0 0 11.5886 0 0 0 0 0 0 0 0 0 12.2062 0 0 0 0 0 0 0 0 11.8521 0 12.5042 0 12.837 0 0 0 0 0 0 0 10.497 0 0 0 11.2307 0 0 0 0 0 0 0 0 0 0 0 0 10.6403 0 0 0 0 0 0 P50458 LHX2_HUMAN "LIM/homeobox protein Lhx2, Homeobox protein LH-2, LIM homeobox protein 2" LHX2 LH2 Homo sapiens (Human) "axon extension [GO:0048675]; axon guidance [GO:0007411]; cerebral cortex development [GO:0021987]; dorsal/ventral pattern formation [GO:0009953]; hair follicle development [GO:0001942]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm development [GO:0007498]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; telencephalon regionalization [GO:0021978]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cerebral cortex development [GO:0021987]; dorsal/ventral pattern formation [GO:0009953]; hair follicle development [GO:0001942]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm development [GO:0007498]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; olfactory bulb development [GO:0021772]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; telencephalon regionalization [GO:0021978]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001843; GO:0001942; GO:0003682; GO:0005634; GO:0006357; GO:0007411; GO:0007498; GO:0009953; GO:0021772; GO:0021978; GO:0021987; GO:0030182; GO:0045199; GO:0045814; GO:0045893; GO:0046872; GO:0048675; GO:0050768; GO:0060041; GO:2000179; GO:2000678 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DGSIYCKEDYYR 0.95099 0.83624 11.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN73 PCDA6_HUMAN "Protocadherin alpha-6, PCDH-alpha-6" PCDHA6 CNRS2 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005576; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] HRLLVLVK 0.951 2.7776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7214 0 0 0 0 0 10.8404 11.7942 0 0 0 0 0 0 0 13.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3776 0 12.249 13.2976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3822 12.97 0 0 12.4961 0 12.8779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZQ3 COMD5_HUMAN "COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein, HCaRG)" COMMD5 HT002 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005829 SAVGAATPYLHHPGDSHSGR 0.95102 0.83311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZQ3 SPN90_HUMAN "NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein, VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1, DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein, WISH) (Wiskott-Aldrich syndrome protein-interacting protein)" NCKIPSD AF3P21 SPIN90 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976] cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634] cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of neuron projection development [GO:0010976] GO:0005634; GO:0005829; GO:0005882; GO:0006897; GO:0007010; GO:0008092; GO:0010976; GO:0017124; GO:0071933 Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124] AAPTTPPPPVK 0.95103 3.9535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1414 14.7503 0 15.0912 15.2 15.952 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9195 11.6833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.894 0 13.1678 0 0 0 0 0 0 0 14.6322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBW8 CSN7A_HUMAN "COP9 signalosome complex subunit 7a, SGN7a, Signalosome subunit 7a (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a)" COPS7A CSN7A DERP10 Homo sapiens (Human) COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] GO:0000338; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008180; GO:0010387; GO:0045116; GO:2000434 CIPYAVLLEALALRNVRQLEDLVIEAVYADVLR 0.95105 2.8299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1716 0 0 0 0 0 0 0 0 13.7951 0 0 0 12.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.451 0 0 0 0 0 0 0 12.7879 11.623 0 0 0 0 0 0 0 0 0 13.5887 13.7037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRY7 PLS2_HUMAN "Phospholipid scramblase 2, PL scramblase 2 (Ca(2+)-dependent phospholipid scramblase 2)" PLSCR2 Homo sapiens (Human) plasma membrane phospholipid scrambling [GO:0017121] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phospholipid scramblase activity [GO:0017128]; plasma membrane phospholipid scrambling [GO:0017121] GO:0005509; GO:0005654; GO:0005783; GO:0005886; GO:0016021; GO:0017121; GO:0017128; GO:0043231 calcium ion binding [GO:0005509]; phospholipid scramblase activity [GO:0017128] EAFTDADNFGIQFPRDLDVKMK 0.95106 0.78822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.107 14.5033 12.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A286YEX9 SCGRX_HUMAN Small cysteine and glycine repeat-containing protein 10 (Keratin-associated protein 28 family pseudogene 2) SCYGR10 KRTAP28p2 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CSGGCGGGCGGGCGGGCGGGCGGCGGGCGSYTTCR 0.95107 2.9196 0 0 0 0 0 0 0 0 0 0 0 10.763 0 0 0 0 11.2732 0 0 0 0 0 0 11.9792 0 0 0 0 10.7196 0 0 0 0 0 0 0 0 10.1361 0 0 0 0 10.9446 0 0 0 0 0 0 0 0 0 11.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98142 0 0 0 0 0 0 0 0 0 0 13.0415 0 11.5013 11.8906 0 0 11.9428 0 0 0 0 0 0 12.2593 0 0 0 12.0645 0 0 0 0 12.7051 0 0 0 0 11.7735 0 0 11.254 12.2621 12.7255 13.8904 0 13.1278 0 0 13.007 13.8029 0 0 10.7201 12.5754 12.0984 0 10.88 0 0 0 0 0 0 0 0 0 0 11.2766 0 13.6753 0 13.1555 12.515 0 0 0 0 0 0 13.7195 0 0 11.3383 11.5932 0 11.0346 0 0 0 0 0 0 10.478 0 0 0 0 0 0 0 0 0 12.3827 0 0 0 0 0 0 O75467 Z324A_HUMAN Zinc finger protein 324A (Zinc finger protein ZF5128) ZNF324 ZNF324A Homo sapiens (Human) cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000082; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008283; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CSECGKAFSHGSNLSQHR 0.9511 0.80136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1412 12.0948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1184 0 0 0 13.562 0 0 0 13.4428 13.5155 0 0 0 0 0 13.4323 0 0 13.6047 14.4678 0 0 0 13.5182 13.1908 0 14.3046 0 0 14.6697 13.6098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9584 0 0 0 0 0 0 0 0 13.6789 0 0 14.4923 13.1554 0 0 12.5865 0 0 0 0 0 0 13.4246 0 0 0 0 0 0 0 0 0 14.798 12.8467 0 0 0 0 0 0 0 0 12.1735 0 0 0 12.1039 0 0 13.8402 0 0 0 0 0 0 0 0 Q6V9R5 ZN562_HUMAN Zinc finger protein 562 ZNF562 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNRSSTLTQHR 0.9511 0.78712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5834 11.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35225 IL13_HUMAN "Interleukin-13, IL-13" IL13 NC30 Homo sapiens (Human) cellular response to cytokine stimulus [GO:0071345]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; inflammatory response [GO:0006954]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung ciliated cell differentiation [GO:1901247]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of neuron death [GO:1901215]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of lung goblet cell differentiation [GO:1901251]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of pancreatic stellate cell proliferation [GO:2000231]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of proton transport [GO:0010155]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-13 receptor binding [GO:0005144]; cellular response to cytokine stimulus [GO:0071345]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; inflammatory response [GO:0006954]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung ciliated cell differentiation [GO:1901247]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of neuron death [GO:1901215]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of lung goblet cell differentiation [GO:1901251]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of pancreatic stellate cell proliferation [GO:2000231]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of proton transport [GO:0010155]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094] GO:0001774; GO:0002639; GO:0005125; GO:0005144; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0006955; GO:0009897; GO:0010155; GO:0010628; GO:0030890; GO:0032496; GO:0032723; GO:0032733; GO:0033861; GO:0035094; GO:0042116; GO:0042531; GO:0043032; GO:0043306; GO:0045471; GO:0048661; GO:0050714; GO:0050728; GO:0051281; GO:0071260; GO:0071345; GO:0071635; GO:0120162; GO:1901215; GO:1901247; GO:1901251; GO:1903660; GO:2000231; GO:2000352 cytokine activity [GO:0005125]; interleukin-13 receptor binding [GO:0005144] DLLLHLKKLFR 0.95111 0.80494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3059 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYQ2 KRA94_HUMAN Keratin-associated protein 9-4 (Keratin-associated protein 9.4) (Ultrahigh sulfur keratin-associated protein 9.4) KRTAP9-4 KAP9.4 KRTAP9.4 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTHCCSPCCQPTCCR 0.95111 0.80067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9194 11.0182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7787 0 0 0 O95704 APBB3_HUMAN "Amyloid-beta A4 precursor protein-binding family B member 3 (Protein Fe65-like 2, Fe65L2)" APBB3 FE65L2 Homo sapiens (Human) "positive regulation of protein secretion [GO:0050714]; regulation of transcription, DNA-templated [GO:0006355]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750]; positive regulation of protein secretion [GO:0050714]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0015629; GO:0016020; GO:0050714; GO:0050750 amyloid-beta binding [GO:0001540]; low-density lipoprotein particle receptor binding [GO:0050750] CHVFCCDVPAK 0.95112 0.83363 0 0 0 0 0 0 0 0 0 0 0 13.8087 0 0 12.6585 0 0 11.7754 0 0 0 0 0 0 0 0 0 12.8003 0 0 0 13.318 0 0 13.1349 0 0 0 0 13.5791 12.9251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4761 0 14.0707 12.9738 0 0 0 0 14.0022 0 12.4681 0 0 0 0 0 0 0 0 0 0 0 Q6GPH4 XAF1_HUMAN XIAP-associated factor 1 (BIRC4-binding protein) XAF1 BIRC4BP XIAPAF1 Homo sapiens (Human) apoptotic process [GO:0006915]; response to interferon-beta [GO:0035456] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; response to interferon-beta [GO:0035456] GO:0005654; GO:0005739; GO:0005829; GO:0006915; GO:0008270; GO:0035456 zinc ion binding [GO:0008270] EGDFSVCRNCKR 0.95113 0.80383 0 0 0 0 0 0 0 0 0 0 11.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3432 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6237 9.95819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2203 11.8078 0 0 14.2483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7403 12.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7219 0 0 0 0 12.0404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.237 0 11.1062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSV7 YF010_HUMAN Putative uncharacterized protein FLJ45177 Homo sapiens (Human) AVLQGLPHFSVNLGVQPSALAGR 0.95113 0.80067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01350 GAST_HUMAN "Gastrin [Cleaved into: Gastrin-71 (Gastrin component I); Gastrin-52, G52; Big gastrin (Gastrin component II) (Gastrin-34, G34); Gastrin (Gastrin component III) (Gastrin-17, G17); Gastrin-14, G14; Gastrin-6, G6 ]" GAST GAS Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; response to food [GO:0032094]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; G protein-coupled receptor signaling pathway [GO:0007186]; response to food [GO:0032094]; signal transduction [GO:0007165] GO:0005179; GO:0005576; GO:0005615; GO:0007165; GO:0007186; GO:0032094 hormone activity [GO:0005179] QLGPQGPPHLVADPSK 0.95115 0.83152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LI66 KRA62_HUMAN Keratin-associated protein 6-2 KRTAP6-2 KAP6.2 Homo sapiens (Human) keratinization [GO:0031424] cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882]; identical protein binding [GO:0042802]; keratinization [GO:0031424] GO:0005829; GO:0005882; GO:0031424; GO:0042802 identical protein binding [GO:0042802] CGSYYGNYYGDHGYGCCGYEGLGYGYGSLR 0.95122 4.203 0 0 0 0 0 0 0 10.6737 13.9196 0 0 0 0 13.449 0 14.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4007 0 0 0 0 0 12.7534 0 0 0 0 12.467 0 0 11.7737 0 12.3197 0 15.0554 0 14.4519 0 11.575 0 0 0 0 0 12.269 0 0 0 0 0 13.3146 0 0 15.0071 12.778 0 0 11.7675 0 0 0 11.6051 0 0 0 0 0 0 12.9591 0 0 12.253 10.3712 0 0 0 0 0 10.92 0 0 0 0 0 0 0 0 0 0 0 13.1854 0 0 0 0 14.6896 9.62309 0 0 0 0 0 0 0 14.1571 13.2886 14.3534 0 0 0 0 14.1219 0 0 0 13.8079 0 13.006 13.7787 0 0 0 0 11.5806 11.9382 13.1803 12.6625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0381 0 0 0 13.5092 13.5217 0 0 0 0 0 0 0 0 0 0 0 0 10.5049 Q9NWW9 PLAT2_HUMAN "Phospholipase A and acyltransferase 2, EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4 (HRAS-like suppressor 2)" PLAAT2 HRASLS2 Homo sapiens (Human) lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acyltransferase activity [GO:0016746]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152] GO:0004623; GO:0005737; GO:0005829; GO:0008970; GO:0016021; GO:0016042; GO:0016410; GO:0016746; GO:0036152; GO:0052739; GO:0052740; GO:0070292 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acyltransferase activity [GO:0016746]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] MALARPRPR 0.95125 0.81624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5456 0 13.7713 0 13.9851 0 0 12.8234 0 0 0 0 13.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7063 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9758 0 0 15.045 14.279 13.807 14.3632 0 0 0 0 13.5634 0 0 0 0 0 0 0 0 0 0 15.0902 0 14.6422 14.5297 0 14.0698 0 0 0 14.4381 14.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BR9 ZBT8A_HUMAN "Zinc finger and BTB domain-containing protein 8A (BTB/POZ and zinc-finger domain-containing factor) (BTB/POZ and zinc-finger domains factor on chromosome 1, BOZ-F1)" ZBTB8A BOZF1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000976; GO:0000977; GO:0001223; GO:0001227; GO:0005634; GO:0006357; GO:0046872; GO:0061629 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]" DSRWHLSEDENR 0.95127 0.81561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1036 0 0 13.2688 0 0 0 0 0 0 0 0 13.139 13.1232 13.004 0 0 11.6384 0 0 0 0 0 0 10.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8221 0 0 0 0 12.8198 0 0 0 0 0 0 0 0 0 0 0 0 12.4115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5MY95 ENTP8_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 8, E-NTPDase 8, NTPDase 8, NTPDase8, EC 3.6.1.5" ENTPD8 UNQ2492/PRO5779 Homo sapiens (Human) nucleoside diphosphate biosynthetic process [GO:0009133]; nucleoside diphosphate catabolic process [GO:0009134]; nucleoside monophosphate biosynthetic process [GO:0009124] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; guanosine-diphosphatase activity [GO:0004382]; metal ion binding [GO:0046872]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; nucleoside diphosphate biosynthetic process [GO:0009133]; nucleoside diphosphate catabolic process [GO:0009134]; nucleoside monophosphate biosynthetic process [GO:0009124] GO:0004382; GO:0005524; GO:0005886; GO:0009124; GO:0009133; GO:0009134; GO:0016020; GO:0016021; GO:0017110; GO:0017111; GO:0045134; GO:0046872; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; guanosine-diphosphatase activity [GO:0004382]; metal ion binding [GO:0046872]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134] EQVFLALLGASGVSGLTALILLLVEATSVLLPTDIK 0.95128 3.9375 12.4099 0 0 0 0 0 10.4894 0 0 0 0 0 0 0 0 11.1832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2408 0 12.2582 0 0 0 0 0 0 9.48182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3691 0 0 0 0 11.96 0 0 0 0 0 13.6389 0 0 0 0 0 0 0 13.7812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0893 0 14.0186 0 0 0 0 0 0 0 0 0 0 0 0 11.8191 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5653 0 0 12.4606 0 0 0 0 0 0 0 0 14.4747 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KP4 CNDP2_HUMAN "Cytosolic non-specific dipeptidase, EC 3.4.13.18 (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase)" CNDP2 CN2 CPGL HEL-S-13 PEPA Homo sapiens (Human) proteolysis [GO:0006508] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233]; proteolysis [GO:0006508] GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0016805; GO:0046872; GO:0070062; GO:0070573; GO:0103046 alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; peptidase activity [GO:0008233] AALTTLFKYIDENQDRYIK 0.95128 2.8248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2322 0 0 0 0 0 0 12.6847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVH2 INT7_HUMAN "Integrator complex subunit 7, Int7" INTS7 C1orf73 Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0000077; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0016180; GO:0016604; GO:0032039; GO:0034243; GO:0034472; GO:0071479 ALSVESK 0.95129 0.78829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3571 0 0 0 12.3475 0 12.0712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.301 0 0 0 0 0 0 0 0 0 11.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.342 0 0 0 0 0 0 0 14.0482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8128 0 0 0 17.687 0 0 0 0 A8MWA4 Z705E_HUMAN Putative zinc finger protein 705EP (zinc finger protein 705E pseudogene) ZNF705EP ZNF705E Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ESALKKTHMISMHPIIR 0.9513 0.83231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2222 0 0 0 0 0 0 0 0 0 0 14.3587 0 12.7516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01111 RASN_HUMAN "GTPase NRas, EC 3.6.5.2 (Transforming protein N-Ras)" NRAS HRAS1 Homo sapiens (Human) MAPK cascade [GO:0000165]; positive regulation of endothelial cell proliferation [GO:0001938]; Ras protein signal transduction [GO:0007265] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; MAPK cascade [GO:0000165]; positive regulation of endothelial cell proliferation [GO:0001938]; Ras protein signal transduction [GO:0007265] GO:0000139; GO:0000165; GO:0001938; GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0007265; GO:0016020; GO:0019003; GO:0044877; GO:0070062; GO:0070821 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877] LNSSDDGTQGCMGLPCVVM 0.95131 0.83192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02383 SEMG2_HUMAN "Semenogelin-2 (Semenogelin II, SGII)" SEMG2 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; coagulation [GO:0050817]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; antibacterial humoral response [GO:0019731]; coagulation [GO:0050817]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240] GO:0002020; GO:0005615; GO:0005634; GO:0008270; GO:0019731; GO:0048240; GO:0050817; GO:0070062; GO:1900005; GO:1901318 protease binding [GO:0002020]; zinc ion binding [GO:0008270] ENKISYQSSSTEER 0.95134 3.3189 0 0 0 0 0 0 0 0 13.722 12.838 0 0 0 12.9017 0 0 0 0 0 12.5611 0 0 13.1914 12.5509 0 0 12.3883 0 12.8334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.503 0 0 11.2613 0 12.9683 13.8894 11.6595 0 0 0 0 0 0 12.8586 0 0 0 0 0 14.5617 0 0 14.9742 15.632 0 14.9929 14.8841 0 0 0 0 0 0 16.0176 0 0 0 0 14.6315 0 11.3709 13.9719 0 11.0668 0 0 0 0 13.7255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7957 0 0 0 0 0 0 12.4461 0 0 0 0 0 0 0 0 0 0 0 0 13.2842 10.0788 0 0 0 0 12.7803 0 0 0 0 0 0 0 0 Q14677 EPN4_HUMAN "Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region, Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein, EpsinR)" CLINT1 ENTH EPN4 EPNR KIAA0171 Homo sapiens (Human) endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897] GO:0005543; GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0030125; GO:0030276; GO:0043231; GO:0045296; GO:0048471 cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] EDSPERCSDSDEEK 0.95134 0.805 0 0 0 0 0 0 0 9.28351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3283 0 11.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8445 0 0 0 0 0 0 0 0 11.3951 0 0 0 0 0 0 0 0 0 0 12.4317 0 0 0 0 13.0876 12.6998 14.704 0 12.6538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3491 14.5923 0 0 0 0 0 0 14.0607 0 0 0 0 0 0 13.5984 0 0 9.73052 12.9578 0 0 0 0 10.3601 0 0 0 0 0 0 0 0 0 0 0 0 11.976 0 0 0 0 0 12.8234 0 0 0 0 0 0 0 0 10.3405 0 0 0 0 0 0 0 0 0 14.328 11.8557 0 0 Q15776 ZKSC8_HUMAN Zinc finger protein with KRAB and SCAN domains 8 (LD5-1) (Zinc finger protein 192) ZKSCAN8 ZNF192 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DLLGRLERQR 0.95134 0.8341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2933 0 0 13.5926 16.3418 0 0 0 0 0 0 0 0 0 0 0 12.2896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.958 0 13.2592 11.6501 0 0 0 0 0 12.1469 0 0 0 0 0 0 0 0 0 0 0 0 0 O60883 G37L1_HUMAN "G-protein coupled receptor 37-like 1 (Endothelin B receptor-like protein 2, ETBR-LP-2)" GPR37L1 ETBRLP2 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; Bergmann glial cell differentiation [GO:0060020]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of MAPK cascade [GO:0043410]; smoothened signaling pathway [GO:0007224] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; Bergmann glial cell differentiation [GO:0060020]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of MAPK cascade [GO:0043410]; smoothened signaling pathway [GO:0007224] GO:0003085; GO:0004930; GO:0005886; GO:0007193; GO:0007224; GO:0008528; GO:0016021; GO:0021940; GO:0036505; GO:0042277; GO:0043235; GO:0043410; GO:0045665; GO:0045879; GO:0048712; GO:0060020; GO:0060170; GO:1903206 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505] FHVATSTLPKVRPIER 0.95137 2.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6974 0 0 0 0 0 0 0 0 10.7112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6Q5 HV364_HUMAN Immunoglobulin heavy variable 3-64 IGHV3-64 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] MMEFGLSWVFLVAIFK 0.95138 0.83152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92874 DNSL2_HUMAN "Deoxyribonuclease-1-like 2, EC 3.1.21.- (DNase I homolog protein DHP1) (Deoxyribonuclease I-like 2, DNase I-like 2)" DNASE1L2 DHP1 DNAS1L2 Homo sapiens (Human) "corneocyte development [GO:0003335]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA metabolic process [GO:0006259]; hair follicle development [GO:0001942]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; corneocyte development [GO:0003335]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA metabolic process [GO:0006259]; hair follicle development [GO:0001942]" GO:0000737; GO:0001942; GO:0003335; GO:0003677; GO:0004530; GO:0004536; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0006259; GO:0006308 calcium ion binding [GO:0005509]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677] DQYKEMYLFVYRK 0.95139 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N326 CJ111_HUMAN Putative uncharacterized protein RPP38-DT (RPP38 divergent transcript protein) RPP38-DT C10orf111 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LRNLDLLIYPWPELRR 0.9514 2.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1644 13.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9845 0 0 13.1679 13.025 0 0 0 0 0 0 14.2564 13.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4269 0 12.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H344 O51I2_HUMAN Olfactory receptor 51I2 (Odorant receptor HOR5'beta12) (Olfactory receptor OR11-38) OR51I2 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] RAIFRMFHHIK 0.95141 0.81004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6532 0 0 0 0 0 0 0 0 0 0 0 0 12.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N895 ZN366_HUMAN "Zinc finger protein 366 (Dendritic cell-specific transcript protein, DC-SCRIPT)" ZNF366 Homo sapiens (Human) negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627] GO:0000122; GO:0000978; GO:0003700; GO:0003714; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0030331; GO:0033147; GO:0043627; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor activity [GO:0003714] EDASKGEWEKR 0.95145 2.8226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9508 0 0 13.0895 0 0 0 O60927 PP1RB_HUMAN "E3 ubiquitin-protein ligase PPP1R11, EC 2.3.2.27 (Hemochromatosis candidate gene V protein, HCG V) (Protein phosphatase 1 regulatory subunit 11) (Protein phosphatase inhibitor 3)" PPP1R11 HCGV TCTE5 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine production [GO:0001818]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine production [GO:0001818]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001818; GO:0004865; GO:0005634; GO:0005737; GO:0006511; GO:0008157; GO:0032515; GO:0050830; GO:0061630 protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630] AFGESSTESDEEEEEGCGHTHCVR 0.95146 0.8179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 16.306 0 0 0 0 0 0 0 0 0 14.1328 12.9346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4354 0 0 0 0 0 0 0 19.3717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6845 0 0 0 0 0 0 0 0 0 11.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0913 0 0 14.3651 0 0 0 0 0 0 0 0 0 0 0 0 11.0393 0 0 0 0 0 0 0 11.2011 0 0 0 0 Q495N2 S36A3_HUMAN "Proton-coupled amino acid transporter 3, Proton/amino acid transporter 3 (Solute carrier family 36 member 3) (Tramdorin-2)" SLC36A3 PAT3 TRAMD2 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193]; amino acid transmembrane transport [GO:0003333]; glycine transport [GO:0015816]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proton transmembrane transport [GO:1902600] GO:0003333; GO:0005280; GO:0015179; GO:0015180; GO:0015187; GO:0015193; GO:0015808; GO:0015816; GO:0016021; GO:0035524; GO:1902600 amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193] FYMLIILPFLILLVFIQNLK 0.95146 0.83311 0 0 0 0 11.9864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3255 0 0 0 0 0 0 0 0 0 A6NFE3 EFC10_HUMAN EF-hand calcium-binding domain-containing protein 10 EFCAB10 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] PKEYLISLLERLR 0.95147 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3112 0 13.2249 0 0 0 0 0 0 0 13.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSB3 CB046_HUMAN Putative uncharacterized protein encoded by LINC00299 LINC00299 C2orf46 NCRNA00299 Homo sapiens (Human) CFLAVPDPLLGVQHWLHLWR 0.95147 0.83311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9145 0 14.5257 0 0 0 15.0943 0 0 0 14.7857 14.4316 0 14.4452 0 14.7254 0 0 14.8122 0 14.2763 0 14.586 0 14.6295 0 0 14.4988 0 0 14.7115 0 0 14.5269 0 0 0 14.437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD23 MRS2_HUMAN "Magnesium transporter MRS2 homolog, mitochondrial (MRS2-like protein)" MRS2 HPT MRS2L Homo sapiens (Human) magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; mitochondrial magnesium ion transmembrane transport [GO:0045016]; transmembrane transport [GO:0055085] GO:0005739; GO:0005743; GO:0015095; GO:0015693; GO:0016021; GO:0045016; GO:0055085 magnesium ion transmembrane transporter activity [GO:0015095] AMRLPRR 0.95147 0.81744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9962 13.5983 12.7119 0 0 0 0 17.0481 0 0 16.9533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8371 0 13.2207 16.6929 0 0 0 0 0 16.6937 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9755 0 0 0 11.2925 0 0 13.996 13.7894 13.8259 0 0 14.3824 0 14.31 0 14.5356 14.4808 14.7606 0 0 0 0 14.0524 0 0 14.8737 0 14.4852 19.0812 0 0 0 18.4235 0 0 14.8799 14.8394 18.8888 0 0 0 19.4629 19.2144 0 11.0405 0 0 14.4134 0 0 0 14.8856 0 0 0 0 0 14.8147 14.6439 0 0 14.4691 0 0 14.6055 0 0 0 14.118 14.6299 0 14.3558 0 14.4053 0 0 14.8833 0 0 15.374 13.6531 0 0 0 14.656 0 0 0 0 0 0 0 0 0 0 13.0405 15.3338 14.3321 0 14.578 0 0 0 19.0036 14.1454 10.7479 0 14.2705 14.01 13.6138 15.311 0 A0A1B0GV90 CTXD2_HUMAN Cortexin domain containing 2 CTXND2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GFAIAFVVLLFLFLIVMIFR 0.95148 0.83311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1548 0 0 13.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5087 0 0 0 0 0 13.7691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7263 0 14.56 0 0 0 0 0 13.8795 0 0 0 0 0 0 0 12.311 12.497 0 0 0 0 0 0 0 0 0 0 0 0 13.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4975 0 0 0 0 0 0 0 0 0 0 Q92466 DDB2_HUMAN "DNA damage-binding protein 2 (DDB p48 subunit, DDBb) (Damage-specific DNA-binding protein 2) (UV-damaged DNA-binding protein 2, UV-DDB 2)" DDB2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; nucleotide-excision repair [GO:0006289]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; UV-damage excision repair [GO:0070914] cell junction [GO:0030054]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734] cell junction [GO:0030054]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; nucleotide-excision repair [GO:0006289]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; UV-damage excision repair [GO:0070914] GO:0000209; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006290; GO:0006974; GO:0009411; GO:0030054; GO:0031464; GO:0031465; GO:0032991; GO:0034644; GO:0035518; GO:0044877; GO:0051865; GO:0070914; GO:0080008; GO:0090734 damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877] SPLELEPEAK 0.95148 0.817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82777 0 9.86459 0 0 0 0 0 0 10.6581 0 0 0 0 0 0 0 0 0 0 0 0 0 14.134 0 0 0 12.0904 0 0 0 0 0 0 0 9.96061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7157 0 0 0 0 0 12.3911 0 0 0 0 0 0 0 P25106 ACKR3_HUMAN "Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7, CXC-R7, CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog, RDC-1)" ACKR3 CMKOR1 CXCR7 GPR159 RDC1 Homo sapiens (Human) angiogenesis [GO:0001525]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; chemokine-mediated signaling pathway [GO:0070098]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; oculomotor nerve development [GO:0021557]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mesenchymal stem cell migration [GO:1905322]; receptor internalization [GO:0031623]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine binding [GO:0019958]; C-X-C chemokine receptor activity [GO:0016494]; coreceptor activity [GO:0015026]; scavenger receptor activity [GO:0005044]; angiogenesis [GO:0001525]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; chemokine-mediated signaling pathway [GO:0070098]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; oculomotor nerve development [GO:0021557]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mesenchymal stem cell migration [GO:1905322]; receptor internalization [GO:0031623]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0005044; GO:0005634; GO:0005768; GO:0005769; GO:0005886; GO:0005905; GO:0006955; GO:0007155; GO:0007204; GO:0008285; GO:0009897; GO:0009986; GO:0015026; GO:0016021; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0019958; GO:0021557; GO:0031623; GO:0043231; GO:0055037; GO:0060326; GO:0070098; GO:0070374; GO:1902230; GO:1905322 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine binding [GO:0019958]; C-X-C chemokine receptor activity [GO:0016494]; coreceptor activity [GO:0015026]; scavenger receptor activity [GO:0005044] NYRYELMKAFIFK 0.95149 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1193 0 0 0 0 0 0 0 0 P21741 MK_HUMAN "Midkine, MK (Amphiregulin-associated protein, ARAP) (Midgestation and kidney protein) (Neurite outgrowth-promoting factor 2) (Neurite outgrowth-promoting protein)" MDK MK1 NEGF2 Homo sapiens (Human) "adrenal gland development [GO:0030325]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cerebellar granular layer development [GO:0021681]; cerebral cortex development [GO:0021987]; cytoskeleton organization [GO:0007010]; defecation [GO:0030421]; dentate gyrus development [GO:0021542]; estrous cycle [GO:0044849]; glial cell projection elongation [GO:0106091]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion [GO:0007162]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of regulatory T cell differentiation [GO:0045590]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of behavior [GO:0050795]; regulation of bone remodeling [GO:0046850]; regulation of chondrocyte differentiation [GO:0032330]; response to auditory stimulus [GO:0010996]; response to glucocorticoid [GO:0051384]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; T cell activation involved in immune response [GO:0002286]; tissue regeneration [GO:0042246]" cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular region [GO:0005576] "cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; adrenal gland development [GO:0030325]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cerebellar granular layer development [GO:0021681]; cerebral cortex development [GO:0021987]; cytoskeleton organization [GO:0007010]; defecation [GO:0030421]; dentate gyrus development [GO:0021542]; estrous cycle [GO:0044849]; glial cell projection elongation [GO:0106091]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion [GO:0007162]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of regulatory T cell differentiation [GO:0045590]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of behavior [GO:0050795]; regulation of bone remodeling [GO:0046850]; regulation of chondrocyte differentiation [GO:0032330]; response to auditory stimulus [GO:0010996]; response to glucocorticoid [GO:0051384]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; T cell activation involved in immune response [GO:0002286]; tissue regeneration [GO:0042246]" GO:0001662; GO:0002232; GO:0002286; GO:0002690; GO:0005576; GO:0005737; GO:0007010; GO:0007162; GO:0007165; GO:0007399; GO:0007614; GO:0008083; GO:0008201; GO:0009410; GO:0009611; GO:0010667; GO:0010718; GO:0010759; GO:0010838; GO:0010976; GO:0010996; GO:0021542; GO:0021681; GO:0021987; GO:0030154; GO:0030279; GO:0030325; GO:0030335; GO:0030421; GO:0032330; GO:0032735; GO:0035374; GO:0042246; GO:0042995; GO:0043524; GO:0044849; GO:0045582; GO:0045590; GO:0045785; GO:0045893; GO:0046850; GO:0048477; GO:0048714; GO:0050729; GO:0050795; GO:0051384; GO:0051781; GO:0061036; GO:0071673; GO:0090023; GO:0090090; GO:0106015; GO:0106016; GO:0106091; GO:1900026; GO:1903039; GO:1904036; GO:1904399; GO:1904996; GO:1905555; GO:1905564; GO:1905653; GO:2000179; GO:2000249; GO:2000347; GO:2000391; GO:2001224 chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201] CRVPCNWKK 0.9515 3.7926 0 0 0 0 0 0 0 0 0 0 0 0 13.037 0 0 0 0 0 0 0 0 0 0 14.0909 14.8219 12.7135 0 0 0 0 0 0 0 0 0 12.3664 0 0 13.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4939 10.8472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9266 13.7463 0 0 0 14.8482 9.6725 0 0 0 0 15.1097 0 0 0 0 0 0 0 0 15.7163 0 0 14.7954 14.2912 0 15.1908 0 0 0 0 0 0 13.0164 0 0 14.5314 10.7492 0 0 0 0 0 0 15.4028 16.4217 0 0 0 0 13.1757 12.5787 0 0 15.0604 0 0 0 0 0 0 0 0 10.5954 0 15.9151 0 0 0 0 0 0 0 15.4453 0 0 0 0 0 14.0653 0 0 0 0 15.503 0 0 13.7263 0 0 0 0 0 13.5781 14.3069 0 14.5054 0 0 0 13.8148 16.1869 0 15.7583 12.0268 0 Q5W5W9 RES18_HUMAN Regulated endocrine-specific protein 18 RESP18 Homo sapiens (Human) cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794] GO:0005783; GO:0005794; GO:0031410 ALFPTKTTESPLAKVNR 0.95151 0.83568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1S5 S39AB_HUMAN "Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11, ZIP-11)" SLC39A11 C17orf26 ZIP11 Homo sapiens (Human) zinc ion transmembrane transport [GO:0071577] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577] GO:0005385; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0071577 zinc ion transmembrane transporter activity [GO:0005385] NLAIGIGIQNFPEGLAVSLPLR 0.95152 0.82893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6K4 LV310_HUMAN Immunoglobulin lambda variable 3-10 IGLV3-10 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 FSGSSSGTMATLTISGAQVEDEADYYCYSTDSSGNH 0.95153 0.83234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14515 SPRL1_HUMAN "SPARC-like protein 1 (High endothelial venule protein, Hevin) (MAST 9)" SPARCL1 Homo sapiens (Human) anatomical structure development [GO:0048856]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; anatomical structure development [GO:0048856]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560] GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0005788; GO:0007165; GO:0048856; GO:0050840; GO:0062023; GO:0098978; GO:0099560 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840] AENSSNEEETSSEGNMR 0.95153 2.7157 0 0 0 0 0 0 0 0 0 0 12.0118 12.0317 0 12.204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8528 0 0 0 0 0 0 0 12.8625 13.0029 0 12.6202 13.1134 0 0 13.6279 12.3957 0 0 0 0 0 12.0493 0 13.6251 12.4978 0 11.442 0 0 0 21.8917 0 0 14.1267 0 0 0 20.1814 0 0 12.3588 12.8344 0 0 0 13.5299 0 0 0 0 20.0209 0 14.3288 12.7341 12.4189 0 0 13.1546 13.8669 0 0 0 13.3245 0 0 0 0 0 0 0 0 0 0 0 0 14.2451 13.5581 0 0 0 17.6707 0 0 0 11.6904 0 0 19.0947 0 0 0 0 13.8988 0 0 0 0 0 0 0 0 0 12.4314 0 0 12.0658 0 11.7058 0 0 0 0 0 Q9NQT4 EXOS5_HUMAN Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B) EXOSC5 CML28 RRP46 Homo sapiens (Human) "defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0043928; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723] ATLEVILRPKIGLPGVAEK 0.95153 0.83519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HH9 GRM2B_HUMAN GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2) GRAMD2B GRAMD3 NS3TP2 Homo sapiens (Human) cytoplasmic microtubule [GO:0005881] cytoplasmic microtubule [GO:0005881]; identical protein binding [GO:0042802] GO:0005881; GO:0042802 identical protein binding [GO:0042802] CPMLHHILIFYAIVVCALIISTFYMR 0.95155 0.83485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9091 0 0 0 0 0 0 11.4465 0 0 0 0 0 0 0 13.7051 14.7403 14.246 11.8838 18.3839 18.2247 0 0 13.8505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2573 0 0 0 0 0 0 0 0 12.8856 11.7072 13.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3748 0 0 0 0 0 0 0 0 11.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4368 0 Q9BTE7 DCNL5_HUMAN "DCN1-like protein 5, DCNL5 (DCUN1 domain-containing protein 5) (Defective in cullin neddylation protein 1-like protein 5) (Squamous cell carcinoma-related oncogene 5)" DCUN1D5 SCCRO5 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell growth [GO:0001558]; regulation of protein neddylation [GO:2000434] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell growth [GO:0001558]; regulation of protein neddylation [GO:2000434] GO:0000151; GO:0001558; GO:0005634; GO:0005737; GO:0005819; GO:0006974; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000434; GO:2000436 cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182] LISGEEHFSSKK 0.95155 0.80149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6686 0 0 0 0 0 0 14.3879 0 0 0 0 13.1053 0 0 0 0 0 12.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17568 NDUB7_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18, CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit)" NDUFB7 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] ERRLLQR 0.95156 0.83456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3413 0 0 0 0 13.438 0 0 0 0 0 0 0 0 0 12.4208 0 12.3076 0 0 0 0 11.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.34 0 0 0 0 12.8886 12.1253 0 0 0 0 0 0 0 12.4203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2629 0 0 0 12.4119 Q96GX1 TECT2_HUMAN Tectonic-2 TCTN2 C12orf38 TECT2 Homo sapiens (Human) cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038] ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; MKS complex [GO:0036038]; cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] GO:0005737; GO:0005856; GO:0007224; GO:0016021; GO:0036038; GO:0060170; GO:0060271; GO:1904491 CCCDQECSSNLTTLFR 0.95157 0.83418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.47 0 0 0 0 10.0462 12.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5141 11.8359 0 0 15.3129 0 11.5835 0 0 0 0 0 0 0 14.5317 0 0 0 0 14.1165 0 0 16.6832 0 0 0 0 0 0 11.9561 14.8679 0 0 14.3691 0 0 14.898 0 0 0 14.4086 0 0 0 0 0 0 13.5758 0 0 0 0 12.6889 0 0 14.8298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8821 0 0 0 0 0 0 0 0 0 Q8N2M4 TM86A_HUMAN Lysoplasmalogenase-like protein TMEM86A (Transmembrane protein 86A) TMEM86A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; alkenylglycerophosphocholine hydrolase activity [GO:0047408]; alkenylglycerophosphoethanolamine hydrolase activity [GO:0047409] GO:0016021; GO:0047408; GO:0047409 alkenylglycerophosphocholine hydrolase activity [GO:0047408]; alkenylglycerophosphoethanolamine hydrolase activity [GO:0047409] AMAGLRLAGADWR 0.95161 0.83159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1H1 GTSFL_HUMAN Gametocyte-specific factor 1-like (Protein FAM112A) GTSF1L C20orf65 FAM112A Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] NLEEHEAVCVNR 0.95161 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP55 BPIA1_HUMAN "BPI fold-containing family A member 1 (Lung-specific protein X) (Nasopharyngeal carcinoma-related protein) (Palate lung and nasal epithelium clone protein) (Secretory protein in upper respiratory tracts) (Short PLUNC1, SPLUNC1) (Tracheal epithelium-enriched protein) (Von Ebner protein Hl)" BPIFA1 LUNX NASG PLUNC SPLUNC1 SPURT UNQ787/PRO1606 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to virus [GO:0051607]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; innate immune response [GO:0045087]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; regulation of liquid surface tension [GO:0050828]; regulation of sodium ion transmembrane transport [GO:1902305] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lipid binding [GO:0008289]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to virus [GO:0051607]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; innate immune response [GO:0045087]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; regulation of liquid surface tension [GO:0050828]; regulation of sodium ion transmembrane transport [GO:1902305] GO:0002395; GO:0005576; GO:0005615; GO:0008289; GO:0019731; GO:0045087; GO:0050828; GO:0050891; GO:0051607; GO:0061844; GO:1900229; GO:1902305 lipid binding [GO:0008289] LAVKLDITAEILAVRDK 0.95161 3.7908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2672 0 0 0 0 0 0 0 0 13.4805 0 0 0 0 0 0 0 12.9773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3879 0 0 0 0 0 13.5923 0 0 0 14.225 0 0 0 0 0 0 0 0 13.7734 0 0 0 0 0 13.2851 0 0 0 13.2396 0 0 0 0 13.8087 0 0 12.8281 0 0 0 0 0 0 12.9007 12.9413 0 0 0 0 0 12.214 0 0 12.9898 0 0 0 0 0 12.1055 0 0 0 0 0 0 0 12.1446 0 0 0 0 12.5882 0 0 0 12.4823 0 0 0 0 0 0 P62380 TBPL1_HUMAN "TATA box-binding protein-like 1, TBP-like 1 (21 kDa TBP-like protein) (Second TBP of unique DNA protein, STUD) (TATA box-binding protein-related factor 2, TBP-related factor 2) (TBP-like factor) (TBP-related protein)" TBPL1 TLF TLP TLP21 TRF2 TRP Homo sapiens (Human) "acrosome assembly [GO:0001675]; DNA-templated transcription, initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366]" cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; transcription factor TFIIA complex [GO:0005672] "cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; transcription factor TFIIA complex [GO:0005672]; general transcription initiation factor activity [GO:0140223]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; acrosome assembly [GO:0001675]; DNA-templated transcription, initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366]" GO:0000979; GO:0001673; GO:0001675; GO:0005672; GO:0005737; GO:0006235; GO:0006352; GO:0006366; GO:0007289; GO:0016251; GO:0140223 general transcription initiation factor activity [GO:0140223]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251] KIALEGANVIYKR 0.95164 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49590 SYHM_HUMAN "Histidine--tRNA ligase, mitochondrial, EC 6.1.1.21 (Histidine--tRNA ligase-like) (Histidyl-tRNA synthetase, HisRS)" HARS2 HARSL HARSR HO3 Homo sapiens (Human) histidyl-tRNA aminoacylation [GO:0006427]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; histidyl-tRNA aminoacylation [GO:0006427]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418] GO:0003723; GO:0004821; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006412; GO:0006418; GO:0006427; GO:0042802 ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] EKILDLVISCFK 0.95165 2.9371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2939 0 0 14.9232 0 0 0 14.2793 0 12.6186 13.8246 0 0 0 0 0 14.4431 0 0 0 13.7914 0 12.0883 0 0 0 0 0 11.8897 0 0 0 11.6728 0 13.0419 0 0 0 15.364 0 0 0 0 11.5093 0 0 0 0 0 0 0 0 0 13.9782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1381 0 0 0 0 0 0 0 0 0 0 0 0 13.1473 0 0 0 0 0 0 0 11.0015 0 0 0 P27448 MARK3_HUMAN "MAP/microtubule affinity-regulating kinase 3, EC 2.7.11.1 (C-TAK1, cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2, EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1, Par-1a) (Serine/threonine-protein kinase p78)" MARK3 CTAK1 EMK2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468] GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0018105; GO:0030425; GO:0032092; GO:0035331; GO:0035556; GO:0036289; GO:0048156; GO:0050321; GO:0070062; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] DTENHTSHGDGR 0.95166 2.7415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4829 0 0 0 0 0 0 14.7672 0 0 0 0 0 0 13.6805 0 0 0 0 11.0042 0 0 12.807 10.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0469 Q96QH8 LYZL5_HUMAN "Sperm acrosome-associated protein 5, EC 3.2.1.17 (Lysozyme-like protein 5) (Sperm-specific lysozyme-like protein X, SLLP-X)" SPACA5 LYZL5 SPACA5A UNQ6288/PRO20753; SPACA5B Homo sapiens (Human) metabolic process [GO:0008152] extracellular region [GO:0005576] extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; metabolic process [GO:0008152] GO:0003796; GO:0005576; GO:0008152 lysozyme activity [GO:0003796] IYERCELAARLER 0.95167 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0834 0 0 0 0 0 13.0305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01721 LV657_HUMAN Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT) IGLV6-57 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814 antigen binding [GO:0003823] PGSAPTTVIYEDNQR 0.95168 0.79158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6853 0 0 0 0 0 0 0 0 0 0 11.4391 0 0 11.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1712 0 0 13.499 0 12.7176 0 12.1952 0 0 13.5519 0 0 0 14.9746 0 0 0 13.3607 12.9002 12.3665 0 13.3834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1967 0 0 0 0 0 13.5934 0 0 0 0 0 14.4696 12.7972 0 0 14.4438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12974 TP4A2_HUMAN "Protein tyrosine phosphatase type IVA 2, EC 3.1.3.48 (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2, PRL-2)" PTP4A2 PRL2 PTPCAAX2 BM-008 Homo sapiens (Human) protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006470; GO:0008138 prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] DTNGHCCVQ 0.95168 0.81879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7813 13.6071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95361 TRI16_HUMAN "Tripartite motif-containing protein 16, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRIM16) (Estrogen-responsive B box protein)" TRIM16 EBBP Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; response to growth hormone [GO:0060416]; response to organophosphorus [GO:0046683]; response to retinoic acid [GO:0032526]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; PML body [GO:0016605] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; PML body [GO:0016605]; DNA binding [GO:0003677]; interleukin-1 binding [GO:0019966]; NACHT domain binding [GO:0032089]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; response to growth hormone [GO:0060416]; response to organophosphorus [GO:0046683]; response to retinoic acid [GO:0032526]" GO:0003677; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0016605; GO:0016740; GO:0019966; GO:0032089; GO:0032526; GO:0032731; GO:0043966; GO:0043967; GO:0045618; GO:0045893; GO:0046683; GO:0048386; GO:0060416 DNA binding [GO:0003677]; interleukin-1 binding [GO:0019966]; NACHT domain binding [GO:0032089]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270] EQFLQYAYDITFDPDTAHKYLR 0.95169 0.81841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0213 13.6234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9648 0 0 12.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6112 0 13.4357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6807 0 0 0 0 0 0 0 0 0 0 0 15.3928 13.2912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3924 0 0 0 0 0 0 0 Q9GZK7 O11A1_HUMAN Olfactory receptor 11A1 (Hs6M1-18) (Olfactory receptor 11A2) (Olfactory receptor OR6-30) OR11A1 OR11A2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EVHQALRKILCIK 0.9517 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1566 11.0043 0 0 0 0 0 0 0 0 12.1184 12.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5549 0 0 0 0 0 0 Q00613 HSF1_HUMAN "Heat shock factor protein 1, HSF 1 (Heat shock transcription factor 1, HSTF 1)" HSF1 HSTF1 Homo sapiens (Human) cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of gene expression [GO:0010629]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to hypobaric hypoxia [GO:1990910]; response to nutrient [GO:0007584]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574] centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904] "centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; translation elongation factor binding [GO:0061770]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transcription [GO:0009299]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of gene expression [GO:0010629]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to hypobaric hypoxia [GO:1990910]; response to nutrient [GO:0007584]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]" GO:0000122; GO:0000165; GO:0000776; GO:0000785; GO:0000791; GO:0000792; GO:0000976; GO:0000978; GO:0000981; GO:0001162; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006357; GO:0006397; GO:0006952; GO:0007584; GO:0008284; GO:0009299; GO:0010628; GO:0010629; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0042531; GO:0042802; GO:0043280; GO:0043565; GO:0043621; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0051028; GO:0051091; GO:0051879; GO:0061408; GO:0061770; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1900365; GO:1901215; GO:1902512; GO:1903936; GO:1904385; GO:1904528; GO:1904843; GO:1904845; GO:1990837; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; translation elongation factor binding [GO:0061770]" HAQQQKVVNK 0.95172 0.79474 0 0 0 0 0 0 10.2722 0 0 0 0 0 0 0 0 0 11.6238 12.5555 12.7524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5434 0 0 0 0 0 0 0 11.5865 0 0 10.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.088 13.8743 0 0 14.0441 0 0 0 13.3469 0 0 14.7332 0 0 0 12.907 0 0 15.503 0 0 0 0 0 0 0 13.4484 0 0 15.1772 0 0 0 0 0 0 13.8188 0 0 0 0 13.4124 0 12.8939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2746 0 0 0 0 12.1713 0 0 15.1093 0 0 11.7359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8277 0 0 0 13.0538 0 0 13.4952 0 0 0 Q9NWM8 FKB14_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP14, PPIase FKBP14, EC 5.2.1.8 (22 kDa FK506-binding protein, 22 kDa FKBP, FKBP-22) (FK506-binding protein 14, FKBP-14) (Rotamase)" FKBP14 FKBP22 UNQ322/PRO381 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GO:0003755; GO:0005509; GO:0005788 calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] HNNGQPIWFTLGILEALKGWDQGLKGMCVGEK 0.95172 2.934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9145 0 0 13.2469 12.8422 12.9557 0 0 0 0 0 13.4135 0 0 0 0 0 0 0 12.8267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9519 0 0 0 0 0 0 0 0 14.277 0 14.2134 0 0 0 14.0308 0 0 0 0 0 0 0 0 0 0 0 0 15.0172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3127 0 0 0 0 12.9867 0 0 0 0 0 0 0 0 0 14.3179 15.2677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7585 0 0 0 0 0 0 13.7324 0 0 0 0 0 Q9UN75 PCDAC_HUMAN "Protocadherin alpha-12, PCDH-alpha-12" PCDHA12 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DKSILPELVLR 0.95173 0.78971 0 13.1218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1019 0 15.0062 0 13.5209 0 0 0 0 0 0 0 0 0 0 0 0 13.7471 0 0 0 0 0 0 0 0 0 0 0 15.5375 0 0 0 0 0 0 0 0 0 14.0374 0 0 0 0 0 0 14.1261 0 0 0 0 0 0 0 0 0 0 0 13.7875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5E9 PCDBE_HUMAN "Protocadherin beta-14, PCDH-beta-14" PCDHB14 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] KRQVLIFLVLLGLSR 0.95174 0.78935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.751 0 0 0 0 0 0 0 0 0 0 13.0201 0 0 0 0 0 0 0 0 0 0 12.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3061 0 0 0 12.5981 0 0 0 0 0 0 11.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2325 0 0 0 0 0 0 0 0 P06576 ATPB_HUMAN "ATP synthase subunit beta, mitochondrial, EC 7.1.2.2 (ATP synthase F1 subunit beta)" ATP5F1B ATP5B ATPMB ATPSB Homo sapiens (Human) angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453] "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]" "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]" GO:0001525; GO:0001649; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006091; GO:0006629; GO:0006754; GO:0006933; GO:0009986; GO:0015986; GO:0016020; GO:0031966; GO:0042288; GO:0042645; GO:0042776; GO:0043532; GO:0043536; GO:0045259; GO:0045261; GO:0046933; GO:0046961; GO:0051453; GO:0070062; GO:0098761; GO:1902600 "angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" ARVALTGLTVAEYFRDQEGQDVLLFIDNIFR 0.95175 0.82899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.703 13.2789 0 0 12.8678 12.9133 13.014 12.9109 13.0725 13.2718 0 12.6604 12.4554 0 12.8091 12.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5141 13.7665 0 14.6742 0 15.1028 0 0 14.6667 0 0 0 0 0 0 0 0 14.327 0 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9415 14.2323 0 0 0 0 0 0 0 0 0 0 12.0485 0 0 0 0 0 0 14.4252 0 0 0 0 0 0 0 13.7381 0 0 0 0 0 0 0 0 0 13.537 0 0 Q03113 GNA12_HUMAN "Guanine nucleotide-binding protein subunit alpha-12, G alpha-12, G-protein subunit alpha-12" GNA12 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266] GO:0001664; GO:0001701; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0005886; GO:0005925; GO:0007186; GO:0007188; GO:0007266; GO:0007596; GO:0008217; GO:0008360; GO:0009410; GO:0010259; GO:0010762; GO:0016328; GO:0019888; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0032516; GO:0042733; GO:0043005; GO:0043025; GO:0046872; GO:0051721; GO:1904706; GO:1904753 D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888] DSGIREAFSR 0.95176 0.83256 0 0 0 0 0 0 0 0 0 13.5167 0 0 12.462 16.0291 0 0 0 0 0 0 0 0 0 0 0 12.9544 0 0 12.9402 0 0 0 0 15.1831 0 0 0 0 0 0 0 12.8426 9.89697 13.1549 0 0 12.5581 11.8799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0207 0 0 0 0 0 0 0 0 0 0 0 0 12.9472 13.4668 0 0 0 14.7247 0 0 0 0 12.5806 0 0 0 0 13.692 0 0 0 0 0 0 0 12.7326 0 14.2277 0 12.6989 0 11.2508 0 0 13.0436 0 0 0 0 0 13.4454 0 0 0 12.8786 0 0 0 0 13.5182 12.4187 0 0 0 0 0 11.0177 0 12.4353 12.5572 0 0 0 0 0 14.0055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8054 0 12.8678 13.0772 12.8508 17.5487 0 0 0 0 14.1745 0 14.1964 11.7396 16.9814 Q8NDY4 MDS2_HUMAN Myelodysplastic syndrome 2 translocation-associated protein MDS2 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 EPSPGICWHLNLGLPSLHNCEE 0.95178 0.82893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG04 S2610_HUMAN Solute carrier family 26 member 10 SLC26A10 Homo sapiens (Human) basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] GO:0005887; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016323; GO:0019531 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] ALTSGAALHVLLSQLPSLLGLSLPR 0.95178 2.9333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9633 0 0 0 0 0 0 0 10.0289 11.2189 0 0 10.954 0 0 0 11.8392 0 0 15.2022 15.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1548 0 0 0 0 0 14.8938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9912 11.1525 0 0 0 0 0 0 0 0 0 0 13.6076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DPF5 CB27A_HUMAN Uncharacterized protein C2orf27A C2orf27A Homo sapiens (Human) PPPPGMEVCPQLGIWAICP 0.95181 0.83192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C2S0 CTXN2_HUMAN Cortexin-2 CTXN2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TGFAFVGILCIFLGLLIIR 0.95182 0.83192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5511 0 0 0 13.2101 0 0 0 0 0 0 0 0 0 0 14.535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NEV1 PR23A_HUMAN Proline-rich protein 23A PRR23A Homo sapiens (Human) VPLDDVDLVLELPPTSILR 0.95183 0.83192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43759 SNG1_HUMAN Synaptogyrin-1 SYNGR1 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; protein targeting [GO:0006605]; regulated exocytosis [GO:0045055]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle membrane organization [GO:0048499] anchoring junction [GO:0070161]; azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; cellular response to leukemia inhibitory factor [GO:1990830]; protein targeting [GO:0006605]; regulated exocytosis [GO:0045055]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle membrane organization [GO:0048499] GO:0005886; GO:0006605; GO:0016021; GO:0030285; GO:0030672; GO:0031594; GO:0035577; GO:0042470; GO:0045055; GO:0048169; GO:0048172; GO:0048499; GO:0070161; GO:1990830 DNPLNEGTDAAR 0.95184 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4959 0 0 0 13.3695 13.9115 0 0 13.4268 13.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19404 NDUV2_HUMAN "NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial, EC 7.1.1.2 (NADH-ubiquinone oxidoreductase 24 kDa subunit)" NDUFV2 Homo sapiens (Human) "aerobic respiration [GO:0009060]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007399; GO:0008137; GO:0009055; GO:0009060; GO:0042776; GO:0046872; GO:0048738; GO:0051537 "2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]" DTPENNPDTPFDFTPENYK 0.95185 0.83192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2K6 ERMP1_HUMAN "Endoplasmic reticulum metallopeptidase 1, EC 3.4.-.- (Felix-ina)" ERMP1 FXNA KIAA1815 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508] GO:0005783; GO:0005789; GO:0006508; GO:0008235; GO:0016020; GO:0016021; GO:0030968; GO:0034599; GO:0046872 metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235] AALGLALYLIALRTLVQLSLQQLVLRGAAGHR 0.95185 2.8985 0 0 0 0 0 10.4935 0 0 0 0 0 0 0 0 0 14.7557 0 0 0 0 0 0 0 0 0 0 0 0 12.8852 0 0 11.913 0 12.4658 0 0 0 0 0 0 13.8183 12.9286 0 0 0 0 0 0 10.6404 0 0 0 0 0 11.3728 0 11.6654 0 0 0 0 0 0 0 0 0 0 0 12.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5974 0 0 0 0 0 13.0845 0 13.0989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.404 10.9203 0 0 12.402 0 14.049 0 0 0 0 0 0 0 0 0 0 11.0347 0 0 0 0 11.8855 0 13.4506 0 0 0 14.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8082 P10767 FGF6_HUMAN "Fibroblast growth factor 6, FGF-6 (Heparin secretory-transforming protein 2, HST-2, HSTF-2) (Heparin-binding growth factor 6, HBGF-6)" FGF6 HST2 HSTF2 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; myoblast differentiation [GO:0045445]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcolemma [GO:0042383] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcolemma [GO:0042383]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; myoblast differentiation [GO:0045445]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334] GO:0001502; GO:0001525; GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0030154; GO:0030334; GO:0042383; GO:0045445; GO:0051781 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] LYATPSFQEECK 0.95188 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70Z44 5HT3D_HUMAN "5-hydroxytryptamine receptor 3D, 5-HT3-D, 5-HT3D (Serotonin receptor 3D)" HTR3D Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0098662; GO:1904315; GO:1904602 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] KAIGPVTNYSVATHVNISFTLSAIWNCYSR 0.9519 2.7837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4043 0 0 15.7468 0 0 0 0 0 0 15.8494 15.1221 0 15.6102 15.5889 0 0 0 0 14.8605 13.8911 0 0 0 0 0 0 0 14.4503 14.0383 0 0 15.7112 0 0 14.2983 0 0 0 0 0 14.8575 0 0 13.6531 0 14.7584 14.0127 13.7825 0 0 0 0 0 0 0 0 14.4115 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5359 0 0 0 0 0 0 0 0 0 0 Q9NYA1 SPHK1_HUMAN "Sphingosine kinase 1, SK 1, SPK 1, EC 2.7.1.91 (Acetyltransferase SPHK1, EC 2.3.1.-)" SPHK1 SK1 SPHK SPK Homo sapiens (Human) blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] anchoring junction [GO:0070161]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] anchoring junction [GO:0070161]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA biosynthetic process [GO:0071897]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ceramide biosynthetic process [GO:1900060]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of smooth muscle contraction [GO:0045987]; protein acetylation [GO:0006473]; regulation of endocytosis [GO:0030100]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of interleukin-1 beta production [GO:0032651]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of phagocytosis [GO:0050764]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; sphingoid catabolic process [GO:0046521]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] GO:0000287; GO:0001568; GO:0001727; GO:0003677; GO:0003951; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006473; GO:0006665; GO:0006670; GO:0006954; GO:0007420; GO:0008283; GO:0008289; GO:0008481; GO:0010800; GO:0010803; GO:0016020; GO:0016310; GO:0016407; GO:0017050; GO:0019722; GO:0030100; GO:0030139; GO:0030148; GO:0030307; GO:0030335; GO:0031398; GO:0031901; GO:0032651; GO:0032740; GO:0034612; GO:0035556; GO:0035924; GO:0038036; GO:0043066; GO:0043231; GO:0045766; GO:0045840; GO:0045931; GO:0045987; GO:0046512; GO:0046521; GO:0048146; GO:0050764; GO:0051092; GO:0051721; GO:0070161; GO:0070301; GO:0071363; GO:0071897; GO:0098793; GO:0150077; GO:1900060; GO:1900745; GO:1901224; GO:1903978; GO:1905364 acetyltransferase activity [GO:0016407]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; D-erythro-sphingosine kinase activity [GO:0017050]; DNA binding [GO:0003677]; lipid binding [GO:0008289]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; protein phosphatase 2A binding [GO:0051721]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036] FTLGTFLRLAALR 0.9519 0.79256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50616 TOB1_HUMAN Protein Tob1 (Transducer of erbB-2 1) TOB1 TOB TROB1 Homo sapiens (Human) "negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]; regulation of SMAD protein signal transduction [GO:0060390]" CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; receptor tyrosine kinase binding [GO:0030971]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of translation [GO:0017148]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of gene expression [GO:0010468]; regulation of SMAD protein signal transduction [GO:0060390]" GO:0003714; GO:0005634; GO:0005737; GO:0008285; GO:0010468; GO:0017148; GO:0030014; GO:0030514; GO:0030971; GO:0045668; GO:0046332; GO:0060212; GO:0060213; GO:0060390; GO:1900153 receptor tyrosine kinase binding [GO:0030971]; SMAD binding [GO:0046332]; transcription corepressor activity [GO:0003714] QLEIQVALNFIISYLYNKLPR 0.95191 0.81907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5954 0 0 0 0 0 0 0 13.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.224 0 0 0 0 0 0 0 0 0 0 0 0 Q5VXD3 SAM13_HUMAN "Sterile alpha motif domain-containing protein 13, SAM domain-containing protein 13" SAMD13 HSD-42 HSD42 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393] IYEYHVKPLQTKHLK 0.95191 0.79197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5416 0 0 0 0 14.4223 0 0 0 0 15.1806 14.5642 0 0 0 0 0 14.2349 0 0 0 13.6891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6754 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5575 0 0 0 0 Q6UWS5 PT117_HUMAN "Protein PET117 homolog, mitochondrial" PET117 UNQ607/PRO1194 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617] GO:0005739; GO:0033617 KENIRLLGEQIILTEQLEAER 0.95196 2.783 0 0 0 0 0 0 0 0 0 0 0 0 12.79 12.713 0 0 12.7218 0 0 0 0 0 0 0 0 0 0 10.5094 0 0 0 11.5491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7122 0 0 0 13.1212 0 0 0 0 12.8576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4606 0 14.2375 0 0 0 0 0 0 0 13.2796 0 0 0 0 0 0 0 0 0 0 13.1745 0 12.998 14.0356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2383 14.4526 0 12.3387 0 0 0 0 13.0332 0 13.93 0 0 0 0 0 13.5984 0 0 0 0 0 12.2959 A8MTL3 R212B_HUMAN RING finger protein 212B RNF212B C14orf164 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; protein sumoylation [GO:0016925]; reciprocal meiotic recombination [GO:0007131] synaptonemal complex [GO:0000795] synaptonemal complex [GO:0000795]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; homologous chromosome pairing at meiosis [GO:0007129]; protein sumoylation [GO:0016925]; reciprocal meiotic recombination [GO:0007131] GO:0000795; GO:0007129; GO:0007131; GO:0016925; GO:0019789; GO:0046872 metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789] ENGELKKFLAILK 0.95197 2.8962 0 0 0 0 0 0 0 11.4213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5611 0 0 0 13.5305 0 0 0 0 0 0 0 12.6167 0 0 0 11.5415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UW78 UQCC3_HUMAN Ubiquinol-cytochrome-c reductase complex assembly factor 3 (Assembly factor CBP4 homolog) UQCC3 C11orf83 UNQ655/PRO1286 Homo sapiens (Human) "ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]" cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cardiolipin binding [GO:1901612]; phosphatidic acid binding [GO:0070300]; ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]" GO:0005654; GO:0005739; GO:0005829; GO:0006122; GO:0006754; GO:0031305; GO:0034551; GO:0042407; GO:0070300; GO:1901612 cardiolipin binding [GO:1901612]; phosphatidic acid binding [GO:0070300] TQQLLLATLQEAATTQENVAWR 0.95204 0.82893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TGS1 HES3_HUMAN "Transcription factor HES-3 (Class B basic helix-loop-helix protein 43, bHLHb43) (Hairy and enhancer of split 3)" HES3 BHLHB43 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; negative regulation of neuron differentiation [GO:0045665]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; N-box binding [GO:0071820]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; negative regulation of neuron differentiation [GO:0045665]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007219; GO:0009952; GO:0045665; GO:0046983; GO:0050767; GO:0070888; GO:0071820 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; N-box binding [GO:0071820]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ARINVSLEQLKSLLEK 0.95205 2.834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0644 0 0 0 0 0 0 0 0 0 0 0 16.3234 0 0 0 0 15.4732 15.3971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5089 0 13.0135 0 0 0 13.232 14.2715 0 0 0 0 0 12.3817 13.6741 13.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0433 0 0 0 0 0 0 0 0 0 0 0 12.6271 0 0 0 0 0 0 0 0 P48506 GSH1_HUMAN "Glutamate--cysteine ligase catalytic subunit, EC 6.3.2.2 (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase)" GCLC GLCL GLCLC Homo sapiens (Human) "aging [GO:0007568]; blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]" cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]" GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237 ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877] GEKVVINVPIFK 0.95206 0.82836 0 0 0 0 0 0 0 0 14.388 0 0 0 0 0 0 0 12.7951 0 0 12.3967 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6956 0 0 0 12.4363 0 0 0 0 0 0 0 10.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9062 0 17.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0444 11.7864 10.4818 15.8493 0 0 0 0 0 0 0 0 0 0 0 0 14.115 0 0 0 0 14.1497 14.5802 0 0 13.9712 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4398 0 0 0 0 0 0 0 0 17.2353 0 0 0 0 0 0 Q8N5H3 LRA25_HUMAN Leucine repeat adapter protein 25 FAM89B Lrap25 Homo sapiens (Human) establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335] cytoplasm [GO:0005737]; lamellipodium [GO:0030027] cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; transcription corepressor binding [GO:0001222]; establishment of cell polarity [GO:0030010]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335] GO:0001222; GO:0005737; GO:0030010; GO:0030027; GO:0030335; GO:0030512; GO:0060392 transcription corepressor binding [GO:0001222] PVNLDSALAALR 0.95206 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2401 0 0 0 0 0 0 0 0 Q96GF1 RN185_HUMAN "E3 ubiquitin-protein ligase RNF185, EC 2.3.2.27 (RING finger protein 185)" RNF185 Homo sapiens (Human) autophagy [GO:0006914]; defense response to virus [GO:0051607]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; autophagy [GO:0006914]; defense response to virus [GO:0051607]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005741; GO:0005783; GO:0005789; GO:0006511; GO:0006914; GO:0016021; GO:0030433; GO:0036503; GO:0043130; GO:0044314; GO:0044322; GO:0044390; GO:0044877; GO:0045087; GO:0046872; GO:0051607; GO:0051865; GO:0055085; GO:0060340; GO:0061630; GO:0071712; GO:1904294; GO:1904380 metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] LFLFVALVIMFWLLIA 0.95207 0.82829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8444 0 0 0 0 14.0919 0 0 0 0 0 0 0 13.5405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BX93 PG12B_HUMAN "Group XIIB secretory phospholipase A2-like protein (Group XIII secretory phospholipase A2-like protein, GXIII sPLA2-like) (sPLA2-GXIIB, GXIIB)" PLA2G12B PLA2G13 FKSG71 Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; cholesterol homeostasis [GO:0042632]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; triglyceride homeostasis [GO:0070328] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; cholesterol homeostasis [GO:0042632]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; triglyceride homeostasis [GO:0070328] GO:0004623; GO:0005509; GO:0005576; GO:0006644; GO:0016042; GO:0042632; GO:0050482; GO:0070328 calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623] CCNQLDVCYDTCGANK 0.95208 0.82814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.114 12.8772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4244 14.7848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9553 0 0 0 0 15.0705 0 Q96ET8 TV23C_HUMAN Golgi apparatus membrane protein TVP23 homolog C TVP23C FAM18B2 Nbla10383 Homo sapiens (Human) protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] integral component of Golgi membrane [GO:0030173] integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] GO:0009306; GO:0016192; GO:0030173 ALYWKPAPRLSSPPLR 0.9521 2.8325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1693 0 0 P62263 RS14_HUMAN 40S ribosomal protein S14 (Small ribosomal subunit protein uS11) RPS14 PRO2640 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; cytoplasmic translation [GO:0002181]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" GO:0000028; GO:0000122; GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022626; GO:0022627; GO:0030218; GO:0030490; GO:0045182; GO:0048027; GO:0070062; GO:0070181 mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182] ETICRVTGGMKVK 0.95213 0.80327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8499 0 0 0 0 0 0 0 0 Q03933 HSF2_HUMAN "Heat shock factor protein 2, HSF 2 (Heat shock transcription factor 2, HSTF 2)" HSF2 HSTF2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001162; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007283; GO:0042802; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" EPTDNHHHK 0.95213 2.7258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9884 0 0 0 0 0 0 0 0 0 0 0 12.8349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1017 0 13.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1507 11.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86Y82 STX12_HUMAN Syntaxin-12 STX12 Homo sapiens (Human) autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000045; GO:0000139; GO:0000149; GO:0000407; GO:0005484; GO:0005654; GO:0005794; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0030285; GO:0031201; GO:0031901; GO:0031982; GO:0033344; GO:0043231; GO:0045121; GO:0045335; GO:0048278; GO:0050821; GO:0055038; GO:0098837 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] KMCILVLVLSVIILILGLIIWLVYK 0.95216 3.7718 0 0 0 0 0 0 0 0 0 11.1777 0 0 0 0 11.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2815 0 0 0 0 0 0 14.11 14.3719 14.2811 0 13.5984 0 0 0 0 0 0 17.1998 12.8454 0 0 0 0 0 0 0 13.2515 0 0 0 12.9843 17.3658 0 0 13.694 0 0 0 0 0 15.2974 0 15.2544 0 0 0 17.0312 0 0 0 0 15.3316 0 0 0 0 16.7954 0 15.7364 0 0 0 0 0 15.7527 0 0 0 15.5654 12.913 0 12.9608 12.453 0 0 0 14.6406 14.0498 13.4681 12.8908 0 0 13.233 0 0 0 0 11.5691 15.9405 0 0 0 0 0 0 0 0 0 0 0 14.218 0 0 0 12.3361 14.9532 0 0 10.9386 0 0 0 A0A0B4J1Y8 LV949_HUMAN Immunoglobulin lambda variable 9-49 IGLV9-49 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 FSVLGSGLNR 0.95218 0.79022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13489 RINI_HUMAN "Ribonuclease inhibitor (Placental ribonuclease inhibitor, Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1, RAI)" RNH1 PRI RNH Homo sapiens (Human) mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765] angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] angiogenin-PRI complex [GO:0032311]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ribonuclease inhibitor activity [GO:0008428]; mRNA catabolic process [GO:0006402]; regulation of angiogenesis [GO:0045765] GO:0005654; GO:0005829; GO:0006402; GO:0008428; GO:0032311; GO:0045765; GO:0070062 ribonuclease inhibitor activity [GO:0008428] LESCGVTSDNCR 0.95222 3.2879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3676 0 13.2682 0 0 0 13.0046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2772 13.3871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7C0 LRC52_HUMAN Leucine-rich repeat-containing protein 52 (BK channel auxiliary gamma subunit LRRC52) LRRC52 Homo sapiens (Human) establishment of localization in cell [GO:0051649]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; reproductive process [GO:0022414] integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076] integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]; potassium channel activator activity [GO:0099104]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; establishment of localization in cell [GO:0051649]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; reproductive process [GO:0022414] GO:0005249; GO:0005887; GO:0008076; GO:0022414; GO:0044325; GO:0051649; GO:0071805; GO:0099104; GO:1903818 potassium channel activator activity [GO:0099104]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] SSEEDEDEAGTR 0.95227 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8Q6 HEAS1_HUMAN Putative uncharacterized protein encoded by HEXA-AS1 (HEXA antisense RNA 1) (HEXA antisense gene protein 1) HEXA-AS1 C15orf34 Homo sapiens (Human) LTINLLVTTHIPFPQTKPHIAR 0.95227 0.66011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60238 BNI3L_HUMAN "BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X, NIP3L)" BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of apoptotic process [GO:0043065]; positive regulation of macroautophagy [GO:0016239]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of programmed cell death [GO:0043067]; regulation of protein targeting to mitochondrion [GO:1903214] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; positive regulation of apoptotic process [GO:0043065]; positive regulation of macroautophagy [GO:0016239]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of programmed cell death [GO:0043067]; regulation of protein targeting to mitochondrion [GO:1903214] GO:0005521; GO:0005634; GO:0005635; GO:0005739; GO:0005741; GO:0005783; GO:0016021; GO:0016239; GO:0016607; GO:0031224; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043067; GO:0051607; GO:0060548; GO:0071456; GO:0097345; GO:1903146; GO:1903214 identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803] VFIPSLFLSHVLALGLGIYIGK 0.95228 0.82893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.669 0 0 0 0 0 0 0 0 Q9Y244 POMP_HUMAN "Proteasome maturation protein (Proteassemblin) (Protein UMP1 homolog, hUMP1) (Voltage-gated K channel beta subunit 4.1)" POMP C13orf12 UMP1 HSPC014 HSPC036 PNAS-110 Homo sapiens (Human) proteasome assembly [GO:0043248] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; proteasome assembly [GO:0043248] GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0016020; GO:0016607; GO:0043248 NELLPSHPLELSEKNFQLNQDK 0.95229 0.66011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2N7 KLH13_HUMAN Kelch-like protein 13 (BTB and kelch domain-containing protein 2) KLHL13 BKLHD2 KIAA1309 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; cullin family protein binding [GO:0097602]; protein N-terminus binding [GO:0047485]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] GO:0005829; GO:0007049; GO:0016567; GO:0031463; GO:0032465; GO:0047485; GO:0051301; GO:0097602 cullin family protein binding [GO:0097602]; protein N-terminus binding [GO:0047485] IANTYNLTEVDKYVNSFVLKNFPALLSTGEFLK 0.9523 3.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2501 0 0 0 0 0 0 0 13.1437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7133 0 0 0 0 0 0 0 0 14.5447 0 0 0 0 0 0 0 0 13.508 0 0 0 13.7708 0 12.808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5694 0 0 0 0 0 0 0 0 12.8589 0 0 0 0 0 11.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8439 0 0 Q96GD4 AURKB_HUMAN "Aurora kinase B, EC 2.7.11.1 (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1, AIM-1) (Aurora/IPL1-related kinase 2, ARK-2, Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B)" AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 Homo sapiens (Human) abscission [GO:0009838]; aging [GO:0007568]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; histone modification [GO:0016570]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of cytokinesis [GO:0032467]; positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore [GO:1905116]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; spindle organization [GO:0007051] "chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]" "chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; kinase binding [GO:0019900]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; abscission [GO:0009838]; aging [GO:0007568]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; histone modification [GO:0016570]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of cytokinesis [GO:0032467]; positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore [GO:1905116]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; spindle organization [GO:0007051]" GO:0000122; GO:0000278; GO:0000281; GO:0000776; GO:0000779; GO:0001934; GO:0002903; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005876; GO:0006468; GO:0007051; GO:0007052; GO:0007094; GO:0007568; GO:0008283; GO:0008608; GO:0009838; GO:0010369; GO:0015630; GO:0016570; GO:0019900; GO:0030496; GO:0031616; GO:0032091; GO:0032133; GO:0032212; GO:0032465; GO:0032466; GO:0032467; GO:0034501; GO:0034644; GO:0035174; GO:0036089; GO:0043687; GO:0043988; GO:0044878; GO:0046777; GO:0051233; GO:0051256; GO:0051973; GO:0051983; GO:0062033; GO:0090267; GO:0097431; GO:0106310; GO:1901796; GO:1901970; GO:1902425; GO:1903490; GO:1904355; GO:1905116; GO:1990023 ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; kinase binding [GO:0019900]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] FGNVYLAREKK 0.95232 2.8536 0 0 0 0 0 0 0 0 0 0 0 0 11.7043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5115 0 0 14.4308 13.5733 0 13.5101 0 0 0 12.7192 0 12.9609 0 0 0 0 0 0 0 0 0 0 0 14.5341 0 12.9564 12.9957 0 0 0 0 0 13.7952 13.6261 0 16.2169 0 0 13.3707 0 0 0 0 0 0 0 0 0 0 13.8107 0 0 0 0 14.1324 0 14.2899 0 0 0 0 0 0 0 0 14.7898 0 0 13.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4194 0 18.6803 0 0 0 0 0 0 14.1261 0 A0A0K2S4Q6 CD3CH_HUMAN Protein CD300H (CD300 antigen-like family member H) CD300H Homo sapiens (Human) neutrophil chemotaxis [GO:0030593] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; neutrophil chemotaxis [GO:0030593] GO:0004888; GO:0005576; GO:0005886; GO:0016021; GO:0030593 transmembrane signaling receptor activity [GO:0004888] VPLLLSILGAILWVNR 0.95233 0.82811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5198 0 0 0 14.1591 0 0 0 14.7868 0 0 14.6624 13.7682 0 0 0 0 0 0 0 0 0 14.8598 0 0 0 0 0 0 14.6983 14.7054 0 0 0 0 0 0 0 14.3281 13.5806 0 0 0 0 0 0 0 0 14.494 0 0 0 0 0 0 13.4614 0 0 0 0 0 0 14.3059 14.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0259 0 0 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.897 0 0 12.2498 0 0 P51911 CNN1_HUMAN "Calponin-1 (Basic calponin) (Calponin H1, smooth muscle)" CNN1 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; regulation of smooth muscle contraction [GO:0006940] cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; actomyosin structure organization [GO:0031032]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; regulation of smooth muscle contraction [GO:0006940] GO:0003779; GO:0005516; GO:0005856; GO:0005925; GO:0006940; GO:0031032; GO:1904706 actin binding [GO:0003779]; calmodulin binding [GO:0005516] LQPGSVK 0.95233 0.81909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53004 BIEA_HUMAN "Biliverdin reductase A, BVR A, EC 1.3.1.24 (Biliverdin-IX alpha-reductase)" BLVRA BLVR BVR Homo sapiens (Human) heme catabolic process [GO:0042167] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; heme catabolic process [GO:0042167] GO:0000166; GO:0004074; GO:0005829; GO:0008270; GO:0042167; GO:0070062; GO:0106276; GO:0106277 biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)+) activity [GO:0004074]; biliverdin reductase (NADP+) activity [GO:0106277]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270] FGVVVVGVGR 0.95233 2.7527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9564 0 0 0 0 0 0 0 12.9232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2092 12.9478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46093 GPR4_HUMAN "G-protein coupled receptor 4 (G-protein coupled receptor 6C.l, GPR6C.l)" GPR4 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis involved in wound healing [GO:0060055]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular mesangial cell development [GO:0072144]; negative regulation of angiogenesis [GO:0016525]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inflammatory response [GO:0050729]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis involved in wound healing [GO:0060055]; G protein-coupled receptor signaling pathway [GO:0007186]; glomerular mesangial cell development [GO:0072144]; negative regulation of angiogenesis [GO:0016525]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inflammatory response [GO:0050729]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007200; GO:0010447; GO:0016525; GO:0030155; GO:0035025; GO:0043114; GO:0050729; GO:0051482; GO:0060055; GO:0072144 G protein-coupled receptor activity [GO:0004930] GNHTWEGCHVDSR 0.95238 4.7225 12.2082 12.117 0 0 0 0 0 0 0 0 10.838 0 0 0 0 15.4928 0 0 0 0 15.3536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6179 12.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9516 0 0 0 0 0 0 0 0 0 0 12.0336 0 14.1519 13.3211 0 0 0 12.6344 0 0 0 0 16.3074 0 0 0 0 0 0 0 0 0 16.1521 0 0 0 0 0 0 0 0 0 0 0 0 15.0496 0 0 0 0 0 0 11.3231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9446 0 0 0 0 13.2943 0 0 13.9962 0 14.3336 0 0 0 0 0 0 0 0 10.6779 0 0 0 0 14.8898 0 0 13.8317 0 0 Q96QG7 MTMR9_HUMAN Myotubularin-related protein 9 (Inactive phosphatidylinositol 3-phosphatase 9) MTMR9 C8orf9 MTMR8 Homo sapiens (Human) endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; endocytosis [GO:0006897]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] GO:0004438; GO:0005737; GO:0005783; GO:0005829; GO:0006897; GO:0010507; GO:0010922; GO:0019903; GO:0030234; GO:0032587; GO:0032991; GO:0046856; GO:0048471; GO:0050821; GO:0060304 enzyme regulator activity [GO:0030234]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903] ELQAKVNILRR 0.95238 3.6118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8005 12.7536 0 0 0 0 0 0 0 0 0 0 12.6856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.332 0 0 0 0 0 0 14.1682 0 0 0 14.2313 0 0 0 13.3455 0 0 14.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7997 0 0 0 0 0 0 0 0 0 0 11.3019 0 0 0 0 0 0 0 0 0 0 14.3639 0 0 0 0 0 0 0 13.6487 0 0 0 0 0 0 0 0 0 12.9459 0 0 0 0 0 0 0 0 0 11.7598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UI38 TSP50_HUMAN "Probable threonine protease PRSS50, EC 3.4.25.- (Cancer/testis antigen 20) (Serine protease 50) (Testis-specific protease-like protein 50)" PRSS50 CT20 TSP50 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; serine-type endopeptidase activity [GO:0004252]; threonine-type endopeptidase activity [GO:0004298]; proteolysis [GO:0006508] GO:0004252; GO:0004298; GO:0005737; GO:0005783; GO:0006508 serine-type endopeptidase activity [GO:0004252]; threonine-type endopeptidase activity [GO:0004298] ADGMWPQFRTIQEK 0.95238 4.4748 0 0 0 0 11.7581 0 0 0 13.0122 13.0074 14.1109 13.3028 13.0011 12.7448 11.405 13.2713 0 12.85 0 0 0 14.0602 0 0 12.1079 0 0 13.2247 12.9266 13.0304 13.3556 11.5429 12.2461 0 13.0568 11.567 11.0877 13.2948 12.4046 11.8089 12.8102 12.0509 12.9232 0 11.863 13.7492 13.0123 0 0 0 0 0 0 10.7463 0 0 0 0 0 0 0 0 0 0 0 0 13.5533 0 0 14.0072 0 0 10.0562 0 0 0 0 0 0 12.3422 0 0 15.0853 15.173 15.2648 0 0 15.0254 14.8802 0 15.7719 13.9951 14.1843 0 13.946 14.8903 15.5832 11.4047 0 0 13.6603 12.0304 13.7102 0 0 11.3544 14.6512 0 0 0 0 0 0 13.4475 0 13.5458 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65451 0 0 13.2551 11.0247 0 0 0 0 0 12.5368 0 0 11.4033 0 13.4846 12.5151 0 0 0 0 13.0281 0 0 0 0 0 0 14.0033 13.4253 13.237 13.5854 14.8 14.1503 13.8179 10.3526 11.3112 0 12.1382 13.2952 14.2756 12.3196 13.9908 13.3082 11.9096 13.709 13.8579 0 14.4378 0 11.0564 Q9Y6I8 PXMP4_HUMAN Peroxisomal membrane protein 4 (24 kDa peroxisomal intrinsic membrane protein) PXMP4 PMP24 Homo sapiens (Human) cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] GO:0005777; GO:0005778; GO:0005829; GO:0016021 AAPPQLRALLVVVNALLR 0.95238 2.7169 0 0 0 13.2369 11.8919 0 0 12.5747 0 0 0 0 0 0 13.1033 0 13.4013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8118 0 13.8369 0 0 0 0 11.332 0 0 0 0 0 13.6517 0 0 14.3544 15.4293 0 0 0 0 0 12.3056 0 14.634 0 0 12.968 12.3438 0 11.9676 15.0612 0 15.0257 0 0 0 0 15.9657 0 12.1879 13.0723 0 15.5307 0 0 0 14.3534 0 11.3042 14.7443 14.9446 14.1235 0 11.5576 0 13.7046 0 0 13.782 0 0 0 0 0 0 0 11.019 14.2763 14.2378 14.9052 14.3498 0 0 0 0 0 0 0 0 17.3628 0 0 0 0 0 13.206 0 0 10.1334 0 0 0 0 0 0 0 0 0 12.2173 0 0 0 0 0 0 12.5881 9.18008 0 0 0 0 0 0 0 0 13.9897 0 0 0 0 0 0 0 P31431 SDC4_HUMAN "Syndecan-4, SYND4 (Amphiglycan) (Ryudocan core protein)" SDC4 Homo sapiens (Human) cell migration [GO:0016477]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stress fiber assembly [GO:0051496]; regulation of fibroblast migration [GO:0010762]; ureteric bud development [GO:0001657]; wound healing [GO:0042060] cell surface [GO:0009986]; costamere [GO:0043034]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; costamere [GO:0043034]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; thrombospondin receptor activity [GO:0070053]; cell migration [GO:0016477]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stress fiber assembly [GO:0051496]; regulation of fibroblast migration [GO:0010762]; ureteric bud development [GO:0001657]; wound healing [GO:0042060] GO:0001657; GO:0001843; GO:0001968; GO:0005080; GO:0005796; GO:0005886; GO:0005887; GO:0005925; GO:0009986; GO:0010762; GO:0016477; GO:0042060; GO:0042130; GO:0042802; GO:0043034; GO:0043202; GO:0045121; GO:0045860; GO:0051496; GO:0051894; GO:0060122; GO:0070053; GO:0070062; GO:1903543; GO:1903553 fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; thrombospondin receptor activity [GO:0070053] PIYKKAPTNEFYA 0.9524 0.79032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VU36 S31A5_HUMAN Spermatogenesis-associated protein 31A5 (Protein FAM75A5) SPATA31A5 FAM75A5 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 AGETREAVPQCR 0.95247 0.66011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DMQ5 INAM2_HUMAN Putative transmembrane protein INAFM2 (InaF-motif-containing protein 2) (Osteogenesis up-regulated transcript 1) INAFM2 LINC00984 OGU1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DAAPAERGKPATYTGDK 0.95252 0.65993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FA7 ZB10P_HUMAN Putative protein ZBED10P (ZBED6 C-terminal-like protein) (zinc finger BED-type containing 10 pseudogene) ZBED10P C7orf29 ZBED6CL Homo sapiens (Human) EAWPPSICLTPHRSLL 0.95261 0.66103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1863 0 0 0 0 0 0 0 P48065 S6A12_HUMAN Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12) SLC6A12 Homo sapiens (Human) amino acid transport [GO:0006865]; gamma-aminobutyric acid reuptake [GO:0051936]; monocarboxylic acid transport [GO:0015718]; sodium ion transmembrane transport [GO:0035725] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; amino acid transport [GO:0006865]; gamma-aminobutyric acid reuptake [GO:0051936]; monocarboxylic acid transport [GO:0015718]; sodium ion transmembrane transport [GO:0035725] GO:0005332; GO:0005886; GO:0005887; GO:0006865; GO:0008028; GO:0015171; GO:0015718; GO:0016021; GO:0035725; GO:0043005; GO:0051936; GO:0098793 amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028] FYDNIEDMIGYRPWPLVK 0.95264 2.7436 0 0 0 0 0 0 0 0 0 0 0 11.0397 12.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5389 0 0 12.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5789 0 0 0 11.1206 0 12.9051 0 0 0 0 0 0 0 0 0 12.2371 0 0 0 0 0 0 0 10.607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01201 RELB_HUMAN Transcription factor RelB (I-Rel) RELB Homo sapiens (Human) "antigen processing and presentation [GO:0019882]; cellular response to osmotic stress [GO:0071470]; circadian regulation of gene expression [GO:0032922]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lymphocyte differentiation [GO:0030098]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; T-helper 1 cell differentiation [GO:0045063]" chromatin [GO:0000785]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; antigen processing and presentation [GO:0019882]; cellular response to osmotic stress [GO:0071470]; circadian regulation of gene expression [GO:0032922]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lymphocyte differentiation [GO:0030098]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription, DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; T-helper 1 cell differentiation [GO:0045063]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006357; GO:0006954; GO:0007249; GO:0017053; GO:0019882; GO:0019901; GO:0030098; GO:0032688; GO:0032922; GO:0032991; GO:0034097; GO:0038061; GO:0042802; GO:0043011; GO:0045063; GO:0045087; GO:0045892; GO:0045944; GO:0071159; GO:0071470 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DWPHRVHPHSLVGKDCTDGICR 0.95266 2.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2968 0 0 0 0 0 0 0 0 0 0 13.4378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3082 0 0 0 12.6218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PII3 CC174_HUMAN Coiled-coil domain-containing protein 174 CCDC174 C3orf19 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654 MTKGDFIDEEVEDMYLVDFTQK 0.95268 0.66011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78334 GBRE_HUMAN Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) GABRE Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; negative regulation of chloride transport [GO:2001226]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; negative regulation of chloride transport [GO:2001226]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0070161; GO:0098794; GO:1902476; GO:1902711; GO:1904315; GO:2001226 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] AHASPKLRHPR 0.95269 2.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1607 10.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7353 9.51881 12.048 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4385 0 14.4007 0 0 0 14.7445 0 0 0 10.8803 0 0 13.6193 0 15.0085 0 15.9988 0 0 0 0 0 0 0 0 0 0 0 14.4832 0 14.2242 0 15.2122 13.9916 13.0693 0 14.7912 14.8711 14.9517 14.7946 13.8397 0 0 0 0 13.804 0 0 0 0 10.3679 0 0 0 0 0 0 0 0 0 13.3277 0 0 0 0 0 0 15.2871 0 0 0 0 0 0 0 0 0 13.9487 0 0 0 0 0 0 0 0 0 0 0 0 12.7969 0 0 P00414 COX3_HUMAN "Cytochrome c oxidase subunit 3, EC 7.1.1.9 (Cytochrome c oxidase polypeptide III)" MT-CO3 COIII COXIII MTCO3 Homo sapiens (Human) "aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory chain complex IV assembly [GO:0008535]" integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; oxidoreduction-driven active transmembrane transporter activity [GO:0015453]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory chain complex IV assembly [GO:0008535]" GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0006123; GO:0008535; GO:0009055; GO:0009060; GO:0015453; GO:0016021; GO:0031966; GO:0045277; GO:0045333 cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; oxidoreduction-driven active transmembrane transporter activity [GO:0015453] MTHQSHAYHMVK 0.95272 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9114 0 14.6375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBG0 MRC2_HUMAN "C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein, UPAR-associated protein, Urokinase receptor-associated protein) (CD antigen CD280)" MRC2 CLEC13E ENDO180 KIAA0709 UPARAP Homo sapiens (Human) collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023]; collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649] GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0016021; GO:0030246; GO:0030574; GO:0038023 carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023] CVYMTASREDWGDQR 0.95273 4.4694 0 0 0 11.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2046 0 8.95957 0 0 0 9.72344 9.12156 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.014 0 0 0 0 11.9256 0 0 0 0 0 0 12.676 0 0 0 0 0 0 12.4014 0 0 0 0 14.0885 0 0 0 0 0 0 0 0 10.6006 0 13.0051 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4511 0 0 0 0 0 0 0 0 9.34576 13.1768 0 0 0 0 0 0 0 0 0 0 13.3411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.31818 0 0 13.3245 0 0 0 0 12.3744 0 0 0 0 0 0 0 0 Q5T752 LCE1D_HUMAN Late cornified envelope protein 1D (Late envelope protein 4) LCE1D LEP4 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; cognition [GO:0050890]; keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; cellular response to calcium ion [GO:0071277]; cognition [GO:0050890]; keratinization [GO:0031424] GO:0001533; GO:0005737; GO:0031424; GO:0042802; GO:0048471; GO:0050890; GO:0071277 identical protein binding [GO:0042802] CTPKCPAPKCPPK 0.95276 4.5786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4078 0 0 0 0 0 0 13.5177 0 0 0 0 12.2164 0 11.5688 0 0 0 0 0 0 0 0 0 0 15.6704 0 0 0 14.2516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5122 0 0 0 12.5511 0 0 0 0 0 0 0 0 15.6922 0 0 15.3558 0 0 12.5594 13.8588 0 13.5458 0 0 0 0 12.1329 0 0 0 0 0 0 0 0 0 0 0 13.0863 0 12.7244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9076 0 12.6947 0 0 0 12.9033 0 0 0 0 0 0 0 0 12.5298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8026 0 0 11.7669 0 0 0 0 13.2268 P54107 CRIS1_HUMAN "Cysteine-rich secretory protein 1, CRISP-1 (AEG-like protein) (ARP) (Acidic epididymal glycoprotein homolog)" CRISP1 AEGL1 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; regulation of acrosome reaction [GO:0060046] extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium channel regulator activity [GO:0005246]; binding of sperm to zona pellucida [GO:0007339]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; regulation of acrosome reaction [GO:0060046] GO:0005246; GO:0005615; GO:0005634; GO:0007339; GO:0007342; GO:0060046 calcium channel regulator activity [GO:0005246] EIKHLLFLVAAACLLPMLSMKK 0.9528 0.81913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6272 0 0 11.4593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UW02 CP20A_HUMAN "Cytochrome P450 20A1, EC 1.14.-.-" CYP20A1 UNQ667/PRO1301 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] "integral component of membrane [GO:0016021]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" GO:0004497; GO:0005506; GO:0016020; GO:0016021; GO:0016705; GO:0020037 "heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" FAYMVTTVLLSVLVKRLHLLSVEGQVIETK 0.95281 0.66174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1037 0 0 0 0 0 0 0 0 0 0 0 14.7733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49AH0 CDNF_HUMAN Cerebral dopamine neurotrophic factor (ARMET-like protein 1) (Conserved dopamine neurotrophic factor) CDNF ARMETL1 Homo sapiens (Human) dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175] GO:0005615; GO:0005783; GO:0008083; GO:0031175; GO:0071542 growth factor activity [GO:0008083] QILHSWGEECR 0.95283 0.82734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60806 TBX19_HUMAN "T-box transcription factor TBX19, T-box protein 19 (T-box factor, pituitary)" TBX19 TPIT Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; mesoderm formation [GO:0001707]; pituitary gland development [GO:0021983]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; mesoderm formation [GO:0001707]; pituitary gland development [GO:0021983]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001707; GO:0001708; GO:0003007; GO:0005634; GO:0006357; GO:0009653; GO:0021983; GO:0042127; GO:0045595; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" APISFSKVKLTNK 0.95284 0.66085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15371 EIF3D_HUMAN "Eukaryotic translation initiation factor 3 subunit D, eIF3d (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66)" EIF3D EIF3S7 Homo sapiens (Human) cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]" GO:0001732; GO:0002191; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0033290; GO:0045727; GO:0071541; GO:0075522; GO:0075525; GO:0098808; GO:1902416 mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] TLNEWDSRHCNGVDWR 0.95285 0.66082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZY2 ABCA7_HUMAN "Phospholipid-transporting ATPase ABCA7, EC 7.6.2.1 (ABCA-SSN) (ATP-binding cassette sub-family A member 7) (Autoantigen SS-N) (Macrophage ABC transporter)" ABCA7 Homo sapiens (Human) amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta formation [GO:0034205]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; memory [GO:0007613]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of endocytosis [GO:0045806]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; plasma membrane raft organization [GO:0044857]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to nucleus [GO:0034504]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of lipid metabolic process [GO:0019216]; visual learning [GO:0008542] cell junction [GO:0030054]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cell junction [GO:0030054]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor activity [GO:0034188]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta formation [GO:0034205]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; memory [GO:0007613]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of endocytosis [GO:0045806]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; phospholipid efflux [GO:0033700]; phospholipid translocation [GO:0045332]; plasma membrane raft organization [GO:0044857]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to nucleus [GO:0034504]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of lipid metabolic process [GO:0019216]; visual learning [GO:0008542] GO:0000139; GO:0001891; GO:0005319; GO:0005524; GO:0005548; GO:0005783; GO:0005794; GO:0005886; GO:0006869; GO:0006909; GO:0007613; GO:0008542; GO:0009986; GO:0010875; GO:0016021; GO:0018149; GO:0019216; GO:0030054; GO:0031901; GO:0032587; GO:0033344; GO:0033700; GO:0034188; GO:0034205; GO:0034380; GO:0034504; GO:0038027; GO:0042626; GO:0042985; GO:0043231; GO:0043409; GO:0044857; GO:0045332; GO:0045806; GO:0050766; GO:0070374; GO:0090554; GO:0090556; GO:0097386; GO:0140328; GO:0140359; GO:0150094; GO:1900223; GO:1901076; GO:1902430; GO:1902991; GO:1902995; GO:1903898; GO:2000010 ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor activity [GO:0034188]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548] ALLQRPR 0.95286 3.3218 0 0 0 0 0 0 0 0 0 0 11.5062 0 11.5871 0 0 12.6227 12.5562 0 0 13.802 0 13.1285 0 0 0 0 12.6529 14.0606 0 0 0 0 0 13.2537 13.8724 0 0 9.68641 0 0 0 14.3281 13.9599 13.856 14.5092 11.6101 0 0 12.2815 0 12.8034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.852 14.1408 0 12.9257 11.2552 10.1246 0 12.9048 0 0 13.7066 0 14.3387 14.7733 0 0 13.8352 0 14.3125 0 14.5555 13.3058 13.7302 0 15.7919 15.9198 15.7718 15.8682 14.5512 14.4415 12.8479 0 0 14.8385 15.5122 14.9824 0 14.4809 15.1252 14.8673 15.6988 0 16.169 0 13.6703 13.128 13.6533 15.3181 16.0696 15.1688 15.7128 15.0686 0 0 15.7763 15.1051 14.6277 0 16.0167 13.8729 0 12.885 16.1829 0 13.2266 15.6527 13.9899 15.2855 15.4979 0 15.4215 13.5113 12.4248 16.2331 15.0984 15.2112 14.0875 12.5013 12.2416 0 0 0 14.5986 13.4812 12.5356 14.7423 13.8781 0 15.3754 0 0 15.2038 0 0 13.2333 12.4731 13.8305 0 12.7974 0 12.4994 14.9355 11.9363 0 14.8389 0 12.4448 13.2596 12.0196 12.7855 0 11.269 Q9BSJ2 GCP2_HUMAN "Gamma-tubulin complex component 2, GCP-2, hGCP2 (Gamma-ring complex protein 103 kDa, h103p, hGrip103) (Spindle pole body protein Spc97 homolog, hSpc97)" TUBGCP2 GCP2 Homo sapiens (Human) brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; brain development [GO:0007420]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0001764; GO:0005654; GO:0005813; GO:0005815; GO:0005829; GO:0005881; GO:0007020; GO:0007420; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0065003 gamma-tubulin binding [GO:0043015] GPPAPAPRVAVTAQ 0.95287 2.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1785 0 0 0 0 0 0 0 0 11.6313 0 0 0 0 0 0 12.973 0 0 0 0 0 0 0 0 0 0 0 0 15.4125 0 0 0 0 0 0 11.7514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1712 0 0 0 0 11.3599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4656 13.7576 13.4533 12.9713 12.9137 0 0 0 0 0 0 0 0 0 0 0 0 P0DTW1 GAGE1_HUMAN "G antigen 1, GAGE-1 (Antigen MZ2-F) (Cancer/testis antigen 4.1, CT4.1)" GAGE1 Homo sapiens (Human) PEADSQEQGHPQTGCECEDGPDGQEMDPPNPEEVK 0.95288 0.82577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2145 0 0 0 0 0 0 0 0 0 12.9555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12907 LMAN2_HUMAN "Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36, VIP36)" LMAN2 C5orf8 Homo sapiens (Human) "endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] "cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005537; GO:0005615; GO:0005789; GO:0005793; GO:0005794; GO:0005887; GO:0006888; GO:0006890; GO:0007029; GO:0007030; GO:0009986; GO:0015031; GO:0030134; GO:0030246; GO:0031072; GO:0033116; GO:0046872; GO:0050766; GO:0070062 carbohydrate binding [GO:0030246]; heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872] EGSIWNHQPCFLKDWEMHVHFK 0.95288 0.66011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9603 0 0 0 0 14.6703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.005 0 0 0 0 0 0 0 0 0 14.5426 0 0 0 0 0 14.8488 0 0 0 0 0 0 0 0 Q8NDA2 HMCN2_HUMAN Hemicentin-2 HMCN2 Homo sapiens (Human) response to stimulus [GO:0050896] cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; response to stimulus [GO:0050896] GO:0005509; GO:0005615; GO:0031012; GO:0032154; GO:0050896; GO:0062023 calcium ion binding [GO:0005509] AAVEVANPGSFIYVFSDARAK 0.95291 2.7869 0 0 0 0 0 0 16.2101 0 13.2633 0 0 0 0 0 0 0 12.0253 0 0 12.5608 0 0 11.9135 13.5175 11.9885 0 13.5063 13.2043 12.5097 0 14.1073 0 0 16.4766 0 0 16.7227 12.9496 0 0 0 0 0 10.8184 14.2443 0 0 0 11.2862 0 0 13.4525 12.2532 0 0 0 0 0 0 0 0 0 0 0 0 12.5642 0 0 12.0144 13.3973 12.4769 0 12.6914 13.6022 0 0 0 0 0 0 0 0 11.0525 14.6321 15.6381 16.5086 12.9599 14.1415 0 0 13.4971 0 0 0 15.1311 12.7157 0 14.1504 11.0517 0 14.3178 0 13.3626 0 15.2781 0 14.3054 14.2401 13.9027 0 12.859 14.9455 0 14.3744 0 16.1241 0 0 15.4864 0 12.8071 12.5121 13.9333 0 0 0 12.4137 0 13.6199 14.2466 0 0 0 0 0 0 0 12.1849 0 0 14.5997 13.2359 0 13.1212 0 12.9557 11.7183 0 14.2371 0 0 11.3325 14.4168 0 0 13.0539 0 0 0 13.5077 18.2143 0 0 0 13.5893 18.7617 0 17.3185 0 11.6406 14.7195 0 0 0 0 0 13.1497 14.8004 13.4493 0 Q96GU1 PAGE5_HUMAN "P antigen family member 5, PAGE-5 (Cancer/testis antigen 16.1, CT16.1) (G antigen family E member 1) (Prostate-associated gene 5 protein)" PAGE5 GAGEE1 Homo sapiens (Human) GWAGTREEVRDMSEHVTR 0.95294 0.82421 0 0 0 0 0 0 0 0 0 0 0 12.9451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4E5 RHOJ_HUMAN Rho-related GTP-binding protein RhoJ (Ras-like protein family member 7B) (Tc10-like GTP-binding protein) RHOJ ARHJ RASL7B RHOI TCL Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]; retina vasculature morphogenesis in camera-type eye [GO:0061299] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670]; retina vasculature morphogenesis in camera-type eye [GO:0061299] GO:0001525; GO:0003924; GO:0005525; GO:0005886; GO:0006897; GO:0007163; GO:0008360; GO:0010594; GO:0030036; GO:0032488; GO:0061299; GO:0070062; GO:0090050; GO:1903670 GTP binding [GO:0005525]; GTPase activity [GO:0003924] EGTDSSCGCRGNDEKK 0.95294 4.5761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3858 0 12.6184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7532 11.5273 0 0 0 0 0 0 9.67179 0 0 0 0 10.8696 0 0 0 0 0 0 0 0 0 0 0 10.7248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7715 0 0 0 10.6865 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPR9 GP108_HUMAN Protein GPR108 (Lung seven transmembrane receptor 2) GPR108 LUSTR2 Homo sapiens (Human) negative regulation of toll-like receptor signaling pathway [GO:0034122]; regulation of immune response [GO:0050776] cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; regulation of immune response [GO:0050776] GO:0000139; GO:0005794; GO:0005802; GO:0016020; GO:0016021; GO:0033106; GO:0034122; GO:0050776 EILFLVDLICCGAILFPVVWSIRHLQDASGTDGK 0.95294 3.3204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8493 11.5878 0 0 14.2728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0012 0 0 0 11.0505 0 0 0 0 10.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNW8 GP132_HUMAN Probable G-protein coupled receptor 132 (G2 accumulation protein) GPR132 G2A Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] GO:0000082; GO:0004930; GO:0005886; GO:0010972; GO:0016021 G protein-coupled receptor activity [GO:0004930] ETCFDMLQMDSR 0.95294 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0475 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZWK4 RHEX_HUMAN Regulator of hemoglobinization and erythroid cell expansion protein (Regulator of human erythroid cell expansion protein) RHEX C1orf186 Homo sapiens (Human) cellular response to erythropoietin [GO:0036018]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; positive regulation of erythrocyte differentiation [GO:0045648] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; erythropoietin receptor binding [GO:0005128]; cellular response to erythropoietin [GO:0036018]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; positive regulation of erythrocyte differentiation [GO:0045648] GO:0005128; GO:0005886; GO:0016021; GO:0036018; GO:0038162; GO:0043249; GO:0045648 erythropoietin receptor binding [GO:0005128] EITDYVNVNPER 0.95295 0.79311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FB5 MT25B_HUMAN Methyltransferase-like protein 25B (Protein RRNAD1) (Ribosomal RNA adenine dimethylase domain-containing protein 1) METTL25B C1orf66 RRNAD1 CGI-41 Homo sapiens (Human) integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" GO:0000179; GO:0016021 "rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" KQLAVNLTRVLALYR 0.95295 0.82397 0 0 0 0 0 0 0 0 0 0 13.9349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4079 0 0 0 0 0 0 0 0 0 0 0 13.6702 0 0 0 0 P35346 SSR5_HUMAN "Somatostatin receptor type 5, SS-5-R, SS5-R, SS5R, SST5" SSTR5 Homo sapiens (Human) "cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796]" integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467]; regulation of insulin secretion [GO:0050796]" GO:0004930; GO:0004994; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007218; GO:0008285; GO:0032467; GO:0042277; GO:0042923; GO:0043005; GO:0050796; GO:0071385 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994] AVLVPVLYLLVCAAGLGGNTLVIYVVLRFAK 0.95297 2.7849 0 0 0 0 0 0 0 0 0 13.2673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5358 0 0 0 0 0 0 0 15.6536 14.8083 15.2496 0 12.6824 0 0 0 15.53 0 14.0449 14.3695 13.7161 14.528 14.1376 14.0639 0 0 13.3887 0 0 0 12.8412 0 0 13.7816 0 0 0 14.2405 13.9424 0 13.3647 0 0 0 0 0 0 0 13.1249 0 0 0 0 0 0 13.3708 0 13.6179 0 0 0 0 0 0 0 0 0 0 11.8713 0 0 13.366 0 0 0 0 0 0 0 0 0 11.4099 0 11.9321 0 0 0 0 0 13.167 0 0 0 0 11.6557 0 0 0 13.1945 0 0 11.2563 13.083 0 0 Q86WA9 S2611_HUMAN Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11) SLC26A11 Homo sapiens (Human) ion transport [GO:0006811]; sulfate transport [GO:0008272] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; ion transport [GO:0006811]; sulfate transport [GO:0008272] GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0008272; GO:0008509; GO:0015116; GO:0015301; GO:0016021; GO:0043231; GO:0070062 anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] GLVWAATTAR 0.953 3.9773 0 0 13.8764 0 11.9947 0 0 13.14 0 0 0 0 14.2688 13.932 14.7402 0 0 0 0 0 0 0 13.7146 0 0 0 0 14.6523 14.625 0 0 0 0 0 0 0 12.4544 0 0 0 13.9056 0 0 0 0 14.4527 14.1559 0 0 0 0 0 12.3343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4092 0 0 13.239 0 0 0 0 0 0 0 0 0 0 0 0 13.2352 0 0 0 0 0 0 0 14.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6421 0 0 0 0 0 12.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2G6 ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 ZCCHC24 C10orf56 Homo sapiens (Human) RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0008270 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] CFGEYKCPKCK 0.95302 0.66183 0 10.4323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7925 0 0 14.9513 0 0 0 0 0 0 0 0 0 15.8624 0 0 0 12.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5751 0 0 0 0 0 0 Q86XN8 MEX3D_HUMAN RNA-binding protein MEX3D (RING finger and KH domain-containing protein 1) (RING finger protein 193) (TINO) MEX3D KIAA2031 RKHD1 RNF193 Homo sapiens (Human) mRNA destabilization [GO:0061157]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; mRNA destabilization [GO:0061157]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609] GO:0003723; GO:0005634; GO:0010609; GO:0035925; GO:0046872; GO:0048471; GO:0061157 metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723] LELPLSRRGAPDPVGALSWR 0.95303 0.81919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4 0 0 0 0 0 0 0 0 0 0 0 0 P54922 ADPRH_HUMAN "ADP-ribosylhydrolase ARH1, EC 3.2.2.19 (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase, ADP-ribosylarginine hydrolase, hARH1)" ADPRH ARH1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211]; regulation of autophagosome assembly [GO:2000785] autophagosome [GO:0005776]; cytosol [GO:0005829]; extracellular space [GO:0005615]; recycling endosome [GO:0055037] autophagosome [GO:0005776]; cytosol [GO:0005829]; extracellular space [GO:0005615]; recycling endosome [GO:0055037]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; activation of GTPase activity [GO:0090630]; protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211]; regulation of autophagosome assembly [GO:2000785] GO:0000287; GO:0003875; GO:0005096; GO:0005615; GO:0005776; GO:0005829; GO:0030955; GO:0036211; GO:0051725; GO:0055037; GO:0090630; GO:2000785 ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955] LTQLYYLLAKHYQDCMEDMDGR 0.95309 0.66011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07507 DERM_HUMAN "Dermatopontin (Tyrosine-rich acidic matrix protein, TRAMP)" DPT Homo sapiens (Human) cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; negative regulation of cell population proliferation [GO:0008285] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; negative regulation of cell population proliferation [GO:0008285] GO:0005201; GO:0005615; GO:0007155; GO:0008285; GO:0030199; GO:0062023 extracellular matrix structural constituent [GO:0005201] EWQFYCCRYSK 0.95309 0.82656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8261 0 Q96HV5 TM41A_HUMAN Transmembrane protein 41A TMEM41A UNQ168/PRO194 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 KVEENRNSLFFFLLFLR 0.95309 3.6534 0 0 0 0 0 0 0 0 0 0 0 12.5876 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9378 0 0 0 0 0 0 0 0 11.6172 0 0 0 0 0 0 0 0 11.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9432 14.7731 0 0 14.2696 0 0 0 0 0 0 0 0 0 13.3208 14.0076 14.9161 0 0 13.248 13.208 0 13.3274 15.3611 0 0 13.343 13.5436 0 13.3877 0 0 0 0 0 0 0 13.2761 0 0 0 0 14.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72857 0 0 0 0 0 0 0 0 0 0 0 0 12.0936 0 0 Q9UQ53 MGT4B_HUMAN "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, EC 2.4.1.145 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb, GlcNAc-T IVb, GnT-IVb, N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)" MGAT4B UNQ906/PRO1927 Homo sapiens (Human) N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]" GO:0000139; GO:0005783; GO:0005793; GO:0005795; GO:0006486; GO:0006487; GO:0006491; GO:0008375; GO:0008454; GO:0016021; GO:0019082; GO:0046872 "acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]" DAKHCDR 0.95309 2.7282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1956 0 0 0 11.5911 0 0 0 0 0 0 0 13.6709 0 13.9275 0 0 0 13.2137 0 0 0 0 14.558 0 0 0 0 0 0 0 0 12.5552 0 0 0 0 0 0 0 11.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9508 0 0 0 0 0 0 0 0 0 0 0 0 12.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD19 NEK9_HUMAN "Serine/threonine-protein kinase Nek9, EC 2.7.11.1 (Nercc1 kinase) (Never in mitosis A-related kinase 9, NimA-related protein kinase 9) (NimA-related kinase 8, Nek8)" NEK9 KIAA1995 NEK8 NERCC Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0007049; GO:0019901; GO:0046872; GO:0051301; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] HCDSINSDFGSESGGCGDSSPGPSASQGPR 0.9531 3.3085 0 0 0 0 0 0 0 0 0 0 0 0 12.1101 0 0 0 0 0 0 0 0 0 11.8408 0 0 12.4112 0 0 0 0 0 0 0 0 12.5883 0 0 11.5719 0 0 0 12.2296 0 12.7493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0554 0 0 0 0 0 0 0 13.8187 0 0 0 0 12.9456 0 13.6604 0 0 0 14.0847 0 0 0 0 0 0 0 12.7827 0 0 14.0553 12.5574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0051 0 14.6044 0 0 0 0 0 0 0 0 0 12.4937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4037 0 0 0 0 0 0 0 0 0 13.2473 0 0 0 0 0 0 11.9073 0 0 0 0 0 0 0 0 P46087 NOP2_HUMAN "Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase, EC 2.1.1.- (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)" NOP2 NOL1 NSUN1 Homo sapiens (Human) maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] GO:0000027; GO:0000470; GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0008284; GO:0009383; GO:0070475; GO:1901796 RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383] GPQSLFNAPRGKK 0.95314 2.8966 0 11.6763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7688 0 0 0 0 13.6986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.431 0 11.7819 11.5663 0 0 0 0 0 11.7402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5661 0 14.0117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0162 0 0 0 0 0 0 0 0 0 12.9625 0 17.9427 13.8824 0 0 0 0 0 Q08357 S20A2_HUMAN "Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2, GLVR-2) (Phosphate transporter 2, PiT-2, Pit2, hPit2) (Solute carrier family 20 member 2)" SLC20A2 GLVR2 PIT2 Homo sapiens (Human) ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]; virus receptor activity [GO:0001618]; ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435] GO:0001618; GO:0005315; GO:0005436; GO:0005886; GO:0005887; GO:0006811; GO:0016020; GO:0035435; GO:0038023; GO:0070062 inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]; virus receptor activity [GO:0001618] AVDWRLFRNIFVAWFVTVPVAGLFSAAVMALLMYGILPYV 0.95314 2.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7032 0 0 0 0 10.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9786 13.3491 0 0 0 0 0 13.3663 14.408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0901 0 0 0 0 15.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2359 0 14.3789 0 0 0 12.5129 13.838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5968 13.5792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHQ4 BAP29_HUMAN "B-cell receptor-associated protein 29, BCR-associated protein 29, Bap29" BCAP29 BAP29 Homo sapiens (Human) apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973] GO:0001649; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0016021; GO:0070973 AFLTIIILLIVLFLDAVR 0.95316 2.8345 0 0 0 0 0 0 0 0 0 0 0 0 10.9344 0 0 0 0 0 0 0 12.0824 0 11.9567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6846 0 0 0 10.9507 0 0 0 0 0 0 0 10.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3394 0 13.649 13.9717 0 15.3689 13.6019 13.9423 14.8075 11.9942 15.4434 0 0 0 0 0 13.6783 0 0 0 0 0 0 13.0729 11.1173 0 0 11.9691 0 0 0 0 0 12.0669 0 11.61 12.769 0 0 0 0 0 0 11.0539 0 0 0 12.6481 0 0 0 14.2278 0 0 12.8344 0 12.5852 0 0 11.4215 10.7861 0 0 13.2178 0 13.0855 0 0 0 11.4355 0 0 0 0 0 0 0 0 0 0 0 0 12.5372 0 14.0885 12.2898 0 0 0 0 0 0 0 0 0 11.9726 0 0 0 0 0 0 0 0 13.6151 12.8434 10.5784 0 0 0 0 12.0554 0 Q9NUP1 BL1S4_HUMAN "Biogenesis of lysosome-related organelles complex 1 subunit 4, BLOC-1 subunit 4 (Protein cappuccino homolog)" BLOC1S4 CNO Homo sapiens (Human) anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; cytosol [GO:0005829] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527] GO:0005737; GO:0005829; GO:0008089; GO:0031083; GO:0031175; GO:0032438; GO:0048490; GO:0050885; GO:0070527; GO:1904115 TEDYFPCCSER 0.95317 0.8245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20292 AL5AP_HUMAN Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein) ALOX5AP FLAP Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; leukotriene biosynthetic process [GO:0019370]; leukotriene production involved in inflammatory response [GO:0002540]; lipoxygenase pathway [GO:0019372]; positive regulation of acute inflammatory response [GO:0002675]; protein homotrimerization [GO:0070207] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonic acid binding [GO:0050544]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; cellular response to calcium ion [GO:0071277]; leukotriene biosynthetic process [GO:0019370]; leukotriene production involved in inflammatory response [GO:0002540]; lipoxygenase pathway [GO:0019372]; positive regulation of acute inflammatory response [GO:0002675]; protein homotrimerization [GO:0070207] GO:0002540; GO:0002675; GO:0004051; GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0008047; GO:0016020; GO:0016021; GO:0019370; GO:0019372; GO:0019899; GO:0031965; GO:0042802; GO:0044877; GO:0047485; GO:0050544; GO:0070207; GO:0071277 arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonic acid binding [GO:0050544]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877] QKYFVGYLGER 0.95322 0.66191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMX1 SUFU_HUMAN "Suppressor of fused homolog, SUFUH" SUFU UNQ650/PRO1280 Homo sapiens (Human) "aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart looping [GO:0001947]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; skin development [GO:0043588]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; ventricular septum development [GO:0003281]" ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GLI-SUFU complex [GO:1990788]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart looping [GO:0001947]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural tube closure [GO:0001843]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; skin development [GO:0043588]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; smoothened signaling pathway involved in spinal cord motor neuron cell fate specification [GO:0021776]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; ventricular septum development [GO:0003281]" GO:0000122; GO:0001843; GO:0001947; GO:0003281; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007165; GO:0008013; GO:0019901; GO:0021775; GO:0021776; GO:0035904; GO:0042308; GO:0042994; GO:0043433; GO:0043588; GO:0045668; GO:0045879; GO:0060831; GO:0060976; GO:0097542; GO:0097546; GO:1901621; GO:1990787; GO:1990788; GO:2000059 beta-catenin binding [GO:0008013]; protein kinase binding [GO:0019901]; transcription corepressor activity [GO:0003714] LLHGRHFTYK 0.95322 0.82292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15699 ALX1_HUMAN "ALX homeobox protein 1 (Cartilage homeoprotein 1, CART-1)" ALX1 CART1 Homo sapiens (Human) "embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell migration [GO:0001755]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001755; GO:0005634; GO:0005654; GO:0005794; GO:0006357; GO:0010718; GO:0016604; GO:0045892; GO:0045893; GO:0045944; GO:0048704; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" DTSSCMTPYSHSPR 0.95323 0.82191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7061 0 0 0 0 0 0 0 0 0 0 13.8525 0 0 0 0 0 12.1549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0351 11.4202 0 0 0 0 0 0 0 0 0 Q05996 ZP2_HUMAN "Zona pellucida sperm-binding protein 2 (Zona pellucida glycoprotein 2, Zp-2) (Zona pellucida protein A) [Cleaved into: Processed zona pellucida sperm-binding protein 2 ]" ZP2 ZPA Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; acrosin binding [GO:0032190]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804]; binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468] GO:0005576; GO:0005771; GO:0005783; GO:0005886; GO:0007339; GO:0015026; GO:0016021; GO:0032190; GO:0035804; GO:0035805; GO:0042802; GO:0060468; GO:0062023 acrosin binding [GO:0032190]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804] CLLHQFYLASLKLTFLLR 0.95324 2.7234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4494 14.0656 0 0 0 13.9436 0 14.2019 0 0 0 15.62 0 0 0 0 0 0 0 0 0 0 14.3392 13.9994 11.5914 0 11.4005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.981 0 14.1774 0 0 11.4034 0 12.9689 0 11.4093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7K0 ZN433_HUMAN Zinc finger protein 433 ZNF433 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CKFCGKALMFLSLYLIHK 0.95325 0.82083 0 0 0 0 0 0 0 0 12.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5497 0 0 0 0 0 0 0 0 12.2583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3101 0 0 0 0 0 0 0 0 0 14.1594 14.6316 13.8249 0 0 0 0 15.1474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0149 0 11.437 0 0 0 0 0 13.6812 13.7699 14.0391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0424 11.7664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXT2 DMRTD_HUMAN Doublesex- and mab-3-related transcription factor C2 DMRTC2 Homo sapiens (Human) germ cell development [GO:0007281]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; male meiosis I [GO:0007141]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; spermatid nucleus elongation [GO:0007290] chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741] "chromatin [GO:0000785]; nucleus [GO:0005634]; XY body [GO:0001741]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; germ cell development [GO:0007281]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; male meiosis I [GO:0007141]; positive regulation of histone H3-K9 dimethylation [GO:1900111]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; spermatid nucleus elongation [GO:0007290]" GO:0000785; GO:0000978; GO:0000981; GO:0001741; GO:0005634; GO:0006357; GO:0007141; GO:0007281; GO:0007290; GO:0007548; GO:0036123; GO:0036124; GO:0042802; GO:0046872; GO:1900111; GO:1900114; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" HLMRRGEASPK 0.95326 0.82014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8688 0 0 0 0 0 0 0 0 0 0 0 0 P28907 CD38_HUMAN "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, EC 3.2.2.6 (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1, ADPRC 1) (Cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1) (T10) (CD antigen CD38)" CD38 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; artery smooth muscle contraction [GO:0014824]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; female pregnancy [GO:0007565]; long-term synaptic depression [GO:0060292]; NAD metabolic process [GO:0019674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone resorption [GO:0045779]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell growth [GO:0030307]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; response to estradiol [GO:0032355]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]" basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]; apoptotic signaling pathway [GO:0097190]; artery smooth muscle contraction [GO:0014824]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; female pregnancy [GO:0007565]; long-term synaptic depression [GO:0060292]; NAD metabolic process [GO:0019674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone resorption [GO:0045779]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell growth [GO:0030307]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; response to estradiol [GO:0032355]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]" GO:0001666; GO:0003953; GO:0005634; GO:0005886; GO:0007165; GO:0007204; GO:0007565; GO:0009410; GO:0009986; GO:0010977; GO:0014824; GO:0016020; GO:0016021; GO:0016323; GO:0016740; GO:0016849; GO:0019674; GO:0030307; GO:0030667; GO:0030890; GO:0032024; GO:0032355; GO:0032526; GO:0032570; GO:0033194; GO:0042100; GO:0042802; GO:0043066; GO:0045779; GO:0045892; GO:0045893; GO:0045907; GO:0050135; GO:0050853; GO:0060292; GO:0061809; GO:0070062; GO:0070555; GO:0097190 "identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]" AQLCLGVSILVLILVVVLAVVVPR 0.95329 3.6507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6502 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8238 0 0 11.4399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6983 0 0 0 0 0 0 0 0 0 12.5858 0 0 0 11.6691 0 0 0 0 0 0 0 0 0 0 0 0 12.1699 0 0 0 0 0 0 0 0 11.2901 0 0 0 0 0 11.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3793 0 0 0 0 13.0234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.141 Q9NV92 NFIP2_HUMAN NEDD4 family-interacting protein 2 (NEDD4 WW domain-binding protein 5A) (Putative MAPK-activating protein PM04/PM05/PM06/PM07) (Putative NF-kappa-B-activating protein 413) NDFIP2 KIAA1165 N4WBP5A Homo sapiens (Human) metal ion transport [GO:0030001]; negative regulation of gene expression [GO:0010629]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; perinuclear region of cytoplasm [GO:0048471]; WW domain binding [GO:0050699]; metal ion transport [GO:0030001]; negative regulation of gene expression [GO:0010629]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034] GO:0000139; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006511; GO:0007034; GO:0010629; GO:0016021; GO:0030001; GO:0031398; GO:0032410; GO:0032585; GO:0043123; GO:0043231; GO:0048471; GO:0050699; GO:0051224 WW domain binding [GO:0050699] NMSESMAAAHR 0.95334 0.82604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.68 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60484 PTEN_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67 (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)" PTEN MMAC1 TEP1 Homo sapiens (Human) "adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cellular senescence [GO:2000773]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of macrophage apoptotic process [GO:2000109]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell proliferation [GO:0042098]" apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular region [GO:0005576]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202] "apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular region [GO:0005576]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; Schmidt-Lanterman incisure [GO:0043220]; synapse [GO:0045202]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; lipid binding [GO:0008289]; myosin phosphatase activity [GO:0017018]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; cellular response to hypoxia [GO:0071456]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; dephosphorylation [GO:0016311]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cellular senescence [GO:2000773]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cellular localization [GO:0060341]; regulation of macrophage apoptotic process [GO:2000109]; regulation of neuron projection development [GO:0010975]; regulation of protein kinase B signaling [GO:0051896]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; T cell proliferation [GO:0042098]" GO:0001525; GO:0001933; GO:0002902; GO:0004438; GO:0004721; GO:0004722; GO:0004725; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006470; GO:0006661; GO:0006915; GO:0007270; GO:0007416; GO:0007417; GO:0007507; GO:0007611; GO:0007626; GO:0008284; GO:0008285; GO:0008289; GO:0009898; GO:0010719; GO:0010975; GO:0010977; GO:0010997; GO:0014065; GO:0014067; GO:0016311; GO:0016314; GO:0016324; GO:0016477; GO:0016605; GO:0017018; GO:0019899; GO:0019901; GO:0021542; GO:0021955; GO:0030165; GO:0030336; GO:0030534; GO:0030889; GO:0031642; GO:0031647; GO:0032228; GO:0032286; GO:0032535; GO:0033137; GO:0033555; GO:0035176; GO:0035749; GO:0042098; GO:0042100; GO:0042130; GO:0042711; GO:0042802; GO:0042995; GO:0043005; GO:0043066; GO:0043220; GO:0043491; GO:0043542; GO:0045202; GO:0045475; GO:0045736; GO:0045792; GO:0046621; GO:0046855; GO:0046856; GO:0048681; GO:0048738; GO:0048853; GO:0048854; GO:0048870; GO:0050680; GO:0050771; GO:0050821; GO:0051091; GO:0051548; GO:0051717; GO:0051800; GO:0051895; GO:0051896; GO:0051898; GO:0060024; GO:0060044; GO:0060070; GO:0060074; GO:0060134; GO:0060179; GO:0060291; GO:0060341; GO:0060736; GO:0060997; GO:0061002; GO:0070373; GO:0070374; GO:0071257; GO:0071456; GO:0090071; GO:0090394; GO:0097105; GO:0097107; GO:1902807; GO:1903690; GO:1903984; GO:1904668; GO:1904706; GO:1990381; GO:2000060; GO:2000109; GO:2000134; GO:2000463; GO:2000773; GO:2000808 "anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; lipid binding [GO:0008289]; myosin phosphatase activity [GO:0017018]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin-specific protease binding [GO:1990381]" GVTIPSQRRYVYYYSYLLK 0.95336 2.7535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5334 14.8722 0 0 0 14.9438 0 0 0 0 0 0 0 0 14.3135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0602 14.9617 0 0 0 14.123 14.0191 14.7307 0 0 0 0 0 0 0 0 0 0 0 14.0289 14.7425 14.9384 0 0 0 0 0 0 0 0 0 0 14.5051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2868 Q9H5J0 ZBTB3_HUMAN Zinc finger and BTB domain-containing protein 3 ZBTB3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AVLASCSPFFQLFYK 0.95337 0.78648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1844 0 0 11.5544 12.254 12.5579 0 0 0 0 0 0 0 13.9633 0 0 0 0 0 0 0 14.1074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4667 0 0 14.5939 0 0 0 0 0 0 0 0 14.4638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0939 0 0 0 P15692 VEGFA_HUMAN "Vascular endothelial growth factor A, VEGF-A (Vascular permeability factor, VPF)" VEGFA VEGF Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; induction of positive chemotaxis [GO:0050930]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172]; activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; induction of positive chemotaxis [GO:0050930]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190] GO:0000122; GO:0001525; GO:0001541; GO:0001569; GO:0001570; GO:0001666; GO:0001701; GO:0001822; GO:0001934; GO:0001938; GO:0001968; GO:0002040; GO:0002042; GO:0002052; GO:0002092; GO:0002575; GO:0002687; GO:0003007; GO:0003151; GO:0003169; GO:0005125; GO:0005161; GO:0005172; GO:0005576; GO:0005615; GO:0005737; GO:0005912; GO:0006357; GO:0007399; GO:0007498; GO:0007595; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009986; GO:0010595; GO:0010628; GO:0010629; GO:0010749; GO:0014068; GO:0016020; GO:0030141; GO:0030224; GO:0030225; GO:0030324; GO:0030335; GO:0030855; GO:0031012; GO:0031077; GO:0031093; GO:0031334; GO:0031954; GO:0032147; GO:0032793; GO:0033138; GO:0035148; GO:0035767; GO:0035924; GO:0036303; GO:0036324; GO:0038033; GO:0038084; GO:0038089; GO:0038091; GO:0038190; GO:0038191; GO:0042056; GO:0042327; GO:0042462; GO:0042802; GO:0042803; GO:0043066; GO:0043117; GO:0043129; GO:0043154; GO:0043183; GO:0043184; GO:0043406; GO:0043410; GO:0043536; GO:0045766; GO:0045785; GO:0045944; GO:0048010; GO:0048018; GO:0048469; GO:0048593; GO:0048842; GO:0048844; GO:0050679; GO:0050731; GO:0050840; GO:0050918; GO:0050927; GO:0050930; GO:0051781; GO:0051894; GO:0051897; GO:0055013; GO:0060319; GO:0060749; GO:0060754; GO:0060948; GO:0060982; GO:0061042; GO:0061419; GO:0070374; GO:0071456; GO:0071542; GO:0071679; GO:0090037; GO:0090050; GO:0090190; GO:0090259; GO:0097475; GO:0097533; GO:0120162; GO:1900086; GO:1900745; GO:1901165; GO:1901727; GO:1902336; GO:1902966; GO:1903141; GO:1903392; GO:1903572; GO:1903589; GO:1903672; GO:1905278; GO:1905604; GO:2000048; GO:2000573 chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172] CCLMPWSLPGPHPCGPCSERRK 0.95339 2.718 0 0 0 0 0 0 0 0 0 0 0 0 12.4409 0 10.7934 0 0 13.5085 0 0 0 0 0 0 0 0 0 0 0 12.5424 0 0 0 0 0 0 0 0 13.7986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2736 0 0 0 0 0 12.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6803 0 12.2926 0 0 0 0 0 0 0 0 0 0 0 12.4875 0 0 0 0 0 0 0 11.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1779 0 0 0 0 0 0 0 0 0 0 P0DL12 SIM17_HUMAN Small integral membrane protein 17 SMIM17 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AWEKPPHPACTK 0.9534 0.82519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAW8 UD110_HUMAN "UDP-glucuronosyltransferase 1A10, UGT1A10, EC 2.4.1.17 (UDP-glucuronosyltransferase 1-10, UDPGT 1-10, UGT1*10, UGT1-10, UGT1.10) (UDP-glucuronosyltransferase 1-J, UGT-1J, UGT1J)" UGT1A10 GNT1 UGT1 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic metabolic process [GO:0006805] GO:0001889; GO:0005080; GO:0005783; GO:0005789; GO:0006629; GO:0006805; GO:0015020; GO:0016021; GO:0019899; GO:0042803; GO:0045922; GO:0046982; GO:0051552; GO:0052695; GO:1904224; GO:2001030 enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080] LILRGHEVVVVMPEVSWQLER 0.9534 0.66251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13469 NFAC2_HUMAN "Nuclear factor of activated T-cells, cytoplasmic 2, NF-ATc2, NFATc2 (NFAT pre-existing subunit, NF-ATp) (T-cell transcription factor NFAT1)" NFATC2 NFAT1 NFATP Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; calcineurin-NFAT signaling cascade [GO:0033173]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; myotube cell development [GO:0014904]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatase binding [GO:0019902]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell receptor signaling pathway [GO:0050853]; calcineurin-NFAT signaling cascade [GO:0033173]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; myotube cell development [GO:0014904]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0006974; GO:0009410; GO:0010628; GO:0014904; GO:0016477; GO:0019902; GO:0030890; GO:0033173; GO:0035976; GO:0045893; GO:0050853; GO:1901741; GO:1905064; GO:1990837; GO:1990904 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatase binding [GO:0019902]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" IEITPSHELIQAVGPLR 0.95345 0.82304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1521 0 0 0 0 0 0 0 0 0 0 0 0 14.064 0 0 0 0 0 0 0 0 0 0 0 13.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6861 0 12.7728 0 0 0 13.2877 0 0 0 0 13.855 0 0 0 0 0 0 0 0 0 0 12.6983 0 0 0 0 0 12.5858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04279 SEMG1_HUMAN "Semenogelin-1 (Cancer/testis antigen 103) (Semenogelin I, SGI) [Cleaved into: Alpha-inhibin-92; Alpha-inhibin-31; Seminal basic protein ]" SEMG1 SEMG Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; coagulation [GO:0050817]; insemination [GO:0007320]; killing of cells of another organism [GO:0031640]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; zinc ion binding [GO:0008270]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; coagulation [GO:0050817]; insemination [GO:0007320]; killing of cells of another organism [GO:0031640]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; positive regulation of serine-type endopeptidase activity [GO:1900005]; sperm capacitation [GO:0048240] GO:0005576; GO:0005615; GO:0005634; GO:0007320; GO:0008270; GO:0019731; GO:0031640; GO:0032991; GO:0048240; GO:0050817; GO:0061844; GO:0070062; GO:0090281; GO:1900005; GO:1901318 zinc ion binding [GO:0008270] ISYQSSSTEERR 0.95346 2.7523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8355 0 0 0 0 0 0 16.0064 14.4053 0 0 0 0 11.8445 0 0 0 0 15.095 0 0 0 0 0 0 13.7575 0 0 14.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9227 13.925 0 0 0 0 0 0 0 0 0 0 0 0 14.1895 13.7214 14.931 0 0 0 0 13.862 13.6975 0 14.2774 0 0 11.673 14.7124 0 0 0 0 12.9526 0 13.4857 0 0 0 14.6567 0 0 0 0 10.7449 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2533 0 0 0 0 12.6727 Q4AC99 1A1L2_HUMAN "Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2, ACC synthase-like protein 2" ACCSL Homo sapiens (Human) biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520] pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520] GO:0006520; GO:0008483; GO:0009058; GO:0030170 pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] ALEIPFHNRSSGLYVWINLKK 0.95349 3.9543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2013 13.6098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2238 15.3204 14.4404 15.9284 13.0023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6414 0 0 0 0 0 0 12.1027 0 0 0 0 0 0 14.859 0 0 0 0 0 0 12.1523 11.9564 0 0 0 13.6884 13.6622 13.9465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13263 TIF1B_HUMAN "Transcription intermediary factor 1-beta, TIF1-beta (E3 SUMO-protein ligase TRIM28, EC 2.3.2.27) (KRAB-associated protein 1, KAP-1) (KRAB-interacting protein 1, KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)" TRIM28 KAP1 RNF96 TIF1B Homo sapiens (Human) "chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]; suppression of viral release by host [GO:0044790]" chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]; suppression of viral release by host [GO:0044790]" GO:0000122; GO:0000785; GO:0000791; GO:0000792; GO:0001837; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0007265; GO:0007566; GO:0008270; GO:0016925; GO:0019789; GO:0031625; GO:0032991; GO:0035851; GO:0042307; GO:0043045; GO:0043388; GO:0044790; GO:0045087; GO:0045739; GO:0045869; GO:0045892; GO:0045893; GO:0046777; GO:0060028; GO:0060669; GO:0070087; GO:0090309; GO:0090575; GO:1901536; GO:1990841; GO:2000653 chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] DCQLNAHK 0.95361 0.78598 0 0 0 10.8425 0 0 0 0 0 0 0 0 14.9788 0 14.7835 0 0 0 0 0 15.2438 0 0 0 14.0373 0 0 0 14.3178 0 0 0 15.8794 0 0 0 0 0 0 0 10.2188 13.6414 13.3304 0 0 0 0 0 0 0 11.5622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0807 0 0 0 0 0 0 0 0 0 14.6002 0 0 0 16.5926 0 0 0 0 0 0 0 0 0 0 14.9487 0 16.1048 0 0 11.5028 0 12.8185 0 15.3641 0 11.9993 13.4754 12.0105 13.7366 0 0 0 0 0 0 12.8198 0 0 0 0 0 0 0 14.7296 0 15.6566 0 0 0 14.9533 15.6523 0 0 0 0 15.5157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.664 0 0 0 0 0 15.5366 11.684 0 0 0 0 0 Q9H5Z6 F124B_HUMAN Protein FAM124B FAM124B Homo sapiens (Human) mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] GO:0005654; GO:0005739 EEDEEEFFI 0.95361 0.6591 0 0 0 0 0 0 0 0 12.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SM3 CPXM1_HUMAN "Probable carboxypeptidase X1, EC 3.4.17.- (Metallocarboxypeptidase CPX-1)" CPXM1 CPX1 CPXM UNQ3015/PRO9782 Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485] GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] QRLRELLAAGAK 0.95363 0.78524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZL4 HPBP1_HUMAN "Hsp70-binding protein 1, HspBP1 (Heat shock protein-binding protein 1) (Hsp70-binding protein 2, HspBP2) (Hsp70-interacting protein 1) (Hsp70-interacting protein 2)" HSPBP1 HSPBP PP1845 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein folding [GO:0006457] adenyl-nucleotide exchange factor activity [GO:0000774]; enzyme inhibitor activity [GO:0004857]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein folding [GO:0006457] GO:0000774; GO:0004857; GO:0006457; GO:0031398; GO:0031625; GO:0032436 adenyl-nucleotide exchange factor activity [GO:0000774]; enzyme inhibitor activity [GO:0004857]; ubiquitin protein ligase binding [GO:0031625] LDGFSVLMR 0.95364 0.78451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3048 0 12.2464 0 0 0 0 0 0 0 0 0 12.2351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKU9 ANGL2_HUMAN Angiopoietin-related protein 2 (Angiopoietin-like protein 2) ANGPTL2 ARP2 UNQ170/PRO196 Homo sapiens (Human) cell-cell signaling [GO:0007267] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; cell-cell signaling [GO:0007267] GO:0005102; GO:0005615; GO:0007267; GO:0062023; GO:0070062 signaling receptor binding [GO:0005102] GGSYSLKKVVMMIR 0.95366 2.7439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4227 0 0 13.5564 0 0 0 0 0 0 0 0 0 0 0 0 14.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3421 0 0 0 0 15.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5375 0 0 12.8787 0 0 0 0 11.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Q6 TNR11_HUMAN "Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor, ODFR) (Receptor activator of NF-KB) (CD antigen CD265)" TNFRSF11A RANK Homo sapiens (Human) adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; circadian temperature homeostasis [GO:0060086]; lymph node development [GO:0048535]; mammary gland alveolus development [GO:0060749]; monocyte chemotaxis [GO:0002548]; multinuclear osteoclast differentiation [GO:0072674]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; TNFSF11-mediated signaling pathway [GO:0071847]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; tumor necrosis factor receptor activity [GO:0005031]; adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; circadian temperature homeostasis [GO:0060086]; lymph node development [GO:0048535]; mammary gland alveolus development [GO:0060749]; monocyte chemotaxis [GO:0002548]; multinuclear osteoclast differentiation [GO:0072674]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to radiation [GO:0009314]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; TNFSF11-mediated signaling pathway [GO:0071847]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0001503; GO:0002250; GO:0002548; GO:0004888; GO:0005031; GO:0005829; GO:0005886; GO:0007165; GO:0007267; GO:0008284; GO:0009314; GO:0009897; GO:0016021; GO:0019955; GO:0030316; GO:0032496; GO:0033209; GO:0034097; GO:0034612; GO:0038023; GO:0043507; GO:0045780; GO:0046872; GO:0048535; GO:0051091; GO:0051092; GO:0060086; GO:0060749; GO:0070555; GO:0071812; GO:0071847; GO:0071848; GO:0072674 cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; tumor necrosis factor receptor activity [GO:0005031] HYEHLGRCCNK 0.95368 2.8497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2857 12.2029 0 0 0 0 0 11.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9719 0 0 0 0 0 0 0 12.2005 0 0 0 0 12.9818 0 0 0 0 0 0 0 0 0 14.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A286YEV6 SCGR4_HUMAN Small cysteine and glycine repeat-containing protein 4 (Keratin-associated protein 28-4) SCYGR4 KRTAP28-4 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CCCQKQCCC 0.9537 4.8117 0 0 0 0 10.9212 0 0 0 0 0 12.5594 10.814 0 0 0 0 0 10.4911 0 12.0755 0 11.5222 0 0 0 0 0 14.7223 0 0 0 11.7168 0 11.0179 10.6571 0 12.1484 0 0 0 13.311 0 11.977 0 0 0 0 0 0 0 13.4833 0 10.1522 0 0 0 11.4354 0 13.2333 0 0 0 0 0 0 0 13.8426 0 15.832 12.1456 13.2347 0 13.7919 11.1629 12.3585 15.2188 0 0 0 0 13.6374 0 15.5896 0 0 0 10.6425 16.4397 0 16.8375 12.3691 0 13.8341 13.6573 14.4591 0 14.5515 14.4592 11.5612 16.3829 0 0 16.2534 0 15.8884 14.5407 0 13.6289 15.1392 12.9503 0 0 15.5596 14.5105 15.4092 0 14.3259 0 0 11.2292 13.2884 14.5014 11.191 14.0613 15.4846 0 0 14.6333 0 15.0351 14.9248 13.1944 15.4634 13.3228 0 15.8782 0 14.768 12.6457 15.1209 14.5992 13.4363 11.3245 0 14.4235 0 11.5874 12.0479 0 0 0 0 13.6924 14.7283 0 13.8317 0 0 0 0 0 10.3114 0 0 0 0 0 0 11.503 0 0 0 12.9379 10.8711 0 0 11.938 11.9297 0 0 Q8N3F0 MTURN_HUMAN Maturin (Maturin neural progenitor differentiation regulator protein homolog) (Protein Ells1) MTURN C7orf41 Homo sapiens (Human) negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of signaling [GO:0023051] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of signaling [GO:0023051] GO:0005737; GO:0023051; GO:0032088; GO:0045654; GO:0046330; GO:0070374 PLLGLPDADDDAFEEYSADVEEEEPEADHPQMGVSQQ 0.9537 0.65694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0818 0 0 0 13.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1967 0 0 0 0 0 0 0 0 0 12.5414 0 0 0 0 0 0 0 0 0 0 0 12.7074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBU6 FA8A1_HUMAN Protein FAM8A1 (Autosomal highly conserved protein) FAM8A1 AHCP Homo sapiens (Human) ubiquitin-dependent ERAD pathway [GO:0030433] Hrd1p ubiquitin ligase complex [GO:0000836]; integral component of membrane [GO:0016021] Hrd1p ubiquitin ligase complex [GO:0000836]; integral component of membrane [GO:0016021]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000836; GO:0016021; GO:0030433 VLVIPSSNVSITTSTIR 0.95371 0.65662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96R27 OR2M4_HUMAN Olfactory receptor 2M4 (HTPCRX18) (OST710) (Olfactory receptor OR1-55) (Olfactory receptor TPCR100) OR2M4 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LLVICCVVMLIFPVSVIILSYSHVLR 0.95377 0.63758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4107 0 0 0 13.2215 0 0 0 0 14.2178 13.5561 0 0 0 0 12.7866 13.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4105 0 0 0 12.1517 0 0 12.7004 0 0 0 11.9207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5833 0 0 0 0 0 0 0 0 0 0 0 0 Q6IPR1 ETFR1_HUMAN Electron transfer flavoprotein regulatory factor 1 (LYR motif-containing protein 5) ETFRF1 LYRM5 Homo sapiens (Human) respiratory electron transport chain [GO:0022904] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; respiratory electron transport chain [GO:0022904] GO:0005739; GO:0022904 ELEALYFLRKYR 0.95378 0.63757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7133 14.481 0 0 0 0 0 0 12.275 0 0 0 0 0 0 0 0 0 0 0 12.8503 0 12.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAY2 MAGF1_HUMAN "Melanoma-associated antigen F1, MAGE-F1 (MAGE-F1 antigen)" MAGEF1 Homo sapiens (Human) negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; protein ubiquitination [GO:0016567] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; protein ubiquitination [GO:0016567] GO:0000122; GO:0005634; GO:0016567; GO:0097428; GO:2000042; GO:2000060 AAEHLRYVFGFELK 0.95379 2.8472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4245 0 0 0 0 0 0 0 10.7326 0 0 0 0 11.6012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1741 13.44 14.2154 0 0 0 0 0 0 0 14.6673 0 12.9546 0 16.6968 12.1813 14.2316 0 10.4007 0 0 0 0 0 0 0 0 13.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0727 14.2164 0 0 0 0 0 12.1794 0 0 0 0 0 14.2841 0 0 0 0 0 0 0 0 0 0 15.4547 14.471 14.8702 0 12.3917 17.6014 0 14.5755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0165 0 0 0 11.8968 15.4578 0 0 0 0 15.7626 0 0 0 P98077 SHC2_HUMAN "SHC-transforming protein 2 (Protein Sck) (SHC-transforming protein B) (Src homology 2 domain-containing-transforming protein C2, SH2 domain protein C2)" SHC2 SCK SHCB Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; intracellular signal transduction [GO:0035556]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005829; GO:0005886; GO:0007169; GO:0019901; GO:0030971; GO:0035556; GO:0043410 protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] APNKALASVLGKSNLR 0.9538 3.2922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3622 0 0 0 0 0 0 9.34685 0 0 0 9.6576 0 13.8092 9.8046 0 0 0 0 0 0 0 0 0 0 10.9726 0 0 0 0 0 0 0 0 0 0 14.7435 0 0 0 0 0 0 0 13.5779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94619 0 0 0 9.14088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4766 0 0 0 0 0 0 0 0 0 0 0 0 P0C864 DANCR_HUMAN Putative uncharacterized protein DANCR (Anti-differentiation ncRNA protein) (Differentiation antagonizing non-protein coding RNA) (Small nucleolar RNA host gene protein 13) DANCR ANCR KIAA0114 SNHG13 Homo sapiens (Human) SQASLSAGVARADAPLCSGFR 0.95381 0.66251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C5Y4 KRA14_HUMAN Keratin-associated protein 1-4 (High sulfur keratin-associated protein 1.4) (Keratin-associated protein 1.4) KRTAP1-4 KAP1.4 KRTAP1.4 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 PACCCHCCEPTC 0.95382 0.63571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9173 11.4628 0 0 11.2258 0 0 0 11.643 0 12.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1778 0 0 0 0 0 P27469 G0S2_HUMAN G0/G1 switch protein 2 (G0/G1 switch regulatory protein 2) (Putative lymphocyte G0/G1 switch gene) G0S2 Homo sapiens (Human) extrinsic apoptotic signaling pathway [GO:0097191]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238] lipid droplet [GO:0005811]; mitochondrion [GO:0005739] lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; extrinsic apoptotic signaling pathway [GO:0097191]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238] GO:0005739; GO:0005811; GO:0097191; GO:0120162; GO:2001238 QALQKQALQEKGK 0.95382 0.78651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTX7 RN146_HUMAN "E3 ubiquitin-protein ligase RNF146, EC 2.3.2.27 (Dactylidin) (Iduna) (RING finger protein 146) (RING-type E3 ubiquitin transferase RNF146)" RNF146 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263 poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GEGEEDHESPSSGR 0.95386 0.65775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6387 0 0 0 14.5917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32970 CD70_HUMAN "CD70 antigen (CD27 ligand, CD27-L) (Tumor necrosis factor ligand superfamily member 7) (CD antigen CD70)" CD70 CD27L CD27LG TNFSF7 Homo sapiens (Human) B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway [GO:0097191]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]; tumor necrosis factor-mediated signaling pathway [GO:0033209] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway [GO:0097191]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0002020; GO:0002456; GO:0005102; GO:0005125; GO:0005164; GO:0005886; GO:0005887; GO:0007165; GO:0007267; GO:0019724; GO:0033209; GO:0042100; GO:0042102; GO:0070062; GO:0097191 cytokine activity [GO:0005125]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] NTDETFFGVQWVRP 0.95387 0.65722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94768 ST17B_HUMAN "Serine/threonine-protein kinase 17B, EC 2.7.11.1 (DAP kinase-related apoptosis-inducing protein kinase 2)" STK17B DRAK2 Homo sapiens (Human) apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005793; GO:0005886; GO:0006468; GO:0006915; GO:0015629; GO:0035556; GO:0043065; GO:0046777; GO:0106310; GO:2000271 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GKFAVVRQCISK 0.95388 0.78367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.61097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2832 0 0 0 11.5745 0 0 0 0 0 0 0 12.86 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46095 GPR6_HUMAN G-protein coupled receptor 6 (Sphingosine 1-phosphate receptor GPR6) GPR6 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of metabolic process [GO:0019222] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sphingosine-1-phosphate receptor activity [GO:0038036]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of metabolic process [GO:0019222] GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007204; GO:0019222; GO:0038036 G protein-coupled receptor activity [GO:0004930]; sphingosine-1-phosphate receptor activity [GO:0038036] YLSLYNALTYYSRR 0.95388 0.65722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14894 T4S5_HUMAN Transmembrane 4 L6 family member 5 (Tetraspan transmembrane protein L6H) TM4SF5 Homo sapiens (Human) cell cycle [GO:0007049]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; arginine binding [GO:0034618]; cell cycle [GO:0007049]; regulation of G1/S transition of mitotic cell cycle [GO:2000045] GO:0005765; GO:0005886; GO:0005887; GO:0007049; GO:0016021; GO:0034618; GO:2000045 arginine binding [GO:0034618] GCCGAGCCGNR 0.9539 0.78272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3859 0 11.2105 0 0 0 0 0 0 0 0 0 0 0 13.528 0 12.7908 0 0 0 0 0 0 12.8434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.256 0 11.2596 0 14.2797 0 0 0 0 12.6411 0 0 0 0 0 0 0 0 0 10.4194 0 0 0 12.4326 0 0 12.7485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1447 13.743 0 13.22 13.1244 0 0 0 13.9321 0 0 0 0 0 0 14.519 13.5786 15.4074 0 0 13.8337 13.3065 0 0 0 0 0 0 0 0 0 13.6147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13323 BIK_HUMAN Bcl-2-interacting killer (Apoptosis inducer NBK) (BIP1) (BP4) BIK NBK Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; male gonad development [GO:0008584]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981] Bcl-2 family protein complex [GO:0097136]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966] Bcl-2 family protein complex [GO:0097136]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; male gonad development [GO:0008584]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981] GO:0006915; GO:0008584; GO:0008637; GO:0012505; GO:0016021; GO:0031334; GO:0031966; GO:0042981; GO:0090200; GO:0097136 SPNPGSWVSCEQVLLALLLLLALLLPLLSGGLHLLLK 0.9539 0.65694 0 0 0 0 0 0 0 0 0 0 0 0 13.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50213 IDH3A_HUMAN "Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial, EC 1.1.1.41 (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)" IDH3A Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial isocitrate dehydrogenase complex (NAD+) [GO:0005962]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099] GO:0000287; GO:0004449; GO:0005634; GO:0005739; GO:0005759; GO:0005962; GO:0005975; GO:0006099; GO:0006102; GO:0051287 isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] CSDFTEEICR 0.95391 0.78235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14689 DIP2A_HUMAN "Disco-interacting protein 2 homolog A, DIP2 homolog A, EC 6.2.1.1" DIP2A C21orf106 DIP2 KIAA0184 Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; dendritic spine morphogenesis [GO:0060997]; negative regulation of gene expression [GO:0010629]; positive regulation of peptidyl-lysine acetylation [GO:2000758] anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendritic spine [GO:0043197]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendritic spine [GO:0043197]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; acetate-CoA ligase activity [GO:0003987]; acetyl-CoA biosynthetic process [GO:0006085]; dendritic spine morphogenesis [GO:0060997]; negative regulation of gene expression [GO:0010629]; positive regulation of peptidyl-lysine acetylation [GO:2000758] GO:0003987; GO:0005739; GO:0005886; GO:0006085; GO:0009986; GO:0010629; GO:0016020; GO:0043197; GO:0060997; GO:0070161; GO:2000758 acetate-CoA ligase activity [GO:0003987] AQTGEVAAFK 0.95391 2.7355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.085 0 0 0 0 0 0 0 0 11.9304 12.8767 12.9561 0 12.9433 12.6033 12.001 0 13.048 0 0 0 0 0 0 0 13.8927 0 0 0 0 0 0 0 0 13.9051 0 14.2245 0 0 0 10.8049 0 0 0 14.1962 0 0 0 0 0 0 0 0 0 0 13.2096 0 0 0 0 0 12.963 0 0 0 0 12.0415 11.3901 14.1109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07306 ASGR1_HUMAN "Asialoglycoprotein receptor 1, ASGP-R 1, ASGPR 1 (C-type lectin domain family 4 member H1) (Hepatic lectin H1, HL-1)" ASGR1 CLEC4H1 Homo sapiens (Human) cellular response to extracellular stimulus [GO:0031668]; receptor-mediated endocytosis [GO:0006898] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular response to extracellular stimulus [GO:0031668]; receptor-mediated endocytosis [GO:0006898] GO:0004873; GO:0005576; GO:0005886; GO:0005887; GO:0006898; GO:0009897; GO:0030246; GO:0031668; GO:0042802; GO:0046872 asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] PEQPDDWYGHGLGGGEDCAHFTDDGR 0.95397 0.63758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7081 0 0 0 0 11.5478 12.5664 12.3541 0 0 0 0 0 0 11.6178 0 10.835 0 0 0 0 0 0 0 0 12.3408 12.0124 0 0 0 0 0 11.2405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1945 0 12.1482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13072 BAGE1_HUMAN "B melanoma antigen 1, B melanoma antigen (Antigen MZ2-BA) (Cancer/testis antigen 2.1, CT2.1)" BAGE BAGE1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AARAVFLALSAQLLQAR 0.95398 0.66283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXT9 ABH15_HUMAN "Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15, Abhydrolase domain-containing protein 15)" ABHD15 UNQ6510/PRO21435 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255] extracellular region [GO:0005576]; membrane [GO:0016020] extracellular region [GO:0005576]; membrane [GO:0016020]; acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338]; cellular lipid metabolic process [GO:0044255] GO:0005576; GO:0016020; GO:0034338; GO:0044255; GO:0047372 acylglycerol lipase activity [GO:0047372]; short-chain carboxylesterase activity [GO:0034338] ALTEFFRTEERIK 0.95399 4.213 0 0 0 0 0 0 11.0417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6014 0 13.4911 0 0 0 0 0 0 11.5247 0 0 0 0 0 12.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6733 0 15.8165 0 0 0 0 0 0 0 0 0 12.2248 0 0 12.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5166 0 0 0 0 0 0 0 0 10.6074 0 0 13.1314 0 0 12.3964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9671 11.165 0 13.3208 0 13.045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3411 0 0 0 0 0 0 0 0 0 0 0 12.429 13.317 0 0 0 0 0 0 11.9801 Q9NWZ8 GEMI8_HUMAN "Gem-associated protein 8, Gemin-8 (Protein FAM51A1)" GEMIN8 FAM51A1 Homo sapiens (Human) spliceosomal snRNP assembly [GO:0000387] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal snRNP assembly [GO:0000387] GO:0000387; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032797; GO:0034719; GO:0097504 QYFAETERHREER 0.954 0.78651 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4FU01 MTMRB_HUMAN "Myotubularin-related protein 11 (Cisplatin resistance-associated protein, hCRA) (Inactive phosphatidylinositol 3-phosphatase 11)" MTMR11 Homo sapiens (Human) phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol dephosphorylation [GO:0046856] GO:0004438; GO:0005737; GO:0046856; GO:0070062 phosphatidylinositol-3-phosphatase activity [GO:0004438] AQSNQAQQYSGITLSK 0.95401 0.63691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58751 0 14.3793 0 0 0 0 0 0 0 0 0 0 0 0 11.2945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2767 0 0 0 0 0 0 0 0 0 0 13.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3063 0 0 0 0 0 11.8344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7719 0 12.7714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGJ8 O51S1_HUMAN Olfactory receptor 51S1 (Olfactory receptor OR11-24) OR51S1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALAICRPLHYPALLTNGVISK 0.95401 0.66251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZH5 PTTG2_HUMAN Securin-2 (Pituitary tumor-transforming gene 2 protein) PTTG2 Homo sapiens (Human) chromosome organization [GO:0051276]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SH3 domain binding [GO:0017124]; chromosome organization [GO:0051276]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816] GO:0005634; GO:0005737; GO:0017124; GO:0045143; GO:0051276; GO:2000816 SH3 domain binding [GO:0017124] FFPFNLLDFESFDLPEER 0.95402 0.63582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7257 0 0 0 0 0 10.9951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99942 RNF5_HUMAN "E3 ubiquitin-protein ligase RNF5, EC 2.3.2.27 (RING finger protein 5) (Ram1 homolog, HsRma1)" RNF5 G16 NG2 RMA1 Homo sapiens (Human) endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; negative regulation of autophagy [GO:0010507]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; negative regulation of autophagy [GO:0010507]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; transmembrane transport [GO:0055085]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005783; GO:0005789; GO:0005886; GO:0006511; GO:0008270; GO:0009617; GO:0010507; GO:0016021; GO:0030163; GO:0030433; GO:0031648; GO:0031966; GO:0036503; GO:0042802; GO:0044322; GO:0044390; GO:0044877; GO:0055085; GO:0061630; GO:0070534; GO:0070936; GO:0071712; GO:1904380; GO:2000785 identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] EKVVPLYGRGSQK 0.95403 0.78651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60033 CD81_HUMAN "CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28, Tspan-28) (CD antigen CD81)" CD81 TAPA1 TSPAN28 Homo sapiens (Human) "CD4-positive, alpha-beta T cell costimulation [GO:0035783]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; immunological synapse formation [GO:0001771]; macrophage fusion [GO:0034238]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; osteoclast fusion [GO:0072675]; positive regulation of 1-phosphatidylinositol 4-kinase activity [GO:0043128]; positive regulation of adaptive immune memory response [GO:1905676]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein catabolic process in the vacuole [GO:1904352]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of receptor clustering [GO:1903911]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein localization to lysosome [GO:0061462]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of macrophage migration [GO:1905521]; regulation of protein stability [GO:0031647]; viral entry into host cell [GO:0046718]" basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; vesicle [GO:0031982] "basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; vesicle [GO:0031982]; cholesterol binding [GO:0015485]; integrin binding [GO:0005178]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; transferrin receptor binding [GO:1990459]; virus receptor activity [GO:0001618]; CD4-positive, alpha-beta T cell costimulation [GO:0035783]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; immunological synapse formation [GO:0001771]; macrophage fusion [GO:0034238]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; osteoclast fusion [GO:0072675]; positive regulation of 1-phosphatidylinositol 4-kinase activity [GO:0043128]; positive regulation of adaptive immune memory response [GO:1905676]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein catabolic process in the vacuole [GO:1904352]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of receptor clustering [GO:1903911]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein localization to lysosome [GO:0061462]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of macrophage migration [GO:1905521]; regulation of protein stability [GO:0031647]; viral entry into host cell [GO:0046718]" GO:0001618; GO:0001771; GO:0001772; GO:0002455; GO:0002863; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0008104; GO:0008284; GO:0009925; GO:0014905; GO:0015485; GO:0016020; GO:0016021; GO:0016323; GO:0023026; GO:0030890; GO:0031623; GO:0031647; GO:0031982; GO:0034238; GO:0035783; GO:0042289; GO:0043128; GO:0043410; GO:0045944; GO:0046718; GO:0046813; GO:0050731; GO:0050861; GO:0050862; GO:0061462; GO:0070062; GO:0070863; GO:0071404; GO:0072659; GO:0072675; GO:0097197; GO:1903911; GO:1904352; GO:1905521; GO:1905676; GO:1990459; GO:2000553; GO:2000563; GO:2001190 cholesterol binding [GO:0015485]; integrin binding [GO:0005178]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; transferrin receptor binding [GO:1990459]; virus receptor activity [GO:0001618] LYLIGIAAIVVAVIMIFEMILSMVLCCGIR 0.95406 0.65832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCA9 ZN784_HUMAN Zinc finger protein 784 ZNF784 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0002244; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFKALAPLLRHQHR 0.95406 2.7318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2689 0 0 14.0468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60602 ROMO1_HUMAN "Reactive oxygen species modulator 1, ROS modulator 1 (Epididymis tissue protein Li 175) (Glyrichin) (Mitochondrial targeting GxxxG motif protein, MTGM) (Protein MGR2 homolog)" ROMO1 C20orf52 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; intracellular protein transport [GO:0006886]; killing of cells of another organism [GO:0031640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative senescence [GO:0090399] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to reactive oxygen species [GO:0034614]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; intracellular protein transport [GO:0006886]; killing of cells of another organism [GO:0031640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; replicative senescence [GO:0090399] GO:0005739; GO:0005743; GO:0005744; GO:0006886; GO:0008284; GO:0016021; GO:0030150; GO:0031640; GO:0034614; GO:0042742; GO:0045039; GO:0050829; GO:0050830; GO:0051838; GO:0061844; GO:0090399; GO:2000379 MPVAVGPYGQSQPSCFDR 0.95407 0.63431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5Y5 PEX16_HUMAN Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16) PEX16 Homo sapiens (Human) ER-dependent peroxisome localization [GO:0106101]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein to membrane docking [GO:0022615] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ER-dependent peroxisome localization [GO:0106101]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein to membrane docking [GO:0022615] GO:0005777; GO:0005778; GO:0005779; GO:0005783; GO:0005789; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016020; GO:0016557; GO:0016558; GO:0022615; GO:0032581; GO:0045046; GO:0106101 protein C-terminus binding [GO:0008022] KKLPVSLSQQK 0.95408 2.9386 0 0 0 0 0 0 0 0 0 0 0 13.6515 0 13.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4525 0 0 0 0 0 0 0 0 13.0512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6106 0 12.9008 0 0 0 0 0 0 12.6478 15.0257 13.2418 0 0 0 0 0 0 0 0 0 0 13.2896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3325 12.2718 14.9976 0 0 0 0 14.447 0 0 0 0 0 0 13.2112 13.7339 0 0 0 0 0 0 0 15.2621 14.7908 0 13.0673 0 13.4851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2937 0 0 0 Q96P67 GPR82_HUMAN Probable G-protein coupled receptor 82 GPR82 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930] DSSQETTSCYEK 0.9541 3.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.085 15.0013 0 0 0 0 11.61 0 0 0 0 0 0 0 0 0 0 14.8472 0 0 14.2689 0 0 0 0 0 0 13.7371 0 14.0832 14.4316 15.3037 0 0 0 0 14.0779 0 0 0 0 0 11.6071 0 0 0 15.1426 0 0 0 0 0 0 0 0 0 0 0 9.06024 0 0 11.1713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8879 0 0 0 0 0 0 0 0 0 11.1116 0 0 0 0 0 14.2496 0 0 0 0 10.5262 0 0 0 0 0 0 Q9UJA2 CRLS1_HUMAN "Cardiolipin synthase (CMP-forming), CLS, EC 2.7.8.41 (Protein GCD10 homolog)" CRLS1 C20orf155 CLS1 Homo sapiens (Human) cardiolipin biosynthetic process [GO:0032049]; glycerophospholipid biosynthetic process [GO:0046474]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; response to phosphatidylethanolamine [GO:1905711]; response to thyroxine [GO:0097068] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; cardiolipin synthase activity [GO:0008808]; CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity [GO:0043337]; cardiolipin biosynthetic process [GO:0032049]; glycerophospholipid biosynthetic process [GO:0046474]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; response to phosphatidylethanolamine [GO:1905711]; response to thyroxine [GO:0097068] GO:0003841; GO:0005739; GO:0005743; GO:0008808; GO:0016021; GO:0032049; GO:0036148; GO:0043337; GO:0046474; GO:0047144; GO:0097068; GO:1905711 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; cardiolipin synthase activity [GO:0008808]; CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity [GO:0043337] GAAWAPGTRPSKR 0.95411 2.7293 0 0 12.3662 0 0 0 11.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2831 11.465 0 0 0 0 0 0 13.7175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7979 13.9134 13.563 12.9048 14.1048 0 13.4525 13.5535 15.1069 0 14.3322 13.2636 0 0 0 16.3663 0 16.6491 16.5978 0 16.6374 14.7337 16.2436 15.7222 0 13.4861 13.0993 0 13.6382 0 14.0398 12.9177 14.0692 13.2156 14.4753 12.8873 0 0 0 14.5853 0 0 0 0 0 12.6059 14.2222 0 0 14.7508 13.95 14.4824 0 0 13.4945 0 15.3477 0 13.5706 13.9038 13.5258 0 0 0 0 0 0 12.0616 16.3638 14.3773 14.0892 13.5118 0 12.1834 0 0 14.4259 0 0 0 0 16.0312 0 0 0 0 0 0 0 0 0 0 12.3297 0 0 12.8334 0 0 14.808 14.1558 14.0433 0 0 0 0 0 Q08477 CP4F3_HUMAN "Cytochrome P450 4F3, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3, EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2, EC 1.14.14.94)" CYP4F3 LTB4H Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692]; arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376] GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0006691; GO:0008391; GO:0010430; GO:0016021; GO:0019369; GO:0020037; GO:0036101; GO:0042361; GO:0042376; GO:0043231; GO:0050051; GO:0070330; GO:0097258; GO:0097259; GO:0097267; GO:0102033; GO:0102207; GO:0120319; GO:0140692; GO:2001302; GO:2001304 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692] ACRLVHDFTDAVIQER 0.95413 0.78277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8504 0 0 0 0 0 11.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVH4 MMAA_HUMAN "Methylmalonic aciduria type A protein, mitochondrial, EC 3.6.-.-" MMAA Homo sapiens (Human) cobalamin metabolic process [GO:0009235] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235] GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009235; GO:0042802; GO:0042803 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] ELAQVLLQKVLLYHR 0.95413 4.7977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4173 0 0 0 0 0 0 0 12.0739 14.492 0 14.861 12.2871 0 0 14.4913 0 13.7255 14.2638 0 13.5211 0 14.5329 0 0 0 0 0 13.4705 0 0 14.3801 0 0 0 0 0 0 0 0 13.605 0 0 0 0 0 0 13.4976 14.1644 14.088 0 0 14.1643 0 12.625 12.448 13.1003 0 0 0 0 11.23 12.3296 13.7359 0 0 0 0 0 0 0 0 0 0 0 0 0 13.946 0 0 0 12.5218 0 12.2022 0 0 0 0 0 0 0 0 11.8057 0 0 0 0 0 0 0 11.7218 0 0 0 0 0 0 Q7RTY0 MOT13_HUMAN "Monocarboxylate transporter 13, MCT 13 (Solute carrier family 16 member 13)" SLC16A13 MCT13 Homo sapiens (Human) monocarboxylic acid transport [GO:0015718] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718] GO:0000139; GO:0005794; GO:0005829; GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021 monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] GSLLLVSALSLHLVACGALLR 0.95414 0.63888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZE3 BARH1_HUMAN BarH-like 1 homeobox protein BARHL1 FKSG31 Homo sapiens (Human) midbrain development [GO:0030901]; negative regulation of outer hair cell apoptotic process [GO:1905586]; neuron migration [GO:0001764]; outer hair cell apoptotic process [GO:1905584]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; midbrain development [GO:0030901]; negative regulation of outer hair cell apoptotic process [GO:1905586]; neuron migration [GO:0001764]; outer hair cell apoptotic process [GO:1905584]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001764; GO:0005634; GO:0006357; GO:0007605; GO:0030901; GO:1905584; GO:1905586; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AAEDFRDKLDK 0.95415 0.63831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00480 OTC_HUMAN "Ornithine transcarbamylase, mitochondrial, OTCase, EC 2.1.3.3 (Ornithine carbamoyltransferase, mitochondrial)" OTC Homo sapiens (Human) ammonium homeostasis [GO:0097272]; anion homeostasis [GO:0055081]; arginine biosynthetic process via ornithine [GO:0042450]; citrulline biosynthetic process [GO:0019240]; liver development [GO:0001889]; midgut development [GO:0007494]; ornithine catabolic process [GO:0006593]; response to biotin [GO:0070781]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; ornithine carbamoyltransferase activity [GO:0004585]; phosphate ion binding [GO:0042301]; phospholipid binding [GO:0005543]; ammonium homeostasis [GO:0097272]; anion homeostasis [GO:0055081]; arginine biosynthetic process via ornithine [GO:0042450]; citrulline biosynthetic process [GO:0019240]; liver development [GO:0001889]; midgut development [GO:0007494]; ornithine catabolic process [GO:0006593]; response to biotin [GO:0070781]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] GO:0000050; GO:0001889; GO:0004585; GO:0005543; GO:0005739; GO:0005743; GO:0005759; GO:0006593; GO:0007494; GO:0009410; GO:0010043; GO:0016597; GO:0019240; GO:0032868; GO:0042301; GO:0042450; GO:0042802; GO:0043231; GO:0055081; GO:0070781; GO:0097272 amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; ornithine carbamoyltransferase activity [GO:0004585]; phosphate ion binding [GO:0042301]; phospholipid binding [GO:0005543] ILLNNAAFR 0.95416 0.78204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9313 14.284 14.0974 14.3524 14.2872 14.1375 12.7717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9175 0 0 0 0 0 0 0 15.5079 0 0 0 15.0243 0 0 0 0 0 0 0 0 0 Q08AI6 S38AB_HUMAN Putative sodium-coupled neutral amino acid transporter 11 (Solute carrier family 38 member 11) SLC38A11 AVT2 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814] GO:0003333; GO:0006814; GO:0015179; GO:0016021 L-amino acid transmembrane transporter activity [GO:0015179] HFIIGLSTVTFTLPLSLYRNIAK 0.95416 3.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2833 0 0 0 0 14.2411 0 0 0 0 0 0 0 0 14.1253 13.8986 13.5684 13.6039 0 0 0 0 0 0 0 13.8646 0 0 0 0 0 0 0 14.0184 13.5328 0 0 0 0 13.3049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.284 0 0 0 0 0 0 P25116 PAR1_HUMAN "Proteinase-activated receptor 1, PAR-1 (Coagulation factor II receptor) (Thrombin receptor)" F2R CF2R PAR1 TR Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cell-cell junction maintenance [GO:0045217]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; dendritic cell homeostasis [GO:0036145]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of renin secretion into blood stream [GO:1900134]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of blood coagulation [GO:0030194]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of blood coagulation [GO:0030193]; regulation of interleukin-1 beta production [GO:0032651]; regulation of sensory perception of pain [GO:0051930]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]" caveola [GO:0005901]; cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; platelet dense tubular network [GO:0031094]; postsynaptic membrane [GO:0045211] "caveola [GO:0005901]; cell surface [GO:0009986]; early endosome [GO:0005769]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; platelet dense tubular network [GO:0031094]; postsynaptic membrane [GO:0045211]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; signaling receptor binding [GO:0005102]; thrombin-activated receptor activity [GO:0015057]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; anatomical structure morphogenesis [GO:0009653]; cell-cell junction maintenance [GO:0045217]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; dendritic cell homeostasis [GO:0036145]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of renin secretion into blood stream [GO:1900134]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of blood coagulation [GO:0030194]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of blood coagulation [GO:0030193]; regulation of interleukin-1 beta production [GO:0032651]; regulation of sensory perception of pain [GO:0051930]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]" GO:0001965; GO:0002248; GO:0003105; GO:0004930; GO:0005102; GO:0005576; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0005901; GO:0006919; GO:0006954; GO:0007186; GO:0007200; GO:0007204; GO:0007205; GO:0007529; GO:0008284; GO:0008285; GO:0009611; GO:0009653; GO:0009986; GO:0014068; GO:0015057; GO:0030168; GO:0030193; GO:0030194; GO:0030335; GO:0031094; GO:0031594; GO:0031681; GO:0032496; GO:0032651; GO:0032755; GO:0032757; GO:0032967; GO:0035025; GO:0036145; GO:0043123; GO:0043280; GO:0043410; GO:0043524; GO:0043547; GO:0045211; GO:0045217; GO:0045893; GO:0045907; GO:0045987; GO:0046427; GO:0048873; GO:0051209; GO:0051281; GO:0051482; GO:0051928; GO:0051930; GO:0060155; GO:0070374; GO:0099553; GO:1900134 G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; signaling receptor binding [GO:0005102]; thrombin-activated receptor activity [GO:0015057] ASFTCLAIWALAIAGVVPLLLK 0.95417 3.281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5203 0 14.3635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5375 0 0 0 0 0 0 11.1585 0 0 0 0 0 0 0 0 11.2451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGL1 OR5DI_HUMAN Olfactory receptor 5D18 (Olfactory receptor OR11-143) (Olfactory receptor OR11-152) OR5D18 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] LCVLLVVGSYAWGVSCSLELTCSALK 0.95417 0.63758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3T3 SEM6B_HUMAN "Semaphorin-6B (Semaphorin-Z, Sema Z)" SEMA6B SEMAN SEMAZ UNQ1907/PRO4353 Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system development [GO:0007417]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0007417; GO:0021766; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] MKGKQEGECR 0.95418 0.66295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0626 15.8938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L50 LLR1_HUMAN "Leucine-rich repeat protein 1 (4-1BB-mediated-signaling molecule) (4-1BBlrr) (LRR-repeat protein 1, LRR-1) (Peptidylprolyl isomerase-like 5)" LRR1 PPIL5 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567 AISSSLKGFLSAMR 0.95422 0.65087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4604 0 0 0 0 0 0 0 0 0 0 11.4666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4479 Q9HCN8 SDF2L_HUMAN "Stromal cell-derived factor 2-like protein 1, SDF2-like protein 1 (PWP1-interacting protein 8)" SDF2L1 UNQ1941/PRO4424 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; ER-associated misfolded protein catabolic process [GO:0071712]; regulation of apoptotic process [GO:0042981] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; chaperone cofactor-dependent protein refolding [GO:0051085]; ER-associated misfolded protein catabolic process [GO:0071712]; regulation of apoptotic process [GO:0042981] GO:0005783; GO:0005788; GO:0016020; GO:0034663; GO:0042981; GO:0051085; GO:0051087; GO:0051117; GO:0051787; GO:0071712; GO:0101031 ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787] GGAAWPVLLGLLLALLVPGGGAAK 0.95424 0.76769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5445 0 0 0 0 0 0 0 0 11.7 0 0 10.9284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2652 0 0 0 0 0 0 0 0 11.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P69 GPR78_HUMAN G-protein coupled receptor 78 GPR78 UNQ5925/PRO19818 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] QVLAGMVHRLLKR 0.95425 0.78651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11245 ARY2_HUMAN "Arylamine N-acetyltransferase 2, EC 2.3.1.5 (Arylamide acetylase 2) (N-acetyltransferase type 2, NAT-2) (Polymorphic arylamine N-acetyltransferase, PNAT)" NAT2 AAC2 Homo sapiens (Human) xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829] cytosol [GO:0005829]; arylamine N-acetyltransferase activity [GO:0004060]; xenobiotic metabolic process [GO:0006805] GO:0004060; GO:0005829; GO:0006805 arylamine N-acetyltransferase activity [GO:0004060] KHQKIYLFTLEPR 0.95426 0.78651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LI76 KR151_HUMAN Keratin-associated protein 15-1 KRTAP15-1 KAP15.1 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 MSYNCSSGNFSSCCFGSYLR 0.95427 0.63439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GX8 CP074_HUMAN Uncharacterized protein C16orf74 C16orf74 Homo sapiens (Human) HLDVPDIIITPPTPTGMMLPR 0.95427 0.64982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35348 ADA1A_HUMAN "Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor, Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c)" ADRA1A ADRA1C Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; apoptotic process [GO:0006915]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; micturition [GO:0060073]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018] "caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; Z disc [GO:0030018]; alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adult heart development [GO:0007512]; aging [GO:0007568]; apoptotic process [GO:0006915]; calcium ion transport into cytosol [GO:0060402]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; micturition [GO:0060073]; multicellular organism aging [GO:0010259]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of action potential [GO:0045760]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to hormone [GO:0009725]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0003084; GO:0004930; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0006915; GO:0006939; GO:0007165; GO:0007186; GO:0007200; GO:0007202; GO:0007204; GO:0007267; GO:0007512; GO:0007568; GO:0008285; GO:0009410; GO:0009725; GO:0010259; GO:0010507; GO:0010613; GO:0030018; GO:0030315; GO:0031965; GO:0032230; GO:0035024; GO:0035556; GO:0043231; GO:0043410; GO:0045760; GO:0045907; GO:0045987; GO:0046982; GO:0060073; GO:0060402; GO:0060452; GO:0061049; GO:0070374; GO:0071880; GO:0090037; GO:0097195; GO:0098691; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0150099; GO:1903997; GO:2000300 alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982] GLMALLCVWALSLVISIGPLFGWR 0.95428 2.8346 0 0 0 0 0 0 0 0 0 0 0 13.1127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8453 0 0 0 0 12.9805 0 0 0 0 0 0 0 0 0 0 13.7985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4319 0 0 0 0 0 0 0 0 12.8171 0 0 0 0 0 0 0 0 0 0 12.4485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3456 0 0 0 0 Q9H2H8 PPIL3_HUMAN "Peptidyl-prolyl cis-trans isomerase-like 3, PPIase, EC 5.2.1.8 (Cyclophilin J, CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3)" PPIL3 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" catalytic step 2 spliceosome [GO:0071013] "catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" GO:0000398; GO:0000413; GO:0003755; GO:0006457; GO:0071013 peptidyl-prolyl cis-trans isomerase activity [GO:0003755] TCENFLALCASNYYNGCIFHR 0.95428 0.64982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JUK2 SOLH1_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1 SOHLH1 C9orf157 NOHLH TEB2 Homo sapiens (Human) cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007283; GO:0009994; GO:0030154; GO:0042803; GO:0046982 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GCNGSLSGALSCCEDSAR 0.9543 0.6333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15482 TEX28_HUMAN Testis-specific protein TEX28 TEX28 CXorf2; TEX28P1; TEX28P2 Homo sapiens (Human) endomembrane system [GO:0012505]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021] GO:0012505; GO:0016021 ERSLTDLQLLLESLQEEKCR 0.95431 0.63243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8035 0 0 0 0 12.83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31513 FMO3_HUMAN "Dimethylaniline monooxygenase [N-oxide-forming] 3, EC 1.14.13.8, EC 1.14.14.73 (Dimethylaniline oxidase 3) (FMO II) (FMO form 2) (Hepatic flavin-containing monooxygenase 3, FMO 3) (Trimethylamine monooxygenase, EC 1.14.13.148)" FMO3 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]" GO:0004497; GO:0004499; GO:0005789; GO:0016021; GO:0034899; GO:0043231; GO:0050660; GO:0050661 "flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]" GKCFHSRDYK 0.95434 0.63968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9549 0 0 0 0 0 0 12.8437 0 0 0 0 0 0 0 0 0 0 0 0 11.4409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2098 0 0 14.9835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3124 0 0 0 0 0 0 0 0 0 11.0966 0 0 0 0 0 0 0 0 0 0 0 0 0 11.139 0 0 0 12.217 0 0 0 0 0 0 0 0 0 0 10.1835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7496 0 0 11.0976 0 0 0 0 0 0 0 0 0 0 15.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYV7 T2R16_HUMAN "Taste receptor type 2 member 16, T2R16" TAS2R16 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186] endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001580; GO:0004930; GO:0005783; GO:0005802; GO:0005886; GO:0007186; GO:0009897; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] CWLWVWEAFVYAFILMHSTSLMLSSPTLKRILK 0.95434 3.7718 0 0 0 0 0 0 0 0 0 0 0 11.0523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.716 0 0 0 0 0 12.7298 0 0 0 0 0 0 11.0049 0 0 13.8213 16.6204 0 0 14.4183 0 12.1938 0 10.5692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M3M2 SC5A9_HUMAN "Sodium/glucose cotransporter 4, Na(+)/glucose cotransporter 4, hSGLT4 (Solute carrier family 5 member 9)" SLC5A9 SGLT4 Homo sapiens (Human) hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362]; hexose transmembrane transport [GO:0008645]; sodium ion transport [GO:0006814] GO:0005362; GO:0005412; GO:0005886; GO:0006814; GO:0008645; GO:0016021; GO:0070062 glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362] IQVYMSVLSLILYIFTK 0.95436 0.65625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.51777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LB0 MRGX3_HUMAN Mas-related G-protein coupled receptor member X3 (Sensory neuron-specific G-protein coupled receptor 1/2) MRGPRX3 MRGX3 SNSR1 SNSR2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930] ILCGSRK 0.95436 0.66311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00887 PSG9_HUMAN "Pregnancy-specific beta-1-glycoprotein 9, PS-beta-G-9, PSBG-9, Pregnancy-specific glycoprotein 9 (PS34) (Pregnancy-specific beta-1 glycoprotein B, PS-beta-B) (Pregnancy-specific beta-1-glycoprotein 11, PS-beta-G-11, PSBG-11, Pregnancy-specific glycoprotein 11) (Pregnancy-specific glycoprotein 7, PSG7)" PSG9 PSG11 Homo sapiens (Human) Fc receptor mediated inhibitory signaling pathway [GO:0002774]; female pregnancy [GO:0007565]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; positive regulation of gene expression [GO:0010628]; regulation of immune system process [GO:0002682]; regulation of regulatory T cell differentiation [GO:0045589]; signal transduction [GO:0007165]; tolerance induction dependent upon immune response [GO:0002461]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 activation [GO:0036364] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; female pregnancy [GO:0007565]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; positive regulation of gene expression [GO:0010628]; regulation of immune system process [GO:0002682]; regulation of regulatory T cell differentiation [GO:0045589]; signal transduction [GO:0007165]; tolerance induction dependent upon immune response [GO:0002461]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 activation [GO:0036364] GO:0002461; GO:0002682; GO:0002774; GO:0005576; GO:0005886; GO:0007165; GO:0007179; GO:0007565; GO:0009986; GO:0010628; GO:0036364; GO:0044877; GO:0045589; GO:0070021; GO:1900016; GO:1990782 protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877] DRYGGLRSNPVILNVLYGPDLPR 0.95437 0.6376 0 0 0 0 0 14.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9438 0 0 0 0 17.8066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2945 0 0 0 0 0 0 16.9125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y535 RPC8_HUMAN "DNA-directed RNA polymerase III subunit RPC8, RNA polymerase III subunit C8 (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit, RPC22.9)" POLR3H KIAA1665 RPC8 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384] centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384] GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0043231; GO:0045087; GO:0051607 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899] FVLVEMVDTVRIPPWQFER 0.95437 0.66311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG43 F157C_HUMAN Putative protein FAM157C FAM157C Homo sapiens (Human) IQISLWPRK 0.95438 0.66311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16609 LPAL2_HUMAN "Putative apolipoprotein(a)-like protein 2, Apo(a)-like protein 2, Lp(a)-liker protein 2 (Apolipoprotein a-related gene C protein, Apo(a)rg-C)" LPAL2 APOARGC Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897] extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; endopeptidase activity [GO:0004175]; signaling receptor binding [GO:0005102]; proteolysis [GO:0006508] GO:0004175; GO:0005102; GO:0005615; GO:0006508; GO:0019897 endopeptidase activity [GO:0004175]; signaling receptor binding [GO:0005102] EHKEVVLLLLLFLK 0.95439 0.66305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCU3 S7A13_HUMAN Solute carrier family 7 member 13 (Sodium-independent aspartate/glutamate transporter 1) (X-amino acid transporter 2) SLC7A13 AGT1 XAT2 Homo sapiens (Human) aspartate transmembrane transport [GO:0015810]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179]; protein heterodimerization activity [GO:0046982]; aspartate transmembrane transport [GO:0015810]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] GO:0015179; GO:0015810; GO:0015811; GO:0015813; GO:0016021; GO:0016324; GO:0046982 L-amino acid transmembrane transporter activity [GO:0015179]; protein heterodimerization activity [GO:0046982] GVKEVTWLQIASSVLK 0.95439 3.3232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8896 0 0 0 0 11.7685 0 0 0 0 0 0 0 0 13.3455 13.4432 0 13.2294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3478 13.154 13.3044 0 0 0 0 0 12.5326 0 13.1798 14.3358 0 0 0 0 12.362 0 0 0 0 0 0 0 0 13.022 12.6178 0 0 0 0 12.6557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0D9 TPRGL_HUMAN Tumor protein p63-regulated gene 1-like protein (Mossy fiber terminal-associated vertebrate-specific presynaptic protein) (Protein FAM79A) TPRG1L FAM79A MOVER Homo sapiens (Human) "regulation of synaptic transmission, glutamatergic [GO:0051966]" anchoring junction [GO:0070161]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; regulation of synaptic transmission, glutamatergic [GO:0051966]" GO:0005737; GO:0008021; GO:0030672; GO:0044305; GO:0048786; GO:0051966; GO:0070062; GO:0070161 ALLIQAVKKAQK 0.9544 2.719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0534 0 0 0 11.1215 0 0 0 13.4823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2835 0 0 0 0 14.2085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6272 0 0 0 0 0 0 0 0 15.4186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13228 SBP1_HUMAN "Methanethiol oxidase, MTO, EC 1.8.3.4 (56 kDa selenium-binding protein, SBP56, SP56) (Selenium-binding protein 1)" SELENBP1 SBP Homo sapiens (Human) protein transport [GO:0015031] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031] GO:0001650; GO:0005615; GO:0005730; GO:0005829; GO:0008430; GO:0015031; GO:0016020; GO:0018549; GO:0070062 methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430] APKLHKVIEPK 0.95442 0.65099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2824 0 0 0 0 10.9054 0 0 0 0 0 0 0 0 10.3225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0129 0 13.3676 0 0 0 0 13.4359 0 0 0 13.3708 0 0 13.1443 12.6741 13.0279 0 0 0 0 14.1574 0 0 17.1235 0 12.9888 0 0 0 0 0 0 12.2203 0 0 0 0 0 0 12.0526 0 0 0 0 0 0 12.0657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1368 0 0 0 13.0564 0 Q5JTB6 PLAC9_HUMAN Placenta-specific protein 9 PLAC9 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 RPLLCALTGLALLR 0.95442 0.76899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16222 UAP1_HUMAN "UDP-N-acetylhexosamine pyrophosphorylase (Antigen X, AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase, EC 2.7.7.83 (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase, EC 2.7.7.23 (AGX-2) ]" UAP1 SPAG2 Homo sapiens (Human) UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] GO:0003977; GO:0005654; GO:0005829; GO:0005886; GO:0006048; GO:0042802; GO:0052630 identical protein binding [GO:0042802]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977] FVFDIFQFAKKFVVYEVLR 0.95443 0.77952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9576 13.1864 0 0 0 0 0 13.0653 14.6547 0 0 0 14.3565 14.1646 15.1277 0 0 12.4427 0 0 0 0 0 0 0 0 13.043 0 13.7484 13.9185 0 0 0 0 0 0 14.0994 0 0 0 0 0 0 0 0 14.8662 15.4107 0 0 0 0 0 0 0 13.9905 14.9752 0 0 0 0 0 0 0 0 0 15.13 14.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6292 14.4618 0 0 0 0 0 0 0 0 0 0 0 12.9473 0 0 0 0 0 0 0 0 0 0 0 0 Q13432 U119A_HUMAN "Protein unc-119 homolog A (Retinal protein 4, hRG4)" UNC119 RG4 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; lipoprotein transport [GO:0042953]; mitotic cytokinesis [GO:0000281]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; nervous system development [GO:0007399]; phototransduction [GO:0007602]; positive regulation of protein tyrosine kinase activity [GO:0061098]; visual perception [GO:0007601] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synapse [GO:0045202] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synapse [GO:0045202]; lipid binding [GO:0008289]; chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; lipoprotein transport [GO:0042953]; mitotic cytokinesis [GO:0000281]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; nervous system development [GO:0007399]; phototransduction [GO:0007602]; positive regulation of protein tyrosine kinase activity [GO:0061098]; visual perception [GO:0007601] GO:0000281; GO:0000922; GO:0005813; GO:0005829; GO:0006897; GO:0007268; GO:0007399; GO:0007601; GO:0007602; GO:0008289; GO:0042953; GO:0045171; GO:0045202; GO:0051233; GO:0061098; GO:1900186; GO:2001287 lipid binding [GO:0008289] HPYETQSDSFYFVDDRLVMHNK 0.95444 0.7786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0781 0 0 0 0 0 0 12.4285 0 0 0 0 0 0 0 0 0 0 0 11.5077 0 0 0 0 0 0 0 0 0 0 0 13.0754 0 0 0 0 18.1513 0 0 0 0 0 0 0 0 0 14.5816 0 0 0 0 19.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBR5 CSAS1_HUMAN Putative uncharacterized protein CIRBP-AS1 (CIRBP antisense RNA 1) (CIRBP antisense gene protein 1) CIRBP-AS1 C19orf23 Homo sapiens (Human) KLRLGLPY 0.95444 0.76878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3693 0 0 0 0 0 0 0 0 0 0 0 0 13.6163 0 0 13.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3145 0 0 0 0 0 0 11.3058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16790 CAH9_HUMAN "Carbonic anhydrase 9, EC 4.2.1.1 (Carbonate dehydratase IX) (Carbonic anhydrase IX, CA-IX, CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250, RCC-associated antigen G250) (pMW1)" CA9 G250 MN Homo sapiens (Human) morphogenesis of an epithelium [GO:0002009]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; secretion [GO:0046903] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; morphogenesis of an epithelium [GO:0002009]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; secretion [GO:0046903] GO:0001666; GO:0002009; GO:0004089; GO:0005730; GO:0005886; GO:0006730; GO:0008270; GO:0009410; GO:0016021; GO:0016323; GO:0016836; GO:0031528; GO:0033574; GO:0046903 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] MAPLCPSPWLPLLIPAPAPGLTVQLLLSLLLLVPVHPQR 0.95446 0.76775 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6927 0 0 0 0 0 0 0 11.4585 0 0 0 11.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3002 0 0 0 0 0 0 0 0 13.903 0 0 0 0 13.8331 0 13.5657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4786 0 0 0 0 12.385 0 0 0 0 0 0 0 0 0 0 0 0 12.9867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43897 TLL1_HUMAN "Tolloid-like protein 1, EC 3.4.24.-" TLL1 TLL Homo sapiens (Human) cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485]; skeletal system development [GO:0001501] GO:0001501; GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199 calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] DNGGCQHECVNTMGSYMCQCR 0.95447 0.63494 0 9.97269 0 0 0 0 0 0 12.5375 0 0 0 0 0 0 0 0 0 0 10.8209 0 0 0 0 0 0 0 0 0 10.9478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6288 0 0 0 11.7202 0 0 0 0 0 0 0 0 0 0 0 0 0 12.749 10.7778 0 0 0 0 21.5632 12.655 21.2929 0 0 0 10.5314 0 0 12.2393 0 0 0 0 0 0 0 0 11.0137 0 0 0 0 0 0 0 13.9184 0 0 0 0 0 0 0 0 0 0 0 13.5988 0 0 0 0 0 0 0 0 15.1899 0 0 14.2246 15.2228 0 0 0 0 0 17.6707 0 0 0 0 0 0 13.4507 0 19.1979 0 19.1687 0 18.9417 0 0 0 0 0 0 0 0 0 0 12.0504 14.2053 0 0 18.6437 0 18.5903 14.7536 0 Q9NXS2 QPCTL_HUMAN "Glutaminyl-peptide cyclotransferase-like protein, EC 2.3.2.5 (Golgi-resident glutaminyl-peptide cyclotransferase) (isoQC, gQC)" QPCTL Homo sapiens (Human) "peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]" GO:0000139; GO:0005794; GO:0008270; GO:0016020; GO:0016021; GO:0016603; GO:0017186 glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270] AARHLTLACHYDSK 0.95447 3.3226 0 0 0 0 0 0 0 0 0 12.035 10.9125 0 0 0 0 0 0 10.2844 0 0 0 0 0 0 0 0 12.6906 0 0 0 0 0 11.9059 0 0 0 11.1615 0 0 0 10.8276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1044 0 0 21.408 12.4898 0 0 0 0 0 0 0 0 12.8963 0 0 0 0 0 14.1539 0 0 0 0 0 0 13.245 0 0 0 0 0 14.824 0 11.1143 0 11.8626 13.3651 0 0 14.8069 0 0 0 0 0 0 10.4413 0 0 0 12.6008 0 0 0 0 14.164 14.0291 0 11.7823 0 13.6516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5386 0 0 0 0 0 Q96GE9 DMAC1_HUMAN Distal membrane-arm assembly complex protein 1 (Transmembrane protein 261) DMAC1 C9orf123 TMEM261 Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005743; GO:0016021; GO:0032981 LSQPFESYITAPPGTAAAPAK 0.95448 0.64982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VYV0 FOXB2_HUMAN Forkhead box protein B2 FOXB2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HPFAIENIIGR 0.9545 0.65212 0 0 0 0 0 0 0 0 0 0 0 0 9.59352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6X5 TVA18_HUMAN T cell receptor alpha variable 18 TRAV18 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0006955; GO:0042101 MLSASCSGLVILLIFR 0.95452 0.64826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3536 0 0 0 0 0 0 0 11.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12926 ELAV2_HUMAN "ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B, HuB) (Nervous system-specific RNA-binding protein Hel-N1)" ELAVL2 HUB Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] "nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003723; GO:0003730; GO:0005654; GO:0006355; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723] IITSRILVDQVTGISR 0.95453 0.66313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0Z9 VSI10_HUMAN V-set and immunoglobulin domain-containing protein 10 VSIG10 Homo sapiens (Human) cell-cell adhesion [GO:0098609] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion [GO:0098609] GO:0005887; GO:0005911; GO:0050839; GO:0098609 cell adhesion molecule binding [GO:0050839] ILWLRNLTQPEVIIQPSSR 0.95454 0.66311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGX2 O2T35_HUMAN Olfactory receptor 2T35 (Olfactory receptor OR1-66) OR2T35 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] VVSAFYTILTPMLNPLIYSLRNK 0.95454 0.63186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5777 0 0 0 0 0 0 0 0 0 0 0 P48029 SC6A8_HUMAN "Sodium- and chloride-dependent creatine transporter 1, CT1, Creatine transporter 1 (Solute carrier family 6 member 8)" SLC6A8 Homo sapiens (Human) creatine metabolic process [GO:0006600]; creatine transmembrane transport [GO:0015881]; muscle contraction [GO:0006936]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; sodium ion transmembrane transport [GO:0035725] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; creatine transmembrane transporter activity [GO:0005308]; creatine:sodium symporter activity [GO:0005309]; creatine metabolic process [GO:0006600]; creatine transmembrane transport [GO:0015881]; muscle contraction [GO:0006936]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; sodium ion transmembrane transport [GO:0035725] GO:0005308; GO:0005309; GO:0005886; GO:0005887; GO:0006600; GO:0006836; GO:0006936; GO:0015881; GO:0016021; GO:0035725; GO:0071705 creatine transmembrane transporter activity [GO:0005308]; creatine:sodium symporter activity [GO:0005309] STGKIVYFTATFPYVVLVVLLVR 0.95455 0.63186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2D7 TBC28_HUMAN TBC1 domain family member 28 TBC1D28 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0090630 GTPase activator activity [GO:0005096] LSQRVCKVIPLAVR 0.95455 2.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9748 0 P01222 TSHB_HUMAN "Thyrotropin subunit beta (Thyroid-stimulating hormone subunit beta, TSH-B, TSH-beta) (Thyrotropin beta chain) (Thyrotropin alfa)" TSHB Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to vitamin A [GO:0033189] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696]; hormone activity [GO:0005179]; anatomical structure morphogenesis [GO:0009653]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to vitamin A [GO:0033189] GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007186; GO:0007267; GO:0009653; GO:0009755; GO:0033189; GO:0043627; GO:0051592; GO:0061696 hormone activity [GO:0005179] MTALFLMSMLFGLTCGQAMSFCIPTEYTMHIER 0.95456 0.63133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1965 12.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1508 13.0104 0 0 12.6785 0 0 0 0 0 0 0 0 0 0 0 0 0 P58550 FXYD8_HUMAN Putative FXYD domain-containing ion transport regulator 8 FXYD6P3 FXYD8 Homo sapiens (Human) ion transport [GO:0006811]; regulation of ion transport [GO:0043269] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; ion channel regulator activity [GO:0099106]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269] GO:0006811; GO:0016021; GO:0043269; GO:0099106 ion channel regulator activity [GO:0099106] EVVLIFVYSLLVPVVLASAAKEK 0.95456 0.63186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3622 11.9077 11.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3U1 YS014_HUMAN Putative uncharacterized protein LOC400692 Homo sapiens (Human) FGLARLLGSQDHGDDPAER 0.95456 0.66311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34130 NTF4_HUMAN "Neurotrophin-4, NT-4 (Neurotrophin-5, NT-5) (Neutrophic factor 4)" NTF4 NTF5 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; epidermis development [GO:0008544]; ganglion mother cell fate determination [GO:0007402]; innervation [GO:0060384]; long-term memory [GO:0007616]; mechanoreceptor differentiation [GO:0042490]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of neuron differentiation [GO:0045664]; sensory organ boundary specification [GO:0008052]; taste bud development [GO:0061193]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021]; growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]; adult locomotory behavior [GO:0008344]; epidermis development [GO:0008544]; ganglion mother cell fate determination [GO:0007402]; innervation [GO:0060384]; long-term memory [GO:0007616]; mechanoreceptor differentiation [GO:0042490]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of neuron differentiation [GO:0045664]; sensory organ boundary specification [GO:0008052]; taste bud development [GO:0061193]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005163; GO:0005576; GO:0005615; GO:0007169; GO:0007402; GO:0007422; GO:0007613; GO:0007616; GO:0008021; GO:0008052; GO:0008083; GO:0008344; GO:0008544; GO:0021675; GO:0030424; GO:0030425; GO:0033138; GO:0038180; GO:0042490; GO:0043524; GO:0045664; GO:0048812; GO:0050804; GO:0060384; GO:0061193 growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163] CKADNAEEGGPGAGGGGCR 0.95457 0.66311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01594 KV133_HUMAN Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka) IGKV1-33 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; identical protein binding [GO:0042802]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0042802; GO:0072562 antigen binding [GO:0003823]; identical protein binding [GO:0042802] VPAQLLGLLLLWLSGAR 0.95461 0.65426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW27 ABEC4_HUMAN "Putative C->U-editing enzyme APOBEC-4, EC 3.5.4.- (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 4)" APOBEC4 C1orf169 Homo sapiens (Human) mRNA processing [GO:0006397] "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines [GO:0016814]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]" GO:0006397; GO:0008270; GO:0016814 "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines [GO:0016814]; zinc ion binding [GO:0008270]" APVVFVLVPLR 0.95462 0.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93015 NAA80_HUMAN "N-alpha-acetyltransferase 80, HsNAAA80, EC 2.3.1.- (N-acetyltransferase 6) (Protein fusion-2, Protein fus-2)" NAA80 FUS2 NAT6 Homo sapiens (Human) actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064] GO:0004596; GO:0005737; GO:0005829; GO:0006473; GO:0008064; GO:0008080; GO:0017190; GO:0018002; GO:0030047; GO:1905502 acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596] VLNQPQSLLVETVVVARALR 0.95462 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7S9 ZN703_HUMAN Zinc finger protein 703 (Zinc finger elbow-related proline domain protein 1) ZNF703 ZEPPO1 ZPO1 Homo sapiens (Human) "adherens junction assembly [GO:0034333]; cellular response to estradiol stimulus [GO:0071392]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]" cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; adherens junction assembly [GO:0034333]; cellular response to estradiol stimulus [GO:0071392]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]" GO:0005634; GO:0005737; GO:0006355; GO:0008284; GO:0010718; GO:0016363; GO:0017015; GO:0030335; GO:0032991; GO:0033601; GO:0034111; GO:0034333; GO:0045892; GO:0046872; GO:0051726; GO:0060644; GO:0060828; GO:0071392; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872] MSDSPAGSNPR 0.95462 0.65106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087X0K7 TVB17_HUMAN Probable non-functional T cell receptor beta variable 17 TRBV17 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 LLISFQYQNIAVDSGMPKER 0.95464 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX82 LYPD8_HUMAN Ly6/PLAUR domain-containing protein 8 LYPD8 UNQ511/PRO1026 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; defense response to Gram-negative bacterium [GO:0050829] GO:0005576; GO:0005615; GO:0005886; GO:0031225; GO:0050829 ASLYLLALASLLLR 0.95464 0.76962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0484 0 0 0 0 0 15.6167 0 0 0 0 0 0 0 0 10.4134 0 0 0 0 0 0 0 0 0 0 0 13.0029 13.9901 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9487 0 0 0 0 0 0 0 0 0 13.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0823 0 12.9403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969Q5 RAB24_HUMAN Ras-related protein Rab-24 RAB24 Homo sapiens (Human) autophagy [GO:0006914]; intracellular protein transport [GO:0006886] autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] autophagosome [GO:0005776]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886] GO:0003924; GO:0005525; GO:0005768; GO:0005776; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0030139; GO:0030667 GTP binding [GO:0005525]; GTPase activity [GO:0003924] PNPYFYSCCHH 0.95465 0.77968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9124 0 0 0 0 0 0 0 0 0 0 0 Q9H8W4 PKHF2_HUMAN "Pleckstrin homology domain-containing family F member 2, PH domain-containing family F member 2 (Endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains, EAPF) (PH and FYVE domain-containing protein 2) (Phafin-2, Phafin2) (Zinc finger FYVE domain-containing protein 18)" PLEKHF2 ZFYVE18 Homo sapiens (Human) endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; protein transport [GO:0015031] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; protein transport [GO:0015031] GO:0005769; GO:0005783; GO:0007032; GO:0008333; GO:0015031; GO:0030133; GO:0031901; GO:0035091; GO:0046872 metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091] FTPVNRR 0.95466 0.76887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0531 0 0 0 0 0 0 0 0 0 14.7717 12.9079 0 0 0 15.3786 12.3112 0 0 15.9509 10.9239 11.6312 0 13.8158 0 14.0956 0 0 0 14.9193 0 0 0 0 0 0 0 0 0 12.3895 12.2763 0 0 12.3767 0 0 0 0 0 0 0 0 0 0 0 10.0312 13.5412 0 0 0 11.5837 0 0 0 0 12.3251 0 0 12.2862 14.4663 0 0 0 0 0 0 0 0 0 0 0 15.348 0 12.7603 0 0 0 0 0 0 0 0 10.5911 12.3334 0 0 0 0 0 0 0 0 0 0 0 12.8273 0 0 0 11.0528 0 13.8203 A8MWE9 EFCB8_HUMAN EF-hand calcium-binding domain-containing protein 8 EFCAB8 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] VDSDCEGFVTWQKYVDYMMR 0.95467 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15126 PMVK_HUMAN "Phosphomevalonate kinase, PMKase, hPMK, EC 2.7.4.2" PMVK PMKI Homo sapiens (Human) "cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; phosphorylation [GO:0016310]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]" cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; phosphorylation [GO:0016310]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]" GO:0004631; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0016020; GO:0016126; GO:0016310; GO:0019287; GO:0070062; GO:0070723 ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631] MAPLGGAPRLVLLFSGK 0.95468 0.76782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4H0 SPA6L_HUMAN Spermatogenesis associated 6-like protein SPATA6L C9orf68 Homo sapiens (Human) spermatogenesis [GO:0007283] sperm connecting piece [GO:0097224] sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; spermatogenesis [GO:0007283] GO:0007283; GO:0032027; GO:0097224 myosin light chain binding [GO:0032027] EVLMKTALGFPGIAPK 0.95468 0.64983 0 0 0 0 0 0 0 0 0 0 11.9898 0 0 0 0 0 0 0 0 0 12.8736 0 0 0 0 0 0 0 0 0 0 12.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2033 0 0 0 0 0 0 0 0 0 13.5839 13.6844 0 0 0 0 0 0 0 0 13.5142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4855 0 14.4151 0 13.6065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZS7 CLCL1_HUMAN "C-type lectin-like domain family 1 (Dendritic cell-associated lectin 1, DC-associated lectin-1, DCAL-1)" CLECL1 DCAL1 Homo sapiens (Human) B cell adhesion [GO:0097323]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of T cell proliferation [GO:0042102] centriolar satellite [GO:0034451]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] centriolar satellite [GO:0034451]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; B cell adhesion [GO:0097323]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of T cell proliferation [GO:0042102] GO:0005886; GO:0016021; GO:0030246; GO:0032753; GO:0034451; GO:0042102; GO:0097323 carbohydrate binding [GO:0030246] FAISIYLSEVSLQK 0.95469 2.7454 0 0 0 0 0 0 0 0 0 0 0 10.4397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1568 16.2409 16.6243 0 0 16.3272 0 0 0 0 0 0 0 10.8855 0 0 0 0 0 0 0 0 0 0 0 12.4706 9.95278 0 0 0 12.9105 0 0 0 0 0 0 0 0 12.0017 0 11.3468 11.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCL8 TM116_HUMAN Transmembrane protein 116 TMEM116 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189] GO:0004930; GO:0005886; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] PQDTKLHMALYVLQALTATSQGLLNCGVYGWTQHK 0.9547 0.65226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5834 0 0 14.1424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34910 EVI2B_HUMAN "Protein EVI2B (Ecotropic viral integration site 2B protein homolog, EVI-2B) (CD antigen CD361)" EVI2B EVDB Homo sapiens (Human) myeloid cell development [GO:0061515]; negative regulation of apoptotic process [GO:0043066]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of neutrophil differentiation [GO:0045660]; regulation of cell cycle [GO:0051726]; regulation of stem cell division [GO:2000035] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; myeloid cell development [GO:0061515]; negative regulation of apoptotic process [GO:0043066]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of neutrophil differentiation [GO:0045660]; regulation of cell cycle [GO:0051726]; regulation of stem cell division [GO:2000035] GO:0005887; GO:0030854; GO:0043066; GO:0045660; GO:0051726; GO:0061515; GO:2000035 KPVLNDQNWAGRSPFADGETPDICMDNIR 0.95472 0.66345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0187 0 0 17.1675 12.5364 0 10.5612 0 9.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5223 0 0 0 0 0 0 0 0 0 0 Q6ZTC4 YT009_HUMAN Putative uncharacterized protein FLJ44790 Homo sapiens (Human) MQLGEHTHPQK 0.95472 0.65201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.706 Q6UX07 DHR13_HUMAN "Dehydrogenase/reductase SDR family member 13, EC 1.1.-.- (Short chain dehydrogenase/reductase family 7C member 5, Protein SDR7C5)" DHRS13 SDR7C5 UNQ419/PRO853 Homo sapiens (Human) retinal metabolic process [GO:0042574] extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal metabolic process [GO:0042574] GO:0005576; GO:0005743; GO:0016020; GO:0042574; GO:0052650 NADP-retinol dehydrogenase activity [GO:0052650] LDRPVVGWRQELR 0.95477 0.7463 0 0 0 0 0 0 11.1369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5536 13.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60583 CCNT2_HUMAN "Cyclin-T2, CycT2" CCNT2 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]" cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]" GO:0000079; GO:0001223; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006366; GO:0006468; GO:0007049; GO:0007519; GO:0008024; GO:0016538; GO:0019085; GO:0019086; GO:0019901; GO:0032786; GO:0032968; GO:0045944; GO:0048471; GO:0051147; GO:0051301; GO:0061575; GO:0070063; GO:0097322 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223] GASSRWFFTR 0.95478 0.63053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0034 0 0 0 0 0 0 Q71RG6 YH006_HUMAN Putative chemokine-related protein FP248 (Protein N73) FP248 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 PSSDFVGCAQGMCCHGR 0.9548 0.65461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVE6 TM171_HUMAN Transmembrane protein 171 TMEM171 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GQQMDPDRAFICGESR 0.9548 0.6298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZD6 S22AF_HUMAN "Solute carrier family 22 member 15 (Fly-like putative transporter 1, Flipt 1)" SLC22A15 FLIPT1 UNQ9429/PRO34686 Homo sapiens (Human) ion transport [GO:0006811] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811] GO:0006811; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] HVHFSSSFTSIASEWFLIANR 0.95481 0.62685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T1Q4 S35F1_HUMAN Solute carrier family 35 member F1 SLC35F1 C6orf169 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] YLSEDFHANTPVFQSFLNYILLFLVYTTTLAVR 0.95482 0.65429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0313 0 0 0 0 0 0 12.8729 0 0 0 0 0 12.7189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9962 0 0 0 0 13.0753 0 0 0 0 12.4619 0 0 0 0 0 0 13.1209 0 0 0 0 0 0 0 12.9394 0 0 0 0 12.564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7118 0 Q8WVM8 SCFD1_HUMAN "Sec1 family domain-containing protein 1 (SLY1 homolog, Sly1p) (Syntaxin-binding protein 1-like 2)" SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23 Homo sapiens (Human) "cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle-mediated transport [GO:0016192]" cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886] "cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle-mediated transport [GO:0016192]" GO:0000139; GO:0000902; GO:0001666; GO:0005789; GO:0005798; GO:0005801; GO:0005829; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0006892; GO:0009636; GO:0016192; GO:0019905; GO:0032580; GO:0044877; GO:0047485; GO:0051223; GO:0060628; GO:1901998; GO:1902902 protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905] ARKLDVYFEYEEK 0.95482 2.8504 0 0 0 0 0 0 0 0 0 0 0 11.4313 0 0 0 0 0 0 0 11.9811 0 0 0 0 11.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.377 0 0 11.0768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6212 0 0 0 0 0 0 0 0 0 0 0 11.5596 0 0 0 0 0 0 12.7623 11.0201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9885 0 0 0 0 0 P08754 GNAI3_HUMAN Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3) GNAI3 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; GTP metabolic process [GO:0046039]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; vesicle fusion [GO:0006906] centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588] centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell cycle [GO:0007049]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; GTP metabolic process [GO:0046039]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; vesicle fusion [GO:0006906] GO:0001664; GO:0003924; GO:0005525; GO:0005737; GO:0005765; GO:0005794; GO:0005813; GO:0005834; GO:0005886; GO:0006906; GO:0007049; GO:0007188; GO:0007193; GO:0007194; GO:0007212; GO:0007420; GO:0016020; GO:0016239; GO:0019003; GO:0019904; GO:0030496; GO:0031683; GO:0031821; GO:0032794; GO:0032930; GO:0033864; GO:0042588; GO:0045121; GO:0046039; GO:0046872; GO:0051301; GO:0070062; GO:1904707; GO:2001234 G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904] EVKLLLLGAGESGK 0.95483 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UC2 RSPH3_HUMAN Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2) RSPH3 RSHL2 RSP3 Homo sapiens (Human) cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] GO:0005737; GO:0005856; GO:0005929 AASLARNLAK 0.95483 0.64508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4743 13.8391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5562 0 0 0 0 0 14.1868 0 0 0 0 0 0 0 16.654 0 0 0 0 0 0 0 0 0 0 0 11.2486 0 0 0 0 0 0 0 0 0 0 11.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0481 0 0 0 0 0 0 0 0 0 0 0 Q8N8W4 PLPL1_HUMAN "Omega-hydroxyceramide transacylase, EC 2.3.1.296 (Patatin-like phospholipase domain-containing protein 1)" PNPLA1 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; omega-hydroxyceramide biosynthetic process [GO:0106342]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020] "cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; omega-hydroxyceramide transacylase activity [GO:0106341]; structural constituent of skin epidermis [GO:0030280]; triglyceride lipase activity [GO:0004806]; ceramide biosynthetic process [GO:0046513]; lipid homeostasis [GO:0055088]; omega-hydroxyceramide biosynthetic process [GO:0106342]; triglyceride catabolic process [GO:0019433]" GO:0004806; GO:0005737; GO:0005811; GO:0016020; GO:0016747; GO:0019433; GO:0030280; GO:0046513; GO:0055088; GO:0106341; GO:0106342 "acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; omega-hydroxyceramide transacylase activity [GO:0106341]; structural constituent of skin epidermis [GO:0030280]; triglyceride lipase activity [GO:0004806]" QASLEGATQPHK 0.95483 0.77157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0615 0 0 0 0 14.383 0 0 0 0 0 0 0 0 0 13.8886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0579 0 0 0 0 0 14.2907 0 0 0 0 0 0 0 0 0 13.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15255 CXX1_HUMAN CAAX box protein 1 (Cerebral protein 5) RTL8C CXX1 FAM127A MAR8 MAR8C MART8 hucep-5 Homo sapiens (Human) plasma membrane [GO:0005886] plasma membrane [GO:0005886] GO:0005886 HPSHPTDRLLLLVIWTHLGGIWAGHSPWTVIQTAGR 0.95484 0.65416 0 0 0 0 0 0 0 0 0 0 0 0 12.3751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4887 0 0 0 0 12.947 0 0 0 0 14.3729 0 0 0 0 0 0 0 13.5801 0 0 0 12.7816 0 0 0 0 0 0 0 0 12.7089 0 0 0 12.4399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1065 0 0 0 0 0 0 0 0 0 0 0 13.0724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8328 0 0 0 0 P0DPA2 VSIG8_HUMAN V-set and immunoglobulin domain-containing protein 8 VSIG8 C1orf204 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; RNA binding [GO:0003723] GO:0003723; GO:0016021 RNA binding [GO:0003723] ENVFLSYQDKRINHGSLPHLQQR 0.95485 0.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6807 0 0 0 0 0 0 0 0 0 0 11.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08188 TGM3_HUMAN "Protein-glutamine gamma-glutamyltransferase E, EC 2.3.2.13 (Transglutaminase E, TG(E), TGE, TGase E) (Transglutaminase-3, TGase-3) [Cleaved into: Protein-glutamine gamma-glutamyltransferase E 50 kDa catalytic chain; Protein-glutamine gamma-glutamyltransferase E 27 kDa non-catalytic chain ]" TGM3 Homo sapiens (Human) cell envelope organization [GO:0043163]; hair follicle morphogenesis [GO:0031069]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein modification process [GO:0036211] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; protein-containing complex [GO:0032991]; acyltransferase activity [GO:0016746]; calcium ion binding [GO:0005509]; catalytic activity [GO:0003824]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural molecule activity [GO:0005198]; cell envelope organization [GO:0043163]; hair follicle morphogenesis [GO:0031069]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein modification process [GO:0036211] GO:0003810; GO:0003824; GO:0005198; GO:0005509; GO:0005737; GO:0016746; GO:0018149; GO:0030216; GO:0031069; GO:0031234; GO:0031424; GO:0032991; GO:0036211; GO:0043163; GO:0070062 acyltransferase activity [GO:0016746]; calcium ion binding [GO:0005509]; catalytic activity [GO:0003824]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural molecule activity [GO:0005198] LKVAGMLAVGKEVNLVLLLK 0.95486 0.76979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4266 0 0 0 14.1539 0 14.356 0 14 13.9405 0 10.3633 0 14.2253 0 0 0 0 14.1064 14.5447 13.4091 0 13.8893 0 0 0 10.389 14.3632 13.8489 0 13.0825 0 0 13.7561 11.5638 11.9194 0 0 0 14.2053 0 14.1539 0 0 0 14.38 0 0 14.1291 0 0 0 14.0793 0 0 0 0 11.9933 0 0 0 13.7459 0 0 0 0 0 0 0 14.0944 0 0 0 0 0 14.3539 14.3144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15431 COPT1_HUMAN "High affinity copper uptake protein 1 (Copper transporter 1, hCTR1) (Solute carrier family 31 member 1)" SLC31A1 COPT1 CTR1 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649] integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; cellular copper ion homeostasis [GO:0006878]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649] GO:0005375; GO:0005770; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0014704; GO:0015677; GO:0042802; GO:0051649; GO:0055037 copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802] AVVVDITEHCH 0.95487 0.65303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5277 0 0 0 0 0 0 0 0 0 0 0 0 P0DP01 HV108_HUMAN Immunoglobulin heavy variable 1-8 IGHV1-8 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] VTMTRNTSISTAYMELSSLR 0.95488 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9476 0 0 0 14.8206 0 0 14.4842 14.3254 0 0 13.8134 0 14.1427 14.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2461 0 0 0 14.6794 15.0791 0 0 13.9231 0 0 0 14.364 0 0 0 0 0 14.8233 0 0 0 0 Q8TC17 GRAPL_HUMAN GRB2-related adapter protein-like GRAPL Homo sapiens (Human) cell migration [GO:0016477]; signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; cell migration [GO:0016477]; signal transduction [GO:0007165] GO:0005737; GO:0007165; GO:0016477; GO:0030971; GO:0035591 receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591] ESESSPGEFSVSVNNR 0.95488 0.65022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4P9 SPEF1_HUMAN Sperm flagellar protein 1 SPEF1 C20orf28 Homo sapiens (Human) "axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of cell death [GO:0060548]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]" 9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902] "9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of cell death [GO:0060548]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cytoskeleton organization [GO:0051493]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]" GO:0001578; GO:0003341; GO:0003779; GO:0005737; GO:0005874; GO:0005902; GO:0005930; GO:0007026; GO:0008017; GO:0016323; GO:0016324; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0046847; GO:0051493; GO:0060548; GO:0097542; GO:0097729; GO:1904158; GO:1990716; GO:2000095 actin binding [GO:0003779]; microtubule binding [GO:0008017] ASSVDEEALHQLYLWVDNIPLSRPKR 0.95488 0.77992 0 0 0 0 0 0 12.5497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4414 0 0 0 0 0 15.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9286 0 0 0 0 0 12.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.912 0 0 0 0 0 0 18.4113 0 0 0 13.3184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4469 0 0 0 0 0 0 0 11.7511 0 0 0 0 Q6ZNX1 SHLD3_HUMAN Shieldin complex subunit 3 (REV7-interacting novel NHEJ regulator 1) (Shield complex subunit 3) SHLD3 FLJ26957 RINN1 Homo sapiens (Human) DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247] chromatin [GO:0000785]; chromosome [GO:0005694]; site of double-strand break [GO:0035861] chromatin [GO:0000785]; chromosome [GO:0005694]; site of double-strand break [GO:0035861]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247] GO:0000785; GO:0002208; GO:0005694; GO:0006281; GO:0035861; GO:0043247; GO:0045830; GO:2000042; GO:2001034 ARWTIEHTICNSQTLEDIWTKLNQIIR 0.95489 0.73914 0 0 0 0 0 0 0 0 0 0 0 15.137 0 0 0 17.8312 0 0 13.281 0 13.1228 0 13.1344 0 0 13.2703 13.1549 0 0 0 0 0 0 0 0 0 0 14.794 0 16.1978 0 16.3015 0 16.5804 12.6075 12.2029 0 0 0 12.6305 12.3849 0 0 17.5456 0 17.0199 17.169 16.2254 16.6384 13.9834 14.9921 15.8476 15.8735 16.8782 16.9776 15.6438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7528 0 17.1667 17.4652 0 12.4874 0 12.578 0 0 0 0 0 0 0 0 14.8064 0 12.8588 0 0 P15941 MUC1_HUMAN "Mucin-1, MUC-1 (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3, CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6, KL-6) (PEMT) (Peanut-reactive urinary mucin, PUM) (Polymorphic epithelial mucin, PEM) (Tumor-associated epithelial membrane antigen, EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha, MUC1-NT, MUC1-alpha; Mucin-1 subunit beta, MUC1-beta (MUC1-CT) ]" MUC1 PUM Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]" apical plasma membrane [GO:0016324]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982] "apical plasma membrane [GO:0016324]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]" GO:0000785; GO:0000978; GO:0002039; GO:0003712; GO:0005615; GO:0005634; GO:0005796; GO:0005886; GO:0005887; GO:0006977; GO:0006978; GO:0010944; GO:0016324; GO:0031982; GO:0033629; GO:0036003; GO:0043618; GO:0070062; GO:0090240; GO:1902166 p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712] NYGQLDIFPAR 0.95489 0.65291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15519 CFLAR_HUMAN "CASP8 and FADD-like apoptosis regulator (Caspase homolog, CASH) (Caspase-eight-related protein, Casper) (Caspase-like apoptosis regulatory protein, CLARP) (Cellular FLICE-like inhibitory protein, c-FLIP) (FADD-like antiapoptotic molecule 1, FLAME-1) (Inhibitor of FLICE, I-FLICE) (MACH-related inducer of toxicity, MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12 ]" CFLAR CASH CASP8AP1 CLARP MRIT Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of myoblast fusion [GO:1901740]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteolysis [GO:0006508]; regulation of necroptotic process [GO:0060544]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue regeneration [GO:0043403]; skeletal myofibril assembly [GO:0014866]; wound healing [GO:0042060] CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; ripoptosome [GO:0097342] CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death receptor binding [GO:0005123]; enzyme activator activity [GO:0008047]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of myoblast fusion [GO:1901740]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteolysis [GO:0006508]; regulation of necroptotic process [GO:0060544]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; skeletal muscle tissue development [GO:0007519]; skeletal muscle tissue regeneration [GO:0043403]; skeletal myofibril assembly [GO:0014866]; wound healing [GO:0042060] GO:0002020; GO:0005123; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006919; GO:0007519; GO:0008047; GO:0010667; GO:0010976; GO:0014732; GO:0014842; GO:0014866; GO:0031264; GO:0031265; GO:0032869; GO:0033574; GO:0042060; GO:0043066; GO:0043123; GO:0043403; GO:0044877; GO:0045121; GO:0051092; GO:0060544; GO:0070374; GO:0071364; GO:0071392; GO:0071456; GO:0071549; GO:0071732; GO:0072126; GO:0097153; GO:0097199; GO:0097200; GO:0097342; GO:1901740; GO:1902042; GO:1903055; GO:1903427; GO:1903845; GO:1903944; GO:2000347; GO:2001237 cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death receptor binding [GO:0005123]; enzyme activator activity [GO:0008047]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877] CLKNIHRIDLK 0.9549 0.72272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8139 0 0 12.7651 12.4317 0 0 0 0 14.2802 0 0 0 0 0 13.2061 0 0 14.3053 0 11.3089 12.7915 12.5701 0 0 0 14.7478 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3422 12.4394 0 0 0 12.4701 0 0 12.997 0 14.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8091 0 0 0 12.4011 0 0 0 0 0 0 14.0279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4213 16.64 14.8836 0 0 13.8884 0 0 Q5VTM2 AGAP9_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9, AGAP-9 (Centaurin-gamma-like family member 6)" AGAP9 CTGLF6 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630] GO:0003924; GO:0005096; GO:0046872; GO:0090630 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] AIPIKQGMLLK 0.9549 0.65242 0 12.0528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAD4 ZNT5_HUMAN "Zinc transporter 5, ZnT-5 (Solute carrier family 30 member 5) (ZnT-like transporter 1, hZTL1)" SLC30A5 ZNT5 ZNTL1 ZTL1 UNQ863/PRO1879 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; cobalt ion transport [GO:0006824]; insulin processing [GO:0030070]; metal ion transport [GO:0030001]; regulation of proton transport [GO:0010155]; response to zinc ion [GO:0010043]; zinc ion import into Golgi apparatus [GO:1904257]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667] apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; cobalt ion transport [GO:0006824]; insulin processing [GO:0030070]; metal ion transport [GO:0030001]; regulation of proton transport [GO:0010155]; response to zinc ion [GO:0010043]; zinc ion import into Golgi apparatus [GO:1904257]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] GO:0005385; GO:0005654; GO:0005730; GO:0005794; GO:0005887; GO:0006824; GO:0006829; GO:0006882; GO:0008270; GO:0010043; GO:0010155; GO:0016020; GO:0016324; GO:0030001; GO:0030070; GO:0030141; GO:0030667; GO:0031410; GO:0046873; GO:0071577; GO:1904257 metal ion transmembrane transporter activity [GO:0046873]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385] ELHIALEKIQK 0.9549 0.66396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P31 FCRL3_HUMAN "Fc receptor-like protein 3, FcR-like protein 3, FcRL3 (Fc receptor homolog 3, FcRH3) (IFGP family protein 3, hIFGP3) (Immune receptor translocation-associated protein 3) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c)" FCRL3 FCRH3 IFGP3 IRTA3 SPAP2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of immunoglobulin production [GO:0002638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein serine/threonine phosphatase activity [GO:1905184]; regulation of B cell activation [GO:0050864]; regulation of B cell differentiation [GO:0045577]; regulation of calcium ion import [GO:0090279]; regulation of toll-like receptor 9 signaling pathway [GO:0034163] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of immunoglobulin production [GO:0002638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein serine/threonine phosphatase activity [GO:1905184]; regulation of B cell activation [GO:0050864]; regulation of B cell differentiation [GO:0045577]; regulation of calcium ion import [GO:0090279]; regulation of toll-like receptor 9 signaling pathway [GO:0034163] GO:0002638; GO:0004888; GO:0005887; GO:0007166; GO:0009986; GO:0019900; GO:0019902; GO:0019903; GO:0030890; GO:0034163; GO:0043410; GO:0045577; GO:0050859; GO:0050864; GO:0090279; GO:1905184; GO:1990782 kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; transmembrane signaling receptor activity [GO:0004888] AHEEDDEENYENVPR 0.95491 0.72147 0 0 11.2702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7074 0 0 11.8768 9.85417 0 0 0 9.74854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6661 0 0 0 0 0 0 0 0 0 10.7074 0 12.6908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1137 0 0 0 14.5892 0 0 0 0 0 16.2538 0 0 0 0 0 0 0 10.0185 15.1107 0 0 0 0 11.2386 0 0 0 0 0 13.8466 0 0 0 0 0 0 0 0 0 0 14.8968 0 0 0 0 0 12.3583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1199 0 0 0 0 11.5598 P56703 WNT3_HUMAN Proto-oncogene Wnt-3 (Proto-oncogene Int-4 homolog) WNT3 INT4 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; gene expression [GO:0010467]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; gene expression [GO:0010467]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089] GO:0000902; GO:0001707; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0007276; GO:0007411; GO:0009948; GO:0009950; GO:0010467; GO:0010628; GO:0019904; GO:0030177; GO:0030182; GO:0030666; GO:0031012; GO:0035115; GO:0035116; GO:0044338; GO:0044339; GO:0045165; GO:0048018; GO:0048697; GO:0048843; GO:0050767; GO:0060064; GO:0060070; GO:0060174; GO:0060323; GO:0061180; GO:0070062; GO:0071300; GO:0072089; GO:1904954; GO:1905474; GO:1990909 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018] AIGDFLKDK 0.95492 2.8483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6494 0 0 0 0 0 0 0 0 0 0 12.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99613 EIF3C_HUMAN "Eukaryotic translation initiation factor 3 subunit C, eIF3c (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110)" EIF3C EIF3S8 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413] GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0043022; GO:0045727; GO:1902416 ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] ALSTLRQK 0.95492 0.73003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0748 0 0 0 11.8485 0 0 0 0 0 0 0 0 0 0 0 13.1996 0 0 0 0 0 0 0 0 0 0 13.3204 13.3129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1577 0 0 0 0 0 0 P53794 SC5A3_HUMAN "Sodium/myo-inositol cotransporter, Na(+)/myo-inositol cotransporter (Sodium/myo-inositol transporter 1, SMIT1) (Solute carrier family 5 member 3)" SLC5A3 Homo sapiens (Human) fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol import across plasma membrane [GO:1904679]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transmembrane transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transporter activity [GO:0032409]; transport across blood-brain barrier [GO:0150104] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; fucose transmembrane transport [GO:0015756]; glucose transmembrane transport [GO:1904659]; inositol metabolic process [GO:0006020]; myo-inositol import across plasma membrane [GO:1904679]; myo-inositol transport [GO:0015798]; pentose transmembrane transport [GO:0015750]; peripheral nervous system development [GO:0007422]; polyol transmembrane transport [GO:0015791]; positive regulation of catalytic activity [GO:0043085]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transporter activity [GO:0032409]; transport across blood-brain barrier [GO:0150104] GO:0005365; GO:0005367; GO:0005412; GO:0005886; GO:0005887; GO:0006020; GO:0007422; GO:0008076; GO:0015146; GO:0015150; GO:0015166; GO:0015459; GO:0015750; GO:0015756; GO:0015791; GO:0015798; GO:0016021; GO:0032409; GO:0043085; GO:0043576; GO:0044325; GO:0048471; GO:0150104; GO:1903428; GO:1904659; GO:1904679; GO:1905477 fucose transmembrane transporter activity [GO:0015150]; glucose:sodium symporter activity [GO:0005412]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:sodium symporter activity [GO:0005367]; pentose transmembrane transporter activity [GO:0015146]; polyol transmembrane transporter activity [GO:0015166]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325] EEGNPVASLGHSEAETPVDAYSNGQAALMGEK 0.95493 0.73789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4741 0 0 0 12.4037 0 12.5719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3536 0 0 14.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3K6 MIER3_HUMAN "Mesoderm induction early response protein 3, Mi-er3" MIER3 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0032991; GO:0042826 histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714] IMDRISAGTHTR 0.95493 0.66356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7559 0 0 0 12.4434 0 0 0 0 0 0 0 0 0 0 12.7315 0 0 13.0313 12.709 12.4324 13.479 0 0 13.6807 0 13.1002 0 0 0 0 0 0 0 0 0 0 12.4741 0 13.9241 13.4747 0 0 0 0 0 0 0 0 0 12.0416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9729 0 0 0 0 0 0 0 12.6747 0 0 0 0 13.4713 P02787 TRFE_HUMAN "Serotransferrin, Transferrin (Beta-1 metal-binding globulin) (Siderophilin)" TF PRO1400 Homo sapiens (Human) "actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]" apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982] "apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]; actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]" GO:0001895; GO:0005576; GO:0005615; GO:0005769; GO:0005770; GO:0005788; GO:0005886; GO:0005905; GO:0006826; GO:0006879; GO:0007015; GO:0008198; GO:0008199; GO:0009925; GO:0009986; GO:0010008; GO:0016324; GO:0019731; GO:0030139; GO:0030316; GO:0030669; GO:0031232; GO:0031410; GO:0031647; GO:0031982; GO:0034756; GO:0034774; GO:0034986; GO:0042327; GO:0045178; GO:0045780; GO:0045893; GO:0048260; GO:0048471; GO:0055037; GO:0055072; GO:0060395; GO:0070062; GO:0070371; GO:0071281; GO:0072562; GO:1990459; GO:1990712; GO:2000147 ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459] DLLFRDDTVCLAK 0.95494 0.7506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0288 0 0 0 0 14.1312 13.9283 0 13.8841 0 0 0 0 0 0 0 11.6352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8658 10.8101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2544 0 12.635 0 0 0 0 0 0 0 0 0 0 0 11.0832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0K9 FRS1L_HUMAN DOMON domain-containing protein FRRS1L (Brain protein CG-6) (Ferric-chelate reductase 1-like protein) FRRS1L C9orf4 Homo sapiens (Human) "regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synaptic transmission, glutamatergic [GO:0051966]" anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; dynein intermediate chain binding [GO:0045505]; protein-containing complex binding [GO:0044877]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synaptic transmission, glutamatergic [GO:0051966]" GO:0005886; GO:0016021; GO:0044877; GO:0045202; GO:0045505; GO:0051966; GO:0070161; GO:0099072; GO:1900449; GO:1904717 dynein intermediate chain binding [GO:0045505]; protein-containing complex binding [GO:0044877] KMGGDDVMACVHDDNGR 0.95494 2.7369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2853 0 12.0418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4405 0 0 0 0 0 12.0018 0 0 13.0448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y376 CAB39_HUMAN Calcium-binding protein 39 (MO25alpha) (Protein Mo25) CAB39 MO25 CGI-66 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; serine/threonine protein kinase complex [GO:1902554]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; serine/threonine protein kinase complex [GO:1902554]; Z disc [GO:0030018]; kinase binding [GO:0019900]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165] GO:0005576; GO:0005737; GO:0005829; GO:0007165; GO:0010800; GO:0014823; GO:0016020; GO:0018105; GO:0019900; GO:0030018; GO:0030295; GO:0032147; GO:0034774; GO:0035556; GO:0043539; GO:0070062; GO:0071476; GO:0071902; GO:0097066; GO:1901017; GO:1901380; GO:1902554; GO:1904813 kinase binding [GO:0019900]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539] DLKRPAQQEA 0.95494 0.73764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0604 0 13.3914 0 0 0 0 0 0 0 0 13.9217 15.8058 0 0 0 0 10.1047 0 0 0 0 0 0 14.8846 0 0 0 14.0234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1819 0 0 0 14.0718 14.6739 14.6299 14.7706 13.8452 13.975 15.2389 0 0 14.5994 14.7275 0 14.0762 15.1406 15.9094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2719 10.7873 0 0 0 0 0 0 0 11.2946 0 0 0 0 0 0 0 0 0 0 11.4898 0 0 0 0 0 0 0 11.5464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3438 0 F2Z398 LMO7D_HUMAN LMO7 downstream neighbor protein LMO7DN C13orf45 Homo sapiens (Human) GVWTQEDENSCSFSESDFPGCR 0.95495 0.64742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.33796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWL2 SFTA1_HUMAN "Pulmonary surfactant-associated protein A1, PSP-A, PSPA, SP-A, SP-A1 (35 kDa pulmonary surfactant-associated protein) (Alveolar proteinosis protein) (Collectin-4)" SFTPA1 COLEC4 PSAP SFTP1 SFTPA SFTPA1B Homo sapiens (Human) opsonization [GO:0008228]; respiratory gaseous exchange by respiratory system [GO:0007585] clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791] clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]; carbohydrate binding [GO:0030246]; lipid transporter activity [GO:0005319]; opsonization [GO:0008228]; respiratory gaseous exchange by respiratory system [GO:0007585] GO:0005319; GO:0005576; GO:0005581; GO:0005615; GO:0005771; GO:0005789; GO:0005791; GO:0007585; GO:0008228; GO:0030246; GO:0042599; GO:0045334 carbohydrate binding [GO:0030246]; lipid transporter activity [GO:0005319] EQCVEMYTDGQWNDR 0.95496 0.73003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LM1 CL037_HUMAN Putative uncharacterized protein encoded by LINC00615 LINC00615 C12orf37 Homo sapiens (Human) AQSQDARPLAPAACISK 0.95498 0.65184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01583 IL1A_HUMAN "Interleukin-1 alpha, IL-1 alpha (Hematopoietin-1)" IL1A IL1F1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283] GO:0001660; GO:0001666; GO:0001819; GO:0002248; GO:0005125; GO:0005149; GO:0005507; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006883; GO:0006915; GO:0006954; GO:0006955; GO:0007283; GO:0007507; GO:0008285; GO:0009986; GO:0010193; GO:0010243; GO:0010332; GO:0010575; GO:0010628; GO:0010893; GO:0019221; GO:0031424; GO:0032308; GO:0032743; GO:0032755; GO:0032760; GO:0032956; GO:0033092; GO:0033591; GO:0034605; GO:0035234; GO:0043123; GO:0045766; GO:0045840; GO:0045944; GO:0046330; GO:0046688; GO:0050714; GO:0050999; GO:0051781; GO:0051930; GO:0070374; GO:0071222; GO:0097192; GO:1902624; GO:1904445; GO:2001240 copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149] DDAKITVILRISK 0.95499 0.74637 0 0 0 0 0 0 0 0 0 0 0 14.0747 0 14.4229 15.1907 0 14.132 0 14.0347 0 0 0 0 0 0 0 0 13.5709 0 0 0 0 0 13.4253 0 0 0 0 0 0 13.3645 0 16.8274 0 13.9966 0 0 0 0 0 0 13.8403 13.8725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7071 0 0 0 12.3348 0 0 0 13.5156 0 0 13.6257 0 13.5015 0 13.1889 0 0 0 0 0 13.6765 12.9266 0 0 11.5717 14.7077 0 0 12.6361 13.8224 12.9331 0 13.1897 14.1856 12.6789 0 0 0 0 0 0 0 14.3817 0 12.5711 11.7025 12.504 0 13.7951 13.5934 13.3873 0 12.3532 12.0084 0 13.2531 0 12.4291 0 0 0 14.4643 0 14.1089 13.8373 0 0 0 0 0 0 0 0 0 12.8202 0 0 0 14.1159 14.3609 14.4812 13.9247 0 0 0 0 0 0 16.2127 0 12.3479 0 0 0 14.7307 0 0 0 0 0 16.1497 0 0 0 0 Q8N9W8 GAR2_HUMAN Golgi associated RAB2 interactor protein 2 GARIN2 C14orf54 FAM71D Homo sapiens (Human) flagellated sperm motility [GO:0030317] sperm midpiece [GO:0097225] sperm midpiece [GO:0097225]; flagellated sperm motility [GO:0030317] GO:0030317; GO:0097225 LVPHLSAPFSR 0.955 0.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BX68 HINT2_HUMAN "Adenosine 5'-monophosphoramidase HINT2, EC 3.9.1.- (HINT-3) (HIT-17kDa) (Histidine triad nucleotide-binding protein 2, mitochondrial, HINT-2) (PKCI-1-related HIT protein)" HINT2 Homo sapiens (Human) apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; adenosine 5'-monophosphoramidase activity [GO:0043530]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694] GO:0000166; GO:0005737; GO:0005739; GO:0005741; GO:0006694; GO:0006915; GO:0016042; GO:0016787; GO:0043530; GO:2000757 adenosine 5'-monophosphoramidase activity [GO:0043530]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166] AAAVVLAAGLRAAR 0.955 3.3004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9066 0 0 0 0 0 13.2945 0 12.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8761 11.9877 0 11.1364 13.3529 0 0 0 16.4412 0 16.1858 0 0 0 0 0 0 0 0 0 0 0 16.0714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41586 PACR_HUMAN "Pituitary adenylate cyclase-activating polypeptide type I receptor, PACAP type I receptor, PACAP-R-1, PACAP-R1" ADCYAP1R1 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; development of primary female sexual characteristics [GO:0046545]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283] GO:0004999; GO:0005768; GO:0005791; GO:0005886; GO:0005887; GO:0005901; GO:0005923; GO:0007166; GO:0007188; GO:0007202; GO:0007283; GO:0008179; GO:0008528; GO:0009410; GO:0009986; GO:0010524; GO:0017046; GO:0019933; GO:0030154; GO:0031267; GO:0032355; GO:0033555; GO:0038023; GO:0042923; GO:0043005; GO:0043231; GO:0043235; GO:0043950; GO:0045471; GO:0046545; GO:0051057; GO:0060548; GO:0060732 adenylate cyclase binding [GO:0008179]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; signaling receptor activity [GO:0038023]; small GTPase binding [GO:0031267]; vasoactive intestinal polypeptide receptor activity [GO:0004999] DWILYAEQDSNHCFISTVECK 0.95501 0.62685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0ZSE6 CC50C_HUMAN Cell cycle control protein 50C (Transmembrane protein 30C) TMEM30CP CDC50C TMEM30C Homo sapiens (Human) phospholipid translocation [GO:0045332] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid translocation [GO:0045332] GO:0005783; GO:0005794; GO:0005886; GO:0016021; GO:0045332 LLDNSALKQQELPIHRLYFTAR 0.95502 0.6459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2786 0 10.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14798 TR10C_HUMAN "Tumor necrosis factor receptor superfamily member 10C (Antagonist decoy receptor for TRAIL/Apo-2L) (Decoy TRAIL receptor without death domain) (Decoy receptor 1, DcR1) (Lymphocyte inhibitor of TRAIL) (TNF-related apoptosis-inducing ligand receptor 3, TRAIL receptor 3, TRAIL-R3) (TRAIL receptor without an intracellular domain) (CD antigen CD263)" TNFRSF10C DCR1 LIT TRAILR3 TRID UNQ321/PRO366 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065]; TRAIL-activated apoptotic signaling pathway [GO:0036462] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888]; positive regulation of apoptotic process [GO:0043065]; TRAIL-activated apoptotic signaling pathway [GO:0036462] GO:0004888; GO:0005886; GO:0009986; GO:0031225; GO:0036462; GO:0043065; GO:0045569 TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888] SEHTGACNPCTEGVDYTNASNNEPSCFPCTVCK 0.95502 0.65429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0725 0 11.6984 0 0 0 0 0 11.0288 0 0 0 0 0 11.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14901 KLF11_HUMAN "Krueppel-like factor 11 (Transforming growth factor-beta-inducible early growth response protein 2, TGFB-inducible early growth response protein 2, TIEG-2)" KLF11 FKLF TIEG2 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to peptide [GO:1901653]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; apoptotic process [GO:0006915]; cellular response to peptide [GO:1901653]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]" GO:0000083; GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006357; GO:0006915; GO:0008285; GO:0016604; GO:0043065; GO:0046872; GO:1901653; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" PFNCSWDGCDK 0.95503 0.65113 0 0 0 0 0 0 11.2489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5014 0 0 0 0 0 0 11.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0618 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5524 0 0 0 0 0 0 0 0 13.7278 0 0 0 12.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3674 0 12.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CE72 ONCO_HUMAN "Oncomodulin-1, OM (Parvalbumin beta)" OCM OCM1 OCMN Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509] GO:0005509; GO:0005634; GO:0005737 calcium ion binding [GO:0005509] FESGARELTESETK 0.95503 0.64526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5613 0 0 0 0 0 0 0 0 11.0218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5H913 AR13A_HUMAN ADP-ribosylation factor-like protein 13A ARL13A Homo sapiens (Human) non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500] ciliary membrane [GO:0060170]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730] ciliary membrane [GO:0060170]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500] GO:0003924; GO:0005525; GO:0031514; GO:0060170; GO:0097500; GO:0097730; GO:1905515 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IILTHLLSDK 0.95503 2.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.144 0 14.2448 0 0 0 13.5322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9443 0 14.6114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6193 0 0 0 0 12.8027 0 12.7907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3209 0 0 0 0 0 0 0 0 0 0 0 0 13.2596 0 Q9UHP7 CLC2D_HUMAN "C-type lectin domain family 2 member D (Lectin-like NK cell receptor) (Lectin-like transcript 1, LLT-1) (Osteoclast inhibitory lectin)" CLEC2D CLAX LLT1 OCIL Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; natural killer cell lectin-like receptor binding [GO:0046703]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166] GO:0004888; GO:0005783; GO:0005886; GO:0005887; GO:0007166; GO:0009897; GO:0009986; GO:0016020; GO:0030246; GO:0046703 carbohydrate binding [GO:0030246]; natural killer cell lectin-like receptor binding [GO:0046703]; transmembrane signaling receptor activity [GO:0004888] CFYFSDDTKNWTSSQR 0.95504 0.62684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1E2 LYG1_HUMAN "Lysozyme g-like protein 1, EC 3.2.1.-" LYG1 UNQ1939/PRO4422 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830]; peptidoglycan catabolic process [GO:0009253] extracellular region [GO:0005576] extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; defense response to Gram-positive bacterium [GO:0050830]; peptidoglycan catabolic process [GO:0009253] GO:0003796; GO:0005576; GO:0009253; GO:0050830 lysozyme activity [GO:0003796] SSQDLSCDFCNDVLARAK 0.95505 0.77253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9544 0 0 0 0 0 0 0 0 0 0 11.9922 12.8846 0 0 11.9765 0 0 0 0 0 12.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7087 0 11.6468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9641 12.0571 11.8329 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6V9 LDAH_HUMAN "Lipid droplet-associated hydrolase, EC 3.1.1.- (Lipid droplet-associated serine hydrolase, hLDAH)" LDAH C2orf43 Homo sapiens (Human) lipid catabolic process [GO:0016042]; lipid storage [GO:0019915] endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; sterol esterase activity [GO:0004771]; lipid catabolic process [GO:0016042]; lipid storage [GO:0019915] GO:0004771; GO:0005783; GO:0005811; GO:0016042; GO:0019915 sterol esterase activity [GO:0004771] EYYEDIKKDFPEGDIR 0.95506 0.65351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3467 0 0 0 0 0 11.5277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6Y2 WDR55_HUMAN WD repeat-containing protein 55 WDR55 Homo sapiens (Human) rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rRNA processing [GO:0006364] GO:0005654; GO:0005730; GO:0005737; GO:0006364 EEGEDSMAQEEK 0.95506 0.77159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6784 0 0 0 0 0 0 0 0 0 0 0 9.9009 0 11.7601 0 11.6842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8702 0 0 0 0 0 0 0 0 0 12.7188 0 0 0 0 0 0 14.0478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3551 0 0 0 12.5213 0 0 0 0 12.9378 0 0 0 12.4678 0 0 0 0 0 12.5678 0 0 12.99 12.8737 0 0 0 0 0 0 0 0 12.5452 0 0 0 0 0 0 0 0 0 0 0 0 13.0467 0 0 12.0436 0 0 0 0 0 0 0 0 12.5171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15560 TCEA2_HUMAN Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l) TCEA2 Homo sapiens (Human) "DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023] "centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; DNA-templated transcription, elongation [GO:0006354]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006351; GO:0006354; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0045944 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] CREMLTAALQTDHDHVAIGADCER 0.95507 0.65311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8535 0 0 0 0 0 0 0 12.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5023 0 0 0 0 0 0 0 0 H0YL14 TM250_HUMAN Transmembrane protein 250 (Herpes virus UL25-binding protein) TMEM250 C9orf69 Homo sapiens (Human) cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of viral process [GO:0048524]; protein localization [GO:0008104] cell division site [GO:0032153]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940] cell division site [GO:0032153]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of viral process [GO:0048524]; protein localization [GO:0008104] GO:0003924; GO:0005634; GO:0005654; GO:0005737; GO:0005940; GO:0008104; GO:0008284; GO:0015630; GO:0016021; GO:0031105; GO:0032153; GO:0048524; GO:0060090; GO:0060271; GO:0061640 GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] FQRKLSVLLLLLGR 0.95508 2.7319 0 0 0 13.8675 0 0 0 12.4758 15.0273 15.0641 0 0 13.9504 0 0 10.6474 0 0 10.366 0 0 0 10.7823 0 0 0 0 0 0 13.792 12.3987 0 0 0 0 0 0 0 13.4167 0 0 13.1698 0 0 0 0 0 0 0 0 0 11.9507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0213 0 0 0 0 0 0 0 0 13.1661 0 0 11.2773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2048 0 0 0 12.4547 0 0 14.0097 0 0 0 10.7532 0 0 0 0 0 0 0 0 0 0 0 13.2518 0 11.3431 0 0 0 0 0 0 0 10.7093 0 0 0 11.1011 11.3965 0 12.2207 0 10.4013 0 0 0 0 10.8259 0 0 0 0 0 0 0 0 0 10.4115 0 0 0 0 0 0 0 0 11.2046 0 0 0 0 11.9025 11.9719 0 0 0 11.168 0 0 0 0 0 11.1385 Q5VW32 BROX_HUMAN BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein) BROX BROFTI C1orf58 Homo sapiens (Human) extracellular exosome [GO:0070062]; membrane [GO:0016020] extracellular exosome [GO:0070062]; membrane [GO:0016020] GO:0016020; GO:0070062 DTGCYIS 0.95508 0.77108 0 0 0 0 0 0 0 0 0 11.6714 11.023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6644 0 0 0 0 0 0 0 0 12.8815 0 0 0 0 0 0 0 0 0 0 0 16.0617 0 0 12.7782 0 18.9794 0 0 0 0 0 0 0 0 11.6909 0 0 0 12.2117 0 0 0 0 0 0 0 0 0 0 0 0 10.3298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4362 0 11.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96019 ACL6A_HUMAN "Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A, BAF53A) (INO80 complex subunit K)" ACTL6A BAF53 BAF53A INO80K Homo sapiens (Human) "blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of growth [GO:0040008]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; telomere maintenance [GO:0000723]" brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; Ino80 complex [GO:0031011]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] "brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; Ino80 complex [GO:0031011]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of growth [GO:0040008]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; telomere maintenance [GO:0000723]" GO:0000723; GO:0000776; GO:0000785; GO:0000786; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007165; GO:0007399; GO:0008284; GO:0016363; GO:0016514; GO:0016573; GO:0016586; GO:0021510; GO:0030071; GO:0031011; GO:0032991; GO:0033044; GO:0035060; GO:0035267; GO:0040008; GO:0042981; GO:0043486; GO:0043967; GO:0043968; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0070316; GO:0071564; GO:0140288; GO:1902459; GO:1904507; GO:1905168; GO:2000045; GO:2000779; GO:2000781; GO:2000819 chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713] EKLTELMFEHYNIPAFFLCK 0.95509 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGN2 O10S1_HUMAN Olfactory receptor 10S1 (Olfactory receptor OR11-279) OR10S1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] YLAICQPLHYPVAMNR 0.95509 0.65022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5347 0 0 0 0 0 0 0 0 0 12.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16284 PECA1_HUMAN "Platelet endothelial cell adhesion molecule, PECAM-1 (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31)" PECAM1 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell recognition [GO:0008037]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diapedesis [GO:0050904]; establishment of endothelial barrier [GO:0061028]; glomerular endothelium development [GO:0072011]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte cell-cell adhesion [GO:0007159]; maintenance of blood-brain barrier [GO:0035633]; monocyte extravasation [GO:0035696]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to cell-cell junction [GO:0150107]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; bicellular tight junction assembly [GO:0070830]; cell recognition [GO:0008037]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diapedesis [GO:0050904]; establishment of endothelial barrier [GO:0061028]; glomerular endothelium development [GO:0072011]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte cell-cell adhesion [GO:0007159]; maintenance of blood-brain barrier [GO:0035633]; monocyte extravasation [GO:0035696]; neutrophil extravasation [GO:0072672]; phagocytosis [GO:0006909]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to cell-cell junction [GO:0150107]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] GO:0001934; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0006909; GO:0007156; GO:0007159; GO:0007165; GO:0007166; GO:0008037; GO:0030335; GO:0030667; GO:0031092; GO:0032991; GO:0035633; GO:0035696; GO:0042803; GO:0045121; GO:0050731; GO:0050904; GO:0061028; GO:0070062; GO:0070830; GO:0072011; GO:0072672; GO:0098609; GO:0098742; GO:0150107 protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888] AKAKQMPVEMSR 0.9551 0.72313 0 0 0 0 13.8625 0 0 11.8503 0 0 10.9656 0 13.2319 13.3982 0 12.0515 13.2599 0 12.4027 13.2306 13.9574 15.1001 0 0 13.0996 15.1154 0 13.2793 13.4026 0 0 0 12.1026 0 0 13.6035 0 0 0 0 12.331 10.9864 11.4528 0 0 14.4766 0 0 0 0 0 0 0 12.1703 0 13.4144 0 11.3987 0 0 0 0 0 11.5954 0 0 14.8138 11.9073 12.2969 14.5442 15.4038 11.1944 0 0 11.9638 10.6203 10.3107 0 0 15.4337 0 12.8667 13.3301 14.83 13.8867 0 16.8178 15.6138 16.4002 14.3848 15.3397 16.0747 15.4921 15.9496 17.0872 16.4479 16.4056 15.462 0 16.4559 15.2131 16.024 15.1441 16.1103 15.372 15.2722 16.1194 16.0105 0 15.6993 15.8434 0 16.1555 0 16.339 15.616 16.0147 14.4696 15.1667 12.3286 13.8768 0 13.5215 14.5974 0 16.5873 15.7111 0 16.2716 0 0 15.0854 15.2289 0 15.8114 14.7679 14.2825 15.8093 0 0 15.5573 14.5091 16.2119 14.866 15.6999 14.2724 14.5409 14.4065 11.6854 14.811 13.0244 14.0408 15.8404 15.5075 13.8497 13.4558 11.5419 0 0 13.3442 11.9006 0 12.4948 0 13.3009 14.618 0 12.9902 0 0 12.5751 14.5431 13.6089 0 13.2074 0 0 0 14.3259 0 Q8N755 S66A3_HUMAN Solute carrier family 66 member 3 (PQ-loop repeat-containing protein 3) SLC66A3 C2orf22 PQLC3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FVIMLALNIWVTVTVLRYRK 0.95511 0.74121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2865 15.9864 15.6996 0 15.6779 0 15.2399 14.3944 0 16.8386 16.7163 16.739 0 0 0 0 0 0 0 0 0 0 0 0 15.4843 0 0 16.5613 0 0 0 0 12.931 0 0 0 0 0 0 15.3564 0 0 0 0 0 16.2627 16.3741 0 0 16.5408 0 0 0 0 16.4639 16.414 0 16.065 0 15.7759 0 0 16.1238 0 0 0 0 0 0 15.8357 0 0 0 0 14.9961 0 0 0 0 0 14.8337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4914 0 15.4746 0 0 15.4811 0 0 0 H3BNL1 CC084_HUMAN Uncharacterized protein C3orf84 C3orf84 Homo sapiens (Human) TTYQQNFCCPSQGGHYGSYK 0.95512 0.75276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.735 0 0 0 12.8393 0 12.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4406 0 0 0 14.1635 0 15.1269 0 0 0 0 0 0 0 0 0 0 0 11.4531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNC8 MBOA1_HUMAN "Lysophospholipid acyltransferase 1, LPLAT 1 (1-acylglycerophosphocholine O-acyltransferase, EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase, EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase MBOAT1, EC 2.3.1.n6) (Lysophosphatidylserine acyltransferase, LPSAT, Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 1, O-acyltransferase domain-containing protein 1)" MBOAT1 OACT1 Homo sapiens (Human) lipid modification [GO:0030258]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of neuron projection development [GO:0010975] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lipid modification [GO:0030258]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of neuron projection development [GO:0010975] GO:0003841; GO:0005789; GO:0008654; GO:0010975; GO:0016020; GO:0016021; GO:0016746; GO:0030258; GO:0036150; GO:0036152; GO:0047144; GO:0047184; GO:0106262; GO:0106263 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746] GFHSLPEPSPTGAVIHKLGITLVSLLLFLTLTK 0.95513 0.6402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z429 LFG1_HUMAN Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3) GRINA LFG1 NMDARA1 TMBIM3 Homo sapiens (Human) endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transmembrane transporter binding [GO:0044325]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236] GO:0005783; GO:0005794; GO:0016020; GO:0016021; GO:0032469; GO:0044325; GO:1902236; GO:2001234 transmembrane transporter binding [GO:0044325] ENVWTYYVSYAVFFISLIVLSCCGDFRRK 0.95513 3.6538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46926 GNPI1_HUMAN "Glucosamine-6-phosphate isomerase 1, EC 3.5.99.6 (Glucosamine-6-phosphate deaminase 1, GNPDA 1, GlcN6P deaminase 1) (Oscillin)" GNPDA1 GNPI HLN KIAA0060 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; single fertilization [GO:0007338]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; single fertilization [GO:0007338]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] GO:0004342; GO:0005737; GO:0005829; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0006091; GO:0007338; GO:0019262; GO:0042802; GO:0070062 glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802] LIEYYKNGDLSFK 0.95514 0.66361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.006 0 10.5176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PEW0 PRS54_HUMAN "Inactive serine protease 54 (Cancer/testis antigen 67, CT67) (Plasma kallikrein-like protein 4)" PRSS54 KLKBL4 Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508 serine-type endopeptidase activity [GO:0004252] GVLNFGGETCPGLFLYTKVEDYSK 0.95514 0.75113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2357 0 0 0 0 0 0 0 17.6171 0 0 13.6034 0 13.2428 0 0 0 0 0 0 0 0 13.5606 0 0 12.8094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1208 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3952 0 0 0 0 12.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2477 0 0 0 0 0 0 0 Q9NQN1 OR2S1_HUMAN Olfactory receptor 2S2 (Olfactory receptor OR9-3) OR2S2 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IPSAEGR 0.95514 0.64018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 E5RHQ5 NPB11_HUMAN Nuclear pore complex-interacting protein family member B11 NPIPB11 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 DVITLRR 0.95515 0.72131 0 0 0 12.3905 0 0 0 0 13.7408 12.2697 0 0 0 0 0 0 0 0 0 12.7166 12.7835 0 12.704 0 0 0 0 16.5906 12.7321 0 0 0 0 0 0 0 0 13.142 0 12.5593 0 11.1464 0 0 0 0 0 0 0 13.649 13.1513 0 12.8797 13.2035 12.6768 12.6616 0 0 9.09107 0 0 0 0 0 0 0 12.4083 12.4095 0 12.3822 0 0 0 0 0 17.3991 0 13.5079 0 0 13.6427 0 0 0 0 0 0 14.5105 15.5379 13.9511 16.3558 0 15.6882 0 0 0 14.6613 0 0 0 0 16.355 12.6223 0 16.1207 0 0 0 0 16.4524 0 14.6357 15.5152 0 15.7064 13.2764 0 0 0 14.2263 0 0 0 15.7177 15.7932 0 0 0 16.0028 13.1802 0 0 16.1221 0 14.8341 14.2724 13.2576 15.8689 0 15.8886 0 0 0 15.7444 0 18.7263 0 12.837 15.834 0 15.6509 0 0 15.2184 0 15.3085 0 20.0076 19.5974 0 0 0 18.7586 19.2958 12.4234 0 12.7988 13.0221 0 0 0 15.1645 0 15.3146 15.9651 12.2079 0 0 15.5143 18.9144 Q969X5 ERGI1_HUMAN "Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein, ERGIC-32)" ERGIC1 ERGIC32 KIAA1181 HT034 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0005654; GO:0005783; GO:0005793; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0030173; GO:0030176; GO:0033116; GO:0043231 QRYSYQYTVANK 0.95515 0.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1819 L0R6Q1 S35U4_HUMAN SLC35A4 upstream open reading frame protein SLC35A4 Homo sapiens (Human) positive regulation of translation in response to stress [GO:0032056] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; positive regulation of translation in response to stress [GO:0032056] GO:0016021; GO:0032056 DLAFLKNQLESLQRR 0.95516 0.72091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5015 0 15.4699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75365 TP4A3_HUMAN "Protein tyrosine phosphatase type IVA 3, EC 3.1.3.48 (PRL-R) (Protein-tyrosine phosphatase 4a3) (Protein-tyrosine phosphatase of regenerating liver 3, PRL-3)" PTP4A3 PRL3 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; endothelial cell migration [GO:0043542]; Notch signaling pathway [GO:0007219]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular permeability [GO:0043117]; protein dephosphorylation [GO:0006470]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]" cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to leukemia inhibitory factor [GO:1990830]; endothelial cell migration [GO:0043542]; Notch signaling pathway [GO:0007219]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular permeability [GO:0043117]; protein dephosphorylation [GO:0006470]; regulation of transcription, DNA-templated [GO:0006355]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]" GO:0004725; GO:0004727; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006355; GO:0006470; GO:0007219; GO:0008138; GO:0043117; GO:0043542; GO:1900746; GO:1901224; GO:1904951; GO:1990830 prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] FLITHNPTNATLSTFIEDLKK 0.95517 0.75068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6746 12.2963 0 0 0 0 0 0 0 0 0 0 0 12.7718 0 0 0 0 0 0 0 0 0 0 0 0 10.994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8154 0 0 0 0 0 0 0 0 0 0 0 P43307 SSRA_HUMAN "Translocon-associated protein subunit alpha, TRAP-alpha (Signal sequence receptor subunit alpha, SSR-alpha)" SSR1 TRAPA PSEC0262 Homo sapiens (Human) cotranslational protein targeting to membrane [GO:0006613]; positive regulation of cell population proliferation [GO:0008284] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]; positive regulation of cell population proliferation [GO:0008284] GO:0005783; GO:0005789; GO:0006613; GO:0008284; GO:0016021 LLLLLLLVFPATVLFR 0.95517 4.3966 0 0 0 10.708 0 0 0 0 0 11.5634 13.7127 0 0 0 0 10.7951 0 0 0 0 0 0 0 11.2045 0 0 0 0 10.7945 0 0 10.0171 0 0 0 0 0 12.5187 0 0 0 0 0 0 0 0 0 11.0431 12.2574 0 0 0 11.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6765 0 0 13.2982 0 0 12.4714 0 0 0 0 0 14.8614 0 0 0 0 0 0 0 11.8672 0 0 0 0 0 0 0 13.1088 11.5403 0 0 0 0 0 13.3243 0 0 0 0 0 0 0 0 12.8667 0 0 0 12.709 11.5441 0 0 0 0 0 0 0 0 12.2461 0 0 0 0 12.1534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5606 0 0 0 0 0 0 0 0 11.4806 0 0 11.2759 0 0 0 0 0 0 0 0 0 0 0 11.4788 0 0 12.8356 0 0 11.2242 13.4882 P23083 HV102_HUMAN Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35) IGHV1-2 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0005576; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] ASGYTFTGYYMHWVR 0.95518 0.73003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.59 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHM4 TRY6_HUMAN "Putative trypsin-6, EC 3.4.21.4 (Serine protease 3 pseudogene 2) (Trypsinogen C)" PRSS3P2 T6 TRY6 Homo sapiens (Human) endothelial cell migration [GO:0043542]; proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; endothelial cell migration [GO:0043542]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508; GO:0043542; GO:0046872 metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] DTIAANS 0.95519 0.65191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EH3 MASU1_HUMAN Mitochondrial assembly of ribosomal large subunit protein 1 MALSU1 C7orf30 Homo sapiens (Human) negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; negative regulation of mitochondrial translation [GO:0070130]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148]; ribosomal large subunit biogenesis [GO:0042273] GO:0005739; GO:0005759; GO:0005829; GO:0017148; GO:0042273; GO:0043023; GO:0070130; GO:0090071 ribosomal large subunit binding [GO:0043023] LLAPLMWRR 0.95519 0.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7826 0 0 0 16.9589 12.8424 0 14.9852 14.6751 0 0 0 0 0 13.7676 0 0 14.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02161 RHD_HUMAN "Blood group Rh(D) polypeptide (RHXIII) (Rh polypeptide 2, RhPII) (Rhesus D antigen) (CD antigen CD240D)" RHD Homo sapiens (Human) ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488] GO:0005886; GO:0005887; GO:0008519; GO:0072488; GO:0097272 ammonium transmembrane transporter activity [GO:0008519] RCLPLWALTLEAALILLFYFFTHYDASLEDQK 0.9552 0.7474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5837 0 14.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1652 0 0 12.8969 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0698 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5131 0 0 12.4268 0 0 0 0 0 0 0 O00631 SARCO_HUMAN Sarcolipin SLN Homo sapiens (Human) calcium ion transport [GO:0006816]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import [GO:0090281]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of catalytic activity [GO:0043086]; negative regulation of protein-containing complex disassembly [GO:0043242]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein depolymerization [GO:1901881]; regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901894]; regulation of calcium ion transport [GO:0051924]; regulation of relaxation of muscle [GO:1901077]; sarcoplasmic reticulum calcium ion transport [GO:0070296] integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017] integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATPase binding [GO:0051117]; enzyme inhibitor activity [GO:0004857]; calcium ion transport [GO:0006816]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import [GO:0090281]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of catalytic activity [GO:0043086]; negative regulation of protein-containing complex disassembly [GO:0043242]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein depolymerization [GO:1901881]; regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901894]; regulation of calcium ion transport [GO:0051924]; regulation of relaxation of muscle [GO:1901077]; sarcoplasmic reticulum calcium ion transport [GO:0070296] GO:0004857; GO:0006816; GO:0016021; GO:0016529; GO:0033017; GO:0043086; GO:0043242; GO:0051117; GO:0051924; GO:0070296; GO:0090281; GO:0120162; GO:1901020; GO:1901077; GO:1901877; GO:1901881; GO:1901894; GO:1901895 ATPase binding [GO:0051117]; enzyme inhibitor activity [GO:0004857] ELFLNFTIVLITVILMWLLVR 0.95521 0.62685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSK0 MALD1_HUMAN MARVEL domain-containing protein 1 MARVELD1 MRVLDC1 Homo sapiens (Human) cell cycle [GO:0007049]; myelination [GO:0042552] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; structural constituent of myelin sheath [GO:0019911]; cell cycle [GO:0007049]; myelination [GO:0042552] GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0007049; GO:0016021; GO:0019911; GO:0042552 structural constituent of myelin sheath [GO:0019911] LQRPFLRSPLGVLR 0.95521 0.74655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1468 0 0 0 0 0 0 0 0 0 P20963 CD3Z_HUMAN T-cell surface glycoprotein CD3 zeta chain (T-cell receptor T3 zeta chain) (CD antigen CD247) CD247 CD3Z T3Z TCRZ Homo sapiens (Human) adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; Fc-gamma receptor signaling pathway [GO:0038094]; gamma-delta T cell activation [GO:0046629]; positive regulation of protein localization to cell surface [GO:2000010]; protein-containing complex assembly [GO:0065003]; T cell receptor signaling pathway [GO:0050852] alpha-beta T cell receptor complex [GO:0042105]; cytoplasm [GO:0005737]; Fc-gamma receptor III complex [GO:0033001]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] alpha-beta T cell receptor complex [GO:0042105]; cytoplasm [GO:0005737]; Fc-gamma receptor III complex [GO:0033001]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; Fc-gamma receptor signaling pathway [GO:0038094]; gamma-delta T cell activation [GO:0046629]; positive regulation of protein localization to cell surface [GO:2000010]; protein-containing complex assembly [GO:0065003]; T cell receptor signaling pathway [GO:0050852] GO:0002250; GO:0004888; GO:0005737; GO:0005794; GO:0005886; GO:0007166; GO:0016021; GO:0033001; GO:0038094; GO:0042101; GO:0042105; GO:0042106; GO:0042802; GO:0042803; GO:0046629; GO:0046631; GO:0046982; GO:0050852; GO:0065003; GO:1990782; GO:2000010 identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase binding [GO:1990782]; transmembrane signaling receptor activity [GO:0004888] DPEMGGK 0.95522 0.65136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2097 0 0 0 0 12.9411 13.0739 0 0 12.5617 0 10.684 0 0 0 0 14.2508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1468 0 0 0 0 0 0 0 0 0 0 0 0 12.1473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL17 TBX21_HUMAN "T-box transcription factor TBX21, T-box protein 21 (T-cell-specific T-box transcription factor T-bet) (Transcription factor TBLYM)" TBX21 TBET TBLYM Homo sapiens (Human) "cell fate specification [GO:0001708]; cellular response to organic substance [GO:0071310]; lymphocyte migration [GO:0072676]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of T cell differentiation [GO:0045580]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]; T-helper 1 cell lineage commitment [GO:0002296]" neuronal cell body [GO:0043025]; nucleus [GO:0005634] "neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell fate specification [GO:0001708]; cellular response to organic substance [GO:0071310]; lymphocyte migration [GO:0072676]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of T cell differentiation [GO:0045580]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]; T-helper 1 cell lineage commitment [GO:0002296]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001708; GO:0002296; GO:0005634; GO:0006357; GO:0009615; GO:0032703; GO:0043025; GO:0043161; GO:0043565; GO:0045580; GO:0045892; GO:0045893; GO:0045944; GO:0048304; GO:0071310; GO:0072676; GO:1990837; GO:2000320; GO:2000329; GO:2000552; GO:2000556 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" MFVDVVLVDQHHWR 0.95522 0.64621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXH6 T53I2_HUMAN "Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U, PIG-U)" TP53INP2 C20orf110 DOR PINH Homo sapiens (Human) "autophagosome assembly [GO:0000045]; negative regulation of protein localization [GO:1903828]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511]" autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605] "autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; negative regulation of protein localization [GO:1903828]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000045; GO:0001649; GO:0001894; GO:0005634; GO:0005776; GO:0005829; GO:0006511; GO:0008104; GO:0010508; GO:0016605; GO:0031410; GO:0043130; GO:0045893; GO:1903828 ubiquitin binding [GO:0043130] AALLEKAGQVR 0.95523 0.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20823 HNF1A_HUMAN "Hepatocyte nuclear factor 1-alpha, HNF-1-alpha, HNF-1A (Liver-specific transcription factor LF-B1, LFB1) (Transcription factor 1, TCF-1)" HNF1A TCF1 Homo sapiens (Human) "glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; insulin secretion [GO:0030073]; liver development [GO:0001889]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; renal glucose absorption [GO:0035623]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; insulin secretion [GO:0030073]; liver development [GO:0001889]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; renal glucose absorption [GO:0035623]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0030073; GO:0031016; GO:0032991; GO:0035623; GO:0042593; GO:0042803; GO:0045893; GO:0045944; GO:0046323; GO:0046982; GO:0046983; GO:0060261 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" EERETLVEECNR 0.95524 0.7451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGM8 OR6M1_HUMAN Olfactory receptor 6M1 (Olfactory receptor OR11-271) OR6M1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] VAAVLITVVTPLLNPFIYSLR 0.95524 0.62685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6491 0 0 0 0 0 0 0 0 0 13.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3308 0 0 0 0 0 0 14.3485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3351 0 0 0 0 13.7812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H665 IGFR1_HUMAN IGF-like family receptor 1 (Transmembrane protein 149) (U2 small nuclear RNA auxiliary factor 1-like 4) IGFLR1 TMEM149 U2AF1L4 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005886; GO:0016021 HLAARYGLPAAWSTFAYSLR 0.95524 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIH7 U119B_HUMAN Protein unc-119 homolog B UNC119B Homo sapiens (Human) cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399] ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829] ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; lipid binding [GO:0008289]; cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399] GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271 lipid binding [GO:0008289] KAGGGVLNR 0.95527 0.77253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8401 0 0 11.7459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1M0 S27A4_HUMAN "Long-chain fatty acid transport protein 4, FATP-4, Fatty acid transport protein 4 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase, EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4, ACSVL4, EC 6.2.1.-)" SLC27A4 ACSVL4 FATP4 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; establishment of localization in cell [GO:0051649]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0062003]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760]" brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] "brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; activation of GTPase activity [GO:0090630]; establishment of localization in cell [GO:0051649]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0062003]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760]" GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0005902; GO:0006631; GO:0007584; GO:0015245; GO:0015908; GO:0015909; GO:0016020; GO:0016021; GO:0031526; GO:0031957; GO:0042760; GO:0043065; GO:0043588; GO:0044381; GO:0044539; GO:0046627; GO:0047676; GO:0051649; GO:0062003; GO:0090433; GO:0090434; GO:0090630; GO:0150104; GO:1901480; GO:1990379 arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957] DIFGGLVLLKVK 0.95528 4.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5368 0 0 0 0 11.0503 0 11.8164 0 0 0 9.79354 0 0 0 0 0 0 14.7716 0 14.9105 14.6951 0 0 0 13.5416 13.5675 0 0 0 0 0 0 0 0 0 0 0 14.6199 9.73307 0 0 0 0 0 0 16.3002 16.0566 16.231 0 14.4734 0 14.117 15.274 0 14.2593 16.3037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6231 0 15.3213 14.5157 11.0738 0 0 0 0 0 0 0 0 0 15.0907 0 0 0 0 0 0 0 0 0 0 14.4497 0 0 0 14.8847 0 0 14.6525 0 0 0 0 0 Q9P2X8 CI027_HUMAN Putative uncharacterized protein encoded by LINC00474 (Protein EST-YD1) LINC00474 C9orf27 Homo sapiens (Human) TSNWGSSFSEKSGCMQTHPSMNLDCR 0.95529 0.65027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13064 MKRN3_HUMAN "Probable E3 ubiquitin-protein ligase makorin-3, EC 2.3.2.27 (RING finger protein 63) (RING-type E3 ubiquitin transferase makorin-3) (Zinc finger protein 127)" MKRN3 D15S9 RNF63 ZNF127 Homo sapiens (Human) protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] ribonucleoprotein complex [GO:1990904] ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] GO:0000209; GO:0003723; GO:0016567; GO:0042802; GO:0046872; GO:0061630; GO:1990904 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] EGENCRYSHDLSGR 0.9553 2.9391 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2107 0 0 11.3388 0 0 0 0 0 12.4297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.583 0 0 0 0 0 0 0 12.7298 0 0 0 0 0 12.2869 0 0 0 0 0 0 0 0 0 12.4001 0 0 0 0 0 0 0 0 0 13.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2653 0 0 0 0 0 Q7Z6A9 BTLA_HUMAN B- and T-lymphocyte attenuator (B- and T-lymphocyte-associated protein) (CD antigen CD272) BTLA Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response-regulating cell surface receptor signaling pathway [GO:0002768] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; immune response-regulating cell surface receptor signaling pathway [GO:0002768] GO:0002250; GO:0002768; GO:0005886; GO:0005887; GO:0038023 signaling receptor activity [GO:0038023] YCANRPHVTWCK 0.9553 0.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3H5 GPT_HUMAN "UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase, EC 2.7.8.15 (GlcNAc-1-P transferase, G1PT, GPT) (N-acetylglucosamine-1-phosphate transferase)" DPAGT1 DPAGT2 Homo sapiens (Human) dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047] GO:0003975; GO:0003976; GO:0005789; GO:0006047; GO:0006487; GO:0006488; GO:0008963; GO:0016020; GO:0016021; GO:0016757; GO:0019348; GO:0030176; GO:0042802; GO:0043231; GO:0046872 glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity [GO:0003975]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] NLTLLLLLLQILGSAITFSIR 0.9553 0.64298 0 0 0 12.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5247 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7498 0 0 0 0 0 0 0 0 0 15.8299 0 0 0 0 0 0 0 0 0 0 0 0 13.9547 0 13.1479 0 0 0 0 0 0 0 0 0 14.8097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9405 0 0 0 0 0 0 11.7619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06127 CD5_HUMAN T-cell surface glycoprotein CD5 (Lymphocyte antigen T1/Leu-1) (CD antigen CD5) CD5 LEU1 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; cell recognition [GO:0008037]; T cell costimulation [GO:0031295] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; apoptotic signaling pathway [GO:0097190]; cell recognition [GO:0008037]; T cell costimulation [GO:0031295] GO:0005044; GO:0005886; GO:0005887; GO:0008037; GO:0009897; GO:0031295; GO:0038023; GO:0097190 scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023] DGWHMVCSQSWGR 0.95531 0.73082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59797 SELV_HUMAN "Selenoprotein V, SelV" SELENOV SELV Homo sapiens (Human) response to selenium ion [GO:0010269] cytosol [GO:0005829] cytosol [GO:0005829]; response to selenium ion [GO:0010269] GO:0005829; GO:0010269 IPRLVPPPAPAWIPTPVPTPVPVR 0.95532 3.6515 0 0 0 0 0 0 0 0 0 0 0 13.2104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8175 0 0 0 0 14.0117 0 0 0 0 0 12.6544 0 0 11.9393 12.4444 13.2706 0 0 0 0 0 0 0 11.4207 0 0 0 0 0 0 0 0 0 0 11.5184 0 0 0 0 0 0 12.3848 0 13.3993 0 0 0 10.8393 0 11.2073 0 0 0 0 0 14.0075 0 0 0 0 0 0 0 0 0 11.5885 0 12.0935 0 0 0 12.248 0 11.9613 0 0 12.7739 0 0 0 0 0 14.5712 0 14.8243 0 0 10.9092 0 0 0 0 0 0 0 0 0 0 12.0177 0 0 0 11.921 0 0 0 0 0 0 Q8NAV1 PR38A_HUMAN Pre-mRNA-splicing factor 38A PRPF38A Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0071005; GO:0071011 RNA binding [GO:0003723] RRSPSPR 0.95532 0.72324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57088 TMM33_HUMAN Transmembrane protein 33 (Protein DB83) (SHINC-3) TMEM33 DB83 Homo sapiens (Human) endoplasmic reticulum tubular network organization [GO:0071786]; innate immune response [GO:0045087]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; melanosome [GO:0042470]; nuclear envelope [GO:0005635]; endoplasmic reticulum tubular network organization [GO:0071786]; innate immune response [GO:0045087]; membrane organization [GO:0061024]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of endoplasmic reticulum tubular network organization [GO:1903371]; response to endoplasmic reticulum stress [GO:0034976] GO:0005635; GO:0005783; GO:0005789; GO:0030176; GO:0034976; GO:0042470; GO:0045087; GO:0061024; GO:0071786; GO:1903371; GO:1903896; GO:1903899 NPYCRTLFNELR 0.95533 0.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTY7 OVCH1_HUMAN "Ovochymase-1, EC 3.4.21.-" OVCH1 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0046872 metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] AKHIIVHEDFNTLSYDSDIALIQLSSPLEYNSVVR 0.95533 0.64058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9177 0 0 0 0 11.1302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7923 0 14.247 0 0 0 0 13.8715 0 0 0 11.4581 13.6985 11.0168 0 0 10.8187 0 0 11.6742 0 0 0 0 12.4572 0 13.2206 0 14.8467 0 14.755 13.9809 0 0 0 0 13.5656 13.6051 10.6758 15.3574 0 14.6431 13.0973 15.8878 13.4244 13.2161 0 0 12.8124 0 13.4695 0 13.8499 0 13.35 13.045 0 0 0 0 0 13.7397 0 0 0 0 0 10.2463 0 0 0 13.2726 12.8997 0 13.129 0 0 0 0 0 0 13.4477 0 0 0 12.4005 0 0 0 10.7807 12.9243 0 0 0 0 0 11.1423 0 0 11.1704 0 0 12.4836 12.4654 0 0 0 13.4173 0 13.62 12.9831 14.136 0 0 0 0 12.7049 0 13.4862 0 0 0 0 0 0 Q9HB71 CYBP_HUMAN "Calcyclin-binding protein, CacyBP, hCacyBP (S100A6-binding protein) (Siah-interacting protein)" CACYBP S100A6BP SIP PNAS-107 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507] beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507] GO:0005634; GO:0005641; GO:0005654; GO:0005829; GO:0007507; GO:0015631; GO:0019005; GO:0019904; GO:0030877; GO:0031625; GO:0042803; GO:0044548; GO:0070062; GO:1990830 protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625] DLEEVKVLLEKATR 0.95533 0.75322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95490 AGRL2_HUMAN "Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2, CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1)" ADGRL2 KIAA0786 LEC1 LPHH1 LPHN2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007420; GO:0016021; GO:0016524; GO:0030246; GO:0043005 carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524] AALPFGLVR 0.95534 0.75294 0 0 0 0 0 0 10.3416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2052 0 13.2049 0 13.1093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2714 0 0 13.1581 0 0 0 0 0 0 11.6958 0 0 0 0 0 0 13.3511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8076 0 0 0 0 0 0 0 14.0559 0 0 0 0 0 0 0 0 0 12.8537 13.7922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB20 PKHA3_HUMAN "Pleckstrin homology domain-containing family A member 3, PH domain-containing family A member 3 (Phosphatidylinositol-four-phosphate adapter protein 1, FAPP-1, Phosphoinositol 4-phosphate adapter protein 1)" PLEKHA3 FAPP1 Homo sapiens (Human) ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009] GO:0000139; GO:0005794; GO:0005829; GO:0035627; GO:0042802; GO:0070273; GO:0120009; GO:1902387; GO:1902388 ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273] EISETSESLKTKMSELR 0.95534 0.66387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFX7 STXB6_HUMAN Syntaxin-binding protein 6 (Amisyn) STXBP6 HSPC156 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of exocytosis [GO:0045920]; regulation of SNARE complex assembly [GO:0035542]; SNARE complex assembly [GO:0035493] adherens junction [GO:0005912]; exocyst [GO:0000145]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; exocyst [GO:0000145]; plasma membrane [GO:0005886]; cadherin binding involved in cell-cell adhesion [GO:0098641]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of exocytosis [GO:0045920]; regulation of SNARE complex assembly [GO:0035542]; SNARE complex assembly [GO:0035493]" GO:0000145; GO:0005546; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0035493; GO:0035542; GO:0045920; GO:0098641 "cadherin binding involved in cell-cell adhesion [GO:0098641]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" VKQFEGSTSFVR 0.95535 0.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWY9 CDAN1_HUMAN Codanin-1 CDAN1 UNQ664/PRO1295 Homo sapiens (Human) chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; protein localization [GO:0008104] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin assembly [GO:0031497]; chromatin organization [GO:0006325]; negative regulation of DNA replication [GO:0008156]; protein localization [GO:0008104] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0008156; GO:0012505; GO:0016021; GO:0031497 DIFTLLLR 0.95537 3.2929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0966 14.1161 0 0 0 0 0 0 0 0 0 0 0 14.0899 0 0 0 0 12.8291 12.5585 0 12.7564 12.0176 0 0 0 0 0 0 0 12.9628 0 13.7691 0 0 0 0 0 0 13.7921 13.6507 0 0 0 0 0 13.2257 0 13.4132 0 13.7959 0 0 10.8273 0 11.5201 0 13.3871 0 0 12.1684 13.3224 13.5588 0 13.4152 0 0 0 0 0 14.2951 13.7327 0 0 0 13.4645 0 0 13.2297 0 0 0 11.4461 13.7073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8262 0 0 13.7683 12.602 0 0 0 0 12.1106 Q9BXS4 TMM59_HUMAN Transmembrane protein 59 (Liver membrane-bound protein) TMEM59 C1orf8 HSPC001 UNQ169/PRO195 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of autophagy [GO:0010508]; protein glycosylation [GO:0006486] extracellular exosome [GO:0070062]; Golgi cis cisterna [GO:0000137]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; Golgi cis cisterna [GO:0000137]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; autophagy [GO:0006914]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of autophagy [GO:0010508]; protein glycosylation [GO:0006486] GO:0000137; GO:0000138; GO:0000139; GO:0004175; GO:0005764; GO:0005765; GO:0005770; GO:0005797; GO:0005886; GO:0006486; GO:0006914; GO:0010508; GO:0016021; GO:0031902; GO:0070062; GO:1903077 endopeptidase activity [GO:0004175] MHLLFPLTLVR 0.95539 0.65191 0 13.3887 0 0 0 14.2544 0 0 13.7859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.926 13.4944 0 0 0 0 0 0 0 0 0 0 14.4897 14.8295 0 0 0 0 0 0 0 0 0 0 0 14.8113 0 14.2791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6107 0 0 0 0 0 0 0 0 13.893 0 14.6173 0 0 14.929 0 0 13.8004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40616 ARL1_HUMAN ADP-ribosylation factor-like protein 1 ARL1 Homo sapiens (Human) "activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; activation of phospholipase D activity [GO:0031584]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; toxin metabolic process [GO:0009404]; vesicle-mediated transport [GO:0016192]" GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007030; GO:0008047; GO:0009404; GO:0016192; GO:0019904; GO:0031584; GO:0032588; GO:0034067; GO:0042147; GO:0046872; GO:0048193 enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904] AILVVFANKQDMEQAMTSSEMANSLGLPALK 0.9554 2.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8486 0 11.5838 0 11.2413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2419 0 0 0 0 0 0 0 15.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.704 0 0 0 0 0 13.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2118 0 0 0 0 0 0 0 0 0 0 0 13.895 0 0 0 0 0 13.3147 12.1098 0 0 0 Q6UWV7 SHL2A_HUMAN Protein shisa-like-2A SHISAL2A FAM159A UNQ2783/PRO7171 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 SGACTSYVSAEQEVVR 0.9554 0.62712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VD9 PIGZ_HUMAN "GPI mannosyltransferase 4, EC 2.4.1.- (GPI mannosyltransferase IV, GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein, PIG-Z) (SMP3 homolog, hSMP3)" PIGZ SMP3 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]" GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506; GO:0016021; GO:0016254 "alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]" LQVGLQASAQMGLLR 0.9554 0.73003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6AW86 Z324B_HUMAN Zinc finger protein 324B ZNF324B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CSECGKAFSHGSNLSQHR 0.95543 0.65146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H72 S39AD_HUMAN "Zinc transporter ZIP13 (LIV-1 subfamily of ZIP zinc transporter 9, LZT-Hs9) (Solute carrier family 39 member 13) (Zrt- and Irt-like protein 13, ZIP-13)" SLC39A13 ZIP13 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; connective tissue development [GO:0061448]; zinc ion transmembrane transport [GO:0071577] Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; connective tissue development [GO:0061448]; zinc ion transmembrane transport [GO:0071577] GO:0005385; GO:0005794; GO:0006882; GO:0016021; GO:0030173; GO:0042803; GO:0048471; GO:0061448; GO:0071577 protein homodimerization activity [GO:0042803]; zinc ion transmembrane transporter activity [GO:0005385] MPGCPCPGCGMAGPR 0.95544 0.73003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKJ1 PILRA_HUMAN Paired immunoglobulin-like type 2 receptor alpha (Cell surface receptor FDF03) (Inhibitory receptor PILR-alpha) PILRA Homo sapiens (Human) signal transduction [GO:0007165] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; MHC class I protein binding [GO:0042288]; signal transduction [GO:0007165] GO:0005886; GO:0007165; GO:0016021; GO:0042288; GO:0070062 MHC class I protein binding [GO:0042288] PPSIHKDYVNR 0.95544 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H668 STN1_HUMAN CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog) STN1 OBFC1 Homo sapiens (Human) negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833] "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; fibrillar center [GO:0001650]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]" GO:0000723; GO:0000781; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0010833; GO:0016233; GO:0032211; GO:0042162; GO:0043047; GO:0043231; GO:0045111; GO:0045740; GO:1990879 single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; telomeric DNA binding [GO:0042162] AIHSIFKNAIQLLQEKGLVFQK 0.95547 4.6147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3029 0 0 0 0 0 0 0 0 0 0 Q68D85 NR3L1_HUMAN "Natural cytotoxicity triggering receptor 3 ligand 1 (B7 homolog 6, B7-H6)" NCR3LG1 B7H6 Homo sapiens (Human) regulation of immune response [GO:0050776] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; regulation of immune response [GO:0050776] GO:0003823; GO:0005886; GO:0016021; GO:0050776 antigen binding [GO:0003823] DNPDLCQCCR 0.95549 0.64318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYJ9 YTHD1_HUMAN "YTH domain-containing family protein 1, DF1 (Dermatomyositis associated with cancer putative autoantigen 1, DACA-1)" YTHDF1 C20orf21 Homo sapiens (Human) immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of mRNA stability [GO:0043488]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; immune system process [GO:0002376]; learning [GO:0007612]; memory [GO:0007613]; mRNA destabilization [GO:0061157]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of antigen processing and presentation [GO:0002577]; regulation of axon guidance [GO:1902667]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of mRNA stability [GO:0043488]; stress granule assembly [GO:0034063] GO:0000932; GO:0002376; GO:0002577; GO:0003723; GO:0003729; GO:0005737; GO:0007612; GO:0007613; GO:0010494; GO:0034063; GO:0043022; GO:0043488; GO:0045727; GO:0045948; GO:0061157; GO:0070925; GO:1900271; GO:1902667; GO:1990247 mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] AAHSYNPKEFEWNLK 0.95549 0.77285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0507 0 0 0 0 0 12.2475 0 0 0 0 0 0 0 0 0 0 12.2045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZU8 DSEL_HUMAN "Dermatan-sulfate epimerase-like protein, EC 5.1.-.-" DSEL C18orf4 NCAG1 Homo sapiens (Human) chondroitin sulfate metabolic process [GO:0030204]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate metabolic process [GO:0030205] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin-glucuronate 5-epimerase activity [GO:0047757]; sulfotransferase activity [GO:0008146]; chondroitin sulfate metabolic process [GO:0030204]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate metabolic process [GO:0030205] GO:0000139; GO:0008146; GO:0016021; GO:0030204; GO:0030205; GO:0030208; GO:0047757 chondroitin-glucuronate 5-epimerase activity [GO:0047757]; sulfotransferase activity [GO:0008146] ASHLHLFRAIR 0.9555 0.64311 0 11.1496 0 0 0 0 0 0 0 11.8042 0 0 0 0 0 0 0 0 0 14.5264 11.5074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7065 0 0 0 0 0 14.2475 0 0 12.4946 0 14.1005 13.8626 0 0 0 0 0 0 0 13.5505 0 0 0 0 0 0 14.7143 13.7379 14.809 0 0 13.4534 0 13.0609 0 0 0 0 0 0 0 0 0 0 0 14.2107 0 0 0 13.8387 13.0744 13.5792 0 0 0 13.6372 13.5359 12.3806 13.8938 0 0 0 12.5567 13.2976 0 13.5498 0 0 0 13.5975 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8935 0 0 0 0 0 0 0 0 0 0 0 12.4085 13.0913 11.941 0 0 0 12.9918 0 10.3492 0 Q96BN2 TADA1_HUMAN "Transcriptional adapter 1 (SPT3-associated factor 42, STAF42) (Transcriptional adapter 1-like protein)" TADA1 TADA1L Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006282; GO:0006357; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893 transcription coactivator activity [GO:0003713] DILTSVVSRRK 0.9555 0.62437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.121 0 0 0 0 0 0 0 0 0 0 0 14.5453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6405 0 0 0 0 0 0 0 0 0 0 0 12.6284 0 0 0 0 0 0 0 0 0 0 0 Q9BZJ8 GPR61_HUMAN G-protein coupled receptor 61 (Biogenic amine receptor-like G-protein coupled receptor) GPR61 BALGR GPCR3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950] endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; arrestin family protein binding [GO:1990763]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950] GO:0004930; GO:0005768; GO:0005886; GO:0007186; GO:0010008; GO:0016021; GO:0043235; GO:0043950; GO:1990763 arrestin family protein binding [GO:1990763]; G protein-coupled receptor activity [GO:0004930] VARVAAMQHGPLPTWMETPRQR 0.95552 0.64187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8988 0 0 0 0 0 0 0 0 0 0 0 0 11.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBV4 WNT16_HUMAN Protein Wnt-16 WNT16 Homo sapiens (Human) bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399] GO:0003408; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0010628; GO:0014068; GO:0030182; GO:0030216; GO:0043616; GO:0045165; GO:0046330; GO:0046849; GO:0060070; GO:0060317; GO:0060548; GO:0090399; GO:0090403 cytokine activity [GO:0005125]; frizzled binding [GO:0005109] CECKFIWCCYVRCR 0.95552 0.73105 0 0 0 0 0 0 0 0 0 0 12.2767 0 0 0 0 0 0 0 0 0 0 0 14.5358 11.3713 0 0 0 0 0 0 0 0 11.078 0 12.3456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1492 0 13.226 0 0 0 0 0 0 0 0 0 13.6891 0 12.8944 0 12.9314 13.1996 0 13.1113 0 11.8727 12.4074 0 0 13.2721 0 12.9627 0 0 0 0 0 0 0 13.7556 0 0 0 0 13.0616 13.6888 13.8194 12.2536 12.4444 0 0 13.5867 0 0 0 0 0 0 13.7229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5985 0 0 0 13.6781 0 0 0 0 0 0 0 0 0 0 0 12.5728 0 14.258 0 11.9954 0 0 0 0 P30273 FCERG_HUMAN "High affinity immunoglobulin epsilon receptor subunit gamma (Fc receptor gamma-chain, FcRgamma) (Fc-epsilon RI-gamma) (IgE Fc receptor subunit gamma, FceRI gamma)" FCER1G Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; defense response to bacterium [GO:0042742]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway [GO:0038094]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; interleukin-3-mediated signaling pathway [GO:0038156]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of phagocytosis [GO:0050766]; receptor internalization [GO:0031623]; regulation of platelet activation [GO:0010543]; T cell differentiation involved in immune response [GO:0002292] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; Fc-epsilon receptor I complex [GO:0032998]; Fc-gamma receptor III complex [GO:0033001]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; Fc-epsilon receptor I complex [GO:0032998]; Fc-gamma receptor III complex [GO:0033001]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; identical protein binding [GO:0042802]; IgE binding [GO:0019863]; IgE receptor activity [GO:0019767]; IgG binding [GO:0019864]; protein homodimerization activity [GO:0042803]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; defense response to bacterium [GO:0042742]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway [GO:0038094]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; interleukin-3-mediated signaling pathway [GO:0038156]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of phagocytosis [GO:0050766]; receptor internalization [GO:0031623]; regulation of platelet activation [GO:0010543]; T cell differentiation involved in immune response [GO:0002292] GO:0002283; GO:0002292; GO:0002431; GO:0005886; GO:0005887; GO:0009897; GO:0009986; GO:0010543; GO:0016064; GO:0019767; GO:0019863; GO:0019864; GO:0019886; GO:0030593; GO:0031623; GO:0032753; GO:0032998; GO:0033001; GO:0038094; GO:0038095; GO:0038156; GO:0042590; GO:0042742; GO:0042802; GO:0042803; GO:0045087; GO:0050766; GO:0070821; GO:0071404; GO:0101003 identical protein binding [GO:0042802]; IgE binding [GO:0019863]; IgE receptor activity [GO:0019767]; IgG binding [GO:0019864]; protein homodimerization activity [GO:0042803] NQETYETLKHEK 0.95553 0.6243 0 0 0 0 0 0 0 0 0 0 11.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95833 CLIC3_HUMAN Chloride intracellular channel protein 3 CLIC3 Homo sapiens (Human) chloride transport [GO:0006821]; glutathione metabolic process [GO:0006749]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleus [GO:0005634]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; chloride transport [GO:0006821]; glutathione metabolic process [GO:0006749]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165] GO:0005244; GO:0005254; GO:0005634; GO:0005737; GO:0006749; GO:0006821; GO:0007165; GO:0016020; GO:0016604; GO:0034707; GO:0034765; GO:0070062 chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244] AETKLQLFVKASEDGESVGHCPSCQR 0.95554 0.72384 0 0 0 0 0 0 0 0 0 0 0 0 11.3602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.475 0 0 0 12.3798 0 10.088 0 0 0 0 0 0 0 0 0 15.115 0 15.7534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02585 TNNC2_HUMAN "Troponin C, skeletal muscle" TNNC2 Homo sapiens (Human) regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; troponin complex [GO:0005861] cytosol [GO:0005829]; troponin complex [GO:0005861]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009] GO:0003009; GO:0005509; GO:0005829; GO:0005861; GO:0006937; GO:0048306; GO:0051015 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] ELGTVMR 0.95554 0.74198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1372 0 10.3006 0 0 0 0 0 12.2051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUF6 NC336_HUMAN Putative uncharacterized protein encoded by LINC00336 LINC00336 C6orf227 NCRNA00336 Homo sapiens (Human) DLGRPQAFDSSRTPGPR 0.95554 0.64062 0 0 0 0 0 0 0 0 0 10.7303 13.0283 0 0 12.9319 0 0 0 0 0 0 0 0 0 0 12.6371 0 0 0 0 10.4574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5282 13.4204 13.0177 0 13.289 0 13.6134 0 13.6766 15.4222 14.2345 0 14.2842 13.2815 0 13.799 14.9676 14.4222 0 14.3863 13.8134 14.006 0 0 13.78 0 14.7875 14.684 0 14.3109 9.09977 0 13.3688 15.181 0 14.3015 0 11.514 15.1371 14.3214 14.4275 12.5684 0 0 13.5895 14.4108 0 0 0 13.5383 0 13.8108 14.0704 13.6553 0 13.5125 0 0 0 13.2439 13.5207 13.9432 0 0 13.9316 0 0 13.3382 13.5113 13.4006 13.9676 0 14.1924 0 0 0 13.0089 0 0 14.1297 0 12.1765 0 0 0 0 0 0 13.4215 13.4134 0 13.48 0 13.8769 0 0 0 12.6701 13.7122 0 0 0 0 0 0 0 Q8NGG0 OR8J3_HUMAN Olfactory receptor 8J3 (Olfactory receptor OR11-173) OR8J3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] FMENPCYSFKSM 0.95555 0.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBF2 COPG2_HUMAN "Coatomer subunit gamma-2 (Gamma-2-coat protein, Gamma-2-COP)" COPG2 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005198; GO:0005783; GO:0005789; GO:0005793; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0009306; GO:0030126; GO:0030133; GO:0030426; GO:0072384 structural molecule activity [GO:0005198] CMMDTDDEVR 0.95555 0.74186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5912 0 0 0 0 Q9BYV2 TRI54_HUMAN "Tripartite motif-containing protein 54 (Muscle-specific RING finger protein, MuRF) (Muscle-specific RING finger protein 3, MuRF-3, MuRF3) (RING finger protein 30)" TRIM54 MURF MURF3 RNF30 Homo sapiens (Human) cell differentiation [GO:0030154]; microtubule-based process [GO:0007017]; negative regulation of microtubule depolymerization [GO:0007026]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; Z disc [GO:0030018] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; Z disc [GO:0030018]; microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; microtubule-based process [GO:0007017]; negative regulation of microtubule depolymerization [GO:0007026]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] GO:0005737; GO:0005874; GO:0005875; GO:0007017; GO:0007026; GO:0007165; GO:0008017; GO:0008270; GO:0016567; GO:0030018; GO:0030154; GO:0061630 microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AEQHLMCEEHEEEKINIYCLSCEVPTCSLCK 0.95556 0.75326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13310 PABP4_HUMAN "Polyadenylate-binding protein 4, PABP-4, Poly(A)-binding protein 4 (Activated-platelet protein 1, APP-1) (Inducible poly(A)-binding protein, iPABP)" PABPC4 APP1 PABP4 Homo sapiens (Human) blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412] GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0006412; GO:0007596; GO:0008143; GO:0008266; GO:0010494; GO:0043488; GO:0061515; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] EISGKIIFVGRAQK 0.95558 0.62393 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2494 13.4043 13.3426 13.3754 14.4447 13.3092 13.1282 14.3035 0 12.998 0 0 14.2897 13.32 0 0 13.2283 13.3422 0 0 0 0 0 0 0 0 0 0 13.2344 13.2532 0 14.2044 13.1197 0 0 0 13.4419 12.4834 0 12.1318 12.7152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3209 15.806 16.2931 0 0 16.5724 16.0928 0 0 0 15.8658 0 0 0 0 16.7225 0 19.5663 0 0 0 0 0 0 12.3298 0 0 0 0 0 0 0 0 0 0 0 16.745 0 0 0 0 0 0 0 12.7241 16.7032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.473 0 0 0 0 0 0 0 0 13.3504 0 0 0 0 0 0 13.3589 0 0 0 0 0 0 0 Q96MB7 HARB1_HUMAN "Putative nuclease HARBI1, EC 3.1.-.- (Harbinger transposase-derived nuclease)" HARBI1 C11orf77 Homo sapiens (Human) centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] GO:0004518; GO:0005634; GO:0005829; GO:0005886; GO:0034451; GO:0046872 metal ion binding [GO:0046872]; nuclease activity [GO:0004518] AIPITVLDCDLLLYGR 0.9556 0.62718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZP1 NRSN2_HUMAN Neurensin-2 NRSN2 C20orf98 Homo sapiens (Human) nervous system development [GO:0007399] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; nervous system development [GO:0007399] GO:0005886; GO:0007399; GO:0016021; GO:0030133; GO:0043005; GO:0043025 MMPSCNRSCSCSR 0.95562 0.71833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.466 10.1699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8572 0 11.8009 0 0 13.608 0 0 0 0 0 0 0 0 0 0 0 0 13.1977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95498 VNN2_HUMAN "Pantetheine hydrolase VNN2, EC 3.5.1.92 (Glycosylphosphatidyl inositol-anchored protein GPI-80) (Protein FOAP-4) (Vascular non-inflammatory molecule 2, Vanin-2)" VNN2 Homo sapiens (Human) pantothenate metabolic process [GO:0015939] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pantetheine hydrolase activity [GO:0017159]; pantothenate metabolic process [GO:0015939] GO:0005576; GO:0005886; GO:0015939; GO:0017159; GO:0031225 pantetheine hydrolase activity [GO:0017159] ELCCHLSYRMLQK 0.95563 0.71721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4871 15.6721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05386 RLA1_HUMAN 60S acidic ribosomal protein P1 (Large ribosomal subunit protein P1) RPLP1 RRP1 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]; translational elongation [GO:0006414] GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0006414; GO:0022625; GO:0022626; GO:0030295; GO:0043021 protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735] EESEESDDDMGFGLFD 0.95563 0.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.268 0 11.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5099 0 0 0 0 11.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BH3 ESPB1_HUMAN "Epididymal sperm-binding protein 1 (Epididymal secretory protein 12, hE12)" ELSPBP1 E12 Homo sapiens (Human) single fertilization [GO:0007338]; sperm capacitation [GO:0048240] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; single fertilization [GO:0007338]; sperm capacitation [GO:0048240] GO:0005576; GO:0007338; GO:0008201; GO:0009986; GO:0048240 heparin binding [GO:0008201] GSVYFTCTHIHSLSPWCATR 0.95563 0.6516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53611 PGTB2_HUMAN "Geranylgeranyl transferase type-2 subunit beta, EC 2.5.1.60 (Geranylgeranyl transferase type II subunit beta, GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta, Rab GG transferase beta, Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta)" RABGGTB GGTB Homo sapiens (Human) protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; protein prenylation [GO:0018342]; visual perception [GO:0007601] cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968] cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; protein prenylation [GO:0018342]; visual perception [GO:0007601] GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0007601; GO:0008270; GO:0018342; GO:0018344; GO:0031267; GO:0036211 Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] EEILAFIK 0.95564 0.71685 0 0 0 0 0 0 0 0 0 13.6562 0 0 14.3654 0 0 0 0 0 14.375 13.2913 0 0 0 0 0 0 0 0 0 0 0 13.9835 0 0 0 14.0143 0 0 14.7907 14.7624 0 0 0 14.7885 0 0 0 0 0 13.0728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7834 0 0 0 0 0 0 0 0 0 0 0 0 Q96HR3 MED30_HUMAN "Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30) (TRAP/Mediator complex component TRAP25) (Thyroid hormone receptor-associated protein 6) (Thyroid hormone receptor-associated protein complex 25 kDa component, Trap25)" MED30 THRAP6 TRAP25 Homo sapiens (Human) "positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]" GO:0000151; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0016592; GO:0030374; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0061630; GO:0070847 nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] QIMDQLRNLIWDINAMLAMR 0.95565 0.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0987 0 0 0 0 12.7836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15166 PON3_HUMAN "Serum paraoxonase/lactonase 3, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1" PON3 Homo sapiens (Human) aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; coumarin catabolic process [GO:0046226]; establishment of localization in cell [GO:0051649]; negative regulation of superoxide anion generation [GO:0032929]; phenylacetate catabolic process [GO:0010124]; renal sodium ion transport [GO:0003096]; response to toxic substance [GO:0009636] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; 3,4-dihydrocoumarin hydrolase activity [GO:0018733]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; coumarin catabolic process [GO:0046226]; establishment of localization in cell [GO:0051649]; negative regulation of superoxide anion generation [GO:0032929]; phenylacetate catabolic process [GO:0010124]; renal sodium ion transport [GO:0003096]; response to toxic substance [GO:0009636]" GO:0003096; GO:0004063; GO:0004064; GO:0005576; GO:0005615; GO:0009636; GO:0010124; GO:0018733; GO:0019439; GO:0032929; GO:0042803; GO:0043231; GO:0046226; GO:0046395; GO:0046872; GO:0051649; GO:0070062; GO:0102007 "3,4-dihydrocoumarin hydrolase activity [GO:0018733]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]" SLVYLKTIKHELLK 0.95566 0.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4991 14.1152 13.1501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYS1 P20D2_HUMAN "Xaa-Arg dipeptidase, EC 3.4.13.4 (Beta-Ala-Lys dipeptidase)" PM20D2 ACY1L2 Homo sapiens (Human) proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268] GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0032268; GO:0042802 carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802] ELQVLTKKAEDCFR 0.95566 0.73551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9643 0 10.1883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NL3 ZN599_HUMAN Zinc finger protein 599 ZNF599 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" KWALVRHQQIHAGVK 0.95567 3.2842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7081 0 0 0 0 0 0 0 0 11.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9344 0 11.462 0 0 0 0 0 0 0 0 0 12.8121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7238 0 0 0 0 0 0 12.9178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6103 0 12.6407 0 0 0 0 0 0 0 0 0 14.8654 0 0 0 0 12.1581 0 0 0 0 12.4584 0 0 Q9NWQ9 CN119_HUMAN Uncharacterized protein C14orf119 C14orf119 My028 Homo sapiens (Human) cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739] GO:0005739; GO:0005829 FYQAVAATAGK 0.95567 0.62888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1737 0 0 0 0 0 0 0 0 0 0 0 0 13.1335 0 0 0 0 0 0 0 0 0 0 0 13.0423 13.5951 0 0 0 0 0 0 13.5196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8982 0 0 0 0 0 0 O60431 OR1I1_HUMAN "Olfactory receptor 1I1 (Olfactory receptor 19-20, OR19-20)" OR1I1 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AALGKLIGKVAVPCPR 0.95568 0.77441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5673 0 0 0 11.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55327 TPD52_HUMAN Tumor protein D52 (Protein N8) TPD52 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; secretion [GO:0046903] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; secretion [GO:0046903] GO:0005509; GO:0005737; GO:0005783; GO:0009653; GO:0030183; GO:0042803; GO:0046903; GO:0048471 calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803] EMDLYEDYQSPFDFDAGVNK 0.95569 0.62864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00403 TF2B_HUMAN "Transcription initiation factor IIB, EC 2.3.1.48 (General transcription factor TFIIB) (S300-II)" GTF2B TF2B TFIIB Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; positive regulation of core promoter binding [GO:1904798]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083]" chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550] "chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]; acetyltransferase activity [GO:0016407]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; nuclear thyroid hormone receptor binding [GO:0046966]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of core promoter binding [GO:1904798]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083]" GO:0000979; GO:0000993; GO:0001174; GO:0004402; GO:0005634; GO:0005654; GO:0005669; GO:0005694; GO:0006352; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0019083; GO:0032993; GO:0046966; GO:0051123; GO:0090575; GO:0097550; GO:0140297; GO:1904798; GO:1990114; GO:1990841 acetyltransferase activity [GO:0016407]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; nuclear thyroid hormone receptor binding [GO:0046966]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270] VIDVGSEWR 0.95569 0.72849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS82 R9BP_HUMAN Regulator of G-protein signaling 9-binding protein (RGS9-anchoring protein) RGS9BP R9AP Homo sapiens (Human) detection of light stimulus involved in visual perception [GO:0050908]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750]; detection of light stimulus involved in visual perception [GO:0050908]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] GO:0001750; GO:0007186; GO:0009968; GO:0016021; GO:0043005; GO:0050908 ALAAILFGAVLLAAVALAVCVAK 0.95569 0.64341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8618 0 0 0 0 0 0 0 0 11.6711 0 0 0 0 0 0 0 0 0 0 10.4699 0 0 0 11.0974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7363 0 0 0 14.2138 13.0238 0 0 14.0497 14.058 0 0 0 12.404 0 12.4798 0 0 13.157 13.9959 13.9647 0 0 0 13.4675 0 0 12.5377 0 13.514 0 0 13.5231 14.4425 0 0 0 0 0 0 13.5497 0 0 10.4017 0 0 12.9915 0 0 0 0 0 13.1064 0 0 0 0 0 0 0 12.7446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2072 0 0 0 0 12.4901 0 12.8734 0 0 0 0 0 0 12.6321 0 0 9.73239 12.0138 0 0 Q969I3 GLYL1_HUMAN "Glycine N-acyltransferase-like protein 1, EC 2.3.1.68 (Acyl-CoA:glycine N-acyltransferase-like protein 1) (Glutamine N-acyltransferase)" GLYATL1 GNAT Homo sapiens (Human) glutamine metabolic process [GO:0006541] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; glutamine metabolic process [GO:0006541] GO:0005739; GO:0006541; GO:0016410; GO:0047946; GO:0047961 glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410] GKNERSLHYIK 0.95569 0.62495 0 0 0 0 0 0 0 0 0 0 0 12.0965 11.7528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2554 13.5271 0 0 0 0 10.6974 0 0 15.0446 13.9499 0 0 14.4759 0 13.9636 14.1369 14.1484 0 0 0 0 12.9656 0 0 0 0 14.6274 0 0 0 0 0 14.3387 0 13.7476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0182 0 0 0 0 0 0 13.6051 0 0 14.4977 14.101 13.7315 0 0 0 0 0 0 0 0 0 0 0 0 13.0137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8201 0 0 0 0 0 13.7868 0 0 0 Q9BY32 ITPA_HUMAN "Inosine triphosphate pyrophosphatase, ITPase, Inosine triphosphatase, EC 3.6.1.9 (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase, NTPase) (Putative oncogene protein hlc14-06-p)" ITPA C20orf37 My049 OK/SW-cl.9 Homo sapiens (Human) chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222]; chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143] GO:0000166; GO:0005654; GO:0005737; GO:0005829; GO:0006193; GO:0009143; GO:0009204; GO:0035529; GO:0035870; GO:0036218; GO:0036220; GO:0036222; GO:0042802; GO:0043231; GO:0046872; GO:0047429; GO:0051276 dITP diphosphatase activity [GO:0035870]; dTTP diphosphatase activity [GO:0036218]; identical protein binding [GO:0042802]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222] GCQDFGWDPCFQPDGYEQTYAEMPK 0.95569 0.77406 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7473 13.0978 13.0227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3083 0 0 0 0 0 0 0 0 0 0 0 12.7524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11836 CD20_HUMAN B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1) (Bp35) (Leukocyte surface antigen Leu-16) (Membrane-spanning 4-domains subfamily A member 1) (CD antigen CD20) MS4A1 CD20 Homo sapiens (Human) B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; calcium ion import into cytosol [GO:1902656]; cell surface receptor signaling pathway [GO:0007166]; humoral immune response [GO:0006959]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; protein tetramerization [GO:0051262]; response to bacterium [GO:0009617]; store-operated calcium entry [GO:0002115] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; MHC class II protein complex binding [GO:0023026]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; calcium ion import into cytosol [GO:1902656]; cell surface receptor signaling pathway [GO:0007166]; humoral immune response [GO:0006959]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; protein tetramerization [GO:0051262]; response to bacterium [GO:0009617]; store-operated calcium entry [GO:0002115] GO:0002115; GO:0005154; GO:0005615; GO:0005654; GO:0005886; GO:0005887; GO:0006959; GO:0007166; GO:0009617; GO:0009897; GO:0009986; GO:0019865; GO:0023026; GO:0030183; GO:0042100; GO:0042113; GO:0042802; GO:0044853; GO:0050853; GO:0051262; GO:0070062; GO:1902656; GO:1905665 epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; MHC class II protein complex binding [GO:0023026] PKSNIVLLSAEEK 0.9557 0.72809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6J272 F166A_HUMAN Protein FAM166A FAM166A HSD46 Homo sapiens (Human) ciliary basal body [GO:0036064]; nucleus [GO:0005634] ciliary basal body [GO:0036064]; nucleus [GO:0005634] GO:0005634; GO:0036064 HDLFTPEPHYVPGYAGFFPQLR 0.9557 0.62445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7556 0 0 O95857 TSN13_HUMAN "Tetraspanin-13, Tspan-13 (Tetraspan NET-6) (Transmembrane 4 superfamily member 13)" TSPAN13 NET6 TM4SF13 UNQ260/PRO296 Homo sapiens (Human) regulation of calcium ion transmembrane transport [GO:1903169] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; regulation of calcium ion transmembrane transport [GO:1903169] GO:0005246; GO:0005887; GO:0016020; GO:1903169 calcium channel regulator activity [GO:0005246] VCGGFACSK 0.95571 0.77406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9948 11.0986 0 13.8754 0 13.7116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GVH4 PRS51_HUMAN Serine protease-like protein 51 PRSS51 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508 serine-type endopeptidase activity [GO:0004252] FQLLIPLLLALK 0.95572 0.72673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3895 0 0 0 0 0 0 P21757 MSRE_HUMAN Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204) MSR1 SCARA1 Homo sapiens (Human) "amyloid-beta clearance [GO:0097242]; cellular response to organic cyclic compound [GO:0071407]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; negative regulation of gene expression [GO:0010629]; phagocytosis, engulfment [GO:0006911]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; receptor-mediated endocytosis [GO:0006898]" collagen trimer [GO:0005581]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886] "collagen trimer [GO:0005581]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; amyloid-beta clearance [GO:0097242]; cellular response to organic cyclic compound [GO:0071407]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; negative regulation of gene expression [GO:0010629]; phagocytosis, engulfment [GO:0006911]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; receptor-mediated endocytosis [GO:0006898]" GO:0001540; GO:0005044; GO:0005581; GO:0005829; GO:0005886; GO:0005887; GO:0006898; GO:0006911; GO:0009897; GO:0010629; GO:0010744; GO:0010886; GO:0016021; GO:0030169; GO:0030301; GO:0030666; GO:0034362; GO:0034381; GO:0038024; GO:0042953; GO:0051649; GO:0071407; GO:0097242 amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044] AALIALYLLVFAVLIPLIGIVAAQLLK 0.95572 4.4798 0 11.1638 0 0 0 11.9796 0 11.8197 0 0 0 0 0 11.9829 0 0 11.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5195 0 0 10.953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5635 0 0 0 0 0 0 0 0 0 14.7928 0 14.8353 14.6089 0 0 0 0 11.4871 14.5772 11.8174 11.3134 12.4929 0 11.723 0 0 0 14.0084 11.8484 13.2164 10.7668 0 0 0 0 0 0 0 0 12.6355 0 0 0 0 0 0 0 0 0 0 11.1217 0 0 0 0 11.1593 0 0 0 0 0 0 12.4932 0 12.487 0 0 0 14.2715 0 0 0 0 0 11.7422 0 0 0 0 12.3841 11.5351 12.0152 0 0 10.8588 0 0 0 0 0 14.4957 0 0 0 0 0 0 0 12.4543 0 0 0 0 0 13.9136 0 0 0 0 12.768 0 11.9112 0 10.8183 10.7067 13.6249 0 0 10.2363 0 0 10.6897 0 P26678 PPLA_HUMAN "Cardiac phospholamban, PLB" PLN PLB Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; blood circulation [GO:0008015]; cardiac muscle tissue development [GO:0048738]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import [GO:0090281]; negative regulation of calcium ion import into sarcoplasmic reticulum [GO:1902081]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of catalytic activity [GO:0043086]; negative regulation of heart rate [GO:0010459]; Notch signaling pathway [GO:0007219]; regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901894]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; relaxation of cardiac muscle [GO:0055119] calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017] calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; blood circulation [GO:0008015]; cardiac muscle tissue development [GO:0048738]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of calcium ion binding [GO:1901877]; negative regulation of calcium ion import [GO:0090281]; negative regulation of calcium ion import into sarcoplasmic reticulum [GO:1902081]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of catalytic activity [GO:0043086]; negative regulation of heart rate [GO:0010459]; Notch signaling pathway [GO:0007219]; regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901894]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; relaxation of cardiac muscle [GO:0055119] GO:0002026; GO:0004857; GO:0005739; GO:0005783; GO:0007219; GO:0008015; GO:0008016; GO:0010459; GO:0010881; GO:0016020; GO:0016529; GO:0031966; GO:0032780; GO:0033017; GO:0042030; GO:0042802; GO:0042803; GO:0043086; GO:0046716; GO:0048471; GO:0048738; GO:0051117; GO:0051480; GO:0051924; GO:0051926; GO:0055119; GO:0060314; GO:0086004; GO:0086023; GO:0086036; GO:0086092; GO:0090281; GO:0090534; GO:1901020; GO:1901877; GO:1901894; GO:1901895; GO:1901897; GO:1902081 ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] LQNLFINFCLILICLLLICIIVMLL 0.95572 0.77406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60369 KR103_HUMAN Keratin-associated protein 10-3 (High sulfur keratin-associated protein 10.3) (Keratin-associated protein 10.3) (Keratin-associated protein 18-3) (Keratin-associated protein 18.3) KRTAP10-3 KAP10.3 KAP18-3 KRTAP10.3 KRTAP18-3 KRTAP18.3 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 LSSACCGLSSGQKSSC 0.95572 2.7462 0 0 0 0 0 0 0 11.6607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8113 0 0 0 0 12.253 0 0 0 0 0 0 0 0 0 0 14.5312 0 0 0 0 0 0 0 0 0 0 0 0 13.4259 0 14.8927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.646 0 0 11.8711 0 0 0 0 0 0 0 0 0 0 0 0 13.6262 0 0 0 0 0 0 0 0 0 0 0 0 Q12770 SCAP_HUMAN "Sterol regulatory element-binding protein cleavage-activating protein, SCAP, SREBP cleavage-activating protein" SCAP KIAA0199 PSEC0227 Homo sapiens (Human) aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SREBP-SCAP complex [GO:0032936] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SREBP-SCAP complex [GO:0032936]; protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082]; aging [GO:0007568]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; negative regulation of cholesterol biosynthetic process [GO:0045541]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; SREBP signaling pathway [GO:0032933] GO:0000139; GO:0001666; GO:0005783; GO:0005789; GO:0005794; GO:0006955; GO:0007568; GO:0008203; GO:0012507; GO:0016021; GO:0032868; GO:0032933; GO:0032934; GO:0032936; GO:0042304; GO:0044255; GO:0044877; GO:0045540; GO:0045541; GO:0045542; GO:0051082; GO:0090110 protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934]; unfolded protein binding [GO:0051082] IPRPGRQR 0.95572 0.74387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.557 13.4001 0 0 0 0 0 0 0 0 0 0 0 0 10.8827 12.1361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.116 0 13.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7278 0 0 0 0 0 0 0 0 12.0925 0 0 0 0 0 0 0 0 0 0 0 0 10.9746 0 11.6906 0 0 0 0 11.7221 0 Q9ULX9 MAFF_HUMAN Transcription factor MafF (U-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog F) MAFF Homo sapiens (Human) in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; parturition [GO:0007567]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; parturition [GO:0007567]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007567; GO:0035914; GO:0043565; GO:0045604; GO:0045944; GO:0090575; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GPATLVAPASVITIVK 0.95572 0.76564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4969 0 0 0 0 14.0561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W186 CST9_HUMAN Cystatin-9 (Cystatin-like molecule) CST9 CLM CTES7A Homo sapiens (Human) antimicrobial humoral response [GO:0019730] extracellular space [GO:0005615] extracellular space [GO:0005615]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; antimicrobial humoral response [GO:0019730] GO:0004869; GO:0005615; GO:0019730 cysteine-type endopeptidase inhibitor activity [GO:0004869] GKMVFSMNLQLR 0.95573 0.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TB92 HMGC2_HUMAN "3-hydroxy-3-methylglutaryl-CoA lyase, cytoplasmic, EC 4.1.3.4 (3-hydroxy-3-methylglutaryl-CoA lyase-like protein 1, HMGCL-like 1) (Endoplasmic reticulum 3-hydroxy-3-methylglutaryl-CoA lyase, er-cHL)" HMGCLL1 Homo sapiens (Human) ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629] GO:0004419; GO:0005783; GO:0005789; GO:0005829; GO:0006552; GO:0006629; GO:0016020; GO:0046872; GO:0046951; GO:0048471 hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; metal ion binding [GO:0046872] DGLQNEKVIVPTDIK 0.95573 0.75524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14728 MFS10_HUMAN Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein) MFSD10 TETRAN Homo sapiens (Human) apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252] brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493]; apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252] GO:0005637; GO:0006915; GO:0008493; GO:0008514; GO:0016021; GO:0030659; GO:0031526; GO:0043252 organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493] ALLLLVPAFLLIGWGR 0.95574 0.75485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7264 0 0 0 0 12.7877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9105 0 0 13.7848 0 0 0 0 0 13.1325 0 0 0 0 11.8311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86T26 TM11B_HUMAN "Transmembrane protease serine 11B, EC 3.4.21.- (Airway trypsin-like protease 5)" TMPRSS11B HATL5 Homo sapiens (Human) proteolysis [GO:0006508] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0070062 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] FKFPPAEGVSMR 0.95574 0.73119 0 0 0 0 0 0 0 0 0 11.5846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2003 12.5663 0 0 0 0 0 0 0 0 0 12.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3468 0 0 0 0 0 0 0 0 0 0 12.597 12.0632 0 0 0 0 0 0 0 0 0 11.8622 0 0 0 0 0 0 0 0 0 0 0 0 11.6874 0 11.856 0 0 0 0 0 0 0 0 0 11.9882 0 0 0 0 0 0 0 11.4663 0 0 0 0 0 0 12.2264 0 A2RU54 HMX2_HUMAN Homeobox protein HMX2 (Homeobox protein H6 family member 2) HMX2 Homo sapiens (Human) "brain development [GO:0007420]; cell differentiation [GO:0030154]; epithelial cell proliferation [GO:0050673]; inner ear morphogenesis [GO:0042472]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell proliferation [GO:0072089]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; cell differentiation [GO:0030154]; epithelial cell proliferation [GO:0050673]; inner ear morphogenesis [GO:0042472]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell proliferation [GO:0072089]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007420; GO:0030154; GO:0042472; GO:0048026; GO:0050673; GO:0050679; GO:0072089; GO:1990837; GO:2000648 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" LLPAGSPSPGSER 0.95575 0.74229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16595 FRDA_HUMAN "Frataxin, mitochondrial, EC 1.16.3.1 (Friedreich ataxia protein, Fxn) [Cleaved into: Frataxin intermediate form, i-FXN; Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN) ]" FXN FRDA X25 Homo sapiens (Human) adult walking behavior [GO:0007628]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; organ growth [GO:0035265]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]; adult walking behavior [GO:0007628]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; organ growth [GO:0035265]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039]" GO:0004322; GO:0005739; GO:0005759; GO:0005829; GO:0006119; GO:0006783; GO:0006811; GO:0006879; GO:0007005; GO:0007628; GO:0008198; GO:0008199; GO:0008284; GO:0009792; GO:0010039; GO:0010722; GO:0016226; GO:0016540; GO:0018283; GO:0019230; GO:0030307; GO:0034986; GO:0035265; GO:0040015; GO:0043066; GO:0043085; GO:0046621; GO:0046716; GO:0051349; GO:0051537; GO:0070301; GO:0090201; GO:1904231; GO:1904234; GO:1990221; GO:1990229 "2 iron, 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]" LDLSSLAYSGK 0.95575 0.72511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55212 CASP6_HUMAN "Caspase-6, CASP-6, CSP-6, EC 3.4.22.59 (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18 (Caspase-6 subunit p20); Caspase-6 subunit p11 (Caspase-6 subunit p10) ]" CASP6 MCH2 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; hepatocyte apoptotic process [GO:0097284]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028] caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; epithelial cell differentiation [GO:0030855]; hepatocyte apoptotic process [GO:0097284]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028] GO:0002218; GO:0004197; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0008303; GO:0016540; GO:0030855; GO:0042802; GO:0043065; GO:0060545; GO:0070269; GO:0072332; GO:0072734; GO:0097153; GO:0097200; GO:0097202; GO:0097284; GO:1901028 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802] RGIALIFNHER 0.95576 0.72398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9809 12.3915 12.0242 0 12.5125 0 0 0 0 0 0 12.9528 14.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13166 CATR1_HUMAN CATR tumorigenic conversion 1 protein (CATR1.3) CATR1 Homo sapiens (Human) HAHELRNLCVSQSR 0.95576 0.74198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4798 0 13.8717 0 0 0 0 0 0 12.1902 0 0 0 0 0 0 0 0 11.6277 0 0 12.5202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49447 CY561_HUMAN "Transmembrane ascorbate-dependent reductase CYB561, EC 7.2.1.- (Cytochrome b-561) (Cytochrome b561)" CYB561 Homo sapiens (Human) ascorbate homeostasis [GO:0140576]; cellular iron ion homeostasis [GO:0006879]; electron transport chain [GO:0022900] chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765] chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane monodehydroascorbate reductase activity [GO:0140575]; ascorbate homeostasis [GO:0140576]; cellular iron ion homeostasis [GO:0006879]; electron transport chain [GO:0022900] GO:0005765; GO:0006879; GO:0016021; GO:0016491; GO:0022900; GO:0042584; GO:0046872; GO:0140575; GO:0140576 metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; transmembrane monodehydroascorbate reductase activity [GO:0140575] ADWKRPSQAEEQALSMDFK 0.95577 0.7536 0 0 0 0 0 0 0 0 0 0 0 0 13.7272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2218 0 0 0 0 0 0 0 12.0966 0 0 0 0 0 11.6344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6778 0 0 0 0 0 0 0 13.0201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9381 13.0359 0 0 13.3008 0 11.8229 0 0 0 13.1058 0 0 0 0 0 0 0 14.3154 0 0 0 0 0 0 0 0 0 0 13.2195 0 0 0 0 0 12.8507 Q2TBC4 PRIC4_HUMAN Prickle-like protein 4 (Overexpressed breast tumor protein) PRICKLE4 C6orf49 OEBT Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] adherens junction [GO:0005912]; filamentous actin [GO:0031941]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] adherens junction [GO:0005912]; filamentous actin [GO:0031941]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; muscle alpha-actinin binding [GO:0051371]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] GO:0001725; GO:0003779; GO:0005634; GO:0005912; GO:0007507; GO:0008270; GO:0030018; GO:0030036; GO:0031941; GO:0051371; GO:0061061 actin binding [GO:0003779]; muscle alpha-actinin binding [GO:0051371]; zinc ion binding [GO:0008270] WHENHFCCQDCAGPLGGGR 0.95578 0.62745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6612 0 0 0 0 0 0 12.6269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AH0 SOSB2_HUMAN "SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2, SOSS-B2) (Single-stranded DNA-binding protein 2, hSSB2)" NABP1 OBFC2A SSB2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212] "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212]" GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010212; GO:0035861; GO:0044818; GO:0070876 DNA binding [GO:0003677]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] DGHEVRSCKVADK 0.95578 3.3332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3366 0 0 0 0 0 0 13.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4573 0 0 0 13.3841 12.859 13.116 0 0 0 0 0 0 0 0 0 0 0 14.7689 0 0 0 0 13.0493 14.4859 0 0 0 11.7675 0 0 0 0 0 0 0 0 0 0 13.8692 12.7325 0 12.4283 0 0 0 0 0 0 0 0 0 14.9181 0 0 0 0 14.0855 0 0 0 0 13.2996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2424 0 0 0 0 0 0 0 0 0 Q9NS25 SPNXB_HUMAN "Sperm protein associated with the nucleus on the X chromosome B1 (Cancer/testis antigen 11.2, CT11.2) (Nuclear-associated protein SPAN-Xb, SPANX-B) (SPANX family member B1) (SPANX family member F1)" SPANXB1 SPANXB SPANXB2 SPANXF1 Homo sapiens (Human) spermatid development [GO:0007286] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; spermatid development [GO:0007286] GO:0005634; GO:0005737; GO:0007286 MKTSESSTILVVR 0.95578 0.75343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15927 RFA2_HUMAN "Replication protein A 32 kDa subunit, RP-A p32 (Replication factor A protein 2, RF-A protein 2) (Replication protein A 34 kDa subunit, RP-A p34)" RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]" GO:0000723; GO:0000724; GO:0000781; GO:0000785; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0010569; GO:0016604; GO:0016605; GO:0019899; GO:0019903; GO:0031571; GO:0031625; GO:0034502; GO:0047485; GO:0098505; GO:2000001 damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] IGNVEISQVTIVGIIR 0.9558 0.62718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4361 0 0 0 0 0 0 13.4855 0 0 0 0 0 0 0 13.4011 0 0 0 Q02223 TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269) TNFRSF17 BCM BCMA Homo sapiens (Human) adaptive immune response [GO:0002250]; lymphocyte homeostasis [GO:0002260]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; lymphocyte homeostasis [GO:0002260]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0002250; GO:0002260; GO:0005886; GO:0007165; GO:0012505; GO:0016021; GO:0033209; GO:0038023 signaling receptor activity [GO:0038023] GLEYTVEECTCEDCIK 0.9558 0.62364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWN8 ISK6_HUMAN Serine protease inhibitor Kazal-type 6 (Kallikrein inhibitor) SPINK6 UNQ844/PRO1782 Homo sapiens (Human) cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572] GO:0004867; GO:0005576; GO:0007417; GO:0030154; GO:1900004; GO:1902572 serine-type endopeptidase inhibitor activity [GO:0004867] ESNPHCGSDGQTYGNK 0.95583 0.64668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1118 0 0 0 0 0 0 0 0 Q9NQP4 PFD4_HUMAN Prefoldin subunit 4 (Protein C-1) PFDN4 PFD4 Homo sapiens (Human) negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:1905907 amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] ITELKEEIEVK 0.95585 0.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0461 0 0 0 0 0 0 0 O75558 STX11_HUMAN Syntaxin-11 STX11 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0005484; GO:0005794; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0031201; GO:0031629; GO:0048278; GO:0048787; GO:0061025 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] AMHDYNQAEMK 0.95586 0.76042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0729 0 0 0 0 0 12.8513 0 0 0 0 0 0 0 0 0 0 0 0 13.3663 13.4278 0 0 0 12.7008 13.1208 0 0 0 0 0 13.4771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7X4 FHL19_HUMAN Putative ferritin heavy polypeptide-like 19 (Ferritin heavy polypeptide 1 pseudogene 19) FTH1P19 FTHL19 Homo sapiens (Human) intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826] GO:0005737; GO:0006826; GO:0006880; GO:0008198; GO:0008199 ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198] AFYFDQDDAALEHFDRYFLR 0.95589 0.62506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21217 FUT3_HUMAN "3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3, EC 2.4.1.65 (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase, EC 2.4.1.152) (Alpha-3-fucosyltransferase FUT3, EC 2.4.1.-) (Blood group Lewis alpha-4-fucosyltransferase, Lewis FT) (Fucosyltransferase 3) (Fucosyltransferase III, FucT-III)" FUT3 FT3B LE Homo sapiens (Human) cell-cell recognition [GO:0009988]; ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; macromolecule glycosylation [GO:0043413]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; positive regulation of cell-cell adhesion [GO:0022409]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127] extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; cell-cell recognition [GO:0009988]; ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; macromolecule glycosylation [GO:0043413]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; positive regulation of cell-cell adhesion [GO:0022409]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127] GO:0000139; GO:0006487; GO:0006493; GO:0006672; GO:0008417; GO:0009311; GO:0009312; GO:0009988; GO:0016020; GO:0016021; GO:0017060; GO:0017083; GO:0022409; GO:0030334; GO:0032580; GO:0036065; GO:0042127; GO:0043413; GO:0046920; GO:0070062 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] DLARYLQELDK 0.9559 0.75755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41247 PLPL4_HUMAN "Patatin-like phospholipase domain-containing protein 4, EC 3.1.1.3 (Calcium-independent phospholipase A2-eta, iPLA2-eta, EC 3.1.1.4) (Protein GS2)" PNPLA4 DXS1283E GS2 Homo sapiens (Human) lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433]" GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088 "acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]" ENHLVSTFSSR 0.9559 0.77445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2066 0 0 0 0 0 0 0 0 0 0 12.7236 0 0 12.5121 0 0 0 0 12.7328 0 0 0 0 0 0 0 0 0 0 0 Q14108 SCRB2_HUMAN "Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein, LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II, LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36)" SCARB2 CD36L2 LIMP2 LIMPII Homo sapiens (Human) aminophospholipid transport [GO:0015917]; gene expression [GO:0010467]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]; sensory perception of sound [GO:0007605] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; aminophospholipid transport [GO:0015917]; gene expression [GO:0010467]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of cellular carbohydrate catabolic process [GO:0043471]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramidase activity [GO:1905123]; regulation of lysosome organization [GO:1905671]; sensory perception of sound [GO:0007605] GO:0000139; GO:0001618; GO:0001786; GO:0004888; GO:0005044; GO:0005737; GO:0005765; GO:0005789; GO:0005886; GO:0005925; GO:0006622; GO:0006898; GO:0007605; GO:0010008; GO:0010467; GO:0010976; GO:0015485; GO:0015917; GO:0016020; GO:0016021; GO:0019899; GO:0030666; GO:0030669; GO:0031210; GO:0031902; GO:0038024; GO:0042803; GO:0043202; GO:0043471; GO:0051087; GO:0070062; GO:1904978; GO:1905123; GO:1905671 cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] DEILSLIHVFR 0.9559 0.73482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP99 TREM1_HUMAN "Triggering receptor expressed on myeloid cells 1, TREM-1 (Triggering receptor expressed on monocytes 1) (CD antigen CD354)" TREM1 Homo sapiens (Human) acute inflammatory response [GO:0002526]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil chemotaxis [GO:0030593]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; acute inflammatory response [GO:0002526]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; neutrophil chemotaxis [GO:0030593]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945] GO:0002250; GO:0002526; GO:0005576; GO:0005886; GO:0006959; GO:0016021; GO:0030593; GO:0035556; GO:0038023; GO:0045087; GO:0070945; GO:0097110 scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] GFSGTPGSNENSTQNVYKIPPTTTK 0.95591 0.75743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6861 0 0 0 13.798 0 0 0 0 12.2467 0 0 0 0 0 P23515 OMGP_HUMAN Oligodendrocyte-myelin glycoprotein OMG OMGP Homo sapiens (Human) cell adhesion [GO:0007155]; neuron projection regeneration [GO:0031102] anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; neuron projection regeneration [GO:0031102] GO:0005886; GO:0007155; GO:0031102; GO:0031225 NMLEKVVLIKNTLR 0.95593 0.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H255 O51E2_HUMAN Olfactory receptor 51E2 (HPRAJ) (Olfactory receptor OR11-16) (Prostate-specific G-protein coupled receptor) OR51E2 PSGR Homo sapiens (Human) cell migration [GO:0016477]; cellular response to fatty acid [GO:0071398]; melanocyte differentiation [GO:0030318]; melanocyte proliferation [GO:0097325]; positive regulation of blood pressure [GO:0045777]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of renin secretion into blood stream [GO:1900135]; steroid hormone mediated signaling pathway [GO:0043401] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; nuclear steroid receptor activity [GO:0003707]; olfactory receptor activity [GO:0004984]; signaling receptor activity [GO:0038023]; cell migration [GO:0016477]; cellular response to fatty acid [GO:0071398]; melanocyte differentiation [GO:0030318]; melanocyte proliferation [GO:0097325]; positive regulation of blood pressure [GO:0045777]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of renin secretion into blood stream [GO:1900135]; steroid hormone mediated signaling pathway [GO:0043401] GO:0003707; GO:0004930; GO:0004984; GO:0005886; GO:0016021; GO:0016477; GO:0030318; GO:0031901; GO:0038023; GO:0043229; GO:0043401; GO:0043950; GO:0045777; GO:0071398; GO:0097325; GO:1900135 G protein-coupled receptor activity [GO:0004930]; nuclear steroid receptor activity [GO:0003707]; olfactory receptor activity [GO:0004984]; signaling receptor activity [GO:0038023] GSLFFFPLPLLIKR 0.95593 3.3275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8699 14.6037 15.1478 12.5717 13.7001 0 13.3811 0 0 0 0 0 0 0 0 0 0 0 13.1014 0 0 12.168 0 0 0 0 0 12.4159 0 0 0 14.9105 13.7091 0 0 0 11.7066 0 0 0 0 0 0 0 0 0 0 12.7892 0 0 0 0 0 0 0 0 0 0 13.7843 10.8761 0 0 0 13.9438 0 0 14.9457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KRB8 RHGBB_HUMAN Inactive Rho GTPase-activating protein 11B (Rho-type GTPase-activating protein 11B) ARHGAP11B FAM7B1 Homo sapiens (Human) cerebral cortex development [GO:0021987]; glutamine catabolic process [GO:0006543]; negative regulation of mitochondrial membrane permeability [GO:0035795]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; GTPase activator activity [GO:0005096]; cerebral cortex development [GO:0021987]; glutamine catabolic process [GO:0006543]; negative regulation of mitochondrial membrane permeability [GO:0035795]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005759; GO:0005829; GO:0006543; GO:0007165; GO:0021987; GO:0035795; GO:0051056 GTPase activator activity [GO:0005096] AFYGIKVK 0.95594 0.76567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4869 0 0 0 0 0 12.9421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1032 0 0 0 0 12.6925 0 0 0 0 0 0 0 0 13.6451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4581 0 Q5SWH9 TMM69_HUMAN Transmembrane protein 69 TMEM69 C1orf154 HSPC229 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALRIVVTLLATFSFIITLVVK 0.95594 0.72697 11.9254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0186 14.0273 0 12.7373 0 13.1629 0 12.9718 0 0 0 13.3046 0 0 0 0 0 0 0 0 0 0 0 0 13.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.607 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.716 0 0 0 0 0 0 0 0 0 0 12.3707 0 0 12.6894 14.4656 0 0 0 0 0 0 0 0 0 13.6809 0 0 14.2917 15.8044 0 0 0 0 0 13.7863 0 0 13.7387 0 0 0 14.415 15.2376 0 0 0 0 0 0 15.0468 0 0 0 12.216 0 0 0 11.8587 0 0 13.3449 0 0 0 0 0 0 0 0 0 0 13.8003 0 0 0 0 0 0 13.9559 0 0 0 0 0 0 0 0 Q6UWI2 PARM1_HUMAN "Prostate androgen-regulated mucin-like protein 1, PARM-1" PARM1 UNQ1879/PRO4322 Homo sapiens (Human) positive regulation of telomerase activity [GO:0051973] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; positive regulation of telomerase activity [GO:0051973] GO:0000139; GO:0005654; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0016021; GO:0043231; GO:0051973 LLDDHDYGSWGNYNNPLYDDS 0.95594 0.74392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NI61 MYMK_HUMAN Protein myomaker (Myoblast fusion maker) (Transmembrane protein 226) (Transmembrane protein 8C) MYMK TMEM226 TMEM8C Homo sapiens (Human) muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206] integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; positive regulation of skeletal muscle hypertrophy [GO:1904206] GO:0005886; GO:0005887; GO:0007517; GO:0007520; GO:0014905; GO:0030173; GO:0045026; GO:1904206 LDCSTLCCACV 0.95595 2.8506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.773 0 0 0 0 0 0 14.2492 0 0 0 0 0 13.1123 0 0 0 13.5587 0 0 0 0 0 13.3399 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2801 0 0 0 0 0 0 11.337 0 10.7732 0 0 0 0 0 0 0 0 Q8IZR5 CKLF4_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4) CMTM4 CKLFSF4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IPQINWNLTDLVNTGLSAFLFFIASIVLAALNHR 0.95595 0.75562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H3BQJ8 LY6L_HUMAN Lymphocyte antigen 6L (Lymphocyte antigen 6 complex locus protein L) LY6L Homo sapiens (Human) anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886] GO:0005886; GO:0031225 NLSCYQCFK 0.95596 0.73155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.085 0 0 0 0 0 0 0 0 0 0 0 12.1937 0 0 0 0 0 0 0 12.5819 0 0 0 0 0 12.7363 0 12.778 0 0 0 0 0 13.8686 13.3343 12.8477 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8873 0 0 0 0 12.085 13.4027 13.225 13.0907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N434 SVOPL_HUMAN Putative transporter SVOPL (SV2-related protein-like) (SVOP-like protein) SVOPL Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] ATKPTEPVTILSLRK 0.95596 3.9549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.134 0 0 0 0 0 0 0 0 0 0 0 0 15.305 0 0 0 0 0 0 0 0 13.9936 0 0 0 13.6833 0 0 0 0 0 0 0 0 0 0 0 0 13.6963 0 0 0 12.3732 0 0 0 13.1964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A11 G3ST3_HUMAN "Galactose-3-O-sulfotransferase 3, Gal3ST-3, EC 2.8.2.- (Beta-galactose-3-O-sulfotransferase 3, Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)" GAL3ST3 Homo sapiens (Human) glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; monosaccharide metabolic process [GO:0005996]; oligosaccharide metabolic process [GO:0009311]; poly-N-acetyllactosamine metabolic process [GO:0030309]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] GO:0001733; GO:0005996; GO:0006790; GO:0008146; GO:0009247; GO:0009311; GO:0016021; GO:0030166; GO:0030246; GO:0030309; GO:0032580; GO:0050656; GO:0050694; GO:0050698 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; carbohydrate binding [GO:0030246]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146] HMTVAFLKTHK 0.95596 0.71563 0 0 0 0 0 0 0 0 0 0 0 0 13.5848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8772 14.0733 0 14.7863 13.1256 0 0 13.5359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4997 0 0 0 0 0 0 0 0 0 0 0 0 10.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0276 0 0 0 0 0 0 0 0 12.6987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q63HK5 TSH3_HUMAN Teashirt homolog 3 (Zinc finger protein 537) TSHZ3 KIAA1474 TSH3 ZNF537 Homo sapiens (Human) "long-term synaptic potentiation [GO:0060291]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; long-term synaptic potentiation [GO:0060291]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0002087; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0030426; GO:0045892; GO:0046872; GO:0051968; GO:0060291 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" ACPSYQNSPAAEFSCHEMDSESHISETSDR 0.95597 0.74253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7791 0 0 0 0 11.6797 13.1154 0 0 11.2945 0 0 0 0 0 0 0 0 13.902 0 0 0 0 15.6157 0 0 0 12.4007 0 0 0 0 13.3965 12.7488 0 13.3883 0 0 12.9087 0 0 13.638 0 0 0 0 13.2411 13.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBI1 COMD3_HUMAN COMM domain-containing protein 3 (Protein Bup) (Protein PIL) COMMD3 BUP C10orf8 Homo sapiens (Human) sodium ion transport [GO:0006814] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; sodium ion transport [GO:0006814] GO:0005576; GO:0005634; GO:0006814; GO:1904813 SLPHITDVSWRLEYQIK 0.95597 0.72563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96R48 OR2A5_HUMAN "Olfactory receptor 2A5 (Olfactory receptor 2A26) (Olfactory receptor 2A8) (Olfactory receptor 7-138/7-141, OR7-138, OR7-141)" OR2A5 OR2A26 OR2A8 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] HPEEQQK 0.95598 0.75448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZW4 TM6S2_HUMAN Transmembrane 6 superfamily member 2 TM6SF2 Homo sapiens (Human) lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; regulation of lipid metabolic process [GO:0019216] GO:0005789; GO:0006629; GO:0016021; GO:0019216; GO:0033116; GO:0042802; GO:0055088 identical protein binding [GO:0042802] GLLQRPADLALVIYLILAGFFTLFR 0.95599 0.75392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4849 0 0 0 0 0 0 12.0709 0 13.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6807 0 0 0 0 0 0 11.5406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19784 CSK22_HUMAN "Casein kinase II subunit alpha', CK II alpha', EC 2.7.11.1" CSNK2A2 CK2A2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055] acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956] acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]; ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055] GO:0000785; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005956; GO:0006915; GO:0007049; GO:0007283; GO:0016055; GO:0018105; GO:0018107; GO:0021987; GO:0047485; GO:0051726; GO:0097421; GO:0106310; GO:1903146; GO:1903955; GO:1905818; GO:2000059; GO:2001234 ATP binding [GO:0005524]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EYWDYEAHVPSWGNQDDYQLVRK 0.95601 3.3233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.817 0 0 0 0 0 0 0 0 0 11.2836 0 0 0 0 0 0 11.7461 0 0 0 0 0 0 0 0 13.7629 0 0 0 0 0 0 13.5036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6308 0 0 Q14508 WFDC2_HUMAN WAP four-disulfide core domain protein 2 (Epididymal secretory protein E4) (Major epididymis-specific protein E4) (Putative protease inhibitor WAP5) WFDC2 HE4 WAP5 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] GO:0004866; GO:0004867; GO:0004869; GO:0005615; GO:0006508; GO:0007283; GO:0019731; GO:0019828; GO:0045087; GO:0070062 aspartic-type endopeptidase inhibitor activity [GO:0019828]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] CCSAGCATFCSLPNDK 0.95603 0.6467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61916 NPC2_HUMAN "NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1, He1) (Niemann-Pick disease type C2 protein)" NPC2 HE1 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615]; sterol transport [GO:0015918] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; sterol binding [GO:0032934]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615]; sterol transport [GO:0015918] GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0015485; GO:0015914; GO:0015918; GO:0019747; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0032934; GO:0033344; GO:0035578; GO:0042632; GO:0043202; GO:0046836; GO:0070062; GO:0120020 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; sterol binding [GO:0032934] LPVKSEYPSIK 0.95606 0.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9977 0 0 0 0 0 13.3489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5947 0 0 0 0 0 0 0 0 0 0 0 12.0917 0 0 0 0 0 0 0 0 0 0 0 0 11.8711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LB4 VATG3_HUMAN "V-type proton ATPase subunit G 3, V-ATPase subunit G 3 (V-ATPase 13 kDa subunit 3) (Vacuolar proton pump subunit G 3)" ATP6V1G3 ATP6G3 Homo sapiens (Human) cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471] "cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" GO:0005829; GO:0005886; GO:0016471; GO:0046961; GO:0051117 "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" EEAMVEIDQYRMQR 0.95606 0.76307 11.1996 0 0 0 0 0 0 0 0 0 0 0 0 0 10.663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1984 0 0 0 0 0 0 0 13.3224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40692 MLH1_HUMAN DNA mismatch repair protein Mlh1 (MutL protein homolog 1) MLH1 COCA2 Homo sapiens (Human) double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283] chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I plate congression [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283] GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032300; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0140664 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137] HREDSDVEMVEDDSR 0.95608 0.76167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3485 0 14.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99697 PITX2_HUMAN Pituitary homeobox 2 (ALL1-responsive protein ARP1) (Homeobox protein PITX2) (Paired-like homeodomain transcription factor 2) (RIEG bicoid-related homeobox transcription factor) (Solurshin) PITX2 ARP1 RGS RIEG RIEG1 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in outflow tract morphogenesis [GO:0061325]; deltoid tuberosity development [GO:0035993]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; hair cell differentiation [GO:0035315]; iris morphogenesis [GO:0061072]; left/right axis specification [GO:0070986]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prolactin secreting cell differentiation [GO:0060127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatotropin secreting cell differentiation [GO:0060126]; spleen development [GO:0048536]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in outflow tract morphogenesis [GO:0061325]; deltoid tuberosity development [GO:0035993]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; hair cell differentiation [GO:0035315]; iris morphogenesis [GO:0061072]; left/right axis specification [GO:0070986]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prolactin secreting cell differentiation [GO:0060127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatotropin secreting cell differentiation [GO:0060126]; spleen development [GO:0048536]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003253; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007368; GO:0009653; GO:0035315; GO:0035993; GO:0042476; GO:0042802; GO:0042803; GO:0043010; GO:0043021; GO:0045944; GO:0048536; GO:0051219; GO:0060126; GO:0060127; GO:0060971; GO:0061072; GO:0061325; GO:0061629; GO:0070986; GO:0140297; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" DTCNSSLASLRLK 0.9561 0.75919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5G9 PCDG4_HUMAN "Protocadherin gamma-A4, PCDH-gamma-A4" PCDHGA4 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] ATDPDEGANGDVTYSFR 0.95612 0.77569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28066 PSA5_HUMAN Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain) PSMA5 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813 EAIKSSLIILK 0.95614 0.73432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7076 0 0 0 0 0 0 0 0 0 0 13.7704 0 0 0 0 12.3961 14.6384 12.8801 0 0 0 0 0 0 0 15.5126 0 15.6095 0 0 0 0 12.463 13.0867 14.2917 0 14.8264 13.5462 0 0 0 0 0 15.5208 0 0 0 0 0 0 0 15.0464 13.9556 13.6422 0 13.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.21 0 0 0 0 0 0 0 0 Q15233 NONO_HUMAN "Non-POU domain-containing octamer-binding protein, NonO protein (54 kDa nuclear RNA- and DNA-binding protein, p54(nrb), p54nrb) (55 kDa nuclear protein, NMT55) (DNA-binding p52/p100 complex, 52 kDa subunit)" NONO NRB54 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" chromosome [GO:0005694]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575] "chromosome [GO:0005694]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" GO:0001650; GO:0002218; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006355; GO:0006397; GO:0007623; GO:0008380; GO:0016020; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0042802; GO:0045087; GO:0045892; GO:0090575; GO:1903377 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] RQQEGFKGTFPDAR 0.95615 0.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SM5 MRGRG_HUMAN Mas-related G-protein coupled receptor member G (G-protein coupled receptor 169) MRGPRG GPR169 MRGG Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930] CLSDLFPACYQGCR 0.95615 0.76637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6804 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PJX2 TLDC2_HUMAN TLD domain-containing protein 2 (TBC/LysM-associated domain-containing protein 2) TLDC2 Homo sapiens (Human) response to oxidative stress [GO:0006979] nucleus [GO:0005634] nucleus [GO:0005634]; response to oxidative stress [GO:0006979] GO:0005634; GO:0006979 GDLDSLMMGSGSGR 0.95616 0.75567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4654 0 0 0 0 0 0 13.2879 0 0 13.6152 0 0 0 0 0 12.4408 0 0 0 0 11.3089 12.3268 0 0 0 0 0 0 0 0 0 12.3898 0 0 12.797 12.784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0132 12.6715 0 0 0 0 0 0 0 Q86TJ5 ZN554_HUMAN Zinc finger protein 554 ZNF554 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005654; GO:0005730; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFNRISSLTQHQR 0.95616 0.76601 0 0 0 0 0 0 0 0 0 0 11.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9965 0 0 0 0 0 0 0 0 11.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8803 0 0 0 0 0 0 0 P10153 RNAS2_HUMAN "Non-secretory ribonuclease, EC 4.6.1.18 (Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2, RNase 2) (Ribonuclease US)" RNASE2 EDN RNS2 Homo sapiens (Human) chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540]; chemotaxis [GO:0006935]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501] GO:0002227; GO:0003676; GO:0004522; GO:0004540; GO:0005576; GO:0005615; GO:0006401; GO:0006935; GO:0016829; GO:0035578; GO:0051607; GO:0070062; GO:0090501 lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540] PPQFTWAQWFETQHINMTSQQCTNAMQVINNYQR 0.95617 0.75562 0 0 0 0 0 0 0 0 15.075 0 0 14.3786 0 0 14.5882 0 0 0 0 0 0 0 0 0 0 0 0 14.2126 0 0 0 0 0 0 14.0806 0 0 0 0 0 0 0 0 0 12.9207 13.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7598 0 13.7664 0 0 0 0 0 0 0 0 14.173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4059 0 0 0 0 0 0 0 0 0 0 0 14.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3588 13.84 0 0 Q04917 1433F_HUMAN 14-3-3 protein eta (Protein AS1) YWHAH YWHA1 Homo sapiens (Human) "glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; nuclear glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization [GO:0008104]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]" GO:0002028; GO:0003779; GO:0005159; GO:0005737; GO:0005829; GO:0005886; GO:0006713; GO:0006886; GO:0007165; GO:0008104; GO:0014704; GO:0017080; GO:0019899; GO:0019904; GO:0021762; GO:0035259; GO:0042802; GO:0042921; GO:0044325; GO:0045664; GO:0045893; GO:0046982; GO:0048167; GO:0050774; GO:0070062; GO:0086010; GO:2000649 actin binding [GO:0003779]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; nuclear glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] NCNDFQYESK 0.95617 0.73261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP86 CABP5_HUMAN "Calcium-binding protein 5, CaBP5" CABP5 CABP3 Homo sapiens (Human) regulation of voltage-gated calcium channel activity [GO:1901385]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; regulation of voltage-gated calcium channel activity [GO:1901385]; signal transduction [GO:0007165] GO:0005246; GO:0005509; GO:0005737; GO:0005829; GO:0007165; GO:1901385 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509] DAFKEFDTNGDGEITLVELQQAMQRLLGER 0.95618 0.73175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8386 13.6441 13.7673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59780 AP3S2_HUMAN "AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adaptor-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin, Sigma3B-adaptin) (Sigma-adaptin 3b)" AP3S2 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; presynapse [GO:0098793] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; presynapse [GO:0098793]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" GO:0005769; GO:0005794; GO:0006886; GO:0006896; GO:0008089; GO:0016183; GO:0016192; GO:0030123; GO:0030659; GO:0035654; GO:0036465; GO:0043231; GO:0046907; GO:0048490; GO:0060155; GO:0098793; GO:1903232; GO:1904115 AVSAVKNINLPEIPRNINIGDLNIK 0.95621 0.76492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5521 0 0 0 0 0 0 0 0 0 0 0 Q5JPI3 CC038_HUMAN Uncharacterized protein C3orf38 C3orf38 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065] nucleus [GO:0005634] nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065] GO:0005634; GO:0006915; GO:0043065 FINLKIMGESSLAPGTLPK 0.95623 0.62224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3006 0 0 0 0 0 0 0 0 0 11.4758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8217 0 0 0 0 0 13.978 0 0 0 0 0 0 0 0 0 0 0 13.842 13.0075 0 0 0 0 0 0 0 0 0 0 0 14.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5083 0 0 0 0 0 0 13.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA79 LCE2A_HUMAN Late cornified envelope protein 2A (Late envelope protein 9) LCE2A LEP9 Homo sapiens (Human) keratinization [GO:0031424] keratinization [GO:0031424] GO:0031424 HQSPDCCECEPSGGSGCCHSSGDCC 0.95626 2.8425 0 12.8454 0 0 0 0 0 0 0 0 11.5836 0 0 0 0 0 0 0 0 0 11.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2702 0 0 14.6275 14.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1444 0 0 0 0 12.402 10.2086 0 0 13.2906 0 11.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4033 0 0 0 0 0 11.9142 0 0 0 0 0 0 0 0 0 13.1318 0 0 0 0 0 0 10.5262 0 0 0 11.1803 0 0 0 0 0 12.2264 0 0 0 0 0 0 0 0 0 12.25 0 11.3981 0 0 0 0 0 0 0 11.7803 0 0 0 0 0 0 0 0 Q06265 EXOS9_HUMAN "Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa, PM/Scl-75)" EXOSC9 PMSCL1 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; immune response [GO:0006955]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; immune response [GO:0006955]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0000467; GO:0000956; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006955; GO:0016075; GO:0030307; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0043928; GO:0045944; GO:0061629; GO:0070062; GO:0071028; GO:0071035; GO:0071038; GO:0071042; GO:0101019 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] MKETPLSNCER 0.95627 0.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DP75 M14OS_HUMAN Putative uncharacterized protein MED14OS (MED14 antisense gene protein 1) (MED14 opposite strand protein) MED14OS MED14-AS1 Homo sapiens (Human) SPPTPGTGARGGGR 0.95628 0.76307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7665 0 0 0 0 0 0 0 0 12.8874 14.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3H0 PANKY_HUMAN Photoreceptor ankyrin repeat protein (Ankyrin repeat domain-containing protein 33) ANKRD33 C12orf7 PANKY Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; skeletal muscle cell differentiation [GO:0035914] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; skeletal muscle cell differentiation [GO:0035914] GO:0000122; GO:0005634; GO:0005829; GO:0035914; GO:2000678 DSTSPRPQVPKILLSK 0.9563 0.76192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5779 0 0 0 0 0 0 0 0 12.7405 13.6656 13.8983 0 0 0 0 0 0 0 0 13.6317 0 0 13.7357 13.6805 13.6879 13.5491 13.5142 0 0 12.6885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9456 13.2505 0 0 0 0 0 0 0 0 0 14.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV44 TRI41_HUMAN "E3 ubiquitin-protein ligase TRIM41, EC 2.3.2.27 (RING finger-interacting protein with C kinase, RINCK) (Tripartite motif-containing protein 41)" TRIM41 RINCK Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; defense response to virus [GO:0051607]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; defense response to virus [GO:0051607]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567] GO:0005730; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0016604; GO:0042802; GO:0051091; GO:0051607; GO:0060340; GO:0061630; GO:0071222; GO:0071225 identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AKLQGHVEPLRK 0.95632 2.8414 0 13.9851 0 0 12.854 0 0 0 0 0 0 0 0 0 0 0 11.3671 0 0 0 0 0 13.1561 0 0 0 0 0 0 11.0748 0 0 0 0 0 0 0 0 0 0 13.4524 0 0 0 0 12.3655 13.248 11.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1103 11.91 0 0 0 0 0 0 0 13.9085 0 14.6212 15.1316 0 0 0 0 13.5582 0 0 13.1309 0 0 0 0 0 0 13.9506 0 0 0 0 0 13.0797 0 12.1528 0 0 0 0 0 0 0 0 13.9835 0 0 0 0 12.1769 0 0 0 0 0 0 0 0 0 0 0 13.8394 0 0 0 0 11.9947 0 0 0 13.3799 0 0 14.033 0 0 0 0 0 0 0 13.9713 0 0 0 0 0 0 0 14.1677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8356 13.6668 0 0 0 0 0 0 0 0 Q3LI67 KRA63_HUMAN Keratin-associated protein 6-3 KRTAP6-3 KAP6.3 Homo sapiens (Human) keratinization [GO:0031424] cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882]; keratinization [GO:0031424] GO:0005829; GO:0005882; GO:0031424 CGSGYGSSFGYYY 0.95634 0.77651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6199 0 0 0 0 0 0 0 0 0 12.9083 0 0 0 13.0916 0 0 0 0 0 13.4083 0 0 0 13.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8651 Q8N0W3 FCSK_HUMAN "L-fucose kinase, Fucokinase, EC 2.7.1.52" FCSK FUK Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350] GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201; GO:1903350 ATP binding [GO:0005524]; fucokinase activity [GO:0050201] AWDLWDPETLPAEYCLPSARLFPVLHPSR 0.95634 0.75815 0 0 0 0 0 0 0 11.8919 0 13.0162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8711 0 0 0 10.4831 0 0 0 12.633 0 0 0 0 0 0 0 0 0 13.2097 0 0 12.5537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8707 0 0 0 11.9829 17.5495 0 0 0 0 12.8381 12.2473 0 0 13.0148 18.9707 13.1676 12.9456 0 12.772 0 13.4338 11.231 0 0 0 12.6652 13.093 0 17.8929 11.9193 0 0 0 0 0 13.016 0 0 0 0 0 0 0 0 0 0 0 17.7789 15.3848 0 0 0 12.7185 0 0 13.1947 0 10.8778 0 0 0 0 0 0 11.5197 0 17.5356 0 0 18.2029 0 0 16.8863 11.723 0 0 0 0 17.3881 0 0 0 0 0 0 0 12.9975 0 18.4309 0 0 12.9984 14.4535 0 0 12.8495 0 0 0 12.5439 12.8538 0 0 0 0 12.6717 0 0 16.6647 0 P36402 TCF7_HUMAN "Transcription factor 7, TCF-7 (T-cell-specific transcription factor 1, T-cell factor 1, TCF-1)" TCF7 TCF1 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cellular response to interleukin-4 [GO:0071353]; gamma-delta T cell differentiation [GO:0042492]; immune response [GO:0006955]; regulation of gamma-delta T cell differentiation [GO:0045586]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T cell receptor V(D)J recombination [GO:0033153]" beta-catenin-TCF complex [GO:1990907]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "beta-catenin-TCF complex [GO:1990907]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; canonical Wnt signaling pathway [GO:0060070]; cellular response to interleukin-4 [GO:0071353]; gamma-delta T cell differentiation [GO:0042492]; immune response [GO:0006955]; regulation of gamma-delta T cell differentiation [GO:0045586]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T cell receptor V(D)J recombination [GO:0033153]" GO:0000976; GO:0000978; GO:0000981; GO:0001217; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006955; GO:0008013; GO:0016604; GO:0033153; GO:0042492; GO:0045586; GO:0060070; GO:0071353; GO:1990837; GO:1990907 "beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" LPEPLEDGLKAPECTSGMYK 0.95635 0.77618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TD97 FHL5_HUMAN "Four and a half LIM domains protein 5, FHL-5 (Activator of cAMP-responsive element modulator in testis, Activator of CREM in testis)" FHL5 ACT Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634]; Z disc [GO:0030018] nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003712; GO:0003713; GO:0005634; GO:0030018; GO:0045944; GO:0046872 metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] DDSPYCVTCYDR 0.95635 4.5869 0 0 10.8659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4868 0 0 10.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2636 0 0 0 0 0 0 0 11.5572 0 0 11.1702 11.8273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.258 11.4916 11.5421 12.7657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2E3 ODFP4_HUMAN "Outer dense fiber protein 4 (Outer dense fiber of sperm tails protein 4) (Testis-specific protein oppo 1, hOPPO1)" ODF4 OPPO1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005886; GO:0007283; GO:0016021; GO:0030154 KWLDLSRSLFYQR 0.95636 0.62798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6 0 14.4747 14.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3332 0 0 14.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0578 0 0 0 0 0 0 0 10.7949 0 0 0 14.0106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3369 0 0 14.7214 14.0266 14.4404 0 14.8293 14.8822 0 14.8031 0 14.7214 0 0 0 0 0 15.3952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVA1 TBB2B_HUMAN Tubulin beta-2B chain TUBB2B Homo sapiens (Human) embryonic brain development [GO:1990403]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; positive regulation of axon guidance [GO:1902669] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; Schaffer collateral - CA1 synapse [GO:0098685] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; Schaffer collateral - CA1 synapse [GO:0098685]; GTP binding [GO:0005525]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200]; embryonic brain development [GO:1990403]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; positive regulation of axon guidance [GO:1902669] GO:0000226; GO:0000278; GO:0001764; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0007017; GO:0015630; GO:0045171; GO:0046982; GO:0050804; GO:0072686; GO:0098685; GO:1902669; GO:1990403 GTP binding [GO:0005525]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200] HGRYLTVAAIFRGR 0.95636 0.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9319 0 0 0 0 0 0 0 Q8N8G6 CO054_HUMAN Putative uncharacterized protein encoded by LINC02915 LINC02915 C15orf54 Homo sapiens (Human) LLSWIILSNLFLHLR 0.95637 0.7674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5152 0 0 0 13.5332 12.5499 0 0 0 0 0 0 0 0 0 12.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NC78 GOG8I_HUMAN Putative golgin subfamily A member 8I (Golgin subfamily A member 8I pseudogene) GOLGA8IP GOLGA8I GOLGA9P Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 AVVLDSRSVEISQLK 0.95638 0.756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW62 TMED6_HUMAN "Transmembrane emp24 domain-containing protein 6 (p24 family protein gamma-5, p24gamma5)" TMED6 UNQ9146/PRO34237 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886] GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134 SPLLFGAGLVVLNLVTSAR 0.95638 0.62745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7K0 COXM1_HUMAN "COX assembly mitochondrial protein homolog, Cmc1p" CMC1 C3orf68 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739]; metal ion binding [GO:0046872] GO:0005739; GO:0046872 metal ion binding [GO:0046872] CSEQVQDFTKCCK 0.95639 0.73291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9517 0 0 Q8N4Q1 MIA40_HUMAN Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4) CHCHD4 MIA40 Homo sapiens (Human) 'de novo' post-translational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; peptidyl-cysteine oxidation [GO:0018171]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; protein-disulfide reductase activity [GO:0015035]; 'de novo' post-translational protein folding [GO:0051084]; mitochondrial respiratory chain complex assembly [GO:0033108]; peptidyl-cysteine oxidation [GO:0018171]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation by protein folding [GO:0022417] GO:0005739; GO:0005758; GO:0015035; GO:0018171; GO:0022417; GO:0033108; GO:0045041; GO:0051084 protein-disulfide reductase activity [GO:0015035] AMQECMQKYPDLYPQEDEDEEEER 0.95639 0.71594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4Q2 HEAT3_HUMAN HEAT repeat-containing protein 3 HEATR3 Homo sapiens (Human) protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273] unfolded protein binding [GO:0051082]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273] GO:0006606; GO:0042273; GO:0051082 unfolded protein binding [GO:0051082] DAVRRLGPLLLDPSLAVR 0.95641 2.941 0 13.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2025 14.6203 0 13.8006 0 0 0 0 0 0 0 0 0 0 0 0 13.8421 0 0 13.7894 13.9824 12.1869 0 0 0 0 0 14.3481 11.582 0 0 0 13.4974 0 13.8143 13.0224 0 0 0 0 0 0 14.295 13.74 14.5402 0 0 0 14.2987 0 0 0 0 13.5263 0 13.7386 0 0 0 0 0 14.0766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3188 0 0 0 0 0 11.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGR3 OR1K1_HUMAN Olfactory receptor 1K1 OR1K1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] DVQGALRALLIGRR 0.95643 0.76509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6089 0 13.3716 13.3116 0 0 0 0 0 0 0 0 0 13.1418 13.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZ72 IZUM3_HUMAN Izumo sperm-egg fusion protein 3 IZUMO3 C9orf134 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803] GO:0005886; GO:0016021; GO:0042803 protein homodimerization activity [GO:0042803] CFKGEYCGDEDPRK 0.95644 0.66531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUE6 H2A2B_HUMAN Histone H2A type 2-B (H2A-clustered histone 21) H2AC21 HIST2H2AB Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AGLQFPVGR 0.95645 0.66515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8754 0 0 0 0 0 12.5339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0122 0 0 0 0 0 0 11.019 0 0 0 0 0 0 0 Q8NHZ8 CDC26_HUMAN "Anaphase-promoting complex subunit CDC26 (Anaphase-promoting complex subunit 12, APC12) (Cell division cycle protein 26 homolog)" CDC26 ANAPC12 C9orf17 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071] GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0030071; GO:0031145; GO:0051301; GO:0051445; GO:0070979 EQMINDRIGYK 0.95647 0.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2WGJ8 TM249_HUMAN Cation channel sperm-associated auxiliary subunit TMEM249 (Transmembrane protein 249) TMEM249 C8orfK29 Homo sapiens (Human) CatSper complex [GO:0036128]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; sperm principal piece [GO:0097228] GO:0036128; GO:0097228 GMLLFIISVVLVSFSSLREVQK 0.95648 0.44857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH61 O51F2_HUMAN Olfactory receptor 51F2 (Olfactory receptor OR11-23) OR51F2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IGMSMLIRNVAVMLPVMLFVKR 0.95649 0.69889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.342 0 11.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0138 0 0 0 0 12.6585 0 13.8284 13.3254 0 0 0 0 0 0 0 14.21 0 0 0 0 12.8582 14.255 14.3053 0 0 13.6012 0 13.3876 0 0 0 14.2357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BPW9 DHRS9_HUMAN "Dehydrogenase/reductase SDR family member 9, EC 1.1.1.209, EC 1.1.1.53 (3-alpha hydroxysteroid dehydrogenase, 3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15, EC 1.1.1.105) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase, RDH-TBE)" DHRS9 RDH15 SDR9C4 UNQ835/PRO1773 Homo sapiens (Human) 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; racemase and epimerase activity [GO:0016854]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]" GO:0004022; GO:0004745; GO:0005789; GO:0008202; GO:0008209; GO:0016229; GO:0016491; GO:0016854; GO:0030176; GO:0030855; GO:0042448; GO:0042572; GO:0042904; GO:0043231; GO:0047023; GO:0047035; GO:0047044 "alcohol dehydrogenase (NAD+) activity [GO:0004022]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; racemase and epimerase activity [GO:0016854]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" AQGRVINVSSVGGR 0.9565 0.76307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14773 TPP1_HUMAN "Tripeptidyl-peptidase 1, TPP-1, EC 3.4.14.9 (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease, LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I, TPP-I)" TPP1 CLN2 GIG1 UNQ267/PRO304 Homo sapiens (Human) "bone resorption [GO:0045453]; central nervous system development [GO:0007417]; epithelial cell differentiation [GO:0030855]; lipid metabolic process [GO:0006629]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]" extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; recycling endosome [GO:0055037] "extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; recycling endosome [GO:0055037]; endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240]; bone resorption [GO:0045453]; central nervous system development [GO:0007417]; epithelial cell differentiation [GO:0030855]; lipid metabolic process [GO:0006629]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]" GO:0004175; GO:0004252; GO:0005764; GO:0005794; GO:0006508; GO:0006629; GO:0007040; GO:0007399; GO:0007417; GO:0008233; GO:0008236; GO:0008240; GO:0030163; GO:0030855; GO:0035727; GO:0042277; GO:0042470; GO:0043171; GO:0043202; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070062; GO:0070198; GO:0120146; GO:1905146 endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240] PSPLTLHTVQKWLLAAGAQK 0.95651 0.69797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A455ZAR2 PNT87_HUMAN Transcriptional regulator PINT87aa LINC-PINT Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 GSCSARSPSGMLRGAPGGWR 0.95652 2.9395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2306 0 0 0 13.1731 0 0 0 0 0 0 0 0 0 14.0685 0 12.5498 0 0 0 0 0 0 0 0 0 0 12.3007 0 0 0 0 0 0 0 11.5201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1767 0 0 0 0 0 11.7808 0 0 0 0 0 11.8497 0 0 0 0 11.7984 11.6424 0 0 0 0 12.0506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9657 0 0 0 0 0 O95202 LETM1_HUMAN Mitochondrial proton/calcium exchanger protein (Leucine zipper-EF-hand-containing transmembrane protein 1) LETM1 Homo sapiens (Human) calcium export from the mitochondrion [GO:0099093]; cellular metal ion homeostasis [GO:0006875]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; cellular metal ion homeostasis [GO:0006875]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069] GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0006875; GO:0015369; GO:0016021; GO:0034214; GO:0042407; GO:0043022; GO:0051260; GO:0051560; GO:0051562; GO:0099093; GO:1900069 calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022] APARLPPPPRYTVPR 0.95652 2.835 0 0 0 0 0 0 0 0 0 15.6801 0 0 0 0 0 0 0 0 0 0 0 12.3722 0 12.5504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9954 0 0 0 0 14.6658 0 0 13.1282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4338 0 0 0 0 0 14.8337 0 0 0 0 0 0 0 13.0293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2185 0 0 0 0 11.977 0 16.9752 0 0 0 0 0 0 0 15.1585 0 0 0 0 0 0 0 0 0 0 0 P13497 BMP1_HUMAN "Bone morphogenetic protein 1, BMP-1, EC 3.4.24.19 (Mammalian tolloid protein, mTld) (Procollagen C-proteinase, PCP)" BMP1 PCOLC Homo sapiens (Human) cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0004252; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0031982; GO:0042802; GO:0061036 calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] CSCDPGYELAPDKR 0.95652 3.7726 12.5041 0 12.612 0 0 0 0 0 0 14.3085 0 11.2321 0 14.5488 0 13.2374 0 12.8064 10.1047 0 0 0 12.697 14.1957 10.8662 14.0702 10.8032 13.5188 0 0 0 0 0 0 11.5017 0 0 10.6055 0 0 9.85941 13.0936 0 12.2954 0 10.7394 0 0 0 12.5752 0 12.7906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4477 0 11.3681 11.254 0 13.5831 0 0 0 0 0 15.9458 13.5012 16.4174 0 11.9587 18.0935 0 0 0 11.752 13.8917 12.169 0 12.0078 0 14.2633 14.9676 14.425 0 0 12.6067 13.8105 13.1339 15.5755 14.6243 0 9.10478 13.217 0 11.6701 11.0466 0 0 0 15.1939 0 0 14.2205 18.3908 0 18.3276 13.1356 0 0 0 0 0 0 0 11.2053 12.9178 0 0 11.9103 0 16.847 12.3842 0 0 0 0 0 15.995 0 0 14.5296 12.3176 0 12.951 0 15.7206 0 13.8283 0 11.6017 15.4717 0 13.1996 14.5843 12.2196 10.6968 14.2478 0 0 14.6282 12.7851 9.2165 0 14.0396 10.4661 0 0 0 13.4206 19.6588 0 0 0 15.7526 13.0953 0 0 13.1311 Q6UXB4 CLC4G_HUMAN "C-type lectin domain family 4 member G (Liver and lymph node sinusoidal endothelial cell C-type lectin, LSECtin)" CLEC4G UNQ431/PRO792 Homo sapiens (Human) alpha-beta T cell proliferation [GO:0046633]; immature T cell proliferation in thymus [GO:0033080]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell mediated immunity [GO:0002710]; positive regulation of viral life cycle [GO:1903902]; T cell mediated immunity [GO:0002456]; viral entry into host cell [GO:0046718] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; glycosylated region protein binding [GO:0140081]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618]; alpha-beta T cell proliferation [GO:0046633]; immature T cell proliferation in thymus [GO:0033080]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell mediated immunity [GO:0002710]; positive regulation of viral life cycle [GO:1903902]; T cell mediated immunity [GO:0002456]; viral entry into host cell [GO:0046718] GO:0001618; GO:0002456; GO:0002710; GO:0005537; GO:0005886; GO:0005887; GO:0009897; GO:0030246; GO:0030247; GO:0033080; GO:0033088; GO:0046633; GO:0046642; GO:0046718; GO:0070061; GO:0097367; GO:0120274; GO:0140081; GO:1903902 carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; fructose binding [GO:0070061]; glycosylated region protein binding [GO:0140081]; mannose binding [GO:0005537]; polysaccharide binding [GO:0030247]; virus coreceptor activity [GO:0120274]; virus receptor activity [GO:0001618] DGWICEKRHNC 0.95652 4.5809 0 0 0 0 0 0 0 0 0 0 0 12.2228 0 0 0 0 0 0 0 0 13.4738 0 0 0 0 0 0 0 0 0 13.4148 0 0 0 0 0 0 0 0 0 0 13.5427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4707 10.9377 0 0 12.834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9108 0 0 14.0155 0 0 13.9813 0 0 0 0 11.8719 0 12.3414 0 0 0 0 13.8382 0 0 0 13.6363 0 0 0 0 0 0 0 0 0 0 0 13.8221 0 0 0 0 0 0 0 0 0 11.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6988 0 0 0 10.6998 0 0 13.7206 0 0 0 0 12.9058 0 0 0 0 0 P0C5K7 CT62_HUMAN "Cancer/testis antigen 62, CT62" CT62 Homo sapiens (Human) FCSHSSEDMSK 0.95655 0.62823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5994 0 0 0 0 0 0 0 0 0 0 0 Q13137 CACO2_HUMAN "Calcium-binding and coiled-coil domain-containing protein 2 (Antigen nuclear dot 52 kDa protein) (Nuclear domain 10 protein NDP52, Nuclear domain 10 protein 52) (Nuclear dot protein 52)" CALCOCO2 NDP52 Homo sapiens (Human) positive regulation of autophagosome maturation [GO:1901098]; response to interferon-gamma [GO:0034341]; viral process [GO:0016032]; xenophagy [GO:0098792] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; positive regulation of autophagosome maturation [GO:1901098]; response to interferon-gamma [GO:0034341]; viral process [GO:0016032]; xenophagy [GO:0098792] GO:0000421; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0005856; GO:0016020; GO:0016032; GO:0016605; GO:0031410; GO:0034341; GO:0042803; GO:0043231; GO:0046872; GO:0048471; GO:0098792; GO:1901098 metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] LEQTVEQMK 0.95656 0.62804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.56102 0 0 0 0 0 0 0 0 0 0 0 0 Q1ZYL8 IZUM4_HUMAN Izumo sperm-egg fusion protein 4 (Sperm 22 kDa protein c113) IZUMO4 C19orf36 UNQ831/PRO1758 Homo sapiens (Human) extracellular region [GO:0005576]; nucleus [GO:0005634] extracellular region [GO:0005576]; nucleus [GO:0005634] GO:0005576; GO:0005634 ELHLAIPAKITREK 0.95658 0.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1533 0 0 0 0 0 0 0 0 0 0 11.8798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.743 12.4174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98164 LRP2_HUMAN "Low-density lipoprotein receptor-related protein 2, LRP-2 (Glycoprotein 330, gp330) (Megalin)" LRP2 Homo sapiens (Human) amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124]; amyloid-beta clearance [GO:0097242]; aorta development [GO:0035904]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; coronary artery morphogenesis [GO:0060982]; diol metabolic process [GO:0034311]; endocytosis [GO:0006897]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; kidney development [GO:0001822]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein kinase B signaling [GO:0051897]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; retinoid metabolic process [GO:0001523]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359] GO:0001523; GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0003281; GO:0005041; GO:0005509; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0015031; GO:0016021; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0030669; GO:0030900; GO:0031526; GO:0031904; GO:0031994; GO:0034311; GO:0035904; GO:0038024; GO:0042359; GO:0042562; GO:0043066; GO:0043235; GO:0044321; GO:0045056; GO:0050769; GO:0051087; GO:0051897; GO:0060068; GO:0060982; GO:0061156; GO:0070062; GO:0070447; GO:0071363; GO:0097242; GO:0140058; GO:0140318; GO:0150104; GO:1904447; GO:1905167 calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; chaperone binding [GO:0051087]; hormone binding [GO:0042562]; insulin-like growth factor I binding [GO:0031994]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transporter activity [GO:0140318]; SH3 domain binding [GO:0017124] AWLCDRDNDCGDMSDEK 0.95659 3.3033 0 10.4566 14.3729 0 0 0 12.2741 0 14.2594 0 12.6176 14.0715 0 0 14.338 14.0878 0 0 13.164 12.8306 14.0295 11.3439 13.9437 13.4891 12.7523 11.4733 0 12.8139 12.1735 11.2321 13.8579 13.4765 13.0004 13.3749 13.2543 0 11.8567 11.7872 12.5035 13.2779 0 13.217 0 0 10.9155 11.9956 0 12.9068 0 12.6918 10.8639 11.7226 10.9279 12.686 11.4214 0 0 0 0 0 0 0 0 0 0 11.958 15.0164 16.2329 16.1403 13.5378 13.3283 14.0915 14.3503 14.5623 13.0425 10.8179 14.7404 15.2092 0 14.4537 14.9721 15.1906 16.8782 16.0933 12.9131 0 16.1041 14.9972 15.1382 0 15.5228 15.2389 14.9821 13.6467 11.699 10.0006 13.6976 15.0818 13.8317 16.5945 11.203 13.3515 14.4055 16.075 12.3669 14.1068 0 14.0587 14.9489 14.5821 15.6985 13.6247 14.8742 16.2879 14.1806 12.8895 12.2458 16.3759 11.44 12.4675 14.6143 14.1128 16.2427 0 12.0839 0 12.2661 14.1894 0 15.0192 14.0962 13.5618 12.6843 13.9395 12.2351 12.5829 10.2495 14.3412 12.5048 15.087 14.8325 15.3418 12.376 14.5707 13.0907 12.4648 14.7683 0 11.4911 11.5058 15.2397 15.8096 15.1115 15.2529 14.2088 13.7637 0 0 13.3684 12.8627 16.8462 11.7027 12.5743 0 12.0178 12.7375 13.2838 11.684 0 0 11.9364 14.6495 13.2253 15.0404 12.8856 0 12.4695 12.8822 13.7819 14.8348 Q8N6M8 IQCF1_HUMAN IQ domain-containing protein F1 IQCF1 Homo sapiens (Human) positive regulation of acrosome reaction [GO:2000344]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474] acrosomal vesicle [GO:0001669] acrosomal vesicle [GO:0001669]; calmodulin binding [GO:0005516]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474] GO:0001669; GO:0005516; GO:0060474; GO:2000344 calmodulin binding [GO:0005516] ALLHAALSACIIQCWWRLILSKILK 0.95664 0.66545 11.7772 0 12.6829 14.3496 12.1468 14.8279 0 0 0 0 0 12.4565 0 13.2012 0 0 0 0 0 9.97957 10.1369 0 16.82 16.6734 12.6014 0 0 0 0 0 0 0 0 12.2443 13.0489 0 0 0 0 0 0 0 13.1093 0 0 10.7394 0 0 0 0 0 0 0 0 12.7287 0 13.3894 0 0 0 0 0 0 0 0 0 18.0825 13.5153 12.1607 0 0 0 0 0 18.2447 13.2142 18.5216 18.405 18.3489 12.6776 18.3022 18.7287 18.0403 18.0381 18.0779 18.0553 18.0838 14.5502 18.2174 12.704 14.6213 18.9373 18.1857 18.2947 18.3137 18.1669 0 18.7166 13.4746 0 18.3386 18.0748 0 17.6168 17.5477 0 0 13.6715 18.0399 12.3933 13.1926 17.9268 13.0133 17.908 18.0438 13.9834 13.4114 0 0 17.9567 12.0584 14.0446 18.0089 18.0189 17.9555 0 17.8867 0 12.2331 17.8408 17.9038 17.8294 17.849 17.9168 12.278 17.8459 17.7918 0 17.8208 17.8588 17.879 17.7313 17.8061 17.7872 17.7095 17.6745 17.8103 0 0 0 17.6472 17.6301 17.6727 17.5759 17.5748 17.6929 17.631 0 14.2334 0 0 0 14.0804 14.2211 0 11.6844 14.3538 0 13.9543 0 0 17.5602 17.5167 17.6418 13.2608 0 0 0 0 0 Q13405 RM49_HUMAN "39S ribosomal protein L49, mitochondrial, L49mt, MRP-L49 (Mitochondrial large ribosomal subunit protein mL49) (Neighbor of FAU, NOF) (Protein NOF1)" MRPL49 C11orf4 NOF1 OK/SW-cl.67 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 structural constituent of ribosome [GO:0003735] HEHYPTPSGWQPPR 0.95665 0.44915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00254 PAR3_HUMAN "Proteinase-activated receptor 3, PAR-3 (Coagulation factor II receptor-like 2) (Thrombin receptor-like 2)" F2RL2 PAR3 Homo sapiens (Human) blood coagulation [GO:0007596]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; response to wounding [GO:0009611] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G protein-coupled receptor activity [GO:0004930]; phosphatidylinositol phospholipase C activity [GO:0004435]; thrombin-activated receptor activity [GO:0015057]; blood coagulation [GO:0007596]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; response to wounding [GO:0009611] GO:0004435; GO:0004930; GO:0005576; GO:0005886; GO:0005887; GO:0007596; GO:0009611; GO:0015057; GO:0016324; GO:0030168; GO:0032991; GO:0035025; GO:0051482 G protein-coupled receptor activity [GO:0004930]; phosphatidylinositol phospholipase C activity [GO:0004435]; thrombin-activated receptor activity [GO:0015057] TLNAYDHRWLWYVK 0.95668 0.76307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20336 RAB3A_HUMAN Ras-related protein Rab-3A RAB3A Homo sapiens (Human) acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; calcium-ion regulated exocytosis [GO:0017156]; constitutive secretory pathway [GO:0045054]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; lung development [GO:0030324]; lysosome localization [GO:0032418]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; post-embryonic development [GO:0009791]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of plasma membrane repair [GO:1905684]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904] acrosomal vesicle [GO:0001669]; anchored component of synaptic vesicle membrane [GO:0098993]; anchoring junction [GO:0070161]; axon [GO:0030424]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] acrosomal vesicle [GO:0001669]; anchored component of synaptic vesicle membrane [GO:0098993]; anchoring junction [GO:0070161]; axon [GO:0030424]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GDP-dissociation inhibitor binding [GO:0051021]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022]; acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; calcium-ion regulated exocytosis [GO:0017156]; constitutive secretory pathway [GO:0045054]; evoked neurotransmitter secretion [GO:0061670]; exocytosis [GO:0006887]; lung development [GO:0030324]; lysosome localization [GO:0032418]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; post-embryonic development [GO:0009791]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of plasma membrane repair [GO:1905684]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle recycling [GO:0036465]; synaptic vesicle transport [GO:0048489]; vesicle docking involved in exocytosis [GO:0006904] GO:0001669; GO:0001671; GO:0001778; GO:0003016; GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0008022; GO:0009306; GO:0009791; GO:0010807; GO:0014059; GO:0016079; GO:0016188; GO:0017156; GO:0017157; GO:0030324; GO:0030424; GO:0030667; GO:0030742; GO:0031489; GO:0031630; GO:0032418; GO:0032991; GO:0036465; GO:0043195; GO:0043231; GO:0045054; GO:0045055; GO:0045921; GO:0048172; GO:0048471; GO:0048489; GO:0048786; GO:0048790; GO:0050975; GO:0051021; GO:0051117; GO:0051602; GO:0060201; GO:0060203; GO:0060478; GO:0061202; GO:0061670; GO:0070083; GO:0070161; GO:0072659; GO:0097091; GO:0098793; GO:0098794; GO:0098993; GO:1903307; GO:1903561; GO:1905684; GO:2000300 ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; GDP-dissociation inhibitor binding [GO:0051021]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein C-terminus binding [GO:0008022] DNINVKQTFER 0.95668 0.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7818 0 0 0 0 0 0 0 0 11.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10092 CALCB_HUMAN "Calcitonin gene-related peptide 2 (Beta-type CGRP, Beta-CGRP) (Calcitonin gene-related peptide II, CGRP-II)" CALCB CALC2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular calcium ion homeostasis [GO:0006874]; regulation of cytosolic calcium ion concentration [GO:0051480]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcitonin receptor binding [GO:0031716]; neuropeptide hormone activity [GO:0005184]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular calcium ion homeostasis [GO:0006874]; regulation of cytosolic calcium ion concentration [GO:0051480]; signal transduction [GO:0007165] GO:0005184; GO:0005576; GO:0005615; GO:0006874; GO:0007165; GO:0007189; GO:0031716; GO:0051480 calcitonin receptor binding [GO:0031716]; neuropeptide hormone activity [GO:0005184] ACNTATCVTHRLAGLLSRSGGMVK 0.95671 0.69968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3558 0 0 0 0 0 0 0 0 12.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01160 ANF_HUMAN "Natriuretic peptides A (Atrial natriuretic factor prohormone, proANF) (Atrial natriuretic peptide prohormone, preproANP, proANP) (Atriopeptigen) (Cardiodilatin, CDD) (preproCDD-ANF) [Cleaved into: Long-acting natriuretic peptide, LANP (Long-acting natriuretic hormone, LANH) (Pro atrial natriuretic factor 1-30, proANF 1-30) (Pro atrial natriuretic peptide 1-30, proANP 1-30); Vessel dilator, VSDL (Pro atrial natriuretic factor 31-67, proANF 31-67) (Pro atrial natriuretic peptide 31-67, proANP 31-67); Kaliuretic peptide, KP (Pro atrial natriuretic factor 79-98, proANF 79-98) (Pro atrial natriuretic peptide 79-98, proANP 79-98); Urodilatin, URO (CDD 95-126) (CDD-ANP (95-126)) (Pro atrial natriuretic peptide 95-126, proANP 95-126); Auriculin-C (Atrial natriuretic factor 1-33, ANF 1-33); Auriculin-D (Atrial natriuretic factor 3-33, ANF 3-33); Atrial natriuretic peptide, ANP (Alpha-atrial natriuretic peptide) (Alpha-hANP) (Atrial natriuretic factor, ANF) (CDD-ANF) (CDD-ANP (99-126)) (Cardionatrin) (Pro atrial natriuretic factor 99-126, proANF 99-126); Auriculin-B (Atrial natriuretic factor 8-33, ANF 8-33); Auriculin-A; Atriopeptin-1 (Atriopeptin I); Atriopeptin-2 (Atriopeptin II); Atriopeptin-3 (Atriopeptin III) ]" NPPA ANP PND Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; vasodilation [GO:0042311] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102]; aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; vasodilation [GO:0042311] GO:0003085; GO:0003161; GO:0003180; GO:0005102; GO:0005179; GO:0005184; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006182; GO:0006457; GO:0007168; GO:0007218; GO:0007565; GO:0008217; GO:0010460; GO:0014898; GO:0019934; GO:0032991; GO:0035994; GO:0036376; GO:0042059; GO:0042311; GO:0042995; GO:0043204; GO:0043508; GO:0051427; GO:0060372; GO:0060452; GO:0062023; GO:0071855; GO:0090090; GO:1901841; GO:1902261; GO:1902514; GO:1903766 hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102] LRALLTAPRSLR 0.95673 0.69822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7033 0 0 0 14.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7882 0 0 0 0 0 0 0 Q8WZ79 DNS2B_HUMAN "Deoxyribonuclease-2-beta, EC 3.1.22.1 (DNase II-like acid DNase) (DNase2-like acid DNase) (Deoxyribonuclease II beta, DNase II beta) (Endonuclease DLAD)" DNASE2B DLAD Homo sapiens (Human) apoptotic DNA fragmentation [GO:0006309] extracellular region [GO:0005576]; lysosome [GO:0005764] extracellular region [GO:0005576]; lysosome [GO:0005764]; deoxyribonuclease II activity [GO:0004531]; apoptotic DNA fragmentation [GO:0006309] GO:0004531; GO:0005576; GO:0005764; GO:0006309 deoxyribonuclease II activity [GO:0004531] TLQQLYEAYASKSNNTAYLIYNDGVPK 0.95675 0.69739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1A519 F170A_HUMAN Protein FAM170A (Zinc finger domain-containing protein) (Zinc finger protein ZNFD) FAM170A ZNFD Homo sapiens (Human) "fertilization [GO:0009566]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; fertilization [GO:0009566]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase II [GO:0006366]" GO:0003677; GO:0005634; GO:0006366; GO:0009566; GO:0045893; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] EGFSCHVFHLTMAQLTGNMESESTQDEQEEENGNEK 0.9568 3.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.789 0 0 13.5683 0 12.6156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94788 AL1A2_HUMAN "Retinal dehydrogenase 2, RALDH 2, RalDH2, EC 1.2.1.36 (Aldehyde dehydrogenase family 1 member A2) (Retinaldehyde-specific dehydrogenase type 2, RALDH(II))" ALDH1A2 RALDH2 Homo sapiens (Human) 9-cis-retinoic acid biosynthetic process [GO:0042904]; blood vessel development [GO:0001568]; cardiac muscle tissue development [GO:0048738]; cell population proliferation [GO:0008283]; cellular response to retinoic acid [GO:0071300]; determination of bilateral symmetry [GO:0009855]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic forelimb morphogenesis [GO:0035115]; face development [GO:0060324]; heart morphogenesis [GO:0003007]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; liver development [GO:0001889]; lung development [GO:0030324]; midgut development [GO:0007494]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; neural crest cell development [GO:0014032]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to vitamin A [GO:0033189]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway involved in somitogenesis [GO:0090242]; retinol metabolic process [GO:0042572]; ureter maturation [GO:0035799]; vitamin A metabolic process [GO:0006776] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; retinal binding [GO:0016918]; retinal dehydrogenase activity [GO:0001758]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; blood vessel development [GO:0001568]; cardiac muscle tissue development [GO:0048738]; cell population proliferation [GO:0008283]; cellular response to retinoic acid [GO:0071300]; determination of bilateral symmetry [GO:0009855]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic forelimb morphogenesis [GO:0035115]; face development [GO:0060324]; heart morphogenesis [GO:0003007]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; liver development [GO:0001889]; lung development [GO:0030324]; midgut development [GO:0007494]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; neural crest cell development [GO:0014032]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to vitamin A [GO:0033189]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway involved in somitogenesis [GO:0090242]; retinol metabolic process [GO:0042572]; ureter maturation [GO:0035799]; vitamin A metabolic process [GO:0006776] GO:0001568; GO:0001758; GO:0001822; GO:0001889; GO:0002138; GO:0003007; GO:0004028; GO:0004029; GO:0005737; GO:0005829; GO:0006776; GO:0007494; GO:0008283; GO:0008284; GO:0008285; GO:0009855; GO:0009954; GO:0010628; GO:0014032; GO:0016331; GO:0016918; GO:0021915; GO:0021983; GO:0030182; GO:0030324; GO:0030902; GO:0031016; GO:0031076; GO:0032355; GO:0033189; GO:0034097; GO:0035115; GO:0035799; GO:0042572; GO:0042573; GO:0042574; GO:0042904; GO:0043065; GO:0048471; GO:0048566; GO:0048738; GO:0051289; GO:0060324; GO:0071300; GO:0090242; GO:1905562 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; retinal binding [GO:0016918]; retinal dehydrogenase activity [GO:0001758] LLDKLADLVER 0.95683 0.66563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47881 OR3A1_HUMAN "Olfactory receptor 3A1 (Olfactory receptor 17-40, OR17-40) (Olfactory receptor OR17-15)" OR3A1 OLFRA03 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FLAICRPLTYSTRMSQTVQR 0.95684 0.66547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2342 14.1328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W064 LIPJ_HUMAN "Lipase member J, EC 3.1.1.- (Lipase-like abhydrolase domain-containing protein 1)" LIPJ LIPL1 Homo sapiens (Human) lipid catabolic process [GO:0016042] intracellular membrane-bounded organelle [GO:0043231] "intracellular membrane-bounded organelle [GO:0043231]; hydrolase activity, acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042]" GO:0016042; GO:0016788; GO:0043231 "hydrolase activity, acting on ester bonds [GO:0016788]" QTRQEEIFYVGHSQGTTIGFITFSTISK 0.95686 0.41723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50052 AGTR2_HUMAN "Type-2 angiotensin II receptor (Angiotensin II type-2 receptor, AT2 receptor)" AGTR2 Homo sapiens (Human) "angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; brain renin-angiotensin system [GO:0002035]; cell surface receptor signaling pathway [GO:0007166]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of heart rate [GO:0010459]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; neuron apoptotic process [GO:0051402]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of metanephros size [GO:0035566]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; vasodilation [GO:0042311]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; angiotensin type II receptor activity [GO:0004945]; G protein-coupled receptor activity [GO:0004930]; receptor antagonist activity [GO:0048019]; angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002033]; blood vessel remodeling [GO:0001974]; brain development [GO:0007420]; brain renin-angiotensin system [GO:0002035]; cell surface receptor signaling pathway [GO:0007166]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of heart rate [GO:0010459]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; neuron apoptotic process [GO:0051402]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of metanephros size [GO:0035566]; regulation of systemic arterial blood pressure by circulatory renin-angiotensin [GO:0001991]; vasodilation [GO:0042311]" GO:0001974; GO:0001991; GO:0002033; GO:0002035; GO:0004930; GO:0004945; GO:0005886; GO:0005887; GO:0006954; GO:0007166; GO:0007186; GO:0007199; GO:0007263; GO:0007420; GO:0008217; GO:0010459; GO:0030308; GO:0032516; GO:0035556; GO:0035566; GO:0035640; GO:0042311; GO:0043537; GO:0045429; GO:0045893; GO:0048019; GO:0051000; GO:0051387; GO:0051402; GO:0072300; GO:0090190; GO:2001238 angiotensin type II receptor activity [GO:0004945]; G protein-coupled receptor activity [GO:0004930]; receptor antagonist activity [GO:0048019] DVRTIEYLGVNACIMAFPPEKYAQWSAGIALMK 0.95688 0.71307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8954 0 0 0 0 14.4519 0 0 0 0 0 0 0 0 0 0 0 0 14.1006 0 0 0 0 0 0 0 14.5512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61328 FGF12_HUMAN "Fibroblast growth factor 12, FGF-12 (Fibroblast growth factor homologous factor 1, FHF-1) (Myocyte-activating factor)" FGF12 FGF12B FHF1 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165] GO:0005615; GO:0005634; GO:0005737; GO:0007165; GO:0007254; GO:0007267; GO:0007268; GO:0007399; GO:0007507; GO:0008083; GO:0008201; GO:0008344; GO:0008543; GO:0010765; GO:0017080; GO:0044325; GO:0045202; GO:0050905; GO:0086002; GO:0098908; GO:1902305; GO:1905150; GO:2000649 growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] ASLYVAMNGEGYLYSSDVFTPECK 0.95689 0.66485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.835 0 0 0 0 0 0 0 0 0 0 0 0 0 12.126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1732 0 0 12.559 12.3506 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5389 0 0 0 0 P01817 HV205_HUMAN Immunoglobulin heavy variable 2-5 (Ig heavy chain V-II region HE) (Ig heavy chain V-II region MCE) IGHV2-5 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0005576; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] MDTLCSTLLLLTIPSWVLSQITLKESGPTLVK 0.95691 0.44779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UDX3 S14L4_HUMAN SEC14-like protein 4 (Tocopherol-associated protein 3) SEC14L4 TAP3 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; lipid binding [GO:0008289] GO:0005737; GO:0008289 lipid binding [GO:0008289] FDNTYSRMHAK 0.95691 0.67662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15573 TAF1A_HUMAN "TATA box-binding protein-associated factor RNA polymerase I subunit A (RNA polymerase I-specific TBP-associated factor 48 kDa, TAFI48) (TATA box-binding protein-associated factor 1A, TBP-associated factor 1A) (Transcription factor SL1) (Transcription initiation factor SL1/TIF-IB subunit A)" TAF1A Homo sapiens (Human) transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668]; DNA binding [GO:0003677]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366] GO:0003677; GO:0005654; GO:0005668; GO:0006360; GO:0006366; GO:0015630 DNA binding [GO:0003677] EDTALACEK 0.95692 4.2171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2142 0 0 0 11.178 0 0 0 15.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4682 0 0 10.7042 11.0981 0 0 0 0 12.075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1812 0 0 0 0 0 0 0 11.3838 0 0 16.4646 0 0 0 0 0 0 0 0 11.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1959 0 0 0 0 0 0 0 11.189 0 0 0 0 0 0 0 0 13.2828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TB61 S35B2_HUMAN Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2) SLC35B2 PAPST1 PSEC0149 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; 3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0000139; GO:0005794; GO:0016020; GO:0016021; GO:0022857; GO:0030173; GO:0030176; GO:0043123; GO:0046963; GO:0046964; GO:0050428 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; transmembrane transporter activity [GO:0022857] VIPVMLMGK 0.95692 0.69996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2251 0 0 12.2491 0 12.3765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7912 0 10.8857 0 12.7357 0 13.1536 0 0 0 0 0 0 0 0 13.262 0 0 0 0 0 0 0 0 12.7122 0 0 0 12.825 0 0 0 0 0 0 12.5521 0 12.608 0 0 13.1068 0 0 12.8139 0 0 0 0 0 0 Q8TAM1 BBS10_HUMAN Bardet-Biedl syndrome 10 protein BBS10 C12orf58 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cilium [GO:0005929] cilium [GO:0005929]; ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; chaperone-mediated protein complex assembly [GO:0051131]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; regulation of protein-containing complex assembly [GO:0043254]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005524; GO:0005929; GO:0007601; GO:0043254; GO:0045494; GO:0050896; GO:0051131; GO:0061629; GO:1905515 ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] FCKPLILRSK 0.95695 3.295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6346 0 0 0 0 15.637 0 0 0 10.96 11.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9029 0 0 0 0 0 0 0 10.9331 0 0 11.6014 0 0 0 0 0 0 0 11.2343 0 0 0 0 0 0 12.3548 0 0 0 0 0 0 0 0 0 0 12.2973 0 13.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVV8 NKAI4_HUMAN "Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4, Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 4 (Protein FAM77A)" NKAIN4 C20orf58 FAM77A Homo sapiens (Human) regulation of sodium ion transport [GO:0002028] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028] GO:0002028; GO:0005886; GO:0016021 LRYVMVYTLWAAVWVTWNVFIICFYLEVGGLLK 0.95698 0.40231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ92 COPRS_HUMAN Coordinator of PRMT5 and differentiation stimulator (Cooperator of PRMT5) (Protein TTP1) COPRS C17orf79 COPR5 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H4-R3 methylation [GO:0043985]; muscle organ development [GO:0007517] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; histone H4-R3 methylation [GO:0043985]; muscle organ development [GO:0007517] GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006325; GO:0007517; GO:0042393; GO:0043985 histone binding [GO:0042393] LARGTQSIPNDSPAR 0.95698 0.40243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q496H8 NRN1L_HUMAN Neuritin-like protein NRN1L UNQ2446/PRO5725 Homo sapiens (Human) neuron projection extension [GO:1990138] anchored component of plasma membrane [GO:0046658]; axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; neuron projection extension [GO:1990138] GO:0005576; GO:0005615; GO:0005886; GO:0030424; GO:0042802; GO:0046658; GO:1990138 identical protein binding [GO:0042802] ATAPALPMAPAPPLLAAALALAYLLRPLA 0.957 0.67584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRW3 ABC3C_HUMAN "DNA dC->dU-editing enzyme APOBEC-3C, A3C, EC 3.5.4.38 (APOBEC1-like) (Phorbolin I)" APOBEC3C APOBEC1L PBI Homo sapiens (Human) cytidine deamination [GO:0009972]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071] GO:0000932; GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0008270; GO:0009972; GO:0010529; GO:0016554; GO:0045071; GO:0045087; GO:0045869; GO:0047844; GO:0051607; GO:0070383; GO:0080111 cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] LYYFQYPCYQEGLR 0.95701 0.44915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2U7 VGLU1_HUMAN "Vesicular glutamate transporter 1, VGluT1 (Brain-specific Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 7)" SLC17A7 BNPI VGLUT1 Homo sapiens (Human) "anion transport [GO:0006820]; brain development [GO:0007420]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle membrane [GO:0030672]; chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:inorganic phosphate symporter activity [GO:0015319]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; brain development [GO:0007420]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter transport [GO:0006836]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]" GO:0003407; GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006811; GO:0006817; GO:0006820; GO:0006836; GO:0007420; GO:0015319; GO:0015386; GO:0015813; GO:0016021; GO:0022857; GO:0030285; GO:0030672; GO:0035249; GO:0043005; GO:0044341; GO:0048786; GO:0050803; GO:0055062; GO:0060076; GO:0060203; GO:0070161; GO:0098700; GO:1900242 chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:inorganic phosphate symporter activity [GO:0015319]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857] VGLVSALPHLVMTIIVPIGGQIADFLRSR 0.95701 0.67584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00352 AL1A1_HUMAN "Aldehyde dehydrogenase 1A1, EC 1.2.1.19, EC 1.2.1.28, EC 1.2.1.3, EC 1.2.1.36 (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1, RALDH 1, RalDH1)" ALDH1A1 ALDC ALDH1 PUMB1 Homo sapiens (Human) cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; 3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758]; cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] GO:0001523; GO:0001758; GO:0004029; GO:0005096; GO:0005497; GO:0005737; GO:0005829; GO:0006081; GO:0009449; GO:0018479; GO:0019145; GO:0030392; GO:0030424; GO:0036438; GO:0042572; GO:0043878; GO:0045202; GO:0051287; GO:0070062; GO:0106373; GO:0110095; GO:0120163 3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758] IQYTKIFINNEWHDSVSGKK 0.95704 0.66586 0 0 0 0 0 0 0 0 0 0 0 0 14.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8302 0 0 0 0 0 0 13.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3654 0 0 0 0 0 0 0 0 0 12.7828 0 0 0 0 0 0 0 0 0 0 0 0 P61981 1433G_HUMAN "14-3-3 protein gamma (Protein kinase C inhibitor protein 1, KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed ]" YWHAG Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; negative regulation of protein kinase activity [GO:0006469]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of neuron differentiation [GO:0045664]; regulation of signal transduction [GO:0009966]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; presynapse [GO:0098793] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; negative regulation of protein kinase activity [GO:0006469]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of neuron differentiation [GO:0045664]; regulation of signal transduction [GO:0009966]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165] GO:0003723; GO:0005080; GO:0005159; GO:0005737; GO:0005829; GO:0005925; GO:0006469; GO:0006605; GO:0007165; GO:0008104; GO:0008426; GO:0009966; GO:0016020; GO:0019904; GO:0030971; GO:0032869; GO:0042802; GO:0045664; GO:0048167; GO:0070062; GO:0098793 identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723] DNLTLWTSDQQDDDGGEGNN 0.95704 0.4173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69033 0 13.124 0 0 13.6116 0 13.4134 0 0 0 0 0 0 13.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6515 0 0 0 0 0 0 0 0 0 0 P15086 CBPB1_HUMAN "Carboxypeptidase B, EC 3.4.17.2 (Pancreas-specific protein, PASP)" CPB1 CPB PCPB Homo sapiens (Human) proteolysis [GO:0006508] cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615] cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0004180; GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0031410 carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] AIYLLKVGKAGQNK 0.95705 0.7051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55055 NR1H2_HUMAN Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor) NR1H2 LXRB NER UNR Homo sapiens (Human) "cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of gene expression [GO:0010628]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; positive regulation of lipid storage [GO:0010884]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of secretion of lysosomal enzymes [GO:0090340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to nutrient levels [GO:0031667]; retinoic acid receptor signaling pathway [GO:0048384]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; apolipoprotein A-I receptor binding [GO:0034191]; ATPase binding [GO:0051117]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of gene expression [GO:0010628]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; positive regulation of lipid storage [GO:0010884]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of secretion of lysosomal enzymes [GO:0090340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to nutrient levels [GO:0031667]; retinoic acid receptor signaling pathway [GO:0048384]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010628; GO:0010629; GO:0010745; GO:0010867; GO:0010875; GO:0010884; GO:0010887; GO:0030154; GO:0031490; GO:0031667; GO:0032369; GO:0032376; GO:0034191; GO:0036151; GO:0042632; GO:0045723; GO:0045861; GO:0045892; GO:0045893; GO:0045944; GO:0046965; GO:0048384; GO:0048550; GO:0051006; GO:0051117; GO:0051247; GO:0060336; GO:0090108; GO:0090187; GO:0090340; GO:0090575; GO:0120163; GO:1902895; GO:1903573 "apolipoprotein A-I receptor binding [GO:0034191]; ATPase binding [GO:0051117]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" RPQDQLRFPR 0.95708 0.57261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15273 TELT_HUMAN Telethonin (Titin cap protein) TCAP Homo sapiens (Human) adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of mechanical stimulus [GO:0050982]; detection of muscle stretch [GO:0035995]; otic vesicle formation [GO:0030916]; protein-containing complex assembly [GO:0065003]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756] cytosol [GO:0005829]; I band [GO:0031674]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] cytosol [GO:0005829]; I band [GO:0031674]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]; BMP binding [GO:0036122]; FATZ binding [GO:0051373]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325]; adult heart development [GO:0007512]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of mechanical stimulus [GO:0050982]; detection of muscle stretch [GO:0035995]; otic vesicle formation [GO:0030916]; protein-containing complex assembly [GO:0065003]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756] GO:0001756; GO:0003009; GO:0003300; GO:0005829; GO:0007512; GO:0008307; GO:0014898; GO:0030018; GO:0030240; GO:0030241; GO:0030674; GO:0030916; GO:0031432; GO:0031674; GO:0035994; GO:0035995; GO:0036122; GO:0044325; GO:0045214; GO:0048769; GO:0050982; GO:0051373; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0065003; GO:0070080; GO:1990733 BMP binding [GO:0036122]; FATZ binding [GO:0051373]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325] GLQEYQLPYQR 0.95709 0.57148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGR8 OR1L8_HUMAN Olfactory receptor 1L8 (Olfactory receptor OR9-24) OR1L8 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ILTTVLKIPSTSGK 0.9571 0.67741 0 0 0 0 0 0 0 0 0 0 12.0681 0 12.0686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.038 0 0 0 0 0 11.0902 0 0 12.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7699 0 0 0 0 0 0 0 17.4838 0 0 0 0 0 0 15.8504 0 0 0 0 15.8538 0 0 0 15.0081 0 0 0 11.7396 15.9226 0 0 0 16.7395 15.8018 16.0411 0 0 14.6576 0 0 0 15.3465 15.7383 0 0 15.5017 0 0 0 0 0 0 0 0 0 0 0 14.4278 0 0 0 0 0 16.0017 0 15.3379 0 15.8877 0 0 15.6154 0 0 0 0 11.5517 0 14.722 0 0 13.6276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5309 15.3902 0 14.4986 0 0 0 0 0 O14830 PPE2_HUMAN "Serine/threonine-protein phosphatase with EF-hands 2, PPEF-2, EC 3.1.3.16" PPEF2 Homo sapiens (Human) detection of stimulus involved in sensory perception [GO:0050906]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; protein dephosphorylation [GO:0006470]; regulation of JUN kinase activity [GO:0043506]; regulation of MAP kinase activity [GO:0043405]; visual perception [GO:0007601] cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; protein dephosphorylation [GO:0006470]; regulation of JUN kinase activity [GO:0043506]; regulation of MAP kinase activity [GO:0043405]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0007601; GO:0010801; GO:0017018; GO:0030145; GO:0030544; GO:0031435; GO:0043405; GO:0043409; GO:0043506; GO:0050906; GO:0051879 calcium ion binding [GO:0005509]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] AAALIQRWYRR 0.95712 0.67688 14.7225 0 0 14.6778 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8989 0 0 0 0 0 0 0 0 0 0 13.0687 0 0 0 0 0 0 0 0 12.7234 0 0 0 0 0 0 0 0 13.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4483 0 0 13.2436 0 0 0 13.0592 0 0 0 0 14.944 0 0 0 0 0 0 0 0 0 9.79933 0 0 0 0 0 0 0 0 0 0 0 0 13.645 0 0 12.4452 0 0 0 0 11.4246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.973 13.0372 14.2662 0 0 0 0 0 0 0 0 0 0 11.8513 0 0 0 12.765 0 0 0 0 12.5028 0 0 0 0 0 0 0 0 0 0 0 0 O43264 ZW10_HUMAN Centromere/kinetochore protein zw10 homolog ZW10 Homo sapiens (Human) "cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] "cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; centromeric DNA binding [GO:0019237]; cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0065003; GO:0070939; GO:1990423 centromeric DNA binding [GO:0019237] EDLGTRISR 0.95712 0.71239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1422 0 15.8743 15.4624 0 12.9706 0 17.5897 16.977 18.0922 0 14.2907 0 0 0 0 14.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8974 0 0 0 0 Q96LI5 CNO6L_HUMAN "CCR4-NOT transcription complex subunit 6-like, EC 3.1.13.4 (Carbon catabolite repressor protein 4 homolog B)" CNOT6L CCR4B Homo sapiens (Human) gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] GO:0000175; GO:0000289; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008284; GO:0010606; GO:0030014; GO:0031047; GO:0046872 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535] IYTIMSAEEVANGK 0.95715 0.40251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5783 0 0 0 0 0 Q2L4Q9 PRS53_HUMAN "Serine protease 53, EC 3.4.21.- (Polyserine protease 3, Polyserase-3)" PRSS53 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508 serine-type endopeptidase activity [GO:0004252] GWVLGRARPGAGISSLQTVPVTLLGPR 0.95718 0.61804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EZ4 MYEOV_HUMAN Myeloma-overexpressed gene protein (Oncogene in multiple myeloma) MYEOV OCIM Homo sapiens (Human) HPTPHCSTWGLPLR 0.95719 0.44915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15178 TBXT_HUMAN T-box transcription factor T (Brachyury protein) (Protein T) TBXT T Homo sapiens (Human) "anterior/posterior axis specification, embryo [GO:0008595]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior axis specification, embryo [GO:0008595]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell fate specification [GO:0001708]; heart morphogenesis [GO:0003007]; mesoderm development [GO:0007498]; mesoderm formation [GO:0001707]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001707; GO:0001708; GO:0001756; GO:0003007; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007165; GO:0007498; GO:0008595; GO:0043433; GO:0045944; GO:0060379; GO:0061629; GO:0090009; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" IKYNPFAKAFLDAK 0.95722 0.69739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30531 SC6A1_HUMAN "Sodium- and chloride-dependent GABA transporter 1, GAT-1 (Solute carrier family 6 member 1)" SLC6A1 GABATR GABT1 GAT1 Homo sapiens (Human) "associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]" anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] "anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; response to calcium ion [GO:0051592]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; response to purine-containing compound [GO:0014074]; response to sucrose [GO:0009744]; response to toxic substance [GO:0009636]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104]" GO:0005332; GO:0005886; GO:0005887; GO:0007268; GO:0007613; GO:0008306; GO:0009636; GO:0009744; GO:0009986; GO:0010035; GO:0010288; GO:0014054; GO:0014074; GO:0015185; GO:0015378; GO:0016020; GO:0016021; GO:0030424; GO:0032229; GO:0032355; GO:0035725; GO:0042220; GO:0042802; GO:0043005; GO:0043025; GO:0046872; GO:0050808; GO:0051592; GO:0051936; GO:0051939; GO:0070161; GO:0098658; GO:0098719; GO:0098982; GO:0099055; GO:0099056; GO:0150104; GO:1902476 gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378] CFSNYSMVNTTNMTSAVVEFWER 0.95722 0.41743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2786 0 12.7749 0 14.108 0 0 0 12.9736 0 0 0 12.2437 12.7716 12.2464 0 0 0 0 0 12.9357 0 0 0 0 0 12.431 0 0 0 0 13.1902 0 0 0 0 0 0 0 0 0 0 0 12.7276 0 0 13.2305 0 0 0 0 0 0 12.6776 0 0 0 0 0 0 0 0 0 0 13.168 0 0 0 12.7796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.182 0 0 0 0 12.7929 0 0 0 0 0 12.3904 O14558 HSPB6_HUMAN "Heat shock protein beta-6, HspB6 (Heat shock 20 kDa-like protein p20)" HSPB6 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; protein refolding [GO:0042026]; response to heat [GO:0009408] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; protein refolding [GO:0042026]; response to heat [GO:0009408] GO:0005212; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0009408; GO:0042026; GO:0042803; GO:0043066; GO:0045766; GO:0051082; GO:0051087; GO:0061077 chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; unfolded protein binding [GO:0051082] RASAPLPGLSAPGR 0.95723 0.70532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0C4DH32 HV320_HUMAN Immunoglobulin heavy variable 3-20 IGHV3-20 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] QAPGKGLEWVSGINWNGGSTGYADSVK 0.95724 0.69739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9533 0 0 0 0 0 0 0 0 0 0 0 10.2505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SZI1 LRAD2_HUMAN Low-density lipoprotein receptor class A domain-containing protein 2 LDLRAD2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CIPSSLVCDPWGMDNCGDGSDQGSWSPADCR 0.95724 0.66626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MT66 YU005_HUMAN Putative uncharacterized protein ENSP00000383407 Homo sapiens (Human) FMSENKIFEGK 0.95725 0.66609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7244 0 0 0 0 0 14.8216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZP4 PITH1_HUMAN PITH domain-containing protein 1 PITHD1 C1orf128 AD039 HT014 PP603 Homo sapiens (Human) "penetration of cumulus oophorus [GO:0061956]; penetration of zona pellucida [GO:0007341]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm cytoplasmic droplet [GO:0097598]; penetration of cumulus oophorus [GO:0061956]; penetration of zona pellucida [GO:0007341]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]" GO:0005634; GO:0005737; GO:0007286; GO:0007341; GO:0045654; GO:0045893; GO:0061136; GO:0061956; GO:0097598 VFYIGLRGEWTELR 0.95725 0.67483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B9A064 IGLL5_HUMAN Immunoglobulin lambda-like polypeptide 5 (G lambda-1) (Germline immunoglobulin lambda 1) IGLL5 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0070062 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] LLLQPSPQR 0.95726 0.41532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6628 14.5302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9661 0 0 0 0 0 0 0 0 0 0 0 13.7957 0 0 0 13.6731 0 0 0 14.5201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBK9 UXT_HUMAN "Protein UXT (Androgen receptor trapped clone 27 protein, ART-27) (Ubiquitously expressed transcript protein)" UXT HSPC024 Homo sapiens (Human) apoptotic process [GO:0006915]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; spindle pole [GO:0000922] centrosome [GO:0005813]; chaperone complex [GO:0101031]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; spindle pole [GO:0000922]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0000226; GO:0000785; GO:0000922; GO:0003682; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005856; GO:0006357; GO:0006915; GO:0007098; GO:0008017; GO:0047497; GO:0048487; GO:0050821; GO:0101031; GO:1990062 beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] KSSLLTELSNSLTK 0.95726 0.70532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06055 AT5G2_HUMAN "ATP synthase F(0) complex subunit C2, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase membrane subunit c locus 2) (ATP synthase proteolipid P2) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C2) (ATPase protein 9) (ATPase subunit c)" ATP5MC2 ATP5G2 PSEC0033 Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; lipid binding [GO:0008289]; proton transmembrane transporter activity [GO:0015078]; proton motive force-driven ATP synthesis [GO:0015986]" GO:0000276; GO:0005741; GO:0005743; GO:0005753; GO:0008289; GO:0015078; GO:0015986; GO:0016021; GO:0045263 lipid binding [GO:0008289]; proton transmembrane transporter activity [GO:0015078] FVSTPSLVKSTSQLLSRPLSAVVLK 0.95727 0.70513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.442 0 0 0 0 0 0 0 0 0 14.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15293 RCN1_HUMAN Reticulocalbin-1 RCN1 RCN Homo sapiens (Human) camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701] GO:0001701; GO:0005509; GO:0005783; GO:0005788; GO:0043010 calcium ion binding [GO:0005509] EEFTAFLHPEEFEHMK 0.95727 0.57288 0 0 0 13.2475 0 0 0 0 0 0 0 12.5826 0 13.5886 0 0 0 0 12.1134 11.3779 14.2261 0 0 10.983 0 0 0 0 15.4806 12.586 13.735 0 0 0 12.3252 0 12.7832 13.0572 13.4771 0 0 0 0 14.1686 12.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2211 0 0 0 0 12.3425 13.6131 0 14.599 0 15.6902 0 11.2507 12.108 0 15.3328 16.0724 15.3855 16.3015 14.2315 15.5115 16.25 15.7668 0 14.9462 13.7902 14.0588 16.5235 14.9891 0 13.6072 16.1048 0 0 16.6711 13.9575 13.5079 0 13.6755 0 12.9314 0 0 0 11.6427 0 14.4434 0 10.9569 11.5578 0 15.3734 12.6806 0 14.6345 12.6692 14.728 0 11.3779 12.1145 16.6507 12.7428 12.392 14.5268 14.3152 16.7118 0 16.2194 15.1452 0 0 15.4197 13.5274 13.6936 15.1487 12.4409 13.7258 0 13.6177 0 15.1917 0 0 13.1927 15.1883 0 0 16.3899 11.9056 0 12.4988 0 11.0309 11.3315 0 12.4707 0 0 13.3871 13.5159 0 0 0 0 0 16.7352 0 0 0 0 0 0 15.2147 13.2192 P17181 INAR1_HUMAN "Interferon alpha/beta receptor 1, IFN-R-1, IFN-alpha/beta receptor 1 (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1, CRF2-1) (Type I interferon receptor 1)" IFNAR1 IFNAR Homo sapiens (Human) cellular response to interferon-alpha [GO:0035457]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cellular respiration [GO:1901857]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]; cellular response to interferon-alpha [GO:0035457]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cellular respiration [GO:1901857]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] GO:0004896; GO:0004905; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0007259; GO:0009615; GO:0019221; GO:0019962; GO:0032496; GO:0035457; GO:0060337; GO:0098586; GO:1901857 cytokine receptor activity [GO:0004896]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905] NPGNHLYKWK 0.95729 0.57148 0 0 0 0 0 0 0 0 12.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.208 0 0 0 0 0 0 12.0763 0 0 0 0 0 0 0 14.6788 0 0 0 0 14.0294 0 0 0 0 0 0 0 0 13.6315 0 0 0 0 0 0 0 13.8281 0 0 0 11.7969 0 0 12.2682 0 0 0 12.9401 0 13.3197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8321 0 0 0 0 0 0 0 0 0 0 14.7879 0 Q9UMX3 BOK_HUMAN "Bcl-2-related ovarian killer protein, hBOK (Bcl-2-like protein 9, Bcl2-L-9)" BOK BCL2L9 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836] cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein complex oligomerization [GO:0051259]; regulation of autophagy [GO:0010506]; regulation of chorionic trophoblast cell proliferation [GO:1901382]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of granulosa cell apoptotic process [GO:1904708]; release of cytochrome c from mitochondria [GO:0001836] GO:0001836; GO:0005102; GO:0005634; GO:0005640; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0006915; GO:0006919; GO:0006921; GO:0007420; GO:0008584; GO:0008630; GO:0008635; GO:0010506; GO:0016020; GO:0016021; GO:0031625; GO:0031901; GO:0031966; GO:0032588; GO:0033106; GO:0042803; GO:0043065; GO:0043524; GO:0044877; GO:0046982; GO:0048709; GO:0051259; GO:0051400; GO:0051402; GO:0051480; GO:0051902; GO:0055038; GO:0060546; GO:0072332; GO:0097192; GO:1900119; GO:1901029; GO:1901030; GO:1901382; GO:1902237; GO:1903899; GO:1904708; GO:2001244 BH domain binding [GO:0051400]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625] ELVAQAKALGR 0.95729 0.70456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49682 CXCR3_HUMAN "C-X-C chemokine receptor type 3, CXC-R3, CXCR-3 (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor, IP-10 receptor) (CD antigen CD183)" CXCR3 GPR9 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of leukocyte migration [GO:0002685] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine binding [GO:0019958]; C-X-C chemokine receptor activity [GO:0016494]; chemokine binding [GO:0019956]; chemokine receptor activity [GO:0004950]; signaling receptor activity [GO:0038023]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell adhesion [GO:0030155]; regulation of leukocyte migration [GO:0002685] GO:0001525; GO:0001937; GO:0002685; GO:0004950; GO:0005737; GO:0005886; GO:0005887; GO:0006915; GO:0006935; GO:0006954; GO:0006955; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0007204; GO:0008284; GO:0009897; GO:0016493; GO:0016494; GO:0016525; GO:0019722; GO:0019956; GO:0019957; GO:0019958; GO:0030155; GO:0038023; GO:0045766; GO:0045944; GO:0050921; GO:0051281; GO:0060326; GO:1900118; GO:1900119 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine binding [GO:0019958]; C-X-C chemokine receptor activity [GO:0016494]; chemokine binding [GO:0019956]; chemokine receptor activity [GO:0004950]; signaling receptor activity [GO:0038023] DSSWSETSEASYSGL 0.9573 0.70379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PEX3 KR261_HUMAN Keratin-associated protein 26-1 KRTAP26-1 KAP26.1 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 MSCPNYCSGNSNSGSLR 0.95731 0.67802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N668 COMD1_HUMAN COMM domain-containing protein 1 (Protein Murr1) COMMD1 C2orf5 MURR1 Homo sapiens (Human) copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037] "Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]; copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]" GO:0005507; GO:0005546; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006289; GO:0006893; GO:0010008; GO:0015031; GO:0019871; GO:0031398; GO:0031462; GO:0032088; GO:0032434; GO:0042802; GO:0042803; GO:0043325; GO:0048227; GO:0055037; GO:0055070; GO:0070300; GO:0080025; GO:1902306; GO:2000009 "copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]" PFLAKMRGILK 0.95731 0.62066 0 0 12.8224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0018 0 13.2054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0181 0 0 0 13.5376 13.2981 13.3757 0 0 0 0 0 0 0 0 0 0 0 13.0533 13.8028 0 0 13.1274 0 0 0 0 0 14.0026 0 0 0 0 0 0 0 13.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4842 0 0 0 Q8N8S7 ENAH_HUMAN Protein enabled homolog ENAH MENA Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411] cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411] GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030054; GO:0030175; GO:0045202; GO:0050699; GO:0070358 actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699] PLTGLAAAIAGAKLRK 0.95732 0.70228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4678 0 0 0 0 0 0 0 0 Q6UXG3 CLM9_HUMAN "CMRF35-like molecule 9, CLM-9 (CD300 antigen-like family member G) (Triggering receptor expressed on myeloid cells 4, TREM-4) (CD antigen CD300g)" CD300LG CLM9 TREM4 UNQ422/PRO846 Homo sapiens (Human) immune system process [GO:0002376] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; immune system process [GO:0002376] GO:0002376; GO:0004888; GO:0005886; GO:0016021; GO:0016323; GO:0016324; GO:0032585 transmembrane signaling receptor activity [GO:0004888] GRVSIRDSR 0.95733 0.67706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXE9 VN1R3_HUMAN Vomeronasal type-1 receptor 3 (V1r-like receptor 3) VN1R3 V1RL3 FKSG46 Homo sapiens (Human) response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pheromone receptor activity [GO:0016503]; response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] GO:0005886; GO:0007606; GO:0016021; GO:0016503; GO:0019236 pheromone receptor activity [GO:0016503] SFILVLCWILNTLVNITVLLHVTGK 0.95734 0.56959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4185 11.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4239 0 0 0 0 0 0 O75871 CEAM4_HUMAN "Carcinoembryonic antigen-related cell adhesion molecule 4, CEA cell adhesion molecule 4 (Carcinoembryonic antigen CGM7) (Non-specific cross-reacting antigen W236)" CEACAM4 CGM7 Homo sapiens (Human) phagocytosis [GO:0006909]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; phagocytosis [GO:0006909]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] GO:0002682; GO:0005886; GO:0005887; GO:0006909; GO:0007165; GO:0009986; GO:0016020; GO:1990782 protein tyrosine kinase binding [GO:1990782] ETVYPNGSLLFQNITLEDAGSYTLR 0.95735 0.56959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5K8 VATD_HUMAN "V-type proton ATPase subunit D, V-ATPase subunit D (V-ATPase 28 kDa accessory protein) (Vacuolar proton pump subunit D)" ATP6V1D ATP6M VATD Homo sapiens (Human) cilium assembly [GO:0060271]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; protein localization to cilium [GO:0061512]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "cilium [GO:0005929]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; specific granule membrane [GO:0035579]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "cilium [GO:0005929]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; specific granule membrane [GO:0035579]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cilium assembly [GO:0060271]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; protein localization to cilium [GO:0061512]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" GO:0000139; GO:0000221; GO:0005765; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0030665; GO:0033176; GO:0035579; GO:0046961; GO:0048388; GO:0051452; GO:0060271; GO:0061512; GO:0061795; GO:0070062; GO:1902600 "proton-transporting ATPase activity, rotational mechanism [GO:0046961]" ITNRRVNAIEHVIIPR 0.95735 0.70077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9554 0 0 15.0809 0 0 0 0 15.2714 0 0 0 0 0 0 0 0 12.6076 0 0 0 0 0 13.5438 0 0 0 0 0 0 0 0 16.3248 0 0 14.4985 0 0 0 0 0 0 0 0 0 0 0 0 14.6689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0222 0 0 0 0 0 0 0 0 0 0 0 14.4457 0 0 0 0 0 0 0 0 0 0 0 16.3802 0 0 0 0 0 0 0 0 0 0 0 Q8N129 CNPY4_HUMAN Protein canopy homolog 4 CNPY4 PSEC0237 UNQ1909/PRO4354 Homo sapiens (Human) positive regulation of protein localization to plasma membrane [GO:1903078] extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; positive regulation of protein localization to plasma membrane [GO:1903078] GO:0005102; GO:0005576; GO:1903078 signaling receptor binding [GO:0005102] EVLELGQVLDTGKRK 0.95736 0.40186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3112 0 0 0 0 0 0 0 0 0 0 0 Q6S5L8 SHC4_HUMAN "SHC-transforming protein 4 (Rai-like protein, RaLP) (SHC-transforming protein D, hShcD) (Src homology 2 domain-containing-transforming protein C4, SH2 domain protein C4)" SHC4 SHCD UNQ6438/PRO21364 Homo sapiens (Human) apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of cell population proliferation [GO:0008284]; regulation of gene expression [GO:0010468]; stem cell differentiation [GO:0048863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] anchoring junction [GO:0070161]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of cell population proliferation [GO:0008284]; regulation of gene expression [GO:0010468]; stem cell differentiation [GO:0048863]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005886; GO:0006915; GO:0007169; GO:0008284; GO:0010468; GO:0019901; GO:0019904; GO:0030971; GO:0035556; GO:0045211; GO:0048863; GO:0070161 protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] HLLLVDPEGKVR 0.95737 0.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1KXE4 F168B_HUMAN "Myelin-associated neurite-outgrowth inhibitor, Mani (p20)" FAM168B KIAA0280L MANI Homo sapiens (Human) axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] axon [GO:0030424]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] GO:0005886; GO:0016021; GO:0030424; GO:0048471; GO:0070062 APGTPTYSYVPPQW 0.95738 0.44915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9406 0 0 0 0 0 0 12.6025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09455 RET1_HUMAN "Retinol-binding protein 1 (Cellular retinol-binding protein, CRBP) (Cellular retinol-binding protein I, CRBP-I)" RBP1 CRBP1 Homo sapiens (Human) fatty acid transport [GO:0015908]; lipid homeostasis [GO:0055088]; retinoic acid biosynthetic process [GO:0002138]; vitamin A metabolic process [GO:0006776] cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; all-trans-retinol binding [GO:1904768]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; fatty acid transport [GO:0015908]; lipid homeostasis [GO:0055088]; retinoic acid biosynthetic process [GO:0002138]; vitamin A metabolic process [GO:0006776] GO:0002138; GO:0005501; GO:0005504; GO:0005634; GO:0005654; GO:0005811; GO:0005829; GO:0006776; GO:0015908; GO:0016918; GO:0055088; GO:1904768 all-trans-retinol binding [GO:1904768]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoid binding [GO:0005501] ALDVNVALRKIANLLK 0.95738 0.61845 0 0 0 0 0 0 0 0 12.5534 12.5853 0 0 0 0 0 0 0 0 9.88137 0 0 0 0 0 0 0 0 0 0 9.90724 0 0 11.2964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2894 0 11.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5819 0 0 11.0633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.765 11.7471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2015 0 0 11.7421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN79 SOX13_HUMAN Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12) SOX13 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; gamma-delta T cell differentiation [GO:0042492]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell fate commitment [GO:0045165]; gamma-delta T cell differentiation [GO:0042492]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001217; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0009653; GO:0021529; GO:0042492; GO:0042802; GO:0043565; GO:0045165; GO:0045588; GO:0045892; GO:0090090; GO:0090336 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" EEGEGTDDRHSVADGEMYRYSEDEDSEGEEK 0.9574 0.41745 10.37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6369 0 0 0 11.6258 0 0 11.8752 0 0 0 0 0 0 11.6139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9633 0 0 0 0 0 0 0 0 12.5878 12.417 12.6667 0 0 0 12.5173 0 0 0 0 0 0 0 16.7321 0 0 0 0 0 0 12.4397 0 0 0 12.7875 0 0 0 0 0 0 12.6361 0 0 0 0 0 12.9421 0 0 0 0 0 0 0 0 0 0 0 0 12.679 0 13.5803 0 0 0 0 0 0 0 0 0 0 0 13.2259 12.8897 0 13.2241 12.8734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WK9 PAQR7_HUMAN "Membrane progestin receptor alpha, mPR alpha (Membrane progesterone P4 receptor alpha) (Membrane progesterone receptor alpha) (Progesterone and adipoQ receptor family member 7) (Progestin and adipoQ receptor family member 7) (Progestin and adipoQ receptor family member VII)" PAQR7 MRPA Homo sapiens (Human) oogenesis [GO:0048477]; response to steroid hormone [GO:0048545] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nuclear steroid receptor activity [GO:0003707]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545] GO:0003707; GO:0005496; GO:0005886; GO:0016021; GO:0038023; GO:0048477; GO:0048545 nuclear steroid receptor activity [GO:0003707]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496] LSHLLPSLRQVIQEPQLSLQPEPVFTVDR 0.95742 0.67584 0 0 0 0 0 0 0 0 0 0 0 11.6549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5872 0 0 0 11.6161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4007 0 0 0 0 0 0 0 0 0 0 12.6513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BT43 RPC7L_HUMAN "DNA-directed RNA polymerase III subunit RPC7-like, RNA polymerase III subunit C7-like (DNA-directed RNA polymerase III subunit G-like) (RNA polymerase III 32 kDa beta subunit, RPC32-beta)" POLR3GL Homo sapiens (Human) transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; transcription by RNA polymerase III [GO:0006383] GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006383 EEEVTSEEDEEK 0.95743 0.40758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9959 0 0 0 0 0 0 0 0 0 0 P04141 CSF2_HUMAN "Granulocyte-macrophage colony-stimulating factor, GM-CSF (Colony-stimulating factor, CSF) (Molgramostin) (Sargramostim)" CSF2 GMCSF Homo sapiens (Human) "cell population proliferation [GO:0008283]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; embryonic placenta development [GO:0001892]; epithelial fluid transport [GO:0042045]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; histamine secretion [GO:0001821]; immune response [GO:0006955]; macrophage activation [GO:0042116]; macrophage differentiation [GO:0030225]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to fluid shear stress [GO:0034405]; response to silicon dioxide [GO:0034021]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; granulocyte macrophage colony-stimulating factor receptor binding [GO:0005129]; growth factor activity [GO:0008083]; cell population proliferation [GO:0008283]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; embryonic placenta development [GO:0001892]; epithelial fluid transport [GO:0042045]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; histamine secretion [GO:0001821]; immune response [GO:0006955]; macrophage activation [GO:0042116]; macrophage differentiation [GO:0030225]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to fluid shear stress [GO:0034405]; response to silicon dioxide [GO:0034021]" GO:0001821; GO:0001892; GO:0005125; GO:0005129; GO:0005576; GO:0005615; GO:0005886; GO:0006468; GO:0006955; GO:0007259; GO:0008083; GO:0008283; GO:0008284; GO:0010628; GO:0010744; GO:0030099; GO:0030223; GO:0030224; GO:0030225; GO:0030526; GO:0032747; GO:0034021; GO:0034405; GO:0038157; GO:0042045; GO:0042116; GO:0042531; GO:0043011; GO:0043231; GO:0045187; GO:0045892; GO:0070665; GO:0071222; GO:0071803; GO:0097011; GO:0097028; GO:2001240 cytokine activity [GO:0005125]; granulocyte macrophage colony-stimulating factor receptor binding [GO:0005129]; growth factor activity [GO:0008083] LELYKQGLRGSLTK 0.95744 0.66627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13535 MYH8_HUMAN "Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal, MyHC-perinatal)" MYH8 Homo sapiens (Human) ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle contraction [GO:0003009] cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; myosin phosphatase activity [GO:0017018]; structural constituent of muscle [GO:0008307]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle contraction [GO:0003009] GO:0000146; GO:0003009; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005859; GO:0006936; GO:0008307; GO:0016460; GO:0016887; GO:0017018; GO:0030017; GO:0030049; GO:0032027; GO:0032982; GO:0046034; GO:0051015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; myosin phosphatase activity [GO:0017018]; structural constituent of muscle [GO:0008307] AFMNVKHWPWMKLFFK 0.95744 0.7063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.583 0 0 0 0 0 0 0 0 0 0 0 10.9109 0 11.6791 0 15.901 0 0 0 13.6213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6662 0 0 16.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9551 0 0 0 0 0 0 10.9841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8127 0 0 0 0 0 0 0 0 P26378 ELAV4_HUMAN "ELAV-like protein 4 (Hu-antigen D, HuD) (Paraneoplastic encephalomyelitis antigen HuD)" ELAVL4 HUD PNEM Homo sapiens (Human) "3'-UTR-mediated mRNA stabilization [GO:0070935]; aging [GO:0007568]; associative learning [GO:0008306]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; locomotory behavior [GO:0007626]; mRNA processing [GO:0006397]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of dendrite development [GO:1900006]; regeneration [GO:0031099]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; polysomal ribosome [GO:0042788] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; perikaryon [GO:0043204]; polysomal ribosome [GO:0042788]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; translation regulator activity [GO:0045182]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; aging [GO:0007568]; associative learning [GO:0008306]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; locomotory behavior [GO:0007626]; mRNA processing [GO:0006397]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of dendrite development [GO:1900006]; regeneration [GO:0031099]; regulation of translation at synapse, modulating synaptic transmission [GO:0099547]; response to cocaine [GO:0042220]; response to endoplasmic reticulum stress [GO:0034976]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" GO:0003730; GO:0005635; GO:0005737; GO:0005829; GO:0005856; GO:0006396; GO:0006397; GO:0007568; GO:0007626; GO:0008143; GO:0008306; GO:0008380; GO:0016020; GO:0021895; GO:0030424; GO:0030425; GO:0030426; GO:0031099; GO:0034976; GO:0035925; GO:0042220; GO:0042788; GO:0043204; GO:0045182; GO:0048813; GO:0070935; GO:0097158; GO:0098978; GO:0099547; GO:1900006; GO:1905870; GO:1990090 mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; translation regulator activity [GO:0045182] LGDRVLQVSFK 0.95745 0.70586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92529 SHC3_HUMAN "SHC-transforming protein 3 (Neuronal Shc, N-Shc) (Protein Rai) (SHC-transforming protein C) (Src homology 2 domain-containing-transforming protein C3, SH2 domain protein C3)" SHC3 NSHC SHCC Homo sapiens (Human) central nervous system development [GO:0007417]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; central nervous system development [GO:0007417]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001784; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007417; GO:0019901; GO:0030971; GO:0035556 phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971] KGRPGDEPLPR 0.95746 0.57316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A2R8Y4Y8 OSP4B_HUMAN Oocyte-secreted protein 4B OOSP4B Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 FPSVMHFGMSGFDAHTLKEIPQK 0.95747 0.40569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CJ1 EAF2_HUMAN ELL-associated factor 2 (Testosterone-regulated apoptosis inducer and tumor suppressor protein) EAF2 TRAITS BM-040 Homo sapiens (Human) "apoptotic process [GO:0006915]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; transcription elongation regulator activity [GO:0003711]; apoptotic process [GO:0006915]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" GO:0003711; GO:0005654; GO:0006915; GO:0008023; GO:0016607; GO:0030308; GO:0032783; GO:0034243; GO:0045893; GO:0045944; GO:0060767; GO:0060770 transcription elongation regulator activity [GO:0003711] AEASLMDQMSSCDSSSDSKSSSSSSSEDSSSDSEDEDCK 0.95748 0.40501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0391 0 0 0 0 0 0 0 0 0 0 0 11.5506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2992 0 18.1157 0 0 0 0 0 13.3794 12.1638 0 0 12.9075 0 0 0 0 0 0 16.2883 16.3906 0 0 0 0 0 0 0 0 0 0 0 0 Q8NI99 ANGL6_HUMAN Angiopoietin-related protein 6 (Angiopoietin-like protein 6) (Angiopoietin-related growth factor) (Angiopoietin-related protein 5) ANGPTL6 AGF ARP5 UNQ152/PRO178 Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; secretory granule [GO:0030141] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154] GO:0001525; GO:0005102; GO:0005615; GO:0030141; GO:0030154; GO:0062023; GO:0070062 signaling receptor binding [GO:0005102] AAMLIRPLKL 0.95749 0.44693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4691 0 0 0 0 0 0 0 0 0 14.9439 0 15.4284 14.3865 0 0 0 0 0 0 0 0 0 14.3261 0 0 0 0 15.3485 0 0 0 0 Q504T8 MIDN_HUMAN Midnolin (Midbrain nucleolar protein) MIDN Homo sapiens (Human) negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; kinase binding [GO:0019900]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676] GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0019900; GO:0033132; GO:0046676 kinase binding [GO:0019900] LQLLLQQKRLR 0.9575 0.67368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JUS6 ADM5_HUMAN Putative adrenomedullin-5-like protein ADM5 C19orf76 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; positive regulation of heart rate [GO:0010460]; regulation of systemic arterial blood pressure [GO:0003073] extracellular space [GO:0005615] extracellular space [GO:0005615]; adrenomedullin receptor binding [GO:0031700]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; positive regulation of heart rate [GO:0010460]; regulation of systemic arterial blood pressure [GO:0003073] GO:0003073; GO:0005615; GO:0007189; GO:0010460; GO:0031700; GO:1990410 adrenomedullin receptor binding [GO:0031700] MTIHILILLLLLAFSAQGDLDTAAR 0.95752 0.56959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9845 0 0 0 0 11.7899 0 0 0 0 0 0 0 0 11.7095 0 0 0 0 11.9237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.782 0 11.6394 0 0 0 11.6528 0 0 12.1719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW50 F219A_HUMAN Protein FAM219A FAM219A C9orf25 Homo sapiens (Human) PLVALDTDSDDDFDMSR 0.95752 0.67802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A37 RN166_HUMAN "E3 ubiquitin-protein ligase RNF166, EC 2.3.2.27 (RING finger protein 166) (RING-type E3 ubiquitin transferase RNF166)" RNF166 Homo sapiens (Human) autophagy [GO:0006914]; innate immune response [GO:0045087]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; autophagy [GO:0006914]; innate immune response [GO:0045087]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0005737; GO:0006511; GO:0006914; GO:0045087; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] SANFLQHLLHRHK 0.95753 0.7024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DOX3 IGD_HUMAN Immunoglobulin delta heavy chain (Immunoglobulin delta heavy chain WAH) Homo sapiens (Human) adaptive immune response [GO:0002250]; monocyte activation [GO:0042117]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; monocyte activation [GO:0042117]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760] GO:0002250; GO:0005615; GO:0005886; GO:0019814; GO:0032731; GO:0032732; GO:0032760; GO:0042117 SMSAADTAMYYCAR 0.95755 0.44915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13555 KCC2G_HUMAN "Calcium/calmodulin-dependent protein kinase type II subunit gamma, CaM kinase II subunit gamma, CaMK-II subunit gamma, EC 2.7.11.17" CAMK2G CAMK CAMK-II CAMKG Homo sapiens (Human) cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of calcium ion transport [GO:0051924]; regulation of neuron projection development [GO:0010975]; regulation of skeletal muscle adaptation [GO:0014733] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of calcium ion transport [GO:0051924]; regulation of neuron projection development [GO:0010975]; regulation of skeletal muscle adaptation [GO:0014733] GO:0004683; GO:0004723; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005954; GO:0006468; GO:0007399; GO:0010975; GO:0014733; GO:0016020; GO:0030073; GO:0030154; GO:0030666; GO:0033017; GO:0042802; GO:0042803; GO:0043005; GO:0051924; GO:0106310 ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310] CKGAAVK 0.95755 0.70143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5933 0 0 0 0 0 0 0 0 0 12.5322 0 0 0 0 0 0 0 0 0 0 0 0 13.2591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBF9 MYOTI_HUMAN Myotilin (57 kDa cytoskeletal protein) (Myofibrillar titin-like Ig domains protein) (Titin immunoglobulin domain protein) MYOT TTID Homo sapiens (Human) homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; muscle contraction [GO:0006936]; synapse organization [GO:0050808] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; axon guidance receptor activity [GO:0008046]; structural constituent of muscle [GO:0008307]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; muscle contraction [GO:0006936]; synapse organization [GO:0050808] GO:0003779; GO:0005886; GO:0006936; GO:0007156; GO:0008046; GO:0008307; GO:0015629; GO:0030018; GO:0030424; GO:0042383; GO:0043025; GO:0050808; GO:0051393 actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; axon guidance receptor activity [GO:0008046]; structural constituent of muscle [GO:0008307] MIVSEKGLHSLIFEVVR 0.95755 0.58087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75427 LRCH4_HUMAN "Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4, Leucine-rich neuronal protein)" LRCH4 LRN LRRN1 LRRN4 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]" cytoplasm [GO:0005737]; PML body [GO:0016605] "cytoplasm [GO:0005737]; PML body [GO:0016605]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]" GO:0005737; GO:0007399; GO:0016605; GO:0045892 EEPAGEER 0.95756 0.5801 0 0 0 0 0 0 0 0 0 0 0 13.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4062 0 0 0 12.2054 0 0 0 0 0 11.0829 0 0 0 11.4526 0 0 0 0 0 0 0 11.4354 0 0 0 0 10.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCZ2 C99L2_HUMAN CD99 antigen-like protein 2 (MIC2-like protein 1) (CD antigen CD99) CD99L2 MIC2L1 UNQ1964/PRO4486 Homo sapiens (Human) cell adhesion [GO:0007155]; diapedesis [GO:0050904]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T cell extravasation [GO:2000409] adherens junction [GO:0005912]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; diapedesis [GO:0050904]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T cell extravasation [GO:2000409] GO:0005886; GO:0005912; GO:0005925; GO:0007155; GO:0009986; GO:0016021; GO:0050904; GO:2000391; GO:2000409 DLEDIVGGGEYK 0.95756 0.70094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.006 0 0 0 0 0 0 0 0 0 0 0 11.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M78 FEAS2_HUMAN Putative uncharacterized protein encoded by FER1L6-AS2 (FER1L6 antisense RNA 2) (FER1L6 antisense gene protein 2) FER1L6-AS2 C8orf78 Homo sapiens (Human) VVLVALDHAGLHTLSSALNESLR 0.95756 0.61916 0 0 0 0 0 0 0 0 11.87 0 0 0 0 0 0 0 0 0 11.2765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.322 0 0 0 0 0 13.1076 0 12.8986 0 0 0 0 12.6993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ40 S52A3_HUMAN "Solute carrier family 52, riboflavin transporter, member 3 (Riboflavin transporter 2, hRFT2)" SLC52A3 C20orf54 RFT2 RFVT3 Homo sapiens (Human) cellular response to heat [GO:0034605]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]; sensory perception of sound [GO:0007605] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; riboflavin transmembrane transporter activity [GO:0032217]; cellular response to heat [GO:0034605]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218]; sensory perception of sound [GO:0007605] GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006771; GO:0007605; GO:0016324; GO:0031965; GO:0032217; GO:0032218; GO:0034605 riboflavin transmembrane transporter activity [GO:0032217] LFSSADFCNLHCPA 0.95756 0.44915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60411 KR109_HUMAN Keratin-associated protein 10-9 (High sulfur keratin-associated protein 10.9) (Keratin-associated protein 10.9) (Keratin-associated protein 18-9) (Keratin-associated protein 18.9) KRTAP10-9 KAP10.9 KAP18-9 KRTAP10.9 KRTAP18-9 KRTAP18.9 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MAASTMSIR 0.95757 0.61909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3291 0 0 0 0 0 0 0 0 0 0 0 0 10.5578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWU5 TCP11_HUMAN T-complex protein 11 homolog TCP11 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; germ cell development [GO:0007281]; protein kinase A signaling [GO:0010737]; regulation of sperm capacitation [GO:1902490]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] GO:0001669; GO:0007165; GO:0007189; GO:0007281; GO:0007283; GO:0010737; GO:0016021; GO:0036126; GO:0097225; GO:1902490 EIKEILLSLLLPR 0.95758 0.41757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7215 0 0 0 0 0 0 0 0 13.6887 0 13.5951 0 0 0 0 0 13.9904 14.1271 0 0 0 0 0 16.9716 0 0 0 12.5073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88771 0 0 0 12.7741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74 0 0 0 0 12.1923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LR2 LURA1_HUMAN Leucine rich adaptor protein 1 (Leucine repeat adapter protein 35A) LURAP1 C1orf190 LRAP35A LRP35A Homo sapiens (Human) positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of signal transduction [GO:0009966] GO:0001819; GO:0005737; GO:0005829; GO:0009966; GO:0043123; GO:0043231 LGFEAHWFWEQCQDDVTFL 0.95758 0.57814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0W8 SMG9_HUMAN Nonsense-mediated mRNA decay factor SMG9 SMG9 C19orf61 Homo sapiens (Human) "brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" cytosol [GO:0005829] "cytosol [GO:0005829]; identical protein binding [GO:0042802]; brain development [GO:0007420]; eye development [GO:0001654]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" GO:0000184; GO:0001654; GO:0001701; GO:0005829; GO:0007420; GO:0007507; GO:0042802 identical protein binding [GO:0042802] DASEETSTSVMQK 0.95758 0.67627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.746 0 0 0 12.2062 0 12.7466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4621 0 0 0 0 0 0 0 0 11.8746 0 0 0 0 0 12.4234 0 0 0 0 0 0 0 12.602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IQ55 TTBK2_HUMAN "Tau-tubulin kinase 2, EC 2.7.11.1" TTBK2 KIAA0847 Homo sapiens (Human) cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; cerebellar granular layer development [GO:0021681]; cerebellar granule cell precursor tangential migration [GO:0021935]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein localization to microtubule [GO:1902817]; peptidyl-serine phosphorylation [GO:0018105]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224] GO:0000226; GO:0004672; GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0007026; GO:0007165; GO:0007224; GO:0018105; GO:0019894; GO:0021549; GO:0021681; GO:0021935; GO:0030334; GO:0035869; GO:0036064; GO:0048156; GO:0050321; GO:0051010; GO:0060271; GO:0106310; GO:1902817; GO:1904527 ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule plus-end binding [GO:0051010]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] AYQPDLVKLLVEKR 0.95759 0.71002 0 0 0 12.0293 11.0606 0 0 0 0 0 12.784 0 0 0 0 0 0 0 0 0 0 12.4369 0 11.8521 0 0 0 0 0 0 0 0 0 0 0 0 10.4471 0 0 0 0 0 0 12.2308 0 0 0 0 0 12.4999 13.379 11.7334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1681 14.2777 14.2859 14.2169 0 0 0 14.6255 0 14.1453 13.9386 14.7481 14.0295 13.7622 13.325 15.5574 16.7233 15.5767 13.2168 15.8306 14.1614 15.8899 14.7307 14.7705 14.264 15.5625 16.188 14.5993 17.1247 16.0979 0 15.069 14.6766 13.7054 0 12.8756 16.0531 14.1857 14.9097 0 14.7921 14.8448 0 14.9264 14.2795 0 15.7356 15.4924 13.4134 15.2281 16.3181 14.2424 15.7068 16.1729 12.9029 15.2942 0 15.6782 15.4908 0 13.5046 0 12.2197 15.2056 0 12.7432 0 14.5551 13.9215 0 15.1978 15.0532 14.7261 15.8047 14.7673 13.0197 16.123 19.0259 15.5187 0 0 13.5749 15.455 17.9434 10.9851 13.6504 14.6987 16.0763 15.4582 17.0568 15.1688 0 0 14.6365 0 0 0 0 0 0 0 0 0 0 0 12.1088 0 13.7429 15.4869 0 0 0 0 0 A6NGY1 FRG2C_HUMAN Protein FRG2-like-2 (FSHD region gene 2 protein family member C) (HSA3-FRG2) FRG2C Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 ACTGRSK 0.9576 0.67593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4918 12.0766 0 0 0 0 10.9562 0 0 0 0 11.4764 0 0 0 0 0 0 0 0 Q8NGB4 OR4S1_HUMAN Olfactory receptor 4S1 (Olfactory receptor OR11-100) OR4S1 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LIILFNIVMPPLLNPLIYTLR 0.9576 0.7091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99873 ANM1_HUMAN "Protein arginine N-methyltransferase 1, EC 2.1.1.319 (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4)" PRMT1 HMT2 HRMT1L2 IR1B4 Homo sapiens (Human) cardiac muscle tissue development [GO:0048738]; cell surface receptor signaling pathway [GO:0007166]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of JNK cascade [GO:0046329]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380]; viral protein processing [GO:0019082] cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047]; cardiac muscle tissue development [GO:0048738]; cell surface receptor signaling pathway [GO:0007166]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of JNK cascade [GO:0046329]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380]; viral protein processing [GO:0019082] GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0007166; GO:0008168; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0008380; GO:0016274; GO:0016571; GO:0018216; GO:0019082; GO:0019899; GO:0031175; GO:0034709; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0043985; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0046329; GO:0046985; GO:0048273; GO:0048738; GO:0051260; GO:1900745; GO:1904047 enzyme binding [GO:0019899]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047] ANKLDHVVTIIKGK 0.9576 2.8378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9062 12.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.226 12.2801 0 0 14.2037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0506 0 0 A0A0G2JMD5 PRA33_HUMAN PRAME family member 33 PRAMEF33 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 DCRIQDPQLR 0.95761 0.40792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIV1 CNOT7_HUMAN "CCR4-NOT transcription complex subunit 7, EC 3.1.13.4 (BTG1-binding factor 1) (CCR4-associated factor 1, CAF-1) (Caf1a)" CNOT7 CAF1 Homo sapiens (Human) "deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]" CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932] "CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]" GO:0000175; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0005829; GO:0008284; GO:0008285; GO:0010629; GO:0016020; GO:0016604; GO:0016607; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0035195; GO:0042509; GO:0043928; GO:0045070; GO:0045892; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0061014; GO:0140297; GO:1900153 3'-5'-exoribonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] ILTNSNLPEEELDFFEILRLFFPVIYDVK 0.95761 0.67584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56539 CAV3_HUMAN Caveolin-3 (M-caveolin) CAV3 Homo sapiens (Human) actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cardiac muscle cell development [GO:0055013]; cardiac muscle hypertrophy [GO:0003300]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; cholesterol homeostasis [GO:0042632]; cytoplasmic microtubule organization [GO:0031122]; detection of muscle stretch [GO:0035995]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; glucose homeostasis [GO:0042593]; heart trabecula formation [GO:0060347]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell size [GO:0045792]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900826]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sarcomere organization [GO:0060299]; nucleus localization [GO:0051647]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of membrane potential [GO:0042391]; regulation of nerve growth factor receptor activity [GO:0051394]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by receptor internalization [GO:0038009]; regulation of skeletal muscle contraction [GO:0014819]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; T-tubule organization [GO:0033292]; triglyceride metabolic process [GO:0006641]; ventricular cardiac muscle cell action potential [GO:0086005] caveola [GO:0005901]; cell surface [GO:0009986]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018] caveola [GO:0005901]; cell surface [GO:0009986]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018]; alpha-tubulin binding [GO:0043014]; calcium channel regulator activity [GO:0005246]; connexin binding [GO:0071253]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; potassium channel inhibitor activity [GO:0019870]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cardiac muscle cell development [GO:0055013]; cardiac muscle hypertrophy [GO:0003300]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; cellular response to organonitrogen compound [GO:0071417]; cholesterol homeostasis [GO:0042632]; cytoplasmic microtubule organization [GO:0031122]; detection of muscle stretch [GO:0035995]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; glucose homeostasis [GO:0042593]; heart trabecula formation [GO:0060347]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of cell size [GO:0045792]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900826]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sarcomere organization [GO:0060299]; nucleus localization [GO:0051647]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of calcium ion import [GO:0090279]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; regulation of heart rate [GO:0002027]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of membrane potential [GO:0042391]; regulation of nerve growth factor receptor activity [GO:0051394]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by receptor internalization [GO:0038009]; regulation of skeletal muscle contraction [GO:0014819]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; T-tubule organization [GO:0033292]; triglyceride metabolic process [GO:0006641]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0000139; GO:0000165; GO:0001666; GO:0001778; GO:0002027; GO:0002931; GO:0003300; GO:0005246; GO:0005783; GO:0005886; GO:0005887; GO:0005901; GO:0006469; GO:0006641; GO:0006816; GO:0006897; GO:0007009; GO:0007015; GO:0007204; GO:0007517; GO:0007520; GO:0008016; GO:0008022; GO:0008104; GO:0008284; GO:0009986; GO:0010614; GO:0010831; GO:0014704; GO:0014819; GO:0016010; GO:0017015; GO:0017080; GO:0019870; GO:0030018; GO:0030154; GO:0030315; GO:0031116; GO:0031122; GO:0031579; GO:0031594; GO:0031982; GO:0033292; GO:0035995; GO:0038009; GO:0042383; GO:0042391; GO:0042593; GO:0042632; GO:0043014; GO:0043231; GO:0043407; GO:0043409; GO:0044325; GO:0044877; GO:0045121; GO:0045792; GO:0046716; GO:0050998; GO:0051001; GO:0051394; GO:0051480; GO:0051647; GO:0051649; GO:0051896; GO:0051926; GO:0055013; GO:0055117; GO:0060090; GO:0060299; GO:0060307; GO:0060347; GO:0060373; GO:0060762; GO:0061052; GO:0070836; GO:0071253; GO:0071417; GO:0072659; GO:0086005; GO:0090279; GO:0098909; GO:1900744; GO:1900825; GO:1900826; GO:1901017; GO:1901019; GO:1901380; GO:2000009; GO:2000060; GO:2000649; GO:2001288 alpha-tubulin binding [GO:0043014]; calcium channel regulator activity [GO:0005246]; connexin binding [GO:0071253]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; potassium channel inhibitor activity [GO:0019870]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] NINEDIVKVDFEDVIAEPVGTYSFDGVWK 0.95763 0.67584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2923 0 0 0 0 11.418 0 0 0 0 0 0 0 0 0 0 9.92401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7948 10.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0R1 AP5M1_HUMAN "AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1, Mu5) (Mu-2-related death-inducing protein, MuD) (Putative HIV-1 infection-related protein)" AP5M1 C14orf108 MUDENG Homo sapiens (Human) endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599 LHFRILDYTLTGCYADQHSVQVFASGK 0.95763 0.7078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3094 0 0 0 0 0 0 0 0 0 0 18.1617 0 0 0 0 0 0 0 0 0 0 0 15.4527 0 0 0 0 10.5547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04035 HMDH_HUMAN "3-hydroxy-3-methylglutaryl-coenzyme A reductase, HMG-CoA reductase, EC 1.1.1.34" HMGCR Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADPH binding [GO:0070402]; cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542] GO:0004420; GO:0005778; GO:0005783; GO:0005789; GO:0006695; GO:0008299; GO:0008542; GO:0015936; GO:0016021; GO:0016126; GO:0042177; GO:0043407; GO:0050709; GO:0070402; GO:0120225; GO:1900222 coenzyme A binding [GO:0120225]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADPH binding [GO:0070402] CDSVEEETGINRER 0.95764 2.942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8539 0 0 0 0 10.8628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4566 0 0 10.3229 0 0 0 0 0 0 0 13.1561 13.7185 0 0 0 13.1632 0 0 0 14.096 0 0 11.9338 0 0 0 0 0 0 0 0 11.7434 0 13.855 0 0 0 0 13.7605 0 0 0 0 0 12.4859 0 0 0 0 0 14.2266 0 0 0 0 14.292 13.6757 0 0 0 10.5886 13.9174 0 0 0 13.8139 0 0 12.9647 0 0 0 0 0 12.7749 0 0 0 O95158 NXPH4_HUMAN Neurexophilin-4 NXPH4 NPH4 UNQ1928/PRO4403 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; neuropeptide signaling pathway [GO:0007218] GO:0005102; GO:0005576; GO:0007218 signaling receptor binding [GO:0005102] HNSSSLGNLSVSIVPPSKR 0.95765 3.2742 0 0 0 0 0 0 0 0 0 0 9.98057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1801 13.5958 13.6419 0 0 0 0 0 0 0 0 0 0 0 0 10.997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5553 0 0 0 0 0 15.6018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09017 HXC4_HUMAN Homeobox protein Hox-C4 (Homeobox protein CP19) (Homeobox protein Hox-3E) HOXC4 HOX3E Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; embryonic skeletal system morphogenesis [GO:0048704]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; embryonic skeletal system morphogenesis [GO:0048704]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0045944; GO:0048704; GO:0051216; GO:0071837; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DHRLPNTKVR 0.95765 0.40573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4897 0 12.4657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8683 0 12.8842 0 0 12.2011 0 0 0 12.3707 0 0 13.1334 0 0 0 0 0 0 12.1631 0 0 0 0 0 11.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17R31 TATD3_HUMAN "Putative deoxyribonuclease TATDN3, EC 3.1.21.-" TATDN3 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] GO:0004518; GO:0005634; GO:0046872 metal ion binding [GO:0046872]; nuclease activity [GO:0004518] QVLIRQIQLAK 0.95765 0.70644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2285 0 0 0 0 0 Q63ZY6 NSN5C_HUMAN "Putative methyltransferase NSUN5C, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 5C) (Williams-Beuren syndrome chromosomal region 20C protein)" NSUN5P2 NSUN5C WBSCR20B WBSCR20C Homo sapiens (Human) RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] nucleolus [GO:0005730] nucleolus [GO:0005730]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] GO:0001510; GO:0003723; GO:0005730; GO:0008168; GO:0070475 methyltransferase activity [GO:0008168]; RNA binding [GO:0003723] LAPALPARPHR 0.95766 0.57319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2261 0 0 0 13.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4659 0 0 0 0 0 0 0 0 0 0 0 12.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG20 PRR35_HUMAN Proline-rich protein 35 (Uncharacterized protein RJD1) PRR35 C16orf11 Homo sapiens (Human) PLREQLGKIR 0.95767 0.40374 0 0 0 0 0 0 0 0 0 0 13.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0999 0 0 0 0 0 0 0 0 0 13.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6321 0 0 0 0 0 0 0 0 0 0 12.1337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UF83 YM012_HUMAN Uncharacterized protein DKFZp434B061 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 ASLTGTSSTASLTR 0.95769 0.45117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5326 0 0 0 0 0 0 0 0 0 0 0 11.8261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4065 0 0 0 0 0 0 0 0 13.9478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6287 0 0 0 0 0 0 0 0 0 0 0 Q8WVL7 ANR49_HUMAN Ankyrin repeat domain-containing protein 49 (Fetal globin-inducing factor) ANKRD49 FGIF Homo sapiens (Human) "cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" GO:0005634; GO:0005829; GO:0007283; GO:0030154; GO:0045893 DPSRLLLWAAEK 0.9577 0.45095 0 11.7798 0 0 0 0 0 13.9345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8447 13.3931 12.9373 13.2608 0 0 13.8616 0 0 0 16.8414 16.6584 0 0 0 0 0 16.2356 0 13.4156 13.065 13.2759 0 0 0 0 13.6738 13.7262 15.4683 0 0 14.5577 18.0549 14.036 0 0 0 0 0 13.3662 16.9291 13.7244 0 0 0 0 0 0 13.2618 0 13.703 18.4846 16.2254 16.2301 13.5531 0 0 0 0 0 0 0 0 0 13.8553 14.0351 15.3629 13.6198 0 0 14.0244 0 0 0 0 0 13.7775 0 0 14.1984 0 16.0445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78543 BTG2_HUMAN Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3) BTG2 PC3 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein methylation [GO:0006479]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914] GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006479; GO:0006974; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0014070; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0045930; GO:0051602; GO:0060213; GO:0061351; GO:0070062; GO:2000178 transcription corepressor activity [GO:0003714] VASQIGLSQPQLHQLLPSELTLWVDPYEVSYR 0.9577 0.67409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1162 0 0 0 0 0 0 0 12.6825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07316 CRGB_HUMAN Gamma-crystallin B (Gamma-B-crystallin) (Gamma-crystallin 1-2) CRYGB CRYG2 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; visual perception [GO:0007601] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; visual perception [GO:0007601] GO:0002088; GO:0005212; GO:0005634; GO:0005737; GO:0007601; GO:0070309 structural constituent of eye lens [GO:0005212] ITFYEDRAFQGRSYECTTDCPNLQPYFSR 0.95773 0.67193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7B7 DB132_HUMAN "Beta-defensin 132 (Beta-defensin 32, BD-32, DEFB-32) (Defensin HEL-75) (Defensin, beta 132)" DEFB132 DEFB32 UNQ827/PRO1754 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640] extracellular space [GO:0005615]; sperm head [GO:0061827] extracellular space [GO:0005615]; sperm head [GO:0061827]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640] GO:0005615; GO:0031640; GO:0045087; GO:0050829; GO:0061827 TCCHWGETALFMCNASR 0.95773 0.67816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NB59 SYT14_HUMAN "Synaptotagmin-14 (Synaptotagmin XIV, SytXIV)" SYT14 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; phospholipid binding [GO:0005543] GO:0005543; GO:0016021 phospholipid binding [GO:0005543] CPSEGSTGHEIESFHNK 0.95773 0.62001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5194 13.9157 0 14.8118 0 0 0 0 0 0 0 0 11.6689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6627 13.9951 0 0 0 0 0 0 0 13.9882 13.883 0 0 0 13.608 0 0 0 0 0 0 0 0 0 0 0 12.765 0 0 0 14.6142 0 0 0 13.6761 0 0 0 12.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1939 0 0 0 0 0 0 Q9GZT6 CC90B_HUMAN "Coiled-coil domain-containing protein 90B, mitochondrial" CCDC90B CUA003 MDS011 MDS025 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] GO:0005739; GO:0016021; GO:0031966 KDMVILEKSEFANLR 0.95773 0.58278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2644 0 0 0 0 0 16.5175 0 16.2605 16.4868 0 0 0 15.6382 11.4347 0 0 13.3677 13.133 0 0 0 0 13.0443 0 0 0 0 0 12.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3904 0 10.9855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NF83 NUPR2_HUMAN Nuclear protein 2 (Nuclear transcriptional regulator 1-like protein) (Nuclear transcriptional regulator protein 2) NUPR2 NUPR1L Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0005634; GO:0006357; GO:0006974; GO:0007049; GO:0008285; GO:0009267; GO:0045786; GO:0051726 LLNGQRK 0.95774 0.67164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0686 0 0 0 0 0 0 11.1571 0 0 11.514 0 16.8054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4145 18.1007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1468 0 0 0 0 0 Q52MB2 CC184_HUMAN Coiled-coil domain-containing protein 184 CCDC184 C12orf68 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 EMPSPATPSSHCER 0.95774 0.44915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43868 S28A2_HUMAN "Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2, CNT 2, hCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside co-transporter, SPNT) (Solute carrier family 28 member 2)" SLC28A2 CNT2 Homo sapiens (Human) adenosine transport [GO:0032238]; azole transmembrane transport [GO:0045117]; inosine transport [GO:0035340]; neurotransmitter transport [GO:0006836]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; retina homeostasis [GO:0001895]; transport across blood-brain barrier [GO:0150104]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] brush border membrane [GO:0031526]; coated vesicle [GO:0030135]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] brush border membrane [GO:0031526]; coated vesicle [GO:0030135]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; azole transmembrane transporter activity [GO:1901474]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine nucleoside transmembrane transporter activity [GO:0015211]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]; adenosine transport [GO:0032238]; azole transmembrane transport [GO:0045117]; inosine transport [GO:0035340]; neurotransmitter transport [GO:0006836]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; retina homeostasis [GO:0001895]; transport across blood-brain barrier [GO:0150104]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] GO:0001895; GO:0005326; GO:0005337; GO:0005345; GO:0005415; GO:0005886; GO:0005887; GO:0006139; GO:0006836; GO:0006855; GO:0012506; GO:0015211; GO:0015213; GO:0015293; GO:0015389; GO:0015860; GO:0015862; GO:0016020; GO:0030135; GO:0031526; GO:0032238; GO:0035340; GO:0045117; GO:0072531; GO:0150104; GO:1901474; GO:1901642; GO:1904823 azole transmembrane transporter activity [GO:1901474]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; purine nucleoside transmembrane transporter activity [GO:0015211]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213] ALALFVITCLVIFVLVHSFLKK 0.95775 0.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7334 0 0 14.2332 0 0 0 0 0 0 0 0 0 14.8754 14.7681 0 14.684 12.7822 0 14.37 14.5209 0 0 0 0 0 0 0 0 14.6886 0 0 0 0 12.1793 0 0 0 0 0 0 15.438 16.1894 0 0 0 0 15.2095 0 14.8374 0 14.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8352 0 0 0 14.9942 0 0 0 14.9074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60900 PSA6_HUMAN "Proteasome subunit alpha type-6 (27 kDa prosomal protein, PROS-27, p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)" PSMA6 PROS27 Homo sapiens (Human) positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of inflammatory response [GO:0050727] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; purine ribonucleoside triphosphate binding [GO:0035639]; RNA binding [GO:0003723]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of inflammatory response [GO:0050727]" GO:0000502; GO:0000932; GO:0003723; GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0005844; GO:0010498; GO:0016363; GO:0019773; GO:0030016; GO:0030017; GO:0035639; GO:0043161; GO:0050727; GO:0051059; GO:0051092; GO:0051603; GO:0070062 endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; purine ribonucleoside triphosphate binding [GO:0035639]; RNA binding [GO:0003723] ATAAGVK 0.95775 0.61939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1803 0 0 0 13.1608 13.8643 0 0 0 0 0 13.3164 12.6648 13.6638 0 13.459 0 0 0 0 0 0 0 0 0 0 12.9807 0 13.3106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3799 15.7184 15.1956 13.9803 0 0 0 14.5362 0 0 14.4517 0 13.3086 13.4699 0 0 0 0 13.7873 0 0 0 0 Q96K12 FACR2_HUMAN "Fatty acyl-CoA reductase 2, EC 1.2.1.84 (Male sterility domain-containing protein 1)" FAR2 MLSTD1 Homo sapiens (Human) lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025] integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491]; lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025] GO:0005777; GO:0005778; GO:0005779; GO:0006629; GO:0010025; GO:0016491; GO:0035336; GO:0043231; GO:0080019; GO:0102965 alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491] AGQTLQQR 0.95775 2.9396 13.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7897 0 0 0 0 15.4614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1102 0 0 0 0 0 0 0 0 0 0 0 0 11.8776 0 0 12.1421 0 0 0 0 0 0 0 0 0 0 0 12.2063 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1397 0 0 0 0 0 0 0 15.6023 0 0 0 0 0 0 0 0 0 0 0 0 15.1204 0 0 0 0 0 0 0 13.0305 0 0 13.3483 0 0 0 0 0 0 0 0 0 0 0 14.6735 14.9104 0 0 0 0 13.689 0 0 0 15.0808 0 0 0 15.617 0 0 0 0 0 0 0 0 0 13.8244 15.8856 0 13.244 0 0 0 0 0 0 0 0 0 0 0 13.8928 0 0 0 0 0 14.6475 0 0 13.647 0 0 0 0 0 Q9UGK3 STAP2_HUMAN "Signal-transducing adaptor protein 2, STAP-2 (Breast tumor kinase substrate, BRK substrate)" STAP2 BKS Homo sapiens (Human) cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; signaling adaptor activity [GO:0035591] GO:0005829; GO:0005886; GO:0035591 signaling adaptor activity [GO:0035591] ALETPSCFLK 0.95775 0.58113 0 0 0 0 0 0 0 0 0 0 0 11.6947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1304 0 13.5092 0 0 0 0 0 0 0 10.8355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5236 0 0 0 0 0 13.0531 12.7047 13.0987 0 0 0 15.9841 16.2767 16.0499 0 11.8409 10.6684 0 16.2736 16.2366 0 14.0017 13.3454 10.578 13.3545 0 0 15.6222 0 0 0 0 13.2268 0 0 13.2239 0 0 12.9804 0 15.4696 13.4353 0 0 12.8806 12.8089 0 0 0 0 0 0 0 0 0 0 12.1878 0 0 11.6486 0 0 0 0 0 0 0 15.3641 0 0 0 0 10.6115 15.578 0 10.4612 0 0 0 12.9657 14.1403 0 0 0 0 0 A8MUH7 PDZ1P_HUMAN Putative PDZ domain-containing protein PDZK1P1 (PDZ domain-containing 1 pseudogene 1) (PDZ domain-containing 1 pseudogene 2) PDZK1P1 PDZK1P2 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659] apical plasma membrane [GO:0016324] apical plasma membrane [GO:0016324]; protein-membrane adaptor activity [GO:0043495]; protein localization to plasma membrane [GO:0072659] GO:0016324; GO:0043495; GO:0072659 protein-membrane adaptor activity [GO:0043495] HVEQKIQFKR 0.95776 0.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01133 EGF_HUMAN "Pro-epidermal growth factor, EGF [Cleaved into: Epidermal growth factor (Urogastrone) ]" EGF Homo sapiens (Human) "angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cerebellar granule cell precursor proliferation [GO:0021930]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]" clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093] "clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cerebellar granule cell precursor proliferation [GO:0021930]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]" GO:0001525; GO:0001938; GO:0002092; GO:0005085; GO:0005154; GO:0005509; GO:0005576; GO:0005615; GO:0005765; GO:0005886; GO:0007173; GO:0008083; GO:0008284; GO:0010595; GO:0010628; GO:0010800; GO:0014068; GO:0016021; GO:0018108; GO:0021930; GO:0021940; GO:0030297; GO:0030335; GO:0030669; GO:0031093; GO:0038029; GO:0038134; GO:0042327; GO:0043388; GO:0043406; GO:0043410; GO:0045740; GO:0045741; GO:0045840; GO:0045893; GO:0046425; GO:0048018; GO:0048754; GO:0050673; GO:0051048; GO:0051897; GO:0060749; GO:0070062; GO:0070371; GO:0090263; GO:0090279; GO:0090370; GO:1900127; GO:1902966; GO:1905278; GO:2000008; GO:2000060 calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] CQYRDLK 0.95776 0.61917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4781 0 0 0 10.823 0 0 0 0 0 0 9.59139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8522 0 0 0 0 0 0 0 0 12.4114 0 0 0 0 0 0 0 0 11.917 0 0 0 0 0 0 15.5391 0 0 0 13.4748 0 0 0 0 0 13.5476 0 0 0 0 0 0 0 14.393 0 0 13.3424 0 12.5268 0 14.9257 0 0 0 0 0 16.0072 0 0 12.0047 0 13.3253 0 12.8396 0 0 0 15.0561 15.9436 0 14.6933 14.0399 0 15.1695 0 13.4886 13.4955 0 12.2586 14.511 0 11.947 14.9646 12.7047 14.6447 0 0 0 14.7735 0 0 12.6176 0 0 0 0 0 0 0 0 12.4831 0 0 0 14.9989 0 0 0 0 0 0 0 0 0 0 11.6267 0 0 12.0121 0 11.7151 14.7616 0 14.7954 0 0 0 0 0 Q8N377 YJ004_HUMAN Putative uncharacterized protein LOC387726 Homo sapiens (Human) AGPCTPHPSLLGF 0.95776 0.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y676 RT18B_HUMAN "28S ribosomal protein S18b, mitochondrial, MRP-S18-b, Mrps18-b, S18mt-b (28S ribosomal protein S18-2, mitochondrial, MRP-S18-2) (Mitochondrial small ribosomal subunit protein bS18b) (Mitochondrial small ribosomal subunit protein mS40)" MRPS18B C6orf14 HSPC183 PTD017 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0030054; GO:0032543 structural constituent of ribosome [GO:0003735] GGVPPQRTR 0.95776 0.41862 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2758 0 0 0 0 0 12.5319 0 0 0 0 0 0 0 0 0 11.4114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2966 0 0 13.6929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3541 13.6319 O94777 DPM2_HUMAN "Dolichol phosphate-mannose biosynthesis regulatory protein (Dolichol-phosphate mannose synthase subunit 2, DPM synthase subunit 2)" DPM2 My026 Homo sapiens (Human) dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein O-linked mannosylation [GO:0035269]; regulation of protein stability [GO:0031647] dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of endoplasmic reticulum membrane [GO:0030176] dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of endoplasmic reticulum membrane [GO:0030176]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein O-linked mannosylation [GO:0035269]; regulation of protein stability [GO:0031647] GO:0000506; GO:0005789; GO:0006506; GO:0008047; GO:0019348; GO:0030176; GO:0030234; GO:0031647; GO:0033185; GO:0035269 enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234] AYAVAIPLAAGLLLLLFVGLFISYVMLKTK 0.95778 0.67102 0 0 0 0 0 0 0 0 0 0 0 13.4976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0614 0 0 0 0 0 0 0 0 0 0 0 0 13.8699 14.1499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8747 0 0 0 0 0 13.7775 0 Q8NC26 ZN114_HUMAN Zinc finger protein 114 ZNF114 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" extracellular exosome [GO:0070062]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0042802; GO:0046872; GO:0070062 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DESPVSICEDHEMR 0.95778 0.57824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9227 0 0 0 0 0 10.3635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7385 0 0 0 0 0 0 0 0 0 0 0 11.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NDI0 TR49B_HUMAN Putative tripartite motif-containing protein 49B (RING finger protein 18B) TRIM49B RNF18B Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] HCPIESAAEEHQEK 0.95782 0.57587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16695 H31T_HUMAN "Histone H3.1t, H3/t, H3t (H3/g) (Histone H3.4)" H3-4 H3FT HIST3H3 Homo sapiens (Human) nucleosome assembly [GO:0006334] "chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; nucleosome assembly [GO:0006334]" GO:0000781; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006334; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] ARTKQTAR 0.95782 0.40678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5918 0 12.9076 0 0 0 0 0 12.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31943 HNRH1_HUMAN "Heterogeneous nuclear ribonucleoprotein H, hnRNP H [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed ]" HNRNPH1 HNRPH HNRPH1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006396; GO:0008266; GO:0016020; GO:0042802; GO:0043484; GO:0071013; GO:1990904 identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] AEVRTHYDPPR 0.95783 0.40576 0 0 0 0 0 13.7572 12.716 13.6037 0 0 0 0 0 0 0 0 0 13.4476 0 0 0 0 0 11.2224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.835 0 0 0 10.6561 0 0 0 12.1139 11.356 12.444 0 0 0 13.7703 0 0 0 0 13.9816 0 14.3531 0 13.9509 13.4881 12.3069 12.9065 0 0 14.3426 0 0 12.1651 0 0 0 0 12.7723 12.9565 11.9649 0 0 0 0 0 0 13.2656 12.6703 0 0 0 0 14.1322 13.4083 0 0 0 11.7323 0 11.7124 14.2516 12.1544 0 0 14.153 0 0 0 0 0 0 0 0 12.2907 0 0 0 0 13.9317 0 0 0 13.7447 13.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0306 11.2345 0 0 0 0 10.763 0 0 0 0 0 0 0 0 Q9NVD3 SETD4_HUMAN "SET domain-containing protein 4, EC 2.1.1.-, EC 2.1.1.364" SETD4 C21orf18 C21orf27 Homo sapiens (Human) histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 monomethylation [GO:0097692]; histone H4-K20 trimethylation [GO:0034773]; inflammatory response [GO:0006954]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; protein-lysine N-methyltransferase activity [GO:0016279]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 monomethylation [GO:0097692]; histone H4-K20 trimethylation [GO:0034773]; inflammatory response [GO:0006954]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863] GO:0005634; GO:0005829; GO:0006954; GO:0016279; GO:0018023; GO:0018026; GO:0032755; GO:0032760; GO:0034773; GO:0042799; GO:0042800; GO:0044648; GO:0050729; GO:0071863; GO:0097692 histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; protein-lysine N-methyltransferase activity [GO:0016279] GKGRTSR 0.95783 0.57543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.678 0 13.1324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8517 0 0 12.9518 0 0 0 0 0 0 12.6227 15.427 15.3298 0 0 0 0 0 0 14.8931 15.1461 0 0 15.1997 0 0 15.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1032 0 0 0 0 0 15.3099 0 0 15.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCC5 SPX3_HUMAN Sugar phosphate exchanger 3 (Solute carrier family 37 member 3) SLC37A3 SPX3 Homo sapiens (Human) carbohydrate transport [GO:0008643] integral component of endoplasmic reticulum membrane [GO:0030176] integral component of endoplasmic reticulum membrane [GO:0030176]; transmembrane transporter activity [GO:0022857]; carbohydrate transport [GO:0008643] GO:0008643; GO:0022857; GO:0030176 transmembrane transporter activity [GO:0022857] DKLGWMWVFYFFILMTSCTIVFISPLIVR 0.95784 0.67584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHP7 EXD1_HUMAN piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) EXD1 EXDL1 Homo sapiens (Human) gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587] P granule [GO:0043186]; PET complex [GO:1990923] P granule [GO:0043186]; PET complex [GO:1990923]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587] GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:1990923 protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] EHFMTPKHEFQASLSLK 0.95784 0.57497 0 0 0 0 0 13.6074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3967 0 0 12.2686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9J3I9 CE058_HUMAN Putative uncharacterized protein C5orf58 C5orf58 Homo sapiens (Human) VIKNINTISSELKK 0.95785 0.66627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L3X0 ELOV7_HUMAN "Elongation of very long chain fatty acids protein 7, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL7) (ELOVL fatty acid elongase 7, ELOVL FA elongase 7) (Very long chain 3-ketoacyl-CoA synthase 7) (Very long chain 3-oxoacyl-CoA synthase 7)" ELOVL7 Homo sapiens (Human) "fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102336; GO:0102756 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756] KPFELKK 0.95786 0.45152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TI4 WDR86_HUMAN WD repeat-containing protein 86 WDR86 Homo sapiens (Human) VWSVDKGQMSREFR 0.95786 0.66627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8428 0 0 0 0 0 0 0 0 15.4402 14.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5426 0 0 0 12.86 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD64 XAGE1_HUMAN "X antigen family member 1, XAGE-1 (Cancer/testis antigen 12.1, CT12.1) (G antigen family D member 2)" XAGE1A GAGED2 XAGE1; XAGE1B XAGE1C XAGE1D XAGE1E Homo sapiens (Human) IIPKEEHCK 0.95786 0.70703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6707 0 0 0 13.5187 0 0 0 0 14.7658 0 13.4597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6261 0 0 0 0 0 0 0 0 0 13.3228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.789 0 0 0 0 0 0 0 0 0 14.0918 0 0 0 12.0266 0 0 13.6092 0 0 0 0 0 Q9BY11 PACN1_HUMAN Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1) PACSIN1 KIAA1379 Homo sapiens (Human) actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; negative regulation of endocytosis [GO:0045806]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; negative regulation of endocytosis [GO:0045806]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to plasma membrane [GO:0072659]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488] GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007010; GO:0007015; GO:0008092; GO:0030100; GO:0030137; GO:0030659; GO:0032587; GO:0042802; GO:0043679; GO:0045202; GO:0045806; GO:0048471; GO:0048488; GO:0048812; GO:0070161; GO:0072657; GO:0072659; GO:0097320; GO:0098684; GO:0098833; GO:1900006 cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543] GQPYATEWSDDESGNPFGGSETNGGANPFEDDSKGVR 0.95787 0.70645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6461 0 0 0 0 0 0 0 11.9846 0 17.3714 13.146 0 0 0 12.4045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9892 0 0 0 0 0 0 0 0 11.0289 0 0 0 12.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S96 PEBP4_HUMAN "Phosphatidylethanolamine-binding protein 4, PEBP-4, hPEBP4 (Protein cousin-of-RKIP 1)" PEBP4 CORK1 UNQ1933/PRO4408 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 FLNRFHLGEPEASTQFMTQNYQDSPTLQAPR 0.95789 0.67896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6L8G8 KRA57_HUMAN Keratin-associated protein 5-7 (Keratin-associated protein 5-3) (Keratin-associated protein 5.3) (Keratin-associated protein 5.7) (Ultrahigh sulfur keratin-associated protein 5.7) KRTAP5-7 KAP5-7 KAP5.3 KRTAP5.3 KRTAP5.7 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 GGCGSCGCSQCSCYK 0.9579 0.67896 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SJ6 DSG4_HUMAN Desmoglein-4 (Cadherin family member 13) DSG4 CDHF13 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cell-cell adhesion [GO:0098609]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte differentiation [GO:0030216] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; BMP signaling pathway [GO:0030509]; cell-cell adhesion [GO:0098609]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte differentiation [GO:0030216] GO:0001533; GO:0001942; GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0016021; GO:0030057; GO:0030216; GO:0030509; GO:0098609 calcium ion binding [GO:0005509] DGAADGLSSECDCR 0.95791 0.44915 0 0 0 0 0 0 0 0 12.9011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9246 0 0 0 0 0 0 0 13.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8889 0 0 0 0 0 0 14.5333 0 0 0 15.1068 0 14.452 15.7071 0 0 13.1616 13.5818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1777 0 13.2903 0 0 13.3614 14.2367 0 0 14.1207 0 0 14.8012 0 12.882 0 0 13.3908 13.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0871 0 13.8646 0 0 0 0 0 0 Q9Y6X1 SERP1_HUMAN Stress-associated endoplasmic reticulum protein 1 (Ribosome-attached membrane protein 4) SERP1 RAMP4 Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; multicellular organism aging [GO:0010259]; muscle organ morphogenesis [GO:0048644]; plasma membrane organization [GO:0007009]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of organ growth [GO:0046622]; positive regulation of translation [GO:0045727]; post-embryonic development [GO:0009791]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; skeletal system development [GO:0001501] cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ribosome [GO:0005840] cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ribosome [GO:0005840]; endoplasmic reticulum unfolded protein response [GO:0030968]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; multicellular organism aging [GO:0010259]; muscle organ morphogenesis [GO:0048644]; plasma membrane organization [GO:0007009]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin secretion [GO:0032024]; positive regulation of organ growth [GO:0046622]; positive regulation of translation [GO:0045727]; post-embryonic development [GO:0009791]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; skeletal system development [GO:0001501] GO:0001501; GO:0005783; GO:0005789; GO:0005829; GO:0005840; GO:0005881; GO:0006006; GO:0006486; GO:0007009; GO:0009791; GO:0010259; GO:0016021; GO:0030073; GO:0030968; GO:0032024; GO:0036211; GO:0045727; GO:0046622; GO:0048644; GO:0060124 ASVGPWLLALFIFVVCGSAIFQIIQSIRMGM 0.95791 0.67896 0 0 0 0 12.1862 0 0 0 0 10.9319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2938 13.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZF3 AGRF4_HUMAN Adhesion G protein-coupled receptor F4 (G-protein coupled receptor 115) (G-protein coupled receptor PGR18) ADGRF4 GPR115 PGR18 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] ALLAFAIPAFVIVAVNLIVVLVVAVNTQR 0.95792 0.61248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.65 0 0 10.6253 11.0189 0 0 0 13.5325 10.6945 0 0 0 0 13.5571 0 0 0 12.6439 0 15.2178 0 15.5406 15.5952 15.8053 0 15.927 0 0 14.3523 15.1993 15.5329 15.0094 13.9546 0 0 13.8248 0 13.1177 0 13.2063 0 0 0 9.83207 0 0 0 0 0 0 13.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9653 13.7067 0 0 0 0 0 0 0 12.9577 0 0 12.4246 0 0 0 0 11.7321 11.8721 0 0 0 0 0 0 0 10.6325 11.0629 0 0 0 0 0 0 12.216 0 0 0 0 0 0 0 0 0 0 10.7416 0 0 Q9UHY8 FEZ2_HUMAN Fasciculation and elongation protein zeta-2 (Zygin II) (Zygin-2) FEZ2 Homo sapiens (Human) axon guidance [GO:0007411]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737] axon [GO:0030424]; cytoplasm [GO:0005737]; axon guidance [GO:0007411]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; signal transduction [GO:0007165] GO:0005737; GO:0007165; GO:0007399; GO:0007411; GO:0030424; GO:1902902 EDSEKVPSLLTDYILKVLCPT 0.95792 0.58361 0 0 0 0 0 0 0 0 0 11.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00194 RB27B_HUMAN "Ras-related protein Rab-27B, EC 3.6.5.2 (C25KG)" RAB27B Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; exocytosis [GO:0006887]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] anchored component of synaptic vesicle membrane [GO:0098993]; apical plasma membrane [GO:0016324]; axon cytoplasm [GO:1904115]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; secretory granule [GO:0030141]; trans-Golgi network transport vesicle [GO:0030140]; zymogen granule membrane [GO:0042589] anchored component of synaptic vesicle membrane [GO:0098993]; apical plasma membrane [GO:0016324]; axon cytoplasm [GO:1904115]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; secretory granule [GO:0030141]; trans-Golgi network transport vesicle [GO:0030140]; zymogen granule membrane [GO:0042589]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; anterograde axonal protein transport [GO:0099641]; exocytosis [GO:0006887]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0003925; GO:0005525; GO:0005770; GO:0005794; GO:0005795; GO:0005886; GO:0006887; GO:0016192; GO:0016324; GO:0019003; GO:0019904; GO:0030140; GO:0030141; GO:0031088; GO:0031489; GO:0032585; GO:0042470; GO:0042589; GO:0045921; GO:0048488; GO:0070062; GO:0070382; GO:0071985; GO:0098993; GO:0099641; GO:1904115 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904] AVETLLDLIMKR 0.95793 0.58283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8171 13.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47944 MT4_HUMAN "Metallothionein-4, MT-4 (Metallothionein-IV, MT-IV)" MT4 Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] GO:0005634; GO:0005737; GO:0006882; GO:0010273; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872] DPRECVCMSGGICMCGDNCK 0.95794 4.8193 12.4 0 0 0 0 0 0 0 0 0 0 10.838 11.6801 0 0 0 0 0 0 9.96622 0 0 0 10.7165 0 0 0 0 0 0 0 0 0 0 0 12.5511 0 12.2656 0 0 0 0 0 0 0 0 0 0 0 12.9664 13.4872 0 13.0038 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7886 0 10.4169 0 0 0 11.8846 11.4875 0 0 0 0 0 0 0 10.6278 0 0 12.7764 11.9998 0 12.6989 0 0 12.4555 11.5387 11.5998 0 0 0 0 0 0 0 0 11.7658 11.5993 14.3848 0 0 0 0 0 0 0 0 0 0 0 10.2291 0 0 14.9216 13.1865 0 0 9.71819 0 14.0638 0 0 0 0 0 0 0 12.1501 0 0 0 0 0 0 12.1111 0 0 0 0 0 0 0 0 9.92217 0 0 0 0 11.5257 0 0 12.1627 0 0 0 12.0202 12.2193 0 12.3559 0 0 0 0 0 0 0 0 0 11.3663 10.1508 0 0 11.3786 0 12.8015 B7Z1M9 C2D4D_HUMAN C2 calcium-dependent domain-containing protein 4D C2CD4D FAM148D Homo sapiens (Human) AGYKVGAAEPAAR 0.95795 0.42619 0 0 14.8819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3039 0 0 0 13.5475 0 0 0 0 11.9496 13.9767 11.8379 0 10.7364 12.3733 0 12.2277 0 12.5567 0 0 0 0 0 0 0 0 0 0 0 13.9256 0 Q92813 IOD2_HUMAN "Type II iodothyronine deiodinase, EC 1.21.99.4 (5DII) (DIOII) (Type 2 DI) (Type-II 5'-deiodinase)" DIO2 ITDI2 TXDI2 Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; cellular lipid metabolic process [GO:0044255]; hormone biosynthetic process [GO:0042446]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; response to lipopolysaccharide [GO:0032496]; selenocysteine incorporation [GO:0001514]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; ubiquitin protein ligase binding [GO:0031625]; brown fat cell differentiation [GO:0050873]; cellular lipid metabolic process [GO:0044255]; hormone biosynthetic process [GO:0042446]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; response to lipopolysaccharide [GO:0032496]; selenocysteine incorporation [GO:0001514]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403] GO:0001514; GO:0004800; GO:0005886; GO:0006590; GO:0008430; GO:0009409; GO:0016020; GO:0016021; GO:0031625; GO:0032496; GO:0033798; GO:0042403; GO:0042404; GO:0042446; GO:0044255; GO:0050873; GO:0120162 selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; ubiquitin protein ligase binding [GO:0031625] HVVLLLSRSK 0.95795 0.6783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9W6 BOLL_HUMAN Protein boule-like BOLL BOULE Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283] GO:0003730; GO:0005737; GO:0007283; GO:0008494; GO:0030154; GO:0042802; GO:0045948; GO:0051321; GO:0070935 identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494] IFVGGIDFKTNESDLRK 0.95797 0.6946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2674 12.8549 14.2117 16.0215 13.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7765 0 0 0 12.7691 0 0 0 0 12.4706 0 0 0 0 0 0 0 0 0 12.7989 0 0 14.4396 12.1923 13.256 0 13.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M43 NBPF4_HUMAN Neuroblastoma breakpoint family member 4 NBPF4 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ALVHSQAKELTQLR 0.95797 0.66689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9174 0 0 16.1075 0 9.82869 0 0 0 0 0 0 15.8758 0 13.3222 0 15.1575 14.9464 0 0 14.4722 11.0705 0 0 15.9093 13.4819 0 0 0 0 0 14.4884 13.2621 0 0 0 15.7954 0 13.4376 0 14.6295 0 14.8632 0 0 0 0 11.8284 0 0 0 13.8248 12.883 12.9925 0 0 0 12.6064 0 0 0 12.7142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1049 0 12.7072 0 0 0 0 P32242 OTX1_HUMAN Homeobox protein OTX1 (Orthodenticle homolog 1) OTX1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030901; GO:0042472; GO:0045944; GO:0048852; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AKCRQQQQSGSGTK 0.95799 0.66627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NET4 OR5K3_HUMAN Olfactory receptor 5K3 OR5K3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] DIPVAIFYTLVIPLLNPFIYSLR 0.958 0.57744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9027 0 0 0 0 Q5STR5 SIM40_HUMAN Small integral membrane protein 40 SMIM40 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AFFIFLALFLTLLMLEAAYKLLWLLLWAK 0.958 0.40678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5283 0 0 0 13.6758 0 0 0 0 0 0 0 0 0 0 14.165 0 0 0 0 P52926 HMGA2_HUMAN High mobility group protein HMGI-C (High mobility group AT-hook protein 2) HMGA2 HMGIC Homo sapiens (Human) "base-excision repair [GO:0006284]; cell cycle [GO:0007049]; cell division [GO:0051301]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; endodermal cell differentiation [GO:0035987]; epithelial to mesenchymal transition [GO:0001837]; fat cell differentiation [GO:0045444]; heterochromatin assembly [GO:0031507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesodermal cell differentiation [GO:0048333]; mesodermal-endodermal cell signaling [GO:0003131]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA binding [GO:0043392]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of gene expression [GO:0010628]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; response to virus [GO:0009615]; stem cell differentiation [GO:0048863]" nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; senescence-associated heterochromatin focus [GO:0035985]; SMAD protein complex [GO:0071141] "nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; senescence-associated heterochromatin focus [GO:0035985]; SMAD protein complex [GO:0071141]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; C2H2 zinc finger domain binding [GO:0070742]; cAMP response element binding [GO:0035497]; DNA binding, bending [GO:0008301]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; MH1 domain binding [GO:0035501]; MH2 domain binding [GO:0035500]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; cell division [GO:0051301]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; endodermal cell differentiation [GO:0035987]; epithelial to mesenchymal transition [GO:0001837]; fat cell differentiation [GO:0045444]; heterochromatin assembly [GO:0031507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; mesodermal cell differentiation [GO:0048333]; mesodermal-endodermal cell signaling [GO:0003131]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA binding [GO:0043392]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of gene expression [GO:0010628]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; response to virus [GO:0009615]; stem cell differentiation [GO:0048863]" GO:0000122; GO:0000228; GO:0000976; GO:0001837; GO:0002062; GO:0003131; GO:0003680; GO:0003712; GO:0003714; GO:0003906; GO:0005634; GO:0005654; GO:0006284; GO:0006325; GO:0006355; GO:0007049; GO:0008301; GO:0009615; GO:0010564; GO:0010628; GO:0030261; GO:0031492; GO:0031507; GO:0032993; GO:0035497; GO:0035500; GO:0035501; GO:0035556; GO:0035985; GO:0035987; GO:0035988; GO:0040008; GO:0043066; GO:0043392; GO:0043922; GO:0045444; GO:0045766; GO:0045869; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0048333; GO:0048762; GO:0048863; GO:0051301; GO:0051575; GO:0061629; GO:0070742; GO:0071141; GO:0071864; GO:0071902; GO:0090402; GO:2000036; GO:2000648; GO:2000773; GO:2001033 "5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; C2H2 zinc finger domain binding [GO:0070742]; cAMP response element binding [GO:0035497]; DNA binding, bending [GO:0008301]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; MH1 domain binding [GO:0035501]; MH2 domain binding [GO:0035500]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]" KQQQEPTGEPSPKR 0.95801 0.66627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUW5 RELL1_HUMAN RELT-like protein 1 RELL1 PSEC0162 Homo sapiens (Human) positive regulation of p38MAPK cascade [GO:1900745] integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; positive regulation of p38MAPK cascade [GO:1900745] GO:0005886; GO:0015630; GO:0016021; GO:1900745 CTTEAEQDIEEEK 0.95801 0.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01008 ANT3_HUMAN "Antithrombin-III, ATIII (Serpin C1)" SERPINC1 AT3 PRO0309 Homo sapiens (Human) "blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951]; regulation of blood coagulation, intrinsic pathway [GO:2000266]" GO:0002020; GO:0004867; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008201; GO:0010951; GO:0042802; GO:0062023; GO:0070062; GO:0072562; GO:2000266 heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] ADGESCSASMMYQEGKFR 0.95803 0.41382 0 0 0 0 0 0 0 0 15.7767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4028 0 12.9047 0 0 0 0 0 0 0 0 14.0358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0134 0 0 11.3817 0 14.9471 0 0 0 0 0 13.6964 0 0 0 0 0 0 0 12.7584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0382 0 14.5672 0 12.3339 12.2644 0 0 0 0 0 11.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1963 0 0 Q8IYP2 PRS58_HUMAN "Serine protease 58, EC 3.4.21.4 (Trypsin-X3)" PRSS58 TRY1 TRYX3 UNQ2540/PRO6090 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576]; secretory granule [GO:0030141] extracellular region [GO:0005576]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508; GO:0030141 serine-type endopeptidase activity [GO:0004252] ADVGIYAKIFYYIPWIENVIQNN 0.95803 0.57552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15843 NEDD8_HUMAN "NEDD8 (Neddylin) (Neural precursor cell expressed developmentally down-regulated protein 8, NEDD-8) (Ubiquitin-like protein Nedd8)" NEDD8 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; modification-dependent protein catabolic process [GO:0019941]; protein localization [GO:0008104]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of proteolysis [GO:0030162]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein tag [GO:0031386]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; modification-dependent protein catabolic process [GO:0019941]; protein localization [GO:0008104]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of proteolysis [GO:0030162]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006508; GO:0006511; GO:0008104; GO:0009653; GO:0019941; GO:0030162; GO:0031386; GO:0031625; GO:0036211; GO:0045116; GO:0070062 protein tag [GO:0031386]; ubiquitin protein ligase binding [GO:0031625] EIEIDIEPTDKVERIK 0.95804 0.61531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3963 0 0 0 0 9.95174 12.553 0 0 0 0 0 0 0 0 0 0 0 0 10.1663 0 0 0 0 0 13.7316 0 0 0 0 0 0 0 0 14.2732 0 0 0 0 0 0 0 0 0 12.7024 0 0 0 0 12.5735 9.82157 0 0 0 0 0 10.378 0 0 0 0 0 0 0 0 0 0 9.65744 0 12.1129 0 0 0 0 0 0 0 0 0 10.4366 0 0 15.2466 0 11.724 0 0 0 0 0 0 0 0 0 0 9.44228 0 0 0 0 0 0 9.74559 0 0 0 0 12.7929 0 0 0 Q7Z5Y7 KCD20_HUMAN BTB/POZ domain-containing protein KCTD20 (Potassium channel tetramerization domain containing 20) KCTD20 C6orf69 Homo sapiens (Human) positive regulation of phosphorylation [GO:0042327] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; positive regulation of phosphorylation [GO:0042327] GO:0005737; GO:0042327 NVHRGSDSDR 0.95804 0.41373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1062 0 0 0 0 0 0 0 10.8849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29377 S100G_HUMAN "Protein S100-G (Calbindin-D9k) (S100 calcium-binding protein G) (Vitamin D-dependent calcium-binding protein, intestinal, CABP)" S100G CABP9K CALB3 S100D Homo sapiens (Human) apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914]; vitamin D binding [GO:0005499] GO:0005499; GO:0005509; GO:0005615; GO:0005737; GO:0016323; GO:0016324; GO:0046914; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914]; vitamin D binding [GO:0005499] DELKLLIQAEFPSLLK 0.95805 0.6151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5935 13.2966 0 0 0 0 13.7127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q30KQ4 DB116_HUMAN "Beta-defensin 116 (Beta-defensin 16, DEFB-16) (Defensin, beta 116)" DEFB116 DEFB16 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 NACREYEIQYLTCPNDQK 0.95809 0.66932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07864 LDHC_HUMAN "L-lactate dehydrogenase C chain, LDH-C, EC 1.1.1.27 (Cancer/testis antigen 32, CT32) (LDH testis subunit) (LDH-X)" LDHC LDH3 LDHX Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; flagellated sperm motility [GO:0030317]; lactate biosynthetic process from pyruvate [GO:0019244]; lactate metabolic process [GO:0006089]; lactate oxidation [GO:0019516]; pyruvate metabolic process [GO:0006090] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; L-lactate dehydrogenase activity [GO:0004459]; ATP biosynthetic process [GO:0006754]; flagellated sperm motility [GO:0030317]; lactate biosynthetic process from pyruvate [GO:0019244]; lactate metabolic process [GO:0006089]; lactate oxidation [GO:0019516]; pyruvate metabolic process [GO:0006090] GO:0004459; GO:0005634; GO:0005829; GO:0006089; GO:0006090; GO:0006754; GO:0019244; GO:0019516; GO:0030317; GO:0031514; GO:0070062; GO:1990204 L-lactate dehydrogenase activity [GO:0004459] GYTSWAIGLSVMDLVGSILKNLRR 0.95811 0.41904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5567 0 0 0 0 0 0 0 0 0 0 0 12.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6587 0 0 0 0 0 0 11.1609 18.3396 18.2239 18.3627 0 23.3204 0 0 0 0 0 0 0 0 0 0 0 18.6588 10.7383 0 0 12.0119 20.0282 0 0 18.9001 18.958 18.9821 0 0 0 0 0 18.5281 19.2686 17.6776 19.416 0 0 0 0 0 0 0 20.0538 20.0546 0 0 0 21.0404 0 0 0 0 19.6803 0 20.0474 0 0 0 0 19.2536 0 0 13.9323 20.1186 0 0 0 0 0 0 0 18.6953 13.3304 0 20.0576 0 19.0155 0 11.9924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4S9 MALD2_HUMAN MARVEL domain-containing protein 2 (Tricellulin) MARVELD2 TRIC Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; establishment of endothelial barrier [GO:0061028]; sensory perception of sound [GO:0007605] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; paranodal junction [GO:0033010]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; paranodal junction [GO:0033010]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; establishment of endothelial barrier [GO:0061028]; sensory perception of sound [GO:0007605] GO:0005737; GO:0005923; GO:0007605; GO:0016021; GO:0016323; GO:0016324; GO:0030054; GO:0031410; GO:0033010; GO:0043220; GO:0045216; GO:0061028; GO:0061689; GO:0070160; GO:0070830 HTQTVRTYSEK 0.95811 0.58375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16696 CP2AD_HUMAN "Cytochrome P450 2A13, EC 1.14.14.1 (CYPIIA13)" CYP2A13 Homo sapiens (Human) aflatoxin metabolic process [GO:0046222]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; aflatoxin metabolic process [GO:0046222]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008389; GO:0008392; GO:0008395; GO:0009804; GO:0016712; GO:0019373; GO:0020037; GO:0043231; GO:0046222; GO:0070330 "arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" MPYTEAVIHEIQR 0.95812 0.61251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZR03 YU004_HUMAN Uncharacterized protein FLJ46757 Homo sapiens (Human) ANLKPWDGRAAPLGK 0.95812 0.42754 0 0 0 0 0 0 0 11.516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4558 0 0 0 0 0 0 0 0 0 A0JD37 TRDV3_HUMAN T cell receptor delta variable 3 TRDV3 hDV103S1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955]; innate immune response [GO:0045087] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955]; innate immune response [GO:0045087] GO:0002250; GO:0005615; GO:0006955; GO:0042101; GO:0045087 AFHLVISPVRTEDSATYYCAF 0.95813 0.42633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q496F6 CLM2_HUMAN "CMRF35-like molecule 2, CLM-2 (CD300 antigen-like family member E) (CMRF35-A5) (Immune receptor expressed on myeloid cells 2, IREM-2) (Polymeric immunoglobulin receptor 2, PIgR-2, PIgR2, Poly-Ig receptor 2) (CD antigen CD300e)" CD300E CD300LE CLM2 CMRF35A5 IREM2 Homo sapiens (Human) immune system process [GO:0002376] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; immune system process [GO:0002376] GO:0002376; GO:0004888; GO:0005886; GO:0016021 transmembrane signaling receptor activity [GO:0004888] LSSPHFLLVVLLK 0.95813 0.40881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8523 0 14.7362 0 0 0 0 0 0 0 0 13.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDM5 SACA4_HUMAN Sperm acrosome membrane-associated protein 4 (Sperm acrosomal membrane-associated protein 14) SPACA4 SAMP14 UNQ3046/PRO9862 Homo sapiens (Human) cell adhesion [GO:0007155]; sperm-egg recognition [GO:0035036] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; sperm-egg recognition [GO:0035036] GO:0001669; GO:0005576; GO:0005886; GO:0007155; GO:0016020; GO:0031225; GO:0035036 GCLRATSCGLEEPVSYR 0.95814 0.42543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99661 KIF2C_HUMAN "Kinesin-like protein KIF2C (Kinesin-like protein 6) (Mitotic centromere-associated kinesin, MCAK)" KIF2C KNSL6 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983] "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]" "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]" GO:0000775; GO:0000776; GO:0003777; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007080; GO:0008017; GO:0015630; GO:0016020; GO:0016887; GO:0019237; GO:0030951; GO:0035371; GO:0051010; GO:0051301; GO:0051310; GO:0051315; GO:0051983 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; centromeric DNA binding [GO:0019237]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010] ALGQNKAHTPFR 0.95814 4.813 0 0 0 0 11.8166 0 0 0 0 0 11.4604 0 0 0 0 0 0 0 0 10.1244 0 0 0 0 0 0 0 11.3108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6411 0 0 0 0 0 0 0 0 11.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9347 10.47 0 15.4378 0 0 0 0 13.9314 0 0 0 13.3833 0 0 0 0 0 0 0 0 0 0 0 13.0179 0 0 12.6586 0 0 13.1101 13.0894 14.2766 13.9933 0 15.9817 0 0 13.8882 0 0 13.8342 14.5418 13.743 13.9401 14.604 0 0 0 14.8506 0 0 0 13.3768 13.4587 13.4489 13.4861 14.6357 0 14.8757 0 14.1029 16.0539 11.8367 0 0 0 13.2112 14.3935 0 0 0 0 0 0 15.0034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.753 0 0 14.5448 0 0 0 0 0 Q7L8A9 VASH1_HUMAN "Tubulinyl-Tyr carboxypeptidase 1, EC 3.4.17.17 (Tubulin carboxypeptidase 1) (Tyrosine carboxypeptidase 1, TTCP 1) (Vasohibin-1)" VASH1 KIAA1036 VASH Homo sapiens (Human) angiogenesis [GO:0001525]; cell cycle [GO:0007049]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611] GO:0001525; GO:0001937; GO:0003779; GO:0004181; GO:0005615; GO:0005737; GO:0005783; GO:0006508; GO:0007049; GO:0009611; GO:0010596; GO:0016525; GO:0043537; GO:0045177; GO:0045765; GO:0060716; GO:1901491; GO:2000772 actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181] GGLPVDEATWER 0.95815 0.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.458 0 0 0 0 0 0 0 0 0 0 14.129 0 0 13.511 0 0 13.0986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5Z5 KCD17_HUMAN BTB/POZ domain-containing protein KCTD17 KCTD17 Homo sapiens (Human) cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; cell projection organization [GO:0030030]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; positive regulation of cilium assembly [GO:0045724]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] GO:0005737; GO:0005783; GO:0030030; GO:0031463; GO:0032469; GO:0042802; GO:0043161; GO:0045724; GO:0051260; GO:0097602 cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] LNVGGTVFLTTR 0.95816 0.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQY9 DBND2_HUMAN "Dysbindin domain-containing protein 2 (Casein kinase-1 binding protein, CK1BP) (HSMNP1)" DBNDD2 C20orf35 Homo sapiens (Human) negative regulation of protein kinase activity [GO:0006469] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; negative regulation of protein kinase activity [GO:0006469] GO:0005737; GO:0006469 GDGGAEPGACS 0.95816 0.56253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3283 0 0 0 0 13.5881 0 0 0 0 0 0 0 13.8537 0 0 0 0 0 0 0 0 0 14.9348 0 0 12.8772 0 0 0 0 0 0 0 0 12.4927 0 12.3186 12.8253 0 12.7276 12.5032 0 12.9129 0 0 0 0 0 0 0 0 0 12.4655 0 0 0 11.2725 0 11.1311 0 0 0 0 0 0 0 0 0 0 11.5271 0 0 0 0 0 0 0 12.3464 0 0 0 0 0 0 0 13.03 0 0 0 0 0 0 0 0 0 0 0 0 0 P01714 LV319_HUMAN Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH) IGLV3-19 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062 antigen binding [GO:0003823] FSGSSSGNTASLTITGAQAEDEADYYCNSRDSS 0.95817 0.66699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12968 NFAC3_HUMAN "Nuclear factor of activated T-cells, cytoplasmic 3, NF-ATc3, NFATc3 (NFATx) (T-cell transcription factor NFAT4, NF-AT4, NF-AT4c)" NFATC3 NFAT4 Homo sapiens (Human) calcineurin-NFAT signaling cascade [GO:0033173]; inflammatory response [GO:0006954]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; calcineurin-NFAT signaling cascade [GO:0033173]; inflammatory response [GO:0006954]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0006954; GO:0033173; GO:0045944; GO:1902894; GO:1905064; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" FTYTPVLMK 0.95817 0.56205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A7MCY6 TBKB1_HUMAN "TANK-binding kinase 1-binding protein 1, TBK1-binding protein 1" TBKBP1 KIAA0775 SINTBAD Homo sapiens (Human) defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; type I interferon signaling pathway [GO:0060337] GO:0005737; GO:0007249; GO:0046872; GO:0051607; GO:0060337; GO:1902554 metal ion binding [GO:0046872] AYGSELYGPGRPLSPR 0.95818 0.69468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7599 0 0 0 0 0 0 15.6964 0 0 0 15.2543 0 0 0 0 0 0 0 0 0 0 15.3427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3268 0 0 0 14.7676 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4297 0 0 0 0 0 0 Q2M238 RN3P1_HUMAN Putative RRN3-like protein RRN3P1 (RNA polymerase I transcription factor homolog pseudogene 1) RRN3P1 Homo sapiens (Human) transcription initiation from RNA polymerase I promoter [GO:0006361] nucleus [GO:0005634] nucleus [GO:0005634]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361] GO:0001042; GO:0001181; GO:0005634; GO:0006361 RNA polymerase I core binding [GO:0001042]; RNA polymerase I general transcription initiation factor activity [GO:0001181] EGLQYPQSLNFER 0.95818 0.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N816 TMM99_HUMAN Uncharacterized protein KRT10-AS1 (Transmembrane protein 99) KRT10-AS1 TMEM99 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 VLACSLPQVFLKPWIFVEHFSSWLSLELFSFLR 0.95818 0.66699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24522 GA45A_HUMAN "Growth arrest and DNA damage-inducible protein GADD45 alpha (DNA damage-inducible transcript 1 protein, DDIT-1)" GADD45A DDIT1 GADD45 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to ionizing radiation [GO:0071479]; cellular response to mechanical stimulus [GO:0071260]; centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; signal transduction in response to DNA damage [GO:0042770] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase binding [GO:0019900]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; apoptotic process [GO:0006915]; cellular response to ionizing radiation [GO:0071479]; cellular response to mechanical stimulus [GO:0071260]; centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; signal transduction in response to DNA damage [GO:0042770] GO:0000079; GO:0000122; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006915; GO:0007098; GO:0016525; GO:0016607; GO:0019900; GO:0033140; GO:0042770; GO:0042803; GO:0043065; GO:0043537; GO:0046330; GO:0046982; GO:0047485; GO:0051726; GO:0071260; GO:0071479; GO:0071901; GO:1900745; GO:1990841; GO:2000379 kinase binding [GO:0019900]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485] DVALQIHFTLIQAFCCENDINILRVSNPGR 0.9582 0.67102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2144 0 0 0 0 0 0 0 12.6893 0 12.0521 A0A075B6N1 TVB19_HUMAN T cell receptor beta variable 19 TRBV19 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] alpha-beta T cell receptor complex [GO:0042105]; plasma membrane [GO:0005886] alpha-beta T cell receptor complex [GO:0042105]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042105 EGQNVTLSCEQNLNHDAMYWYRQDPGQGLR 0.95821 0.67102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8561 11.531 0 0 0 0 0 0 0 Q96HQ2 C2AIL_HUMAN CDKN2AIP N-terminal-like protein (CDKN2A-interacting protein N-terminal-like protein) CDKN2AIPNL Homo sapiens (Human) nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] GO:0005654; GO:0005730 ARMEFILRHLPDYR 0.95821 0.66627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1006 0 0 0 0 0 13.216 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7273 0 0 0 0 A6NNL5 CO061_HUMAN Uncharacterized protein C15orf61 C15orf61 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 RAHEVALRLLLCR 0.95822 0.36198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7531 0 12.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7067 0 0 0 0 0 0 0 0 0 P54105 ICLN_HUMAN "Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln, I(Cln)) (Chloride ion current inducer protein, ClCI) (Reticulocyte pICln)" CLNS1A CLCI ICLN Homo sapiens (Human) "cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; histone H4-R3 methylation [GO:0043985]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spliceosomal snRNP assembly [GO:0000387]" cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; histone H4-R3 methylation [GO:0043985]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715; GO:0043985; GO:0045292; GO:0048026 RNA binding [GO:0003723] SFPPPGPAEGLLR 0.95822 0.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2517 0 0 0 0 0 0 0 0 0 0 0 0 14.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60294 TYW4_HUMAN "tRNA wybutosine-synthesizing protein 4, tRNA yW-synthesizing protein 4, EC 2.1.1.290, EC 2.3.1.231 (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase)" LCMT2 KIAA0547 TYW4 Homo sapiens (Human) tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; wybutosine biosynthetic process [GO:0031591] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; wybutosine biosynthetic process [GO:0031591] GO:0005737; GO:0006400; GO:0008175; GO:0030488; GO:0031591 tRNA methyltransferase activity [GO:0008175] GYYVRARAVR 0.95823 0.45164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7118 15.1025 0 14.9379 14.6807 13.7419 0 0 0 13.2193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DPF3 NBPF9_HUMAN Neuroblastoma breakpoint family member 9 NBPF9 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DQEEEEDQGPPCPR 0.95823 0.61613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHR7 TERB2_HUMAN Telomere repeats-binding bouquet formation protein 2 TERB2 C15orf43 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141] "chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]" "chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]" GO:0000781; GO:0005637; GO:0007129; GO:0045141; GO:0070197 SPEKHFIRTPVVEK 0.95823 0.66627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36537 UDB10_HUMAN "UDP-glucuronosyltransferase 2B10, UDPGT 2B10, EC 2.4.1.17" UGT2B10 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; UDP-glycosyltransferase activity [GO:0008194]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629] GO:0005789; GO:0006629; GO:0008194; GO:0008210; GO:0016021; GO:0052695 UDP-glycosyltransferase activity [GO:0008194] AKGAAVR 0.95826 0.46672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97441 0 0 0 0 0 0 0 10.3106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.874 13.3387 0 0 0 0 0 0 14.6272 0 0 0 0 13.3178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2486 13.7282 0 B2RUZ4 SMIM1_HUMAN Small integral membrane protein 1 (Vel blood group antigen) SMIM1 Homo sapiens (Human) cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803] GO:0005886; GO:0009986; GO:0016021; GO:0042803 protein homodimerization activity [GO:0042803] DGVSLGAVSSTEEASRCR 0.95829 0.66936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20061 TCO1_HUMAN "Transcobalamin-1, TC-1 (Haptocorrin, HC) (Protein R) (Transcobalamin I, TC I, TCI)" TCN1 TC1 Homo sapiens (Human) cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cobalamin binding [GO:0031419]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] GO:0005576; GO:0005615; GO:0006824; GO:0015889; GO:0031419; GO:0035580; GO:1904724 cobalamin binding [GO:0031419] GTSAVNVVLSLKLVGIQIQTLMQK 0.95829 0.42841 0 0 0 0 0 0 0 0 13.6734 13.2168 13.0721 13.4921 13.2775 0 13.068 12.7417 0 13.4027 0 13.4311 13.2523 0 0 0 12.4135 13.1158 13.3127 0 0 13.314 13.4952 13.1707 0 13.4344 0 0 0 0 12.9864 0 13.2233 0 13.159 13.1442 13.1126 0 13.3144 13.2326 0 12.6296 0 0 0 12.0118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6943 0 0 14.8276 14.9348 14.8042 14.7268 14.9566 0 0 0 0 0 14.6083 0 0 12.6605 0 P21291 CSRP1_HUMAN "Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1, CRP, CRP1) (Epididymis luminal protein 141, HEL-141)" CSRP1 CSRP CYRP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214] GO:0003723; GO:0005634; GO:0005737; GO:0005925; GO:0008270; GO:0008307; GO:0030018; GO:0030036; GO:0042805; GO:0045214; GO:0060537; GO:0070062; GO:0070527 actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270] HEEAPGHRPTTNPNASK 0.95829 0.69071 0 0 0 0 11.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56557 TM50B_HUMAN Transmembrane protein 50B (HCV p7-trans-regulated protein 3) TMEM50B C21orf4 UNQ167/PRO193 Homo sapiens (Human) late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511] GO:0000139; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0032511 AGFLDNFRWPECECIDWSERR 0.95829 0.41927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1414 0 0 0 0 0 0 0 0 0 12.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IA17 SIGIR_HUMAN "Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8, TIR8)" SIGIRR UNQ301/PRO342 Homo sapiens (Human) acute-phase response [GO:0006953]; negative regulation of chemokine production [GO:0032682]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acute-phase response [GO:0006953]; negative regulation of chemokine production [GO:0032682]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; signal transduction [GO:0007165] GO:0001960; GO:0005886; GO:0006953; GO:0007165; GO:0016020; GO:0016021; GO:0031665; GO:0032682; GO:0043433 AGPTSHVAAVLASLLVLLALLLAALLYVKCR 0.95829 0.40904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8149 13.0208 0 0 0 0 0 0 0 0 13.3711 13.0186 0 0 0 0 13.9192 0 14.408 13.5035 0 13.5575 13.7605 13.7818 13.5233 13.6272 0 0 0 0 0 10.3249 0 0 0 0 0 13.7189 14.293 0 0 0 0 13.8613 13.7208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2043 0 0 0 0 0 0 0 0 13.432 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0207 0 13.161 0 0 0 0 14.7626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7T0 CTSRB_HUMAN "Cation channel sperm-associated auxiliary subunit beta, CatSper-beta" CATSPERB C14orf161 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; cilium [GO:0005929]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; cilium [GO:0005929]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005886; GO:0005929; GO:0007283; GO:0030154; GO:0036128; GO:0097228 CFANREHFEVDYVTVTFERNR 0.9583 0.42768 0 0 0 0 0 0 0 11.6786 0 0 0 0 0 0 0 12.6572 0 0 12.0406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8008 0 0 0 0 13.8281 0 0 0 0 0 12.5983 0 0 0 0 0 12.6056 0 0 0 12.547 0 0 0 0 0 0 12.2178 0 0 0 0 13.6975 0 0 0 0 0 0 12.854 0 10.5528 0 0 0 13.4066 0 0 0 12.456 0 0 0 0 0 10.8572 12.7021 0 0 0 0 10.8919 0 O00213 APBB1_HUMAN Amyloid beta precursor protein binding family B member 1 (Amyloid-beta A4 precursor protein-binding family B member 1) (Protein Fe65) APBB1 FE65 RIR Homo sapiens (Human) "apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H4 acetylation [GO:0043967]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle receptor binding [GO:0050750]; proline-rich region binding [GO:0070064]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H4 acetylation [GO:0043967]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" GO:0000122; GO:0001540; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005886; GO:0006325; GO:0006355; GO:0006915; GO:0006939; GO:0006974; GO:0007165; GO:0007409; GO:0016607; GO:0030027; GO:0030426; GO:0031625; GO:0042393; GO:0043065; GO:0043967; GO:0045202; GO:0045893; GO:0045944; GO:0050714; GO:0050750; GO:0070064; GO:1902807 amyloid-beta binding [GO:0001540]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; low-density lipoprotein particle receptor binding [GO:0050750]; proline-rich region binding [GO:0070064]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625] LQATAVGPK 0.95831 0.58415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG08 GPHRB_HUMAN Golgi pH regulator B (Protein GPR89B) GPR89B GPHRB GPR89C HSPC201 Homo sapiens (Human) intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; T cell differentiation [GO:0030217] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; voltage-gated anion channel activity [GO:0008308]; intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; regulation of ion transmembrane transport [GO:0034765]; T cell differentiation [GO:0030217] GO:0000139; GO:0008308; GO:0015031; GO:0016021; GO:0030217; GO:0032580; GO:0034765; GO:0051452 voltage-gated anion channel activity [GO:0008308] LLFSCLLWLTFMYFFWK 0.95831 0.67911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUA6 MYL10_HUMAN "Myosin regulatory light chain 10 (Myosin light chain 2, lymphocyte-specific) (Precursor lymphocyte-specific regulatory light chain)" MYL10 MYLC2PL PLRLC Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509] GO:0005509; GO:0005737; GO:0005739; GO:0005829 calcium ion binding [GO:0005509] LLRLVSNSWPQVILPPR 0.95831 0.68993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSP4 CENPM_HUMAN "Centromere protein M, CENP-M (Interphase centromere complex protein 39) (Proliferation-associated nuclear element protein 1)" CENPM C22orf18 ICEN39 PANE1 Homo sapiens (Human) cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654] GO:0000776; GO:0005654; GO:0005829 ATMAQRLVRVLQICAGHVPGVSALNLLSLLR 0.95831 0.67958 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0078 0 13.0269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3048 0 0 0 0 0 0 0 0 0 P00395 COX1_HUMAN "Cytochrome c oxidase subunit 1, EC 7.1.1.9 (Cytochrome c oxidase polypeptide I)" MT-CO1 COI COXI MTCO1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular respiration [GO:0045333]; cerebellum development [GO:0021549]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory electron transport chain [GO:0022904]; response to copper ion [GO:0046688]; response to electrical stimulus [GO:0051602]; response to oxidative stress [GO:0006979]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular respiration [GO:0045333]; cerebellum development [GO:0021549]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory electron transport chain [GO:0022904]; response to copper ion [GO:0046688]; response to electrical stimulus [GO:0051602]; response to oxidative stress [GO:0006979]" GO:0004129; GO:0005743; GO:0005750; GO:0005751; GO:0006123; GO:0006979; GO:0007568; GO:0009060; GO:0015990; GO:0020037; GO:0021549; GO:0022904; GO:0031966; GO:0045277; GO:0045333; GO:0046688; GO:0046872; GO:0051602 cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872] WLFSTNHKDIGTLYLLFGAWAGVLGTALSLLIR 0.95833 0.66699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3R1 NDST4_HUMAN "Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4, EC 2.8.2.8 (Glucosaminyl N-deacetylase/N-sulfotransferase 4, NDST-4) (N-heparan sulfate sulfotransferase 4, N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4, EC 3.-.-.-; Heparan sulfate N-sulfotransferase 4, EC 2.8.2.- ]" NDST4 HSST4 Homo sapiens (Human) "heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" GO:0000139; GO:0005794; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210 [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213] AASLVPK 0.95833 4.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7591 0 16.4615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3776 0 0 0 0 0 0 0 0 0 0 0 13.1199 0 0 0 0 0 0 0 0 0 13.5041 0 0 0 0 0 0 0 13.8255 0 0 12.8138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4782 0 0 0 0 10.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3S2 ZN330_HUMAN Zinc finger protein 330 (Nucleolar autoantigen 36) (Nucleolar cysteine-rich protein) ZNF330 NOA36 Homo sapiens (Human) "chromosome, centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]" GO:0000775; GO:0005634; GO:0005654; GO:0005730; GO:0008270; GO:0030496; GO:0046872 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] AFCYFCNSVQKLPICAQCGKTK 0.95833 4.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8141 0 0 0 0 11.0247 0 0 0 0 0 0 13.8812 16.1302 0 0 0 0 0 0 0 0 0 12.4413 0 0 0 13.5291 11.45 0 0 0 0 12.8858 0 0 0 0 13.0006 0 0 0 0 0 0 0 13.6032 0 0 0 0 0 0 0 0 13.8518 0 0 0 0 0 13.9204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8893 19.7269 10.5658 0 0 0 0 0 Q92783 STAM1_HUMAN "Signal transducing adapter molecule 1, STAM-1" STAM STAM1 Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of extracellular exosome assembly [GO:1903551]; signal transduction [GO:0007165] GO:0005829; GO:0007165; GO:0016236; GO:0031901; GO:0033565; GO:0035091; GO:0036258; GO:0043130; GO:0043231; GO:0043328; GO:0044389; GO:0090148; GO:1903543; GO:1903551 phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389] VMEALSLYTKLMNEDPMYSMYAK 0.95834 0.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MZ36 EVPLL_HUMAN Envoplakin-like protein EVPLL Homo sapiens (Human) epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; wound healing [GO:0042060] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; membrane [GO:0016020] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; membrane [GO:0016020]; intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198]; epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; wound healing [GO:0042060] GO:0001533; GO:0005198; GO:0005737; GO:0008544; GO:0016020; GO:0019215; GO:0042060; GO:0045104 intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198] EAEVLLKDLFLDVDKAR 0.95835 0.56255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8987 0 0 0 10.8957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58400 NRX1B_HUMAN Neurexin-1-beta (Neurexin I-beta) NRXN1 Homo sapiens (Human) "adult behavior [GO:0030534]; angiogenesis [GO:0001525]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion involved in synapse maturation [GO:0090125]; cellular response to calcium ion [GO:0071277]; cerebellar granule cell differentiation [GO:0021707]; establishment of protein localization [GO:0045184]; gamma-aminobutyric acid receptor clustering [GO:0097112]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; guanylate kinase-associated protein clustering [GO:0097117]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; learning [GO:0007612]; maintenance of synapse structure [GO:0099558]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of gene expression [GO:0010629]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal signal transduction [GO:0023041]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein-containing complex assembly involved in synapse maturation [GO:0090126]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic vesicle clustering [GO:0097091]; vocalization behavior [GO:0071625]" anchoring junction [GO:0070161]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of presynaptic membrane [GO:0099056]; neuromuscular junction [GO:0031594]; neuron to neuron synapse [GO:0098984]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; protein complex involved in cell-cell adhesion [GO:0098635]; vesicle [GO:0031982] "anchoring junction [GO:0070161]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of presynaptic membrane [GO:0099056]; neuromuscular junction [GO:0031594]; neuron to neuron synapse [GO:0098984]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; protein complex involved in cell-cell adhesion [GO:0098635]; vesicle [GO:0031982]; calcium-dependent protein binding [GO:0048306]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; type 1 fibroblast growth factor receptor binding [GO:0005105]; adult behavior [GO:0030534]; angiogenesis [GO:0001525]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion involved in synapse maturation [GO:0090125]; cellular response to calcium ion [GO:0071277]; cerebellar granule cell differentiation [GO:0021707]; establishment of protein localization [GO:0045184]; gamma-aminobutyric acid receptor clustering [GO:0097112]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; guanylate kinase-associated protein clustering [GO:0097117]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; learning [GO:0007612]; maintenance of synapse structure [GO:0099558]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of gene expression [GO:0010629]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal signal transduction [GO:0023041]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of presynaptic active zone assembly [GO:1905520]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein-containing complex assembly involved in synapse maturation [GO:0090126]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic vesicle clustering [GO:0097091]; vocalization behavior [GO:0071625]" GO:0001525; GO:0004888; GO:0005102; GO:0005105; GO:0005783; GO:0005886; GO:0007157; GO:0007158; GO:0007165; GO:0007416; GO:0007612; GO:0009986; GO:0010628; GO:0010629; GO:0010739; GO:0010976; GO:0016339; GO:0021707; GO:0023041; GO:0030139; GO:0030534; GO:0031175; GO:0031594; GO:0031965; GO:0031982; GO:0032230; GO:0033138; GO:0035176; GO:0035418; GO:0042734; GO:0043025; GO:0044295; GO:0045184; GO:0045743; GO:0046872; GO:0048306; GO:0048812; GO:0050839; GO:0051490; GO:0051897; GO:0051965; GO:0051968; GO:0060074; GO:0060076; GO:0060077; GO:0070161; GO:0070374; GO:0071277; GO:0071625; GO:0090125; GO:0090126; GO:0097091; GO:0097104; GO:0097105; GO:0097109; GO:0097112; GO:0097114; GO:0097116; GO:0097117; GO:0097118; GO:0097119; GO:0097120; GO:0098635; GO:0098793; GO:0098978; GO:0098982; GO:0098984; GO:0099056; GO:0099558; GO:1900020; GO:1900075; GO:1903078; GO:1905520; GO:2000310; GO:2000311; GO:2000463 calcium-dependent protein binding [GO:0048306]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; type 1 fibroblast growth factor receptor binding [GO:0005105] GGGQITYK 0.95835 0.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12429 ANXA3_HUMAN "Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III, PAP-III)" ANXA3 ANX3 Homo sapiens (Human) animal organ regeneration [GO:0031100]; defense response to bacterium [GO:0042742]; hippocampus development [GO:0021766]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; response to glucocorticoid [GO:0051384]; response to growth factor [GO:0070848] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; specific granule [GO:0042581] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; specific granule [GO:0042581]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; phospholipase A2 inhibitor activity [GO:0019834]; animal organ regeneration [GO:0031100]; defense response to bacterium [GO:0042742]; hippocampus development [GO:0021766]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; response to glucocorticoid [GO:0051384]; response to growth factor [GO:0070848] GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0006909; GO:0010595; GO:0016020; GO:0019834; GO:0021766; GO:0030424; GO:0030425; GO:0030670; GO:0031100; GO:0042581; GO:0042742; GO:0043025; GO:0043312; GO:0045766; GO:0048306; GO:0051054; GO:0051091; GO:0051384; GO:0070062; GO:0070848 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; phospholipase A2 inhibitor activity [GO:0019834] FTEILCLRSFPQLKLTFDEYR 0.95836 0.67853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH89 O5AK3_HUMAN Putative olfactory receptor 5AK3 OR5AK3P OR5AK3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] VASIFYGTVIPMLNPLIYSLRNK 0.95836 0.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIG4 PS1C2_HUMAN Psoriasis susceptibility 1 candidate gene 2 protein (Protein SPR1) PSORS1C2 C6orf17 SPR1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 TDPPQPPRPDDPWPAGPQPPENPWPPAPEVDNR 0.95836 0.66699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AQ8 MCUR1_HUMAN "Mitochondrial calcium uniporter regulator 1, MCU regulator 1 (Coiled-coil domain-containing protein 90A, mitochondrial)" MCUR1 C6orf79 CCDC90A Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] GO:0005739; GO:0006851; GO:0031305; GO:0036444; GO:0051561; GO:0070509 APAARGGVSR 0.95837 0.67842 0 0 0 0 0 0 0 0 11.5275 0 0 0 0 0 0 0 0 0 0 13.2226 0 0 0 0 0 0 10.8446 0 0 0 0 0 0 0 11.7294 0 0 0 0 10.1279 0 0 0 0 0 0 0 13.1445 0 0 0 0 0 11.3607 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1453 0 0 11.2616 11.5979 0 12.747 12.3869 0 12.1189 12.6739 12.7641 13.7305 10.9743 13.6922 0 15.2511 0 13.0823 14.7254 0 0 0 0 0 0 16.4676 11.9112 0 0 14.1887 0 10.9772 0 11.898 0 11.7316 0 13.1461 15.0064 0 0 10.1211 13.0235 0 0 0 0 0 0 11.8762 0 12.5822 12.2177 11.5713 15.47 13.8711 12.7284 0 0 0 14.5065 0 12.5433 11.933 0 0 12.5518 11.2429 12.4203 0 12.4954 0 12.3217 0 0 0 0 0 0 0 0 0 0 0 0 13.9726 13.5 16.176 11.4812 0 0 0 0 0 0 12.4638 0 0 0 0 11.9954 0 0 0 0 0 0 0 9.96737 0 0 0 P59540 T2R46_HUMAN "Taste receptor type 2 member 46, T2R46 (Taste receptor type 2 member 54, T2R54)" TAS2R46 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038; GO:0060170 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] GEKPSSS 0.95838 0.69588 12.4844 0 11.4965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8901 0 0 0 14.5982 15.0375 0 15.1521 0 0 0 0 0 14.4876 0 0 0 0 0 0 0 0 0 0 0 P78329 CP4F2_HUMAN "Cytochrome P450 4F2, EC 1.14.14.1 (20-hydroxyeicosatetraenoic acid synthase, 20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase, EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1, EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2, EC 1.14.14.78)" CYP4F2 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805]" GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006690; GO:0006691; GO:0006805; GO:0007596; GO:0008217; GO:0008391; GO:0008392; GO:0010430; GO:0016324; GO:0016709; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0032304; GO:0032305; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0042377; GO:0043231; GO:0050051; GO:0052869; GO:0052871; GO:0052872; GO:0055078; GO:0070330; GO:0097258; GO:0097259; GO:0097267; GO:0102033; GO:0102207 "20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; docosanoate omega-hydroxylase activity [GO:0102207]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]" ACRLVHDFTDAVIQER 0.95838 0.66699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1754 0 0 0 0 0 0 Q6UXU6 TMM92_HUMAN Transmembrane protein 92 TMEM92 UNQ5801/PRO19608 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 GFKCCGDSCCQENELFPGPVR 0.95839 0.4536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN68 D19P2_HUMAN "Putative C-mannosyltransferase DPY19L2P2, EC 2.4.1.- (Dpy-19-like protein 2 pseudogene 2) (Protein dpy-19 homolog 2-like 2)" DPY19L2P2 Homo sapiens (Human) spermatid development [GO:0007286] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; spermatid development [GO:0007286] GO:0007286; GO:0016021; GO:0016757 glycosyltransferase activity [GO:0016757] ATLLIYTKTLLLPVVMVITCFIFK 0.95839 0.36234 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3313 0 0 0 0 0 0 0 0 0 10.6303 0 12.9581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8512 0 0 0 0 0 0 0 13.4991 0 0 0 0 0 0 0 0 0 11.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0431 0 0 0 10.5716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGJ1 GCP4_HUMAN "Gamma-tubulin complex component 4, GCP-4, hGCP4 (Gamma-ring complex protein 76 kDa, h76p, hGrip76)" TUBGCP4 76P GCP4 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003 gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200] HLKSNQTDAIKWR 0.95839 0.69562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6945 0 0 0 0 0 0 0 0 11.9769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6943 0 10.8833 0 0 0 12.7119 12.39 0 0 0 0 0 0 0 0 0 0 0 0 12.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1316 0 0 0 0 12.9109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1221 0 0 0 0 0 0 0 12.1412 0 0 11.5186 0 0 0 0 0 0 12.5113 0 0 0 Q9NST1 PLPL3_HUMAN "1-acylglycerol-3-phosphate O-acyltransferase PNPLA3, EC 2.3.1.51 (Acylglycerol transacylase) (Adiponutrin, ADPN) (Calcium-independent phospholipase A2-epsilon, iPLA2-epsilon, EC 3.1.1.4) (Lysophosphatidic acid acyltransferase) (Patatin-like phospholipase domain-containing protein 3, EC 3.1.1.3)" PNPLA3 ADPN C22orf20 Homo sapiens (Human) "acylglycerol acyl-chain remodeling [GO:0036155]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to insulin stimulus [GO:0032869]; glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to sucrose [GO:0009744]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]; white fat cell differentiation [GO:0050872]" cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acylglycerol O-acyltransferase activity [GO:0016411]; diolein transacylation activity [GO:0051265]; lipoprotein lipase activity [GO:0004465]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806]; acylglycerol acyl-chain remodeling [GO:0036155]; cellular response to 3,3',5-triiodo-L-thyronine [GO:1905243]; cellular response to insulin stimulus [GO:0032869]; glycerophospholipid metabolic process [GO:0006650]; lipid droplet organization [GO:0034389]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]; phosphatidic acid biosynthetic process [GO:0006654]; response to sucrose [GO:0009744]; triglyceride acyl-chain remodeling [GO:0036153]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]; white fat cell differentiation [GO:0050872]" GO:0001676; GO:0003841; GO:0004465; GO:0004623; GO:0004806; GO:0005737; GO:0005789; GO:0005811; GO:0006650; GO:0006654; GO:0009744; GO:0016020; GO:0016021; GO:0016411; GO:0019432; GO:0019433; GO:0032869; GO:0034389; GO:0035727; GO:0036042; GO:0036153; GO:0036155; GO:0042171; GO:0050872; GO:0051264; GO:0051265; GO:0055088; GO:1905243 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acylglycerol O-acyltransferase activity [GO:0016411]; diolein transacylation activity [GO:0051265]; lipoprotein lipase activity [GO:0004465]; long-chain fatty acyl-CoA binding [GO:0036042]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophosphatidic acid binding [GO:0035727]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; triglyceride lipase activity [GO:0004806] CLPANVHQLISGKIGISLTRVSDGENVLVSDFR 0.9584 0.61137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9161 0 0 0 11.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32119 PRDX2_HUMAN "Peroxiredoxin-2, EC 1.11.1.24 (Natural killer cell-enhancing factor B, NKEF-B) (PRP) (Thiol-specific antioxidant protein, TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2)" PRDX2 NKEFB TDPX1 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway [GO:0097191]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; thymus development [GO:0048538] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; antioxidant activity [GO:0016209]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway [GO:0097191]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation [GO:0045581]; positive regulation of blood coagulation [GO:0030194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide metabolic process [GO:0010310]; removal of superoxide radicals [GO:0019430]; respiratory burst involved in inflammatory response [GO:0002536]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; thymus development [GO:0048538] GO:0002357; GO:0002536; GO:0005737; GO:0005829; GO:0006979; GO:0008379; GO:0010310; GO:0016209; GO:0019430; GO:0030194; GO:0031665; GO:0032088; GO:0032496; GO:0034599; GO:0042098; GO:0042744; GO:0042981; GO:0043029; GO:0043066; GO:0043410; GO:0045321; GO:0045454; GO:0045581; GO:0048538; GO:0070062; GO:0097191; GO:2001240 antioxidant activity [GO:0016209]; thioredoxin peroxidase activity [GO:0008379] YVVLFFYPLDFTFVCPTEIIAFSNRAEDFR 0.95841 0.67102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4445 0 0 0 0 0 0 0 0 13.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3S9 NT2NA_HUMAN Notch homolog 2 N-terminal-like protein A (Notch homolog 2 N-terminal-like protein) NOTCH2NLA N2N NOTCH2NL Homo sapiens (Human) cell differentiation [GO:0030154]; cerebral cortex development [GO:0021987]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell differentiation [GO:0030154]; cerebral cortex development [GO:0021987]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747] GO:0005112; GO:0005509; GO:0005576; GO:0005737; GO:0007219; GO:0021987; GO:0030154; GO:0045747 calcium ion binding [GO:0005509]; Notch binding [GO:0005112] ECQWTDACLSHPCANGSTCTTVANQFSCK 0.95841 0.45191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0226 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9X5 TMM75_HUMAN Putative protein encoded by LINC02912 LINC02912 TMEM75 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 SCHFALSFLIGKMGIIILSVCLICTR 0.95841 0.45287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2659 0 0 13.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 11.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9151 0 0 0 0 0 0 0 11.1737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59544 T2R50_HUMAN "Taste receptor type 2 member 50, T2R50 (Taste receptor type 2 member 51, T2R51)" TAS2R50 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] ALQTLISFLLLCAIFFLFLIVSVWSPRR 0.95842 0.61007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.95 0 13.9464 0 0 0 13.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 12.805 0 0 0 0 0 0 0 0 12.5608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.974 0 14.2441 0 0 0 0 0 10.7586 0 0 0 0 0 0 0 0 0 0 0 0 11.8987 0 0 0 0 0 P56856 CLD18_HUMAN Claudin-18 CLDN18 UNQ778/PRO1572 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; digestive tract development [GO:0048565]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast development [GO:2001205]; negative regulation of protein localization to nucleus [GO:1900181]; protein localization to nucleus [GO:0034504]; response to ethanol [GO:0045471]; TNFSF11-mediated signaling pathway [GO:0071847] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; digestive tract development [GO:0048565]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast development [GO:2001205]; negative regulation of protein localization to nucleus [GO:1900181]; protein localization to nucleus [GO:0034504]; response to ethanol [GO:0045471]; TNFSF11-mediated signaling pathway [GO:0071847] GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016338; GO:0034504; GO:0042802; GO:0045471; GO:0045779; GO:0048565; GO:0070830; GO:0071847; GO:1900181; GO:2001205 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] ALMIVGIVLGAIGLLVSIFALK 0.95843 0.41167 0 0 9.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1564 0 0 0 12.0235 0 0 0 0 0 0 0 0 0 11.8231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9537 0 0 0 0 0 10.911 0 0 11.8955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2499 0 0 11.14 0 0 0 0 0 0 0 0 0 0 0 11.001 0 0 0 0 0 0 0 0 10.6568 0 0 0 17.3635 15.8115 13.5675 0 0 0 0 0 0 0 0 11.4178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7974 0 13.0189 0 0 11.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5542 Q5H8A3 NMS_HUMAN Neuromedin-S NMS Homo sapiens (Human) locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218] GO:0001664; GO:0005576; GO:0007218; GO:0045475 G protein-coupled receptor binding [GO:0001664] FLFHYSRTQEATHPVK 0.95844 0.6937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q71F78 LCA10_HUMAN Putative lung carcinoma-associated protein 10 LCA10 Homo sapiens (Human) CPEPDARHGWGSGSNAGYR 0.95844 0.41039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPE3 NOP10_HUMAN H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10) NOP10 NOLA3 Homo sapiens (Human) positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; pseudouridine synthesis [GO:0001522]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004] box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697] box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; pseudouridine synthesis [GO:0001522]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004] GO:0001522; GO:0003723; GO:0005654; GO:0005697; GO:0005732; GO:0007004; GO:0016604; GO:0031118; GO:0031120; GO:0031429; GO:0034513; GO:0070034; GO:0072589; GO:0090661; GO:1904874 box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] FSPDDKYSR 0.95845 0.4672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3916 0 0 0 0 0 0 0 0 0 Q9Y217 MTMR6_HUMAN "Myotubularin-related protein 6 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTMR6 Homo sapiens (Human) endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]" GO:0004438; GO:0004722; GO:0004725; GO:0005635; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0006470; GO:0006661; GO:0006897; GO:0032587; GO:0046856; GO:0048471; GO:0052629; GO:0106018 "phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]" DIKDLESKIK 0.95845 0.69253 0 0 0 0 0 0 0 0 0 0 0 0 9.80797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5692 0 0 0 0 0 0 0 0 12.5342 0 0 0 0 0 0 0 10.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7449 11.2816 0 0 0 0 0 12.8784 0 12.3903 13.6595 0 0 0 12.1803 0 0 0 0 0 0 0 0 11.0822 0 0 13.0267 0 0 0 0 0 0 0 0 0 0 0 0 11.2038 13.7955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRX1 PNO1_HUMAN RNA-binding protein PNO1 (Partner of NOB1) PNO1 Homo sapiens (Human) cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0005829 RNA binding [GO:0003723] AEEGFTQVTRK 0.95846 0.46611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D1Z8 GRIFN_HUMAN Grifin (Galectin-related inter-fiber protein) GRIFIN Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; carbohydrate binding [GO:0030246] GO:0005737; GO:0030246 carbohydrate binding [GO:0030246] QRPLGATTR 0.95847 0.42012 0 0 0 11.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8664 0 0 0 0 0 0 0 0 0 0 0 12.7504 0 0 11.8156 12.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1216 12.4481 0 11.5531 0 12.6109 0 0 0 0 0 0 0 0 12.7476 12.8565 12.602 13.3362 0 0 0 0 0 10.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60673 PROF3_HUMAN Profilin-3 (Profilin III) PFN3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of actin filament polymerization [GO:0030833] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of actin filament polymerization [GO:0030833] GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0008289; GO:0030036; GO:0030833; GO:0032233 actin binding [GO:0003779]; lipid binding [GO:0008289] ALLVLMGR 0.95847 0.40943 0 0 0 0 0 0 0 12.0191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5341 0 0 0 0 0 0 13.3204 0 0 0 12.9358 13.2697 0 0 0 0 0 0 0 0 0 0 0 0 15.8774 0 0 0 0 14.2245 0 0 0 0 0 14.3108 14.4288 0 13.8381 0 0 14.5582 0 0 0 0 0 0 0 0 0 0 0 0 16.1224 0 0 0 0 14.5985 0 0 0 0 0 0 12.1909 0 0 12.8219 0 0 14.7438 15.5178 0 15.1872 14.5971 0 0 14.0638 0 0 0 0 0 0 0 0 0 11.2878 0 0 0 0 0 0 0 Q7L2H7 EIF3M_HUMAN "Eukaryotic translation initiation factor 3 subunit M, eIF3m (Fetal lung protein B5, hFL-B5) (PCI domain-containing protein 1)" EIF3M HFLB5 PCID1 GA17 PNAS-125 Homo sapiens (Human) cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]" GO:0001732; GO:0002183; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290; GO:0071541 translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] DPNAFLFDHLLTLKPVKFLEGELIHDLLTIFVSAK 0.95847 0.41954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3652 0 0 0 0 0 11.42 12.1783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6979 0 0 0 11.7077 0 0 0 0 0 12.9354 0 0 0 12.0667 0 0 0 11.3858 0 0 0 0 0 0 0 0 12.0914 0 0 12.1612 0 0 0 0 0 12.3202 0 12.0501 0 0 13.6958 0 11.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1974 0 0 0 0 11.3062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92670 ZN75C_HUMAN Putative zinc finger protein 75C (Zinc finger protein 75C pseudogene) ZNF75CP ZNF75C Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GTTVAPGFKWK 0.95847 0.42919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.824 0 0 11.4044 12.5959 0 0 11.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5512 13.6057 13.3465 0 12.7068 0 0 14.3392 0 13.364 0 0 16.8101 15.3303 0 0 14.0398 0 0 0 0 0 16.2528 0 0 0 0 0 12.7544 0 0 14.1258 0 0 0 0 14.3354 0 0 0 0 0 0 0 0 14.1595 12.5524 0 0 0 0 0 0 0 13.7648 13.5873 12.8742 0 14.1114 13.2917 13.4484 0 0 0 0 13.5476 0 0 0 14.716 0 0 0 0 0 0 14.1459 0 0 14.0513 18.1225 14.3126 0 0 0 0 13.4939 0 0 0 0 0 0 0 0 0 0 14.3211 14.9099 0 0 0 0 0 0 0 Q9BXI9 C1QT6_HUMAN Complement C1q tumor necrosis factor-related protein 6 C1QTNF6 CTRP6 UNQ581/PRO1151 Homo sapiens (Human) collagen trimer [GO:0005581]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802] GO:0005581; GO:0005615; GO:0042802 identical protein binding [GO:0042802] GDKGEMGSPGAPCQK 0.95847 0.40922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T3Y7 BVAS1_HUMAN Putative uncharacterized protein BVES-AS1 (BVES antisense RNA 1) (BVES antisense gene protein 1) BVES-AS1 C6orf112 Homo sapiens (Human) STFTVHWTTILGICRPIK 0.95848 0.67001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KC2 ARL5B_HUMAN ADP-ribosylation factor-like protein 5B (ADP-ribosylation factor-like protein 8) ARL5B ARL8 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] trans-Golgi network [GO:0005802] trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0016192; GO:1903292 GTP binding [GO:0005525]; GTPase activity [GO:0003924] GLIFAKLWSLFCNQEHK 0.95848 0.69181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H772 GREM2_HUMAN "Gremlin-2 (Cysteine knot superfamily 1, BMP antagonist 2) (DAN domain family member 3) (Protein related to DAN and cerberus)" GREM2 CKTSF1B2 DAND3 PRDC Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal identity [GO:0048263]; embryonic body morphogenesis [GO:0010172]; regulation of cytokine activity [GO:0060300]; sequestering of BMP from receptor via BMP binding [GO:0038098] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; cytokine activity [GO:0005125]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018]; animal organ morphogenesis [GO:0009887]; cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal identity [GO:0048263]; embryonic body morphogenesis [GO:0010172]; regulation of cytokine activity [GO:0060300]; sequestering of BMP from receptor via BMP binding [GO:0038098] GO:0005125; GO:0005576; GO:0005615; GO:0008201; GO:0009887; GO:0010172; GO:0019221; GO:0036122; GO:0038098; GO:0042802; GO:0048018; GO:0048263; GO:0060300 BMP binding [GO:0036122]; cytokine activity [GO:0005125]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018] EEESFQSCAFCK 0.95848 4.4017 12.2802 0 0 0 9.96867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7023 0 0 0 0 0 0 0 13.4667 0 13.4569 0 11.0395 0 0 12.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9755 0 0 0 0 0 0 0 0 0 0 0 0 11.1423 0 0 0 0 0 0 0 0 0 0 0 12.9395 0 0 0 0 0 0 0 0 0 12.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4135 0 0 0 12.4024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47874 OMP_HUMAN Olfactory marker protein (Olfactory neuronal-specific protein) OMP Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neurogenesis [GO:0022008]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] axon [GO:0030424]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202] axon [GO:0030424]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202]; peptide binding [GO:0042277]; chemical synaptic transmission [GO:0007268]; neurogenesis [GO:0022008]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] GO:0005634; GO:0005829; GO:0007165; GO:0007268; GO:0007608; GO:0022008; GO:0030424; GO:0042277; GO:0043025; GO:0045202 peptide binding [GO:0042277] EDSDAIDWNEADALEFGER 0.95849 0.69143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4408 0 0 0 0 0 0 0 0 0 0 13.9847 0 0 0 0 0 0 0 0 0 0 0 0 12.1534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3676 0 0 0 0 0 14.468 0 0 0 0 0 0 0 0 0 0 12.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8813 0 0 0 0 0 0 0 Q8TF63 DCNP1_HUMAN Dendritic cell nuclear protein 1 (Dendritic cell nuclear protein-1) (Dendritic cell-associated nuclear protein) DCANP1 C5orf20 DCNP1 Homo sapiens (Human) auditory behavior [GO:0031223]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; craniofacial suture morphogenesis [GO:0097094]; genitalia development [GO:0048806]; genitalia morphogenesis [GO:0035112]; hard palate morphogenesis [GO:1905748]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; learned vocalization behavior [GO:0098583]; mastication [GO:0071626]; negative regulation of relaxation of muscle [GO:1901078]; negative regulation of saliva secretion [GO:1905747]; neuromuscular process controlling balance [GO:0050885]; peristalsis [GO:0030432]; regulation of muscle organ development [GO:0048634]; thorax and anterior abdomen determination [GO:0007356]; trigeminal nerve development [GO:0021559]; vestibulocochlear nerve formation [GO:0021650] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; auditory behavior [GO:0031223]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; craniofacial suture morphogenesis [GO:0097094]; genitalia development [GO:0048806]; genitalia morphogenesis [GO:0035112]; hard palate morphogenesis [GO:1905748]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; learned vocalization behavior [GO:0098583]; mastication [GO:0071626]; negative regulation of relaxation of muscle [GO:1901078]; negative regulation of saliva secretion [GO:1905747]; neuromuscular process controlling balance [GO:0050885]; peristalsis [GO:0030432]; regulation of muscle organ development [GO:0048634]; thorax and anterior abdomen determination [GO:0007356]; trigeminal nerve development [GO:0021559]; vestibulocochlear nerve formation [GO:0021650] GO:0003677; GO:0005654; GO:0005737; GO:0007356; GO:0016604; GO:0021559; GO:0021650; GO:0030432; GO:0031223; GO:0035112; GO:0042472; GO:0048634; GO:0048806; GO:0048839; GO:0050885; GO:0071626; GO:0090102; GO:0090103; GO:0097094; GO:0098583; GO:1901078; GO:1905747; GO:1905748 DNA binding [GO:0003677] AVKLCPSETSFFLSR 0.95849 0.61409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VCS5 AMOT_HUMAN Angiomotin AMOT KIAA1071 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; establishment of epithelial cell polarity [GO:0090162]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570] actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725] actin filament [GO:0005884]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell migration involved in gastrulation [GO:0042074]; cell-cell junction assembly [GO:0007043]; chemotaxis [GO:0006935]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; establishment of epithelial cell polarity [GO:0090162]; gastrulation with mouth forming second [GO:0001702]; hippo signaling [GO:0035329]; in utero embryonic development [GO:0001701]; negative regulation of angiogenesis [GO:0016525]; negative regulation of GTPase activity [GO:0034260]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell size [GO:0045793]; positive regulation of embryonic development [GO:0040019]; positive regulation of stress fiber assembly [GO:0051496]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0001701; GO:0001702; GO:0001725; GO:0001726; GO:0003365; GO:0005654; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005923; GO:0006935; GO:0007043; GO:0008104; GO:0009897; GO:0009986; GO:0016021; GO:0016525; GO:0030027; GO:0030036; GO:0030054; GO:0030139; GO:0030334; GO:0031410; GO:0034260; GO:0035329; GO:0038023; GO:0040019; GO:0042074; GO:0043116; GO:0043532; GO:0043534; GO:0043536; GO:0045793; GO:0051056; GO:0051496; GO:0090162 angiostatin binding [GO:0043532]; signaling receptor activity [GO:0038023] DCSTQTERGTESNK 0.9585 0.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9407 0 Q6ZMH5 S39A5_HUMAN "Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5, ZIP-5)" SLC39A5 ZIP5 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; eye development [GO:0001654]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neural precursor cell proliferation [GO:0061351]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; zinc ion import across plasma membrane [GO:0071578]" basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] "basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; BMP signaling pathway [GO:0030509]; cellular response to zinc ion starvation [GO:0034224]; cellular zinc ion homeostasis [GO:0006882]; eye development [GO:0001654]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neural precursor cell proliferation [GO:0061351]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; zinc ion import across plasma membrane [GO:0071578]" GO:0001654; GO:0005385; GO:0005887; GO:0006882; GO:0016323; GO:0030509; GO:0034224; GO:0048026; GO:0061351; GO:0070062; GO:0070315; GO:0071578 zinc ion transmembrane transporter activity [GO:0005385] LLGPRLLR 0.9585 0.66938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0N4 NAKD2_HUMAN "NAD kinase 2, mitochondrial, EC 2.7.1.23 (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)" NADK2 C5orf33 MNADK NADKD1 Homo sapiens (Human) NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310] GO:0003951; GO:0005524; GO:0005739; GO:0005759; GO:0006741; GO:0016310; GO:0019674; GO:0042803 ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803] GFLLGSCCRVAGGRAAALR 0.95851 0.61351 0 0 0 0 0 0 0 0 10.723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75572 0 0 0 0 0 0 0 0 0 10.4206 0 0 0 12.0581 0 0 0 0 0 0 10.4886 0 0 0 0 0 14.237 14.1493 0 0 0 0 0 0 0 0 0 0 Q5T9A4 ATD3B_HUMAN ATPase family AAA domain-containing protein 3B (AAA-TOB3) ATAD3B KIAA1273 TOB3 Homo sapiens (Human) mitochondrion organization [GO:0007005] ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrion organization [GO:0007005] GO:0005524; GO:0005739; GO:0005743; GO:0005886; GO:0007005; GO:0016887; GO:0030667; GO:0101003 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] AERENADIIREQIR 0.95851 0.68084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7791 13.5902 0 13.9615 0 12.7786 12.4857 12.1732 0 0 0 11.2986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0772 0 0 0 0 0 0 14.3862 15.5803 0 15.2537 15.6738 0 0 0 15.0111 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7932 0 0 15.0644 15.8377 14.8167 0 0 0 14.284 0 0 0 0 0 0 0 0 0 12.5269 0 0 12.5208 0 0 0 0 0 0 0 0 0 0 11.1308 0 0 0 0 0 13.0506 0 0 0 0 0 0 0 0 14.4361 0 0 0 11.5188 0 12.846 12.8447 13.8402 14.8725 13.6897 13.7315 0 0 12.9925 11.5626 0 15.3459 0 12.9794 0 0 0 13.8151 Q12929 EPS8_HUMAN Epidermal growth factor receptor kinase substrate 8 EPS8 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] anchoring junction [GO:0070161]; brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] anchoring junction [GO:0070161]; brush border [GO:0005903]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030426; GO:0030832; GO:0031267; GO:0031532; GO:0031982; GO:0032420; GO:0032426; GO:0032587; GO:0035023; GO:0035591; GO:0036336; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070062; GO:0070161; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830 actin binding [GO:0003779]; signaling adaptor activity [GO:0035591]; small GTPase binding [GO:0031267] DAMITVDDGIR 0.95852 0.68023 0 0 0 0 0 0 0 0 13.8554 14.1525 14.1165 13.8178 14.0937 13.4606 14.0293 0 0 0 13.6381 0 0 0 0 0 0 0 0 0 13.4984 0 13.9441 13.5467 13.5701 13.5304 0 13.8908 13.3974 13.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8342 0 0 0 0 0 0 13.2668 0 0 0 0 0 0 0 0 0 13.3591 0 14.2541 16.2012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5984 0 0 11.2265 13.5804 10.0422 11.9049 11.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6721 0 0 0 0 0 0 0 0 15.5504 0 0 11.9412 0 0 0 0 0 0 Q5TG53 SEAS1_HUMAN Putative uncharacterized protein SERTAD4-AS1 (SERTAD4 antisense RNA 1) (SERTAD4 antisense gene protein 1) SERTAD4-AS1 C1orf133 Homo sapiens (Human) ALLTSTIPLSPPAKR 0.95852 0.69031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92185 SIA8A_HUMAN "Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase, EC 2.4.99.8 (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Ganglioside GT3 synthase) (Sialyltransferase 8A, SIAT8-A) (Sialyltransferase St8Sia I, ST8SiaI)" ST8SIA1 SIAT8 SIAT8A Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cellular response to heat [GO:0034605]; epithelial cell proliferation [GO:0050673]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; positive regulation of epithelial cell proliferation [GO:0050679]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]; carbohydrate metabolic process [GO:0005975]; cellular response to heat [GO:0034605]; epithelial cell proliferation [GO:0050673]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; positive regulation of epithelial cell proliferation [GO:0050679]; protein glycosylation [GO:0006486]" GO:0000139; GO:0003828; GO:0005975; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009311; GO:0016021; GO:0034605; GO:0050673; GO:0050679 "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]" DVGSKSQLVTANPSIIR 0.95853 0.42543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MUP6 GS1L2_HUMAN "Germ cell-specific gene 1-like protein 2, GSG1-like protein 2" GSG1L2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 AKQQQALLLLPVCLALTFSLTAVVSSHWCEGTR 0.95854 0.66699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6203 11.7773 0 0 0 0 0 0 0 0 0 12.3979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZY5 BLID_HUMAN BH3-like motif-containing cell death inducer (Breast cancer cell protein 2) BLID BRCC2 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] GO:0005739; GO:0005829; GO:0006915; GO:0043280 ARLPLEALLGSNK 0.95854 0.56274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4034 0 11.6344 11.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3982 13.174 13.8406 0 0 13.8109 0 0 0 0 0 0 0 0 13.0686 0 0 0 0 0 0 0 11.6032 12.7726 0 0 0 0 0 0 0 0 13.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8995 0 0 0 0 0 0 0 Q9BVS4 RIOK2_HUMAN "Serine/threonine-protein kinase RIO2, EC 2.7.11.1 (RIO kinase 2)" RIOK2 RIO2 Homo sapiens (Human) cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ribosomal small subunit biogenesis [GO:0042274]" GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0030071; GO:0030490; GO:0030688; GO:0042274; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AEVYGSENESERNCLEESEGCYCR 0.95854 3.2951 0 0 0 0 0 0 0 0 13.848 14.2125 14.7563 0 14.0187 10.5798 0 0 0 11.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9199 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9078 0 0 0 0 0 0 0 12.2038 0 0 10.5857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.964 0 0 0 0 0 0 0 0 0 0 11.1027 0 0 0 0 0 0 0 13.1418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1224 0 0 13.2978 0 0 0 0 0 0 12.2939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8448 0 0 0 0 11.3297 0 0 0 A0A0B4J238 TVA12_HUMAN T cell receptor alpha variable 1-2 TRAV1-2 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 MWGVFLLYVSMK 0.95855 0.6116 0 0 0 11.1147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUT2 CJ143_HUMAN Uncharacterized protein C10orf143 C10orf143 Homo sapiens (Human) DSLALGR 0.95855 0.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3591 0 0 0 0 0 0 0 0 11.2653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14817 TSN4_HUMAN "Tetraspanin-4, Tspan-4 (Novel antigen 2, NAG-2) (Transmembrane 4 superfamily member 7)" TSPAN4 NAG2 TM4SF7 Homo sapiens (Human) protein-containing complex assembly [GO:0065003] focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982] focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; antigen binding [GO:0003823]; integrin binding [GO:0005178]; protein-containing complex assembly [GO:0065003] GO:0003823; GO:0005178; GO:0005886; GO:0005887; GO:0005925; GO:0031982; GO:0065003 antigen binding [GO:0003823]; integrin binding [GO:0005178] CLLLTFFLLLLLVFLLEATIAILFFAYTDKIDR 0.95856 0.66699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0C4DH59 TVB54_HUMAN T cell receptor beta variable 5-4 TRBV5-4 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 GPGLLCWALLCLLGAGSVETGVTQSPTHLIKTR 0.95857 0.66699 0 0 0 0 0 0 0 0 0 0 12.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9663 0 0 0 0 0 0 0 0 13.8383 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5809 12.6806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6019 15.3925 14.7801 0 0 0 0 14.7491 0 14.8139 0 0 0 0 0 0 0 14.3794 0 0 0 0 0 15.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9062 0 14.8592 0 0 0 0 0 0 0 0 0 14.1055 0 0 Q86Y79 PTH_HUMAN "Probable peptidyl-tRNA hydrolase, PTH, EC 3.1.1.29" PTRH1 C9orf115 Homo sapiens (Human) aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723] GO:0003723; GO:0004045 aminoacyl-tRNA hydrolase activity [GO:0004045]; RNA binding [GO:0003723] AAELFGLTAEEVYLVHDELDKPLGR 0.95857 0.45375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.64006 0 0 0 0 16.1715 0 0 0 0 0 0 0 11.4663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGV5 O13D1_HUMAN Olfactory receptor 13D1 (Olfactory receptor OR9-15) OR13D1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KKAFSTCSAHSIVVILFYGSALFMYMK 0.95859 0.36075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A7E2S9 A30BL_HUMAN Putative ankyrin repeat domain-containing protein 30B-like ANKRD30BL NCRNA00164 Homo sapiens (Human) AGHTPLLLAIRKR 0.9586 0.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8913 0 13.3571 0 0 0 0 0 13.31 0 0 0 0 13.4665 0 0 0 0 0 0 0 0 0 13.5441 0 12.64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7005 12.1501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9561 0 0 0 13.0433 0 0 10.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75841 UPK1B_HUMAN "Uroplakin-1b, UP1b (Tetraspanin-20, Tspan-20) (Uroplakin Ib, UPIb)" UPK1B TSPAN20 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; response to bacterium [GO:0009617] apical plasma membrane urothelial plaque [GO:0120001]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] apical plasma membrane urothelial plaque [GO:0120001]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; response to bacterium [GO:0009617] GO:0005198; GO:0005887; GO:0009617; GO:0016021; GO:0030855; GO:0070062; GO:0120001 structural molecule activity [GO:0005198] TENNDADYPWPR 0.9586 0.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43913 ORC5_HUMAN Origin recognition complex subunit 5 ORC5 ORC5L Homo sapiens (Human) DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275]" GO:0000166; GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006260; GO:0006270; GO:0006275 ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166] DDTDPGQLK 0.95862 0.35801 0 0 0 15.627 0 0 0 0 12.1686 0 0 12.6698 0 11.4429 0 14.6695 0 10.9299 0 0 0 0 14.8761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.064 0 0 0 0 19.0127 0 0 16.9566 0 16.9848 17.3939 17.5391 0 0 16.6893 17.0063 17.1116 17.4979 16.3078 0 0 0 0 16.3665 0 0 16.3461 16.5652 16.6357 16.3915 0 16.2161 0 0 16.3109 0 16.7965 16.3265 0 17.762 16.4464 16.9683 16.8741 0 16.7863 16.2488 0 0 0 0 0 12.6946 16.403 16.9079 0 12.7343 0 17.6561 17.9317 16.8574 0 16.431 16.8127 16.8337 16.7006 0 0 0 0 0 0 0 16.794 0 0 0 0 0 0 0 0 0 0 13.7117 0 0 13.8467 13.7122 12.766 17.6207 16.2209 16.3181 0 0 0 0 0 0 Q8IV50 LYSM2_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 2 LYSMD2 Homo sapiens (Human) EESRDEESPYATSLYHS 0.95862 0.42121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1992 0 0 0 0 0 0 0 0 0 Q8N1N0 CLC4F_HUMAN "C-type lectin domain family 4 member F (C-type lectin superfamily member 13, C-type lectin 13)" CLEC4F CLECSF13 Homo sapiens (Human) endocytosis [GO:0006897] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; endocytosis [GO:0006897] GO:0006897; GO:0009897; GO:0016021; GO:0030246 carbohydrate binding [GO:0030246] EAEMRELIQTFK 0.95862 0.61041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7043 0 9.71819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4302 0 13.7546 0 0 14.5961 0 11.4055 0 0 0 0 0 0 0 0 0 0 0 0 9.59811 0 0 0 0 0 0 0 0 0 0 0 0 10.9227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NI28 RHG42_HUMAN Rho GTPase-activating protein 42 (Rho GTPase-activating protein 10-like) (Rho-type GTPase-activating protein 42) ARHGAP42 GRAF3 TMEM133 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; signal transduction [GO:0007165] GO:0003085; GO:0005096; GO:0007165; GO:0035024; GO:0090630; GO:1904694 GTPase activator activity [GO:0005096] CLAEPLMTYK 0.95863 0.42083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5601 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2824 0 0 0 0 0 0 16.1291 0 0 13.0477 0 14.31 0 11.9631 0 15.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8899 0 0 0 12.3316 0 0 0 0 11.6499 15.0457 15.1442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16949 STMN1_HUMAN "Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18, Op18) (Phosphoprotein p19, pp19) (Prosolin) (Protein Pr22) (pp17)" STMN1 C1orf215 LAP18 OP18 Homo sapiens (Human) axonogenesis [GO:0007409]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615]; signal transduction [GO:0007165] GO:0000281; GO:0005737; GO:0005829; GO:0005874; GO:0007019; GO:0007052; GO:0007165; GO:0007409; GO:0009615; GO:0015631; GO:0016020; GO:0031110; GO:0031115; GO:0031175; GO:0035024; GO:0035556; GO:0043005; GO:0048012; GO:0051497; GO:0061436; GO:0070062; GO:0070495; GO:1905098 tubulin binding [GO:0015631] ESKDPADETEAD 0.95863 0.46724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5981 0 0 0 12.7083 0 14.8615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4712 0 0 0 0 0 0 13.1364 0 14.7456 0 0 0 0 0 0 0 0 0 14.9555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SSQ6 SAPC1_HUMAN Suppressor APC domain-containing protein 1 (Protein G7d) SAPCD1 C6orf26 G7D NG23 Homo sapiens (Human) QDPGAQSFFLWLR 0.95863 0.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MWK0 FS2P1_HUMAN "Putative fatty acid desaturase 2-like protein FADS2B (Fatty acid desaturase 2 pseudogene 1) (Fatty acid desaturase 2B, pseudogene)" FADS2B FADS2P1 Homo sapiens (Human) lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636]" GO:0005789; GO:0006629; GO:0006636; GO:0016021; GO:0016717; GO:0046872 "metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]" YINYEEQHLYFYK 0.95864 0.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2I7 EBLN2_HUMAN "Endogenous Bornavirus-like nucleoprotein 2 (Endogenous Borna-like N element-2, EBLN-2)" EBLN2 GK006 Homo sapiens (Human) LYAYVNSHSLFVWVCDR 0.95864 0.4466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5F2 CK001_HUMAN UPF0686 protein C11orf1 C11orf1 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 CTEKSTYMNSYSK 0.95865 0.42015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAT8 PELI2_HUMAN "E3 ubiquitin-protein ligase pellino homolog 2, Pellino-2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase pellino homolog 2)" PELI2 Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592] cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592] GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] FSPGQEEHCAPNK 0.95865 0.36492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRW1 RAB6B_HUMAN "Ras-related protein Rab-6B, EC 3.6.5.2" RAB6B Homo sapiens (Human) "Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; protein localization to Golgi membrane [GO:1903292]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; presynapse [GO:0098793] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; neuron projection development [GO:0031175]; protein localization to Golgi membrane [GO:1903292]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0003924; GO:0005525; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0007030; GO:0031175; GO:0031410; GO:0031489; GO:0042147; GO:0098793; GO:1903292 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] LDKPQEPPASEGGCSC 0.95865 0.42943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5599 0 0 0 0 12.3971 12.393 12.8752 0 0 13.3212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30874 SSR2_HUMAN "Somatostatin receptor type 2, SS-2-R, SS2-R, SS2R, SST2 (SRIF-1)" SSTR2 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432]; regulation of muscle contraction [GO:0006937]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]" cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; peristalsis [GO:0030432]; regulation of muscle contraction [GO:0006937]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]" GO:0004930; GO:0004994; GO:0005829; GO:0005886; GO:0005887; GO:0006937; GO:0007187; GO:0007193; GO:0007218; GO:0007283; GO:0008285; GO:0021549; GO:0030165; GO:0030432; GO:0030900; GO:0042277; GO:0042594; GO:0042923; GO:0043005; GO:0071385; GO:0071392 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994] YLAVVHPIKSAK 0.95866 0.35524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95716 RAB3D_HUMAN Ras-related protein Rab-3D RAB3D GOV RAB16 Homo sapiens (Human) bone resorption [GO:0045453]; peptidyl-cysteine methylation [GO:0018125]; positive regulation of regulated secretory pathway [GO:1903307]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] azurophil granule membrane [GO:0035577]; cytoplasmic microtubule [GO:0005881]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021]; zymogen granule [GO:0042588] azurophil granule membrane [GO:0035577]; cytoplasmic microtubule [GO:0005881]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; synaptic vesicle [GO:0008021]; zymogen granule [GO:0042588]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; bone resorption [GO:0045453]; peptidyl-cysteine methylation [GO:0018125]; positive regulation of regulated secretory pathway [GO:1903307]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] GO:0003924; GO:0005525; GO:0005768; GO:0005881; GO:0005886; GO:0006904; GO:0008021; GO:0009306; GO:0017157; GO:0018125; GO:0030742; GO:0031489; GO:0035577; GO:0042588; GO:0043231; GO:0045453; GO:0070062; GO:0072659; GO:0099503; GO:1903307 GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] ENINVKQVFER 0.95867 0.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCP6 HHATL_HUMAN Protein-cysteine N-palmitoyltransferase HHAT-like protein (Glycerol uptake/transporter homolog) (Hedgehog acyltransferase-like protein) HHATL C3orf3 GUP1 KIAA1173 Homo sapiens (Human) negative regulation of N-terminal protein palmitoylation [GO:0060262] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; acyltransferase activity [GO:0016746]; negative regulation of N-terminal protein palmitoylation [GO:0060262] GO:0005783; GO:0005789; GO:0016021; GO:0016746; GO:0048471; GO:0060262 acyltransferase activity [GO:0016746] NVIIFALSGHVLFAKLCTMVAPK 0.95867 0.37231 0 0 0 0 0 0 0 0 0 0 0 14.93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9657 0 0 0 0 0 0 0 0 0 0 0 15.1043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5344 0 0 0 0 14.5937 15.345 0 0 0 0 0 0 0 0 0 0 0 0 13.8664 0 0 0 0 0 14.8501 0 0 0 0 0 0 0 0 0 0 16.1028 0 0 0 0 0 0 Q9Y345 SC6A5_HUMAN "Sodium- and chloride-dependent glycine transporter 2, GlyT-2, GlyT2 (Solute carrier family 6 member 5)" SLC6A5 GLYT2 NET1 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012]" dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886] "dense core granule [GO:0031045]; endosome [GO:0005768]; glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; neurotransmitter uptake [GO:0001504]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012]" GO:0001504; GO:0005768; GO:0005886; GO:0005887; GO:0007268; GO:0015375; GO:0016021; GO:0031045; GO:0035725; GO:0046872; GO:0060012; GO:0098690; GO:0099056; GO:1903804 glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872] GIKTSGKVVYFTATFPYVVLVILLIR 0.95867 0.44526 0 0 0 0 0 0 0 0 0 0 10.8496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2844 0 0 0 0 0 11.0635 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0572 0 0 0 0 0 0 0 0 11.8394 0 0 0 0 0 0 0 0 12.6473 12.989 0 0 12.3168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.642 10.9809 0 0 0 0 11.763 0 0 0 0 0 0 0 0 Q8WWF3 SSMM1_HUMAN Serine-rich single-pass membrane protein 1 SSMEM1 C7orf45 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 KMAQRQR 0.95868 0.56616 0 0 0 10.5769 0 0 0 0 11.812 0 0 0 0 0 0 0 0 0 11.463 0 0 11.1632 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1468 0 9.8461 0 0 0 0 0 0 0 0 0 0 0 0 11.8277 0 0 0 12.4374 12.3026 0 0 0 0 0 0 0 0 0 0 0 12.466 11.8834 0 0 0 0 13.1401 0 0 0 0 12.5613 0 0 0 0 12.0591 0 0 0 0 0 0 0 0 0 0 0 0 12.4901 0 0 0 0 12.165 0 0 12.4288 12.3101 0 0 0 0 12.4567 0 0 12.3034 0 12.6982 0 0 0 0 0 12.5796 0 0 0 0 0 11.8756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0924 0 0 0 0 0 0 16.0433 P0DMN0 ST1A4_HUMAN "Sulfotransferase 1A4, ST1A4, EC 2.8.2.1 (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4)" SULT1A4 Homo sapiens (Human) catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] GO:0004062; GO:0005737; GO:0005829; GO:0006584; GO:0008146; GO:0008202; GO:0051923 aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] DTPPPRLIK 0.95869 0.61412 0 0 0 0 0 0 0 0 0 0 0 12.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17509 HXB6_HUMAN Homeobox protein Hox-B6 (Homeobox protein Hox-2.2) (Homeobox protein Hox-2B) (Homeobox protein Hu-2) HOXB6 HOX2B Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; erythrocyte homeostasis [GO:0034101]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; erythrocyte homeostasis [GO:0034101]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0006357; GO:0009952; GO:0034101; GO:0048704; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GFATSSYYPPAGGGYGR 0.95869 0.67047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N387 MUC15_HUMAN "Mucin-15, MUC-15" MUC15 UNQ750/PRO1481 Homo sapiens (Human) extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005576; GO:0005796; GO:0005886; GO:0016021 LALAKILLISTLFYSLLSGSHGK 0.95869 0.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17302 CXA1_HUMAN "Gap junction alpha-1 protein (Connexin-43, Cx43) (Gap junction 43 kDa heart protein)" GJA1 GJAL Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; bone development [GO:0060348]; bone remodeling [GO:0046849]; cardiac conduction system development [GO:0003161]; cell communication by electrical coupling [GO:0010644]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; establishment of mitotic spindle orientation [GO:0000132]; export across plasma membrane [GO:0140115]; gap junction assembly [GO:0016264]; glutamate secretion [GO:0014047]; ion transmembrane transport [GO:0034220]; maintenance of blood-brain barrier [GO:0035633]; microtubule-based transport [GO:0099111]; negative regulation of cell growth [GO:0030308]; negative regulation of gonadotropin secretion [GO:0032277]; negative regulation of trophoblast cell migration [GO:1901164]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mesodermal cell differentiation [GO:1905772]; positive regulation of morphogenesis of an epithelium [GO:1905332]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization [GO:0008104]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; gap junction [GO:0005921]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; gap junction [GO:0005921]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; efflux transmembrane transporter activity [GO:0015562]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in cardiac conduction electrical coupling [GO:0086075]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763]; gap junction hemi-channel activity [GO:0055077]; glutathione transmembrane transporter activity [GO:0034634]; ion transmembrane transporter activity [GO:0015075]; tubulin binding [GO:0015631]; atrial cardiac muscle cell action potential [GO:0086014]; bone development [GO:0060348]; bone remodeling [GO:0046849]; cardiac conduction system development [GO:0003161]; cell communication by electrical coupling [GO:0010644]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell signaling [GO:0007267]; cellular response to amyloid-beta [GO:1904646]; establishment of mitotic spindle orientation [GO:0000132]; export across plasma membrane [GO:0140115]; gap junction assembly [GO:0016264]; glutamate secretion [GO:0014047]; ion transmembrane transport [GO:0034220]; maintenance of blood-brain barrier [GO:0035633]; microtubule-based transport [GO:0099111]; negative regulation of cell growth [GO:0030308]; negative regulation of gonadotropin secretion [GO:0032277]; negative regulation of trophoblast cell migration [GO:1901164]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mesodermal cell differentiation [GO:1905772]; positive regulation of morphogenesis of an epithelium [GO:1905332]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization [GO:0008104]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; xenobiotic transport [GO:0042908] GO:0000132; GO:0000139; GO:0003161; GO:0005243; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0005921; GO:0005922; GO:0005925; GO:0007165; GO:0007267; GO:0007283; GO:0008013; GO:0008104; GO:0010628; GO:0010644; GO:0014047; GO:0014704; GO:0015075; GO:0015562; GO:0015631; GO:0016264; GO:0016324; GO:0030054; GO:0030308; GO:0030660; GO:0032277; GO:0034220; GO:0034634; GO:0035633; GO:0042908; GO:0043014; GO:0043123; GO:0043231; GO:0044291; GO:0045121; GO:0046849; GO:0055077; GO:0060348; GO:0070160; GO:0086014; GO:0086064; GO:0086075; GO:0099111; GO:0120162; GO:0140115; GO:1901164; GO:1903763; GO:1904646; GO:1904707; GO:1905332; GO:1905772; GO:2000648 alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; efflux transmembrane transporter activity [GO:0015562]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in cardiac conduction electrical coupling [GO:0086075]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763]; gap junction hemi-channel activity [GO:0055077]; glutathione transmembrane transporter activity [GO:0034634]; ion transmembrane transporter activity [GO:0015075]; tubulin binding [GO:0015631] CNTQQPGCENVCYDK 0.9587 0.69187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9922 0 0 13.4819 0 0 0 12.7636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9207 0 0 0 0 0 0 0 0 0 0 0 P05451 REG1A_HUMAN "Lithostathine-1-alpha (Islet cells regeneration factor, ICRF) (Islet of Langerhans regenerating protein, REG) (Pancreatic stone protein, PSP) (Pancreatic thread protein, PTP) (Regenerating islet-derived protein 1-alpha, REG-1-alpha) (Regenerating protein I alpha)" REG1A PSPS PSPS1 REG Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell wall disruption in another organism [GO:0044278]; positive regulation of cell population proliferation [GO:0008284]; response to peptide hormone [GO:0043434] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; signaling receptor activity [GO:0038023]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell wall disruption in another organism [GO:0044278]; positive regulation of cell population proliferation [GO:0008284]; response to peptide hormone [GO:0043434] GO:0005615; GO:0008083; GO:0008284; GO:0038023; GO:0042834; GO:0043434; GO:0044278; GO:0061844; GO:0070062; GO:0070492 growth factor activity [GO:0008083]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; signaling receptor activity [GO:0038023] DVPCEDKFSFVCK 0.95872 0.40058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZC3 GDE1_HUMAN "Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1, EC 3.1.4.44) (Lysophospholipase D GDE1, EC 3.1.4.-) (Membrane-interacting protein of RGS16) (RGS16-interacting membrane protein)" GDE1 MIR16 Homo sapiens (Human) ethanolamine metabolic process [GO:0006580]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; ethanolamine metabolic process [GO:0006580]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644] GO:0004622; GO:0005886; GO:0006580; GO:0006629; GO:0006644; GO:0008889; GO:0016021; GO:0030659; GO:0046475; GO:0046872; GO:0047395; GO:0070291 glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872] GIQVVGWTVNTFDEKSYYESHLGSSYITDSMVEDCEPHF 0.95872 0.68094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6391 0 19.5968 0 0 0 0 0 0 0 12.5577 0 0 0 18.621 0 0 0 0 14.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1964 0 0 0 0 0 0 0 0 0 17.8544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q19AV6 ZSWM7_HUMAN Zinc finger SWIM domain-containing protein 7 (SWIM domain-containing and Srs2-interacting protein 1 homolog) (SWIM-type zinc finger domain-containing protein 7) ZSWIM7 SWS1 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; protein stabilization [GO:0050821] nucleus [GO:0005634]; Shu complex [GO:0097196] nucleus [GO:0005634]; Shu complex [GO:0097196]; zinc ion binding [GO:0008270]; double-strand break repair via homologous recombination [GO:0000724]; protein stabilization [GO:0050821] GO:0000724; GO:0005634; GO:0008270; GO:0050821; GO:0097196 zinc ion binding [GO:0008270] AVVLPAVVEELLSEMAAAVQESAR 0.95874 0.56322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYF5 FA13B_HUMAN Protein FAM13B (GAP-like protein N61) FAM13B C5orf5 FAM13B1 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0007165; GO:0051056 GTPase activator activity [GO:0005096] EATLELILKR 0.95875 0.35058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4202 0 0 0 0 0 0 0 0 14.648 0 0 11.833 0 13.729 14.1048 13.7653 0 13.6323 14.6204 14.171 13.628 0 0 0 0 0 0 0 11.7695 0 11.6304 0 0 0 0 0 0 0 14.2699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2761 0 0 0 0 0 0 0 0 0 0 0 11.8366 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2739 P81277 PRRP_HUMAN "Prolactin-releasing peptide, PrRP (Prolactin-releasing hormone) [Cleaved into: Prolactin-releasing peptide PrRP31; Prolactin-releasing peptide PrRP20 ]" PRLH PRH Homo sapiens (Human) autonomic nervous system development [GO:0048483]; energy reserve metabolic process [GO:0006112]; fat cell differentiation [GO:0045444]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of multicellular organism growth [GO:0040014]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; tissue homeostasis [GO:0001894] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; prolactin-releasing peptide receptor binding [GO:0031861]; autonomic nervous system development [GO:0048483]; energy reserve metabolic process [GO:0006112]; fat cell differentiation [GO:0045444]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of multicellular organism growth [GO:0040014]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; tissue homeostasis [GO:0001894] GO:0001894; GO:0002023; GO:0005179; GO:0005184; GO:0005576; GO:0005737; GO:0006112; GO:0006629; GO:0007186; GO:0007631; GO:0009749; GO:0031861; GO:0032868; GO:0040014; GO:0043434; GO:0045444; GO:0048483 hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; prolactin-releasing peptide receptor binding [GO:0031861] VLRAWLLCLLMLGLALR 0.95876 0.42285 0 0 12.3101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20339 RAB5A_HUMAN "Ras-related protein Rab-5A, EC 3.6.5.2" RAB5A RAB5 Homo sapiens (Human) amyloid-beta clearance by transcytosis [GO:0150093]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; modulation by host of viral process [GO:0044788]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; regulation of autophagosome assembly [GO:2000785]; regulation of endocytosis [GO:0030100]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465] actin cytoskeleton [GO:0015629]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; axon terminus [GO:0043679]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic early endosome [GO:0098842]; ruffle [GO:0001726]; somatodendritic compartment [GO:0036477]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] actin cytoskeleton [GO:0015629]; anchored component of synaptic vesicle membrane [GO:0098993]; axon [GO:0030424]; axon terminus [GO:0043679]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic early endosome [GO:0098842]; ruffle [GO:0001726]; somatodendritic compartment [GO:0036477]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; amyloid-beta clearance by transcytosis [GO:0150093]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; modulation by host of viral process [GO:0044788]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; regulation of autophagosome assembly [GO:2000785]; regulation of endocytosis [GO:0030100]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465] GO:0001726; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006909; GO:0008021; GO:0010008; GO:0015629; GO:0019003; GO:0030100; GO:0030139; GO:0030424; GO:0030425; GO:0030669; GO:0030670; GO:0031901; GO:0032009; GO:0036465; GO:0036477; GO:0042470; GO:0043025; GO:0043195; GO:0043231; GO:0043679; GO:0044788; GO:0045022; GO:0045121; GO:0045335; GO:0045921; GO:0048169; GO:0051036; GO:0051489; GO:0070062; GO:0098559; GO:0098842; GO:0098993; GO:0150093; GO:2000286; GO:2000300; GO:2000785 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] LVLLGESAVGKSSLVLR 0.95878 0.68959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.906 0 0 0 0 0 14.4253 14.4962 0 14.7914 0 0 0 14.2586 14.3096 0 0 14.0746 0 0 0 0 0 0 0 0 13.1764 0 0 0 0 0 0 0 0 13.6422 0 0 13.838 0 0 0 12.9845 0 0 0 0 0 13.6102 0 0 0 0 0 13.1397 0 13.1362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1981 0 0 0 0 0 11.5467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2I0M4 LRC26_HUMAN Leucine-rich repeat-containing protein 26 (BK channel auxiliary gamma subunit LRRC26) (Cytokeratin-associated protein in cancer) LRRC26 CAPC Homo sapiens (Human) positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805] GO:0005249; GO:0005737; GO:0005856; GO:0005887; GO:0008076; GO:0015459; GO:0044325; GO:0070062; GO:0071805; GO:0099104; GO:1903818 potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] ALRNLSLAGNRLAR 0.95879 0.35924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6844 12.8823 0 0 0 0 11.7602 0 0 11.517 0 0 0 0 13.5998 0 0 0 0 0 0 0 0 0 0 11.3078 0 0 11.778 0 12.8571 0 0 13.1068 0 0 0 0 0 0 0 0 0 12.012 0 0 0 0 0 0 13.2923 14.3173 12.8269 0 12.0759 0 0 12.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8651 0 12.84 0 0 14.4013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5A9 TAFA1_HUMAN Chemokine-like protein TAFA-1 TAFA1 FAM19A1 Homo sapiens (Human) neuroblast differentiation [GO:0014016]; regulation of neuroblast proliferation [GO:1902692]; regulation of signaling receptor activity [GO:0010469] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; neuroblast differentiation [GO:0014016]; regulation of neuroblast proliferation [GO:1902692]; regulation of signaling receptor activity [GO:0010469] GO:0005615; GO:0005783; GO:0010469; GO:0014016; GO:0048018; GO:1902692 receptor ligand activity [GO:0048018] TLPDNSGWMCATGNKIK 0.9588 0.42132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5I0 PCDAD_HUMAN "Protocadherin alpha-13, PCDH-alpha-13" PCDHA13 CNRS5 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] PLQVFHVEVK 0.95882 0.40959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02679 FIBG_HUMAN Fibrinogen gamma chain FGG PRO2061 Homo sapiens (Human) "blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; fibrinolysis [GO:0042730]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of platelet aggregation [GO:0090331]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; platelet maturation [GO:0036345]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein secretion [GO:0009306]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] "blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; fibrinolysis [GO:0042730]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of platelet aggregation [GO:0090331]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; platelet maturation [GO:0036345]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein secretion [GO:0009306]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005788; GO:0005886; GO:0007160; GO:0009306; GO:0009897; GO:0009986; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0036345; GO:0042730; GO:0042802; GO:0045907; GO:0045921; GO:0046872; GO:0050714; GO:0050839; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0071347; GO:0071354; GO:0072378; GO:0072562; GO:0090277; GO:0090331; GO:1900026; GO:1902042; GO:2000352 cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] LTYAYFAGGDAGDAFDGFDFGDDPSDK 0.95883 0.42016 0 0 0 0 0 0 0 0 9.62845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41732 TSN7_HUMAN "Tetraspanin-7, Tspan-7 (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1, TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231)" TSPAN7 A15 DXS1692E MXS1 TM4SF2 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887] GO:0005887 RMETKPVITCLK 0.95883 0.42996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MYX2 FM25E_HUMAN Protein FAM25E FAM25E FAM25D Homo sapiens (Human) INGSALSPHPGLR 0.95884 0.36492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31260 HXA10_HUMAN Homeobox protein Hox-A10 (Homeobox protein Hox-1.8) (Homeobox protein Hox-1H) (PL) HOXA10 HOX1H Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; uterus development [GO:0060065] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic limb morphogenesis [GO:0030326]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; uterus development [GO:0060065]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007283; GO:0007338; GO:0008584; GO:0009952; GO:0009954; GO:0030326; GO:0030850; GO:0033574; GO:0042826; GO:0043627; GO:0045944; GO:0060065; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CPKVSATAAELAPFPR 0.95884 0.35525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7157 0 14.0452 0 14.6401 14.2362 0 0 0 0 0 0 13.9935 0 0 0 0 0 0 14.4643 0 14.3413 0 0 O14668 TMG1_HUMAN "Transmembrane gamma-carboxyglutamic acid protein 1 (Proline-rich gamma-carboxyglutamic acid protein 1, Proline-rich Gla protein 1)" PRRG1 PRGP1 TMG1 Homo sapiens (Human) extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0005886; GO:0005887 calcium ion binding [GO:0005509] ECKEEFCTFEEAR 0.95885 0.56863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.488 0 0 0 0 0 10.7385 0 0 0 12.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0946 0 0 0 0 0 13.3548 0 0 12.9766 0 0 0 0 0 0 0 0 0 0 0 0 0 O95782 AP2A1_HUMAN AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] AP-2 adaptor complex [GO:0030122]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] GO:0005829; GO:0005886; GO:0006886; GO:0006895; GO:0006897; GO:0006898; GO:0009898; GO:0016020; GO:0016192; GO:0019901; GO:0030122; GO:0030130; GO:0030666; GO:0030669; GO:0032433; GO:0035615; GO:0036020; GO:0045334; GO:0050750; GO:0072583; GO:0098794; GO:0098884; GO:0140312; GO:1900126 cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901] AADLLYAMCDR 0.95886 0.44621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3767 0 0 0 0 0 0 0 15.7967 0 0 0 0 19.3362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6612 0 0 0 0 0 0 0 0 0 0 0 12.6065 0 0 0 11.5635 0 0 0 0 0 0 0 0 0 0 11.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08865 RSSA_HUMAN "40S ribosomal protein SA (37 kDa laminin receptor precursor, 37LRP) (37/67 kDa laminin receptor, LRP/LR) (67 kDa laminin receptor, 67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1, LamR) (Laminin-binding protein precursor p40, LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)" RPSA LAMBR LAMR1 Homo sapiens (Human) cell adhesion [GO:0007155]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; virus receptor activity [GO:0001618]; cell adhesion [GO:0007155]; cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] GO:0000028; GO:0001618; GO:0002181; GO:0003723; GO:0003735; GO:0005055; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006412; GO:0007155; GO:0016020; GO:0022626; GO:0022627; GO:0043022; GO:0043236; GO:0070062 laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; virus receptor activity [GO:0001618] EPRLLVVTDPR 0.95886 0.56798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUN0 ACSM5_HUMAN "Acyl-coenzyme A synthetase ACSM5, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 5)" ACSM5 MACS3 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] GO:0004321; GO:0005524; GO:0005525; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0031956; GO:0046872; GO:0047760 ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872] ASPPYDVQIVDDEGNVLPPGEEGNVAVRIRPTR 0.95887 2.9423 0 12.2783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3909 0 9.5292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8064 0 0 0 0 12.8118 0 0 13.0973 12.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9921 0 0 0 0 0 0 0 0 0 0 11.1186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2811 0 12.0099 0 0 11.2392 0 0 0 0 0 0 12.8722 0 0 0 0 0 0 0 0 11.4385 13.2275 12.7742 0 0 12.3792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6026 0 0 0 0 0 0 0 0 0 11.8151 0 0 0 0 P00325 ADH1B_HUMAN "All-trans-retinol dehydrogenase [NAD(+)] ADH1B, EC 1.1.1.105 (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta)" ADH1B ADH2 Homo sapiens (Human) ethanol oxidation [GO:0006069]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]" GO:0001523; GO:0004024; GO:0004745; GO:0005654; GO:0005829; GO:0005886; GO:0006069; GO:0008270; GO:0042572; GO:0042573 "alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]" CRVCKNPESNYCLK 0.95889 0.56464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4926 0 0 0 0 0 0 0 0 0 0 0 0 14.4025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58511 SIM11_HUMAN Small integral membrane protein 11 SMIM11 C21orf51 FAM165B SMIM11A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RLEAKQQK 0.9589 0.35375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5049 0 0 0 0 0 0 0 0 10.6139 0 0 0 0 0 0 0 0 0 0 Q9UJU2 LEF1_HUMAN "Lymphoid enhancer-binding factor 1, LEF-1 (T cell-specific transcription factor 1-alpha, TCF1-alpha)" LEF1 Homo sapiens (Human) "anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell proliferation [GO:0042100]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-4 [GO:0071353]; chorio-allantoic fusion [GO:0060710]; dentate gyrus development [GO:0021542]; embryonic limb morphogenesis [GO:0030326]; epithelial cell apoptotic process [GO:1904019]; epithelial to mesenchymal transition [GO:0001837]; face morphogenesis [GO:0060325]; forebrain neuroblast division [GO:0021873]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; histone H3 acetylation [GO:0043966]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; mammary gland development [GO:0030879]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; paraxial mesoderm formation [GO:0048341]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary palate development [GO:0062009]; sensory perception of taste [GO:0050909]; somitogenesis [GO:0001756]; sprouting angiogenesis [GO:0002040]; T cell receptor V(D)J recombination [GO:0033153]; T-helper 1 cell differentiation [GO:0045063]; tongue development [GO:0043586]; trachea gland development [GO:0061153]; transcription by RNA polymerase II [GO:0006366]" beta-catenin-TCF complex [GO:1990907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] "beta-catenin-TCF complex [GO:1990907]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; gamma-catenin binding [GO:0045295]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; transcription regulator inhibitor activity [GO:0140416]; anatomical structure regression [GO:0060033]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell proliferation [GO:0042100]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to interleukin-4 [GO:0071353]; chorio-allantoic fusion [GO:0060710]; dentate gyrus development [GO:0021542]; embryonic limb morphogenesis [GO:0030326]; epithelial cell apoptotic process [GO:1904019]; epithelial to mesenchymal transition [GO:0001837]; face morphogenesis [GO:0060325]; forebrain neuroblast division [GO:0021873]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; histone H3 acetylation [GO:0043966]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; mammary gland development [GO:0030879]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; paraxial mesoderm formation [GO:0048341]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell cycle process [GO:0090068]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary palate development [GO:0062009]; sensory perception of taste [GO:0050909]; somitogenesis [GO:0001756]; sprouting angiogenesis [GO:0002040]; T cell receptor V(D)J recombination [GO:0033153]; T-helper 1 cell differentiation [GO:0045063]; tongue development [GO:0043586]; trachea gland development [GO:0061153]; transcription by RNA polymerase II [GO:0006366]" GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0001228; GO:0001569; GO:0001649; GO:0001756; GO:0001837; GO:0002040; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0008013; GO:0008284; GO:0008301; GO:0010628; GO:0010718; GO:0021542; GO:0021861; GO:0021873; GO:0021943; GO:0022408; GO:0022409; GO:0030177; GO:0030223; GO:0030326; GO:0030331; GO:0030335; GO:0030509; GO:0030854; GO:0030879; GO:0032696; GO:0032713; GO:0032714; GO:0032993; GO:0033153; GO:0042100; GO:0042393; GO:0042475; GO:0042826; GO:0043066; GO:0043392; GO:0043565; GO:0043586; GO:0043923; GO:0043966; GO:0043967; GO:0045063; GO:0045295; GO:0045588; GO:0045597; GO:0045843; GO:0045892; GO:0045893; GO:0045944; GO:0048341; GO:0050767; GO:0050909; GO:0060033; GO:0060070; GO:0060325; GO:0060326; GO:0060710; GO:0061153; GO:0062009; GO:0070016; GO:0070742; GO:0071345; GO:0071353; GO:0071864; GO:0071866; GO:0090068; GO:0097043; GO:0140416; GO:1902262; GO:1902732; GO:1904019; GO:1990837; GO:1990907 "armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; gamma-catenin binding [GO:0045295]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; transcription regulator inhibitor activity [GO:0140416]" EKLQESASGTGPR 0.9589 0.40058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1132 0 0 0 0 0 0 13.6129 0 0 0 0 0 13.3989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KP22 MAJIN_HUMAN Membrane-anchored junction protein MAJIN C11orf85 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141] "chromosome, telomeric region [GO:0000781]; integral component of nuclear inner membrane [GO:0005639]" "chromosome, telomeric region [GO:0000781]; integral component of nuclear inner membrane [GO:0005639]; DNA binding [GO:0003677]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]" GO:0000781; GO:0003677; GO:0005639; GO:0007129; GO:0045141; GO:0070197 DNA binding [GO:0003677] AVGAVMRKR 0.95891 0.35241 0 0 0 0 0 0 0 0 0 12.7837 12.5814 0 11.3866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3136 0 12.2304 12.0408 11.1918 0 0 0 11.9209 0 0 0 0 0 0 0 0 11.7556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4625 0 0 0 0 13.6959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0366 13.8655 0 0 0 12.5318 0 0 0 0 11.9452 0 0 0 0 0 0 0 0 0 0 0 Q9BY10 TSCOT_HUMAN Thymic stromal cotransporter homolog (Solute carrier family 46 member 2) SLC46A2 TSCOT Homo sapiens (Human) negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; regulation of T cell differentiation [GO:0045580]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; transmembrane transport [GO:0055085] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; regulation of T cell differentiation [GO:0045580]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; transmembrane transport [GO:0055085] GO:0005886; GO:0009986; GO:0015293; GO:0016020; GO:0016021; GO:0022857; GO:0043029; GO:0045580; GO:0048538; GO:0055085; GO:0070233; GO:0070430 symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] LILIDLMLGLAGFCGSMASGHLFK 0.95892 0.56322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60423 AT8B3_HUMAN "Phospholipid-transporting ATPase IK, EC 7.6.2.1 (ATPase class I type 8B member 3)" ATP8B3 ATP1K FOS37502_2 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; establishment of localization in cell [GO:0051649]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] acrosomal membrane [GO:0002080]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] acrosomal membrane [GO:0002080]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556]; binding of sperm to zona pellucida [GO:0007339]; establishment of localization in cell [GO:0051649]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] GO:0000287; GO:0002080; GO:0005524; GO:0005789; GO:0005802; GO:0005886; GO:0007030; GO:0007339; GO:0016020; GO:0016021; GO:0016887; GO:0045332; GO:0051649; GO:0090556; GO:0140326; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine floppase activity [GO:0090556] ALIVALVKK 0.95893 0.35095 0 0 0 0 0 0 13.3053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7022 0 0 0 0 0 0 0 0 0 0 0 0 13.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3144 0 0 0 0 0 0 0 10.5209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1594 0 0 0 0 0 0 0 14.6757 0 0 0 0 0 0 0 0 0 0 12.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0271 13.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5I0X7 TTC32_HUMAN "Tetratricopeptide repeat protein 32, TPR repeat protein 32" TTC32 Homo sapiens (Human) CACAASSDESPGSK 0.95893 0.68097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7297 10.7769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CJ77 HMN10_HUMAN "Humanin-like 10, HN10 (MT-RNR2-like protein 10)" MTRNR2L10 Homo sapiens (Human) negative regulation of execution phase of apoptosis [GO:1900118] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; receptor antagonist activity [GO:0048019]; negative regulation of execution phase of apoptosis [GO:1900118] GO:0005576; GO:0005737; GO:0048019; GO:1900118 receptor antagonist activity [GO:0048019] GFSCLLLLIREIDLSAK 0.95894 0.42285 0 0 0 0 0 0 0 0 0 0 0 12.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9281 14.3855 13.3983 0 0 13.6427 0 12.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2966 0 14.8794 0 0 0 0 0 0 0 0 0 13.9068 0 0 0 0 0 0 0 0 12.9993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3847 0 0 0 0 Q5VTJ3 KLD7A_HUMAN Kelch domain-containing protein 7A KLHDC7A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AEAPQGCSCENPR 0.95894 0.45381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.75 12.9126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2563 0 0 0 0 0 0 0 0 12.505 0 0 0 0 12.6391 0 0 0 0 0 0 0 0 12.7794 0 0 0 0 12.3339 0 0 0 13.919 0 0 0 0 0 14.0314 0 0 0 0 0 0 0 0 0 0 0 0 12.5529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PL2 TECTB_HUMAN Beta-tectorin TECTB Homo sapiens (Human) anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201] GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0009986; GO:0031225 extracellular matrix structural constituent [GO:0005201] LLRDQTGGVLVVELSLR 0.95895 0.42275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43610 SPY3_HUMAN "Protein sprouty homolog 3, Spry-3 (Sprouty RTK signaling antagonist 3) (Sprouty3)" SPRY3 Homo sapiens (Human) animal organ development [GO:0048513]; axon development [GO:0061564]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron projection arborization [GO:0150013]; negative regulation of Ras protein signal transduction [GO:0046580] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; animal organ development [GO:0048513]; axon development [GO:0061564]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron projection arborization [GO:0150013]; negative regulation of Ras protein signal transduction [GO:0046580] GO:0005829; GO:0016020; GO:0040037; GO:0043407; GO:0043409; GO:0046580; GO:0048513; GO:0061564; GO:0070373; GO:0150013 CKRHTNTVCR 0.95896 0.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52823 STC1_HUMAN "Stanniocalcin-1, STC-1" STC1 STC Homo sapiens (Human) bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280] GO:0001503; GO:0001886; GO:0003421; GO:0005179; GO:0005615; GO:0005634; GO:0005737; GO:0006874; GO:0007566; GO:0010596; GO:0016324; GO:0030336; GO:0033280; GO:0035988; GO:0042802; GO:0044070; GO:0046697; GO:0051926; GO:0060348; GO:0071320; GO:0071385; GO:0071456; GO:0086004; GO:0090280; GO:1903403 hormone activity [GO:0005179]; identical protein binding [GO:0042802] CIANGVTSK 0.95898 0.42153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SWW7 CJ055_HUMAN Uncharacterized protein C10orf55 C10orf55 Homo sapiens (Human) identical protein binding [GO:0042802] GO:0042802 identical protein binding [GO:0042802] MFLHLDSHSSLER 0.95898 0.36492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUD9 PIGV_HUMAN "GPI mannosyltransferase 2, EC 2.4.1.- (GPI mannosyltransferase II, GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein, PIG-V)" PIGV Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyltransferase complex [GO:0031501]; alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]" GO:0000009; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0016254; GO:0031501 "alpha-1,6-mannosyltransferase activity [GO:0000009]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]" SKNNKTLEK 0.95899 0.44128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 E5RG02 PRS46_HUMAN "Putative serine protease 46, EC 3.4.21.- (Serine protease 46 pseudogene)" PRSS46P PRSS46 Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508 serine-type endopeptidase activity [GO:0004252] LDYQPSIEGPWLR 0.959 0.36492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7328 0 0 P14550 AK1A1_HUMAN "Aldo-keto reductase family 1 member A1, EC 1.1.1.2, EC 1.1.1.372, EC 1.1.1.54 (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase, EC 1.1.1.19) (Glucuronolactone reductase, EC 1.1.1.20)" AKR1A1 ALDR1 ALR Homo sapiens (Human) aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid biosynthetic process [GO:0019853]; lipid metabolic process [GO:0006629] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; synapse [GO:0045202] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; synapse [GO:0045202]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; glycerol dehydrogenase [NADP+] activity [GO:0047956]; L-glucuronate reductase activity [GO:0047939]; methylglyoxal reductase (NADPH-dependent, acetol producing) [GO:1990002]; oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor [GO:0016657]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid biosynthetic process [GO:0019853]; lipid metabolic process [GO:0006629]" GO:0004032; GO:0004033; GO:0005615; GO:0005829; GO:0006629; GO:0016324; GO:0016657; GO:0019640; GO:0019853; GO:0042840; GO:0044597; GO:0044598; GO:0045202; GO:0046185; GO:0047655; GO:0047939; GO:0047941; GO:0047956; GO:0070062; GO:0110095; GO:1901687; GO:1990002 "alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; glycerol dehydrogenase [NADP+] activity [GO:0047956]; L-glucuronate reductase activity [GO:0047939]; methylglyoxal reductase (NADPH-dependent, acetol producing) [GO:1990002]; oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor [GO:0016657]" HHPEDVEPALRK 0.959 0.46755 0 0 17.062 0 0 0 15.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15393 TMPS2_HUMAN "Transmembrane protease serine 2, EC 3.4.21.- (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain ]" TMPRSS2 PRSS10 Homo sapiens (Human) positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; positive regulation of viral entry into host cell [GO:0046598]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] GO:0004252; GO:0005044; GO:0005576; GO:0005654; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0016540; GO:0046598; GO:0070062 scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] ALCITLTLGTFLVGAALAAGLLWK 0.95901 0.43039 0 0 0 0 0 0 0 0 0 0 0 15.0656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14392 LRC32_HUMAN "Transforming growth factor beta activator LRRC32 (Garpin) (Glycoprotein A repetitions predominant, GARP) (Leucine-rich repeat-containing protein 32)" LRRC32 D11S833E Homo sapiens (Human) negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cytokine production [GO:0001818]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; regulation of transforming growth factor beta3 activation [GO:1901398]; secondary palate development [GO:0062009]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; transforming growth factor beta binding [GO:0050431]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cytokine production [GO:0001818]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; regulation of transforming growth factor beta3 activation [GO:1901398]; secondary palate development [GO:0062009]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001818; GO:0005615; GO:0005654; GO:0005887; GO:0007179; GO:0009986; GO:0010628; GO:0031012; GO:0046007; GO:0050431; GO:0062009; GO:1901388; GO:1901398 transforming growth factor beta binding [GO:0050431] LIYLNLSNNLIR 0.95903 0.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8436 0 9.62503 0 0 0 0 12.6009 0 12.5654 13.7211 15.2174 0 14.6259 14.1563 0 0 0 0 0 0 0 0 10.6441 0 0 0 12.0556 0 0 0 0 0 0 0 0 0 0 0 0 13.9317 0 0 0 0 0 0 0 0 0 0 11.7433 0 0 0 0 0 0 0 13.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15270 NKX11_HUMAN "NK1 transcription factor-related protein 1 (Homeobox protein 153, HPX-153) (Homeobox protein SAX-2) (NKX-1.1)" NKX1-1 HPX153 SAX2 Homo sapiens (Human) cell differentiation [GO:0030154]; lipid metabolic process [GO:0006629]; nervous system process [GO:0050877]; regulation of generation of precursor metabolites and energy [GO:0043467]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; lipid metabolic process [GO:0006629]; nervous system process [GO:0050877]; regulation of generation of precursor metabolites and energy [GO:0043467]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006629; GO:0010906; GO:0030154; GO:0043467; GO:0050877 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LNLALSLSLTETQVKIWFQNR 0.95905 0.37132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8277 0 0 0 0 0 0 0 0 13.4442 0 0 0 0 0 0 14.3457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3989 0 0 0 0 14.6866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAM2 TTC8_HUMAN "Tetratricopeptide repeat protein 8, TPR repeat protein 8 (Bardet-Biedl syndrome 8 protein)" TTC8 BBS8 Homo sapiens (Human) axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893] BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391] BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893] GO:0001736; GO:0005813; GO:0005829; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0021772; GO:0032391; GO:0032880; GO:0034260; GO:0034464; GO:0035264; GO:0036064; GO:0045198; GO:0045444; GO:0048560; GO:0050893; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0061629; GO:0072659; GO:0097730; GO:1903251; GO:1905515 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] RKFQLCADLCTQMLEK 0.95906 0.37005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7R5 ZN665_HUMAN Zinc finger protein 665 (Zinc finger protein 160-like) ZNF665 ZFP160L Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CKECGKCFTQNSHLASHR 0.95906 0.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5797 11.0033 0 0 0 10.4783 0 0 0 0 0 0 0 0 0 0 9.76966 0 0 0 0 0 0 0 0 0 10.7487 0 0 0 0 0 11.2527 0 0 0 9.52317 0 0 12.9784 0 0 0 0 0 0 0 0 0 0 11.1657 0 0 0 0 0 0 0 0 0 17.0559 16.0444 13.7778 0 0 0 0 0 16.2533 0 16.282 0 0 0 0 0 0 0 0 12.4826 11.8554 0 0 0 0 0 16.973 16.6236 0 0 0 0 0 0 0 0 0 0 11.382 0 0 0 0 0 0 0 0 10.1213 0 0 0 0 0 15.048 12.6223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4185 0 0 0 Q9NY35 CLDN1_HUMAN Claudin domain-containing protein 1 (Membrane protein GENX-3745) CLDND1 C3orf4 HSPC174 PSEC0054 UNQ2511/PRO6000 Homo sapiens (Human) apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021] GO:0009986; GO:0016021; GO:0016324 CQFLLPFVSLGLMCFGALIGLCACICR 0.95906 0.60866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL26 RB22A_HUMAN "Ras-related protein Rab-22A, Rab-22" RAB22A RAB22 Homo sapiens (Human) endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494] GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0010008; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0070062; GO:0097494 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] ALRELKVCLLGDTGVGK 0.95906 0.43731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3858 0 0 0 0 0 0 0 14.7805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2881 0 0 0 0 0 0 9.53537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9593 0 12.8981 0 0 0 0 14.0314 0 0 12.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7827 0 0 0 0 0 0 0 0 0 0 0 0 Q8N141 ZFP82_HUMAN "Zinc finger protein 82 homolog, Zfp-82 (Zinc finger protein 545)" ZFP82 KIAA1948 ZNF545 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRVRQQLTLHQR 0.95907 0.60677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9256 0 0 14.0318 0 0 0 0 0 0 0 13.6217 0 0 0 0 0 0 0 0 0 0 0 0 14.1618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5102 0 0 11.6074 0 0 15.2362 13.5011 0 0 0 0 0 13.3855 0 0 14.2108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0182 0 0 11.8359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4558 0 0 0 0 12.9263 0 13.4824 13.1143 0 0 0 12.5948 0 0 0 0 0 13.4635 0 0 Q96MV1 TLCD4_HUMAN TLC domain-containing protein 4 (Transmembrane protein 56) TLCD4 TMEM56 Homo sapiens (Human) lipid homeostasis [GO:0055088] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid homeostasis [GO:0055088] GO:0005783; GO:0016021; GO:0055088 AIVINGILMTVVFFIVR 0.95907 0.60835 0 0 0 0 0 0 0 0 0 0 11.2969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYS1 KRA15_HUMAN Keratin-associated protein 1-5 (High sulfur keratin-associated protein 1.5) (Keratin-associated protein 1.5) KRTAP1-5 KAP1.5 KRTAP1.5 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTCCQTSFCGYPSFSISGTCGSSCCQPSCCETSCCQPR 0.95907 0.35398 0 0 0 0 0 0 0 0 0 10.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8782 0 0 0 0 0 0 0 0 0 0 14.6353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6958 0 0 0 0 0 0 0 0 0 0 13.5836 15.4054 12.7663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0683 0 0 0 0 0 0 0 0 0 0 0 11.2259 14.0239 0 0 0 0 0 0 0 0 0 0 0 Q96G74 OTUD5_HUMAN "OTU domain-containing protein 5, EC 3.4.19.12 (Deubiquitinating enzyme A, DUBA)" OTUD5 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of type I interferon production [GO:0032480]; neural crest cell differentiation [GO:0014033]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of type I interferon production [GO:0032480]; neural crest cell differentiation [GO:0014033]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; response to lipopolysaccharide [GO:0032496] GO:0004843; GO:0005634; GO:0005829; GO:0014033; GO:0016579; GO:0032480; GO:0032496; GO:0061578; GO:0070536; GO:0071108; GO:0090090; GO:0101005; GO:1904263; GO:1904515; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578] EDGACLFR 0.95908 0.35253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5411 0 0 0 0 0 0 11.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5681 0 0 0 0 0 0 0 0 0 0 12.633 0 0 0 0 0 14.8998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30679 GNA15_HUMAN "Guanine nucleotide-binding protein subunit alpha-15, G alpha-15, G-protein subunit alpha-15 (Epididymis tissue protein Li 17E) (Guanine nucleotide-binding protein subunit alpha-16, G alpha-16, G-protein subunit alpha-16)" GNA15 GNA16 Homo sapiens (Human) action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482] GO:0001508; GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007188; GO:0007202; GO:0007207; GO:0031683; GO:0045202; GO:0046872; GO:0051482; GO:0060158 G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] AMIEAMERLQIPFSRPESK 0.95909 0.60584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2051 0 11.6936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8801 0 0 0 0 0 0 0 0 11.9719 0 12.0661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7043 0 0 0 0 0 0 0 0 0 0 0 10.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQR9 G6PC2_HUMAN "Glucose-6-phosphatase 2, G-6-Pase 2, G6Pase 2, EC 3.1.3.9 (Islet-specific glucose-6-phosphatase catalytic subunit-related protein)" G6PC2 IGRP Homo sapiens (Human) gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796] GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0016021; GO:0042593; GO:0050796; GO:0051156 glucose-6-phosphatase activity [GO:0004346] MDFLHRNGVLIIQHLQKDYR 0.95909 0.20613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHA6 OR2W6_HUMAN Putative olfactory receptor 2W6 (Olfactory receptor OR6-3) (Putative olfactory receptor 2W7) OR2W6P OR2W7P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FLTLFYTIVTPSVNPLIYTLR 0.9591 0.35151 0 0 0 0 0 0 0 0 13.5238 14.2339 0 13.7454 0 14.2541 18.1409 13.2609 13.5628 13.8798 0 13.6133 13.8842 0 0 0 13.8172 13.9894 13.9169 0 14.8243 0 14.7123 0 13.6338 13.3845 13.6765 14.1836 13.6316 13.6954 13.7214 13.5688 13.6077 13.7047 14.5218 13.356 0 0 14.6416 13.6505 13.8184 0 0 0 0 13.8772 0 14.0238 0 0 0 14.5401 0 14.5106 0 18.3249 13.7566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1549 0 0 0 0 0 0 0 0 0 0 12.2629 0 0 0 0 10.9493 0 0 10.9192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3026 0 0 0 14.981 0 15.1943 0 14.9496 0 14.7747 15.1443 15.0715 0 0 0 0 0 0 15.1925 0 0 O14896 IRF6_HUMAN "Interferon regulatory factor 6, IRF-6" IRF6 Homo sapiens (Human) "cell development [GO:0048468]; cranial skeletal system development [GO:1904888]; immune system process [GO:0002376]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; stem cell proliferation [GO:0072089]" cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; cranial skeletal system development [GO:1904888]; immune system process [GO:0002376]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; stem cell proliferation [GO:0072089]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0008285; GO:0010839; GO:0030054; GO:0030216; GO:0043565; GO:0043616; GO:0045893; GO:0045944; GO:0048468; GO:0060021; GO:0060173; GO:0060644; GO:0070062; GO:0072089; GO:1904888; GO:1990837; GO:2000647 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" EVPMNPVK 0.95911 4.4996 0 0 13.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8004 0 0 12.5816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.81 0 0 0 15.0546 0 0 0 0 0 0 14.4925 0 0 0 10.9506 12.0458 0 0 0 13.8653 13.772 14.86 0 0 0 0 14.689 0 0 16.5925 0 0 0 14.3194 14.279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4335 0 0 0 0 14.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9775 14.5895 13.7966 0 0 0 0 0 0 13.5288 13.0606 13.8083 0 13.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HA47 UCK1_HUMAN "Uridine-cytidine kinase 1, UCK 1, EC 2.7.1.48 (Cytidine monophosphokinase 1) (Uridine monophosphokinase 1)" UCK1 URK1 Homo sapiens (Human) CTP salvage [GO:0044211]; phosphorylation [GO:0016310]; UMP salvage [GO:0044206] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; phosphorylation [GO:0016310]; UMP salvage [GO:0044206] GO:0004849; GO:0005524; GO:0005737; GO:0005829; GO:0016310; GO:0043771; GO:0044206; GO:0044211 ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; uridine kinase activity [GO:0004849] ASAGGEDCESPAPEADR 0.95911 0.46461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ84 GPC5C_HUMAN "G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein, RAIG-3)" GPRC5C RAIG3 PSEC0087 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; vesicle [GO:0031982] cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; vesicle [GO:0031982]; G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0030295; GO:0030659; GO:0031982; GO:0043231; GO:0043235; GO:0070062 G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295] DGKNSQVFRNPYVWD 0.95911 0.4232 0 0 0 0 12.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8226 12.6541 0 0 0 0 0 0 0 12.07 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8952 0 0 0 14.1885 14.1361 14.2572 0 11.9551 0 0 0 0 0 12.8303 13.9611 0 0 0 0 0 0 0 14.2715 14.0569 0 0 0 0 13.9334 0 0 0 13.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9905 0 0 0 0 0 0 A6NK58 LIPT2_HUMAN "Putative lipoyltransferase 2, mitochondrial, EC 2.3.1.181 (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)" LIPT2 Homo sapiens (Human) carboxylic acid metabolic process [GO:0019752]; positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819]; carboxylic acid metabolic process [GO:0019752]; positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249] GO:0005739; GO:0005759; GO:0009249; GO:0016874; GO:0019752; GO:0033819; GO:2000376 ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819] ELQRHVTVEEVMPPFLVAFK 0.95912 0.45391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5NE16 CATL3_HUMAN Putative inactive cathepsin L-like protein CTSL3P (Cathepsin L3 pseudogene) (HCTSL-s) CTSL3P CTSL3 Homo sapiens (Human) proteolysis involved in protein catabolic process [GO:0051603] extracellular space [GO:0005615]; lysosome [GO:0005764] extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in protein catabolic process [GO:0051603] GO:0004197; GO:0005615; GO:0005764; GO:0051603 cysteine-type endopeptidase activity [GO:0004197] DQCNWGSVRTDVR 0.95912 0.40058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49281 NRAM2_HUMAN "Natural resistance-associated macrophage protein 2, NRAMP 2 (Divalent cation transporter 1) (Divalent metal transporter 1, DMT-1) (Solute carrier family 11 member 2)" SLC11A2 DCT1 DMT1 NRAMP2 OK/SW-cl.20 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; cellular iron ion homeostasis [GO:0006879]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; vanadium ion transport [GO:0015676] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion transmembrane transporter activity [GO:0005385]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; cellular iron ion homeostasis [GO:0006879]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; vanadium ion transport [GO:0015676] GO:0001666; GO:0003032; GO:0005375; GO:0005381; GO:0005384; GO:0005385; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005802; GO:0005886; GO:0005887; GO:0006783; GO:0006824; GO:0006825; GO:0006826; GO:0006828; GO:0006879; GO:0006919; GO:0007611; GO:0009986; GO:0010039; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015099; GO:0015100; GO:0015295; GO:0015675; GO:0015676; GO:0015692; GO:0016020; GO:0016324; GO:0022890; GO:0031410; GO:0031526; GO:0031902; GO:0033212; GO:0034599; GO:0034755; GO:0045177; GO:0045178; GO:0046870; GO:0046915; GO:0048471; GO:0048813; GO:0048821; GO:0055037; GO:0060586; GO:0070574; GO:0070826; GO:1903561; GO:1905394 cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion transmembrane transporter activity [GO:0005385] IPLWGGVLITIADTFVFLFLDKYGLRK 0.95915 0.42204 0 12.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6649 0 0 0 0 0 0 0 12.9166 11.7225 12.788 0 0 0 13.4359 0 0 0 0 0 13.7176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2126 0 0 14.5241 14.7305 10.9995 0 0 14.3331 0 0 14.4765 13.0894 13.8922 0 12.1552 0 0 13.5348 0 13.1135 13.2202 0 13.2286 0 0 0 0 17.0101 0 0 0 12.4279 12.282 0 17.0819 0 0 12.9198 0 0 0 0 0 0 0 17.3103 0 13.4218 0 0 0 14.3757 0 0 0 0 0 12.0241 0 14.6548 13.8311 0 0 0 0 0 0 0 14.3975 0 12.2345 17.2044 0 0 0 17.1162 12.1695 0 0 11.4002 0 12.1447 0 12.6275 0 11.0073 0 0 0 12.6666 0 0 0 0 12.9412 13.074 0 0 0 12.2731 0 0 0 0 0 0 12.9452 0 0 0 0 0 0 Q9NPB3 CABP2_HUMAN "Calcium-binding protein 2, CaBP2" CABP2 Homo sapiens (Human) regulation of voltage-gated calcium channel activity [GO:1901385]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; visual perception [GO:0007601] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; regulation of voltage-gated calcium channel activity [GO:1901385]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0005246; GO:0005509; GO:0005737; GO:0005794; GO:0005886; GO:0007165; GO:0007601; GO:0007605; GO:0048471; GO:1901385 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509] AALKALLGERLSQR 0.95915 0.68149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8956 0 0 12.0985 0 0 0 0 0 0 0 0 10.9569 0 0 0 0 0 0 0 0 0 0 9.96362 0 0 0 0 0 0 0 0 0 0 0 13.8083 0 Q9Y315 DEOC_HUMAN "Deoxyribose-phosphate aldolase, DERA, EC 4.1.2.4 (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase, Deoxyriboaldolase)" DERA CGI-26 Homo sapiens (Human) carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]; pentose-phosphate shunt [GO:0006098] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]; pentose-phosphate shunt [GO:0006098] GO:0004139; GO:0005576; GO:0005654; GO:0005829; GO:0006098; GO:0009264; GO:0016052; GO:0034774; GO:0046121; GO:0046386; GO:1904813 deoxyribose-phosphate aldolase activity [GO:0004139] GITTAAVCVYPAR 0.95915 0.3652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8696 0 0 12.95 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.963 0 0 13.1895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6K0 LV316_HUMAN Immunoglobulin lambda variable 3-16 IGLV3-16 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 DSERPSGIPER 0.95916 0.42158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.499 11.1061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3396 0 0 0 0 11.8088 11.5496 0 0 0 0 0 0 0 0 0 0 12.4818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4798 0 0 0 0 0 0 0 0 0 0 12.7104 0 0 0 0 12.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9323 0 0 0 0 11.9471 0 0 0 0 0 12.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBT0 POC1A_HUMAN POC1 centriolar protein homolog A (Pix2) (Proteome of centriole protein 1A) (WD repeat-containing protein 51A) POC1A WDR51A Homo sapiens (Human) cilium assembly [GO:0060271] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cilium assembly [GO:0060271] GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0036064; GO:0060271 IWVPNVK 0.95917 0.44136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0993 0 0 0 0 0 0 11.1835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3106 14.7274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8298 0 0 0 0 0 0 0 19.0759 0 0 0 0 14.0682 0 0 0 0 0 0 0 19.4807 0 16.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BX59 TPSNR_HUMAN "Tapasin-related protein, TAPASIN-R (TAP-binding protein-like) (TAP-binding protein-related protein, TAPBP-R) (Tapasin-like)" TAPBPL Homo sapiens (Human) negative regulation of antigen processing and presentation of peptide antigen via MHC class I [GO:0002590]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; regulation of immune response [GO:0050776] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; MHC class I protein complex binding [GO:0023024]; negative regulation of antigen processing and presentation of peptide antigen via MHC class I [GO:0002590]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; regulation of immune response [GO:0050776] GO:0000139; GO:0002502; GO:0002590; GO:0003823; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0023024; GO:0050776 antigen binding [GO:0003823]; MHC class I protein complex binding [GO:0023024] QAPTGLGLLQAER 0.95917 0.36492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUE1 TF2LX_HUMAN "Homeobox protein TGIF2LX (TGF-beta-induced transcription factor 2-like protein) (TGFB-induced factor 2-like protein, X-linked) (TGIF-like on the X)" TGIF2LX TGIFLX Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EAAADGPAETQSPVEKDSPAKTQSPAQDTSIMSR 0.95918 0.55111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8312 16.8127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SZ6 CK5P1_HUMAN "Mitochondrial tRNA methylthiotransferase CDK5RAP1, EC 2.8.4.3 (CDK5 activator-binding protein C42) (CDK5 regulatory subunit-associated protein 1) (mt-tRNA-2-methylthio-N6-dimethylallyladenosine synthase) (mt-tRNA-N6-(dimethylallyl)adenosine(37) methylthiotransferase)" CDK5RAP1 C20orf34 CGI-05 HSPC167 Homo sapiens (Human) brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664] cytosol [GO:0005829]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein kinase binding [GO:0019901]; brain development [GO:0007420]; mitochondrial tRNA modification [GO:0070900]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of translational fidelity [GO:0045903]; regulation of neuron differentiation [GO:0045664]" GO:0005739; GO:0005829; GO:0007420; GO:0019901; GO:0035597; GO:0045664; GO:0045736; GO:0045903; GO:0046872; GO:0051539; GO:0070131; GO:0070900 "4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-isopentenyladenosine methylthiotransferase activity [GO:0035597]; protein kinase binding [GO:0019901]" EAYVELVHHIR 0.95918 0.43106 0 0 0 0 0 0 0 0 10.8841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3936 0 0 0 0 0 0 12.5605 12.6885 12.8073 0 12.9431 0 0 13.4062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5353 16.2975 15.9824 14.7887 0 0 0 13.4131 0 0 0 0 0 0 0 0 0 13.4027 12.2637 0 13.2688 12.6483 0 0 0 0 13.0046 0 13.2302 0 0 0 0 0 0 12.8361 13.5915 13.7175 13.2488 0 0 0 0 0 0 0 0 0 0 15.6024 14.2398 0 0 13.1366 11.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2224 0 0 0 0 0 0 0 14.7748 0 Q9NQY0 BIN3_HUMAN Bridging integrator 3 BIN3 Homo sapiens (Human) actin cortical patch localization [GO:0051666]; actin filament organization [GO:0007015]; cytoskeleton-dependent cytokinesis [GO:0061640]; division septum assembly [GO:0000917]; endocytosis [GO:0006897]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; plasma membrane tubulation [GO:0097320]; protein localization [GO:0008104]; regulation of lamellipodium assembly [GO:0010591]; skeletal muscle fiber development [GO:0048741]; unidimensional cell growth [GO:0009826] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeletal anchor activity [GO:0008093]; actin cortical patch localization [GO:0051666]; actin filament organization [GO:0007015]; cytoskeleton-dependent cytokinesis [GO:0061640]; division septum assembly [GO:0000917]; endocytosis [GO:0006897]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; plasma membrane tubulation [GO:0097320]; protein localization [GO:0008104]; regulation of lamellipodium assembly [GO:0010591]; skeletal muscle fiber development [GO:0048741]; unidimensional cell growth [GO:0009826] GO:0000917; GO:0005737; GO:0006897; GO:0007015; GO:0008093; GO:0008104; GO:0009826; GO:0010591; GO:0014839; GO:0015629; GO:0048741; GO:0051666; GO:0061640; GO:0097320 cytoskeletal anchor activity [GO:0008093] AQVVYYSEMHK 0.95918 0.35538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0363 0 0 0 Q13510 ASAH1_HUMAN "Acid ceramidase, AC, ACDase, Acid CDase, EC 3.5.1.23 (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1, EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein, PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta ]" ASAH1 ASAH HSD-33 HSD33 Homo sapiens (Human) cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512]" GO:0003714; GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0006631; GO:0016810; GO:0016811; GO:0016922; GO:0017040; GO:0017064; GO:0030216; GO:0043202; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0070062; GO:0071356; GO:0102121; GO:1903507; GO:1904724; GO:1904813 "ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]" KGHLIHGR 0.95919 0.46783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6032 15.4233 0 0 0 0 0 0 0 0 14.0047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3216 0 0 0 0 0 15.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z401 MYCPP_HUMAN C-myc promoter-binding protein (DENN domain-containing protein 4A) DENND4A IRLB MYCPBP Homo sapiens (Human) "regulation of Rab protein signal transduction [GO:0032483]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Rab protein signal transduction [GO:0032483]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483 DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] CICLLSHWPFFDAFR 0.95919 0.37281 0 0 0 0 0 0 0 0 0 13.8395 10.138 0 0 0 0 12.3882 12.8103 12.3925 0 0 13.1061 0 0 0 0 12.3224 12.51 12.3963 0 12.5413 0 0 0 11.5898 0 0 0 0 0 0 0 10.261 0 0 0 12.6671 12.4102 12.4115 0 12.2911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8415 13.1004 0 0 11.6422 0 0 0 0 0 10.5161 0 0 0 0 15.6985 13.8236 0 0 0 0 0 0 0 0 0 0 14.013 0 12.5345 0 0 0 13.447 11.5548 0 0 0 13.208 0 13.1822 0 0 0 0 0 0 0 0 0 0 12.9004 13.0126 0 0 14.6925 0 13.5794 0 0 0 0 0 13.478 0 0 0 0 0 0 0 12.7967 0 0 0 0 0 14.765 13.3192 0 0 13.285 0 0 0 11.7765 13.4083 13.0305 0 0 13.3212 12.8846 12.9118 0 0 0 14.1626 13.8958 0 12.4895 0 13.1658 14.1421 0 0 14.4176 13.9273 13.738 0 0 Q9NRN5 OLFL3_HUMAN Olfactomedin-like protein 3 (HNOEL-iso) (hOLF44) OLFML3 PSEC0035 PSEC0173 PSEC0244 UNQ663/PRO1294 Homo sapiens (Human) signal transduction [GO:0007165] extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; signal transduction [GO:0007165] GO:0005615; GO:0007165; GO:1903561 ILKRFGGPAGLWTK 0.95919 0.43044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4266 0 0 0 0 0 0 0 0 13.7433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8133 14.855 0 0 0 0 10.5661 0 0 0 14.1958 0 0 11.4181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2527 0 0 0 0 0 0 13.6658 0 0 0 14.1366 0 0 14.2386 0 0 0 0 0 0 0 0 0 0 0 Q15834 CC85B_HUMAN "Coiled-coil domain-containing protein 85B (Hepatitis delta antigen-interacting protein A, Delta-interacting protein A)" CCDC85B DIPA Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]" adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; delta-catenin binding [GO:0070097]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0005634; GO:0005737; GO:0005813; GO:0005912; GO:0030154; GO:0030308; GO:0045599; GO:0045892; GO:0070097 delta-catenin binding [GO:0070097] LQAENRELRDLCCFLDSER 0.9592 0.19978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4N3 KLH36_HUMAN Kelch-like protein 36 KLHL36 C16orf44 Homo sapiens (Human) protein ubiquitination [GO:0016567] cullin family protein binding [GO:0097602]; protein ubiquitination [GO:0016567] GO:0016567; GO:0097602 cullin family protein binding [GO:0097602] ETPLPARR 0.9592 0.37271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3889 0 0 13.4274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9646 0 0 0 0 13.1942 13.3529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7495 15.8734 13.2107 15.6837 13.2282 14.3228 12.4695 12.3113 0 0 15.2119 0 0 0 13.8159 0 0 0 0 0 0 15.8522 11.1702 0 0 14.0082 0 0 15.9895 0 0 15.5962 13.0302 0 12.5428 0 15.6999 0 0 0 0 0 0 12.5112 0 0 14.7948 14.1951 14.0741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3Q3 G3ST2_HUMAN "Galactose-3-O-sulfotransferase 2, Gal3ST-2, EC 2.8.2.- (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2) (Glycoprotein beta-Gal 3'-sulfotransferase 2)" GAL3ST2 GP3ST Homo sapiens (Human) glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101] GO:0001733; GO:0008146; GO:0009101; GO:0009247; GO:0016020; GO:0016021; GO:0032580; GO:0050694 galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146] AELGPRRLR 0.9592 0.60298 0 14.292 0 14.0047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6992 0 0 0 0 0 0 0 0 15.1137 0 0 0 0 0 0 14.2314 14.1634 0 0 0 0 0 11.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7958 0 0 0 0 0 0 0 0 0 0 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.50611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0V4 LGI2_HUMAN Leucine-rich repeat LGI family member 2 (LGI1-like protein 2) (Leucine-rich glioma-inactivated protein 2) LGI2 KIAA1916 LGIL2 Homo sapiens (Human) inhibitory synapse assembly [GO:1904862] extracellular region [GO:0005576] extracellular region [GO:0005576]; inhibitory synapse assembly [GO:1904862] GO:0005576; GO:1904862 DFFFASSFKGK 0.95922 3.2754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4768 0 12.9825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4766 0 10.4967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2425 0 0 11.6324 0 0 0 0 0 0 0 0 0 0 0 0 13.5067 0 0 0 0 Q9HAW0 BRF2_HUMAN "Transcription factor IIIB 50 kDa subunit, TFIIIB50, hTFIIIB50 (B-related factor 2, BRF-2) (hBRFU)" BRF2 BRFU PRO1470 Homo sapiens (Human) "cellular response to oxidative stress [GO:0034599]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription preinitiation complex assembly [GO:0070897]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; cellular response to oxidative stress [GO:0034599]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription preinitiation complex assembly [GO:0070897]" GO:0000126; GO:0001006; GO:0005634; GO:0005654; GO:0006352; GO:0006359; GO:0017025; GO:0034599; GO:0046872; GO:0070897; GO:0097550 metal ion binding [GO:0046872]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025] RSVVKHIGDLLQHR 0.95922 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHQ1 NARF_HUMAN "Nuclear prelamin A recognition factor (Iron-only hydrogenase-like protein 2, IOP2)" NARF Homo sapiens (Human) lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] lamin filament [GO:0005638]; nuclear lamina [GO:0005652]; nuclear lumen [GO:0031981]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; lamin binding [GO:0005521] GO:0005521; GO:0005638; GO:0005652; GO:0005654; GO:0005730; GO:0031981 lamin binding [GO:0005521] ECSKKTK 0.95922 0.43966 0 12.5312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9056 0 0 0 0 0 0 0 0 0 15.0763 0 0 0 0 13.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GK7 FAH2A_HUMAN "Fumarylacetoacetate hydrolase domain-containing protein 2A, EC 3.-.-.-" FAHD2A CGI-105 Homo sapiens (Human) hydro-lyase activity [GO:0016836]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] GO:0016787; GO:0016836; GO:0046872 hydro-lyase activity [GO:0016836]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] ALAAQLPVLPRSEVTFLAPVTRPDK 0.95923 3.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3486 0 0 0 0 12.1845 0 0 0 0 0 0 12.473 0 Q9NP85 PODO_HUMAN Podocin NPHS2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; glomerular filtration [GO:0003094]; metanephric podocyte development [GO:0072249] cell-cell junction [GO:0005911]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057] cell-cell junction [GO:0005911]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; actin cytoskeleton reorganization [GO:0031532]; glomerular filtration [GO:0003094]; metanephric podocyte development [GO:0072249] GO:0003094; GO:0005783; GO:0005886; GO:0005887; GO:0005911; GO:0031235; GO:0031532; GO:0032991; GO:0036057; GO:0045121; GO:0070062; GO:0072249 GGRTPHK 0.95923 0.37155 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4206 0 0 0 0 0 0 0 0 0 0 0 0 13.8489 0 0 0 13.9978 0 0 0 0 12.6653 0 0 0 0 14.0562 0 0 14.6417 0 0 0 0 0 0 0 0 0 0 13.2192 13.4934 0 13.9147 0 0 0 0 0 0 0 0 0 0 0 13.1832 0 0 0 0 0 0 11.3628 0 0 0 0 0 0 0 14.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NC42 DPPA5_HUMAN "Developmental pluripotency-associated 5 protein, hDPPA5 (Embryonal stem cell-specific gene 1 protein, ESG-1)" DPPA5 ESG1 Homo sapiens (Human) regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; regulation of gene expression [GO:0010468] GO:0003729; GO:0005737; GO:0010468 mRNA binding [GO:0003729] GTLPARRHIPPWVK 0.95925 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7596 0 0 0 0 0 0 0 0 0 0 0 13.7932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6S5H5 POTEG_HUMAN "POTE ankyrin domain family member G (ANKRD26-like family C member 2) (Prostate, ovary, testis-expressed protein on chromosome 14, POTE-14)" POTEG A26C2 POTE14 Homo sapiens (Human) EYAVSSHHNVICQLLSDYKEKQMLK 0.95925 0.44453 0 0 0 0 0 0 0 0 0 13.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JG80 NPIB4_HUMAN Nuclear pore complex-interacting protein family member B4 NPIPB4 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 DVITLRR 0.95926 0.2063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5268 0 0 0 0 0 0 0 0 0 0 0 0 12.5088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9325 11.1311 0 0 0 0 0 0 0 0 0 12.995 0 0 0 0 0 0 0 0 0 0 0 0 P10114 RAP2A_HUMAN "Ras-related protein Rap-2a, EC 3.6.5.2 (RbBP-30)" RAP2A Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular response to xenobiotic stimulus [GO:0071466]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328] cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; actin cytoskeleton reorganization [GO:0031532]; cellular response to xenobiotic stimulus [GO:0071466]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328] GO:0000287; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0008104; GO:0019003; GO:0030033; GO:0030336; GO:0030496; GO:0031532; GO:0031954; GO:0032486; GO:0045184; GO:0046328; GO:0048814; GO:0055037; GO:0055038; GO:0071466; GO:0072659 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] DDPCCSACNIQ 0.95926 0.44438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VW38 GP107_HUMAN Protein GPR107 (Lung seven transmembrane receptor 1) GPR107 KIAA1624 LUSTR1 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583] GO:0005654; GO:0005769; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0030136; GO:0032050; GO:0072583 clathrin heavy chain binding [GO:0032050] AGITAAINLAKLKLFR 0.95926 4.4888 0 0 0 0 0 0 0 0 13.1748 0 11.3141 0 0 0 0 0 11.7228 0 10.6809 0 0 11.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4988 0 0 12.5613 0 0 11.8099 0 0 0 0 0 13.5887 0 0 14.2698 0 0 0 0 0 0 0 0 0 0 13.0749 0 0 0 0 12.2123 12.7383 0 0 13.3354 0 13.8975 13.3375 11.7638 0 13.6358 0 0 0 0 0 0 0 0 0 0 0 13.5751 0 0 0 12.0561 0 0 12.5147 12.144 12.5712 0 11.6032 0 10.6617 0 11.9637 0 14.2225 0 13.3382 0 0 0 0 12.7824 0 0 0 0 12.1422 12.1105 0 0 12.0482 0 0 0 0 0 0 0 0 0 0 0 0 11.7563 0 0 0 0 0 Q9Y3A0 COQ4_HUMAN "Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (Coenzyme Q biosynthesis protein 4 homolog)" COQ4 CGI-92 Homo sapiens (Human) ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142]; ubiquinone biosynthetic process [GO:0006744] GO:0005739; GO:0005743; GO:0006744; GO:0031314; GO:0032991; GO:0110142 RDPEGAQILQERPR 0.95926 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK55 ZPI_HUMAN "Protein Z-dependent protease inhibitor, PZ-dependent protease inhibitor, PZI (Serpin A10)" SERPINA10 ZPI UNQ707/PRO1358 Homo sapiens (Human) blood coagulation [GO:0007596]; liver regeneration [GO:0097421]; negative regulation of endopeptidase activity [GO:0010951] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; liver regeneration [GO:0097421]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0005788; GO:0007596; GO:0008201; GO:0010951; GO:0070062; GO:0097421 heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] LFDEINPETKLILVDYILFKGK 0.95928 4.7823 0 0 0 0 0 0 0 0 0 11.6938 0 0 0 0 0 0 0 12.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.805 0 0 11.5225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.164 0 0 0 12.0134 14.5005 0 0 0 0 0 0 0 0 14.0132 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 13.3929 0 0 0 0 13.332 0 0 0 13.2612 13.6232 14.009 13.6463 0 13.3025 0 0 0 0 0 0 12.6526 0 13.5417 0 0 0 13.0587 0 0 14.4553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1524 0 0 0 0 0 13.0828 13.6253 0 0 0 0 0 0 12.8579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG01 GKN3_HUMAN Gastrokine-3 GKN3P Homo sapiens (Human) regulation of cell population proliferation [GO:0042127] extracellular space [GO:0005615] extracellular space [GO:0005615]; regulation of cell population proliferation [GO:0042127] GO:0005615; GO:0042127 MKHLVASSILGVFVLTPSLAMMNIR 0.95929 0.60648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08116 RGS1_HUMAN "Regulator of G-protein signaling 1, RGS1 (B-cell activation protein BL34) (Early response protein 1R20)" RGS1 1R20 BL34 IER1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; leukotriene signaling pathway [GO:0061737]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] GO:0001965; GO:0003924; GO:0005096; GO:0005516; GO:0005829; GO:0005886; GO:0006955; GO:0007165; GO:0007186; GO:0007193; GO:0008277; GO:0009617; GO:0009968; GO:0031234; GO:0043547; GO:0061737 calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GTTHSLLDDKMQK 0.95929 0.40058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9537 0 0 0 Q9BSE2 TMM79_HUMAN Transmembrane protein 79 (Mattrin) TMEM79 MATT Homo sapiens (Human) cornification [GO:0070268]; cuticle development [GO:0042335]; epithelial cell maturation [GO:0002070]; establishment of skin barrier [GO:0061436]; hair follicle morphogenesis [GO:0031069]; positive regulation of epidermis development [GO:0045684]; regulated exocytosis [GO:0045055] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; identical protein binding [GO:0042802]; cornification [GO:0070268]; cuticle development [GO:0042335]; epithelial cell maturation [GO:0002070]; establishment of skin barrier [GO:0061436]; hair follicle morphogenesis [GO:0031069]; positive regulation of epidermis development [GO:0045684]; regulated exocytosis [GO:0045055] GO:0002070; GO:0005765; GO:0016021; GO:0031069; GO:0032588; GO:0042335; GO:0042802; GO:0045055; GO:0045684; GO:0061436; GO:0070268 identical protein binding [GO:0042802] CEAGEGECR 0.9593 0.20328 0 0 0 0 0 0 0 0 0 10.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1615 11.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9412 0 0 0 11.838 0 0 0 0 0 0 0 0 11.5612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A286YFK9 SIM38_HUMAN Small integral membrane protein 38 SMIM38 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TSWPGGSFGPDPLLALLVVILLAR 0.95931 0.56322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4LEZ3 AARD_HUMAN Alanine and arginine-rich domain-containing protein AARD C8orf85 Homo sapiens (Human) LTRAFQWAVQR 0.95931 0.45392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P45452 MMP13_HUMAN "Collagenase 3, EC 3.4.24.- (Matrix metalloproteinase-13, MMP-13)" MMP13 Homo sapiens (Human) bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; collagen catabolic process [GO:0030574]; endochondral ossification [GO:0001958]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; proteolysis [GO:0006508]; response to amyloid-beta [GO:1904645] GO:0001958; GO:0003417; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030282; GO:0030574; GO:0031012; GO:0060349; GO:1904645 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] IDAAYEHPSHDLIFIFRGR 0.95932 0.21502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3811 0 0 0 0 0 0 0 12.8989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.351 0 0 0 10.9825 12.3551 11.3438 0 13.5561 13.2715 0 0 0 10.5375 0 0 0 0 0 0 0 0 0 11.8001 0 0 0 0 0 0 0 12.1626 0 0 0 0 12.633 0 0 0 0 0 0 0 0 12.1259 0 0 0 0 0 0 Q8NGP0 OR4CD_HUMAN Olfactory receptor 4C13 (Olfactory receptor OR11-260) OR4C13 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ANRNNVTEFILLGLTENPKMQK 0.95932 0.21457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BU79 TM243_HUMAN "Transmembrane protein 243 (MDR1- and mitochondrial taxol resistance-associated protein, MM-TRAG)" TMEM243 C7orf23 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DRIINLVVGSLTSLLILVTLISAFVFPQLPPK 0.95932 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9009 0 0 0 0 A8MUU1 FB5L3_HUMAN Putative fatty acid-binding protein 5-like protein 3 (Fatty acid-binding protein 5 pseudogene 3) FABP5P3 FABP5L3 Homo sapiens (Human) fatty acid transport [GO:0015908] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; fatty acid transport [GO:0015908] GO:0005504; GO:0005634; GO:0005829; GO:0015908 fatty acid binding [GO:0005504] ESTITRKLK 0.95934 0.47371 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6028 0 0 0 0 0 0 0 0 0 0 0 0 16.9862 0 0 0 0 13.4832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9697 0 12.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGA1 OR1M1_HUMAN "Olfactory receptor 1M1 (Olfactory receptor 19-6, OR19-6) (Olfactory receptor OR19-5)" OR1M1 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IFILIVAGMVIATPFVCILASYARILVAIMK 0.95935 0.44179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL33 TPC2L_HUMAN Trafficking protein particle complex subunit 2-like protein TRAPPC2L HSPC126 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006888; GO:0006901; GO:0030008; GO:0043231; GO:0048208; GO:0048471; GO:0099022; GO:1990071; GO:1990072 DNEIRSMFRK 0.95936 0.43113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16233 LIPP_HUMAN "Pancreatic triacylglycerol lipase, PL, PTL, Pancreatic lipase, EC 3.1.1.3" PNLIP Homo sapiens (Human) intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365] extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]" GO:0004806; GO:0005576; GO:0005615; GO:0006629; GO:0016042; GO:0016298; GO:0030299; GO:0046872; GO:0047376; GO:0061365 "all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]" FYLDTGDASNFARWR 0.95937 0.37287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2816 0 0 0 0 0 0 0 0 0 0 14.2235 14.16 0 0 0 0 0 0 0 0 0 13.1573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8194 12.7348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12644 BMP4_HUMAN "Bone morphogenetic protein 4, BMP-4 (Bone morphogenetic protein 2B, BMP-2B)" BMP4 BMP2B DVR4 Homo sapiens (Human) "ameloblast differentiation [GO:0036305]; anterior/posterior axis specification [GO:0009948]; aortic valve morphogenesis [GO:0003180]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; BMP signaling pathway involved in nephric duct formation [GO:0071893]; BMP signaling pathway involved in renal system segmentation [GO:0061151]; BMP signaling pathway involved in ureter morphogenesis [GO:0061149]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchus development [GO:0060433]; bud dilation involved in lung branching [GO:0060503]; bud elongation involved in lung branching [GO:0060449]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum development [GO:0003279]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; cloacal septation [GO:0060197]; common-partner SMAD protein phosphorylation [GO:0007182]; coronary vasculature development [GO:0060976]; cranial suture morphogenesis [GO:0060363]; deltoid tuberosity development [GO:0035993]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion development [GO:0003197]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal cell signaling [GO:0060684]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; glomerular capillary formation [GO:0072104]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear auditory receptor cell differentiation [GO:0042491]; intermediate mesodermal cell differentiation [GO:0048392]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage differentiation [GO:0030225]; mammary gland formation [GO:0060592]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; mesenchymal cell proliferation involved in ureter development [GO:0072198]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate determination [GO:0007500]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [GO:0072097]; negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of glomerulus development [GO:0090194]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell proliferation involved in ureter development [GO:0072200]; negative regulation of metanephric comma-shaped body morphogenesis [GO:2000007]; negative regulation of metanephric S-shaped body morphogenesis [GO:2000005]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; pericyte cell differentiation [GO:1904238]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cardiac muscle fiber development [GO:0055020]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in outflow tract morphogenesis [GO:1901964]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; prostatic bud formation [GO:0060513]; protein localization to nucleus [GO:0034504]; pulmonary artery endothelial tube morphogenesis [GO:0061155]; pulmonary valve morphogenesis [GO:0003184]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell fate commitment [GO:0010453]; regulation of mesodermal cell differentiation [GO:1905770]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein import into nucleus [GO:0042306]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system process [GO:0003014]; secondary heart field specification [GO:0003139]; sinoatrial node development [GO:0003163]; SMAD protein signal transduction [GO:0060395]; smooth muscle tissue development [GO:0048745]; specification of animal organ position [GO:0010159]; specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [GO:0072101]; steroid hormone mediated signaling pathway [GO:0043401]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; tendon cell differentiation [GO:0035990]; trachea development [GO:0060438]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell development [GO:0003323]; ureter epithelial cell differentiation [GO:0072192]; ureter smooth muscle cell differentiation [GO:0072193]; ureteric bud development [GO:0001657]" endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; chemoattractant activity [GO:0042056]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; ameloblast differentiation [GO:0036305]; anterior/posterior axis specification [GO:0009948]; aortic valve morphogenesis [GO:0003180]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; BMP signaling pathway involved in nephric duct formation [GO:0071893]; BMP signaling pathway involved in renal system segmentation [GO:0061151]; BMP signaling pathway involved in ureter morphogenesis [GO:0061149]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchus development [GO:0060433]; bud dilation involved in lung branching [GO:0060503]; bud elongation involved in lung branching [GO:0060449]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum development [GO:0003279]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; cloacal septation [GO:0060197]; common-partner SMAD protein phosphorylation [GO:0007182]; coronary vasculature development [GO:0060976]; cranial suture morphogenesis [GO:0060363]; deltoid tuberosity development [GO:0035993]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion development [GO:0003197]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; epithelial-mesenchymal cell signaling [GO:0060684]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; glomerular capillary formation [GO:0072104]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear auditory receptor cell differentiation [GO:0042491]; intermediate mesodermal cell differentiation [GO:0048392]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage differentiation [GO:0030225]; mammary gland formation [GO:0060592]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; mesenchymal cell proliferation involved in ureter development [GO:0072198]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate determination [GO:0007500]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [GO:0072097]; negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of glomerulus development [GO:0090194]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell proliferation involved in ureter development [GO:0072200]; negative regulation of metanephric comma-shaped body morphogenesis [GO:2000007]; negative regulation of metanephric S-shaped body morphogenesis [GO:2000005]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; pericyte cell differentiation [GO:1904238]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cardiac muscle fiber development [GO:0055020]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in outflow tract morphogenesis [GO:1901964]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; prostatic bud formation [GO:0060513]; protein localization to nucleus [GO:0034504]; pulmonary artery endothelial tube morphogenesis [GO:0061155]; pulmonary valve morphogenesis [GO:0003184]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell fate commitment [GO:0010453]; regulation of mesodermal cell differentiation [GO:1905770]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein import into nucleus [GO:0042306]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system process [GO:0003014]; secondary heart field specification [GO:0003139]; sinoatrial node development [GO:0003163]; SMAD protein signal transduction [GO:0060395]; smooth muscle tissue development [GO:0048745]; specification of animal organ position [GO:0010159]; specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [GO:0072101]; steroid hormone mediated signaling pathway [GO:0043401]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; tendon cell differentiation [GO:0035990]; trachea development [GO:0060438]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]; type B pancreatic cell development [GO:0003323]; ureter epithelial cell differentiation [GO:0072192]; ureter smooth muscle cell differentiation [GO:0072193]; ureteric bud development [GO:0001657]" GO:0000122; GO:0001649; GO:0001657; GO:0001658; GO:0001822; GO:0001823; GO:0001843; GO:0001934; GO:0001938; GO:0001958; GO:0002043; GO:0002062; GO:0002244; GO:0002320; GO:0003014; GO:0003130; GO:0003139; GO:0003148; GO:0003149; GO:0003163; GO:0003180; GO:0003184; GO:0003197; GO:0003279; GO:0003323; GO:0003337; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0006366; GO:0007182; GO:0007281; GO:0007492; GO:0007500; GO:0008083; GO:0008201; GO:0008284; GO:0008285; GO:0009791; GO:0009948; GO:0010159; GO:0010453; GO:0010595; GO:0010628; GO:0010629; GO:0010718; GO:0010862; GO:0010942; GO:0021537; GO:0021904; GO:0021978; GO:0021983; GO:0030218; GO:0030224; GO:0030225; GO:0030501; GO:0030509; GO:0030513; GO:0032092; GO:0032331; GO:0032967; GO:0033085; GO:0033088; GO:0034504; GO:0035116; GO:0035990; GO:0035993; GO:0036305; GO:0039706; GO:0042056; GO:0042306; GO:0042326; GO:0042475; GO:0042476; GO:0042487; GO:0042491; GO:0042733; GO:0043065; GO:0043066; GO:0043401; GO:0043407; GO:0043410; GO:0045603; GO:0045606; GO:0045662; GO:0045666; GO:0045669; GO:0045778; GO:0045786; GO:0045839; GO:0045843; GO:0045892; GO:0045893; GO:0045944; GO:0048286; GO:0048392; GO:0048661; GO:0048663; GO:0048701; GO:0048745; GO:0048754; GO:0050679; GO:0050680; GO:0051150; GO:0055007; GO:0055020; GO:0060197; GO:0060235; GO:0060272; GO:0060363; GO:0060391; GO:0060393; GO:0060395; GO:0060425; GO:0060433; GO:0060438; GO:0060440; GO:0060441; GO:0060442; GO:0060449; GO:0060502; GO:0060503; GO:0060513; GO:0060548; GO:0060592; GO:0060684; GO:0060686; GO:0060687; GO:0060976; GO:0061036; GO:0061047; GO:0061149; GO:0061151; GO:0061155; GO:0061312; GO:0061626; GO:0070244; GO:0070374; GO:0070700; GO:0071773; GO:0071893; GO:0072015; GO:0072097; GO:0072101; GO:0072104; GO:0072125; GO:0072138; GO:0072161; GO:0072192; GO:0072193; GO:0072198; GO:0072200; GO:0072205; GO:0090184; GO:0090191; GO:0090194; GO:1900745; GO:1901964; GO:1902894; GO:1903800; GO:1904238; GO:1905312; GO:1905770; GO:2000005; GO:2000007; GO:2000137; GO:2001237 BMP receptor binding [GO:0070700]; chemoattractant activity [GO:0042056]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201] EQVDQGPDWER 0.95938 0.60429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6432 0 0 0 0 0 0 0 0 0 0 0 13.1118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P45983 MK08_HUMAN "Mitogen-activated protein kinase 8, MAP kinase 8, MAPK 8, EC 2.7.11.24 (JNK-46) (Stress-activated protein kinase 1c, SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1)" MAPK8 JNK1 PRKM8 SAPK1 SAPK1C Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell killing [GO:0031343]; positive regulation of cyclase activity [GO:0031281]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein metabolic process [GO:0051247]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of macroautophagy [GO:0016241]; regulation of protein localization [GO:0032880]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; stress-activated MAPK cascade [GO:0051403] anchoring junction [GO:0070161]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell killing [GO:0031343]; positive regulation of cyclase activity [GO:0031281]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein metabolic process [GO:0051247]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of macroautophagy [GO:0016241]; regulation of protein localization [GO:0032880]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; stress-activated MAPK cascade [GO:0051403] GO:0004674; GO:0004705; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006979; GO:0007254; GO:0007258; GO:0009411; GO:0009612; GO:0010628; GO:0016241; GO:0018105; GO:0018107; GO:0019899; GO:0019903; GO:0030424; GO:0031281; GO:0031343; GO:0032091; GO:0032880; GO:0034198; GO:0034599; GO:0034614; GO:0035033; GO:0035556; GO:0038095; GO:0042752; GO:0042826; GO:0043065; GO:0043066; GO:0045202; GO:0048511; GO:0051090; GO:0051247; GO:0051403; GO:0070161; GO:0071222; GO:0071260; GO:0071276; GO:0090045; GO:0090398; GO:0097441; GO:0106310; GO:0120283; GO:1900740; GO:1902595 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283] AYRELVLMK 0.9594 0.60306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99871 HAUS7_HUMAN HAUS augmin-like complex subunit 7 (26S proteasome-associated UCH37-interacting protein 1) (UCHL5-interacting protein) (X-linked protein STS1769) HAUS7 UCHL5IP UIP1 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; microtubule minus-end binding [GO:0051011]; thioesterase binding [GO:0031996]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0005730; GO:0005813; GO:0005829; GO:0005886; GO:0007098; GO:0031996; GO:0051011; GO:0051225; GO:0051301; GO:0070652; GO:1990498 microtubule minus-end binding [GO:0051011]; thioesterase binding [GO:0031996] AAVEVFGKLK 0.9594 0.22 0 0 0 13.5214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8977 11.3845 0 10.8416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1947 0 0 0 0 0 0 0 0 13.6879 13.653 0 0 0 12.716 13.4798 13.0717 0 11.9766 0 0 0 0 0 0 0 0 0 0 0 13.7013 0 13.3382 12.9317 14.5516 0 0 13.806 0 13.9722 14.0196 0 11.7568 0 14.644 0 0 0 0 0 13.5493 13.5401 0 13.6222 0 0 0 0 0 0 0 0 12.0599 0 0 0 0 0 0 15.3142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14530 TXND9_HUMAN Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4) TXNDC9 APACD Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein folding [GO:0006457] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; microtubule cytoskeleton organization [GO:0000226]; protein folding [GO:0006457] GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0030496; GO:0045296 cadherin binding [GO:0045296] AQQQKQEWLSK 0.95941 0.20707 0 0 0 0 0 0 0 0 0 14.2899 0 0 0 0 0 0 0 15.121 0 0 0 0 0 0 0 0 0 0 14.9471 0 0 0 0 0 0 0 11.1053 9.32663 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.04 0 12.3207 0 0 0 0 0 0 0 0 0 0 14.3688 13.543 15.4886 14.365 14.634 13.1783 11.8755 12.8675 11.4222 0 0 12.0881 0 0 0 13.4248 0 14.3764 12.8664 13.4285 0 10.8999 13.6188 13.1674 13.177 0 12.3478 10.9254 0 0 13.1589 0 0 13.045 11.5077 0 0 0 13.0161 0 0 0 12.5929 0 13.4318 12.7506 11.4488 0 11.9457 0 0 0 0 0 0 11.6853 0 0 0 10.4425 0 0 0 0 0 10.7036 0 0 0 10.0523 0 0 0 0 0 12.6113 0 0 11.9642 0 12.4561 0 0 0 0 13.0252 0 12.1347 0 0 0 0 0 0 0 0 12.7218 0 Q9NX02 NALP2_HUMAN "NACHT, LRR and PYD domains-containing protein 2 (Nucleotide-binding site protein 1) (PYRIN domain and NACHT domain-containing protein 1) (PYRIN-containing APAF1-like protein 2)" NLRP2 NALP2 NBS1 PAN1 PYPAF2 Homo sapiens (Human) apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; Pyrin domain binding [GO:0032090]; apoptotic process [GO:0006915]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; regulation of inflammatory response [GO:0050727] GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006954; GO:0010804; GO:0032088; GO:0032090; GO:0032731; GO:0043231; GO:0043280; GO:0045087; GO:0050727 ATP binding [GO:0005524]; Pyrin domain binding [GO:0032090] ALRDLRILAEEPIYIR 0.95941 0.20699 0 0 10.98 0 0 0 12.1672 0 0 0 0 0 0 0 0 0 12.8624 13.2022 0 0 0 0 0 14.5204 0 0 0 0 13.361 13.0127 0 0 0 0 0 0 0 12.7857 0 11.5879 0 0 0 0 10.6115 0 11.9254 0 11.0993 0 0 0 0 0 0 0 0 13.066 0 0 0 0 0 0 0 0 12.0771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5539 0 0 14.5662 0 0 9.86099 0 0 0 11.7466 0 0 11.6121 11.6851 0 11.9032 0 0 0 0 10.846 15.5489 0 0 0 0 0 0 15.2603 0 0 13.8107 11.6744 0 13.3722 13.7348 13.1297 11.9681 14.1364 0 12.3473 13.7215 14.0671 13.758 0 0 12.0734 12.024 0 0 0 0 13.9685 15.4637 0 0 0 0 0 12.2502 0 0 0 0 0 0 0 12.2506 14.7273 0 12.8863 12.9192 0 0 0 0 0 13.7732 0 0 0 0 0 0 0 0 12.9388 0 0 13.3975 14.2481 0 13.2748 11.6794 0 0 0 0 P60842 IF4A1_HUMAN "Eukaryotic initiation factor 4A-I, eIF-4A-I, eIF4A-I, EC 3.6.4.13 (ATP-dependent RNA helicase eIF4A-1)" EIF4A1 DDX2A EIF4A Homo sapiens (Human) cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; translational initiation [GO:0006413]" GO:0000339; GO:0002183; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0003743; GO:0004386; GO:0005524; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016020; GO:0016281; GO:0016887; GO:0070062 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; RNA helicase activity [GO:0003724]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" DFTVSAMHGDMDQKER 0.95942 0.43883 0 0 0 0 0 0 0 0 10.6392 0 0 12.3551 12.6332 0 0 11.2779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0404 0 0 0 0 0 0 0 0 0 0 10.634 0 0 0 0 0 0 14.3334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8713 0 12.638 0 0 13.2013 0 0 0 0 11.5983 0 0 0 0 13.9895 0 0 0 13.5846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1255 11.8563 11.6965 10.7581 0 0 0 0 0 Q13610 PWP1_HUMAN Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502) PWP1 Homo sapiens (Human) "histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA processing [GO:0006364]; transcription, DNA-templated [GO:0006351]" chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634] "chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA processing [GO:0006364]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0005694; GO:0005730; GO:0005794; GO:0006351; GO:0006364; GO:0033140; GO:0034773; GO:1901838; GO:1990889; GO:2000738 H4K20me3 modified histone binding [GO:1990889] EPLEDGDPEDDR 0.95942 0.20644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBE5 IL21R_HUMAN "Interleukin-21 receptor, IL-21 receptor, IL-21R (Novel interleukin receptor) (CD antigen CD360)" IL21R NILR UNQ3121/PRO10273 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; immunoglobulin mediated immune response [GO:0016064]; natural killer cell activation [GO:0030101] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interleukin-21 receptor activity [GO:0001532]; transmembrane signaling receptor activity [GO:0004888]; cytokine-mediated signaling pathway [GO:0019221]; immunoglobulin mediated immune response [GO:0016064]; natural killer cell activation [GO:0030101] GO:0001532; GO:0004888; GO:0004896; GO:0005886; GO:0009897; GO:0016021; GO:0016064; GO:0019221; GO:0030101 cytokine receptor activity [GO:0004896]; interleukin-21 receptor activity [GO:0001532]; transmembrane signaling receptor activity [GO:0004888] EGWNPHLLLLLLLVIVFIPAFWSLKTHPLWRLWK 0.95942 0.35411 0 0 0 0 0 0 0 0 0 0 0 0 11.3087 0 0 0 11.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4304 0 0 12.2704 0 0 0 0 0 0 0 11.9964 0 14.3703 0 0 13.9996 0 0 0 0 0 14.0593 14.2983 12.3201 13.3319 13.8685 0 0 0 0 0 0 0 0 0 0 11.7684 0 12.5865 12.9655 0 12.5229 12.1844 0 0 13.4294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9829 0 0 0 0 12.3135 12.4522 0 0 0 0 0 0 12.6401 0 0 11.8363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5079 0 0 0 0 0 0 0 12.2084 0 12.0193 0 12.9433 0 0 Q96DZ5 CLIP3_HUMAN "CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein, CLIP-170-related 59 kDa protein, CLIPR-59)" CLIP3 CLIPR59 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122]; fat cell differentiation [GO:0045444]; membrane biogenesis [GO:0044091]; negative regulation of microtubule polymerization [GO:0031115]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein transport along microtubule [GO:0098840] GO:0001934; GO:0005634; GO:0005737; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0008017; GO:0010828; GO:0018230; GO:0031115; GO:0031122; GO:0031901; GO:0032588; GO:0035371; GO:0035594; GO:0043065; GO:0044091; GO:0045121; GO:0045444; GO:0045807; GO:0051010; GO:0055038; GO:0098840; GO:1903078 ganglioside binding [GO:0035594]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010] FCGTTEFASGQWVGVELDEPEGK 0.95944 0.59437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5205 0 0 0 0 0 0 0 0 0 14.906 15.2815 0 0 0 16.7407 0 0 15.1412 0 11.0683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7889 0 0 14.8392 15.0446 0 0 11.0289 0 0 0 0 0 0 14.8343 0 0 0 0 15.0298 14.9011 0 13.6732 13.5274 0 0 0 0 0 0 15.2905 0 0 0 0 15.3759 0 0 14.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9445 0 0 0 15.1797 0 O60749 SNX2_HUMAN "Sorting nexin-2 (Transformation-related gene 9 protein, TRG-9)" SNX2 TRG9 Homo sapiens (Human) "early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0006897; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031901; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0045296; GO:0046982; GO:0072673; GO:1990459; GO:1990460 cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459] EEIEEEANGDIFDIEIGVSDPEK 0.95945 0.58644 0 0 0 0 0 0 0 0 0 0 0 0 13.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2196 0 0 0 0 0 13.7126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9119 13.3358 0 0 0 0 0 13.8217 0 0 0 0 0 0 13.9151 0 0 0 0 0 0 0 0 0 0 12.2938 0 0 0 0 0 0 0 15.0183 0 14.3778 12.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P4H8 ACKMT_HUMAN "ATP synthase subunit C lysine N-methyltransferase, EC 2.1.1.- (Protein N-lysine methyltransferase FAM173B, hFAM173B)" ATPSCKMT FAM173B Homo sapiens (Human) "peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]" integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]" GO:0005739; GO:0016021; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706 protein-lysine N-methyltransferase activity [GO:0016279] EGGGGIPLETLK 0.95945 0.59432 0 0 0 0 0 0 0 0 0 0 0 0 15.5114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7306 0 0 0 0 0 0 0 0 0 0 14.8818 0 0 0 0 0 13.895 0 14.9138 0 0 0 14.4907 0 0 0 0 14.5062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5749 0 0 14.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4W6 DJC22_HUMAN DnaJ homolog subfamily C member 22 DNAJC22 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 PIAILPISVAASITAQRHRR 0.95945 0.21624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11597 CETP_HUMAN Cholesteryl ester transfer protein (Lipid transfer protein I) CETP Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; high-density lipoprotein particle remodeling [GO:0034375]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid transport [GO:2001140]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle remodeling [GO:0034372] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; vesicle [GO:0031982] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; vesicle [GO:0031982]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phospholipid transporter activity [GO:0005548]; triglyceride binding [GO:0017129]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; high-density lipoprotein particle remodeling [GO:0034375]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid transport [GO:2001140]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle remodeling [GO:0034372] GO:0005548; GO:0005576; GO:0005615; GO:0006641; GO:0006869; GO:0008203; GO:0008289; GO:0010745; GO:0010874; GO:0015485; GO:0017129; GO:0030301; GO:0031210; GO:0031982; GO:0032376; GO:0034197; GO:0034364; GO:0034372; GO:0034374; GO:0034375; GO:0042632; GO:0043691; GO:0046470; GO:0055088; GO:0055091; GO:0070062; GO:0070328; GO:0120020; GO:2001140 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phospholipid transporter activity [GO:0005548]; triglyceride binding [GO:0017129] GTSHEAGIVCRITK 0.95946 3.7287 0 0 0 0 0 0 0 0 0 0 11.4248 0 0 0 11.3969 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3809 0 0 0 0 0 0 0 0 10.6684 0 11.2055 0 0 0 10.4142 10.4603 0 0 10.499 0 0 0 0 0 0 10.4783 10.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9897 12.4279 0 0 10.7888 0 15.9166 10.6384 0 0 0 0 0 0 0 13.5652 0 0 0 0 0 0 0 0 0 0 0 0 11.4693 13.2202 0 0 0 0 0 0 0 0 0 0 0 14.0461 0 0 11.1679 0 14.481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9012 0 0 0 0 0 0 0 0 0 0 0 0 12.6211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5889 0 0 0 13.8917 0 12.086 0 0 0 Q7Z6J8 UBE3D_HUMAN "E3 ubiquitin-protein ligase E3D, EC 2.3.2.26 (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein)" UBE3D C6orf157 H10BH UBE2CBP Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209] cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209] GO:0000151; GO:0000209; GO:0005634; GO:0005829; GO:0006513; GO:0030332; GO:0031624; GO:0043161; GO:0044390; GO:0051865; GO:0061630 cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] ANTKVICKR 0.95946 4.7743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2485 0 0 11.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8183 0 13.5788 0 0 0 0 0 13.3014 12.975 0 0 0 12.8542 0 13.0815 0 0 0 0 0 0 0 0 0 0 0 0 12.6996 0 0 0 0 10.9415 12.5845 0 0 12.2942 0 0 0 0 10.4575 11.2689 0 12.0082 12.3088 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4462 0 0 0 0 0 0 0 13.4405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRT8 CBWD1_HUMAN "COBW domain-containing protein 1 (Cobalamin synthase W domain-containing protein 1, COBP) (NPC-A-6 COBW domain-containing protein 1, NPC-A-6)" CBWD1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524] GO:0005524; GO:0005737 ATP binding [GO:0005524] DSGLRAIENLMQKK 0.95946 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9785 12.3507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55001 MFAP2_HUMAN "Microfibrillar-associated protein 2, MFAP-2 (Microfibril-associated glycoprotein 1, MAGP, MAGP-1)" MFAP2 MAGP1 Homo sapiens (Human) embryonic eye morphogenesis [GO:0048048]; positive regulation of cold-induced thermogenesis [GO:0120162]; post-embryonic eye morphogenesis [GO:0048050] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527]; embryonic eye morphogenesis [GO:0048048]; positive regulation of cold-induced thermogenesis [GO:0120162]; post-embryonic eye morphogenesis [GO:0048050] GO:0001527; GO:0005576; GO:0048048; GO:0048050; GO:0062023; GO:0120162 CGVMASSGLCQSVAASCARSCGSC 0.95947 0.59888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGF6 O10W1_HUMAN Olfactory receptor 10W1 (Olfactory receptor OR11-236) OR10W1 OR10W1P UNQ6469/PRO34070 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] QDRFISLVYTLGTPLLNPLIYALR 0.95947 0.59888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGY0 O10X1_HUMAN Olfactory receptor 10X1 (Olfactory receptor OR1-14) OR10X1 OR10X1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NAFRRMMGNTVALK 0.95947 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60493 SNX3_HUMAN Sorting nexin-3 (Protein SDP3) SNX3 Homo sapiens (Human) endocytic recycling [GO:0032456]; intralumenal vesicle formation [GO:0070676]; late endosome to Golgi transport [GO:0034499]; membrane invagination [GO:0010324]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein transport [GO:0051224]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of neuron projection development [GO:0010976]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; response to bacterium [GO:0009617] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; retromer complex [GO:0030904] "clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; retromer complex [GO:0030904]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein phosphatase binding [GO:0019903]; retromer complex binding [GO:1905394]; endocytic recycling [GO:0032456]; intralumenal vesicle formation [GO:0070676]; late endosome to Golgi transport [GO:0034499]; membrane invagination [GO:0010324]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein transport [GO:0051224]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of neuron projection development [GO:0010976]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; response to bacterium [GO:0009617]" GO:0005737; GO:0005769; GO:0005829; GO:0009617; GO:0010008; GO:0010314; GO:0010324; GO:0010976; GO:0015031; GO:0019903; GO:0022615; GO:0030111; GO:0030136; GO:0030904; GO:0031901; GO:0032009; GO:0032266; GO:0032456; GO:0034499; GO:0042177; GO:0046597; GO:0050765; GO:0051224; GO:0070062; GO:0070273; GO:0070676; GO:0080025; GO:1905394; GO:2000642 "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein phosphatase binding [GO:0019903]; retromer complex binding [GO:1905394]" ESKVVVPPLPGK 0.95948 0.21517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7069 0 0 0 0 15.6012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0741 0 0 0 0 0 0 12.0652 0 0 0 0 0 0 0 0 13.6711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZU15 SEP14_HUMAN Septin-14 SEPTIN14 SEPT14 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; neuron migration [GO:0001764]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; axon [GO:0030424]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940] acrosomal vesicle [GO:0001669]; axon [GO:0030424]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; neuron migration [GO:0001764]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; spermatid development [GO:0007286] GO:0001669; GO:0001764; GO:0003924; GO:0005525; GO:0005737; GO:0005856; GO:0005940; GO:0007286; GO:0008104; GO:0015630; GO:0030424; GO:0030425; GO:0031105; GO:0032153; GO:0043204; GO:0048471; GO:0060090; GO:0061640; GO:1905719 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] NLDSKVNIIPLIAK 0.95948 0.58483 0 0 0 0 0 0 0 0 14.6488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0096 0 0 0 0 0 12.5887 0 0 0 0 0 0 0 0 0 0 12.6553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2583 0 0 0 13.7445 0 15.3573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.764 0 0 0 0 0 P59539 T2R45_HUMAN "Taste receptor type 2 member 45, T2R45 (G-protein coupled receptor 59)" TAS2R45 GPR59 Homo sapiens (Human) sensory perception of taste [GO:0050909] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of taste [GO:0050909] GO:0004930; GO:0005886; GO:0016021; GO:0050909 G protein-coupled receptor activity [GO:0004930] KLKQTYLSVLWQMR 0.95949 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZU7 CTDS1_HUMAN "Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1, EC 3.1.3.16 (Nuclear LIM interactor-interacting factor 3, NLI-IF, NLI-interacting factor 3) (Small C-terminal domain phosphatase 1, SCP1, Small CTD phosphatase 1)" CTDSP1 NIF3 NLIIF SCP1 Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0001933; GO:0004721; GO:0005634; GO:0005654; GO:0006357; GO:0006470; GO:0008420; GO:0017018; GO:0045665; GO:0046872; GO:0050768; GO:0070062; GO:2000134 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] ESCVFHR 0.95949 0.45399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY49 PAQRA_HUMAN Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X) MMD2 PAQR10 Homo sapiens (Human) positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880] integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471] integral component of Golgi membrane [GO:0030173]; perinuclear region of cytoplasm [GO:0048471]; protein kinase activity [GO:0004672]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of protein localization [GO:0032880] GO:0004672; GO:0030173; GO:0032880; GO:0045666; GO:0045860; GO:0046579; GO:0048471 protein kinase activity [GO:0004672] MFAPRLLDFQKTK 0.9595 0.36555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9R0 CP081_HUMAN Putative uncharacterized protein encoded by LINC00304 LINC00304 C16orf81 NCRNA00304 Homo sapiens (Human) RLPSVGGR 0.9595 0.34799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2816 0 0 0 0 11.8744 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBM7 TM254_HUMAN Transmembrane protein 254 TMEM254 C10orf57 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AQLLWFLQTFFFGIASLTILIAYK 0.9595 0.56322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2966 0 0 0 11.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZU1 FLRT1_HUMAN Leucine-rich repeat transmembrane protein FLRT1 (Fibronectin-like domain-containing leucine-rich transmembrane protein 1) FLRT1 UNQ752/PRO1483 Homo sapiens (Human) cell adhesion [GO:0007155]; dendrite development [GO:0016358]; fibroblast growth factor receptor signaling pathway [GO:0008543]; neuron projection extension [GO:1990138] cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection terminus [GO:0044306]; neuronal cell body membrane [GO:0032809]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection terminus [GO:0044306]; neuronal cell body membrane [GO:0032809]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; fibroblast growth factor receptor signaling pathway [GO:0008543]; neuron projection extension [GO:1990138] GO:0005615; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007155; GO:0008543; GO:0016358; GO:0030659; GO:0030674; GO:0031012; GO:0031410; GO:0032809; GO:0044306; GO:0048471; GO:1990138 protein-macromolecule adaptor activity [GO:0030674] DDYMESGTK 0.9595 0.34686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6107 0 12.7663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2927 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2119 0 0 0 0 0 0 0 14.2976 15.0484 14.7619 15.1123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3487 0 0 13.9287 15.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2315 0 0 0 0 0 Q9Y3Q8 T22D4_HUMAN TSC22 domain family protein 4 (TSC22-related-inducible leucine zipper protein 2) (Tsc-22-like protein THG-1) TSC22D4 THG1 TILZ2 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]" nucleus [GO:0005634] "nucleus [GO:0005634]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970]" GO:0005634; GO:0006357; GO:0006970; GO:0045892 AATPLPSLR 0.95952 0.20029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.053 0 0 0 0 0 0 0 0 0 0 0 0 0 13.386 0 0 0 0 0 0 0 0 0 0 12.0756 0 0 0 0 0 0 0 0 12.5057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.735 0 0 0 0 0 0 0 10.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0367 0 O43315 AQP9_HUMAN "Aquaporin-9, AQP-9 (Aquaglyceroporin-9) (Small solute channel 1)" AQP9 SSC1 Homo sapiens (Human) amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; cellular response to cAMP [GO:0071320]; glycerol transmembrane transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; amine transport [GO:0015837]; canalicular bile acid transport [GO:0015722]; cellular response to cAMP [GO:0071320]; glycerol transmembrane transport [GO:0015793]; purine nucleobase transport [GO:0006863]; pyrimidine nucleobase transport [GO:0015855]; urea transmembrane transport [GO:0071918]; water transport [GO:0006833] GO:0005345; GO:0005350; GO:0005886; GO:0005887; GO:0006833; GO:0006863; GO:0015204; GO:0015250; GO:0015254; GO:0015265; GO:0015722; GO:0015793; GO:0015837; GO:0015855; GO:0016323; GO:0043231; GO:0071320; GO:0071918 glycerol channel activity [GO:0015254]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine nucleobase transmembrane transporter activity [GO:0005350]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] SSLAKETLSEFLGTFILIVLGCGCVAQAILSR 0.95953 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZN8 CT027_HUMAN UPF0687 protein C20orf27 C20orf27 Homo sapiens (Human) positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511] protein phosphatase 1 binding [GO:0008157]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511] GO:0008157; GO:0030511; GO:1901224 protein phosphatase 1 binding [GO:0008157] HHGTPMLLDGVKCVGAELEYDSEHSDWHGFD 0.95953 0.37357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3692 13.2296 0 0 13.5174 0 0 13.6479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2R5 KLK15_HUMAN "Kallikrein-15, EC 3.4.21.- (ACO protease)" KLK15 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576]; secretory granule [GO:0030141] extracellular region [GO:0005576]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508; GO:0008236; GO:0030141 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] LVQPARLNPQVRPAVLPTR 0.95953 0.47434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4555 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1523 0 0 0 0 0 16.2086 0 0 0 0 0 0 0 0 0 0 11.5007 0 0 0 0 0 11.8652 0 0 0 14.7476 12.0416 11.5263 0 0 0 0 0 0 0 0 0 0 0 12.5184 0 0 0 0 0 0 0 0 0 0 13.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQB0 TF7L2_HUMAN "Transcription factor 7-like 2 (HMG box transcription factor 4) (T-cell-specific transcription factor 4, T-cell factor 4, TCF-4, hTCF-4)" TCF7L2 TCF4 Homo sapiens (Human) "blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; fat cell differentiation [GO:0045444]; glucose homeostasis [GO:0042593]; maintenance of DNA repeat elements [GO:0043570]; myoblast fate commitment [GO:0048625]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; pancreas development [GO:0031016]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein binding [GO:0032092]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone metabolic process [GO:0032350]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]" beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; catenin-TCF7L2 complex [GO:0071664]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993] "beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; catenin-TCF7L2 complex [GO:0071664]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; gamma-catenin binding [GO:0045295]; nuclear receptor binding [GO:0016922]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; fat cell differentiation [GO:0045444]; glucose homeostasis [GO:0042593]; maintenance of DNA repeat elements [GO:0043570]; myoblast fate commitment [GO:0048625]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; pancreas development [GO:0031016]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein binding [GO:0032092]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone metabolic process [GO:0032350]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001568; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008013; GO:0009749; GO:0010909; GO:0016605; GO:0016922; GO:0019901; GO:0031016; GO:0032024; GO:0032092; GO:0032350; GO:0032993; GO:0042593; GO:0043433; GO:0043565; GO:0043570; GO:0044334; GO:0045295; GO:0045444; GO:0045892; GO:0045944; GO:0046827; GO:0048625; GO:0048660; GO:0050679; GO:0051897; GO:0060070; GO:0061629; GO:0070016; GO:0070369; GO:0071664; GO:0090090; GO:1990907; GO:2000675; GO:2001237 "armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; gamma-catenin binding [GO:0045295]; nuclear receptor binding [GO:0016922]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" CRARFGLDQQNNWCGPCR 0.95955 0.43139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0306 0 0 0 0 0 0 0 0 0 14.0476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0481 0 0 0 0 0 0 Q9NRR2 TRYG1_HUMAN "Tryptase gamma, EC 3.4.21.- (Serine protease 31) (Transmembrane tryptase) [Cleaved into: Tryptase gamma light chain; Tryptase gamma heavy chain ]" TPSG1 PRSS31 TMT Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0005887; GO:0006508; GO:0008236 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] MALGACGLLLLLAVPGVSLRTLQPGCGR 0.95956 0.46861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6E2 5MP1_HUMAN eIF5-mimic protein 1 (Basic leucine zipper and W2 domain-containing protein 2) BZW2 5MP1 HSPC028 MSTP017 Homo sapiens (Human) regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; regulation of translational initiation [GO:0006446] GO:0005737; GO:0006446; GO:0016020; GO:0045296 cadherin binding [GO:0045296] KLLLFLK 0.95956 0.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.314 0 Q8TC84 FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 FANK1 HSD13 UNQ6504/PRO21382 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]" ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]" GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005929; GO:0036064; GO:0042981; GO:0043065; GO:0043066; GO:0045893; GO:0051091; GO:0097546 ILQGGRVKVDVPNK 0.95957 0.20753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.295 0 0 13.0541 0 0 0 0 13.0709 0 0 0 0 0 0 0 0 0 0 0 0 12.4313 0 0 0 12.801 0 0 0 0 0 0 0 12.4447 0 0 0 0 12.5448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQV4 LAMP3_HUMAN "Lysosome-associated membrane glycoprotein 3, LAMP-3, Lysosomal-associated membrane protein 3 (DC-lysosome-associated membrane glycoprotein, DC LAMP) (Protein TSC403) (CD antigen CD208)" LAMP3 DCLAMP TSC403 Homo sapiens (Human) adaptive immune response [GO:0002250]; establishment of protein localization to organelle [GO:0072594]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of gene expression [GO:0010628]; regulation of autophagy [GO:0010506]; regulation of viral life cycle [GO:1903900]; response to interferon-alpha [GO:0035455] alveolar lamellar body membrane [GO:0097233]; cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] alveolar lamellar body membrane [GO:0097233]; cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; adaptive immune response [GO:0002250]; establishment of protein localization to organelle [GO:0072594]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of gene expression [GO:0010628]; regulation of autophagy [GO:0010506]; regulation of viral life cycle [GO:1903900]; response to interferon-alpha [GO:0035455] GO:0002250; GO:0005765; GO:0005769; GO:0005886; GO:0009986; GO:0010506; GO:0010628; GO:0016021; GO:0031901; GO:0031902; GO:0031982; GO:0035455; GO:0043154; GO:0043231; GO:0048471; GO:0072594; GO:0097233; GO:1901799; GO:1903900 AKAFPETRDYSQPTAAATVQDIK 0.95957 0.22191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.913 0 0 0 0 Q86XT9 TM219_HUMAN "Insulin-like growth factor-binding protein 3 receptor, IGFBP-3R (Transmembrane protein 219)" TMEM219 Homo sapiens (Human) apoptotic process [GO:0006915] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915] GO:0005886; GO:0006915; GO:0016021 SFGQLTLCPR 0.95958 0.21814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.612 0 0 0 0 0 0 0 0 13.8188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4447 0 0 0 0 0 Q8NGI8 O5AN1_HUMAN Olfactory receptor 5AN1 (Olfactory receptor OR11-244) OR5AN1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception [GO:0050907] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception [GO:0050907] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050907 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IIKVLFTIFLVIYITSLAWNLSLIVLIR 0.95958 0.68629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0175 0 12.7213 0 0 11.9524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXH6 RB40A_HUMAN "Ras-related protein Rab-40A (SOCS box-containing protein RAR2A, Protein Rar-2)" RAB40A Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0043231; GO:0072659 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IEEHAPGVPKILVGNRLHLAFK 0.95958 0.35524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRJ7 TIRR_HUMAN Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos) NUDT16L1 SDOS TIRR Homo sapiens (Human) negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033] GO:0003723; GO:0005634; GO:0030515; GO:2001033 RNA binding [GO:0003723]; snoRNA binding [GO:0030515] STAAVPELKQISR 0.95958 0.60451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8266 0 0 0 0 0 0 0 0 14.798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3L0 MMAD_HUMAN "Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial)" MMADHC C2orf25 CL25022 HSPC161 My011 Homo sapiens (Human) cobalamin metabolic process [GO:0009235] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; cobalamin metabolic process [GO:0009235] GO:0005737; GO:0005739; GO:0005829; GO:0009235 YRHLGFSVDDLGCCK 0.95958 0.56122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGC1 O11G2_HUMAN Olfactory receptor 11G2 (Olfactory receptor OR14-34) OR11G2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVLRVPSAAGRR 0.95959 0.35486 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2222 0 0 0 0 0 0 14.5241 15.1396 15.9107 15.1934 0 14.3752 12.6009 15.4496 11.9972 12.2237 18.4901 16.0949 0 11.7008 0 0 15.5299 0 0 0 0 0 0 0 0 16.1052 0 14.1712 15.0958 0 0 11.377 0 0 0 0 12.9775 0 0 14.9826 12.9066 13.8094 16.8473 0 13.617 15.7544 0 12.4893 15.3725 0 13.4071 0 0 0 11.2068 0 0 0 0 0 15.3336 14.9975 15.6222 15.6342 0 12.4783 15.7101 15.3118 0 14.6553 15.3918 14.3007 15.8088 0 0 0 0 0 16.1607 0 0 12.4825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1463 14.354 13.8535 0 0 11.5855 0 0 P06340 DOA_HUMAN "HLA class II histocompatibility antigen, DO alpha chain (MHC DN-alpha) (MHC DZ alpha) (MHC class II antigen DOA)" HLA-DOA HLA-DNA HLA-DZA Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; regulation of T cell differentiation [GO:0045580] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; negative regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002587]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870]; regulation of T cell differentiation [GO:0045580] GO:0002250; GO:0002503; GO:0002587; GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0019886; GO:0023026; GO:0032395; GO:0042613; GO:0045580; GO:0050870 MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395] SEAVWRLPEFGDFAR 0.9596 0.56122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00116 ADAS_HUMAN "Alkyldihydroxyacetonephosphate synthase, peroxisomal, Alkyl-DHAP synthase, EC 2.5.1.26 (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)" AGPS AAG5 Homo sapiens (Human) ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610] GO:0005730; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0016491; GO:0071949 alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491] DRDPDPDR 0.95961 0.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7465 12.1948 0 0 0 0 0 0 0 0 0 0 14.0897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3798 0 0 Q8N1A6 CD033_HUMAN UPF0462 protein C4orf33 C4orf33 Homo sapiens (Human) DPPAPLGEPGK 0.95962 0.20546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2285 0 0 13.2281 0 12.9898 0 12.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7023 0 0 0 0 0 0 0 0 Q9H496 IFG15_HUMAN "Torsin-1A-interacting protein 2, isoform IFRG15 (15 kDa interferon-responsive protein, IFRG15)" TOR1AIP2 IFRG15 Homo sapiens (Human) RIHDSRVAGFNPALQLILTR 0.95962 0.21624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQQ7 S35C2_HUMAN Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein) SLC35C2 C20orf5 OVCOV1 CGI-15 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786] GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0010629; GO:0015297; GO:0015786; GO:0016021; GO:0033116; GO:0036066; GO:0045747 antiporter activity [GO:0015297] SSQREEGDNEEEEYFVAQGQQ 0.95962 0.58748 0 0 0 0 0 0 0 0 0 12.6909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2652 13.2508 0 0 0 13.0395 12.6816 0 13.8153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.083 0 0 0 0 0 0 0 0 0 12.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61956 SUMO2_HUMAN "Small ubiquitin-related modifier 2, SUMO-2 (HSMT3) (SMT3 homolog 2) (SUMO-3) (Sentrin-2) (Ubiquitin-like protein SMT3B, Smt3B)" SUMO2 SMT3B SMT3H2 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein sumoylation [GO:0016925] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein tag [GO:0031386]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein sumoylation [GO:0016925] GO:0003723; GO:0005634; GO:0005654; GO:0016605; GO:0016925; GO:0031386; GO:0031625; GO:0032436; GO:0044389 protein tag [GO:0031386]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389] EGVKTENNDHINLKVAGQDGSVVQFK 0.95963 0.58682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22557 HEM0_HUMAN "5-aminolevulinate synthase, erythroid-specific, mitochondrial, ALAS-E, EC 2.3.1.37 (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)" ALAS2 ALASE ASB Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; oxygen homeostasis [GO:0032364]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; cellular iron ion homeostasis [GO:0006879]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; oxygen homeostasis [GO:0032364]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to hypoxia [GO:0001666] GO:0001666; GO:0003870; GO:0005739; GO:0005743; GO:0005759; GO:0006782; GO:0006783; GO:0006879; GO:0030170; GO:0030218; GO:0032364; GO:0042541; GO:0048821 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170] PVHFELMSEWER 0.95964 0.21534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.30056 0 0 0 0 0 12.1303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13021 MALL_HUMAN MAL-like protein (Protein BENE) MALL BENE Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; myelination [GO:0042552] clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; structural constituent of myelin sheath [GO:0019911]; cholesterol homeostasis [GO:0042632]; myelination [GO:0042552] GO:0000139; GO:0005886; GO:0016021; GO:0019911; GO:0030136; GO:0031410; GO:0042552; GO:0042632; GO:0045121 structural constituent of myelin sheath [GO:0019911] LLDPRIYYINSAASFFAFIATLLYILHAFSIYYH 0.95964 0.58681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXR0 IIGP5_HUMAN "Interferon-inducible GTPase 5, EC 3.6.5.- (Immunity-related GTPase cinema 1)" IRGC IIGP5 IRGC1 Homo sapiens (Human) cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-beta [GO:0035458]; defense response [GO:0006952] GO:0003924; GO:0005525; GO:0005789; GO:0006952; GO:0035458 GTP binding [GO:0005525]; GTPase activity [GO:0003924] KKAMLQEQVLK 0.95964 0.59442 0 0 10.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94888 UBXN7_HUMAN UBX domain-containing protein 7 UBXN7 KIAA0794 UBXD7 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] DFQTETIR 0.95965 0.68308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3927 0 16.4331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1784 11.6406 13.6559 0 0 0 0 10.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8245 0 0 0 0 0 0 9.13553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24539 AT5F1_HUMAN "ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b, ATPase subunit b)" ATP5PB ATP5F1 Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; substantia nigra development [GO:0021762] "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleus [GO:0005634]" "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; substantia nigra development [GO:0021762]" GO:0000276; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0015078; GO:0015986; GO:0016020; GO:0021762; GO:0042776 proton transmembrane transporter activity [GO:0015078] RKEQEHMINWVEK 0.95965 0.45624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3802 0 0 0 0 0 0 11.334 0 0 0 0 0 0 0 0 0 0 11.5655 Q5SR56 MF14B_HUMAN Hippocampus abundant transcript-like protein 1 (Major facilitator superfamily domain-containing 14B) MFSD14B HIATL1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] GLLSFLSAPLIGALSDVWGRK 0.95965 0.58681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5H2 PCDGB_HUMAN "Protocadherin gamma-A11, PCDH-gamma-A11" PCDHGA11 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DLELRVIAR 0.95965 0.45589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5743 0 14.2628 0 0 12.8113 0 0 0 13.7237 0 0 13.5317 0 0 0 0 13.6475 13.5345 13.4221 0 0 0 0 0 0 13.6697 15.0757 0 0 0 0 0 13.2363 13.3708 0 0 0 13.7632 0 0 0 0 0 0 0 0 0 0 0 13.0793 0 0 12.796 0 0 0 0 12.6233 0 10.7779 0 0 12.6559 0 0 0 14.3664 0 12.4652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3564 0 0 0 0 0 0 0 0 0 0 12.3901 0 0 0 0 0 0 0 0 Q6NTF7 ABC3H_HUMAN "DNA dC->dU-editing enzyme APOBEC-3H, EC 3.5.4.38 (APOBEC-related protein 10, ARP-10) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H, A3H)" APOBEC3H Homo sapiens (Human) cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral process [GO:0048525] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral process [GO:0048525] GO:0000932; GO:0003723; GO:0004126; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010529; GO:0016554; GO:0045087; GO:0045869; GO:0047844; GO:0048525; GO:0051607; GO:0070383; GO:0080111 cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] IKIPGVRAQGR 0.95966 0.59898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWF1 CA054_HUMAN Uncharacterized protein C1orf54 C1orf54 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MDVLFVAIFAVPLILGQEYEDEER 0.95967 0.58618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7 0 Q9H094 NBPF3_HUMAN Neuroblastoma breakpoint family member 3 (Protein AE2) (Protein SHIIIa4) NBPF3 L7 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DLIKSMLRDER 0.95967 0.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3F4 STRAP_HUMAN Serine-threonine kinase receptor-associated protein (MAP activator with WD repeats) (UNR-interacting protein) (WD-40 repeat protein PT-WD) STRAP MAWD UNRIP Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447]; alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]" GO:0000122; GO:0000380; GO:0000387; GO:0003723; GO:0003729; GO:0005102; GO:0005634; GO:0005737; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:1990447 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447] LLRIYDLNK 0.95967 0.3659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95777 LSM8_HUMAN U6 snRNA-associated Sm-like protein LSm8 LSM8 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]" Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] "Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; RNA metabolic process [GO:0016070]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0016070; GO:0017070; GO:0046540; GO:0071005; GO:0071011; GO:0120115 RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] AEPLNSVAH 0.95968 0.45447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1862 0 12.9408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2I0M5 RSPO4_HUMAN "R-spondin-4 (Roof plate-specific spondin-4, hRspo4)" RSPO4 C20orf182 Homo sapiens (Human) nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055] extracellular region [GO:0005576] extracellular region [GO:0005576]; heparin binding [GO:0008201]; nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055] GO:0005576; GO:0008201; GO:0016055; GO:0030177; GO:0035878 heparin binding [GO:0008201] CGATCESCFSQDFCIR 0.95968 0.37758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7536 0 0 0 11.2643 0 0 0 0 0 0 11.1214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1726 0 0 0 0 0 0 0 0 0 12.2789 0 0 0 0 0 0 0 12.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6166 0 0 0 0 0 12.5091 0 0 0 0 0 0 0 0 11.9111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13336 UT1_HUMAN "Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte)" SLC14A1 HUT11 JK RACH1 UT1 UTE Homo sapiens (Human) establishment of localization in cell [GO:0051649]; transmembrane transport [GO:0055085]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water transmembrane transporter activity [GO:0005372]; establishment of localization in cell [GO:0051649]; transmembrane transport [GO:0055085]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840] GO:0005372; GO:0005886; GO:0005887; GO:0015204; GO:0015265; GO:0015840; GO:0016323; GO:0051649; GO:0055085; GO:0071918 urea channel activity [GO:0015265]; urea transmembrane transporter activity [GO:0015204]; water transmembrane transporter activity [GO:0005372] DKPVVLQFIDWILR 0.95969 0.20032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0235 17.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5508 0 0 0 15.0417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN30 SCML1_HUMAN Sex comb on midleg-like protein 1 SCML1 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393] ALLLLTSDVLLKHLGVK 0.95969 0.3768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5962 13.1916 12.4147 0 0 0 0 0 0 12.697 0 11.9642 0 0 0 0 0 0 14.5114 0 0 12.7432 0 0 0 0 0 0 0 0 0 0 12.1259 0 0 14.7102 0 0 0 14.5195 0 0 0 0 0 0 0 13.9577 0 0 0 0 0 0 0 0 0 0 0 0 0 11.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWX0 ASB5_HUMAN "Ankyrin repeat and SOCS box protein 5, ASB-5" ASB5 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556; GO:0045732 ILLQHEATPSSLYQLCR 0.9597 0.43435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30084 ECHM_HUMAN "Enoyl-CoA hydratase, mitochondrial, mECH, mECH1, EC 4.2.1.17, EC 5.3.3.8 (Enoyl-CoA hydratase 1, ECHS1) (Short-chain enoyl-CoA hydratase, SCEH)" ECHS1 Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; crotonyl-CoA hydratase activity [GO:0120092]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation [GO:0006635] GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0009083; GO:0043956; GO:0120092 3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; crotonyl-CoA hydratase activity [GO:0120092]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300] AALRVLLSCVRGPLR 0.95971 0.39926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M1Z3 RHG31_HUMAN Rho GTPase-activating protein 31 (Cdc42 GTPase-activating protein) ARHGAP31 CDGAP KIAA1204 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027] cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0005096; GO:0005829; GO:0005925; GO:0007264; GO:0017124; GO:0030027; GO:0051056 GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] KLRTDLYIDQLK 0.95971 0.47168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5207 0 19.7714 20.085 0 19.4365 19.8126 0 0 0 0 0 0 0 0 0 19.5733 0 19.5924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7622 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5017 13.3993 0 0 11.5337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4106 0 0 0 0 0 0 0 0 11.0629 0 0 0 0 0 Q8NFV4 ABHDB_HUMAN "Protein ABHD11, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 11, Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein)" ABHD11 WBSCR21 PP1226 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; carboxylic ester hydrolase activity [GO:0052689]; cellular lipid metabolic process [GO:0044255] GO:0005739; GO:0044255; GO:0052689 carboxylic ester hydrolase activity [GO:0052689] GGAEPRPLPLSYRLLDGEAALPAVVFLHGLFGSK 0.95971 0.37358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4983 0 0 0 12.3488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92871 PMM1_HUMAN "Phosphomannomutase 1, PMM 1, EC 5.4.2.8 (PMMH-22)" PMM1 PMMH22 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487] cytosol [GO:0005829]; neuronal cell body [GO:0043025] cytosol [GO:0005829]; neuronal cell body [GO:0043025]; metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615]; cellular response to leukemia inhibitory factor [GO:1990830]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487] GO:0004615; GO:0005829; GO:0006013; GO:0006487; GO:0009298; GO:0043025; GO:0046872; GO:1990830 metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615] AVTAQAARR 0.95971 0.47448 0 0 0 0 0 0 0 0 12.5882 12.8576 12.8733 12.319 12.9748 12.3613 12.3016 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2284 12.7147 12.8229 12.6244 12.5477 12.2879 11.5624 12.5237 0 12.2789 12.3798 0 0 12.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7419 14.6048 0 0 15.04 0 15.099 0 0 14.685 0 0 0 0 0 0 18.4923 0 0 0 Q01850 CDR2_HUMAN Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen) CDR2 PCD17 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ELYDLRQHFVYDHVFAEK 0.95973 0.22205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6896 0 0 0 0 0 0 0 0 P06454 PTMA_HUMAN "Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed; Thymosin alpha-1 ]" PTMA TMSA Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0042393; GO:0043066; GO:0045944; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393] RAAEDDEDDDVDTK 0.95974 0.46884 0 0 0 0 0 0 0 13.5542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55344 LMIP_HUMAN Lens fiber membrane intrinsic protein (MP18) (MP19) (MP20) LIM2 Homo sapiens (Human) cell-cell junction assembly [GO:0007043]; lens development in camera-type eye [GO:0002088] cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982] cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; structural constituent of eye lens [GO:0005212]; cell-cell junction assembly [GO:0007043]; lens development in camera-type eye [GO:0002088] GO:0002088; GO:0005212; GO:0005886; GO:0007043; GO:0016021; GO:0030054; GO:0031982 structural constituent of eye lens [GO:0005212] FGDWRFSWSYILGWVAVLMTFFAGIFYMCAYR 0.95974 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0042 0 0 0 12.3109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXA8 SIR5_HUMAN "NAD-dependent protein deacylase sirtuin-5, mitochondrial, EC 2.3.1.- (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)" SIRT5 SIR2L5 Homo sapiens (Human) mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-lysine demalonylation [GO:0036047]; peptidyl-lysine desuccinylation [GO:0036049]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566]; response to nutrient levels [GO:0031667] GO:0003950; GO:0005634; GO:0005739; GO:0005758; GO:0005759; GO:0005829; GO:0006471; GO:0006476; GO:0007005; GO:0008270; GO:0010566; GO:0010667; GO:0031667; GO:0034979; GO:0036046; GO:0036047; GO:0036048; GO:0036049; GO:0036054; GO:0036055; GO:0061697; GO:0061698; GO:0070403; GO:2000378 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270] AIAECETRLGKQGR 0.95974 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3163 0 12.3828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0C4DH36 HV338_HUMAN Probable non-functional immunoglobulin heavy variable 3-38 IGHV3-38 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] GVQCEVQLVESGGGLVQPR 0.95975 0.59703 0 0 0 0 0 0 0 0 0 0 0 15.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1035 13.7736 0 0 0 0 11.4156 0 0 18.1557 0 0 0 0 0 0 0 0 0 0 10.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEZ2 VP37A_HUMAN "Vacuolar protein sorting-associated protein 37A, hVps37A (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1)" VPS37A HCRP1 Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] GO:0000813; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043231; GO:0043328; GO:0090148 DVEYRLPFTINNLTININILLPPQFPQEK 0.95975 0.19461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0953 0 0 0 0 0 0 0 0 12.433 12.0107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3048 0 0 0 0 0 0 0 0 0 13.8067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6375 0 0 0 0 0 Q9BXA9 SALL3_HUMAN "Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3, hSALL3)" SALL3 ZNF796 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFTTKGNLKVHMGTHMWNNAPAR 0.95975 4.2276 0 0 0 0 0 0 0 0 10.5871 0 0 0 0 14.2901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 0 0 0 0 0 0 13.8264 16.4578 0 12.3075 14.0443 16.2956 14.5203 14.8612 15.4446 0 16.1636 16.2158 0 0 15.7983 0 0 13.9215 0 13.6898 0 14.5528 14.8114 0 0 0 0 0 12.0085 0 0 0 11.7663 13.3959 0 0 0 0 0 0 0 14.0879 0 12.8532 12.4637 0 0 0 0 12.5169 0 0 0 0 0 13.7053 0 0 0 0 12.3473 0 0 0 0 0 0 0 0 10.4233 0 0 12.0574 0 0 0 0 0 0 0 0 0 0 0 15.1654 0 0 0 0 0 0 0 0 0 0 0 13.1238 Q9NQX6 ZN331_HUMAN Zinc finger protein 331 (C2H2-like zinc finger protein rearranged in thyroid adenomas) (Zinc finger protein 361) (Zinc finger protein 463) ZNF331 RITA ZNF361 ZNF463 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" ECGKAFR 0.95975 0.68302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VAQ4 SMAGP_HUMAN Small cell adhesion glycoprotein (Small transmembrane and glycosylated protein) SMAGP Homo sapiens (Human) cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005886; GO:0016021; GO:0030054; GO:0030659 TSLLTTPSPR 0.95976 0.55296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MIR4 CC50B_HUMAN Cell cycle control protein 50B (P4-ATPase flippase complex beta subunit TMEM30B) (Transmembrane protein 30B) TMEM30B CDC50B Homo sapiens (Human) aminophospholipid transport [GO:0015917]; phospholipid translocation [GO:0045332]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; aminophospholipid flippase activity [GO:0015247]; aminophospholipid transport [GO:0015917]; phospholipid translocation [GO:0045332]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863] GO:0005783; GO:0005794; GO:0005886; GO:0015247; GO:0015917; GO:0016021; GO:0045332; GO:0070863; GO:1990531 aminophospholipid flippase activity [GO:0015247] YQDQDDDDEE 0.95976 0.19403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4564 0 0 11.3227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5787 0 0 0 0 0 0 0 0 0 0 0 P98177 FOXO4_HUMAN Forkhead box protein O4 (Fork head domain transcription factor AFX1) FOXO4 AFX AFX1 MLLT7 Homo sapiens (Human) "aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to nutrient levels [GO:0031667]; response to water-immersion restraint stress [GO:1990785]; stem cell differentiation [GO:0048863]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007095; GO:0007517; GO:0007568; GO:0008013; GO:0008285; GO:0008286; GO:0014911; GO:0016525; GO:0016607; GO:0019899; GO:0031667; GO:0042802; GO:0043565; GO:0045944; GO:0048863; GO:0051151; GO:0070317; GO:0140297; GO:1990785; GO:1990837; GO:1990841 "beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" EEADMWTTFR 0.95978 0.68282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6611 0 0 0 0 0 0 Q8IYJ3 SYTL1_HUMAN Synaptotagmin-like protein 1 (Exophilin-7) (Protein JFC1) SYTL1 SLP1 SB146 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] GO:0005886; GO:0006886; GO:0006887; GO:0019897; GO:0031267; GO:0031528; GO:0042043; GO:0042470; GO:0070062; GO:0070382 neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267] ASVADPGQLK 0.95978 0.60451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15533 TPSN_HUMAN "Tapasin, TPN, TPSN (NGS-17) (TAP-associated protein) (TAP-binding protein)" TAPBP NGS17 TAPA Homo sapiens (Human) "antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; immune response [GO:0006955]; MHC class I protein complex assembly [GO:0002397]; MHC class Ib protein complex assembly [GO:0002398]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide antigen stabilization [GO:0050823]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of immune response [GO:0050776]; regulation of protein complex stability [GO:0061635]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; Tapasin-ERp57 complex [GO:0061779] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; Tapasin-ERp57 complex [GO:0061779]; ABC-type peptide antigen transporter activity [GO:0015433]; antigen binding [GO:0003823]; MHC class I protein binding [GO:0042288]; peptide antigen binding [GO:0042605]; TAP complex binding [GO:0062061]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; unfolded protein binding [GO:0051082]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; immune response [GO:0006955]; MHC class I protein complex assembly [GO:0002397]; MHC class Ib protein complex assembly [GO:0002398]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide antigen stabilization [GO:0050823]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; regulation of immune response [GO:0050776]; regulation of protein complex stability [GO:0061635]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0002397; GO:0002398; GO:0002502; GO:0003823; GO:0005783; GO:0005789; GO:0006890; GO:0006955; GO:0010468; GO:0015433; GO:0016021; GO:0019885; GO:0030670; GO:0033116; GO:0042288; GO:0042605; GO:0042824; GO:0046978; GO:0046979; GO:0050776; GO:0050823; GO:0051082; GO:0061635; GO:0061779; GO:0062061; GO:0065003; GO:0071556 ABC-type peptide antigen transporter activity [GO:0015433]; antigen binding [GO:0003823]; MHC class I protein binding [GO:0042288]; peptide antigen binding [GO:0042605]; TAP complex binding [GO:0062061]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979]; unfolded protein binding [GO:0051082] GGPGGRSQKAEGQR 0.9598 0.19267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22466 GALA_HUMAN "Galanin peptides [Cleaved into: Galanin; Galanin message-associated peptide, GMAP ]" GAL GAL1 GALN GLNN Homo sapiens (Human) cAMP-mediated signaling [GO:0019933]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; negative regulation of lymphocyte proliferation [GO:0050672]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of timing of catagen [GO:0051795]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase A signaling [GO:0010737]; regulation of glucocorticoid metabolic process [GO:0031943]; response to estrogen [GO:0043627]; response to immobilization stress [GO:0035902]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]; galanin receptor activity [GO:0004966]; galanin receptor binding [GO:0031763]; neuropeptide hormone activity [GO:0005184]; type 1 galanin receptor binding [GO:0031764]; type 2 galanin receptor binding [GO:0031765]; type 3 galanin receptor binding [GO:0031766]; cAMP-mediated signaling [GO:0019933]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; negative regulation of lymphocyte proliferation [GO:0050672]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of timing of catagen [GO:0051795]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase A signaling [GO:0010737]; regulation of glucocorticoid metabolic process [GO:0031943]; response to estrogen [GO:0043627]; response to immobilization stress [GO:0035902]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] GO:0004966; GO:0005184; GO:0005576; GO:0005615; GO:0005794; GO:0006954; GO:0007218; GO:0007631; GO:0009410; GO:0010737; GO:0019933; GO:0030073; GO:0030141; GO:0031763; GO:0031764; GO:0031765; GO:0031766; GO:0031943; GO:0032868; GO:0035902; GO:0043025; GO:0043065; GO:0043627; GO:0045944; GO:0050672; GO:0051464; GO:0051795; GO:1902608 galanin receptor activity [GO:0004966]; galanin receptor binding [GO:0031763]; neuropeptide hormone activity [GO:0005184]; type 1 galanin receptor binding [GO:0031764]; type 2 galanin receptor binding [GO:0031765]; type 3 galanin receptor binding [GO:0031766] GSALLLASLLLAAALSASAGLWSPAKEK 0.95981 0.68629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35398 RORA_HUMAN Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha) RORA NR1F1 RZRA Homo sapiens (Human) "angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to sterol [GO:0036315]; cellular response to tumor necrosis factor [GO:0071356]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell differentiation [GO:0021702]; cGMP metabolic process [GO:0046068]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; intracellular receptor signaling pathway [GO:0030522]; muscle cell differentiation [GO:0042692]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of glucose metabolic process [GO:0010906]; regulation of macrophage activation [GO:0043030]; regulation of smoothened signaling pathway [GO:0008589]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T-helper 17 cell differentiation [GO:0072539]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805]" chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to sterol [GO:0036315]; cellular response to tumor necrosis factor [GO:0071356]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell differentiation [GO:0021702]; cGMP metabolic process [GO:0046068]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; intracellular receptor signaling pathway [GO:0030522]; muscle cell differentiation [GO:0042692]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of glucose metabolic process [GO:0010906]; regulation of macrophage activation [GO:0043030]; regulation of smoothened signaling pathway [GO:0008589]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; T-helper 17 cell differentiation [GO:0072539]; triglyceride homeostasis [GO:0070328]; xenobiotic metabolic process [GO:0006805]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001223; GO:0001525; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006357; GO:0006805; GO:0006809; GO:0008013; GO:0008142; GO:0008270; GO:0008589; GO:0010575; GO:0010906; GO:0019218; GO:0021702; GO:0021930; GO:0030522; GO:0032922; GO:0036315; GO:0042632; GO:0042692; GO:0042753; GO:0043030; GO:0043124; GO:0043565; GO:0045599; GO:0045893; GO:0045944; GO:0046068; GO:0050728; GO:0070328; GO:0071347; GO:0071356; GO:0071456; GO:0072539; GO:0098531 "beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]" GISVTKK 0.95981 0.36823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8591 15.8799 0 14.7781 0 14.9584 0 0 0 0 0 15.3763 0 0 0 16.6583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSY5 PPR3F_HUMAN "Protein phosphatase 1 regulatory subunit 3F, R3F" PPP1R3F Homo sapiens (Human) regulation of glycogen (starch) synthase activity [GO:2000465]; regulation of glycogen biosynthetic process [GO:0005979] integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein phosphatase type 1 complex [GO:0000164] integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; regulation of glycogen (starch) synthase activity [GO:2000465]; regulation of glycogen biosynthetic process [GO:0005979] GO:0000164; GO:0005979; GO:0008157; GO:0016020; GO:0016021; GO:0019903; GO:2000465; GO:2001069 glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903] PPVLRGLVRVLNR 0.95982 0.58771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60925 PFD1_HUMAN Prefoldin subunit 1 PFDN1 PFD1 Homo sapiens (Human) negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; prefoldin complex [GO:0016272] cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0001540; GO:0005737; GO:0006457; GO:0016272; GO:0044183; GO:0050821; GO:0051082; GO:1905907 amyloid-beta binding [GO:0001540]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] KAFTELQAK 0.95983 0.59522 0 0 0 0 0 0 0 9.54185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08J23 NSUN2_HUMAN "RNA cytosine C(5)-methyltransferase NSUN2, EC 2.1.1.- (Myc-induced SUN domain-containing protein, Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (mRNA cytosine C(5)-methyltransferase, EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase, EC 2.1.1.-, EC 2.1.1.203) (tRNA methyltransferase 4 homolog, hTrm4)" NSUN2 SAKI TRM4 Homo sapiens (Human) cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416] GO:0000049; GO:0001510; GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006400; GO:0007286; GO:0008168; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:0080009; GO:2000736 methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] EILFYDRILCDVPCSGDGTMR 0.95983 0.36765 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4629 0 0 14.1323 11.6532 12.6081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NV58 RN19A_HUMAN "E3 ubiquitin-protein ligase RNF19A, EC 2.3.2.31 (Double ring-finger protein, Dorfin) (RING finger protein 19A) (p38)" RNF19A RNF19 Homo sapiens (Human) "microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000151; GO:0000209; GO:0000226; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576 metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] CAAYIIKMNDGSCNHMTCAVCGCEFCWLCMK 0.95984 4.5982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.309 0 0 0 0 0 0 0 12.7 12.7307 0 0 0 0 12.8823 0 14.2712 0 14.6796 13.8846 14.0274 0 12.5792 0 10.3069 0 14.7517 14.4612 0 11.5631 0 14.2819 0 13.4205 0 0 0 0 0 0 0 0 0 15.8538 0 13.9503 15.0719 12.8113 0 0 10.036 0 0 0 0 0 0 13.5599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7924 0 0 0 0 0 0 0 0 0 0 0 10.8944 0 11.3437 0 0 0 0 0 13.0796 12.2238 0 0 0 0 12.3599 0 0 14.3591 12.3712 11.8694 0 Q7Z7D3 VTCN1_HUMAN "V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4, B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x)" VTCN1 B7H4 UNQ659/PRO1291 Homo sapiens (Human) adaptive immune response [GO:0002250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; response to protozoan [GO:0001562]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; regulation of cytokine production [GO:0001817]; response to protozoan [GO:0001562]; T cell receptor signaling pathway [GO:0050852] GO:0001562; GO:0001817; GO:0002250; GO:0005102; GO:0009897; GO:0016021; GO:0032743; GO:0042102; GO:0042130; GO:0043066; GO:0050852; GO:0050868 signaling receptor binding [GO:0005102] ASLGQILFWSIISIIIILAGAIALIIGFGISGR 0.95985 0.60004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.606 0 0 0 11.7777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6373 0 0 0 0 0 0 0 0 0 Q8NGC8 O11H7_HUMAN Olfactory receptor 11H7 (Olfactory receptor OR14-32) OR11H7 OR11H7P Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004984; GO:0004993; GO:0005887; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984] YALHHVFCGMRIIQR 0.95985 0.37761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6YBV0 S36A4_HUMAN "Proton-coupled amino acid transporter 4, Proton/amino acid transporter 4 (Solute carrier family 36 member 4)" SLC36A4 PAT4 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; L-alanine transport [GO:0015808]; L-proline import across plasma membrane [GO:1904271]; L-tryptophan transmembrane transport [GO:1904556]; proline transport [GO:0015824]; tryptophan transport [GO:0015827] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193]; L-tryptophan transmembrane transporter activity [GO:0015196]; symporter activity [GO:0015293]; amino acid transmembrane transport [GO:0003333]; L-alanine transport [GO:0015808]; L-proline import across plasma membrane [GO:1904271]; L-tryptophan transmembrane transport [GO:1904556]; proline transport [GO:0015824]; tryptophan transport [GO:0015827] GO:0003333; GO:0005886; GO:0015179; GO:0015180; GO:0015193; GO:0015196; GO:0015293; GO:0015808; GO:0015824; GO:0015827; GO:0016021; GO:1904271; GO:1904556 L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193]; L-tryptophan transmembrane transporter activity [GO:0015196]; symporter activity [GO:0015293] IYMLCFLPFIILLVFIRELK 0.95986 0.43516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2769 0 0 0 0 0 0 11.6948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0288 0 13.6227 0 0 12.9155 0 0 13.3507 0 0 0 12.7089 0 0 0 0 0 0 13.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H707 ZN552_HUMAN Zinc finger protein 552 ZNF552 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HKYHLIAHQR 0.95986 0.45482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5666 12.7391 0 0 0 0 0 0 B2RXH8 HNRC2_HUMAN "Heterogeneous nuclear ribonucleoprotein C-like 2, hnRNP C-like-2" HNRNPCL2 HNRNPCP5 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0042802 identical protein binding [GO:0042802]; RNA binding [GO:0003723] DAEEGEDNRDSTNGQDDS 0.95987 0.43482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.691 0 12.5585 0 13.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8406 0 0 0 0 0 0 0 0 10.6542 0 11.6346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8359 0 0 0 0 0 0 0 0 11.582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01374 TNFB_HUMAN "Lymphotoxin-alpha, LT-alpha (TNF-beta) (Tumor necrosis factor ligand superfamily member 1)" LTA TNFB TNFSF1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] GO:0001666; GO:0002876; GO:0002925; GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005886; GO:0006915; GO:0006959; GO:0007165; GO:0007267; GO:0007584; GO:0009410; GO:0032496; GO:0032729; GO:0043065; GO:0048147; GO:0048535; GO:0050830; GO:0060252 cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] VCGTTLHLLLLGLLLVLLPGAQGLPGVGLTPSAAQTAR 0.95987 0.68373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6125 0 0 0 0 0 12.1354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UX2 ITIH5_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H5, ITI heavy chain H5, ITI-HC5, Inter-alpha-inhibitor heavy chain 5" ITIH5 KIAA1953 PP14776 UNQ311/PRO354 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] GO:0004867; GO:0005576; GO:0030212; GO:0062023 serine-type endopeptidase inhibitor activity [GO:0004867] DALFTILHDLRPQDRFSIIGFSNR 0.95987 0.34625 0 0 0 11.3197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6223 0 0 15.0612 0 0 13.8647 0 11.6121 13.994 0 0 14.0481 12.0967 0 0 15.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8301 0 15.8353 12.9152 0 0 13.2343 0 11.9873 0 0 0 0 0 0 0 0 11.3157 0 0 14.1357 0 0 0 0 0 0 0 0 0 0 0 0 13.4132 0 0 0 0 0 0 14.5563 0 0 0 0 0 14.6446 0 0 0 14.4018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0243 0 0 0 0 0 0 12.9909 0 0 0 0 0 0 0 0 0 0 0 0 13.8914 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBC3 SHKB1_HUMAN SH3KBP1-binding protein 1 (SETA-binding protein 1) SHKBP1 SB1 PP203 Homo sapiens (Human) positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260] lysosome [GO:0005764] lysosome [GO:0005764]; identical protein binding [GO:0042802]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein homooligomerization [GO:0051260] GO:0005764; GO:0042802; GO:0045742; GO:0051260 identical protein binding [GO:0042802] GPPGEVIHLNVGGKR 0.95987 0.26135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0861 0 0 0 0 0 0 0 0 0 0 0 13.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4505 0 0 0 13.3951 0 0 0 0 0 0 0 0 0 15.0015 0 0 0 0 0 0 0 13.0996 0 17.9091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.099 0 0 0 0 0 0 17.4805 0 13.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8Y8 GORS2_HUMAN "Golgi reassembly-stacking protein 2, GRS2 (Golgi phosphoprotein 6, GOLPH6) (Golgi reassembly-stacking protein of 55 kDa, GRASP55) (p59)" GORASP2 GOLPH6 Homo sapiens (Human) cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283] cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283] GO:0000139; GO:0005789; GO:0005794; GO:0005801; GO:0006996; GO:0007030; GO:0007283; GO:0016020; GO:0030154; GO:0034976; GO:0061951; GO:0070925 VGDSTPVSEK 0.95987 0.47299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TS9 RM52_HUMAN "39S ribosomal protein L52, mitochondrial, L52mt, MRP-L52 (Mitochondrial large ribosomal subunit protein mL52)" MRPL52 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 structural constituent of ribosome [GO:0003735] PKGASLKSPLPSQ 0.95988 0.22493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8459 0 0 0 0 14.6914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J77 TPD55_HUMAN "Tumor protein D55, hD55 (Testis development protein NYD-SP25) (Tumor protein D52-like 3)" TPD52L3 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 KLGLTALVGLRQNLSK 0.95988 0.37448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91377 0 0 0 0 0 0 0 0 13.9669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4009 0 Q96MV8 ZDH15_HUMAN "Palmitoyltransferase ZDHHC15, EC 2.3.1.225 (Acyltransferase ZDHHC15, EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 15, DHHC-15)" ZDHHC15 UNQ1969/PRO4501 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to postsynapse [GO:0062237]; protein palmitoylation [GO:0018345]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; regulation of dendritic spine morphogenesis [GO:0061001]; synaptic vesicle maturation [GO:0016188] anchoring junction [GO:0070161]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; protein localization to postsynapse [GO:0062237]; protein palmitoylation [GO:0018345]; protein targeting to Golgi apparatus [GO:0140450]; protein targeting to membrane [GO:0006612]; regulation of dendritic spine morphogenesis [GO:0061001]; synaptic vesicle maturation [GO:0016188] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008270; GO:0014069; GO:0016188; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0030173; GO:0061001; GO:0062237; GO:0070161; GO:0072657; GO:0098794; GO:0140439; GO:0140450; GO:1900006 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270] CHHCSVCAMCVLK 0.95988 0.22383 10.7898 0 0 0 10.7661 0 0 0 0 0 0 0 0 13.6147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3922 0 0 0 13.3332 0 0 13.8246 11.2322 0 0 0 0 11.9383 13.1247 0 13.6569 0 0 0 0 10.8506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3849 0 0 0 0 0 0 12.0419 0 13.1803 14.6078 0 0 12.3274 0 12.5193 0 0 13.4937 0 12.1535 0 0 13.9715 0 0 12.5024 0 0 0 0 0 0 0 0 0 0 13.2826 12.2585 0 0 12.3922 12.3225 0 0 0 0 0 0 0 0 12.2462 0 0 0 0 14.0986 0 0 0 0 0 0 0 0 0 0 0 14.0705 13.7435 0 0 0 0 0 13.8008 0 0 0 0 0 0 0 12.5289 0 0 0 0 0 0 0 0 14.2204 0 0 0 0 0 0 0 A6NKH3 RL37L_HUMAN Putative 60S ribosomal protein L37a-like protein (Ribosomal protein L37a pseudogene 8) RPL37AP8 RPL37L Homo sapiens (Human) translation [GO:0006412] cytosolic large ribosomal subunit [GO:0022625] cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412] GO:0003735; GO:0006412; GO:0022625; GO:0046872 metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735] CTKKVGGIVSK 0.95989 0.34371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15527 OGG1_HUMAN "N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase, EC 3.2.2.-; DNA-(apurinic or apyrimidinic site) lyase, AP lyase, EC 4.2.99.18 ]" OGG1 MMH MUTM OGH1 Homo sapiens (Human) "acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; depurination [GO:0045007]; depyrimidination [GO:0045008]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair, DNA incision [GO:0033683]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; depurination [GO:0045007]; depyrimidination [GO:0045008]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair, DNA incision [GO:0033683]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]" GO:0002526; GO:0003684; GO:0004519; GO:0005634; GO:0005654; GO:0005759; GO:0005829; GO:0006284; GO:0006285; GO:0006355; GO:0006974; GO:0006979; GO:0007568; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0032355; GO:0032357; GO:0032991; GO:0033683; GO:0034039; GO:0043066; GO:0045007; GO:0045008; GO:0045471; GO:0051593; GO:0071276; GO:0140078; GO:1901291 "8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]" AILEEQGGLAWLQQLRESSYEEAHKALCILPGVGTK 0.95989 0.39983 0 0 11.4133 0 0 0 0 0 13.9352 0 0 0 0 0 13.852 0 15.2836 0 0 14.7229 15.2184 0 0 0 13.8745 0 0 0 0 0 13.1016 0 0 0 13.5479 0 0 13.2936 13.0082 0 0 0 0 14.9316 13.0464 14.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8926 14.7299 0 0 0 0 0 0 0 0 0 0 0 0 15.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8603 0 0 0 12.8428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUZ4 TRAF4_HUMAN "TNF receptor-associated factor 4, EC 2.3.2.27 (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein, MLN 62) (RING finger protein 83)" TRAF4 CART1 MLN62 RNF83 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323] GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007250; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699 identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270] AKPNLECFSPAFYTHKYGYK 0.95989 0.47274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4285 0 0 0 12.693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.933 0 13.9557 13.9376 0 0 0 0 0 0 0 14.4333 13.3257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8793 0 0 0 14.636 0 0 0 0 0 0 0 0 0 0 14.5468 0 0 0 0 0 0 0 0 0 0 0 0 12.6493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4211 0 0 0 0 0 0 0 0 0 0 0 Q9H6W3 RIOX1_HUMAN "Ribosomal oxygenase 1 (60S ribosomal protein L8 histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66, EC 1.14.11.-, EC 1.14.11.27) (Histone lysine demethylase NO66) (Myc-associated protein with JmjC domain) (Nucleolar protein 66, hsNO66) (Ribosomal oxygenase NO66, ROX)" RIOX1 C14orf169 MAPJD NO66 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; iron ion binding [GO:0005506]; chromatin organization [GO:0006325]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0016706; GO:0032453; GO:0034647; GO:0034720; GO:0045668; GO:0045892; GO:0051864; GO:0070544; GO:0140680 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; iron ion binding [GO:0005506] DFIHDSLPPVLTDRER 0.95989 0.20872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58417 NXPH1_HUMAN Neurexophilin-1 NXPH1 NPH1 Nbla00697 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005576 signaling receptor binding [GO:0005102] NTLCNYDPSKTCYQEQTQSHVSWLCSK 0.9599 0.47218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4548 0 0 0 0 0 0 0 14.8658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.821 0 0 0 13.4543 0 Q7L592 NDUF7_HUMAN "Protein arginine methyltransferase NDUFAF7, mitochondrial, EC 2.1.1.320 (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)" NDUFAF7 C2orf56 PRO1853 Homo sapiens (Human) "mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]" extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme binding [GO:0019899]; methyltransferase activity [GO:0008168]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]" GO:0005615; GO:0005739; GO:0005759; GO:0008168; GO:0019899; GO:0019918; GO:0032981; GO:0035243 enzyme binding [GO:0019899]; methyltransferase activity [GO:0008168]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243] GTLVGDILR 0.9599 0.47482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7906 0 0 0 12.344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0315 0 0 0 14.3278 0 0 0 12.1075 0 0 0 0 0 0 0 0 0 0 0 0 10.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0514 0 0 13.7048 0 0 0 0 0 13.567 0 0 0 0 0 0 0 Q8TCY9 URGCP_HUMAN Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein) (HBxAg up-regulated gene 4 protein) URGCP KIAA1507 URG4 Homo sapiens (Human) cell cycle [GO:0007049] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; cell cycle [GO:0007049] GO:0005525; GO:0005634; GO:0005829; GO:0007049 GTP binding [GO:0005525] DLPWNFLRK 0.9599 0.22262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9004 0 0 0 0 0 0 0 0 0 0 10.2101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9209 0 0 0 14.5995 13.0328 14.6857 14.5489 0 14.4008 0 17.2635 16.7221 13.7668 13.5381 0 17.1777 14.1219 0 0 0 13.6234 0 13.4691 14.1996 0 14.2392 0 14.0512 0 0 0 0 0 14.1944 0 0 0 0 14.0301 0 0 0 0 0 0 14.6468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8506 0 0 0 0 0 0 12.7047 0 0 0 0 0 0 13.7732 14.3832 0 12.0283 12.6911 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7174 0 0 0 0 0 11.3855 0 0 Q9GZL7 WDR12_HUMAN Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12) WDR12 Homo sapiens (Human) "maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]" "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; Notch signaling pathway [GO:0007219]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]" GO:0000463; GO:0000466; GO:0005654; GO:0005730; GO:0007219; GO:0030687; GO:0042273; GO:0043021; GO:0051726; GO:0070545 ribonucleoprotein complex binding [GO:0043021] GQFLRMPLDK 0.9599 0.20833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4681 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4429 0 0 0 15.1199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVF9 EKI2_HUMAN "Ethanolamine kinase 2, EKI 2, EC 2.7.1.82 (Ethanolamine kinase-like protein)" ETNK2 EKI2 HMFT1716 Homo sapiens (Human) in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310]; placenta development [GO:0001890]; post-embryonic development [GO:0009791] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310]; placenta development [GO:0001890]; post-embryonic development [GO:0009791] GO:0001701; GO:0001890; GO:0004305; GO:0005524; GO:0005737; GO:0005829; GO:0006646; GO:0009791; GO:0016310; GO:0035264 ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305] AHSCAPK 0.95991 0.39823 0 0 0 0 0 0 0 11.6027 0 0 0 0 0 0 12.0923 11.7945 0 0 0 11.9299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1285 0 0 0 0 0 0 0 0 0 0 0 12.2903 12.4887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5058 0 11.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F2Z3M2 CQ112_HUMAN Uncharacterized protein encoded by LINC02876 (Long intergenic non-protein coding RNA 2876) LINC02876 C17orf112 Homo sapiens (Human) LGPSFILTGIFLGNGR 0.95992 0.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6077 0 0 Q5VST6 AB17B_HUMAN "Alpha/beta hydrolase domain-containing protein 17B, Abhydrolase domain-containing protein 17B, EC 3.1.2.22" ABHD17B C9orf77 FAM108B1 CGI-67 Homo sapiens (Human) negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; proteolysis [GO:0006508]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse organization [GO:0099175]; regulation of protein localization to synapse [GO:1902473] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; serine-type peptidase activity [GO:0008236]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; proteolysis [GO:0006508]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse organization [GO:0099175]; regulation of protein localization to synapse [GO:1902473] GO:0002084; GO:0005886; GO:0006508; GO:0008236; GO:0008474; GO:0010008; GO:0016020; GO:0043197; GO:0055038; GO:0070161; GO:0098839; GO:0099175; GO:1902473; GO:1902817; GO:1902950; GO:1905668 palmitoyl-(protein) hydrolase activity [GO:0008474]; serine-type peptidase activity [GO:0008236] NLYADIEAAWLALRTR 0.95994 0.39721 0 0 0 0 0 0 0 0 13.7326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0123 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0759 0 0 0 13.6141 0 0 0 0 0 0 0 0 0 0 14.1016 0 0 Q6X9E4 FBW12_HUMAN F-box/WD repeat-containing protein 12 (F-box and WD-40 domain-containing protein 12) (F-box only protein 35) FBXW12 FBW12 FBXO12 FBXO35 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 LPDLALKRIFSFLDLFGLLQVSQVNK 0.95994 0.5973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1268 0 0 Q9NYW7 TA2R1_HUMAN "Taste receptor type 2 member 1, T2R1 (Taste receptor family B member 7, TRB7)" TAS2R1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] HPLFIWLKMR 0.95994 0.21712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1277 0 0 0 0 0 0 0 0 0 0 14.8132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.484 0 19.2851 0 13.055 0 0 0 0 0 0 0 15.091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6945 12.5617 0 12.6631 19.0608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2575 0 0 0 0 0 0 0 0 0 0 11.8294 0 0 0 0 0 0 0 11.411 0 11.3662 0 14.7254 0 0 11.0179 0 0 14.3529 Q16548 B2LA1_HUMAN "Bcl-2-related protein A1 (Bcl-2-like protein 5, Bcl2-L-5) (Hemopoietic-specific early response protein) (Protein BFL-1) (Protein GRS)" BCL2A1 BCL2L5 BFL1 GRS HBPA1 Homo sapiens (Human) extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066] GO:0005737; GO:0005741; GO:0005829; GO:0008630; GO:0042803; GO:0043066; GO:0046982; GO:0097192 protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] IVTIFAFEGILIK 0.95995 0.55331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHL3 F153A_HUMAN Protein FAM153A (Renal carcinoma antigen NY-REN-7) FAM153A KIAA0752 Homo sapiens (Human) LRELHLYSTWK 0.95995 0.39691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14316 IRF2_HUMAN "Interferon regulatory factor 2, IRF-2" IRF2 Homo sapiens (Human) "cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0006357; GO:0008283; GO:0045944; GO:0051607; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ETRASVIKK 0.95996 0.19292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7576 0 13.21 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4292 0 0 Q3LI54 KR198_HUMAN Keratin-associated protein 19-8 KRTAP19-8 KAP19.8 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 SYYRSYYGGLGYGYGGFGGWGYGYGCGYGSFR 0.95996 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07315 CRGC_HUMAN Gamma-crystallin C (Gamma-C-crystallin) (Gamma-crystallin 2-1) (Gamma-crystallin 3) CRYGC CRYG3 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] GO:0002088; GO:0005212; GO:0005634; GO:0005737; GO:0007601 structural constituent of eye lens [GO:0005212] GLMMELSEDCPSIQDR 0.95998 0.60467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2441 0 0 0 0 0 0 0 0 11.6852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68D20 PMS2L_HUMAN Protein PMS2CL (PMS2-C terminal-like protein) PMS2CL PMS2P13 Homo sapiens (Human) APETDDSFSDVDCHSNQEDTGCK 0.95998 0.5962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3641 0 0 12.6444 0 0 0 11.9175 0 0 0 0 0 0 0 0 12.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWT4 CE046_HUMAN Uncharacterized protein C5orf46 C5orf46 UNQ472/PRO839 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 PDDSGKDPKPDFPK 0.95998 0.68302 0 0 0 0 0 0 0 0 0 0 11.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2A8 PLD6_HUMAN "Mitochondrial cardiolipin hydrolase, EC 3.1.-.- (Choline phosphatase 6) (Mitochondrial phospholipase, MitoPLD, EC 3.1.4.-) (Phosphatidylcholine-hydrolyzing phospholipase D6) (Phospholipase D6, PLD6) (Protein zucchini homolog)" PLD6 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; lipid catabolic process [GO:0016042]; meiotic cell cycle [GO:0051321]; mitochondrial fusion [GO:0008053]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; positive regulation of mitochondrial fusion [GO:0010636]; spermatid development [GO:0007286] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cardiolipin hydrolase activity [GO:0035755]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; DNA methylation involved in gamete generation [GO:0043046]; lipid catabolic process [GO:0016042]; meiotic cell cycle [GO:0051321]; mitochondrial fusion [GO:0008053]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; positive regulation of mitochondrial fusion [GO:0010636]; spermatid development [GO:0007286]" GO:0005739; GO:0005741; GO:0005794; GO:0007286; GO:0008053; GO:0010636; GO:0016021; GO:0016042; GO:0016891; GO:0030719; GO:0034587; GO:0035755; GO:0042803; GO:0043046; GO:0046872; GO:0051321 "cardiolipin hydrolase activity [GO:0035755]; endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]" ENVLITEDDEYVRLFLEEFER 0.95998 0.36883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8044 0 0 0 0 0 0 0 0 0 0 12.2732 0 0 0 0 0 0 0 0 0 12.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8642 0 0 0 0 0 0 0 0 0 0 0 0 Q16378 PROL4_HUMAN Proline-rich protein 4 (Lacrimal proline-rich protein) (Nasopharyngeal carcinoma-associated proline-rich protein 4) PRR4 LPRP PROL4 Homo sapiens (Human) retina homeostasis [GO:0001895]; visual perception [GO:0007601] extracellular space [GO:0005615] extracellular space [GO:0005615]; retina homeostasis [GO:0001895]; visual perception [GO:0007601] GO:0001895; GO:0005615; GO:0007601 PPGDSGNQDDGPQQR 0.95999 0.20276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q499Z3 SLNL1_HUMAN Schlafen-like protein 1 SLFNL1 Homo sapiens (Human) ATP binding [GO:0005524] GO:0005524 ATP binding [GO:0005524] LQTALEEHLILKELAARGK 0.95999 0.58858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7769 0 0 0 13.892 0 0 0 0 0 0 0 0 14.5406 0 13.975 0 0 0 14.5001 0 0 13.311 0 0 14.1707 0 15.8316 0 0 0 0 0 0 0 0 0 0 0 0 13.5322 13.1102 0 0 0 0 14.8463 0 0 0 0 0 0 13.9078 13.7044 0 0 0 0 0 0 0 0 0 13.8679 0 13.705 0 14.9609 0 0 14.5025 0 14.4175 0 0 0 13.4018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3888 0 0 0 0 0 Q8ND25 ZNRF1_HUMAN "E3 ubiquitin-protein ligase ZNRF1, EC 2.3.2.27 (Nerve injury-induced gene 283 protein) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1)" ZNRF1 NIN283 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; synaptic vesicle membrane [GO:0030672]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0016020; GO:0030672; GO:0043161; GO:0043231; GO:0046872; GO:0061630; GO:0070161; GO:0070936 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GTGDSERAPGGGGSASDSTYAHGNGYQETGGGHHR 0.95999 0.25191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2115 0 0 0 15.1381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6479 0 0 0 0 0 0 12.5259 0 0 0 0 0 0 0 0 0 0 0 Q5T319 F182B_HUMAN Protein FAM182B FAM182B Homo sapiens (Human) ELWMWNVEEEEHEVGICTWGGQHCGCPAK 0.96 0.58845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1949 0 0 0 0 12.4935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZRF7 ZN818_HUMAN Putative zinc finger protein 818 ZNF818P ZNF818 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FINHQIVHTGENFPNVLNVARLLRMALNSGLTK 0.96 4.5947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0719 11.8153 14.0813 0 0 0 0 14.4546 11.9079 0 0 0 0 0 0 0 10.3824 0 0 0 0 14.5855 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8087 0 0 0 0 0 13.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1611 0 0 0 0 13.5964 0 0 0 0 13.0409 0 0 0 0 0 0 0 12.6569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTS6 OTOP2_HUMAN Proton channel OTOP2 (Otopetrin-2) OTOP2 Homo sapiens (Human) proton transmembrane transport [GO:1902600] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600] GO:0005886; GO:0015252; GO:0016021; GO:1902600 proton channel activity [GO:0015252] GGRLLSVLLAVNVLLLACTLISGGAFNK 0.96001 0.68629 0 0 0 0 0 0 0 0 0 0 13.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BT67 NFIP1_HUMAN NEDD4 family-interacting protein 1 (Breast cancer-associated protein SGA-1M) (NEDD4 WW domain-binding protein 5) (Putative MAPK-activating protein PM13) (Putative NF-kappa-B-activating protein 164) (Putative NFKB and MAPK-activating protein) NDFIP1 N4WBP5 PSEC0192 PSEC0223 Homo sapiens (Human) "CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]" anchoring junction [GO:0070161]; cell cortex [GO:0005938]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] "anchoring junction [GO:0070161]; cell cortex [GO:0005938]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; WW domain binding [GO:0050699]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]" GO:0000139; GO:0002761; GO:0002829; GO:0005576; GO:0005783; GO:0005794; GO:0005938; GO:0006511; GO:0006879; GO:0007034; GO:0010008; GO:0010629; GO:0016021; GO:0030001; GO:0030425; GO:0031398; GO:0032410; GO:0032713; GO:0035739; GO:0043123; GO:0045202; GO:0045619; GO:0045732; GO:0048294; GO:0048302; GO:0048471; GO:0050699; GO:0050728; GO:0051224; GO:0070161; GO:2000562 WW domain binding [GO:0050699] AEATIPLVPGR 0.96001 0.20076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5707 0 0 0 0 0 0 0 0 0 0 0 11.5533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.773 0 0 0 0 0 12.9163 0 0 12.8898 14.2474 0 12.254 12.7351 0 0 0 0 13.5018 0 0 0 0 Q96JP5 ZFP91_HUMAN "E3 ubiquitin-protein ligase ZFP91, EC 2.3.2.27 (RING-type E3 ubiquitin transferase ZFP91) (Zinc finger protein 757) (Zinc finger protein 91 homolog, Zfp-91)" ZFP91 ZNF757 FKSG11 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0007250; GO:0046872; GO:0070534 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] AFKSSHNLAVHR 0.96002 0.36712 10.9251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4418 0 14.0893 0 0 0 0 0 0 0 0 0 0 13.0942 0 0 0 0 0 0 13.7677 0 0 13.9483 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2562 0 0 0 0 0 0 0 0 13.1079 0 13.5147 0 0 0 0 0 0 0 0 13.7747 13.3285 0 16.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5554 0 0 0 0 0 13.9636 0 P61204 ARF3_HUMAN ADP-ribosylation factor 3 ARF3 Homo sapiens (Human) "intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" GO:0000139; GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0006890; GO:0016192; GO:0048471; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924] ERVNEAREELMR 0.96003 0.37792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4005 0 0 0 12.1636 0 0 0 0 0 0 0 0 0 0 17.6925 0 0 0 Q8N9Z0 ZN610_HUMAN Zinc finger protein 610 ZNF610 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRECSGLTTHLVIHTGEKPYK 0.96004 0.22499 0 0 0 0 0 15.5738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7437 0 13.7612 0 0 0 0 0 0 14.0602 0 0 14.0223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0877 0 11.6749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.103 0 Q9NPG8 ZDHC4_HUMAN "Palmitoyltransferase ZDHHC4, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 4, DHHC-4) (Zinc finger protein 374)" ZDHHC4 ZNF374 DC1 UNQ5787/PRO19576 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0018230; GO:0019706 protein-cysteine S-palmitoyltransferase activity [GO:0019706] ANELLFLHVYEFDEVMFPKNVR 0.96004 0.60073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7493 0 0 0 0 0 0 0 0 0 13.0765 12.8582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9203 0 0 0 13.1375 0 0 0 0 0 0 12.4086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9409 0 0 0 0 0 0 0 0 0 13.6883 0 0 0 0 0 0 0 0 0 0 14.2281 0 0 0 0 0 0 0 0 0 0 0 0 13.5716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL25 RAB21_HUMAN Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157] axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506] axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157] GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005789; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0008089; GO:0009898; GO:0012506; GO:0017157; GO:0019003; GO:0030516; GO:0031901; GO:0032154; GO:0032482; GO:0032580; GO:0045202; GO:0048260; GO:0050775; GO:0050821; GO:0070062; GO:0098559; GO:1904115; GO:2000643 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] MIETAQVDERAK 0.96004 0.21136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9771 13.0541 12.7256 13.0876 12.3455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13098 CSN1_HUMAN "COP9 signalosome complex subunit 1, SGN1, Signalosome subunit 1 (G protein pathway suppressor 1, GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH)" GPS1 COPS1 CSN1 Homo sapiens (Human) JNK cascade [GO:0007254]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; JNK cascade [GO:0007254]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] GO:0000338; GO:0005095; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007254; GO:0008180; GO:0045116; GO:2000434 GTPase inhibitor activity [GO:0005095] AAVLRNQIHVK 0.96005 0.20898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5858 0 14.8871 0 0 0 10.6324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2945 0 0 0 0 0 0 11.5812 0 0 0 0 0 0 13.4493 0 0 0 0 0 15.3458 0 0 0 0 0 0 12.6326 0 0 0 0 0 0 12.9974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4546 12.1539 12.0618 0 0 0 12.4918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5585 0 0 0 12.0854 0 0 0 0 0 0 0 0 0 0 0 Q8IZ20 ZN683_HUMAN "Tissue-resident T-cell transcription regulator protein ZNF683 (Homolog of Blimp-1 in T-cell, Hobit) (Zinc finger protein 683)" ZNF683 Homo sapiens (Human) adaptive immune response [GO:0002250]; cellular response to ionomycin [GO:1904637]; innate immune response [GO:0045087]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adaptive immune response [GO:0002250]; cellular response to ionomycin [GO:1904637]; innate immune response [GO:0045087]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of natural killer cell differentiation involved in immune response [GO:0032826]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852] GO:0000122; GO:0000978; GO:0002250; GO:0003700; GO:0005634; GO:0006357; GO:0010468; GO:0010628; GO:0032689; GO:0032823; GO:0032826; GO:0033082; GO:0045087; GO:0046872; GO:0050852; GO:0051136; GO:1904637; GO:1990841 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] KFTVKYPQNK 0.96005 0.21088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0N8 MARH2_HUMAN "E3 ubiquitin-protein ligase MARCHF2, EC 2.3.2.27 (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II, MARCH-II) (RING finger protein 172) (RING-type E3 ubiquitin transferase MARCHF2)" MARCHF2 MARCH2 RNF172 HSPC240 Homo sapiens (Human) antibacterial innate immune response [GO:0140367]; antiviral innate immune response [GO:0140374]; endocytosis [GO:0006897]; positive regulation of lysosomal protein catabolic process [GO:1905167]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; antibacterial innate immune response [GO:0140367]; antiviral innate immune response [GO:0140374]; endocytosis [GO:0006897]; positive regulation of lysosomal protein catabolic process [GO:1905167]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] GO:0000139; GO:0004842; GO:0005737; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006897; GO:0008270; GO:0010008; GO:0016021; GO:0016567; GO:0031410; GO:0044790; GO:0061630; GO:0140367; GO:0140374; GO:1905167 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] LLSTVIR 0.96005 0.45483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2609 0 11.1387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH16 OR2L2_HUMAN Olfactory receptor 2L2 (HTPCRH07) (Olfactory receptor 2L12) (Olfactory receptor 2L4) OR2L2 OR2L12 OR2L4P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EVMGALTQVIQK 0.96006 0.3456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6U7 RN215_HUMAN RING finger protein 215 RNF215 Homo sapiens (Human) Golgi to vacuole transport [GO:0006896]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process [GO:0006511] endosome [GO:0005768]; Golgi transport complex [GO:0017119]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] endosome [GO:0005768]; Golgi transport complex [GO:0017119]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; Golgi to vacuole transport [GO:0006896]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005768; GO:0005802; GO:0006511; GO:0006623; GO:0006896; GO:0016020; GO:0016021; GO:0017119; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] ALFLGASALLLLILNHNVVR 0.96006 0.68578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9947 0 0 0 0 0 0 0 11.7171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9604 0 0 0 0 0 12.8983 0 0 13.4516 0 0 0 0 0 0 0 0 0 0 0 0 12.14 0 0 0 0 0 0 0 0 0 0 0 11.8111 0 0 0 0 0 0 0 11.7837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98169 ZXDB_HUMAN Zinc finger X-linked protein ZXDB ZXDB Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003712; GO:0005634; GO:0006357; GO:0046872 metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] ACRLKIHLR 0.96007 3.2962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3865 0 0 0 0 0 0 0 0 13.5239 0 0 0 0 0 0 0 0 0 0 0 0 14.1844 0 14.8171 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6136 0 0 0 0 0 0 0 15.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7588 13.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2R0 COA3_HUMAN "Cytochrome c oxidase assembly factor 3 homolog, mitochondrial (Coiled-coil domain-containing protein 56) (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa)" COA3 CCDC56 MITRAC12 HSPC009 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131] GO:0005739; GO:0031305; GO:0033617; GO:0070131 EKLTPEQLHSMR 0.96007 0.19483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4889 0 0 0 0 0 0 0 0 0 0 0 0 12.2331 0 0 0 0 0 0 0 0 0 0 0 0 12.3968 12.5754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBF5 PIGX_HUMAN "Phosphatidylinositol-glycan biosynthesis class X protein, PIG-X" PIGX Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506] GO:0005789; GO:0006506; GO:0016021 NVILQVPVGLTVHTSLVCSVTLLITILCSTLILVAVFK 0.96008 0.68373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.846 0 0 0 0 0 0 Q9NR90 DAZ3_HUMAN Deleted in azoospermia protein 3 DAZ3 Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283] GO:0003730; GO:0005634; GO:0005737; GO:0007283; GO:0008494; GO:0030154; GO:0032991; GO:0045948; GO:0070935 mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494] IITNRTGVSKGYGFVSFVNDVDVQK 0.96008 0.47521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8761 0 0 0 12.6816 0 0 0 0 0 0 0 0 0 12.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9339 0 0 0 14.2761 0 0 0 0 0 13.3681 13.2282 0 13.5184 0 0 0 0 0 0 0 0 0 0 12.8242 0 0 0 0 0 13.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7319 0 Q8N812 CL076_HUMAN Uncharacterized protein C12orf76 C12orf76 Homo sapiens (Human) EIGKIIPFTIAFKR 0.96009 0.47511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUK4 REEP3_HUMAN Receptor expression-enhancing protein 3 REEP3 C10orf74 Homo sapiens (Human) cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule binding [GO:0008017]; cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998] GO:0005789; GO:0005881; GO:0006998; GO:0007084; GO:0008017; GO:0016020; GO:0016021; GO:0051301; GO:0071782; GO:0071786 microtubule binding [GO:0008017] VSWMISRAVVLVFGMLYPAYYSYK 0.9601 0.59888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YQ2 LATH_HUMAN "Putative BPIFA4P protein (BPI fold containing family A, member 4, pseudogene) (Breast cancer and salivary gland-expressed protein) (Putative latherin)" BPIFA4P BASE LATH Homo sapiens (Human) regulation of liquid surface tension [GO:0050828] extracellular region [GO:0005576] extracellular region [GO:0005576]; lipid binding [GO:0008289]; regulation of liquid surface tension [GO:0050828] GO:0005576; GO:0008289; GO:0050828 lipid binding [GO:0008289] YELAFGNCRLLPEAIWIQTGVQLAPAQNLLWQT 0.9601 0.39794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAP1 CAST3_HUMAN Putative protein CASTOR 3 (STAG3 opposite strand transcript protein) CASTOR3 GATS STAG3OS Homo sapiens (Human) cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] cytosol [GO:0005829] cytosol [GO:0005829]; cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262]; regulation of intracellular signal transduction [GO:1902531] GO:0005829; GO:1902531; GO:1903577; GO:1904262 VSRCSPTGLIK 0.96011 0.39757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY64 GTR8_HUMAN "Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8, GLUT-8) (Glucose transporter type X1)" SLC2A8 GLUT8 GLUTX1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666]; transmembrane transport [GO:0055085] clathrin-coated endocytic vesicle membrane [GO:0030669]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] clathrin-coated endocytic vesicle membrane [GO:0030669]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; transmembrane transporter activity [GO:0022857]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666]; transmembrane transport [GO:0055085] GO:0001666; GO:0005353; GO:0005355; GO:0005536; GO:0005765; GO:0005886; GO:0005887; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0016020; GO:0022857; GO:0030669; GO:0033300; GO:0055056; GO:0055085; GO:0070837; GO:1904659 D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; transmembrane transporter activity [GO:0022857] RQEAMAALR 0.96011 0.59087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3379 0 0 11.9842 0 0 0 0 0 0 0 0 0 0 12.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5157 13.4493 0 0 0 0 0 0 0 P80188 NGAL_HUMAN "Neutrophil gelatinase-associated lipocalin, NGAL (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin) (p25)" LCN2 HNL NGAL Homo sapiens (Human) apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of cold-induced thermogenesis [GO:0120162]; sequestering of iron ion [GO:0097577]; siderophore transport [GO:0015891] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; enterobactin binding [GO:1903981]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; small molecule binding [GO:0036094]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of cold-induced thermogenesis [GO:0120162]; sequestering of iron ion [GO:0097577]; siderophore transport [GO:0015891] GO:0005506; GO:0005576; GO:0005615; GO:0006915; GO:0015891; GO:0035580; GO:0036094; GO:0042742; GO:0042802; GO:0045087; GO:0070062; GO:0097577; GO:0120162; GO:1903981 enterobactin binding [GO:1903981]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; small molecule binding [GO:0036094] SYNVTSVLFRKK 0.96012 0.39731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.273 0 0 0 17.9894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PEY1 TMM88_HUMAN Transmembrane protein 88 TMEM88 TMEM88A Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; Wnt signaling pathway [GO:0016055] GO:0005829; GO:0005886; GO:0016021; GO:0016055; GO:0030165; GO:0050821; GO:0072659; GO:0090090 PDZ domain binding [GO:0030165] DPGFTALLVTGFLLLVPLLVLALASYRRLCLR 0.96012 0.19346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0665 0 0 0 0 0 13.4995 0 0 0 0 0 0 0 0 0 0 0 0 12.7555 0 0 0 0 0 0 0 0 12.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4229 12.5669 0 0 0 0 0 0 0 0 0 0 0 12.8693 0 0 11.8845 0 12.9649 0 0 0 0 0 0 0 0 0 0 0 11.8876 0 0 12.1109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3S5 PIGM_HUMAN "GPI mannosyltransferase 1, EC 2.4.1.- (GPI mannosyltransferase I, GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein, PIG-M)" PIGM Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-mannosyltransferase I complex [GO:1990529]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-mannosyltransferase I complex [GO:1990529]; integral component of membrane [GO:0016021]; alpha-1,4-mannosyltransferase activity [GO:0051751]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]" GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0051751; GO:1990529 "alpha-1,4-mannosyltransferase activity [GO:0051751]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]" DLVFCCFLHTSIFVTFNK 0.96013 3.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4224 0 0 0 0 0 0 0 0 0 0 11.8003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1284 12.93 0 0 0 0 0 0 0 11.85 0 0 0 0 13.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7925 0 0 0 0 0 0 0 0 Q8WWM9 CYGB_HUMAN "Cytoglobin (Histoglobin, HGb) (Stellate cell activation-associated protein)" CYGB STAP Homo sapiens (Human) fatty acid oxidation [GO:0019395]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of hepatic stellate cell activation [GO:2000490]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; catalase activity [GO:0004096]; fatty acid peroxidase activity [GO:0047888]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; peroxidase activity [GO:0004601]; fatty acid oxidation [GO:0019395]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of hepatic stellate cell activation [GO:2000490]; oxygen transport [GO:0015671]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] GO:0001666; GO:0004096; GO:0004601; GO:0005344; GO:0005506; GO:0005829; GO:0006979; GO:0010764; GO:0015671; GO:0019395; GO:0019825; GO:0020037; GO:0032966; GO:0043005; GO:0043025; GO:0047888; GO:2000490 catalase activity [GO:0004096]; fatty acid peroxidase activity [GO:0047888]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; peroxidase activity [GO:0004601] SPQLRKHACR 0.96014 0.554 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9026 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5729 0 0 0 0 0 12.4155 0 0 0 0 0 0 0 0 0 0 11.4214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3922 0 0 0 0 14.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1154 14.4834 14.2293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9029 13.3767 0 0 13.281 13.7497 0 13.5838 0 0 13.0686 13.0321 13.2568 0 12.9313 14.0076 12.085 14.2055 0 0 0 0 0 0 P16118 F261_HUMAN "6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1, 6PF-2-K/Fru-2,6-P2ase 1, PFK/FBPase 1 (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]" PFKFB1 F6PK PFRX Homo sapiens (Human) "animal organ regeneration [GO:0031100]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594]" "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]" "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; animal organ regeneration [GO:0031100]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594]" GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003; GO:0006094; GO:0006096; GO:0019900; GO:0031100; GO:0032868; GO:0033133; GO:0033762; GO:0042594; GO:0042802; GO:0043540; GO:0051384; GO:0051591; GO:0070095 "6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]" ALNEIDAGVCEEMTYEEIQEHYPEEFALRDQDKYR 0.96015 0.25291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5459 0 0 0 0 14.4687 0 0 0 0 14.5027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UW60 PCSK4_HUMAN "Proprotein convertase subtilisin/kexin type 4, EC 3.4.21.- (Proprotein convertase 4, PC4)" PCSK4 PC4 UNQ2757/PRO6496 Homo sapiens (Human) acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; serine-type endopeptidase activity [GO:0004252]; acrosome reaction [GO:0007340]; binding of sperm to zona pellucida [GO:0007339]; fertilization [GO:0009566]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; reproductive process [GO:0022414]; sperm capacitation [GO:0048240] GO:0001669; GO:0002080; GO:0004252; GO:0005802; GO:0007339; GO:0007340; GO:0009566; GO:0016020; GO:0016485; GO:0016486; GO:0022414; GO:0030173; GO:0048240 serine-type endopeptidase activity [GO:0004252] CAVRVQSRPTPILPLIYIR 0.96016 4.5912 0 0 0 0 10.8191 0 9.96353 0 0 0 0 0 0 0 13.961 12.9624 0 10.7896 11.5924 0 0 0 0 0 0 0 0 0 0 16.1031 14.5283 0 0 0 0 0 0 0 0 0 0 0 15.2482 0 0 10.7874 0 0 15.3791 0 0 14.9271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7325 15.8246 14.8084 14.9023 0 14.7002 0 14.9821 17.1178 16.3044 14.3465 14.3879 14.7937 12.9553 16.1366 0 14.8083 14.7536 0 0 14.9203 15.7904 15.0143 16.1773 14.0637 0 12.9116 13.0718 16.0247 12.6725 14.9565 14.2133 13.5337 15.9219 16.2508 0 0 0 0 13.7438 12.7235 12.67 14.2022 15.2557 16.3784 0 0 14.0918 14.0617 13.1139 15.2234 16.3877 15.7304 16.8931 16.4393 12.7888 13.2338 12.8594 0 0 12.7445 0 12.6745 14.0434 0 13.8914 0 0 12.3777 16.3097 13.7551 0 15.3574 15.9681 15.6911 12.7977 15.9534 12.3821 15.491 15.4632 16.9656 0 17.399 0 15.7231 16.7403 12.0425 12.3525 0 12.7406 15.177 11.2729 13.197 0 0 0 12.4326 0 12.8107 15.1755 0 12.7857 0 12.7786 0 14.8595 12.8245 15.2383 12.1479 0 0 0 17.3934 0 P0DME0 SETLP_HUMAN Protein SETSIP (SET pseudogene protein 18) (SET similar protein) (Similar to SET translocation protein) SETSIP SETP18 Homo sapiens (Human) endothelial cell differentiation [GO:0045446]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; endothelial cell differentiation [GO:0045446]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005811; GO:0006334; GO:0042393; GO:0045446; GO:0045944 chromatin binding [GO:0003682]; histone binding [GO:0042393] LNEQDSEEILKVEQK 0.96016 0.20217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5729 0 12.9606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14210 HGF_HUMAN "Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor, SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain ]" HGF HPTA Homo sapiens (Human) animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947]; skeletal muscle cell proliferation [GO:0014856] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947]; skeletal muscle cell proliferation [GO:0014856] GO:0000278; GO:0000902; GO:0001837; GO:0001889; GO:0001934; GO:0005102; GO:0005576; GO:0005615; GO:0008083; GO:0010507; GO:0014068; GO:0014856; GO:0016020; GO:0030335; GO:0031093; GO:0031100; GO:0031643; GO:0032715; GO:0032733; GO:0033137; GO:0035729; GO:0042056; GO:0042802; GO:0043066; GO:0043154; GO:0043410; GO:0044877; GO:0045669; GO:0045766; GO:0045944; GO:0048012; GO:0050673; GO:0050728; GO:0050731; GO:0051450; GO:0060326; GO:0060665; GO:0070572; GO:0090201; GO:1900744; GO:1901299; GO:1902042; GO:1902947; GO:2000573 chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] EFGHEFDLYENK 0.96016 0.6051 0 0 0 0 0 0 0 0 0 11.3585 0 0 0 0 0 12.2288 0 0 0 0 11.6405 0 0 0 0 0 14.3038 0 0 0 0 12.7892 11.7857 0 0 0 13.5442 0 0 13.0759 0 10.9073 0 0 0 0 0 11.4783 0 0 0 0 0 0 0 0 11.567 0 0 0 0 13.7953 13.1955 0 0 0 0 11.4899 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7634 12.7523 14.063 12.7574 0 0 0 0 0 12.5271 0 0 12.4074 13.1544 0 0 0 0 0 0 12.883 0 0 0 0 12.8337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7246 0 0 11.902 0 0 0 0 0 0 0 0 0 15.7331 0 12.742 0 0 0 0 0 0 0 0 0 0 Q9UMX6 GUC1B_HUMAN "Guanylyl cyclase-activating protein 2, GCAP 2 (Guanylate cyclase activator 1B)" GUCA1B GCAP2 Homo sapiens (Human) body fluid secretion [GO:0007589]; cell-cell signaling [GO:0007267]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of guanylate cyclase activity [GO:0031282]; visual perception [GO:0007601] cone photoreceptor outer segment [GO:0120199]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886] cone photoreceptor outer segment [GO:0120199]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; body fluid secretion [GO:0007589]; cell-cell signaling [GO:0007267]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of guanylate cyclase activity [GO:0031282]; visual perception [GO:0007601] GO:0001917; GO:0005509; GO:0005886; GO:0007168; GO:0007267; GO:0007589; GO:0007601; GO:0008048; GO:0031282; GO:0097381; GO:0120199 calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048] LELLNIVEGIYQLK 0.96016 0.2521 0 0 0 0 0 0 0 0 0 14.1196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5593 0 0 0 Q6ZVK1 T179A_HUMAN Transmembrane protein 179 (Transmembrane protein 179A) TMEM179 C14orf90 TMEM179A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FTVQEWGPPAACRFSLLASLLSLLLAAAHAWR 0.96017 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2934 0 Q99624 S38A3_HUMAN Sodium-coupled neutral amino acid transporter 3 (N-system amino acid transporter 1) (Na(+)-coupled neutral amino acid transporter 3) (Solute carrier family 38 member 3) (System N amino acid transporter 1) SLC38A3 G17 NAT1 SN1 SNAT3 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transport [GO:0006867]; brain development [GO:0007420]; cellular response to potassium ion starvation [GO:0051365]; female pregnancy [GO:0007565]; glutamine transport [GO:0006868]; histidine transport [GO:0015817]; L-alanine transport [GO:0015808]; positive regulation of glutamine transport [GO:2000487]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; symporter activity [GO:0015293]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transport [GO:0006867]; brain development [GO:0007420]; cellular response to potassium ion starvation [GO:0051365]; female pregnancy [GO:0007565]; glutamine transport [GO:0006868]; histidine transport [GO:0015817]; L-alanine transport [GO:0015808]; positive regulation of glutamine transport [GO:2000487]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104] GO:0003333; GO:0005290; GO:0005886; GO:0005887; GO:0006814; GO:0006865; GO:0006867; GO:0006868; GO:0007420; GO:0007565; GO:0015171; GO:0015179; GO:0015180; GO:0015182; GO:0015186; GO:0015293; GO:0015297; GO:0015808; GO:0015817; GO:0016323; GO:0016324; GO:0051365; GO:0061402; GO:0150104; GO:2000487 amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; symporter activity [GO:0015293] AFGTPGK 0.96017 0.60472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9537 13.7369 14.0964 0 0 0 0 0 14.5957 0 0 0 12.4132 0 0 0 0 0 0 0 0 0 14.3652 0 0 14.3225 0 0 0 12.9544 15.641 13.9159 0 0 11.6447 0 13.5479 0 14.1384 0 13.9858 0 0 13.7652 0 0 12.3032 0 14.0831 14.8432 14.1414 14.5334 10.742 12.4999 0 0 14.5182 14.1299 0 14.1877 14.0267 0 14.0447 13.9448 0 13.8409 0 14.0308 11.8975 0 0 0 0 14.1038 0 0 0 0 0 0 0 0 0 0 13.9426 0 0 0 0 14.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2272 12.8169 0 0 0 0 0 12.924 0 Q9NQX0 PRDM6_HUMAN "Putative histone-lysine N-methyltransferase PRDM6, EC 2.1.1.361 (PR domain zinc finger protein 6) (PR domain-containing protein 6)" PRDM6 PFM3 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468] GO:0000122; GO:0005634; GO:0006325; GO:0010468; GO:0022008; GO:0042054; GO:0042802; GO:0046872; GO:0051151 histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] PYQCGHCSQSFSQPSELR 0.96017 0.2019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NLX3 SPDE4_HUMAN Speedy protein E4 SPDYE4 Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0019901; GO:0045737 protein kinase binding [GO:0019901] TWVSPEEMEEIQAYDPEHWVWAR 0.96018 0.5962 0 0 0 0 0 0 0 0 0 0 0 0 11.4111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94925 GLSK_HUMAN "Glutaminase kidney isoform, mitochondrial, GLS, EC 3.5.1.2 (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain ]" GLS GLS1 KIAA0838 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; glutaminase activity [GO:0004359]; chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamate homeostasis [GO:0090461]; glutamine catabolic process [GO:0006543]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967] GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0045202; GO:0051289; GO:0090461 glutaminase activity [GO:0004359] ENQTVHK 0.96018 0.20095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9387 0 0 0 0 0 0 0 0 0 12.8615 0 13.8161 0 0 0 0 0 0 0 0 0 0 0 13.4974 0 0 0 0 0 0 0 0 0 13.5739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8569 0 14.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8531 0 0 0 0 0 0 0 Q6ZMD2 SPNS3_HUMAN Protein spinster homolog 3 SPNS3 Homo sapiens (Human) lipid transport [GO:0006869] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; transmembrane transporter activity [GO:0022857]; lipid transport [GO:0006869] GO:0006869; GO:0016020; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] ARRPDSYLQR 0.96018 0.4566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7615 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L170 CA226_HUMAN Uncharacterized protein C1orf226 C1orf226 Homo sapiens (Human) MFENLNTALTPK 0.96019 0.58864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q32M92 CO032_HUMAN Uncharacterized protein C15orf32 C15orf32 Homo sapiens (Human) EDLHPADPQSGEGVPPNR 0.96019 0.26243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7796 14.6291 0 0 0 0 0 0 0 13.2884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5XG99 LYSM4_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 4 LYSMD4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EQDLYALKSVKIPVR 0.96019 0.37923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1726 0 0 0 0 0 0 0 0 0 10.3335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEG0 GAR6_HUMAN Golgi associated RAB2 interactor protein 6 GARIN6 FAM71C Homo sapiens (Human) LLPLMFVK 0.96019 0.26199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0912 0 0 0 0 0 0 0 13.7434 0 0 0 0 0 0 0 0 0 0 0 14.8875 0 0 0 0 0 0 0 0 0 0 0 14.7952 17.257 0 0 0 0 0 13.0995 0 13.6915 0 13.6126 0 0 0 0 14.0776 0 0 0 0 0 17.1555 0 14.638 17.1377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13367 AP3B2_HUMAN AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) (Neuron-specific vesicle coat protein beta-NAP) AP3B2 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; presynapse [GO:0098793] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; presynapse [GO:0098793]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" GO:0005769; GO:0005794; GO:0006886; GO:0008089; GO:0016183; GO:0016192; GO:0030123; GO:0030665; GO:0035654; GO:0036465; GO:0046907; GO:0048490; GO:0097708; GO:0098793; GO:1904115 AFYGSEEDEAK 0.9602 0.2114 0 0 0 0 0 0 13.2135 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6882 12.5485 0 0 12.8658 0 0 0 11.3798 0 0 0 0 11.2324 0 0 0 0 0 0 11.3295 0 0 10.985 0 0 0 0 0 12.2466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3906 0 0 0 0 0 0 13.239 13.2961 0 0 12.4564 0 0 13.2879 0 13.937 0 0 13.7147 11.3994 0 13.5022 0 15.3501 0 14.2069 0 0 14.4975 0 0 15.7392 14.6345 0 0 0 0 14.4278 0 0 13.3997 0 0 12.6313 0 0 12.6202 0 13.3291 0 0 11.98 0 0 0 0 0 13.3559 13.3339 0 0 0 11.1745 0 0 11.4235 0 12.6714 0 0 0 0 0 0 0 12.2209 0 12.8878 0 12.3979 11.3818 0 0 12.5945 0 0 0 13.3619 0 0 11.908 0 0 0 0 10.2416 13.4165 0 13.5032 0 13.7446 0 0 13.9564 0 0 0 0 0 0 0 12.0446 0 Q16650 TBR1_HUMAN "T-box brain protein 1, T-brain-1, TBR-1 (TES-56)" TBR1 Homo sapiens (Human) "amygdala development [GO:0021764]; brain development [GO:0007420]; cell fate specification [GO:0001708]; cerebral cortex development [GO:0021987]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; conditioned taste aversion [GO:0001661]; gene expression [GO:0010467]; hindbrain development [GO:0030902]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon guidance [GO:1902667]; regulation of neuron projection development [GO:0010975]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; amygdala development [GO:0021764]; brain development [GO:0007420]; cell fate specification [GO:0001708]; cerebral cortex development [GO:0021987]; chromatin remodeling [GO:0006338]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; conditioned taste aversion [GO:0001661]; gene expression [GO:0010467]; hindbrain development [GO:0030902]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of axon guidance [GO:1902667]; regulation of neuron projection development [GO:0010975]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]" GO:0000978; GO:0000981; GO:0001661; GO:0001708; GO:0003700; GO:0005634; GO:0006338; GO:0006357; GO:0007420; GO:0010092; GO:0010467; GO:0010975; GO:0016575; GO:0019901; GO:0021764; GO:0021902; GO:0021987; GO:0030902; GO:0031490; GO:0045892; GO:0045944; GO:1902667 "chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HQTEMIITK 0.9602 0.22601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9275 0 0 12.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3063 0 13.1215 0 0 0 13.6137 0 0 13.1448 0 0 0 0 0 12.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC29 NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1) NOD2 CARD15 IBD1 Homo sapiens (Human) activation of immune response [GO:0002253]; biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0002815]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gamma-delta T cell activation [GO:0046645]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584]; toll-like receptor 2 signaling pathway [GO:0034134]; xenophagy [GO:0098792] anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982] anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; activation of immune response [GO:0002253]; biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0002815]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to organic cyclic compound [GO:0071407]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; positive regulation of B cell activation [GO:0050871]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gamma-delta T cell activation [GO:0046645]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to nutrient [GO:0007584]; toll-like receptor 2 signaling pathway [GO:0034134]; xenophagy [GO:0098792] GO:0002221; GO:0002227; GO:0002253; GO:0002606; GO:0002710; GO:0002720; GO:0002732; GO:0002815; GO:0002830; GO:0002862; GO:0002925; GO:0003779; GO:0005524; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006909; GO:0006952; GO:0006965; GO:0007249; GO:0007254; GO:0007584; GO:0009595; GO:0009986; GO:0010936; GO:0016045; GO:0016323; GO:0018108; GO:0019899; GO:0019901; GO:0030277; GO:0030544; GO:0031982; GO:0032088; GO:0032495; GO:0032498; GO:0032500; GO:0032689; GO:0032695; GO:0032701; GO:0032703; GO:0032720; GO:0032731; GO:0032733; GO:0032735; GO:0032740; GO:0032755; GO:0032757; GO:0032760; GO:0032874; GO:0032991; GO:0034134; GO:0034136; GO:0035556; GO:0038061; GO:0038187; GO:0042742; GO:0042834; GO:0043123; GO:0043330; GO:0043406; GO:0043552; GO:0044877; GO:0045087; GO:0045089; GO:0045335; GO:0045747; GO:0045944; GO:0046330; GO:0046645; GO:0046658; GO:0050679; GO:0050700; GO:0050727; GO:0050731; GO:0050766; GO:0050871; GO:0051092; GO:0051353; GO:0051649; GO:0051770; GO:0051879; GO:0060585; GO:0060907; GO:0070371; GO:0070374; GO:0070431; GO:0071222; GO:0071224; GO:0071225; GO:0071407; GO:0071639; GO:0090022; GO:0098792; GO:1900017; GO:1901224; GO:1902523; GO:1904417; GO:2000110; GO:2000363 actin binding [GO:0003779]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] ARRLLDLATVK 0.9602 0.37826 0 0 0 0 0 0 0 0 0 0 0 12.8805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7409 0 14.516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8461 0 0 0 0 14.1464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6986 0 0 0 0 0 14.3737 0 0 0 0 0 0 0 0 0 10.9394 0 0 13.5505 0 0 0 0 0 0 0 0 0 0 13.3187 0 0 12.967 0 0 0 0 0 0 0 Q02779 M3K10_HUMAN "Mitogen-activated protein kinase kinase kinase 10, EC 2.7.11.25 (Mixed lineage kinase 2) (Protein kinase MST)" MAP3K10 MLK2 MST Homo sapiens (Human) "apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein autophosphorylation [GO:0046777]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein autophosphorylation [GO:0046777]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]" GO:0003714; GO:0004672; GO:0004674; GO:0004706; GO:0005524; GO:0005737; GO:0006915; GO:0007165; GO:0007224; GO:0007254; GO:0018105; GO:0018107; GO:0042803; GO:0043065; GO:0043425; GO:0043433; GO:0043507; GO:0045892; GO:0046330; GO:0046777; GO:0106310 ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor activity [GO:0003714] AIRLTPVDCGGSSSGSSSGGSGTWSR 0.96021 0.22528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4715 14.4793 14.1777 0 0 0 0 13.7893 0 14.4041 0 0 0 13.8757 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4787 13.5846 0 0 0 0 0 0 13.412 0 0 0 0 0 0 0 0 0 0 0 0 13.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.891 0 0 0 0 0 0 Q96AQ7 CIDEC_HUMAN Cell death activator CIDE-3 (Cell death-inducing DFFA-like effector protein C) (Fat-specific protein FSP27 homolog) CIDEC FSP27 Homo sapiens (Human) apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]; lipid transport [GO:0006869]; regulation of apoptotic process [GO:0042981] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; lipid droplet organization [GO:0034389]; lipid transport [GO:0006869]; regulation of apoptotic process [GO:0042981] GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0006869; GO:0006915; GO:0034389; GO:0042981; GO:0097194 HPLSLSHKPAKK 0.96021 0.26171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SXH7 PKHS1_HUMAN "Pleckstrin homology domain-containing family S member 1, PH domain-containing family S member 1 (Epididymis luminal protein 185, hEL185)" PLEKHS1 C10orf81 Homo sapiens (Human) ACMESDWCRDSK 0.96022 0.54927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7552 0 0 0 0 0 0 0 0 0 12.8996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78358 CTG1B_HUMAN "Cancer/testis antigen 1 (Autoimmunogenic cancer/testis antigen NY-ESO-1) (Cancer/testis antigen 6.1, CT6.1) (L antigen family member 2, LAGE-2)" CTAG1A CTAG CTAG1 ESO1 LAGE2 LAGE2A; CTAG1B LAGE2B Homo sapiens (Human) tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] GO:0005737; GO:0042802; GO:0070525 identical protein binding [GO:0042802] GPHGGAASGLNGCCR 0.96023 0.54852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36969 GPX4_HUMAN "Phospholipid hydroperoxide glutathione peroxidase, PHGPx, EC 1.11.1.12 (Glutathione peroxidase 4, GPx-4, GSHPx-4)" GPX4 Homo sapiens (Human) aging [GO:0007568]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; glutathione metabolic process [GO:0006749]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of ferroptosis [GO:0110076]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430]; aging [GO:0007568]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; glutathione metabolic process [GO:0006749]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of ferroptosis [GO:0110076]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283] GO:0004601; GO:0004602; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006325; GO:0006644; GO:0006749; GO:0006979; GO:0007283; GO:0007568; GO:0008430; GO:0019369; GO:0019372; GO:0032355; GO:0032991; GO:0042759; GO:0042802; GO:0047066; GO:0050727; GO:0051258; GO:0070062; GO:0110076 glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430] GFVCIVTNVASQUGK 0.96024 0.54852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0917 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.55 12.2523 0 0 0 0 12.3104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTP0 NIPA1_HUMAN Magnesium transporter NIPA1 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 1) (Spastic paraplegia 6 protein) NIPA1 SPG6 Homo sapiens (Human) magnesium ion transport [GO:0015693]; transmembrane transport [GO:0055085] early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693]; transmembrane transport [GO:0055085] GO:0005769; GO:0005886; GO:0015095; GO:0015693; GO:0016020; GO:0016021; GO:0055085 magnesium ion transmembrane transporter activity [GO:0015095] LNILGKLGCLLSCAGSVVLIIHSPK 0.96024 0.60148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60669 MOT2_HUMAN "Monocarboxylate transporter 2, MCT 2 (Solute carrier family 16 member 7)" SLC16A7 MCT2 Homo sapiens (Human) lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293]; lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104] GO:0005477; GO:0005654; GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0016021; GO:0035873; GO:0050833; GO:0150104; GO:1901475 lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293] AVTVFFK 0.96026 0.47536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3056 0 0 0 16.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3I5F7 ACOT6_HUMAN "Acyl-coenzyme A thioesterase 6, Acyl-CoA thioesterase 6, EC 3.1.2.-" ACOT6 C14orf42 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] GO:0005782; GO:0005829; GO:0006631; GO:0006637; GO:0047617; GO:0052689 acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689] AQVDAWQQIQTFFHK 0.96026 0.54852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N436 CPXM2_HUMAN Inactive carboxypeptidase-like protein X2 CPXM2 CPX2 UNQ676/PRO1310 Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485] GO:0004181; GO:0005615; GO:0006518; GO:0008270; GO:0016485 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] QPVSLPARR 0.96026 0.34308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7V7 SC11B_HUMAN "Putative signal peptidase complex catalytic subunit SEC11B, EC 3.4.21.89 (SEC11 homolog B) (SEC11-like protein 2)" SEC11B SEC11L2 SPCS4B Homo sapiens (Human) signal peptide processing [GO:0006465] integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787] integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465] GO:0004252; GO:0005787; GO:0006465; GO:0008233; GO:0016021 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] GLYKQDQHWLEKK 0.96027 0.54805 0 11.3434 0 0 10.9924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6044 0 0 0 0 13.0087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0778 0 0 0 0 0 0 0 0 0 0 12.1355 0 0 0 0 0 0 0 0 12.5265 0 0 0 0 0 18.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2557 0 0 0 0 0 0 0 0 Q96BF3 TMIG2_HUMAN "Transmembrane and immunoglobulin domain-containing protein 2 (CD28 homolog) (Immunoglobulin and proline-rich receptor 1, IGPR-1)" TMIGD2 CD28H IGPR1 UNQ3059/PRO9879 Homo sapiens (Human) immune response [GO:0006955]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytokine production [GO:0001819]; T cell costimulation [GO:0031295] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; coreceptor activity [GO:0015026]; immune response [GO:0006955]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytokine production [GO:0001819]; T cell costimulation [GO:0031295] GO:0001819; GO:0005615; GO:0005886; GO:0006955; GO:0015026; GO:0016021; GO:0031295; GO:0042104; GO:0045766 coreceptor activity [GO:0015026] DSGNSPGNAFYSNVLYR 0.96028 0.6859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3671 0 0 0 0 12.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6322 13.1694 13.3741 0 13.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TBK1 N42L1_HUMAN NEDD4-binding protein 2-like 1 N4BP2L1 CG081 Homo sapiens (Human) ERYEHDVTFHSVLHAEK 0.96029 0.59194 0 0 0 0 0 0 0 0 0 0 0 11.6489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2013 0 0 0 0 0 0 0 0 11.4378 0 0 0 0 0 12.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGF3 O51D1_HUMAN Olfactory receptor 51D1 (Olfactory receptor OR11-14) OR51D1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] VNVVYGLFIILSVMGVDSLFIGFSYILILWAVLELSSR 0.96029 0.68373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5361 0 0 0 12.1823 11.5581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11465 PSG2_HUMAN "Pregnancy-specific beta-1-glycoprotein 2, PS-beta-G-2, PSBG-2, Pregnancy-specific glycoprotein 2 (Pregnancy-specific beta-1 glycoprotein E, PS-beta-E)" PSG2 PSBG2 Homo sapiens (Human) cell migration [GO:0016477]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; cell migration [GO:0016477]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] GO:0005576; GO:0007157; GO:0007565; GO:0009986; GO:0016477 MGPLSAPPCTEHIKWK 0.9603 0.4624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8764 0 0 0 0 0 0 0 0 0 0 12.2811 0 0 0 0 0 0 0 13.4148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FV9 THOC1_HUMAN "THO complex subunit 1, Tho1 (Nuclear matrix protein p84, p84N5) (hTREX84)" THOC1 HPR1 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]" cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] "cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]" GO:0000018; GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607; GO:0031297; GO:0032784; GO:0032786; GO:0046784; GO:0048297; GO:2000002 DNA binding [GO:0003677]; RNA binding [GO:0003723] EEGMDVEEGEMGDEEAPTTCSIPIDYNLYR 0.9603 0.55581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9507 0 0 0 0 0 0 0 15.8766 0 0 0 0 0 0 0 14.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L157 TSN11_HUMAN "Tetraspanin-11, Tspan-11" TSPAN11 Homo sapiens (Human) cell migration [GO:0016477] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cell migration [GO:0016477] GO:0005887; GO:0016477 CCGSNSSADWQHSTYILLREAEGR 0.96031 0.59888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4286 0 0 0 0 0 0 0 0 11.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96E14 RMI2_HUMAN "RecQ-mediated genome instability protein 2, hRMI2 (BLM-associated protein of 18 kDa, BLAP18)" RMI2 C16orf75 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; maintenance of rDNA [GO:0043007]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of sister chromatid segregation [GO:0033045]; resolution of recombination intermediates [GO:0071139] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; maintenance of rDNA [GO:0043007]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of sister chromatid segregation [GO:0033045]; resolution of recombination intermediates [GO:0071139] GO:0000724; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0016607; GO:0031422; GO:0033045; GO:0043007; GO:0071139; GO:2000042 DNA binding [GO:0003677] DPSGDFSVR 0.96031 0.55548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NS1 YPEL4_HUMAN Protein yippee-like 4 YPEL4 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730]; metal ion binding [GO:0046872] GO:0005730; GO:0046872 metal ion binding [GO:0046872] LLLTGLHSVADIFCESCK 0.96031 0.59091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087WV53 SPEGN_HUMAN SPEG neighbor protein SPEGNB Homo sapiens (Human) AAPAKKPVAVAPAPGCTLDINDPQVQSAAIR 0.96032 0.25388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3351 0 0 0 0 0 0 0 0 0 13.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9648 13.8533 0 14.92 13.2578 0 12.5426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4454 13.0134 0 0 0 0 0 0 15.9227 0 0 0 0 0 13.0621 0 0 0 13.6511 0 0 0 0 0 13.1733 0 0 0 0 0 0 0 0 0 12.5375 0 0 0 0 12.5142 0 0 0 0 0 12.9401 0 0 0 0 13.7759 0 16.2701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXR4 SPA13_HUMAN Putative serpin A13 SERPINA13P SERPINA13 UNQ6121/PRO20043 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0010951 serine-type endopeptidase inhibitor activity [GO:0004867] ELDFHFPKFSISRTCR 0.96032 0.55455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3817 13.9124 0 0 0 0 13.5325 0 0 0 0 13.6839 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7742 0 0 13.0347 0 0 0 0 13.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N414 PGBD5_HUMAN "PiggyBac transposable element-derived protein 5, EC 3.1.-.- (PiggyBac domain-related protein 5) (PiggyBac transposase 5)" PGBD5 Homo sapiens (Human) "non-replicative transposition, DNA-mediated [GO:0098038]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; transposase activity [GO:0004803]; non-replicative transposition, DNA-mediated [GO:0098038]" GO:0004519; GO:0004803; GO:0005634; GO:0005654; GO:0098038 endonuclease activity [GO:0004519]; transposase activity [GO:0004803] GQYQIKMKGNMSLICWYNK 0.96032 0.59826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N819 PPM1N_HUMAN "Probable protein phosphatase 1N, EC 3.1.3.16" PPM1N Homo sapiens (Human) negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263] GO:0000287; GO:0004722; GO:0005634; GO:0005829; GO:0017018; GO:0030145; GO:0035970; GO:0043124; GO:0090263 magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] AGAVAFSTEDHRPLR 0.96033 0.55414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9293 0 0 0 0 0 0 0 0 13.5793 0 0 0 0 11.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13725 ONCM_HUMAN "Oncostatin-M, OSM" OSM Homo sapiens (Human) immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036] GO:0002675; GO:0005125; GO:0005147; GO:0005576; GO:0005615; GO:0006955; GO:0008083; GO:0008284; GO:0008285; GO:0014068; GO:0032740; GO:0033138; GO:0038165; GO:0040008; GO:0042531; GO:0043410; GO:0045944; GO:0046888; GO:0050729; GO:0050731; GO:0051781; GO:0051897; GO:1902036 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147] LQMARPNILGLR 0.96034 0.59787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96E93 KLRG1_HUMAN Killer cell lectin-like receptor subfamily G member 1 (C-type lectin domain family 15 member A) (ITIM-containing receptor MAFA-L) (MAFA-like receptor) (Mast cell function-associated antigen) KLRG1 CLEC15A MAFA MAFAL Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; inflammatory response [GO:0006954]; innate immune response [GO:0045087] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; inflammatory response [GO:0006954]; innate immune response [GO:0045087] GO:0005886; GO:0006954; GO:0006968; GO:0007166; GO:0016021; GO:0030246; GO:0038023; GO:0043231; GO:0045087 carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023] YGNHCYYFSVEEKDWNSSLEFCLAR 0.96035 0.60525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4867 0 12.9004 0 0 12.1832 11.7336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7583 0 0 0 0 0 0 0 0 0 13.9863 0 0 0 0 0 14.0717 0 0 12.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5051 0 13.1453 0 0 0 0 0 0 0 0 0 0 0 12.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCK5 AGO4_HUMAN "Protein argonaute-4, Argonaute4, hAgo4 (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4, eIF-2C 4, eIF2C 4)" AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; pre-miRNA processing [GO:0031054]; regulation of cell morphogenesis [GO:0022604]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; synaptonemal complex assembly [GO:0007130] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; negative regulation of apoptotic process [GO:0043066]; pre-miRNA processing [GO:0031054]; regulation of cell morphogenesis [GO:0022604]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; synaptonemal complex assembly [GO:0007130] GO:0000932; GO:0003723; GO:0003725; GO:0003727; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0007130; GO:0007140; GO:0008584; GO:0010501; GO:0010586; GO:0016020; GO:0016442; GO:0022604; GO:0031054; GO:0035196; GO:0035198; GO:0035278; GO:0036464; GO:0043066; GO:0070578; GO:0070922 double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] EVVDTMVRHFK 0.96035 4.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0874 0 0 0 0 0 0 0 0 0 0 11.6103 0 0 0 0 0 0 0 0 13.4974 0 0 0 0 11.4588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8665 0 0 0 12.5108 0 0 13.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9468 0 0 0 0 0 0 0 0 0 0 Q8NGR5 OR1L4_HUMAN "Olfactory receptor 1L4 (OST046) (Olfactory receptor 1L5) (Olfactory receptor 9-E, OR9-E) (Olfactory receptor OR9-29)" OR1L4 OR1L5 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LQKPLFAIFLIMYLLTAVGNVLIILAIYSDPR 0.96036 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LB2 MRGX1_HUMAN Mas-related G-protein coupled receptor member X1 (Sensory neuron-specific G-protein coupled receptor 3/4) MRGPRX1 MRGX1 SNSR3 SNSR4 Homo sapiens (Human) acute-phase response [GO:0006953]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; response to chloroquine [GO:1902349]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; acute-phase response [GO:0006953]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; response to chloroquine [GO:1902349]; signal transduction [GO:0007165] GO:0004888; GO:0004930; GO:0005886; GO:0006953; GO:0007165; GO:0007166; GO:0007186; GO:0009986; GO:0016021; GO:1902349 G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888] ILCGSRK 0.96036 0.22634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSG0 PADC1_HUMAN "Protease-associated domain-containing protein 1 (Protease-associated domain-containing protein of 21 kDa, hPAP21)" PRADC1 C2orf7 PAP21 UNQ833/PRO1760 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 IHDYLYFQVLSPGDIRYIFTATPAK 0.96036 0.60525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6013 0 0 0 0 0 Q9UHI6 DDX20_HUMAN "Probable ATP-dependent RNA helicase DDX20, EC 3.6.1.15, EC 3.6.4.13 (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3)" DDX20 DP103 GEMIN3 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; RNA processing [GO:0006396]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; RNA processing [GO:0006396]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244] GO:0000122; GO:0000244; GO:0000387; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006396; GO:0008285; GO:0016020; GO:0016887; GO:0019904; GO:0030674; GO:0032797; GO:0034719; GO:0042826; GO:0043065; GO:0048477; GO:0050810; GO:0090571; GO:0097504; GO:0140297 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] LSFSDTYQDYEEYWR 0.96036 0.22615 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0083 0 0 0 0 0 13.812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8962 0 0 0 0 0 0 0 13.9194 0 0 12.7219 13.2414 13.2074 0 13.0407 0 20.1816 0 0 0 0 0 0 0 0 12.7681 0 0 0 0 0 0 0 14.211 0 0 0 0 0 14.2715 0 0 0 0 0 0 0 0 0 0 0 13.653 0 0 12.8142 0 0 0 0 0 0 13.8889 13.5023 0 0 0 0 13.389 13.9729 0 0 0 0 14.7909 0 0 0 14.0645 0 0 0 0 0 12.9904 0 0 0 0 13.1517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6951 12.761 0 0 0 0 0 O43815 STRN_HUMAN Striatin STRN Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; Wnt signaling pathway [GO:0016055] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; nuclear estrogen receptor binding [GO:0030331]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; bicellular tight junction assembly [GO:0070830]; dendrite development [GO:0016358]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; Wnt signaling pathway [GO:0016055] GO:0005516; GO:0005829; GO:0005923; GO:0007626; GO:0008285; GO:0014069; GO:0016020; GO:0016055; GO:0016358; GO:0030331; GO:0030425; GO:0043025; GO:0043197; GO:0044877; GO:0045211; GO:0051721; GO:0070016; GO:0070830; GO:0090443 armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; nuclear estrogen receptor binding [GO:0030331]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877] EKSVIDTSTIVRK 0.96037 0.60474 0 0 0 10.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4874 0 0 0 0 0 14.081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9482 0 0 0 0 0 0 0 0 0 0 0 0 11.1546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15003 CND2_HUMAN "Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H, hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)" NCAPH BRRN BRRN1 CAPH KIAA0074 Homo sapiens (Human) cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] GO:0000794; GO:0000796; GO:0003682; GO:0005654; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0051301; GO:0051309; GO:0051984; GO:1905820; GO:1905821 chromatin binding [GO:0003682] AATILTK 0.96037 0.37941 0 0 0 0 0 0 0 0 0 12.1295 12.0961 11.7066 0 11.583 0 12.5236 0 11.6608 0 0 0 0 0 0 0 0 0 0 12.5096 14.0341 13.0401 0 0 12.6183 0 11.4423 0 12.867 12.6596 12.7086 0 0 0 13.36 0 0 0 12.8086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3343 0 0 0 0 12.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY41 HDAC8_HUMAN "Histone deacetylase 8, HD8, EC 3.5.1.98 (Protein deacetylase HDAC8, EC 3.5.1.-) (Protein decrotonylase HDAC8, EC 3.5.1.-)" HDAC8 HDACL1 CDA07 Homo sapiens (Human) chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; sister chromatid cohesion [GO:0007062] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone decrotonylase activity [GO:0160009]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cohesin loading [GO:0071922]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; sister chromatid cohesion [GO:0007062] GO:0000118; GO:0000122; GO:0000228; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0007062; GO:0016575; GO:0030544; GO:0031397; GO:0031647; GO:0032204; GO:0046872; GO:0051879; GO:0071922; GO:0140297; GO:0160009 DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone decrotonylase activity [GO:0160009]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872] VAINWSGGWHHAK 0.96037 0.38789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZC4 EHF_HUMAN "ETS homologous factor, hEHF (ETS domain-containing transcription factor) (Epithelium-specific Ets transcription factor 3, ESE-3)" EHF ESE3 ESE3B ESEJ Homo sapiens (Human) cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0006357; GO:0006366; GO:0030154; GO:0030855; GO:0045944; GO:0050673 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FLKSEAVAQLWGK 0.96037 0.45711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41134 ID1_HUMAN "DNA-binding protein inhibitor ID-1 (Class B basic helix-loop-helix protein 24, bHLHb24) (Inhibitor of DNA binding 1) (Inhibitor of differentiation 1)" ID1 BHLHB24 ID Homo sapiens (Human) "angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cell-abiotic substrate adhesion [GO:0036164]; cellular response to dopamine [GO:1903351]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to peptide [GO:1901653]; circadian regulation of gene expression [GO:0032922]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; regulation of vasculature development [GO:1901342]; transforming growth factor beta receptor signaling pathway [GO:0007179]" centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; proteasome binding [GO:0070628]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription regulator inhibitor activity [GO:0140416]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cell-abiotic substrate adhesion [GO:0036164]; cellular response to dopamine [GO:1903351]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to peptide [GO:1901653]; circadian regulation of gene expression [GO:0032922]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; regulation of vasculature development [GO:1901342]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000122; GO:0001525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0007179; GO:0007420; GO:0008022; GO:0010621; GO:0010628; GO:0030154; GO:0030182; GO:0032091; GO:0032233; GO:0032922; GO:0036164; GO:0042802; GO:0043066; GO:0043392; GO:0043433; GO:0043534; GO:0045602; GO:0045892; GO:0046983; GO:0047485; GO:0048514; GO:0050679; GO:0050774; GO:0070628; GO:0071364; GO:0120163; GO:0140416; GO:1901342; GO:1901653; GO:1903351; GO:1990090 identical protein binding [GO:0042802]; proteasome binding [GO:0070628]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription regulator inhibitor activity [GO:0140416] VEILQHVIDYIR 0.96038 0.58864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6J3 SMA5O_HUMAN SMAD5 antisense gene protein 1 (10.3 kDa proline-rich protein DAMS) (SMAD5 antisense RNA 1) (SMAD5 opposite strand protein) SMAD5-AS1 DAMS SMAD5OS Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 LLPPPATPPPPPQSSSWSGNIVFTIKINIWLR 0.96038 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42766 RL35_HUMAN 60S ribosomal protein L35 (Large ribosomal subunit protein uL29) RPL35 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleolus [GO:0005730] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleolus [GO:0005730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]" GO:0000463; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] HEENLKTKK 0.9604 0.2598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9963 11.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6593 14.5882 14.1707 14.1625 0 16.1859 14.5656 14.3712 0 0 0 0 0 0 0 0 0 0 14.3947 0 0 14.3328 14.5189 0 14.3687 0 0 0 14.0911 13.8969 0 14.1339 13.6411 0 13.2049 0 0 13.9264 14.3935 0 0 13.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8833 0 0 0 0 0 13.8201 0 0 13.4451 0 0 0 0 0 P0DTU4 TRBR2_HUMAN "T cell receptor beta chain MC.7.G5 (TR beta chain TRBV25-1*01J2S3*01C2*01, MC.7.G5 TRB)" TRB Homo sapiens (Human) detection of tumor cell [GO:0002355]; T cell mediated cytotoxicity directed against tumor cell target [GO:0002419] alpha-beta T cell receptor complex [GO:0042105]; integral component of membrane [GO:0016021] alpha-beta T cell receptor complex [GO:0042105]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; detection of tumor cell [GO:0002355]; T cell mediated cytotoxicity directed against tumor cell target [GO:0002419] GO:0002355; GO:0002419; GO:0016021; GO:0038023; GO:0042105 signaling receptor activity [GO:0038023] PSHTSQYLCASSEAR 0.96042 0.54852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N697 S15A4_HUMAN "Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1, hPHT1)" SLC15A4 PHT1 PTR4 FP12591 Homo sapiens (Human) dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; ion transport [GO:0006811]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424] GO:0005290; GO:0005765; GO:0005886; GO:0006811; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0031303; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0035579; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206; GO:1905103 dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] AILLSLALYLLGMLAFPLLAAPATR 0.96042 0.59538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0097 0 0 13.0693 0 0 15.1671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6148 0 0 0 0 0 P15538 C11B1_HUMAN "Cytochrome P450 11B1, mitochondrial (CYPXIB1) (Cytochrome P-450c11, Cytochrome P450C11) (Steroid 11-beta-hydroxylase, CYP11B1, EC 1.14.15.4)" CYP11B1 S11BH Homo sapiens (Human) aldosterone biosynthetic process [GO:0032342]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to hormone stimulus [GO:0032870]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to potassium ion [GO:0035865]; cholesterol metabolic process [GO:0008203]; cortisol biosynthetic process [GO:0034651]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; glucose homeostasis [GO:0042593]; immune response [GO:0006955]; regulation of blood pressure [GO:0008217]; sterol metabolic process [GO:0016125] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507]; aldosterone biosynthetic process [GO:0032342]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to hormone stimulus [GO:0032870]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to potassium ion [GO:0035865]; cholesterol metabolic process [GO:0008203]; cortisol biosynthetic process [GO:0034651]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; glucose homeostasis [GO:0042593]; immune response [GO:0006955]; regulation of blood pressure [GO:0008217]; sterol metabolic process [GO:0016125] GO:0004507; GO:0005506; GO:0005739; GO:0005743; GO:0006700; GO:0006704; GO:0006955; GO:0008203; GO:0008217; GO:0016125; GO:0020037; GO:0032342; GO:0032870; GO:0034650; GO:0034651; GO:0035865; GO:0042593; GO:0047783; GO:0071375 corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507] KVLQNAR 0.96048 0.24251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGU1 OR9A1_HUMAN Olfactory receptor 9A1 (HSHTPRX06) OR9A1P OR9A1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] SFSTCASHFTYVVIGYGSCLFLYVK 0.96049 0.59255 10.2644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 10.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1002 0 11.8291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94985 CSTN1_HUMAN "Calsyntenin-1 (Alcadein-alpha, Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha, SAlc-alpha; CTF1-alpha (C-terminal fragment 1-alpha) ]" CLSTN1 CS1 KIAA0911 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003] anchoring junction [GO:0070161]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003] GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005576; GO:0005634; GO:0005789; GO:0007155; GO:0007156; GO:0009986; GO:0014069; GO:0016021; GO:0019894; GO:0042988; GO:0043005; GO:0045211; GO:0050806; GO:0051965; GO:0070161; GO:0090128; GO:0098845; GO:0098969; GO:0098978; GO:0099003 amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988] DGYIKNTEKLNYGK 0.96051 0.59125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4138 0 0 0 0 0 0 14.8213 14.0493 13.438 0 13.5885 13.4466 13.9127 13.6695 13.5674 0 14.0387 0 0 0 13.6186 0 13.522 0 0 0 0 13.5486 0 0 0 0 0 0 0 0 14.4804 0 0 13.9676 0 0 12.8301 0 13.7986 0 13.5167 14.5608 14.1669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5677 13.6309 14.5315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1A2 MBOA5_HUMAN "Lysophospholipid acyltransferase 5, LPLAT 5, EC 2.3.1.- (1-acylglycerophosphocholine O-acyltransferase, EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase, EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase, EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase, LPCAT, Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3, Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase, LPSAT, Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5, O-acyltransferase domain-containing protein 5)" LPCAT3 MBOAT5 OACT5 Homo sapiens (Human) chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sterol regulatory element binding protein cleavage [GO:1901310]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617]; chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sterol regulatory element binding protein cleavage [GO:1901310]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0003841; GO:0005789; GO:0006656; GO:0016020; GO:0016021; GO:0016746; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047144; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0106262; GO:0106263; GO:1901310; GO:1903573; GO:1905885 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophospholipid acyltransferase activity [GO:0071617] IPNSIIPALK 0.96052 0.22689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.099 0 0 0 12.6646 12.8497 12.6186 0 0 0 0 14.4064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3096 12.3272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1298 0 0 0 0 0 0 0 17.2346 0 0 P50553 ASCL1_HUMAN "Achaete-scute homolog 1, ASH-1, hASH1 (Class A basic helix-loop-helix protein 46, bHLHa46)" ASCL1 ASH1 BHLHA46 HASH1 Homo sapiens (Human) "adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; motor neuron migration [GO:0097475]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]" chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; motor neuron migration [GO:0097475]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; regulation of transcription by RNA polymerase II [GO:0006357]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to lithium ion [GO:0010226]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003358; GO:0003359; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0010226; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042802; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0046983; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0048935; GO:0050767; GO:0050769; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:0097475; GO:1990837; GO:2000179 "bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" SSSPELMRCK 0.96053 0.38055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEU8 WFKN2_HUMAN "WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 (Growth and differentiation factor-associated serum protein 1, GASP-1, hGASP-1) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing-related protein) (WFIKKN-related protein)" WFIKKN2 GASP1 WFIKKNRP UNQ9235/PRO31996 Homo sapiens (Human) muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular space [GO:0005615] extracellular space [GO:0005615]; metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001501; GO:0004867; GO:0005615; GO:0007179; GO:0008191; GO:0030512; GO:0032091; GO:0043392; GO:0048019; GO:0050431; GO:0055001; GO:0060021 metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431] CYMDAEACSK 0.96053 4.7424 0 0 10.5509 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4827 0 0 0 0 0 10.7306 11.8658 0 0 11.4113 0 0 0 13.0888 0 0 0 0 0 0 0 0 0 11.8767 0 0 0 0 0 0 0 0 0 9.85577 0 0 0 0 10.9287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1552 0 0 0 12.1201 0 11.5323 0 14.0659 13.8401 0 0 0 13.5682 0 14.4542 11.6793 0 13.1767 12.8772 11.9342 12.5979 0 11.6998 14.1266 0 0 0 0 0 0 14.2875 0 0 12.7198 0 14.1883 0 0 0 0 11.9299 0 0 0 0 12.0899 13.9826 13.4276 13.0293 13.6054 0 0 0 0 13.5852 0 0 0 0 0 14.1652 0 14.8315 0 15.0318 0 13.1066 0 0 0 0 0 0 0 0 14.0405 13.0464 0 0 0 0 14.0782 12.2016 0 0 0 0 0 13.716 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0185 0 0 15.5324 0 A8MV65 VGLL3_HUMAN "Transcription cofactor vestigial-like protein 3, Vgl-3" VGLL3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005634; GO:0006357 QEEEDEEEEEEEK 0.96054 0.38789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8877 0 0 0 0 0 0 12.6212 0 0 0 12.5173 0 0 0 0 0 0 12.1359 11.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60291 MGRN1_HUMAN "E3 ubiquitin-protein ligase MGRN1, EC 2.3.2.27 (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1)" MGRN1 KIAA0544 RNF156 Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0006513; GO:0008333; GO:0016020; GO:0016567; GO:0043231; GO:0043951; GO:0045744; GO:0045879; GO:0046872; GO:0061630; GO:0070062 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ALLQIRAVRK 0.96054 0.38001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.604 0 0 13.476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9576 0 0 0 0 0 0 0 0 0 14.6518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3137 0 0 0 0 16.2293 0 14.3104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.712 0 0 15.7165 0 0 0 0 10.6668 14.8985 0 0 0 0 0 0 14.6491 14.6817 0 0 0 0 0 0 0 0 0 0 0 0 13.8545 0 0 0 0 10.7953 0 0 0 0 0 14.8464 0 Q9NWW6 NRK1_HUMAN "Nicotinamide riboside kinase 1, NRK 1, NmR-K 1, EC 2.7.1.22 (Nicotinic acid riboside kinase 1, EC 2.7.1.173) (Ribosylnicotinamide kinase 1, RNK 1) (Ribosylnicotinic acid kinase 1)" NMRK1 C9orf95 NRK1 Homo sapiens (Human) NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; phosphorylation [GO:0016310] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; phosphorylation [GO:0016310] GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0016310; GO:0019674; GO:0046872; GO:0050262; GO:0061769 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribosylnicotinamide kinase activity [GO:0050262]; ribosylnicotinate kinase activity [GO:0061769] MMSAISCWMESAR 0.96054 0.38789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0366 Q96A46 MFRN2_HUMAN "Mitoferrin-2 (Mitochondrial RNA-splicing protein 3/4 homolog, MRS3/4, hMRS3/4) (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28)" SLC25A28 MFRN2 NPD016 Homo sapiens (Human) iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; ferrous iron transmembrane transporter activity [GO:0015093]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072] GO:0005743; GO:0015093; GO:0016021; GO:0031966; GO:0048250; GO:0055072 ferrous iron transmembrane transporter activity [GO:0015093] NVLEALWRIIR 0.96055 0.39565 0 0 0 0 0 11.0403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVC4 LST8_HUMAN "Target of rapamycin complex subunit LST8, TORC subunit LST8 (G protein beta subunit-like, Gable, Protein GbetaL) (Mammalian lethal with SEC13 protein 8, mLST8)" MLST8 GBL LST8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0007010; GO:0010507; GO:0016310; GO:0030307; GO:0030838; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0032008; GO:0032956; GO:0038202; GO:0043066; GO:0043087; GO:0043539; GO:0045821; GO:0046889; GO:0050731; GO:0071456; GO:0071470; GO:1905857 protein serine/threonine kinase activator activity [GO:0043539] WMYTGGEDCTAR 0.96058 0.58864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.646 0 0 0 15.8243 0 0 13.8077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4353 0 14.0922 14.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9586 0 0 0 0 0 0 P41159 LEP_HUMAN Leptin (Obese protein) (Obesity factor) LEP OB OBS Homo sapiens (Human) activation of protein kinase C activity [GO:1990051]; adipose tissue development [GO:0060612]; adult feeding behavior [GO:0008343]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; bile acid metabolic process [GO:0008206]; bone growth [GO:0098868]; bone mineralization involved in bone maturation [GO:0035630]; cardiac muscle hypertrophy [GO:0003300]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-ascorbic acid [GO:0071298]; cellular response to leptin stimulus [GO:0044320]; cellular response to retinoic acid [GO:0071300]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; eating behavior [GO:0042755]; elastin metabolic process [GO:0051541]; energy reserve metabolic process [GO:0006112]; fatty acid beta-oxidation [GO:0006635]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process [GO:0006114]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; intestinal absorption [GO:0050892]; intracellular signal transduction [GO:0035556]; leptin-mediated signaling pathway [GO:0033210]; leukocyte tethering or rolling [GO:0050901]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of autophagy [GO:0010507]; negative regulation of cartilage development [GO:0061037]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of glucose import [GO:0046325]; negative regulation of glutamine transport [GO:2000486]; negative regulation of lipid storage [GO:0010888]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vasoconstriction [GO:0045906]; ovulation from ovarian follicle [GO:0001542]; phagocytosis [GO:0006909]; placenta development [GO:0001890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of fat cell apoptotic process [GO:1904651]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of ion transport [GO:0043270]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of TOR signaling [GO:0032008]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin secretion [GO:0032310]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of bone remodeling [GO:0046850]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell cycle [GO:0051726]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of endothelial cell proliferation [GO:0001936]; regulation of gluconeogenesis [GO:0006111]; regulation of insulin secretion [GO:0050796]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of lipoprotein lipid oxidation [GO:0060587]; regulation of natural killer cell activation [GO:0032814]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]; regulation of natural killer cell proliferation [GO:0032817]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin E [GO:0033197]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; tyrosine phosphorylation of STAT protein [GO:0007260] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; DNA binding [GO:0003677]; hormone activity [GO:0005179]; leptin receptor binding [GO:1990460]; peptide hormone receptor binding [GO:0051428]; activation of protein kinase C activity [GO:1990051]; adipose tissue development [GO:0060612]; adult feeding behavior [GO:0008343]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; bile acid metabolic process [GO:0008206]; bone growth [GO:0098868]; bone mineralization involved in bone maturation [GO:0035630]; cardiac muscle hypertrophy [GO:0003300]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-ascorbic acid [GO:0071298]; cellular response to leptin stimulus [GO:0044320]; cellular response to retinoic acid [GO:0071300]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; eating behavior [GO:0042755]; elastin metabolic process [GO:0051541]; energy reserve metabolic process [GO:0006112]; fatty acid beta-oxidation [GO:0006635]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process [GO:0006114]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; intestinal absorption [GO:0050892]; intracellular signal transduction [GO:0035556]; leptin-mediated signaling pathway [GO:0033210]; leukocyte tethering or rolling [GO:0050901]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of autophagy [GO:0010507]; negative regulation of cartilage development [GO:0061037]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of glucose import [GO:0046325]; negative regulation of glutamine transport [GO:2000486]; negative regulation of lipid storage [GO:0010888]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vasoconstriction [GO:0045906]; ovulation from ovarian follicle [GO:0001542]; phagocytosis [GO:0006909]; placenta development [GO:0001890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of fat cell apoptotic process [GO:1904651]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of ion transport [GO:0043270]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of TOR signaling [GO:0032008]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin secretion [GO:0032310]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of bone remodeling [GO:0046850]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell cycle [GO:0051726]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of endothelial cell proliferation [GO:0001936]; regulation of gluconeogenesis [GO:0006111]; regulation of insulin secretion [GO:0050796]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of lipoprotein lipid oxidation [GO:0060587]; regulation of natural killer cell activation [GO:0032814]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]; regulation of natural killer cell proliferation [GO:0032817]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin E [GO:0033197]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0000122; GO:0001525; GO:0001542; GO:0001666; GO:0001890; GO:0001934; GO:0001936; GO:0002021; GO:0003300; GO:0003677; GO:0005179; GO:0005576; GO:0005615; GO:0005829; GO:0006006; GO:0006111; GO:0006112; GO:0006114; GO:0006629; GO:0006635; GO:0006909; GO:0007260; GO:0007565; GO:0007623; GO:0008203; GO:0008206; GO:0008217; GO:0008340; GO:0008343; GO:0010507; GO:0010888; GO:0014068; GO:0014823; GO:0019953; GO:0021954; GO:0030073; GO:0030217; GO:0030300; GO:0032008; GO:0032099; GO:0032310; GO:0032355; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0032814; GO:0032817; GO:0032868; GO:0032869; GO:0033197; GO:0033210; GO:0033686; GO:0035360; GO:0035556; GO:0035630; GO:0035904; GO:0038108; GO:0042102; GO:0042269; GO:0042307; GO:0042445; GO:0042531; GO:0042593; GO:0042755; GO:0043066; GO:0043270; GO:0043410; GO:0044320; GO:0045471; GO:0045765; GO:0045906; GO:0046325; GO:0046427; GO:0046628; GO:0046850; GO:0046881; GO:0048639; GO:0050796; GO:0050810; GO:0050892; GO:0050901; GO:0050999; GO:0051428; GO:0051541; GO:0051726; GO:0051897; GO:0060587; GO:0060612; GO:0061037; GO:0070093; GO:0071298; GO:0071300; GO:0090335; GO:0098868; GO:0120162; GO:1900015; GO:1900745; GO:1904651; GO:1990051; GO:1990460; GO:2000379; GO:2000486; GO:2000491 DNA binding [GO:0003677]; hormone activity [GO:0005179]; leptin receptor binding [GO:1990460]; peptide hormone receptor binding [GO:0051428] MHWGTLCGFLWLWPYLFYVQAVPIQKVQDDTK 0.96059 0.68679 0 0 0 0 0 0 0 0 0 0 12.1751 0 0 0 0 11.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6381 0 0 0 0 0 0 11.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4551 0 A0A0C4DH43 HV70D_HUMAN Immunoglobulin heavy variable 2-70D IGHV2-70D Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] MDILCSTLLLLTVPSWVLSQVTLKESGPALVK 0.9606 0.68679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2806 Q96N06 SPT33_HUMAN Spermatogenesis-associated protein 33 SPATA33 C16orf55 Homo sapiens (Human) mitophagy [GO:0000423] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226]; mitophagy [GO:0000423] GO:0000423; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0097225; GO:0097226 ASNETLVSCSSSGSDQQR 0.96062 0.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1406 0 0 0 0 0 12.7045 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2336 0 0 0 13.4054 0 0 0 0 0 0 11.7348 0 0 0 0 11.8051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5263 0 0 0 0 0 0 0 0 Q9H1U4 MEGF9_HUMAN "Multiple epidermal growth factor-like domains protein 9, Multiple EGF-like domains protein 9 (Epidermal growth factor-like protein 5, EGF-like protein 5)" MEGF9 EGFL5 KIAA0818 UNQ671/PRO1305 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; integral component of membrane [GO:0016021] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005604; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0034446 CENGYYNFDSICR 0.96065 0.2552 0 0 0 0 0 0 0 0 0 11.7855 0 0 0 0 0 14.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1491 0 0 14.7725 0 14.5622 0 0 13.6562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2274 0 14.2194 0 0 0 0 14.1972 0 0 0 0 0 12.6189 0 12.1264 0 13.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXZ3 CLM5_HUMAN "CMRF35-like molecule 5, CLM-5 (CD300 antigen-like family member D) (CMRF35-A4) (CD antigen CD300d)" CD300LD CD300D CMRF35A4 UNQ9218/PRO28686 Homo sapiens (Human) immune system process [GO:0002376] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; immune system process [GO:0002376] GO:0002376; GO:0004888; GO:0005886; GO:0016021 transmembrane signaling receptor activity [GO:0004888] CQGADWNYCNILVKTNGSEQEVKK 0.96068 0.55645 0 0 0 0 0 0 0 0 0 0 0 9.96737 0 0 11.3161 0 0 0 0 0 0 0 0 0 0 0 10.8097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3103 0 16.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1079 16.3718 0 0 0 0 0 0 0 0 0 0 0 13.7576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9142 0 0 0 0 0 0 0 0 0 15.2985 0 0 14.84 0 18.3829 0 0 0 0 0 14.7003 0 0 0 0 0 0 0 0 0 0 0 0 14.7094 0 0 14.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NDU8 RIMC1_HUMAN RAB7A-interacting MON1-CCZ1 complex subunit 1 (UPF0600 protein C5orf51) RIMOC1 C5orf51 Homo sapiens (Human) mitophagy [GO:0000423] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; mitophagy [GO:0000423] GO:0000423; GO:0005654; GO:0005829 GALLYMYCHSLTKR 0.96069 0.46069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8682 14.3331 0 0 0 0 0 0 0 0 0 P01569 IFNA5_HUMAN "Interferon alpha-5, IFN-alpha-5 (Interferon alpha-61) (Interferon alpha-G, LeIF G)" IFNA5 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005126; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132] ITLYLTEKK 0.96069 0.55604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3047 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY34 S15A3_HUMAN Solute carrier family 15 member 3 (Osteoclast transporter) (Peptide transporter 3) (Peptide/histidine transporter 2) SLC15A3 OCTP PHT2 PTR3 Homo sapiens (Human) dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; protein transport [GO:0015031] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647]; dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; protein transport [GO:0015031] GO:0005765; GO:0006811; GO:0010008; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016021; GO:0043231; GO:0045087; GO:0070434; GO:0071916; GO:0140206 dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647] AQGSSYTIPEAWLLLANVVVVLILVPLK 0.96069 0.22698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8517 0 0 0 13.1632 0 12.086 0 0 0 0 0 0 0 0 0 0 0 12.64 0 15.1968 0 0 0 11.7188 0 14.5263 13.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4083 12.9918 13.0279 0 0 0 0 0 0 0 0 0 12.846 0 0 0 0 13.0934 0 13.5223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9252 13.3127 0 13.1769 0 0 0 0 12.9792 0 0 0 0 0 0 0 0 0 0 0 0 13.3497 0 0 0 0 Q9Y442 CV024_HUMAN Putative uncharacterized protein YWHAH-AS1 (YWHAH antisense RNA 1) YWHAH-AS1 C22orf24 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 MTTQEDTTGLHQK 0.96071 0.38789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UH62 ARMX3_HUMAN "Armadillo repeat-containing X-linked protein 3 (ARM protein lost in epithelial cancers on chromosome X 3, Protein ALEX3)" ARMCX3 ALEX3 BM-017 UNQ2517/PRO6007 Homo sapiens (Human) axonal transport of mitochondrion [GO:0019896]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; nucleus [GO:0005634] axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; axonal transport of mitochondrion [GO:0019896]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104] GO:0005634; GO:0005739; GO:0005829; GO:0007005; GO:0008104; GO:0019896; GO:0031307; GO:0045944; GO:1904115 DIIRDLGGLPIVAK 0.96073 0.39588 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3996 0 13.3714 13.8412 13.2681 13.1874 0 14.0779 0 0 0 13.965 14.0532 0 0 13.5714 13.7866 0 0 14.4788 14.3097 11.8273 12.8215 0 0 0 0 0 15.2092 0 0 0 0 0 0 0 0 0 0 12.8139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5681 0 0 0 0 0 0 0 0 0 13.2645 0 0 0 11.1989 0 0 0 0 0 0 0 0 0 14.4738 11.898 13.1236 0 0 0 0 13.6951 0 0 12.051 11.0496 0 13.8646 0 0 12.6866 0 0 15.2359 0 15.4112 10.4482 12.5086 0 0 15.1632 15.3025 0 0 0 0 0 0 0 0 0 13.2786 0 0 0 0 13.5053 0 12.1551 0 0 0 0 0 0 0 0 0 11.5432 0 0 0 15.0499 0 14.7563 0 14.4286 14.4031 15.8823 14.8468 0 15.3459 15.046 0 0 0 0 0 0 0 0 0 0 14.9342 0 0 15.881 0 Q92947 GCDH_HUMAN "Glutaryl-CoA dehydrogenase, mitochondrial, GCD, EC 1.3.8.6" GCDH Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; tryptophan metabolic process [GO:0006568] GO:0000062; GO:0004361; GO:0005739; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660 fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361] AHYNSSNKSYTLNGTK 0.96074 0.45748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EH5 RL39L_HUMAN 60S ribosomal protein L39-like (60S ribosomal protein L39-2) (Large ribosomal subunit protein eL39-like) RPL39L RPL39L1 Homo sapiens (Human) spermatogenesis [GO:0007283]; translation [GO:0006412] cytosolic large ribosomal subunit [GO:0022625] cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; spermatogenesis [GO:0007283]; translation [GO:0006412] GO:0003735; GO:0006412; GO:0007283; GO:0022625 structural constituent of ribosome [GO:0003735] FLAKKQK 0.96074 0.24539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N205 SYNE4_HUMAN "Nesprin-4 (KASH domain-containing protein 4, KASH4) (Nuclear envelope spectrin repeat protein 4)" SYNE4 C19orf46 Homo sapiens (Human) establishment of epithelial cell apical/basal polarity [GO:0045198] integral component of nuclear outer membrane [GO:0031309]; meiotic nuclear membrane microtubule tethering complex [GO:0034993] integral component of nuclear outer membrane [GO:0031309]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; establishment of epithelial cell apical/basal polarity [GO:0045198] GO:0031309; GO:0034993; GO:0045198 HSLLRKPQDK 0.96076 0.25938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX94 WBP1L_HUMAN WW domain binding protein 1-like (Outcome predictor in acute leukemia 1) WBP1L C10orf26 OPA1L Homo sapiens (Human) CXCL12-activated CXCR4 signaling pathway [GO:0038160]; hemopoiesis [GO:0030097]; positive regulation of protein ubiquitination [GO:0031398] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; hemopoiesis [GO:0030097]; positive regulation of protein ubiquitination [GO:0031398] GO:0016021; GO:0030097; GO:0031398; GO:0031625; GO:0038160 ubiquitin protein ligase binding [GO:0031625] DDSSEHGAPDSK 0.96076 0.58864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76011 KRT34_HUMAN "Keratin, type I cuticular Ha4 (Hair keratin, type I Ha4) (Keratin-34, K34)" KRT34 HHA4 HKA4 KRTHA4 Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005615; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0030855; GO:0045109 structural molecule activity [GO:0005198] LASYLEKVRQLER 0.96078 3.2771 0 11.4915 0 0 0 0 0 0 0 14.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1724 0 0 0 0 0 0 0 0 0 0 14.2715 0 0 0 0 0 0 0 0 0 0 0 13.8846 0 0 0 0 0 0 0 0 0 0 11.006 0 14.0829 0 0 0 0 0 0 0 0 0 0 0 0 16.3 0 0 0 16.0231 13.6608 0 0 0 13.5628 0 0 0 0 0 0 0 0 12.0137 0 0 0 0 0 0 0 0 0 0 13.1057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9331 0 0 10.8593 0 0 0 0 0 0 0 0 0 11.4991 0 0 0 Q8WXQ8 CBPA5_HUMAN "Carboxypeptidase A5, EC 3.4.17.-" CPA5 Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0004181; GO:0005615; GO:0006508; GO:0008270 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] ALISIHSYSQMLMYPYGRLLEPVSNQRELYDLAK 0.96078 0.3913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8844 10.9221 0 0 0 16.046 15.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA50 CPTP_HUMAN "Ceramide-1-phosphate transfer protein, CPTP (Glycolipid transfer protein domain-containing protein 1, GLTP domain-containing protein 1)" CPTP GLTPD1 Homo sapiens (Human) ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; glycosphingolipid metabolic process [GO:0006687]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; phospholipid binding [GO:0005543]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; glycosphingolipid metabolic process [GO:0006687]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226] GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0006687; GO:0010008; GO:0010507; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389 ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; phospholipid binding [GO:0005543] LHRALHWLQLFLEGLR 0.96079 0.39119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A096LPI5 GVQW2_HUMAN Putative uncharacterized protein CCDC28A-AS1 (GVQW motif-containing protein 2) CCDC28A-AS1 GVQW2 Homo sapiens (Human) QFSCHSLPSSWDYRWNLTLSPR 0.9608 0.39106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MTJ3 GNAT3_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-3 (Gustducin alpha-3 chain) GNAT3 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to nicotine [GO:0035094]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; axoneme [GO:0005930]; heterotrimeric G-protein complex [GO:0005834]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; axoneme [GO:0005930]; heterotrimeric G-protein complex [GO:0005834]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to nicotine [GO:0035094]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] GO:0001580; GO:0001664; GO:0001669; GO:0001750; GO:0001917; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0005930; GO:0007188; GO:0016324; GO:0031683; GO:0032991; GO:0035094; GO:0046872; GO:0050916; GO:0050917 G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] EIYSHMTCATDTQNVKFVFDAVTDIIIKENLK 0.96081 0.34155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92561 PHYIP_HUMAN "Phytanoyl-CoA hydroxylase-interacting protein (Phytanoyl-CoA hydroxylase-associated protein 1, PAHX-AP1, PAHXAP1)" PHYHIP DYRK1AP3 KIAA0273 Homo sapiens (Human) protein localization [GO:0008104] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein tyrosine kinase binding [GO:1990782]; protein localization [GO:0008104] GO:0005737; GO:0008104; GO:1990782 protein tyrosine kinase binding [GO:1990782] ENKNSNKFK 0.96081 0.39106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6642 0 0 0 0 0 0 0 0 0 0 11.8033 12.2225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MY7 F161B_HUMAN Protein FAM161B FAM161B C14orf44 Homo sapiens (Human) cilium organization [GO:0044782] cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630] cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630]; cilium organization [GO:0044782] GO:0005881; GO:0015630; GO:0044782 AQRQGEEEAECHR 0.96081 0.24397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1156 0 0 14.3676 13.519 0 0 0 16.1867 0 0 0 0 13.5255 0 0 12.6853 0 0 0 0 0 0 0 0 0 0 12.705 0 0 0 0 0 0 0 0 13.4329 0 0 0 0 0 13.1663 0 0 13.8906 0 0 12.6012 11.338 13.8768 0 13.3676 0 0 13.5553 0 0 12.8899 13.7497 0 13.0604 0 13.8097 0 0 0 0 0 12.9559 0 0 0 0 0 0 13.0214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4481 0 0 0 12.4839 0 0 0 0 Q9NRJ3 CCL28_HUMAN "C-C motif chemokine 28 (Mucosae-associated epithelial chemokine, MEC) (Protein CCK1) (Small-inducible cytokine A28)" CCL28 SCYA28 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; cytolysis in another organism [GO:0051715]; immune response [GO:0006955]; killing of cells of another organism [GO:0031640]; negative regulation of leukocyte tethering or rolling [GO:1903237]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to nutrient [GO:0007584] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; cytolysis in another organism [GO:0051715]; immune response [GO:0006955]; killing of cells of another organism [GO:0031640]; negative regulation of leukocyte tethering or rolling [GO:1903237]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to nutrient [GO:0007584] GO:0001954; GO:0005576; GO:0005615; GO:0006935; GO:0006955; GO:0007204; GO:0007584; GO:0008009; GO:0031640; GO:0051715; GO:0060326; GO:0061844; GO:0070062; GO:1903237 chemokine activity [GO:0008009] RICVSPHNHTVK 0.96082 0.39045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6HA08 ASTL_HUMAN "Astacin-like metalloendopeptidase, EC 3.4.-.- (Oocyte astacin) (Ovastacin) (ZP2-proteinase)" ASTL Homo sapiens (Human) cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]; proteolysis [GO:0006508] cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cortical granule [GO:0060473]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell adhesion [GO:0007155]; fertilization [GO:0009566]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of protein processing [GO:0010954]; prevention of polyspermy [GO:0060468]; proteolysis [GO:0006508] GO:0004222; GO:0005737; GO:0005886; GO:0006508; GO:0007155; GO:0008270; GO:0009566; GO:0010954; GO:0060468; GO:0060473; GO:0070001; GO:0070002; GO:2000360 aspartic-type peptidase activity [GO:0070001]; glutamic-type peptidase activity [GO:0070002]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GLPTITPLWAPSVHIGQRWNLSASDITRVLK 0.96083 0.24084 0 0 0 0 0 0 0 0 0 0 0 11.9673 11.9131 0 0 0 0 0 0 0 0 0 0 11.2659 0 0 0 0 11.9913 0 0 0 0 0 0 0 0 0 0 10.5374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2825 0 0 0 12.2752 0 12.5402 0 12.1121 0 0 0 0 12.5499 0 0 0 12.6865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3986 0 0 12.3216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3I0 RTCB_HUMAN "RNA-splicing ligase RtcB homolog, EC 6.5.1.8 (3'-phosphate/5'-hydroxy nucleic acid ligase)" RTCB C22orf28 HSPC117 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0000971; GO:0001701; GO:0001890; GO:0003723; GO:0003972; GO:0005525; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006388; GO:0017166; GO:0043231; GO:0046872; GO:0072669 GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA ligase (ATP) activity [GO:0003972]; vinculin binding [GO:0017166] AIKLRPIAVIK 0.96083 0.19163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5066 0 0 0 0 0 12.8148 0 0 0 14.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2894 0 0 0 0 0 0 0 12.6774 0 0 0 0 0 0 0 12.9663 11.5676 0 0 0 13.2579 0 11.93 0 0 0 12.4354 11.2866 11.7482 13.6145 13.768 14.9954 0 0 10.6988 14.834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2481 12.823 0 13.055 0 0 0 0 0 P05937 CALB1_HUMAN "Calbindin (Calbindin D28) (D-28K) (Vitamin D-dependent calcium-binding protein, avian-type)" CALB1 CAB27 Homo sapiens (Human) cellular response to organic substance [GO:0071310]; cochlea development [GO:0090102]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; metanephric collecting duct development [GO:0072205]; metanephric connecting tubule development [GO:0072286]; metanephric distal convoluted tubule development [GO:0072221]; metanephric part of ureteric bud development [GO:0035502]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; retina layer formation [GO:0010842]; short-term memory [GO:0007614] axon [GO:0030424]; calyx of Held [GO:0044305]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; stereocilium [GO:0032420]; synapse [GO:0045202]; terminal bouton [GO:0043195] axon [GO:0030424]; calyx of Held [GO:0044305]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; stereocilium [GO:0032420]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099567]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; cellular response to organic substance [GO:0071310]; cochlea development [GO:0090102]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; metanephric collecting duct development [GO:0072205]; metanephric connecting tubule development [GO:0072286]; metanephric distal convoluted tubule development [GO:0072221]; metanephric part of ureteric bud development [GO:0035502]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; retina layer formation [GO:0010842]; short-term memory [GO:0007614] GO:0005499; GO:0005509; GO:0005634; GO:0005829; GO:0007614; GO:0007616; GO:0007626; GO:0008270; GO:0010842; GO:0030424; GO:0030425; GO:0032420; GO:0032437; GO:0035502; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0044305; GO:0045202; GO:0051480; GO:0070062; GO:0071310; GO:0072205; GO:0072221; GO:0072286; GO:0090102; GO:0098686; GO:0098978; GO:0098982; GO:0099509; GO:0099523; GO:0099524; GO:0099534; GO:0099567; GO:1900271 calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099567]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270] ANKTVDDTK 0.96085 0.3382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60510 PP4C_HUMAN "Serine/threonine-protein phosphatase 4 catalytic subunit, PP4C, Pp4, EC 3.1.3.16 (Protein phosphatase X, PP-X)" PPP4C PPP4 PPX Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine phosphatase activity [GO:0004722]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569] GO:0000724; GO:0000785; GO:0004704; GO:0004722; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0006470; GO:0010569; GO:0017018; GO:0030289; GO:0033128; GO:0046872; GO:2000779 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; NF-kappaB-inducing kinase activity [GO:0004704]; protein serine/threonine phosphatase activity [GO:0004722] RCELIKESEVK 0.96085 0.22714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12908 NTCP2_HUMAN "Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter, ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter, IBAT, ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)" SLC10A2 ASBT ISBT NTCP2 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721]; response to bacterium [GO:0009617] GO:0005886; GO:0005887; GO:0005902; GO:0008508; GO:0009617; GO:0015721; GO:0016324 bile acid:sodium symporter activity [GO:0008508] AKIILKIGSIAGAILIVLIAVVGGILYQSAWIIAPK 0.96086 0.26406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8422 11.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4414 17.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4007 0 0 0 0 0 0 0 0 16.6348 0 0 0 0 0 0 0 22.1822 14.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4961 0 0 19.912 0 0 12.0895 0 0 0 0 0 0 0 0 12.4586 0 0 0 0 0 11.7999 0 0 0 0 0 11.7917 11.7381 0 0 0 0 0 20.496 0 0 0 0 0 16.2095 0 Q0D2H9 GOG8D_HUMAN Putative golgin subfamily A member 8D GOLGA8DP GOLGA8D Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 EAMSGFMDHLEEK 0.96087 0.38789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2H0 CXXC4_HUMAN CXXC-type zinc finger protein 4 (Inhibition of the Dvl and axin complex protein) CXXC4 IDAX Homo sapiens (Human) negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]; zygotic specification of dorsal/ventral axis [GO:0007352] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; PDZ domain binding [GO:0030165]; zinc ion binding [GO:0008270]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]; zygotic specification of dorsal/ventral axis [GO:0007352] GO:0005634; GO:0005737; GO:0007352; GO:0008270; GO:0008327; GO:0016055; GO:0030165; GO:0030178; GO:0031410 methyl-CpG binding [GO:0008327]; PDZ domain binding [GO:0030165]; zinc ion binding [GO:0008270] LINCGVCSSCRNR 0.96087 0.55686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3291 0 0 0 0 0 0 0 0 0 0 11.8042 0 0 0 0 0 0 0 0 Q6ZVH6 YK004_HUMAN Putative uncharacterized protein FLJ42569 Homo sapiens (Human) MGPWPRDWLGK 0.9609 0.39596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43365 HXA3_HUMAN Homeobox protein Hox-A3 (Homeobox protein Hox-1E) HOXA3 HOX1E Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; anterior/posterior pattern specification [GO:0009952]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; embryonic skeletal system morphogenesis [GO:0048704]; gene expression [GO:0010467]; glossopharyngeal nerve morphogenesis [GO:0021615]; parathyroid gland development [GO:0060017]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ position [GO:0010159]; stem cell proliferation [GO:0072089]; thymus development [GO:0048538]; thyroid gland development [GO:0030878] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; anterior/posterior pattern specification [GO:0009952]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; embryonic skeletal system morphogenesis [GO:0048704]; gene expression [GO:0010467]; glossopharyngeal nerve morphogenesis [GO:0021615]; parathyroid gland development [GO:0060017]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ position [GO:0010159]; stem cell proliferation [GO:0072089]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]" GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001974; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0010159; GO:0010467; GO:0021615; GO:0030878; GO:0048538; GO:0048645; GO:0048704; GO:0051216; GO:0060017; GO:0071837; GO:0072089; GO:2000648 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" TAYTSAQLVELEKEFHFNR 0.96092 0.24468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4JDL3 PTN20_HUMAN "Tyrosine-protein phosphatase non-receptor type 20, hPTPN20, EC 3.1.3.48" PTPN20 PTPN20A PTPN20B Homo sapiens (Human) protein dephosphorylation [GO:0006470] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005654; GO:0005737; GO:0005874; GO:0006470; GO:0034451 protein tyrosine phosphatase activity [GO:0004725] HFRVFLENYQILQYFIIR 0.96092 0.45757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SQN1 SNP47_HUMAN "Synaptosomal-associated protein 47, SNAP-47 (Epididymis luminal protein 170) (Synaptosomal-associated 47 kDa protein)" SNAP47 C1orf142 HEL170 SVAP1 Homo sapiens (Human) exocytosis [GO:0006887]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906] endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201] endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906] GO:0005484; GO:0005886; GO:0006887; GO:0006906; GO:0012505; GO:0016082; GO:0019905; GO:0031201; GO:0031629; GO:0048471; GO:0098793 SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905] MPEVIPILEVQFSK 0.96093 0.24468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7924 0 0 0 0 0 0 0 14.9382 16.0372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95486 SC24A_HUMAN Protein transport protein Sec24A (SEC24-related protein A) SEC24A Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol transport [GO:0032374] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; cholesterol homeostasis [GO:0042632]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of protein secretion [GO:0050714]; regulation of cholesterol transport [GO:0032374] GO:0000149; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0032374; GO:0042632; GO:0050714; GO:0070971; GO:0090110 SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] AKLPLGLLLHPFK 0.96094 4.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.635 0 0 0 0 0 0 0 0 0 0 11.6683 0 0 14.2192 0 0 0 0 0 0 0 0 0 0 11.4937 0 11.5891 0 0 12.6609 0 0 0 0 0 0 0 0 14.3398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5329 0 0 0 0 0 0 0 0 0 0 13.5446 0 0 0 17.2906 0 16.9309 13.6361 0 0 0 0 16.6963 0 14.1973 15.9582 16.6213 13.814 14.6511 0 0 0 0 0 16.7739 14.7034 13.7009 14.8708 0 0 16.0885 0 14.1478 13.7662 0 12.7882 14.6963 13.9989 0 15.6883 14.6458 15.2971 14.6378 15.3507 0 15.4064 16.2083 13.6505 13.3329 12.4257 0 13.2398 14.6447 0 12.6865 14.5751 0 13.8238 0 0 0 14.8651 14.0311 13.0065 13.4075 14.2348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.529 12.2907 0 0 0 0 0 13.5142 15.1821 0 0 0 0 0 0 Q8NBB2 STAS1_HUMAN Putative uncharacterized protein ST20-AS1 (ST20 antisense RNA 1) (ST20 antisense gene protein 1) ST20-AS1 C15orf37 Homo sapiens (Human) PTRGILRDVLR 0.96094 0.25884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MG8 PCMD1_HUMAN Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 PCMTD1 Homo sapiens (Human) cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719] GO:0004719; GO:0005737; GO:0016020 protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719] GIPQRAPPKR 0.96095 0.25814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSC2 SALL1_HUMAN "Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1, HSal1, Sal-1)" SALL1 SAL1 ZNF794 Homo sapiens (Human) "adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]" chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; gonad development [GO:0008406]; heart development [GO:0007507]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]" GO:0000122; GO:0000792; GO:0000978; GO:0000981; GO:0001227; GO:0001657; GO:0001658; GO:0001822; GO:0003281; GO:0003337; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007507; GO:0008013; GO:0008406; GO:0010369; GO:0021553; GO:0021889; GO:0021983; GO:0030177; GO:0030325; GO:0031129; GO:0042733; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048566; GO:0060173; GO:0061034; GO:0072073; GO:0072092 "beta-catenin binding [GO:0008013]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CRFCAKVFGSDSALQIHLR 0.96095 3.6667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5255 0 0 0 16.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.613 0 12.1252 0 0 0 0 0 0 0 0 12.0211 0 0 13.5044 0 0 0 0 0 0 0 0 0 0 0 15.4859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7668 0 0 0 11.5283 0 0 16.3975 0 0 0 0 0 0 14.2466 0 0 0 11.572 0 0 0 10.763 0 0 0 0 0 0 0 0 0 0 Q53HV7 SMUG1_HUMAN "Single-strand selective monofunctional uracil DNA glycosylase, EC 3.2.2.-" SMUG1 Homo sapiens (Human) base-excision repair [GO:0006284]; depyrimidination [GO:0045008] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; identical protein binding [GO:0042802]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008] GO:0000703; GO:0001650; GO:0003677; GO:0004844; GO:0005654; GO:0005730; GO:0005829; GO:0006284; GO:0017065; GO:0019104; GO:0042802; GO:0045008 DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; identical protein binding [GO:0042802]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-strand selective uracil DNA N-glycosylase activity [GO:0017065]; uracil DNA N-glycosylase activity [GO:0004844] LNELGLLPLLLK 0.96096 0.58864 0 0 0 0 0 0 0 0 13.0986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99447 PCY2_HUMAN "Ethanolamine-phosphate cytidylyltransferase, EC 2.7.7.14 (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase)" PCYT2 Homo sapiens (Human) phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654] GO:0004306; GO:0005737; GO:0005789; GO:0006646; GO:0008654 ethanolamine-phosphate cytidylyltransferase activity [GO:0004306] AHHSSQEMSSEYR 0.96096 0.25672 0 0 0 0 0 0 0 0 0 14.0524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBB6 NCDN_HUMAN Neurochondrin NCDN KIAA0607 Homo sapiens (Human) bone resorption [GO:0045453]; neuron projection development [GO:0031175]; regulation of neuronal synaptic plasticity [GO:0048168] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynapse [GO:0098794] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; bone resorption [GO:0045453]; neuron projection development [GO:0031175]; regulation of neuronal synaptic plasticity [GO:0048168] GO:0005829; GO:0010008; GO:0016020; GO:0030425; GO:0031175; GO:0043025; GO:0043204; GO:0045453; GO:0048168; GO:0070161; GO:0098794 ILGSKLSSWQRNPALK 0.96096 0.3916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8296 0 11.9999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75792 RNH2A_HUMAN "Ribonuclease H2 subunit A, RNase H2 subunit A, EC 3.1.26.4 (Aicardi-Goutieres syndrome 4 protein, AGS4) (RNase H(35)) (Ribonuclease HI large subunit, RNase HI large subunit) (Ribonuclease HI subunit A)" RNASEH2A RNASEHI RNHIA Homo sapiens (Human) "DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]" GO:0003723; GO:0004523; GO:0004540; GO:0005654; GO:0005829; GO:0006260; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872 metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523] LQDLDTDYGSGYPNDPK 0.96097 0.24422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6606 0 0 0 0 0 0 0 0 13.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2622 0 0 0 Q8N1Q8 THEM5_HUMAN "Acyl-coenzyme A thioesterase THEM5, Acyl-CoA thioesterase THEM5, EC 3.1.2.2 (Acyl-coenzyme A thioesterase 15) (Thioesterase superfamily member 5)" THEM5 ACOT15 Homo sapiens (Human) cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA metabolic process [GO:0035336] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA metabolic process [GO:0035336] GO:0005759; GO:0006631; GO:0016290; GO:0035336; GO:0035965; GO:0102991 myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] IRRCFQVAAR 0.96097 0.26609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBB5 MBD2_HUMAN "Methyl-CpG-binding domain protein 2 (Demethylase, DMTase) (Methyl-CpG-binding protein MBD2)" MBD2 Homo sapiens (Human) "aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone deacetylation [GO:0016575]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone deacetylation [GO:0016575]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0000785; GO:0000792; GO:0003682; GO:0003696; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006346; GO:0007507; GO:0007568; GO:0008327; GO:0009612; GO:0016055; GO:0016575; GO:0016581; GO:0019904; GO:0030177; GO:0031667; GO:0032355; GO:0032991; GO:0035197; GO:0035563; GO:0042127; GO:0042711; GO:0044030; GO:0045892; GO:0045893; GO:0048568; GO:0065003; GO:0070742; GO:0071407 C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197] AHPGGGR 0.96097 0.25649 0 0 0 0 0 0 11.0964 0 0 0 0 0 0 0 9.34407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6304 0 0 0 0 0 0 0 0 0 12.8322 0 0 0 0 0 0 0 13.1311 11.8633 0 0 0 0 0 12.0938 0 13.348 13.6582 11.4922 0 0 0 12.5906 0 12.5593 0 11.3055 0 0 0 0 0 0 14.0599 0 0 12.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0285 13.5968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBY8 SGK2_HUMAN "Serine/threonine-protein kinase Sgk2, EC 2.7.11.1 (Serum/glucocorticoid-regulated kinase 2)" SGK2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; response to oxidative stress [GO:0006979] GO:0001558; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0006979; GO:0015459; GO:0017080; GO:0018105; GO:0032411; GO:0035556; GO:0042127; GO:0106310 ATP binding [GO:0005524]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080] NHVFFSPINWDDLYHKR 0.96099 0.34158 0 11.6455 0 0 11.2675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2831 18.3484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9551 0 0 0 0 0 0 0 18.4368 0 0 0 0 0 18.306 0 0 0 18.6654 13.5097 0 18.3274 0 18.2278 0 0 0 0 12.3361 0 0 12.5361 18.3331 0 0 0 12.2496 0 0 0 0 0 0 0 18.4349 18.3593 0 0 0 0 18.4632 0 0 0 0 0 18.6674 0 0 0 0 13.7181 0 0 0 13.7504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4354 0 P51531 SMCA2_HUMAN "Probable global transcription activator SNF2L2, EC 3.6.4.- (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B, BAF190B) (Protein brahma homolog, hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2)" SMARCA2 BAF190B BRM SNF2A SNF2L2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]" bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatid development [GO:0007286]" GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003682; GO:0003713; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0007286; GO:0007399; GO:0008094; GO:0008284; GO:0008285; GO:0016514; GO:0016887; GO:0030071; GO:0030308; GO:0035060; GO:0042393; GO:0043231; GO:0045111; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]" AKPVVSDFDSDEEQDEREQSEGSGTDDE 0.961 0.19031 0 0 0 0 0 0 0 0 14.4603 0 0 13.2835 0 0 0 14.1798 12.7535 0 0 0 0 0 0 12.8733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7021 0 0 0 11.9814 0 0 0 0 14.7941 0 0 11.9257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4804 0 10.8084 0 12.898 0 0 0 10.9012 13.6941 12.8389 0 0 11.9594 0 16.7879 0 0 0 0 0 0 10.7401 0 0 11.8631 0 0 16.6298 0 0 0 0 10.8666 0 0 0 0 14.2011 0 12.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3238 0 10.3395 0 0 11.8259 0 0 0 0 10.2336 12.6626 0 0 0 0 0 12.5581 0 0 0 0 0 0 13.1484 0 0 11.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.586 0 12.6513 0 11.1148 0 0 12.0922 0 0 0 0 12.0081 0 A0A1B0GUC4 MYCOS_HUMAN Myocilin opposite strand protein MYOCOS Homo sapiens (Human) AQKSLANNSINLPYK 0.96101 0.56122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5U2 TSSC4_HUMAN Protein TSSC4 (Tumor-suppressing STF cDNA 4 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 4 protein) TSSC4 Homo sapiens (Human) DIFDCLEGAAR 0.96101 0.38291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.842 10.3388 0 0 0 10.5911 0 0 0 0 0 0 0 11.0011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.283 0 0 0 0 0 0 0 13.5237 14.9278 0 0 0 0 0 0 0 0 0 15.6523 0 0 11.3753 12.154 0 0 0 11.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3793 0 0 0 0 0 11.1448 0 0 0 0 0 11.3726 0 0 0 0 0 0 0 10.7093 0 0 0 0 0 0 0 11.3131 0 0 0 0 0 0 P02776 PLF4_HUMAN "Platelet factor 4, PF-4 (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Cleaved into: Platelet factor 4, short form (Endothelial cell growth inhibitor) ]" PF4 CXCL4 SCYB4 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; inflammatory response [GO:0006954]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; leukocyte chemotaxis [GO:0030595]; negative regulation of angiogenesis [GO:0016525]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of MHC class II biosynthetic process [GO:0045347]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; heparin binding [GO:0008201]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; inflammatory response [GO:0006954]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; leukocyte chemotaxis [GO:0030595]; negative regulation of angiogenesis [GO:0016525]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of MHC class II biosynthetic process [GO:0045347]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127] GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0007189; GO:0008009; GO:0008201; GO:0010628; GO:0010744; GO:0016525; GO:0019221; GO:0030168; GO:0030593; GO:0030595; GO:0031093; GO:0031640; GO:0032760; GO:0042127; GO:0042832; GO:0045236; GO:0045347; GO:0045651; GO:0045653; GO:0045944; GO:0048248; GO:0051873; GO:0061844; GO:0062023; GO:0070098; GO:0071222; GO:2001240 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; heparin binding [GO:0008201] HITSLEVIKAGPHCPTAQLIATLK 0.96102 0.22722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P499 NPAL3_HUMAN NIPA-like protein 3 NIPAL3 NPAL3 Homo sapiens (Human) magnesium ion transport [GO:0015693] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693] GO:0015095; GO:0015693; GO:0016020; GO:0016021 magnesium ion transmembrane transporter activity [GO:0015095] DPRAYFKTK 0.96102 0.33861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.626 0 0 0 0 0 0 0 0 11.9105 11.1675 0 0 0 0 0 0 0 0 0 12.9393 0 0 0 13.8954 0 14.3317 0 0 13.2935 0 0 0 0 16.2832 0 0 0 0 16.6865 0 0 0 0 0 14.1342 0 0 0 0 15.1057 0 13.3343 13.9131 0 0 14.9838 15.873 14.982 0 0 0 0 14.475 0 0 0 0 0 0 13.7989 0 0 0 0 0 0 12.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2631 14.7428 0 0 0 0 0 0 Q9H9V4 RN122_HUMAN RING finger protein 122 RNF122 Homo sapiens (Human) negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865] GO:0005737; GO:0005783; GO:0005794; GO:0010917; GO:0012505; GO:0016021; GO:0043065; GO:0043161; GO:0046872; GO:0051865; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LQLYGQTCAVCLEDFK 0.96102 0.26413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3417 0 13.4927 13.3555 0 0 0 0 0 14.0394 0 0 0 14.4455 0 0 0 0 0 0 0 0 0 0 0 0 13.5915 0 0 0 0 0 0 0 0 0 0 0 12.7459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0U1RRK4 LBHD2_HUMAN LBH domain-containing protein 2 LBHD2 Homo sapiens (Human) PAPPQPGAAEGAGGPEGKAVAGAWEK 0.96104 0.38122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1279 11.7731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1094 0 0 0 0 0 0 0 0 0 0 P0DN25 C1C1L_HUMAN C1GALT1-specific chaperone 1-like protein C1GALT1C1L Homo sapiens (Human) "O-glycan processing, core 1 [GO:0016267]" integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; O-glycan processing, core 1 [GO:0016267]" GO:0016021; GO:0016263; GO:0016267 glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263] VILLELSKSIR 0.96104 0.38837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q30KP8 DB136_HUMAN Defensin beta 136 (Beta-defensin 136) (DEFB137) DEFB136 Homo sapiens (Human) antibacterial innate immune response [GO:0140367]; antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830] extracellular region [GO:0005576] extracellular region [GO:0005576]; lipopolysaccharide binding [GO:0001530]; antibacterial innate immune response [GO:0140367]; antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830] GO:0001530; GO:0005576; GO:0050829; GO:0050830; GO:0061760; GO:0140367 lipopolysaccharide binding [GO:0001530] WIAFCHNILSCCK 0.96104 0.38789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UY11 DLK2_HUMAN "Protein delta homolog 2, DLK-2 (Epidermal growth factor-like protein 9, EGF-like protein 9)" DLK2 EGFL9 UNQ2903/PRO28633 Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; regulation of fat cell differentiation [GO:0045598] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; negative regulation of Notch signaling pathway [GO:0045746]; regulation of fat cell differentiation [GO:0045598] GO:0005112; GO:0005509; GO:0016021; GO:0042802; GO:0045598; GO:0045746 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; Notch binding [GO:0005112] ADDCSSHCDLAHGCCAPDGSCR 0.96104 2.9598 0 0 0 0 0 0 0 0 0 9.94339 0 11.3982 0 0 0 0 10.5161 0 0 0 0 0 10.3267 0 0 0 0 0 0 11.3899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9612 0 0 0 11.3594 0 0 0 0 16.2493 0 0 11.1988 0 0 13.8234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0665 0 0 0 10.4814 0 0 12.8226 0 0 0 0 0 0 0 11.4024 11.8129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0708 0 0 0 9.97513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5504 0 0 0 0 0 0 11.3655 11.78 0 0 0 11.3375 0 0 Q86SS6 SYT9_HUMAN "Synaptotagmin-9 (Synaptotagmin IX, SytIX)" SYT9 Homo sapiens (Human) calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "anchoring junction [GO:0070161]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of insulin secretion [GO:0050796]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030285; GO:0030667; GO:0030669; GO:0031045; GO:0042802; GO:0045956; GO:0050796; GO:0070161; GO:0070382; GO:0071277; GO:0098686; GO:0099502 "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" IHKAVNLPAK 0.96104 0.50286 0 0 0 0 0 0 0 0 0 0 0 15.137 0 0 14.8712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6128 0 0 14.5029 0 0 0 0 16.3519 0 0 0 0 17.4138 0 0 0 0 0 0 0 0 0 17.0199 17.0804 16.2254 0 0 0 15.9648 16.8525 0 0 15.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4782 0 0 0 0 0 0 0 0 0 O60635 TSN1_HUMAN "Tetraspanin-1, Tspan-1 (Tetraspan NET-1) (Tetraspanin TM4-C)" TSPAN1 Homo sapiens (Human) protein stabilization [GO:0050821] cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; protein stabilization [GO:0050821] GO:0005654; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0016020; GO:0030054; GO:0031982; GO:0043231; GO:0048471; GO:0050821; GO:0070062 ENSAFPPFCCNDNVTNTANETCTKQK 0.96105 0.38122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09972 ALDOC_HUMAN "Fructose-bisphosphate aldolase C, EC 4.1.2.13 (Brain-type aldolase)" ALDOC ALDC Homo sapiens (Human) "epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]" cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332]; epithelial cell differentiation [GO:0030855]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]" GO:0004332; GO:0005576; GO:0005829; GO:0005856; GO:0006000; GO:0006094; GO:0006096; GO:0008092; GO:0030388; GO:0030855; GO:0034774; GO:0070062; GO:1904724; GO:1904813 cytoskeletal protein binding [GO:0008092]; fructose-bisphosphate aldolase activity [GO:0004332] ELSDIALRIVAPGK 0.96105 0.28034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8007 0 0 0 0 0 0 0 0 P19622 HME2_HUMAN "Homeobox protein engrailed-2, Homeobox protein en-2, Hu-En-2" EN2 Homo sapiens (Human) dopaminergic neuron differentiation [GO:0071542]; embryonic brain development [GO:1990403]; hindbrain development [GO:0030902]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; dopaminergic neuron differentiation [GO:0071542]; embryonic brain development [GO:1990403]; hindbrain development [GO:0030902]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016020; GO:0030182; GO:0030901; GO:0030902; GO:0043524; GO:0045944; GO:0048666; GO:0071542; GO:1990403; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DAGTCCAGAGGGR 0.96105 0.38789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49768 PSN1_HUMAN "Presenilin-1, PS-1, EC 3.4.23.- (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12, PS1-CTF12 ]" PSEN1 AD3 PS1 PSNL1 Homo sapiens (Human) "amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; autophagosome assembly [GO:0000045]; blood vessel development [GO:0001568]; brain morphogenesis [GO:0048854]; Cajal-Retzius cell differentiation [GO:0021870]; calcium ion transport [GO:0006816]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum development [GO:0021549]; cerebral cortex cell migration [GO:0021795]; choline transport [GO:0015871]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic limb morphogenesis [GO:0030326]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; L-glutamate import across plasma membrane [GO:0098712]; learning or memory [GO:0007611]; locomotion [GO:0040011]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; memory [GO:0007613]; mitochondrial transport [GO:0006839]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of axonogenesis [GO:0050771]; negative regulation of core promoter binding [GO:1904797]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural retina development [GO:0003407]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron development [GO:0048666]; neuron migration [GO:0001764]; neuron projection maintenance [GO:1990535]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of coagulation [GO:0050820]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor recycling [GO:0001921]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; post-embryonic development [GO:0009791]; protein glycosylation [GO:0006486]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of gene expression [GO:0010468]; regulation of neuron projection development [GO:0010975]; regulation of phosphorylation [GO:0042325]; regulation of resting membrane potential [GO:0060075]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to oxidative stress [GO:0006979]; sequestering of calcium ion [GO:0051208]; skeletal system morphogenesis [GO:0048705]; skin morphogenesis [GO:0043589]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; somitogenesis [GO:0001756]; synapse organization [GO:0050808]; synaptic vesicle targeting [GO:0016080]; T cell activation involved in immune response [GO:0002286]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]" aggresome [GO:0016235]; anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; Z disc [GO:0030018] "aggresome [GO:0016235]; anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; Z disc [GO:0030018]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; aspartic-type endopeptidase activity [GO:0004190]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; endopeptidase activity [GO:0004175]; growth factor receptor binding [GO:0070851]; PDZ domain binding [GO:0030165]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; autophagosome assembly [GO:0000045]; blood vessel development [GO:0001568]; brain morphogenesis [GO:0048854]; Cajal-Retzius cell differentiation [GO:0021870]; calcium ion transport [GO:0006816]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum development [GO:0021549]; cerebral cortex cell migration [GO:0021795]; choline transport [GO:0015871]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic limb morphogenesis [GO:0030326]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; L-glutamate import across plasma membrane [GO:0098712]; learning or memory [GO:0007611]; locomotion [GO:0040011]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; memory [GO:0007613]; mitochondrial transport [GO:0006839]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of axonogenesis [GO:0050771]; negative regulation of core promoter binding [GO:1904797]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural retina development [GO:0003407]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron development [GO:0048666]; neuron migration [GO:0001764]; neuron projection maintenance [GO:1990535]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of coagulation [GO:0050820]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor recycling [GO:0001921]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; post-embryonic development [GO:0009791]; protein glycosylation [GO:0006486]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of gene expression [GO:0010468]; regulation of neuron projection development [GO:0010975]; regulation of phosphorylation [GO:0042325]; regulation of resting membrane potential [GO:0060075]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to oxidative stress [GO:0006979]; sequestering of calcium ion [GO:0051208]; skeletal system morphogenesis [GO:0048705]; skin morphogenesis [GO:0043589]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; somitogenesis [GO:0001756]; synapse organization [GO:0050808]; synaptic vesicle targeting [GO:0016080]; T cell activation involved in immune response [GO:0002286]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]" GO:0000045; GO:0000122; GO:0000139; GO:0000776; GO:0001568; GO:0001708; GO:0001756; GO:0001764; GO:0001921; GO:0001947; GO:0002038; GO:0002244; GO:0002265; GO:0002286; GO:0003407; GO:0004175; GO:0004190; GO:0005262; GO:0005634; GO:0005640; GO:0005654; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005789; GO:0005790; GO:0005791; GO:0005794; GO:0005813; GO:0005886; GO:0005887; GO:0005938; GO:0006486; GO:0006509; GO:0006816; GO:0006839; GO:0006974; GO:0006979; GO:0007175; GO:0007219; GO:0007220; GO:0007611; GO:0007613; GO:0008013; GO:0008021; GO:0009791; GO:0009986; GO:0010468; GO:0010628; GO:0010629; GO:0010975; GO:0015031; GO:0015871; GO:0016020; GO:0016021; GO:0016080; GO:0016235; GO:0016324; GO:0016485; GO:0021549; GO:0021795; GO:0021870; GO:0021904; GO:0030018; GO:0030054; GO:0030165; GO:0030326; GO:0030426; GO:0031293; GO:0031594; GO:0031901; GO:0031965; GO:0032092; GO:0032436; GO:0032469; GO:0032760; GO:0032991; GO:0034205; GO:0035253; GO:0035556; GO:0035577; GO:0040011; GO:0042307; GO:0042325; GO:0042327; GO:0042383; GO:0042500; GO:0042982; GO:0042987; GO:0043005; GO:0043011; GO:0043025; GO:0043065; GO:0043066; GO:0043085; GO:0043198; GO:0043406; GO:0043524; GO:0043589; GO:0045121; GO:0045296; GO:0045821; GO:0045893; GO:0048143; GO:0048167; GO:0048471; GO:0048538; GO:0048666; GO:0048705; GO:0048854; GO:0050435; GO:0050673; GO:0050771; GO:0050808; GO:0050820; GO:0050852; GO:0051117; GO:0051208; GO:0051402; GO:0051444; GO:0051563; GO:0051966; GO:0060075; GO:0060828; GO:0060999; GO:0070050; GO:0070161; GO:0070765; GO:0070851; GO:0097190; GO:0098609; GO:0098712; GO:0099056; GO:1904646; GO:1904797; GO:1905908; GO:1990535; GO:2000059; GO:2001234 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; aspartic-type endopeptidase activity [GO:0004190]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; endopeptidase activity [GO:0004175]; growth factor receptor binding [GO:0070851]; PDZ domain binding [GO:0030165]" ALHSILNAAIMISVIVVMTILLVVLYKYR 0.96105 0.50196 0 0 0 0 0 0 0 0 0 0 0 0 13.0974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8085 0 0 0 0 0 0 0 0 0 0 0 11.9198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8336 0 0 0 0 0 0 0 0 0 0 0 0 13.4733 10.8133 0 0 0 11.9113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.216 0 0 0 0 0 0 0 0 10.3785 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ74 PSG8_HUMAN "Pregnancy-specific beta-1-glycoprotein 8, PS-beta-G-8, PSBG-8, Pregnancy-specific glycoprotein 8" PSG8 Homo sapiens (Human) regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] GO:0002682; GO:0005576; GO:0005886; GO:0007165; GO:0009986; GO:1990782 protein tyrosine kinase binding [GO:1990782] GLLLTASLLNFWNPPTTAQVTIEAQPTKVSEGK 0.96106 0.23752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IEV9 OR4CB_HUMAN Olfactory receptor 4C11 (Olfactory receptor OR11-136) OR4C11 OR4C11P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IITYNECMTQVFALHLFGCMEIFVLILMAVDRYVAICK 0.96107 0.24586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92913 FGF13_HUMAN "Fibroblast growth factor 13, FGF-13 (Fibroblast growth factor homologous factor 2, FHF-2)" FGF13 FHF2 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814] GO:0000165; GO:0001764; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006814; GO:0007026; GO:0007165; GO:0007267; GO:0007399; GO:0007612; GO:0007613; GO:0008017; GO:0008083; GO:0014704; GO:0016328; GO:0017080; GO:0021766; GO:0021795; GO:0030175; GO:0030295; GO:0030424; GO:0030425; GO:0030426; GO:0042383; GO:0043005; GO:0044325; GO:0045200; GO:0046785; GO:0048487; GO:0048671; GO:0072659; GO:0098909; GO:1904862; GO:1905150 beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] LYLAMNSEGYLYTSELFTPECKFK 0.96107 0.55698 0 0 0 0 0 0 0 0 12.2309 0 0 0 11.2766 0 0 0 0 13.5729 0 13.4849 12.8638 0 13.0027 0 14.3074 0 0 13.69 0 0 0 13.3443 11.8588 0 11.7346 0 12.1087 0 0 11.7971 12.8733 0 11.4674 0 11.8318 13.0607 0 12.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8625 0 0 0 0 0 0 0 0 0 0 0 0 13.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7887 0 12.5029 0 13.0113 0 0 0 0 0 0 0 0 0 0 13.3509 0 0 A0A0B4J244 TVA3_HUMAN T cell receptor alpha variable 3 TRAV3 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 GLQFLLKYITGDNLVK 0.96108 0.49961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0D9SF12 CC163_HUMAN Transmembrane protein CCDC163 (Coiled-coil domain-containing protein 163) (coiled-coil domain containing 163 pseudogene) CCDC163 C1orf231 CCDC163P Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 QAQVGSWKIPR 0.96108 0.39596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6882 0 0 0 0 0 0 0 0 0 0 12.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969W8 ZN566_HUMAN Zinc finger protein 566 ZNF566 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AQESVMFSDVSVDFSQEEWECLNDDQRDLYR 0.96109 0.45998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1481 11.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAV5 TNR27_HUMAN "Tumor necrosis factor receptor superfamily member 27 (X-linked ectodysplasin-A2 receptor, EDA-A2 receptor)" EDA2R TNFRSF27 XEDAR UNQ2448/PRO5727/PRO34080 Homo sapiens (Human) ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031]; ectodermal cell differentiation [GO:0010668]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] GO:0005031; GO:0005886; GO:0005887; GO:0008544; GO:0010668; GO:0016021; GO:0038023; GO:0043123; GO:0046330; GO:0051092; GO:0072332 signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031] DCQENEYWDQWGR 0.96109 0.4982 0 0 0 0 0 0 0 0 0 0 0 10.1772 0 0 0 0 11.9143 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1779 0 0 0 0 0 0 12.1597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5137 0 0 0 12.532 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4943 18.2061 16.3559 17.6996 14.9711 14.6479 14.5555 18.061 18.0637 0 16.5335 17.6417 13.5984 0 0 0 0 15.261 13.1547 14.4432 0 0 0 0 0 0 17.5153 12.7955 0 0 0 12.3771 0 0 0 12.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 12.168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8719 0 0 0 0 0 11.8397 0 14.4086 0 0 0 0 Q9NWZ3 IRAK4_HUMAN "Interleukin-1 receptor-associated kinase 4, IRAK-4, EC 2.7.11.1 (Renal carcinoma antigen NY-REN-64)" IRAK4 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein phosphorylation [GO:0006468]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein phosphorylation [GO:0006468]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224] GO:0000287; GO:0002224; GO:0002446; GO:0002755; GO:0004674; GO:0005149; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0010008; GO:0019221; GO:0019901; GO:0034162; GO:0035556; GO:0043123; GO:0045087; GO:0048661; GO:0070498; GO:0106310; GO:1990266 ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EEIEDEEKTIEDYIDK 0.9611 0.45867 0 0 0 0 0 0 0 0 14.4477 15.0298 14.8833 15.6053 11.4782 15.3129 14.8712 17.8564 12.5378 0 12.334 12.3509 12.5652 0 0 0 0 0 12.3387 0 12.2034 0 16.8216 16.4767 16.6597 14.8737 14.6092 14.8591 14.8934 15.198 12.5573 16.1978 16.3519 16.2178 16.5601 16.6301 16.711 17.4138 17.1953 17.1535 14.4216 14.2832 14.299 0 0 15.7242 0 17.0199 18.8604 18.56 18.2911 18.0051 19.3124 19.8328 19.958 18.7106 18.8221 18.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2376 0 0 0 0 0 0 0 0 0 0 12.7909 0 0 0 0 13.5344 0 0 0 0 0 0 0 0 15.0151 0 0 0 0 0 0 0 0 0 0 0 11.8388 0 0 0 0 0 0 0 0 0 0 11.7095 0 0 0 0 0 0 0 0 0 0 12.1775 10.6206 14.183 0 0 0 0 0 0 0 0 19.7012 19.3996 18.7695 17.7528 18.3811 17.1667 14.8583 14.0579 15.8675 15.9319 18.3092 16.1002 17.9836 17.7195 17.5205 0 0 0 0 14.5549 0 13.7936 0 0 Q9UJX0 OSGI1_HUMAN "Oxidative stress-induced growth inhibitor 1 (Bone marrow stromal cell-derived growth inhibitor, BMSC-derived growth inhibitor) (Ovary, kidney and liver protein 38, huOKL38) (Pregnancy-induced growth inhibitor OKL38)" OSGIN1 BDGI OKL38 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127] growth factor activity [GO:0008083]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127] GO:0008083; GO:0030154; GO:0030308; GO:0030334; GO:0042127; GO:0042981; GO:0043065 growth factor activity [GO:0008083] SQSPVALLFDALLR 0.9611 0.24468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01854 IGHE_HUMAN Immunoglobulin heavy constant epsilon (Ig epsilon chain C region) (Ig epsilon chain C region ND) IGHE Homo sapiens (Human) "adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgE immunoglobulin complex [GO:0071742]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgE immunoglobulin complex [GO:0071742]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0071742 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] DWIEGETYQCRVTHPHLPR 0.96111 0.26764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XJ0 CAHM3_HUMAN Calcium homeostasis modulator protein 3 (Protein A) CALHM3 FAM26A Homo sapiens (Human) ATP transport [GO:0015867]; protein heterooligomerization [GO:0051291]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; voltage-gated ion channel activity [GO:0005244]; ATP transport [GO:0015867]; protein heterooligomerization [GO:0051291]; response to stimulus [GO:0050896]; sensory perception of taste [GO:0050909] GO:0005244; GO:0005261; GO:0005887; GO:0015867; GO:0016323; GO:0050896; GO:0050909; GO:0051291 cation channel activity [GO:0005261]; voltage-gated ion channel activity [GO:0005244] APTLALGTR 0.96111 0.45827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0866 0 12.9638 0 0 0 12.8007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5K5 UCHL5_HUMAN "Ubiquitin carboxyl-terminal hydrolase isozyme L5, UCH-L5, EC 3.4.19.12 (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5)" UCHL5 UCH37 AD-019 CGI-70 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA repair [GO:0045739]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of proteasomal protein catabolic process [GO:0061136]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA repair [GO:0045739]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of proteasomal protein catabolic process [GO:0061136]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000723; GO:0003723; GO:0004843; GO:0004866; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006511; GO:0016579; GO:0021670; GO:0030901; GO:0031011; GO:0031597; GO:0032435; GO:0033044; GO:0045739; GO:0045880; GO:0045893; GO:0045995; GO:0048853; GO:0051726; GO:0060382; GO:0061136; GO:0070628; GO:1904507 cysteine-type deubiquitinase activity [GO:0004843]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723] TLAEHQQLIPLVEK 0.96112 0.26764 12.3442 0 0 0 0 0 0 0 0 0 0 0 0 13.7787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75791 GRAP2_HUMAN "GRB2-related adapter protein 2 (Adapter protein GRID) (GRB-2-like protein, GRB2L) (GRBLG) (GRBX) (Grf40 adapter protein, Grf-40) (Growth factor receptor-binding protein) (Hematopoietic cell-associated adapter protein GrpL) (P38) (Protein GADS) (SH3-SH2-SH3 adapter Mona)" GRAP2 GADS GRB2L GRID Homo sapiens (Human) cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] GO:0001784; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007267; GO:0043408 phosphotyrosine residue binding [GO:0001784] AELGSQEGYVPKNFIDIQFPKWFHEGLSR 0.96113 0.39172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46020 KPB1_HUMAN "Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform, Phosphorylase kinase alpha M subunit" PHKA1 PHKA Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977] GO:0004689; GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005977; GO:0006091 calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689] LAPTSQK 0.96113 0.2445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6824 0 0 0 0 0 0 0 0 0 0 17.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75030 MITF_HUMAN "Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32, bHLHe32)" MITF BHLHE32 Homo sapiens (Human) "bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; cell fate commitment [GO:0045165]; melanocyte apoptotic process [GO:1902362]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; cell fate commitment [GO:0045165]; melanocyte apoptotic process [GO:1902362]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0010628; GO:0016055; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0043066; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:1902362; GO:2000144; GO:2001141 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ELGTLIPK 0.96114 0.49452 12.7192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2784 0 0 0 0 19.5707 0 0 0 0 0 0 0 0 0 0 0 13.3072 13.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7068 0 13.1825 0 0 0 0 0 0 0 0 11.8523 0 0 0 0 0 0 0 0 0 0 0 0 11.9865 0 0 0 11.6477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH40 OR6S1_HUMAN Olfactory receptor 6S1 (Olfactory receptor OR14-37) OR6S1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LACTNTK 0.96114 0.24439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2716 0 0 0 13.0757 14.3635 14.1989 0 0 0 0 0 0 0 0 0 0 0 0 14.4644 14.0349 0 0 0 0 0 0 0 14.5077 14.7914 13.5383 0 0 0 13.1257 0 0 0 0 0 0 0 14.9465 0 14.7279 0 0 14.3963 0 0 0 13.5313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.117 0 0 0 0 0 0 12.6594 0 0 0 13.7042 0 13.9732 14.6134 14.5445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKB5 AJAP1_HUMAN Adherens junction-associated protein 1 (Membrane protein shrew-1) AJAP1 MOT8 SHREW1 Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of wound healing [GO:0061045]; regulation of polarized epithelial cell differentiation [GO:0030860] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; cytoplasmic side of plasma membrane [GO:0009898]; spanning component of plasma membrane [GO:0044214] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; cytoplasmic side of plasma membrane [GO:0009898]; spanning component of plasma membrane [GO:0044214]; beta-catenin binding [GO:0008013]; protein-containing complex binding [GO:0044877]; cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of wound healing [GO:0061045]; regulation of polarized epithelial cell differentiation [GO:0030860] GO:0001953; GO:0005912; GO:0007155; GO:0008013; GO:0009898; GO:0009986; GO:0016323; GO:0016324; GO:0030860; GO:0044214; GO:0044291; GO:0044877; GO:0061045 beta-catenin binding [GO:0008013]; protein-containing complex binding [GO:0044877] DQAAALVPKAGLAKPPAAAK 0.96114 0.26645 0 0 0 0 0 0 0 0 11.967 0 0 0 0 0 0 0 11.6541 0 0 11.4779 0 0 0 0 0 0 0 0 11.7397 0 0 0 0 0 0 0 0 0 0 0 0 11.6125 0 11.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8567 0 0 0 12.6059 0 0 0 0 12.6298 0 11.5137 12.6754 0 0 0 0 12.4999 0 0 0 0 0 0 0 0 0 0 0 0 11.6131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0561 0 0 0 0 0 0 12.0947 0 0 0 0 0 0 0 0 0 0 12.5989 0 0 12.5558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3778 0 0 0 0 0 0 0 0 0 0 0 0 Q15744 CEBPE_HUMAN "CCAAT/enhancer-binding protein epsilon, C/EBP epsilon" CEBPE Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; granulocyte differentiation [GO:0030851]; integrated stress response signaling [GO:0140467]; macrophage differentiation [GO:0030225]; myeloid cell differentiation [GO:0030099]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; granulocyte differentiation [GO:0030851]; integrated stress response signaling [GO:0140467]; macrophage differentiation [GO:0030225]; myeloid cell differentiation [GO:0030099]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0006909; GO:0006952; GO:0010628; GO:0030099; GO:0030225; GO:0030851; GO:0042802; GO:0044877; GO:0045944; GO:0071222; GO:0090575; GO:0140467; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" MSHGTYYECEPR 0.96115 0.58864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L1I2 SV2B_HUMAN Synaptic vesicle glycoprotein 2B SV2B KIAA0735 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] acrosomal vesicle [GO:0001669]; anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] GO:0001669; GO:0005886; GO:0006836; GO:0007268; GO:0008021; GO:0016020; GO:0016021; GO:0022857; GO:0030672; GO:0043005; GO:0070161 transmembrane transporter activity [GO:0022857] FGAILGNTIFASFVGITKVVPILLAAASLVGGGLIALRLPETR 0.96115 0.25595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4945 14.2938 0 0 0 0 14.0578 0 0 0 0 0 0 11.312 0 11.4958 0 0 0 0 10.0178 10.4428 0 14.7554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9377 11.4334 0 10.6294 0 0 0 0 0 15.0925 0 14.4026 14.6694 12.4817 0 12.6947 16.2402 16.2633 16.0108 15.5188 15.5798 0 16.0477 16.0556 14.3782 16.3143 16.1178 15.5896 15.385 15.7789 15.4806 13.8114 0 13.8385 14.2868 0 13.894 0 14.9134 15.0007 13.263 0 0 0 0 0 14.6465 13.554 12.9884 0 14.1794 0 0 14.068 0 12.8487 12.9273 14.1916 13.7487 0 12.8778 13.0707 13.9739 13.7388 12.9885 0 0 0 0 0 0 14.2795 0 0 0 0 0 12.7737 0 0 0 12.9182 13.2307 0 0 12.4726 0 0 0 12.8604 0 13.4422 0 0 0 0 0 0 0 0 0 13.5398 12.0955 0 0 0 0 0 0 0 0 0 15.4509 0 Q969E8 TSR2_HUMAN Pre-rRNA-processing protein TSR2 homolog TSR2 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" nucleus [GO:0005634] "nucleus [GO:0005634]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0005634 KCKVTATALK 0.96115 0.26505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY42 CD019_HUMAN Uncharacterized protein C4orf19 C4orf19 Homo sapiens (Human) cell junction [GO:0030054]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; nucleoplasm [GO:0005654] GO:0005654; GO:0030054 KTESSSR 0.96116 0.26464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4784 0 0 0 0 Q13133 NR1H3_HUMAN Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3) NR1H3 LXRA Homo sapiens (Human) "apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage activation [GO:0043031]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of circadian rhythm [GO:0042752]; response to progesterone [GO:0032570]; sterol homeostasis [GO:0055092]; triglyceride homeostasis [GO:0070328]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; cholesterol binding [GO:0015485]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sterol response element binding [GO:0032810]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage activation [GO:0043031]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of circadian rhythm [GO:0042752]; response to progesterone [GO:0032570]; sterol homeostasis [GO:0055092]; triglyceride homeostasis [GO:0070328]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0009755; GO:0010745; GO:0010867; GO:0010875; GO:0010887; GO:0015485; GO:0030154; GO:0031490; GO:0032369; GO:0032376; GO:0032411; GO:0032570; GO:0032810; GO:0034145; GO:0036151; GO:0042632; GO:0042752; GO:0042789; GO:0043031; GO:0043235; GO:0043277; GO:0045723; GO:0045861; GO:0045893; GO:0045944; GO:0048550; GO:0050728; GO:0051006; GO:0051247; GO:0055088; GO:0055092; GO:0060336; GO:0070328; GO:0071222; GO:0090188; GO:0090341; GO:0090575; GO:0120163; GO:1903573 "cholesterol binding [GO:0015485]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sterol response element binding [GO:0032810]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" DFSYNREDFAKAGLQVEFINPIFEFSR 0.96117 3.263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9046 0 0 11.6258 0 0 0 0 12.1155 0 0 0 0 0 0 0 0 0 0 12.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NKD9 CC85C_HUMAN Coiled-coil domain-containing protein 85C CCDC85C Homo sapiens (Human) cerebral cortex development [GO:0021987] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; bicellular tight junction [GO:0005923] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; bicellular tight junction [GO:0005923]; cerebral cortex development [GO:0021987] GO:0005912; GO:0005923; GO:0021987; GO:0043296 LAREWQRFGR 0.96118 0.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4381 0 0 0 13.0466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58170 OR1D5_HUMAN "Olfactory receptor 1D5 (Olfactory receptor 17-31, OR17-31)" OR1D5 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] MLVNFQSQNK 0.96118 0.26447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9715 13.2254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59998 ARPC4_HUMAN "Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit, p20-ARC)" ARPC4 ARC20 Homo sapiens (Human) actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833] Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833] GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005885; GO:0019899; GO:0030041; GO:0030833; GO:0034314; GO:0035861; GO:0042995; GO:0045010; GO:0070062 actin binding [GO:0003779]; enzyme binding [GO:0019899]; structural constituent of cytoskeleton [GO:0005200] AENFFILRR 0.96118 0.16691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW36 ZCH13_HUMAN Zinc finger CCHC domain-containing protein 13 ZCCHC13 Homo sapiens (Human) positive regulation of cytoplasmic translation [GO:2000767] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; positive regulation of cytoplasmic translation [GO:2000767] GO:0003727; GO:0003729; GO:0005737; GO:0008270; GO:0045182; GO:2000767 mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270] RGGGHGR 0.96118 0.26464 9.65317 11.1597 0 14.5889 15.1583 14.7969 13.3613 14.941 0 0 0 0 10.4017 0 0 0 12.0146 14.0703 11.658 11.8325 15.3596 15.7188 15.7647 15.6582 0 13.5512 0 0 11.8739 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2687 0 0 11.757 13.8653 0 10.5978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0033 0 0 0 0 0 0 0 0 13.9407 0 15.7753 16.3064 16.5799 16.8566 17.086 16.8199 16.6754 16.9267 16.9979 16.8179 16.7437 17.1698 16.3398 16.5232 16.5824 17.0681 17.1133 16.5094 16.7224 16.8958 17.3165 16.4939 16.7553 14.9173 16.8531 14.5607 16.6433 13.0963 15.2747 16.9111 16.7017 16.8207 0 16.0464 17.1866 16.8047 15.3853 17.1395 14.0881 15.296 16.3192 15.1037 16.4858 16.6079 16.6866 16.6352 16.7863 13.8675 14.4387 0 16.0411 14.0406 0 0 15.0751 12.1447 0 16.6851 14.3383 15.2818 16.5544 16.2617 16.6001 13.3219 16.5194 16.3794 16.7098 16.4089 0 16.3963 0 0 0 0 17.0903 14.6827 16.8057 0 0 0 0 0 0 0 0 0 12.5308 12.2251 0 0 0 0 16.5359 16.6303 14.2154 13.4331 0 16.5164 11.5413 15.44 13.5424 A1L1A6 IGS23_HUMAN Immunoglobulin superfamily member 23 IGSF23 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RAKPQSPLPR 0.96119 0.23985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75023 LIRB5_HUMAN "Leukocyte immunoglobulin-like receptor subfamily B member 5 (CD85 antigen-like family member C) (Leukocyte immunoglobulin-like receptor 8, LIR-8) (CD antigen CD85c)" LILRB5 LIR8 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952] GO:0002250; GO:0004888; GO:0005886; GO:0006952; GO:0007166; GO:0016021; GO:0019221; GO:0032396 inhibitory MHC class I receptor activity [GO:0032396]; transmembrane signaling receptor activity [GO:0004888] AKFHIPSTVYDSAGRYR 0.96119 0.38298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5916 12.5796 0 0 0 15.5147 0 12.8511 0 11.1239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.663 0 0 0 0 0 0 0 0 0 14.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.463 0 0 0 0 10.6273 11.6483 0 0 0 0 0 0 0 0 0 0 0 0 11.0159 0 0 0 0 12.9464 0 0 0 0 0 Q5SWL8 PRA19_HUMAN PRAME family member 19 PRAMEF19 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 DQALAISVLDELPR 0.96119 0.26447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4095 13.5772 13.1059 13.4576 13.8484 0 0 13.2679 0 0 0 15.0623 12.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S16 JMJD8_HUMAN JmjC domain-containing protein 8 (Jumonji domain-containing protein 8) JMJD8 C16orf20 PP14397 Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302] GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006110; GO:0043123; GO:1903302; GO:1903672 LLASFGDR 0.9612 0.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6998 0 13.515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4175 0 12.0862 0 0 0 0 0 0 11.7454 0 0 0 0 0 0 0 0 0 0 0 0 13.7077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60609 GFRA3_HUMAN "GDNF family receptor alpha-3, GDNF receptor alpha-3, GDNFR-alpha-3, GFR-alpha-3" GFRA3 UNQ339/PRO538/PRO3664 Homo sapiens (Human) nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peripheral nervous system development [GO:0007422]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485] GO:0001764; GO:0005102; GO:0005829; GO:0005886; GO:0007165; GO:0007399; GO:0007422; GO:0008046; GO:0009897; GO:0016167; GO:0019898; GO:0031225; GO:0038023; GO:0043235; GO:0048485 axon guidance receptor activity [GO:0008046]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102] AYGEACSGPHCQR 0.96121 0.38138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8161 0 0 0 0 0 0 0 0 0 0 0 11.6631 0 0 0 0 0 0 0 0 0 0 0 12.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12872 MOTI_HUMAN "Promotilin [Cleaved into: Motilin; Motilin-associated peptide, MAP ]" MLN Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; hormone activity [GO:0005179]; motilin receptor binding [GO:0031788] GO:0005179; GO:0005576; GO:0031788 hormone activity [GO:0005179]; motilin receptor binding [GO:0031788] LTAPLEIGMRMNSR 0.96121 0.28034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6A555 TXND8_HUMAN "Thioredoxin domain-containing protein 8 (Spermatid-specific thioredoxin-3, Sptrx-3) (Thioredoxin-6)" TXNDC8 SPTRX3 TRX6 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005737; GO:0005794; GO:0007283; GO:0030154; GO:0070062 KSQKVTLFSR 0.96121 0.38154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGI2 O52N4_HUMAN Olfactory receptor 52N4 (Olfactory receptor OR11-64) OR52N4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FGEHIIPPSCHIIVANIYLLLPPTMNPIVYGVKTK 0.96121 0.17329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96E11 RRFM_HUMAN "Ribosome-recycling factor, mitochondrial, RRF (Ribosome-releasing factor, mitochondrial)" MRRF Homo sapiens (Human) ribosome disassembly [GO:0032790]; translation [GO:0006412] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; ribosome disassembly [GO:0032790]; translation [GO:0006412] GO:0005739; GO:0005759; GO:0006412; GO:0032790; GO:0043023 ribosomal large subunit binding [GO:0043023] CFRMVHPTFRNYLAASIR 0.96121 0.38854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8452 0 0 0 0 0 14.9923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHY1 NRBP_HUMAN Nuclear receptor-binding protein NRBP1 BCON3 NRBP Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular signal transduction [GO:0035556] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular signal transduction [GO:0035556] GO:0004672; GO:0005524; GO:0005654; GO:0005737; GO:0005938; GO:0006888; GO:0012505; GO:0016020; GO:0030027; GO:0035556; GO:0042803 ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672] FHKYWADIKENK 0.96121 0.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6172 0 0 0 15.0574 0 14.1414 13.3127 0 0 0 15.4312 0 0 0 0 0 0 0 0 0 0 14.0086 14.1787 0 15.3265 13.7187 13.7778 0 0 0 0 0 0 0 13.3896 13.068 0 0 16.0223 14.2891 13.6337 0 0 0 0 0 0 13.7348 0 0 0 13.1518 0 0 0 0 0 0 0 0 14.8251 13.9554 0 14.0597 14.6658 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5728 16.7788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8953 0 14.9326 0 0 0 0 0 0 P62875 RPAB5_HUMAN "DNA-directed RNA polymerases I, II, and III subunit RPABC5, RNA polymerases I, II, and III subunit ABC5 (DNA-directed RNA polymerase III subunit L) (RNA polymerase II 7.6 kDa subunit, RPB7.6) (RPB10 homolog)" POLR2L Homo sapiens (Human) regulation of transcription by RNA polymerase I [GO:0006356]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; tRNA transcription by RNA polymerase III [GO:0042797] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase I [GO:0006356]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; tRNA transcription by RNA polymerase III [GO:0042797]" GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006356; GO:0006360; GO:0006366; GO:0008270; GO:0042797 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270] IIPVRCFTCGK 0.96122 0.23785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6936 0 0 0 0 0 0 10.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A096LNP1 D131B_HUMAN "Beta-defensin 131B (Defensin, beta 131)" DEFB131B Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005615; GO:0042742; GO:0045087 CNADEHAIRYCADFSICCK 0.96123 0.48714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9654 0 0 0 0 0 12.52 0 0 0 0 0 0 12.3947 0 11.9333 0 11.2368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VYV7 SLX4I_HUMAN Protein SLX4IP (SLX4-interacting protein) SLX4IP C20orf94 Homo sapiens (Human) DLLASQNEDLTER 0.96123 0.50297 0 0 0 0 15.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6503 0 0 0 0 0 0 0 0 0 0 0 0 O15511 ARPC5_HUMAN "Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit, p16-ARC)" ARPC5 ARC16 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; regulation of actin filament polymerization [GO:0030833]; smooth muscle cell migration [GO:0014909] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; regulation of actin filament polymerization [GO:0030833]; smooth muscle cell migration [GO:0014909] GO:0003779; GO:0005200; GO:0005576; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0014909; GO:0015629; GO:0016477; GO:0021769; GO:0030011; GO:0030027; GO:0030036; GO:0030426; GO:0030833; GO:0034314; GO:0034774; GO:0035861; GO:0051639; GO:0061842; GO:0070062; GO:0097581; GO:1904813 actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200] AGSIVLKVLISFK 0.96124 0.55933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7392 0 0 0 0 0 0 0 0 13.4793 13.512 12.0447 0 0 0 0 0 12.4338 0 11.3034 0 0 0 0 0 0 0 11.8879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TCM9 LCE5A_HUMAN Late cornified envelope protein 5A (Late envelope protein 18) (Small proline-rich-like epidermal differentiation complex protein 5A) LCE5A LEP18 SPRL5A Homo sapiens (Human) keratinization [GO:0031424] identical protein binding [GO:0042802]; keratinization [GO:0031424] GO:0031424; GO:0042802 identical protein binding [GO:0042802] CPPQCSAPCPPPVSSCCGSSSGGCCSSEGGGCCLSHHR 0.96124 0.50222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9051 0 0 0 0 0 0 0 0 12.374 0 0 0 0 0 12.5292 0 0 0 0 0 0 0 0 0 13.5786 0 0 0 0 0 0 0 0 0 0 11.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 E7ERA6 RN223_HUMAN RING finger protein 223 RNF223 Homo sapiens (Human) protein ubiquitination [GO:0016567] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567] GO:0016021; GO:0016567; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LAAAQPVGRPGGEAVPCPFCR 0.96125 0.39346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9481 0 14.1537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 E9PJ23 NPIB6_HUMAN Nuclear pore complex-interacting protein family member B6 NPIPB6 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 DVITLRR 0.96125 0.39346 11.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UI08 EVL_HUMAN Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like) EVL RNB6 Homo sapiens (Human) actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; animal organ morphogenesis [GO:0009887]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; animal organ morphogenesis [GO:0009887]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of stress fiber assembly [GO:0051496]; protein homotetramerization [GO:0051289] GO:0003779; GO:0005522; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0007015; GO:0007166; GO:0007399; GO:0008154; GO:0009887; GO:0010633; GO:0016020; GO:0017124; GO:0030027; GO:0030838; GO:0045010; GO:0051289; GO:0051496; GO:1900028 actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124] PWERSNSVEK 0.96125 0.55728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01764 HV323_HUMAN Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP) IGHV3-23 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0070062; GO:0072562 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] EFGLSWLFLVAILK 0.96126 0.26764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5522 0 0 0 0 12.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXQ8 YO002_HUMAN Putative uncharacterized protein UNQ6190/PRO20217 UNQ6190/PRO20217 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 ARAPLPLALLLSLPAAPGGR 0.96126 0.18369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2151 0 16.2703 0 0 0 13.547 12.8543 0 0 0 0 0 0 13.8992 0 15.0604 0 0 13.5675 14.5092 0 0 0 13.87 0 12.7009 13.7002 0 0 13.082 0 0 0 0 0 0 0 14.0707 0 0 0 14.6416 0 0 0 0 0 14.6983 0 13.1075 0 0 0 12.8578 0 0 0 0 0 0 16.3985 0 0 0 0 0 0 0 0 13.1568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92966 SNPC3_HUMAN "snRNA-activating protein complex subunit 3, SNAPc subunit 3 (Proximal sequence element-binding transcription factor subunit beta, PSE-binding factor subunit beta, PTF subunit beta) (Small nuclear RNA-activating complex polypeptide 3) (snRNA-activating protein complex 50 kDa subunit, SNAPc 50 kDa subunit)" SNAPC3 SNAP50 Homo sapiens (Human) snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]; bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; snRNA transcription [GO:0009301]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] GO:0000995; GO:0001006; GO:0003677; GO:0003681; GO:0005634; GO:0005654; GO:0005730; GO:0006366; GO:0006383; GO:0009301; GO:0016604; GO:0019185; GO:0042795; GO:0042796 bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006] EPPASALPGSQAADSDREDAAVAR 0.96126 0.55698 0 0 0 0 0 0 0 0 0 11.8582 13.4318 0 0 0 0 0 10.1294 0 0 0 0 0 0 11.9505 0 0 0 0 0 0 0 0 11.8503 0 12.9545 0 0 0 0 11.4819 0 11.641 12.8217 0 0 0 0 0 0 0 0 0 0 0 0 13.0365 0 13.9952 13.504 13.1204 12.3915 12.0381 11.8791 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5242 0 0 0 0 0 0 0 0 0 13.8451 0 0 0 0 0 0 0 0 0 0 0 12.9473 13.5839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 13.0259 14.1707 13.1566 0 0 0 0 13.0975 13.1376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0115 13.2884 0 12.8888 13.1014 0 0 12.9738 14.757 13.4878 0 0 0 13.2143 13.1153 0 0 0 12.8835 0 0 11.2978 0 12.0019 0 0 0 0 12.333 0 0 0 0 0 13.4538 0 0 0 0 13.1374 0 P0C0P6 NPS_HUMAN Neuropeptide S NPS Homo sapiens (Human) "neuropeptide signaling pathway [GO:0007218]; positive regulation of action potential [GO:0045760]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542]" extracellular region [GO:0005576]; synapse [GO:0045202] "extracellular region [GO:0005576]; synapse [GO:0045202]; neuropeptide signaling pathway [GO:0007218]; positive regulation of action potential [GO:0045760]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; synaptic transmission, glutamatergic [GO:0035249]; visual learning [GO:0008542]" GO:0005576; GO:0007218; GO:0008542; GO:0010841; GO:0032230; GO:0035249; GO:0045202; GO:0045760; GO:0051968 SDYFLILLNSCPTR 0.96127 0.26764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.221 0 0 11.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8877 0 0 0 0 12.1813 0 0 0 0 0 11.9079 0 0 0 0 0 0 0 0 0 0 0 0 Q29980 MICB_HUMAN "MHC class I polypeptide-related sequence B, MIC-B" MICB PERB11.2 Homo sapiens (Human) adaptive immune response [GO:0002250]; cytolysis [GO:0019835]; gamma-delta T cell activation [GO:0046629]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; negative regulation of defense response to virus by host [GO:0050689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to retinoic acid [GO:0032526] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; adaptive immune response [GO:0002250]; cytolysis [GO:0019835]; gamma-delta T cell activation [GO:0046629]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; negative regulation of defense response to virus by host [GO:0050689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to retinoic acid [GO:0032526] GO:0002250; GO:0002429; GO:0005615; GO:0005886; GO:0006979; GO:0009408; GO:0009897; GO:0009986; GO:0016021; GO:0019835; GO:0032526; GO:0046629; GO:0046703; GO:0050689 natural killer cell lectin-like receptor binding [GO:0046703] AQTLAMNVTNFWK 0.96127 0.50003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7511 0 0 0 0 0 0 0 0 13.0341 0 12.5869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T700 LRAD1_HUMAN Low-density lipoprotein receptor class A domain-containing protein 1 LDLRAD1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TCTHGEDEDESLCR 0.96128 0.26764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P589 TP8L2_HUMAN "Tumor necrosis factor alpha-induced protein 8-like protein 2, TIPE2, TNF alpha-induced protein 8-like protein 2, TNFAIP8-like protein 2 (Inflammation factor protein 20)" TNFAIP8L2 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell activation [GO:0050868]; regulation of apoptotic process [GO:0042981]; T cell activation [GO:0042110] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell activation [GO:0050868]; regulation of apoptotic process [GO:0042981]; T cell activation [GO:0042110] GO:0005737; GO:0042110; GO:0042981; GO:0045087; GO:0050728; GO:0050868 DLIKVAIKVAVLHR 0.96128 0.49831 0 0 0 0 0 0 0 0 0 12.3505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5614 0 0 0 0 0 0 0 11.9058 0 0 0 0 0 0 0 0 11.9823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.493 0 0 0 0 0 0 0 0 0 0 12.782 0 0 0 0 0 0 0 0 0 13.8064 12.0512 0 0 0 0 13.0313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MWL6 SNG2L_HUMAN Putative synaptogyrin-2 like protein Homo sapiens (Human) integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672] integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672] GO:0016021; GO:0030672; GO:0031594 QMYCVFNHNEDACR 0.96129 0.26764 0 0 0 0 0 0 0 0 0 0 10.4716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.906 0 0 0 11.4868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15247 CLIC2_HUMAN Chloride intracellular channel protein 2 (XAP121) CLIC2 Homo sapiens (Human) chloride transport [GO:0006821]; glutathione metabolic process [GO:0006749]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of binding [GO:0051099]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602]; voltage-gated ion channel activity [GO:0005244]; chloride transport [GO:0006821]; glutathione metabolic process [GO:0006749]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of binding [GO:0051099]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165] GO:0004602; GO:0005244; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006749; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707; GO:0051099; GO:0060315 chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602]; voltage-gated ion channel activity [GO:0005244] PGTQVDPEIELFVK 0.96129 0.24468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31946 1433B_HUMAN "14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1, KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed ]" YWHAB Homo sapiens (Human) cytoplasmic sequestering of protein [GO:0051220]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of catalytic activity [GO:0043085]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; cytoplasmic sequestering of protein [GO:0051220]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of catalytic activity [GO:0043085]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165] GO:0004860; GO:0005737; GO:0005774; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0008104; GO:0016020; GO:0019899; GO:0019904; GO:0035308; GO:0042470; GO:0042802; GO:0042826; GO:0043085; GO:0045296; GO:0045744; GO:0048471; GO:0050815; GO:0051219; GO:0051220; GO:0070062 cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860] NLLSVAYK 0.96129 0.54532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6469 0 0 0 0 0 0 0 0 0 14.2707 13.3396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q147X3 NAA30_HUMAN "N-alpha-acetyltransferase 30, EC 2.3.1.256 (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit)" NAA30 C14orf35 MAK3 NAT12 Homo sapiens (Human) N-terminal peptidyl-methionine acetylation [GO:0017196] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196] GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417 peptide alpha-N-acetyltransferase activity [GO:0004596] RNGIGTNLVKK 0.96129 0.38685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2098 0 0 11.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0749 12.9615 0 0 0 0 0 13.2688 0 0 0 0 0 0 14.0338 0 0 0 0 14.8987 13.9015 12.7807 0 0 0 0 13.0387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9406 0 0 0 0 0 Q9NRX5 SERC1_HUMAN Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2) SERINC1 KIAA1253 TDE1L TDE2 UNQ396/PRO732 Homo sapiens (Human) membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; membrane biogenesis [GO:0044091]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665] GO:0005789; GO:0005886; GO:0006658; GO:0006665; GO:0008654; GO:0016020; GO:0016021; GO:0030674; GO:0044091; GO:1904219; GO:1904222 protein-macromolecule adaptor activity [GO:0030674] AFISVNMLLCVGASVMSILPKIQESQPR 0.96129 3.6575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7313 0 0 0 13.2694 0 0 0 0 0 0 0 0 0 12.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6H6 KCNE3_HUMAN Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2) KCNE3 Homo sapiens (Human) cellular chloride ion homeostasis [GO:0030644]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential [GO:1905025]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion export across plasma membrane [GO:0097623]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transport [GO:0006814]; ventricular cardiac muscle cell action potential [GO:0086005] basolateral part of cell [GO:1990794]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; vesicle [GO:0031982] basolateral part of cell [GO:1990794]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; cellular chloride ion homeostasis [GO:0030644]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential [GO:1905025]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion export across plasma membrane [GO:0097623]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transport [GO:0006814]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0005249; GO:0005737; GO:0005886; GO:0006814; GO:0015459; GO:0016021; GO:0030425; GO:0030644; GO:0031982; GO:0032809; GO:0043204; GO:0044325; GO:0045121; GO:0060307; GO:0086005; GO:0086011; GO:0086091; GO:0097623; GO:0098915; GO:1902260; GO:1903765; GO:1903817; GO:1905025; GO:1990794 potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] SDPYHVYIKNR 0.9613 0.39174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63130 GAK7_HUMAN "Endogenous retrovirus group K member 7 Gag polyprotein (HERV-K(III) Gag protein) (HERV-K102 Gag protein) (HERV-K_1q22 provirus ancestral Gag polyprotein, Gag polyprotein)" ERVK-7 Homo sapiens (Human) viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032] GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032 nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] GPELVGPSESK 0.96131 0.39524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JPI9 EFMT2_HUMAN "EEF1A lysine methyltransferase 2, EC 2.1.1.- (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase METTL10)" EEF1AKMT2 C10orf138 METTL10 Homo sapiens (Human) peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; protein methylation [GO:0006479] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine monomethylation [GO:0018026]; protein methylation [GO:0006479] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006479; GO:0008168; GO:0016279; GO:0016604; GO:0018022; GO:0018026; GO:0018027; GO:0043231 methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279] SLSRVLKVK 0.96132 0.54429 0 0 0 0 0 0 9.9309 0 0 0 0 0 0 0 0 10.365 0 0 9.55919 0 0 0 0 0 0 13.3496 0 0 0 14.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0977 0 0 0 0 16.6141 0 0 0 0 0 0 0 0 0 0 14.5142 0 0 0 0 9.59186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14508 SOCS2_HUMAN "Suppressor of cytokine signaling 2, SOCS-2 (Cytokine-inducible SH2 protein 2, CIS-2) (STAT-induced STAT inhibitor 2, SSI-2)" SOCS2 CIS2 SSI2 STATI2 Homo sapiens (Human) cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]; cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355] GO:0001558; GO:0005131; GO:0005159; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0007595; GO:0008269; GO:0009966; GO:0016567; GO:0032355; GO:0032870; GO:0035556; GO:0040015; GO:0043066; GO:0045666; GO:0046426; GO:0046854; GO:0046935; GO:0060396; GO:0060749 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269] LDSIICVKSKLK 0.96133 0.54278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VI4 LAP4B_HUMAN Lysosomal-associated transmembrane protein 4B (Lysosome-associated transmembrane protein 4-beta) LAPTM4B PSEC0001 Homo sapiens (Human) endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of transforming growth factor beta1 production [GO:0032911]; regulation of lysosomal membrane permeability [GO:0097213]; regulation of lysosome organization [GO:1905671] "cell projection [GO:0042995]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]" "cell projection [GO:0042995]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; ceramide binding [GO:0097001]; kinase binding [GO:0019900]; phosphatidylinositol bisphosphate binding [GO:1902936]; ubiquitin protein ligase binding [GO:0031625]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of transforming growth factor beta1 production [GO:0032911]; regulation of lysosomal membrane permeability [GO:0097213]; regulation of lysosome organization [GO:1905671]" GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007032; GO:0016021; GO:0019900; GO:0031625; GO:0031902; GO:0032509; GO:0032585; GO:0032911; GO:0042995; GO:0097001; GO:0097213; GO:0097487; GO:1902936; GO:1905166; GO:1905671 ceramide binding [GO:0097001]; kinase binding [GO:0019900]; phosphatidylinositol bisphosphate binding [GO:1902936]; ubiquitin protein ligase binding [GO:0031625] AHGRAGR 0.96133 0.49462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8253 0 0 13.9203 14.5656 0 0 0 0 0 0 13.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3673 12.2777 0 0 0 0 0 0 0 14.2249 0 0 15.4628 19.5355 15.5712 19.542 14.8366 14.6713 16.337 15.5986 19.5557 15.6814 14.9699 13.9642 0 15.4637 19.3347 15.5552 15.4852 0 0 14.7384 14.3918 14.2685 19.2063 14.1801 15.8457 15.5702 19.2342 15.6596 19.1787 15.2554 15.1091 0 0 0 0 19.1566 14.9557 15.5877 13.7445 16.286 14.8545 0 14.7844 19.0996 19.1198 14.2179 14.7523 14.328 14.71 19.0754 14.3101 0 0 0 0 0 0 15.5567 0 0 0 19.169 13.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5515 0 0 0 0 0 0 0 0 15.5594 0 Q99712 KCJ15_HUMAN "ATP-sensitive inward rectifier potassium channel 15 (Inward rectifier K(+) channel Kir1.3) (Inward rectifier K(+) channel Kir4.2) (Potassium channel, inwardly rectifying subfamily J member 15)" KCNJ15 KCNJ14 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005886; GO:0005887; GO:0006813; GO:0034765; GO:1990573 inward rectifier potassium channel activity [GO:0005242] DAIHIGMSSTPLVKHTAGAGLKANR 0.96133 0.15783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9758 0 0 Q9BTX7 TTPAL_HUMAN Alpha-tocopherol transfer protein-like TTPAL C20orf121 Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020]; phosphatidylinositol bisphosphate binding [GO:1902936] GO:0016020; GO:1902936 phosphatidylinositol bisphosphate binding [GO:1902936] AVKSQLYSCY 0.96133 0.15799 0 0 0 0 12.4978 0 10.2239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0395 0 0 0 0 0 0 0 0 0 0 0 0 10.5445 0 0 11.0881 0 0 0 15.0554 0 13.0412 0 0 13.1262 0 0 14.8721 0 15.1085 15.0243 0 13.6056 0 0 0 0 12.3137 0 0 0 0 0 0 0 0 0 13.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9083 0 10.6086 0 0 0 0 0 0 12.5932 0 0 0 0 0 0 10.9074 0 13.0484 12.6192 13.1498 9.96622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6768 0 0 0 0 13.4694 Q9Y5G7 PCDG6_HUMAN "Protocadherin gamma-A6, PCDH-gamma-A6" PCDHGA6 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] LNLYPVEVEIVDINDNTPRFLK 0.96133 0.38463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFF2 NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4) SLC24A4 NCKX4 Homo sapiens (Human) amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; ion transport [GO:0006811]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signaling receptor activity [GO:0010469]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] "apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]; amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; ion transport [GO:0006811]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signaling receptor activity [GO:0010469]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]" GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010469; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834 "calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]" GLVYSVVLLLGSVALTVLGIHLNK 0.96134 2.9444 0 0 0 0 0 0 0 0 10.8296 0 0 10.1829 0 0 0 0 0 0 0 0 12.8097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6543 0 0 0 0 0 12.2987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8826 12.6845 0 13.9643 12.9602 0 13.1509 12.5924 0 13.3888 12.4004 13.2591 0 0 14.6054 0 12.5758 0 0 11.8566 0 12.2185 11.4212 0 0 0 0 0 0 12.3937 0 0 11.9532 0 11.2235 0 13.5337 0 0 0 0 0 11.9782 0 0 13.3551 0 0 14.2542 0 0 12.5248 13.491 0 13.4528 0 0 0 0 0 0 0 13.9218 0 0 0 0 13.7789 13.6149 11.012 13.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5646 0 0 12.7324 0 13.4021 0 0 0 0 0 12.9256 14.5758 0 0 0 0 13.3014 0 0 Q8TDU5 VNRL4_HUMAN "Putative vomeronasal receptor-like protein 4 (G-protein coupled receptor GPCR23, hGPCR23)" VN1R17P VNRL4 Homo sapiens (Human) response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pheromone receptor activity [GO:0016503]; response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] GO:0005886; GO:0007606; GO:0016021; GO:0016503; GO:0019236 pheromone receptor activity [GO:0016503] SLFFILMVLR 0.96134 0.16696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2712 13.3604 12.9938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7274 12.6159 0 0 0 0 0 0 0 0 0 0 0 0 13.2585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y242 TCF19_HUMAN "Transcription factor 19, TCF-19 (Transcription factor SC1)" TCF19 SC1 Homo sapiens (Human) regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of gene expression [GO:0010468] GO:0005634; GO:0010468; GO:0046872 metal ion binding [GO:0046872] EADFRCPGCR 0.96135 0.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.983 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0PNE2 ELP6_HUMAN Elongator complex protein 6 (Angiotonin-transactivated protein 1) (Protein TMEM103) ELP6 ATP1 C3orf75 TMEM103 Homo sapiens (Human) positive regulation of cell migration [GO:0030335]; regulation of translation [GO:0006417]; tRNA wobble uridine modification [GO:0002098] cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634] cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; regulation of translation [GO:0006417]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0005634; GO:0005829; GO:0006417; GO:0030335; GO:0033588 DQSFTYQYKIQDK 0.96136 0.38308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0K1 S39A8_HUMAN "Metal cation symporter ZIP8 (BCG-induced integral membrane protein in monocyte clone 103 protein) (LIV-1 subfamily of ZIP zinc transporter 6, LZT-Hs6) (Solute carrier family 39 member 8) (Zrt- and Irt-like protein 8, ZIP-8)" SLC39A8 BIGM103 ZIP8 PP3105 Homo sapiens (Human) "arginine metabolic process [GO:0006525]; bicarbonate transport [GO:0015701]; cadmium ion transmembrane transport [GO:0070574]; cartilage homeostasis [GO:1990079]; cellular cadmium ion homeostasis [GO:0006876]; cellular manganese ion homeostasis [GO:0030026]; cellular zinc ion homeostasis [GO:0006882]; cobalt ion transport [GO:0006824]; extracellular matrix organization [GO:0030198]; iron ion import across plasma membrane [GO:0098711]; leukocyte adhesion to arterial endothelial cell [GO:0061757]; manganese ion transmembrane transport [GO:0071421]; mitochondrial manganese ion transmembrane transport [GO:1990540]; plasma membrane selenite transport [GO:0097080]; protein N-linked glycosylation [GO:0006487]; regulation of membrane potential [GO:0042391]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]" apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; anion:cation symporter activity [GO:0015296]; bicarbonate transmembrane transporter activity [GO:0015106]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; selenite:proton symporter activity [GO:0097079]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:bicarbonate symporter activity [GO:0140412]; arginine metabolic process [GO:0006525]; bicarbonate transport [GO:0015701]; cadmium ion transmembrane transport [GO:0070574]; cartilage homeostasis [GO:1990079]; cellular cadmium ion homeostasis [GO:0006876]; cellular manganese ion homeostasis [GO:0030026]; cellular zinc ion homeostasis [GO:0006882]; cobalt ion transport [GO:0006824]; extracellular matrix organization [GO:0030198]; iron ion import across plasma membrane [GO:0098711]; leukocyte adhesion to arterial endothelial cell [GO:0061757]; manganese ion transmembrane transport [GO:0071421]; mitochondrial manganese ion transmembrane transport [GO:1990540]; plasma membrane selenite transport [GO:0097080]; protein N-linked glycosylation [GO:0006487]; regulation of membrane potential [GO:0042391]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829]" GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0005887; GO:0006351; GO:0006355; GO:0006487; GO:0006525; GO:0006824; GO:0006829; GO:0006876; GO:0006882; GO:0015086; GO:0015087; GO:0015106; GO:0015296; GO:0015701; GO:0016323; GO:0016324; GO:0030026; GO:0030198; GO:0031090; GO:0042391; GO:0061757; GO:0070574; GO:0071421; GO:0071577; GO:0071578; GO:0097079; GO:0097080; GO:0098711; GO:0140412; GO:1990079; GO:1990540 anion:cation symporter activity [GO:0015296]; bicarbonate transmembrane transporter activity [GO:0015106]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; selenite:proton symporter activity [GO:0097079]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:bicarbonate symporter activity [GO:0140412] PSHSEVWGYGFLSVTIINLASLLGLILTPLIKKSYFPK 0.96136 0.508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAT0 ROP1A_HUMAN "Ropporin-1A (Cancer/testis antigen 91, CT91) (Rhophilin-associated protein 1A)" ROPN1 ROPN1A Homo sapiens (Human) cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240] cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634] cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240] GO:0001932; GO:0005634; GO:0005737; GO:0030317; GO:0031514; GO:0042802; GO:0044782; GO:0048240; GO:0061512 identical protein binding [GO:0042802] AELTPELLKILHSQVAGRLIIR 0.96136 0.47796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7031 10.9654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53H12 AGK_HUMAN "Acylglycerol kinase, mitochondrial, hAGK, EC 2.7.1.107, EC 2.7.1.138, EC 2.7.1.94 (Multiple substrate lipid kinase, HsMuLK, MuLK, Multi-substrate lipid kinase)" AGK MULK Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; glycerolipid metabolic process [GO:0046486]; phosphorylation [GO:0016310]; protein insertion into mitochondrial inner membrane [GO:0045039]; sphingolipid metabolic process [GO:0006665] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; diacylglycerol kinase activity [GO:0004143]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; ceramide biosynthetic process [GO:0046513]; glycerolipid metabolic process [GO:0046486]; phosphorylation [GO:0016310]; protein insertion into mitochondrial inner membrane [GO:0045039]; sphingolipid metabolic process [GO:0006665] GO:0001727; GO:0001729; GO:0003951; GO:0004143; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0006665; GO:0016020; GO:0016310; GO:0031305; GO:0031966; GO:0042721; GO:0043231; GO:0045039; GO:0046486; GO:0046513; GO:0047620; GO:0102773 acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; diacylglycerol kinase activity [GO:0004143]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951] KLLELMENTDVIIVAGGDGTLQEVVTGVLRR 0.96137 0.33952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVD5 RN141_HUMAN RING finger protein 141 (Zinc finger protein 230) RNF141 ZNF230 Homo sapiens (Human) "protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]" membrane [GO:0016020] "membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; regulation of transcription, DNA-templated [GO:0006355]" GO:0004842; GO:0006355; GO:0016020; GO:0046872; GO:0051865 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] LPEKVAK 0.96137 0.23953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.118 0 0 0 0 0 0 13.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9561 0 0 0 0 0 0 13.1402 13.3425 0 0 0 0 17.1829 13.1333 0 0 0 0 0 0 0 12.6092 0 0 0 0 0 0 0 0 0 0 0 0 12.2553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1661 12.0917 12.1735 0 0 0 0 0 Q92730 RND1_HUMAN Rho-related GTP-binding protein Rho6 (Rho family GTPase 1) (Rnd1) RND1 RHO6 Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of cell adhesion [GO:0007162]; neuron remodeling [GO:0016322]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of cell adhesion [GO:0007162]; neuron remodeling [GO:0016322]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005102; GO:0005525; GO:0005856; GO:0005886; GO:0005912; GO:0005938; GO:0007015; GO:0007162; GO:0007163; GO:0007264; GO:0008360; GO:0015629; GO:0016322; GO:0016477; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0043231 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102] QLGAEIYLEGSAFTSEKSIHSIFR 0.96137 0.17464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0Y2 ZN444_HUMAN "Zinc finger protein 444 (Endothelial zinc finger protein 2, EZF-2) (Zinc finger and SCAN domain-containing protein 17)" ZNF444 EZF2 ZSCAN17 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EALGLLRALCRDWLR 0.96138 0.17373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7742 0 0 12.2857 0 0 0 0 11.5752 0 0 0 11.7325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5759 0 0 0 0 0 0 0 0 14.1172 0 0 14.4483 0 0 0 0 0 0 0 0 0 0 14.7923 15.3476 0 0 0 0 0 0 0 14.0209 0 0 0 0 0 0 0 0 0 14.6944 17.315 0 0 0 0 0 16.9549 0 0 0 0 14.4811 0 0 0 0 13.8544 0 0 0 0 0 0 0 14.5383 0 0 0 0 0 14.1202 0 0 13.5152 0 0 0 0 0 0 0 0 12.0985 0 0 0 10.6957 0 14.6632 14.5995 14.6224 14.4736 0 0 14.0807 0 0 14.734 0 0 0 13.9826 0 0 0 13.4851 14.2149 0 0 Q8N7U7 TPRX1_HUMAN Tetra-peptide repeat homeobox protein 1 TPRX1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" MLSLREQQLQVWFK 0.96138 0.28034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGR2 OR1L6_HUMAN Olfactory receptor 1L6 (Olfactory receptor 1L7) (Olfactory receptor OR9-30) OR1L6 OR1L7 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LPFTSLPLLLQTLSR 0.96138 0.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8096 0 16.3369 15.8045 0 0 0 16.6666 0 0 16.7363 0 0 0 0 0 0 0 0 0 0 0 14.7299 0 0 0 0 0 0 0 0 0 0 0 11.3556 0 0 0 0 13.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4065 0 10.5926 0 0 0 0 0 0 0 13.1565 0 14.4703 0 0 0 0 0 10.0371 13.9192 10.9934 0 P08949 NMB_HUMAN Neuromedin-B [Cleaved into: Neuromedin-B-32; Neuromedin-B ] NMB Homo sapiens (Human) antiviral innate immune response [GO:0140374]; arachidonic acid secretion [GO:0050482]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; Leydig cell proliferation [GO:0160024]; negative regulation of hormone secretion [GO:0046888]; negative regulation of interleukin-6 production [GO:0032715]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hormone secretion [GO:0046887]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; positive regulation of testosterone secretion [GO:2000845]; sensory perception of itch [GO:0160025]; signal transduction [GO:0007165]; sneeze reflex [GO:0160023] extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005] extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; hormone activity [GO:0005179]; neuromedin B receptor binding [GO:0031710]; neuropeptide hormone activity [GO:0005184]; antiviral innate immune response [GO:0140374]; arachidonic acid secretion [GO:0050482]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; Leydig cell proliferation [GO:0160024]; negative regulation of hormone secretion [GO:0046888]; negative regulation of interleukin-6 production [GO:0032715]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hormone secretion [GO:0046887]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of respiratory gaseous exchange [GO:1903942]; positive regulation of testosterone secretion [GO:2000845]; sensory perception of itch [GO:0160025]; signal transduction [GO:0007165]; sneeze reflex [GO:0160023] GO:0005179; GO:0005184; GO:0005576; GO:0005615; GO:0007165; GO:0007204; GO:0007218; GO:0007267; GO:0031710; GO:0032715; GO:0032727; GO:0042593; GO:0043005; GO:0046887; GO:0046888; GO:0050482; GO:0090290; GO:0140374; GO:0160023; GO:0160024; GO:0160025; GO:1903942; GO:2000845 hormone activity [GO:0005179]; neuromedin B receptor binding [GO:0031710]; neuropeptide hormone activity [GO:0005184] DQRLQLSHDLLGILLLK 0.96139 0.50685 0 0 0 11.2348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5701 0 0 0 0 0 13.6298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8118 0 0 0 11.3169 0 0 0 0 0 0 0 0 15.3323 0 0 0 0 15.1323 0 0 0 0 0 0 0 0 0 12.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9479 0 13.246 0 0 0 0 0 0 0 11.6298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0825 0 0 0 0 0 13.3026 0 0 12.4 12.7157 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD20 AT131_HUMAN "Endoplasmic reticulum transmembrane helix translocase, EC 7.4.2.- (Endoplasmic reticulum P5A-ATPase)" ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ABC-type manganese transporter activity [GO:0015410]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; transmembrane protein dislocase activity [GO:0140567]; cellular calcium ion homeostasis [GO:0006874]; extraction of mislocalized protein from ER membrane [GO:0140569]; ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]; transmembrane transport [GO:0055085] GO:0005524; GO:0005789; GO:0006874; GO:0015031; GO:0015410; GO:0015662; GO:0016020; GO:0016887; GO:0030176; GO:0034220; GO:0046872; GO:0055085; GO:0140567; GO:0140569 ABC-type manganese transporter activity [GO:0015410]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; transmembrane protein dislocase activity [GO:0140567] ATTGLKPVDSGCVAYVLRTGFNTSQGK 0.96139 0.38857 0 0 0 0 0 0 11.28 0 13.1167 0 0 0 0 0 0 0 0 12.0783 0 0 11.7025 12.7847 12.9845 0 0 0 12.2279 11.5118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9925 0 0 12.1351 12.2574 0 16.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 14.225 14.4815 0 12.0302 0 14.5558 0 0 15.9358 16.4234 16.246 16.216 15.1276 16.0573 15.1634 17.3774 15.9576 15.4415 0 14.7628 15.9339 15.2129 15.6367 17.8591 0 15.9796 16.2004 13.1068 14.6057 14.6152 16.778 15.1537 0 13.743 15.0054 15.6347 0 0 0 15.4228 15.2128 14.0285 14.9444 15.4671 15.825 0 12.8704 13.1494 14.1607 14.6883 14.5465 0 15.8485 14.6994 14.5737 15.2592 13.5863 0 0 14.5022 14.6739 13.2922 13.8507 13.5986 14.9341 15.0752 16.9756 14.1968 14.0802 15.0151 14.1121 0 15.2478 14.5703 13.8059 15.2723 11.6512 13.0993 14.7047 14.1248 0 13.4906 0 0 14.916 12.9731 0 13.8659 13.6965 13.4861 12.9099 12.042 13.8396 0 0 0 0 0 13.8933 13.1434 13.0309 0 0 0 0 13.19 14.7356 14.3263 0 0 13.3915 0 0 0 Q9BQ65 USB1_HUMAN "U6 snRNA phosphodiesterase 1, hUsb1 (3'-5' RNA exonuclease USB1, EC 4.6.1.-) (Mutated in poikiloderma with neutropenia protein 1, Mutated in PN protein 1, hMpn1)" USB1 C16orf57 Mpn1 Homo sapiens (Human) RNA splicing [GO:0008380]; snRNA 3'-end processing [GO:0034472]; U6 snRNA 3'-end processing [GO:0034477] intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; lyase activity [GO:0016829]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]; RNA splicing [GO:0008380]; snRNA 3'-end processing [GO:0034472]; U6 snRNA 3'-end processing [GO:0034477]" GO:0000175; GO:0005634; GO:0005654; GO:0008380; GO:0016829; GO:0034472; GO:0034477; GO:0045171; GO:1990838 "3'-5'-exoribonuclease activity [GO:0000175]; lyase activity [GO:0016829]; poly(U)-specific exoribonuclease activity, producing 3' uridine cyclic phosphate ends [GO:1990838]" HHWILPFVQALKAR 0.9614 0.39394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2849 0 11.0973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8181 0 0 0 0 0 0 0 0 0 10.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1867 0 0 0 0 0 0 0 Q9NT62 ATG3_HUMAN "Ubiquitin-like-conjugating enzyme ATG3, EC 2.3.2.- (Autophagy-related protein 3, APG3-like, hApg3) (Protein PC3-96)" ATG3 APG3 APG3L Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017] cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829] cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; protein targeting to membrane [GO:0006612]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017] GO:0000045; GO:0000153; GO:0000422; GO:0005829; GO:0006612; GO:0016567; GO:0019776; GO:0019777; GO:0019787; GO:0019899; GO:0043653; GO:0044804; GO:0050765; GO:1902017 Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787] AYLPTGKQFLVTK 0.9614 0.33686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8141 13.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0805 0 0 13.1743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGA9 TM202_HUMAN Transmembrane protein 202 TMEM202 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 PPYYLQYSRAFFLISVFTILTGLGWLFSSWILNR 0.96141 0.39385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7813 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51151 RAB9A_HUMAN Ras-related protein Rab-9A RAB9A RAB9 Homo sapiens (Human) "negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005789; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030133; GO:0030670; GO:0032482; GO:0032588; GO:0032880; GO:0042147; GO:0042470; GO:0045335; GO:0045921; GO:0052403; GO:0070062 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] FDTQLFHTIGVEFLNK 0.96141 0.17051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0614 0 11.3259 0 0 0 0 12.2232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6086 0 0 0 0 0 0 12.5204 0 0 0 0 0 13.4542 14.3687 0 13.6222 13.8535 0 13.195 0 0 0 13.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7738 0 0 0 0 0 0 15.3656 14.291 0 0 0 0 0 0 0 0 14.561 0 0 0 0 0 0 0 0 0 0 0 0 Q6UB28 MAP12_HUMAN "Methionine aminopeptidase 1D, mitochondrial, MAP 1D, MetAP 1D, EC 3.4.11.18 (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D)" METAP1D MAP1D Homo sapiens (Human) N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; proteolysis [GO:0006508] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; proteolysis [GO:0006508] GO:0004177; GO:0005739; GO:0006508; GO:0008235; GO:0018206; GO:0031365; GO:0046872; GO:0070006; GO:0070084 aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235] PDYVTTGIVPDWGDSIEVK 0.96145 0.55735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1389 0 0 0 Q96MM3 ZFP42_HUMAN "Zinc finger protein 42 homolog, Zfp-42 (Reduced expression protein 1, REX-1, hREX-1) (Zinc finger protein 754)" ZFP42 REX1 ZNF754 Homo sapiens (Human) female gonad development [GO:0008585]; male gonad development [GO:0008584]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; female gonad development [GO:0008585]; male gonad development [GO:0008584]; meiotic cell cycle [GO:0051321]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003700; GO:0005667; GO:0005737; GO:0006357; GO:0008584; GO:0008585; GO:0031519; GO:0046872; GO:0051321; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LKRHFLVHTGEK 0.96145 0.53041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5926 0 0 15.3111 14.7973 0 0 0 0 0 0 0 14.2646 0 14.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9743 0 0 0 0 0 0 0 0 14.0276 0 18.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M85 YV008_HUMAN Putative uncharacterized protein FLJ32756 Homo sapiens (Human) GFLKPLINWDAILYFK 0.96147 0.39198 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99990 VGLL1_HUMAN "Transcription cofactor vestigial-like protein 1, Vgl-1 (Protein TONDU)" VGLL1 TDU Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0006357 transcription coactivator activity [GO:0003713] YSLTPPNHWGHPHR 0.96147 0.24468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MX19 F90AC_HUMAN Putative protein FAM90A12P FAM90A12P FAM90A12 Homo sapiens (Human) ENLKPWKPR 0.96148 0.15911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2849 15.0779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8635 0 0 0 0 Q8NG11 TSN14_HUMAN "Tetraspanin-14, Tspan-14 (DC-TM4F2) (Transmembrane 4 superfamily member 14)" TSPAN14 TM4SF14 Homo sapiens (Human) positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] GO:0005788; GO:0005886; GO:0005887; GO:0009986; GO:0019899; GO:0035579; GO:0045747; GO:0051604; GO:0070821; GO:0072659; GO:0097197 enzyme binding [GO:0019899] WDESIFTKGCIQALESWLPR 0.96148 0.39524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1Z4 WDR13_HUMAN WD repeat-containing protein 13 WDR13 Homo sapiens (Human) negative regulation of type B pancreatic cell proliferation [GO:1904691] centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centriolar satellite [GO:0034451]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; promoter-specific chromatin binding [GO:1990841]; negative regulation of type B pancreatic cell proliferation [GO:1904691] GO:0005634; GO:0005654; GO:0005886; GO:0034451; GO:1904691; GO:1990841 promoter-specific chromatin binding [GO:1990841] QYLRLRGQLLGQR 0.96148 0.52878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2541 0 0 0 0 0 0 0 0 0 12.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D1F6 LRRD1_HUMAN Leucine-rich repeat and death domain-containing protein 1 LRRD1 Homo sapiens (Human) positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] GO:0007165; GO:0046579 AHQALVIWK 0.96149 0.16723 0 0 0 11.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1352 0 0 0 12.733 0 0 0 14.9604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.065 13.2247 0 14.6466 14.335 0 0 0 14.3467 0 0 0 11.1932 12.5043 0 0 0 0 12.8913 13.3846 0 14.4525 12.015 12.3698 13.9876 12.4046 0 15.2661 0 0 14.3524 0 0 0 13.3836 15.3092 0 13.7559 0 13.1155 13.9715 0 17.3852 11.8195 0 0 0 12.7164 12.5882 0 0 0 14.5214 15.0366 12.9071 14.1185 0 0 0 0 14.9404 0 15.5461 12.8868 15.7481 0 0 0 13.3191 0 13.1652 12.4091 13.2981 13.9272 0 12.534 0 0 12.895 11.3675 12.2052 17.6822 0 0 14.5409 0 12.0456 0 12.1638 13.456 15.6893 0 12.9645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2316 0 0 14.957 0 0 0 0 13.7876 0 12.1151 0 0 0 10.9948 12.1242 0 0 A6NGC4 TLCD2_HUMAN TLC domain-containing protein 2 TLCD2 Homo sapiens (Human) lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid homeostasis [GO:0055088]; membrane assembly [GO:0071709]; phospholipid homeostasis [GO:0055091]; plasma membrane organization [GO:0007009]; regulation of membrane lipid distribution [GO:0097035] GO:0005886; GO:0007009; GO:0016021; GO:0055088; GO:0055091; GO:0071709; GO:0097035 MAPTGLLVAGASFLAFRGLHWGLRR 0.96149 0.1587 0 0 0 0 0 0 0 0 0 0 0 11.8456 0 0 0 0 0 0 0 0 0 0 0 0 11.3444 11.2881 0 0 0 0 0 0 0 0 0 0 0 0 0 10.742 0 0 0 11.2513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7822 0 0 0 0 0 0 0 13.5818 0 0 0 0 0 0 0 12.4584 13.6459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9639 0 0 0 13.3515 0 13.4363 0 0 0 12.0852 0 0 12.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5406 0 12.1902 0 0 0 0 0 0 12.4682 0 0 0 0 0 0 Q8NCQ3 NC301_HUMAN Putative uncharacterized protein encoded by LINC00301 LINC00301 C11orf64 NCRNA00301 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ELQLLVR 0.96149 0.49735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P03999 OPSB_HUMAN "Short-wave-sensitive opsin 1 (Blue cone photoreceptor pigment) (Blue-sensitive opsin, BOP)" OPN1SW BCP Homo sapiens (Human) cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; signal transduction [GO:0007165]; visual perception [GO:0007601] cone photoreceptor outer segment [GO:0120199]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] cone photoreceptor outer segment [GO:0120199]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor disc membrane [GO:0097381]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; G protein-coupled photoreceptor activity [GO:0008020]; signaling receptor activity [GO:0038023]; cellular response to light stimulus [GO:0071482]; cellular response to UV-A [GO:0071492]; G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0005886; GO:0005887; GO:0007165; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0038023; GO:0048471; GO:0071482; GO:0071492; GO:0097381; GO:0120199 G protein-coupled photoreceptor activity [GO:0008020]; signaling receptor activity [GO:0038023] AEREVSR 0.9615 0.49713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TGJ6 HDGL1_HUMAN Hepatoma-derived growth factor-like protein 1 (PWWP domain-containing protein 1) HDGFL1 PWWP1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003690; GO:0003712; GO:0005634; GO:0006357 double-stranded DNA binding [GO:0003690]; transcription coregulator activity [GO:0003712] EAAPDQEEEAEAER 0.9615 0.28218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7849 12.8149 0 0 0 0 14.2991 0 0 0 0 0 11.3311 0 0 12.1953 0 0 0 0 0 0 0 0 0 0 10.0844 0 0 0 0 0 0 0 0 0 0 0 0 13.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6159 0 0 14.245 9.77522 0 0 0 0 0 0 0 10.4369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.62724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VU92 DC121_HUMAN DDB1- and CUL4-associated factor 12-like protein 1 (WD repeat-containing protein 40B) DCAF12L1 WDR40B Homo sapiens (Human) Cul4-RING E3 ubiquitin ligase complex [GO:0080008] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] GO:0080008 AIINPSNRKVR 0.9615 0.52578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.37265 14.3213 0 0 0 15.137 0 0 0 0 0 13.5967 0 0 0 14.0689 0 0 14.0252 0 0 14.4505 0 13.5121 0 0 0 0 13.7153 0 0 0 0 0 0 0 0 12.9095 13.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.383 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6699 14.0995 0 0 0 0 13.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7LGA3 HS2ST_HUMAN "Heparan sulfate 2-O-sulfotransferase 1, 2-O-sulfotransferase, 2OST, EC 2.8.2.-" HS2ST1 HS2ST KIAA0448 Homo sapiens (Human) "gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]" GO:0000139; GO:0004394; GO:0006024; GO:0008146; GO:0010467; GO:0015014; GO:0015015; GO:0016020; GO:0016021; GO:0030202; GO:0060676 heparan sulfate 2-O-sulfotransferase activity [GO:0004394]; sulfotransferase activity [GO:0008146] DPIERLVSYYYFLRFGDDYR 0.96151 0.22779 0 0 0 0 0 0 0 0 0 0 0 13.1407 13.1689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.719 0 0 0 0 0 0 0 0 0 0 12.9322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7538 13.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4821 17.4243 0 0 0 15.8222 11.5327 0 0 0 13.909 0 0 13.4009 0 0 0 0 0 0 0 0 0 0 0 13.3337 0 0 13.7586 0 0 11.3736 0 0 13.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5645 0 0 0 0 0 0 0 11.4002 0 0 13.0683 0 Q9Y680 FKBP7_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP7, PPIase FKBP7, EC 5.2.1.8 (23 kDa FK506-binding protein, 23 kDa FKBP, FKBP-23) (FK506-binding protein 7, FKBP-7) (Rotamase)" FKBP7 FKBP23 UNQ670/PRO1304 Homo sapiens (Human) peptidyl-proline modification [GO:0018208] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; peptidyl-proline modification [GO:0018208] GO:0003755; GO:0005509; GO:0005528; GO:0005783; GO:0005788; GO:0018208 calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] QIDMDNDRQLSKAEINLYLQR 0.96151 0.22819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NJ88 SGE2P_HUMAN Putative SAGE1-like protein (Sarcoma antigen 2 pseudogene) SAGE2P Homo sapiens (Human) snRNA 3'-end processing [GO:0034472] integrator complex [GO:0032039] integrator complex [GO:0032039]; snRNA 3'-end processing [GO:0034472] GO:0032039; GO:0034472 EVQRFGQNYKR 0.96152 0.49473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6151 0 0 0 0 13.9376 14.165 13.801 13.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6RVD6 SPAT8_HUMAN Spermatogenesis-associated protein 8 (Spermatogenesis-related protein 8) SPATA8 Homo sapiens (Human) EENSCSHGR 0.96152 0.54444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6884 12.6399 12.8554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2319 12.5173 0 0 0 12.7886 0 13.0473 13.3403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5314 0 0 0 0 0 0 13.1944 0 13.0749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5QP82 DCA10_HUMAN DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32) DCAF10 WDR32 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567] GO:0005654; GO:0016567; GO:0080008 GYIKELCFSPDGR 0.96153 0.38343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3859 11.8047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGL4 OR5DD_HUMAN Olfactory receptor 5D13 (Olfactory receptor OR11-142) (Olfactory receptor OR11-148) OR5D13 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] LVVTKLIYH 0.96153 0.17464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9664 0 0 0 0 13.4696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8639 0 0 13.8039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5979 0 0 13.4264 0 0 0 0 0 12.9526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DP25 CALM3_HUMAN Calmodulin-3 CALM3 CALML2 CAM3 CAMC CAMIII Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762] calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] calcium channel complex [GO:0034704]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; mitochondrial membrane [GO:0031966]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800]; activation of adenylate cyclase activity [GO:0007190]; detection of calcium ion [GO:0005513]; establishment of protein localization to mitochondrial membrane [GO:0090151]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of DNA binding [GO:0043388]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; response to corticosterone [GO:0051412]; substantia nigra development [GO:0021762] GO:0000086; GO:0000922; GO:0001975; GO:0002027; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0005886; GO:0007186; GO:0007190; GO:0008076; GO:0008179; GO:0010800; GO:0010801; GO:0010856; GO:0010880; GO:0010881; GO:0019901; GO:0019904; GO:0021762; GO:0030017; GO:0030234; GO:0030235; GO:0030426; GO:0030672; GO:0031432; GO:0031800; GO:0031954; GO:0031966; GO:0031982; GO:0031997; GO:0032465; GO:0032516; GO:0032991; GO:0034704; GO:0035307; GO:0043209; GO:0043388; GO:0043539; GO:0043548; GO:0044325; GO:0048306; GO:0050848; GO:0050998; GO:0051000; GO:0051343; GO:0051412; GO:0051592; GO:0055117; GO:0060315; GO:0060316; GO:0071902; GO:0072542; GO:0090151; GO:0097225; GO:0097718; GO:0098901; GO:1900242; GO:1901842; GO:1901844; GO:1902494; GO:1905913; GO:2000300 adenylate cyclase activator activity [GO:0010856]; adenylate cyclase binding [GO:0008179]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; disordered domain specific binding [GO:0097718]; enzyme regulator activity [GO:0030234]; N-terminal myristoylation domain binding [GO:0031997]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; type 3 metabotropic glutamate receptor binding [GO:0031800] DGNGYISAAELR 0.96154 0.47887 0 0 11.953 0 0 0 0 0 0 0 0 0 0 0 0 13.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7228 0 13.7337 0 14.0257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9147 0 0 0 0 0 0 0 0 13.477 0 0 0 0 0 0 0 13.1005 0 0 0 0 0 0 0 0 0 12.6284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22223 CADH3_HUMAN "Cadherin-3 (Placental cadherin, P-cadherin)" CDH3 CDHP Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta2 production [GO:0032912]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; positive regulation of tyrosinase activity [GO:0032773]; regulation of hair cycle by canonical Wnt signaling pathway [GO:0060901]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]; wound healing [GO:0042060] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; hair cycle process [GO:0022405]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinization [GO:0031424]; negative regulation of timing of catagen [GO:0051796]; negative regulation of transforming growth factor beta2 production [GO:0032912]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanosome transport [GO:1902910]; positive regulation of tyrosinase activity [GO:0032773]; regulation of hair cycle by canonical Wnt signaling pathway [GO:0060901]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]; wound healing [GO:0042060] GO:0001895; GO:0005509; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007156; GO:0007601; GO:0009410; GO:0010628; GO:0010838; GO:0016021; GO:0016342; GO:0022405; GO:0030054; GO:0031424; GO:0032773; GO:0032912; GO:0042060; GO:0043568; GO:0045296; GO:0048023; GO:0051796; GO:0060901; GO:0090263; GO:0098742; GO:1902910 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] ATVCDCHGHVETCPGPWK 0.96154 4.4076 0 0 0 0 13.0666 0 0 0 12.6437 0 0 0 0 0 14.9966 0 0 12.1297 11.0824 0 0 9.89659 12.4927 11.1534 0 11.0227 14.1919 0 14.9915 0 0 0 0 0 0 0 12.6768 0 0 0 0 0 12.2617 0 0 0 0 0 14.4425 0 0 0 0 0 13.9899 0 0 0 0 0 0 0 0 0 0 0 13.8111 0 0 12.0897 0 11.52 13.8149 13.9078 0 12.2222 14.499 0 14.2863 0 0 15.0487 14.4565 15.0064 13.7052 13.4805 0 14.4179 14.6343 11.4775 10.6705 0 11.5613 0 13.6327 14.1629 0 0 0 15.0311 14.9031 16.4501 0 0 0 0 16.9668 0 12.323 13.1977 15.9157 0 15.5784 13.9407 12.724 15.0051 12.0159 14.0947 14.989 14.8197 19.0345 13.9327 13.8941 12.4415 14.139 16.1879 0 16.7521 11.5942 13.8605 14.1299 14.4286 16.7619 0 16.7415 14.7532 15.5911 12.7364 15.7123 14.0625 0 18.4719 0 15.7849 0 0 0 15.1061 0 0 13.4301 15.0147 0 13.0124 0 11.1426 13.7771 0 0 0 0 0 13.5658 0 0 0 13.7624 0 0 14.5114 0 0 14.8108 11.7946 0 11.5755 0 0 0 0 Q15517 CDSN_HUMAN Corneodesmosin (S protein) CDSN Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; corneocyte desquamation [GO:0003336]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; negative regulation of cornification [GO:1905716]; skin morphogenesis [GO:0043589] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; corneocyte desquamation [GO:0003336]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; negative regulation of cornification [GO:1905716]; skin morphogenesis [GO:0043589] GO:0001533; GO:0003336; GO:0005576; GO:0005886; GO:0005911; GO:0007155; GO:0008544; GO:0030057; GO:0030216; GO:0042803; GO:0043589; GO:0098609; GO:1905716 protein homodimerization activity [GO:0042803] IILQPCGSK 0.96154 0.542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4483 0 14.8309 0 0 0 0 14.2509 0 14.7261 12.6953 14.1813 0 0 14.6083 0 0 0 12.3557 0 0 0 15.3741 12.4448 13.078 14.7806 0 12.431 0 13.133 0 12.8903 12.7156 0 12.6627 14.1455 0 0 14.4811 15.3019 14.3137 11.8969 14.1215 14.9143 15.5284 0 15.3907 14.2772 15.6849 12.0853 14.7091 0 14.4666 15.5285 12.9202 0 12.1103 15.1327 15.0286 0 0 12.3944 14.7224 13.5294 15.5952 14.8331 15.3573 0 15.0276 13.686 0 14.9707 15.4258 14.9314 15.0537 13.57 15.3786 15.2326 14.076 0 13.3852 0 14.5909 10.4489 0 14.7239 0 15.4858 15.5621 14.874 0 0 11.9674 0 0 0 0 0 0 12.1356 0 0 0 0 0 14.9164 14.6826 14.5026 14.2513 0 0 12.1559 15.945 0 Q9Y5G8 PCDG5_HUMAN "Protocadherin gamma-A5, PCDH-gamma-A5" PCDHGA5 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DADVGVNSLR 0.96154 0.33978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18627 LAG3_HUMAN "Lymphocyte activation gene 3 protein, LAG-3 (CD antigen CD223) [Cleaved into: Secreted lymphocyte activation gene 3 protein, sLAG-3 ]" LAG3 FDC Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of regulatory T cell differentiation [GO:0045590]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; MHC class II protein binding [GO:0042289]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of regulatory T cell differentiation [GO:0045590]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110] GO:0002250; GO:0002270; GO:0003823; GO:0004888; GO:0005576; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0032703; GO:0042110; GO:0042267; GO:0042289; GO:0045590; GO:0045954; GO:0050776 antigen binding [GO:0003823]; MHC class II protein binding [GO:0042289]; transmembrane signaling receptor activity [GO:0004888] SGRAPGALPAGHLLLFLILGVLSLLLLVTGAFGFHLWR 0.96155 0.23915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.735 0 12.8147 0 0 0 0 0 0 0 0 0 0 0 13.5454 0 0 12.1399 12.0935 0 11.8598 0 0 12.0836 0 0 0 0 0 0 0 0 0 0 0 0 12.1899 0 0 0 0 0 12.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6215 0 12.1288 0 0 0 0 12.52 0 0 0 12.0375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26368 U2AF2_HUMAN "Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit, hU2AF(65), hU2AF65) (U2 snRNP auxiliary factor large subunit)" U2AF2 U2AF65 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]" commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701] "commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]; C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]" GO:0000243; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701 C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723] SDFDEFERQLNENK 0.96155 0.28034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGP9 O5AR1_HUMAN Olfactory receptor 5AR1 (Olfactory receptor OR11-209) OR5AR1 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; copper ion binding [GO:0005507]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005507; GO:0005549; GO:0005887 copper ion binding [GO:0005507]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] AAFKKLIGK 0.96155 0.23848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0485 0 13.3666 0 13.8273 0 0 0 0 0 0 0 0 0 0 18.2056 18.0348 17.6648 0 0 0 0 12.8548 0 0 12.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99618 CDCA3_HUMAN "Cell division cycle-associated protein 3 (Gene-rich cluster protein C8) (Trigger of mitotic entry protein 1, TOME-1)" CDCA3 C8 GRCC8 TOME1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567] adherens junction [GO:0005912]; cytosol [GO:0005829] adherens junction [GO:0005912]; cytosol [GO:0005829]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567] GO:0005829; GO:0005912; GO:0007049; GO:0016567; GO:0051301 TGGRAWEQGQDHDK 0.96155 0.28034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4G1 CST9L_HUMAN Cystatin-9-like (Testatin) CST9L CTES7B UNQ1835/PRO3543 Homo sapiens (Human) antimicrobial humoral response [GO:0019730] extracellular space [GO:0005615] extracellular space [GO:0005615]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; antimicrobial humoral response [GO:0019730] GO:0004869; GO:0005615; GO:0019730 cysteine-type endopeptidase inhibitor activity [GO:0004869] DYYAYRLGHILNSWKEQVESK 0.96155 0.50813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8757 0 0 0 0 0 13.2052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7192 0 0 0 0 0 0 0 10.4065 0 0 0 0 0 0 0 0 0 0 13.8173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2C5 O52A5_HUMAN Olfactory receptor 52A5 (Odorant receptor HOR3'beta5) (Olfactory receptor OR11-33) OR52A5 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAILIIPSLGLIK 0.96157 0.1712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7391 0 0 11.3414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7295 0 0 0 0 11.9944 0 11.4456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6153 0 0 0 0 0 0 0 0 0 0 0 0 14.8525 0 0 0 0 0 0 0 14.4617 0 0 0 0 0 0 0 0 0 0 0 14.9198 0 0 0 13.633 13.9344 0 0 0 0 0 0 0 0 0 0 0 13.9218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1371 12.7625 0 13.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0704 0 0 0 0 0 0 0 Q9HCC0 MCCB_HUMAN "Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial, MCCase subunit beta, EC 6.4.1.4 (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)" MCCC2 MCCB Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552] "3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]" "3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; branched-chain amino acid catabolic process [GO:0009083]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552]" GO:0002169; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0009083; GO:0015936; GO:1905202 ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485] ASPAGPR 0.96157 0.33687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZA1 CLIC5_HUMAN Chloride intracellular channel protein 5 CLIC5 Homo sapiens (Human) chloride transport [GO:0006821]; female pregnancy [GO:0007565]; glutathione metabolic process [GO:0006749]; regulation of ion transmembrane transport [GO:0034765]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; stereocilium bundle [GO:0032421] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; stereocilium bundle [GO:0032421]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; chloride transport [GO:0006821]; female pregnancy [GO:0007565]; glutathione metabolic process [GO:0006749]; regulation of ion transmembrane transport [GO:0034765]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] GO:0005244; GO:0005254; GO:0005794; GO:0005815; GO:0005938; GO:0006749; GO:0006821; GO:0007565; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0032421; GO:0034707; GO:0034765; GO:0050896; GO:0070062 chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244] FSAYIKNTKQQNNAALER 0.96157 0.50789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15365 PCBP1_HUMAN "Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1, hnRNP E1) (Nucleic acid-binding protein SUB2.3)" PCBP1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]" GO:0000981; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0010468; GO:0016020; GO:0016607; GO:0036464; GO:0039694; GO:0045296; GO:0045944; GO:0051252; GO:0070062; GO:0098847 "cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]" LLMHGKEVGSIIGKK 0.96158 0.18392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92484 ASM3A_HUMAN "Acid sphingomyelinase-like phosphodiesterase 3a, ASM-like phosphodiesterase 3a, EC 3.1.4.-" SMPDL3A ASML3A Homo sapiens (Human) nucleoside triphosphate catabolic process [GO:0009143] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; nucleoside triphosphate catabolic process [GO:0009143] GO:0005615; GO:0008081; GO:0008270; GO:0009143; GO:0070062 phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270] LEYILTQTYDIEDLQPESLYGLAKQFTILDSKQFIK 0.96158 0.50753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5395 0 0 0 0 0 0 0 0 0 0 0 12.2888 0 0 0 0 16.0686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWP8 COL11_HUMAN "Collectin-11 (Collectin kidney protein 1, CL-K1)" COLEC11 UNQ596/PRO1182 Homo sapiens (Human) "antimicrobial humoral response [GO:0019730]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]; execution phase of apoptosis [GO:0097194]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370] "collagen trimer [GO:0005581]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; calcium-dependent carbohydrate binding [GO:0120153]; DNA binding [GO:0003677]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; oligosaccharide binding [GO:0070492]; antimicrobial humoral response [GO:0019730]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation [GO:0006956]; complement activation, lectin pathway [GO:0001867]; developmental process [GO:0032502]; execution phase of apoptosis [GO:0097194]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" GO:0001867; GO:0002752; GO:0003677; GO:0005509; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006956; GO:0009897; GO:0019730; GO:0032502; GO:0042802; GO:0042806; GO:0070492; GO:0097194; GO:0120153; GO:1903028; GO:1905370 calcium ion binding [GO:0005509]; calcium-dependent carbohydrate binding [GO:0120153]; DNA binding [GO:0003677]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; oligosaccharide binding [GO:0070492] YADAQLSCQGRGGTLSMPK 0.96158 0.39405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBB4 ZSCA1_HUMAN Zinc finger and SCAN domain-containing protein 1 ZSCAN1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" APGLLGSRARLPLK 0.96159 0.23545 11.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2627 0 14.5829 12.1393 0 0 0 0 0 0 0 15.7129 0 0 0 0 0 0 13.7996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4653 0 0 0 13.6978 13.0583 0 13.6011 11.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L443 NTM2F_HUMAN NUT family member 2F NUTM2F FAM22F Homo sapiens (Human) GDPLASRRK 0.9616 0.26764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8103 0 0 0 0 0 0 0 0 0 0 P49789 FHIT_HUMAN "Bis(5'-adenosyl)-triphosphatase, EC 3.6.1.29 (AP3A hydrolase, AP3Aase) (Adenosine 5'-monophosphoramidase FHIT, EC 3.9.1.-) (Adenylylsulfatase, EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase, EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein)" FHIT Homo sapiens (Human) diadenosine triphosphate catabolic process [GO:0015964]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; purine nucleotide metabolic process [GO:0006163] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine 5'-monophosphoramidase activity [GO:0043530]; adenylylsulfatase activity [GO:0047627]; adenylylsulfate-ammonia adenylyltransferase activity [GO:0047352]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; ubiquitin protein ligase binding [GO:0031625]; diadenosine triphosphate catabolic process [GO:0015964]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; purine nucleotide metabolic process [GO:0006163] GO:0000166; GO:0001650; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006163; GO:0015964; GO:0031625; GO:0032435; GO:0042802; GO:0043530; GO:0047352; GO:0047627; GO:0047710; GO:0072332 adenosine 5'-monophosphoramidase activity [GO:0043530]; adenylylsulfatase activity [GO:0047627]; adenylylsulfate-ammonia adenylyltransferase activity [GO:0047352]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; ubiquitin protein ligase binding [GO:0031625] FGQHLIKPSVVFLK 0.9616 0.48848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKQ9 KLK9_HUMAN "Kallikrein-9, EC 3.4.21.- (Kallikrein-like protein 3, KLK-L3)" KLK9 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576]; secretory granule [GO:0030141] extracellular region [GO:0005576]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508; GO:0030141 serine-type endopeptidase activity [GO:0004252] WEGPEQLFRVTDFFPHPGFNK 0.9616 0.39346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IQ26 DEN5A_HUMAN "DENN domain-containing protein 5A (Rab6-interacting protein 1, Rab6IP1)" DENND5A KIAA1091 RAB6IP1 Homo sapiens (Human) "negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; negative regulation of neuron projection development [GO:0010977]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0005085; GO:0005802; GO:0005829; GO:0010977; GO:0031267; GO:0042147 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] ENETIARLQALVKR 0.96161 0.50421 0 0 0 0 0 0 0 0 11.5994 0 0 13.2149 0 0 0 0 11.8446 0 10.7669 0 0 0 0 0 0 0 0 0 0 0 12.4108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0015 0 14.1314 11.3712 0 0 0 11.0696 0 0 0 0 0 10.7712 10.1543 0 0 10.2454 0 0 0 0 0 0 0 0 0 11.5705 0 0 0 0 0 0 12.1421 0 0 13.5857 15.0935 13.2298 0 13.3651 13.4855 0 14.2186 12.8592 0 0 0 0 0 0 0 0 0 0 15.1116 0 0 0 0 12.6163 0 0 12.2936 0 0 0 0 0 0 0 0 0 0 12.7318 13.3161 0 0 0 12.7787 0 0 0 0 0 0 0 0 13.0698 11.6197 0 0 0 0 10.8992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2317 0 12.6317 0 0 0 12.6633 0 0 17.6552 12.8496 12.4765 0 0 0 0 0 0 0 12.9289 0 11.496 0 0 Q9HBG7 LY9_HUMAN "T-lymphocyte surface antigen Ly-9 (Cell surface molecule Ly-9) (Lymphocyte antigen 9) (SLAM family member 3, SLAMF3) (Signaling lymphocytic activation molecule 3) (CD antigen CD229)" LY9 CDABP0070 Homo sapiens (Human) cell adhesion [GO:0007155]; innate immune response [GO:0045087]; positive regulation of interleukin-17 production [GO:0032740]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; positive regulation of interleukin-17 production [GO:0032740]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540] GO:0005886; GO:0007155; GO:0009897; GO:0016021; GO:0032740; GO:0042110; GO:0045087; GO:0072540 NALAFARPK 0.96161 0.18206 0 0 0 0 0 0 10.2256 0 0 0 11.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0308 0 0 0 0 13.3174 17.3369 17.3513 0 0 0 0 0 0 13.2237 0 0 13.2812 12.8696 0 14.0654 12.2567 13.0952 13.3264 16.8434 13.1441 0 12.6228 13.5174 0 0 0 0 13.1455 0 13.2755 0 0 Q92834 RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator RPGR RP3 XLRP3 Homo sapiens (Human) cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0001750; GO:0003723; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0005929; GO:0006886; GO:0007601; GO:0036064; GO:0036126; GO:0042073; GO:0050896; GO:0060271 guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] DADQNHMSQNHQNIPPTNTER 0.96163 0.39304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9774 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6747 13.4433 11.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2409 13.8105 0 0 0 0 0 0 13.177 0 0 0 0 0 12.2299 12.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5729 0 0 0 0 0 0 0 0 0 0 0 12.1469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01619 KV320_HUMAN Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL) IGKV3-20 Homo sapiens (Human) adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; glomerular filtration [GO:0003094]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; monomeric IgA immunoglobulin complex [GO:0071748]; pentameric IgM immunoglobulin complex [GO:0071756]; plasma membrane [GO:0005886]; secretory IgA immunoglobulin complex [GO:0071751] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; monomeric IgA immunoglobulin complex [GO:0071748]; pentameric IgM immunoglobulin complex [GO:0071756]; plasma membrane [GO:0005886]; secretory IgA immunoglobulin complex [GO:0071751]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; glomerular filtration [GO:0003094]; immune response [GO:0006955] GO:0002250; GO:0003094; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019731; GO:0070062; GO:0071748; GO:0071751; GO:0071756; GO:0072562 antigen binding [GO:0003823] LLIYGASSRATGIPDR 0.96164 0.39272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CP2 FWCH2_HUMAN FLYWCH family member 2 FLYWCH2 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] KFSKLVLLTASK 0.96164 0.48526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22087 FBRL_HUMAN "rRNA 2'-O-methyltransferase fibrillarin, EC 2.1.1.- (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin)" FBL FIB1 FLRN Homo sapiens (Human) box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; osteoblast differentiation [GO:0001649]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254] GO:0000494; GO:0001094; GO:0001649; GO:0001650; GO:0001651; GO:0001652; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0008649; GO:0015030; GO:0016020; GO:0031167; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070062; GO:1990258; GO:1990259 ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094] GGFGGGR 0.96165 0.53103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.346 0 0 12.5478 13.9794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.58 0 0 0 0 0 0 0 0 0 0 0 13.7254 14.3728 0 0 13.8956 0 0 0 0 13.5841 0 0 0 12.213 0 0 0 0 0 0 13.7177 0 13.6405 0 0 0 0 12.9614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2495 0 14.2476 0 0 0 0 0 0 P0C862 C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A (Complement C1q and tumor necrosis factor-related protein 9) C1QTNF9 C1QTNF9A UNQ6503/PRO21380 Homo sapiens (Human) collagen trimer [GO:0005581]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; extracellular region [GO:0005576]; hormone activity [GO:0005179]; identical protein binding [GO:0042802] GO:0005179; GO:0005576; GO:0005581; GO:0042802 hormone activity [GO:0005179]; identical protein binding [GO:0042802] IGETLVLPKSAFTVGLTVLSK 0.96166 0.39197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51800 CLCKA_HUMAN "Chloride channel protein ClC-Ka, Chloride channel Ka (ClC-K1)" CLCNKA Homo sapiens (Human) chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; transepithelial chloride transport [GO:0030321] GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0030321; GO:0034707; GO:0034765; GO:0042802; GO:0046872; GO:0070293 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247] AHQWLYR 0.96166 0.22857 0 0 0 0 0 0 0 0 18.111 13.6095 0 17.7209 0 14.5067 14.5248 0 17.3977 0 12.9676 13.4977 12.8463 0 0 0 0 0 0 17.3439 17.2967 17.1844 0 13.7489 14.3102 0 13.0918 0 0 17.2173 0 0 0 0 0 13.1061 17.0228 12.9743 16.9485 13.1414 0 12.5799 0 15.3759 0 17.1571 17.2878 0 12.937 0 10.4909 0 0 0 0 0 0 0 10.2475 0 0 0 0 0 0 11.1249 0 0 0 0 0 0 0 0 0 0 18.0505 0 0 0 0 0 0 17.9263 17.9489 0 0 0 0 0 17.6424 18.1631 0 0 0 0 0 0 16.9805 17.9727 17.7352 0 16.3527 15.6651 17.5858 17.7022 17.0791 17.1643 17.8389 0 0 0 0 0 0 16.9797 0 19.6669 0 0 0 0 0 0 0 0 16.1085 16.5976 0 0 0 0 0 0 16.2484 0 17.2658 15.9863 16.9847 0 15.7849 0 0 0 0 15.5277 0 16.9779 16.7658 0 0 19.5826 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0704 0 0 0 18.9274 15.5601 11.9839 P20711 DDC_HUMAN "Aromatic-L-amino-acid decarboxylase, AADC, EC 4.1.1.28 (DOPA decarboxylase, DDC)" DDC AADC Homo sapiens (Human) aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to growth factor stimulus [GO:0071363]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; synaptic vesicle [GO:0008021]; 5-hydroxy-L-tryptophan decarboxylase activity [GO:0036467]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; catecholamine metabolic process [GO:0006584]; cellular amino acid metabolic process [GO:0006520]; cellular response to alkaloid [GO:0071312]; cellular response to growth factor stimulus [GO:0071363]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; dopamine biosynthetic process [GO:0042416]; isoquinoline alkaloid metabolic process [GO:0033076]; multicellular organism aging [GO:0010259]; phytoalexin metabolic process [GO:0052314]; response to pyrethroid [GO:0046684]; serotonin biosynthetic process [GO:0042427] GO:0004058; GO:0005737; GO:0005829; GO:0006520; GO:0006584; GO:0007623; GO:0008021; GO:0010259; GO:0015842; GO:0016597; GO:0016831; GO:0019899; GO:0019904; GO:0030170; GO:0030424; GO:0033076; GO:0036467; GO:0036468; GO:0042416; GO:0042427; GO:0043025; GO:0046684; GO:0052314; GO:0070062; GO:0071312; GO:0071363; GO:0071466 5-hydroxy-L-tryptophan decarboxylase activity [GO:0036467]; amino acid binding [GO:0016597]; aromatic-L-amino-acid decarboxylase activity [GO:0004058]; carboxy-lyase activity [GO:0016831]; enzyme binding [GO:0019899]; L-dopa decarboxylase activity [GO:0036468]; protein domain specific binding [GO:0019904]; pyridoxal phosphate binding [GO:0030170] EMVDYMANYMEGIEGRQVYPDVEPGYLR 0.96167 0.48324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.321 0 0 Q8IXW5 RPAP2_HUMAN "Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2, EC 3.1.3.16 (RNA polymerase II-associated protein 2)" RPAP2 C1orf82 Homo sapiens (Human) dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; snRNA transcription [GO:0009301]" GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008420; GO:0009301; GO:0016591; GO:0017018; GO:0043175; GO:0046872; GO:0070940 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] AAGTKQTSTLK 0.96167 4.4059 0 0 0 0 12.2658 12.0136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6302 0 0 14.1841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1126 0 0 0 0 0 13.1824 0 0 0 13.2793 0 0 0 0 0 0 0 14.9706 0 0 0 0 13.9663 0 13.831 13.348 14.2937 0 0 14.9406 14.0195 12.4045 0 0 15.2963 12.9279 0 0 0 0 13.5203 0 15.1505 0 0 0 0 0 0 0 0 0 14.4853 0 0 0 12.755 15.4659 14.783 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2048 0 0 0 0 14.2372 0 0 0 0 0 0 12.5081 0 0 0 0 0 Q96DD7 SHSA4_HUMAN Protein shisa-4 (Transmembrane protein 58) SHISA4 C1orf40 TMEM58 UNQ583/PRO1153 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DLTLLITER 0.96167 0.27556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2N4 ATS9_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 9, ADAM-TS 9, ADAM-TS9, ADAMTS-9, EC 3.4.24.-" ADAMTS9 KIAA1312 Homo sapiens (Human) aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192] GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0090673; GO:1903671 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] AEEWQECTK 0.96167 0.52931 14.72 0 0 0 0 0 0 0 0 0 10.7284 0 0 10.6246 0 0 9.21527 11.3799 10.9592 0 0 0 0 0 0 0 0 0 9.69115 0 11.5344 12.148 0 0 0 0 0 0 10.9583 0 0 0 0 0 0 12.5363 10.7551 0 0 0 0 0 10.7106 0 10.7299 0 0 0 0 0 0 0 0 0 0 0 11.4651 13.314 12.8264 14.49 0 0 0 0 13.9215 10.9948 0 0 12.7647 11.5017 0 13.2081 0 0 15.5633 15.0018 0 12.0338 13.2975 0 0 15.6218 0 0 0 13.0925 0 0 12.4994 0 0 0 0 0 0 0 0 0 10.952 0 0 12.8077 0 0 0 0 0 11.5468 0 15.4655 0 17.0051 11.6278 0 0 11.5835 0 0 12.4683 0 12.4723 13.0927 0 13.4967 0 0 0 13.5678 0 0 0 0 11.9441 0 0 0 0 12.126 0 0 0 0 0 15.1441 0 13.1752 0 13.3383 0 0 0 0 0 0 0 12.8453 0 13.0397 0 11.0906 13.3191 0 12.2127 0 10.8347 0 0 12.1952 0 0 X6R8D5 GUCNB_HUMAN Putative uncharacterized protein GUCA1ANB (GUCA1A neighbor) GUCA1ANB Homo sapiens (Human) GRKEHESPSQPHMCGWEDSQK 0.96167 0.2284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCE2 MTMRE_HUMAN "Myotubularin-related protein 14, EC 3.1.3.- (HCV NS5A-transactivated protein 4 splice variant A-binding protein 1, NS5ATP4ABP1) (hJumpy)" MTMR14 C3orf29 Homo sapiens (Human) dephosphorylation [GO:0016311]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726] "cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; dephosphorylation [GO:0016311]; macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661]" GO:0001726; GO:0004438; GO:0004722; GO:0005829; GO:0006661; GO:0016236; GO:0016311; GO:0048471; GO:0052629 "phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]" AKDGSGTGGSK 0.96168 0.48179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6231 13.7314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0165 0 0 0 0 0 0 0 0 0 0 0 12.2318 0 0 0 11.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0484 12.5827 12.6514 0 0 0 13.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0019 12.0852 0 0 11.7649 0 0 12.255 0 0 0 0 11.8168 0 0 0 0 0 0 0 0 13.0152 0 0 0 0 0 12.9305 0 0 0 0 0 0 0 12.2585 0 P0CG30 GSTT2_HUMAN "Glutathione S-transferase theta-2B, EC 2.5.1.18 (Glutathione S-transferase theta-2, GST class-theta-2)" GSTT2B GSTT2 Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749] GO:0004364; GO:0005654; GO:0005737; GO:0005829; GO:0006749; GO:0070062 glutathione transferase activity [GO:0004364] GLELFLDLVSQPSRAVYIFAKK 0.96169 0.28044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3617 0 0 0 12.7658 0 0 0 0 0 0 0 0 14.4726 0 0 0 0 0 0 13.0888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2301 0 Q96CW1 AP2M1_HUMAN AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein) AP2M1 CLAPM1 KIAA0109 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; low-density lipoprotein particle receptor binding [GO:0050750]; signal sequence binding [GO:0005048]; transmembrane transporter binding [GO:0044325]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192] GO:0002092; GO:0005048; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006886; GO:0006897; GO:0006900; GO:0008289; GO:0009898; GO:0016192; GO:0030122; GO:0030666; GO:0030669; GO:0031410; GO:0031623; GO:0035615; GO:0036020; GO:0044325; GO:0045334; GO:0048488; GO:0050750; GO:0065003; GO:0070062; GO:0072583; GO:0097494; GO:0097718; GO:0098793; GO:0098794; GO:0098884; GO:0098978; GO:1900244; GO:1903077 clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; low-density lipoprotein particle receptor binding [GO:0050750]; signal sequence binding [GO:0005048]; transmembrane transporter binding [GO:0044325] ASENAIVWKIKR 0.96169 0.52629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4493 13.7438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9583 12.6839 0 0 13.5864 0 12.9656 0 13.3995 0 12.0861 0 13.8129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3967 0 0 0 0 0 0 0 0 14.5783 0 0 0 12.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZP9 DERL2_HUMAN "Derlin-2 (Degradation in endoplasmic reticulum protein 2, DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa)" DERL2 DER2 FLANA CGI-101 SBBI53 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]" early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020] "early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; late endosome [GO:0005770]; membrane [GO:0016020]; misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000839; GO:0001967; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0030176; GO:0030307; GO:0030433; GO:0030968; GO:0030970; GO:0044877; GO:0051787; GO:1904153 misfolded protein binding [GO:0051787]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047] AYTTACVLTTAAVQLELITPFQLYFNPELIFK 0.96169 0.17545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6238 0 0 0 0 0 P35712 SOX6_HUMAN Transcription factor SOX-6 SOX6 Homo sapiens (Human) "brain development [GO:0007420]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord oligodendrocyte cell differentiation [GO:0021529]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001217; GO:0001502; GO:0002062; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0007517; GO:0021529; GO:0032332; GO:0042803; GO:0045165; GO:0051216; GO:0061036; GO:0071560; GO:2000726; GO:2000741 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GHVSHPQINQRLK 0.9617 0.49501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1514 0 0 0 0 0 0 0 0 0 18.0025 0 0 0 0 0 0 0 0 0 14.6415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53QV2 LBH_HUMAN "Protein LBH, hLBH (Limb bud and heart development protein homolog)" LBH Homo sapiens (Human) "mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of mammary stem cell proliferation [GO:2000103]; positive regulation of somatic stem cell division [GO:1904677]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of MAPK cascade [GO:0043408]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of mammary stem cell proliferation [GO:2000103]; positive regulation of somatic stem cell division [GO:1904677]; positive regulation of somatic stem cell population maintenance [GO:1904674]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of MAPK cascade [GO:0043408]" GO:0005634; GO:0005737; GO:0032991; GO:0033147; GO:0043408; GO:0045892; GO:0045893; GO:0060644; GO:1904674; GO:1904677; GO:2000103; GO:2000737 DGLSYQIFPDPSDFDRCCK 0.9617 0.4812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMM2 ATL5_HUMAN "ADAMTS-like protein 5, ADAMTSL-5 (Thrombospondin type-1 domain-containing protein 6)" ADAMTSL5 THSD6 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; microfibril binding [GO:0050436] GO:0001527; GO:0004222; GO:0005576; GO:0008201; GO:0031012; GO:0050436 heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; microfibril binding [GO:0050436] VQALGWPLRQPQPR 0.9617 0.28034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXU2 TX13B_HUMAN Testis-expressed protein 13B TEX13B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005737 mRNA binding [GO:0003729]; RNA binding [GO:0003723] ALRPEDPSSGFRHGNVVAFIIEK 0.9617 0.54454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6735 0 0 11.3568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.458 0 0 11.8709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4533 13.4731 0 0 0 0 0 12.6774 0 12.829 12.7305 0 0 0 0 0 0 0 0 16.4739 14.0873 0 14.147 0 0 0 0 0 0 0 0 0 13.3587 13.2434 0 0 0 0 13.3681 0 0 0 0 0 0 0 0 14.4965 13.8539 13.9964 0 0 0 0 0 0 0 0 0 0 0 0 13.5482 0 13.0964 0 0 0 0 13.5137 0 0 0 14.1191 12.9522 13.4439 13.0923 13.8608 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9085 0 0 0 0 14.5735 0 0 0 0 0 0 0 13.3798 0 13.6069 0 0 0 14.7869 0 0 P38405 GNAL_HUMAN "Guanine nucleotide-binding protein G(olf) subunit alpha (Adenylate cyclase-stimulating G alpha protein, olfactory type)" GNAL Homo sapiens (Human) adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0007191; GO:0007606; GO:0031683; GO:0046872; GO:0070062 G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] FFIRDLFLR 0.96173 0.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6433 0 0 0 0 0 0 0 0 0 0 12.227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4978 13.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0631 0 13.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14060 3BHS1_HUMAN "3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I, 3-beta-HSD I) (3-beta-hydroxy-5-ene steroid dehydrogenase) (3-beta-hydroxy-Delta(5)-steroid dehydrogenase, EC 1.1.1.145) (3-beta-hydroxysteroid 3-dehydrogenase, EC 1.1.1.270) (Delta-5-3-ketosteroid isomerase) (Dihydrotestosterone oxidoreductase, EC 1.1.1.210) (Steroid Delta-isomerase, EC 5.3.3.1) (Trophoblast antigen FDO161G)" HSD3B1 3BH HSDB3A Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; C21-steroid hormone metabolic process [GO:0008207]; estrogen biosynthetic process [GO:0006703]; hippocampus development [GO:0021766]; response to corticosterone [GO:0051412]; steroid biosynthetic process [GO:0006694] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; smooth endoplasmic reticulum membrane [GO:0030868] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; smooth endoplasmic reticulum membrane [GO:0030868]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-keto sterol reductase activity [GO:0000253]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; cholesterol dehydrogenase activity [GO:0102294]; cycloeucalenone reductase activity [GO:0102176]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid delta-isomerase activity [GO:0004769]; androgen biosynthetic process [GO:0006702]; C21-steroid hormone metabolic process [GO:0008207]; estrogen biosynthetic process [GO:0006703]; hippocampus development [GO:0021766]; response to corticosterone [GO:0051412]; steroid biosynthetic process [GO:0006694]" GO:0000253; GO:0003854; GO:0004769; GO:0005730; GO:0005737; GO:0005743; GO:0005758; GO:0005783; GO:0005789; GO:0006694; GO:0006702; GO:0006703; GO:0008207; GO:0016021; GO:0016616; GO:0021766; GO:0030868; GO:0043231; GO:0045171; GO:0047024; GO:0051412; GO:0102176; GO:0102294 "3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-keto sterol reductase activity [GO:0000253]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; cholesterol dehydrogenase activity [GO:0102294]; cycloeucalenone reductase activity [GO:0102176]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid delta-isomerase activity [GO:0004769]" ELKEIRVLDK 0.96174 0.50834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95994 AGR2_HUMAN "Anterior gradient protein 2 homolog, AG-2, hAG-2 (HPC8) (Secreted cement gland protein XAG-2 homolog)" AGR2 AG2 UNQ515/PRO1030 Homo sapiens (Human) digestive tract morphogenesis [GO:0048546]; lung goblet cell differentiation [GO:0060480]; mucus secretion [GO:0070254]; negative regulation of cell death [GO:0060548]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of developmental growth [GO:0048639]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of gene expression [GO:0010628]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; positive regulation of protein localization to plasma membrane [GO:1903078] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; dystroglycan binding [GO:0002162]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; digestive tract morphogenesis [GO:0048546]; lung goblet cell differentiation [GO:0060480]; mucus secretion [GO:0070254]; negative regulation of cell death [GO:0060548]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of developmental growth [GO:0048639]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of gene expression [GO:0010628]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; positive regulation of protein localization to plasma membrane [GO:1903078] GO:0002162; GO:0005154; GO:0005576; GO:0005615; GO:0005783; GO:0010628; GO:0010811; GO:0042802; GO:0045742; GO:0048546; GO:0048639; GO:0060480; GO:0060548; GO:0070254; GO:1903078; GO:1903896; GO:1903899 dystroglycan binding [GO:0002162]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802] EKIPVSAFLLLVALSYTLAR 0.96175 0.18448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3286 0 0 0 0 0 0 0 0 12.6262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5821 0 12.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05388 RLA0_HUMAN 60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10) RPLP0 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to interleukin-4 [GO:0071353]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to Thyroid stimulating hormone [GO:1904401]; cytoplasmic translation [GO:0002181]; lactation [GO:0007595]; response to selenium ion [GO:0010269]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; large ribosomal subunit rRNA binding [GO:0070180]; peptide binding [GO:0042277]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to cAMP [GO:0071320]; cellular response to interleukin-4 [GO:0071353]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to Thyroid stimulating hormone [GO:1904401]; cytoplasmic translation [GO:0002181]; lactation [GO:0007595]; response to selenium ion [GO:0010269]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0007595; GO:0010269; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0030425; GO:0036464; GO:0042277; GO:0070062; GO:0070180; GO:0071320; GO:0071353; GO:0098794; GO:1904401; GO:1904628; GO:1990904 large ribosomal subunit rRNA binding [GO:0070180]; peptide binding [GO:0042277]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AIRGHLENNPALEKLLPHIR 0.96175 0.53974 0 0 0 17.1709 0 0 0 0 0 0 13.1881 0 13.2024 0 0 13.4935 0 13.5236 0 12.8201 0 0 12.5983 0 13.5365 13.5872 0 11.9787 13.2587 0 0 13.1308 0 0 0 0 12.1086 13.07 0 0 0 13.1126 13.4852 13.3083 13.4149 13.3887 0 0 0 0 13.9171 0 13.8153 13.6973 13.2186 0 0 0 11.9294 0 0 0 12.7922 14.1806 0 12.2877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4426 0 0 10.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6811 0 0 13.6272 0 0 0 0 0 0 0 0 13.6546 13.7568 14.3581 14.5433 14.7329 14.4195 15.6198 14.8335 14.6574 0 0 0 0 0 0 0 14.336 0 14.5378 0 0 Q9H6S3 ES8L2_HUMAN "Epidermal growth factor receptor kinase substrate 8-like protein 2, EPS8-like protein 2 (Epidermal growth factor receptor pathway substrate 8-related protein 2, EPS8-related protein 2)" EPS8L2 EPS8R2 PP13181 Homo sapiens (Human) positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266]; sensory perception of sound [GO:0007605] GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0007605; GO:0031982; GO:0032421; GO:0032426; GO:0032587; GO:0032991; GO:0035023; GO:0045296; GO:0050790; GO:0070062; GO:1900029 actin binding [GO:0003779]; cadherin binding [GO:0045296] IKLAINLLAKLQK 0.96175 0.27865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5719 0 16.8634 13.5031 0 0 0 0 0 0 0 0 0 0 0 13.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13946 PDE7A_HUMAN "High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A, EC 3.1.4.53 (HCP1) (TM22)" PDE7A Homo sapiens (Human) cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; signal transduction [GO:0007165] cytosol [GO:0005829] "cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; signal transduction [GO:0007165]" GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0019933; GO:0046872 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" QWSEKVTEEFFHQGDIEK 0.96176 0.26802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7781 12.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4617 0 0 0 0 0 0 0 14.0591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5BIV9 SPRN_HUMAN "Shadow of prion protein, Protein shadoo" SPRN SHO Homo sapiens (Human) protein import into nucleus [GO:0006606] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; protein import into nucleus [GO:0006606] GO:0003676; GO:0005576; GO:0005634; GO:0005886; GO:0006606; GO:0031225 nucleic acid binding [GO:0003676] GPRLCLVLGGALGALGLLR 0.96176 0.39405 0 0 0 0 0 0 0 0 13.6793 0 0 0 0 0 0 0 0 13.7597 0 0 0 0 0 0 0 13.2884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0534 0 0 0 0 0 0 Q8TDP1 RNH2C_HUMAN "Ribonuclease H2 subunit C, RNase H2 subunit C (Aicardi-Goutieres syndrome 3 protein, AGS3) (RNase H1 small subunit) (Ribonuclease HI subunit C)" RNASEH2C AYP1 Homo sapiens (Human) mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401] nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299] nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401] GO:0005634; GO:0006298; GO:0006401; GO:0032299 DFDRFIGATANFSR 0.96177 0.26786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSM1 PCGF1_HUMAN "Polycomb group RING finger protein 1 (Nervous system Polycomb-1, NSPc1) (RING finger protein 68)" PCGF1 NSPC1 RNF68 Homo sapiens (Human) "histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0005634; GO:0005654; GO:0006355; GO:0008022; GO:0031519; GO:0035102; GO:0035518; GO:0036353; GO:0046872; GO:1990841 metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022] LDRVMQDIVYKLVPGLQDSEEK 0.96177 0.16825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.369 13.332 13.7881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.231 0 0 0 0 15.6044 0 0 0 0 12.6059 0 0 0 0 0 0 0 0 0 12.0047 0 12.4529 0 0 13.2266 13.8064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB15 KCNKC_HUMAN "Potassium channel subfamily K member 12 (Tandem pore domain halothane-inhibited potassium channel 2, THIK-2)" KCNK12 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] GO:0005887; GO:0015271; GO:0022841; GO:0030322; GO:0034765; GO:0071805 outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841] DLTASNKVSLALLQK 0.96177 0.49047 0 0 0 0 0 0 0 0 0 14.6226 0 10.8558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5717 0 0 0 12.8528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6997 0 12.9917 13.5245 0 0 0 11.5517 0 0 0 0 0 0 0 0 0 13.0409 0 0 0 0 0 0 0 0 0 0 12.5694 0 10.5575 0 0 0 0 0 0 0 0 0 0 0 0 12.9945 0 Q9NS69 TOM22_HUMAN "Mitochondrial import receptor subunit TOM22 homolog, hTom22 (1C9-2) (Translocase of outer membrane 22 kDa subunit homolog)" TOMM22 TOM22 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; positive regulation of apoptotic process [GO:0043065]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626] GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0008320; GO:0016020; GO:0016021; GO:0043065; GO:0045040 protein transmembrane transporter activity [GO:0008320] GDAEKPEEELEEDDDEELDETLSER 0.96177 0.33619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5967 0 0 0 0 12.8931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2471 0 0 0 P54252 ATX3_HUMAN "Ataxin-3, EC 3.4.19.12 (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein)" ATXN3 ATX3 MJD MJD1 SCA3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; chemical synaptic transmission [GO:0007268]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; nervous system development [GO:0007399]; nucleotide-excision repair [GO:0006289]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; chemical synaptic transmission [GO:0007268]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; nervous system development [GO:0007399]; nucleotide-excision repair [GO:0006289]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000226; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006289; GO:0006511; GO:0006515; GO:0007268; GO:0007399; GO:0010810; GO:0016363; GO:0016579; GO:0030036; GO:0031625; GO:0031966; GO:0034605; GO:0035520; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0045202; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904294; GO:1904379; GO:1990380 ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; ubiquitin protein ligase binding [GO:0031625] LIGEELAQLK 0.96178 0.16123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31645 SC6A4_HUMAN "Sodium-dependent serotonin transporter, SERT (5HT transporter, 5HTT) (Solute carrier family 6 member 4)" SLC6A4 HTT SERT Homo sapiens (Human) "brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; neurotransmitter transport [GO:0006836]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; regulation of thalamus size [GO:0090067]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; serotonin uptake [GO:0051610]; social behavior [GO:0035176]; sodium ion transmembrane transport [GO:0035725]; sperm ejaculation [GO:0042713]; vasoconstriction [GO:0042310]" endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154]; synapse [GO:0045202] "endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154]; synapse [GO:0045202]; actin filament binding [GO:0051015]; cocaine binding [GO:0019811]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nitric-oxide synthase binding [GO:0050998]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; syntaxin-1 binding [GO:0017075]; brain morphogenesis [GO:0048854]; cellular response to cGMP [GO:0071321]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; memory [GO:0007613]; monoamine transport [GO:0015844]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of organ growth [GO:0046621]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; neurotransmitter transport [GO:0006836]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of serotonin secretion [GO:0014064]; regulation of thalamus size [GO:0090067]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; serotonin uptake [GO:0051610]; social behavior [GO:0035176]; sodium ion transmembrane transport [GO:0035725]; sperm ejaculation [GO:0042713]; vasoconstriction [GO:0042310]" GO:0001666; GO:0005326; GO:0005335; GO:0005886; GO:0005887; GO:0005925; GO:0006836; GO:0007584; GO:0007613; GO:0007623; GO:0008504; GO:0009410; GO:0009636; GO:0010008; GO:0010628; GO:0012505; GO:0014064; GO:0015844; GO:0017075; GO:0019811; GO:0021941; GO:0032227; GO:0032355; GO:0035176; GO:0035725; GO:0042310; GO:0042713; GO:0042802; GO:0043005; GO:0045121; GO:0045202; GO:0045665; GO:0045787; GO:0046621; GO:0046872; GO:0048854; GO:0050998; GO:0051015; GO:0051378; GO:0051610; GO:0071300; GO:0071321; GO:0090067; GO:0099055; GO:0099056; GO:0099154 actin filament binding [GO:0051015]; cocaine binding [GO:0019811]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nitric-oxide synthase binding [GO:0050998]; serotonin binding [GO:0051378]; serotonin:sodium symporter activity [GO:0005335]; syntaxin-1 binding [GO:0017075] GATLPGAWRGVLFYLK 0.96179 0.48883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N140 EID3_HUMAN "EP300-interacting inhibitor of differentiation 3, EID-3 (E1A-like inhibitor of differentiation 3) (EID-1-like inhibitor of differentiation 3) (Non-structural maintenance of chromosomes element 4 homolog B, NS4EB, Non-SMC element 4 homolog B)" EID3 Homo sapiens (Human) DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0016925; GO:0030915; GO:0032204 AAGCSDDLSSGEADVDPKLLELTADEEK 0.96179 0.23207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0685 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7406 0 0 13.629 0 0 12.4684 0 13.0506 0 12.2962 0 0 0 0 0 12.3051 0 0 0 0 0 0 0 12.4763 0 0 0 0 0 0 0 0 0 12.3805 0 13.8447 14.8406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H910 JUPI2_HUMAN "Jupiter microtubule associated homolog 2 (Hematological and neurological expressed 1-like protein, HN1-like protein)" JPT2 C16orf34 HN1L L11 Homo sapiens (Human) endocytosis involved in viral entry into host cell [GO:0075509]; regulation of calcium-mediated signaling [GO:0050848] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; endocytosis involved in viral entry into host cell [GO:0075509]; regulation of calcium-mediated signaling [GO:0050848] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0050848; GO:0075509 FQVPDSEGGR 0.9618 0.15958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4906 13.2188 0 0 12.4968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6293 0 0 Q8NGX8 OR6Y1_HUMAN Olfactory receptor 6Y1 (Olfactory receptor 6Y2) (Olfactory receptor OR1-11) OR6Y1 OR6Y2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IPSAQGR 0.96181 0.076429 0 0 0 0 0 0 0 0 0 16.6481 16.559 11.9848 16.6256 0 16.4783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0422 0 17.1559 0 0 0 0 0 0 0 0 0 0 0 17.2943 0 17.1829 0 0 0 0 16.5034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2729 12.2944 0 17.3789 0 17.3096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5058 0 0 P42830 CXCL5_HUMAN C-X-C motif chemokine 5 (ENA-78(1-78)) (Epithelial-derived neutrophil-activating protein 78) (Neutrophil-activating peptide ENA-78) (Small-inducible cytokine B5) [Cleaved into: ENA-78(8-78); ENA-78(9-78) ] CXCL5 ENA78 SCYB5 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; identical protein binding [GO:0042802]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165] GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007267; GO:0008009; GO:0008284; GO:0030593; GO:0042802; GO:0045236; GO:0061844; GO:0070098; GO:0071222 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; identical protein binding [GO:0042802] VPGPSSSLCALLVLLLLLTQPGPIASAGPAAAVLR 0.96183 0.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02297 NRG1_HUMAN "Pro-neuregulin-1, membrane-bound isoform, Pro-NRG1 [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity, ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin, HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor) ]" NRG1 GGF HGL HRGA NDF SMDF Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB signaling pathway [GO:0038127]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERBB2-ERBB4 signaling pathway [GO:0038135]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neuron migration [GO:0001764]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; protein catabolic process [GO:0030163]; protein kinase B signaling [GO:0043491]; protein-containing complex disassembly [GO:0032984]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654] "apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB signaling pathway [GO:0038127]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERBB2-ERBB4 signaling pathway [GO:0038135]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neuron migration [GO:0001764]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; protein catabolic process [GO:0030163]; protein kinase B signaling [GO:0043491]; protein-containing complex disassembly [GO:0032984]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" GO:0000165; GO:0000902; GO:0001764; GO:0003161; GO:0003222; GO:0003712; GO:0005102; GO:0005125; GO:0005176; GO:0005178; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005887; GO:0007154; GO:0007169; GO:0007171; GO:0007399; GO:0007416; GO:0007626; GO:0008083; GO:0008283; GO:0008284; GO:0010628; GO:0010667; GO:0014032; GO:0016020; GO:0016324; GO:0021781; GO:0021842; GO:0022011; GO:0030154; GO:0030163; GO:0030296; GO:0030297; GO:0030307; GO:0030424; GO:0030879; GO:0030971; GO:0031334; GO:0031594; GO:0032148; GO:0032984; GO:0035556; GO:0038127; GO:0038129; GO:0038130; GO:0038133; GO:0038135; GO:0038138; GO:0042060; GO:0042177; GO:0043125; GO:0043491; GO:0045213; GO:0045499; GO:0045785; GO:0045892; GO:0046579; GO:0048018; GO:0048513; GO:0048663; GO:0048709; GO:0051048; GO:0051155; GO:0051897; GO:0055007; GO:0055012; GO:0060045; GO:0060379; GO:0060956; GO:0070374; GO:0070886; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:0099149; GO:0099527; GO:0099560; GO:1900086; GO:2001223; GO:2001240 chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] CAEKEKTFCVNGGECFMVK 0.96183 4.5284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0796 0 0 0 0 0 0 0 0 0 0 10.4788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6881 0 0 0 0 0 0 0 0 0 0 0 12.8878 0 0 0 14.6059 0 12.3258 0 0 0 0 0 0 0 0 0 11.9496 0 0 13.8273 13.3865 0 11.0349 0 0 0 13.5047 0 0 14.6803 12.5758 0 0 0 0 0 0 0 12.4677 0 0 0 0 0 0 12.8074 0 12.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0474 0 0 0 0 0 0 0 0 11.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8588 11.9594 11.8548 0 0 0 0 0 Q9UK73 FEM1B_HUMAN "Protein fem-1 homolog B, FEM1b (FEM1-beta) (Fem-1-like death receptor-binding protein alpha) (Fem-1-like in apoptotic pathway protein alpha, F1A-alpha)" FEM1B F1AA KIAA0396 Homo sapiens (Human) apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; apoptotic process [GO:0006915]; branching involved in prostate gland morphogenesis [GO:0060442]; epithelial cell maturation involved in prostate gland development [GO:0060743]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0051438; GO:0060442; GO:0060743; GO:0140627; GO:1902041; GO:1990756; GO:2000001 death receptor binding [GO:0005123]; ubiquitin ligase-substrate adaptor activity [GO:1990756] ADVVELLLSHADCDR 0.96183 0.22863 0 0 0 0 0 0 15.116 0 13.4011 0 13.6126 12.8544 14.1439 13.3712 12.9489 12.2979 0 0 0 0 0 0 0 0 0 0 11.9974 0 12.6541 12.7094 12.0133 0 11.8188 12.1784 12.6171 0 0 0 12.3773 0 11.6888 12.0348 0 11.9878 0 0 0 11.9124 0 11.8243 0 0 11.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7763 0 0 10.9202 0 0 0 0 0 0 0 0 0 0 0 14.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0026 0 0 0 0 0 0 0 0 0 0 0 14.1682 0 0 0 0 0 0 0 0 0 15.2009 16.4716 13.2342 15.4337 15.0651 18.0575 14.2555 15.1661 0 13.6466 15.8073 13.8063 0 15.3842 0 0 0 0 15.0903 0 15.0251 0 0 P51677 CCR3_HUMAN "C-C chemokine receptor type 3, C C CKR3, C-C CKR-3, CC-CKR-3, CCR-3, CCR3, CKR 3, CKR3 (Eosinophil eotaxin receptor) (CD antigen CD193)" CCR3 CMKBR3 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell proliferation [GO:0001938] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell proliferation [GO:0001938] GO:0001938; GO:0004950; GO:0005737; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007155; GO:0007188; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0045766; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950] ALMAQFVPPLYSLVFTVGLLGNVVVVMILIK 0.96184 0.5316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.816 0 0 0 0 0 0 0 0 0 16.2361 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25105 PTAFR_HUMAN "Platelet-activating factor receptor, PAF-R, PAFr" PTAFR PAFR Homo sapiens (Human) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine [GO:1904317]; cellular response to cAMP [GO:0071320]; cellular response to fatty acid [GO:0071398]; cellular response to gravity [GO:0071258]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of blood pressure [GO:0045776]; parturition [GO:0007567]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of gastro-intestinal system smooth muscle contraction [GO:1904306]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of maternal process involved in parturition [GO:1904303]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcytosis [GO:1904300]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; regulation of transcription by RNA polymerase II [GO:0006357]; response to dexamethasone [GO:0071548]; response to symbiotic bacterium [GO:0009609]; transcytosis [GO:0045056] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; mitogen-activated protein kinase binding [GO:0051019]; phospholipid binding [GO:0005543]; platelet activating factor receptor activity [GO:0004992]; cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine [GO:1904317]; cellular response to cAMP [GO:0071320]; cellular response to fatty acid [GO:0071398]; cellular response to gravity [GO:0071258]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inositol trisphosphate biosynthetic process [GO:0032959]; negative regulation of blood pressure [GO:0045776]; parturition [GO:0007567]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of gastro-intestinal system smooth muscle contraction [GO:1904306]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of maternal process involved in parturition [GO:1904303]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcytosis [GO:1904300]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; regulation of transcription by RNA polymerase II [GO:0006357]; response to dexamethasone [GO:0071548]; response to symbiotic bacterium [GO:0009609]; transcytosis [GO:0045056] GO:0001530; GO:0001875; GO:0002693; GO:0004930; GO:0004992; GO:0005543; GO:0005886; GO:0005887; GO:0006357; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007567; GO:0009609; GO:0010863; GO:0016021; GO:0030667; GO:0032755; GO:0032760; GO:0032959; GO:0043315; GO:0045028; GO:0045056; GO:0045727; GO:0045776; GO:0048015; GO:0048661; GO:0051019; GO:0060732; GO:0070821; GO:0071258; GO:0071320; GO:0071398; GO:0071548; GO:1902943; GO:1903238; GO:1904058; GO:1904300; GO:1904303; GO:1904306; GO:1904317 G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; mitogen-activated protein kinase binding [GO:0051019]; phospholipid binding [GO:0005543]; platelet activating factor receptor activity [GO:0004992] EPHDSSHMDSEFR 0.96185 0.48329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4772 0 0 0 0 12.2948 0 15.0735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4492 0 0 0 0 0 0 0 10.7973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IFH4 OR6B2_HUMAN Olfactory receptor 6B2 (Olfactory receptor OR2-1) OR6B2 OR6B2P Homo sapiens (Human) cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005829; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ALGLGQTSH 0.96185 0.072446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9402 0 0 14.7427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1N2 DYNAP_HUMAN "Dynactin-associated protein, Full" DYNAP C18orf26 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; cellular response to ergosterol [GO:1901625]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; activation of protein kinase B activity [GO:0032148]; cellular response to ergosterol [GO:1901625]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981] GO:0000139; GO:0005794; GO:0005886; GO:0008284; GO:0016021; GO:0032148; GO:0042981; GO:1901625 EACDTGSSRMDR 0.96186 0.18829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.727 0 0 12.6023 0 14.9874 0 15.7715 14.1484 0 13.7974 0 0 0 14.6857 0 0 0 14.1298 0 0 0 0 0 13.2174 14.4626 0 0 0 0 0 13.8052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTU7 CBLN4_HUMAN Cerebellin-4 (Cerebellin-like glycoprotein 1) CBLN4 CBLNL1 UNQ718/PRO1382 Homo sapiens (Human) inhibitory synapse assembly [GO:1904862]; maintenance of synapse structure [GO:0099558]; protein secretion [GO:0009306] anchoring junction [GO:0070161]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; synapse [GO:0045202] anchoring junction [GO:0070161]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; synapse [GO:0045202]; inhibitory synapse assembly [GO:1904862]; maintenance of synapse structure [GO:0099558]; protein secretion [GO:0009306] GO:0005576; GO:0005615; GO:0009306; GO:0045202; GO:0062023; GO:0070161; GO:0098982; GO:0099558; GO:1904862 PVISAFAGDKDVTR 0.96186 0.52961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DN82 O12D1_HUMAN Olfactory receptor 12D1 OR12D1 OR12D1P Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ITAIMYTVVTPVLNPLIYTLRNK 0.96187 0.39514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6216 0 0 0 0 0 0 0 0 0 0 P43115 PE2R3_HUMAN "Prostaglandin E2 receptor EP3 subtype, PGE receptor EP3 subtype, PGE2 receptor EP3 subtype (PGE2-R) (Prostanoid EP3 receptor)" PTGER3 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell death [GO:0008219]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intestine smooth muscle contraction [GO:0014827]; negative regulation of gastric acid secretion [GO:0060455]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fever generation [GO:0031622] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; prostaglandin E receptor activity [GO:0004957]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell death [GO:0008219]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intestine smooth muscle contraction [GO:0014827]; negative regulation of gastric acid secretion [GO:0060455]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fever generation [GO:0031622] GO:0004957; GO:0005635; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007189; GO:0007200; GO:0007204; GO:0008219; GO:0014827; GO:0016021; GO:0031622; GO:0060455 prostaglandin E receptor activity [GO:0004957] ETRGYGGDAPFCTR 0.96187 0.28034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1W2PP97 THSD8_HUMAN Thrombospondin type-1 domain-containing protein 8 THSD8 Homo sapiens (Human) DCPSCKPFDCDWR 0.96188 0.52745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2519 0 13.0115 0 0 0 0 0 0 0 13.4544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8762 0 0 0 0 0 0 0 0 0 0 0 0 14.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.61835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55085 PAR2_HUMAN "Proteinase-activated receptor 2, PAR-2 (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2 ]" F2RL1 GPR11 PAR2 Homo sapiens (Human) "blood coagulation [GO:0007596]; cell-cell junction maintenance [GO:0045217]; defense response to virus [GO:0051607]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; leukocyte proliferation [GO:0070661]; mature conventional dendritic cell differentiation [GO:0097029]; negative regulation of chemokine production [GO:0032682]; negative regulation of JNK cascade [GO:0046329]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neutrophil activation [GO:0042119]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070963]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of renin secretion into blood stream [GO:1900135]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of blood coagulation [GO:0030193]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of JNK cascade [GO:0046328]; T cell activation involved in immune response [GO:0002286]; vasodilation [GO:0042311]" early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] "early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; thrombin-activated receptor activity [GO:0015057]; blood coagulation [GO:0007596]; cell-cell junction maintenance [GO:0045217]; defense response to virus [GO:0051607]; establishment of endothelial barrier [GO:0061028]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; leukocyte proliferation [GO:0070661]; mature conventional dendritic cell differentiation [GO:0097029]; negative regulation of chemokine production [GO:0032682]; negative regulation of JNK cascade [GO:0046329]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neutrophil activation [GO:0042119]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of cell migration [GO:0030335]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070963]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of renin secretion into blood stream [GO:1900135]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of blood coagulation [GO:0030193]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of JNK cascade [GO:0046328]; T cell activation involved in immune response [GO:0002286]; vasodilation [GO:0042311]" GO:0001965; GO:0002286; GO:0002690; GO:0002720; GO:0003104; GO:0004930; GO:0005102; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007204; GO:0007596; GO:0010804; GO:0014068; GO:0015057; GO:0030193; GO:0030335; GO:0030836; GO:0031143; GO:0031274; GO:0031681; GO:0032682; GO:0032722; GO:0032729; GO:0032731; GO:0032733; GO:0032755; GO:0032757; GO:0032930; GO:0034137; GO:0034140; GO:0034141; GO:0034145; GO:0035025; GO:0038023; GO:0042119; GO:0042311; GO:0043122; GO:0043123; GO:0043311; GO:0043547; GO:0045087; GO:0045217; GO:0045944; GO:0046328; GO:0046329; GO:0046330; GO:0050900; GO:0050921; GO:0050927; GO:0051482; GO:0051607; GO:0060100; GO:0061028; GO:0070374; GO:0070661; GO:0070963; GO:0097029; GO:1900135; GO:2000341 G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; thrombin-activated receptor activity [GO:0015057] KANIAIGISLAIWLLILLVTIPLYVVK 0.96188 3.7251 0 10.9266 0 0 0 0 0 0 0 0 0 0 11.2603 0 11.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0781 0 0 11.8548 0 0 0 0 0 0 0 11.6846 0 0 0 0 0 0 10.3243 0 0 0 9.56723 9.5216 0 0 0 0 0 0 0 0 0 0 0 0 14.0404 0 0 11.1652 0 0 0 11.9631 0 10.9537 0 14.4774 0 0 0 0 11.918 12.2081 0 0 0 13.4696 0 0 11.8494 0 0 0 0 11.1324 0 0 0 0 0 0 0 0 0 12.1846 0 0 0 12.7622 0 11.8801 0 0 0 0 0 0 0 0 0 0 11.7073 0 0 0 0 0 0 0 0 12.819 0 0 12.8084 0 0 0 0 12.3929 0 0 11.7868 15.3827 0 0 0 0 0 0 0 13.3671 0 0 0 0 0 0 0 0 0 11.4123 13.0503 0 0 0 0 0 0 11.2422 0 0 11.364 11.7834 0 0 0 P54108 CRIS3_HUMAN "Cysteine-rich secretory protein 3, CRISP-3 (Specific granule protein of 28 kDa, SGP28)" CRISP3 Homo sapiens (Human) defense response [GO:0006952]; innate immune response [GO:0045087] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; defense response [GO:0006952]; innate immune response [GO:0045087] GO:0005576; GO:0005615; GO:0006952; GO:0031012; GO:0035580; GO:0042581; GO:0045087; GO:1904724 DSCKASCNCSNSIY 0.96189 0.16392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56277 CMC4_HUMAN "Cx9C motif-containing protein 4 (Mature T-cell proliferation 1 neighbor protein) (Mature T-cell proliferation-1 type A, MTCP-1 type A) (Protein p8 MTCP-1, p8MTCP1)" CMC4 C6.1B MTCP1 MTCP1NB Homo sapiens (Human) mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] GO:0005739; GO:0005758 CLQANSYMESKCQAVIQELR 0.96189 0.48153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVM7 STAG1_HUMAN Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1) STAG1 SA1 SCC3 Homo sapiens (Human) cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]" GO:0000775; GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007062; GO:0008278; GO:0016363; GO:0016604; GO:0034089; GO:0051301; GO:0090307; GO:0097431 chromatin binding [GO:0003682] EDLLVLRKTVK 0.96191 0.1635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7673 O60664 PLIN3_HUMAN "Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein, 47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17, PP17)" PLIN3 M6PRBP1 TIP47 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; positive regulation of sequestering of triglyceride [GO:0010890]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; transport vesicle [GO:0030133] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid storage [GO:0019915]; positive regulation of sequestering of triglyceride [GO:0010890]; vesicle-mediated transport [GO:0016192] GO:0005737; GO:0005768; GO:0005794; GO:0005811; GO:0005829; GO:0010008; GO:0010890; GO:0016020; GO:0016192; GO:0019915; GO:0030133; GO:0042149; GO:0045296; GO:1905691 cadherin binding [GO:0045296] GVRTLTAAAVSGAQPILSK 0.96192 0.39405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1029 0 0 0 0 0 14.0973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9J202 AG1L2_HUMAN "Putative glycosyltransferase ALG1L2, EC 2.4.1.-" ALG1L2 Homo sapiens (Human) protein glycosylation [GO:0006486] endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783]; mannosyltransferase activity [GO:0000030]; protein glycosylation [GO:0006486] GO:0000030; GO:0005783; GO:0006486 mannosyltransferase activity [GO:0000030] CLHELVKHEENR 0.96193 0.50839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4909 11.8781 0 13.221 11.8823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92186 SIA8B_HUMAN "Alpha-2,8-sialyltransferase 8B, EC 2.4.99.- (Sialyltransferase 8B, SIAT8-B) (Sialyltransferase St8Sia II, ST8SiaII) (Sialyltransferase X, STX)" ST8SIA2 SIAT8B STX Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; neuron projection extension [GO:1990138]; oligosaccharide metabolic process [GO:0009311]; positive regulation of neuron death [GO:1901216]; positive regulation of synapse assembly [GO:0051965]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; response to cocaine [GO:0042220] early endosome [GO:0005769]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] "early endosome [GO:0005769]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialic acid binding [GO:0033691]; carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; N-glycan processing [GO:0006491]; nervous system development [GO:0007399]; neuron projection extension [GO:1990138]; oligosaccharide metabolic process [GO:0009311]; positive regulation of neuron death [GO:1901216]; positive regulation of synapse assembly [GO:0051965]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; response to cocaine [GO:0042220]" GO:0000139; GO:0001574; GO:0003828; GO:0005769; GO:0005886; GO:0005975; GO:0006486; GO:0006491; GO:0007399; GO:0009311; GO:0016021; GO:0033691; GO:0036211; GO:0042220; GO:0048471; GO:0051965; GO:0055037; GO:1901216; GO:1990138 "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialic acid binding [GO:0033691]" HNIQPASSK 0.96193 0.52502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3H1 MOD5_HUMAN "tRNA dimethylallyltransferase, EC 2.5.1.75 (Isopentenyl-diphosphate:tRNA isopentenyltransferase, IPP transferase, IPPT) (hGRO1) (tRNA isopentenyltransferase 1, IPTase)" TRIT1 IPT MOD5 Homo sapiens (Human) mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270]; mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400] GO:0003676; GO:0005524; GO:0005739; GO:0005759; GO:0006400; GO:0008270; GO:0052381; GO:0070900 ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270] EFHEYLITEGKCTLETSNQLLK 0.96194 0.23485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22674 CCNO_HUMAN Cyclin-O CCNO Homo sapiens (Human) cell division [GO:0051301]; cilium assembly [GO:0060271]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; multi-ciliated epithelial cell differentiation [GO:1903251]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to xenobiotic stimulus [GO:0009410] cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; cilium assembly [GO:0060271]; mitotic cell cycle [GO:0000278]; mitotic cell cycle phase transition [GO:0044772]; multi-ciliated epithelial cell differentiation [GO:1903251]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to xenobiotic stimulus [GO:0009410] GO:0000079; GO:0000278; GO:0000307; GO:0005634; GO:0005730; GO:0005737; GO:0009410; GO:0016538; GO:0044772; GO:0051301; GO:0060271; GO:0097124; GO:1903251 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] AQESHFHPREALAR 0.96195 0.2341 0 0 0 0 0 0 0 0 13.9825 0 0 0 0 12.7948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3335 0 0 0 0 0 0 0 0 13.0161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5613 9.83208 0 0 0 0 0 0 0 0 0 16.1364 0 0 11.7548 11.1966 0 11.5295 11.44 0 0 0 0 12.8959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56178 DLX5_HUMAN Homeobox protein DLX-5 DLX5 Homo sapiens (Human) "anatomical structure formation involved in morphogenesis [GO:0048646]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; embryonic limb morphogenesis [GO:0030326]; endochondral ossification [GO:0001958]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; inner ear morphogenesis [GO:0042472]; interneuron axon guidance [GO:0097376]; nervous system development [GO:0007399]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory pit development [GO:0060166]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure formation involved in morphogenesis [GO:0048646]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; embryonic limb morphogenesis [GO:0030326]; endochondral ossification [GO:0001958]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; inner ear morphogenesis [GO:0042472]; interneuron axon guidance [GO:0097376]; nervous system development [GO:0007399]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory pit development [GO:0060166]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001649; GO:0001958; GO:0005634; GO:0005737; GO:0006357; GO:0007399; GO:0008283; GO:0010628; GO:0021889; GO:0030154; GO:0030326; GO:0030509; GO:0030855; GO:0042472; GO:0045893; GO:0048646; GO:0050679; GO:0060021; GO:0060166; GO:0060325; GO:0071773; GO:0071837; GO:0090263; GO:0097376; GO:1901522; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" IMKNGEMPPEHSPSSSDPMACNSPQSPAVWEPQGSSR 0.96196 0.49052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTR8 T2R42_HUMAN "Taste receptor type 2 member 42, T2R42 (Taste receptor type 2 member 55, T2R55)" TAS2R42 TAS2R55 Homo sapiens (Human) sensory perception of taste [GO:0050909] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of taste [GO:0050909] GO:0004930; GO:0005886; GO:0016021; GO:0050909 G protein-coupled receptor activity [GO:0004930] HTRNLKLSSLGSR 0.96197 0.076451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2301 12.9066 0 0 12.5318 12.8441 0 0 0 0 12.5661 11.9566 0 0 0 12.1861 0 0 0 0 0 0 0 0 0 0 11.7351 13.5813 0 0 0 12.8913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.886 0 0 0 14.383 0 0 0 13.2672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.678 0 0 0 0 0 0 0 11.8995 0 0 0 0 0 0 0 0 0 0 11.1731 0 0 0 0 0 0 12.9416 0 0 13.8866 0 0 0 0 Q9P0L0 VAPA_HUMAN "Vesicle-associated membrane protein-associated protein A, VAMP-A, VAMP-associated protein A, VAP-A (33 kDa VAMP-associated protein, VAP-33)" VAPA VAP33 Homo sapiens (Human) cell death [GO:0008219]; ceramide transport [GO:0035627]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; phospholipid transport [GO:0015914]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918]; viral release from host cell [GO:0019076] azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982] azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; cell death [GO:0008219]; ceramide transport [GO:0035627]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; phospholipid transport [GO:0015914]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918]; viral release from host cell [GO:0019076] GO:0000139; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0005923; GO:0006686; GO:0006888; GO:0008017; GO:0008219; GO:0015630; GO:0015914; GO:0015918; GO:0016021; GO:0019076; GO:0019904; GO:0031175; GO:0031965; GO:0031982; GO:0033149; GO:0035577; GO:0035627; GO:0043123; GO:0044828; GO:0044829; GO:0045296; GO:0046982; GO:0061025; GO:0070972; GO:0090114 cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982] HEQILVLDPPTDLKFK 0.96197 0.53729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UH64 NSGX_HUMAN Putative protein CDKN2A-DT (CDKN2A antisense RNA 1) (CDKN2A antisense gene protein 1) (Protein CDKN2A-AS1) (Susceptibility protein NSG-x) CDKN2A-DT C9orf53 CDKN2A-AS1 Homo sapiens (Human) GGDWEPSRIPR 0.96197 0.53821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9447 0 0 0 0 0 11.1416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.468 0 P59534 T2R39_HUMAN "Taste receptor type 2 member 39, T2R39 (Taste receptor type 2 member 57, T2R57)" TAS2R39 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] ILVFLSVSR 0.96198 0.23132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4707 0 0 Q16799 RTN1_HUMAN Reticulon-1 (Neuroendocrine-specific protein) RTN1 NSP Homo sapiens (Human) negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuronal cell body [GO:0043025] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuronal cell body [GO:0043025]; negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182] GO:0000139; GO:0005783; GO:0005789; GO:0030176; GO:0030182; GO:0030425; GO:0043025; GO:1902430 ELRRLFLVQDLVDSLK 0.96198 0.48927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2578 0 0 15.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2116 0 0 0 0 0 0 0 0 0 0 0 0 14.9533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVH2 FOXP4_HUMAN Forkhead box protein P4 (Fork head-related protein-like A) FOXP4 FKHLA Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DLEEELPGEELS 0.96199 0.22969 0 0 0 0 0 10.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5589 0 0 0 0 11.8868 0 0 0 0 0 0 0 0 0 13.0044 0 0 12.541 12.3214 12.5636 0 0 0 11.5367 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1264 0 0 Q6S545 POTEH_HUMAN "POTE ankyrin domain family member H (ANKRD26-like family C member 3) (Prostate, ovary, testis-expressed protein on chromosome 22, POTE-22)" POTEH A26C3 ACTBL1 POTE22 Homo sapiens (Human) KDLIVMLK 0.962 0.27579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0175 0 0 13.7003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8132 0 0 0 0 14.2318 0 13.3191 13.1803 0 0 0 0 0 0 0 0 0 0 13.7896 0 0 0 14.1095 0 0 0 0 13.7197 0 0 0 0 0 0 0 0 0 13.938 0 13.8526 0 0 0 13.6227 0 0 0 0 0 0 0 13.0455 0 0 0 13.9036 14.0513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWX5 SGPP2_HUMAN "Sphingosine-1-phosphate phosphatase 2, SPPase2, Spp2, hSPP2, EC 3.1.3.- (Sphingosine-1-phosphatase 2)" SGPP2 Homo sapiens (Human) phospholipid dephosphorylation [GO:0046839]; regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; phospholipid dephosphorylation [GO:0046839]; regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670] GO:0005783; GO:0005789; GO:0006670; GO:0016020; GO:0016021; GO:0030148; GO:0042392; GO:0046839; GO:0061469; GO:0070780 dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392] AAAPEAYVQKYVVK 0.962 0.073637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8035 0 0 0 0 0 0 0 0 16.6545 16.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1189 0 0 0 11.7795 0 10.9838 0 0 0 0 0 0 0 0 13.769 13.5366 0 0 0 0 12.6915 0 12.9568 0 0 0 0 0 0 0 0 13.8378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.214 0 0 0 0 0 Q12791 KCMA1_HUMAN "Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel, MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog, Slo homolog, hSlo)" KCNMA1 KCNMA SLO Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083] apical plasma membrane [GO:0016324]; caveola [GO:0005901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076] apical plasma membrane [GO:0016324]; caveola [GO:0005901]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; cellular potassium ion homeostasis [GO:0030007]; micturition [GO:0060073]; negative regulation of cell volume [GO:0045794]; positive regulation of apoptotic process [GO:0043065]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; relaxation of vascular associated smooth muscle [GO:0060087]; response to calcium ion [GO:0051592]; response to carbon monoxide [GO:0034465]; response to hypoxia [GO:0001666]; response to osmotic stress [GO:0006970]; smooth muscle contraction involved in micturition [GO:0060083] GO:0001666; GO:0003779; GO:0005249; GO:0005886; GO:0005901; GO:0006813; GO:0006970; GO:0008076; GO:0015269; GO:0016021; GO:0016324; GO:0030007; GO:0034465; GO:0034765; GO:0042391; GO:0042802; GO:0043065; GO:0045211; GO:0045794; GO:0046872; GO:0051592; GO:0060072; GO:0060073; GO:0060083; GO:0060087 actin binding [GO:0003779]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] ACCFDCGR 0.96201 0.53399 0 11.9635 0 0 0 0 0 0 0 12.6705 0 0 0 13.0243 0 0 0 0 0 0 11.2219 14.5286 11.945 0 12.165 0 0 0 0 0 0 0 0 12.44 0 0 0 0 0 0 12.1671 11.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3337 0 0 0 0 0 0 14.0038 0 0 0 0 11.3504 0 0 0 0 10.6333 0 0 12.6691 13.0257 0 0 13.1869 12.5661 0 0 0 0 0 0 0 0 0 0 0 0 14.2852 0 10.8925 0 0 0 0 0 0 0 12.6722 0 10.9105 0 14.1577 13.7766 12.5419 0 11.6436 0 0 0 14.8626 0 11.8658 0 0 0 0 13.3587 0 0 11.5999 15.93 0 0 0 0 0 0 15.8445 0 0 0 12.0469 0 0 0 0 0 13.7363 0 12.1372 0 14.9652 0 0 13.3776 0 0 13.4922 10.1816 0 12.197 0 0 0 19.4311 0 19.3873 0 18.0812 0 0 12.2713 0 0 0 0 0 0 0 Q86SQ6 AGRA1_HUMAN Adhesion G protein-coupled receptor A1 (G-protein coupled receptor 123) ADGRA1 GPR123 KIAA1828 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] GO:0004930; GO:0005886; GO:0007165; GO:0007166; GO:0007186; GO:0014069; GO:0016021; GO:0098978 G protein-coupled receptor activity [GO:0004930] EAALGPGHLEMLR 0.96201 0.28401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5218 0 13.2325 0 0 0 0 0 0 0 0 13.2022 0 0 0 0 13.4914 13.5092 0 0 0 0 0 0 0 0 0 12.0093 12.7738 0 0 0 0 0 0 0 12.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.632 0 0 0 14.272 0 0 13.2599 0 0 0 0 0 11.5918 0 0 0 0 0 0 0 0 0 12.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7771 0 0 0 12.9758 0 0 Q9UHP9 SMPX_HUMAN Small muscular protein (Stretch-responsive skeletal muscle protein) SMPX SRMX Homo sapiens (Human) striated muscle contraction [GO:0006941] costamere [GO:0043034]; M band [GO:0031430]; muscle tendon junction [GO:0005927]; nucleus [GO:0005634] costamere [GO:0043034]; M band [GO:0031430]; muscle tendon junction [GO:0005927]; nucleus [GO:0005634]; striated muscle contraction [GO:0006941] GO:0005634; GO:0005927; GO:0006941; GO:0031430; GO:0043034 LPGPAVNLSEIQNIKSELK 0.96201 0.17676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y689 ARL5A_HUMAN ADP-ribosylation factor-like protein 5A ARL5A ARFLP5 ARL5 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] trans-Golgi network [GO:0005802] trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0016192; GO:1903292 GTP binding [GO:0005525]; GTPase activity [GO:0003924] ECMTVAEISQFLK 0.96202 0.17571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHD9 UBQL2_HUMAN "Ubiquilin-2 (Chap1) (DSK2 homolog) (Protein linking IAP with cytoskeleton 2, PLIC-2, hPLIC-2) (Ubiquitin-like product Chap1/Dsk2)" UBQLN2 N4BP4 PLIC2 HRIHFB2157 Homo sapiens (Human) autophagosome assembly [GO:0000045]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; autophagosome assembly [GO:0000045]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000045; GO:0005634; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0006511; GO:0016241; GO:0030433; GO:0031410; GO:0031593; GO:0042802; GO:1900186; GO:1903071; GO:1904021; GO:2000785 identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593] IIKVTVKTPK 0.96203 0.53282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.442 17.2912 0 0 20.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5C1 ANGL3_HUMAN "Angiopoietin-related protein 3 (Angiopoietin-5, ANG-5) (Angiopoietin-like protein 3) [Cleaved into: ANGPTL3(17-221); ANGPTL3(17-224) ]" ANGPTL3 ANGPT5 UNQ153/PRO179 Homo sapiens (Human) acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; integrin-mediated signaling pathway [GO:0007229]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; enzyme inhibitor activity [GO:0004857]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]; signaling receptor binding [GO:0005102]; acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; integrin-mediated signaling pathway [GO:0007229]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328] GO:0001525; GO:0004857; GO:0004859; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005769; GO:0005794; GO:0006071; GO:0006631; GO:0006644; GO:0007160; GO:0007165; GO:0007229; GO:0008083; GO:0008201; GO:0008203; GO:0009395; GO:0009725; GO:0009986; GO:0010519; GO:0019915; GO:0030027; GO:0030335; GO:0042632; GO:0045766; GO:0048844; GO:0050996; GO:0051005; GO:0055088; GO:0055090; GO:0055091; GO:0062023; GO:0070328 enzyme inhibitor activity [GO:0004857]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]; signaling receptor binding [GO:0005102] DLVFSTWDHK 0.96205 0.27234 0 0 0 0 0 0 0 0 0 0 0 0 11.2158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4927 0 11.18 0 0 10.2154 0 0 0 0 0 0 0 0 0 0 0 10.7252 0 0 0 0 0 0 0 0 0 12.6517 10.6854 0 0 0 0 12.2957 13.7206 0 0 0 12.7187 12.6524 0 0 0 0 0 0 10.8816 0 0 0 0 0 0 12.072 13.7164 0 0 0 0 0 0 0 0 0 0 11.3653 0 0 0 0 0 0 0 0 0 11.2115 0 10.0581 0 0 0 0 0 0 0 P17676 CEBPB_HUMAN "CCAAT/enhancer-binding protein beta, C/EBP beta (Liver activator protein, LAP) (Liver-enriched inhibitory protein, LIP) (Nuclear factor NF-IL6) (Transcription factor 5, TCF-5)" CEBPB TCF5 PP9092 Homo sapiens (Human) "acute-phase response [GO:0006953]; brown fat cell differentiation [GO:0050873]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; embryonic placenta development [GO:0001892]; granuloma formation [GO:0002432]; hepatocyte proliferation [GO:0072574]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; mammary gland epithelial cell differentiation [GO:0060644]; mammary gland epithelial cell proliferation [GO:0033598]; memory [GO:0007613]; myeloid cell development [GO:0061515]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of odontoblast differentiation [GO:1901329]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; T-helper 1 cell activation [GO:0035711]; transcription by RNA polymerase II [GO:0006366]" "C/EBP complex [GO:1990647]; CHOP-C/EBP complex [GO:0036488]; chromatin [GO:0000785]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]" "C/EBP complex [GO:1990647]; CHOP-C/EBP complex [GO:0036488]; chromatin [GO:0000785]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear glucocorticoid receptor binding [GO:0035259]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]; acute-phase response [GO:0006953]; brown fat cell differentiation [GO:0050873]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; embryonic placenta development [GO:0001892]; granuloma formation [GO:0002432]; hepatocyte proliferation [GO:0072574]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; mammary gland epithelial cell differentiation [GO:0060644]; mammary gland epithelial cell proliferation [GO:0033598]; memory [GO:0007613]; myeloid cell development [GO:0061515]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of dendritic cell differentiation [GO:2001198]; regulation of interleukin-6 production [GO:0032675]; regulation of odontoblast differentiation [GO:1901329]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; T-helper 1 cell activation [GO:0035711]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000779; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001541; GO:0001892; GO:0002432; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0006953; GO:0006954; GO:0006955; GO:0007613; GO:0016363; GO:0019900; GO:0030182; GO:0031490; GO:0032675; GO:0032753; GO:0033598; GO:0034976; GO:0035035; GO:0035259; GO:0035711; GO:0036488; GO:0042130; GO:0042742; GO:0042803; GO:0042826; GO:0043524; GO:0044389; GO:0045595; GO:0045600; GO:0045669; GO:0045670; GO:0045893; GO:0045944; GO:0046982; GO:0050729; GO:0050873; GO:0060644; GO:0061515; GO:0070059; GO:0070169; GO:0071222; GO:0071230; GO:0071347; GO:0071407; GO:0072574; GO:0090575; GO:0097421; GO:0120162; GO:0140467; GO:1901329; GO:1990440; GO:1990647; GO:1990837; GO:2000120; GO:2001198 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; nuclear glucocorticoid receptor binding [GO:0035259]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]" MRNLETQHKVLELTAENER 0.96206 0.27199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22392 NDKB_HUMAN "Nucleoside diphosphate kinase B, NDK B, NDP kinase B, EC 2.7.4.6 (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB, EC 2.7.13.3) (nm23-H2)" NME2 NM23B Homo sapiens (Human) "cell adhesion [GO:0007155]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; UTP biosynthetic process [GO:0006228]" cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774] "cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; transcription coactivator activity [GO:0003713]; cell adhesion [GO:0007155]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; UTP biosynthetic process [GO:0006228]" GO:0001726; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007155; GO:0007229; GO:0009142; GO:0019003; GO:0030027; GO:0034774; GO:0042981; GO:0043066; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0070062; GO:0071944; GO:1904813 ATP binding [GO:0005524]; DNA binding [GO:0003677]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; transcription coactivator activity [GO:0003713] ASEEHLKQHYIDLK 0.96206 0.18557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6198 13.7806 15.6495 0 0 0 0 12.2496 0 0 0 0 0 0 0 0 13.719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8667 0 0 0 0 0 0 0 0 0 0 10.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96636 0 0 0 0 0 0 0 Q9NWU1 OXSM_HUMAN "3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial, EC 2.3.1.41 (Beta-ketoacyl-ACP synthase)" OXSM Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790] GO:0004315; GO:0005739; GO:0005829; GO:0006633; GO:0006637; GO:0051790; GO:0051792 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315] FFGTVPISRLHRR 0.96206 0.16392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14649 MYL6B_HUMAN "Myosin light chain 6B (Myosin light chain 1 slow-twitch muscle A isoform, MLC1sa) (Smooth muscle and nonmuscle myosin light chain alkali 6B)" MYL6B MLC1SA Homo sapiens (Human) muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; calcium ion binding [GO:0005509]; cytoskeletal motor activity [GO:0003774]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; skeletal muscle tissue development [GO:0007519] GO:0003774; GO:0005509; GO:0005829; GO:0005859; GO:0006936; GO:0007519; GO:0008307; GO:0016459; GO:0016460; GO:0016461; GO:0030049; GO:0070062 calcium ion binding [GO:0005509]; cytoskeletal motor activity [GO:0003774]; structural constituent of muscle [GO:0008307] GQGTYEDYLEGFR 0.96207 0.18544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5007 0 0 0 0 0 0 0 15.6908 0 0 0 0 0 0 0 0 0 0 0 14.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B3EWF7 EP2A2_HUMAN "Laforin, isoform 9" EPM2A Homo sapiens (Human) negative regulation of TOR signaling [GO:0032007]; positive regulation of macroautophagy [GO:0016239] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of TOR signaling [GO:0032007]; positive regulation of macroautophagy [GO:0016239] GO:0005634; GO:0016239; GO:0032007 ASALRLPPGAPFALR 0.9621 0.26821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2589 P62952 BLCAP_HUMAN "Bladder cancer-associated protein (Bladder cancer 10 kDa protein, Bc10)" BLCAP BC10 Homo sapiens (Human) apoptotic nuclear changes [GO:0030262]; cell cycle [GO:0007049] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; apoptotic nuclear changes [GO:0030262]; cell cycle [GO:0007049] GO:0007049; GO:0016021; GO:0030262 MYCLQWLLPVLLIPK 0.9621 0.52556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8474 0 0 Q9GZN4 BSSP4_HUMAN "Brain-specific serine protease 4, BSSP-4, EC 3.4.21.- (Serine protease 22) (Serine protease 26) (Tryptase epsilon)" PRSS22 BSSP4 PRSS26 SP001LA UNQ302/PRO343 Homo sapiens (Human) positive regulation of peptidase activity [GO:0010952]; proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252]; positive regulation of peptidase activity [GO:0010952]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508; GO:0010952; GO:0016504 peptidase activator activity [GO:0016504]; serine-type endopeptidase activity [GO:0004252] AQGGGALRAPSQGSGAAAR 0.9621 0.39405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5999 13.1612 11.7057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7377 0 0 0 0 0 0 0 10.523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D1S5 RAB19_HUMAN Ras-related protein Rab-19 RAB19 RAB19B Homo sapiens (Human) autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886] GO:0000045; GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IILIGDSNVGKTCVVQHFK 0.96211 0.39405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0361 0 12.4544 0 0 P01574 IFNB_HUMAN "Interferon beta, IFN-beta (Fibroblast interferon)" IFNB1 IFB IFNB Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell surface receptor signaling pathway [GO:0007166]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of MHC class I biosynthetic process [GO:0045343]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chloramphenicol O-acetyltransferase activity [GO:0008811]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell surface receptor signaling pathway [GO:0007166]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of MHC class I biosynthetic process [GO:0045343]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002312; GO:0002323; GO:0005125; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0007166; GO:0008811; GO:0009615; GO:0019221; GO:0030101; GO:0030183; GO:0033141; GO:0035458; GO:0042100; GO:0043330; GO:0045071; GO:0045089; GO:0045343; GO:0045581; GO:0045944; GO:0051607; GO:0060337; GO:0071360; GO:0098586; GO:2000552; GO:2001235 chloramphenicol O-acetyltransferase activity [GO:0008811]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132] AKEYSHCAWTIVR 0.96211 0.16159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDI8 TMC1_HUMAN Transmembrane channel-like protein 1 (Transmembrane cochlear-expressed protein 1) TMC1 Homo sapiens (Human) auditory receptor cell development [GO:0060117]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426]; mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245]; auditory receptor cell development [GO:0060117]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005] GO:0005245; GO:0005887; GO:0008381; GO:0009897; GO:0032426; GO:0050910; GO:0060005; GO:0060117; GO:1903169 mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245] AAAAAGRQ 0.96212 0.50921 0 11.2235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6572 0 0 0 0 0 0 0 0 0 0 0 0 10.7072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.053 0 0 0 0 0 0 0 13.1364 0 0 0 0 11.6451 0 0 0 0 0 0 15.9519 0 0 0 0 14.5678 0 0 0 0 0 11.8818 0 0 0 0 0 0 0 0 0 0 0 0 13.0642 0 0 0 0 0 0 0 0 0 0 12.3003 0 0 0 0 0 0 13.0488 0 0 0 0 13.6854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9518 0 11.7869 0 0 0 0 0 0 13.0879 0 0 0 0 0 0 12.3822 0 12.6681 0 0 0 0 0 0 0 14.1003 0 0 0 13.6358 0 0 0 0 0 0 0 0 12.0965 0 0 Q9Y278 HS3S2_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 2, EC 2.8.2.29 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 2, 3-OST-2, Heparan sulfate 3-O-sulfotransferase 2, h3-OST-2)" HS3ST2 3OST2 UNQ2442/PRO5004 Homo sapiens (Human) glycosaminoglycan biosynthetic process [GO:0006024] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 2 activity [GO:0033871]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024] GO:0000139; GO:0006024; GO:0008146; GO:0008467; GO:0016021; GO:0033871 [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; [heparan sulfate]-glucosamine 3-sulfotransferase 2 activity [GO:0033871]; sulfotransferase activity [GO:0008146] DTKLIVVVR 0.96212 0.5106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9534 0 0 0 14.1741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2N9 AN36B_HUMAN Ankyrin repeat domain-containing protein 36B (CLL-associated antigen KW-1) ANKRD36B Homo sapiens (Human) identical protein binding [GO:0042802] GO:0042802 identical protein binding [GO:0042802] AEREVAVR 0.96213 0.076798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3214 0 0 0 0 0 16.509 12.9733 13.0129 14.9587 14.7657 14.5363 0 0 0 0 12.3546 0 0 0 0 13.5579 14.752 10.963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8368 0 0 0 0 0 0 0 0 0 0 0 0 10.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2D0 CAH5B_HUMAN "Carbonic anhydrase 5B, mitochondrial, EC 4.2.1.1 (Carbonate dehydratase VB) (Carbonic anhydrase VB, CA-VB)" CA5B Homo sapiens (Human) one-carbon metabolic process [GO:0006730]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]; response to bacterium [GO:0009617] GO:0004089; GO:0005737; GO:0005739; GO:0005759; GO:0006730; GO:0008270; GO:0009617; GO:0016836 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] CFPAELHLVHWNAVRFENFEDAALEENGLAVIGVFLK 0.96213 0.16043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5705 14.3453 13.7066 0 0 12.2686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2Y8 PRG3_HUMAN "Proteoglycan 3 (Eosinophil major basic protein homolog) (Prepro-major basic protein homolog, Prepro-MBPH)" PRG3 MBPH UNQ486/PRO1002 Homo sapiens (Human) basophil activation [GO:0045575]; histamine biosynthetic process [GO:0001694]; immune response [GO:0006955]; leukotriene biosynthetic process [GO:0019370]; negative regulation of translation [GO:0017148]; neutrophil activation [GO:0042119]; positive regulation of interleukin-8 production [GO:0032757]; superoxide anion generation [GO:0042554] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; basophil activation [GO:0045575]; histamine biosynthetic process [GO:0001694]; immune response [GO:0006955]; leukotriene biosynthetic process [GO:0019370]; negative regulation of translation [GO:0017148]; neutrophil activation [GO:0042119]; positive regulation of interleukin-8 production [GO:0032757]; superoxide anion generation [GO:0042554] GO:0001694; GO:0005576; GO:0006955; GO:0017148; GO:0019370; GO:0030021; GO:0030246; GO:0032757; GO:0035580; GO:0042119; GO:0042554; GO:0045575; GO:0062023; GO:1904724 carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021] FCWTDGSHWNFAYWSPGQPGNGQGSCVALCTKGGYWR 0.96214 0.49155 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2581 0 0 0 0 0 0 0 0 0 0 12.3992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8369 0 0 0 0 0 0 0 0 13.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8299 0 0 0 0 0 0 0 O00574 CXCR6_HUMAN "C-X-C chemokine receptor type 6, CXC-R6, CXCR-6 (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD antigen CD186)" CXCR6 BONZO STRL33 TYMSTR Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; viral genome replication [GO:0019079] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; viral genome replication [GO:0019079] GO:0004930; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0015026; GO:0016493; GO:0016494; GO:0019079; GO:0019722; GO:0019957; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930] FIVVVKATK 0.96216 0.53849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9212 0 12.3255 0 0 0 0 0 0 16.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61236 YPEL3_HUMAN Protein yippee-like 3 YPEL3 FKSG5 Homo sapiens (Human) positive regulation of cellular senescence [GO:2000774] nucleolus [GO:0005730] nucleolus [GO:0005730]; metal ion binding [GO:0046872]; positive regulation of cellular senescence [GO:2000774] GO:0005730; GO:0046872; GO:2000774 metal ion binding [GO:0046872] PKTFQAYLDDCHR 0.96217 0.28417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV74 NUDT8_HUMAN "Mitochondrial coenzyme A diphosphatase NUDT8, EC 3.6.1.- (Nucleoside diphosphate-linked moiety X motif 8, Nudix motif 8)" NUDT8 Homo sapiens (Human) acetyl-CoA catabolic process [GO:0046356]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA catabolic process [GO:1902859]; succinyl-CoA catabolic process [GO:1901289] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; acetyl-CoA catabolic process [GO:0046356]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA catabolic process [GO:1902859]; succinyl-CoA catabolic process [GO:1901289] GO:0000287; GO:0005739; GO:0010945; GO:0015938; GO:0030145; GO:0036114; GO:0044580; GO:0046356; GO:0106399; GO:1901289; GO:1902859; GO:2001294 acyl-coenzyme A diphosphatase activity [GO:0106399]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] RLLAGATARLR 0.96217 0.28402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2554 0 0 0 0 0 14.2364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1B7 I2BPL_HUMAN "Probable E3 ubiquitin-protein ligase IRF2BPL, EC 2.3.2.27 (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like)" IRF2BPL C14orf4 EAP1 KIAA1865 My039 Homo sapiens (Human) development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0003714; GO:0005615; GO:0005634; GO:0005654; GO:0006357; GO:0007399; GO:0045944; GO:0046543; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630] AEEWASKPK 0.96217 0.2758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0581 0 0 0 16.7547 16.5468 0 0 0 0 0 0 0 0 0 0 0 0 17.893 0 Q96NB1 CEP20_HUMAN Centrosomal protein 20 (FGFR1OP N-terminal-like protein) (FOP-related protein of 20 kDa) (LisH domain-containing protein FOPNL) CEP20 C16orf63 FOPNL FOR20 PHSECRG2 Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453] GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0031514; GO:0034451; GO:0034453; GO:0036064; GO:0042802; GO:0060271 identical protein binding [GO:0042802] IRAEVFNALDDDR 0.96218 0.13153 0 0 0 0 0 0 0 0 0 0 10.6936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NZ8 WFKN1_HUMAN "WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1 (Growth and differentiation factor-associated serum protein 2, GASP-2, hGASP-2) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing protein)" WFIKKN1 C16orf12 GASP2 WFIKKN PSEC0040 Homo sapiens (Human) muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular space [GO:0005615] extracellular space [GO:0005615]; metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] GO:0001501; GO:0004867; GO:0005615; GO:0008191; GO:0030512; GO:0032091; GO:0043392; GO:0048019; GO:0050431; GO:0055001; GO:0060021 metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431] CYMDAEACLR 0.96218 0.17588 0 0 15.4565 0 13.5486 0 0 0 0 0 0 0 0 12.5698 0 13.7867 0 12.5344 0 0 10.1877 9.27461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8821 0 0 0 0 0 0 12.8047 13.6617 0 0 12.7288 0 0 0 0 11.6991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2802 0 0 0 0 0 0 0 0 0 0 0 12.32 0 0 0 0 14.2685 0 0 0 0 0 0 0 0 0 12.1979 0 0 14.9305 13.2962 13.9743 0 0 10.312 0 13.3016 13.1055 13.2389 0 0 0 12.1636 13.2822 14.3208 13.2815 12.502 0 0 0 0 0 11.5413 13.4638 0 11.1656 12.9463 0 0 13.4217 0 0 0 13.4337 13.4815 0 0 0 0 0 13.2164 0 14.5687 11.5843 13.3142 0 0 0 0 0 0 14.5409 10.4659 0 13.1383 0 0 0 0 0 0 0 13.9885 0 0 0 0 0 0 0 0 0 0 0 10.9506 12.8957 0 0 0 P04440 DPB1_HUMAN "HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)" HLA-DPB1 HLA-DP1B Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; T cell receptor signaling pathway [GO:0050852] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102]; T cell receptor signaling pathway [GO:0050852] GO:0000139; GO:0002250; GO:0002503; GO:0005765; GO:0005886; GO:0009986; GO:0010008; GO:0012507; GO:0016020; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0032588; GO:0032729; GO:0042102; GO:0042605; GO:0042613; GO:0050852; GO:0050870; GO:0071556 MHC class II protein complex binding [GO:0023026]; peptide antigen binding [GO:0042605] ATPENYLFQGRQECYAFNGTQR 0.9622 0.53519 11.8836 12.8639 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4854 0 0 12.5672 12.9876 13.7989 12.2567 13.1646 0 13.1155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6029 0 0 0 0 0 0 0 0 0 0 0 12.0395 0 0 0 0 0 0 0 0 0 0 0 15.6862 15.2004 15.9812 15.6664 15.6439 0 15.6 18.5328 14.3139 0 0 15.4904 0 15.5147 14.7229 13.869 15.4175 13.9369 16.3335 0 0 0 14.6926 0 16.0067 15.0527 14.7076 16.6841 0 15.4521 0 15.1627 13.771 14.7042 15.4385 13.4051 15.5538 13.9739 0 0 0 14.3044 0 0 0 13.2948 0 0 15.3031 0 13.861 0 15.6177 0 14.6798 13.4167 0 13.6937 14.071 13.2723 17.9153 0 0 13.5731 14.5888 0 14.5656 14.7005 13.3315 14.8054 14.312 0 13.5926 0 0 0 0 0 13.8015 13.7978 14.5656 14.0947 0 0 0 0 0 0 0 12.4656 13.8934 0 0 13.0588 0 14.2155 13.9923 14.1636 0 0 0 0 0 0 0 Q9H841 NPAL2_HUMAN NIPA-like protein 2 NIPAL2 NPAL2 Homo sapiens (Human) magnesium ion transport [GO:0015693] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium ion transport [GO:0015693] GO:0015095; GO:0015693; GO:0016020; GO:0016021 magnesium ion transmembrane transporter activity [GO:0015095] GMKHMVILLTLVAILASLTVISVK 0.96221 0.18731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0004 0 0 0 0 0 O43296 ZN264_HUMAN Zinc finger protein 264 ZNF264 KIAA0412 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AELICHLEHGQEPWTRKEDLSQDTCPGDK 0.96222 0.27238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3293 0 0 0 0 10.9718 0 0 0 0 0 0 0 0 0 0 0 0 11.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29459 IL12A_HUMAN "Interleukin-12 subunit alpha, IL-12A (Cytotoxic lymphocyte maturation factor 35 kDa subunit, CLMF p35) (IL-12 subunit p35) (NK cell stimulatory factor chain 1, NKSF1)" IL12A NKSF1 Homo sapiens (Human) cell migration [GO:0016477]; cellular response to virus [GO:0098586]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to lipopolysaccharide [GO:0032496]; response to UV-B [GO:0010224]; response to virus [GO:0009615] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; interleukin-12 receptor complex [GO:0042022]; late endosome lumen [GO:0031906]; plasma membrane [GO:0005886] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; interleukin-12 receptor complex [GO:0042022]; late endosome lumen [GO:0031906]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-12 beta subunit binding [GO:0042163]; interleukin-12 receptor binding [GO:0005143]; interleukin-27 binding [GO:0045513]; protein heterodimerization activity [GO:0046982]; cell migration [GO:0016477]; cellular response to virus [GO:0098586]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to lipopolysaccharide [GO:0032496]; response to UV-B [GO:0010224]; response to virus [GO:0009615] GO:0001916; GO:0002860; GO:0005125; GO:0005143; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006955; GO:0008083; GO:0009615; GO:0010224; GO:0016477; GO:0031906; GO:0032496; GO:0032700; GO:0032729; GO:0032816; GO:0032819; GO:0032946; GO:0034393; GO:0042022; GO:0042102; GO:0042163; GO:0042531; GO:0043514; GO:0045513; GO:0045785; GO:0045954; GO:0046427; GO:0046982; GO:0048662; GO:0050671; GO:0050709; GO:0050830; GO:0051135; GO:0051142; GO:0097191; GO:0098586; GO:1900747; GO:1903588; GO:2000510 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-12 beta subunit binding [GO:0042163]; interleukin-12 receptor binding [GO:0005143]; interleukin-27 binding [GO:0045513]; protein heterodimerization activity [GO:0046982] ETSFITNGSCLASR 0.96222 0.53292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6497 0 10.8517 10.5987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55072 TERA_HUMAN "Transitional endoplasmic reticulum ATPase, TER ATPase, EC 3.6.4.6 (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein, VCP)" VCP Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral genome replication [GO:0019079]" ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730] "ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-specific protease binding [GO:1990381]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral genome replication [GO:0019079]" GO:0000502; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0006281; GO:0006302; GO:0006734; GO:0006888; GO:0006914; GO:0006919; GO:0006974; GO:0008289; GO:0010494; GO:0010498; GO:0010918; GO:0016236; GO:0016567; GO:0016887; GO:0019079; GO:0019903; GO:0019904; GO:0019985; GO:0030433; GO:0030968; GO:0030970; GO:0031334; GO:0031593; GO:0031625; GO:0032436; GO:0032510; GO:0032991; GO:0034098; GO:0034605; GO:0034774; GO:0035578; GO:0035617; GO:0035800; GO:0035861; GO:0036297; GO:0036435; GO:0036503; GO:0036513; GO:0042288; GO:0042802; GO:0042981; GO:0043161; GO:0043231; GO:0043531; GO:0044389; GO:0045184; GO:0045732; GO:0045879; GO:0046034; GO:0048471; GO:0050807; GO:0051228; GO:0061857; GO:0070062; GO:0070842; GO:0071712; GO:0072389; GO:0090263; GO:0097352; GO:0098978; GO:0106300; GO:1903006; GO:1903007; GO:1903715; GO:1903843; GO:1903862; GO:1904288; GO:1904813; GO:1904949; GO:1905634; GO:1990381; GO:1990730; GO:2001171 ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-specific protease binding [GO:1990381] AIGVKPPR 0.96223 0.064681 0 0 0 0 0 11.2227 0 0 0 0 0 0 0 0 14.8712 17.8381 17.7692 17.4564 17.0702 17.169 16.8422 11.7133 16.0498 0 15.223 15.2719 15.5227 13.9204 0 13.3211 16.8216 0 0 0 13.9817 0 0 0 0 0 0 16.2178 16.5601 16.5804 16.6626 17.4285 17.3119 17.1535 14.4216 14.2832 14.299 17.3043 18.8797 18.88 17.4414 17.0199 18.6409 18.365 17.4375 0 18.9485 18.428 17.826 15.1877 0 17.2078 0 0 10.8177 0 0 0 0 0 15.5266 13.9045 0 0 14.7226 16.0375 14.5233 14.4093 14.8206 14.1523 0 15.8565 15.7821 14.8 15.0037 14.9992 20.8763 15.4629 20.921 20.7549 19.8115 20.0115 14.542 22.1777 20.3057 0 15.5562 15.4972 15.2774 0 0 11.9338 0 18.1532 0 0 0 19.7921 19.5738 0 19.5932 19.018 18.4442 19.8219 0 15.7958 14.2307 0 0 15.5886 12.7047 20.0697 20.859 15.8611 11.327 0 0 15.2791 0 14.9196 20.5092 20.3684 20.1747 19.8415 14.7969 15.6922 15.0603 19.9159 19.4991 0 19.4221 0 18.5628 18.592 18.4113 18.3274 0 0 0 15.7991 15.489 19.7824 20.1904 13.5525 0 0 0 0 12.1232 11.8315 0 0 0 18.2807 17.9448 17.7324 17.5408 20.5646 20.496 20.5686 18.8433 0 17.4666 0 0 0 O00321 ETV2_HUMAN ETS translocation variant 2 (Ets-related protein 71) ETV2 ER71 ETSRP71 Homo sapiens (Human) blastocyst development [GO:0001824]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway involved in mesodermal cell fate specification [GO:0060803]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; Notch signaling pathway [GO:0007219]; placenta development [GO:0001890]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of gene expression [GO:0010628]; positive regulation of mesoderm development [GO:2000382]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; blastocyst development [GO:0001824]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway involved in mesodermal cell fate specification [GO:0060803]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; Notch signaling pathway [GO:0007219]; placenta development [GO:0001890]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of gene expression [GO:0010628]; positive regulation of mesoderm development [GO:2000382]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" GO:0000978; GO:0000981; GO:0001228; GO:0001824; GO:0001890; GO:0005634; GO:0006357; GO:0007219; GO:0010628; GO:0016055; GO:0030154; GO:0030218; GO:0045603; GO:0048514; GO:0060803; GO:1990837; GO:2000382 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DIVRKSGGR 0.96223 0.065753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3105 0 0 0 0 0 0 0 12.4387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9116 0 0 0 0 12.8369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969S8 HDA10_HUMAN "Polyamine deacetylase HDAC10, EC 3.5.1.48, EC 3.5.1.62 (Histone deacetylase 10, HD10)" HDAC10 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]" cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein lysine deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deacetylation [GO:0016575]; homologous recombination [GO:0035825]; macroautophagy [GO:0016236]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine deacetylation [GO:0034983]; polyamine deacetylation [GO:0106047]; positive regulation of mismatch repair [GO:0032425]; protein deacetylation [GO:0006476]; regulation of transcription, DNA-templated [GO:0006355]; spermidine deacetylation [GO:0106048]" GO:0000118; GO:0000122; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006325; GO:0006355; GO:0006476; GO:0008270; GO:0016236; GO:0016575; GO:0019213; GO:0019899; GO:0032425; GO:0033558; GO:0034983; GO:0035825; GO:0042826; GO:0045892; GO:0047609; GO:0047611; GO:0106047; GO:0106048 acetylputrescine deacetylase activity [GO:0047609]; acetylspermidine deacetylase activity [GO:0047611]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; protein lysine deacetylase activity [GO:0033558]; zinc ion binding [GO:0008270] ETQVLGK 0.96224 0.13808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQI9 NRIP2_HUMAN Nuclear receptor-interacting protein 2 NRIP2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; proteolysis [GO:0006508] GO:0000122; GO:0004190; GO:0005634; GO:0005737; GO:0006508; GO:0007219 aspartic-type endopeptidase activity [GO:0004190] AHLSQQRR 0.96224 0.064435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6533 0 13.2295 0 0 0 11.8549 11.6414 0 11.7829 13.1052 0 12.6781 0 0 0 12.9767 0 0 0 13.2213 0 0 12.4083 0 0 0 0 0 13.3603 0 0 13.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4186 0 14.3962 12.474 0 13.0878 0 13.4503 0 0 0 15.998 0 13.0195 13.1317 0 0 0 0 0 0 0 13.3578 0 0 0 0 0 0 0 11.1115 13.545 0 0 0 0 0 0 0 12.8955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6242 0 14.1272 0 0 0 0 0 0 P06276 CHLE_HUMAN "Cholinesterase, EC 3.1.1.8 (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase)" BCHE CHE1 Homo sapiens (Human) acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805]" GO:0001540; GO:0003824; GO:0003990; GO:0004104; GO:0005576; GO:0005615; GO:0005641; GO:0005788; GO:0005886; GO:0006581; GO:0006805; GO:0007612; GO:0008285; GO:0014016; GO:0016486; GO:0016788; GO:0019695; GO:0019899; GO:0033265; GO:0042802; GO:0043279; GO:0050783; GO:0050805; GO:0051384; GO:0051593; GO:0052689; GO:0072562 "acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; carboxylic ester hydrolase activity [GO:0052689]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]" AQQCRFWTSFFPK 0.96225 0.26993 0 0 0 0 0 0 0 0 0 0 13.7349 0 0 0 10.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8528 13.9793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2483 0 0 0 0 10.8882 0 0 0 11.2052 0 0 0 0 11.2786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2521 0 0 15.1644 0 0 15.1004 0 0 0 13.0076 0 0 0 12.7152 0 0 0 0 0 0 0 0 Q15041 AR6P1_HUMAN "ADP-ribosylation factor-like protein 6-interacting protein 1, ARL-6-interacting protein 1, Aip-1 (Apoptotic regulator in the membrane of the endoplasmic reticulum)" ARL6IP1 ARL6IP ARMER KIAA0069 Homo sapiens (Human) apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; regulation of endoplasmic reticulum tubular network organization [GO:1903371] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; regulation of endoplasmic reticulum tubular network organization [GO:1903371] GO:0002038; GO:0005784; GO:0005789; GO:0005829; GO:0006613; GO:0006915; GO:0016020; GO:0016021; GO:0030176; GO:0042802; GO:0043066; GO:0043154; GO:0071787; GO:1903371; GO:1990809 identical protein binding [GO:0042802] EINKLLKQK 0.96226 0.26829 0 0 14.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGK3 O52K2_HUMAN Olfactory receptor 52K2 (Olfactory receptor OR11-7) OR52K2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVTLMTPLPFLLRCFHYCR 0.96228 0.39405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SC8 DMTA2_HUMAN Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5) DMRTA2 DMRT5 Homo sapiens (Human) cerebral cortex regionalization [GO:0021796]; dopaminergic neuron differentiation [GO:0071542]; neuroblast proliferation [GO:0007405]; neuron fate specification [GO:0048665]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; skeletal muscle cell differentiation [GO:0035914]; stem cell fate specification [GO:0048866] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cerebral cortex regionalization [GO:0021796]; dopaminergic neuron differentiation [GO:0071542]; neuroblast proliferation [GO:0007405]; neuron fate specification [GO:0048665]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; skeletal muscle cell differentiation [GO:0035914]; stem cell fate specification [GO:0048866]" GO:0000785; GO:0000978; GO:0000981; GO:0002052; GO:0005634; GO:0006357; GO:0007405; GO:0007548; GO:0021796; GO:0035914; GO:0042802; GO:0046872; GO:0048665; GO:0048866; GO:0071542; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DCLCAKCTLIAERQR 0.96228 0.12761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4115 12.7278 0 0 0 0 13.3109 0 0 0 0 0 0 0 0 13.3696 0 0 0 13.7242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2638 0 0 0 0 0 0 0 0 0 0 0 12.1887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3434 0 0 0 0 0 0 0 A6NFE2 SMCO2_HUMAN Single-pass membrane and coiled-coil domain-containing protein 2 SMCO2 C12orf70 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 NLLELCLKGMFLKLNYWNTK 0.96229 0.27772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3LI77 KR134_HUMAN Keratin-associated protein 13-4 KRTAP13-4 KAP13.4 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 DCQKTCWEPASCQK 0.96229 0.28869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IE36 OVOS2_HUMAN Ovostatin homolog 2 OVOS2 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005615 serine-type endopeptidase inhibitor activity [GO:0004867] ENVVFVQTDKPTYK 0.96229 2.96 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5813 0 0 0 10.4767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2793 12.3233 0 0 0 0 0 0 0 0 0 0 15.0463 11.422 13.9933 0 0 0 0 0 0 0 0 0 0 0 0 13.2772 0 0 0 0 0 0 0 0 0 0 0 0 11.7009 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5251 0 0 0 0 0 0 0 0 0 0 11.7584 0 0 0 0 12.2973 0 12.4216 12.5789 0 10.9247 0 0 11.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWH4 ASZ1_HUMAN "Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Ankyrin-like protein 1) (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)" ASZ1 ALP1 ANKL1 C7orf7 GASZ Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; pi-body [GO:0071546] cytoplasm [GO:0005737]; pi-body [GO:0071546]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0005737; GO:0007140; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071546 ENDPTHIQLREEVSTWNSRILK 0.96229 0.18017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5872 16.7433 0 11.8566 0 0 12.4368 0 0 0 0 0 0 0 0 0 11.5683 0 0 11.192 0 0 0 0 0 0 0 0 0 12.0593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9334 11.7372 0 0 12.9188 0 14.2129 0 14.432 12.8 0 0 0 13.5456 0 14.2171 0 0 0 0 0 0 11.8061 12.9132 13.5579 0 16.3105 0 14.3448 13.4851 14.6592 0 0 0 0 13.5768 14.8435 14.2465 10.8676 0 0 13.9709 12.9598 15.4961 0 0 0 0 0 12.1506 13.468 17.5733 0 0 0 0 15.8461 14.9261 0 0 14.7899 14.1059 14.3791 0 15.7123 15.2778 15.5422 15.0995 17.7966 15.2948 14.4791 0 14.3994 14.6302 14.7235 14.0928 17.3995 0 11.905 0 0 0 0 13.6399 0 0 0 0 0 0 0 0 0 12.8398 0 0 0 0 0 0 15.6971 0 15.9438 0 0 0 0 0 0 P35247 SFTPD_HUMAN "Pulmonary surfactant-associated protein D, PSP-D, SP-D (Collectin-7) (Lung surfactant protein D)" SFTPD COLEC7 PSPD SFTP4 Homo sapiens (Human) defense response to bacterium [GO:0042742]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; lung alveolus development [GO:0048286]; macrophage chemotaxis [GO:0048246]; negative regulation by host of symbiont catalytic activity [GO:0052403]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of phagocytosis [GO:0050766]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; regulation of adhesion of symbiont to host epithelial cell [GO:1905226]; regulation of cytokine production [GO:0001817]; respiratory gaseous exchange by respiratory system [GO:0007585]; surfactant homeostasis [GO:0043129] clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791] clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; defense response to bacterium [GO:0042742]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; lung alveolus development [GO:0048286]; macrophage chemotaxis [GO:0048246]; negative regulation by host of symbiont catalytic activity [GO:0052403]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of phagocytosis [GO:0050766]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; regulation of adhesion of symbiont to host epithelial cell [GO:1905226]; regulation of cytokine production [GO:0001817]; respiratory gaseous exchange by respiratory system [GO:0007585]; surfactant homeostasis [GO:0043129] GO:0001817; GO:0005576; GO:0005581; GO:0005615; GO:0005764; GO:0005771; GO:0005789; GO:0005791; GO:0006898; GO:0007585; GO:0030139; GO:0030246; GO:0032703; GO:0042130; GO:0042742; GO:0042802; GO:0043129; GO:0043152; GO:0045087; GO:0045334; GO:0048246; GO:0048286; GO:0050766; GO:0052403; GO:0072593; GO:1905226 carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802] GEAGPKGEVGAPGMQGSAGAR 0.9623 0.27755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0093 0 0 0 0 12.0561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13686 ALKB1_HUMAN "Nucleic acid dioxygenase ALKBH1, EC 1.14.11.- (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1, EC 1.14.11.51) (DNA lyase ABH1, EC 4.2.99.18) (DNA oxidative demethylase ALKBH1, EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase, EC 1.14.11.-)" ALKBH1 ABH ABH1 ALKBH Homo sapiens (Human) developmental growth [GO:0048589]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative demethylation [GO:0070989]; oxidative RNA demethylation [GO:0035513]; oxidative single-stranded DNA demethylation [GO:0035552]; placenta development [GO:0001890]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; RNA repair [GO:0042245]; tRNA demethylation [GO:1990983]; tRNA wobble cytosine modification [GO:0002101] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; euchromatin [GO:0000791]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; euchromatin [GO:0000791]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984]; developmental growth [GO:0048589]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative demethylation [GO:0070989]; oxidative RNA demethylation [GO:0035513]; oxidative single-stranded DNA demethylation [GO:0035552]; placenta development [GO:0001890]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; RNA repair [GO:0042245]; tRNA demethylation [GO:1990983]; tRNA wobble cytosine modification [GO:0002101] GO:0000049; GO:0000791; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0006281; GO:0006307; GO:0006446; GO:0006448; GO:0008198; GO:0016706; GO:0031175; GO:0035513; GO:0035515; GO:0035516; GO:0035552; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0070129; GO:0070579; GO:0070989; GO:0080111; GO:0140078; GO:1990983; GO:1990984 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984] DSMVEPCSMEDWQVCASYLK 0.9623 0.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.852 0 0 0 0 0 0 0 0 12.4338 0 0 0 0 0 0 0 0 0 11.3676 0 0 0 11.4554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15661 TRYB1_HUMAN "Tryptase alpha/beta-1, Tryptase-1, EC 3.4.21.59 (Tryptase I) (Tryptase alpha-1)" TPSAB1 TPS1 TPS2 TPSB1 Homo sapiens (Human) defense response [GO:0006952]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase complex [GO:1905368] extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase complex [GO:1905368]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; defense response [GO:0006952]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0006952; GO:0008236; GO:0022617; GO:0042802; GO:1905368 identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] LNLLLLALPVLASR 0.96231 0.51066 0 0 0 0 0 0 0 0 10.4944 0 0 0 0 0 0 0 0 0 0 0 0 13.2093 0 0 10.213 0 0 0 0 0 0 0 0 10.7124 0 0 0 0 0 0 0 0 9.39896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5149 14.0836 0 14.914 0 0 15.1305 0 12.8781 0 12.8515 0 13.7685 0 0 0 0 0 0 0 0 0 12.0778 0 12.685 12.9205 0 0 12.3873 0 0 0 0 14.4326 0 0 0 0 12.0949 0 0 0 12.6582 0 0 0 0 0 0 0 0 0 0 12.4095 0 0 0 12.2517 0 0 0 0 0 0 12.3236 12.5172 0 0 0 0 0 0 0 0 0 13.7685 13.1603 12.034 0 15.4815 0 0 0 0 13.6742 0 0 15.6126 14.6299 14.359 12.9103 14.6371 0 0 11.2531 11.4851 0 0 0 0 0 Q8IVB4 SL9A9_HUMAN "Sodium/hydrogen exchanger 9 (Na(+)/H(+) exchanger 9, NHE-9) (Solute carrier family 9 member 9)" SLC9A9 NHE9 Nbla00118 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0031902; GO:0051453; GO:0055037; GO:0071805; GO:0098719 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] EDPSSQHQEANNLDK 0.96231 0.52556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49642 PRI1_HUMAN "DNA primase small subunit, EC 2.7.7.102 (DNA primase 49 kDa subunit, p49)" PRIM1 Homo sapiens (Human) "DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]" alpha DNA polymerase:primase complex [GO:0005658]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "alpha DNA polymerase:primase complex [GO:0005658]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA primase activity [GO:0003896]; magnesium ion binding [GO:0000287]; ribonucleotide binding [GO:0032553]; zinc ion binding [GO:0008270]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]" GO:0000287; GO:0003896; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0008270; GO:0016020; GO:0032553 DNA primase activity [GO:0003896]; magnesium ion binding [GO:0000287]; ribonucleotide binding [GO:0032553]; zinc ion binding [GO:0008270] DYKKTSLAPYVK 0.96232 0.33489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8317 0 0 0 0 0 0 0 11.9356 12.4417 0 0 0 0 0 0 17.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 W6CW81 PYDC5_HUMAN Pyrin domain-containing protein 5 (Pyrin domain-only protein 3) PYDC5 POP3 Homo sapiens (Human) activation of innate immune response [GO:0002218]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; inflammatory response [GO:0006954]; negative regulation of protein-containing complex assembly [GO:0031333] AIM2 inflammasome complex [GO:0097169] AIM2 inflammasome complex [GO:0097169]; double-stranded DNA binding [GO:0003690]; activation of innate immune response [GO:0002218]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; inflammatory response [GO:0006954]; negative regulation of protein-containing complex assembly [GO:0031333] GO:0002218; GO:0003690; GO:0006954; GO:0031333; GO:0035458; GO:0097169; GO:0098586 double-stranded DNA binding [GO:0003690] LNYMLVAKCLR 0.96232 0.17725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YJ7 AN13B_HUMAN Ankyrin repeat domain-containing protein 13B ANKRD13B Homo sapiens (Human) negative regulation of receptor internalization [GO:0002091] cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091] GO:0002091; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0043231; GO:0048471; GO:0140036 ubiquitin-dependent protein binding [GO:0140036] GYSMMGGQR 0.96233 0.2851 0 0 10.9321 0 0 0 0 0 0 0 0 0 15.3094 0 0 13.3371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9736 14.4199 14.8953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3018 0 10.5787 0 0 13.5167 0 14.5241 0 0 0 15.9648 0 0 12.7987 0 0 0 0 0 0 10.8979 0 0 0 0 0 0 0 11.7454 0 0 14.2479 0 0 0 0 0 0 0 13.5398 0 0 0 14.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0246 0 0 0 0 0 12.845 0 0 0 0 0 0 0 0 0 0 0 13.3735 0 0 0 0 0 0 0 14.6927 0 0 0 0 0 0 Q9C0C6 CIPC_HUMAN CLOCK-interacting pacemaker (CLOCK-interacting circadian protein) CIPC KIAA1737 Homo sapiens (Human) "negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0042754; GO:0045892; GO:0048511 DSGFSDGSSECLSSAEQMESEDMLSALGWSREDR 0.96233 0.49163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50148 GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ GAQ Homo sapiens (Human) "action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; blood coagulation [GO:0007596]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of protein kinase activity [GO:0006469]; phototransduction, visible light [GO:0007603]; protein stabilization [GO:0050821]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of platelet activation [GO:0010543]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; nuclear membrane [GO:0031965]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; nuclear membrane [GO:0031965]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; blood coagulation [GO:0007596]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of protein kinase activity [GO:0006469]; phototransduction, visible light [GO:0007603]; protein stabilization [GO:0050821]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of platelet activation [GO:0010543]" GO:0001508; GO:0001664; GO:0001750; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005765; GO:0005794; GO:0005834; GO:0005886; GO:0006469; GO:0007188; GO:0007189; GO:0007202; GO:0007213; GO:0007215; GO:0007596; GO:0007603; GO:0009649; GO:0010543; GO:0031683; GO:0031965; GO:0045202; GO:0046872; GO:0050821; GO:0060828; GO:0070062 G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] DAQAAREFILK 0.96234 0.5235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH00 OR2T4_HUMAN Olfactory receptor 2T4 (Olfactory receptor OR1-60) OR2T4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DVMGALK 0.96234 0.13153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y262 EIF3L_HUMAN "Eukaryotic translation initiation factor 3 subunit L, eIF3l (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein)" EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] GO:0001650; GO:0001732; GO:0003723; GO:0003743; GO:0005654; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0033290; GO:0075525 RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] DMIHIADTKVAR 0.96234 0.27589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8228 0 0 0 0 0 11.4818 17.8122 11.729 0 17.5977 0 13.2062 0 12.8221 0 0 0 0 0 0 0 0 0 0 0 0 13.2428 13.5879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1401 0 0 0 0 10.0741 0 0 14.9237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTU2 SRB4D_HUMAN Scavenger receptor cysteine-rich domain-containing group B protein (Four scavenger receptor cysteine-rich domains-containing protein) (S4D-SRCRB) SSC4D SRCRB4D Homo sapiens (Human) extracellular region [GO:0005576]; membrane [GO:0016020] extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044] GO:0005044; GO:0005576; GO:0016020 scavenger receptor activity [GO:0005044] LVGGPGPCRGR 0.96236 0.068306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8127 0 0 0 0 0 0 0 0 0 0 12.9111 0 12.8403 0 0 0 0 0 0 12.5821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2196 0 0 0 0 0 0 0 0 0 13.2301 0 0 0 0 12.9469 0 12.2053 13.6071 0 0 11.7785 0 0 0 0 12.0911 0 0 0 0 0 0 14.027 0 0 13.0653 0 0 0 0 0 0 11.3004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4152 P05981 HEPS_HUMAN "Serine protease hepsin, EC 3.4.21.106 (Transmembrane protease serine 1) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain ]" HPN TMPRSS1 Homo sapiens (Human) basement membrane disassembly [GO:0034769]; cochlea morphogenesis [GO:0090103]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pilomotor reflex [GO:0097195]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of thyroid hormone generation [GO:2000611]; potassium ion transmembrane transport [GO:0071805]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; response to thyroid hormone [GO:0097066] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; basement membrane disassembly [GO:0034769]; cochlea morphogenesis [GO:0090103]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pilomotor reflex [GO:0097195]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of thyroid hormone generation [GO:2000611]; potassium ion transmembrane transport [GO:0071805]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; response to thyroid hormone [GO:0097066] GO:0004252; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0006508; GO:0008233; GO:0008236; GO:0008360; GO:0009986; GO:0010628; GO:0010719; GO:0010756; GO:0016021; GO:0016324; GO:0030307; GO:0034769; GO:0043025; GO:0043066; GO:0043923; GO:0050680; GO:0050910; GO:0070008; GO:0070062; GO:0071805; GO:0090103; GO:0097066; GO:0097195; GO:2000347; GO:2000611 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236] GRFLAAICQDCGR 0.96237 0.13153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8721 0 0 0 0 0 Q6P5X7 TMM71_HUMAN Transmembrane protein 71 TMEM71 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] GO:0005739; GO:0016021 ENLVRIFRK 0.96237 0.18734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2443 0 0 0 0 0 0 0 0 0 O00623 PEX12_HUMAN "Peroxisome assembly protein 12 (Peroxin-12) (Peroxisome assembly factor 3, PAF-3)" PEX12 PAF3 Homo sapiens (Human) peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein targeting to peroxisome [GO:0006625] GO:0004842; GO:0005777; GO:0005778; GO:0005779; GO:0005829; GO:0006513; GO:0006625; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:1990429 protein C-terminus binding [GO:0008022]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] EEDEYSIHPPSSRWK 0.96238 0.066365 0 0 0 0 0 0 0 0 0 0 13.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2463 13.8944 0 14.9195 0 13.7474 12.8637 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4405 0 0 0 13.5412 0 0 0 0 12.8874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.64 0 0 0 0 0 0 0 0 0 0 10.9897 0 0 0 0 0 0 0 0 11.085 0 0 0 0 0 0 0 0 0 Q6UXP9 YO001_HUMAN Putative uncharacterized protein UNQ9370/PRO34162 UNQ9370/PRO34162 Homo sapiens (Human) AAVYLNLSLPLKSVHR 0.96238 0.53659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8508 0 0 0 0 0 0 0 0 0 0 0 0 0 P36508 ZNF76_HUMAN Zinc finger protein 76 (Zinc finger protein 523) ZNF76 D6S229E ZNF523 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]" GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0043565; GO:0045944; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" RPRIAYLSEVK 0.96239 0.27247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JX71 F209A_HUMAN Protein FAM209A FAM209A C20orf106 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005634; GO:0005637; GO:0007283; GO:0016021; GO:0030154; GO:0070062 DCAFNTLMELEVELMK 0.96239 0.53561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4431 0 0 0 0 0 0 13.0584 12.9824 0 0 0 0 0 0 0 0 0 13.3102 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5095 0 0 0 0 0 0 0 0 13.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TAC2 CCD57_HUMAN Coiled-coil domain-containing protein 57 CCDC57 Homo sapiens (Human) centriole replication [GO:0007099]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle microtubule [GO:0005876]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule nucleation [GO:0007020]; positive regulation of mitotic cell cycle [GO:0045931] GO:0000086; GO:0005737; GO:0005813; GO:0005814; GO:0005876; GO:0007020; GO:0007099; GO:0034451; GO:0045931; GO:0060271 AVTLERDQAVQALRMHGLPR 0.9624 0.13826 0 0 0 0 0 0 0 0 13.9826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6214 0 0 0 0 0 13.3584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7317 0 0 0 0 0 0 0 0 0 0 0 0 15.7006 0 0 0 0 0 11.2956 0 0 15.7414 0 0 0 0 0 0 0 0 0 0 10.3492 0 0 0 0 0 13.3752 0 0 15.5337 11.0994 0 0 0 0 0 0 0 0 12.4364 0 13.7232 9.54257 0 0 0 0 0 0 0 0 11.9749 12.3504 0 0 13.7849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1818 0 0 0 12.8781 0 0 0 0 0 Q9UPW6 SATB2_HUMAN DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2) SATB2 KIAA1034 Homo sapiens (Human) cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cartilage development [GO:0051216]; cellular response to organic substance [GO:0071310]; chromatin remodeling [GO:0006338]; embryonic pattern specification [GO:0009880]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]" GO:0000118; GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001764; GO:0002076; GO:0003682; GO:0005654; GO:0005667; GO:0006338; GO:0006357; GO:0009880; GO:0016363; GO:0042826; GO:0045944; GO:0048704; GO:0051216; GO:0060021; GO:0071310 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AAPAEIDQR 0.96241 0.5337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2154 0 0 0 0 0 0 0 0 0 0 13.1015 0 0 0 13.0061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5462 12.1597 0 0 0 0 10.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y343 SNX24_HUMAN Sorting nexin-24 SNX24 SBBI31 UNQ654/PRO1284 Homo sapiens (Human) protein transport [GO:0015031] cytoplasmic vesicle membrane [GO:0030659] cytoplasmic vesicle membrane [GO:0030659]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein transport [GO:0015031] GO:0010314; GO:0015031; GO:0030659; GO:0032266; GO:0070273; GO:1901981 phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] LFLDFLNVRHLPSLPK 0.96241 0.13731 0 0 0 0 0 0 0 0 0 0 0 0 10.5681 0 0 0 0 0 0 0 0 0 0 0 15.0943 0 0 0 10.082 0 0 0 14.9233 0 0 0 14.3036 0 14.5487 0 0 0 0 13.6957 0 14.4484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00512 BCL9_HUMAN "B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, Bcl-9 (Protein legless homolog)" BCL9 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; myoblast differentiation [GO:0045445]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366] beta-catenin-TCF complex [GO:1990907]; cis-Golgi network [GO:0005801]; nucleoplasm [GO:0005654]; sarcoplasm [GO:0016528] beta-catenin-TCF complex [GO:1990907]; cis-Golgi network [GO:0005801]; nucleoplasm [GO:0005654]; sarcoplasm [GO:0016528]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; myoblast differentiation [GO:0045445]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366] GO:0003713; GO:0005654; GO:0005801; GO:0006366; GO:0008013; GO:0014908; GO:0016528; GO:0035019; GO:0035914; GO:0045445; GO:0045944; GO:0060070; GO:1990907 beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] LPGFAGMINSEMEGPNVPNPASR 0.96243 0.13662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4385 0 0 0 0 0 12.5264 0 12.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04435 TVB79_HUMAN T cell receptor beta variable 7-9 TRBV7-9 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; MHC protein binding [GO:0042287]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955] GO:0002250; GO:0005886; GO:0006955; GO:0007166; GO:0042101; GO:0042287; GO:0042605 MHC protein binding [GO:0042287]; peptide antigen binding [GO:0042605] LLSDRFSAER 0.96243 0.29194 0 0 0 0 0 0 14.7396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8822 0 0 0 0 0 0 12.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8659 P12074 CX6A1_HUMAN "Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver) (Cytochrome c oxidase subunit VIA-liver, COX VIa-L)" COX6A1 COX6AL Homo sapiens (Human) "cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]; cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0006091; GO:0006123; GO:0016021; GO:0030234; GO:0031966; GO:0045333 cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234] AVVGVSSVSRLLGRSR 0.96243 0.1618 0 0 0 0 0 0 0 0 0 0 0 12.8632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2B1 RXLT1_HUMAN "Ribitol-5-phosphate xylosyltransferase 1, EC 2.4.2.61 (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase)" RXYLT1 TMEM5 Homo sapiens (Human) protein O-linked mannosylation [GO:0035269] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; ribitol beta-1,4-xylosyltransferase activity [GO:0120053]; protein O-linked mannosylation [GO:0035269]" GO:0000139; GO:0005654; GO:0005794; GO:0005887; GO:0035269; GO:0120053 "ribitol beta-1,4-xylosyltransferase activity [GO:0120053]" ELPAVLEKEK 0.96243 0.13683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7896 13.1278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3912 13.509 13.4126 0 0 12.9812 0 0 0 14.9014 0 14.1457 0 0 14.0716 0 13.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6246 11.809 0 0 0 0 0 0 0 P05062 ALDOB_HUMAN "Fructose-bisphosphate aldolase B, EC 4.1.2.13 (Liver-type aldolase)" ALDOB ALDB Homo sapiens (Human) "fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; NADH oxidation [GO:0006116]; positive regulation of ATP-dependent activity [GO:0032781]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]" centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815] "centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; NADH oxidation [GO:0006116]; positive regulation of ATP-dependent activity [GO:0032781]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]" GO:0004332; GO:0005815; GO:0005829; GO:0006000; GO:0006096; GO:0006116; GO:0008092; GO:0030388; GO:0032781; GO:0034451; GO:0042802; GO:0051117; GO:0061609; GO:0061624; GO:0070061; GO:0070062; GO:0070072 ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802] AHRFPALTQEQKK 0.96244 0.077139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4729 0 0 0 0 0 0 13.5047 0 0 0 0 0 0 0 0 13.3995 0 0 0 0 13.0282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4968 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NF64 ZMIZ2_HUMAN Zinc finger MIZ domain-containing protein 2 (PIAS-like protein Zimp7) ZMIZ2 KIAA1886 ZIMP7 HRIHFB2007 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mitochondrion [GO:0005739]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008270; GO:0030374; GO:0043596; GO:0045944 nuclear receptor coactivator activity [GO:0030374]; zinc ion binding [GO:0008270] DGVVLEPFRLQHNLAVSNHVFQLR 0.96245 0.28968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0083 0 0 0 0 0 0 17.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GTI1 CC201_HUMAN Coiled-coil domain-containing protein 201 CCDC201 Homo sapiens (Human) AAAMERVRQWEIYVLQNIEEATQHELTIEDD 0.96246 0.13372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUA7 TEX51_HUMAN Testis-expressed protein 51 TEX51 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CWPELSALIDYDLQILWVTPGPPTELSQNR 0.96249 0.27687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6927 0 0 0 0 0 11.5544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13595 TRA2A_HUMAN "Transformer-2 protein homolog alpha, TRA-2 alpha, TRA2-alpha (Transformer-2 protein homolog A)" TRA2A Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]" intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0043231; GO:0048026 RNA binding [GO:0003723] DSYYDRGYDR 0.96249 0.51156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7422 0 0 0 0 0 0 15.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2794 0 0 0 0 13.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.93 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHB4 NDOR1_HUMAN "NADPH-dependent diflavin oxidoreductase 1, EC 1.18.1.- (NADPH-dependent FMN and FAD-containing oxidoreductase) (Novel reductase 1)" NDOR1 NR1 Homo sapiens (Human) cell death [GO:0008219]; cellular response to menadione [GO:0036245]; electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO:0016731]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226]" GO:0003958; GO:0005654; GO:0005737; GO:0005829; GO:0008219; GO:0009055; GO:0010181; GO:0016226; GO:0016491; GO:0016653; GO:0016731; GO:0022900; GO:0036245; GO:0045111; GO:0048471; GO:0050660; GO:0050661; GO:0070402; GO:0071949 "electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO:0016731]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]" LQILVAVVQFQTR 0.96249 0.28591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2898 0 0 0 0 0 0 0 0 0 13.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2369 0 0 0 0 0 0 0 13.1528 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NMD0 IFM10_HUMAN "Interferon-induced transmembrane protein 10 (Dispanin subfamily A member 3, DSPA3)" IFITM10 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 PPAGSPK 0.9625 0.27619 0 0 0 0 10.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1197 0 0 0 0 0 0 C0HLU2 SEHBP_HUMAN Transcriptional regulator SEHBP (Short ORF-encoded histone-binding protein) (ZNF689 upstream open reading frame protein) ZNF689 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone binding [GO:0042393]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005634; GO:0005737; GO:0006357; GO:0042393 histone binding [GO:0042393] CLSPKFGQEFPE 0.9625 0.28518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5595 15.9186 0 0 16.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50542 PEX5_HUMAN "Peroxisomal targeting signal 1 receptor, PTS1 receptor, PTS1R (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)" PEX5 PXR1 Homo sapiens (Human) "cell development [GO:0048468]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; very long-chain fatty acid metabolic process [GO:0000038]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein sequestering activity [GO:0140311]; small GTPase binding [GO:0031267]; cell development [GO:0048468]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; very long-chain fatty acid metabolic process [GO:0000038]" GO:0000038; GO:0000268; GO:0001764; GO:0005052; GO:0005737; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006635; GO:0007006; GO:0007029; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0019899; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0040018; GO:0045046; GO:0047485; GO:0048468; GO:0050905; GO:0051262; GO:0140311 enzyme binding [GO:0019899]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein sequestering activity [GO:0140311]; small GTPase binding [GO:0031267] VDDPKLANSEFLK 0.9625 0.13153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1544 0 11.8376 0 0 0 0 10.2161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14410 GLPK2_HUMAN "Glycerol kinase 2, GK 2, Glycerokinase 2, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 2) (Glycerol kinase, testis specific 2)" GK2 GKP2 GKTA Homo sapiens (Human) flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226] "extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; sperm mitochondrial sheath [GO:0097226]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; flagellated sperm motility [GO:0030317]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283]; triglyceride metabolic process [GO:0006641]" GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0007283; GO:0016021; GO:0016310; GO:0016773; GO:0019563; GO:0030317; GO:0046167; GO:0070062; GO:0097225; GO:0097226; GO:0120317 "ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" EGWVEQDPK 0.9625 0.51079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2J7 S6A15_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT2 (Sodium- and chloride-dependent neurotransmitter transporter NTT73) (Sodium-coupled branched-chain amino-acid transporter 1) (Solute carrier family 6 member 15) (Transporter v7-3) SLC6A15 B0AT2 NTT73 SBAT1 Homo sapiens (Human) amino acid transport [GO:0006865]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter transmembrane transporter activity [GO:0005326]; proline:sodium symporter activity [GO:0005298]; amino acid transport [GO:0006865]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725] GO:0005298; GO:0005326; GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0015171; GO:0015804; GO:0015820; GO:0015824; GO:0016021; GO:0035725 amino acid transmembrane transporter activity [GO:0015171]; neurotransmitter transmembrane transporter activity [GO:0005326]; proline:sodium symporter activity [GO:0005298] DMLGFAPSR 0.9625 0.069436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6578 0 0 0 0 0 0 12.5036 0 0 0 14.3491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2822 0 0 A0A0C4DH39 HV158_HUMAN Immunoglobulin heavy variable 1-58 IGHV1-58 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] SEDTAVYYCAA 0.96251 0.12351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGY1 O10Z1_HUMAN Olfactory receptor 10Z1 (Olfactory receptor OR1-15) OR10Z1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] AIQTALRNAFRGR 0.96252 0.068896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSA3 CNBP1_HUMAN Beta-catenin-interacting protein 1 (Inhibitor of beta-catenin and Tcf-4) CTNNBIP1 ICAT Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528]; Wnt signaling pathway [GO:0016055] GO:0001658; GO:0002528; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008013; GO:0009952; GO:0016055; GO:0030178; GO:0030877; GO:0031333; GO:0032091; GO:0043392; GO:0043433; GO:0045657; GO:0045669; GO:0048662; GO:0060633; GO:0070016; GO:0072201; GO:0090090; GO:1990711 armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013] EGAPGKSPEEMYIQQK 0.96252 0.12268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00219 HYAS3_HUMAN "Hyaluronan synthase 3, EC 2.4.1.212 (Hyaluronate synthase 3) (Hyaluronic acid synthase 3, HA synthase 3)" HAS3 Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of transcription, DNA-templated [GO:0045893]" early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hyaluranon cable [GO:0036117]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hyaluranon cable [GO:0036117]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; hyaluronan biosynthetic process [GO:0030213]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000139; GO:0005634; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0005975; GO:0016021; GO:0030213; GO:0036117; GO:0042802; GO:0045226; GO:0045893; GO:0050501; GO:0085029; GO:1900106 hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802] AGQALKLPSPR 0.96253 0.29316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0439 0 0 0 0 0 0 0 15.2775 0 0 0 14.5236 14.8442 0 14.373 14.7023 0 0 14.1585 0 0 0 14.4517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1494 0 0 0 0 0 0 0 0 0 0 13.864 14.8632 0 14.5044 0 0 16.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHJ6 LIRB4_HUMAN "Leukocyte immunoglobulin-like receptor subfamily B member 4, B4 (CD85 antigen-like family member K) (Immunoglobulin-like transcript 3, ILT-3) (Leukocyte immunoglobulin-like receptor 5, LIR-5) (Monocyte inhibitory receptor HM18) (CD antigen CD85k)" LILRB4 ILT3 LIR5 Homo sapiens (Human) "adaptive immune response [GO:0002250]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; interleukin-10-mediated signaling pathway [GO:0140105]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of chemokine production [GO:0032682]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of cytotoxic T cell differentiation [GO:0045584]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of IP-10 production [GO:0071659]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of monocyte activation [GO:0150102]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell anergy [GO:0002669]; receptor internalization [GO:0031623]; tolerance induction [GO:0002507]" cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of the cytoplasmic side of the plasma membrane [GO:0098752]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of the cytoplasmic side of the plasma membrane [GO:0098752]; plasma membrane [GO:0005886]; apolipoprotein binding [GO:0034185]; fibronectin binding [GO:0001968]; protein phosphatase binding [GO:0019903]; signaling receptor inhibitor activity [GO:0030547]; transmembrane receptor protein tyrosine kinase inhibitor activity [GO:0030293]; adaptive immune response [GO:0002250]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; interleukin-10-mediated signaling pathway [GO:0140105]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of chemokine production [GO:0032682]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of cytotoxic T cell differentiation [GO:0045584]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of IP-10 production [GO:0071659]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of monocyte activation [GO:0150102]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell anergy [GO:0002669]; receptor internalization [GO:0031623]; tolerance induction [GO:0002507]" GO:0001968; GO:0002250; GO:0002507; GO:0002669; GO:0002725; GO:0002774; GO:0005886; GO:0009986; GO:0019903; GO:0030293; GO:0030547; GO:0031623; GO:0032682; GO:0032689; GO:0032691; GO:0032693; GO:0032703; GO:0032714; GO:0032715; GO:0032720; GO:0034185; GO:0042130; GO:0043124; GO:0043378; GO:0043409; GO:0045584; GO:0045591; GO:0045671; GO:0046007; GO:0050860; GO:0061099; GO:0070062; GO:0071659; GO:0098752; GO:0140105; GO:0150102; GO:1900016; GO:1900181; GO:1902894; GO:2000272; GO:2000524 apolipoprotein binding [GO:0034185]; fibronectin binding [GO:0001968]; protein phosphatase binding [GO:0019903]; signaling receptor inhibitor activity [GO:0030547]; transmembrane receptor protein tyrosine kinase inhibitor activity [GO:0030293] ARFSIPSMTEDYAGR 0.96253 2.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15353 FOXN1_HUMAN Forkhead box protein N1 (Winged-helix transcription factor nude) FOXN1 RONU WHN Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; defense response [GO:0006952]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; keratinocyte differentiation [GO:0030216]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus epithelium morphogenesis [GO:0097536] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; defense response [GO:0006952]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; keratinocyte differentiation [GO:0030216]; lymphoid lineage cell migration into thymus [GO:0097535]; nail development [GO:0035878]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of hair follicle development [GO:0051798]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell homeostasis [GO:0043029]; T cell lineage commitment [GO:0002360]; thymus epithelium morphogenesis [GO:0097536]" GO:0000785; GO:0000976; GO:0000981; GO:0001228; GO:0001942; GO:0002360; GO:0005634; GO:0006357; GO:0006952; GO:0008544; GO:0009887; GO:0030216; GO:0030858; GO:0035878; GO:0043029; GO:0048514; GO:0051798; GO:0097535; GO:0097536; GO:1902232 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; transcription cis-regulatory region binding [GO:0000976]" MQEELQKWK 0.96254 0.085026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969H8 MYDGF_HUMAN "Myeloid-derived growth factor, MYDGF" MYDGF C19orf10 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001525; GO:0001934; GO:0001938; GO:0005615; GO:0005783; GO:0005788; GO:0005793; GO:0005794; GO:0006915; GO:0014068; GO:0043066; GO:0043410; GO:0045766; GO:0045944; GO:0051897 AELSKLVIVAKASR 0.96254 0.29231 0 0 0 0 0 0 0 0 0 12.5091 12.0594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3048 0 0 13.6977 0 0 0 0 0 0 11.7909 0 0 0 0 0 0 0 15.3947 0 0 0 0 0 0 0 15.5674 0 0 0 14.7097 10.1706 14.8573 0 13.9192 0 0 15.2911 0 0 0 0 0 0 14.897 0 0 0 0 0 13.6554 13.4476 0 0 0 14.614 0 0 14.3314 14.4154 13.8572 0 13.5354 0 0 0 13.2775 0 0 0 13.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRQ5 SMCO4_HUMAN Single-pass membrane and coiled-coil domain-containing protein 4 (Protein FN5) SMCO4 C11orf75 FN5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ERKQAMQEAR 0.96254 0.29276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6735 0 0 0 0 0 0 0 0 0 0 12.0371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PIZ9 TRAT1_HUMAN "T-cell receptor-associated transmembrane adapter 1 (T-cell receptor-interacting molecule, TRIM) (pp29/30)" TRAT1 TCRIM HSPC062 Homo sapiens (Human) adaptive immune response [GO:0002250]; cellular defense response [GO:0006968]; negative regulation of receptor recycling [GO:0001920]; negative regulation of transport [GO:0051051]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell receptor signaling pathway [GO:0050862]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; integral component of plasma membrane [GO:0005887]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] centriolar satellite [GO:0034451]; integral component of plasma membrane [GO:0005887]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; adaptive immune response [GO:0002250]; cellular defense response [GO:0006968]; negative regulation of receptor recycling [GO:0001920]; negative regulation of transport [GO:0051051]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell receptor signaling pathway [GO:0050862]; signal transduction [GO:0007165] GO:0001920; GO:0002250; GO:0005068; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0034451; GO:0042101; GO:0050850; GO:0050862; GO:0051051; GO:0072686 transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] LFGLIRAKR 0.96256 0.13838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5605 0 0 0 0 0 0 0 0 0 0 17.0908 0 0 0 0 0 0 0 0 0 16.0552 0 0 16.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y286 SIGL7_HUMAN "Sialic acid-binding Ig-like lectin 7, Siglec-7 (Adhesion inhibitory receptor molecule 1, AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328)" SIGLEC7 AIRM1 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155] GO:0005886; GO:0005887; GO:0007155; GO:0030246; GO:0033691; GO:0038023 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023] APVATNNPAWAVQEETRDRFHLLGDPQTK 0.96258 2.9471 0 12.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9851 0 0 0 11.0411 0 0 0 0 0 0 0 0 0 0 0 0 10.6864 0 12.7697 10.4536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3139 0 0 0 0 0 0 0 0 0 9.54668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1443 0 0 0 0 0 0 0 0 0 0 11.0217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.649 14.2787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5788 0 13.0562 13.4498 0 0 14.2488 0 0 0 0 0 0 0 0 0 15.0547 15.3027 0 0 0 0 0 14.1795 0 0 0 13.8631 0 0 0 0 0 0 0 0 0 0 0 P31269 HXA9_HUMAN Homeobox protein Hox-A9 (Homeobox protein Hox-1G) HOXA9 HOX1G Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; definitive hemopoiesis [GO:0060216]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell activation [GO:0042118]; male gonad development [GO:0008584]; mammary gland development [GO:0030879]; negative regulation of myeloid cell differentiation [GO:0045638]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; uterus development [GO:0060065]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; definitive hemopoiesis [GO:0060216]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell activation [GO:0042118]; male gonad development [GO:0008584]; mammary gland development [GO:0030879]; negative regulation of myeloid cell differentiation [GO:0045638]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]; uterus development [GO:0060065]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006351; GO:0006357; GO:0007283; GO:0007338; GO:0008584; GO:0009952; GO:0009954; GO:0019899; GO:0030850; GO:0030879; GO:0033574; GO:0035115; GO:0042118; GO:0045638; GO:0048704; GO:0060065; GO:0060216; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EFLFNMYLTR 0.96259 0.16193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q30154 DRB5_HUMAN "HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5)" HLA-DRB5 Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of T cell activation [GO:0050870] GO:0000139; GO:0002250; GO:0002503; GO:0005765; GO:0005886; GO:0012507; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0031902; GO:0032588; GO:0042605; GO:0042613; GO:0050870; GO:0070062; GO:0071556 MHC class II protein complex binding [GO:0023026]; peptide antigen binding [GO:0042605] DIYNQEEDLR 0.96259 4.3617 0 0 0 0 0 0 0 0 0 0 12.0346 11.5153 0 11.2539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5583 0 0 0 12.8316 0 0 12.7191 0 13.8507 0 0 12.9475 14.3043 0 0 12.9722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2108 0 0 0 0 0 0 0 0 0 11.7695 12.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2777 0 0 0 0 0 0 0 0 0 0 11.3851 0 0 0 0 0 13.6796 0 0 0 0 0 A0A075B6S2 KVD29_HUMAN Immunoglobulin kappa variable 2D-29 IGKV2D-29 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 FSGVPDR 0.9626 0.52034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAP8 PPR35_HUMAN Protein phosphatase 1 regulatory subunit 35 PPP1R35 C7orf47 Homo sapiens (Human) negative regulation of phosphatase activity [GO:0010923]; notochord morphogenesis [GO:0048570]; positive regulation of centriole elongation [GO:1903724]; positive regulation of cilium assembly [GO:0045724] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923]; notochord morphogenesis [GO:0048570]; positive regulation of centriole elongation [GO:1903724]; positive regulation of cilium assembly [GO:0045724] GO:0004864; GO:0005737; GO:0005813; GO:0005814; GO:0010923; GO:0019902; GO:0045724; GO:0048570; GO:1903724 phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864] EKLALLPPQARAPHPK 0.9626 0.077979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6643 0 0 0 0 0 14.4353 0 0 0 0 0 0 0 0 0 13.6416 0 0 0 0 11.8476 15.1398 0 0 0 13.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T76 MMS19_HUMAN "MMS19 nucleotide excision repair protein homolog, hMMS19 (MET18 homolog) (MMS19-like protein)" MMS19 MMS19L Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; nucleotide-excision repair [GO:0006289]; phosphorelay signal transduction system [GO:0000160]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to hormone [GO:0009725]; transcription, DNA-templated [GO:0006351]" CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675] "CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIIH holo complex [GO:0005675]; enzyme binding [GO:0019899]; nuclear estrogen receptor binding [GO:0030331]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor complex adaptor activity [GO:0030159]; transcription coactivator activity [GO:0003713]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; nucleotide-excision repair [GO:0006289]; phosphorelay signal transduction system [GO:0000160]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; response to hormone [GO:0009725]; transcription, DNA-templated [GO:0006351]" GO:0000160; GO:0003713; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0006259; GO:0006281; GO:0006289; GO:0006351; GO:0006974; GO:0007059; GO:0009725; GO:0016020; GO:0016226; GO:0019899; GO:0030159; GO:0030331; GO:0030674; GO:0045893; GO:0071817; GO:0097361; GO:0097428; GO:1905168 enzyme binding [GO:0019899]; nuclear estrogen receptor binding [GO:0030331]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor complex adaptor activity [GO:0030159]; transcription coactivator activity [GO:0003713] AIQLLSQVLLHCHTLLLEKEVVHLILFYENR 0.9626 0.12891 0 0 0 13.1158 0 0 0 0 0 0 0 0 0 12.642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0128 0 0 0 0 0 0 0 12.1869 0 0 0 0 0 0 0 0 0 0 13.6011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4043 0 11.7912 0 0 0 0 0 11.4857 0 0 0 0 0 13.2463 13.1974 0 0 0 0 12.3978 0 0 0 0 0 12.7044 0 0 0 14.1924 0 0 0 0 14.5854 0 0 0 0 14.2867 0 15.4759 0 0 0 0 0 13.4463 0 0 0 0 13.1539 0 0 14.5312 0 0 0 0 14.1466 0 0 13.9795 0 0 12.6484 0 0 0 0 0 0 0 0 12.851 0 0 0 12.9423 0 0 11.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2646 0 13.5293 0 0 0 0 0 0 Q9H4Q3 PRD13_HUMAN "PR domain zinc finger protein 13, EC 2.1.1.- (PR domain-containing protein 13)" PRDM13 PFM10 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468] GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0010468; GO:0022008; GO:0042054; GO:0046872; GO:0061629 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] CEFCGKVLVR 0.96261 0.13538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3314 12.4714 12.6764 12.5877 12.6158 12.9593 12.7609 0 0 0 0 12.5809 15.7487 12.5731 0 12.7586 12.5647 12.6764 0 0 0 0 0 0 0 12.5598 12.9674 0 0 0 0 0 0 12.6393 0 12.0227 12.7901 0 12.0273 12.1709 0 11.7397 11.5637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0755 0 13.4051 0 0 0 0 0 0 0 0 0 14.6605 0 0 0 0 0 0 0 0 0 0 11.314 13.4919 0 0 0 0 0 0 0 0 13.9044 0 0 13.87 0 0 11.1352 0 0 0 0 0 0 12.9637 0 0 0 0 0 18.8483 0 0 0 0 14.3195 10.7222 0 0 0 0 0 0 0 13.9134 0 0 0 0 14.2415 14.2814 14.5745 0 0 14.3763 10.8689 0 0 13.9832 0 0 0 0 13.8858 0 0 0 0 Q5TF39 MFS4B_HUMAN Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B) MFSD4B KIAA1919 NAGLT1 HSPC100 Homo sapiens (Human) sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814] GO:0005355; GO:0006814; GO:0015293; GO:0016021; GO:0016324 glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293] ASAETFRR 0.96262 0.28971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9373 0 0 0 0 0 0 0 11.7437 0 0 0 14.7743 15.1889 0 0 12.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.45364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35452 HXD12_HUMAN Homeobox protein Hox-D12 (Homeobox protein Hox-4H) HOXD12 HOX4H Homo sapiens (Human) embryonic digit morphogenesis [GO:0042733]; pattern specification process [GO:0007389]; skeletal system development [GO:0001501] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic digit morphogenesis [GO:0042733]; pattern specification process [GO:0007389]; skeletal system development [GO:0001501]" GO:0000785; GO:0000981; GO:0001501; GO:0005634; GO:0005667; GO:0007389; GO:0042733; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" AAKYDYAGVGR 0.96263 0.39471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11230 ACHB_HUMAN Acetylcholine receptor subunit beta CHRNB1 ACHRB CHRNB Homo sapiens (Human) "acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell development [GO:0055001]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; postsynaptic membrane organization [GO:0001941]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; synaptic transmission, cholinergic [GO:0007271]" GO:0001941; GO:0003009; GO:0004888; GO:0005231; GO:0005887; GO:0005892; GO:0006812; GO:0006936; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0015267; GO:0015276; GO:0022848; GO:0030594; GO:0031594; GO:0034220; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0055001; GO:0070161; GO:0095500; GO:0099060; GO:1904315 acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] EGQRQEVIFYLIIRR 0.96265 0.17763 0 0 0 0 0 0 0 0 0 0 13.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3591 0 0 0 0 0 0 0 0 11.0936 0 0 0 13.9261 0 0 0 11.4395 0 13.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1173 11.9436 0 0 0 0 0 0 0 0 0 14.2371 0 0 14.2829 0 0 13.1093 0 0 0 12.3346 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00501 CLD5_HUMAN "Claudin-5 (Transmembrane protein deleted in VCFS, TMDVCF)" CLDN5 AWAL TMVCF Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; establishment of blood-retinal barrier [GO:1990963]; face morphogenesis [GO:0060325]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; myelination [GO:0042552]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular permeability [GO:0043116]; outflow tract morphogenesis [GO:0003151]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; response to ethanol [GO:0045471]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; transforming growth factor beta receptor signaling pathway [GO:0007179] apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160] apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; establishment of blood-retinal barrier [GO:1990963]; face morphogenesis [GO:0060325]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; myelination [GO:0042552]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular permeability [GO:0043116]; outflow tract morphogenesis [GO:0003151]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; response to ethanol [GO:0045471]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0003151; GO:0005198; GO:0005886; GO:0005911; GO:0005923; GO:0007043; GO:0007155; GO:0007179; GO:0007612; GO:0008284; GO:0010628; GO:0010629; GO:0016021; GO:0016327; GO:0016328; GO:0016338; GO:0016525; GO:0030054; GO:0030336; GO:0032092; GO:0033270; GO:0035633; GO:0042552; GO:0042802; GO:0043116; GO:0043220; GO:0045471; GO:0060021; GO:0060325; GO:0070160; GO:0070830; GO:0120192; GO:1903142; GO:1903348; GO:1990963 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] PDLSFPVKYSAPR 0.96266 0.13153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8773 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y291 RT33_HUMAN "28S ribosomal protein S33, mitochondrial, MRP-S33, S33mt (Mitochondrial small ribosomal subunit protein mS33)" MRPS33 CGI-139 PTD003 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0032543 structural constituent of ribosome [GO:0003735] LFSELPLAK 0.96266 0.28594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50549 ETV1_HUMAN ETS translocation variant 1 (Ets-related protein 81) ETV1 ER81 Homo sapiens (Human) axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" NRPAMNYDK 0.96267 0.51338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8712 17.8454 17.6969 0 17.0702 17.1076 16.8422 0 0 0 15.223 15.2719 15.5227 13.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.454 11.0002 10.632 0 0 0 0 17.6147 17.5456 17.4414 17.0199 0 16.2254 0 0 16.1005 0 15.791 0 0 16.3092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2215 0 0 0 0 0 0 0 0 0 20.2763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4113 18.3274 0 0 0 0 0 0 0 0 0 0 12.6406 0 0 0 0 0 0 0 0 0 13.6396 0 20.496 0 0 0 0 0 0 0 Q6Q8B3 MO2R2_HUMAN "Cell surface glycoprotein CD200 receptor 2 (CD200 cell surface glycoprotein receptor-like 2, CD200 receptor-like 2, HuCD200R2) (CD200 cell surface glycoprotein receptor-like a, CD200RLa) (Cell surface glycoprotein CD200 receptor 1-like) (Cell surface glycoprotein OX2 receptor 2)" CD200R1L CD200R2 Homo sapiens (Human) regulation of neuroinflammatory response [GO:0150077] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; regulation of neuroinflammatory response [GO:0150077] GO:0009897; GO:0016021; GO:0038023; GO:0150077 signaling receptor activity [GO:0038023] NITAVCKAVTGK 0.96267 0.29492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1616 0 0 0 0 0 0 0 0 0 0 0 0 13.9823 0 0 13.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.37959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UP0 CAD24_HUMAN Cadherin-24 CDH24 CDH11L UNQ2834/PRO34009 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007156; GO:0008013; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045294; GO:0045296; GO:0070097; GO:0098609; GO:0098742 alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; delta-catenin binding [GO:0070097] DGSASLLLPSRPAPPR 0.96267 0.28526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4513 0 0 0 0 0 12.2823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99417 MYCBP_HUMAN "c-Myc-binding protein (Associate of Myc 1, AMY-1)" MYCBP AMY1 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006355; GO:0007283 transcription coactivator activity [GO:0003713] PNSALDFLKHHLGAATPENPEIELLR 0.96267 0.12353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NU23 LYRM2_HUMAN LYR motif-containing protein 2 LYRM2 Homo sapiens (Human) ILQTIRQVPNDSDR 0.96267 0.27621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0213 0 0 0 0 0 0 0 13.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6101 0 0 0 15.3815 0 0 0 0 13.0054 0 0 14.2174 13.6322 0 0 0 0 0 13.3322 0 0 0 0 Q9NRX4 PHP14_HUMAN "14 kDa phosphohistidine phosphatase, EC 3.9.1.3 (Phosphohistidine phosphatase 1, PHPT1) (Protein histidine phosphatase, PHP) (Protein janus-A homolog)" PHPT1 PHP14 CGI-202 HSPC141 Homo sapiens (Human) negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; protein dephosphorylation [GO:0006470]; regulation of actin cytoskeleton reorganization [GO:2000249] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium channel inhibitor activity [GO:0019855]; protein histidine phosphatase activity [GO:0101006]; transmembrane transporter binding [GO:0044325]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; protein dephosphorylation [GO:0006470]; regulation of actin cytoskeleton reorganization [GO:2000249] GO:0005654; GO:0005829; GO:0005886; GO:0006470; GO:0016604; GO:0019855; GO:0035971; GO:0044325; GO:0050860; GO:0051350; GO:0070062; GO:0101006; GO:2000147; GO:2000249; GO:2000984 calcium channel inhibitor activity [GO:0019855]; protein histidine phosphatase activity [GO:0101006]; transmembrane transporter binding [GO:0044325] IKAKYPDYEVTWANDGY 0.96268 0.5125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5083 0 0 0 0 0 0 0 13.468 0 0 14.1639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5XKR4 OTP_HUMAN Homeobox protein orthopedia OTP Homo sapiens (Human) dopaminergic neuron differentiation [GO:0071542]; forebrain neuron differentiation [GO:0021879]; hypothalamus cell differentiation [GO:0021979]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuroendocrine cell differentiation [GO:0061101]; neurohypophysis development [GO:0021985]; neuron differentiation [GO:0030182]; positive regulation of neuroblast proliferation [GO:0002052] chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; dopaminergic neuron differentiation [GO:0071542]; forebrain neuron differentiation [GO:0021879]; hypothalamus cell differentiation [GO:0021979]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuroendocrine cell differentiation [GO:0061101]; neurohypophysis development [GO:0021985]; neuron differentiation [GO:0030182]; positive regulation of neuroblast proliferation [GO:0002052]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0002052; GO:0003677; GO:0005654; GO:0007405; GO:0016604; GO:0021879; GO:0021979; GO:0021985; GO:0030182; GO:0061101; GO:0071542 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" MLSHADLLDARLGMKDAAELLGHR 0.96269 0.29355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0682 0 0 0 12.3605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0322 0 13.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQC8 IFT46_HUMAN Intraflagellar transport protein 46 homolog IFT46 C11orf2 C11orf60 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; protein stabilization [GO:0050821] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; protein stabilization [GO:0050821] GO:0005737; GO:0005813; GO:0005929; GO:0008022; GO:0030992; GO:0031514; GO:0035720; GO:0042073; GO:0050821; GO:0060271; GO:0097542 protein C-terminus binding [GO:0008022] ADNSSDECEEENNK 0.96269 4.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0659 0 0 0 0 0 0 11.8689 0 0 0 0 10.7143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4705 0 0 0 0 0 0 0 0 0 0 0 0 12.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.816 0 11.9447 0 12.233 0 0 0 0 11.5889 0 0 0 11.8262 0 0 0 0 0 0 11.2557 0 0 0 0 0 0 0 0 0 0 0 11.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9264 0 0 0 0 0 0 0 0 0 11.5416 0 0 0 0 13.4396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14770 GPIX_HUMAN "Platelet glycoprotein IX, GP-IX, GPIX (Glycoprotein 9) (CD antigen CD42a)" GP9 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" GO:0005886; GO:0005887; GO:0007155; GO:0007596; GO:0007597; GO:0010572; GO:0035855; GO:0051209; GO:1990779 CASPSLAAHGPLGR 0.9627 0.1403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01105 SET_HUMAN "Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase, IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A, I-2PP2A) (Template-activating factor I, TAF-I)" SET Homo sapiens (Human) "DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]" GO:0000785; GO:0003677; GO:0003682; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0019888; GO:0032991; GO:0035067; GO:0042393; GO:0043524; GO:0045892; GO:0048471 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888] DLTKRSSQTQNK 0.9627 0.085174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15822 ACHA2_HUMAN Neuronal acetylcholine receptor subunit alpha-2 CHRNA2 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular bridge [GO:0045171]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular bridge [GO:0045171]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; heterocyclic compound binding [GO:1901363]; neurotransmitter receptor activity [GO:0030594]; quaternary ammonium group binding [GO:0050997]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" GO:0005231; GO:0005654; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0007165; GO:0007268; GO:0007271; GO:0015464; GO:0016021; GO:0022848; GO:0030594; GO:0034220; GO:0035094; GO:0042391; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050877; GO:0050997; GO:0051899; GO:0070161; GO:1901363; GO:1904315; GO:1905144 acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; heterocyclic compound binding [GO:1901363]; neurotransmitter receptor activity [GO:0030594]; quaternary ammonium group binding [GO:0050997]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] DYWESGEWAIVNATGTYNSKK 0.9627 0.29322 0 0 0 0 0 0 0 0 0 0 0 12.7658 0 0 0 0 0 0 0 0 0 0 12.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8215 0 0 0 0 0 0 0 0 0 P30536 TSPO_HUMAN "Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor, PBR)" TSPO BZRP MBR Homo sapiens (Human) adrenal gland development [GO:0030325]; aging [GO:0007568]; anion transport [GO:0006820]; behavioral response to pain [GO:0048266]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; cholesterol homeostasis [GO:0042632]; contact inhibition [GO:0060242]; glial cell migration [GO:0008347]; heme biosynthetic process [GO:0006783]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of corticosterone secretion [GO:2000853]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein targeting to mitochondrion [GO:0006626]; regulation of cell population proliferation [GO:0042127]; regulation of cholesterol transport [GO:0032374]; regulation of steroid biosynthetic process [GO:0050810]; response to acetylcholine [GO:1905144]; response to manganese ion [GO:0010042]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; transmembrane transporter binding [GO:0044325]; adrenal gland development [GO:0030325]; aging [GO:0007568]; anion transport [GO:0006820]; behavioral response to pain [GO:0048266]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; cholesterol homeostasis [GO:0042632]; contact inhibition [GO:0060242]; glial cell migration [GO:0008347]; heme biosynthetic process [GO:0006783]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of autophagy of mitochondrion [GO:1903147]; negative regulation of corticosterone secretion [GO:2000853]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein targeting to mitochondrion [GO:0006626]; regulation of cell population proliferation [GO:0042127]; regulation of cholesterol transport [GO:0032374]; regulation of steroid biosynthetic process [GO:0050810]; response to acetylcholine [GO:1905144]; response to manganese ion [GO:0010042]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202] GO:0005497; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006626; GO:0006700; GO:0006783; GO:0006820; GO:0006821; GO:0007568; GO:0008202; GO:0008347; GO:0008503; GO:0009410; GO:0010042; GO:0010266; GO:0010940; GO:0014012; GO:0015485; GO:0016021; GO:0030325; GO:0031397; GO:0032374; GO:0032570; GO:0032720; GO:0033574; GO:0042127; GO:0042632; GO:0043065; GO:0043231; GO:0044325; GO:0045019; GO:0048266; GO:0050810; GO:0051901; GO:0051928; GO:0060242; GO:0060252; GO:0060253; GO:0070062; GO:0071222; GO:0071294; GO:0071476; GO:0072656; GO:0120020; GO:1903147; GO:1903579; GO:1905144; GO:2000379; GO:2000853 androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; transmembrane transporter binding [GO:0044325] AVVPLGLYTGQLALNWAWPPIFFGAR 0.96272 0.13894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15027 ACAP1_HUMAN "Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (Centaurin-beta-1, Cnt-b1)" ACAP1 CENTB1 KIAA0050 Homo sapiens (Human) protein transport [GO:0015031] membrane [GO:0016020]; recycling endosome membrane [GO:0055038] membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031] GO:0005096; GO:0015031; GO:0016020; GO:0046872; GO:0055038 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] DFSLMASDDPEKLSRR 0.96273 4.2324 0 0 0 0 0 0 0 0 0 0 0 0 10.3625 0 13.0627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1739 0 0 0 0 11.6224 0 0 0 0 14.2547 0 0 0 0 0 0 0 11.3682 0 0 0 0 0 0 0 0 0 12.0739 14.0992 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2808 12.7507 0 0 0 0 12.0813 12.7317 12.677 0 0 0 0 0 0 0 13.4094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.706 0 0 0 0 0 14.1738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9951 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSN1 YI023_HUMAN Putative uncharacterized protein FLJ45355 Homo sapiens (Human) AREGRGAGSQSPPR 0.96274 0.061512 10.932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5926 0 0 0 0 0 0 0 0 0 0 0 0 12.67 0 0 0 0 0 0 0 0 0 0 0 0 12.7426 12.062 0 0 11.5745 0 0 0 0 12.5691 0 0 0 12.1655 0 0 0 0 0 0 0 0 0 11.4182 13.6679 13.6682 13.5424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTQ7 GRK7_HUMAN "Rhodopsin kinase GRK7, EC 2.7.11.14 (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7)" GRK7 GPRK7 Homo sapiens (Human) protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381] cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0007601; GO:0009966; GO:0022400; GO:0046777; GO:0050254; GO:0097381 ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254] FLQWKLFEMQPVSDKYFTEFR 0.96275 0.060257 0 0 0 0 0 0 0 0 11.7807 0 0 12.8538 0 0 0 0 11.994 13.2196 0 12.8465 0 0 0 0 0 0 0 0 0 12.8752 0 13.0327 0 0 0 0 0 0 0 0 0 0 0 12.8363 12.9715 0 0 13.0338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4688 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2709 15.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4125 0 0 0 0 0 14.2805 0 0 0 0 0 0 14.1018 0 0 15.3975 0 15.4131 9.56596 0 15.5023 15.4282 0 0 0 0 0 15.3061 0 0 0 0 Q49A33 Z876P_HUMAN Putative zinc finger protein 876 ZNF876P Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGKAFR 0.96276 0.29216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4H8 PLGT3_HUMAN "Protein O-glucosyltransferase 3, EC 2.4.1.- (KDEL motif-containing protein 2) (Protein O-xylosyltransferase POGLUT3, EC 2.4.2.-)" POGLUT3 KDELC2 UNQ1904/PRO4350 Homo sapiens (Human) protein O-linked glycosylation via serine [GO:0018242] endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788] endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242] GO:0005788; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527; GO:0140561; GO:0140562 EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252] ALLLQLRLALLVAAGAPEVLVSAPR 0.96276 0.07798 0 0 0 0 13.1757 14.03 13.7157 13.9981 0 0 0 0 0 0 0 0 0 0 13.3346 12.7509 13.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0345 0 13.9758 0 0 0 0 14.3549 0 0 0 0 0 0 0 0 0 10.2736 0 0 0 12.695 0 0 0 0 11.4607 0 0 0 0 0 13.5491 10.5834 0 0 0 0 0 0 0 0 0 12.4216 0 0 0 0 0 0 0 0 13.9651 0 0 0 0 0 0 0 0 0 0 16.0459 0 0 0 14.0215 13.8621 0 0 16.0662 14.5704 0 0 0 0 0 0 0 14.7117 0 0 14.3614 14.1892 13.638 0 0 0 12.2793 0 0 0 0 0 0 0 0 0 0 10.9091 13.4173 13.7684 0 0 12.3082 13.4653 12.5481 0 0 0 0 0 14.0295 0 0 0 0 14.0152 0 0 11.2546 0 15.9183 0 0 0 0 14.0903 0 0 0 12.9182 0 12.8818 0 0 0 0 0 0 0 0 12.8503 17.7614 0 Q9NR12 PDLI7_HUMAN "PDZ and LIM domain protein 7 (LIM mineralization protein, LMP) (Protein enigma)" PDLIM7 ENIGMA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; heart development [GO:0007507]; muscle structure development [GO:0061061]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; heart development [GO:0007507]; muscle structure development [GO:0061061]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898] GO:0001503; GO:0001725; GO:0001726; GO:0003779; GO:0005654; GO:0005829; GO:0005912; GO:0005925; GO:0006898; GO:0007507; GO:0015629; GO:0030018; GO:0030036; GO:0030154; GO:0031941; GO:0045669; GO:0046872; GO:0051371; GO:0061061 actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371] ACGERLSLGLSRAQPVQSK 0.96276 0.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.494 11.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99570 PI3R4_HUMAN "Phosphoinositide 3-kinase regulatory subunit 4, PI3-kinase regulatory subunit 4, EC 2.7.11.1 (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein)" PIK3R4 VPS15 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241] "autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]" "autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; autophagosome maturation [GO:0097352]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]" GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016236; GO:0016241; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036092; GO:0042149; GO:0043231; GO:0043552; GO:0045022; GO:0045324; GO:0071561; GO:0097352; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GVIDLAALGITGRQVDLVKTK 0.96277 0.29205 0 0 0 0 0 0 0 0 14.8844 0 0 15.3813 15.2305 14.809 0 0 0 0 10.8409 0 0 11.8466 15.0885 0 11.7819 0 0 13.1077 0 14.3518 0 13.2883 0 13.3959 0 0 0 14.743 0 11.5422 0 0 0 0 0 0 0 0 12.83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5734 0 0 0 12.2664 0 13.4639 0 14.0555 13.9063 15.2853 14.0273 0 0 13.786 12.12 0 0 12.8027 13.4081 14.5472 15.0741 0 15.0077 15.6416 0 0 0 0 15.6283 0 0 0 0 15.3412 16.1581 0 14.6526 15.3022 16.2132 16.0655 12.4861 14.7395 15.5629 0 13.4663 13.7514 13.7335 15.0138 14.7993 15.5543 15.2579 0 0 0 14.6623 14.2441 0 0 14.672 15.5828 14.5338 15.8308 14.8089 0 14.2454 0 0 0 12.2821 12.2099 0 14.1108 14.1864 13.9322 14.3961 0 14.5837 12.9112 12.7544 15.2557 0 0 0 12.9129 0 0 0 0 0 13.8696 11.9566 0 0 0 0 0 13.4179 13.488 13.673 0 0 0 12.3541 12.1047 0 0 0 0 0 0 0 12.3712 0 Q9H492 MLP3A_HUMAN "Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A, MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha)" MAP1LC3A Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to morphine [GO:0043278] autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; synapse [GO:0045202] autolysosome [GO:0044754]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; synapse [GO:0045202]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to morphine [GO:0043278] GO:0000045; GO:0000421; GO:0000422; GO:0005543; GO:0005770; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0009267; GO:0010040; GO:0010288; GO:0016236; GO:0031090; GO:0031625; GO:0034198; GO:0043231; GO:0043278; GO:0044754; GO:0045202; GO:0070301; GO:0071280; GO:0097352 microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; ubiquitin protein ligase binding [GO:0031625] DEDGFLYMVYASQETFGF 0.96279 0.52034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1832 0 0 0 0 0 0 0 0 12.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53GL0 PKHO1_HUMAN "Pleckstrin homology domain-containing family O member 1, PH domain-containing family O member 1 (C-Jun-binding protein, JBP) (Casein kinase 2-interacting protein 1, CK2-interacting protein 1, CKIP-1) (Osteoclast maturation-associated gene 120 protein)" PLEKHO1 CKIP1 OC120 HQ0024c Homo sapiens (Human) lamellipodium morphogenesis [GO:0072673]; myoblast fusion [GO:0007520]; myoblast migration [GO:0051451]; regulation of cell shape [GO:0008360]; regulation of myoblast fusion [GO:1901739] cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; muscle cell projection membrane [GO:0036195]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; lamellipodium morphogenesis [GO:0072673]; myoblast fusion [GO:0007520]; myoblast migration [GO:0051451]; regulation of cell shape [GO:0008360]; regulation of myoblast fusion [GO:1901739] GO:0005634; GO:0005737; GO:0007520; GO:0008360; GO:0032587; GO:0036195; GO:0051451; GO:0072673; GO:1901739 KAKDPPR 0.9628 0.13307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5H943 KKLC1_HUMAN "Kita-kyushu lung cancer antigen 1, KK-LC-1 (Cancer/testis antigen 83)" CT83 CXorf61 KKLC1 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GO:0005634; GO:0005886; GO:0016021 LVELEHTLLSK 0.96281 0.17846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N22 ZN681_HUMAN Zinc finger protein 681 ZNF681 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LNEYKECGKAFNQSSHLTR 0.96281 0.12509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5594 0 0 0 0 0 0 0 0 0 14.6916 0 0 0 14.4246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WR7 PRSR2_HUMAN Proline and serine-rich protein 2 PROSER2 C10orf47 Homo sapiens (Human) APSPPVEHPRLLRSVPTPLVMAQK 0.96282 0.12466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0482 0 0 12.0946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99622 C10_HUMAN Protein C10 C12orf57 C10 Homo sapiens (Human) camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678] cytoplasm [GO:0005737]; nuclear speck [GO:0016607] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678] GO:0005737; GO:0009791; GO:0014819; GO:0016607; GO:0021540; GO:0021678; GO:0036343; GO:0048593; GO:0050890 DNACNDMGK 0.96282 0.51528 0 9.45605 0 0 0 0 0 0 0 10.0074 12.4743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9917 0 0 0 0 0 10.009 0 0 0 0 11.2527 12.3243 0 0 10.5186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.014 0 12.5565 12.9136 13.4427 11.9786 13.219 12.6333 14.1994 12.8635 0 0 12.3117 13.786 12.345 12.5324 12.0426 12.3796 14.3585 13.2424 12.5558 14.8619 14.9859 14.4571 14.5061 13.1774 13.699 13.8324 14.9775 14.1303 15.5051 14.0545 14.9361 13.9464 0 14.4067 15.0034 15.2002 15.2847 15.2534 15.5809 16.1368 15.9822 15.1376 15.4952 15.5264 14.8908 13.189 14.4671 15.1517 14.7496 14.6678 15.9151 0 13.6099 0 0 15.0455 13.3028 13.0682 15.5584 15.3788 13.5177 15.7187 15.0728 15.3495 14.5855 11.8517 13.7243 0 0 0 13.9226 13.5388 0 11.3132 0 13.8386 0 0 0 0 12.6987 12.842 13.2477 0 11.6286 12.1914 12.0676 0 0 12.747 0 16.2075 15.6719 15.6891 14.6527 0 0 0 13.9254 0 Q9H1V8 S6A17_HUMAN Sodium-dependent neutral amino acid transporter SLC6A17 (Sodium-dependent neurotransmitter transporter NTT4) (Solute carrier family 6 member 17) SLC6A17 NTT4 Homo sapiens (Human) alanine transport [GO:0032328]; brain development [GO:0007420]; glycine transport [GO:0015816]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104] anchoring junction [GO:0070161]; cell projection [GO:0042995]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of membrane [GO:0031224]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; cell projection [GO:0042995]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of membrane [GO:0031224]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021]; symporter activity [GO:0015293]; alanine transport [GO:0032328]; brain development [GO:0007420]; glycine transport [GO:0015816]; leucine transport [GO:0015820]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104] GO:0005887; GO:0006836; GO:0007420; GO:0008021; GO:0015293; GO:0015804; GO:0015816; GO:0015820; GO:0015824; GO:0030285; GO:0031224; GO:0032328; GO:0035725; GO:0042995; GO:0070161; GO:0098794; GO:0098978; GO:0098982; GO:0150104 symporter activity [GO:0015293] QKAVEEELDAEDR 0.96282 0.13153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14695 K0087_HUMAN Uncharacterized protein KIAA0087 KIAA0087 HA1002 Homo sapiens (Human) DGSVSLPGEAASCDLDTLEPEHGNR 0.96285 0.29502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5225 0 0 0 0 11.324 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76064 RNF8_HUMAN "E3 ubiquitin-protein ligase RNF8, hRNF8, EC 2.3.2.27 (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8)" RNF8 KIAA0646 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone exchange [GO:0043486]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000151; GO:0000781; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0007049; GO:0007286; GO:0008270; GO:0010212; GO:0016567; GO:0030496; GO:0031625; GO:0033522; GO:0033523; GO:0034244; GO:0035093; GO:0035861; GO:0036297; GO:0042393; GO:0042802; GO:0042803; GO:0043130; GO:0043486; GO:0045190; GO:0045739; GO:0051301; GO:0051865; GO:0061630; GO:0070534; GO:0070535; GO:0070936 chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] DFEAIIQAKNK 0.96286 0.14031 0 0 10.024 0 0 0 0 0 0 0 0 0 0 0 0 10.6406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5832 10.692 14.2562 0 0 0 14.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8583 14.1667 0 0 0 0 0 15.0888 14.7947 14.459 0 12.3073 12.711 11.7932 0 0 14.2986 0 13.9077 0 0 0 0 0 0 0 14.332 13.6731 0 0 11.7069 0 0 0 13.1384 0 15.1547 0 0 0 0 0 0 0 13.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7771 0 14.3775 0 P03915 NU5M_HUMAN "NADH-ubiquinone oxidoreductase chain 5, EC 7.1.1.2 (NADH dehydrogenase subunit 5)" MT-ND5 MTND5 NADH5 ND5 Homo sapiens (Human) "aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to organonitrogen compound [GO:0010243]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; neuron projection [GO:0043005] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; neuron projection [GO:0043005]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to organonitrogen compound [GO:0010243]" GO:0001666; GO:0003954; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0010243; GO:0015990; GO:0032981; GO:0042542; GO:0042776; GO:0043005 NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954] LTALAVTFLGLLTALDLNYLTNKLK 0.96286 0.29398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5217 0 0 0 0 0 0 0 0 P24941 CDK2_HUMAN "Cyclin-dependent kinase 2, EC 2.7.11.22 (Cell division protein kinase 2) (p33 protein kinase)" CDK2 CDKN2 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to nitric oxide [GO:0071732]; cellular senescence [GO:0090398]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; histone phosphorylation [GO:0016572]; meiotic cell cycle [GO:0051321]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated DNA replication initiation [GO:0032298]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion transport [GO:0006813]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" "Cajal body [GO:0015030]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; X chromosome [GO:0000805]; Y chromosome [GO:0000806]" "Cajal body [GO:0015030]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; X chromosome [GO:0000805]; Y chromosome [GO:0000806]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to nitric oxide [GO:0071732]; cellular senescence [GO:0090398]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; histone phosphorylation [GO:0016572]; meiotic cell cycle [GO:0051321]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated DNA replication initiation [GO:0032298]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion transport [GO:0006813]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]" GO:0000082; GO:0000086; GO:0000122; GO:0000287; GO:0000307; GO:0000781; GO:0000793; GO:0000805; GO:0000806; GO:0001673; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0006260; GO:0006281; GO:0006351; GO:0006468; GO:0006813; GO:0007099; GO:0007165; GO:0007265; GO:0008284; GO:0010389; GO:0010468; GO:0015030; GO:0016572; GO:0018105; GO:0019904; GO:0030332; GO:0031453; GO:0031571; GO:0032298; GO:0045893; GO:0051298; GO:0051301; GO:0051321; GO:0071732; GO:0090398; GO:0097123; GO:0097124; GO:0097134; GO:0097135; GO:0097472; GO:0106310; GO:1905784 ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AFGVPVR 0.96286 0.11133 0 0 13.0661 0 0 0 0 0 0 0 0 0 0 13.9862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8082 0 0 0 0 12.9201 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8236 0 0 13.8635 0 0 0 0 13.8107 0 0 0 0 0 0 0 0 0 0 0 13.8971 0 15.221 0 0 0 0 0 13.495 13.7728 12.4347 0 0 13.9846 0 0 0 0 0 0 0 0 0 0 0 13.9259 0 14.8208 0 0 0 14.4817 0 0 0 13.8201 0 13.9581 13.3069 0 13.6618 0 0 12.6001 14.7108 13.9134 0 0 0 14.5377 0 14.2107 0 0 0 0 14.1444 13.3243 0 13.8893 12.9628 0 0 0 0 0 0 0 0 0 0 0 0 13.2847 13.4663 0 0 14.1449 0 13.3938 0 0 0 13.7113 0 14.2496 0 0 0 0 0 0 Q9H756 LRC19_HUMAN Leucine-rich repeat-containing protein 19 LRRC19 Homo sapiens (Human) host-mediated regulation of intestinal microbiota composition [GO:0048874]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; toll-like receptor signaling pathway [GO:0002224]; TRAF-mediated signal transduction [GO:0038008] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; toll-like receptor signaling pathway [GO:0002224]; TRAF-mediated signal transduction [GO:0038008] GO:0001817; GO:0002224; GO:0005886; GO:0016021; GO:0038008; GO:0038023; GO:0048874; GO:0050727; GO:1901224 signaling receptor activity [GO:0038023] KVTGITILFWPLSMILLSDK 0.96286 0.085356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6707 0 0 0 0 0 0 0 0 0 0 0 0 10.2597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6196 14.1996 0 0 0 0 0 0 0 0 0 0 0 0 15.077 0 13.8084 0 0 0 0 0 0 14.0091 0 0 0 0 0 0 0 0 0 0 0 0 0 14.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1242 0 0 0 0 0 0 0 Q9Y5F9 PCDGI_HUMAN "Protocadherin gamma-B6, PCDH-gamma-B6" PCDHGB6 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DHGSPTLSANVSLR 0.96286 0.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8232 0 0 0 0 0 0 0 0 11.3991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9459 0 0 0 0 0 0 0 0 0 0 0 11.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15910 EZH2_HUMAN "Histone-lysine N-methyltransferase EZH2, EC 2.1.1.356 (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6)" EZH2 KMT6 Homo sapiens (Human) "B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte homeostasis [GO:0036333]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; keratinocyte differentiation [GO:0030216]; liver regeneration [GO:0097421]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; stem cell differentiation [GO:0048863]; subtelomeric heterochromatin assembly [GO:0031509]; synaptic transmission, GABAergic [GO:0051932]" "chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; pronucleus [GO:0045120]; synapse [GO:0045202]" "chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; pronucleus [GO:0045120]; synapse [GO:0045202]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; lncRNA binding [GO:0106222]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte homeostasis [GO:0036333]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; keratinocyte differentiation [GO:0030216]; liver regeneration [GO:0097421]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of circadian rhythm [GO:0042752]; regulation of gliogenesis [GO:0014013]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; stem cell differentiation [GO:0048863]; subtelomeric heterochromatin assembly [GO:0031509]; synaptic transmission, GABAergic [GO:0051932]" GO:0000082; GO:0000122; GO:0000781; GO:0000785; GO:0000978; GO:0000979; GO:0001222; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005737; GO:0006306; GO:0006325; GO:0006338; GO:0006355; GO:0008284; GO:0010718; GO:0014013; GO:0014834; GO:0014898; GO:0016279; GO:0016571; GO:0018024; GO:0021695; GO:0021766; GO:0030183; GO:0030216; GO:0031490; GO:0031507; GO:0031509; GO:0032355; GO:0034244; GO:0035098; GO:0035984; GO:0036333; GO:0042054; GO:0042752; GO:0043021; GO:0043406; GO:0043433; GO:0043547; GO:0045120; GO:0045202; GO:0045617; GO:0045814; GO:0045892; GO:0046976; GO:0048387; GO:0048468; GO:0048511; GO:0048863; GO:0051154; GO:0051932; GO:0070301; GO:0070314; GO:0070734; GO:0070878; GO:0071168; GO:0071902; GO:0097421; GO:0098532; GO:0106222; GO:1900006; GO:1900016; GO:1902808; GO:1904772; GO:1990841; GO:2000134; GO:2000737 chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone-lysine N-methyltransferase activity [GO:0018024]; lncRNA binding [GO:0106222]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] CKAQCNTK 0.96287 0.11085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.695 0 0 0 0 0 0 0 0 12.1483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75864 PPR37_HUMAN Protein phosphatase 1 regulatory subunit 37 (Leucine-rich repeat-containing protein 68) PPP1R37 KIAA1986 LRRC68 Homo sapiens (Human) protein phosphatase inhibitor activity [GO:0004864] GO:0004864 protein phosphatase inhibitor activity [GO:0004864] ALRIRSSLAVLHLENASLSGR 0.96288 0.13973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H293 IL25_HUMAN "Interleukin-25, IL-25 (Interleukin-17E, IL-17E)" IL25 IL17E UNQ3120/PRO10272 Homo sapiens (Human) eosinophil differentiation [GO:0030222]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fungus [GO:0009620]; response to nematode [GO:0009624] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-17E receptor binding [GO:0030380]; eosinophil differentiation [GO:0030222]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fungus [GO:0009620]; response to nematode [GO:0009624] GO:0002437; GO:0005125; GO:0005576; GO:0005615; GO:0009620; GO:0009624; GO:0030222; GO:0030380; GO:0045944 cytokine activity [GO:0005125]; interleukin-17E receptor binding [GO:0030380] RLYRVSLACVCVR 0.96289 0.15247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6928 14.8964 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1159 0 0 O95372 LYPA2_HUMAN "Acyl-protein thioesterase 2, APT-2, EC 3.1.2.- (Lysophospholipase II, LPL-II, LysoPLA II) (Palmitoyl-protein hydrolase, EC 3.1.2.22)" LYPLA2 APT2 Homo sapiens (Human) acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; acylglycerol catabolic process [GO:0046464]; axon guidance [GO:0007411]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084] GO:0002084; GO:0004622; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0007411; GO:0008474; GO:0045296; GO:0046464; GO:0052689; GO:0070062; GO:1905344 cadherin binding [GO:0045296]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474] FGALTAEKLR 0.9629 0.079801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8432 0 0 0 0 0 0 0 15.2066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8787 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93097 WNT2B_HUMAN Protein Wnt-2b (Protein Wnt-13) WNT2B WNT13 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190] GO:0002062; GO:0002088; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0008584; GO:0009267; GO:0021871; GO:0030182; GO:0043231; GO:0045165; GO:0060070; GO:0060492; GO:0060638; GO:0061072; GO:0061303; GO:0062023; GO:0071425; GO:0090190 cytokine activity [GO:0005125]; frizzled binding [GO:0005109] ACSQGELSVCSCDPYTR 0.96291 0.078609 11.1219 0 0 0 0 11.4672 0 0 0 0 12.6783 0 0 0 0 0 0 0 0 0 10.2423 0 0 0 0 12.7685 0 0 0 0 0 0 13.4727 0 0 0 0 0 0 13.8736 0 0 0 0 11.9227 0 0 0 0 0 0 12.1281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4007 15.6442 14.0351 0 0 0 0 0 0 0 0 0 12.8037 0 13.6531 0 16.2496 16.2836 16.3908 16.9852 16.5953 14.1269 16.4478 17.5254 14.3053 16.4193 17.7941 0 15.6133 11.5118 0 16.0962 0 14.8288 0 15.5491 13.9862 15.0681 0 13.6294 15.7112 14.8635 0 0 14.7717 14.0055 12.8859 15.4351 0 14.7665 0 0 13.254 0 0 16.1184 13.4256 0 13.6357 11.7323 13.5028 0 13.3946 14.7544 0 13.6083 12.0112 14.0342 10.4999 0 14.2356 0 0 0 0 0 0 14.1504 0 12.9858 0 0 0 0 11.6717 13.2686 0 0 0 0 14.9518 12.5552 0 0 14.782 0 0 0 13.1467 14.2375 13.2912 0 0 0 0 12.533 14.0139 15.258 0 0 0 0 0 0 A6NM45 CLD24_HUMAN Putative claudin-24 (Claudin-21) CLDN24 CLDN21 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155] GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0070830 structural molecule activity [GO:0005198] IGESQRDLK 0.96291 0.060425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8789 0 0 0 0 0 0 0 0 13.9413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UVW9 CLC2A_HUMAN "C-type lectin domain family 2 member A (Keratinocyte-associated C-type lectin, KACL) (Proliferation-induced lymphocyte-associated receptor, PILAR)" CLEC2A KACL UNQ5792/PRO19597 Homo sapiens (Human) natural killer cell mediated cytotoxicity [GO:0042267] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; protein homodimerization activity [GO:0042803]; natural killer cell mediated cytotoxicity [GO:0042267] GO:0005886; GO:0009897; GO:0016021; GO:0030246; GO:0042267; GO:0042803 carbohydrate binding [GO:0030246]; protein homodimerization activity [GO:0042803] CFYFSDDTRNWTASK 0.96291 0.29216 0 10.2501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92623 TTC9A_HUMAN "Tetratricopeptide repeat protein 9A, TPR repeat protein 9A" TTC9 KIAA0227 TTC9A Homo sapiens (Human) bone development [GO:0060348] bone development [GO:0060348] GO:0060348 ALLELKGLLPPPGER 0.96292 0.29216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1961 0 13.8631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43166 CAH7_HUMAN "Carbonic anhydrase 7, EC 4.2.1.1 (Carbonate dehydratase VII) (Carbonic anhydrase VII, CA-VII)" CA7 Homo sapiens (Human) "neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]" cytosol [GO:0005829] "cytosol [GO:0005829]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; neuron cellular homeostasis [GO:0070050]; one-carbon metabolic process [GO:0006730]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]" GO:0004089; GO:0005829; GO:0006730; GO:0008270; GO:0016836; GO:0032230; GO:0032849; GO:0051453; GO:0070050; GO:2001225 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] TVVTGGPLEGPYRLK 0.96293 0.29216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18085 ARF4_HUMAN ADP-ribosylation factor 4 ARF4 ARF2 Homo sapiens (Human) "activation of phospholipase D activity [GO:0031584]; apical protein localization [GO:0045176]; cell migration [GO:0016477]; cilium assembly [GO:0060271]; dendritic spine development [GO:0060996]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175]; regulation of reactive oxygen species metabolic process [GO:2000377]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; epidermal growth factor receptor binding [GO:0005154]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of phospholipase D activity [GO:0031584]; apical protein localization [GO:0045176]; cell migration [GO:0016477]; cilium assembly [GO:0060271]; dendritic spine development [GO:0060996]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular protein transport [GO:0006886]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175]; regulation of reactive oxygen species metabolic process [GO:2000377]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" GO:0003924; GO:0005085; GO:0005154; GO:0005525; GO:0005794; GO:0005829; GO:0005886; GO:0006471; GO:0006886; GO:0006888; GO:0006890; GO:0007612; GO:0016020; GO:0016192; GO:0016477; GO:0031584; GO:0032587; GO:0043066; GO:0043197; GO:0045176; GO:0045197; GO:0045944; GO:0060271; GO:0060996; GO:0061512; GO:0070062; GO:0098978; GO:0099175; GO:2000377 epidermal growth factor receptor binding [GO:0005154]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085] MGLTISSLFSRLFGK 0.96296 0.12521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1K5 THMS1_HUMAN Protein THEMIS (Thymocyte-expressed molecule involved in selection) THEMIS C6orf190 C6orf207 Homo sapiens (Human) adaptive immune response [GO:0002250]; negative T cell selection [GO:0043383]; positive T cell selection [GO:0043368]; T cell receptor signaling pathway [GO:0050852] cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; adaptive immune response [GO:0002250]; negative T cell selection [GO:0043383]; positive T cell selection [GO:0043368]; T cell receptor signaling pathway [GO:0050852] GO:0002250; GO:0005634; GO:0005737; GO:0005911; GO:0008180; GO:0043368; GO:0043383; GO:0050852 DAEPFLVRTLVEEITEEQYYMMRR 0.96297 0.12512 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8946 14.0984 12.8586 0 0 15.9872 16.5014 13.5258 0 0 0 0 0 12.0997 0 0 0 13.1922 0 0 0 0 0 0 0 0 0 0 0 0 13.1828 0 0 0 14.6549 0 0 0 18.2676 0 17.6766 0 15.8507 15.5528 18.9464 19.1188 18.1219 17.3922 18.8463 18.8166 17.3896 17.2512 16.7547 0 0 0 12.2798 13.3509 13.7515 0 0 0 14.1459 0 0 14.4521 11.6773 0 13.5155 0 10.4952 0 11.969 14.1939 0 0 0 17.7832 15.2527 0 18.318 13.2216 18.5565 13.582 0 0 0 12.4214 0 11.9756 0 0 0 0 0 0 0 12.0883 11.7618 11.8377 18.0207 0 16.4125 0 0 0 0 0 0 0 0 0 0 0 11.4815 13.1884 11.2444 0 0 0 13.3195 0 18.1119 18.0496 0 0 0 13.9678 0 0 0 0 13.0202 0 0 0 0 0 0 0 0 0 0 15.0077 0 0 0 0 0 12.1398 11.6549 11.2334 0 12.4834 12.1433 0 0 0 0 15.7977 0 0 0 11.0315 0 10.5797 0 Q15545 TAF7_HUMAN "Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit, TAF(II)55, TAFII-55, TAFII55)" TAF7 TAF2F TAFII55 Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; intracellular estrogen receptor signaling pathway [GO:0030520]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class I biosynthetic process [GO:0045344]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermine transport [GO:0000296]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; P-TEFb complex binding [GO:0106140]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription cis-regulatory region binding [GO:0000976]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; intracellular estrogen receptor signaling pathway [GO:0030520]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class I biosynthetic process [GO:0045344]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermine transport [GO:0000296]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000122; GO:0000296; GO:0000976; GO:0001097; GO:0001673; GO:0005634; GO:0005654; GO:0005667; GO:0005669; GO:0005737; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006468; GO:0006469; GO:0016251; GO:0030520; GO:0033276; GO:0035035; GO:0035067; GO:0035521; GO:0035522; GO:0042789; GO:0042809; GO:0043966; GO:0045344; GO:0045347; GO:0045892; GO:0045893; GO:0045944; GO:0046966; GO:0046982; GO:0051123; GO:0060261; GO:0071339; GO:0090241; GO:0106140; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; P-TEFb complex binding [GO:0106140]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription cis-regulatory region binding [GO:0000976] KYIESPDVEKEVK 0.96301 0.51592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BW92 SYTM_HUMAN "Threonine--tRNA ligase, mitochondrial, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase-like 1)" TARS2 TARSL1 Homo sapiens (Human) mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829]; mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435] GO:0002161; GO:0004829; GO:0005524; GO:0005759; GO:0006435; GO:0042803; GO:0070159 aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829] PRSWRELPLR 0.96301 0.11289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6Y5 MAGIX_HUMAN PDZ domain-containing protein MAGIX MAGIX Homo sapiens (Human) GLLKDGPAQR 0.96301 0.11283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7841 0 0 0 0 0 0 0 0 0 0 0 0 0 13.046 0 0 0 0 0 0 0 12.5869 0 0 0 0 0 0 0 0 0 0 0 12.9986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1103 0 0 0 13.4227 13.1996 0 0 0 0 0 0 0 Q9H720 PG2IP_HUMAN PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog) CWH43 PGAP2IP Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506] GO:0005783; GO:0006506; GO:0016021 DIDSTDHDR 0.96301 0.1406 0 0 0 0 0 0 0 0 0 0 12.6087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9213 0 0 0 0 16.3933 0 0 0 11.9313 0 0 0 0 0 0 0 0 15.6325 0 12.1117 12.4269 14.0599 0 0 0 0 0 12.0026 11.492 0 0 0 0 0 0 0 0 0 0 0 12.8438 0 0 0 0 13.2229 0 0 0 0 0 14.2316 14.0415 0 0 0 0 0 11.0651 11.3238 11.9911 0 0 13.3587 14.5035 0 14.0175 0 0 0 0 0 0 14.8818 0 14.8258 0 0 0 0 0 0 0 0 0 0 0 0 13.6271 13.0862 0 0 0 14.4781 0 0 0 0 0 0 Q9P2W9 STX18_HUMAN Syntaxin-18 (Cell growth-inhibiting gene 9 protein) STX18 GIG9 Homo sapiens (Human) "endoplasmic reticulum membrane organization [GO:0090158]; intracellular protein transport [GO:0006886]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of organelle assembly [GO:1902117]; regulation of Golgi organization [GO:1903358]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum membrane organization [GO:0090158]; intracellular protein transport [GO:0006886]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of organelle assembly [GO:1902117]; regulation of Golgi organization [GO:1903358]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0016021; GO:0019904; GO:0031201; GO:0090158; GO:1902117; GO:1902953; GO:1903358 protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484] DELFRRSPR 0.96301 0.29655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8878 0 0 11.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IZ6 MET2A_HUMAN "tRNA N(3)-methylcytidine methyltransferase METTL2A, EC 2.1.1.- (Methyltransferase-like protein 2A)" METTL2A METTL2 HSPC266 Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA methylation [GO:0030488] GO:0005737; GO:0030488; GO:0052735 tRNA (cytosine-3-)-methyltransferase activity [GO:0052735] AINRLSR 0.96302 0.085416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYR8 RDH8_HUMAN "Retinol dehydrogenase 8, EC 1.1.1.300 (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2)" RDH8 PRRDH SDR28C2 Homo sapiens (Human) estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491]; estrogen biosynthetic process [GO:0006703]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; visual perception [GO:0007601] GO:0004303; GO:0004745; GO:0005829; GO:0005887; GO:0006694; GO:0006703; GO:0007601; GO:0016491; GO:0042572; GO:0050896; GO:0052650 estradiol 17-beta-dehydrogenase activity [GO:0004303]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity [GO:0016491] AVLPGMKR 0.96302 0.29541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6939 0 0 0 11.7629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6H8Z2 F221B_HUMAN Protein FAM221B FAM221B C9orf128 Homo sapiens (Human) CFMFCFIPSR 0.96304 0.13992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0225 0 0 0 13.9032 0 12.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8638 0 0 0 0 0 0 0 0 0 0 12.1574 0 0 0 12.0558 0 12.1132 0 0 12.5006 0 0 12.2379 0 0 0 0 0 12.0529 0 0 11.7389 12.2242 0 0 0 11.9212 14.0622 0 0 0 0 0 0 12.5241 0 0 0 12.1702 0 0 12.1165 10.8015 0 0 0 0 16.9496 12.0612 0 0 13.1876 0 0 0 0 0 0 0 0 0 0 15.4232 0 0 0 0 0 0 0 0 0 12.0155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00238 BMR1B_HUMAN "Bone morphogenetic protein receptor type-1B, BMP type-1B receptor, BMPR-1B, EC 2.7.11.30 (CD antigen CDw293)" BMPR1B Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cartilage condensation [GO:0001502]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte development [GO:0002063]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; eye development [GO:0001654]; inflammatory response [GO:0006954]; negative regulation of chondrocyte proliferation [GO:1902731]; osteoblast differentiation [GO:0001649]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290] HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; BMP signaling pathway [GO:0030509]; cartilage condensation [GO:0001502]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte development [GO:0002063]; dorsal/ventral pattern formation [GO:0009953]; endochondral bone morphogenesis [GO:0060350]; eye development [GO:0001654]; inflammatory response [GO:0006954]; negative regulation of chondrocyte proliferation [GO:1902731]; osteoblast differentiation [GO:0001649]; ovarian cumulus expansion [GO:0001550]; ovulation cycle [GO:0042698]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]" GO:0001502; GO:0001550; GO:0001649; GO:0001654; GO:0002063; GO:0004674; GO:0004675; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0006954; GO:0009953; GO:0016021; GO:0019211; GO:0021953; GO:0030166; GO:0030501; GO:0030509; GO:0031290; GO:0032332; GO:0036122; GO:0042698; GO:0043235; GO:0043539; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0060041; GO:0060350; GO:0061036; GO:0071363; GO:0071773; GO:0098821; GO:1902043; GO:1902731; GO:1990712 "ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]" HENILGFIAADIK 0.96305 0.10605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8827 0 0 0 0 0 0 0 0 0 0 0 0 P35410 MAS1L_HUMAN "Mas-related G-protein coupled receptor MRG, MAS-R (MAS1-like)" MAS1L MRG Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930] ESLRVILQR 0.96305 0.5136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3688 0 0 0 0 0 0 0 14.2504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6S9Z5 ZN474_HUMAN "Zinc finger protein 474 (Testis-specific zinc finger protein, TSZFP)" ZNF474 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] ISNKLQQTFHHSK 0.96305 0.15353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG75 OR5T1_HUMAN Olfactory receptor 5T1 (Olfactory receptor OR11-179) OR5T1 OR5T1P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LLVRNWFINK 0.96305 0.12047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4481 0 0 0 14.2943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2893 0 0 0 0 0 0 0 0 0 0 13.1452 0 0 0 0 0 0 0 0 12.9804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3078 0 Q9NRG0 CHRC1_HUMAN "Chromatin accessibility complex protein 1, CHRAC-1 (Chromatin accessibility complex 15 kDa protein, CHRAC-15, HuCHRAC15) (DNA polymerase epsilon subunit p15)" CHRAC1 CHRAC15 Homo sapiens (Human) chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; regulation of DNA replication [GO:0006275] CHRAC [GO:0008623]; epsilon DNA polymerase complex [GO:0008622]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] CHRAC [GO:0008623]; epsilon DNA polymerase complex [GO:0008622]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; regulation of DNA replication [GO:0006275] GO:0003677; GO:0003887; GO:0005634; GO:0005721; GO:0006275; GO:0006334; GO:0006338; GO:0008622; GO:0008623; GO:0046982 DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982] DKGGEQRLISLPLSR 0.96305 0.12097 0 14.8822 0 12.1538 0 0 12.636 0 0 13.2932 12.0744 12.5908 0 10.1366 0 0 0 0 10.4174 0 0 15.6112 15.3188 0 0 0 0 0 0 0 0 11.5249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6428 12.7648 14.0477 11.046 0 0 0 0 0 0 0 12.319 0 0 0 0 13.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5684 13.215 0 0 11.1922 0 0 0 0 14.4277 0 14.3585 0 15.1415 0 0 0 14.5784 12.3582 0 0 12.2929 0 0 0 0 0 0 0 0 0 0 12.9777 0 0 0 12.4184 13.869 0 0 0 14.7598 0 0 0 0 0 11.6905 0 14.6607 12.7969 13.1822 0 0 11.9998 0 0 12.6549 0 0 0 0 12.9596 15.6549 0 12.7006 0 11.6153 0 0 A6NNA5 DRGX_HUMAN Dorsal root ganglia homeobox protein (Paired-related homeobox protein-like 1) DRGX PRRXL1 Homo sapiens (Human) axon guidance [GO:0007411]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; axon guidance [GO:0007411]; detection of chemical stimulus [GO:0009593]; detection of temperature stimulus [GO:0016048]; dorsal spinal cord development [GO:0021516]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of mechanical stimulus [GO:0050954]; trigeminal nerve development [GO:0021559]" GO:0000785; GO:0000977; GO:0000981; GO:0001764; GO:0005634; GO:0006357; GO:0007411; GO:0009593; GO:0016048; GO:0021516; GO:0021559; GO:0050954; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" EALEAQQSLGR 0.96306 0.080524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q1MX18 INSC_HUMAN Protein inscuteable homolog INSC Homo sapiens (Human) apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647] apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] apical cortex [GO:0045179]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; apical protein localization [GO:0045176]; asymmetric cell division [GO:0008356]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; nervous system development [GO:0007399]; regulation of asymmetric cell division [GO:0009786]; regulation of protein stability [GO:0031647] GO:0000132; GO:0005886; GO:0007399; GO:0008093; GO:0008356; GO:0009786; GO:0019904; GO:0030154; GO:0030674; GO:0031647; GO:0032991; GO:0045176; GO:0045179 cytoskeletal anchor activity [GO:0008093]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674] IIAKEGGVVALFK 0.96306 0.15248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6278 0 0 0 0 11.6791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0822 0 0 11.2384 0 0 0 0 0 0 0 0 0 17.3273 0 0 0 0 0 12.5809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32241 VIPR1_HUMAN "Vasoactive intestinal polypeptide receptor 1, VIP-R-1 (Pituitary adenylate cyclase-activating polypeptide type II receptor, PACAP type II receptor, PACAP-R-2, PACAP-R2) (VPAC1)" VIPR1 Homo sapiens (Human) "adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of cell population proliferation [GO:0008284]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of cell population proliferation [GO:0008284]" GO:0004999; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007187; GO:0007188; GO:0008284; GO:0008528; GO:0017046; GO:0043235 G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] GPILTSILVNFILFICIIRILLQKLR 0.96307 0.11911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3444 0 0 0 0 0 13.5524 12.4276 0 13.668 0 0 0 0 13.2175 15.8083 15.024 13.987 15.116 15.7399 12.1476 0 14.0722 16.1215 13.7692 14.0264 15.4977 0 14.9782 14.8474 14.8311 0 14.1523 13.8305 0 0 0 13.8013 14.1975 13.3397 0 0 0 13.2044 0 0 0 13.0579 15.5138 14.6353 13.9315 0 12.6788 0 0 13.3435 14.4802 14.1602 13.1316 13.2272 0 13.9314 13.1379 0 0 14.3748 12.9962 0 0 0 12.7877 0 13.0632 11.9524 12.6311 12.5511 0 13.7714 0 0 12.1916 0 0 0 0 0 0 0 0 0 12.7642 0 12.2025 12.3666 0 0 0 12.4731 0 0 0 0 0 0 12.3724 0 0 0 0 0 0 0 0 Q5SR53 CA200_HUMAN Putative uncharacterized protein PIK3CD-AS1 (PIK3CD antisense RNA 1) (PIK3CD antisense gene protein 1) PIK3CD-AS1 C1orf200 Homo sapiens (Human) PSQSACPVLSTAPGTPCDLRKHLLNMVSEEK 0.96308 0.058219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGH3 S23A2_HUMAN "Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2, hSVCT2) (Yolk sac permease-like molecule 2)" SLC23A2 KIAA0238 NBTL1 SLC23A1 SVCT2 YSPL2 Homo sapiens (Human) cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; negative regulation of neuron death [GO:1901215]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979] GO:0005737; GO:0005886; GO:0005887; GO:0006979; GO:0008520; GO:0015229; GO:0015882; GO:0016021; GO:0016323; GO:0016324; GO:0019852; GO:0071361; GO:1901215; GO:1903861 L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229] AILSLDKWK 0.96308 0.11769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22612 KAPCG_HUMAN "cAMP-dependent protein kinase catalytic subunit gamma, PKA C-gamma, EC 2.7.11.11" PRKACG Homo sapiens (Human) high-density lipoprotein particle assembly [GO:0034380]; male gonad development [GO:0008584]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; renal water homeostasis [GO:0003091]; spermatogenesis [GO:0007283] ciliary base [GO:0097546]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ciliary base [GO:0097546]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; high-density lipoprotein particle assembly [GO:0034380]; male gonad development [GO:0008584]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; renal water homeostasis [GO:0003091]; spermatogenesis [GO:0007283] GO:0003091; GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006468; GO:0007283; GO:0008584; GO:0010737; GO:0034237; GO:0034380; GO:0097546; GO:0106310 AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein kinase A regulatory subunit binding [GO:0034237]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] HLLRSLLQVDLTKR 0.96309 0.11721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5561 0 0 0 0 0 11.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TB33 CX024_HUMAN Putative uncharacterized protein encoded by LINC01560 LINC01560 CXorf24 Homo sapiens (Human) GALFRLLLQER 0.96309 0.1504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0543 0 14.1941 0 0 0 0 0 0 14.3683 0 0 0 0 0 0 0 0 0 14.2766 15.1798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C2W7 CT47B_HUMAN "Cancer/testis antigen 47B (Cancer/testis antigen 47.13, CT47.13)" CT47B1 CT47.13 Homo sapiens (Human) EPAEEAADEKPPEEAAEEK 0.9631 0.055095 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6145 0 0 16.5713 0 14.0519 13.7085 16.7259 13.6185 15.7427 0 14.3373 0 15.1614 16.8984 0 15.5116 0 0 0 0 0 0 0 0 14.089 0 0 0 16.7201 0 15.7908 0 0 14.6909 0 16.7564 16.4278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4372 0 0 0 0 13.9595 14.2318 14.1466 13.8038 14.108 0 0 0 14.3963 0 14.4427 0 0 17.6666 14.3551 17.5885 0 0 0 14.1215 0 0 14.6855 14.3092 0 0 14.7493 0 0 0 0 0 0 13.9055 13.7827 0 0 0 0 0 0 14.5239 0 14.3377 0 0 0 0 13.9823 14.5767 14.1547 14.1402 0 0 0 0 14.4729 0 0 0 14.4075 0 0 14.3514 13.9347 14.2538 0 13.9409 0 14.2549 13.9081 14.3446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1242 0 0 0 17.6026 0 0 0 P0C7X3 CCYL3_HUMAN Putative cyclin-Y-like protein 3 CCNYL3 Homo sapiens (Human) regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859] GO:0005886; GO:0045859; GO:0060828; GO:0061575 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575] HTLERYANR 0.9631 0.056501 0 0 0 0 0 0 0 0 0 0 0 0 10.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0256 0 0 11.9775 0 0 0 0 0 0 0 0 12.6564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5713 0 0 0 0 0 0 13.8989 0 0 0 0 14.779 0 0 0 0 0 0 0 14.8399 0 0 0 0 0 0 13.9325 0 12.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9145 0 0 0 12.0639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9391 0 0 0 0 0 0 0 0 12.1232 0 P0C7L1 ISK8_HUMAN Serine protease inhibitor Kazal-type 8 SPINK8 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576 serine-type endopeptidase inhibitor activity [GO:0004867] LYDGQCENS 0.96314 0.52229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQG1 MANBL_HUMAN Protein MANBAL MANBAL Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AAVPSVNKRPK 0.96315 0.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9756 0 0 0 0 0 0 0 0 P31639 SC5A2_HUMAN "Sodium/glucose cotransporter 2, Na(+)/glucose cotransporter 2 (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2)" SLC5A2 SGLT2 Homo sapiens (Human) alpha-glucoside transport [GO:0000017]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; hexose transmembrane transport [GO:0008645]; renal glucose absorption [GO:0035623]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-glucoside transmembrane transporter activity [GO:0015151]; D-glucose transmembrane transporter activity [GO:0055056]; glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362]; alpha-glucoside transport [GO:0000017]; carbohydrate metabolic process [GO:0005975]; glucose import across plasma membrane [GO:0098708]; hexose transmembrane transport [GO:0008645]; renal glucose absorption [GO:0035623]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transport [GO:0006814] GO:0000017; GO:0005362; GO:0005412; GO:0005886; GO:0005975; GO:0006814; GO:0008645; GO:0015151; GO:0016021; GO:0016324; GO:0035623; GO:0055056; GO:0070062; GO:0098708; GO:0098719 alpha-glucoside transmembrane transporter activity [GO:0015151]; D-glucose transmembrane transporter activity [GO:0055056]; glucose:sodium symporter activity [GO:0005412]; low-affinity glucose:sodium symporter activity [GO:0005362] HLHRLVFSLR 0.96317 0.14089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4643 0 0 0 0 0 0 0 0 0 11.1492 10.3677 0 0 0 0 0 0 0 0 0 10.7389 0 11.3963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6605 0 0 0 0 0 13.8192 0 0 0 12.9151 0 0 0 0 0 0 0 13.5826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0009 15.0117 0 0 0 0 0 0 0 11.758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5805 0 13.7276 11.2365 15.8224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55957 BID_HUMAN "BH3-interacting domain death agonist (p22 BID, BID) [Cleaved into: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID) ]" BID Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; establishment of protein localization to membrane [GO:0090150]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein targeting to mitochondrion [GO:0006626]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of T cell proliferation [GO:0042129]; release of cytochrome c from mitochondria [GO:0001836]; signal transduction in response to DNA damage [GO:0042770]; supramolecular fiber organization [GO:0097435] cytosol [GO:0005829]; integral component of mitochondrial membrane [GO:0032592]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of mitochondrial membrane [GO:0032592]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; death receptor binding [GO:0005123]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; establishment of protein localization to membrane [GO:0090150]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein targeting to mitochondrion [GO:0006626]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of T cell proliferation [GO:0042129]; release of cytochrome c from mitochondria [GO:0001836]; signal transduction in response to DNA damage [GO:0042770]; supramolecular fiber organization [GO:0097435] GO:0001836; GO:0005123; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006919; GO:0008625; GO:0008637; GO:0010918; GO:0016020; GO:0031334; GO:0031625; GO:0032592; GO:0042129; GO:0042770; GO:0042775; GO:0043065; GO:0050678; GO:0051402; GO:0065003; GO:0090150; GO:0090200; GO:0097284; GO:0097345; GO:0097435; GO:1902230; GO:2000045; GO:2000271; GO:2001238; GO:2001244 death receptor binding [GO:0005123]; ubiquitin protein ligase binding [GO:0031625] DVFHTTVNFINQNLRTYVR 0.96317 0.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0283 0 0 0 0 0 0 0 0 0 11.818 0 0 0 0 0 0 0 0 0 11.504 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8078 0 0 0 0 13.157 0 13.5223 0 0 0 0 0 0 11.5067 0 0 0 0 0 0 15.3157 0 0 0 0 0 0 0 11.6741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35244 RFA3_HUMAN "Replication protein A 14 kDa subunit, RP-A p14 (Replication factor A protein 3, RF-A protein 3)" RPA3 REPA3 RPA14 Homo sapiens (Human) base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; regulation of cell population proliferation [GO:0042127]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723] DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861] DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; regulation of cell population proliferation [GO:0042127]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723] GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005654; GO:0005662; GO:0006260; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0007346; GO:0035861; GO:0042127 damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697] ATILCTSYVQFK 0.96318 0.085982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3461 0 0 0 0 0 0 0 12.6814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1112 0 12.7234 0 0 0 0 0 0 0 Q16739 CEGT_HUMAN "Ceramide glucosyltransferase, EC 2.4.1.80 (GLCT-1) (Glucosylceramide synthase, GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase)" UGCG Homo sapiens (Human) cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid metabolic process [GO:0006687]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ceramide glucosyltransferase activity [GO:0008120]; dihydroceramide glucosyltransferase activity [GO:0102769]; cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid metabolic process [GO:0006687]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966] GO:0000139; GO:0006497; GO:0006679; GO:0006687; GO:0008120; GO:0008544; GO:0009966; GO:0016020; GO:0016021; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:0102769; GO:1903575 ceramide glucosyltransferase activity [GO:0008120]; dihydroceramide glucosyltransferase activity [GO:0102769] LPGVSLLKPLK 0.9632 0.51645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7802 0 12.6201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5V8 CDCP1_HUMAN "CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein, SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318)" CDCP1 TRASK UNQ2486/PRO5773 Homo sapiens (Human) extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005576; GO:0005886; GO:0016021 AFMIIQEQRTR 0.9632 0.51872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0633 0 0 0 0 0 0 0 0 12.8532 0 0 0 0 12.171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3933 0 0 0 0 0 0 0 0 0 0 0 13.742 0 0 0 0 0 11.1246 0 0 0 0 0 14.4665 0 0 13.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4111 0 0 0 15.7899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7944 13.7586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGQ4 O10Q1_HUMAN Olfactory receptor 10Q1 (Olfactory receptor OR11-233) OR10Q1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] DVKGALRSAIIR 0.96321 0.10617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF65 GIPC2_HUMAN PDZ domain-containing protein GIPC2 GIPC2 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802] GO:0005737; GO:0042802; GO:0070062 identical protein binding [GO:0042802] IGCGRATLR 0.96321 0.10637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQD7 ANKMT_HUMAN "Adenine nucleotide translocase lysine N-methyltransferase, ANT-KMT, EC 2.1.1.-" ANTKMT C16orf24 FAM173A RJD7 Homo sapiens (Human) "peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]" integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]" GO:0005739; GO:0016021; GO:0016279; GO:0018023; GO:0031966; GO:1905273; GO:1905706 protein-lysine N-methyltransferase activity [GO:0016279] LQVPYVGASAR 0.96321 0.15377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5698 0 0 12.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG13 CTF8_HUMAN "Chromosome transmission fidelity protein 8 homolog, hCTF8" CHTF8 CTF8 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654] Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0003677; GO:0005654; GO:0006260; GO:0007064; GO:0031390; GO:0032508; GO:1900264 DNA binding [GO:0003677] ETGTRYLVTALIKDK 0.96322 0.10511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8293 0 0 14.0177 0 0 0 0 0 11.4746 0 0 0 0 12.7399 0 0 12.3602 0 14.0657 0 0 0 0 0 0 0 12.4851 0 13.2348 0 0 0 0 11.2441 0 0 0 0 0 0 0 0 12.8226 0 0 12.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31273 HXC8_HUMAN Homeobox protein Hox-C8 (Homeobox protein Hox-3A) HOXC8 HOX3A Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system morphogenesis [GO:0048705] chromatin [GO:0000785]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system morphogenesis [GO:0048705]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0015630; GO:0030182; GO:0048705; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AGESLEPAYYDCR 0.96322 0.080919 0 0 0 0 0 0 0 0 0 0 0 10.9418 0 0 0 0 0 12.786 0 13.061 0 0 0 10.1209 0 0 0 12.4111 0 0 10.9045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4699 0 0 0 0 0 0 0 0 0 0 13.7592 0 14.5483 0 14.2731 14.378 0 0 12.1184 14.4357 14.4237 12.3308 0 0 0 11.0503 0 14.4847 0 15.4276 15.2441 0 12.4056 0 14.3114 13.0682 14.9737 14.8918 13.2129 14.3637 0 0 0 0 13.8869 0 0 0 0 0 15.0087 11.4798 15.164 0 15.0305 0 0 15.1946 15.0258 13.3066 0 0 0 14.444 0 0 0 0 0 11.7591 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4235 11.1433 12.977 13.3946 0 12.321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPF4 OSGEP_HUMAN "tRNA N6-adenosine threonylcarbamoyltransferase, EC 2.3.1.234 (N6-L-threonylcarbamoyladenine synthase, t(6)A synthase) (O-sialoglycoprotein endopeptidase, hOSGEP) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP) (tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP)" OSGEP GCPL1 Homo sapiens (Human) tRNA threonylcarbamoyladenosine modification [GO:0002949] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949] GO:0000408; GO:0002949; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0016607; GO:0046872; GO:0061711 metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711] LQEMMATMCQER 0.96323 0.5144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75715 GPX5_HUMAN "Epididymal secretory glutathione peroxidase, EC 1.11.1.9 (Epididymis-specific glutathione peroxidase-like protein, EGLP) (Glutathione peroxidase 5, GPx-5, GSHPx-5)" GPX5 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; lipid metabolic process [GO:0006629] extracellular region [GO:0005576] extracellular region [GO:0005576]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599]; lipid metabolic process [GO:0006629] GO:0004601; GO:0004602; GO:0005576; GO:0006629; GO:0034599 glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601] TDILAYLKQFKTK 0.96324 0.1507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQB8 BAIP2_HUMAN "Brain-specific angiogenesis inhibitor 1-associated protein 2, BAI-associated protein 2, BAI1-associated protein 2, Protein BAP2 (Fas ligand-associated factor 3, FLAF3) (Insulin receptor substrate p53/p58, IRS-58, IRSp53/58) (Insulin receptor substrate protein of 53 kDa, IRSp53, Insulin receptor substrate p53)" BAIAP2 Homo sapiens (Human) "actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; insulin receptor signaling pathway [GO:0008286]; modification of synaptic structure, modulating synaptic transmission [GO:0099564]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synaptic plasticity [GO:0048167]; response to bacterium [GO:0009617]" "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; rough endoplasmic reticulum [GO:0005791]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060]" "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine cytoplasm [GO:0061846]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; neuron projection branch point [GO:0061845]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density, intracellular component [GO:0099092]; presynaptic cytosol [GO:0099523]; rough endoplasmic reticulum [GO:0005791]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; synaptic membrane [GO:0097060]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to L-glutamate [GO:1905232]; dendrite development [GO:0016358]; insulin receptor signaling pathway [GO:0008286]; modification of synaptic structure, modulating synaptic transmission [GO:0099564]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synaptic plasticity [GO:0048167]; response to bacterium [GO:0009617]" GO:0001221; GO:0001726; GO:0005654; GO:0005737; GO:0005791; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0007009; GO:0007409; GO:0007420; GO:0008022; GO:0008093; GO:0008286; GO:0008360; GO:0009617; GO:0016358; GO:0030027; GO:0030141; GO:0030165; GO:0030175; GO:0030838; GO:0032956; GO:0035418; GO:0042802; GO:0043025; GO:0043198; GO:0044306; GO:0048167; GO:0051017; GO:0051764; GO:0060076; GO:0061003; GO:0061845; GO:0061846; GO:0070062; GO:0070064; GO:0071364; GO:0097060; GO:0097110; GO:0098641; GO:0098685; GO:0098978; GO:0099092; GO:0099523; GO:0099524; GO:0099564; GO:1905232; GO:1905274; GO:2000251; GO:2000463 cadherin binding involved in cell-cell adhesion [GO:0098641]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; scaffold protein binding [GO:0097110]; transcription coregulator binding [GO:0001221] DGWHYGESEK 0.96324 0.51425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13688 CEAM1_HUMAN "Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1, BGP-1) (CD antigen CD66a)" CEACAM1 BGP BGP1 Homo sapiens (Human) "angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of immune system process [GO:0002682]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]" adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658] "adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658]; actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of immune system process [GO:0002682]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; signal transduction [GO:0007165]; wound healing, spreading of cells [GO:0044319]" GO:0001525; GO:0001558; GO:0001568; GO:0001915; GO:0002682; GO:0002859; GO:0003779; GO:0005516; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006469; GO:0007155; GO:0007156; GO:0007165; GO:0007229; GO:0009925; GO:0009986; GO:0010594; GO:0014066; GO:0015125; GO:0015721; GO:0016020; GO:0016021; GO:0016324; GO:0016328; GO:0016477; GO:0019900; GO:0019903; GO:0030054; GO:0030334; GO:0030658; GO:0030853; GO:0031005; GO:0031528; GO:0032692; GO:0032869; GO:0035579; GO:0035726; GO:0038016; GO:0038158; GO:0042058; GO:0042802; GO:0042803; GO:0043116; GO:0043318; GO:0044319; GO:0045601; GO:0045717; GO:0046983; GO:0050860; GO:0051055; GO:0060312; GO:0070062; GO:0070372; GO:0070821; GO:0090331; GO:0098742; GO:1901143; GO:1903385; GO:1903670; GO:1990782; GO:2000346; GO:2001214 actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782] TIIVTELSPVVAK 0.96325 0.15043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZW7 TSG10_HUMAN Testis-specific gene 10 protein (Testis development protein NYD-SP7) TSGA10 CEP4L Homo sapiens (Human) spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] centriole [GO:0005814]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; spermatogenesis [GO:0007283] GO:0005737; GO:0005814; GO:0007283; GO:0031514 ELLNRQLVAK 0.96325 0.056593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6998 0 0 0 0 0 0 0 0 0 0 0 0 10.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8812 11.9274 0 0 0 0 0 0 0 14.4869 13.6976 0 0 0 0 12.215 11.8579 0 11.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7243 0 13.5375 15.1787 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8873 12.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6059 0 0 0 0 0 0 0 0 0 0 0 15.229 0 0 0 0 Q6UWM5 GPRL1_HUMAN GLIPR1-like protein 1 GLIPR1L1 UNQ2972/PRO7434 Homo sapiens (Human) single fertilization [GO:0007338] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; single fertilization [GO:0007338] GO:0001669; GO:0005615; GO:0005886; GO:0007338; GO:0031225; GO:0045121 APQQTAFNPFSLGFLLLRIF 0.96327 0.14745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DN80 OR5H8_HUMAN Olfactory receptor 5H8 (Olfactory receptor 5H8 pseudogene) (Olfactory receptor OR3-7) OR5H8 OR5H8P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IPLFLAFLVIYLITIMANLGLIAVIWK 0.96329 0.11672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3012 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5386 0 0 0 0 0 0 0 0 0 0 0 0 11.5362 0 0 0 0 11.5386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6165 0 0 0 0 0 0 0 0 11.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21453 S1PR1_HUMAN "Sphingosine 1-phosphate receptor 1, S1P receptor 1, S1P1 (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1, S1P receptor Edg-1) (CD antigen CD363)" S1PR1 CHEDG1 EDG1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226] cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; brain development [GO:0007420]; cardiac muscle tissue growth involved in heart morphogenesis [GO:0003245]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chemotaxis [GO:0006935]; endothelial cell differentiation [GO:0045446]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula morphogenesis [GO:0061384]; lamellipodium assembly [GO:0030032]; leukocyte chemotaxis [GO:0030595]; negative regulation of stress fiber assembly [GO:0051497]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of GTPase activity [GO:0043547]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone mineralization [GO:0030500]; regulation of bone resorption [GO:0045124]; regulation of cell adhesion [GO:0030155]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell migration [GO:0072678]; transmission of nerve impulse [GO:0019226] GO:0001525; GO:0001664; GO:0001955; GO:0003245; GO:0003376; GO:0004930; GO:0005654; GO:0005737; GO:0005768; GO:0005886; GO:0006935; GO:0007155; GO:0007186; GO:0007189; GO:0007193; GO:0007420; GO:0008283; GO:0009897; GO:0016021; GO:0016477; GO:0019222; GO:0019226; GO:0030032; GO:0030155; GO:0030182; GO:0030335; GO:0030500; GO:0030595; GO:0031226; GO:0031532; GO:0038036; GO:0043231; GO:0043547; GO:0045121; GO:0045124; GO:0045446; GO:0045944; GO:0046625; GO:0048661; GO:0050927; GO:0051482; GO:0051497; GO:0061384; GO:0072678 G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; sphingolipid binding [GO:0046625]; sphingosine-1-phosphate receptor activity [GO:0038036] CPSGDSAGK 0.96329 0.052784 0 0 0 0 0 0 0 0 0 0 0 0 10.8893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.662 0 13.2525 0 13.7639 12.1434 12.8709 12.5298 0 0 13.7993 0 0 0 0 0 0 0 13.4358 0 0 0 0 0 0 14.3164 0 0 13.3556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0104 11.9304 0 0 0 0 14.6976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4124 0 0 0 Q9Y6J8 STYL1_HUMAN Serine/threonine/tyrosine-interacting-like protein 1 (Dual specificity phosphatase inhibitor MK-STYX) (Dual specificity protein phosphatase 24) (Inactive dual specificity protein phosphatase MK-STYX) (Map kinase phosphatase-like protein MK-STYX) STYXL1 DUSP24 MKSTYX Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; protein dephosphorylation [GO:0006470]; regulation of intrinsic apoptotic signaling pathway [GO:2001242] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]; intracellular signal transduction [GO:0035556]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; protein dephosphorylation [GO:0006470]; regulation of intrinsic apoptotic signaling pathway [GO:2001242] GO:0001691; GO:0004864; GO:0005739; GO:0005759; GO:0006470; GO:0008138; GO:0010976; GO:0019903; GO:0032515; GO:0035556; GO:0062030; GO:2001242; GO:2001244 protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691] CKNNMCPNRGLVSQLLEWEK 0.9633 0.14467 0 0 0 0 0 0 0 0 0 0 11.274 0 0 0 0 0 0 0 0 0 0 0 10.8673 0 0 10.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1267 0 0 0 0 0 0 12.3033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3041 0 0 0 0 0 0 0 P62166 NCS1_HUMAN "Neuronal calcium sensor 1, NCS-1 (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein)" NCS1 FLUP FREQ Homo sapiens (Human) regulation of neuron projection development [GO:0010975] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; voltage-gated calcium channel activity [GO:0005245]; regulation of neuron projection development [GO:0010975] GO:0005245; GO:0005509; GO:0005737; GO:0005794; GO:0005886; GO:0008048; GO:0010975; GO:0014069; GO:0030424; GO:0030425; GO:0043231; GO:0048471; GO:0070161 calcium ion binding [GO:0005509]; calcium sensitive guanylate cyclase activator activity [GO:0008048]; voltage-gated calcium channel activity [GO:0005245] LKPEVVEELTRK 0.96331 0.14244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7362 0 0 13.3806 0 0 0 0 0 0 0 0 13.6294 0 0 13.6056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1R2 DUS15_HUMAN "Dual specificity protein phosphatase 15, EC 3.1.3.16, EC 3.1.3.48 (VH1-related member Y) (Vaccinia virus VH1-related dual-specific protein phosphatase Y)" DUSP15 C20orf57 VHY Homo sapiens (Human) dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte differentiation [GO:0048713]; signal transduction [GO:0007165] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte differentiation [GO:0048713]; signal transduction [GO:0007165] GO:0004725; GO:0005829; GO:0005886; GO:0006470; GO:0007165; GO:0008138; GO:0016311; GO:0016791; GO:0017018; GO:0048713 myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] ATRPIANPNPGFR 0.96332 0.11392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1598 0 12.3717 12.1598 0 14.6733 0 0 0 0 0 0 0 0 0 0 0 10.7337 0 0 0 0 0 12.2365 0 0 0 0 0 0 0 0 14.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4681 0 0 0 0 0 P18124 RL7_HUMAN 60S ribosomal protein L7 (Large ribosomal subunit protein uL30) RPL7 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]" GO:0000463; GO:0002181; GO:0003677; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0042273; GO:0042802; GO:1990904 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EANNFLWPFK 0.96333 0.14125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4301 0 14.5788 0 0 0 0 0 12.6267 0 12.5596 0 0 0 0 0 0 0 13.6594 0 0 0 0 0 0 14.2867 0 0 0 0 0 0 0 12.2908 12.7736 0 0 0 0 0 0 0 0 0 13.4103 0 0 0 0 0 0 12.4804 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5049 0 0 0 11.4322 0 13.8098 0 11.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7743 0 0 0 0 0 0 0 0 Q9H8J5 MANS1_HUMAN MANSC domain-containing protein 1 (Loss of heterozygosity 12 chromosomal region 3 protein) MANSC1 LOH12CR3 UNQ316/PRO361 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FGSSDHLEK 0.96333 0.14131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1265 0 0 0 0 0 0 13.8665 0 0 0 0 0 0 13.8409 0 0 0 0 0 0 0 14.5877 0 14.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9219 0 0 0 0 13.6432 0 11.665 0 0 0 13.3401 0 0 15.4221 0 0 0 0 0 0 0 0 0 0 0 16.0942 0 0 0 0 0 0 0 0 0 13.4719 0 14.0054 0 13.7586 0 0 0 0 0 0 0 0 0 0 0 15.5434 0 0 0 0 0 0 0 Q16649 NFIL3_HUMAN Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A) NFIL3 E4BP4 IL3BP1 Homo sapiens (Human) "cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001779; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0006366; GO:0006955; GO:0007623; GO:0010628; GO:0042802; GO:0045892; GO:0045893; GO:0071353; GO:0090575 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" LIALGEENATLKAELLSLKLK 0.96334 0.29791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4292 0 0 0 0 0 0 0 0 0 0 0 11.4764 0 0 0 0 0 0 0 0 0 12.8127 0 0 0 0 0 0 0 0 0 0 11.5286 0 0 0 0 11.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B1AKI9 ISM1_HUMAN Isthmin-1 ISM1 C20orf82 ISM Homo sapiens (Human) negative regulation of angiogenesis [GO:0016525] extracellular region [GO:0005576] extracellular region [GO:0005576]; negative regulation of angiogenesis [GO:0016525] GO:0005576; GO:0016525 GWDHTAPGHRTFETK 0.96336 0.10689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0073 0 0 0 0 0 0 0 0 11.3187 0 0 0 0 0 13.5939 0 0 0 0 0 0 0 10.962 0 0 0 10.9863 0 0 0 0 0 0 10.4527 0 0 0 0 0 0 0 0 11.541 0 0 0 0 0 0 0 10.1625 0 0 11.9897 0 0 0 0 0 11.7982 0 0 0 0 0 0 11.9231 0 0 0 0 0 12.9245 0 0 0 0 0 0 0 0 0 12.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0788 0 0 P16050 LOX15_HUMAN "Polyunsaturated fatty acid lipoxygenase ALOX15 (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type, 12-LOX, EC 1.13.11.31) (Arachidonate 15-lipoxygenase, 15-LOX, 15-LOX-1, EC 1.13.11.33) (Arachidonate omega-6 lipoxygenase) (Hepoxilin A3 synthase Alox15, EC 1.13.11.-) (Linoleate 13S-lipoxygenase, EC 1.13.11.12)" ALOX15 LOG15 Homo sapiens (Human) apoptotic cell clearance [GO:0043277]; arachidonic acid metabolic process [GO:0019369]; bone mineralization [GO:0030282]; cellular response to calcium ion [GO:0071277]; cellular response to interleukin-13 [GO:0035963]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; inflammatory response [GO:0006954]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of adaptive immune response [GO:0002820]; ossification [GO:0001503]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of engulfment of apoptotic cell [GO:1901074]; regulation of inflammatory response [GO:0050727]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; response to endoplasmic reticulum stress [GO:0034976]; wound healing [GO:0042060] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; apoptotic cell clearance [GO:0043277]; arachidonic acid metabolic process [GO:0019369]; bone mineralization [GO:0030282]; cellular response to calcium ion [GO:0071277]; cellular response to interleukin-13 [GO:0035963]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; inflammatory response [GO:0006954]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of adaptive immune response [GO:0002820]; ossification [GO:0001503]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of engulfment of apoptotic cell [GO:1901074]; regulation of inflammatory response [GO:0050727]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; response to endoplasmic reticulum stress [GO:0034976]; wound healing [GO:0042060]" GO:0001503; GO:0002820; GO:0004052; GO:0005506; GO:0005546; GO:0005811; GO:0005829; GO:0005886; GO:0006629; GO:0006646; GO:0006954; GO:0010811; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019395; GO:0030282; GO:0030838; GO:0031234; GO:0034440; GO:0034976; GO:0035358; GO:0035963; GO:0042060; GO:0042759; GO:0043277; GO:0043651; GO:0050473; GO:0050727; GO:0051122; GO:0070374; GO:0071277; GO:1901074; GO:2001303 "arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" ANVILCSQQHLAAPLVMLKLQPDGKLLPMVIQLQLPR 0.96336 3.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5447 0 0 0 0 0 13.8231 0 14.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7626 0 0 0 0 11.9157 0 0 11.9737 0 0 0 0 0 0 11.3905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7745 0 0 13.025 13.2817 13.374 13.7126 13.1977 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9679 13.5814 13.4171 0 0 0 0 0 0 15.5258 0 0 0 0 0 0 0 12.2035 0 0 14.6402 0 15.0075 14.6284 15.1375 0 15.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43623 SNAI2_HUMAN Zinc finger protein SNAI2 (Neural crest transcription factor Slug) (Protein snail homolog 2) SNAI2 SLUG SLUGH Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to ionizing radiation [GO:0071479]; desmosome disassembly [GO:0035921]; endothelial cell migration [GO:0043542]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; epithelium development [GO:0060429]; hematopoietic stem cell proliferation [GO:0071425]; myeloid cell apoptotic process [GO:0033028]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of hematopoietic stem cell proliferation [GO:1902034]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; neural crest cell development [GO:0014032]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; osteoblast differentiation [GO:0001649]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of histone acetylation [GO:0035066]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]; regulation of chemokine production [GO:0032642]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; white fat cell differentiation [GO:0050872]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to ionizing radiation [GO:0071479]; desmosome disassembly [GO:0035921]; endothelial cell migration [GO:0043542]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; epithelium development [GO:0060429]; hematopoietic stem cell proliferation [GO:0071425]; myeloid cell apoptotic process [GO:0033028]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of hematopoietic stem cell proliferation [GO:1902034]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; neural crest cell development [GO:0014032]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; osteoblast differentiation [GO:0001649]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of histone acetylation [GO:0035066]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]; regulation of chemokine production [GO:0032642]; regulation of osteoblast differentiation [GO:0045667]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; white fat cell differentiation [GO:0050872]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001649; GO:0001837; GO:0003180; GO:0003198; GO:0003273; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006933; GO:0007219; GO:0007605; GO:0010839; GO:0010957; GO:0014032; GO:0030335; GO:0032331; GO:0032642; GO:0033028; GO:0033033; GO:0033629; GO:0035066; GO:0035921; GO:0043473; GO:0043518; GO:0043542; GO:0043565; GO:0045600; GO:0045667; GO:0046872; GO:0050872; GO:0060021; GO:0060429; GO:0060536; GO:0060693; GO:0061314; GO:0070563; GO:0070888; GO:0071364; GO:0071425; GO:0071479; GO:0090090; GO:1902034; GO:1902230; GO:1990837; GO:2000810; GO:2000811; GO:2001240 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" MPRSFLVKK 0.96337 0.15399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3332 13.0871 0 0 0 0 0 0 0 0 13.2024 0 13.8108 0 0 0 0 0 12.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3278 0 0 0 0 11.5665 0 0 0 0 0 0 0 0 0 0 0 0 E9PQ53 NDUCR_HUMAN "NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2 (NDUFC2-KCTD14 readthrough transcript protein)" NDUFC2-KCTD14 Homo sapiens (Human) "mitochondrial electron transport, NADH to ubiquinone [GO:0006120]" mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]" GO:0005739; GO:0005747; GO:0006120 IARRNPEPLR 0.9634 0.33151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75787 RENR_HUMAN "Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9, ATP6M8-9, V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment ]" ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072 Homo sapiens (Human) angiotensin maturation [GO:0002003]; central nervous system maturation [GO:0021626]; endosomal lumen acidification [GO:0048388]; eye pigmentation [GO:0048069]; Golgi lumen acidification [GO:0061795]; head morphogenesis [GO:0060323]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903]; vacuolar acidification [GO:0007035] "anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cell body [GO:0044297]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; signaling receptor activity [GO:0038023]; angiotensin maturation [GO:0002003]; central nervous system maturation [GO:0021626]; endosomal lumen acidification [GO:0048388]; eye pigmentation [GO:0048069]; Golgi lumen acidification [GO:0061795]; head morphogenesis [GO:0060323]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903]; vacuolar acidification [GO:0007035]" GO:0000139; GO:0000220; GO:0000421; GO:0002003; GO:0005764; GO:0005765; GO:0005789; GO:0005886; GO:0007035; GO:0007042; GO:0009897; GO:0010008; GO:0016020; GO:0016021; GO:0016324; GO:0016471; GO:0021626; GO:0021903; GO:0030177; GO:0030424; GO:0030665; GO:0030672; GO:0032591; GO:0032914; GO:0033176; GO:0038023; GO:0043408; GO:0044297; GO:0045211; GO:0048069; GO:0048388; GO:0051452; GO:0060323; GO:0061795; GO:0070062; GO:0070161; GO:0070821; GO:0090263; GO:0101003; GO:1902600 signaling receptor activity [GO:0038023] AVFVVLLALVAGVLGNEFSILK 0.96343 0.053642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2323 0 0 0 0 0 0 0 0 0 0 13.6379 0 0 0 0 0 12.0425 0 0 0 0 0 0 0 12.9861 0 0 0 0 0 0 12.8212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.889 0 0 0 0 0 Q16385 SSX2_HUMAN "Protein SSX2 (Cancer/testis antigen 5.2, CT5.2) (Synovial sarcoma, X breakpoint 2) (Tumor antigen HOM-MEL-40)" SSX2 SSX2A; SSX2B Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 IFYVYMKRK 0.96344 0.11689 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9112 0 0 0 11.9321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6136 0 0 0 0 0 0 0 0 0 12.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3197 0 0 0 0 0 0 0 0 0 0 13.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2032 0 0 12.2105 0 0 0 0 0 0 0 0 14.2886 0 14.6879 0 15.3122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQB9 AURKC_HUMAN "Aurora kinase C, EC 2.7.11.1 (Aurora 3) (Aurora/IPL1-related kinase 3, ARK-3, Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C)" AURKC AIE2 AIK3 AIRK3 ARK3 STK13 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; histone modification [GO:0016570]; meiotic cell cycle [GO:0051321]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; oocyte development [GO:0048599]; positive regulation of cytokinesis [GO:0032467]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283] "chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]" "chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; histone modification [GO:0016570]; meiotic cell cycle [GO:0051321]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; oocyte development [GO:0048599]; positive regulation of cytokinesis [GO:0032467]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]" GO:0000775; GO:0000793; GO:0004672; GO:0004712; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005876; GO:0006468; GO:0007052; GO:0007283; GO:0008608; GO:0016570; GO:0030496; GO:0031616; GO:0032133; GO:0032465; GO:0032467; GO:0035174; GO:0048599; GO:0051233; GO:0051256; GO:0051301; GO:0051321; GO:0106310 ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine/tyrosine kinase activity [GO:0004712] DLISRLLRYQPLER 0.96344 0.052912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0254 0 0 0 0 0 0 12.085 0 0 0 0 0 12.3474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NT3 GUCD1_HUMAN Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4) GUCD1 C22orf13 LLN4 Homo sapiens (Human) HFDTEETRVNQLFAQAK 0.96345 0.14569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAU0 NKX23_HUMAN Homeobox protein Nkx-2.3 (Homeobox protein NK-2 homolog C) NKX2-3 NKX23 NKX2C Homo sapiens (Human) "CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cell differentiation [GO:0030154]; gland morphogenesis [GO:0022612]; leukocyte homeostasis [GO:0001776]; leukocyte migration [GO:0050900]; lymph node development [GO:0048535]; macrophage differentiation [GO:0030225]; odontogenesis of dentin-containing tooth [GO:0042475]; Peyer's patch development [GO:0048541]; plasma cell differentiation [GO:0002317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic digestive tract morphogenesis [GO:0048621]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366]; triglyceride metabolic process [GO:0006641]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cell differentiation [GO:0030154]; gland morphogenesis [GO:0022612]; leukocyte homeostasis [GO:0001776]; leukocyte migration [GO:0050900]; lymph node development [GO:0048535]; macrophage differentiation [GO:0030225]; odontogenesis of dentin-containing tooth [GO:0042475]; Peyer's patch development [GO:0048541]; plasma cell differentiation [GO:0002317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic digestive tract morphogenesis [GO:0048621]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; spleen development [GO:0048536]; transcription by RNA polymerase II [GO:0006366]; triglyceride metabolic process [GO:0006641]" GO:0000785; GO:0000978; GO:0000981; GO:0001776; GO:0002317; GO:0005634; GO:0006357; GO:0006366; GO:0006641; GO:0022612; GO:0030154; GO:0030225; GO:0042475; GO:0043367; GO:0045944; GO:0048535; GO:0048536; GO:0048541; GO:0048621; GO:0050678; GO:0050900; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AAEESERPK 0.96346 0.11617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DP5 FMT_HUMAN "Methionyl-tRNA formyltransferase, mitochondrial, MtFMT, EC 2.1.2.9" MTFMT FMT FMT1 Homo sapiens (Human) conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; methionyl-tRNA formyltransferase activity [GO:0004479]; conversion of methionyl-tRNA to N-formyl-methionyl-tRNA [GO:0071951] GO:0004479; GO:0005739; GO:0071951 methionyl-tRNA formyltransferase activity [GO:0004479] LTGQALIPGSVIYHK 0.96347 0.11522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC78 ZBT20_HUMAN Zinc finger and BTB domain-containing protein 20 (Dendritic-derived BTB/POZ zinc finger protein) (Zinc finger protein 288) ZBTB20 DPZF ZNF288 Homo sapiens (Human) cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to glucose stimulus [GO:0071333]; lipid homeostasis [GO:0055088]; negative regulation of gene expression [GO:0010629]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000976; GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010629; GO:0016604; GO:0032728; GO:0032755; GO:0032760; GO:0045821; GO:0046872; GO:0046889; GO:0055088; GO:0071333; GO:1990837 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" NESEECTEDTDQAEGTESEPK 0.96347 0.11554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1905 0 0 0 0 0 0 0 0 0 13.0608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DMQ9 CH089_HUMAN Putative uncharacterized protein C8orf89 C8orf89 Homo sapiens (Human) AVLETQKIKK 0.96351 0.29861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1907 0 15.0063 14.622 0 0 0 0 15.1483 14.2791 0 0 0 0 0 0 14.9312 0 0 0 14.1859 0 14.1082 0 14.8869 0 0 14.7418 0 14.7574 14.1313 14.322 0 0 14.7101 0 0 0 0 0 0 0 0 14.4015 14.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2546 0 14.1322 0 14.2024 0 0 0 0 14.1813 0 0 0 0 0 13.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P39656 OST48_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit, DDOST 48 kDa subunit, Oligosaccharyl transferase 48 kDa subunit" DDOST KIAA0115 OST48 OK/SW-cl.45 Homo sapiens (Human) protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110] GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006487; GO:0008047; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0031647; GO:0034097; GO:0035577; GO:0042110; GO:0043231 enzyme activator activity [GO:0008047] NNARVIFSGSLDFFSDSFFNSAVQK 0.96354 2.9602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2635 0 0 0 0 0 0 0 0 0 0 0 0 10.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2672 0 0 0 0 0 0 0 0 13.0184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00743 PPP6_HUMAN "Serine/threonine-protein phosphatase 6 catalytic subunit, PP6C, EC 3.1.3.16 [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed ]" PPP6C PPP6 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; COPII vesicle coating [GO:0048208]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470] GO:0000082; GO:0004722; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006470; GO:0017018; GO:0045087; GO:0046872; GO:0048208 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] LVTVWSAPNYCYR 0.96356 0.10341 0 0 0 0 0 0 0 0 0 11.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7073 11.9005 11.7607 0 0 0 0 0 0 0 0 11.4175 0 0 0 0 0 0 11.5455 0 0 0 0 11.8384 0 0 12.4422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2706 0 0 0 0 Q8IYB9 ZN595_HUMAN Zinc finger protein 595 ZNF595 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFTRSTTLNEHK 0.96357 -0.17448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1727 12.5881 12.2193 0 0 14.8883 0 0 12.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2554 0 0 0 0 0 0 0 0 0 0 0 10.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51504 ZNF80_HUMAN Zinc finger protein 80 (ZNFpT17) ZNF80 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CSECGKTFTYRSVFFR 0.9636 0.11692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14656 TM187_HUMAN Transmembrane protein 187 (Protein ITBA1) TMEM187 CXorf12 DXS9878E ITBA1 Homo sapiens (Human) integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] GO:0016021; GO:0030133 LWTQWRR 0.9636 0.30122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7793 0 0 0 0 0 0 0 A0A1B0GTW7 CIROP_HUMAN "Ciliated left-right organizer metallopeptidase (Leishmanolysin-like peptidase 2, EC 3.4.24.-)" CIROP LMLN2 Homo sapiens (Human) cell adhesion [GO:0007155]; establishment of left/right asymmetry [GO:0061966]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; cell adhesion [GO:0007155]; establishment of left/right asymmetry [GO:0061966]; proteolysis [GO:0006508] GO:0004222; GO:0005737; GO:0006508; GO:0007155; GO:0008233; GO:0016021; GO:0046872; GO:0061966 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233] ALAAVREATQRIQAVLAVQGPLLLSR 0.96364 4.7827 0 0 0 0 0 0 0 0 11.5127 0 0 0 11.4229 0 0 0 0 13.3989 0 10.9379 13.4134 0 12.6545 11.4345 0 0 0 0 0 0 13.6034 0 14.9142 0 11.215 12.171 12.7639 0 14.7905 0 0 0 0 0 12.8365 0 0 0 0 13.9157 13.1475 11.5561 0 0 11.4257 12.9703 0 0 0 0 0 0 0 0 0 0 0 10.7386 11.7231 0 0 0 0 0 0 0 14.7016 0 0 0 11.0253 11.1823 0 0 0 0 0 0 0 0 0 0 0 0 14.656 0 0 11.0515 0 0 0 0 12.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2975 0 0 13.9547 0 11.4823 0 17.3022 12.2654 11.3105 0 17.6623 17.5029 14.4905 0 0 0 0 0 0 0 0 0 17.9526 0 0 0 11.4069 0 14.6998 0 0 0 0 11.6208 0 0 0 0 0 0 0 11.0136 15.6207 14.8896 11.6776 15.1959 13.4945 12.4638 13.4161 0 11.8137 0 0 0 0 0 12.7556 Q9NVK5 FGOP2_HUMAN FGFR1 oncogene partner 2 FGFR1OP2 HSPC123 Homo sapiens (Human) response to wounding [GO:0009611]; wound healing [GO:0042060] cytosol [GO:0005829] cytosol [GO:0005829]; identical protein binding [GO:0042802]; response to wounding [GO:0009611]; wound healing [GO:0042060] GO:0005829; GO:0009611; GO:0042060; GO:0042802 identical protein binding [GO:0042802] EILQITR 0.96364 0.089216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7122 0 0 Q8IUQ0 CLVS1_HUMAN Clavesin-1 (Cellular retinaldehyde-binding protein-like) (Retinaldehyde-binding protein 1-like 1) (clathrin vesicle-associated Sec14 protein 1) CLVS1 CRALBPL RLBP1L1 Homo sapiens (Human) lysosome organization [GO:0007040] clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; lysosome organization [GO:0007040]" GO:0005768; GO:0005802; GO:0007040; GO:0030136; GO:0031901; GO:0032588; GO:0080025; GO:1902936 "phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]" KILLLFAANWDQSRNSFTDILR 0.96365 -0.083325 0 0 0 0 0 0 0 0 0 11.8922 0 0 0 0 0 0 0 0 0 0 0 0 11.1066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.989 0 0 0 0 0 11.3839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.371 0 0 0 0 13.6536 12.9796 0 0 0 0 13.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2833 0 0 0 0 0 0 0 0 0 0 0 0 12.166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FT7 ASIC4_HUMAN "Acid-sensing ion channel 4, ASIC4 (Amiloride-sensitive cation channel 4) (Amiloride-sensitive cation channel 4, pituitary)" ASIC4 ACCN4 Homo sapiens (Human) behavioral fear response [GO:0001662]; sodium ion transmembrane transport [GO:0035725] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; ligand-gated sodium channel activity [GO:0015280]; sodium ion transmembrane transporter activity [GO:0015081]; behavioral fear response [GO:0001662]; sodium ion transmembrane transport [GO:0035725] GO:0001662; GO:0005216; GO:0005887; GO:0015081; GO:0015280; GO:0035725 ion channel activity [GO:0005216]; ligand-gated sodium channel activity [GO:0015280]; sodium ion transmembrane transporter activity [GO:0015081] EAVLQRCHCR 0.96366 -0.084563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2729 0 0 0 0 0 9.50126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2181 0 0 0 12.5451 0 0 0 12.837 0 14.0688 0 0 Q8NG97 OR2Z1_HUMAN Olfactory receptor 2Z1 (Olfactory receptor 2Z2) (Olfactory receptor OR19-4) OR2Z1 OR2Z2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NPEVWMALVK 0.96367 -0.18853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0374 0 0 0 15.515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61081 UBC12_HUMAN "NEDD8-conjugating enzyme Ubc12, EC 2.3.2.34 (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M)" UBE2M UBC12 Homo sapiens (Human) positive regulation of neuron apoptotic process [GO:0043525]; post-translational protein modification [GO:0043687]; protein modification process [GO:0036211]; protein neddylation [GO:0045116] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of neuron apoptotic process [GO:0043525]; post-translational protein modification [GO:0043687]; protein modification process [GO:0036211]; protein neddylation [GO:0045116] GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0019788; GO:0036211; GO:0043525; GO:0043687; GO:0045116 ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842] ASAAQLRIQK 0.96368 0.29887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7309 0 0 0 15.372 14.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6L0 PRRT2_HUMAN "Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3, DSPB3)" PRRT2 Homo sapiens (Human) calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; negative regulation of short-term synaptic potentiation [GO:1905513]; negative regulation of SNARE complex assembly [GO:0035544]; neuromuscular process controlling posture [GO:0050884]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]; syntaxin-1 binding [GO:0017075]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; negative regulation of short-term synaptic potentiation [GO:1905513]; negative regulation of SNARE complex assembly [GO:0035544]; neuromuscular process controlling posture [GO:0050884]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629] GO:0005886; GO:0008021; GO:0016020; GO:0017075; GO:0030672; GO:0031629; GO:0031982; GO:0035544; GO:0042734; GO:0043197; GO:0043679; GO:0050884; GO:0070161; GO:0098793; GO:0098839; GO:0098978; GO:0099056; GO:0099502; GO:1905513 syntaxin-1 binding [GO:0017075] KSPPANGAPPRVLQQLVEEDR 0.96368 2.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1465 0 0 0 0 0 0 0 0 0 0 11.4936 0 11.5724 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1684 11.0769 0 0 0 0 0 0 0 0 0 10.947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08684 CP3A4_HUMAN "Cytochrome P450 3A4, EC 1.14.14.1 (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase, EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming), EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase, EC 1.14.14.55)" CYP3A4 CYP3A3 Homo sapiens (Human) aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; heterocycle metabolic process [GO:0046483]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]; aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; heterocycle metabolic process [GO:0046483]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006629; GO:0006706; GO:0006805; GO:0008202; GO:0008203; GO:0008209; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016021; GO:0016098; GO:0016491; GO:0019825; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0042759; GO:0043231; GO:0046222; GO:0046483; GO:0050591; GO:0050649; GO:0062181; GO:0062187; GO:0062188; GO:0062189; GO:0070330; GO:0070576; GO:0070989; GO:0101020; GO:0101021; GO:0102320 "1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]" DVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKK 0.96371 4.6009 0 0 0 0 0 0 0 0 0 0 13.383 0 0 0 0 0 0 0 0 0 11.4192 10.7964 14.1709 0 0 0 0 0 0 0 0 0 13.6925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3953 0 0 0 14.5375 0 0 0 11.5054 13.0731 0 0 0 0 0 0 0 0 12.6853 14.6777 13.3511 13.6122 0 13.7483 0 0 0 0 0 0 0 0 0 0 0 0 13.8757 0 0 0 0 0 0 0 0 0 0 0 0 11.9508 0 0 11.796 0 0 0 14.1951 0 0 0 0 0 0 0 0 0 0 14.9532 0 0 0 0 0 0 0 0 0 P0DW14 TFKLJ_HUMAN TATA-box-binding protein-associated factor 11-like protein 10 TAF11L10 Homo sapiens (Human) EAVRRLK 0.96375 -0.11489 14.6482 13.2372 15.9966 12.4776 12.495 0 14.1994 0 0 0 0 0 0 10.7172 0 0 0 0 0 0 0 15.4005 0 15.9846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3808 15.884 15.1976 16.6436 0 14.8059 0 0 16.5459 16.5761 16.8263 16.4108 17.2738 17.257 16.0874 15.8529 0 0 16.5078 13.4993 0 16.8748 0 0 15.5189 16.0771 16.0894 0 14.8831 14.9534 14.4148 0 16.5486 15.8947 14.2523 16.9708 0 0 0 16.4299 18.5781 16.3761 16.2168 19.7846 15.6442 14.5287 15.2824 18.986 14.9707 19.3662 19.2649 16.0764 0 19.6993 15.6634 16.1532 0 15.2698 0 15.1056 14.3567 15.7083 15.6422 16.3662 16.6836 16.4759 15.1073 15.8464 16.5274 14.5039 15.7306 16.2498 19.6899 19.4716 19.2416 19.4056 15.7276 19.5842 19.3093 15.3919 15.9436 0 17.2064 0 16.1248 16.8465 19.5083 15.2864 16.3917 16.283 15.3022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0688 16.6565 17.1925 15.0317 0 14.7432 0 15.6198 0 P63146 UBE2B_HUMAN "Ubiquitin-conjugating enzyme E2 B, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme B) (RAD6 homolog B, HR6B, hHR6B) (Ubiquitin carrier protein B) (Ubiquitin-conjugating enzyme E2-17 kDa) (Ubiquitin-protein ligase B)" UBE2B RAD6B Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; histone H2A ubiquitination [GO:0033522]; histone lysine demethylation [GO:0070076]; histone ubiquitination [GO:0016574]; in utero embryonic development [GO:0001701]; meiotic telomere clustering [GO:0045141]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of developmental process [GO:0051093]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of reproductive process [GO:2000242]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of reciprocal meiotic recombination [GO:0010845]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; synaptonemal complex organization [GO:0070193]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; cytoplasm [GO:0005737]; HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; replication fork [GO:0005657]; XY body [GO:0001741] chromatin [GO:0000785]; cytoplasm [GO:0005737]; HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; replication fork [GO:0005657]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; histone H2A ubiquitination [GO:0033522]; histone lysine demethylation [GO:0070076]; histone ubiquitination [GO:0016574]; in utero embryonic development [GO:0001701]; meiotic telomere clustering [GO:0045141]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of developmental process [GO:0051093]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of reproductive process [GO:2000242]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of reciprocal meiotic recombination [GO:0010845]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; synaptonemal complex organization [GO:0070193]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0000785; GO:0001701; GO:0001741; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005886; GO:0006281; GO:0006301; GO:0006511; GO:0006513; GO:0006915; GO:0006974; GO:0007283; GO:0007288; GO:0009410; GO:0009411; GO:0010845; GO:0016567; GO:0016574; GO:0031625; GO:0033128; GO:0033503; GO:0033522; GO:0035234; GO:0043066; GO:0043161; GO:0043951; GO:0045141; GO:0050821; GO:0051026; GO:0051093; GO:0051865; GO:0061631; GO:0070076; GO:0070193; GO:0070534; GO:0070936; GO:0070979; GO:0090263; GO:2000242 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] MSTPARR 0.96377 0.30122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C0HLS1 OSCRI_HUMAN "SCRIB overlapping open reading frame protein, oSCRIB" SCRIB Homo sapiens (Human) negative regulation of translational initiation [GO:0045947] negative regulation of translational initiation [GO:0045947] GO:0045947 RQPAARAAQAFFPAAELAQAGPER 0.96378 0.3303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZW8 CD244_HUMAN "Natural killer cell receptor 2B4 (NK cell activation-inducing ligand, NAIL) (NK cell type I receptor protein 2B4, NKR2B4, h2B4) (SLAM family member 4, SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244)" CD244 2B4 Homo sapiens (Human) adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of granzyme B production [GO:0071663]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; MHC class I protein binding [GO:0042288]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of granzyme B production [GO:0071663]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; signal transduction [GO:0007165] GO:0002250; GO:0002323; GO:0005886; GO:0007165; GO:0009897; GO:0016021; GO:0032729; GO:0032757; GO:0038023; GO:0042288; GO:0045087; GO:0060732; GO:0071663 MHC class I protein binding [GO:0042288]; signaling receptor activity [GO:0038023] FSFIVKNLSLLIK 0.96378 2.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4046 0 0 0 0 0 0 14.1574 0 0 0 13.9432 0 0 0 0 0 12.0975 10.8802 0 0 0 0 0 0 0 14.0399 0 0 10.6699 0 0 0 0 0 13.9921 10.2138 11.3176 0 0 0 0 12.8729 0 16.4311 0 15.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2576 0 0 0 10.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9929 0 0 15.3166 0 0 0 13.6673 0 0 12.5406 0 Q53LP3 SWAHC_HUMAN Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C) SOWAHC ANKRD57 C2orf26 Homo sapiens (Human) ASGSSSGRIK 0.96379 -0.08199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BV0 ZN775_HUMAN Zinc finger protein 775 ZNF775 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGKSFSQK 0.96379 0.089942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7288 14.402 0 14.1132 0 14.0177 0 0 0 0 0 0 0 0 0 11.7346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1197 13.3414 0 0 13.9323 15.5489 14.9961 0 0 0 0 11.9896 0 14.6003 0 0 0 10.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0645 0 0 0 0 0 0 0 13.5564 13.5914 0 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6893 0 0 0 0 0 0 0 0 0 0 0 0 13.4272 0 0 15.4934 0 0 0 12.4186 12.0376 13.0343 0 0 0 13.8363 12.9682 0 0 0 0 0 0 0 0 0 0 0 0 Q4G148 GXLT1_HUMAN "Glucoside xylosyltransferase 1, EC 2.4.2.42 (Glycosyltransferase 8 domain-containing protein 3)" GXYLT1 GLT8D3 Homo sapiens (Human) O-glycan processing [GO:0016266] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]" GO:0016021; GO:0016266; GO:0035252; GO:0140563 "UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252]" KYFKNDMTTVR 0.9638 -0.083165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EBL8 PDZ11_HUMAN "PDZ domain-containing protein 11 (ATPase-interacting PDZ protein) (Plasma membrane calcium ATPase-interacting single-PDZ protein, PMCA-interacting single-PDZ protein)" PDZD11 AIPP1 PDZK11 PISP HSPC227 UNQ6486/PRO21335 Homo sapiens (Human) maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; pore complex assembly [GO:0046931]; protein localization to basolateral plasma membrane [GO:1903361] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular region [GO:0005576]; pore complex [GO:0046930]; presynapse [GO:0098793]; synapse [GO:0045202] adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular region [GO:0005576]; pore complex [GO:0046930]; presynapse [GO:0098793]; synapse [GO:0045202]; protein C-terminus binding [GO:0008022]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; pore complex assembly [GO:0046931]; protein localization to basolateral plasma membrane [GO:1903361] GO:0005576; GO:0005829; GO:0005911; GO:0005912; GO:0007269; GO:0008022; GO:0016323; GO:0045199; GO:0045202; GO:0046930; GO:0046931; GO:0098793; GO:1903361 protein C-terminus binding [GO:0008022] AGLQEGDQVLAVNDVDFQDIEHSK 0.9638 -0.082733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8519 15.9185 0 11.9425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4986 0 0 13.1469 12.8919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1628 0 0 0 0 0 12.0986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAF5 LQK1_HUMAN Putative uncharacterized protein LQK1 (FLVCR1 antisense RNA 1) (FLVCR1 divergent transcript) FLVCR1-DT FLVCR1-AS1 LQK1 Homo sapiens (Human) GLLHLRVGGR 0.9638 0.089384 0 0 0 0 0 0 14.8243 0 0 0 0 0 0 12.1462 0 0 0 0 0 0 0 15.8761 0 15.7128 0 0 0 0 0 11.362 11.4339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8287 12.844 0 0 0 0 0 13.4644 0 0 13.5248 13.749 0 13.9461 0 0 0 0 0 0 14.5858 0 0 0 0 0 0 0 0 13.0455 0 13.7119 0 0 13.3236 0 0 0 0 0 0 12.3766 0 0 0 0 0 0 0 13.1467 20.826 0 0 0 0 11.4984 0 0 0 0 0 13.1701 0 0 0 0 0 0 0 12.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M385 MPEG1_HUMAN "Macrophage-expressed gene 1 protein, Macrophage gene 1 protein, Mpg-1 (Perforin-2, P-2)" MPEG1 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; pore formation in membrane of another organism [GO:0035915] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; pore formation in membrane of another organism [GO:0035915] GO:0005576; GO:0016021; GO:0030659; GO:0031410; GO:0035915; GO:0042742; GO:0045087; GO:0045335; GO:0050829; GO:0050830 KKAYQAIEER 0.96381 -0.075228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1101 0 12.8644 0 0 0 0 0 13.2748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3529 0 0 0 0 0 0 13.1431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY43 BARH2_HUMAN BarH-like 2 homeobox protein BARHL2 Homo sapiens (Human) amacrine cell differentiation [GO:0035881]; cell fate determination [GO:0001709]; neuron migration [GO:0001764]; positive regulation of translation [GO:0045727]; regulation of axon extension [GO:0030516]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; amacrine cell differentiation [GO:0035881]; cell fate determination [GO:0001709]; neuron migration [GO:0001764]; positive regulation of translation [GO:0045727]; regulation of axon extension [GO:0030516]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001709; GO:0001764; GO:0005634; GO:0006357; GO:0030516; GO:0035881; GO:0045727; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" CHGTKEEGDREITSSR 0.96381 -0.18737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P055 JKAMP_HUMAN "JNK1/MAPK8-associated membrane protein, JKAMP (JNK1-associated membrane protein, JAMP) (Medulloblastoma antigen MU-MB-50.4)" JKAMP C14orf100 JAMP CDA06 HSPC213 HSPC327 Homo sapiens (Human) response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005789; GO:0006986; GO:0016021; GO:0030433; GO:0031625 ubiquitin protein ligase binding [GO:0031625] KIACGLGKSDR 0.96384 0.30013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12829 RB40B_HUMAN "Ras-related protein Rab-40B (SOCS box-containing protein RAR, Protein Rar)" RAB40B SEC4L Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567]; toxin transport [GO:1901998] GO:0003924; GO:0005525; GO:0005635; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0043231; GO:0048471; GO:0072659; GO:1901998 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IVLLRHGMDRLWR 0.96385 0.29905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3014 0 0 0 0 0 0 0 0 0 0 0 0 12.7341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7822 0 0 0 0 13.4401 0 0 0 0 0 0 0 0 14.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0F6 SHRPN_HUMAN "Sharpin (Shank-associated RH domain-interacting protein) (Shank-interacting protein-like 1, hSIPL1)" SHARPIN SIPL1 PSEC0216 Homo sapiens (Human) apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; defense response to bacterium [GO:0042742]; keratinization [GO:0031424]; mitochondrion organization [GO:0007005]; negative regulation of inflammatory response [GO:0050728]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; regulation of CD40 signaling pathway [GO:2000348]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; LUBAC complex [GO:0071797]; postsynaptic density [GO:0014069]; ubiquitin ligase complex [GO:0000151] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; LUBAC complex [GO:0071797]; postsynaptic density [GO:0014069]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; defense response to bacterium [GO:0042742]; keratinization [GO:0031424]; mitochondrion organization [GO:0007005]; negative regulation of inflammatory response [GO:0050728]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; regulation of CD40 signaling pathway [GO:2000348]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803] GO:0000151; GO:0004842; GO:0005829; GO:0007005; GO:0007420; GO:0010803; GO:0014069; GO:0030262; GO:0030425; GO:0031424; GO:0031593; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0046872; GO:0050728; GO:0070161; GO:0071797; GO:0097039; GO:2000348 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842] APPAGGAAAAASDLGSAAVLLAVHAAVR 0.9639 -0.11441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60427 FADS1_HUMAN "Acyl-CoA (8-3)-desaturase, EC 1.14.19.44 (Delta(5) fatty acid desaturase, D5D, Delta(5) desaturase, Delta-5 desaturase) (Fatty acid desaturase 1)" FADS1 FADSD5 Homo sapiens (Human) "alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]" endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; linoleoyl-CoA desaturase activity [GO:0016213]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of transcription, DNA-templated [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636]" GO:0000248; GO:0005739; GO:0005789; GO:0006355; GO:0006629; GO:0006636; GO:0007267; GO:0008654; GO:0009267; GO:0016020; GO:0016021; GO:0016213; GO:0016491; GO:0016717; GO:0036109; GO:0042759; GO:0043231; GO:0043651; GO:0045485; GO:0045595; GO:0046456; GO:0062076 "acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; linoleoyl-CoA desaturase activity [GO:0016213]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]" GAPASWWNHMHFQHHAKPNCFR 0.96391 -0.11535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8863 0 0 12.1465 12.9891 11.8889 0 0 0 0 0 0 0 0 0 0 0 11.5657 0 0 0 12.9771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5467 0 0 0 0 0 13.0587 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0049 0 0 13.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3613 0 0 0 0 0 0 0 0 0 0 0 12.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5881 0 0 0 13.1792 0 0 0 0 0 0 0 0 0 P57103 NAC3_HUMAN Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3) SLC8A3 NCX3 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808] GO:0002244; GO:0005432; GO:0005516; GO:0005741; GO:0005789; GO:0005886; GO:0005887; GO:0006811; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015491; GO:0016020; GO:0016528; GO:0030001; GO:0030424; GO:0030425; GO:0031226; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0070161; GO:0070588; GO:0071456; GO:0071901; GO:0098703; GO:0098794; GO:0098815; GO:0099580; GO:1903779 calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872] GCKLATTWLFVSLWLLYILFATLEAYCYIK 0.96393 -0.16443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5396 0 0 0 0 0 13.1006 12.6994 13.0018 11.8968 0 0 12.4865 0 0 0 0 0 0 11.8292 0 0 0 0 10.9934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.764 0 0 13.8721 0 0 0 0 0 0 0 0 11.4013 11.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0876 0 0 0 0 0 0 0 0 12.6873 11.8432 0 0 0 0 0 0 0 0 0 0 0 0 O43414 ERI3_HUMAN "ERI1 exoribonuclease 3, EC 3.1.-.- (Prion interactor 1) (Prion protein-interacting protein)" ERI3 PINT1 PRNPIP PRNPIP1 Homo sapiens (Human) "exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]" "3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]" GO:0000175; GO:0000467; GO:0003723; GO:0046872 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] QWINLKK 0.96394 0.30122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00506 STK25_HUMAN "Serine/threonine-protein kinase 25, EC 2.7.11.1 (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1, SOK-1, Ste20/oxidant stress response kinase 1)" STK25 SOK1 YSK1 Homo sapiens (Human) axonogenesis [GO:0007409]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; axonogenesis [GO:0007409]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0006468; GO:0006979; GO:0007163; GO:0007165; GO:0007409; GO:0032874; GO:0036481; GO:0042542; GO:0042803; GO:0046777; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0070062; GO:0090168; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GTALHSSQKPAEPVKR 0.96395 0.33076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3639 0 0 0 0 0 0 13.4634 0 0 0 0 0 0 12.8837 0 0 O60662 KLH41_HUMAN Kelch-like protein 41 (Kel-like protein 23) (Kelch repeat and BTB domain-containing protein 10) (Kelch-related protein 1) (Sarcosin) KLHL41 KBTBD10 KRP1 Homo sapiens (Human) myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; pseudopodium assembly [GO:0031269]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]; striated muscle contraction [GO:0006941] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; M band [GO:0031430]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; sarcoplasmic reticulum membrane [GO:0033017]; myofibril assembly [GO:0030239]; protein ubiquitination [GO:0016567]; pseudopodium assembly [GO:0031269]; regulation of myoblast differentiation [GO:0045661]; regulation of myoblast proliferation [GO:2000291]; regulation of skeletal muscle cell differentiation [GO:2001014]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber development [GO:0048741]; striated muscle contraction [GO:0006941] GO:0001726; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0006941; GO:0016567; GO:0030239; GO:0031143; GO:0031269; GO:0031430; GO:0031463; GO:0033017; GO:0035914; GO:0045214; GO:0045661; GO:0048741; GO:2000291; GO:2001014 AGDKSLPCHR 0.96395 -0.073403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40938 RFC3_HUMAN "Replication factor C subunit 3 (Activator 1 38 kDa subunit, A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit, RF-C 38 kDa subunit, RFC38)" RFC3 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683]" GO:0000731; GO:0003677; GO:0003689; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006271; GO:0006281; GO:0008094; GO:0031390; GO:0032508; GO:0046683; GO:1900264 "ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]" AIYHLEAFVAKFMALYKK 0.96395 0.091154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7896 0 12.0571 0 0 0 0 0 0 12.4542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4363 0 0 0 0 Q5VWM6 PRA13_HUMAN Putative PRAME family member 13 PRAMEF13 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 DVDENFWARWPGAWALSCFPETMSK 0.96395 -0.18658 0 0 0 0 0 0 0 0 11.9921 0 0 0 0 0 11.6761 11.5968 0 0 0 0 0 0 0 0 0 13.7868 0 0 12.6062 14.4708 0 0 13.0587 0 0 0 0 0 0 0 13.171 12.8982 0 11.8345 0 0 0 12.3876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4097 0 0 0 0 0 0 0 0 12.4253 11.7112 13.4361 0 0 14.2629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7756 0 0 0 0 0 0 0 0 0 0 0 12.8871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2249 0 0 12.725 11.8478 0 0 0 0 O60676 CST8_HUMAN Cystatin-8 (Cystatin-related epididymal spermatogenic protein) CST8 CRES Homo sapiens (Human) cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869] GO:0004869; GO:0005576; GO:0005737; GO:0009986 cysteine-type endopeptidase inhibitor activity [GO:0004869] CRWLSLILLTIPLALVAR 0.96396 -0.16885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8891 13.0674 13.3772 0 0 0 0 0 0 0 13.0266 13.0973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.919 0 0 0 14.1263 0 0 0 0 0 0 0 0 11.1864 14.5856 0 13.2919 0 14.8406 0 0 0 0 0 12.3204 0 0 0 0 0 0 13.4955 0 0 0 0 15.6339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.167 0 0 0 0 0 0 0 0 Q9UHJ9 PGAP2_HUMAN Post-GPI attachment to proteins factor 2 (FGF receptor-activating protein 1) PGAP2 FRAG1 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GPI anchor biosynthetic process [GO:0006506] GO:0000139; GO:0005789; GO:0006506; GO:0016021 HTVSQEDRKSYSWK 0.96396 -0.16995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1653 0 13.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95452 CXB6_HUMAN "Gap junction beta-6 protein (Connexin-30, Cx30)" GJB6 Homo sapiens (Human) aging [GO:0007568]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; ear morphogenesis [GO:0042471]; gap junction assembly [GO:0016264]; gap junction-mediated intercellular transport [GO:1990349]; inner ear development [GO:0048839]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; sensory perception of sound [GO:0007605]; sinoatrial node development [GO:0003163]; transmembrane transport [GO:0055085] actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; connexin complex [GO:0005922]; cytosol [GO:0005829]; gap junction [GO:0005921]; integral component of membrane [GO:0016021] actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; connexin complex [GO:0005922]; cytosol [GO:0005829]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763]; microtubule binding [GO:0008017]; aging [GO:0007568]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; ear morphogenesis [GO:0042471]; gap junction assembly [GO:0016264]; gap junction-mediated intercellular transport [GO:1990349]; inner ear development [GO:0048839]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; sensory perception of sound [GO:0007605]; sinoatrial node development [GO:0003163]; transmembrane transport [GO:0055085] GO:0003163; GO:0005243; GO:0005829; GO:0005884; GO:0005921; GO:0005922; GO:0006915; GO:0007267; GO:0007568; GO:0007605; GO:0008017; GO:0008285; GO:0016021; GO:0016264; GO:0016324; GO:0030054; GO:0032496; GO:0035633; GO:0042471; GO:0048487; GO:0048839; GO:0051015; GO:0051602; GO:0055085; GO:0071333; GO:1903763; GO:1990349 actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763]; microtubule binding [GO:0008017] ESKQNEMNELISDSGQNAITGFPS 0.96398 0.32982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4547 0 0 0 0 11.5904 0 0 0 0 P30050 RL12_HUMAN 60S ribosomal protein L12 (Large ribosomal subunit protein uL11) RPL12 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0015934; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:0070180 large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EILGTAQSVGCNVDGR 0.96398 0.32876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPZ5 B3GA2_HUMAN "Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2, EC 2.4.1.135 (Beta-1,3-glucuronyltransferase 2) (GlcAT-D) (UDP-glucuronosyltransferase S, GlcAT-S, Glucuronosyltransferase S)" B3GAT2 GLCATS KIAA1963 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; carbohydrate biosynthetic process [GO:0016051]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486] GO:0000139; GO:0005975; GO:0006486; GO:0015018; GO:0016021; GO:0016051; GO:0046872; GO:0050650 galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872] FFILLPWILIVIIMLDVDTRR 0.96398 -0.1714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.952 0 0 15.2366 14.709 0 15.1146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1723 0 0 12.4503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4193 12.3562 0 0 0 0 0 0 0 14.1755 0 14.6956 0 0 0 0 0 0 0 13.0741 0 0 0 0 12.9277 0 0 0 0 0 0 0 14.0926 14.4127 0 0 13.6451 0 0 0 0 0 0 0 0 17.018 0 0 0 0 0 0 15.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3826 0 0 0 0 0 0 14.8983 0 P08758 ANXA5_HUMAN "Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I, CPB-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4, PP4) (Placental anticoagulant protein I, PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha, VAC-alpha)" ANXA5 ANX5 ENX2 PP4 Homo sapiens (Human) blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] GO:0004859; GO:0005509; GO:0005543; GO:0005544; GO:0005576; GO:0005737; GO:0005829; GO:0005925; GO:0007165; GO:0007596; GO:0009897; GO:0010033; GO:0016020; GO:0043066; GO:0050819; GO:0062023; GO:0070062; GO:0072563 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543] GLGTDEESILTLLTSRSNAQR 0.96401 0.3003 0 0 0 0 0 0 0 0 0 0 0 12.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9351 12.9647 0 14.1207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2277 13.6885 0 0 0 0 0 0 13.842 0 0 0 0 0 0 0 0 0 12.9782 13.3596 0 0 13.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5935 0 13.0159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7R0 ZN442_HUMAN Zinc finger protein 442 ZNF442 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFFWPSLFRMHER 0.96402 -0.17728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.61147 0 0 0 0 0 0 0 0 0 0 10.2881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7794 0 0 0 13.4633 0 0 0 0 0 0 13.7312 0 0 13.514 0 0 14.1704 0 11.9058 0 0 15.794 15.5694 15.4314 0 0 13.6734 0 0 0 0 0 11.3567 0 11.118 14.4495 0 0 0 0 13.5479 0 0 14.4652 13.0702 0 0 0 14.3987 0 0 13.8822 0 0 0 13.3867 12.5325 0 14.2961 0 0 12.9093 12.2567 13.2909 12.5302 0 0 0 0 12.1719 0 0 0 12.1778 13.5256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8491 13.641 13.7242 0 0 0 0 0 0 P11217 PYGM_HUMAN "Glycogen phosphorylase, muscle form, EC 2.4.1.1 (Myophosphorylase)" PYGM Homo sapiens (Human) glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977] GO:0000166; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0008184; GO:0030170; GO:0070062; GO:0102250; GO:0102499 glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499] DFYELEPHK 0.96404 3.7252 0 0 0 0 0 0 0 0 0 0 0 13.1466 0 0 0 0 0 0 0 0 0 0 0 13.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2748 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1321 0 0 0 0 0 0 0 11.0494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0077 0 13.9463 0 0 0 0 0 0 0 0 0 0 0 Q969M3 YIPF5_HUMAN "Protein YIPF5 (Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5) (Smooth muscle cell-associated protein 5, SMAP-5) (YIP1 family member 5) (YPT-interacting protein 1 A)" YIPF5 FINGER5 YIP1A PP12723 SB140 UNQ3123/PRO10275 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; insulin processing [GO:0030070]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; vesicle fusion with Golgi apparatus [GO:0048280] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; insulin processing [GO:0030070]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; vesicle fusion with Golgi apparatus [GO:0048280] GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0006888; GO:0015031; GO:0016021; GO:0030070; GO:0030134; GO:0043231; GO:0048280; GO:0060628; GO:0070971 SGFENLNTDFYQTSYSIDDQSQQSYDYGGSGGPYSK 0.96405 -0.11425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6523 0 0 0 0 0 0 0 15.4961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7982 0 0 0 0 0 0 Q9NPF0 CD320_HUMAN "CD320 antigen (8D6 antigen) (FDC-signaling molecule 8D6, FDC-SM-8D6) (Transcobalamin receptor, TCblR) (CD antigen CD320)" CD320 8D6A UNQ198/PRO224 Homo sapiens (Human) B cell costimulation [GO:0031296]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; positive regulation of B cell proliferation [GO:0030890]; regulation of vitamin metabolic process [GO:0030656] endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; growth factor activity [GO:0008083]; B cell costimulation [GO:0031296]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; positive regulation of B cell proliferation [GO:0030890]; regulation of vitamin metabolic process [GO:0030656] GO:0005509; GO:0005783; GO:0005886; GO:0005887; GO:0008083; GO:0009235; GO:0010008; GO:0015889; GO:0016020; GO:0030656; GO:0030890; GO:0031296; GO:0031419; GO:0038024 calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; growth factor activity [GO:0008083] AQERLRPLGLLVAMK 0.96406 3.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0295 0 11.1219 0 0 0 0 0 0 0 0 0 0 0 11.455 0 0 0 0 0 13.519 11.7955 13.5791 14.3526 13.0846 14.2496 0 0 12.4198 0 0 0 0 0 0 0 14.6742 0 12.8689 0 0 0 12.2096 15.3627 0 0 12.8634 14.3108 0 12.4668 0 0 0 0 0 0 12.6531 11.8387 0 0 0 12.0525 12.6799 0 0 14.9165 14.3606 0 0 0 12.7489 0 14.5419 0 0 0 0 0 0 0 0 11.5833 13.0421 12.8775 0 0 0 13.9854 0 12.0513 0 13.9256 12.941 0 0 0 0 13.9333 0 13.9533 14.0858 0 0 0 0 0 0 0 0 0 10.7522 0 0 0 0 0 0 0 0 11.8006 13.8378 0 0 0 0 P23760 PAX3_HUMAN Paired box protein Pax-3 (HuP2) PAX3 HUP2 Homo sapiens (Human) "anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0006357; GO:0006915; GO:0007399; GO:0007517; GO:0007605; GO:0009887; GO:0043565; GO:0045893; GO:0045944; GO:0048856; GO:0071837; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" KIEEYKR 0.96408 -0.16417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EQ0 SGTB_HUMAN Small glutamine-rich tetratricopeptide repeat-containing protein beta (Beta-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 2) SGTB SGT2 Homo sapiens (Human) post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433] membrane [GO:0016020]; TRC complex [GO:0072380] membrane [GO:0016020]; TRC complex [GO:0072380]; molecular adaptor activity [GO:0060090]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0006620; GO:0016020; GO:0030433; GO:0060090; GO:0072380 molecular adaptor activity [GO:0060090] HLVYAVIRFLR 0.96408 -0.080333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2W6 RM46_HUMAN "39S ribosomal protein L46, mitochondrial, L46mt, MRP-L46 (Mitochondrial large ribosomal subunit protein mL46) (P2ECSL)" MRPL46 C15orf4 LIECG2 Homo sapiens (Human) mitochondrial translation [GO:0032543] cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0030054; GO:0032543 structural constituent of ribosome [GO:0003735] FLGNAPCGHYTFK 0.96409 -0.072573 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7863 0 0 0 0 0 0 0 0 0 10.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NT16 S18B1_HUMAN MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) SLC18B1 C6orf192 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] RSKSQNILSTEEER 0.9641 -0.18632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P64 AGAP4_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4, AGAP-4 (Centaurin-gamma-like family member 1) (Centaurin-gamma-like family member 5)" AGAP4 AGAP8 CTGLF1 CTGLF5 MRIP2 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630] GO:0003924; GO:0005096; GO:0046872; GO:0090630 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] AIPIKQGMLLK 0.9641 -0.073003 0 0 0 0 0 0 0 0 0 0 0 0 11.834 0 0 0 0 11.0926 0 0 0 0 0 0 0 10.9779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2519 0 0 10.6861 0 11.0893 0 13.4647 0 0 0 0 0 0 0 0 12.645 13.1051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0616 0 0 0 12.0755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3559 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7459 0 0 12.5878 0 12.0085 0 0 0 0 0 0 12.4311 0 0 0 0 11.3472 11.2189 0 0 0 0 0 0 0 0 12.9841 0 0 0 0 0 0 0 0 0 0 11.6613 0 0 0 0 0 0 0 0 Q9UM13 APC10_HUMAN "Anaphase-promoting complex subunit 10, APC10 (Cyclosome subunit 10)" ANAPC10 APC10 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0070979 TFMIQIAVLANHQNGR 0.9641 -0.16842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0841 0 0 0 0 0 0 0 0 0 0 13.263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKU7 ACAD8_HUMAN "Isobutyryl-CoA dehydrogenase, mitochondrial, IBDH, EC 1.3.8.- (Activator-recruited cofactor 42 kDa component, ARC42) (Acyl-CoA dehydrogenase family member 8, ACAD-8)" ACAD8 ARC42 IBD Homo sapiens (Human) lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574] GO:0003995; GO:0005759; GO:0006574; GO:0006629; GO:0050660 acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660] TGGPGPK 0.96411 0.30122 0 0 0 11.6753 0 0 0 10.6899 0 14.6569 0 10.7062 14.137 0 0 14.0705 12.6741 14.8898 13.6619 14.9705 13.5129 0 14.2853 0 14.1791 10.785 13.4921 14.3602 14.7415 14.5466 11.1618 11.1051 0 13.4852 0 0 0 0 0 0 12.7449 0 0 13.2047 0 13.6785 13.6844 10.921 10.9719 14.8189 11.1864 14.4209 15.0626 15.0982 14.2389 13.1426 12.1314 0 0 0 12.3191 0 12.3944 0 0 9.21383 0 13.4991 12.563 12.8372 12.1894 0 12.6686 10.8125 14.5223 0 0 14.8978 0 0 13.9427 13.4086 0 14.5185 13.4043 0 14.1178 14.5223 0 0 0 14.4876 0 0 0 13.3041 16.1417 12.8421 13.9562 14.2581 15.4318 15.1696 12.6755 0 0 0 0 0 13.9093 13.4656 13.2391 15.7376 13.7739 12.9959 12.7488 16.608 0 15.7978 15.2871 0 0 12.6784 0 0 0 15.3238 0 13.9046 12.8322 13.8411 0 0 11.9391 14.5373 14.4624 13.0396 13.8529 14.329 0 0 0 14.2544 0 0 13.6657 12.7687 0 12.0766 0 0 0 14.6935 0 14.4198 13.8523 14.3256 15.4154 14.0411 13.2404 14.3224 13.9264 13.0536 13.7658 13.7908 14.2908 12.9891 13.0086 12.5578 11.9492 12.2312 0 14.0322 0 11.7789 0 13.4329 0 0 0 0 Q8WUA4 TF3C2_HUMAN "General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit, TFIIIC 110 kDa subunit, TFIIIC110) (Transcription factor IIIC subunit beta)" GTF3C2 KIAA0011 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] GO:0000127; GO:0000995; GO:0005654; GO:0006383; GO:0042791; GO:0042797 RNA polymerase III general transcription initiation factor activity [GO:0000995] KGTVWSLSGSDWLGTIAAGDISGELIAAILPDMALNPINVKR 0.96411 0.091355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5165 0 0 19.1523 0 0 0 0 0 0 Q15121 PEA15_HUMAN "Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes, PED)" PEA15 Homo sapiens (Human) apoptotic process [GO:0006915]; carbohydrate transport [GO:0008643]; MAPK cascade [GO:0000165]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glucose import [GO:0046325]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; response to morphine [GO:0043278] cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; apoptotic process [GO:0006915]; carbohydrate transport [GO:0008643]; MAPK cascade [GO:0000165]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of glucose import [GO:0046325]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; response to morphine [GO:0043278] GO:0000165; GO:0005654; GO:0005829; GO:0005875; GO:0006915; GO:0008643; GO:0043278; GO:0046325; GO:1902042; GO:1902043 DNLSYIEHIFEISRRPDLLTMVVDYR 0.96414 -0.17209 0 0 0 0 0 0 0 0 0 13.2441 13.5068 0 0 13.435 0 0 0 0 0 0 0 0 0 0 0 12.4124 0 0 12.5648 0 13.1029 0 13.333 0 0 0 0 0 0 0 13.0563 13.2804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5816 15.1405 0 0 0 15.4726 0 0 0 15.4884 0 0 0 0 0 0 0 0 0 0 14.9574 0 0 Q9BPV8 P2Y13_HUMAN "P2Y purinoceptor 13, P2Y13 (G-protein coupled receptor 86) (G-protein coupled receptor 94)" P2RY13 GPR86 GPR94 FKSG77 Homo sapiens (Human) cellular response to organic cyclic compound [GO:0071407]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; cellular response to organic cyclic compound [GO:0071407]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194] GO:0005783; GO:0005886; GO:0007186; GO:0007194; GO:0016021; GO:0045028; GO:0071407 G protein-coupled purinergic nucleotide receptor activity [GO:0045028] VYDSYRK 0.96414 0.30122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7612 0 13.3035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09086 PO2F2_HUMAN "POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2, Oct-2) (Octamer-binding transcription factor 2, OTF-2)" POU2F2 OCT2 OTF2 Homo sapiens (Human) cellular response to virus [GO:0098586]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to virus [GO:0098586]; humoral immune response [GO:0006959]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006959; GO:0032755; GO:0043231; GO:0043565; GO:0045944; GO:0098586; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" FEALNLSFKNMCKLK 0.96415 0.32982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BQ3 TRI43_HUMAN Tripartite motif-containing protein 43 TRIM43 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] KLHPVLHK 0.96418 0.30043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH56 O52N5_HUMAN Olfactory receptor 52N5 (Olfactory receptor OR11-62) OR52N5 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAISLSSSDAR 0.96419 -0.11388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09529 INHBB_HUMAN Inhibin beta B chain (Activin beta-B chain) INHBB Homo sapiens (Human) activin receptor signaling pathway [GO:0032924]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; cellular response to starvation [GO:0009267]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cellular response to thyroid hormone stimulus [GO:0097067]; defense response [GO:0006952]; fat cell differentiation [GO:0045444]; multicellular organism aging [GO:0010259]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of hepatocyte growth factor production [GO:0032686]; negative regulation of insulin secretion [GO:0046676]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pituitary gland development [GO:0021983]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; response to gonadotropin [GO:0034698]; response to insecticide [GO:0017085]; response to wounding [GO:0009611]; seminiferous tubule development [GO:0072520]; SMAD protein signal transduction [GO:0060395]; spermatogenesis [GO:0007283] cell periphery [GO:0071944]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471] cell periphery [GO:0071944]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; host cell surface receptor binding [GO:0046789]; protein homodimerization activity [GO:0042803]; activin receptor signaling pathway [GO:0032924]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; cellular response to starvation [GO:0009267]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cellular response to thyroid hormone stimulus [GO:0097067]; defense response [GO:0006952]; fat cell differentiation [GO:0045444]; multicellular organism aging [GO:0010259]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of hepatocyte growth factor production [GO:0032686]; negative regulation of insulin secretion [GO:0046676]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pituitary gland development [GO:0021983]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; response to gonadotropin [GO:0034698]; response to insecticide [GO:0017085]; response to wounding [GO:0009611]; seminiferous tubule development [GO:0072520]; SMAD protein signal transduction [GO:0060395]; spermatogenesis [GO:0007283] GO:0001541; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0006952; GO:0007283; GO:0008083; GO:0009267; GO:0009611; GO:0010259; GO:0010862; GO:0017085; GO:0021983; GO:0030154; GO:0032686; GO:0032869; GO:0032924; GO:0034698; GO:0042803; GO:0044320; GO:0045444; GO:0046676; GO:0046789; GO:0046881; GO:0046882; GO:0048471; GO:0048599; GO:0060279; GO:0060395; GO:0071277; GO:0071320; GO:0071347; GO:0071397; GO:0071944; GO:0072520; GO:0097067; GO:0097190; GO:1904017; GO:2001235 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; host cell surface receptor binding [GO:0046789]; protein homodimerization activity [GO:0042803] GLECDGRTNLCCRQQFFIDFR 0.96422 -0.16404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09238 MMP10_HUMAN "Stromelysin-2, SL-2, EC 3.4.24.22 (Matrix metalloproteinase-10, MMP-10) (Transin-2)" MMP10 STMY2 Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012 metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] SNSWLHC 0.96423 -0.071433 0 0 0 0 0 0 0 0 0 12.9859 0 0 0 0 0 0 0 11.2711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8949 0 12.2975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4754 0 0 0 0 0 0 0 0 0 0 0 0 12.4934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36959 GMPR1_HUMAN "GMP reductase 1, GMPR 1, EC 1.7.1.7 (Guanosine 5'-monophosphate oxidoreductase 1, Guanosine monophosphate reductase 1)" GMPR GMPR1 Homo sapiens (Human) purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409] cytosol [GO:0005829]; GMP reductase complex [GO:1902560] cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; purine nucleobase metabolic process [GO:0006144]; purine nucleotide metabolic process [GO:0006163]; response to cold [GO:0009409] GO:0003920; GO:0005829; GO:0006144; GO:0006163; GO:0009409; GO:0046872; GO:1902560 GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872] AEVDLERTFTFR 0.96424 -0.071758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8182 12.7557 13.3845 0 0 0 0 13.9957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36897 TGFR1_HUMAN "TGF-beta receptor type-1, TGFR-1, EC 2.7.11.30 (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5, ALK-5, ALK5) (Serine/threonine-protein kinase receptor R4, SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I, TGF-beta receptor type I, TbetaR-I)" TGFBR1 ALK5 SKR4 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021] "activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein binding [GO:0043393]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" GO:0001501; GO:0001701; GO:0001822; GO:0001824; GO:0001837; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0004672; GO:0004674; GO:0005024; GO:0005025; GO:0005114; GO:0005524; GO:0005634; GO:0005768; GO:0005886; GO:0005923; GO:0006355; GO:0006468; GO:0006915; GO:0007165; GO:0007179; GO:0007399; GO:0007507; GO:0008284; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0010862; GO:0016020; GO:0016361; GO:0018105; GO:0018107; GO:0030199; GO:0030307; GO:0030335; GO:0031396; GO:0032331; GO:0032924; GO:0035556; GO:0042060; GO:0042118; GO:0043062; GO:0043235; GO:0043393; GO:0043410; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048179; GO:0048185; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0048870; GO:0050431; GO:0051491; GO:0051496; GO:0051726; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060389; GO:0060391; GO:0060412; GO:0060978; GO:0060982; GO:0070021; GO:0070411; GO:0070723; GO:0071363; GO:0071560; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237 "activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]" DLIYDMTTSGSGSGLPLLVQRTIAR 0.96427 -0.17073 0 0 0 0 0 0 0 0 10.6294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0B9 ZN362_HUMAN Zinc finger protein 362 ZNF362 PP6997 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AYCCSMCGRAYTSETYLMKHMSK 0.96427 0.091692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNP4 SIAT9_HUMAN "Lactosylceramide alpha-2,3-sialyltransferase, EC 2.4.99.9 (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase) (GM3 synthase) (Ganglioside GM3 synthase) (ST3Gal V, ST3GalV) (Sialyltransferase 9)" ST3GAL5 SIAT9 UNQ2510/PRO5998 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; lactosylceramide alpha-2,3-sialyltransferase activity [GO:0047291]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]; carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; protein glycosylation [GO:0006486]" GO:0000139; GO:0001574; GO:0003836; GO:0004513; GO:0005887; GO:0005975; GO:0006486; GO:0006688; GO:0008373; GO:0016021; GO:0047291 "beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; lactosylceramide alpha-2,3-sialyltransferase activity [GO:0047291]; neolactotetraosylceramide alpha-2,3-sialyltransferase activity [GO:0004513]; sialyltransferase activity [GO:0008373]" AMPSEYTYVK 0.96427 -0.075803 0 0 0 0 0 0 0 0 0 15.2963 0 16.1137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5438 0 13.7617 12.4846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13640 MT1G_HUMAN "Metallothionein-1G, MT-1G (Metallothionein-1K, MT-1K) (Metallothionein-IG, MT-IG)" MT1G MT1K MT1M Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; monocyte activation [GO:0042117]; monocyte differentiation [GO:0030224]; negative regulation of growth [GO:0045926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; monocyte activation [GO:0042117]; monocyte differentiation [GO:0030224]; negative regulation of growth [GO:0045926] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010273; GO:0030224; GO:0035924; GO:0042117; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCICKGASEK 0.96429 4.7627 0 11.4091 0 0 0 0 0 0 0 0 0 0 12.1023 0 0 0 0 0 0 0 12.3487 11.1717 0 0 0 0 11.5888 0 0 0 0 0 0 0 0 0 0 0 0 0 10.988 0 0 0 0 0 11.5499 0 0 0 12.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6681 10.8746 0 0 9.31043 0 0 0 0 0 0 0 13.6376 0 0 0 10.6768 0 0 14.206 0 0 0 11.9348 0 0 0 0 0 0 0 0 0 11.1546 0 0 0 0 0 0 13.081 0 9.88455 0 0 0 12.2164 0 12.709 0 12.3282 12.1721 12.2604 0 11.4542 0 0 0 0 0 0 11.7595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9479 12.3192 11.5122 0 0 0 0 0 0 0 12.1412 0 0 0 0 0 0 0 11.1748 0 0 0 P57059 SIK1_HUMAN "Serine/threonine-protein kinase SIK1, EC 2.7.11.1 (Salt-inducible kinase 1, SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1, Serine/threonine-protein kinase SNF1LK)" SIK1 SIK SNF1LK Homo sapiens (Human) anoikis [GO:0043276]; cardiac muscle cell differentiation [GO:0055007]; cell cycle [GO:0007049]; cellular response to glucose starvation [GO:0042149]; entrainment of circadian clock by photoperiod [GO:0043153]; intracellular signal transduction [GO:0035556]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of anoikis [GO:2000210]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of mitotic cell cycle [GO:0007346]; regulation of myotube differentiation [GO:0010830]; regulation of sodium ion transport [GO:0002028]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; anoikis [GO:0043276]; cardiac muscle cell differentiation [GO:0055007]; cell cycle [GO:0007049]; cellular response to glucose starvation [GO:0042149]; entrainment of circadian clock by photoperiod [GO:0043153]; intracellular signal transduction [GO:0035556]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of anoikis [GO:2000210]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of mitotic cell cycle [GO:0007346]; regulation of myotube differentiation [GO:0010830]; regulation of sodium ion transport [GO:0002028]; rhythmic process [GO:0048511] GO:0000287; GO:0002028; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007049; GO:0007346; GO:0008140; GO:0010830; GO:0010868; GO:0019901; GO:0032792; GO:0035556; GO:0042149; GO:0042826; GO:0043153; GO:0043276; GO:0045595; GO:0045721; GO:0046777; GO:0048511; GO:0055007; GO:0071889; GO:0106310; GO:2000210 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GFLGLNKIKGLAR 0.96429 -0.076473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VUD6 DIK1B_HUMAN Divergent protein kinase domain 1B (Protein FAM69B) DIPK1B C9orf136 FAM69B PP6977 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 CEHSTDCTYGR 0.96429 0.30135 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1984 12.7682 10.5981 0 0 0 0 0 0 0 0 12.7083 0 0 12.4466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5503 0 0 0 12.7456 0 0 13.2894 0 0 0 0 13.7339 13.9897 0 0 0 0 0 0 0 13.6518 0 0 0 13.1511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95433 AHSA1_HUMAN "Activator of 90 kDa heat shock protein ATPase homolog 1, AHA1 (p38)" AHSA1 C14orf3 HSPC322 Homo sapiens (Human) positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457] GO:0001671; GO:0005783; GO:0005829; GO:0006457; GO:0032781; GO:0045296; GO:0051087; GO:0051879; GO:0070062 ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879] PAPSKTQARPVGVK 0.96433 -0.11225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02689 MYP2_HUMAN Myelin P2 protein (Peripheral myelin protein 2) PMP2 Homo sapiens (Human) fatty acid transport [GO:0015908]; membrane organization [GO:0061024] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504]; fatty acid transport [GO:0015908]; membrane organization [GO:0061024] GO:0005504; GO:0005634; GO:0005829; GO:0015485; GO:0015908; GO:0043209; GO:0061024; GO:0070062 cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504] ALGVGLATRKLGNLAK 0.96434 -0.11369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H477 RBSK_HUMAN "Ribokinase, RK, EC 2.7.1.15" RBKS RBSK Homo sapiens (Human) D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098] GO:0004747; GO:0005524; GO:0005634; GO:0005829; GO:0006098; GO:0019303; GO:0042802; GO:0046872 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747] AAANVISRAK 0.96436 0.30044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5051 11.0329 0 0 0 0 0 0 13.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGY3 CE052_HUMAN Uncharacterized protein C5orf52 C5orf52 Homo sapiens (Human) ITQRIYEMEVSALEKTK 0.96437 -0.16363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9313 0 0 0 0 0 0 0 0 0 0 0 12.9113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3934 0 0 0 0 Q8IYN0 ZN100_HUMAN Zinc finger protein 100 ZNF100 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNESSNLTTHKMIHTGEKPYK 0.96437 -0.070208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2934 0 0 13.0869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4858 0 0 0 0 0 0 0 0 0 0 0 11.1224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQS6 HSPB9_HUMAN "Heat shock protein beta-9, HspB9 (Cancer/testis antigen 51, CT51)" HSPB9 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0043231 LGSLGSKASNLTR 0.96439 0.09625 0 0 14.8819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H239 MMP28_HUMAN "Matrix metalloproteinase-28, MMP-28, EC 3.4.24.- (Epilysin)" MMP28 MMP25 UNQ1893/PRO4339 Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of macrophage chemotaxis [GO:0010760]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of macrophage chemotaxis [GO:0010760]; proteolysis [GO:0006508] GO:0004222; GO:0005615; GO:0005737; GO:0006508; GO:0008270; GO:0010760; GO:0030198; GO:0030574; GO:0031012; GO:0062023 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] GEAHFDQDER 0.96439 -0.18588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7658 0 0 10.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5674 0 13.9963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4571 0 0 0 0 0 0 0 0 0 0 13.5436 12.9716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8475 0 0 0 Q9Y5G4 PCDG9_HUMAN "Protocadherin gamma-A9, PCDH-gamma-A9" PCDHGA9 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; RNA binding [GO:0003723]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0003723; GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509]; RNA binding [GO:0003723] EELCAQSPRCLVNFKVLVEDR 0.96442 0.30637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14449 GRB14_HUMAN Growth factor receptor-bound protein 14 (GRB14 adapter protein) GRB14 Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; signal transduction [GO:0007165] GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008286; GO:0010008; GO:0030674; GO:0030971; GO:0043231; GO:0046627 protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971] LIIQQGLVDGVFLVR 0.96444 0.30356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T6F2 UBAP2_HUMAN "Ubiquitin-associated protein 2, UBAP-2" UBAP2 KIAA1491 Homo sapiens (Human) regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of gene expression [GO:0010468] GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0010468; GO:0045296 cadherin binding [GO:0045296]; RNA binding [GO:0003723] GGYAGSSQAPNKSAGSGPGKGVSVSSSTTGLPDMTGSVYNK 0.96444 -0.19191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5663 0 0 0 0 15.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3334 0 0 0 0 0 0 0 0 0 0 0 13.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7156 0 0 0 12.9277 0 0 0 0 11.1191 0 0 0 0 0 0 0 0 0 14.7217 0 0 Q9NX14 NDUBB_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS, CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 17.3, Np17.3, p17.3)" NDUFB11 UNQ111/PRO1064 Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] GO:0005739; GO:0005743; GO:0005747; GO:0009060; GO:0032981; GO:0042776 RLLAAAATRGLPAAR 0.96444 0.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14CZ8 HECAM_HUMAN "Hepatocyte cell adhesion molecule, Protein hepaCAM" HEPACAM Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; protein localization [GO:0008104]; regulation of growth [GO:0040008] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; protein localization [GO:0008104]; regulation of growth [GO:0040008] GO:0005737; GO:0005911; GO:0007049; GO:0007155; GO:0008104; GO:0016021; GO:0030424; GO:0040008 MLLSPDQKVLTITR 0.96446 0.30137 15.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3073 0 0 0 0 0 14.595 0 0 0 0 0 0 0 0 0 0 14.3788 0 0 0 0 0 0 0 0 0 0 14.5388 14.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFT2 STEA2_HUMAN "Metalloreductase STEAP2, EC 1.16.1.- (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer, PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1)" STEAP2 PCANAP1 STAMP1 UNQ6507/PRO23203 Homo sapiens (Human) copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; iron ion import across plasma membrane [GO:0098711]; regulated exocytosis [GO:0045055]; response to hormone [GO:0009725] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140] cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; metal ion binding [GO:0046872]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; iron ion import across plasma membrane [GO:0098711]; regulated exocytosis [GO:0045055]; response to hormone [GO:0009725] GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006893; GO:0006897; GO:0008823; GO:0009725; GO:0010008; GO:0015677; GO:0030140; GO:0030173; GO:0045055; GO:0046872; GO:0052851; GO:0098705; GO:0098711 cupric reductase activity [GO:0008823]; ferric-chelate reductase (NADPH) activity [GO:0052851]; metal ion binding [GO:0046872] FYTPPNFVLALVLPSIVILGK 0.96446 -0.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0273 12.499 0 0 0 0 0 14.7849 11.1518 0 13.588 12.926 12.309 13.7516 11.9646 0 14.1467 14.1071 13.5761 0 0 0 0 0 13.9192 0 0 0 0 0 0 0 0 15.0872 0 0 14.1243 11.5413 0 0 0 0 0 0 0 0 12.5787 0 0 0 13.3168 0 0 0 0 0 0 0 12.8432 0 0 0 15.2448 0 0 0 0 11.7782 0 0 10.9513 11.1772 0 0 0 0 0 10.7161 0 0 0 0 0 14.0023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6847 0 0 0 0 13.1076 0 0 0 0 Q15466 NR0B2_HUMAN Nuclear receptor subfamily 0 group B member 2 (Orphan nuclear receptor SHP) (Small heterodimer partner) NR0B2 SHP Homo sapiens (Human) "animal organ regeneration [GO:0031100]; bile acid and bile salt transport [GO:0015721]; cholesterol metabolic process [GO:0008203]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to organic cyclic compound [GO:0014070]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; animal organ regeneration [GO:0031100]; bile acid and bile salt transport [GO:0015721]; cholesterol metabolic process [GO:0008203]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to organic cyclic compound [GO:0014070]" GO:0000122; GO:0000785; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007219; GO:0007623; GO:0008203; GO:0009749; GO:0010628; GO:0010629; GO:0014070; GO:0015721; GO:0019904; GO:0031100; GO:0032024; GO:0032922; GO:0032991; GO:0042803; GO:0042975; GO:0043231; GO:0043433; GO:0044877; GO:0045471; GO:0045892; GO:0045893; GO:0046965; GO:0046966; GO:0140416 nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] LTRVLLTASTLK 0.96447 -0.19544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7892 13.0938 13.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV37 ZN480_HUMAN Zinc finger protein 480 ZNF480 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSEYSGLSAHLVIHTGEK 0.96449 -0.079126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4764 0 0 0 0 0 0 0 0 0 16.4516 0 0 0 0 0 0 0 0 0 0 11.6132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75506 HSBP1_HUMAN "Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13, NPC-A-13)" HSBP1 HSF1BP Homo sapiens (Human) axonal transport of mitochondrion [GO:0019896]; cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; muscle contraction [GO:0006936]; negative regulation of transcription by RNA polymerase II [GO:0000122] axon cytoplasm [GO:1904115]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] axon cytoplasm [GO:1904115]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; axonal transport of mitochondrion [GO:0019896]; cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; muscle contraction [GO:0006936]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0006936; GO:0019896; GO:0035987; GO:0042802; GO:0070370; GO:1904115 identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714] IPATQKS 0.9645 0.30122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9928 0 0 13.9065 0 14.4838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0928 0 19.1363 0 0 0 19.0577 0 19.205 0 19.1898 0 0 19.1423 0 0 0 0 19.2908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1966 0 19.2045 19.2671 0 0 0 0 0 Q9NP62 GCM1_HUMAN "Chorion-specific transcription factor GCMa, hGCMa (GCM motif protein 1) (Glial cells missing homolog 1)" GCM1 GCMA Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; astrocyte fate commitment [GO:0060018]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation involved in embryonic placenta development [GO:0060706]; gliogenesis [GO:0042063]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; syncytium formation by plasma membrane fusion [GO:0000768]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; astrocyte fate commitment [GO:0060018]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation involved in embryonic placenta development [GO:0060706]; gliogenesis [GO:0042063]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; syncytium formation by plasma membrane fusion [GO:0000768]; transcription by RNA polymerase II [GO:0006366]" GO:0000768; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0006366; GO:0008270; GO:0009653; GO:0042063; GO:0042826; GO:0045893; GO:0045944; GO:0060018; GO:0060143; GO:0060670; GO:0060706; GO:0060800; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" EPDDFDSEDK 0.96451 -0.16362 0 0 0 0 0 0 0 0 0 0 10.7603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1792 0 0 0 0 0 0 0 0 0 0 11.6306 0 0 0 0 0 10.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.14 0 0 0 0 0 0 0 0 0 0 0 13.674 0 0 0 0 0 0 0 0 0 0 10.9294 0 0 14.0118 14.081 0 16.5636 0 0 0 0 0 0 0 0 9.85123 0 0 0 0 0 0 0 0 10.8207 10.8303 0 11.1754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0199 0 0 0 0 0 9.56775 0 0 0 0 9.41865 0 11.5689 0 0 0 0 0 0 0 0 0 12.3611 0 0 0 0 10.0577 0 0 0 0 0 0 0 0 0 0 12.3336 0 13.8698 0 0 Q10469 MGAT2_HUMAN "Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, EC 2.4.1.143 (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II, GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)" MGAT2 Homo sapiens (Human) oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]" GO:0000139; GO:0005794; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030145; GO:0042803 "alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]" AGTWAPR 0.96453 -0.18478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9476 0 0 0 0 0 0 0 10.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3884 0 0 0 0 0 16.7473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7091 0 0 0 0 0 12.102 0 0 0 16.1444 0 0 0 0 0 0 0 0 0 0 0 12.5162 0 0 0 11.6382 0 0 0 13.4255 0 0 0 0 0 0 0 0 0 0 0 10.9725 0 0 0 0 0 0 0 12.3296 0 0 0 0 0 0 0 0 0 0 14.2063 0 0 11.2685 0 0 0 0 0 0 0 Q14847 LASP1_HUMAN "LIM and SH3 domain protein 1, LASP-1 (Metastatic lymph node gene 50 protein, MLN 50)" LASP1 MLN50 Homo sapiens (Human) ion transport [GO:0006811] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; ion transmembrane transporter activity [GO:0015075]; metal ion binding [GO:0046872]; ion transport [GO:0006811] GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0045296; GO:0046872; GO:0051015 actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; ion transmembrane transporter activity [GO:0015075]; metal ion binding [GO:0046872] NPNCARCGK 0.96453 0.32696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02655 APOC2_HUMAN "Apolipoprotein C-II, Apo-CII, ApoC-II (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II, ProapoC-II ]" APOC2 APC2 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; high-density lipoprotein particle clearance [GO:0034384]; lipid catabolic process [GO:0016042]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; phospholipid efflux [GO:0033700]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipid catabolic process [GO:0060697]; positive regulation of triglyceride catabolic process [GO:0010898]; positive regulation of very-low-density lipoprotein particle remodeling [GO:0010902]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; triglyceride-rich lipoprotein particle remodeling [GO:0034370]; very-low-density lipoprotein particle remodeling [GO:0034372] chylomicron [GO:0042627]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate-density lipoprotein particle [GO:0034363]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361] chylomicron [GO:0042627]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate-density lipoprotein particle [GO:0034363]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; identical protein binding [GO:0042802]; lipase inhibitor activity [GO:0055102]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; high-density lipoprotein particle clearance [GO:0034384]; lipid catabolic process [GO:0016042]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; phospholipid efflux [GO:0033700]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipid catabolic process [GO:0060697]; positive regulation of triglyceride catabolic process [GO:0010898]; positive regulation of very-low-density lipoprotein particle remodeling [GO:0010902]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; triglyceride-rich lipoprotein particle remodeling [GO:0034370]; very-low-density lipoprotein particle remodeling [GO:0034372] GO:0005576; GO:0005615; GO:0005769; GO:0008289; GO:0010518; GO:0010898; GO:0010902; GO:0010916; GO:0016004; GO:0016042; GO:0032375; GO:0033344; GO:0033700; GO:0034361; GO:0034362; GO:0034363; GO:0034366; GO:0034370; GO:0034371; GO:0034372; GO:0034382; GO:0034384; GO:0042627; GO:0042632; GO:0042802; GO:0043274; GO:0043691; GO:0045723; GO:0045833; GO:0048261; GO:0051006; GO:0055102; GO:0060230; GO:0060697; GO:0070328 identical protein binding [GO:0042802]; lipase inhibitor activity [GO:0055102]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274] MGTRLLPALFLVLLVLGFEVQGTQQPQQDEMPSPTFLTQVK 0.96454 0.32677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.97 Q6YN16 HSDL2_HUMAN "Hydroxysteroid dehydrogenase-like protein 2, EC 1.-.-.- (Short chain dehydrogenase/reductase family 13C member 1)" HSDL2 C9orf99 SDR13C1 Homo sapiens (Human) membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491] GO:0005739; GO:0005777; GO:0016020; GO:0016491 oxidoreductase activity [GO:0016491] ACIPYLK 0.96455 0.096373 0 0 11.5738 0 0 0 0 0 0 0 0 0 0 12.5505 13.0973 0 0 12.2914 0 0 0 0 12.1574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2991 0 0 0 0 14.327 15.4097 0 12.3166 0 0 0 0 0 0 12.2355 0 0 12.6961 0 0 0 0 0 0 0 0 13.0791 0 0 0 0 0 0 0 0 13.4122 0 0 0 0 0 0 11.3183 0 12.442 0 0 0 0 13.0742 0 0 0 0 14.094 0 0 0 0 0 0 0 14.276 0 13.3343 0 13.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8383 0 0 P11473 VDR_HUMAN "Vitamin D3 receptor, VDR (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)" VDR NR1I1 Homo sapiens (Human) "apoptotic process involved in mammary gland involution [GO:0060057]; bile acid signaling pathway [GO:0038183]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; decidualization [GO:0046697]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; mammary gland branching involved in pregnancy [GO:0060745]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of calcidiol 1-monooxygenase activity [GO:0060558]; skeletal system development [GO:0001501]; vitamin D receptor signaling pathway [GO:0070561]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; lithocholic acid receptor activity [GO:0038186]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; apoptotic process involved in mammary gland involution [GO:0060057]; bile acid signaling pathway [GO:0038183]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular calcium ion homeostasis [GO:0006874]; decidualization [GO:0046697]; intestinal absorption [GO:0050892]; lactation [GO:0007595]; mammary gland branching involved in pregnancy [GO:0060745]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of calcidiol 1-monooxygenase activity [GO:0060558]; skeletal system development [GO:0001501]; vitamin D receptor signaling pathway [GO:0070561]" GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0001501; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006816; GO:0006874; GO:0007595; GO:0008270; GO:0008285; GO:0010628; GO:0010839; GO:0010980; GO:0030154; GO:0030501; GO:0038183; GO:0038186; GO:0042789; GO:0043235; GO:0045618; GO:0045892; GO:0045944; GO:0046697; GO:0046965; GO:0050892; GO:0060057; GO:0060058; GO:0060558; GO:0060745; GO:0070561; GO:0070564; GO:0090575; GO:1902098; GO:1902121 "calcitriol binding [GO:1902098]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; lithocholic acid receptor activity [GO:0038186]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AGHSLELIEPLIKFQVGLKK 0.9646 4.7501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1359 0 12.2595 0 0 0 12.9395 0 0 0 0 0 0 0 0 0 0 13.3449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2962 0 0 0 0 0 0 0 0 0 0 0 0 11.5687 11.9334 0 0 0 0 0 0 0 0 0 13.4449 0 0 0 0 0 15.9894 11.5612 0 0 0 0 0 0 12.1948 0 11.9043 0 15.7595 12.7866 11.1718 0 9.70622 0 0 0 0 0 9.99492 0 0 0 0 0 0 0 12.1351 0 0 0 0 0 12.6078 0 0 9.91305 0 0 0 0 0 0 0 0 0 0 9.69478 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7299 12.0154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6302 0 12.9549 0 0 0 0 0 10.9786 9.99421 0 0 0 0 Q6ICC9 RTL6_HUMAN Retrotransposon Gag-like protein 6 (Leucine zipper protein down-regulated in cancer cells-like) (Mammalian retrotransposon-derived protein 6) (Protein LDOC1L) RTL6 LDOC1L MAR6 MART6 Homo sapiens (Human) TYKSPLRHAR 0.9646 0.046251 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5302 0 0 0 0 0 0 12.1647 0 0 0 12.4607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5126 0 0 0 0 0 0 12.5617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43903 GAS2_HUMAN "Growth arrest-specific protein 2, GAS-2" GAS2 Homo sapiens (Human) actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020] actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] GO:0001544; GO:0001547; GO:0005829; GO:0005884; GO:0006915; GO:0007049; GO:0008017; GO:0008093; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051764; GO:0071711 actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017] ISEDPPCKCPNKFCVER 0.96463 -0.19703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7099 13.7747 13.7606 0 0 0 0 0 0 13.266 0 0 0 0 13.6957 0 14.042 0 0 0 0 0 14.8912 0 0 0 0 0 0 0 0 0 0 13.2583 0 0 11.2251 12.418 0 0 0 0 0 0 0 0 0 12.1819 0 0 12.5366 12.7722 12.5604 0 0 0 0 0 0 12.2665 0 0 0 0 0 0 0 0 13.9889 0 0 12.2586 0 0 0 0 0 0 0 0 0 0 0 11.9231 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZ03 NXNL2_HUMAN "Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2, RdCVF2)" NXNL2 C9orf121 Homo sapiens (Human) photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601] photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601] GO:0007601; GO:0007608; GO:0045494 LVIVKQNGEVITNK 0.96463 -0.11189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PU8 QKI_HUMAN "Protein quaking, Hqk, HqkI" QKI HKQ Homo sapiens (Human) "long-chain fatty acid biosynthetic process [GO:0042759]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; myelination [GO:0042552]; positive regulation of gene expression [GO:0010628]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]; spermatid development [GO:0007286]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculogenesis [GO:0001570]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; long-chain fatty acid biosynthetic process [GO:0042759]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; myelination [GO:0042552]; positive regulation of gene expression [GO:0010628]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]; spermatid development [GO:0007286]; vascular associated smooth muscle cell differentiation [GO:0035886]; vasculogenesis [GO:0001570]" GO:0001570; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006397; GO:0006417; GO:0007286; GO:0008380; GO:0010628; GO:0017124; GO:0035886; GO:0042552; GO:0042759; GO:0045202; GO:0048024; GO:0051028 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124] DANIKSPALAFSLAATAQAAPRIITGPAPVLPPAALR 0.96463 0.30137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8494 0 12.5929 0 0 0 0 0 0 0 0 0 12.6893 0 0 0 0 0 0 0 0 11.8397 0 0 0 0 0 0 0 0 0 0 0 0 12.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1603 0 0 0 0 12.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MUP2 CSKMT_HUMAN "Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial, CS-KMT, EC 2.1.1.- (Methyltransferase-like protein 12, mitochondrial)" CSKMT METTL12 Homo sapiens (Human) peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] GO:0005739; GO:0006479; GO:0016278; GO:0016279; GO:0018023; GO:0018026; GO:0018027 lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279] AALRRMLHLPSLMMGTCR 0.96464 -0.19852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8939 0 12.1896 0 0 0 0 0 0 0 0 0 0 0 15.6142 15.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84662 0 0 0 0 0 0 0 0 O15514 RPB4_HUMAN "DNA-directed RNA polymerase II subunit RPB4, RNA polymerase II subunit B4 (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit, RPB16)" POLR2D Homo sapiens (Human) "mRNA export from nucleus in response to heat stress [GO:0031990]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]" "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus in response to heat stress [GO:0031990]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000166; GO:0000288; GO:0000932; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0006367; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0045948 nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369] ETIASVRSLLLQK 0.96464 -0.078863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L0X2 ERIP6_HUMAN Glutamate-rich protein 6 (Protein FAM194A) ERICH6 C3orf44 FAM194A Homo sapiens (Human) DEEEETSPK 0.96465 -0.20041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8235 0 0 0 0 0 10.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8089 0 0 0 0 11.0521 0 10.7687 0 0 10.1964 14.9597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8301 0 0 0 0 0 0 14.2774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGE2 O2AP1_HUMAN Olfactory receptor 2AP1 (Olfactory receptor OR12-9) OR2AP1 OR2AP1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DMVKKLLNL 0.96465 -0.080024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4439 0 0 0 0 12.9446 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0715 0 0 0 0 0 0 0 0 0 0 0 12.8731 0 12.3052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5337 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0129 0 0 0 0 0 0 0 12.0428 0 13.171 0 0 0 0 0 0 0 10.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7501 0 0 0 0 0 0 0 0 0 0 0 Q8NGG3 OR5T3_HUMAN Olfactory receptor 5T3 (Olfactory receptor OR11-178) OR5T3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004984; GO:0004993; GO:0005887; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984] AVKKMLK 0.96465 -0.19926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6982 0 0 0 13.1636 0 0 0 0 0 0 0 0 0 15.7922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8184 0 0 15.3129 0 0 0 0 0 0 14.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58872 RHBL3_HUMAN "Rhomboid-related protein 3, EC 3.4.21.105 (Ventrhoid transmembrane protein)" RHBDL3 RHBDL4 VRHO Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005509; GO:0006508; GO:0016021 calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252] GLSLSQRLIR 0.96466 -0.16356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3128 0 0 0 0 0 0 0 0 0 0 13.775 14.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6055 0 0 13.5135 0 0 0 0 0 0 12.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2525 0 0 0 0 Q969J5 I22R2_HUMAN "Interleukin-22 receptor subunit alpha-2, IL-22 receptor subunit alpha-2, IL-22R-alpha-2, IL-22RA2 (Cytokine receptor class-II member 10) (Cytokine receptor family 2 member 10, CRF2-10) (Cytokine receptor family type 2, soluble 1, CRF2-S1) (Interleukin-22-binding protein, IL-22BP, IL22BP) (ZcytoR16)" IL22RA2 UNQ5793/PRO19598/PRO19822 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; negative regulation of inflammatory response [GO:0050728]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; cytokine receptor activity [GO:0004896]; interleukin-22 binding [GO:0042017]; interleukin-22 receptor activity [GO:0042018]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of inflammatory response [GO:0050728]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509] GO:0004896; GO:0005576; GO:0005615; GO:0005829; GO:0005887; GO:0019221; GO:0042017; GO:0042018; GO:0042509; GO:0050728 cytokine receptor activity [GO:0004896]; interleukin-22 binding [GO:0042017]; interleukin-22 receptor activity [GO:0042018] IDPPVMNITQVNGSLLVILHAPNLPYRYQKEK 0.96468 -0.18465 0 0 0 0 0 0 0 0 0 14.9373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1832 0 0 0 0 0 12.9916 0 0 0 0 0 0 0 0 13.4836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.787 10.8203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6571 0 0 0 0 0 0 0 0 0 13.8531 0 0 0 12.2903 0 0 0 0 0 0 0 0 0 0 0 12.0482 0 14.3879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4156 0 0 0 0 0 0 0 Q695T7 S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1) SLC6A19 B0AT1 Homo sapiens (Human) amino acid transport [GO:0006865]; response to nutrient [GO:0007584]; sodium ion transmembrane transport [GO:0035725]; viral life cycle [GO:0019058] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; response to nutrient [GO:0007584]; sodium ion transmembrane transport [GO:0035725]; viral life cycle [GO:0019058] GO:0005886; GO:0005887; GO:0006865; GO:0007584; GO:0015171; GO:0015175; GO:0015293; GO:0016324; GO:0019058; GO:0031526; GO:0035725; GO:0070062 amino acid transmembrane transporter activity [GO:0015171]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293] VRLVLPNPGLDAR 0.9647 -0.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTZ2 U17L1_HUMAN "Ubiquitin carboxyl-terminal hydrolase 17-like protein 1, EC 3.4.19.12 (Deubiquitinating enzyme 17-like protein 1) (Ubiquitin thioesterase 17-like protein 1) (Ubiquitin-specific-processing protease 17-like protein 1)" USP17L1 USP17L USP17L1P Homo sapiens (Human) apoptotic process [GO:0006915]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005783; GO:0005829; GO:0006511; GO:0006915; GO:0016579; GO:0042981 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] DTTLIHQIFGGCWR 0.9647 0.30078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13740 CD166_HUMAN CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166) ALCAM MEMD Homo sapiens (Human) adaptive immune response [GO:0002250]; axon extension involved in axon guidance [GO:0048846]; cell adhesion [GO:0007155]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; motor neuron axon guidance [GO:0008045]; neuron projection extension [GO:1990138]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; axon extension involved in axon guidance [GO:0048846]; cell adhesion [GO:0007155]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; motor neuron axon guidance [GO:0008045]; neuron projection extension [GO:1990138]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] GO:0001772; GO:0002250; GO:0005102; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007157; GO:0007165; GO:0008045; GO:0009897; GO:0030424; GO:0030425; GO:0031226; GO:0031290; GO:0042802; GO:0043025; GO:0048846; GO:0070062; GO:1990138 identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] EKVNDQAK 0.96471 -0.11729 13.7065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.339 0 11.3922 0 0 0 0 15.1931 14.6644 0 0 0 0 0 0 0 0 14.4413 0 0 0 0 0 0 11.7268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9996 0 0 0 0 0 0 0 0 11.5781 Q00978 IRF9_HUMAN "Interferon regulatory factor 9, IRF-9 (IFN-alpha-responsive transcription factor subunit) (ISGF3 p48 subunit) (Interferon-stimulated gene factor 3 gamma, ISGF-3 gamma) (Transcriptional regulator ISGF3 subunit gamma)" IRF9 ISGF3G Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0002376; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0007166; GO:0045944; GO:0051607; GO:0070721; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LLSQLERGILVASNPRGLFVQR 0.96473 -0.19043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5096 0 0 11.016 12.3223 0 0 0 0 0 0 0 0 0 0 0 11.3749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4546 13.3838 13.7648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06546 GABPA_HUMAN "GA-binding protein alpha chain, GABP subunit alpha (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60)" GABPA E4TF1A Homo sapiens (Human) blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001825; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0030154; GO:0045653; GO:0045944; GO:1903351; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ELCSLNQEDFFQR 0.96473 -0.19129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0236 14.9305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0223 0 0 13.3536 0 13.2415 13.6118 0 0 0 0 0 0 0 12.9842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9952 0 0 0 0 0 0 0 0 P11844 CRGA_HUMAN Gamma-crystallin A (Gamma-A-crystallin) (Gamma-crystallin 5) CRYGA CRYG1 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] GO:0002088; GO:0005212; GO:0007601 structural constituent of eye lens [GO:0005212] CYNCISDCPNLR 0.96474 0.093119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26196 DDX6_HUMAN "Probable ATP-dependent RNA helicase DDX6, EC 3.6.4.13 (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK)" DDX6 HLR2 RCK Homo sapiens (Human) miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; P-body assembly [GO:0033962]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; RISC complex [GO:0016442]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; P-body assembly [GO:0033962]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074] GO:0000932; GO:0003723; GO:0003724; GO:0003729; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0016442; GO:0016887; GO:0017148; GO:0019074; GO:0019827; GO:0019904; GO:0030182; GO:0033962; GO:0034063; GO:0035278; GO:0036464; GO:0045296; GO:0045665 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AKNGTGKSGAYLIPLLER 0.96476 0.30715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5053 13.1139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96B96 LDAF1_HUMAN Lipid droplet assembly factor 1 (Promethin) (Transmembrane protein 159) LDAF1 TMEM159 Homo sapiens (Human) lipid droplet formation [GO:0140042] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; lipid droplet formation [GO:0140042] GO:0005789; GO:0005811; GO:0016021; GO:0140042 LSLLIDSFQNNSK 0.96476 0.04717 0 14.2004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9418 0 0 0 0 0 0 Q9H2G9 GO45_HUMAN Golgin-45 (Basic leucine zipper nuclear factor 1) (JEM-1) (p45 basic leucine-zipper nuclear factor) BLZF1 JEM1 Homo sapiens (Human) Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001] GO:0000139; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005801; GO:0007030; GO:0019899; GO:0031625; GO:0043001 enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625] AVRILVPKAAITHDIPNK 0.96477 -0.11088 0 0 12.5886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P69849 NOMO3_HUMAN Nodal modulator 3 (pM5 protein 3) NOMO3 Homo sapiens (Human) negative regulation of nodal signaling pathway [GO:1900108] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; ribosome binding [GO:0043022]; negative regulation of nodal signaling pathway [GO:1900108] GO:0005789; GO:0016021; GO:0030246; GO:0043022; GO:1900108 carbohydrate binding [GO:0030246]; ribosome binding [GO:0043022] AYALAGVSFEIK 0.96478 0.30451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15070 OXA1L_HUMAN "Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein, OXA1-like protein)" OXA1L Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262] integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] integral component of mitochondrial inner membrane [GO:0031305]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262] GO:0005739; GO:0005759; GO:0009060; GO:0031305; GO:0031966; GO:0032592; GO:0032780; GO:0032977; GO:0032979; GO:0032981; GO:0032991; GO:0033615; GO:0042803; GO:0051205; GO:0051262; GO:0051354; GO:0097177 membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803] FSSRIREAK 0.96478 -0.11116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.482 10.8156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1266 0 0 0 0 0 0 0 0 14.3702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5868 0 0 0 0 0 0 0 0 0 13.3527 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5793 0 0 0 0 0 0 13.7316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3514 0 Q8WZA6 OR1E3_HUMAN "Olfactory receptor 1E3 (Olfactory receptor 17-210, OR17-210) (Olfactory receptor OR17-7)" OR1E3 OR1E3P Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ENFFVFKIVIVGILPLLNLVGVVK 0.96478 -0.19669 0 0 0 0 0 0 0 0 12.8872 0 0 0 0 0 0 0 11.9867 0 0 0 11.5825 10.0158 11.7005 0 10.9789 0 11.9077 0 0 0 0 12.2333 0 0 11.2739 11.0224 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9177 0 0 0 9.98954 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2523 12.4148 13.6912 0 0 0 0 0 0 0 12.8043 14.8852 13.9097 0 13.556 15.4343 0 16.0584 16.075 0 12.1479 14.9957 0 0 15.1335 13.1553 0 14.9232 0 11.1881 0 14.7869 0 10.9537 0 0 12.2885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8471 0 0 14.4312 0 0 14.7075 0 0 0 12.1781 0 0 0 0 10.6665 11.3319 0 0 0 0 0 0 0 0 12.1922 0 0 0 0 0 0 0 0 12.909 0 14.694 0 0 0 0 12.9571 0 0 11.931 0 0 11.594 0 0 0 0 0 0 0 12.867 0 0 0 0 0 0 Q92905 CSN5_HUMAN "COP9 signalosome complex subunit 5, SGN5, Signalosome subunit 5, EC 3.4.-.- (Jun activation domain-binding protein 1)" COPS5 CSN5 JAB1 Homo sapiens (Human) exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; regulation of protein neddylation [GO:2000434]; translation [GO:0006412] anchoring junction [GO:0070161]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; deNEDDylase activity [GO:0019784]; enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743]; exosomal secretion [GO:1990182]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of JNK cascade [GO:0046328]; regulation of protein neddylation [GO:2000434]; translation [GO:0006412] GO:0000338; GO:0003713; GO:0003743; GO:0004222; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006412; GO:0008021; GO:0008180; GO:0008237; GO:0016579; GO:0019784; GO:0019899; GO:0035718; GO:0043066; GO:0043687; GO:0045116; GO:0045944; GO:0046328; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0070122; GO:0070161; GO:0140492; GO:1903894; GO:1990182; GO:2000434 deNEDDylase activity [GO:0019784]; enzyme binding [GO:0019899]; isopeptidase activity [GO:0070122]; macrophage migration inhibitory factor binding [GO:0035718]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; transcription coactivator activity [GO:0003713]; translation initiation factor activity [GO:0003743] ATRDSCKTTIEAIHGLMSQVIK 0.96478 -0.12276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.655 0 0 0 15.5731 0 0 14.1524 13.9391 0 13.6206 0 0 14.5392 0 0 0 0 0 0 0 0 14.5699 0 0 0 0 0 0 0 0 0 14.6317 0 0 0 0 0 14.0164 0 14.3838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BT40 INP5K_HUMAN "Inositol polyphosphate 5-phosphatase K, EC 3.1.3.56 (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase, EC 3.1.3.86) (Phosphatidylinositol-4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (Skeletal muscle and kidney-enriched inositol phosphatase)" INPP5K PPS SKIP Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178]" GO:0001701; GO:0001726; GO:0001933; GO:0004439; GO:0004445; GO:0005000; GO:0005634; GO:0005737; GO:0005783; GO:0005802; GO:0005829; GO:0005886; GO:0005979; GO:0006469; GO:0006661; GO:0007186; GO:0010801; GO:0010829; GO:0016020; GO:0016311; GO:0016312; GO:0030036; GO:0032587; GO:0032869; GO:0032870; GO:0033137; GO:0034485; GO:0034594; GO:0034595; GO:0035305; GO:0035810; GO:0042577; GO:0042593; GO:0043005; GO:0043407; GO:0043922; GO:0045719; GO:0045869; GO:0045892; GO:0045893; GO:0046030; GO:0046627; GO:0046855; GO:0046856; GO:0048471; GO:0051497; GO:0051898; GO:0051926; GO:0052658; GO:0052659; GO:0071320; GO:0071356; GO:0071364; GO:0072659; GO:0090315; GO:0097178; GO:2000466; GO:2001153 "inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]" FDRNSNDYDTSEKK 0.96479 -0.19817 0 0 0 0 0 0 0 11.0158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2516 0 0 11.8392 11.6857 0 17.1976 17.9206 17.9785 17.4414 0 0 0 0 0 15.7217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4712 0 0 0 0 0 0 0 0 0 0 0 0 20.8693 0 20.8869 19.6997 0 0 13.1916 0 20.2763 0 0 0 0 0 0 0 0 18.035 0 0 0 0 19.5738 0 19.5932 19.018 0 0 0 0 0 0 0 0 11.2773 20.0697 0 0 0 0 0 0 0 0 20.4837 0 20.1678 0 0 0 0 19.912 0 0 0 0 0 0 18.4113 18.3274 0 0 0 11.66 0 0 19.6789 12.1652 0 0 0 0 18.4864 0 0 0 0 0 0 17.7195 17.4782 20.5646 20.496 0 0 0 0 0 0 0 Q9BV10 ALG12_HUMAN "Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, EC 2.4.1.260 (Asparagine-linked glycosylation protein 12 homolog, hALG12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog) (Membrane protein SB87)" ALG12 PP14673 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase [GO:0052917]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]" GO:0000009; GO:0000030; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0006487; GO:0006488; GO:0016020; GO:0016021; GO:0052917 "alpha-1,6-mannosyltransferase activity [GO:0000009]; dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichol alpha-1,6-mannosyltransferase [GO:0052917]; mannosyltransferase activity [GO:0000030]" FYSQLIVRGVLGLGVIFGLWTLQKEVR 0.9648 2.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0579 0 0 0 0 0 0 14.6172 12.7077 14.2484 0 0 12.7723 0 0 0 14.0663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3502 0 0 0 0 13.3312 0 14.6113 0 0 0 0 0 15.8865 0 14.498 0 0 0 0 0 0 14.765 11.9442 0 0 0 0 0 0 0 0 0 14.6311 0 12.1509 0 0 0 0 0 0 0 0 0 12.6723 14.3394 0 0 0 12.9276 0 11.4209 0 0 0 0 0 0 0 0 0 0 14.0723 14.7499 0 0 0 0 0 0 0 15.2363 11.9357 0 0 0 0 14.842 0 14.0403 0 0 0 0 0 0 0 0 0 11.9696 0 0 0 0 0 0 0 15.2061 12.5495 0 0 0 0 0 10.3562 0 0 0 13.7837 0 13.0933 Q9UJC5 SH3L2_HUMAN SH3 domain-binding glutamic acid-rich-like protein 2 (Fovea-associated SH3 domain-binding protein) SH3BGRL2 FASH3 Homo sapiens (Human) nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; SH3 domain binding [GO:0017124] GO:0005654; GO:0017124; GO:0031965 SH3 domain binding [GO:0017124] KKQQDVVR 0.9648 -0.14247 0 0 0 11.053 0 0 0 10.9538 14.4975 14.8642 14.9637 14.3351 14.8289 13.8066 14.2714 13.3803 13.778 14.7545 0 11.9713 0 0 12.7444 0 14.187 14.424 14.404 12.9541 14.6046 13.8169 14.1536 14.208 16.6942 13.9465 14.8603 16.6776 0 15.007 14.6557 14.0918 13.5627 16.4196 14.1553 13.2528 0 14.3206 13.5325 12.1901 13.6365 0 14.2661 0 0 0 12.1757 12.5352 12.3059 0 15.9661 14.12 13.9872 13.5483 14.0174 14.4957 15.6511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3837 0 0 0 0 0 0 12.3754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2638 0 17.6441 0 0 0 0 0 0 0 16.15 19.2429 15.4403 19.0082 14.2189 15.7559 15.094 16.3394 14.9393 16.3727 15.2214 15.6269 15.9889 16.5975 0 0 0 0 14.5245 0 15.6854 19.353 0 Q9BRK3 MXRA8_HUMAN Matrix remodeling-associated protein 8 (Limitrin) MXRA8 Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; establishment of glial blood-brain barrier [GO:0060857] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; establishment of glial blood-brain barrier [GO:0060857] GO:0005634; GO:0005788; GO:0005923; GO:0007155; GO:0009986; GO:0016021; GO:0030154; GO:0060170; GO:0060857; GO:0070062 AHFFQQLGYVLATLLLFILLLVTVLLAARR 0.96481 -0.069092 0 0 0 0 0 11.3426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8591 12.1657 0 0 0 0 0 0 0 0 Q9BZM3 GSX2_HUMAN GS homeobox 2 (Genetic-screened homeobox 2) (Homeobox protein GSH-2) GSX2 GSH2 Homo sapiens (Human) forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; GABAergic neuron differentiation [GO:0097154]; hindbrain morphogenesis [GO:0021575]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; olfactory bulb interneuron differentiation [GO:0021889]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of cell migration [GO:0030334]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; spinal cord association neuron differentiation [GO:0021527]; subpallium neuron fate commitment [GO:0060163]; telencephalon regionalization [GO:0021978] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; GABAergic neuron differentiation [GO:0097154]; hindbrain morphogenesis [GO:0021575]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; olfactory bulb interneuron differentiation [GO:0021889]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of cell migration [GO:0030334]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; spinal cord association neuron differentiation [GO:0021527]; subpallium neuron fate commitment [GO:0060163]; telencephalon regionalization [GO:0021978]" GO:0000785; GO:0000981; GO:0002087; GO:0005634; GO:0005737; GO:0007219; GO:0021527; GO:0021575; GO:0021798; GO:0021889; GO:0021978; GO:0030334; GO:0045747; GO:0048665; GO:0048714; GO:0048853; GO:0060163; GO:0097154; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" FHCLTMGGSDASQVPNGKRMR 0.96481 -0.1835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6116 0 0 0 0 0 0 0 14.84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4FU28 CTGE9_HUMAN "cTAGE family member 9, Protein cTAGE-9" CTAGE9 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971 GHDNWLAAR 0.96482 -0.20152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99985 SEM3C_HUMAN "Semaphorin-3C (Semaphorin-E, Sema E)" SEMA3C SEMAE Homo sapiens (Human) axon guidance [GO:0007411]; blood vessel remodeling [GO:0001974]; cardiac endothelial to mesenchymal transition [GO:0140074]; cardiac right ventricle morphogenesis [GO:0003215]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; immune response [GO:0006955]; limb bud formation [GO:0060174]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neural tube development [GO:0021915]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell migration [GO:0030335]; post-embryonic development [GO:0009791]; pulmonary myocardium development [GO:0003350]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; blood vessel remodeling [GO:0001974]; cardiac endothelial to mesenchymal transition [GO:0140074]; cardiac right ventricle morphogenesis [GO:0003215]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; immune response [GO:0006955]; limb bud formation [GO:0060174]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neural tube development [GO:0021915]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell migration [GO:0030335]; post-embryonic development [GO:0009791]; pulmonary myocardium development [GO:0003350]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756] GO:0001755; GO:0001756; GO:0001974; GO:0003148; GO:0003215; GO:0003350; GO:0005615; GO:0005887; GO:0006955; GO:0007411; GO:0009410; GO:0009791; GO:0021915; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0060174; GO:0060666; GO:0070062; GO:0071526; GO:0140074; GO:1905312 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] CHIYGTACADCCLARDPYCAWDGHSCSRFYPTGK 0.96482 -0.18373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8964 0 0 0 0 0 0 0 10.6493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6048 0 0 0 0 0 10.5331 0 0 9.7528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8533 12.9627 12.7939 0 12.4834 17.0539 0 0 0 0 0 0 0 11.7374 10.0411 0 0 0 12.8335 0 0 0 0 13.0358 0 0 0 0 0 11.5301 0 0 0 0 0 0 0 0 12.7005 0 0 11.4083 0 13.0358 0 0 0 0 0 0 12.4949 0 0 0 0 0 13.9307 0 0 0 0 0 0 0 12.1255 0 0 14.1644 0 0 0 0 0 0 0 0 0 11.366 10.9929 11.781 0 0 0 0 0 0 0 0 0 0 0 10.8042 0 0 0 0 11.4029 0 0 P12838 DEF4_HUMAN "Defensin alpha 4 (Corticostatin HP-4) (HNP-4, HP-4) (Neutrophil defensin 4)" DEFA4 DEF4 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; T cell chemotaxis [GO:0010818] azurophil granule [GO:0042582]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; specific granule lumen [GO:0035580]; transport vesicle [GO:0030133] azurophil granule [GO:0042582]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; specific granule lumen [GO:0035580]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; T cell chemotaxis [GO:0010818] GO:0002227; GO:0005576; GO:0005615; GO:0005796; GO:0010818; GO:0019730; GO:0019731; GO:0019732; GO:0030133; GO:0031640; GO:0035580; GO:0042582; GO:0042803; GO:0045087; GO:0050829; GO:0050830; GO:0050832; GO:0051673; GO:0061844; GO:0071222 protein homodimerization activity [GO:0042803] GMVCSCR 0.96483 -0.12383 0 0 0 0 0 0 0 0 0 13.6 0 0 0 13.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8352 10.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8476 0 0 0 0 0 0 0 0 0 0 0 0 15.072 0 0 0 0 0 12.6988 14.9273 0 13.7062 15.5749 0 0 10.523 14.1288 0 0 0 0 0 11.8111 0 0 0 0 11.0116 0 0 0 0 0 0 0 0 9.98114 0 0 0 0 0 0 14.7414 0 0 13.6088 0 0 0 0 0 0 0 0 0 0 0 14.2483 0 0 0 0 0 0 0 0 0 0 0 13.9981 0 10.5366 0 0 0 13.2093 0 0 0 0 0 11.1503 0 14.8893 0 0 12.2088 17.9471 0 15.0694 0 0 0 0 0 0 0 0 0 0 0 0 10.2209 0 0 0 0 15.467 0 10.6609 13.2566 12.5173 0 0 12.7454 Q6ZRY4 RBPS2_HUMAN "RNA-binding protein with multiple splicing 2 (RNA binding protein, mRNA processing factor 2)" RBPMS2 Homo sapiens (Human) embryonic digestive tract morphogenesis [GO:0048557]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell proliferation [GO:0048661] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; embryonic digestive tract morphogenesis [GO:0048557]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of smooth muscle cell proliferation [GO:0048661] GO:0003729; GO:0005737; GO:0030514; GO:0042802; GO:0042803; GO:0048557; GO:0048661; GO:0051151 identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803] ELYLLFRPFK 0.96484 -0.12482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.755 0 0 0 0 0 0 0 0 0 0 0 Q9Y600 CSAD_HUMAN "Cysteine sulfinic acid decarboxylase, EC 4.1.1.29 (Aspartate 1-decarboxylase, EC 4.1.1.11) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)" CSAD CSD Homo sapiens (Human) L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412] GO:0004068; GO:0004782; GO:0005737; GO:0016831; GO:0019449; GO:0019452; GO:0030170; GO:0042412 aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782] LSKVAPVLKER 0.96485 -0.12598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9545 0 0 0 0 0 0 0 0 0 0 13.217 0 0 14.1998 0 14.1977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8619 0 0 0 0 0 0 0 0 0 0 0 13.4466 0 13.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4375 0 0 0 0 0 0 13.9082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00231 PSD11_HUMAN 26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5) PSMD11 Homo sapiens (Human) proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000502; GO:0005198; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0034774; GO:0043161; GO:0043248; GO:0048863; GO:1904813 structural molecule activity [GO:0005198] ADVERKLSQMILDK 0.96486 -0.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7347 0 10.9235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9215 Q5XG85 U633C_HUMAN Putative UPF0633 protein LOC554249 Homo sapiens (Human) ISEVPRR 0.96486 0.30122 0 0 0 0 0 0 0 0 12.6825 0 0 13.618 13.1344 0 0 0 12.2371 0 0 0 0 0 0 0 0 0 0 0 12.7557 12.9907 0 15.0231 0 0 0 11.8784 0 12.6376 12.4147 0 0 15.1267 0 0 0 0 0 15.7117 0 0 0 0 13.1008 12.3785 15.7154 12.9321 0 14.3297 14.4813 0 15.3972 15.2965 15.3149 14.001 14.6152 14.5902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.726 16.0842 17.188 0 16.0411 0 16.6966 16.3577 13.3085 0 0 0 0 0 13.7744 0 0 0 0 P62760 VISL1_HUMAN "Visinin-like protein 1, VILIP, VLP-1 (Hippocalcin-like protein 3, HLP3)" VSNL1 VISL1 Homo sapiens (Human) negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; negative regulation of insulin secretion [GO:0046676]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] GO:0005509; GO:0005829; GO:0016020; GO:0035774; GO:0045921; GO:0046676 calcium ion binding [GO:0005509] LAPEVMEDLVK 0.96487 0.30115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5541 12.473 0 11.8768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6406 0 12.6919 0 12.4036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14914 PTGR1_HUMAN "Prostaglandin reductase 1, PRG-1 (15-oxoprostaglandin 13-reductase, EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein, D3T-inducible gene 1 protein, DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase, EC 1.3.1.74)" PTGR1 LTB4DH Homo sapiens (Human) leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257]; leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693]; response to antineoplastic agent [GO:0097327] GO:0005737; GO:0006691; GO:0006693; GO:0035798; GO:0036102; GO:0036132; GO:0036185; GO:0047522; GO:0070062; GO:0097257; GO:0097327; GO:2001302 13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADP+) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257] GDNLGKTIVK 0.96487 -0.10295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBM6 TAF9B_HUMAN "Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7, DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L)" TAF9B TAF9L Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein stabilization [GO:0050821]" nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; protein stabilization [GO:0050821]" GO:0000122; GO:0003714; GO:0005654; GO:0005669; GO:0006352; GO:0016251; GO:0030307; GO:0033276; GO:0043066; GO:0046982; GO:0050821; GO:1902166 protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription corepressor activity [GO:0003714] HEDDDDNDIM 0.96487 -0.38269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4323 0 0 0 0 0 0 0 12.5591 0 12.663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8089 0 0 0 0 0 15.5517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2243 0 0 0 0 11.9641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W0N0 CI057_HUMAN Uncharacterized protein C9orf57 C9orf57 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LLGVILFGR 0.96488 -0.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8748 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50053 KHK_HUMAN "Ketohexokinase, EC 2.7.1.3 (Hepatic fructokinase)" KHK Homo sapiens (Human) fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043] GO:0004454; GO:0005524; GO:0005737; GO:0005829; GO:0006000; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0032868; GO:0070062; GO:0070873 ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454] FGCQVAGKK 0.96489 -0.38599 0 0 0 0 11.8001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0645 0 0 0 0 0 0 0 0 0 0 0 0 Q14699 RFTN1_HUMAN Raftlin (Cell migration-inducing gene 2 protein) (Raft-linking protein) RFTN1 KIAA0084 MIG2 Homo sapiens (Human) B cell receptor signaling pathway [GO:0050853]; dsRNA transport [GO:0033227]; membrane raft assembly [GO:0001765]; positive regulation of growth rate [GO:0040010]; positive regulation of interleukin-17 production [GO:0032740]; protein localization to membrane raft [GO:1903044]; protein transport into membrane raft [GO:0032596]; response to exogenous dsRNA [GO:0043330]; T cell antigen processing and presentation [GO:0002457]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; double-stranded RNA binding [GO:0003725]; B cell receptor signaling pathway [GO:0050853]; dsRNA transport [GO:0033227]; membrane raft assembly [GO:0001765]; positive regulation of growth rate [GO:0040010]; positive regulation of interleukin-17 production [GO:0032740]; protein localization to membrane raft [GO:1903044]; protein transport into membrane raft [GO:0032596]; response to exogenous dsRNA [GO:0043330]; T cell antigen processing and presentation [GO:0002457]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138] GO:0001765; GO:0002457; GO:0003725; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0032596; GO:0032740; GO:0032991; GO:0033227; GO:0034138; GO:0040010; GO:0043330; GO:0045121; GO:0050852; GO:0050853; GO:0070062; GO:1903044 double-stranded RNA binding [GO:0003725] AGDMGNCVSGQQQEGGVSEEMK 0.96489 -0.10827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15173 PGRC2_HUMAN Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6) PGRMC2 DG6 PMBP Homo sapiens (Human) adipose tissue development [GO:0060612] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; nuclear steroid receptor activity [GO:0003707]; steroid binding [GO:0005496]; adipose tissue development [GO:0060612] GO:0003707; GO:0005496; GO:0005635; GO:0005783; GO:0012505; GO:0015232; GO:0016020; GO:0016021; GO:0020037; GO:0060612 heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; nuclear steroid receptor activity [GO:0003707]; steroid binding [GO:0005496] EKYDYVGRLLK 0.9649 -0.12166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3504 0 12.4842 12.4742 0 10.9506 0 13.4147 0 0 0 0 0 0 0 0 0 0 0 12.8477 0 0 0 0 0 0 0 0 13.6194 0 0 0 14.8534 14.9246 14.6238 14.3971 0 0 0 14.497 0 0 0 0 0 0 0 0 14.8813 0 0 0 0 0 0 0 0 0 14.2335 0 0 13.9732 0 0 0 0 0 14.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6667 0 12.7006 0 0 0 0 0 0 Q6ZNB5 XNDC1_HUMAN Protein XNDC1N (XRCC1 N-terminal domain-containing 1 N-terminal like) XNDC1N Homo sapiens (Human) single strand break repair [GO:0000012] chromosome [GO:0005694]; nucleolus [GO:0005730] chromosome [GO:0005694]; nucleolus [GO:0005730]; damaged DNA binding [GO:0003684]; single strand break repair [GO:0000012] GO:0000012; GO:0003684; GO:0005694; GO:0005730 damaged DNA binding [GO:0003684] PWLGCPQDKSGQLK 0.9649 -0.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTN6 STRAA_HUMAN "STE20-related kinase adapter protein alpha, STRAD alpha (STE20-related adapter protein) (Serologically defined breast cancer antigen NY-BR-96)" STRADA LYK5 STRAD Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; G1 to G0 transition [GO:0070314]; protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular protein-containing complex [GO:0140535]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular protein-containing complex [GO:0140535]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539]; activation of protein kinase activity [GO:0032147]; G1 to G0 transition [GO:0070314]; protein export from nucleus [GO:0006611] GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0019900; GO:0030295; GO:0032147; GO:0043539; GO:0070314; GO:0140535; GO:1902554 ATP binding [GO:0005524]; kinase binding [GO:0019900]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539] SFLVSKPERIR 0.9649 0.09376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61626 LYSC_HUMAN "Lysozyme C, EC 3.2.1.17 (1,4-beta-N-acetylmuramidase C)" LYZ LZM Homo sapiens (Human) antimicrobial humoral response [GO:0019730]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; metabolic process [GO:0008152]; retina homeostasis [GO:0001895] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; identical protein binding [GO:0042802]; lysozyme activity [GO:0003796]; antimicrobial humoral response [GO:0019730]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; metabolic process [GO:0008152]; retina homeostasis [GO:0001895] GO:0001895; GO:0003796; GO:0005576; GO:0005615; GO:0006954; GO:0008152; GO:0019730; GO:0019835; GO:0031640; GO:0035578; GO:0035580; GO:0042742; GO:0042802; GO:0050829; GO:0050830; GO:0070062; GO:1904724 identical protein binding [GO:0042802]; lysozyme activity [GO:0003796] ALIVLGLVLLSVTVQGK 0.96491 4.4095 0 0 0 0 0 10.799 0 0 0 0 0 0 0 0 0 11.4031 0 0 0 0 0 11.4339 0 0 0 0 11.7251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2651 0 0 0 0 0 10.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.47283 0 0 0 0 0 0 0 12.0216 0 0 0 0 0 0 11.7057 0 15.9169 0 0 0 0 12.8929 0 0 0 0 13.1349 0 0 14.6357 12.5575 0 0 0 13.3295 0 0 0 0 0 0 0 12.7802 0 0 0 14 0 12.2609 11.9224 0 0 0 0 13.9108 13.7502 0 13.7985 0 0 11.9202 12.0967 11.346 0 0 0 0 0 0 0 0 0 0 12.9684 0 12.4212 0 13.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9613 0 0 0 0 0 0 0 0 0 11.8135 0 12.494 0 0 0 12.1098 0 0 12.5797 Q13126 MTAP_HUMAN "S-methyl-5'-thioadenosine phosphorylase, EC 2.4.2.28 (5'-methylthioadenosine phosphorylase, MTA phosphorylase, MTAP, MTAPase)" MTAP MSAP Homo sapiens (Human) L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; purine ribonucleoside salvage [GO:0006166]; response to testosterone [GO:0033574]" GO:0004645; GO:0005654; GO:0005829; GO:0006139; GO:0006166; GO:0017061; GO:0019509; GO:0032259; GO:0033574; GO:0070062 "1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]" ENANKAKSLLLTTIPQIGSTEWSETLHNLK 0.96491 -0.13432 0 0 0 0 0 0 15.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1K1 HRG1_HUMAN "Heme transporter HRG1 (Heme-responsive gene 1 protein homolog, HRG-1, hHRG-1) (Solute carrier family 48 member 1)" SLC48A1 HRG1 Homo sapiens (Human) heme transport [GO:0015886] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; heme transport [GO:0015886] GO:0005765; GO:0005886; GO:0010008; GO:0015232; GO:0015886; GO:0016021; GO:0020037 heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232] APSRLQLGLR 0.96491 -0.11011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.299 0 0 0 0 0 0 0 0 0 0 0 0 11.9689 0 0 0 0 0 0 0 10.809 0 10.5545 0 0 0 0 0 0 0 0 0 0 0 0 11.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0895 0 0 0 0 10.7207 0 0 0 0 0 0 0 0 10.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX53 MET7B_HUMAN "Thiol S-methyltransferase METTL7B (Methyltransferase-like protein 7B, EC 2.1.1.9)" METTL7B UNQ594/PRO1180 Homo sapiens (Human) methylation [GO:0032259] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; thiol S-methyltransferase activity [GO:0018708]; methylation [GO:0032259] GO:0005789; GO:0005811; GO:0008168; GO:0008757; GO:0018708; GO:0032259 methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; thiol S-methyltransferase activity [GO:0018708] KVLQEVR 0.96492 -0.1225 11.7422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4633 14.1787 14.4115 0 0 0 0 0 13.7425 13.8622 14.0587 13.9495 0 0 0 0 0 13.5248 0 0 14.1075 14.3337 14.4234 0 14.0484 0 0 0 0 0 0 0 14.4086 13.4686 0 0 0 12.5486 0 0 0 0 0 14.4518 0 0 0 0 14.0409 0 0 0 0 15.0414 13.5867 13.7131 12.865 13.5184 12.0216 0 0 13.7466 14.6565 19.0962 12.0747 0 13.6364 14.295 0 0 0 14.2528 13.3556 0 0 0 14.2083 14.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32238 CCKAR_HUMAN "Cholecystokinin receptor type A, CCK-A receptor, CCK-AR (Cholecystokinin-1 receptor, CCK1-R)" CCKAR CCKRA Homo sapiens (Human) axonogenesis [GO:0007409]; cholecystokinin signaling pathway [GO:0038188]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; axonogenesis [GO:0007409]; cholecystokinin signaling pathway [GO:0038188]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of hormone secretion [GO:0046883] GO:0001764; GO:0004930; GO:0004951; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007409; GO:0016020; GO:0017046; GO:0030900; GO:0038188; GO:0046883 cholecystokinin receptor activity [GO:0004951]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046] EWQPAVQILLYSLIFLLSVLGNTLVITVLIRNK 0.96493 0.30715 0 0 0 0 0 0 0 0 0 12.8928 12.1795 0 12.0063 0 0 0 0 0 0 0 0 0 0 0 12.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2976 0 0 0 0 0 0 14.3325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15562 TEAD2_HUMAN "Transcriptional enhancer factor TEF-4 (TEA domain family member 2, TEAD-2)" TEAD2 TEF4 Homo sapiens (Human) "cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; negative regulation of cell death [GO:0060548]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]" chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; negative regulation of cell death [GO:0060548]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]" GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001570; GO:0001843; GO:0003143; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006355; GO:0006357; GO:0006366; GO:0030903; GO:0035329; GO:0043231; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0048568; GO:0060548; GO:0065003; GO:0071300; GO:0097718; GO:0140552; GO:1990837; GO:2000736 "disordered domain specific binding [GO:0097718]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]" AQLEDGRFVYR 0.96493 0.30777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L8W6 DPH6_HUMAN "Diphthine--ammonia ligase, EC 6.3.1.14 (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog)" DPH6 ATPBD4 Homo sapiens (Human) peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0017178; GO:0017183 ATP binding [GO:0005524]; diphthine-ammonia ligase activity [GO:0017178] CEGDEVEDLYELLKLVK 0.96494 0.3208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7R1 P1L12_HUMAN POM121-like protein 12 POM121L12 Homo sapiens (Human) protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] nuclear pore [GO:0005643] nuclear pore [GO:0005643]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] GO:0005643; GO:0006405; GO:0006606; GO:0008139; GO:0017056 nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] PTQDPAK 0.96494 -0.064755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3445 0 0 15.1503 0 0 0 0 0 0 14.4598 14.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61576 REC04_HUMAN Endogenous retrovirus group K member 104 Rec protein (HERV-K104 Rec protein) (HERV-K_5q13.3 provirus Rec protein) HERV-K104 Homo sapiens (Human) mRNA transport [GO:0051028] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; mRNA transport [GO:0051028] GO:0003723; GO:0005730; GO:0005737; GO:0051028 RNA binding [GO:0003723] AEPLTWAQLKKLTQLATK 0.96495 -0.18121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6178 0 0 15.6908 0 0 0 0 0 0 0 0 0 12.9236 0 0 0 0 0 0 0 0 0 13.9813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LB3 IFT74_HUMAN "Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein, CMG-1) (Coiled-coil domain-containing protein 2)" IFT74 CCDC2 CMG1 Homo sapiens (Human) cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003334; GO:0003682; GO:0005634; GO:0005813; GO:0005929; GO:0007219; GO:0007368; GO:0007507; GO:0010839; GO:0030992; GO:0031410; GO:0031514; GO:0033630; GO:0035720; GO:0035735; GO:0043616; GO:0045944; GO:0048487; GO:0060271; GO:0097542; GO:1905515 beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682] IKKLHQER 0.96495 -0.18199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5485 0 0 0 0 0 0 0 0 0 0 0 13.3654 0 0 0 0 0 0 0 0 11.4955 0 0 0 0 13.2222 13.5104 0 0 0 0 13.038 0 0 0 0 0 0 0 0 13.556 0 0 12.4647 13.1365 0 0 0 0 0 0 0 12.9649 0 13.5723 13.4122 13.6589 0 0 0 0 0 11.866 12.4965 0 12.8578 0 0 0 14.5044 14.3602 14.6851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94916 NFAT5_HUMAN "Nuclear factor of activated T-cells 5, NF-AT5 (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein, TonE-binding protein, TonEBP)" NFAT5 KIAA0827 TONEBP Homo sapiens (Human) calcineurin-NFAT signaling cascade [GO:0033173]; cellular hyperosmotic response [GO:0071474]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular hyperosmotic response [GO:0071474]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0006366; GO:0007165; GO:0010628; GO:0033173; GO:0045944; GO:0070884; GO:0071345; GO:0071474; GO:1901224; GO:1904996; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EISSPARPCSFEEAMKAMK 0.96496 -0.09309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7341 0 0 0 11.8974 0 0 0 0 13.2844 12.6417 12.9442 0 12.7337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89651 0 0 0 0 15.3395 0 0 0 0 0 15.672 0 0 0 0 0 0 15.3212 17.3353 13.0249 11.7631 13.3271 0 0 0 0 0 13.9334 0 0 0 13.7495 18.5073 14.5096 0 0 15.2645 0 0 12.4355 13.4685 0 0 12.4121 0 0 0 0 0 0 13.0447 15.0647 0 0 0 15.1407 0 15.0853 0 0 0 0 0 0 19.0939 0 0 12.2254 13.4979 0 0 0 0 0 0 0 0 15.0439 0 0 0 12.7833 13.3685 15.4238 0 0 0 0 0 0 0 0 0 0 0 0 15.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9644 0 0 0 0 0 15.6343 0 P35408 PE2R4_HUMAN "Prostaglandin E2 receptor EP4 subtype, PGE receptor EP4 subtype, PGE2 receptor EP4 subtype (Prostanoid EP4 receptor)" PTGER4 PTGER2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cellular response to mechanical stimulus [GO:0071260]; cellular response to prostaglandin E stimulus [GO:0071380]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; negative regulation of cytokine production [GO:0001818]; negative regulation of eosinophil extravasation [GO:2000420]; negative regulation of inflammatory response [GO:0050728]; negative regulation of integrin activation [GO:0033624]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of inflammatory response [GO:0050729]; regulation of ossification [GO:0030278]; regulation of stress fiber assembly [GO:0051492]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nematode [GO:0009624]; T-helper cell differentiation [GO:0042093] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; prostaglandin E receptor activity [GO:0004957]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; cellular response to mechanical stimulus [GO:0071260]; cellular response to prostaglandin E stimulus [GO:0071380]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; negative regulation of cytokine production [GO:0001818]; negative regulation of eosinophil extravasation [GO:2000420]; negative regulation of inflammatory response [GO:0050728]; negative regulation of integrin activation [GO:0033624]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of inflammatory response [GO:0050729]; regulation of ossification [GO:0030278]; regulation of stress fiber assembly [GO:0051492]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nematode [GO:0009624]; T-helper cell differentiation [GO:0042093] GO:0001818; GO:0001819; GO:0004957; GO:0005886; GO:0006954; GO:0006955; GO:0007188; GO:0007189; GO:0007204; GO:0007254; GO:0009612; GO:0009624; GO:0016021; GO:0030278; GO:0032496; GO:0033624; GO:0042093; GO:0050728; GO:0050729; GO:0051492; GO:0060348; GO:0070371; GO:0071260; GO:0071380; GO:2000420 prostaglandin E receptor activity [GO:0004957] IASVNPILDPWIYILLRK 0.96496 0.31968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4039 12.0967 13.3906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9465 13.2698 0 13.1106 12.2292 0 0 0 15.3864 16.0375 15.3669 0 0 0 0 0 0 0 15.9621 0 11.8884 0 14.7826 15.6851 0 0 0 0 0 0 0 0 0 0 14.2186 0 0 14.7761 0 0 0 0 14.1423 0 0 0 0 0 0 0 0 10.4346 0 15.06 0 0 0 0 10.6373 0 0 0 0 0 0 0 0 13.1408 0 0 12.788 0 0 0 0 11.6318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0363 0 12.518 0 0 0 0 12.3234 0 0 10.9671 0 Q14154 DELE1_HUMAN "DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form, DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form, DELE1(S), S-DELE1 ]" DELE1 DELE KIAA0141 Homo sapiens (Human) extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281] GO:0005739; GO:0005743; GO:0005829; GO:0008625; GO:0019901; GO:0043281; GO:0043539; GO:0140467; GO:0140468 protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] NFSHNSLRGAR 0.96496 -0.068502 0 0 0 0 0 0 0 0 12.3809 0 0 0 0 12.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6241 0 0 0 0 0 0 0 0 0 0 0 0 12.5295 0 0 0 12.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TID7 CC181_HUMAN Coiled-coil domain-containing protein 181 CCDC181 C1orf114 Homo sapiens (Human) cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017] GO:0002177; GO:0005737; GO:0005874; GO:0008017; GO:0036126 microtubule binding [GO:0008017] AFKQWLR 0.96496 -0.092578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.435 0 0 0 0 0 0 0 0 0 0 0 0 11.3074 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6084 15.4624 0 0 0 15.7744 0 14.1265 14.034 0 0 10.8721 13.5155 0 0 0 0 0 0 0 0 13.1195 0 0 11.4118 0 0 0 0 0 11.8105 0 0 0 0 0 0 0 0 0 0 0 14.9091 0 0 0 0 0 0 0 0 11.0345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN57 ZFP2_HUMAN "Zinc finger protein ZFP2, Zfp-2 (Zinc finger protein 751)" ZFP2 ZNF751 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSKNSSLTQHRR 0.96497 -0.14465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1755 0 0 0 0 0 0 13.1964 0 0 0 0 0 0 0 0 0 0 12.1374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1582 0 12.4743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NNZ3 DNJC4_HUMAN DnaJ homolog subfamily C member 4 (DnaJ-like protein HSPF2) (Multiple endocrine neoplasia type 1 candidate protein number 18) DNAJC4 HSPF2 MCG18 Homo sapiens (Human) protein folding [GO:0006457]; response to unfolded protein [GO:0006986] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986] GO:0006457; GO:0006986; GO:0016020; GO:0016021; GO:0051082 unfolded protein binding [GO:0051082] LLGAAAGQR 0.965 -0.38146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4921 0 0 0 0 0 0 0 0 0 12.665 0 0 0 0 0 14.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3165 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0893 0 10.7416 0 0 0 0 0 0 0 10.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4269 0 0 0 0 0 0 Q8IWD4 CC117_HUMAN Coiled-coil domain-containing protein 117 CCDC117 Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739] GO:0005634; GO:0005737; GO:0008284; GO:0045739; GO:0072686 EEEEDDDCPVR 0.96501 -0.10222 0 0 0 0 0 0 0 0 0 0 10.7814 0 0 0 10.6353 0 0 0 0 0 0 0 0 11.4409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4195 0 0 11.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4132 12.5441 0 0 13.1561 0 0 13.5336 14.219 15.5333 14.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8018 0 0 0 0 0 0 0 0 0 12.7725 0 0 11.8029 12.3772 0 0 0 0 13.5483 0 0 0 0 0 0 0 0 12.6139 0 11.8757 0 0 0 15.3001 10.4077 0 0 0 9.15692 0 10.6131 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IU2 ZBED3_HUMAN Zinc finger BED domain-containing protein 3 (Axin-interacting protein) ZBED3 Homo sapiens (Human) actin filament organization [GO:0007015]; endoplasmic reticulum localization [GO:0051643]; establishment of spindle localization [GO:0051293]; mitochondrion localization [GO:0051646]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; actin filament organization [GO:0007015]; endoplasmic reticulum localization [GO:0051643]; establishment of spindle localization [GO:0051293]; mitochondrion localization [GO:0051646]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000976; GO:0000981; GO:0001933; GO:0005615; GO:0005737; GO:0005829; GO:0006357; GO:0007015; GO:0009749; GO:0016020; GO:0016055; GO:0032868; GO:0040019; GO:0045944; GO:0046872; GO:0050821; GO:0051293; GO:0051643; GO:0051646; GO:0090263 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]" DDPEGDR 0.96501 -0.38245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2889 0 0 0 0 0 0 0 11.9224 0 0 0 0 0 0 0 0 0 10.9312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3705 14.044 0 0 0 0 0 0 0 0 0 0 12.4305 0 0 0 0 0 0 10.9506 0 0 0 0 0 0 13.3112 13.578 14.0624 0 0 12.6759 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0039 13.0852 0 0 0 0 0 0 0 0 0 0 13.8033 0 0 0 13.4019 0 0 13.9809 13.2693 0 0 0 0 13.7424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3806 0 0 0 0 0 0 0 13.5196 0 0 14.0068 0 0 0 0 0 0 0 0 11.3375 0 0 10.4568 P19388 RPAB1_HUMAN "DNA-directed RNA polymerases I, II, and III subunit RPABC1, RNA polymerases I, II, and III subunit ABC1 (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4)" POLR2E Homo sapiens (Human) protein stabilization [GO:0050821]; transcription by RNA polymerase II [GO:0006366] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein stabilization [GO:0050821]; transcription by RNA polymerase II [GO:0006366]" GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006366; GO:0050821; GO:1990062 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899] DDEEETYRLWK 0.96502 0.3141 0 0 0 10.079 0 0 0 0 0 0 11.4299 0 0 0 0 0 0 0 0 0 0 0 11.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8612 0 11.1925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.625 11.2577 0 0 0 0 12.7412 0 0 0 0 0 0 0 15.5119 0 0 0 0 0 0 0 0 0 12.4072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28676 GRAN_HUMAN Grancalcin GCA GCL Homo sapiens (Human) membrane fusion [GO:0061025] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; membrane fusion [GO:0061025] GO:0005509; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0035578; GO:0042803; GO:0046982; GO:0061025; GO:0070062 calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] ELWAALNAWK 0.96502 -0.38433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46937 YAP1_HUMAN "Transcriptional coactivator YAP1, Yes-associated protein 1 (Protein yorkie homolog) (Yes-associated protein YAP65 homolog)" YAP1 YAP65 Homo sapiens (Human) "bud elongation involved in lung branching [GO:0060449]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue regeneration [GO:0061026]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to retinoic acid [GO:0071300]; contact inhibition [GO:0060242]; embryonic heart tube morphogenesis [GO:0003143]; enterocyte differentiation [GO:1903703]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway [GO:0097191]; glandular epithelial cell differentiation [GO:0002067]; heart process [GO:0003015]; hippo signaling [GO:0035329]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; keratinocyte differentiation [GO:0030216]; lateral mesoderm development [GO:0048368]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cilium assembly [GO:1902018]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord development [GO:0030903]; organ growth [GO:0035265]; paraxial mesoderm development [GO:0048339]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein-containing complex assembly [GO:0065003]; regulation of keratinocyte proliferation [GO:0010837]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; response to progesterone [GO:0032570]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; wound healing [GO:0042060]" cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germ cell nucleus [GO:0001674]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552] "cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germ cell nucleus [GO:0001674]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; bud elongation involved in lung branching [GO:0060449]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue regeneration [GO:0061026]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to retinoic acid [GO:0071300]; contact inhibition [GO:0060242]; embryonic heart tube morphogenesis [GO:0003143]; enterocyte differentiation [GO:1903703]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway [GO:0097191]; glandular epithelial cell differentiation [GO:0002067]; heart process [GO:0003015]; hippo signaling [GO:0035329]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; keratinocyte differentiation [GO:0030216]; lateral mesoderm development [GO:0048368]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cilium assembly [GO:1902018]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord development [GO:0030903]; organ growth [GO:0035265]; paraxial mesoderm development [GO:0048339]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; protein-containing complex assembly [GO:0065003]; regulation of keratinocyte proliferation [GO:0010837]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; response to progesterone [GO:0032570]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; wound healing [GO:0042060]" GO:0000122; GO:0000902; GO:0000976; GO:0000978; GO:0001570; GO:0001674; GO:0001829; GO:0001894; GO:0002067; GO:0003015; GO:0003143; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0008022; GO:0008283; GO:0010628; GO:0010629; GO:0010837; GO:0016020; GO:0030054; GO:0030216; GO:0030307; GO:0030857; GO:0030903; GO:0032570; GO:0033148; GO:0035019; GO:0035265; GO:0035329; GO:0042060; GO:0045599; GO:0045669; GO:0045747; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0050673; GO:0050679; GO:0050767; GO:0050847; GO:0060045; GO:0060070; GO:0060242; GO:0060449; GO:0060487; GO:0060576; GO:0061026; GO:0065003; GO:0070064; GO:0070102; GO:0071300; GO:0071480; GO:0072089; GO:0072091; GO:0072307; GO:0090263; GO:0097191; GO:0140297; GO:0140552; GO:1900182; GO:1902018; GO:1902459; GO:1903703; GO:1904036; GO:2000648; GO:2000737; GO:2001237 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] GDSETDLEALFNAVMNPK 0.96502 -0.12848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5K131 CLLU1_HUMAN Chronic lymphocytic leukemia up-regulated protein 1 CLLU1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 FQLLRVCW 0.96502 -0.38567 0 0 0 9.97169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0332 0 0 0 0 0 0 0 0 0 0 0 12.2198 0 12.5263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9804 0 0 0 0 0 0 0 0 0 0 13.2404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7589 0 13.694 14.5491 13.2623 0 0 0 0 0 0 0 13.7182 0 0 0 14.0479 0 0 0 0 0 0 0 14.0528 0 0 0 0 12.524 0 0 0 0 0 0 0 0 0 14.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1832 0 0 0 0 0 0 0 0 0 0 0 11.1087 0 0 0 0 0 0 0 12.9241 0 0 0 0 0 Q6ZVW7 I17EL_HUMAN "Putative interleukin-17 receptor E-like, IL-17 receptor E-like, IL-17RE-like" IL17REL Homo sapiens (Human) interleukin-17 receptor activity [GO:0030368] GO:0030368 interleukin-17 receptor activity [GO:0030368] FSTSWGSWVR 0.96502 0.31553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8586 0 0 0 11.6307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75493 CAH11_HUMAN "Carbonic anhydrase-related protein 11 (CA-RP XI, CA-XI, CARP XI) (Carbonic anhydrase-related protein 2, CA-RP II, CARP-2)" CA11 CARP2 UNQ211/PRO237 Homo sapiens (Human) one-carbon metabolic process [GO:0006730] basolateral plasma membrane [GO:0016323]; extracellular region [GO:0005576] basolateral plasma membrane [GO:0016323]; extracellular region [GO:0005576]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730] GO:0005576; GO:0006730; GO:0008270; GO:0016323; GO:0016836 hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] PLQPLAHRALR 0.96503 -0.10593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8456 0 14.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9147 0 0 0 0 11.1212 0 0 13.1589 12.6968 0 0 0 0 14.093 14.0793 0 0 0 0 0 0 0 12.667 0 0 0 12.449 12.3095 13.1571 12.3148 0 0 0 0 0 13.6929 11.9416 14.9312 14.4061 12.7537 13.332 12.5157 0 0 0 0 0 0 0 0 0 0 0 13.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03519 TAP2_HUMAN "Antigen peptide transporter 2, APT2, EC 7.4.2.- (ATP-binding cassette sub-family B member 3) (Peptide supply factor 2) (Peptide transporter PSF2, PSF-2) (Peptide transporter TAP2) (Peptide transporter involved in antigen processing 2) (Really interesting new gene 11 protein, RING11)" TAP2 ABCB3 PSF2 RING11 Y1 Homo sapiens (Human) "antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein transport [GO:0015031]; response to molecule of bacterial origin [GO:0002237]; T cell mediated cytotoxicity [GO:0001913]; transmembrane transport [GO:0055085]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]; ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; tapasin binding [GO:0046980]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; peptide transport [GO:0015833]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein transport [GO:0015031]; response to molecule of bacterial origin [GO:0002237]; T cell mediated cytotoxicity [GO:0001913]; transmembrane transport [GO:0055085]" GO:0001913; GO:0001916; GO:0002237; GO:0002481; GO:0002485; GO:0002489; GO:0005524; GO:0005783; GO:0005789; GO:0015031; GO:0015433; GO:0015440; GO:0015833; GO:0016020; GO:0016021; GO:0016607; GO:0019885; GO:0023029; GO:0030176; GO:0030670; GO:0033116; GO:0042605; GO:0042626; GO:0042824; GO:0042825; GO:0046872; GO:0046967; GO:0046968; GO:0046978; GO:0046980; GO:0055085 ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; metal ion binding [GO:0046872]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; tapasin binding [GO:0046980] AGQVVREAVGGLQTVR 0.96503 2.9541 0 0 0 0 0 0 0 0 0 14.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0432 0 14.4662 0 14.0946 0 11.9008 11.542 14.8543 13.8673 0 0 14.2828 0 0 0 0 0 13.9001 0 0 0 0 0 14.0113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9863 0 0 0 0 11.0794 0 13.4176 11.8214 0 0 0 0 0 0 0 14.776 13.8638 12.4965 13.8887 0 12.5164 11.6523 0 13.8062 12.599 13.7507 0 0 0 0 0 0 11.5385 12.8926 11.6551 0 0 0 14.1017 12.4063 12.8753 0 0 0 17.7547 0 13.6508 0 0 0 0 0 0 0 0 0 12.3651 0 0 0 0 18.548 11.7766 0 0 14.8395 0 0 16.0414 0 0 11.8836 0 0 0 0 0 0 0 0 0 0 12.3924 0 0 0 0 0 0 0 0 0 0 11.0357 0 0 0 0 0 0 0 13.0592 0 0 18.9358 14.7744 13.2499 0 0 0 0 14.6488 0 Q7Z3J3 RGPD4_HUMAN RanBP2-like and GRIP domain-containing protein 4 RGPD4 RGP4 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006607; GO:0050790 AAKLFPGSPAIYKLK 0.96504 -0.12083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5Y3 GPR45_HUMAN Probable G-protein coupled receptor 45 (PSP24-1) (PSP24-alpha) GPR45 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930] AYVVTLVVAVFFAPFGVMLCAYMCILNTVRK 0.96504 -0.12124 0 0 0 0 0 0 0 0 0 10.2854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9647 0 0 0 11.9739 0 0 10.8412 0 0 0 0 0 0 11.9452 14.295 0 12.8677 0 13.4858 11.0028 0 0 0 0 0 0 0 0 0 10.6652 0 0 0 0 0 0 0 0 0 11.7622 10.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0491 0 0 0 0 0 0 0 12.6991 0 0 0 0 13.0829 11.5253 0 0 0 0 0 0 0 0 0 0 0 0 12.2779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6872 0 0 0 0 0 0 0 0 0 0 0 Q9BWX5 GATA5_HUMAN Transcription factor GATA-5 (GATA-binding factor 5) GATA5 Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; cardiac muscle tissue development [GO:0048738]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion fusion [GO:0003274]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac endothelial to mesenchymal transition [GO:0062000]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; aortic valve morphogenesis [GO:0003180]; cardiac muscle tissue development [GO:0048738]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion fusion [GO:0003274]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac endothelial to mesenchymal transition [GO:0062000]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003180; GO:0003274; GO:0003700; GO:0005634; GO:0005654; GO:0008270; GO:0010614; GO:0010628; GO:0010629; GO:0035481; GO:0045165; GO:0045944; GO:0048738; GO:0060575; GO:0062000; GO:0071773; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" DGTGHYLCNACGLYHKMNGVNR 0.96506 0.094183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8153 0 0 0 0 14.3716 14.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16619 CL3L1_HUMAN C-C motif chemokine 3-like 1 (G0/G1 switch regulatory protein 19-2) (LD78-beta(1-70)) (PAT 464.2) (Small-inducible cytokine A3-like 1) (Tonsillar lymphocyte LD78 beta protein) [Cleaved into: LD78-beta(3-70); LD78-beta(5-70) ] CCL3L1 D17S1718 G0S19-2 SCYA3L1; CCL3L3 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] GO:0002548; GO:0005576; GO:0005615; GO:0006954; GO:0007186; GO:0008009; GO:0008285; GO:0030593; GO:0043547; GO:0048020; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009] GRQVCADPSEEWVQK 0.96507 -0.063595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXN8 CLC9A_HUMAN C-type lectin domain family 9 member A (CD antigen CD370) CLEC9A UNQ9341/PRO34046 Homo sapiens (Human) positive regulation of cytokine production [GO:0001819]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; positive regulation of cytokine production [GO:0001819]; receptor-mediated endocytosis [GO:0006898] GO:0001819; GO:0006898; GO:0009986; GO:0016021; GO:0030246 carbohydrate binding [GO:0030246] ALLNFTEWK 0.96507 0.31029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPJ1 MKKS_HUMAN Molecular chaperone MKKS (Bardet-Biedl syndrome 6 protein) (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) MKKS BBS6 Homo sapiens (Human) artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; determination of left/right symmetry [GO:0007368]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; pigment granule aggregation in cell center [GO:0051877]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; determination of left/right symmetry [GO:0007368]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; pigment granule aggregation in cell center [GO:0051877]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601] GO:0001947; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007368; GO:0007507; GO:0007601; GO:0007608; GO:0008406; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0032402; GO:0032502; GO:0034260; GO:0035176; GO:0038108; GO:0040018; GO:0042311; GO:0045444; GO:0045494; GO:0045776; GO:0046907; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0051877; GO:0060027; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902636; GO:1905515 ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082] AFLLTIPENAEGHIILGKSLIVPLK 0.96507 0.31053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2134 0 0 11.7535 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0783 0 0 13.329 0 0 0 0 0 13.3228 0 0 0 0 0 12.3277 0 12.9601 12.2834 0 0 0 0 12.1617 0 10.4339 0 13.0279 0 0 0 0 0 0 0 0 0 0 0 0 11.1669 0 0 12.7948 12.4033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0847 0 0 0 0 0 0 0 0 0 0 0 Q8IYX0 ZN679_HUMAN Zinc finger protein 679 ZNF679 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFTWSSTLTKHR 0.96508 0.30959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75449 KTNA1_HUMAN "Katanin p60 ATPase-containing subunit A1, Katanin p60 subunit A1, EC 5.6.1.1 (p60 katanin)" KATNA1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013] centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013] GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007049; GO:0008017; GO:0008352; GO:0008568; GO:0015630; GO:0016853; GO:0016887; GO:0030496; GO:0031122; GO:0046982; GO:0051013; GO:0051301; GO:0097431 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; protein heterodimerization activity [GO:0046982] DIISQNPNVRWDDIADLVEAKK 0.96509 -0.14117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8462 14.5863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0181 0 0 0 0 0 0 0 0 0 0 0 11.1574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 D6REC4 CFA99_HUMAN Cilia- and flagella-associated protein 99 CFAP99 Homo sapiens (Human) motile cilium [GO:0031514] motile cilium [GO:0031514] GO:0031514 AAERSRQAALLHVSAPR 0.9651 0.045113 0 0 0 12.0017 0 0 0 0 0 0 0 0 10.7291 0 0 0 0 0 0 12.0916 0 11.833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7348 0 0 0 0 0 0 0 10.3798 12.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9905 0 0 0 13.2615 15.9491 13.4439 0 14.7861 0 0 0 0 0 0 0 0 0 10.6124 0 0 0 0 0 13.2602 0 0 0 0 0 0 0 0 0 0 0 15.3639 0 0 0 0 E9PGG2 ANHX_HUMAN Anomalous homeobox protein ANHX Homo sapiens (Human) eye development [GO:0001654]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; eye development [GO:0001654]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001654; GO:0005634; GO:0005667; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ENLALETSLTPEQVYNWFANYR 0.96511 0.04363 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3978 0 0 0 15.3688 0 0 0 0 14.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13114 TRAF3_HUMAN "TNF receptor-associated factor 3, EC 2.3.2.27 (CD40 receptor-associated factor 1, CRAF1) (CD40-binding protein, CD40BP) (LMP1-associated protein 1, LAP1) (RING-type E3 ubiquitin transferase TRAF3)" TRAF3 CAP-1 CRAF1 TRAFAMN Homo sapiens (Human) apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; mitochondrion [GO:0005739]; serine/threonine protein kinase complex [GO:1902554]; ubiquitin ligase complex [GO:0000151] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; mitochondrion [GO:0005739]; serine/threonine protein kinase complex [GO:1902554]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337] GO:0000151; GO:0001817; GO:0002224; GO:0004842; GO:0005164; GO:0005739; GO:0005768; GO:0005829; GO:0006915; GO:0007165; GO:0008063; GO:0008270; GO:0009898; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0035666; GO:0042802; GO:0042981; GO:0043122; GO:0046330; GO:0050688; GO:0051607; GO:0060337; GO:0070534; GO:1902554 identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CTACQESIVK 0.96511 -0.067516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.421 0 0 0 0 0 0 13.5048 12.512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6333 0 0 0 0 0 0 0 0 0 0 0 0 0 13.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4781 0 0 0 0 0 0 0 0 0 0 13.0293 0 0 0 0 12.1314 0 0 0 0 0 12.0109 0 0 0 0 Q9NPF7 IL23A_HUMAN "Interleukin-23 subunit alpha, IL-23 subunit alpha, IL-23-A (Interleukin-23 subunit p19, IL-23p19)" IL23A SGRF UNQ2498/PRO5798 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; T cell proliferation [GO:0042098]; tissue remodeling [GO:0048771] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; interleukin-23 complex [GO:0070743]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; interleukin-23 complex [GO:0070743]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; interleukin-23 receptor binding [GO:0045519]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; T cell proliferation [GO:0042098]; tissue remodeling [GO:0048771] GO:0001916; GO:0002230; GO:0002827; GO:0005125; GO:0005576; GO:0005788; GO:0005886; GO:0006954; GO:0006955; GO:0010536; GO:0032693; GO:0032725; GO:0032729; GO:0032733; GO:0032735; GO:0032740; GO:0032760; GO:0032816; GO:0032819; GO:0034105; GO:0042098; GO:0042102; GO:0042104; GO:0042509; GO:0042531; GO:0043382; GO:0045087; GO:0045519; GO:0045672; GO:0045944; GO:0046427; GO:0048771; GO:0050729; GO:0050829; GO:0051135; GO:0051142; GO:0051607; GO:0070743; GO:0072536; GO:0090023; GO:1901224; GO:2000318; GO:2000330 cytokine activity [GO:0005125]; interleukin-23 receptor binding [GO:0045519] AVMLLLLLPWTAQGR 0.96511 -0.14337 0 0 12.8485 0 13.4173 0 13.0728 0 16.1462 15.3496 0 0 0 15.5517 0 16.1548 11.1278 14.6572 11.7193 15.5303 11.5897 0 11.8686 0 14.6572 11.3578 0 0 0 13.9663 16.3162 14.9737 13.7317 0 14.6385 0 15.1543 11.5787 14.7739 0 14.4743 11.563 0 14.5712 10.2038 11.6604 0 0 0 0 0 0 12.0055 11.5258 0 11.9376 0 0 10.9402 10.6466 0 0 0 10.2884 0 0 0 0 14.0675 0 0 0 0 0 0 0 0 0 0 12.0362 11.9243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7481 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7062 11.6476 0 13.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.783 0 10.6238 10.3837 0 0 0 12.2048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9926 0 0 0 0 0 0 0 11.9966 12.682 0 0 0 0 0 0 0 0 0 0 9.91204 0 0 0 0 0 0 0 A0AVF1 IFT56_HUMAN "Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26, TPR repeat protein 26)" TTC26 IFT56 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224] GO:0005813; GO:0005929; GO:0007224; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0043005; GO:0060271; GO:0061512; GO:0097542; GO:0097546; GO:0120170; GO:1905198 intraciliary transport particle B binding [GO:0120170] ETLREVLHLLRSTGNTQVEYMIR 0.96512 0.32089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6417 0 0 13.6115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5087 14.8844 14.3093 14.1301 18.1491 13.9517 0 0 14.2298 14.1201 0 0 0 0 0 0 14.5285 0 0 0 14.0818 14.3595 0 0 14.1934 13.6856 13.6136 0 12.4304 14.2515 14.4814 14.4122 14.3455 0 0 13.0749 0 0 15.1044 15.3383 14.6469 15.652 0 14.9689 0 0 13.1798 0 14.982 14.4234 0 15.4279 0 13.5695 14.7007 0 0 0 15.1681 14.5751 0 15.7927 19.0043 14.8016 0 14.1552 14.9859 0 18.9422 0 14.969 0 0 14.4076 15.0206 14.315 14.3918 0 14.3613 15.3979 14.4539 0 0 0 0 0 0 0 14.9474 15.061 12.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3717 14.6909 0 14.9123 0 0 0 0 0 Q9Y3Q7 ADA18_HUMAN "Disintegrin and metalloproteinase domain-containing protein 18, ADAM 18 (Transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein III, tMDC III)" ADAM18 TMDC3 UNQ858/PRO1867 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] GO:0004222; GO:0006508; GO:0007155; GO:0007283; GO:0007339; GO:0008237; GO:0016020; GO:0016021; GO:0030154 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] CCDYNTCK 0.96512 4.5424 0 0 0 0 0 0 0 11.9234 0 0 0 0 0 0 12.521 0 10.997 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4819 0 0 0 0 0 0 0 0 11.9655 0 0 12.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6937 0 0 0 0 0 0 0 0 0 14.0182 11.6664 0 0 0 0 0 0 0 0 0 0 0 13.9756 0 14.4674 0 0 0 0 0 0 0 0 0 0 0 13.4789 11.7443 0 0 0 0 0 0 12.9103 0 0 15.2122 0 0 0 14.2515 0 11.9778 0 0 0 13.9825 0 0 0 0 12.5598 13.1962 0 13.9845 11.8107 0 0 0 0 0 0 0 0 13.2434 0 0 0 0 13.1379 14.6018 0 0 0 0 0 0 0 12.5839 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1978 13.5054 0 0 0 0 0 0 O60266 ADCY3_HUMAN "Adenylate cyclase type 3, EC 4.6.1.1 (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III, AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3, AC3)" ADCY3 KIAA0511 Homo sapiens (Human) acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338] GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0016021; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322 adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] DQQQFNTMYMYR 0.96513 0.3202 0 0 0 0 0 0 0 0 0 0 10.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6197 0 0 0 0 0 0 11.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3002 11.9535 0 0 0 0 0 0 13.0365 0 0 0 0 0 0 0 0 0 15.6284 11.8143 13.7139 0 0 0 13.6602 0 13.9644 0 0 0 0 13.4597 0 13.0625 0 0 0 12.795 13.5348 0 0 0 11.2316 13.3879 0 0 13.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7403 14.0797 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3918 0 11.3509 0 0 11.4266 0 0 O60543 CIDEA_HUMAN Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A) CIDEA Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of sequestering of triglyceride [GO:0010890]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to stilbenoid [GO:0035634]; temperature homeostasis [GO:0001659] GO:0001659; GO:0001818; GO:0005634; GO:0005737; GO:0005739; GO:0005740; GO:0005811; GO:0005829; GO:0006629; GO:0006915; GO:0010890; GO:0019915; GO:0030512; GO:0032720; GO:0035634; GO:0042803; GO:0042981; GO:0050995; GO:0070417; GO:0120163; GO:1900118; GO:1902510 protein homodimerization activity [GO:0042803] RVLFTPLMHPAR 0.96513 0.010079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75473 LGR5_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 5 (G-protein coupled receptor 49) (G-protein coupled receptor 67) (G-protein coupled receptor HG38) LGR5 GPR49 GPR67 Homo sapiens (Human) epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; inner ear development [GO:0048839]; oocyte differentiation [GO:0009994]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; G protein-coupled receptor signaling pathway [GO:0007186]; hair follicle development [GO:0001942]; inner ear development [GO:0048839]; oocyte differentiation [GO:0009994]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of cell population proliferation [GO:0042127] GO:0001942; GO:0004888; GO:0004930; GO:0005654; GO:0005794; GO:0005886; GO:0005887; GO:0007186; GO:0009994; GO:0016500; GO:0032588; GO:0042127; GO:0048839; GO:0090263; GO:2001013 G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888] APFSSLKVIILLCALLALTMAAVPLLGGSK 0.96514 3.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6334 0 12.5829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8151 0 0 0 0 0 11.1923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9647 0 0 0 0 0 12.4755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8738 0 11.6416 0 12.3378 0 0 0 0 0 11.6015 0 0 0 10.7482 0 0 0 0 12.5013 0 0 0 0 0 0 0 11.1164 0 0 0 0 0 0 0 11.8402 0 0 0 0 12.5677 0 0 10.0463 0 0 0 12.8176 0 0 0 0 18.0432 0 0 0 0 0 0 0 Q14236 EPAG_HUMAN Early lymphoid activation gene protein (DIAPH2 antisense RNA 1) (DIAPH2 antisense gene protein 1) DIAPH2-AS1 EPAG Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 MNLYLHPK 0.96514 0.0080349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.41179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4644 0 0 0 0 0 0 0 11.3683 0 0 0 0 0 0 0 0 11.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK97 FBX9_HUMAN F-box only protein 9 (Cross-immune reaction antigen 1) (Renal carcinoma antigen NY-REN-57) FBXO9 FBX9 VCIA1 Homo sapiens (Human) fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000151; GO:0004842; GO:0005737; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0032006; GO:0045087; GO:0045444 ubiquitin-protein transferase activity [GO:0004842] ADDDEENESPAETDLQAQLQMFR 0.96514 -0.38124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86219 0 0 0 11.5299 0 0 0 0 0 0 0 0 0 0 0 10.2808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8072 0 0 0 0 0 0 0 10.7461 0 0 0 0 0 0 0 0 13.1662 0 0 0 13.2528 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Y9 LY96_HUMAN "Lymphocyte antigen 96, Ly-96 (ESOP-1) (Protein MD-2)" LY96 ESOP1 MD2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224] endosome membrane [GO:0010008]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] endosome membrane [GO:0010008]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; coreceptor activity [GO:0015026]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; Toll-like receptor 4 binding [GO:0035662]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224] GO:0001530; GO:0001875; GO:0002224; GO:0005576; GO:0005615; GO:0005886; GO:0006954; GO:0006968; GO:0007166; GO:0010008; GO:0015026; GO:0031226; GO:0031666; GO:0032496; GO:0032497; GO:0032760; GO:0034142; GO:0035662; GO:0043235; GO:0045087; GO:0046696; GO:0071222 coreceptor activity [GO:0015026]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; Toll-like receptor 4 binding [GO:0035662] EVICRGSDDDYSFCR 0.96514 -0.098354 0 0 11.6381 0 0 0 0 0 0 12.2362 0 0 0 0 0 0 0 0 0 0 0 0 9.07486 0 0 0 0 0 0 9.65363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0955 0 0 0 13.0218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4086 0 0 0 0 0 0 0 0 0 0 0 0 0 P51460 INSL3_HUMAN "Insulin-like 3 (Leydig insulin-like peptide, Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain ]" INSL3 RLF RLNL Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; oocyte maturation [GO:0001556]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of wound healing [GO:0090303]; spermatogenesis [GO:0007283] extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471] extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; oocyte maturation [GO:0001556]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of wound healing [GO:0090303]; spermatogenesis [GO:0007283] GO:0001556; GO:0001664; GO:0002020; GO:0005102; GO:0005158; GO:0005179; GO:0005576; GO:0005615; GO:0007193; GO:0007267; GO:0007283; GO:0008284; GO:0008285; GO:0008584; GO:0010634; GO:0043066; GO:0043950; GO:0048471; GO:0090303 G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102] PATGGDR 0.96515 -0.38245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1797 0 0 0 0 12.9338 13.2622 0 0 0 0 13.2938 0 0 0 0 0 0 0 13.2257 12.8806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5475 0 0 0 0 0 0 0 0 0 12.6464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43711 TLX3_HUMAN T-cell leukemia homeobox protein 3 (Homeobox protein Hox-11L2) TLX3 HOX11L2 Homo sapiens (Human) animal organ development [GO:0048513]; central nervous system development [GO:0007417]; GABAergic neuron differentiation [GO:0097154]; negative regulation of neuron differentiation [GO:0045665]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ development [GO:0048513]; central nervous system development [GO:0007417]; GABAergic neuron differentiation [GO:0097154]; negative regulation of neuron differentiation [GO:0045665]; neuron fate specification [GO:0048665]; neuron migration [GO:0001764]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]" GO:0000785; GO:0000978; GO:0000981; GO:0001764; GO:0002087; GO:0005634; GO:0005654; GO:0006357; GO:0007417; GO:0007585; GO:0045665; GO:0048513; GO:0048665; GO:0097154; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" SLKMTDAQVK 0.96517 0.040632 0 0 0 0 0 0 0 0 0 0 0 11.4559 12.5968 0 11.7491 0 0 0 0 0 12.4984 0 0 0 0 0 0 0 0 0 11.9358 0 11.6228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2843 0 0 0 0 0 0 0 0 13.4757 0 0 0 0 12.599 13.8169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55082 MFAP3_HUMAN Microfibril-associated glycoprotein 3 MFAP3 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GO:0005576; GO:0005634; GO:0005737; GO:0005886; GO:0016021 AFEIAKRIPIITSAK 0.96517 -0.12809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8872 P08319 ADH4_HUMAN "All-trans-retinol dehydrogenase [NAD(+)] ADH4, EC 1.1.1.105 (Alcohol dehydrogenase 4) (Alcohol dehydrogenase class II pi chain)" ADH4 Homo sapiens (Human) alcohol catabolic process [GO:0046164]; alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; quinone metabolic process [GO:1901661]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; all-trans retinal binding [GO:0005503]; benzaldehyde dehydrogenase [NAD(P)+] activity [GO:0019115]; ethanol binding [GO:0035276]; NAD binding [GO:0051287]; NAD-retinol dehydrogenase activity [GO:0004745]; NADPH:quinone reductase activity [GO:0003960]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; retinol binding [GO:0019841]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; alcohol catabolic process [GO:0046164]; alcohol metabolic process [GO:0006066]; cellular aldehyde metabolic process [GO:0006081]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; quinone metabolic process [GO:1901661]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]" GO:0001523; GO:0003960; GO:0004022; GO:0004024; GO:0004032; GO:0004745; GO:0005503; GO:0005654; GO:0005829; GO:0006066; GO:0006069; GO:0006081; GO:0008270; GO:0010430; GO:0016620; GO:0019115; GO:0019841; GO:0035276; GO:0042572; GO:0046164; GO:0046294; GO:0051287; GO:0051903; GO:1901661 "alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; all-trans retinal binding [GO:0005503]; benzaldehyde dehydrogenase [NAD(P)+] activity [GO:0019115]; ethanol binding [GO:0035276]; NAD binding [GO:0051287]; NAD-retinol dehydrogenase activity [GO:0004745]; NADPH:quinone reductase activity [GO:0003960]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; retinol binding [GO:0019841]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]" DLHKPIQEVIIELTK 0.96518 0.31578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1958 0 0 0 0 0 0 11.6785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5602 13.3663 0 0 0 0 0 0 0 12.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1454 13.315 0 0 0 0 0 13.1072 0 0 0 0 Q8WZA2 RPGF4_HUMAN "Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2, EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II, cAMP-GEFII)" RAPGEF4 CGEF2 EPAC2 Homo sapiens (Human) adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle cycle [GO:0098693] GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0031267; GO:0043547; GO:0098686; GO:0098693 cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] AYRLTVAKLEPPLIPFMPLLIK 0.96519 -0.11994 0 0 11.1616 0 11.0938 0 0 0 0 0 11.0539 0 0 0 0 0 0 0 0 0 0 0 11.4354 0 0 0 0 0 0 10.5922 11.6175 0 0 0 0 13.7102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.008 12.3693 15.1851 10.1257 0 0 0 0 0 0 0 0 0 0 0 0 14.6482 0 0 10.9527 0 0 12.7314 0 13.3238 0 0 14.2862 13.1689 14.9016 0 0 0 14.4623 12.0574 0 0 0 0 0 0 0 12.5957 0 0 0 0 0 0 12.0168 13.6678 0 0 0 11.6196 0 13.6949 0 0 0 0 18.1001 0 0 0 0 0 0 0 0 0 0 11.6303 0 0 12.7213 0 0 0 11.0278 0 13.0433 0 0 0 0 0 0 12.6371 0 0 0 0 0 0 0 0 0 13.1276 0 0 0 12.0325 13.9941 14.1524 14.1919 0 14.7061 0 0 11.6216 14.7578 13.1924 0 12.8477 0 12.1656 0 0 10.6905 0 0 14.0276 11.2836 11.2447 Q7RTY8 TMPS7_HUMAN "Transmembrane protease serine 7, EC 3.4.21.- (Matriptase-3)" TMPRSS7 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005886; GO:0006508; GO:0008236; GO:0016021 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] CDGTVDCPDGSDEEGCTCSR 0.9652 -0.15549 0 0 0 0 0 0 0 14.4333 11.6464 0 0 13.2896 12.4859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7669 0 0 0 0 0 14.0042 0 15.244 15.2231 15.0281 14.6099 14.3967 14.4349 0 0 0 12.0131 0 0 17.9989 0 0 0 0 0 0 0 14.2957 12.5697 0 0 0 0 13.0065 13.4073 16.6499 0 0 0 17.7465 0 15.5527 0 13.1228 15.1463 14.4299 0 14.1004 13.9091 0 0 0 0 15.0978 15.0878 14.9095 0 0 0 0 16.0301 15.8136 0 0 15.1713 15.1796 0 14.4467 0 14.2527 15.5983 14.5889 14.8628 11.8101 16.5057 14.6199 15.9807 0 0 0 13.9042 0 0 0 12.9721 0 13.761 0 0 0 0 0 0 0 0 10.1726 0 11.9878 0 0 0 12.9513 0 0 11.7691 0 15.1114 14.8246 14.4579 14.0176 0 11.7077 0 0 0 Q9BSE4 HERP2_HUMAN Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein HERPUD2 Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030968 LKTHLSNVYPSKPLTK 0.9652 -0.15583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4519 0 0 0 0 0 0 0 0 0 0 0 14.3708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43566 RGS14_HUMAN "Regulator of G-protein signaling 14, RGS14" RGS14 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070] anchoring junction [GO:0070161]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922] anchoring junction [GO:0070161]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; spindle [GO:0005819]; spindle pole [GO:0000922]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic cell cycle [GO:0000278]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of synaptic plasticity [GO:0031914]; nucleocytoplasmic transport [GO:0006913]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neurogenesis [GO:0050769]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to oxidative stress [GO:0006979]; spindle organization [GO:0007051]; visual learning [GO:0008542]; zygote asymmetric cell division [GO:0010070] GO:0000278; GO:0000922; GO:0001965; GO:0003924; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005886; GO:0006913; GO:0006979; GO:0007051; GO:0007059; GO:0007186; GO:0007612; GO:0007616; GO:0008017; GO:0008277; GO:0008542; GO:0010070; GO:0014069; GO:0016604; GO:0016605; GO:0019901; GO:0030159; GO:0030425; GO:0031914; GO:0032794; GO:0035556; GO:0043197; GO:0043407; GO:0043547; GO:0043620; GO:0045744; GO:0048008; GO:0050769; GO:0051301; GO:0060291; GO:0070161; GO:0070373; GO:0098978 G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; signaling receptor complex adaptor activity [GO:0030159] FVKSPLYR 0.96522 -0.062046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1854 17.3304 17.4704 16.2543 0 16.8824 0 16.3628 0 15.895 16.05 15.5752 14.7098 14.3997 14.5658 0 0 0 0 0 0 0 0 0 12.0556 0 0 16.7682 16.6795 16.7895 17.2791 17.2915 16.9548 14.5396 14.5174 14.4236 16.5613 17.6751 17.5064 13.9059 16.0624 0 16.9557 14.7524 14.2615 13.3154 16.34 0 12.016 14.5675 13.3261 0 14.4312 0 13.1779 0 0 0 0 0 0 0 0 0 0 0 15.4483 0 17.3023 0 0 13.1319 21.0421 20.994 20.5183 20.5294 0 20.6512 20.7844 18.6588 20.03 14.9364 0 23.1905 14.4373 0 0 0 19.9985 18.1729 0 0 14.1286 0 18.4657 18.5281 19.8563 19.9153 19.8333 20.3032 19.781 19.4809 19.6161 0 20.2389 19.8043 19.3482 0 0 0 0 0 0 0 0 0 0 13.1714 12.6611 19.9549 20.6453 0 0 19.2796 0 13.8046 0 0 0 19.9749 19.421 19.1995 14.2933 19.0268 19.8914 0 0 19.6496 0 0 0 14.7493 0 0 11.5849 0 0 0 0 14.3491 14.0482 13.4277 18.9982 18.1922 18.0675 17.6662 20.8109 20.7556 20.8469 20.1347 12.4909 20.9201 14.2701 19.7084 18.932 Q92896 GSLG1_HUMAN "Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1, ESL-1) (Golgi sialoglycoprotein MG-160)" GLG1 CFR1 ESL1 MG160 Homo sapiens (Human) bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein processing [GO:0016485]; regulation of chondrocyte differentiation [GO:0032330]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein processing [GO:0016485]; regulation of chondrocyte differentiation [GO:0032330]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0000139; GO:0005102; GO:0005794; GO:0005856; GO:0005886; GO:0007179; GO:0010955; GO:0016020; GO:0016021; GO:0016485; GO:0017134; GO:0030512; GO:0031012; GO:0032330; GO:0060349; GO:0070062 fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102] AKDDSELEGQVISCLKLR 0.96522 -0.39852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6497 0 0 0 0 0 0 0 0 0 0 0 0 11.8242 0 0 0 0 0 0 0 0 0 0 0 10.2123 0 0 0 0 0 0 0 0 11.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0774 13.8821 0 0 0 0 0 13.3965 0 0 0 12.8198 12.6782 0 12.932 11.5509 13.8158 0 0 0 0 13.9754 0 0 0 0 0 0 0 0 0 13.5918 0 0 0 0 13.926 0 12.7318 0 12.8175 0 12.9837 0 0 0 0 0 0 13.2157 15.2763 13.0066 0 0 0 0 0 12.8652 13.8798 12.8246 0 0 0 0 0 0 12.2776 0 0 0 0 0 0 0 0 0 12.5003 0 0 0 0 0 0 0 0 0 0 0 0 12.5774 0 0 0 0 13.3989 13.7998 13.7622 0 0 0 0 0 0 Q99471 PFD5_HUMAN Prefoldin subunit 5 (Myc modulator 1) (c-Myc-binding protein Mm-1) PFDN5 MM1 PFD5 Homo sapiens (Human) "negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]" GO:0001540; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006457; GO:0016272; GO:0045111; GO:0045892; GO:0050821; GO:0051082; GO:0060041; GO:0090090; GO:1905907 amyloid-beta binding [GO:0001540]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082] IQPALQEKHAMKQAVMEMMSQK 0.96522 0.31201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8053 0 13.8684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5762 14.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGN9 IGLO5_HUMAN IgLON family member 5 IGLON5 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GQAGEYECVTHNGVNSAPDSRR 0.96523 -0.051398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2132 0 0 0 0 0 0 0 0 0 0 13.5007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N468 MFD4A_HUMAN Major facilitator superfamily domain-containing protein 4A (Major facilitator superfamily domain-containing protein 4) MFSD4A MFSD4 UNQ3064/PRO9894 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355] GO:0005355; GO:0016021 glucose transmembrane transporter activity [GO:0005355] LLSIPISSRMK 0.96523 -0.15961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6165 13.9929 0 0 0 0 12.6914 0 0 0 0 0 13.8842 0 12.5752 11.1864 0 0 12.4472 13.3508 13.1123 0 0 0 0 0 0 0 0 0 13.2405 13.7371 13.5296 11.6045 0 0 0 13.6793 0 0 0 0 14.483 11.642 0 0 0 0 0 0 0 0 14.1327 0 0 0 0 0 0 12.276 0 0 0 0 0 0 13.3678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWW5 CLN6_HUMAN "Ceroid-lipofuscinosis neuronal protein 6, Protein CLN6" CLN6 Homo sapiens (Human) cellular macromolecule catabolic process [GO:0044265]; cholesterol metabolic process [GO:0008203]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; locomotion involved in locomotory behavior [GO:0031987]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; positive regulation of proteolysis [GO:0045862]; protein catabolic process [GO:0030163]; visual perception [GO:0007601] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; lysophosphatidic acid binding [GO:0035727]; protein homodimerization activity [GO:0042803]; sulfatide binding [GO:0120146]; cellular macromolecule catabolic process [GO:0044265]; cholesterol metabolic process [GO:0008203]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; locomotion involved in locomotory behavior [GO:0031987]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; positive regulation of proteolysis [GO:0045862]; protein catabolic process [GO:0030163]; visual perception [GO:0007601] GO:0001573; GO:0005730; GO:0005769; GO:0005783; GO:0005788; GO:0005789; GO:0007040; GO:0007042; GO:0007601; GO:0008203; GO:0016020; GO:0016021; GO:0030163; GO:0030203; GO:0031987; GO:0035727; GO:0042803; GO:0043231; GO:0044265; GO:0045121; GO:0045862; GO:0120146 lysophosphatidic acid binding [GO:0035727]; protein homodimerization activity [GO:0042803]; sulfatide binding [GO:0120146] LIERSPR 0.96523 -0.39952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1005 0 0 15.5012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3904 0 0 0 17.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63096 GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein) GNAI1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]; response to peptide hormone [GO:0043434] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]; response to peptide hormone [GO:0043434] GO:0000287; GO:0001664; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0005813; GO:0005834; GO:0005886; GO:0005938; GO:0007049; GO:0007186; GO:0007188; GO:0007193; GO:0019003; GO:0030496; GO:0031683; GO:0031821; GO:0043434; GO:0043949; GO:0051301; GO:0060236; GO:0070062; GO:0099738; GO:1904322; GO:1904778 G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] AVVYSNTIQSIIAIIR 0.96524 -0.16007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8449 0 0 0 0 0 10.7898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0671 0 0 0 0 0 0 0 0 0 0 0 Q8N5U6 RNF10_HUMAN RING finger protein 10 RNF10 KIAA0262 RIE2 Homo sapiens (Human) "negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autoubiquitination [GO:0051865]" cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of Schwann cell proliferation [GO:0010626]; positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein autoubiquitination [GO:0051865]" GO:0000976; GO:0005634; GO:0005737; GO:0010626; GO:0031643; GO:0045893; GO:0045944; GO:0046872; GO:0051865; GO:0061630; GO:0098978; GO:0099147; GO:0099527 metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630] CGHIFCWACILHYLSLSEK 0.96524 0.31064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9705 0 0 12.1736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8286 0 0 0 0 0 0 0 0 0 13.2066 0 12.9193 0 0 0 0 0 0 0 0 0 0 0 0 15.2559 0 0 0 0 14.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9903 14.6936 0 0 12.9959 12.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2631 0 0 0 0 0 0 10.565 0 0 0 0 16.1701 0 0 0 0 0 0 13.3946 12.4194 0 0 0 0 0 0 0 0 0 0 0 12.2753 0 0 0 0 Q8NBU5 ATAD1_HUMAN "Outer mitochondrial transmembrane helix translocase, EC 7.4.2.- (ATPase family AAA domain-containing protein 1, hATAD1) (Thorase)" ATAD1 FNP001 Homo sapiens (Human) "extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]" anchoring junction [GO:0070161]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211] "anchoring junction [GO:0070161]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; transmembrane protein dislocase activity [GO:0140567]; extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]" GO:0002092; GO:0005524; GO:0005741; GO:0005778; GO:0005829; GO:0007612; GO:0007613; GO:0016020; GO:0016021; GO:0016887; GO:0045211; GO:0051967; GO:0070161; GO:0098978; GO:0099149; GO:0140567; GO:0140570 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; transmembrane protein dislocase activity [GO:0140567] LMKQIGVK 0.96524 -0.40032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0286 0 0 Q9H093 NUAK2_HUMAN "NUAK family SNF1-like kinase 2, EC 2.7.11.1 (Omphalocele kinase 2) (SNF1/AMP kinase-related kinase, SNARK)" NUAK2 OMPHK2 SNARK Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of hippo signaling [GO:0035330] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of hippo signaling [GO:0035330] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0030036; GO:0034504; GO:0035330; GO:0035556; GO:0042149; GO:0043066; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ASMADWLRRSSR 0.96524 -0.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.314 0 0 0 0 0 0 0 0 0 0 12.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6834 0 0 0 0 0 13.7488 0 0 0 0 0 12.1808 13.5851 0 0 0 0 0 0 13.7386 0 15.398 0 0 19.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8388 12.674 0 0 0 0 0 0 0 0 0 0 Q6IAA8 LTOR1_HUMAN "Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA, p27RF-Rho)" LAMTOR1 C11orf59 PDRO PP7157 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; protein localization [GO:0008104]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]; TORC1 signaling [GO:0038202] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]; GTPase binding [GO:0051020]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; protein localization [GO:0008104]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]; TORC1 signaling [GO:0038202] GO:0001558; GO:0001919; GO:0005764; GO:0005765; GO:0005886; GO:0007032; GO:0007040; GO:0008104; GO:0010872; GO:0010874; GO:0016197; GO:0031902; GO:0032008; GO:0032418; GO:0035577; GO:0035579; GO:0038202; GO:0042632; GO:0043410; GO:0045121; GO:0050790; GO:0051020; GO:0060620; GO:0070062; GO:0071230; GO:0071986; GO:0101003 GTPase binding [GO:0051020] EELVVQFGIP 0.96525 4.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1591 11.3249 0 0 0 0 0 0 0 0 10.8821 0 11.7071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8434 11.0602 0 0 11.9719 0 12.7172 0 0 13.818 15.0348 0 0 0 14.9979 0 12.3609 15.1654 12.2559 11.8138 0 11.7773 0 11.1363 14.4619 13.8436 13.8731 0 14.4712 14.7723 11.3275 0 0 12.8022 12.2927 0 0 12.3299 0 0 0 0 0 12.3834 13.8694 0 0 0 0 0 0 12.4842 0 11.784 0 11.4976 0 0 11.1636 0 12.6766 12.416 0 0 12.4838 0 0 0 0 12.4236 0 0 0 0 12.5375 0 12.6125 0 0 0 11.5821 0 11.7555 0 0 0 0 0 12.4266 0 0 12.6983 14.0165 0 0 0 12.3198 0 0 12.5699 0 0 14.3873 0 12.1588 0 0 14.8189 11.4549 0 0 0 Q7Z3T1 OR2W3_HUMAN Olfactory receptor 2W3 (Olfactory receptor 2W8) (Olfactory receptor OR1-49) OR2W3 OR2W3P OR2W8P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVLQIRSASGRQK 0.96526 -0.066603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A286YF60 SCGR3_HUMAN Small cysteine and glycine repeat-containing protein 3 (Keratin-associated protein 28-3) SCYGR3 KRTAP28-3 Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882] GO:0005882 CCCQKQCCC 0.96527 -0.20307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9901 0 0 0 0 0 0 0 0 0 0 0 0 11.4279 0 0 0 0 0 0 0 10.9629 0 0 0 0 0 0 0 0 0 11.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60741 HCN1_HUMAN "Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1, BCNG-1)" HCN1 BCNG1 Homo sapiens (Human) "apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]" axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; apical protein localization [GO:0045176]; cellular response to cAMP [GO:0071320]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; retinal cone cell development [GO:0046549]; sodium ion transmembrane transport [GO:0035725]" GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005267; GO:0005886; GO:0005887; GO:0022843; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0045176; GO:0046549; GO:0051289; GO:0051967; GO:0071320; GO:0071805; GO:0086091; GO:0098855; GO:0098907; GO:2001257 cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; potassium channel activity [GO:0005267]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] FEVFQPGDYIIR 0.96527 -0.38008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2224 0 0 0 0 0 0 0 0 0 0 12.8858 0 0 0 0 12.9413 0 0 0 0 12.9709 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5735 0 0 0 0 0 12.2044 0 0 0 0 0 0 0 0 0 0 12.4754 0 0 0 0 0 0 0 0 12.4881 0 14.7924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5075 0 0 0 0 0 0 0 0 0 0 0 P82970 HMGN5_HUMAN High mobility group nucleosome-binding domain-containing protein 5 (Nucleosome-binding protein 1) HMGN5 NSBP1 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0006355; GO:0008284; GO:0010628; GO:0031492; GO:0043066; GO:0045893 chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723] DEKGEEDGK 0.96527 0.043757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6761 0 0 0 0 0 0 0 0 Q96GQ5 RUSF1_HUMAN RUS family member 1 RUSF1 C16orf58 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 AAADGSLQWEVGGWR 0.96527 0.30818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6497 0 0 0 0 0 0 0 0 0 0 0 0 12.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3491 0 0 0 0 0 0 0 0 0 0 0 Q99062 CSF3R_HUMAN "Granulocyte colony-stimulating factor receptor, G-CSF receptor, G-CSF-R (CD antigen CD114)" CSF3R GCSFR Homo sapiens (Human) cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165] endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165] GO:0004896; GO:0005576; GO:0005765; GO:0005886; GO:0005887; GO:0006952; GO:0007155; GO:0007165; GO:0009897; GO:0019221; GO:0019955; GO:0030593; GO:0030666; GO:0038023; GO:0043235; GO:0045637; GO:0051916 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023] DGQSHCCIPR 0.96527 -0.38067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5056 12.9577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKG4 S13A4_HUMAN Solute carrier family 13 member 4 (Na(+)/sulfate cotransporter SUT-1) (NaS2) SLC13A4 SUT1 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium:sulfate symporter activity [GO:0015382]; anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272] GO:0005886; GO:0005887; GO:0008272; GO:0015382; GO:0016021; GO:0098656 sodium:sulfate symporter activity [GO:0015382] EQLSEKRIQEEYEK 0.96527 -0.096232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.892 0 0 0 0 0 0 0 0 0 0 0 0 13.0278 0 0 0 0 0 0 0 0 13.6509 0 0 0 0 0 0 12.31 12.5099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969Y2 GTPB3_HUMAN "tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 3) (Mitochondrial GTP-binding protein 1)" GTPBP3 MTGP1 Homo sapiens (Human) tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005739; GO:0030488 GTP binding [GO:0005525]; GTPase activity [GO:0003924] ALQVALGAHLRDAR 0.96528 0.010664 0 0 0 0 0 0 0 0 0 11.0098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9483 0 0 0 0 0 0 0 0 0 0 0 11.8551 12.4958 0 0 0 0 0 0 0 0 11.866 0 0 0 0 0 0 0 0 0 0 Q9BQ13 KCD14_HUMAN BTB/POZ domain-containing protein KCTD14 KCTD14 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 AVLDNSDLMHCLEMDIKAQGYK 0.96528 0.321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7374 16.6702 16.6246 0 0 0 16.1528 16.3745 16.5445 0 16.4548 16.5309 0 16.3379 16.4233 0 0 14.6489 0 0 0 0 0 14.3451 0 0 0 0 0 0 0 0 13.5338 0 0 0 0 14.4134 14.5521 0 14.7841 0 0 14.2979 14.1398 0 13.3056 0 0 0 0 0 0 0 13.8167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4H9 F220A_HUMAN Protein FAM220A (STAT3-interacting protein as a repressor) FAM220A C7orf70 SIPAR Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470] nucleus [GO:0005634] nucleus [GO:0005634]; STAT family protein binding [GO:0097677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470] GO:0000122; GO:0005634; GO:0006470; GO:0097677 STAT family protein binding [GO:0097677] QTIEFKKMLK 0.96529 0.32089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.789 0 0 0 0 0 16.4959 16.4599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8656 0 0 0 0 0 0 0 Q8NCN5 PDPR_HUMAN "Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial, PDPr" PDPR KIAA1990 Homo sapiens (Human) positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253]; oxidoreductase activity [GO:0016491]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] GO:0005737; GO:0005739; GO:0005759; GO:0006470; GO:0016491; GO:0045253; GO:1904184 oxidoreductase activity [GO:0016491] LAAGSTR 0.96529 0.043152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3901 0 14.5341 0 14.4384 0 0 14.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5953 0 0 0 0 0 12.5521 0 0 0 0 0 0 0 0 0 0 0 0 11.3157 0 0 0 0 0 0 0 P04818 TYSY_HUMAN "Thymidylate synthase, TS, TSase, EC 2.1.1.45" TYMS TS OK/SW-cl.29 Homo sapiens (Human) aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; negative regulation of translation [GO:0017148]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; folic acid binding [GO:0005542]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; negative regulation of translation [GO:0017148]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860] GO:0000900; GO:0004799; GO:0005542; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006231; GO:0006235; GO:0007568; GO:0007623; GO:0009410; GO:0009636; GO:0017148; GO:0019860; GO:0032259; GO:0032570; GO:0033189; GO:0034097; GO:0035999; GO:0042803; GO:0045471; GO:0046683; GO:0048589; GO:0051216; GO:0051384; GO:0051593; GO:0060574; GO:0071897; GO:0097421; GO:1990825 folic acid binding [GO:0005542]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799] DAEPRPPHGELQYLGQIQHILR 0.96531 -0.10093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7562 13.4041 11.5555 0 0 0 0 0 0 0 0 0 12.3616 0 0 0 0 0 0 12.5043 0 0 0 13.0723 12.962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1687 0 13.2698 0 12.1006 0 0 0 0 0 0 0 0 0 0 0 0 12.833 0 14.2401 0 14.6106 0 0 0 0 0 0 11.6284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5648 0 0 0 0 0 0 0 0 0 0 0 0 P62191 PRS4_HUMAN "26S proteasome regulatory subunit 4, P26s4 (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)" PSMC1 Homo sapiens (Human) negative regulation of neuron death [GO:1901215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]" "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025]; negative regulation of neuron death [GO:1901215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016887; GO:0017025; GO:0022624; GO:0036402; GO:0043161; GO:1901215 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; RNA binding [GO:0003723]; TBP-class protein binding [GO:0017025] IEFPLPDEKTK 0.96532 -0.15301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.022 0 0 0 0 0 13.1235 Q12834 CDC20_HUMAN Cell division cycle protein 20 homolog (p55CDC) CDC20 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0051444; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757 anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein C-terminus binding [GO:0008022]; ubiquitin ligase activator activity [GO:1990757] ATPGSSR 0.96532 0.31864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3924 0 0 0 0 0 0 0 0 0 0 0 0 0 14.986 0 0 0 0 0 0 0 0 0 14.263 0 14.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0938 0 13.7866 0 0 0 0 0 0 0 0 0 0 0 0 15.1368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7635 0 0 13.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 P41217 OX2G_HUMAN OX-2 membrane glycoprotein (CD antigen CD200) CD200 MOX1 MOX2 My033 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; heterotypic cell-cell adhesion [GO:0034113]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of macrophage activation [GO:0043031]; negative regulation of macrophage migration [GO:1905522]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell migration [GO:2000405]; positive regulation of arginase activity [GO:0150072]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO:0150074]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of immune response [GO:0050776]; regulation of neuroinflammatory response [GO:0150077] axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; glycosylated region protein binding [GO:0140081]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; cell-cell adhesion [GO:0098609]; heterotypic cell-cell adhesion [GO:0034113]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of macrophage activation [GO:0043031]; negative regulation of macrophage migration [GO:1905522]; negative regulation of matrix metallopeptidase secretion [GO:1904465]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell migration [GO:2000405]; positive regulation of arginase activity [GO:0150072]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO:0150074]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of immune response [GO:0050776]; regulation of neuroinflammatory response [GO:0150077] GO:0002695; GO:0005886; GO:0005887; GO:0008285; GO:0009986; GO:0016020; GO:0030424; GO:0032088; GO:0032715; GO:0032793; GO:0034113; GO:0043005; GO:0043025; GO:0043031; GO:0044297; GO:0050776; GO:0071636; GO:0086080; GO:0098609; GO:0098632; GO:0140081; GO:0150072; GO:0150074; GO:0150077; GO:0150079; GO:1901215; GO:1904465; GO:1905522; GO:2000405 cell-cell adhesion mediator activity [GO:0098632]; glycosylated region protein binding [GO:0140081]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080] QTVNKGYWFSVPLLLSIVSLVILLVLISILLYWK 0.96533 0.31775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01973 ROR1_HUMAN "Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)" ROR1 NTRKR1 Homo sapiens (Human) astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725] "axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; sensory perception of sound [GO:0007605]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0007169; GO:0007605; GO:0009986; GO:0010976; GO:0014002; GO:0014068; GO:0017147; GO:0033674; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092; GO:1904929 "ATP binding [GO:0005524]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]" IYKGHLYLPGMDHAQLVAIKTLK 0.96533 -0.39099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9565 0 0 0 0 0 0 10.2082 0 0 0 11.4177 0 0 0 0 0 11.5081 0 0 0 14.3548 0 13.7405 17.651 0 0 0 0 0 0 13.8958 0 0 0 15.3883 0 11.5454 0 0 0 0 14.0717 0 0 0 0 14.6897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.169 0 0 0 0 0 12.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1674 0 0 0 0 0 0 0 0 0 0 0 0 17.1045 0 13.7694 0 0 0 0 0 Q5JTZ5 CI152_HUMAN Uncharacterized protein C9orf152 C9orf152 Homo sapiens (Human) AVESGLKFSTQCPLSIK 0.96534 -0.91573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8517 0 0 0 0 0 0 0 0 0 0 0 0 13.8081 0 0 0 0 0 0 0 0 0 0 11.9405 0 0 0 0 0 0 12.1501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0876 14.0611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0496 0 0 Q8N2X6 EXAS1_HUMAN Uncharacterized protein EXOC3-AS1 (EXOC3 antisense RNA 1) (EXOC3 antisense gene protein 1) EXOC3-AS1 C5orf55 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 PAVFMLASSSALQCGRGVPRFPR 0.96534 0.31747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VXU3 CHIC1_HUMAN Cysteine-rich hydrophobic domain-containing protein 1 (Brain X-linked protein) CHIC1 BRX Homo sapiens (Human) cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] GO:0005886; GO:0031410 ALPVNVK 0.96535 0.31705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3432 0 0 0 0 0 0 0 0 0 18.9632 0 0 0 0 0 0 0 0 0 0 0 13.6313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4054 17.8519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43143 DHX15_HUMAN "ATP-dependent RNA helicase DHX15, EC 3.6.4.13 (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43, hPrp43)" DHX15 DBP1 DDX15 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380] GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0009636; GO:0016607; GO:0016887; GO:0042742; GO:0043123; GO:0043279; GO:0051607; GO:0140374 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] DNQVVQLHPSTVLDHKPEWVLYNEFVLTTKNYIR 0.96536 -0.060471 14.3049 0 13.3383 0 0 0 16.9544 16.1909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2572 0 14.0069 0 0 0 0 0 0 0 0 0 14.5034 0 0 0 0 0 0 0 0 0 0 11.5505 0 0 0 13.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1394 0 0 0 0 0 13.7449 0 0 11.1852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4715 Q14953 KI2S5_HUMAN "Killer cell immunoglobulin-like receptor 2DS5 (CD158 antigen-like family member G) (Natural killer-associated transcript 9, NKAT-9) (CD antigen CD158g)" KIR2DS5 CD158G NKAT9 Homo sapiens (Human) immune response [GO:0006955] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; HLA-C specific inhibitory MHC class I receptor activity [GO:0030110]; immune response [GO:0006955] GO:0005886; GO:0005887; GO:0006955; GO:0016021; GO:0030110 HLA-C specific inhibitory MHC class I receptor activity [GO:0030110] LIGEHIDGVSKGNFSIGRMTQDLAGTYR 0.96536 0.31617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RU7 TRIB3_HUMAN "Tribbles homolog 3, TRB-3 (Neuronal cell death-inducible putative kinase) (SINK) (p65-interacting inhibitor of NF-kappa-B)" TRIB3 C20orf97 NIPK SKIP3 TRB3 Homo sapiens (Human) "cellular response to insulin stimulus [GO:0032869]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of glucose transmembrane transport [GO:0010827]; regulation of MAP kinase activity [GO:0043405]; response to endoplasmic reticulum stress [GO:0034976]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; cellular response to insulin stimulus [GO:0032869]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of glucose transmembrane transport [GO:0010827]; regulation of MAP kinase activity [GO:0043405]; response to endoplasmic reticulum stress [GO:0034976]" GO:0000122; GO:0003714; GO:0004860; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006468; GO:0006469; GO:0010506; GO:0010827; GO:0019901; GO:0031434; GO:0031625; GO:0032092; GO:0032436; GO:0032869; GO:0034976; GO:0043405; GO:0045599; GO:0045717; GO:0045892; GO:0051443; GO:0055106; GO:0070059 ATP binding [GO:0005524]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106] ARSGPQPRLPPCLLPLSPPTAPDR 0.96536 -0.39604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2432 0 0 0 0 0 0 0 0 13.9205 13.0252 0 0 0 0 0 0 0 0 0 12.5986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5368 0 14.9212 0 14.4751 14.0515 0 0 0 0 0 0 15.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2747 0 0 0 0 0 0 0 0 0 14.3828 0 0 0 0 0 0 0 0 0 10.4939 0 0 11.3691 0 0 0 0 0 13.8088 0 0 0 0 0 0 15.2387 0 0 Q99729 ROAA_HUMAN "Heterogeneous nuclear ribonucleoprotein A/B, hnRNP A/B (APOBEC1-binding protein 1, ABBP-1)" HNRNPAB ABBP1 HNRPAB Homo sapiens (Human) "cellular response to amino acid stimulus [GO:0071230]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to amino acid stimulus [GO:0071230]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]" GO:0001837; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0016556; GO:0030425; GO:0044877; GO:0045293; GO:0045893; GO:0071230; GO:0071598; GO:0090575; GO:1901537; GO:1904580; GO:1990124; GO:1990837; GO:1990904; GO:2000623 mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837] EEEPVKKVLEK 0.96536 -0.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3773 0 0 0 0 0 0 12.7572 0 0 0 0 0 0 0 0 0 0 0 13.5006 14.5076 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1207 0 0 13.1668 0 0 0 14.8447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7119 0 0 0 0 0 O75352 MPU1_HUMAN "Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog, SL15)" MPDU1 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide biosynthetic process [GO:0009312]; protein folding [GO:0006457] GO:0005789; GO:0006457; GO:0006488; GO:0009312; GO:0016020; GO:0016021 AAEADGPLK 0.96538 4.537 0 14.2863 0 0 0 0 0 0 0 0 0 0 12.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0796 0 0 0 0 0 0 11.8353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2566 15.2012 0 14.0088 14.0184 13.798 10.759 0 13.1945 0 0 0 0 0 0 0 0 0 0 0 15.9328 0 0 13.4336 0 0 0 10.715 0 0 0 0 0 0 0 9.99138 0 0 0 0 0 0 13.2491 0 0 0 0 0 10.1107 0 0 0 0 12.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9325 0 0 0 0 0 0 0 0 11.8816 0 0 0 0 12.5305 0 0 0 0 0 0 0 0 9.26716 0 0 0 0 11.0729 0 0 0 0 0 0 0 0 12.6982 0 0 0 0 0 0 P42331 RHG25_HUMAN Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25) ARHGAP25 KIAA0053 Homo sapiens (Human) "actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; signal transduction [GO:0007165]" phagocytic cup [GO:0001891] "phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; signal transduction [GO:0007165]" GO:0001891; GO:0005096; GO:0006911; GO:0007015; GO:0007165; GO:0051058; GO:0090630 GTPase activator activity [GO:0005096] FLHEIQLNCAVNK 0.96539 -0.06424 0 0 0 0 0 0 0 0 0 0 14.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6419 0 0 0 0 0 0 0 0 0 0 0 14.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N511 TM199_HUMAN Transmembrane protein 199 TMEM199 C17orf32 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] COPI-coated vesicle membrane [GO:0030663]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471] COPI-coated vesicle membrane [GO:0030663]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] GO:0005764; GO:0005783; GO:0005789; GO:0006879; GO:0007042; GO:0012505; GO:0016021; GO:0016471; GO:0030663; GO:0033116; GO:0036295; GO:0070072; GO:1905146 KLRAELEAALGK 0.9654 -0.37994 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9663 0 0 13.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5423 0 0 0 0 0 0 13.8994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0961 14.255 0 0 0 0 0 15.3226 0 0 0 0 12.5088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9343 0 0 0 13.3471 0 0 17.6822 0 0 0 0 0 13.7574 0 0 0 0 14.4385 0 0 0 0 0 0 0 0 0 0 0 0 13.991 0 0 0 0 0 13.6481 13.9176 0 0 0 0 0 0 0 0 0 0 0 0 Q86WQ0 NR2CA_HUMAN Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein) NR2C2AP TRA16 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 VVIYHLR 0.96541 0.31064 0 11.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6501 0 15.9806 0 0 0 0 0 18.0924 0 0 18.8089 0 0 0 14.3998 0 0 0 0 14.763 14.6261 0 0 0 14.4915 0 0 0 0 0 14.1159 0 15.8491 0 0 0 0 0 0 0 14.9527 0 12.5592 0 0 0 0 13.6686 14.4439 0 0 0 12.5189 0 0 0 0 0 0 0 12.8477 0 19.1891 0 12.9341 0 0 14.2994 0 18.6025 0 0 0 0 0 0 0 0 0 0 14.7875 0 0 0 15.8339 0 0 13.1095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2594 0 14.7144 0 0 0 0 0 0 Q9GZS3 WDR61_HUMAN "WD repeat-containing protein 61 (Meiotic recombination REC14 protein homolog) (SKI8 homolog, Ski8) [Cleaved into: WD repeat-containing protein 61, N-terminally processed ]" WDR61 Homo sapiens (Human) histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087] Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] GO:0000791; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006368; GO:0016055; GO:0016593; GO:0045638; GO:0051568; GO:0051571; GO:0055087; GO:0080182; GO:2001162 GKFILSIAYSPDGK 0.96542 0.01128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRV8 SIKE1_HUMAN Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] GO:0005829; GO:0019901; GO:0031267 protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] KQMLQLMVAK 0.96543 0.010724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5956 0 0 0 13.9278 0 0 13.8141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4315 0 12.9207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.922 0 0 Q9Y216 MTMR7_HUMAN "Myotubularin-related protein 7 (Inositol 1,3-bisphosphate phosphatase, EC 3.1.3.-) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTMR7 Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; inositol bisphosphate phosphatase activity [GO:0016312]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]" GO:0004438; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0012505; GO:0016020; GO:0016312; GO:0046855; GO:0046856; GO:0052629 "inositol bisphosphate phosphatase activity [GO:0016312]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]" ETWILHSQISTIEKQATTATGCPLLIR 0.96543 0.044436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0595 0 0 0 0 12.4344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.64 0 0 0 0 0 11.648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15559 NQO1_HUMAN "NAD(P)H dehydrogenase [quinone] 1, EC 1.6.5.2 (Azoreductase) (DT-diaphorase, DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1, QR1)" NQO1 DIA4 NMOR1 Homo sapiens (Human) "aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to metal ion [GO:0071248]; cellular response to oxidative stress [GO:0034599]; NADH oxidation [GO:0006116]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of neuron apoptotic process [GO:0043525]; removal of superoxide radicals [GO:0019430]; response to alkaloid [GO:0043279]; response to amine [GO:0014075]; response to carbohydrate [GO:0009743]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to flavonoid [GO:1905395]; response to hormone [GO:0009725]; response to hydrogen sulfide [GO:1904880]; response to ischemia [GO:0002931]; response to L-glutamine [GO:1904844]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to testosterone [GO:0033574]; response to tetrachloromethane [GO:1904772]; response to toxic substance [GO:0009636]; synaptic transmission, cholinergic [GO:0007271]; ubiquinone metabolic process [GO:0006743]; vitamin E metabolic process [GO:0042360]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; identical protein binding [GO:0042802]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADH dehydrogenase (quinone) activity [GO:0050136]; NADPH dehydrogenase (quinone) activity [GO:0008753]; RNA binding [GO:0003723]; superoxide dismutase activity [GO:0004784]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to metal ion [GO:0071248]; cellular response to oxidative stress [GO:0034599]; NADH oxidation [GO:0006116]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of neuron apoptotic process [GO:0043525]; removal of superoxide radicals [GO:0019430]; response to alkaloid [GO:0043279]; response to amine [GO:0014075]; response to carbohydrate [GO:0009743]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to flavonoid [GO:1905395]; response to hormone [GO:0009725]; response to hydrogen sulfide [GO:1904880]; response to ischemia [GO:0002931]; response to L-glutamine [GO:1904844]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to testosterone [GO:0033574]; response to tetrachloromethane [GO:1904772]; response to toxic substance [GO:0009636]; synaptic transmission, cholinergic [GO:0007271]; ubiquinone metabolic process [GO:0006743]; vitamin E metabolic process [GO:0042360]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]" GO:0002931; GO:0003723; GO:0003955; GO:0004128; GO:0004784; GO:0005737; GO:0005829; GO:0006116; GO:0006743; GO:0006805; GO:0006809; GO:0006979; GO:0007271; GO:0007568; GO:0007584; GO:0008753; GO:0009636; GO:0009725; GO:0009743; GO:0014075; GO:0019430; GO:0030425; GO:0032355; GO:0033574; GO:0034599; GO:0042177; GO:0042360; GO:0042373; GO:0042802; GO:0043025; GO:0043066; GO:0043086; GO:0043279; GO:0043525; GO:0045202; GO:0045454; GO:0045471; GO:0050136; GO:0051602; GO:0070301; GO:0070995; GO:0071248; GO:1904772; GO:1904844; GO:1904880; GO:1905395 "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; identical protein binding [GO:0042802]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADH dehydrogenase (quinone) activity [GO:0050136]; NADPH dehydrogenase (quinone) activity [GO:0008753]; RNA binding [GO:0003723]; superoxide dismutase activity [GO:0004784]" VGRRALIVLAHSER 0.96544 -0.098249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35611 ADDA_HUMAN Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cellular response to calcium ion [GO:0071277]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cellular response to calcium ion [GO:0071277]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of protein binding [GO:0032092] GO:0003723; GO:0003779; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0008290; GO:0014069; GO:0016604; GO:0030036; GO:0030507; GO:0032092; GO:0042803; GO:0045296; GO:0046982; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:1903142; GO:1903393 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507] IREQNLQDIK 0.96544 0.043168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.912 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3142 0 0 0 0 0 0 0 0 0 12.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05121 PAI1_HUMAN "Plasminogen activator inhibitor 1, PAI, PAI-1 (Endothelial plasminogen activator inhibitor) (Serpin E1)" SERPINE1 PAI1 PLANH1 Homo sapiens (Human) angiogenesis [GO:0001525]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; dentinogenesis [GO:0097187]; fibrinolysis [GO:0042730]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukotriene production involved in inflammatory response [GO:0035491]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of signaling receptor activity [GO:0010469]; replicative senescence [GO:0090399] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase inhibitor complex [GO:1904090]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; serine protease inhibitor complex [GO:0097180] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase inhibitor complex [GO:1904090]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; serine protease inhibitor complex [GO:0097180]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; dentinogenesis [GO:0097187]; fibrinolysis [GO:0042730]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukotriene production involved in inflammatory response [GO:0035491]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of receptor-mediated endocytosis [GO:0048260]; regulation of signaling receptor activity [GO:0010469]; replicative senescence [GO:0090399] GO:0001525; GO:0002020; GO:0004867; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0010469; GO:0010757; GO:0010951; GO:0014912; GO:0030194; GO:0030195; GO:0030336; GO:0031093; GO:0032757; GO:0033629; GO:0035491; GO:0042730; GO:0045766; GO:0048260; GO:0050729; GO:0050829; GO:0051918; GO:0061044; GO:0061045; GO:0062023; GO:0070062; GO:0071222; GO:0090026; GO:0090399; GO:0097180; GO:0097187; GO:1901331; GO:1902042; GO:1904090; GO:2000098; GO:2000352 protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102] FIINDWVKTHTKGMISNLLGK 0.96546 0.32127 0 0 0 0 0 0 0 0 0 0 13.4307 0 0 0 11.6358 13.7595 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6533 0 12.936 0 0 0 0 0 0 12.515 0 0 0 13.6923 0 10.9067 11.8986 14.0425 0 0 0 0 0 0 0 13.1242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.509 0 0 0 0 0 0 0 0 0 0 0 0 14.8817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9562 0 0 12.7314 0 0 0 0 0 0 0 0 0 15.9107 0 0 0 0 Q16206 ENOX2_HUMAN "Ecto-NOX disulfide-thiol exchanger 2 (APK1 antigen) (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase, tNOX) [Includes: Hydroquinone [NADH] oxidase, EC 1.-.-.-; Protein disulfide-thiol oxidoreductase, EC 1.-.-.- ]" ENOX2 COVA1 Homo sapiens (Human) electron transport chain [GO:0022900]; regulation of growth [GO:0040008]; ultradian rhythm [GO:0007624] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; electron transport chain [GO:0022900]; regulation of growth [GO:0040008]; ultradian rhythm [GO:0007624] GO:0003723; GO:0005615; GO:0005829; GO:0005886; GO:0007624; GO:0009897; GO:0015035; GO:0022900; GO:0040008 protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723] ALYLSGYRIR 0.96546 -0.10092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84405 0 12.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1855 0 12.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.984 0 0 0 0 13.714 0 0 0 0 13.5075 0 0 11.5429 0 14.0058 11.8097 0 0 13.4629 0 14.2335 0 0 0 0 0 0 0 0 13.5531 0 0 11.8244 0 13.2221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0094 0 0 0 0 0 0 0 0 0 0 0 12.9471 0 0 0 0 0 0 0 Q6ZNH5 ZN497_HUMAN Zinc finger protein 497 ZNF497 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ALRPSPLPEEPGCRCGECGK 0.96546 -0.91401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.958 10.2619 0 0 0 0 0 0 0 0 0 0 0 12.8615 0 0 0 0 0 0 0 0 0 11.3098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8E8 CSR2B_HUMAN "Cysteine-rich protein 2-binding protein, CSRP2-binding protein (ADA2A-containing complex subunit 2, ATAC2) (CRP2-binding partner, CRP2BP) (Lysine acetyltransferase 14)" KAT14 CSRP2BP Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] "ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; LIM domain binding [GO:0030274]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" GO:0004402; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0030274; GO:0031063; GO:0043966; GO:0044154; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140672 histone acetyltransferase activity [GO:0004402]; LIM domain binding [GO:0030274] DVTLHVSASNPAMLLYQK 0.96546 -0.39023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6235 0 11.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9412 0 0 0 0 0 0 0 0 0 0 0 0 12.0818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6601 0 0 0 0 15.0145 0 0 0 0 0 0 13.1216 0 0 0 0 0 0 0 0 0 0 0 0 12.6762 0 0 0 12.9881 0 0 0 0 0 0 0 0 0 0 0 14.2365 0 0 0 0 0 0 0 0 0 0 13.4463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4451 0 0 13.5221 0 0 12.4246 0 0 13.4396 0 12.9344 0 12.9362 14.4819 13.5044 0 12.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4011 0 13.471 0 13 0 P13716 HEM2_HUMAN "Delta-aminolevulinic acid dehydratase, ALADH, EC 4.2.1.24 (Porphobilinogen synthase)" ALAD Homo sapiens (Human) cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043] GO:0001666; GO:0003824; GO:0004655; GO:0005576; GO:0005634; GO:0005829; GO:0006782; GO:0006783; GO:0006979; GO:0008270; GO:0009410; GO:0009635; GO:0010039; GO:0010043; GO:0010044; GO:0010212; GO:0010266; GO:0010269; GO:0014823; GO:0032025; GO:0032496; GO:0033197; GO:0034774; GO:0042802; GO:0043200; GO:0045471; GO:0046685; GO:0046686; GO:0046689; GO:0051260; GO:0051384; GO:0051597; GO:0070062; GO:0070541; GO:0070542; GO:0071284; GO:0071353; GO:1901799; GO:1904813; GO:1904854 catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270] GLALRAVDRDVR 0.96547 -0.39422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18505 GBRB1_HUMAN Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) GABRB1 Homo sapiens (Human) cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system process [GO:0050877]; ovulation cycle [GO:0042698]; regulation of membrane potential [GO:0042391]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] GO:0004890; GO:0005231; GO:0005635; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007214; GO:0007268; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030425; GO:0030594; GO:0032570; GO:0034220; GO:0034707; GO:0042391; GO:0042698; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0070161; GO:0071420; GO:0098982; GO:1902476; GO:1902711; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ITTTAACMMDLR 0.96547 -0.91798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE12 LMX1A_HUMAN "LIM homeobox transcription factor 1-alpha (LIM/homeobox protein 1.1, LMX-1.1) (LIM/homeobox protein LMX1A)" LMX1A Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system neuron differentiation [GO:0021953]; cerebellum development [GO:0021549]; dentate gyrus development [GO:0021542]; dopaminergic neuron differentiation [GO:0071542]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of neuron differentiation [GO:0045665]; neuron differentiation [GO:0030182]; olfactory behavior [GO:0042048]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse organization [GO:0050808] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; axon guidance [GO:0007411]; central nervous system neuron differentiation [GO:0021953]; cerebellum development [GO:0021549]; dentate gyrus development [GO:0021542]; dopaminergic neuron differentiation [GO:0071542]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of neuron differentiation [GO:0045665]; neuron differentiation [GO:0030182]; olfactory behavior [GO:0042048]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse organization [GO:0050808]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001558; GO:0005634; GO:0006357; GO:0007411; GO:0007613; GO:0007626; GO:0021542; GO:0021549; GO:0021953; GO:0030182; GO:0042048; GO:0045665; GO:0045944; GO:0046872; GO:0050808; GO:0071542; GO:1904948; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GDYEKERELLSLVSPAASDSGK 0.96547 -0.15296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4583 0 11.8478 0 0 9.77294 0 11.4144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.041 0 12.8103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6922 0 0 0 0 0 0 0 0 0 0 0 0 10.1235 0 0 0 0 0 0 0 0 0 0 0 0 14.1897 0 14.6398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RL6 SIG11_HUMAN "Sialic acid-binding Ig-like lectin 11, Sialic acid-binding lectin 11, Siglec-11" SIGLEC11 UNQ9222/PRO28718 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] GO:0005886; GO:0007155; GO:0016021; GO:0019902; GO:0030246; GO:0033691 carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; sialic acid binding [GO:0033691] GSCSLVIRDAQR 0.96547 -0.033015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6294 0 0 14.7501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWD8 CP054_HUMAN Transmembrane protein C16orf54 C16orf54 UNQ9389/PRO34280 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 APTLVWR 0.96548 0.0072848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.662 0 0 15.895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.5294 0 0 0 0 0 0 12.5572 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.2225 0 0 18.1063 17.9216 0 0 20.2289 19.3892 18.8079 0 19.3873 0 0 0 0 0 0 0 0 0 19.1816 13.4236 0 Q8NEP9 ZN555_HUMAN Zinc finger protein 555 ZNF555 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFNCSSSLRRHVR 0.96548 0.006458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9735 0 0 0 0 0 0 0 0 15.5559 0 0 0 0 0 0 0 0 15.5772 14.7183 0 14.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7724 15.4984 0 0 13.5656 0 0 0 0 0 0 0 0 11.3568 0 0 0 0 0 0 0 11.601 0 0 0 0 0 13.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6766 0 0 0 0 0 0 0 0 0 0 0 P54851 EMP2_HUMAN "Epithelial membrane protein 2, EMP-2 (Protein XMP)" EMP2 XMP Homo sapiens (Human) actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; activation of protein kinase activity [GO:0032147]; bleb assembly [GO:0032060]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; early endosome to late endosome transport [GO:0045022]; embryo implantation [GO:0007566]; embryonic process involved in female pregnancy [GO:0060136]; heart formation [GO:0060914]; membrane raft assembly [GO:0001765]; natural killer cell proliferation [GO:0001787]; neutrophil migration [GO:1990266]; plasma membrane raft assembly [GO:0044854]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of cell-matrix adhesion [GO:0001952]; regulation of endothelial cell migration [GO:0010594]; regulation of glomerular filtration [GO:0003093]; regulation of kinase activity [GO:0043549]; regulation of vasculogenesis [GO:2001212]; T cell mediated cytotoxicity [GO:0001913] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; activation of protein kinase activity [GO:0032147]; bleb assembly [GO:0032060]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell death [GO:0008219]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; early endosome to late endosome transport [GO:0045022]; embryo implantation [GO:0007566]; embryonic process involved in female pregnancy [GO:0060136]; heart formation [GO:0060914]; membrane raft assembly [GO:0001765]; natural killer cell proliferation [GO:0001787]; neutrophil migration [GO:1990266]; plasma membrane raft assembly [GO:0044854]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of cell-matrix adhesion [GO:0001952]; regulation of endothelial cell migration [GO:0010594]; regulation of glomerular filtration [GO:0003093]; regulation of kinase activity [GO:0043549]; regulation of vasculogenesis [GO:2001212]; T cell mediated cytotoxicity [GO:0001913] GO:0000139; GO:0001765; GO:0001787; GO:0001913; GO:0001952; GO:0001954; GO:0003093; GO:0005178; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007015; GO:0007155; GO:0007160; GO:0007566; GO:0008219; GO:0008284; GO:0009986; GO:0010594; GO:0016021; GO:0016324; GO:0016477; GO:0019900; GO:0019901; GO:0031410; GO:0032060; GO:0032147; GO:0034394; GO:0043534; GO:0043549; GO:0044854; GO:0045022; GO:0045121; GO:0045177; GO:0045765; GO:0045766; GO:0060136; GO:0060914; GO:0062043; GO:0070252; GO:0072659; GO:1990266; GO:2001046; GO:2001212 integrin binding [GO:0005178]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901] EDIHDKNAK 0.96549 -0.39595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2976 0 0 14.1482 0 0 0 0 0 13.2146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2703 0 12.5717 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4X5 AF1L2_HUMAN "Actin filament-associated protein 1-like 2, AFAP1-like protein 2" AFAP1L2 KIAA1914 XB130 Homo sapiens (Human) "inflammatory response [GO:0006954]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of interleukin-6 production [GO:0032675]; regulation of mitotic cell cycle [GO:0007346]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein tyrosine kinase activator activity [GO:0030296]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; inflammatory response [GO:0006954]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of interleukin-6 production [GO:0032675]; regulation of mitotic cell cycle [GO:0007346]" GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007346; GO:0017124; GO:0030296; GO:0032675; GO:0032757; GO:0035591; GO:0042169; GO:0045742; GO:0045893 protein tyrosine kinase activator activity [GO:0030296]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] ELKETLLKCTDK 0.96549 -0.033764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2724 0 11.9975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2576 13.9893 13.9843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6526 0 13.4929 0 12.4644 0 0 0 0 0 0 14.8036 14.8307 0 0 14.5323 0 0 0 14.8679 14.9145 0 0 0 0 14.9622 0 0 0 11.9849 0 14.6953 0 0 0 0 14.91 0 0 12.2855 0 0 13.4286 0 0 0 0 0 14.8122 0 0 0 0 0 0 0 0 0 0 0 12.7818 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6476 0 0 13.05 0 0 0 0 0 0 0 14.0027 13.547 0 0 0 0 0 13.7427 0 0 0 13.7212 0 0 0 0 P48163 MAOX_HUMAN "NADP-dependent malic enzyme, NADP-ME, EC 1.1.1.40 (Malic enzyme 1)" ME1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; nucleotide biosynthetic process [GO:0009165]; protein homotetramerization [GO:0051289]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; nucleotide biosynthetic process [GO:0009165]; protein homotetramerization [GO:0051289]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725] GO:0000287; GO:0004470; GO:0004471; GO:0004473; GO:0005737; GO:0005739; GO:0005829; GO:0005975; GO:0006090; GO:0006108; GO:0006734; GO:0006739; GO:0008948; GO:0009055; GO:0009165; GO:0009725; GO:0009743; GO:0030145; GO:0042802; GO:0043531; GO:0050661; GO:0051287; GO:0051289; GO:1902031 ADP binding [GO:0043531]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; manganese ion binding [GO:0030145]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxaloacetate decarboxylase activity [GO:0008948] DVSLKIAEKIVK 0.9655 -0.035044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58180 OR4D2_HUMAN Olfactory receptor 4D2 (B-lymphocyte membrane protein BC2009) (Olfactory receptor OR17-24) OR4D2 Homo sapiens (Human) integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ISNSGLLDVVWFFLLLMSYLFILVMLRSHPGEAR 0.9655 0.31775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6U4 TVA7_HUMAN T cell receptor alpha variable 7 TRAV7 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 FNNLQWYR 0.96551 -0.37459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31271 HXA13_HUMAN Homeobox protein Hox-A13 (Homeobox protein Hox-1J) HOXA13 HOX1J Homo sapiens (Human) artery morphogenesis [GO:0048844]; branching involved in prostate gland morphogenesis [GO:0060442]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindgut morphogenesis [GO:0048619]; endothelial cell fate specification [GO:0060847]; endothelial cell morphogenesis [GO:0001886]; inner ear development [GO:0048839]; male genitalia development [GO:0030539]; mesenchymal cell apoptotic process [GO:0097152]; mitotic nuclear division [GO:0140014]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of BMP signaling pathway [GO:0030510]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular septum development [GO:0003281] chromatin [GO:0000785]; chromosome [GO:0005694]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; chromosome [GO:0005694]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; artery morphogenesis [GO:0048844]; branching involved in prostate gland morphogenesis [GO:0060442]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindgut morphogenesis [GO:0048619]; endothelial cell fate specification [GO:0060847]; endothelial cell morphogenesis [GO:0001886]; inner ear development [GO:0048839]; male genitalia development [GO:0030539]; mesenchymal cell apoptotic process [GO:0097152]; mitotic nuclear division [GO:0140014]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of BMP signaling pathway [GO:0030510]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular septum development [GO:0003281]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001570; GO:0001886; GO:0001894; GO:0003281; GO:0003677; GO:0005654; GO:0005694; GO:0006357; GO:0006366; GO:0030510; GO:0030539; GO:0033574; GO:0035115; GO:0043565; GO:0045111; GO:0045840; GO:0048619; GO:0048839; GO:0048844; GO:0060442; GO:0060847; GO:0097152; GO:0140014; GO:1990837; GO:2001055 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" KRVPYTK 0.96551 -0.37539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0565 0 0 0 0 16.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.58 12.5092 0 12.8662 12.5024 0 0 0 0 12.8451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87415 O75629 CREG1_HUMAN Protein CREG1 (Cellular repressor of E1A-stimulated genes 1) CREG1 CREG UNQ727/PRO1409 Homo sapiens (Human) regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; transcription regulator complex [GO:0005667] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003714; GO:0005576; GO:0005615; GO:0005667; GO:0006357; GO:0035578; GO:0040008; GO:0070062 transcription corepressor activity [GO:0003714] AGLSRGSARALLAALLASTLLALLVSPAR 0.96552 4.5286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8163 0 0 0 0 0 0 0 0 0 0 0 0 11.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15407 FOSL1_HUMAN "Fos-related antigen 1, FRA-1" FOSL1 FRA1 Homo sapiens (Human) "cellular defense response [GO:0006968]; cellular response to extracellular stimulus [GO:0031668]; chemotaxis [GO:0006935]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; integrated stress response signaling [GO:0140467]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of miRNA transcription [GO:1902895]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; vitellogenesis [GO:0007296]" chromatin [GO:0000785]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic membrane [GO:0042734]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular defense response [GO:0006968]; cellular response to extracellular stimulus [GO:0031668]; chemotaxis [GO:0006935]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; integrated stress response signaling [GO:0140467]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; placenta blood vessel development [GO:0060674]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of miRNA transcription [GO:1902895]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; vitellogenesis [GO:0007296]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006935; GO:0006968; GO:0007296; GO:0007565; GO:0007612; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009615; GO:0009629; GO:0031668; GO:0032570; GO:0034097; GO:0042542; GO:0042734; GO:0043005; GO:0043065; GO:0045787; GO:0051091; GO:0051412; GO:0051591; GO:0060674; GO:0090575; GO:0140467; GO:1902895; GO:1990837; GO:2000144 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ELTDFLQAETDKLEDEKSGLQR 0.96552 0.31754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3693 10.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63220 RS21_HUMAN 40S ribosomal protein S21 (Small ribosomal subunit protein eS21) RPS21 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000461]; translation [GO:0006412]" GO:0000447; GO:0000461; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005791; GO:0005829; GO:0006412; GO:0015935; GO:0022626; GO:0022627; GO:0042788; GO:0045202; GO:0047485 protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] LAKADGIVSK 0.96553 -0.050961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0477 0 13.7314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A3B3IT33 TR51G_HUMAN Putative tripartite motif-containing protein 51G (Tripartite motif-containing 51G pseudogene) TRIM51G TRIM51GP Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] IRCWKDYVSLR 0.96554 -0.036744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6D5 ANR29_HUMAN Ankyrin repeat domain-containing protein 29 ANKRD29 Homo sapiens (Human) ELLKFSPTLGILK 0.96557 3.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3578 0 14.2177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5425 0 0 0 0 0 14.8975 11.5693 0 0 0 0 0 0 0 9.67064 0 0 0 0 0 0 0 11.6567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.032 11.4167 0 13.37 0 Q969H4 CNKR1_HUMAN "Connector enhancer of kinase suppressor of ras 1, Connector enhancer of KSR 1 (CNK homolog protein 1, CNK1, hCNK1) (Connector enhancer of KSR-like)" CNKSR1 CNK1 Homo sapiens (Human) Ras protein signal transduction [GO:0007265]; Rho protein signal transduction [GO:0007266]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; Ras protein signal transduction [GO:0007265]; Rho protein signal transduction [GO:0007266]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005886; GO:0005911; GO:0005938; GO:0007169; GO:0007265; GO:0007266; GO:0030674 protein-macromolecule adaptor activity [GO:0030674] ELGRPDCDGWLLLR 0.96557 0.01128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14625 CXL11_HUMAN "C-X-C motif chemokine 11 (Beta-R1) (H174) (Interferon gamma-inducible protein 9, IP-9) (Interferon-inducible T-cell alpha chemoattractant, I-TAC) (Small-inducible cytokine B11)" CXCL11 ITAC SCYB11 SCYB9B Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; heparin binding [GO:0008201]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818] GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007189; GO:0007267; GO:0008009; GO:0008201; GO:0010818; GO:0030593; GO:0031640; GO:0042127; GO:0045236; GO:0048248; GO:0051281; GO:0061844; GO:0070098; GO:0071222 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; heparin binding [GO:0008201] SKQARLIIK 0.96558 -0.20421 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4053 13.6494 0 0 0 0 0 0 0 0 0 14.4972 0 0 0 0 17.7298 0 0 0 0 0 0 0 17.7477 0 0 12.8276 0 0 0 13.7613 0 0 0 0 0 0 0 0 0 0 17.5814 0 17.161 16.8015 16.885 0 16.9833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92544 TM9S4_HUMAN Transmembrane 9 superfamily member 4 (Tumor cannibalism associated protein 1) TM9SF4 KIAA0255 TUCAP1 Homo sapiens (Human) cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0016021; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010 EDDIEDTMEESGWK 0.96558 0.011091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14683 P5I11_HUMAN Tumor protein p53-inducible protein 11 (p53-induced gene 11 protein) TP53I11 PIG11 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; negative regulation of cell population proliferation [GO:0008285] GO:0008285; GO:0016021 FTIREPLGLR 0.96559 -0.20424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.574 0 0 0 0 0 0 0 0 0 0 0 12.5267 0 12.7071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.327 0 0 0 0 0 0 P30046 DOPD_HUMAN "D-dopachrome decarboxylase, EC 4.1.1.84 (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II)" DDT Homo sapiens (Human) melanin biosynthetic process [GO:0042438]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of tumor necrosis factor production [GO:0032760] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cytokine receptor binding [GO:0005126]; D-dopachrome decarboxylase activity [GO:0033981]; dopachrome isomerase activity [GO:0004167]; phenylpyruvate tautomerase activity [GO:0050178]; melanin biosynthetic process [GO:0042438]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of tumor necrosis factor production [GO:0032760] GO:0004167; GO:0005126; GO:0005615; GO:0005737; GO:0010760; GO:0032760; GO:0033981; GO:0042438; GO:0050178; GO:0050729; GO:0070062; GO:0070374 cytokine receptor binding [GO:0005126]; D-dopachrome decarboxylase activity [GO:0033981]; dopachrome isomerase activity [GO:0004167]; phenylpyruvate tautomerase activity [GO:0050178] FFPLESWQIGK 0.96559 -0.91395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4635 0 0 0 0 Q6NXT4 ZNT6_HUMAN "Zinc transporter 6, ZnT-6 (Solute carrier family 30 member 6)" SLC30A6 ZNT6 Homo sapiens (Human) insulin processing [GO:0030070]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; zinc ion transmembrane transporter activity [GO:0005385]; insulin processing [GO:0030070]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] GO:0000139; GO:0005385; GO:0005794; GO:0006829; GO:0016021; GO:0030070; GO:0071577 zinc ion transmembrane transporter activity [GO:0005385] NEHFWTLGFGSLAGSVHVRIRR 0.9656 -0.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRI3 ZNT2_HUMAN "Zinc transporter 2, ZnT-2 (Solute carrier family 30 member 2)" SLC30A2 ZNT2 Homo sapiens (Human) positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385]; positive regulation of sequestering of zinc ion [GO:0061090]; regulation of sequestering of zinc ion [GO:0061088]; response to zinc ion [GO:0010043]; zinc ion transmembrane transport [GO:0071577] GO:0005385; GO:0005737; GO:0005765; GO:0005770; GO:0005886; GO:0010043; GO:0016021; GO:0042802; GO:0043231; GO:0061088; GO:0061090; GO:0071577 identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385] DCQACQGPSD 0.9656 -0.053762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXB0 F131A_HUMAN Protein FAM131A FAM131A C3orf40 UNQ715/PRO1378 Homo sapiens (Human) PMISVLGKMFLWQR 0.96561 -0.92202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7204 0 0 0 0 0 0 0 0 0 0 Q3KNW1 SNAI3_HUMAN Zinc finger protein SNAI3 (Protein snail homolog 3) (Zinc finger protein 293) SNAI3 ZNF293 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; copper ion binding [GO:0005507]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0001227; GO:0005507; GO:0005634; GO:0005667; GO:0006355; GO:1990837 "copper ion binding [GO:0005507]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AAIVPLK 0.96562 -0.031785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5169 0 10.7949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6638 0 0 0 0 0 0 14.3303 13.9544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VXU2 PAP1L_HUMAN Polyadenylate-binding protein 1-like PABPC1L C20orf119 Homo sapiens (Human) cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:0070062; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] FEQMKQDR 0.96562 -0.15226 0 0 0 0 0 0 0 13.8055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3725 0 0 0 0 0 14.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.064 0 0 0 0 0 13.7161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YJ6 THNS2_HUMAN "Threonine synthase-like 2, TSH2, EC 4.2.3.- (Secreted osteoclastogenic factor of activated T-cells, SOFAT)" THNSL2 Homo sapiens (Human) 2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; 2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071] GO:0005125; GO:0005615; GO:0009071; GO:0016311; GO:0016829; GO:0030170; GO:0046360; GO:0070905 cytokine activity [GO:0005125]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905] TQSVNLPKELHSKLSEAVTSVSVSDEAITQTMGR 0.96562 0.32293 0 0 0 0 0 0 0 0 0 0 0 11.6751 0 0 0 0 0 0 0 0 11.2008 11.1422 0 0 0 0 11.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7453 0 0 0 0 0 0 0 0 12.3594 0 0 0 0 0 0 0 0 0 0 0 12.5743 0 0 12.4657 0 12.5308 12.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.207 0 0 13.0481 0 0 0 0 0 0 0 0 0 12.7547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8154 0 0 0 0 0 0 0 0 0 12.7555 0 0 0 Q9NRE1 MMP26_HUMAN "Matrix metalloproteinase-26, MMP-26, EC 3.4.24.- (Endometase) (Matrilysin-2)" MMP26 Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of inflammatory response [GO:0050728]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; negative regulation of inflammatory response [GO:0050728]; proteolysis [GO:0006508] GO:0004222; GO:0005576; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0050728 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] IQHLYGEKCSSDIP 0.96563 -0.39595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYJ0 FGFP2_HUMAN "Fibroblast growth factor-binding protein 2, FGF-BP2, FGF-binding protein 2, FGFBP-2 (37 kDa killer-specific secretory protein, Ksp37) (HBp17-related protein, HBp17-RP)" FGFBP2 KSP37 UNQ425/PRO1065 Homo sapiens (Human) cell-cell signaling [GO:0007267] extracellular space [GO:0005615] extracellular space [GO:0005615]; growth factor binding [GO:0019838]; cell-cell signaling [GO:0007267] GO:0005615; GO:0007267; GO:0019838 growth factor binding [GO:0019838] PKATVKLTEATQLGK 0.96564 -0.033589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYN1 RASLC_HUMAN "Ras-like protein family member 12, EC 3.6.5.2 (Ras-like protein Ris)" RASL12 RIS Homo sapiens (Human) signal transduction [GO:0007165] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165] GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007165; GO:0019003 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] APTLTLLKGFKIF 0.96564 -0.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.26716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7641 0 0 0 0 0 0 0 15.0937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0012 0 0 0 12.9791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6767 0 14.4588 0 0 0 Q6ZMS4 ZN852_HUMAN Zinc finger protein 852 ZNF852 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNECGRAFCSNR 0.96566 -0.37648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPJ6 MED4_HUMAN "Mediator of RNA polymerase II transcription subunit 4 (Activator-recruited cofactor 36 kDa component, ARC36) (Mediator complex subunit 4) (TRAP/SMCC/PC2 subunit p36 subunit) (Vitamin D3 receptor-interacting protein complex 36 kDa component, DRIP36)" MED4 ARC36 DRIP36 VDRIP HSPC126 Homo sapiens (Human) "positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]" GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0016020; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0070847 nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] ENEDDVEIMSTDSSSSSSESD 0.96566 -0.37616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2146 9.89756 0 0 0 0 0 0 0 0 0 0 0 10.8434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2314 0 0 14.4778 0 0 0 13.4603 0 13.2486 0 0 0 0 0 0 15.0176 0 0 0 0 10.1119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75181 0 0 0 0 0 0 13.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05023 AT1A1_HUMAN "Sodium/potassium-transporting ATPase subunit alpha-1, Na(+)/K(+) ATPase alpha-1 subunit, EC 7.2.2.13 (Sodium pump subunit alpha-1)" ATP1A1 Homo sapiens (Human) cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to glycoside [GO:1903416]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376] apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315] apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to glycoside [GO:1903416]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376] GO:0002026; GO:0002028; GO:0005391; GO:0005524; GO:0005783; GO:0005794; GO:0005886; GO:0005890; GO:0006883; GO:0008217; GO:0009410; GO:0010248; GO:0014069; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016791; GO:0016887; GO:0019829; GO:0030007; GO:0030315; GO:0030424; GO:0030955; GO:0031090; GO:0031402; GO:0031947; GO:0032991; GO:0036126; GO:0036376; GO:0042383; GO:0042470; GO:0045121; GO:0045822; GO:0045823; GO:0045989; GO:0046982; GO:0051087; GO:0055119; GO:0060342; GO:0070062; GO:0071383; GO:0086002; GO:0086009; GO:0086013; GO:0086064; GO:1902600; GO:1903416; GO:1903561; GO:1990239; GO:1990573 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239] CIELCCGSVKEMRER 0.96567 -0.90574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2165 0 0 0 0 0 0 0 0 Q9H0R6 GATA_HUMAN "Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial, Glu-AdT subunit A, EC 6.3.5.7 (Glutaminyl-tRNA synthase-like protein 1)" QRSL1 Homo sapiens (Human) glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of protein stability [GO:0031647] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of protein stability [GO:0031647] GO:0005524; GO:0005739; GO:0030956; GO:0031647; GO:0032543; GO:0050567; GO:0070681 ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567] CLSLIKKTK 0.96567 -0.050937 0 0 0 0 0 11.3772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0098 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0773 0 0 0 0 0 0 0 0 0 0 0 12.806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1785 0 0 0 0 0 0 0 0 0 0 0 0 12.8144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6756 0 0 P22459 KCNA4_HUMAN Potassium voltage-gated channel subfamily A member 4 (HPCN2) (Voltage-gated K(+) channel HuKII) (Voltage-gated potassium channel HBK4) (Voltage-gated potassium channel HK1) (Voltage-gated potassium channel subunit Kv1.4) KCNA4 KCNA4L Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] axon [GO:0030424]; axon initial segment [GO:0043194]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] axon [GO:0030424]; axon initial segment [GO:0043194]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium ion binding [GO:0030955]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0030424; GO:0030955; GO:0034765; GO:0043194; GO:0043197; GO:0051260; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; potassium ion binding [GO:0030955]; voltage-gated potassium channel activity [GO:0005249] CQGKGDDSETDKNNCSNAK 0.96568 -0.91008 0 0 0 0 0 0 0 0 0 12.9619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2535 0 0 0 0 0 0 0 0 0 12.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9668 0 13.3826 0 13.006 0 13.2192 0 0 0 0 0 0 0 0 0 0 0 11.5771 0 0 0 0 0 11.6096 0 0 0 0 0 0 14.5885 0 0 0 0 0 0 0 13.4459 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1724 0 13.432 0 0 13.7189 0 12.5575 0 13.5025 10.5686 0 0 0 0 0 0 13.0588 0 0 12.9175 0 0 0 0 10.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3378 0 10.2953 0 0 0 0 0 0 Q96LC7 SIG10_HUMAN "Sialic acid-binding Ig-like lectin 10, Siglec-10 (Siglec-like protein 2)" SIGLEC10 SLG2 UNQ477/PRO940 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; negative regulation of inflammatory response to wounding [GO:0106015] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; sialic acid binding [GO:0033691]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; negative regulation of inflammatory response to wounding [GO:0106015] GO:0002250; GO:0005576; GO:0005886; GO:0007155; GO:0016021; GO:0019902; GO:0030246; GO:0033691; GO:0042169; GO:0045087; GO:0106015 carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; sialic acid binding [GO:0033691] DLVISISR 0.96568 -0.37928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0347 0 0 0 0 0 0 0 0 0 0 14.201 0 0 0 0 0 0 0 13.3159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00585 CCL21_HUMAN "C-C motif chemokine 21 (6Ckine) (Beta-chemokine exodus-2) (Secondary lymphoid-tissue chemokine, SLC) (Small-inducible cytokine A21)" CCL21 SCYA21 UNQ784/PRO1600 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295] GO:0001768; GO:0001771; GO:0001954; GO:0002407; GO:0002548; GO:0002606; GO:0005576; GO:0005615; GO:0006954; GO:0006955; GO:0007186; GO:0007267; GO:0008009; GO:0010560; GO:0010820; GO:0030593; GO:0030838; GO:0031274; GO:0031295; GO:0031529; GO:0031640; GO:0031732; GO:0033630; GO:0034695; GO:0035759; GO:0038116; GO:0042379; GO:0043123; GO:0043547; GO:0043552; GO:0045860; GO:0046330; GO:0048020; GO:0048245; GO:0048247; GO:0048260; GO:0048469; GO:0050921; GO:0051209; GO:0051491; GO:0051897; GO:0060326; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0090023; GO:0090630; GO:0097026; GO:1903237; GO:1990869; GO:2000147; GO:2000406; GO:2000529; GO:2000548; GO:2000669 CCR chemokine receptor binding [GO:0048020]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379] AQSLALSLLILVLAFGIPR 0.9657 0.03957 14.3127 0 0 0 0 0 0 0 0 14.8711 0 13.232 0 0 13.1481 0 0 0 13.055 0 0 0 0 0 0 11.9551 0 0 0 0 14.5288 0 12.5121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9868 0 0 0 0 10.7704 12.3939 12.359 13.8377 0 0 0 0 0 0 0 14.2412 0 12.5663 0 14.9797 14.5506 0 0 12.9202 12.0943 0 0 0 0 0 0 0 0 0 11.8322 0 0 0 0 11.7878 0 0 0 0 0 0 0 0 0 0 14.8645 15.2043 13.7134 13.8197 0 14.2112 0 0 0 11.1826 0 0 0 0 0 0 0 0 13.4516 0 0 12.8905 11.9351 0 11.496 0 0 0 0 0 14.0607 0 0 0 0 0 0 0 0 0 12.9223 0 0 0 0 0 0 0 0 13.6841 0 0 0 0 0 13.2177 0 0 0 0 0 0 0 Q8TC20 CAGE1_HUMAN "Cancer-associated gene 1 protein, CAGE-1 (Cancer/testis antigen 3, CT3)" CAGE1 CTAG3 Homo sapiens (Human) HLEDLIRKPR 0.9657 -0.91351 0 0 0 0 0 0 0 0 13.8577 0 0 0 0 13.731 13.4209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0467 13.5327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1G2 RBAS1_HUMAN Putative uncharacterized protein encoded by RBM12B-AS1 (RBM12B antisense RNA 1) (RBM12B antisense gene protein 1) RBM12B-AS1 C8orf39 PRO1905 Homo sapiens (Human) FYSPKPLSTTPR 0.96571 -0.91372 0 0 12.2452 0 0 0 0 13.0495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00453 LST1_HUMAN Leukocyte-specific transcript 1 protein (Protein B144) LST1 B144 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell morphogenesis [GO:0000902]; dendrite development [GO:0016358]; immune response [GO:0006955]; negative regulation of lymphocyte proliferation [GO:0050672]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anatomical structure morphogenesis [GO:0009653]; cell morphogenesis [GO:0000902]; dendrite development [GO:0016358]; immune response [GO:0006955]; negative regulation of lymphocyte proliferation [GO:0050672]; regulation of cell shape [GO:0008360] GO:0000139; GO:0000902; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006955; GO:0008360; GO:0009653; GO:0016021; GO:0016358; GO:0050672 LPVPSSEGPDLRGR 0.96573 0.01128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWV2 MPZL3_HUMAN Myelin protein zero-like protein 3 MPZL3 UNQ2966/PRO7425 Homo sapiens (Human) cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; hair cycle [GO:0042633] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; hair cycle [GO:0042633] GO:0005886; GO:0007155; GO:0016021; GO:0030198; GO:0042633 ADAHVRGYVGEK 0.96573 4.2364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.307 0 0 0 0 0 0 0 0 0 0 0 12.7647 9.86669 0 0 0 0 0 0 0 0 0 11.9781 0 0 10.1056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7863 0 0 0 0 0 0 0 0 0 12.8823 14.4888 12.8212 0 13.1955 14.9676 0 14.2394 13.0014 0 0 0 0 13.733 13.8195 14.0607 13.1442 13.2859 0 13.9519 0 0 0 0 0 0 0 13.3414 13.6199 0 0 0 12.9904 0 0 12.6774 0 9.51983 0 13.6355 0 13.3417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5311 0 0 0 12.6081 0 0 11.1833 0 13.1939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7311 12.0396 0 0 0 Q8NBS3 S4A11_HUMAN "Solute carrier family 4 member 11 (Sodium borate cotransporter 1, NaBC1)" SLC4A11 BTR1 Homo sapiens (Human) bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; proton transmembrane transporter activity [GO:0015078]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; water transmembrane transporter activity [GO:0005372]; bicarbonate transport [GO:0015701]; borate transport [GO:0046713]; cellular cation homeostasis [GO:0030003]; cellular hypotonic response [GO:0071476]; cellular response to oxidative stress [GO:0034599]; fluid transport [GO:0042044]; ion homeostasis [GO:0050801]; proton transmembrane transport [GO:1902600]; regulation of mesenchymal stem cell differentiation [GO:2000739]; regulation of mitochondrial membrane potential [GO:0051881]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085] GO:0005272; GO:0005372; GO:0005452; GO:0005886; GO:0006814; GO:0012506; GO:0015078; GO:0015106; GO:0015252; GO:0015293; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0030003; GO:0034599; GO:0042044; GO:0046713; GO:0046715; GO:0046983; GO:0050801; GO:0051881; GO:0055085; GO:0071476; GO:1902600; GO:2000739 active borate transmembrane transporter activity [GO:0046715]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; protein dimerization activity [GO:0046983]; proton channel activity [GO:0015252]; proton transmembrane transporter activity [GO:0015078]; sodium channel activity [GO:0005272]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; water transmembrane transporter activity [GO:0005372] EIEMSKFR 0.96574 -0.14881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6664 12.6053 13.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4562 0 0 Q9NYP9 MS18A_HUMAN Protein Mis18-alpha (FAPP1-associated protein 1) MIS18A C21orf45 C21orf46 FASP1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA methylation [GO:0044030] "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA methylation [GO:0044030]" GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0007059; GO:0034080; GO:0042802; GO:0044030; GO:0046872; GO:0051301 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] CSRGCAGGCECGDK 0.96574 -0.92149 0 0 0 0 0 0 0 0 11.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1862 0 0 0 0 0 10.9507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.198 0 0 0 0 0 0 0 0 0 10.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2031 10.3365 0 0 0 0 0 0 0 10.5392 0 0 0 0 0 0 10.8097 0 11.8383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2J2 TUTLA_HUMAN "Protein turtle homolog A (Immunoglobulin superfamily member 9A, IgSF9A)" IGSF9 IGSF9A KIAA1355 NRT1 Homo sapiens (Human) axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807] anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of synapse organization [GO:0050807] GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0016358; GO:0030424; GO:0030425; GO:0050807; GO:0060077; GO:0070161; GO:0070593; GO:0098632 cell-cell adhesion mediator activity [GO:0098632] ARLPAYR 0.96574 -0.14829 0 0 0 0 0 0 0 0 11.4592 12.6714 0 0 0 0 16.8468 0 0 0 0 0 0 0 0 0 0 0 0 17.0329 17.082 17.1628 0 0 16.905 0 11.7309 0 17.0574 0 16.9702 11.6919 16.9011 0 12.6401 0 0 12.4051 16.6896 11.7261 13.5053 17.1184 12.5893 0 0 16.7528 16.6933 17.008 17.0758 16.9701 12.3344 16.543 16.4762 16.3347 16.4751 16.2439 0 16.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9595 13.9545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5287 13.4855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.935 0 0 0 0 0 0 0 0 0 0 13.5418 13.6758 18.0274 0 0 13.6203 13.5499 0 0 13.1658 0 12.6156 0 0 0 0 0 15.8578 0 13.3346 0 0 O95571 ETHE1_HUMAN "Persulfide dioxygenase ETHE1, mitochondrial, EC 1.13.11.18 (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)" ETHE1 HSCO Homo sapiens (Human) glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813]" GO:0005506; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006749; GO:0016788; GO:0042802; GO:0050313; GO:0070813 "hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]" IMGNLNLPK 0.96575 -0.15029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2564 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6V4 CJ053_HUMAN UPF0728 protein C10orf53 C10orf53 Homo sapiens (Human) ARIAVLNAY 0.96575 -0.14918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5587 0 12.4966 12.373 11.6826 0 0 0 0 0 12.1294 12.3256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0139 0 12.6775 0 0 0 0 12.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0899 0 0 0 0 12.2585 0 0 0 0 0 15.9311 0 0 0 0 0 11.9712 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0B1 FTO_HUMAN "Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO, EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, m6A(m)-demethylase FTO, EC 1.14.11.-) (mRNA N(6)-methyladenosine demethylase FTO, EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO, EC 1.14.11.-)" FTO KIAA1752 Homo sapiens (Human) adipose tissue development [GO:0060612]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; mRNA destabilization [GO:0061157]; oxidative demethylation [GO:0070989]; oxidative single-stranded DNA demethylation [GO:0035552]; oxidative single-stranded RNA demethylation [GO:0035553]; regulation of brown fat cell differentiation [GO:0090335]; regulation of lipid storage [GO:0010883]; regulation of multicellular organism growth [GO:0040014]; regulation of respiratory system process [GO:0044065]; regulation of white fat cell proliferation [GO:0070350]; RNA repair [GO:0042245]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; transferase activity [GO:0016740]; tRNA demethylase activity [GO:1990984]; adipose tissue development [GO:0060612]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; mRNA destabilization [GO:0061157]; oxidative demethylation [GO:0070989]; oxidative single-stranded DNA demethylation [GO:0035552]; oxidative single-stranded RNA demethylation [GO:0035553]; regulation of brown fat cell differentiation [GO:0090335]; regulation of lipid storage [GO:0010883]; regulation of multicellular organism growth [GO:0040014]; regulation of respiratory system process [GO:0044065]; regulation of white fat cell proliferation [GO:0070350]; RNA repair [GO:0042245]; temperature homeostasis [GO:0001659] GO:0001659; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006307; GO:0008198; GO:0010883; GO:0016607; GO:0016740; GO:0035515; GO:0035516; GO:0035552; GO:0035553; GO:0040014; GO:0042245; GO:0043231; GO:0043734; GO:0044065; GO:0060612; GO:0061157; GO:0070350; GO:0070989; GO:0080111; GO:0090335; GO:1990931; GO:1990984 DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; transferase activity [GO:0016740]; tRNA demethylase activity [GO:1990984] EWHARCQSR 0.96575 -0.053656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKY7 CDV3_HUMAN Protein CDV3 homolog CDV3 H41 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] GO:0005737; GO:0005829; GO:0005886 EEDDNEKRQDPGDNWEEGGGGGGGMEK 0.96575 -0.28834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3032 0 0 0 0 0 0 0 0 0 O75478 TAD2A_HUMAN "Transcriptional adapter 2-alpha (Transcriptional adapter 2-like, ADA2-like protein)" TADA2A TADA2L KL04P Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of histone acetylation [GO:0035066]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; chromosome [GO:0005694]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] "ATAC complex [GO:0140672]; chromosome [GO:0005694]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of histone acetylation [GO:0035066]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" GO:0000124; GO:0003677; GO:0003682; GO:0003713; GO:0005634; GO:0005694; GO:0006338; GO:0006355; GO:0006357; GO:0016573; GO:0031063; GO:0035066; GO:0043966; GO:0044154; GO:0045995; GO:0046872; GO:0051302; GO:0051726; GO:0070461; GO:0072686; GO:0090043; GO:0140672 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713] CAECGPPPFFLCLQCFTRGFEYKK 0.96576 -0.15166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7298 0 0 0 0 0 0 0 0 0 13.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4394 14.7583 0 0 0 0 0 0 0 12.7388 0 0 0 0 0 0 12.7352 0 0 0 0 0 0 0 0 0 0 12.0658 0 13.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1713 0 0 12.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5561 12.3815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16298 PP2BB_HUMAN "Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, EC 3.1.3.16 (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform, CNA beta)" PPP3CB CALNA2 CALNB CNA2 Homo sapiens (Human) "axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of signaling [GO:0023057]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell mediated cytotoxicity [GO:0001913]; T cell proliferation [GO:0042098]" calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; T-tubule [GO:0030315]; Z disc [GO:0030018] "calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; myosin phosphatase activity [GO:0017018]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722]; axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of signaling [GO:0023057]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell mediated cytotoxicity [GO:0001913]; T cell proliferation [GO:0042098]" GO:0001913; GO:0001915; GO:0001946; GO:0004722; GO:0005509; GO:0005516; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005955; GO:0006468; GO:0006470; GO:0007165; GO:0007507; GO:0007612; GO:0007613; GO:0008287; GO:0016311; GO:0017018; GO:0017156; GO:0019899; GO:0023057; GO:0030018; GO:0030217; GO:0030315; GO:0030346; GO:0031987; GO:0033173; GO:0033192; GO:0034097; GO:0035774; GO:0042098; GO:0042110; GO:0043029; GO:0045893; GO:0045944; GO:0046983; GO:0048167; GO:0048675; GO:0048741; GO:0050796; GO:0070886; GO:0097720; GO:0098978; GO:1900242; GO:1901386; GO:1901387; GO:1905665; GO:1905949 calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; myosin phosphatase activity [GO:0017018]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722] HLTEYFTFKQECKIK 0.96576 -0.39505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5396 17.7968 17.5218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LB9 PGRP3_HUMAN "Peptidoglycan recognition protein 3 (Peptidoglycan recognition protein I-alpha, PGLYRPIalpha, PGRP-I-alpha) (Peptidoglycan recognition protein intermediate alpha)" PGLYRP3 PGRPIA Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253] extracellular region [GO:0005576]; membrane [GO:0016020]; protein-containing complex [GO:0032991] extracellular region [GO:0005576]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; protein heterodimerization activity [GO:0046982]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253] GO:0005576; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016020; GO:0016045; GO:0031640; GO:0032689; GO:0032827; GO:0032991; GO:0042834; GO:0045087; GO:0046982; GO:0050830; GO:0051701; GO:0061844 N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; protein heterodimerization activity [GO:0046982]; zinc ion binding [GO:0008270] GLQSHSVYTIGWCDVAYNFLVGDDGR 0.96576 -0.15062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2323 12.5831 0 0 0 0 0 12.2705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9654 0 11.0093 0 0 0 0 0 0 0 0 0 0 0 0 10.9564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54750 PDE1A_HUMAN "Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A, Cam-PDE 1A, EC 3.1.4.17 (61 kDa Cam-PDE) (hCam-1)" PDE1A Homo sapiens (Human) signal transduction [GO:0007165] cytosol [GO:0005829]; neuronal cell body [GO:0043025] "cytosol [GO:0005829]; neuronal cell body [GO:0043025]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]; signal transduction [GO:0007165]" GO:0004114; GO:0004117; GO:0005516; GO:0005829; GO:0007165; GO:0043025; GO:0046872; GO:0048101 "3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]" FMIYELFTR 0.96577 -0.37087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5401 0 0 0 0 0 0 11.7597 0 0 11.6576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2005 0 0 0 0 0 0 0 0 0 0 0 0 12.6425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6QNK2 AGRD1_HUMAN Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) ADGRD1 GPR133 PGR25 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005654; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] AAFKHKTK 0.96577 -0.39538 0 0 0 0 0 0 0 0 0 0 11.3122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5337 0 0 13.8803 0 0 0 13.2613 0 0 0 0 0 0 0 0 0 0 0 0 11.5629 0 0 14.9912 13.774 14.0024 0 13.0156 0 0 11.4676 12.0615 0 11.9268 0 12.308 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5686 0 0 0 12.3426 12.4493 12.9414 0 12.7963 0 0 0 0 0 13.0026 0 0 0 0 0 0 0 0 0 0 11.9748 0 0 0 13.0084 0 0 0 0 0 0 12.2547 0 0 0 0 0 0 0 0 0 0 0 0 12.8644 0 12.0116 0 0 11.9168 0 Q8WW12 PCNP_HUMAN "PEST proteolytic signal-containing nuclear protein, PCNP, PEST-containing nuclear protein" PCNP Homo sapiens (Human) cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005654; GO:0007049; GO:0016567; GO:0016604; GO:0043161 ADGKAGDEKPEK 0.96577 -0.030938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4K8 TRI46_HUMAN "Tripartite motif-containing protein 46 (Gene Y protein, GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein)" TRIM46 TRIFIC Homo sapiens (Human) anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of protein localization [GO:0032880] axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769] axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoskeleton [GO:0005856]; main axon [GO:0044304]; proximal neuron projection [GO:1990769]; zinc ion binding [GO:0008270]; anterograde synaptic vesicle transport [GO:0048490]; axonogenesis [GO:0007409]; microtubule bundle formation [GO:0001578]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; positive regulation of anterograde dense core granule transport [GO:1901953]; protein localization to axon [GO:0099612]; regulation of protein localization [GO:0032880] GO:0001578; GO:0001764; GO:0005856; GO:0007409; GO:0008270; GO:0030517; GO:0032880; GO:0043194; GO:0044304; GO:0048490; GO:0099612; GO:1901953; GO:1904115; GO:1990769 zinc ion binding [GO:0008270] DGPTAGCTVPLPPRLGICLDYERGR 0.96578 -0.37371 0 0 0 0 0 0 0 0 0 0 0 0 10.4187 0 15.6504 14.0077 0 0 0 0 14.4404 0 0 0 0 14.4852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5926 14.1463 12.8473 0 0 13.1126 0 14.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5452 12.3296 0 0 0 14.6091 13.0769 0 12.5007 19.9941 0 0 0 0 0 14.8229 0 0 0 0 14.2933 0 0 0 0 0 0 11.9603 0 0 0 0 0 0 0 0 0 13.646 0 0 0 0 0 0 13.0689 0 0 0 0 0 11.9825 0 0 0 0 0 0 0 0 0 12.2684 0 0 0 0 0 0 0 0 0 0 14.8235 0 0 14.2311 0 0 0 12.4262 0 0 0 12.7768 0 0 0 0 0 0 0 0 0 15.6764 0 0 0 0 0 0 0 10.9654 0 0 0 0 12.0363 0 Q96AP0 ACD_HUMAN Adrenocortical dysplasia protein homolog (POT1 and TIN2-interacting protein) ACD PIP1 PTOP TINT1 TPP1 Homo sapiens (Human) "embryonic limb morphogenesis [GO:0030326]; establishment of protein localization to telomere [GO:0070200]; intracellular protein transport [GO:0006886]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of single-stranded telomeric DNA binding [GO:0060381]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; segmentation [GO:0035282]; skeletal system development [GO:0001501]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; urogenital system development [GO:0001655]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomerase holoenzyme complex [GO:0005697]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]; embryonic limb morphogenesis [GO:0030326]; establishment of protein localization to telomere [GO:0070200]; intracellular protein transport [GO:0006886]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of single-stranded telomeric DNA binding [GO:0060381]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; segmentation [GO:0035282]; skeletal system development [GO:0001501]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; urogenital system development [GO:0001655]" GO:0000723; GO:0000781; GO:0000783; GO:0001501; GO:0001655; GO:0005654; GO:0005697; GO:0006886; GO:0007004; GO:0016233; GO:0016604; GO:0030326; GO:0031848; GO:0032202; GO:0032206; GO:0032211; GO:0032212; GO:0035282; GO:0042162; GO:0044877; GO:0051973; GO:0060381; GO:0070182; GO:0070187; GO:0070198; GO:0070200 DNA polymerase binding [GO:0070182]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162] EALDTSDWEEKEFGFR 0.96578 -0.37313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15172 MYOD1_HUMAN "Myoblast determination protein 1 (Class C basic helix-loop-helix protein 1, bHLHc1) (Myogenic factor 3, Myf-3)" MYOD1 BHLHC1 MYF3 MYOD Homo sapiens (Human) "cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to oxygen levels [GO:0071453]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; myoblast fate determination [GO:0007518]; myoblast fusion [GO:0007520]; myotube cell development [GO:0014904]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of chromatin binding [GO:0035562]; negative regulation of myoblast proliferation [GO:2000818]; positive regulation of binding [GO:0051099]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; euchromatin [GO:0000791]; myofibril [GO:0030016]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; euchromatin [GO:0000791]; myofibril [GO:0030016]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin protein ligase binding [GO:0031625]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to oxygen levels [GO:0071453]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; myoblast fate determination [GO:0007518]; myoblast fusion [GO:0007520]; myotube cell development [GO:0014904]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of chromatin binding [GO:0035562]; negative regulation of myoblast proliferation [GO:2000818]; positive regulation of binding [GO:0051099]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle fiber adaptation [GO:0043503]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]" GO:0000381; GO:0000785; GO:0000791; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006366; GO:0006468; GO:0007517; GO:0007518; GO:0007519; GO:0007520; GO:0009267; GO:0014904; GO:0014908; GO:0016922; GO:0030016; GO:0031490; GO:0031625; GO:0035562; GO:0035914; GO:0042693; GO:0042803; GO:0043415; GO:0043425; GO:0043484; GO:0043503; GO:0043966; GO:0043967; GO:0045663; GO:0045944; GO:0048741; GO:0048743; GO:0051099; GO:0051149; GO:0061629; GO:0070888; GO:0071356; GO:0071385; GO:0071392; GO:0071453; GO:1901741; GO:1905382; GO:1990837; GO:1990841; GO:2000818 "bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin protein ligase binding [GO:0031625]" CLLWACKACK 0.96579 -0.033294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0955 12.7035 11.3533 0 0 0 0 0 0 0 0 0 11.7552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3786 11.0908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MN9 ZN488_HUMAN Zinc finger protein 488 ZNF488 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0005634; GO:0006355; GO:0014003; GO:0031643; GO:0045892; GO:0046872; GO:0048714 DNA binding [GO:0003677]; metal ion binding [GO:0046872] CNLSFRLTSDLVFHMRSHHK 0.96579 -0.057169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYZ2 MFRN1_HUMAN Mitoferrin-1 (Mitochondrial iron transporter 1) (Mitochondrial solute carrier protein) (Solute carrier family 25 member 37) SLC25A37 MFRN MSCP HT015 Homo sapiens (Human) iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]; positive regulation of hemoglobin biosynthetic process [GO:0046985] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ferrous iron transmembrane transporter activity [GO:0015093]; iron import into the mitochondrion [GO:0048250]; iron ion homeostasis [GO:0055072]; positive regulation of hemoglobin biosynthetic process [GO:0046985] GO:0005739; GO:0005743; GO:0015093; GO:0016021; GO:0031966; GO:0046985; GO:0048250; GO:0055072 ferrous iron transmembrane transporter activity [GO:0015093] KIMRTEGFWR 0.96579 -0.90496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46108 CRK_HUMAN Adapter molecule crk (Proto-oncogene c-Crk) (p38) CRK Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to endothelin [GO:1990859]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nitric oxide [GO:0071732]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of cell growth [GO:0030307]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to membrane [GO:0072657]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein binding [GO:0043393]; regulation of Rac protein signal transduction [GO:0035020]; regulation of signal transduction [GO:0009966]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholecystokinin [GO:0061847]; response to hepatocyte growth factor [GO:0035728]; response to hydrogen peroxide [GO:0042542]; response to yeast [GO:0001878]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; insulin-like growth factor receptor binding [GO:0005159]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; protein phosphorylated amino acid binding [GO:0045309]; protein self-association [GO:0043621]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to endothelin [GO:1990859]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nitric oxide [GO:0071732]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of cell growth [GO:0030307]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to membrane [GO:0072657]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein binding [GO:0043393]; regulation of Rac protein signal transduction [GO:0035020]; regulation of signal transduction [GO:0009966]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholecystokinin [GO:0061847]; response to hepatocyte growth factor [GO:0035728]; response to hydrogen peroxide [GO:0042542]; response to yeast [GO:0001878]; signal transduction [GO:0007165] GO:0001764; GO:0001784; GO:0001878; GO:0005159; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006629; GO:0007165; GO:0008092; GO:0008283; GO:0008360; GO:0009966; GO:0014911; GO:0015629; GO:0016020; GO:0016358; GO:0016477; GO:0017124; GO:0019900; GO:0021766; GO:0021987; GO:0030010; GO:0030036; GO:0030159; GO:0030307; GO:0030971; GO:0031625; GO:0032956; GO:0032991; GO:0033628; GO:0035020; GO:0035591; GO:0035685; GO:0035728; GO:0038026; GO:0042169; GO:0042542; GO:0043087; GO:0043393; GO:0043621; GO:0045121; GO:0045309; GO:0045953; GO:0046330; GO:0046875; GO:0048013; GO:0050773; GO:0060326; GO:0061045; GO:0061847; GO:0070062; GO:0071560; GO:0071732; GO:0072657; GO:0090630; GO:0097110; GO:0098749; GO:1900026; GO:1902531; GO:1990090; GO:1990314; GO:1990782; GO:1990859; GO:2000146; GO:2000404 cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; insulin-like growth factor receptor binding [GO:0005159]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; protein phosphorylated amino acid binding [GO:0045309]; protein self-association [GO:0043621]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin protein ligase binding [GO:0031625] LLDQQNPDEDFS 0.9658 -0.060186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2983 0 0 0 0 0 0 14.1545 0 13.8861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.813 0 0 0 12.8278 0 0 0 0 0 0 0 0 0 0 0 12.4105 0 0 0 0 0 0 0 0 0 14.9532 14.9505 0 0 0 0 0 0 0 0 0 0 14.4152 0 0 Q8IVL5 P3H2_HUMAN "Prolyl 3-hydroxylase 2, EC 1.14.11.7 (Leprecan-like protein 1) (Myxoid liposarcoma-associated protein 4)" P3H2 LEPREL1 MLAT4 Homo sapiens (Human) collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511] basement membrane [GO:0005604]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529] basement membrane [GO:0005604]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-proline hydroxylation [GO:0019511] GO:0005506; GO:0005604; GO:0005654; GO:0005783; GO:0005788; GO:0005794; GO:0005829; GO:0008285; GO:0016529; GO:0019511; GO:0019797; GO:0031418; GO:0032963; GO:0043231 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797] ELATRPGR 0.9658 -0.9088 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0291 0 14.5899 0 0 0 0 0 0 12.32 0 0 0 0 0 14.2233 0 0 0 0 0 0 0 0 11.2697 0 0 0 12.82 0 0 12.9186 0 0 12.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4865 0 13.8089 0 0 0 0 0 0 0 0 14.2115 0 13.1977 14.4951 13.9461 11.8011 0 0 0 0 0 0 14.1023 14.6585 14.2842 14.2099 13.4521 13.7174 0 0 14.2338 0 0 0 0 12.7935 13.0978 0 12.9469 0 0 15.1815 0 0 0 0 13.7087 13.3582 13.3512 0 0 0 14.0884 0 0 0 0 0 0 14.1695 14.8159 0 12.5209 0 0 0 0 0 0 0 12.3104 0 0 11.4693 14.5041 15.4677 15.4468 14.7703 0 0 0 0 0 14.0229 0 13.3943 0 0 0 0 13.0824 0 13.6104 0 0 12.5198 0 0 11.0267 0 0 Q96PD7 DGAT2_HUMAN "Diacylglycerol O-acyltransferase 2, EC 2.3.1.20 (Acyl-CoA retinol O-fatty-acyltransferase, ARAT, Retinol O-fatty-acyltransferase, EC 2.3.1.76) (Diglyceride acyltransferase 2)" DGAT2 HMFN1045 UNQ738/PRO1433 Homo sapiens (Human) bile acid signaling pathway [GO:0038183]; cellular response to oleic acid [GO:0071400]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; diacylglycerol biosynthetic process [GO:0006651]; diacylglycerol metabolic process [GO:0046339]; fat pad development [GO:0060613]; fatty acid homeostasis [GO:0055089]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; low-density lipoprotein particle clearance [GO:0034383]; monoacylglycerol biosynthetic process [GO:0006640]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cholesterol metabolic process [GO:0090181]; regulation of lipoprotein metabolic process [GO:0050746]; regulation of plasma lipoprotein particle levels [GO:0097006]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; protein homodimerization activity [GO:0042803]; retinol O-fatty-acyltransferase activity [GO:0050252]; bile acid signaling pathway [GO:0038183]; cellular response to oleic acid [GO:0071400]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; diacylglycerol biosynthetic process [GO:0006651]; diacylglycerol metabolic process [GO:0046339]; fat pad development [GO:0060613]; fatty acid homeostasis [GO:0055089]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; low-density lipoprotein particle clearance [GO:0034383]; monoacylglycerol biosynthetic process [GO:0006640]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cholesterol metabolic process [GO:0090181]; regulation of lipoprotein metabolic process [GO:0050746]; regulation of plasma lipoprotein particle levels [GO:0097006]; triglyceride biosynthetic process [GO:0019432] GO:0003846; GO:0004144; GO:0005739; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0010867; GO:0016021; GO:0019432; GO:0019915; GO:0030176; GO:0034383; GO:0035336; GO:0035356; GO:0038183; GO:0042632; GO:0042803; GO:0043231; GO:0045722; GO:0046322; GO:0046339; GO:0048471; GO:0050252; GO:0050746; GO:0055089; GO:0060613; GO:0071400; GO:0090181; GO:0097006; GO:1990578 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; protein homodimerization activity [GO:0042803]; retinol O-fatty-acyltransferase activity [GO:0050252] GLFSSDTWGLVPYSKPITTVVGEPITIPK 0.9658 -0.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9482 0 0 11.6692 0 0 0 0 0 0 0 0 0 0 15.5604 0 14.0943 13.7815 0 0 0 0 0 0 0 0 0 0 12.131 0 0 13.4653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1981 0 0 0 0 0 Q1A5X7 WHAL1_HUMAN "Putative WASP homolog-associated protein with actin, membranes and microtubules-like protein 1 (WAS protein homolog associated with actin, Golgi membranes and microtubules pseudogene 3) (WAS protein homology region 2 domain-containing protein 1-like protein 1, WH2 domain-containing protein 1-like protein 1, WHDC1-like protein 1)" WHAMMP3 WHAMML1 WHDC1L1 Homo sapiens (Human) Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Arp2/3 complex binding [GO:0071933]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888] GO:0005737; GO:0006888; GO:0033116; GO:0034314; GO:0071933 Arp2/3 complex binding [GO:0071933] EILLTTQLDSLERLIK 0.96581 0.0052808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.512 0 0 13.6473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9261 13.8117 0 0 14.4591 0 0 0 0 0 0 0 0 0 Q86YN1 DOPP1_HUMAN "Dolichyldiphosphatase 1, EC 3.6.1.43 (Dolichyl pyrophosphate phosphatase 1)" DOLPP1 LSFR2 Homo sapiens (Human) dolichyl diphosphate biosynthetic process [GO:0006489]; lipid biosynthetic process [GO:0008610]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; dolichyldiphosphatase activity [GO:0047874]; dolichyl diphosphate biosynthetic process [GO:0006489]; lipid biosynthetic process [GO:0008610]; protein N-linked glycosylation [GO:0006487] GO:0005789; GO:0006487; GO:0006489; GO:0008610; GO:0030176; GO:0043231; GO:0047874 dolichyldiphosphatase activity [GO:0047874] ELHTISFLGGLALNEGVNWLIKNVIQEPR 0.96581 -0.37868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5302 13.8236 0 0 0 0 14.5637 0 14.4293 0 0 0 0 0 0 0 0 14.7942 0 0 0 0 0 14.4768 14.1894 14.6646 14.3003 0 14.6272 14.0572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7263 0 0 0 14.1514 0 0 0 0 0 0 16.0631 0 0 0 11.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VUB5 F1711_HUMAN "Protein FAM171A1 (Astroprincin, APCN)" FAM171A1 APCN C10orf38 Homo sapiens (Human) regulation of cell shape [GO:0008360]; stress fiber assembly [GO:0043149] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of cell shape [GO:0008360]; stress fiber assembly [GO:0043149] GO:0005886; GO:0008360; GO:0016021; GO:0043149 GDALSLQQNYPPVQEHQQKEPR 0.96582 -0.91327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6417 0 0 0 0 0 11.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4567 0 0 0 0 0 0 0 0 12.0529 14.279 0 0 0 0 0 12.9674 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8585 18.2471 17.3275 17.0613 0 0 0 17.873 17.7574 0 16.5583 17.6477 0 0 0 0 0 17.7724 0 16.603 0 17.5786 19.2001 18.5248 0 0 17.8883 18.2178 18.9639 17.962 16.8585 0 16.8271 16.9782 16.334 11.362 17.9182 17.5267 17.3175 0 0 18.2044 17.5228 17.7263 0 0 16.7097 0 0 0 0 0 0 0 16.035 0 0 0 0 0 0 12.128 0 0 0 0 0 0 11.1315 0 14.1804 13.6819 18.1655 17.8531 17.7439 0 0 0 0 0 0 Q8N137 CNTRB_HUMAN Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8) CNTROB LIP8 PP1221 Homo sapiens (Human) centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017] GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0019904; GO:0051299; GO:1902017; GO:1902410 protein domain specific binding [GO:0019904] HCERHIQSLQTRVLELQQQLAVAVAADR 0.96582 -0.049851 0 0 9.35621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3615 0 11.5066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1049 0 0 0 14.834 0 0 0 0 0 0 0 0 0 0 0 12.7215 0 12.3517 0 0 12.7235 0 0 0 0 0 13.688 0 11.6291 0 0 13.0153 0 0 0 0 0 0 0 0 0 0 0 10.7068 0 0 12.4028 0 11.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGI6 OR4DA_HUMAN Olfactory receptor 4D10 (Olfactory receptor OR11-251) OR4D10 OR4D10P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AISVTFTVISPLLNPLIYTLR 0.96582 -0.049712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36980 FHR2_HUMAN "Complement factor H-related protein 2, FHR-2 (DDESK59) (H factor-like 3) (H factor-like protein 2)" CFHR2 CFHL2 FHR2 HFL3 Homo sapiens (Human) complement activation [GO:0006956]; cytolysis by host of symbiont cells [GO:0051838]; negative regulation of protein binding [GO:0032091] extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; complement component C3b binding [GO:0001851]; identical protein binding [GO:0042802]; complement activation [GO:0006956]; cytolysis by host of symbiont cells [GO:0051838]; negative regulation of protein binding [GO:0032091] GO:0001851; GO:0005576; GO:0005615; GO:0006956; GO:0032091; GO:0032991; GO:0042802; GO:0051838 complement component C3b binding [GO:0001851]; identical protein binding [GO:0042802] TGDIVEFVCK 0.96586 -0.36437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0A6YYL3 POTEB_HUMAN "POTE ankyrin domain family member B (ANKRD26-like family B member 1) (Prostate, ovary, testis-expressed protein on chromosome 15, POTE-15)" POTEB Homo sapiens (Human) KDLIVMLR 0.96587 0.01128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3Q3 TMED3_HUMAN "Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4, p24gamma4) (p26)" TMED3 C15orf22 UNQ5357/PRO1078 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886] COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886] GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030126; GO:0030133; GO:0030134; GO:0032580; GO:0033116 GSTVPRSASVLLLLLLLR 0.96587 4.3625 0 0 14.7539 0 13.2122 0 0 0 0 0 0 0 14.1219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3386 0 0 0 0 0 0 0 0 0 11.6345 0 13.9281 14.2444 0 13.2317 0 14.3396 0 0 0 0 0 0 11.2262 12.7523 0 0 13.3028 13.2418 0 12.031 12.7919 0 0 0 14.1132 14.73 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2664 11.8192 10.6352 0 0 0 0 0 0 0 13.1018 0 12.9467 0 0 0 11.9742 0 0 0 0 10.356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4763 0 0 0 0 Q9Y6D0 SELK_HUMAN "Selenoprotein K, SelK" SELENOK SELK HSPC030 HSPC297 Homo sapiens (Human) calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; establishment of localization in cell [GO:0051649]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; macrophage derived foam cell differentiation [GO:0010742]; neutrophil migration [GO:1990266]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; protein palmitoylation [GO:0018345]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein transport [GO:0051223]; respiratory burst after phagocytosis [GO:0045728]; response to oxidative stress [GO:0006979]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; calcium ion transport [GO:0006816]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; establishment of localization in cell [GO:0051649]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; macrophage derived foam cell differentiation [GO:0010742]; neutrophil migration [GO:1990266]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; protein palmitoylation [GO:0018345]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein transport [GO:0051223]; respiratory burst after phagocytosis [GO:0045728]; response to oxidative stress [GO:0006979]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098] GO:0002230; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006816; GO:0006979; GO:0010742; GO:0016021; GO:0018345; GO:0032469; GO:0032755; GO:0032760; GO:0042098; GO:0042102; GO:0042802; GO:0045728; GO:0050848; GO:0051223; GO:0051649; GO:0070059; GO:0071639; GO:0072678; GO:1902624; GO:1990266; GO:2000406 identical protein binding [GO:0042802] SYGNSSDSRYDDGR 0.96587 0.01128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NH52 TV23A_HUMAN Golgi apparatus membrane protein TVP23 homolog A TVP23A FAM18A Homo sapiens (Human) protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] integral component of Golgi membrane [GO:0030173] integral component of Golgi membrane [GO:0030173]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] GO:0009306; GO:0016192; GO:0030173 IRHPLATFFHLFFR 0.96588 0.01128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76071 CIAO1_HUMAN Probable cytosolic iron-sulfur protein assembly protein CIAO1 (WD repeat-containing protein 39) CIAO1 CIA1 WDR39 Homo sapiens (Human) chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of cell population proliferation [GO:0008284]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of transcription by RNA polymerase II [GO:0006357] CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817] CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of cell population proliferation [GO:0008284]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005737; GO:0006357; GO:0007059; GO:0008284; GO:0016226; GO:0071817; GO:0097361; GO:0097428 DSLVLLGR 0.96588 -0.89707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.635 0 0 10.746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4891 0 0 0 0 0 0 0 0 0 0 0 0 10.1478 0 0 0 15.336 0 0 0 0 12.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2925 0 0 12.3633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9573 0 0 0 0 0 0 0 0 0 0 0 0 11.5699 0 0 0 0 16.81 15.7297 15.5891 14.8474 14.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05408 7B2_HUMAN Neuroendocrine protein 7B2 (Pituitary polypeptide) (Secretogranin V) (Secretogranin-5) (Secretory granule endocrine protein I) [Cleaved into: N-terminal peptide; C-terminal peptide ] SCG5 SGNE1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; regulation of hormone secretion [GO:0046883] extracellular region [GO:0005576]; nucleus [GO:0005634]; secretory granule [GO:0030141] extracellular region [GO:0005576]; nucleus [GO:0005634]; secretory granule [GO:0030141]; enzyme inhibitor activity [GO:0004857]; enzyme regulator activity [GO:0030234]; GTP binding [GO:0005525]; unfolded protein binding [GO:0051082]; intracellular protein transport [GO:0006886]; neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; regulation of hormone secretion [GO:0046883] GO:0004857; GO:0005525; GO:0005576; GO:0005634; GO:0006886; GO:0007218; GO:0016486; GO:0030141; GO:0030234; GO:0046883; GO:0051082 enzyme inhibitor activity [GO:0004857]; enzyme regulator activity [GO:0030234]; GTP binding [GO:0005525]; unfolded protein binding [GO:0051082] WNKKLLYEK 0.9659 -0.20587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N485 LIX1_HUMAN Protein limb expression 1 homolog LIX1 C5orf11 Homo sapiens (Human) autophagosome maturation [GO:0097352] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352] GO:0005737; GO:0097352 ALRETKCSR 0.9659 -0.9039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0239 0 0 0 0 0 0 12.3635 13.326 12.7135 0 0 0 0 0 0 0 0 0 0 0 Q96LS8 CB048_HUMAN Putative uncharacterized protein C2orf48 C2orf48 Homo sapiens (Human) CYSGCASGSGR 0.9659 -0.37084 0 0 0 0 0 0 12.1421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00483 NDUA4_HUMAN "Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ, CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit)" NDUFA4 Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; positive regulation of cytochrome-c oxidase activity [GO:1904960]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein-containing complex binding [GO:0044877]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; positive regulation of cytochrome-c oxidase activity [GO:1904960]" GO:0005739; GO:0005743; GO:0005747; GO:0005751; GO:0006120; GO:0006123; GO:0008137; GO:0031966; GO:0044877; GO:0045333; GO:1904960 NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein-containing complex binding [GO:0044877] MLRQIIGQAK 0.96591 -0.90466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2032 0 0 0 0 0 11.8693 0 0 0 0 0 0 0 11.5821 0 0 0 0 0 0 15.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14745 NHRF1_HUMAN "Na(+)/H(+) exchange regulatory cofactor NHE-RF1, NHERF-1 (Ezrin-radixin-moesin-binding phosphoprotein 50, EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1)" SLC9A3R1 NHERF NHERF1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; fibroblast migration [GO:0010761]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of protein kinase activity [GO:0045859]; regulation of renal phosphate excretion [GO:1903402]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane protein complex [GO:0098797]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; stereocilium tip [GO:0032426]; vesicle [GO:0031982]; beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; auditory receptor cell stereocilium organization [GO:0060088]; bile acid secretion [GO:0032782]; cellular phosphate ion homeostasis [GO:0030643]; cerebrospinal fluid circulation [GO:0090660]; cilium organization [GO:0044782]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; fibroblast migration [GO:0010761]; gamma-aminobutyric acid import [GO:0051939]; gland morphogenesis [GO:0022612]; glutathione transport [GO:0034635]; import across plasma membrane [GO:0098739]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; microvillus assembly [GO:0030033]; morphogenesis of an epithelium [GO:0002009]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sodium:proton antiporter activity [GO:0032416]; nuclear migration [GO:0007097]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; plasma membrane organization [GO:0007009]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ion transmembrane transport [GO:0034767]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of protein kinase activity [GO:0045859]; regulation of renal phosphate excretion [GO:1903402]; regulation of sodium:proton antiporter activity [GO:0032415]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; renal sodium ion transport [GO:0003096]; sensory perception of sound [GO:0007605]; transport across blood-brain barrier [GO:0150104]; Wnt signaling pathway [GO:0016055] GO:0001726; GO:0002009; GO:0003096; GO:0005102; GO:0005737; GO:0005902; GO:0007009; GO:0007097; GO:0007191; GO:0007605; GO:0008013; GO:0008285; GO:0008360; GO:0008361; GO:0010642; GO:0010761; GO:0010764; GO:0012505; GO:0014067; GO:0015185; GO:0015629; GO:0016020; GO:0016055; GO:0016324; GO:0017081; GO:0019902; GO:0022612; GO:0030033; GO:0030036; GO:0030165; GO:0030175; GO:0030643; GO:0031526; GO:0031528; GO:0031698; GO:0031799; GO:0031800; GO:0031982; GO:0032415; GO:0032416; GO:0032426; GO:0032782; GO:0034635; GO:0034767; GO:0042802; GO:0043495; GO:0043621; GO:0044782; GO:0044877; GO:0045121; GO:0045159; GO:0045198; GO:0045199; GO:0045859; GO:0045930; GO:0047485; GO:0048471; GO:0050780; GO:0051683; GO:0051898; GO:0051939; GO:0060088; GO:0060158; GO:0065003; GO:0070062; GO:0070293; GO:0070373; GO:0070851; GO:0071944; GO:0072659; GO:0090090; GO:0090660; GO:0097225; GO:0097291; GO:0098739; GO:0098797; GO:0150104; GO:1903402; GO:2001244 beta-2 adrenergic receptor binding [GO:0031698]; beta-catenin binding [GO:0008013]; chloride channel regulator activity [GO:0017081]; dopamine receptor binding [GO:0050780]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; phosphatase binding [GO:0019902]; protein N-terminus binding [GO:0047485]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800] EADKSHPEQRELR 0.96591 -0.2904 0 0 0 0 0 11.9264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1132 13.0681 0 14.9293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7864 0 12.6789 0 0 0 0 0 0 0 0 13.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1563 13.0027 0 0 0 0 13.0732 0 0 0 0 0 0 0 0 13.0746 0 0 0 0 P61601 NCALD_HUMAN Neurocalcin-delta NCALD Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; regulation of systemic arterial blood pressure [GO:0003073]; vesicle-mediated transport [GO:0016192] clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytosol [GO:0005829] clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytosol [GO:0005829]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; tubulin binding [GO:0015631]; calcium-mediated signaling [GO:0019722]; regulation of systemic arterial blood pressure [GO:0003073]; vesicle-mediated transport [GO:0016192] GO:0003073; GO:0003779; GO:0005509; GO:0005829; GO:0015631; GO:0016192; GO:0019722; GO:0030130; GO:0030276; GO:0043014 actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; tubulin binding [GO:0015631] EFIIALSVTSRGKLEQK 0.96591 -0.3725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66811 0 0 0 0 0 P35219 CAH8_HUMAN "Carbonic anhydrase-related protein, CARP (Carbonic anhydrase VIII, CA-VIII)" CA8 CALS Homo sapiens (Human) one-carbon metabolic process [GO:0006730]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]; phosphatidylinositol-mediated signaling [GO:0048015] GO:0004089; GO:0005737; GO:0006730; GO:0008270; GO:0016836; GO:0048015 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] SKTIPCFNPNTLLPDPLLR 0.96593 -0.056007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3768 17.6959 17.6303 17.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A3QJZ7 PRA27_HUMAN PRAME family member 27 PRAMEF27 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 DLRHPKR 0.96594 -0.056741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBG4 VPP4_HUMAN "V-type proton ATPase 116 kDa subunit a 4, V-ATPase 116 kDa isoform a 4 (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform)" ATP6V0A4 ATP6N1B ATP6N2 Homo sapiens (Human) intracellular pH reduction [GO:0051452]; ossification [GO:0001503]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; renal tubular secretion [GO:0097254]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035] "apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; intracellular pH reduction [GO:0051452]; ossification [GO:0001503]; proton transmembrane transport [GO:1902600]; regulation of pH [GO:0006885]; renal tubular secretion [GO:0097254]; sensory perception of sound [GO:0007605]; vacuolar acidification [GO:0007035]" GO:0000220; GO:0001503; GO:0005765; GO:0005768; GO:0005886; GO:0006885; GO:0007035; GO:0007605; GO:0010008; GO:0016021; GO:0016323; GO:0016324; GO:0016471; GO:0030670; GO:0031526; GO:0033176; GO:0045177; GO:0046961; GO:0051117; GO:0051452; GO:0070062; GO:0097254; GO:1902600 "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" CESLERILRFLEDEMQNEIVVQLLEK 0.96595 -0.06002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0189 0 0 0 0 0 0 0 0 0 0 0 0 12.2234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7201 0 0 0 0 0 0 0 0 12.4532 0 0 0 0 0 10.9673 0 0 0 0 0 0 0 0 0 0 0 12.6596 14.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5672 0 0 11.1952 0 0 0 0 0 0 12.0316 0 0 0 0 0 0 0 0 0 0 0 0 12.2182 0 Q8NCC3 PAG15_HUMAN "Phospholipase A2 group XV (1-O-acylceramide synthase, ACS) (LCAT-like lysophospholipase, LLPL, EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A and acyltransferase, EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4) (Lysosomal phospholipase A2, LPLA2)" PLA2G15 LYPLA3 UNQ341/PRO540 Homo sapiens (Human) ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; lipid metabolic process [GO:0006629]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270]; ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; lipid metabolic process [GO:0006629]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644] GO:0004622; GO:0005543; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006629; GO:0006644; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0009062; GO:0016020; GO:0016411; GO:0034638; GO:0043231; GO:0046338; GO:0046470; GO:0046471; GO:0047499; GO:0052739; GO:0052740; GO:0070062; GO:0102545 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270] FFQDIGFEDGWLMR 0.96597 0.0054488 0 0 0 0 11.8304 0 14.2915 13.7123 0 0 0 0 0 0 0 12.0454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3633 0 10.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8623 0 0 0 0 0 0 0 0 0 17.705 0 0 0 17.7219 0 0 18.1397 0 12.8683 13.2787 13.6494 0 13.1186 0 0 0 0 0 0 0 0 12.719 12.6252 0 0 0 10.9577 0 0 0 10.409 11.8909 10.94 0 12.6813 11.765 0 0 0 0 11.737 0 0 18.6938 0 12.6245 11.596 0 13.834 0 0 0 0 0 0 0 0 0 10.6153 0 10.6823 0 0 18.2316 18.185 0 0 0 13.2916 13.1239 13.5689 0 0 0 12.9401 13.0289 0 0 12.0013 0 11.2485 0 12.5435 0 17.8118 0 11.1945 0 0 0 0 0 0 0 12.0216 0 0 0 0 0 0 0 0 0 0 0 0 10.6896 11.6644 0 0 0 0 Q9BR26 OCSTP_HUMAN "Osteoclast stimulatory transmembrane protein, OC-STAMP" OCSTAMP C20orf123 Homo sapiens (Human) cellular response to estrogen stimulus [GO:0071391]; cellular response to tumor necrosis factor [GO:0071356]; multinuclear osteoclast differentiation [GO:0072674]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of osteoclast proliferation [GO:0090290] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cellular response to estrogen stimulus [GO:0071391]; cellular response to tumor necrosis factor [GO:0071356]; multinuclear osteoclast differentiation [GO:0072674]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of osteoclast proliferation [GO:0090290] GO:0016021; GO:0034241; GO:0045672; GO:0071356; GO:0071391; GO:0072674; GO:0090290 LGLLALLLVATAVAVATDHVAFLLAQATVDWAQK 0.96598 0.0044651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2655 0 0 0 0 0 0 0 0 0 0 0 0 12.5303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1839 0 0 0 13.7567 0 Q2M3T9 HYAL4_HUMAN "Hyaluronidase-4, Hyal-4, EC 3.2.1.35 (Chondroitin sulfate endo-beta-N-acetylgalactosaminidase) (Chondroitin sulfate hydrolase, CSHY) (Hyaluronoglucosaminidase-4)" HYAL4 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate catabolic process [GO:0030207]; glycosaminoglycan catabolic process [GO:0006027]; hyaluronan catabolic process [GO:0030214] GO:0004415; GO:0005975; GO:0006027; GO:0009986; GO:0016021; GO:0030207; GO:0030214; GO:0031410 hyalurononglucosaminidase activity [GO:0004415] ETIKLGIK 0.966 -0.9253 13.3573 14.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7865 0 0 0 0 13.5174 0 0 0 0 0 0 0 0 0 0 10.3538 0 0 0 0 0 0 0 0 0 0 10.9215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1465 0 0 0 0 0 0 0 0 0 0 0 0 12.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9374 0 0 0 0 0 0 0 0 12.4144 13.6745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7461 0 0 0 0 0 0 0 0 11.0674 0 0 0 0 0 0 0 0 0 13.6124 0 0 11.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IMI6 ST1C3_HUMAN "Sulfotransferase 1C3, ST1C3, EC 2.8.2.1, EC 2.8.2.2" SULT1C3 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; sulfation [GO:0051923]; sulfur compound metabolic process [GO:0006790]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; alcohol sulfotransferase activity [GO:0004027]; aryl sulfotransferase activity [GO:0004062]; bile-salt sulfotransferase activity [GO:0047704]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; sulfation [GO:0051923]; sulfur compound metabolic process [GO:0006790]; xenobiotic metabolic process [GO:0006805] GO:0004027; GO:0004062; GO:0005737; GO:0006629; GO:0006790; GO:0006805; GO:0008146; GO:0008203; GO:0047704; GO:0050427; GO:0050656; GO:0051923 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; alcohol sulfotransferase activity [GO:0004027]; aryl sulfotransferase activity [GO:0004062]; bile-salt sulfotransferase activity [GO:0047704]; sulfotransferase activity [GO:0008146] EIEKILK 0.966 -0.89589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A5D8T8 CL18A_HUMAN C-type lectin domain family 18 member A (Mannose receptor-like protein 2) CLEC18A MRLP2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; polysaccharide binding [GO:0030247] GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0030247 polysaccharide binding [GO:0030247] EEECSCVCDIGYGGAQCATK 0.96601 -0.92688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8417 0 15.2761 0 0 0 0 0 12.9783 0 0 0 0 0 12.7499 0 0 0 15.3756 0 0 0 0 15.2447 0 0 14.3936 13.9306 13.6982 0 0 0 0 0 0 13.9931 0 0 0 0 11.779 0 0 0 0 15.2034 0 0 0 0 14.5986 0 12.3082 15.0178 0 0 13.9184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0682 0 0 0 0 0 0 0 0 Q8WVE0 EFMT1_HUMAN "EEF1A lysine methyltransferase 1, EC 2.1.1.- (N(6)-adenine-specific DNA methyltransferase 2) (Protein-lysine N-methyltransferase N6AMT2) (eEF1A-KMT)" EEF1AKMT1 N6AMT2 Homo sapiens (Human) peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479] cytosol [GO:0005829] cytosol [GO:0005829]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479] GO:0003676; GO:0005829; GO:0006479; GO:0008168; GO:0016279; GO:0018022 methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-lysine N-methyltransferase activity [GO:0016279] IACVSAPSVYQKLR 0.96602 0.01128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8A6 DDX51_HUMAN "ATP-dependent RNA helicase DDX51, EC 3.6.4.13 (DEAD box protein 51)" DDX51 Homo sapiens (Human) rRNA processing [GO:0006364] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016020; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] EQESLVQKTADGYR 0.96603 -0.90286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2466 0 0 0 0 0 0 0 0 11.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6895 0 0 12.4898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6927 0 0 0 0 12.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.5392 0 21.9091 0 0 0 0 0 0 0 0 20.9712 0 0 0 0 0 20.0486 0 19.547 0 0 0 14.555 0 13.6763 12.5717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1641 0 19.4615 19.5347 0 0 0 0 0 0 19.1575 18.6088 0 0 0 0 0 0 0 0 19.3443 0 0 13.8946 0 0 0 0 0 0 0 0 0 0 13.2928 0 0 0 0 0 0 18.6216 0 16.4972 0 16.7236 0 Q8NA29 NLS1_HUMAN "Sodium-dependent lysophosphatidylcholine symporter 1, NLS1, Sodium-dependent LPC symporter 1 (Major facilitator superfamily domain-containing protein 2A, HsMFSD2A, MFSD2a)" MFSD2A MFSD2 NLS1 HMFN0656 PP9177 UNQ300/PRO341 Homo sapiens (Human) brain development [GO:0007420]; carbohydrate transport [GO:0008643]; cellular response to starvation [GO:0009267]; cognition [GO:0050890]; energy homeostasis [GO:0097009]; establishment of blood-brain barrier [GO:0060856]; fatty acid transport [GO:0015908]; hippocampus development [GO:0021766]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid transport [GO:0015909]; lysophospholipid translocation [GO:0140329]; lysophospholipid transport [GO:0051977]; maintenance of blood-brain barrier [GO:0035633]; motor behavior [GO:0061744]; negative regulation of fatty acid beta-oxidation [GO:0031999]; organic substance transport [GO:0071702]; phosphatidylcholine biosynthetic process [GO:0006656]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cell growth [GO:0030307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of dendrite development [GO:0050773]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron projection arborization [GO:0150011]; regulation of phosphatidylcholine metabolic process [GO:0150172]; regulation of phosphatidylethanolamine metabolic process [GO:0150175]; regulation of phosphatidylserine metabolic process [GO:0150178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal pigment epithelium development [GO:0003406]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; lysophosphatidylcholine flippase activity [GO:0140348]; lysophospholipid:sodium symporter activity [GO:0051978]; oleate transmembrane transporter activity [GO:1901480]; phospholipid transporter activity [GO:0005548]; brain development [GO:0007420]; carbohydrate transport [GO:0008643]; cellular response to starvation [GO:0009267]; cognition [GO:0050890]; energy homeostasis [GO:0097009]; establishment of blood-brain barrier [GO:0060856]; fatty acid transport [GO:0015908]; hippocampus development [GO:0021766]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid transport [GO:0015909]; lysophospholipid translocation [GO:0140329]; lysophospholipid transport [GO:0051977]; maintenance of blood-brain barrier [GO:0035633]; motor behavior [GO:0061744]; negative regulation of fatty acid beta-oxidation [GO:0031999]; organic substance transport [GO:0071702]; phosphatidylcholine biosynthetic process [GO:0006656]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cell growth [GO:0030307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of dendrite development [GO:0050773]; regulation of multicellular organism growth [GO:0040014]; regulation of neuron projection arborization [GO:0150011]; regulation of phosphatidylcholine metabolic process [GO:0150172]; regulation of phosphatidylethanolamine metabolic process [GO:0150175]; regulation of phosphatidylserine metabolic process [GO:0150178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal pigment epithelium development [GO:0003406]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0003406; GO:0005324; GO:0005548; GO:0005789; GO:0005886; GO:0005887; GO:0006656; GO:0007420; GO:0008594; GO:0008643; GO:0009267; GO:0010867; GO:0015245; GO:0015908; GO:0015909; GO:0016021; GO:0021766; GO:0030307; GO:0031999; GO:0034379; GO:0035633; GO:0035845; GO:0040014; GO:0045056; GO:0050773; GO:0050890; GO:0051977; GO:0051978; GO:0060042; GO:0060856; GO:0061744; GO:0071702; GO:0097009; GO:0140329; GO:0140348; GO:0150011; GO:0150104; GO:0150172; GO:0150175; GO:0150178; GO:1901480; GO:1990379 fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; lysophosphatidylcholine flippase activity [GO:0140348]; lysophospholipid:sodium symporter activity [GO:0051978]; oleate transmembrane transporter activity [GO:1901480]; phospholipid transporter activity [GO:0005548] FTLNMLVTMAPIVLILLGLLLFK 0.96603 -0.32348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H35 RBM18_HUMAN Probable RNA-binding protein 18 (RNA-binding motif protein 18) RBM18 Homo sapiens (Human) cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005829; GO:0045171 RNA binding [GO:0003723] KLVVRWAHAQVK 0.96603 -0.36898 0 0 0 0 0 0 0 0 10.7215 0 0 0 0 0 0 0 0 0 0 0 11.5507 0 0 0 0 10.6956 10.8074 0 0 0 0 0 0 0 0 0 0 11.5087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3783 12.1906 0 0 0 0 0 0 15.5165 0 0 12.9088 0 13.0494 15.3594 19.1088 0 0 0 0 0 13.2752 0 0 0 0 13.2504 0 0 14.3496 14.2496 0 12.7177 0 0 0 0 0 14.6757 0 0 0 14.2446 14.7961 13.5706 0 0 0 0 0 0 22.267 0 0 0 0 0 11.9832 0 0 12.7439 12.464 12.6103 0 19.6701 0 12.1852 0 12.722 0 0 0 0 0 12.3877 0 0 12.5015 0 0 12.4956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1831 12.2295 0 0 0 0 Q9UM01 YLAT1_HUMAN "Y+L amino acid transporter 1 (Monocyte amino acid permease 2, MOP-2) (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1, Y+LAT1, y+LAT-1)" SLC7A7 Homo sapiens (Human) basic amino acid transmembrane transport [GO:1990822]; regulation of arginine metabolic process [GO:0000821] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; basic amino acid transmembrane transport [GO:1990822]; regulation of arginine metabolic process [GO:0000821] GO:0000821; GO:0005886; GO:0005887; GO:0015174; GO:0015179; GO:0016323; GO:1990822 basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179] VLALIAVIVAGIVR 0.96603 -0.93104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9518 0 0 11.8512 0 12.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56559 ARL4C_HUMAN ADP-ribosylation factor-like protein 4C (ADP-ribosylation factor-like protein 7) (ADP-ribosylation factor-like protein LAK) ARL4C ARL7 Homo sapiens (Human) endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-tubulin binding [GO:0043014]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0030175; GO:0032456; GO:0043014 alpha-tubulin binding [GO:0043014]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] LYEMILKRR 0.96604 -0.20587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9516 0 0 12.7424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9569 0 Q6ZQW0 I23O2_HUMAN "Indoleamine 2,3-dioxygenase 2, IDO-2, EC 1.13.11.- (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1)" IDO2 INDOL1 Homo sapiens (Human) 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; immune system process [GO:0002376]; tryptophan catabolic process to kynurenine [GO:0019441]" GO:0002376; GO:0004833; GO:0005737; GO:0005829; GO:0019441; GO:0020037; GO:0033754; GO:0034354; GO:0046872 "heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]" EAVPGIK 0.96604 -0.3699 0 0 0 0 0 0 0 0 0 0 0 11.9566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0692 0 0 15.3918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGA0 OR7G1_HUMAN "Olfactory receptor 7G1 (Olfactory receptor 19-15, OR19-15) (Olfactory receptor OR19-8)" OR7G1 OR7G1P Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KLIGRLFPF 0.96605 -0.29006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6795 0 0 0 0 0 0 P33947 ERD22_HUMAN "ER lumen protein-retaining receptor 2 (ERD2-like protein 1, ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2, KDEL receptor 2)" KDELR2 ERD2.2 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005801; GO:0006621; GO:0006888; GO:0006890; GO:0015031; GO:0016021; GO:0030133; GO:0030663; GO:0035437; GO:0046923 ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046] LTGDLSHLAAIVILLLK 0.96606 2.9659 0 0 0 0 0 0 0 0 0 13.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0977 11.8488 0 0 0 0 0 0 0 15.6823 0 15.2219 0 14.2586 0 0 0 0 12.4048 12.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1991 0 0 0 0 0 0 15.4023 0 0 0 0 0 0 0 0 0 0 0 0 16.0648 0 0 12.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7387 0 0 0 0 0 0 12.4749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2848 0 0 0 0 15.5045 0 0 0 0 0 0 12.5588 15.5414 0 0 14.5011 0 0 15.6043 0 0 0 0 0 0 0 Q00796 DHSO_HUMAN "Sorbitol dehydrogenase, SDH, EC 1.1.1.- ((R,R)-butanediol dehydrogenase, EC 1.1.1.4) (L-iditol 2-dehydrogenase, EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase, RDH, EC 1.1.1.56) (Xylitol dehydrogenase, XDH, EC 1.1.1.9)" SORD Homo sapiens (Human) flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; L-xylitol catabolic process [GO:0051160]; L-xylitol metabolic process [GO:0051164]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; response to xenobiotic stimulus [GO:0009410]; sorbitol catabolic process [GO:0006062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; (R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase activity [GO:0050255]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; L-xylitol catabolic process [GO:0051160]; L-xylitol metabolic process [GO:0051164]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; response to xenobiotic stimulus [GO:0009410]; sorbitol catabolic process [GO:0006062]" GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0006970; GO:0008270; GO:0009410; GO:0009725; GO:0016020; GO:0030246; GO:0030317; GO:0031514; GO:0031667; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0046686; GO:0046688; GO:0047833; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062 "(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase activity [GO:0050255]; zinc ion binding [GO:0008270]" ALEAFETFKK 0.96607 -0.054758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1938 0 0 0 0 0 13.0863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y577 TRI17_HUMAN "E3 ubiquitin-protein ligase TRIM17, EC 2.3.2.27 (RING finger protein 16) (RING-type E3 ubiquitin transferase TRIM17) (Testis RING finger protein) (Tripartite motif-containing protein 17)" TRIM17 RBCC RNF16 TERF Homo sapiens (Human) autophagy [GO:0006914]; innate immune response [GO:0045087]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880] cytoplasm [GO:0005737]; lysosome [GO:0005764] cytoplasm [GO:0005737]; lysosome [GO:0005764]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; innate immune response [GO:0045087]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880] GO:0004842; GO:0005737; GO:0005764; GO:0006914; GO:0008270; GO:0010468; GO:0016567; GO:0030674; GO:0032880; GO:0045087; GO:0051865; GO:0061630 protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ACIQLSWEKAR 0.96607 3.257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77179 0 0 9.96427 13.8828 0 17.0018 0 16.978 0 16.7001 16.5789 16.2994 0 0 0 0 0 0 16.7862 0 0 0 0 0 0 0 0 0 13.5252 11.8219 0 12.7646 13.4165 13.395 0 0 13.2565 0 0 12.1966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5577 0 0 0 0 12.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY21 GPR87_HUMAN G-protein coupled receptor 87 (G-protein coupled receptor 95) GPR87 GPR95 FKSG78 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194] GO:0005886; GO:0007186; GO:0007194; GO:0016021; GO:0045028 G protein-coupled purinergic nucleotide receptor activity [GO:0045028] IPFTFSHLDRLLDESAQKILYYCK 0.96608 -0.055954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7673 0 0 14.359 13.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.829 0 0 0 0 12.2753 13.9833 0 0 0 0 0 13.2531 0 0 0 0 13.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1728 0 12.5244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5295 0 0 0 0 0 0 0 0 0 0 0 0 Q04656 ATP7A_HUMAN "Copper-transporting ATPase 1, EC 7.2.2.8 (Copper pump 1) (Menkes disease-associated protein)" ATP7A MC1 MNK Homo sapiens (Human) blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of response to wounding [GO:1903036]; positive regulation of tyrosinase activity [GO:0032773]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; small GTPase binding [GO:0031267]; superoxide dismutase copper chaperone activity [GO:0016532]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of response to wounding [GO:1903036]; positive regulation of tyrosinase activity [GO:0032773]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568] GO:0001568; GO:0001701; GO:0001889; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005634; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006568; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007565; GO:0007595; GO:0007626; GO:0010041; GO:0010042; GO:0010043; GO:0010273; GO:0010468; GO:0010592; GO:0014069; GO:0015677; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016532; GO:0016887; GO:0018205; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030141; GO:0030198; GO:0030199; GO:0030424; GO:0030425; GO:0030670; GO:0031069; GO:0031252; GO:0031267; GO:0031526; GO:0031901; GO:0032588; GO:0032767; GO:0032773; GO:0033162; GO:0034760; GO:0036120; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042428; GO:0043005; GO:0043025; GO:0043085; GO:0043204; GO:0043473; GO:0043588; GO:0043682; GO:0045121; GO:0045793; GO:0048023; GO:0048251; GO:0048286; GO:0048471; GO:0048812; GO:0050679; GO:0051087; GO:0051216; GO:0051542; GO:0055070; GO:0060003; GO:0070161; GO:0071230; GO:0071236; GO:0071276; GO:0071279; GO:0071280; GO:0071281; GO:0071284; GO:0071456; GO:0140581; GO:1903036; GO:1903136; GO:1904754; GO:1904959 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; small GTPase binding [GO:0031267]; superoxide dismutase copper chaperone activity [GO:0016532] CYIQVTGMTCASCVANIER 0.96611 -0.89176 0 0 0 0 0 0 0 11.3002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1806 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3978 0 0 0 0 0 0 0 0 0 0 12.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8U9 BMPER_HUMAN "BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2, hCV2)" BMPER KIAA1965 Homo sapiens (Human) blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; common-partner SMAD protein phosphorylation [GO:0007182]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization [GO:0032880]; ureteric bud development [GO:0001657] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; common-partner SMAD protein phosphorylation [GO:0007182]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization [GO:0032880]; ureteric bud development [GO:0001657] GO:0001568; GO:0001657; GO:0002043; GO:0005615; GO:0007182; GO:0010594; GO:0030509; GO:0030514; GO:0031012; GO:0032880; GO:0042118; GO:0045765; GO:0048839; GO:0060393; GO:0070374; GO:1903672 CSHPGGCDQGQEGCCEECLLR 0.96612 -0.89337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9077 0 12.133 12.4372 0 0 0 0 12.8142 0 13.0644 13.4701 0 11.7256 0 0 0 0 0 0 14.1048 0 0 0 0 0 0 0 13.0344 0 0 0 0 0 0 0 0 0 0 0 0 11.4971 0 0 12.8284 11.9487 0 0 0 0 0 11.7194 14.4444 0 0 0 12.4562 0 0 0 15.2119 0 0 0 0 0 0 13.9921 0 0 0 0 0 12.2258 0 14.4578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBR0 S38AA_HUMAN Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10) SLC38A10 PP1744 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; bone development [GO:0060348]; sodium ion transport [GO:0006814] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; bone development [GO:0060348]; sodium ion transport [GO:0006814] GO:0003333; GO:0005794; GO:0006814; GO:0015179; GO:0016021; GO:0060348 L-amino acid transmembrane transporter activity [GO:0015179] GGPPPGNAAGDTGQPAEDSDHGGK 0.96612 -0.8948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4324 0 14.1529 12.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.677 11.7057 0 0 0 0 11.9728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0353 0 0 0 0 0 O95428 PPN_HUMAN Papilin PAPLN UNQ2420/PRO4977 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198] GO:0004222; GO:0004867; GO:0005576; GO:0030198; GO:0031012 metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867] FWYGGCHGNANNFASEQECMSSCQGSLHGPR 0.96613 -0.89556 0 0 0 0 0 0 0 0 11.3526 12.4909 13.932 0 0 0 11.0238 0 12.6815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8022 15.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5457 0 14.3455 0 0 0 14.0354 0 13.9954 11.4446 10.8616 13.2257 0 15.3237 0 13.2775 12.6519 0 0 12.2307 14.5442 0 12.9846 0 0 0 12.7446 15.6337 0 13.6865 0 0 0 0 14.0754 0 14.9415 13.8841 0 0 0 0 15.76 0 0 14.8439 0 0 15.086 14.6947 0 12.8565 0 0 0 0 0 0 0 0 0 14.1853 15.4348 0 0 0 14.7719 15.0482 0 14.8484 15.477 13.4856 13.962 0 0 12.9548 15.167 0 0 0 0 10.6997 11.8737 0 14.7579 0 0 0 15.584 0 0 0 0 14.7283 0 10.9682 14.2859 14.3485 0 0 13.9336 13.3947 9.85439 0 0 14.5652 0 0 P17021 ZNF17_HUMAN Zinc finger protein 17 (Zinc finger protein HPF3) (Zinc finger protein KOX10) ZNF17 KIAA1947 KOX10 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CRSTLDTHQR 0.96613 -0.36436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.557 0 0 0 0 0 0 11.5202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2953 0 14.2638 14.8685 0 15.1349 0 0 11.8891 0 0 0 0 0 0 0 0 0 0 13.9531 0 0 0 15.3559 13.1462 0 14.2847 0 0 0 0 0 0 0 0 13.9516 0 12.3372 0 0 0 0 14.209 13.3292 0 13.9343 0 0 11.4754 0 14.3779 0 0 0 0 0 0 0 0 0 0 0 14.8239 0 0 14.2317 0 0 11.5813 0 0 0 0 11.5879 0 0 0 0 14.8609 14.4311 0 0 0 0 0 0 0 0 0 0 12.2268 0 0 0 0 0 0 0 0 0 0 14.7349 0 0 0 Q5T2D2 TRML2_HUMAN "Trem-like transcript 2 protein, TLT-2 (Triggering receptor expressed on myeloid cells-like protein 2)" TREML2 C6orf76 TLT2 UNQ6268/PRO20473 Homo sapiens (Human) T cell activation [GO:0042110] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; T cell activation [GO:0042110] GO:0005886; GO:0009986; GO:0016021; GO:0038023; GO:0042110 signaling receptor activity [GO:0038023] HQDVYSTVLGVVLTLLVLMLIMVYGFWKK 0.96613 -0.92455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3385 0 0 0 0 0 0 16.817 0 0 0 0 0 0 0 0 0 0 0 0 14.1376 0 0 0 0 14.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3231 12.2569 0 12.5825 0 13.7565 0 0 0 0 0 0 12.6355 13.8272 0 0 12.9834 0 0 0 0 0 0 0 0 0 0 15.0689 0 14.5517 0 0 0 13.0147 13.1862 12.8867 0 0 0 0 12.9376 0 0 0 13.1835 0 0 12.8154 13.1291 14.2056 0 12.9532 0 12.8226 13.2479 0 13.0894 12.8709 13.0976 12.9099 0 0 0 14.2644 12.8981 0 12.5888 0 0 12.8453 0 0 0 0 0 12.7256 13.2939 0 0 13.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0896 0 0 0 0 0 0 0 Q96HL8 SH3Y1_HUMAN SH3 domain-containing YSC84-like protein 1 SH3YL1 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; regulation of ruffle assembly [GO:1900027] ruffle membrane [GO:0032587] ruffle membrane [GO:0032587]; phosphatase binding [GO:0019902]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of ruffle assembly [GO:1900027] GO:0006661; GO:0019902; GO:0032587; GO:0035091; GO:1900027 phosphatase binding [GO:0019902]; phosphatidylinositol binding [GO:0035091] AVEAFAKGGNLTLGGNLTVAVGPLGR 0.96613 3.2562 0 0 0 0 0 0 0 0 10.2818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8584 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBL1 PGLT1_HUMAN "Protein O-glucosyltransferase 1, EC 2.4.1.376 (CAP10-like 46 kDa protein, hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) (O-glucosyltransferase Rumi homolog, hRumi) (Protein O-xylosyltransferase POGLUT1, EC 2.4.2.63)" POGLUT1 C3orf9 CLP46 KTELC1 MDSRP MDS010 UNQ490/PRO1006 Homo sapiens (Human) axial mesoderm development [GO:0048318]; circulatory system development [GO:0072359]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; axial mesoderm development [GO:0048318]; circulatory system development [GO:0072359]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756] GO:0001756; GO:0005783; GO:0005788; GO:0006493; GO:0007369; GO:0010470; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537; GO:0072359; GO:0140561; GO:0140562 EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252] DVHLVDHCKYK 0.96614 -0.90056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.136 0 0 0 0 0 0 0 0 0 0 0 13.461 0 0 0 0 0 13.0969 0 0 13.634 0 0 0 0 0 0 0 13.2673 0 10.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75582 KS6A5_HUMAN "Ribosomal protein S6 kinase alpha-5, S6K-alpha-5, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase, RSKL)" RPS6KA5 MSK1 Homo sapiens (Human) "axon guidance [GO:0007411]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone kinase activity (H2A-S1 specific) [GO:0044024]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-S28 specific) [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; axon guidance [GO:0007411]; histone phosphorylation [GO:0016572]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0016572; GO:0018105; GO:0032793; GO:0033129; GO:0035066; GO:0035175; GO:0035556; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0106310 ATP binding [GO:0005524]; histone kinase activity (H2A-S1 specific) [GO:0044024]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-S28 specific) [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] IIDFGFARLKPPDNQPLK 0.96615 -0.90275 0 0 0 0 0 0 0 0 14.009 0 0 0 15.4363 15.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8851 15.6258 15.8856 15.4761 14.93 14.0818 0 0 16.3366 18.7276 0 0 0 0 0 0 0 0 11.7234 0 0 0 0 10.1109 0 17.4824 16.3234 16.0735 15.9717 13.5303 0 15.4732 13.8658 16.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1219 0 12.8334 0 0 14.2442 0 0 0 0 12.3544 0 0 0 0 0 0 0 0 0 0 0 12.4096 13.2067 0 0 0 13.2189 13.2438 0 0 0 0 0 0 0 0 12.8357 0 0 0 10.4714 0 0 11.7283 0 0 0 0 0 0 0 0 10.8666 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8338 17.1591 17.0581 16.7528 17.773 0 16.7547 0 17.8351 18.0184 0 0 0 14.7735 0 0 13.6761 0 0 18.1286 17.893 18.0607 Q9H1C0 LPAR5_HUMAN "Lysophosphatidic acid receptor 5, LPA receptor 5, LPA-5 (G-protein coupled receptor 92) (G-protein coupled receptor 93)" LPAR5 GPR92 GPR93 Homo sapiens (Human) behavioral response to pain [GO:0048266]; positive regulation of CREB transcription factor activity [GO:0032793] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; behavioral response to pain [GO:0048266]; positive regulation of CREB transcription factor activity [GO:0032793] GO:0004930; GO:0005886; GO:0016021; GO:0032793; GO:0048266 G protein-coupled receptor activity [GO:0004930] CRYRDLEVR 0.96615 -0.92964 0 0 0 0 0 0 0 0 0 0 0 13.8474 0 0 12.4575 0 12.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8055 11.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1244 0 13.7337 0 14.4574 0 0 0 13.3845 0 0 0 0 0 0 0 12.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6117 0 0 13.2673 0 0 0 0 0 0 0 0 13.0494 0 0 0 0 0 0 0 0 12.284 0 13.5422 13.4742 12.3198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6445 0 0 0 0 0 0 0 0 0 0 0 0 13.1594 0 0 0 0 0 0 0 0 0 0 0 P55916 UCP3_HUMAN "Mitochondrial uncoupling protein 3, UCP 3 (Solute carrier family 25 member 9)" UCP3 SLC25A9 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; proton transmembrane transport [GO:1902600]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to superoxide [GO:0000303] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; transmembrane transporter activity [GO:0022857]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; proton transmembrane transport [GO:1902600]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to superoxide [GO:0000303] GO:0000303; GO:0001666; GO:0005739; GO:0005743; GO:0006629; GO:0006631; GO:0006839; GO:0007568; GO:0007584; GO:0007585; GO:0009409; GO:0014823; GO:0016021; GO:0017077; GO:0022857; GO:0032868; GO:0032870; GO:0051384; GO:1902600; GO:1990542; GO:1990845 oxidative phosphorylation uncoupler activity [GO:0017077]; transmembrane transporter activity [GO:0022857] ALMKVQMLR 0.96616 -0.36801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7121 13.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HYI8 RABL3_HUMAN Rab-like protein 3 RABL3 Homo sapiens (Human) B cell differentiation [GO:0030183]; intracellular protein transport [GO:0006886]; natural killer cell differentiation [GO:0001779]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077] GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; B cell differentiation [GO:0030183]; intracellular protein transport [GO:0006886]; natural killer cell differentiation [GO:0001779]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077] GO:0001779; GO:0003924; GO:0005525; GO:0006886; GO:0030183; GO:0033077; GO:0042803; GO:0046578; GO:0050821; GO:1903059 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803] KRFGAGTLK 0.96616 -0.93117 0 0 0 0 0 0 0 0 0 0 0 0 13.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1202 0 0 0 0 0 0 0 0 12.2006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9893 0 0 Q86UG4 SO6A1_HUMAN "Solute carrier organic anion transporter family member 6A1 (Cancer/testis antigen 48, CT48) (Gonad-specific transporter, GST) (Organic anion-transporting polypeptide 6A1) (Organic anion-transporting polypeptide I, OATP-I) (Solute carrier family 21 member 19)" SLCO6A1 OATP6A1 SLC21A19 Homo sapiens (Human) sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252] GO:0005887; GO:0015347; GO:0043252 sodium-independent organic anion transmembrane transporter activity [GO:0015347] ALMRFIMVTSVISLILLVFIIFVR 0.96616 -0.32315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7J7 LHPL4_HUMAN LHFPL tetraspan subfamily member 4 protein (GABAA receptor regulatory Lhfpl4) (Lipoma HMGIC fusion partner-like 4 protein) LHFPL4 GARLH4 Homo sapiens (Human) gamma-aminobutyric acid receptor clustering [GO:0097112]; regulation of inhibitory synapse assembly [GO:1905702]; sensory perception of sound [GO:0007605] anchoring junction [GO:0070161]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; GABA receptor binding [GO:0050811]; gamma-aminobutyric acid receptor clustering [GO:0097112]; regulation of inhibitory synapse assembly [GO:1905702]; sensory perception of sound [GO:0007605] GO:0005886; GO:0007605; GO:0016020; GO:0016021; GO:0030425; GO:0045211; GO:0050811; GO:0060077; GO:0070161; GO:0097112; GO:1905702 GABA receptor binding [GO:0050811] DMCGAKTGK 0.96617 0.011761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01148 GON1_HUMAN "Progonadoliberin-1 (Progonadoliberin I) [Cleaved into: Gonadoliberin-1 (Gonadoliberin I) (Gonadorelin) (Gonadotropin-releasing hormone I, GnRH-I) (Luliberin I) (Luteinizing hormone-releasing hormone I, LH-RH I); GnRH-associated peptide 1 (GnRH-associated peptide I) ]" GNRH1 GNRH GRH LHRH Homo sapiens (Human) cell-cell signaling [GO:0007267]; negative regulation of neuron migration [GO:2001223]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; reproduction [GO:0000003]; response to ethanol [GO:0045471]; response to steroid hormone [GO:0048545]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; gonadotropin hormone-releasing hormone activity [GO:0005183]; gonadotropin-releasing hormone receptor binding [GO:0031530]; hormone activity [GO:0005179]; cell-cell signaling [GO:0007267]; negative regulation of neuron migration [GO:2001223]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; reproduction [GO:0000003]; response to ethanol [GO:0045471]; response to steroid hormone [GO:0048545]; signal transduction [GO:0007165] GO:0000003; GO:0005179; GO:0005183; GO:0005576; GO:0005615; GO:0007165; GO:0007267; GO:0010468; GO:0031530; GO:0045471; GO:0048545; GO:2000354; GO:2001223 gonadotropin hormone-releasing hormone activity [GO:0005183]; gonadotropin-releasing hormone receptor binding [GO:0031530]; hormone activity [GO:0005179] EVGQLAETQRFECTTHQPR 0.96619 -0.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.233 0 0 0 0 0 0 0 0 10.2192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92956 TNR14_HUMAN "Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A, Herpesvirus entry mediator A, HveA) (Tumor necrosis factor receptor-like 2, TR2) (CD antigen CD270)" TNFRSF14 HVEA HVEM UNQ329/PRO509 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of adaptive immune memory response [GO:1905675]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell migration [GO:2000406]; T cell costimulation [GO:0031295] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine binding [GO:0019955]; tumor necrosis factor receptor activity [GO:0005031]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of adaptive immune memory response [GO:1905675]; negative regulation of alpha-beta T cell proliferation [GO:0046642]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell migration [GO:2000406]; T cell costimulation [GO:0031295] GO:0001618; GO:0002250; GO:0002720; GO:0005031; GO:0005886; GO:0006955; GO:0007166; GO:0009897; GO:0016021; GO:0019955; GO:0031295; GO:0031625; GO:0045087; GO:0046642; GO:0050731; GO:0050829; GO:0050830; GO:1905675; GO:2000406 cytokine binding [GO:0019955]; tumor necrosis factor receptor activity [GO:0005031]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618] VIVSVQRKR 0.9662 -0.29163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MZ26 EFCB9_HUMAN EF-hand calcium-binding domain-containing protein 9 EFCAB9 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] GO:0005509; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228 calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891] HSRPVFDLLDLK 0.96621 0.026875 0 0 0 0 0 0 0 0 0 11.2842 0 0 0 0 0 0 0 0 0 0 0 0 11.812 0 0 0 0 0 0 0 0 0 11.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3425 0 0 0 0 0 12.2076 11.5701 0 0 0 0 0 0 0 10.9059 0 0 0 0 0 0 0 0 0 0 0 10.8391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q32P44 EMAL3_HUMAN "Echinoderm microtubule-associated protein-like 3, EMAP-3" EML3 Homo sapiens (Human) cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; mitotic metaphase plate congression [GO:0007080]; regulation of mitotic spindle assembly [GO:1901673] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; mitotic metaphase plate congression [GO:0007080]; regulation of mitotic spindle assembly [GO:1901673] GO:0000226; GO:0005634; GO:0005737; GO:0005819; GO:0005876; GO:0007080; GO:0008017; GO:0015630; GO:0030496; GO:0043621; GO:0051301; GO:1901673; GO:1990498 microtubule binding [GO:0008017]; protein self-association [GO:0043621] AISSANLLVR 0.96621 -0.20802 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0126 0 0 0 14.3347 12.8349 0 0 0 0 0 0 12.8764 12.1827 12.0026 0 0 0 0 0 11.6263 0 0 0 14.4301 0 0 12.7577 0 0 0 0 13.7076 0 0 0 0 0 14.2398 0 0 0 0 0 0 0 12.5838 0 12.6562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9774 0 14.4528 0 13.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HZ4 HES6_HUMAN "Transcription cofactor HES-6 (C-HAIRY1) (Class B basic helix-loop-helix protein 41, bHLHb41) (Hairy and enhancer of split 6)" HES6 BHLHB41 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; nervous system development [GO:0007399]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cell differentiation [GO:0030154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; nervous system development [GO:0007399]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0006357; GO:0007399; GO:0009952; GO:0030154; GO:0043433; GO:0046983; GO:0050767; GO:0061629; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" EDEDGWETRGDR 0.96621 -0.88593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8306 13.5525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00175 CCL24_HUMAN "C-C motif chemokine 24 (CK-beta-6) (Eosinophil chemotactic protein 2, Eotaxin-2) (Myeloid progenitor inhibitory factor 2, MPIF-2) (Small-inducible cytokine A24)" CCL24 MPIF2 SCYA24 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165] extracellular space [GO:0005615] extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; receptor ligand activity [GO:0048018]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165] GO:0001938; GO:0002548; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007010; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0008360; GO:0030335; GO:0030593; GO:0030838; GO:0031728; GO:0043547; GO:0045766; GO:0048018; GO:0048020; GO:0048245; GO:0048247; GO:0050729; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:2000418 CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; receptor ligand activity [GO:0048018] ARAVAVKGPVQR 0.96622 -0.88806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22303 ACES_HUMAN "Acetylcholinesterase, AChE, EC 3.1.1.7" ACHE Homo sapiens (Human) "acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416]" anchored component of membrane [GO:0031225]; anchoring junction [GO:0070161]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083] "anchored component of membrane [GO:0031225]; anchoring junction [GO:0070161]; basement membrane [GO:0005604]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine hydrolase activity [GO:0017171]; acetylcholine catabolic process [GO:0006581]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; acetylcholine receptor signaling pathway [GO:0095500]; amyloid precursor protein metabolic process [GO:0042982]; cell adhesion [GO:0007155]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein secretion [GO:0050714]; receptor internalization [GO:0031623]; regulation of receptor recycling [GO:0001919]; retina development in camera-type eye [GO:0060041]; synapse assembly [GO:0007416]" GO:0001507; GO:0001540; GO:0001919; GO:0002076; GO:0003990; GO:0004104; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005794; GO:0005886; GO:0006581; GO:0007155; GO:0007399; GO:0007416; GO:0009986; GO:0016020; GO:0016787; GO:0017171; GO:0031225; GO:0031594; GO:0031623; GO:0032223; GO:0042166; GO:0042803; GO:0042982; GO:0043083; GO:0043236; GO:0043621; GO:0045202; GO:0048471; GO:0050714; GO:0060041; GO:0070161; GO:0095500; GO:0120162 acetylcholine binding [GO:0042166]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; cholinesterase activity [GO:0004104]; collagen binding [GO:0005518]; hydrolase activity [GO:0016787]; laminin binding [GO:0043236]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; serine hydrolase activity [GO:0017171] PLEVRRGLR 0.96622 -0.29299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28845 DHI1_HUMAN "11-beta-hydroxysteroid dehydrogenase 1, 11-DH, 11-beta-HSD1, EC 1.1.1.146 (7-oxosteroid reductase, EC 1.1.1.201) (Corticosteroid 11-beta-dehydrogenase isozyme 1) (Short chain dehydrogenase/reductase family 26C member 1)" HSD11B1 HSD11 HSD11L SDR26C1 Homo sapiens (Human) lung development [GO:0030324]; steroid catabolic process [GO:0006706] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; 11-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0070524]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; cortisol dehydrogenase activity [GO:0102196]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; lung development [GO:0030324]; steroid catabolic process [GO:0006706] GO:0005496; GO:0005789; GO:0006706; GO:0016020; GO:0016491; GO:0030176; GO:0030324; GO:0042803; GO:0043231; GO:0047022; GO:0050661; GO:0070524; GO:0102196 11-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0070524]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; cortisol dehydrogenase activity [GO:0102196]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496] KVIVTGASKGIGR 0.96622 -0.044391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62195 PRS8_HUMAN "26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1, TRIP1) (p45/SUG)" PSMC5 SUG1 Homo sapiens (Human) "modulation of chemical synaptic transmission [GO:0050804]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of transcription by RNA polymerase II [GO:0006357]" "blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]" "blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; general transcription initiation factor binding [GO:0140296]; proteasome-activating activity [GO:0036402]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000502; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0008134; GO:0008540; GO:0016020; GO:0016234; GO:0016887; GO:0017025; GO:0022624; GO:0031410; GO:0031531; GO:0031595; GO:0031597; GO:0036402; GO:0043069; GO:0043161; GO:0045892; GO:0045893; GO:0050804; GO:0070062; GO:0072562; GO:0090261; GO:0098794; GO:0140296; GO:0140297; GO:1901800 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; general transcription initiation factor binding [GO:0140296]; proteasome-activating activity [GO:0036402]; TBP-class protein binding [GO:0017025]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134] DSEKNMSIK 0.96623 -0.055509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5018 0 0 0 0 0 0 0 0 13.5718 0 13.7329 0 0 0 14.3735 15.1697 14.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2167 13.2096 0 0 0 13.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2517 13.8588 13.3274 13.1843 0 13.3264 0 0 0 0 13.729 14.5158 0 0 0 Q2MKA7 RSPO1_HUMAN "R-spondin-1 (Roof plate-specific spondin-1, hRspo1)" RSPO1 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of receptor internalization [GO:0002090]; Wnt signaling pathway [GO:0016055] extracellular region [GO:0005576]; nucleus [GO:0005634] extracellular region [GO:0005576]; nucleus [GO:0005634]; G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of receptor internalization [GO:0002090]; Wnt signaling pathway [GO:0016055] GO:0001664; GO:0001934; GO:0002090; GO:0005102; GO:0005576; GO:0005634; GO:0008201; GO:0016055; GO:0030177; GO:0090263 G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] KGGQGRR 0.96623 -0.89138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IEZ7 OR2T5_HUMAN Olfactory receptor 2T5 (Olfactory receptor OR1-62) OR2T5 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DVMGALK 0.96623 -0.045763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9715 0 0 0 0 0 0 0 0 0 0 0 Q8IYJ1 CPNE9_HUMAN Copine-9 (Copine IX) CPNE9 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] GO:0005544; GO:0005615; GO:0005886; GO:0030154; GO:0046872; GO:0070062; GO:0071277; GO:1903861 calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] ASQEWREFGR 0.96623 0.024662 0 0 0 0 0 0 0 0 0 12.5676 12.3989 0 0 0 0 0 0 14.5863 0 0 12.1035 0 0 0 0 11.5307 13.9542 0 15.1916 10.1753 13.6676 14.8528 14.7429 0 0 0 0 0 0 0 0 11.1891 12.1311 11.03 0 11.9941 13.0292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5528 0 0 10.3235 0 0 0 0 0 12.0965 15.05 14.816 14.6473 15.2144 13.6647 13.0498 15.0036 14.0101 0 16.1153 14.4612 0 0 13.2322 0 0 0 0 15.6121 0 15.5664 0 0 A6NFR6 CE060_HUMAN Uncharacterized protein C5orf60 C5orf60 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CSDPNLGLSWRQEAARAWCHCTSSQFPFK 0.96624 -0.89309 10.0741 0 0 0 15.2961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0266 0 0 11.5586 11.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5078 15.7123 0 0 15.7088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4378 13.847 0 12.1515 0 13.6185 12.6576 14.151 17.4274 0 0 0 12.5716 0 0 0 12.6937 14.7057 0 0 0 0 0 14.5094 14.1447 0 13.6317 0 13.354 0 0 14.3643 0 0 14.3968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54725 RD23A_HUMAN "UV excision repair protein RAD23 homolog A, HR23A, hHR23A" RAD23A Homo sapiens (Human) nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381]; nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434] GO:0000502; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006289; GO:0019900; GO:0031593; GO:0031648; GO:0032434; GO:0032436; GO:0032991; GO:0043130; GO:0043161; GO:0043231; GO:0045070; GO:0045787; GO:0070628; GO:1990381 damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381] IDEKNFVVVMVTKTK 0.96624 3.2519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1928 0 0 11.3227 13.4648 14.027 13.4311 13.1596 0 13.2007 16.0374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2514 0 0 0 0 0 0 0 14.3771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5504 0 14.2481 0 0 0 0 0 0 0 14.6427 13.7861 13.5429 0 0 0 0 0 13.2089 0 0 0 0 12.3593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8781 0 P04080 CYTB_HUMAN Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B) CSTB CST6 STFB Homo sapiens (Human) adult locomotory behavior [GO:0008344]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861] GO:0002020; GO:0003723; GO:0004866; GO:0004869; GO:0005576; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0008344; GO:0010466; GO:0034774; GO:0045861; GO:0062023; GO:0070062; GO:1904724; GO:1904813 cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; RNA binding [GO:0003723] FPVFKAVSFK 0.96625 -0.047537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46597 ASMT_HUMAN "Acetylserotonin O-methyltransferase, EC 2.1.1.4 (Hydroxyindole O-methyltransferase, HIOMT)" ASMT Homo sapiens (Human) aromatic compound biosynthetic process [GO:0019438]; indolalkylamine biosynthetic process [GO:0046219]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412] cytosol [GO:0005829] cytosol [GO:0005829]; acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; S-methyltransferase activity [GO:0008172]; aromatic compound biosynthetic process [GO:0019438]; indolalkylamine biosynthetic process [GO:0046219]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412] GO:0005829; GO:0006412; GO:0006629; GO:0008171; GO:0008172; GO:0008757; GO:0017096; GO:0019438; GO:0030187; GO:0032259; GO:0042802; GO:0042803; GO:0046219 acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; S-methyltransferase activity [GO:0008172] GSSEDQAYR 0.96625 0.014359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9251 0 0 0 0 0 0 0 0 11.5668 0 0 0 0 11.8194 0 0 0 0 0 11.5377 0 12.0494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5063 0 0 0 0 0 0 0 0 0 0 13.1154 0 12.7083 13.3351 0 0 0 0 13.3886 0 0 0 0 Q3LHN2 KR192_HUMAN Keratin-associated protein 19-2 KRTAP19-2 KAP19.2 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 CYGYGCGCGSFCR 0.96629 4.5088 0 0 0 0 0 0 0 0 0 0 0 0 13.1951 0 0 0 0 0 0 0 0 0 13.5204 0 13.23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.49 0 0 12.266 0 0 0 12.7031 0 0 0 0 0 10.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9342 0 0 12.0387 0 0 0 10.6788 13.0616 0 11.671 11.6813 14.3615 13.6344 13.044 0 0 12.543 0 0 14.3185 12.9603 0 15.0574 0 16.4985 16.1141 0 0 15.0033 13.875 15.8491 14.8095 0 15.6932 13.4562 0 13.8231 13.0205 0 0 14.1566 14.9674 14.3613 0 0 0 13.2535 0 0 0 13.5889 0 13.9136 0 15.1062 0 11.3624 0 0 0 0 14.5584 0 0 0 0 0 0 11.2115 0 0 0 12.3255 0 0 12.6746 0 0 11.3671 0 13.7558 0 12.5781 0 0 0 10.7733 0 0 0 13.9334 0 0 0 0 0 0 0 10.8114 0 12.3085 10.8484 11.1633 0 0 0 0 0 9.75634 0 Q8TDY2 RBCC1_HUMAN "RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa, FIP200)" RB1CC1 KIAA0203 RBICC Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; reticulophagy [GO:0061709] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; reticulophagy [GO:0061709] GO:0000045; GO:0000407; GO:0000421; GO:0000422; GO:0001889; GO:0001934; GO:0005764; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007049; GO:0007507; GO:0008285; GO:0010508; GO:0019898; GO:0019901; GO:0030242; GO:0031965; GO:0034045; GO:0034727; GO:0045793; GO:0046330; GO:0046777; GO:0060090; GO:0061709; GO:0061723; GO:0097191; GO:1903059; GO:1990316; GO:2001237 molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901] AENLKDASVLPDLCLSHANQLMIMLQNHRK 0.96629 3.2484 0 0 0 0 0 0 0 0 0 0 0 12.2298 0 0 14.5544 0 0 0 13.6375 11.9367 14.8329 0 11.4314 0 0 10.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7406 11.7422 14.0875 0 0 16.4843 16.3438 16.7834 11.7633 0 10.887 0 0 15.1026 14.136 0 0 0 0 0 0 0 0 0 0 0 0 9.76597 11.9978 0 0 0 0 0 0 0 15.3492 16.8033 15.2642 15.1306 0 14.833 0 0 0 0 15.4119 0 15.4223 0 0 12.6473 13.7237 15.0057 0 0 15.0294 11.7674 0 15.2166 0 0 0 0 0 15.0107 0 0 0 0 15.1696 0 14.0327 0 13.3684 0 0 15.6877 0 15.2978 12.9339 12.159 15.9396 14.3848 0 15.3495 15.1739 0 0 0 0 0 12.1224 0 0 0 0 0 0 0 0 0 0 0 12.6341 0 0 0 15.2642 0 0 0 0 0 Q96T52 IMP2L_HUMAN "Mitochondrial inner membrane protease subunit 2, EC 3.4.21.- (IMP2-like protein)" IMMP2L Homo sapiens (Human) blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial inner membrane peptidase complex [GO:0042720] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial inner membrane peptidase complex [GO:0042720]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801] GO:0001541; GO:0004175; GO:0004252; GO:0005743; GO:0006465; GO:0006627; GO:0006801; GO:0006974; GO:0007283; GO:0007420; GO:0008015; GO:0008233; GO:0016021; GO:0022904; GO:0030728; GO:0033108; GO:0042720; GO:0061300 endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] GDIVSLVSPKNPEQKIIK 0.9663 -0.32287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.329 0 0 0 0 0 0 0 0 0 14.6434 14.3104 0 0 0 0 12.6634 0 0 13.1145 0 0 12.9638 13.2631 13.0024 14.8291 0 0 13.8948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LK8 SPT32_HUMAN Spermatogenesis-associated protein 32 (Testis-expressed protein 34) SPATA32 C17orf46 TEX34 Homo sapiens (Human) spermatogenesis [GO:0007283] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; spermatogenesis [GO:0007283] GO:0003779; GO:0007283; GO:0048471 actin binding [GO:0003779] EARAPLK 0.96632 -0.88323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3758 0 0 0 0 0 0 0 0 0 0 0 9.82696 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6688 0 0 0 0 0 0 14.0224 0 0 0 0 0 0 0 0 0 0 16.7477 0 0 0 0 13.3249 0 0 0 13.1409 0 0 14.4812 0 0 14.5596 0 0 14.7109 14.562 0 0 0 0 0 0 0 0 0 0 0 0 12.4361 0 0 13.3639 0 14.2885 0 0 0 0 12.0228 0 0 0 0 0 0 12.8585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5831 0 0 0 0 0 0 12.6817 0 0 0 0 0 0 16.2761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T3I0 GPTC4_HUMAN G patch domain-containing protein 4 GPATCH4 GPATC4 Homo sapiens (Human) regulation of ribosome biogenesis [GO:0090069] nucleolus [GO:0005730] nucleolus [GO:0005730]; RNA binding [GO:0003723]; regulation of ribosome biogenesis [GO:0090069] GO:0003723; GO:0005730; GO:0090069 RNA binding [GO:0003723] DLESCSDDDNQGSK 0.96633 4.3521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.03 0 0 0 0 0 0 0 0 0 0 0 0 18.212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4463 0 0 10.5454 0 0 0 0 12.6038 0 0 0 0 0 0 0 0 0 0 0 0 14.2014 0 0 12.7609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JA4 M4A14_HUMAN Membrane-spanning 4-domains subfamily A member 14 (Testis development protein NYD-SP21) MS4A14 MS4A13 MS4A16 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166] GO:0005886; GO:0007166; GO:0016021 SEEELHRRK 0.96633 -0.40561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVX7 FBX50_HUMAN "F-box only protein 50 (NCC receptor protein 1 homolog, NCCRP-1) (Non-specific cytotoxic cell receptor protein 1 homolog)" NCCRP1 FBXO50 Homo sapiens (Human) glycoprotein catabolic process [GO:0006516]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; SCF ubiquitin ligase complex [GO:0019005]; glycoprotein catabolic process [GO:0006516]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005737; GO:0006516; GO:0008284; GO:0016567; GO:0019005; GO:0030433; GO:0031146; GO:0070062 LDACVYELHVWLLAADR 0.96634 -0.88545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3403 0 0 0 0 0 0 0 0 0 0 0 13.514 0 0 0 0 0 0 10.6245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H3BQB6 STMD1_HUMAN Stathmin domain-containing protein 1 STMND1 Homo sapiens (Human) microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; neuron projection [GO:0043005] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0005737; GO:0007019; GO:0015631; GO:0031110; GO:0031175; GO:0043005 tubulin binding [GO:0015631] DFTMKDIEEKMEAAEER 0.96635 -0.041443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43312 MTSS1_HUMAN Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein) MTSS1 KIAA0429 MIM Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; ruffle [GO:0001726]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; positive regulation of actin filament bundle assembly [GO:0032233]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001726; GO:0003779; GO:0003785; GO:0005102; GO:0005543; GO:0005737; GO:0007009; GO:0007155; GO:0007169; GO:0015629; GO:0030035; GO:0030036; GO:0030139; GO:0031235; GO:0032233; GO:0034334; GO:0042802; GO:0050680; GO:0061333; GO:0071498; GO:0072102; GO:0072160; GO:2001013 actin binding [GO:0003779]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102] GTIGAGPIPIKTPVIPVK 0.96635 -0.29244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7358 0 0 0 0 0 0 0 0 13.724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7642 0 0 0 0 18.871 19.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P435 SMG1L_HUMAN Putative uncharacterized SMG1-like protein Homo sapiens (Human) LSNLLRRITR 0.96635 0.0286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0985 15.2128 0 0 15.0194 0 14.8849 0 13.1974 0 0 0 12.6157 0 0 0 0 0 0 15.2224 0 0 P61366 OSTN_HUMAN Osteocrin (Musclin) [Cleaved into: Processed Osteocrin ] OSTN Homo sapiens (Human) cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endochondral bone growth [GO:0003416]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of dendrite extension [GO:1903860]; negative regulation of glucose import [GO:0046325]; negative regulation of osteoblast differentiation [GO:0045668] extracellular space [GO:0005615] extracellular space [GO:0005615]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endochondral bone growth [GO:0003416]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of dendrite extension [GO:1903860]; negative regulation of glucose import [GO:0046325]; negative regulation of osteoblast differentiation [GO:0045668] GO:0003416; GO:0005102; GO:0005179; GO:0005615; GO:0007166; GO:0009755; GO:0030154; GO:0045668; GO:0046325; GO:1903860 hormone activity [GO:0005179]; signaling receptor binding [GO:0005102] FGIPMDRIGR 0.96636 -0.043624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6893 0 0 0 0 13.9874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P289 STK26_HUMAN "Serine/threonine-protein kinase 26, EC 2.7.11.1 (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4, MST-4, STE20-like kinase MST4) (Serine/threonine-protein kinase MASK)" STK26 MASK MST4 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542] apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506] apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; response to hydrogen peroxide [GO:0042542] GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0006468; GO:0006915; GO:0009267; GO:0012506; GO:0016020; GO:0016324; GO:0030033; GO:0030336; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0046777; GO:0048471; GO:0070062; GO:0071944; GO:0106310; GO:1903205 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AEGHSDDESDSEGSDSESTSR 0.96636 -0.89092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6553 0 0 13.2154 0 0 0 0 13.0854 0 0 0 0 0 0 14.0728 0 0 14.8994 0 0 0 0 0 13.8249 0 12.191 13.4067 0 0 0 0 0 0 0 0 0 0 0 0 13.3841 13.9611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1524 0 11.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1894 0 0 0 0 0 0 0 0 15.5356 0 0 0 0 0 0 0 12.7012 11.5803 15.5733 0 0 0 O43809 CPSF5_HUMAN "Cleavage and polyadenylation specificity factor subunit 5 (Cleavage and polyadenylation specificity factor 25 kDa subunit, CPSF 25 kDa subunit) (Cleavage factor Im complex 25 kDa subunit, CFIm25) (Nucleoside diphosphate-linked moiety X motif 21, Nudix motif 21) (Nudix hydrolase 21) (Pre-mRNA cleavage factor Im 68 kDa subunit)" NUDT21 CFIM25 CPSF25 CPSF5 Homo sapiens (Human) cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; post-transcriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; post-transcriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005847; GO:0005849; GO:0006378; GO:0006397; GO:0010608; GO:0016604; GO:0030154; GO:0031124; GO:0031439; GO:0034451; GO:0035925; GO:0042382; GO:0042802; GO:0042803; GO:0042826; GO:0051262; GO:0051290; GO:0098789; GO:0110104; GO:1900365; GO:1990120; GO:2000738; GO:2000975 chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] LFLVQLQEK 0.96637 -0.29423 0 0 0 0 0 0 0 0 0 0 0 14.0798 0 0 10.587 11.6527 0 0 0 14.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1074 0 0 0 0 0 0 13.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2024 0 0 0 0 0 0 0 0 0 0 Q8IW45 NNRD_HUMAN "ATP-dependent (S)-NAD(P)H-hydrate dehydratase, EC 4.2.1.93 (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase)" NAXD CARKD Homo sapiens (Human) metabolite repair [GO:0110051]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; metabolite repair [GO:0110051]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356] GO:0005524; GO:0005759; GO:0034356; GO:0047453; GO:0052855; GO:0110051 ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453] AGAGTAVAGAVVVALLSAALALYGPPLDAVLER 0.96638 0.024815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3829 0 0 0 0 10.7612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3684 0 0 0 13.6923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9943 0 12.4931 0 0 14.0273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8062 0 0 0 0 0 0 0 0 0 12.421 0 0 0 0 11.1111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6475 Q96MU5 CQ077_HUMAN Uncharacterized protein CD300LD-AS1 (CD300LD antisense RNA 1) CD300LD-AS1 C17orf77 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 EQEEPGGTQALRSCGIYCLEER 0.96639 -0.28492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2502 0 0 0 0 11.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2698 0 0 Q6ZR54 YN009_HUMAN Putative uncharacterized protein FLJ46641 Homo sapiens (Human) GFADVSQQIRVR 0.96641 -0.36417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KT6 CH014_HUMAN Putative uncharacterized protein encoded by LINC00208 LINC00208 C8orf14 NCRNA00208 Homo sapiens (Human) LLPAPSAHFLK 0.96642 -0.28734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99496 RING2_HUMAN "E3 ubiquitin-protein ligase RING2, EC 2.3.2.27 (Huntingtin-interacting protein 2-interacting protein 3, HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B, RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2)" RNF2 BAP1 DING HIPI3 RING1B Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0000151; GO:0000278; GO:0000791; GO:0001702; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0007281; GO:0008270; GO:0009948; GO:0010467; GO:0016604; GO:0031519; GO:0035102; GO:0035518; GO:0036353; GO:0043433; GO:0061630; GO:0071339; GO:0071535 chromatin binding [GO:0003682]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DEYEAHQERVLAR 0.96643 -0.36732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3137 0 14.6619 0 0 0 A9QM74 IMA8_HUMAN Importin subunit alpha-8 (Karyopherin subunit alpha-7) KPNA7 Homo sapiens (Human) blastocyst development [GO:0001824]; negative regulation of gene expression [GO:0010629]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 trimethylation [GO:1902466] cytosol [GO:0005829]; female germ cell nucleus [GO:0001674]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] cytosol [GO:0005829]; female germ cell nucleus [GO:0001674]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; blastocyst development [GO:0001824]; negative regulation of gene expression [GO:0010629]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 trimethylation [GO:1902466] GO:0001674; GO:0001824; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0006607; GO:0008139; GO:0010628; GO:0010629; GO:0042564; GO:0061608; GO:1902466 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] GVAVSLTLGEIIK 0.96644 -0.88301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95619 YETS4_HUMAN "YEATS domain-containing protein 4 (Glioma-amplified sequence 41, Gas41) (NuMA-binding protein 1, NuBI-1, NuBI1)" YEATS4 GAS41 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle [GO:0000278]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] "NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; protein C-terminus binding [GO:0008022]; structural constituent of cytoskeleton [GO:0005200]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; mitotic cell cycle [GO:0000278]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000278; GO:0000786; GO:0005200; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0008022; GO:0016363; GO:0016573; GO:0031965; GO:0035267; GO:0040008; GO:0042393; GO:0042981; GO:0043486; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:0070577; GO:0140030; GO:1905168; GO:2000779 histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; protein C-terminus binding [GO:0008022]; structural constituent of cytoskeleton [GO:0005200] ETINCLKNEIRK 0.96644 3.71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4448 0 13.1539 0 0 0 16.6288 0 0 0 0 0 0 0 0 13.9378 0 0 0 0 14.4553 0 0 0 0 0 0 0 0 13.8599 9.86632 0 0 0 0 13.627 12.5142 0 10.1404 0 0 0 0 0 0 10.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.781 0 0 0 0 0 0 0 0 14.2441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P67812 SC11A_HUMAN "Signal peptidase complex catalytic subunit SEC11A, EC 3.4.21.89 (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit, SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18)" SEC11A SEC11L1 SPC18 SPCS4A Homo sapiens (Human) signal peptide processing [GO:0006465] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465] GO:0004252; GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] GLYKQGQHWLEKK 0.96644 -0.32236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY37 ASIC5_HUMAN "Acid-sensing ion channel 5, ASIC5 (Amiloride-sensitive cation channel 5) (Human intestine Na(+) channel, HINaC)" ASIC5 ACCN5 HINAC Homo sapiens (Human) sodium ion transmembrane transport [GO:0035725] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252]; sodium ion transmembrane transport [GO:0035725] GO:0005886; GO:0005887; GO:0015252; GO:0015280; GO:0035725 ligand-gated sodium channel activity [GO:0015280]; proton channel activity [GO:0015252] VLWLVVVLGSVSLVTWQIYIR 0.96646 -0.8854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0114 0 0 0 0 0 0 0 0 0 0 0 13.4644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94941 RNF37_HUMAN "RING finger protein 37, EC 2.3.2.27 (RING-type E3 ubiquitin transferase RNF37) (U-box domain-containing protein 5) (UbcM4-interacting protein 5, hUIP5) (Ubiquitin-conjugating enzyme 7-interacting protein 5)" UBOX5 KIAA0860 RNF37 UBCE7IP5 UIP5 Homo sapiens (Human) protein polyubiquitination [GO:0000209] focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005634; GO:0005654; GO:0005925; GO:0016604; GO:0031625; GO:0034450; GO:0046872 metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450] CNRSEATWGR 0.96647 -0.30692 0 0 0 13.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2754 0 0 0 0 0 0 14.8412 0 0 0 15.4774 0 0 0 12.8693 0 0 0 0 13.9078 13.8256 14.309 13.5923 0 0 0 0 0 0 13.909 0 0 0 0 0 0 12.885 0 13.6582 0 0 12.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2874 0 0 0 Q9UBV2 SE1L1_HUMAN "Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1, Sel-1L)" SEL1L TSA305 UNQ128/PRO1063 Homo sapiens (Human) "ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]" Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021] "Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of membrane [GO:0016021]; ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0016021; GO:0030433; GO:0030970; GO:0036503; GO:0036513; GO:0050821 EYDECTSDGR 0.96647 -0.4056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3411 0 0 0 0 0 0 13.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6294 0 0 0 12.0329 0 0 0 0 0 0 15.3854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6329 0 0 0 0 0 0 0 0 0 0 Q1T7F1 CCB42_HUMAN Putative chemokine-related protein B42 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 MPLSDWCCGICEEAPLGR 0.9665 -0.041141 0 0 0 0 0 0 0 0 0 0 0 0 0 11.905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBR5 CKLF_HUMAN Chemokine-like factor (C32) CKLF CKLF1 HSPC224 UNQ410/PRO772 Homo sapiens (Human) lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; secretion by cell [GO:0032940] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chemokine activity [GO:0008009]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; secretion by cell [GO:0032940] GO:0005576; GO:0005615; GO:0008009; GO:0016020; GO:0016021; GO:0030593; GO:0032940; GO:0048246; GO:0048247 chemokine activity [GO:0008009] KLLFNPSGPYQK 0.96651 0.028624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6866 0 16.5832 16.5904 0 0 0 0 0 0 0 15.5251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6302 0 0 0 0 0 0 0 0 0 0 0 12.5708 0 0 0 0 0 0 0 0 0 0 0 13.2432 0 0 0 0 0 0 0 0 0 0 12.5686 0 0 0 0 0 0 0 0 0 0 0 Q15078 CD5R1_HUMAN "Cyclin-dependent kinase 5 activator 1, CDK5 activator 1 (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35, p35; Cyclin-dependent kinase 5 activator 1, p25, p25 (Tau protein kinase II 23 kDa subunit, p23) ]" CDK5R1 CDK5R NCK5A Homo sapiens (Human) "axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signaling receptor activity [GO:2000273]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic vesicle cycle [GO:0098693]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]" axon [GO:0030424]; contractile fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533] "axon [GO:0030424]; contractile fiber [GO:0043292]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ephrin receptor binding [GO:0046875]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; brain development [GO:0007420]; cerebellum development [GO:0021549]; embryo development ending in birth or egg hatching [GO:0009792]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G1 to G0 transition involved in cell differentiation [GO:0070315]; hippocampus development [GO:0021766]; ionotropic glutamate receptor signaling pathway [GO:0035235]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of signaling receptor activity [GO:2000273]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic vesicle cycle [GO:0098693]; rhythmic process [GO:0048511]; serine phosphorylation of STAT protein [GO:0042501]; superior olivary nucleus maturation [GO:0021722]" GO:0000079; GO:0000226; GO:0000307; GO:0001764; GO:0002020; GO:0004672; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007158; GO:0007213; GO:0007411; GO:0007413; GO:0007420; GO:0009792; GO:0014069; GO:0016020; GO:0016241; GO:0016301; GO:0016533; GO:0018105; GO:0018107; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030182; GO:0030295; GO:0030424; GO:0030425; GO:0030426; GO:0031116; GO:0031175; GO:0031594; GO:0032956; GO:0035235; GO:0035255; GO:0042501; GO:0043005; GO:0043014; GO:0043025; GO:0043197; GO:0043204; GO:0043231; GO:0043292; GO:0043525; GO:0043539; GO:0045296; GO:0045348; GO:0045664; GO:0045892; GO:0046875; GO:0048013; GO:0048471; GO:0048487; GO:0048511; GO:0051015; GO:0061001; GO:0061575; GO:0070315; GO:0090314; GO:0098693; GO:0098793; GO:2000273 actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; ephrin receptor binding [GO:0046875]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; protease binding [GO:0002020]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] IVAVSAKKK 0.96652 -0.36136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6687 0 0 0 0 9.93939 0 0 0 0 0 0 0 0 0 13.9902 0 0 0 0 0 13.5955 0 0 11.2279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5BKU9 OXLD1_HUMAN Oxidoreductase-like domain-containing protein 1 OXLD1 C17orf90 Homo sapiens (Human) GSGARRFSSPDCCQR 0.96652 -0.36221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2465 0 0 0 0 0 0 0 10.8502 0 0 0 0 0 0 0 0 0 0 12.7449 0 0 0 0 0 0 0 P23610 HAP40_HUMAN "40-kDa huntingtin-associated protein, HAP40 (CpG island protein) (Factor VIII intron 22 protein)" F8A1; F8A2; F8A3 Homo sapiens (Human) negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518] early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634] early endosome [GO:0005769]; nuclear body [GO:0016604]; nucleus [GO:0005634]; negative regulation of proteasomal protein catabolic process [GO:1901799]; vesicle cytoskeletal trafficking [GO:0099518] GO:0005634; GO:0005769; GO:0016604; GO:0099518; GO:1901799 LVSNKLKK 0.96653 -0.28429 0 0 0 0 0 0 13.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6339 0 12.6408 0 0 0 0 0 0 0 0 15.404 11.0857 11.8989 0 0 11.5403 0 0 0 12.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.887 0 0 0 0 13.5955 0 0 0 0 0 15.175 13.7061 0 0 14.1755 15.026 11.2428 14.1905 0 0 0 0 11.5027 0 15.4598 0 0 0 12.7651 0 0 0 0 0 0 0 0 0 15.0385 0 0 0 0 0 0 0 0 13.9709 0 14.714 0 0 13.4111 0 0 0 0 0 13.6544 0 0 0 0 0 0 0 0 0 0 0 13.6288 0 12.0459 0 0 0 0 12.0239 0 0 0 12.632 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5114 0 0 0 15.0242 0 0 0 0 0 0 0 0 0 13.0981 12.93 0 0 Q96IT6 ARAS1_HUMAN Putative uncharacterized protein ARHGAP5-AS1 (ARHGAP5 antisense RNA 1) (ARHGAP5 antisense gene protein 1) ARHGAP5-AS1 C14orf128 Homo sapiens (Human) GAGLRVAQK 0.96653 -0.36239 0 10.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2362 12.9582 0 0 0 12.1894 0 12.8285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8296 0 0 14.6543 13.1317 0 0 0 0 0 13.4062 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3201 0 0 0 0 0 0 0 0 0 13.357 0 0 0 13.3794 0 0 0 0 14.1846 0 0 0 0 0 0 0 0 0 0 0 14.0171 0 0 0 0 0 0 0 0 13.6311 0 0 0 0 0 0 0 0 13.0688 13.6472 0 0 0 0 0 0 0 12.3771 0 12.9556 0 0 0 0 0 0 0 0 0 0 0 0 13.4198 0 0 0 0 0 O75553 DAB1_HUMAN Disabled homolog 1 DAB1 Homo sapiens (Human) adult walking behavior [GO:0007628]; astrocyte differentiation [GO:0048708]; axonogenesis [GO:0007409]; cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration [GO:0021813]; cerebellum structural organization [GO:0021589]; dendrite development [GO:0016358]; Golgi localization [GO:0051645]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; radial glia guided migration of Purkinje cell [GO:0021942]; radial glia-guided pyramidal neuron migration [GO:0140650]; receptor signaling pathway via JAK-STAT [GO:0007259]; small GTPase mediated signal transduction [GO:0007264]; ventral spinal cord development [GO:0021517] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; adult walking behavior [GO:0007628]; astrocyte differentiation [GO:0048708]; axonogenesis [GO:0007409]; cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration [GO:0021813]; cerebellum structural organization [GO:0021589]; dendrite development [GO:0016358]; Golgi localization [GO:0051645]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; radial glia guided migration of Purkinje cell [GO:0021942]; radial glia-guided pyramidal neuron migration [GO:0140650]; receptor signaling pathway via JAK-STAT [GO:0007259]; small GTPase mediated signal transduction [GO:0007264]; ventral spinal cord development [GO:0021517] GO:0005737; GO:0005829; GO:0007162; GO:0007259; GO:0007264; GO:0007409; GO:0007628; GO:0016358; GO:0021517; GO:0021589; GO:0021766; GO:0021813; GO:0021942; GO:0043231; GO:0045666; GO:0045860; GO:0046426; GO:0048471; GO:0048708; GO:0048712; GO:0050771; GO:0051645; GO:0097477; GO:0140650 DITDHRAFGYVCGK 0.96654 -0.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3138 0 0 0 0 0 0 0 0 18.7003 18.6623 0 0 0 0 0 0 11.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6523 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0122 0 12.255 0 0 0 0 0 0 0 0 Q7Z3Y7 K1C28_HUMAN "Keratin, type I cytoskeletal 28 (Cytokeratin-28, CK-28) (Keratin-25D, K25D) (Keratin-28, K28) (Type I inner root sheath-specific keratin-K25irs4)" KRT28 KRT25D Homo sapiens (Human) cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0070062 structural molecule activity [GO:0005198] AEYEALAEQNRK 0.96654 -0.36318 0 13.5639 0 0 0 0 0 0 0 0 0 10.1857 0 0 0 0 0 0 0 0 0 12.0925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.212 0 0 0 0 0 0 0 0 0 0 11.6973 0 0 0 0 0 0 12.8666 0 0 0 0 0 10.5501 0 0 11.2783 0 12.9738 0 13.5536 14.8666 0 13.2945 12.6541 0 0 13.4095 0 13.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7896 0 13.0101 0 0 0 10.3484 0 11.8839 14.1908 0 15.2459 13.2836 0 0 0 0 0 0 13.3287 0 0 0 0 0 0 0 11.0995 0 0 0 0 0 0 0 0 0 0 Q9BQS2 SYT15_HUMAN "Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV, SytXV)" SYT15 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0070382; GO:0071277 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] KHQLLGQVLFPLK 0.96654 0.024932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.552 0 0 0 14.4279 0 0 0 9.59958 0 0 0 0 11.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0542 0 0 0 0 0 9.83709 0 0 0 0 13.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5145 0 10.3206 0 0 0 0 0 13.6932 Q9H013 ADA19_HUMAN "Disintegrin and metalloproteinase domain-containing protein 19, ADAM 19, EC 3.4.24.- (Meltrin-beta) (Metalloprotease and disintegrin dendritic antigen marker, MADDAM)" ADAM19 MLTNB FKSG34 Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; protein processing [GO:0016485] collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; membrane protein ectodomain proteolysis [GO:0006509]; placenta development [GO:0001890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; protein processing [GO:0016485] GO:0001890; GO:0004222; GO:0005634; GO:0005794; GO:0005886; GO:0006509; GO:0010628; GO:0016021; GO:0016485; GO:0017124; GO:0042987; GO:0046872; GO:0062023; GO:1902945; GO:2000049 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; SH3 domain binding [GO:0017124] ALPANPVPGRRSLPR 0.96654 -0.36392 0 0 0 0 0 0 0 0 15.2261 0 10.9313 0 0 0 14.4308 0 0 14.3113 0 13.0815 12.7849 0 0 13.688 0 0 12.6807 12.5388 14.1642 13.5139 14.3703 0 0 0 0 13.7616 14.6706 0 14.5317 0 0 0 12.7435 0 0 0 12.6708 12.5307 0 10.6845 0 0 0 12.3501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6954 0 0 13.7761 0 0 0 0 13.5223 0 0 0 0 0 0 0 0 14.1596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9102 0 0 0 14.5314 0 0 8.96038 0 0 0 15.1779 0 0 0 0 0 0 12.6065 0 0 0 0 0 0 0 13.6758 0 0 0 0 0 0 13.5356 0 0 12.4387 0 12.3486 0 0 14.5628 0 0 0 12.585 0 0 0 0 0 0 0 0 0 0 0 0 0 13.567 13.384 0 0 0 0 0 0 0 12.3719 0 0 0 0 0 Q15040 JOS1_HUMAN "Josephin-1, EC 3.4.19.12 (Josephin domain-containing protein 1)" JOSD1 JSPH1 KIAA0063 Homo sapiens (Human) protein deubiquitination [GO:0016579] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579] GO:0004843; GO:0005829; GO:0005886; GO:0016020; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843] DTLQEIFQRLSPNTMVTPHK 0.96655 -0.29848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4091 0 0 0 0 14.2971 0 0 0 0 17.4824 0 0 17.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6618 0 0 12.2256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56597 NDK5_HUMAN "Nucleoside diphosphate kinase homolog 5, NDK-H 5, NDP kinase homolog 5 (Inhibitor of p53-induced apoptosis-beta, IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5)" NME5 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591] cilium [GO:0005929]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126] cilium [GO:0005929]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591] GO:0003341; GO:0003351; GO:0004550; GO:0005576; GO:0005929; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0009116; GO:0021591; GO:0036126; GO:0051649; GO:0060271; GO:1902176 nucleoside diphosphate kinase activity [GO:0004550] LSPEQCSNFYVEKYGK 0.96656 -0.88284 0 14.4293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15052 ARHG6_HUMAN Rho guanine nucleotide exchange factor 6 (Alpha-Pix) (COOL-2) (PAK-interacting exchange factor alpha) (Rac/Cdc42 guanine nucleotide exchange factor 6) ARHGEF6 COOL2 KIAA0006 PIXA Homo sapiens (Human) apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; apoptotic process [GO:0006915]; JNK cascade [GO:0007254]; lamellipodium assembly [GO:0030032] GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0006915; GO:0007254; GO:0030027; GO:0030032 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] LEKYVTLLQELER 0.96656 3.2356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1342 0 0 0 0 0 0 11.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 9.52478 0 0 0 0 0 0 0 0 0 0 0 0 13.9149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1773 0 0 0 0 0 0 0 0 0 0 14.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 11.765 11.125 0 0 0 0 12.7222 0 0 0 12.4554 0 0 0 0 0 0 0 Q96S19 MTL26_HUMAN Methyltransferase-like 26 METTL26 JFP2 C16orf13 Homo sapiens (Human) CLDSIAATTQAQGLTNVK 0.96656 -0.28709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0933 15.5816 13.5088 0 0 13.5233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60983 GMFB_HUMAN "Glia maturation factor beta, GMF-beta" GMFB Homo sapiens (Human) actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468] actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; protein kinase inhibitor activity [GO:0004860]; actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468] GO:0003779; GO:0004860; GO:0006468; GO:0007399; GO:0008047; GO:0008083; GO:0034316; GO:0071846; GO:0071933 actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; protein kinase inhibitor activity [GO:0004860] NKLVQTAELTK 0.96657 -0.048306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00142 KITM_HUMAN "Thymidine kinase 2, mitochondrial, EC 2.7.1.21 (2'-deoxyuridine kinase TK2, EC 2.7.1.74) (Deoxycytidine kinase TK2, EC 2.7.1.-) (Mt-TK)" TK2 Homo sapiens (Human) deoxycytidine metabolic process [GO:0046092]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; phosphorylation [GO:0016310]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; nucleoside kinase activity [GO:0019206]; thymidine kinase activity [GO:0004797]; deoxycytidine metabolic process [GO:0046092]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; phosphorylation [GO:0016310]; pyrimidine nucleoside salvage [GO:0043097]; thymidine metabolic process [GO:0046104] GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0006139; GO:0016310; GO:0019136; GO:0019206; GO:0043097; GO:0046092; GO:0046104; GO:0071897 ATP binding [GO:0005524]; deoxycytidine kinase activity [GO:0004137]; deoxynucleoside kinase activity [GO:0019136]; nucleoside kinase activity [GO:0019206]; thymidine kinase activity [GO:0004797] ILTPENRK 0.96658 -0.32129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1623 0 0 0 0 0 0 0 0 0 0 0 0 13.2634 0 0 0 18.4569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75459 PAGE1_HUMAN "P antigen family member 1, PAGE-1 (AL5) (G antigen 9, GAGE-9) (G antigen family B member 1) (Prostate-associated gene 1 protein)" PAGE1 GAGE9 GAGEB1 Homo sapiens (Human) GFLRRLIYR 0.96658 -0.21075 14.733 14.9422 13.0058 13.3504 12.2852 14.0293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3647 0 12.8622 12.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2696 0 0 0 13.4881 0 Q7Z6Z6 PLPL5_HUMAN "Patatin-like phospholipase domain-containing protein 5, EC 3.1.1.3 (GS2-like protein)" PNPLA5 GS2L Homo sapiens (Human) lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; triglyceride lipase activity [GO:0004806]; lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433] GO:0004806; GO:0005737; GO:0005811; GO:0005829; GO:0016020; GO:0019433; GO:0055088 triglyceride lipase activity [GO:0004806] APRLLQGAR 0.96658 0.01401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4429 0 0 0 0 0 0 Q9H6B1 Z385D_HUMAN Zinc finger protein 385D (Zinc finger protein 659) ZNF385D ZNF659 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] GO:0005634; GO:0008270; GO:1990837 sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] AAGKPPK 0.96658 0.023683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2839 11.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2389 0 16.068 16.2163 0 0 0 0 0 0 15.959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55087 AQP4_HUMAN "Aquaporin-4, AQP-4 (Mercurial-insensitive water channel, MIWC) (WCH4)" AQP4 Homo sapiens (Human) carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; female pregnancy [GO:0007565]; hyperosmotic salinity response [GO:0042538]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water homeostasis [GO:0003091]; response to glucocorticoid [GO:0051384]; response to radiation [GO:0009314]; water homeostasis [GO:0030104]; water transport [GO:0006833] astrocyte end-foot [GO:0097450]; basolateral plasma membrane [GO:0016323]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315] astrocyte end-foot [GO:0097450]; basolateral plasma membrane [GO:0016323]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; identical protein binding [GO:0042802]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; cell-cell adhesion [GO:0098609]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid circulation [GO:0090660]; female pregnancy [GO:0007565]; hyperosmotic salinity response [GO:0042538]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; protein homotetramerization [GO:0051289]; regulation of vascular endothelial growth factor production [GO:0010574]; renal water homeostasis [GO:0003091]; response to glucocorticoid [GO:0051384]; response to radiation [GO:0009314]; water homeostasis [GO:0030104]; water transport [GO:0006833] GO:0003091; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0006833; GO:0007565; GO:0009314; GO:0009897; GO:0009992; GO:0010008; GO:0010574; GO:0015250; GO:0015670; GO:0016021; GO:0016323; GO:0030104; GO:0030315; GO:0031253; GO:0032691; GO:0032715; GO:0032991; GO:0042383; GO:0042538; GO:0042802; GO:0050891; GO:0051289; GO:0051384; GO:0060354; GO:0071333; GO:0071346; GO:0071347; GO:0071354; GO:0071392; GO:0090660; GO:0097450; GO:0098609 identical protein binding [GO:0042802]; water channel activity [GO:0015250] GSYMEVEDNR 0.9666 -0.30607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUX4 ABC3F_HUMAN "DNA dC->dU-editing enzyme APOBEC-3F, EC 3.5.4.38 (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F, A3F)" APOBEC3F Homo sapiens (Human) base conversion or substitution editing [GO:0016553]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of defense response to virus by host [GO:0002230] apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; base conversion or substitution editing [GO:0016553]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of defense response to virus by host [GO:0002230] GO:0000932; GO:0002230; GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0008270; GO:0010529; GO:0016553; GO:0016554; GO:0030895; GO:0042802; GO:0045071; GO:0045087; GO:0045869; GO:0047844; GO:0048525; GO:0051607; GO:0070383; GO:0080111; GO:1990904 cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] IMDDEEFAYCWENFVYSEGQPFMPWYK 0.96661 -0.40544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2771 0 0 0 0 0 0 0 17.2059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4195 0 0 0 0 0 0 0 0 Q969J3 BORC5_HUMAN "BLOC-1-related complex subunit 5 (Loss of heterozygosity 12 chromosomal region 1) (Myristoylated lysosomal protein, Myrlysin)" BORCS5 LOH12CR1 Homo sapiens (Human) lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] GO:0005886; GO:0030672; GO:0031224; GO:0032418; GO:0043231; GO:0051036; GO:0062196; GO:0072384; GO:0098574; GO:0099078; GO:1903744 GSEQSSEAESR 0.96662 -0.30817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2007 0 14.423 15.8393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9882 Q9BUW7 BBLN_HUMAN Bublin coiled-coil protein (UPF0184 protein C9orf16) BBLN C9orf16 EST00098 Homo sapiens (Human) NDHLHARLQELLESNR 0.96663 0.0027676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9192 0 14.2948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HD1 CREL1_HUMAN "Protein disulfide isomerase CRELD1, EC 5.3.4.1 (Cysteine-rich with EGF-like domain protein 1)" CRELD1 CIRRIN UNQ188/PRO214 Homo sapiens (Human) cardiac septum development [GO:0003279]; endocardial cushion development [GO:0003197] collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021] collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756]; cardiac septum development [GO:0003279]; endocardial cushion development [GO:0003197] GO:0003197; GO:0003279; GO:0003756; GO:0005509; GO:0016021; GO:0062023 calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756] CSGPEESNCLQCKK 0.96665 -0.041031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6353 0 11.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5203 0 0 0 0 12.1719 0 0 0 0 0 0 0 0 0 13.4198 0 0 0 0 12.1463 0 14.5674 0 13.726 0 0 14.536 0 14.7015 14.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8981 0 0 0 0 0 0 0 0 0 0 13.9311 0 0 0 0 0 0 0 0 13.5353 0 0 0 0 0 0 11.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1776 0 0 0 0 0 0 12.3753 0 0 0 0 0 12.5398 0 0 0 0 0 10.4503 0 0 Q6P5S2 LEG1H_HUMAN Protein LEG1 homolog LEG1 C6orf58 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] GO:0005615; GO:0070062 IILNQTARYFAKFAPDNEQNILWGLPLQYGWQYR 0.96666 -0.36054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXC3 PYDC1_HUMAN "Pyrin domain-containing protein 1 (PAAD-only protein 1) (Pyrin-only protein 1) (cellular POP1, cPOP1)" PYDC1 ASC2 ASCI POP1 PYC1 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of interleukin-1 beta production [GO:0032731]; proteolysis [GO:0006508]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleus [GO:0005634] cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of interleukin-1 beta production [GO:0032731]; proteolysis [GO:0006508]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0004197; GO:0005634; GO:0005829; GO:0006469; GO:0006508; GO:0008385; GO:0010804; GO:0032088; GO:0032731; GO:0033209; GO:0045087 cysteine-type endopeptidase activity [GO:0004197] LGTVPLREGFERIPR 0.96666 0.028664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6J2 LV233_HUMAN Probable non-functional immunoglobulin lambda variable 2-33 IGLV2-33 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 LLIYNVNTR 0.96667 -0.28345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.003 0 0 0 0 0 0 0 0 0 0 14.9333 0 0 0 0 0 0 0 0 0 0 Q96G25 MED8_HUMAN "Mediator of RNA polymerase II transcription subunit 8 (Activator-recruited cofactor 32 kDa component, ARC32) (Mediator complex subunit 8)" MED8 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0000978; GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0016567; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712] HEKTPLFRNQVIIPLVLSPDR 0.96667 -0.04235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NA96 YE027_HUMAN Putative uncharacterized protein FLJ35723 Homo sapiens (Human) AWCHCTSSQYPFK 0.96668 -0.20977 0 0 0 0 0 0 0 0 0 0 12.2834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5349 14.438 14.41 14.6715 14.2481 0 0 0 14.6976 0 0 0 0 0 0 0 0 0 0 13.8841 0 0 Q9H0M5 ZN700_HUMAN Zinc finger protein 700 ZNF700 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFRYRPSIR 0.96668 -0.88224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4214 0 0 0 11.0739 0 0 0 0 0 0 0 13.6269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3837 0 13.3483 0 0 0 11.4882 0 0 0 12.3634 0 14.1665 0 0 0 0 0 0 0 0 0 14.1753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6Z9 EGLN3_HUMAN "Prolyl hydroxylase EGLN3, EC 1.14.11.- (Egl nine homolog 3, EC 1.14.11.29) (HPH-1) (Hypoxia-inducible factor prolyl hydroxylase 3, HIF-PH3, HIF-prolyl hydroxylase 3, HPH-3) (Prolyl hydroxylase domain-containing protein 3, PHD3)" EGLN3 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein hydroxylation [GO:0018126]; regulation of cell population proliferation [GO:0042127]; regulation of neuron apoptotic process [GO:0043523]; response to hypoxia [GO:0001666] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; protein hydroxylation [GO:0018126]; regulation of cell population proliferation [GO:0042127]; regulation of neuron apoptotic process [GO:0043523]; response to hypoxia [GO:0001666] GO:0001666; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0008198; GO:0016706; GO:0018126; GO:0018401; GO:0031418; GO:0031543; GO:0031545; GO:0042127; GO:0043523; GO:0071456 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543] LGKYYVK 0.96668 -0.88106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.381 14.4251 0 14.6083 14.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9169 0 11.9228 0 12.7758 16.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25325 THTM_HUMAN "3-mercaptopyruvate sulfurtransferase, MST, EC 2.8.1.2" MPST TST2 Homo sapiens (Human) cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] anchoring junction [GO:0070161]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202] anchoring junction [GO:0070161]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792]; cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] GO:0000098; GO:0001822; GO:0001889; GO:0004792; GO:0005739; GO:0005759; GO:0005829; GO:0009440; GO:0009636; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070161; GO:0070814 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792] HLFQEKKVDLSK 0.96669 -0.88281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ69 CK040_HUMAN Putative uncharacterized protein C11orf40 (Ro/SSA1-related protein) C11orf40 NOV1 Homo sapiens (Human) ALVQALVPRER 0.96669 -0.28674 14.6061 15.1636 16.6712 0 11.2344 16.0786 17.2572 14.2184 0 0 0 0 0 0 0 16.6791 16.5958 16.7636 14.4629 16.596 0 0 0 0 0 0 16.6882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7956 0 0 0 11.3363 0 14.1215 14.6115 13.7903 15.1227 13.9571 12.6715 14.2982 13.8016 13.5513 11.0515 13.9186 13.1695 12.4534 14.2883 13.9547 0 14.4025 12.9172 14.6563 0 11.4272 0 0 0 0 13.3783 12.8429 12.2802 0 13.1233 0 13.9615 13.7199 12.283 0 12.5848 13.6418 0 14.7404 0 13.6119 12.5282 14.9725 0 14.3207 14.4072 14.3378 0 14.1418 0 13.4462 0 13.8281 0 13.7366 13.6944 0 12.3813 14.0406 0 13.6007 13.8141 12.2619 12.3425 13.8656 14.1496 0 14.293 13.8656 14.8142 13.8505 12.1134 0 12.0474 0 0 13.5106 14.8077 13.9775 0 12.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4521 13.7128 0 0 0 0 0 0 Q9BV20 MTNA_HUMAN "Methylthioribose-1-phosphate isomerase, M1Pi, MTR-1-P isomerase, EC 5.3.1.23 (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein)" MRI1 MRDI UNQ6390/PRO21135 Homo sapiens (Human) L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284] cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284] GO:0001650; GO:0005654; GO:0005829; GO:0019284; GO:0019509; GO:0042802; GO:0042995; GO:0046523 identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523] GSLQILDQLLLPK 0.96669 -0.29819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0713 0 12.9948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.621 0 0 0 0 14.8528 14.8876 12.2129 11.9678 0 0 0 0 0 0 13.3295 0 12.6752 0 13.4466 15.0295 0 15.1822 14.7311 15.8368 15.4139 14.5027 15.0363 15.7436 0 0 12.8434 15.0638 15.7764 14.3648 0 13.4574 14.9084 15.4267 15.4736 0 0 14.681 15.3055 0 15.4781 0 0 0 14.8264 0 14.8273 0 12.6352 14.8868 0 12.9411 14.6833 14.9759 15.6212 0 15.2061 15.3876 0 15.38 15.0936 0 0 0 0 14.9901 15.1827 0 14.8271 0 0 12.8333 15.0289 13.413 0 12.6064 0 0 0 14.6321 15.3754 14.7689 14.9374 15.2334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6761 13.4362 0 0 0 14.5237 0 Q9NX45 SOLH2_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 SOHLH2 TEB1 Homo sapiens (Human) cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; oocyte differentiation [GO:0009994]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007283; GO:0009994; GO:0030154; GO:0042803; GO:0046982; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GCISGHGMDIALTEPLTMEK 0.9667 0.037151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2644 14.0656 14.2035 0 13.4209 14.0002 0 0 0 0 0 12.6782 0 0 0 0 0 0 0 0 13.3832 0 0 0 0 0 0 0 0 0 0 0 13.236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00757 F16P2_HUMAN "Fructose-1,6-bisphosphatase isozyme 2, FBPase 2, EC 3.1.3.11 (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)" FBP2 Homo sapiens (Human) "fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]" anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; sucrose biosynthetic process [GO:0005986]" GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0030018; GO:0030388; GO:0042132; GO:0042802; GO:0046872; GO:0070062; GO:0070161 "fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" DALQCGR 0.96671 -0.30191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8656 0 0 0 13.168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8735 0 0 0 0 0 0 0 0 0 12.4008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75610 LFTY1_HUMAN Left-right determination factor 1 (Left-right determination factor B) (Protein lefty-1) (Protein lefty-B) LEFTY1 LEFTB LEFTYB UNQ278/PRO317 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0000122; GO:0003007; GO:0005125; GO:0005160; GO:0005615; GO:0007179; GO:0007368; GO:0008083; GO:0010862; GO:0030509; GO:0060395 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160] AQYVALLQR 0.96671 -0.30098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8131 A6NMX2 I4E1B_HUMAN Eukaryotic translation initiation factor 4E type 1B EIF4E1B Homo sapiens (Human) eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845] eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743] GO:0000340; GO:0003743; GO:0005845; GO:0016281 RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743] ARTGGPMEVK 0.96672 -0.32078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2577 0 0 0 0 0 0 13.0289 0 0 0 0 12.0148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5295 0 13.994 0 0 0 0 0 11.1542 0 0 0 0 11.7694 0 0 0 0 0 0 0 0 0 0 12.8455 0 0 0 0 0 12.544 0 0 0 0 0 0 16.7358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7717 0 0 0 0 0 0 0 0 0 13.891 0 0 0 0 0 0 12.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2434 0 0 0 0 0 0 P11441 UBL4A_HUMAN Ubiquitin-like protein 4A (Ubiquitin-like protein GDX) UBL4A DXS254E GDX UBL4 Homo sapiens (Human) post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein modification process [GO:0036211]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; ubiquitin-like protein transferase activity [GO:0019787]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein modification process [GO:0036211]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006620; GO:0016020; GO:0019787; GO:0031647; GO:0036211; GO:0051087; GO:0071816; GO:0071818 chaperone binding [GO:0051087]; ubiquitin-like protein transferase activity [GO:0019787] ALADGKR 0.96672 -0.30392 0 0 0 0 0 0 0 0 14.2496 16.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7276 0 0 0 14.4233 0 0 0 0 0 0 0 0 0 0 9.45381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7427 0 0 0 0 0 0 0 0 0 0 0 12.1199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1234 0 0 0 0 Q6ZTR7 CBAR2_HUMAN CBY1-interacting BAR domain-containing protein 2 (Protein FAM92B) CIBAR2 FAM92B Homo sapiens (Human) cilium assembly [GO:0060271] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271] GO:0005737; GO:0005814; GO:0035869; GO:0036064; GO:0060271 DLLDFRAKMQGVYGHYDTR 0.96672 -0.30334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7711 0 0 0 0 0 0 0 0 10.6545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97441 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3437 0 10.775 0 0 11.6352 0 0 0 0 0 0 0 0 Q9Y3D0 CIA2B_HUMAN Cytosolic iron-sulfur assembly component 2B (MSS19-interacting protein of 18 kDa) (Mitotic spindle-associated MMXD complex subunit MIP18) (Protein FAM96B) CIAO2B CIAB FAM96B MIP18 CGI-128 HSPC118 Homo sapiens (Human) chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428] CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428] GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0016226; GO:0030496; GO:0071817; GO:0097361; GO:0097428; GO:0106035 VKLLRSLPQR 0.96672 -0.21039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5706 13.7668 14.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9094 0 0 14.5223 0 0 0 0 0 0 14.1163 0 0 0 0 0 0 0 0 0 13.9119 0 0 A0A087WSY6 KVD15_HUMAN Immunoglobulin kappa variable 3D-15 IGKV3D-15 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 LLIYGASIR 0.96673 -0.30455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4874 15.6117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13520 AQP6_HUMAN "Aquaporin-6, AQP-6 (Aquaporin-2-like) (Kidney-specific aquaporin, hKID)" AQP6 AQP2L Homo sapiens (Human) carbon dioxide transport [GO:0015670]; odontogenesis [GO:0042476]; renal water transport [GO:0003097]; water transport [GO:0006833] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; water channel activity [GO:0015250]; carbon dioxide transport [GO:0015670]; odontogenesis [GO:0042476]; renal water transport [GO:0003097]; water transport [GO:0006833] GO:0003097; GO:0005886; GO:0006833; GO:0015112; GO:0015250; GO:0015670; GO:0016021; GO:0016324; GO:0030659; GO:0042476 nitrate transmembrane transporter activity [GO:0015112]; water channel activity [GO:0015250] ETLGINVVR 0.96675 0.013073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6435 0 0 0 0 0 0 0 0 0 0 15.0604 0 14.9412 0 0 14.9948 0 14.8627 14.6906 14.6366 15.5577 14.5787 0 0 0 0 15.374 0 0 0 0 14.9828 0 0 0 0 0 14.7834 0 0 0 0 13.9838 13.6962 14.0056 0 0 0 13.2481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9775 0 14.8746 0 0 0 0 0 14.8227 0 0 0 14.5968 0 0 0 0 0 0 0 0 0 13.076 0 0 0 0 0 0 14.1603 0 0 0 0 0 0 0 0 Q6ZPA2 YS039_HUMAN Putative uncharacterized protein FLJ26174 Homo sapiens (Human) LLLSLHWDWGR 0.96675 -0.32622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96I24 FUBP3_HUMAN "Far upstream element-binding protein 3, FUSE-binding protein 3" FUBP3 FBP3 Homo sapiens (Human) "positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]" GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006351; GO:0010468; GO:0010628; GO:0016020; GO:0045893; GO:0045944 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] EKDQADFRGVR 0.96675 -0.0084724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6905 0 0 0 12.7012 0 0 0 0 0 0 0 0 0 0 0 13.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3653 15.8422 0 0 0 0 0 0 15.4156 0 13.3129 0 0 0 0 16.4091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7365 0 0 0 0 0 0 0 0 0 13.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DN81 O13C7_HUMAN Olfactory receptor 13C7 OR13C7 OR13C7P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DLIFQKCFA 0.96676 -0.86954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2937 0 0 0 0 0 0 0 17.5014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0D2K2 KLH30_HUMAN Kelch-like protein 30 KLHL30 Homo sapiens (Human) AKRWMALPDFPDYHK 0.96676 0.012332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A3B3IU63 H2AL3_HUMAN "Histone H2A-like 3, H2A.L.3" H2AL3 H2AL1RP Homo sapiens (Human) nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] EEEMVVLVVMGGRR 0.96677 -0.35266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01449 MLRA_HUMAN "Myosin regulatory light chain 2, atrial isoform, MLC-2a, MLC2a, Myosin light chain 2a (Myosin regulatory light chain 7)" MYL7 MYL2A MYLC2A Homo sapiens (Human) cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047] A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; myofibril [GO:0030016]; myosin complex [GO:0016459] A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; myofibril [GO:0030016]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047] GO:0005509; GO:0005737; GO:0005829; GO:0016459; GO:0030016; GO:0031672; GO:0043197; GO:0048738; GO:0060047 calcium ion binding [GO:0005509] KAGTRGK 0.96679 -0.36035 0 0 0 0 0 0 0 0 14.749 13.9036 13.2507 14.8277 13.0812 15.3694 13.901 14.5877 14.3973 15.1084 14.2766 13.7154 14.5106 0 0 0 15.2633 15.343 14.578 15.5078 14.7922 14.664 0 0 13.6297 13.2556 13.56 0 0 13.0303 13.533 13.5427 14.448 0 15.2803 14.6458 14.5576 14.1048 15.0782 13.5641 15.0928 14.0562 15.1921 0 0 11.335 13.5254 13.5549 0 11.7642 0 0 12.6461 12.176 13.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5339 0 0 0 0 0 0 0 0 0 13.3219 15.6354 14.2321 14.1618 0 15.4462 15.1439 0 15.2335 15.0074 16.1238 15.0707 15.5653 16.5681 0 0 0 0 0 0 16.2554 0 0 Q969U6 FBXW5_HUMAN F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5) FBXW5 FBW5 PP3971 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein kinase binding [GO:0019901]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0005737; GO:0005829; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008 protein kinase binding [GO:0019901] EGLRHFLDR 0.96679 0.0028807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43292 GPAA1_HUMAN "Glycosylphosphatidylinositol anchor attachment 1 protein, GPI anchor attachment protein 1 (GAA1 protein homolog, hGAA1)" GPAA1 GAA1 Homo sapiens (Human) attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003] centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; mitochondrion [GO:0005739] centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; tubulin binding [GO:0015631]; attachment of GPI anchor to protein [GO:0016255]; protein retention in ER lumen [GO:0006621]; protein-containing complex assembly [GO:0065003] GO:0005739; GO:0005783; GO:0005789; GO:0005813; GO:0005829; GO:0006621; GO:0015631; GO:0016020; GO:0016255; GO:0042765; GO:0065003 tubulin binding [GO:0015631] ARAFARDFAAHR 0.9668 -0.88049 0 12.308 0 0 0 0 0 0 11.47 0 0 12.4282 0 0 12.5826 0 0 0 0 0 0 0 11.4937 0 0 0 0 0 0 0 0 0 0 11.2855 12.2869 0 0 0 12.402 0 0 0 0 12.5664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0215 14.4135 14.1023 0 0 0 14.1901 14.1351 0 0 13.2578 0 0 12.8587 0 0 0 0 0 0 13.6099 0 0 P00709 LALBA_HUMAN Alpha-lactalbumin (Lactose synthase B protein) (Lysozyme-like protein 7) LALBA LYZL7 Homo sapiens (Human) apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to bacterium [GO:0042742]; lactose biosynthetic process [GO:0005989]; signal transduction [GO:0007165] extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991] extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; lactose synthase activity [GO:0004461]; lysozyme activity [GO:0003796]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to bacterium [GO:0042742]; lactose biosynthetic process [GO:0005989]; signal transduction [GO:0007165] GO:0000139; GO:0003796; GO:0004461; GO:0005509; GO:0005615; GO:0005796; GO:0005989; GO:0006915; GO:0007165; GO:0007267; GO:0032991; GO:0042742 calcium ion binding [GO:0005509]; lactose synthase activity [GO:0004461]; lysozyme activity [GO:0003796] FFVPLFLVGILFPAILAK 0.9668 -0.88099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3881 10.7364 0 0 12.4487 0 0 11.6838 0 12.8954 12.9538 12.9219 0 0 14.1703 11.4115 0 0 0 13.7608 14.6033 11.4121 0 0 13.9088 12.8601 0 14.8565 14.9386 0 0 13.6945 13.901 0 13.124 0 0 0 0 0 0 13.9339 15.0381 0 0 13.2968 0 0 12.7746 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1096 12.5205 12.8936 12.1196 0 0 0 0 14.8952 0 0 0 0 0 0 0 12.7216 12.0955 0 0 0 0 0 0 0 0 0 0 0 0 14.3332 0 0 12.404 12.3813 12.7359 0 0 0 11.4628 0 0 Q8NGS4 O13F1_HUMAN Olfactory receptor 13F1 (Olfactory receptor OR9-6) OR13F1 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] VALKKLLIR 0.9668 -0.93117 13.0655 11.8951 12.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.802 0 0 0 0 0 0 0 0 0 14.1666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76162 0 0 0 13.9727 0 0 0 0 0 0 0 0 0 0 0 0 11.4885 0 0 0 0 0 0 13.7215 0 0 0 0 O00295 TULP2_HUMAN "Tubby-related protein 2 (Cancer/testis antigen 65, CT65) (Tubby-like protein 2)" TULP2 TUBL2 Homo sapiens (Human) protein localization to cilium [GO:0061512]; visual perception [GO:0007601] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; protein-containing complex binding [GO:0044877]; protein localization to cilium [GO:0061512]; visual perception [GO:0007601] GO:0005576; GO:0005737; GO:0005929; GO:0007601; GO:0044877; GO:0061512 protein-containing complex binding [GO:0044877] HQEHLVLQFGR 0.96681 0.0157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.468 13.3267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5H4 ZN768_HUMAN Zinc finger protein 768 ZNF768 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000977; GO:0000981; GO:0003723; GO:0005634; GO:0006357; GO:0006366; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" PYKCPRCGK 0.96681 -0.2832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9722 0 12.6092 0 13.7127 0 0 0 0 0 14.1994 0 0 11.5574 0 12.0477 12.0797 0 0 0 0 12.8969 13.073 12.0775 0 0 0 0 0 0 0 0 12.4788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.845 16.9731 0 0 0 0 0 12.7621 0 0 0 0 0 0 12.5777 0 0 0 0 0 0 0 0 13.2365 0 0 0 0 0 0 0 0 0 0 0 17.5953 0 0 11.6054 0 0 0 0 0 0 12.2225 0 0 0 12.8648 0 0 0 0 0 0 17.4264 0 0 0 17.4293 0 16.345 0 0 12.476 0 12.7708 0 12.2924 12.9836 12.3144 0 0 0 0 12.903 0 0 0 0 0 13.255 0 0 0 0 0 0 0 0 13.7907 0 12.459 13.7197 0 13.3884 0 0 0 0 0 0 0 0 17.2325 14.8619 0 0 11.8032 13.4467 0 0 Q9NWT1 PK1IP_HUMAN "p21-activated protein kinase-interacting protein 1 (PAK/PLC-interacting protein 1, hPIP1) (PAK1-interacting protein 1) (WD repeat-containing protein 84)" PAK1IP1 PIP1 WDR84 Homo sapiens (Human) cell population proliferation [GO:0008283]; negative regulation of signal transduction [GO:0009968]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit biogenesis [GO:0042273]; roof of mouth development [GO:0060021] nucleolus [GO:0005730] nucleolus [GO:0005730]; cell population proliferation [GO:0008283]; negative regulation of signal transduction [GO:0009968]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit biogenesis [GO:0042273]; roof of mouth development [GO:0060021] GO:0005730; GO:0008283; GO:0009968; GO:0042273; GO:0060021; GO:1901796 MVEMLEKKR 0.96681 -0.93117 0 0 0 0 0 0 0 0 0 0 13.9167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21731 TA2R_HUMAN "Thromboxane A2 receptor, TXA2-R (Prostanoid TP receptor)" TBXA2R Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of vasoconstriction [GO:0045907]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; second-messenger-mediated signaling [GO:0019932]; smooth muscle contraction [GO:0006939] acrosomal vesicle [GO:0001669]; integral component of plasma membrane [GO:0005887]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; integral component of plasma membrane [GO:0005887]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; thromboxane A2 receptor activity [GO:0004961]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of vasoconstriction [GO:0045907]; response to ethanol [GO:0045471]; response to nutrient [GO:0007584]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; second-messenger-mediated signaling [GO:0019932]; smooth muscle contraction [GO:0006939] GO:0001669; GO:0004961; GO:0005085; GO:0005886; GO:0005887; GO:0006939; GO:0006954; GO:0007186; GO:0007189; GO:0007204; GO:0007584; GO:0009410; GO:0016607; GO:0019932; GO:0030194; GO:0033574; GO:0045471; GO:0045766; GO:0045777; GO:0045907; GO:0045987; GO:0071222; GO:0090051 guanyl-nucleotide exchange factor activity [GO:0005085]; thromboxane A2 receptor activity [GO:0004961] ELLIYLR 0.96682 -0.93136 0 0 0 0 11.2744 0 0 12.1258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8357 0 0 0 13.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6071 0 0 0 0 0 0 0 0 0 0 0 0 0 11.07 0 0 13.9977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BS92 NPS3B_HUMAN "Protein NipSnap homolog 3B, NipSnap3B (SNAP1)" NIPSNAP3B NIPSNAP3 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 KNIHLRTSYSELVGFWSVEFGGR 0.96682 -0.29738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3353 0 0 0 0 9.19207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5F3 PCDB1_HUMAN "Protocadherin beta-1, PCDH-beta-1" PCDHB1 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] IPESTPLGSR 0.96682 -0.29704 0 0 11.5804 0 0 0 0 0 0 0 0 11.7928 0 11.8916 0 11.0391 0 12.0923 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6971 0 0 0 0 0 0 0 0 10.5409 0 0 0 11.3756 0 0 0 0 0 0 0 0 0 13.544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2677 0 15.0662 0 12.9311 0 0 0 0 0 0 0 13.2591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5668 0 10.8503 0 0 12.7959 0 0 0 0 0 0 13.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7307 11.8845 0 0 0 0 0 0 0 0 0 0 0 0 11.5451 0 0 0 0 12.6962 0 0 0 0 0 0 0 0 0 0 12.5059 0 Q9NV35 NUD15_HUMAN "Nucleotide triphosphate diphosphatase NUDT15, EC 3.6.1.9 (MutT homolog 2, MTH2) (Nucleoside diphosphate-linked moiety X motif 15, Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15, Nudix hydrolase 15)" NUDT15 MTH2 Homo sapiens (Human) dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate catabolic process [GO:1901292]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]; response to reactive oxygen species [GO:0000302]; xenobiotic catabolic process [GO:0042178] cytosol [GO:0005829] "cytosol [GO:0005829]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; 8-oxo-dGDP phosphatase activity [GO:0044715]; dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate catabolic process [GO:1901292]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]; response to reactive oxygen species [GO:0000302]; xenobiotic catabolic process [GO:0042178]" GO:0000278; GO:0000302; GO:0005829; GO:0006195; GO:0006203; GO:0008413; GO:0035529; GO:0035539; GO:0036218; GO:0042178; GO:0042262; GO:0044715; GO:0046872; GO:0047429; GO:0055086; GO:0061136; GO:1901292 "8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; 8-oxo-dGDP phosphatase activity [GO:0044715]; dTTP diphosphatase activity [GO:0036218]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]" HPRCVLLGKR 0.96684 -0.21039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62851 RS25_HUMAN 40S ribosomal protein S25 (Small ribosomal subunit protein eS25) RPS25 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006364; GO:0006412; GO:0014069; GO:0015935; GO:0022626; GO:0022627; GO:0042274; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AQVIYTRNTK 0.96686 -0.30298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SY77 UD3A2_HUMAN "UDP-glucuronosyltransferase 3A2, UDPGT 3A2, EC 2.4.1.17" UGT3A2 PSEC0073 UNQ842/PRO1780 Homo sapiens (Human) cellular response to genistein [GO:0071412] integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541] integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to genistein [GO:0071412] GO:0008194; GO:0015020; GO:0016021; GO:0043541; GO:0071412 glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194] AGQRVLLLVGFLLPGVLLSEAAK 0.96686 0.037327 0 0 0 0 0 0 0 0 0 0 13.1034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0351 0 0 0 15.9098 15.7733 15.4383 14.9511 15.8024 15.8968 14.9318 14.3617 13.5047 13.6812 15.2893 13.7695 12.4138 0 0 0 0 0 0 0 0 12.6228 0 13.4846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6521 0 0 0 0 0 0 12.6898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1455 0 12.1861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y653 AGRG1_HUMAN "Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment, ADGRG1 NT (GPR56 N-terminal fragment, GPR56 NT, GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment, ADGRG1 CT (GPR56 C-terminal fragment, GPR56 CT, GPR56(C)) (GPR56 seven-transmembrane subunit, GPR56 7TM) (GPR56 subunit beta) ]" ADGRG1 GPR56 TM7LN4 TM7XN1 UNQ540/PRO1083 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cerebral cortex radial glia-guided migration [GO:0021801]; cerebral cortex regionalization [GO:0021796]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic stem cell homeostasis [GO:0061484]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121] extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cerebral cortex radial glia-guided migration [GO:0021801]; cerebral cortex regionalization [GO:0021796]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic stem cell homeostasis [GO:0061484]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573] GO:0001525; GO:0004930; GO:0005518; GO:0005887; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0007266; GO:0007267; GO:0007420; GO:0008201; GO:0008285; GO:0010573; GO:0016021; GO:0016477; GO:0021796; GO:0021801; GO:0021819; GO:0035025; GO:0045121; GO:0045785; GO:0050840; GO:0061351; GO:0061484; GO:0070062; GO:0070528; GO:0072520; GO:0097451; GO:2000179; GO:2001223 collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201] HAGRLHLLYGKR 0.96686 -0.32023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5014 0 0 0 0 0 0 0 0 0 0 12.0377 0 13.6959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4213 9.98328 0 0 0 11.668 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4087 12.8112 12.1814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3544 13.8363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8767 0 0 0 0 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9241 0 0 0 14.2755 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A075B6N4 TVBY1_HUMAN T cell receptor beta variable 25-1 TRBV25-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 LLCYVGFYFLGAGLMEADIYQTPRYLVIGTGKK 0.96687 -0.0058878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86U17 SPA11_HUMAN Serpin A11 SERPINA11 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0010951 serine-type endopeptidase inhibitor activity [GO:0004867] HPFSRYQTQKQESFFVDER 0.96687 -0.86515 0 0 0 0 0 0 0 0 0 0 0 12.5885 0 0 0 11.2494 0 12.0324 0 12.2822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7703 12.1887 12.8747 0 13.2514 0 0 0 16.8437 12.8773 13.5695 13.7444 13.2202 13.6357 12.6176 12.5988 12.1924 12.6237 12.5113 12.0522 12.2532 0 0 12.5126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8323 12.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3868 0 0 0 0 0 0 0 0 0 0 0 12.4727 0 0 0 0 0 11.4738 0 0 0 0 0 0 0 0 0 0 0 0 12.0768 0 0 0 0 0 0 13.8177 12.4132 0 0 0 0 0 0 0 0 0 0 0 12.3724 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NKW6 SHL2B_HUMAN Protein shisa-like-2B SHISAL2B FAM159B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PQRLDTGLK 0.96688 -0.86828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7437 0 0 0 13.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F8WCM5 INSR2_HUMAN "Insulin, isoform 2 (INS-IGF2 readthrough transcript protein)" INS-IGF2 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; hormone activity [GO:0005179] GO:0005179; GO:0005615 hormone activity [GO:0005179] EPSPEVSCCGLWPRRPQR 0.96688 -0.0068871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ45 CISD1_HUMAN CDGSH iron-sulfur domain-containing protein 1 (MitoNEET) CISD1 C10orf70 ZCD1 MDS029 Homo sapiens (Human) regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457]" GO:0005739; GO:0005741; GO:0010506; GO:0016021; GO:0042802; GO:0043457; GO:0046872; GO:0051537 "2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" AMINLHIQK 0.96688 -0.30563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4653 0 0 12.4022 0 0 0 0 0 12.3555 13.4285 0 12.5995 13.9122 13.0018 0 0 0 0 12.0712 0 12.2232 0 0 0 13.8034 0 0 13.2458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGE7 URAD_HUMAN "Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase, OHCU decarboxylase, EC 4.1.1.97 (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase)" URAD PRHOXNB Homo sapiens (Human) allantoin metabolic process [GO:0000255]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628] peroxisome [GO:0005777] peroxisome [GO:0005777]; 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity [GO:0051997]; carboxy-lyase activity [GO:0016831]; allantoin metabolic process [GO:0000255]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628] GO:0000255; GO:0005777; GO:0006144; GO:0016831; GO:0019628; GO:0051997 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity [GO:0051997]; carboxy-lyase activity [GO:0016831] ARFGFPFVLAAR 0.96689 -0.35147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2945 0 14.1312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2278 0 0 0 0 Q11130 FUT7_HUMAN "Alpha-(1,3)-fucosyltransferase 7, EC 2.4.1.- (Fucosyltransferase 7) (Fucosyltransferase VII, Fuc-TVII, FucT-VII) (Galactoside 3-L-fucosyltransferase) (Selectin ligand synthase)" FUT7 Homo sapiens (Human) "CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; ceramide metabolic process [GO:0006672]; embryo implantation [GO:0007566]; fucosylation [GO:0036065]; inflammatory response [GO:0006954]; L-fucose catabolic process [GO:0042355]; leukocyte migration involved in immune response [GO:0002522]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration into lymph node [GO:0097022]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; protein glycosylation [GO:0006486]; regulation of cell adhesion molecule production [GO:0060353]; regulation of cell-cell adhesion [GO:0022407]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of leukocyte cell-cell adhesion [GO:1903037]; regulation of leukocyte tethering or rolling [GO:1903236]; regulation of neutrophil extravasation [GO:2000389]; regulation of type IV hypersensitivity [GO:0001807]; T cell migration [GO:0072678]" Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; ceramide metabolic process [GO:0006672]; embryo implantation [GO:0007566]; fucosylation [GO:0036065]; inflammatory response [GO:0006954]; L-fucose catabolic process [GO:0042355]; leukocyte migration involved in immune response [GO:0002522]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration into lymph node [GO:0097022]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; protein glycosylation [GO:0006486]; regulation of cell adhesion molecule production [GO:0060353]; regulation of cell-cell adhesion [GO:0022407]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of leukocyte cell-cell adhesion [GO:1903037]; regulation of leukocyte tethering or rolling [GO:1903236]; regulation of neutrophil extravasation [GO:2000389]; regulation of type IV hypersensitivity [GO:0001807]; T cell migration [GO:0072678]" GO:0000139; GO:0001807; GO:0002361; GO:0002522; GO:0002523; GO:0005794; GO:0005802; GO:0006486; GO:0006672; GO:0006954; GO:0007566; GO:0008417; GO:0009312; GO:0016020; GO:0016021; GO:0017083; GO:0022407; GO:0022409; GO:0032580; GO:0036065; GO:0042355; GO:0045785; GO:0046626; GO:0046920; GO:0060353; GO:0072678; GO:0097022; GO:1902624; GO:1903037; GO:1903236; GO:1903238; GO:1904996; GO:2000389 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] LRGLGVLAGVALLAALWLLWLLGSAPR 0.96689 -0.00734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4436 0 0 0 0 0 0 0 0 0 0 0 0 11.8499 0 0 0 0 0 0 12.1683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16204 CCDC6_HUMAN Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4) CCDC6 D10S170 TST1 Homo sapiens (Human) cytoskeleton [GO:0005856]; cytosol [GO:0005829] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802 identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200] CKALQEENRDLR 0.9669 -0.3521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9204 0 0 0 0 0 0 0 0 14.3524 0 0 0 0 0 0 12.5122 0 0 0 11.1418 0 0 0 13.2318 0 0 10.1814 12.8483 0 0 0 0 13.6996 0 0 15.3799 14.0132 0 0 11.1148 0 0 0 0 0 0 14.1679 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7894 0 0 13.4354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2515 0 0 0 0 0 0 0 14.2465 13.8097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0K7 STRAB_HUMAN "STE20-related kinase adapter protein beta, STRAD beta (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein) (CALS-21) (ILP-interacting protein) (Pseudokinase ALS2CR2)" STRADB ALS2CR2 ILPIP PRO1038 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; JNK cascade [GO:0007254]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein export from nucleus [GO:0006611] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; protein serine/threonine kinase activator activity [GO:0043539]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; JNK cascade [GO:0007254]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein export from nucleus [GO:0006611] GO:0000902; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006611; GO:0007049; GO:0007254; GO:0016235; GO:0032147; GO:0043539; GO:1902554; GO:2001240 ATP binding [GO:0005524]; protein serine/threonine kinase activator activity [GO:0043539] HGQRHRAVYDFPQFSTSVQPWLSPELLR 0.9669 -0.40649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8441 0 Q9Y3X0 CCDC9_HUMAN Coiled-coil domain-containing protein 9 CCDC9 Homo sapiens (Human) exon-exon junction complex [GO:0035145] exon-exon junction complex [GO:0035145]; RNA binding [GO:0003723] GO:0003723; GO:0035145 RNA binding [GO:0003723] GGGAGGR 0.9669 -0.0084304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6857 14.0731 0 0 0 0 0 0 0 0 0 0 12.4349 0 0 0 0 0 0 0 0 0 14.5908 0 0 0 0 0 0 0 0 0 14.8774 0 0 0 0 0 0 0 0 0 0 0 0 14.7496 13.5874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.875 0 0 0 0 0 0 0 O14520 AQP7_HUMAN "Aquaporin-7, AQP-7 (Aquaglyceroporin-7) (Aquaporin adipose, AQPap) (Aquaporin-7-like)" AQP7 AQP7L AQP9 Homo sapiens (Human) glycerol transmembrane transport [GO:0015793]; water transport [GO:0006833] basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250]; glycerol transmembrane transport [GO:0015793]; water transport [GO:0006833] GO:0005737; GO:0005811; GO:0005886; GO:0005887; GO:0005911; GO:0005938; GO:0006833; GO:0015204; GO:0015250; GO:0015254; GO:0015793; GO:0016323; GO:0030659 glycerol channel activity [GO:0015254]; urea transmembrane transporter activity [GO:0015204]; water channel activity [GO:0015250] IQEILQR 0.96692 -0.31124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94817 ATG12_HUMAN "Ubiquitin-like protein ATG12 (Autophagy-related protein 12, APG12-like)" ATG12 APG12 APG12L Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; protein lipidation [GO:0006497]; regulation of autophagosome maturation [GO:1901096] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; protein lipidation [GO:0006497]; regulation of autophagosome maturation [GO:1901096] GO:0000045; GO:0000422; GO:0005654; GO:0005776; GO:0005829; GO:0006497; GO:0006501; GO:0016236; GO:0030670; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0043231; GO:0044804; GO:0045824; GO:0050687; GO:1901096; GO:1904973 TIQGLIDFIKK 0.96692 -0.35669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34810 CD68_HUMAN Macrosialin (Gp110) (CD antigen CD68) CD68 Homo sapiens (Human) aging [GO:0007568]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; establishment of protein localization to organelle [GO:0072594]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aging [GO:0007568]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; establishment of protein localization to organelle [GO:0072594]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605] GO:0002437; GO:0002605; GO:0005764; GO:0005765; GO:0005886; GO:0007568; GO:0016020; GO:0016021; GO:0031669; GO:0031902; GO:0035577; GO:0071222; GO:0072594; GO:0140052 SHKTTTHR 0.96693 -0.35986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.36328 0 0 0 0 0 0 13.289 0 0 0 0 11.2837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6917 0 0 10.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8439 0 0 0 0 0 0 10.8115 0 0 0 0 0 0 0 11.4404 0 10.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6145 0 0 0 0 0 0 0 0 0 Q6NUQ4 TM214_HUMAN Transmembrane protein 214 TMEM214 PP446 Homo sapiens (Human) apoptotic process [GO:0006915] cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915] GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005881; GO:0006915; GO:0016021 ALDVADLQKELDK 0.96693 -0.35892 0 0 0 12.3413 0 0 0 0 0 0 0 13.8865 0 0 0 0 0 0 0 0 0 0 0 0 11.3248 0 13.897 0 0 13.8493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.45335 0 0 0 0 0 0 0 0 11.9633 0 0 0 0 0 14.1563 14.8759 14.0342 14.5379 0 0 0 14.4609 0 0 0 0 0 0 15.6958 13.2119 0 0 0 0 0 0 14.6575 14.2892 13.169 0 0 0 0 0 0 0 0 0 14.7803 0 0 14.9304 12.1197 0 0 14.6259 15.1531 0 14.7614 0 14.5925 12.8891 0 11.7511 0 14.0577 0 0 14.4884 14.1991 14.3265 14.3747 14.0618 14.7457 14.3701 15.019 0 15.5687 14.2017 15.6628 14.7399 14.481 15.6672 0 0 14.5762 0 0 0 0 15.2125 0 0 0 14.4338 0 14.4582 0 0 0 0 0 0 0 0 0 0 0 15.0993 0 0 0 15.595 15.4084 0 0 0 0 14.5245 0 Q6XLA1 CSC2A_HUMAN "Protein CASC2, isoform 3 (Cancer susceptibility candidate gene 2 protein, isoform 3)" CASC2 C10orf5 Homo sapiens (Human) defense response to tumor cell [GO:0002357]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] defense response to tumor cell [GO:0002357]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] GO:0002357; GO:0043280; GO:0043409 CANQHQHR 0.96695 -0.9313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12882 MYH1_HUMAN "Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x, MyHC-2x) (Myosin heavy chain IIx/d, MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1)" MYH1 Homo sapiens (Human) muscle contraction [GO:0006936] A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; intercalated disc [GO:0014704]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460] A band [GO:0031672]; cytoplasmic ribonucleoprotein granule [GO:0036464]; intercalated disc [GO:0014704]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; muscle contraction [GO:0006936] GO:0000146; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0014704; GO:0016460; GO:0031672; GO:0032982; GO:0036464; GO:0051015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AGLLGLLEEMRDEKLAQLITR 0.96697 -0.030436 0 0 0 0 11.6501 10.4883 0 0 0 0 0 0 0 0 0 0 0 10.4223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3921 0 0 0 0 0 12.3501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2118 0 12.3814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5712 0 0 0 0 0 0 12.9088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2902 0 0 15.8064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3928 0 0 0 0 0 0 Q4G0T1 SRCRM_HUMAN Scavenger receptor cysteine-rich domain-containing protein SCART1 (Scavenger receptor family member expressed on T cells 1) SCART1 Homo sapiens (Human) T cell mediated immunity [GO:0002456] brush border [GO:0005903]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] brush border [GO:0005903]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; T cell mediated immunity [GO:0002456] GO:0002456; GO:0005044; GO:0005737; GO:0005903; GO:0009897; GO:0016021 scavenger receptor activity [GO:0005044] CDGRVEVSLDGVWGR 0.96697 -0.86043 0 0 0 0 0 0 0 0 11.3572 0 0 0 0 0 11.1277 0 0 0 0 0 12.7398 12.183 0 0 0 0 0 0 0 0 11.4722 0 13.1594 0 0 0 0 0 0 0 11.7737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0904 13.8982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8001 12.759 0 0 0 11.3871 0 14.0395 0 11.7761 11.4127 14.2597 12.5568 13.9982 12.9582 14.4764 0 13.9371 14.2595 0 0 0 0 0 0 13.9169 0 13.757 0 0 0 0 0 0 11.7318 13.8323 0 13.4881 0 0 0 0 10.9221 0 0 0 0 0 0 0 0 0 0 0 14.7327 0 0 0 0 0 12.9037 0 13.5525 11.2675 0 0 12.7803 0 14.0746 13.6497 0 0 0 0 13.53 0 0 Q9H400 LIME1_HUMAN "Lck-interacting transmembrane adapter 1, Lck-interacting membrane protein (Lck-interacting molecule)" LIME1 LIME LP8067 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of MAP kinase activity [GO:0043405]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852] B cell receptor complex [GO:0019815]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] B cell receptor complex [GO:0019815]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; protein kinase binding [GO:0019901]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of MAP kinase activity [GO:0043405]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell receptor signaling pathway [GO:0050852] GO:0002250; GO:0005615; GO:0006357; GO:0014066; GO:0016021; GO:0019815; GO:0019901; GO:0043122; GO:0043405; GO:0050852; GO:0050853; GO:0051279; GO:1901222 protein kinase binding [GO:0019901] ARLQGSATAAEASLLRR 0.96697 0.0010488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8976 0 0 0 0 0 0 12.5386 0 0 0 0 0 0 0 11.5998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9185 0 0 0 0 0 0 0 0 0 0 P10914 IRF1_HUMAN "Interferon regulatory factor 1, IRF-1" IRF1 Homo sapiens (Human) "apoptotic process [GO:0006915]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cellular response to interferon-beta [GO:0035458]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of regulatory T cell differentiation [GO:0045590]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; regulation of adaptive immune response [GO:0002819]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of cell cycle [GO:0051726]; regulation of innate immune response [GO:0045088]; regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034124]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; apoptotic process [GO:0006915]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cellular response to interferon-beta [GO:0035458]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; interferon-gamma-mediated signaling pathway [GO:0060333]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of regulatory T cell differentiation [GO:0045590]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon production [GO:0032481]; regulation of adaptive immune response [GO:0002819]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of cell cycle [GO:0051726]; regulation of innate immune response [GO:0045088]; regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034124]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0002819; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0006915; GO:0008285; GO:0032481; GO:0032728; GO:0032735; GO:0034124; GO:0035458; GO:0043374; GO:0045088; GO:0045590; GO:0045892; GO:0045893; GO:0045944; GO:0051607; GO:0051726; GO:0060333; GO:0071260; GO:2000564 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" LPEDIMK 0.96698 -0.30045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3661 Q8N3J5 PPM1K_HUMAN "Protein phosphatase 1K, mitochondrial, EC 3.1.3.16 (PP2C domain-containing protein phosphatase 1K) (PP2C-like mitochondrial protein) (PP2C-type mitochondrial phosphoprotein phosphatase, PTMP) (Protein phosphatase 2C isoform kappa, PP2C-kappa)" PPM1K PP2CM Homo sapiens (Human) peptidyl-threonine dephosphorylation [GO:0035970] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; peptidyl-threonine dephosphorylation [GO:0035970] GO:0004722; GO:0005739; GO:0005759; GO:0017018; GO:0035970; GO:0046872 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] ISLENVGCASQIGKRK 0.96698 -0.86205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92949 FOXJ1_HUMAN "Forkhead box protein J1 (Forkhead-related protein FKHL13) (Hepatocyte nuclear factor 3 forkhead homolog 4, HFH-4)" FOXJ1 FKHL13 HFH4 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; central tolerance induction [GO:0002508]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelium development [GO:0060429]; establishment of apical/basal cell polarity [GO:0035089]; glomerular parietal epithelial cell development [GO:0072016]; heart development [GO:0007507]; humoral immune response [GO:0006959]; left/right pattern formation [GO:0060972]; leukocyte migration [GO:0050900]; lung epithelium development [GO:0060428]; metanephric part of ureteric bud development [GO:0035502]; motile cilium assembly [GO:0044458]; negative regulation of B cell activation [GO:0050869]; negative regulation of germinal center formation [GO:0002635]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; positive regulation of central B cell tolerance induction [GO:0002897]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; central tolerance induction [GO:0002508]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelium development [GO:0060429]; establishment of apical/basal cell polarity [GO:0035089]; glomerular parietal epithelial cell development [GO:0072016]; heart development [GO:0007507]; humoral immune response [GO:0006959]; left/right pattern formation [GO:0060972]; leukocyte migration [GO:0050900]; lung epithelium development [GO:0060428]; metanephric part of ureteric bud development [GO:0035502]; motile cilium assembly [GO:0044458]; negative regulation of B cell activation [GO:0050869]; negative regulation of germinal center formation [GO:0002635]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pattern specification process [GO:0007389]; positive regulation of central B cell tolerance induction [GO:0002897]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002508; GO:0002635; GO:0002897; GO:0002924; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0006959; GO:0007283; GO:0007368; GO:0007389; GO:0007420; GO:0007507; GO:0008104; GO:0030036; GO:0032053; GO:0032088; GO:0032715; GO:0033085; GO:0035082; GO:0035089; GO:0035502; GO:0042130; GO:0044458; GO:0045944; GO:0050869; GO:0050900; GO:0060271; GO:0060428; GO:0060429; GO:0060972; GO:0072016; GO:0090630; GO:1901248 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" LLSGAFKKR 0.96698 0.00026757 0 0 0 14.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0893 0 0 10.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04808 REL1_HUMAN Prorelaxin H1 [Cleaved into: Relaxin B chain; Relaxin A chain ] RLN1 Homo sapiens (Human) female pregnancy [GO:0007565]; signal transduction [GO:0007165] extracellular region [GO:0005576] extracellular region [GO:0005576]; hormone activity [GO:0005179]; female pregnancy [GO:0007565]; signal transduction [GO:0007165] GO:0005179; GO:0005576; GO:0007165; GO:0007565 hormone activity [GO:0005179] AVAAKWK 0.967 -0.86475 0 0 0 0 0 0 0 0 15.7316 18.5153 0 17.5487 17.7692 17.9203 18.0103 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7547 0 17.7121 0 0 0 17.2143 16.1847 14.0308 17.9348 0 0 0 19.014 18.6666 18.4058 16.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.763 14.0966 0 0 0 0 0 0 0 0 0 0 0 0 13.7714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8861 13.329 13.356 0 0 0 0 0 0 16.491 0 15.4238 0 0 0 0 0 0 0 0 0 16.2969 0 0 0 0 0 P33151 CADH5_HUMAN "Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin, VE-cadherin) (CD antigen CD144)" CDH5 Homo sapiens (Human) adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; blood vessel endothelial cell migration [GO:0043534]; blood vessel maturation [GO:0001955]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to bicellular tight junction [GO:1902396]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein phosphorylation [GO:0001932]; regulation of vascular permeability [GO:0043114]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculature development [GO:0001944] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; fibrinogen binding [GO:0070051]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; blood vessel endothelial cell migration [GO:0043534]; blood vessel maturation [GO:0001955]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microtubule polymerization [GO:0031115]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of gene expression [GO:0010628]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to bicellular tight junction [GO:1902396]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein phosphorylation [GO:0001932]; regulation of vascular permeability [GO:0043114]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculature development [GO:0001944] GO:0000902; GO:0001932; GO:0001944; GO:0001955; GO:0005102; GO:0005509; GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0006874; GO:0007043; GO:0007156; GO:0007179; GO:0008013; GO:0008285; GO:0009897; GO:0009986; GO:0010628; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0019903; GO:0030054; GO:0030335; GO:0030513; GO:0031115; GO:0031334; GO:0031965; GO:0034332; GO:0035307; GO:0035633; GO:0043114; GO:0043184; GO:0043534; GO:0044325; GO:0044331; GO:0045296; GO:0045766; GO:0050728; GO:0070051; GO:0070700; GO:0070830; GO:0098609; GO:0098742; GO:1902396; GO:1903142; GO:1990782; GO:2000114; GO:2000352 beta-catenin binding [GO:0008013]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; fibrinogen binding [GO:0070051]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; vascular endothelial growth factor receptor 2 binding [GO:0043184] IITITKSLDREK 0.967 -0.32023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0816 0 0 10.3059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2908 0 0 0 0 0 0 0 12.9353 0 0 0 0 0 0 0 0 0 0 13.2988 0 0 0 0 0 15.265 0 0 0 0 0 0 0 0 12.9671 0 0 0 0 0 0 0 0 0 0 0 0 14.867 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14246 AGRE1_HUMAN Adhesion G protein-coupled receptor E1 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor) ADGRE1 EMR1 TM7LN3 Homo sapiens (Human) adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0002250; GO:0004930; GO:0005509; GO:0005887; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0009897 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] DGFSDPIIYTLENIQPKQK 0.967 -0.3409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.39227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0093 0 0 0 10.0093 0 0 0 0 11.7852 0 0 0 0 12.2006 13.8611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6073 0 0 0 0 0 0 0 11.3313 0 0 13.7641 0 0 13.545 0 10.434 0 0 0 0 10.9023 0 13.4822 0 0 0 0 0 0 11.775 14.0795 13.4002 13.8429 0 0 0 0 10.5834 0 11.586 0 0 0 0 0 0 0 0 0 13.5603 14.608 0 0 0 0 11.1048 14.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99988 GDF15_HUMAN "Growth/differentiation factor 15, GDF-15 (Macrophage inhibitory cytokine 1, MIC-1) (NSAID-activated gene 1 protein, NAG-1) (NSAID-regulated gene 1 protein, NRG-1) (Placental TGF-beta) (Placental bone morphogenetic protein) (Prostate differentiation factor)" GDF15 MIC1 PDF PLAB PTGFB Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0002023; GO:0005125; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005794; GO:0007165; GO:0007179; GO:0007267; GO:0008083; GO:0010862; GO:0030509; GO:0035860; GO:0040015; GO:0042803; GO:0043410; GO:0051897; GO:0060395; GO:0060400; GO:0070062; GO:0070700; GO:1901741 BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803] PGQELRTVNGSQMLLVLLVLSWLPHGGALSLAEASR 0.967 -0.86802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9542 0 0 0 0 0 0 0 0 0 0 11.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20933 ASPG_HUMAN "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase, EC 3.5.1.26 (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain ]" AGA Homo sapiens (Human) protein deglycosylation [GO:0006517]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233]; protein deglycosylation [GO:0006517]; proteolysis [GO:0006508] GO:0003948; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0006508; GO:0006517; GO:0008233; GO:0035578 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233] IKNAIGVARK 0.96701 -0.21039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96F44 TRI11_HUMAN "E3 ubiquitin-protein ligase TRIM11, EC 2.3.2.27 (Protein BIA1) (RING finger protein 92) (RING-type E3 ubiquitin transferase TRIM11) (Tripartite motif-containing protein 11)" TRIM11 RNF92 Homo sapiens (Human) "innate immune response [GO:0045087]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of viral entry into host cell [GO:0046598]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of viral entry into host cell [GO:0046598]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790]" GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0016567; GO:0019904; GO:0032897; GO:0044790; GO:0045087; GO:0045892; GO:0046597; GO:0046598; GO:0050768; GO:0061630 protein domain specific binding [GO:0019904]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AAPDLSTNLQEEATCAICLDYFTDPVMTDCGHNFCR 0.96701 -0.34655 0 0 0 0 0 0 0 0 0 0 12.9458 0 0 0 0 13.4896 0 0 0 0 0 0 0 0 0 11.612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9526 0 13.6035 0 0 12.2588 0 0 0 0 0 0 0 0 0 14.3157 0 0 13.2991 13.3329 14.2516 13.869 0 13.2674 0 14.3524 0 0 0 14.2658 0 14.9507 13.3512 0 0 0 0 0 0 0 0 14.8477 14.1624 0 0 0 0 0 15.1376 0 0 0 13.1952 13.6832 0 0 14.1815 13.3392 13.7632 0 13.4733 0 13.2407 13.1818 0 0 0 0 0 0 13.4041 0 0 12.9415 0 0 0 0 12.215 0 0 0 0 0 0 0 0 0 14.2581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RU67 F234B_HUMAN Protein FAM234B FAM234B KIAA1467 Homo sapiens (Human) cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] GO:0005794; GO:0005856; GO:0016021 FVEAPYEI 0.96703 -0.35125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3296 0 0 0 0 0 0 0 0 0 0 0 13.1753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y215 COLQ_HUMAN Acetylcholinesterase collagenic tail peptide (AChE Q subunit) (Acetylcholinesterase-associated collagen) COLQ Homo sapiens (Human) acetylcholine catabolic process in synaptic cleft [GO:0001507]; establishment of protein localization to membrane [GO:0090150]; extracellular matrix organization [GO:0030198]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340] anchoring junction [GO:0070161]; basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083] anchoring junction [GO:0070161]; basement membrane [GO:0005604]; cell junction [GO:0030054]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; acetylcholine catabolic process in synaptic cleft [GO:0001507]; establishment of protein localization to membrane [GO:0090150]; extracellular matrix organization [GO:0030198]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340] GO:0001507; GO:0005201; GO:0005581; GO:0005604; GO:0005615; GO:0005886; GO:0008201; GO:0008582; GO:0030054; GO:0030198; GO:0031012; GO:0031594; GO:0043083; GO:0062023; GO:0070161; GO:0071340; GO:0090150 extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201] GEPGIAGHR 0.96704 -0.32814 0 0 0 0 0 0 0 0 0 0 0 11.8633 0 11.4427 12.2849 12.0476 0 0 0 0 0 0 0 0 0 0 12.2274 0 0 12.3838 11.5116 0 0 0 12.425 0 0 0 0 0 0 11.6217 0 0 0 0 0 12.472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.389 0 0 0 0 0 0 0 0 0 0 0 0 12.2972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3659 13.2516 0 0 0 14.0387 0 12.8377 13.7293 0 13.1151 0 0 0 12.4235 0 0 11.2481 0 12.5361 0 0 0 0 P32322 P5CR1_HUMAN "Pyrroline-5-carboxylate reductase 1, mitochondrial, P5C reductase 1, P5CR 1, EC 1.5.1.2" PYCR1 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881] GO:0004735; GO:0005739; GO:0005759; GO:0006561; GO:0034599; GO:0042802; GO:0051881; GO:0055129; GO:1903206 identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735] LAVRLGAQALLGAAKMLLHSEQHPGQLK 0.96705 -0.0071559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8768 15.3162 0 0 0 0 15.3554 0 0 0 15.3989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PF2 TSSK2_HUMAN "Testis-specific serine/threonine-protein kinase 2, TSK-2, TSK2, TSSK-2, Testis-specific kinase 2, EC 2.7.11.1 (DiGeorge syndrome protein G, DGS-G) (Serine/threonine-protein kinase 22B)" TSSK2 DGSG SPOGA2 STK22B Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0006468; GO:0007286; GO:0018105; GO:0035556; GO:0044877; GO:0046777; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] KMLRIQK 0.96706 -0.33125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.832 0 0 0 12.0635 19.8787 0 0 19.8876 0 0 0 0 0 19.8837 0 12.4598 0 0 19.905 0 19.8966 0 0 0 0 0 0 0 0 0 0 0 0 19.9289 0 0 0 0 0 0 0 11.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0J9YY54 TX13D_HUMAN Testis-expressed protein 13D TEX13D Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005737; GO:0046872 metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] AINFSWR 0.96707 -0.3572 0 0 0 0 0 0 0 12.7819 0 0 0 0 0 0 0 11.2869 0 0 0 0 11.4586 0 11.8739 0 0 0 13.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3845 0 12.1368 0 12.9394 12.8044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.604 0 0 0 0 0 0 0 0 0 14.0984 14.2501 13.2999 0 0 0 0 0 0 0 13.0583 0 0 0 0 0 0 0 0 0 0 0 13.1184 0 12.9293 0 0 0 13.1965 0 13.0346 13.1293 0 0 0 0 13.0218 0 0 0 0 0 0 0 13.1745 0 0 13.2752 0 0 13.3086 0 0 13.0122 12.5674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P37108 SRP14_HUMAN "Signal recognition particle 14 kDa protein, SRP14 (18 kDa Alu RNA-binding protein)" SRP14 Homo sapiens (Human) cotranslational protein targeting to membrane [GO:0006613]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; RNA binding [GO:0003723]; cotranslational protein targeting to membrane [GO:0006613]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]" GO:0003723; GO:0005576; GO:0005634; GO:0005737; GO:0005786; GO:0005829; GO:0006613; GO:0006614; GO:0008312; GO:0030942; GO:0034774; GO:0045047; GO:1904813 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; RNA binding [GO:0003723] CRTSGSVYITLKK 0.96707 -0.31217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4248 0 0 11.1445 11.4471 0 0 13.9119 0 14.6961 11.6662 0 0 0 0 0 0 0 0 0 11.7912 0 0 Q14247 SRC8_HUMAN Src substrate cortactin (Amplaxin) (Oncogene EMS1) CTTN EMS1 Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]" cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076] "cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; site of polarized growth [GO:0030427]; voltage-gated potassium channel complex [GO:0008076]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration, cell extension [GO:0006930]" GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0008076; GO:0030027; GO:0030041; GO:0030427; GO:0030516; GO:0030833; GO:0030838; GO:0030863; GO:0030864; GO:0031532; GO:0043197; GO:0043231; GO:0045296; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0051015; GO:0097062; GO:0097191; GO:0097581; GO:1903146; GO:1990023; GO:2001237 actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522] CALGWDHQEK 0.96707 0.020706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7733 13.6853 0 13.8168 0 0 0 0 12.0946 12.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3879 0 0 0 0 0 0 0 0 0 0 0 0 13.6276 0 13.9511 0 0 0 0 14.4108 12.37 0 0 0 0 14.2737 0 0 0 0 0 0 0 0 14.6552 0 0 0 0 0 0 0 0 0 14.7731 0 13.9777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N144 CXD3_HUMAN "Gap junction delta-3 protein (Connexin-31.9, Cx31.9) (Gap junction alpha-11 protein) (Gap junction chi-1 protein)" GJD3 GJA11 GJC1 Homo sapiens (Human) cell communication [GO:0007154]; cell-cell signaling [GO:0007267]; gap junction assembly [GO:0016264]; negative regulation of cardiac conduction [GO:1903780]; negative regulation of heart rate [GO:0010459]; response to glucose [GO:0009749] cell surface [GO:0009986]; connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887]; gap junction channel activity [GO:0005243]; ion channel activity [GO:0005216]; cell communication [GO:0007154]; cell-cell signaling [GO:0007267]; gap junction assembly [GO:0016264]; negative regulation of cardiac conduction [GO:1903780]; negative regulation of heart rate [GO:0010459]; response to glucose [GO:0009749] GO:0005216; GO:0005243; GO:0005887; GO:0005922; GO:0007154; GO:0007267; GO:0009749; GO:0009986; GO:0010459; GO:0016264; GO:1903780 gap junction channel activity [GO:0005243]; ion channel activity [GO:0005216] AHEEAQKLLPPPPPPPPPPALPSR 0.96708 -0.31469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8774 0 12.5448 0 12.4699 0 0 0 0 0 0 0 0 0 0 0 11.9717 0 0 0 0 0 13.1741 0 0 0 0 14.0191 0 0 0 0 12.2146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8N7 PTGR2_HUMAN "Prostaglandin reductase 2, PRG-2, EC 1.3.1.48 (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 1)" PTGR2 ZADH1 Homo sapiens (Human) prostaglandin metabolic process [GO:0006693] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; prostaglandin metabolic process [GO:0006693] GO:0005737; GO:0006693; GO:0036132; GO:0047522 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522] IVQRVVLNSRPGK 0.96708 0.019793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6934 14.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PL45 BRID5_HUMAN BRICHOS domain-containing protein 5 BRICD5 C16orf79 Homo sapiens (Human) regulation of cell population proliferation [GO:0042127] extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; regulation of cell population proliferation [GO:0042127] GO:0005615; GO:0016021; GO:0042127 AVSLLLLLLLLVLAAVGVVAGGLLGSAQGPPK 0.96709 -0.93368 10.1113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8446 0 0 0 0 11.8732 13.0781 0 0 0 0 11.321 11.7322 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0696 0 0 12.5282 0 0 0 12.3852 11.9628 0 0 0 0 0 0 0 0 0 0 0 0 13.637 0 0 0 0 0 0 0 0 0 0 0 12.7363 12.4848 0 12.143 0 0 0 0 12.567 0 0 0 13.0525 0 12.9968 0 11.3309 0 0 0 0 11.4916 0 0 0 0 0 0 11.8631 0 0 0 0 0 0 0 0 0 12.7501 0 0 0 11.677 0 0 11.9637 0 0 13.6499 0 0 0 0 0 10.9211 0 14.2988 0 0 0 0 0 0 0 0 0 0 13.6251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2227 0 0 0 0 0 0 0 0 13.0742 Q8IUF8 RIOX2_HUMAN "Ribosomal oxygenase 2 (60S ribosomal protein L27a histidine hydroxylase) (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA, EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) (Mineral dust-induced gene protein) (Nucleolar protein 52) (Ribosomal oxygenase MINA, ROX)" RIOX2 MDIG MINA MINA53 NO52 Homo sapiens (Human) histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; ribosome biogenesis [GO:0042254] GO:0003714; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0016706; GO:0032452; GO:0032453; GO:0034720; GO:0042254; GO:0042802; GO:0046872; GO:0051864; GO:0070544 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] LTDLKSLCSRGMYYGR 0.96709 -0.93474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57796 CABP4_HUMAN "Calcium-binding protein 4, CaBP4" CABP4 Homo sapiens (Human) photoreceptor cell morphogenesis [GO:0008594]; phototransduction [GO:0007602]; regulation of voltage-gated calcium channel activity [GO:1901385]; retinal bipolar neuron differentiation [GO:0060040]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; synapse [GO:0045202]; terminal bouton [GO:0043195] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325]; photoreceptor cell morphogenesis [GO:0008594]; phototransduction [GO:0007602]; regulation of voltage-gated calcium channel activity [GO:1901385]; retinal bipolar neuron differentiation [GO:0060040]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0005246; GO:0005509; GO:0005576; GO:0005737; GO:0005829; GO:0007165; GO:0007601; GO:0007602; GO:0008594; GO:0043195; GO:0044325; GO:0045202; GO:0046549; GO:0060040; GO:0070161; GO:1901385 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325] DGYISHRELGDCMR 0.96711 -0.86171 0 0 0 0 10.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.35865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43366 MAGB1_HUMAN "Melanoma-associated antigen B1 (Cancer/testis antigen 3.1, CT3.1) (DSS-AHC critical interval MAGE superfamily 10, DAM10) (MAGE-B1 antigen) (MAGE-XP antigen)" MAGEB1 MAGEL1 MAGEXP Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 VVDEKYK 0.96712 -0.33912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P67775 PP2AA_HUMAN "Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, PP2A-alpha, EC 3.1.3.16 (Replication protein C, RP-C)" PPP2CA Homo sapiens (Human) "apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; mitotic cell cycle [GO:0000278]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of microtubule binding [GO:1904528]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of growth [GO:0040008]; regulation of microtubule binding [GO:1904526]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to lead ion [GO:0010288]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; synapse [GO:0045202]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; synapse [GO:0045202]; GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; tau protein binding [GO:0048156]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; mitotic cell cycle [GO:0000278]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of microtubule binding [GO:1904528]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of growth [GO:0040008]; regulation of microtubule binding [GO:1904526]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to lead ion [GO:0010288]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]" GO:0000159; GO:0000278; GO:0000775; GO:0000922; GO:0001932; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007498; GO:0008022; GO:0008380; GO:0010033; GO:0010288; GO:0010719; GO:0015630; GO:0016020; GO:0017018; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0035970; GO:0040008; GO:0042532; GO:0045121; GO:0045202; GO:0045595; GO:0046872; GO:0046982; GO:0048156; GO:0050811; GO:0051321; GO:0051898; GO:0070062; GO:0070262; GO:0071902; GO:1904526; GO:1904528; GO:2000045 GABA receptor binding [GO:0050811]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; tau protein binding [GO:0048156] CPVTVCGDVHGQFHDLMELFR 0.96712 0.015916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8857 0 0 0 0 0 0 0 0 0 0 15.3444 0 0 0 15.5291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2492 0 0 0 13.6251 0 0 0 0 0 0 0 0 13.032 0 0 0 0 0 0 0 Q5T3J3 LRIF1_HUMAN "Ligand-dependent nuclear receptor-interacting factor 1 (HP1-binding protein enriched in inactive X chromosome protein 1, HBiX1) (Receptor-interacting factor 1)" LRIF1 C1orf103 RIF1 Homo sapiens (Human) "dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of transcription, DNA-templated [GO:0006355]" Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] "Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nuclear retinoic acid receptor binding [GO:0042974]; dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001740; GO:0005654; GO:0006355; GO:0009048; GO:0016363; GO:0034451; GO:0042974 nuclear retinoic acid receptor binding [GO:0042974] IHNEMASTSDK 0.96712 -0.030435 0 0 0 0 0 0 0 0 11.9054 12.1366 11.3941 0 11.635 12.866 0 0 0 0 0 0 0 0 12.8744 0 0 0 0 0 0 0 0 0 14.1853 0 0 0 12.3418 0 0 0 0 0 0 0 0 0 0 14.2603 12.4769 0 0 0 0 0 13.4762 14.0031 0 13.1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.447 0 0 0 0 0 0 0 0 0 0 0 13.8537 0 0 13.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9692 12.7235 13.6251 0 0 0 0 0 0 0 0 Q9UKK6 NXT1_HUMAN NTF2-related export protein 1 (Protein p15) NXT1 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small GTPase binding [GO:0031267]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0016607; GO:0031267; GO:0042272; GO:0044613 small GTPase binding [GO:0031267] FEGNKQR 0.96712 -0.33912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4012 0 0 0 0 0 0 0 0 0 0 0 0 15.7542 0 15.8848 0 0 0 0 0 0 16.8556 0 15.2231 0 0 0 16.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5703 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y297 FBW1A_HUMAN F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit) BTRC BTRCP FBW1A FBXW1A Homo sapiens (Human) "branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase activity [GO:0061630]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]" GO:0000209; GO:0005654; GO:0005829; GO:0006470; GO:0006511; GO:0007165; GO:0008013; GO:0016055; GO:0016567; GO:0016874; GO:0019005; GO:0031146; GO:0031648; GO:0033598; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0043433; GO:0045309; GO:0045862; GO:0045879; GO:0045892; GO:0045893; GO:0046983; GO:0048511; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:0071407; GO:1904668; GO:1990756; GO:1990757 beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase activity [GO:0061630] CLYNPGTGALTAFQNSSEREDCNNGEPPRK 0.96712 -0.86433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4871 0 0 11.6699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5312 15.2472 0 0 0 0 0 0 12.4132 0 0 13.1655 0 14.5273 0 0 0 0 0 0 0 0 0 0 12.2653 0 13.7638 0 12.6568 0 0 0 0 13.8467 0 0 14.2868 0 0 0 12.0067 0 0 0 11.8795 0 0 0 0 11.9084 0 0 0 0 0 0 0 0 0 11.4324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2802 0 13.1833 0 0 0 0 P17861 XBP1_HUMAN "X-box-binding protein 1, XBP-1 (Tax-responsive element-binding protein 5, TREB-5) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form ]" XBP1 TREB5 XBP2 Homo sapiens (Human) adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; ATF6-mediated unfolded protein response [GO:0036500]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; ERAD pathway [GO:0036503]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; immune response [GO:0006955]; IRE1-mediated unfolded protein response [GO:0036498]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; organelle organization [GO:0006996]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; ATF6-mediated unfolded protein response [GO:0036500]; autophagy [GO:0006914]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fluid shear stress [GO:0071498]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nutrient [GO:0031670]; cellular response to oxidative stress [GO:0034599]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; ERAD pathway [GO:0036503]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; immune response [GO:0006955]; IRE1-mediated unfolded protein response [GO:0036498]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron development [GO:0048666]; organelle organization [GO:0006996]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of histone methylation [GO:0031062]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]" GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001558; GO:0001889; GO:0001934; GO:0001935; GO:0002020; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006366; GO:0006511; GO:0006633; GO:0006914; GO:0006915; GO:0006955; GO:0006990; GO:0006996; GO:0007517; GO:0008284; GO:0010508; GO:0010832; GO:0014065; GO:0015031; GO:0016021; GO:0019901; GO:0030176; GO:0030331; GO:0030335; GO:0030512; GO:0030968; GO:0031062; GO:0031490; GO:0031625; GO:0031647; GO:0031648; GO:0031670; GO:0032008; GO:0032755; GO:0032869; GO:0034599; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0036498; GO:0036500; GO:0036503; GO:0042149; GO:0042307; GO:0042632; GO:0042802; GO:0042803; GO:0043066; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0048010; GO:0048666; GO:0051897; GO:0055089; GO:0055092; GO:0060394; GO:0060612; GO:0070373; GO:0071073; GO:0071222; GO:0071230; GO:0071332; GO:0071333; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:0090575; GO:1900100; GO:1900102; GO:1900103; GO:1901985; GO:1902236; GO:1903071; GO:1903489; GO:1904707; GO:1904754; GO:1990418; GO:1990440; GO:1990837; GO:2000347; GO:2000353 "chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]" LLLENQLLR 0.96713 0.030742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0196 0 0 12.3483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0751 0 0 0 0 13.6793 0 0 0 0 13.0296 0 0 0 0 0 0 13.8029 0 0 13.3599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5581 0 0 0 0 P55145 MANF_HUMAN Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET) MANF ARMET ARP Homo sapiens (Human) dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; sulfatide binding [GO:0120146]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to unfolded protein [GO:0006986] GO:0003723; GO:0005576; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0005829; GO:0006986; GO:0008083; GO:0031175; GO:0033018; GO:0048471; GO:0071542; GO:0120146; GO:1905897 growth factor activity [GO:0008083]; RNA binding [GO:0003723]; sulfatide binding [GO:0120146] ALRPGDCEVCISYLGR 0.96713 -0.31968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9131 0 0 0 0 0 0 0 0 13.7466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5D1E8 ZC12A_HUMAN "Endoribonuclease ZC3H12A, EC 3.1.-.- (Monocyte chemotactic protein-induced protein 1, MCP-induced protein 1, MCPIP-1) (Regnase-1, Reg1) (Zinc finger CCCH domain-containing protein 12A)" ZC3H12A MCPIP MCPIP1 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; miRNA catabolic process [GO:0010587]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage activation [GO:0043031]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; regulation of gene expression [GO:0010468]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; miRNA catabolic process [GO:0010587]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage activation [GO:0043031]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; regulation of gene expression [GO:0010468]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852]" GO:0000294; GO:0000932; GO:0001525; GO:0001933; GO:0002230; GO:0002757; GO:0003677; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0004521; GO:0004532; GO:0004540; GO:0005634; GO:0005654; GO:0005737; GO:0005791; GO:0005856; GO:0006915; GO:0006954; GO:0006974; GO:0007399; GO:0010468; GO:0010508; GO:0010587; GO:0010595; GO:0010628; GO:0010629; GO:0010656; GO:0010884; GO:0010942; GO:0016579; GO:0030154; GO:0030867; GO:0032088; GO:0032689; GO:0032691; GO:0032715; GO:0032720; GO:0032991; GO:0034599; GO:0035198; GO:0035613; GO:0035925; GO:0036464; GO:0042149; GO:0042307; GO:0042406; GO:0043022; GO:0043031; GO:0043124; GO:0044828; GO:0045019; GO:0045600; GO:0045766; GO:0045944; GO:0046872; GO:0050852; GO:0051259; GO:0051607; GO:0055118; GO:0061014; GO:0061158; GO:0071222; GO:0071347; GO:0071356; GO:0090501; GO:0090502; GO:0098586; GO:1900016; GO:1900119; GO:1900745; GO:1901223; GO:1903003; GO:1903799; GO:1903936; GO:1904637; GO:1990869; GO:2000320; GO:2000379; GO:2000627 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613] EVFSCRGILLAVNWFLERGHTDITVFVPSWR 0.96714 -0.32023 0 0 0 9.92255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5122 0 0 0 0 0 0 0 0 0 0 0 12.2318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.098 13.165 0 12.4748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99689 FEZ1_HUMAN Fasciculation and elongation protein zeta-1 (Zygin I) (Zygin-1) FEZ1 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; establishment of cell polarity [GO:0030010]; establishment of mitochondrion localization [GO:0051654]; hippocampus development [GO:0021766]; mitochondrion morphogenesis [GO:0070584]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; positive regulation of anterograde axonal transport of mitochondrion [GO:0061881]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to growth factor stimulus [GO:0071363]; establishment of cell polarity [GO:0030010]; establishment of mitochondrion localization [GO:0051654]; hippocampus development [GO:0021766]; mitochondrion morphogenesis [GO:0070584]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; positive regulation of anterograde axonal transport of mitochondrion [GO:0061881]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976] GO:0005080; GO:0005737; GO:0005739; GO:0005794; GO:0005813; GO:0005874; GO:0005886; GO:0007155; GO:0007399; GO:0007411; GO:0010976; GO:0021766; GO:0030010; GO:0030424; GO:0030425; GO:0030426; GO:0043015; GO:0043025; GO:0045666; GO:0047485; GO:0051654; GO:0061881; GO:0070584; GO:0071363; GO:1902902 gamma-tubulin binding [GO:0043015]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485] EVKNSFITVLIEVQNKQK 0.96714 -0.34399 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8902 0 0 0 0 0 0 0 Q6ZTN6 AN13D_HUMAN Ankyrin repeat domain-containing protein 13D ANKRD13D Homo sapiens (Human) negative regulation of receptor internalization [GO:0002091] cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of receptor internalization [GO:0002091] GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036 ubiquitin-dependent protein binding [GO:0140036] ATQRLAGIPELLNKLR 0.96715 -0.34585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0517 10.8969 13.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEQ6 SRARP_HUMAN "Steroid receptor-associated and regulated protein (Estrogen receptor-related factor, ER-related factor) (Steroid receptor-regulated protein)" SRARP C1orf64 ERRF SSPR Homo sapiens (Human) positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear estrogen receptor binding [GO:0030331]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148] GO:0005634; GO:0005737; GO:0030331; GO:0033148 nuclear estrogen receptor binding [GO:0030331] GLVTPPMK 0.96716 -0.4127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.2225 20.0076 19.5974 18.1063 17.9216 17.5503 0 19.266 19.3109 0 12.4982 12.2209 0 0 0 0 0 0 0 13.2575 0 0 0 0 Q9P1A2 PP4RL_HUMAN Putative serine/threonine-protein phosphatase 4 regulatory subunit 1-like PPP4R1L C20orf192 PRO1085 Homo sapiens (Human) protein dephosphorylation [GO:0006470] protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470] GO:0006470; GO:0019888 protein phosphatase regulator activity [GO:0019888] AEIPLYFVDLQDDLDDYGFEDYGTDCDNMR 0.96716 -0.87811 11.3178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8419 0 0 11.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0761 0 0 0 0 0 11.543 0 0 13.2772 0 11.2353 0 0 0 0 0 0 0 0 0 0 0 11.4347 0 0 0 0 0 0 0 0 0 0 0 14.1565 0 0 0 14.1395 12.4638 0 0 0 0 0 0 0 0 11.498 10.8306 11.9449 0 0 0 12.4357 0 0 11.207 0 0 0 13.1025 12.8002 12.5965 0 0 0 0 0 0 0 0 0 12.6792 0 12.243 0 0 0 0 0 0 0 0 0 0 0 0 12.1591 0 0 0 0 0 0 13.1729 0 0 0 0 0 0 0 0 0 0 12.0324 0 0 0 0 0 0 0 0 0 13.2347 0 0 0 0 0 11.8569 0 Q8TDH9 BL1S5_HUMAN "Biogenesis of lysosome-related organelles complex 1 subunit 5, BLOC-1 subunit 5 (Protein Muted homolog)" BLOC1S5 MUTED Homo sapiens (Human) anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosome to melanosome transport [GO:0035646]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; neuron projection development [GO:0031175]; otolith morphogenesis [GO:0032474]; positive regulation of pigment cell differentiation [GO:0050942]; vesicle-mediated transport [GO:0016192] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; transport vesicle [GO:0030133] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; transport vesicle [GO:0030133]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosome to melanosome transport [GO:0035646]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; neuron projection development [GO:0031175]; otolith morphogenesis [GO:0032474]; positive regulation of pigment cell differentiation [GO:0050942]; vesicle-mediated transport [GO:0016192] GO:0008089; GO:0016192; GO:0030133; GO:0031083; GO:0031175; GO:0032402; GO:0032438; GO:0032474; GO:0035646; GO:0048490; GO:0050942; GO:1904115 DLAKFSTF 0.96717 -0.35091 11.0441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGI0 ZRAN1_HUMAN "Ubiquitin thioesterase ZRANB1, EC 3.4.19.12 (TRAF-binding domain-containing protein, hTrabid) (Zinc finger Ran-binding domain-containing protein 1)" ZRANB1 TRABID Homo sapiens (Human) cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055] GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0031593; GO:0035523; GO:0043231; GO:0046872; GO:0070530; GO:0070536; GO:0071947; GO:0101005; GO:1990168 cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593] AIRCTQCLSQR 0.96718 3.6693 0 0 0 0 0 0 0 0 0 14.75 0 0 0 13.7754 0 0 0 0 0 9.94024 0 0 0 0 0 0 0 13.767 0 12.1593 10.488 0 0 0 0 0 11.8928 0 11.1592 13.5207 13.1147 0 0 0 0 14.1463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.568 0 0 0 15.7085 0 0 10.9039 0 15.0179 14.0029 12.7001 0 13.6908 12.2581 0 0 0 10.3305 0 0 13.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7568 13.0567 13.1265 0 0 10.188 0 0 0 0 13.6117 0 0 11.114 0 13.0195 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99195 0 0 0 0 0 0 13.9993 13.8635 12.7943 0 0 0 0 13.4318 0 14.6328 0 0 0 0 0 0 0 0 0 0 14.5941 0 0 0 0 0 15.1353 0 11.2981 0 0 P62701 RS4X_HUMAN "40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)" RPS4X CCG2 RPS4 SCAR Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; response to ethanol [GO:0045471]; translation [GO:0006412] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; response to ethanol [GO:0045471]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005829; GO:0005840; GO:0005844; GO:0005925; GO:0006412; GO:0008284; GO:0015935; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0036464; GO:0045471; GO:0045727; GO:0070062; GO:1990904 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] HLKRVAAPK 0.96719 -0.28174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9198 12.8568 14.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27338 AOFB_HUMAN "Amine oxidase [flavin-containing] B, EC 1.4.3.21, EC 1.4.3.4 (Monoamine oxidase type B, MAO-B)" MAOB Homo sapiens (Human) dopamine catabolic process [GO:0042420]; hydrogen peroxide biosynthetic process [GO:0050665]; negative regulation of serotonin secretion [GO:0014063]; neurotransmitter catabolic process [GO:0042135]; positive regulation of dopamine metabolic process [GO:0045964]; response to aluminum ion [GO:0010044]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; substantia nigra development [GO:0021762] integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; aliphatic-amine oxidase activity [GO:0052595]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; dopamine catabolic process [GO:0042420]; hydrogen peroxide biosynthetic process [GO:0050665]; negative regulation of serotonin secretion [GO:0014063]; neurotransmitter catabolic process [GO:0042135]; positive regulation of dopamine metabolic process [GO:0045964]; response to aluminum ion [GO:0010044]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; substantia nigra development [GO:0021762] GO:0005739; GO:0005740; GO:0005741; GO:0008131; GO:0009055; GO:0009410; GO:0009636; GO:0010044; GO:0010269; GO:0014063; GO:0016021; GO:0021762; GO:0032496; GO:0042135; GO:0042420; GO:0042802; GO:0045471; GO:0045964; GO:0050660; GO:0050665; GO:0051412; GO:0052595; GO:0052596; GO:0097621 aliphatic-amine oxidase activity [GO:0052595]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131] EPFWRKK 0.9672 -0.33119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.928 0 0 12.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3455 13.6951 16.2086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8182 0 0 0 0 0 0 12.9811 0 0 13.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q71RS6 NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5) SLC24A5 JSX NCKX5 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896] integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "integral component of membrane [GO:0016021]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; negative regulation of melanin biosynthetic process [GO:0048022]; response to stimulus [GO:0050896]" GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0016021; GO:0030318; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0050896; GO:0070509; GO:0070588 "calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]" AMERSEQQPLMGWEDEGQPFIR 0.96721 -0.93335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1004 0 0 0 0 0 0 0 0 0 0 0 11.7537 0 0 0 0 Q96T54 KCNKH_HUMAN "Potassium channel subfamily K member 17 (2P domain potassium channel Talk-2) (Acid-sensitive potassium channel protein TASK-4) (TWIK-related acid-sensitive K(+) channel 4) (TWIK-related alkaline pH-activated K(+) channel 2, TALK-2)" KCNK17 TALK2 TASK4 UNQ5816/PRO19634 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0015271; GO:0022841; GO:0030322; GO:0034765; GO:0071805 outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] PRARAAPEGR 0.96722 -0.86028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0578 0 0 0 0 0 0 0 0 0 0 12.9177 0 14.3345 0 0 0 0 0 13.3756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2092 0 13.6885 13.7359 13.7551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95416 SOX14_HUMAN Transcription factor SOX-14 (Protein SOX-28) SOX14 SOX28 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; entrainment of circadian clock [GO:0009649]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; entrainment of circadian clock [GO:0009649]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0005667; GO:0006355; GO:0007399; GO:0007601; GO:0009649; GO:0009653; GO:0030154; GO:0043565; GO:0045892; GO:1990837; GO:2001222 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AQHMKEHPDYK 0.96723 0.020859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4237 0 0 0 0 Q96G04 EF2KT_HUMAN "Protein-lysine N-methyltransferase EEF2KMT, EC 2.1.1.- (eEF2-lysine methyltransferase, eEF2-KMT)" EEF2KMT FAM86A SB153 Homo sapiens (Human) peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] GO:0005737; GO:0005829; GO:0006479; GO:0016279; GO:0018023; GO:0032991 protein-lysine N-methyltransferase activity [GO:0016279] DSSDSELLR 0.96724 -0.41088 0 0 0 0 0 0 0 0 10.4761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5657 0 0 0 0 16.2384 0 14.6009 0 0 0 0 0 0 0 0 0 0 0 0 13.9746 0 0 0 0 0 0 0 15.5728 0 0 0 0 0 15.3269 0 15.9759 0 0 0 0 0 0 0 0 0 0 0 12.2436 0 0 15.7097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2534 14.1214 0 0 0 0 0 0 11.7607 13.0226 0 12.054 0 0 14.7288 0 0 0 0 0 12.6444 0 0 Q9H490 PIGU_HUMAN "Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1, Protein CDC91-like 1) (GPI transamidase component PIG-U)" PIGU CDC91L1 PSEC0205 UNQ3055/PRO9875 Homo sapiens (Human) attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; protein localization to cell surface [GO:0034394]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] GO:0005789; GO:0005886; GO:0006506; GO:0016020; GO:0016255; GO:0034394; GO:0042765; GO:0046425 AAPLVLVLVVAVTVR 0.96724 -0.029164 0 0 0 0 0 0 0 0 9.47267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5521 0 0 0 15.5138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7019 0 14.4111 0 0 12.2473 0 0 13.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.986 0 0 0 15.753 0 0 0 0 0 0 0 0 15.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5878 0 0 0 0 0 0 0 P21589 5NTD_HUMAN "5'-nucleotidase, 5'-NT, EC 3.1.3.5 (Ecto-5'-nucleotidase) (CD antigen CD73)" NT5E NT5 NTE Homo sapiens (Human) adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; XMP 5'-nucleosidase activity [GO:0106411]; adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; DNA metabolic process [GO:0006259]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035] GO:0000166; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0006259; GO:0007159; GO:0008253; GO:0009897; GO:0009986; GO:0010035; GO:0016020; GO:0031225; GO:0033198; GO:0046032; GO:0046034; GO:0046086; GO:0046872; GO:0050728; GO:0055074; GO:0070062; GO:0106411; GO:0110148 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; XMP 5'-nucleosidase activity [GO:0106411] ECNMGNLICDAMINNNLR 0.96725 3.6682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1215 0 0 0 0 0 0 0 0 0 0 0 0 13.9006 0 0 0 0 0 0 0 0 0 10.9283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2409 0 0 0 0 13.3556 13.583 0 0 0 0 0 0 0 0 0 0 11.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1055 13.7189 0 P09651 ROA1_HUMAN "Heterogeneous nuclear ribonucleoprotein A1, hnRNP A1 (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed ]" HNRNPA1 HNRPA1 Homo sapiens (Human) "cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA export from nucleus [GO:0006405]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752]; cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA export from nucleus [GO:0006405]" GO:0000381; GO:0000398; GO:0003697; GO:0003723; GO:0003727; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006405; GO:0016020; GO:0019904; GO:0032211; GO:0032212; GO:0035198; GO:0036002; GO:0042149; GO:0042802; GO:0043484; GO:0051028; GO:0051168; GO:0051170; GO:0061752; GO:0070062; GO:0071013; GO:0098505; GO:1903936; GO:1990904 G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752] GGFGGSR 0.96726 -1.0465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.637 0 14.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1107 13.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0164 0 0 0 0 0 0 0 0 0 0 0 0 12.7318 0 12.6632 0 0 11.8913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15169 CBPN_HUMAN "Carboxypeptidase N catalytic chain, CPN, EC 3.4.17.3 (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N, SCPN)" CPN1 ACBP Homo sapiens (Human) bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; response to glucocorticoid [GO:0051384] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; bradykinin catabolic process [GO:0010815]; peptide metabolic process [GO:0006518]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; response to glucocorticoid [GO:0051384] GO:0004181; GO:0005576; GO:0005615; GO:0006518; GO:0008270; GO:0010815; GO:0016485; GO:0030163; GO:0051384 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] QLQRGPA 0.96726 -0.33912 0 0 9.93702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.117 13.3749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.107 0 0 0 0 0 0 0 0 0 0 Q7Z7E8 UB2Q1_HUMAN "Ubiquitin-conjugating enzyme E2 Q1, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1)" UBE2Q1 NICE5 UBE2Q PRO3094 Homo sapiens (Human) embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967] cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634] cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967] GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] ELKLLESIFHR 0.96726 0.01803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.081 0 0 0 10.4758 0 0 0 0 0 0 0 15.6762 0 0 12.5966 0 0 0 0 0 0 0 0 11.9655 0 0 0 0 0 0 0 13.0051 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92673 SORL_HUMAN "Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats, LDLR relative with 11 ligand-binding repeats, LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats, SorLA)" SORL1 C11orf32 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910] cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]; adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910] GO:0000139; GO:0001540; GO:0002024; GO:0004888; GO:0005041; GO:0005615; GO:0005641; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006605; GO:0006622; GO:0006892; GO:0006898; GO:0007218; GO:0008283; GO:0009986; GO:0010008; GO:0010897; GO:0014910; GO:0016020; GO:0016021; GO:0016477; GO:0030169; GO:0030514; GO:0030658; GO:0031267; GO:0031333; GO:0031901; GO:0031985; GO:0032091; GO:0032585; GO:0034067; GO:0038020; GO:0042923; GO:0043025; GO:0043407; GO:0045053; GO:0045732; GO:0046628; GO:0050768; GO:0051604; GO:0055037; GO:0055038; GO:0070062; GO:0070863; GO:0097356; GO:1900168; GO:1901215; GO:1902430; GO:1902771; GO:1902948; GO:1902953; GO:1902955; GO:1902960; GO:1902963; GO:1902966; GO:1902997; GO:1904179; GO:1990845; GO:2001137 amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888] CDGFLDCSDESDEK 0.96726 0.017951 13.105 0 11.1328 0 10.3136 0 12.4992 0 0 13.4987 0 0 0 10.8296 0 0 0 0 0 0 10.6997 0 0 0 0 12.0204 0 14.5567 0 13.139 0 0 0 0 15.7646 0 14.9411 0 0 13.9782 0 9.90445 0 0 12.087 10.1007 10.6538 0 0 0 13.2818 11.9756 0 0 12.8537 14.4953 0 13.1817 13.0833 0 11.611 12.29 0 11.7814 11.6248 0 14.5003 0 12.1881 0 0 13.7878 0 12.0996 13.2262 0 10.7677 10.765 11.0612 13.9378 14.6969 11.456 0 0 11.9862 14.9352 0 0 14.4491 14.1084 0 13.8141 14.493 11.0904 14.5138 14.8583 14.8966 15.4461 14.3283 14.2827 0 0 12.6235 14.0602 0 14.5183 13.0893 12.9302 14.561 15.1918 14.363 14.5564 11.0201 13.6593 0 13.7558 0 0 11.4636 0 12.5556 14.9559 10.8531 0 12.7556 0 0 15.2641 10.6574 11.8597 0 0 13.5381 13.5342 0 0 11.2626 0 0 0 0 12.7833 0 0 0 12.8467 0 13.4814 0 0 12.5505 0 12.0459 0 10.1467 11.2191 12.1889 18.2904 18.1871 0 12.4068 10.9417 0 0 0 0 0 14.9678 14.6397 13.2592 13.4876 0 12.75 0 11.3141 0 0 11.523 11.5204 18.1969 Q9NYW6 TA2R3_HUMAN "Taste receptor type 2 member 3, T2R3" TAS2R3 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] AIRIILSFFFLFLLYFLAFLIASFGNFLPKTK 0.96727 -0.030302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8708 0 0 0 0 0 0 0 0 0 11.5962 0 0 0 0 0 0 0 12.2302 0 11.0432 0 12.379 0 0 0 0 0 11.6384 0 0 0 0 0 11.7223 0 0 0 0 0 0 0 0 0 0 0 12.5703 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9571 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0494 0 0 0 0 0 0 0 0 0 0 11.4516 11.8644 0 0 0 0 0 0 0 0 0 0 0 O95631 NET1_HUMAN Netrin-1 (Epididymis tissue protein Li 131P) NTN1 NTN1L Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]" actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654] "actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]" GO:0005576; GO:0005604; GO:0005654; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0008045; GO:0009887; GO:0009888; GO:0014009; GO:0015629; GO:0016358; GO:0030517; GO:0032488; GO:0033564; GO:0042472; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0097475; GO:0098609; GO:1903975; GO:2000147 CRFNMELYKLSGR 0.96728 -0.87686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1604 0 0 0 0 0 0 0 0 0 0 0 10.8968 0 13.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54539 0 10.6131 0 0 10.4945 0 10.3045 0 0 0 0 0 0 0 11.9933 13.4471 0 0 0 13.5658 0 0 0 0 0 0 0 0 0 13.0011 0 11.7873 14.4402 13.5934 0 0 0 0 0 0 0 0 0 10.8684 0 0 0 0 0 0 0 0 0 0 0 11.6288 0 0 0 0 0 0 0 0 17.0145 0 12.0964 0 12.2397 0 0 0 13.4206 0 0 12.8873 0 0 0 0 0 12.2462 12.4167 0 0 0 0 0 0 0 0 0 0 13.0465 0 0 10.7169 11.8522 0 0 0 10.1068 0 0 11.224 0 0 0 0 0 0 0 0 0 0 Q30KQ7 DB113_HUMAN "Beta-defensin 113 (Beta-defensin 13, DEFB-13) (Defensin, beta 113)" DEFB113 DEFB13 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 PIINKITSK 0.96728 0.030769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0707 0 0 0 0 0 0 0 0 0 0 14.2187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1354 0 0 0 0 Q13325 IFIT5_HUMAN "Interferon-induced protein with tetratricopeptide repeats 5, IFIT-5 (Interferon-induced 58 kDa protein) (Retinoic acid- and interferon-inducible 58 kDa protein, P58)" IFIT5 ISG58 RI58 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; double-stranded DNA binding [GO:0003690]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0000049; GO:0000339; GO:0003690; GO:0003723; GO:0003727; GO:0005829; GO:0005886; GO:0008266; GO:0015629; GO:0032587; GO:0043123; GO:0045071; GO:0045087; GO:0045177; GO:0051607 double-stranded DNA binding [GO:0003690]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049] AQMIQIKK 0.96729 -0.41221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7127 0 0 0 0 0 0 0 0 0 0 12.0956 0 13.4531 0 0 0 0 0 0 0 0 0 13.3555 13.0729 0 0 0 0 12.3644 16.8674 0 0 13.3494 0 0 0 0 0 0 0 14.1012 0 12.0132 0 0 Q16875 F263_HUMAN "6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3, 6PF-2-K/Fru-2,6-P2ase 3, PFK/FBPase 3 (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]" PFKFB3 Homo sapiens (Human) "brain development [GO:0007420]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; brain development [GO:0007420]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]" GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0007420 "6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]" DCNSAEAMDDFMK 0.9673 -0.41297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9537 10.8302 0 0 0 12.1053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1039 0 0 0 0 0 0 0 0 11.6055 0 0 0 0 0 10.6414 0 0 0 11.784 0 0 0 0 11.3919 10.3536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4143 0 0 0 14.634 0 15.0841 0 0 0 0 0 12.2743 0 0 0 0 0 0 0 Q3ZCT1 ZN260_HUMAN "Zinc finger protein 260, Zfp-260" ZNF260 ZFP260 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KMHTGEKSHECTECGK 0.9673 -0.0015751 0 0 0 12.1723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6325 0 0 0 0 11.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9781 0 0 0 0 0 0 13.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6387 0 0 0 0 0 0 14.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7696 0 0 0 0 0 0 0 0 0 0 13.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4865 0 0 0 0 0 0 0 0 0 0 0 Q8TDD2 SP7_HUMAN Transcription factor Sp7 (Zinc finger protein osterix) SP7 OSX Homo sapiens (Human) cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; osteoblast differentiation [GO:0001649]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hydrolase activity [GO:0051336]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cementum mineralization [GO:0071529]; diphosphate metabolic process [GO:0071344]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; osteoblast differentiation [GO:0001649]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hydrolase activity [GO:0051336]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0003677; GO:0005634; GO:0005737; GO:0006357; GO:0010467; GO:0017151; GO:0045944; GO:0046872; GO:0051336; GO:0060218; GO:0071344; GO:0071529; GO:2000738 "DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FTCLLCSKRFTR 0.96731 -0.35083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9277 0 0 0 0 9.51059 0 0 0 0 0 0 0 0 12.0325 0 0 0 0 0 0 0 0 0 0 11.4513 0 12.1148 16.0781 0 0 0 0 0 0 0 0 0 10.4397 9.90052 0 0 0 0 0 0 0 0 0 0 11.1047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49AM3 TTC31_HUMAN "Tetratricopeptide repeat protein 31, TPR repeat protein 31" TTC31 Homo sapiens (Human) CPRSTALRSPGLSPLLHYPSCHR 0.96732 -0.0043058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5707 0 0 0 0 0 13.9715 0 0 13.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1546 0 0 0 0 0 0 0 P00338 LDHA_HUMAN "L-lactate dehydrogenase A chain, LDH-A, EC 1.1.1.27 (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit, LDH-M) (Renal carcinoma antigen NY-REN-59)" LDHA PIG19 Homo sapiens (Human) glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090]; substantia nigra development [GO:0021762] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090]; substantia nigra development [GO:0021762] GO:0004459; GO:0005634; GO:0005829; GO:0006089; GO:0006090; GO:0006096; GO:0016020; GO:0021762; GO:0042802; GO:0045296; GO:0070062; GO:1990204 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459] EEQTPQNK 0.96733 -0.93297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8973 0 0 0 0 0 0 0 0 0 12.3834 0 0 0 0 0 13.5792 0 0 0 0 0 0 0 0 13.1004 0 0 0 0 13.0164 0 0 13.101 0 0 0 0 0 0 0 0 13.6841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1963 0 0 13.0639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGC9 O11H4_HUMAN Olfactory receptor 11H4 (Olfactory receptor OR14-36) OR11H4 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004984; GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984] LALRNVLFGMRIR 0.96733 -0.28158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3205 0 Q5JUQ0 FA78A_HUMAN Protein FAM78A FAM78A C9orf59 Homo sapiens (Human) ASAQVVMPPIPKK 0.96735 -0.86023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1853 0 0 14.1605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3037 14.8528 0 0 0 13.4082 13.8944 0 0 0 14.4227 0 0 0 13.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4102 0 0 0 0 0 0 0 0 0 0 14.9451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q709F0 ACD11_HUMAN "Acyl-CoA dehydrogenase family member 11, ACAD-11, EC 1.3.8.-" ACAD11 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] GO:0003995; GO:0004466; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005777; GO:0006635; GO:0017099; GO:0031966; GO:0033539; GO:0050660; GO:0070991 acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099] CRGINSILPNWNFFLALSYFK 0.96735 -0.33233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3069 0 0 0 0 0 0 0 12.4968 0 0 13.3745 0 0 0 0 0 11.4184 0 0 0 0 0 0 0 0 0 13.2446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.417 0 0 0 0 0 0 0 0 0 0 13.6762 0 0 0 0 0 0 0 14.2023 0 0 0 0 0 0 0 0 0 0 12.6186 0 0 0 13.4785 12.8938 0 0 0 13.9809 12.7486 0 0 0 0 0 0 0 13.1786 0 0 0 0 12.8696 0 12.9931 12.1501 0 0 0 0 13.9831 14.3216 0 0 13.0381 12.8519 0 13.2537 15.1467 0 0 12.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8822 0 0 P23258 TBG1_HUMAN "Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1, GCP-1)" TUBG1 TUBG Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052] apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; mitotic spindle microtubule [GO:1990498]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819] apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; mitotic spindle microtubule [GO:1990498]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052] GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005874; GO:0005881; GO:0007017; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0043005; GO:0045177; GO:0055037; GO:0097730; GO:1990498 GTP binding [GO:0005525]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200] EDMFKDNFDEMDTSR 0.96738 -1.0463 0 0 0 0 0 0 0 0 0 0 13.1911 11.1111 13.0585 11.8942 12.3453 11.9762 11.8034 12.0539 0 12.6628 12.5206 0 13.0133 0 12.6176 12.3498 12.7889 0 0 11.8935 0 12.4418 0 0 11.5393 0 0 0 0 0 0 0 11.6263 12.3928 11.9645 0 13.8891 12.7563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5963 15.6801 14.6085 14.6959 0 14.8837 14.6159 0 14.9893 15.042 0 12.3147 0 0 0 0 0 0 0 0 13.8684 0 0 Q6ZMR5 TM11A_HUMAN "Transmembrane protease serine 11A, EC 3.4.21.- (Airway trypsin-like protease 1) (Epidermal type-II transmembrane serine protease) (Esophageal cancer-susceptibility gene 1 protein)" TMPRSS11A ECRG1 HATL1 HESP Homo sapiens (Human) cell cycle [GO:0007049]; proteolysis [GO:0006508] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; cell cycle [GO:0007049]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0007049 serine-type endopeptidase activity [GO:0004252] EYYHGSFK 0.96739 -0.33875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5997 0 0 0 12.1868 0 0 0 0 0 0 0 0 17.6147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3295 12.5434 0 0 0 0 12.0237 0 0 0 12.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1375 0 0 0 0 0 0 0 0 0 0 13.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2H9 S38A1_HUMAN Sodium-coupled neutral amino acid transporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1) SLC38A1 ATA1 NAT2 SAT1 SNAT1 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; female pregnancy [GO:0007565]; glutamine transport [GO:0006868]; L-alpha-amino acid transmembrane transport [GO:1902475]; neurotransmitter uptake [GO:0001504]; neutral amino acid transport [GO:0015804]; transport across blood-brain barrier [GO:0150104] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; neutral amino acid transmembrane transporter activity [GO:0015175]; neutral amino acid:sodium symporter activity [GO:0005295]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; female pregnancy [GO:0007565]; glutamine transport [GO:0006868]; L-alpha-amino acid transmembrane transport [GO:1902475]; neurotransmitter uptake [GO:0001504]; neutral amino acid transport [GO:0015804]; transport across blood-brain barrier [GO:0150104] GO:0001504; GO:0003333; GO:0005283; GO:0005295; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0007565; GO:0015171; GO:0015175; GO:0015179; GO:0015186; GO:0015804; GO:0016021; GO:0016323; GO:0030424; GO:0043025; GO:0070062; GO:0098591; GO:0150104; GO:1902475 amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; neutral amino acid transmembrane transporter activity [GO:0015175]; neutral amino acid:sodium symporter activity [GO:0005295] DIFGVVGVTSANMLIFILPSSLYLKITDQDGDK 0.96739 4.4455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3412 0 0 12.1206 0 0 0 0 0 11.7899 0 12.1791 0 0 0 0 0 0 0 14.2888 0 0 0 11.4019 12.3826 12.45 13.6794 14.0568 13.7138 11.2722 0 0 13.7279 12.3623 10.948 0 0 0 0 0 15.3689 0 0 11.9023 0 13.2265 10.8119 0 0 0 12.2794 0 12.2985 0 0 11.8193 0 0 0 12.0802 0 12.5272 0 12.466 0 0 0 0 0 12.5874 0 12.4344 0 0 0 0 0 11.3017 0 0 0 0 0 0 0 11.4017 0 0 0 0 0 0 0 0 0 0 0 12.2329 0 0 0 0 0 0 12.4448 0 0 0 0 13.3489 0 11.5956 0 Q6DKI1 RL7L_HUMAN 60S ribosomal protein L7-like 1 (Large ribosomal subunit protein uL30-like 1) RPL7L1 Homo sapiens (Human) "blastocyst formation [GO:0001825]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730] "cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; blastocyst formation [GO:0001825]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" GO:0000463; GO:0001825; GO:0003723; GO:0003735; GO:0005730; GO:0022625 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ELILKRGQAK 0.9674 -1.0477 0 0 0 0 0 0 0 0 0 0 14.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9925 0 0 0 0 0 0 0 0 0 0 0 11.8203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8202 0 0 0 0 0 12.1197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4535 0 0 15.7408 0 0 0 0 0 0 0 0 0 0 16.0978 12.6962 13.3102 0 0 0 0 0 12.7487 14.7298 0 12.8531 12.1149 0 0 0 0 0 0 0 12.9077 0 0 12.6748 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0186 13.0685 0 0 0 0 12.4688 0 0 0 0 0 0 0 0 14.6749 0 13.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4L0 COX8C_HUMAN "Cytochrome c oxidase subunit 8C, mitochondrial (Cytochrome c oxidase polypeptide 8 isoform 3) (Cytochrome c oxidase polypeptide VIII isoform 3, COX VIII-3) (Cytochrome c oxidase subunit 8-3, COX8-3) (Cytochrome c oxidase subunit VIIIC)" COX8C Homo sapiens (Human) "mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277] "integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" GO:0005739; GO:0005751; GO:0006123; GO:0016021; GO:0045277 MPLLRGR 0.9674 -0.33912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0417 13.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7529 14.103 0 0 0 0 0 0 0 0 0 10.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGH9 O52E4_HUMAN Olfactory receptor 52E4 (Olfactory receptor OR11-55) OR52E4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EQIVKIFVQK 0.9674 -0.31854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.726 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9549 0 0 0 0 0 0 0 0 0 0 0 0 12.1012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2D4 EXC6B_HUMAN Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2) EXOC6B KIAA0919 SEC15B SEC15L2 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] exocyst [GO:0000145] exocyst [GO:0000145]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522 ECEQFAR 0.9674 -1.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5454 0 0 0 0 0 0 0 12.9046 0 0 0 0 0 0 0 0 0 0 17.4088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10720 PF4V_HUMAN Platelet factor 4 variant (C-X-C motif chemokine 4 variant) (CXCL4L1) (PF4alt) (PF4var1) [Cleaved into: Platelet factor 4 variant(4-74); Platelet factor 4 variant(5-74); Platelet factor 4 variant(6-74) ] PF4V1 CXCL4V1 SCYB4V1 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168] extracellular space [GO:0005615] extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168] GO:0005615; GO:0006954; GO:0008009; GO:0008201; GO:0030168; GO:0030593; GO:0045236; GO:0061844; GO:0070098; GO:0071222 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201] ATRQEMLFLALLLLPVVVAFARAEAEEDGDLQCLCVK 0.96741 -0.31923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q659C4 LAR1B_HUMAN La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2) LARP1B LARP2 Homo sapiens (Human) positive regulation of translation [GO:0045727] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727] GO:0003723; GO:0005634; GO:0005829; GO:0010494; GO:0045727 RNA binding [GO:0003723] AIDVKSPR 0.96741 0.018306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5551 0 13.2159 0 12.6969 0 0 13.0681 0 0 0 0 0 0 0 0 0 0 0 14.3299 0 0 0 0 13.1892 0 0 0 0 0 0 0 0 12.3196 11.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8478 0 0 0 0 0 0 0 14.1466 0 0 0 0 0 0 0 0 0 0 0 16.0479 0 13.3689 13.6108 14.6422 0 0 0 0 0 0 0 0 0 0 13.8466 0 0 14.5667 0 0 0 0 0 0 14.0527 0 0 0 0 0 0 13.2528 12.9073 0 0 0 12.4391 0 0 0 14.1592 13.0519 0 0 0 0 0 0 0 0 0 12.6548 0 0 0 0 0 0 0 0 0 0 0 14.1853 13.5248 0 13.0512 0 0 0 14.6814 0 0 13.7798 0 12.6044 12.2197 0 0 12.3588 0 0 0 0 12.4904 0 12.5657 0 0 O43187 IRAK2_HUMAN "Interleukin-1 receptor-associated kinase-like 2, IRAK-2" IRAK2 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein phosphorylation [GO:0006468]; regulation of cytokine-mediated signaling pathway [GO:0001959]; response to interleukin-1 [GO:0070555] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein phosphorylation [GO:0006468]; regulation of cytokine-mediated signaling pathway [GO:0001959]; response to interleukin-1 [GO:0070555] GO:0001959; GO:0002755; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006954; GO:0007249; GO:0010008; GO:0019221; GO:0031663; GO:0032088; GO:0035556; GO:0042803; GO:0046982; GO:0051092; GO:0070498; GO:0070555 ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674] PEKPLAASVR 0.96742 -0.030066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0674 0 0 0 0 0 0 0 0 0 11.1427 0 0 0 0 0 0 0 0 0 0 0 12.6154 0 0 0 0 0 13.4558 12.2702 0 0 12.8355 13.222 0 0 0 0 15.4118 0 0 0 15.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7617 12.4342 0 0 0 0 0 0 0 Q9HD33 RM47_HUMAN "39S ribosomal protein L47, mitochondrial, L47mt, MRP-L47 (Mitochondrial large ribosomal subunit protein uL29m) (Nasopharyngeal carcinoma metastasis-related protein 1)" MRPL47 NCM1 CGI-204 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 structural constituent of ribosome [GO:0003735] DIFGRIIWHK 0.96744 0.030776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7936 0 0 14.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10606 COX5B_HUMAN "Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)" COX5B Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]" GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0006123; GO:0007585; GO:0031966; GO:0045333; GO:0046872 cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872] LLRGAGTLAAQALRAR 0.96745 -0.45032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6823 11.8262 0 0 0 11.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6447 0 0 0 0 11.0463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8653 0 Q8N8F7 LSME1_HUMAN Leucine-rich single-pass membrane protein 1 LSMEM1 C7orf53 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 INNMIVKR 0.96745 -0.35054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4513 0 0 0 0 0 0 0 0 14.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.476 0 0 12.5882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2757 0 0 0 0 0 0 0 0 0 0 0 0 12.2295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3369 0 0 0 0 0 0 0 13.4477 13.1466 0 12.9347 0 12.7958 0 12.858 12.9279 0 0 16.9706 0 12.8236 16.6018 0 0 0 0 0 0 0 0 0 Q8N9G6 YJ012_HUMAN Putative UPF0607 protein FLJ37424 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] EGRLQHGNMRK 0.96746 -0.9599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2705 0 19.0366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8443 19.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2R5 RT17_HUMAN "28S ribosomal protein S17, mitochondrial, MRP-S17, S17mt (Mitochondrial small ribosomal subunit protein uS17m)" MRPS17 RPMS17 HSPC011 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0019843; GO:0032543 rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] ALPVPRAKHVK 0.96746 -0.41558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7006 0 12.9511 12.1653 0 0 0 12.5072 0 0 0 0 0 0 13.5553 0 0 0 0 0 0 0 0 12.9026 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3034 0 0 0 0 0 0 0 0 0 0 0 0 12.7171 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0071 0 0 0 0 0 0 0 0 0 0 15.2306 0 0 0 0 12.9394 14.853 14.031 0 0 0 0 0 0 0 0 0 0 0 13.233 13.7196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5PT55 NTCP5_HUMAN Sodium/bile acid cotransporter 5 (Na(+)/bile acid cotransporter 5) (Solute carrier family 10 member 5) SLC10A5 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721] GO:0008508; GO:0015721; GO:0016021 bile acid:sodium symporter activity [GO:0008508] ASFLERIIRPLSFILMFVGIYLTFTVGLVFLK 0.96747 -0.28151 0 0 0 0 0 10.9984 10.536 0 14.5745 0 0 12.3079 0 0 0 12.6143 0 0 0 0 0 0 0 13.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3807 15.0692 0 0 0 0 0 12.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0582 0 15.35 0 0 0 0 0 0 0 0 0 0 14.3187 0 12.3617 15.0856 15.4646 13.9083 15.7555 15.5282 15.1255 15.6985 14.0872 15.547 0 13.4966 13.7037 13.7168 15.4159 14.3503 13.9183 0 13.5263 13.414 0 13.6729 0 0 0 13.759 13.1664 0 0 14.4059 0 13.7631 12.5839 0 14.0037 0 0 0 0 14.4054 13.2731 0 0 15.189 0 13.1439 0 0 0 13.0703 12.9861 0 0 0 0 0 12.1827 0 0 11.9199 0 13.9547 0 0 12.8757 0 17.6471 0 0 11.4367 0 0 0 0 0 0 11.2268 0 0 0 0 17.5705 0 0 0 12.2653 0 0 11.0515 0 0 0 12.5328 14.2454 0 0 11.5797 0 0 Q8NGK0 O51G2_HUMAN Olfactory receptor 51G2 (Olfactory receptor OR11-28) OR51G2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ANSIYGMFVIVSTVGIDSLLILFSYALILR 0.96747 -0.8602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3866 13.0197 13.4384 0 12.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.641 0 0 0 0 0 0 0 0 11.2744 0 0 0 0 0 0 0 0 0 0 Q8WYQ9 ZCH14_HUMAN Zinc finger CCHC domain-containing protein 14 (BDG-29) ZCCHC14 KIAA0579 Homo sapiens (Human) nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270] GO:0003676; GO:0008270; GO:0035091 nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270] EESSDSAEENDR 0.96747 -0.004256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00499 BIN1_HUMAN Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1) BIN1 AMPHL Homo sapiens (Human) cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; positive regulation of GTPase activity [GO:0043547]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292] GO:0000122; GO:0002020; GO:0005543; GO:0005634; GO:0005635; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0006997; GO:0007010; GO:0008021; GO:0008333; GO:0010564; GO:0015629; GO:0016020; GO:0019828; GO:0030018; GO:0030276; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0033268; GO:0033292; GO:0042802; GO:0043065; GO:0043194; GO:0043196; GO:0043547; GO:0043679; GO:0044300; GO:0045664; GO:0045807; GO:0048156; GO:0048488; GO:0048711; GO:0051015; GO:0051020; GO:0051087; GO:0051647; GO:0060987; GO:0060988; GO:0070063; GO:0086091; GO:0090571; GO:0098850; GO:0098978; GO:1901380; GO:1902430; GO:1902960; GO:1903946; GO:1904878 actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156] AQEKVLQK 0.96748 -1.0379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04920 B3A2_HUMAN "Anion exchange protein 2, AE 2, Anion exchanger 2 (Non-erythroid band 3-like protein, BND3L) (Solute carrier family 4 member 2)" SLC4A2 AE2 EPB3L1 HKB3 MPB3L Homo sapiens (Human) amelogenesis [GO:0097186]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; positive regulation of enamel mineralization [GO:0070175]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]; amelogenesis [GO:0097186]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; ion homeostasis [GO:0050801]; positive regulation of enamel mineralization [GO:0070175]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085] GO:0005452; GO:0005886; GO:0005925; GO:0006820; GO:0007283; GO:0008509; GO:0015301; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019899; GO:0022857; GO:0048565; GO:0050801; GO:0051453; GO:0055085; GO:0070175; GO:0097186 anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; enzyme binding [GO:0019899]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857] ELPPPAPPAGITR 0.96748 -0.0047878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.34 0 0 0 0 0 0 0 16.7545 0 0 12.3742 0 0 0 13.7144 14.1789 15.1413 0 0 0 0 0 0 0 13.3297 0 0 0 0 0 12.8434 12.5741 14.5291 14.4873 14.1821 0 12.8834 12.6626 0 0 0 0 13.1255 0 0 0 0 0 0 0 0 0 13.0537 0 13.2391 0 0 13.0823 12.2231 0 13.0564 12.0226 0 0 13.0057 0 0 0 12.6891 0 0 12.8953 0 12.8369 0 0 0 0 0 0 0 12.6944 0 13.66 13.683 13.8274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9872 0 0 0 0 0 0 0 Q6EBC2 IL31_HUMAN "Interleukin-31, IL-31" IL31 Homo sapiens (Human) immune system process [GO:0002376] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; immune system process [GO:0002376] GO:0002376; GO:0005125; GO:0005126; GO:0005576; GO:0005615 cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126] GVLVSQNYTLPCLSPDAQPPNNIHSPAIRAYLK 0.96748 -1.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSB4 ATGA1_HUMAN Autophagy-related protein 101 ATG101 C12orf44 PP894 Homo sapiens (Human) autophagosome assembly [GO:0000045]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059] Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407] Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; autophagosome assembly [GO:0000045]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059] GO:0000045; GO:0000407; GO:0005789; GO:0005829; GO:0006468; GO:0008285; GO:0010508; GO:0042802; GO:0044877; GO:0046777; GO:1903059; GO:1990316 identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] MPTQSEVDNVFDTGLR 0.96748 -0.93712 0 9.84844 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9521 0 0 0 0 0 0 12.1912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0167 0 0 0 0 0 0 0 0 0 0 0 12.9071 0 0 0 0 13.3454 0 0 0 0 0 0 11.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8995 0 0 0 0 0 0 0 11.9071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0D3 ZY11B_HUMAN Protein zyg-11 homolog B ZYG11B KIAA1730 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] Cul2-RING ubiquitin ligase complex [GO:0031462] Cul2-RING ubiquitin ligase complex [GO:0031462]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] GO:0006515; GO:0031462; GO:0032436 ACIRKAK 0.9675 -1.0449 0 0 0 0 0 0 0 0 0 0 13.5497 0 0 0 0 13.7432 0 14.0016 14.2351 13.4867 0 0 13.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3658 0 13.3681 0 0 18.4425 0 0 0 13.7243 14.0433 0 11.5171 0 14.0978 0 18.9689 11.2991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5846 0 0 0 0 12.8549 0 0 0 0 0 0 13.8118 0 0 10.6379 13.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8911 0 0 0 13.3292 13.7526 0 0 13.5143 13.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5458 0 14.2232 0 0 0 0 0 0 Q9H7F4 T185B_HUMAN Transmembrane protein 185B (Protein FAM11B) TMEM185B FAM11B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EYGNISYDLHHEDSEDAEETSVPEAPK 0.9675 -1.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9391 0 0 13.0397 0 0 0 0 0 12.8664 13.7773 0 0 13.2872 0 0 0 0 0 0 13.2181 0 13.4515 0 0 13.3869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0989 0 0 0 0 0 0 0 0 13.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14543 SOCS3_HUMAN "Suppressor of cytokine signaling 3, SOCS-3 (Cytokine-inducible SH2 protein 3, CIS-3) (STAT-induced STAT inhibitor 3, SSI-3)" SOCS3 CIS3 SSI3 Homo sapiens (Human) branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to interleukin-17 [GO:0097398]; cellular response to leukemia inhibitory factor [GO:1990830]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; miRNA binding [GO:0035198]; phosphotyrosine residue binding [GO:0001784]; protein kinase inhibitor activity [GO:0004860]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to interleukin-17 [GO:0097398]; cellular response to leukemia inhibitory factor [GO:1990830]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; placenta blood vessel development [GO:0060674]; positive regulation of cell differentiation [GO:0045597]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008] GO:0001784; GO:0004860; GO:0005829; GO:0005942; GO:0007259; GO:0016567; GO:0030154; GO:0035198; GO:0035556; GO:0040008; GO:0042532; GO:0043066; GO:0045597; GO:0046426; GO:0046627; GO:0046854; GO:0046935; GO:0050728; GO:0060670; GO:0060674; GO:0097398; GO:1990830 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; miRNA binding [GO:0035198]; phosphotyrosine residue binding [GO:0001784]; protein kinase inhibitor activity [GO:0004860] HFFTLSVKTQSGTKNLR 0.96752 -0.21456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.251 0 0 0 0 0 0 0 0 0 0 0 13.9578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14116 IL18_HUMAN "Interleukin-18, IL-18 (Iboctadekin) (Interferon gamma-inducing factor, IFN-gamma-inducing factor) (Interleukin-1 gamma, IL-1 gamma)" IL18 IGIF IL1F4 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; cellular response to organic cyclic compound [GO:0071407]; cholesterol homeostasis [GO:0042632]; defense response to Gram-positive bacterium [GO:0050830]; establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil activation [GO:0042119]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell adhesion [GO:0030155]; sleep [GO:0030431]; T-helper 1 type immune response [GO:0042088]; triglyceride homeostasis [GO:0070328]; type 2 immune response [GO:0042092] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; interleukin-18 receptor binding [GO:0045515]; activation of protein kinase B activity [GO:0032148]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; cellular response to organic cyclic compound [GO:0071407]; cholesterol homeostasis [GO:0042632]; defense response to Gram-positive bacterium [GO:0050830]; establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil activation [GO:0042119]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell adhesion [GO:0030155]; sleep [GO:0030431]; T-helper 1 type immune response [GO:0042088]; triglyceride homeostasis [GO:0070328]; type 2 immune response [GO:0042092] GO:0000165; GO:0001525; GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0006954; GO:0007267; GO:0008283; GO:0010744; GO:0014068; GO:0030101; GO:0030155; GO:0030431; GO:0031663; GO:0032148; GO:0032722; GO:0032725; GO:0032729; GO:0032736; GO:0032740; GO:0032819; GO:0034105; GO:0035655; GO:0038061; GO:0042088; GO:0042092; GO:0042104; GO:0042119; GO:0042267; GO:0042531; GO:0042632; GO:0045515; GO:0045630; GO:0045662; GO:0045944; GO:0048661; GO:0050729; GO:0050830; GO:0051092; GO:0051142; GO:0051897; GO:0061436; GO:0070328; GO:0071407; GO:0120162; GO:0150078; GO:1901224; GO:2000556 cytokine activity [GO:0005125]; interleukin-18 receptor binding [GO:0045515] ERDLFKLILK 0.96752 -0.31554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0434 0 0 0 0 0 0 12.1471 0 0 12.1128 0 0 0 0 11.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9F0 NAT8L_HUMAN "N-acetylaspartate synthetase, NAA synthetase, EC 2.3.1.17 (Camello-like protein 3) (N-acetyltransferase 8-like protein)" NAT8L CML3 Homo sapiens (Human) aspartate family amino acid metabolic process [GO:0009066] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; aspartate N-acetyltransferase activity [GO:0017188]; N-acetyltransferase activity [GO:0008080]; aspartate family amino acid metabolic process [GO:0009066] GO:0005737; GO:0005739; GO:0005759; GO:0005789; GO:0008080; GO:0009066; GO:0016021; GO:0017188; GO:0031966 aspartate N-acetyltransferase activity [GO:0017188]; N-acetyltransferase activity [GO:0008080] KVIRAYLECALHTDMADIEQYYMK 0.96752 -1.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P11 NSUN5_HUMAN "28S rRNA (cytosine-C(5))-methyltransferase, EC 2.1.1.- (NOL1-related protein, NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein)" NSUN5 NSUN5A WBSCR20 WBSCR20A Homo sapiens (Human) cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; RNA methylation [GO:0001510]; rRNA base methylation [GO:0070475] GO:0001510; GO:0003723; GO:0005654; GO:0005730; GO:0009383; GO:0014003; GO:0021987; GO:0022038; GO:0031641; GO:0045727; GO:0050890; GO:0070475 RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383] ALLGRHQAR 0.96752 -0.21478 0 0 0 0 0 0 11.0918 0 0 0 0 0 0 0 0 0 0 13.7658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.15363 0 0 0 0 0 11.5145 0 0 9.59585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0215 0 0 0 0 14.5436 14.6927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7218 0 0 0 14.5965 0 0 0 0 0 0 14.2973 0 0 0 0 0 0 0 0 10.7202 0 0 0 0 0 0 0 13.009 0 0 0 0 0 0 0 0 14.3735 0 0 14.0484 0 15.0368 0 0 0 0 0 0 13.8564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NFA1 TIKI2_HUMAN "Metalloprotease TIKI2, EC 3.4.-.- (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B)" TRABD2B HKAT TIKI2 Homo sapiens (Human) negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein oxidation [GO:1904808]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] GO:0004222; GO:0005887; GO:0006508; GO:0016020; GO:0016055; GO:0017147; GO:0030178; GO:0031301; GO:0031334; GO:0046872; GO:1904808 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; Wnt-protein binding [GO:0017147] ARPQPPDGGQCR 0.96753 4.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7653 0 0 11.8686 10.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3071 0 0 0 0 0 0 0 0 0 0 0 0 14.092 0 11.3623 0 13.2091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C617 O5AL1_HUMAN Olfactory receptor 5AL1 (Olfactory receptor OR11-184) OR5AL1 OR5AL1P Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] RIIEKLCLAVK 0.96753 -0.33772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9145 0 0 0 0 13.1109 0 11.8637 0 0 0 0 0 0 0 0 0 0 13.0879 0 14.045 13.854 0 0 0 0 12.4876 0 11.8228 0 14.756 13.4662 0 0 0 13.3515 0 13.1468 0 0 0 13.8514 14.2985 0 0 13.638 0 13.5108 12.9381 0 13.7583 13.1203 0 0 0 13.2658 0 0 12.8028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26641 EF1G_HUMAN "Elongation factor 1-gamma, EF-1-gamma (eEF-1B gamma)" EEF1G EF1G PRO1608 Homo sapiens (Human) glutathione metabolic process [GO:0006749]; response to virus [GO:0009615]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746]; glutathione metabolic process [GO:0006749]; response to virus [GO:0009615]; translational elongation [GO:0006414] GO:0003746; GO:0005634; GO:0005737; GO:0005829; GO:0006414; GO:0006749; GO:0009615; GO:0016020; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746] EEVRRILGLLDAYLK 0.96753 -0.026602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HYW2 NHSL2_HUMAN NHS-like protein 2 NHSL2 Homo sapiens (Human) cell differentiation [GO:0030154] cell differentiation [GO:0030154] GO:0030154 ALLQKKGSK 0.96753 -0.31664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6247 0 0 0 0 12.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2569 0 0 13.8425 11.5266 15.979 13.4628 0 0 0 12.6179 0 0 0 13.3916 0 12.9606 0 0 15.6097 0 14.9869 0 0 0 0 0 0 0 11.5741 0 0 13.8264 0 14.2743 12.7214 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5678 0 0 0 0 0 13.613 14.1372 13.4397 0 0 12.6385 13.2961 0 12.9605 17.0831 0 0 11.0066 0 0 0 0 0 11.8267 0 0 0 14.9018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5372 0 10.4623 13.0441 0 0 14.3895 12.5134 0 0 11.8834 0 15.4304 0 A6NIX2 WTIP_HUMAN "Wilms tumor protein 1-interacting protein, WT1-interacting protein" WTIP Homo sapiens (Human) "cell projection organization [GO:0030030]; cytoskeleton organization [GO:0007010]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of hippo signaling [GO:0035331]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" adherens junction [GO:0005912]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667] "adherens junction [GO:0005912]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell projection organization [GO:0030030]; cytoskeleton organization [GO:0007010]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of hippo signaling [GO:0035331]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" GO:0000932; GO:0001666; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0022604; GO:0030030; GO:0035195; GO:0035331; GO:0046872; GO:2000637 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] EGGPSAAER 0.96754 -0.31825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SX64 OD3L2_HUMAN Outer dense fiber protein 3-like protein 2 ODF3L2 C19orf19 Homo sapiens (Human) cytoplasmic microtubule [GO:0005881]; cytoskeleton [GO:0005856] cytoplasmic microtubule [GO:0005881]; cytoskeleton [GO:0005856] GO:0005856; GO:0005881 ARAPAFSMGIRHSK 0.96754 -0.028514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9964 0 0 0 15.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY56 OBP2A_HUMAN "Odorant-binding protein 2a (Odorant-binding protein IIa, OBPIIa)" OBP2A Homo sapiens (Human) response to stimulus [GO:0050896]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608] extracellular space [GO:0005615] extracellular space [GO:0005615]; odorant binding [GO:0005549]; small molecule binding [GO:0036094]; response to stimulus [GO:0050896]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608] GO:0005549; GO:0005615; GO:0007606; GO:0007608; GO:0036094; GO:0050896 odorant binding [GO:0005549]; small molecule binding [GO:0036094] DFPEDRRPR 0.96754 -0.31768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3424 0 0 0 0 0 0 0 O95644 NFAC1_HUMAN "Nuclear factor of activated T-cells, cytoplasmic 1, NF-ATc1, NFATc1 (NFAT transcription complex cytosolic component, NF-ATc, NFATc)" NFATC1 NFAT2 NFATC Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; calcineurin-NFAT signaling cascade [GO:0033173]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pulmonary valve morphogenesis [GO:0003184]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; FK506 binding [GO:0005528]; mitogen-activated protein kinase p38 binding [GO:0048273]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; aortic valve morphogenesis [GO:0003180]; calcineurin-NFAT signaling cascade [GO:0033173]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pulmonary valve morphogenesis [GO:0003184]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0003180; GO:0003184; GO:0003700; GO:0005528; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0016604; GO:0030178; GO:0033173; GO:0035556; GO:0045893; GO:0045944; GO:0048273; GO:0061629; GO:1905064; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; FK506 binding [GO:0005528]; mitogen-activated protein kinase p38 binding [GO:0048273]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]" DESPTAGPR 0.96758 -0.45018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7871 0 0 0 0 11.6196 0 0 0 0 0 12.6455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XI6 PPR3B_HUMAN "Protein phosphatase 1 regulatory subunit 3B (Hepatic glycogen-targeting protein phosphatase 1 regulatory subunit GL) (Protein phosphatase 1 regulatory subunit 4, PP1 subunit R4) (Protein phosphatase 1 subunit GL, PTG)" PPP1R3B PPP1R4 Homo sapiens (Human) glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] glycogen granule [GO:0042587]; intracellular membrane-bounded organelle [GO:0043231]; protein phosphatase type 1 complex [GO:0000164] glycogen granule [GO:0042587]; intracellular membrane-bounded organelle [GO:0043231]; protein phosphatase type 1 complex [GO:0000164]; [phosphorylase] phosphatase activity [GO:0050196]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] GO:0000164; GO:0005977; GO:0005979; GO:0005981; GO:0008157; GO:0019888; GO:0042587; GO:0043231; GO:0050196; GO:2001069 [phosphorylase] phosphatase activity [GO:0050196]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888] FAFKISPK 0.96758 -0.95944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0615 12.2879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6557 12.7608 12.9012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0163 0 13.8253 0 0 12.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6359 0 0 0 0 0 0 13.3529 14.1574 14.4198 0 0 13.3383 0 0 12.4496 0 0 0 0 0 0 16.6953 0 0 0 0 0 0 11.4637 0 0 0 0 0 0 0 0 0 0 0 13.5727 0 0 0 0 0 0 0 0 13.7957 0 0 0 0 0 14.0473 0 0 0 0 0 0 0 0 P08238 HS90B_HUMAN "Heat shock protein HSP 90-beta, HSP 90 (Heat shock 84 kDa, HSP 84, HSP84)" HSP90AB1 HSP90B HSPC2 HSPCB Homo sapiens (Human) axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062] apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913] apical plasma membrane [GO:0016324]; aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; inclusion body [GO:0016234]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm head plasma membrane [GO:1990913]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; axon extension [GO:0048675]; cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; cellular response to organic cyclic compound [GO:0071407]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transforming growth factor beta activation [GO:1901389]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell size [GO:0045793]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to cocaine [GO:0042220]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062] GO:0001890; GO:0002134; GO:0002135; GO:0003723; GO:0003725; GO:0005524; GO:0005525; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0005886; GO:0006457; GO:0006986; GO:0007004; GO:0009410; GO:0009651; GO:0009986; GO:0016020; GO:0016234; GO:0016323; GO:0016324; GO:0016887; GO:0017098; GO:0019062; GO:0019887; GO:0019900; GO:0019901; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030511; GO:0030911; GO:0031072; GO:0031396; GO:0031526; GO:0031625; GO:0032092; GO:0032435; GO:0032516; GO:0032564; GO:0032880; GO:0032991; GO:0033138; GO:0034605; GO:0034751; GO:0034774; GO:0042220; GO:0042277; GO:0042307; GO:0042470; GO:0042802; GO:0042803; GO:0042826; GO:0043008; GO:0043025; GO:0043524; GO:0044183; GO:0044294; GO:0044295; GO:0044325; GO:0045296; GO:0045429; GO:0045597; GO:0045793; GO:0046983; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051082; GO:0051131; GO:0051248; GO:0051726; GO:0051897; GO:0051973; GO:0070062; GO:0070182; GO:0071353; GO:0071407; GO:0071902; GO:0097435; GO:0097718; GO:0120293; GO:1901389; GO:1901799; GO:1902949; GO:1903660; GO:1904031; GO:1904813; GO:1905323; GO:1990226; GO:1990565; GO:1990913; GO:1990917; GO:2000010 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; cadherin binding [GO:0045296]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; RNA binding [GO:0003723]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134] ALLFIPRR 0.96759 -0.41544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3523 0 0 0 0 0 0 13.4201 0 0 0 14.5016 0 0 13.1781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5621 0 0 0 0 0 0 0 0 13.5085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1978 0 0 0 0 0 0 0 Q02363 ID2_HUMAN "DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26, bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2)" ID2 BHLHB26 Homo sapiens (Human) "bundle of His development [GO:0003166]; cell differentiation [GO:0030154]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal digestive tract morphogenesis [GO:0061031]; entrainment of circadian clock by photoperiod [GO:0043153]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; heart development [GO:0007507]; locomotor rhythm [GO:0045475]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate commitment [GO:0048663]; olfactory bulb development [GO:0021772]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of blood pressure [GO:0045777]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid metabolic process [GO:0019216]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron differentiation [GO:0045664]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein dimerization activity [GO:0046983]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; transmembrane transporter binding [GO:0044325]; bundle of His development [GO:0003166]; cell differentiation [GO:0030154]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal digestive tract morphogenesis [GO:0061031]; entrainment of circadian clock by photoperiod [GO:0043153]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; heart development [GO:0007507]; locomotor rhythm [GO:0045475]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron fate commitment [GO:0048663]; olfactory bulb development [GO:0021772]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of blood pressure [GO:0045777]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid metabolic process [GO:0019216]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron differentiation [GO:0045664]" GO:0000122; GO:0000791; GO:0003166; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007507; GO:0007623; GO:0010628; GO:0010629; GO:0019216; GO:0021772; GO:0030154; GO:0032922; GO:0032991; GO:0033598; GO:0042752; GO:0043153; GO:0043353; GO:0043433; GO:0044325; GO:0045475; GO:0045578; GO:0045600; GO:0045651; GO:0045664; GO:0045777; GO:0045892; GO:0045893; GO:0046983; GO:0048557; GO:0048661; GO:0048663; GO:0048711; GO:0051148; GO:0060749; GO:0061030; GO:0061031; GO:0061629; GO:0071931; GO:0090398; GO:0140416; GO:2000045; GO:2000177 protein dimerization activity [GO:0046983]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; transmembrane transporter binding [GO:0044325] AFSPVRSVRK 0.96759 -0.41464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKI8 TLK1_HUMAN "Serine/threonine-protein kinase tousled-like 1, EC 2.7.11.1 (PKU-beta) (Tousled-like kinase 1)" TLK1 KIAA0137 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275] GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0006468; GO:0006886; GO:0006974; GO:0007049; GO:0007059; GO:0018105; GO:0035556; GO:0106310; GO:1902275 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ELDHPRIVK 0.96759 -0.85928 0 0 0 0 0 0 0 0 0 11.7317 0 0 11.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5392 0 0 0 0 0 13.062 0 0 13.1691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3211 0 0 0 0 0 0 0 0 15.3328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1877 E5RJM6 ANR65_HUMAN Ankyrin repeat domain-containing protein 65 ANKRD65 Homo sapiens (Human) GHAPLVRLLLQRGAPVGAVDR 0.9676 -1.0372 0 0 0 0 0 0 0 0 0 0 0 13.4529 0 0 0 0 0 12.5116 0 0 10.872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDY3 ACTT2_HUMAN "Actin-related protein T2, ARP-T2 (Actin-related protein M2)" ACTRT2 ARPM2 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] GO:0005737; GO:0005856 GLITGWDDVER 0.9676 0.03079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6633 0 0 0 0 16.4977 16.4673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.86 0 0 0 0 0 0 0 0 0 0 0 11.699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9508 0 0 0 0 0 Q6PJG6 BRAT1_HUMAN BRCA1-associated ATM activator 1 (BRCA1-associated protein required for ATM activation protein 1) BRAT1 BAAT1 C7orf27 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; glucose metabolic process [GO:0006006]; mitochondrion localization [GO:0051646]; positive regulation of cell growth [GO:0030307]; positive regulation of protein phosphorylation [GO:0001934]; response to ionizing radiation [GO:0010212] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; glucose metabolic process [GO:0006006]; mitochondrion localization [GO:0051646]; positive regulation of cell growth [GO:0030307]; positive regulation of protein phosphorylation [GO:0001934]; response to ionizing radiation [GO:0010212] GO:0001934; GO:0005634; GO:0005654; GO:0005737; GO:0006006; GO:0006915; GO:0006974; GO:0008283; GO:0010212; GO:0016020; GO:0016477; GO:0030307; GO:0051646 ALSCLGPTHMGPLALGILKLEHCPQALR 0.96761 -0.2812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.608 0 0 0 0 0 0 12.3472 0 0 0 0 0 18.9951 0 17.7527 0 0 16.3837 0 0 10.7193 0 10.2658 0 0 0 0 0 0 12.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.684 0 0 10.59 0 0 0 0 0 0 0 0 0 0 10.4442 0 0 Q08ET2 SIG14_HUMAN "Sialic acid-binding Ig-like lectin 14, Siglec-14" SIGLEC14 UNQ294/PRO333 Homo sapiens (Human) cell adhesion [GO:0007155] ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0033691; GO:0070821; GO:0101003 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] QGAQVTTERTVQLNVSYAPQNLAISIFFRNGTGTALR 0.96762 -0.0040621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00154 BACH_HUMAN "Cytosolic acyl coenzyme A thioester hydrolase, EC 3.1.2.2 (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase, BACH, hBACH) (CTE-IIa, CTE-II) (Long chain acyl-CoA thioester hydrolase)" ACOT7 BACH Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; protein homodimerization activity [GO:0042803]; acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535] GO:0000062; GO:0005654; GO:0005739; GO:0005829; GO:0006631; GO:0006637; GO:0015937; GO:0016290; GO:0036042; GO:0036114; GO:0036116; GO:0042803; GO:0047617; GO:0051792; GO:0052689; GO:0070062; GO:0102991; GO:1900535 acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; protein homodimerization activity [GO:0042803] MKLLARALR 0.96763 -0.21155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGY2 OR6K2_HUMAN Olfactory receptor 6K2 (Olfactory receptor OR1-17) OR6K2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IHSAGGR 0.96764 -0.2119 0 13.2558 12.8018 0 11.8036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3452 0 0 0 0 0 0 0 0 11.9141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4387 11.3329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4283 0 0 13.588 13.6461 0 0 0 0 0 12.7686 0 13.5278 0 14.9315 0 13.7966 0 0 11.3307 15.1144 0 14.8073 0 0 0 13.2543 11.9382 0 0 11.1768 0 12.6272 0 0 0 0 0 13.5601 0 0 12.1935 0 0 0 0 0 0 0 0 0 0 13.6265 0 0 0 0 0 0 14.5179 0 0 0 0 0 0 12.498 0 0 0 0 0 0 0 0 14.6391 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7346 0 11.4595 0 0 0 0 0 0 0 0 0 0 Q96FV0 LRC46_HUMAN Leucine-rich repeat-containing protein 46 LRRC46 Homo sapiens (Human) positive regulation of protein dephosphorylation [GO:0035307] protein phosphatase type 1 complex [GO:0000164] protein phosphatase type 1 complex [GO:0000164]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of protein dephosphorylation [GO:0035307] GO:0000164; GO:0004865; GO:0035307 protein serine/threonine phosphatase inhibitor activity [GO:0004865] ELEQELSR 0.96765 -1.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9759 12.8577 13.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1386 0 0 0 0 0 0 0 12.5502 13.3771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7731 0 0 0 0 0 0 0 Q9GZK6 OR2J1_HUMAN "Olfactory receptor 2J1 (Hs6M1-4) (Olfactory receptor 6-5, OR6-5)" OR2J1 OR2J1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GAVKRLMGWEWGM 0.96766 -0.33764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4I3 TRABD_HUMAN TraB domain-containing protein (Protein TTG2) TRABD TTG2 PP2447 Homo sapiens (Human) QAARRLELPR 0.96766 -1.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09466 PAEP_HUMAN "Glycodelin, GD (Placental protein 14, PP14) (Pregnancy-associated endometrial alpha-2 globulin, PAEG, PEG) (Progestagen-associated endometrial protein) (Progesterone-associated endometrial protein) (Zona-binding inhibitory factor-1, ZIF-1)" PAEP Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of sperm capacitation [GO:1902491]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; regulation of binding of sperm to zona pellucida [GO:2000359] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; small molecule binding [GO:0036094]; apoptotic process [GO:0006915]; negative regulation of sperm capacitation [GO:1902491]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; regulation of binding of sperm to zona pellucida [GO:2000359] GO:0005576; GO:0005615; GO:0006915; GO:0032725; GO:0036094; GO:1902491; GO:2000359 small molecule binding [GO:0036094] AFRPLPR 0.96767 -1.0557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0167 0 11.5182 15.237 0 15.3134 0 12.0041 0 0 11.9108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9404 16.1083 13.384 14.7021 14.4879 0 0 0 0 14.2833 14.1418 14.435 0 13.3208 13.4719 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7737 13.7717 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7963 14.0329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3614 0 13.3756 0 0 0 0 0 0 14.2874 0 0 0 0 15.8379 0 0 19.0579 0 0 0 0 0 0 Q9BT22 ALG1_HUMAN "Chitobiosyldiphosphodolichol beta-mannosyltransferase, EC 2.4.1.142 (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1, MT-1, hMat-1)" ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486] GO:0000030; GO:0004578; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016020; GO:0016021 chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; mannosyltransferase activity [GO:0000030] AARHVVAVVLGDVGR 0.96769 -0.027758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7857 13.5652 0 0 0 0 13.7334 0 15.0123 0 0 13.5573 12.9644 13.254 0 0 0 0 12.9908 0 0 0 0 0 0 0 0 0 12.7627 0 0 0 0 0 0 0 0 0 0 0 0 12.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3577 0 0 0 0 0 0 0 0 Q9UBF1 MAGC2_HUMAN "Melanoma-associated antigen C2 (Cancer/testis antigen 10, CT10) (Hepatocellular carcinoma-associated antigen 587) (MAGE-C2 antigen) (MAGE-E1 antigen)" MAGEC2 HCA587 MAGEE1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein catabolic process [GO:0030163] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein catabolic process [GO:0030163] GO:0000122; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0031625; GO:0051443 ubiquitin protein ligase binding [GO:0031625] KKVLEFLAK 0.96769 -0.95873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95922 TTLL1_HUMAN "Polyglutamylase complex subunit TTLL1, EC 6.3.2.- (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3, PGs3) (Tubulin--tyrosine ligase-like protein 1)" TTLL1 C22orf7 Homo sapiens (Human) cerebellar Purkinje cell differentiation [GO:0021702]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; cerebellar Purkinje cell differentiation [GO:0021702]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288] GO:0000226; GO:0002395; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005929; GO:0007288; GO:0015631; GO:0018095; GO:0021702; GO:0031514; GO:0036064; GO:0046872; GO:0070740; GO:0120197; GO:0120222 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] AGRSRDSGR 0.9677 -0.027876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.126 0 0 0 0 0 0 0 0 0 0 0 13.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3E5 ARMC9_HUMAN LisH domain-containing protein ARMC9 (Armadillo repeat-containing protein 9) (Melanoma/melanocyte-specific tumor antigen KU-MEL-1) (NS21) ARMC9 KIAA1868 Homo sapiens (Human) cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0005737; GO:0005814; GO:0036064; GO:0045880; GO:0060271; GO:0070062; GO:0097542 ASLAPVKLKDVPLLPSLDYEK 0.96771 -0.85713 0 0 0 0 0 0 0 0 14.0844 0 0 0 0 0 0 0 0 0 0 0 13.674 0 0 13.8963 0 0 0 0 0 0 0 0 10.7551 0 0 0 0 0 10.7107 13.0207 0 0 0 0 0 0 15.8511 0 0 0 13.8469 0 0 0 0 0 11.5712 0 0 11.4269 0 0 0 0 0 0 0 0 0 0 11.4842 0 13.4108 13.6969 0 0 13.6177 0 0 13.9792 0 13.0996 0 11.9877 12.7524 13.9267 0 0 14.5059 0 0 0 11.3724 0 13.8328 14.249 0 0 0 0 12.4732 0 14.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9962 0 0 0 14.2082 0 12.8372 0 0 0 0 0 0 0 0 0 12.8777 0 13.9 0 0 0 10.0531 0 14.1235 13.0669 0 0 0 0 0 12.8317 0 0 0 0 0 13.3802 0 0 0 0 12.8559 0 0 13.3562 0 0 0 13.4927 0 0 0 12.6136 12.3673 12.8874 0 0 0 0 Q9H1A3 METL9_HUMAN "Protein-L-histidine N-pros-methyltransferase, EC 2.1.1.- (DORA reverse strand protein, DREV, DREV1) (Methyltransferase-like protein 9, hMETTL9)" METTL9 DREV CGI-81 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; protein-L-histidine N-pros-methyltransferase activity [GO:0106370] GO:0005739; GO:0005783; GO:0106370 protein-L-histidine N-pros-methyltransferase activity [GO:0106370] ENHQWYVCNR 0.96771 -0.96341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3551 0 0 0 0 13.9341 0 13.8727 14.5576 13.7359 0 14.4491 14.6223 0 13.7104 0 0 13.9221 0 0 0 0 0 14.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06609 RAD51_HUMAN "DNA repair protein RAD51 homolog 1, HsRAD51, hRAD51 (RAD51 homolog A)" RAD51 RAD51A RECA Homo sapiens (Human) cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; histone H2A monoubiquitination [GO:0035518]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; protein autoubiquitination [GO:0051865]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to glucoside [GO:1904631]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; histone H2A monoubiquitination [GO:0035518]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; protein autoubiquitination [GO:0051865]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to glucoside [GO:1904631]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]" GO:0000150; GO:0000152; GO:0000228; GO:0000722; GO:0000724; GO:0000730; GO:0000781; GO:0000785; GO:0000793; GO:0000794; GO:0000800; GO:0001673; GO:0001932; GO:0003682; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005815; GO:0006268; GO:0006281; GO:0006310; GO:0006312; GO:0006974; GO:0007131; GO:0008022; GO:0008094; GO:0009410; GO:0009636; GO:0010165; GO:0010569; GO:0010833; GO:0016605; GO:0017116; GO:0019899; GO:0031297; GO:0032991; GO:0035518; GO:0035861; GO:0036297; GO:0042148; GO:0042802; GO:0048471; GO:0051106; GO:0051321; GO:0051865; GO:0070182; GO:0070192; GO:0071479; GO:0071480; GO:0072711; GO:0072719; GO:0072757; GO:0140664; GO:1904631; GO:1990414; GO:1990426; GO:2000001 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]" KELINIKGISEAK 0.96772 -0.44995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12933 TRAF2_HUMAN "TNF receptor-associated factor 2, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)" TRAF2 TRAP3 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; TRAF2-GSTP1 complex [GO:0097057]; tumor necrosis factor receptor superfamily complex [GO:0002947]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506] CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; TRAF2-GSTP1 complex [GO:0097057]; tumor necrosis factor receptor superfamily complex [GO:0002947]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238 CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] APCCGADVK 0.96772 -0.85837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8723 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWB7 WDFY1_HUMAN "WD repeat and FYVE domain-containing protein 1 (FYVE domain-containing protein localized to endosomes 1, FENS-1) (Phosphoinositide-binding protein 1) (WD40- and FYVE domain-containing protein 1) (Zinc finger FYVE domain-containing protein 17)" WDFY1 FENS1 KIAA1435 WDF1 ZFYVE17 Homo sapiens (Human) positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145] cell junction [GO:0030054]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634] cell junction [GO:0030054]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145] GO:0005545; GO:0005634; GO:0005730; GO:0005769; GO:0005794; GO:0005829; GO:0008270; GO:0030054; GO:0034141; GO:0034145; GO:0043231 1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270] CEQPFFWNIKQMWDTKTLGLR 0.96772 -1.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNU6 CP8B1_HUMAN "7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, EC 1.14.14.139 (7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase) (CYPVIIIB1) (Cytochrome P450 8B1) (Sterol 12-alpha-hydroxylase)" CYP8B1 CYP12 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; positive regulation of intestinal cholesterol absorption [GO:0045797]; response to cholesterol [GO:0070723]; response to nutrient levels [GO:0031667]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase activity [GO:0033779]; 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity [GO:0033778]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; sterol 12-alpha-hydroxylase activity [GO:0008397]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; positive regulation of intestinal cholesterol absorption [GO:0045797]; response to cholesterol [GO:0070723]; response to nutrient levels [GO:0031667]; sterol metabolic process [GO:0016125]" GO:0005506; GO:0005789; GO:0006699; GO:0008397; GO:0016021; GO:0016125; GO:0019825; GO:0020037; GO:0031667; GO:0033778; GO:0033779; GO:0038183; GO:0045797; GO:0070723 "5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase activity [GO:0033779]; 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity [GO:0033778]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; sterol 12-alpha-hydroxylase activity [GO:0008397]" EWLEVGRLQR 0.96772 -1.0364 0 0 0 0 0 0 0 0 0 0 0 14.6878 0 0 0 0 12.2757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1604 0 0 13.7708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3435 0 0 0 0 0 0 0 0 0 0 0 14.3383 0 14.9972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2581 14.4035 0 0 0 0 0 14.9407 0 0 0 0 0 0 0 0 0 0 12.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3974 0 0 0 0 0 0 A6NFA0 F205C_HUMAN Protein FAM205C (FAM205C pseudogene) FAM205C FAM205CP Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CHRRVQQK 0.96774 -0.94108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42127 ASIP_HUMAN "Agouti-signaling protein, ASP (Agouti switch protein)" ASIP AGTI AGTIL ASP Homo sapiens (Human) adult feeding behavior [GO:0008343]; cell-cell signaling [GO:0007267]; generation of precursor metabolites and energy [GO:0006091]; genomic imprinting [GO:0071514]; hormone-mediated signaling pathway [GO:0009755]; melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; positive regulation of melanin biosynthetic process [GO:0048023]; signal transduction [GO:0007165] extracellular space [GO:0005615] extracellular space [GO:0005615]; melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782]; adult feeding behavior [GO:0008343]; cell-cell signaling [GO:0007267]; generation of precursor metabolites and energy [GO:0006091]; genomic imprinting [GO:0071514]; hormone-mediated signaling pathway [GO:0009755]; melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; positive regulation of melanin biosynthetic process [GO:0048023]; signal transduction [GO:0007165] GO:0005102; GO:0005184; GO:0005615; GO:0006091; GO:0007165; GO:0007267; GO:0008343; GO:0009755; GO:0031779; GO:0031781; GO:0031782; GO:0032402; GO:0032438; GO:0042438; GO:0048023; GO:0071514 melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782] LRDDRSLR 0.96775 -0.4177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9453 0 13.7113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8724 0 14.171 0 0 0 14.3729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V86 PIM3_HUMAN "Serine/threonine-protein kinase pim-3, EC 2.7.11.1" PIM3 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346] GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0007346; GO:0043066; GO:0046777; GO:0061179; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ERVTEWGSLGGATVPLEVVLLRK 0.96775 -0.28085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.177 0 0 0 0 0 0 0 0 0 9.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02511 CRYAB_HUMAN "Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5, HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component)" CRYAB CRYA2 HSPB5 Homo sapiens (Human) "apoptotic process involved in morphogenesis [GO:0060561]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; microtubule polymerization or depolymerization [GO:0031109]; multicellular organism aging [GO:0010259]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cell death [GO:0010941]; response to estradiol [GO:0032355]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; tubulin complex assembly [GO:0007021]" actin filament bundle [GO:0032432]; axon [GO:0030424]; cardiac myofibril [GO:0097512]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; M band [GO:0031430]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; Z disc [GO:0030018] "actin filament bundle [GO:0032432]; axon [GO:0030424]; cardiac myofibril [GO:0097512]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; M band [GO:0031430]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; Z disc [GO:0030018]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082]; apoptotic process involved in morphogenesis [GO:0060561]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; microtubule polymerization or depolymerization [GO:0031109]; multicellular organism aging [GO:0010259]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of cell death [GO:0010941]; response to estradiol [GO:0032355]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; tubulin complex assembly [GO:0007021]" GO:0001540; GO:0001666; GO:0002088; GO:0005198; GO:0005212; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005764; GO:0005794; GO:0005829; GO:0006457; GO:0006936; GO:0007021; GO:0007517; GO:0008017; GO:0009408; GO:0009986; GO:0010259; GO:0010629; GO:0010941; GO:0014069; GO:0015630; GO:0030018; GO:0030308; GO:0030424; GO:0031109; GO:0031333; GO:0031430; GO:0032355; GO:0032387; GO:0032432; GO:0032991; GO:0042026; GO:0042542; GO:0042802; GO:0042803; GO:0043066; GO:0043154; GO:0043197; GO:0043204; GO:0044877; GO:0045892; GO:0046872; GO:0050821; GO:0051082; GO:0051403; GO:0060561; GO:0070062; GO:0071480; GO:0097060; GO:0097512; GO:1905907; GO:2000378 amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082] APSWFDTGLSEMRLEK 0.96779 -0.33497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P84157 MXRA7_HUMAN Matrix-remodeling-associated protein 7 MXRA7 Homo sapiens (Human) collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] GO:0005783; GO:0016021; GO:0062023 EAPAELLAALPALATALALLLAWLLVR 0.96779 3.2543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.991 0 0 0 0 12.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3505 13.8235 0 13.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3019 0 0 0 0 0 0 0 0 14.1798 0 0 0 0 0 0 0 0 0 15.1102 11.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9858 0 0 12.5092 0 0 0 0 0 0 0 0 0 0 13.1073 0 0 12.7105 0 0 0 0 0 0 0 0 0 0 11.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15742 NAB2_HUMAN "NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein, Protein MADER)" NAB2 MADER Homo sapiens (Human) "endochondral ossification [GO:0001958]; myelination [GO:0042552]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of tau-protein kinase activity [GO:1902949]; regulation of epidermis development [GO:0045682]; regulation of transcription, DNA-templated [GO:0006355]; Schwann cell differentiation [GO:0014037]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; endochondral ossification [GO:0001958]; myelination [GO:0042552]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of tau-protein kinase activity [GO:1902949]; regulation of epidermis development [GO:0045682]; regulation of transcription, DNA-templated [GO:0006355]; Schwann cell differentiation [GO:0014037]" GO:0001958; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006355; GO:0014037; GO:0016480; GO:0042552; GO:0042802; GO:0045682; GO:1902949 identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] LEPEMVR 0.96779 -1.0553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTZ1 OVCH2_HUMAN "Ovochymase-2, EC 3.4.21.- (Oviductin)" OVCH2 OVTN Homo sapiens (Human) fertilization [GO:0009566]; proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; fertilization [GO:0009566]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0009566; GO:0046872 metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] AGKKIELPTLWFPVLILVM 0.96779 -0.84625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1235 0 0 0 14.3622 0 0 0 0 0 0 0 0 0 13.1883 0 0 0 0 0 0 0 0 0 13.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6657 0 0 0 0 12.4813 0 0 0 0 0 0 0 0 0 0 0 10.788 0 12.1465 0 0 13.4951 0 0 0 0 0 0 12.9136 0 0 0 0 0 0 0 0 13.3873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4621 0 0 0 0 0 0 0 13.284 Q7Z4J2 GL6D1_HUMAN "Putative glycosyltransferase 6 domain-containing protein 1, EC 2.4.1.- (Galactosyltransferase family 6 domain-containing 1)" GLT6D1 GLTDC1 GT6M7 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; hexosyltransferase activity [GO:0016758]; carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259] GO:0005794; GO:0005975; GO:0016021; GO:0016758; GO:0030259; GO:0031982 hexosyltransferase activity [GO:0016758] HFMTGYRVIFYIMVDAFFKLPDIEPSPLR 0.9678 -0.21443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92539 LPIN2_HUMAN "Phosphatidate phosphatase LPIN2, EC 3.1.3.4 (Lipin-2)" LPIN2 KIAA0249 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944 phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] EEQAASAAAEDTCDVGVSSDDDK 0.96782 -0.95756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RU48 SMCO3_HUMAN Single-pass membrane and coiled-coil domain-containing protein 3 SMCO3 C12orf69 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IAIVQKVISVILGEATSAASAVAVK 0.96783 -0.024625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0984 0 0 0 0 15.7407 0 0 13.1943 0 0 0 0 0 0 0 0 0 12.8239 0 0 13.3914 0 0 0 0 13.0518 13.2295 0 0 0 0 0 13.764 0 0 0 0 0 0 12.9503 0 12.4358 0 12.6393 0 0 0 0 0 0 0 0 13.5693 0 12.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7792 0 0 0 0 0 0 0 0 0 0 0 0 P35226 BMI1_HUMAN Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) (RING finger protein 51) BMI1 PCGF4 RNF51 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-1 [GO:0071347]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression [GO:0010468]; rostrocaudal neural tube patterning [GO:0021903]; segment specification [GO:0007379]; somatic stem cell division [GO:0048103]" cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151] "cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; ubiquitin ligase complex [GO:0000151]; promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-1 [GO:0071347]; DNA methylation [GO:0006306]; embryonic skeletal system morphogenesis [GO:0048704]; hemopoiesis [GO:0030097]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression [GO:0010468]; rostrocaudal neural tube patterning [GO:0021903]; segment specification [GO:0007379]; somatic stem cell division [GO:0048103]" GO:0000122; GO:0000151; GO:0000792; GO:0000978; GO:0001701; GO:0005634; GO:0005654; GO:0005829; GO:0006306; GO:0006959; GO:0007379; GO:0007420; GO:0008270; GO:0010468; GO:0016573; GO:0016604; GO:0021903; GO:0030097; GO:0030890; GO:0031519; GO:0033092; GO:0035102; GO:0036353; GO:0045814; GO:0048103; GO:0048146; GO:0048704; GO:0051443; GO:0071347; GO:0071535; GO:0071549; GO:0097027; GO:0097190; GO:1990841; GO:2000011; GO:2001234 promoter-specific chromatin binding [GO:1990841]; RING-like zinc finger domain binding [GO:0071535]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-protein transferase activator activity [GO:0097027]; zinc ion binding [GO:0008270] CPAAMTVMHLRK 0.96783 -0.025341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0246 0 0 0 0 0 0 0 0 17.5672 0 0 0 0 0 11.7143 0 0 0 15.3472 0 0 0 12.7102 0 0 0 0 14.9417 0 13.1761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1189 13.3593 0 11.9992 19.0156 0 0 0 11.4863 0 11.3096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8605 13.2852 0 0 13.1833 0 0 0 0 0 0 0 0 0 0 0 11.9705 11.612 0 0 0 0 0 0 0 0 Q96RR4 KKCC2_HUMAN "Calcium/calmodulin-dependent protein kinase kinase 2, CaM-KK 2, CaM-kinase kinase 2, CaMKK 2, EC 2.7.11.17 (Calcium/calmodulin-dependent protein kinase kinase beta, CaM-KK beta, CaM-kinase kinase beta, CaMKK beta)" CAMKK2 CAMKKB KIAA0787 Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]; signal transduction [GO:0007165]" cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; calcium-mediated signaling [GO:0019722]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to reactive oxygen species [GO:0034614]; MAPK cascade [GO:0000165]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase activity [GO:0045859]; signal transduction [GO:0007165]" GO:0000165; GO:0001934; GO:0004674; GO:0004683; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007165; GO:0019722; GO:0032147; GO:0034614; GO:0043005; GO:0045859; GO:0045893; GO:0046777; GO:0061762; GO:0106310; GO:1903599 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] ECESLSELKEARQR 0.96784 -1.0336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3725 0 0 0 11.772 0 0 0 0 11.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2501 0 0 0 0 0 0 14.3583 10.5446 0 0 0 0 11.3272 0 0 0 0 14.0709 0 0 13.7656 0 0 0 0 14.6547 0 14.6488 0 14.39 0 0 0 14.5242 0 14.9841 0 14.2468 13.7694 0 0 15.2853 0 0 0 14.4871 0 0 15.1301 13.6413 0 0 14.609 14.6704 0 0 0 0 0 14.5355 0 14.2366 0 0 13.6986 0 0 0 0 0 0 0 0 12.9264 0 13.1255 14.6912 0 0 0 0 0 0 0 0 13.9792 14.2959 14.7003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3701 0 0 0 0 0 0 0 0 Q9NW68 BSDC1_HUMAN BSD domain-containing protein 1 BSDC1 UNQ2494/PRO5781 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 EAKVPVAK 0.96784 -0.96503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3466 0 0 0 0 0 0 0 0 9.97327 0 0 0 0 0 0 13.5746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3719 0 0 0 0 0 0 0 0 0 0 0 0 0 P31644 GBRA5_HUMAN Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) GABRA5 Homo sapiens (Human) "associative learning [GO:0008306]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0001662; GO:0004890; GO:0005231; GO:0005237; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007420; GO:0007605; GO:0008306; GO:0022851; GO:0030594; GO:0032590; GO:0032809; GO:0034220; GO:0034707; GO:0038023; GO:0042391; GO:0043005; GO:0043524; GO:0045202; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0060119; GO:0060384; GO:0070161; GO:0090102; GO:0098794; GO:0098982; GO:0099056; GO:0099060; GO:1902476; GO:1902711; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ILDGLLDGYDNRLRPGLGER 0.96785 -0.44992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3785 0 14.8206 0 0 14.9975 0 14.3782 14.7446 14.0287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0093 0 0 12.929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3857 0 0 0 O95983 MBD3_HUMAN Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3) MBD3 Homo sapiens (Human) "aging [GO:0007568]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA methylation [GO:0044030]; regulation of stem cell differentiation [GO:2000736]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]; tissue development [GO:0009888]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methyl-CpG binding [GO:0008327]; aging [GO:0007568]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA methylation [GO:0044030]; regulation of stem cell differentiation [GO:2000736]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]; tissue development [GO:0009888]" GO:0000122; GO:0000785; GO:0000792; GO:0001701; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006338; GO:0006346; GO:0007420; GO:0007507; GO:0007568; GO:0008327; GO:0009888; GO:0016573; GO:0016575; GO:0016581; GO:0031667; GO:0032355; GO:0032991; GO:0042659; GO:0044030; GO:0045892; GO:0045893; GO:0048568; GO:2000736 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methyl-CpG binding [GO:0008327] ACAEDDDEEDEEEEEEEPDPDPEMEHV 0.96786 -0.94073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9559 13.2361 0 0 13.9104 0 0 0 0 0 0 0 0 0 0 0 14.8942 0 0 0 0 11.8121 0 0 0 14.3258 0 0 12.2241 12.3703 0 0 0 0 0 0 0 0 0 13.5678 0 0 12.2916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3254 0 0 0 13.9679 0 Q01860 PO5F1_HUMAN "POU domain, class 5, transcription factor 1 (Octamer-binding protein 3, Oct-3) (Octamer-binding protein 4, Oct-4) (Octamer-binding transcription factor 3, OTF-3)" POU5F1 OCT3 OCT4 OTF3 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; BMP signaling pathway involved in heart induction [GO:0003130]; cardiac cell fate determination [GO:0060913]; cell fate commitment involved in formation of primary germ layer [GO:0060795]; endodermal cell fate specification [GO:0001714]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of asymmetric cell division [GO:0009786]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]; regulation of gene expression [GO:0010468]; regulation of heart induction by regulation of canonical Wnt signaling pathway [GO:0090081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to wounding [GO:0009611]; somatic stem cell population maintenance [GO:0035019]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; BMP signaling pathway involved in heart induction [GO:0003130]; cardiac cell fate determination [GO:0060913]; cell fate commitment involved in formation of primary germ layer [GO:0060795]; endodermal cell fate specification [GO:0001714]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of asymmetric cell division [GO:0009786]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]; regulation of gene expression [GO:0010468]; regulation of heart induction by regulation of canonical Wnt signaling pathway [GO:0090081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to wounding [GO:0009611]; somatic stem cell population maintenance [GO:0035019]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001714; GO:0001824; GO:0003130; GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0006355; GO:0006357; GO:0009611; GO:0009653; GO:0009786; GO:0010468; GO:0031625; GO:0035019; GO:0035198; GO:0043565; GO:0045944; GO:0060391; GO:0060795; GO:0060913; GO:0060965; GO:0061629; GO:0090081; GO:0090263; GO:0090308; GO:1902894; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]" FEALQLSFKNMCKLR 0.9679 -0.41906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9215 0 0 0 0 0 0 0 14.9508 0 0 0 14.0527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC94 ACTL9_HUMAN Actin-like protein 9 ACTL9 ACTL7C HSD21 Homo sapiens (Human) acrosome assembly [GO:0001675]; fertilization [GO:0009566]; single fertilization [GO:0007338] acrosomal vesicle [GO:0001669]; dynactin complex [GO:0005869]; perinuclear theca [GO:0033011]; sperm head [GO:0061827] acrosomal vesicle [GO:0001669]; dynactin complex [GO:0005869]; perinuclear theca [GO:0033011]; sperm head [GO:0061827]; acrosome assembly [GO:0001675]; fertilization [GO:0009566]; single fertilization [GO:0007338] GO:0001669; GO:0001675; GO:0005869; GO:0007338; GO:0009566; GO:0033011; GO:0061827 EKLVEVAFESLR 0.9679 -0.41928 0 0 0 0 0 0 0 0 0 0 0 11.4064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.785 0 0 0 0 0 0 0 0 0 0 10.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5819 0 0 0 0 0 0 12.7098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.422 0 0 0 0 0 0 0 12.1111 0 19.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3296 0 0 0 0 0 0 0 0 0 Q9NS86 LANC2_HUMAN LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]" cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; carbohydrate metabolic process [GO:0005975]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]" GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0032266; GO:0045892; GO:0070273 ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] EAMECSDVIWQRGLLRK 0.96791 -0.84624 0 0 0 0 14.0315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14613 BORG1_HUMAN Cdc42 effector protein 2 (Binder of Rho GTPases 1) CDC42EP2 BORG1 CEP2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; opioid peptide activity [GO:0001515]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] GO:0001515; GO:0005096; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007015; GO:0007266; GO:0008360; GO:0012505; GO:0015630; GO:0016020; GO:0030036; GO:0030838; GO:0031267; GO:0031274; GO:0031334; GO:0045335; GO:0071346 GTPase activator activity [GO:0005096]; opioid peptide activity [GO:0001515]; small GTPase binding [GO:0031267] LRDLLSSDMISPPLGDFR 0.96792 -0.84814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9221 0 0 0 12.4972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.245 0 0 0 0 0 0 0 0 0 0 0 0 15.922 0 0 0 0 0 0 0 0 14.2652 0 0 16.2283 0 0 0 0 0 0 0 0 0 0 0 0 15.3825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1572 0 0 14.9592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.729 0 0 15.3226 0 0 0 0 0 Q96DZ1 ERLEC_HUMAN "Endoplasmic reticulum lectin 1 (ER lectin, Erlectin) (XTP3-transactivated gene B protein)" ERLEC1 C2orf30 XTP3TPB UNQ1878/PRO4321 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]" endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322] "endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; unfolded protein binding [GO:0051082]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0005788; GO:0030433; GO:0030968; GO:0036503; GO:0044322; GO:0051082; GO:1904153 unfolded protein binding [GO:0051082] FPAIHKSIAIGSQPVLTVGTTHISK 0.96792 -0.84702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4774 13.1222 13.4966 13.6647 12.4985 0 0 13.1228 0 13.2174 12.8917 12.8464 0 0 12.5397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1979 0 12.6003 0 13.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2071 0 0 0 P0C7N1 OR8U8_HUMAN Olfactory receptor 8U8 OR8U8 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] DVKDALKK 0.96793 -0.33396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30047 GFRP_HUMAN "GTP cyclohydrolase 1 feedback regulatory protein, GFRP (GTP cyclohydrolase I feedback regulatory protein) (p35)" GCHFR GFRP Homo sapiens (Human) negative regulation of biosynthetic process [GO:0009890]; negative regulation of GTP cyclohydrolase I activity [GO:0043105]; neurotransmitter metabolic process [GO:0042133]; nitric oxide biosynthetic process [GO:0006809]; protein-containing complex assembly [GO:0065003] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome [GO:0042470]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; melanosome [GO:0042470]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; amino acid binding [GO:0016597]; enzyme inhibitor activity [GO:0004857]; GTP cyclohydrolase binding [GO:0044549]; GTP-dependent protein binding [GO:0030742]; protein-containing complex binding [GO:0044877]; negative regulation of biosynthetic process [GO:0009890]; negative regulation of GTP cyclohydrolase I activity [GO:0043105]; neurotransmitter metabolic process [GO:0042133]; nitric oxide biosynthetic process [GO:0006809]; protein-containing complex assembly [GO:0065003] GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006809; GO:0009890; GO:0016597; GO:0030425; GO:0030742; GO:0031965; GO:0032991; GO:0042133; GO:0042470; GO:0043105; GO:0044549; GO:0044877; GO:0065003 amino acid binding [GO:0016597]; enzyme inhibitor activity [GO:0004857]; GTP cyclohydrolase binding [GO:0044549]; GTP-dependent protein binding [GO:0030742]; protein-containing complex binding [GO:0044877] IVLDKLERR 0.96794 -0.21265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.088 0 13.5175 0 13.5522 0 0 0 0 0 0 0 0 0 0 13.0728 0 0 0 0 0 0 0 0 13.2027 0 0 0 0 0 0 13.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6552 0 0 12.0016 0 0 0 0 0 0 0 0 0 0 0 Q13886 KLF9_HUMAN "Krueppel-like factor 9 (Basic transcription element-binding protein 1, BTE-binding protein 1) (GC-box-binding protein 1) (Transcription factor BTEB1)" KLF9 BTEB BTEB1 Homo sapiens (Human) cellular response to cortisol stimulus [GO:0071387]; cellular response to thyroid hormone stimulus [GO:0097067]; circadian rhythm [GO:0007623]; negative regulation of keratinocyte proliferation [GO:0010839]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to cortisol stimulus [GO:0071387]; cellular response to thyroid hormone stimulus [GO:0097067]; circadian rhythm [GO:0007623]; negative regulation of keratinocyte proliferation [GO:0010839]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0007623; GO:0010839; GO:0046872; GO:0071387; GO:0097067 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHYRVHTGER 0.96794 -0.33626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0193 0 0 0 0 0 0 0 0 12.9473 0 0 0 0 0 0 0 0 12.6692 0 0 0 13.2028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5786 0 0 12.6799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0559 0 0 0 0 0 0 0 0 0 0 Q9NPI9 KCJ16_HUMAN "Inward rectifier potassium channel 16 (Inward rectifier K(+) channel Kir5.1) (Potassium channel, inwardly rectifying subfamily J member 16)" KCNJ16 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005886; GO:0006813; GO:0008076; GO:0016323; GO:0034765; GO:1990573 inward rectifier potassium channel activity [GO:0005242] AQTIRFSYFALIGMR 0.96794 -0.95732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6258 14.9167 0 0 0 0 0 0 0 0 0 0 0 14.9211 0 0 0 0 0 0 0 0 14.9362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8749 0 0 0 0 0 0 0 0 0 0 0 Q5TEZ5 CF163_HUMAN Uncharacterized protein C6orf163 C6orf163 Homo sapiens (Human) AEAEVWAQANER 0.96795 -1.0311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8552 9.74106 10.7552 11.1873 0 11.6119 0 0 0 0 0 11.7214 11.3371 0 11.5225 0 0 11.322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6518 16.8881 13.2274 0 0 0 0 0 13.4303 14.0883 0 0 12.4066 0 0 12.6561 0 0 0 13.5881 0 0 10.489 13.1562 15.4148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5915 0 12.5511 0 14.1111 0 12.605 12.7169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3P7 GCP60_HUMAN "Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1, GOCAP1) (Golgi phosphoprotein 1, GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) [Cleaved into: Golgi resident protein GCP60, N-terminally processed ]" ACBD3 GCP60 GOCAP1 GOLPH1 Homo sapiens (Human) steroid biosynthetic process [GO:0006694] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694] GO:0000062; GO:0000139; GO:0005739; GO:0005794; GO:0006694; GO:0016020; GO:0034237 fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237] LLNRCCHLFSTYVASHK 0.96795 -0.21402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6006 0 13.9075 0 0 0 0 0 0 0 0 0 0 13.7853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9077 0 0 12.9301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UX7 URP2_HUMAN Fermitin family homolog 3 (Kindlin-3) (MIG2-like protein) (Unc-112-related protein 2) FERMT3 KIND3 MIG2B URP2 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446] cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102] cell projection [GO:0042995]; cell-substrate junction [GO:0030055]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; podosome [GO:0002102]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; platelet aggregation [GO:0070527]; positive regulation of cell migration [GO:0030335]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0002102; GO:0005178; GO:0005576; GO:0007159; GO:0007160; GO:0007229; GO:0016020; GO:0030055; GO:0030335; GO:0031093; GO:0033622; GO:0033632; GO:0034446; GO:0042995; GO:0070062; GO:0070527 integrin binding [GO:0005178] AKQLTPRILEAHQNVAQLSLAEAQLR 0.96796 -1.0335 0 0 0 0 0 0 0 0 10.5022 0 0 0 0 0 0 0 14.4679 0 0 0 0 0 12.6953 0 0 0 0 0 0 0 12.6906 0 12.8367 0 0 13.0798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3699 0 0 0 0 0 0 0 0 0 0 14.0092 0 15.6943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6269 0 16.1363 0 0 0 0 16.0057 0 0 0 0 0 0 0 0 0 14.4838 0 0 0 0 0 0 0 0 0 0 0 0 0 14.909 0 0 15.2531 0 15.0532 0 0 0 11.9658 0 0 0 12.207 0 0 0 0 0 10.3616 0 0 0 0 0 11.4535 0 0 0 0 0 11.9708 0 0 0 0 0 0 15.2755 0 0 0 0 0 14.8801 0 Q96IM9 DYDC2_HUMAN DPY30 domain-containing protein 2 DYDC2 Homo sapiens (Human) histone H3-K4 methylation [GO:0051568] MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188] MLL3/4 complex [GO:0044666]; Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568] GO:0044666; GO:0048188; GO:0051568 AKEENREK 0.96796 -0.85365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01019 ANGT_HUMAN "Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I, Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II, Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III, Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV, Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4 ]" AGT SERPINA8 Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; aging [GO:0007568]; angiotensin-activated signaling pathway [GO:0038166]; angiotensin-mediated drinking behavior [GO:0003051]; artery smooth muscle contraction [GO:0014824]; associative learning [GO:0008306]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; fibroblast proliferation [GO:0048144]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; kidney development [GO:0001822]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of gene expression [GO:0010629]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of tissue remodeling [GO:0034104]; nitric oxide mediated signal transduction [GO:0007263]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of blood pressure [GO:0045777]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of L-arginine import across plasma membrane [GO:1905589]; positive regulation of L-lysine import across plasma membrane [GO:1905010]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of membrane hyperpolarization [GO:1902632]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of blood volume by renin-angiotensin [GO:0002016]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac conduction [GO:1903779]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of extracellular matrix assembly [GO:1901201]; regulation of heart rate [GO:0002027]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of norepinephrine secretion [GO:0014061]; regulation of renal output by angiotensin [GO:0002019]; regulation of renal sodium excretion [GO:0035813]; regulation of transmission of nerve impulse [GO:0051969]; regulation of vasoconstriction [GO:0019229]; renal system process [GO:0003014]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to estradiol [GO:0032355]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; smooth muscle cell proliferation [GO:0048659]; stress-activated MAPK cascade [GO:0051403]; uterine smooth muscle contraction [GO:0070471]; vasodilation [GO:0042311]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor ligand activity [GO:0048018]; serine-type endopeptidase inhibitor activity [GO:0004867]; sodium channel regulator activity [GO:0017080]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; type 1 angiotensin receptor binding [GO:0031702]; type 2 angiotensin receptor binding [GO:0031703]; activation of phospholipase C activity [GO:0007202]; aging [GO:0007568]; angiotensin-activated signaling pathway [GO:0038166]; angiotensin-mediated drinking behavior [GO:0003051]; artery smooth muscle contraction [GO:0014824]; associative learning [GO:0008306]; blood vessel remodeling [GO:0001974]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; fibroblast proliferation [GO:0048144]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; kidney development [GO:0001822]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of gene expression [GO:0010629]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of tissue remodeling [GO:0034104]; nitric oxide mediated signal transduction [GO:0007263]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of blood pressure [GO:0045777]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of L-arginine import across plasma membrane [GO:1905589]; positive regulation of L-lysine import across plasma membrane [GO:1905010]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of membrane hyperpolarization [GO:1902632]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of blood volume by renin-angiotensin [GO:0002016]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac conduction [GO:1903779]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of extracellular matrix assembly [GO:1901201]; regulation of heart rate [GO:0002027]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of norepinephrine secretion [GO:0014061]; regulation of renal output by angiotensin [GO:0002019]; regulation of renal sodium excretion [GO:0035813]; regulation of transmission of nerve impulse [GO:0051969]; regulation of vasoconstriction [GO:0019229]; renal system process [GO:0003014]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to estradiol [GO:0032355]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; smooth muscle cell proliferation [GO:0048659]; stress-activated MAPK cascade [GO:0051403]; uterine smooth muscle contraction [GO:0070471]; vasodilation [GO:0042311]" GO:0001558; GO:0001819; GO:0001822; GO:0001974; GO:0002016; GO:0002018; GO:0002019; GO:0002027; GO:0002034; GO:0003014; GO:0003051; GO:0003331; GO:0004867; GO:0005179; GO:0005576; GO:0005615; GO:0005829; GO:0006606; GO:0006883; GO:0007166; GO:0007186; GO:0007199; GO:0007200; GO:0007202; GO:0007204; GO:0007263; GO:0007267; GO:0007565; GO:0007568; GO:0008083; GO:0008217; GO:0008306; GO:0010536; GO:0010595; GO:0010613; GO:0010629; GO:0010666; GO:0010744; GO:0010951; GO:0010976; GO:0014061; GO:0014068; GO:0014824; GO:0014873; GO:0016176; GO:0016525; GO:0017080; GO:0019229; GO:0030308; GO:0031702; GO:0031703; GO:0032355; GO:0032930; GO:0033864; GO:0034104; GO:0034374; GO:0035106; GO:0035813; GO:0035815; GO:0038166; GO:0042127; GO:0042311; GO:0042981; GO:0043407; GO:0045429; GO:0045742; GO:0045777; GO:0045893; GO:0046628; GO:0048018; GO:0048144; GO:0048146; GO:0048169; GO:0048659; GO:0050729; GO:0050731; GO:0051092; GO:0051247; GO:0051387; GO:0051403; GO:0051924; GO:0051969; GO:0061049; GO:0061098; GO:0062023; GO:0070062; GO:0070371; GO:0070471; GO:0071260; GO:0072562; GO:0090190; GO:1901201; GO:1902632; GO:1903598; GO:1903779; GO:1904385; GO:1904707; GO:1904754; GO:1905010; GO:1905589; GO:1905920; GO:2000379; GO:2000650; GO:2001238 growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor ligand activity [GO:0048018]; serine-type endopeptidase inhibitor activity [GO:0004867]; sodium channel regulator activity [GO:0017080]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; type 1 angiotensin receptor binding [GO:0031702]; type 2 angiotensin receptor binding [GO:0031703] ANAGKPK 0.96798 -0.4484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.432 0 0 0 0 0 0 0 0 0 13.8381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4863 0 0 13.8756 0 0 0 0 0 11.2265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2675 0 0 14.6234 P0CW27 CC166_HUMAN Coiled-coil domain-containing protein 166 CCDC166 Homo sapiens (Human) ALVAHTQAIK 0.96798 -0.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8104 0 13.2033 0 0 0 0 0 0 0 0 0 11.4814 0 0 0 0 0 0 0 12.555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5271 0 0 0 0 12.0535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.837 0 0 0 11.8614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3814 0 0 0 11.6826 0 13.248 0 0 0 0 0 0 0 Q9H963 ZN702_HUMAN Putative zinc finger protein 702 ZNF702P ZNF702 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AFNCSSLLKK 0.96798 -0.24362 0 0 0 0 0 0 0 0 0 0 0 0 12.4958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.924 0 0 0 0 0 0 0 0 0 14.121 0 0 0 13.1789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1126 0 13.2818 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8433 0 0 0 0 0 0 0 0 0 0 0 12.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9957 0 12.9071 0 0 Q9UI14 PRAF1_HUMAN Prenylated Rab acceptor protein 1 (PRA1 family protein 1) RABAC1 PRA1 PRAF1 Homo sapiens (Human) anchoring junction [GO:0070161]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022] GO:0005794; GO:0005886; GO:0008021; GO:0008022; GO:0016020; GO:0016021; GO:0042802; GO:0070064; GO:0070161 identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022] PRNLGELCQRLVR 0.968 -0.94528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.62222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JWF8 ACL10_HUMAN Actin-like protein 10 ACTL10 C20orf134 Homo sapiens (Human) dynactin complex [GO:0005869] dynactin complex [GO:0005869] GO:0005869 ALQKMPKTLR 0.96801 -0.27962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7378 0 14.9745 0 0 0 0 0 0 13.4871 0 0 0 0 Q96N58 ZN578_HUMAN Zinc finger protein 578 ZNF578 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHTSEKPYKCNECGK 0.96801 -0.97681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7824 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9279 0 0 0 12.4143 0 0 0 0 0 10.9915 11.4481 0 0 0 15.791 0 0 0 11.6305 0 12.5766 13.2151 0 12.1571 0 0 0 0 0 11.8789 11.1551 0 0 0 0 13.9727 13.4105 0 0 0 0 10.835 0 0 0 0 0 10.1214 0 0 13.4286 0 15.0698 0 11.179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5005 0 14.5301 0 0 0 0 0 0 0 0 13.7246 0 0 0 13.7661 13.5515 0 0 0 0 11.3453 0 0 0 0 0 0 0 0 0 0 0 13.4176 0 0 0 0 0 0 0 Q9NR50 EI2BG_HUMAN Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma) EIF2B3 Homo sapiens (Human) cytoplasmic translational initiation [GO:0002183]; oligodendrocyte development [GO:0014003]; regulation of catalytic activity [GO:0050790]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor complex [GO:0032045] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; oligodendrocyte development [GO:0014003]; regulation of catalytic activity [GO:0050790]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] GO:0002183; GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0016779; GO:0032045; GO:0043434; GO:0050790; GO:0050852 nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743] FHTGLVDAHLYCLKK 0.96802 -0.2213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3758 0 0 0 0 0 0 0 0 0 0 15.2064 0 0 0 0 0 0 0 14.3765 14.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFZ6 VN1R2_HUMAN "Vomeronasal type-1 receptor 2 (G-protein coupled receptor GPCR25, hGPCR25) (V1r-like receptor 2)" VN1R2 V1RL2 Homo sapiens (Human) response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pheromone receptor activity [GO:0016503]; response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] GO:0005886; GO:0007606; GO:0016021; GO:0016503; GO:0019236 pheromone receptor activity [GO:0016503] HLTVADSLVILSKR 0.96803 -0.41884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30041 PRDX6_HUMAN "Peroxiredoxin-6, EC 1.11.1.27 (1-Cys peroxiredoxin, 1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2, aiPLA2, EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5, LPC acyltransferase 5, LPCAT-5, Lyso-PC acyltransferase 5, EC 2.3.1.23) (Non-selenium glutathione peroxidase, NSGPx) (Red blood cells page spot 12)" PRDX6 AOP2 KIAA0106 Homo sapiens (Human) "cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]" azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipase A2 activity [GO:0004623]; thioredoxin peroxidase activity [GO:0008379]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]" GO:0004602; GO:0004623; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006979; GO:0008379; GO:0016020; GO:0031625; GO:0035578; GO:0042802; GO:0045296; GO:0045454; GO:0046475; GO:0047184; GO:0047499; GO:0048026; GO:0048471; GO:0070062; GO:0098869 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipase A2 activity [GO:0004623]; thioredoxin peroxidase activity [GO:0008379]; ubiquitin protein ligase binding [GO:0031625] DGDSVMVLPTIPEEEAK 0.96804 -0.84605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7788 0 0 0 0 0 0 13.5396 13.3636 13.3884 0 0 0 0 0 0 0 0 0 13.3308 12.3492 0 0 0 12.8916 0 0 0 0 0 0 0 0 0 0 0 13.5097 0 0 0 0 0 0 0 0 13.7782 0 0 0 0 0 0 0 0 0 0 0 0 12.3971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2461 0 0 0 0 0 P62699 YPEL5_HUMAN Protein yippee-like 5 YPEL5 CGI-127 Homo sapiens (Human) cell population proliferation [GO:0008283] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell population proliferation [GO:0008283] GO:0000151; GO:0005576; GO:0005634; GO:0005815; GO:0008283; GO:0030496; GO:0046872; GO:0097431; GO:1904724; GO:1904813 metal ion binding [GO:0046872] ESEGFEEHVPSDNS 0.96804 -0.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16720 AT2B3_HUMAN "Plasma membrane calcium-transporting ATPase 3, PMCA3, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3)" ATP2B3 Homo sapiens (Human) calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480] anchoring junction [GO:0070161]; extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; parallel fiber [GO:1990032]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; parallel fiber [GO:1990032]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0006874; GO:0015085; GO:0016887; GO:0019829; GO:0030165; GO:0034220; GO:0043231; GO:0046872; GO:0051480; GO:0070161; GO:0098688; GO:0098978; GO:0098982; GO:0099056; GO:1903561; GO:1903779; GO:1905056; GO:1990032; GO:1990034 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165] DEMTDEELAEGEEEIDHAER 0.96804 4.786 0 0 0 0 0 0 0 0 0 0 0 0 13.619 0 0 0 0 13.9352 0 0 12.5996 0 0 0 0 0 0 0 13.8293 0 0 13.3856 11.741 9.56773 0 0 0 0 0 0 0 0 11.4648 13.917 0 0 0 13.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.083 0 0 0 0 0 0 0 0 0 0 0 13.1474 13.569 0 0 13.1677 0 0 0 0 0 12.2003 0 0 0 13.9676 0 0 14.4138 0 0 12.3969 0 0 0 0 0 0 0 0 0 0 11.6642 0 0 0 0 14.4212 12.7293 0 0 12.5111 0 0 12.5934 0 0 0 0 0 0 15.2934 0 0 0 0 14.2332 14.4791 0 0 10.702 0 14.4617 0 0 15.0761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UI42 CBPA4_HUMAN "Carboxypeptidase A4, EC 3.4.17.- (Carboxypeptidase A3)" CPA4 CPA3 UNQ694/PRO1339 Homo sapiens (Human) histone acetylation [GO:0016573]; proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; histone acetylation [GO:0016573]; proteolysis [GO:0006508] GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0016573 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] IVSDYQR 0.96804 -0.22377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3299 0 0 0 0 0 0 0 0 0 0 0 11.572 0 0 0 13.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1596 0 0 0 0 0 11.7133 0 0 0 0 0 0 0 0 0 0 0 11.8321 0 0 0 0 0 0 0 0 0 15.9223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0Z9 MCMD2_HUMAN "Minichromosome maintenance domain-containing protein 2, MCM domain-containing protein 2" MCMDC2 C8orf45 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; double-strand break repair via break-induced replication [GO:0000727]; meiotic cell cycle [GO:0051321] ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; double-strand break repair via break-induced replication [GO:0000727]; meiotic cell cycle [GO:0051321] GO:0000727; GO:0003677; GO:0005524; GO:0032508; GO:0051321 ATP binding [GO:0005524]; DNA binding [GO:0003677] HLVSTEIFPTLSRNK 0.96805 4.2617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0881 12.3607 0 15.5945 12.3794 0 0 10.8277 0 0 0 0 12.4708 0 0 0 0 0 12.8827 0 0 0 0 0 0 0 0 0 0 0 12.1826 0 0 0 12.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8582 11.5319 0 17.4541 0 0 0 0 0 0 0 0 17.7683 17.9586 0 0 0 0 0 0 10.6119 0 0 17.546 0 0 14.942 0 0 0 17.4695 0 0 14.5333 0 0 14.6038 0 0 0 0 0 0 0 0 18.4031 0 0 0 0 0 0 0 0 0 0 0 0 13.5217 0 0 0 0 0 0 0 0 13.488 0 0 14.0228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34969 5HT7R_HUMAN "5-hydroxytryptamine receptor 7, 5-HT-7, 5-HT7 (5-HT-X) (Serotonin receptor 7)" HTR7 Homo sapiens (Human) "blood circulation [GO:0008015]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; blood circulation [GO:0008015]; chemical synaptic transmission [GO:0007268]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; smooth muscle contraction [GO:0006939]; vasoconstriction [GO:0042310]" GO:0004993; GO:0005886; GO:0005887; GO:0006939; GO:0007187; GO:0007268; GO:0007623; GO:0008015; GO:0030425; GO:0030594; GO:0032588; GO:0042310; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] PDLYGHLR 0.96806 -0.9571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3772 0 0 0 0 14.1507 0 0 0 14.2603 0 0 0 0 0 0 0 0 0 12.7761 0 0 0 0 0 14.0875 0 0 14.1456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3522 0 0 0 0 0 13.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CD2 COAC_HUMAN "Phosphopantothenoylcysteine decarboxylase, PPC-DC, EC 4.1.1.36 (CoaC)" PPCDC COAC MDS018 UNQ9365/PRO34154 Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937] cytosol [GO:0005829]; phosphopantothenoylcysteine decarboxylase complex [GO:0071513] cytosol [GO:0005829]; phosphopantothenoylcysteine decarboxylase complex [GO:0071513]; FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937] GO:0004633; GO:0005829; GO:0010181; GO:0015937; GO:0042802; GO:0071513 FMN binding [GO:0010181]; identical protein binding [GO:0042802]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633] EPKASCPAAAPLMER 0.96806 -0.4395 0 0 0 11.9837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5425 0 0 13.3765 13.061 13.1505 0 0 0 0 0 0 0 11.5915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4398 0 0 0 0 0 0 0 0 0 0 0 Q6ZMN7 PZRN4_HUMAN PDZ domain-containing RING finger protein 4 (Ligand of Numb protein X 4) (SEMACAP3-like protein) PDZRN4 LNX4 SEMCAP3L Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] ADGLEIHDKIMEVNGKDLSK 0.96807 -0.019017 0 0 0 0 0 0 0 0 12.2951 0 13.066 0 0 0 0 0 11.2038 0 12.0277 11.4743 0 0 11.2248 0 0 0 0 0 12.1799 0 0 0 0 0 13.3979 11.833 0 12.7589 0 0 11.6145 0 0 10.0132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3192 12.9593 0 13.5812 0 0 0 0 0 0 0 0 0 0 0 12.245 0 0 0 0 0 0 0 0 0 12.3399 0 0 0 0 0 0 13.6139 0 0 0 14.5299 0 0 0 12.3971 13.319 0 0 0 0 0 0 0 0 0 12.915 0 0 0 0 0 0 11.4613 0 12.8021 0 0 0 0 0 0 0 13.6151 0 0 0 0 0 0 0 0 0 0 0 14.5802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH64 O51A7_HUMAN Olfactory receptor 51A7 (Olfactory receptor OR11-27) OR51A7 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FLAIHNPLR 0.96807 -0.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4104 12.933 13.1052 0 0 0 10.7872 0 0 0 12.691 13.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3329 10.9838 0 0 0 0 0 11.989 14.531 12.0311 15.1913 0 0 0 12.8547 0 13.4856 0 0 13.1593 0 13.0781 0 13.2299 0 13.9751 14.0598 0 14.9215 0 13.2598 0 0 0 0 0 0 0 12.0679 0 0 0 12.534 0 0 13.4828 0 0 0 12.1974 0 0 0 0 0 0 0 0 10.7897 0 12.6039 13.4111 0 11.5692 0 12.247 0 12.6991 12.5234 10.4655 0 0 13.6721 0 0 0 0 0 0 0 12.0441 0 12.1392 0 0 0 13.1038 0 0 0 0 12.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HF1 SFRP2_HUMAN "Secreted frizzled-related protein 2, FRP-2, sFRP-2 (Secreted apoptosis-related protein 1, SARP-1)" SFRP2 FRP2 SARP1 FKSG12 UNQ361/PRO697 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell apoptotic process [GO:0010659]; cell-cell signaling [GO:0007267]; cellular response to extracellular stimulus [GO:0031668]; cellular response to X-ray [GO:0071481]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; convergent extension involved in axis elongation [GO:0060028]; digestive tract morphogenesis [GO:0048546]; embryonic digit morphogenesis [GO:0042733]; hematopoietic stem cell proliferation [GO:0071425]; male gonad development [GO:0008584]; mesodermal cell fate specification [GO:0007501]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dermatome development [GO:0061185]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; regulation of stem cell division [GO:2000035]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sclerotome development [GO:0061056]; stem cell fate specification [GO:0048866]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] "collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; endopeptidase activator activity [GO:0061133]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018]; Wnt-protein binding [GO:0017147]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell apoptotic process [GO:0010659]; cell-cell signaling [GO:0007267]; cellular response to extracellular stimulus [GO:0031668]; cellular response to X-ray [GO:0071481]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; convergent extension involved in axis elongation [GO:0060028]; digestive tract morphogenesis [GO:0048546]; embryonic digit morphogenesis [GO:0042733]; hematopoietic stem cell proliferation [GO:0071425]; male gonad development [GO:0008584]; mesodermal cell fate specification [GO:0007501]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dermatome development [GO:0061185]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; regulation of stem cell division [GO:2000035]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sclerotome development [GO:0061056]; stem cell fate specification [GO:0048866]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" GO:0001569; GO:0001968; GO:0002063; GO:0003151; GO:0003214; GO:0003402; GO:0005178; GO:0005615; GO:0007267; GO:0007501; GO:0007584; GO:0008284; GO:0008285; GO:0008584; GO:0009410; GO:0010629; GO:0010659; GO:0010667; GO:0010719; GO:0010975; GO:0017147; GO:0030178; GO:0030199; GO:0030307; GO:0030308; GO:0030336; GO:0030509; GO:0030514; GO:0031668; GO:0033138; GO:0033630; GO:0036342; GO:0042662; GO:0042733; GO:0043065; GO:0043154; GO:0043508; GO:0045600; GO:0045669; GO:0045766; GO:0045892; GO:0045944; GO:0048018; GO:0048546; GO:0048866; GO:0050680; GO:0050732; GO:0060028; GO:0060070; GO:0061056; GO:0061133; GO:0061185; GO:0062023; GO:0071425; GO:0071481; GO:0090090; GO:0090179; GO:0090244; GO:0090263; GO:1902042; GO:1902230; GO:1904956; GO:2000035; GO:2000041 endopeptidase activator activity [GO:0061133]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018]; Wnt-protein binding [GO:0017147] CAPVMSAFGFPWPDMLECDR 0.96808 -1.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8714 0 0 0 0 0 0 0 0 0 12.3519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.724 0 0 12.0063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0134 0 0 0 0 0 0 12.8388 0 Q96PP4 TSG13_HUMAN Testis-specific gene 13 protein TSGA13 Homo sapiens (Human) APQWIIK 0.96808 -0.85351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5534 0 0 0 0 0 0 0 0 0 0 0 16.739 0 0 0 0 19.7442 0 15.4529 13.2631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2787 0 0 19.6889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59045 NAL11_HUMAN "NACHT, LRR and PYD domains-containing protein 11 (Nucleotide-binding oligomerization domain protein 17) (PAAD-and NACHT domain-containing protein 10) (PYRIN-containing APAF1-like protein 6)" NLRP11 NALP11 NOD17 PAN10 PYPAF6 Homo sapiens (Human) regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; ATP binding [GO:0005524]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; RNA binding [GO:0003723]; regulation of inflammatory response [GO:0050727]" GO:0003723; GO:0005524; GO:0005737; GO:0016715; GO:0050727 "ATP binding [GO:0005524]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO:0016715]; RNA binding [GO:0003723]" DRQRASAALQLVHEDEILVGLCR 0.9681 3.2363 0 12.4121 0 0 0 14.8643 0 0 0 10.3915 14.1361 11.2961 0 0 0 11.9032 0 0 0 0 0 0 0 14.9846 0 0 10.0473 0 0 10.5498 0 11.879 0 0 0 0 12.7608 13.3979 0 13.9506 0 0 13.5173 11.1894 0 0 0 0 0 0 0 12.8325 0 0 0 12.8501 0 0 0 0 0 0 0 0 0 0 14.637 0 0 0 0 0 0 9.95957 0 13.3238 12.6046 0 0 0 0 12.5358 12.434 0 0 0 13.3134 0 0 0 0 0 14.1041 13.5452 0 0 0 0 0 0 12.8047 13.6979 0 12.5422 0 0 12.3437 0 16.0358 0 13.9048 0 14.3214 0 0 0 10.3901 0 0 0 0 0 0 10.7842 0 12.7842 11.8483 0 13.0468 12.5762 0 12.5151 11.2258 0 10.6497 0 12.7444 14.0801 13.9524 0 0 12.7228 0 0 0 0 0 0 12.8392 10.7459 0 0 0 0 0 13.238 0 11.7885 0 0 12.3548 0 12.2735 0 0 0 0 12.2317 14.218 0 0 0 0 0 0 0 11.823 0 11.9921 0 Q8N9W5 DAAF3_HUMAN Dynein axonemal assembly factor 3 DNAAF3 C19orf51 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; motile cilium assembly [GO:0044458] dynein axonemal particle [GO:0120293] dynein axonemal particle [GO:0120293]; axonemal dynein complex assembly [GO:0070286]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; motile cilium assembly [GO:0044458] GO:0007368; GO:0007507; GO:0044458; GO:0070286; GO:0120293 GVSDWDLRMK 0.9681 -0.9677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3106 0 0 0 0 0 0 14.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1657 12.6931 0 0 0 0 0 0 12.7548 13.3322 12.8801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0966 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WU20 FRS2_HUMAN "Fibroblast growth factor receptor substrate 2, FGFR substrate 2 (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1, SNT-1)" FRS2 Homo sapiens (Human) "anterior/posterior axis specification, embryo [GO:0008595]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; ventricular septum development [GO:0003281]" adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; anterior/posterior axis specification, embryo [GO:0008595]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; ventricular septum development [GO:0003281]" GO:0001702; GO:0001759; GO:0003281; GO:0005068; GO:0005104; GO:0005168; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0007169; GO:0007185; GO:0007186; GO:0007405; GO:0008543; GO:0008595; GO:0012505; GO:0016020; GO:0019211; GO:0030900; GO:0042981; GO:0043410; GO:0046619; GO:0050678; GO:0060527; GO:0070307; GO:0070372; GO:1904707; GO:2000726 fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] DQVSGSGANNTEWDTGYDSDERR 0.9681 -0.44404 0 0 0 0 0 0 0 10.2098 0 10.6927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7471 0 0 0 0 0 0 10.5919 0 0 12.7608 0 10.9019 11.4867 0 12.8116 12.8132 12.9269 13.8096 11.9132 12.0178 0 13.0468 0 0 0 0 0 13.6242 0 0 0 0 11.9966 14.1879 12.5891 9.33885 0 0 0 0 0 0 11.8169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1681 0 0 13.5174 0 12.6722 0 0 0 0 0 0 0 0 0 0 12.1398 0 0 10.3921 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4005 0 0 0 11.8111 0 0 0 0 0 0 12.0547 0 0 0 0 0 0 0 9.72744 0 Q9UQN3 CHM2B_HUMAN "Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b, CHMP2b) (Vacuolar protein sorting-associated protein 2-2, Vps2-2, hVps2-2)" CHMP2B CGI-84 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cognition [GO:0050890]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; neuron cellular homeostasis [GO:0070050]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cognition [GO:0050890]; endosome organization [GO:0007032]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; neuron cellular homeostasis [GO:0070050]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005737; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007032; GO:0007080; GO:0010824; GO:0015031; GO:0016236; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0043162; GO:0045296; GO:0045324; GO:0046761; GO:0050890; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070050; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904903; GO:1904930 cadherin binding [GO:0045296]; protein domain specific binding [GO:0019904] MAKIGNK 0.96811 -0.44581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.332 0 0 0 0 0 0 0 0 14.0981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.153 0 0 0 0 0 0 0 A8MYJ7 TTC34_HUMAN "Tetratricopeptide repeat protein 34, TPR repeat protein 34" TTC34 Homo sapiens (Human) ARLGLLQLK 0.96812 -0.97475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9982 0 12.8415 12.3677 0 13.8907 12.0383 13.8594 0 13.5599 14.1017 0 12.6342 0 10.2445 0 0 0 0 0 0 0 0 0 0 12.071 0 0 0 0 0 0 0 13.2478 12.6049 11.9187 13.2579 0 0 0 0 0 0 0 0 0 10.6691 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6487 14.3478 12.4808 13.3796 14.8074 13.6402 0 0 0 0 0 0 15.2386 0 0 14.284 15.2522 15.017 15.3481 14.5972 0 14.274 13.2842 0 15.5734 14.3625 14.5433 0 16.0005 15.5122 0 14.4781 14.4411 14.8816 15.2622 0 15.4638 0 0 14.9409 14.5861 0 14.319 14.8338 12.5649 14.0363 14.1327 14.0018 14.4942 13.9189 13.891 13.6915 15.0514 14.2417 15.1805 14.5105 14.9246 13.8997 14.1968 15.2624 15.4441 13.5164 15.4187 14.5983 14.5128 14.8778 10.9946 0 13.5716 15.244 14.9708 0 14.0571 0 0 14.7176 0 0 0 0 14.6379 14.0823 13.2761 0 11.5334 13.4705 0 0 13.1167 13.7036 0 11.8013 13.4569 13.0329 14.0325 14.5074 13.671 13.9866 14.5395 14.6087 15.2877 0 13.4689 0 0 O43324 MCA3_HUMAN Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18) EEF1E1 AIMP3 P18 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]" aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; translation [GO:0006412]" GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006412; GO:0008285; GO:0017101; GO:0043065; GO:0043517; GO:1990830; GO:2000774; GO:2001235 FIVDLTVQEK 0.96812 -0.97459 0 0 0 0 0 0 0 0 15.9034 14.7706 0 14.4275 16.206 14.7753 15.5249 0 0 0 0 0 0 0 0 0 0 0 14.9929 0 0 15.2812 14.6963 0 16.238 15.1147 0 0 0 0 0 15.8395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6361 0 0 0 0 13.8616 0 0 0 0 14.4088 0 0 0 0 0 0 0 14.6107 0 14.6353 0 0 P08631 HCK_HUMAN "Tyrosine-protein kinase HCK, EC 2.7.10.2 (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck)" HCK Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response-activating signal transduction [GO:0002758]; integrin-mediated signaling pathway [GO:0007229]; interferon-gamma-mediated signaling pathway [GO:0060333]; leukocyte degranulation [GO:0043299]; leukocyte migration involved in immune response [GO:0002522]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; respiratory burst after phagocytosis [GO:0045728]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] caveola [GO:0005901]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response-activating signal transduction [GO:0002758]; integrin-mediated signaling pathway [GO:0007229]; interferon-gamma-mediated signaling pathway [GO:0060333]; leukocyte degranulation [GO:0043299]; leukocyte migration involved in immune response [GO:0002522]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; mesoderm development [GO:0007498]; negative regulation of apoptotic process [GO:0043066]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764]; regulation of podosome assembly [GO:0071801]; respiratory burst after phagocytosis [GO:0045728]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001784; GO:0002522; GO:0002758; GO:0002862; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006954; GO:0007155; GO:0007169; GO:0007229; GO:0007498; GO:0008284; GO:0008360; GO:0018108; GO:0019221; GO:0030133; GO:0030154; GO:0030838; GO:0031234; GO:0031663; GO:0038096; GO:0042995; GO:0043066; GO:0043231; GO:0043299; GO:0045087; GO:0045728; GO:0046777; GO:0050727; GO:0050764; GO:0051090; GO:0060333; GO:0071801; GO:2000251 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] DEERAPRMGCMK 0.96812 -0.94447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0686 0 0 0 0 0 10.9302 0 0 13.6264 0 14.5007 0 0 0 0 0 0 0 0 0 0 14.017 0 0 0 0 0 0 0 0 0 12.9617 0 0 13.2344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4277 0 13.4573 0 0 12.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6597 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0154 0 P28749 RBL1_HUMAN "Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein, p107) (pRb1)" RBL1 Homo sapiens (Human) cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550] GO:0000122; GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0006325; GO:0007049; GO:0010629; GO:0030154; GO:0043550; GO:0051302; GO:1990841; GO:2000134; GO:2000773 promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] AQEVHSTGINRPKR 0.96812 -0.9716 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5864 0 0 0 0 11.1741 0 0 0 0 0 0 0 13.4018 0 0 0 0 0 0 0 0 0 0 0 13.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7955 0 0 0 0 0 0 0 0 10.6994 0 0 0 12.2467 0 0 12.9833 14.2806 0 0 0 0 0 0 15.0611 15.2801 0 15.4826 15.7014 0 0 0 0 0 13.6914 0 14.103 0 0 10.8718 0 0 0 0 0 0 15.1108 0 0 0 15.1455 0 0 0 0 15.6316 15.2571 0 0 10.5621 12.6804 0 0 13.9194 15.3003 14.3573 15.2745 0 0 0 15.2267 0 0 0 0 0 0 0 0 0 0 0 15.218 0 14.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1125 13.4982 0 15.9987 0 0 0 0 0 0 Q9BRF8 CPPED_HUMAN "Serine/threonine-protein phosphatase CPPED1, EC 3.1.3.16 (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1)" CPPED1 CSTP1 Homo sapiens (Human) azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018] GO:0005576; GO:0005829; GO:0005886; GO:0017018; GO:0035578; GO:0046872 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018] AWSTGDCDNGGDEWEQEIR 0.96812 -0.2763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2756 0 0 0 0 0 0 18.9371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7021 0 0 0 0 0 0 0 0 0 0 11.5477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00339 MATN2_HUMAN Matrilin-2 MATN2 UNQ193/PRO219 Homo sapiens (Human) extracellular matrix organization [GO:0030198] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198] GO:0005201; GO:0005509; GO:0005576; GO:0030198; GO:0031012; GO:0062023 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] CVAVDYCASENHGCEHECVNADGSYLCQCHEGFALNPDK 0.96813 -0.97641 0 0 0 0 0 0 10.5926 0 0 0 0 0 0 0 0 0 0 11.4785 0 0 0 0 0 0 0 11.7433 0 0 0 12.7842 0 0 0 0 0 0 10.1948 0 11.6637 0 0 0 10.8174 12.7443 0 0 0 12.3577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6601 0 0 0 0 0 0 12.9264 13.6495 0 14.6816 0 0 0 0 11.4563 0 0 0 0 0 0 0 0 0 0 0 0 13.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1443 0 0 0 0 0 0 0 0 12.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8241 12.4365 13.4383 0 0 0 0 0 0 0 0 0 0 0 12.6781 12.2984 0 0 0 0 0 0 0 0 0 11.463 Q8WU68 U2AF4_HUMAN "Splicing factor U2AF 26 kDa subunit (U2 auxiliary factor 26) (U2 small nuclear RNA auxiliary factor 1-like protein 4, U2AF1-like 4) (U2(RNU2) small nuclear RNA auxiliary factor 1-like protein 3, U2 small nuclear RNA auxiliary factor 1-like protein 3, U2AF1-like protein 3)" U2AF1L4 U2AF1-RS3 U2AF1L3 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0005654; GO:0005681; GO:0005737; GO:0016607; GO:0030628; GO:0046872; GO:0089701 metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628] ESCCRQYEMGECTR 0.96814 -0.97885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXA5 SUCR1_HUMAN Succinate receptor 1 (G-protein coupled receptor 91) (P2Y purinoceptor 1-like) SUCNR1 GPR91 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; macrophage activation involved in immune response [GO:0002281]; positive regulation of chemotaxis [GO:0050921]; positive regulation of inflammatory response [GO:0050729]; regulation of angiotensin metabolic process [GO:0060177]; renin secretion into blood stream [GO:0002001]; response to calcium ion [GO:0051592] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; macrophage activation involved in immune response [GO:0002281]; positive regulation of chemotaxis [GO:0050921]; positive regulation of inflammatory response [GO:0050729]; regulation of angiotensin metabolic process [GO:0060177]; renin secretion into blood stream [GO:0002001]; response to calcium ion [GO:0051592] GO:0002001; GO:0002281; GO:0004930; GO:0005886; GO:0007186; GO:0016021; GO:0038023; GO:0042593; GO:0050729; GO:0050921; GO:0051592; GO:0060177; GO:0070062 G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023] IALFLKQRNR 0.96815 -0.27872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09104 ENOG_HUMAN "Gamma-enolase, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase, NSE)" ENO2 Homo sapiens (Human) canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; multicellular organismal reproductive process [GO:0048609]; negative regulation of neuron death [GO:1901215]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410] cell cortex [GO:0005938]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060] cell cortex [GO:0005938]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; multicellular organismal reproductive process [GO:0048609]; negative regulation of neuron death [GO:1901215]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410] GO:0000015; GO:0000287; GO:0001917; GO:0004634; GO:0005615; GO:0005829; GO:0005886; GO:0005938; GO:0006094; GO:0006096; GO:0009410; GO:0009986; GO:0016020; GO:0019899; GO:0030426; GO:0032355; GO:0042802; GO:0043204; GO:0044877; GO:0045121; GO:0048609; GO:0061621; GO:0070062; GO:0097060; GO:1901215 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877] GLFRAAVPSGASTGIYEALELR 0.96816 -0.98559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q32M88 PGGHG_HUMAN "Protein-glucosylgalactosylhydroxylysine glucosidase, EC 3.2.1.107 (Acid trehalase-like protein 1)" PGGHG ATHL1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] cytosol [GO:0005829] "cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]" GO:0004553; GO:0005829; GO:0005975; GO:0047402 "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]" FRASQCIYAHRTLPHVLAFR 0.96816 -0.2806 14.1142 0 0 0 0 0 0 0 0 0 13.6572 14.6001 13.7751 0 0 14.2741 0 0 0 14.9398 13.9264 0 0 0 0 14.9845 0 0 14.3997 0 0 0 12.9206 0 0 0 0 0 0 0 0 0 0 14.5178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4743 0 0 0 0 0 12.1834 0 0 0 0 0 0 0 0 12.2505 0 0 0 0 0 0 0 0 13.2805 0 12.0313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2731 0 13.5643 0 0 0 11.9992 0 0 14.2121 0 15.3629 0 0 14.6396 0 0 14.5882 0 0 0 0 0 13.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3531 0 0 0 0 0 0 0 Q8TCP9 F200A_HUMAN Protein FAM200A FAM200A C7orf38 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALLSSYLVAYR 0.96816 -0.2209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H324 ATS10_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 10, ADAM-TS 10, ADAM-TS10, ADAMTS-10, EC 3.4.24.-" ADAMTS10 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] GO:0001527; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0062023 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] CDSPTPGDGPEECK 0.96816 -0.22005 0 0 0 0 0 0 0 0 0 0 11.7431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.048 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1844 13.7508 0 0 0 0 0 13.7983 13.5287 13.6749 0 14.6156 0 13.4704 14.5696 14.8374 14.0212 14.2097 0 14.2878 14.2254 0 0 0 0 13.5934 0 0 0 0 0 0 0 14.9801 13.6806 13.734 14.2944 0 14.4058 14.8163 13.9306 13.8226 0 0 0 13.6895 10.6721 0 12.895 0 0 13.4132 0 12.2321 12.6854 0 0 15.3259 13.9814 0 14.3632 13.9636 12.9874 0 11.4296 13.7811 0 0 0 0 0 13.3994 0 0 10.9031 0 0 0 0 0 0 10.5109 0 0 0 11.2541 0 0 0 0 11.8635 0 0 13.8453 13.3692 0 0 0 0 0 Q8N2E6 TOR2X_HUMAN Prosalusin (Torsin family 2 member A) (Torsin-2A) [Cleaved into: Salusin-alpha; Salusin-beta ] TOR2A HEMBA1005096 PSEC0218 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; vasopressin secretion [GO:0030103]; water homeostasis [GO:0030104] extracellular region [GO:0005576] extracellular region [GO:0005576]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hormone activity [GO:0005179]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; vasopressin secretion [GO:0030103]; water homeostasis [GO:0030104] GO:0005179; GO:0005524; GO:0005576; GO:0008284; GO:0010628; GO:0016887; GO:0030103; GO:0030104; GO:0031640; GO:0043950; GO:0051673; GO:0061844; GO:1904427 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hormone activity [GO:0005179] KAIFIFIRWLLK 0.96817 -0.43631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6753 0 0 0 0 13.7625 13.8953 14.3896 0 0 0 0 14.157 0 0 0 0 15.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4435 14.1654 0 0 0 14.2986 0 0 0 0 19.3341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1134 0 0 0 0 0 0 Q13106 ZN154_HUMAN Zinc finger protein 154 ZNF154 KIAA2003 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" QHLGEKHFRSNVGR 0.96818 -0.22164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2182 0 0 14.39 0 14.7031 15.032 15.1007 0 16.4451 16.619 16.4325 16.8274 16.6957 16.8647 0 0 17.0089 0 0 14.5886 0 0 0 0 0 0 17.1584 17.2192 17.7621 11.6933 15.773 15.6592 16.0523 15.9312 15.8898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0882 18.0903 12.4926 0 0 0 13.1661 0 16.7059 0 0 17.3725 0 0 0 0 0 0 0 0 0 17.1353 0 0 Q6P6B7 ANR16_HUMAN Ankyrin repeat domain-containing protein 16 ANKRD16 Homo sapiens (Human) tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA modification [GO:0006400] GO:0005634; GO:0005737; GO:0006400 DGWNSFHIASR 0.96818 -0.95685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0525 16.1686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8116 12.9513 0 13.0178 0 12.0437 0 0 0 0 0 0 0 0 12.2452 11.6052 0 11.781 0 0 0 0 0 0 0 0 10.5641 0 0 12.4965 0 0 0 0 0 15.5741 12.0908 0 0 0 0 0 0 0 0 0 11.6309 12.3098 11.5777 0 0 0 0 0 11.724 0 0 0 0 10.8793 0 0 0 0 0 0 0 0 0 0 0 0 18.3482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRS6 SNX15_HUMAN Sorting nexin-15 SNX15 Homo sapiens (Human) intracellular protein transport [GO:0006886] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886] GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0030659; GO:0035091; GO:0043231 phosphatidylinositol binding [GO:0035091] QEGVKKK 0.96818 -0.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14757 CHK1_HUMAN "Serine/threonine-protein kinase Chk1, EC 2.7.11.1 (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1)" CHEK1 CHK1 Homo sapiens (Human) apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; cellular response to caffeine [GO:0071313]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to mechanical stimulus [GO:0071260]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; G2/M transition of mitotic cell cycle [GO:0000086]; inner cell mass cell proliferation [GO:0001833]; intracellular signal transduction [GO:0035556]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of mitotic nuclear division [GO:0045839]; nucleus organization [GO:0006997]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle [GO:0045787]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of mitotic centrosome separation [GO:0046602]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; replicative senescence [GO:0090399] centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; replication fork [GO:0005657] centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; ATP binding [GO:0005524]; histone kinase activity (H3-T11 specific) [GO:0035402]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; cellular response to caffeine [GO:0071313]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to mechanical stimulus [GO:0071260]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; G2/M transition of mitotic cell cycle [GO:0000086]; inner cell mass cell proliferation [GO:0001833]; intracellular signal transduction [GO:0035556]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of mitotic nuclear division [GO:0045839]; nucleus organization [GO:0006997]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle [GO:0045787]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of mitotic centrosome separation [GO:0046602]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; replicative senescence [GO:0090399] GO:0000077; GO:0000086; GO:0000785; GO:0000794; GO:0001833; GO:0004672; GO:0004674; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005829; GO:0006260; GO:0006281; GO:0006468; GO:0006915; GO:0006974; GO:0006975; GO:0006997; GO:0007095; GO:0010569; GO:0010767; GO:0018107; GO:0019904; GO:0032991; GO:0035402; GO:0035556; GO:0042127; GO:0043231; GO:0044818; GO:0045787; GO:0045815; GO:0045839; GO:0046602; GO:0070317; GO:0071260; GO:0071313; GO:0090399; GO:0106310; GO:1901796; GO:1902742; GO:2000279; GO:2000615 ATP binding [GO:0005524]; histone kinase activity (H3-T11 specific) [GO:0035402]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ETCEKLGYQWK 0.96819 -0.84958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3441 0 0 0 0 0 14.0777 0 0 0 0 11.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1948 0 0 0 0 0 0 10.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8742 Q5T292 TM273_HUMAN Transmembrane protein 273 TMEM273 C10orf128 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RDAQVIEL 0.96819 -1.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3719 Q8NGV7 OR5H2_HUMAN Olfactory receptor 5H2 (Olfactory receptor OR3-10) OR5H2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] NKQVIDSFTK 0.96819 -0.43919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2855 0 0 0 0 0 15.4426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UM07 PADI4_HUMAN "Protein-arginine deiminase type-4, EC 3.5.3.15 (HL-60 PAD) (Peptidylarginine deiminase IV) (Protein-arginine deiminase type IV)" PADI4 PAD4 PADI5 PDI5 Homo sapiens (Human) chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; innate immune response [GO:0045087]; nucleosome assembly [GO:0006334]; post-translational protein modification [GO:0043687]; protein modification process [GO:0036211]; stem cell population maintenance [GO:0019827] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; histone-arginine deiminase activity (H3-R17 specific) [GO:0140797]; histone-arginine deiminase activity (H3-R2 specific) [GO:0140795]; histone-arginine deiminase activity (H3-R26 specific) [GO:0140798]; histone-arginine deiminase activity (H3-R8 specific) [GO:0140796]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; innate immune response [GO:0045087]; nucleosome assembly [GO:0006334]; post-translational protein modification [GO:0043687]; protein modification process [GO:0036211]; stem cell population maintenance [GO:0019827] GO:0004668; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006334; GO:0006338; GO:0019827; GO:0032991; GO:0036211; GO:0036413; GO:0036414; GO:0042802; GO:0043687; GO:0045087; GO:0140795; GO:0140796; GO:0140797; GO:0140798 calcium ion binding [GO:0005509]; histone-arginine deiminase activity (H3-R17 specific) [GO:0140797]; histone-arginine deiminase activity (H3-R2 specific) [GO:0140795]; histone-arginine deiminase activity (H3-R26 specific) [GO:0140798]; histone-arginine deiminase activity (H3-R8 specific) [GO:0140796]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668] GFRLLLASPR 0.96819 -0.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7703 0 0 0 0 0 12.8942 0 0 12.7815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7485 0 0 0 0 13.4346 0 0 0 0 0 0 0 O15130 NPFF_HUMAN "Pro-FMRFamide-related neuropeptide FF (FMRFamide-related peptides) [Cleaved into: Neuropeptide SF, NPSF; Neuropeptide FF, NPFF; Neuropeptide AF, NPAF ]" NPFF Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; neuropeptide signaling pathway [GO:0007218] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; postsynapse [GO:0098794] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; neuropeptide signaling pathway [GO:0007218] GO:0001664; GO:0005102; GO:0005184; GO:0005576; GO:0005615; GO:0007218; GO:0007268; GO:0030425; GO:0043204; GO:0043679; GO:0060079; GO:0098794 G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102] FGRNTQGSWR 0.9682 -0.85264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6874 0 0 0 12.7846 11.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3172 0 13.0741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUK4 TMM26_HUMAN Transmembrane protein 26 TMEM26 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EPRYWLLALLNLLLFLETALTLK 0.9682 -0.22505 13.7309 0 0 0 0 0 0 0 0 0 11.9753 0 0 0 11.9054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8037 0 0 11.904 13.0867 0 0 11.2377 0 10.8187 12.6642 10.8268 0 10.7768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2411 0 0 0 0 0 0 0 0 14.5421 11.8252 0 0 0 13.0647 0 12.5485 0 14.8318 0 0 0 0 0 0 0 0 13.3451 11.3717 0 14.1917 14.7596 0 0 0 0 0 0 13.7107 12.9279 0 13.518 0 0 12.1328 0 13.7939 0 11.3866 11.8197 0 0 0 14.3161 0 0 12.4825 0 0 0 14.5185 0 0 0 0 0 0 0 12.376 0 0 0 0 0 0 0 0 15.9357 13.8837 0 13.9373 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3794 0 0 13.6204 0 0 0 0 0 0 0 Q8WWV6 FCAMR_HUMAN High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor (Fc alpha/mu receptor) (CD antigen CD351) FCAMR FKSG87 Homo sapiens (Human) adaptive immune response [GO:0002250] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250] GO:0002250; GO:0004888; GO:0005886; GO:0016021 transmembrane signaling receptor activity [GO:0004888] RPHPRWLWEGSLPSR 0.96823 -0.96611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6601 13.8202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVA1 UQCC1_HUMAN "Ubiquinol-cytochrome-c reductase complex assembly factor 1 (Basic FGF-repressed Zic-binding protein, bFGF-repressed Zic-binding protein, bFZb) (Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog)" UQCC1 BZFB C20orf44 UQCC Homo sapiens (Human) mitochondrial respiratory chain complex III assembly [GO:0034551] cytoplasmic vesicle [GO:0031410]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] cytoplasmic vesicle [GO:0031410]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex III assembly [GO:0034551] GO:0005739; GO:0005743; GO:0031410; GO:0034551 CQMPDTFNSWFLITLLHVWMCLVRMKQEGR 0.96823 -0.96878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7647 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2886 0 15.3971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.801 0 0 0 12.9615 0 0 0 12.4804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20700 LMNB1_HUMAN Lamin-B1 LMNB1 LMN2 LMNB Homo sapiens (Human) heterochromatin assembly [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435] lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; heterochromatin assembly [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435] GO:0005198; GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0016020; GO:0016363; GO:0031507; GO:0031965; GO:0043274; GO:0051664; GO:0090435; GO:1990837 phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] EELRELNDR 0.96824 -0.97147 0 0 0 0 0 0 0 0 0 0 11.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQW1 SC31B_HUMAN Protein transport protein Sec31B (SEC31-like protein 2) (SEC31-related protein B) (SEC31B-1) SEC31B SEC31L2 Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; vesicle coat [GO:0030120] COPII vesicle coat [GO:0030127]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; vesicle coat [GO:0030120]; structural molecule activity [GO:0005198]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; intracellular protein transport [GO:0006886] GO:0005198; GO:0005789; GO:0006886; GO:0007029; GO:0030120; GO:0030127; GO:0070971; GO:0090110 structural molecule activity [GO:0005198] ALTSEAR 0.96825 -0.24164 16.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2557 11.7426 0 0 0 0 0 0 0 0 0 10.8041 0 0 0 0 0 0 0 0 0 0 11.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8953 14.0152 0 0 0 0 0 0 13.6905 13.5333 0 0 0 0 0 14.319 0 0 0 0 0 0 0 0 0 0 14.333 14.1783 0 0 13.9858 0 0 0 0 0 14.323 0 15.8519 0 14.2064 0 0 14.2841 0 14.5672 0 0 13.7388 0 13.7798 0 0 0 14.3813 10.3192 13.9717 13.0213 13.9637 14.0442 0 0 0 13.8575 0 14.3473 14.4616 0 0 0 0 0 0 0 0 0 0 0 13.5194 0 13.6155 13.5649 0 0 15.195 14.8394 13.7305 0 0 11.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3068 12.8745 0 0 13.7529 0 P08237 PFKAM_HUMAN "ATP-dependent 6-phosphofructokinase, muscle type, ATP-PFK, PFK-M, EC 2.7.1.11 (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A, PFK-A) (Phosphohexokinase)" PFKM PFKX Homo sapiens (Human) "canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycolysis from storage polysaccharide through glucose-1-phosphate [GO:0093001]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]" 6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; sperm principal piece [GO:0097228] "6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; sperm principal piece [GO:0097228]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycolysis from storage polysaccharide through glucose-1-phosphate [GO:0093001]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0003872; GO:0005524; GO:0005634; GO:0005829; GO:0005945; GO:0005980; GO:0006002; GO:0006096; GO:0008022; GO:0016020; GO:0016208; GO:0016324; GO:0019900; GO:0030388; GO:0032024; GO:0042593; GO:0042802; GO:0045944; GO:0046716; GO:0046872; GO:0048029; GO:0061615; GO:0061621; GO:0070061; GO:0070095; GO:0093001; GO:0097228 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein C-terminus binding [GO:0008022] EQWWLKLRPILK 0.96826 -0.94701 0 0 0 15.0887 14.9113 15.6622 14.799 0 0 9.0702 0 0 0 15.1104 0 0 13.0126 13.2139 12.7994 12.1004 0 0 12.6908 12.4132 11.2746 0 0 12.8536 13.0321 0 0 0 0 13.2777 9.66033 13.5852 0 0 10.8242 0 13.3454 0 11.3644 12.0842 0 0 17.1953 0 0 0 0 10.4788 0 0 0 0 17.0804 0 17.4375 16.8113 16.1005 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7146 13.3031 0 0 14.6622 0 14.8022 14.2882 0 14.4715 0 0 13.5833 14.3759 15.5178 12.451 0 14.1172 12.9833 0 12.4613 14.2217 13.2827 0 14.0663 14.5525 13.6184 10.8109 13.6001 0 13.2805 13.8041 0 0 12.5246 13.8867 14.2183 13.2832 14.2299 13.6669 13.0978 0 15.144 0 15.2142 12.7315 14.3818 14.0363 0 14.2941 12.5389 0 13.661 14.7784 14.3989 14.9504 13.4192 13.5134 14.3549 14.8903 13.8982 14.8976 13.9712 14.2031 14.6032 13.7356 13.5738 0 0 13.8377 14.8385 14.9113 13.6837 0 0 14.6911 13.5013 0 0 0 13.6723 14.6014 12.1907 13.0658 0 17.7528 0 0 0 0 12.663 12.9209 0 13.2992 0 0 0 0 14.8353 0 14.7181 0 0 0 13.61 0 Q6NXS1 IPP2B_HUMAN "Protein phosphatase inhibitor 2 family member B (PPP1R2 family member B) (Protein phosphatase 1, regulatory subunit 2 pseudogene 3) (Protein phosphatase inhibitor 2-like protein 3)" PPP1R2B PPP1R2P3 Homo sapiens (Human) glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966] protein phosphatase inhibitor activity [GO:0004864]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966] GO:0004864; GO:0005977; GO:0009966; GO:0043666 protein phosphatase inhibitor activity [GO:0004864] KSQKWDEINILATYHPADK 0.96826 -0.9474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0921 0 0 0 0 0 0 0 0 0 12.7685 12.3697 0 0 0 0 0 0 0 0 0 11.6123 0 13.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6V0L0 CP26C_HUMAN "Cytochrome P450 26C1, EC 1.14.-.-" CYP26C1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; neural crest cell development [GO:0014032]; organelle fusion [GO:0048284]; retinoic acid catabolic process [GO:0034653]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; neural crest cell development [GO:0014032]; organelle fusion [GO:0048284]; retinoic acid catabolic process [GO:0034653]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766] GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006766; GO:0007417; GO:0008401; GO:0009952; GO:0014032; GO:0016021; GO:0016125; GO:0016491; GO:0020037; GO:0034653; GO:0048284; GO:0048387 heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972] GIRARDQLHR 0.96826 -0.24219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3134 0 0 0 0 0 0 0 0 0 0 0 0 15.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9478 0 13.1981 0 0 0 13.8384 0 15.1476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25788 PSA3_HUMAN Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) PSMA3 HC8 PSC8 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548]" GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0031625; GO:0043161; GO:0045202; GO:0052548; GO:0070062 ubiquitin protein ligase binding [GO:0031625] EEDESDDDNM 0.96828 -0.21741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0269 0 0 0 0 11.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.82 0 0 0 0 0 0 13.1175 0 0 0 12.3884 0 13.0067 0 0 0 0 0 0 0 0 0 0 0 0 15.0145 0 0 0 0 11.0243 0 0 0 0 0 12.7594 0 0 0 0 0 11.8205 0 0 0 12.2807 0 0 0 11.4835 0 0 11.6502 0 0 0 0 0 13.7629 0 0 0 0 10.9856 0 12.8808 0 0 0 0 0 0 11.4019 0 0 0 0 0 0 0 12.8981 0 0 0 0 0 10.6726 0 0 0 0 0 0 11.5115 0 0 13.3953 0 0 0 0 0 0 0 0 0 0 0 0 11.0635 0 A0A075B6T8 TVA91_HUMAN T cell receptor alpha variable 9-1 TRAV9-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0006955; GO:0042101 DSVQESDSAVYFCALS 0.9683 -0.45523 0 0 0 0 0 0 0 0 13.2963 0 0 0 14.4831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B3GLJ2 PATE3_HUMAN "Prostate and testis expressed protein 3 (Acrosomal vesicle protein HEL-127) (PATE-like protein DJ, PATE-DJ)" PATE3 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GEACMLLR 0.9683 -0.95555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4167 0 0 0 0 0 0 0 0 13.4907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43739 CYH3_HUMAN "Cytohesin-3 (ARF nucleotide-binding site opener 3, Protein ARNO3) (General receptor of phosphoinositides 1, Grp1) (PH, SEC7 and coiled-coil domain-containing protein 3)" CYTH3 ARNO3 GRP1 PSCD3 Homo sapiens (Human) establishment of epithelial cell polarity [GO:0090162]; Golgi vesicle transport [GO:0048193]; positive regulation of cell adhesion [GO:0045785]; regulation of ARF protein signal transduction [GO:0032012] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; establishment of epithelial cell polarity [GO:0090162]; Golgi vesicle transport [GO:0048193]; positive regulation of cell adhesion [GO:0045785]; regulation of ARF protein signal transduction [GO:0032012]" GO:0000139; GO:0001726; GO:0005085; GO:0005547; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0031234; GO:0032012; GO:0045785; GO:0048193; GO:0090162 "guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" EELLDIRRR 0.9683 -0.45662 0 0 0 0 0 0 0 0 0 0 0 0 11.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4651 0 0 0 0 0 0 0 0 11.5764 0 0 0 0 0 12.2282 0 0 0 0 0 0 0 0 0 0 Q96EN9 REX1B_HUMAN Required for excision 1-B domain-containing protein REX1BD C19orf60 Homo sapiens (Human) DAPIRTLVQR 0.9683 -0.21907 0 0 0 0 0 0 0 0 0 0 12.3067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0934 0 0 0 13.3243 0 0 0 0 0 0 0 0 0 0 0 13.6486 0 0 0 0 0 11.3743 13.6272 0 0 0 0 0 0 0 0 0 0 0 11.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4665 0 0 0 0 0 0 0 12.4905 0 0 0 0 0 0 0 0 13.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX70 MED29_HUMAN Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29) MED29 IXL Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 transcription coregulator activity [GO:0003712] AQISCAKDIHTALLDCANK 0.9683 -0.21946 0 0 0 0 15.8339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2875 0 13.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7656 0 Q8N7C4 TM217_HUMAN Transmembrane protein 217 TMEM217 C6orf128 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 QQQWCGMTAK 0.96831 -0.4568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92995 UBP13_HUMAN "Ubiquitin carboxyl-terminal hydrolase 13, EC 3.4.19.12 (Deubiquitinating enzyme 13) (Isopeptidase T-3, ISOT-3) (Ubiquitin thioesterase 13) (Ubiquitin-specific-processing protease 13)" USP13 ISOT3 Homo sapiens (Human) "autophagy [GO:0006914]; cell population proliferation [GO:0008283]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; melanocyte differentiation [GO:0030318]; positive regulation of ERAD pathway [GO:1904294]; protein deubiquitination [GO:0016579]; protein K29-linked deubiquitination [GO:0035523]; protein K6-linked deubiquitination [GO:0044313]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; melanocyte differentiation [GO:0030318]; positive regulation of ERAD pathway [GO:1904294]; protein deubiquitination [GO:0016579]; protein K29-linked deubiquitination [GO:0035523]; protein K6-linked deubiquitination [GO:0044313]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006511; GO:0006914; GO:0008270; GO:0008283; GO:0010506; GO:0016579; GO:0030318; GO:0031625; GO:0035523; GO:0043130; GO:0044313; GO:0044389; GO:0050821; GO:0051087; GO:0070536; GO:0070628; GO:1904288; GO:1904294; GO:1904378; GO:1990380 BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270] DLGYMYFYRR 0.96831 -1.0259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5775 0 13.8754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6784 0 0 0 0 0 11.5571 0 0 0 0 0 0 0 0 0 0 0 11.5039 0 12.3698 0 0 Q9BWM7 SFXN3_HUMAN Sideroflexin-3 SFXN3 Homo sapiens (Human) mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300] GO:0005739; GO:0006730; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542 serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857] AKYVYDSAFHPDTGEKVVLIGR 0.96831 4.4119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3479 0 0 11.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5922 0 0 0 0 13.7127 0 0 0 0 0 0 0 0 12.7081 0 0 13.3161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PJX4 SHSA3_HUMAN Protein shisa-3 homolog SHISA3 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090] GO:0005789; GO:0016021; GO:0090090 LEQGGCTNDR 0.96832 -1.0288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4709 0 0 0 0 0 12.9491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.21 0 Q96S38 KS6C1_HUMAN "Ribosomal protein S6 kinase delta-1, S6K-delta-1, EC 2.7.11.1 (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein)" RPS6KC1 RPK118 Homo sapiens (Human) protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020] early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004674; GO:0005524; GO:0005764; GO:0005768; GO:0005769; GO:0006468; GO:0007165; GO:0016020; GO:0035091; GO:0106310 ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AGELIKLALKK 0.96832 -0.45869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0874 0 0 0 0 0 0 0 0 0 0 0 0 13.2351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5243 0 16.0507 0 0 0 0 0 0 0 0 0 0 0 0 14.0642 0 0 0 0 0 0 0 0 0 0 14.7154 0 0 0 0 13.0254 11.3931 0 14.6723 0 0 0 14.5078 14.9359 0 14.6565 0 0 14.4357 0 14.2338 0 0 0 0 0 0 0 14.7783 0 0 0 0 0 0 0 0 14.0769 0 0 0 0 0 0 0 0 0 14.4015 14.2849 0 14.4778 14.2793 0 13.3918 0 0 15.0272 13.9324 0 0 0 0 0 0 0 14.1279 0 13.6817 0 0 Q9NZI7 UBIP1_HUMAN Upstream-binding protein 1 (Transcription factor LBP-1) UBP1 LBP1 Homo sapiens (Human) angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LVKSIIRVVFHDR 0.96836 -0.22629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75593 FOXH1_HUMAN "Forkhead box protein H1 (Forkhead activin signal transducer 1, Fast-1, hFAST-1) (Forkhead activin signal transducer 2, Fast-2)" FOXH1 FAST1 FAST2 Homo sapiens (Human) "aorta morphogenesis [GO:0035909]; axial mesoderm development [GO:0048318]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to cytokine stimulus [GO:0071345]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; heart looping [GO:0001947]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; secondary heart field specification [GO:0003139]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular trabecula myocardium morphogenesis [GO:0003222]" activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; nuclear androgen receptor binding [GO:0050681]; protein domain specific binding [GO:0019904]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; aorta morphogenesis [GO:0035909]; axial mesoderm development [GO:0048318]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to cytokine stimulus [GO:0071345]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; heart looping [GO:0001947]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; secondary heart field specification [GO:0003139]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular trabecula myocardium morphogenesis [GO:0003222]" GO:0000122; GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001228; GO:0001947; GO:0003139; GO:0003151; GO:0003215; GO:0003222; GO:0003700; GO:0005634; GO:0005667; GO:0007179; GO:0019904; GO:0032444; GO:0033147; GO:0035054; GO:0035909; GO:0043425; GO:0043433; GO:0043565; GO:0045893; GO:0045944; GO:0046332; GO:0048318; GO:0050681; GO:0060766; GO:0070410; GO:0070412; GO:0071345; GO:0140297; GO:1900164 "bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; nuclear androgen receptor binding [GO:0050681]; protein domain specific binding [GO:0019904]; R-SMAD binding [GO:0070412]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]" DLGPYVLHGRPYR 0.96837 -0.44317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35218 CAH5A_HUMAN "Carbonic anhydrase 5A, mitochondrial, EC 4.2.1.1 (Carbonate dehydratase VA) (Carbonic anhydrase VA, CA-VA)" CA5A CA5 Homo sapiens (Human) one-carbon metabolic process [GO:0006730] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730] GO:0004089; GO:0005737; GO:0005739; GO:0005759; GO:0006730; GO:0008270; GO:0016836 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] EAVVGENGLAVIGVFLK 0.96837 -0.83666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2262 0 0 0 0 0 0 0 0 0 0 12.061 0 0 0 0 0 0 0 0 12.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6646 15.4294 0 0 0 0 0 0 0 0 14.5866 0 0 0 0 0 0 0 0 0 15.1889 0 0 0 0 0 13.6195 0 0 0 0 0 14.7461 0 0 15.9574 0 0 0 0 0 13.3693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3259 0 0 0 0 0 0 Q8TB73 NDNF_HUMAN Protein NDNF (Neuron-derived neurotrophic factor) NDNF C4orf31 UNQ2748/PRO6487 Homo sapiens (Human) angiogenesis [GO:0001525]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hypoxia [GO:0071456]; extracellular matrix organization [GO:0030198]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; nitric oxide mediated signal transduction [GO:0007263]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron projection development [GO:0010976]; response to ischemia [GO:0002931]; vascular wound healing [GO:0061042] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; angiogenesis [GO:0001525]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hypoxia [GO:0071456]; extracellular matrix organization [GO:0030198]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; nitric oxide mediated signal transduction [GO:0007263]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron projection development [GO:0010976]; response to ischemia [GO:0002931]; vascular wound healing [GO:0061042] GO:0001525; GO:0001764; GO:0002931; GO:0005539; GO:0005576; GO:0005615; GO:0007263; GO:0008201; GO:0010811; GO:0010976; GO:0019800; GO:0021828; GO:0030198; GO:0031012; GO:0043524; GO:0044344; GO:0061042; GO:0071456; GO:2000352 glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201] GNKKGASMLK 0.96838 -0.8374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5502 0 0 0 10.4486 0 0 0 0 0 0 0 0 0 0 0 12.4624 0 0 13.254 0 0 0 0 0 13.6304 11.8031 0 0 0 0 0 P23327 SRCH_HUMAN Sarcoplasmic reticulum histidine-rich calcium-binding protein HRC HCP Homo sapiens (Human) muscle contraction [GO:0006936]; positive regulation of heart contraction [GO:0045823]; positive regulation of heart rate [GO:0010460]; positive regulation of relaxation of cardiac muscle [GO:1901899]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314] endoplasmic reticulum lumen [GO:0005788]; sarcoplasmic reticulum lumen [GO:0033018]; Z disc [GO:0030018] endoplasmic reticulum lumen [GO:0005788]; sarcoplasmic reticulum lumen [GO:0033018]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325]; muscle contraction [GO:0006936]; positive regulation of heart contraction [GO:0045823]; positive regulation of heart rate [GO:0010460]; positive regulation of relaxation of cardiac muscle [GO:1901899]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314] GO:0002027; GO:0005509; GO:0005788; GO:0006936; GO:0010460; GO:0010880; GO:0010881; GO:0030018; GO:0033018; GO:0033135; GO:0044325; GO:0045823; GO:0051117; GO:0051480; GO:0060314; GO:1901844; GO:1901899; GO:1903169 ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; transmembrane transporter binding [GO:0044325] DEEEDEDVSTER 0.96839 -0.021587 0 10.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6432 0 0 0 0 0 0 0 11.8711 0 0 0 0 0 0 0 0 13.7406 0 0 0 0 11.2405 0 0 0 0 0 0 11.2164 0 0 10.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5132 15.9826 0 0 0 0 0 0 0 0 11.755 0 0 11.6885 14.7253 0 0 0 13.3348 0 12.898 0 0 0 0 0 0 0 0 0 0 0 0 12.5406 0 13.7825 14.8023 12.2965 10.056 14.4157 14.4987 0 0 11.2653 0 0 13.572 12.4398 0 0 0 0 0 0 13.6935 0 0 0 0 10.6439 0 0 14.5193 0 0 0 0 0 0 0 12.0028 0 0 0 15.4908 0 0 14.3456 0 12.7319 0 0 12.3652 11.0142 15.6667 0 0 12.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3587 0 15.1488 0 0 0 0 0 0 0 0 0 0 Q5BJE1 CC178_HUMAN Coiled-coil domain-containing protein 178 CCDC178 C18orf34 Homo sapiens (Human) ciliary basal body [GO:0036064] ciliary basal body [GO:0036064] GO:0036064 ADAEEALKQQR 0.9684 -0.84206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1427 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6811 13.6634 0 0 0 0 0 0 13.8717 14.5801 0 0 0 0 0 0 0 14.769 14.7219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4107 0 0 10.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8653 Q5T0T0 MARH8_HUMAN "E3 ubiquitin-protein ligase MARCHF8, EC 2.3.2.27 (Cellular modulator of immune recognition, c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII, MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCHF8)" MARCHF8 MARCH8 MIR RNF178 Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0002250; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0006955; GO:0008270; GO:0016021; GO:0031901; GO:0031902; GO:0042287; GO:0061630 MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] VIYVQNCPETSKKNIFEK 0.9684 -0.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9676 0 0 0 0 14.6809 14.6928 0 0 0 0 0 0 0 0 0 14.3085 0 0 0 13.3122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXF7 ATLA1_HUMAN "Atlastin-1, EC 3.6.5.- (Brain-specific GTP-binding protein) (GTP-binding protein 3, GBP-3, hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A)" ATL1 GBP3 SPG3A Homo sapiens (Human) axonogenesis [GO:0007409]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; axonogenesis [GO:0007409]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; protein homooligomerization [GO:0051260] GO:0000137; GO:0000139; GO:0003924; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007029; GO:0007409; GO:0016021; GO:0030424; GO:0042802; GO:0051260; GO:0071782; GO:0098826; GO:1990809 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] DKEVVAVSVAGAFR 0.9684 -0.81433 0 0 0 0 0 0 0 0 0 14.2827 14.0814 0 0 0 0 0 0 0 12.5165 0 14.7063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0581 0 0 0 0 0 0 0 12.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5187 15.3283 0 15.6921 0 0 15.5472 0 0 15.9377 15.418 0 0 15.3932 15.8266 0 0 16.1415 16.3697 0 0 0 0 0 16.3681 0 0 0 0 0 0 15.0934 15.0991 0 16.1756 0 0 16.1729 0 15.5702 15.5615 15.2935 0 15.8965 0 15.913 0 0 0 0 16.0499 0 0 0 0 0 0 0 0 0 15.6488 0 16.8328 0 15.6679 0 0 0 15.5542 0 0 0 14.6595 0 14.8575 0 0 0 0 14.706 13.9706 0 0 0 0 0 0 0 0 15.047 15.1544 0 15.5289 0 0 0 16.4183 0 Q9NZI8 IF2B1_HUMAN "Insulin-like growth factor 2 mRNA-binding protein 1, IGF2 mRNA-binding protein 1, IMP-1, IMP1 (Coding region determinant-binding protein, CRD-BP) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zipcode-binding protein 1, ZBP-1)" IGF2BP1 CRDBP VICKZ1 ZBP1 Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of mRNA stability involved in response to stress [GO:0010610]; regulation of RNA metabolic process [GO:0051252]" anchoring junction [GO:0070161]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904] "anchoring junction [GO:0070161]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; dendrite arborization [GO:0140059]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of mRNA stability involved in response to stress [GO:0010610]; regulation of RNA metabolic process [GO:0051252]" GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007399; GO:0010468; GO:0010494; GO:0010610; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0043025; GO:0043197; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0051252; GO:0070161; GO:0070934; GO:0070937; GO:0097150; GO:0140059; GO:1900152; GO:1990247; GO:1990904; GO:2000767 mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] FASASIK 0.9684 -0.84473 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3663 0 0 0 0 0 0 0 0 0 0 0 0 12.4381 0 13.5528 13.9365 0 0 0 0 12.951 0 0 0 0 13.043 13.435 13.8264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.878 14.7966 0 0 0 0 0 0 0 0 0 0 0 12.1191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7259 0 0 0 0 0 0 0 0 0 14.0484 13.2876 0 0 14.2808 0 0 14.4712 0 0 14.341 0 0 0 0 0 0 0 14.1376 0 0 0 0 P08559 ODPA_HUMAN "Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial, EC 1.2.4.1 (PDHE1-A type I)" PDHA1 PHE1A Homo sapiens (Human) acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099] GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0045254; GO:0061732 pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604] ADQLYKQKIIR 0.96841 -0.98484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2957 0 12.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1784 0 0 0 0 13.7766 0 0 0 0 0 0 0 0 13.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6184 0 0 0 0 0 0 0 0 13.2071 0 0 0 0 0 0 0 0 0 0 0 0 13.5498 0 0 0 0 0 0 0 0 0 0 0 0 0 O95197 RTN3_HUMAN "Reticulon-3 (Homolog of ASY protein, HAP) (Neuroendocrine-specific protein-like 2, NSP-like protein 2) (Neuroendocrine-specific protein-like II, NSP-like protein II, NSPLII)" RTN3 ASYIP NSPL2 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182]; vesicle-mediated transport [GO:0016192] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; apoptotic process [GO:0006915]; brain development [GO:0007420]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005615; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006915; GO:0007420; GO:0014069; GO:0016021; GO:0016192; GO:0030182; GO:0043005; GO:0071786; GO:0071787; GO:1902430 ALKLIIRLFLVEDLVDSLK 0.96842 -1.0212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1175 13.4445 13.9254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6334 0 0 P60953 CDC42_HUMAN "Cell division control protein 42 homolog, EC 3.6.5.2 (G25K GTP-binding protein)" CDC42 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; embryonic heart tube development [GO:0035050]; endocytosis [GO:0006897]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; modification of synaptic structure [GO:0099563]; modulation by host of viral process [GO:0044788]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; regulation of stress fiber assembly [GO:0051492]; substantia nigra development [GO:0021762]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322] "apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]; apolipoprotein A-I receptor binding [GO:0034191]; G protein activity [GO:0003925]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cellular response to interferon-gamma [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; embryonic heart tube development [GO:0035050]; endocytosis [GO:0006897]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; modification of synaptic structure [GO:0099563]; modulation by host of viral process [GO:0044788]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell growth [GO:0030307]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein binding [GO:0043393]; regulation of stress fiber assembly [GO:0051492]; substantia nigra development [GO:0021762]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0000139; GO:0000322; GO:0003161; GO:0003253; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005789; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006897; GO:0006911; GO:0007015; GO:0007030; GO:0007088; GO:0007097; GO:0007163; GO:0007229; GO:0008104; GO:0010591; GO:0010592; GO:0016020; GO:0017119; GO:0019901; GO:0021762; GO:0030036; GO:0030175; GO:0030225; GO:0030307; GO:0030496; GO:0030742; GO:0031256; GO:0031274; GO:0031333; GO:0031996; GO:0032427; GO:0032467; GO:0032488; GO:0032991; GO:0034191; GO:0034329; GO:0034332; GO:0035050; GO:0036336; GO:0036464; GO:0038189; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043393; GO:0043410; GO:0043552; GO:0044788; GO:0045177; GO:0045198; GO:0045335; GO:0046847; GO:0048549; GO:0048664; GO:0051233; GO:0051489; GO:0051491; GO:0051492; GO:0051496; GO:0051683; GO:0051988; GO:0060047; GO:0060071; GO:0060501; GO:0060997; GO:0061630; GO:0070062; GO:0071346; GO:0072384; GO:0072686; GO:0086101; GO:0099563; GO:1900026; GO:2000251 apolipoprotein A-I receptor binding [GO:0034191]; G protein activity [GO:0003925]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630] DDPSTIEK 0.96842 -1.0614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14134 TRI29_HUMAN Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein) TRIM29 ATDC Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122] adherens junction [GO:0005912]; lysosome [GO:0005764] adherens junction [GO:0005912]; lysosome [GO:0005764]; cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0002039; GO:0005764; GO:0005912; GO:0008270; GO:0042802; GO:0045087; GO:0098641; GO:1900181 cadherin binding involved in cell-cell adhesion [GO:0098641]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270] CPVHGKTMELFCQTDQTCICYLCMFQEHK 0.96842 -0.81806 0 0 0 0 0 0 0 0 0 13.8552 12.9311 0 0 0 0 0 0 0 13.8572 0 0 0 0 0 0 0 11.4306 0 0 0 0 0 0 0 0 0 0 0 0 12.1443 0 13.0928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5264 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2409 0 0 0 0 0 0 12.6266 0 0 0 0 0 0 0 10.5364 13.9481 13.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1911 0 0 0 12.945 0 0 0 0 14.8749 14.8434 0 13.1371 0 0 15.0265 0 0 12.9029 0 14.4053 0 0 0 0 0 0 0 0 0 13.0973 14.9093 0 0 0 11.9435 10.781 0 13.8901 14.3767 0 0 14.3124 14.8381 0 0 0 0 0 0 0 10.9083 0 0 0 0 0 0 0 15.0147 0 Q6P4F1 FUT10_HUMAN "Alpha-(1,3)-fucosyltransferase 10, EC 2.4.1.- (Fucosyltransferase X, Fuc-TX, FucT-X) (Galactoside 3-L-fucosyltransferase 10, Fucosyltransferase 10)" FUT10 Homo sapiens (Human) cerebral cortex radially oriented cell migration [GO:0021799]; fertilization [GO:0009566]; fucosylation [GO:0036065]; hemopoiesis [GO:0030097]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; neuronal stem cell division [GO:0036445]; neuronal stem cell population maintenance [GO:0097150]; protein folding [GO:0006457]; protein glycosylation [GO:0006486]; protein targeting [GO:0006605]; wound healing [GO:0042060] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; cerebral cortex radially oriented cell migration [GO:0021799]; fertilization [GO:0009566]; fucosylation [GO:0036065]; hemopoiesis [GO:0030097]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; neuronal stem cell division [GO:0036445]; neuronal stem cell population maintenance [GO:0097150]; protein folding [GO:0006457]; protein glycosylation [GO:0006486]; protein targeting [GO:0006605]; wound healing [GO:0042060] GO:0000139; GO:0005654; GO:0005764; GO:0005783; GO:0005789; GO:0005794; GO:0006457; GO:0006486; GO:0006605; GO:0007399; GO:0008417; GO:0009566; GO:0016021; GO:0021799; GO:0030097; GO:0036065; GO:0036071; GO:0036445; GO:0042060; GO:0042355; GO:0046920; GO:0097150 alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] KRLAPLVYVQSDCDPPSDR 0.96842 -0.8173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6939 13.7103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9795 13.8381 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2879 0 0 13.4573 0 0 0 0 0 0 0 0 13.6845 13.4766 0 0 0 13.8918 13.2055 0 14.8583 13.8516 0 0 0 0 0 14.3426 14.3096 14.8357 13.9309 0 0 14.575 11.8383 13.3707 0 0 0 0 0 10.431 0 0 0 0 0 0 13.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1302 0 0 0 0 0 0 Q8IYM2 SLN12_HUMAN "Ribonuclease SLFN12, EC 3.1.-.- (Schlafen family member 12)" SLFN12 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; rRNA catabolic process [GO:0016075] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonuclease activity [GO:0004540]; ribosome binding [GO:0043022]; apoptotic signaling pathway [GO:0097190]; rRNA catabolic process [GO:0016075] GO:0004540; GO:0005634; GO:0005829; GO:0016075; GO:0043022; GO:0097190 ribonuclease activity [GO:0004540]; ribosome binding [GO:0043022] EPDSWHVK 0.96842 -0.95546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6936 0 0 0 0 0 13.1555 0 0 0 0 14.8191 0 0 0 0 13.2172 14.4786 0 0 0 0 0 0 0 0 0 0 0 0 13.3116 0 13.7124 0 0 0 0 17.9623 17.8909 0 17.1815 17.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6308 0 0 0 0 0 0 0 0 Q9UGL9 CRCT1_HUMAN Cysteine-rich C-terminal protein 1 (Protein NICE-1) CRCT1 C1orf42 NICE1 Homo sapiens (Human) GCCGDSGCCGSSSTSCCCFPR 0.96842 -1.0229 0 0 0 0 0 0 0 11.8379 0 0 0 0 0 12.0711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3963 0 0 0 0 0 0 0 0 0 0 11.9714 0 10.0289 0 0 0 0 0 0 0 11.3302 0 13.7561 0 11.8605 12.5143 12.9091 0 0 11.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5993 0 0 0 11.6366 0 0 11.5171 0 10.7853 0 0 0 0 0 0 0 0 0 0 0 12.2732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4195 0 0 0 0 0 0 0 0 0 0 0 0 0 11.67 11.4849 0 0 0 0 0 0 0 11.221 11.4691 0 11.2811 0 0 0 11.5804 12.1385 0 0 0 0 0 0 Q9Y5G1 PCDGF_HUMAN "Protocadherin gamma-B3, PCDH-gamma-B3" PCDHGB3 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] GNFPFKIVQDTK 0.96842 -0.98744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6466 0 14.1072 13.6033 14.0979 0 0 0 0 13.3962 0 0 0 13.6077 0 0 0 0 0 0 13.3938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9927 0 0 0 13.4198 13.1907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0173 0 0 0 0 0 11.4464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10075 GLI4_HUMAN Zinc finger protein GLI4 (Krueppel-related zinc finger protein 4) (Protein HKR4) GLI4 HKR4 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGECGQAFSQSSNLVR 0.96843 -1.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6552 0 0 0 0 0 0 0 0 0 0 10.7373 0 0 14.0198 0 0 0 0 0 0 0 0 0 12.0203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8978 11.6838 0 0 0 11.3089 0 0 15.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9169 0 0 0 0 0 0 Q68CJ9 CR3L3_HUMAN "Cyclic AMP-responsive element-binding protein 3-like protein 3, cAMP-responsive element-binding protein 3-like protein 3 (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3 ]" CREB3L3 CREBH HYST1481 Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000139; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002675; GO:0005634; GO:0005654; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0016020; GO:0016021; GO:0030968; GO:0035497; GO:0042802; GO:0042803; GO:0045944; GO:0046982; GO:1990440 "cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" KVLHLEKQNLSLLEQLK 0.96843 -0.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1744 0 0 0 0 0 0 0 0 0 0 0 0 13.9211 15.1572 0 0 0 0 0 0 0 15.9855 15.266 0 14.6327 0 0 0 0 0 0 0 0 0 0 0 12.1748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9349 0 0 0 0 0 0 0 14.9547 0 0 0 14.1616 0 0 0 0 0 0 0 0 0 0 0 14.7576 0 0 0 11.802 Q9NZH4 PTTG3_HUMAN "Putative pituitary tumor-transforming gene 3 protein, hPTTG3 (Securin-3) (rcPTTG1)" PTTG3P PTTG3 Homo sapiens (Human) chromosome organization [GO:0051276]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SH3 domain binding [GO:0017124]; chromosome organization [GO:0051276]; homologous chromosome segregation [GO:0045143]; negative regulation of mitotic sister chromatid separation [GO:2000816] GO:0005634; GO:0005737; GO:0017124; GO:0045143; GO:0051276; GO:2000816 SH3 domain binding [GO:0017124] ATEKSVKTNGPLK 0.96843 -0.27802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7285 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7233 0 0 0 0 13.8522 0 13.7991 0 0 0 13.4526 13.9296 13.946 0 0 14.0338 0 0 13.6769 0 0 0 0 13.1577 12.6015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0314 0 0 0 0 0 0 0 13.1592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28566 5HT1E_HUMAN "5-hydroxytryptamine receptor 1E, 5-HT-1E, 5-HT1E (S31) (Serotonin receptor 1E)" HTR1E Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004930; GO:0004993; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007193; GO:0007198; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0051378 G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] AARILGLILGAFILSWLPFFIK 0.96844 -0.24683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8895 0 0 0 0 13.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4034 0 0 11.5487 0 0 13.0755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4569 10.8627 0 14.4556 0 0 0 0 0 13.4277 13.5703 0 13.8402 12.4751 0 0 0 0 0 0 0 11.6058 0 0 0 0 0 0 0 13.5774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08380 LG3BP_HUMAN "Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein, MAC2BP, Mac-2 BP) (Tumor-associated antigen 90K)" LGALS3BP M2BP Homo sapiens (Human) cell adhesion [GO:0007155]; cellular defense response [GO:0006968]; signal transduction [GO:0007165] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; cellular defense response [GO:0006968]; signal transduction [GO:0007165] GO:0005044; GO:0005576; GO:0005615; GO:0006968; GO:0007155; GO:0007165; GO:0016020; GO:0031089; GO:0062023; GO:0070062; GO:0072562 scavenger receptor activity [GO:0005044] ASHEEVEGLVEK 0.96849 -0.2721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1472 0 13.1462 12.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1364 0 0 0 0 0 12.0966 0 0 0 0 0 0 0 0 0 12.1565 17.5566 0 0 0 0 0 12.3283 0 0 0 0 0 14.5471 12.0773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4017 0 0 0 0 0 0 0 17.3577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4988 0 0 0 13.1061 Q15818 NPTX1_HUMAN "Neuronal pentraxin-1, NP1 (Neuronal pentraxin I, NP-I)" NPTX1 Homo sapiens (Human) axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133] glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133]; metal ion binding [GO:0046872]; axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] GO:0005739; GO:0005886; GO:0006839; GO:0007268; GO:0007417; GO:0030133; GO:0035865; GO:0043005; GO:0043083; GO:0043653; GO:0046872; GO:0060385; GO:0071333; GO:0098962; GO:0098978; GO:0099151; GO:0099645 metal ion binding [GO:0046872] ISELEKGQK 0.96849 -1.0065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.63041 0 0 0 0 0 12.251 0 0 10.9055 0 11.9872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.194 0 0 0 0 0 0 0 0 0 0 0 0 14.3608 0 0 0 0 0 0 0 17.7089 0 15.4521 0 0 0 0 0 0 0 0 0 0 0 0 16.6922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.76241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6468 0 0 0 0 0 0 O95199 RCBT2_HUMAN "RCC1 and BTB domain-containing protein 2 (Chromosome condensation 1-like, CHC1-L) (RCC1-like G exchanging factor) (Regulator of chromosome condensation and BTB domain-containing protein 2)" RCBTB2 CHC1L RLG Homo sapiens (Human) acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0001669; GO:0005085; GO:0005737 guanyl-nucleotide exchange factor activity [GO:0005085] VAALQGIRVQR 0.9685 -0.2258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1115 0 0 0 0 0 0 0 0 18.0463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9394 0 0 15.8141 0 0 0 Q7Z6R9 AP2D_HUMAN "Transcription factor AP-2-delta, AP2-delta (Activating enhancer-binding protein 2-delta) (Transcription factor AP-2-beta-like 1)" TFAP2D TFAP2BL1 Homo sapiens (Human) anatomical structure development [GO:0048856]; inferior colliculus development [GO:0061379]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; anatomical structure development [GO:0048856]; inferior colliculus development [GO:0061379]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005667; GO:0006357; GO:0006366; GO:0042127; GO:0043524; GO:0045944; GO:0048856; GO:0061379 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" LGLNLPAGRRK 0.9685 -0.83646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7299 0 14.7405 13.7189 13.7853 14.6473 13.6334 14.1753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2631 0 0 0 0 0 0 0 13.0129 0 0 0 0 0 0 0 O75956 CDKA2_HUMAN "Cyclin-dependent kinase 2-associated protein 2, CDK2-associated protein 2 (DOC-1-related protein, DOC-1R)" CDK2AP2 DOC1R Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stem cell division [GO:2000035] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stem cell division [GO:2000035] GO:0005634; GO:0005737; GO:0005874; GO:0070507; GO:2000035; GO:2000134 PTYAGSK 0.96852 -0.81369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9354 0 0 0 13.9077 0 0 0 13.2107 13.9212 0 0 0 0 13.567 0 0 0 0 14.1443 13.7865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6319 0 0 0 0 0 0 13.6248 0 0 0 0 13.6208 0 0 0 0 0 12.8466 12.0096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9401 13.3159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4807 0 0 0 0 Q9Y463 DYR1B_HUMAN "Dual specificity tyrosine-phosphorylation-regulated kinase 1B, EC 2.7.12.1 (Minibrain-related kinase) (Mirk protein kinase)" DYRK1B MIRK Homo sapiens (Human) "adipose tissue development [GO:0060612]; DNA repair [GO:0006281]; myoblast fusion [GO:0007520]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription coactivator activity [GO:0003713]; adipose tissue development [GO:0060612]; DNA repair [GO:0006281]; myoblast fusion [GO:0007520]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" GO:0003713; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006468; GO:0007520; GO:0018105; GO:0018107; GO:0045893; GO:0046777; GO:0060612; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transcription coactivator activity [GO:0003713] AFLNQAQIELRLLELMNQHDTEMK 0.96852 -0.015808 0 11.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1836 0 0 0 0 0 0 0 0 15.1628 0 0 0 0 0 12.2959 15.0412 0 0 0 0 0 0 15.0065 16.8668 0 16.5021 0 0 0 14.1004 16.8239 14.7595 13.936 0 0 0 0 0 0 0 0 14.7017 0 0 0 0 14.881 14.799 0 14.9078 0 14.8196 0 0 14.6981 0 14.9161 14.8811 14.8218 0 0 14.8442 14.636 14.8118 14.8324 14.7049 14.8843 0 14.6662 0 0 0 14.8509 14.9049 14.8439 14.9061 0 14.8405 0 14.9356 0 0 0 0 14.6782 14.4688 14.6748 14.567 0 0 0 14.5854 0 0 0 0 14.5929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7168 14.7609 0 0 0 0 14.5725 0 Q9H568 ACTL8_HUMAN "Actin-like protein 8 (Cancer/testis antigen 57, CT57)" ACTL8 Homo sapiens (Human) epithelial cell differentiation [GO:0030855] cytoplasm [GO:0005737]; dynactin complex [GO:0005869] cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; epithelial cell differentiation [GO:0030855] GO:0005737; GO:0005869; GO:0030855 AIVESVESCEISLRPLLVSHVMACGGNTLYPGFTKR 0.96853 -0.98305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4069 0 0 0 0 0 0 0 0 0 0 0 12.4223 12.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1026 12.9007 0 13.3883 0 0 0 0 0 0 0 0 0 10.7583 0 0 0 0 12.4523 0 0 0 0 0 0 0 0 0 12.282 0 15.6696 0 11.4783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8041 0 0 0 0 13.7831 0 0 11.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7423 0 0 0 14.2486 0 0 0 13.7287 0 12.8327 0 0 11.2687 0 0 0 0 0 0 0 0 13.4533 13.3264 13.6505 0 0 Q9Y614 ACL7B_HUMAN Actin-like protein 7B (Actin-like-7-beta) ACTL7B Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200] GO:0005200; GO:0005634; GO:0005737; GO:0005869; GO:0015629 structural constituent of cytoskeleton [GO:0005200] LITIGQER 0.96853 -0.81496 0 11.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3819 13.0679 0 0 0 0 0 13.972 0 13.2704 0 0 0 0 0 0 0 16.346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43237 DC1L2_HUMAN "Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic, LIC-2) (LIC53/55)" DYNC1LI2 DNCLI2 LIC2 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018] GO:0000226; GO:0000776; GO:0005524; GO:0005764; GO:0005770; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0016020; GO:0030286; GO:0042802; GO:0045504; GO:0051642; GO:1990090 ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802] ARSKLPSGK 0.96854 -0.27556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7135 0 0 0 0 0 0 0 0 0 0 12.1089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4805 0 15.1086 16.2048 0 0 14.3816 0 0 0 0 0 0 0 0 0 0 0 12.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42330 AK1C3_HUMAN "Aldo-keto reductase family 1 member C3, EC 1.1.1.-, EC 1.1.1.210, EC 1.1.1.53, EC 1.1.1.62 (17-beta-hydroxysteroid dehydrogenase type 5, 17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2, 3-alpha-HSD type 2, EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3, DD-3, DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Prostaglandin F synthase, PGFS, EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5, EC 1.1.1.239, EC 1.1.1.64)" AKR1C3 DDH1 HSD17B5 KIAA0119 PGFS Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; geranylgeranyl reductase activity [GO:0045550]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; prostaglandin-F synthase activity [GO:0047017]; retinal dehydrogenase activity [GO:0001758]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370]" GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0004745; GO:0005634; GO:0005737; GO:0005829; GO:0006693; GO:0007186; GO:0007584; GO:0008202; GO:0008284; GO:0008584; GO:0009267; GO:0010942; GO:0016229; GO:0016488; GO:0016655; GO:0018636; GO:0019371; GO:0030216; GO:0032052; GO:0034614; GO:0035410; GO:0036130; GO:0036131; GO:0042448; GO:0042574; GO:0043170; GO:0044594; GO:0044597; GO:0044598; GO:0045550; GO:0045703; GO:0047017; GO:0047020; GO:0047023; GO:0047024; GO:0047035; GO:0047044; GO:0047045; GO:0047086; GO:0047787; GO:0048385; GO:0051897; GO:0052650; GO:0061370; GO:0070062; GO:0070293; GO:0071276; GO:0071277; GO:0071379; GO:0071384; GO:0071395; GO:0071799; GO:1900053; GO:2000224; GO:2000353; GO:2000379 "15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; geranylgeranyl reductase activity [GO:0045550]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; prostaglandin-F synthase activity [GO:0047017]; retinal dehydrogenase activity [GO:0001758]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" ALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIR 0.96854 -0.81699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6158 11.8541 12.1789 0 0 0 0 0 9.60426 0 0 0 0 11.5192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7849 12.5102 0 0 0 0 14.8907 15.1115 14.7308 0 0 12.4207 0 0 0 0 0 0 0 15.0794 0 0 0 12.826 0 16.6412 0 12.8677 12.9231 0 13.8587 13.2604 0 0 0 0 0 0 0 0 0 13.3566 0 0 0 0 13.6338 13.7942 14.2715 0 14.7504 14.4943 0 13.9884 0 12.6808 12.998 0 12.2016 0 14.0497 13.1174 12.9702 0 0 0 0 0 15.5335 0 0 9.74256 0 0 0 12.1958 0 0 0 12.4905 0 0 0 0 0 0 0 0 0 0 0 0 10.1685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q693B1 KCD11_HUMAN BTB/POZ domain-containing protein KCTD11 (KCASH1 protein) (Potassium channel tetramerization domain-containing protein 11) (RING-type E3 ubiquitin transferase subunit KCTD11) KCTD11 C17orf36 REN Homo sapiens (Human) cell cycle [GO:0007049]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] identical protein binding [GO:0042802]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] GO:0007049; GO:0016567; GO:0016740; GO:0040008; GO:0042802; GO:0045666; GO:0051260 identical protein binding [GO:0042802]; transferase activity [GO:0016740] HILNFLRLGR 0.96854 -1.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P5R6 RL22L_HUMAN 60S ribosomal protein L22-like 1 (Large ribosomal subunit protein eL22-like 1) RPL22L1 Homo sapiens (Human) cytoplasmic translation [GO:0002181] ribosome [GO:0005840] ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181] GO:0002181; GO:0003723; GO:0003735; GO:0005840 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] MAPQKDR 0.96854 -0.81533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG31 KNL1_HUMAN "Kinetochore scaffold 1 (ALL1-fused gene from chromosome 15q14 protein, AF15q14) (Bub-linking kinetochore protein, Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29, CT29) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14)" KNL1 CASC5 KIAA1570 Homo sapiens (Human) acrosome assembly [GO:0001675]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; protein localization to kinetochore [GO:0034501] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acrosome assembly [GO:0001675]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; protein localization to kinetochore [GO:0034501] GO:0000776; GO:0001669; GO:0001675; GO:0005634; GO:0005654; GO:0005829; GO:0008608; GO:0016604; GO:0031617; GO:0034501; GO:0051301 DSRDEENK 0.96854 -0.2392 0 0 0 0 11.6263 0 0 0 0 13.7793 0 0 0 11.1816 0 0 0 12.6218 0 0 0 0 0 0 0 12.9247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0989 14.1021 14.9955 0 18.5655 0 0 0 0 0 14.2473 12.4821 11.2389 0 0 0 0 0 0 0 0 0 0 11.7618 14.3351 14.3803 15.0093 13.3075 0 0 0 0 0 0 0 14.1827 0 0 0 15.3195 15.8228 0 0 0 13.1874 0 0 0 0 0 0 0 0 14.2966 0 0 13.5061 0 0 0 15.0613 13.2039 15.3707 0 0 0 0 0 0 11.9499 0 0 0 14.9302 14.2528 14.5851 14.7307 0 0 0 13.5203 0 0 0 0 0 0 0 0 10.9791 0 0 0 0 0 11.893 0 0 12.2477 0 10.5121 0 Q8TAC2 JOS2_HUMAN "Josephin-2, EC 3.4.19.12 (Josephin domain-containing protein 2)" JOSD2 SBBI54 Homo sapiens (Human) protein deubiquitination [GO:0016579] cytosol [GO:0005829] cytosol [GO:0005829]; cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579] GO:0004843; GO:0005829; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843] PLSQLALPQVLGLILNLPSPVSLGLLSLPLR 0.96854 -0.81634 0 0 0 0 0 0 0 0 0 0 0 12.758 0 0 11.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4444 0 9.11416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3163 0 12.5072 0 0 0 0 13.6575 0 13.3656 0 0 12.1076 0 0 0 0 0 12.1424 0 0 0 0 0 0 12.4522 0 0 0 13.1936 0 0 0 0 0 0 0 0 13.0915 0 0 0 0 0 0 0 0 0 0 13.6497 0 0 0 0 0 0 0 0 13.8332 0 0 0 0 11.9634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3753 0 0 0 12.0595 0 0 0 0 0 0 0 0 0 12.8324 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYC8 RM32_HUMAN "39S ribosomal protein L32, mitochondrial, L32mt, MRP-L32 (Mitochondrial large ribosomal subunit protein bL32m)" MRPL32 HSPC283 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] HVLCAYCYEKVCK 0.96854 -0.95328 17.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9597 0 0 0 0 0 0 0 0 15.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAT2 SIAE_HUMAN "Sialate O-acetylesterase, EC 3.1.1.53 (H-Lse) (Sialic acid-specific 9-O-acetylesterase)" SIAE YSG2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; sialate 4-O-acetylesterase activity [GO:0106331]; sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682] GO:0001681; GO:0002682; GO:0005615; GO:0005764; GO:0005975; GO:0070062; GO:0106330; GO:0106331 sialate 4-O-acetylesterase activity [GO:0106331]; sialate 9-O-acetylesterase activity [GO:0106330]; sialate O-acetylesterase activity [GO:0001681] ALAYGEK 0.96854 -0.95503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9248 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3567 0 13.4524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NDL8 O6C68_HUMAN Olfactory receptor 6C68 OR6C68 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EEVNINK 0.96855 -1.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5745 0 12.1724 12.7691 12.5779 11.4815 0 10.7363 0 13.066 0 12.2687 0 12.4861 0 0 0 10.5507 0 0 0 0 0 0 0 0 0 14.5205 10.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8187 0 0 16.0055 0 0 0 0 10.7691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3737 0 0 14.8683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7336 0 0 0 0 0 0 0 0 0 15.3455 15.7336 15.1208 0 15.1265 14.8841 14.9011 0 14.2691 14.547 0 0 0 0 0 0 0 0 0 0 14.5532 0 0 Q99767 APBA2_HUMAN "Amyloid-beta A4 precursor protein-binding family A member 2 (Adapter protein X11beta) (Neuron-specific X11L protein) (Neuronal Munc18-1-interacting protein 2, Mint-2)" APBA2 MINT2 X11L Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; protein transport [GO:0015031]; regulation of gene expression [GO:0010468]; regulation of synaptic vesicle exocytosis [GO:2000300] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; chemical synaptic transmission [GO:0007268]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; protein transport [GO:0015031]; regulation of gene expression [GO:0010468]; regulation of synaptic vesicle exocytosis [GO:2000300] GO:0001540; GO:0001701; GO:0005737; GO:0005886; GO:0007268; GO:0007399; GO:0007626; GO:0008021; GO:0010468; GO:0015031; GO:0035264; GO:0042802; GO:0043197; GO:0098685; GO:2000300 amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802] GGIAERGGVR 0.96855 -1.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9237 0 0 14.5987 0 0 0 0 0 0 0 0 0 14.3617 15.2403 14.4769 0 0 0 0 0 0 0 0 13.6035 14.2807 14.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5167 15.1116 15.5238 0 0 14.741 15.2122 15.1367 0 0 0 0 0 0 0 14.961 0 0 0 0 0 0 0 0 0 14.9973 14.4663 0 14.8756 14.3717 0 0 0 15.0362 0 0 0 0 0 14.9656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2509 14.3808 0 0 0 0 0 Q7Z2Z2 EFL1_HUMAN Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A) EFL1 EFTUD1 FAM42A Homo sapiens (Human) GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256] ribonucleoprotein complex [GO:1990904] ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; mature ribosome assembly [GO:0042256] GO:0003746; GO:0003924; GO:0005525; GO:0042256; GO:0043022; GO:0046039; GO:1990904 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746] ARQRHAEK 0.96857 -0.9984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2041 0 0 13.3078 14.2627 13.8185 0 0 0 0 0 0 0 10.6474 11.8893 0 0 12.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.235 0 0 0 11.3531 0 0 0 14.2092 0 0 0 0 0 0 0 0 0 0 0 0 13.1785 0 0 0 0 0 11.2879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4987 0 0 9.60742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8355 0 0 0 0 0 0 0 Q9BQ51 PD1L2_HUMAN "Programmed cell death 1 ligand 2, PD-1 ligand 2, PD-L2, PDCD1 ligand 2, Programmed death ligand 2 (Butyrophilin B7-DC, B7-DC) (CD antigen CD273)" PDCD1LG2 B7DC CD273 PDCD1L2 PDL2 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295] endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295] GO:0002250; GO:0005576; GO:0005886; GO:0006955; GO:0007166; GO:0009897; GO:0012505; GO:0016021; GO:0031295; GO:0032689; GO:0032693; GO:0042102; GO:0042130; GO:0046007; GO:0071222 ERATLLEEQLPLGKASFHIPQVQVR 0.96857 -0.27769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4939 0 0 0 0 13.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0176 0 13.1994 0 0 13.7689 0 13.2022 0 14.3224 0 0 0 0 0 13.7601 0 0 0 0 0 0 0 13.5159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EP9 NTCP4_HUMAN Sodium/bile acid cotransporter 4 (Na(+)/bile acid cotransporter 4) (Solute carrier family 10 member 4) SLC10A4 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; bile acid and bile salt transport [GO:0015721] GO:0005886; GO:0008508; GO:0015721; GO:0016021 bile acid:sodium symporter activity [GO:0008508] RDPLDEDEDTDISYKK 0.96858 -0.24672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6QHC5 DEGS2_HUMAN "Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2, EC 1.14.18.5, EC 1.14.19.17 (Degenerative spermatocyte homolog 2) (Sphingolipid 4-desaturase) (Sphingolipid C4-monooxygenase)" DEGS2 C14orf66 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; sphinganine metabolic process [GO:0006667]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sphingolipid delta-4 desaturase activity [GO:0042284]; sphingosine hydroxylase activity [GO:0000170]; ceramide biosynthetic process [GO:0046513]; sphinganine metabolic process [GO:0006667]; sphingolipid biosynthetic process [GO:0030148] GO:0000170; GO:0005789; GO:0006667; GO:0016021; GO:0030148; GO:0042284; GO:0046513 sphingolipid delta-4 desaturase activity [GO:0042284]; sphingosine hydroxylase activity [GO:0000170] GNSASRSDFEWVYTDQPHTQRR 0.96859 2.9667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8863 0 0 0 0 0 0 0 0 0 0 0 0 0 13.081 0 0 0 0 0 0 0 13.1109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXX5 DNJC9_HUMAN "DnaJ homolog subfamily C member 9, HDJC9 (DnaJ protein SB73)" DNAJC9 Homo sapiens (Human) nucleosome assembly [GO:0006334]; positive regulation of ATP-dependent activity [GO:0032781] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334]; positive regulation of ATP-dependent activity [GO:0032781] GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006334; GO:0031072; GO:0032781; GO:0042393; GO:0051087; GO:0101031 chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393] EASDGEVRR 0.96859 -0.43842 0 0 0 0 0 0 0 0 0 13.9471 13.6281 13.8492 12.3053 12.8124 0 13.3592 13.7182 0 0 12.5332 0 0 15.0007 0 12.9616 12.2531 0 0 11.6105 0 13.7048 14.435 13.2323 13.7851 12.9731 12.2198 0 0 0 13.2766 14.776 14.0365 0 0 0 14.002 0 13.6028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3639 13.16 14.5502 13.9823 15.7009 15.434 14.9821 0 14.468 15.5813 13.0979 14.6724 15.3836 0 0 0 0 0 0 15.6313 0 0 Q4G0X4 KCD21_HUMAN BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21) KCTD21 Homo sapiens (Human) negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511] cullin family protein binding [GO:0097602]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0006511; GO:0016567; GO:0040008; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602 cullin family protein binding [GO:0097602]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] DGKVFRYILNFLR 0.9686 -1.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9085 0 0 0 0 13.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A99 PTX4_HUMAN Pentraxin-4 PTX4 C16orf38 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; metal ion binding [GO:0046872] GO:0005576; GO:0046872 metal ion binding [GO:0046872] LGTLLSYATEDNDNK 0.9686 -1.0045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LB1 MRGX2_HUMAN Mas-related G-protein coupled receptor member X2 MRGPRX2 MRGX2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; mast cell activation [GO:0045576]; mast cell degranulation [GO:0043303]; positive regulation of cytokinesis [GO:0032467]; sensory perception of pain [GO:0019233]; sleep [GO:0030431] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; mast cell secretagogue receptor activity [GO:1990595]; neuropeptide binding [GO:0042923]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell activation [GO:0045576]; mast cell degranulation [GO:0043303]; positive regulation of cytokinesis [GO:0032467]; sensory perception of pain [GO:0019233]; sleep [GO:0030431] GO:0004930; GO:0005886; GO:0007186; GO:0016021; GO:0019233; GO:0030431; GO:0032467; GO:0042923; GO:0043303; GO:0045576; GO:1990595 G protein-coupled receptor activity [GO:0004930]; mast cell secretagogue receptor activity [GO:1990595]; neuropeptide binding [GO:0042923] ETLIPVFLILFIALVGLVGNGFVLWLLGFR 0.9686 3.2149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5918 0 0 0 0 0 0 0 0 0 0 14.5043 0 0 0 0 0 0 0 0 0 14.9303 0 13.6172 14.0001 0 0 0 0 0 0 15.3623 0 0 0 14.8064 0 0 0 0 14.1688 0 0 0 0 13.2102 0 0 0 10.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.395 13.1244 0 0 0 13.2735 0 0 0 0 0 0 0 0 0 13.0508 0 14.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14854 CX6B1_HUMAN "Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1, COX VIb-1)" COX6B1 COX6B Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; substantia nigra development [GO:0021762]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; substantia nigra development [GO:0021762]" GO:0004129; GO:0005739; GO:0005743; GO:0005751; GO:0006123; GO:0021762; GO:0031966; GO:0045277; GO:0045333 cytochrome-c oxidase activity [GO:0004129] CQKAMTAK 0.96861 -1.0065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2122 0 0 0 0 0 0 17.1106 0 13.5228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7311 15.891 0 16.303 0 14.6195 0 0 0 0 0 0 14.9557 0 0 0 14.9211 0 0 0 0 0 0 0 14.2644 0 0 0 0 0 0 0 0 0 0 14.9772 0 0 0 0 0 0 0 0 0 14.8278 0 0 0 13.4181 14.8555 14.9473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y581 INSL6_HUMAN "Insulin-like peptide INSL6, Insulin-like peptide 6 (Relaxin/insulin-like factor 1) [Cleaved into: Insulin-like peptide INSL6 B chain; Insulin-like peptide INSL6 A chain ]" INSL6 RIF1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; hormone activity [GO:0005179] GO:0005179; GO:0005576 hormone activity [GO:0005179] EIEKLCGHANWSQFR 0.96861 4.7679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85244 0 10.7888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0719 14.0438 14.5236 14.7571 14.5889 0 12.6414 12.8532 0 0 0 0 0 0 0 0 0 0 0 13.7661 14.7453 0 0 0 12.6045 0 0 0 0 12.0646 12.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0741 0 0 0 0 9.5792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8245 0 0 11.9515 0 0 0 0 0 0 0 0 0 0 11.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3273 0 0 0 9.9461 0 0 0 0 Q8N0V5 GNT2A_HUMAN "N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase, N-acetylglucosaminyltransferase, EC 2.4.1.150 (I-branching enzyme) (IGNT)" GCNT2 GCNT5 II NACGT1 Homo sapiens (Human) glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of protein kinase B signaling [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000139; GO:0005794; GO:0006024; GO:0006486; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0016021; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374 "acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]" FELNTYPLTVECLELRHRER 0.96862 -0.46259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCN3 PGAP6_HUMAN "Post-GPI attachment to proteins factor 6, EC 3.1.1.4 (GPI processing phospholipase A2, GPI-PLA2) (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8) (Transmembrane protein 8A)" PGAP6 TMEM6 TMEM8 TMEM8A Homo sapiens (Human) lipid metabolic process [GO:0006629] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; phospholipase A2 activity [GO:0004623]; lipid metabolic process [GO:0006629] GO:0004623; GO:0005765; GO:0005886; GO:0005887; GO:0006629; GO:0070062 phospholipase A2 activity [GO:0004623] FPCHYQICKNDR 0.96862 -0.83634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6747 0 12.6882 0 0 0 0 14.4914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0364 0 0 0 0 0 12.1431 0 0 Q96E40 SACA9_HUMAN Sperm acrosome-associated protein 9 SPACA9 C9orf9 Homo sapiens (Human) acrosomal vesicle [GO:0001669]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasmic microtubule [GO:0005881]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasmic microtubule [GO:0005881]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; calcium-dependent protein binding [GO:0048306] GO:0001669; GO:0005634; GO:0005881; GO:0036064; GO:0036126; GO:0048306; GO:0097546 calcium-dependent protein binding [GO:0048306] CRQLTKASLK 0.96863 -0.27151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B7Z368 CJ142_HUMAN Uncharacterized protein encoded by LINC02881 (Long intergenic non-protein coding RNA 2881) LINC02881 C10orf142 Homo sapiens (Human) QDSAAGNSEEREPR 0.96864 -0.84078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9558 0 0 0 0 0 12.8576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7006 0 0 0 0 0 0 0 0 0 0 11.176 0 0 0 0 0 9.55198 0 0 0 0 12.3281 0 13.0593 0 0 0 0 0 0 0 0 14.0835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57789 KCNKA_HUMAN Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit) KCNK10 TREK2 Homo sapiens (Human) memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; stabilization of membrane potential [GO:0030322] GO:0005267; GO:0005886; GO:0005887; GO:0007165; GO:0007613; GO:0015271; GO:0022841; GO:0030322; GO:0034765; GO:0071805 outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] ANVTAEFRETRR 0.96864 -0.97999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5123 0 11.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7982 0 0 0 0 0 0 0 0 0 20.7209 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1791 12.3687 0 0 0 0 12.5645 16.2954 0 0 0 0 0 0 0 12.6267 0 0 12.5094 0 0 13.1346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VSG8 MANEL_HUMAN "Glycoprotein endo-alpha-1,2-mannosidase-like protein, EC 3.2.1.-" MANEAL Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559] GO:0000139; GO:0004559; GO:0005794; GO:0016021 alpha-mannosidase activity [GO:0004559] AIPKKTPTR 0.96864 -0.81221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0869 0 0 0 0 0 0 0 0 11.14 0 0 10.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VQ3 TXND2_HUMAN "Thioredoxin domain-containing protein 2 (Spermatid-specific thioredoxin-1, Sptrx-1)" TXNDC2 SPTRX SPTRX1 Homo sapiens (Human) cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283] GO:0004791; GO:0005737; GO:0007283; GO:0030154; GO:0045454 thioredoxin-disulfide reductase activity [GO:0004791] HEDVVFLEVDADNCEEVVRECAIMCVPTFQFYK 0.96864 -0.25176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7141 0 0 11.2024 0 0 0 0 0 0 0 0 0 10.8292 0 0 15.0238 14.0153 14.1356 0 14.2931 0 0 0 14.2276 14.0069 11.1498 0 0 0 14.428 0 0 0 0 0 0 0 0 11.7353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0426 0 0 0 0 14.0758 0 0 0 0 12.1699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4584 0 0 Q8TDS5 OXER1_HUMAN Oxoeicosanoid receptor 1 (5-oxo-ETE G-protein coupled receptor) (G-protein coupled receptor 170) (G-protein coupled receptor R527) (G-protein coupled receptor TG1019) OXER1 GPR170 TG1019 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [GO:0050648]; 5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [GO:0050647]; 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [GO:0050646]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled receptor signaling pathway [GO:0007186]" GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0016021; GO:0050646; GO:0050647; GO:0050648 "5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [GO:0050648]; 5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding [GO:0050647]; 5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding [GO:0050646]; G protein-coupled receptor activity [GO:0004930]" FGAAACK 0.96864 -0.27323 0 0 10.1935 0 0 0 0 0 0 0 0 13.6381 0 0 0 0 14.5032 13.2307 13.6695 13.0623 14.4284 0 13.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1147 15.521 15.8175 16.829 16.8002 17.2274 16.7345 15.6385 16.8694 15.1522 16.3122 0 0 11.3312 0 0 0 0 0 0 0 0 0 0 0 12.4312 0 0 11.5053 0 0 0 0 0 13.229 0 0 13.3711 14.2083 0 0 0 0 13.6327 0 13.7051 0 0 0 13.2229 13.1052 0 0 0 0 0 12.3694 13.7832 13.266 13.3682 0 0 14.4468 14.5267 0 0 0 0 0 14.1995 0 0 0 0 0 0 11.3612 0 13.9033 0 0 0 0 0 0 14.0045 0 11.9019 0 0 13.5207 0 13.4726 0 12.2264 0 0 14.0472 0 0 0 12.8502 13.7819 0 0 0 0 14.3113 0 Q9NQS5 GPR84_HUMAN G-protein coupled receptor 84 (Inflammation-related G-protein coupled receptor EX33) GPR84 EX33 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604]; neuropeptide signaling pathway [GO:0007218] GO:0001604; GO:0005886; GO:0005887; GO:0007218; GO:0008528; GO:0035579; GO:0043235; GO:0070821 G protein-coupled peptide receptor activity [GO:0008528]; urotensin II receptor activity [GO:0001604] APDSSSEFGK 0.96864 -0.25099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5236 0 0 0 0 0 0 0 0 12.416 0 0 0 0 0 0 0 0 0 13.275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8111 0 0 0 0 0 0 0 0 0 0 0 0 13.1573 0 0 0 0 13.0302 0 0 11.1037 Q14653 IRF3_HUMAN "Interferon regulatory factor 3, IRF-3" IRF3 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage apoptotic process [GO:0071888]; MDA-5 signaling pathway [GO:0039530]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; programmed necrotic cell death [GO:0097300]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon signaling pathway [GO:0060337] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage apoptotic process [GO:0071888]; MDA-5 signaling pathway [GO:0039530]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; programmed necrotic cell death [GO:0097300]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon signaling pathway [GO:0060337]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006915; GO:0006974; GO:0019904; GO:0031663; GO:0032481; GO:0032727; GO:0032728; GO:0035666; GO:0039530; GO:0042802; GO:0042803; GO:0042981; GO:0043123; GO:0043565; GO:0045944; GO:0050727; GO:0051607; GO:0060337; GO:0060340; GO:0071360; GO:0071888; GO:0097300; GO:0098586; GO:1990837; GO:1990841 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" FRIPWKHGLR 0.96865 -0.42107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.243 0 0 0 12.8149 12.89 12.3654 0 0 12.2266 0 0 0 0 13.9684 12.6924 0 0 0 11.4688 0 0 0 0 0 0 0 0 0 11.7124 0 13.3134 11.1071 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9694 13.3888 0 11.2743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1287 13.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SXY8 AR13B_HUMAN "ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1, ARL2-like protein 1)" ARL13B ARL2L1 Homo sapiens (Human) cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730] axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224] GO:0001947; GO:0003924; GO:0005525; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0009953; GO:0010226; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0060170; GO:0060271; GO:0070986; GO:0097500; GO:0097730; GO:1905515 GTP binding [GO:0005525]; GTPase activity [GO:0003924] DSDGCHLK 0.96865 -0.84108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6V5 ADAT2_HUMAN "tRNA-specific adenosine deaminase 2, EC 3.5.4.33 (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2)" ADAT2 DEADC1 Homo sapiens (Human) tRNA wobble adenosine to inosine editing [GO:0002100] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270]; tRNA wobble adenosine to inosine editing [GO:0002100] GO:0002100; GO:0005654; GO:0008270; GO:0052717 tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270] GRNEVNQTK 0.96865 -0.81278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N370 LAT4_HUMAN Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2) SLC43A2 LAT4 PP7664 Homo sapiens (Human) amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804] GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0016021; GO:0051956; GO:0060358 amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175] APTLATAHRR 0.96865 -1.0167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5R6 AB1IP_HUMAN "Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1-interacting protein 1) (Proline-rich EVH1 ligand 1, PREL-1) (Proline-rich protein 73) (Rap1-GTP-interacting adapter molecule, RIAM) (Retinoic acid-responsive proline-rich protein 1, RARP-1)" APBB1IP PREL1 RARP1 RIAM Homo sapiens (Human) positive regulation of cell adhesion [GO:0045785]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; positive regulation of cell adhesion [GO:0045785]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] GO:0002291; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007165; GO:0030027; GO:0042101; GO:0045785 AVAKAGLASR 0.96866 -1.0209 17.0059 0 0 0 0 16.4235 16.7744 0 13.9099 12.1124 0 0 12.005 0 14.2409 15.2421 12.4078 0 0 0 0 12.8563 0 13.8551 10.8471 0 11.1445 0 0 0 11.5642 12.5531 0 13.3848 12.3812 12.1145 0 13.7231 0 13.4546 12.8268 0 0 13.3902 0 12.6501 0 0 0 13.5341 12.9377 13.5124 13.7132 14.2678 14.5356 13.292 13.0867 12.5269 0 0 0 0 10.8246 0 0 0 17.5409 14.9817 14.2261 14.5951 0 12.7661 12.9677 18.0226 17.5481 19.7438 19.6852 19.0748 17.5653 17.5361 17.6808 18.9094 18.9349 18.9254 19.6122 19.5934 19.6601 14.3145 18.5242 17.3063 19.0305 15.5431 17.5805 13.1612 18.7064 18.6783 14.1253 19.4755 14.0256 19.7135 19.9321 19.0103 18.6258 19.4014 14.4677 15.5622 18.2151 0 19.4304 19.6137 19.4007 19.2435 18.5585 0 19.3732 19.378 19.3377 0 18.6212 18.6659 18.5428 18.2649 14.7898 13.4318 19.7358 18.809 18.7201 19.3625 0 12.5032 18.2985 18.3411 17.9299 17.8988 13.2609 18.4708 18.6408 18.4256 19.8346 14.593 13.3927 0 0 13.9539 14.3386 14.5961 13.6373 13.1768 12.0949 0 20.0579 19.1702 14.6445 0 18.8689 18.9235 18.2758 0 15.6437 0 12.3445 0 0 13.3518 13.1171 0 13.6994 13.6195 0 0 0 18.1399 12.8717 18.1943 15.6099 13.7518 0 14.0955 0 0 O14793 GDF8_HUMAN "Growth/differentiation factor 8, GDF-8 (Myostatin)" MSTN GDF8 Homo sapiens (Human) "cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" cytoplasm [GO:0005737]; extracellular space [GO:0005615] "cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0005102; GO:0005125; GO:0005615; GO:0005737; GO:0007179; GO:0007517; GO:0008083; GO:0008201; GO:0009408; GO:0009629; GO:0010592; GO:0010759; GO:0010862; GO:0014732; GO:0014741; GO:0014839; GO:0014850; GO:0022602; GO:0033574; GO:0033673; GO:0042802; GO:0042803; GO:0043627; GO:0045471; GO:0045662; GO:0045893; GO:0046627; GO:0046716; GO:0048632; GO:0051602; GO:0051898; GO:0060395; GO:0071549; GO:1902723; GO:1902725; GO:2000818 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] DFGLDCDEHSTESR 0.96866 -0.95302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1012 12.6957 0 0 0 0 0 0 0 0 13.3008 0 13.2379 13.8739 13.8177 0 0 0 0 0 12.2623 0 0 14.0009 0 0 14.1346 0 0 0 0 0 15.471 14.0133 13.4621 0 15.4501 14.6963 0 13.2433 13.4755 0 13.5287 0 0 0 14.0065 14.1723 12.0085 14.0462 14.2986 14.175 0 0 13.594 0 0 0 0 0 0 14.2892 0 0 13.6345 14.2159 0 13.7875 0 0 0 14.2832 14.2067 0 10.259 0 0 0 0 0 11.9201 0 0 0 0 0 0 13.6683 9.19094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51793 CLCN4_HUMAN "H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4, ClC-4) (Chloride transporter ClC-4)" CLCN4 Homo sapiens (Human) chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; non-motile cilium assembly [GO:1905515] ciliary base [GO:0097546]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021] ciliary base [GO:0097546]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; non-motile cilium assembly [GO:1905515] GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005887; GO:0006821; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0031901; GO:0031902; GO:0034220; GO:0055037; GO:0055038; GO:0097546; GO:1905515 antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247] ETDYNGFPVVVSR 0.96866 -0.8149 0 0 0 0 0 0 0 0 0 0 12.8235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7929 0 0 0 0 0 0 14.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6113 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1599 0 0 0 0 O75348 VATG1_HUMAN "V-type proton ATPase subunit G 1, V-ATPase subunit G 1 (V-ATPase 13 kDa subunit 1) (Vacuolar proton pump subunit G 1) (Vacuolar proton pump subunit M16)" ATP6V1G1 ATP6G ATP6G1 ATP6J Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; regulation of macroautophagy [GO:0016241] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; regulation of macroautophagy [GO:0016241]" GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0006879; GO:0016241; GO:0016324; GO:0016471; GO:0016887; GO:0036295; GO:0046961; GO:0051117; GO:0070062 "ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" ASQSQGIQQLLQAEKR 0.96867 -0.23065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2322 0 0 0 11.329 10.7448 0 0 11.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20962 PTMS_HUMAN Parathymosin PTMS Homo sapiens (Human) DNA replication [GO:0006260]; immune system process [GO:0002376]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] nucleus [GO:0005634]; histone binding [GO:0042393]; DNA replication [GO:0006260]; immune system process [GO:0002376]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0002376; GO:0005634; GO:0006260; GO:0042393; GO:0043066; GO:0045944 histone binding [GO:0042393] MSEKSVEAAAELSAKDLK 0.96868 -0.43526 14.6785 13.7726 13.4622 0 0 13.348 0 0 0 0 0 0 0 0 0 0 0 0 13.0692 0 13.5913 16.1423 0 14.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.828 0 0 11.9534 0 0 0 0 0 0 0 0 0 0 0 0 15.8783 0 0 0 0 0 0 17.2296 16.9487 17.7572 16.9786 17.3532 16.8302 15.7181 17.4072 15.6138 15.7631 14.4363 15.5492 14.8106 15.9588 13.671 14.2189 16.6852 15.9814 15.8403 15.3949 13.9907 15.8698 15.9957 15.9345 16.7974 0 13.6884 14.9108 0 0 14.1346 14.3197 15.4241 15.2844 15.3468 16.261 0 0 0 16.155 15.6017 14.2257 16.3782 14.5329 15.3925 15.2459 0 14.3343 15.8488 15.1681 14.9126 15.229 14.4263 0 16.7265 15.5495 17.1363 14.8262 15.7534 17.3737 14.9334 14.0532 15.2767 17.21 16.4111 14.7049 15.5278 15.8726 15.8059 13.8646 15.7339 13.1837 15.0183 0 14.8749 0 17.2837 17.2329 0 0 15.0072 14.4271 15.2823 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4832 16.0021 0 17.1257 13.2419 0 0 0 15.7737 0 P28331 NDUS1_HUMAN "NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial, EC 7.1.1.2 (Complex I-75kD, CI-75kD)" NDUFS1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]" mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]" GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0005759; GO:0006120; GO:0008137; GO:0008637; GO:0009055; GO:0009060; GO:0032981; GO:0042776; GO:0045333; GO:0046034; GO:0046872; GO:0051537; GO:0051539; GO:0051881; GO:0072593 "2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]" ALVGLSKSPKGCVR 0.96868 -0.23257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.367 0 0 0 0 0 0 0 0 12.7077 0 13.6165 13.6486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4624 0 0 0 0 0 0 0 0 0 0 0 0 12.538 0 0 15.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2525 0 0 0 0 0 0 0 0 0 0 12.7904 0 0 0 0 11.8773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99801 NKX31_HUMAN Homeobox protein Nkx-3.1 (Homeobox protein NK-3 homolog A) NKX3-1 NKX3.1 NKX3A Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; androgen receptor signaling pathway [GO:0030521]; branching involved in prostate gland morphogenesis [GO:0060442]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal aorta development [GO:0035907]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; heart development [GO:0007507]; male gonad development [GO:0008584]; metanephros development [GO:0001656]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription, DNA-templated [GO:0045892]; pharyngeal system development [GO:0060037]; positive regulation of androgen secretion [GO:2000836]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; salivary gland development [GO:0007431]; somitogenesis [GO:0001756]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; MADS box domain binding [GO:0097162]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor activity [GO:0004879]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; androgen receptor signaling pathway [GO:0030521]; branching involved in prostate gland morphogenesis [GO:0060442]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal aorta development [GO:0035907]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; heart development [GO:0007507]; male gonad development [GO:0008584]; metanephros development [GO:0001656]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of transcription, DNA-templated [GO:0045892]; pharyngeal system development [GO:0060037]; positive regulation of androgen secretion [GO:2000836]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell death [GO:0010942]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; salivary gland development [GO:0007431]; somitogenesis [GO:0001756]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001656; GO:0001756; GO:0001934; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0006919; GO:0007431; GO:0007507; GO:0008284; GO:0008285; GO:0008584; GO:0008656; GO:0010628; GO:0010629; GO:0010942; GO:0014068; GO:0030154; GO:0030331; GO:0030521; GO:0032880; GO:0033574; GO:0035907; GO:0042826; GO:0043280; GO:0043491; GO:0043565; GO:0043569; GO:0043621; GO:0045892; GO:0045893; GO:0045931; GO:0045944; GO:0048754; GO:0050680; GO:0051091; GO:0051781; GO:0060037; GO:0060442; GO:0060664; GO:0060767; GO:0060770; GO:0071347; GO:0071356; GO:0071383; GO:0071456; GO:0071466; GO:0090734; GO:0097162; GO:0140297; GO:0140416; GO:1902807; GO:1990837; GO:2000836; GO:2001022; GO:2001235; GO:2001244 "cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; MADS box domain binding [GO:0097162]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor activity [GO:0004879]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]" DPEPEPEPEPEGGR 0.9687 -0.23514 0 0 0 0 0 0 0 0 0 0 12.588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1N0 C2D1A_HUMAN "Coiled-coil and C2 domain-containing protein 1A (Akt kinase-interacting protein 1) (Five prime repressor element under dual repression-binding protein 1, FRE under dual repression-binding protein 1, Freud-1) (Putative NF-kappa-B-activating protein 023N)" CC2D1A AKI1 Homo sapiens (Human) negative regulation of snRNA transcription by RNA polymerase II [GO:1905381]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of snRNA transcription by RNA polymerase II [GO:1905381]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001227; GO:0001650; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0006357; GO:0016020; GO:0043123; GO:0045296; GO:0070062; GO:1905381 "cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" APPSRTPQSGSAPTAKAPPK 0.96872 -1.0044 0 0 13.1599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3938 0 0 0 0 0 0 0 0 10.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.386 0 0 14.0718 0 13.0311 0 0 0 0 0 14.9495 13.3396 13.5164 12.4823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1308 0 13.4722 0 0 0 0 14.3569 0 12.567 0 0 0 0 14.3257 0 0 0 0 0 0 0 0 0 15.2216 0 0 0 0 0 13.617 14.2041 13.9956 0 0 14.3004 13.4246 0 0 0 13.0016 0 0 0 0 0 0 0 0 0 0 12.3268 0 11.9856 12.3613 13.3959 0 0 13.7132 12.4276 0 12.2599 14.9052 0 A0A494BZU4 T217B_HUMAN Putative transmembrane protein 217B TMEM217B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LCSTIAVNS 0.96873 -0.24666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36383 CXG1_HUMAN "Gap junction gamma-1 protein (Connexin-45, Cx45) (Gap junction alpha-7 protein)" GJC1 GJA7 Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; AV node cell to bundle of His cell communication by electrical coupling [GO:0086053]; cardiac muscle tissue development [GO:0048738]; cell development [GO:0048468]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; gap junction assembly [GO:0016264]; muscle contraction [GO:0006936]; SA node cell to atrial cardiac muscle cell communication by electrical coupling [GO:0086021]; vasculogenesis [GO:0001570]; visual perception [GO:0007601] connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; synapse [GO:0045202] connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; synapse [GO:0045202]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling [GO:0086077]; gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling [GO:0086020]; ion channel activity [GO:0005216]; atrial cardiac muscle cell action potential [GO:0086014]; AV node cell to bundle of His cell communication by electrical coupling [GO:0086053]; cardiac muscle tissue development [GO:0048738]; cell development [GO:0048468]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; gap junction assembly [GO:0016264]; muscle contraction [GO:0006936]; SA node cell to atrial cardiac muscle cell communication by electrical coupling [GO:0086021]; vasculogenesis [GO:0001570]; visual perception [GO:0007601] GO:0001570; GO:0005216; GO:0005243; GO:0005789; GO:0005886; GO:0005921; GO:0005922; GO:0006936; GO:0007043; GO:0007267; GO:0007268; GO:0007601; GO:0014704; GO:0016021; GO:0016264; GO:0045202; GO:0048468; GO:0048738; GO:0086014; GO:0086020; GO:0086021; GO:0086053; GO:0086077 gap junction channel activity [GO:0005243]; gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling [GO:0086077]; gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling [GO:0086020]; ion channel activity [GO:0005216] IWLTVLIVFR 0.96875 -0.83604 13.2164 0 13.1333 12.8227 13.8982 14.0284 13.9634 13.3019 0 0 0 0 0 0 0 0 0 0 0 0 11.4683 14.3285 0 15.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4817 0 0 0 0 0 15.2368 15.4415 16.9022 14.6849 14.8984 16.3172 16.7439 13.6971 14.4263 0 0 17.9982 0 16.5643 0 16.5723 16.0486 0 16.2057 15.3143 13.1632 16.4617 16.281 0 0 0 0 16.7823 14.8676 16.1837 14.3247 0 0 14.3768 16.4066 15.8556 16.2225 16.5504 14.2779 0 15.8108 15.7374 16.7942 0 16.2778 15.1292 16.1207 15.4447 16.8849 17.2308 15.546 15.5452 16.4059 15.3912 16.8463 15.3557 17.1791 15.3508 0 16.2424 14.6367 15.9124 16.863 16.3321 17.2481 16.0343 15.9133 16.1716 16.741 15.6559 16.5485 15.0701 16.1998 14.7906 16.142 0 15.0714 0 16.3299 0 17.4589 16.2628 0 16.1298 15.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9009 14.0411 15.1282 14.7498 0 0 0 17.048 0 Q8N3J2 METL4_HUMAN "N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4, EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4, EC 2.1.1.-)" METTL4 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347]; chromatin organization [GO:0006325]; DNA methylation on adenine [GO:0032775]; regulation of chromatin organization [GO:1902275]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049] GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0006325; GO:0008168; GO:0008173; GO:0009007; GO:0032775; GO:0043484; GO:0090296; GO:0106347; GO:0120049; GO:1902275; GO:1903108 methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347] MSVVHQLSAGWLLDHLSFINKINYQLHQHHEPCCR 0.96875 -0.46158 11.9015 0 0 0 0 0 0 0 0 13.0715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7918 0 0 13.4547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6189 14.9014 0 0 14.0352 0 0 0 0 0 0 14.05 0 0 0 13.5984 0 14.3295 13.4346 0 13.4665 0 0 0 0 0 0 0 0 13.5792 0 13.6288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0981 0 0 0 0 0 0 0 0 0 0 12.7636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAV2 CH058_HUMAN Uncharacterized protein C8orf58 C8orf58 Homo sapiens (Human) GDKFRGVGR 0.96875 -0.80971 10.0458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4439 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9081 14.6922 14.7699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99218 AMELY_HUMAN "Amelogenin, Y isoform" AMELY AMGL AMGY Homo sapiens (Human) enamel mineralization [GO:0070166] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; structural constituent of tooth enamel [GO:0030345]; enamel mineralization [GO:0070166] GO:0005576; GO:0030345; GO:0062023; GO:0070166 structural constituent of tooth enamel [GO:0030345] IALVLTPLK 0.96875 -0.24779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84879 0 0 0 0 0 0 0 0 Q9BYQ4 KRA92_HUMAN Keratin-associated protein 9-2 (Keratin-associated protein 9.2) (Ultrahigh sulfur keratin-associated protein 9.2) KRTAP9-2 KAP9.2 KRTAP9.2 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; identical protein binding [GO:0042802] GO:0005829; GO:0042802; GO:0045095 identical protein binding [GO:0042802] MTHCCSPCCQPTCCR 0.96875 4.2381 13.5145 0 0 0 0 0 0 15.0897 0 0 0 11.8131 0 0 0 13.0774 0 14.485 0 0 14.0406 0 14.415 0 13.9362 0 13.1886 0 13.2732 0 0 0 0 0 0 0 0 12.7356 0 11.9156 12.3449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6008 0 0 0 0 0 0 0 0 0 0 0 0 13.6185 13.6819 0 0 13.5475 12.2882 0 10.3209 0 0 0 13.0461 13.728 0 13.2125 0 0 13.593 12.7976 0 13.9473 13.0667 0 13.8633 10.3992 11.83 12.0623 13.0679 0 0 14.8983 13.8204 13.9827 0 14.6903 12.4847 12.3393 11.6252 13.5489 12.0506 12.5167 13.5992 0 0 0 0 13.986 14.547 14.1072 16.1112 15.5395 16.0537 0 15.2948 13.1489 17.0937 14.228 14.4372 0 0 14.8542 0 14.2019 14.5175 0 0 13.0771 0 0 10.0447 12.6119 13.0554 12.3165 13.9117 13.8934 15.2929 10.8651 0 0 0 11.2457 0 0 14.547 0 0 13.6493 0 0 12.9734 0 0 0 0 0 0 13.0647 0 0 0 11.9662 0 0 0 14.1173 12.5171 0 11.0827 12.8841 0 0 0 Q9BZW5 TM6S1_HUMAN Transmembrane 6 superfamily member 1 TM6SF1 Homo sapiens (Human) integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765] GO:0005765; GO:0016021 CIYKPEFFIKTK 0.96876 -0.46214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6574 0 0 0 0 0 0 11.9179 0 0 0 0 0 0 0 0 0 11.2728 0 0 0 0 0 0 0 0 0 11.1517 0 0 0 0 0 0 11.5329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3M7 TXNIP_HUMAN Thioredoxin-interacting protein (Thioredoxin-binding protein 2) (Vitamin D3 up-regulated protein 1) TXNIP VDUP1 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to tumor cell [GO:0071228]; keratinocyte differentiation [GO:0030216]; negative regulation of cell division [GO:0051782]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031]; regulation of cell population proliferation [GO:0042127]; response to calcium ion [GO:0051592]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; enzyme inhibitor activity [GO:0004857]; ubiquitin protein ligase binding [GO:0031625]; cell cycle [GO:0007049]; cellular response to tumor cell [GO:0071228]; keratinocyte differentiation [GO:0030216]; negative regulation of cell division [GO:0051782]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031]; regulation of cell population proliferation [GO:0042127]; response to calcium ion [GO:0051592]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to xenobiotic stimulus [GO:0009410] GO:0000122; GO:0004857; GO:0005634; GO:0005737; GO:0005758; GO:0005829; GO:0006606; GO:0007049; GO:0009410; GO:0009612; GO:0009749; GO:0015031; GO:0030216; GO:0031625; GO:0032355; GO:0032570; GO:0042127; GO:0042542; GO:0043065; GO:0048008; GO:0051592; GO:0051782; GO:0071228 enzyme inhibitor activity [GO:0004857]; ubiquitin protein ligase binding [GO:0031625] GKYGCVDYWVKAFLDR 0.96876 -0.8122 0 0 0 0 0 0 10.9068 0 0 0 14.4258 0 0 0 0 0 0 0 0 0 0 0 0 11.7015 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 12.6393 12.3772 0 0 0 0 0 0 0 10.0815 11.8956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7663 0 0 0 0 0 0 13.0561 0 13.8175 13.7709 12.7935 0 13.87 13.806 14.2257 15.2552 14.1573 15.8165 13.9179 16.2354 14.4198 0 14.5974 0 13.9362 13.691 0 0 12.1584 13.5746 0 13.5398 0 13.4301 0 12.0693 14.365 0 14.4359 14.3604 13.3465 13.5307 14.6341 12.1203 0 14.9472 12.4748 14.4351 13.8645 13.9645 13.1977 12.831 0 0 0 13.7326 12.7599 12.6182 12.7733 13.5561 14.3523 0 0 0 0 13.835 13.8572 13.1862 15.4302 0 13.4698 13.3945 13.7579 0 12.8554 13.3207 0 0 13.407 13.2445 11.5916 0 0 0 13.2275 0 0 0 0 12.6901 0 0 0 0 0 12.8252 0 11.5193 0 0 0 11.9145 13.1746 0 0 0 0 0 0 0 Q96EF6 FBX17_HUMAN F-box only protein 17 (F-box only protein 26) FBXO17 FBG4 FBX17 FBX26 FBXO26 Homo sapiens (Human) glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005737; GO:0005829; GO:0006516; GO:0016567; GO:0019005; GO:0030433; GO:0031146 CRPVCRAWR 0.96877 -0.23868 0 0 0 0 0 0 0 0 0 0 0 11.4913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9752 10.5355 11.2969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.772 0 14.4569 0 13.8736 0 0 0 0 0 0 0 12.3296 0 0 0 0 0 13.1777 0 14.5693 0 0 0 0 0 0 0 0 0 15.124 0 0 12.133 0 15.7917 0 0 0 0 0 0 0 15.2933 0 0 0 14.7617 0 12.6171 0 0 0 0 0 0 0 0 0 0 0 0 11.6121 12.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.261 0 0 0 14.1114 11.2269 0 10.9481 11.7999 0 0 B2RUY7 VWC2L_HUMAN "von Willebrand factor C domain-containing protein 2-like, VWC2-like protein (Brorin-like)" VWC2L Homo sapiens (Human) negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; extracellular space [GO:0005615]; synapse [GO:0045202] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666] GO:0005615; GO:0030514; GO:0032281; GO:0045202; GO:0045666; GO:0070161 IHPKCTK 0.96877 -0.84042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75747 P3C2G_HUMAN "Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma, PI3K-C2-gamma, PtdIns-3-kinase C2 subunit gamma, EC 2.7.1.137, EC 2.7.1.154 (Phosphoinositide 3-kinase-C2-gamma)" PIK3C2G Homo sapiens (Human) cell migration [GO:0016477]; chemotaxis [GO:0006935]; modulation by host of viral process [GO:0044788]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate kinase activity [GO:0016307]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; modulation by host of viral process [GO:0044788]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310] GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006935; GO:0014065; GO:0016020; GO:0016303; GO:0016307; GO:0016310; GO:0016477; GO:0019898; GO:0035005; GO:0035091; GO:0036092; GO:0044788; GO:0046854; GO:0048015; GO:0052742 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol phosphate kinase activity [GO:0016307] ALNDEFSKEQKLIK 0.96877 -1.0163 0 0 0 0 0 0 0 0 0 0 0 14.6789 0 0 0 0 0 0 0 0 0 13.6246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.07 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4931 0 0 0 10.9831 0 0 0 0 0 14.0758 0 15.2203 15.4775 0 11.4662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8342 0 0 0 0 0 0 0 14.632 0 0 0 0 0 0 0 0 0 0 0 0 15.0338 0 0 0 0 0 0 0 11.9111 0 0 0 0 0 0 0 0 13.4282 0 0 0 0 0 0 0 0 0 0 0 0 P15621 ZNF44_HUMAN "Zinc finger protein 44 (Gonadotropin-inducible ovary transcription repressor 2, GIOT-2) (Zinc finger protein 55) (Zinc finger protein 58) (Zinc finger protein KOX7)" ZNF44 GIOT2 KOX7 ZNF55 ZNF58 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" KAFFWPSFLLR 0.96877 -0.94822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1248 0 0 0 0 0 0 0 10.6776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY57 ST32B_HUMAN "Serine/threonine-protein kinase 32B, EC 2.7.11.1 (Yet another novel kinase 2)" STK32B YANK2 UNQ3003/PRO9744 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DGTKDSCPLNGHLQHCLETVREEFIIFNR 0.96877 -0.27151 0 0 0 0 0 0 0 0 13.3076 0 0 0 0 0 0 0 0 12.3035 0 0 0 0 0 11.436 0 0 0 0 0 0 0 0 0 0 0 12.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7748 0 0 0 0 0 0 0 0 0 0 0 0 Q12857 NFIA_HUMAN "Nuclear factor 1 A-type, NF1-A, Nuclear factor 1/A (CCAAT-box-binding transcription factor, CTF) (Nuclear factor I/A, NF-I/A, NFI-A) (TGGCA-binding protein)" NFIA KIAA1439 Homo sapiens (Human) "DNA replication [GO:0006260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]" cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; DNA replication [GO:0006260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; synapse maturation [GO:0060074]; ureter development [GO:0072189]; viral genome replication [GO:0019079]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006355; GO:0006357; GO:0019079; GO:0030054; GO:0045944; GO:0060074; GO:0072189; GO:0140297 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" MSKEEERAVK 0.96878 -0.24741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13216 ERCC8_HUMAN DNA excision repair protein ERCC-8 (Cockayne syndrome WD repeat protein CSA) ERCC8 CKN1 CSA Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of transcription-coupled nucleotide-excision repair [GO:0090262]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283] GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0005654; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0010165; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0044877; GO:0045739; GO:0051865; GO:0080008; GO:0090262; GO:0097680 protein-containing complex binding [GO:0044877] VCNNSKKGLK 0.96878 -1.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.065 0 0 0 0 11.0883 0 0 0 0 0 0 0 0 12.6152 12.2361 0 12.9087 0 0 0 0 0 0 0 0 0 0 0 0 11.9393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3241 0 0 0 12.9929 0 0 0 0 0 0 12.73 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2687 0 0 0 0 0 0 0 0 0 0 14.4092 13.0444 0 0 14.1454 0 0 0 0 0 Q9NRF2 SH2B1_HUMAN "SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator, PSM) (SH2 domain-containing protein 1B)" SH2B1 KIAA1299 SH2B Homo sapiens (Human) intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278] GO:0005068; GO:0005634; GO:0005829; GO:0005886; GO:0030032; GO:0035556; GO:0045840; GO:0060391; GO:2000278 transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] FRLYLASHPQYAGPGAEAAFSR 0.96878 -0.25089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4874 0 0 0 12.7412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6722 0 0 0 12.964 0 0 0 0 0 0 12.6011 0 13.7007 0 0 0 0 12.7529 14.1446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0423 0 0 0 0 0 0 Q9UBN1 CCG4_HUMAN "Voltage-dependent calcium channel gamma-4 subunit (Neuronal voltage-gated calcium channel gamma-4 subunit) (Transmembrane AMPAR regulatory protein gamma-4, TARP gamma-4)" CACNG4 Homo sapiens (Human) "neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; response to cocaine [GO:0042220]; transmission of nerve impulse [GO:0019226]" AMPA glutamate receptor complex [GO:0032281]; cell body [GO:0044297]; cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; somatodendritic compartment [GO:0036477] "AMPA glutamate receptor complex [GO:0032281]; cell body [GO:0044297]; cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; somatodendritic compartment [GO:0036477]; calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; ionotropic glutamate receptor binding [GO:0035255]; voltage-gated calcium channel activity [GO:0005245]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; response to cocaine [GO:0042220]; transmission of nerve impulse [GO:0019226]" GO:0005245; GO:0005246; GO:0005886; GO:0005887; GO:0009986; GO:0016247; GO:0019226; GO:0030666; GO:0032281; GO:0035255; GO:0036477; GO:0042220; GO:0044297; GO:0051968; GO:0098839; GO:0098943; GO:0098962; GO:0098970; GO:0098978; GO:0099061; GO:0099590; GO:1990454; GO:2000311; GO:2000969 calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; ionotropic glutamate receptor binding [GO:0035255]; voltage-gated calcium channel activity [GO:0005245] ASSSSPYAR 0.96878 -0.27321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q537H7 SPT45_HUMAN Spermatogenesis-associated protein 45 SPATA45 C1orf227 HSD-44 HSD44 Homo sapiens (Human) EPVPNSGR 0.96879 -0.95276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4389 12.4595 0 0 0 0 0 13.6019 0 13.5529 0 0 0 0 0 0 0 0 0 0 11.8958 0 0 0 13.9124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.431 0 0 0 0 12.9066 0 0 0 0 0 0 11.8232 0 0 0 0 0 0 0 0 0 14.3978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2W9 PIAS4_HUMAN "E3 SUMO-protein ligase PIAS4, EC 2.3.2.27 (PIASy) (Protein inhibitor of activated STAT protein 4) (Protein inhibitor of activated STAT protein gamma, PIAS-gamma)" PIAS4 PIASG Homo sapiens (Human) "central nervous system development [GO:0007417]; double-strand break repair [GO:0006302]; hair follicle development [GO:0001942]; limb epidermis development [GO:0060887]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vitamin D metabolic process [GO:0042359]; Wnt signaling pathway [GO:0016055]" cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transferase complex [GO:1990234] "cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transferase complex [GO:1990234]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; double-strand break repair [GO:0006302]; hair follicle development [GO:0001942]; limb epidermis development [GO:0060887]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; vitamin D metabolic process [GO:0042359]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0001942; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0006357; GO:0007417; GO:0008022; GO:0008270; GO:0010804; GO:0016055; GO:0016363; GO:0016605; GO:0016925; GO:0019789; GO:0031625; GO:0032088; GO:0033235; GO:0042359; GO:0045892; GO:0060887; GO:0061665; GO:1902174; GO:1902231; GO:1905168; GO:1990234 DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] AAELVEAKNMVMSFR 0.9688 -0.25449 0 0 0 0 0 0 0 0 0 0 0 0 12.3727 0 12.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9379 0 0 0 0 0 0 0 0 0 0 0 0 13.9252 0 16.3922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8888 0 0 0 0 0 0 0 12.3712 0 12.139 0 0 0 0 0 0 0 0 0 0 0 0 12.2409 0 15.7892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2741 0 0 0 11.7808 0 13.9921 0 0 0 12.8453 0 0 0 0 0 0 19.3871 0 0 0 0 0 Q9Y6M1 IF2B2_HUMAN "Insulin-like growth factor 2 mRNA-binding protein 2, IGF2 mRNA-binding protein 2, IMP-2 (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2)" IGF2BP2 IMP2 VICKZ2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252] GO:0000932; GO:0001817; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0009653; GO:0010468; GO:0010494; GO:0017148; GO:0045182; GO:0048027; GO:0051028; GO:0051252; GO:0070934; GO:1990247 mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] FAGASIK 0.9688 3.205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8409 0 0 0 12.4991 0 12.2336 0 0 11.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6666 14.8739 0 0 0 0 12.5174 0 12.8563 13.7178 0 14.2281 14.0138 0 0 0 13.037 13.708 13.6144 13.5749 13.0851 14.6797 0 13.6765 0 0 0 14.3036 14.0774 0 0 0 12.3428 0 0 0 14.682 0 13.6086 0 0 0 0 14.5788 14.7728 13.108 0 13.335 0 0 0 13.6712 14.371 0 0 14.7593 0 0 0 14.232 14.2102 13.6811 13.5013 0 12.7079 12.866 13.1958 0 0 0 0 0 0 13.0112 13.8537 12.8555 0 0 0 0 0 0 0 13.2432 13.2618 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5239 0 0 0 0 12.9324 0 0 0 12.7041 0 0 0 Q5W0V3 FHI2A_HUMAN "FHF complex subunit HOOK interacting protein 2A, FHIP2A" FHIP2A FAM160B1 KIAA1600 Homo sapiens (Human) DYCAICLRWEWPGSPK 0.96881 -0.23046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4602 0 13.3041 0 12.6097 0 0 12.6289 0 0 0 0 0 12.7383 0 0 0 0 0 0 0 0 12.8747 0 0 13.8226 12.8482 13.1209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1823 0 0 0 13.1295 12.1558 0 0 0 0 0 0 0 0 0 0 0 13.332 15.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5056 0 0 0 0 0 12.6336 0 0 0 0 0 0 0 0 13.1258 0 0 0 0 0 0 0 0 0 0 0 12.7269 0 0 11.3473 0 0 0 0 0 11.8161 0 0 11.9788 0 0 Q6IQ49 SDE2_HUMAN Replication stress response regulator SDE2 SDE2 C1orf55 Homo sapiens (Human) cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; damaged DNA binding [GO:0003684]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567] GO:0003684; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0006260; GO:0016485; GO:0016567; GO:0016607; GO:0031571; GO:0034644; GO:0051301 damaged DNA binding [GO:0003684] DKETEERTDGER 0.96881 -0.99624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4177 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTW3 COG1_HUMAN "Conserved oligomeric Golgi complex subunit 1, COG complex subunit 1 (Component of oligomeric Golgi complex 1)" COG1 KIAA1381 LDLB Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" GO:0000139; GO:0000301; GO:0005794; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0070085 FPILIRQVAAASHFR 0.96881 -1.0672 0 0 0 0 0 11.7526 0 0 0 0 0 0 0 13.6682 0 14.9993 0 11.9767 11.2947 0 0 0 0 0 0 12.3387 12.7551 0 0 0 13.1792 0 0 0 0 0 0 0 0 0 0 12.4922 15.1838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5442 14.7712 0 0 0 0 0 11.7474 0 13.6251 0 0 13.2782 0 11.6288 0 0 0 0 0 0 12.9506 0 0 0 0 14.2484 14.919 0 0 0 14.5139 13.4471 0 15.8471 0 0 11.7996 11.3769 0 0 0 0 15.1878 13.6405 14.9865 13.3819 14.3416 14.0201 14.1196 15.6014 0 0 0 13.7266 14.3947 0 0 13.5587 0 0 0 0 14.5749 0 0 13.6128 0 0 0 15.1179 0 0 0 11.386 0 0 0 0 15.5527 0 0 0 0 0 0 0 14.091 13.2456 0 0 0 0 0 0 0 0 0 0 0 17.7816 0 0 Q9BYR5 KRA42_HUMAN Keratin-associated protein 4-2 (Keratin-associated protein 4.2) (Ultrahigh sulfur keratin-associated protein 4.2) KRTAP4-2 KAP4.2 KRTAP4.2 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; identical protein binding [GO:0042802] GO:0005829; GO:0042802; GO:0045095 identical protein binding [GO:0042802] MVNSCCGSVCSDQGCGLENCCR 0.96881 -0.43487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5192 0 0 0 0 0 0 0 0 0 0 0 12.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 11.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2583 14.337 0 13.8525 13.8515 0 0 0 0 10.5965 0 0 0 0 0 12.9442 0 0 12.2361 0 0 0 0 0 0 0 11.1388 0 0 0 0 11.5341 0 0 12.643 0 0 0 0 0 0 0 0 0 0 0 11.5646 0 0 0 0 0 0 0 10.6301 0 11.4902 0 0 0 0 0 0 0 0 13.8567 10.2577 0 0 10.9106 0 0 11.4396 0 0 0 0 0 0 10.5148 0 0 0 0 0 10.3069 0 0 10.9631 0 0 0 11.0941 0 11.4267 10.192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17612 KAPCA_HUMAN "cAMP-dependent protein kinase catalytic subunit alpha, PKA C-alpha, EC 2.7.11.11" PRKACA PKACA Homo sapiens (Human) calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein kinase A signaling [GO:0010737]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; calcium channel complex [GO:0034704]; cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane raft [GO:0044853]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to cold [GO:0070417]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to glucose stimulus [GO:0071333]; cellular response to heat [GO:0034605]; cellular response to parathyroid hormone stimulus [GO:0071374]; cytokine-mediated signaling pathway [GO:0019221]; high-density lipoprotein particle assembly [GO:0034380]; mesoderm formation [GO:0001707]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein kinase A signaling [GO:0010737]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of macroautophagy [GO:0016241]; regulation of osteoblast differentiation [GO:0045667]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein binding [GO:0043393]; regulation of protein processing [GO:0070613]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; renal water homeostasis [GO:0003091]; sperm capacitation [GO:0048240] GO:0000287; GO:0001669; GO:0001707; GO:0001843; GO:0002027; GO:0003091; GO:0004672; GO:0004674; GO:0004679; GO:0004691; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005952; GO:0006397; GO:0006468; GO:0006611; GO:0010737; GO:0010881; GO:0016020; GO:0016241; GO:0016607; GO:0018105; GO:0018107; GO:0019221; GO:0019901; GO:0019904; GO:0030145; GO:0031588; GO:0031594; GO:0031625; GO:0034237; GO:0034380; GO:0034605; GO:0034704; GO:0035584; GO:0036126; GO:0043197; GO:0043393; GO:0044853; GO:0045667; GO:0046777; GO:0046827; GO:0048240; GO:0048471; GO:0050804; GO:0051480; GO:0051726; GO:0055117; GO:0060314; GO:0061136; GO:0070062; GO:0070417; GO:0070613; GO:0071333; GO:0071374; GO:0071872; GO:0086064; GO:0097225; GO:0097546; GO:0106310; GO:1901621; GO:1903779; GO:1990044; GO:2000810 AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein domain specific binding [GO:0019904]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] CGKEFSEF 0.96882 -0.01531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2579 0 0 0 13.8169 13.1803 12.8762 0 0 13.9769 13.1717 12.691 0 13.718 0 0 0 0 13.73 0 0 13.5109 12.0353 12.5507 0 13.5409 12.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82906 0 0 0 14.4364 11.463 0 0 0 0 0 0 0 0 13.6907 0 0 0 0 0 0 11.1628 0 0 0 13.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7276 0 0 0 0 0 0 0 0 0 0 0 0 11.0755 0 0 0 0 0 0 0 10.8633 0 0 0 P08620 FGF4_HUMAN "Fibroblast growth factor 4, FGF-4 (Heparin secretory-transforming protein 1, HST, HST-1, HSTF-1) (Heparin-binding growth factor 4, HBGF-4) (Transforming protein KS3)" FGF4 HST HSTF1 KS3 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process involved in morphogenesis [GO:0060561]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to leukemia inhibitory factor [GO:1990830]; chondroblast differentiation [GO:0060591]; cranial suture morphogenesis [GO:0060363]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial cell apoptotic process [GO:1904019]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mesenchymal cell proliferation [GO:0010463]; negative regulation of apoptotic process [GO:0043066]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; animal organ morphogenesis [GO:0009887]; apoptotic process involved in morphogenesis [GO:0060561]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to leukemia inhibitory factor [GO:1990830]; chondroblast differentiation [GO:0060591]; cranial suture morphogenesis [GO:0060363]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial cell apoptotic process [GO:1904019]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mesenchymal cell proliferation [GO:0010463]; negative regulation of apoptotic process [GO:0043066]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089] GO:0001502; GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0009887; GO:0010463; GO:0010628; GO:0030154; GO:0030334; GO:0035019; GO:0035116; GO:0042475; GO:0043066; GO:0045944; GO:0051781; GO:0060363; GO:0060561; GO:0060591; GO:0070374; GO:0072089; GO:1904019; GO:1990830; GO:2000544; GO:2000648 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201] VTHFLPR 0.96884 -1.0042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7209 0 0 0 0 0 0 0 0 0 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3365 13.3136 12.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0976 0 0 0 0 0 0 0 0 0 P43119 PI2R_HUMAN "Prostacyclin receptor (Prostaglandin I2 receptor, PGI receptor, PGI2 receptor) (Prostanoid IP receptor)" PTGIR PRIPR Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496]" cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; prostacyclin receptor activity [GO:0016501]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to lipopolysaccharide [GO:0032496]" GO:0005085; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0007187; GO:0007189; GO:0007204; GO:0007267; GO:0010642; GO:0016501; GO:0032496; GO:0048662 guanyl-nucleotide exchange factor activity [GO:0005085]; prostacyclin receptor activity [GO:0016501] AEASVACSLC 0.96887 -0.83481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T871 LELP1_HUMAN Late cornified envelope-like proline-rich protein 1 (Novel small proline-rich protein) LELP1 Homo sapiens (Human) CFEKCPWEK 0.96887 -1.0077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5153 0 14.4394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1X5 TAF2_HUMAN "Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit, TAF(II)150, TAFII-150, TAFII150)" TAF2 CIF150 TAF2B Homo sapiens (Human) "G2/M transition of mitotic cell cycle [GO:0000086]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000086; GO:0000976; GO:0003682; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006357; GO:0006367; GO:0006468; GO:0014070; GO:0016251; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043966; GO:0045893; GO:0051123; GO:0060261 chromatin binding [GO:0003682]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976] DVHNLCPK 0.96887 -1.0081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2811 0 0 0 0 0 0 0 0 0 15.2379 0 13.1088 0 0 0 0 0 0 0 0 0 0 13.8535 0 0 0 14.4393 0 13.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8121 0 0 0 14.1244 0 0 0 0 0 12.2631 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1768 0 0 0 11.8826 0 11.2517 0 0 0 0 12.1313 11.7363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.545 0 0 0 0 0 0 17.8351 18.0184 0 0 0 0 0 0 0 18.0438 0 18.1286 0 0 Q9BTT6 LRRC1_HUMAN Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein) LRRC1 LANO Homo sapiens (Human) cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020] GO:0005829; GO:0016020 CGALENLVNDVSDEAWNERAVNR 0.96887 4.5435 0 0 0 0 0 0 0 0 0 0 0 10.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8511 0 0 0 0 0 0 0 0 0 0 0 0 11.9545 0 0 12.3539 0 0 0 0 12.3872 0 10.3992 0 0 0 0 0 0 0 0 12.4693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8152 0 0 0 0 0 0 0 0 0 0 11.889 0 0 0 11.4944 0 0 0 0 0 0 0 0 0 0 0 13.0664 0 0 0 11.2881 0 0 0 0 0 0 0 10.722 11.5275 0 10.757 11.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2611 0 0 11.4734 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6193 0 0 0 0 0 0 12.2357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2787 P06850 CRF_HUMAN "Corticoliberin (Corticotropin-releasing factor, CRF) (Corticotropin-releasing hormone)" CRH Homo sapiens (Human) "adrenal gland development [GO:0030325]; chemical synaptic transmission [GO:0007268]; female pregnancy [GO:0007565]; glucocorticoid biosynthetic process [GO:0006704]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; locomotory exploration behavior [GO:0035641]; lung development [GO:0030324]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of glucagon secretion [GO:0070093]; parturition [GO:0007567]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of cortisol secretion [GO:0051464]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; corticotropin-releasing hormone activity [GO:0017045]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; adrenal gland development [GO:0030325]; chemical synaptic transmission [GO:0007268]; female pregnancy [GO:0007565]; glucocorticoid biosynthetic process [GO:0006704]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; locomotory exploration behavior [GO:0035641]; lung development [GO:0030324]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of glucagon secretion [GO:0070093]; parturition [GO:0007567]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of cortisol secretion [GO:0051464]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]" GO:0001963; GO:0005102; GO:0005179; GO:0005184; GO:0005576; GO:0005615; GO:0006704; GO:0006954; GO:0007165; GO:0007268; GO:0007565; GO:0007567; GO:0007611; GO:0010841; GO:0017045; GO:0030324; GO:0030325; GO:0032811; GO:0035641; GO:0042322; GO:0043025; GO:0045202; GO:0051461; GO:0051464; GO:0070093; GO:2000310 corticotropin-releasing hormone activity [GO:0017045]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102] ALLSRGPVPGAR 0.96888 -0.80965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5177 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.715 13.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96D70 R3HD4_HUMAN R3H domain-containing protein 4 R3HDM4 C19orf22 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; nucleic acid binding [GO:0003676] GO:0003676; GO:0005634 nucleic acid binding [GO:0003676] QHFINQAVR 0.96888 -0.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.41606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7167 14.6531 0 0 0 13.6169 13.9806 0 0 0 14.0171 0 0 0 15.5533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A2R8YFL7 OSP4A_HUMAN Oocyte-secreted protein 4A OOSP4A Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 FPIILVMRGRENDSR 0.96889 4.7544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4442 0 0 0 0 0 0 0 0 0 0 0 13.5622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1709 0 0 0 0 0 13.6715 0 0 0 0 0 0 15.2078 0 16.4143 0 0 0 12.5831 0 0 13.8573 0 14.3137 0 0 0 0 0 0 0 0 0 0 0 12.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7115 0 0 0 0 0 0 0 0 0 0 0 0 12.2331 0 0 0 12.7737 12.8048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14559 RHG33_HUMAN Rho GTPase-activating protein 33 (Rho-type GTPase-activating protein 33) (Sorting nexin-26) (Tc10/CDC42 GTPase-activating protein) ARHGAP33 SNX26 TCGAP Homo sapiens (Human) protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264] GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0015031; GO:0019901; GO:0032991; GO:0035091 GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901] LAGLLRTFMR 0.96889 -0.812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9722 0 0 10.4642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9749 0 15.8095 0 0 0 0 0 0 0 0 12.2638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2063 12.5636 0 0 0 0 0 0 10.5077 0 9.8427 0 0 0 0 0 0 11.1178 0 0 0 0 0 0 0 0 0 0 0 0 13.4593 0 11.3414 15.8589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1L0 MI1HG_HUMAN Uncharacterized protein MIR1-1HG (MIR1-1 host gene protein) MIR1-1HG C20orf166 Homo sapiens (Human) GEPGSAR 0.96889 -0.24779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7599 0 0 0 0 P59535 T2R40_HUMAN "Taste receptor type 2 member 40, T2R40 (G-protein coupled receptor 60) (Taste receptor type 2 member 58, T2R58)" TAS2R40 GPR60 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] DVFNVYVNSSIPIPSSNSTEK 0.9689 3.2016 0 0 11.7271 10.1951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8445 0 13.1792 0 0 0 0 0 0 0 12.8188 0 0 13.1177 13.3727 11.9389 0 13.5948 0 12.4635 13.3995 0 0 0 0 14.7317 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9502 12.8845 0 13.0373 0 0 0 0 12.0449 13.8377 0 0 14.2711 0 0 12.9938 0 13.1843 13.2756 0 0 0 12.8784 0 13.0801 0 13.7721 14.6033 12.5223 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6099 0 0 12.163 0 0 12.5765 0 13.3879 0 0 12.54 0 0 0 0 0 13.7177 0 13.7645 12.1389 13.143 0 0 0 0 0 0 0 0 0 0 0 Q9UHW9 S12A6_HUMAN Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3) SLC12A6 KCC3 Homo sapiens (Human) ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] GO:0001525; GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0008519; GO:0015079; GO:0015379; GO:0016021; GO:0016323; GO:0019901; GO:0030424; GO:0045202; GO:0055064; GO:0055075; GO:0071333; GO:0071476; GO:0071477; GO:0140157; GO:1902476; GO:1990573 ammonium transmembrane transporter activity [GO:0008519]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901] AWKTFIGTVRVTTAAHLALLVAK 0.9689 -1.0161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.097 11.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6652 0 15.0911 0 0 0 0 0 A6NNX1 RIAD1_HUMAN RIIa domain-containing protein 1 RIIAD1 C1orf230 Homo sapiens (Human) IHMQLIKDKK 0.96891 -0.46406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9541 0 0 0 0 0 0 13.1573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8795 12.1322 0 0 0 13.3022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0491 0 10.5284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8963 0 0 0 13.0702 0 0 P48066 S6A11_HUMAN "Sodium- and chloride-dependent GABA transporter 3, GAT-3 (Solute carrier family 6 member 11)" SLC6A11 GABT3 GAT3 Homo sapiens (Human) brain development [GO:0007420]; gamma-aminobutyric acid reuptake [GO:0051936]; monocarboxylic acid transport [GO:0015718]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; neurotransmitter binding [GO:0042165]; taurine:sodium symporter activity [GO:0005369]; brain development [GO:0007420]; gamma-aminobutyric acid reuptake [GO:0051936]; monocarboxylic acid transport [GO:0015718]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] GO:0005332; GO:0005369; GO:0005737; GO:0005886; GO:0005887; GO:0007420; GO:0008028; GO:0009410; GO:0015718; GO:0016021; GO:0035725; GO:0042165; GO:0043005; GO:0051936; GO:0098982; GO:0099055; GO:0099056 gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; neurotransmitter binding [GO:0042165]; taurine:sodium symporter activity [GO:0005369] VFRRGYR 0.96891 -0.24804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0993 0 0 0 0 0 14.1908 14.4686 14.9423 0 0 0 0 0 0 13.403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZT21 TMPPE_HUMAN "Transmembrane protein with metallophosphoesterase domain, EC 3.1.-.-" TMPPE Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] GO:0016021; GO:0016787; GO:0046872 hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] ISATRAQR 0.96891 -0.2502 0 0 0 10.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9288 0 0 11.4403 0 0 0 0 0 0 0 0 11.699 0 0 0 0 0 0 0 0 0 0 0 12.4518 13.6487 0 11.966 0 0 0 0 0 0 0 0 0 0 0 0 10.4462 0 0 0 0 0 0 0 14.4427 0 0 0 0 0 0 0 0 11.8807 0 0 0 14.2133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3021 11.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8343 0 0 0 0 13.2555 0 0 12.7724 13.0295 12.5176 0 11.18 0 0 13.7741 0 0 0 0 P32856 STX2_HUMAN Syntaxin-2 (Epimorphin) STX2 EPIM STX2A STX2B STX2C Homo sapiens (Human) acrosome reaction [GO:0007340]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; cornified envelope assembly [GO:1903575]; ectoderm development [GO:0007398]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] basolateral plasma membrane [GO:0016323]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] basolateral plasma membrane [GO:0016323]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; structural molecule activity [GO:0005198]; acrosome reaction [GO:0007340]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; cornified envelope assembly [GO:1903575]; ectoderm development [GO:0007398]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0005198; GO:0005484; GO:0005615; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0007165; GO:0007340; GO:0007398; GO:0008021; GO:0009887; GO:0012505; GO:0016021; GO:0016323; GO:0030027; GO:0030154; GO:0031201; GO:0031629; GO:0032991; GO:0034599; GO:0042802; GO:0043231; GO:0048278; GO:0048306; GO:0048787; GO:1903575 calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; structural molecule activity [GO:0005198] KKWIIIAVSVVLVAIIALIIGLSVGK 0.96892 -0.4206 0 0 0 0 0 0 10.0471 12.1094 0 0 0 14.1673 0 0 11.2991 0 0 0 0 0 0 0 0 12.0366 0 0 0 12.1847 0 0 0 0 0 0 0 0 0 0 0 0 9.85359 14.1021 0 12.1385 0 0 0 0 0 0 12.0748 0 0 0 13.0968 0 10.8677 12.5561 11.7555 0 0 11.351 0 0 0 0 16.6716 16.5778 17.7934 15.1877 0 13.2319 17.3805 16.6942 16.3505 15.8824 0 14.6398 14.2198 0 0 0 0 13.7372 11.728 0 13.4285 0 0 0 0 0 10.9408 10.9546 11.7406 0 0 0 0 0 0 13.3879 0 0 0 0 0 0 0 0 14.214 0 0 0 0 13.0619 13.9078 0 14.1284 0 14.1212 0 0 0 0 0 0 0 0 0 14.1475 0 13.991 0 0 0 0 0 13.7764 9.8106 0 0 0 13.0917 0 0 0 13.8195 0 0 13.6521 0 0 12.9283 0 0 0 13.7822 14.0264 13.8565 14.1113 14.1323 14.7183 0 0 0 0 0 13.7885 0 13.3372 0 12.3765 0 0 16.5093 0 0 0 0 G3V0H7 SO1B7_HUMAN "Putative solute carrier organic anion transporter family member 1B7 (Liver-specific organic anion transporter 3, LST-3)" SLCO1B7 LST3 LST3TM12 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; sodium-independent organic anion transport [GO:0043252] GO:0005887; GO:0015125; GO:0015347; GO:0015721; GO:0043252 bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] AFFGLKVALIFPVLVLLTVFIFVVRK 0.96893 -1.0662 0 0 0 0 0 0 0 0 0 0 0 0 13.4367 12.024 0 0 0 0 0 0 0 11.4248 0 0 0 0 0 0 0 0 12.0089 0 0 11.1812 0 0 11.0577 0 0 10.6572 0 0 0 0 13.1021 0 0 0 0 0 0 0 0 0 0 0 12.7832 0 0 0 0 0 0 0 0 0 0 0 15.6181 0 0 0 0 0 13.5845 14.2452 0 0 0 14.9362 12.9871 12.2641 0 0 0 11.1867 10.9569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5005 0 0 0 0 0 0 10.9617 0 0 0 0 13.3515 11.5127 0 0 0 0 0 11.1673 0 0 0 0 0 0 0 0 0 0 0 0 11.9632 0 0 0 0 0 0 12.5999 0 0 0 0 0 0 13.7491 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92729 PTPRU_HUMAN "Receptor-type tyrosine-protein phosphatase U, R-PTP-U, EC 3.1.3.48 (Pancreatic carcinoma phosphatase 2, PCP-2) (Protein-tyrosine phosphatase J, PTP-J, hPTP-J) (Protein-tyrosine phosphatase pi, PTP pi) (Protein-tyrosine phosphatase receptor omicron, PTP-RO) (Receptor-type protein-tyrosine phosphatase psi, R-PTP-psi)" PTPRU FMI PCP2 PTPRO Homo sapiens (Human) animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; animal organ regeneration [GO:0031100]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; response to glucocorticoid [GO:0051384]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0007155; GO:0007185; GO:0008013; GO:0008285; GO:0030154; GO:0030336; GO:0031100; GO:0034109; GO:0034394; GO:0051384; GO:0090090; GO:2000049 beta-catenin binding [GO:0008013]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] EIEYRMAR 0.96893 -1.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9019 0 0 13.0066 0 0 0 0 0 0 0 0 13.6714 0 0 0 0 0 13.4785 0 15.1737 12.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5069 0 0 0 0 0 0 0 0 0 0 12.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5276 0 0 11.5718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.481 0 13.5013 15.1507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUT9 DEN5B_HUMAN DENN domain-containing protein 5B (Rab6IP1-like protein) DENND5B Homo sapiens (Human) positive regulation of triglyceride transport [GO:1905885] cytosol [GO:0005829]; integral component of membrane [GO:0016021] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; positive regulation of triglyceride transport [GO:1905885] GO:0005085; GO:0005829; GO:0016021; GO:0031267; GO:1905885 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] AWIRLSLEKK 0.96894 -0.25424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1009 13.1347 13.3301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0235 0 0 0 0 0 0 0 0 0 0 13.817 0 0 0 0 0 0 0 0 0 0 0 13.8903 0 0 0 0 0 0 0 13.0581 13.9401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3488 0 0 0 12.5492 0 0 12.5787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7223 0 0 0 0 0 0 12.2454 0 0 0 0 0 0 0 0 0 0 0 0 O43677 NDUC1_HUMAN "NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial (Complex I-KFYI, CI-KFYI) (NADH-ubiquinone oxidoreductase KFYI subunit)" NDUFC1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] APSALLRPLSRLLAPAR 0.96895 -0.4343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5865 0 0 0 0 0 0 0 0 0 12.6948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6241 0 0 0 0 0 0 0 0 0 12.1093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2521 10.4567 0 0 0 0 0 0 0 0 13.2685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NKP2 D42E2_HUMAN "Putative short-chain dehydrogenase/reductase family 42E member 2, EC 1.1.1.-" SDR42E2 Homo sapiens (Human) steroid biosynthetic process [GO:0006694] "3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid biosynthetic process [GO:0006694]" GO:0003854; GO:0006694; GO:0016616 "3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" DEEALYR 0.96896 -0.42686 0 0 0 0 0 0 0 0 0 0 0 0 12.9294 0 11.0904 0 0 0 0 12.3064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4558 0 0 0 0 0 13.3975 0 0 0 0 16.6118 13.3817 14.4108 0 0 0 0 0 13.7856 13.6308 0 15.2695 0 0 15.5619 0 0 0 14.3264 0 0 0 0 0 14.0192 12.6797 0 0 0 0 0 0 0 0 0 13.3981 12.3766 14.8733 0 13.2053 13.8597 0 13.1819 0 0 13.8548 13.5982 0 0 0 12.8354 13.058 0 0 0 0 0 0 13.5304 0 12.1314 13.4488 0 0 0 0 0 0 0 13.2551 14.03 11.9966 0 0 11.2445 0 0 0 12.9902 0 12.7126 0 0 0 12.2705 0 12.3199 12.4983 0 14.8186 0 13.2349 0 0 0 0 0 Q96LA8 ANM6_HUMAN "Protein arginine N-methyltransferase 6, EC 2.1.1.319 (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 6) (Histone-arginine N-methyltransferase PRMT6)" PRMT6 HRMT1L6 Homo sapiens (Human) "base-excision repair [GO:0006284]; cellular senescence [GO:0090398]; chromatin organization [GO:0006325]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; base-excision repair [GO:0006284]; cellular senescence [GO:0090398]; chromatin organization [GO:0006325]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]" GO:0000122; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006325; GO:0008469; GO:0010821; GO:0016274; GO:0016571; GO:0019919; GO:0031064; GO:0034970; GO:0035241; GO:0035242; GO:0042054; GO:0042393; GO:0044020; GO:0045652; GO:0045892; GO:0051572; GO:0070611; GO:0070612; GO:0090398; GO:1901796 chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241] LESGGGGEGGEGTEEEDGAER 0.96896 -1.0022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6M9 NDUB9_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22, CI-B22) (LYR motif-containing protein 3) (NADH-ubiquinone oxidoreductase B22 subunit)" NDUFB9 LYRM3 UQOR22 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; sensory perception of sound [GO:0007605]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; sensory perception of sound [GO:0007605]" GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007605; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] AMYPDYFAKR 0.96896 -1.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95164 UBL3_HUMAN "Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein, HsMUB, MUB) (Protein HCG-1)" UBL3 PNSC1 Homo sapiens (Human) extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] GO:0005886; GO:0070062 LILVSGK 0.96897 -1.0032 0 0 0 0 0 0 0 0 0 0 11.9084 0 0 0 0 0 0 0 0 0 11.9073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0162 0 0 12.4999 11.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9431 0 0 0 0 0 0 0 0 0 0 0 0 13.4075 13.3008 0 12.0328 0 0 0 0 12.9506 12.9633 0 0 0 0 0 12.2444 0 12.9488 0 0 Q9UGI6 KCNN3_HUMAN "Small conductance calcium-activated potassium channel protein 3, SK3, SKCa 3, SKCa3 (KCa2.3)" KCNN3 K3 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805] GO:0005242; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0016021; GO:0016286; GO:0043005; GO:0043025; GO:0071805 calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286] ALFEKRK 0.96898 -0.82848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7092 14.7414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDU6 GPBAR_HUMAN "G-protein coupled bile acid receptor 1 (G-protein coupled receptor GPCR19, hGPCR19) (Membrane-type receptor for bile acids, M-BAR) (hBG37, BG37)" GPBAR1 TGR5 Homo sapiens (Human) cell surface bile acid receptor signaling pathway [GO:0038184]; cellular response to bile acid [GO:1903413]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of bicellular tight junction assembly [GO:2000810] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; bile acid receptor activity [GO:0038181]; G protein-coupled bile acid receptor activity [GO:0038182]; G protein-coupled receptor activity [GO:0004930]; cell surface bile acid receptor signaling pathway [GO:0038184]; cellular response to bile acid [GO:1903413]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of bicellular tight junction assembly [GO:2000810] GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0038181; GO:0038182; GO:0038184; GO:0043235; GO:0070374; GO:1903413; GO:1904056; GO:2000810 bile acid receptor activity [GO:0038181]; G protein-coupled bile acid receptor activity [GO:0038182]; G protein-coupled receptor activity [GO:0004930] AVCRDEPSALARALTWR 0.969 -0.83258 0 0 0 11.3078 11.2675 0 12.2903 12.2849 0 0 0 11.4661 0 13.5503 13.8795 14.1129 14.4195 14.4925 14.086 12.9471 12.604 0 13.7948 0 11.8173 14.4323 12.5212 0 14.3988 13.5198 13.554 0 0 0 0 0 0 0 12.2055 13.3092 0 13.8255 0 0 13.616 14.16 14.2496 13.0547 0 0 13.8067 12.4946 0 12.6026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.364 15.0702 0 0 0 0 0 0 0 13.6162 0 14.8255 13.6392 17.883 0 13.2193 19.7549 13.6535 18.5071 0 18.9366 18.8379 0 18.6452 0 18.6711 18.4316 0 0 16.3989 0 0 0 0 0 13.9958 0 0 0 0 0 15.6965 18.4303 0 16.7056 16.8204 0 0 0 16.026 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1618 0 0 15.9786 0 0 0 16.6491 0 15.3562 0 0 13.5497 0 13.2531 0 18.4716 0 0 0 0 0 0 16.1272 12.9467 0 0 0 14.8139 13.8008 0 13.168 16.1157 13.5625 14.0036 14.3851 15.1805 15.1442 15.7205 0 0 15.2803 19.135 0 13.4017 0 0 Q5VXT5 SYPL2_HUMAN Synaptophysin-like protein 2 SYPL2 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; substantia nigra development [GO:0021762]; T-tubule organization [GO:0033292] integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672] integral component of membrane [GO:0016021]; synaptic vesicle membrane [GO:0030672]; cellular calcium ion homeostasis [GO:0006874]; heart development [GO:0007507]; substantia nigra development [GO:0021762]; T-tubule organization [GO:0033292] GO:0006874; GO:0007507; GO:0016021; GO:0021762; GO:0030672; GO:0033292 FHNLYTENK 0.969 -0.80962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.334 0 0 0 0 0 0 0 0 13.9431 0 0 0 0 14.1057 0 0 0 13.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4284 0 13.9071 13.4489 0 0 13.6149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92832 NELL1_HUMAN Protein kinase C-binding protein NELL1 (NEL-like protein 1) (Nel-related protein 1) NELL1 NRP1 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; nervous system development [GO:0007399]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]; cell differentiation [GO:0030154]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; nervous system development [GO:0007399]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468] GO:0005080; GO:0005509; GO:0005576; GO:0005635; GO:0005737; GO:0007399; GO:0008201; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0042177; GO:0045669; GO:0048471 calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080] CSVCSCKDGKIFCR 0.96902 -1.015 0 0 0 0 0 0 0 13.172 0 0 0 0 11.6407 0 14.0317 13.9872 14.4805 10.8278 0 0 0 0 0 11.473 0 14.568 0 0 14.8497 0 0 14.2763 0 0 0 0 14.1406 0 11.5897 10.8041 14.1343 0 0 14.3368 0 0 0 13.3366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6479 0 12.2186 0 0 0 0 10.774 0 12.4843 0 0 12.6692 0 14.0542 0 0 0 0 14.2365 0 14.0159 0 14.2991 14.1061 0 0 0 0 0 0 0 12.5781 0 0 13.5162 0 0 0 0 0 0 0 15.8595 0 0 0 13.379 0 0 0 15.6591 14.8838 14.3138 0 14.6152 13.255 0 15.5996 0 15.0046 15.5343 0 12.4954 14.2841 0 14.5948 15.3555 0 0 0 13.1405 15.1153 15.2291 0 0 0 0 0 12.8897 0 0 13.3502 0 0 16.0505 0 13.8039 0 0 0 0 0 0 0 0 0 10.8077 0 0 14.0654 11.2544 11.97 0 0 0 0 15.0234 14.7843 12.2374 0 0 13.1544 11.7603 15.4442 Q8NG68 TTL_HUMAN "Tubulin--tyrosine ligase, TTL, EC 6.3.2.25" TTL Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; positive regulation of mitotic cell cycle [GO:0045931]; post-translational protein modification [GO:0043687]; regulation of axon extension [GO:0030516]; regulation of metaphase plate congression [GO:0090235] spindle microtubule [GO:0005876] spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; tubulin-tyrosine ligase activity [GO:0004835]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of mitotic cell cycle [GO:0045931]; post-translational protein modification [GO:0043687]; regulation of axon extension [GO:0030516]; regulation of metaphase plate congression [GO:0090235] GO:0000226; GO:0004835; GO:0005524; GO:0005876; GO:0030516; GO:0043687; GO:0045931; GO:0090235 ATP binding [GO:0005524]; tubulin-tyrosine ligase activity [GO:0004835] EFNQYLTSALNITLESSILLQIKHIIR 0.96903 -0.95197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1466 0 0 0 11.543 0 0 0 0 0 0 0 11.7432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2465 0 0 11.8043 0 0 0 0 0 0 0 0 0 0 0 13.0571 0 0 0 0 0 0 0 0 0 12.6694 0 0 0 0 0 0 0 0 0 0 0 0 13.3745 0 13.9829 0 0 14.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y530 OARD1_HUMAN "ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1, EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1, EC 3.2.2.-)" OARD1 C6orf130 TARG1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278] GO:0001883; GO:0005654; GO:0005730; GO:0006974; GO:0042278; GO:0051725; GO:0061463; GO:0090734; GO:0140291; GO:0140293 ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883] DGRYIYYLITKK 0.96905 -0.46484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYS7 WSB2_HUMAN "WD repeat and SOCS box-containing protein 2, WSB-2 (CS box-containing WD protein)" WSB2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein polyubiquitination [GO:0000209] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005829; GO:0035556 ALRSFLTTYQVLALPIPK 0.96906 -0.23826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2362 0 0 0 0 0 0 0 0 0 0 14.194 0 0 0 13.2816 16.2732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8001 0 0 0 0 0 0 0 0 0 17.0141 11.9874 0 0 0 0 0 0 0 0 18.6655 A6NK06 IRG1_HUMAN "Cis-aconitate decarboxylase, CAD, EC 4.1.1.6 (Aconitate decarboxylase) (Aconitate decarboxylase 1) (Cis-aconitic acid decarboxylase) (Immune-responsive gene 1 protein)" ACOD1 IRG1 Homo sapiens (Human) cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to progesterone stimulus [GO:0071393]; cellular response to tumor necrosis factor [GO:0071356]; defense response [GO:0006952]; defense response to virus [GO:0051607]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of type I interferon production [GO:0032480]; positive regulation of antimicrobial humoral response [GO:0002760]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; tolerance induction to lipopolysaccharide [GO:0072573] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; aconitate decarboxylase activity [GO:0047613]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to progesterone stimulus [GO:0071393]; cellular response to tumor necrosis factor [GO:0071356]; defense response [GO:0006952]; defense response to virus [GO:0051607]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of type I interferon production [GO:0032480]; positive regulation of antimicrobial humoral response [GO:0002760]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; tolerance induction to lipopolysaccharide [GO:0072573] GO:0002760; GO:0005739; GO:0006952; GO:0006954; GO:0007566; GO:0032088; GO:0032480; GO:0034136; GO:0034144; GO:0035458; GO:0045824; GO:0047613; GO:0050728; GO:0051607; GO:0071219; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0071393; GO:0072573; GO:2000379 aconitate decarboxylase activity [GO:0047613] ALLPTDYIKR 0.96907 -1.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8592 0 0 0 0 0 0 0 11.8306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22680 CP7A1_HUMAN "Cytochrome P450 7A1 (24-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.26) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cholesterol 7-alpha-monooxygenase, EC 1.14.14.23)" CYP7A1 CYP7 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of gene expression [GO:0010468]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125] GO:0005506; GO:0005789; GO:0006699; GO:0006707; GO:0008123; GO:0008395; GO:0010468; GO:0015721; GO:0016021; GO:0016125; GO:0020037; GO:0032966; GO:0033782; GO:0038183; GO:0042632; GO:0043231; GO:0045471; GO:0045542; GO:0045717; GO:0070857; GO:0071333; GO:0071397 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395] DLTRRDTQK 0.96907 -0.82009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58513 CU042_HUMAN Putative uncharacterized protein encoded by LINC00158 LINC00158 C21orf42 NCRNA00158 Homo sapiens (Human) IQSHFGTLPRIK 0.96907 -1.0754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PJW8 DAPL1_HUMAN Death-associated protein-like 1 (Early epithelial differentiation-associated protein) DAPL1 EEDA Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507] death domain binding [GO:0070513]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507] GO:0010507; GO:0030154; GO:0034198; GO:0070513; GO:0097190 death domain binding [GO:0070513] KQEIGTLER 0.96908 -1.0766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9396 15.0293 15.2695 14.6207 14.5795 0 0 0 0 0 0 0 14.3424 13.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7131 12.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1205 0 15.282 0 0 14.9294 0 0 0 0 0 0 0 14.6962 0 12.795 0 0 0 0 0 0 0 0 0 0 14.0129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43602 DCX_HUMAN "Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X, Lis-X)" DCX DBCN LISX Homo sapiens (Human) axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; photoreceptor cell development [GO:0042461]; retina development in camera-type eye [GO:0060041] axoneme [GO:0005930]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005] axoneme [GO:0005930]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; axoneme assembly [GO:0035082]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; photoreceptor cell development [GO:0042461]; retina development in camera-type eye [GO:0060041] GO:0001764; GO:0005829; GO:0005856; GO:0005874; GO:0005875; GO:0005930; GO:0007399; GO:0007417; GO:0008017; GO:0019901; GO:0035082; GO:0035556; GO:0042461; GO:0043005; GO:0060041 microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] DFVRPKLVTIIR 0.96909 3.6768 0 12.3093 0 0 0 0 0 0 0 0 0 12.8058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2299 0 0 0 0 12.3453 0 0 0 0 0 0 0 12.7171 0 0 0 0 0 0 0 0 0 0 12.544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1533 0 0 0 0 0 0 0 11.5253 13.933 0 0 0 0 10.5019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N972 ZN709_HUMAN Zinc finger protein 709 ZNF709 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFSCSSSVR 0.96909 -0.42441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8803 0 0 0 15.9021 0 0 0 0 12.5474 0 0 0 13.1431 0 0 0 13.8187 0 0 12.3791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43474 KLF4_HUMAN Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor) KLF4 EZF GKLF Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; defense response to tumor cell [GO:0002357]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; glandular epithelial cell differentiation [GO:0002067]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; canonical Wnt signaling pathway [GO:0060070]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; defense response to tumor cell [GO:0002357]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436]; fat cell differentiation [GO:0045444]; glandular epithelial cell differentiation [GO:0002067]; mesodermal cell fate determination [GO:0007500]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001010; GO:0001228; GO:0002067; GO:0002357; GO:0003700; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0006366; GO:0007500; GO:0008013; GO:0008270; GO:0008285; GO:0009913; GO:0010628; GO:0010629; GO:0015630; GO:0016525; GO:0019827; GO:0031077; GO:0031490; GO:0032088; GO:0032526; GO:0032717; GO:0034115; GO:0035019; GO:0035166; GO:0043154; GO:0045429; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046985; GO:0048679; GO:0048730; GO:0050728; GO:0051247; GO:0051973; GO:0060070; GO:0060761; GO:0061436; GO:0061629; GO:0071363; GO:0071499; GO:0090051; GO:0120222; GO:1902895; GO:1903672; GO:1904798; GO:1904998; GO:1990830; GO:1990837; GO:1990841; GO:2000134; GO:2000342 "beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" GRRSWPR 0.9691 -0.42656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5888 0 0 0 0 0 0 0 11.284 12.368 0 0 0 0 0 12.3917 0 0 0 0 0 0 0 0 13.628 13.105 13.2494 13.4975 13.5801 10.311 13.7223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4346 0 11.4516 0 0 0 0 0 0 0 0 10.6652 0 0 0 13.2849 0 15.0973 0 14.7972 0 14.3508 0 13.6297 14.3731 0 0 0 0 0 0 0 0 0 0 13.8888 0 0 0 0 0 13.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3454 0 0 0 0 0 13.21 13.7036 12.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3156 0 0 12.051 13.8654 0 0 0 0 0 Q86VU5 CMTD1_HUMAN "Catechol O-methyltransferase domain-containing protein 1, EC 2.1.1.-" COMTD1 UNQ766/PRO1558 Homo sapiens (Human) methylation [GO:0032259] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; O-methyltransferase activity [GO:0008171]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259] GO:0008171; GO:0008757; GO:0016021; GO:0032259 O-methyltransferase activity [GO:0008171]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] CLQLLRPGGILAVLR 0.9691 -0.25851 0 0 12.9059 0 9.98982 12.9855 12.1225 0 0 0 0 0 0 10.3102 0 0 0 0 0 0 0 0 0 0 0 10.6514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2233 0 0 0 0 0 14.4673 0 0 0 0 0 0 0 0 0 10.2954 0 0 0 0 0 0 0 0 0 0 10.4282 0 0 13.0158 0 0 0 0 0 0 0 0 0 0 12.505 13.7688 0 0 0 0 0 0 10.799 0 0 0 0 0 14.2119 10.4969 0 0 0 0 0 0 0 13.9183 0 0 0 0 0 13.3236 0 0 0 0 0 0 0 12.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1261 0 0 0 0 12.2019 0 0 0 0 13.65 0 0 0 0 0 0 0 0 0 0 0 0 12.7542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5J3 HEY1_HUMAN "Hairy/enhancer-of-split related with YRPW motif protein 1 (Cardiovascular helix-loop-helix factor 2, CHF-2) (Class B basic helix-loop-helix protein 31, bHLHb31) (HES-related repressor protein 1) (Hairy and enhancer of split-related protein 1, HESR-1) (Hairy-related transcription factor 1, HRT-1, hHRT1)" HEY1 BHLHB31 CHF2 HERP2 HESR1 HRT1 Homo sapiens (Human) "angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; arterial endothelial cell differentiation [GO:0060842]; atrioventricular valve formation [GO:0003190]; cardiac conduction system development [GO:0003161]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac septum morphogenesis [GO:0060411]; cardiac ventricle morphogenesis [GO:0003208]; circulatory system development [GO:0072359]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vasculogenesis [GO:2001212]; umbilical cord morphogenesis [GO:0036304]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; arterial endothelial cell differentiation [GO:0060842]; atrioventricular valve formation [GO:0003190]; cardiac conduction system development [GO:0003161]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac septum morphogenesis [GO:0060411]; cardiac ventricle morphogenesis [GO:0003208]; circulatory system development [GO:0072359]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vasculogenesis [GO:2001212]; umbilical cord morphogenesis [GO:0036304]; ventricular septum morphogenesis [GO:0060412]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001525; GO:0003161; GO:0003180; GO:0003184; GO:0003190; GO:0003203; GO:0003208; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007219; GO:0009952; GO:0010628; GO:0035912; GO:0036304; GO:0045665; GO:0045746; GO:0045892; GO:0045944; GO:0046983; GO:0050767; GO:0060317; GO:0060347; GO:0060411; GO:0060412; GO:0060716; GO:0060842; GO:0061314; GO:0061629; GO:0070168; GO:0072359; GO:1990837; GO:2000678; GO:2000820; GO:2001212 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" INNSLSELR 0.9691 -0.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43895 XPP2_HUMAN "Xaa-Pro aminopeptidase 2, EC 3.4.11.9 (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P, Membrane-bound APP, Membrane-bound AmP, mAmP) (X-Pro aminopeptidase 2)" XPNPEP2 Homo sapiens (Human) proteolysis [GO:0006508] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; proteolysis [GO:0006508] GO:0004177; GO:0005576; GO:0005886; GO:0006508; GO:0016020; GO:0031225; GO:0046872; GO:0070006; GO:0070062 aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006] DAVAVIRYLVWLEK 0.96912 -0.83157 0 0 0 0 0 0 0 0 0 0 11.2151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0623 0 0 0 0 0 0 0 12.1168 0 0 0 0 0 0 0 12.1089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9516 0 0 0 0 0 0 0 0 0 12.8723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7944 0 Q53G44 IF44L_HUMAN Interferon-induced protein 44-like IFI44L C1orf29 GS3686 Homo sapiens (Human) defense response to virus [GO:0051607]; immune response [GO:0006955] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955] GO:0005525; GO:0005737; GO:0006955; GO:0051607 GTP binding [GO:0005525] GCMPDRYQFNSR 0.96913 -1.014 0 0 0 0 0 0 0 0 0 12.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7441 0 0 0 0 0 0 0 13.9898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7892 0 14.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYQ9 KRA48_HUMAN Keratin-associated protein 4-8 (Keratin-associated protein 4.8) (Ultrahigh sulfur keratin-associated protein 4.8) KRTAP4-8 KAP4.8 KRTAP4.8 Homo sapiens (Human) aging [GO:0007568]; hair cycle [GO:0042633] cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; aging [GO:0007568]; hair cycle [GO:0042633] GO:0005829; GO:0007568; GO:0042633; GO:0045095 PACVISTCPRPVCCASSCC 0.96913 -0.80933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.765 0 0 0 0 13.3678 0 0 0 0 0 0 Q9UBG3 CRNN_HUMAN Cornulin (53 kDa putative calcium-binding protein) (53 kDa squamous epithelial-induced stress protein) (58 kDa heat shock protein) (Squamous epithelial heat shock protein 53) (Tumor-related protein) CRNN C1orf10 DRC1 PDRC1 SEP53 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of gene expression [GO:0010468]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to heat [GO:0009408] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of gene expression [GO:0010468]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to heat [GO:0009408] GO:0005509; GO:0005737; GO:0009408; GO:0010468; GO:0010838; GO:0014066; GO:0016020; GO:0046914; GO:0048306; GO:0051092; GO:0070062; GO:0071345; GO:0098609; GO:1902808 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914] ELYSYLR 0.96914 -1.0148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5445 0 0 0 14.1358 13.1099 12.8748 12.7786 12.295 12.5381 12.5239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7015 0 12.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3719 0 0 0 14.6421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22003 BMP5_HUMAN "Bone morphogenetic protein 5, BMP-5" BMP5 Homo sapiens (Human) allantois development [GO:1905069]; anterior head development [GO:0097065]; BMP signaling pathway [GO:0030509]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; chorio-allantoic fusion [GO:0060710]; ear development [GO:0043583]; endocardial cushion formation [GO:0003272]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; male genitalia development [GO:0030539]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of steroid biosynthetic process [GO:0010894]; neural fold elevation formation [GO:0021502]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323] extracellular space [GO:0005615]; vesicle [GO:0031982] extracellular space [GO:0005615]; vesicle [GO:0031982]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; allantois development [GO:1905069]; anterior head development [GO:0097065]; BMP signaling pathway [GO:0030509]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; chorio-allantoic fusion [GO:0060710]; ear development [GO:0043583]; endocardial cushion formation [GO:0003272]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; male genitalia development [GO:0030539]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of steroid biosynthetic process [GO:0010894]; neural fold elevation formation [GO:0021502]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323] GO:0001501; GO:0001503; GO:0003272; GO:0003323; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0008083; GO:0008284; GO:0008285; GO:0010719; GO:0010862; GO:0010894; GO:0021502; GO:0030509; GO:0030539; GO:0030902; GO:0031982; GO:0032348; GO:0043569; GO:0043583; GO:0045944; GO:0048738; GO:0050679; GO:0051216; GO:0060037; GO:0060395; GO:0060411; GO:0060710; GO:0061384; GO:0070700; GO:0071676; GO:0097065; GO:1900006; GO:1902042; GO:1905069; GO:2000065 BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083] ASEVLLRSVRAANK 0.96915 -0.95188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7275 0 0 0 0 0 12.4012 10.8033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3805 0 10.6774 0 0 0 0 0 0 13.7883 0 12.9874 0 0 0 0 0 0 0 0 0 0 12.7464 0 0 0 0 0 0 0 0 0 11.9464 0 0 13.6533 14.9769 12.6693 12.8147 0 0 0 0 0 0 0 0 0 13.3771 13.7036 0 0 12.8091 0 13.3756 0 14.4832 0 0 0 0 0 0 13.397 12.5603 0 13.6072 12.3984 12.5593 0 0 13.7209 15.0274 0 0 0 0 13.4318 0 0 0 0 13.9044 12.7059 12.9473 12.0096 0 12.3351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6707 0 0 0 0 0 0 0 11.4582 0 0 Q9Y2E5 MA2B2_HUMAN "Epididymis-specific alpha-mannosidase, EC 3.2.1.24 (Alpha-1,6-mannosidase) (Mannosidase alpha class 2B member 2)" MAN2B2 KIAA0935 Homo sapiens (Human) mannose metabolic process [GO:0006013] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013] GO:0004559; GO:0005764; GO:0006013; GO:0030246; GO:0043202; GO:0046872; GO:0070062 alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] FIAVEQEFFR 0.96917 -0.42967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2466 0 0 0 10.5593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NLI5 TR64C_HUMAN Tripartite motif-containing protein 64C TRIM64C Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DSDTLRVFQNELICCICVNYFIDPVTTDCVHSFCR 0.96919 -0.27014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2771 13.5868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1211 0 0 0 0 0 0 0 0 0 0 0 0 12.734 0 0 0 0 12.461 12.8813 0 0 11.9198 0 0 0 0 12.5764 0 0 18.3617 12.8712 0 12.2889 0 0 0 0 13.0545 0 12.4177 0 0 0 0 0 12.8246 0 0 0 0 12.2245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6619 0 13.1153 0 0 0 0 0 0 Q14590 ZN235_HUMAN "Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog, Zfp-93) (Zinc finger protein HZF6)" ZNF235 ZFP93 ZNF270 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FNWSLNLHNHQR 0.96919 -0.46638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6762 0 11.8479 0 0 0 0 0 10.98 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 10.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7705 0 0 0 0 0 0 0 0 12.1814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.411 0 0 0 0 12.7107 0 12.2995 0 12.6527 14.0451 0 0 0 0 13.7886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9141 0 0 0 0 14.8442 13.7083 0 0 0 0 0 Q5T4H9 CSC10_HUMAN Putative uncharacterized protein encoded by MIR1915-HG (Cancer susceptibility 10 protein) (Cancer susceptibility candidate gene 10 protein) (MIR1915 host gene protein) MIR1915HG C10orf114 CASC10 Homo sapiens (Human) LLRWHHR 0.96919 -1.0724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95070 YIF1A_HUMAN Protein YIF1A (54TMp) (YIP1-interacting factor homolog A) YIF1A 54TM HYIF1P YIF1 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031] GO:0005789; GO:0005793; GO:0005794; GO:0006888; GO:0015031; GO:0030134; GO:0030173; GO:0033116; GO:0043231 ELHRFVSVSKLK 0.9692 -0.23807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2206 0 0 0 10.8803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR11 ZN302_HUMAN Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327) ZNF302 ZNF135L ZNF140L ZNF327 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" SFSRVSLLIQHLRIHTQEK 0.96922 -0.82655 0 0 0 10.7401 0 0 0 0 11.7588 12.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.855 0 0 0 0 0 0 0 12.5521 0 0 10.0761 12.7918 0 0 12.1801 0 0 13.7083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.541 0 0 15.0972 0 0 0 0 12.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7957 13.6493 13.1449 0 13.909 13.0943 13.2606 12.526 13.0533 0 13.0074 0 0 0 0 12.6781 0 12.5662 0 0 0 13.2766 0 0 H3BU77 CC179_HUMAN Coiled-coil domain-containing protein 179 CCDC179 Homo sapiens (Human) QHHPSEVTER 0.96923 -0.82734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5832 12.4473 0 12.268 0 12.695 0 0 0 0 12.1787 12.4594 0 0 0 0 0 0 0 11.7885 0 0 P20719 HXA5_HUMAN Homeobox protein Hox-A5 (Homeobox protein Hox-1C) HOXA5 HOX1C Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; bronchiole development [GO:0060435]; cell migration [GO:0016477]; cell-cell signaling involved in mammary gland development [GO:0060764]; embryonic skeletal system morphogenesis [GO:0048704]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; intestinal epithelial cell maturation [GO:0060574]; lung alveolus development [GO:0048286]; lung goblet cell differentiation [GO:0060480]; lung-associated mesenchyme development [GO:0060484]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal-epithelial cell signaling [GO:0060638]; multicellular organism growth [GO:0035264]; negative regulation of angiogenesis [GO:0016525]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system process [GO:0003016]; thyroid gland development [GO:0030878]; trachea cartilage morphogenesis [GO:0060535] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; bronchiole development [GO:0060435]; cell migration [GO:0016477]; cell-cell signaling involved in mammary gland development [GO:0060764]; embryonic skeletal system morphogenesis [GO:0048704]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; intestinal epithelial cell maturation [GO:0060574]; lung alveolus development [GO:0048286]; lung goblet cell differentiation [GO:0060480]; lung-associated mesenchyme development [GO:0060484]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal-epithelial cell signaling [GO:0060638]; multicellular organism growth [GO:0035264]; negative regulation of angiogenesis [GO:0016525]; negative regulation of erythrocyte differentiation [GO:0045647]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system process [GO:0003016]; thyroid gland development [GO:0030878]; trachea cartilage morphogenesis [GO:0060535]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003016; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0009952; GO:0010628; GO:0016477; GO:0016525; GO:0030878; GO:0033599; GO:0035264; GO:0043065; GO:0045639; GO:0045647; GO:0045944; GO:0048286; GO:0048704; GO:0060435; GO:0060441; GO:0060480; GO:0060484; GO:0060535; GO:0060574; GO:0060638; GO:0060644; GO:0060749; GO:0060764; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" MSSYFVNSFCGRYPNGPDYQLHNYGDHSSVSEQFR 0.96924 -0.4258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG23 ZN853_HUMAN Zinc finger protein 853 ZNF853 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASRPAALGGPAR 0.96925 -0.80904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0097 0 0 0 0 0 0 0 16.2655 0 0 0 0 12.9643 0 13.4671 0 0 0 0 0 0 0 13.2091 0 0 0 0 0 11.9767 12.9539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.004 0 0 0 0 0 0 13.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34949 MPI_HUMAN "Mannose-6-phosphate isomerase, EC 5.3.1.8 (Phosphohexomutase) (Phosphomannose isomerase, PMI)" MPI PMI1 Homo sapiens (Human) GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611] GO:0004476; GO:0005829; GO:0008270; GO:0009298; GO:0061611; GO:0070062 mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270] DLLIFRACCLL 0.96928 3.1919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1065 0 0 0 12.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX47 MARH5_HUMAN "E3 ubiquitin-protein ligase MARCHF5, EC 2.3.2.27 (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V, MARCH-V) (Mitochondrial ubiquitin ligase, MITOL) (RING finger protein 153) (RING-type E3 ubiquitin transferase MARCHF5)" MARCHF5 MARCH5 RNF153 Homo sapiens (Human) positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTPase binding [GO:0051020]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140] GO:0000209; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0008270; GO:0016020; GO:0016021; GO:0051020; GO:0051865; GO:0061630; GO:0070585; GO:0090140; GO:0090141 GTPase binding [GO:0051020]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ILNYPEQEEA 0.96928 -0.42918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0876 0 12.4227 0 0 0 14.3231 14.3387 14.1298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9256 0 0 0 0 0 0 0 0 0 0 0 12.6754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5505 0 0 13.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYL4 FKB11_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP11, PPIase FKBP11, EC 5.2.1.8 (19 kDa FK506-binding protein, 19 kDa FKBP, FKBP-19) (FK506-binding protein 11, FKBP-11) (Rotamase)" FKBP11 FKBP19 UNQ336/PRO535 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413] GO:0000413; GO:0003755; GO:0005783; GO:0016020; GO:0016021; GO:0061077 peptidyl-prolyl cis-trans isomerase activity [GO:0003755] AIIPSHLAYGKR 0.9693 3.6695 0 0 0 0 0 0 0 11.4572 0 0 0 0 0 0 11.3866 0 0 0 0 12.9055 0 0 17.1915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0829 0 13.4182 0 0 14.2872 0 0 0 0 16.6012 0 0 0 14.6927 0 0 0 14.7144 0 0 14.2643 0 0 0 0 14.1246 0 0 0 0 15.1664 0 0 0 0 0 0 12.5897 0 0 0 0 0 14.2033 0 0 14.6918 0 0 0 13.6573 0 0 0 0 14.684 0 0 0 0 0 13.5338 0 13.579 0 0 0 0 0 0 0 0 0 0 0 13.6959 0 0 0 11.7152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9786 0 Q5T0J3 CA220_HUMAN Putative uncharacterized protein C1orf220 C1orf220 Homo sapiens (Human) GTWGSKPSCTVPALSATSQLLQLGR 0.96931 -0.26732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2NL98 VMAC_HUMAN Vimentin-type intermediate filament-associated coiled-coil protein VMAC Homo sapiens (Human) cytoplasm [GO:0005737]; type III intermediate filament [GO:0045098] cytoplasm [GO:0005737]; type III intermediate filament [GO:0045098] GO:0005737; GO:0045098 DELIRQLQPRAELLQDICR 0.96933 -0.69971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2259 0 12.8483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6092 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6166 0 0 13.5878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0W2 DUS28_HUMAN "Dual specificity phosphatase 28, EC 3.1.3.16, EC 3.1.3.48" DUSP28 Homo sapiens (Human) dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470] myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0006470; GO:0008138; GO:0016311; GO:0016791; GO:0017018 myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] AGGACLVYCKNGR 0.96933 -0.75984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCS4 TF7L1_HUMAN "Transcription factor 7-like 1 (HMG box transcription factor 3, TCF-3)" TCF7L1 TCF3 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]" beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; canonical Wnt signaling pathway [GO:0060070]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]" GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0006357; GO:0008013; GO:0030111; GO:0060070; GO:1990837; GO:1990907 "beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ESAAINQILGRKWHNLSR 0.96933 -0.26991 0 0 0 0 0 0 0 0 0 0 13.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.935 0 0 0 0 0 0 0 0 0 14.1865 0 0 0 0 0 0 0 0 0 0 0 12.5658 0 0 0 0 0 13.8076 14.3039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0852 0 0 0 0 0 0 0 0 0 13.8152 0 0 0 0 0 0 0 0 13.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9152 0 0 0 0 0 0 0 0 0 0 Q9BT78 CSN4_HUMAN "COP9 signalosome complex subunit 4, SGN4, Signalosome subunit 4 (JAB1-containing signalosome subunit 4)" COPS4 CSN4 Homo sapiens (Human) protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] anchoring junction [GO:0070161]; cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; deNEDDylase activity [GO:0019784]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] GO:0000338; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008180; GO:0016607; GO:0019784; GO:0030054; GO:0045116; GO:0070161; GO:2000434 deNEDDylase activity [GO:0019784] ATTADGSSILDR 0.96934 -0.23773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0714 0 0 13.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAB2 KBTB3_HUMAN Kelch repeat and BTB domain-containing protein 3 (BTB and kelch domain-containing protein 3) KBTBD3 BKLHD3 Homo sapiens (Human) CCRTVRLHIAESYHDATDQTWCYCPVK 0.96935 -0.8258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3873 0 0 0 0 0 0 0 0 0 16.0479 0 0 0 0 16.3375 0 0 0 0 0 0 0 0 0 0 0 0 10.4052 0 0 0 13.9373 0 0 0 0 0 0 0 0 10.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5061 0 0 11.7126 0 0 0 0 0 14.7595 0 0 0 15.4675 0 12.7073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBM4 OPT_HUMAN Opticin (Oculoglycan) OPTC OPT Homo sapiens (Human) collagen fibril organization [GO:0030199] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; collagen fibril organization [GO:0030199] GO:0005201; GO:0005576; GO:0030199; GO:0031012 extracellular matrix structural constituent [GO:0005201] FNRISRIR 0.96936 -0.82731 0 0 0 0 0 0 15.0228 15.0897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6864 12.5596 0 12.6862 0 0 0 0 0 0 0 0 0 0 0 0 18.6676 0 0 0 0 0 0 0 0 0 0 17.9829 0 0 0 0 0 0 16.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8517 18.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1113 14.2685 0 0 12.2619 0 0 0 0 0 0 0 15.6113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0545 0 0 0 0 Q08499 PDE4D_HUMAN "cAMP-specific 3',5'-cyclic phosphodiesterase 4D, EC 3.1.4.53 (DPDE3) (PDE43)" PDE4D DPDE3 Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; establishment of endothelial barrier [GO:0061028]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] "apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; enzyme binding [GO:0019899]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate [GO:0086024]; adrenergic receptor signaling pathway [GO:0071875]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; establishment of endothelial barrier [GO:0061028]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]" GO:0002027; GO:0004114; GO:0004115; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0005891; GO:0006198; GO:0007165; GO:0010469; GO:0010880; GO:0016020; GO:0016324; GO:0019899; GO:0019933; GO:0030552; GO:0031698; GO:0032729; GO:0032743; GO:0032754; GO:0033137; GO:0034704; GO:0043951; GO:0044325; GO:0045822; GO:0046872; GO:0048471; GO:0050852; GO:0051117; GO:0060314; GO:0061028; GO:0071320; GO:0071872; GO:0071875; GO:0086004; GO:0086024; GO:0097110; GO:1901363; GO:1901844; GO:1901898 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; ATPase binding [GO:0051117]; beta-2 adrenergic receptor binding [GO:0031698]; cAMP binding [GO:0030552]; enzyme binding [GO:0019899]; heterocyclic compound binding [GO:1901363]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]" AMDRTSYAVETGHR 0.96937 3.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7E2 CBLL2_HUMAN "E3 ubiquitin-protein ligase CBLL2, EC 2.3.2.27 (Cbl proto-oncogene-like protein 2) (RING-type E3 ubiquitin transferase ZNF645) (Zinc finger protein 645) (c-Cbl-like protein 2)" CBLL2 ZNF645 Homo sapiens (Human) protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155] GO:0005737; GO:0016567; GO:0030155; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] HAFCYHCANLYDKVGYK 0.96937 -0.80815 0 0 12.2874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0537 0 0 0 0 0 0 0 12.9388 0 0 0 0 0 0 0 0 12.5044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1179 0 0 0 14.8217 0 12.8627 12.6487 0 0 13.2876 0 0 14.454 0 Q8NB46 ANR52_HUMAN "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C, PP6-ARS-C, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C (Ankyrin repeat domain-containing protein 52)" ANKRD52 Homo sapiens (Human) SLLSQKENINVLDQERR 0.96937 -0.42537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.414 0 0 0 0 0 0 0 0 0 0 13.6611 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4884 0 0 15.0539 0 0 14.4053 0 0 0 0 0 0 0 0 0 15.0381 0 14.9292 0 14.6978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92754 AP2C_HUMAN "Transcription factor AP-2 gamma, AP2-gamma (Activating enhancer-binding protein 2 gamma) (Transcription factor ERF-1)" TFAP2C Homo sapiens (Human) "anatomical structure development [GO:0048856]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0007267; GO:0008584; GO:0040029; GO:0042127; GO:0045944; GO:0048856; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" EFTELLSQDR 0.96938 -0.54835 0 0 0 0 0 0 0 0 12.9637 11.6557 0 13.022 0 11.978 12.9621 0 0 0 0 0 0 0 12.177 0 0 13.3088 0 13.114 12.3266 0 0 0 12.8958 0 0 0 12.9238 0 0 0 0 0 0 13.3678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3788 0 0 0 0 0 12.2166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4768 0 0 0 14.2543 0 0 14.2136 13.5324 0 0 12.9748 0 0 0 0 13.7253 0 0 0 0 P57739 CLD2_HUMAN Claudin-2 (SP82) CLDN2 PSEC0059 SP82 UNQ705/PRO1356 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609] GO:0005198; GO:0005886; GO:0005911; GO:0005923; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0070830; GO:0098609 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] ASLGLQLVGYILGLLGLLGTLVAMLLPSWK 0.96939 -0.55005 0 0 0 0 0 0 0 0 0 0 12.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1882 13.4892 12.6188 12.1682 0 0 0 0 12.0381 0 0 13.6707 0 13.6396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6959 14.5948 0 14.3156 14.5744 0 13.4833 0 13.1258 14.0224 12.896 0 0 0 0 0 0 0 0 0 0 0 Q6B8I1 DS13A_HUMAN "Dual specificity protein phosphatase 13 isoform A, DUSP13A, EC 3.1.3.16, EC 3.1.3.48 (Branching-enzyme interacting DSP) (Muscle-restricted DSP, MDSP)" DUSP13 BEDP DUSP13A MDSP Homo sapiens (Human) dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dephosphorylation [GO:0016311]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005737; GO:0006470; GO:0008138; GO:0016311; GO:0016791; GO:0017018 myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GFLHQLCR 0.96939 -0.68515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5888 13.5002 0 14.8002 0 0 0 0 0 0 0 0 0 14.133 0 0 13.787 0 0 0 0 0 0 0 14.3248 0 0 0 0 0 14.1799 0 0 0 0 0 13.5933 0 0 0 12.2088 13.2902 0 0 0 0 0 13.5433 0 0 0 0 0 0 13.9 0 0 0 0 0 0 12.9355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2201 0 12.5047 0 0 0 Q5BKT4 AG10A_HUMAN "Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase, EC 2.4.1.256 (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A)" ALG10 ALG10A Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]" GO:0005783; GO:0005789; GO:0006487; GO:0006488; GO:0016021; GO:0106073 "dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity [GO:0106073]" AQLEGYYFSAALSCTFLVSCLLFSAFSR 0.9694 -0.55013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7752 0 14.1625 0 0 0 10.8614 0 0 0 0 11.894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4073 13.0079 0 13.904 13.6422 0 0 0 13.8188 17.6272 0 0 0 13.4167 0 13.8303 0 0 0 0 14.4053 14.2822 0 0 0 14.4349 15.4471 0 14.9978 0 15.0877 0 12.673 12.6141 13.8096 0 16.493 0 0 0 0 0 0 0 18.4345 0 14.3482 13.4078 18.5086 14.5686 12.4875 18.8742 13.9412 14.6276 0 0 13.4824 0 13.7818 0 14.8245 13.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3275 0 0 0 0 0 12.7077 0 0 0 0 0 0 11.9676 0 0 0 0 0 0 0 0 19.225 13.4516 13.0474 0 0 0 0 0 0 Q96GW7 PGCB_HUMAN "Brevican core protein (Brain-enriched hyaluronan-binding protein, BEHAB) (Chondroitin sulfate proteoglycan 7)" BCAN BEHAB CSPG7 UNQ2525/PRO6018 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perineuronal net [GO:0072534] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; perineuronal net [GO:0072534]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074] GO:0001501; GO:0005540; GO:0005576; GO:0005796; GO:0007155; GO:0007417; GO:0021766; GO:0030246; GO:0031012; GO:0031225; GO:0043202; GO:0060074; GO:0072534; GO:0098978 carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540] ALEEEEKYEDEEEK 0.96941 -0.69067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2831 14.6631 0 0 0 0 0 12.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7749 0 0 0 0 11.5328 0 0 0 0 0 0 0 0 0 0 0 Q5H9R4 ARMX4_HUMAN Armadillo repeat-containing X-linked protein 4 ARMCX4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AMVGAEPETQSESK 0.96942 3.1871 0 0 0 0 0 0 0 9.70127 0 0 0 0 0 0 0 0 0 0 0 11.8383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.59109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.925 0 0 0 0 0 0 0 0 10.9015 15.4459 0 0 12.621 10.4624 0 0 0 0 15.1761 0 0 14.5339 0 0 0 0 0 0 0 0 13.5218 0 0 0 0 0 13.8016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6027 0 0 0 11.0505 0 0 0 11.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6254 0 0 12.946 0 0 0 0 0 0 14.226 0 0 0 0 0 0 0 0 0 13.8338 P27986 P85A_HUMAN "Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha)" PIK3R1 GRB1 Homo sapiens (Human) B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366] "cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]" "cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]" GO:0001678; GO:0001784; GO:0001953; GO:0002687; GO:0005068; GO:0005158; GO:0005159; GO:0005168; GO:0005634; GO:0005737; GO:0005801; GO:0005829; GO:0005886; GO:0005911; GO:0005942; GO:0005943; GO:0006366; GO:0006468; GO:0006606; GO:0006955; GO:0008286; GO:0008625; GO:0008630; GO:0010592; GO:0014065; GO:0016020; GO:0019903; GO:0030183; GO:0030217; GO:0030316; GO:0032760; GO:0032869; GO:0033120; GO:0034446; GO:0034644; GO:0034976; GO:0035014; GO:0036312; GO:0042307; GO:0043066; GO:0043125; GO:0043548; GO:0043551; GO:0043559; GO:0043560; GO:0045671; GO:0045944; GO:0046326; GO:0046626; GO:0046854; GO:0046935; GO:0046982; GO:0048009; GO:0048471; GO:0050821; GO:0051491; GO:0051497; GO:0060396; GO:0097529; GO:0120183; GO:1900103; GO:1903078; GO:1990578 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] EEVNEKLR 0.96944 -0.26594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1174 12.6769 0 0 0 0 0 0 0 0 0 0 0 12.6215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03426 KIME_HUMAN "Mevalonate kinase, MK, EC 2.7.1.36" MVK Homo sapiens (Human) "cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; phosphorylation [GO:0016310]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisome [GO:0005777] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]; phosphorylation [GO:0016310]" GO:0000287; GO:0004496; GO:0005524; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0016310; GO:0019287; GO:0042802; GO:0043231; GO:0050728 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496] ALVAGVRNRLLK 0.96945 -0.75891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4332 0 0 0 0 0 14.5696 0 0 0 0 0 0 13.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6482 0 0 0 0 0 0 0 Q12824 SNF5_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47, BAF47) (Integrase interactor 1 protein) (SNF5 homolog, hSNF5)" SMARCB1 BAF47 INI1 SNF5L1 Homo sapiens (Human) blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; DNA integration [GO:0015074]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone H3-K9 dimethylation [GO:1900110]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]; single stranded viral RNA replication via double stranded DNA intermediate [GO:0039692] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; fibrillar center [GO:0001650]; germ cell nucleus [GO:0043073]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; fibrillar center [GO:0001650]; germ cell nucleus [GO:0043073]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; DNA integration [GO:0015074]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone H3-K9 dimethylation [GO:1900110]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]; single stranded viral RNA replication via double stranded DNA intermediate [GO:0039692] GO:0000228; GO:0000776; GO:0000785; GO:0001188; GO:0001650; GO:0001741; GO:0001835; GO:0002039; GO:0003677; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006337; GO:0006338; GO:0006357; GO:0007049; GO:0007399; GO:0008285; GO:0015074; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030957; GO:0032991; GO:0035060; GO:0039692; GO:0042802; GO:0043073; GO:0043231; GO:0043923; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0051091; GO:0070316; GO:0070365; GO:0071564; GO:0071565; GO:0090240; GO:0140092; GO:1900110; GO:1900113; GO:1901838; GO:1902459; GO:1902661; GO:2000045; GO:2000617; GO:2000781; GO:2000819 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] AVSISTEPPTYLR 0.96945 -0.26674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5209 0 0 0 12.3552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8566 0 0 0 0 0 0 0 0 12.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12846 STX4_HUMAN Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to oxidative stress [GO:0034599]; cornified envelope assembly [GO:1903575]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; organelle fusion [GO:0048284]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; regulation of exocytosis [GO:0017157]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; SNARE complex assembly [GO:0035493]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lateral loop [GO:0043219]; membrane [GO:0016020]; myelin sheath adaxonal region [GO:0035749]; neuron projection membrane [GO:0032589]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; specific granule [GO:0042581]; storage vacuole [GO:0000322]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lateral loop [GO:0043219]; membrane [GO:0016020]; myelin sheath adaxonal region [GO:0035749]; neuron projection membrane [GO:0032589]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; specific granule [GO:0042581]; storage vacuole [GO:0000322]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; cellular response to interferon-gamma [GO:0071346]; cellular response to oxidative stress [GO:0034599]; cornified envelope assembly [GO:1903575]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; organelle fusion [GO:0048284]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; regulation of exocytosis [GO:0017157]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; SNARE complex assembly [GO:0035493]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0000322; GO:0002639; GO:0005484; GO:0005615; GO:0005768; GO:0005773; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0008021; GO:0008284; GO:0009986; GO:0012505; GO:0016020; GO:0016021; GO:0016230; GO:0016323; GO:0017157; GO:0030027; GO:0030335; GO:0030670; GO:0031201; GO:0031629; GO:0032589; GO:0034394; GO:0034599; GO:0035493; GO:0035749; GO:0035774; GO:0036477; GO:0042581; GO:0043085; GO:0043197; GO:0043219; GO:0043311; GO:0045202; GO:0045785; GO:0048278; GO:0048284; GO:0048471; GO:0048787; GO:0050921; GO:0060291; GO:0070062; GO:0071346; GO:0098794; GO:0098978; GO:1902041; GO:1903078; GO:1903575; GO:2000010 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; sphingomyelin phosphodiesterase activator activity [GO:0016230] KKVLIAICVSITVVLLAVIIGVTVVG 0.96945 -0.42991 0 0 0 0 0 0 0 0 0 0 0 13.4375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6104 0 0 0 0 0 0 0 0 0 0 11.4439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4893 0 0 13.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7309 0 0 12.6428 0 14.7884 12.8925 13.4862 0 13.138 0 13.8501 0 0 13.7142 14.0151 14.3356 0 0 13.9239 0 0 0 12.7946 0 12.1085 14.2808 0 0 10.7275 10.1398 13.982 13.3566 13.9487 13.8433 0 0 14.0826 0 9.9088 0 0 12.9826 0 10.3203 0 0 0 12.6617 13.1807 14.293 0 0 14.0107 11.3421 0 12.4971 0 0 0 0 0 0 0 0 0 0 0 13.1572 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0764 12.4881 0 0 0 0 0 0 Q504Y0 S39AC_HUMAN "Zinc transporter ZIP12 (LIV-1 subfamily of ZIP zinc transporter 8, LZT-Hs8) (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12, ZIP-12)" SLC39A12 ZIP12 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; response to decreased oxygen levels [GO:0036293]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578] extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471] extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; response to decreased oxygen levels [GO:0036293]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578] GO:0005385; GO:0005887; GO:0006882; GO:0007165; GO:0010975; GO:0031113; GO:0036293; GO:0048471; GO:0071578; GO:1903561; GO:1903672 zinc ion transmembrane transporter activity [GO:0005385] LILQLFVGLAVGTLSGDALLHLIPQVLGLHK 0.96945 -0.26651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2946 0 0 0 0 13.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6111 0 0 0 0 0 0 0 0 0 15.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7732 0 0 0 0 0 0 Q7Z6I6 RHG30_HUMAN Rho GTPase-activating protein 30 (Rho-type GTPase-activating protein 30) ARHGAP30 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0005096; GO:0005829; GO:0007264; GO:0031410; GO:0043231; GO:0051056 GTPase activator activity [GO:0005096] ASEDRGEAGGSQETK 0.96945 -0.69895 0 16.4732 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0857 0 12.2822 12.0038 0 0 0 12.3474 0 0 0 0 12.1347 12.3141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0613 0 0 0 0 0 11.1243 0 0 0 0 0 0 0 0 14.1042 10.176 0 0 0 12.411 0 0 0 0 0 0 0 0 0 13.2349 0 0 0 0 0 0 0 14.7666 0 0 0 12.0926 0 0 13.9943 0 0 0 0 0 0 10.7214 0 0 0 0 0 0 0 0 11.6792 0 0 0 0 0 12.4078 0 16.1051 13.7433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7339 0 0 13.67 0 0 0 0 0 0 0 14.4909 0 13.2881 13.8964 0 0 13.5025 0 0 12.0545 0 0 0 Q8IYU2 HACE1_HUMAN "E3 ubiquitin-protein ligase HACE1, EC 2.3.2.26 (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1) (HECT-type E3 ubiquitin transferase HACE1)" HACE1 KIAA1320 Homo sapiens (Human) cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nuclear body [GO:0016604]; nucleus [GO:0005634]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000139; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005783; GO:0006511; GO:0007030; GO:0007049; GO:0016567; GO:0016601; GO:0016604; GO:0030334; GO:0031267; GO:0032580; GO:0043161; GO:0061025; GO:0061630; GO:0070936 small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] DTAQILLLRGAK 0.96945 -0.75737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8738 0 0 0 16.4217 0 0 0 0 0 0 11.3329 0 12.2838 0 0 0 0 0 0 0 0 0 12.072 0 12.2247 0 0 0 0 0 0 0 0 0 0 0 0 12.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2VPA4 CR1L_HUMAN Complement component receptor 1-like protein (Complement C4b-binding protein CR-1-like protein) CR1L Homo sapiens (Human) "negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]" cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235] "cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]" GO:0005615; GO:0005737; GO:0016020; GO:0030449; GO:0043235; GO:0045959; GO:1903659 APPVRLER 0.96946 -0.75948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9832 11.9222 0 0 0 0 0 0 0 0 0 0 14.2488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0411 0 Q8TDV0 GP151_HUMAN "G-protein coupled receptor 151 (G-protein coupled receptor PGR7) (GPCR-2037) (Galanin receptor 4) (Galanin-receptor-like protein, GalRL)" GPR151 GALR4 GALRL PGR7 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of immune response [GO:0050778]; response to acidic pH [GO:0010447]; response to ischemia [GO:0002931] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of immune response [GO:0050778]; response to acidic pH [GO:0010447]; response to ischemia [GO:0002931] GO:0002931; GO:0004930; GO:0005887; GO:0007186; GO:0010447; GO:0042802; GO:0050778 G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802] GKTEKAEIPILPDVEQFWHER 0.96946 -0.26855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3897 0 0 0 17.3785 0 0 0 0 0 0 13.1721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TEZ4 CF164_HUMAN Putative uncharacterized protein encoded by LINC01590 (Long intergenic non-protein coding RNA 1590) LINC01590 C6orf164 Homo sapiens (Human) DHDPEVLTRNSACK 0.96947 -0.23651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3534 0 0 0 11.7875 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PCB6 AB17C_HUMAN "Alpha/beta hydrolase domain-containing protein 17C, Abhydrolase domain-containing protein 17C, EC 3.1.2.22" ABHD17C FAM108C1 Homo sapiens (Human) negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; regulation of postsynapse organization [GO:0099175] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; palmitoyl-(protein) hydrolase activity [GO:0008474]; negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; regulation of postsynapse organization [GO:0099175] GO:0002084; GO:0005886; GO:0008474; GO:0010008; GO:0043197; GO:0055038; GO:0070161; GO:0098839; GO:0098978; GO:0099175; GO:1902817; GO:1905668 palmitoyl-(protein) hydrolase activity [GO:0008474] KTYCFDAFPSIDK 0.96947 -0.26972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07738 PMGE_HUMAN "Bisphosphoglycerate mutase, BPGM, EC 5.4.2.4 (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase, EC 5.4.2.11) (2,3-diphosphoglycerate mutase, DPGM) (BPG-dependent PGAM)" BPGM Homo sapiens (Human) carbohydrate derivative catabolic process [GO:1901136]; carbohydrate metabolic process [GO:0005975]; defense response to protozoan [GO:0042832]; erythrocyte development [GO:0048821]; establishment of blood-brain barrier [GO:0060856]; glycolytic process [GO:0006096]; neuroinflammatory response [GO:0150076]; oxygen transport [GO:0015671]; respiratory gaseous exchange by respiratory system [GO:0007585] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; carbohydrate derivative catabolic process [GO:1901136]; carbohydrate metabolic process [GO:0005975]; defense response to protozoan [GO:0042832]; erythrocyte development [GO:0048821]; establishment of blood-brain barrier [GO:0060856]; glycolytic process [GO:0006096]; neuroinflammatory response [GO:0150076]; oxygen transport [GO:0015671]; respiratory gaseous exchange by respiratory system [GO:0007585] GO:0004082; GO:0004619; GO:0005829; GO:0005975; GO:0006096; GO:0007585; GO:0015671; GO:0016787; GO:0042832; GO:0048821; GO:0060856; GO:0070062; GO:0150076; GO:1901136 bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619] HYGALIGLNREQMALNHGEEQVRLWR 0.96948 -0.23703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2222 0 0 0 0 0 0 0 0 0 0 0 11.8963 0 0 0 12.9453 12.8384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZU1 MCLN1_HUMAN "Mucolipin-1, ML1 (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1, TRPML1)" MCOLN1 ML4 TRPML1 MSTP080 Homo sapiens (Human) adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; phagosome maturation [GO:0090382]; protein homotetramerization [GO:0051289]; transferrin transport [GO:0033572] cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; iron ion transmembrane transporter activity [GO:0005381]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; autophagosome maturation [GO:0097352]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular response to calcium ion [GO:0071277]; cellular response to pH [GO:0071467]; phagosome maturation [GO:0090382]; protein homotetramerization [GO:0051289]; transferrin transport [GO:0033572]" GO:0001891; GO:0002250; GO:0005261; GO:0005262; GO:0005381; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006812; GO:0008289; GO:0010008; GO:0016020; GO:0016021; GO:0030670; GO:0031902; GO:0033572; GO:0042802; GO:0042995; GO:0043231; GO:0043235; GO:0051289; GO:0070588; GO:0071277; GO:0071467; GO:0072345; GO:0090382; GO:0097352; GO:0097682; GO:0099604 "calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; iron ion transmembrane transporter activity [GO:0005381]; ligand-gated calcium channel activity [GO:0099604]; lipid binding [GO:0008289]; NAADP-sensitive calcium-release channel activity [GO:0072345]" NLTLKFHK 0.96948 -0.23736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9516 0 13.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5906 0 0 0 0 0 12.2727 0 12.0111 12.8169 13.0917 0 0 0 0 13.7928 0 0 12.241 0 0 0 0 13.4815 0 0 11.067 0 0 0 0 0 0 0 0 13.1571 0 0 0 0 0 0 0 13.6617 0 13.6304 0 0 0 0 13.6338 0 0 0 0 0 0 0 0 0 13.6436 0 0 0 0 12.7238 14.0616 0 0 13.6116 0 0 0 0 0 0 0 0 13.1409 13.1118 0 0 0 0 0 0 0 0 0 0 11.9843 0 0 0 0 0 0 12.7557 0 0 12.9655 0 0 0 E7ETH6 Z587B_HUMAN Zinc finger protein 587B ZNF587B Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EECYVCCECGK 0.9695 -0.46898 0 0 0 0 0 0 0 0 11.139 0 0 10.8091 0 0 10.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.122 0 0 11.4612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2082 0 12.32 0 0 0 0 0 0 0 0 0 0 0 0 11.2212 0 0 0 0 0 0 0 0 12.7483 0 0 12.7738 0 0 13.0204 0 0 0 0 12.2858 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5D0 WDTC1_HUMAN WD and tetratricopeptide repeats protein 1 WDTC1 KIAA1037 Homo sapiens (Human) cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; cellular chemical homeostasis [GO:0055082]; cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361] GO:0000122; GO:0001701; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082; GO:0080008 enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826] AHFRLAR 0.96952 -0.54774 0 0 0 13.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5029 0 0 0 0 13.7383 0 0 0 0 0 0 0 0 0 0 11.499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6846 0 0 0 0 0 0 12.4246 0 0 0 13.4955 0 14.2054 14.8247 16.2712 0 14.0773 0 13.9731 0 12.3476 0 0 0 13.6686 0 0 14.1971 0 13.3295 13.6208 14.7793 0 0 0 0 0 0 0 15.6423 0 0 0 0 0 13.3285 0 15.1841 0 0 0 0 0 13.2884 0 15.4879 15.8189 0 13.5172 0 13.9256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1532 0 0 13.3436 14.4009 0 0 17.3662 0 17.7607 0 16.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46736 BRCC3_HUMAN "Lys-63-specific deubiquitinase BRCC36, EC 3.4.19.- (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36)" BRCC3 BRCC36 C6.1A CXorf53 Homo sapiens (Human) cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; cysteine-type deubiquitinase activity [GO:0004843]; enzyme regulator activity [GO:0030234]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165] GO:0000151; GO:0000152; GO:0000922; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0008237; GO:0010165; GO:0010212; GO:0016579; GO:0030234; GO:0031593; GO:0035518; GO:0044818; GO:0045739; GO:0046872; GO:0051301; GO:0051865; GO:0061578; GO:0070122; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0071479; GO:0140492; GO:2000001 cysteine-type deubiquitinase activity [GO:0004843]; enzyme regulator activity [GO:0030234]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593] EEERYERIEIPIHIVPHVTIGK 0.96954 -0.68914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4808 0 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7675 0 0 14.8264 0 0 14.5699 13.8943 0 12.1306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7936 0 0 0 0 0 0 0 14.9106 0 11.5142 0 0 0 0 12.0925 0 0 0 0 0 0 0 0 0 14.7111 0 0 0 0 0 0 0 0 11.9454 0 0 0 0 0 0 0 0 10.9961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0152 0 0 0 Q14694 UBP10_HUMAN "Ubiquitin carboxyl-terminal hydrolase 10, EC 3.4.19.12 (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10)" USP10 KIAA0190 Homo sapiens (Human) "autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0002039; GO:0003723; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0019985; GO:0030330; GO:0032991; GO:0043124; GO:0044325; GO:0045111; GO:0071347 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325] LPPVLVLHLKR 0.96954 -0.74935 0 0 0 0 0 0 0 0 11.5368 0 0 0 0 0 0 0 0 15.2572 14.6607 0 0 0 0 0 0 0 15.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3941 13.4435 0 14.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6479 0 0 0 0 0 0 0 13.937 13.9647 0 0 0 0 0 0 12.9399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5287 0 0 0 0 13.2943 0 0 0 0 0 0 13.0901 0 0 14.2578 13.3769 0 0 0 0 0 0 13.2729 0 0 13.4621 0 0 0 0 12.9257 0 0 0 0 12.8151 0 0 0 0 0 0 0 0 0 0 0 12.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1482 0 0 0 0 0 12.4694 0 0 0 0 0 12.4047 0 Q502W7 CCD38_HUMAN Coiled-coil domain-containing protein 38 CCDC38 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 ANIILPKILAK 0.96954 -0.74952 0 0 0 0 0 0 0 0 0 11.2422 0 0 0 0 0 0 0 0 0 13.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0495 0 0 0 0 0 11.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7737 0 0 0 0 0 14.4929 14.3604 16.2638 0 0 0 0 0 12.6784 0 0 0 12.8029 11.0823 0 12.2639 0 0 13.9563 14.5857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7498 0 0 0 13.6621 11.621 15.0354 0 0 15.1955 0 0 11.5949 0 0 0 0 0 0 0 0 0 0 13.6703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3701 0 0 0 10.6916 0 0 11.9396 0 0 0 0 0 0 0 12.0929 0 0 0 0 0 0 0 0 0 0 0 0 Q5VVX9 UBE2U_HUMAN "Ubiquitin-conjugating enzyme E2 U, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme U) (Ubiquitin carrier protein U) (Ubiquitin-protein ligase U)" UBE2U Homo sapiens (Human) DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] HULC complex [GO:0033503] HULC complex [GO:0033503]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; DNA repair [GO:0006281]; histone ubiquitination [GO:0016574]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005524; GO:0006281; GO:0016574; GO:0033503; GO:0043161; GO:0061631 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] AYLLLHR 0.96955 -0.69416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8623 0 0 0 0 0 0 0 0 Q6A163 K1C39_HUMAN "Keratin, type I cytoskeletal 39 (Cytokeratin-39, CK-39) (Keratin-39, K39) (Type I hair keratin Ka35)" KRT39 KA35 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109 structural molecule activity [GO:0005198] CEPSPWTSCK 0.96955 3.2444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92681 RSCA1_HUMAN "Regulatory solute carrier protein family 1 member 1 (Transporter regulator RS1, hRS1)" RSC1A1 Homo sapiens (Human) "negative regulation of exocytosis [GO:0045920]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of nucleoside transport [GO:0032243]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of transport [GO:0051051]; regulation of transcription, DNA-templated [GO:0006355]" cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel inhibitor activity [GO:0019871]; negative regulation of exocytosis [GO:0045920]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of nucleoside transport [GO:0032243]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of transport [GO:0051051]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0010829; GO:0019871; GO:0030054; GO:0032243; GO:0042997; GO:0045920; GO:0051051; GO:1903077 sodium channel inhibitor activity [GO:0019871] EAVENVNFR 0.96955 -0.75264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3596 0 0 0 0 0 0 0 0 0 0 13.4887 0 0 0 0 12.8527 0 13.3965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9163 0 0 0 0 13.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4631 0 0 0 0 11.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96R54 O14A2_HUMAN Olfactory receptor 14A2 (Olfactory receptor 5AX1) (Olfactory receptor OR1-31) OR14A2 OR5AX1 OR5AX1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] CALIRLLQK 0.96956 -0.6944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.477 0 0 0 0 0 0 0 0 0 0 0 0 14.0896 0 0 0 0 0 0 0 0 13.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26006 ITA3_HUMAN "Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3, GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain ]" ITGA3 MSK18 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; dendritic spine maintenance [GO:0097062]; exploration behavior [GO:0035640]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; negative regulation of cell projection organization [GO:0031345]; negative regulation of Rho protein signal transduction [GO:0035024]; nephron development [GO:0072006]; neuron migration [GO:0001764]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of BMP signaling pathway [GO:0030510]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of Wnt signaling pathway [GO:0030111]; renal filtration [GO:0097205]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skin development [GO:0043588] basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; growth cone filopodium [GO:1990812]; integrin alpha3-beta1 complex [GO:0034667]; integrin complex [GO:0008305]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synaptic membrane [GO:0097060] basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; growth cone filopodium [GO:1990812]; integrin alpha3-beta1 complex [GO:0034667]; integrin complex [GO:0008305]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synaptic membrane [GO:0097060]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; dendritic spine maintenance [GO:0097062]; exploration behavior [GO:0035640]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; negative regulation of cell projection organization [GO:0031345]; negative regulation of Rho protein signal transduction [GO:0035024]; nephron development [GO:0072006]; neuron migration [GO:0001764]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of BMP signaling pathway [GO:0030510]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of Wnt signaling pathway [GO:0030111]; renal filtration [GO:0097205]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skin development [GO:0043588] GO:0001764; GO:0001968; GO:0002020; GO:0005178; GO:0005518; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0007266; GO:0007507; GO:0007613; GO:0008305; GO:0009410; GO:0009897; GO:0009986; GO:0010628; GO:0010634; GO:0010811; GO:0010976; GO:0016323; GO:0017015; GO:0019904; GO:0030111; GO:0030324; GO:0030510; GO:0031345; GO:0031527; GO:0033627; GO:0034667; GO:0034698; GO:0035024; GO:0035640; GO:0043235; GO:0043236; GO:0043588; GO:0046872; GO:0046982; GO:0048333; GO:0048471; GO:0050900; GO:0060076; GO:0060135; GO:0070062; GO:0071944; GO:0072006; GO:0097060; GO:0097062; GO:0097205; GO:0098609; GO:1903078; GO:1990812 collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982] AKSETVLTCATGR 0.96957 -0.75711 0 0 0 0 0 10.7019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2923 0 0 0 0 0 0 0 0 0 14.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4896 0 0 0 13.4197 0 0 0 0 0 0 0 0 0 0 0 13.7905 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49019 HCAR3_HUMAN Hydroxycarboxylic acid receptor 3 (G-protein coupled receptor 109B) (G-protein coupled receptor HM74) (G-protein coupled receptor HM74B) (Niacin receptor 2) (Nicotinic acid receptor 2) HCAR3 GPR109B HCA3 HM74B NIACR2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; nicotinic acid receptor activity [GO:0070553]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0030054; GO:0070553 G protein-coupled receptor activity [GO:0004930]; nicotinic acid receptor activity [GO:0070553] AITFIMVVAIVFVICFLPSVVVR 0.96957 -0.26548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8711 14.0275 0 0 0 0 13.3426 0 0 0 13.8941 0 0 0 0 0 0 0 13.7141 0 13.4098 0 0 Q16558 KCMB1_HUMAN "Calcium-activated potassium channel subunit beta-1 (BK channel subunit beta-1, BKbeta, BKbeta1, Hbeta1) (Calcium-activated potassium channel, subfamily M subunit beta-1, Calcium-activated potassium channel subunit beta) (Charybdotoxin receptor subunit beta-1) (K(VCA)beta-1) (Maxi K channel subunit beta-1) (Slo-beta-1, Slo-beta)" KCNMB1 Homo sapiens (Human) aging [GO:0007568]; cellular response to bile acid [GO:1903413]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; detection of calcium ion [GO:0005513]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transport [GO:0006813]; vasodilation [GO:0042311] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; calcium-activated potassium channel activity [GO:0015269]; potassium channel regulator activity [GO:0015459]; aging [GO:0007568]; cellular response to bile acid [GO:1903413]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; detection of calcium ion [GO:0005513]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transport [GO:0006813]; vasodilation [GO:0042311] GO:0005513; GO:0005886; GO:0006813; GO:0007268; GO:0007568; GO:0008076; GO:0015269; GO:0015459; GO:0042311; GO:0045202; GO:0071361; GO:0071456; GO:1901381; GO:1903413 calcium-activated potassium channel activity [GO:0015269]; potassium channel regulator activity [GO:0015459] FQEQQVFYCFSAPR 0.96957 -0.69725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6345 0 0 12.1303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0L1 ZKSC7_HUMAN Zinc finger protein with KRAB and SCAN domains 7 (Zinc finger protein 167) (Zinc finger protein 448) (Zinc finger protein 64) ZKSCAN7 ZNF167 ZNF448 ZNF64 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNECGRAFCSNR 0.96957 -0.69582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JNZ5 RS26L_HUMAN Putative 40S ribosomal protein S26-like 1 RPS26P11 RPS26L1 Homo sapiens (Human) translation [GO:0006412] cytosolic small ribosomal subunit [GO:0022627] cytosolic small ribosomal subunit [GO:0022627]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412] GO:0003729; GO:0003735; GO:0006412; GO:0022627 mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735] FVIRNIVEAAAVR 0.96958 -0.26589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3989 0 0 0 0 0 0 0 0 0 17.2526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2G4 LYPD1_HUMAN "Ly6/PLAUR domain-containing protein 1 (Putative HeLa tumor suppressor, PHTS)" LYPD1 LYPDC1 PSEC0181 UNQ3079/PRO9917 Homo sapiens (Human) "acetylcholine receptor signaling pathway [GO:0095500]; behavioral fear response [GO:0001662]; negative regulation of protein localization to plasma membrane [GO:1903077]; protein localization to plasma membrane [GO:0072659]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]" anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]; acetylcholine receptor signaling pathway [GO:0095500]; behavioral fear response [GO:0001662]; negative regulation of protein localization to plasma membrane [GO:1903077]; protein localization to plasma membrane [GO:0072659]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]" GO:0001662; GO:0005576; GO:0005886; GO:0007271; GO:0030550; GO:0031225; GO:0033130; GO:0035094; GO:0045202; GO:0072659; GO:0095500; GO:1903077 acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550] PGLRTTILFLK 0.96958 -0.69879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3214 0 0 0 0 0 0 0 0 0 0 10.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7715 0 12.5013 0 10.4136 0 0 0 12.3268 0 12.9003 0 13.5137 12.3094 0 0 0 0 12.0511 0 0 0 12.6213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7746 0 0 0 13.2512 0 0 0 0 11.1506 0 13.4301 0 0 0 0 0 13.2838 0 0 0 0 0 0 0 0 0 0 12.3316 0 12.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2445 0 0 0 0 0 0 0 0 0 0 12.5975 0 0 0 0 0 0 Q02962 PAX2_HUMAN Paired box protein Pax-2 PAX2 Homo sapiens (Human) "aging [GO:0007568]; anatomical structure development [GO:0048856]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]; visual perception [GO:0007601]" centriolar satellite [GO:0034451]; chromatin [GO:0000785]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993] "centriolar satellite [GO:0034451]; chromatin [GO:0000785]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription factor binding [GO:0008134]; aging [GO:0007568]; anatomical structure development [GO:0048856]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]; visual perception [GO:0007601]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001655; GO:0001658; GO:0001709; GO:0001823; GO:0001843; GO:0002072; GO:0003337; GO:0003406; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005764; GO:0005815; GO:0006357; GO:0007409; GO:0007501; GO:0007568; GO:0007601; GO:0008134; GO:0010001; GO:0021554; GO:0021631; GO:0021633; GO:0021650; GO:0031667; GO:0032991; GO:0032993; GO:0034451; GO:0035566; GO:0035799; GO:0039003; GO:0042472; GO:0043010; GO:0043066; GO:0043069; GO:0043154; GO:0043491; GO:0045892; GO:0045893; GO:0045944; GO:0048793; GO:0048854; GO:0048856; GO:0048863; GO:0050679; GO:0060231; GO:0061360; GO:0070301; GO:0071300; GO:0071333; GO:0071364; GO:0072075; GO:0072108; GO:0072162; GO:0072179; GO:0072189; GO:0072205; GO:0072207; GO:0072221; GO:0072289; GO:0072300; GO:0072305; GO:0072307; GO:0072593; GO:0090102; GO:0090103; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000378; GO:2000594; GO:2000597 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription factor binding [GO:0008134]" IAEYKRQNPTMFAWEIR 0.9696 3.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.15 14.0385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12883 MYH7_HUMAN "Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform, MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform, MyHC-beta)" MYH7 MYHCB Homo sapiens (Human) adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; regulation of heart rate [GO:0002027]; regulation of slow-twitch skeletal muscle fiber contraction [GO:0031449]; regulation of the force of heart contraction [GO:0002026]; regulation of the force of skeletal muscle contraction [GO:0014728]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009]; striated muscle contraction [GO:0006941]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0000146; GO:0001725; GO:0002026; GO:0002027; GO:0003009; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0006941; GO:0007512; GO:0014728; GO:0014883; GO:0014898; GO:0016459; GO:0016460; GO:0030016; GO:0030017; GO:0030018; GO:0030049; GO:0031449; GO:0032982; GO:0045214; GO:0046034; GO:0051015; GO:0055010; GO:0060048 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] EALEKSEARR 0.96962 -0.80718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2924 0 0 0 0 10.5355 0 0 0 0 10.5678 0 0 11.5514 0 0 0 0 0 0 0 0 0 11.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87764 0 12.266 0 9.68633 0 0 0 0 0 0 0 0 0 0 0 10.9612 0 0 0 0 0 12.9162 11.9476 0 0 0 0 0 0 0 0 13.1848 12.0986 0 12.2725 0 0 0 12.7656 0 11.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5289 0 0 0 0 0 0 0 0 0 10.6251 0 12.3193 0 0 0 0 0 0 0 0 0 10.2824 0 10.563 0 14.2437 0 0 13.4029 0 0 0 0 0 0 0 0 0 0 0 11.5787 0 0 0 0 0 0 0 0 0 0 0 0 Q16527 CSRP2_HUMAN "Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2, CRP2) (LIM domain only protein 5, LMO-5) (Smooth muscle cell LIM protein, SmLIM)" CSRP2 LMO5 SMLIM Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; cell differentiation [GO:0030154]; muscle tissue development [GO:0060537]; sarcomere organization [GO:0045214] GO:0005634; GO:0005737; GO:0005925; GO:0008307; GO:0030018; GO:0030036; GO:0030154; GO:0042805; GO:0045214; GO:0046872; GO:0060537 actinin binding [GO:0042805]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307] IIGAGKPWHK 0.96962 -0.8074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A5D8V6 VP37C_HUMAN "Vacuolar protein sorting-associated protein 37C, hVps37C (ESCRT-I complex subunit VPS37C)" VPS37C PML39 Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902] endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; calcium-dependent protein binding [GO:0048306]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] GO:0000813; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0048306; GO:0070062; GO:0090148 calcium-dependent protein binding [GO:0048306] ASQELAGDAPPPR 0.96963 -0.54328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7294 0 0 0 0 0 0 0 0 0 0 0 0 P57082 TBX4_HUMAN "T-box transcription factor TBX4, T-box protein 4" TBX4 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell fate specification [GO:0001708]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic lung development [GO:1990401]; limb morphogenesis [GO:0035108]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system morphogenesis [GO:0048705]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; cell fate specification [GO:0001708]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic lung development [GO:1990401]; limb morphogenesis [GO:0035108]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system morphogenesis [GO:0048705]" GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001708; GO:0002009; GO:0003677; GO:0005634; GO:0006357; GO:0030324; GO:0035108; GO:0035116; GO:0045893; GO:0048705; GO:1990401 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DSSLFYHCLKR 0.96963 -0.68194 0 0 0 11.8093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9737 0 0 0 0 0 0 0 0 0 12.8211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8998 13.6808 0 0 0 0 0 0 0 0 0 0 0 12.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7673 13.2996 13.4868 12.7072 0 0 0 0 0 Q9H4G0 E41L1_HUMAN "Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1, 4.1N)" EPB41L1 KIAA0338 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; cortical actin cytoskeleton organization [GO:0030866] GO:0003779; GO:0005198; GO:0005829; GO:0005856; GO:0005886; GO:0030866; GO:0031032 actin binding [GO:0003779]; structural molecule activity [GO:0005198] APESDTGDEDQDQER 0.96963 -0.74112 0 0 0 0 0 0 0 11.0018 0 0 0 12.5561 0 0 12.1805 0 13.5824 13.691 0 11.5734 11.5727 0 0 0 0 0 0 0 12.3815 12.3635 11.2619 11.7568 0 0 0 0 0 12.2077 0 0 0 0 0 0 11.6728 0 12.0989 0 0 9.68989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3544 9.72744 0 0 11.7375 0 0 0 0 15.3628 0 0 0 0 0 0 11.9278 0 0 0 0 0 0 0 0 0 0 13.6187 13.788 0 0 0 14.5391 15.9576 0 0 0 0 0 0 0 0 0 0 11.6167 0 0 12.7582 12.5071 14.9856 13.6909 0 0 9.81092 0 0 0 0 14.8209 0 15.8284 0 0 0 0 0 0 12.3226 0 0 0 0 0 0 0 0 0 15.1833 0 0 0 0 15.735 0 0 0 10.8977 0 0 0 0 12.2433 0 0 0 0 0 0 0 12.7155 0 12.5254 12.3344 0 0 0 0 0 0 11.108 13.292 Q9H816 DCR1B_HUMAN "5' exonuclease Apollo, EC 3.1.-.- (Beta-lactamase DCLRE1B, EC 3.5.2.6) (DNA cross-link repair 1B protein) (SNM1 homolog B, SNMIB, hSNM1B)" DCLRE1B SNM1B Homo sapiens (Human) double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627]" GO:0000723; GO:0000781; GO:0003684; GO:0005654; GO:0005737; GO:0005813; GO:0006303; GO:0008409; GO:0008800; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] AFVAALK 0.96963 -0.46877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2911 0 0 13.8474 0 0 0 0 0 13.5506 0 0 0 0 14.0942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8936 14.6435 14.9052 0 0 0 0 0 0 0 0 0 0 13.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7748 0 0 14.1298 12.4273 0 0 0 0 14.1632 13.7424 0 14.6522 0 0 0 0 0 0 0 13.6342 0 0 0 0 0 13.7273 0 0 0 0 0 0 0 0 14.2401 14.1154 0 14.435 14.8543 14.4168 0 0 0 12.9836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2058 0 0 0 0 13.9495 0 0 0 0 0 0 P37235 HPCL1_HUMAN "Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3, VILIP-3)" HPCAL1 BDR1 Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020]; calcium ion binding [GO:0005509] GO:0005509; GO:0016020 calcium ion binding [GO:0005509] EFIIALSVTSRGKLEQK 0.96964 -0.47083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6861 0 0 0 0 0 14.3174 0 0 0 0 0 0 0 0 0 0 0 0 14.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ81 MAGB5_HUMAN "Melanoma-associated antigen B5 (Cancer/testis antigen 3.3, CT3.3) (MAGE-B5 antigen)" MAGEB5 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 IHVGKVLPKTGLLMTFLVVIFLK 0.96964 -0.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2716 12.7327 13.9511 15.0546 0 0 0 0 0 0 0 0 12.8685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6238 0 0 0 0 0 0 0 0 10.9753 0 0 0 13.9282 0 12.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8589 0 0 0 0 13.0721 0 0 0 0 0 0 14.1448 0 0 0 12.0666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04054 PA21B_HUMAN "Phospholipase A2, EC 3.1.1.4 (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B)" PLA2G1B PLA2 PLA2A PPLA2 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of phospholipase A2 activity [GO:0032431]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; arachidonic acid secretion [GO:0050482]; cellular response to insulin stimulus [GO:0032869]; defense response to Gram-positive bacterium [GO:0050830]; fatty acid biosynthetic process [GO:0006633]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; leukotriene biosynthetic process [GO:0019370]; lipid catabolic process [GO:0016042]; neutrophil chemotaxis [GO:0030593]; neutrophil mediated immunity [GO:0002446]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of immune response [GO:0050778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of podocyte apoptotic process [GO:1904635]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose import [GO:0046324]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; bile acid binding [GO:0032052]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; activation of phospholipase A2 activity [GO:0032431]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; arachidonic acid secretion [GO:0050482]; cellular response to insulin stimulus [GO:0032869]; defense response to Gram-positive bacterium [GO:0050830]; fatty acid biosynthetic process [GO:0006633]; innate immune response in mucosa [GO:0002227]; intracellular signal transduction [GO:0035556]; leukotriene biosynthetic process [GO:0019370]; lipid catabolic process [GO:0016042]; neutrophil chemotaxis [GO:0030593]; neutrophil mediated immunity [GO:0002446]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of immune response [GO:0050778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of podocyte apoptotic process [GO:1904635]; positive regulation of protein secretion [GO:0050714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose import [GO:0046324]; signal transduction [GO:0007165] GO:0002227; GO:0002446; GO:0004623; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0006633; GO:0007015; GO:0007165; GO:0008284; GO:0009986; GO:0010524; GO:0016042; GO:0019370; GO:0019731; GO:0030141; GO:0030593; GO:0032052; GO:0032431; GO:0032757; GO:0032869; GO:0035556; GO:0043406; GO:0045944; GO:0046324; GO:0046470; GO:0046471; GO:0047498; GO:0048146; GO:0050482; GO:0050714; GO:0050778; GO:0050830; GO:0051092; GO:0061844; GO:1904635 bile acid binding [GO:0032052]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; signaling receptor binding [GO:0005102] CCQTHDNCYDQAK 0.96965 3.239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.023 0 0 0 0 0 11.2706 13.7602 0 0 11.9903 13.1684 0 14.4856 0 0 0 0 0 12.1433 0 0 10.6704 12.513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7156 10.7551 0 12.1277 0 11.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4955 0 0 0 15.1071 13.9936 9.22407 0 0 0 0 12.9101 13.1256 0 0 0 0 14.5248 0 0 12.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0136 0 0 0 0 0 0 0 0 0 Q7Z2H8 S36A1_HUMAN "Proton-coupled amino acid transporter 1, Proton/amino acid transporter 1, hPAT1 (Solute carrier family 36 member 1)" SLC36A1 PAT1 Homo sapiens (Human) alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; taurine transport [GO:0015734] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297]; taurine transmembrane transporter activity [GO:0005368]; alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; ion transport [GO:0006811]; L-alanine transport [GO:0015808]; proline transmembrane transport [GO:0035524]; proline transport [GO:0015824]; proton transmembrane transport [GO:1902600]; taurine transport [GO:0015734] GO:0003333; GO:0005280; GO:0005297; GO:0005368; GO:0005765; GO:0005783; GO:0005886; GO:0006811; GO:0006865; GO:0015171; GO:0015179; GO:0015180; GO:0015187; GO:0015193; GO:0015734; GO:0015808; GO:0015816; GO:0015824; GO:0016021; GO:0022858; GO:0032328; GO:0035524; GO:0089718; GO:1902600 alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:proton symporter activity [GO:0005280]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-proline transmembrane transporter activity [GO:0015193]; proline:proton symporter activity [GO:0005297]; taurine transmembrane transporter activity [GO:0005368] CAHHFCR 0.96965 -0.68413 0 0 0 0 0 0 0 0 0 0 13.2711 0 0 0 0 0 0 11.7222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0748 0 0 0 0 0 0 0 10.5341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9021 0 13.5471 12.2587 13.7621 13.8033 0 13.5868 0 0 14.0165 0 0 0 13.5541 11.1591 0 12.3845 0 0 14.1291 0 12.6484 12.8771 0 15.0104 0 0 14.8795 0 0 0 15.4937 15.7511 15.123 0 0 0 0 0 0 15.4345 0 0 0 0 0 13.5245 0 10.8687 0 0 0 0 0 0 0 0 0 12.9236 0 0 0 0 12.2028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5575 0 0 0 0 0 0 13.3857 13.3658 0 0 0 13.0656 0 0 0 0 0 0 0 12.8996 0 13.2753 0 Q8NGH5 O56A1_HUMAN Olfactory receptor 56A1 (Olfactory receptor OR11-75) OR56A1 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EIKQGIQK 0.96965 -0.47286 0 0 0 0 0 0 0 12.1393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4851 13.7874 0 0 0 0 0 0 0 13.5697 0 0 0 11.9998 0 11.7786 0 0 0 0 0 18.3736 0 0 0 0 0 0 13.3112 0 0 0 0 0 13.2619 11.8305 13.8513 0 13.661 0 13.6117 13.6013 0 0 0 0 14.5077 0 13.5285 13.6659 0 0 13.2328 0 0 0 0 13.309 0 0 0 0 0 0 13.815 0 13.5702 0 0 0 13.361 0 11.623 0 0 0 11.2596 0 0 13.1419 0 0 0 0 12.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3339 0 0 0 0 0 0 0 0 0 0 Q07973 CP24A_HUMAN "1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial, 24-OHase, Vitamin D(3) 24-hydroxylase, EC 1.14.15.16 (Cytochrome P450 24A1) (Cytochrome P450-CC24)" CYP24A1 CYP24 Homo sapiens (Human) fatty acid omega-oxidation [GO:0010430]; osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin D receptor signaling pathway [GO:0070561]; vitamin metabolic process [GO:0006766] mitochondrial inner membrane [GO:0005743] "mitochondrial inner membrane [GO:0005743]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [GO:0030342]; 25-hydroxycholecalciferol-23-hydroxylase activity [GO:0062180]; 25-hydroxycholecalciferol-24-hydroxylase activity [GO:0008403]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; vitamin D 25-hydroxylase activity [GO:0070643]; fatty acid omega-oxidation [GO:0010430]; osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin D receptor signaling pathway [GO:0070561]; vitamin metabolic process [GO:0006766]" GO:0001649; GO:0005506; GO:0005743; GO:0006766; GO:0008403; GO:0010430; GO:0020037; GO:0030342; GO:0033280; GO:0042359; GO:0042369; GO:0062180; GO:0062181; GO:0070561; GO:0070643 "1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [GO:0030342]; 25-hydroxycholecalciferol-23-hydroxylase activity [GO:0062180]; 25-hydroxycholecalciferol-24-hydroxylase activity [GO:0008403]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; vitamin D 25-hydroxylase activity [GO:0070643]" ELYAAVTELQLAAVETTANSLMWILYNLSR 0.96966 -0.68727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3522 0 0 0 0 13.3943 11.7889 0 0 0 0 0 0 0 0 0 0 0 0 13.3802 0 12.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61313 RL15_HUMAN 60S ribosomal protein L15 (Large ribosomal subunit protein eL15) RPL15 EC45 TCBAP0781 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]; translation [GO:0006412] A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840] A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0031672; GO:0045296; GO:0045471 cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ARRLGYK 0.96967 -0.68874 0 0 0 16.5414 0 0 0 12.1147 16.9681 13.0981 12.9874 0 13.1447 12.8792 13.1455 0 11.6582 0 0 0 0 0 0 0 0 0 14.4895 13.1286 0 12.4103 12.8798 13.8628 0 12.3464 12.3901 0 0 13.9536 12.437 0 13.0213 12.7044 12.87 0 0 12.7661 11.7167 0 0 0 0 0 0 0 0 0 0 16.3846 0 0 0 0 0 0 0 0 0 13.5419 15.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7472 0 0 0 0 13.5051 0 0 14.9384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0208 0 0 0 0 0 0 0 0 0 0 16.2631 0 0 14.9917 0 11.9078 0 0 0 0 0 0 0 13.5746 13.5831 14.7902 13.3361 17.2749 14.6912 13.2189 13.0027 18.2144 13.4819 13.5191 12.7902 13.9271 12.9607 0 19.0491 0 0 0 0 0 0 0 Q8WVB3 HEXD_HUMAN "Hexosaminidase D, EC 3.2.1.52 (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase)" HEXD HEXDC Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular vesicle [GO:1903561]; nucleus [GO:0005634]; beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; carbohydrate metabolic process [GO:0005975] GO:0004563; GO:0005634; GO:0005737; GO:0005975; GO:0015929; GO:0102148; GO:1903561 beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148] AKVENLLGISSLEK 0.96968 -0.75209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2509 0 0 0 0 0 0 0 0 0 0 0 12.9791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1194 0 0 0 0 10.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSA2 KCND1_HUMAN Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1) KCND1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076] dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005250; GO:0005886; GO:0008076; GO:0014069; GO:0016021; GO:0034765; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805 A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated potassium channel activity [GO:0005249] CRFLRSVMSLIDVVAILPYYIGLLVPK 0.96968 -0.69185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8717 0 0 0 0 0 0 0 0 0 0 0 11.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3725 0 0 0 0 0 0 0 0 0 0 0 0 Q3SY56 SP6_HUMAN Transcription factor Sp6 (Krueppel-like factor 14) SP6 KLF14 Homo sapiens (Human) regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005829; GO:0006357; GO:0042481; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EEAAGAASGEGKAGGAVEPPGGK 0.96969 -0.69552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXZ0 TMIG1_HUMAN Transmembrane and immunoglobulin domain-containing protein 1 TMIGD1 TMIGD UNQ9372/PRO34164 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of membrane permeability [GO:0090559] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; negative regulation of apoptotic process [GO:0043066]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of membrane permeability [GO:0090559] GO:0005737; GO:0005886; GO:0016021; GO:0030334; GO:0042127; GO:0043005; GO:0043066; GO:0090559 DPHSETAL 0.9697 -0.69823 0 0 0 14.0869 0 0 0 0 0 0 0 0 0 0 15.3787 0 14.9051 0 0 0 0 0 0 0 13.9643 13.6891 0 0 0 0 14.7452 15.6854 0 0 0 0 13.8868 0 0 14.6251 0 14.1674 0 0 0 0 15.433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9995 0 0 14.4962 0 0 15.1711 0 15.764 15.0739 15.3269 14.8071 15.1724 12.6969 0 0 15.3719 15.2445 0 15.0636 0 0 13.0976 0 15.2297 0 0 13.8174 0 0 15.1257 15.0035 0 0 0 0 13.3999 0 14.9233 0 14.9317 0 0 0 0 14.8828 0 15.0068 12.0769 14.9831 13.3424 14.7195 12.9576 0 0 0 0 0 0 0 0 10.6636 0 0 0 0 0 0 0 13.7105 0 0 0 0 0 0 14.9127 0 0 0 0 0 14.9671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2311 0 15.4757 0 0 Q9Y2U9 KLDC2_HUMAN "Kelch domain-containing protein 2 (Hepatocellular carcinoma-associated antigen 33) (Host cell factor homolog LCP) (Host cell factor-like protein 1, HCLP-1)" KLHDC2 HCA33 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul2-RING ubiquitin ligase complex [GO:0031462]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0005634; GO:0005654; GO:0016567; GO:0016604; GO:0031462; GO:0031965; GO:0043161; GO:0140627; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] EMLANSWNCLPKHLLHSVNQR 0.9697 -0.75699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02153 GCYB1_HUMAN "Guanylate cyclase soluble subunit beta-1, GCS-beta-1, EC 4.6.1.2 (Guanylate cyclase soluble subunit beta-3, GCS-beta-3) (Soluble guanylate cyclase small subunit)" GUCY1B1 GUC1B3 GUCSB3 GUCY1B3 Homo sapiens (Human) "blood circulation [GO:0008015]; cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide mediated signal transduction [GO:0007263]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to oxygen levels [GO:0070482]; trans-synaptic signaling by nitric oxide, modulating synaptic transmission [GO:0099555]" "glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]" "glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; adenylate cyclase activity [GO:0004016]; cytidylate cyclase activity [GO:0047805]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; blood circulation [GO:0008015]; cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide mediated signal transduction [GO:0007263]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to oxygen levels [GO:0070482]; trans-synaptic signaling by nitric oxide, modulating synaptic transmission [GO:0099555]" GO:0004016; GO:0004383; GO:0005525; GO:0006182; GO:0007263; GO:0008015; GO:0008074; GO:0019934; GO:0020037; GO:0038023; GO:0038060; GO:0044877; GO:0046872; GO:0047805; GO:0051879; GO:0070482; GO:0071732; GO:0098831; GO:0098978; GO:0099555 adenylate cyclase activity [GO:0004016]; cytidylate cyclase activity [GO:0047805]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] FDTLTDSRKNPFVYK 0.96971 -0.26474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4234 0 0 0 0 13.11 0 13.0928 13.3769 0 13.6108 0 0 0 0 0 13.3662 14.0044 0 12.494 0 0 0 0 0 0 0 0 13.9096 12.3985 14.1756 0 0 0 0 11.9084 0 0 0 0 0 0 0 0 0 0 0 13.5512 12.9302 0 0 0 0 0 0 0 12.5945 0 0 0 0 0 0 0 0 0 0 0 0 14.2347 14.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8542 0 0 0 0 0 12.4135 0 0 0 0 0 Q5J8M3 EMC4_HUMAN ER membrane protein complex subunit 4 (Cell proliferation-inducing gene 17 protein) (Transmembrane protein 85) EMC4 TMEM85 HSPC184 PIG17 Homo sapiens (Human) apoptotic process [GO:0006915]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005789; GO:0006915; GO:0016021; GO:0030176; GO:0045050; GO:0071816; GO:0072546 MEFSGGGLLL 0.96971 -0.55535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2587 0 0 0 0 0 0 0 0 0 0 15.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8263 0 0 12.2728 0 0 0 15.8763 0 0 0 10.8901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4292 0 0 0 0 0 15.7309 0 0 0 12.8432 0 0 9.2861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0861 0 0 0 0 0 0 0 0 12.5003 0 0 0 0 11.5321 0 0 0 0 0 0 Q9H741 SPRNG_HUMAN SREBP regulating gene protein (SREBF pathway regulator in Golgi 1) SPRING1 C12orf49 SPRING Homo sapiens (Human) positive regulation of SREBP signaling pathway [GO:2000640] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; positive regulation of SREBP signaling pathway [GO:2000640] GO:0000139; GO:0016021; GO:2000640 QYCCDGCWPNGCCSAYEYCVSCCLQPNK 0.96971 -0.26547 0 0 0 0 0 0 0 0 0 0 0 13.4625 0 0 0 0 0 0 0 0 0 0 0 0 11.3334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3624 0 0 13.8271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0951 13.9048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1558 0 0 0 13.3946 0 0 0 0 0 0 0 0 0 0 0 13.744 12.0648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5384 0 0 0 0 12.4641 0 O76082 S22A5_HUMAN Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2) SLC22A5 OCTN2 Homo sapiens (Human) (R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; (R)-carnitine transmembrane transporter activity [GO:1901235]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910]; (R)-carnitine transmembrane transport [GO:1902270]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1901235; GO:1902270; GO:1902603; GO:1990961 (R)-carnitine transmembrane transporter activity [GO:1901235]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910] NHTVPLRLR 0.96972 -0.70399 0 0 0 0 0 0 0 0 13.3742 13.6629 13.5358 17.6212 13.2932 0 13.5751 13.3312 13.2391 0 0 0 0 0 0 0 0 0 0 0 0 17.1844 13.5631 13.5031 13.0586 0 12.8918 13.2156 13.0435 13.2736 13.3496 0 13.2826 0 0 0 0 0 0 0 0 0 0 0 0 12.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4676 0 0 0 0 0 0 11.7659 0 0 0 0 0 0 0 0 14.0054 14.7139 0 0 12.486 14.8426 0 13.3036 0 13.015 14.782 15.3553 12.6542 0 12.5068 13.8352 0 0 0 0 0 0 0 0 0 0 0 14.0477 0 0 0 0 0 13.0602 0 0 0 0 12.1719 11.9067 0 13.2577 0 0 0 0 0 11.6879 12.8351 12.0852 0 19.4823 0 12.6318 12.4059 12.5881 0 0 13.4362 0 0 13.084 0 0 15.5539 0 0 0 13.3442 0 0 11.984 13.054 0 0 0 0 0 0 0 12.1638 0 0 0 15.6872 0 0 0 0 13.7491 12.6236 0 0 0 0 0 0 O15304 SIVA_HUMAN "Apoptosis regulatory protein Siva (CD27-binding protein, CD27BP)" SIVA1 SIVA Homo sapiens (Human) activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; metal ion binding [GO:0046872]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030] GO:0001618; GO:0005164; GO:0005175; GO:0005654; GO:0005737; GO:0005739; GO:0006924; GO:0008270; GO:0032088; GO:0046872; GO:0097191; GO:0097193; GO:1901030 CD27 receptor binding [GO:0005175]; metal ion binding [GO:0046872]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] TCWGCGSVACTLCGLVDCSDMYEKVLCTSCAMFET 0.96973 -0.76129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9417 0 19.0694 0 0 0 18.3022 18.2111 0 0 0 0 0 0 0 0 0 18.1823 0 0 O95377 CXB5_HUMAN "Gap junction beta-5 protein (Connexin-31.1, Cx31.1)" GJB5 Homo sapiens (Human) cell-cell signaling [GO:0007267]; epidermis development [GO:0008544]; epididymis development [GO:1905867]; labyrinthine layer morphogenesis [GO:0060713]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707] connexin complex [GO:0005922]; integral component of membrane [GO:0016021] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; epidermis development [GO:0008544]; epididymis development [GO:1905867]; labyrinthine layer morphogenesis [GO:0060713]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707] GO:0005243; GO:0005922; GO:0007267; GO:0008544; GO:0016021; GO:0060707; GO:0060708; GO:0060713; GO:1905867 gap junction channel activity [GO:0005243] IWLSLVFIFRVLVYLVTAER 0.96973 -0.5372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8527 0 0 0 0 0 0 0 0 0 0 0 0 12.2013 0 0 0 0 0 0 0 0 0 11.4257 10.8422 0 0 12.0304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8578 0 0 11.3931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24310 CX7A1_HUMAN "Cytochrome c oxidase subunit 7A1, mitochondrial (Cytochrome c oxidase subunit VIIa-heart, Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase subunit VIIa-muscle, Cytochrome c oxidase subunit VIIa-M)" COX7A1 COX7AH Homo sapiens (Human) "generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]" integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]" GO:0002082; GO:0004129; GO:0005739; GO:0005746; GO:0005751; GO:0006091; GO:0006123; GO:0016021; GO:0097250 cytochrome-c oxidase activity [GO:0004129] QALRVSQALIR 0.96973 -0.76144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WI0 LHPL1_HUMAN LHFPL tetraspan subfamily member 1 protein (Lipoma HMGIC fusion partner-like 1 protein) LHFPL1 UNQ5824/PRO19643 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 GEGHSLIMVEECGR 0.96973 -0.70414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9567 0 0 13.4843 0 0 0 0 0 0 0 0 0 0 0 0 12.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PL1 SG3A2_HUMAN "Secretoglobin family 3A member 2 (Pneumo secretory protein 1, PnSP-1) (Uteroglobin-related protein 1)" SCGB3A2 PNSP1 UGRP1 UNQ566/PRO1128 Homo sapiens (Human) endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615] GO:0005576; GO:0005615; GO:0071682 LAPLPLDNILPFMDPLKLLLK 0.96974 -0.80698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9092 0 13.8355 13.1055 0 14.8569 17.7103 0 13.6008 16.2152 18.4954 15.8813 15.3497 15.5658 15.6307 16.6271 16.7585 14.854 17.396 0 0 16.0317 15.7127 0 14.9367 14.8903 0 0 15.4488 14.7597 15.6499 0 13.5166 15.8936 16.9573 15.4485 14.1877 14.7856 14.0637 15.4873 15.2126 15.3512 15.9092 15.3434 14.3747 0 14.8257 15.8036 13.2836 15.869 15.599 15.3692 14.1187 15.6293 14.9497 14.4982 17.3415 15.6873 16.8645 16.5679 15.6324 15.2784 15.7103 15.989 14.8871 13.495 16.8039 16.6306 14.8532 14.9432 0 14.9027 16.9254 15.1677 14.1461 14.2041 15.7834 15.2002 16.3069 15.4788 15.6331 0 15.3103 0 17.0296 14.5065 0 15.7143 14.8628 13.7334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9774 14.6687 14.2432 0 0 0 14.2606 0 P23945 FSHR_HUMAN "Follicle-stimulating hormone receptor, FSH-R (Follitropin receptor)" FSHR LGR1 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; gonad development [GO:0008406]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738]; spermatogenesis [GO:0007283] GO:0004963; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007190; GO:0007283; GO:0007292; GO:0008406; GO:0008528; GO:0008584; GO:0008585; GO:0009755; GO:0010738; GO:0014068; GO:0016021; GO:0042699; GO:0043235; GO:0070374; GO:0071372 follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528] AKILLVLFHPINSCANPFLYAIFTK 0.96974 -0.80531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5897 0 0 15.8021 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1621 0 0 0 0 10.2917 0 0 0 12.3273 P05231 IL6_HUMAN "Interleukin-6, IL-6 (B-cell stimulatory factor 2, BSF-2) (CTL differentiation factor, CDF) (Hybridoma growth factor) (Interferon beta-2, IFN-beta-2)" IL6 IFNB2 Homo sapiens (Human) "acute-phase response [GO:0006953]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; endocrine pancreas development [GO:0031018]; germinal center B cell differentiation [GO:0002314]; glucagon secretion [GO:0070091]; glucose homeostasis [GO:0042593]; hepatic immune response [GO:0002384]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; liver regeneration [GO:0097421]; maintenance of blood-brain barrier [GO:0035633]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine production [GO:0032682]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of lipid storage [GO:0010888]; negative regulation of neurogenesis [GO:0050768]; negative regulation of primary miRNA processing [GO:2000635]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; neutrophil apoptotic process [GO:0001781]; neutrophil mediated immunity [GO:0002446]; platelet activation [GO:0030168]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell activation [GO:0050871]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of angiogenesis [GO:0045765]; regulation of astrocyte activation [GO:0061888]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of vascular endothelial growth factor production [GO:0010574]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to peptidoglycan [GO:0032494]; T follicular helper cell differentiation [GO:0061470]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]" endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896] "endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-6 receptor binding [GO:0005138]; acute-phase response [GO:0006953]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; endocrine pancreas development [GO:0031018]; germinal center B cell differentiation [GO:0002314]; glucagon secretion [GO:0070091]; glucose homeostasis [GO:0042593]; hepatic immune response [GO:0002384]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; liver regeneration [GO:0097421]; maintenance of blood-brain barrier [GO:0035633]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine production [GO:0032682]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of lipid storage [GO:0010888]; negative regulation of neurogenesis [GO:0050768]; negative regulation of primary miRNA processing [GO:2000635]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; neutrophil apoptotic process [GO:0001781]; neutrophil mediated immunity [GO:0002446]; platelet activation [GO:0030168]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell activation [GO:0050871]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of angiogenesis [GO:0045765]; regulation of astrocyte activation [GO:0061888]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of vascular endothelial growth factor production [GO:0010574]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to peptidoglycan [GO:0032494]; T follicular helper cell differentiation [GO:0061470]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]" GO:0001781; GO:0002314; GO:0002384; GO:0002446; GO:0002548; GO:0002639; GO:0002675; GO:0002690; GO:0005125; GO:0005138; GO:0005576; GO:0005615; GO:0005788; GO:0005896; GO:0006953; GO:0006954; GO:0006959; GO:0008083; GO:0008284; GO:0008285; GO:0010573; GO:0010574; GO:0010575; GO:0010628; GO:0010718; GO:0010888; GO:0014823; GO:0019221; GO:0030168; GO:0031018; GO:0031175; GO:0032494; GO:0032682; GO:0032722; GO:0032731; GO:0032733; GO:0032740; GO:0032745; GO:0032755; GO:0032757; GO:0032760; GO:0032966; GO:0033138; GO:0035633; GO:0042102; GO:0042531; GO:0042593; GO:0043065; GO:0043066; GO:0043410; GO:0045599; GO:0045669; GO:0045727; GO:0045765; GO:0045779; GO:0045893; GO:0045944; GO:0046427; GO:0048661; GO:0050731; GO:0050768; GO:0050796; GO:0050829; GO:0050830; GO:0050871; GO:0051091; GO:0051384; GO:0051607; GO:0060252; GO:0061470; GO:0061888; GO:0070050; GO:0070091; GO:0070092; GO:0070102; GO:0070301; GO:0071222; GO:0072540; GO:0072574; GO:0090091; GO:0097421; GO:0098586; GO:0150077; GO:0150078; GO:1900017; GO:1901731; GO:1902512; GO:1903800; GO:1903978; GO:1904894; GO:1904996; GO:2000553; GO:2000635; GO:2000660; GO:2000676 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-6 receptor binding [GO:0005138] DGCFQSGFNEETCLVK 0.96975 -0.74057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6441 0 0 0 0 0 0 0 0 0 14.1762 13.96 13.811 0 14.2717 0 0 0 0 0 14.1632 0 0 0 0 0 13.9793 0 0 13.4247 0 0 0 0 0 13.2235 0 0 0 0 0 12.0479 0 10.716 0 0 0 0 11.2392 0 0 11.6108 11.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A3B3IT52 MSD5_HUMAN Putative uncharacterized protein MSANTD5 (Myb/SANT DNA binding domain-containing protein 5) MSANTD5 Homo sapiens (Human) ILGYRWK 0.96976 -0.46762 0 0 0 0 0 0 0 0 0 0 0 0 13.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1724 0 0 12.3936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17535 JUND_HUMAN Transcription factor JunD (Transcription factor AP-1 subunit JunD) JUND Homo sapiens (Human) aging [GO:0007568]; cellular response to calcium ion [GO:0071277]; cellular response to hypoxia [GO:0071456]; circadian rhythm [GO:0007623]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of macrophage activation [GO:0043032]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; aging [GO:0007568]; cellular response to calcium ion [GO:0071277]; cellular response to hypoxia [GO:0071456]; circadian rhythm [GO:0007623]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of macrophage activation [GO:0043032]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0002076; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006366; GO:0007568; GO:0007623; GO:0009416; GO:0009612; GO:0014070; GO:0016922; GO:0017053; GO:0019899; GO:0032496; GO:0032993; GO:0035976; GO:0042127; GO:0043032; GO:0043434; GO:0045669; GO:0045944; GO:0051726; GO:0071277; GO:0071456; GO:0090575; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]" ISRLEEKVK 0.96976 -0.68156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3097 13.0978 13.962 14.0087 0 0 13.7197 0 0 0 0 0 0 0 14.213 0 0 Q8NCT1 ARRD4_HUMAN Arrestin domain-containing protein 4 ARRDC4 Homo sapiens (Human) extracellular vesicle biogenesis [GO:0140112]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; extracellular vesicle biogenesis [GO:0140112]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567] GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0016567; GO:0043231; GO:0051443; GO:0140112; GO:1903561; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] EPPAGEGIILLQPGKHEFPFR 0.96976 -0.46794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48723 HSP13_HUMAN Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein) HSPA13 STCH Homo sapiens (Human) cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026] GO:0005524; GO:0005737; GO:0005739; GO:0005783; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0043231; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0140662 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] ILVPIQQVLK 0.96977 -0.78896 0 0 0 0 0 0 0 0 0 0 14.6296 0 13.9 14.7221 0 0 13.9669 12.1324 14.2052 0 0 0 12.9057 0 0 0 0 0 0 0 12.5737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3982 0 16.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5342 16.8401 16.282 16.4758 0 16.2997 0 16.3 0 17.2601 0 0 0 0 0 0 0 16.474 0 0 0 0 0 0 0 0 0 0 0 13.8698 13.9103 15.8476 0 0 15.8384 0 0 0 0 15.7056 0 Q14974 IMB1_HUMAN "Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit, PTAC97)" KPNB1 NTF97 Homo sapiens (Human) astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; Ran protein signal transduction [GO:0031291]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404] GO:0003723; GO:0005576; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0008139; GO:0008270; GO:0010494; GO:0016020; GO:0019899; GO:0019904; GO:0030953; GO:0031267; GO:0031291; GO:0031965; GO:0035580; GO:0040001; GO:0042564; GO:0045184; GO:0051879; GO:0061608; GO:0061676; GO:0070062; GO:0071782; GO:0090307; GO:1904813 enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] DPDIKAQYQQR 0.96977 -0.68351 0 0 9.83229 0 0 10.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7572 0 0 0 0 0 0 0 10.7168 0 0 0 0 12.0053 12.7763 0 0 0 10.7143 0 15.9903 0 0 0 0 0 0 0 0 0 11.923 0 10.7636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.57 0 12.4037 11.2867 11.4117 0 0 0 0 0 0 0 11.7827 0 0 0 0 0 0 10.3381 10.4239 0 0 0 0 12.3059 0 0 0 0 0 0 0 0 0 0 0 10.7539 0 0 0 0 0 0 0 0 0 11.1726 0 0 0 0 0 0 0 0 0 A6NFD8 HELT_HUMAN Hairy and enhancer of split-related protein HELT (HES/HEY-like transcription factor) HELT Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; GABAergic neuron differentiation in basal ganglia [GO:0021858]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; GABAergic neuron differentiation in basal ganglia [GO:0021858]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005667; GO:0006357; GO:0006366; GO:0007417; GO:0009791; GO:0009952; GO:0010259; GO:0021858; GO:0035264; GO:0042802; GO:0045944; GO:0046983; GO:0050767 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LEKAEILEMTVQYLRALHSADFPR 0.96978 -0.54686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.526 0 0 0 12.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0009 13.6978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4487 0 0 12.955 11.7543 0 0 13.0021 13.4414 0 0 0 0 13.4418 0 0 0 12.8636 0 0 12.759 0 0 0 0 0 13.1836 13.8527 10.4382 0 0 11.7091 0 0 0 0 13.5137 13.531 0 0 0 0 0 0 0 14.4571 0 0 0 13.2991 0 14.5902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7641 14.4142 0 0 0 0 0 0 O43603 GALR2_HUMAN "Galanin receptor type 2, GAL2-R, GALR-2" GALR2 GALNR2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; galanin-activated signaling pathway [GO:0090663]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; muscle contraction [GO:0006936]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944] cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; galanin-activated signaling pathway [GO:0090663]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; muscle contraction [GO:0006936]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0004966; GO:0005886; GO:0005887; GO:0005929; GO:0006936; GO:0007166; GO:0007188; GO:0007189; GO:0007194; GO:0007200; GO:0007204; GO:0007218; GO:0007611; GO:0007631; GO:0008528; GO:0016021; GO:0017046; GO:0031175; GO:0042923; GO:0043647; GO:0045944; GO:0046488; GO:0090663; GO:1902608 G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046] YLWRAVDPVAAGSGARR 0.96978 -0.54737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV92 MITD1_HUMAN MIT domain-containing protein 1 MITD1 Homo sapiens (Human) midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; negative regulation of protein binding [GO:0032091] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; negative regulation of protein binding [GO:0032091] GO:0000281; GO:0019898; GO:0019904; GO:0030496; GO:0031902; GO:0032091; GO:0035091; GO:0042802; GO:0043231; GO:0061952; GO:0070062 identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904] FSLGYCDFDLR 0.96978 -0.47245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6525 0 0 0 0 0 0 13.1996 0 0 0 0 15.0309 0 0 0 0 0 0 0 15.0559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.358 0 0 0 0 0 0 0 0 0 0 0 0 13.001 0 0 12.0549 0 0 0 0 0 0 0 0 12.7464 0 0 0 0 0 0 0 0 0 0 0 0 12.5737 0 0 12.1439 0 Q17RP2 TIGD6_HUMAN Tigger transposable element-derived protein 6 TIGD6 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] DRHGIALKAVCR 0.96979 -0.74836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5445 13.1183 0 13.7977 0 0 11.777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0498 0 0 0 0 0 0 0 0 11.4955 0 0 0 0 0 0 0 Q6RUI8 CS048_HUMAN Uncharacterized protein C19orf48 (Multidrug resistance-related protein) C19orf48 Homo sapiens (Human) QARILGELLLV 0.96979 -0.79221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9856 0 Q7L266 ASGL1_HUMAN "Isoaspartyl peptidase/L-asparaginase, EC 3.4.19.5, EC 3.5.1.1 (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain ]" ASRGL1 ALP CRASH Homo sapiens (Human) asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508] GO:0001917; GO:0004067; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008798; GO:0033345 asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798] LARLVMEK 0.96979 -0.68716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5241 0 0 0 0 16.0079 16.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.548 0 0 0 0 0 0 0 0 0 0 0 14.9671 0 0 0 11.8853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1911 0 0 0 0 0 0 0 0 0 0 0 11.7533 11.9971 0 0 0 0 0 0 0 0 0 14.6862 0 12.8903 0 0 0 0 0 0 0 0 0 0 0 0 14.7191 0 0 0 0 14.6554 0 14.4529 0 0 0 0 0 11.2848 13.1334 0 0 0 O60674 JAK2_HUMAN "Tyrosine-protein kinase JAK2, EC 2.7.10.2 (Janus kinase 2, JAK-2)" JAK2 Homo sapiens (Human) actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell differentiation [GO:0030154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chromatin organization [GO:0006325]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; post-translational protein modification [GO:0043687]; postsynapse to nucleus signaling pathway [GO:0099527]; programmed cell death induced by symbiont [GO:0034050]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to amine [GO:0014075]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]; actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell differentiation [GO:0030154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chromatin organization [GO:0006325]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; immune response [GO:0006955]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of heart contraction [GO:0045822]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; post-translational protein modification [GO:0043687]; postsynapse to nucleus signaling pathway [GO:0099527]; programmed cell death induced by symbiont [GO:0034050]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to amine [GO:0014075]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0000791; GO:0001774; GO:0002250; GO:0004672; GO:0004713; GO:0004715; GO:0005102; GO:0005126; GO:0005131; GO:0005143; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006325; GO:0006366; GO:0006468; GO:0006915; GO:0006919; GO:0006955; GO:0007165; GO:0007167; GO:0007186; GO:0007204; GO:0007259; GO:0007260; GO:0007498; GO:0008022; GO:0008285; GO:0008631; GO:0010572; GO:0010667; GO:0010811; GO:0014068; GO:0014075; GO:0018108; GO:0019221; GO:0019901; GO:0020037; GO:0022408; GO:0030041; GO:0030154; GO:0030218; GO:0030335; GO:0030526; GO:0031103; GO:0031702; GO:0031904; GO:0031959; GO:0032024; GO:0032496; GO:0032516; GO:0032729; GO:0032731; GO:0032740; GO:0032760; GO:0032819; GO:0033130; GO:0033194; GO:0033209; GO:0034050; GO:0034612; GO:0035166; GO:0035401; GO:0035556; GO:0035722; GO:0036016; GO:0038065; GO:0038157; GO:0042022; GO:0042102; GO:0042169; GO:0042307; GO:0042393; GO:0042531; GO:0042802; GO:0042976; GO:0042981; GO:0043388; GO:0043392; GO:0043410; GO:0043524; GO:0043548; GO:0043560; GO:0043687; GO:0045121; GO:0045348; GO:0045428; GO:0045429; GO:0045597; GO:0045822; GO:0045944; GO:0046425; GO:0046427; GO:0046677; GO:0046777; GO:0046872; GO:0048008; GO:0050727; GO:0050729; GO:0050731; GO:0050804; GO:0051091; GO:0051142; GO:0051428; GO:0051770; GO:0060333; GO:0060391; GO:0060396; GO:0060397; GO:0060399; GO:0061180; GO:0070102; GO:0070665; GO:0070671; GO:0070757; GO:0071222; GO:0071549; GO:0072536; GO:0097191; GO:0097296; GO:0098586; GO:0098794; GO:0098978; GO:0099527; GO:0120162; GO:1901731; GO:1902728; GO:1904037; GO:1904707; GO:2000273; GO:2000318; GO:2001235 acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone kinase activity (H3-Y41 specific) [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702] DFNKYFLTFAVERENVIEYK 0.96981 4.5136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5526 0 12.1759 0 0 0 0 0 0 0 12.921 13.1472 13.4574 13.3788 0 0 0 0 0 0 0 13.131 0 0 0 0 0 0 12.4404 17.1913 0 0 0 14.0102 0 0 0 13.9113 0 13.005 13.085 0 0 0 0 0 0 0 0 0 0 0 0 14.4855 0 0 0 0 14.6237 11.4883 0 0 12.9044 0 14.0011 0 0 0 0 0 12.4574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5216 12.4262 13.9103 0 0 0 0 0 0 Q86Y07 VRK2_HUMAN "Serine/threonine-protein kinase VRK2, EC 2.7.11.1 (Vaccinia-related kinase 2)" VRK2 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of interleukin-1-mediated signaling pathway [GO:2000659]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to oxidative stress [GO:0034599]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of interleukin-1-mediated signaling pathway [GO:2000659]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] GO:0004674; GO:0005524; GO:0005634; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0006468; GO:0007165; GO:0016021; GO:0016572; GO:0018105; GO:0019901; GO:0019904; GO:0031966; GO:0032991; GO:0034599; GO:0043408; GO:0046777; GO:0106310; GO:2000659 ATP binding [GO:0005524]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DARHVVK 0.96983 -1.0785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8046 0 0 0 0 0 0 0 0 10.9037 0 0 0 0 0 0 0 0 0 0 14.6561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4262 0 0 0 0 0 0 0 0 0 0 0 12.2512 0 P09769 FGR_HUMAN "Tyrosine-protein kinase Fgr, EC 2.7.10.2 (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr)" FGR SRC2 Homo sapiens (Human) bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of natural killer cell activation [GO:0032815]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774] actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; defense response to Gram-positive bacterium [GO:0050830]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of natural killer cell activation [GO:0032815]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production [GO:0001819]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of innate immune response [GO:0045088]; regulation of phagocytosis [GO:0050764]; regulation of protein kinase activity [GO:0045859]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001784; GO:0001819; GO:0002768; GO:0002862; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005576; GO:0005743; GO:0005758; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007229; GO:0008360; GO:0009615; GO:0014068; GO:0015629; GO:0016235; GO:0018108; GO:0019901; GO:0030154; GO:0030282; GO:0030335; GO:0031234; GO:0032587; GO:0032815; GO:0034774; GO:0034987; GO:0034988; GO:0038096; GO:0043306; GO:0043552; GO:0045087; GO:0045088; GO:0045859; GO:0046777; GO:0048705; GO:0050764; GO:0050830; GO:0070062 ATP binding [GO:0005524]; Fc-gamma receptor I complex binding [GO:0034988]; immunoglobulin receptor binding [GO:0034987]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] DDEYNPCQGSK 0.96984 -0.55524 0 0 0 0 0 0 9.88634 0 0 0 0 0 0 0 0 0 12.3175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0696 11.941 0 0 11.7644 13.5001 13.9493 0 0 13.9563 13.8385 0 0 14.8563 14.9699 15.5183 0 15.5096 15.0677 12.3979 0 15.2085 0 16.6269 12.216 15.045 13.4353 0 17.1827 0 0 0 0 0 0 0 12.4906 0 0 0 0 0 0 0 0 0 0 0 0 11.6926 0 12.1804 0 0 0 0 11.4899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5821 0 0 15.4614 0 9.89474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4311 0 0 0 0 0 0 0 0 0 Q13286 CLN3_HUMAN Battenin (Batten disease protein) (Protein CLN3) CLN3 BTS Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amyloid precursor protein catabolic process [GO:0042987]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; blood vessel endothelial cell migration [GO:0043534]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]" anchoring junction [GO:0070161]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] "anchoring junction [GO:0070161]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146]; actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amyloid precursor protein catabolic process [GO:0042987]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; blood vessel endothelial cell migration [GO:0043534]; cellular water homeostasis [GO:0009992]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; ionotropic glutamate receptor signaling pathway [GO:0035235]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter metabolic process [GO:0042133]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of intracellular pH [GO:0051453]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]" GO:0000139; GO:0001508; GO:0001934; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005776; GO:0005783; GO:0005794; GO:0005795; GO:0005802; GO:0005829; GO:0005886; GO:0005901; GO:0006468; GO:0006898; GO:0007040; GO:0007042; GO:0007611; GO:0008021; GO:0008306; GO:0009992; GO:0010762; GO:0016021; GO:0016243; GO:0016485; GO:0030036; GO:0030176; GO:0031901; GO:0031902; GO:0032228; GO:0035235; GO:0035752; GO:0036359; GO:0042133; GO:0042987; GO:0042998; GO:0043005; GO:0043066; GO:0043086; GO:0043524; GO:0043534; GO:0044754; GO:0044857; GO:0045121; GO:0045861; GO:0046474; GO:0046836; GO:0047496; GO:0048172; GO:0048306; GO:0048549; GO:0050885; GO:0051453; GO:0051480; GO:0051489; GO:0051493; GO:0051861; GO:0051966; GO:0055037; GO:0061024; GO:0061909; GO:0070161; GO:0070613; GO:0072659; GO:0090160; GO:0090384; GO:0090385; GO:0097352; GO:0106049; GO:0120146; GO:1900079; GO:1901096; GO:1903076; GO:1903826; GO:1905146; GO:1905162; GO:1905244; GO:2001288 calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; sulfatide binding [GO:0120146] FDCNSVSTAAVLLADILPTLVIK 0.96985 -0.26467 0 0 0 0 0 0 0 0 0 12.2046 0 0 0 0 0 0 12.7027 0 0 0 0 0 0 0 0 0 12.7609 10.0896 11.9971 0 0 0 0 0 12.6616 0 13.6454 12.5157 12.6356 0 0 0 12.153 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7212 0 0 0 0 0 0 9.91822 0 0 0 0 0 0 0 11.7229 0 0 0 0 0 0 0 0 0 0 14.7475 14.469 14.3649 0 0 14.0647 0 0 0 0 15.1333 0 0 0 0 14.3589 0 13.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5039 0 0 12.5129 0 0 11.5603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0132 13.865 0 0 9.37236 0 0 0 0 0 0 0 0 0 13.9963 0 0 Q5RGS3 F74A1_HUMAN Protein FAM74A1 FAM74A1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TWKQLRR 0.96986 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4771 0 0 0 0 0 0 0 0 Q8NGJ4 O52E2_HUMAN Olfactory receptor 52E2 OR52E2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALIFVIPSILLILR 0.96986 -0.73677 0 0 0 0 0 0 13.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.978 0 0 0 0 0 0 0 0 0 0 10.7495 0 0 0 0 0 0 0 0 11.6903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3955 0 0 0 0 0 0 0 0 13.5345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8213 0 14.896 0 13.7004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.671 0 0 0 0 0 0 0 0 0 0 0 15.2048 0 0 0 14.2977 15.0836 0 0 0 0 0 0 10.4719 0 0 0 0 0 12.3933 0 0 0 0 0 0 10.2241 0 0 0 0 Q9NVV2 CS073_HUMAN Putative uncharacterized protein C19orf73 C19orf73 Homo sapiens (Human) GLGLRPQTLLR 0.96986 2.9695 0 0 0 0 0 0 12.0651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5793 0 0 0 0 0 0 13.579 0 0 0 0 0 0 0 12.9903 14.1319 14.1706 0 0 12.7066 13.5452 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1799 0 14.2391 13.1257 0 0 0 0 0 0 14.6033 14.0226 0 0 0 13.6938 0 0 0 0 0 0 0 0 0 0 0 13.7201 0 13.4314 0 0 14.766 12.0977 0 0 0 14.1002 0 0 0 0 0 13.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5A9 YTHD2_HUMAN "YTH domain-containing family protein 2, DF2 (CLL-associated antigen KW-14) (High-glucose-regulated protein 8) (Renal carcinoma antigen NY-REN-2)" YTHDF2 HGRG8 Homo sapiens (Human) cell cycle [GO:0007049]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; embryonic morphogenesis [GO:0048598]; endothelial to hematopoietic transition [GO:0098508]; gamete generation [GO:0007276]; hematopoietic stem cell proliferation [GO:0071425]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oocyte maturation [GO:0001556]; organelle assembly [GO:0070925]; positive regulation of cap-independent translational initiation [GO:1903679]; regulation of cell adhesion [GO:0030155]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of mRNA stability [GO:0043488]; regulation of neurogenesis [GO:0050767]; regulation of rRNA processing [GO:2000232]; spermatogonial cell division [GO:0007284]; stress granule assembly [GO:0034063] GO:0000932; GO:0001556; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006402; GO:0006959; GO:0007049; GO:0007276; GO:0007284; GO:0010494; GO:0030155; GO:0034063; GO:0034451; GO:0036464; GO:0043488; GO:0045087; GO:0045746; GO:0048598; GO:0050767; GO:0060339; GO:0061157; GO:0062153; GO:0070925; GO:0071425; GO:0098508; GO:1902036; GO:1903538; GO:1903679; GO:1990247; GO:2000232; GO:2000737 C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723] AKQVLKIIASYK 0.96986 -0.80469 0 0 0 0 0 0 0 0 0 0 9.76326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.411 0 0 0 0 0 0 0 0 0 0 10.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3228 0 0 0 0 0 0 0 0 0 13.4583 14.3878 0 13.7957 0 0 0 14.2969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1007 0 0 0 0 0 0 0 0 11.8529 0 0 0 13.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8808 0 0 0 0 0 0 0 O95299 NDUAA_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD, CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)" NDUFA10 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005737; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] GDPHEMK 0.96987 -0.80594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4154 0 0 0 11.7817 0 0 11.7846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6226 0 0 0 0 0 0 0 0 0 12.8986 0 0 0 0 0 13.3049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKY0 PRND_HUMAN Prion-like protein doppel (PrPLP) (Prion protein 2) PRND DPL UNQ1830/PRO3443 Homo sapiens (Human) acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260] GO:0005507; GO:0005576; GO:0005886; GO:0006878; GO:0007340; GO:0031362; GO:0051260 copper ion binding [GO:0005507] PGAFIKQGR 0.96987 -0.76337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P33681 CD80_HUMAN "T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1, B7) (CD antigen CD80)" CD80 CD28LG CD28LG1 LAB7 Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of transcription, DNA-templated [GO:0045893]; T cell costimulation [GO:0031295]" cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636] "cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; coreceptor activity [GO:0015026]; virus receptor activity [GO:0001618]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of signal transduction [GO:0009967]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of transcription, DNA-templated [GO:0045893]; T cell costimulation [GO:0031295]" GO:0001618; GO:0005886; GO:0006955; GO:0007166; GO:0009897; GO:0009967; GO:0009986; GO:0015026; GO:0016021; GO:0031295; GO:0032725; GO:0032743; GO:0035556; GO:0042102; GO:0042130; GO:0045627; GO:0045893; GO:0050731; GO:0071222; GO:0098636 coreceptor activity [GO:0015026]; virus receptor activity [GO:0001618] RESVRPV 0.96988 -0.47982 0 0 0 0 0 0 0 0 0 0 0 15.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7098 0 0 0 0 16.6437 0 0 0 0 0 0 16.5453 0 16.3808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.2225 0 14.3481 18.1063 0 0 0 19.2545 20.3318 20.1259 0 0 0 0 0 0 0 0 0 0 0 19.1816 0 0 Q14153 FA53B_HUMAN Protein FAM53B (Protein simplet) FAM53B KIAA0140 SMP Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein import into nucleus [GO:0006606]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634] nucleus [GO:0005634]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein import into nucleus [GO:0006606]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] GO:0005634; GO:0006606; GO:0016055; GO:0060828; GO:0090263 PSLDLAK 0.96988 -0.74047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9347 0 0 0 0 0 0 10.2624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2771 0 0 0 0 0 0 0 0 0 0 0 0 12.6897 0 0 0 0 0 0 0 0 11.6889 0 0 14.6608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4LDR2 CTXN3_HUMAN Cortexin-3 (Kidney and brain-expressed protein) CTXN3 KABE Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CFRILLDPYR 0.96988 -0.53955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3Q1 S46A3_HUMAN Solute carrier family 46 member 3 SLC46A3 FKSG16 Homo sapiens (Human) transmembrane transport [GO:0055085]; vacuolar transmembrane transport [GO:0034486] extracellular exosome [GO:0070062]; integral component of lysosomal membrane [GO:1905103]; membrane [GO:0016020] extracellular exosome [GO:0070062]; integral component of lysosomal membrane [GO:1905103]; membrane [GO:0016020]; transmembrane transporter activity [GO:0022857]; transmembrane transport [GO:0055085]; vacuolar transmembrane transport [GO:0034486] GO:0016020; GO:0022857; GO:0034486; GO:0055085; GO:0070062; GO:1905103 transmembrane transporter activity [GO:0022857] ECSSQNVTMSCSEGFK 0.96988 -0.76636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.742 13.8475 0 0 0 0 0 12.4036 12.8271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7654 13.2963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0003 0 0 0 0 0 0 0 Q96MW1 CCD43_HUMAN Coiled-coil domain-containing protein 43 CCDC43 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 KEDEVQAIATLIEKQAQIVVK 0.96988 -0.73935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75648 MTU1_HUMAN "Mitochondrial tRNA-specific 2-thiouridylase 1, EC 2.8.1.14 (MTO2 homolog)" TRMU MTU1 TRMT1 Homo sapiens (Human) tRNA wobble position uridine thiolation [GO:0002143] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tRNA-5-taurinomethyluridine 2-sulfurtransferase [GO:0061708]; tRNA wobble position uridine thiolation [GO:0002143] GO:0000049; GO:0002143; GO:0005524; GO:0005739; GO:0061708 ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tRNA-5-taurinomethyluridine 2-sulfurtransferase [GO:0061708] DKMMECHFRFR 0.96989 -0.68062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8531 12.4197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05186 PPBT_HUMAN "Alkaline phosphatase, tissue-nonspecific isozyme, AP-TNAP, TNS-ALP, TNSALP, EC 3.1.3.1 (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase, EC 3.9.1.1)" ALPL Homo sapiens (Human) bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; adenosine-diphosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to organic cyclic compound [GO:0071407]; cementum mineralization [GO:0071529]; dephosphorylation [GO:0016311]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; multicellular organism aging [GO:0010259]; osteoblast differentiation [GO:0001649]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501] GO:0001501; GO:0001649; GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005576; GO:0005758; GO:0005886; GO:0010259; GO:0016020; GO:0016311; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031225; GO:0031966; GO:0032496; GO:0033280; GO:0033883; GO:0034516; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0070062; GO:0071407; GO:0071529; GO:0120162; GO:1904383 adenosine-diphosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462] KNPKGFFLLVEGGR 0.96989 -0.76883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1211 0 0 0 0 11.5974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A57 TM230_HUMAN Transmembrane protein 230 TMEM230 C20orf30 HSPC274 UNQ2432/PRO4992 Homo sapiens (Human) synaptic vesicle transport [GO:0048489] anchoring junction [GO:0070161]; autophagosome [GO:0005776]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] anchoring junction [GO:0070161]; autophagosome [GO:0005776]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; synaptic vesicle transport [GO:0048489] GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005802; GO:0008021; GO:0012505; GO:0016021; GO:0048489; GO:0055037; GO:0070161 AIALATVLFLIGAFLIIIGSLLLSGYISKGGADR 0.96989 -0.74244 0 0 0 0 0 0 0 0 13.3254 0 0 0 0 12.9813 0 0 0 11.9239 11.5889 0 0 0 12.3266 0 0 0 11.5411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2199 0 0 0 11.4173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.319 0 0 0 0 13.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8371 0 0 0 0 0 0 0 0 0 0 0 0 12.3937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5064 0 0 0 0 0 0 Q9HBX3 SNIT1_HUMAN Uncharacterized protein encoded by SND1-IT1 (Brain and nasopharyngeal carcinoma susceptibility protein NSG-x) (Nasopharyngeal carcinoma-associated gene 8 protein) (SND1 intronic transcript 1) SND1-IT1 C7orf54 NAG8 Homo sapiens (Human) MSHHPHSLRNSCLIR 0.96989 -0.76815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQK1 PPR3C_HUMAN "Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5, PP1 subunit R5) (Protein targeting to glycogen, PTG)" PPP1R3C PPP1R5 Homo sapiens (Human) glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979] cytosol [GO:0005829]; protein phosphatase type 1 complex [GO:0000164] cytosol [GO:0005829]; protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; molecular adaptor activity [GO:0060090]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979] GO:0000164; GO:0004722; GO:0005829; GO:0005977; GO:0005978; GO:0005979; GO:0008157; GO:0019903; GO:0060090; GO:2001069 glycogen binding [GO:2001069]; molecular adaptor activity [GO:0060090]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722] HFVNKLK 0.96989 -0.54302 0 0 0 0 0 0 0 0 12.7576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6084 0 13.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.772 14.6323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04234 CD3D_HUMAN T-cell surface glycoprotein CD3 delta chain (T-cell receptor T3 delta chain) (CD antigen CD3d) CD3D T3D Homo sapiens (Human) adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; positive thymic T cell selection [GO:0045059]; T cell receptor signaling pathway [GO:0050852] alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] alpha-beta T cell receptor complex [GO:0042105]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; cell surface receptor signaling pathway [GO:0007166]; positive thymic T cell selection [GO:0045059]; T cell receptor signaling pathway [GO:0050852] GO:0002250; GO:0004888; GO:0005737; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0030669; GO:0042101; GO:0042105; GO:0042802; GO:0045059; GO:0046631; GO:0050852 identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888] DDAQYSHLGGNWAR 0.96991 -0.54602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJN7 ZN391_HUMAN Zinc finger protein 391 ZNF391 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CNECGKAFGDR 0.96991 -0.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7892 0 0 15.1379 0 14.2413 0 0 0 0 14.3935 15.3263 14.4251 14.2423 0 0 0 12.5631 0 0 0 0 0 13.0606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14908 GIPC1_HUMAN "PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2, TIP-2)" GIPC1 C19orf3 GIPC RGS19IP1 Homo sapiens (Human) cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300] GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005938; GO:0006605; GO:0007186; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0045296; GO:0048023; GO:0048167; GO:0070062; GO:0098685; GO:0098761; GO:0098978; GO:2000300 actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102] LLKELPRGR 0.96992 -0.79348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1666 13.9721 14.1165 13.923 13.8508 14.0776 0 14.1734 0 12.8965 14.1521 14.0201 13.2523 0 0 0 0 0 0 0 0 0 0 0 0 12.9063 0 13.5011 12.707 12.2848 0 0 0 0 14.4153 0 12.8812 13.2245 13.2629 13.0504 0 0 0 0 0 0 13.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBN3 TM87A_HUMAN Transmembrane protein 87A TMEM87A PSEC0094 Homo sapiens (Human) "retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0032580; GO:0042147 AEEVELYLEKLKEK 0.96992 -0.7717 0 0 0 0 0 0 0 0 0 0 0 0 10.8538 0 12.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3353 0 10.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2193 14.5482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUD5 ZCHC3_HUMAN Zinc finger CCHC domain-containing protein 3 ZCCHC3 C20orf99 Homo sapiens (Human) activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481] GO:0002218; GO:0003690; GO:0003723; GO:0005737; GO:0008270; GO:0009597; GO:0032481; GO:0045087; GO:0051607; GO:0071360; GO:1900246 double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] AVHNSVAAQLTGVAGH 0.96992 -0.79317 0 0 0 0 0 0 0 0 14.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6813 14.568 0 0 0 0 13.5119 0 0 0 0 0 0 0 0 0 0 13.1239 0 0 0 0 0 0 0 0 0 11.6891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9083 0 0 0 14.1378 13.4851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NJ08 MB3L5_HUMAN "Putative methyl-CpG-binding domain protein 3-like 5, MBD3-like protein 5" MBD3L5 Homo sapiens (Human) AGAERVRIPLEPTPGR 0.96995 -0.55109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5405 0 0 0 0 12.9272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR56 MBNL1_HUMAN Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) MBNL1 EXP KIAA0428 MBNL Homo sapiens (Human) "embryonic limb morphogenesis [GO:0030326]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; myoblast differentiation [GO:0045445]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; embryonic limb morphogenesis [GO:0030326]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; myoblast differentiation [GO:0045445]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" GO:0000381; GO:0001069; GO:0001701; GO:0003723; GO:0003725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007399; GO:0008380; GO:0010494; GO:0030326; GO:0043484; GO:0045445; GO:0046872 double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723] AVSVTPIR 0.96995 -0.75524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6854 0 0 0 15.7509 0 0 0 0 0 18.2239 18.3627 0 0 0 0 0 0 0 0 0 0 0 0 17.107 17.0803 0 0 0 14.8944 0 0 0 18.9001 20.1984 0 0 19.5571 0 18.8764 0 0 19.5531 18.5147 17.8401 12.4747 0 0 0 0 0 0 0 0 0 0 0 0 20.7925 0 0 0 19.6803 0 0 0 0 0 20.1466 0 0 19.2594 0 0 19.8386 0 0 0 18.9138 0 19.0285 18.8961 18.9395 18.2661 18.0136 19.1836 20.2253 0 0 0 17.1288 0 0 17.0263 0 0 0 0 0 0 0 0 0 15.1226 0 19.3871 0 0 0 0 0 Q5TFE4 NT5D1_HUMAN "5'-nucleotidase domain-containing protein 1, EC 3.1.3.-" NT5DC1 NT5C2L1 LP2642 Homo sapiens (Human) 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] GO:0008253; GO:0046872 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] AKPLNTSSKK 0.96996 -0.55449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5497 0 0 0 0 13.2805 0 0 0 0 12.9427 12.4646 0 0 0 0 0 0 0 0 0 0 13.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNT1 RBL2B_HUMAN Rab-like protein 2B RABL2B Homo sapiens (Human) cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073] GO:0000242; GO:0003924; GO:0005525; GO:0005737; GO:0005814; GO:0006886; GO:0036064; GO:0042073; GO:0060271 GTP binding [GO:0005525]; GTPase activity [GO:0003924] AHACIMVFDVQR 0.96998 -0.80447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DPB3 SCHI1_HUMAN "Schwannomin-interacting protein 1, SCHIP-1" SCHIP1 Homo sapiens (Human) positive regulation of hippo signaling [GO:0035332] cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; positive regulation of hippo signaling [GO:0035332] GO:0005737; GO:0005886; GO:0030054; GO:0035332; GO:0042802 identical protein binding [GO:0042802] DTTEEESESLDDMDFLTR 0.96999 -0.47917 0 0 0 0 0 0 0 0 10.5487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0333 0 0 0 0 0 0 0 0 13.8853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30086 PEBP1_HUMAN "Phosphatidylethanolamine-binding protein 1, PEBP-1 (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein, RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide, HCNP ]" PEBP1 PBP PEBP Homo sapiens (Human) negative regulation of MAPK cascade [GO:0043409] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; phosphatidylethanolamine binding [GO:0008429]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of MAPK cascade [GO:0043409] GO:0003723; GO:0004867; GO:0005524; GO:0005634; GO:0005829; GO:0008429; GO:0019899; GO:0019901; GO:0043409; GO:0070062 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; phosphatidylethanolamine binding [GO:0008429]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867] LYTLVLTDPDAPSR 0.96999 -0.53645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9701 0 0 0 0 0 14.9621 0 15.0314 0 0 0 0 0 0 0 0 14.1585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0045 0 0 0 0 0 0 14.8304 0 0 0 0 0 0 0 0 0 13.4138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02078 MEF2A_HUMAN Myocyte-specific enhancer factor 2A (Serum response factor-like protein 1) MEF2A MEF2 Homo sapiens (Human) "apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005]" GO:0000002; GO:0000122; GO:0000165; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006351; GO:0006357; GO:0006915; GO:0007507; GO:0007517; GO:0010613; GO:0010628; GO:0019901; GO:0030154; GO:0035035; GO:0042826; GO:0043565; GO:0045944; GO:0046326; GO:0046332; GO:0046982; GO:0048311; GO:0048813; GO:0055005; GO:0061337; GO:0061629; GO:0070375; GO:0071277; GO:0140297 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]" INEEFDNMMR 0.96999 -0.26376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2217 11.1879 0 0 0 0 0 10.6872 0 0 0 0 0 0 0 0 0 13.2668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.64926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2D5 PLPR4_HUMAN "Phospholipid phosphatase-related protein type 4 (Brain-specific phosphatidic acid phosphatase-like protein 1) (Inactive 2-lysophosphatidate phosphatase PLPPR4) (Lipid phosphate phosphatase-related protein type 4) (Plasticity-related gene 1 protein, PRG-1)" PLPPR4 KIAA0455 LPPR4 PHP1 PRG1 Homo sapiens (Human) "axonogenesis [GO:0007409]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; lipid import into cell [GO:0140354]; phospholipid metabolic process [GO:0006644]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]" anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] "anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; axonogenesis [GO:0007409]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; lipid import into cell [GO:0140354]; phospholipid metabolic process [GO:0006644]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]" GO:0005886; GO:0005887; GO:0006644; GO:0007165; GO:0007186; GO:0007409; GO:0008195; GO:0042577; GO:0048839; GO:0051966; GO:0070161; GO:0098839; GO:0098978; GO:0099061; GO:0140354 lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195] ANADVEIITPR 0.96999 -0.73598 0 0 0 0 0 0 0 0 0 0 11.4725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0845 0 0 10.7813 0 0 0 0 0 0 14.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6372 0 0 13.0797 0 0 0 0 0 0 0 0 0 0 12.3644 11.8761 0 0 0 0 12.2716 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4104 0 0 0 0 0 0 0 0 0 0 0 0 13.5256 0 0 0 11.5141 0 0 0 0 0 0 0 0 0 11.9631 0 13.6985 13.8417 0 0 0 0 0 0 14.3247 0 0 0 0 0 0 12.3819 0 0 0 0 0 0 0 0 0 0 13.5199 13.3048 0 0 0 13.2322 0 14.0505 0 0 14.6922 0 0 0 0 Q9HC57 WFDC1_HUMAN WAP four-disulfide core domain protein 1 (Prostate stromal protein ps20) (ps20 growth inhibitor) WFDC1 PS20 Homo sapiens (Human) negative regulation of cell growth [GO:0030308]; negative regulation of inflammatory response [GO:0050728]; negative regulation of wound healing [GO:0061045]; regulation of cell growth [GO:0001558] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of cell growth [GO:0030308]; negative regulation of inflammatory response [GO:0050728]; negative regulation of wound healing [GO:0061045]; regulation of cell growth [GO:0001558] GO:0001558; GO:0004867; GO:0005615; GO:0030308; GO:0050728; GO:0061045 serine-type endopeptidase inhibitor activity [GO:0004867] HKLYKEYPEGDSK 0.96999 -0.73674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7332 0 0 0 0 0 0 0 14.05 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7271 0 15.5248 13.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7287 0 0 0 0 0 0 13.8198 0 0 0 0 0 13.9895 0 0 15.7307 0 13.4565 0 0 13.1329 0 0 0 14.4023 12.5434 14.5446 13.2469 0 0 0 13.2437 0 13.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.787 13.7401 0 12.7354 13.2883 0 0 0 0 0 0 0 0 0 12.8191 0 0 0 0 0 0 0 0 0 13.4079 0 0 0 0 0 0 0 0 11.0506 0 0 0 0 0 0 0 0 12.197 0 0 0 0 0 0 P10643 CO7_HUMAN Complement component C7 C7 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]" GO:0005576; GO:0005579; GO:0005615; GO:0005886; GO:0006956; GO:0006957; GO:0006958; GO:0019835; GO:0050778; GO:0070062 CDAESSKCVCREASECEEEGFSICVEVNGK 0.97 -0.73798 0 0 0 0 0 0 0 0 0 0 0 0 12.7913 0 12.3119 0 0 0 0 0 0 0 0 11.4807 0 11.9757 0 0 0 0 0 0 0 0 0 0 0 0 12.312 0 0 0 0 0 0 0 0 0 0 0 10.9489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9293 12.409 12.5845 0 12.9627 0 0 0 0 0 0 10.15 0 0 11.6029 0 15.1964 0 0 14.1126 0 0 0 0 0 0 13.6196 18.5259 0 10.8199 0 18.2516 12.7727 0 0 0 0 0 0 0 0 0 0 0 0 11.6732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49758 RGS6_HUMAN "Regulator of G-protein signaling 6, RGS6 (S914)" RGS6 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0019898; GO:0035556; GO:0043005; GO:0043547 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] DGGRYTFEDAQEHIYKLMK 0.97 -0.55932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RJ3 TR13C_HUMAN "Tumor necrosis factor receptor superfamily member 13C (B-cell-activating factor receptor) (BAFF receptor, BAFF-R) (BLyS receptor 3) (CD antigen CD268)" TNFRSF13C BAFFR BR3 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell costimulation [GO:0031296]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; B cell costimulation [GO:0031296]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0002250; GO:0005886; GO:0009897; GO:0016021; GO:0030890; GO:0031295; GO:0031296; GO:0033209; GO:0038023; GO:0042102 signaling receptor activity [GO:0038023] RGPRSLR 0.97 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6R0 NUMBL_HUMAN "Numb-like protein (Numb-related protein, Numb-R)" NUMBL Homo sapiens (Human) adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538] GO:0005737; GO:0007399; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0034332; GO:0050769 GMHVCEDAVK 0.97 -0.53702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2259 16.0639 0 0 0 0 12.7377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0653 0 0 0 0 0 0 0 0 0 11.1172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6857 0 0 0 0 0 0 0 0 O15354 GPR37_HUMAN "Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1, ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor, PAELR)" GPR37 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuropeptide signaling pathway [GO:0007218]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; ubiquitin ligase complex [GO:0000151]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; dendrite development [GO:0016358]; dopamine biosynthetic process [GO:0042416]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; neuropeptide signaling pathway [GO:0007218]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of MAPK cascade [GO:0043410] GO:0000151; GO:0004930; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007218; GO:0008188; GO:0008528; GO:0009986; GO:0016358; GO:0030165; GO:0030544; GO:0031072; GO:0031625; GO:0031987; GO:0036505; GO:0042277; GO:0042416; GO:0042923; GO:0043235; GO:0043410; GO:0045202; GO:0045964; GO:1903206 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; prosaposin receptor activity [GO:0036505]; ubiquitin protein ligase binding [GO:0031625] AFMECCCCCCEECIQK 0.97001 -0.78586 0 0 0 0 0 0 0 0 0 0 0 13.3167 0 0 0 0 0 0 0 0 0 0 12.2336 0 0 13.4886 0 0 11.4177 0 0 0 13.8887 12.2672 0 0 0 0 0 0 0 0 0 0 0 0 13.8473 0 11.4108 0 0 0 0 10.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7462 13.3494 0 11.3744 0 0 0 10.4834 0 12.8797 0 12.9743 0 0 0 0 0 13.8969 0 0 13.8904 0 0 0 0 12.7303 0 0 0 0 0 0 14.0577 13.7521 0 0 0 0 12.3309 13.7622 14.0694 0 12.427 11.0196 14.5003 0 13.6155 12.68 0 0 0 12.8609 0 14.1656 0 13.3684 0 14.2499 0 0 11.7432 0 12.5213 12.6898 0 11.0778 10.6053 15.5077 13.0376 0 11.9232 0 0 0 11.643 11.0024 12.6322 14.1033 0 0 0 11.5036 0 0 0 0 0 13.1116 13.3608 13.4472 11.5436 12.1053 0 12.9404 0 11.7709 0 0 0 0 0 0 0 0 11.4851 0 10.9853 13.5621 0 13.463 0 P48594 SPB4_HUMAN "Serpin B4 (Leupin) (Peptidase inhibitor 11, PI-11) (Squamous cell carcinoma antigen 2, SCCA-2)" SERPINB4 PI11 SCCA2 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; negative regulation of peptidase activity [GO:0010466]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of proteolysis [GO:0030162] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; enzyme binding [GO:0019899]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of peptidase activity [GO:0010466]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of proteolysis [GO:0030162] GO:0002020; GO:0004867; GO:0005615; GO:0005737; GO:0010466; GO:0010951; GO:0019899; GO:0030162; GO:0042270 enzyme binding [GO:0019899]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] GQWENKFKK 0.97001 -0.76492 0 0 0 0 0 0 0 0 0 0 11.8761 0 0 0 0 0 0 0 11.8815 11.8134 11.1819 0 0 0 0 0 0 0 0 11.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1032 0 0 0 0 10.7062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.515 0 0 0 0 0 0 0 0 0 0 0 0 13.3567 0 0 0 12.5982 0 13.2498 0 0 13.4236 0 0 0 0 0 0 0 0 0 12.8335 0 0 0 0 0 0 0 12.9895 0 0 0 0 0 0 0 0 0 0 0 0 13.2396 0 0 Q15388 TOM20_HUMAN Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20) TOMM20 KIAA0016 Homo sapiens (Human) protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; tRNA import into mitochondrion [GO:0016031] integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225] integral component of mitochondrial outer membrane [GO:0031307]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; tRNA import into mitochondrion [GO:0016031] GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0015450; GO:0016031; GO:0030150; GO:0030943; GO:0031307; GO:0044233; GO:0045040; GO:0051082; GO:0097225 mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082] QKLAKER 0.97001 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31274 HXC9_HUMAN Homeobox protein Hox-C9 (Homeobox protein Hox-3B) HOXC9 HOX3B Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell cycle [GO:0045786]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" aggresome [GO:0016235]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "aggresome [GO:0016235]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of cell cycle [GO:0045786]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0009952; GO:0009954; GO:0016235; GO:0017053; GO:0045786; GO:0048704; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CPYTKYQTLELEK 0.97002 -0.78802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VGL1 LTOR4_HUMAN "Ragulator complex protein LAMTOR4 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4) [Cleaved into: Ragulator complex protein LAMTOR4, N-terminally processed ]" LAMTOR4 C7orf59 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790]; regulation of cell size [GO:0008361]; TORC1 signaling [GO:0038202] intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Ragulator complex [GO:0071986] intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; Ragulator complex [GO:0071986]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790]; regulation of cell size [GO:0008361]; TORC1 signaling [GO:0038202] GO:0005764; GO:0005765; GO:0008361; GO:0031902; GO:0032008; GO:0038202; GO:0043231; GO:0050790; GO:0061462; GO:0071230; GO:0071986 MTSALTQGLER 0.97002 -0.68027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5901 13.7873 0 0 13.8844 0 13.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.702 15.2611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13242 SRSF9_HUMAN "Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)" SRSF9 SFRS9 SRP30C Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]" nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]" GO:0000380; GO:0000398; GO:0003723; GO:0005654; GO:0005730; GO:0006376; GO:0006397; GO:0009636; GO:0016607; GO:0019904; GO:0043279; GO:0048025 protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] GGEGDGR 0.97002 -0.56409 0 0 0 0 0 0 0 0 12.6816 0 0 0 0 0 0 0 0 0 0 0 11.0108 0 9.86245 0 0 0 0 0 0 0 12.0145 0 0 0 0 0 0 0 0 0 0 0 12.9119 12.4864 12.8207 0 0 0 12.407 12.8271 12.5837 13.7939 12.5075 13.3733 0 0 0 0 0 0 10.5865 0 0 10.6871 11.2379 0 11.5263 12.2764 0 10.7691 0 0 11.4013 0 10.9696 13.8147 12.844 12.0522 13.821 0 0 13.5108 16.5512 16.7605 17.6429 16.8493 17.8416 15.9077 16.8347 17.1607 17.7878 18.1084 18.3016 16.2205 16.9884 17.2652 15.8236 16.7825 16.5976 16.3736 16.025 14.6107 0 13.8835 16.7824 16.9854 16.5356 17.1218 11.2977 12.8233 15.2308 15.665 17.357 17.9947 17.1731 17.4674 15.8463 13.7455 13.7054 14.4152 12.5475 15.0408 16.6384 16.6629 14.8212 16.274 13.0283 0 0 16.0596 0 14.4285 15.3974 13.6099 13.7021 15.9323 15.6976 0 0 14.8208 14.4614 13.8898 15.8352 15.292 14.6946 14.8448 0 12.3375 0 0 0 0 0 0 13.7594 13.5634 16.1441 0 0 14.8021 13.742 0 13.7212 0 0 15.3268 0 0 15.2411 14.6075 14.9723 15.837 14.2375 16.1302 0 13.4074 0 13.7524 0 12.3213 Q9NZL9 MAT2B_HUMAN "Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta, MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase)" MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 Homo sapiens (Human) one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556] GO:0005634; GO:0005829; GO:0006556; GO:0006730; GO:0019899; GO:0048269; GO:0048270; GO:0070062 enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270] EEDIPAPLNLYGKTK 0.97002 -0.78719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3782 0 0 0 0 0 0 0 0 0 0 0 10.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9402 0 0 0 0 0 0 0 0 0 0 0 0 16.1929 0 12.3755 0 15.8267 0 0 0 0 16.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4699 0 0 Q6P2D0 ZFP1_HUMAN "Zinc finger protein 1 homolog, Zfp-1 (Zinc finger protein 475)" ZFP1 ZNF475 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AAIFKHQKIK 0.97004 -0.54574 0 0 0 0 0 0 0 0 0 0 0 0 13.3283 0 0 0 0 12.9526 0 0 0 0 0 0 0 0 0 0 0 12.0992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.224 0 0 0 0 0 0 0 0 0 0 0 10.3992 0 0 13.8169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9465 0 0 0 11.9878 0 11.6153 0 0 13.3794 11.7552 0 17.6768 12.6195 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 0 13.9209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0A1 ZFHX2_HUMAN "Zinc finger homeobox protein 2 (Zinc finger homeodomain protein 2, ZFH-2)" ZFHX2 KIAA1056 KIAA1762 ZNF409 Homo sapiens (Human) adult behavior [GO:0030534]; brain development [GO:0007420]; regulation of neuron differentiation [GO:0045664]; regulation of sensory perception of pain [GO:0051930]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; brain development [GO:0007420]; regulation of neuron differentiation [GO:0045664]; regulation of sensory perception of pain [GO:0051930]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007420; GO:0008270; GO:0030534; GO:0045664; GO:0051930 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" ALISFLEPK 0.97004 -0.77137 0 10.2535 0 0 0 0 0 0 0 0 13.4976 0 10.7917 0 0 0 0 0 0 0 0 0 0 0 0 12.6097 0 0 0 0 0 0 13.7964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3589 0 0 0 0 0 0 12.1834 12.4646 0 9.67612 0 14.9338 0 0 0 11.6976 0 12.4076 15.062 17.2963 14.9494 0 14.7613 14.8117 0 0 0 0 11.4943 14.8209 0 11.1342 14.7976 0 15.1501 0 0 0 0 0 0 0 13.4867 14.7756 13.0624 14.1158 0 12.1518 0 0 0 13.7428 14.7583 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5264 10.7254 0 0 0 0 0 0 0 0 0 0 0 0 13.7067 12.3971 0 0 14.7541 14.7166 0 0 0 0 0 0 0 0 0 0 11.9145 0 10.1986 0 0 0 9.75909 0 11.8174 0 0 14.29 0 0 0 Q9UJ83 HACL1_HUMAN "2-hydroxyacyl-CoA lyase 1, EC 4.1.2.63 (2-hydroxyphytanoyl-CoA lyase, 2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2)" HACL1 HPCL HPCL2 PHYH2 HSPC279 Homo sapiens (Human) fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity [GO:0106360]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625] GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:0106360; GO:0106376; GO:1903512 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity [GO:0106360]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] FIQVDICAEELGNNVK 0.97004 -0.7906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1129 13.8963 0 13.9115 0 0 0 0 0 0 11.1558 0 0 0 0 0 0 14.0646 0 16.0163 0 0 0 13.7867 0 11.3848 0 0 0 0 0 0 0 14.1198 0 0 0 0 12.8884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8646 0 0 0 12.6722 0 0 12.9922 0 11.4676 0 0 0 13.1711 0 0 0 0 12.2405 0 0 0 0 0 0 11.2035 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8988 0 14.182 0 10.3625 0 0 0 0 Q96KR6 F210B_HUMAN "Protein FAM210B, mitochondrial" FAM210B C20orf108 PSEC0265 Homo sapiens (Human) cellular response to estradiol stimulus [GO:0071392]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648] integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; cellular response to estradiol stimulus [GO:0071392]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648] GO:0005739; GO:0005741; GO:0016021; GO:0031224; GO:0043249; GO:0045648; GO:0071392 AGLLALLGPAGRVGAR 0.97005 -0.74805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2622 0 14.6745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3441 0 11.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4646 0 0 0 0 0 0 11.1964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4348 0 0 0 0 0 0 0 0 0 0 10.765 P43358 MAGA4_HUMAN "Melanoma-associated antigen 4 (Cancer/testis antigen 1.4, CT1.4) (MAGE-4 antigen) (MAGE-41 antigen) (MAGE-X2 antigen)" MAGEA4 MAGE4 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787] nucleus [GO:0005634] nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787] GO:0000122; GO:0005634; GO:0042826; GO:0043066; GO:0045787 histone deacetylase binding [GO:0042826] AKELVTKAEMLER 0.97006 -0.57256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7148 0 0 0 0 0 0 14.0151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92563 TICN2_HUMAN "Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2)" SPOCK2 KIAA0275 TICN2 UNQ269/PRO306 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; extracellular matrix organization [GO:0030198]; negative regulation of endopeptidase activity [GO:0010951]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of cell differentiation [GO:0045595]; synapse assembly [GO:0007416] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; metalloendopeptidase inhibitor activity [GO:0008191]; cellular response to leukemia inhibitory factor [GO:1990830]; extracellular matrix organization [GO:0030198]; negative regulation of endopeptidase activity [GO:0010951]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of cell differentiation [GO:0045595]; synapse assembly [GO:0007416] GO:0005509; GO:0005539; GO:0005576; GO:0007416; GO:0008191; GO:0010811; GO:0010951; GO:0019800; GO:0030198; GO:0031012; GO:0045595; GO:0050840; GO:1990830; GO:2000147 calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; glycosaminoglycan binding [GO:0005539]; metalloendopeptidase inhibitor activity [GO:0008191] APGCGRLVLPLLLLAAAALAEGDAK 0.97008 -0.77361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1184 0 0 0 0 0 0 0 0 0 0 10.019 0 0 0 0 0 0 11.028 0 0 0 0 11.428 0 0 0 0 12.0781 0 0 0 10.3694 0 0 0 0 0 0 12.7411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4021 0 0 0 11.7124 0 0 0 0 0 0 13.8935 0 0 0 0 0 0 0 0 12.0948 13.7101 12.203 0 0 0 0 0 0 0 0 0 0 0 0 14.3208 12.5913 12.8774 0 0 0 0 0 0 0 0 11.502 12.6452 0 12.2036 0 0 0 0 0 11.2705 0 11.3683 0 0 0 0 0 0 0 0 0 11.3058 12.0958 0 0 0 0 0 0 0 0 0 0 11.2488 0 0 0 12.356 0 0 13.4426 0 0 0 0 0 0 0 0 0 13.0164 0 0 0 0 Q05707 COEA1_HUMAN Collagen alpha-1(XIV) chain (Undulin) COL14A1 UND Homo sapiens (Human) cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614] collagen trimer [GO:0005581]; collagen type XIV trimer [GO:0005596]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; cell-cell adhesion [GO:0098609]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198] GO:0003723; GO:0005201; GO:0005518; GO:0005576; GO:0005581; GO:0005596; GO:0005614; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0062023; GO:0098609 collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] EVCKAAK 0.97009 -0.55407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8749 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4529 13.3757 13.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3076 0 13.1341 0 0 P09341 GROA_HUMAN "Growth-regulated alpha protein (C-X-C motif chemokine 1) (GRO-alpha(1-73)) (Melanoma growth stimulatory activity, MGSA) (Neutrophil-activating protein 3, NAP-3) [Cleaved into: GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73) ]" CXCL1 GRO GRO1 GROA MGSA SCYB1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of another organism [GO:0031640]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neutrophil chemotaxis [GO:0030593]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of another organism [GO:0031640]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neutrophil chemotaxis [GO:0030593]; signal transduction [GO:0007165] GO:0005102; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007186; GO:0007399; GO:0008009; GO:0008047; GO:0008083; GO:0008285; GO:0030036; GO:0030593; GO:0031640; GO:0035556; GO:0035580; GO:0045236; GO:0061844; GO:0070098; GO:0071222; GO:1904724 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102] AAGASVATELR 0.9701 4.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7615 12.5821 0 0 0 0 12.6665 0 0 0 0 0 0 0 0 0 10.3229 0 0 0 0 0 0 0 0 10.0353 11.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0176 0 0 9.90946 11.3456 0 0 11.5384 0 0 0 0 0 11.2486 0 0 0 0 0 14.4387 14.2369 0 0 13.119 0 0 0 0 0 15.2082 0 0 0 0 0 12.6517 0 0 0 0 10.9217 0 11.0939 0 14.0565 12.9908 0 0 0 0 12.2591 0 12.1895 0 12.979 0 0 12.5505 0 0 0 11.2366 14.0351 11.4467 10.5505 0 0 0 0 0 11.1946 0 10.4061 0 11.1726 0 0 0 0 13.4323 0 0 0 10.5528 0 0 0 14.7952 11.2973 0 11.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0019 0 Q9Y5Q0 FADS3_HUMAN "Fatty acid desaturase 3, EC 1.14.19.- (Delta(13) fatty acid desaturase, Delta(13) desaturase)" FADS3 CYB5RP Homo sapiens (Human) lipid metabolic process [GO:0006629]; sphingolipid metabolic process [GO:0006665]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; lipid metabolic process [GO:0006629]; sphingolipid metabolic process [GO:0006665]; unsaturated fatty acid biosynthetic process [GO:0006636]" GO:0005789; GO:0006629; GO:0006636; GO:0006665; GO:0016020; GO:0016021; GO:0016717 "oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]" EIGHEKHR 0.9701 -0.53022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6148 0 0 0 12.4687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5249 0 0 0 13.3696 0 14.0393 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9389 0 0 0 0 0 0 12.6518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2786 0 0 0 0 0 0 0 A8MRT5 NPIB5_HUMAN Nuclear pore complex-interacting protein family member B5 NPIPB5 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 DVITLRR 0.97011 -0.80408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4356 0 0 0 12.1996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3686 0 0 0 0 0 0 0 0 0 0 10.7238 0 0 0 0 0 0 0 0 0 0 0 0 O75936 BODG_HUMAN "Gamma-butyrobetaine dioxygenase, EC 1.14.11.1 (Gamma-butyrobetaine hydroxylase, Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)" BBOX1 BBH BBOX Homo sapiens (Human) carnitine biosynthetic process [GO:0045329] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270]; carnitine biosynthetic process [GO:0045329] GO:0005506; GO:0005739; GO:0005829; GO:0008270; GO:0008336; GO:0042802; GO:0045329; GO:0070062 gamma-butyrobetaine dioxygenase activity [GO:0008336]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270] DNCPCSDCYLDSAKAR 0.97011 -0.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8319 0 16.0457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78380 OLR1_HUMAN "Oxidized low-density lipoprotein receptor 1, Ox-LDL receptor 1 (C-type lectin domain family 8 member A) (Lectin-like oxidized LDL receptor 1, LOX-1, Lectin-like oxLDL receptor 1, hLOX-1) (Lectin-type oxidized LDL receptor 1) [Cleaved into: Oxidized low-density lipoprotein receptor 1, soluble form ]" OLR1 CLEC8A LOX1 Homo sapiens (Human) blood circulation [GO:0008015]; cell death [GO:0008219]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; lipoprotein metabolic process [GO:0042157]; proteolysis [GO:0006508] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor activity [GO:0005041]; blood circulation [GO:0008015]; cell death [GO:0008219]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; lipoprotein metabolic process [GO:0042157]; proteolysis [GO:0006508] GO:0002376; GO:0005041; GO:0005576; GO:0005654; GO:0005886; GO:0005887; GO:0006508; GO:0006954; GO:0007159; GO:0008015; GO:0008219; GO:0016020; GO:0030246; GO:0035579; GO:0042157; GO:0042802; GO:0043231; GO:0043235; GO:0045121; GO:0070821 carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor activity [GO:0005041] QQAEEASQESENELK 0.97011 -0.53085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.134 0 0 0 0 0 0 Q8WWT9 S13A3_HUMAN "Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3, NaDC-3, hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2)" SLC13A3 NADC3 SDCT2 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; citrate transport [GO:0015746]; dicarboxylic acid transport [GO:0006835]; glutathione transmembrane transport [GO:0034775]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104] GO:0005310; GO:0005886; GO:0006835; GO:0015137; GO:0015139; GO:0015141; GO:0015362; GO:0015746; GO:0016021; GO:0016323; GO:0017153; GO:0034634; GO:0034775; GO:0070062; GO:0071422; GO:0098656; GO:0150104 alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; citrate transmembrane transporter activity [GO:0015137]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; glutathione transmembrane transporter activity [GO:0034634]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141] AALAAAAK 0.97011 -0.7345 0 0 0 0 0 10.4276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.08 0 0 0 0 0 0 0 0 0 10.6982 0 12.5991 0 0 0 15.7745 0 0 14.3535 14.3973 0 15.2061 14.3668 15.3897 15.1162 0 13.9368 0 0 15.0296 0 0 13.2935 0 0 13.9312 0 0 0 0 0 12.0386 0 13.8505 14.1139 13.2652 0 0 0 0 0 0 0 0 13.0048 13.6636 12.8341 0 0 0 0 12.5311 0 12.9844 0 0 0 13.1879 0 0 0 12.9457 12.3528 12.6427 0 0 0 0 0 0 0 0 0 0 13.3779 11.3071 0 0 0 0 0 0 11.4788 0 0 0 11.8089 0 0 0 12.6832 0 0 0 0 0 11.9539 0 0 0 0 Q9H340 O51B6_HUMAN Olfactory receptor 51B6 (Odorant receptor HOR5'beta6) OR51B6 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AHHWIFIPLLAAYISILLGNGTLLFLIR 0.97011 -0.53221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1521 13.5565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.161 0 0 14.1352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0332 0 0 0 0 0 13.2992 0 0 0 0 0 0 0 0 0 0 A6PVY3 F177B_HUMAN Protein FAM177B FAM177B Homo sapiens (Human) FAVFFGLTQPKYQYVLNEFYRIQNK 0.97012 -0.78044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4885 0 0 0 0 0 0 16.0427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.616 0 0 0 0 0 0 0 13.9191 0 0 0 0 0 0 0 0 0 0 0 10.0467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30988 CALCR_HUMAN "Calcitonin receptor, CT-R" CALCR Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384] amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] amylin receptor complex 1 [GO:0150056]; amylin receptor complex 2 [GO:0150057]; amylin receptor complex 3 [GO:0150058]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amylin receptor activity [GO:0097643]; amyloid-beta binding [GO:0001540]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; amylin receptor signaling pathway [GO:0097647]; cell surface receptor signaling pathway [GO:0007166]; cross-receptor inhibition within G protein-coupled receptor heterodimer [GO:0038041]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; response to amyloid-beta [GO:1904645]; response to glucocorticoid [GO:0051384] GO:0001540; GO:0001635; GO:0004948; GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0007204; GO:0008528; GO:0010628; GO:0010739; GO:0010942; GO:0030424; GO:0032841; GO:0033138; GO:0038041; GO:0045762; GO:0051384; GO:0051897; GO:0070374; GO:0097643; GO:0097647; GO:0150056; GO:0150057; GO:0150058; GO:1904645; GO:1905665 amylin receptor activity [GO:0097643]; amyloid-beta binding [GO:0001540]; calcitonin binding [GO:0032841]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528] AVKATMILVPLLGIQFVVFPWR 0.97012 -0.53643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.272 0 11.6704 0 0 0 0 0 0 0 0 0 13.9145 16.9101 16.7685 16.7068 16.6361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3622 0 0 0 0 0 13.4184 13.1104 14.1071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6208 13.0375 13.7033 0 0 0 0 13.5328 0 0 0 13.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0699 18.8338 15.4541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48595 SPB10_HUMAN "Serpin B10 (Bomapin) (Peptidase inhibitor 10, PI-10)" SERPINB10 PI10 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] cytosol [GO:0005829]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cytosol [GO:0005829]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0010951; GO:0030667; GO:0101003 serine-type endopeptidase inhibitor activity [GO:0004867] KKLHIFHIEK 0.97012 -0.78056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24844 MYL9_HUMAN "Myosin regulatory light polypeptide 9 (20 kDa myosin light chain, LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)" MYL9 MLC2 MRLC1 MYRL2 Homo sapiens (Human) myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937] GO:0001725; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0070527 calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307] MSSKRAK 0.97013 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWA0 WDR75_HUMAN WD repeat-containing protein 75 (U3 small nucleolar RNA-associated protein 17 homolog) WDR75 UTP17 Homo sapiens (Human) positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0045943; GO:2000234 RNA binding [GO:0003723] CTFCQRAGKIR 0.97013 3.2158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8591 0 0 0 0 11.0986 0 0 0 11.8971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6607 0 0 0 13.2503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7064 0 0 0 15.4651 0 0 0 0 0 0 0 0 0 0 0 14.1735 0 0 13.8226 0 0 0 0 0 0 0 0 0 0 13.4751 0 12.9087 0 0 0 0 0 0 0 0 0 0 14.0978 0 0 0 0 0 0 0 11.019 0 0 0 12.2084 0 0 0 0 0 0 0 0 0 0 12.2467 0 0 0 0 P55769 NH2L1_HUMAN "NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (OTK27) (SNU13 homolog, hSNU13) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed ]" SNU13 NHP2L1 Homo sapiens (Human) "box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]" box C/D RNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690] "box C/D RNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; ATPase binding [GO:0051117]; box C/D RNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; single fertilization [GO:0007338]" GO:0000398; GO:0000470; GO:0000492; GO:0001651; GO:0003723; GO:0005634; GO:0005654; GO:0005690; GO:0005730; GO:0007338; GO:0030490; GO:0030621; GO:0030622; GO:0031428; GO:0032040; GO:0032991; GO:0034511; GO:0034512; GO:0046540; GO:0051117; GO:0071005; GO:0071011 ATPase binding [GO:0051117]; box C/D RNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] AYPLADAHLTKKLLDLVQQSCNYK 0.97014 -0.76387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3084 0 0 0 0 0 0 0 0 0 10.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRY6 PLS3_HUMAN "Phospholipid scramblase 3, PL scramblase 3 (Ca(2+)-dependent phospholipid scramblase 3)" PLSCR3 Homo sapiens (Human) apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cardiolipin biosynthetic process [GO:0032049]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; plasma membrane phospholipid scrambling [GO:0017121]; regulation of apoptotic process [GO:0042981]; regulation of release of cytochrome c from mitochondria [GO:0090199] GO:0000287; GO:0005509; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0005886; GO:0006915; GO:0016021; GO:0017121; GO:0017124; GO:0017128; GO:0032049; GO:0032791; GO:0042593; GO:0042632; GO:0042981; GO:0043621; GO:0045340; GO:0048306; GO:0071222; GO:0090199 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; phospholipid scramblase activity [GO:0017128]; protein self-association [GO:0043621]; SH3 domain binding [GO:0017124] FSIQDADR 0.97014 -0.48846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4289 0 0 0 0 0 0 0 0 0 0 11.2965 0 0 0 0 0 0 11.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3034 0 0 0 0 14.0642 14.3429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3299 0 0 0 0 0 0 0 0 12.2669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8568 0 0 0 0 0 0 0 0 0 0 11.8969 0 10.9745 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2K6 UBP20_HUMAN "Ubiquitin carboxyl-terminal hydrolase 20, EC 3.4.19.12 (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2, hVDU2)" USP20 KIAA1003 LSFR3A VDU2 Homo sapiens (Human) endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001664; GO:0004197; GO:0004843; GO:0005737; GO:0005813; GO:0005829; GO:0006511; GO:0006897; GO:0008270; GO:0008277; GO:0016579; GO:0048471; GO:0070536; GO:0071108 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; zinc ion binding [GO:0008270] EGDRSPSEDEFLSCDSSSDR 0.97014 -0.78467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0221 9.93807 0 0 0 0 0 10.088 0 0 0 0 0 0 0 11.8977 0 0 0 0 0 12.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3677 12.5825 0 0 0 0 0 0 0 13.9526 0 0 0 0 0 0 0 0 11.0529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.946 0 13.1248 0 0 0 0 0 0 0 14.6723 13.1562 11.4699 0 0 0 12.3919 0 0 0 13.9631 16.2066 0 0 12.954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4487 0 0 0 0 0 0 0 0 0 0 0 11.0529 0 0 0 0 0 0 0 10.5551 10.5901 0 0 0 0 0 0 18.21 0 0 0 0 0 0 Q9Y6Z4 KIAS1_HUMAN Putative uncharacterized protein KIF25-AS1 (KIF25 antisense RNA 1) (KIF25 antisense gene protein 1) (Protein HGC6.1) KIF25-AS1 C6orf54 NCRNA00300 Homo sapiens (Human) AVACAPHCFGPR 0.97014 -0.56068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5995 0 14.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 I3L0S3 PYAS1_HUMAN Putative uncharacterized protein PYCARD-AS1 (PYCARD antisense RNA 1) (PYCARD antisense gene protein 1) (PYCARD opposite strand protein) PYCARD-AS1 C16orf98 PYCARDOS Homo sapiens (Human) IQDGVAR 0.97015 -0.56342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8313 0 0 0 13.9912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZRN7 YP029_HUMAN Putative uncharacterized protein FLJ46214 Homo sapiens (Human) APLPRPPPR 0.97015 -0.7864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9633 0 0 0 0 0 0 0 0 0 0 13.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ55 BSND_HUMAN Barttin BSND BART Homo sapiens (Human) chloride transport [GO:0006821] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; chloride channel activity [GO:0005254]; chloride channel regulator activity [GO:0017081]; chloride transport [GO:0006821] GO:0005254; GO:0005737; GO:0005886; GO:0005887; GO:0006821; GO:0016323; GO:0017081; GO:0032991 chloride channel activity [GO:0005254]; chloride channel regulator activity [GO:0017081] EASDTGGEEPEKEEEDLYYGLPDGAGDLLPDKELGFEPDTQG 0.97016 -0.79053 0 0 0 0 0 0 0 0 0 0 0 11.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6658 0 0 0 0 0 0 0 16.4225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTU3 OLIG3_HUMAN "Oligodendrocyte transcription factor 3, Oligo3 (Class B basic helix-loop-helix protein 7, bHLHb7) (Class E basic helix-loop-helix protein 20, bHLHe20)" OLIG3 BHLHB7 BHLHE20 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron migration [GO:0097476] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron migration [GO:0097476]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0021520; GO:0030182; GO:0046983; GO:0097476; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" IATLLLARNYILMLTSSLEEMK 0.97017 -0.74801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUT4 LRRN4_HUMAN "Leucine-rich repeat neuronal protein 4 (Neuronal leucine-rich repeat protein 4, NLRR-4)" LRRN4 C20orf75 Homo sapiens (Human) long-term memory [GO:0007616]; visual learning [GO:0008542] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; long-term memory [GO:0007616]; visual learning [GO:0008542] GO:0005887; GO:0007616; GO:0008542; GO:0070062 ALALAGNPLR 0.97017 -0.74686 0 0 0 0 0 10.5578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1558 0 0 0 0 0 0 0 0 12.324 0 0 0 0 0 0 0 0 0 14.2795 0 14.6379 0 0 0 0 12.2101 0 15.657 0 0 0 0 0 0 0 0 0 0 12.8743 0 0 0 0 0 0 14.1775 0 13.5946 14.7104 14.1179 0 0 0 0 0 0 0 0 0 0 0 0 11.7718 0 13.2173 0 12.6083 0 0 0 0 13.0644 13.0523 12.3149 0 12.6851 0 12.4933 0 0 0 0 0 0 0 0 0 0 0 0 11.6189 0 0 0 0 0 0 0 0 0 0 13.4821 11.8574 12.5936 0 0 0 0 11.8015 0 Q8NG48 LINES_HUMAN Protein Lines homolog 1 (Wnt-signaling molecule Lines homolog 1) LINS1 LINS WINS1 Homo sapiens (Human) cognition [GO:0050890] cognition [GO:0050890] GO:0050890 ASLGIYLTLTR 0.97018 -0.57138 0 0 0 0 0 0 11.1878 0 0 0 0 0 0 0 0 11.6449 0 0 0 0 13.0621 0 0 0 0 0 0 0 0 12.0799 0 0 0 10.4367 0 14.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.723 0 0 0 0 14.0425 0 0 0 0 10.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8424 0 0 12.3608 0 12.2663 12.2681 0 14.7306 13.6776 13.4506 0 14.8495 13.599 14.4527 13.6275 13.438 13.7226 14.1219 0 13.5035 0 0 13.7264 13.2688 0 13.4025 14.5507 0 0 13.3662 13.5098 13.2148 13.6155 0 13.379 0 12.9064 13.7977 0 16.4111 0 13.5337 12.9488 0 13.4102 14.4972 0 13.8377 12.9259 0 13.8689 13.3387 12.7318 0 12.763 0 0 0 0 0 14.1042 10.0218 12.805 0 13.0481 14.3327 14.0378 14.3449 14.6152 13.9163 13.6404 0 14.445 0 15.2148 13.8806 0 14.788 0 13.9543 0 0 0 0 0 0 0 0 10.4442 0 0 0 0 0 0 13.3417 13.1689 0 13.1685 0 0 0 0 0 Q9H0R5 GBP3_HUMAN "Guanylate-binding protein 3, EC 3.6.5.- (GTP-binding protein 3, GBP-3) (Guanine nucleotide-binding protein 3)" GBP3 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607] GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0031410; GO:0042802; GO:0042803; GO:0048471; GO:0051607; GO:0071346; GO:0071347; GO:0071356 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] AIAHYDQQMGQK 0.97018 -0.57155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3323 0 0 11.7386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3201 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6C9 MTCH2_HUMAN Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein) MTCH2 MIMP HSPC032 Homo sapiens (Human) lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635] GO:0005634; GO:0005739; GO:0005741; GO:0010635; GO:0016020; GO:0016021; GO:0043065; GO:0055088; GO:0070585; GO:2000738 GNSLFFRKVPFGK 0.97019 -0.57256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0223 0 0 0 0 0 0 0 0 0 0 Q9H195 MUC3B_HUMAN "Mucin-3B, MUC-3B (Intestinal mucin-3B)" MUC3B Homo sapiens (Human) Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005796; GO:0005886; GO:0016021 ALVGGLTAGAALLVLLLLALGVR 0.9702 4.32 0 0 0 0 0 0 0 0 0 12.0426 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4886 0 10.7875 0 11.5976 0 0 0 12.4957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.51 0 0 0 0 0 0 12.7793 0 0 14.9643 0 0 14.7425 0 0 14.6382 14.2274 0 0 0 0 0 11.5915 0 0 0 0 0 0 0 13.9834 0 0 0 0 0 0 0 0 14.8509 0 0 0 0 0 0 0 0 0 0 13.0694 12.8862 0 0 13.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3056 0 0 0 0 0 12.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.931 0 0 O75496 GEMI_HUMAN Geminin GMNN Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-templated DNA replication [GO:2000104]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-templated DNA replication [GO:2000104]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346]" GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006275; GO:0007346; GO:0008156; GO:0009887; GO:0017053; GO:0030174; GO:0035563; GO:0042826; GO:0045786; GO:0045892; GO:0071163; GO:0140297; GO:2000104 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714] ALYEALK 0.97021 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29558 RBMS1_HUMAN "RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2)" RBMS1 C2orf12 MSSP MSSP1 SCR2 Homo sapiens (Human) DNA replication [GO:0006260]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; RNA processing [GO:0006396] GO:0003690; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006260; GO:0006396; GO:0008143; GO:0008266; GO:1990904 double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] AILDKTTNKCK 0.97021 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8518 0 0 0 0 0 0 0 0 0 0 14.0911 0 0 0 0 0 0 14.6496 0 0 0 0 0 0 14.1182 0 0 0 0 14.7845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4188 0 0 0 0 0 0 0 P46778 RL21_HUMAN 60S ribosomal protein L21 (Large ribosomal subunit protein eL21) RPL21 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ILAKRINVR 0.97021 -0.77321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1251 0 0 0 13.877 0 0 14.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15540 FABP7_HUMAN "Fatty acid-binding protein, brain (Brain lipid-binding protein, BLBP) (Brain-type fatty acid-binding protein, B-FABP) (Fatty acid-binding protein 7) (Mammary-derived growth inhibitor related)" FABP7 BLBP FABPB MRG Homo sapiens (Human) epithelial cell proliferation [GO:0050673]; fatty acid transport [GO:0015908]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; lipid binding [GO:0008289]; epithelial cell proliferation [GO:0050673]; fatty acid transport [GO:0015908]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399] GO:0005504; GO:0005634; GO:0005829; GO:0007399; GO:0008285; GO:0008289; GO:0015908; GO:0050673 fatty acid binding [GO:0005504]; lipid binding [GO:0008289] MVEAFCATWK 0.97022 -0.77521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGG1 OR8J2_HUMAN Olfactory receptor 8J2 OR8J2 OR8J2P Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] HLAIINLCNSTVVAPKMLVNFLVTK 0.97022 -0.77494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.492 0 0 0 0 0 0 13.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0V9 SEP10_HUMAN Septin-10 SEPTIN10 SEPT10 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104] GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0060090; GO:0061640 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] ELQAKFEHLKR 0.97023 -0.80338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0043 0 0 0 0 10.838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29372 3MG_HUMAN "DNA-3-methyladenine glycosylase, EC 3.2.2.21 (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase)" MPG AAG ANPG MID1 Homo sapiens (Human) base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307] cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA dealkylation involved in DNA repair [GO:0006307] GO:0003684; GO:0003905; GO:0005654; GO:0005829; GO:0006284; GO:0006307; GO:0008725; GO:0019104; GO:0042645; GO:0043916; GO:0045007; GO:0052821; GO:0052822 alkylbase DNA N-glycosylase activity [GO:0003905]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916] KGTASRVLK 0.97024 -0.5298 0 0 0 0 0 16.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4874 0 13.8021 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6666 0 13.4962 0 0 0 0 0 0 0 0 0 0 0 0 12.3693 0 13.2217 0 0 0 0 14.2362 14.3024 0 0 0 0 0 0 13.5954 0 0 14.4599 0 0 0 0 0 0 11.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5951 14.6861 0 0 0 0 0 0 Q14973 NTCP_HUMAN Sodium/bile acid cotransporter (Cell growth-inhibiting gene 29 protein) (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (Solute carrier family 10 member 1) SLC10A1 NTCP GIG29 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; cellular response to xenobiotic stimulus [GO:0071466]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid:sodium symporter activity [GO:0008508]; virus receptor activity [GO:0001618]; bile acid and bile salt transport [GO:0015721]; bile acid signaling pathway [GO:0038183]; cellular response to xenobiotic stimulus [GO:0071466]; regulation of bile acid secretion [GO:0120188]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667] GO:0001618; GO:0005886; GO:0005887; GO:0008508; GO:0010468; GO:0015721; GO:0016323; GO:0031667; GO:0038183; GO:0045471; GO:0071466; GO:0120188; GO:1904486 bile acid:sodium symporter activity [GO:0008508]; virus receptor activity [GO:0001618] GEDCSPCTA 0.97024 -0.77963 0 0 0 11.9701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2994 0 0 0 0 0 0 0 0 0 0 15.3816 0 0 0 0 0 12.1824 0 0 13.324 12.1932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.457 0 11.2662 0 0 0 0 13.0398 0 0 12.1113 0 11.851 0 12.1019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9994 0 0 0 10.6649 0 0 0 0 0 0 0 0 0 0 11.1703 0 0 Q9P0L9 PK2L1_HUMAN Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1) PKD2L1 PKD2L PKDL TRPP3 Homo sapiens (Human) cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725] actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; sour taste receptor activity [GO:0033040]; cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; protein homotetramerization [GO:0051289]; response to water [GO:0009415]; sensory perception of sour taste [GO:0050915]; smoothened signaling pathway [GO:0007224]; sodium ion transmembrane transport [GO:0035725] GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0006812; GO:0007224; GO:0008092; GO:0009415; GO:0009986; GO:0015269; GO:0015629; GO:0016020; GO:0016021; GO:0031410; GO:0033040; GO:0034704; GO:0035725; GO:0042802; GO:0043231; GO:0043235; GO:0050912; GO:0050915; GO:0050982; GO:0051289; GO:0051371; GO:0051393; GO:0060170; GO:0071468; GO:0071805; GO:0097730; GO:0098662 alpha-actinin binding [GO:0051393]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated potassium channel activity [GO:0015269]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; sodium channel activity [GO:0005272]; sour taste receptor activity [GO:0033040] GEIPTLQR 0.97024 -0.73433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VTQ0 TT39B_HUMAN "Tetratricopeptide repeat protein 39B, TPR repeat protein 39B" TTC39B C9orf52 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol storage [GO:0010887]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol metabolic process [GO:0090181] cholesterol homeostasis [GO:0042632]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol storage [GO:0010887]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol metabolic process [GO:0090181] GO:0006629; GO:0010874; GO:0010887; GO:0042632; GO:0090181 DALQTCQKYR 0.97025 -0.47502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1521 0 0 0 0 0 0 0 0 0 0 0 13.6488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.245 0 0 0 0 0 0 0 0 0 Q8NEM7 SP20H_HUMAN "Transcription factor SPT20 homolog (p38-interacting protein, p38IP)" SUPT20H C13orf19 FAM48A FP757 Homo sapiens (Human) "autophagy [GO:0006914]; gastrulation [GO:0007369]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] "SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; transcription coregulator activity [GO:0003712]; autophagy [GO:0006914]; gastrulation [GO:0007369]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000124; GO:0003712; GO:0006282; GO:0006357; GO:0006914; GO:0007369; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0070461 transcription coregulator activity [GO:0003712] KAGQHYDLK 0.97025 -0.53448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.622 0 0 0 0 0 0 0 0 0 12.0766 11.5013 0 0 0 0 0 0 0 0 0 0 0 13.2334 13.3246 12.3206 12.147 0 12.2245 12.8211 13.1959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3607 12.5518 0 0 15.7291 0 0 0 0 0 0 14.8947 0 0 12.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7893 0 0 0 0 0 Q96BJ8 ELMO3_HUMAN Engulfment and cell motility protein 3 ELMO3 Homo sapiens (Human) actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis [GO:0006909] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis [GO:0006909] GO:0005737; GO:0006909; GO:0006915; GO:0007015; GO:0017124; GO:0048870 SH3 domain binding [GO:0017124] APPRNVVKIAIK 0.97025 -0.55699 0 0 0 0 0 0 0 0 0 0 0 14.5269 0 0 0 0 0 14.496 13.1757 0 0 0 0 0 13.0572 14.6348 0 14.5768 14.4245 14.6049 13.4232 14.4633 14.6725 0 0 0 0 0 0 14.521 12.923 0 0 13.1112 12.0373 0 0 14.3904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3631 0 0 0 0 0 13.9202 0 12.6089 13.6485 0 0 0 0 0 0 14.0076 0 0 13.9685 12.5847 0 13.62 0 0 0 0 0 13.178 0 0 0 14.3225 14.3077 0 0 0 0 0 0 14.5853 0 0 0 0 0 0 0 13.2951 10.4057 0 0 0 13.3613 11.4675 0 0 13.1417 0 13.4693 13.4243 0 0 13.9147 0 13.4091 0 0 0 0 0 0 0 0 0 0 12.8466 0 16.0667 0 0 0 0 0 0 13.4638 0 16.1834 12.4727 12.0005 0 12.9786 12.8 12.8472 16.3959 14.0785 0 14.0291 13.9183 13.6542 0 0 0 0 16.3757 0 16.2935 0 0 O75844 FACE1_HUMAN "CAAX prenyl protease 1 homolog, EC 3.4.24.84 (Farnesylated proteins-converting enzyme 1, FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog)" ZMPSTE24 FACE1 STE24 Homo sapiens (Human) "adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of miRNA maturation [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]" extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991] "extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of miRNA maturation [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; prenylated protein catabolic process [GO:0030327]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]" GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004222; GO:0005637; GO:0006281; GO:0006325; GO:0006508; GO:0006925; GO:0006998; GO:0007628; GO:0008235; GO:0008340; GO:0008360; GO:0010506; GO:0010906; GO:0016020; GO:0019216; GO:0030176; GO:0030282; GO:0030327; GO:0030500; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0043007; GO:0043516; GO:0043979; GO:0044029; GO:0044255; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070062; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903025; GO:1903463; GO:1903799; GO:1990036; GO:1990164; GO:2000618; GO:2000730; GO:2000772 double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235] DIQEDSGMEPR 0.97026 -0.53633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VTY9 HHAT_HUMAN "Protein-cysteine N-palmitoyltransferase HHAT, EC 2.3.1.- (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2, MART-2) (Skinny hedgehog protein 1)" HHAT MART2 SKI1 Homo sapiens (Human) N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acyltransferase activity [GO:0016746]; GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; protein palmitoylation [GO:0018345]; smoothened signaling pathway [GO:0007224] GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0008374; GO:0016021; GO:0016409; GO:0016746; GO:0018009; GO:0018345 acyltransferase activity [GO:0016746]; GTP binding [GO:0005525]; O-acyltransferase activity [GO:0008374]; palmitoyltransferase activity [GO:0016409] EHEEELDQEFELETDTLFGGLK 0.97026 -0.78394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8653 0 13.3375 0 0 13.6302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W041 ARMC3_HUMAN "Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81, CT81) (KU-CT-1)" ARMC3 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 AKLQELNAIPPILDLLK 0.97026 -0.55899 0 0 0 0 0 0 0 0 0 0 0 13.7368 0 0 0 0 0 0 0 0 0 0 14.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0045 0 0 0 0 17.2805 13.7141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3G9 TM130_HUMAN Transmembrane protein 130 TMEM130 UNQ719/PRO1383 Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887] GO:0000139; GO:0005794; GO:0005887 AQAVWSR 0.97027 -0.48688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3015 0 13.0067 0 0 0 0 0 13.2632 11.0229 0 0 15.3515 0 0 0 0 0 0 13.4737 11.1158 0 0 0 0 0 13.2999 0 12.7508 0 12.8473 12.8982 0 0 0 13.5069 0 0 0 0 0 0 0 0 13.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15182 CETN3_HUMAN Centrin-3 CETN3 CEN3 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; mRNA transport [GO:0051028]; protein transport [GO:0015031] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; mRNA transport [GO:0051028]; protein transport [GO:0015031] GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390 calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; microtubule binding [GO:0008017] QEIKDAFELFDTDK 0.97028 -0.56342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0W0 IFNK_HUMAN "Interferon kappa, IFN-kappa" IFNK UNQ6124/PRO20084 Homo sapiens (Human) "adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of transcription, DNA-templated [GO:0006355]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]" extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of transcription, DNA-templated [GO:0006355]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]" GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005132; GO:0005576; GO:0005615; GO:0006355; GO:0006959; GO:0008285; GO:0009615; GO:0019221; GO:0030101; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0045089; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132] EMKENEMKPSEAR 0.97029 -0.74507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.913 0 0 0 11.3978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6808 0 0 O75943 RAD17_HUMAN "Cell cycle checkpoint protein RAD17, hRad17 (RF-C/activator 1 homolog)" RAD17 R24L Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; regulation of phosphorylation [GO:0042325] GO:0000076; GO:0000077; GO:0003682; GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0008156; GO:0031389; GO:0031573; GO:0033314; GO:0042325 ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA clamp loader activity [GO:0003689] EYSTSIATR 0.9703 -0.74591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3833 12.3436 0 0 0 0 0 10.337 0 0 0 0 0 0 10.7299 0 0 0 0 10.4366 0 0 0 0 A6NHG9 O5H14_HUMAN Olfactory receptor 5H14 OR5H14 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IPLFLAFLVIYLITIMGNLGLIAVIWK 0.97031 -0.57128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5643 0 0 0 11.2453 0 0 0 0 0 0 0 0 0 0 0 0 9.03218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2K1 UB2J2_HUMAN "Ubiquitin-conjugating enzyme E2 J2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme J2) (Non-canonical ubiquitin-conjugating enzyme 2, NCUBE-2)" UBE2J2 NCUBE2 Homo sapiens (Human) positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0005829; GO:0006986; GO:0016021; GO:0030433; GO:0031625; GO:0061631; GO:1903955 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625] LKQDYLRIK 0.97032 -0.79509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4353 13.9745 0 0 0 13.9206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3B1 PLD3B_HUMAN PRELI domain containing protein 3B (Protein slowmo homolog 2) PRELID3B C20orf45 SLMO2 CGI-107 Homo sapiens (Human) phospholipid transport [GO:0015914] mitochondrial intermembrane space [GO:0005758] mitochondrial intermembrane space [GO:0005758]; phosphatidic acid transfer activity [GO:1990050]; phospholipid transport [GO:0015914] GO:0005758; GO:0015914; GO:1990050 phosphatidic acid transfer activity [GO:1990050] SLIGAARTK 0.97032 -0.7725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13349 MYF5_HUMAN "Myogenic factor 5, Myf-5 (Class C basic helix-loop-helix protein 2, bHLHc2)" MYF5 BHLHC2 Homo sapiens (Human) camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; embryonic skeletal system morphogenesis [GO:0048704]; extracellular matrix organization [GO:0030198]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle tissue morphogenesis [GO:0060415]; ossification [GO:0001503]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of skeletal muscle fiber development [GO:0048743]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; camera-type eye development [GO:0043010]; cartilage condensation [GO:0001502]; embryonic skeletal system morphogenesis [GO:0048704]; extracellular matrix organization [GO:0030198]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle tissue morphogenesis [GO:0060415]; ossification [GO:0001503]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of skeletal muscle fiber development [GO:0048743]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001502; GO:0001503; GO:0001756; GO:0001952; GO:0005654; GO:0006357; GO:0007517; GO:0007519; GO:0030198; GO:0035914; GO:0042693; GO:0043010; GO:0045663; GO:0046983; GO:0048704; GO:0048743; GO:0060415; GO:0090575 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LPKVEILRNAIR 0.97034 -0.77291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5729 0 0 0 0 0 0 0 12.9791 11.0926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8913 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFQ8 TOIP2_HUMAN Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1) TOR1AIP2 IFRG15 LULL1 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; membrane organization [GO:0061024]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; endoplasmic reticulum organization [GO:0007029]; membrane organization [GO:0061024]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435] GO:0001671; GO:0005783; GO:0005789; GO:0007029; GO:0016020; GO:0016021; GO:0031965; GO:0032781; GO:0051117; GO:0061024; GO:0090435 ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117] ETEEKVRDLLWAK 0.97034 -0.80019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.608 0 0 16.5574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3656 16.5814 0 0 0 0 0 0 0 0 0 0 0 16.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0647 0 0 0 0 0 0 0 Q9BZP6 CHIA_HUMAN "Acidic mammalian chitinase, AMCase, EC 3.2.1.14 (Lung-specific protein TSA1902)" CHIA Homo sapiens (Human) apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; chitin metabolic process [GO:0006030]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; chitin metabolic process [GO:0006030]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532] GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006030; GO:0006032; GO:0006915; GO:0008061; GO:0019900; GO:0032722; GO:0044245 chitin binding [GO:0008061]; chitinase activity [GO:0004568]; kinase binding [GO:0019900] EAFEQEAK 0.97034 -0.80098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2579 0 0 0 0 0 0 13.8699 13.9893 13.6523 13.7192 0 0 0 13.0017 0 13.7383 14.1645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43548 TGM5_HUMAN "Protein-glutamine gamma-glutamyltransferase 5, EC 2.3.2.13 (Transglutaminase X, TG(X), TGX, TGase X) (Transglutaminase-5, TGase-5)" TGM5 TGMX Homo sapiens (Human) epidermis development [GO:0008544]; peptide cross-linking [GO:0018149]; protein modification process [GO:0036211] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; epidermis development [GO:0008544]; peptide cross-linking [GO:0018149]; protein modification process [GO:0036211] GO:0003810; GO:0005737; GO:0005886; GO:0008544; GO:0018149; GO:0036211; GO:0046872 metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] DDITENYK 0.97036 -0.80294 0 0 0 0 0 0 0 0 10.2221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9515 0 0 0 0 0 0 0 0 0 0 0 0 11.2527 0 0 0 0 13.8141 0 0 0 0 0 0 0 0 0 0 14.7294 14.9078 15.84 13.4663 13.67 0 11.1515 0 0 0 0 0 0 0 0 0 0 10.7577 0 0 9.53019 0 0 0 10.8864 12.9399 12.2167 0 12.5767 0 0 14.8239 14.7738 0 0 0 0 0 13.4426 10.5344 13.8587 13.864 13.9378 13.9036 12.7762 0 13.2228 0 0 0 0 14.0075 14.325 0 0 0 13.226 0 0 12.9285 0 0 12.7521 0 0 0 0 0 13.0816 12.4893 14.3905 10.9833 12.662 0 0 0 0 12.1241 0 0 0 0 0 0 0 0 0 0 0 0 14.6741 0 0 0 0 0 0 0 Q8N1V2 CFA52_HUMAN Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) (WD40-repeat protein up-regulated in HCC) CFAP52 WDR16 WDRPUH Homo sapiens (Human) cilium assembly [GO:0060271]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] 9+2 motile cilium [GO:0097729]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930] 9+2 motile cilium [GO:0097729]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; cilium assembly [GO:0060271]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] GO:0005879; GO:0005930; GO:0030317; GO:0060271; GO:0061966; GO:0097729 FSLGVSAIRCLKMGGLLVGSGAGLLVFCK 0.97036 -0.77706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5282 13.0637 12.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3828 P0C629 O10J4_HUMAN Olfactory receptor 10J4 OR10J4 OR10J4P Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] EFITLLISLCVLVLPMVLIFISYVLIVTTILK 0.97037 -0.73265 0 0 0 0 0 0 0 0 0 0 0 0 13.7822 0 12.8289 15.9122 16.0643 0 0 0 0 0 0 0 0 0 16.1638 0 0 0 0 0 0 0 12.4499 0 0 0 0 0 15.8744 0 12.3674 15.94 15.7997 0 0 0 15.873 0 15.9673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6816 0 0 0 18.2062 0 0 14.5413 0 13.8263 0 13.4696 0 0 0 0 0 0 0 0 0 0 0 14.016 0 0 0 0 0 0 0 0 0 13.4621 0 0 0 0 0 0 0 0 17.9928 0 13.7384 0 0 0 0 0 0 0 0 0 13.7217 0 0 0 13.4714 0 18.1565 0 0 13.0482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.329 0 0 0 0 0 0 12.945 0 Q6UXP7 F151B_HUMAN Protein FAM151B FAM151B UNQ9217/PRO28685 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 QAIGIKVNL 0.97037 -0.68014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B2RD01 CENP1_HUMAN Putative CENPB DNA-binding domain-containing protein 1 CENPBD1P CENPBD1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] AEFDDLQR 0.97038 -0.48208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7248 13.6128 0 0 0 0 0 0 0 11.7781 0 0 0 0 0 0 0 0 12.8959 0 0 0 0 0 0 0 0 0 11.9826 0 13.1469 0 11.5775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2238 0 0 0 0 0 0 Q12947 FOXF2_HUMAN "Forkhead box protein F2 (Forkhead-related activator 2, FREAC-2) (Forkhead-related protein FKHL6) (Forkhead-related transcription factor 2)" FOXF2 FKHL6 FREAC2 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract development [GO:0048566]; epithelial to mesenchymal transition [GO:0001837]; establishment of planar polarity of embryonic epithelium [GO:0042249]; extracellular matrix organization [GO:0030198]; genitalia development [GO:0048806]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein polyubiquitination [GO:1902914]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; TFIIB-class transcription factor binding [GO:0001093]; animal organ morphogenesis [GO:0009887]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract development [GO:0048566]; epithelial to mesenchymal transition [GO:0001837]; establishment of planar polarity of embryonic epithelium [GO:0042249]; extracellular matrix organization [GO:0030198]; genitalia development [GO:0048806]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein polyubiquitination [GO:1902914]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001093; GO:0001228; GO:0001837; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0009887; GO:0030198; GO:0032434; GO:0042249; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048566; GO:0048596; GO:0048806; GO:0060021; GO:0140296; GO:1902914 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; TFIIB-class transcription factor binding [GO:0001093]" GAYQGWKNSVR 0.97039 -0.78308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUM9 RETST_HUMAN "All-trans-retinol 13,14-reductase, EC 1.3.99.23 (All-trans-13,14-dihydroretinol saturase, RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)" RETSAT PPSIG UNQ439/PRO872 Homo sapiens (Human) retinol metabolic process [GO:0042572] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640] "endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; all-trans-retinol 13,14-reductase activity [GO:0051786]; oxidoreductase activity [GO:0016491]; retinol metabolic process [GO:0042572]" GO:0005640; GO:0005789; GO:0016020; GO:0016491; GO:0031965; GO:0042572; GO:0051786 "all-trans-retinol 13,14-reductase activity [GO:0051786]; oxidoreductase activity [GO:0016491]" LVKVVSSGAPHAILLKFLPLPVVQLLDR 0.97039 4.3073 11.777 0 0 0 0 0 0 0 0 0 0 0 13.9097 0 11.8216 0 0 13.2251 0 13.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5344 14.2057 14.8947 14.1962 13.7164 12.0409 0 13.7915 0 0 12.9477 0 0 0 0 0 0 0 0 0 0 12.7597 14.2098 13.1919 11.5897 0 0 0 0 0 0 0 0 12.9092 0 0 0 0 11.5083 11.9119 0 0 0 12.0367 12.6067 0 12.5769 0 0 0 0 0 0 0 13.4301 12.4018 0 13.7087 0 11.2193 0 0 0 12.7798 0 0 0 0 0 0 0 12.6755 13.9421 0 0 0 13.5927 12.3544 0 0 14.1724 0 0 0 10.0258 0 0 0 0 0 0 0 0 0 0 0 12.8124 0 0 0 12.1697 0 0 12.304 0 0 0 0 0 0 0 0 14.5033 Q6ZMC9 SIG15_HUMAN "Sialic acid-binding Ig-like lectin 15, Siglec-15 (CD33 antigen-like 3)" SIGLEC15 CD33L3 Homo sapiens (Human) regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of osteoclast development [GO:2001204] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of osteoclast development [GO:2001204] GO:0005886; GO:0016021; GO:0032956; GO:0032991; GO:0045124; GO:2001204 ALLLLGVLAARAARR 0.9704 3.2018 0 0 0 0 0 0 0 0 0 0 0 0 14.8926 0 0 0 0 11.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0342 15.7001 0 0 16.3473 0 0 0 15.1164 0 0 0 0 0 14.9704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1017 0 0 0 0 0 0 13.7043 12.0971 0 0 0 0 0 0 0 0 0 0 0 12.9352 0 13.0994 15.0162 0 13.3689 13.418 0 14.6423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6575 0 0 0 0 0 0 0 0 12.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2816 13.9528 0 0 13.2554 0 0 0 0 0 0 0 0 0 0 0 13.5764 0 0 0 0 0 0 0 0 0 0 0 12.7991 0 12.6953 0 P40429 RL13A_HUMAN 60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13) RPL13A Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cytoplasmic translation [GO:0002181]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interferon-gamma [GO:0071346]; cytoplasmic translation [GO:0002181]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0015934; GO:0016020; GO:0017148; GO:0022625; GO:0022626; GO:0071346; GO:0097452; GO:1901194; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AEVQVLVLDGRGHLLGRLAAIVAK 0.97042 -0.74507 0 0 0 0 0 0 0 0 0 0 0 13.3045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9939 0 13.9649 0 0 0 0 0 0 0 0 13.3946 0 12.2808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9414 0 14.1369 0 13.2451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5522 0 13.0226 0 0 13.2061 0 0 14.3647 0 0 13.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5981 13.6633 13.6987 0 0 13.6071 13.3922 13.787 0 13.7896 13.1097 0 0 0 0 0 0 0 13.6884 0 0 12.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6177 13.7027 0 13.6603 0 0 0 0 0 0 Q9BSK4 FEM1A_HUMAN "Protein fem-1 homolog A, FEM1a (FEM1-alpha) (Prostaglandin E receptor 4-associated protein)" FEM1A EPRAP Homo sapiens (Human) negative regulation of inflammatory response [GO:0050728]; positive regulation of inflammatory response [GO:0050729]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ubiquitin ligase complex [GO:0000151] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ubiquitin ligase complex [GO:0000151]; EP4 subtype prostaglandin E2 receptor binding [GO:0031867]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; negative regulation of inflammatory response [GO:0050728]; positive regulation of inflammatory response [GO:0050729]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-protein transferase activity [GO:0051438]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0000151; GO:0005739; GO:0005829; GO:0006511; GO:0016567; GO:0031462; GO:0031867; GO:0050728; GO:0050729; GO:0051438; GO:0140627; GO:1990756 EP4 subtype prostaglandin E2 receptor binding [GO:0031867]; ubiquitin ligase-substrate adaptor activity [GO:1990756] ALAIILHLLYLLEKVECTPSQEHLKHQTVYR 0.97042 -0.71514 0 0 0 0 0 0 0 0 0 0 17.2901 17.2418 0 0 0 0 0 11.4669 0 10.8567 0 0 11.253 0 0 11.2115 0 0 0 17.6031 0 0 0 17.5878 0 17.6345 17.6114 0 17.612 17.5681 0 0 0 0 0 0 0 17.6039 12.164 0 0 0 11.5291 0 13.423 13.3117 17.9099 18.9088 0 0 0 0 0 17.2332 10.8808 17.3447 0 0 0 0 0 0 0 0 13.47 0 0 0 0 0 15.5422 0 11.8564 0 0 0 0 12.6026 0 13.25 13.3231 12.7663 0 13.3347 14.0909 14.8778 0 13.5324 0 12.9748 0 10.9812 0 0 0 0 13.8004 0 0 0 0 15.2371 0 13.5386 13.3829 13.2044 0 0 0 0 13.5873 0 0 0 0 12.9394 0 0 0 0 0 0 0 13.7259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.763 0 13.9249 19.4386 19.5091 0 19.4808 19.5035 19.4763 19.5462 13.9626 13.7073 19.4737 0 13.7806 0 13.5937 11.8969 0 0 0 0 0 0 Q6AI12 ANR40_HUMAN Ankyrin repeat domain-containing protein 40 ANKRD40 Homo sapiens (Human) EIRKIMGVEEEDDDDDDDDNLPQLK 0.97043 -0.5679 0 15.9356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5978 0 0 11.4275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.146 0 0 13.9411 0 0 0 0 0 0 0 0 0 0 0 13.2328 0 Q8NGJ3 O52E1_HUMAN Olfactory receptor 52E1 OR52E1 OR52E1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LKAFSTCGSHVCVMLTFYMPAFFSFMTHR 0.97044 -0.57101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5023 13.5398 0 14.9063 0 0 0 0 0 0 0 0 0 0 0 0 12.1789 0 0 0 0 0 0 0 0 14.0441 0 0 0 0 0 0 0 13.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6137 0 13.8288 12.8438 0 0 0 0 0 0 0 0 0 0 13.8832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.335 0 14.5787 0 Q6UXX9 RSPO2_HUMAN "R-spondin-2 (Roof plate-specific spondin-2, hRspo2)" RSPO2 UNQ9384/PRO34209 Homo sapiens (Human) bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; dopaminergic neuron differentiation [GO:0071542]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; limb development [GO:0060173]; lung growth [GO:0060437]; negative regulation of odontogenesis of dentin-containing tooth [GO:0042489]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; trachea cartilage morphogenesis [GO:0060535] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; dopaminergic neuron differentiation [GO:0071542]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; limb development [GO:0060173]; lung growth [GO:0060437]; negative regulation of odontogenesis of dentin-containing tooth [GO:0042489]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; trachea cartilage morphogenesis [GO:0060535] GO:0001649; GO:0005102; GO:0005576; GO:0008201; GO:0009986; GO:0030177; GO:0030282; GO:0035115; GO:0035116; GO:0042489; GO:0060070; GO:0060173; GO:0060437; GO:0060441; GO:0060535; GO:0071542; GO:0090263 heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] CRIENCDSCFSK 0.97045 -0.79698 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.33351 0 0 0 10.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1693 10.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.199 0 0 0 0 11.0041 0 0 0 0 0 0 0 0 0 0 11.3235 0 0 0 0 0 13.4524 0 0 0 0 11.4543 0 0 0 11.2596 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6668 11.4576 11.0298 0 12.0297 0 0 0 0 11.1617 0 0 0 0 0 12.6603 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AE4 FUBP1_HUMAN "Far upstream element-binding protein 1, FBP, FUSE-binding protein 1 (DNA helicase V, hDH V)" FUBP1 Homo sapiens (Human) positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468] GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0010628 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] DALQRARQIAAK 0.97045 -0.79645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RUT3 TMM89_HUMAN Transmembrane protein 89 TMEM89 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 GTSTQSG 0.97046 -1.0794 0 0 0 0 0 0 0 0 0 0 10.4497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4023 0 13.5572 0 0 0 0 0 11.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9645 0 0 0 12.6655 0 0 14.0233 11.2993 0 0 0 0 0 0 0 0 0 0 16.5519 P43320 CRBB2_HUMAN Beta-crystallin B2 (Beta-B2 crystallin) (Beta-crystallin Bp) CRYBB2 CRYB2 CRYB2A Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; response to stimulus [GO:0050896]; visual perception [GO:0007601] identical protein binding [GO:0042802]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; lens development in camera-type eye [GO:0002088]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0002088; GO:0005198; GO:0005212; GO:0007601; GO:0042802; GO:0050896 identical protein binding [GO:0042802]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198] GAFHPSN 0.97046 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1215 0 0 0 0 13.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2879 0 0 0 0 0 0 13.1718 0 15.0654 0 0 0 0 0 0 0 0 13.8611 0 0 0 13.1432 Q86VZ5 SMS1_HUMAN "Phosphatidylcholine:ceramide cholinephosphotransferase 1, EC 2.7.8.27 (Medulla oblongata-derived protein, Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23)" SGMS1 MOB SMS1 TMEM23 Homo sapiens (Human) apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; phosphorylation [GO:0016310]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; phosphorylation [GO:0016310]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] GO:0000138; GO:0000139; GO:0002950; GO:0005634; GO:0005783; GO:0005886; GO:0005887; GO:0006686; GO:0006915; GO:0016020; GO:0016301; GO:0016310; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:2001242 ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188] FFCIVGTLYLYR 0.97046 -0.79883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.49023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6566 0 0 0 0 0 0 0 0 0 0 0 0 16.4171 0 0 0 0 13.3092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43320 FGF16_HUMAN "Fibroblast growth factor 16, FGF-16" FGF16 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to temperature stimulus [GO:0009266]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to temperature stimulus [GO:0009266]; signal transduction [GO:0007165] GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008284; GO:0008543; GO:0009266; GO:0009887; GO:0010628; GO:0030154; GO:0030334; GO:2000546 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] LGQIEGK 0.97047 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2421 0 0 0 0 0 0 0 0 Q96L33 RHOV_HUMAN "Rho-related GTP-binding protein RhoV (CDC42-like GTPase 2) (GTP-binding protein-like 2) (Rho GTPase-like protein ARHV) (Wnt-1 responsive Cdc42 homolog 2, WRCH-2)" RHOV ARHV WRCH2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163] endosome membrane [GO:0010008]; plasma membrane [GO:0005886] endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; Cdc42 protein signal transduction [GO:0032488]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163] GO:0003924; GO:0005525; GO:0005886; GO:0006897; GO:0007163; GO:0010008; GO:0030036; GO:0032488; GO:0046872 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] ACCYLECSALTQK 0.97047 -0.8 0 0 0 0 0 0 0 0 0 13.5276 15.5436 0 15.9317 0 0 0 0 0 0 0 0 0 0 11.7664 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4295 0 0 11.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6053 14.2335 0 0 0 0 0 15.5117 0 0 0 0 0 17.0456 0 0 17.4015 0 0 0 15.5951 0 0 0 0 13.5356 0 0 0 0 0 0 0 0 0 0 0 13.8723 0 13.1682 14.1164 15.1003 0 0 0 10.4937 0 0 0 0 0 17.6632 0 16.2122 0 0 13.2875 0 0 0 0 0 0 0 0 14.7763 0 0 0 0 0 0 Q0Z7S8 FABP9_HUMAN "Fatty acid-binding protein 9 (Testis lipid-binding protein, TLBP) (Testis-type fatty acid-binding protein, T-FABP)" FABP9 Homo sapiens (Human) acrosome assembly [GO:0001675]; fatty acid transport [GO:0015908] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; acrosome assembly [GO:0001675]; fatty acid transport [GO:0015908] GO:0001669; GO:0001675; GO:0005504; GO:0005634; GO:0005829; GO:0015908 fatty acid binding [GO:0005504] IVDEKMVVECK 0.97048 -0.80158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2C8 MED27_HUMAN "Mediator of RNA polymerase II transcription subunit 27 (Cofactor required for Sp1 transcriptional activation subunit 8, CRSP complex subunit 8) (Mediator complex subunit 27) (P37 TRAP/SMCC/PC2 subunit) (Transcriptional coactivator CRSP34)" MED27 CRSP34 CRSP8 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367] core mediator complex [GO:0070847]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151] core mediator complex [GO:0070847]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0006357; GO:0006367; GO:0016592; GO:0032968; GO:0035019; GO:0051123; GO:0060261; GO:0061630; GO:0070847 transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630] VLKVIVVMR 0.97048 -0.68014 0 0 0 0 0 0 0 0 0 0 0 0 17.9411 11.9494 10.864 17.7205 17.5895 15.9534 0 0 0 0 0 0 0 0 18.1841 17.8774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7673 0 17.7333 17.7989 0 0 0 17.8452 17.7225 0 0 17.7289 17.6475 0 10.0406 0 0 0 0 0 0 0 0 0 0 0 0 18.3329 0 0 18.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9017 18.4626 0 18.9185 18.5817 0 0 0 0 19.6246 0 11.7856 0 0 0 0 0 0 18.3439 0 18.2166 0 0 0 0 18.7319 0 0 13.354 0 0 0 18.6888 0 18.6588 0 0 0 12.8646 12.1396 0 0 0 0 0 0 18.6038 0 0 0 18.4419 18.5381 18.5865 18.6601 0 0 18.5225 0 18.7191 18.731 18.7333 0 0 0 0 0 0 13.0468 0 0 0 0 11.895 0 0 0 0 12.2056 0 0 0 0 0 0 0 18.5641 0 0 0 0 0 P80297 MT1X_HUMAN "Metallothionein-1X, MT-1X (Metallothionein-IX, MT-IX)" MT1X Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to erythropoietin [GO:0036018]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926]; response to metal ion [GO:0010038] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to erythropoietin [GO:0036018]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273]; negative regulation of growth [GO:0045926]; response to metal ion [GO:0010038] GO:0005634; GO:0005737; GO:0006882; GO:0008270; GO:0010038; GO:0010273; GO:0036018; GO:0045926; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872]; zinc ion binding [GO:0008270] CAQGCICKGTSDKCSCCA 0.97049 4.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7896 0 0 0 0 0 0 13.5699 13.8822 10.8849 0 0 11.867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2037 0 11.2367 0 11.4229 0 12.9059 12.5954 0 0 0 11.8017 0 11.6284 0 0 14.1925 0 0 0 11.8213 0 0 0 0 14.6532 0 0 0 0 0 0 13.9281 0 0 12.098 0 0 0 0 0 11.0889 0 0 0 0 0 12.5062 0 0 0 0 0 0 0 0 11.5613 10.272 0 0 10.2471 0 0 0 0 0 0 0 0 11.6124 11.2072 0 0 0 0 0 10.0267 14.6737 0 0 0 14.0586 0 14.0435 0 0 0 0 9.9928 0 0 0 12.3432 12.7138 14.7939 0 0 0 0 0 P49116 NR2C2_HUMAN Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4) NR2C2 TAK1 TR4 Homo sapiens (Human) "anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of embryonic development [GO:0040019]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0007399; GO:0008270; GO:0030154; GO:0040019; GO:0043565; GO:0045944; GO:0048856; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" ILVRLPALR 0.9705 -0.5291 0 0 0 0 0 0 0 0 11.7983 14.5058 14.0525 13.3355 14.9336 13.4264 13.6043 0 0 13.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7792 14.7697 13.8389 12.6514 13.1722 13.8542 0 0 0 14.074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4355 12.1587 0 0 0 0 0 12.9273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7363 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5158 0 0 0 0 0 0 0 0 0 13.1597 13.0364 0 13.6033 15.7249 15.3333 0 15.6392 0 15.6873 12.8234 12.5688 13.7167 14.5172 0 0 0 0 0 0 12.1694 0 0 Q96H22 CENPN_HUMAN "Centromere protein N, CENP-N (Interphase centromere complex protein 32)" CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382] GO:0000776; GO:0005654; GO:0005829; GO:0007059; GO:0051382 ERVQRITQETFGDYPQPQLEFAQYK 0.97052 -0.48205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3128 0 0 0 0 0 0 0 0 11.5604 0 11.3866 0 0 0 0 0 12.3506 0 0 0 0 0 0 0 0 0 0 0 13.5655 0 0 0 0 0 0 0 0 0 0 13.2978 0 0 0 0 0 0 0 10.6676 0 0 0 12.484 0 0 0 0 0 0 0 0 11.0908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.494 0 0 13.0229 0 0 0 0 0 0 0 0 Q8NCL9 APCDL_HUMAN Protein APCDD1-like (Adenomatosis polyposis coli down-regulated 1 protein-like) APCDD1L Homo sapiens (Human) negative regulation of Wnt signaling pathway [GO:0030178] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt-protein binding [GO:0017147]; negative regulation of Wnt signaling pathway [GO:0030178] GO:0005886; GO:0016021; GO:0017147; GO:0030178 Wnt-protein binding [GO:0017147] AHQFYYEDPFCGEPAHSLLVKGKVR 0.97053 -0.48389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW59 SPRY4_HUMAN SPRY domain-containing protein 4 SPRYD4 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 MALLFARSLR 0.97053 -0.70971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UII2 ATIF1_HUMAN "ATPase inhibitor, mitochondrial (ATP synthase F1 subunit epsilon) (Inhibitor of F(1)F(o)-ATPase, IF(1), IF1)" ATP5IF1 ATPI ATPIF1 Homo sapiens (Human) angiogenesis [GO:0001525]; erythrocyte differentiation [GO:0030218]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; mitochondrial depolarization [GO:0051882]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of hydrolase activity [GO:0051346]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; reactive oxygen species metabolic process [GO:0072593]; regulation of ATP metabolic process [GO:1903578]; regulation of protein targeting to mitochondrion [GO:1903214] cell surface [GO:0009986]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] cell surface [GO:0009986]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; angiostatin binding [GO:0043532]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mitochondrial proton-transporting ATP synthase complex binding [GO:0140260]; protein homodimerization activity [GO:0042803]; angiogenesis [GO:0001525]; erythrocyte differentiation [GO:0030218]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; mitochondrial depolarization [GO:0051882]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of hydrolase activity [GO:0051346]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; reactive oxygen species metabolic process [GO:0072593]; regulation of ATP metabolic process [GO:1903578]; regulation of protein targeting to mitochondrion [GO:1903214] GO:0001525; GO:0001937; GO:0004857; GO:0005516; GO:0005739; GO:0006091; GO:0006783; GO:0009986; GO:0019899; GO:0030218; GO:0032780; GO:0032991; GO:0042030; GO:0042802; GO:0042803; GO:0043532; GO:0051117; GO:0051346; GO:0051882; GO:0072593; GO:0140260; GO:1901030; GO:1903052; GO:1903214; GO:1903578; GO:1904925 angiostatin binding [GO:0043532]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mitochondrial proton-transporting ATP synthase complex binding [GO:0140260]; protein homodimerization activity [GO:0042803] KHHEEEIVHHKK 0.97053 -0.4854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9843 0 0 0 0 0 0 0 0 0 0 0 15.0345 14.8217 0 0 0 0 0 0 0 0 0 0 Q00534 CDK6_HUMAN "Cyclin-dependent kinase 6, EC 2.7.11.22 (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)" CDK6 CDKN6 Homo sapiens (Human) astrocyte development [GO:0014002]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323] centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726] centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; astrocyte development [GO:0014002]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323] GO:0000082; GO:0000122; GO:0000307; GO:0001726; GO:0001954; GO:0003323; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007219; GO:0008285; GO:0008353; GO:0009615; GO:0010468; GO:0010628; GO:0014002; GO:0016592; GO:0021542; GO:0021670; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045596; GO:0045638; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0048699; GO:0050680; GO:0051301; GO:0051726; GO:0060218; GO:0097132; GO:0098770; GO:0106310; GO:1902036; GO:2000145; GO:2000773 ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] DLLLKCLTFNPAKR 0.97055 -0.71392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8268 0 0 0 0 12.3523 0 13.2462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6Q788 APOA5_HUMAN "Apolipoprotein A-V, Apo-AV, ApoA-V (Apolipoprotein A5) (Regeneration-associated protein 3)" APOA5 RAP3 UNQ411/PRO773 Homo sapiens (Human) acylglycerol homeostasis [GO:0055090]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of triglyceride catabolic process [GO:0010898]; positive regulation of very-low-density lipoprotein particle remodeling [GO:0010902]; regulation of intestinal cholesterol absorption [GO:0030300]; tissue regeneration [GO:0042246]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle remodeling [GO:0034372] chylomicron [GO:0042627]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; high-density lipoprotein particle [GO:0034364]; late endosome [GO:0005770]; very-low-density lipoprotein particle [GO:0034361] chylomicron [GO:0042627]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; high-density lipoprotein particle [GO:0034364]; late endosome [GO:0005770]; very-low-density lipoprotein particle [GO:0034361]; cholesterol binding [GO:0015485]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; lipase activator activity [GO:0060229]; lipase binding [GO:0035473]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; acylglycerol homeostasis [GO:0055090]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; high-density lipoprotein particle assembly [GO:0034380]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of triglyceride catabolic process [GO:0010898]; positive regulation of very-low-density lipoprotein particle remodeling [GO:0010902]; regulation of intestinal cholesterol absorption [GO:0030300]; tissue regeneration [GO:0042246]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle remodeling [GO:0034372] GO:0005543; GO:0005576; GO:0005615; GO:0005769; GO:0005770; GO:0005788; GO:0005794; GO:0006641; GO:0006695; GO:0006869; GO:0008047; GO:0008201; GO:0008289; GO:0010873; GO:0010898; GO:0010902; GO:0015485; GO:0019433; GO:0019899; GO:0030300; GO:0031210; GO:0033344; GO:0033700; GO:0034361; GO:0034364; GO:0034372; GO:0034380; GO:0035473; GO:0042157; GO:0042246; GO:0042627; GO:0042632; GO:0045723; GO:0046470; GO:0046889; GO:0048260; GO:0050750; GO:0050996; GO:0051006; GO:0055090; GO:0060228; GO:0060229; GO:0060230; GO:0070325; GO:0070328 cholesterol binding [GO:0015485]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; lipase activator activity [GO:0060229]; lipase binding [GO:0035473]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543] GFWDYFSQTSGDK 0.97055 -0.71445 0 0 0 0 0 0 0 0 0 11.1905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4621 0 15.3198 0 0 0 14.8735 0 0 0 14.8827 14.7697 14.7649 14.7325 0 14.8526 0 0 14.6992 14.1238 0 0 14.1832 0 14.9663 14.2235 14.6001 14.0919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2331 14.3785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVM7 TM1L2_HUMAN TOM1-like protein 2 (Target of Myb-like protein 2) TOM1L2 Homo sapiens (Human) negative regulation of mitotic nuclear division [GO:0045839]; protein transport [GO:0015031]; signal transduction [GO:0007165] endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020] endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; negative regulation of mitotic nuclear division [GO:0045839]; protein transport [GO:0015031]; signal transduction [GO:0007165] GO:0005768; GO:0007165; GO:0015031; GO:0016020; GO:0019901; GO:0030276; GO:0035091; GO:0043130; GO:0045839; GO:0070062 clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130] KTVTYEDPQAVGGLASALDNRK 0.97056 -0.56972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75879 GATB_HUMAN "Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial, Glu-AdT subunit B, EC 6.3.5.- (Cytochrome c oxidase assembly factor PET112 homolog)" GATB PET112 PET112L HSPC199 Homo sapiens (Human) glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739] glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543] GO:0005524; GO:0005739; GO:0030956; GO:0032543; GO:0050567; GO:0070681 ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567] ADPVMIKEILEK 0.97057 -0.57098 0 0 0 0 0 0 0 0 13.2854 13.0373 0 14.1622 0 0 13.0389 14.1695 13.5468 0 0 0 0 0 0 0 0 0 0 12.579 0 0 13.9266 13.6636 14.3294 0 13.3305 0 0 13.6711 13.4844 13.4277 13.7092 0 0 0 0 0 14.033 12.5994 0 0 13.8586 10.0091 13.3291 12.7126 0 13.6199 0 13.3563 0 0 12.0028 11.9645 0 13.2722 13.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3167 0 0 13.361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8843 0 0 0 0 0 0 0 15.013 0 0 15.4588 15.984 0 0 0 0 0 16.037 0 0 0 0 Q6ZTU2 E400N_HUMAN Putative EP400-like protein (EP400 pseudogene 1) EP400P1 EP400NL Homo sapiens (Human) DNA repair [GO:0006281]; histone H4 acetylation [GO:0043967] NuA4 histone acetyltransferase complex [GO:0035267]; Swr1 complex [GO:0000812] NuA4 histone acetyltransferase complex [GO:0035267]; Swr1 complex [GO:0000812]; chromatin binding [GO:0003682]; DNA repair [GO:0006281]; histone H4 acetylation [GO:0043967] GO:0000812; GO:0003682; GO:0006281; GO:0035267; GO:0043967 chromatin binding [GO:0003682] MEASKRQ 0.97057 -0.47982 0 0 0 0 0 0 0 0 12.8317 0 0 12.6578 0 11.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8969 0 0 12.3733 0 0 0 12.481 11.8101 0 0 0 0 0 0 11.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3141 0 0 0 0 0 0 0 0 0 12.7929 0 0 0 0 0 0 0 0 Q9BRY0 S39A3_HUMAN "Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3, ZIP-3)" SLC39A3 ZIP3 Homo sapiens (Human) cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577] GO:0000902; GO:0001701; GO:0005385; GO:0005886; GO:0016020; GO:0016021; GO:0043029; GO:0048701; GO:0060173; GO:0071577 zinc ion transmembrane transporter activity [GO:0005385] ASPVRLLSLAFALSAHSVFEGLALGLQEEGEK 0.97057 -0.71867 0 13.1232 0 12.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.941 0 0 0 0 0 0 14.5 14.535 14.8046 15.1137 0 0 0 0 14.32 0 0 0 0 0 14.0244 13.6565 13.7228 13.6664 0 0 0 0 0 0 0 15.5069 0 13.6428 0 0 0 0 13.1999 0 15.42 15.4526 0 0 16.482 0 0 0 0 15.3613 15.6686 15.6304 13.4822 0 0 0 0 0 13.128 15.2222 0 0 0 15.4163 15.5758 0 15.6654 0 15.5265 0 15.4285 15.6669 0 15.1809 12.503 0 15.5231 15.0189 0 0 0 14.4144 0 0 0 11.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4073 0 0 0 11.0031 0 Q9P2W1 HOP2_HUMAN "Homologous-pairing protein 2 homolog (Nuclear receptor coactivator GT198) (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein) (Tat-binding protein 1-interacting protein, TBP-1-interacting protein)" PSMC3IP HOP2 TBPIP Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic joint molecule formation [GO:0000709]; meiotic strand invasion involved in reciprocal meiotic recombination [GO:0010774]; reciprocal meiotic recombination [GO:0007131] condensed nuclear chromosome [GO:0000794]; DNA recombinase auxiliary factor complex [GO:0120231]; nucleoplasm [GO:0005654] condensed nuclear chromosome [GO:0000794]; DNA recombinase auxiliary factor complex [GO:0120231]; nucleoplasm [GO:0005654]; double-stranded DNA binding [GO:0003690]; nuclear receptor coactivator activity [GO:0030374]; recombinase activator activity [GO:0120230]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic joint molecule formation [GO:0000709]; meiotic strand invasion involved in reciprocal meiotic recombination [GO:0010774]; reciprocal meiotic recombination [GO:0007131] GO:0000709; GO:0000794; GO:0003690; GO:0005654; GO:0007129; GO:0007131; GO:0010774; GO:0030374; GO:0120230; GO:0120231 double-stranded DNA binding [GO:0003690]; nuclear receptor coactivator activity [GO:0030374]; recombinase activator activity [GO:0120230] YCKEWRK 0.97058 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17643 TYRP1_HUMAN "5,6-dihydroxyindole-2-carboxylic acid oxidase, DHICA oxidase, EC 1.14.18.- (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1, TRP, TRP-1, TRP1)" TYRP1 CAS2 TYRP TYRRP Homo sapiens (Human) acetoacetic acid metabolic process [GO:0043438]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; positive regulation of melanin biosynthetic process [GO:0048023] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; melanosome membrane [GO:0033162] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503]; acetoacetic acid metabolic process [GO:0043438]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome organization [GO:0032438]; positive regulation of melanin biosynthetic process [GO:0048023] GO:0004503; GO:0005737; GO:0010008; GO:0016021; GO:0016491; GO:0030318; GO:0030669; GO:0032438; GO:0033162; GO:0042438; GO:0042470; GO:0042803; GO:0043438; GO:0046872; GO:0048023; GO:0097708 metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tyrosinase activity [GO:0004503] CGSSSGRGRCEAVTADSR 0.97059 4.2983 0 0 0 0 0 0 0 0 15.1248 0 14.5201 12.7812 15.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0496 0 12.5041 0 0 0 0 0 12.8781 0 0 0 0 0 0 13.098 0 0 0 0 0 0 12.531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7909 0 0 11.6173 11.2777 0 0 12.0947 0 0 0 13.9421 0 13.7341 0 0 0 11.9107 0 10.2782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7661 0 0 0 0 0 0 0 9.5955 0 0 12.1643 13.6684 9.67737 13.9869 0 13.6877 0 0 0 13.2005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8706 0 0 12.5424 0 0 P59942 MCCD1_HUMAN Mitochondrial coiled-coil domain protein 1 MCCD1 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 HQESLGGGA 0.97059 -0.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6H9L7 ISM2_HUMAN Isthmin-2 (Thrombospondin and AMOP domain-containing isthmin-like protein 1) (Thrombospondin type-1 domain-containing protein 3) ISM2 TAIL1 THSD3 PSEC0137 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 ACTDNPLEEEYLAQLQEAKEY 0.97059 3.0005 0 14.3199 0 0 0 0 0 0 0 0 0 0 0 14.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6319 0 13.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6995 0 11.878 0 0 0 0 0 0 13.2588 0 0 0 12.8107 12.073 0 0 0 0 0 0 0 0 0 0 10.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0657 0 0 0 0 0 0 10.9507 12.3858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBH0 RHOF_HUMAN Rho-related GTP-binding protein RhoF (Rho family GTPase Rif) (Rho in filopodia) RHOF ARHF RIF Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005085; GO:0005525; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030667; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0051056; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901] RRLCLLL 0.9706 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6087 13.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2571 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1409 0 0 0 0 0 0 0 0 0 13.5258 0 0 0 13.8129 0 13.3933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWS0 PIHD1_HUMAN PIH1 domain-containing protein 1 (Nucleolar protein 17 homolog) PIH1D1 NOP17 Homo sapiens (Human) box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; epithelial cell differentiation [GO:0030855]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of histone H3-K9 dimethylation [GO:1900110]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; protein stabilization [GO:0050821]; regulation of histone H3-K4 methylation [GO:0051569]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]; TORC1 complex assembly [GO:1905669] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; ATPase binding [GO:0051117]; histone binding [GO:0042393]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; epithelial cell differentiation [GO:0030855]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of histone H3-K9 dimethylation [GO:1900110]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; protein stabilization [GO:0050821]; regulation of histone H3-K4 methylation [GO:0051569]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]; TORC1 complex assembly [GO:1905669] GO:0000492; GO:0001164; GO:0005634; GO:0005730; GO:0005737; GO:0006338; GO:0006364; GO:0019901; GO:0030855; GO:0031334; GO:0042393; GO:0048254; GO:0050821; GO:0051117; GO:0051219; GO:0051569; GO:0070761; GO:0071169; GO:0071902; GO:0090240; GO:0097255; GO:1900110; GO:1900113; GO:1901838; GO:1902661; GO:1904263; GO:1905669; GO:1990062; GO:1990904; GO:2000617; GO:2000619; GO:2001268 ATPase binding [GO:0051117]; histone binding [GO:0042393]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164] AAFHRKR 0.9706 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GVR7 F240C_HUMAN Protein FAM240C FAM240C Homo sapiens (Human) SLTLKNPGR 0.97061 -0.68014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28482 MK01_HUMAN "Mitogen-activated protein kinase 1, MAP kinase 1, MAPK 1, EC 2.7.11.24 (ERT1) (Extracellular signal-regulated kinase 2, ERK-2) (MAP kinase isoform p42, p42-MAPK) (Mitogen-activated protein kinase 2, MAP kinase 2, MAPK 2)" MAPK1 ERK2 PRKM1 PRKM2 Homo sapiens (Human) apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440] azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202] azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440] GO:0001784; GO:0003677; GO:0004674; GO:0004707; GO:0004708; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005788; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006468; GO:0006915; GO:0006935; GO:0006974; GO:0007049; GO:0007165; GO:0007166; GO:0007268; GO:0007611; GO:0008353; GO:0010628; GO:0010759; GO:0010800; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032212; GO:0032872; GO:0033598; GO:0034198; GO:0034614; GO:0035094; GO:0035556; GO:0035578; GO:0038127; GO:0042473; GO:0042802; GO:0043330; GO:0045202; GO:0045596; GO:0048538; GO:0050852; GO:0050853; GO:0051403; GO:0051493; GO:0051973; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0070371; GO:0070849; GO:0071276; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0106310; GO:0120041; GO:1903351; GO:1904355; GO:1904813; GO:2000641 ATP binding [GO:0005524]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] FDMELDDLPKEKLK 0.97062 -0.47994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.733 0 13.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8846 10.36 0 0 0 0 0 0 0 0 0 0 0 12.861 0 0 0 0 0 12.143 0 0 12.7599 0 12.9001 0 0 0 0 0 12.9109 10.0565 0 0 0 11.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6618 12.7789 13.0933 0 0 0 0 12.4141 0 0 0 0 0 0 0 0 0 0 0 P59542 T2R19_HUMAN "Taste receptor type 2 member 19 (Taste receptor type 2 member 23) (Taste receptor type 2 member 48, T2R48)" TAS2R19 TAS2R23 TAS2R48 Homo sapiens (Human) sensory perception of taste [GO:0050909] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of taste [GO:0050909] GO:0004930; GO:0005886; GO:0016021; GO:0050909 G protein-coupled receptor activity [GO:0004930] EYEGNVTWKIKLR 0.97062 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0909 0 0 0 0 0 0 0 0 14.7677 0 0 0 0 0 0 0 0 0 0 19.1817 0 0 0 Q12950 FOXD4_HUMAN "Forkhead box protein D4 (Forkhead-related protein FKHL9) (Forkhead-related transcription factor 5, FREAC-5) (Myeloid factor-alpha)" FOXD4 FKHL9 FOXD4A FREAC5 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008301; GO:0009653; GO:0030154; GO:0043565 "DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" IPREPGR 0.97062 -0.77637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5252 0 0 0 15.3405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68D91 MBLC2_HUMAN "Acyl-coenzyme A thioesterase MBLAC2, Acyl-CoA thioesterase MBLAC2, EC 3.1.2.2 (Beta-lactamase MBLAC2, EC 3.5.2.6) (Metallo-beta-lactamase domain-containing protein 2) (Palmitoyl-coenzyme A thioesterase MBLAC2)" MBLAC2 Homo sapiens (Human) fatty acid metabolic process [GO:0006631] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; metal ion binding [GO:0046872]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; fatty acid metabolic process [GO:0006631] GO:0005789; GO:0005886; GO:0006631; GO:0008800; GO:0016290; GO:0046872; GO:0070062; GO:0102991 beta-lactamase activity [GO:0008800]; metal ion binding [GO:0046872]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] EAKEDAARR 0.97062 -0.73143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1978 0 15.4232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4673 0 0 15.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8976 0 13.9709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0184 0 0 0 15.1341 0 0 0 0 0 0 0 0 Q9H7X3 ZN696_HUMAN Zinc finger protein 696 ZNF696 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFIHSSHVVRHQRAHSGER 0.97063 2.9991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1786 0 0 0 0 0 0 0 10.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL19 PLAT4_HUMAN "Phospholipase A and acyltransferase 4, EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4 (HRAS-like suppressor 4, HRSL4) (RAR-responsive protein TIG3) (Retinoic acid receptor responder protein 3) (Retinoid-inducible gene 1 protein) (Tazarotene-induced gene 3 protein)" PLAAT4 RARRES3 RIG1 TIG3 Homo sapiens (Human) lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phospholipid metabolic process [GO:0006644]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO:0150074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acyltransferase activity [GO:0016746]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; lipid catabolic process [GO:0016042]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phospholipid metabolic process [GO:0006644]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO:0150074] GO:0004623; GO:0005737; GO:0005829; GO:0006644; GO:0008285; GO:0008970; GO:0016020; GO:0016021; GO:0016042; GO:0016410; GO:0016746; GO:0036152; GO:0045618; GO:0052739; GO:0052740; GO:0070292; GO:0150074 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; acyltransferase activity [GO:0016746]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] ERLEDVVGGCCYR 0.97063 -0.52901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NR8 RDH12_HUMAN "Retinol dehydrogenase 12, EC 1.1.1.300 (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2)" RDH12 SDR7C2 Homo sapiens (Human) cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342] endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095 11-cis-retinol dehydrogenase activity [GO:0102354]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650] LANVLFTRELAKR 0.97064 -0.48078 0 0 0 0 0 0 0 13.4944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6517 0 0 0 0 0 0 0 0 0 Q9NUQ8 ABCF3_HUMAN ATP-binding cassette sub-family F member 3 ABCF3 Homo sapiens (Human) defense response to virus [GO:0051607] membrane [GO:0016020] membrane [GO:0016020]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; defense response to virus [GO:0051607] GO:0005524; GO:0016020; GO:0045296; GO:0051607 ATP binding [GO:0005524]; cadherin binding [GO:0045296] LALARALFAR 0.97065 -0.48146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0654 0 0 0 0 0 0 0 0 11.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.59677 0 0 0 0 0 0 14.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7879 0 0 0 0 0 0 0 0 0 0 0 11.9421 0 0 13.0345 0 0 0 14.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5V9 STEEP_HUMAN "STING ER exit protein, STEEP" STEEP1 CXorf56 Homo sapiens (Human) endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888] cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cell body [GO:0044297]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888] GO:0005634; GO:0005737; GO:0006888; GO:0044297; GO:0090158 DMGKFSSVTVSTIDEEEEEIEAR 0.97066 -0.70957 0 0 0 0 0 0 0 0 0 12.8324 12.7811 13.6451 0 12.1646 13.3622 0 0 12.3028 0 0 0 0 0 0 0 0 0 12.6835 0 0 13.8284 12.6904 0 13.3953 0 13.9553 13.6559 13.6401 14.0331 13.9286 13.7133 0 12.5736 13.8549 0 0 12.8946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3426 0 0 0 0 0 0 0 0 0 0 0 0 0 14.201 14.31 0 14.2197 13.3277 0 14.9519 0 13.4836 0 14.0933 0 0 14.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4784 0 14.9099 13.872 0 0 0 0 0 0 0 0 0 0 13.0745 0 0 0 0 P49643 PRI2_HUMAN "DNA primase large subunit (DNA primase 58 kDa subunit, p58)" PRIM2 PRIM2A Homo sapiens (Human) "DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; positive regulation of DNA primase activity [GO:1903934]" alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654] "alpha DNA polymerase:primase complex [GO:0005658]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA/RNA hybrid binding [GO:0071667]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; positive regulation of DNA primase activity [GO:1903934]" GO:0003677; GO:0005654; GO:0005658; GO:0006269; GO:0006270; GO:0046872; GO:0051539; GO:0071667; GO:1903934 "4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA/RNA hybrid binding [GO:0071667]; metal ion binding [GO:0046872]" DIVAIILNEFRAKLSK 0.97067 -0.71289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.444 0 0 0 0 0 0 0 0 11.4931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3633 0 0 0 0 0 0 14.8249 0 0 0 0 0 0 0 0 0 11.4478 0 0 13.8335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7325 0 0 0 12.148 0 0 0 0 0 11.9979 12.4121 12.7172 0 0 0 13.8688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0G2 H1AS1_HUMAN Putative uncharacterized protein H1-10-AS1 (H1-10 antisense RNA 1) (H1FX antisense RNA 1) H1-10-AS1 C3orf47 H1FX-AS1 Homo sapiens (Human) QPGHDPEQDTCSTSPFAMSK 0.97067 -0.71225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.149 0 0 0 0 0 0 0 0 0 0 0 16.5463 Q96Q40 CDK15_HUMAN "Cyclin-dependent kinase 15, EC 2.7.11.22 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein) (Cell division protein kinase 15) (Serine/threonine-protein kinase ALS2CR7) (Serine/threonine-protein kinase PFTAIRE-2)" CDK15 ALS2CR7 PFTK2 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] GO:0000083; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0030332; GO:0046872; GO:0106310 ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GLKHANIVLLHDIIHTK 0.97067 2.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7521 0 0 0 0 0 0 0 0 0 0 0 12.7409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6242 0 0 0 0 0 14.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99551 MTEF1_HUMAN "Transcription termination factor 1, mitochondrial (Mitochondrial transcription termination factor 1, mTERF, mTERF1)" MTERF1 MTERF Homo sapiens (Human) "DNA geometric change [GO:0032392]; DNA-templated transcription, termination [GO:0006353]; regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]" mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; DNA-templated transcription, termination [GO:0006353]; regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]" GO:0003676; GO:0003690; GO:0003723; GO:0005739; GO:0005759; GO:0006353; GO:0006355; GO:0006393; GO:0032392; GO:0042645 double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723] CLCRLLTNAPR 0.97068 4.2905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7844 0 0 13.1078 0 0 0 15.6012 11.8153 13.1686 0 0 0 0 0 0 0 0 0 10.8488 0 0 0 0 0 0 0 12.7279 0 0 0 0 13.4836 11.3615 0 0 0 17.0489 0 0 0 0 0 0 0 0 0 11.7688 13.7807 0 0 0 0 16.1513 0 0 0 0 0 0 0 0 0 0 0 0 14.2796 0 0 0 0 0 0 0 0 0 0 0 0 14.7787 0 0 0 0 0 0 0 0 0 0 17.1557 0 0 0 15.1039 0 0 14.0931 14.8588 17.9328 0 0 0 0 Q92633 LPAR1_HUMAN "Lysophosphatidic acid receptor 1, LPA receptor 1, LPA-1 (Lysophosphatidic acid receptor Edg-2)" LPAR1 EDG2 LPA1 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bleb assembly [GO:0032060]; cell chemotaxis [GO:0060326]; cellular response to 1-oleoyl-sn-glycerol 3-phosphate [GO:1904566]; cellular response to oxygen levels [GO:0071453]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; G protein-coupled receptor signaling pathway [GO:0007186]; myelination [GO:0042552]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; oligodendrocyte development [GO:0014003]; optic nerve development [GO:0021554]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222] cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915]; PDZ domain binding [GO:0030165]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bleb assembly [GO:0032060]; cell chemotaxis [GO:0060326]; cellular response to 1-oleoyl-sn-glycerol 3-phosphate [GO:1904566]; cellular response to oxygen levels [GO:0071453]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; G protein-coupled receptor signaling pathway [GO:0007186]; myelination [GO:0042552]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; oligodendrocyte development [GO:0014003]; optic nerve development [GO:0021554]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of metabolic process [GO:0019222] GO:0001965; GO:0004930; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007193; GO:0007202; GO:0007204; GO:0008360; GO:0009986; GO:0010977; GO:0014003; GO:0019222; GO:0021549; GO:0021554; GO:0022008; GO:0022038; GO:0030165; GO:0032060; GO:0035025; GO:0035727; GO:0042552; GO:0043025; GO:0043065; GO:0043123; GO:0043197; GO:0043198; GO:0043410; GO:0043951; GO:0051482; GO:0051496; GO:0060326; GO:0060999; GO:0070915; GO:0071453; GO:0071673; GO:1904566 G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915]; PDZ domain binding [GO:0030165] LTVSTWLLRQGLIDTSLTASVANLLAIAIERHITVFR 0.97069 -0.67264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.119 0 0 0 11.4816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5422 0 0 0 0 0 0 0 0 14.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHF1 EGFL7_HUMAN "Epidermal growth factor-like protein 7, EGF-like protein 7 (Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7) (NOTCH4-like protein) (Vascular endothelial statin, VE-statin) (Zneu1)" EGFL7 MEGF7 UNQ187/PRO1449 Homo sapiens (Human) anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] GO:0001525; GO:0001568; GO:0001570; GO:0001938; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0007155; GO:0009986; GO:0045746; GO:0048856; GO:0062023 calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102] CRCPAGWR 0.9707 -0.7169 0 0 0 0 0 0 0 0 0 0 0 0 11.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5974 0 0 0 0 0 13.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79216 0 0 0 0 0 0 0 0 0 0 11.2343 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y617 SERC_HUMAN "Phosphoserine aminotransferase, EC 2.6.1.52 (Phosphohydroxythreonine aminotransferase, PSAT)" PSAT1 PSA Homo sapiens (Human) L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615] GO:0004648; GO:0005737; GO:0005829; GO:0006564; GO:0008615; GO:0030170; GO:0042802; GO:0070062 identical protein binding [GO:0042802]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; pyridoxal phosphate binding [GO:0030170] ALELNMLSLKGHR 0.9707 -0.57091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43482 MS18B_HUMAN "Protein Mis18-beta (Cancer/testis antigen 86, CT86) (Opa-interacting protein 5, OIP-5)" OIP5 MIS18B Homo sapiens (Human) cell communication [GO:0007154]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059] "Cajal body [GO:0015030]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "Cajal body [GO:0015030]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]" GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0007049; GO:0007059; GO:0007154; GO:0010369; GO:0015030; GO:0016607; GO:0034080; GO:0042802; GO:0043231; GO:0046872; GO:0051301 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] AAQPLRHRSR 0.97072 -0.49703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9062 0 0 0 0 12.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19397 CD53_HUMAN "Leukocyte surface antigen CD53 (Cell surface glycoprotein CD53) (Tetraspanin-25, Tspan-25) (CD antigen CD53)" CD53 MOX44 TSPAN25 Homo sapiens (Human) positive regulation of myoblast fusion [GO:1901741]; signal transduction [GO:0007165] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; identical protein binding [GO:0042802]; positive regulation of myoblast fusion [GO:1901741]; signal transduction [GO:0007165] GO:0001772; GO:0005886; GO:0005887; GO:0005911; GO:0007165; GO:0009986; GO:0035579; GO:0042802; GO:0070062; GO:0070821; GO:1901741 identical protein binding [GO:0042802] TSQTIGL 0.97072 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8128 Q5W188 CST9P_HUMAN Putative cystatin-9-like protein CST9LP1 (Cystatin-9-like pseudogene 1) CST9LP1 Homo sapiens (Human) antimicrobial humoral response [GO:0019730] extracellular space [GO:0005615] extracellular space [GO:0005615]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; antimicrobial humoral response [GO:0019730] GO:0004869; GO:0005615; GO:0019730 cysteine-type endopeptidase inhibitor activity [GO:0004869] TCSGGHS 0.97072 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5028 0 0 0 0 0 0 0 0 0 0 0 14.0556 0 0 0 0 0 0 0 0 0 14.6668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06520 ST2A1_HUMAN "Sulfotransferase 2A1, ST2A1, EC 2.8.2.2 (Bile salt sulfotransferase, EC 2.8.2.14) (Dehydroepiandrosterone sulfotransferase, DHEA-ST, DHEA-ST8) (Hydroxysteroid Sulfotransferase, HST) (ST2) (SULT2A3)" SULT2A1 HST STD Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; bile acid catabolic process [GO:0030573]; cholesterol metabolic process [GO:0008203]; ethanol catabolic process [GO:0006068]; lipid catabolic process [GO:0016042]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; alcohol sulfotransferase activity [GO:0004027]; bile-salt sulfotransferase activity [GO:0047704]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; bile acid catabolic process [GO:0030573]; cholesterol metabolic process [GO:0008203]; ethanol catabolic process [GO:0006068]; lipid catabolic process [GO:0016042]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805] GO:0004027; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0008202; GO:0008203; GO:0016042; GO:0030573; GO:0042403; GO:0047704; GO:0050294; GO:0050427; GO:0050656; GO:0051923 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; alcohol sulfotransferase activity [GO:0004027]; bile-salt sulfotransferase activity [GO:0047704]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146] LFQEKMADLPRELFPWE 0.97074 -0.67998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7296 0 0 0 0 0 14.9732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8352 0 0 0 13.1305 0 0 0 13.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NNP5 CC169_HUMAN Coiled-coil domain-containing protein 169 CCDC169 C13orf38 Homo sapiens (Human) HKITELEAKLNTDNEGSEWK 0.97075 -0.6515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3604 0 13.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0656 0 0 0 14.8746 13.8038 0 12.3355 12.2048 0 0 0 0 0 0 16.3996 13.5201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5567 0 0 0 0 0 0 0 0 14.8083 14.0175 0 0 0 0 0 0 15.3798 0 0 0 0 0 0 0 0 12.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3885 0 12.5197 0 0 0 0 0 0 0 0 0 0 0 0 0 13.361 0 0 0 0 0 0 12.6249 0 0 0 0 0 Q07065 CKAP4_HUMAN "Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein, Climp-63, p63)" CKAP4 Homo sapiens (Human) azurophil granule membrane [GO:0035577]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579]; RNA binding [GO:0003723] GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005811; GO:0005856; GO:0005886; GO:0016020; GO:0016021; GO:0035577; GO:0035579; GO:0042599; GO:0048471; GO:0070062 RNA binding [GO:0003723] DFTSLENTVEER 0.97075 -0.65204 0 0 0 0 13.8344 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1901 0 0 0 0 0 0 0 0 11.7311 0 0 0 0 0 0 0 0 0 0 0 0 12.1234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6624 0 0 0 0 0 17.4824 0 0 0 0 0 0 14.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAN9 NMNA1_HUMAN "Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide-nucleotide adenylyltransferase 1, NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1, NaMN adenylyltransferase 1)" NMNAT1 NMNAT Homo sapiens (Human) ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of neuron death [GO:1901215]; nucleotide biosynthetic process [GO:0009165]; response to wounding [GO:0009611] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of neuron death [GO:1901215]; nucleotide biosynthetic process [GO:0009165]; response to wounding [GO:0009611] GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0009165; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:1901215; GO:1990966 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515] DYMNGTGR 0.97075 -0.73115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0812 0 13.6904 0 0 11.6937 0 0 0 13.1318 0 0 0 0 0 0 0 0 0 0 0 0 12.1338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13257 MD2L1_HUMAN "Mitotic spindle assembly checkpoint protein MAD2A, HsMAD2 (Mitotic arrest deficient 2-like protein 1, MAD2-like protein 1)" MAD2L1 MAD2 Homo sapiens (Human) cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267] cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267] GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007094; GO:0008022; GO:0033597; GO:0042177; GO:0042802; GO:0042803; GO:0043066; GO:0044615; GO:0045930; GO:0048471; GO:0051301; GO:0051444; GO:0051660; GO:0072686; GO:0090267; GO:1904667; GO:1990728 identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803] DWLYKCSVQK 0.97076 -0.52722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2637 13.9842 13.581 13.5372 0 0 13.6632 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9312 0 0 0 0 13.6664 0 0 0 0 0 13.7886 0 0 14.1137 16.5504 0 0 0 0 0 0 0 0 12.3438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8416 15.2277 14.8658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78415 IRX3_HUMAN Iroquois-class homeodomain protein IRX-3 (Homeodomain protein IRXB1) (Iroquois homeobox protein 3) IRX3 IRXB1 Homo sapiens (Human) atrioventricular bundle cell differentiation [GO:0003167]; cell development [GO:0048468]; energy homeostasis [GO:0097009]; His-Purkinje system cell differentiation [GO:0060932]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Purkinje myocyte development [GO:0003165]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086] axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; atrioventricular bundle cell differentiation [GO:0003167]; cell development [GO:0048468]; energy homeostasis [GO:0097009]; His-Purkinje system cell differentiation [GO:0060932]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Purkinje myocyte development [GO:0003165]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001656; GO:0003165; GO:0003167; GO:0005634; GO:0005737; GO:0006357; GO:0007498; GO:0030182; GO:0030424; GO:0045665; GO:0045666; GO:0045944; GO:0048468; GO:0060932; GO:0072086; GO:0097009; GO:1901844; GO:1903598; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DGDLGLGPISDSK 0.97077 -0.65731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8024 0 0 0 0 0 0 0 15.1212 0 0 0 0 0 0 0 0 0 0 14.9507 0 0 0 0 0 0 0 0 0 0 14.4884 0 14.2536 14.0817 0 0 0 0 0 0 0 0 0 0 0 0 14.4385 0 0 0 0 0 0 14.4331 0 0 0 0 14.1586 0 0 0 0 0 0 0 0 0 0 0 0 11.1639 0 0 0 0 12.9386 0 0 0 0 0 0 0 0 0 0 0 12.6866 0 0 12.4242 12.2544 0 0 0 0 0 0 0 0 0 0 Q9BQI5 SGIP1_HUMAN SH3-containing GRB2-like protein 3-interacting protein 1 (Endophilin-3-interacting protein) SGIP1 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021] AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; energy homeostasis [GO:0097009]; positive regulation of feeding behavior [GO:2000253]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to dietary excess [GO:0002021] GO:0002021; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0008017; GO:0017124; GO:0030122; GO:0030136; GO:0048260; GO:0048268; GO:0072583; GO:0097009; GO:2000253 microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; SH3 domain binding [GO:0017124] FAAGKYLADN 0.97077 3.1925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2985 13.1055 12.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0032 0 0 0 16.0674 0 15.4472 0 0 14.1219 0 0 0 0 0 14.0753 0 0 13.7182 16.0048 13.7389 0 14.8727 0 0 0 0 0 0 0 0 0 13.564 13.1748 0 13.8958 13.6996 0 12.5876 0 0 0 16.8505 0 0 0 14.0118 15.1134 0 0 0 0 15.9875 15.9314 0 0 0 12.9241 0 0 0 0 14.4716 16.3507 15.2945 0 0 0 0 0 0 0 11.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6738 15.7005 0 0 0 0 14.8508 0 Q9UBP4 DKK3_HUMAN "Dickkopf-related protein 3, Dickkopf-3, Dkk-3, hDkk-3" DKK3 REIC UNQ258/PRO295 Homo sapiens (Human) "adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of anti-Mullerian hormone signaling pathway [GO:1902613]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; Wnt signaling pathway [GO:0016055]" extracellular space [GO:0005615] "extracellular space [GO:0005615]; co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of anti-Mullerian hormone signaling pathway [GO:1902613]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; Wnt signaling pathway [GO:0016055]" GO:0005615; GO:0009653; GO:0016055; GO:0017015; GO:0030325; GO:0032348; GO:0039706; GO:0045892; GO:0048019; GO:0090090; GO:1902613; GO:2000065 co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019] DSECCGDQLCVWGHCTKMATRGSNGTICDNQR 0.97078 -0.66116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6097 0 0 0 0 0 0 0 0 11.0431 0 0 0 0 0 14.8448 14.5404 0 0 0 0 0 0 0 0 0 0 14.6789 0 13.9488 0 0 0 0 0 0 14.6311 0 0 0 13.0024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7774 11.7416 0 0 0 0 0 12.9313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2294 0 0 0 0 0 0 12.903 0 0 0 A6NHT5 HMX3_HUMAN Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1) HMX3 NKX-5.1 NKX5-1 Homo sapiens (Human) brain development [GO:0007420]; cell differentiation [GO:0030154]; embryo implantation [GO:0007566]; inner ear morphogenesis [GO:0042472]; maternal process involved in female pregnancy [GO:0060135]; neuromuscular process controlling balance [GO:0050885]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; brain development [GO:0007420]; cell differentiation [GO:0030154]; embryo implantation [GO:0007566]; inner ear morphogenesis [GO:0042472]; maternal process involved in female pregnancy [GO:0060135]; neuromuscular process controlling balance [GO:0050885]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007420; GO:0007566; GO:0030154; GO:0042472; GO:0050885; GO:0060135 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" MPEPGPDAAGTASAQPQPPPPPPPAPKESPFSIK 0.97082 -0.67078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15691 MARE1_HUMAN "Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1, EB1)" MAPRE1 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; negative regulation of microtubule polymerization [GO:0031115]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]; protein localization to astral microtubule [GO:1902888]; protein localization to centrosome [GO:0071539]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225] cell projection membrane [GO:0031253]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; mitotic spindle pole [GO:0097431]; spindle midzone [GO:0051233] cell projection membrane [GO:0031253]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; mitotic spindle pole [GO:0097431]; spindle midzone [GO:0051233]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; negative regulation of microtubule polymerization [GO:0031115]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]; protein localization to astral microtubule [GO:1902888]; protein localization to centrosome [GO:0071539]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225] GO:0000132; GO:0001578; GO:0003723; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005874; GO:0005881; GO:0005925; GO:0008022; GO:0008104; GO:0016477; GO:0019901; GO:0030981; GO:0031110; GO:0031115; GO:0031116; GO:0031253; GO:0035371; GO:0035372; GO:0036064; GO:0042802; GO:0045296; GO:0046785; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0051315; GO:0071539; GO:0097431; GO:1902888; GO:1903033; GO:1904825; GO:1905515; GO:1905721 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] FFDANYDGK 0.97082 -0.67236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8098 0 14.8373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.442 13.2673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43234 CATO_HUMAN "Cathepsin O, EC 3.4.22.42" CTSO CTSO1 Homo sapiens (Human) proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] extracellular space [GO:0005615]; lysosome [GO:0005764] extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0051603 cysteine-type endopeptidase activity [GO:0004197] GYSAYDFSDQEDEMAK 0.97083 -0.67483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.844 14.643 0 0 0 0 0 0 0 0 0 0 14.2258 0 12.8349 0 13.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3716 0 0 13.9608 0 0 12.8714 0 12.294 0 0 12.4616 0 13.5413 0 0 13.1307 0 0 0 0 0 0 0 0 0 13.254 0 0 0 0 0 0 0 0 0 12.7327 0 14.0784 0 0 0 12.8822 0 0 0 12.8658 0 0 12.9555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2739 0 0 0 12.7262 12.8541 0 0 0 0 0 Q6NUM6 TYW1B_HUMAN "S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1B, EC 4.1.3.44 (Radical S-adenosyl methionine and flavodoxin domain-containing protein 2) (tRNA wybutosine-synthesizing protein 1 homolog B)" TYW1B RSAFD2 Homo sapiens (Human) wybutosine biosynthetic process [GO:0031591] "4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]; wybutosine biosynthetic process [GO:0031591]" GO:0010181; GO:0031591; GO:0046872; GO:0051539; GO:0102521 "4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]" AMITPALREALTK 0.97085 -0.49657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4377 0 0 0 0 0 0 0 0 18.1116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DPH9 CX05B_HUMAN Uncharacterized protein CXorf51B CXorf51B Homo sapiens (Human) GRYHRLK 0.97086 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXP6 NXRD1_HUMAN "NADP-dependent oxidoreductase domain-containing protein 1, EC 1.-.-.- (Pyrroline-5-carboxylate reductase-like protein C14orf148)" NOXRED1 C14orf148 Homo sapiens (Human) L-proline biosynthetic process [GO:0055129] pyrroline-5-carboxylate reductase activity [GO:0004735]; L-proline biosynthetic process [GO:0055129] GO:0004735; GO:0055129 pyrroline-5-carboxylate reductase activity [GO:0004735] ASIVYSFVAAIPLPRLKLLLNHTNILR 0.97086 3.189 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0129 13.4911 0 12.9414 0 13.1374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4332 0 0 0 0 14.288 0 0 0 12.8081 0 0 0 Q5PR19 YI024_HUMAN Putative UPF0607 protein LOC392364 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] IPHLRGK 0.97087 -0.52675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCH0 NCK5L_HUMAN "Nck-associated protein 5-like, NCKAP5-like (Centrosomal protein of 169 kDa, Cep169)" NCKAP5L CEP169 KIAA1602 FP1193 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] GO:0001578; GO:0005737; GO:0005813; GO:0007019; GO:0035371 KKAQILEVLR 0.97087 -0.72771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6094 0 0 0 0 0 12.9265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8942 0 0 0 12.8938 0 13.343 0 0 0 0 11.43 0 0 0 14.1202 0 13.1817 0 0 0 0 0 0 0 0 0 0 0 13.9706 0 0 13.2143 0 12.4782 0 0 0 12.9384 12.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5684 0 11.6653 10.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.745 0 0 0 0 0 0 13.7438 13.1469 0 0 0 0 0 0 0 0 0 0 Q8WWW0 RASF5_HUMAN "Ras association domain-containing protein 5 (New ras effector 1) (Regulator for cell adhesion and polarization enriched in lymphoid tissues, RAPL)" RASSF5 NORE1 RAPL Homo sapiens (Human) apoptotic process [GO:0006915]; lymphocyte proliferation [GO:0046651]; negative regulation of lymphocyte proliferation [GO:0050672]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to nucleus [GO:1900180]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; lymphocyte proliferation [GO:0046651]; negative regulation of lymphocyte proliferation [GO:0050672]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to nucleus [GO:1900180]; signal transduction [GO:0007165] GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0007165; GO:0031267; GO:0031398; GO:0042802; GO:0042981; GO:0046651; GO:0046872; GO:0050672; GO:1900180 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] ASRPARPLR 0.97088 -0.65108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2958 0 0 0 0 0 0 0 0 0 0 0 11.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2975 0 0 0 0 0 0 0 0 0 0 0 0 10.4015 0 0 0 0 0 0 0 0 0 0 0 13.3113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8732 0 0 0 0 0 0 0 0 0 0 0 11.3873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01859 IGHG2_HUMAN Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE) IGHG2 Homo sapiens (Human) "adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgG immunoglobulin complex [GO:0071735]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgG immunoglobulin complex [GO:0071735]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0070062; GO:0071735; GO:0072562 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] GLPAPIEK 0.97089 -0.65532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.359 17.0089 14.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4061 13.311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1364 16.1893 0 0 0 0 0 0 0 0 10.8203 0 0 0 0 0 0 11.4488 0 0 0 11.8015 0 0 0 0 0 P24046 GBRR1_HUMAN Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor) GABRR1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; identical protein binding [GO:0042802]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:0098978; GO:0098982; GO:0099507; GO:1902476; GO:1902711; GO:1904315 chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; identical protein binding [GO:0042802]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GRPQRQR 0.97089 -0.65554 0 0 0 0 0 0 0 0 0 0 0 0 13.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3365 14.2681 14.9516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9578 0 12.6491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0216 0 11.5772 0 0 0 0 0 0 0 P62495 ERF1_HUMAN "Eukaryotic peptide chain release factor subunit 1, Eukaryotic release factor 1, eRF1 (Protein Cl1) (TB3-1)" ETF1 ERF1 RF1 SUP45L1 Homo sapiens (Human) "cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]" GO:0000184; GO:0002184; GO:0003723; GO:0003747; GO:0005737; GO:0005829; GO:0006415; GO:0006449; GO:0006479; GO:0008079; GO:0016149; GO:0018444; GO:0043022; GO:1990825 "ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]" EVLHKFTVDLPKK 0.9709 -0.52821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9862 10.7837 0 0 0 0 13.317 0 13.2031 0 13.512 0 14.0626 0 13.9159 0 13.4593 0 0 0 0 13.0035 0 0 0 0 0 0 0 11.3677 13.7462 0 0 0 0 11.834 0 0 0 14.9221 0 0 0 0 0 0 0 0 0 12.3349 0 0 0 0 12.8665 13.5533 12.7073 0 0 12.9451 0 0 14.2809 0 0 0 0 0 12.5102 0 0 0 0 0 13.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MJ13 WDR72_HUMAN WD repeat-containing protein 72 WDR72 Homo sapiens (Human) enamel mineralization [GO:0070166]; extracellular matrix disassembly [GO:0022617]; protein localization to plasma membrane [GO:0072659] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; enamel mineralization [GO:0070166]; extracellular matrix disassembly [GO:0022617]; protein localization to plasma membrane [GO:0072659] GO:0005634; GO:0005737; GO:0005768; GO:0022617; GO:0070166; GO:0072659 ARIILNCCDDSQLVK 0.9709 -0.65936 0 0 0 0 0 11.4168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1942 0 0 0 0 0 0 0 0 0 0 0 11.8728 0 0 12.2174 0 0 0 0 0 0 0 0 12.2235 0 0 0 0 11.8167 0 0 0 11.0476 10.9276 0 0 0 9.78664 0 0 10.9548 0 13.1274 0 0 0 0 0 0 0 0 0 0 0 15.3047 13.8992 0 0 0 0 0 0 13.7732 0 13.8809 14.683 0 9.46571 0 0 0 0 14.3074 0 0 0 0 0 0 0 0 0 0 0 0 12.7849 0 12.1398 0 0 0 0 13.9597 0 0 0 0 0 13.0775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1151 0 0 12.6054 0 0 0 13.24 0 14.5381 0 13.1599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60810 PRAM4_HUMAN PRAME family member 4 PRAMEF4 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 DLRHPKR 0.97091 -0.66072 0 0 0 0 0 0 11.8075 0 0 0 0 0 0 0 13.4503 0 0 13.7832 0 0 13.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1486 0 0 0 13.5516 0 0 14.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8447 0 0 0 0 0 0 14.3083 11.6326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4537 0 0 0 0 0 0 0 0 Q9HAP2 MLXIP_HUMAN "MLX-interacting protein (Class E basic helix-loop-helix protein 36, bHLHe36) (Transcriptional activator MondoA)" MLXIP BHLHE36 KIAA0867 MIR MONDOA Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634] "chromatin [GO:0000785]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005741; GO:0006357; GO:0045944; GO:0046983 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" FWIFSIIIK 0.97092 -0.66293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1403 0 12.9624 18.4091 12.652 0 0 0 0 0 0 0 0 16.9788 0 17.5205 13.0076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.534 0 0 0 0 0 0 0 0 0 0 12.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0214 0 17.4776 0 0 0 0 0 0 12.8735 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6852 0 13.4315 0 0 0 0 0 0 0 O00253 AGRP_HUMAN Agouti-related protein AGRP AGRT ART Homo sapiens (Human) adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868] extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025] extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025]; melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]; adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868] GO:0005102; GO:0005184; GO:0005615; GO:0005796; GO:0007218; GO:0007623; GO:0007631; GO:0008343; GO:0009755; GO:0031779; GO:0032868; GO:0042755; GO:0043025; GO:0048571; GO:0060135; GO:0060259; GO:0070996; GO:2000253 melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996] FFNAFCYCRK 0.97094 -0.66732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5894 0 12.506 12.7391 0 0 12.8706 0 0 0 0 0 0 0 0 12.5663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3843 0 0 0 0 12.5469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RP8 KCNA7_HUMAN Potassium voltage-gated channel subfamily A member 7 (Voltage-gated potassium channel subunit Kv1.7) KCNA7 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] CPPPCGCCER 0.97094 -0.6671 0 0 0 0 0 0 0 0 12.2605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4994 0 12.6927 0 11.8556 0 0 0 0 0 12.6712 0 0 0 0 11.9352 13.0343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5095 0 0 0 0 0 0 0 0 0 0 0 12.1265 0 0 0 0 0 0 0 0 12.7058 0 0 0 0 0 0 0 0 0 0 12.1026 0 12.1387 12.989 0 0 0 0 0 13.7584 0 0 0 0 0 0 0 0 0 0 0 12.535 0 0 0 0 0 0 14.2266 0 0 0 11.8173 0 0 0 0 14.2094 0 0 0 0 0 0 0 15.321 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A3B3IRV3 MCTS2_HUMAN Malignant T-cell-amplified sequence 2 MCTS2 Homo sapiens (Human) formation of translation preinitiation complex [GO:0001731] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723]; formation of translation preinitiation complex [GO:0001731] GO:0001731; GO:0003723; GO:0005737 RNA binding [GO:0003723] CHEHTEILTVSGELLFFRQR 0.97095 -0.67056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7517 0 12.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8968 11.2588 12.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1996 0 Q5IJ48 CRUM2_HUMAN Protein crumbs homolog 2 (Crumbs-like protein 2) CRB2 Homo sapiens (Human) circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]; visual perception [GO:0007601] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877]; circulatory system development [GO:0072359]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; ingression involved in gastrulation with mouth forming second [GO:0055111]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesoderm formation [GO:0001707]; negative regulation of endopeptidase activity [GO:0010951]; notochord formation [GO:0014028]; photoreceptor cell maintenance [GO:0045494]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; regulation of gastrulation [GO:0010470]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; retinal cone cell development [GO:0046549]; somitogenesis [GO:0001756]; visual perception [GO:0007601] GO:0001707; GO:0001756; GO:0001895; GO:0005509; GO:0005737; GO:0005886; GO:0007157; GO:0007601; GO:0010470; GO:0010718; GO:0010951; GO:0014028; GO:0016021; GO:0016324; GO:0016327; GO:0019828; GO:0030010; GO:0030513; GO:0032991; GO:0035003; GO:0043296; GO:0044877; GO:0045197; GO:0045199; GO:0045494; GO:0046549; GO:0050896; GO:0055111; GO:0070062; GO:0072359 aspartic-type endopeptidase inhibitor activity [GO:0019828]; calcium ion binding [GO:0005509]; protein-containing complex binding [GO:0044877] CDCAGTGYEGTHCER 0.97097 4.2809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1669 0 0 0 0 0 0 0 0 0 0 0 13.9917 0 0 0 14.547 0 11.6269 0 0 0 0 12.3409 0 0 12.7815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.636 11.4569 0 0 0 0 0 0 0 0 15.7523 0 0 0 0 9.49159 0 0 0 0 0 0 0 0 0 0 12.551 0 0 0 0 12.8242 0 11.0568 0 A6NNN8 S38A8_HUMAN Putative sodium-coupled neutral amino acid transporter 8 (Solute carrier family 38 member 8) SLC38A8 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; sodium ion transport [GO:0006814] GO:0003333; GO:0006814; GO:0015179; GO:0016021 L-amino acid transmembrane transporter activity [GO:0015179] EGQTPGSR 0.97098 -0.52427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8619 0 0 0 0 0 0 0 0 0 14.7138 0 14.518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60548 FOXD2_HUMAN "Forkhead box protein D2 (Forkhead-related protein FKHL17) (Forkhead-related transcription factor 9, FREAC-9)" FOXD2 FKHL17 FREAC9 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0009653; GO:0030154; GO:0043565; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" DVLPHGHEPPAEEAEADLAEDEEESGGCSDGEPRALASR 0.97098 -0.72401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.5415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7U1 CCSE2_HUMAN Serine-rich coiled-coil domain-containing protein 2 (Coiled-coil serine-rich protein 2) (Protein GCAP14 homolog) CCSER2 FAM190B KIAA1128 NPD012 Homo sapiens (Human) microtubule bundle formation [GO:0001578] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017]; microtubule bundle formation [GO:0001578] GO:0001578; GO:0005737; GO:0008017; GO:0015630 microtubule binding [GO:0008017] AVDLTKPYQNQQLSIR 0.97098 3.6984 0 11.6812 0 0 0 0 11.4474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9243 0 0 0 0 0 0 10.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4335 0 13.5509 12.8518 0 0 0 0 15.0588 14.9321 13.8178 13.6457 12.7716 11.4473 13.7054 14.4893 0 0 0 11.8427 0 13.4836 12.9484 12.9748 13.5028 0 14.4668 12.631 0 14.3023 0 11.2985 0 12.9038 12.6297 0 0 0 0 12.5245 14.5764 12.4721 0 13.5699 0 0 14.1687 0 0 0 0 0 0 12.9006 0 14.4858 13.2035 13.0116 0 0 0 14.0179 0 12.7225 0 14.2438 13.8318 13.8312 13.8714 0 14.2349 13.5158 12.9026 0 0 12.809 14.5495 14.7117 14.337 12.9666 0 11.1678 0 15.3995 12.9415 13.0755 0 13.9443 0 14.0736 0 0 0 0 0 0 0 0 12.5198 0 0 0 10.8878 0 0 13.9754 14.2951 12.7386 14.091 0 0 0 0 0 P13056 NR2C1_HUMAN Nuclear receptor subfamily 2 group C member 1 (Orphan nuclear receptor TR2) (Testicular receptor 2) NR2C1 TR2 Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; PML body [GO:0016605] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003707; GO:0004879; GO:0005654; GO:0006357; GO:0008270; GO:0016605; GO:0030154; GO:0038023; GO:0042803; GO:0042826; GO:0048386; GO:0048856; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]" GLIGNIRIDSVIPHILK 0.97099 -0.49629 0 0 0 0 13.1195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7651 0 0 0 0 0 0 0 0 0 12.5875 0 12.4105 0 0 0 0 0 0 0 0 0 0 11.3879 0 0 0 0 0 14.2933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1536 15.2587 0 0 0 0 14.5436 13.627 0 0 0 13.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.829 0 13.9266 0 0 0 0 0 0 0 0 14.7416 0 0 0 0 0 14.9856 0 0 0 0 0 14.2262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8396 0 0 12.2246 0 0 Q96SY0 INT14_HUMAN Integrator complex subunit 14 (von Willebrand factor A domain-containing protein 9) INTS14 C15orf44 VWA9 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243; GO:0034472 ENPYGEDDNK 0.97099 -0.72492 0 0 0 0 0 0 0 0 11.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6608 0 0 0 0 0 0 0 0 0 10.5848 12.2029 0 13.4818 0 0 0 0 0 0 0 0 0 0 12.4694 0 0 0 10.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93549 0 0 0 11.8607 0 12.4634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9411 0 0 0 0 0 0 0 0 11.1731 0 12.0407 0 0 0 0 0 0 0 10.1712 0 0 12.0246 0 0 0 0 0 0 0 0 12.4675 0 13.0994 0 11.6249 0 0 0 0 0 0 12.3386 0 0 0 0 0 0 0 0 0 0 12.2495 0 0 0 0 0 A0A0C4DH25 KVD20_HUMAN Immunoglobulin kappa variable 3D-20 IGKV3D-20 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814 LLIYDASSR 0.971 -0.52622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00479 HMGN4_HUMAN "High mobility group nucleosome-binding domain-containing protein 4 (Non-histone chromosomal protein HMG-17-like 3, Non-histone chromosomal protein)" HMGN4 HMG17L3 NHC Homo sapiens (Human) chromatin organization [GO:0006325] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; chromatin organization [GO:0006325] GO:0000785; GO:0003682; GO:0005634; GO:0006325; GO:0031492 chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492] DEPQRRSAR 0.971 -0.47982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08861 CEL3B_HUMAN "Chymotrypsin-like elastase family member 3B, EC 3.4.21.70 (Elastase IIIB) (Elastase-3B) (Protease E)" CELA3B ELA3B Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508; GO:0008233 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] WNWWGSSVK 0.971 -0.52675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99578 RIT2_HUMAN "GTP-binding protein Rit2, EC 3.6.5.2 (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2)" RIT2 RIN ROC2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic tree [GO:0097447]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic tree [GO:0097447]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; maintenance of protein location in cell [GO:0032507]; negative regulation of neuron projection development [GO:0010977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of calcium-mediated signaling [GO:0050848]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of endocytosis [GO:0030100]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264] GO:0001932; GO:0003682; GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007189; GO:0007264; GO:0007265; GO:0007268; GO:0010976; GO:0010977; GO:0019003; GO:0030100; GO:0030215; GO:0032489; GO:0032507; GO:0035556; GO:0043005; GO:0043410; GO:0044297; GO:0045121; GO:0045202; GO:0045944; GO:0050848; GO:0097447 calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215] DSLWKKLK 0.971 -0.72725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4P1 ATG4B_HUMAN "Cysteine protease ATG4B, EC 3.4.22.- (AUT-like 1 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 1, Autophagin-1) (Autophagy-related protein 4 homolog B, HsAPG4B, hAPG4B)" ATG4B APG4B AUTL1 KIAA0943 Homo sapiens (Human) autophagy [GO:0006914]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; otolith mineralization completed early in development [GO:0031173]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; proteolysis [GO:0006508] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; Atg8-specific peptidase activity [GO:0019786]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; scaffold protein binding [GO:0097110]; autophagy [GO:0006914]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; otolith mineralization completed early in development [GO:0031173]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; proteolysis [GO:0006508] GO:0000423; GO:0004175; GO:0004197; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0006508; GO:0006914; GO:0008234; GO:0015031; GO:0016236; GO:0016237; GO:0019786; GO:0031173; GO:0031410; GO:0034497; GO:0051697; GO:0097110 Atg8-specific peptidase activity [GO:0019786]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; scaffold protein binding [GO:0097110] HLGRDWRWTQR 0.971 -0.67977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y605 MOFA1_HUMAN MORF4 family-associated protein 1 (Protein PGR1) (Protein associated with MRG of 14 kDa) MRFAP1 PAM14 PGR1 Homo sapiens (Human) nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] GO:0005654; GO:0048471 EHGRAYLRNR 0.971 -0.65028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.196 12.9849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6EIG7 CLC6A_HUMAN "C-type lectin domain family 6 member A (C-type lectin superfamily member 10) (Dendritic cell-associated C-type lectin 2, DC-associated C-type lectin 2, Dectin-2)" CLEC6A CLECSF10 DECTIN2 Homo sapiens (Human) adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; defense response to fungus [GO:0050832]; detection of yeast [GO:0001879]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T-helper 17 type immune response [GO:2000318]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; pattern recognition receptor activity [GO:0038187]; phospholipase binding [GO:0043274]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; defense response to fungus [GO:0050832]; detection of yeast [GO:0001879]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T-helper 17 type immune response [GO:2000318]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223] GO:0001819; GO:0001878; GO:0001879; GO:0002223; GO:0002250; GO:0005509; GO:0005537; GO:0005886; GO:0006955; GO:0009897; GO:0016021; GO:0030246; GO:0038187; GO:0043123; GO:0043274; GO:0045087; GO:0050731; GO:0050832; GO:0061760; GO:1902533; GO:2000318 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; pattern recognition receptor activity [GO:0038187]; phospholipase binding [GO:0043274] MMQEQQPQSTEK 0.97101 -0.65085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.807 0 0 0 0 0 0 0 0 0 13.8294 0 0 0 0 0 0 0 0 0 0 0 13.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3552 0 0 12.8387 0 0 0 0 0 0 0 0 0 11.6859 0 0 0 0 0 0 0 12.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3493 0 0 0 0 0 11.7543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VAA2 LR74A_HUMAN Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74) LRRC74A C14orf166B LRRC74 Homo sapiens (Human) GLESNESLRVLKLFLNPINMDGAILLILAIK 0.97105 3.6957 0 0 0 0 0 0 0 11.0276 0 0 0 0 0 0 0 10.2021 0 0 0 12.4711 11.3683 0 0 0 0 0 0 0 0 0 0 0 0 12.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5819 0 0 0 0 0 13.3784 0 0 0 13.0745 0 0 0 0 0 12.6485 0 0 0 0 0 13.712 0 13.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7969 0 16.3372 0 0 0 0 0 0 0 13.0264 0 0 0 0 0 0 13.2633 14.8291 12.9072 0 0 0 0 0 0 0 0 0 0 0 12.4103 0 0 0 0 0 0 0 0 0 14.0965 0 0 0 0 0 0 0 0 13.8089 0 11.2098 0 0 0 0 0 0 0 0 11.5867 0 0 0 Q8N8L2 ZN491_HUMAN Zinc finger protein 491 ZNF491 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EKPFDCKECEK 0.97105 -0.66272 0 0 0 0 0 0 0 0 0 0 0 10.6851 0 0 14.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4188 0 0 0 0 0 0 12.8749 0 0 0 0 0 11.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4188 0 14.0028 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8949 0 0 0 0 0 0 0 0 0 11.8704 0 0 0 0 0 0 0 10.8304 0 0 0 11.6159 0 0 0 0 0 0 0 0 11.3161 0 0 0 0 0 0 0 0 0 0 11.0144 0 0 15.0887 0 0 0 0 0 0 11.5274 10.5 0 Q6ZUI0 TPRG1_HUMAN Tumor protein p63-regulated gene 1 protein (Protein FAM79B) TPRG1 FAM79B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 IDHWNNEKERILLVTDK 0.97106 -0.66682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89638 0 0 0 0 0 0 0 14.0098 0 0 0 0 0 14.0813 0 0 0 0 0 0 0 0 0 0 11.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1507 0 14.4997 0 0 13.8843 0 0 0 14.0113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHW3 MAFA_HUMAN Transcription factor MafA (Pancreatic beta-cell-specific transcriptional activator) (RIPE3b1 factor) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog A) MAFA Homo sapiens (Human) "insulin secretion [GO:0030073]; nitric oxide mediated signal transduction [GO:0007263]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; insulin secretion [GO:0030073]; nitric oxide mediated signal transduction [GO:0007263]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007263; GO:0009749; GO:0030073; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EPSPPQAGPGGAKGTADFFL 0.97108 -0.66898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.254 0 0 0 0 0 0 Q9Y2N7 HIF3A_HUMAN "Hypoxia-inducible factor 3-alpha, HIF-3-alpha, HIF3-alpha (Basic-helix-loop-helix-PAS protein MOP7) (Class E basic helix-loop-helix protein 17, bHLHe17) (HIF3-alpha-1) (Inhibitory PAS domain protein, IPAS) (Member of PAS protein 7) (PAS domain-containing protein 7)" HIF3A BHLHE17 MOP7 PASD7 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001525; GO:0001666; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0006357; GO:0006366; GO:0006915; GO:0016607; GO:0046983 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" FTYCDDR 0.9711 -0.72089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4452 13.5477 13.2323 0 0 0 0 0 0 0 12.7426 0 0 0 0 0 0 0 0 0 12.9199 0 0 0 13.0537 0 11.9857 0 0 0 11.9254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5134 0 0 12.8516 0 0 0 0 0 0 0 13.3591 0 0 0 0 0 0 0 0 0 0 0 0 A8MQ03 CRTP1_HUMAN Cysteine-rich tail protein 1 CYSRT1 C9orf169 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; identical protein binding [GO:0042802] GO:0042802; GO:0070062 identical protein binding [GO:0042802] CHSCCCCVIS 0.97111 -0.49295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9477 0 10.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4021 10.1733 14.3575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.511 0 0 0 0 0 0 0 0 0 11.5651 0 0 0 0 0 0 0 0 0 0 10.3775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13601 KRR1_HUMAN "KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1, Rip-1)" KRR1 HRB2 Homo sapiens (Human) rRNA processing [GO:0006364] chromosome [GO:0005694]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] chromosome [GO:0005694]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006364; GO:0016020; GO:0032040; GO:0045171 RNA binding [GO:0003723] DLIKLLARSVSFEQAVR 0.97111 -0.72366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6116 0 0 0 0 0 0 13.1416 0 0 12.8119 0 0 0 0 0 0 0 13.1475 13.3287 0 0 0 0 0 0 12.9727 0 0 0 0 0 0 0 0 0 0 0 15.4319 0 0 0 0 0 0 0 14.3114 0 0 0 0 12.8043 0 0 0 14.0126 0 0 0 0 0 0 15.1424 0 0 0 12.5952 0 0 0 0 12.0904 0 0 0 12.9947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.241 0 0 0 0 12.6641 Q30KQ1 DB133_HUMAN "Beta-defensin 133 (Defensin, beta 133)" DEFB133 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 CRHECHDFEKPIGFCTK 0.97111 3.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8812 0 14.8269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q569K6 CC157_HUMAN Coiled-coil domain-containing protein 157 CCDC157 KIAA1656 Homo sapiens (Human) ASLQFPATTFK 0.97111 -0.49418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1856 0 0 0 0 0 13.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYG2 ZDHC3_HUMAN "Palmitoyltransferase ZDHHC3, EC 2.3.1.225 (Acyltransferase ZDHHC3, EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3, DHHC-3)" ZDHHC3 HSD49 Homo sapiens (Human) "lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]" endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]" GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0016020; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0032230; GO:0036462; GO:0042803; GO:0044873; GO:0072659; GO:0140439; GO:1902685; GO:1903546 palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] MDHHCPWVNNCVGENNQK 0.97111 -0.72277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2068 0 0 0 0 0 0 0 0 0 0 Q14774 HLX_HUMAN H2.0-like homeobox protein (Homeobox protein HB24) (Homeobox protein HLX1) HLX HLX1 Homo sapiens (Human) embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064]" GO:0000785; GO:0000981; GO:0001889; GO:0005634; GO:0007165; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]" ILSAEFDPK 0.97112 -0.52398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16520 BATF_HUMAN "Basic leucine zipper transcriptional factor ATF-like (B-cell-activating transcription factor, B-ATF) (SF-HT-activated gene 2 protein, SFA-2)" BATF Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hematopoietic stem cell differentiation [GO:0060218]; integrated stress response signaling [GO:0140467]; isotype switching [GO:0045190]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of cytokine production [GO:0001819]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 2 cell differentiation [GO:0045064]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hematopoietic stem cell differentiation [GO:0060218]; integrated stress response signaling [GO:0140467]; isotype switching [GO:0045190]; lymphoid progenitor cell differentiation [GO:0002320]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of cytokine production [GO:0001819]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 2 cell differentiation [GO:0045064]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001819; GO:0002320; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006974; GO:0030330; GO:0042832; GO:0043011; GO:0043565; GO:0045064; GO:0045190; GO:0060218; GO:0072539; GO:0072540; GO:0090575; GO:0140467; GO:1990837; GO:2000319 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" IAAQKSRQR 0.97112 -0.67872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S44 PRPK_HUMAN "EKC/KEOPS complex subunit TP53RK, EC 3.6.-.- (Atypical serine/threonine protein kinase TP53RK) (Nori-2) (TP53-regulating kinase, EC 2.7.11.1) (p53-related protein kinase)" TP53RK C20orf64 PRPK Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] GO:0000408; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0008033; GO:0016787; GO:0070525; GO:0106310; GO:1901796 ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AAVIKHRFPK 0.97112 -0.72671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5932 17.4047 0 0 0 0 0 0 0 0 0 14.3286 0 0 0 0 0 0 0 0 14.7331 0 12.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8007 0 0 0 0 0 0 12.9878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0895 0 0 0 0 0 0 11.7205 12.5998 10.8535 0 0 0 0 0 0 0 0 13.1136 0 0 0 0 0 0 0 0 12.5499 0 0 Q8NG84 O2AK2_HUMAN Olfactory receptor 2AK2 (Olfactory receptor 2AK1) (Olfactory receptor OR1-47) OR2AK2 OR2AK1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVAVFYTIVTPLLNPFIYSLR 0.97113 2.972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.905 0 0 0 0 0 13.8223 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969T3 SNX21_HUMAN "Sorting nexin-21 (Sorting nexin L, SNX-L)" SNX21 C20orf161 SNXL Homo sapiens (Human) protein transport [GO:0015031] early endosome membrane [GO:0031901] "early endosome membrane [GO:0031901]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein transport [GO:0015031]" GO:0005546; GO:0015031; GO:0031901; GO:0032266; GO:1901981 "phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" LSWRLGLDKR 0.97113 -0.6795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15406 NR6A1_HUMAN "Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor, GCNF, hGCNF) (Retinoid receptor-related testis-specific receptor, RTR, hRTR)" NR6A1 GCNF Homo sapiens (Human) gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; gamete generation [GO:0007276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0004879; GO:0005654; GO:0005667; GO:0006357; GO:0007276; GO:0008270; GO:0042803; GO:0043565; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" KLPFFCELSIKDYTCLLSSTWQELILLSSLTVYSK 0.97115 4.2706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9095 0 0 0 0 0 0 0 0 11.4103 0 12.4253 0 11.3506 0 0 0 0 0 0 0 0 0 11.2684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2756 12.2876 12.9013 0 0 0 0 0 0 0 0 0 0 13.2738 12.2546 0 0 0 0 0 0 0 0 0 0 0 15.2225 0 14.8401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1063 13.3887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.117 0 0 12.7405 0 0 0 0 0 0 13.3666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0971 0 0 0 0 0 0 0 0 0 0 0 0 O00214 LEG8_HUMAN "Galectin-8, Gal-8 (Po66 carbohydrate-binding protein, Po66-CBP) (Prostate carcinoma tumor antigen 1, PCTA-1)" LGALS8 Homo sapiens (Human) cellular response to virus [GO:0098586]; lymphatic endothelial cell migration [GO:1904977]; xenophagy [GO:0098792] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; integrin binding [GO:0005178]; cellular response to virus [GO:0098586]; lymphatic endothelial cell migration [GO:1904977]; xenophagy [GO:0098792] GO:0005178; GO:0005615; GO:0005737; GO:0005829; GO:0016020; GO:0030246; GO:0031410; GO:0098586; GO:0098792; GO:1904977 carbohydrate binding [GO:0030246]; integrin binding [GO:0005178] FKELSSIDTLEINGDIHLLEVR 0.97118 -0.63354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6818 0 0 0 0 14.2522 0 0 14.0192 13.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q56VL3 OCAD2_HUMAN OCIA domain-containing protein 2 (Ovarian carcinoma immunoreactive antigen-like protein) OCIAD2 Homo sapiens (Human) endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; response to bacterium [GO:0009617] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; response to bacterium [GO:0009617] GO:0005764; GO:0005768; GO:0005794; GO:0006897; GO:0009617; GO:0046427; GO:0061484 FGSLPKVALAGLLGFGLGK 0.97119 -0.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1096 11.3801 0 0 0 0 0 0 0 0 0 0 Q9H469 FXL15_HUMAN F-box/LRR-repeat protein 15 (F-box only protein 37) FBXL15 FBXO37 Homo sapiens (Human) bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; bone mineralization [GO:0030282]; dorsal/ventral pattern formation [GO:0009953]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of BMP signaling pathway [GO:0030513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0005737; GO:0005829; GO:0009953; GO:0016567; GO:0019005; GO:0030282; GO:0030513; GO:0031146 AFRSLVQLHLAGLRR 0.97119 -0.63426 0 0 0 0 0 0 0 0 0 0 0 0 14.1745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5884 0 0 0 0 13.4246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.389 Q12794 HYAL1_HUMAN "Hyaluronidase-1, Hyal-1, EC 3.2.1.35 (Hyaluronoglucosaminidase-1) (Lung carcinoma protein 1, LuCa-1)" HYAL1 LUCA1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; chondroitin sulfate catabolic process [GO:0030207]; embryonic skeletal joint morphogenesis [GO:0060272]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of growth [GO:0045927]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; hyaluronan synthase activity [GO:0050501]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; chondroitin sulfate catabolic process [GO:0030207]; embryonic skeletal joint morphogenesis [GO:0060272]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of growth [GO:0045927]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615] GO:0000302; GO:0004415; GO:0005615; GO:0005737; GO:0005764; GO:0005975; GO:0006954; GO:0009615; GO:0010634; GO:0030207; GO:0030212; GO:0030213; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0043202; GO:0044344; GO:0045766; GO:0045785; GO:0045927; GO:0046677; GO:0050501; GO:0050679; GO:0051216; GO:0060272; GO:0070062; GO:0071347; GO:0071356; GO:0071467; GO:0071493; GO:1900087; GO:1900106 hyaluronan synthase activity [GO:0050501]; hyalurononglucosaminidase activity [GO:0004415] GALSLEDQAQMAVEFK 0.97123 -0.67603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9805 0 0 0 0 0 0 0 0 0 0 0 0 15.2514 0 13.1177 0 12.7787 9.9306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7G2 CPLX4_HUMAN "Complexin-4 (Complexin IV, CPX IV)" CPLX4 Homo sapiens (Human) regulation of neurotransmitter secretion [GO:0046928]; response to stimulus [GO:0050896]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601] anchoring junction [GO:0070161]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195] anchoring junction [GO:0070161]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; regulation of neurotransmitter secretion [GO:0046928]; response to stimulus [GO:0050896]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601] GO:0000149; GO:0005886; GO:0007601; GO:0016079; GO:0019905; GO:0031201; GO:0043195; GO:0046928; GO:0050896; GO:0070161 SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] MVDEDQEEEEDK 0.97123 -0.64168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5349 0 0 0 0 0 0 0 0 0 0 0 10.4487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGU9 GP150_HUMAN Probable G-protein coupled receptor 150 GPR150 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0042277 G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277] ALAALGWLLALLLALPPAFVVR 0.97123 -0.64107 0 13.574 0 0 10.5344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3174 0 13.2623 12.2499 0 0 13.1548 12.0276 0 0 0 0 14.2481 0 13.7094 0 12.4434 0 11.7658 0 0 0 11.8417 0 0 11.3139 12.8706 0 0 0 0 13.8149 0 13.0678 14.5643 0 11.8204 0 0 0 0 0 13.995 0 12.4747 12.0919 0 0 0 10.9693 0 0 15.9088 0 0 13.206 13.8481 0 0 10.9805 0 0 13.225 0 0 0 0 12.263 12.4209 0 14.1036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4083 0 13.4495 0 0 0 0 0 0 Q9Y4E5 ZN451_HUMAN "E3 SUMO-protein ligase ZNF451, EC 2.3.2.- (Coactivator for steroid receptors) (E3 SUMO-protein transferase ZNF451) (Zinc finger protein 451)" ZNF451 COASTER KIAA0576 KIAA1702 Homo sapiens (Human) negative regulation of histone H3-K9 acetylation [GO:2000616]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468] nucleus [GO:0005634]; PML body [GO:0016605] nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; SUMO ligase activity [GO:0061665]; transcription corepressor activity [GO:0003714]; negative regulation of histone H3-K9 acetylation [GO:2000616]; negative regulation of transcription initiation from RNA polymerase II promoter [GO:0060633]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468] GO:0003714; GO:0005634; GO:0010468; GO:0016605; GO:0016925; GO:0030512; GO:0045944; GO:0046872; GO:0060633; GO:0061665; GO:2000616 metal ion binding [GO:0046872]; SUMO ligase activity [GO:0061665]; transcription corepressor activity [GO:0003714] AFHDPESAQQHFHRK 0.97124 3.6811 0 0 0 0 17.2016 14.4943 16.9624 0 10.9058 0 0 0 0 0 0 0 0 0 16.9752 17.1337 12.7118 17.0441 12.2945 16.907 0 12.547 11.7974 0 0 0 9.21825 0 0 0 0 0 0 0 0 0 0 0 0 11.1189 0 0 0 0 0 0 0 0 0 0 10.6638 0 10.3191 12.449 12.0473 0 0 0 0 0 0 0 18.0749 13.5335 0 18.0767 0 12.7988 18.0857 0 18.1558 18.1854 0 0 0 11.2821 0 16.1585 13.2084 17.704 0 0 13.6749 0 18.3032 18.2055 0 18.3526 0 14.0431 18.2545 18.3482 18.7721 19.2404 18.522 18.1949 18.0838 18.1447 18.2611 18.2294 18.3479 13.7031 18.1682 18.132 13.1199 13.3644 18.5116 18.2094 18.4592 14.9117 18.33 0 18.3049 0 18.2787 0 18.1792 0 0 0 18.1801 13.449 18.2232 11.8972 0 18.1981 0 18.1662 18.0815 14.566 18.1278 18.1161 12.6075 18.1804 18.2413 0 0 0 18.1892 18.1329 0 9.60426 17.9895 0 12.2783 0 18.2039 18.0976 18.1307 0 0 18.2013 0 0 0 0 14.599 0 0 0 13.5206 11.1978 0 0 0 12.2916 0 18.0314 18.0229 0 0 12.5662 0 0 0 13.4597 Q6ZUT3 FRMD7_HUMAN FERM domain-containing protein 7 FRMD7 Homo sapiens (Human) negative regulation of protein binding [GO:0032091]; negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of protein binding [GO:0032091]; negative regulation of stress fiber assembly [GO:0051497]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of neuron projection development [GO:0010975] GO:0005085; GO:0005615; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007399; GO:0010592; GO:0010975; GO:0030426; GO:0032091; GO:0043005; GO:0043025; GO:0051057; GO:0051497 guanyl-nucleotide exchange factor activity [GO:0005085] GRLKSLPFER 0.97125 -0.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NVY1 HIBCH_HUMAN "3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, EC 3.1.2.4 (3-hydroxyisobutyryl-coenzyme A hydrolase, HIB-CoA hydrolase, HIBYL-CoA-H)" HIBCH Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; branched-chain amino acid catabolic process [GO:0009083]; valine catabolic process [GO:0006574] GO:0003860; GO:0005739; GO:0005759; GO:0006574; GO:0009083 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860] GHDFHEGVR 0.97126 -0.65019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7977 12.1311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9708 12.8741 0 0 0 0 0 0 13.9308 14.1788 14.191 0 12.4531 13.4612 0 0 0 0 0 14.0332 0 17.2066 0 17.756 0 0 0 0 0 14.3831 14.0866 0 13.1002 18.4043 0 0 11.8153 0 13.2871 0 14.2277 0 14.0677 0 0 0 0 0 12.8926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01033 TIMP1_HUMAN "Metalloproteinase inhibitor 1 (Erythroid-potentiating activity, EPA) (Fibroblast collagenase inhibitor, Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1, TIMP-1)" TIMP1 CLGI TIMP Homo sapiens (Human) aging [GO:0007568]; cartilage development [GO:0051216]; cell activation [GO:0001775]; cellular response to UV-A [GO:0071492]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of trophoblast cell migration [GO:1901164]; positive regulation of cell population proliferation [GO:0008284]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metalloendopeptidase inhibitor activity [GO:0008191]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cartilage development [GO:0051216]; cell activation [GO:0001775]; cellular response to UV-A [GO:0071492]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of trophoblast cell migration [GO:1901164]; positive regulation of cell population proliferation [GO:0008284]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434] GO:0001775; GO:0002020; GO:0002248; GO:0005125; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0007568; GO:0008083; GO:0008191; GO:0008270; GO:0008284; GO:0009725; GO:0010033; GO:0010951; GO:0030414; GO:0031012; GO:0031093; GO:0034097; GO:0043066; GO:0043086; GO:0043434; GO:0051045; GO:0051216; GO:0070062; GO:0071492; GO:1901164; GO:1905049; GO:2001044 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metalloendopeptidase inhibitor activity [GO:0008191]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270] HLACLPR 0.97129 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8575 0 0 17.5883 12.6453 18.05 17.0381 0 18.3546 15.5796 0 15.3549 15.5522 14.611 15.5854 0 12.1978 0 0 18.1226 17.941 0 14.3591 14.2938 0 0 0 0 0 0 0 0 0 0 0 13.3426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4977 0 0 15.2718 14.3283 0 0 0 0 12.0243 0 0 0 14.5143 0 0 13.9992 0 0 0 0 12.3454 12.4121 0 12.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SY68 S1A7B_HUMAN Protein S100-A7-like 2 (S100 calcium-binding protein A7-like 2) S100A7L2 S100A7B Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914] GO:0005509; GO:0005615; GO:0046914; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914] MDMPGLVNLMK 0.97131 -0.62983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2144 0 0 12.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5W9 SNX11_HUMAN Sorting nexin-11 SNX11 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050] endosome [GO:0005768]; membrane [GO:0016020] endosome [GO:0005768]; membrane [GO:0016020]; phosphatidylinositol phosphate binding [GO:1901981]; intracellular protein transport [GO:0006886]; vesicle organization [GO:0016050] GO:0005768; GO:0006886; GO:0016020; GO:0016050; GO:1901981 phosphatidylinositol phosphate binding [GO:1901981] EGTSTLQSVR 0.97131 -0.63091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3594 0 0 15.3079 0 0 0 0 0 0 0 0 0 0 0 0 0 14.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PCD5 RFWD3_HUMAN "E3 ubiquitin-protein ligase RFWD3, EC 2.3.2.27 (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201)" RFWD3 RNF201 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297]; response to ionizing radiation [GO:0010212] GO:0000724; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0010212; GO:0016567; GO:0016605; GO:0031297; GO:0031571; GO:0036297; GO:0046872; GO:0061630; GO:0090734; GO:0097371; GO:2000001 MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; ubiquitin protein ligase activity [GO:0061630] CGHLFGYR 0.97137 -0.52319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6286 0 14.1906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H511 KLH31_HUMAN Kelch-like protein 31 (BTB and kelch domain-containing protein 6) (Kelch repeat and BTB domain-containing protein 1) (Kelch-like protein KLHL) KLHL31 BKLHD6 KBTBD1 KLHL Homo sapiens (Human) negative regulation of JNK cascade [GO:0046329]; negative regulation of protein phosphorylation [GO:0001933] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein phosphorylation [GO:0001933] GO:0001933; GO:0005634; GO:0005737; GO:0046329 LTLSLYTIGSIISAAVYLQIHTLVK 0.97137 -0.64356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4242 0 0 0 0 0 0 0 0 12.1631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4062 0 0 0 0 0 0 11.5901 0 0 0 13.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.667 0 0 0 0 0 0 0 0 0 0 13.9172 0 0 0 0 0 12.5428 0 0 0 0 0 0 0 0 0 0 0 14.7275 0 0 0 0 0 13.116 0 0 11.5041 0 0 0 0 0 0 0 0 0 0 16.6151 0 0 0 0 0 0 13.5435 0 0 0 Q9UI30 TR112_HUMAN Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog) TRMT112 AD-001 HSPC152 HSPC170 Homo sapiens (Human) histone lysine methylation [GO:0034968]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]; tRNA N2-guanine methylation [GO:0002940] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; histone lysine methylation [GO:0034968]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; tRNA methylation [GO:0030488]; tRNA N2-guanine methylation [GO:0002940] GO:0002940; GO:0005654; GO:0005829; GO:0008276; GO:0018364; GO:0030488; GO:0031167; GO:0032991; GO:0034968; GO:0046982; GO:0048471; GO:0070476; GO:2000234 protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276] GVGSRGFPLR 0.97138 -0.64417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L3X4 MT1DP_HUMAN Putative metallothionein MT1DP MT1DP MTM Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] GO:0005634; GO:0005737; GO:0006882; GO:0010273; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872] CTSCKKNCCSCCPMGCAK 0.97139 -0.64904 0 0 0 0 0 0 10.249 12.2307 12.4509 0 0 13.407 0 0 0 0 0 12.4471 19.2219 0 0 0 11.2497 0 9.97054 11.9251 0 14.2869 0 11.463 0 12.8826 0 0 0 0 15.5866 0 0 12.2492 0 13.9717 14.1094 0 11.8738 13.8565 11.0796 0 0 13.1445 10.786 0 0 0 10.3113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8994 0 0 12.734 0 0 13.487 10.8604 13.6354 11.2907 20.1628 0 12.5701 12.0608 0 0 11.1295 0 0 11.5546 0 0 11.0609 13.2076 0 0 11.4577 0 12.9018 0 12.5494 0 0 13.525 0 20.4034 0 0 13.866 0 0 0 0 13.2175 0 0 0 0 12.0802 12.0632 0 13.7693 0 11.248 20.4082 0 11.6391 0 13.9437 12.5294 11.4177 11.8285 19.7823 0 14.17 0 0 0 0 0 19.9323 0 15.256 19.5884 14.6393 0 13.8493 16.3389 0 12.5708 13.9954 0 0 0 0 13.881 0 12.6903 13.8473 13.082 0 15.3522 16.4885 15.6407 13.5757 14.0516 13.9499 13.1596 15.5275 15.108 0 13.244 0 15.2575 0 0 20.4949 15.5003 0 15.4226 P10619 PPGB_HUMAN "Lysosomal protective protein, EC 3.4.16.5 (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A, PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain ]" CTSA PPGB Homo sapiens (Human) intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185]; intracellular protein transport [GO:0006886]; negative regulation of chaperone-mediated autophagy [GO:1904715]; proteolysis [GO:0006508]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of protein stability [GO:0031647] GO:0004180; GO:0004185; GO:0005576; GO:0005764; GO:0005783; GO:0006508; GO:0006886; GO:0008047; GO:0016020; GO:0031647; GO:0035578; GO:0043202; GO:0043231; GO:0070062; GO:1904714; GO:1904715 carboxypeptidase activity [GO:0004180]; enzyme activator activity [GO:0008047]; serine-type carboxypeptidase activity [GO:0004185] AAPPPLFLLLLLLLLLVSWASR 0.97141 -0.50073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.703 0 0 14.7999 13.4961 0 0 14.6702 0 0 0 0 0 0 0 11.7514 0 0 0 0 0 0 0 0 12.9671 0 0 0 0 0 10.9227 0 11.2241 0 0 0 13.8379 0 11.498 0 0 0 0 12.8328 0 0 13.3002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.148 14.1232 0 0 0 0 0 0 0 0 0 12.041 11.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0596 0 12.6213 0 0 0 14.7776 0 0 0 15.0217 0 15.5958 0 0 0 0 0 0 0 0 0 14.7743 0 0 0 0 0 0 0 0 0 O00330 ODPX_HUMAN "Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein, E3BP) (Lipoyl-containing pyruvate dehydrogenase complex component X) (proX)" PDHX PDX1 Homo sapiens (Human) acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; acyltransferase activity [GO:0016746]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732] GO:0005739; GO:0005759; GO:0005967; GO:0006086; GO:0016746; GO:0045254; GO:0061732 acyltransferase activity [GO:0016746] LLRYLVGFPGRR 0.97142 -0.62551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95992 CH25H_HUMAN "Cholesterol 25-hydroxylase, EC 1.14.99.38 (Cholesterol 25-monooxygenase, h25OH)" CH25H Homo sapiens (Human) B cell chemotaxis [GO:0035754]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of fusion of virus membrane with host plasma membrane [GO:1903914]; response to type I interferon [GO:0034340]; sterol biosynthetic process [GO:0016126] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; C-4 methylsterol oxidase activity [GO:0000254]; cholesterol 25-hydroxylase activity [GO:0001567]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; steroid hydroxylase activity [GO:0008395]; B cell chemotaxis [GO:0035754]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of fusion of virus membrane with host plasma membrane [GO:1903914]; response to type I interferon [GO:0034340]; sterol biosynthetic process [GO:0016126] GO:0000254; GO:0001567; GO:0005506; GO:0005789; GO:0005829; GO:0006629; GO:0008203; GO:0008395; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0034340; GO:0035754; GO:1903914 C-4 methylsterol oxidase activity [GO:0000254]; cholesterol 25-hydroxylase activity [GO:0001567]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; steroid hydroxylase activity [GO:0008395] TASVPAR 0.97143 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5W8 FA24B_HUMAN Protein FAM24B FAM24B Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MPVIAGGILAALLLLIVVVLCLYFKIHNALK 0.97143 3.6701 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5902 0 10.3106 0 0 0 0 0 0 0 0 0 0 0 12.2769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0614 12.9122 0 0 0 12.8237 0 12.6871 0 15.6982 0 14.8211 14.5782 0 0 14.778 0 0 0 15.2791 11.1541 15.4425 10.7355 14.3524 0 0 0 0 0 14.0678 0 0 15.8769 0 13.1934 15.1576 13.574 0 0 0 11.758 0 0 0 0 14.3837 0 15.1477 14.9339 0 0 11.3288 0 0 0 0 0 0 13.0157 0 0 0 13.3378 0 13.9019 14.2797 12.8784 0 12.5305 0 0 0 0 0 0 0 11.5411 13.5951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9046 12.5225 0 0 0 0 0 0 Q9BX70 BTBD2_HUMAN BTB/POZ domain-containing protein 2 BTBD2 Homo sapiens (Human) neurogenesis [GO:0022008] cytosol [GO:0005829]; P-body [GO:0000932] cytosol [GO:0005829]; P-body [GO:0000932]; neurogenesis [GO:0022008] GO:0000932; GO:0005829; GO:0022008 ECSINRFQQVESRWGYSGTSDR 0.97143 4.2509 0 0 0 0 0 0 0 0 0 0 12.8429 0 0 0 12.3375 11.8779 0 12.1422 0 0 0 0 0 0 0 0 0 11.7123 0 11.311 0 0 0 0 0 11.1521 0 0 11.9349 0 0 0 0 12.4166 0 0 11.4464 10.838 0 0 0 0 0 0 0 0 10.1862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.302 0 0 0 0 12.3599 0 0 15.604 15.604 15.3735 13.0354 16.1165 15.6158 16.002 14.6997 15.3474 15.6043 15.5034 16.6045 14.8943 16.4301 0 15.4292 15.0174 15.0767 15.2977 0 16.3574 14.7286 16.1102 15.3428 16.5657 15.2695 15.8592 0 0 0 15.3293 0 15.8928 15.9632 14.8236 14.6756 14.383 14.5055 0 14.4303 14.2332 14.5183 15.6696 13.9352 14.3598 14.4769 14.6715 14.5449 0 0 0 0 14.0308 14.6354 14.1093 15.601 14.2184 0 0 14.0588 0 14.5464 14.865 14.1328 13.9548 0 0 0 14.2583 0 0 13.4114 0 0 14.1309 0 0 0 12.776 0 0 0 0 0 0 0 0 0 0 14.0018 0 14.1159 0 0 0 0 0 0 P0C7N5 OR8U9_HUMAN Olfactory receptor 8U9 OR8U9 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] EALKKIIINK 0.97144 -0.62931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.17 0 0 0 0 0 0 0 0 0 11.6076 0 12.0621 0 0 0 0 0 0 11.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VV17 OTUD1_HUMAN "OTU domain-containing protein 1, EC 3.4.19.12 (DUBA-7)" OTUD1 DUBA7 OTDC1 Homo sapiens (Human) protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536] cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536] GO:0004843; GO:0016579; GO:0070536 cysteine-type deubiquitinase activity [GO:0004843] QALAAAK 0.97144 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8259 0 0 0 0 0 0 0 16.8517 0 0 0 0 0 13.3315 13.7747 0 0 0 0 0 0 0 14.7168 14.8598 0 0 0 0 0 0 0 0 0 16.3335 0 0 0 0 15.0375 15.2238 0 15.1232 15.1709 0 13.0368 0 0 0 0 0 13.1659 12.7667 0 0 0 0 0 0 13.3907 13.8531 0 0 0 0 0 0 0 0 0 0 0 14.3083 0 13.6344 15.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8521 0 0 0 0 0 0 0 0 O15266 SHOX_HUMAN Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein) SHOX PHOG Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" GO:0000785; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0043231; GO:0043565; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" EELSQRLGLSEARVQVWFQNR 0.97146 -0.63573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15506 SP17_HUMAN "Sperm surface protein Sp17 (Cancer/testis antigen 22, CT22) (Sp17-1) (Sperm autoantigenic protein 17, Sperm protein 17)" SPA17 SP17 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228] cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] GO:0003351; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0007283; GO:0007338; GO:0007339; GO:0009897; GO:0031514; GO:0035686; GO:0043005; GO:0097228 calmodulin binding [GO:0005516] EEAKKMK 0.97147 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7945 14.8875 0 0 0 14.4759 13.8807 0 0 0 0 14.2283 0 0 13.3902 0 0 0 0 15.995 14.4722 0 0 0 0 0 0 0 16.2695 15.7404 0 0 0 0 0 0 0 0 0 13.9703 0 13.9221 0 0 0 0 0 0 13.3977 0 0 0 13.7673 0 0 0 0 0 0 0 0 0 14.0673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4995 0 0 0 0 0 0 Q96A58 RERG_HUMAN "Ras-related and estrogen-regulated growth inhibitor, EC 3.6.5.2" RERG Homo sapiens (Human) negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; small GTPase mediated signal transduction [GO:0007264] GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0007265; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331] LAIFGRAGVGKSALVVR 0.97148 -0.51565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9G7 AGO3_HUMAN "Protein argonaute-3, Argonaute3, hAgo3, EC 3.1.26.n2 (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3, eIF-2C 3, eIF2C 3)" AGO3 EIF2C3 Homo sapiens (Human) miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; pre-miRNA processing [GO:0031054]; regulation of stem cell proliferation [GO:0072091]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501] condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA catabolic process [GO:0006402]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; pre-miRNA processing [GO:0031054]; regulation of stem cell proliferation [GO:0072091]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]" GO:0000794; GO:0000932; GO:0003723; GO:0003725; GO:0003727; GO:0004521; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0010501; GO:0010628; GO:0016020; GO:0016442; GO:0031054; GO:0035196; GO:0035198; GO:0035278; GO:0036464; GO:0046872; GO:0070578; GO:0070922; GO:0072091; GO:0090624; GO:1901224 "double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]" DAGMPIQGQPCFCKYAQGADSVEPMFR 0.97148 -0.63996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3009 0 0 0 13.0665 0 0 0 0 0 0 0 14.7192 0 0 0 0 0 0 13.3336 0 0 0 0 0 0 0 0 0 12.9331 0 0 0 0 0 0 12.7792 16.2291 0 12.3494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5522 0 0 0 14.1585 0 0 12.3636 A1L020 MEX3A_HUMAN RNA-binding protein MEX3A (RING finger and KH domain-containing protein 4) MEX3A RKHD4 Homo sapiens (Human) cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0000932; GO:0003723; GO:0005634; GO:0005829; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723] LCALYKEAELR 0.97149 -0.6408 0 0 0 0 0 0 13.6964 0 0 0 0 0 0 0 14.6734 0 0 0 0 0 0 0 0 0 0 0 14.0464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9454 0 0 0 0 0 0 12.694 0 15.9119 13.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4359 14.8815 14.74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6154 0 16.8261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43699 NKX21_HUMAN "Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1, TTF-1) (Thyroid-specific enhancer-binding protein, T/EBP)" NKX2-1 NKX2A TITF1 TTF1 Homo sapiens (Human) "anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex cell migration [GO:0021795]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; club cell differentiation [GO:0060486]; developmental induction [GO:0031128]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain neuron fate commitment [GO:0021877]; gene expression [GO:0010467]; globus pallidus development [GO:0021759]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; interneuron migration [GO:1904936]; Leydig cell differentiation [GO:0033327]; locomotory behavior [GO:0007626]; lung development [GO:0030324]; lung saccule development [GO:0060430]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oligodendrocyte differentiation [GO:0048709]; phospholipid metabolic process [GO:0006644]; pituitary gland development [GO:0021983]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]; type II pneumocyte differentiation [GO:0060510]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure formation involved in morphogenesis [GO:0048646]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebral cortex cell migration [GO:0021795]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; club cell differentiation [GO:0060486]; developmental induction [GO:0031128]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain neuron fate commitment [GO:0021877]; gene expression [GO:0010467]; globus pallidus development [GO:0021759]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; interneuron migration [GO:1904936]; Leydig cell differentiation [GO:0033327]; locomotory behavior [GO:0007626]; lung development [GO:0030324]; lung saccule development [GO:0060430]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oligodendrocyte differentiation [GO:0048709]; phospholipid metabolic process [GO:0006644]; pituitary gland development [GO:0021983]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]; rhythmic process [GO:0048511]; thyroid gland development [GO:0030878]; type II pneumocyte differentiation [GO:0060510]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001161; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006644; GO:0007411; GO:0007420; GO:0007492; GO:0007626; GO:0009725; GO:0010467; GO:0010628; GO:0010719; GO:0019899; GO:0021759; GO:0021766; GO:0021795; GO:0021798; GO:0021854; GO:0021877; GO:0021892; GO:0021983; GO:0030154; GO:0030324; GO:0030336; GO:0030512; GO:0030878; GO:0030900; GO:0031128; GO:0033327; GO:0042753; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0048646; GO:0048709; GO:0060430; GO:0060441; GO:0060486; GO:0060510; GO:0061629; GO:1904936 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]" HTTPFSVSDILSPLEESYK 0.9715 -0.64315 0 0 0 0 0 0 0 0 15.5076 0 16.2122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9831 0 15.9398 0 16.0832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8669 13.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FW1 OTUB1_HUMAN "Ubiquitin thioesterase OTUB1, EC 3.4.19.12 (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1, hOTU1) (Ubiquitin-specific-processing protease OTUB1)" OTUB1 OTB1 OTU1 HSPC263 Homo sapiens (Human) adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108] GO:0002250; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0019784; GO:0031625; GO:0043130; GO:0070062; GO:0071108; GO:1901315; GO:2000780 cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] GEGGTTNPHIFPEGSEPKVYLLYR 0.97152 -0.6489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S59 RANB9_HUMAN "Ran-binding protein 9, RanBP9 (BPM-L) (BPM90) (Ran-binding protein M, RanBPM) (RanBP7)" RANBP9 RANBPM Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; protein-containing complex assembly [GO:0065003] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; enzyme binding [GO:0019899]; small GTPase binding [GO:0031267]; cell surface receptor signaling pathway [GO:0007166]; cytoskeleton organization [GO:0007010]; microtubule nucleation [GO:0007020]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; protein-containing complex assembly [GO:0065003] GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007010; GO:0007020; GO:0007166; GO:0016604; GO:0019899; GO:0031267; GO:0065003; GO:0070373; GO:1902993 enzyme binding [GO:0019899]; small GTPase binding [GO:0031267] EGEWQTMIQK 0.97155 -0.62506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NU1 SAM11_HUMAN "Sterile alpha motif domain-containing protein 11, SAM domain-containing protein 11" SAMD11 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393] DSDGEDPETAAVGCR 0.97156 3.2197 0 0 0 0 0 11.6739 10.0712 0 0 0 0 0 13.6251 0 0 0 10.4827 11.6056 0 0 0 0 0 0 0 0 0 0 9.77271 0 0 0 0 0 0 0 0 0 10.4784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7764 0 0 0 16.5972 11.2406 14.3078 0 13.3049 12.2036 0 0 0 11.7814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5693 0 0 0 0 14.4083 0 14.2926 0 0 0 0 0 0 0 0 0 14.0243 0 0 0 0 0 0 0 0 13.7123 0 13.1936 0 0 0 0 0 13.957 12.5092 13.0406 0 0 0 0 14.5105 13.1421 0 0 0 12.8698 0 0 13.4606 0 0 0 12.9474 12.9532 14.9882 13.3685 0 0 0 0 0 0 0 0 12.1683 0 0 0 0 0 0 0 0 0 0 0 12.9708 0 12.1519 0 0 0 Q03014 HHEX_HUMAN "Hematopoietically-expressed homeobox protein HHEX, Homeobox protein HEX (Homeobox protein PRH)" HHEX HEX PRH PRHX Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; cell differentiation [GO:0030154]; DNA conformation change [GO:0071103]; mRNA export from nucleus [GO:0006406]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to nucleus [GO:0034504]; regulation of leukocyte proliferation [GO:0070663]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; eukaryotic initiation factor 4E binding [GO:0008190]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription cis-regulatory region binding [GO:0000976]; anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; cell differentiation [GO:0030154]; DNA conformation change [GO:0071103]; mRNA export from nucleus [GO:0006406]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription by transcription factor localization [GO:0010621]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to nucleus [GO:0034504]; regulation of leukocyte proliferation [GO:0070663]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005737; GO:0006357; GO:0006406; GO:0008190; GO:0008301; GO:0009952; GO:0010621; GO:0010944; GO:0016055; GO:0016525; GO:0016973; GO:0017025; GO:0030154; GO:0030177; GO:0030183; GO:0030948; GO:0032993; GO:0034504; GO:0042803; GO:0043565; GO:0045736; GO:0045892; GO:0045893; GO:0045944; GO:0070663; GO:0071103; GO:0090263; GO:0140297 "DNA binding, bending [GO:0008301]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; eukaryotic initiation factor 4E binding [GO:0008190]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription cis-regulatory region binding [GO:0000976]" PLLWSPFLQR 0.97157 -0.50435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5137 12.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H777 RNZ1_HUMAN "Zinc phosphodiesterase ELAC protein 1, EC 3.1.26.11 (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1, RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1)" ELAC1 D29 Homo sapiens (Human) tRNA 3'-trailer cleavage [GO:0042779] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]; tRNA 3'-trailer cleavage [GO:0042779] GO:0005634; GO:0005654; GO:0005829; GO:0042779; GO:0042781; GO:0046872 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872] CEGECWLFDCGEGTQTQLMK 0.97157 -0.50349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5975 0 0 0 0 0 0 12.4934 0 0 0 0 0 0 0 0 0 0 0 13.9912 18.8349 0 0 19.0899 0 0 0 0 0 0 0 0 0 11.461 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2647 0 0 0 0 19.6889 0 0 0 0 0 0 0 0 0 19.4224 0 11.6171 0 0 0 0 13.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2602 0 0 0 0 0 19.7778 0 0 0 0 0 Q9NUM3 S39A9_HUMAN "Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9, ZIP-9)" SLC39A9 ZIP9 UNQ714/PRO1377 Homo sapiens (Human) zinc ion transport [GO:0006829] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873]; zinc ion transport [GO:0006829] GO:0006829; GO:0016021; GO:0046873 metal ion transmembrane transporter activity [GO:0046873] PDATGGR 0.97157 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4666 0 15.2509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7287 0 0 0 12.9456 0 0 0 13.637 13.106 0 0 12.8083 0 13.236 0 0 0 14.6689 12.7316 0 0 13.5929 0 0 12.7742 0 0 0 0 0 13.196 0 0 13.6376 14.7535 0 12.7078 0 0 0 0 0 0 13.4966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7673 0 14.4816 0 0 0 0 0 E5RIL1 UPKL2_HUMAN Uroplakin-3b-like protein 2 UPK3BL2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ANRVLYQTR 0.97158 -0.50752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6401 0 0 0 0 0 0 11.1237 0 0 0 0 0 0 0 0 0 P08195 4F2_HUMAN "4F2 cell-surface antigen heavy chain, 4F2hc (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98)" SLC3A2 MDU1 Homo sapiens (Human) amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; phenylalanine transport [GO:0015823]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718] amino acid transport complex [GO:1990184]; anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; apical pole of neuron [GO:0044225]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] amino acid transport complex [GO:1990184]; anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; apical pole of neuron [GO:0044225]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; aromatic amino acid transmembrane transporter activity [GO:0015173]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; double-stranded RNA binding [GO:0003725]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723]; amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; phenylalanine transport [GO:0015823]; response to exogenous dsRNA [GO:0043330]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718] GO:0003723; GO:0003725; GO:0005432; GO:0005654; GO:0005765; GO:0005886; GO:0005975; GO:0006816; GO:0006865; GO:0009925; GO:0009986; GO:0015173; GO:0015175; GO:0015180; GO:0015190; GO:0015820; GO:0015823; GO:0015827; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0042470; GO:0043330; GO:0044225; GO:0045202; GO:0045296; GO:0046718; GO:0070062; GO:0070161; GO:0098713; GO:1903801; GO:1904273; GO:1990184 aromatic amino acid transmembrane transporter activity [GO:0015173]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; double-stranded RNA binding [GO:0003725]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; RNA binding [GO:0003723] GLVLGPIHK 0.97161 3.2186 13.2709 0 0 0 0 11.2352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6266 0 12.2778 11.7124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3453 14.7077 14.2536 14.5008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0175 0 0 0 0 0 0 0 0 0 16.8256 0 0 0 0 0 0 0 0 14.07 0 14.593 0 11.2755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6021 0 0 0 0 11.9037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0065 0 0 0 0 0 0 0 0 0 0 0 P52895 AK1C2_HUMAN "Aldo-keto reductase family 1 member C2, EC 1.-.-.-, EC 1.1.1.112, EC 1.1.1.209, EC 1.1.1.53, EC 1.1.1.62, EC 1.3.1.20 (3-alpha-HSD3) (Chlordecone reductase homolog HAKRD) (Dihydrodiol dehydrogenase 2, DD-2, DD2) (Dihydrodiol dehydrogenase/bile acid-binding protein, DD/BABP) (Type III 3-alpha-hydroxysteroid dehydrogenase, EC 1.1.1.357)" AKR1C2 DDH2 Homo sapiens (Human) cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202] cytosol [GO:0005829] "cytosol [GO:0005829]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; steroid dehydrogenase activity [GO:0016229]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]" GO:0004032; GO:0005829; GO:0006693; GO:0007186; GO:0007586; GO:0008202; GO:0008284; GO:0016229; GO:0016655; GO:0018636; GO:0030855; GO:0031406; GO:0032052; GO:0042448; GO:0044594; GO:0044597; GO:0044598; GO:0047023; GO:0047044; GO:0047086; GO:0047115; GO:0047718; GO:0051897; GO:0071395; GO:0071799 "17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; phenanthrene 9,10-monooxygenase activity [GO:0018636]; steroid dehydrogenase activity [GO:0016229]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]" IADGSVKREDIFYTSK 0.97161 -0.63883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4613 0 0 0 0 0 0 0 0 0 0 0 0 17.0168 0 0 0 17.5011 0 0 0 0 0 0 0 0 16.5949 0 15.4624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7874 0 0 0 0 0 0 0 0 P35270 SPRE_HUMAN "Sepiapterin reductase, SPR, EC 1.1.1.153" SPR Homo sapiens (Human) nitric oxide biosynthetic process [GO:0006809]; tetrahydrobiopterin biosynthetic process [GO:0006729] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; aldo-keto reductase (NADP) activity [GO:0004033]; NADP binding [GO:0050661]; sepiapterin reductase activity [GO:0004757]; nitric oxide biosynthetic process [GO:0006809]; tetrahydrobiopterin biosynthetic process [GO:0006729] GO:0004033; GO:0004757; GO:0005654; GO:0005829; GO:0006729; GO:0006809; GO:0050661; GO:0070062 aldo-keto reductase (NADP) activity [GO:0004033]; NADP binding [GO:0050661]; sepiapterin reductase activity [GO:0004757] AVCLLTGASR 0.97162 -0.51763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3296 0 0 0 0 0 0 0 0 15.153 15.3032 0 0 0 0 0 0 0 0 0 0 0 12.7393 0 14.4433 0 0 14.5891 0 13.9882 0 0 0 0 0 0 0 0 0 12.5468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9032 0 0 0 0 P21695 GPDA_HUMAN "Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic, GPD-C, GPDH-C, EC 1.1.1.8" GPD1 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821] GO:0004367; GO:0004368; GO:0005829; GO:0006072; GO:0006094; GO:0006116; GO:0006127; GO:0009331; GO:0042803; GO:0045821; GO:0046168; GO:0046486; GO:0051287; GO:0070062; GO:0071320; GO:0071356 glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803] ANATGISLIK 0.97165 -0.64847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EM0 T3HPD_HUMAN "Trans-3-hydroxy-L-proline dehydratase, EC 4.2.1.77 (Trans-L-3-hydroxyproline dehydratase)" L3HYPDH C14orf149 Homo sapiens (Human) hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346] GO:0016836; GO:0050346 hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346] IALQYHKGLLELNQMRAFK 0.97165 3.216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2795 0 0 0 0 0 0 12.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48729 KC1A_HUMAN "Casein kinase I isoform alpha, CKI-alpha, EC 2.7.11.1 (CK1)" CSNK1A1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell surface receptor signaling pathway [GO:0007166]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055] GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0006468; GO:0007030; GO:0007049; GO:0007165; GO:0007166; GO:0016020; GO:0016055; GO:0016607; GO:0018105; GO:0019082; GO:0030877; GO:0032436; GO:0036064; GO:0043161; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1904424 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AEFIVGGKYK 0.97168 -1.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2823 0 0 0 0 0 13.3971 0 15.5034 12.1003 0 0 0 0 0 0 0 0 0 13.7883 0 0 0 0 0 13.7986 0 0 0 0 13.6128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5637 14.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.832 0 0 0 0 0 0 Q8IXH7 NELFD_HUMAN "Negative elongation factor C/D, NELF-C/D (TH1-like protein)" NELFCD NELFD TH1 TH1L HSPC130 Homo sapiens (Human) negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244] membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244] GO:0003723; GO:0005634; GO:0005654; GO:0016020; GO:0032021; GO:0034244 RNA binding [GO:0003723] DLFYKLAEAHPDCLMLNFTVK 0.97168 -0.62329 0 0 0 11.2796 0 0 0 0 0 12.774 0 0 0 0 0 12.7113 0 0 0 0 0 0 12.3714 0 0 0 0 0 0 0 0 0 0 12.1717 0 0 12.77 0 0 12.2855 0 0 0 0 0 0 10.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6211 0 0 0 12.0207 0 0 0 0 0 12.7966 12.6956 0 12.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2242 0 0 0 0 0 0 0 12.0088 0 13.6631 0 0 0 0 0 0 0 13.097 0 0 0 0 0 0 12.2026 0 12.5687 0 0 0 0 0 0 13.864 0 13.2978 0 13.6302 0 13.0011 12.539 0 0 14.1393 0 13.5714 0 0 0 0 0 13.4633 0 13.133 0 13.7099 0 0 11.5401 0 0 0 0 0 0 13.8669 14.4023 12.7638 0 0 14.9021 14.5146 0 0 0 13.4731 0 0 Q96BA8 CR3L1_HUMAN "Cyclic AMP-responsive element-binding protein 3-like protein 1, cAMP-responsive element-binding protein 3-like protein 1 (Old astrocyte specifically-induced substance, OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1 ]" CREB3L1 OASIS PSEC0238 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix constituent secretion [GO:0070278]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634] "chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; endoplasmic reticulum unfolded protein response [GO:0030968]; extracellular matrix constituent secretion [GO:0070278]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000981; GO:0001227; GO:0001228; GO:0001649; GO:0003682; GO:0005634; GO:0005783; GO:0005789; GO:0006357; GO:0010629; GO:0016020; GO:0016021; GO:0030968; GO:0032967; GO:0035497; GO:0040037; GO:0045892; GO:0046332; GO:0070278; GO:1902236; GO:1903671; GO:1990440; GO:1990837 "cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]" KKEYVECLEK 0.97171 -0.50724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4444 0 0 0 0 0 0 0 13.4598 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3506 0 0 0 0 14.2958 0 0 0 12.2877 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0064 0 0 0 0 0 0 0 0 0 12.5319 0 0 0 0 0 Q9BXL5 HEMGN_HUMAN "Hemogen (Erythroid differentiation-associated gene protein, EDAG-1) (Hemopoietic gene protein) (Negative differentiation regulator protein)" HEMGN EDAG NDR PRO1037 PRO1620 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of osteoblast differentiation [GO:0045667] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; cell differentiation [GO:0030154]; regulation of osteoblast differentiation [GO:0045667] GO:0005654; GO:0030154; GO:0045667 AEVHEKETSQWLFGEQK 0.97171 -1.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1853 0 0 14.6291 0 0 0 0 14.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2223 0 0 0 0 0 0 0 0 0 14.6465 0 0 0 0 0 0 0 0 0 0 0 0 14.2412 0 14.2787 0 0 0 14.6448 0 0 0 0 0 0 0 0 14.2916 0 0 14.978 0 0 0 0 0 0 0 0 0 12.5101 12.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4051 0 0 0 0 0 0 16.347 0 Q9H4B0 OSGL1_HUMAN "tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, EC 2.3.1.234 (N6-L-threonylcarbamoyladenine synthase, t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1, OSGEP-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1) (tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1)" OSGEPL1 GCP1 Homo sapiens (Human) tRNA threonylcarbamoyladenosine modification [GO:0002949] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949] GO:0002949; GO:0005739; GO:0046872; GO:0061711 metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711] AIEHLAKQGNRFHFDIK 0.97171 -0.50414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7654 0 0 0 0 0 16.3357 0 0 0 0 13.6969 0 0 0 0 0 0 0 14.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49703 ARL4D_HUMAN ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) ARL4D ARF4L Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005730; GO:0005737; GO:0005886; GO:0006886; GO:0009306; GO:0016192 GTP binding [GO:0005525]; GTPase activity [GO:0003924] LYEMILKRK 0.97173 -0.51027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2206 0 0 0 0 0 0 13.8597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7457 0 11.1191 0 0 0 0 0 0 0 0 13.8834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0491 0 0 0 0 0 0 0 P51665 PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40) PSMD7 MOV34L Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; protein homodimerization activity [GO:0042803]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813 protein homodimerization activity [GO:0042803] DTTVGTLSQR 0.97173 4.4131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0949 11.4926 11.7887 13.0944 0 0 0 11.409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6012 0 0 12.1872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5321 0 0 0 Q5VWP2 TET5C_HUMAN "Terminal nucleotidyltransferase 5C, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46C)" TENT5C FAM46C Homo sapiens (Human) in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; mRNA stabilization [GO:0048255]; negative regulation of cell differentiation [GO:0045596] GO:0001701; GO:0003723; GO:0004652; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0045596; GO:0048255; GO:1990817 polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723] LEEAGIKVHDVRLNGSAAGHVLVK 0.97173 3.1453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1079 0 0 0 0 0 0 0 0 0 11.1216 0 0 0 0 0 0 0 0 0 15.4866 0 0 0 0 0 0 10.9284 0 12.8656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4775 0 0 0 0 0 0 0 11.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5906 0 Q9Y4M8 CH071_HUMAN Putative uncharacterized protein encoded by LINC00588 LINC00588 C8orf71 Homo sapiens (Human) CSAIGFR 0.97173 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1655 0 0 0 0 0 0 11.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8336 0 0 0 0 11.9176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.423 0 Q3ZCW2 LEGL_HUMAN Galectin-related protein (Galectin-like protein) (Lectin galactoside-binding-like protein) LGALSL GRP HSPC159 Homo sapiens (Human) carbohydrate binding [GO:0030246] GO:0030246 carbohydrate binding [GO:0030246] FRVFVDGHQLFDFYHRIQTLSAIDTIK 0.97176 -0.5202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7688 0 0 0 11.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3572 0 0 13.4503 13.7993 13.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.092 0 0 0 0 0 0 0 0 0 0 0 0 0 11.309 0 0 0 12.4151 0 0 0 0 0 0 0 0 0 12.8171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07196 NFL_HUMAN "Neurofilament light polypeptide, NF-L (68 kDa neurofilament protein) (Neurofilament triplet L protein)" NEFL NF68 NFL Homo sapiens (Human) anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cerebral cortex development [GO:0021987]; hippocampus development [GO:0021766]; intermediate filament organization [GO:0045109]; intermediate filament polymerization or depolymerization [GO:0045105]; locomotion [GO:0040011]; microtubule cytoskeleton organization [GO:0000226]; motor neuron apoptotic process [GO:0097049]; negative regulation of motor neuron apoptotic process [GO:2000672]; neurofilament bundle assembly [GO:0033693]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular process controlling balance [GO:0050885]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axonogenesis [GO:0050772]; protein polymerization [GO:0051258]; regulation of axon diameter [GO:0031133]; response to acrylamide [GO:1903937]; response to corticosterone [GO:0051412]; response to peptide hormone [GO:0043434]; response to sodium arsenite [GO:1903935]; response to toxic substance [GO:0009636]; retrograde axonal transport [GO:0008090]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intermediate filament [GO:0005882]; neurofilament [GO:0005883]; neuromuscular junction [GO:0031594]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; presynaptic intermediate filament cytoskeleton [GO:0099182]; Schaffer collateral - CA1 synapse [GO:0098685] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cholinergic synapse [GO:0098981]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intermediate filament [GO:0005882]; neurofilament [GO:0005883]; neuromuscular junction [GO:0031594]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; presynaptic intermediate filament cytoskeleton [GO:0099182]; Schaffer collateral - CA1 synapse [GO:0098685]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic intermediate filament cytoskeleton [GO:0099184]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cerebral cortex development [GO:0021987]; hippocampus development [GO:0021766]; intermediate filament organization [GO:0045109]; intermediate filament polymerization or depolymerization [GO:0045105]; locomotion [GO:0040011]; microtubule cytoskeleton organization [GO:0000226]; motor neuron apoptotic process [GO:0097049]; negative regulation of motor neuron apoptotic process [GO:2000672]; neurofilament bundle assembly [GO:0033693]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular process controlling balance [GO:0050885]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axonogenesis [GO:0050772]; protein polymerization [GO:0051258]; regulation of axon diameter [GO:0031133]; response to acrylamide [GO:1903937]; response to corticosterone [GO:0051412]; response to peptide hormone [GO:0043434]; response to sodium arsenite [GO:1903935]; response to toxic substance [GO:0009636]; retrograde axonal transport [GO:0008090]; spinal cord development [GO:0021510]; synapse maturation [GO:0060074] GO:0000226; GO:0005200; GO:0005737; GO:0005829; GO:0005882; GO:0005883; GO:0007409; GO:0008022; GO:0008089; GO:0008090; GO:0009636; GO:0014012; GO:0019896; GO:0019904; GO:0021510; GO:0021766; GO:0021987; GO:0030424; GO:0030426; GO:0030674; GO:0031133; GO:0031594; GO:0033693; GO:0040011; GO:0042802; GO:0043274; GO:0043434; GO:0044877; GO:0045105; GO:0045109; GO:0050772; GO:0050885; GO:0051258; GO:0051412; GO:0060052; GO:0060074; GO:0097049; GO:0098685; GO:0098981; GO:0099160; GO:0099182; GO:0099184; GO:1903935; GO:1903937; GO:1904115; GO:2000672 identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic intermediate filament cytoskeleton [GO:0099184] DEPPSEGEAEEEEKDK 0.97179 4.2381 0 0 0 0 0 0 0 0 0 12.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9981 0 0 10.468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3173 0 0 0 0 0 0 0 0 12.4841 0 0 0 0 0 0 0 0 0 14.1175 0 0 11.4009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8265 0 0 0 0 12.8617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6157 0 0 0 0 0 0 11.6945 10.9592 0 0 0 0 0 0 0 0 0 Q99743 NPAS2_HUMAN "Neuronal PAS domain-containing protein 2, Neuronal PAS2 (Basic-helix-loop-helix-PAS protein MOP4) (Class E basic helix-loop-helix protein 9, bHLHe9) (Member of PAS protein 4) (PAS domain-containing protein 4)" NPAS2 BHLHE9 MOP4 PASD4 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; negative regulation of cell death [GO:0060548]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775]; response to xenobiotic stimulus [GO:0009410]" chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; negative regulation of cell death [GO:0060548]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775]; response to xenobiotic stimulus [GO:0009410]" GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0006974; GO:0007417; GO:0009410; GO:0032922; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0046983; GO:0051775; GO:0051879; GO:0060548; GO:1990513; GO:1990837; GO:2000987; GO:2001020 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" IQEQLCLVQDSNVQMFLQQPAVSLSFSSTQR 0.97179 -0.58745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7864 0 0 11.9452 13.4996 0 0 12.4513 12.426 12.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6904 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05091 ALDH2_HUMAN "Aldehyde dehydrogenase, mitochondrial, EC 1.2.1.3 (ALDH class 2) (ALDH-E2) (ALDHI)" ALDH2 ALDM Homo sapiens (Human) alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylic ester hydrolase activity [GO:0052689]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627] GO:0004029; GO:0004030; GO:0005739; GO:0005759; GO:0005975; GO:0006066; GO:0006068; GO:0008957; GO:0009055; GO:0018547; GO:0043878; GO:0046185; GO:0051287; GO:0052689; GO:0070062; GO:1903179; GO:1905627 aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylic ester hydrolase activity [GO:0052689]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957] FGPRLGRR 0.9718 -1.0801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.46469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4948 14.111 13.51 14.6517 0 0 14.2764 0 0 16.7211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZS6 DYLT2_HUMAN "Dynein light chain Tctex-type protein 2 (T-complex testis-specific protein 3) (T-complex-associated testis-expressed protein 3, Tcte-3) (Tctex1 domain-containing protein 3)" DYNLT2 TCTE3 TCTEX1D3 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; membrane [GO:0016020]; microtubule [GO:0005874] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; membrane [GO:0016020]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; microtubule-based movement [GO:0007018] GO:0005737; GO:0005868; GO:0005874; GO:0007018; GO:0016020; GO:0045505 dynein intermediate chain binding [GO:0045505] FIIKVLFIQK 0.97181 -0.62293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8327 0 0 10.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVA2 SEP11_HUMAN Septin-11 SEPTIN11 SEPT11 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104] anchoring junction [GO:0070161]; axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725] anchoring junction [GO:0070161]; axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104] GO:0001725; GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0030424; GO:0031105; GO:0032153; GO:0043197; GO:0060090; GO:0061640; GO:0070161 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] DTDPDSKPFSLQETYEAK 0.97181 3.1429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1577 0 0 0 0 0 14.6515 0 0 0 11.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0247 0 11.5175 12.9599 0 0 0 0 0 0 0 0 0 0 10.5503 0 0 0 0 0 0 0 0 0 11.6269 0 0 Q96H78 S2544_HUMAN Solute carrier family 25 member 44 SLC25A44 KIAA0446 Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; branched-chain amino acid transmembrane transporter activity [GO:0015658]; branched-chain amino acid catabolic process [GO:0009083]; branched-chain amino acid transport [GO:0015803]; regulation of cold-induced thermogenesis [GO:0120161] GO:0005739; GO:0009083; GO:0015658; GO:0015803; GO:0016021; GO:0031966; GO:0120161 branched-chain amino acid transmembrane transporter activity [GO:0015658] GFYRGYVASLLTYIPNSAVWWPFYHFYAEQLSYLCPK 0.97184 -1.0922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.436 0 0 0 0 0 9.75692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3325 0 0 0 0 0 0 0 0 0 0 0 12.4031 0 0 0 0 0 0 0 12.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6338 0 0 0 0 12.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02413 DSG1_HUMAN "Desmoglein-1 (Cadherin family member 4) (Desmosomal glycoprotein 1, DG1, DGI) (Pemphigus foliaceus antigen)" DSG1 CDHF4 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maternal process involved in female pregnancy [GO:0060135]; protein stabilization [GO:0050821]; response to progesterone [GO:0032570] apical plasma membrane [GO:0016324]; cornified envelope [GO:0001533]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cornified envelope [GO:0001533]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; toxic substance binding [GO:0015643]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maternal process involved in female pregnancy [GO:0060135]; protein stabilization [GO:0050821]; response to progesterone [GO:0032570] GO:0001533; GO:0005509; GO:0005829; GO:0005886; GO:0007043; GO:0007156; GO:0009898; GO:0015643; GO:0016021; GO:0016324; GO:0016328; GO:0016339; GO:0030057; GO:0032570; GO:0045295; GO:0050821; GO:0060135; GO:0098609; GO:0101003 calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; toxic substance binding [GO:0015643] DGGADGMSAECECNIK 0.97185 3.0011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2749 0 0 0 0 0 0 0 0 0 0 0 0 0 11.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7342 0 0 0 0 0 0 0 0 0 0 0 Q99832 TCPH_HUMAN "T-complex protein 1 subunit eta, TCP-1-eta (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed ]" CCT7 CCTH NIP7-1 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998] GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:0140662; GO:1901998; GO:1904851; GO:1904871; GO:1904874 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] AEKDNAEIR 0.97186 -0.50897 0 0 0 0 0 0 15.1278 0 15.009 0 13.7593 0 12.3971 0 12.0951 0 0 0 12.8432 0 0 0 0 0 0 0 0 0 11.6535 11.4103 0 0 15.6258 15.0433 15.4761 0 0 16.2095 15.5603 17.4114 0 0 10.6391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6486 17.4629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9638 0 0 16.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0M8Q6 IGLC7_HUMAN Immunoglobulin lambda constant 7 (Ig lambda-7 chain C region) IGLC7 Homo sapiens (Human) "adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgD immunoglobulin complex [GO:0071738]; IgE immunoglobulin complex [GO:0071742]; IgG immunoglobulin complex [GO:0071735]; IgM immunoglobulin complex [GO:0071753]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgD immunoglobulin complex [GO:0071738]; IgE immunoglobulin complex [GO:0071742]; IgG immunoglobulin complex [GO:0071735]; IgM immunoglobulin complex [GO:0071753]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0071735; GO:0071738; GO:0071742; GO:0071745; GO:0071753 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] VGVETTK 0.97187 -0.51016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4238 0 0 0 0 0 0 0 0 0 16.6181 0 0 0 0 0 14.118 12.9343 0 13.1289 14.8008 0 0 0 0 0 16.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0165 0 14.2251 0 0 0 0 0 0 0 0 0 0 14.39 0 0 0 0 0 0 14.6 0 0 0 0 0 0 0 0 0 14.6972 0 14.7188 0 0 0 0 14.3317 0 0 0 0 0 0 0 14.4003 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9642 0 0 0 0 0 0 0 0 14.5555 14.0282 0 0 0 0 0 0 0 0 14.8173 0 0 0 0 0 0 0 0 0 0 0 17.4331 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGH7 CC160_HUMAN Coiled-coil domain-containing protein 160 CCDC160 Homo sapiens (Human) GELSVIKNELRTEK 0.97187 -0.51138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92552 RT27_HUMAN "28S ribosomal protein S27, mitochondrial, MRP-S27, S27mt (Mitochondrial ribosomal protein S27) (Mitochondrial small ribosomal subunit protein mS27)" MRPS27 KIAA0264 Homo sapiens (Human) cell population proliferation [GO:0008283]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; cell population proliferation [GO:0008283]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131] GO:0000049; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005763; GO:0008283; GO:0019843; GO:0032543; GO:0070131; GO:0097177 mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049] LCREALDVLGAVLK 0.97188 -0.51322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWX9 SELM_HUMAN "Selenoprotein M, SelM" SELENOM SELM Homo sapiens (Human) adipose tissue development [GO:0060612]; corticosterone secretion [GO:0035934]; hormone metabolic process [GO:0042445]; multicellular organism growth [GO:0035264]; response to selenium ion [GO:0010269] endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; oxidoreductase activity [GO:0016491]; adipose tissue development [GO:0060612]; corticosterone secretion [GO:0035934]; hormone metabolic process [GO:0042445]; multicellular organism growth [GO:0035264]; response to selenium ion [GO:0010269] GO:0005788; GO:0005794; GO:0010269; GO:0016491; GO:0035264; GO:0035934; GO:0042445; GO:0048471; GO:0060612 oxidoreductase activity [GO:0016491] SLLLPPLALLLLLAALVAPATAATAYR 0.97189 3.001 0 0 0 0 0 0 0 0 0 0 13.7104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7351 0 0 0 0 0 0 0 0 0 0 12.6426 0 12.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.578 14.353 0 0 0 0 0 0 0 0 0 10.6513 0 0 13.6385 0 0 0 0 0 13.512 0 0 14.0745 0 0 0 0 0 0 14.3413 0 0 14.1443 0 0 0 0 0 0 0 0 0 0 13.672 0 0 0 0 13.3894 13.5285 0 0 13.4126 11.8048 0 0 0 0 0 13.4512 0 0 0 0 0 0 0 0 14.3866 0 0 12.913 13.5399 11.8929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3749 0 0 0 0 0 14.3243 0 0 0 0 0 0 0 0 13.3092 Q8NH48 OR5B3_HUMAN Olfactory receptor 5B3 (Olfactory receptor 5B13) (Olfactory receptor OR11-239) OR5B3 OR5B13 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] KVVEKAK 0.9719 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1969 16.0909 0 0 0 16.9743 0 16.7636 0 15.9713 0 0 0 0 0 0 0 0 16.3093 0 15.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2025 16.3652 0 16.3461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9814 0 0 0 P50222 MEOX2_HUMAN Homeobox protein MOX-2 (Growth arrest-specific homeobox) (Mesenchyme homeobox 2) MEOX2 GAX MOX2 Homo sapiens (Human) angiogenesis [GO:0001525]; limb development [GO:0060173]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]; somite development [GO:0061053]; somite specification [GO:0001757] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; limb development [GO:0060173]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]; somite development [GO:0061053]; somite specification [GO:0001757]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001757; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007519; GO:0016607; GO:0043565; GO:0045944; GO:0060021; GO:0060173; GO:0061053; GO:0090051; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" QALSPAEAEK 0.97192 -1.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9507 0 0 0 0 0 0 0 0 0 0 0 0 Q15185 TEBP_HUMAN "Prostaglandin E synthase 3, EC 5.3.99.3 (Cytosolic prostaglandin E2 synthase, cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23)" PTGES3 P23 TEBP Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; cyclooxygenase pathway [GO:0019371]; fibroblast proliferation [GO:0048144]; glucocorticoid receptor signaling pathway [GO:0042921]; glycogen biosynthetic process [GO:0005978]; lung saccule development [GO:0060430]; positive regulation of phosphorylation [GO:0042327]; positive regulation of telomerase activity [GO:0051973]; prostaglandin biosynthetic process [GO:0001516]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; signal transduction [GO:0007165]; skin development [GO:0043588]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004] "chaperone complex [GO:0101031]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; telomerase holoenzyme complex [GO:0005697]" "chaperone complex [GO:0101031]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; telomerase holoenzyme complex [GO:0005697]; chaperone binding [GO:0051087]; DNA polymerase binding [GO:0070182]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; telomerase activity [GO:0003720]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; cyclooxygenase pathway [GO:0019371]; fibroblast proliferation [GO:0048144]; glucocorticoid receptor signaling pathway [GO:0042921]; glycogen biosynthetic process [GO:0005978]; lung saccule development [GO:0060430]; positive regulation of phosphorylation [GO:0042327]; positive regulation of telomerase activity [GO:0051973]; prostaglandin biosynthetic process [GO:0001516]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; signal transduction [GO:0007165]; skin development [GO:0043588]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]" GO:0000723; GO:0000781; GO:0001516; GO:0003720; GO:0005634; GO:0005654; GO:0005697; GO:0005829; GO:0005978; GO:0006457; GO:0007004; GO:0007165; GO:0019371; GO:0032991; GO:0042327; GO:0042921; GO:0043588; GO:0048144; GO:0050220; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0051131; GO:0051879; GO:0051973; GO:0060430; GO:0070182; GO:0101031; GO:1905323 chaperone binding [GO:0051087]; DNA polymerase binding [GO:0070182]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; telomerase activity [GO:0003720]; unfolded protein binding [GO:0051082] DVNVNFEK 0.97193 -0.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3995 0 12.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9372 0 0 0 13.9248 0 0 0 0 0 0 0 0 0 11.1387 0 0 10.5954 0 0 0 0 0 0 11.7325 13.5477 0 0 12.5484 12.7509 0 0 10.8225 0 0 0 11.785 0 0 0 0 10.6545 0 0 0 13.246 11.2098 0 11.2636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8433 13.8474 0 0 0 0 0 0 0 0 15.0927 0 13.8187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWB1 I27RA_HUMAN "Interleukin-27 receptor subunit alpha, IL-27 receptor subunit alpha, IL-27R subunit alpha, IL-27R-alpha, IL-27RA (Cytokine receptor WSX-1) (Cytokine receptor-like 1) (Type I T-cell cytokine receptor, TCCR) (ZcytoR1)" IL27RA CRL1 TCCR WSX1 UNQ296/PRO336 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell extravasation [GO:2000408]; negative regulation of T-helper 17 type immune response [GO:2000317]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T-helper 1 type immune response [GO:0002827]; regulation of isotype switching to IgG isotypes [GO:0048302] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-27 receptor activity [GO:0045509]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell extravasation [GO:2000408]; negative regulation of T-helper 17 type immune response [GO:2000317]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of T-helper 1 type immune response [GO:0002827]; regulation of isotype switching to IgG isotypes [GO:0048302] GO:0002827; GO:0002829; GO:0004888; GO:0004896; GO:0005886; GO:0005887; GO:0006955; GO:0007166; GO:0009897; GO:0019221; GO:0019955; GO:0032700; GO:0032715; GO:0032720; GO:0032729; GO:0042022; GO:0042104; GO:0043235; GO:0043524; GO:0045509; GO:0048302; GO:0050830; GO:0072536; GO:2000317; GO:2000408 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-27 receptor activity [GO:0045509]; transmembrane signaling receptor activity [GO:0004888] CYHLRHKVLPR 0.97194 -0.62206 0 0 0 0 0 0 0 0 0 0 0 13.317 0 0 0 0 10.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9087 0 15.019 0 0 14.4291 13.5274 0 0 0 11.928 13.9941 14.8962 0 0 0 0 12.9073 0 0 0 0 0 0 0 0 12.9531 0 0 0 0 0 0 0 12.7559 0 0 0 0 11.1712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5199 0 0 0 0 0 0 0 0 10.7722 0 0 0 0 0 0 0 0 0 12.7371 11.5249 0 O43736 ITM2A_HUMAN Integral membrane protein 2A (Protein E25) ITM2A UNQ603/PRO1189 Homo sapiens (Human) negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; plasma cell differentiation [GO:0002317] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; plasma cell differentiation [GO:0002317] GO:0001540; GO:0002317; GO:0005794; GO:0005886; GO:0016021; GO:0042985 amyloid-beta binding [GO:0001540] DLLLGFNK 0.97196 -1.0968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7275 0 0 0 13.1245 0 10.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H790 EXO5_HUMAN "Exonuclease V, Exo V, hExo5, EC 3.1.-.- (Defects in morphology protein 1 homolog)" EXO5 C1orf176 DEM1 Homo sapiens (Human) interstrand cross-link repair [GO:0036297] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; interstrand cross-link repair [GO:0036297]" GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0008310; GO:0036297; GO:0045145; GO:0046872; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]" CRTCTYADICEWR 0.97196 -1.0914 0 0 0 0 0 0 0 0 12.808 0 0 0 0 0 0 0 0 15.5547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5346 11.7902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0564 0 0 0 0 0 13.1879 0 0 0 12.6866 0 12.9147 0 15.911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47985 UCRI_HUMAN "Cytochrome b-c1 complex subunit Rieske, mitochondrial, EC 7.1.1.8 (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein, RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9, Su9, Subunit 9 (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence, UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein) ]" UQCRFS1 Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; respiratory electron transport chain [GO:0022904]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; respiratory electron transport chain [GO:0022904]" GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006122; GO:0008121; GO:0016491; GO:0022904; GO:0034551; GO:0045333; GO:0046872; GO:0051537 "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]" NAVTQFVSSMSASADVLALAKIEIK 0.97199 -0.5087 0 0 0 0 0 0 15.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60985 KTDAP_HUMAN Keratinocyte differentiation-associated protein KRTDAP KDAP UNQ467/PRO826 Homo sapiens (Human) cell differentiation [GO:0030154]; epidermis development [GO:0008544] extracellular space [GO:0005615]; lamellar body [GO:0042599] extracellular space [GO:0005615]; lamellar body [GO:0042599]; cell differentiation [GO:0030154]; epidermis development [GO:0008544] GO:0005615; GO:0008544; GO:0030154; GO:0042599 SATPDAQ 0.97199 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6318 0 13.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6648 0 12.428 12.502 0 0 13.2959 0 12.8192 0 0 0 0 0 0 13.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8616 0 0 0 0 0 0 0 0 0 0 13.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N443 RIBC1_HUMAN RIB43A-like with coiled-coils protein 1 RIBC1 Homo sapiens (Human) MQQGQFR 0.97202 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8233 0 0 0 0 15.2569 14.8365 14.8502 14.5084 14.6692 14.9967 14.9271 0 0 14.1766 0 0 13.7091 0 0 14.4174 0 0 0 0 14.1857 0 0 0 14.7246 14.2102 14.2573 0 0 0 0 0 14.0818 0 14.0469 0 0 0 0 0 0 0 13.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHS0 DNJB8_HUMAN DnaJ homolog subfamily B member 8 DNAJB8 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of inclusion body assembly [GO:0090084] GO:0005634; GO:0005737; GO:0005829; GO:0044183; GO:0051082; GO:0051087; GO:0061077; GO:0090084 chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] KRSLYDR 0.97203 -1.0794 0 0 0 0 0 0 0 0 0 14.3398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0241 0 0 0 0 0 0 0 0 0 0 14.965 0 14.7524 0 0 14.2449 14.0009 13.756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3745 0 0 0 12.9731 0 0 0 0 13.7177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8311 0 0 0 0 15.1999 0 0 0 0 0 0 0 0 0 0 12.5313 0 0 0 Q9H299 SH3L3_HUMAN "SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1, SH3BP-1)" SH3BGRL3 P1725 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604] GO:0005737; GO:0016604; GO:0070062 ALAGNPK 0.97203 -1.0794 0 0 0 0 0 0 0 0 0 0 11.5583 0 0 0 0 0 0 0 0 0 0 13.5405 14.0764 14.2087 0 0 0 0 0 11.0825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6396 0 0 0 13.7636 0 0 0 0 0 0 0 0 0 0 0 0 0 P62502 LCN6_HUMAN Epididymal-specific lipocalin-6 (Lipocalin-5) LCN6 LCN5 UNQ643/PRO1273 Homo sapiens (Human) single fertilization [GO:0007338] extracellular region [GO:0005576] extracellular region [GO:0005576]; small molecule binding [GO:0036094]; single fertilization [GO:0007338] GO:0005576; GO:0007338; GO:0036094 small molecule binding [GO:0036094] SLGFLSQ 0.97204 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7058 15.5951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8584 0 0 0 0 0 P31025 LCN1_HUMAN "Lipocalin-1 (Tear lipocalin, Tlc) (Tear prealbumin, TP) (von Ebner gland protein, VEG protein)" LCN1 VEGP Homo sapiens (Human) proteolysis [GO:0006508]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; sensory perception of taste [GO:0050909] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; signaling receptor binding [GO:0005102]; small molecule binding [GO:0036094]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; sensory perception of taste [GO:0050909] GO:0001895; GO:0004869; GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0031404; GO:0036094; GO:0050896; GO:0050909 chloride ion binding [GO:0031404]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; signaling receptor binding [GO:0005102]; small molecule binding [GO:0036094]; zinc ion binding [GO:0008270] QSETCSPGSD 0.97205 -0.61618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0S3 ORML1_HUMAN ORM1-like protein 1 (Adoplin-1) ORMDL1 HSPC202 Homo sapiens (Human) cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; motor behavior [GO:0061744]; myelination [GO:0042552]; negative regulation of ceramide biosynthetic process [GO:1900060]; sphingomyelin biosynthetic process [GO:0006686] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SPOTS complex [GO:0035339]; cellular sphingolipid homeostasis [GO:0090156]; ceramide metabolic process [GO:0006672]; motor behavior [GO:0061744]; myelination [GO:0042552]; negative regulation of ceramide biosynthetic process [GO:1900060]; sphingomyelin biosynthetic process [GO:0006686] GO:0005783; GO:0005789; GO:0006672; GO:0006686; GO:0016021; GO:0035339; GO:0042552; GO:0061744; GO:0090156; GO:1900060 ARLLTHWEQLDYGVQFTSSR 0.97205 -0.58697 0 0 0 0 0 0 0 0 0 0 0 12.9035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9409 0 0 15.0388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IQ19 CCSAP_HUMAN "Centriole, cilia and spindle-associated protein" CCSAP C1orf96 CSAP Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; mitotic spindle microtubule depolymerization [GO:1990755]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of embryonic development [GO:0045995]; regulation of mitotic spindle assembly [GO:1901673] axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; spindle [GO:0005819] axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; mitotic spindle microtubule depolymerization [GO:1990755]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of embryonic development [GO:0045995]; regulation of mitotic spindle assembly [GO:1901673] GO:0005813; GO:0005814; GO:0005819; GO:0005929; GO:0005930; GO:0007049; GO:0008017; GO:0030424; GO:0035869; GO:0036064; GO:0045995; GO:0051301; GO:0060296; GO:0061673; GO:0072686; GO:1901673; GO:1990755 microtubule binding [GO:0008017] ELLHYRLGRR 0.97206 -0.58995 0 0 0 12.0392 0 12.7533 0 0 0 0 0 10.4151 0 0 0 14.2536 10.535 11.5766 0 0 11.4833 0 0 0 0 10.4177 0 0 0 0 0 0 0 10.9211 0 0 0 10.6027 0 0 0 0 0 0 11.8818 17.4138 0 0 0 0 0 0 0 17.5456 0 0 0 11.2895 0 0 0 0 0 0 15.2451 0 0 0 0 0 13.703 0 0 0 0 13.2153 0 12.8439 0 0 0 14.1759 0 15.9615 12.9738 13.4397 14.5852 14.5884 13.6018 15.2389 12.9499 14.628 14.5827 14.6821 12.9581 13.8282 16.8307 14.005 14.4869 12.6131 0 13.3142 14.243 15.685 0 0 0 0 14.4824 13.2991 0 0 0 0 14.523 19.0638 0 0 0 0 10.3562 12.2153 12.7667 0 12.87 20.0697 14.593 13.1367 11.8151 15.0062 14.4794 13.4005 14.2988 15.0955 14.691 14.5703 13.6274 13.828 14.8833 13.8639 0 13.165 13.3185 14.2783 13.4852 0 0 15.3621 14.5909 0 13.6525 12.287 0 0 9.8029 15.1257 0 13.9444 13.608 11.6567 0 11.2614 0 13.2189 16.5096 16.7411 0 13.2292 11.7051 13.1083 13.0045 13.3536 15.0392 20.5733 0 11.7672 0 14.7528 0 0 O43240 KLK10_HUMAN "Kallikrein-10, EC 3.4.21.- (Normal epithelial cell-specific 1) (Protease serine-like 1)" KLK10 NES1 PRSSL1 Homo sapiens (Human) cell cycle [GO:0007049]; proteolysis [GO:0006508] extracellular region [GO:0005576]; secretory granule [GO:0030141] extracellular region [GO:0005576]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cell cycle [GO:0007049]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508; GO:0007049; GO:0008236; GO:0030141 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] LARPVVLGPRVR 0.97207 -0.62168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4606 0 0 0 0 0 0 0 0 0 12.0198 0 0 0 0 0 0 0 0 0 0 0 12.3583 0 0 0 0 0 0 0 0 11.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3392 0 0 0 0 12.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4464 0 12.6642 0 0 0 0 11.6068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6819 0 0 13.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8188 10.8022 P37058 DHB3_HUMAN "17-beta-hydroxysteroid dehydrogenase type 3, 17-beta-HSD 3 (Estradiol 17-beta-dehydrogenase 2, EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 2) (Testicular 17-beta-hydroxysteroid dehydrogenase) (Testosterone 17-beta-dehydrogenase 3, EC 1.1.1.64)" HSD17B3 EDH17B3 SDR12C2 Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; male genitalia development [GO:0030539]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; oxidoreductase activity [GO:0016491]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; androgen biosynthetic process [GO:0006702]; male genitalia development [GO:0030539]; steroid biosynthetic process [GO:0006694]; testosterone biosynthetic process [GO:0061370] GO:0005783; GO:0005789; GO:0006694; GO:0006702; GO:0016491; GO:0030283; GO:0030539; GO:0043231; GO:0047045; GO:0061370; GO:0072582 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; oxidoreductase activity [GO:0016491]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283] AYSFELAK 0.97207 -1.0863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5826 0 0 12.5081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6162 0 0 0 0 0 14.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3744 0 0 0 0 0 0 0 13.8793 14.7217 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6737 0 0 0 0 0 0 0 0 0 13.4027 0 0 0 0 0 0 Q9P2K9 DISP3_HUMAN Protein dispatched homolog 3 (Patched domain-containing protein 2) DISP3 KIAA1337 PTCHD2 Homo sapiens (Human) cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224] GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016021; GO:0030154; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179 AKFQSFVVTYVAMLAKQSTSK 0.97207 -0.61835 0 11.478 0 0 12.0787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.397 0 0 0 12.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9107 0 0 13.6714 11.89 0 0 10.7501 0 0 0 0 0 16.2006 0 0 0 0 0 0 0 0 12.4637 13.0039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1597 12.4848 13.2913 0 11.0865 13.8755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1401 0 13.5305 13.6747 13.8522 13.8024 11.707 0 0 12.8124 13.4297 18.674 11.4483 12.847 0 0 0 0 Q16775 GLO2_HUMAN "Hydroxyacylglutathione hydrolase, mitochondrial, EC 3.1.2.6 (Glyoxalase II, Glx II)" HAGH GLO2 HAGH1 Homo sapiens (Human) glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243] GO:0004416; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006749; GO:0006750; GO:0019243; GO:0046872 hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] ALLEVLGR 0.97209 -1.0982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 E2RYF6 MUC22_HUMAN Mucin-22 (Panbronchiolitis-related mucin-like protein 1) MUC22 G4 PBMUCL1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TTTGSTR 0.97212 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7576 0 12.7158 13.5548 0 0 13.899 14.1087 13.8801 13.8332 0 0 14.5156 0 14.5302 0 0 0 0 0 0 14.2178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5576 0 0 14.1532 0 0 0 0 13.6118 14.0144 0 13.4826 0 0 0 13.5481 0 0 13.135 0 0 13.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0594 0 0 0 0 0 0 0 12.9712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40425 PBX2_HUMAN Pre-B-cell leukemia transcription factor 2 (Homeobox protein PBX2) (Protein G17) PBX2 G17 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003682; GO:0005634; GO:0005667; GO:0006357; GO:0007420; GO:0009887; GO:0009954; GO:0030326; GO:0045944; GO:0048568; GO:0048666; GO:0140297 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" HALNCHR 0.97212 -0.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8647 0 0 17.2831 0 0 12.9684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0346 12.4486 12.6944 11.3633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5825 15.5203 0 0 0 0 0 0 16.2291 0 0 0 0 0 0 0 0 0 0 0 P0CJ79 ZN888_HUMAN Zinc finger protein 888 ZNF888 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRHDSHLAQHIVIHTR 0.97214 3.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8538 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9481 15.4579 0 13.7183 0 0 0 0 0 0 0 0 0 0 12.1864 12.0401 0 0 0 0 0 0 13.4338 0 11.1692 0 0 13.5299 0 0 0 0 0 0 13.6547 13.8275 0 0 0 0 13.9733 0 0 14.0736 0 0 14.1619 0 15.1385 0 13.7457 14.048 0 14.0356 13.5666 14.2228 0 14.8291 0 0 14.451 0 0 0 14.7758 13.7268 13.9525 0 0 15.4549 11.3082 13.0355 13.9859 13.0502 15.0779 14.8639 15.1085 14.7775 0 14.4087 0 12.0522 0 0 14.8288 13.6715 13.798 13.5879 14.8684 0 0 0 0 0 0 0 0 0 0 11.319 0 0 0 0 12.4821 0 13.2216 14.8561 0 0 0 0 13.73 0 P12104 FABPI_HUMAN "Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein, I-FABP)" FABP2 FABPI Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal lipid absorption [GO:0098856] apical cortex [GO:0045179]; cytosol [GO:0005829]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical cortex [GO:0045179]; cytosol [GO:0005829]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal lipid absorption [GO:0098856] GO:0005324; GO:0005504; GO:0005634; GO:0005829; GO:0005886; GO:0005902; GO:0006631; GO:0015908; GO:0036041; GO:0045179; GO:0098856 fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324] AFDSTWK 0.97214 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6581 13.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7469 0 0 0 0 0 0 0 0 0 0 0 12.1848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5N7 RM50_HUMAN "39S ribosomal protein L50, mitochondrial, L50mt, MRP-L50 (Mitochondrial large ribosomal subunit protein mL50)" MRPL50 Homo sapiens (Human) mitochondrial translation [GO:0032543] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005762; GO:0005829; GO:0032543 EFWSRFR 0.97214 -0.57504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9895 0 0 0 0 0 0 0 0 0 0 13.3632 0 0 0 0 0 0 0 0 0 0 13.0943 0 0 0 0 0 0 0 0 0 0 0 13.6839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75031 HSF2B_HUMAN Heat shock factor 2-binding protein HSF2BP MEILB2 Homo sapiens (Human) double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] chromosome [GO:0005694]; cytosol [GO:0005829] chromosome [GO:0005694]; cytosol [GO:0005829]; double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] GO:0005694; GO:0005829; GO:0006366; GO:0007141; GO:0007144; GO:0007283; GO:1990918 ARLETVQADNIR 0.97217 -0.61396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.521 0 0 0 0 0 0 0 0 0 0 10.32 0 0 0 0 0 0 0 0 10.329 0 0 0 11.7103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1299 0 0 0 0 0 0 0 12.3359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.157 0 0 0 0 0 0 0 0 12.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9863 A0A0C4DH26 KVD41_HUMAN Probable non-functional immunoglobulin kappa variable 6D-41 IGKV6D-41 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 LLLLWVPASR 0.97218 -0.58581 0 0 10.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9434 0 0 0 0 0 0 0 0 P61578 REC16_HUMAN Endogenous retrovirus group K member 16 Rec protein (HERV-K_10p14 provirus Rec protein) ERVK-16 Homo sapiens (Human) mRNA transport [GO:0051028] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; mRNA transport [GO:0051028] GO:0003723; GO:0005730; GO:0005737; GO:0051028 RNA binding [GO:0003723] APSSHKMNK 0.97218 -0.61491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6717 0 14.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY78 RNF26_HUMAN "E3 ubiquitin-protein ligase RNF26, EC 2.3.2.27 (RING finger protein 26)" RNF26 Homo sapiens (Human) endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005789; GO:0006511; GO:0007032; GO:0008270; GO:0016021; GO:0016567; GO:0032479; GO:0050687; GO:0061630; GO:0070979; GO:1905719 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GVLLSLLALIEAVVR 0.97218 -1.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8612 0 17.7693 0 0 17.6218 0 0 0 11.5026 0 0 0 0 0 18.5194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3547 0 0 0 0 0 0 0 0 0 0 0 18.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8892 0 0 0 0 0 0 0 0 0 11.1365 0 0 0 0 0 0 0 0 0 0 0 10.4097 0 16.6524 0 Q8N165 PDK1L_HUMAN "Serine/threonine-protein kinase PDIK1L, EC 2.7.11.1 (PDLIM1-interacting kinase 1-like)" PDIK1L CLIK1L Homo sapiens (Human) meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0051321; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ELLGSYVKQGTEIVPVGEALLENPK 0.97219 -1.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5658 13.6224 14.31 0 0 0 0 0 0 0 0 14.2325 0 0 0 0 0 0 14.3697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8824 12.9511 14.0072 0 0 0 0 0 0 0 13.2421 0 0 0 0 0 13.4489 0 12.3941 0 0 13.2715 0 0 0 0 0 0 0 0 0 0 13.0313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7P3 CLD22_HUMAN Claudin-22 CLDN22 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0070830 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] IGESQRDLK 0.9722 -0.62162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5642 0 0 0 0 0 0 0 0 0 0 0 0 15.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4503 0 0 0 0 0 0 0 12.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.069 0 0 0 0 0 0 Q99519 NEUR1_HUMAN "Sialidase-1, EC 3.2.1.18 (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1)" NEU1 NANH Homo sapiens (Human) ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580] cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; ganglioside catabolic process [GO:0006689]; oligosaccharide catabolic process [GO:0009313] GO:0004308; GO:0005576; GO:0005737; GO:0005764; GO:0005765; GO:0005886; GO:0006689; GO:0009313; GO:0016020; GO:0016997; GO:0030054; GO:0035580; GO:0043202; GO:0043231; GO:0052794; GO:0052795; GO:0052796; GO:0070062 alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308] NQNNYHCHCR 0.9722 -0.61833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2874 0 0 11.648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14923 PLAK_HUMAN Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3) JUP CTNNG DP3 Homo sapiens (Human) bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to indole-3-methanol [GO:0071681]; desmosome assembly [GO:0002159]; detection of mechanical stimulus [GO:0050982]; endothelial cell-cell adhesion [GO:0071603]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell population proliferation [GO:0042127]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; gamma-catenin-TCF7L2 complex [GO:0071665]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; specific granule lumen [GO:0035580]; Z disc [GO:0030018]; zonula adherens [GO:0005915] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; gamma-catenin-TCF7L2 complex [GO:0071665]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; specific granule lumen [GO:0035580]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; cytoskeletal protein-membrane anchor activity [GO:0106006]; DNA-binding transcription factor binding [GO:0140297]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; transcription coactivator activity [GO:0003713]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to indole-3-methanol [GO:0071681]; desmosome assembly [GO:0002159]; detection of mechanical stimulus [GO:0050982]; endothelial cell-cell adhesion [GO:0071603]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell population proliferation [GO:0042127]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588] GO:0001533; GO:0001954; GO:0002159; GO:0003713; GO:0005198; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0005886; GO:0005911; GO:0005912; GO:0005915; GO:0005916; GO:0005925; GO:0009898; GO:0014704; GO:0015629; GO:0016327; GO:0016328; GO:0016342; GO:0016477; GO:0019903; GO:0030018; GO:0030057; GO:0032993; GO:0035580; GO:0042127; GO:0042307; GO:0042803; GO:0043537; GO:0043588; GO:0044877; GO:0045294; GO:0045296; GO:0045766; GO:0045944; GO:0050839; GO:0050982; GO:0051091; GO:0060070; GO:0070062; GO:0071603; GO:0071665; GO:0071681; GO:0072659; GO:0086073; GO:0086083; GO:0086091; GO:0090263; GO:0098609; GO:0098911; GO:0106006; GO:0140297; GO:1904813; GO:1990782 alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; cytoskeletal protein-membrane anchor activity [GO:0106006]; DNA-binding transcription factor binding [GO:0140297]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; transcription coactivator activity [GO:0003713] GIMEEDEACGR 0.97221 -0.59594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4209 0 0 0 0 0 11.2577 0 0 0 13.0753 0 0 0 0 0 13.915 0 0 0 0 0 15.9016 0 0 0 12.4629 0 0 0 0 0 9.61383 0 0 0 14.6067 0 0 0 0 0 0 0 0 0 12.425 0 13.1128 13.2441 0 0 0 14.719 0 0 11.7432 0 0 0 0 0 0 0 12.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4165 0 0 0 0 0 0 0 0 0 0 0 0 12.5548 Q8N8J7 F241A_HUMAN Uncharacterized protein FAM241A FAM241A C4orf32 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] GO:0005794; GO:0016021; GO:0043231 GGDGGER 0.97224 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7717 0 0 14.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG12 DERPC_HUMAN Decreased expression in renal and prostate cancer protein DERPC Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] GO:0005654; GO:0070062 MNGPAGK 0.97226 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0444 0 0 0 0 0 0 Q7L1V2 MON1B_HUMAN Vacuolar fusion protein MON1 homolog B (HSV-1 stimulation-related gene 1 protein) (HSV-I stimulating-related protein) MON1B HSRG1 KIAA0872 SAND2 Homo sapiens (Human) early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; Mon1-Ccz1 complex [GO:0035658] cytoplasm [GO:0005737]; Mon1-Ccz1 complex [GO:0035658]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] GO:0005737; GO:0006623; GO:0016192; GO:0019085; GO:0019086; GO:0035658 AGAILVVTKLLRWVK 0.97227 3.1925 0 0 0 0 15.2469 0 0 0 15.8522 14.441 0 0 12.5685 12.8524 0 0 0 0 0 0 0 0 0 0 15.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2098 0 0 0 0 0 0 0 0 0 13.9182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.004 0 0 0 14.9226 14.663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8143 12.7205 B2RXF0 T229A_HUMAN Transmembrane protein 229A TMEM229A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LRYGRQR 0.97228 -0.57912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29992 GNA11_HUMAN "Guanine nucleotide-binding protein subunit alpha-11, G alpha-11, G-protein subunit alpha-11 (Guanine nucleotide-binding protein G(y) subunit alpha)" GNA11 GA11 Homo sapiens (Human) "action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to pH [GO:0071467]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; heart development [GO:0007507]; multicellular organism aging [GO:0010259]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phototransduction, visible light [GO:0007603]; regulation of blood pressure [GO:0008217]; regulation of melanocyte differentiation [GO:0045634]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; action potential [GO:0001508]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cellular response to pH [GO:0071467]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; endothelin receptor signaling pathway [GO:0086100]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; heart development [GO:0007507]; multicellular organism aging [GO:0010259]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phototransduction, visible light [GO:0007603]; regulation of blood pressure [GO:0008217]; regulation of melanocyte differentiation [GO:0045634]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]" GO:0001501; GO:0001508; GO:0001664; GO:0001750; GO:0003924; GO:0005525; GO:0005737; GO:0005765; GO:0005834; GO:0005886; GO:0007165; GO:0007188; GO:0007213; GO:0007507; GO:0007603; GO:0008217; GO:0009649; GO:0010259; GO:0031683; GO:0045202; GO:0045634; GO:0046872; GO:0048066; GO:0060158; GO:0070062; GO:0071467; GO:0086100; GO:1904888 G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] AMETLKILYK 0.97229 -0.5826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43749 OR1F1_HUMAN "Olfactory receptor 1F1 (Olfactory receptor 16-35, OR16-35) (Olfactory receptor 1F10) (Olfactory receptor 1F4) (Olfactory receptor 1F5) (Olfactory receptor 1F6) (Olfactory receptor 1F7) (Olfactory receptor 1F8) (Olfactory receptor 1F9) (Olfactory receptor OR16-4)" OR1F1 OLFMF OR1F10 OR1F4 OR1F5 OR1F6 OR1F7 OR1F8 OR1F9 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KVVGRVVFSV 0.9723 -0.58428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.24 0 13.5563 13.7547 14.0224 0 0 0 13.2714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8914 0 0 0 0 0 0 13.327 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5261 0 0 13.335 0 0 0 12.8159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1868 0 12.8915 0 0 0 0 0 0 P56589 PEX3_HUMAN Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3) PEX3 Homo sapiens (Human) peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046] endoplasmic reticulum [GO:0005783]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein-lipid complex [GO:0032994] endoplasmic reticulum [GO:0005783]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein-lipid complex [GO:0032994]; lipid binding [GO:0008289]; protein-macromolecule adaptor activity [GO:0030674]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046] GO:0005654; GO:0005777; GO:0005778; GO:0005779; GO:0005783; GO:0007031; GO:0008289; GO:0016020; GO:0030674; GO:0032991; GO:0032994; GO:0045046 lipid binding [GO:0008289]; protein-macromolecule adaptor activity [GO:0030674] LEIWEDLK 0.9723 -0.6135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0481 0 0 0 0 15.1409 0 0 0 16.5177 15.9308 17.8341 0 0 0 0 14.4114 0 0 0 15.5768 0 0 0 0 0 0 0 11.3845 0 0 0 0 0 0 0 0 12.5562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3114 0 0 0 0 0 0 0 0 0 0 Q68DL7 CR063_HUMAN Uncharacterized protein C18orf63 C18orf63 Homo sapiens (Human) DFHANKHAVIER 0.9723 -0.58443 0 13.9238 0 0 0 0 0 0 11.4594 11.6475 12.1795 0 0 0 11.7847 0 11.6813 0 0 0 11.571 0 0 0 11.6832 12.7504 0 0 0 11.9705 11.3685 0 0 0 11.9027 0 0 0 0 0 0 0 0 0 0 12.4205 0 0 13.2213 0 0 0 0 11.9668 16.3728 0 16.2084 15.9687 0 0 12.3366 12.8168 12.8639 14.0334 0 0 0 0 0 0 0 0 0 0 0 13.6305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4327 0 14.1272 0 0 0 0 0 0 0 0 0 0 10.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2077 0 0 14.2825 13.5993 13.9447 0 0 14.1542 0 0 14.2137 0 13.7858 0 0 11.7714 0 0 0 0 0 0 0 0 Q6ZTQ3 RASF6_HUMAN Ras association domain-containing protein 6 RASSF6 Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] GO:0006915; GO:0007165; GO:0042981 AIILKCLQNKLVIK 0.9723 -0.58307 0 0 0 0 0 0 0 0 0 14.4846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7321 0 0 0 0 0 0 0 0 0 0 14.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3545 0 0 0 0 0 0 0 0 11.4821 12.7852 12.9145 0 0 0 0 16.3065 0 13.32 13.7025 12.6989 13.4256 0 0 0 0 0 0 0 0 0 12.7918 0 0 0 10.9904 12.9241 0 0 0 0 0 14.1347 0 0 0 11.242 0 12.4828 0 13.3226 0 14.3161 0 0 12.9971 0 13.0553 13.1355 0 0 0 0 0 0 0 0 14.2743 0 14.3369 12.2504 0 0 0 0 0 13.6348 0 0 13.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04004 VTNC_HUMAN "Vitronectin, VN (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B ]" VTN Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; liver regeneration [GO:0097421]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of wound healing [GO:0090303]; protein polymerization [GO:0051258]; regulation of cell adhesion [GO:0030155]; smooth muscle cell-matrix adhesion [GO:0061302] alphav-beta3 integrin-vitronectin complex [GO:0071062]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; peptidase inhibitor complex [GO:1904090]; protein complex involved in cell-matrix adhesion [GO:0098637]; rough endoplasmic reticulum lumen [GO:0048237] alphav-beta3 integrin-vitronectin complex [GO:0071062]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; peptidase inhibitor complex [GO:1904090]; protein complex involved in cell-matrix adhesion [GO:0098637]; rough endoplasmic reticulum lumen [GO:0048237]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; immune response [GO:0006955]; liver regeneration [GO:0097421]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of wound healing [GO:0090303]; protein polymerization [GO:0051258]; regulation of cell adhesion [GO:0030155]; smooth muscle cell-matrix adhesion [GO:0061302] GO:0005044; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0005796; GO:0006955; GO:0007155; GO:0007160; GO:0008201; GO:0010811; GO:0010951; GO:0014911; GO:0016477; GO:0030155; GO:0030195; GO:0030198; GO:0030247; GO:0030949; GO:0032092; GO:0033627; GO:0035987; GO:0042802; GO:0043231; GO:0048237; GO:0048260; GO:0048709; GO:0050731; GO:0050840; GO:0051258; GO:0051918; GO:0061302; GO:0062023; GO:0070062; GO:0071062; GO:0072562; GO:0090303; GO:0097421; GO:0098637; GO:1904090 collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044] CQCDELCSYYQSCCTDYTAECK 0.97231 -0.5849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0136 0 0 0 0 0 0 0 0 11.5402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2331 0 0 0 0 0 0 0 0 0 13.3496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0063 0 0 12.3917 0 0 Q6P1L8 RM14_HUMAN "39S ribosomal protein L14, mitochondrial, L14mt, MRP-L14 (39S ribosomal protein L32, mitochondrial, L32mt, MRP-L32) (Mitochondrial large ribosomal subunit protein uL14m)" MRPL14 MRPL32 RPML32 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] APRCIHVYK 0.97231 -0.58558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8Q8 COX18_HUMAN "Cytochrome c oxidase assembly protein COX18, mitochondrial, COX18Hs (Cytochrome c oxidase assembly protein 18)" COX18 OXA1L2 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]; respiratory chain complex IV assembly [GO:0008535] integral component of mitochondrial inner membrane [GO:0031305] integral component of mitochondrial inner membrane [GO:0031305]; membrane insertase activity [GO:0032977]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; protein insertion into membrane [GO:0051205]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]; respiratory chain complex IV assembly [GO:0008535] GO:0008535; GO:0031305; GO:0032977; GO:0032979; GO:0033617; GO:0051204; GO:0051205 membrane insertase activity [GO:0032977] DARLTYLK 0.97231 -1.0858 0 11.2953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53FP2 NACHO_HUMAN Novel acetylcholine receptor chaperone TMEM35A NACHO TMEM35 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of protein localization to cell surface [GO:2000010] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; acetylcholine receptor regulator activity [GO:0030548]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of protein localization to cell surface [GO:2000010] GO:0005778; GO:0005783; GO:0005789; GO:0016021; GO:0030548; GO:0031410; GO:0051131; GO:2000010 acetylcholine receptor regulator activity [GO:0030548] ALPLLKKMGINSILLR 0.97233 -0.61823 0 0 0 0 0 0 0 0 0 0 0 11.003 0 0 0 0 0 0 11.0456 12.5181 10.9803 0 0 0 0 0 0 0 0 0 0 12.7026 0 0 0 0 13.3059 0 0 0 0 0 0 0 0 0 13.0002 0 0 0 12.4292 0 10.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8224 0 0 13.1266 11.9049 0 0 0 14.8526 0 0 14.0328 0 13.5073 0 0 0 0 0 0 13.2646 0 0 0 15.4946 0 0 13.868 0 0 0 13.7922 0 13.5817 0 0 0 0 0 0 13.0245 0 0 12.8929 12.6011 17.5679 0 0 12.4833 0 0 0 0 13.4712 0 13.4831 11.9685 0 0 15.5063 0 13.0353 12.3136 12.8653 0 12.5659 13.0784 0 0 0 13.2858 0 0 12.1426 12.9611 0 0 0 0 12.4956 0 0 0 0 0 0 0 0 12.8222 0 0 0 0 0 0 0 0 13.984 0 13.4002 0 12.586 0 0 0 0 Q30KQ8 DB112_HUMAN "Beta-defensin 112 (Beta-defensin 12, DEFB-12) (Defensin, beta 112)" DEFB112 DEFB12 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 CKNQCDDSEFRISYCAR 0.97235 -0.59521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4055 0 0 0 11.8949 0 0 0 0 0 0 0 0 0 0 0 12.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXJ1 C1QT1_HUMAN "Complement C1q tumor necrosis factor-related protein 1 (G protein-coupled receptor-interacting protein, GIP)" C1QTNF1 CTRP1 UNQ310/PRO353 Homo sapiens (Human) negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906] GO:0005518; GO:0005581; GO:0005615; GO:0005887; GO:0007204; GO:0010544; GO:0010628; GO:0010906; GO:0042802; GO:0043410; GO:0051897; GO:0090331; GO:2000860 collagen binding [GO:0005518]; identical protein binding [GO:0042802] TGSAGAR 0.97236 -1.0794 11.7023 11.2796 0 14.6994 13.1368 0 13.3344 0 0 0 0 0 0 0 0 0 0 11.7191 0 13.3501 0 19.3425 12.0242 19.2976 0 12.2407 0 0 0 0 0 0 13.4959 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0293 12.1232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8997 13.1373 13.4637 0 0 0 0 0 13.8516 14.1192 14.6249 14.7206 13.6735 14.6564 20.2031 14.905 20.2354 20.2442 20.2079 20.2448 13.8431 15.2005 13.9836 15.2156 15.5746 15.0926 15.6853 0 15.1492 14.8513 15.3871 20.2492 0 15.3976 13.9075 20.1508 20.2267 15.3011 15.9347 20.1226 14.8803 14.8283 20.2078 13.9792 20.141 0 14.9907 0 0 0 16.0102 14.7389 13.5762 14.6408 14.6899 15.3789 20.1107 20.1268 20.1739 0 15.1984 20.1747 14.6554 20.1762 0 20.2197 14.6366 14.7278 15.2767 13.9194 15.3689 16.2099 14.7069 13.2939 14.9371 0 13.3813 15.0992 14.666 15.4634 13.4742 0 0 0 14.4923 13.5545 15.3456 20.1879 14.6469 13.5766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9409 13.3473 13.766 13.9902 0 0 0 0 0 Q9NZI2 KCIP1_HUMAN "Kv channel-interacting protein 1, KChIP1 (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1) (Vesicle APC-binding protein)" KCNIP1 KCHIP1 VABP Homo sapiens (Human) regulation of potassium ion transmembrane transport [GO:1901379] cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; regulation of potassium ion transmembrane transport [GO:1901379] GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0031234; GO:0044325; GO:1901379 calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244] YTYPVLK 0.97236 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29218 IMPA1_HUMAN "Inositol monophosphatase 1, IMP 1, IMPase 1, EC 3.1.3.25 (D-galactose 1-phosphate phosphatase, EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1)" IMPA1 IMPA Homo sapiens (Human) inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165] GO:0000287; GO:0005737; GO:0005829; GO:0006020; GO:0006021; GO:0006661; GO:0006796; GO:0007165; GO:0008934; GO:0030145; GO:0031403; GO:0042802; GO:0042803; GO:0046854; GO:0046855; GO:0052832; GO:0052833; GO:0052834 identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803] VIAANNR 0.97238 -1.0794 10.2635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5223 0 0 0 0 0 13.8107 0 13.9502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWU2 GID8_HUMAN "Glucose-induced degradation protein 8 homolog (Two hybrid-associated protein 1 with RanBPM, Twa1)" GID8 C20orf11 TWA1 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; Wnt signaling pathway [GO:0016055] GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0016055; GO:0030054; GO:0042803; GO:0043161; GO:0090263 protein homodimerization activity [GO:0042803] LAKLLKLLLWAQNELDQK 0.9724 2.9734 0 0 0 0 0 0 0 0 0 0 0 12.7328 0 0 0 0 0 0 0 0 0 0 14.9195 0 0 0 14.7435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7535 14.088 11.9494 0 0 0 0 17.3798 0 13.8868 0 0 0 0 12.9439 0 0 13.8462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1286 0 0 0 0 0 0 0 0 14.3024 0 0 0 0 0 0 0 0 0 12.4537 0 0 17.2071 12.5346 0 11.8265 12.7091 0 0 0 0 0 0 0 0 12.8334 12.1188 0 0 0 0 13.7637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0293 0 0 0 0 0 0 0 0 0 0 0 P09917 LOX5_HUMAN "Polyunsaturated fatty acid 5-lipoxygenase, EC 1.13.11.- (Arachidonate 5-lipoxygenase, 5-LO, 5-lipoxygenase, EC 1.13.11.34)" ALOX5 LOG5 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; hepoxilin biosynthetic process [GO:0051122]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774] "cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; hepoxilin biosynthetic process [GO:0051122]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]" GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016525; GO:0016702; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0043651; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0051122; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301 "arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]" AREQLICECGLFDK 0.97242 -0.58189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0289 0 0 0 13.9497 0 13.7328 0 0 0 16.1536 15.848 0 0 0 0 10.9352 11.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2266 0 0 0 0 0 0 0 10.7551 0 0 0 0 0 0 0 0 0 0 12.1192 0 0 0 14.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1228 0 0 0 0 0 14.1426 0 0 11.4916 0 0 12.3892 0 15.4591 15.0855 15.0935 0 0 0 0 0 0 0 12.7156 0 0 Q6IAN0 DRS7B_HUMAN "Dehydrogenase/reductase SDR family member 7B, EC 1.1.-.- (Short-chain dehydrogenase/reductase family 32C member 1, Protein SDR32C1)" DHRS7B SDR32C1 CGI-93 UNQ212/PRO238 Homo sapiens (Human) adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; ether lipid biosynthetic process [GO:0008611]; inflammatory response [GO:0006954]; negative regulation of protein binding [GO:0032091]; neutrophil differentiation [GO:0030223]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of cold-induced thermogenesis [GO:0120161] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; transcription regulator complex [GO:0005667] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; transcription regulator complex [GO:0005667]; acylglycerone-phosphate reductase activity [GO:0000140]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; ether lipid biosynthetic process [GO:0008611]; inflammatory response [GO:0006954]; negative regulation of protein binding [GO:0032091]; neutrophil differentiation [GO:0030223]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of cold-induced thermogenesis [GO:0120161] GO:0000140; GO:0003714; GO:0005634; GO:0005667; GO:0005778; GO:0005789; GO:0006656; GO:0006954; GO:0008611; GO:0016020; GO:0016021; GO:0030223; GO:0032091; GO:0050873; GO:0060612; GO:0120161; GO:0140297 acylglycerone-phosphate reductase activity [GO:0000140]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714] ALLPSMIK 0.97242 -0.58158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77304 12.564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7C7 RN148_HUMAN RING finger protein 148 RNF148 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005737; GO:0005770; GO:0005783; GO:0005794; GO:0006511; GO:0016021; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] HFFHKACIDPWLLAHR 0.97242 -0.61103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3055 0 0 0 0 0 17.3629 0 16.2107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2172 0 0 19.0523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1954 0 0 0 0 0 0 0 0 0 0 0 0 19.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NC96 NECP1_HUMAN "Adaptin ear-binding coat-associated protein 1 (NECAP endocytosis-associated protein 1, NECAP-1)" NECAP1 Homo sapiens (Human) endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0005829; GO:0005905; GO:0006897; GO:0015031; GO:0016192; GO:0030125 GKTAYIK 0.97242 -0.58255 0 10.6494 0 0 0 0 0 0 0 0 0 0 12.3728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1874 10.2123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9296 14.8376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6876 0 0 0 0 0 0 0 0 0 0 0 0 13.5741 0 0 0 0 0 0 0 11.3978 0 0 0 0 0 11.3655 10.2437 0 0 0 0 0 0 0 12.3307 13.5226 13.7391 0 13.0312 0 13.2187 12.1148 0 0 11.6489 0 0 13.1844 0 0 0 0 0 0 0 0 0 0 0 13.0485 0 0 0 11.2965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAE7 KCNG3_HUMAN Potassium voltage-gated channel subfamily G member 3 (Voltage-gated potassium channel subunit Kv10.1) (Voltage-gated potassium channel subunit Kv6.3) KCNG3 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] DVLEVCDDYDRERNEYFFDR 0.97243 -1.0855 0 0 0 0 0 0 0 0 14.7772 0 0 0 0 0 0 12.4956 0 0 11.8281 0 12.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1359 14.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6631 0 0 0 0 0 0 0 0 10.8057 0 12.1068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2953 0 0 0 0 11.0209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3502 0 0 0 0 0 13.0849 0 0 0 0 0 0 0 15.0059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ10 DHDH_HUMAN "Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase, EC 1.3.1.20 (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase, EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) (Hum2DD)" DHDH 2DD Homo sapiens (Human) D-xylose catabolic process [GO:0042843] "D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; D-xylose catabolic process [GO:0042843]" GO:0000166; GO:0042843; GO:0047115; GO:0047837 "D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; nucleotide binding [GO:0000166]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]" AEFGKNLIHVPRAVDR 0.97243 -0.61326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1258 0 0 0 0 0 0 0 0 11.7606 0 0 11.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8827 0 14.9781 0 14.4356 0 14.4084 0 15.728 15.5528 0 0 0 15.7195 0 0 0 0 0 0 15.1987 15.1934 15.0524 15.0108 0 15.2708 0 0 15.1552 0 0 0 15.1216 0 0 15.1113 0 0 12.137 0 0 0 0 0 15.0923 0 0 0 15.0182 14.8892 15.0803 15.1999 0 0 15.2561 15.1968 14.8815 0 14.7793 0 0 0 15.005 0 0 15.1526 14.7337 14.7197 0 0 0 0 0 0 0 0 14.4092 12.3331 0 14.1795 14.0956 0 14.3532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3212 14.2137 0 0 0 0 13.7676 0 P54821 PRRX1_HUMAN "Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1, PRX-1)" PRRX1 PMX1 Homo sapiens (Human) artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; mesenchymal cell proliferation [GO:0010463]; middle ear morphogenesis [GO:0042474]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of DNA repair by transcription from RNA polymerase II promoter [GO:0100026]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron projection regeneration [GO:0070570]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; artery morphogenesis [GO:0048844]; cartilage development [GO:0051216]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; inner ear morphogenesis [GO:0042472]; mesenchymal cell proliferation [GO:0010463]; middle ear morphogenesis [GO:0042474]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of DNA repair by transcription from RNA polymerase II promoter [GO:0100026]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of neuron projection regeneration [GO:0070570]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002053; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007224; GO:0010463; GO:0016251; GO:0030326; GO:0042472; GO:0042474; GO:0045880; GO:0048664; GO:0048701; GO:0048844; GO:0051216; GO:0060021; GO:0061629; GO:0070570; GO:0071837; GO:0072089; GO:0097150; GO:0100026; GO:2000648 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" QPALGGR 0.97251 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6738 14.7953 14.243 14.5757 15.0061 14.5435 12.0344 0 13.0638 0 0 0 0 0 0 0 0 0 12.066 0 0 0 0 0 0 0 0 0 0 0 0 13.2802 0 0 0 0 13.3045 0 0 0 0 12.5748 0 0 0 0 12.1638 0 0 0 0 0 0 0 0 0 13.0492 0 13.6728 14.4888 14.4667 14.4249 14.5713 0 13.0964 14.1025 0 14.6525 13.2894 14.3502 12.5589 0 0 0 0 0 14.2886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.293 0 13.6191 0 0 0 0 0 A0A075B6H8 KVD42_HUMAN Probable non-functional immunoglobulin kappa variable 1D-42 IGKV1D-42 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 PEDFAAYYCK 0.97253 -0.60315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7212 0 0 0 0 0 0 0 12.6618 0 0 0 0 0 0 12.4545 0 0 0 0 0 0 0 0 12.726 0 12.1322 0 0 0 0 0 11.1008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5771 0 0 0 12.0959 0 12.4053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51654 GPC3_HUMAN Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Glypican-3 alpha subunit; Glypican-3 beta subunit ] GPC3 OCI5 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial cell proliferation [GO:0050673]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of peptidase activity [GO:0010466]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]; smoothened signaling pathway [GO:0007224]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886] "anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; peptidyl-dipeptidase inhibitor activity [GO:0060422]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial cell proliferation [GO:0050673]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of peptidase activity [GO:0010466]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]; smoothened signaling pathway [GO:0007224]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001658; GO:0005788; GO:0005796; GO:0005886; GO:0007224; GO:0009617; GO:0009653; GO:0009948; GO:0009986; GO:0010171; GO:0010466; GO:0016477; GO:0030282; GO:0030316; GO:0030324; GO:0030513; GO:0031226; GO:0035116; GO:0042074; GO:0043202; GO:0045732; GO:0045807; GO:0045879; GO:0045880; GO:0045926; GO:0046326; GO:0046658; GO:0050673; GO:0050680; GO:0060070; GO:0060071; GO:0060422; GO:0060828; GO:0060976; GO:0062023; GO:0072111; GO:0072138; GO:0072180; GO:0072203; GO:0090090; GO:0090263; GO:1905475; GO:2000050; GO:2000096 peptidyl-dipeptidase inhibitor activity [GO:0060422] GPEPVVSQIIDKLKHINQLLR 0.97255 -0.60722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8572 0 0 0 0 14.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8926 0 0 0 0 0 0 0 0 0 0 0 Q9P2K2 TXD16_HUMAN Thioredoxin domain-containing protein 16 TXNDC16 ERP90 KIAA1344 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] GO:0005788; GO:0070062 AGVLLLLRDSLEVNIPQDANVVFK 0.97255 -0.61002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6184 0 0 0 0 12.5332 11.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9031 0 0 0 0 0 11.6206 0 0 0 0 0 0 0 0 0 0 11.154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5682 0 0 0 Q6P1N9 TATD1_HUMAN "Deoxyribonuclease TATDN1, EC 3.1.21.- (Hepatocarcinoma high expression protein)" TATDN1 CDA11 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; metal ion binding [GO:0046872] GO:0005654; GO:0008296; GO:0046872 3'-5'-exodeoxyribonuclease activity [GO:0008296]; metal ion binding [GO:0046872] STHAGSK 0.97262 -1.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6578 0 0 13.432 0 12.8205 0 0 0 0 0 0 13.742 0 13.8697 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.923 0 0 0 0 0 0 0 12.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NB37 GALD1_HUMAN Glutamine amidotransferase-like class 1 domain-containing protein 1 (Parkinson disease 7 domain-containing protein 1) GATD1 PDDC1 Homo sapiens (Human) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243] GO:0005737; GO:0019172; GO:0019243; GO:0070062 glyoxalase III activity [GO:0019172] AYASPAK 0.97263 -1.0794 0 0 0 0 0 0 9.30877 0 0 0 0 0 0 0 9.78996 0 0 0 0 0 0 16.7169 11.535 16.7699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6109 0 17.551 17.5245 0 17.5752 0 0 0 0 0 0 13.9426 14.5408 0 0 0 0 18.2448 12.504 0 13.7547 12.7895 0 11.6473 0 0 0 0 13.2701 11.5775 0 0 13.013 0 0 17.9289 0 0 0 0 0 0 13.4232 11.8597 17.9483 12.2147 13.7928 0 14.115 0 0 17.9023 13.9506 11.7074 18.0309 13.5194 18.0357 0 0 0 12.7109 0 0 14.0731 0 14.497 0 0 0 0 0 12.0536 13.9583 0 0 0 0 0 11.1168 0 0 0 0 0 0 0 11.699 11.8905 11.8672 0 0 0 0 0 0 0 0 0 0 11.3496 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2S2 CRYL1_HUMAN "Lambda-crystallin homolog, EC 1.1.1.45 (L-gulonate 3-dehydrogenase, Gul3DH)" CRYL1 CRY Homo sapiens (Human) fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631] GO:0005829; GO:0006631; GO:0016491; GO:0042803; GO:0050104; GO:0070062; GO:0070403 L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803] NALENIRK 0.97263 -0.59915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAT2 FGFP3_HUMAN "Fibroblast growth factor-binding protein 3, FGF-BP3, FGF-binding protein 3, FGFBP-3" FGFBP3 C10orf13 PSEC0101 Homo sapiens (Human) cell-cell signaling [GO:0007267]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of vascular permeability [GO:0043117] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of vascular permeability [GO:0043117] GO:0005576; GO:0007267; GO:0008201; GO:0017134; GO:0019838; GO:0043117; GO:0045743; GO:0062023 fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201] QVLGGLRK 0.97264 -0.59915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14763 TR10B_HUMAN "Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2) (CD antigen CD262)" TNFRSF10B DR5 KILLER TRAILR2 TRICK2 ZTNFR9 UNQ160/PRO186 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462] GO:0002357; GO:0005886; GO:0006915; GO:0007166; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0034976; GO:0036462; GO:0036463; GO:0038023; GO:0042981; GO:0043065; GO:0043123; GO:0045569; GO:0070059; GO:0071260 signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463] DCISCKYGQDYSTHWNDLLFCLR 0.97267 -0.60282 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3456 0 0 0 0 0 0 0 0 0 0 0 0 13.356 0 0 12.335 0 0 0 0 0 0 0 12.4092 0 0 0 0 0 0 0 0 12.1352 0 0 0 0 0 0 0 12.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0934 0 0 0 11.4067 0 0 0 0 0 13.0222 0 0 0 11.517 0 11.3526 11.3285 0 0 0 0 15.4911 0 0 0 0 0 0 15.531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0044 0 0 0 0 0 0 12.4482 0 0 0 0 0 0 0 0 0 11.1892 0 11.7245 0 0 12.0935 0 0 0 0 0 13.0953 0 0 0 0 0 0 11.1521 0 Q96HA9 PX11C_HUMAN "Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma, PEX11-gamma)" PEX11G PEX11C Homo sapiens (Human) peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375] integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] integral component of peroxisomal membrane [GO:0005779]; intrinsic component of peroxisomal membrane [GO:0031231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375] GO:0005777; GO:0005778; GO:0005779; GO:0016559; GO:0031231; GO:0032991; GO:0044375 GVLWAGR 0.97267 -0.60457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0897 0 0 0 0 0 0 0 0 11.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3337 0 0 0 0 0 0 Q96GV9 MACIR_HUMAN Macrophage immunometabolism regulator MACIR C5orf30 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cell migration [GO:0010631]; fibroblast migration [GO:0010761]; inflammatory response [GO:0006954]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of inflammatory response [GO:0050728]; protein transport [GO:0015031] ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737] ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271]; epithelial cell migration [GO:0010631]; fibroblast migration [GO:0010761]; inflammatory response [GO:0006954]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of inflammatory response [GO:0050728]; protein transport [GO:0015031] GO:0005737; GO:0006954; GO:0010631; GO:0010633; GO:0010761; GO:0010764; GO:0015031; GO:0035869; GO:0050728; GO:0060271; GO:1900016 AEAMPSLR 0.97268 -0.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20742 PZP_HUMAN Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6) PZP CPAMD6 Homo sapiens (Human) female pregnancy [GO:0007565] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565] GO:0002020; GO:0004866; GO:0004867; GO:0005576; GO:0007565; GO:0070062; GO:0072562 endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] AHTSFQISLTISYTGNRPASNMVIVDVKMVSGFIPLK 0.97271 -1.1024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4F7 RN175_HUMAN RING finger protein 175 RNF175 Homo sapiens (Human) ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000139; GO:0005789; GO:0016021; GO:0030433; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AAGTAARK 0.97276 -0.59915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43908 NKG2F_HUMAN NKG2-F type II integral membrane protein (NK cell receptor F) (NKG2-F-activating NK receptor) KLRC4 NKG2F Homo sapiens (Human) positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; stimulatory C-type lectin receptor signaling pathway [GO:0002223] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; transmembrane signaling receptor activity [GO:0004888]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; stimulatory C-type lectin receptor signaling pathway [GO:0002223] GO:0002223; GO:0004888; GO:0005887; GO:0009897; GO:0045954 transmembrane signaling receptor activity [GO:0004888] HCGHCPEEWITYSNSCYYIGKERR 0.97278 -0.59915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3099 0 0 0 12.1638 0 0 0 0 0 0 0 0 0 0 0 0 13.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8216 0 0 0 12.4842 0 0 0 0 0 0 0 0 0 0 0 13.0357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZI3 TM268_HUMAN Transmembrane protein 268 TMEM268 C9orf91 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 RYIIYNSR 0.97278 -0.59915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7364 12.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36575 ARRC_HUMAN "Arrestin-C (Cone arrestin, C-arrestin, cArr) (Retinal cone arrestin-3) (X-arrestin)" ARR3 ARRX CAR Homo sapiens (Human) G protein-coupled receptor internalization [GO:0002031]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202] cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219]; G protein-coupled receptor internalization [GO:0002031]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0001664; GO:0001750; GO:0001917; GO:0001932; GO:0002031; GO:0002046; GO:0005737; GO:0007165; GO:0007601; GO:0045202; GO:0051219 G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219] AVEAEGDEGS 0.9728 -0.60201 0 0 0 0 0 0 0 10.9937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5338 0 11.2859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54578 UBP14_HUMAN "Ubiquitin carboxyl-terminal hydrolase 14, EC 3.4.19.12 (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14)" USP14 TGT Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202] cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; synapse [GO:0045202]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; chemical synaptic transmission [GO:0007268]; innate immune response [GO:0045087]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of chemotaxis [GO:0050920]; regulation of proteasomal protein catabolic process [GO:0061136] GO:0000502; GO:0004197; GO:0004843; GO:0004866; GO:0005829; GO:0005886; GO:0007268; GO:0009986; GO:0016579; GO:0031410; GO:0043161; GO:0045087; GO:0045202; GO:0050920; GO:0061136; GO:0070062; GO:0070628; GO:1903070 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628] GEQGQYLQQDANECWIQMMRVLQQK 0.97289 -0.59849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3613 0 12.0401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4145 0 0 0 0 11.6284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1123 0 0 0 0 0 0 0 0 P55209 NP1L1_HUMAN "Nucleosome assembly protein 1-like 1 (NAP-1-related protein, hNRP)" NAP1L1 NRP Homo sapiens (Human) DNA replication [GO:0006260]; nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769] chromatin [GO:0000785]; cytoplasm [GO:0005737]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; nervous system development [GO:0007399]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769] GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005737; GO:0006260; GO:0006334; GO:0007399; GO:0008284; GO:0016020; GO:0042393; GO:0042470; GO:0050769; GO:2000179 chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723] DIKVKFSDAGQPMSFVLEFHFEPNEYFTNEVLTK 0.97289 -0.59884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5262 0 0 0 10.8518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8525 0 0 0 0 0 0 0 0 0 11.7912 0 0 0 0 0 0 14.8937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6012 0 0 0 0 0 0 0 0 12.567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47890 OR1G1_HUMAN "Olfactory receptor 1G1 (Olfactory receptor 17-209, OR17-209) (Olfactory receptor 1G2) (Olfactory receptor OR17-8)" OR1G1 OR1G2 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IPSAQGKR 0.97291 -0.59915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2677 14.1427 14.1316 14.1529 0 13.6563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UDW1 QCR9_HUMAN Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein) UQCR10 UCRC HSPC119 Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]" GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0045333 ubiquinol-cytochrome-c reductase activity [GO:0008121] LYSLLFRR 0.97291 -0.59915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KP31 ZN791_HUMAN Zinc finger protein 791 ZNF791 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFSRISYFRIHER 0.97293 -0.60106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1577 0 0 0 0 0 0 0 0 0 0 0 0 11.6226 0 11.6591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43613 OX1R_HUMAN "Orexin/Hypocretin receptor type 1 (Hypocretin receptor type 1) (Orexin receptor type 1, Ox-1-R, Ox1-R, Ox1R)" HCRTR1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0007268; GO:0007631; GO:0016499; GO:0017046; GO:0045202; GO:0051480; GO:0070374 G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046] IYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGR 0.97297 3.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2231 0 0 0 0 0 16.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8802 11.9618 0 0 0 16.4106 15.5931 16.6766 0 0 15.8425 15.5313 15.9716 15.4368 15.2635 0 14.9854 15.2908 15.0267 0 0 0 0 0 0 12.8284 0 14.021 14.4362 13.2814 0 0 0 12.9667 0 14.9038 0 0 13.9144 0 0 0 0 0 13.6269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2389 0 0 0 0 0 0 P78563 RED1_HUMAN "Double-stranded RNA-specific editase 1, EC 3.5.4.37 (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase)" ADARB1 ADAR2 DRADA2 RED1 Homo sapiens (Human) adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965] GO:0003723; GO:0003725; GO:0003726; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008251; GO:0008285; GO:0016553; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0042802; GO:0044387; GO:0045070; GO:0045087; GO:0045202; GO:0046872; GO:0050884; GO:0051607; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049 double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251] AKLHAAEKALR 0.97302 3.2223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2389 0 13.3292 12.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.888 14.0943 13.5105 0 0 13.8502 12.8257 0 0 14.3092 0 13.6818 0 0 13.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3549 0 0 0 0 0 0 Q8N357 S35F6_HUMAN "Solute carrier family 35 member F6 (ANT2-binding protein, ANT2BP) (Transport and Golgi organization 9 homolog)" SLC35F6 C2orf18 UNQ3047/PRO9863 Homo sapiens (Human) negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transmembrane transporter activity [GO:0022857]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284] GO:0005654; GO:0005739; GO:0005765; GO:0005829; GO:0008284; GO:0016020; GO:0016021; GO:0022857; GO:0043231; GO:0070062; GO:1901029 transmembrane transporter activity [GO:0022857] LVLSQWLGILATIAGLVVVGLADLLSKHDSQHK 0.97306 -0.60093 0 0 0 0 0 0 0 0 13.127 0 11.9626 0 0 0 0 0 0 0 0 0 0 0 13.2899 0 0 12.8862 0 0 0 12.4035 12.803 0 0 13.1622 12.3625 0 0 11.8325 13.929 0 0 11.5559 11.8351 0 0 12.5002 0 0 0 0 0 0 0 0 14.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.131 0 0 0 0 0 0 0 0 0 13.8853 0 0 13.6682 0 0 13.9936 12.6183 0 0 12.8218 0 0 0 0 12.3438 0 0 0 0 12.9145 0 0 Q92551 IP6K1_HUMAN "Inositol hexakisphosphate kinase 1, InsP6 kinase 1, EC 2.7.4.21 (Inositol hexaphosphate kinase 1)" IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol diphosphate tetrakisphosphate kinase activity [GO:0052839]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; kinase activity [GO:0016301]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]" GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016301; GO:0016310; GO:0032958; GO:0043647; GO:0046854; GO:0052723; GO:0052724; GO:0052836; GO:0052839; GO:0120163 "ATP binding [GO:0005524]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol diphosphate tetrakisphosphate kinase activity [GO:0052839]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; kinase activity [GO:0016301]" ECRAESCLDR 0.97306 3.2216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1411 0 0 12.9404 0 12.8332 0 0 0 0 12.0985 0 0 0 0 0 0 0 14.0834 0 0 0 0 13.7662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JS37 NHLC3_HUMAN NHL repeat-containing protein 3 NHLRC3 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576] azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005576; GO:0035578; GO:0043161; GO:0061630 ubiquitin protein ligase activity [GO:0061630] DTGEWLGAWNNCFTEEGPSSVR 0.97309 3.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3675 0 0 0 A6NNW6 ENO4_HUMAN "Enolase 4, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase)" ENO4 C10orf134 Homo sapiens (Human) cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; glycolytic process [GO:0006096] phosphopyruvate hydratase complex [GO:0000015]; sperm principal piece [GO:0097228] phosphopyruvate hydratase complex [GO:0000015]; sperm principal piece [GO:0097228]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; glycolytic process [GO:0006096] GO:0000015; GO:0000287; GO:0004634; GO:0006096; GO:0030317; GO:0044782; GO:0097228 magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634] AETKKGHDGSK 0.9731 3.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0766 0 0 14.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5L0 VMO1_HUMAN Vitelline membrane outer layer protein 1 homolog VMO1 UNQ6350/PRO21055 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] GO:0005615; GO:0070062 CSDGEELQGPGLSWGDFGDWSDHCPK 0.97315 3.0011 0 14.127 10.7865 14.3053 0 10.6929 13.0665 13.5787 15.3645 15.7642 15.2933 13.2452 14.4825 14.4879 15.4538 15.0448 15.6448 13.115 14.6201 13.6856 13.2326 13.5631 13.8642 14.215 13.2824 13.4881 10.67 10.3645 16.0153 14.183 13.0044 12.7038 0 13.9989 9.9562 13.2398 13.3852 11.5232 13.2382 14.4475 14.4118 13.4729 13.3538 15.3652 13.5823 15.5093 13.2154 14.0249 14.3173 0 0 11.3568 0 0 0 0 11.6339 0 0 0 0 0 0 9.20342 0 0 0 0 0 0 14.7303 14.6939 10.775 11.0445 14.3071 14.5238 16.0935 14.4158 14.5854 15.785 14.5965 13.6184 15.5153 15.2865 16.3875 15.8275 16.2801 16.579 14.4067 14.9124 14.4407 14.9157 16.4887 14.9568 15.606 14.2504 16.2044 16.4298 0 15.1517 0 14.3441 0 15.4508 14.8186 15.022 12.9746 13.5652 0 14.8758 13.2741 11.9401 15.7103 13.2598 0 14.1451 15.7395 0 13.8234 0 0 0 14.0223 14.2529 14.8408 16.0053 0 13.4186 0 14.7998 13.2069 10.9713 0 14.8317 11.9688 0 12.3959 12.2442 13.5453 0 0 13.2842 0 14.7827 0 0 13.5079 12.5428 14.6889 0 0 0 0 11.2779 0 14.2798 15.3063 15.638 13.356 12.91 13.9294 14.5232 12.6598 15.3098 14.3932 13.1088 15.9213 15.7637 15.1415 15.3124 14.9158 15.0972 12.7446 14.0608 14.791 14.842 0 15.4373 0 0 Q6ZN19 ZN841_HUMAN Zinc finger protein 841 ZNF841 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EIRKNLQEVDFQWK 0.97317 3.146 0 0 0 0 0 0 0 0 0 0 0 11.0844 10.6544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.131 9.74898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6642 0 0 0 13.0514 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1616 0 0 12.6291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6121 0 10.9049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12769 NU160_HUMAN Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160) NUP160 KIAA0197 NUP120 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] GO:0005635; GO:0005643; GO:0005829; GO:0006406; GO:0006913; GO:0015031; GO:0017056; GO:0031080; GO:0072006 structural constituent of nuclear pore [GO:0017056] ATRDLLYRR 0.97324 4.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3923 0 0 0 0 0 0 11.5318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91976 0 0 0 0 0 0 0 12.8121 0 11.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2521 0 0 17.412 0 0 0 0 0 13.4841 12.3713 14.2513 0 13.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65768 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6485 0 0 0 0 0 0 0 0 0 11.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PQ1 SIG12_HUMAN "Sialic acid-binding Ig-like lectin 12, Siglec-12 (Sialic acid-binding Ig-like lectin-like 1, Siglec-L1)" SIGLEC12 SIGLECL1 SLG UNQ9215/PRO34042 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0033691 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] LLLLLLLPPLLCGR 0.97333 4.3258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8876 0 13.0624 13.9225 0 0 12.3894 11.2459 0 0 0 0 14.5354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1944 0 0 0 0 0 0 0 0 12.0035 0 0 0 0 0 0 0 15.0671 0 14.5737 0 11.7151 0 0 0 15.612 0 16.0825 0 0 0 0 0 0 0 0 0 10.8474 0 12.597 0 0 0 0 15.8726 11.6545 0 0 0 0 0 0 12.4186 12.5659 0 0 0 0 0 0 0 0 11.8125 0 0 0 0 0 0 0 0 11.9079 0 0 0 0 0 11.5147 0 0 0 13.7279 0 13.1608 0 13.2438 11.5595 11.4799 0 14.7277 0 13.0033 13.4127 0 0 12.0363 0 11.0881 0 0 0 0 0 0 0 0 0 13.5454 0 0 0 10.7214 0 15.5688 0 0 14.829 0 0 0 0 13.6416 Q14627 I13R2_HUMAN "Interleukin-13 receptor subunit alpha-2, IL-13 receptor subunit alpha-2, IL-13R subunit alpha-2, IL-13R-alpha-2, IL-13RA2 (Interleukin-13-binding protein) (CD antigen CD213a2)" IL13RA2 IL13R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of mast cell degranulation [GO:0043305] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cytokine-mediated signaling pathway [GO:0019221]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of mast cell degranulation [GO:0043305] GO:0002638; GO:0004896; GO:0005576; GO:0005615; GO:0009897; GO:0016021; GO:0016064; GO:0019221; GO:0019955; GO:0043235; GO:0043305 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896] CFDYEIEIR 0.97339 3.682 0 0 0 0 12.8728 0 14.1887 0 0 0 0 0 0 0 0 11.2149 0 0 0 11.0053 0 0 0 0 0 11.0151 0 0 0 0 0 0 0 0 0 0 0 10.4887 0 0 0 14.9039 0 0 0 0 0 0 0 11.6568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8313 0 0 0 0 0 0 14.5997 11.8062 0 0 0 14.0838 0 0 14.018 0 0 0 13.8329 0 10.5419 13.9883 0 13.3993 14.104 15.0671 12.8826 14.8496 0 14.764 15.0069 13.9538 13.7399 0 13.9661 15.197 0 11.9859 14.6518 13.5288 0 0 0 13.2375 0 0 0 15.2678 15.7065 12.5948 11.9765 11.2372 11.7001 12.0053 0 0 0 14.4185 13.8571 0 10.4749 0 0 0 14.5361 0 11.7376 15.1302 0 0 0 0 12.6983 0 0 0 0 0 0 0 0 12.2643 13.9777 0 0 11.2701 0 0 0 0 14.345 11.9488 0 11.9059 0 0 0 13.1882 11.8617 0 0 0 0 0 0 15.1202 0 0 0 11.4638 0 0 Q9Y450 HBS1L_HUMAN HBS1-like protein (ERFS) HBS1L HBS1 KIAA1038 Homo sapiens (Human) signal transduction [GO:0007165]; translation [GO:0006412] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; signal transduction [GO:0007165]; translation [GO:0006412] GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0007165; GO:0016020; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746] ASFAYAWVLDETGEERER 0.97345 3.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0697 0 0 0 12.8452 0 0 0 0 0 0 0 0 0 14.9067 0 14.4474 0 15.1741 14.2526 0 15.0102 0 0 0 0 0 0 0 0 0 14.1819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5511 0 0 0 12.1917 0 12.7816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9541 0 0 0 0 0 0 15.2887 0 0 0 0 0 0 0 0 0 0 0 12.783 0 0 0 0 0 14.7314 0 0 0 13.9088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.945 0 14.6466 0 13.5911 0 0 0 0 0 0 0 0 0 0 0 0 13.6758 13.325 0 12.9181 0 0 0 0 0 0 0 0 O95407 TNF6B_HUMAN "Tumor necrosis factor receptor superfamily member 6B (Decoy receptor 3, DcR3) (Decoy receptor for Fas ligand) (M68)" TNFRSF6B DCR3 TR6 UNQ186/PRO212 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; signaling receptor activity [GO:0038023]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066] GO:0005576; GO:0005615; GO:0006915; GO:0038023; GO:0043066 signaling receptor activity [GO:0038023] ACHATHNRACR 0.9736 4.308 0 0 0 0 0 0 0 0 0 0 10.891 0 0 0 0 0 0 0 0 0 0 12.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5948 0 0 0 12.7931 12.7016 0 14.6441 0 13.1038 0 0 0 0 0 12.8567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.689 11.99 0 0 14.1432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2794 0 0 0 11.6092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1102 0 0 0 0 Q86YV9 HPS6_HUMAN "BLOC-2 complex member HPS6 (Hermansky-Pudlak syndrome 6 protein) (Ruby-eye protein homolog, Ru)" HPS6 Homo sapiens (Human) blood coagulation [GO:0007596]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]; protein localization to membrane [GO:0072657] BLOC-2 complex [GO:0031084]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] BLOC-2 complex [GO:0031084]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267]; blood coagulation [GO:0007596]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155]; protein localization to membrane [GO:0072657] GO:0005765; GO:0005769; GO:0005783; GO:0006996; GO:0007596; GO:0016020; GO:0030318; GO:0030742; GO:0031084; GO:0031267; GO:0031901; GO:0032418; GO:0046907; GO:0060155; GO:0072657; GO:1903232 GTP-dependent protein binding [GO:0030742]; small GTPase binding [GO:0031267] ALQLQLDGNGKLRSQAPPDVWK 0.97364 3.1985 0 0 0 0 0 0 0 0 0 11.9398 0 0 11.914 0 0 0 0 11.9777 0 0 0 12.6446 10.8512 0 0 12.6579 0 0 0 0 13.0911 0 0 0 0 13.2897 13.9912 0 0 0 0 13.1179 0 0 12.8231 13.1483 0 14.3046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7664 0 0 0 11.4641 13.9726 13.3519 0 14.2321 14.9758 12.6432 14.3212 12.6684 0 0 0 0 13.2973 14.5084 0 13.5456 13.2909 13.358 0 0 0 0 0 13.7326 0 15.5501 12.9253 0 14.4278 0 13.2315 0 0 0 0 0 0 15.4466 0 0 13.7323 0 0 0 0 0 0 0 13.1935 0 0 0 0 0 0 13.1119 12.2053 0 0 13.0195 0 0 0 12.9141 12.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 14.056 0 11.9496 0 0 11.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01524 DEF6_HUMAN "Defensin-6 (Defensin, alpha 6)" DEFA6 DEF6 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; transport vesicle [GO:0030133] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673] GO:0002227; GO:0005576; GO:0005615; GO:0005796; GO:0019731; GO:0030133; GO:0031640; GO:0042803; GO:0050829; GO:0050830; GO:0050832; GO:0051673; GO:0061844; GO:0071222 protein homodimerization activity [GO:0042803] MRTLTILTAVLLVALQAK 0.97365 2.9771 0 0 0 0 0 0 0 0 0 0 12.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6922 11.2295 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6674 12.9718 0 11.3192 12.9432 12.2557 0 0 0 0 11.1646 0 11.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8438 0 0 0 0 0 0 0 0 0 Q8N2H3 PYRD2_HUMAN "Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2, EC 1.-.-.-" PYROXD2 C10orf33 Homo sapiens (Human) mitochondrion organization [GO:0007005] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; oxidoreductase activity [GO:0016491]; mitochondrion organization [GO:0007005] GO:0005759; GO:0007005; GO:0016491 oxidoreductase activity [GO:0016491] LGVNTAVFERR 0.97372 3.1935 0 0 0 0 0 13.1638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4928 0 0 0 0 0 0 0 16.3396 0 0 0 0 0 0 11.64 0 0 11.4 0 0 0 0 0 0 13.6254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6194 0 16.4789 0 15.1813 12.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11686 PSPC_HUMAN "Pulmonary surfactant-associated protein C, SP-C (Pulmonary surfactant-associated proteolipid SPL(Val)) (SP5)" SFTPC SFTP2 Homo sapiens (Human) respiratory gaseous exchange by respiratory system [GO:0007585] alveolar lamellar body [GO:0097208]; clathrin-coated endocytic vesicle [GO:0045334]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; multivesicular body lumen [GO:0097486] alveolar lamellar body [GO:0097208]; clathrin-coated endocytic vesicle [GO:0045334]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; multivesicular body lumen [GO:0097486]; identical protein binding [GO:0042802]; respiratory gaseous exchange by respiratory system [GO:0007585] GO:0005576; GO:0005615; GO:0005789; GO:0007585; GO:0042599; GO:0042802; GO:0045334; GO:0097208; GO:0097486 identical protein binding [GO:0042802] FGIPCCPVHLKR 0.97377 3.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.426 0 11.2288 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8754 0 0 0 0 0 0 10.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.805 10.8165 0 0 0 0 0 0 0 0 0 10.8205 0 0 0 0 0 0 0 10.8811 0 0 0 0 10.9599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0538 11.3633 0 0 0 0 0 0 0 0 0 0 11.1051 0 11.2772 0 0 0 0 0 0 0 10.935 0 0 0 0 0 0 0 0 0 0 0 0 11.2266 0 0 0 10.8615 0 0 0 0 0 0 0 0 0 0 0 0 11.569 0 0 0 0 P78560 CRADD_HUMAN Death domain-containing protein CRADD (Caspase and RIP adapter with death domain) (RIP-associated protein with a death domain) CRADD RAIDD Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase complex [GO:1905369]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase complex [GO:1905369]; nucleolus [GO:0005730]; nucleus [GO:0005634]; death domain binding [GO:0070513]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]" GO:0002020; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006919; GO:0006974; GO:0006977; GO:0008625; GO:0030674; GO:0043065; GO:0070513; GO:0071260; GO:0097190; GO:1905369; GO:2001235 death domain binding [GO:0070513]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674] AREEAMTDLPAGDR 0.97422 -1.1129 0 0 0 0 0 0 0 0 0 0 11.9888 0 0 0 0 0 0 0 11.9148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00889 PSG6_HUMAN "Pregnancy-specific beta-1-glycoprotein 6, PS-beta-G-6, PSBG-6, Pregnancy-specific glycoprotein 6 (Pregnancy-specific beta-1-glycoprotein 10, PS-beta-G-10, PSBG-10, Pregnancy-specific glycoprotein 10) (Pregnancy-specific beta-1-glycoprotein 12, PS-beta-G-12, PSBG-12, Pregnancy-specific glycoprotein 12)" PSG6 CGM3 PSG10 PSG12 PSGGB Homo sapiens (Human) female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; female pregnancy [GO:0007565]; regulation of immune system process [GO:0002682]; signal transduction [GO:0007165] GO:0002682; GO:0005576; GO:0005886; GO:0007165; GO:0007565; GO:0009986; GO:1990782 protein tyrosine kinase binding [GO:1990782] GLLLTASLLNFWNLPTTAQVIIEAK 0.97434 -1.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.434 13.7824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1958 14.0236 0 0 12.8154 0 0 10.7302 13.0557 13.8139 0 0 0 12.8411 0 0 0 0 0 13.3267 0 0 13.9679 0 0 0 13.8769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0213 13.5033 14.2006 0 0 0 0 0 0 14.7277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94901 SUN1_HUMAN SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1) SUN1 KIAA0810 UNC84A Homo sapiens (Human) centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283] GO:0005521; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0021817; GO:0031965; GO:0034993; GO:0043231; GO:0043495; GO:0051642; GO:0070197; GO:0090292; GO:0140444 cytoskeleton-nuclear membrane anchor activity [GO:0140444]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495] ELTTLLQKLQAR 0.97446 3.0012 12.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3234 0 15.9717 0 0 15.4732 0 10.1523 0 15.1061 0 0 14.9048 0 0 0 0 0 0 12.8829 0 12.6783 0 0 0 0 10.2207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.664 12.2472 12.3492 0 0 0 0 0 0 0 0 12.4684 12.8432 13.4387 13.5404 0 13.3298 13.2752 0 0 0 0 12.7792 0 0 0 0 0 0 0 0 0 0 11.51 0 0 14.0368 16.2867 0 14.3986 0 13.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3503 0 0 0 0 0 0 0 0 0 0 12.6931 13.3041 0 0 0 17.893 18.0607 P32245 MC4R_HUMAN "Melanocortin receptor 4, MC4-R" MC4R Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; diet induced thermogenesis [GO:0002024]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; insulin secretion [GO:0030073]; negative regulation of feeding behavior [GO:2000252]; positive regulation of bone resorption [GO:0045780]; regulation of eating behavior [GO:1903998]; regulation of grooming behavior [GO:2000821]; regulation of metabolic process [GO:0019222]; response to insulin [GO:0032868]; response to melanocyte-stimulating hormone [GO:1990680] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; diet induced thermogenesis [GO:0002024]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; insulin secretion [GO:0030073]; negative regulation of feeding behavior [GO:2000252]; positive regulation of bone resorption [GO:0045780]; regulation of eating behavior [GO:1903998]; regulation of grooming behavior [GO:2000821]; regulation of metabolic process [GO:0019222]; response to insulin [GO:0032868]; response to melanocyte-stimulating hormone [GO:1990680] GO:0002024; GO:0004930; GO:0004977; GO:0004980; GO:0005634; GO:0005737; GO:0005886; GO:0006112; GO:0007188; GO:0007189; GO:0007631; GO:0016021; GO:0017046; GO:0019222; GO:0030073; GO:0031625; GO:0032868; GO:0042923; GO:0045780; GO:1903998; GO:1990680; GO:2000252; GO:2000821 G protein-coupled receptor activity [GO:0004930]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; neuropeptide binding [GO:0042923]; peptide hormone binding [GO:0017046]; ubiquitin protein ligase binding [GO:0031625] LHIKRIAVLPGTGAIR 0.97452 4.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7425 0 0 0 11.6625 11.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1368 0 0 0 0 0 11.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.763 0 0 0 0 0 0 0 0 0 0 0 0 12.5419 0 0 0 0 0 0 0 0 0 0 0 13.6569 0 0 11.4325 0 0 0 0 0 0 0 11.7165 0 0 0 0 0 14.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2392 0 0 0 0 0 0 0 12.3736 0 12.3582 12.3705 0 O75379 VAMP4_HUMAN "Vesicle-associated membrane protein 4, VAMP-4" VAMP4 Homo sapiens (Human) Golgi ribbon formation [GO:0090161]; microtubule cytoskeleton organization [GO:0000226]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; Golgi ribbon formation [GO:0090161]; microtubule cytoskeleton organization [GO:0000226]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189] GO:0000139; GO:0000226; GO:0005764; GO:0005768; GO:0005794; GO:0005802; GO:0005886; GO:0008021; GO:0009986; GO:0016021; GO:0016189; GO:0030133; GO:0030669; GO:0031201; GO:0032588; GO:0035493; GO:0090161; GO:1900242 AIMALVAAILLLVIIILIVMK 0.97455 3.1522 0 0 0 0 0 0 0 0 0 0 14.2029 0 14.0473 0 0 15.1814 16.0138 0 0 14.2278 14.7901 0 0 11.1541 0 0 0 0 0 0 0 0 14.078 15.6587 0 14.0709 15.1849 13.5882 13.6768 0 0 0 13.4534 0 0 0 0 0 13.1296 14.5933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4132 14.4222 0 14.4293 0 14.3009 0 0 0 0 0 0 0 0 0 14.3637 0 0 0 0 0 15.6412 0 0 14.8873 14.0935 14.1298 0 0 13.6792 0 0 14.1796 0 0 0 0 0 0 11.7733 0 0 13.9699 0 0 13.6074 0 0 0 15.6614 13.218 0 14.2306 0 0 0 0 0 13.1032 0 0 0 0 11.4077 0 0 0 0 0 0 0 0 0 0 12.0572 0 0 15.0057 15.1772 0 0 0 0 0 0 0 14.2454 0 0 0 0 0 12.088 11.8409 12.152 12.7624 0 12.3933 14.4026 0 0 0 0 15.8061 13.919 0 13.3411 0 0 0 0 0 10.9831 P00797 RENI_HUMAN "Renin, EC 3.4.23.15 (Angiotensinogenase)" REN Homo sapiens (Human) amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; cell maturation [GO:0048469]; cellular response to xenobiotic stimulus [GO:0071466]; drinking behavior [GO:0042756]; hormone-mediated signaling pathway [GO:0009755]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mesonephros development [GO:0001823]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of MAPK cascade [GO:0043408]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to cAMP [GO:0051591]; response to cGMP [GO:0070305]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; aspartic-type endopeptidase activity [GO:0004190]; insulin-like growth factor receptor binding [GO:0005159]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; amyloid-beta metabolic process [GO:0050435]; angiotensin maturation [GO:0002003]; cell maturation [GO:0048469]; cellular response to xenobiotic stimulus [GO:0071466]; drinking behavior [GO:0042756]; hormone-mediated signaling pathway [GO:0009755]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mesonephros development [GO:0001823]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of MAPK cascade [GO:0043408]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to cAMP [GO:0051591]; response to cGMP [GO:0070305]; response to immobilization stress [GO:0035902]; response to lipopolysaccharide [GO:0032496] GO:0001822; GO:0001823; GO:0002003; GO:0002018; GO:0004190; GO:0005102; GO:0005159; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008233; GO:0008584; GO:0009755; GO:0032496; GO:0035902; GO:0042756; GO:0043408; GO:0045177; GO:0048469; GO:0050435; GO:0051591; GO:0070305; GO:0071466 aspartic-type endopeptidase activity [GO:0004190]; insulin-like growth factor receptor binding [GO:0005159]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102] MDGWRRMPR 0.97463 -1.1242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7827 12.8601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0P0 5NT3A_HUMAN "Cytosolic 5'-nucleotidase 3A, EC 3.1.3.5 (7-methylguanosine phosphate-specific 5'-nucleotidase, 7-methylguanosine nucleotidase, EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III, cN-III) (Pyrimidine 5'-nucleotidase 1, P5'N-1, P5N-1, PN-I) (Uridine 5'-monophosphate hydrolase 1) (p36)" NT5C3A NT5C3 P5N1 UMPH1 HSPC233 Homo sapiens (Human) defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside metabolic process [GO:0006213] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; tRNA 2'-phosphotransferase activity [GO:0000215]; XMP 5'-nucleosidase activity [GO:0106411]; defense response to virus [GO:0051607]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside metabolic process [GO:0006213] GO:0000166; GO:0000215; GO:0000287; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006213; GO:0008253; GO:0009117; GO:0016604; GO:0051607; GO:0106411 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; tRNA 2'-phosphotransferase activity [GO:0000215]; XMP 5'-nucleosidase activity [GO:0106411] GFKGELIHVFNK 0.97466 -1.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7863 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VFZ6 CF210_HUMAN Cilia- and flagella- associated protein 210 (Coiled-coil domain-containing protein 173) CFAP210 C2orf77 CCDC173 Homo sapiens (Human) axonemal microtubule [GO:0005879] axonemal microtubule [GO:0005879] GO:0005879 EQKLEAKK 0.97472 -1.1188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0338 0 14.0232 0 0 0 12.9989 13.3115 0 0 12.6483 13.1116 0 12.6833 0 0 12.7304 0 0 0 0 0 0 12.0849 0 0 0 0 0 0 14.9632 12.6301 0 0 12.8591 0 17.8735 0 0 0 0 0 0 12.7114 0 13.0974 12.8239 0 0 0 0 0 0 0 0 0 0 0 12.8156 0 13.4712 13.7111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DW6 S2538_HUMAN Mitochondrial glycine transporter (Appoptosin) (Mitochondrial glycine transporter GlyC) (Solute carrier family 25 member 38) SLC25A38 Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983]; heme biosynthetic process [GO:0006783] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; glycine transmembrane transporter activity [GO:0015187]; erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983]; heme biosynthetic process [GO:0006783] GO:0005739; GO:0005743; GO:0006783; GO:0015187; GO:0016021; GO:0030218; GO:1904983 glycine transmembrane transporter activity [GO:0015187] RVGMLAVLLKVVR 0.97473 2.9879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8269 0 0 0 0 0 0 0 13.7746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3836 0 0 0 0 0 0 0 0 0 Q969G2 LHX4_HUMAN "LIM/homeobox protein Lhx4, LIM homeobox protein 4" LHX4 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0006357; GO:0006915; GO:0008045; GO:0008327; GO:0009887; GO:0021526; GO:0030182; GO:0043066; GO:0043565; GO:0045944; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" FILKVLDR 0.97478 -1.1242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60880 SH21A_HUMAN "SH2 domain-containing protein 1A (Duncan disease SH2-protein) (Signaling lymphocytic activation molecule-associated protein, SLAM-associated protein) (T-cell signal transduction molecule SAP)" SH2D1A DSHP SAP Homo sapiens (Human) adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; humoral immune response [GO:0006959]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; humoral immune response [GO:0006959]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966] GO:0002250; GO:0005737; GO:0005829; GO:0006959; GO:0006968; GO:0007267; GO:0009966; GO:0042267; GO:0045954; GO:0050776; GO:0050860 DAVAVYHGK 0.97481 3.1398 0 0 0 0 0 0 0 0 0 10.8357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4513 0 0 0 0 0 0 0 0 0 0 11.8628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4552 0 0 0 0 0 0 0 11.1152 0 0 0 0 0 0 13.6679 0 0 0 15.1908 13.1315 12.891 0 0 0 13.4368 0 0 13.0515 13.1777 0 0 0 13.2291 12.2948 0 0 0 10.5325 10.3713 0 0 0 12.5523 9.98769 0 10.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1982 0 0 11.5344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5111 0 14.2848 0 14.6883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0415 0 0 0 0 0 0 Q16827 PTPRO_HUMAN "Receptor-type tyrosine-protein phosphatase O, R-PTP-O, EC 3.1.3.48 (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2, PTP-U2, PTPase U2)" PTPRO GLEPP1 PTPU2 Homo sapiens (Human) axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron projection development [GO:0010977]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; podocyte differentiation [GO:0072112]; protein dephosphorylation [GO:0006470]; regulation of glomerular filtration [GO:0003093]; regulation of synapse organization [GO:0050807]; slit diaphragm assembly [GO:0036060] apical plasma membrane [GO:0016324]; axon [GO:0030424]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; axon [GO:0030424]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; Wnt-protein binding [GO:0017147]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; glomerulus development [GO:0032835]; lamellipodium assembly [GO:0030032]; monocyte chemotaxis [GO:0002548]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of glomerular filtration [GO:0003105]; negative regulation of neuron projection development [GO:0010977]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; podocyte differentiation [GO:0072112]; protein dephosphorylation [GO:0006470]; regulation of glomerular filtration [GO:0003093]; regulation of synapse organization [GO:0050807]; slit diaphragm assembly [GO:0036060] GO:0000902; GO:0002548; GO:0003093; GO:0003105; GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007411; GO:0010812; GO:0010977; GO:0016021; GO:0016324; GO:0016328; GO:0016791; GO:0017147; GO:0030027; GO:0030032; GO:0030424; GO:0030426; GO:0032835; GO:0035335; GO:0036060; GO:0042803; GO:0043005; GO:0043197; GO:0045296; GO:0050807; GO:0070062; GO:0072112; GO:0090090; GO:0090260; GO:0098978; GO:0098982; GO:0099061; GO:1990264 cadherin binding [GO:0045296]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; Wnt-protein binding [GO:0017147] DMAKDSDYKFSLQFEELK 0.97484 -1.1175 0 0 0 0 0 0 0 0 0 14.4903 10.4754 0 0 0 13.6495 0 0 0 0 10.2808 0 0 0 0 0 0 0 0 0 14.4603 0 0 14.6802 0 0 0 0 0 0 0 0 15.5314 0 0 0 0 0 0 0 11.8429 0 0 0 0 0 14.9417 0 0 0 17.4555 0 0 17.2934 0 0 0 0 0 12.3061 0 10.9264 0 11.7747 0 0 0 13.2187 0 0 11.5273 13.2596 15.1685 0 0 13.721 0 0 11.9506 0 12.5391 0 14.3162 0 15.1028 0 0 0 12.6037 0 15.2082 15.3883 11.6387 0 0 0 12.7532 14.6881 15.1743 0 15.2747 0 0 0 0 0 0 0 14.6055 0 0 0 0 0 12.3167 12.5216 14.7052 0 0 0 0 11.8862 0 10.6109 12.0605 0 0 21.1803 0 15.3489 0 0 0 0 0 0 0 12.1852 16.7817 0 16.6388 0 0 0 0 14.5871 14.1634 11.2609 19.5498 20.015 21.721 0 14.995 14.1611 19.8094 20.7846 14.4146 16.8701 14.9697 12.2218 0 13.5198 0 12.8989 0 0 18.1602 0 20.645 19.2241 0 Q9NT99 LRC4B_HUMAN "Leucine-rich repeat-containing protein 4B (Netrin-G3 ligand, NGL-3)" LRRC4B LRIG4 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] anchoring junction [GO:0070161]; cerebellar mossy fiber [GO:0044300]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; cerebellar mossy fiber [GO:0044300]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; signaling receptor binding [GO:0005102]; positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560] GO:0005102; GO:0005886; GO:0042734; GO:0044300; GO:0051965; GO:0070161; GO:0098978; GO:0099061; GO:0099151; GO:0099560; GO:1905606 signaling receptor binding [GO:0005102] AHYSSNPSGGGCGGK 0.97484 4.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9865 13.0553 13.9157 0 0 0 0 0 0 13.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6451 0 0 0 0 0 0 11.1142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7268 0 0 0 15.4644 12.7403 12.9042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6926 12.4875 0 0 0 0 0 14.5239 13.2304 13.3151 13.2863 0 0 13.9275 0 0 0 0 0 0 0 0 0 0 0 0 12.6457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBC4 UBA3_HUMAN "NEDD8-activating enzyme E1 catalytic subunit, EC 6.2.1.64 (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3, Ubiquitin-activating enzyme 3)" UBA3 UBE1C Homo sapiens (Human) endomitotic cell cycle [GO:0007113]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; NEDD8 transferase activity [GO:0019788]; protein heterodimerization activity [GO:0046982]; endomitotic cell cycle [GO:0007113]; post-translational protein modification [GO:0043687]; protein modification by small protein conjugation [GO:0032446]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726] GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0007113; GO:0019781; GO:0019788; GO:0032446; GO:0032991; GO:0036211; GO:0042802; GO:0043687; GO:0045116; GO:0046982; GO:0051726 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; NEDD8 transferase activity [GO:0019788]; protein heterodimerization activity [GO:0046982] GVTYRLTQGVVK 0.97485 3.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4585 0 0 0 0 0 12.1077 0 0 15.0378 0 0 0 14.4157 15.0155 15.2983 0 15.0673 0 0 0 14.0904 0 0 0 0 14.3283 0 0 14.6921 14.616 0 14.4374 14.4604 14.7833 14.4521 0 0 0 13.9679 14.2114 14.243 0 0 14.5819 0 0 13.7967 14.1417 0 0 0 0 14.3078 14.288 13.8291 0 0 14.3493 0 14.0821 0 14.1748 0 0 0 0 0 0 0 14.0846 0 0 0 0 0 0 13.2634 0 13.5968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1596 14.0464 14.0543 13.871 0 0 0 0 0 0 Q5T1S8 NCMAP_HUMAN "Noncompact myelin-associated protein (Myelin protein of 11 kDa, MP11)" NCMAP C1orf130 Homo sapiens (Human) peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643] integral component of plasma membrane [GO:0005887]; paranode region of axon [GO:0033270]; Schmidt-Lanterman incisure [GO:0043220] integral component of plasma membrane [GO:0005887]; paranode region of axon [GO:0033270]; Schmidt-Lanterman incisure [GO:0043220]; structural constituent of myelin sheath [GO:0019911]; peripheral nervous system myelin formation [GO:0032290]; positive regulation of myelination [GO:0031643] GO:0005887; GO:0019911; GO:0031643; GO:0032290; GO:0033270; GO:0043220 structural constituent of myelin sheath [GO:0019911] GEDFLYKSSGAIVAAVVVVVIIIFTVVLILLK 0.97493 2.9781 0 0 0 0 0 0 0 0 0 11.9159 0 0 0 0 0 0 13.4143 0 0 13.1114 0 0 0 12.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3513 0 13.9551 13.366 0 0 0 12.7775 0 0 0 0 0 0 0 12.6964 0 0 0 0 0 0 13.6058 0 0 0 0 0 0 0 13.7163 11.7969 0 0 0 13.5471 15.4318 13.2919 0 0 12.5357 0 0 0 0 13.5178 0 0 14.0674 0 12.3639 0 0 13.7206 0 0 11.009 0 13.2084 13.4442 0 0 0 0 0 14.689 13.1819 12.0426 13.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3382 0 0 0 Q08397 LOXL1_HUMAN "Lysyl oxidase homolog 1, EC 1.4.3.- (Lysyl oxidase-like protein 1, LOL)" LOXL1 LOXL Homo sapiens (Human) aorta development [GO:0035904]; collagen fibril organization [GO:0030199]; peptidyl-lysine oxidation [GO:0018057]; protein deamination [GO:0018277]; response to lipopolysaccharide [GO:0032496] acrosomal vesicle [GO:0001669]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] acrosomal vesicle [GO:0001669]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; aorta development [GO:0035904]; collagen fibril organization [GO:0030199]; peptidyl-lysine oxidation [GO:0018057]; protein deamination [GO:0018277]; response to lipopolysaccharide [GO:0032496] GO:0001669; GO:0004720; GO:0005507; GO:0005576; GO:0005604; GO:0005615; GO:0018057; GO:0018277; GO:0030199; GO:0032496; GO:0035904; GO:0062023 copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720] CLASTAYAPEATDYDVR 0.97496 3.1241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6543 0 0 0 0 12.9391 0 0 11.263 0 0 0 0 0 0 13.0865 0 0 0 0 10.688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5026 0 12.9529 0 0 0 0 0 0 0 12.4387 12.3392 0 13.8486 13.2511 14.7272 0 14.4999 0 14.9439 12.4609 12.5423 0 0 13.0066 12.9384 0 0 0 14.978 15.5569 0 0 0 12.8525 13.131 0 12.7178 13.703 12.2756 0 0 0 0 0 0 0 0 12.4815 0 12.8179 0 0 12.7157 12.5563 0 0 0 13.6348 0 12.498 0 0 0 0 0 0 0 0 0 0 13.7855 12.3082 0 0 0 0 0 0 0 0 0 0 13.9335 0 0 0 0 12.4058 0 0 0 0 0 13.3418 0 12.0453 12.7317 0 11.7633 0 0 0 0 12.426 0 Q05329 DCE2_HUMAN "Glutamate decarboxylase 2, EC 4.1.1.15 (65 kDa glutamic acid decarboxylase, GAD-65) (Glutamate decarboxylase 65 kDa isoform)" GAD2 GAD65 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410] anchored component of membrane [GO:0031225]; anchoring junction [GO:0070161]; axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672] anchored component of membrane [GO:0031225]; anchoring junction [GO:0070161]; axon [GO:0030424]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; carboxy-lyase activity [GO:0016831]; glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170]; chemical synaptic transmission [GO:0007268]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamate decarboxylation to succinate [GO:0006540]; neurotransmitter biosynthetic process [GO:0042136]; response to xenobiotic stimulus [GO:0009410] GO:0000139; GO:0004351; GO:0005737; GO:0005829; GO:0005886; GO:0006540; GO:0007268; GO:0009410; GO:0009449; GO:0016595; GO:0016831; GO:0030170; GO:0030424; GO:0030672; GO:0031225; GO:0042136; GO:0042734; GO:0044877; GO:0048471; GO:0060077; GO:0061202; GO:0070161 carboxy-lyase activity [GO:0016831]; glutamate binding [GO:0016595]; glutamate decarboxylase activity [GO:0004351]; protein-containing complex binding [GO:0044877]; pyridoxal phosphate binding [GO:0030170] ASPGSGFWSFGSEDGSGDSENPGTAR 0.97498 -1.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6113 0 0 13.2404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z403 TMC6_HUMAN Transmembrane channel-like protein 6 (Epidermodysplasia verruciformis protein 1) (Protein LAK-4) TMC6 EVER1 EVIN1 Homo sapiens (Human) cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; mechanosensitive ion channel activity [GO:0008381] GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0008381; GO:0031965; GO:0035579; GO:0070062; GO:0070821 mechanosensitive ion channel activity [GO:0008381] EVTGSSQQTLWR 0.97498 -1.1226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8214 0 0 0 14.2514 0 14.1962 13.9187 0 0 0 0 13.9575 0 14.0485 13.6255 0 0 0 0 0 13.2295 0 0 0 0 0 0 0 0 13.2344 13.5986 13.3031 13.5324 0 14.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0399 0 0 0 0 12.7852 13.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3596 0 0 0 0 0 0 0 0 0 13.4038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYG7 MSTRO_HUMAN Protein maestro (Male-specific transcription in the developing reproductive organs) (Protein B29) MRO B29 C18orf3 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730] GO:0005730 NLGTMAYEAPDKVR 0.9751 -1.1209 0 0 0 13.5865 14.0119 0 0 0 0 0 0 0 0 0 0 0 0 13.1883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8853 0 14.8098 13.7447 14.2406 13.8511 0 0 13.7629 13.8177 14.8279 0 14.0366 13.4689 13.8067 0 0 13.5744 0 13.1738 0 0 0 0 0 0 14.5395 0 0 0 0 0 15.8761 15.6691 0 15.3953 0 0 19.2368 15.9786 14.7434 14.9078 0 15.8251 16.1337 0 15.1331 0 14.8095 14.8205 15.6639 15.2164 14.2756 0 0 19.1181 14.6775 15.4919 0 14.3312 0 14.4546 14.4151 14.2286 14.0609 14.2504 15.0761 15.1457 13.8929 0 0 0 0 0 0 13.9553 15.0895 13.779 0 13.9373 13.7175 0 0 0 14.5722 13.8678 0 0 0 0 16.0633 0 0 0 0 0 0 0 0 12.2163 0 0 0 0 0 14.2171 12.4051 13.9049 0 13.464 0 0 0 0 Q15620 OR8B8_HUMAN Olfactory receptor 8B8 (Olfactory receptor TPCR85) (Olfactory-like receptor JCG8) OR8B8 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] VALKKILNK 0.97511 -1.1242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4668 0 0 0 0 0 0 12.3534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6742 0 0 0 0 0 0 0 11.9283 0 0 0 0 0 0 O15245 S22A1_HUMAN "Solute carrier family 22 member 1 (Organic cation transporter 1, hOCT1)" SLC22A1 OCT1 Homo sapiens (Human) dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; dopamine uptake [GO:0090494]; epinephrine transport [GO:0048241]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] GO:0005277; GO:0005326; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0008513; GO:0010248; GO:0015101; GO:0015214; GO:0015651; GO:0015695; GO:0015697; GO:0015874; GO:0016020; GO:0016323; GO:0016324; GO:0019534; GO:0042802; GO:0042908; GO:0042910; GO:0048241; GO:0051610; GO:0072530; GO:0090494; GO:0098793; GO:0150104; GO:1901998; GO:1990962 acetylcholine transmembrane transporter activity [GO:0005277]; dopamine:sodium symporter activity [GO:0005330]; identical protein binding [GO:0042802]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; norepinephrine:sodium symporter activity [GO:0005334]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910] DAENLGRKAK 0.97528 -1.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TER0 SNED1_HUMAN "Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1, IRE-BP1)" SNED1 Homo sapiens (Human) cell-matrix adhesion [GO:0007160] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell-matrix adhesion [GO:0007160] GO:0005112; GO:0005509; GO:0005576; GO:0007160; GO:0031012 calcium ion binding [GO:0005509]; Notch binding [GO:0005112] AGDVYYR 0.97528 -1.1305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6893 0 13.0765 0 0 11.6349 0 0 0 0 12.6543 11.0937 0 0 0 0 0 0 13.3853 0 11.6286 0 0 11.8739 11.9665 0 11.5574 0 0 0 0 13.4261 0 0 0 0 0 0 0 0 0 13.7357 0 0 0 0 0 0 10.9107 0 0 0 12.9739 13.1453 0 0 9.90357 0 0 0 0 0 0 0 12.0779 0 14.3127 0 15.2308 0 14.7325 14.3207 0 0 0 0 14.4477 0 13.6521 0 0 13.8228 0 0 0 13.3845 0 0 0 0 0 14.5165 12.4028 0 12.1256 0 0 12.4435 0 13.9867 13.4091 10.9336 12.6548 0 0 0 12.0407 0 0 0 12.5792 0 0 0 0 0 0 0 0 0 12.8155 0 0 12.8035 0 12.1166 0 12.3878 0 0 13.1525 0 12.3124 0 13.0723 0 0 13.8155 0 0 12.3647 0 0 0 15.1043 0 0 14.6683 0 12.306 0 13.1359 0 0 0 12.8178 0 12.5025 15.5112 0 0 0 12.2405 13.4078 0 0 P08F94 PKHD1_HUMAN Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin) (Tigmin) PKHD1 FCYT TIGM1 Homo sapiens (Human) branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular calcium ion homeostasis [GO:0006874]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; homeostatic process [GO:0042592]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of cell adhesion [GO:0030155]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of centrosome duplication [GO:0010824]; regulation of cholangiocyte proliferation [GO:1904054]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of planar polarity [GO:0090175]; regulation of TOR signaling [GO:0032006] "9+0 non-motile cilium [GO:0097731]; anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]" "9+0 non-motile cilium [GO:0097731]; anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor activity [GO:0038023]; branching morphogenesis of an epithelial tube [GO:0048754]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular calcium ion homeostasis [GO:0006874]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; homeostatic process [GO:0042592]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of cell adhesion [GO:0030155]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of centrosome duplication [GO:0010824]; regulation of cholangiocyte proliferation [GO:1904054]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of planar polarity [GO:0090175]; regulation of TOR signaling [GO:0032006]" GO:0000132; GO:0000775; GO:0001822; GO:0001952; GO:0003382; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005929; GO:0006874; GO:0008284; GO:0010824; GO:0016021; GO:0016324; GO:0022407; GO:0030155; GO:0031362; GO:0032006; GO:0032088; GO:0036064; GO:0038023; GO:0042592; GO:0043066; GO:0045216; GO:0048471; GO:0048754; GO:0050679; GO:0051660; GO:0051898; GO:0060271; GO:0070062; GO:0070372; GO:0072686; GO:0090175; GO:0097731; GO:0098609; GO:1904036; GO:1904054 signaling receptor activity [GO:0038023] CKLEPLWSNILLR 0.97529 -1.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7513 0 0 0 13.7527 0 12.9029 0 0 0 0 12.6772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4289 0 11.8127 0 0 0 0 0 11.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9247 0 14.9215 0 15.4948 0 0 15.6629 15.6192 15.2251 14.1728 15.3955 15.1673 14.8529 13.9153 0 13.6419 13.7252 16.6616 0 14.8637 0 14.0332 11.9961 0 0 0 13.7084 13.6683 0 13.8533 0 15.6416 0 15.0033 0 0 0 13.6597 13.7757 14.5691 13.9167 15.0064 15.0317 0 0 14.7116 13.4427 14.6864 0 15.0497 13.7486 15.5821 14.8621 15.5794 0 16.3888 15.1417 14.1055 15.0278 15.528 0 14.7295 15.2007 15.0022 13.8563 13.7748 16.6472 12.4258 0 15.1667 0 14.1328 13.7093 13.5359 0 15.1028 15.2587 13.4063 0 0 15.5179 0 14.9417 13.9099 0 13.0625 15.201 14.2013 0 12.1328 0 0 0 0 13.437 12.6788 15.4276 10.7066 0 0 0 0 0 14.0754 15.1332 12.4976 14.6866 0 0 14.2351 0 0 Q9H9K5 MER34_HUMAN "Endogenous retroviral envelope protein HEMO (Endogenous retrovirus group MER34 member 1 Env polyprotein) (HERV-MER_4q12 provirus ancestral Env polyprotein) (Human endogenous MER34 (medium-reiteration-frequency-family-34) open reading frame) (Human endogenous MER34 ORF, HEMO) [Cleaved into: Endogenous retroviral envelope protein HEMO, secreted form (Endogenous retroviral envelope protein HEMO, 48 kDa form) ]" ERVMER34-1 HEMO LP9056 Homo sapiens (Human) extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005576; GO:0005886; GO:0016021 GLLYQLFRNLFCSYGLTEAHGKWR 0.9753 -1.1349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0794 0 0 0 0 0 0 0 0 0 P08637 FCG3A_HUMAN "Low affinity immunoglobulin gamma Fc region receptor III-A, IgG Fc receptor III-A (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a)" FCGR3A CD16A FCG3 FCGR3 IGFR3 Homo sapiens (Human) antibody-dependent cellular cytotoxicity [GO:0001788]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; macrophage activation [GO:0042116]; natural killer cell activation [GO:0030101]; natural killer cell degranulation [GO:0043320]; natural killer cell mediated cytotoxicity [GO:0042267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune response [GO:0050776] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Fc-gamma receptor III complex [GO:0033001]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Fc-gamma receptor III complex [GO:0033001]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; IgG binding [GO:0019864]; immune receptor activity [GO:0140375]; low-affinity IgG receptor activity [GO:0019772]; transmembrane signaling receptor activity [GO:0004888]; antibody-dependent cellular cytotoxicity [GO:0001788]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; macrophage activation [GO:0042116]; natural killer cell activation [GO:0030101]; natural killer cell degranulation [GO:0043320]; natural killer cell mediated cytotoxicity [GO:0042267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune response [GO:0050776] GO:0001788; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0007166; GO:0009897; GO:0014065; GO:0019722; GO:0019772; GO:0019864; GO:0030101; GO:0032760; GO:0032819; GO:0033001; GO:0038094; GO:0042116; GO:0042267; GO:0043320; GO:0050776; GO:0070062; GO:0140375 IgG binding [GO:0019864]; immune receptor activity [GO:0140375]; low-affinity IgG receptor activity [GO:0019772]; transmembrane signaling receptor activity [GO:0004888] DSGSYFCR 0.97541 -1.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1695 14.2973 0 0 0 13.9507 0 0 13.9008 0 15.4327 0 0 0 13.8309 0 0 0 0 0 12.3765 0 0 0 0 0 0 0 16.1386 14.9955 14.7427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4591 0 0 0 0 0 0 0 0 Q6UWE0 LRSM1_HUMAN "E3 ubiquitin-protein ligase LRSAM1, EC 2.3.2.27 (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase, hTAL)" LRSAM1 TAL UNQ6496/PRO21356 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755] GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0046872; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] EAGADDILDISK 0.97553 -1.133 0 0 0 0 0 0 0 0 0 0 10.643 11.3116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9616 0 0 0 0 0 0 0 13.8323 0 0 0 0 15.9814 0 0 0 0 12.8186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0751 0 0 13.4626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7317 0 13.5259 0 13.187 0 0 0 0 0 0 0 13.8157 0 13.4533 0 15.0549 0 12.6162 12.638 0 0 0 12.2092 13.197 13.3386 13.2154 0 14.0371 0 0 0 13.8674 13.2613 0 0 0 0 0 0 0 0 13.8552 0 0 0 0 Q53GS9 SNUT2_HUMAN "U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein, 65K)" USP39 CGI-21 HSPC332 PRO2855 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0007049; GO:0008270; GO:0008380; GO:0016579; GO:0046540; GO:0051301 zinc ion binding [GO:0008270] EVDEDSEPER 0.97577 3.0019 0 0 0 13.9177 0 0 0 0 0 0 0 0 0 0 0 13.7057 0 13.0598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7211 0 0 0 0 0 0 0 0 0 14.9257 0 0 0 0 0 14.6222 0 0 0 14.2476 0 0 0 0 0 0 0 0 0 14.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15400 STX7_HUMAN Syntaxin-7 STX7 Homo sapiens (Human) intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982] azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076 chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] ERNLVSWESQTQPQVQVQDEEITEDDLRLIHER 0.97601 3.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.101 0 0 12.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0261 0 0 0 0 0 0 0 0 0 0 Q8NDI1 EHBP1_HUMAN EH domain-binding protein 1 EHBP1 KIAA0903 NACSIN Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endosome [GO:0005768]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin cytoskeleton organization [GO:0030036]; endocytosis [GO:0006897]; protein transport [GO:0015031] GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006897; GO:0015031; GO:0030036; GO:0031941 EQLLLDELVALVNKR 0.97603 2.9949 0 0 0 0 0 0 0 0 0 0 13.223 12.8917 0 0 12.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1221 0 13.3824 0 13.3229 0 0 12.5783 0 13.1844 13.2061 13.261 0 0 12.814 0 10.1902 0 0 0 9.96622 0 0 0 0 12.2565 0 0 0 0 0 10.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1749 0 0 0 12.3281 0 0 14.5826 0 0 11.9742 0 0 0 0 11.2809 0 0 0 0 14.6076 0 0 0 0 0 0 14.5067 0 0 0 0 12.468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3188 12.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1268 0 0 0 0 0 14.266 0 0 0 14.7569 13.9942 0 0 0 0 0 0 0 0 10.7468 11.1834 0 0 0 0 14.3534 0 0 Q8NGP3 OR5M9_HUMAN Olfactory receptor 5M9 (Olfactory receptor OR11-190) OR5M9 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] YMAGCNPLLYGSKMSR 0.97604 -1.139 0 0 0 10.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTA4 TRI67_HUMAN Tripartite motif-containing protein 67 (TRIM9-like protein) TRIM67 TNL Homo sapiens (Human) negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of protein localization [GO:0032880] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; zinc ion binding [GO:0008270]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of protein localization [GO:0032880] GO:0005737; GO:0005856; GO:0008270; GO:0010976; GO:0032880; GO:0046580; GO:2000060 zinc ion binding [GO:0008270] AKLLTKVTK 0.97609 -1.1933 11.8605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4278 0 14.6203 0 12.1253 0 0 0 0 0 0 0 17.9291 0 18.0827 14.5022 13.1648 0 18.0191 0 18.0166 0 0 11.5784 0 0 0 0 0 0 10.6728 0 0 0 17.9792 0 0 0 18.1694 0 0 0 0 16.8489 0 0 14.9586 13.6259 0 15.845 14.6117 14.8128 14.5361 15.5808 15.1148 15.1693 15.1035 0 14.7784 16.1575 15.137 16.1154 14.9783 15.8809 0 0 0 14.1673 15.8284 0 0 15.1003 0 16.1627 14.6474 0 14.9722 0 0 14.8001 12.9741 0 16.5166 0 14.6366 14.6567 0 14.4493 14.5682 15.7481 0 14.9585 14.6931 15.0791 0 13.0277 0 0 14.9079 0 14.9855 15.3961 14.6615 14.6939 14.7406 13.4922 14.84 14.5454 14.1197 0 14.7937 15.3888 15.7678 0 14.4681 14.9318 14.7056 0 15.3916 14.5833 0 14.8074 0 14.9193 0 14.982 13.9045 14.7367 0 15.2069 0 14.8497 14.4442 15.6595 0 0 0 0 14.1695 0 0 0 14.6714 0 13.0079 14.3461 0 0 0 0 14.8608 14.8443 13.8795 15.9149 0 0 13.8811 15.0355 0 P43378 PTN9_HUMAN "Tyrosine-protein phosphatase non-receptor type 9, EC 3.1.3.48 (Protein-tyrosine phosphatase MEG2, PTPase MEG2)" PTPN9 Homo sapiens (Human) negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0006470; GO:0010977; GO:0035335; GO:0044306; GO:1903078 non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] DFWLMVWEQK 0.9762 -1.1902 0 0 0 0 0 0 0 0 12.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8379 0 0 0 0 0 0 11.587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2884 0 0 0 0 15.7886 0 0 0 0 0 0 0 0 0 14.4749 0 14.234 13.3903 0 14.2597 13.5785 14.0054 11.1163 15.1551 0 13.7934 14.5814 0 0 13.2461 13.4247 12.8598 0 0 13.4455 11.993 13.2502 0 0 14.0851 0 12.1928 14.2163 0 12.7186 12.8871 0 0 12.8559 0 13.4149 14.6789 0 12.7542 0 12.5523 0 0 0 0 0 0 0 13.9115 0 0 0 0 0 12.4394 12.8865 12.3038 0 0 11.9253 0 0 12.0021 0 0 0 0 0 0 0 0 12.3316 0 0 0 0 0 0 13.2174 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6469 O43768 ENSA_HUMAN Alpha-endosulfine (ARPP-19e) ENSA Homo sapiens (Human) cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; regulation of insulin secretion [GO:0050796]; response to nutrient [GO:0007584] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ion channel inhibitor activity [GO:0008200]; phosphatase inhibitor activity [GO:0019212]; potassium channel inhibitor activity [GO:0019870]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; regulation of insulin secretion [GO:0050796]; response to nutrient [GO:0007584] GO:0000086; GO:0000278; GO:0004864; GO:0005102; GO:0005654; GO:0005737; GO:0007584; GO:0008200; GO:0019212; GO:0019870; GO:0019888; GO:0035308; GO:0050796; GO:0051301; GO:0051721 ion channel inhibitor activity [GO:0008200]; phosphatase inhibitor activity [GO:0019212]; potassium channel inhibitor activity [GO:0019870]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102] QEEENPAEETGEEK 0.97621 -1.1933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6796 0 0 0 0 0 0 0 0 0 13.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N112 LSME2_HUMAN Leucine-rich single-pass membrane protein 2 LSMEM2 C3orf45 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GGFLLLLALLVLTCLVLALLAVYLSVLQSESLRILAHTLR 0.97622 2.9782 0 0 0 0 0 0 10.1284 0 0 0 0 0 11.731 0 12.0396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5171 0 0 0 0 0 11.7416 0 0 0 11.4503 0 0 0 0 0 0 11.3959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3815 0 0 0 0 0 0 0 0 0 0 0 0 12.3462 0 0 0 0 14.8335 0 0 0 13.403 0 0 12.2463 0 0 13.2582 0 0 0 12.7405 12.7072 13.5715 14.0075 0 0 12.7475 0 0 0 0 0 0 0 11.7293 11.1179 0 0 0 0 13.2561 0 0 12.7035 0 0 0 12.2804 0 0 0 0 0 12.9349 0 13.0529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8122 0 0 0 12.4968 0 0 0 0 0 0 12.8463 12.8333 0 0 0 12.7485 0 0 0 0 0 12.1907 0 0 0 0 0 0 0 0 Q96N38 ZN714_HUMAN Zinc finger protein 714 ZNF714 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNVSSHLTTHKMIHTGEKPYK 0.97631 -1.145 0 0 9.40478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.61546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7287 11.6395 16.4838 0 0 0 0 0 0 12.4408 0 0 0 0 12.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS85 CAH10_HUMAN "Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X, CA-RP X, CARP X) (Cerebral protein 15)" CA10 hucep-15 UNQ533/PRO1076 Homo sapiens (Human) brain development [GO:0007420]; one-carbon metabolic process [GO:0006730] carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; one-carbon metabolic process [GO:0006730] GO:0004089; GO:0006730; GO:0007420; GO:0008270; GO:0016836 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] KVSGTMYNTGR 0.97631 -1.1444 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2658 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3465 0 0 12.4445 12.0446 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0971 0 0 0 11.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.681 0 0 0 13.8838 13.9749 14.2899 14.0947 0 13.7547 0 0 13.9196 14.249 0 13.2467 13.3635 0 0 0 0 0 0 0 0 0 Q9NYI0 PSD3_HUMAN "PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D, Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3)" PSD3 EFA6D EFA6R HCA67 KIAA0942 Homo sapiens (Human) regulation of ARF protein signal transduction [GO:0032012] anchoring junction [GO:0070161]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587] anchoring junction [GO:0070161]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of ARF protein signal transduction [GO:0032012] GO:0005085; GO:0014069; GO:0032012; GO:0032587; GO:0070161 guanyl-nucleotide exchange factor activity [GO:0005085] DRERISEQEEHVK 0.97632 -1.1898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8962 0 0 0 15.433 0 0 0 0 0 0 0 0 0 10.1967 15.2814 0 14.5699 0 9.51452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92601 0 0 0 0 0 0 10.1991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54257 0 0 10.0367 0 0 10.0647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H160 ING2_HUMAN "Inhibitor of growth protein 2 (Inhibitor of growth 1-like protein, ING1Lp) (p32) (p33ING2)" ING2 ING1L Homo sapiens (Human) "chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]" CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580] "CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]" GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005886; GO:0006325; GO:0006355; GO:0007141; GO:0007165; GO:0007283; GO:0007286; GO:0008285; GO:0016580; GO:0016602; GO:0030317; GO:0030336; GO:0030511; GO:0030512; GO:0031065; GO:0035064; GO:0035091; GO:0040008; GO:0044877; GO:0045893; GO:0046872; GO:0048133; GO:0072520; GO:1902166; GO:1902455; GO:1902459; GO:2000772; GO:2001020 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877] ARQMELHSQCFQDPAESER 0.97634 -1.1951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63133 POK8_HUMAN "Endogenous retrovirus group K member 8 Pol protein (HERV-K115 Pol protein) (HERV-K_8p23.1 provirus ancestral Pol protein) [Includes: Reverse transcriptase, RT, EC 2.7.7.49; Ribonuclease H, RNase H, EC 3.1.26.4; Integrase, IN ]" ERVK-8 Homo sapiens (Human) DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] GO:0003677; GO:0003964; GO:0004523; GO:0006281; GO:0006310; GO:0008270; GO:0015074; GO:0035613 DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270] AAYTGPK 0.97642 -1.1417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7366 0 14.0448 15.1406 15.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0935 0 0 0 0 0 0 14.4095 0 14.9638 0 0 0 0 13.611 19.3349 0 0 0 0 0 0 14.9135 0 0 0 0 0 0 0 0 0 0 14.7847 0 0 0 0 0 0 0 12.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9209 0 0 14.5785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A3QJZ6 PRA22_HUMAN PRAME family member 22 PRAMEF22 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 FIRLEPLRALLEK 0.97643 -1.145 12.6596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q30KP9 DB135_HUMAN "Beta-defensin 135 (Defensin, beta 135)" DEFB135 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 SVLLALVVLNLLFYVPPGR 0.97643 -1.1888 11.5784 0 0 14.5247 0 0 14.446 14.0968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3536 0 13.3369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7721 0 0 0 0 13.7105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4624 0 0 0 0 0 0 0 0 0 0 0 0 13.1409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SY84 K2C71_HUMAN "Keratin, type II cytoskeletal 71 (Cytokeratin-71, CK-71) (Keratin-71, K71) (Type II inner root sheath-specific keratin-K6irs1, Keratin 6 irs, hK6irs, hK6irs1) (Type-II keratin Kb34)" KRT71 K6IRS1 KB34 KRT6IRS1 Homo sapiens (Human) hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005829; GO:0030280; GO:0031069; GO:0031424; GO:0045095; GO:0045109; GO:0070062 structural constituent of skin epidermis [GO:0030280] FASFIDK 0.97643 -1.1444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5BLP8 CD048_HUMAN Neuropeptide-like protein C4orf48 C4orf48 Chr4_55 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 SPMSPPPPPLLLLLLSLALLGARAR 0.97643 -1.1434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4116 0 13.4944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3408 0 0 0 12.6745 13.9269 13.0665 13.2859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.702 0 Q6ZNI0 GCNT7_HUMAN "Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7, EC 2.4.1.-" GCNT7 C20orf105 Homo sapiens (Human) protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; protein glycosylation [GO:0006486] GO:0000139; GO:0006486; GO:0008375; GO:0016021 acetylglucosaminyltransferase activity [GO:0008375] ATKSGLVVRAVICIFIFLYLR 0.97644 -1.1889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7445 0 0 0 0 0 0 0 0 11.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8534 0 0 0 11.3069 0 0 0 0 15.575 15.3768 14.6502 0 14.6386 14.3701 15.3151 0 0 0 14.4598 0 0 0 0 0 0 11.7768 0 0 15.0536 0 0 Q9NY25 CLC5A_HUMAN "C-type lectin domain family 5 member A (C-type lectin superfamily member 5) (Myeloid DAP12-associating lectin 1, MDL-1)" CLEC5A CLECSF5 MDL1 Homo sapiens (Human) cellular defense response [GO:0006968]; innate immune response [GO:0045087]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid cell apoptotic process [GO:0033033]; osteoblast development [GO:0002076]; positive regulation of cytokine production [GO:0001819]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; virus receptor activity [GO:0001618]; cellular defense response [GO:0006968]; innate immune response [GO:0045087]; myeloid cell differentiation [GO:0030099]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid cell apoptotic process [GO:0033033]; osteoblast development [GO:0002076]; positive regulation of cytokine production [GO:0001819]; signal transduction [GO:0007165] GO:0001618; GO:0001819; GO:0002076; GO:0005829; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0009986; GO:0030099; GO:0030246; GO:0033033; GO:0035579; GO:0043066; GO:0045087; GO:0070821 carbohydrate binding [GO:0030246]; virus receptor activity [GO:0001618] DWEFYQAR 0.97644 -1.1892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34096 RNAS4_HUMAN "Ribonuclease 4, RNase 4, EC 3.1.27.-" RNASE4 RNS4 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830]; mRNA cleavage [GO:0006379]; RNA phosphodiester bond hydrolysis [GO:0090501] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540]; defense response to Gram-positive bacterium [GO:0050830]; mRNA cleavage [GO:0006379]; RNA phosphodiester bond hydrolysis [GO:0090501] GO:0003676; GO:0004522; GO:0004540; GO:0005576; GO:0005615; GO:0006379; GO:0050830; GO:0090501 nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540] KMTLYHCK 0.97645 -1.1514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8023 0 0 0 0 0 0 0 13.9805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9839 0 0 0 0 0 12.6834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1821 Q9UHR6 ZNHI2_HUMAN Zinc finger HIT domain-containing protein 2 (Protein FON) ZNHIT2 C11orf5 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] GPVSPLVR 0.97646 -1.1947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5021 0 0 0 0 0 0 0 19.0979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8905 0 0 0 0 0 0 0 0 Q92733 PRCC_HUMAN Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein) PRCC TPRC Homo sapiens (Human) cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005654; GO:0007049; GO:0016607; GO:0051726 GPGLNLPPPIGGAGPPLGLPKPK 0.97651 4.3348 0 12.638 0 14.0524 13.3333 0 14.1616 13.6535 0 0 0 0 11.3893 0 0 0 0 16.3659 15.1858 15.3589 0 0 0 0 0 16.0702 0 0 0 0 0 0 0 0 11.5356 0 11.1341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9727 11.5919 0 0 0 0 0 0 0 0 0 0 0 0 12.1781 11.0749 0 0 0 12.162 10.4385 0 0 0 0 11.8435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0652 0 0 0 0 0 10.9189 0 0 0 0 0 10.7246 0 0 12.0271 12.1755 0 0 0 0 0 10.2363 0 0 0 12.0615 0 16.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3385 0 15.0791 0 13.5379 0 Q7Z7L1 SLN11_HUMAN "Schlafen family member 11, EC 3.6.-.-" SLFN11 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA replication [GO:0008156]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell death [GO:0010942]; replication fork arrest [GO:0043111] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; tRNA binding [GO:0000049]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of DNA replication [GO:0008156]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell death [GO:0010942]; replication fork arrest [GO:0043111] GO:0000049; GO:0002376; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0008156; GO:0010942; GO:0016887; GO:0043111; GO:0051607; GO:0090734; GO:2000134 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; tRNA binding [GO:0000049] DYLEYGEILPFPESQLVEFKQFSTK 0.97655 -1.1853 0 0 10.8155 0 0 0 0 0 0 0 13.9452 0 0 0 0 0 0 0 0 0 0 0 0 12.6655 0 0 0 0 0 0 0 11.0059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6341 0 0 0 0 0 14.4351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8886 0 0 0 0 0 0 0 0 0 0 13.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96B77 TM186_HUMAN Transmembrane protein 186 TMEM186 C16orf51 Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005739; GO:0005743; GO:0016021; GO:0032981 EKLPNAETEK 0.97656 -1.1475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0679 0 0 0 0 0 0 0 0 13.6107 0 0 13.5298 0 15.1285 14.2458 13.9485 13.7887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0224 14.0447 0 0 0 0 0 0 0 0 0 0 0 16.6128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46977 STT3A_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A, Oligosaccharyl transferase subunit STT3A, STT3-A, EC 2.4.99.18 (B5) (Integral membrane protein 1) (Transmembrane protein TMC)" STT3A ITM1 TMC Homo sapiens (Human) co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase III complex [GO:0035000] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] GO:0004579; GO:0005789; GO:0006487; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0035000; GO:0043686; GO:0043687; GO:0046872 dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872] ENDYYTPTGEFRVDR 0.97657 -1.1504 0 0 0 0 0 0 0 0 0 0 0 12.7212 0 11.9782 0 0 0 0 12.7182 0 0 0 0 0 0 0 0 0 13.9882 0 0 13.0941 0 0 0 0 0 0 0 11.784 0 0 0 0 0 0 0 0 0 0 0 12.5948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4622 0 0 0 0 0 0 0 0 0 12.5258 0 0 0 0 0 0 0 12.8593 0 0 0 0 0 12.2612 0 0 0 14.758 0 0 0 0 0 0 0 0 0 0 12.8011 16.0998 0 0 0 12.8763 13.1024 12.6691 0 0 0 0 0 0 0 13.7984 0 12.2482 12.6611 0 0 0 0 0 14.3257 0 0 0 0 13.2069 0 15.042 0 0 0 0 0 0 12.9036 0 0 0 0 15.6054 0 0 14.4009 0 0 0 0 0 0 0 0 0 0 0 15.3703 0 0 0 12.4335 13.6184 P56693 SOX10_HUMAN Transcription factor SOX-10 SOX10 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell maturation [GO:0048469]; cellular response to progesterone stimulus [GO:0071393]; cellular response to xenobiotic stimulus [GO:0071466]; central nervous system myelination [GO:0022010]; developmental growth [GO:0048589]; digestive tract morphogenesis [GO:0048546]; enteric nervous system development [GO:0048484]; in utero embryonic development [GO:0001701]; lacrimal gland development [GO:0032808]; melanocyte differentiation [GO:0030318]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system development [GO:0007422]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of myelination [GO:0031643]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]" chromatin [GO:0000785]; extrinsic component of mitochondrial outer membrane [GO:0031315]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; extrinsic component of mitochondrial outer membrane [GO:0031315]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell maturation [GO:0048469]; cellular response to progesterone stimulus [GO:0071393]; cellular response to xenobiotic stimulus [GO:0071466]; central nervous system myelination [GO:0022010]; developmental growth [GO:0048589]; digestive tract morphogenesis [GO:0048546]; enteric nervous system development [GO:0048484]; in utero embryonic development [GO:0001701]; lacrimal gland development [GO:0032808]; melanocyte differentiation [GO:0030318]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; peripheral nervous system development [GO:0007422]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of myelination [GO:0031643]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0001701; GO:0001755; GO:0002009; GO:0002052; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0006368; GO:0007405; GO:0007422; GO:0009653; GO:0010626; GO:0010628; GO:0014003; GO:0014015; GO:0022010; GO:0030318; GO:0031315; GO:0031643; GO:0032808; GO:0042802; GO:0043066; GO:0045893; GO:0048469; GO:0048484; GO:0048546; GO:0048589; GO:0048709; GO:0061138; GO:0071393; GO:0071466; GO:0090090; GO:0140297; GO:1990837; GO:1990841 "DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" LLNESDK 0.97657 -1.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9081 0 0 0 0 0 0 0 0 0 0 0 14.4161 0 0 13.7678 14.5163 13.4922 0 0 0 13.5799 0 13.5994 14.4485 13.7328 0 0 0 0 0 0 12.1381 0 0 13.2852 0 13.4248 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96I13 ABHD8_HUMAN "Protein ABHD8, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 8, Abhydrolase domain-containing protein 8)" ABHD8 Homo sapiens (Human) lipid homeostasis [GO:0055088]; phosphatidic acid biosynthetic process [GO:0006654] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lipid homeostasis [GO:0055088]; phosphatidic acid biosynthetic process [GO:0006654] GO:0005739; GO:0006654; GO:0042171; GO:0052689; GO:0055088; GO:0070062 carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171] LLVENLGR 0.97658 -1.1546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5552 13.4747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZZ8 LACRT_HUMAN Extracellular glycoprotein lacritin LACRT Homo sapiens (Human) calcineurin-NFAT signaling cascade [GO:0033173]; calcium-mediated signaling [GO:0019722]; defense response to bacterium [GO:0042742]; epithelial structure maintenance [GO:0010669]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of secretion [GO:0051047]; protein acetylation [GO:0006473]; protein localization to Golgi apparatus [GO:0034067]; tear secretion [GO:0070075] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; laminin-1 binding [GO:0043237]; protein N-terminus binding [GO:0047485]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-mediated signaling [GO:0019722]; defense response to bacterium [GO:0042742]; epithelial structure maintenance [GO:0010669]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of secretion [GO:0051047]; protein acetylation [GO:0006473]; protein localization to Golgi apparatus [GO:0034067]; tear secretion [GO:0070075] GO:0001968; GO:0005518; GO:0005576; GO:0005615; GO:0006473; GO:0008083; GO:0008284; GO:0010669; GO:0016239; GO:0019722; GO:0030141; GO:0031665; GO:0033173; GO:0034067; GO:0042742; GO:0043066; GO:0043237; GO:0047485; GO:0050679; GO:0050731; GO:0050850; GO:0051047; GO:0051281; GO:0060054; GO:0070075; GO:0070886 collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; laminin-1 binding [GO:0043237]; protein N-terminus binding [GO:0047485] FSLLKPWA 0.97658 -1.1961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8491 0 0 0 0 0 0 13.3965 0 0 0 13.4185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6641 0 0 0 0 15.0566 0 0 0 0 12.0865 12.7804 0 0 0 13.6473 0 12.9005 0 13.1165 13.1386 0 15.1305 0 13.1528 0 0 13.5638 0 0 15.252 0 0 0 0 11.7043 0 0 0 0 0 0 0 0 11.6797 0 0 13.9759 12.65 0 13.1861 0 0 12.8523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0116 0 14.6535 0 0 0 0 0 0 0 0 0 0 13.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8179 0 0 0 0 0 0 P42858 HD_HUMAN "Huntingtin (Huntington disease protein, HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment ]" HTT HD IT15 Homo sapiens (Human) "apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]" autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991] "autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]" GO:0000132; GO:0002039; GO:0005522; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005776; GO:0005783; GO:0005794; GO:0005814; GO:0005829; GO:0006890; GO:0006915; GO:0007030; GO:0016234; GO:0019900; GO:0030424; GO:0030425; GO:0030659; GO:0031072; GO:0031587; GO:0031648; GO:0032991; GO:0034452; GO:0042297; GO:0042802; GO:0043065; GO:0043666; GO:0044325; GO:0045505; GO:0045724; GO:0047496; GO:0048471; GO:0048487; GO:0099111; GO:0099523; GO:0099524; GO:1903599; GO:1904504; GO:1905289; GO:1905337; GO:2000479; GO:2001237 beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325] AALPSLTNPPSLSPIRRK 0.97659 -1.1564 0 0 13.6257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.763 0 0 0 0 12.9839 12.9197 13.638 14.3178 12.9839 13.5366 11.6026 0 0 12.4215 0 0 0 0 0 0 0 13.831 13.3433 12.5465 0 14.8075 0 13.1224 15.3631 13.7353 0 12.1086 0 0 0 0 0 0 0 0 0 0 13.3031 14.582 0 13.5331 13.9288 0 0 0 14.6883 0 15.468 12.8657 12.8486 11.4147 0 0 0 13.5372 0 15.4257 0 14.4905 0 13.2111 0 0 0 0 0 0 0 0 0 0 15.1257 0 15.8426 12.2957 14.65 0 0 0 0 0 0 0 0 0 0 0 11.1635 12.1383 11.9308 0 0 0 0 11.5852 0 0 0 0 0 0 Q7Z7F0 KHDC4_HUMAN KH homology domain-containing protein 4 (Brings lots of money 7) (Pre-mRNA splicing factor protein KHDC4) KHDC4 BLOM7 KIAA0907 SNORA80EHG Homo sapiens (Human) mRNA splice site selection [GO:0006376] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006376 RNA binding [GO:0003723] AVNRIKEIITNGVVK 0.97659 -1.1553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V88 MGDP1_HUMAN "Magnesium-dependent phosphatase 1, MDP-1, EC 3.1.3.-, EC 3.1.3.48" MDP1 Homo sapiens (Human) acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] GO:0003993; GO:0004725; GO:0046872 acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] LYPEVPEVLKR 0.97659 -1.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50406 5HT6R_HUMAN "5-hydroxytryptamine receptor 6, 5-HT-6, 5-HT6 (Serotonin receptor 6)" HTR6 Homo sapiens (Human) "cerebral cortex cell migration [GO:0021795]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of TOR signaling [GO:0032008]" cilium [GO:0005929]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cilium [GO:0005929]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; cerebral cortex cell migration [GO:0021795]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; positive regulation of TOR signaling [GO:0032008]" GO:0004969; GO:0004993; GO:0005886; GO:0005887; GO:0005929; GO:0007187; GO:0007268; GO:0021795; GO:0030425; GO:0030594; GO:0032008; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] ILLAARK 0.9766 -1.1568 12.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0077 0 0 0 0 0 0 0 13.0997 0 0 0 0 13.0704 14.4213 0 0 13.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9897 12.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8876 0 0 0 0 12.7829 0 0 0 0 11.4202 0 0 0 0 0 0 0 0 0 0 0 0 11.6274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95239 KIF4A_HUMAN Chromosome-associated kinesin KIF4A (Chromokinesin-A) KIF4A KIF4 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; spindle elongation [GO:0051231] axon cytoplasm [GO:1904115]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876] axon cytoplasm [GO:1904115]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde axonal transport [GO:0008089]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; spindle elongation [GO:0051231] GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005875; GO:0005876; GO:0006996; GO:0007052; GO:0008017; GO:0008089; GO:0016020; GO:0016363; GO:0030496; GO:0046872; GO:0051231; GO:0051256; GO:0051536; GO:1904115 ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] HLNDLLEDRKILAQDVAQLK 0.97667 -1.1874 0 10.4453 0 0 0 0 0 0 0 0 0 13.1132 10.7865 0 0 0 0 0 0 0 11.538 0 0 0 10.0933 0 0 12.6182 0 12.8375 0 0 0 0 0 0 16.3633 0 11.9188 0 0 0 0 0 0 11.8269 11.7588 0 0 0 0 0 0 0 0 0 0 0 0 12.2271 0 0 11.5497 0 0 0 0 14.7498 14.6812 0 13.6941 0 10.882 0 0 0 0 0 10.2825 11.3629 0 0 0 12.8977 0 0 0 0 12.7571 0 0 0 0 0 0 0 0 0 13.6095 0 0 0 0 10.493 0 0 11.5144 0 0 0 0 0 0 0 10.2246 0 0 0 0 13.6944 0 0 0 0 0 0 13.7509 12.6732 12.4335 0 12.0885 0 0 12.8192 0 9.21053 0 0 11.0026 0 11.5518 0 0 0 9.58329 0 0 0 0 0 0 0 14.4955 12.0743 13.5858 0 13.5909 13.8466 14.0773 12.9012 14.1071 11.3091 0 15.6015 0 13.3246 0 0 0 0 0 0 0 14.7972 0 0 11.6326 0 11.2697 0 Q8TDV2 GP148_HUMAN Probable G-protein coupled receptor 148 (Brain and testis restricted GPCR) (G-protein coupled receptor PGR6) GPR148 BTR PGR6 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] HQAIFTIS 0.97667 -1.1849 0 12.5969 0 0 0 0 0 11.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7366 0 11.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MW99 MEI4_HUMAN Meiosis-specific protein MEI4 MEI4 Homo sapiens (Human) DNA recombination [GO:0006310]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] lateral element [GO:0000800] lateral element [GO:0000800]; DNA recombination [GO:0006310]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283] GO:0000800; GO:0006310; GO:0007129; GO:0007283; GO:0042138; GO:0048477 LALALAIIR 0.9767 -1.1528 0 0 0 0 0 0 0 0 0 0 15.7303 0 14.5841 0 14.9169 0 0 0 15.774 0 0 0 0 0 0 0 0 0 15.5168 0 0 0 16.0739 0 15.3955 0 15.1097 16.2095 0 0 0 0 0 10.3872 0 17.144 0 0 15.5389 0 0 0 0 0 0 15.9365 15.2093 0 16.9563 16.8457 0 0 16.4601 15.8258 16.9557 13.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0443 0 0 13.5693 0 0 12.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2161 0 0 0 0 0 0 0 13.5991 0 14.5212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7991 17.1591 0 0 14.2452 14.4892 14.2168 0 17.8351 18.0184 0 0 0 0 0 0 0 13.0462 0 12.1521 0 0 Q86SX6 GLRX5_HUMAN "Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)" GLRX5 C14orf87 Homo sapiens (Human) [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035] dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634] "dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; glutathione oxidoreductase activity [GO:0097573]; metal ion binding [GO:0046872]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]" GO:0005634; GO:0005739; GO:0005759; GO:0016226; GO:0030097; GO:0030425; GO:0043025; GO:0044571; GO:0045454; GO:0046872; GO:0051537; GO:0055072; GO:0097573; GO:0106034; GO:0106035; GO:1990229 "2 iron, 2 sulfur cluster binding [GO:0051537]; glutathione oxidoreductase activity [GO:0097573]; metal ion binding [GO:0046872]" KDKVVVFLK 0.9767 -1.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYU8 MICU2_HUMAN "Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1)" MICU2 EFHA1 Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561] GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0034704; GO:0036444; GO:0046982; GO:0051560; GO:0051561; GO:0051562; GO:1990246 calcium ion binding [GO:0005509]; protein heterodimerization activity [GO:0046982] EFFKLQKIISK 0.97671 -1.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2953 0 0 0 0 0 0 0 0 0 0 13.6186 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3767 0 13.2016 0 0 12.3379 0 0 0 12.2372 0 12.6761 0 0 0 0 0 0 0 0 0 12.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6209 0 0 0 0 0 0 12.3737 0 0 0 0 0 0 0 14.1701 0 0 0 12.9152 0 0 0 O95461 LARG1_HUMAN "Xylosyl- and glucuronyltransferase LARGE1, EC 2.4.-.- (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) (LARGE xylosyl- and glucuronyltransferase 1) [Includes: Alpha-1,3-xylosyltransferase LARGE1, EC 2.4.2.-; Beta-1,3-glucuronyltransferase LARGE1, EC 2.4.1.- ]" LARGE1 KIAA0609 LARGE Homo sapiens (Human) glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285]; glycoprotein biosynthetic process [GO:0009101]; glycosphingolipid biosynthetic process [GO:0006688]; muscle cell cellular homeostasis [GO:0046716]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403] GO:0000139; GO:0005794; GO:0006044; GO:0006486; GO:0006493; GO:0006688; GO:0008375; GO:0009101; GO:0015020; GO:0016757; GO:0016758; GO:0030145; GO:0030173; GO:0035252; GO:0035269; GO:0042285; GO:0043403; GO:0046716; GO:0060538 acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyltransferase activity [GO:0042285] APSHRRGNHSK 0.97672 -1.1574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7718 0 0 0 0 0 0 0 0 0 0 0 0 0 13.248 0 0 0 0 0 0 0 0 0 12.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8079 0 0 11.2355 0 0 11.3286 0 12.1388 0 0 0 11.5722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5H9S7 DCA17_HUMAN DDB1- and CUL4-associated factor 17 DCAF17 C2orf37 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567] GO:0005654; GO:0005730; GO:0005829; GO:0016021; GO:0016567; GO:0080008 GPTRKPNVCSR 0.97688 3.0923 0 0 0 0 0 0 0 0 0 11.2983 0 11.7043 0 0 0 0 11.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7825 0 0 0 12.3103 12.8879 0 0 0 0 0 13.1037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7197 13.0815 0 0 11.5949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8243 13.3052 12.9452 13.0141 0 0 13.4626 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9215 0 0 0 0 0 13.9214 0 0 0 0 10.563 15.1398 0 0 0 0 0 0 0 0 0 0 0 13.2246 13.2688 0 13.0052 0 0 0 0 0 0 0 Q8IYD1 ERF3B_HUMAN "Eukaryotic peptide chain release factor GTP-binding subunit ERF3B, Eukaryotic peptide chain release factor subunit 3b, eRF3b (G1 to S phase transition protein 2 homolog)" GSPT2 ERF3B Homo sapiens (Human) "cell cycle [GO:0007049]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]" cytosol [GO:0005829]; translation release factor complex [GO:0018444] "cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; cell cycle [GO:0007049]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; translation [GO:0006412]" GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005829; GO:0006412; GO:0007049; GO:0018444 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747] EKLVPFLK 0.97689 -1.1765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4A6 GOLP3_HUMAN "Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor, MIDAS)" GOLPH3 GPP34 Homo sapiens (Human) "asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273]; asymmetric Golgi ribbon formation [GO:0090164]; cell adhesion molecule production [GO:0060352]; cell migration [GO:0016477]; cellular response to rapamycin [GO:0072752]; gene expression [GO:0010467]; glycoprotein biosynthetic process [GO:0009101]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; lamellipodium assembly [GO:0030032]; leukocyte tethering or rolling [GO:0050901]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein secretion [GO:0050714]; positive regulation of TOR signaling [GO:0032008]; protein retention in Golgi apparatus [GO:0045053]; protein secretion [GO:0009306]; regulation of mitochondrion organization [GO:0010821]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005739; GO:0005758; GO:0005768; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006890; GO:0007030; GO:0009101; GO:0009306; GO:0010467; GO:0010821; GO:0016477; GO:0019899; GO:0030032; GO:0031985; GO:0032008; GO:0032580; GO:0043001; GO:0043066; GO:0043231; GO:0045053; GO:0048194; GO:0050714; GO:0050901; GO:0060352; GO:0070273; GO:0072752; GO:0090161; GO:0090164 enzyme binding [GO:0019899]; phosphatidylinositol-4-phosphate binding [GO:0070273] DEQDDDDK 0.97689 -1.1767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7739 0 0 0 0 0 0 0 12.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6666 0 0 14.6374 0 0 14.7523 15.6755 0 0 0 0 0 0 0 0 14.3058 0 0 0 0 13.6789 0 0 0 0 0 0 0 0 0 0 0 0 11.9055 0 0 12.2628 12.2073 0 0 0 0 0 0 13.1002 0 0 0 0 0 9.68335 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4178 0 0 0 0 0 11.8387 0 0 11.6358 0 0 0 11.6318 11.3175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1836 0 0 0 0 0 0 0 0 Q6PIY5 ARMD1_HUMAN Armadillo-like helical domain containing protein 1 (p40) ARMH1 C1orf228 NCRNA00082 Homo sapiens (Human) AIGVLARNDMSIAEELLYLRVVR 0.97693 3.0101 0 0 0 0 0 0 0 0 0 13.3291 0 0 0 0 12.9832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7137 0 0 0 0 14.501 13.9401 13.9162 15.6301 0 16.8073 16.2269 13.2092 16.5946 0 0 0 13.2383 0 0 0 15.3542 0 0 0 11.9838 0 0 12.7331 11.5567 14.0916 0 0 14.7317 15.3488 14.0555 0 0 0 0 14.7543 11.1577 15.3757 0 0 0 0 0 0 0 14.0629 0 13.8373 13.6434 14.2561 14.4859 13.0056 13.3102 0 15.0083 12.136 0 0 0 16.0194 0 0 13.7694 0 13.5131 0 0 13.7903 0 0 12.6587 13.6486 0 0 0 12.9597 0 0 0 12.9873 0 0 15.0858 0 13.0649 0 0 0 14.6495 0 14.9587 0 0 0 0 0 0 0 0 0 0 13.4912 0 0 0 0 0 0 P43003 EAA1_HUMAN "Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1, GLAST-1) (Solute carrier family 1 member 3)" SLC1A3 EAAT1 GLAST GLAST1 Homo sapiens (Human) auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to cocaine [GO:0071314]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; auditory behavior [GO:0031223]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to cocaine [GO:0071314]; cellular sodium ion homeostasis [GO:0006883]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cranial nerve development [GO:0021545]; D-aspartate import across plasma membrane [GO:0070779]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import [GO:0051938]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; positive regulation of synaptic transmission [GO:0050806]; potassium ion transmembrane transport [GO:0071805]; response to antibiotic [GO:0046677]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104] GO:0001504; GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006811; GO:0006836; GO:0006883; GO:0007268; GO:0007605; GO:0009410; GO:0009416; GO:0009449; GO:0009611; GO:0009925; GO:0009986; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0016595; GO:0021545; GO:0031223; GO:0031410; GO:0043005; GO:0043025; GO:0045202; GO:0046677; GO:0046872; GO:0048471; GO:0048667; GO:0050806; GO:0050885; GO:0051938; GO:0070633; GO:0070779; GO:0071314; GO:0071805; GO:0098712; GO:0098796; GO:0140009; GO:0150104; GO:1902476 glutamate binding [GO:0016595]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175] ASGKMGMRAVVYYMTTTIIAVVIGIIIVIIIHPGK 0.97696 3.0094 0 0 0 12.269 0 0 0 0 0 0 14.1443 0 0 0 0 0 0 15.1931 0 14.3278 0 0 0 0 15.2991 0 0 0 14.5798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1464 13.0816 13.4877 0 0 0 0 0 0 0 13.4996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2227 0 0 0 0 0 0 0 0 0 0 0 14.6215 13.7275 0 0 13.3407 0 0 0 0 0 0 13.1647 P50395 GDIB_HUMAN "Rab GDP dissociation inhibitor beta, Rab GDI beta (Guanosine diphosphate dissociation inhibitor 2, GDI-2)" GDI2 RABGDIB Homo sapiens (Human) negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0045202; GO:0070062; GO:1902018; GO:1903565 GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] DPRTFEGIDPK 0.97698 -1.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9645 11.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3115 0 12.5163 0 0 0 0 0 0 13.3891 0 0 0 0 13.3454 0 0 0 0 0 0 0 14.5021 13.8363 13.9407 0 14.0713 0 0 0 0 0 12.7105 0 0 13.9399 13.835 0 0 0 0 12.6397 0 0 0 0 0 0 0 12.8487 0 0 0 0 0 0 13.5572 0 0 0 0 0 0 0 0 0 0 12.9863 0 14.1255 0 0 0 0 0 0 0 0 0 13.2849 0 0 0 0 0 12.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PIU2 NCEH1_HUMAN "Neutral cholesterol ester hydrolase 1, NCEH, EC 3.1.1.- (Acetylalkylglycerol acetylhydrolase, 2-acetyl MAGE hydrolase, EC 3.1.1.71) (Arylacetamide deacetylase-like 1)" NCEH1 AADACL1 KIAA1363 Homo sapiens (Human) ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; protein dephosphorylation [GO:0006470]; SMAD protein signal transduction [GO:0060395]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; sterol esterase activity [GO:0004771]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; protein dephosphorylation [GO:0006470]; SMAD protein signal transduction [GO:0060395]; xenobiotic metabolic process [GO:0006805] GO:0004771; GO:0005789; GO:0005886; GO:0006470; GO:0006805; GO:0016020; GO:0016021; GO:0016042; GO:0017171; GO:0034383; GO:0042301; GO:0046485; GO:0047378; GO:0060395 acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; sterol esterase activity [GO:0004771] ATKYFLK 0.977 -1.1698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.381 0 0 14.6083 0 0 0 0 0 0 0 0 12.4577 11.2833 0 0 0 12.2718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2641 0 0 0 0 0 13.5479 0 0 0 14.093 0 0 0 15.4623 0 0 0 15.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4154 0 0 0 0 0 0 0 O75716 STK16_HUMAN "Serine/threonine-protein kinase 16, EC 2.7.11.1 (Myristoylated and palmitoylated serine/threonine-protein kinase, MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1, TSF-1) (Tyrosine-protein kinase STK16, EC 2.7.10.2) (hPSK)" STK16 MPSK1 PKL12 TSF1 Homo sapiens (Human) cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777] GO:0000978; GO:0004674; GO:0004715; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0045944; GO:0046777; GO:0048471; GO:0071560; GO:0106310 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ILCHEQQDR 0.97701 -1.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3488 0 0 0 0 12.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8313 0 0 0 0 0 11.7398 0 0 0 0 0 0 0 0 0 0 0 0 13.7717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94766 B3GA3_HUMAN "Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3, EC 2.4.1.135 (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I, GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase, GlcUAT-I)" B3GAT3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486] cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486] GO:0000139; GO:0005794; GO:0005801; GO:0005975; GO:0006024; GO:0006486; GO:0015012; GO:0015018; GO:0015020; GO:0016020; GO:0016021; GO:0043085; GO:0046872; GO:0050650; GO:0050651; GO:0070062; GO:0072542; GO:0090316 galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542] AELVRLSQTLSLVPR 0.97701 -1.1747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7462 0 0 0 12.7013 13.0273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16763 UBE2S_HUMAN "Ubiquitin-conjugating enzyme E2 S, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme S) (E2-EPF) (Ubiquitin carrier protein S) (Ubiquitin-conjugating enzyme E2-24 kDa) (Ubiquitin-conjugating enzyme E2-EPF5) (Ubiquitin-protein ligase S)" UBE2S E2EPF OK/SW-cl.73 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0006511; GO:0010458; GO:0010994; GO:0010997; GO:0031145; GO:0035519; GO:0036211; GO:0044314; GO:0051301; GO:0061631; GO:0070534; GO:0070979; GO:0085020; GO:1904668 anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] DWTAELGIRHVLLTIK 0.97702 -1.1811 0 0 0 0 0 0 0 0 0 0 0 14.0876 0 0 14.8614 0 0 0 0 0 0 0 0 0 14.1062 0 0 0 0 14.0464 12.0686 0 0 0 0 0 0 0 0 0 13.9387 0 0 14.0379 0 13.5058 14.8891 0 13.863 0 14.1009 0 0 0 0 0 0 0 0 13.0307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHG3 PCYOX_HUMAN "Prenylcysteine oxidase 1, EC 1.8.3.5 (Prenylcysteine lyase)" PCYOX1 KIAA0908 PCL1 UNQ597/PRO1183 Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361] extracellular exosome [GO:0070062]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; FAD binding [GO:0071949]; farnesylcysteine lyase activity [GO:0102149]; prenylcysteine oxidase activity [GO:0001735]; chloride transmembrane transport [GO:1902476]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328] GO:0001735; GO:0005764; GO:0005886; GO:0030327; GO:0030328; GO:0034361; GO:0070062; GO:0071949; GO:0102149; GO:1902476 FAD binding [GO:0071949]; farnesylcysteine lyase activity [GO:0102149]; prenylcysteine oxidase activity [GO:0001735] KMSNITFLNFDPPIEEFHQYYQHIVTTLVK 0.97702 -1.1781 0 0 0 0 0 0 0 0 13.2291 0 0 0 0 0 0 0 0 0 0 0 0 11.0198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LT6 CA074_HUMAN UPF0739 protein C1orf74 C1orf74 Homo sapiens (Human) DILNTWEK 0.97708 -1.2017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.455 0 0 12.7025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K0R7 ZN839_HUMAN Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50) ZNF839 C14orf131 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] ARLKEFLQQCDR 0.97709 -1.1581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76EJ3 S35D2_HUMAN "UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Homolog of Fringe connection protein 1, HFRC1) (SQV7-like protein, SQV7L) (Solute carrier family 35 member D2) (UDP-galactose transporter-related protein 8, UGTrel8)" SLC35D2 HFRC UGTREL8 Homo sapiens (Human) carbohydrate transport [GO:0008643]; glycosaminoglycan biosynthetic process [GO:0006024]; keratan sulfate biosynthetic process [GO:0018146] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; glycosaminoglycan biosynthetic process [GO:0006024]; keratan sulfate biosynthetic process [GO:0018146] GO:0000139; GO:0005338; GO:0005461; GO:0005462; GO:0005463; GO:0005794; GO:0006024; GO:0008643; GO:0015297; GO:0016021; GO:0018146 antiporter activity [GO:0015297]; nucleotide-sugar transmembrane transporter activity [GO:0005338]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] FTIPLTLLLETIILGK 0.97709 3.0031 0 0 0 0 0 0 0 0 11.2351 0 0 0 0 0 0 0 11.4327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4819 0 0 0 0 11.4959 0 0 0 13.2952 0 0 0 0 0 0 0 0 0 0 0 14.6468 14.2772 0 0 0 0 13.7658 13.9718 14.3575 0 14.5019 0 0 14.3971 0 0 0 0 14.0841 0 12.808 13.1234 0 13.1552 0 0 13.58 0 13.5951 14.0213 0 0 0 0 0 0 14.1417 0 0 13.2418 0 0 0 0 0 0 0 0 0 0 0 0 12.9924 0 12.7182 0 0 11.8534 0 0 0 0 0 0 0 0 0 0 0 0 11.868 0 0 0 0 0 0 0 0 12.0995 0 12.8885 0 0 0 13.888 12.1981 0 0 0 0 0 0 Q5W150 YT011_HUMAN Putative uncharacterized protein MGC163334 Homo sapiens (Human) HLLCAGDKNGTRR 0.9771 -1.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GG9 DCNL1_HUMAN "DCN1-like protein 1, DCNL1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene)" DCUN1D1 DCN1 DCUN1L1 RP42 SCCRO Homo sapiens (Human) positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396] GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0031396; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000434; GO:2000436 cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182] DPQDENK 0.9771 -1.1619 0 0 13.6207 0 0 13.3194 0 0 0 0 0 0 0 0 0 13.0697 0 0 0 0 0 0 0 0 0 0 0 12.4791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2571 0 0 0 0 0 12.9324 0 13.6084 0 0 0 0 0 0 0 0 0 13.8453 0 0 0 0 0 0 0 0 0 0 13.3834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.87 0 0 0 12.7429 0 0 14.1861 13.8425 0 12.2265 0 0 0 0 13.5575 0 0 0 0 Q13576 IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 IQGAP2 Homo sapiens (Human) Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]; thrombin-activated receptor signaling pathway [GO:0070493]" GO:0003779; GO:0005095; GO:0005096; GO:0005516; GO:0005547; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0005902; GO:0007165; GO:0009986; GO:0015629; GO:0030027; GO:0030175; GO:0030667; GO:0031267; GO:0032956; GO:0034314; GO:0043087; GO:0051015; GO:0070062; GO:0070493; GO:0071933; GO:2000249 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]" AAFYEEQINYYDTYIKTCLDNLKR 0.97711 -1.1638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4491 0 11.5503 0 11.799 0 11.5622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7066 0 0 0 0 0 0 0 0 0 0 0 0 11.4403 0 0 0 11.8906 0 11.8686 0 13.2171 0 0 0 0 0 0 0 14.9923 0 0 0 14.6433 0 0 12.2932 0 0 0 0 0 14.5793 11.6605 0 11.0226 13.7791 0 0 16.7793 0 14.8336 0 0 0 0 13.6259 14.7591 14.5023 13.7465 16.4076 13.7436 0 0 0 0 11.0435 0 0 13.7269 0 0 0 0 0 13.3041 0 0 14.4299 0 14.4516 13.8796 16.3967 11.6426 0 12.3363 0 16.8008 0 0 14.0744 0 0 0 11.2361 0 12.4909 0 0 0 0 0 12.9666 0 16.7903 0 0 0 9.90112 0 0 17.0644 0 11.3641 0 14.216 0 0 0 0 13.9064 0 0 P47972 NPTX2_HUMAN "Neuronal pentraxin-2, NP2 (Neuronal pentraxin II, NP-II)" NPTX2 Homo sapiens (Human) associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] GO:0005576; GO:0007268; GO:0008306; GO:0030246; GO:0046872; GO:0098962; GO:0098978 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] CEGLAGGKAR 0.97712 -1.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0828 0 0 0 12.557 0 0 0 12.4366 0 0 0 0 0 12.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9924 0 0 14.2504 0 0 0 14.2145 0 13.8044 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGZ5 OR2G2_HUMAN Olfactory receptor 2G2 (Olfactory receptor OR1-32) OR2G2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALGVNIL 0.97712 -1.1681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4086 0 0 0 0 0 0 0 0 0 0 12.3512 0 0 11.4119 0 0 0 12.5343 0 0 0 12.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0915 0 0 0 0 0 0 12.2814 0 12.5767 0 0 0 0 0 0 0 0 0 0 13.6535 0 16.9008 12.6059 0 10.8213 0 0 0 0 0 0 0 0 16.1785 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9254 0 0 0 0 0 0 0 0 0 0 16.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUQ7 UFSP2_HUMAN "Ufm1-specific protease 2, UfSP2, EC 3.4.22.-" UFSP2 C4orf20 Homo sapiens (Human) proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; deUFMylase activity [GO:0071567]; thiolester hydrolase activity [GO:0016790]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146] GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0016790; GO:0033146; GO:0071567 deUFMylase activity [GO:0071567]; thiolester hydrolase activity [GO:0016790] ELHDLFNLPHDR 0.97712 -1.1697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5243 0 0 0 0 0 14.6682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3711 0 0 0 0 0 0 0 0 0 0 0 12.3991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8057 0 0 0 0 0 0 0 0 0 0 0 12.7346 0 14.7456 Q9NQ87 HEYL_HUMAN "Hairy/enhancer-of-split related with YRPW motif-like protein, hHeyL (Class B basic helix-loop-helix protein 33, bHLHb33) (Hairy-related transcription factor 3, HRT-3, hHRT3)" HEYL BHLHB33 HRT3 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; atrioventricular valve morphogenesis [GO:0003181]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; glomerulus development [GO:0032835]; mesenchymal cell development [GO:0014031]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AF-1 domain binding [GO:0050683]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; atrioventricular valve morphogenesis [GO:0003181]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to BMP stimulus [GO:0071773]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; glomerulus development [GO:0032835]; mesenchymal cell development [GO:0014031]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; ventricular septum morphogenesis [GO:0060412]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003151; GO:0003180; GO:0003181; GO:0003184; GO:0003198; GO:0003203; GO:0003208; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007219; GO:0009952; GO:0010629; GO:0014031; GO:0032835; GO:0035914; GO:0042803; GO:0043433; GO:0045666; GO:0045892; GO:0045944; GO:0050683; GO:0050767; GO:0060317; GO:0060412; GO:0060766; GO:0061314; GO:0071773; GO:0072014 "AF-1 domain binding [GO:0050683]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ATGIILPARR 0.97714 -1.1811 0 0 0 0 0 14.948 15.3389 0 11.2197 0 0 0 0 0 0 11.1148 0 12.6813 13.2579 10.527 12.9243 12.7794 0 11.9741 10.9128 0 0 10.8109 0 0 0 10.9474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8274 13.8213 13.3796 13.7282 0 11.1979 0 0 12.3041 11.9211 12.0805 0 0 12.7171 13.4348 13.6571 12.359 0 0 0 0 0 15.4159 15.004 14.928 15.3813 16.3153 12.8855 15.1172 14.6107 13.0228 15.1861 14.8394 15.4907 13.5326 14.4613 0 14.5733 0 14.3334 15.447 12.8969 0 14.6978 12.6496 0 0 15.563 15.8059 17.6284 17.241 16.3783 16.589 16.1959 15.6875 16.1028 15.5427 16.2126 15.4729 0 13.4071 0 13.9105 15.1002 15.6782 0 0 17.7049 14.3395 14.8055 17.8042 17.6221 16.2168 16.494 16.4255 16.2265 15.1613 16.5563 15.3098 15.2141 16.5062 14.3233 17.8081 15.4254 15.5978 16.2732 17.5956 15.4394 17.4576 15.8708 15.7004 15.7661 14.5393 14.0124 0 14.7248 0 0 13.956 16.2947 0 0 14.1764 0 0 13.6887 0 0 0 0 13.0072 13.1527 12.9327 13.961 13.2955 17.2773 12.4451 0 0 17.304 14.624 15.3903 0 0 0 12.7147 0 0 Q86WS5 TMPSC_HUMAN "Transmembrane protease serine 12, EC 3.4.21.-" TMPRSS12 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; protein processing [GO:0016485] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021] acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; binding of sperm to zona pellucida [GO:0007339]; protein processing [GO:0016485] GO:0001669; GO:0004252; GO:0007339; GO:0016021; GO:0016485 serine-type endopeptidase activity [GO:0004252] CFISGWGRTK 0.97722 -1.1595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5511 0 0 0 0 0 0 13.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9508 0 0 0 0 0 0 0 0 0 0 0 0 15.0532 0 0 13.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.85 0 0 0 0 15.8464 0 0 0 0 0 0 0 0 0 Q6BCY4 NB5R2_HUMAN "NADH-cytochrome b5 reductase 2, b5R.2, EC 1.6.2.2" CYB5R2 Homo sapiens (Human) bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634] "endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; bicarbonate transport [GO:0015701]; sterol biosynthetic process [GO:0016126]" GO:0004128; GO:0005634; GO:0005789; GO:0015701; GO:0016020; GO:0016126; GO:0071949 "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]" GFVDLIIK 0.97734 -1.1595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2285 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3622 Q14002 CEAM7_HUMAN "Carcinoembryonic antigen-related cell adhesion molecule 7, CEA cell adhesion molecule 7 (Carcinoembryonic antigen CGM2)" CEACAM7 CGM2 Homo sapiens (Human) anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] GO:0005576; GO:0005829; GO:0005886; GO:0016324; GO:0031225 LLLSTDNR 0.97739 -1.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H427 KCNKF_HUMAN "Potassium channel subfamily K member 15 (Acid-sensitive potassium channel protein TASK-5) (TWIK-related acid-sensitive K(+) channel 5) (Two pore potassium channel KT3.3, Two pore K(+) channel KT3.3)" KCNK15 TASK5 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] GO:0005886; GO:0005887; GO:0022841; GO:0030322; GO:0034765; GO:0071805 potassium ion leak channel activity [GO:0022841] LLLAAKCCLGLR 0.97739 -1.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4432 0 0 0 0 0 0 0 0 0 0 10.6333 0 0 11.2175 12.8146 0 0 0 0 0 12.7511 13.1001 0 0 0 0 12.1955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7022 0 0 0 0 0 11.9154 14.2884 0 11.9964 0 0 0 0 11.9543 0 14.9416 0 0 0 0 0 0 0 0 13.3533 13.7356 0 11.7483 0 0 0 0 0 13.3871 0 0 0 0 0 11.5173 14.572 0 0 12.9777 14.0202 0 0 0 0 0 0 11.6595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0301 0 0 0 0 0 0 0 12.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2639 0 0 0 Q9BVN2 RUSC1_HUMAN "AP-4 complex accessory subunit RUSC1 (New molecule containing SH3 at the carboxy-terminus, Nesca) (RUN and SH3 domain-containing protein 1)" RUSC1 NESCA Homo sapiens (Human) protein polyubiquitination [GO:0000209] anchoring junction [GO:0070161]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0003779; GO:0005634; GO:0005769; GO:0005794; GO:0005829; GO:0005874; GO:0014069; GO:0015630; GO:0031410; GO:0070161 actin binding [GO:0003779] ALLCNLNHIHLQHVSLGLHLSR 0.97741 3.1559 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3265 0 0 12.114 0 0 0 0 0 12.1214 0 0 0 0 11.4018 12.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7434 0 0 0 0 11.3986 0 0 0 0 0 0 0 0 10.8447 0 0 0 0 0 0 0 0 12.8165 13.5292 13.8387 0 0 0 0 11.939 0 13.4661 0 0 0 18.0887 13.2486 0 13.4802 13.9205 0 0 13.6084 0 12.338 12.0747 0 14.2075 14.354 0 0 11.9589 0 0 13.5217 0 0 0 0 0 0 0 13.9164 0 0 0 13.607 13.6117 0 0 12.806 0 0 0 0 0 0 13.0455 14.4623 15.1097 0 14.1407 0 0 0 17.8973 12.0629 11.9878 15.5832 0 0 0 0 0 12.3566 0 0 0 14.366 0 14.6844 0 0 0 0 0 0 0 0 0 0 0 11.963 12.9893 0 0 0 14.2414 17.8927 0 12.0568 13.4946 0 0 0 Q9P2J3 KLHL9_HUMAN Kelch-like protein 9 KLHL9 KIAA1354 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; midbody [GO:0030496] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; midbody [GO:0030496]; cullin family protein binding [GO:0097602]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] GO:0005829; GO:0007049; GO:0016567; GO:0030496; GO:0031463; GO:0032465; GO:0051301; GO:0097602 cullin family protein binding [GO:0097602] AMMASASDYFK 0.97742 2.9854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2838 0 0 0 0 0 12.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5783 0 0 0 0 0 0 0 0 0 0 0 0 13.7944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0781 0 0 0 0 0 0 0 13.0823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48637 GSHB_HUMAN "Glutathione synthetase, GSH synthetase, GSH-S, EC 6.3.2.3 (Glutathione synthase)" GSS Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; nervous system development [GO:0007399]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; cellular amino acid metabolic process [GO:0006520]; nervous system development [GO:0007399]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979] GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0006520; GO:0006979; GO:0007399; GO:0042802; GO:0042803; GO:0043295; GO:0046686; GO:0070062 ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] HVLSVLSKTK 0.97748 3.1525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7781 0 11.5108 0 0 0 0 0 14.6707 0 0 0 0 14.6694 0 0 12.6237 0 0 0 0 13.4106 0 0 0 Q13151 ROA0_HUMAN "Heterogeneous nuclear ribonucleoprotein A0, hnRNP A0" HNRNPA0 HNRPA0 Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; inflammatory response [GO:0006954]; mRNA processing [GO:0006397]; response to lipopolysaccharide [GO:0032496] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; inflammatory response [GO:0006954]; mRNA processing [GO:0006397]; response to lipopolysaccharide [GO:0032496] GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0006397; GO:0006954; GO:0019901; GO:0032496; GO:0035925; GO:0070935 mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] FHPIQGHR 0.97751 -1.2302 0 0 0 0 14.5838 0 0 12.9379 0 0 0 0 0 0 10.3381 0 11.8409 0 0 0 0 0 0 0 0 0 0 0 10.5492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1279 13.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2478 0 0 0 0 0 0 14.1381 12.9184 13.4298 0 0 0 13.5289 12.6686 0 0 12.217 0 13.0614 0 13.0969 0 16.5151 0 0 0 12.6489 0 16.2782 0 12.8143 13.7623 0 12.4447 0 12.9869 15.8828 16.0899 13.0285 13.1612 16.6008 12.7379 0 0 15.6953 0 0 0 0 0 0 0 0 12.919 0 0 0 12.1019 0 0 11.8071 14.0198 0 0 0 0 15.2675 11.8381 0 0 0 13.5483 13.4402 0 14.8249 0 0 0 0 0 0 0 16.1389 0 12.2753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7773 0 0 0 0 0 13.1301 Q9Y371 SHLB1_HUMAN "Endophilin-B1 (Bax-interacting factor 1, Bif-1) (SH3 domain-containing GRB2-like protein B1)" SH3GLB1 KIAA0491 CGI-61 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; membrane organization [GO:0061024]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647] autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991] autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; membrane fission [GO:0090148]; membrane organization [GO:0061024]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to vacuolar membrane [GO:1903778]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647] GO:0000139; GO:0000421; GO:0005737; GO:0005741; GO:0005829; GO:0006914; GO:0006915; GO:0008289; GO:0010508; GO:0016020; GO:0016241; GO:0030496; GO:0031334; GO:0031410; GO:0031647; GO:0032465; GO:0032801; GO:0032991; GO:0034198; GO:0042149; GO:0042802; GO:0042803; GO:0045296; GO:0048102; GO:0061024; GO:0090148; GO:1903527; GO:1903778; GO:1903955; GO:2000786 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803] AECTKIWTEK 0.97751 -1.2308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.565 0 12.2926 0 0 0 0 0 0 0 0 0 0 13.4242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5X2 SNX8_HUMAN Sorting nexin-8 SNX8 Homo sapiens (Human) early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886] GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231 identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] DTVQVELIPEKKGLFLK 0.97751 2.9796 0 0 0 0 0 0 9.62051 11.9657 0 0 0 0 0 0 0 0 10.8702 0 0 0 0 0 0 0 0 12.0213 0 0 11.6748 11.6615 11.752 0 0 0 0 0 0 0 0 11.3814 0 12.0549 11.9614 0 11.2442 0 0 11.9595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5542 0 0 0 15.2431 0 15.3131 0 0 0 14.1127 0 0 0 0 0 0 0 0 0 0 0 0 13.602 0 0 0 0 0 0 0 13.8603 0 10.8784 0 0 0 0 0 13.3537 0 0 14.4315 0 0 0 0 0 0 0 0 13.9904 13.5005 0 0 0 0 0 0 0 0 16.9196 0 0 0 0 0 0 0 14.2899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2354 0 0 0 0 0 0 0 0 0 0 Q9BV35 SCMC3_HUMAN Calcium-binding mitochondrial carrier protein SCaMC-3 (Mitochondrial ATP-Mg/Pi carrier protein 2) (Mitochondrial Ca(2+)-dependent solute carrier protein 2) (Small calcium-binding mitochondrial carrier protein 3) (Solute carrier family 25 member 23) SLC25A23 APC2 MCSC2 SCAMC3 Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; regulation of cellular hyperosmotic salinity response [GO:1900069]; regulation of oxidative phosphorylation [GO:0002082]; regulation of sequestering of calcium ion [GO:0051282]; urea homeostasis [GO:0097274] GO:0002082; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006851; GO:0016021; GO:0036444; GO:0051282; GO:0051561; GO:0071277; GO:0097274; GO:1900069 ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] GSPGDAER 0.97758 -1.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6K4 NRARP_HUMAN Notch-regulated ankyrin repeat-containing protein NRARP Homo sapiens (Human) blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; somite rostral/caudal axis specification [GO:0032525]; T cell differentiation [GO:0030217]; vascular endothelial cell proliferation [GO:0101023] blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; somite rostral/caudal axis specification [GO:0032525]; T cell differentiation [GO:0030217]; vascular endothelial cell proliferation [GO:0101023] GO:0000122; GO:0001569; GO:0001938; GO:0002043; GO:0007219; GO:0030217; GO:0032525; GO:0045581; GO:0045746; GO:0090263; GO:0101023; GO:1902367; GO:1905564 LLVKFGADIR 0.9776 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZK7 PA2GE_HUMAN "Group IIE secretory phospholipase A2, GIIE sPLA2, sPLA2-IIE, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase 2E)" PLA2G2E Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]; arachidonic acid secretion [GO:0050482]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid metabolic process [GO:0006644] GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005737; GO:0006644; GO:0006954; GO:0016042; GO:0034374; GO:0046470; GO:0046471; GO:0047498; GO:0050482 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543] LTCECDKR 0.9776 -1.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.006 0 0 13.2926 0 0 0 0 0 0 0 0 0 0 0 0 0 13.325 13.8892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1986 0 0 0 0 13.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5637 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8551 0 0 0 0 12.4933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.272 0 0 0 0 0 0 0 P36405 ARL3_HUMAN ADP-ribosylation factor-like protein 3 ARL3 ARFL3 Homo sapiens (Human) cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to ciliary membrane [GO:1903441]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224] GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0006892; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015031; GO:0015630; GO:0019003; GO:0030496; GO:0032391; GO:0032794; GO:0042073; GO:0042461; GO:0060271; GO:0061512; GO:0070062; GO:1903441 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017] GLLSILRKLK 0.97763 -1.2296 0 0 0 0 11.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3868 0 0 0 0 0 11.9438 0 0 0 0 0 14.3761 0 0 0 0 0 0 0 0 0 0 0 0 9.91807 0 0 0 0 0 11.7449 0 0 0 0 0 0 0 0 0 0 0 0 15.5128 15.5461 15.9604 0 0 16.0598 0 0 15.8588 15.3059 0 0 15.9767 0 0 0 11.0913 0 15.6456 15.8866 15.6787 0 0 0 0 15.8014 0 15.9876 15.7116 16.4232 16.1094 15.0831 15.9994 14.6415 0 15.2708 15.2175 0 0 11.8899 0 16.2921 14.7835 0 0 14.4749 0 14.1215 0 14.7582 15.5629 14.8079 14.7062 14.4409 15.3419 14.262 14.644 14.2939 0 0 0 0 0 0 0 0 0 0 14.5064 14.5897 0 0 0 0 0 0 0 10.9867 0 0 0 0 0 0 0 14.3197 13.8649 0 0 0 0 0 0 Q8NHX4 SPTA3_HUMAN Spermatogenesis-associated protein 3 (Testis and spermatogenesis cell-related protein 1) (Testis spermatocyte apoptosis-related protein 1) SPATA3 TSARG1 Homo sapiens (Human) NCGCGSGGSR 0.97768 -1.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22310 UD14_HUMAN "UDP-glucuronosyltransferase 1A4, UGT1A4, EC 2.4.1.17 (Bilirubin-specific UDPGT isozyme 2, hUG-BR2) (UDP-glucuronosyltransferase 1-4, UDPGT 1-4, UGT1*4, UGT1-04, UGT1.4) (UDP-glucuronosyltransferase 1-D, UGT-1D, UGT1D)" UGT1A4 GNT1 UGT1 Homo sapiens (Human) bilirubin conjugation [GO:0006789]; cellular glucuronidation [GO:0052695]; heme catabolic process [GO:0042167]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; vitamin D3 metabolic process [GO:0070640] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; bilirubin conjugation [GO:0006789]; cellular glucuronidation [GO:0052695]; heme catabolic process [GO:0042167]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; vitamin D3 metabolic process [GO:0070640] GO:0005783; GO:0005789; GO:0006789; GO:0015020; GO:0016021; GO:0019899; GO:0042167; GO:0042803; GO:0045922; GO:0046982; GO:0052695; GO:0070640; GO:1904224; GO:2001030 enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GLQVPLPR 0.9777 -1.2067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.07 0 0 0 0 0 0 0 13.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1101 0 0 0 0 0 0 0 0 0 0 0 12.9473 0 0 0 0 13.5333 0 0 0 0 0 16.1103 0 0 0 0 13.2701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55056 APOC4_HUMAN "Apolipoprotein C-IV, Apo-CIV, ApoC-IV (Apolipoprotein C4)" APOC4 Homo sapiens (Human) lipid metabolic process [GO:0006629]; positive regulation of sequestering of triglyceride [GO:0010890]; triglyceride homeostasis [GO:0070328] extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; very-low-density lipoprotein particle [GO:0034361] extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; very-low-density lipoprotein particle [GO:0034361]; lipid transporter activity [GO:0005319]; lipid metabolic process [GO:0006629]; positive regulation of sequestering of triglyceride [GO:0010890]; triglyceride homeostasis [GO:0070328] GO:0005319; GO:0005576; GO:0006629; GO:0010890; GO:0034361; GO:0034364; GO:0070328 lipid transporter activity [GO:0005319] DLGPLTKAWFLESK 0.9777 -1.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1731 0 13.2229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9493 0 0 0 0 0 13.4362 0 0 0 0 0 0 0 0 0 0 0 0 14.7217 P01236 PRL_HUMAN "Prolactin, PRL" PRL Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; lactation [GO:0007595]; mammary gland development [GO:0030879]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lactation [GO:1903489]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of multicellular organism growth [GO:0040014]; response to nutrient levels [GO:0031667] endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; prolactin receptor binding [GO:0005148]; cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; lactation [GO:0007595]; mammary gland development [GO:0030879]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lactation [GO:1903489]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of multicellular organism growth [GO:0040014]; response to nutrient levels [GO:0031667] GO:0001937; GO:0005148; GO:0005179; GO:0005576; GO:0005615; GO:0007166; GO:0007565; GO:0007595; GO:0008284; GO:0016525; GO:0030879; GO:0031667; GO:0031904; GO:0040014; GO:0046427; GO:1902895; GO:1903489 hormone activity [GO:0005179]; prolactin receptor binding [GO:0005148] IDNYLKLLK 0.97771 -1.2656 0 0 0 0 0 0 0 12.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1655 0 0 0 0 16.0019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5I3 KCNRG_HUMAN "Potassium channel regulatory protein, Potassium channel regulator (Protein CLLD4)" KCNRG CLLD4 Homo sapiens (Human) negative regulation of delayed rectifier potassium channel activity [GO:1902260]; protein homooligomerization [GO:0051260] endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783]; identical protein binding [GO:0042802]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; protein homooligomerization [GO:0051260] GO:0005783; GO:0042802; GO:0051260; GO:1902260 identical protein binding [GO:0042802] EALFYELRSLVDLLNPYLLQPR 0.97771 -1.2682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0106 0 0 0 0 0 0 12.6252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7178 0 0 0 11.5962 0 0 0 0 0 0 0 0 0 9.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14931 NCTR3_HUMAN "Natural cytotoxicity triggering receptor 3 (Activating natural killer receptor p30) (Natural killer cell p30-related protein, NK-p30, NKp30) (CD antigen CD337)" NCR3 1C7 LY117 Homo sapiens (Human) cell recognition [GO:0008037]; immune response [GO:0006955]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; inflammatory response [GO:0006954]; natural killer cell activation [GO:0030101]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; cell recognition [GO:0008037]; immune response [GO:0006955]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; inflammatory response [GO:0006954]; natural killer cell activation [GO:0030101]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954] GO:0002429; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0008037; GO:0030101; GO:0042802; GO:0045954 identical protein binding [GO:0042802] GRLAPLASSR 0.97772 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YU3 AN34A_HUMAN Ankyrin repeat domain-containing protein 34A ANKRD34A ANKRD34 Homo sapiens (Human) PPRHPPK 0.97772 -1.2139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4715 0 0 0 0 0 14.0745 0 0 0 0 13.6914 0 0 0 0 0 0 0 0 0 0 0 0 0 12.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35326 SPR2A_HUMAN "Small proline-rich protein 2A, SPR-2A (2-1)" SPRR2A Homo sapiens (Human) antibacterial humoral response [GO:0019731]; defense response to Gram-positive bacterium [GO:0050830]; host-mediated regulation of intestinal microbiota composition [GO:0048874] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; lipid binding [GO:0008289]; antibacterial humoral response [GO:0019731]; defense response to Gram-positive bacterium [GO:0050830]; host-mediated regulation of intestinal microbiota composition [GO:0048874] GO:0001533; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0008289; GO:0019731; GO:0030133; GO:0030141; GO:0048874; GO:0050830 lipid binding [GO:0008289] CPQPCPPQQCQQKYPPVTPSPPCQSKYPPK 0.97773 -1.226 0 0 0 0 0 0 0 0 0 0 0 0 12.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3953 0 0 0 0 0 14.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2B2 PIGL_HUMAN "N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase, EC 3.5.1.89 (Phosphatidylinositol-glycan biosynthesis class L protein, PIG-L)" PIGL Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]" GO:0000225; GO:0005783; GO:0005789; GO:0006506; GO:0016021; GO:0016254; GO:0016811 "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225]" EAMWLLCVALAVLAWGFLWVWDSSERMK 0.97774 -1.2287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1542 0 0 10.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.183 0 12.4206 12.0261 0 0 0 0 10.6952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0504 0 0 0 9.49917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UF11 PKHB1_HUMAN "Pleckstrin homology domain-containing family B member 1, PH domain-containing family B member 1 (Evectin-1) (PH domain-containing protein in retina 1, PHRET1) (Pleckstrin homology domain retinal protein 1)" PLEKHB1 EVT1 KPL1 PHR1 PHRET1 Homo sapiens (Human) phototransduction [GO:0007602]; regulation of cell differentiation [GO:0045595] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; phototransduction [GO:0007602]; regulation of cell differentiation [GO:0045595] GO:0005737; GO:0007602; GO:0016021; GO:0045595 DGLLTVNLR 0.97775 -1.2292 0 12.0717 0 0 0 0 0 0 0 10.9544 0 0 0 0 0 13.1041 12.2685 0 0 0 12.8798 0 0 0 10.7773 11.1142 12.2553 0 12.3046 0 12.0203 0 0 13.105 13.0468 0 0 0 0 0 0 0 12.8123 12.4158 0 0 12.8602 0 0 0 0 0 12.688 12.465 12.6289 11.5068 12.4944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7683 0 0 14.1789 0 0 0 0 12.9091 0 0 0 0 0 0 0 0 0 12.146 0 0 0 0 0 0 11.9612 0 0 0 0 0 0 0 0 0 0 14.3352 0 0 0 12.6275 0 13.5907 13.4445 0 0 0 0 0 0 0 12.277 0 0 0 0 0 0 0 14.2309 0 0 0 12.5548 0 0 0 0 0 12.6248 0 0 16.3888 0 0 0 0 0 0 0 0 12.692 0 0 0 0 0 0 0 11.419 13.3699 0 0 0 0 0 0 0 0 13.2323 0 0 0 0 0 P02741 CRP_HUMAN C-reactive protein [Cleaved into: C-reactive protein(1-205) ] CRP PTX1 Homo sapiens (Human) acute-phase response [GO:0006953]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; opsonization [GO:0008228]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; choline binding [GO:0033265]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; acute-phase response [GO:0006953]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of mononuclear cell proliferation [GO:0032945]; opsonization [GO:0008228]; positive regulation of gene expression [GO:0010628]; positive regulation of superoxide anion generation [GO:0032930]; regulation of interleukin-8 production [GO:0032677]; vasoconstriction [GO:0042310] GO:0001849; GO:0005509; GO:0005576; GO:0005615; GO:0006953; GO:0006954; GO:0008228; GO:0010628; GO:0010745; GO:0010888; GO:0030169; GO:0032677; GO:0032930; GO:0032945; GO:0033265; GO:0042310; GO:0042802; GO:0045087; GO:0050750; GO:0050830 calcium ion binding [GO:0005509]; choline binding [GO:0033265]; complement component C1q complex binding [GO:0001849]; identical protein binding [GO:0042802]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750] APLTKPLK 0.97778 -1.2395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7233 0 0 0 0 0 0 0 0 0 0 0 Q92686 NEUG_HUMAN "Neurogranin, Ng (RC3) [Cleaved into: NEUG(55-78) ]" NRGN Homo sapiens (Human) associative learning [GO:0008306]; nervous system development [GO:0007399]; positive regulation of long-term synaptic potentiation [GO:1900273]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; signal transduction [GO:0007165]; telencephalon development [GO:0021537] axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; trans-Golgi network transport vesicle membrane [GO:0012510] "axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; trans-Golgi network transport vesicle membrane [GO:0012510]; calmodulin binding [GO:0005516]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; associative learning [GO:0008306]; nervous system development [GO:0007399]; positive regulation of long-term synaptic potentiation [GO:1900273]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; signal transduction [GO:0007165]; telencephalon development [GO:0021537]" GO:0005516; GO:0005547; GO:0005634; GO:0005829; GO:0007165; GO:0007399; GO:0008306; GO:0012510; GO:0014069; GO:0021537; GO:0030424; GO:0031966; GO:0043025; GO:0044327; GO:0045211; GO:0070300; GO:0098978; GO:0099170; GO:1900273 "calmodulin binding [GO:0005516]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" GGAGGGPSGD 0.9778 -1.2607 0 0 0 9.53228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1816 0 9.02978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2216 0 0 0 12.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1333 0 0 0 10.3645 0 0 12.9917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9621 10.9383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7F7 UBL4B_HUMAN Ubiquitin-like protein 4B UBL4B Homo sapiens (Human) positive regulation of protein targeting to mitochondrion [GO:1903955] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; positive regulation of protein targeting to mitochondrion [GO:1903955] GO:0005737; GO:1903955 CSLKVSGQESVATLK 0.97782 -1.2636 0 0 10.2991 0 0 0 0 0 0 0 0 0 0 0 0 0 8.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8341 0 0 0 0 0 0 0 0 0 0 0 0 0 12.414 0 0 17.2325 0 0 0 12.0676 0 11.3467 0 11.7081 0 0 0 0 0 0 0 0 11.4124 0 0 14.2923 0 0 0 0 0 12.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.416 0 0 0 0 12.3457 0 0 0 10.937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8533 0 0 0 0 0 0 P80217 IN35_HUMAN "Interferon-induced 35 kDa protein, IFP 35, Ifi-35" IFI35 IFP35 Homo sapiens (Human) innate immune response [GO:0045087]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; innate immune response [GO:0045087]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145] GO:0002281; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0016020; GO:0034145; GO:0042802; GO:0045087; GO:0045089; GO:0050729; GO:1901223; GO:1901224 identical protein binding [GO:0042802] DKVPFSVPKIPLVFR 0.97783 -1.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4846 0 0 0 0 14.8398 0 0 13.2682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.038 0 0 0 13.6314 0 0 0 0 0 13.8296 14.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDG4 HELQ_HUMAN "Helicase POLQ-like, EC 3.6.4.12 (Mus308-like helicase) (POLQ-like helicase)" HELQ HEL308 Homo sapiens (Human) DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; rRNA processing [GO:0006364] nucleus [GO:0005634]; site of DNA damage [GO:0090734] nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; rRNA processing [GO:0006364] GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0006364; GO:0010792; GO:0016887; GO:0045003; GO:0090734; GO:0097681; GO:1905168; GO:1990518 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518] AEALQEEVEELLRLPSDFPGAVASSTDK 0.97783 -1.2133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7983 0 0 0 0 15.3384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5425 0 0 0 0 0 12.2144 0 0 0 0 0 11.3392 11.1695 0 0 0 0 0 12.8166 0 0 0 0 0 12.7077 0 0 0 0 0 0 0 0 0 11.5984 P28324 ELK4_HUMAN "ETS domain-containing protein Elk-4 (Serum response factor accessory protein 1, SAP-1, SRF accessory protein 1)" ELK4 SAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; histone H3 deacetylation [GO:0070932]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0030154; GO:0045944; GO:0070932; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ALRYYYVK 0.97784 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4482 0 0 0 0 11.5095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95237 LRAT_HUMAN "Lecithin retinol acyltransferase, EC 2.3.1.135 (Phosphatidylcholine--retinol O-acyltransferase)" LRAT Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of lipid transport [GO:0032370]; response to bacterium [GO:0009617]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; acyltransferase activity [GO:0016746]; lecithin:11-cis retinol acyltransferase activity [GO:0102279]; O-palmitoyltransferase activity [GO:0016416]; phosphatidylcholine-retinol O-acyltransferase activity [GO:0047173]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of lipid transport [GO:0032370]; response to bacterium [GO:0009617]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776] GO:0001523; GO:0001972; GO:0005771; GO:0005783; GO:0005789; GO:0005791; GO:0006776; GO:0007601; GO:0009617; GO:0016021; GO:0016416; GO:0016746; GO:0019841; GO:0032370; GO:0032526; GO:0033189; GO:0042572; GO:0047173; GO:0048471; GO:0102279; GO:1990830 acyltransferase activity [GO:0016746]; lecithin:11-cis retinol acyltransferase activity [GO:0102279]; O-palmitoyltransferase activity [GO:0016416]; phosphatidylcholine-retinol O-acyltransferase activity [GO:0047173]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841] GRNSFYETSSFHRGDVLEVPR 0.97785 -1.2255 0 0 0 0 0 0 0 0 0 11.5122 13.345 0 0 0 0 0 0 0 0 0 0 0 13.1701 11.5298 10.6373 11.4538 10.7592 0 13.8975 0 0 0 0 11.2713 0 0 0 0 14.4132 13.7289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9657 0 0 0 0 0 0 0 14.0366 0 11.626 0 0 0 14.9841 12.845 0 0 14.1253 0 12.8912 0 12.2656 0 0 15.2838 0 0 13.3486 0 0 15.0401 0 0 0 0 0 0 12.7401 12.186 12.5551 0 0 0 0 0 12.294 0 0 0 0 0 0 0 0 0 0 0 15.0358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1453 13.4878 0 13.7281 12.0981 0 13.0911 12.208 12.2584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9995 0 11.8343 0 12.1294 0 12.2007 0 Q9NRG1 PRDC1_HUMAN Phosphoribosyltransferase domain-containing protein 1 PRTFDC1 HHGP Homo sapiens (Human) purine ribonucleoside salvage [GO:0006166] cytosol [GO:0005829] cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; purine ribonucleoside salvage [GO:0006166] GO:0000166; GO:0000287; GO:0005829; GO:0006166; GO:0042803 magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803] MAGSSEEAPDYGR 0.97785 -1.2229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SY52 ZIK1_HUMAN Zinc finger protein interacting with ribonucleoprotein K (Zinc finger protein 762) ZIK1 ZNF762 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DILHLADLPGQK 0.97786 -1.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2045 0 0 0 0 0 0 10.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15773 MLF2_HUMAN Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2) MLF2 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0005737; GO:0006355; GO:0016020 SAPGGIRETR 0.97787 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.41 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IF42 OR2A2_HUMAN Olfactory receptor 2A2 (Olfactory receptor 2A17) (Olfactory receptor OR7-11) OR2A2 OR2A17P OR2A2P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NAQLKGALHR 0.97787 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95178 NDUB2_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (Complex I-AGGG, CI-AGGG) (NADH-ubiquinone oxidoreductase AGGG subunit)" NDUFB2 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] LASFARVGGR 0.97788 -1.2533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9746 0 0 0 0 0 12.5417 0 0 0 0 B6SEH9 ERVV2_HUMAN Endogenous retrovirus group V member 2 Env polyprotein (HERV-V_19q13.41 provirus ancestral Env polyprotein 2) ERVV-2 ENVV2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ELITWRVLYSLPKAHTVPTWPK 0.97789 -1.2537 0 0 0 0 0 0 0 0 0 11.7163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6524 0 0 0 0 0 0 0 Q96PG1 M4A4E_HUMAN Putative membrane-spanning 4-domains subfamily A member 4E MS4A4E Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005794; GO:0005886; GO:0016021 PKVLGVVR 0.97789 -1.2395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12694 ODBA_HUMAN "2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial, EC 1.2.4.4 (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain, BCKDE1A, BCKDH E1-alpha)" BCKDHA Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; carboxy-lyase activity [GO:0016831]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083] GO:0003863; GO:0005739; GO:0005759; GO:0005947; GO:0009083; GO:0016831; GO:0046872 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; carboxy-lyase activity [GO:0016831]; metal ion binding [GO:0046872] GLSQAALLLLR 0.97792 4.2488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS62 COLC1_HUMAN Colorectal cancer-associated protein 1 COLCA1 C11orf92 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 EASLWFVAQH 0.97792 -1.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29692 EF1D_HUMAN "Elongation factor 1-delta, EF-1-delta (Antigen NY-CO-4)" EEF1D EF1D Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; mRNA transcription [GO:0009299]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of cell death [GO:0010941]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; guanyl-nucleotide exchange factor activity [GO:0005085]; heat shock protein binding [GO:0031072]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]; cellular response to ionizing radiation [GO:0071479]; mRNA transcription [GO:0009299]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of cell death [GO:0010941]; translational elongation [GO:0006414]" GO:0001650; GO:0003677; GO:0003746; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005853; GO:0006414; GO:0008135; GO:0009299; GO:0010941; GO:0031072; GO:0043123; GO:0045296; GO:0071479; GO:0140297 "cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; guanyl-nucleotide exchange factor activity [GO:0005085]; heat shock protein binding [GO:0031072]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]" AKKPALVAK 0.97794 -1.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1963 18.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0702 0 0 0 0 16.3347 0 0 17.4824 0 0 11.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75152 ZC11A_HUMAN Zinc finger CCCH domain-containing protein 11A ZC3H11A KIAA0663 ZC3HDC11A Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; poly(A)+ mRNA export from nucleus [GO:0016973] GO:0003723; GO:0003729; GO:0005654; GO:0016973; GO:0046872 metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] AAVAVVPLVSEDKSVTVPEAENPR 0.97795 -1.208 0 0 0 0 0 0 0 0 0 13.2326 0 0 0 0 0 0 0 0 10.4679 0 0 0 10.4922 0 0 0 0 0 9.94891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89788 0 0 0 0 0 0 0 0 0 0 0 10.3541 0 0 0 0 0 0 0 0 0 0 0 12.6624 0 0 0 0 0 0 0 0 0 12.6595 14.0807 0 12.6197 0 0 0 12.352 21.4055 21.3655 13.9541 0 12.5557 0 12.9552 13.8589 14.9812 13.7035 14.1115 14.7851 0 0 14.2635 13.0369 0 0 13.6041 0 0 14.0996 13.9729 0 0 12.0092 0 0 0 15.0693 12.108 20.8119 0 0 19.585 0 0 20.0539 12.5318 13.2724 0 0 14.5591 15.2857 0 0 0 0 0 0 0 0 12.6869 19.4928 19.2815 0 0 0 18.9518 0 0 0 0 0 0 0 0 0 0 0 14.8424 13.1536 0 0 0 0 0 0 0 0 0 0 11.0101 0 0 0 0 0 0 0 0 0 0 0 0 Q86UD5 SL9B2_HUMAN "Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2, NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2)" SLC9B2 NHA2 NHEDC2 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814] GO:0005451; GO:0005743; GO:0005886; GO:0006814; GO:0010008; GO:0010348; GO:0015385; GO:0016021; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0061178; GO:0070161; GO:0072583; GO:0097228; GO:2001206 identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; monovalent cation:proton antiporter activity [GO:0005451]; sodium:proton antiporter activity [GO:0015385] IFISFAWLPK 0.97795 -1.2127 0 0 0 0 0 0 0 0 0 0 0 13.0984 0 0 0 0 0 0 0 0 0 0 0 0 11.5083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5079 0 0 0 0 0 0 0 0 0 0 15.1418 0 13.5322 12.5824 0 0 0 0 0 0 0 12.7644 0 12.6968 0 13.9455 0 0 11.727 12.3231 14.1202 0 0 0 0 12.1483 11.5534 12.3904 0 14.0559 0 0 13.2505 15.1234 0 13.5833 13.5836 12.8947 0 0 12.3312 12.5791 0 15.7312 12.9018 0 13.8575 0 0 0 0 0 0 0 12.0717 11.9546 13.5179 12.0733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7365 0 0 0 13.4414 0 0 14.2278 14.8756 0 0 14.2211 12.2811 15.1611 13.1622 0 0 15.9523 14.458 0 0 0 0 Q9NXN4 GDAP2_HUMAN Ganglioside-induced differentiation-associated protein 2 GDAP2 Homo sapiens (Human) response to retinoic acid [GO:0032526] lysosomal membrane [GO:0005765] lysosomal membrane [GO:0005765]; response to retinoic acid [GO:0032526] GO:0005765; GO:0032526 KLYDVVDVKYK 0.97795 -1.2093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9355 0 12.7926 0 12.85 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5101 18.0285 0 12.5565 0 18.2486 13.1742 18.4419 0 12.7984 18.4649 13.8075 15.3621 0 13.1677 18.3325 14.7877 14.2117 18.1677 18.7748 0 0 14.2884 18.055 18.057 14.1328 18.6216 16.266 14.5558 13.2055 19.1312 18.7592 18.3161 0 18.6855 0 0 0 13.9891 14.2127 0 0 18.0417 18.5589 17.0115 13.9483 0 13.5524 13.6743 18.7324 0 13.607 16.5991 0 18.707 18.6246 17.7452 14.6152 13.3274 12.3582 18.8702 15.4907 18.6553 0 14.3663 0 12.8991 15.3228 16.2991 14.5008 18.0788 18.847 19.0868 18.6257 0 0 0 0 0 15.5257 13.2247 0 0 18.7326 18.7245 18.4794 0 16.8829 18.4988 0 14.1519 0 0 0 12.9253 13.9814 13.5459 12.7613 0 14.3248 13.3051 0 0 0 12.8638 15.4887 13.379 0 0 0 0 13.8443 0 O14949 QCR8_HUMAN Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C) UQCRQ Homo sapiens (Human) "cellular respiration [GO:0045333]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; cellular respiration [GO:0045333]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]" GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0021539; GO:0021548; GO:0021680; GO:0021766; GO:0021794; GO:0021854; GO:0021860; GO:0030901; GO:0045333 GIPNVLRRIR 0.97796 -1.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5539 0 0 13.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86841 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96R30 OR2V2_HUMAN Olfactory receptor 2V2 (Olfactory receptor 2V3) (Olfactory receptor OR5-3) OR2V2 OR2V3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NREVMGALR 0.97796 -1.2524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96B54 ZN428_HUMAN Zinc finger protein 428 (Enzyme-like protein PIT13) ZNF428 C19orf37 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] LGGGRGGPSR 0.97797 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6295 12.8639 12.7977 12.6543 12.814 0 0 0 0 0 0 0 0 0 0 0 0 0 P01275 GLUC_HUMAN "Pro-glucagon [Cleaved into: Glicentin; Glicentin-related polypeptide, GRPP; Oxyntomodulin, OXM, OXY; Glucagon; Glucagon-like peptide 1, GLP-1 (Incretin hormone); Glucagon-like peptide 1(7-37), GLP-1(7-37); Glucagon-like peptide 1(7-36), GLP-1(7-36); Glucagon-like peptide 2, GLP-2 ]" GCG Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of calcium ion import [GO:0090280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; protein kinase A signaling [GO:0010737]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of calcium ion import [GO:0090280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; protein kinase A signaling [GO:0010737]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823] GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0005788; GO:0006094; GO:0007186; GO:0007188; GO:0007189; GO:0007631; GO:0010737; GO:0010800; GO:0014823; GO:0031767; GO:0031769; GO:0032092; GO:0033138; GO:0034774; GO:0035774; GO:0042593; GO:0042802; GO:0043066; GO:0045722; GO:0045860; GO:0050796; GO:0051571; GO:0070374; GO:0090280; GO:1900118 gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] HSQGTFTSDYSK 0.97798 -1.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BM0 I27L1_HUMAN "Interferon alpha-inducible protein 27-like protein 1 (Interferon-stimulated gene 12c protein, ISG12(c), ISG12C)" IFI27L1 FAM14B Homo sapiens (Human) apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190] GO:0005739; GO:0006915; GO:0016021; GO:0097190 GKESGWDSGR 0.97798 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0I2 EMC3_HUMAN ER membrane protein complex subunit 3 (Transmembrane protein 111) EMC3 TMEM111 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005789; GO:0016021; GO:0030176; GO:0045050; GO:0071816; GO:0072546 VPFPLTLRFK 0.97798 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5591 0 0 0 0 0 0 0 0 14.5697 13.8589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05019 IGF1_HUMAN "Insulin-like growth factor I, IGF-I (Mechano growth factor, MGF) (Somatomedin-C)" IGF1 IBP1 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; bone mineralization involved in bone maturation [GO:0035630]; cell activation [GO:0001775]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; ERK1 and ERK2 cascade [GO:0070371]; glycolate metabolic process [GO:0009441]; insulin-like growth factor receptor signaling pathway [GO:0048009]; muscle hypertrophy [GO:0014896]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; myotube cell development [GO:0014904]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of oocyte development [GO:0060283]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of trophectodermal cell proliferation [GO:1904075]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; proteoglycan biosynthetic process [GO:0030166]; Ras protein signal transduction [GO:0007265]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of protein phosphorylation [GO:0001932]; response to heat [GO:0009408]; signal transduction [GO:0007165]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; skeletal system development [GO:0001501]; wound healing [GO:0042060]" alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; exocytic vesicle [GO:0070382]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; platelet alpha granule lumen [GO:0031093] "alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; exocytic vesicle [GO:0070382]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; platelet alpha granule lumen [GO:0031093]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178]; activation of protein kinase B activity [GO:0032148]; bone mineralization involved in bone maturation [GO:0035630]; cell activation [GO:0001775]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; ERK1 and ERK2 cascade [GO:0070371]; glycolate metabolic process [GO:0009441]; insulin-like growth factor receptor signaling pathway [GO:0048009]; muscle hypertrophy [GO:0014896]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; myotube cell development [GO:0014904]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of oocyte development [GO:0060283]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of trophectodermal cell proliferation [GO:1904075]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; proteoglycan biosynthetic process [GO:0030166]; Ras protein signal transduction [GO:0007265]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; regulation of protein phosphorylation [GO:0001932]; response to heat [GO:0009408]; signal transduction [GO:0007165]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; skeletal system development [GO:0001501]; wound healing [GO:0042060]" GO:0001501; GO:0001775; GO:0001932; GO:0005158; GO:0005159; GO:0005178; GO:0005179; GO:0005576; GO:0005615; GO:0007165; GO:0007265; GO:0007517; GO:0008083; GO:0008283; GO:0008284; GO:0009408; GO:0009441; GO:0010468; GO:0010560; GO:0010613; GO:0010628; GO:0010629; GO:0014065; GO:0014068; GO:0014834; GO:0014896; GO:0014904; GO:0014911; GO:0016942; GO:0030166; GO:0030335; GO:0031093; GO:0032148; GO:0032691; GO:0032720; GO:0034392; GO:0035630; GO:0035867; GO:0040014; GO:0042060; GO:0042104; GO:0042531; GO:0042567; GO:0043066; GO:0043388; GO:0043410; GO:0043491; GO:0043568; GO:0045445; GO:0045669; GO:0045725; GO:0045821; GO:0045840; GO:0045893; GO:0045944; GO:0046326; GO:0046579; GO:0048009; GO:0048015; GO:0048146; GO:0048661; GO:0050679; GO:0050714; GO:0050731; GO:0050821; GO:0051450; GO:0060283; GO:0061051; GO:0070371; GO:0070374; GO:0070382; GO:0070886; GO:0090201; GO:0150079; GO:1902430; GO:1904075; GO:1904646; GO:1904707; GO:1905460; GO:2000679; GO:2001237 growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; integrin binding [GO:0005178] CCFCDFLKVK 0.97799 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5U5X0 LYRM7_HUMAN Complex III assembly factor LYRM7 (LYR motif-containing protein 7) LYRM7 C5orf31 MZM1L Homo sapiens (Human) cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; protein folding chaperone [GO:0044183]; cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551] GO:0005759; GO:0031966; GO:0034551; GO:0044183; GO:0045333 protein folding chaperone [GO:0044183] AVKVLQLFKTLHR 0.978 -1.2536 0 12.2732 0 0 0 11.503 0 0 14.3587 0 0 0 0 0 0 0 13.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4849 13.6485 13.6857 13.8262 0 11.9381 15.5204 0 0 0 13.896 0 0 0 0 13.749 0 14.14 14.4337 0 13.7651 0 0 0 0 0 0 0 0 0 0 0 14.141 0 0 0 13.3759 0 0 0 0 14.2347 13.7541 0 0 0 15.9861 0 14.196 0 0 0 0 0 13.7597 0 0 0 0 0 0 14.0706 13.9045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.405 0 0 15.0263 0 0 0 0 10.9697 0 0 0 A0A1B0GX95 TVB74_HUMAN T cell receptor beta variable 7-4 TRBV7-4 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 SVSTLKIQR 0.97801 -1.2541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2637 0 0 0 A0A1W2PQ73 ERFL_HUMAN ETS domain-containing transcription factor ERF-like (ETS repressor factor-like) ERFL Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:0043565 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]" AGKGGTGS 0.97801 -1.2395 0 0 0 0 11.1093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0889 0 0 0 0 0 0 10.0347 0 0 14.2369 14.3565 14.2461 14.3436 0 12.7078 13.1999 0 12.7747 11.5766 0 0 0 13.2289 13.0454 0 0 0 0 0 12.4307 0 0 0 0 0 0 12.8796 0 0 0 0 0 0 0 0 0 0 0 0 18.546 0 0 0 0 0 0 0 17.6529 0 0 0 0 0 12.8625 17.5719 17.6674 12.4535 16.4324 0 0 0 0 0 0 0 16.4718 16.4818 0 0 16.9838 17.9127 17.922 0 12.7443 0 16.9339 0 0 0 11.9713 0 0 0 0 0 0 16.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1623 0 13.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 Q11201 SIA4A_HUMAN "CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1, Alpha 2,3-ST 1, Beta-galactoside alpha-2,3-sialyltransferase 1, EC 2.4.99.4 (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase, EC 2.4.99.2) (SIATFL) (ST3Gal I, ST3GalI) (ST3GalA.1) (ST3O) (Sialyltransferase 4A, SIAT4-A)" ST3GAL1 SIAT4 SIAT4A Homo sapiens (Human) "ganglioside biosynthetic process via lactosylceramide [GO:0010706]; keratan sulfate biosynthetic process [GO:0018146]; memory B cell differentiation [GO:0002319]; N-acetylneuraminate metabolic process [GO:0006054]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; O-glycan processing [GO:0016266]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein phosphorylation [GO:0006468]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]" extracellular exosome [GO:0070062]; Golgi medial cisterna membrane [GO:1990675]; Golgi membrane [GO:0000139]; Golgi trans cisterna membrane [GO:1990676]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588] "extracellular exosome [GO:0070062]; Golgi medial cisterna membrane [GO:1990675]; Golgi membrane [GO:0000139]; Golgi trans cisterna membrane [GO:1990676]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; keratan sulfate biosynthetic process [GO:0018146]; memory B cell differentiation [GO:0002319]; N-acetylneuraminate metabolic process [GO:0006054]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; O-glycan processing [GO:0016266]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein phosphorylation [GO:0006468]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]" GO:0000139; GO:0002319; GO:0003836; GO:0006054; GO:0006468; GO:0006487; GO:0008373; GO:0010706; GO:0016020; GO:0016021; GO:0016266; GO:0018146; GO:0019082; GO:0032588; GO:0036211; GO:0047288; GO:0070062; GO:0097503; GO:1905403; GO:1990675; GO:1990676; GO:1990743 "beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; sialyltransferase activity [GO:0008373]" ILIYHPAFIK 0.97801 -1.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.796 14.9792 14.7141 14.7665 14.7812 0 0 0 14.3582 0 0 0 14.8295 14.5571 0 0 0 0 0 0 0 0 13.7969 0 0 13.8533 13.7442 0 0 13.6683 0 0 0 13.6133 0 13.6703 0 0 0 0 14.8507 13.7986 0 0 13.4479 0 0 0 13.5998 0 0 0 13.8345 0 0 0 0 0 13.8734 0 0 0 0 13.2383 12.5246 0 0 0 0 13.7175 0 0 13.5823 13.7863 11.4447 0 0 13.4067 0 0 13.6177 0 0 0 0 0 14.6574 0 13.379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5182 0 0 13.1714 13.2326 11.847 13.7682 0 0 0 0 Q9BUN8 DERL1_HUMAN "Derlin-1 (Degradation in endoplasmic reticulum protein 1, DERtrin-1) (Der1-like protein 1)" DERL1 DER1 UNQ243/PRO276 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020] "Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; misfolded protein binding [GO:0051787]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER-associated misfolded protein catabolic process [GO:0071712]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000839; GO:0002020; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0006986; GO:0016020; GO:0016021; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0032092; GO:0036502; GO:0036503; GO:0036513; GO:0038023; GO:0042288; GO:0042802; GO:0044322; GO:0044877; GO:0045184; GO:0051117; GO:0051787; GO:0071712; GO:1990381 ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; misfolded protein binding [GO:0051787]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] AADQNGGGGR 0.97804 -1.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7293 0 16.6105 16.9042 0 0 0 0 0 0 0 0 0 0 0 0 12.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6K5 ARPIN_HUMAN Arpin (Arp2/3 inhibition protein) ARPIN C15orf38 Homo sapiens (Human) directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]; negative regulation of lamellipodium morphogenesis [GO:2000393] lamellipodium [GO:0030027] lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336]; negative regulation of lamellipodium morphogenesis [GO:2000393] GO:0030027; GO:0030336; GO:0033058; GO:0051126; GO:2000393 CNFTGDGKTGASWTDNIMAQK 0.97805 -1.2628 0 0 0 0 0 0 0 0 0 0 12.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.564 0 13.0073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3918 11.2965 0 0 0 0 11.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8425 0 0 0 0 0 0 0 0 0 0 Q96LU5 IMP1L_HUMAN "Mitochondrial inner membrane protease subunit 1, EC 3.4.21.- (IMP1-like protein)" IMMP1L Homo sapiens (Human) protein processing involved in protein targeting to mitochondrion [GO:0006627]; signal peptide processing [GO:0006465] mitochondrial inner membrane [GO:0005743]; mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial inner membrane peptidase complex [GO:0042720]; mitochondrion [GO:0005739]; serine-type endopeptidase activity [GO:0004252]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; signal peptide processing [GO:0006465] GO:0004252; GO:0005739; GO:0005743; GO:0006465; GO:0006627; GO:0042720 serine-type endopeptidase activity [GO:0004252] LRGVLGKTFR 0.97808 -1.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14859 PO2F1_HUMAN "POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1, Oct-1) (Octamer-binding transcription factor 1, OTF-1)" POU2F1 OCT1 OTF1 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000979; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005783; GO:0006357; GO:0042802; GO:0043231; GO:0043565; GO:0045892; GO:0045944; GO:0090575 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific DNA binding [GO:0043565]" FEALNLSFKNMCKLK 0.97809 -1.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYP9 KRA99_HUMAN Keratin-associated protein 9-9 (Keratin-associated protein 9-5) (Keratin-associated protein 9.5) (Keratin-associated protein 9.9) (Ultrahigh sulfur keratin-associated protein 9.9) KRTAP9-9 KAP9.5 KAP9.9 KRTAP9-5 KRTAP9.5 KRTAP9.9 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 MTHCCSPCCQPTCCR 0.97809 -1.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8505 0 0 0 0 0 0 0 0 0 0 0 15.3318 0 0 0 0 0 0 0 0 11.0285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZV8 KCND2_HUMAN Potassium voltage-gated channel subfamily D member 2 (Voltage-gated potassium channel subunit Kv4.2) KCND2 KIAA1044 Homo sapiens (Human) action potential [GO:0001508]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076]; A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233] GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0014069; GO:0016021; GO:0019228; GO:0019233; GO:0031226; GO:0032809; GO:0034765; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0045475; GO:0046872; GO:0051260; GO:0070161; GO:0071456; GO:0071805; GO:0098978; GO:0098982; GO:0099060; GO:1905030 A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249] HILNFYRTGK 0.9781 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.996 0 0 0 0 0 0 Q9NZQ7 PD1L1_HUMAN "Programmed cell death 1 ligand 1, PD-L1, PDCD1 ligand 1, Programmed death ligand 1, hPD-L1 (B7 homolog 1, B7-H1) (CD antigen CD274)" CD274 B7H1 PDCD1L1 PDCD1LG1 PDL1 Homo sapiens (Human) "adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of CD8-positive, alpha-beta T cell activation [GO:2001186]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor superfamily cytokine production [GO:1903556]; positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905404]; positive regulation of cell migration [GO:0030335]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tolerance induction to tumor cell [GO:0002845]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; toxin transport [GO:1901998]" actin cytoskeleton [GO:0015629]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] "actin cytoskeleton [GO:0015629]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of CD8-positive, alpha-beta T cell activation [GO:2001186]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor superfamily cytokine production [GO:1903556]; positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905404]; positive regulation of cell migration [GO:0030335]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tolerance induction to tumor cell [GO:0002845]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; toxin transport [GO:1901998]" GO:0002250; GO:0002845; GO:0005654; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009897; GO:0015629; GO:0016021; GO:0030335; GO:0031295; GO:0031901; GO:0032689; GO:0032693; GO:0032733; GO:0034097; GO:0042102; GO:0042130; GO:0046007; GO:0055038; GO:0070062; GO:0071222; GO:1901998; GO:1903556; GO:1905404; GO:2000562; GO:2001186 CMISYGGADYKR 0.97813 3.1042 0 13.8307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.055 0 0 0 0 13.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35241 RADI_HUMAN Radixin RDX Homo sapiens (Human) apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of Rap protein signal transduction [GO:0032487]; regulation of ruffle assembly [GO:1900027] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of Rap protein signal transduction [GO:0032487]; regulation of ruffle assembly [GO:1900027] GO:0003723; GO:0003779; GO:0005615; GO:0005886; GO:0005902; GO:0005912; GO:0005925; GO:0008360; GO:0008361; GO:0010628; GO:0010737; GO:0016324; GO:0030027; GO:0030175; GO:0030315; GO:0030335; GO:0030496; GO:0030864; GO:0032154; GO:0032231; GO:0032487; GO:0034111; GO:0034260; GO:0036120; GO:0043087; GO:0045176; GO:0045177; GO:0045296; GO:0045732; GO:0045792; GO:0050839; GO:0051016; GO:0051018; GO:0051117; GO:0051286; GO:0061028; GO:0061951; GO:0070062; GO:0071944; GO:0072659; GO:0097067; GO:1900027; GO:1900087; GO:1902115; GO:1902966; GO:1903392; GO:2000643 actin binding [GO:0003779]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723] EKEELMER 0.97814 -1.2395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51649 SSDH_HUMAN "Succinate-semialdehyde dehydrogenase, mitochondrial, EC 1.2.1.24 (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)" ALDH5A1 SSADH Homo sapiens (Human) central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; nitrogen compound metabolic process [GO:0006807]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; neurotransmitter catabolic process [GO:0042135]; nitrogen compound metabolic process [GO:0006807]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105] GO:0004777; GO:0005739; GO:0005759; GO:0006105; GO:0006536; GO:0006807; GO:0007417; GO:0009450; GO:0009791; GO:0042135; GO:0042802 identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777] PLKEAHGEILYSAFFLEWFSEEAR 0.97814 3.0162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1332 0 13.3298 12.6175 0 0 0 0 0 0 0 0 13.2123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.301 0 0 0 0 0 0 0 0 11.3008 0 0 0 11.9953 0 0 0 0 0 0 0 0 0 0 11.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ94 OR5P3_HUMAN Olfactory receptor 5P3 (Olfactory receptor OR11-94) (Olfactory receptor-like protein JCG1) OR5P3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ELRIKIFS 0.97814 -1.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1167 0 0 14.7182 0 0 0 0 0 0 14.1765 0 0 0 0 0 0 0 0 0 13.579 0 13.5733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7885 0 0 0 0 0 0 0 13.934 0 14.2354 14.3534 0 14.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6157 0 0 13.7632 0 0 0 0 0 14.1342 14.0673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JUX0 SPIN3_HUMAN "Spindlin-3 (Spindlin-like protein 3, SPIN-3)" SPIN3 Homo sapiens (Human) "gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; methylated histone binding [GO:0035064]; gamete generation [GO:0007276]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005654; GO:0005829; GO:0006355; GO:0007276; GO:0035064 methylated histone binding [GO:0035064] VSSLEVLPNR 0.97816 -1.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4676 0 0 0 0 0 0 12.9463 0 0 0 0 13.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6711 0 0 0 0 0 0 0 0 0 0 0 0 12.2394 0 0 Q9BZQ4 NMNA2_HUMAN "Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2, NMN/NaMN adenylyltransferase 2, EC 2.7.7.1, EC 2.7.7.18 (Nicotinamide mononucleotide adenylyltransferase 2, NMN adenylyltransferase 2) (Nicotinate-nucleotide adenylyltransferase 2, NaMN adenylyltransferase 2)" NMNAT2 C1orf15 KIAA0479 Homo sapiens (Human) NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165] axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; synapse [GO:0045202]; trans-Golgi network [GO:0005802] axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165] GO:0000139; GO:0000309; GO:0004515; GO:0005524; GO:0005770; GO:0005794; GO:0005802; GO:0005829; GO:0009165; GO:0009435; GO:0030424; GO:0030659; GO:0045202 ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515] IMNHSSILRK 0.97816 -1.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD89 RETN_HUMAN "Resistin (Adipose tissue-specific secretory factor, ADSF) (C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein) (Cysteine-rich secreted protein A12-alpha-like 2) (Cysteine-rich secreted protein FIZZ3)" RETN FIZZ3 HXCP1 RSTN UNQ407/PRO1199 Homo sapiens (Human) aging [GO:0007568]; fat cell differentiation [GO:0045444]; negative regulation of feeding behavior [GO:2000252]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of synaptic transmission [GO:0050806]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; hormone activity [GO:0005179]; aging [GO:0007568]; fat cell differentiation [GO:0045444]; negative regulation of feeding behavior [GO:2000252]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of synaptic transmission [GO:0050806]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612] GO:0005179; GO:0005576; GO:0005615; GO:0005634; GO:0007568; GO:0009612; GO:0032868; GO:0035578; GO:0035580; GO:0045444; GO:0050806; GO:0070062; GO:2000252; GO:2000872 hormone activity [GO:0005179] AETTCHCQCAGMDWTGARCCR 0.97817 3.013 0 0 0 0 0 0 0 0 0 0 0 0 0 10.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.389 0 0 11.3498 0 0 0 0 0 0 0 0 11.1885 12.1032 0 0 0 0 0 0 0 0 0 11.5884 0 12.7099 0 0 11.8636 0 0 0 0 0 0 0 0 0 0 0 0 11.6254 0 0 0 0 0 0 0 12.3975 0 0 0 0 0 0 0 0 0 0 0 0 P45984 MK09_HUMAN "Mitogen-activated protein kinase 9, MAP kinase 9, MAPK 9, EC 2.7.11.24 (JNK-55) (Stress-activated protein kinase 1a, SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)" MAPK9 JNK2 PRKM9 SAPK1A Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; apoptotic signaling pathway [GO:0097190]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription factor catabolic process [GO:1901485]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; rhythmic process [GO:0048511] GO:0004674; GO:0004705; GO:0004707; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0010628; GO:0010744; GO:0016607; GO:0018105; GO:0031398; GO:0034614; GO:0035556; GO:0038095; GO:0042752; GO:0048511; GO:0051090; GO:0061833; GO:0071276; GO:0071803; GO:0090398; GO:0097190; GO:0106310; GO:1901485; GO:2001235 ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] KLQPTVR 0.97819 -1.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.094 0 0 10.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9476 0 13.4344 0 0 0 0 0 0 0 0 0 0 0 13.2685 0 0 0 0 0 0 0 13.1862 0 0 0 0 0 0 0 0 12.0812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7352 0 0 0 0 0 0 0 0 P46439 GSTM5_HUMAN "Glutathione S-transferase Mu 5, EC 2.5.1.18 (GST class-mu 5) (GSTM5-5)" GSTM5 Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytosol [GO:0005829]; intercellular bridge [GO:0045171] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749] GO:0004364; GO:0005829; GO:0006749; GO:0042802; GO:0045171 glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802] DFISRFEGLK 0.97822 -1.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99999 G3ST1_HUMAN "Galactosylceramide sulfotransferase, GalCer sulfotransferase, EC 2.8.2.11 (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase)" GAL3ST1 CST Homo sapiens (Human) galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146]; galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665] GO:0000139; GO:0001733; GO:0005887; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486; GO:0050694 galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146] ANGSAGECQPRRNIVFLK 0.97823 3.0118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5644 0 0 0 0 16.5552 0 13.4878 14.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8294 0 0 16.9275 16.9567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5018 0 0 12.1293 0 0 0 0 14.2769 16.5123 0 16.6774 0 0 0 0 0 0 0 16.8312 16.643 16.7688 14.8484 14.6777 0 0 0 0 11.1018 0 14.3516 16.396 0 0 0 0 0 14.0961 14.0976 16.1974 15.1307 0 0 0 0 0 0 0 13.3607 0 0 14.256 14.6556 0 14.6296 0 0 16.7094 15.3291 17.3848 0 0 14.1524 16.3231 0 16.1718 14.3355 0 0 0 0 15.8861 0 15.1615 0 16.3735 0 0 0 0 0 0 0 13.6476 14.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N688 DB123_HUMAN "Beta-defensin 123 (Beta-defensin 23, DEFB-23) (Defensin, beta 123)" DEFB123 DEFB23 UNQ1963/PRO4485 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 KLLLLTLTVLLLLSQLTPGGTQR 0.97826 3.0103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6474 0 0 0 0 0 0 0 0 15.1533 14.9854 0 15.387 15.1785 14.5084 14.6024 14.7018 0 14.1701 14.2778 0 0 14.2539 15.4533 0 0 0 0 0 0 0 0 11.5136 0 10.4869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43364 HXA2_HUMAN Homeobox protein Hox-A2 (Homeobox protein Hox-1K) HOXA2 HOX1K Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; muscle structure development [GO:0061061]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast development [GO:0002076]; pharyngeal system development [GO:0060037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 2 development [GO:0021568]; rhombomere 3 morphogenesis [GO:0021658]; segment specification [GO:0007379] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; brain segmentation [GO:0035284]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral pattern formation [GO:0009953]; embryonic viscerocranium morphogenesis [GO:0048703]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; muscle structure development [GO:0061061]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast development [GO:0002076]; pharyngeal system development [GO:0060037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 2 development [GO:0021568]; rhombomere 3 morphogenesis [GO:0021658]; segment specification [GO:0007379]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001709; GO:0002076; GO:0005634; GO:0005654; GO:0006357; GO:0007379; GO:0008045; GO:0009952; GO:0009953; GO:0021568; GO:0021658; GO:0035284; GO:0042474; GO:0043231; GO:0045665; GO:0045668; GO:0045944; GO:0048703; GO:0060037; GO:0061061; GO:0071300; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" RVEIAALLDLTER 0.97827 -1.2433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DP72 VSXL2_HUMAN V-set and immunoglobulin domain-containing protein 10-like 2 VSIG10L2 Homo sapiens (Human) cell-cell adhesion [GO:0098609] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion [GO:0098609] GO:0005887; GO:0005911; GO:0050839; GO:0098609 cell adhesion molecule binding [GO:0050839] AQHSPVSLLLLIHLCLLHLR 0.97827 -1.2591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9605 0 0 0 0 14.6804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42857 NSG1_HUMAN Neuronal vesicle trafficking-associated protein 1 (Neuron-enriched endosomal protein of 21 kDa) (Neuron-specific protein family member 1) NSG1 D4S234 NEEP21 Homo sapiens (Human) "amyloid precursor protein metabolic process [GO:0042982]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; dopamine receptor signaling pathway [GO:0007212]; endosomal transport [GO:0016197]; neurotransmitter receptor cycle [GO:0099627]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of receptor recycling [GO:0001921]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; receptor recycling [GO:0001881]; regulation of long-term synaptic potentiation [GO:1900271]; spontaneous synaptic transmission [GO:0098814]; vesicle-mediated transport in synapse [GO:0099003]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lateral plasma membrane [GO:0016328]; lysosomal lumen [GO:0043202]; multivesicular body membrane [GO:0032585]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; trans-Golgi network membrane [GO:0032588] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lateral plasma membrane [GO:0016328]; lysosomal lumen [GO:0043202]; multivesicular body membrane [GO:0032585]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; recycling endosome membrane [GO:0055038]; somatodendritic compartment [GO:0036477]; trans-Golgi network membrane [GO:0032588]; clathrin light chain binding [GO:0032051]; signaling receptor binding [GO:0005102]; amyloid precursor protein metabolic process [GO:0042982]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; dopamine receptor signaling pathway [GO:0007212]; endosomal transport [GO:0016197]; neurotransmitter receptor cycle [GO:0099627]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of receptor recycling [GO:0001921]; postsynaptic neurotransmitter receptor cycle [GO:0099630]; receptor recycling [GO:0001881]; regulation of long-term synaptic potentiation [GO:1900271]; spontaneous synaptic transmission [GO:0098814]; vesicle-mediated transport in synapse [GO:0099003]" GO:0001881; GO:0001921; GO:0005102; GO:0005634; GO:0005737; GO:0005768; GO:0005770; GO:0005783; GO:0005789; GO:0006915; GO:0007212; GO:0016021; GO:0016197; GO:0016328; GO:0030425; GO:0031901; GO:0032051; GO:0032580; GO:0032585; GO:0032588; GO:0036477; GO:0042982; GO:0043202; GO:0045211; GO:0048268; GO:0055038; GO:0098814; GO:0098845; GO:0098887; GO:0098978; GO:0099003; GO:0099627; GO:0099630; GO:1900271 clathrin light chain binding [GO:0032051]; signaling receptor binding [GO:0005102] TKTEYEPDRK 0.97827 -1.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3118 14.4846 14.1774 12.6501 12.7873 0 0 0 0 0 0 0 11.2218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1652 0 0 12.1046 0 0 0 0 0 0 0 0 0 0 0 0 12.8532 0 0 0 0 0 0 12.4775 0 0 Q8NBQ7 AQP11_HUMAN "Aquaporin-11, AQP-11" AQP11 AQPX1 PSEC0027 Homo sapiens (Human) cellular water homeostasis [GO:0009992]; endosomal lumen acidification [GO:0048388]; glycerol transmembrane transport [GO:0015793]; hydrogen peroxide transmembrane transport [GO:0080170]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERAD pathway [GO:1904293]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; oxygen homeostasis [GO:0032364]; positive regulation of cell population proliferation [GO:0008284]; protein glycosylation [GO:0006486]; protein homooligomerization [GO:0051260]; protein targeting to membrane [GO:0006612]; proximal tubule development [GO:0072014]; water homeostasis [GO:0030104]; water transport [GO:0006833] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; channel activity [GO:0015267]; glycerol channel activity [GO:0015254]; water channel activity [GO:0015250]; cellular water homeostasis [GO:0009992]; endosomal lumen acidification [GO:0048388]; glycerol transmembrane transport [GO:0015793]; hydrogen peroxide transmembrane transport [GO:0080170]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERAD pathway [GO:1904293]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; oxygen homeostasis [GO:0032364]; positive regulation of cell population proliferation [GO:0008284]; protein glycosylation [GO:0006486]; protein homooligomerization [GO:0051260]; protein targeting to membrane [GO:0006612]; proximal tubule development [GO:0072014]; water homeostasis [GO:0030104]; water transport [GO:0006833] GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006612; GO:0006833; GO:0008284; GO:0009986; GO:0009992; GO:0015250; GO:0015254; GO:0015267; GO:0015793; GO:0016021; GO:0030104; GO:0030659; GO:0032364; GO:0048388; GO:0048471; GO:0050680; GO:0051260; GO:0072014; GO:0080170; GO:1903573; GO:1904293 channel activity [GO:0015267]; glycerol channel activity [GO:0015254]; water channel activity [GO:0015250] VVARQQLHR 0.97827 -1.2447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.423 0 0 0 13.8598 0 0 0 0 0 0 14.2872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDC0 MYOZ3_HUMAN Myozenin-3 (Calsarcin-3) (FATZ-related protein 3) MYOZ3 FRP3 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; Z disc [GO:0030018]; actin binding [GO:0003779]; FATZ binding [GO:0051373]; telethonin binding [GO:0031433] GO:0003779; GO:0015629; GO:0030018; GO:0031433; GO:0051373 actin binding [GO:0003779]; FATZ binding [GO:0051373]; telethonin binding [GO:0031433] GSLLFQKRQR 0.97827 -1.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96Q06 PLIN4_HUMAN Perilipin-4 (Adipocyte protein S3-12) PLIN4 KIAA1881 Homo sapiens (Human) cytosol [GO:0005829]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] cytosol [GO:0005829]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] GO:0005811; GO:0005829; GO:0005886 AVLMGTK 0.97827 -1.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B9A6J9 TBC3L_HUMAN TBC1 domain family member 3L TBC1D3L Homo sapiens (Human) activation of GTPase activity [GO:0090630] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0005886; GO:0090630 GTPase activator activity [GO:0005096] EAKQIRR 0.97828 -1.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KRA6 CB076_HUMAN UPF0538 protein C2orf76 C2orf76 Homo sapiens (Human) APGEVTITVRLIR 0.97828 -1.2461 0 0 0 17.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0368 0 0 0 12.2526 0 0 0 0 0 0 0 10.6032 0 0 0 0 0 0 10.5349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3775 0 0 0 0 0 0 0 0 13.5229 0 0 0 0 12.3793 0 0 13.4698 0 10.1503 11.4827 0 0 12.352 0 0 0 14.8101 0 0 14.7238 0 0 0 0 0 0 0 0 0 13.746 0 0 0 0 0 0 0 0 0 11.529 0 0 0 0 12.6504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51570 GALK1_HUMAN "Galactokinase, EC 2.7.1.6 (Galactose kinase)" GALK1 GALK Homo sapiens (Human) galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623] GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019388; GO:0019402; GO:0033499; GO:0061623; GO:0070062 ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534] TAQAAAALRR 0.97829 -1.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VUM1 SDHF4_HUMAN "Succinate dehydrogenase assembly factor 4, mitochondrial, SDH assembly factor 4, SDHAF4" SDHAF4 C6orf57 Homo sapiens (Human) cellular respiration [GO:0045333]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex II assembly [GO:0034553]; positive regulation of succinate dehydrogenase activity [GO:1904231] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; cellular respiration [GO:0045333]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex II assembly [GO:0034553]; positive regulation of succinate dehydrogenase activity [GO:1904231] GO:0005739; GO:0005759; GO:0008047; GO:0034553; GO:0045087; GO:0045333; GO:1904231 enzyme activator activity [GO:0008047] SPLLCHSLRK 0.97829 -1.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW81 DMAC2_HUMAN Distal membrane-arm assembly complex protein 2 (ATP synthase subunit s-like protein) DMAC2 ATP5SL Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] mitochondrion [GO:0005739]; SCF ubiquitin ligase complex [GO:0019005] mitochondrion [GO:0005739]; SCF ubiquitin ligase complex [GO:0019005]; mitochondrial respiratory chain complex I assembly [GO:0032981]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0005739; GO:0019005; GO:0031146; GO:0032981 LKELQSLSLQRCCHVDDWCLSR 0.97829 3.0932 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27918 PROP_HUMAN Properdin (Complement factor P) CFP PFC Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]" endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]" GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006955; GO:0006956; GO:0006957; GO:0035580; GO:0042742; GO:0050778; GO:1903028; GO:1904724 LCTPLLPK 0.97831 -1.2504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9645 0 0 0 0 0 0 0 0 0 0 13.9719 0 0 0 0 0 0 0 14.2587 13.5277 0 0 0 0 0 13.1342 0 0 0 0 13.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RN1 S26A8_HUMAN Testis anion transporter 1 (Anion exchange transporter) (Solute carrier family 26 member 8) SLC26A8 TAT1 Homo sapiens (Human) anion transport [GO:0006820]; chloride transport [GO:0006821]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oxalate transport [GO:0019532]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; chloride transport [GO:0006821]; flagellated sperm motility [GO:0030317]; meiotic cell cycle [GO:0051321]; oxalate transport [GO:0019532]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272] GO:0005254; GO:0005886; GO:0005887; GO:0006820; GO:0006821; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0019531; GO:0019532; GO:0030317; GO:0048240; GO:0051321 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] ANSTSILVFLTVVVALRINK 0.97834 4.4345 0 0 0 0 0 0 14.6391 0 0 0 0 0 0 0 0 13.7363 0 0 0 0 0 0 11.4139 0 0 0 0 0 0 0 13.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4235 0 0 0 0 11.5097 0 0 0 0 0 0 16.0941 0 0 0 0 0 0 0 0 0 0 0 0 13.57 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3621 0 0 12.7317 0 0 0 15.8479 0 11.0239 13.0177 0 11.4828 0 0 0 0 0 12.5681 0 12.5704 0 0 0 13.562 0 0 0 16.0976 0 0 0 15.0576 15.9227 15.5696 15.0998 0 0 0 0 0 0 0 0 15.7651 0 0 13.0072 0 0 0 0 0 0 0 0 0 0 0 10.9465 0 15.0366 0 14.9074 0 0 15.8121 0 0 0 Q75WM6 H1FNT_HUMAN Testis-specific H1 histone (Haploid germ cell-specific nuclear protein 1) (Histone H1.7) (Histone H1t2) H1-7 H1FNT HANP1 Homo sapiens (Human) chromosome condensation [GO:0030261]; sperm DNA condensation [GO:0035092]; spermatid nucleus elongation [GO:0007290] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; sperm DNA condensation [GO:0035092]; spermatid nucleus elongation [GO:0007290] GO:0000785; GO:0003677; GO:0005524; GO:0005634; GO:0007290; GO:0030261; GO:0035092 ATP binding [GO:0005524]; DNA binding [GO:0003677] QEEGTRAPWR 0.97839 -1.2588 0 0 0 0 0 0 0 0 0 0 9.93624 0 0 0 0 0 0 0 0 0 0 10.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.261 0 0 0 0 0 12.9123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ78 ZMYM5_HUMAN Zinc finger MYM-type protein 5 (Zinc finger protein 198-like 1) (Zinc finger protein 237) ZMYM5 ZNF198L1 ZNF237 HSPC050 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0008270 zinc ion binding [GO:0008270] AIDAAEHRLYENEK 0.97839 -1.2433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3972 0 0 0 11.3013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9621 0 0 11.3937 0 12.978 0 0 0 12.5603 0 0 12.8154 0 0 0 12.9164 0 12.1161 0 0 0 0 0 0 0 0 13.0917 0 0 0 0 0 12.7594 0 0 0 0 0 0 11.3101 0 0 0 0 0 0 0 0 0 0 0 0 11.5664 13.7492 0 0 0 0 0 0 0 0 0 0 13.4291 0 0 0 13.1287 0 0 0 0 0 0 0 0 0 0 12.6633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2134 12.571 0 0 0 P80748 LV321_HUMAN Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT) IGLV3-21 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062; GO:0072562 antigen binding [GO:0003823] SVHWYQQK 0.9784 -1.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4458 0 0 0 11.2903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22792 CPN2_HUMAN Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit) CPN2 ACBP Homo sapiens (Human) protein stabilization [GO:0050821] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; enzyme regulator activity [GO:0030234]; protein stabilization [GO:0050821] GO:0005576; GO:0005615; GO:0030234; GO:0031012; GO:0050821; GO:0070062; GO:0072562 enzyme regulator activity [GO:0030234] RLFQPLTHLK 0.97841 -1.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6W1 TMCO2_HUMAN Transmembrane and coiled-coil domain-containing protein 2 TMCO2 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 ISFLILLGIGIYALWKR 0.97841 3.004 0 0 0 0 10.1903 0 15.1805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8795 0 0 0 0 0 0 0 0 0 16.808 0 0 0 0 0 0 0 0 0 0 0 0 12.544 0 0 0 0 0 13.4464 0 0 0 0 0 12.3434 0 0 17.3758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5118 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1351 0 0 0 0 0 0 0 0 0 0 10.9355 0 0 11.5276 0 0 0 0 0 0 0 Q13421 MSLN_HUMAN "Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor, MPF; Mesothelin, cleaved form ]" MSLN MPF Homo sapiens (Human) cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; pancreas development [GO:0031016] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; pancreas development [GO:0031016] GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0005886; GO:0007155; GO:0007160; GO:0009986; GO:0016020; GO:0031016; GO:0031225 LLGPHVEGLK 0.97842 -1.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4199 0 13.084 11.8068 0 0 12.729 0 0 0 13.5111 0 13.969 0 0 0 0 0 12.9751 13.6927 0 0 14.2994 0 0 0 0 0 0 0 0 0 0 12.8938 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0179 0 0 0 0 0 0 12.2882 12.5501 0 0 0 0 0 0 0 13.9821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0J0 NDUAD_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6, CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein, GRIM-19, Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit)" NDUFA13 GRIM19 CDA016 CGI-39 Homo sapiens (Human) "aerobic respiration [GO:0009060]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of peptidase activity [GO:0010952]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]" cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; aerobic respiration [GO:0009060]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of peptidase activity [GO:0010952]; positive regulation of protein catabolic process [GO:0045732]; protein insertion into mitochondrial inner membrane [GO:0045039]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]" GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005746; GO:0005747; GO:0009060; GO:0010952; GO:0030308; GO:0031966; GO:0032981; GO:0035458; GO:0042776; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243 ATP binding [GO:0005524] RLQIEDFEAR 0.97842 -1.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4X4 KLF12_HUMAN Krueppel-like factor 12 (Transcriptional repressor AP-2rep) KLF12 AP2REP HSPC122 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0045944; GO:0046872; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CADCDRSFSR 0.97843 -1.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58658 EVA1C_HUMAN Protein eva-1 homolog C (Protein FAM176C) (SUE21) EVA1C C21orf63 C21orf64 FAM176C PRED34 UNQ2504/PRO5993 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; heparin binding [GO:0008201] GO:0008201; GO:0016021; GO:0030246 carbohydrate binding [GO:0030246]; heparin binding [GO:0008201] FLNIYSATYGR 0.97851 -1.2588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0852 11.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VYY1 ANR22_HUMAN Ankyrin repeat domain-containing protein 22 ANKRD22 Homo sapiens (Human) EDSSYANVQDGFNGDTPLICACRR 0.97854 -1.2483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3706 0 0 0 0 0 0 0 0 0 0 0 0 13.0103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3343 0 P08134 RHOC_HUMAN "Rho-related GTP-binding protein RhoC (Rho cDNA clone 9, h9)" RHOC ARH9 ARHC Homo sapiens (Human) "actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of cell migration [GO:0030335]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipase activity [GO:0060193]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]" cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; apical junction assembly [GO:0043297]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; mitotic cytokinesis [GO:0000281]; positive regulation of cell migration [GO:0030335]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipase activity [GO:0060193]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; skeletal muscle satellite cell migration [GO:1902766]; small GTPase mediated signal transduction [GO:0007264]; wound healing, spreading of cells [GO:0044319]" GO:0000281; GO:0003924; GO:0005525; GO:0005634; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030335; GO:0030865; GO:0031334; GO:0031410; GO:0032154; GO:0032420; GO:0032956; GO:0042995; GO:0043005; GO:0043123; GO:0043297; GO:0044319; GO:0051496; GO:0060193; GO:0070062; GO:1902766 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] LVIVGDGACGKTCLLIVFSK 0.97856 -1.2743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6293 12.4515 12.0042 0 0 12.6566 0 13.0628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1529 10.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG81 OR2M7_HUMAN Olfactory receptor 2M7 (Olfactory receptor OR1-58) OR2M7 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NKEVTRALMK 0.97862 -1.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43617 TPPC3_HUMAN Trafficking protein particle complex subunit 3 (BET3 homolog) TRAPPC3 BET3 CDABP0066 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072] cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0000139; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0033106; GO:0048208; GO:0099022; GO:1990071; GO:1990072 DYENDEDVNK 0.97863 -1.2573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z794 K2C1B_HUMAN "Keratin, type II cytoskeletal 1b (Cytokeratin-1B, CK-1B) (Keratin-77, K77) (Type-II keratin Kb39)" KRT77 KRT1B Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0001533; GO:0005829; GO:0005856; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0070062 structural constituent of skin epidermis [GO:0030280] FASFIDK 0.97863 3.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3048 0 0 0 0 0 14.6617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1348 13.8375 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3593 0 13.8929 0 0 0 0 0 14.2046 0 0 0 0 0 0 13.5463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNE2 RPH3L_HUMAN Rab effector Noc2 (No C2 domains protein) (Rabphilin-3A-like protein) RPH3AL NOC2 Homo sapiens (Human) exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of insulin secretion [GO:0032024]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669] cytoplasm [GO:0005737]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] cytoplasm [GO:0005737]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of insulin secretion [GO:0032024]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669] GO:0005737; GO:0006886; GO:0006887; GO:0007186; GO:0008092; GO:0017158; GO:0030658; GO:0031267; GO:0032024; GO:0042593; GO:0045202; GO:0045744; GO:0046872; GO:0061669 cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] GLPKYILPLKTPGR 0.97863 -1.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7075 19.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55291 CAD15_HUMAN "Cadherin-15 (Cadherin-14) (Muscle cadherin, M-cadherin)" CDH15 CDH14 CDH3 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] catenin complex [GO:0016342]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886] catenin complex [GO:0016342]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005794; GO:0005886; GO:0005901; GO:0007155; GO:0007156; GO:0016021; GO:0016342; GO:0031594; GO:0045296; GO:0070062; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] AWVIPPISVSENHK 0.97865 4.4181 0 0 0 0 0 0 0 0 0 0 12.1596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.075 0 0 0 0 0 12.0389 11.5951 0 0 12.1214 0 0 0 0 0 0 0 0 0 0 10.2836 0 0 0 0 0 14.5777 15.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0632 14.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9268 0 14.386 0 0 0 11.638 0 0 12.2894 0 0 0 0 0 0 0 0 0 0 Q9UJQ7 SCP2D_HUMAN SCP2 sterol-binding domain-containing protein 1 SCP2D1 C20orf79 Homo sapiens (Human) phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; steroid biosynthetic process [GO:0006694] sterol binding [GO:0032934]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; steroid biosynthetic process [GO:0006694] GO:0006694; GO:0015914; GO:0032385; GO:0032934 sterol binding [GO:0032934] AFLAGKFKVSGK 0.97866 3.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8442 10.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0853 0 0 0 0 14.4002 0 15.3679 0 14.4516 0 0 0 0 0 0 0 0 0 0 0 15.3306 0 0 0 0 0 0 0 10.6832 0 0 0 0 0 0 0 0 0 11.3546 0 14.9478 0 0 0 13.8382 13.879 0 0 0 12.408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8949 0 0 0 13.5658 11.7836 0 0 0 0 0 0 0 0 0 0 0 0 11.7063 0 0 0 0 14.0172 0 0 0 0 0 10.8605 0 Q9H900 ZWILC_HUMAN "Protein zwilch homolog, hZwilch" ZWILCH Homo sapiens (Human) cell division [GO:0051301]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; RZZ complex [GO:1990423] cytosol [GO:0005829]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; RZZ complex [GO:1990423]; cell division [GO:0051301]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501] GO:0000776; GO:0005828; GO:0005829; GO:0007094; GO:0034501; GO:0051301; GO:1990423 FLLVLADGLR 0.97869 -1.2797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7033 0 0 14.3134 0 0 0 13.7074 0 0 13.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T9G4 ARM12_HUMAN Armadillo repeat-containing protein 12 ARMC12 C6orf81 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; positive regulation of cell growth [GO:0030307]; sperm mitochondrial sheath assembly [GO:0120317] extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634] extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; flagellated sperm motility [GO:0030317]; positive regulation of cell growth [GO:0030307]; sperm mitochondrial sheath assembly [GO:0120317] GO:0005634; GO:0005741; GO:0019898; GO:0030307; GO:0030317; GO:0120317 GKSIPQYLGQLDIRK 0.9787 -1.2837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4033 0 0 0 0 0 15.8523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TC79 ZBT37_HUMAN Zinc finger and BTB domain-containing protein 37 ZBTB37 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DQLEYHIRK 0.97881 -1.2797 0 0 0 0 0 0 0 0 0 0 0 0 16.388 0 0 0 0 0 0 11.1128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6501 0 0 12.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5311 0 0 0 0 0 0 0 12.9997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.597 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3948 0 0 0 17.54 14.0069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2W1 M4A6A_HUMAN Membrane-spanning 4-domains subfamily A member 6A (CD20 antigen-like 3) (Four-span transmembrane protein 3) MS4A6A 4SPAN3 CD20L3 MS4A6 CDA01 MSTP090 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell surface receptor signaling pathway [GO:0007166] GO:0005802; GO:0005886; GO:0007166; GO:0016021 LLVHSSLVGSILSALSALVGFIILSVK 0.97881 2.9813 0 0 0 0 0 0 0 0 0 0 0 12.5935 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8905 0 0 0 0 0 11.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5367 0 0 0 0 0 14.5773 0 0 0 0 0 0 0 0 0 0 0 14.4902 0 0 0 0 0 0 0 12.9054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7065 0 0 0 14.1003 0 13.1959 0 0 0 13.9633 0 0 0 0 0 0 0 0 11.654 0 0 11.4663 O14807 RASM_HUMAN "Ras-related protein M-Ras, EC 3.6.5.2 (Ras-related protein R-Ras3)" MRAS RRAS3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; actin cytoskeleton organization [GO:0030036]; cellular response to leukemia inhibitory factor [GO:1990830]; Ras protein signal transduction [GO:0007265] GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0007265; GO:0019003; GO:0030036; GO:0030742; GO:1990830 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] AFHDLVRVIR 0.97882 -1.2837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9211 0 0 0 0 0 0 Q16270 IBP7_HUMAN "Insulin-like growth factor-binding protein 7, IBP-7, IGF-binding protein 7, IGFBP-7 (IGFBP-rP1) (MAC25 protein) (PGI2-stimulating factor) (Prostacyclin-stimulating factor) (Tumor-derived adhesion factor, TAF)" IGFBP7 MAC25 PSF Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to hormone stimulus [GO:0032870]; embryo implantation [GO:0007566]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; regulation of steroid biosynthetic process [GO:0050810]; response to cortisol [GO:0051414]; response to heat [GO:0009408]; response to retinoic acid [GO:0032526] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding [GO:0005520]; cell adhesion [GO:0007155]; cellular response to hormone stimulus [GO:0032870]; embryo implantation [GO:0007566]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; regulation of steroid biosynthetic process [GO:0050810]; response to cortisol [GO:0051414]; response to heat [GO:0009408]; response to retinoic acid [GO:0032526] GO:0001558; GO:0005520; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007566; GO:0008285; GO:0009408; GO:0009966; GO:0032526; GO:0032870; GO:0050810; GO:0051414; GO:0062023; GO:0070062 insulin-like growth factor binding [GO:0005520] DACGCCPMCAR 0.97882 3.1622 0 0 0 0 12.5916 0 0 0 0 0 11.2258 14.0992 0 0 0 0 0 0 0 0 0 0 13.9496 0 11.0055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7372 12.5177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9166 0 0 0 0 12.9482 0 0 0 0 0 0 0 0 0 0 0 10.991 0 0 0 0 0 0 11.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5781 0 13.0484 0 0 12.9184 12.0752 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7C8 TAF8_HUMAN "Transcription initiation factor TFIID subunit 8 (Protein taube nuss) (TBP-associated factor 43 kDa) (TBP-associated factor 8) (Transcription initiation factor TFIID 43 kDa subunit, TAFII-43, TAFII43, hTAFII43)" TAF8 TAFII43 TBN Homo sapiens (Human) cell differentiation [GO:0030154]; DNA-templated transcription open complex formation [GO:0001112]; inner cell mass cell proliferation [GO:0001833]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of fat cell differentiation [GO:0045598]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIID complex [GO:0005669] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; cell differentiation [GO:0030154]; DNA-templated transcription open complex formation [GO:0001112]; inner cell mass cell proliferation [GO:0001833]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; regulation of fat cell differentiation [GO:0045598]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0001112; GO:0001833; GO:0005634; GO:0005654; GO:0005669; GO:0006367; GO:0006468; GO:0016251; GO:0030154; GO:0042789; GO:0045598; GO:0046982; GO:0048471; GO:0051123; GO:0051457; GO:0060261 protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251] AASQRRDVER 0.97885 -1.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYW3 DB126_HUMAN "Beta-defensin 126 (Beta-defensin 26, DEFB-26) (Defensin, beta 126) (Epididymal secretory protein 13.2, ESP13.2) (HBD26)" DEFB126 C20orf8 DEFB26 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; single fertilization [GO:0007338] extracellular region [GO:0005576] extracellular region [GO:0005576]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; single fertilization [GO:0007338] GO:0005576; GO:0007338; GO:0045087; GO:0050829; GO:0061844 KCLNDVGICK 0.97885 3.1595 0 0 10.7827 0 0 0 0 0 0 0 0 0 0 12.1662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7695 0 0 0 0 12.527 0 12.3493 13.4227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8944 0 0 0 0 0 0 0 0 0 10.8041 0 0 0 10.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1884 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8W3 F204A_HUMAN Protein FAM204A FAM204A C10orf84 Homo sapiens (Human) KKLAWGFEAK 0.97886 -1.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07333 CSF1R_HUMAN "Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor, CSF-1-R, CSF-1R, M-CSF-R, EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115)" CSF1R FMS Homo sapiens (Human) axon guidance [GO:0007411]; cell population proliferation [GO:0008283]; cell-cell junction maintenance [GO:0045217]; cellular response to cytokine stimulus [GO:0071345]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cytokine-mediated signaling pathway [GO:0019221]; forebrain neuron differentiation [GO:0021879]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary gland duct morphogenesis [GO:0060603]; microglial cell proliferation [GO:0061518]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; olfactory bulb development [GO:0021772]; osteoclast differentiation [GO:0030316]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation by host of viral process [GO:0044794]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of bone resorption [GO:0045124]; regulation of cell shape [GO:0008360]; response to ischemia [GO:0002931]; ruffle organization [GO:0031529]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell surface [GO:0009986]; CSF1-CSF1R complex [GO:1990682]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; CSF1-CSF1R complex [GO:1990682]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; axon guidance [GO:0007411]; cell population proliferation [GO:0008283]; cell-cell junction maintenance [GO:0045217]; cellular response to cytokine stimulus [GO:0071345]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cytokine-mediated signaling pathway [GO:0019221]; forebrain neuron differentiation [GO:0021879]; hematopoietic progenitor cell differentiation [GO:0002244]; hemopoiesis [GO:0030097]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary gland duct morphogenesis [GO:0060603]; microglial cell proliferation [GO:0061518]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; olfactory bulb development [GO:0021772]; osteoclast differentiation [GO:0030316]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation by host of viral process [GO:0044794]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of bone resorption [GO:0045124]; regulation of cell shape [GO:0008360]; response to ischemia [GO:0002931]; ruffle organization [GO:0031529]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001934; GO:0002244; GO:0002931; GO:0004713; GO:0004714; GO:0005011; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0006954; GO:0007165; GO:0007169; GO:0007411; GO:0008283; GO:0008284; GO:0008285; GO:0008360; GO:0009986; GO:0010759; GO:0018108; GO:0019221; GO:0019903; GO:0019955; GO:0021772; GO:0021879; GO:0030097; GO:0030224; GO:0030225; GO:0030316; GO:0030335; GO:0031529; GO:0032722; GO:0033674; GO:0036006; GO:0038145; GO:0042531; GO:0042803; GO:0043066; GO:0043231; GO:0043235; GO:0044794; GO:0045087; GO:0045124; GO:0045217; GO:0046488; GO:0046777; GO:0048015; GO:0060603; GO:0061098; GO:0061518; GO:0070374; GO:0071345; GO:0071902; GO:0120041; GO:1990682; GO:2000147; GO:2000249 ATP binding [GO:0005524]; cytokine binding [GO:0019955]; macrophage colony-stimulating factor receptor activity [GO:0005011]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] KVMSISIRLK 0.97888 3.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2346 0 12.4815 0 0 0 0 0 0 0 11.4136 0 0 0 0 12.8809 10.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5394 13.0058 0 13.543 0 13.5696 12.6359 0 0 0 0 0 0 16.3752 0 0 16.5738 0 0 15.3545 13.4291 16.0554 14.6632 16.3 15.7535 0 0 16.0418 12.4385 0 0 0 0 0 15.238 15.0062 14.7945 15.1768 14.2551 0 0 0 0 0 14.8642 0 0 0 0 15.2308 0 0 12.4541 0 0 15.0323 14.796 0 0 0 0 0 13.2862 14.576 0 14.4455 0 0 12.7418 0 0 14.6486 13.8821 13.4562 13.3637 0 0 10.9612 12.9559 0 0 0 0 0 0 12.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGP2 OR8J1_HUMAN Olfactory receptor 8J1 (Olfactory receptor OR11-183) OR8J1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] MLINFLVKKK 0.97888 -1.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7398 0 0 0 0 0 0 0 0 0 0 13.7574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.475 0 0 13.4539 0 0 0 0 0 0 0 0 P21917 DRD4_HUMAN D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor) DRD4 Homo sapiens (Human) "adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; social behavior [GO:0035176]" centrosome [GO:0005813]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] "centrosome [GO:0005813]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adult locomotory behavior [GO:0008344]; arachidonic acid secretion [GO:0050482]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; behavioral response to ethanol [GO:0048149]; cellular calcium ion homeostasis [GO:0006874]; chemical synaptic transmission [GO:0007268]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; fear response [GO:0042596]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inhibitory postsynaptic potential [GO:0060080]; negative regulation of protein secretion [GO:0050709]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dopamine uptake involved in synaptic transmission [GO:0051586]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of sodium:proton antiporter activity [GO:0032417]; regulation of circadian rhythm [GO:0042752]; regulation of dopamine metabolic process [GO:0042053]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to amphetamine [GO:0001975]; response to histamine [GO:0034776]; rhythmic process [GO:0048511]; social behavior [GO:0035176]" GO:0001591; GO:0001662; GO:0001975; GO:0004952; GO:0004993; GO:0005813; GO:0005886; GO:0005887; GO:0006874; GO:0007187; GO:0007195; GO:0007212; GO:0007268; GO:0008344; GO:0015459; GO:0016020; GO:0017124; GO:0030425; GO:0030594; GO:0032417; GO:0033674; GO:0034776; GO:0035176; GO:0035240; GO:0042053; GO:0042417; GO:0042596; GO:0042752; GO:0042802; GO:0043406; GO:0046872; GO:0048148; GO:0048149; GO:0048511; GO:0050482; GO:0050709; GO:0051379; GO:0051380; GO:0051586; GO:0060080; GO:0098794; GO:0098978; GO:0099149; GO:1901386 "dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO:0001591]; epinephrine binding [GO:0051379]; G protein-coupled serotonin receptor activity [GO:0004993]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; SH3 domain binding [GO:0017124]" LVSAVTWLGYVNSALNPVIYTVFNAEFRNVFR 0.97894 -1.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q63ZY3 KANK2_HUMAN "KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein, SIP, SRC-interacting protein, SRC1-interacting protein)" KANK2 ANKRD25 KIAA1518 MXRA3 SIP Homo sapiens (Human) apoptotic process [GO:0006915]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; podocyte cell migration [GO:0090521]; regulation of Rho protein signal transduction [GO:0035023] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; kidney epithelium development [GO:0072073]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D receptor signaling pathway [GO:0070563]; podocyte cell migration [GO:0090521]; regulation of Rho protein signal transduction [GO:0035023] GO:0000122; GO:0005737; GO:0005739; GO:0006915; GO:0008285; GO:0033147; GO:0035023; GO:0043069; GO:0070563; GO:0072073; GO:0090521; GO:2000134 CSFAPMSDDESPTSSSAEE 0.97894 -1.2891 0 0 0 0 0 0 0 0 0 15.4365 0 0 0 0 0 0 12.0021 0 14.2639 0 0 13.5008 0 13.9193 0 0 13.3891 0 0 0 0 0 0 11.483 13.1981 0 0 0 0 0 0 13.8356 0 0 0 0 0 14.221 13.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6354 15.0542 0 0 0 0 15.2643 0 14.9784 0 0 0 0 0 12.964 0 12.0114 0 0 12.068 0 0 0 0 0 0 0 0 11.232 14.125 0 0 0 15.4702 14.6686 0 0 10.9172 0 0 15.0127 0 14.4352 0 0 0 0 12.9238 0 0 0 0 14.3821 15.0677 0 0 0 10.4683 14.3956 0 0 0 0 0 10.9322 0 0 14.6275 0 0 0 0 15.1177 11.9443 0 0 11.624 0 15.7675 0 0 0 0 0 0 0 0 0 12.3805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8824 11.1714 0 0 0 0 P07498 CASK_HUMAN Kappa-casein CSN3 CASK CSN10 CSNK Homo sapiens (Human) lactation [GO:0007595]; protein stabilization [GO:0050821] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lactation [GO:0007595]; protein stabilization [GO:0050821] GO:0005576; GO:0005615; GO:0007595; GO:0050821 PFYQKTAPYVPMYYVPNSYPYYGTNLYQR 0.97895 3.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3277 0 0 0 0 11.4531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUU7 DD19A_HUMAN "ATP-dependent RNA helicase DDX19A, EC 3.6.4.13 (DDX19-like protein) (DEAD box protein 19A)" DDX19A DDX19L Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; poly(A)+ mRNA export from nucleus [GO:0016973] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016020; GO:0016887; GO:0016973 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] FAQKVVPDPNVIKLK 0.97899 3.0472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8787 0 12.3006 0 13.9678 0 0 0 0 0 0 11.5979 0 0 13.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD36 B2L10_HUMAN "Bcl-2-like protein 10, Bcl2-L-10 (Anti-apoptotic protein Boo) (Anti-apoptotic protein NrH) (Apoptosis regulator Bcl-B)" BCL2L10 BCL-B BCLB BOO DIVA Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female gamete generation [GO:0007292]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microtubule organizing center organization [GO:0031023]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; spindle [GO:0005819] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female gamete generation [GO:0007292]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microtubule organizing center organization [GO:0031023]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; spermatogenesis [GO:0007283] GO:0005509; GO:0005739; GO:0005741; GO:0005783; GO:0005819; GO:0005829; GO:0006915; GO:0006919; GO:0007283; GO:0007292; GO:0008630; GO:0016020; GO:0016021; GO:0031023; GO:0031965; GO:0042803; GO:0043066; GO:0044233; GO:0046982; GO:0089720; GO:0097192; GO:2001243 calcium ion binding [GO:0005509]; caspase binding [GO:0089720]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] GPLVTAR 0.97907 -1.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46782 RS5_HUMAN "40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed ]" RPS5 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]; translational initiation [GO:0006413] GO:0000028; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006413; GO:0006450; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0070062; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] FRKAQCPIVER 0.97909 -1.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.675 15.6348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19971 TYPH_HUMAN "Thymidine phosphorylase, TP, EC 2.4.2.4 (Gliostatin) (Platelet-derived endothelial cell growth factor, PD-ECGF) (TdRPase)" TYMP ECGF1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969] cytosol [GO:0005829] "cytosol [GO:0005829]; 1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969]" GO:0000002; GO:0001525; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0006935; GO:0008083; GO:0009032; GO:0016154; GO:0030154; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333 "1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]" ELAKTLVGVGASLGLRVAAALTAMDK 0.97913 -1.3026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3947 0 0 0 0 14.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.006 0 0 0 0 0 0 0 Q13011 ECH1_HUMAN "Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial, EC 5.3.3.-" ECH1 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; delta(3,5)-delta(2,4)-dienoyl-CoA isomerase activity [GO:0051750]; fatty acid beta-oxidation [GO:0006635]" GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0016020; GO:0051750; GO:0070062 "delta(3,5)-delta(2,4)-dienoyl-CoA isomerase activity [GO:0051750]" DIITRYQETFNVIER 0.97919 -1.2915 0 0 0 0 0 0 0 0 0 0 13.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0895 0 0 0 0 0 0 0 0 12.567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1228 0 0 0 0 0 13.3502 0 15.6842 0 14.5564 0 0 0 13.4927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6452 0 0 0 0 13.2812 0 0 12.0772 0 0 0 0 0 0 10.4078 0 0 0 0 0 11.3319 0 0 0 0 0 0 0 0 13.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2147 12.8081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.30741 0 0 0 0 Q9P1W8 SIRPG_HUMAN "Signal-regulatory protein gamma, SIRP-gamma (CD172 antigen-like family member B) (Signal-regulatory protein beta-2, SIRP-b2, SIRP-beta-2) (CD antigen CD172g)" SIRPG SIRPB2 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T cell activation [GO:0050870] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; intracellular signal transduction [GO:0035556]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T cell activation [GO:0050870] GO:0005886; GO:0007155; GO:0007267; GO:0008284; GO:0008285; GO:0016020; GO:0016021; GO:0022409; GO:0035556; GO:0050766; GO:0050870 LALEVTVHQK 0.97919 -1.2924 0 0 0 0 0 0 0 0 0 13.4601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43261 LEU1_HUMAN Leukemia-associated protein 1 (Deleted in lymphocytic leukemia 1) (HBV X-transactivated gene 6 protein) (HBV XAg-transactivated protein 6) DLEU1 LEU1 XTP6 Homo sapiens (Human) NEEQNLQELSHNADKYQMGDCCK 0.97924 -1.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3922 12.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13682 ZNF35_HUMAN Zinc finger protein 35 (Zinc finger protein HF.10) ZNF35 Homo sapiens (Human) "cellular response to retinoic acid [GO:0071300]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to retinoic acid [GO:0071300]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007283; GO:0043565; GO:0046872; GO:0048471; GO:0071300 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]" EAMALAPWGPVKVKK 0.97925 -1.3057 0 0 0 0 0 0 0 0 0 0 13.5211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H3BNL8 ARMD2_HUMAN Armadillo-like helical domain-containing protein 2 ARMH2 C6orf229 Homo sapiens (Human) FWRVTVK 0.97932 -1.2942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0U1RQE8 GLYLB_HUMAN "Putative glycine N-acyltransferase-like protein 1B, EC 2.3.1.68" GLYATL1B Homo sapiens (Human) glutamine metabolic process [GO:0006541] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; glutamine metabolic process [GO:0006541] GO:0005739; GO:0006541; GO:0016410; GO:0047946; GO:0047961 glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410] ALLFVTEDILKLYATNK 0.97933 -1.2984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66LE6 2ABD_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta) PPP2R2D KIAA1541 Homo sapiens (Human) cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; mitotic cell cycle [GO:0000278] GO:0000159; GO:0000278; GO:0005829; GO:0010458; GO:0019888; GO:0051301 protein phosphatase regulator activity [GO:0019888] AEGYNLKDEDGR 0.97933 -1.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8757 0 0 0 14.5438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9321 0 11.7623 0 0 12.7279 12.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8426 11.9346 0 0 0 11.0578 0 0 0 0 0 0 0 0 0 0 0 0 12.0476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9204 0 0 0 0 0 0 0 0 11.0719 0 0 10.1932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17542 TAL1_HUMAN "T-cell acute lymphocytic leukemia protein 1, TAL-1 (Class A basic helix-loop-helix protein 17, bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5)" TAL1 BHLHA17 SCL TCL5 Homo sapiens (Human) "basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; hemopoiesis [GO:0030097]; megakaryocyte differentiation [GO:0030219]; positive regulation of cell division [GO:0051781]; positive regulation of chromatin organization [GO:1905269]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; basophil differentiation [GO:0030221]; cell fate commitment [GO:0045165]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; hemopoiesis [GO:0030097]; megakaryocyte differentiation [GO:0030219]; positive regulation of cell division [GO:0051781]; positive regulation of chromatin organization [GO:1905269]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0019899; GO:0030097; GO:0030218; GO:0030219; GO:0030221; GO:0031334; GO:0035162; GO:0042826; GO:0045165; GO:0045648; GO:0045893; GO:0045931; GO:0045944; GO:0046983; GO:0051781; GO:0061629; GO:0070888; GO:1905269 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]" LAMKYINFLAK 0.97936 -1.3008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1134 0 0 0 13.7269 0 0 0 0 0 12.3154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0115 13.3001 17.196 0 15.8684 0 0 0 13.5233 0 0 0 0 0 0 0 0 0 0 0 0 Q9H221 ABCG8_HUMAN "ATP-binding cassette sub-family G member 8, EC 7.6.2.- (Sterolin-2)" ABCG8 Homo sapiens (Human) bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]; triglyceride homeostasis [GO:0070328] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; phospholipid transport [GO:0015914]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]; triglyceride homeostasis [GO:0070328] GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0009410; GO:0010949; GO:0014850; GO:0015914; GO:0015918; GO:0016020; GO:0016324; GO:0030299; GO:0033344; GO:0038183; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0055085; GO:0070328; GO:0120020; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982] GHGGKIK 0.97937 -1.3056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0602 13.6136 0 13.9731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1931 0 0 0 0 0 0 0 0 0 0 12.831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9788 0 0 0 0 0 0 0 0 0 0 Q9NTK1 DEPP1_HUMAN "Protein DEPP1 (Decidual protein induced by progesterone) (Fasting-induced gene protein, FIG)" DEPP1 C10orf10 DEPP FIG Homo sapiens (Human) autophagy [GO:0006914]; regulation of autophagy [GO:0010506] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506] GO:0005737; GO:0005739; GO:0005777; GO:0006914; GO:0010506; GO:0043231 GRPAVSLR 0.97937 -1.3055 0 15.0738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NB15 ZN511_HUMAN Zinc finger protein 511 ZNF511 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] DHMVRMHLYPADFR 0.97944 -1.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4639 12.9155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ01 TECR_HUMAN "Very-long-chain enoyl-CoA reductase, EC 1.3.1.93 (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase, TER)" TECR GPSN2 SC2 Homo sapiens (Human) fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid metabolic process [GO:0006665]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid metabolic process [GO:0006665]; very long-chain fatty acid biosynthetic process [GO:0042761] GO:0005634; GO:0005783; GO:0005789; GO:0006665; GO:0016491; GO:0017099; GO:0030176; GO:0030497; GO:0035338; GO:0042761; GO:0102758 oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099] KIPYPTK 0.97944 -1.297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8119 13.0454 0 13.441 13.1094 0 13.4449 0 0 0 0 0 0 0 13.3475 0 0 18.2631 0 0 13.4969 18.3007 0 0 0 0 0 13.5852 0 0 0 13.4916 0 0 13.9247 13.66 0 0 14.0366 13.7495 13.3202 13.6741 0 0 0 0 13.8111 0 0 13.8322 13.5274 0 14.0899 0 13.6939 14.1602 0 0 13.7111 14.1903 14.1492 14.4181 14.2198 0 0 14.2608 0 13.704 0 13.9149 0 14.1512 14.0744 0 0 0 0 0 0 13.6957 14.1156 13.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0146 0 0 0 0 0 0 Q30201 HFE_HUMAN Hereditary hemochromatosis protein (HLA-H) HFE HLAH Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; hormone biosynthetic process [GO:0042446]; iron ion homeostasis [GO:0055072]; iron ion import across plasma membrane [GO:0098711]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:1904283]; negative regulation of CD8-positive, alpha-beta T cell activation [GO:2001186]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor binding [GO:1900121]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of T cell antigen processing and presentation [GO:0002626]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of ferrous iron binding [GO:1904434]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor binding [GO:1900122]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transferrin receptor binding [GO:1904437]; protein-containing complex assembly [GO:0065003]; regulation of iron ion transport [GO:0034756]; regulation of protein localization to cell surface [GO:2000008]; response to iron ion [GO:0010039]; response to iron ion starvation [GO:1990641]" apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] "apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; beta-2-microglobulin binding [GO:0030881]; co-receptor binding [GO:0039706]; signaling receptor binding [GO:0005102]; transferrin receptor binding [GO:1990459]; BMP signaling pathway [GO:0030509]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; hormone biosynthetic process [GO:0042446]; iron ion homeostasis [GO:0055072]; iron ion import across plasma membrane [GO:0098711]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:1904283]; negative regulation of CD8-positive, alpha-beta T cell activation [GO:2001186]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor binding [GO:1900121]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of T cell antigen processing and presentation [GO:0002626]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of ferrous iron binding [GO:1904434]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor binding [GO:1900122]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transferrin receptor binding [GO:1904437]; protein-containing complex assembly [GO:0065003]; regulation of iron ion transport [GO:0034756]; regulation of protein localization to cell surface [GO:2000008]; response to iron ion [GO:0010039]; response to iron ion starvation [GO:1990641]" GO:0002626; GO:0002725; GO:0005102; GO:0005615; GO:0005654; GO:0005769; GO:0005886; GO:0005887; GO:0006879; GO:0009897; GO:0010039; GO:0010628; GO:0010862; GO:0030509; GO:0030881; GO:0031410; GO:0032092; GO:0032435; GO:0034756; GO:0039706; GO:0042446; GO:0045177; GO:0045178; GO:0048260; GO:0048471; GO:0055037; GO:0055072; GO:0060586; GO:0065003; GO:0071281; GO:0090277; GO:0098711; GO:1900121; GO:1900122; GO:1904283; GO:1904434; GO:1904437; GO:1990459; GO:1990641; GO:1990712; GO:2000008; GO:2000059; GO:2000272; GO:2000273; GO:2001186 beta-2-microglobulin binding [GO:0030881]; co-receptor binding [GO:0039706]; signaling receptor binding [GO:0005102]; transferrin receptor binding [GO:1990459] ARPALLLLMLLQTAVLQGR 0.97948 3.0171 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0417 0 13.3922 0 0 0 0 0 0 0 12.4027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1711 0 0 14.2774 15.1731 0 0 0 15.1912 0 11.6574 0 0 0 0 0 0 0 0 0 0 0 0 12.6403 0 10.5031 0 0 0 0 0 0 0 0 11.4238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1769 0 12.8743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7226 14.7286 0 0 0 0 0 0 0 0 0 0 P47895 AL1A3_HUMAN "Aldehyde dehydrogenase family 1 member A3, EC 1.2.1.36 (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3, RALDH-3, RalDH3)" ALDH1A3 ALDH6 Homo sapiens (Human) apoptotic process [GO:0006915]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324]; apoptotic process [GO:0006915]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013] GO:0001758; GO:0002072; GO:0002138; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0006915; GO:0007626; GO:0021768; GO:0031076; GO:0042472; GO:0042572; GO:0042573; GO:0042574; GO:0042803; GO:0043065; GO:0048048; GO:0050885; GO:0051289; GO:0060013; GO:0060166; GO:0060324; GO:0070062; GO:0070324; GO:0070384; GO:0070403 aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324] ATANGAVENGQPDR 0.97956 3.1074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3201 0 0 0 10.5532 0 0 0 11.1476 0 0 0 14.0423 0 0 0 0 0 0 0 0 0 0 0 13.6783 0 0 0 0 0 12.9446 0 12.8246 13.8452 0 0 0 0 0 12.5008 12.2939 0 0 0 0 0 11.945 13.0308 0 0 11.9944 0 0 0 12.8969 0 12.6146 0 0 12.183 0 0 0 0 12.0166 0 14.7951 0 0 0 12.3047 0 0 0 0 0 0 0 13.0607 0 0 0 0 12.692 0 0 0 0 0 11.8623 0 0 0 0 14.4379 0 0 0 0 0 0 0 0 0 12.4094 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2166 Q9UPR5 NAC2_HUMAN Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2) SLC8A2 KIAA1087 NCX2 Homo sapiens (Human) calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104] anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; synapse [GO:0045202]; calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cognition [GO:0050890]; ion transport [GO:0006811]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104] GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015081; GO:0015085; GO:0015491; GO:0016020; GO:0016323; GO:0030001; GO:0030424; GO:0030425; GO:0035725; GO:0042383; GO:0043025; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070161; GO:0070588; GO:0071902; GO:0098703; GO:0098793; GO:0098794; GO:0098815; GO:0099608; GO:0106056; GO:0150104; GO:1903779; GO:1905060; GO:1990034 calcium ion transmembrane transporter activity [GO:0015085]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; metal ion binding [GO:0046872]; sodium ion transmembrane transporter activity [GO:0015081] EVIQILK 0.97962 3.0998 0 0 0 0 0 0 0 0 0 0 10.8471 11.9943 0 0 0 0 0 10.7792 0 0 0 0 0 0 0 0 0 10.8367 0 0 0 11.2312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4365 15.3659 0 0 0 0 0 0 0 0 0 0 13.2445 0 14.1226 0 0 0 0 0 0 0 0 0 0 0 0 11.3259 11.3456 0 0 0 0 0 0 12.1525 0 0 0 0 0 0 0 0 0 0 0 0 14.022 12.909 0 0 0 0 13.0828 0 0 0 0 0 12.6809 13.3689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1755 12.3043 0 0 0 0 0 0 Q9NQ30 ESM1_HUMAN "Endothelial cell-specific molecule 1, ESM-1" ESM1 Homo sapiens (Human) angiogenesis [GO:0001525]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hepatocyte growth factor receptor signaling pathway [GO:1902204]; sprouting angiogenesis [GO:0002040] extracellular region [GO:0005576] extracellular region [GO:0005576]; hepatocyte growth factor receptor binding [GO:0005171]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hepatocyte growth factor receptor signaling pathway [GO:1902204]; sprouting angiogenesis [GO:0002040] GO:0001525; GO:0002040; GO:0005171; GO:0005178; GO:0005576; GO:0008284; GO:1902204 hepatocyte growth factor receptor binding [GO:0005171]; integrin binding [GO:0005178] CQPSNGEDPFGEEFGICK 0.97965 3.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4463 0 0 0 0 0 0 0 11.2309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7378 0 0 0 0 0 0 0 13.1466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.11 0 0 0 0 12.1865 0 0 0 0 12.688 0 0 0 0 11.4104 12.0623 0 0 0 0 0 0 0 0 P30085 KCY_HUMAN "UMP-CMP kinase, EC 2.7.4.14 (Deoxycytidylate kinase, CK, dCMP kinase) (Nucleoside-diphosphate kinase, EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase, UMP/CMP kinase, UMP/CMPK)" CMPK1 CMK CMPK UCK UMK UMPK Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; cytidylate kinase activity [GO:0004127]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862]; uridine kinase activity [GO:0004849]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225] GO:0004127; GO:0004550; GO:0004849; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006165; GO:0006207; GO:0006225; GO:0009142; GO:0009220; GO:0015949; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0050145; GO:0070062 ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; cytidylate kinase activity [GO:0004127]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862]; uridine kinase activity [GO:0004849] IVPVEITISLLK 0.97971 3.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6419 0 0 0 11.2441 0 0 0 0 0 0 0 0 11.4952 0 0 0 10.9705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9515 0 0 0 0 0 11.1658 0 11.6542 0 0 0 0 12.8182 0 0 0 0 0 0 0 14.2148 0 0 0 0 0 0 0 0 0 0 11.6748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3YBM2 T176B_HUMAN Transmembrane protein 176B (Protein LR8) TMEM176B LR8 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; dendritic cell differentiation [GO:0097028]; negative regulation of dendritic cell differentiation [GO:2001199] integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; animal organ morphogenesis [GO:0009887]; dendritic cell differentiation [GO:0097028]; negative regulation of dendritic cell differentiation [GO:2001199] GO:0009887; GO:0016021; GO:0031965; GO:0097028; GO:2001199 EECRAYMQMLR 0.97973 3.0044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.92487 0 0 0 12.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.91 0 9.73183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4813 0 0 0 0 0 0 0 0 0 12.6542 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3749 0 0 0 10.2889 0 0 0 0 0 0 10.6301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2622 0 0 0 0 0 P16260 GDC_HUMAN "Solute carrier family 25 member 16 (Graves disease autoantigen, GDA) (Graves disease carrier protein, GDC) (Mitochondrial solute carrier protein homolog)" SLC25A16 GDA Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937]; mitochondrial transport [GO:0006839] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; secondary active transmembrane transporter activity [GO:0015291]; coenzyme A biosynthetic process [GO:0015937]; mitochondrial transport [GO:0006839] GO:0005739; GO:0005743; GO:0006839; GO:0015291; GO:0015297; GO:0015937; GO:0016021 antiporter activity [GO:0015297]; secondary active transmembrane transporter activity [GO:0015291] TIYAKEGGFFGFYR 0.98002 -1.3269 0 0 12.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1089 0 0 0 0 0 0 0 0 0 0 0 11.2355 0 0 10.9471 0 0 0 0 0 0 0 11.9981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4005 0 17.6714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9063 0 0 0 0 0 0 0 0 0 0 0 11.2339 0 13.2534 0 0 0 0 0 0 0 13.2253 0 0 0 0 0 0 0 13.1132 0 0 0 13.5159 13.7184 0 0 0 13.0127 0 0 0 0 13.4409 0 0 13.5867 0 0 0 0 0 17.8041 13.1229 0 0 0 0 13.5063 0 0 0 0 0 0 0 0 13.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.745 0 0 0 0 13.1772 0 0 0 13.4274 0 Q6PIW4 FIGL1_HUMAN "Fidgetin-like protein 1, EC 3.6.4.-" FIGNL1 Homo sapiens (Human) ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568]; ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569] GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568] ALFAVAR 0.98002 -1.326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8064 12.595 12.7815 0 12.9384 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0413 0 0 0 0 17.8283 0 0 0 0 0 0 14.4394 0 0 12.6054 0 12.7417 0 0 0 0 12.6401 0 0 0 0 0 13.1407 0 0 0 0 12.9931 0 0 0 13.2189 13.2074 0 12.8748 0 13.0146 0 0 0 0 0 13.1068 0 0 13.1877 12.9479 0 0 0 0 0 0 0 13.2064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1821 0 0 0 0 0 0 Q9NQ33 ASCL3_HUMAN "Achaete-scute homolog 3, ASH-3, hASH3 (Class A basic helix-loop-helix protein 42, bHLHa42) (bHLH transcriptional regulator Sgn-1)" ASCL3 BHLHA42 HASH3 SGN1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0006357; GO:0045944; GO:0046983; GO:0090575 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" LSKVETLRAAIK 0.98006 3.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.673 0 0 0 0 0 0 0 0 14.8953 0 0 11.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4429 0 0 0 0 0 0 0 14.1102 0 14.8507 0 0 15.0722 14.0113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.167 0 0 0 0 0 0 0 0 0 0 0 0 12.0493 0 13.6216 0 0 Q04323 UBXN1_HUMAN UBX domain-containing protein 1 (SAPK substrate protein 1) (UBA/UBX 33.3 kDa protein) UBXN1 SAKS1 Homo sapiens (Human) negative regulation of ERAD pathway [GO:1904293]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome regulatory particle binding [GO:1904855]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0031397; GO:0031593; GO:0031625; GO:0032435; GO:0034098; GO:0036435; GO:0043130; GO:0043161; GO:0051117; GO:0071796; GO:1903094; GO:1904293; GO:1904855; GO:2000157 ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome regulatory particle binding [GO:1904855]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] AFSEADMERPLQELGLVPSAVLIVAKK 0.98011 3.0663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2175 0 0 0 0 0 0 12.297 0 0 0 0 12.0739 0 0 0 11.9072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2778 0 0 0 0 0 0 0 0 0 12.9626 0 0 0 0 0 0 12.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14576 DC1I1_HUMAN "Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic, DH IC-1)" DYNC1I1 DNCI1 DNCIC1 Homo sapiens (Human) microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]; vesicle transport along microtubule [GO:0047496] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; spindle pole [GO:0000922]; vesicle [GO:0031982]; cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; spectrin binding [GO:0030507]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970]; vesicle transport along microtubule [GO:0047496] GO:0000776; GO:0000922; GO:0003774; GO:0003777; GO:0005634; GO:0005737; GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0008017; GO:0010970; GO:0030507; GO:0031982; GO:0036464; GO:0045503; GO:0045504; GO:0047496; GO:0048471; GO:0055037 cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; spectrin binding [GO:0030507] IWVYDVGELAVPHNDEWTRFARTLVEIR 0.98013 -1.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VB7 C163A_HUMAN "Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163, sCD163 ]" CD163 M130 Homo sapiens (Human) acute-phase response [GO:0006953] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953] GO:0005044; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0006953; GO:0009897; GO:0030666; GO:0097110 scaffold protein binding [GO:0097110]; scavenger receptor activity [GO:0005044] EAILSHTEK 0.9802 3.0632 0 0 0 0 0 0 0 0 0 0 0 11.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6216 0 0 12.4538 0 13.3961 0 0 0 0 0 0 14.7378 0 0 0 0 15.7147 0 11.583 14.7234 14.3758 15.2087 0 0 16.4553 16.2905 15.2933 13.8618 11.0545 0 0 0 14.0412 14.0796 0 0 0 12.6337 0 0 0 0 14.2948 13.8578 0 0 0 0 0 12.4258 0 0 0 13.2975 0 0 0 0 0 13.0525 0 0 0 12.9889 0 0 0 0 0 0 0 14.8209 0 0 0 0 0 0 0 0 0 0 0 0 15.1688 0 0 0 0 11.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NF34 ANTRL_HUMAN Anthrax toxin receptor-like ANTXRL Homo sapiens (Human) toxin transport [GO:1901998] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; toxin transport [GO:1901998] GO:0004888; GO:0005886; GO:0009986; GO:0016021; GO:0046872; GO:1901998 metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888] AHHHHGPGWR 0.98024 3.167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9503 0 0 0 0 0 0 13.3486 13.4225 13.429 0 0 0 0 0 0 0 10.4149 0 0 0 0 0 0 0 0 16.634 0 0 0 0 0 0 0 0 0 0 0 0 12.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1706 0 0 13.9061 14.2691 0 0 0 0 0 0 0 0 0 0 11.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0836 0 0 0 0 11.4689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NDB9 PALM3_HUMAN Paralemmin-3 PALM3 Homo sapiens (Human) negative regulation of cytokine-mediated signaling pathway [GO:0001960]; regulation of cell shape [GO:0008360]; response to lipopolysaccharide [GO:0032496]; Toll signaling pathway [GO:0008063] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; regulation of cell shape [GO:0008360]; response to lipopolysaccharide [GO:0032496]; Toll signaling pathway [GO:0008063] GO:0001960; GO:0005524; GO:0005737; GO:0005886; GO:0008063; GO:0008360; GO:0032496 ATP binding [GO:0005524] EGSESQAEEMNEAGPPLEANTETR 0.98025 -1.3237 0 0 0 0 0 0 0 0 0 0 11.219 11.3486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.131 0 0 13.4424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0228 0 14.3617 10.9227 0 0 0 0 0 0 0 11.8266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43521 B2L11_HUMAN "Bcl-2-like protein 11, Bcl2-L-11 (Bcl2-interacting mediator of cell death)" BCL2L11 BIM Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; B cell homeostasis [GO:0001782]; brain development [GO:0007420]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; developmental pigmentation [GO:0048066]; ear development [GO:0043583]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mammary gland development [GO:0030879]; meiosis I [GO:0007127]; myeloid cell homeostasis [GO:0002262]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy in response to ER overload [GO:0034263]; positive regulation of cell cycle [GO:0045787]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of T cell apoptotic process [GO:0070234]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of apoptotic process [GO:0042981]; regulation of developmental pigmentation [GO:0048070]; regulation of organ growth [GO:0046620]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; thymocyte apoptotic process [GO:0070242]; thymus development [GO:0048538]; tube formation [GO:0035148] Bcl-2 family protein complex [GO:0097136]; BIM-BCL-2 complex [GO:0097141]; BIM-BCL-xl complex [GO:0097140]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] Bcl-2 family protein complex [GO:0097136]; BIM-BCL-2 complex [GO:0097141]; BIM-BCL-xl complex [GO:0097140]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extrinsic component of membrane [GO:0019898]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; B cell homeostasis [GO:0001782]; brain development [GO:0007420]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; developmental pigmentation [GO:0048066]; ear development [GO:0043583]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mammary gland development [GO:0030879]; meiosis I [GO:0007127]; myeloid cell homeostasis [GO:0002262]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy in response to ER overload [GO:0034263]; positive regulation of cell cycle [GO:0045787]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of T cell apoptotic process [GO:0070234]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of apoptotic process [GO:0042981]; regulation of developmental pigmentation [GO:0048070]; regulation of organ growth [GO:0046620]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; thymocyte apoptotic process [GO:0070242]; thymus development [GO:0048538]; tube formation [GO:0035148] GO:0001701; GO:0001782; GO:0001822; GO:0002262; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0006919; GO:0007127; GO:0007160; GO:0007283; GO:0007420; GO:0008017; GO:0008584; GO:0008630; GO:0012505; GO:0019898; GO:0019901; GO:0030879; GO:0031334; GO:0034263; GO:0034976; GO:0035148; GO:0042475; GO:0042981; GO:0043029; GO:0043065; GO:0043280; GO:0043525; GO:0043583; GO:0045787; GO:0046620; GO:0048066; GO:0048070; GO:0048536; GO:0048538; GO:0048563; GO:0070234; GO:0070242; GO:0071385; GO:0071392; GO:0090200; GO:0097136; GO:0097140; GO:0097141; GO:0097192; GO:1902110; GO:1902237; GO:1902263; GO:1903896; GO:1904646; GO:2000271; GO:2001244 microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] AKQPSDVSSECDREGR 0.98027 3.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9154 0 0 0 0 0 13.4992 0 0 0 0 14.303 0 0 0 0 0 13.9085 0 0 0 0 0 0 11.8 0 0 13.8664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 0 0 13.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3471 0 0 0 0 0 0 0 0 0 0 0 0 A0A2R8YCJ5 SIM41_HUMAN Small integral membrane protein 41 SMIM41 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ASREPEPGSASGEDGDDDS 0.9803 3.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4224 0 0 0 0 0 0 0 0 0 0 10.2286 0 0 0 0 0 0 0 0 0 11.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9661 0 0 0 0 0 0 0 0 0 16.7313 0 0 0 20.7483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.833 0 10.4539 0 0 0 0 0 0 0 0 19.298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.463 0 12.0926 10.3901 18.3532 0 0 0 11.3191 0 0 0 0 0 0 0 Q8NGA6 O10H5_HUMAN Olfactory receptor 10H5 (Olfactory receptor OR19-25) (Olfactory receptor OR19-26) OR10H5 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004984; GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984] ELKVAMKK 0.98034 -1.3129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0112 0 0 0 0 12.1805 0 0 0 0 0 0 0 0 0 16.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0184 0 0 0 0 0 0 P37088 SCNNA_HUMAN "Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha, Alpha-ENaC, ENaCA) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA)" SCNN1A SCNN1 Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] GO:0001669; GO:0005737; GO:0005886; GO:0005887; GO:0006883; GO:0008217; GO:0015280; GO:0016324; GO:0031514; GO:0034706; GO:0035725; GO:0036254; GO:0050699; GO:0050891; GO:0050914; GO:0050915; GO:0055078; GO:0060170; GO:0070062; GO:0071468; GO:0097228; GO:0098719; GO:1904045; GO:1904117 ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699] GTLPHPLQRLR 0.98036 -1.3196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4313 0 12.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.349 13.3981 0 0 0 0 0 Q8TF20 ZN721_HUMAN Zinc finger protein 721 ZNF721 KIAA1982 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNRSTNLTAHK 0.98036 3.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8098 0 0 0 0 13.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7495 12.6528 12.1112 11.9618 0 0 14.1268 0 11.3923 0 0 0 0 0 15.2938 14.8343 0 0 0 0 0 0 0 11.8239 0 0 0 0 0 0 0 11.1551 0 0 0 0 0 0 0 0 13.6913 0 0 0 0 0 12.7456 0 0 11.5614 0 0 0 0 0 0 0 0 0 10.4282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.184 0 0 P42338 PK3CB_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform, PI3-kinase subunit beta, PI3K-beta, PI3Kbeta, PtdIns-3-kinase subunit beta, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta, PtdIns-3-kinase subunit p110-beta, p110beta) (Serine/threonine protein kinase PIK3CB, EC 2.7.11.1)" PIK3CB PIK3C1 Homo sapiens (Human) angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; cellular calcium ion homeostasis [GO:0006874]; chemotaxis [GO:0006935]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of autophagy [GO:0010508]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; regulation of clathrin-dependent endocytosis [GO:2000369]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein serine kinase activity [GO:0106310]; angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; cellular calcium ion homeostasis [GO:0006874]; chemotaxis [GO:0006935]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of autophagy [GO:0010508]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; regulation of clathrin-dependent endocytosis [GO:2000369]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0006935; GO:0007156; GO:0007165; GO:0007169; GO:0007186; GO:0010508; GO:0010595; GO:0010628; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030168; GO:0030496; GO:0033031; GO:0035004; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0043231; GO:0043407; GO:0043560; GO:0046854; GO:0046934; GO:0048015; GO:0051000; GO:0051897; GO:0051898; GO:0052742; GO:0052812; GO:0060055; GO:0070527; GO:0106310; GO:1900747; GO:1903298; GO:1903671; GO:2000369 "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein serine kinase activity [GO:0106310]" ALPHFILVECCKIK 0.98037 -1.3226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4443 0 0 13.2081 0 0 0 0 0 12.3621 0 0 0 0 0 13.5706 0 0 0 12.5306 0 0 0 0 12.8103 0 0 0 0 0 0 0 0 0 11.7782 11.9342 0 17.7382 0 0 16.5638 14.706 0 0 15.7199 0 0 0 0 0 0 13.0758 11.6229 0 0 0 0 0 0 0 0 14.0749 0 0 0 0 0 14.7737 0 0 0 0 0 0 0 0 0 0 16.3016 0 0 15.9753 0 0 0 0 0 0 0 13.7505 0 0 0 0 0 0 0 0 0 0 11.6887 0 0 0 0 Q13609 DNSL3_HUMAN "Deoxyribonuclease gamma, DNase gamma, EC 3.1.21.- (DNase I homolog protein DHP2) (Deoxyribonuclease I-like 3, DNase I-like 3) (Liver and spleen DNase, LS-DNase, LSD)" DNASE1L3 DHP2 DNAS1L3 Homo sapiens (Human) "apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA metabolic process [GO:0006259]; neutrophil activation involved in immune response [GO:0002283]; programmed cell death involved in cell development [GO:0010623]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]" endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634] "endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA metabolic process [GO:0006259]; neutrophil activation involved in immune response [GO:0002283]; programmed cell death involved in cell development [GO:0010623]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948]" GO:0000737; GO:0002283; GO:0002673; GO:0003677; GO:0004530; GO:0004536; GO:0005509; GO:0005576; GO:0005634; GO:0005783; GO:0006259; GO:0006308; GO:0006309; GO:0010623; GO:0070948 calcium ion binding [GO:0005509]; deoxyribonuclease activity [GO:0004536]; deoxyribonuclease I activity [GO:0004530]; DNA binding [GO:0003677] ICPILMEK 0.98037 -1.3235 0 0 0 0 0 0 0 0 0 0 13.4171 0 0 0 0 0 0 0 12.3408 0 0 0 0 0 0 12.6518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1409 0 0 0 0 0 0 0 0 0 0 0 14.4626 0 0 0 0 0 0 0 14.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9705 13.6987 0 0 0 0 0 0 0 10.67 0 0 0 12.0479 0 0 0 0 0 0 0 0 0 0 0 0 0 13.476 0 0 0 0 0 0 0 0 0 0 0 13.0092 0 12.6964 0 0 0 0 0 0 0 0 0 0 0 0 P49137 MAPK2_HUMAN "MAP kinase-activated protein kinase 2, MAPK-activated protein kinase 2, MAPKAP kinase 2, MAPKAP-K2, MAPKAPK-2, MK-2, MK2, EC 2.7.11.1" MAPKAPK2 Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; intracellular signal transduction [GO:0035556]; leukotriene metabolic process [GO:0006691]; macropinocytosis [GO:0044351]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of interleukin-6 production [GO:0032675]; regulation of mRNA stability [GO:0043488]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0000165; GO:0002224; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006691; GO:0006954; GO:0006974; GO:0009931; GO:0018105; GO:0032496; GO:0032675; GO:0032680; GO:0032760; GO:0034097; GO:0035556; GO:0035924; GO:0038066; GO:0043488; GO:0044351; GO:0046777; GO:0048010; GO:0048839; GO:0051019; GO:0060907; GO:0070062; GO:0070935; GO:0106310; GO:1900034 ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] KIEDASNPLLLK 0.98038 -1.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1319 12.9529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5601 0 0 Q92604 LGAT1_HUMAN "Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (Acyl-CoA:monoacylglycerol acyltransferase LPGAT1, EC 2.3.1.22) (Lysophospholipid acyltransferase 7, LPLAT7, EC 2.3.1.-) (Stearoyl-CoA:1-lyso-2-acyl-PE acyltransferase)" LPGAT1 FAM34A KIAA0205 Homo sapiens (Human) phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]; triglyceride biosynthetic process [GO:0019432] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophosphatidylethanolamine acyltransferase activity [GO:0071618]; lysophospholipid acyltransferase activity [GO:0071617]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]; triglyceride biosynthetic process [GO:0019432] GO:0003841; GO:0003846; GO:0005737; GO:0005783; GO:0005789; GO:0008654; GO:0012505; GO:0016020; GO:0016021; GO:0016746; GO:0019432; GO:0036148; GO:0036149; GO:0036152; GO:0045723; GO:0047144; GO:0071617; GO:0071618 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746]; lysophosphatidylethanolamine acyltransferase activity [GO:0071618]; lysophospholipid acyltransferase activity [GO:0071617] FWYIEGIMYK 0.98042 3.0426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2C5 S17A4_HUMAN Probable small intestine urate exporter (Solute carrier family 17 member 4) SLC17A4 Homo sapiens (Human) anion transport [GO:0006820]; phosphate-containing compound metabolic process [GO:0006796]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; phosphate-containing compound metabolic process [GO:0006796]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814] GO:0005436; GO:0005764; GO:0005887; GO:0006796; GO:0006814; GO:0006820; GO:0015136; GO:0015739; GO:0016020; GO:0016021; GO:0016324; GO:0022857 sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857] KILRLITIR 0.98045 3.0406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1493 0 10.6109 0 0 0 13.6238 0 0 0 0 0 0 0 12.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1904 0 0 0 0 0 0 0 15.3492 14.689 0 15.446 15.0083 14.9604 14.409 0 14.4278 14.596 14.1119 14.6808 14.36 14.009 14.0172 0 0 13.7813 0 13.5214 13.0745 13.8864 14.3165 14.7013 13.6077 0 0 0 13.9224 14.3806 13.5513 0 13.891 0 12.9263 0 12.9123 0 14.7575 11.6333 0 0 0 13.1313 0 0 0 12.5771 0 12.9316 0 0 13.1793 0 0 0 12.7851 0 12.5692 12.2563 0 13.0748 0 0 0 0 0 0 0 0 0 14.5596 0 0 13.1514 0 11.797 0 0 0 0 0 0 14.8112 0 12.2695 0 13.3868 0 0 0 0 0 12.0568 0 0 0 Q06190 P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B) PPP2R3A PPP2R3 Homo sapiens (Human) eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244] protein phosphatase type 2A complex [GO:0000159] protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; Wnt signaling pathway involved in somitogenesis [GO:0090244] GO:0000159; GO:0001754; GO:0005509; GO:0006470; GO:0007525; GO:0019888; GO:0030674; GO:0045732; GO:0061053; GO:0090090; GO:0090244; GO:0090249; GO:0090263 calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674] ALLLRILESIEDFAQELVECK 0.98048 -1.3194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9479 0 0 0 0 0 0 0 0 0 0 13.8264 0 0 0 0 0 0 0 0 0 0 0 12.8995 0 13.0956 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9987 0 0 13.2653 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9488 13.8428 0 0 0 0 13.0385 0 0 0 0 14.0641 0 0 0 14.6725 0 0 0 0 0 0 0 0 12.3152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1534 0 0 0 0 0 14.6213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.597 0 0 11.8681 0 0 0 0 12.3633 0 0 0 0 0 0 12.3176 12.4801 0 0 0 0 0 0 0 0 Q96KS9 F167A_HUMAN Protein FAM167A FAM167A C8orf13 Homo sapiens (Human) LIGVTKMNINSRR 0.98048 -1.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYT1 S17A9_HUMAN Solute carrier family 17 member 9 SLC17A9 C20orf59 Homo sapiens (Human) ADP transport [GO:0015866]; ATP export [GO:1904669]; ATP transport [GO:0015867]; exocytosis [GO:0006887]; guanine nucleotide transmembrane transport [GO:1903790] chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021] chromaffin granule membrane [GO:0042584]; integral component of membrane [GO:0016021]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; guanine nucleotide transmembrane transporter activity [GO:0001409]; ADP transport [GO:0015866]; ATP export [GO:1904669]; ATP transport [GO:0015867]; exocytosis [GO:0006887]; guanine nucleotide transmembrane transport [GO:1903790] GO:0001409; GO:0005347; GO:0006887; GO:0015217; GO:0015866; GO:0015867; GO:0016021; GO:0042584; GO:1903790; GO:1904669 ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; guanine nucleotide transmembrane transporter activity [GO:0001409] ILMGLLQGVYFPALTSLLSQK 0.98048 -1.3217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63003 0 0 0 0 0 0 0 0 0 0 11.222 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08173 ACM4_HUMAN Muscarinic acetylcholine receptor M4 CHRM4 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; cell surface receptor signaling pathway [GO:0007166]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of locomotion [GO:0040012]; signal transduction [GO:0007165]" anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; cell surface receptor signaling pathway [GO:0007166]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of locomotion [GO:0040012]; signal transduction [GO:0007165]" GO:0004993; GO:0005886; GO:0005887; GO:0007165; GO:0007166; GO:0007187; GO:0007197; GO:0007213; GO:0007268; GO:0016907; GO:0030425; GO:0030594; GO:0040012; GO:0045202; GO:0045211; GO:0070161 G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] AKTLAFLKSPLMK 0.98059 -1.3143 0 10.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3178 0 0 0 0 0 0 0 0 0 10.5616 0 0 0 10.3364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2127 0 0 0 0 12.2969 10.8674 0 0 0 0 0 0 0 0 0 0 12.7697 0 0 0 0 0 0 0 0 0 0 0 11.5085 0 0 0 11.7337 0 0 0 0 0 0 0 0 0 0 11.2904 0 17.3789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6E213 AWAT2_HUMAN "Acyl-CoA wax alcohol acyltransferase 2, EC 2.3.1.75 (11-cis-specific retinyl-ester synthase, 11-cis-RE-synthase) (Acyl-CoA retinol O-fatty-acyltransferase, ARAT, Retinol O-fatty-acyltransferase, EC 2.3.1.76) (Diacylglycerol O-acyltransferase 2-like protein 4) (Diacylglycerol O-acyltransferase candidate 4, hDC4) (Long-chain-alcohol O-fatty-acyltransferase 2) (Multifunctional O-acyltransferase) (Wax synthase, hWS)" AWAT2 DC4 DGAT2L4 MFAT WS Homo sapiens (Human) acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252]; acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; retinoid metabolic process [GO:0001523]; wax biosynthetic process [GO:0010025] GO:0001523; GO:0003846; GO:0005789; GO:0006629; GO:0006640; GO:0010025; GO:0016021; GO:0036155; GO:0047196; GO:0050252; GO:0102966 2-acylglycerol O-acyltransferase activity [GO:0003846]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; retinol O-fatty-acyltransferase activity [GO:0050252] FGISETQELEII 0.98059 -1.3172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7245 13.7021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5145 Q9NXG6 P4HTM_HUMAN "Transmembrane prolyl 4-hydroxylase, P4H-TM, EC 1.14.11.29 (Hypoxia-inducible factor prolyl hydroxylase 4, HIF-PH4, HIF-prolyl hydroxylase 4, HPH-4)" P4HTM PH4 Homo sapiens (Human) peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646] GO:0004656; GO:0005506; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0016706; GO:0018401; GO:0031418; GO:0045646 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656] LIIHLAQMK 0.98059 -1.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1209 0 0 14.2171 13.2398 0 0 11.9663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5106 0 0 0 0 0 0 0 0 0 12.2644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6384 0 0 0 0 11.4339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4138 0 Q9BSF4 TIM29_HUMAN "Mitochondrial import inner membrane translocase subunit Tim29, TIM29" TIMM29 c19orf52 Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; protein transporter activity [GO:0140318]; protein insertion into mitochondrial inner membrane [GO:0045039] GO:0005743; GO:0005758; GO:0016021; GO:0042721; GO:0045039; GO:0140318 protein transporter activity [GO:0140318] ALLRDYAEACRDASAEAR 0.98082 3.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8941 0 0 0 0 0 0 0 0 0 13.2943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2X3 CLC4M_HUMAN "C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein, DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2, DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin, L-SIGN) (CD antigen CD299)" CLEC4M CD209L CD209L1 CD299 Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; peptide antigen transport [GO:0046968]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; peptide antigen transport [GO:0046968]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062] GO:0001618; GO:0002250; GO:0005537; GO:0005576; GO:0005737; GO:0005887; GO:0007159; GO:0009897; GO:0009988; GO:0016020; GO:0019062; GO:0019065; GO:0019079; GO:0019882; GO:0030246; GO:0030369; GO:0035556; GO:0038023; GO:0042605; GO:0043657; GO:0045087; GO:0046718; GO:0046790; GO:0046813; GO:0046872; GO:0046968; GO:0048306; GO:0075733 calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618] AAVGELPEK 0.98087 -1.3326 0 0 0 0 0 0 0 0 0 0 0 0 9.68041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3018 0 0 0 0 0 0 0 0 0 12.4111 0 0 0 0 12.2384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBS8 RNF14_HUMAN "E3 ubiquitin-protein ligase RNF14, EC 2.3.2.31 (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein)" RNF14 ARA54 HRIHFB2038 Homo sapiens (Human) "androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; androgen receptor signaling pathway [GO:0030521]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000151; GO:0000209; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0016567; GO:0019787; GO:0030521; GO:0031624; GO:0032436; GO:0045893; GO:0046872; GO:0050681; GO:0060765; GO:0061630 metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787] ELVEAELFARYDR 0.98087 -1.3316 0 0 0 0 0 0 0 0 0 0 10.9115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3888 11.6773 0 0 0 0 10.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5651 0 0 0 0 0 13.0926 0 13.5933 0 0 0 0 13.397 0 13.2373 12.9944 0 0 13.4303 0 0 0 0 0 0 14.9061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69115 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNK0 STX8_HUMAN Syntaxin-8 STX8 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0005484; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005802; GO:0005829; GO:0005887; GO:0006886; GO:0006906; GO:0008333; GO:0012505; GO:0016021; GO:0019869; GO:0019905; GO:0031201; GO:0031625; GO:0031902; GO:0031982; GO:0045022; GO:0045335; GO:0048278; GO:0048471; GO:0055037; GO:0071346; GO:1903076 chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625] ALLQNLKEKIALLK 0.98097 3.1112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1692 10.7658 0 0 11.428 11.6749 0 0 14.3213 0 0 0 13.1431 0 0 13.1705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7207 0 0 0 0 0 0 0 14.16 14.276 0 0 0 0 0 0 0 12.2073 0 0 0 0 0 0 0 0 0 11.4 0 0 12.9685 0 0 0 0 0 0 0 0 13.5406 0 14.7063 0 0 0 0 0 0 0 0 0 0 0 0 13.4413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0447 0 0 0 0 0 0 0 13.2816 0 Q8NBM4 UBAC2_HUMAN "Ubiquitin-associated domain-containing protein 2, UBA domain-containing protein 2 (Phosphoglycerate dehydrogenase-like protein 1)" UBAC2 PHGDHL1 PSEC0110 Homo sapiens (Human) "negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]" GO:0005783; GO:0005789; GO:0016021; GO:0016055; GO:0070972; GO:0090090; GO:1904153 APLSKSLLLVPSALSLLLALLLPHCQK 0.98099 3.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8346 0 0 0 0 0 0 0 0 0 0 0 16.1884 0 13.9799 14.1986 14.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2545 0 0 0 12.86 0 0 0 0 0 0 13.2066 0 0 0 11.5454 0 13.0116 0 12.8411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02833 RASF7_HUMAN Ras association domain-containing protein 7 (HRAS1-related cluster protein 1) RASSF7 C11orf13 HRC1 Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165] GO:0005737; GO:0006915; GO:0007165; GO:0034451; GO:0070507 FVLVQRLREK 0.981 -1.3333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61966 AP1S1_HUMAN AP-1 complex subunit sigma-1A (Adaptor protein complex AP-1 subunit sigma-1A) (Adaptor-related protein complex 1 subunit sigma-1A) (Clathrin assembly protein complex 1 sigma-1A small chain) (Clathrin coat assembly protein AP19) (Golgi adaptor HA1/AP1 adaptin sigma-1A subunit) (HA1 19 kDa subunit) (Sigma 1a subunit of AP-1 clathrin) (Sigma-adaptin 1A) (Sigma1A-adaptin) AP1S1 AP19 CLAPS1 Homo sapiens (Human) basolateral protein secretion [GO:0110010]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; receptor-mediated endocytosis [GO:0006898]; response to virus [GO:0009615]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; clathrin adaptor activity [GO:0035615]; basolateral protein secretion [GO:0110010]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; receptor-mediated endocytosis [GO:0006898]; response to virus [GO:0009615]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0006898; GO:0009615; GO:0016020; GO:0016192; GO:0030121; GO:0030659; GO:0032588; GO:0035615; GO:0043231; GO:0060155; GO:0110010; GO:1903232 clathrin adaptor activity [GO:0035615] DLKVVYKR 0.98104 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NK89 RASFA_HUMAN Ras association domain-containing protein 10 RASSF10 Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; nervous system development [GO:0007399]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; signal transduction [GO:0007165] GO:0000922; GO:0005815; GO:0005829; GO:0007165; GO:0007399; GO:0050769; GO:2000179 GFERILPNKTR 0.98106 3.0049 0 0 0 0 0 13.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1237 0 0 0 13.8995 0 0 0 0 0 0 0 0 14.0015 0 0 0 0 0 0 0 0 0 0 0 0 10.7787 0 0 0 0 0 0 0 0 13.3773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1491 0 0 Q8NCQ2 CNAS1_HUMAN Uncharacterized protein CSNK1G2-AS1 (CSNK1G2 antisense RNA 1) (CSNK1G2 antisense gene protein 1) CSNK1G2-AS1 C19orf34 Homo sapiens (Human) PWQKPTSPRR 0.98111 -1.3333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61326 MGN_HUMAN Protein mago nashi homolog MAGOH MAGOHA Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA processing [GO:0050684]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; exon-exon junction subcomplex mago-y14 [GO:1990501]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; exon-exon junction subcomplex mago-y14 [GO:1990501]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA processing [GO:0050684]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]" GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006406; GO:0006417; GO:0008380; GO:0016607; GO:0035145; GO:0050684; GO:0071013; GO:1990501; GO:2000622 RNA binding [GO:0003723] CLVFSLIGLHFKIK 0.98114 -1.3397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1012 0 0 0 0 0 0 0 0 12.5992 0 0 0 0 0 0 0 12.5534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.185 0 0 0 12.7939 0 0 12.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV47 DUS26_HUMAN "Dual specificity protein phosphatase 26, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity phosphatase SKRP3) (Low-molecular-mass dual-specificity phosphatase 4, DSP-4, LDP-4) (Mitogen-activated protein kinase phosphatase 8, MAP kinase phosphatase 8, MKP-8) (Novel amplified gene in thyroid anaplastic cancer)" DUSP26 DUSP24 LDP4 MKP8 NATA1 SKRP3 Homo sapiens (Human) negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase phosphatase activity [GO:0033549]; myosin phosphatase activity [GO:0017018]; p53 binding [GO:0002039]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; protein dephosphorylation [GO:0006470] GO:0000122; GO:0002039; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006470; GO:0008138; GO:0017018; GO:0033549; GO:0043409; GO:0045785; GO:0061629; GO:0070062; GO:0070373 MAP kinase phosphatase activity [GO:0033549]; myosin phosphatase activity [GO:0017018]; p53 binding [GO:0002039]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] ALSQPGGK 0.98114 -1.3391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4669 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3989 0 17.1683 0 0 0 0 0 0 0 0 0 0 0 0 11.6644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92535 PIGC_HUMAN "Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (Phosphatidylinositol-glycan biosynthesis class C protein, PIG-C)" PIGC GPI2 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; catalytic activity [GO:0003824]; GPI anchor biosynthetic process [GO:0006506] GO:0000506; GO:0003824; GO:0005789; GO:0006506; GO:0016021 catalytic activity [GO:0003824] KLKACTPR 0.98115 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBI6 GBG12_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 GNG12 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; PDZ domain binding [GO:0030165]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165] GO:0005834; GO:0005886; GO:0007165; GO:0007186; GO:0030165; GO:0031681; GO:0070062 G-protein beta-subunit binding [GO:0031681]; PDZ domain binding [GO:0030165] DKKTCIIL 0.98115 -1.3802 0 0 0 0 0 0 0 0 0 11.4735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5037 0 15.9405 0 13.6184 0 0 0 0 0 13.2979 0 0 0 0 0 0 0 0 0 13.88 0 15.856 Q02577 HEN2_HUMAN "Helix-loop-helix protein 2, HEN-2 (Class A basic helix-loop-helix protein 34, bHLHa34) (Nescient helix loop helix 2, NSCL-2)" NHLH2 BHLHA34 HEN2 KIAA0490 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration in hindbrain [GO:0021535]; central nervous system development [GO:0007417]; hypothalamus gonadotrophin-releasing hormone neuron development [GO:0021888]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; ovulation cycle [GO:0042698]; peripheral nervous system development [GO:0007422]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; apoptotic process [GO:0006915]; cell migration in hindbrain [GO:0021535]; central nervous system development [GO:0007417]; hypothalamus gonadotrophin-releasing hormone neuron development [GO:0021888]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; ovulation cycle [GO:0042698]; peripheral nervous system development [GO:0007422]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0006915; GO:0007417; GO:0007422; GO:0008584; GO:0021535; GO:0021888; GO:0042698; GO:0045944; GO:0046983; GO:0051091; GO:0060179; GO:0061629; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" LLPTLPPDK 0.98123 -1.3333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96F05 CK024_HUMAN Uncharacterized protein C11orf24 (Protein DM4E3) C11orf24 FP2568 UNQ1872/PRO4315 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005794; GO:0005886; GO:0016021; GO:0043231 MWKGLVKR 0.98126 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2573 0 0 0 0 0 0 16.7064 0 0 0 0 0 0 0 0 0 0 0 0 16.7893 0 0 0 0 0 0 17.2159 17.3563 17.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5084 0 0 0 0 16.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1M0 N62CL_HUMAN Nucleoporin-62 C-terminal-like protein NUP62CL NUP62L Homo sapiens (Human) protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] nuclear pore central transport channel [GO:0044613] nuclear pore central transport channel [GO:0044613]; phospholipid binding [GO:0005543]; structural constituent of nuclear pore [GO:0017056]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] GO:0005543; GO:0006405; GO:0006606; GO:0017056; GO:0044613 phospholipid binding [GO:0005543]; structural constituent of nuclear pore [GO:0017056] ILHGEVNKVK 0.98126 -1.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1863 0 0 0 0 0 0 10.4365 0 0 0 12.5899 0 0 0 10.9609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18848 ATF4_HUMAN "Cyclic AMP-dependent transcription factor ATF-4, cAMP-dependent transcription factor ATF-4 (Activating transcription factor 4) (Cyclic AMP-responsive element-binding protein 2, CREB-2, cAMP-responsive element-binding protein 2) (Tax-responsive enhancer element-binding protein 67, TaxREB67)" ATF4 CREB2 TXREB Homo sapiens (Human) "bone mineralization [GO:0030282]; cellular calcium ion homeostasis [GO:0006874]; cellular response to amino acid starvation [GO:0034198]; cellular response to dopamine [GO:1903351]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to UV [GO:0034644]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; endoplasmic reticulum unfolded protein response [GO:0030968]; gamma-aminobutyric acid signaling pathway [GO:0007214]; gluconeogenesis [GO:0006094]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; L-asparagine metabolic process [GO:0070982]; lens fiber cell morphogenesis [GO:0070309]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron differentiation [GO:0030182]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of apoptotic process [GO:0043065]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061395]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of osteoblast differentiation [GO:0045667]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]; transcription by RNA polymerase II [GO:0006366]" ATF1-ATF4 transcription factor complex [GO:1990590]; ATF4-CREB1 transcription factor complex [GO:1990589]; CHOP-ATF4 complex [GO:1990617]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; Lewy body core [GO:1990037]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575] "ATF1-ATF4 transcription factor complex [GO:1990590]; ATF4-CREB1 transcription factor complex [GO:1990589]; CHOP-ATF4 complex [GO:1990617]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; Lewy body core [GO:1990037]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; cAMP response element binding protein binding [GO:0008140]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; bone mineralization [GO:0030282]; cellular calcium ion homeostasis [GO:0006874]; cellular response to amino acid starvation [GO:0034198]; cellular response to dopamine [GO:1903351]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to UV [GO:0034644]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; endoplasmic reticulum unfolded protein response [GO:0030968]; gamma-aminobutyric acid signaling pathway [GO:0007214]; gluconeogenesis [GO:0006094]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; L-asparagine metabolic process [GO:0070982]; lens fiber cell morphogenesis [GO:0070309]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron differentiation [GO:0030182]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of apoptotic process [GO:0043065]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061395]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of osteoblast differentiation [GO:0045667]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006094; GO:0006355; GO:0006357; GO:0006366; GO:0006874; GO:0007214; GO:0008022; GO:0008140; GO:0009636; GO:0010575; GO:0010628; GO:0016607; GO:0019901; GO:0030182; GO:0030282; GO:0030968; GO:0031667; GO:0032057; GO:0032590; GO:0032922; GO:0032991; GO:0034198; GO:0034399; GO:0034599; GO:0034644; GO:0034976; GO:0035162; GO:0036003; GO:0036091; GO:0036499; GO:0042149; GO:0042789; GO:0042802; GO:0043005; GO:0043065; GO:0043267; GO:0043522; GO:0043525; GO:0043565; GO:0045667; GO:0045893; GO:0045943; GO:0045944; GO:0046982; GO:0048167; GO:0061395; GO:0061629; GO:0070059; GO:0070169; GO:0070309; GO:0070982; GO:0090575; GO:0090650; GO:0120163; GO:0140296; GO:0140467; GO:0140468; GO:1903204; GO:1903351; GO:1905461; GO:1990037; GO:1990253; GO:1990440; GO:1990589; GO:1990590; GO:1990617; GO:1990737; GO:1990837; GO:1990841; GO:2000120 "cAMP response element binding protein binding [GO:0008140]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" VKGEKLDK 0.98127 -1.3802 0 0 0 0 0 0 0 0 13.4578 14.0006 0 13.7819 13.8109 13.3194 13.7326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4029 13.2999 13.1739 12.6946 0 0 0 12.8016 0 0 0 0 0 0 13.0105 0 13.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y679 AUP1_HUMAN Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1) AUP1 Homo sapiens (Human) "ER-associated misfolded protein catabolic process [GO:0071712]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipophagy [GO:0061724]; protein localization to lipid droplet [GO:1990044]; response to virus [GO:0009615]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; membrane [GO:0016020] "autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; lipid droplet [GO:0005811]; membrane [GO:0016020]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ER-associated misfolded protein catabolic process [GO:0071712]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipophagy [GO:0061724]; protein localization to lipid droplet [GO:1990044]; response to virus [GO:0009615]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000839; GO:0005776; GO:0005783; GO:0005811; GO:0009615; GO:0016020; GO:0030176; GO:0030433; GO:0030970; GO:0031410; GO:0031624; GO:0031625; GO:0034389; GO:0043130; GO:0061724; GO:0070062; GO:0071712; GO:0097027; GO:0140042; GO:1990044 ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027] GFMEMNGR 0.98127 -1.3406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1274 13.5315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1193 0 0 0 0 0 0 0 0 0 0 0 0 11.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NC62 RAKDN_HUMAN Putative RBAK downstream neighbor protein RBAKDN Homo sapiens (Human) LTPRKAFR 0.98128 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30968 GNRHR_HUMAN "Gonadotropin-releasing hormone receptor, GnRH receptor, GnRH-R" GNRHR GRHR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; gonadotropin secretion [GO:0032274] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186]; gonadotropin secretion [GO:0032274] GO:0004930; GO:0004968; GO:0005886; GO:0005887; GO:0007186; GO:0016020; GO:0032274; GO:0042277 G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277] IRVTVTFFLFLLSATFNASFLLK 0.98137 -1.3364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8731 0 0 10.3006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5099 0 0 0 0 0 0 0 0 Q9NVQ4 FAIM1_HUMAN Fas apoptotic inhibitory molecule 1 FAIM FAIM1 Homo sapiens (Human) apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of neurogenesis [GO:0050769] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of neurogenesis [GO:0050769] GO:0005737; GO:0006915; GO:0007249; GO:0050769; GO:1902042 EEIRKEWMFK 0.98137 -1.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3565 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6732 12.8618 12.6282 12.7927 0 0 0 0 10.1162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5274 0 0 0 0 0 0 0 0 0 14.6503 0 0 13.7732 13.489 0 0 0 0 0 0 0 0 0 0 0 0 P25440 BRD2_HUMAN Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein) BRD2 KIAA9001 RING3 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; chromatin remodeling [GO:0006338]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000785; GO:0001843; GO:0003682; GO:0004674; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0006468; GO:0007283; GO:0016607; GO:0070577 chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674] HPMDLSTVKR 0.98138 -1.3382 0 0 13.1747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8681 0 0 0 0 0 11.2622 0 0 0 0 0 0 0 0 14.4269 0 14.0736 13.9175 0 0 13.6532 13.7635 0 0 0 14.837 14.2416 0 0 0 0 13.5074 14.6676 0 0 11.0895 11.2959 13.4861 0 15.2852 13.2494 14.2011 13.4863 0 12.0974 0 0 0 0 0 0 14.3643 0 10.9034 0 13.705 0 13.5082 0 0 0 13.2047 13.3614 12.9367 0 0 0 0 0 0 13.2231 0 0 0 0 13.1201 0 0 0 0 0 13.3039 0 0 0 14.4303 14.4493 0 13.179 0 13.1657 12.7908 0 0 0 0 0 0 11.3414 0 11.475 0 0 0 0 12.4281 0 0 0 0 10.9989 0 P56385 ATP5I_HUMAN "ATP synthase subunit e, mitochondrial, ATPase subunit e (ATP synthase membrane subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed ]" ATP5ME ATP5I ATP5K Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776 proton transmembrane transporter activity [GO:0015078] IAAEEKKK 0.98138 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13087 PDIA2_HUMAN "Protein disulfide-isomerase A2, EC 5.3.4.1 (Pancreas-specific protein disulfide isomerase, PDIp)" PDIA2 PDIP Homo sapiens (Human) protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein retention in ER lumen [GO:0006621]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; disulfide oxidoreductase activity [GO:0015036]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; steroid binding [GO:0005496]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein retention in ER lumen [GO:0006621]; response to endoplasmic reticulum stress [GO:0034976] GO:0003756; GO:0005496; GO:0005783; GO:0005788; GO:0006457; GO:0006621; GO:0015035; GO:0015036; GO:0034975; GO:0034976 disulfide oxidoreductase activity [GO:0015036]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; steroid binding [GO:0005496] AEAAPTLRLVNLETTK 0.9814 3.0795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5919 0 0 12.2961 0 0 0 0 0 0 0 11.0167 0 0 0 0 0 0 0 0 0 0 0 0 13.082 0 0 0 10.0531 11.9128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6017 0 0 0 0 0 10.7058 0 0 11.9321 12.0158 0 12.8329 0 14.9329 15.9759 15.5624 15.8899 16.3496 14.3729 16.873 15.9492 15.8098 15.1052 16.9894 13.7433 14.3144 15.3234 14.8044 16.3694 15.4914 17.0514 15.634 12.7441 13.911 13.7542 15.0211 12.9192 15.8606 15.2302 15.9473 14.8957 13.125 13.7887 13.7619 14.0815 0 15.4377 14.7111 16.2449 0 14.6096 0 0 11.7284 14.906 13.9083 15.5359 14.2304 16.4887 14.5579 14.6182 15.0438 12.9823 0 12.2336 0 14.1423 13.9868 14.2868 15.3313 14.481 13.7983 15.9373 14.2095 10.8717 15.3001 14.3798 14.3696 14.9001 0 0 0 0 13.1221 14.7282 0 13.9417 0 0 12.8056 0 0 11.0495 0 11.3351 0 0 12.5807 11.2238 0 13.7619 11.62 0 11.3558 14.5989 14.1555 13.9224 0 0 0 0 0 0 Q8IWL3 HSC20_HUMAN "Iron-sulfur cluster co-chaperone protein HscB (DnaJ homolog subfamily C member 20) [Cleaved into: Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic, C-HSC20; Iron-sulfur cluster co-chaperone protein HscB, mitochondrial ]" HSCB DNAJC20 HSC20 Homo sapiens (Human) [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; primitive erythrocyte differentiation [GO:0060319]; primitive hemopoiesis [GO:0060215]; protein complex oligomerization [GO:0051259] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; primitive erythrocyte differentiation [GO:0060319]; primitive hemopoiesis [GO:0060215]; protein complex oligomerization [GO:0051259] GO:0001671; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016226; GO:0042802; GO:0044571; GO:0046872; GO:0051087; GO:0051259; GO:0060215; GO:0060319 ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] DFSEKHSTLVNDAYK 0.98144 -1.3628 14.8755 0 13.0833 0 0 13.6561 0 15.6664 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8761 0 15.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3704 16.3138 16.2411 16.3966 16.3662 16.5153 15.1596 14.992 15.0064 18.6755 18.7003 18.6623 0 0 11.3361 22.6371 14.0998 22.5583 9.98456 0 0 19.8607 0 19.7641 0 17.3763 0 0 19.7433 19.0122 21.4896 14.6826 20.2763 0 0 0 18.3645 0 0 19.6099 18.795 18.035 0 0 0 19.6529 0 19.5569 0 0 0 0 0 0 11.1037 0 0 19.5574 0 17.8615 0 20.5944 20.2474 18.2608 19.0284 0 19.9234 19.6407 0 0 0 19.8415 14.1654 0 13.9878 0 0 19.099 0 18.8811 18.5628 0 0 0 0 18.2695 0 0 0 10.9614 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5144 0 0 15.9173 15.2928 14.642 0 0 0 14.866 0 Q9Y4E6 WDR7_HUMAN WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG) WDR7 KIAA0541 TRAG Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244; GO:0005737 AKGEILRVIEILIEK 0.98146 3.0749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3047 0 0 0 0 0 0 0 0 0 0 0 0 15.95 0 12.7089 0 0 0 14.2909 14.56 13.2449 0 13.1628 0 14.7696 0 0 0 14.3098 13.6813 11.068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3888 0 0 12.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8487 0 0 0 0 15.5234 P35318 ADML_HUMAN "Pro-adrenomedullin [Cleaved into: Adrenomedullin, AM; Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide, PAMP, ProAM-N20) ]" ADM AM Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; calcium ion homeostasis [GO:0055074]; cAMP-mediated signaling [GO:0019933]; cell population proliferation [GO:0008283]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; calcium ion homeostasis [GO:0055074]; cAMP-mediated signaling [GO:0019933]; cell population proliferation [GO:0008283]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] GO:0001570; GO:0001666; GO:0001843; GO:0002026; GO:0002031; GO:0003073; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0006954; GO:0007165; GO:0007189; GO:0007204; GO:0007507; GO:0007565; GO:0007568; GO:0008209; GO:0008283; GO:0008284; GO:0008285; GO:0009409; GO:0009611; GO:0010460; GO:0019731; GO:0019933; GO:0031100; GO:0031102; GO:0031623; GO:0031700; GO:0032496; GO:0032868; GO:0035809; GO:0042475; GO:0042594; GO:0043065; GO:0043116; GO:0045766; GO:0045906; GO:0046879; GO:0048589; GO:0050829; GO:0050830; GO:0051384; GO:0055074; GO:0060670; GO:0060712; GO:0061844; GO:0097084; GO:0097647; GO:1990410; GO:2000184; GO:2001214 adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102] WALSRGKR 0.98149 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T442 CXG2_HUMAN "Gap junction gamma-2 protein (Connexin-46.6, Cx46.6) (Connexin-47, Cx47) (Gap junction alpha-12 protein)" GJC2 GJA12 Homo sapiens (Human) brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cell-cell signaling [GO:0007267]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; regulation of protein phosphorylation [GO:0001932]; response to toxic substance [GO:0009636] connexin complex [GO:0005922]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; proximal neuron projection [GO:1990769] connexin complex [GO:0005922]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; proximal neuron projection [GO:1990769]; gap junction channel activity [GO:0005243]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763]; brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cell-cell signaling [GO:0007267]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; regulation of protein phosphorylation [GO:0001932]; response to toxic substance [GO:0009636] GO:0001932; GO:0005243; GO:0005921; GO:0005922; GO:0007267; GO:0007420; GO:0009636; GO:0010628; GO:0010644; GO:0016021; GO:0033270; GO:0043204; GO:0043209; GO:0070447; GO:1903763; GO:1904427; GO:1990769; GO:2000134 gap junction channel activity [GO:0005243]; gap junction channel activity involved in cell communication by electrical coupling [GO:1903763] FWVFQIVVISTPSVMYLGYAVHRLARASEQER 0.98149 -1.3379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6352 13.4209 0 0 0 0 0 0 0 0 0 0 0 12.3842 0 0 0 0 0 0 11.9299 0 0 0 0 0 0 12.3195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2985 0 0 12.3459 13.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2922 0 0 0 0 16.1748 0 Q86UA6 RIP_HUMAN "RPA-interacting protein, hRIP" RPAIN RIP Homo sapiens (Human) DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; protein import into nucleus [GO:0006606]; response to UV [GO:0009411] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; protein import into nucleus [GO:0006606]; response to UV [GO:0009411] GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0006310; GO:0006606; GO:0009411; GO:0016605; GO:0044877; GO:0046872 metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877] DRLLNRYR 0.9815 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3032 0 0 P26373 RL13_HUMAN 60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13) RPL13 BBC1 OK/SW-cl.46 Homo sapiens (Human) blastocyst development [GO:0001824]; bone development [GO:0060348]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; blastocyst development [GO:0001824]; bone development [GO:0060348]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0001824; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0060348 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] LATQLTGPVMPVRNVYKK 0.98156 -1.3616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9798 0 0 0 0 0 0 0 0 0 0 11.4183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57999 11.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB55 CP343_HUMAN "Cytochrome P450 3A43, EC 1.14.14.1" CYP3A43 Homo sapiens (Human) oxidative demethylation [GO:0070989] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidative demethylation [GO:0070989] GO:0004497; GO:0005506; GO:0005789; GO:0020037; GO:0070330; GO:0070989; GO:0101020 aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497] ETQIPLK 0.98159 3.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8371 0 0 0 0 0 15.6602 0 0 0 0 0 0 0 0 0 13.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3266 0 15.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8013 0 0 0 15.0672 0 0 0 0 15.0753 15.3602 0 0 0 0 0 0 13.4614 0 0 0 0 0 0 0 0 0 0 0 0 13.9234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75438 NDUB1_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 (Complex I-MNLL, CI-MNLL) (NADH-ubiquinone oxidoreductase MNLL subunit)" NDUFB1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0016607; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] NKSMLFKR 0.98161 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01116 RASK_HUMAN "GTPase KRas, EC 3.6.5.2 (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed ]" KRAS KRAS2 RASK2 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; glial cell proliferation [GO:0014009]; homeostasis of number of cells within a tissue [GO:0048873]; MAPK cascade [GO:0000165]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; skeletal muscle cell differentiation [GO:0035914]; striated muscle cell differentiation [GO:0051146]; type I pneumocyte differentiation [GO:0060509]; visual learning [GO:0008542]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; endocrine signaling [GO:0038002]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; glial cell proliferation [GO:0014009]; homeostasis of number of cells within a tissue [GO:0048873]; MAPK cascade [GO:0000165]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission, GABAergic [GO:0032228]; skeletal muscle cell differentiation [GO:0035914]; striated muscle cell differentiation [GO:0051146]; type I pneumocyte differentiation [GO:0060509]; visual learning [GO:0008542]" GO:0000139; GO:0000165; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005741; GO:0005789; GO:0005829; GO:0005886; GO:0005925; GO:0007265; GO:0008284; GO:0008542; GO:0010628; GO:0014009; GO:0016020; GO:0016601; GO:0019003; GO:0021897; GO:0030036; GO:0030857; GO:0031234; GO:0031647; GO:0032228; GO:0035022; GO:0035914; GO:0038002; GO:0042802; GO:0043524; GO:0044877; GO:0048169; GO:0048873; GO:0051146; GO:0051402; GO:0060252; GO:0060441; GO:0060509 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] EIRQYRLK 0.98161 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1523 0 0 0 0 0 0 P22061 PIMT_HUMAN "Protein-L-isoaspartate(D-aspartate) O-methyltransferase, PIMT, EC 2.1.1.77 (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase)" PCMT1 Homo sapiens (Human) protein methylation [GO:0006479]; protein repair [GO:0030091] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; protein methylation [GO:0006479]; protein repair [GO:0030091] GO:0004719; GO:0005737; GO:0005829; GO:0006479; GO:0030091; GO:0045296; GO:0070062; GO:1903561 cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719] EKQWSRWK 0.98161 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8V8 YD018_HUMAN Putative uncharacterized protein FLJ13197 Homo sapiens (Human) AAGALAALRLGPRLR 0.98161 -1.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5028 0 0 0 0 0 0 12.1634 12.5374 0 0 0 0 0 11.7746 0 0 0 13.5628 0 12.9103 0 0 0 0 0 0 0 0 0 0 11.5766 0 0 12.1539 0 0 0 0 13.8258 13.2274 12.7267 14.0268 14.2412 13.9314 11.5578 11.3502 0 11.7463 0 0 0 0 13.5355 0 0 0 0 0 0 13.7932 0 0 11.7074 11.4249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49418 AMPH_HUMAN Amphiphysin AMPH AMPH1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; synaptic vesicle endocytosis [GO:0048488] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytosol [GO:0005829]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytosol [GO:0005829]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; phospholipid binding [GO:0005543]; chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; synaptic vesicle endocytosis [GO:0048488] GO:0005543; GO:0005829; GO:0005886; GO:0006897; GO:0007268; GO:0008021; GO:0015629; GO:0030672; GO:0031256; GO:0048488; GO:0070161 phospholipid binding [GO:0005543] AQEKVLQK 0.98164 3.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9267 14.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9054 14.7517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7816 0 0 0 0 0 0 0 0 0 0 Q8WZ59 TM190_HUMAN Transmembrane protein 190 TMEM190 MDAC1 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] inner acrosomal membrane [GO:0002079]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; protein self-association [GO:0043621]; hematopoietic progenitor cell differentiation [GO:0002244] GO:0002079; GO:0002244; GO:0005634; GO:0016021; GO:0043621 protein self-association [GO:0043621] CCYRNGVCYHQRPDENVR 0.98168 -1.3648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9863 0 0 0 0 0 0 12.2907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7841 Q96E35 ZMY19_HUMAN "Zinc finger MYND domain-containing protein 19 (Melanin-concentrating hormone receptor 1-interacting zinc finger protein, MCH-R1-interacting zinc finger protein)" ZMYND19 MIZIP Homo sapiens (Human) cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; metal ion binding [GO:0046872] GO:0005737; GO:0005886; GO:0016020; GO:0045202; GO:0046872 metal ion binding [GO:0046872] CQVARYCGSQCQQK 0.98168 -1.3611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8911 14.1603 0 0 14.0565 0 0 0 0 0 0 0 0 0 0 0 14.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.504 0 0 0 Q9BYV6 TRI55_HUMAN "Tripartite motif-containing protein 55 (Muscle-specific RING finger protein 2, MuRF-2, MuRF2) (RING finger protein 29)" TRIM55 MURF2 RNF29 Homo sapiens (Human) diapedesis [GO:0050904]; leukocyte migration involved in inflammatory response [GO:0002523]; macrophage migration [GO:1905517]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; diapedesis [GO:0050904]; leukocyte migration involved in inflammatory response [GO:0002523]; macrophage migration [GO:1905517]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165] GO:0002523; GO:0005634; GO:0005737; GO:0005874; GO:0007165; GO:0008270; GO:0016567; GO:0042802; GO:0050904; GO:0061630; GO:1905517 identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] EDEDEEEEEGGEGEK 0.98169 -1.3663 0 0 0 0 0 0 0 0 11.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0804 0 0 11.1049 0 10.9115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.942 0 10.2826 0 0 14.0879 0 0 0 12.2336 11.1025 0 0 0 12.3191 0 0 13.7639 0 0 13.9884 16.5172 0 0 0 0 0 16.1835 0 16.6506 0 13.197 0 0 0 0 13.8758 0 14.4958 0 0 0 10.2559 0 11.0334 0 0 0 0 0 0 0 12.3279 0 0 13.7341 0 0 0 13.4535 11.8344 16.4089 0 0 0 0 0 0 0 0 12.7755 0 0 0 0 0 0 0 0 0 11.4581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4413 0 0 0 0 0 Q9H4A9 DPEP2_HUMAN "Dipeptidase 2, EC 3.4.13.19" DPEP2 UNQ284/PRO323 Homo sapiens (Human) leukotriene D4 catabolic process [GO:1901749]; leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508] anchored component of membrane [GO:0031225] anchored component of membrane [GO:0031225]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; leukotriene D4 catabolic process [GO:1901749]; leukotriene metabolic process [GO:0006691]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508] GO:0006508; GO:0006629; GO:0006691; GO:0016805; GO:0031225; GO:0046872; GO:0070573; GO:1901749 dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573] ALTTLGAPR 0.98169 -1.3701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0322 0 0 9.45668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1081 0 0 0 0 0 0 0 0 0 17.2995 0 0 14.7841 0 0 0 0 0 0 0 0 0 0 0 13.3935 0 0 14.3659 0 0 0 13.6049 14.641 0 0 0 0 0 11.2055 0 0 0 0 0 14.6077 0 0 0 0 0 14.8506 13.8408 0 0 0 0 14.0358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9493 15.2227 0 0 0 0 0 0 14.6477 0 0 0 0 0 13.0456 0 0 0 0 0 11.5538 0 Q13948 CASP_HUMAN Protein CASP CUX1 CUTL1 Homo sapiens (Human) intra-Golgi vesicle-mediated transport [GO:0006891] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; intra-Golgi vesicle-mediated transport [GO:0006891] GO:0000139; GO:0005654; GO:0005794; GO:0006891; GO:0030173 ADNIKLFEK 0.98171 -1.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9046 0 0 0 0 0 0 0 0 0 0 A6NI15 MSGN1_HUMAN "Mesogenin-1 (Paraxial mesoderm-specific mesogenin1) (pMesogenin1, pMsgn1)" MSGN1 Homo sapiens (Human) cell differentiation [GO:0030154]; mesoderm formation [GO:0001707]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; somitogenesis [GO:0001756] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; mesoderm formation [GO:0001707]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]; somitogenesis [GO:0001756]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001707; GO:0001756; GO:0003682; GO:0005634; GO:0006357; GO:0007379; GO:0030154; GO:0046983; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" VRMSVQRR 0.98172 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76KD6 SPERI_HUMAN Speriolin (Spermatogenesis and centriole-associated protein 1) (Spermatogenesis-associated protein 15) (Spermatogenic cell-specific Cdc20-binding protein) SPATC1 SPATA15 SPRN Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 IIQASLNPSDHKLDEKLCQR 0.98174 3.0503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6868 0 0 11.6141 0 0 0 0 11.8624 14.3429 10.896 0 0 11.6988 0 0 14.9623 0 0 0 0 0 0 0 0 0 0 0 11.91 0 0 15.3413 0 0 0 0 0 0 0 14.8341 0 10.8349 0 0 0 0 0 0 0 0 0 15.5423 0 0 0 0 0 10.9264 0 0 17.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYZ4 SIGL8_HUMAN "Sialic acid-binding Ig-like lectin 8, Siglec-8 (Sialoadhesin family member 2, SAF-2)" SIGLEC8 SAF2 Homo sapiens (Human) cell adhesion [GO:0007155]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; signal transduction [GO:0007165] GO:0004888; GO:0005886; GO:0007155; GO:0007165; GO:0016021; GO:0030246; GO:0033691 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888] LLLLLLLPLLWGTK 0.98174 3.1678 0 0 0 0 0 0 0 0 0 0 0 15.3161 0 0 14.883 0 13.1277 0 0 0 0 0 0 0 12.4687 0 0 0 0 0 0 0 12.3711 0 0 0 0 0 0 12.459 12.7149 0 0 0 12.6541 12.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9499 0 0 14.1688 0 9.51844 11.0411 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3952 0 12.701 0 0 15.3244 0 0 0 0 0 0 11.6862 14.8959 11.6392 0 12.9243 0 0 0 0 0 0 13.6729 0 0 0 0 0 0 0 13.9427 0 0 0 13.855 14.8194 0 0 0 15.5371 0 0 0 0 11.2324 0 0 10.2803 14.8595 15.6094 14.0606 0 10.5069 0 0 0 0 0 0 0 17.3216 0 0 0 0 0 15.2881 0 0 0 14.7963 0 0 0 0 14.7688 15.9749 15.6964 17.3524 14.9298 16.5572 0 0 15.6076 0 0 0 16.5902 16.6593 0 16.6365 0 0 P51686 CCR9_HUMAN "C-C chemokine receptor type 9, C-C CKR-9, CC-CKR-9, CCR-9 (G-protein coupled receptor 28) (GPR-9-6) (CD antigen CDw199)" CCR9 GPR28 Homo sapiens (Human) "calcium-mediated signaling [GO:0019722]; CD8-positive, gamma-delta intraepithelial T cell differentiation [GO:0002305]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]" cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; calcium-mediated signaling [GO:0019722]; CD8-positive, gamma-delta intraepithelial T cell differentiation [GO:0002305]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]" GO:0002305; GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0006968; GO:0007186; GO:0007204; GO:0009897; GO:0009986; GO:0016493; GO:0019722; GO:0019957; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950] DLVKTLK 0.98175 -1.3425 0 0 0 18.4275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7KZF4 SND1_HUMAN "Staphylococcal nuclease domain-containing protein 1, EC 3.1.31.1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator)" SND1 TDRD11 Homo sapiens (Human) gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564] cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442] cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; RISC complex [GO:0016442]; cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; mRNA catabolic process [GO:0006402]; osteoblast differentiation [GO:0001649]; regulation of cell cycle process [GO:0010564] GO:0001649; GO:0003712; GO:0003723; GO:0004518; GO:0004519; GO:0004521; GO:0005634; GO:0005829; GO:0006402; GO:0010564; GO:0010587; GO:0016020; GO:0016442; GO:0031047; GO:0042470; GO:0045296; GO:0070062; GO:0097433; GO:1905172 cadherin binding [GO:0045296]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] EADGSETPEPFAAEAK 0.98179 -1.3608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4227 0 0 0 0 17.8517 0 0 0 0 0 0 17.929 0 12.4777 0 0 0 14.1686 0 18.6544 0 13.4573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43220 GLP1R_HUMAN "Glucagon-like peptide 1 receptor, GLP-1 receptor, GLP-1-R, GLP-1R" GLP1R Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; hormone secretion [GO:0046879]; learning or memory [GO:0007611]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; post-translational protein targeting to membrane, translocation [GO:0031204]; regulation of heart contraction [GO:0008016]; response to psychosocial stress [GO:1990911]" integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; glucagon-like peptide 1 receptor activity [GO:0044508]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; hormone secretion [GO:0046879]; learning or memory [GO:0007611]; negative regulation of blood pressure [GO:0045776]; positive regulation of blood pressure [GO:0045777]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; post-translational protein targeting to membrane, translocation [GO:0031204]; regulation of heart contraction [GO:0008016]; response to psychosocial stress [GO:1990911]" GO:0004888; GO:0004967; GO:0005886; GO:0005887; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007204; GO:0007611; GO:0008016; GO:0008528; GO:0016021; GO:0017046; GO:0019933; GO:0031204; GO:0044508; GO:0045776; GO:0045777; GO:0046879; GO:1990911 G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; glucagon-like peptide 1 receptor activity [GO:0044508]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888] AGAPGPLRLALLLLGMVGRAGPR 0.98181 -1.3698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0195 0 0 0 0 0 0 0 0 12.0764 0 0 0 11.6598 0 0 0 14.4673 0 0 0 0 0 0 0 0 9.96708 0 0 10.0042 13.0664 13.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1389 0 0 11.3373 0 0 10.3412 0 0 0 0 0 0 0 0 11.9031 0 0 0 0 0 0 0 0 0 0 0 0 12.3093 0 11.5448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2015 0 0 0 0 0 0 0 0 11.0244 0 0 Q96QC0 PP1RA_HUMAN Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) (PP1-binding protein of 114 kDa) (Phosphatase 1 nuclear targeting subunit) (Protein FB19) (p99) PPP1R10 CAT53 FB19 PNUTS Homo sapiens (Human) negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]; protein import into nucleus [GO:0006606] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]; protein import into nucleus [GO:0006606] GO:0000785; GO:0003677; GO:0003723; GO:0004864; GO:0005634; GO:0005654; GO:0006606; GO:0008157; GO:0010667; GO:0016604; GO:0032206; GO:0046872; GO:0072357; GO:1904290 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723] AETRAEEAPEKK 0.98181 -1.366 0 0 0 14.26 0 0 0 12.3253 0 0 11.4675 0 0 0 0 0 0 13.7804 0 13.1008 0 13.1798 0 0 13.3009 0 0 0 0 0 0 0 12.3589 0 0 0 0 0 0 0 10.7383 0 0 0 13.0546 0 0 0 12.8015 0 0 0 0 0 0 13.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.397 17.5874 17.5837 17.3758 13.9786 13.9629 14.0764 0 0 0 0 0 0 0 0 15.1062 0 14.2372 0 14.2243 0 14.2719 0 0 0 0 15.0691 0 14.6436 14.7723 0 0 0 14.5013 14.3183 12.7102 17.11 0 15.1763 18.3013 12.7104 0 17.9767 0 0 0 0 16.3008 0 0 0 14.4482 15.9704 0 0 0 0 14.1066 14.0588 15.085 18.014 17.9199 0 18.159 14.4394 14.6093 18.0963 18.0704 14.0581 17.9084 18.2146 15.2225 11.9564 0 0 0 0 14.0615 0 15.0943 15.9854 0 17.3393 0 0 0 0 0 0 0 0 0 0 0 0 12.1896 12.6148 14.5847 12.3713 15.4871 18.1555 0 0 0 16.041 0 Q9Y6Q9 NCOA3_HUMAN "Nuclear receptor coactivator 3, NCoA-3, EC 2.3.1.48 (ACTR) (Amplified in breast cancer 1 protein, AIB-1) (CBP-interacting protein, pCIP) (Class E basic helix-loop-helix protein 42, bHLHe42) (Receptor-associated coactivator 3, RAC-3) (Steroid receptor coactivator protein 3, SRC-3) (Thyroid hormone receptor activator molecule 1, TRAM-1)" NCOA3 AIB1 BHLHE42 RAC3 TRAM1 Homo sapiens (Human) cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor transactivation [GO:0035624]; regulation of stem cell division [GO:2000035] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; RNA polymerase II complex binding [GO:0000993]; transcription coactivator activity [GO:0003713]; cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor transactivation [GO:0035624]; regulation of stem cell division [GO:2000035] GO:0000785; GO:0000993; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016922; GO:0030374; GO:0032870; GO:0032991; GO:0035624; GO:0043697; GO:0045618; GO:0045944; GO:0046966; GO:0046983; GO:0047485; GO:0070062; GO:0071392; GO:0097718; GO:1902459; GO:2000035 disordered domain specific binding [GO:0097718]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; RNA polymerase II complex binding [GO:0000993]; transcription coactivator activity [GO:0003713] ENNALLRYLLDRDDPSDALSK 0.98181 -1.3683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3097 10.9977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5662 11.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3017 0 0 0 0 0 0 12.4102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969H0 FBXW7_HUMAN "F-box/WD repeat-containing protein 7 (Archipelago homolog, hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4)" FBXW7 FBW7 FBX30 SEL10 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; lipid homeostasis [GO:0055088]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of osteoclast development [GO:2001205]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of SREBP signaling pathway [GO:2000639]; negative regulation of triglyceride biosynthetic process [GO:0010868]; Notch signaling pathway [GO:0007219]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of lipid storage [GO:0010883]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570] GO:0001570; GO:0001944; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010868; GO:0010883; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0032880; GO:0032991; GO:0034644; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0045741; GO:0045746; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0051443; GO:0055088; GO:0070374; GO:0090049; GO:0097027; GO:1901800; GO:1902806; GO:1903026; GO:1903146; GO:1903378; GO:1903955; GO:1990452; GO:2000060; GO:2000346; GO:2000639; GO:2001205 cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027] CKEEGIDEPLHIKR 0.98182 -1.3706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1258 0 0 0 12.7689 0 0 11.9047 0 0 0 0 0 0 0 0 0 0 0 0 14.204 0 0 0 0 0 0 0 0 0 12.4854 0 0 0 0 0 0 0 0 0 0 0 0 12.2464 0 0 13.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83581 0 12.7077 0 0 0 0 0 0 12.9787 0 0 12.4326 12.642 0 13.0017 0 0 0 0 0 0 0 0 13.1207 0 0 0 0 0 0 13.7758 0 0 0 0 0 0 0 0 0 0 0 0 10.2305 0 Q9ULC5 ACSL5_HUMAN "Long-chain-fatty-acid--CoA ligase 5, EC 6.2.1.3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5, LACS 5)" ACSL5 ACS5 FACL5 UNQ633/PRO1250 Homo sapiens (Human) lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] GO:0001676; GO:0004467; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0008610; GO:0010747; GO:0016020; GO:0016021; GO:0035338; GO:0047676; GO:2001236 arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467] FLLKLAVSSK 0.98182 -1.3712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5659 0 0 0 0 0 0 0 0 11.0113 0 0 0 10.1923 0 0 0 0 0 0 0 0 0 11.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.602 0 12.3356 0 0 14.2036 0 0 0 0 0 0 0 0 0 0 0 14.7355 0 0 0 0 0 0 0 0 0 0 0 11.3433 0 11.8828 0 0 0 0 0 0 0 0 0 12.1923 0 0 12.1993 0 0 13.2064 0 0 0 0 0 11.1938 0 0 0 11.8294 0 0 0 0 0 0 0 0 0 0 0 0 11.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7118 0 0 0 0 0 0 0 Q8N7X8 SIGL1_HUMAN SIGLEC family-like protein 1 SIGLECL1 C19orf75 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155] GO:0005886; GO:0007155; GO:0016021; GO:0033691 sialic acid binding [GO:0033691] GLIQGAIYAGIVIALLFLCLLPLIVK 0.98183 -1.3758 0 0 0 0 0 0 0 0 0 0 0 11.3916 0 0 0 0 0 0 0 0 0 0 0 12.5028 0 0 0 11.9132 12.7366 0 0 0 0 0 0 0 0 12.1972 0 12.1791 0 0 0 0 0 0 12.6976 0 0 0 0 0 0 0 0 12.2946 0 0 0 0 0 0 0 0 0 0 0 11.5141 0 0 12.764 0 0 0 14.0435 15.3079 13.3581 0 14.4508 0 14.1586 14.3864 14.014 14.0172 0 14.33 13.8192 13.9498 0 0 0 13.8863 0 0 0 13.5855 0 13.7716 13.79 14.4645 15.1145 0 0 0 0 13.6041 0 0 0 0 0 14.5187 0 0 11.8798 0 0 0 0 14.3859 14.9886 0 12.0912 14.4234 13.7994 15.4713 0 0 0 0 0 0 0 0 14.0733 13.5204 13.2006 0 0 0 0 0 12.4959 13.7723 0 14.0695 0 12.7784 0 0 0 0 0 0 12.599 0 14.5079 0 0 14.1945 0 0 13.3701 0 0 0 0 0 0 0 0 13.88 0 0 0 0 0 0 0 0 Q9UKR5 ERG28_HUMAN Ergosterol biosynthetic protein 28 homolog ERG28 C14orf1 AD-011 HSPC288 x0006 Homo sapiens (Human) sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; sterol biosynthetic process [GO:0016126] GO:0005783; GO:0005789; GO:0016021; GO:0016126; GO:0030133; GO:0030674; GO:0042802 identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674] MSRFLNVLRSWLVMVSIIAMGNTLQSFR 0.98183 -1.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5QJU3 ACER2_HUMAN "Alkaline ceramidase 2, AlkCDase 2, Alkaline CDase 2, haCER2, EC 3.5.1.-, EC 3.5.1.23 (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like)" ACER2 ASAH3L PP11646 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide catabolic process [GO:0046514]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of protein glycosylation [GO:0060049]; response to retinoic acid [GO:0032526]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide catabolic process [GO:0046514]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-matrix adhesion [GO:0001953]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of protein glycosylation [GO:0060049]; response to retinoic acid [GO:0032526]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512]" GO:0000139; GO:0001953; GO:0005794; GO:0006919; GO:0006974; GO:0008284; GO:0010506; GO:0010942; GO:0017040; GO:0030148; GO:0030173; GO:0030330; GO:0032526; GO:0033629; GO:0042981; GO:0046512; GO:0046514; GO:0046872; GO:0060049; GO:0071466; GO:0071633; GO:0102121 ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040] RYLPKIFR 0.98184 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV20 LACC1_HUMAN "Purine nucleoside phosphorylase LACC1, EC 2.4.2.1 (Adenosine deaminase LACC1, EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1, EC 2.4.2.28)" LACC1 C13orf31 FAMIN Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; peroxisome [GO:0005777] endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; peroxisome [GO:0005777]; adenosine deaminase activity [GO:0004000]; copper ion binding [GO:0005507]; guanosine phosphorylase activity [GO:0047975]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542] GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005507; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0047975; GO:0050727; GO:0070431; GO:1900542 adenosine deaminase activity [GO:0004000]; copper ion binding [GO:0005507]; guanosine phosphorylase activity [GO:0047975]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061] VIVPRHRK 0.98184 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2S6 TMA7_HUMAN Translation machinery-associated protein 7 (Coiled-coil domain-containing protein 72) TMA7 CCDC72 HSPC016 HSPC330 Homo sapiens (Human) QKQKEEQK 0.98184 -1.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0756 0 15.9937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1205 0 12.6762 0 0 14.5519 0 0 0 0 15.4117 15.7445 0 13.7316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q496A3 SPAS1_HUMAN Spermatogenesis-associated serine-rich protein 1 SPATS1 Homo sapiens (Human) FDTFIPLEPLPQIPNLPFWVKEKANSLK 0.98188 -1.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3302 14.6505 0 0 0 0 0 0 0 14.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3285 0 0 0 0 0 0 0 0 0 0 0 13.1466 0 0 0 0 P00738 HPT_HUMAN Haptoglobin (Zonulin) [Cleaved into: Haptoglobin alpha chain; Haptoglobin beta chain ] HP Homo sapiens (Human) acute inflammatory response [GO:0002526]; acute-phase response [GO:0006953]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; negative regulation of hydrogen peroxide catabolic process [GO:2000296]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542]; zymogen activation [GO:0031638] blood microparticle [GO:0072562]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] blood microparticle [GO:0072562]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; antioxidant activity [GO:0016209]; hemoglobin binding [GO:0030492]; serine-type endopeptidase activity [GO:0004252]; acute inflammatory response [GO:0002526]; acute-phase response [GO:0006953]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; negative regulation of hydrogen peroxide catabolic process [GO:2000296]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542]; zymogen activation [GO:0031638] GO:0002376; GO:0002526; GO:0004252; GO:0005576; GO:0005615; GO:0006952; GO:0006953; GO:0010942; GO:0016209; GO:0030492; GO:0031638; GO:0031838; GO:0035580; GO:0042542; GO:0042742; GO:0051354; GO:0070062; GO:0071682; GO:0072562; GO:1904724; GO:2000296 antioxidant activity [GO:0016209]; hemoglobin binding [GO:0030492]; serine-type endopeptidase activity [GO:0004252] LKQKVSVNER 0.98194 -1.3717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8782 0 13.4511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.019 0 0 0 0 13.0049 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4356 0 0 0 0 0 0 17.1665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD94 KLF14_HUMAN "Krueppel-like factor 14 (Basic transcription element-binding protein 5, BTE-binding protein 5) (Transcription factor BTEB5)" KLF14 BTEB5 Homo sapiens (Human) positive regulation of sphingolipid mediated signaling pathway [GO:1902070]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of sphingolipid mediated signaling pathway [GO:1902070]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0043565; GO:0045944; GO:0046872; GO:1902070; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" HYRTHTGEKR 0.98194 -1.3732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7M4 ADIPL_HUMAN Adipolin (Adipose-derived insulin-sensitizing factor) (C1q and TNF related protein 12) (Complement C1q tumor necrosis factor-related protein 12) [Cleaved into: Adipolin fC1QTNF12 (Adipolin fCTRP12) (Adipolin full-length form); Adipolin gC1QTNF12 (Adipolin cleaved form) (Adipolin gCTRP12) ] C1QTNF12 C1QDC2 CTRP12 FAM132A Homo sapiens (Human) establishment of localization in cell [GO:0051649]; gluconeogenesis [GO:0006094]; glucose import [GO:0046323]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase B signaling [GO:0051897]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; establishment of localization in cell [GO:0051649]; gluconeogenesis [GO:0006094]; glucose import [GO:0046323]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase B signaling [GO:0051897]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324] GO:0005179; GO:0005576; GO:0005615; GO:0006094; GO:0035774; GO:0043491; GO:0045721; GO:0046323; GO:0046324; GO:0046326; GO:0046628; GO:0050728; GO:0051649; GO:0051897 hormone activity [GO:0005179] ADPPNATASASSR 0.98195 -1.3797 0 0 0 0 14.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9367 0 0 0 0 14.4194 0 0 0 0 0 0 0 0 0 0 0 0 12.2662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3081 0 0 0 0 0 11.5455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1512 0 0 0 0 0 0 0 0 0 0 0 0 Q14814 MEF2D_HUMAN Myocyte-specific enhancer factor 2D MEF2D Homo sapiens (Human) adult heart development [GO:0007512]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; osteoblast differentiation [GO:0001649]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; adult heart development [GO:0007512]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; osteoblast differentiation [GO:0001649]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0001958; GO:0002062; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006915; GO:0007399; GO:0007512; GO:0007517; GO:0030154; GO:0035914; GO:0042803; GO:0042826; GO:0043231; GO:0045944; GO:0046982; GO:0061629; GO:0140297; GO:1904707; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" GDFGPTLGLLR 0.98199 -1.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8835 0 0 0 0 0 11.4657 12.4038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRY5 F1142_HUMAN Protein FAM114A2 FAM114A2 C5orf3 Homo sapiens (Human) purine nucleotide binding [GO:0017076] GO:0017076 purine nucleotide binding [GO:0017076] EFTTCLTTAGVK 0.98202 3.0274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9873 0 12.1474 0 0 0 0 0 0 0 0 0 10.9119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5557 0 0 0 0 11.2639 0 13.9116 0 0 14.5878 0 13.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1487 0 0 0 0 12.3747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2375 0 0 0 12.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1995 0 0 Q6ZSJ8 CA122_HUMAN Uncharacterized protein C1orf122 (Protein ALAESM) C1orf122 Homo sapiens (Human) DAGDGAAEP 0.98203 -1.3605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9208 0 0 0 0 0 14.2192 14.976 0 15.3851 14.0319 14.1869 13.5625 12.4903 14.479 14.2302 15.4551 14.6466 13.2653 0 12.8597 14.4067 0 0 0 0 0 0 0 0 0 0 0 0 13.4297 0 14.3588 0 0 0 12.4986 13.4528 0 13.3514 0 12.7228 13.026 13.6309 0 0 0 0 0 0 13.094 0 0 0 0 0 0 0 0 14.9589 0 0 0 0 0 0 0 0 0 11.8863 0 0 0 0 0 0 0 0 0 0 12.6534 0 0 0 0 0 13.3215 0 0 0 0 0 12.4087 0 0 O75973 C1QRF_HUMAN "C1q-related factor (C1q and tumor necrosis factor-related protein 14, C1q/TNF-related protein 14) (Complement component 1 Q subcomponent-like 1)" C1QL1 C1QRF CRF CTRP14 Homo sapiens (Human) locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; neuron remodeling [GO:0016322] climbing fiber [GO:0044301]; collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; presynapse [GO:0098793]; synaptic cleft [GO:0043083] climbing fiber [GO:0044301]; collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; presynapse [GO:0098793]; synaptic cleft [GO:0043083]; signaling receptor binding [GO:0005102]; locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; neuron remodeling [GO:0016322] GO:0005102; GO:0005581; GO:0005615; GO:0005737; GO:0007626; GO:0016322; GO:0043083; GO:0044301; GO:0061743; GO:0098793; GO:0099558 signaling receptor binding [GO:0005102] GGDGTSMWADLCK 0.98209 3.0218 0 0 0 0 0 0 0 0 0 0 0 0 11.053 0 0 0 0 0 0 0 10.8387 0 0 0 0 0 10.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5491 0 0 0 0 0 10.3765 0 0 0 0 0 0 0 0 0 0 0 12.8929 0 0 0 13.9302 0 0 0 0 0 0 0 0 0 14.9445 0 0 0 0 0 0 0 0 0 0 0 9.92696 0 0 0 0 0 0 14.1639 0 0 0 0 0 0 0 0 13.9443 11.453 0 0 0 0 0 0 0 0 0 14.8156 0 0 0 10.6428 0 0 0 0 0 0 10.5518 0 0 14.5336 0 14.5524 11.8554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5V6 PPR32_HUMAN Protein phosphatase 1 regulatory subunit 32 PPP1R32 C11orf66 Homo sapiens (Human) ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; phosphatase binding [GO:0019902] GO:0005737; GO:0019902; GO:0036064 phosphatase binding [GO:0019902] DPLDQPDFLQK 0.98211 -1.347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4791 0 0 0 0 0 12.3454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7795 0 13.9032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDN9 RCBT1_HUMAN "RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein, CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1)" RCBTB1 CLLD7 E4.5 Homo sapiens (Human) cell cycle [GO:0007049]; chromatin organization [GO:0006325] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin organization [GO:0006325] GO:0005634; GO:0005737; GO:0006325; GO:0007049 CEHFRSMFQSYWNEDMK 0.98213 -1.3857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7184 13.6936 0 13.6116 0 0 13.9478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0486 0 0 0 0 0 13.5742 0 0 0 0 0 0 0 0 0 0 0 13.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q58FG0 HS905_HUMAN "Putative heat shock protein HSP 90-alpha A5 (Heat shock protein 90-alpha E, Heat shock protein 90Ae)" HSP90AA5P HSP90AE Homo sapiens (Human) protein folding [GO:0006457] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] GO:0005524; GO:0005737; GO:0006457; GO:0016887; GO:0051082 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; unfolded protein binding [GO:0051082] EKYIDQELNKTK 0.98214 -1.3594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1137 0 0 0 0 0 0 14.1933 14.4322 12.7852 0 0 0 0 0 13.0048 0 15.3539 13.4679 0 0 0 0 0 0 0 0 0 0 0 12.7824 0 0 0 0 14.2845 0 0 0 0 13.4148 13.75 0 15.8392 16.7847 15.7879 13.8083 13.4703 0 0 0 0 0 0 0 13.5474 0 0 0 0 0 0 13.5105 0 0 14.6137 0 0 0 13.13 0 0 0 0 14.5263 0 14.6622 0 13.3129 0 0 0 15.531 14.5631 13.1607 0 13.5554 0 0 0 0 0 0 0 15.5697 0 0 14.2834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3369 0 0 0 0 0 0 0 0 Q68DY1 ZN626_HUMAN Zinc finger protein 626 ZNF626 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFNQSSILTTHERIILER 0.98215 -1.3605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC52 CBX8_HUMAN "Chromobox protein homolog 8 (Polycomb 3 homolog, Pc3, hPc3) (Rectachrome 1)" CBX8 PC3 RC1 Homo sapiens (Human) chromatin organization [GO:0006325]; histone ubiquitination [GO:0016574]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027]; chromatin organization [GO:0006325]; histone ubiquitination [GO:0016574]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0000785; GO:0000792; GO:0003682; GO:0003727; GO:0005634; GO:0005654; GO:0006325; GO:0016574; GO:0031519; GO:0035064; GO:0035102; GO:0097027 chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027] ESNTDQGFFKEKR 0.98217 3.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5744 13.501 12.855 13.183 0 13.5663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96ER9 MITOK_HUMAN "Mitochondrial potassium channel, MITOK (Coiled-coil domain-containing protein 51)" CCDC51 MITOK Homo sapiens (Human) cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial ATP-gated potassium channel activity [GO:0062156]; cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805] GO:0005743; GO:0006884; GO:0031305; GO:0062156; GO:0062157; GO:0071805; GO:0140141 mitochondrial ATP-gated potassium channel activity [GO:0062156] ATSTAKTWWDR 0.98226 -1.3593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.363 0 12.9165 0 0 0 0 13.0894 0 0 0 0 0 0 0 0 0 0 0 11.1794 0 0 0 0 0 0 11.9773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60613 SEP15_HUMAN Selenoprotein F (15 kDa selenoprotein) SELENOF SEP15 Homo sapiens (Human) 'de novo' post-translational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379]; 'de novo' post-translational protein folding [GO:0051084]; sperm DNA condensation [GO:0035092] GO:0005788; GO:0008379; GO:0008430; GO:0016491; GO:0035092; GO:0051084 oxidoreductase activity [GO:0016491]; selenium binding [GO:0008430]; thioredoxin peroxidase activity [GO:0008379] PKLFRGLQIK 0.98236 -1.3501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66K41 Z385C_HUMAN Zinc finger protein 385C ZNF385C Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0005634; GO:0008270 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] AVISHTFGVPSPLKKK 0.98237 -2.1985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9278 0 0 0 0 0 0 0 0 12.9918 14.4826 0 0 12.506 0 14.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16442 BGAT_HUMAN "Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase, EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase, EC 2.4.1.37) (Histo-blood group A transferase, A transferase) (Histo-blood group B transferase, B transferase) (NAGAT) [Cleaved into: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form ]" ABO Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; antigen binding [GO:0003823]; fucosylgalactoside 3-alpha-galactosyltransferase activity [GO:0004381]; glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [GO:0004380]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486] GO:0000139; GO:0000166; GO:0003823; GO:0004380; GO:0004381; GO:0005576; GO:0005794; GO:0005975; GO:0006486; GO:0016021; GO:0030145; GO:0030259; GO:0031982; GO:0032580 antigen binding [GO:0003823]; fucosylgalactoside 3-alpha-galactosyltransferase activity [GO:0004381]; glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [GO:0004380]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166] CHALRPMILFLIMLVLVLFGYGVLSPRSLMPGSLER 0.9824 3.1117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1629 0 0 0 17.0537 0 0 0 0 0 13.985 0 0 0 0 0 11.1553 0 11.3111 0 12.1327 11.1475 0 0 0 0 13.5806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7444 0 0 0 0 0 0 0 0 11.3696 0 0 12.7193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12891 HYAL2_HUMAN "Hyaluronidase-2, Hyal-2, EC 3.2.1.35 (Hyaluronoglucosaminidase-2) (Lung carcinoma protein 2, LuCa-2)" HYAL2 LUCA2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; defense response to virus [GO:0051607]; fusion of virus membrane with host plasma membrane [GO:0019064]; glycosaminoglycan catabolic process [GO:0006027]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; kidney development [GO:0001822]; monocyte activation [GO:0042117]; multicellular organism aging [GO:0010259]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cell growth [GO:0030308]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; renal water absorption [GO:0070295]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; viral entry into host cell [GO:0046718] anchored component of external side of plasma membrane [GO:0031362]; anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] anchored component of external side of plasma membrane [GO:0031362]; anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; enzyme binding [GO:0019899]; hyaluronic acid binding [GO:0005540]; hyaluronoglucuronidase activity [GO:0033906]; hyalurononglucosaminidase activity [GO:0004415]; receptor signaling protein tyrosine kinase inhibitor activity [GO:0030294]; receptor tyrosine kinase binding [GO:0030971]; transcription coactivator activity [GO:0003713]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; defense response to virus [GO:0051607]; fusion of virus membrane with host plasma membrane [GO:0019064]; glycosaminoglycan catabolic process [GO:0006027]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; kidney development [GO:0001822]; monocyte activation [GO:0042117]; multicellular organism aging [GO:0010259]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cell growth [GO:0030308]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; renal water absorption [GO:0070295]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615]; skeletal system morphogenesis [GO:0048705]; viral entry into host cell [GO:0046718] GO:0000139; GO:0000302; GO:0001618; GO:0001822; GO:0002244; GO:0003713; GO:0004415; GO:0005540; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0005886; GO:0005902; GO:0005975; GO:0006027; GO:0009615; GO:0009986; GO:0010259; GO:0010764; GO:0016324; GO:0019064; GO:0019899; GO:0030139; GO:0030214; GO:0030294; GO:0030308; GO:0030971; GO:0031362; GO:0031410; GO:0032755; GO:0032757; GO:0033906; GO:0035810; GO:0042117; GO:0042307; GO:0043407; GO:0044344; GO:0045121; GO:0045944; GO:0046658; GO:0046677; GO:0046718; GO:0048471; GO:0048705; GO:0050431; GO:0050729; GO:0051216; GO:0051607; GO:0051898; GO:0060586; GO:0061099; GO:0070295; GO:0071347; GO:0071356; GO:0071493; GO:0071560; GO:0090575; GO:2001238 enzyme binding [GO:0019899]; hyaluronic acid binding [GO:0005540]; hyaluronoglucuronidase activity [GO:0033906]; hyalurononglucosaminidase activity [GO:0004415]; receptor signaling protein tyrosine kinase inhibitor activity [GO:0030294]; receptor tyrosine kinase binding [GO:0030971]; transcription coactivator activity [GO:0003713]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618] AQCHGHGR 0.98248 -2.1978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1026 0 0 9.50424 0 0 0 0 0 0 0 0 0 12.3886 0 0 0 0 0 0 12.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9192 13.4607 13.6226 0 0 14.452 14.3477 0 14.0937 13.4001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2304 0 0 0 0 0 0 0 12.8062 0 0 0 0 12.5652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EB52 MEST_HUMAN "Mesoderm-specific transcript homolog protein, EC 3.-.-.- (Paternally-expressed gene 1 protein)" MEST PEG1 Homo sapiens (Human) mesoderm development [GO:0007498] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; mesoderm development [GO:0007498] GO:0005783; GO:0005789; GO:0007498; GO:0016021; GO:0016787; GO:0070062 hydrolase activity [GO:0016787] EWWVQVGLLAVPLLAAYLHIPPPQLSPALHSWK 0.98249 -1.3577 13.2085 0 0 0 10.5162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6156 0 0 0 0 0 0 11.5725 10.9152 0 9.4095 0 0 0 0 0 0 0 0 0 0 0 12.9047 11.7394 14.0484 0 0 0 0 0 13.688 14.621 13.6877 0 0 13.8864 13.7054 0 0 0 0 0 0 0 0 0 11.4205 13.4065 0 0 13.2899 0 0 0 0 0 12.3816 0 0 13.3527 0 0 13.9981 14.093 0 11.6036 13.1287 0 0 0 0 12.9605 0 0 0 0 13.7111 12.8869 0 0 0 0 12.622 0 0 14.1236 12.8939 0 0 13.9424 0 12.2854 0 0 0 13.3759 0 0 0 0 14.4337 0 0 0 0 0 0 0 0 0 12.9768 0 0 0 0 0 13.2912 13.6674 0 0 10.5299 0 0 0 0 0 0 13.2677 0 0 0 13.3894 0 0 0 0 Q2M2I5 K1C24_HUMAN "Keratin, type I cytoskeletal 24 (Cytokeratin-24, CK-24) (Keratin-24, K24) (Type I keratin-24)" KRT24 KA24 Homo sapiens (Human) cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0070062 structural molecule activity [GO:0005198] KVLDDLTMTR 0.9825 -1.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULJ7 ANR50_HUMAN Ankyrin repeat domain-containing protein 50 ANKRD50 KIAA1223 Homo sapiens (Human) endocytic recycling [GO:0032456]; protein transport [GO:0015031] endosome [GO:0005768] endosome [GO:0005768]; endocytic recycling [GO:0032456]; protein transport [GO:0015031] GO:0005768; GO:0015031; GO:0032456 GYDGRNALR 0.98258 -2.1957 0 0 0 0 0 0 0 12.7425 0 0 0 0 0 0 0 0 0 0 0 0 14.5321 0 0 0 0 0 0 0 0 0 0 0 0 11.0049 0 0 0 10.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8197 0 0 0 0 0 12.1828 0 0 0 0 0 0 0 0 17.3573 0 17.7699 0 0 0 15.5279 12.7323 0 0 0 0 16.1532 15.8353 13.3525 16.1005 15.9917 0 10.3818 0 15.3057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P83111 LACTB_HUMAN "Serine beta-lactamase-like protein LACTB, mitochondrial, EC 3.4.-.-" LACTB MRPL56 UNQ843/PRO1781 Homo sapiens (Human) lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216] GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802 identical protein binding [GO:0042802]; peptidase activity [GO:0008233] AGLPPLGHGWVGGLGLGLGLALGVK 0.9826 -1.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.346 0 0 0 0 0 0 0 0 13.501 0 0 13.621 13.3455 0 13.74 0 0 0 13.1753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8609 0 0 0 0 0 0 12.5694 13.5932 0 0 13.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3724 0 0 10.8231 0 0 11.4544 0 0 0 0 0 0 0 12.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14320 FA50A_HUMAN Protein FAM50A (Protein HXC-26) (Protein XAP-5) FAM50A DXS9928E HXC26 XAP5 Homo sapiens (Human) chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283] GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006397; GO:0007283; GO:0008380; GO:0043484 RNA binding [GO:0003723] DREEEENR 0.98261 -1.3893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZZ5 API5_HUMAN "Apoptosis inhibitor 5, API-5 (Antiapoptosis clone 11 protein, AAC-11) (Cell migration-inducing gene 8 protein) (Fibroblast growth factor 2-interacting factor, FIF) (Protein XAGL)" API5 MIG8 Homo sapiens (Human) fibroblast apoptotic process [GO:0044346]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; fibroblast apoptotic process [GO:0044346]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270] GO:0003723; GO:0005634; GO:0005681; GO:0005737; GO:0016020; GO:0016607; GO:0017134; GO:0043066; GO:0044346; GO:2000270 fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723] AIKFLSTKLK 0.98269 -2.1954 0 0 11.4627 10.9893 0 0 0 12.5758 0 0 0 0 12.4661 0 0 12.0264 0 0 0 12.5231 0 0 0 0 0 0 12.7315 0 0 0 0 0 0 0 11.7444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7937 0 0 0 0 0 12.9058 13.013 0 0 0 0 0 0 18.2993 0 0 0 0 0 0 0 15.3775 11.2423 0 0 15.435 0 0 0 0 0 13.1762 0 13.892 0 0 13.1187 0 13.6701 0 11.9199 0 12.6835 13.3565 0 0 0 0 0 11.4223 0 0 0 12.799 0 0 12.1202 0 0 12.5441 0 0 0 0 0 12.6127 0 0 0 0 13.9873 0 0 0 0 0 15.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3313 12.7166 12.0285 13.2773 13.6908 0 0 0 0 0 Q8WTR4 GDPD5_HUMAN "Glycerophosphodiester phosphodiesterase domain-containing protein 5 (Glycerophosphocholine phosphodiesterase GDPD5, EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 2) (Phosphoinositide phospholipase C GDPD5, EC 3.1.4.11)" GDPD5 GDE2 PP6037 PP9363 UNQ1850/PRO3580 Homo sapiens (Human) lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] endomembrane system [GO:0012505]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] GO:0004435; GO:0005886; GO:0006629; GO:0007399; GO:0008889; GO:0012505; GO:0016020; GO:0016021; GO:0030426; GO:0045666; GO:0047389; GO:0048471 glycerophosphocholine phosphodiesterase activity [GO:0047389]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; phosphatidylinositol phospholipase C activity [GO:0004435] GHIQRLNLR 0.9827 -2.2003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.57 0 0 13.3871 0 0 0 0 0 0 0 13.1498 0 0 0 0 0 11.9626 12.4323 0 0 0 0 0 0 0 12.8535 13.614 13.4546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9771 14.1243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9015 0 0 0 0 0 0 0 11.4813 13.4372 0 0 12.4395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3432 12.7655 0 0 0 0 0 0 0 Q4V9L6 TM119_HUMAN "Transmembrane protein 119 (Osteoblast induction factor, OBIF)" TMEM119 PSEC0199 UNQ731/PRO1415 Homo sapiens (Human) biomineral tissue development [GO:0031214]; endochondral ossification [GO:0001958]; negative regulation of bone resorption [GO:0045779]; negative regulation of myotube differentiation [GO:0010832]; osteoblast differentiation [GO:0001649]; positive regulation of bone development [GO:1903012]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein phosphorylation [GO:0001934]; spermatid differentiation [GO:0048515]; spermatogenesis [GO:0007283] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; biomineral tissue development [GO:0031214]; endochondral ossification [GO:0001958]; negative regulation of bone resorption [GO:0045779]; negative regulation of myotube differentiation [GO:0010832]; osteoblast differentiation [GO:0001649]; positive regulation of bone development [GO:1903012]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein phosphorylation [GO:0001934]; spermatid differentiation [GO:0048515]; spermatogenesis [GO:0007283] GO:0001649; GO:0001934; GO:0001958; GO:0005789; GO:0005886; GO:0007283; GO:0010628; GO:0010832; GO:0016021; GO:0030501; GO:0031214; GO:0033690; GO:0045669; GO:0045779; GO:0048515; GO:1903012 QYVMLIAVVGSLAFLLMFIVCAAVITRQKQK 0.98271 3.0884 0 0 0 0 0 0 10.7736 0 0 0 0 0 0 11.4903 0 0 0 11.6402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1097 0 0 0 0 0 0 0 13.0148 0 10.7265 13.0904 0 0 0 0 13.7007 0 0 0 0 0 10.9686 11.9324 0 0 11.2848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5718 11.691 12.0753 0 0 10.5479 0 0 0 0 12.0439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3015 0 0 0 0 0 0 0 0 0 0 0 P31213 S5A2_HUMAN "3-oxo-5-alpha-steroid 4-dehydrogenase 2, EC 1.3.1.22 (5 alpha-SR2) (SR type 2) (Steroid 5-alpha-reductase 2, S5AR 2) (Type II 5-alpha reductase)" SRD5A2 Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; androgen metabolic process [GO:0008209]; biphenyl metabolic process [GO:0018879]; bone development [GO:0060348]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; dibenzo-p-dioxin metabolic process [GO:0018894]; female genitalia development [GO:0030540]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; phthalate metabolic process [GO:0018963]; response to follicle-stimulating hormone [GO:0032354]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to steroid hormone [GO:0048545]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; steroid biosynthetic process [GO:0006694]; steroid catabolic process [GO:0006706]; testosterone biosynthetic process [GO:0061370] cell body fiber [GO:0070852]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025] cell body fiber [GO:0070852]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; oxidoreductase activity [GO:0016491]; sterol 5-alpha reductase activity [GO:0009917]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; androgen biosynthetic process [GO:0006702]; androgen metabolic process [GO:0008209]; biphenyl metabolic process [GO:0018879]; bone development [GO:0060348]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; dibenzo-p-dioxin metabolic process [GO:0018894]; female genitalia development [GO:0030540]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; phthalate metabolic process [GO:0018963]; response to follicle-stimulating hormone [GO:0032354]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to steroid hormone [GO:0048545]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; steroid biosynthetic process [GO:0006694]; steroid catabolic process [GO:0006706]; testosterone biosynthetic process [GO:0061370] GO:0003865; GO:0005789; GO:0006694; GO:0006702; GO:0006706; GO:0007267; GO:0008209; GO:0008584; GO:0009410; GO:0009917; GO:0016021; GO:0016491; GO:0018879; GO:0018894; GO:0018963; GO:0021766; GO:0021854; GO:0030154; GO:0030283; GO:0030539; GO:0030540; GO:0031667; GO:0032354; GO:0033218; GO:0033574; GO:0043025; GO:0043434; GO:0047751; GO:0048545; GO:0060348; GO:0061370; GO:0070852 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; oxidoreductase activity [GO:0016491]; sterol 5-alpha reductase activity [GO:0009917]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283] AFHHHRFYLKMFEDYPK 0.98272 -1.3533 0 0 12.6652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9593 0 14.3283 0 14.3668 0 0 0 0 0 13.2145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXK4 ASB12_HUMAN "Ankyrin repeat and SOCS box protein 12, ASB-12" ASB12 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; protein ubiquitination [GO:0016567] GO:0000151; GO:0005829; GO:0016567 MNLMDITK 0.98272 -1.3531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JL9 ZN333_HUMAN Zinc finger protein 333 ZNF333 KIAA1806 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CFDCQECGQAFKYSSNLR 0.98273 -1.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4755 0 12.3504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5936 0 0 0 0 0 0 0 0 12.5492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULH4 LRFN2_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1) LRFN2 KIAA1246 SALM1 Homo sapiens (Human) modulation of chemical synaptic transmission [GO:0050804]; regulation of postsynapse organization [GO:0099175] anchoring junction [GO:0070161]; cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; modulation of chemical synaptic transmission [GO:0050804]; regulation of postsynapse organization [GO:0099175] GO:0005886; GO:0009986; GO:0050804; GO:0070161; GO:0098685; GO:0099061; GO:0099175 ARSLLPLPLEGK 0.98273 -1.3573 0 0 13.8951 0 15.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8471 0 0 0 0 0 0 0 0 0 10.7374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8975 15.3259 0 15.1757 14.5844 14.3843 15.3397 15.1824 15.0761 15.2625 0 15.9495 16.6108 0 14.8084 0 0 16.2372 15.7916 15.8658 16.4719 0 14.7719 0 14.7611 16.093 16.4576 16.1582 15.7538 15.5575 16.9278 15.594 16.7171 16.0029 15.7876 15.3039 15.1059 0 14.6528 0 14.2374 15.2432 0 0 16.6144 16.4534 15.5655 0 15.1141 15.3066 15.4761 16.8101 16.6664 0 16.438 0 13.976 15.6739 15.1259 0 0 16.1064 0 15.4007 0 0 15.3195 0 14.8708 14.9462 15.3298 14.9549 13.8926 0 0 20.2042 11.1861 0 0 14.1076 14.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7273 0 15.607 14.4773 0 0 0 14.4736 0 Q9UKA9 PTBP2_HUMAN Polypyrimidine tract-binding protein 2 (Neural polypyrimidine tract-binding protein) (Neurally-enriched homolog of PTB) (PTB-like protein) PTBP2 NPTB PTB PTBLP Homo sapiens (Human) cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of RNA splicing [GO:0043484]; spinal cord development [GO:0021510] growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cerebellum development [GO:0021549]; mRNA splice site selection [GO:0006376]; negative regulation of RNA splicing [GO:0033119]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of RNA splicing [GO:0043484]; spinal cord development [GO:0021510] GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0006376; GO:0021510; GO:0021549; GO:0030426; GO:0033119; GO:0043025; GO:0043484; GO:2000177 mRNA binding [GO:0003729]; RNA binding [GO:0003723] IIRVTLSK 0.98279 -2.195 0 0 0 0 0 0 0 0 11.7837 12.9473 13.4449 11.6383 13.1241 11.4569 13.7751 13.8211 0 0 0 0 13.7229 0 0 0 13.6797 13.2352 13.2201 11.5072 12.6242 15.8849 17.9729 13.0036 17.9708 12.4741 0 12.5755 13.2472 13.6921 12.6072 12.5368 12.5938 12.9276 15.7488 13.1828 11.6393 0 0 14.2335 0 0 15.5261 0 0 0 0 0 0 0 18.4267 0 0 0 0 0 16.8489 0 0 0 0 0 0 11.5695 0 0 0 0 0 0 0 0 10.827 0 0 14.1997 0 13.5139 0 0 0 0 0 0 0 0 0 0 13.9652 13.9779 12.5434 11.8981 0 0 14.7385 0 0 0 0 0 13.6828 0 0 13.0892 0 0 0 0 14.6413 0 0 0 0 0 0 0 0 13.0089 0 0 0 0 12.1607 0 13.5477 12.1053 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3178 0 0 0 15.3712 0 0 13.5028 13.91 13.2709 13.0438 12.9179 0 13.6484 12.3767 13.1834 13.5838 13.4171 0 12.8504 13.4732 11.9084 0 13.7681 0 0 0 0 16.3042 0 14.4212 0 0 O00505 IMA4_HUMAN "Importin subunit alpha-4 (Importin alpha Q2, Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma)" KPNA3 QIP2 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex assembly [GO:0065003]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732] cytosol [GO:0005829]; host cell [GO:0043657]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; host cell [GO:0043657]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022]; NLS-bearing protein import into nucleus [GO:0006607]; protein-containing complex assembly [GO:0065003]; viral entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732] GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0006607; GO:0008022; GO:0008139; GO:0042564; GO:0043657; GO:0046718; GO:0061608; GO:0065003; GO:0075732 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein C-terminus binding [GO:0008022] HRNEVTVELRK 0.98279 -2.1939 0 0 10.9754 0 0 11.8841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6433 0 0 0 0 0 0 0 0 0 11.7803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0053 0 0 0 0 0 0 12.5035 11.553 0 0 0 0 0 0 0 0 0 0 11.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7809 0 0 13.6102 0 0 0 0 0 0 0 11.4007 0 0 0 0 0 0 0 0 0 0 12.3192 0 0 0 0 0 0 0 0 0 12.2866 0 0 0 0 0 0 0 0 0 13.5169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0474 A0AVI4 TM129_HUMAN "E3 ubiquitin-protein ligase TM129, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TM129)" TMEM129 Homo sapiens (Human) "protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000209; GO:0005783; GO:0005789; GO:0006986; GO:0016021; GO:0016567; GO:0030433; GO:0030970; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LFLLLAVTLPSIACILIYYWSRDR 0.98281 -2.204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8986 0 0 0 0 0 11.032 0 0 13.8319 0 0 12.0499 0 12.2298 0 0 0 13.9813 0 0 14.0312 0 0 0 12.3307 0 12.4252 0 0 0 0 0 0 0 0 13.9553 0 0 0 0 0 0 0 0 0 0 0 0 12.9589 0 0 0 11.2146 0 11.3122 0 12.4231 0 0 0 0 0 Q969E3 UCN3_HUMAN "Urocortin-3 (Stresscopin) (Urocortin III, Ucn III)" UCN3 SPC Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane potential [GO:0045838]; response to corticosterone [GO:0051412]; response to glucose [GO:0009749]; response to immobilization stress [GO:0035902]; response to starvation [GO:0042594] axon terminus [GO:0043679]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; varicosity [GO:0043196] axon terminus [GO:0043679]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; varicosity [GO:0043196]; corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane potential [GO:0045838]; response to corticosterone [GO:0051412]; response to glucose [GO:0009749]; response to immobilization stress [GO:0035902]; response to starvation [GO:0042594] GO:0005179; GO:0005576; GO:0005615; GO:0007189; GO:0007586; GO:0009749; GO:0009755; GO:0031669; GO:0032024; GO:0035902; GO:0042594; GO:0043196; GO:0043679; GO:0045838; GO:0051412; GO:0051429; GO:0051431; GO:0071456 corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179] LMPVHFLLLLLLLLGGPR 0.98281 3.0799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8599 13.9191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1953 0 14.0161 0 13.9775 0 0 0 0 0 0 0 0 13.3467 0 13.1049 0 13.3704 13.3482 0 13.8491 0 0 0 0 12.2281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N53 CK037_HUMAN Putative uncharacterized protein encoded by LINC00167 (PRDM10-DT divergent transcript) PRDM10-DT C11orf37 LINC00167 NCRNA00167 Homo sapiens (Human) AACARAK 0.98284 -1.388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSG2 CA112_HUMAN Uncharacterized protein C1orf112 C1orf112 Homo sapiens (Human) GIFWEPFANVTVEEAKR 0.98286 3.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6288 0 0 0 0 0 0 0 0 11.4527 0 0 0 0 0 0 0 0 11.2569 0 0 0 11.7264 0 0 0 0 0 0 0 0 11.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0428 0 0 0 0 12.393 0 12.9426 0 0 0 0 0 0 0 0 13.7067 13.3824 0 0 14.1262 0 0 0 0 0 0 12.3865 0 0 0 12.3752 0 0 0 0 12.6719 12.7225 13.1634 0 0 13.1219 13.5304 0 0 0 0 0 0 12.5864 12.5251 0 0 0 0 0 0 0 0 0 0 0 11.9204 11.9878 13.4723 12.7291 0 0 0 0 12.5335 0 0 0 12.2801 0 13.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5005 0 0 0 0 0 11.975 0 0 0 0 0 0 0 0 0 0 A1YPR0 ZBT7C_HUMAN "Zinc finger and BTB domain-containing protein 7C (Affected by papillomavirus DNA integration in ME180 cells protein 1, APM-1) (Zinc finger and BTB domain-containing protein 36) (Zinc finger protein 857C)" ZBTB7C APM1 ZBTB36 ZNF857C Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008285; GO:0045600; GO:0045944; GO:0046872; GO:1903025 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FVHNYDLKNHMRIHTGVR 0.98288 -2.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3724 0 16.9559 12.9448 0 0 0 0 0 0 14.5005 0 0 0 0 0 0 0 13.0818 0 0 0 0 0 0 0 0 12.2764 0 0 0 0 0 0 0 0 0 0 12.2525 0 0 14.1978 0 0 13.4132 0 0 13.4675 0 0 0 0 0 0 12.9696 0 11.9581 0 12.7658 0 0 0 13.0368 12.8857 0 13.1079 0 13.1027 14.5668 13.4173 0 0 0 12.454 0 11.9171 0 11.9858 0 0 0 0 0 12.3571 11.9767 0 0 0 0 12.5209 0 0 0 0 0 0 0 0 0 0 13.431 0 0 0 0 0 0 12.1219 O00257 CBX4_HUMAN "E3 SUMO-protein ligase CBX4, EC 2.3.2.- (Chromobox protein homolog 4) (Polycomb 2 homolog, Pc2, hPc2)" CBX4 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein sumoylation [GO:0016925]" nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] "nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; phosphoprotein binding [GO:0051219]; single-stranded RNA binding [GO:0003727]; SUMO binding [GO:0032183]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein sumoylation [GO:0016925]" GO:0000122; GO:0000976; GO:0003682; GO:0003714; GO:0003727; GO:0005634; GO:0005654; GO:0006325; GO:0016604; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0031519; GO:0032183; GO:0035064; GO:0035102; GO:0043066; GO:0045892; GO:0051219; GO:0061665 chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; methylated histone binding [GO:0035064]; phosphoprotein binding [GO:0051219]; single-stranded RNA binding [GO:0003727]; SUMO binding [GO:0032183]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] GPKPKPLVVQVPTFAR 0.98292 -2.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9964 10.9829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.962 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3684 0 0 0 0 0 0 0 0 0 0 0 0 12.9801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.382 0 12.962 0 0 11.0334 0 0 0 0 0 0 0 0 0 12.0443 0 12.1175 0 0 0 0 0 0 14.7006 0 0 0 0 0 0 0 0 0 0 9.6171 0 0 0 0 0 12.9332 P28332 ADH6_HUMAN "Alcohol dehydrogenase 6, EC 1.1.1.1" ADH6 Homo sapiens (Human) ethanol oxidation [GO:0006069]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]" GO:0004022; GO:0004024; GO:0004745; GO:0005829; GO:0006069; GO:0008270; GO:0042572; GO:0042573; GO:0045471; GO:0070062 "alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; NAD-retinol dehydrogenase activity [GO:0004745]; zinc ion binding [GO:0008270]" IIGVDVNK 0.98292 -2.2032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRK0 REEP2_HUMAN Receptor expression-enhancing protein 2 REEP2 C5orf19 SGC32445 Homo sapiens (Human) endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule binding [GO:0008017]; taste receptor binding [GO:0031883]; endoplasmic reticulum tubular network organization [GO:0071786]; protein transport into membrane raft [GO:0032596]; regulation of intracellular transport [GO:0032386]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916] GO:0005783; GO:0005789; GO:0005881; GO:0005887; GO:0008017; GO:0016020; GO:0031883; GO:0032386; GO:0032596; GO:0050913; GO:0050916; GO:0071782; GO:0071786 microtubule binding [GO:0008017]; taste receptor binding [GO:0031883] FVHPTLSNK 0.98292 -2.2123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4549 0 13.5937 0 0 0 0 0 0 0 0 0 13.1412 0 0 0 0 0 0 0 0 0 0 0 Q5BKY9 F133B_HUMAN Protein FAM133B FAM133B Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] EKDIKGLSK 0.98298 -2.2542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2219 0 0 0 0 0 0 0 0 15.2987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.665 0 0 0 0 0 0 0 0 0 0 0 0 10.4641 0 0 0 0 0 0 12.9503 11.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPN7 PP6R1_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 1 (SAPS domain family member 1) PPP6R1 KIAA1115 PP6R1 SAPS1 Homo sapiens (Human) regulation of phosphoprotein phosphatase activity [GO:0043666] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; small GTPase binding [GO:0031267]; regulation of phosphoprotein phosphatase activity [GO:0043666] GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0031267; GO:0043666 protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; small GTPase binding [GO:0031267] GARLGQPPGVRSGGSTDSEDEEEEDEEEEEDEEGIGCAAR 0.98298 -2.2525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4894 0 0 13.0716 0 12.2638 0 0 11.9769 0 0 0 0 0 0 0 0 0 0 0 12.4745 0 0 0 0 0 11.8896 0 0 0 0 0 0 0 11.3782 0 0 0 0 0 0 0 10.9183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3769 0 0 12.7952 0 0 0 0 0 13.0137 0 0 0 0 0 0 0 12.136 0 0 0 0 0 0 0 13.6674 0 0 0 0 0 12.6883 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5791 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5686 12.7717 0 0 0 13.7091 0 0 12.4485 0 0 0 0 0 0 0 0 0 0 0 0 12.5399 0 0 0 0 0 12.6145 0 0 0 0 0 0 0 0 0 0 12.8045 12.7142 0 12.4244 0 14.1991 0 0 P08574 CY1_HUMAN "Cytochrome c1, heme protein, mitochondrial, EC 7.1.1.8 (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit, Cytochrome c-1)" CYC1 Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to glucagon [GO:0033762]" membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to glucagon [GO:0033762]" GO:0005634; GO:0005739; GO:0005743; GO:0005750; GO:0006122; GO:0008121; GO:0016020; GO:0020037; GO:0033762; GO:0045333; GO:0046872 heme binding [GO:0020037]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121] GAGLPGARAR 0.98301 -2.1922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.561 0 0 0 0 0 0 0 0 0 0 0 0 O15455 TLR3_HUMAN Toll-like receptor 3 (CD antigen CD283) TLR3 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic signaling pathway [GO:0097527]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type III interferon production [GO:0034346]; regulation of dendritic cell cytokine production [GO:0002730]; response to dsRNA [GO:0043331]; response to exogenous dsRNA [GO:0043330]; signal transduction [GO:0007165]; toll-like receptor 3 signaling pathway [GO:0034138]; type III interferon production [GO:0034343] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic signaling pathway [GO:0097527]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type III interferon production [GO:0034346]; regulation of dendritic cell cytokine production [GO:0002730]; response to dsRNA [GO:0043331]; response to exogenous dsRNA [GO:0043330]; signal transduction [GO:0007165]; toll-like receptor 3 signaling pathway [GO:0034138]; type III interferon production [GO:0034343] GO:0000139; GO:0001774; GO:0002730; GO:0002756; GO:0003725; GO:0004888; GO:0005615; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005887; GO:0006972; GO:0007165; GO:0007250; GO:0007252; GO:0007254; GO:0008584; GO:0009597; GO:0010008; GO:0010628; GO:0016020; GO:0031012; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032735; GO:0032755; GO:0032757; GO:0032760; GO:0034123; GO:0034138; GO:0034343; GO:0034346; GO:0035458; GO:0036020; GO:0038023; GO:0042742; GO:0042802; GO:0043065; GO:0043123; GO:0043330; GO:0043331; GO:0045087; GO:0045671; GO:0045766; GO:0045944; GO:0046330; GO:0050729; GO:0051092; GO:0051607; GO:0060907; GO:0071260; GO:0071346; GO:0071360; GO:0071466; GO:0097191; GO:0097527; GO:0098586; GO:1901224 double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] HKLQVALGSK 0.98307 3.0567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7978 0 0 11.6874 14.7321 13.0886 0 0 0 0 11.2509 0 11.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4398 15.6981 0 0 0 15.1094 0 0 14.7979 14.7004 0 0 13.4853 0 0 0 13.5505 0 16.7067 0 0 13.2867 0 14.6424 0 0 15.9355 0 16.7424 14.4928 0 0 14.7139 0 0 0 0 0 0 0 0 0 0 0 0 13.3756 14.5581 13.9532 0 0 0 0 0 0 13.4895 14.2602 13.1707 0 0 0 0 17.0004 0 0 13.7508 0 0 0 15.5697 0 14.7516 0 0 0 13.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1163 0 0 0 0 0 0 0 0 Q9NPD8 UBE2T_HUMAN "Ubiquitin-conjugating enzyme E2 T, EC 2.3.2.23 (Cell proliferation-inducing gene 50 protein) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T)" UBE2T HSPC150 PIG50 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006513; GO:0006974; GO:0031625; GO:0035519; GO:0044314; GO:0051865; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:0085020 ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] ICLDVLKLPPK 0.98309 -2.2552 0 0 0 0 0 0 11.3414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNW1 MINP1_HUMAN "Multiple inositol polyphosphate phosphatase 1, EC 3.1.3.62 (2,3-bisphosphoglycerate 3-phosphatase, 2,3-BPG phosphatase, EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase, Ins(1,3,4,5)P(4) 3-phosphatase)" MINPP1 MIPP UNQ900/PRO1917 Homo sapiens (Human) bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]; bone mineralization [GO:0030282]; inositol phosphate metabolic process [GO:0043647]; ossification [GO:0001503]; polyphosphate metabolic process [GO:0006797]" GO:0001503; GO:0003993; GO:0005783; GO:0005788; GO:0006797; GO:0030282; GO:0030351; GO:0034417; GO:0043647; GO:0051717; GO:0052745; GO:0052826; GO:0070062; GO:0101006 "acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; protein histidine phosphatase activity [GO:0101006]" LITSSKHR 0.98309 -2.2514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7827 13.5633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3586 0 0 0 0 0 0 A8MT69 CENPX_HUMAN "Centromere protein X, CENP-X (FANCM-associated histone fold protein 2) (FANCM-interacting histone fold protein 2) (Fanconi anemia-associated polypeptide of 10 kDa) (Retinoic acid-inducible gene D9 protein homolog) (Stimulated by retinoic acid gene 13 protein homolog)" CENPX FAAP10 MHF2 STRA13 Homo sapiens (Human) cell division [GO:0051301]; interstrand cross-link repair [GO:0036297]; kinetochore assembly [GO:0051382]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; cell division [GO:0051301]; interstrand cross-link repair [GO:0036297]; kinetochore assembly [GO:0051382]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000712; GO:0000776; GO:0000785; GO:0003677; GO:0005654; GO:0031297; GO:0031398; GO:0036297; GO:0043240; GO:0051301; GO:0051382; GO:0071821 DNA binding [GO:0003677] KELVSRLLHLHFK 0.98311 -2.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8336 0 0 0 0 0 0 0 0 0 0 0 9.75414 0 0 0 0 0 0 12.2642 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1709 0 0 0 12.4957 0 0 0 0 0 0 0 11.9492 0 0 0 0 0 0 P53680 AP2S1_HUMAN AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (HA2 17 kDa subunit) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin) AP2S1 AP17 CLAPS2 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; clathrin adaptor activity [GO:0035615]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0016192; GO:0030100; GO:0030122; GO:0030666; GO:0030669; GO:0035615; GO:0036020; GO:0043231; GO:0045334; GO:0048268; GO:0072583; GO:0098794; GO:0098884 clathrin adaptor activity [GO:0035615] ETSQTKVLK 0.98311 -2.1852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8455 0 0 0 0 0 0 0 0 0 0 0 0 12.1839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6885 0 0 0 11.6868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4E4 PDCL2_HUMAN Phosducin-like protein 2 PDCL2 Homo sapiens (Human) protein folding [GO:0006457] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein folding [GO:0006457] GO:0005737; GO:0006457 DFGILPPKEESK 0.98311 -2.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9832 0 0 0 0 11.6002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J263 TVA39_HUMAN T cell receptor alpha variable 39 TRAV39 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 KLLAMILWLQLDR 0.98312 3.0508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5698 0 13.0299 0 0 13.1357 11.7971 0 0 0 0 0 0 0 12.4183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MXY4 ZNF99_HUMAN Zinc finger protein 99 ZNF99 C19orf9 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFKRFSALR 0.98317 -1.4357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6779 0 0 0 0 0 13.5418 0 0 14.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4638 0 0 0 0 17.1853 0 0 0 0 0 0 0 0 0 0 0 0 14.2033 13.9326 0 0 14.2078 0 0 13.5016 14.306 0 0 14.3479 0 0 17.2136 15.5801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8853 0 0 0 0 0 18.8126 0 0 0 0 0 0 0 0 0 0 0 0 13.0674 0 0 0 0 0 0 0 14.3063 0 12.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3288 0 0 P52435 RPB11_HUMAN "DNA-directed RNA polymerase II subunit RPB11-a, RNA polymerase II subunit B11-a, RPB11a (DNA-directed RNA polymerase II subunit J-1) (RNA polymerase II 13.3 kDa subunit)" POLR2J POLR2J1 Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]" "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; LRR domain binding [GO:0030275]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366]" GO:0001055; GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0030275; GO:0046983 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; LRR domain binding [GO:0030275]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055] FRVAIKDK 0.98319 -2.2451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXS8 F126B_HUMAN Protein FAM126B FAM126B Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005829; GO:0005886; GO:0046854; GO:0072659 CVVEEWLSEFKALPDTQITSYAATLHRK 0.98319 -2.2501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6195 14.6245 13.8059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1944 0 0 0 0 12.3693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2019 0 0 0 11.8056 0 0 0 Q8N5C1 CAHM5_HUMAN Calcium homeostasis modulator protein 5 (Protein FAM26E) CALHM5 C6orf188 FAM26E Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261] GO:0005261; GO:0005887 cation channel activity [GO:0005261] IFPRGHSCR 0.98319 -2.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQQ2 SH2B3_HUMAN SH2B adapter protein 3 (Lymphocyte adapter protein) (Lymphocyte-specific adapter protein Lnk) (Signal transduction protein Lnk) SH2B3 LNK Homo sapiens (Human) cellular response to chemokine [GO:1990869]; cellular response to interleukin-3 [GO:0036016]; embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; hematopoietic stem cell differentiation [GO:0060218]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; monocyte homeostasis [GO:0035702]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; neutrophil homeostasis [GO:0001780]; thrombopoietin-mediated signaling pathway [GO:0038163] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; signaling receptor complex adaptor activity [GO:0030159]; stem cell factor receptor binding [GO:0005173]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to chemokine [GO:1990869]; cellular response to interleukin-3 [GO:0036016]; embryonic hemopoiesis [GO:0035162]; erythrocyte development [GO:0048821]; hematopoietic stem cell differentiation [GO:0060218]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; monocyte homeostasis [GO:0035702]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; neutrophil homeostasis [GO:0001780]; thrombopoietin-mediated signaling pathway [GO:0038163] GO:0001780; GO:0005068; GO:0005173; GO:0005829; GO:0005886; GO:0008285; GO:0030159; GO:0035162; GO:0035556; GO:0035702; GO:0035855; GO:0036016; GO:0038163; GO:0042532; GO:0043407; GO:0046426; GO:0048821; GO:0051898; GO:0060218; GO:0060761; GO:0070100; GO:0090331; GO:1900235; GO:1990782; GO:1990869 protein tyrosine kinase binding [GO:1990782]; signaling receptor complex adaptor activity [GO:0030159]; stem cell factor receptor binding [GO:0005173]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] AEASPEPGPGPAAPGLPK 0.98319 -2.2462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9333 0 0 0 13.7553 0 13.9533 0 13.6204 0 0 0 13.8832 0 14.3697 0 13.5031 12.6719 11.6963 0 0 0 0 0 12.0047 0 0 0 0 0 0 0 0 0 0 0 0 13.0648 0 0 0 0 11.0778 0 0 0 0 0 0 0 0 11.1139 0 0 0 0 0 0 0 13.2536 13.2288 0 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5294 Q9HCF6 TRPM3_HUMAN "Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3, LTrpC-3, LTrpC3) (Melastatin-2, MLSN2)" TRPM3 KIAA1616 LTRPC3 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951] GO:0005227; GO:0005261; GO:0005262; GO:0005886; GO:0005887; GO:0006812; GO:0016048; GO:0050951; GO:0051262; GO:0070588; GO:0098655 calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261] ELITVFR 0.98321 -2.1842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1442 0 0 0 0 0 0 0 0 0 0 0 0 0 12.895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6926 0 0 0 0 12.0392 0 0 12.9122 0 0 0 0 0 0 0 0 0 0 0 0 12.0709 13.8166 0 13.9403 0 0 0 0 0 0 11.3036 0 0 11.3934 0 0 9.35922 0 0 0 13.1561 0 0 0 0 0 0 0 0 0 0 0 14.0333 0 11.0219 0 0 0 0 0 0 0 0 14.0069 0 10.3214 0 0 0 11.0976 13.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5794 14.2804 0 0 0 0 0 0 0 10.9078 0 0 0 13.1396 10.513 0 10.5461 0 0 0 9.78226 0 0 0 14.9604 0 0 0 Q9UKM7 MA1B1_HUMAN "Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase, EC 3.2.1.113 (ER alpha-1,2-mannosidase) (ER mannosidase 1, ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)" MAN1B1 UNQ747/PRO1477 Homo sapiens (Human) "endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082]" cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; viral protein processing [GO:0019082]" GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0006491; GO:0009311; GO:0016020; GO:0016021; GO:0019082; GO:0030433; GO:0031410; GO:0036508; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:1903561; GO:1904380; GO:1904382 "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" KFAWGHDELKPVSR 0.98322 -2.1909 0 0 0 0 0 0 0 0 0 0 0 12.2725 0 0 0 0 0 0 0 11.9294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3648 0 0 0 0 12.8259 0 0 0 15.5893 0 0 0 0 13.3624 0 13.8358 0 0 13.0052 0 14.2324 0 0 0 12.5109 0 13.8123 13.2132 0 0 0 0 0 0 10.9554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3807 0 0 0 0 0 0 0 12.6293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1297 0 0 0 0 Q8WVX9 FACR1_HUMAN "Fatty acyl-CoA reductase 1, EC 1.2.1.84 (Male sterility domain-containing protein 2)" FAR1 MLSTD2 UNQ2423/PRO4981 Homo sapiens (Human) ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025] integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025] GO:0005777; GO:0005778; GO:0005779; GO:0008611; GO:0010025; GO:0016491; GO:0035336; GO:0043231; GO:0046474; GO:0080019; GO:0102965 alcohol-forming fatty acyl-CoA reductase activity [GO:0102965]; fatty-acyl-CoA reductase (alcohol-forming) activity [GO:0080019]; oxidoreductase activity [GO:0016491] LIGDRPNTYIYTKALAEYVVQQEGAK 0.98323 3.1687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7807 0 0 12.5379 0 0 0 0 0 11.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1356 0 0 0 0 0 0 13.5513 0 0 0 0 0 0 0 10.89 13.1571 14.4957 0 0 0 15.0445 0 0 0 14.6848 0 14.4988 0 11.3114 0 0 0 0 0 0 0 0 11.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0329 0 0 0 0 0 0 0 P78417 GSTO1_HUMAN "Glutathione S-transferase omega-1, GSTO-1, EC 2.5.1.18 (Glutathione S-transferase omega 1-1, GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase, EC 1.8.5.1) (Monomethylarsonic acid reductase, MMA(V) reductase, EC 1.20.4.2) (S-(Phenacyl)glutathione reductase, SPG-R)" GSTO1 GSTTLP28 Homo sapiens (Human) cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178] GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0060315; GO:0060316; GO:0070062; GO:0071243 glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491] FCPFAERTRLVLK 0.98326 3.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0679 0 0 0 0 0 0 0 11.4089 0 0 0 11.602 0 0 0 0 0 0 Q6NSJ5 LRC8E_HUMAN Volume-regulated anion channel subunit LRRC8E (Leucine-rich repeat-containing protein 8E) LRRC8E Homo sapiens (Human) anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361] cytoplasm [GO:0005737]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361] GO:0005225; GO:0005737; GO:0005886; GO:0005887; GO:0006884; GO:0015810; GO:0030176; GO:0034702; GO:0071470; GO:0098656; GO:0140361; GO:1905103 volume-sensitive anion channel activity [GO:0005225] FPGTSSK 0.98326 -1.4232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2525 0 0 0 0 12.5919 0 0 0 0 0 0 0 0 0 0 0 13.2216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8647 0 13.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.755 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0668 0 0 0 0 0 0 0 0 0 0 12.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H993 ARMT1_HUMAN "Damage-control phosphatase ARMT1, EC 3.1.3.- (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase, EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1)" ARMT1 C6orf211 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020] enzyme binding [GO:0019899]; fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; protein-glutamate O-methyltransferase activity [GO:0008983]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to DNA damage stimulus [GO:0006974]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020] GO:0006974; GO:0008757; GO:0008983; GO:0016791; GO:0019899; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026; GO:2001020 enzyme binding [GO:0019899]; fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; protein-glutamate O-methyltransferase activity [GO:0008983]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] HKSEFFEK 0.98327 -1.4242 0 0 11.3076 0 0 0 0 0 0 0 0 10.3187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.59089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7834 0 0 12.9681 14.6226 0 0 0 0 0 0 0 0 0 12.5349 0 0 0 0 0 0 0 0 0 14.6699 0 0 0 0 0 0 0 0 14.7946 0 0 0 0 0 0 14.8771 0 0 0 0 0 0 0 0 0 0 10.7598 0 0 0 0 15.503 15.2755 15.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4X5 ARI1_HUMAN "E3 ubiquitin-protein ligase ARIH1, EC 2.3.2.31 (H7-AP2) (HHARI) (Monocyte protein 6, MOP-6) (Protein ariadne-1 homolog, ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein) (Ubiquitin-conjugating enzyme E2-binding protein 1)" ARIH1 ARI MOP6 UBCH7BP HUSSY-27 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0015030; GO:0016567; GO:0016604; GO:0019787; GO:0031624; GO:0031625; GO:0032436; GO:0061630; GO:0097413 ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ECPKCHVTIEKDGGCNHMVCR 0.98327 -1.4251 0 0 0 0 0 0 0 0 0 0 0 9.66883 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3276 0 0 0 0 0 13.6185 0 0 0 0 11.2481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1673 0 0 14.3403 0 0 14.3843 0 0 0 14.0268 0 14.2462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9135 0 0 0 14.9341 0 0 0 0 13.73 0 0 0 0 0 0 13.6246 0 0 0 0 0 0 0 0 0 13.9906 14.0885 0 14.0552 0 0 0 0 0 Q96E09 PBIR1_HUMAN PPP2R1A-PPP2R2A-interacting phosphatase regulator 1 (PABIR family member 1) PABIR1 C9orf42 FAM122A Homo sapiens (Human) mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436] GO:0004865; GO:0005634; GO:0005737; GO:0030307; GO:0032436; GO:0044818 protein serine/threonine phosphatase inhibitor activity [GO:0004865] NSTTFPSR 0.98328 -1.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BPZ3 PAIP2_HUMAN "Polyadenylate-binding protein-interacting protein 2, PABP-interacting protein 2, PAIP-2, Poly(A)-binding protein-interacting protein 2" PAIP2 PAIP2A HSPC218 Homo sapiens (Human) memory [GO:0007613]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; regulation of long-term synaptic potentiation [GO:1900271]; spermatogenesis [GO:0007283]; translation [GO:0006412] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; translation repressor activity [GO:0030371]; memory [GO:0007613]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; regulation of long-term synaptic potentiation [GO:1900271]; spermatogenesis [GO:0007283]; translation [GO:0006412] GO:0000900; GO:0003729; GO:0005737; GO:0006412; GO:0007283; GO:0007613; GO:0017148; GO:0030371; GO:0045947; GO:1900271 mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; translation repressor activity [GO:0030371] SNLNPNAK 0.98328 -2.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P45378 TNNT3_HUMAN "Troponin T, fast skeletal muscle, TnTf (Beta-TnTF) (Fast skeletal muscle troponin T, fTnT)" TNNT3 Homo sapiens (Human) muscle contraction [GO:0006936]; positive regulation of calcium-dependent ATPase activity [GO:1903612]; regulation of ATP-dependent activity [GO:0043462]; regulation of striated muscle contraction [GO:0006942]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; troponin complex [GO:0005861] cytosol [GO:0005829]; troponin complex [GO:0005861]; calcium-dependent protein binding [GO:0048306]; tropomyosin binding [GO:0005523]; troponin C binding [GO:0030172]; troponin I binding [GO:0031013]; muscle contraction [GO:0006936]; positive regulation of calcium-dependent ATPase activity [GO:1903612]; regulation of ATP-dependent activity [GO:0043462]; regulation of striated muscle contraction [GO:0006942]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009] GO:0003009; GO:0005523; GO:0005829; GO:0005861; GO:0006936; GO:0006942; GO:0030172; GO:0031013; GO:0043462; GO:0045214; GO:0048306; GO:1903612 calcium-dependent protein binding [GO:0048306]; tropomyosin binding [GO:0005523]; troponin C binding [GO:0030172]; troponin I binding [GO:0031013] KAGTPAK 0.98329 -2.2442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1768 15.7748 0 0 16.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 13.743 0 0 0 0 0 0 15.1997 0 0 0 0 0 13.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H095 DRC9_HUMAN Dynein regulatory complex protein 9 (IQ domain-containing protein G) IQCG DRC9 Homo sapiens (Human) cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286] GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0030544; GO:0031514; GO:0036126; GO:0044782; GO:0070062 calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544] EEDSLEDSNLPPK 0.9833 -2.2491 0 0 0 0 0 0 0 0 0 0 0 0 11.5609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4643 0 0 0 0 0 11.728 12.977 11.604 0 0 0 12.8636 11.2902 0 10.6472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7654 0 0 0 0 0 13.6354 12.0559 0 10.4772 0 0 13.1698 0 0 0 0 0 0 12.3515 0 0 0 0 12.0683 0 0 0 0 0 0 0 10.8958 0 0 0 0 0 0 0 0 0 10.8482 0 0 0 0 0 12.3501 13.6171 0 0 11.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6201 0 12.723 0 0 0 0 Q9BSK2 S2533_HUMAN "Solute carrier family 25 member 33 (Bone marrow stromal cell mitochondrial carrier protein, BMSC-MCP, HuBMSC-MCP) (Protein PNC1)" SLC25A33 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; mitochondria-nucleus signaling pathway [GO:0031930]; mitochondrial genome maintenance [GO:0000002]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of oxidative phosphorylation [GO:0002082]; regulation of reactive oxygen species biosynthetic process [GO:1903426] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; mitochondria-nucleus signaling pathway [GO:0031930]; mitochondrial genome maintenance [GO:0000002]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrial transcription [GO:0006390]; mitochondrion organization [GO:0007005]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of oxidative phosphorylation [GO:0002082]; regulation of reactive oxygen species biosynthetic process [GO:1903426] GO:0000002; GO:0002082; GO:0005739; GO:0005743; GO:0006390; GO:0006864; GO:0007005; GO:0008284; GO:0015218; GO:0016021; GO:0030307; GO:0031930; GO:0031966; GO:0032869; GO:0034551; GO:0051881; GO:1903426; GO:1990314; GO:1990519 pyrimidine nucleotide transmembrane transporter activity [GO:0015218] AVYFACYSK 0.98332 -2.2615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBA8 DTWD2_HUMAN "tRNA-uridine aminocarboxypropyltransferase 2, EC 2.5.1.25 (DTW domain-containing protein 2)" DTWD2 Homo sapiens (Human) tRNA modification [GO:0006400] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-uridine aminocarboxypropyltransferase activity [GO:0016432]; tRNA modification [GO:0006400] GO:0005634; GO:0005737; GO:0006400; GO:0016432 tRNA-uridine aminocarboxypropyltransferase activity [GO:0016432] FSEERDPELSTVCR 0.98336 -2.2168 0 0 0 0 0 0 0 0 0 0 13.9419 0 0 0 11.0426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0799 12.1918 0 0 12.0027 0 0 0 11.3236 0 0 0 12.6751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7013 0 0 0 0 0 13.7577 0 0 0 0 0 14.5379 0 0 0 0 0 0 0 13.4251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1614 0 12.6385 12.7068 0 0 11.8135 12.3862 0 12.6345 15.3961 12.6011 0 12.8399 0 0 0 0 0 0 0 0 0 A6NGY5 O51F1_HUMAN Olfactory receptor 51F1 OR51F1 OR51F1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AIVLILPLLLLLK 0.98337 -2.2183 0 0 0 0 0 0 0 0 0 16.7945 14.4128 14.0603 14.2874 0 0 14.9999 13.7405 14.8615 0 0 0 0 14.2277 13.5792 14.2824 0 0 0 11.7191 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0509 14.0769 0 14.3362 0 0 0 0 0 0 0 0 0 15.9628 0 13.4606 15.2863 0 12.5918 10.9948 14.0573 11.2013 0 0 14.0375 13.4255 13.8881 0 0 0 0 0 12.0599 15.6996 0 0 15.5204 0 11.1582 14.0086 10.6658 14.2214 0 0 15.2178 10.9098 0 0 14.6669 0 0 0 0 11.3225 0 10.319 0 11.7825 0 0 0 0 0 14.3251 0 15.3712 0 0 0 0 15.734 15.9259 0 0 14.4265 13.8378 0 0 0 0 0 0 0 0 0 0 0 12.6372 15.9861 0 0 0 0 12.2475 0 0 12.8207 0 0 0 0 0 0 0 0 14.3302 0 0 0 0 0 0 0 P29275 AA2BR_HUMAN Adenosine receptor A2b ADORA2B Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of synaptic vesicle exocytosis [GO:2000300]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311] glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of synaptic vesicle exocytosis [GO:2000300]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311] GO:0001609; GO:0002882; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007189; GO:0007190; GO:0010575; GO:0010753; GO:0019934; GO:0031284; GO:0031668; GO:0032722; GO:0032755; GO:0042311; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098978; GO:2000300 G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930] IFLVACRQLQR 0.98337 -2.2208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4435 0 0 0 0 0 0 0 0 0 0 0 13.4691 0 0 0 0 0 0 0 0 13.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQG1 SYT3_HUMAN "Synaptotagmin-3 (Synaptotagmin III, SytIII)" SYT3 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] endosome [GO:0005768]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] endosome [GO:0005768]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005768; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0030658; GO:0070382; GO:0071277; GO:1903861 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] ALILVSDLCARVR 0.98338 3.0286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4904 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60809 0 0 0 11.4829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5701 0 0 0 13.2903 0 0 0 0 0 15.9666 0 0 0 0 15.4023 16.0931 0 0 0 0 0 0 11.7879 15.6918 14.4126 0 0 10.5881 0 14.6748 0 0 0 0 0 0 11.1216 0 13.4221 0 0 0 14.7546 0 0 0 0 0 0 14.1655 9.72739 0 0 14.8098 0 0 0 0 14.5941 0 0 0 0 0 0 0 0 0 0 13.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYW3 TA2R7_HUMAN "Taste receptor type 2 member 7, T2R7 (Taste receptor family B member 4, TRB4)" TAS2R7 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] HASLKVIWK 0.98338 -1.4228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96020 CCNE2_HUMAN G1/S-specific cyclin-E2 CCNE2 Homo sapiens (Human) cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723] centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723] GO:0000079; GO:0000082; GO:0000307; GO:0000723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006270; GO:0007129; GO:0016538; GO:0019901; GO:0032880; GO:0044772; GO:0051301; GO:0097134; GO:0097135 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] ALKWELCPVTIISWLNLFLQVDALKDAPK 0.98339 -1.4272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0908 0 0 0 12.6756 11.3233 13.5864 0 13.8357 12.9126 0 0 0 0 0 0 0 0 0 0 11.3605 0 0 0 12.0637 0 0 0 0 0 0 11.224 0 0 0 0 0 15.017 0 0 13.1054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.211 0 0 0 0 0 0 0 0 0 0 0 16.3027 0 0 0 0 13.1061 0 0 0 0 13.2522 13.9372 0 0 0 0 0 0 0 0 0 0 13.0448 12.995 0 0 0 0 12.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5207 0 0 0 0 0 0 0 0 0 0 0 12.7272 0 0 0 0 0 12.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5KU26 COL12_HUMAN "Collectin-12 (Collectin placenta protein 1, CL-P1, hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin)" COLEC12 CLP1 NSR2 SCARA4 SRCL Homo sapiens (Human) "carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]" collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "collagen trimer [GO:0005581]; endocytic vesicle membrane [GO:0030666]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; carbohydrate mediated signaling [GO:0009756]; cellular response to exogenous dsRNA [GO:0071360]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, recognition [GO:0006910]; plasma membrane raft organization [GO:0044857]; toll-like receptor 3 signaling pathway [GO:0034138]" GO:0005044; GO:0005534; GO:0005581; GO:0005615; GO:0005886; GO:0006910; GO:0006952; GO:0009756; GO:0016021; GO:0030169; GO:0030666; GO:0031012; GO:0034138; GO:0038187; GO:0042742; GO:0044857; GO:0045087; GO:0046872; GO:0071360 galactose binding [GO:0005534]; low-density lipoprotein particle binding [GO:0030169]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044] CKNNWALK 0.98339 -2.2333 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8111 0 0 0 0 0 0 0 12.5883 0 0 0 0 10.6448 0 0 0 0 0 10.5799 0 11.0505 0 0 0 0 0 0 0 0 0 0 0 0 11.2345 0 0 0 0 0 0 0 12.4742 10.6643 0 0 0 0 0 0 0 0 0 0 0 11.2156 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8452 0 0 0 0 0 0 15.2362 13.5078 0 0 0 0 0 0 0 0 0 0 0 15.0958 0 11.7959 0 0 0 0 0 14.0238 0 0 0 0 0 0 0 0 0 0 15.2437 0 0 0 0 0 0 0 15.2791 0 0 0 0 0 0 0 18.8657 0 0 0 0 0 0 0 0 12.2207 0 12.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1475 O15037 KHNYN_HUMAN Protein KHNYN (KH and NYN domain-containing protein) KHNYN KIAA0323 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0090502 endoribonuclease activity [GO:0004521]; mRNA binding [GO:0003729] ISSYDDRFMVK 0.9834 -2.2408 0 0 0 0 0 0 0 0 0 0 0 12.1434 0 11.1317 0 0 0 0 0 0 0 0 0 0 11.6325 0 0 0 12.5652 0 0 13.8312 0 0 0 15.1047 0 11.938 0 0 0 13.8264 0 0 0 0 0 0 0 0 0 0 0 0 14.2106 0 0 0 0 0 0 0 0 0 0 11.4464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3478 0 0 0 0 0 0 0 12.8344 0 12.3594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6376 0 0 O75380 NDUS6_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A, CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)" NDUFS6 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009055; GO:0009060; GO:0042776 electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137] IRFVGRQK 0.9834 -2.2438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2915 13.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2383 0 0 0 0 0 0 0 0 12.2423 12.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2779 12.593 13.0426 0 0 0 13.0817 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4916 10.791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUU3 FOXNB_HUMAN FOXL2 neighbor protein FOXL2NB C3orf72 Homo sapiens (Human) fibrillar center [GO:0001650] fibrillar center [GO:0001650] GO:0001650 AQKTGPGILQQR 0.9834 -1.4327 0 11.8636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4082 0 13.62 14.0875 0 14.7608 14.3485 0 0 0 14.4897 0 0 14.395 0 15.9754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7559 0 0 14.7466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7868 0 14.0872 0 14.2252 14.4437 15.4267 13.659 0 14.6448 14.4293 15.6138 0 0 0 0 0 13.8658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1507 15.2734 0 0 0 0 0 O00237 RN103_HUMAN "E3 ubiquitin-protein ligase RNF103, EC 2.3.2.27 (KF-1, hKF-1) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103 homolog, Zfp-103)" RNF103 ZFP103 Homo sapiens (Human) central nervous system development [GO:0007417]; endoplasmic reticulum mannose trimming [GO:1904380]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; central nervous system development [GO:0007417]; endoplasmic reticulum mannose trimming [GO:1904380]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0004842; GO:0005783; GO:0005789; GO:0007417; GO:0016021; GO:0016567; GO:0030433; GO:0044322; GO:0046872; GO:0061630; GO:1904380 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] FGIRTGTFNCSSDPR 0.98343 -2.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0325 12.4276 0 10.9845 0 10.7107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4767 0 0 0 0 0 0 0 14.9701 13.0979 0 0 11.0616 0 0 0 0 0 0 0 12.0859 0 0 10.8702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8681 0 0 0 0 0 0 0 0 0 13.1026 0 0 0 0 0 13.3302 0 13.5435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.586 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1Z2 CACO1_HUMAN Calcium-binding and coiled-coil domain-containing protein 1 (Calphoglin) (Coiled-coil coactivator protein) (Sarcoma antigen NY-SAR-3) CALCOCO1 KIAA1536 PP13275 UNQ2436/PRO4996 Homo sapiens (Human) "intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000976; GO:0000978; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005829; GO:0007165; GO:0008013; GO:0008022; GO:0010628; GO:0016055; GO:0030374; GO:0030518; GO:0043231; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0070016 armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] AGLLQSVEAEKDKILK 0.98344 -2.2751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2394 0 0 0 0 0 0 0 0 0 0 0 11.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTB9 ZN833_HUMAN Putative zinc finger protein 833 ZNF833P ZNF833 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] MVMHSEDEPYKCK 0.98345 3.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4095 0 0 0 0 0 0 0 0 0 12.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72146 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55851 UCP2_HUMAN "Mitochondrial uncoupling protein 2, UCP 2 (Solute carrier family 25 member 8) (UCPH)" UCP2 SLC25A8 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidative phosphorylation uncoupler activity [GO:0017077]; transmembrane transporter activity [GO:0022857]; adaptive thermogenesis [GO:1990845]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; female pregnancy [GO:0007565]; liver regeneration [GO:0097421]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; positive regulation of cell death [GO:0010942]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of mitochondrial membrane potential [GO:0051881]; response to cold [GO:0009409]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to superoxide [GO:0000303] GO:0000303; GO:0001666; GO:0005739; GO:0005743; GO:0006839; GO:0007565; GO:0007568; GO:0009409; GO:0010942; GO:0016021; GO:0017077; GO:0022857; GO:0032869; GO:0034198; GO:0043066; GO:0051881; GO:0061179; GO:0070542; GO:0071333; GO:0097421; GO:0120162; GO:1902600; GO:1990542; GO:1990845 oxidative phosphorylation uncoupler activity [GO:0017077]; transmembrane transporter activity [GO:0022857] ATASAQYR 0.98347 -2.2182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.198 0 0 0 0 11.4434 0 0 0 0 0 10.0619 0 12.0228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4908 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96001 PPR17_HUMAN Protein phosphatase 1 regulatory subunit 17 (G-substrate) PPP1R17 C7orf16 GSBS Homo sapiens (Human) central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; regulation of phosphatase activity [GO:0010921] protein serine/threonine phosphatase inhibitor activity [GO:0004865]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; regulation of phosphatase activity [GO:0010921] GO:0004865; GO:0007417; GO:0010921; GO:0035556 protein serine/threonine phosphatase inhibitor activity [GO:0004865] LDKLDPR 0.98349 -1.4155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20702 ITAX_HUMAN "Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)" ITGAX CD11C Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; defense response to virus [GO:0051607]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial tube morphogenesis [GO:1905956]; positive regulation of gene expression [GO:0010628]; positive regulation of myelination [GO:0031643] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; defense response to virus [GO:0051607]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial tube morphogenesis [GO:1905956]; positive regulation of gene expression [GO:0010628]; positive regulation of myelination [GO:0031643] GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008284; GO:0008305; GO:0009887; GO:0009897; GO:0009986; GO:0010628; GO:0016020; GO:0030335; GO:0030667; GO:0030971; GO:0031643; GO:0033627; GO:0034113; GO:0034689; GO:0038023; GO:0045766; GO:0046872; GO:0051607; GO:0070821; GO:0098609; GO:0101003; GO:1905956 integrin binding [GO:0005178]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023] AVIFTQVSRQWRMK 0.98349 3.0195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5215 0 12.4997 0 10.5726 0 0 0 0 0 0 0 0 0 0 0 15.8597 0 0 0 0 0 0 0 0 0 13.513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66899 12.6689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30519 HMOX2_HUMAN "Heme oxygenase 2, HO-2, EC 1.14.14.18 [Cleaved into: Heme oxygenase 2 soluble form ]" HMOX2 HO2 Homo sapiens (Human) heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; iron ion homeostasis [GO:0055072]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; iron ion homeostasis [GO:0055072]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979] GO:0001666; GO:0004392; GO:0005789; GO:0005886; GO:0006788; GO:0006979; GO:0016020; GO:0016021; GO:0020037; GO:0035579; GO:0042167; GO:0046872; GO:0055072 heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872] DMEYFFGENWEEQVQCPK 0.98349 -1.4137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8144 0 0 0 0 P36896 ACV1B_HUMAN "Activin receptor type-1B, EC 2.7.11.30 (Activin receptor type IB, ACTR-IB) (Activin receptor-like kinase 4, ALK-4) (Serine/threonine-protein kinase receptor R2, SKR2)" ACVR1B ACVRLK4 ALK4 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]" activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "activin receptor complex [GO:0048179]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; cellular response to growth factor stimulus [GO:0071363]; extrinsic apoptotic signaling pathway [GO:0097191]; G1/S transition of mitotic cell cycle [GO:0000082]; hair follicle development [GO:0001942]; in utero embryonic development [GO:0001701]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; nodal signaling pathway [GO:0038092]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of trophoblast cell migration [GO:1901165]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]" GO:0000082; GO:0001701; GO:0001942; GO:0004674; GO:0004675; GO:0005524; GO:0005829; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007399; GO:0009986; GO:0010628; GO:0010629; GO:0016361; GO:0018107; GO:0030308; GO:0031625; GO:0032924; GO:0032927; GO:0034711; GO:0038092; GO:0043235; GO:0045648; GO:0046332; GO:0046777; GO:0046872; GO:0048179; GO:0048185; GO:0071363; GO:0097191; GO:1901165 "activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; inhibin binding [GO:0034711]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; ubiquitin protein ligase binding [GO:0031625]" DNGTWTQLWLVSDYHEHGSLFDYLNR 0.98349 -2.2329 0 0 0 0 0 0 0 0 14.5754 0 0 0 13.4341 0 0 0 0 0 0 0 10.721 0 0 0 0 12.524 0 0 9.99831 12.9782 0 0 0 0 0 0 0 0 0 13.324 13.9466 0 0 0 12.2154 0 0 14.1463 0 0 0 0 0 0 0 12.3668 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6819 0 0 0 0 13.8397 0 0 12.1485 0 11.8828 12.0245 0 12.4781 0 13.1676 12.9153 0 0 0 0 0 11.5436 0 13.0756 0 13.3192 0 0 0 14.5639 12.9586 0 0 0 0 0 0 11.3787 12.2772 12.4951 12.6973 0 0 0 0 0 13.2851 13.9447 0 13.4328 0 0 0 0 0 0 0 0 0 0 0 0 13.7074 0 0 14.0537 0 0 14.24 0 0 0 0 12.8709 12.977 13.138 0 0 0 0 0 0 0 0 0 13.2439 0 0 0 0 0 0 0 0 0 0 0 10.5366 0 12.5793 0 0 12.5179 0 0 11.4147 0 0 0 13.2139 Q18PE1 DOK7_HUMAN Protein Dok-7 (Downstream of tyrosine kinase 7) DOK7 C4orf25 Homo sapiens (Human) neuromuscular junction development [GO:0007528]; positive regulation of protein tyrosine kinase activity [GO:0061098] anchoring junction [GO:0070161]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; neuromuscular junction development [GO:0007528]; positive regulation of protein tyrosine kinase activity [GO:0061098] GO:0005654; GO:0005739; GO:0005886; GO:0007528; GO:0008289; GO:0019901; GO:0045202; GO:0061098; GO:0070161 lipid binding [GO:0008289]; protein kinase binding [GO:0019901] PGSGGDDR 0.98349 -1.4195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4867 0 12.8952 0 Q9BQ15 SOSB1_HUMAN "SOSS complex subunit B1 (Nucleic acid-binding protein 2) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B) (Sensor of single-strand DNA complex subunit B1) (Sensor of ssDNA subunit B1, SOSS-B1) (Single-stranded DNA-binding protein 1, hSSB1)" NABP2 OBFC2B SSB1 LP3587 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of telomere capping [GO:1904355]; response to ionizing radiation [GO:0010212] "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of telomere capping [GO:1904355]; response to ionizing radiation [GO:0010212]" GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010212; GO:0035861; GO:0044818; GO:0070182; GO:0070200; GO:0070876; GO:0098505; GO:1904355 DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697] DIKPGLKNLNLIFIVLETGR 0.9835 -2.2374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6977 0 0 0 0 0 0 11.5782 0 0 0 12.3127 0 0 0 0 0 0 13.1243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5144 15.1985 0 0 0 0 0 0 0 0 13.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5895 0 O60610 DIAP1_HUMAN "Protein diaphanous homolog 1 (Diaphanous-related formin-1, DRF1)" DIAPH1 DIAP1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]; actin binding [GO:0003779]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; positive regulation of cell migration [GO:0030335]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605] GO:0003723; GO:0003779; GO:0005102; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0007010; GO:0007605; GO:0008360; GO:0030036; GO:0030041; GO:0030335; GO:0030667; GO:0031267; GO:0032587; GO:0032886; GO:0035372; GO:0044325; GO:0051279; GO:0051493; GO:0071420; GO:0072686; GO:0101003 actin binding [GO:0003779]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] AMDPAVPNMMIDAAK 0.98351 -1.4287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8967 0 0 0 0 0 0 0 0 0 0 12.7617 0 0 0 0 15.1626 0 13.4671 14.2277 14.9729 0 0 0 0 11.6632 0 0 13.1715 0 0 0 0 14.8332 0 0 0 0 0 0 0 0 13.9659 0 0 0 13.5501 13.0291 0 0 0 0 0 0 0 15.2422 0 0 0 0 14.1976 12.8456 0 0 0 0 13.2812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78552 I13R1_HUMAN "Interleukin-13 receptor subunit alpha-1, IL-13 receptor subunit alpha-1, IL-13R subunit alpha-1, IL-13R-alpha-1, IL-13RA1 (Cancer/testis antigen 19, CT19) (CD antigen CD213a1)" IL13RA1 IL13R IL13RA Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284] external side of plasma membrane [GO:0009897]; interleukin-13 receptor complex [GO:0005898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; interleukin-13 receptor complex [GO:0005898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284] GO:0004896; GO:0004923; GO:0005127; GO:0005886; GO:0005898; GO:0007166; GO:0008284; GO:0009897; GO:0019221; GO:0019955; GO:0038165; GO:0043235 ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923] DNAGKIK 0.98351 -1.4316 0 0 0 0 0 0 0 0 0 13.6469 0 0 0 0 13.2896 0 0 0 0 0 0 0 0 11.5943 0 0 0 0 12.0783 0 0 0 0 0 0 0 0 0 0 0 0 10.8741 0 11.5181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7234 11.2331 0 0 0 0 12.1951 0 10.6576 0 0 0 12.6842 11.3395 0 12.9658 0 12.3371 12.6866 0 0 10.5413 0 12.6586 0 13.6058 10.7279 0 0 0 15.1697 0 0 10.5144 0 0 0 0 0 0 0 0 0 0 0 11.9929 12.0867 0 14.7311 0 0 0 0 0 13.9251 11.5381 0 0 0 0 11.9256 12.0503 0 0 0 10.3363 12.5099 0 0 13.6531 13.7948 0 0 0 0 0 0 15.5552 0 0 12.164 0 0 0 13.9479 13.3796 0 0 0 0 0 0 0 0 0 0 0 11.7698 0 0 0 0 12.9699 0 0 11.4493 0 0 0 0 0 0 12.8169 0 Q9BY71 LRRC3_HUMAN Leucine-rich repeat-containing protein 3 LRRC3 C21orf102 LRRC3A UNQ9233/PRO31982 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 DPIGPGP 0.98351 -2.2404 0 13.5166 0 15.4859 0 0 0 0 16.9076 16.4202 12.3248 16.2258 13.0755 0 0 16.4379 16.4 14.375 16.8106 15.9906 16.4616 11.6345 17.9576 0 13.6126 16.7133 17.4452 16.5495 16.5995 16.4291 16.681 16.6478 11.9705 13.3012 0 13.8868 11.8061 11.9259 14.7384 0 16.7229 16.4811 16.5545 0 16.4999 16.2129 13.5887 16.4732 0 0 0 0 0 10.8306 0 0 10.7101 0 0 9.90069 10.0638 0 0 0 0 0 0 0 0 0 0 0 13.3076 0 16.7219 16.7751 15.2201 17.0656 0 15.2618 13.5994 14.5673 17.8824 18.2111 18.1497 18.4803 19.1711 16.7505 17.0417 14.9495 17.6281 13.7434 14.8841 15.1638 12.6507 15.9915 18.0802 16.6274 17.0465 15.3876 14.9253 15.2189 13.8277 0 0 15.9195 16.0619 14.8952 14.0008 12.9521 13.2664 14.2719 13.2767 15.3716 15.2637 17.5599 17.5692 17.2242 13.1966 13.7805 12.5981 15.8714 15.1599 13.0939 15.5856 13.1817 0 12.1731 13.0811 14.5329 14.6847 13.4073 14.4209 14.172 17.1026 17.1741 17.5633 12.9473 14.4181 17.554 15.1529 14.8957 0 17.2068 17.2585 15.5538 17.2098 17.1359 17.293 14.076 14.503 12.7206 0 0 0 0 13.3063 0 0 0 0 0 13.4074 12.3267 14.6092 14.0858 0 14.1544 17.2807 15.2641 13.4852 14.0865 17.3007 16.9867 16.982 17.0296 0 14.3529 17.0371 0 P36507 MP2K2_HUMAN "Dual specificity mitogen-activated protein kinase kinase 2, MAP kinase kinase 2, MAPKK 2, EC 2.7.12.2 (ERK activator kinase 2) (MAPK/ERK kinase 2, MEK 2)" MAP2K2 MEK2 MKK2 PRKMK2 Homo sapiens (Human) "epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell motility [GO:2000147]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]" cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778] "cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell motility [GO:2000147]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]" GO:0000165; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005576; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005778; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0005911; GO:0005925; GO:0007507; GO:0009898; GO:0030165; GO:0030878; GO:0032872; GO:0036289; GO:0043539; GO:0045893; GO:0046872; GO:0048471; GO:0048538; GO:0048679; GO:0050772; GO:0060324; GO:0060440; GO:0060502; GO:0070371; GO:0071902; GO:0090170; GO:0097110; GO:0106310; GO:1903800; GO:2000147; GO:2000641 ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110] ADLKMLTNHTFIKR 0.98352 3.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0533 0 0 0 0 0 0 0 0 0 0 0 0 0 14.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9096 0 0 0 0 0 13.5304 0 0 0 14.1519 0 0 0 0 0 0 0 0 15.6288 0 12.7993 0 0 0 0 0 0 0 0 0 14.2962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P260 RELCH_HUMAN "RAB11-binding protein RELCH (LisH domain and HEAT repeat-containing protein KIAA1468) (RAB11 binding and LisH domain, coiled-coil and HEAT repeat-containing) (RAB11-binding protein containing LisH, coiled-coil, and HEAT repeats)" RELCH KIAA1468 Homo sapiens (Human) intracellular cholesterol transport [GO:0032367] recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367] GO:0005802; GO:0032367; GO:0055037 DEFVIPHLHKLALVNNLQIVDSKR 0.98352 -1.4324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9421 0 0 0 0 0 0 0 15.464 0 0 0 0 0 0 0 0 0 11.2623 0 0 11.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9523 0 0 16.4654 0 0 0 0 0 11.7013 0 0 0 0 0 0 0 0 P02763 A1AG1_HUMAN "Alpha-1-acid glycoprotein 1, AGP 1 (Orosomucoid-1, OMD 1)" ORM1 AGP1 Homo sapiens (Human) acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune system process [GO:0002682] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune system process [GO:0002682] GO:0002682; GO:0005576; GO:0005615; GO:0006953; GO:0006954; GO:0031093; GO:0032715; GO:0032720; GO:0032731; GO:0032732; GO:0032760; GO:0035580; GO:0062023; GO:0070062; GO:0072562; GO:1904724 DKCEPLEK 0.98354 -1.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96Q45 TM237_HUMAN Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein) TMEM237 ALS2CR4 Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111] ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200] ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200]; cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111] GO:0016020; GO:0016021; GO:0030111; GO:0032391; GO:0035869; GO:0060271; GO:0120199; GO:0120200 EKEIKASS 0.98354 -2.2686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16602 CALRL_HUMAN "Calcitonin gene-related peptide type 1 receptor, CGRP type 1 receptor (Calcitonin receptor-like receptor)" CALCRL CGRPR Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to sucrose stimulus [GO:0071329]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; heart development [GO:0007507]; negative regulation of inflammatory response [GO:0050728]; negative regulation of smooth muscle contraction [GO:0045986]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; vascular associated smooth muscle cell proliferation [GO:1990874]" adrenomedullin receptor complex [GO:1903143]; CGRP receptor complex [GO:1990406]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886] "adrenomedullin receptor complex [GO:1903143]; CGRP receptor complex [GO:1990406]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenomedullin receptor signaling pathway [GO:1990410]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to sucrose stimulus [GO:0071329]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; heart development [GO:0007507]; negative regulation of inflammatory response [GO:0050728]; negative regulation of smooth muscle contraction [GO:0045986]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; vascular associated smooth muscle cell proliferation [GO:1990874]" GO:0001525; GO:0001605; GO:0001635; GO:0004930; GO:0004948; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005886; GO:0005887; GO:0006816; GO:0007166; GO:0007187; GO:0007188; GO:0007189; GO:0007507; GO:0008528; GO:0015031; GO:0031623; GO:0045986; GO:0050728; GO:0071329; GO:1903143; GO:1904707; GO:1990406; GO:1990408; GO:1990409; GO:1990410; GO:1990874 adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; calcitonin gene-related peptide receptor activity [GO:0001635]; calcitonin receptor activity [GO:0004948]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930] AVRATLILVPLLGIEFVLIPWR 0.98355 -2.2751 0 0 0 0 19.5997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2384 0 0 0 0 0 0 0 17.0607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAY7 F110D_HUMAN Protein FAM110D FAM110D GRRP1 Homo sapiens (Human) ERFFNYCGLER 0.98355 -2.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6957 16.8647 0 0 0 0 0 0 13.9209 0 13.2427 0 0 0 14.8969 15.0357 15.3651 15.5565 14.2187 15.5044 15.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3977 0 0 0 13.5425 0 0 13.4803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1443 0 0 0 0 0 0 0 0 17.277 0 0 0 0 0 12.8954 12.9639 0 0 0 0 16.0474 0 0 0 0 0 0 0 0 0 0 Q8TEY5 CR3L4_HUMAN "Cyclic AMP-responsive element-binding protein 3-like protein 4, cAMP-responsive element-binding protein 3-like protein 4 (Androgen-induced basic leucine zipper protein, AIbZIP) (Attaching to CRE-like 1, ATCE1) (Cyclic AMP-responsive element-binding protein 4, CREB-4, cAMP-responsive element-binding protein 4) (Transcript induced in spermiogenesis protein 40, Tisp40) (hJAL) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4 ]" CREB3L4 AIBZIP CREB4 JAL Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; endoplasmic reticulum unfolded protein response [GO:0030968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000139; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0006357; GO:0007283; GO:0016021; GO:0030968; GO:0031965; GO:0035497; GO:0045944; GO:1990837 "cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" KVQELERHNISLVAQLR 0.98357 -1.3959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6956 0 0 0 13.0171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0016 13.3301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WY22 BRI3B_HUMAN "BRI3-binding protein, I3-binding protein (Cervical cancer 1 proto-oncogene-binding protein KG19) (HCCRBP-1)" BRI3BP KG19 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] GO:0005739; GO:0005741; GO:0016021 AGLLLLLLLLLLLGLLAPGAQGAR 0.98357 -1.3936 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5079 0 0 0 0 11.7738 0 0 0 0 0 0 0 10.8924 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9591 12.1451 0 0 13.1539 12.8698 0 12.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5098 0 0 13.1375 0 13.8087 0 0 0 0 11.6594 0 13.2466 12.3949 13.2336 0 0 0 0 0 0 0 0 13.2338 0 0 0 0 14.8507 12.5661 0 12.0654 12.3952 0 0 13.1577 14.2645 15.6019 0 15.239 13.2283 0 0 13.817 0 0 12.3788 0 12.5539 0 0 13.147 0 12.9842 12.6151 12.8888 12.9063 15.3027 12.651 13.5265 13.3826 0 0 13.2673 12.937 14.1478 0 14.8869 0 0 12.6682 13.6342 11.8951 13.4535 0 0 14.7127 0 0 14.2967 0 0 0 0 14.0435 0 0 15.1394 0 0 0 13.0725 0 0 0 0 0 0 11.6645 0 13.0789 0 0 0 12.8755 12.3591 14.1794 0 0 11.5693 0 0 12.1338 Q14409 GLPK3_HUMAN "Glycerol kinase 3, GK 3, Glycerokinase 3, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 3) (Glycerol kinase 3 pseudogene) (Glycerol kinase, testis specific 1)" GK3P GKP3 GKTB Homo sapiens (Human) glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]" GO:0004370; GO:0005524; GO:0005739; GO:0005741; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167 "ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" EGWVEQDPK 0.98359 -3.1399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.839 0 10.9819 0 0 0 0 0 0 0 13.9748 0 0 0 12.9592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6862 0 0 0 0 0 0 0 Q13557 KCC2D_HUMAN "Calcium/calmodulin-dependent protein kinase type II subunit delta, CaM kinase II subunit delta, CaMK-II subunit delta, EC 2.7.11.17" CAMK2D CAMKD Homo sapiens (Human) cardiac muscle cell contraction [GO:0086003]; cellular response to calcium ion [GO:0071277]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cell growth [GO:0001558]; regulation of cellular localization [GO:0060341]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of histone deacetylase activity [GO:1901725]; regulation of membrane depolarization [GO:0003254]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of transcription by RNA polymerase II [GO:0006357]; relaxation of cardiac muscle [GO:0055119] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017] calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel inhibitor activity [GO:0019871]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325]; cardiac muscle cell contraction [GO:0086003]; cellular response to calcium ion [GO:0071277]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cell growth [GO:0001558]; regulation of cellular localization [GO:0060341]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of histone deacetylase activity [GO:1901725]; regulation of membrane depolarization [GO:0003254]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of transcription by RNA polymerase II [GO:0006357]; relaxation of cardiac muscle [GO:0055119] GO:0001558; GO:0002026; GO:0003254; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005954; GO:0006357; GO:0006468; GO:0008016; GO:0010613; GO:0010649; GO:0010666; GO:0010880; GO:0010881; GO:0016020; GO:0018105; GO:0018107; GO:0019871; GO:0030666; GO:0031432; GO:0032469; GO:0033017; GO:0042383; GO:0042802; GO:0042803; GO:0043005; GO:0044325; GO:0046777; GO:0055119; GO:0060314; GO:0060341; GO:0071277; GO:0086003; GO:0086091; GO:0098901; GO:0098909; GO:0106310; GO:1901725; GO:1901844; GO:1901897; GO:1902306; GO:1902514; GO:2000650 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel inhibitor activity [GO:0019871]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325] FTDEYQLFEELGKGAFSVVR 0.9836 -1.4137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8273 0 0 0 0 0 0 0 12.5124 11.3352 0 0 0 0 0 0 0 0 0 13.7258 12.6941 11.9216 0 0 0 0 0 0 0 0 0 0 14.0714 0 0 0 0 13.5439 0 0 12.7904 0 0 0 0 0 0 13.6387 0 11.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3I7 BBS5_HUMAN Bardet-Biedl syndrome 5 protein BBS5 Homo sapiens (Human) cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; motile cilium assembly [GO:0044458]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0001947; GO:0005829; GO:0005930; GO:0007601; GO:0015031; GO:0032266; GO:0032402; GO:0034451; GO:0034464; GO:0036064; GO:0044458; GO:0046907; GO:0050896; GO:0060170; GO:0060271; GO:0061629 phosphatidylinositol-3-phosphate binding [GO:0032266]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] LLVTNLRILWHSLALSR 0.9836 -1.4098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LR7 CB050_HUMAN Uncharacterized protein C2orf50 C2orf50 Homo sapiens (Human) LEDQMQPI 0.98361 -1.4185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0171 0 0 0 0 0 0 0 0 0 13.2269 0 0 0 0 14.2703 0 0 0 16.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6673 0 12.9703 0 0 0 0 0 0 0 13.53 0 0 0 0 0 0 0 0 13.0399 0 0 0 0 0 0 0 12.6223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4042 0 0 0 0 0 0 11.9707 Q8TF44 C2C4C_HUMAN C2 calcium-dependent domain-containing protein 4C (Nuclear-localized factor 3) (Protein FAM148C) C2CD4C FAM148C KIAA1957 NLF3 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 AQTSYGFAMLAESPHTR 0.98362 -2.3002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6406 0 0 13.3212 0 0 0 0 0 0 0 0 0 13.9047 0 0 0 0 0 0 0 0 0 0 P02745 C1QA_HUMAN Complement C1q subcomponent subunit A C1QA Homo sapiens (Human) "aging [GO:0007568]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement-mediated synapse pruning [GO:0150062]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; neuron remodeling [GO:0016322]; positive regulation of neuron death [GO:1901216]; synapse organization [GO:0050808]; synapse pruning [GO:0098883]; vertebrate eye-specific patterning [GO:0150064]" collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; complement component C1 complex [GO:0005602]; complement component C1q complex [GO:0062167]; extracellular region [GO:0005576]; postsynapse [GO:0098794]; synapse [GO:0045202] "collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; complement component C1 complex [GO:0005602]; complement component C1q complex [GO:0062167]; extracellular region [GO:0005576]; postsynapse [GO:0098794]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; aging [GO:0007568]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; complement-mediated synapse pruning [GO:0150062]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; neuron remodeling [GO:0016322]; positive regulation of neuron death [GO:1901216]; synapse organization [GO:0050808]; synapse pruning [GO:0098883]; vertebrate eye-specific patterning [GO:0150064]" GO:0001540; GO:0001774; GO:0005576; GO:0005581; GO:0005602; GO:0006956; GO:0006958; GO:0007267; GO:0007568; GO:0016322; GO:0045087; GO:0045202; GO:0048143; GO:0050808; GO:0062023; GO:0062167; GO:0098794; GO:0098883; GO:0150062; GO:0150064; GO:1901216 amyloid-beta binding [GO:0001540] GEQGEPGAPGIRTGIQGLK 0.98363 -1.4324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0466 0 0 0 0 0 0 13.201 11.862 13.2612 14.5875 16.4644 15.3841 0 0 0 0 0 12.1472 0 0 0 0 0 0 14.7106 14.9154 0 0 0 0 13.3566 13.313 0 0 0 0 12.3644 13.0927 0 0 12.9993 13.0925 0 0 0 0 0 14.8027 14.0376 13.8059 0 0 0 0 14.3565 0 0 0 0 0 16.0358 13.0194 14.8033 13.3838 13.5331 14.3003 0 0 13.5971 0 14.0739 0 0 0 0 14.0813 0 0 0 0 0 0 13.7724 0 13.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5359 14.7625 13.3225 0 0 0 13.7717 0 Q8IUC4 RHPN2_HUMAN Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE) RHPN2 Homo sapiens (Human) glomerular filtration [GO:0003094]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; glomerular filtration [GO:0003094]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165] GO:0003094; GO:0005829; GO:0005886; GO:0007165; GO:0048471; GO:0051497 AVRMRTGAENLLK 0.98364 -2.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.67894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7784 0 11.7606 0 0 0 0 12.1608 0 0 0 0 0 12.6724 0 0 0 0 0 0 0 0 11.6903 0 0 0 0 12.611 0 0 0 0 0 0 12.8425 11.4958 0 13.0813 0 0 0 0 0 14.0401 13.8249 0 13.6917 0 0 0 0 0 0 12.1713 0 0 14.5034 0 0 14.5643 12.23 0 13.7768 12.5474 13.1279 0 0 13.2211 0 0 0 0 0 0 0 0 0 11.5504 0 0 0 0 12.1739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7248 0 0 0 12.2439 0 10.2452 Q9H6R3 ACSS3_HUMAN "Acyl-CoA synthetase short-chain family member 3, mitochondrial, EC 6.2.1.1 (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase, EC 6.2.1.17)" ACSS3 Homo sapiens (Human) ketone body biosynthetic process [GO:0046951]; lipid metabolic process [GO:0006629] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218]; ketone body biosynthetic process [GO:0046951]; lipid metabolic process [GO:0006629] GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006629; GO:0043231; GO:0046951; GO:0047760; GO:0050218 acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; propionate-CoA ligase activity [GO:0050218] AIRQQDPGAALGKQYSLTR 0.98364 -2.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9402 0 0 0 13.0718 0 0 0 14.2791 13.6584 0 16.7004 14.671 14.3976 13.5293 0 16.643 16.4927 0 0 0 0 0 15.7711 15.4954 0 0 0 16.1571 0 15.2898 15.435 14.9839 0 0 16.2576 16.264 0 16.0083 0 0 0 0 15.9403 15.7197 0 15.9192 0 0 15.6808 15.54 0 0 0 0 0 14.2398 15.3202 15.0796 15.2311 0 0 0 14.7693 14.7996 0 0 0 0 0 0 14.8474 0 0 0 0 0 15.0694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7988 0 0 0 0 0 0 14.776 Q15672 TWST1_HUMAN "Twist-related protein 1 (Class A basic helix-loop-helix protein 38, bHLHa38) (H-twist)" TWIST1 BHLHA38 TWIST Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in heart valve development [GO:2000793]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cranial suture morphogenesis [GO:0060363]; developmental process [GO:0032502]; embryonic camera-type eye formation [GO:0060900]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion morphogenesis [GO:0003203]; eyelid development in camera-type eye [GO:0061029]; in utero embryonic development [GO:0001701]; mitral valve morphogenesis [GO:0003183]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; outer ear morphogenesis [GO:0042473]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell motility [GO:2000147]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [GO:2000802]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of bone mineralization [GO:0030500]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; roof of mouth development [GO:0060021]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator binding [GO:0001221]; aortic valve morphogenesis [GO:0003180]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cell proliferation involved in heart valve development [GO:2000793]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cranial suture morphogenesis [GO:0060363]; developmental process [GO:0032502]; embryonic camera-type eye formation [GO:0060900]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion morphogenesis [GO:0003203]; eyelid development in camera-type eye [GO:0061029]; in utero embryonic development [GO:0001701]; mitral valve morphogenesis [GO:0003183]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; outer ear morphogenesis [GO:0042473]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell motility [GO:2000147]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [GO:2000802]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of bone mineralization [GO:0030500]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; roof of mouth development [GO:0060021]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001221; GO:0001503; GO:0001649; GO:0001701; GO:0001764; GO:0001843; GO:0003180; GO:0003183; GO:0003203; GO:0003253; GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0010628; GO:0010718; GO:0010936; GO:0014067; GO:0019904; GO:0030500; GO:0032000; GO:0032502; GO:0032720; GO:0032755; GO:0032760; GO:0033128; GO:0035067; GO:0035115; GO:0035116; GO:0035359; GO:0042473; GO:0042476; GO:0042733; GO:0042803; GO:0043066; GO:0043425; GO:0043433; GO:0043518; GO:0045668; GO:0045766; GO:0045843; GO:0045892; GO:0045944; GO:0048511; GO:0048642; GO:0048701; GO:0050679; GO:0060021; GO:0060363; GO:0060900; GO:0061029; GO:0070888; GO:0071363; GO:0071456; GO:0071639; GO:0140297; GO:2000144; GO:2000147; GO:2000276; GO:2000679; GO:2000773; GO:2000780; GO:2000793; GO:2000802 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coregulator binding [GO:0001221]" IQTLKLAAR 0.98365 -1.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4992 0 0 0 0 0 0 0 12.893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6V702 CF299_HUMAN Cilia- and flagella-associated protein 299 CFAP299 C4orf22 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 KAAIEIAR 0.98365 -1.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6042 0 0 0 0 0 0 0 0 0 12.4405 0 0 0 0 0 12.3893 13.1661 0 12.7432 0 13.3133 14.9775 0 15.0856 0 0 0 14.0866 13.5335 13.3791 0 0 0 15.1683 16.628 0 0 13.4855 12.8953 0 0 0 0 0 0 16.6929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7227 0 0 0 0 0 0 0 0 0 0 0 12.1986 0 0 14.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.14 13.7463 0 0 0 0 0 0 0 Q8WWG9 KCNE4_HUMAN Potassium voltage-gated channel subfamily E member 4 (MinK-related peptide 3) (Minimum potassium ion channel-related peptide 3) (Potassium channel subunit beta MiRP3) KCNE4 Homo sapiens (Human) membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; potassium ion export across plasma membrane [GO:0097623]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; potassium ion export across plasma membrane [GO:0097623]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0005249; GO:0015459; GO:0016021; GO:0016324; GO:0044325; GO:0060307; GO:0086005; GO:0086011; GO:0086091; GO:0097623; GO:0098915; GO:1902260 potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] PLPVVSGLR 0.98365 -2.2685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2117 13.0573 0 0 0 0 0 0 0 0 13.3693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1179 0 0 12.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7823 0 0 0 0 0 13.3472 0 0 13.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2X6 HIPK2_HUMAN "Homeodomain-interacting protein kinase 2, hHIPk2, EC 2.7.11.1" HIPK2 Homo sapiens (Human) "adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]" cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790]; adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]" GO:0000122; GO:0001654; GO:0001934; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006978; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0030182; GO:0030218; GO:0030511; GO:0030514; GO:0030578; GO:0032092; GO:0042771; GO:0043388; GO:0043524; GO:0045766; GO:0045893; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051091; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790] EFIDLLKK 0.98365 -1.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4441 13.791 0 0 13.7375 12.8776 0 0 12.7397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4719 0 0 0 0 0 0 0 0 0 0 0 13.6162 14.0679 13.34 0 0 0 0 13.5651 0 0 0 0 P10070 GLI2_HUMAN Zinc finger protein GLI2 (GLI family zinc finger protein 2) (Tax helper protein) GLI2 THP Homo sapiens (Human) "axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]" ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cellular response to virus [GO:0098586]; cerebellar cortex morphogenesis [GO:0021696]; developmental growth [GO:0048589]; embryonic digestive tract development [GO:0048566]; epidermal cell differentiation [GO:0009913]; floor plate formation [GO:0021508]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; kidney development [GO:0001822]; lung development [GO:0030324]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pituitary gland development [GO:0021983]; positive regulation of DNA replication [GO:0045740]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in ventral spinal cord interneuron specification [GO:0021775]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord ventral commissure morphogenesis [GO:0021965]; tube development [GO:0035295]; ventral midline development [GO:0007418]; ventral spinal cord development [GO:0021517]" GO:0000122; GO:0000978; GO:0000981; GO:0001501; GO:0001649; GO:0001822; GO:0002076; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006357; GO:0007224; GO:0007389; GO:0007411; GO:0007418; GO:0007442; GO:0007507; GO:0008270; GO:0009913; GO:0009954; GO:0021508; GO:0021513; GO:0021517; GO:0021696; GO:0021775; GO:0021965; GO:0021983; GO:0030324; GO:0030879; GO:0030902; GO:0031069; GO:0033089; GO:0035295; GO:0042475; GO:0043565; GO:0045740; GO:0045893; GO:0045944; GO:0048566; GO:0048589; GO:0048666; GO:0048754; GO:0097542; GO:0097546; GO:0098586; GO:1990837; GO:1990841 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" AQYMLVVHMR 0.98366 -1.4427 0 0 0 0 0 0 0 0 10.9968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1342 0 0 11.4411 13.8278 0 0 0 0 0 14.1016 13.2611 0 13.955 0 0 0 0 15.1582 0 0 0 0 13.0109 0 0 13.667 0 13.2324 0 0 0 0 11.4206 13.0447 0 11.3556 0 14.4865 0 15.1579 0 0 0 0 0 0 14.6359 0 0 12.7619 0 0 0 0 0 14.9788 0 13.7175 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8252 11.3162 0 0 0 0 12.1577 0 0 0 0 0 10.6931 0 0 0 0 0 0 0 0 0 0 Q8IYS2 K2013_HUMAN Uncharacterized protein KIAA2013 KIAA2013 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 AWRGLRER 0.98366 -2.2747 0 0 0 0 0 13.0144 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.99 0 0 0 0 0 12.8507 0 0 0 0 11.1487 0 0 0 0 0 12.4974 12.8363 0 0 0 0 0 0 0 0 0 0 0 0 13.4762 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7201 12.6394 0 14.2111 15.723 0 0 0 0 0 12.2044 0 0 14.8199 0 11.7493 14.3929 14.3336 0 13.7245 0 0 0 15.0888 0 0 0 0 14.355 0 0 0 0 15.9826 0 0 0 0 0 0 14.746 13.6695 0 0 13.3514 0 0 0 13.6522 0 0 0 13.352 0 0 0 13.9446 14.8446 15.1525 0 0 12.8786 14.713 0 0 0 0 0 0 0 0 13.9623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3505 0 0 0 0 15.3112 15.418 14.2779 13.3765 13.2658 0 12.5893 13.1539 0 Q5H9L2 TCAL5_HUMAN "Transcription elongation factor A protein-like 5, TCEA-like protein 5 (Transcription elongation factor S-II protein-like 5)" TCEAL5 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] GO:0005634; GO:0050699 WW domain binding [GO:0050699] DLEDVPYV 0.98368 -3.1397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9675 0 0 0 0 0 0 0 0 0 11.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4013 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8917 0 0 0 0 11.5449 0 0 0 0 13.1139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3346 0 0 12.7742 0 12.1695 0 0 0 12.9147 15.1454 0 0 0 12.5918 12.5656 0 14.7093 0 0 0 0 0 0 14.1199 0 0 0 0 0 15.3956 0 14.4346 0 0 0 0 0 0 0 0 0 11.789 0 0 0 0 0 0 0 0 12.979 0 0 12.6255 0 0 0 0 12.8879 13.6999 0 0 0 0 0 0 12.9972 0 0 0 0 Q71UM5 RS27L_HUMAN 40S ribosomal protein S27-like (Small ribosomal subunit protein eS27-like) RPS27L Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; positive regulation of translation [GO:0045727]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634] "cytosolic small ribosomal subunit [GO:0022627]; nucleus [GO:0005634]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; positive regulation of translation [GO:0045727]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]" GO:0000028; GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0006919; GO:0006978; GO:0008494; GO:0008656; GO:0022627; GO:0031571; GO:0042771; GO:0045727; GO:0046872 cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation activator activity [GO:0008494] ARLTEGCSFR 0.98369 -1.3953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3287 0 0 0 0 0 0 Q969V4 TEKT1_HUMAN Tektin-1 TEKT1 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634] axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] GO:0005634; GO:0005879; GO:0015630; GO:0031514; GO:0060271; GO:0060294 DVAQYRLMK 0.9837 -3.1519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BW85 YJU2_HUMAN Splicing factor YJU2 (Coiled-coil domain-containing protein 94) YJU2 CCDC94 Homo sapiens (Human) "generation of catalytic spliceosome for first transesterification step [GO:0000349]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]" U2-type catalytic step 1 spliceosome [GO:0071006] "U2-type catalytic step 1 spliceosome [GO:0071006]; metal ion binding [GO:0046872]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]" GO:0000349; GO:0008380; GO:0043518; GO:0046872; GO:0071006 metal ion binding [GO:0046872] EREDEELNNPMKVLENR 0.98371 -1.407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.03 0 0 0 0 0 0 0 0 0 11.3531 0 0 12.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4772 0 0 0 0 13.4974 0 12.9605 0 0 0 0 0 11.7909 13.4111 0 0 19.01 0 0 0 13.275 0 0 0 0 0 0 0 0 0 0 13.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1252 0 0 0 0 0 Q9Y6F6 IRAG1_HUMAN "Inositol 1,4,5-triphosphate receptor associated 1 (Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate) (JAW1-related protein MRVI1) (Protein MRVI1)" IRAG1 IRAG JAW1L MRVI1 Homo sapiens (Human) cGMP-mediated signaling [GO:0019934] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; cGMP-mediated signaling [GO:0019934] GO:0005789; GO:0016021; GO:0016529; GO:0019934; GO:0031095; GO:0048471 ARMEEEAYSK 0.98371 -2.2315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1405 0 0 0 0 0 12.9615 0 0 0 0 0 0 0 11.9264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9288 0 0 0 0 0 0 0 0 0 13.7624 0 0 0 0 12.8175 0 16.8583 0 0 12.5377 0 0 0 0 0 0 0 16.0408 0 0 0 0 0 0 0 0 0 0 0 13.2114 13.0249 0 0 0 0 0 0 0 0 0 16.3034 16.2061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N371 KDM8_HUMAN "Bifunctional peptidase and arginyl-hydroxylase JMJD5, EC 1.14.11.73, EC 3.4.-.- (JmjC domain-containing protein 5) (Jumonji C domain-containing protein 5) (L-arginine (3R)-hydroxylase KDM8)" KDM8 JMJD5 Homo sapiens (Human) "chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]" chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; peptidyl-arginine 3-dioxygenase activity [GO:0106157]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; proteolysis [GO:0006508]" GO:0000086; GO:0003682; GO:0004175; GO:0004177; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0006508; GO:0016706; GO:0031648; GO:0032922; GO:0035064; GO:0045892; GO:0045893; GO:0046872; GO:0051864; GO:0070544; GO:0106157 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; chromatin binding [GO:0003682]; endopeptidase activity [GO:0004175]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; peptidyl-arginine 3-dioxygenase activity [GO:0106157] APFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS 0.98372 -1.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7757 0 0 0 0 16.7743 0 15.7509 0 0 12.7847 0 18.3396 0 18.9812 0 0 0 0 0 13.9947 0 0 0 14.3839 0 0 17.107 16.9809 14.4519 0 0 0 0 0 0 18.9499 0 18.9821 12.7776 15.2405 14.5126 0 18.4805 12.941 19.2686 0 13.1116 20.3032 13.852 0 13.8882 13.2976 13.8132 14.0342 20.0647 14.421 12.432 0 0 0 13.9561 12.4817 19.5495 13.739 19.6803 20.2161 0 14.5405 14.5191 0 0 19.2536 0 0 0 0 0 0 0 19.1995 0 0 19.0285 20.2262 18.9395 16.6986 0 20.3364 19.0155 0 13.6014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2089 12.9388 19.3871 0 0 0 0 0 Q9HAA7 YG046_HUMAN Putative uncharacterized protein FLJ11871 Homo sapiens (Human) DQGECANQWR 0.98372 -1.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0D2I5 IFFO1_HUMAN "Non-homologous end joining factor IFFO1, NHEJ factor IFFO1 (Intermediate filament family orphan 1) (Tumor antigen HOM-TES-103)" IFFO1 IFFO Homo sapiens (Human) DNA double-strand break attachment to nuclear envelope [GO:1990683]; double-strand break repair via nonhomologous end joining [GO:0006303]; protein localization to site of double-strand break [GO:1990166] intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861] intermediate filament [GO:0005882]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; double-strand break repair via nonhomologous end joining [GO:0006303]; protein localization to site of double-strand break [GO:1990166] GO:0005637; GO:0005654; GO:0005882; GO:0006303; GO:0016363; GO:0035861; GO:1990166; GO:1990683 AELVVFK 0.98373 -1.4184 0 0 0 0 10.2216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5686 0 0 0 0 0 13.9374 13.982 13.8823 0 14.0773 13.8103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1991 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXR4 TTI2_HUMAN TELO2-interacting protein 2 TTI2 C8orf41 Homo sapiens (Human) positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821] ASTRA complex [GO:0070209]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TTT complex [GO:0110078] ASTRA complex [GO:0070209]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TTT complex [GO:0110078]; positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821] GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0050821; GO:0070209; GO:0110078; GO:2000003 AAQVGLLFLKLLGKVETAK 0.98375 -3.2012 12.9197 0 0 0 13.4522 8.88264 14.6001 13.1365 0 12.1088 14.4686 13.5347 11.8156 14.3099 15.7569 0 0 13.2709 0 0 0 0 0 0 0 0 0 13.5501 0 15.2048 0 11.8675 0 0 0 0 0 0 0 0 0 0 11.5762 0 0 0 15.0208 0 0 0 0 13.5327 0 0 0 0 0 0 0 0 0 0 0 0 13.2852 0 13.9063 0 0 14.3674 13.1582 0 13.8152 14.5449 14.6386 12.4946 14.5106 0 0 14.1867 12.3858 0 12.4832 11.9243 0 10.4151 0 14.6303 14.844 0 0 14.682 0 14.2699 0 14.7371 14.8815 0 0 12.6419 0 0 13.6787 13.9595 0 0 0 12.9225 15.373 11.2891 14.3117 13.1557 0 0 11.7551 0 15.0015 12.8056 0 12.5734 0 13.2429 0 0 11.7244 0 13.8294 0 12.3445 12.121 0 0 0 0 13.9682 12.9226 0 0 13.5539 0 0 0 0 12.8411 0 0 11.0594 12.2421 0 0 0 0 0 15.2611 11.7126 0 0 14.2808 0 0 0 10.1011 10.8791 12.6526 10.7765 14.4766 9.307 12.0333 13.6779 0 14.8713 0 0 0 12.4707 14.2435 0 0 9.61591 0 Q9BSW7 SYT17_HUMAN "Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII, SytXVII)" SYT17 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005802; GO:0005886; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0070382; GO:0071277; GO:1903861 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] IQLVHGLKLVKTK 0.98375 -2.1814 10.7505 0 0 0 0 11.6999 0 0 0 12.4789 14.5658 0 0 0 0 0 0 0 13.2376 0 12.9421 0 0 0 0 0 0 0 0 0 13.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4614 0 0 0 0 0 11.3347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1478 10.8071 0 0 0 0 0 0 0 11.5303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1361 0 0 13.0022 0 0 0 14.2799 0 0 0 0 11.4946 0 17.5696 0 0 0 0 0 0 14.5754 0 13.7077 0 0 Q96EY8 MMAB_HUMAN "Corrinoid adenosyltransferase MMAB, EC 2.5.1.- (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein)" MMAB Homo sapiens (Human) cobalamin metabolic process [GO:0009235] mitochondrial matrix [GO:0005759] "mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; cobalamin metabolic process [GO:0009235]" GO:0005524; GO:0005759; GO:0008817; GO:0009235; GO:0016765; GO:0031419 "ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin binding [GO:0031419]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]" FLNRLSDYLFTLAR 0.98376 -2.2668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5792 0 12.4064 0 0 0 0 0 0 Q9UHW5 GPN3_HUMAN GPN-loop GTPase 3 (ATP-binding domain 1 family member C) GPN3 ATPBD1C AD-009 UNQ1876/PRO4319 Homo sapiens (Human) protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0032991 GTP binding [GO:0005525]; GTPase activity [GO:0003924] EDESSSMFDEYFQECQDE 0.98376 -2.2685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9989 0 10.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3642 0 0 0 0 0 0 12.3917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4307 Q70EL3 UBP50_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 50 (Inactive ubiquitin-specific peptidase 50) USP50 Homo sapiens (Human) endosome organization [GO:0007032]; nuclear speck organization [GO:0035063]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; midbody [GO:0030496]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; midbody [GO:0030496]; postsynaptic density [GO:0014069]; cysteine-type deubiquitinase activity [GO:0004843]; ubiquitin-like protein peptidase activity [GO:0019783]; endosome organization [GO:0007032]; nuclear speck organization [GO:0035063]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004843; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0019783; GO:0019897; GO:0030496; GO:0031313; GO:0032731; GO:0032741; GO:0035063; GO:0043197; GO:0070536; GO:0071108; GO:1900227; GO:2001056 cysteine-type deubiquitinase activity [GO:0004843]; ubiquitin-like protein peptidase activity [GO:0019783] ASISKAPKIIIFHLK 0.98377 -3.131 0 0 0 0 0 0 0 0 12.2175 13.0757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0826 0 0 0 0 0 0 0 0 0 0 12.9393 12.8478 13.3697 0 12.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3414 0 0 0 13.8805 11.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1517 0 0 0 0 0 0 0 12.5849 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWV7 UBR1_HUMAN "E3 ubiquitin-protein ligase UBR1, EC 2.3.2.27 (N-recognin-1) (RING-type E3 ubiquitin transferase UBR1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I)" UBR1 Homo sapiens (Human) cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] GO:0000151; GO:0000502; GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0032007; GO:0061630; GO:0070728; GO:0071233; GO:0071596 leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ALMQFAVAQRITCPQVLIQKHLVR 0.98377 -3.1309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2608 0 0 0 13.5028 0 0 0 0 0 0 13.1145 0 11.2563 11.4015 0 0 0 0 0 0 0 0 0 0 0 0 12.7723 12.2505 0 0 0 0 12.9368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6656 0 13.5477 0 0 0 0 0 0 0 0 0 0 12.8155 0 0 0 0 12.8691 0 0 0 0 0 0 12.4897 0 14.6235 13.8036 0 14.0215 12.0908 12.4704 13.1422 0 0 0 13.5944 0 15.3576 0 14.2918 0 0 0 0 0 0 14.2943 14.0971 0 0 0 11.6383 13.2746 0 0 0 0 13.3769 12.7385 12.9624 13.1061 12.8691 0 0 0 0 13.329 0 14.101 0 0 0 13.4844 13.8689 0 14.4037 0 11.4448 0 0 0 0 0 0 14.7946 14.2063 15.0577 0 0 0 0 0 0 0 0 12.4661 12.6999 0 0 0 0 0 0 0 0 15.0856 0 0 9.47683 12.5578 0 Q9HBT6 CAD20_HUMAN Cadherin-20 CDH20 CDH7L3 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] FYEAFVCENAK 0.98378 -3.1394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9723 0 0 0 0 0 13.4475 13.8554 14.006 13.4691 13.8069 13.9282 0 13.891 13.5742 13.6828 0 13.9335 0 13.8003 0 0 13.9146 0 0 0 0 0 13.865 0 0 0 0 0 14.567 0 0 14.6392 0 13.0075 0 0 0 14.4208 0 0 13.786 0 0 13.2112 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0847 0 0 0 0 0 0 0 0 0 0 0 13.9514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9634 0 Q9UL49 TCFL5_HUMAN "Transcription factor-like 5 protein (Cha transcription factor) (HPV-16 E2-binding protein 1, E2BP-1)" TCFL5 CHA E2BP1 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] "chromatin [GO:0000785]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001673; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006366; GO:0007283; GO:0030154; GO:0042127; GO:0045595; GO:0046983; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFSFCYQQEIESTKQTLGSRNK 0.98378 -1.4421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6478 13.5038 0 11.5434 0 0 10.1972 0 11.2071 12.9084 0 19.38 12.8503 0 0 13.421 0 0 0 0 12.2434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4051 14.8303 12.629 0 0 0 0 0 13.7451 0 13.1156 11.7163 0 0 0 0 0 0 12.8434 12.0754 0 0 0 0 0 12.7853 0 13.3018 0 0 0 0 0 0 0 0 14.8643 0 0 12.8049 0 14.6107 15.1275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0678 0 0 0 0 0 14.0809 0 Q9C002 NMES1_HUMAN Normal mucosa of esophagus-specific gene 1 protein (Protein FOAP-11) NMES1 C15orf48 Homo sapiens (Human) response to bacterium [GO:0009617] mitochondrial respiratory chain complex IV [GO:0005751]; nucleus [GO:0005634] mitochondrial respiratory chain complex IV [GO:0005751]; nucleus [GO:0005634]; response to bacterium [GO:0009617] GO:0005634; GO:0005751; GO:0009617 LITINQQWK 0.98379 -2.2893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCM4 E41L5_HUMAN Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5) EPB41L5 KIAA1548 Homo sapiens (Human) "actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm morphogenesis [GO:0048319]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]" adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm morphogenesis [GO:0048319]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]" GO:0001701; GO:0001837; GO:0001839; GO:0001917; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0031032; GO:0032091; GO:0032092; GO:0032525; GO:0032587; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560 cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904] CAVEHHAFFR 0.98379 -3.1426 0 0 0 0 11.2604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 M0QZC1 RN225_HUMAN RING finger protein 225 RNF225 Homo sapiens (Human) protein ubiquitination [GO:0016567] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567] GO:0016021; GO:0016567; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] APTRLAPR 0.9838 -3.1489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8177 0 0 0 0 13.8666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5261 0 0 0 0 0 0 0 14.6888 0 0 0 0 0 0 0 0 0 0 15.7055 0 0 0 0 0 0 0 0 0 0 12.076 0 0 0 0 0 0 0 0 15.225 0 0 0 0 0 0 11.7092 0 0 11.7888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7552 0 Q6PI47 KCD18_HUMAN BTB/POZ domain-containing protein KCTD18 KCTD18 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 EAGNNVQYIWSYYSVAELK 0.9838 -2.2991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8289 0 0 0 0 0 0 0 0 0 0 0 0 16.6738 12.0934 14.1316 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54699 15.4468 0 0 0 0 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 16.2351 0 0 0 0 0 0 0 0 0 10.946 0 15.7705 0 0 0 0 0 0 0 16.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXH4 ASB11_HUMAN "Ankyrin repeat and SOCS box protein 11, ASB-11" ASB11 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567] GO:0005783; GO:0005829; GO:0016567; GO:0035556; GO:0045732 EDGPVFYGFKNIFITMFATFFFFKLLIK 0.9838 -3.1514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.783 0 12.5372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7192 0 0 0 0 0 0 0 0 0 0 12.6561 0 11.928 0 0 0 0 0 0 0 0 0 0 12.4748 0 0 0 0 0 0 0 P56282 DPOE2_HUMAN DNA polymerase epsilon subunit 2 (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B) POLE2 DPE2 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] epsilon DNA polymerase complex [GO:0008622]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] GO:0003677; GO:0003887; GO:0005654; GO:0006260; GO:0006261; GO:0006281; GO:0008622; GO:0016604; GO:0042276; GO:0043231 DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887] FVYNSERKK 0.98381 -1.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0029 0 0 0 0 0 0 0 0 0 0 0 0 13.2425 13.0354 12.601 0 0 0 0 0 13.0448 13.5771 13.0638 0 0 0 13.8082 0 0 0 0 0 0 0 0 0 0 0 14.0516 0 0 0 0 0 0 0 0 0 0 0 0 12.817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.026 0 0 0 0 0 Q5XUX0 FBX31_HUMAN F-box only protein 31 FBXO31 FBX14 FBX31 PP2386 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to DNA damage stimulus [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron migration [GO:2001224]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] centrosome [GO:0005813]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; SCF ubiquitin ligase complex [GO:0019005] centrosome [GO:0005813]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; SCF ubiquitin ligase complex [GO:0019005]; cyclin binding [GO:0030332]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to DNA damage stimulus [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron migration [GO:2001224]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0005813; GO:0005829; GO:0006974; GO:0016567; GO:0019005; GO:0030332; GO:0031145; GO:0031146; GO:0031571; GO:0043025; GO:0050775; GO:2001224 cyclin binding [GO:0030332] CNQTDHHRMSGGR 0.98381 -2.2272 0 0 0 0 0 0 0 0 12.4336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3701 0 15.4346 0 0 0 0 0 0 0 0 0 13.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUS6 TECT3_HUMAN Tectonic-3 TCTN3 C10orf61 TECT3 PSEC0041 UNQ1881/PRO4324 Homo sapiens (Human) apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; positive regulation of apoptotic process [GO:0043065]; smoothened signaling pathway [GO:0007224] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; positive regulation of apoptotic process [GO:0043065]; smoothened signaling pathway [GO:0007224] GO:0005634; GO:0006915; GO:0007224; GO:0016021; GO:0043065; GO:0060170; GO:0060271 MRTPQLALLQVFFLVFPDGVR 0.98381 -1.4596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0259 0 0 0 0 0 0 0 0 0 0 0 16.4484 0 0 0 17.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZV80 CB091_HUMAN Putative uncharacterized protein LINC02898 (Long intergenic non-protein coding RNA 2898) LINC02898 C2orf91 Homo sapiens (Human) GVYMSGST 0.98381 -2.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH73 OR4S2_HUMAN Olfactory receptor 4S2 (Olfactory receptor OR11-137) OR4S2 OR4S2P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] MVAVFYTIITPMLNPLIYTLR 0.98381 -1.3973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4817 0 0 0 0 0 0 0 0 0 0 0 Q8TAI7 REBL1_HUMAN "GTPase RhebL1 (Ras homolog enriched in brain like-1 c, RhebL1c) (Ras homolog enriched in brain-like protein 1, Rheb-like protein 1) (Rheb2)" RHEBL1 Homo sapiens (Human) positive regulation of NF-kappaB transcription factor activity [GO:0051092]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0007264; GO:0012505; GO:0019003; GO:0031929; GO:0046872; GO:0051092 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] MPLVRYRK 0.98382 -1.4605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L4K1 FSD2_HUMAN Fibronectin type III and SPRY domain-containing protein 2 (SPRY domain-containing protein 1) FSD2 SPRYD1 Homo sapiens (Human) nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529] nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529] GO:0005634; GO:0016529; GO:0048471 DEIHKNMYKLEK 0.98383 -1.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17655 CAN2_HUMAN "Calpain-2 catalytic subunit, EC 3.4.22.53 (Calcium-activated neutral proteinase 2, CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain, M-calpain)" CAPN2 CANPL2 Homo sapiens (Human) behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612] calpain complex [GO:0110158]; chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] calpain complex [GO:0110158]; chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612] GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008234; GO:0009612; GO:0009897; GO:0010666; GO:0016540; GO:0019899; GO:0030425; GO:0030864; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051493; GO:0051603; GO:0070062; GO:0071222; GO:0071230; GO:0097038; GO:0110158; GO:1901216; GO:1901741; GO:2001247 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877] ALQKGSLLGCSIDITSAADSEAITFQK 0.98385 -3.2067 0 0 0 0 0 0 0 0 0 0 0 0 9.59128 0 0 0 11.1311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4653 0 0 0 0 0 0 0 0 10.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.406 0 0 0 0 0 14.5895 0 13.9715 15.1361 0 12.5518 0 0 15.8696 0 14.5555 14.8025 16.1156 0 0 0 11.8031 0 14.4043 14.7759 14.5513 14.4089 0 0 16.2792 15.0451 15.2949 0 0 16.1591 0 0 15.0874 15.2421 0 14.3605 0 0 0 0 15.2484 0 0 14.6192 15.1221 0 14.9595 0 14.8948 0 14.6247 0 15.0763 15.3639 0 15.0562 12.8382 0 14.3523 11.5849 0 0 13.181 0 0 13.092 0 14.6116 0 15.3999 0 0 0 0 14.2688 0 15.1248 0 11.7586 0 0 0 0 0 0 0 15.3753 0 0 0 0 0 0 0 0 0 0 0 14.401 0 0 0 0 0 14.3345 0 Q7Z698 SPRE2_HUMAN "Sprouty-related, EVH1 domain-containing protein 2, Spred-2" SPRED2 Homo sapiens (Human) "negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]" cytosol [GO:0005829]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] "cytosol [GO:0005829]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; stem cell factor receptor binding [GO:0005173]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of protein deacetylation [GO:0090311]" GO:0005173; GO:0005829; GO:0005886; GO:0010719; GO:0010801; GO:0019901; GO:0030291; GO:0030512; GO:0030658; GO:0043409; GO:0043517; GO:0070373; GO:0090311; GO:1902747 protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; stem cell factor receptor binding [GO:0005173] ACYHCGVMCR 0.98385 -3.2012 0 0 0 0 0 0 10.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6365 11.7892 0 0 0 12.4788 0 0 0 0 0 0 0 0 0 0 0 13.327 0 0 0 0 11.3658 0 13.8944 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2258 0 0 0 0 0 0 12.0817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0646 0 0 0 0 0 0 0 0 0 12.6172 0 0 0 0 0 12.2683 12.9223 0 0 0 10.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8ND83 SLAI1_HUMAN SLAIN motif-containing protein 1 SLAIN1 C13orf32 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116] GO:0005737; GO:0005856; GO:0007020; GO:0031116; GO:0031122 ATAYVSPTVQGSSNMPLSNGLQLYSNTGIPTPNKAAASGIMGR 0.98385 -3.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9576 0 0 Q96RJ6 FER3L_HUMAN "Fer3-like protein (Basic helix-loop-helix protein N-twist) (Class A basic helix-loop-helix protein 31, bHLHa31) (Nephew of atonal 3) (Neuronal twist)" FERD3L BHLHA31 NATO3 NTWIST Homo sapiens (Human) "cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032502; GO:0033504; GO:0045892; GO:0046983; GO:0048468; GO:0050767; GO:1904338; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" FEEGDPEEEECEVDQGDGEEEEEEER 0.98385 3.1117 0 0 0 0 0 0 0 0 0 0 0 0 12.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8209 0 0 12.1737 13.2926 0 0 0 0 0 0 0 0 0 0 0 12.5966 0 0 12.0055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8066 0 0 0 11.9302 0 0 0 0 0 0 0 11.6154 10.6051 0 0 0 0 0 12.3385 0 0 0 13.2624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5105 0 0 0 0 0 0 14.0447 0 0 13.3207 0 0 0 10.5955 12.1532 0 0 0 0 0 0 0 0 0 0 0 13.0307 0 0 0 0 0 0 0 13.8399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2B4 S26A1_HUMAN "Sulfate anion transporter 1, SAT-1 (Solute carrier family 26 member 1)" SLC26A1 SAT1 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; chloride transport [GO:0006821]; ion transport [GO:0006811]; oxalate transport [GO:0019532]; sulfate transport [GO:0008272] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; chloride transport [GO:0006821]; ion transport [GO:0006811]; oxalate transport [GO:0019532]; sulfate transport [GO:0008272] GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016021; GO:0016323; GO:0019531; GO:0019532; GO:0050428 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] AALVPAAAGFHTVVIDCAPLLFLDAAGVSTLQDLRR 0.98385 -3.1104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.964 14.7209 16.9538 15.5634 14.7446 14.4227 14.097 16.458 15.6115 15.2684 15.5725 0 11.8954 0 0 0 15.8741 14.1435 0 13.9073 0 13.181 13.6152 13.4274 0 15.4514 0 12.4315 10.8971 14.2421 14.0728 15.0037 0 0 0 14.8769 0 12.3836 11.3159 13.4883 0 0 13.7043 15.9287 12.8673 0 0 0 0 0 0 12.561 13.687 12.7494 0 0 0 13.5362 13.6624 0 0 0 11.1887 0 0 0 0 0 14.64 0 0 0 0 12.6766 0 0 12.0871 0 0 0 0 0 12.6298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ38 IDAS1_HUMAN Uncharacterized protein IDI2-AS1 (IDI2 antisense RNA 1) (IDI2 antisense gene protein 1) IDI2-AS1 C10orf110 HT009 Homo sapiens (Human) ARLLLYVR 0.98385 -2.1798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47755 CAZA2_HUMAN F-actin-capping protein subunit alpha-2 (CapZ alpha-2) CAPZA2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; protein-containing complex assembly [GO:0065003] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; protein-containing complex assembly [GO:0065003] GO:0005576; GO:0005829; GO:0005903; GO:0008290; GO:0015629; GO:0016020; GO:0030036; GO:0030863; GO:0051015; GO:0051016; GO:0065003; GO:0070062 actin filament binding [GO:0051015] ADLEEQLSDEEKVRIAAK 0.98386 -2.1811 0 0 0 0 0 0 0 0 0 10.7598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7005 12.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9074 0 0 0 0 0 0 14.6985 13.93 0 13.4023 14.3682 0 13.9559 0 0 0 0 0 0 11.8442 14.3451 14.7744 14.2029 0 0 0 0 0 13.9068 0 0 0 0 0 0 15.109 13.6466 13.7478 14.8204 14.5294 15.8489 13.1474 14.3597 13.8657 0 0 0 13.3845 0 0 0 0 15.0025 0 0 14.0958 15.0867 14.0199 14.3417 13.8225 0 0 0 10.9461 0 0 0 0 0 13.7878 0 14.9818 14.8913 14.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2122 13.3896 14.3257 13.7084 13.6404 0 0 0 0 0 Q9NP84 TNR12_HUMAN "Tumor necrosis factor receptor superfamily member 12A (Fibroblast growth factor-inducible immediate-early response protein 14, FGF-inducible 14) (Tweak-receptor, TweakR) (CD antigen CD266)" TNFRSF12A FN14 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; regulation of wound healing [GO:0061041] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; regulation of wound healing [GO:0061041] GO:0001525; GO:0005886; GO:0006915; GO:0007155; GO:0016021; GO:0030154; GO:0043065; GO:0061041; GO:2001238 CMDCASCR 0.98386 -2.2648 0 0 0 0 0 0 0 0 12.9302 13.276 11.4326 11.6541 10.3117 0 0 9.81836 13.4214 14.4771 14.2467 13.8472 14.4443 0 14.7704 11.8281 13.102 14.447 13.1799 14.0004 12.8321 0 10.0773 12.4326 0 12.6732 0 0 0 12.4706 0 11.7612 11.8539 12.7005 14.7788 11.8346 0 13.2102 0 0 12.524 0 11.4292 0 0 0 0 11.8195 11.8072 0 0 0 0 0 0 0 0 0 13.4215 0 13.2644 0 0 13.8812 0 0 14.97 16.7653 16.673 15.8639 16.8406 16.916 15.8707 13.5678 13.3026 16.3678 12.929 15.2735 16.0753 16.9857 16.6765 16.1519 16.8598 16.4748 17.3177 16.5912 16.7295 15.9461 15.5634 16.5667 13.6476 16.1724 16.8197 16.484 15.578 15.986 15.1684 16.191 16.5695 17.2408 16.5331 16.103 16.1193 0 17.2738 15.3806 15.9733 15.5699 16.412 15.0104 16.6968 15.7761 16.5239 16.8611 15.9894 16.6579 16.0301 17.1057 15.192 17.1081 15.9613 17.3287 16.221 16.456 16.1733 16.8866 14.5873 16.4359 17.0308 15.8243 16.8777 16.7491 0 15.3977 15.8454 16.8157 16.3939 16.1678 15.4628 12.8666 0 0 16.4504 16.7052 0 0 15.5521 16.4965 15.777 0 0 12.4559 0 12.5547 14.888 12.2105 0 15.0368 12.8945 0 13.4272 14.8335 13.941 16.1619 15.7348 14.8924 14.3034 14.3902 13.393 12.8334 14.1387 0 Q9UHF3 NAT8B_HUMAN "Putative N-acetyltransferase 8B, EC 2.3.1.- (Acetyltransferase 1, ATase1) (Camello-like protein 2)" NAT8B CML2 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]; amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; gastrulation with mouth forming second [GO:0001702]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]" GO:0001702; GO:0004468; GO:0005789; GO:0005793; GO:0008080; GO:0010628; GO:0016021; GO:0018003; GO:0033116; GO:0043066; GO:0050435; GO:1990000 "lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]" ALVRTVLQFAR 0.98386 -2.1802 0 0 0 13.7523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6909 0 0 10.9855 13.679 0 0 Q9NV31 IMP3_HUMAN "U3 small nucleolar ribonucleoprotein protein IMP3, U3 snoRNP protein IMP3 (BRMS2)" IMP3 C15orf12 MRPS4 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364] Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040] Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364] GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0019843; GO:0030490; GO:0030515; GO:0030684; GO:0032040; GO:0034457 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515] RLPTVLLK 0.98387 -3.1289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXQ6 PARP9_HUMAN "Protein mono-ADP-ribosyltransferase PARP9, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 9, ARTD9) (B aggressive lymphoma protein) (Poly [ADP-ribose] polymerase 9, PARP-9)" PARP9 BAL BAL1 Homo sapiens (Human) "cell migration [GO:0016477]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of catalytic activity [GO:0043086]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; post-transcriptional regulation of gene expression [GO:0010608]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; regulation of response to interferon-gamma [GO:0060330]; viral protein processing [GO:0019082]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]; ADP-D-ribose binding [GO:0072570]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; STAT family protein binding [GO:0097677]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein ligase binding [GO:0044389]; cell migration [GO:0016477]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of catalytic activity [GO:0043086]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; post-transcriptional regulation of gene expression [GO:0010608]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; regulation of response to interferon-gamma [GO:0060330]; viral protein processing [GO:0019082]" GO:0000122; GO:0002230; GO:0003714; GO:0003950; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006471; GO:0010608; GO:0010629; GO:0016020; GO:0016477; GO:0019082; GO:0019899; GO:0032991; GO:0034356; GO:0035563; GO:0042393; GO:0042531; GO:0043086; GO:0044389; GO:0045087; GO:0045893; GO:0051607; GO:0060330; GO:0060335; GO:0072570; GO:0090734; GO:0097677; GO:0140289; GO:1900182; GO:1990404; GO:2001034 ADP-D-ribose binding [GO:0072570]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; STAT family protein binding [GO:0097677]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein ligase binding [GO:0044389] HAMKECLEK 0.98389 -2.2888 0 0 0 0 0 0 0 0 11.7693 0 0 0 0 0 0 0 10.809 0 0 0 0 0 0 0 11.0248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2115 0 0 0 12.5585 0 0 0 0 0 0 0 0 0 0 0 0 13.9425 0 0 0 0 0 0 12.7302 0 0 0 13.5734 16.3253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9848 11.7946 0 0 0 0 0 0 0 0 11.8077 0 12.2932 11.8094 0 0 0 0 0 0 0 0 0 12.2125 15.7516 0 0 12.3769 0 0 0 0 0 0 0 0 0 0 11.7585 0 0 10.5845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYZ6 RHBT2_HUMAN Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83) RHOBTB2 DBC2 KIAA0717 Homo sapiens (Human) actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0043652 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] DMKAMSPENQEYFEKHR 0.98389 -1.4419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7128 10.7032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.89 0 0 11.5716 0 19.8681 0 0 0 0 12.2941 0 0 0 0 22.1765 0 0 0 0 17.3888 0 0 0 0 18.035 0 0 0 0 0 0 0 19.018 0 0 0 0 0 0 0 0 20.0566 0 20.826 12.5349 0 11.1641 0 0 19.9234 0 0 20.3684 0 0 0 14.1695 0 0 0 19.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFU0 BEST4_HUMAN Bestrophin-4 (Vitelliform macular dystrophy 2-like protein 2) BEST4 VMD2L2 Homo sapiens (Human) chloride channel complex [GO:0034707]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254] GO:0005254; GO:0005886; GO:0034707 chloride channel activity [GO:0005254] EFLLFGALYAVLSITYRLLLTQEQR 0.9839 -2.297 0 0 0 0 0 0 0 0 0 0 15.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5304 0 0 0 14.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0378 13.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9824 0 0 0 17.016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3205 16.8918 0 0 0 0 0 0 0 0 0 13.099 0 0 16.4728 0 0 0 16.2694 16.4989 0 0 16.1792 0 0 0 0 0 16.6499 0 0 16.5032 16.3288 12.0943 Q9H8M1 CQ10B_HUMAN "Coenzyme Q-binding protein COQ10 homolog B, mitochondrial" COQ10B Homo sapiens (Human) cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744] GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039 ubiquinone binding [GO:0048039] ELMLHEVHHT 0.9839 -3.1454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3572 0 0 0 0 0 0 0 0 0 0 14.3066 0 0 0 0 0 13.2513 0 0 0 0 0 0 0 0 0 0 0 13.489 0 0 0 0 14.8114 14.5074 0 0 0 0 14.2559 0 0 0 0 11.725 0 0 0 0 14.7757 14.1898 15.1579 0 0 14.7167 0 0 0 0 0 0 0 0 0 14.074 0 0 0 0 0 12.4041 12.7651 0 0 0 0 0 0 0 0 0 0 0 0 14.2369 14.7414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0019 0 0 14.2739 0 0 0 0 0 P55103 INHBC_HUMAN Inhibin beta C chain (Activin beta-C chain) INHBC Homo sapiens (Human) positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; transforming growth factor beta receptor binding [GO:0005160]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] GO:0005125; GO:0005160; GO:0005179; GO:0005576; GO:0005615; GO:0008083; GO:0010862; GO:0060395 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; transforming growth factor beta receptor binding [GO:0005160] LHLTQRPTLNRPVSR 0.98392 -2.2272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2739 12.8821 0 0 0 11.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8537 14.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHD2 TBK1_HUMAN "Serine/threonine-protein kinase TBK1, EC 2.7.11.1 (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)" TBK1 NAK Homo sapiens (Human) activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; activation of innate immune response [GO:0002218]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of neuron death [GO:1901214]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] GO:0002218; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010629; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0033138; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0106310; GO:1901214; GO:1902554; GO:1904417 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DIKPGNIMR 0.98393 -1.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4345 0 0 0 0 0 0 0 0 0 0 0 13.9863 14.6269 0 0 0 0 0 0 13.9876 0 0 12.3526 0 0 0 0 0 0 13.1611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4814 0 0 0 0 0 0 0 0 0 0 13.9459 0 0 0 0 0 0 0 0 0 0 0 P51801 CLCKB_HUMAN "Chloride channel protein ClC-Kb, Chloride channel Kb (ClC-K2)" CLCNKB Homo sapiens (Human) chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; renal sodium ion absorption [GO:0070294]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; regulation of ion transmembrane transport [GO:0034765]; renal absorption [GO:0070293]; renal sodium ion absorption [GO:0070294]; transepithelial chloride transport [GO:0030321] GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0030321; GO:0034707; GO:0034765; GO:0046872; GO:0070293; GO:0070294 metal ion binding [GO:0046872]; voltage-gated chloride channel activity [GO:0005247] AHQWLYR 0.98394 -3.201 0 12.2901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6837 0 0 0 14.1802 0 0 12.9542 0 15.7874 0 0 14.8464 14.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8185 0 0 0 0 12.4775 0 0 15.2992 0 0 0 0 0 0 0 0 13.3967 0 0 0 0 0 0 0 12.9187 0 0 11.8535 0 0 0 0 0 0 0 0 13.0373 0 0 0 0 0 0 0 0 0 0 0 12.7183 13.4041 12.2553 0 0 0 12.899 0 0 0 15.0993 0 11.8073 0 0 P06126 CD1A_HUMAN "T-cell surface glycoprotein CD1a (T-cell surface antigen T6/Leu-6, hTa1 thymocyte antigen) (CD antigen CD1a)" CD1A Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation, endogenous lipid antigen via MHC class Ib [GO:0048006]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; immune response [GO:0006955]; positive regulation of T cell mediated cytotoxicity [GO:0001916]" endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; endogenous lipid antigen binding [GO:0030883]; exogenous lipid antigen binding [GO:0030884]; lipopeptide binding [GO:0071723]; adaptive immune response [GO:0002250]; antigen processing and presentation, endogenous lipid antigen via MHC class Ib [GO:0048006]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; immune response [GO:0006955]; positive regulation of T cell mediated cytotoxicity [GO:0001916]" GO:0001916; GO:0002250; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0009897; GO:0010008; GO:0030883; GO:0030884; GO:0045121; GO:0048006; GO:0048007; GO:0071723 endogenous lipid antigen binding [GO:0030883]; exogenous lipid antigen binding [GO:0030884]; lipopeptide binding [GO:0071723] AHLQRQVK 0.98395 -1.4042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54829 PTN5_HUMAN "Tyrosine-protein phosphatase non-receptor type 5, EC 3.1.3.48 (Neural-specific protein-tyrosine phosphatase) (Striatum-enriched protein-tyrosine phosphatase, STEP)" PTPN5 Homo sapiens (Human) peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] GO:0001784; GO:0004725; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006470; GO:0007165; GO:0016021; GO:0019901; GO:0030054; GO:0035335 phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] ENHAADDSEGGALDMCCSER 0.98395 -3.1142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9364 0 0 11.7711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q10586 DBP_HUMAN "D site-binding protein (Albumin D box-binding protein) (Albumin D-element-binding protein) (Tax-responsive enhancer element-binding protein 302, TaxREB302)" DBP Homo sapiens (Human) circadian rhythm [GO:0007623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; circadian rhythm [GO:0007623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007623; GO:0045944; GO:0090575; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ENALLRQEVVAVR 0.98395 -2.3092 0 0 0 0 0 0 0 0 16.4593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2821 0 0 13.724 0 0 0 14.7209 16.8742 0 11.8375 11.1647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9486 0 0 12.2129 0 0 0 13.4497 0 0 0 0 13.7168 0 0 0 0 0 0 0 0 0 0 0 12.3065 0 0 0 0 12.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5378 0 0 0 0 0 0 0 0 0 0 0 14.1829 0 14.5344 0 10.2586 0 0 0 0 0 0 0 0 11.2386 13.0497 12.4911 0 13.2435 12.8127 13.0138 14.1482 0 0 12.0781 0 0 0 0 0 0 13.1392 0 0 0 0 Q8IYK4 GT252_HUMAN "Procollagen galactosyltransferase 2, EC 2.4.1.50 (Collagen beta(1-O)galactosyltransferase 2, ColGalT 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2)" COLGALT2 C1orf17 GLT25D2 KIAA0584 Homo sapiens (Human) collagen fibril organization [GO:0030199] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; collagen fibril organization [GO:0030199] GO:0005788; GO:0030199; GO:0050211 procollagen galactosyltransferase activity [GO:0050211] AARPAATLAWSLLLLSSALLR 0.98395 -3.1103 0 0 0 0 0 0 0 0 14.8557 0 0 0 0 0 0 0 12.8969 0 0 11.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1886 0 0 0 0 0 0 0 13.4866 12.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3916 13.4737 0 13.2198 15.2235 0 0 0 0 11.896 0 0 0 12.5087 0 0 0 0 0 0 13.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6584 0 13.5259 0 0 0 0 0 0 0 0 0 0 0 0 12.4501 13.9493 0 0 0 0 14.3923 0 14.166 11.7007 0 14.7491 14.4857 14.756 14.8753 13.9156 13.4375 0 14.4174 0 0 0 0 0 0 0 0 13.2663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2815 0 0 0 0 Q96C74 ROP1L_HUMAN "Ropporin-1-like protein, ROPN1-like protein (AKAP-associated sperm protein)" ROPN1L ASP RSPH11 Homo sapiens (Human) epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; identical protein binding [GO:0042802]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; regulation of protein phosphorylation [GO:0001932]; sperm capacitation [GO:0048240] GO:0001932; GO:0003351; GO:0005576; GO:0005737; GO:0005929; GO:0030317; GO:0031514; GO:0042802; GO:0048240 identical protein binding [GO:0042802] GDPLPVK 0.98395 -2.3062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSV6 SEN34_HUMAN "tRNA-splicing endonuclease subunit Sen34, EC 4.6.1.16 (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34, HsSen34)" TSEN34 LENG5 SEN34 Homo sapiens (Human) mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA-type intron splice site recognition and cleavage [GO:0000379] GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0006397; GO:0016829 lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213] ARPLDWR 0.98395 -1.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7318 0 11.3722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5936 0 0 0 0 0 11.9342 0 0 0 0 12.8587 0 0 13.1584 0 0 0 0 0 0 0 0 12.6453 15.3609 0 12.8149 0 0 0 11.3198 0 0 0 16.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9633 0 11.7791 0 12.544 0 0 0 0 13.9454 0 0 0 0 13.8147 0 0 0 13.0812 0 0 18.8593 0 0 0 0 14.1834 0 0 0 0 0 0 0 0 0 0 0 0 11.5779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H165 BC11A_HUMAN "B-cell lymphoma/leukemia 11A, BCL-11A (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog, EVI-9) (Zinc finger protein 856)" BCL11A CTIP1 EVI9 KIAA1809 ZNF856 Homo sapiens (Human) cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; postsynaptic density [GO:0014069]; SWI/SNF complex [GO:0016514] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; postsynaptic density [GO:0014069]; SWI/SNF complex [GO:0016514]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription regulatory region nucleic acid binding [GO:0001067]; cellular response to L-glutamate [GO:1905232]; negative regulation of axon extension [GO:0030517]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron projection development [GO:0010977]; negative regulation of neuron remodeling [GO:1904800]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of dendrite development [GO:0050773]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0001067; GO:0001227; GO:0003700; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0010628; GO:0010976; GO:0010977; GO:0014069; GO:0016363; GO:0016514; GO:0016925; GO:0019901; GO:0030517; GO:0032463; GO:0042382; GO:0042803; GO:0045944; GO:0046872; GO:0046982; GO:0048671; GO:0048672; GO:0050773; GO:0140297; GO:1903860; GO:1904800; GO:1905232; GO:2000171; GO:2000173 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription regulatory region nucleic acid binding [GO:0001067]" CELCNYACAQSSK 0.98395 -3.1127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2145 0 0 0 0 13.7393 0 0 0 0 0 10.207 0 0 0 0 0 13.1729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4478 0 0 0 0 14.3656 0 0 0 0 0 13.7013 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9518 0 0 0 0 0 13.2992 0 14.1892 13.6361 11.8304 0 12.6043 0 0 0 0 0 0 0 12.6759 0 13.6154 0 13.0746 0 0 0 0 0 10.9569 0 0 0 0 0 0 0 0 10.5472 0 0 0 0 13.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6889 15.5331 0 0 0 14.6184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNH7 SNX6_HUMAN "Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed ]" SNX6 Homo sapiens (Human) "cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; lysosome [GO:0005764]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; lysosome [GO:0005764]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; type I transforming growth factor beta receptor binding [GO:0034713]; cellular response to amyloid-beta [GO:1904646]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006886; GO:0007175; GO:0016241; GO:0030512; GO:0030904; GO:0030905; GO:0031901; GO:0034452; GO:0034713; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0097422; GO:1904646 dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; type I transforming growth factor beta receptor binding [GO:0034713] DLLYRRSR 0.98395 -3.2093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11474 ERR1_HUMAN "Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha, ERR-alpha) (Nuclear receptor subfamily 3 group B member 1)" ESRRA ERR1 ESRL1 NR3B1 Homo sapiens (Human) "cartilage development [GO:0051216]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]; cartilage development [GO:0051216]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of ossification [GO:0030278]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]" GO:0000785; GO:0000978; GO:0000981; GO:0001650; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008270; GO:0015630; GO:0019904; GO:0030278; GO:0032355; GO:0042127; GO:0043565; GO:0045171; GO:0045667; GO:0045670; GO:0045944; GO:0051216; GO:1900078; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]" AAGLGELGAALLQLVRR 0.98396 -2.1767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8586 0 0 13.8418 0 0 0 0 0 15.7764 0 13.8427 0 14.5711 0 0 13.7317 0 0 0 0 0 0 14.9302 0 0 0 14.5062 0 0 0 13.0281 0 0 0 15.0798 0 14.8418 0 13.6168 0 0 11.5187 0 0 0 0 0 0 0 0 14.7747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9269 0 0 0 12.7309 0 0 0 0 0 0 0 0 0 0 0 0 14.9161 14.2784 0 0 0 14.162 0 0 11.1964 0 0 0 11.9614 0 0 12.2061 0 0 0 0 0 0 0 0 14.1464 0 0 12.935 13.0626 0 P25874 UCP1_HUMAN "Mitochondrial brown fat uncoupling protein 1, UCP 1 (Solute carrier family 25 member 7) (Thermogenin)" UCP1 SLC25A7 UCP Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; brown fat cell differentiation [GO:0050873]; cellular response to cold [GO:0070417]; cellular response to dehydroepiandrosterone [GO:1903495]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; diet induced thermogenesis [GO:0002024]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; response to nutrient levels [GO:0031667]; response to temperature stimulus [GO:0009266] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; long-chain fatty acid binding [GO:0036041]; oxidative phosphorylation uncoupler activity [GO:0017077]; purine ribonucleotide binding [GO:0032555]; transmembrane transporter activity [GO:0022857]; adaptive thermogenesis [GO:1990845]; brown fat cell differentiation [GO:0050873]; cellular response to cold [GO:0070417]; cellular response to dehydroepiandrosterone [GO:1903495]; cellular response to fatty acid [GO:0071398]; cellular response to hormone stimulus [GO:0032870]; cellular response to reactive oxygen species [GO:0034614]; diet induced thermogenesis [GO:0002024]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; positive regulation of cold-induced thermogenesis [GO:0120162]; proton transmembrane transport [GO:1902600]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; response to nutrient levels [GO:0031667]; response to temperature stimulus [GO:0009266] GO:0002024; GO:0005525; GO:0005739; GO:0005743; GO:0006357; GO:0006839; GO:0009266; GO:0009409; GO:0016021; GO:0017077; GO:0019003; GO:0022857; GO:0031667; GO:0032555; GO:0032870; GO:0034614; GO:0036041; GO:0050873; GO:0070417; GO:0071398; GO:0120162; GO:1901612; GO:1902600; GO:1903426; GO:1903495; GO:1990542; GO:1990845 cardiolipin binding [GO:1901612]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; long-chain fatty acid binding [GO:0036041]; oxidative phosphorylation uncoupler activity [GO:0017077]; purine ribonucleotide binding [GO:0032555]; transmembrane transporter activity [GO:0022857] PRYTGTYNAYR 0.98398 -1.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXP2 S12A9_HUMAN "Solute carrier family 12 member 9 (Cation-chloride cotransporter 6, hCCC6) (Cation-chloride cotransporter-interacting protein 1, CCC-interacting protein 1, hCIP1) (Potassium-chloride transporter 9) (WO3.3)" SLC12A9 CCC6 CIP1 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation:chloride symporter activity [GO:0015377]; potassium:chloride symporter activity [GO:0015379]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075] GO:0005886; GO:0006884; GO:0015377; GO:0015379; GO:0016021; GO:0055064; GO:0055075; GO:0070062; GO:1902476 cation:chloride symporter activity [GO:0015377]; potassium:chloride symporter activity [GO:0015379] ASGALPPER 0.98398 -3.2433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4138 17.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7243 16.4903 16.1023 15.7546 14.9659 0 0 14.5488 0 0 13.7991 0 0 0 0 0 11.1595 12.6169 0 0 0 0 0 0 0 12.8638 11.693 10.2181 0 0 0 0 0 0 12.3473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9103 0 0 12.1245 10.4166 0 11.7401 0 0 9.59585 0 0 0 0 0 0 0 0 0 0 0 12.2386 0 0 0 0 0 0 0 0 0 11.9545 0 10.7521 0 0 0 0 0 0 15.5638 0 0 0 0 19.6789 19.3904 18.7557 17.7528 18.3811 0 18.6161 0 0 0 13.6514 13.3362 17.9448 17.7195 0 0 0 0 0 0 0 9.79116 0 0 Q9NZW4 DSPP_HUMAN "Dentin sialophosphoprotein [Cleaved into: Dentin phosphoprotein (Dentin phosphophoryn, DPP); Dentin sialoprotein, DSP ]" DSPP Homo sapiens (Human) biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; odontoblast differentiation [GO:0071895]; regulation of odontoblast differentiation [GO:1901329] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; odontoblast differentiation [GO:0071895]; regulation of odontoblast differentiation [GO:1901329] GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005634; GO:0005737; GO:0031012; GO:0031214; GO:0071895; GO:0097187; GO:1901329 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201] DNGNGSDSKGAEDDDSDSTSDTNNSDSNGNGNNGNDDNDK 0.98398 -3.1385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3418 0 0 0 0 0 0 11.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.17 0 0 12.654 13.059 0 11.6438 0 0 0 12.3646 0 0 13.0127 0 0 0 0 0 0 11.3916 0 12.5812 12.132 0 0 0 12.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0611 0 0 12.4494 0 12.0962 0 0 11.9824 0 0 0 0 12.2622 0 0 11.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8677 0 0 0 0 0 0 10.3922 12.1908 0 0 0 0 P51795 CLCN5_HUMAN "H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5, ClC-5) (Chloride transporter ClC-5)" CLCN5 CLCK2 Homo sapiens (Human) chloride transport [GO:0006821]; endocytosis [GO:0006897]; ion transmembrane transport [GO:0034220]; renal system process [GO:0003014] apical part of cell [GO:0045177]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] apical part of cell [GO:0045177]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; chloride transport [GO:0006821]; endocytosis [GO:0006897]; ion transmembrane transport [GO:0034220]; renal system process [GO:0003014] GO:0000139; GO:0003014; GO:0005247; GO:0005524; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006821; GO:0006897; GO:0008021; GO:0010008; GO:0015297; GO:0015299; GO:0016020; GO:0034220; GO:0042802; GO:0045177 antiporter activity [GO:0015297]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247] AMWQGAMDNR 0.98399 -3.1451 0 0 0 0 0 0 0 0 0 9.84227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8774 0 14.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.886 0 0 0 12.7775 0 0 0 0 13.2808 11.6296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2406 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16281 CNGA3_HUMAN "Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3, CNG channel alpha-3, CNG-3, CNG3)" CNGA3 CNCG3 Homo sapiens (Human) cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601] axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495] axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; inorganic cation import across plasma membrane [GO:0098659]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to magnesium ion [GO:0032026]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0005222; GO:0005223; GO:0005737; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0008022; GO:0015276; GO:0017071; GO:0030425; GO:0030553; GO:0031960; GO:0032026; GO:0043194; GO:0043204; GO:0044877; GO:0051591; GO:0097386; GO:0098655; GO:0098659; GO:1902495 cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] AHSSSEETSSVLQPGIAMETR 0.98399 -2.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4631 12.2442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5482 0 0 0 0 0 0 14.8927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZRQ5 MMS22_HUMAN Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like) MMS22L C6orf167 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] GO:0000724; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0031297; GO:0043596; GO:0090734 single-stranded DNA binding [GO:0003697] DPLGFSWWIITHVASFYK 0.98399 -2.2861 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3894 0 0 0 0 14.0554 10.299 12.4656 0 14.2531 0 0 0 0 0 0 0 0 0 0 14.258 0 0 0 0 0 0 0 0 13.7557 0 0 13.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9797 15.0138 12.2885 12.5404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6583 0 0 0 0 0 0 15.7515 0 0 0 0 0 13.5753 0 0 0 0 0 0 14.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2282 0 0 0 0 0 0 0 13.153 0 0 0 0 0 0 0 0 0 0 0 15.2694 0 0 0 0 0 15.1517 0 0 0 0 0 Q8NAA4 A16L2_HUMAN Protein Atg16l2 (APG16-like 2) (Autophagy-related protein 16-2) (WD repeat-containing protein 80) ATG16L2 WDR80 Homo sapiens (Human) autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein lipidation [GO:0006497]; protein transport [GO:0015031] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; protein lipidation [GO:0006497]; protein transport [GO:0015031] GO:0000045; GO:0000421; GO:0005654; GO:0005829; GO:0006497; GO:0015031; GO:0034045; GO:0034274; GO:0039689 ALFLELVPAYNHLLEKAELLDK 0.98399 -3.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8267 0 0 0 0 0 0 0 12.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NF67 A2012_HUMAN Putative ankyrin repeat domain-containing protein 20A12 pseudogene ANKRD20A12P Homo sapiens (Human) AERVVVVR 0.98399 -3.1446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94972 TRI37_HUMAN "E3 ubiquitin-protein ligase TRIM37, EC 2.3.2.27 (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37)" TRIM37 KIAA0898 MUL POB1 Homo sapiens (Human) aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of centriole replication [GO:0046600]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865] GO:0000122; GO:0003682; GO:0003713; GO:0004842; GO:0005164; GO:0005737; GO:0005777; GO:0005829; GO:0008270; GO:0016235; GO:0031625; GO:0032088; GO:0035518; GO:0036353; GO:0042803; GO:0046600; GO:0048471; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070842 chromatin binding [GO:0003682]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] DQHWYITQLEAAQTSYIQQINNLK 0.984 -3.0706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7395 0 14.3538 0 0 0 0 15.185 0 0 0 14.2499 11.347 0 0 0 0 0 0 0 0 0 0 0 13.6167 0 0 0 0 14.4983 0 0 0 0 0 0 0 0 0 0 12.4996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.024 0 0 0 0 0 13.8394 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1905 0 0 0 0 14.0533 0 0 0 0 0 0 0 13.4042 0 0 0 P15863 PAX1_HUMAN Paired box protein Pax-1 (HuP48) PAX1 HUP48 Homo sapiens (Human) anatomical structure development [GO:0048856]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001501; GO:0005634; GO:0006357; GO:0006366; GO:0048856; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LRIVELAQLGIR 0.984 -2.2884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1341 0 13.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1775 0 0 0 0 0 0 0 0 0 0 0 11.9079 0 0 0 0 0 0 0 0 13.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24821 TENA_HUMAN "Tenascin, TN (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C, TN-C)" TNC HXB Homo sapiens (Human) cell adhesion [GO:0007155]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to wounding [GO:0009611] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]; extracellular matrix structural constituent [GO:0005201]; syndecan binding [GO:0045545]; cell adhesion [GO:0007155]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of inflammatory response [GO:0050727]; response to wounding [GO:0009611] GO:0001558; GO:0001649; GO:0005201; GO:0005576; GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0005925; GO:0007155; GO:0007528; GO:0008284; GO:0009611; GO:0010628; GO:0014012; GO:0016020; GO:0030155; GO:0030334; GO:0031175; GO:0045545; GO:0050727; GO:0060739; GO:0060740; GO:0062023; GO:0090733; GO:0098966 extracellular matrix structural constituent [GO:0005201]; syndecan binding [GO:0045545] AVDIPGLK 0.984 -3.1483 0 0 0 10.2838 0 0 0 0 12.1228 0 0 12.5189 0 0 0 0 10.0633 0 10.3405 0 13.5663 0 11.406 0 0 12.6146 13.7046 10.9214 0 0 0 0 0 12.6751 0 0 0 0 0 0 11.0059 14.206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4029 0 0 0 0 0 0 0 0 0 0 12.8153 0 12.6415 10.93 11.458 0 13.6843 12.2205 15.1787 0 14.5673 0 15.9297 14.371 14.2863 15.388 13.0001 14.4739 14.553 16.2193 15.4443 16.1002 0 13.3969 12.9474 0 17.2959 0 0 13.2493 13.3784 11.1412 0 12.2238 0 0 13.0167 0 14.4402 14.1869 0 11.3314 12.6835 0 0 12.4563 0 0 0 0 0 12.6725 0 0 15.5993 0 13.6162 13.9772 0 13.751 0 12.3554 11.2722 0 0 0 15.3177 11.9345 0 11.4203 0 0 0 10.641 0 0 0 14.6466 13.8695 11.1048 0 13.9136 0 0 0 13.4752 0 11.9314 13.3632 0 10.741 13.0158 0 0 0 10.7144 0 0 12.2976 13.0561 0 0 11.3759 0 0 0 Q96M20 CNBD2_HUMAN Cyclic nucleotide-binding domain-containing protein 2 CNBD2 C20orf152 Homo sapiens (Human) spermatogenesis [GO:0007283] cytosol [GO:0005829] cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283] GO:0005829; GO:0007283; GO:0030552 cAMP binding [GO:0030552] IQSRPAQSIKCAMINIK 0.984 -2.2877 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6089 0 0 13.7582 0 0 0 0 0 0 0 14.7709 15.0021 0 13.1009 0 13.3884 14.6647 0 16.1999 13.0253 16.218 0 0 0 0 0 14.9041 12.7529 0 0 0 0 12.8842 13.0151 12.8885 0 12.236 0 0 13.7707 0 0 0 0 0 0 0 0 0 13.6858 0 0 12.6548 0 13.1732 0 13.2935 0 0 0 0 0 0 0 0 0 0 13.4598 13.133 0 0 0 0 0 0 0 0 13.6613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43680 TCF21_HUMAN "Transcription factor 21, TCF-21 (Capsulin) (Class A basic helix-loop-helix protein 23, bHLHa23) (Epicardin) (Podocyte-expressed 1, Pod-1)" TCF21 BHLHA23 POD1 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nuclear androgen receptor binding [GO:0050681]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001822; GO:0001944; GO:0005634; GO:0005667; GO:0006357; GO:0007530; GO:0014707; GO:0030855; GO:0032502; GO:0032835; GO:0042826; GO:0043425; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0050681; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0070888; GO:0072162; GO:0072277; GO:1990837 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; nuclear androgen receptor binding [GO:0050681]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ARMRVLSK 0.98401 -2.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8575 0 0 0 0 0 14.216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7643 0 0 0 0 0 14.5295 0 0 0 14.9408 13.3993 0 0 0 12.3243 0 0 0 0 14.5823 0 0 0 0 0 0 14.4617 0 0 0 0 12.8018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQW7 XPP1_HUMAN "Xaa-Pro aminopeptidase 1, EC 3.4.11.9 (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P, sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)" XPNPEP1 XPNPEPL XPNPEPL1 Homo sapiens (Human) bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508] GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0070006; GO:0070062 aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803] DVIGKELQKQGR 0.98401 -3.1597 0 0 0 0 0 0 0 0 12.806 0 0 0 0 0 0 0 0 12.311 0 0 0 0 0 0 0 0 0 9.83302 0 0 0 0 0 0 0 0 0 0 10.4595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9988 0 0 0 16.7471 16.6081 0 0 0 0 16.6085 0 0 17.0574 13.8523 0 0 0 0 0 0 13.403 12.9527 0 12.198 0 16.1934 13.5992 0 0 0 0 0 13.3537 13.27 0 12.9734 16.6547 16.5354 0 0 0 16.5775 0 13.072 0 0 0 0 0 0 16.2457 0 12.878 0 0 15.8215 0 0 0 0 0 0 0 0 0 0 0 16.5114 0 15.7434 0 12.2921 0 11.9369 0 15.6331 0 13.9217 0 0 0 0 11.8302 0 0 0 0 0 0 13.1475 0 0 0 12.1044 0 0 0 0 0 12.4658 0 0 0 0 12.0417 0 0 Q9P266 JCAD_HUMAN "Junctional cadherin 5-associated protein (Junctional protein associated with coronary artery disease, JCAD)" JCAD KIAA1462 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748] adherens junction [GO:0005912]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587] adherens junction [GO:0005912]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; cell adhesion [GO:0007155]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748] GO:0005912; GO:0007155; GO:0032587; GO:0043410; GO:0048471; GO:0090050; GO:1900748; GO:1903589; GO:1903672 AQRLGHSLSVSK 0.98401 -2.2944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9569 0 0 0 0 0 0 0 0 0 0 10.7123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4779 0 13.2225 12.5332 14.3308 13.0987 0 13.3004 13.3746 0 0 0 0 0 11.6081 0 0 0 0 14.1312 0 14.4047 13.7581 0 0 0 0 0 13.989 13.9214 0 11.0267 0 0 0 0 15.3652 15.2394 15.3396 0 0 10.9609 0 0 0 0 0 0 13.173 0 0 0 0 10.2226 13.3019 0 0 0 0 0 0 0 13.5814 0 0 0 0 0 0 0 0 0 0 11.8164 0 0 0 0 0 14.0144 0 0 0 0 0 10.7696 0 0 0 0 0 13.8878 13.1385 0 0 13.742 0 0 0 Q6UX06 OLFM4_HUMAN "Olfactomedin-4, OLM4 (Antiapoptotic protein GW112) (G-CSF-stimulated clone 1 protein, hGC-1) (hOLfD)" OLFM4 GW112 UNQ362/PRO698 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercellular bridge [GO:0045171]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165] GO:0005198; GO:0005576; GO:0005615; GO:0005654; GO:0005739; GO:0005829; GO:0005886; GO:0007155; GO:0007165; GO:0032991; GO:0035580; GO:0042581; GO:0045171; GO:0045296; GO:0048471; GO:0070062; GO:1900026; GO:1904724 cadherin binding [GO:0045296]; structural molecule activity [GO:0005198] EGKLDIVMHKMQEK 0.98404 -3.2009 0 0 0 0 0 0 0 0 0 12.7886 0 0 0 0 0 0 0 0 0 0 12.0526 0 0 0 0 0 0 0 0 0 0 12.3266 12.9355 15.0488 0 0 0 0 0 0 0 0 12.8142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96475 0 0 11.3266 0 12.7349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6183 0 0 0 0 0 0 0 0 0 11.3303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969H9 DIRC1_HUMAN Disrupted in renal carcinoma protein 1 (Disrupted in renal cancer protein) DIRC1 Homo sapiens (Human) ILNQLSLT 0.98404 -2.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4255 0 0 0 15.3371 13.4215 0 13.8543 0 0 13.5366 0 0 0 0 14.4822 0 0 0 0 14.3441 0 0 0 0 0 14.3054 14.0647 0 0 14.5926 0 0 0 0 0 14.5844 0 0 0 14.0992 0 0 0 0 14.4193 13.806 0 0 0 0 0 0 14.6875 0 0 14.4355 0 0 0 0 0 14.1465 14.2177 14.0059 0 13.7756 13.2958 0 0 14.5745 0 14.5497 0 14.4113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15531 NDKA_HUMAN "Nucleoside diphosphate kinase A, NDK A, NDP kinase A, EC 2.7.4.6 (Granzyme A-activated DNase, GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein)" NME1 NDPKA NM23 Homo sapiens (Human) cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; nucleoside diphosphate phosphorylation [GO:0006165]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228] GO:0000287; GO:0003723; GO:0004536; GO:0004550; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0006897; GO:0007399; GO:0007595; GO:0008285; GO:0016020; GO:0030154; GO:0032587; GO:0042802; GO:0042981; GO:0043024; GO:0043388; GO:0050679; GO:0070062 ATP binding [GO:0005524]; deoxyribonuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723] GFRLVGLK 0.98405 -1.3997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8495 15.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6793 0 0 0 17.2693 0 0 0 0 17.1429 17.0939 0 0 0 0 0 0 0 0 0 0 13.5429 0 0 13.6676 0 0 0 0 0 0 13.3845 16.845 16.8942 0 0 0 0 0 0 16.8594 0 0 0 11.9116 0 0 0 0 0 0 0 0 0 0 14.1004 0 0 0 0 16.8289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3383 0 0 0 0 0 0 Q86UE3 ZN546_HUMAN Zinc finger protein 546 (Zinc finger protein 49) ZNF546 ZNF49 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGKAFR 0.98405 -3.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0489 14.3064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8531 0 0 0 0 0 0 0 0 0 0 0 Q8N4B5 PRR18_HUMAN Proline-rich protein 18 PRR18 Homo sapiens (Human) FCLNLTPEAVLVIQK 0.98405 -1.5088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5905 0 0 0 0 14.0492 0 13.7289 0 0 0 0 17.2264 18.9283 0 14.8135 0 0 14.7082 0 0 0 0 0 0 0 12.46 0 0 0 0 0 0 0 0 14.5601 0 0 0 13.0298 0 13.167 0 0 13.4834 0 12.8139 0 0 0 0 0 0 0 0 13.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14978 ZN263_HUMAN Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12) ZNF263 FPM315 ZKSCAN12 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0043565; GO:0045944; GO:0046872; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ASGPGSQEREGLLIVK 0.98406 -3.1203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8906 0 19.3365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7956 14.1718 0 0 0 13.3938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8193 0 0 0 0 12.2796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20396 TRH_HUMAN "Pro-thyrotropin-releasing hormone, Pro-TRH (Prothyroliberin) [Cleaved into: Thyrotropin-releasing hormone, TRH (Protirelin) (TSH-releasing factor) (Thyroliberin) (Thyrotropin-releasing factor, TRF) ]" TRH Homo sapiens (Human) adult walking behavior [GO:0007628]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; histamine metabolic process [GO:0001692]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of glutamate secretion [GO:0014050]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of insulin secretion [GO:0032024]; signal transduction [GO:0007165] extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141] extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; thyrotropin-releasing hormone activity [GO:0008437]; adult walking behavior [GO:0007628]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; histamine metabolic process [GO:0001692]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of glutamate secretion [GO:0014050]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of insulin secretion [GO:0032024]; signal transduction [GO:0007165] GO:0001692; GO:0005576; GO:0005634; GO:0005886; GO:0007165; GO:0007267; GO:0007628; GO:0008437; GO:0009755; GO:0014050; GO:0014054; GO:0030141; GO:0032024; GO:0042755 thyrotropin-releasing hormone activity [GO:0008437] LADPKAQR 0.98406 -1.4033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUI8 CRLF3_HUMAN "Cytokine receptor-like factor 3 (Cytokine receptor-like molecule 9, CREME-9) (Cytokine receptor-related protein 4) (Type I cytokine receptor-like factor p48)" CRLF3 CREME9 CRLM9 CYTOR4 P48 Homo sapiens (Human) "negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0030308; GO:0042802; GO:0045893; GO:0045944; GO:0046427; GO:2000134 DNA binding [GO:0003677]; identical protein binding [GO:0042802] LLDERLVTLLQEVDTIEQETIKPLDDCQK 0.98406 -1.4033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9224 0 0 0 0 15.2041 0 14.071 0 0 16.1112 0 0 13.2798 0 0 0 12.3933 0 0 0 0 0 0 0 0 0 0 10.427 0 0 0 10.2938 0 0 11.3141 0 0 0 0 0 11.3002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6Q1 TMC5A_HUMAN Transmembrane and coiled-coil domain-containing protein 5A TMCO5A TMCO5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LLLKIQER 0.98406 -1.4025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UEW8 STK39_HUMAN "STE20/SPS1-related proline-alanine-rich protein kinase, Ste-20-related kinase, EC 2.7.11.1 (DCHT) (Serine/threonine-protein kinase 39)" STK39 SPAK Homo sapiens (Human) cellular chloride ion homeostasis [GO:0030644]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; macrophage activation [GO:0042116]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; response to aldosterone [GO:1904044]; response to dietary excess [GO:0002021]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular chloride ion homeostasis [GO:0030644]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; macrophage activation [GO:0042116]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; response to aldosterone [GO:1904044]; response to dietary excess [GO:0002021]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725] GO:0002021; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006954; GO:0007165; GO:0008217; GO:0010820; GO:0016301; GO:0016323; GO:0016324; GO:0018105; GO:0018107; GO:0019898; GO:0019901; GO:0030644; GO:0032414; GO:0035556; GO:0035725; GO:0035865; GO:0036438; GO:0038146; GO:0042116; GO:0043231; GO:0043268; GO:0044297; GO:0046777; GO:0050727; GO:0071476; GO:0090188; GO:0106310; GO:1900745; GO:1901017; GO:1901380; GO:1904044; GO:1905408; GO:1990869; GO:2000650 ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] LIGFAQLSVS 0.98406 -2.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7015 0 0 12.7057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3317 0 0 0 0 0 0 0 0 0 0 13.8698 0 0 0 0 0 0 0 0 0 13.84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1909 0 P41145 OPRK_HUMAN "Kappa-type opioid receptor, K-OR-1, KOR-1" OPRK1 OPRK Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; chemical synaptic transmission [GO:0007268]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to acrylamide [GO:1903937]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951] axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; dynorphin receptor activity [GO:0038048]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:0031635]; behavioral response to cocaine [GO:0048148]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipopolysaccharide [GO:0071222]; chemical synaptic transmission [GO:0007268]; conditioned place preference [GO:1990708]; defense response to virus [GO:0051607]; eating behavior [GO:0042755]; estrous cycle [GO:0044849]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; immune response [GO:0006955]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; negative regulation of luteinizing hormone secretion [GO:0033685]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of eating behavior [GO:1904000]; positive regulation of locomotion [GO:0040017]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of saliva secretion [GO:0046877]; regulation of sensory perception of pain [GO:0051930]; response to acrylamide [GO:1903937]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to radiation [GO:0009314]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951] GO:0004930; GO:0004985; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0006955; GO:0007193; GO:0007200; GO:0007218; GO:0007268; GO:0007600; GO:0007626; GO:0009314; GO:0016021; GO:0019233; GO:0030285; GO:0030425; GO:0031635; GO:0032868; GO:0033603; GO:0033612; GO:0033685; GO:0038003; GO:0038048; GO:0040017; GO:0042277; GO:0042711; GO:0042755; GO:0042923; GO:0043005; GO:0043204; GO:0043278; GO:0043627; GO:0043679; GO:0044849; GO:0045471; GO:0046877; GO:0048148; GO:0050951; GO:0051607; GO:0051930; GO:0071222; GO:0071333; GO:0099055; GO:0099056; GO:1900745; GO:1901381; GO:1903937; GO:1904000; GO:1990708 dynorphin receptor activity [GO:0038048]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612] AKIINICIWLLSSSVGISAIVLGGTK 0.98407 -3.1259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.614 0 0 0 0 0 0 0 0 0 13.1163 0 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.558 0 0 0 0 12.671 12.4032 0 0 0 0 0 12.6076 0 0 0 0 0 0 0 0 0 0 0 14.0445 0 0 0 12.6276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9118 0 13.0003 0 0 0 0 0 0 0 14.0205 12.7762 0 0 0 0 0 0 0 0 0 14.4161 0 13.3663 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1163 14.1256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75531 BAF_HUMAN "Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed ]" BANF1 BAF BCRG1 Homo sapiens (Human) chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LEM domain binding [GO:0097726]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615] GO:0000793; GO:0003677; GO:0003690; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0007059; GO:0007084; GO:0008022; GO:0009615; GO:0019899; GO:0030261; GO:0032480; GO:0042802; GO:0042803; GO:0045071; GO:0045824; GO:0047485; GO:0097726 DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LEM domain binding [GO:0097726]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485] DCFGCLR 0.98408 -3.1371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27539 GDF1_HUMAN "Embryonic growth/differentiation factor 1, GDF-1" GDF1 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] GO:0005125; GO:0005615; GO:0008083; GO:0010862; GO:0030509; GO:0060395 cytokine activity [GO:0005125]; growth factor activity [GO:0008083] LCHPLAR 0.98408 -3.1374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5D6 GBGT1_HUMAN "Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1, EC 2.4.1.- (Forssman glycolipid synthase-like protein)" GBGT1 UNQ2513/PRO6002 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glycolipid biosynthetic process [GO:0009247]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; globoside alpha-N-acetylgalactosaminyltransferase activity [GO:0047277]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; glycolipid biosynthetic process [GO:0009247]; lipid glycosylation [GO:0030259]; protein glycosylation [GO:0006486] GO:0000139; GO:0005794; GO:0005975; GO:0006486; GO:0009247; GO:0016021; GO:0030259; GO:0031982; GO:0046872; GO:0047277 globoside alpha-N-acetylgalactosaminyltransferase activity [GO:0047277]; metal ion binding [GO:0046872] QQFPYER 0.98408 -3.242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0197 0 0 0 0 0 0 0 0 0 0 P0C7X0 F90AO_HUMAN Putative protein FAM90A24P FAM90A24P FAM90A24 Homo sapiens (Human) ENLKPWKPR 0.98409 -3.2459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9019 0 0 0 0 0 0 0 0 0 0 15.0826 0 0 12.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78504 JAG1_HUMAN "Protein jagged-1, Jagged1, hJ1 (CD antigen CD339)" JAG1 JAGL1 Homo sapiens (Human) angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of reproductive process [GO:2000241]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of reproductive process [GO:2000241]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456] GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005887; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061314; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000241; GO:2000737 calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198] AICRQGCSPK 0.98409 -3.247 0 0 0 12.9707 0 0 0 0 11.2175 0 13.3068 0 0 0 0 0 0 0 10.6411 0 0 11.4548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7227 14.3656 0 0 12.6644 11.0726 0 10.0974 12.5448 12.5981 0 0 0 0 0 0 0 0 0 0 13.6417 13.5982 13.271 14.5901 0 0 12.8622 14.0549 0 0 11.6998 0 0 0 11.6479 0 0 14.4023 15.1556 0 12.1056 12.2129 0 0 13.8722 13.0514 15.4813 14.2521 0 14.7231 0 0 0 14.2487 15.1741 14.8207 13.9431 0 13.0149 0 10.985 14.5153 0 0 0 0 14.3933 12.6326 0 0 0 14.3991 0 14.4587 0 15.8622 0 0 11.3543 0 0 15.1561 14.8428 0 0 13.9631 16.3503 0 0 15.0501 0 14.7974 16.1301 12.0188 0 16.0319 14.3965 14.476 14.1735 0 0 16.13 14.5174 0 0 14.3146 0 15.0236 12.8135 13.227 11.5689 0 0 0 11.4935 13.108 0 0 12.739 0 0 0 11.8205 0 12.8548 15.0693 14.2108 13.1343 13.9488 0 0 0 14.6744 13.3204 Q9BV97 ZN747_HUMAN Zinc finger protein 747 ZNF747 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" "metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]" GO:0006355; GO:0046872 metal ion binding [GO:0046872] AELWDPAAQDPEVAKCPTEADPDSR 0.98409 -3.1445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2006 13.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00534 VMA5A_HUMAN "von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1, BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein)" VWA5A BCSC1 LOH11CR2A Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 AAITFLKSSVDPAIFAF 0.9841 -3.1482 0 0 0 12.1164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9129 0 0 0 13.4504 14.7213 0 0 14.6324 13.451 0 0 0 0 17.0457 0 0 13.8094 0 0 0 0 0 13.4617 0 0 14.0283 0 0 0 14.9614 0 0 0 0 0 0 14.8439 0 0 13.4105 0 0 0 0 0 0 13.0675 0 0 0 0 0 0 0 0 0 0 0 0 15.7645 0 0 15.2095 0 0 0 0 0 0 0 0 0 0 0 0 13.5748 0 0 0 0 0 0 0 0 0 0 0 12.3641 0 0 0 0 0 0 0 0 0 0 0 0 14.6765 0 14.6042 0 0 0 13.145 0 13.8815 0 P22309 UD11_HUMAN "UDP-glucuronosyltransferase 1A1, UGT1A1, EC 2.4.1.17 (Bilirubin-specific UDPGT isozyme 1, hUG-BR1) (UDP-glucuronosyltransferase 1-1, UDPGT 1-1, UGT1*1, UGT1-01, UGT1.1) (UDP-glucuronosyltransferase 1A isoform 1)" UGT1A1 GNT1 UGT1 Homo sapiens (Human) acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; heterocycle metabolic process [GO:0046483]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471] cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; heterocycle metabolic process [GO:0046483]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805] GO:0001889; GO:0001972; GO:0004857; GO:0005496; GO:0005783; GO:0005789; GO:0005887; GO:0006789; GO:0006805; GO:0006953; GO:0007584; GO:0008202; GO:0008210; GO:0015020; GO:0019899; GO:0031100; GO:0032496; GO:0034663; GO:0042573; GO:0042594; GO:0042803; GO:0045922; GO:0045939; GO:0046483; GO:0046982; GO:0048471; GO:0051552; GO:0052695; GO:0052696; GO:0052697; GO:0070069; GO:0070980; GO:0071361; GO:0071385; GO:0071392; GO:1904224; GO:2001030 enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496] EVTVQDLLSSASVWLFRSDFVKDYPR 0.9841 -3.2524 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5567 0 0 0 0 0 14.3575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02878 RL6_HUMAN "60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107, TaxREB107)" RPL6 TXREB1 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; regulation of transcription, DNA-templated [GO:0006355]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; regulation of transcription, DNA-templated [GO:0006355]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412]" GO:0000027; GO:0002181; GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006355; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0036464; GO:0042788; GO:0045296 cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ASITPGTILIILTGRHRGK 0.9841 -3.0705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1243 0 0 0 0 13.0205 0 0 13.1944 0 0 0 0 0 13.196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7003 0 0 0 0 0 0 0 0 0 0 11.153 0 13.4307 0 11.4932 0 14.7879 0 0 0 14.1059 0 0 0 0 0 10.9107 0 11.0772 0 0 0 13.5417 0 0 0 13.4298 13.3359 13.5961 14.1209 0 0 0 0 0 13.6436 0 12.4387 12.8873 0 0 0 14.3136 12.7912 14.7649 0 0 10.9888 0 0 12.3722 0 0 0 12.1653 0 0 0 0 0 0 0 14.029 14.7241 11.7699 12.3998 14.0717 0 0 0 0 0 12.896 13.2755 14.4553 0 13.3745 0 0 0 0 12.9991 0 0 0 0 0 13.2025 0 0 0 0 0 0 11.5923 0 13.9732 Q68D42 TM215_HUMAN Transmembrane protein 215 TMEM215 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LPCFRKPK 0.9841 -3.2525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NV12 TM140_HUMAN Transmembrane protein 140 TMEM140 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LSLPGPGFLALGSAQALLILLLIAMAVFPLRAER 0.9841 -2.2852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.344 0 0 0 0 0 0 0 0 0 0 11.6766 0 0 0 0 0 14.2163 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5304 0 13.745 0 0 0 0 12.9379 0 13.0017 0 0 0 0 0 13.1641 0 13.0767 0 0 14.2552 0 0 0 0 13.6257 0 0 11.8274 0 0 11.7674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5602 0 0 0 0 Q9UFV3 YO007_HUMAN Putative uncharacterized protein DKFZp434L187 Homo sapiens (Human) LIQSRLKLLLHLGSQPPVGK 0.9841 -1.5443 0 0 11.3131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.21177 10.989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4508 12.9267 18.1833 0 0 14.8331 0 0 13.7241 14.1784 0 13.0615 12.9989 14.7398 14.4391 0 14.7457 15.6147 12.7013 0 15.2989 0 13.6198 18.9884 0 18.9272 0 14.7452 13.1764 15.3067 13.8039 0 12.308 0 16.2503 0 0 0 0 0 0 15.9509 16.4748 0 0 19.0794 0 13.6072 0 0 0 0 11.0399 0 12.5752 0 0 0 15.0265 11.1813 0 0 13.7393 0 0 11.8163 0 0 12.3277 0 13.4176 13.7597 13.8648 0 0 0 0 10.8075 0 0 0 11.4135 14.3279 0 0 0 14.5691 13.7954 0 0 0 0 0 0 13.0884 12.8866 0 0 0 0 0 0 0 14.7223 14.1815 0 0 0 0 0 13.5151 0 0 P48546 GIPR_HUMAN "Gastric inhibitory polypeptide receptor, GIP-R (Glucose-dependent insulinotropic polypeptide receptor)" GIPR Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; gastric inhibitory peptide signaling pathway [GO:0038192]; generation of precursor metabolites and energy [GO:0006091]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; regulation of insulin secretion [GO:0050796]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to nutrient [GO:0007584] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; gastric inhibitory peptide receptor activity [GO:0016519]; glucagon family peptide binding [GO:0120022]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; endocrine pancreas development [GO:0031018]; gastric inhibitory peptide signaling pathway [GO:0038192]; generation of precursor metabolites and energy [GO:0006091]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; regulation of insulin secretion [GO:0050796]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to nutrient [GO:0007584] GO:0002029; GO:0004888; GO:0005886; GO:0006091; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007204; GO:0007584; GO:0008528; GO:0009749; GO:0016021; GO:0016519; GO:0017046; GO:0031018; GO:0032024; GO:0038192; GO:0043950; GO:0048678; GO:0050796; GO:0051592; GO:0070542; GO:0120022 G protein-coupled peptide receptor activity [GO:0008528]; gastric inhibitory peptide receptor activity [GO:0016519]; glucagon family peptide binding [GO:0120022]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888] AIWWIIRTPILMTILINFLIFIR 0.98411 -3.1583 0 0 0 0 0 0 0 0 0 0 13.4342 0 0 0 0 11.3297 13.176 0 0 0 0 12.0505 0 0 0 0 0 0 0 0 0 0 12.1347 0 0 0 0 0 0 11.8863 0 0 0 0 0 10.3087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6738 0 0 0 0 0 13.557 0 0 12.5087 0 0 0 0 0 0 0 14.0775 0 0 0 0 0 0 0 14.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.257 0 0 0 0 0 0 0 0 15.0131 0 13.6049 0 0 0 0 0 11.988 12.8891 0 0 0 0 0 0 0 0 0 13.859 0 0 0 0 0 13.1813 0 12.9554 12.5347 0 0 0 0 0 0 13.4645 12.9009 0 13.0341 0 13.2248 13.041 0 0 0 0 0 11.3518 0 15.2082 0 0 0 0 0 0 0 Q8NGJ6 O51A4_HUMAN Olfactory receptor 51A4 OR51A4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FARHVSPLINVLMANVLLLVPPLTNPIVYCVK 0.98411 -3.1594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5376 0 0 0 13.3613 0 13.4951 0 0 0 11.3466 0 0 0 0 12.1835 11.7418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7578 0 0 0 0 12.2875 0 0 0 0 0 0 12.3101 0 11.709 0 0 0 0 0 13.0789 0 0 0 0 0 0 0 0 13.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1419 0 0 0 14.7807 11.5156 11.7726 11.1503 0 0 0 11.9253 0 0 12.0863 0 0 12.3719 0 0 0 0 0 0 0 A8MQB3 CQ051_HUMAN Putative uncharacterized protein LINC02693 LINC02693 C17orf51 Homo sapiens (Human) AQAALYAPALRLR 0.98414 -1.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49895 IOD1_HUMAN "Type I iodothyronine deiodinase, EC 1.21.99.4 (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase)" DIO1 ITDI1 TXDI1 Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; hormone biosynthetic process [GO:0042446]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]; cellular amino acid metabolic process [GO:0006520]; hormone biosynthetic process [GO:0042446]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403] GO:0004800; GO:0005789; GO:0005886; GO:0006520; GO:0006590; GO:0008430; GO:0016021; GO:0042403; GO:0042446 selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800] LQAAHLLLAR 0.98414 -1.4486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4576 0 0 0 0 0 0 0 0 13.3556 0 0 0 0 0 13.1293 12.702 10.8563 11.5309 0 0 0 14.381 15.4027 0 0 14.7788 15.5213 0 0 0 0 0 0 0 0 0 0 11.4015 13.5873 0 0 0 0 12.8665 13.3129 0 0 0 0 0 12.0657 13.7493 0 0 12.8629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5195 0 0 0 0 0 0 0 0 15.0157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2585 0 0 0 12.3897 0 0 0 0 0 0 0 0 10.9582 0 0 0 P09601 HMOX1_HUMAN "Heme oxygenase 1, HO-1, EC 1.14.14.18 [Cleaved into: Heme oxygenase 1 soluble form ]" HMOX1 HO HO1 Homo sapiens (Human) angiogenesis [GO:0001525]; cellular iron ion homeostasis [GO:0006879]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to cisplatin [GO:0072719]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient [GO:0031670]; endothelial cell proliferation [GO:0001935]; epithelial cell apoptotic process [GO:1904019]; erythrocyte homeostasis [GO:0034101]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; iron ion homeostasis [GO:0055072]; liver regeneration [GO:0097421]; low-density lipoprotein particle clearance [GO:0034383]; macroautophagy [GO:0016236]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of chemokine production [GO:0032722]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; smooth muscle hyperplasia [GO:0014806]; wound healing involved in inflammatory response [GO:0002246] caveola [GO:0005901]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] caveola [GO:0005901]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospholipase D activity [GO:0004630]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; cellular iron ion homeostasis [GO:0006879]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to cisplatin [GO:0072719]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient [GO:0031670]; endothelial cell proliferation [GO:0001935]; epithelial cell apoptotic process [GO:1904019]; erythrocyte homeostasis [GO:0034101]; heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; iron ion homeostasis [GO:0055072]; liver regeneration [GO:0097421]; low-density lipoprotein particle clearance [GO:0034383]; macroautophagy [GO:0016236]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of chemokine production [GO:0032722]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; smooth muscle hyperplasia [GO:0014806]; wound healing involved in inflammatory response [GO:0002246] GO:0001525; GO:0001935; GO:0002246; GO:0002686; GO:0004392; GO:0004630; GO:0005198; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0005901; GO:0006788; GO:0006879; GO:0006979; GO:0007264; GO:0008217; GO:0008630; GO:0009410; GO:0010656; GO:0014806; GO:0016020; GO:0016021; GO:0016236; GO:0016239; GO:0016242; GO:0019899; GO:0020037; GO:0031670; GO:0032722; GO:0032764; GO:0034101; GO:0034383; GO:0034395; GO:0034605; GO:0035094; GO:0035556; GO:0042167; GO:0042542; GO:0042802; GO:0042803; GO:0043123; GO:0043305; GO:0043392; GO:0043433; GO:0043524; GO:0043619; GO:0043627; GO:0045765; GO:0045766; GO:0046872; GO:0048471; GO:0048661; GO:0048662; GO:0051090; GO:0055072; GO:0071243; GO:0071276; GO:0071456; GO:0072719; GO:0090050; GO:0097421; GO:1902042; GO:1903589; GO:1904019; GO:1904036; GO:1904037; GO:1904706 enzyme binding [GO:0019899]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phospholipase D activity [GO:0004630]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] APGLRQR 0.98415 -1.4503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5656 0 13.5693 13.452 0 0 13.586 13.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2685 0 0 0 0 0 13.2949 0 0 0 0 0 0 0 0 0 0 0 0 13.0769 0 12.6404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBF8 FA81A_HUMAN Protein FAM81A FAM81A Homo sapiens (Human) ELLQKIDQLSLIVK 0.98415 -3.2119 0 0 0 0 0 0 0 0 11.8263 0 0 0 0 0 0 0 0 12.529 0 0 0 12.081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9713 0 0 13.6939 0 13.4573 13.3004 0 13.3526 0 14.3313 0 13.82 14.5786 0 14.1511 0 13.8914 13.7722 0 14.0658 0 15.8598 0 13.7218 14.6007 14.5358 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2611 0 0 0 0 0 0 0 0 0 14.5567 13.6513 0 0 0 0 0 14.1799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5976 13.8994 14.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43462 MBTP2_HUMAN "Membrane-bound transcription factor site-2 protease, EC 3.4.24.85 (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease, SREBPs intramembrane protease)" MBTPS2 S2P Homo sapiens (Human) ATF6-mediated unfolded protein response [GO:0036500]; bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to endoplasmic reticulum stress [GO:0034976] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; ATF6-mediated unfolded protein response [GO:0036500]; bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; membrane protein intracellular domain proteolysis [GO:0031293]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to endoplasmic reticulum stress [GO:0034976] GO:0000139; GO:0004222; GO:0005737; GO:0008203; GO:0016021; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0046872; GO:0051091; GO:0070977; GO:1905897; GO:1990440 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AFYSWGRR 0.98416 -3.119 0 0 0 0 0 0 0 0 0 0 0 12.4527 0 12.4792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4557 0 12.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5746 0 0 0 0 0 11.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13183 S13A2_HUMAN "Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1, NaDC-1) (Renal sodium/dicarboxylate cotransporter)" SLC13A2 NADC1 SDCT1 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; succinate transmembrane transport [GO:0071422] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; low-affinity sodium:dicarboxylate symporter activity [GO:0015361]; succinate transmembrane transporter activity [GO:0015141]; anion transmembrane transport [GO:0098656]; succinate transmembrane transport [GO:0071422] GO:0005886; GO:0005887; GO:0015141; GO:0015361; GO:0016020; GO:0016021; GO:0070062; GO:0071422; GO:0098656 low-affinity sodium:dicarboxylate symporter activity [GO:0015361]; succinate transmembrane transporter activity [GO:0015141] AISILFVILVLLWFTR 0.98416 -3.1235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1633 0 0 0 11.3755 13.2312 0 0 0 0 0 0 14.6206 10.1088 0 0 0 0 14.5771 13.6479 13.4552 0 14.8296 0 0 0 0 0 0 12.218 0 0 0 0 0 0 0 0 11.9266 0 13.2867 0 0 0 0 0 0 0 0 14.5017 0 0 0 0 12.9172 0 0 0 0 0 0 12.7647 0 0 11.2582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5598 0 0 13.6742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2609 0 0 0 0 0 0 0 0 11.7339 0 0 0 0 Q9UNH5 CC14A_HUMAN "Dual specificity protein phosphatase CDC14A, EC 3.1.3.16, EC 3.1.3.48 (CDC14 cell division cycle 14 homolog A)" CDC14A Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; protein dephosphorylation [GO:0006470]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; protein dephosphorylation [GO:0006470]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605] GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007049; GO:0007096; GO:0007605; GO:0008138; GO:0016604; GO:0017018; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686; GO:1902636 myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] ANAAFLIGAYAVIYLKK 0.98416 -1.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3562 14.4041 18.3334 13.9725 18.347 0 18.2437 0 0 18.7504 0 13.8814 0 14.4931 12.8834 13.6629 0 0 0 0 12.3262 13.7895 0 13.7883 0 0 13.6532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0631 0 0 0 0 0 0 0 0 0 0 15.8393 0 0 0 0 0 0 0 0 0 15.7134 0 0 15.4779 15.6807 0 0 15.6549 0 0 0 0 14.0314 14.2293 0 18.8584 0 0 0 0 0 0 0 I3L273 GFY_HUMAN "Golgi-associated olfactory signaling regulator (Golgi protein in olfactory neurons, Goofy)" GFY Homo sapiens (Human) non-motile cilium assembly [GO:1905515]; protein localization to non-motile cilium [GO:0097499]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] integral component of Golgi membrane [GO:0030173] integral component of Golgi membrane [GO:0030173]; non-motile cilium assembly [GO:1905515]; protein localization to non-motile cilium [GO:0097499]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] GO:0007608; GO:0030173; GO:0050896; GO:0097499; GO:1905515 ESNVPPPSAR 0.98417 -1.508 0 0 0 0 0 0 12.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.30923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1349 0 0 0 0 0 0 13.8098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9238 0 0 0 0 0 0 0 0 O75952 CABYR_HUMAN "Calcium-binding tyrosine phosphorylation-regulated protein (Calcium-binding protein 86) (Cancer/testis antigen 88, CT88) (Fibrousheathin II) (Fibrousheathin-2, FSP-2) (Testis-specific calcium-binding protein CBP86)" CABYR CBP86 FSP2 Homo sapiens (Human) epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; sperm capacitation [GO:0048240] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; SH3 domain binding [GO:0017124]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; sperm capacitation [GO:0048240] GO:0003351; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0017124; GO:0019899; GO:0031514; GO:0035686; GO:0048240 calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; SH3 domain binding [GO:0017124] DLVKQFHQIK 0.98417 -1.3996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9004 0 0 13.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9912 0 0 0 0 13.8888 14.1374 0 13.8631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3497 12.1631 12.2101 11.4077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5894 14.2434 0 0 0 12.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05932 FOLC_HUMAN "Folylpolyglutamate synthase, mitochondrial, EC 6.3.2.17 (Folylpoly-gamma-glutamate synthetase, FPGS) (Tetrahydrofolylpolyglutamate synthase, Tetrahydrofolate synthase)" FPGS Homo sapiens (Human) animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901] GO:0001889; GO:0004326; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006139; GO:0006536; GO:0006730; GO:0006760; GO:0007420; GO:0008283; GO:0009396; GO:0031100; GO:0046655; GO:0046872; GO:0046901 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326] ASRPGLLWQLPLAPVFQPTSHMRLGLR 0.98417 -1.5076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3553 0 0 0 12.2078 0 0 0 0 0 0 0 0 13.8778 0 0 0 0 0 0 14.8715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7071 12.7295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4T4 ARG39_HUMAN Rho guanine nucleotide exchange factor 39 ARHGEF39 C9orf100 Homo sapiens (Human) positive regulation of cell migration [GO:0030335] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of cell migration [GO:0030335] GO:0005085; GO:0005886; GO:0030335 guanyl-nucleotide exchange factor activity [GO:0005085] GFRRFVR 0.98417 -2.1756 0 0 0 0 0 0 0 0 0 12.8502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2598 13.0585 0 0 0 0 0 15.0406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5263 0 16.2757 0 0 0 0 0 0 0 0 13.1311 0 16.6174 0 0 0 0 0 0 0 0 0 13.2107 0 0 0 0 0 0 0 0 13.8115 13.3403 14.1621 15.1571 0 0 0 0 0 0 0 0 0 0 12.9527 14.3848 0 13.4026 14.0378 13.7155 0 0 0 14.3268 0 0 0 0 0 0 0 0 14.9363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7597 0 0 0 0 0 0 0 0 Q99965 ADAM2_HUMAN "Disintegrin and metalloproteinase domain-containing protein 2, ADAM 2 (Cancer/testis antigen 15, CT15) (Fertilin subunit beta) (PH-30, PH30) (PH30-beta)" ADAM2 FTNB Homo sapiens (Human) adult behavior [GO:0030534]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; positive regulation of gene expression [GO:0010628]; proteolysis [GO:0006508]; visual learning [GO:0008542] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; adult behavior [GO:0030534]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; positive regulation of gene expression [GO:0010628]; proteolysis [GO:0006508]; visual learning [GO:0008542] GO:0004222; GO:0005178; GO:0005886; GO:0005887; GO:0006508; GO:0007155; GO:0007339; GO:0007342; GO:0008237; GO:0008542; GO:0009986; GO:0010628; GO:0030534; GO:0032991 integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] AGSNCAEGPCCENCLFMSK 0.98417 -3.1258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.774 0 0 0 0 0 0 11.4403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8626 0 0 0 12.438 Q9HCJ3 RAVR2_HUMAN Ribonucleoprotein PTB-binding 2 (Protein raver-2) RAVER2 KIAA1579 Homo sapiens (Human) "regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737 mRNA binding [GO:0003729]; RNA binding [GO:0003723] GTEISSGAASK 0.98417 3.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0835 0 0 0 0 0 0 0 0 12.5427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7273 0 0 12.1391 0 0 0 0 0 0 12.2259 0 0 0 0 0 0 11.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9111 0 0 0 0 0 0 0 0 0 0 14.8349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GTQ4 MYMX_HUMAN "Protein myomixer (Microprotein inducer of fusion, Protein minion, hMINION)" MYMX Homo sapiens (Human) myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; myoblast fusion [GO:0007520]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; plasma membrane fusion [GO:0045026]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue regeneration [GO:0043403] GO:0000139; GO:0005789; GO:0005886; GO:0005887; GO:0007520; GO:0014905; GO:0043403; GO:0045026; GO:0060538 LLLSCLLLPAAR 0.98418 -3.2416 0 0 0 0 0 0 0 0 0 0 13.673 0 0 0 0 13.4389 0 0 0 0 0 0 0 0 0 12.5507 0 0 0 0 0 0 10.4458 14.64 15.7465 0 0 0 11.179 0 0 0 0 0 0 0 10.4565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7753 0 13.5174 14.3139 0 0 0 0 0 0 12.0073 0 0 0 0 0 15.43 0 13.77 0 15.0555 0 0 13.5793 0 0 13.5816 0 0 0 0 0 0 0 0 0 0 15.5461 0 0 0 0 13.8246 12.0057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.66 0 0 12.1306 0 13.8563 13.5707 0 0 0 0 0 0 0 0 13.6481 11.8657 14.0552 16.479 0 0 0 14.4357 0 0 14.2104 0 0 13.9964 11.3616 13.6959 0 0 0 0 0 0 0 0 11.673 10.1688 0 11.1453 14.8731 0 0 Q9H8G1 ZN430_HUMAN Zinc finger protein 430 ZNF430 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]; substantia nigra development [GO:0021762]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0021762; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EASGCPGADR 0.98418 -3.1368 0 0 0 0 0 0 0 0 0 10.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0815 0 0 0 0 0 0 0 0 0 0 0 11.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5475 0 0 0 0 0 13.1448 0 0 0 0 0 12.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX74 DUS2L_HUMAN "tRNA-dihydrouridine(20) synthase [NAD(P)+]-like, EC 1.3.1.91 (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8, URLC8) (tRNA-dihydrouridine synthase 2-like, hDUS2)" DUS2 DUS2L Homo sapiens (Human) negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264]; negative regulation of cell death [GO:0060548]; tRNA dihydrouridine synthesis [GO:0002943] GO:0000049; GO:0002943; GO:0003725; GO:0004860; GO:0005737; GO:0005783; GO:0005829; GO:0010181; GO:0017150; GO:0050660; GO:0060548; GO:0070402; GO:0102264 double-stranded RNA binding [GO:0003725]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; protein kinase inhibitor activity [GO:0004860]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine20 synthase activity [GO:0102264] EGLRPLEEVMQK 0.98418 -1.4007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8335 14.3676 14.3668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2547 0 0 0 0 17.298 0 0 0 0 0 0 0 0 0 15.2456 0 0 13.5735 0 0 0 0 16.3671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4197 0 0 0 0 0 0 0 0 0 0 11.8924 0 0 0 0 0 0 Q5JRV8 T255A_HUMAN Transmembrane protein 255A (Protein FAM70A) TMEM255A FAM70A Homo sapiens (Human) response to bacterium [GO:0009617] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; response to bacterium [GO:0009617] GO:0009617; GO:0016021 CHYVPKTSQK 0.98419 -3.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5361 0 0 0 0 0 0 10.3865 0 9.9691 0 10.7979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5291 0 0 0 0 0 0 0 13.3523 0 11.3748 0 0 0 11.8354 0 0 0 0 12.6195 13.2289 0 0 0 15.3447 14.501 13.9171 15.233 14.8124 0 10.7559 14.0236 0 14.3186 0 0 14.0304 0 0 0 0 12.4451 0 0 0 0 13.2733 0 0 0 9.56219 10.4148 0 0 0 0 0 0 0 0 0 0 0 13.2735 12.1626 0 0 0 0 0 0 0 0 0 0 0 0 12.4557 0 11.4842 0 0 10.1255 0 0 0 0 0 10.6278 0 0 0 0 0 0 12.9752 0 0 0 0 14.3464 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2936 0 12.1626 0 0 0 10.8108 0 P49747 COMP_HUMAN "Cartilage oligomeric matrix protein, COMP (Thrombospondin-5, TSP5)" COMP Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; proteoglycan binding [GO:0043394]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829] GO:0001501; GO:0002020; GO:0002063; GO:0003417; GO:0005178; GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0008201; GO:0009306; GO:0009887; GO:0010259; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043394; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0051260; GO:0060173; GO:0062023; GO:0070062; GO:0070527; GO:0097084; GO:1900047; GO:1902732; GO:1990079 BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; proteoglycan binding [GO:0043394] DSDGDGIGDACDNCPQK 0.9842 3.0832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4061 10.8262 0 0 0 10.5441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5647 0 0 11.1721 0 0 10.5166 12.3035 11.1579 12.8131 0 0 13.3958 13.0346 13.4311 0 0 13.2397 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2708 0 0 11.6808 11.4842 0 0 0 0 0 0 0 0 10.4202 0 0 11.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9887 12.8466 0 0 12.5671 0 0 0 0 13.0285 0 0 11.8224 0 0 0 0 0 0 13.4616 0 0 0 0 0 13.1316 0 0 0 0 0 11.3432 0 10.5574 0 0 12.3141 0 0 0 13.2846 0 0 Q03181 PPARD_HUMAN "Peroxisome proliferator-activated receptor delta, PPAR-delta (NUCI) (Nuclear hormone receptor 1, NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta, PPAR-beta)" PPARD NR1C2 PPARB Homo sapiens (Human) "adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol metabolic process [GO:0008203]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fat cell proliferation [GO:0070341]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; glucose transmembrane transport [GO:1904659]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipid biosynthetic process [GO:0008654]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fat cell proliferation [GO:0070346]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteoglycan metabolic process [GO:0006029]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axon ensheathment [GO:0008366]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-substrate adhesion [GO:0031589]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol metabolic process [GO:0008203]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; fat cell proliferation [GO:0070341]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; glucose metabolic process [GO:0006006]; glucose transmembrane transport [GO:1904659]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipid biosynthetic process [GO:0008654]; positive regulation of epidermis development [GO:0045684]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fat cell proliferation [GO:0070346]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of skeletal muscle tissue regeneration [GO:0043415]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteoglycan metabolic process [GO:0006029]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to vitamin A [GO:0033189]; vasodilation [GO:0042311]; vitamin A metabolic process [GO:0006776]; wound healing [GO:0042060]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0006006; GO:0006029; GO:0006091; GO:0006357; GO:0006629; GO:0006631; GO:0006635; GO:0006776; GO:0006915; GO:0007507; GO:0007566; GO:0008203; GO:0008270; GO:0008283; GO:0008289; GO:0008366; GO:0008654; GO:0009062; GO:0009749; GO:0009755; GO:0010628; GO:0010887; GO:0014065; GO:0014068; GO:0014823; GO:0014842; GO:0014912; GO:0015908; GO:0019216; GO:0030154; GO:0030308; GO:0031589; GO:0032966; GO:0033189; GO:0033993; GO:0035774; GO:0042060; GO:0042311; GO:0043066; GO:0043415; GO:0043616; GO:0045600; GO:0045662; GO:0045684; GO:0045892; GO:0045893; GO:0045923; GO:0045944; GO:0046321; GO:0046697; GO:0048662; GO:0050680; GO:0050728; GO:0051059; GO:0051546; GO:0060612; GO:0070341; GO:0070346; GO:0070539; GO:0071222; GO:0071456; GO:0097190; GO:0140297; GO:1902894; GO:1904659; GO:1990837; GO:2000288 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; linoleic acid binding [GO:0070539]; lipid binding [GO:0008289]; NF-kappaB binding [GO:0051059]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" ARSILTGK 0.9842 -3.2538 0 0 0 0 0 0 0 0 0 14.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7852 0 10.715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.44 0 0 0 0 10.6932 0 0 0 0 0 Q9HCQ5 GALT9_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 9, EC 2.4.1.41 (Polypeptide GalNAc transferase 9, GalNAc-T9, pp-GaNTase 9) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9)" GALNT9 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] CRQMSYAQDLPQVSVVFIFVNEALSVILR 0.9842 -3.0699 0 0 0 0 0 0 0 0 0 0 0 13.1359 0 14.3564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0148 0 0 12.8588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6945 0 0 0 0 0 0 0 0 0 0 0 0 13.4762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04439 HLAA_HUMAN "HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A, HLA-A)" HLA-A HLAA Homo sapiens (Human) "antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of CD8-positive, alpha-beta T cell activation [GO:2001187]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; T cell mediated cytotoxicity [GO:0001913]; T cell mediated cytotoxicity directed against tumor cell target [GO:0002419]; T cell receptor signaling pathway [GO:0050852]" cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] "cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; beta-2-microglobulin binding [GO:0030881]; CD8 receptor binding [GO:0042610]; peptide antigen binding [GO:0042605]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; TAP binding [GO:0046977]; TAP complex binding [GO:0062061]; antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of CD8-positive, alpha-beta T cell activation [GO:2001187]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; T cell mediated cytotoxicity [GO:0001913]; T cell mediated cytotoxicity directed against tumor cell target [GO:0002419]; T cell receptor signaling pathway [GO:0050852]" GO:0000139; GO:0001913; GO:0001916; GO:0002419; GO:0002485; GO:0002486; GO:0002726; GO:0003723; GO:0005102; GO:0005783; GO:0005789; GO:0005794; GO:0005797; GO:0005886; GO:0005887; GO:0006955; GO:0009986; GO:0012507; GO:0016020; GO:0016045; GO:0019731; GO:0019885; GO:0030670; GO:0030881; GO:0031901; GO:0032729; GO:0036037; GO:0042270; GO:0042590; GO:0042605; GO:0042608; GO:0042610; GO:0042612; GO:0042824; GO:0045087; GO:0046977; GO:0050830; GO:0050852; GO:0055038; GO:0062061; GO:0070062; GO:0070971; GO:0071556; GO:2000566; GO:2000568; GO:2001187 beta-2-microglobulin binding [GO:0030881]; CD8 receptor binding [GO:0042610]; peptide antigen binding [GO:0042605]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; TAP binding [GO:0046977]; TAP complex binding [GO:0062061] GYRQDAYDGK 0.98421 -3.1648 0 0 0 0 0 0 0 0 0 0 0 11.739 0 0 0 0 0 0 0 11.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3052 0 0 13.8376 0 0 14.0315 0 0 0 0 0 0 0 0 0 0 13.2651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8925 0 0 0 0 0 0 0 14.6758 12.2516 0 0 0 12.8124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3081 11.3172 0 0 0 0 0 0 0 0 0 0 0 11.4166 0 0 0 0 12.8913 0 0 0 0 0 13.4546 12.7403 0 Q6ZMZ0 RN19B_HUMAN "E3 ubiquitin-protein ligase RNF19B, EC 2.3.2.31 (IBR domain-containing protein 3) (Natural killer lytic-associated molecule) (RING finger protein 19B)" RNF19B IBRDC3 NKLAM Homo sapiens (Human) adaptive immune response [GO:0002250]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; adaptive immune response [GO:0002250]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0002250; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0042267; GO:0043130; GO:0044194; GO:0046872; GO:0051865; GO:0061630 metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] HQSCEQK 0.98421 -1.5391 0 0 0 0 0 0 0 0 0 0 0 14.409 0 0 0 0 0 0 0 12.7755 0 0 0 14.4596 11.9141 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8055 0 0 0 0 13.2714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1847 0 0 0 0 0 0 13.5969 13.5874 0 0 0 13.2912 0 0 12.9019 13.5694 0 0 0 0 14.4962 0 0 0 13.553 0 0 13.1794 13.3691 0 0 0 0 0 0 13.0131 0 0 12.4879 0 0 0 12.2325 0 0 0 0 0 0 0 0 0 0 0 0 0 14.365 12.8146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4691 0 0 0 0 0 0 0 0 0 0 0 0 14.356 0 0 0 0 13.5621 0 0 0 0 Q8WZ82 OVCA2_HUMAN "Esterase OVCA2, EC 3.1.2.- (Ovarian cancer-associated gene 2 protein)" OVCA2 Homo sapiens (Human) response to retinoic acid [GO:0032526] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; response to retinoic acid [GO:0032526] GO:0005634; GO:0005737; GO:0016787; GO:0032526 hydrolase activity [GO:0016787] AAQRPLR 0.98422 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6616 14.0172 13.941 15.0162 13.9432 13.8633 0 0 18.6282 0 0 0 0 0 0 0 14.033 14.0222 14.6346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4345 0 0 0 0 14.1668 14.367 0 14.5325 0 0 0 0 14.4495 14.625 0 0 0 0 0 14.0581 0 14.0308 0 0 14.7216 14.4863 0 0 0 0 0 14.7018 0 0 0 0 14.5023 14.4494 14.9493 0 0 14.4972 0 0 0 0 0 0 0 0 0 0 14.4455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92772 CDKL2_HUMAN "Cyclin-dependent kinase-like 2, EC 2.7.11.22 (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE)" CDKL2 Homo sapiens (Human) protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; signal transduction [GO:0007165] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468]; sex differentiation [GO:0007548]; signal transduction [GO:0007165] GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0007165; GO:0007548; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] CLHIDPDKRPFCAELLHHDFFQMDGFAER 0.98422 -3.2667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5935 0 0 0 0 0 13.6872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3712 0 0 0 12.3218 0 12.811 0 0 0 0 0 0 0 0 0 0 12.9766 0 0 0 13.3516 13.4021 0 0 0 0 0 0 0 14.5291 13.4485 0 13.6352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0001 0 0 0 0 0 0 0 0 Q9UBV8 PEF1_HUMAN Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1) PEF1 ABP32 UNQ1845/PRO3573 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062] COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592] GO:0003723; GO:0005509; GO:0005737; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0042802; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0051592; GO:0070062; GO:1902527; GO:1990756 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; ubiquitin ligase-substrate adaptor activity [GO:1990756] NLFQQYDR 0.98422 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3D8 KAD6_HUMAN "Adenylate kinase isoenzyme 6, AK6, EC 2.7.4.3 (Adrenal gland protein AD-004) (Coilin-interacting nuclear ATPase protein, hCINAP) (Dual activity adenylate kinase/ATPase, AK/ATPase)" AK6 CINAP AD-004 CGI-137 Homo sapiens (Human) nucleobase-containing small molecule interconversion [GO:0015949]; phosphorylation [GO:0016310] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleoside monophosphate kinase activity [GO:0050145]; nucleobase-containing small molecule interconversion [GO:0015949]; phosphorylation [GO:0016310] GO:0004017; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0015030; GO:0015949; GO:0016020; GO:0016310; GO:0016607; GO:0016887; GO:0050145 adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleoside monophosphate kinase activity [GO:0050145] LLPNILLTGTPGVGK 0.98422 3.0805 0 0 0 0 0 0 0 11.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5373 0 0 0 0 15.6203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2871 0 0 0 0 0 0 0 0 0 13.341 0 0 13.2449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3765 0 13.3088 0 0 0 0 13.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1555 0 0 0 0 13.0484 0 12.5421 0 0 0 0 0 0 O15211 RGL2_HUMAN "Ral guanine nucleotide dissociation stimulator-like 2, RalGDS-like 2 (RalGDS-like factor) (Ras-associated protein RAB2L)" RGL2 RAB2L Homo sapiens (Human) negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0010667; GO:0014068; GO:0032485; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] APSVISRVLK 0.98423 -2.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7827 0 0 0 0 0 0 0 0 0 11.3177 11.1757 0 0 0 0 0 0 0 10.5603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7609 0 0 0 13.7038 0 14.1618 0 19.3785 13.051 0 0 0 0 0 0 0 0 0 0 0 14.3924 0 0 13.7008 0 0 13.5335 0 13.5608 0 0 0 12.4917 0 0 0 0 0 0 0 0 0 0 15.9586 0 0 0 0 0 0 0 12.9502 0 14.7655 12.6571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2375 0 0 11.9729 0 11.7461 0 0 0 0 0 0 0 0 0 Q5T2N8 ATD3C_HUMAN ATPase family AAA domain-containing protein 3C ATAD3C Homo sapiens (Human) mitochondrion organization [GO:0007005] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrion organization [GO:0007005] GO:0005524; GO:0005739; GO:0007005; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ETSRITVLEALR 0.98423 -3.1827 0 0 0 0 0 0 0 0 0 0 10.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1073 0 0 0 0 13.5206 0 0 16.0702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9183 16.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5834 0 0 0 0 0 0 Q9H2P9 DPH5_HUMAN "Diphthine methyl ester synthase, EC 2.1.1.314 (Diphthamide biosynthesis methyltransferase)" DPH5 AD-018 CGI-30 HSPC143 NPD015 Homo sapiens (Human) methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] cytosol [GO:0005829] cytosol [GO:0005829]; diphthine synthase activity [GO:0004164]; methylation [GO:0032259]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] GO:0004164; GO:0005829; GO:0017183; GO:0032259 diphthine synthase activity [GO:0004164] GLEVVRR 0.98424 -3.2003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55060 XPO2_HUMAN "Exportin-2, Exp2 (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter)" CSE1L CAS XPO2 Homo sapiens (Human) protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606] GO:0005049; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006611; GO:0016020; GO:0031267; GO:0070062 nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] AADEEAFEDNSEEYIR 0.98425 -3.1097 0 0 0 0 0 0 0 0 10.6497 0 0 0 0 0 0 0 0 0 0 11.5957 0 0 0 11.2983 0 0 0 0 0 12.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7542 0 0 0 0 0 0 0 0 0 0 13.2066 0 0 0 0 0 0 0 0 0 14.8319 0 16.4256 0 17.3614 14.4013 0 0 0 15.6007 12.8477 0 0 0 0 15.737 0 15.3383 12.7181 14.2777 0 0 14.041 15.0443 15.1168 13.2053 0 0 0 0 0 13.4781 0 14.4833 0 0 0 0 0 14.4569 12.8771 12.936 0 0 0 0 0 0 0 0 0 0 0 15.6649 0 0 0 0 0 0 0 0 0 0 0 0 12.66 0 13.5022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4011 14.28 0 0 14.0573 0 Q04206 TF65_HUMAN Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) RELA NFKB3 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; cellular defense response [GO:0006968]; cellular response to angiotensin [GO:1904385]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to nicotine [GO:0071316]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chromatin organization [GO:0006325]; cytokine-mediated signaling pathway [GO:0019221]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; hair follicle development [GO:0001942]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein catabolic process [GO:0030163]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of inflammatory response [GO:0050727]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; response to organic substance [GO:0010033]; response to UV-B [GO:0010224]; transcription, DNA-templated [GO:0006351]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; NF-kappaB complex [GO:0071159]; NF-kappaB p50/p65 complex [GO:0035525]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; NF-kappaB complex [GO:0071159]; NF-kappaB p50/p65 complex [GO:0035525]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; actinin binding [GO:0042805]; ankyrin repeat binding [GO:0071532]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; peptide binding [GO:0042277]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; cellular defense response [GO:0006968]; cellular response to angiotensin [GO:1904385]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to nicotine [GO:0071316]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chromatin organization [GO:0006325]; cytokine-mediated signaling pathway [GO:0019221]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; hair follicle development [GO:0001942]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; NIK/NF-kappaB signaling [GO:0038061]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse to nucleus signaling pathway [GO:0099527]; protein catabolic process [GO:0030163]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of inflammatory response [GO:0050727]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; response to organic substance [GO:0010033]; response to UV-B [GO:0010224]; transcription, DNA-templated [GO:0006351]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001223; GO:0001227; GO:0001228; GO:0001889; GO:0001942; GO:0002357; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0006357; GO:0006954; GO:0006968; GO:0007218; GO:0007249; GO:0008284; GO:0009887; GO:0010033; GO:0010224; GO:0010628; GO:0019221; GO:0019899; GO:0019901; GO:0030163; GO:0031490; GO:0031625; GO:0032495; GO:0032735; GO:0032757; GO:0033209; GO:0033234; GO:0034097; GO:0035525; GO:0035729; GO:0035924; GO:0035994; GO:0038061; GO:0042177; GO:0042277; GO:0042301; GO:0042802; GO:0042803; GO:0042805; GO:0042826; GO:0043066; GO:0043123; GO:0043620; GO:0045087; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050727; GO:0050862; GO:0051059; GO:0051092; GO:0051607; GO:0070301; GO:0070431; GO:0070498; GO:0070555; GO:0071159; GO:0071222; GO:0071223; GO:0071224; GO:0071316; GO:0071347; GO:0071354; GO:0071356; GO:0071532; GO:0098978; GO:0099527; GO:0140296; GO:0140297; GO:1901222; GO:1901223; GO:1901224; GO:1901522; GO:1902004; GO:1902894; GO:1902895; GO:1904385; GO:1904996; GO:2000630; GO:2001237 "actinin binding [GO:0042805]; ankyrin repeat binding [GO:0071532]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; peptide binding [GO:0042277]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; ubiquitin protein ligase binding [GO:0031625]" ISLVTKDPPHR 0.98426 -3.1234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4981 0 0 15.2628 0 15.2439 0 0 0 0 0 0 0 14.5248 0 0 0 0 0 13.7872 0 0 0 0 0 19.0381 11.9969 0 0 0 0 0 14.4361 0 0 0 0 13.4264 0 13.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9672 0 0 19.1674 0 14.4159 0 13.3159 0 13.0713 14.2775 0 0 0 0 0 0 0 0 0 0 0 13.897 14.5064 0 14.2807 0 0 0 0 0 0 0 0 0 0 0 14.8916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6D2 RN182_HUMAN "E3 ubiquitin-protein ligase RNF182, EC 2.3.2.27 (RING finger protein 182) (RING-type E3 ubiquitin transferase RNF182)" RNF182 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005737; GO:0016021; GO:0016567; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] MASQPPEDTAESQASDELECK 0.98426 -3.2223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0052 0 0 0 0 0 0 0 0 0 0 12.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9831 0 0 0 0 0 0 0 0 O75663 TIPRL_HUMAN "TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein, TIP)" TIPRL Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; TOR signaling [GO:0031929] cytosol [GO:0005829] cytosol [GO:0005829]; DNA damage checkpoint signaling [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of phosphoprotein phosphatase activity [GO:0043666]; TOR signaling [GO:0031929] GO:0000077; GO:0005829; GO:0031929; GO:0032515; GO:0043666 CVNNYQGMLKVACAEEWQESR 0.98427 -1.4562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8529 0 0 0 0 0 0 0 0 P98171 RHG04_HUMAN Rho GTPase-activating protein 4 (Rho-GAP hematopoietic protein C1) (Rho-type GTPase-activating protein 4) (p115) ARHGAP4 KIAA0131 RGC1 RHOGAP4 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast migration [GO:0010764]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; cytoskeleton organization [GO:0007010]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast migration [GO:0010764]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0005096; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0007010; GO:0007266; GO:0007399; GO:0010764; GO:0030336; GO:0030426; GO:0030517; GO:0042802; GO:0051056 GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802] CLVPASPEQHVEVDK 0.98427 -1.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9904 0 0 0 0 0 12.2841 0 0 13.9731 12.774 0 0 0 0 0 13.1086 0 0 0 0 0 0 0 11.6856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0689 0 0 0 0 14.2513 0 0 0 0 12.4126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8401 0 0 0 0 0 0 14.0155 0 0 0 0 0 0 11.7067 0 0 14.0177 12.2706 0 0 13.8541 15.2062 0 0 0 13.7584 0 0 0 0 0 0 0 0 0 0 0 0 12.1996 0 0 0 0 0 0 0 0 0 0 12.8907 0 0 0 0 0 0 0 0 12.4489 0 11.1286 Q5TDP6 LGSN_HUMAN Lengsin (Glutamate-ammonia ligase domain-containing protein 1) (Lens glutamine synthase-like) LGSN GLULD1 LGS Homo sapiens (Human) nitrogen compound metabolic process [GO:0006807] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; nitrogen compound metabolic process [GO:0006807] GO:0003824; GO:0005737; GO:0005886; GO:0006807; GO:0016020 catalytic activity [GO:0003824] KWLAGLLK 0.98427 -1.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YZ3 HORN_HUMAN Hornerin HRNR S100A18 Homo sapiens (Human) cell envelope organization [GO:0043163]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; cell envelope organization [GO:0043163]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424] GO:0001533; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0031424; GO:0035578; GO:0036457; GO:0043163; GO:0046914; GO:0048471; GO:0061436; GO:0062023; GO:0070062 calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] DDTHQHQEEQEETEKEENK 0.98427 -3.2285 0 0 0 0 0 0 0 0 0 0 0 0 12.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.136 0 0 0 10.079 0 0 0 0 0 0 0 0 0 0 0 10.7425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1156 0 0 0 0 0 0 0 0 0 0 0 0 14.4299 0 18.8358 0 13.7887 14.7934 14.4767 0 0 0 0 13.8902 15.6255 13.1253 0 0 14.4803 19.1514 0 19.3835 0 12.7854 0 0 13.2112 0 0 0 0 0 0 0 0 0 9.92898 13.8523 0 12.9121 13.6087 0 0 0 0 0 11.667 0 0 0 0 0 0 0 0 0 13.3092 0 0 0 12.5799 0 12.6006 0 0 12.0478 0 12.3959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8662 0 0 0 Q8TDV5 GP119_HUMAN Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119) GPR119 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; insulin secretion [GO:0030073]; regulation of metabolic process [GO:0019222] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; insulin secretion [GO:0030073]; regulation of metabolic process [GO:0019222] GO:0004930; GO:0005737; GO:0005886; GO:0007189; GO:0016021; GO:0019222; GO:0030073; GO:0031210; GO:0043235 G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210] LQLYHMALGVKKVLTSFLLFLSAR 0.98427 -1.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99706 KI2L4_HUMAN "Killer cell immunoglobulin-like receptor 2DL4 (CD158 antigen-like family member D) (G9P) (Killer cell inhibitory receptor 103AS, KIR-103AS) (MHC class I NK cell receptor KIR103AS) (CD antigen CD158d)" KIR2DL4 CD158D KIR103AS Homo sapiens (Human) cellular defense response [GO:0006968]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of cellular senescence [GO:2000774]; positive regulation of natural killer cell cytokine production [GO:0002729]; signal transduction [GO:0007165] early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; MHC class Ib receptor activity [GO:0032394]; transmembrane signaling receptor activity [GO:0004888]; cellular defense response [GO:0006968]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of cellular senescence [GO:2000774]; positive regulation of natural killer cell cytokine production [GO:0002729]; signal transduction [GO:0007165] GO:0002729; GO:0004888; GO:0005886; GO:0005887; GO:0006968; GO:0007165; GO:0016020; GO:0031901; GO:0032394; GO:0045953; GO:2000774 MHC class Ib receptor activity [GO:0032394]; transmembrane signaling receptor activity [GO:0004888] EGEAHELR 0.98427 -2.3152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UM63 PLAL1_HUMAN "Zinc finger protein PLAGL1 (Lost on transformation 1, LOT-1) (Pleiomorphic adenoma-like protein 1) (Tumor suppressor ZAC)" PLAGL1 LOT1 ZAC Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0005654; GO:0005794; GO:0006357; GO:0006915; GO:0016604; GO:0043231; GO:0045944; GO:0046872; GO:0051726 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DVRRHLVVHTGCK 0.98427 -3.23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42229 STA5A_HUMAN Signal transducer and activator of transcription 5A STAT5A STAT5 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; taurine metabolic process [GO:0019530]" GO:0000785; GO:0000978; GO:0000981; GO:0001938; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0007595; GO:0019221; GO:0019530; GO:0038026; GO:0040014; GO:0042127; GO:0043434; GO:0043536; GO:0045944; GO:0060397; GO:0090575 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ATIISEQQAKSLLK 0.98428 -1.4573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPE6 SPAG4_HUMAN Sperm-associated antigen 4 protein (Outer dense fiber-associated protein SPAG4) (SUN domain-containing protein 4) SPAG4 SUN4 Homo sapiens (Human) cell differentiation [GO:0030154]; nuclear envelope organization [GO:0006998]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635]; protein-membrane adaptor activity [GO:0043495]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; nuclear envelope organization [GO:0006998]; spermatogenesis [GO:0007283] GO:0005198; GO:0005635; GO:0005639; GO:0005737; GO:0005856; GO:0006998; GO:0007283; GO:0030154; GO:0031514; GO:0034993; GO:0043495 protein-membrane adaptor activity [GO:0043495]; structural molecule activity [GO:0005198] FTFDVEK 0.98428 -3.2387 0 0 0 0 11.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1467 0 0 0 0 0 0 0 0 0 0 0 0 11.5487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1857 0 0 0 0 0 0 0 0 0 17.6714 0 0 0 0 0 0 0 0 0 14.6974 0 0 0 0 12.0359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4945 0 0 0 0 0 0 17.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.247 0 0 0 0 0 0 0 0 12.4258 0 0 0 0 17.2998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQT6 FSCN3_HUMAN Fascin-3 (Testis fascin) FSCN3 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; spermatid development [GO:0007286] actin cytoskeleton [GO:0015629]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; spermatid development [GO:0007286] GO:0001726; GO:0005737; GO:0005856; GO:0005902; GO:0007163; GO:0007286; GO:0015629; GO:0016477; GO:0030027; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0051015; GO:0051017 actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674] AASERLNR 0.98428 -2.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9755 0 0 0 0 0 0 0 12.1675 0 0 0 0 0 0 0 0 0 0 0 0 12.3295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2P8 RCL1_HUMAN RNA 3'-terminal phosphate cyclase-like protein RCL1 RNAC RPC2 RPCL1 RTC2 HSPC338 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]" GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005654; GO:0005730 endoribonuclease activity [GO:0004521] HPLKIVLR 0.98428 -3.2406 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5282 0 0 0 0 0 0 0 0 14.0308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6472 16.6968 0 0 16.9154 0 0 0 0 13.1379 0 12.9861 0 0 12.934 0 0 0 0 0 0 12.9588 13.1325 0 13.3129 13.0399 0 13.2494 14.2277 15.0259 0 0 0 0 17.9597 18.0175 0 0 14.2369 0 0 0 0 0 17.5497 0 17.6035 13.623 0 0 0 13.6965 0 0 12.4915 13.376 0 14.3488 0 13.182 12.8034 0 0 0 17.1932 16.9854 17.1127 17.1971 0 14.0841 0 0 0 0 0 0 0 0 0 16.5733 0 0 0 0 0 0 16.406 0 0 15.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6546 0 0 0 0 0 0 0 0 0 O60755 GALR3_HUMAN "Galanin receptor type 3, GAL3-R, GALR-3" GALR3 GALNR3 Homo sapiens (Human) "adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; galanin-activated signaling pathway [GO:0090663]; learning or memory [GO:0007611]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of transcription by RNA polymerase II [GO:0045944]" cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; galanin-activated signaling pathway [GO:0090663]; learning or memory [GO:0007611]; negative regulation of adenylate cyclase activity [GO:0007194]; neuropeptide signaling pathway [GO:0007218]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0004966; GO:0005886; GO:0005887; GO:0005929; GO:0007187; GO:0007188; GO:0007194; GO:0007218; GO:0007268; GO:0007611; GO:0007631; GO:0008528; GO:0016021; GO:0017046; GO:0045202; GO:0045944; GO:0090663; GO:0097730 G protein-coupled peptide receptor activity [GO:0008528]; galanin receptor activity [GO:0004966]; peptide hormone binding [GO:0017046] HFRARFR 0.98429 -1.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4375 0 0 0 0 0 0 0 0 0 0 17.6109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15020 SART3_HUMAN "Squamous cell carcinoma antigen recognized by T-cells 3, SART-3 (Tat-interacting protein of 110 kDa, Tip110) (p110 nuclear RNA-binding protein)" SART3 KIAA0156 TIP110 Homo sapiens (Human) "cell morphogenesis [GO:0000902]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of gene expression [GO:0010468]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244]" ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; RNA binding [GO:0003723]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; U6atac snRNA binding [GO:0030624]; ubiquitin-specific protease binding [GO:1990381]; cell morphogenesis [GO:0000902]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; regulation of gene expression [GO:0010468]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000244; GO:0000387; GO:0000398; GO:0000902; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006334; GO:0010468; GO:0015030; GO:0016607; GO:0017070; GO:0030621; GO:0030624; GO:0042393; GO:0048872; GO:0061574; GO:0071425; GO:1903586; GO:1990381 histone binding [GO:0042393]; RNA binding [GO:0003723]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; U6atac snRNA binding [GO:0030624]; ubiquitin-specific protease binding [GO:1990381] AIRNCPWTVALWSR 0.98429 -1.5122 0 0 11.7055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6006 0 0 0 0 13.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.828 12.5684 12.8398 0 0 0 13.8652 14.3435 0 0 0 12.9272 0 0 0 0 0 0 0 12.3215 0 10.3596 13.8542 0 0 0 0 0 0 0 0 0 0 0 0 16.7914 0 0 0 0 14.2666 0 0 0 0 0 0 Q96CG3 TIFA_HUMAN TRAF-interacting protein with FHA domain-containing protein A (Putative MAPK-activating protein PM14) (Putative NF-kappa-B-activating protein 20) (TRAF2-binding protein) TIFA T2BP Homo sapiens (Human) cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein homooligomerization [GO:0051260] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein homooligomerization [GO:0051260] GO:0002753; GO:0005737; GO:0005829; GO:0007249; GO:0043123; GO:0045087; GO:0051260 NSNICHYTFQDKQVSRVQFSLQLFK 0.98429 -1.4659 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0013 0 0 15.384 0 0 0 0 0 13.6613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDQ0 HAVR2_HUMAN "Hepatitis A virus cellular receptor 2, HAVcr-2 (T-cell immunoglobulin and mucin domain-containing protein 3, TIMD-3) (T-cell immunoglobulin mucin receptor 3, TIM-3) (T-cell membrane protein 3) (CD antigen CD366)" HAVCR2 TIM3 TIMD3 Homo sapiens (Human) adaptive immune response [GO:0002250]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation involved in immune response [GO:0002281]; maternal process involved in female pregnancy [GO:0060135]; natural killer cell tolerance induction [GO:0002519]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte colony-stimulating factor production [GO:0071656]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-3 production [GO:0032712]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myeloid dendritic cell activation [GO:0030886]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 1 type immune response [GO:0002826]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of chemokine production [GO:0032722]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of tolerance induction dependent upon immune response [GO:0002652]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] anchoring junction [GO:0070161]; cell surface [GO:0009986]; early endosome [GO:0005769]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021] anchoring junction [GO:0070161]; cell surface [GO:0009986]; early endosome [GO:0005769]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation involved in immune response [GO:0002281]; maternal process involved in female pregnancy [GO:0060135]; natural killer cell tolerance induction [GO:0002519]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte colony-stimulating factor production [GO:0071656]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-3 production [GO:0032712]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myeloid dendritic cell activation [GO:0030886]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 1 type immune response [GO:0002826]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of chemokine production [GO:0032722]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of tolerance induction dependent upon immune response [GO:0002652]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] GO:0001772; GO:0002250; GO:0002281; GO:0002519; GO:0002652; GO:0002826; GO:0002859; GO:0005769; GO:0006954; GO:0009986; GO:0010629; GO:0016021; GO:0030886; GO:0032088; GO:0032687; GO:0032689; GO:0032703; GO:0032712; GO:0032715; GO:0032720; GO:0032722; GO:0032729; GO:0032732; GO:0032753; GO:0032760; GO:0032815; GO:0034138; GO:0034154; GO:0034162; GO:0042102; GO:0042130; GO:0043032; GO:0045087; GO:0045089; GO:0046872; GO:0050830; GO:0060135; GO:0070161; GO:0070374; GO:0071222; GO:0071656; GO:1900425; GO:1900426; GO:1901224; GO:2000521; GO:2001189 metal ion binding [GO:0046872] DFTAAFPRMLTTR 0.9843 -1.4729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2608 0 0 0 0 14.7844 0 0 0 0 12.8063 13.4765 0 0 0 0 0 0 0 0 0 14.8995 0 0 0 0 0 0 0 0 0 0 13.3691 0 0 14.7258 0 0 0 0 0 0 0 14.0854 0 0 0 0 0 0 13.6923 0 0 0 0 0 0 0 9.62724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7207 0 0 0 0 0 0 0 0 0 0 0 0 15.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4435 0 0 16.1985 12.1758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.843 0 14.4892 0 0 0 0 0 0 0 0 0 0 0 12.4934 0 0 0 Q9UIK4 DAPK2_HUMAN "Death-associated protein kinase 2, DAP kinase 2, EC 2.7.11.1 (DAP-kinase-related protein 1, DRP-1)" DAPK2 Homo sapiens (Human) anoikis [GO:0043276]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of eosinophil chemotaxis [GO:2000424]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of intrinsic apoptotic signaling pathway [GO:2001242] autophagosome lumen [GO:0034423]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] autophagosome lumen [GO:0034423]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; anoikis [GO:0043276]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of eosinophil chemotaxis [GO:2000424]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of intrinsic apoptotic signaling pathway [GO:2001242] GO:0004674; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0006468; GO:0006915; GO:0010506; GO:0031410; GO:0034423; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043231; GO:0043276; GO:0046777; GO:0090023; GO:0106310; GO:2000424; GO:2001242 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] KRLTIQEALR 0.9843 -3.069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULB4 CADH9_HUMAN Cadherin-9 CDH9 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098609; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] NPEAREDSK 0.9843 -2.3394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05997 CO5A2_HUMAN Collagen alpha-2(V) chain COL5A2 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; ossification [GO:0001503]; skeletal system development [GO:0001501]; skin development [GO:0043588] collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; negative regulation of endodermal cell differentiation [GO:1903225]; ossification [GO:0001503]; skeletal system development [GO:0001501]; skin development [GO:0043588] GO:0001501; GO:0001503; GO:0005201; GO:0005576; GO:0005588; GO:0005592; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0043588; GO:0046332; GO:0046872; GO:0048592; GO:0062023; GO:0071230; GO:1903225 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332] FRYIVLQDTCSKR 0.98432 -3.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5296 0 0 0 0 0 0 0 0 0 10.8438 0 0 0 0 0 14.5533 0 14.4997 15.836 0 11.9732 0 0 0 0 0 0 0 0 15.5101 14.6079 0 0 0 12.0226 14.3455 0 13.7816 0 0 14.4714 0 0 14.2011 12.4692 16.6506 0 0 12.985 14.4045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0277 0 13.3794 11.5016 0 0 0 0 0 13.6415 12.9036 13.4746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4547 0 0 0 0 0 13.7771 0 0 0 0 0 0 0 0 12.8419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3518 0 0 P10635 CP2D6_HUMAN "Cytochrome P450 2D6, EC 1.14.14.- (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase)" CYP2D6 CYP2DL1 Homo sapiens (Human) alkaloid catabolic process [GO:0009822]; alkaloid metabolic process [GO:0009820]; arachidonic acid metabolic process [GO:0019369]; cholesterol metabolic process [GO:0008203]; coumarin metabolic process [GO:0009804]; estrogen metabolic process [GO:0008210]; heterocycle metabolic process [GO:0046483]; isoquinoline alkaloid metabolic process [GO:0033076]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; negative regulation of binding [GO:0051100]; negative regulation of cellular organofluorine metabolic process [GO:0090350]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; alkaloid catabolic process [GO:0009822]; alkaloid metabolic process [GO:0009820]; arachidonic acid metabolic process [GO:0019369]; cholesterol metabolic process [GO:0008203]; coumarin metabolic process [GO:0009804]; estrogen metabolic process [GO:0008210]; heterocycle metabolic process [GO:0046483]; isoquinoline alkaloid metabolic process [GO:0033076]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; negative regulation of binding [GO:0051100]; negative regulation of cellular organofluorine metabolic process [GO:0090350]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008203; GO:0008210; GO:0008395; GO:0009804; GO:0009820; GO:0009822; GO:0016098; GO:0016491; GO:0016712; GO:0019369; GO:0020037; GO:0033076; GO:0042178; GO:0042572; GO:0042759; GO:0043231; GO:0046483; GO:0051100; GO:0062187; GO:0062188; GO:0062189; GO:0070989; GO:0090350 "anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" DEAVWEK 0.98432 -3.2658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8061 0 0 11.4504 0 0 0 0 0 0 0 0 14.1344 15.4316 0 15.3639 0 14.8738 14.7456 14.9392 14.6625 0 0 0 14.9138 14.2956 14.5044 0 0 14.0918 0 0 0 0 13.9541 14.5061 13.6714 0 0 0 0 0 13.994 14.8413 11.2335 13.8489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8228 0 0 0 0 0 0 0 0 0 0 12.5131 0 0 12.8996 0 12.6709 12.0628 0 P46019 KPB2_HUMAN "Phosphorylase b kinase regulatory subunit alpha, liver isoform, Phosphorylase kinase alpha L subunit" PHKA2 PHKLA PYK Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; protein modification process [GO:0036211] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; protein modification process [GO:0036211] GO:0004689; GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005975; GO:0005977; GO:0006091; GO:0036211 calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689] HTQSTKDSLHAK 0.98432 -3.1821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5678 0 0 0 0 0 0 0 0 0 0 0 0 14.7134 0 0 0 14.2018 0 0 0 0 0 0 0 0 0 12.0552 0 14.408 14.4791 14.6048 14.5863 13.9497 0 14.8713 0 14.5927 0 0 12.7008 14.7428 0 14.044 0 0 13.3259 0 0 0 13.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2114 0 0 0 12.7085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5916 0 0 0 Q6PCB8 EMB_HUMAN Embigin EMB Homo sapiens (Human) axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; plasma membrane lactate transport [GO:0035879] anchoring junction [GO:0070161]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; plasma membrane lactate transport [GO:0035879] GO:0005886; GO:0005887; GO:0007156; GO:0007411; GO:0030424; GO:0035879; GO:0045202; GO:0070161; GO:0070593; GO:0098632 cell-cell adhesion mediator activity [GO:0098632] ALPGLLEARAR 0.98432 -1.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7295 0 0 0 0 0 0 12.8913 0 0 0 13.6603 12.8783 12.42 0 12.6497 0 0 13.2708 0 0 0 0 12.4078 0 0 0 0 11.0769 0 0 0 0 0 13.3525 0 0 0 0 0 13.5071 0 12.6514 12.6308 12.7695 0 0 0 0 0 0 12.3723 0 0 0 0 13.8641 0 0 0 12.5061 0 10.8 0 12.9796 0 0 0 12.6683 0 0 0 0 0 13.5333 0 0 0 0 0 0 0 14.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6187 0 0 0 0 0 0 0 P47775 GPR12_HUMAN G-protein coupled receptor 12 GPR12 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular calcium ion homeostasis [GO:0006874]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of metabolic process [GO:0019222] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular calcium ion homeostasis [GO:0006874]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of metabolic process [GO:0019222] GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0007186; GO:0007189; GO:0019222; GO:0031210 G protein-coupled receptor activity [GO:0004930]; phosphatidylcholine binding [GO:0031210] VNLSGLPR 0.98433 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7156 0 0 0 Q15761 NPY5R_HUMAN "Neuropeptide Y receptor type 5, NPY5-R (NPY-Y5 receptor, NPYY5-R, Y5 receptor)" NPY5R NPYR5 Homo sapiens (Human) "aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of ovulation cycle rhythm [GO:0060112]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; outflow tract morphogenesis [GO:0003151]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of smooth muscle cell proliferation [GO:0048661]" cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]; aging [GO:0007568]; cardiac left ventricle morphogenesis [GO:0003214]; chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of ovulation cycle rhythm [GO:0060112]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; outflow tract morphogenesis [GO:0003151]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of smooth muscle cell proliferation [GO:0048661]" GO:0001601; GO:0001602; GO:0002675; GO:0002865; GO:0003151; GO:0003214; GO:0004983; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007268; GO:0007568; GO:0008188; GO:0014050; GO:0032229; GO:0042755; GO:0042923; GO:0043005; GO:0043066; GO:0045202; GO:0048661; GO:0060112; GO:0070374 neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601] ILPENFGSVR 0.98434 -1.476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.787 15.0588 0 15.1138 15.0751 0 15.215 14.6994 0 0 0 0 0 13.4857 0 0 13.1763 0 0 0 0 0 0 0 13.2444 12.4899 0 0 0 0 0 0 0 0 0 12.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2T9K0 TMM44_HUMAN Transmembrane protein 44 TMEM44 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LLASLLQENTEILGYLLGSVAAFGSWASR 0.98434 -2.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0916 0 0 0 0 0 0 12.4937 0 13.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6832 0 0 0 0 0 0 14.685 12.9703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1962 0 0 0 0 0 12.1648 0 13.8844 Q4G1C9 GRPL2_HUMAN GLIPR1-like protein 2 GLIPR1L2 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339] extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; binding of sperm to zona pellucida [GO:0007339] GO:0005615; GO:0007339; GO:0016021 CTDFLCSNADRDQATYYR 0.98434 -3.1993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5193 0 0 0 0 0 0 0 12.1003 0 0 0 0 0 0 0 11.4471 0 0 0 0 0 0 0 12.0965 0 0 0 0 0 0 0 0 11.1338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5454 0 0 0 15.7884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9071 0 0 12.7343 0 0 0 0 14.9431 0 0 0 0 Q8NA69 TEX45_HUMAN Testis-expressed protein 45 TEX45 C19orf45 Homo sapiens (Human) APNLHLQQSYLPR 0.98435 -3.1096 0 12.5177 0 0 0 0 0 0 0 13.3926 0 0 0 15.2987 0 13.903 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2915 13.6297 0 14.0036 0 0 0 0 14.3183 0 0 13.3132 13.6151 14.2869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5548 0 0 0 0 0 0 0 0 0 0 0 14.8644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1459 14.7318 0 0 0 14.6606 0 0 0 0 0 0 0 0 0 14.4158 0 0 O75347 TBCA_HUMAN "Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A, CFA)" TBCA Homo sapiens (Human) post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] GO:0003723; GO:0005730; GO:0005737; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015630; GO:0015631; GO:0048487; GO:0051087 beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; tubulin binding [GO:0015631] ADPRVRQIK 0.98436 -3.22 0 0 0 0 10.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6312 0 11.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3536 0 0 0 0 17.0091 13.2556 16.7443 16.1079 17.5001 16.2782 16.1098 16.3839 0 16.414 16.1182 16.5705 16.7293 0 16.674 0 0 12.6194 0 0 14.7567 0 0 0 0 12.1816 12.6897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.661 0 13.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.088 0 0 13.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49356 FNTB_HUMAN "Protein farnesyltransferase subunit beta, FTase-beta, EC 2.5.1.58 (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta)" FNTB Homo sapiens (Human) lipid metabolic process [GO:0006629]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342] cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965] cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; lipid metabolic process [GO:0006629]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342] GO:0004660; GO:0005829; GO:0005875; GO:0005965; GO:0006629; GO:0008270; GO:0018342; GO:0018343 protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270] FNHLVPRLVLQREK 0.98436 -3.2162 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4431 0 0 0 0 12.1205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6133 0 0 0 0 0 0 0 0 0 0 0 0 14.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27169 PON1_HUMAN "Serum paraoxonase/arylesterase 1, PON 1, EC 3.1.1.2, EC 3.1.1.81, EC 3.1.8.1 (Aromatic esterase 1, A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)" PON1 PON Homo sapiens (Human) aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636] GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617 acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803] AKLIALTLLGMGLALFR 0.98437 -3.2322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4ZJI4 SL9B1_HUMAN "Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1, NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)" SLC9B1 NHA1 NHEDC1 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; sodium:proton antiporter activity [GO:0015385]; flagellated sperm motility [GO:0030317]; ion transmembrane transport [GO:0034220]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338] GO:0005886; GO:0007338; GO:0015385; GO:0016021; GO:0030317; GO:0034220; GO:0051453; GO:0097228 sodium:proton antiporter activity [GO:0015385] IPLVPPLPPLLGMLLAGFTIR 0.98437 -3.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q71F23 CENPU_HUMAN "Centromere protein U, CENP-U (Centromere protein of 50 kDa, CENP-50) (Interphase centromere complex protein 24) (KSHV latent nuclear antigen-interacting protein 1) (MLF1-interacting protein) (Polo-box-interacting protein 1)" CENPU ICEN24 KLIP1 MLF1IP PBIP1 Homo sapiens (Human) chordate embryonic development [GO:0043009] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chordate embryonic development [GO:0043009] GO:0000776; GO:0005634; GO:0005654; GO:0005829; GO:0034451; GO:0043009 ISAKKPGR 0.98437 -3.2349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6614 0 14.7796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6469 Q9BYR6 KRA33_HUMAN Keratin-associated protein 3-3 (High sulfur keratin-associated protein 3.3) (Keratin-associated protein 3.3) KRTAP3-3 KAP3.3 KRTAP3.3 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0045095 structural molecule activity [GO:0005198] MDCCASR 0.98437 -3.2332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9348 0 12.2319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MYZ5 IQCF6_HUMAN IQ domain-containing protein F6 IQCF6 Homo sapiens (Human) calmodulin binding [GO:0005516] GO:0005516 calmodulin binding [GO:0005516] MWQARRR 0.98438 -3.2377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5495 13.5686 0 0 0 0 0 0 0 0 0 14.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5121 0 0 0 0 0 0 0 0 Q8IUC1 KR111_HUMAN Keratin-associated protein 11-1 (High sulfur keratin-associated protein 11.1) KRTAP11-1 KAP11.1 KRTAP11.1 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 MSFNCSTR 0.98439 -1.4529 0 0 0 0 0 0 0 0 0 0 0 11.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969Y0 NXPE3_HUMAN NXPE family member 3 (Protein FAM55C) NXPE3 FAM55C MSTP115 UNQ5791/PRO19596 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 LLDRSPKTVVVIR 0.98439 -2.1739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2572 12.3789 0 0 0 0 12.0727 12.7147 0 0 0 0 0 0 0 0 13.2119 11.2673 0 0 0 0 0 0 0 0 0 0 0 0 11.8961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75688 PPM1B_HUMAN "Protein phosphatase 1B, EC 3.1.3.16 (Protein phosphatase 2C isoform beta, PP2C-beta)" PPM1B PP2CB Homo sapiens (Human) N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470] GO:0000287; GO:0004722; GO:0005634; GO:0005730; GO:0005829; GO:0006470; GO:0006499; GO:0016020; GO:0017018; GO:0030145; GO:0032688; GO:0035970; GO:0043124; GO:0050687; GO:0090263; GO:1901223 magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] DSELDKHLESR 0.9844 -3.0689 0 0 0 0 0 0 11.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7211 13.6379 0 0 13.3215 0 0 0 0 0 0 0 13.0268 0 0 0 0 0 0 0 0 0 0 0 0 13.2193 0 0 0 0 0 0 0 13.3089 0 14.1629 0 0 0 0 0 0 0 0 0 0 0 13.1309 0 0 14.4489 13.7321 13.1464 0 0 0 0 0 0 0 0 0 12.7488 0 0 0 0 13.925 0 12.4385 0 0 0 12.7406 0 0 0 0 0 0 12.793 13.0259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07011 TNR9_HUMAN Tumor necrosis factor receptor superfamily member 9 (4-1BB ligand receptor) (CDw137) (T-cell antigen 4-1BB homolog) (T-cell antigen ILA) (CD antigen CD137) TNFRSF9 CD137 ILA Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127]; regulation of immature T cell proliferation in thymus [GO:0033084] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine binding [GO:0019955]; signaling receptor activity [GO:0038023]; apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127]; regulation of immature T cell proliferation in thymus [GO:0033084] GO:0005886; GO:0005887; GO:0006915; GO:0008285; GO:0009897; GO:0019955; GO:0033084; GO:0038023; GO:0042127 cytokine binding [GO:0019955]; signaling receptor activity [GO:0038023] DCCFGTFNDQK 0.9844 -1.5075 0 0 0 0 0 0 0 0 0 11.8123 0 0 0 0 0 0 0 0 12.043 0 0 11.9838 0 0 0 0 0 0 0 0 10.6666 0 0 12.2741 10.7989 0 0 0 0 0 0 12.872 0 0 0 11.1736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1028 0 0 0 0 0 13.4022 0 0 0 0 0 13.2317 0 11.9508 14.7201 0 0 0 0 0 12.406 0 0 0 0 0 12.3323 13.7162 0 12.0676 0 0 0 0 12.4473 0 0 0 0 0 12.6585 0 11.3621 0 0 0 0 12.8117 0 0 0 0 0 0 0 0 0 0 13.0906 12.9782 0 0 0 11.7513 0 0 0 0 0 0 0 12.7917 0 0 0 0 12.9011 0 0 0 0 0 0 0 0 12.8261 0 0 0 0 0 0 0 11.2183 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0795 0 0 Q14623 IHH_HUMAN "Indian hedgehog protein, IHH, EC 3.1.-.- (HHG-2) [Cleaved into: Indian hedgehog protein N-product ]" IHH Homo sapiens (Human) bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; intein-mediated protein splicing [GO:0016539]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; skeletal system development [GO:0001501]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell signaling [GO:0007267]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell morphogenesis [GO:0003382]; epithelial cell-cell adhesion [GO:0090136]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; intein-mediated protein splicing [GO:0016539]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; skeletal system development [GO:0001501]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704] GO:0001501; GO:0001569; GO:0001649; GO:0001701; GO:0001708; GO:0001947; GO:0002053; GO:0003382; GO:0003406; GO:0003413; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0006029; GO:0007224; GO:0007267; GO:0008233; GO:0009612; GO:0009880; GO:0010468; GO:0016539; GO:0016540; GO:0030704; GO:0031012; GO:0031016; GO:0032331; GO:0032355; GO:0032967; GO:0033085; GO:0033088; GO:0033089; GO:0035264; GO:0035988; GO:0040008; GO:0042733; GO:0043066; GO:0045453; GO:0045880; GO:0045944; GO:0046638; GO:0046639; GO:0048074; GO:0048469; GO:0048557; GO:0048596; GO:0048666; GO:0048745; GO:0050679; GO:0051216; GO:0060135; GO:0060220; GO:0060323; GO:0061053; GO:0072498; GO:0090136; GO:0097421 calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233] AHVHCSVK 0.9844 -3.2572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2714 0 0 0 0 0 0 11.7306 0 0 0 0 0 14.7799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVY1 CA210_HUMAN "Type III endosome membrane protein TEMP, TEMP" C1orf210 Homo sapiens (Human) early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] early endosome [GO:0005769]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] GO:0005769; GO:0005886; GO:0016021; GO:0055037 AWPVLVGFVLGAVVLSLLIALAAKCHLCR 0.9844 -3.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3887 12.455 0 0 0 0 0 0 0 0 10.1726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16832 DDR2_HUMAN "Discoidin domain-containing receptor 2, Discoidin domain receptor 2, EC 2.7.10.1 (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)" DDR2 NTRKR3 TKT TYRO10 Homo sapiens (Human) biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of kinase activity [GO:0033673]; negative regulation of necrotic cell death [GO:0060547]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of kinase activity [GO:0033673]; negative regulation of necrotic cell death [GO:0060547]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0033673; GO:0033674; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0060547; GO:0070374; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901216; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491 ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] EIKIMSRLK 0.98441 -2.3384 0 0 0 0 0 0 0 0 0 0 11.6556 0 0 0 0 0 0 0 0 0 0 11.5457 0 0 0 0 12.3793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6313 0 0 0 12.7068 11.6265 0 0 0 0 0 0 0 0 0 11.687 14.5929 0 0 14.7712 0 0 0 0 0 15.1016 15.0073 12.1046 0 0 15.6257 12.7701 14.8725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1744 0 0 0 14.8801 0 12.1135 0 0 13.874 0 0 0 0 0 0 0 0 14.9962 0 0 14.2102 0 0 0 14.0885 0 0 12.5016 0 0 0 0 0 12.9722 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2712 0 13.7769 0 0 0 0 0 0 0 0 0 0 Q86X53 ERIC1_HUMAN Glutamate-rich protein 1 ERICH1 HSPC319 Homo sapiens (Human) AAGLAAK 0.98441 -1.4686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2451 0 0 0 0 0 0 0 0 0 0 0 0 12.7886 0 0 0 0 0 0 0 0 0 12.7657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAC1 RFESD_HUMAN Rieske domain-containing protein RFESD Homo sapiens (Human) "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]" GO:0046872; GO:0051537 "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]" KSERMTAVVHDR 0.98441 -2.3423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2Z4 SYYM_HUMAN "Tyrosine--tRNA ligase, mitochondrial, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS)" YARS2 CGI-04 Homo sapiens (Human) mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831]; mitochondrial tyrosyl-tRNA aminoacylation [GO:0070184]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039] GO:0000049; GO:0003723; GO:0004831; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006412; GO:0016604; GO:0042803; GO:0043039; GO:0070184; GO:0072545 ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine binding [GO:0072545]; tyrosine-tRNA ligase activity [GO:0004831] ANAIPDGPRGYR 0.98441 -1.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1227 0 0 0 0 12.7654 0 0 13.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1175 0 0 14.9093 0 0 0 0 0 0 P51861 CDR1_HUMAN Cerebellar degeneration-related antigen 1 (CDR34) CDR1 Homo sapiens (Human) GFSGRLGGYWKTWIFWK 0.98442 -3.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7311 0 0 0 0 0 0 0 0 0 0 0 Q01082 SPTB2_HUMAN "Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)" SPTBN1 SPTB2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390] axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731] axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390] GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007182; GO:0007417; GO:0008091; GO:0014069; GO:0014731; GO:0021556; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0042995; GO:0043001; GO:0045296; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1903076; GO:1903078 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200] ADDIQKRENEVLEAWK 0.98442 -3.1726 0 0 0 0 0 0 12.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2062 0 0 0 13.7254 0 0 12.7124 0 0 0 10.2113 0 0 0 0 0 0 0 12.2276 0 0 0 0 14.6641 13.9278 0 0 0 13.9896 12.4693 14.3668 0 12.5604 0 0 0 0 0 0 0 12.3991 14.1423 0 0 0 15.2632 0 14.0316 0 12.4081 10.7345 0 0 0 12.0525 14.8992 0 0 0 0 0 12.6541 10.658 0 14.3594 13.2363 12.8942 14.5677 12.5419 0 0 0 12.7467 0 13.3106 0 14.8603 0 0 12.5726 0 0 0 0 13.19 0 11.1602 14.8448 0 0 12.8566 0 0 13.4332 0 11.0752 12.3849 15.4338 0 0 0 0 0 0 14.5714 0 0 0 0 0 0 12.6642 13.0305 0 0 15.2724 13.1918 13.159 0 11.871 0 0 0 0 0 0 0 10.274 0 0 Q14209 E2F2_HUMAN "Transcription factor E2F2, E2F-2" E2F2 Homo sapiens (Human) cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; lens fiber cell apoptotic process [GO:1990086]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; lens fiber cell apoptotic process [GO:1990086]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005654; GO:0006357; GO:0006367; GO:0007049; GO:0043565; GO:0045944; GO:0046983; GO:0051726; GO:0072332; GO:0090575; GO:1903671; GO:1990086; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" EQTVIAVK 0.98442 -3.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6448 0 12.6667 0 0 0 0 0 0 0 0 0 13.5405 0 0 13.3164 0 0 0 12.3779 12.073 11.5225 11.8674 12.07 0 13.8651 0 0 11.4454 0 15.3204 0 0 0 0 11.9484 0 0 0 0 0 0 0 14.3663 0 0 11.4586 0 0 0 0 15.2966 0 0 0 0 0 0 0 12.1284 0 0 0 0 0 0 0 12.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8119 12.1385 13.3283 0 12.2394 10.8296 0 11.725 0 10.7426 0 0 0 0 0 0 0 0 0 12.8102 0 0 0 0 Q8NGK6 O52I1_HUMAN Olfactory receptor 52I1 (Olfactory receptor OR11-13) OR52I1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVFDLSSK 0.98442 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00421 CCRL2_HUMAN C-C chemokine receptor-like 2 (Chemokine receptor CCR11) (Chemokine receptor X) (Putative MCP-1 chemokine receptor) CCRL2 CCR11 CCR6 CKRX CRAM HCR Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR chemokine receptor binding [GO:0048020]; chemokine receptor activity [GO:0004950]; chemokine receptor binding [GO:0042379]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0004950; GO:0005737; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0042379; GO:0048020; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; CCR chemokine receptor binding [GO:0048020]; chemokine receptor activity [GO:0004950]; chemokine receptor binding [GO:0042379] CAFSRTPFLPADETFWKHFLTLK 0.98443 -3.189 0 0 0 0 0 0 0 0 0 12.6975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1198 0 0 0 0 0 0 0 0 0 13.9464 13.5125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7012 0 0 0 0 0 17.1797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZP6 R113B_HUMAN RING finger protein 113B (Zinc finger protein 183-like 1) RNF113B RNF161 ZNF183L1 Homo sapiens (Human) snoRNA splicing [GO:0034247] U2-type spliceosomal complex [GO:0005684] U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; snoRNA splicing [GO:0034247] GO:0005684; GO:0034247; GO:0046872 metal ion binding [GO:0046872] CSQRVQEALR 0.98443 -3.0968 0 0 0 0 0 0 10.6163 0 0 0 0 0 0 0 0 0 0 0 11.5706 0 11.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1896 0 11.2789 0 0 0 12.7722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9415 0 0 0 12.0029 0 0 0 0 0 0 0 13.0988 12.2957 0 0 0 0 11.8974 0 0 0 0 12.4612 0 11.9431 0 12.5577 0 0 12.6161 0 12.5277 15.3668 0 0 0 0 0 0 0 0 13.3641 0 0 0 0 12.0805 0 0 0 13.9335 0 14.0946 0 14.1829 0 0 0 0 0 13.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.703 0 14.7544 0 13.5521 0 P79483 DRB3_HUMAN "HLA class II histocompatibility antigen, DR beta 3 chain (MHC class II antigen DRB3)" HLA-DRB3 Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]" clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658] "clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; myeloid dendritic cell antigen processing and presentation [GO:0002469]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]" GO:0000139; GO:0002250; GO:0002469; GO:0002503; GO:0002842; GO:0005765; GO:0005886; GO:0005887; GO:0007165; GO:0012507; GO:0016020; GO:0019886; GO:0023026; GO:0030658; GO:0030666; GO:0030669; GO:0031902; GO:0032395; GO:0032588; GO:0042605; GO:0042613; GO:0050852; GO:0050870; GO:0071556; GO:2000516 MHC class II protein complex binding [GO:0023026]; MHC class II receptor activity [GO:0032395]; peptide antigen binding [GO:0042605] GRVDNYCR 0.98444 -3.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00535 CDK5_HUMAN "Cyclin-dependent kinase 5, EC 2.7.11.1 (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit, TPKII catalytic subunit)" CDK5 CDKN5 PSSALRE Homo sapiens (Human) "axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]" anchoring junction [GO:0070161]; axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685] "anchoring junction [GO:0070161]; axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]" GO:0000083; GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006468; GO:0006886; GO:0006913; GO:0007005; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0009611; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016310; GO:0016533; GO:0016572; GO:0018105; GO:0018107; GO:0019233; GO:0019901; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0030866; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032092; GO:0032801; GO:0034352; GO:0035249; GO:0035418; GO:0042501; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045860; GO:0045861; GO:0045892; GO:0045956; GO:0046777; GO:0046826; GO:0046875; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070161; GO:0070509; GO:0090314; GO:0098685; GO:0098793; GO:0098883; GO:0098978; GO:0099635; GO:0106310; GO:1901215; GO:1901387; GO:1903076; GO:1903421; GO:1904646; GO:2000251 acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635] NVLHRDLKPQNLLINR 0.98444 -1.5386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PQ0 SORC2_HUMAN VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain ] SORCS2 KIAA1329 Homo sapiens (Human) intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; neuropeptide signaling pathway [GO:0007218] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perikaryon [GO:0043204]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perikaryon [GO:0043204]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]; neuropeptide receptor activity [GO:0008188]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; neuropeptide signaling pathway [GO:0007218] GO:0005829; GO:0005887; GO:0006886; GO:0007218; GO:0008188; GO:0016020; GO:0016021; GO:0031901; GO:0043197; GO:0043204; GO:0043231; GO:0055038; GO:0060292; GO:0070161; GO:0098839 neuropeptide receptor activity [GO:0008188] DSDFLCDYGFER 0.98444 -2.7349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3881 0 0 0 0 0 0 0 14.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1882 0 12.2234 14.5789 0 0 11.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6151 0 0 0 12.9779 0 11.3863 13.6739 0 0 0 0 0 0 0 0 0 0 0 13.4185 0 13.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3836 0 0 11.5313 0 0 0 0 0 0 0 0 0 13.0321 0 0 0 0 0 0 0 0 0 0 0 12.6755 14.1455 14.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY50 SC11C_HUMAN "Signal peptidase complex catalytic subunit SEC11C, EC 3.4.21.89 (Microsomal signal peptidase 21 kDa subunit, SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21)" SEC11C SEC11L3 SPC21 SPCS4C Homo sapiens (Human) signal peptide processing [GO:0006465] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; signal peptide processing [GO:0006465] GO:0004252; GO:0005787; GO:0005789; GO:0006465; GO:0008233; GO:0016021 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] GDNNEVDDR 0.98444 -3.1991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2048 14.0661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRM6 I17RB_HUMAN "Interleukin-17 receptor B, IL-17 receptor B, IL-17RB (Cytokine receptor-like 4) (IL-17 receptor homolog 1, IL-17Rh1, IL17Rh1) (Interleukin-17B receptor, IL-17B receptor)" IL17RB CRL4 EVI27 IL17BR UNQ2501/PRO19612 Homo sapiens (Human) defense response [GO:0006952]; regulation of cell growth [GO:0001558] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interleukin-17 receptor activity [GO:0030368]; defense response [GO:0006952]; regulation of cell growth [GO:0001558] GO:0001558; GO:0004896; GO:0005576; GO:0005886; GO:0005887; GO:0006952; GO:0016020; GO:0030368; GO:0043231 cytokine receptor activity [GO:0004896]; interleukin-17 receptor activity [GO:0030368] KTSFSTTTLLPPIK 0.98444 -1.5356 9.38761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8565 11.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3283 0 11.0573 0 0 0 0 0 0 0 0 0 0 0 0 12.3358 0 0 0 0 0 0 0 0 0 0 0 0 P51172 SCNND_HUMAN "Amiloride-sensitive sodium channel subunit delta (Delta-NaCH) (Epithelial Na(+) channel subunit delta, Delta-ENaC, ENaCD) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED)" SCNN1D DNACH Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; ligand-gated sodium channel activity [GO:0015280]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0008217; GO:0015280; GO:0015629; GO:0016020; GO:0034706; GO:0035725; GO:0036254; GO:0050914; GO:0050915; GO:0071468; GO:0098719; GO:1904045; GO:1904117 ligand-gated sodium channel activity [GO:0015280] AWFSWPR 0.98445 -3.1087 0 13.5159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3382 0 0 0 0 0 0 0 0 0 0 0 12.0779 0 0 0 0 0 0 0 0 0 0 9.39397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7665 0 0 0 0 0 0 15.2687 0 0 15.6599 0 15.0979 0 0 14.7236 0 0 0 0 14.7224 15.3106 0 0 12.5145 0 0 0 0 0 14.9652 9.46628 14.5322 0 0 0 15.289 0 12.9004 12.981 0 0 0 0 0 0 0 0 0 13.3137 0 0 0 0 0 14.817 0 14.4489 0 0 0 0 0 0 0 0 0 0 0 12.7195 0 0 0 0 0 0 0 0 0 0 12.9292 0 0 0 0 0 0 0 0 0 0 0 0 Q86WC6 PPR27_HUMAN Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1) (Toonin) PPP1R27 DYSFIP1 Homo sapiens (Human) phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864] GO:0004864; GO:0019902 phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864] MPSRTAR 0.98445 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92506 DHB8_HUMAN "(3R)-3-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.n12 (17-beta-hydroxysteroid dehydrogenase 8, 17-beta-HSD 8, HSD17B8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit, KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (Estradiol 17-beta-dehydrogenase 8, EC 1.1.1.62) (Protein Ke6, Ke6) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8, EC 1.1.1.239)" HSD17B8 FABGL HKE6 RING2 SDR30C1 Homo sapiens (Human) androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290] mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; oxidoreductase complex [GO:1990204]; plasma membrane [GO:0005886] "mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; oxidoreductase complex [GO:1990204]; plasma membrane [GO:0005886]; (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]" GO:0004303; GO:0005740; GO:0005759; GO:0005886; GO:0006633; GO:0006703; GO:0008209; GO:0016616; GO:0044594; GO:0047035; GO:0048038; GO:0051290; GO:0070404; GO:0106386; GO:1990204 "(3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" LLGGPGSK 0.98445 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6074 16.6654 16.529 16.8172 16.6393 16.6869 16.5257 0 0 0 16.7209 16.8679 16.9324 16.8925 0 0 0 13.6451 0 0 0 17.1444 0 0 0 0 17.1062 0 0 0 0 0 0 0 0 0 0 17.9008 0 17.6025 0 0 0 0 0 0 17.7534 17.7299 0 0 0 0 0 0 17.6821 0 17.6246 0 0 17.6305 0 17.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3706 0 0 0 0 17.5243 0 17.5003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1487 0 0 0 0 0 0 Q96HT8 MR1L1_HUMAN MORF4 family-associated protein 1-like 1 MRFAP1L1 PP784 Homo sapiens (Human) identical protein binding [GO:0042802] GO:0042802 identical protein binding [GO:0042802] IERSESS 0.98445 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8622 15.3624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VDI3 TM267_HUMAN Transmembrane protein 267 TMEM267 C5orf28 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FTMHLFKLK 0.98446 -3.2266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBH7 BEX1_HUMAN Protein BEX1 (Brain-expressed X-linked protein 1) BEX1 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] GO:0005102; GO:0005634; GO:0005667; GO:0005737; GO:0007165; GO:0007399; GO:0030154; GO:0045944; GO:0051091; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102] FRVRQPILQYR 0.98446 -3.2182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6973 0 0 12.7756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX73 CP089_HUMAN UPF0764 protein C16orf89 C16orf89 UNQ904/PRO1925 Homo sapiens (Human) cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; protein homodimerization activity [GO:0042803] GO:0005829; GO:0016020; GO:0042803; GO:0070062 protein homodimerization activity [GO:0042803] AEAIGYAYPTR 0.98449 -3.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.351 0 0 0 0 0 0 0 0 0 0 0 0 13.0848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2131 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6C7 PGSF1_HUMAN Putative uncharacterized protein encoded by MIR7-3HG (Pituitary gland-specific factor 1) MIR7-3HG C19orf30 LINC00306 NCRNA00306 PGSF1 Homo sapiens (Human) AETSRADCLGAPNIR 0.98449 -2.1739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8508 0 0 0 17.7154 17.6051 0 17.1648 0 0 0 0 0 17.8781 0 0 15.8455 0 17.413 17.2752 0 0 0 0 0 13.5742 0 14.7043 0 0 0 15.3684 0 0 0 0 0 0 0 0 0 0 14.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2685 0 0 0 0 0 0 0 0 0 0 10.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15084 ANR28_HUMAN "Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, PP6-ARS-A, Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K, PITK)" ANKRD28 KIAA0379 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 GANINAFDKK 0.9845 -3.0676 0 0 0 0 0 0 0 0 0 0 11.8289 0 11.9105 0 0 0 0 11.3526 0 10.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6157 0 0 13.668 0 0 0 0 14.7999 0 0 0 13.4856 0 12.5596 0 0 0 0 0 0 0 11.8156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.152 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92930 RAB8B_HUMAN Ras-related protein Rab-8B RAB8B Homo sapiens (Human) antigen processing and presentation [GO:0019882]; cell-substrate junction organization [GO:0150115]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] cell tip [GO:0051286]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140] cell tip [GO:0051286]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911]; antigen processing and presentation [GO:0019882]; cell-substrate junction organization [GO:0150115]; endocytic recycling [GO:0032456]; Golgi vesicle fusion to target membrane [GO:0048210]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] GO:0003924; GO:0005102; GO:0005525; GO:0005768; GO:0005778; GO:0005886; GO:0006904; GO:0008021; GO:0009306; GO:0017157; GO:0019003; GO:0019882; GO:0030140; GO:0030670; GO:0030911; GO:0031346; GO:0032456; GO:0043231; GO:0045046; GO:0045335; GO:0048210; GO:0048471; GO:0051286; GO:0051461; GO:0055038; GO:0070062; GO:0072659; GO:0150115 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911] CDMNDKR 0.9845 -3.0615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4161 0 0 0 0 0 11.789 0 0 0 0 0 0 14.1112 0 10.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9977 0 0 0 0 0 0 0 0 0 0 0 0 13.4564 0 0 0 0 0 0 13.9588 0 0 0 0 0 0 0 13.6029 0 0 0 0 Q9UJ99 CAD22_HUMAN "Cadherin-22 (Pituitary and brain cadherin, PB-cadherin)" CDH22 C20orf25 Homo sapiens (Human) adherens junction organization [GO:0034332]; brain development [GO:0007420]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007420; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] AGVALSPALLLLLLLPPPPTLLGR 0.9845 -3.0669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3728 0 0 0 11.752 0 0 0 13.3242 0 0 0 0 0 12.2212 0 0 0 0 0 0 10.8674 0 0 0 0 0 0 0 0 12.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9566 0 0 0 0 0 0 13.6043 14.5844 13.4122 0 14.0643 0 13.6441 0 0 0 0 0 0 15.9595 0 15.6681 0 0 0 14.5393 11.0841 0 0 0 0 0 15.2825 0 0 12.1165 0 11.9512 0 0 14.8624 0 15.1863 0 14.4232 14.0157 0 0 0 0 14.8923 0 0 0 0 0 0 13.1503 0 0 14.1436 0 13.7531 0 0 0 0 0 0 0 0 12.5454 0 0 0 0 0 0 0 0 0 11.9123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MUA0 YB057_HUMAN Putative UPF0607 protein ENSP00000381514 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] AAGHRSR 0.98451 -1.5058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.459 0 0 0 0 0 0 0 0 0 0 12.9974 0 0 0 0 0 0 0 0 0 0 14.4076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0516 0 0 0 0 0 14.607 0 0 0 0 0 0 0 0 0 13.6809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9264 0 13.6761 0 0 O95456 PSMG1_HUMAN "Proteasome assembly chaperone 1, PAC-1 (Chromosome 21 leucine-rich protein, C21-LRP) (Down syndrome critical region protein 2)" PSMG1 C21LRP DSCR2 PAC1 Homo sapiens (Human) cerebellar granule cell precursor proliferation [GO:0021930]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome core complex assembly [GO:0080129] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]; cerebellar granule cell precursor proliferation [GO:0021930]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome core complex assembly [GO:0080129] GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0021930; GO:0051131; GO:0060090; GO:0070628; GO:0080129; GO:0101031 molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] AATFFGEVVKAPCR 0.98451 -2.3362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2392 0 0 0 0 0 0 0 0 0 0 18.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5784 0 0 0 0 0 11.8861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.791 0 0 0 0 0 0 0 14.5961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.428 0 Q9BUF7 CRUM3_HUMAN Protein crumbs homolog 3 CRB3 UNQ588/PRO1158 Homo sapiens (Human) establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of cell junction assembly [GO:1901890]; protein localization to plasma membrane [GO:0072659] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; subapical complex [GO:0035003] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; subapical complex [GO:0035003]; protein domain specific binding [GO:0019904]; SH3 domain binding [GO:0017124]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of cell junction assembly [GO:1901890]; protein localization to plasma membrane [GO:0072659] GO:0005886; GO:0005923; GO:0016021; GO:0016324; GO:0017124; GO:0019904; GO:0030054; GO:0035003; GO:0043296; GO:0045197; GO:0070062; GO:0072659; GO:1901890 protein domain specific binding [GO:0019904]; SH3 domain binding [GO:0017124] ANPGLGLLLALGLPFLLAR 0.98451 3.0542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1261 0 0 0 0 12.8072 0 0 0 0 0 0 0 0 0 0 0 0 15.3998 0 0 13.7937 0 13.0275 0 0 0 13.2344 0 13.2215 0 13.9169 0 0 0 0 13.6564 0 0 11.4402 13.1739 0 13.2959 0 0 13.2812 0 0 0 0 0 11.5091 13.9147 0 0 0 0 13.2585 0 0 0 0 0 0 13.3393 0 13.104 0 0 0 0 12.1166 0 0 0 0 0 13.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0X9 OSBL5_HUMAN "Oxysterol-binding protein-related protein 5, ORP-5, OSBP-related protein 5 (Oxysterol-binding protein homolog 1)" OSBPL5 KIAA1534 OBPH1 ORP5 Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914] GO:0001786; GO:0005548; GO:0005789; GO:0005829; GO:0006893; GO:0008142; GO:0008203; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030301; GO:0032934; GO:0036150; GO:0043231; GO:0070273; GO:0140268; GO:0140343 cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] AAVEEDAYSR 0.98451 -3.2626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4459 0 0 0 0 0 0 0 0 0 10.7986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2503 0 0 0 0 0 0 0 0 0 0 12.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7337 0 0 0 0 0 0 0 0 0 0 0 0 12.4874 12.5411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H845 ACAD9_HUMAN "Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9, ACAD-9, EC 1.3.8.-)" ACAD9 Homo sapiens (Human) long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0000062; GO:0001676; GO:0003995; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991 acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099] AYICAHPLDR 0.98451 -2.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1943 0 0 0 0 0 0 0 0 0 15.0323 0 0 0 0 0 12.3388 0 0 0 0 0 0 0 0 0 0 0 0 13.8463 0 14.6812 11.6189 14.1156 0 0 0 0 0 0 14.8892 0 0 14.2733 0 0 0 0 0 0 14.7711 14.0944 0 13.5581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32243 OTX2_HUMAN Homeobox protein OTX2 (Orthodenticle homolog 2) OTX2 Homo sapiens (Human) "axon guidance [GO:0007411]; dopaminergic neuron differentiation [GO:0071542]; forebrain development [GO:0030900]; midbrain development [GO:0030901]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein-containing complex assembly [GO:0065003]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; growth cone [GO:0030426]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; growth cone [GO:0030426]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; eukaryotic initiation factor 4E binding [GO:0008190]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; axon guidance [GO:0007411]; dopaminergic neuron differentiation [GO:0071542]; forebrain development [GO:0030900]; midbrain development [GO:0030901]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein-containing complex assembly [GO:0065003]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007411; GO:0008190; GO:0008589; GO:0030426; GO:0030900; GO:0030901; GO:0032991; GO:0040019; GO:0040036; GO:0045893; GO:0045944; GO:0065003; GO:0071542; GO:0090009; GO:1990837; GO:2000543 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; eukaryotic initiation factor 4E binding [GO:0008190]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CRQQQQQQQNGGQNKVR 0.98452 -3.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ41 RABX5_HUMAN Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5) RABGEF1 RABEX5 Homo sapiens (Human) Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; nucleolus [GO:0005730]; recycling endosome [GO:0055037] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368] GO:0001933; GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006468; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0030139; GO:0031267; GO:0031901; GO:0032715; GO:0032764; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:1900235 DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GCGYYGNPAWQGFCSK 0.98452 -3.1794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8572 0 0 0 0 0 15.3852 0 0 0 0 13.6702 0 0 13.7938 14.3797 13.3606 13.5084 15.0033 14.5642 13.6785 13.5156 14.6787 14.5637 14.4101 13.6662 14.1254 0 0 0 14.4551 13.6332 0 14.1473 0 14.2667 0 0 0 0 0 14.4393 0 0 0 0 0 0 0 13.8038 13.7753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2029 0 0 0 0 0 0 P35625 TIMP3_HUMAN "Metalloproteinase inhibitor 3 (Protein MIG-5) (Tissue inhibitor of metalloproteinases 3, TIMP-3)" TIMP3 Homo sapiens (Human) cellular response to organic substance [GO:0071310]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; platelet dense granule lumen [GO:0031089] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; platelet dense granule lumen [GO:0031089]; metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; cellular response to organic substance [GO:0071310]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to organic substance [GO:0010033]; visual perception [GO:0007601] GO:0002020; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0007601; GO:0008191; GO:0009725; GO:0010033; GO:0010951; GO:0031012; GO:0031089; GO:0034097; GO:0046872; GO:0051045; GO:0062023; GO:0070373; GO:0071310; GO:1903984; GO:1904684 metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020] GGYCSWYR 0.98453 -3.7754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13571 LAPM5_HUMAN Lysosomal-associated transmembrane protein 5 (Lysosomal-associated multitransmembrane protein 5) (Retinoic acid-inducible E3 protein) LAPTM5 KIAA0085 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; defense response to tumor cell [GO:0002357]; Golgi to lysosome transport [GO:0090160]; induction of programmed cell death [GO:0012502]; intracellular protein transport [GO:0006886]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of B cell activation [GO:0050869]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein targeting to lysosome [GO:0006622] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]; protein sequestering activity [GO:0140311]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; defense response to tumor cell [GO:0002357]; Golgi to lysosome transport [GO:0090160]; induction of programmed cell death [GO:0012502]; intracellular protein transport [GO:0006886]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of B cell activation [GO:0050869]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein targeting to lysosome [GO:0006622] GO:0002357; GO:0002720; GO:0005764; GO:0005765; GO:0005829; GO:0005887; GO:0006622; GO:0006886; GO:0006919; GO:0012502; GO:0030133; GO:0031398; GO:0031410; GO:0031625; GO:0032689; GO:0032703; GO:0032735; GO:0032991; GO:0043410; GO:0048471; GO:0050860; GO:0050868; GO:0050869; GO:0060907; GO:0090160; GO:0097214; GO:0140036; GO:0140311; GO:1901224; GO:1903265; GO:1904093; GO:2000060; GO:2000646 protein sequestering activity [GO:0140311]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036] CVWRCYR 0.98453 -3.1873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8338 0 0 0 11.6885 0 0 0 0 12.315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.251 0 0 0 0 0 0 0 0 0 0 0 Q53HC9 EIPR1_HUMAN EARP and GARP complex-interacting protein 1 (Endosome-associated recycling protein-interacting protein) (Golgi-associated retrograde protein-interacting protein) (Tumor-suppressing STF cDNA 1 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 1 protein) EIPR1 TSSC1 Homo sapiens (Human) "endocytic recycling [GO:0032456]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; protein ubiquitination [GO:0016567]; regulation of insulin secretion [GO:0050796]" trans-Golgi network [GO:0005802] "trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; protein ubiquitination [GO:0016567]; regulation of insulin secretion [GO:0050796]" GO:0005802; GO:0016567; GO:0032456; GO:0050796; GO:1905281; GO:2001137 ALKYHILL 0.98453 -3.1863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9518 14.5081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92624 APBP2_HUMAN "Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2, APP-BP2) (Protein interacting with APP tail 1)" APPBP2 KIAA0228 PAT1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] GO:0003777; GO:0005634; GO:0005654; GO:0005737; GO:0005874; GO:0005875; GO:0006886; GO:0016567; GO:0030659; GO:0031462; GO:0043161; GO:0046907; GO:1990756 microtubule motor activity [GO:0003777]; ubiquitin ligase-substrate adaptor activity [GO:1990756] AIGIITHILPEDHLLLASSKR 0.98453 -3.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.927 0 0 0 14.1819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75191 XYLB_HUMAN "Xylulose kinase, Xylulokinase, EC 2.7.1.17" XYLB Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997] cytosol [GO:0005829] "cytosol [GO:0005829]; ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]; carbohydrate metabolic process [GO:0005975]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; phosphorylation [GO:0016310]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997]" GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0016310; GO:0016773; GO:0019640; GO:0042732 "ATP binding [GO:0005524]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; xylulokinase activity [GO:0004856]" EKIRNESVSR 0.98454 -2.7283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7167 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31267 HXA6_HUMAN Homeobox protein Hox-A6 (Homeobox protein Hox-1B) HOXA6 HOX1B Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system development [GO:0048706]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system development [GO:0048706]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0016607; GO:0048706; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GRQTYTR 0.98454 -3.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q32M78 ZN699_HUMAN Zinc finger protein 699 (Hangover homolog) ZNF699 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFHFLACFK 0.98454 -3.0981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.663 0 0 0 0 0 0 0 0 0 12.962 0 0 0 0 15.734 14.8284 13.8487 0 0 0 0 0 0 0 0 0 13.7617 11.4567 0 0 0 0 0 0 0 0 11.6548 0 0 0 0 0 15.8514 0 0 0 0 0 0 0 0 12.416 0 13.3898 0 14.7468 0 0 0 0 0 0 0 14.2745 14.4334 0 13.5482 0 0 0 14.0099 0 13.6422 0 13.1777 13.0881 13.0238 0 0 0 0 0 0 12.7634 0 0 0 15.388 0 0 0 12.7923 12.6023 0 0 0 0 0 0 0 14.0238 0 12.9818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NB90 SPAT5_HUMAN "Ribosome biogenesis protein SPATA5, EC 3.6.4.10 (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5)" SPATA5 AFG2 SPAF Homo sapiens (Human) brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; spindle [GO:0005819] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283] GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275] AIREIIELPLK 0.98454 -1.4741 0 0 0 0 12.1554 0 0 0 0 12.422 0 13.2455 0 12.2572 0 0 0 11.216 0 0 0 0 0 0 0 0 0 0 13.0394 14.0895 0 0 12.206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2768 0 0 0 0 0 0 0 17.2919 0 0 16.8113 0 0 16.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7285 0 0 0 12.6252 14.5443 0 0 0 0 0 0 0 0 0 0 0 12.2776 0 0 13.6633 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4878 13.2338 12.5377 0 12.2598 12.89 0 0 0 14.648 0 0 0 0 0 0 12.5183 0 0 12.455 0 0 0 13.646 0 0 0 0 0 0 0 11.9067 0 0 0 0 0 0 0 0 11.9606 0 0 0 0 0 13.9049 18.832 0 13.0414 0 0 14.4436 13.7744 13.1665 14.3917 0 0 12.5228 0 0 0 0 0 0 0 0 0 0 Q8WYQ4 CV015_HUMAN Uncharacterized protein C22orf15 (Protein N27C7-3) C22orf15 Homo sapiens (Human) AIYVLVRIIK 0.98454 -1.4719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.481 0 0 0 0 12.4963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6352 0 0 0 0 11.669 0 0 0 0 0 0 0 11.6155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.115 0 0 11.4285 0 0 0 10.8794 0 0 0 0 0 0 0 11.3993 0 0 0 0 0 0 0 0 Q92750 TAF4B_HUMAN "Transcription initiation factor TFIID subunit 4B (Transcription initiation factor TFIID 105 kDa subunit, TAF(II)105, TAFII-105, TAFII105)" TAF4B TAF2C2 TAFII105 Homo sapiens (Human) mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; mRNA transcription by RNA polymerase II [GO:0042789]; oogenesis [GO:0048477]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0001650; GO:0003677; GO:0005654; GO:0005669; GO:0005737; GO:0006367; GO:0006468; GO:0007283; GO:0016251; GO:0042789; GO:0046982; GO:0048477; GO:0051059; GO:0060261 DNA binding [GO:0003677]; NF-kappaB binding [GO:0051059]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251] DEPFLFIGALQKR 0.98454 -3.1924 0 0 0 0 0 0 0 0 0 0 10.7601 13.0516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5278 0 13.2801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9091 13.9116 0 0 0 13.356 0 0 0 0 0 0 0 0 0 16.3097 0 13.0191 0 0 0 0 0 0 14.5794 0 0 0 0 0 13.1715 0 0 0 0 0 0 0 0 0 0 0 12.2344 12.2896 14.0801 0 12.7957 0 0 0 0 0 13.8481 0 0 0 0 0 13.9281 0 0 0 0 13.9665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2405 0 0 0 0 0 0 0 0 0 0 12.5637 0 0 0 0 0 0 13.3873 0 0 0 0 0 0 Q9Y265 RUVB1_HUMAN "RuvB-like 1, EC 3.6.4.12 (49 kDa TATA box-binding protein-interacting protein, 49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein, ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238, NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha, TAP54-alpha)" RUVBL1 INO80H NMP238 TIP49 TIP49A Homo sapiens (Human) "box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]" chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812] "chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; box C/D snoRNP assembly [GO:0000492]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]" GO:0000492; GO:0000723; GO:0000786; GO:0000812; GO:0001094; GO:0003678; GO:0003713; GO:0005524; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007049; GO:0007283; GO:0016020; GO:0016363; GO:0016573; GO:0016887; GO:0017025; GO:0031011; GO:0033044; GO:0035267; GO:0040008; GO:0042981; GO:0043486; GO:0043531; GO:0043967; GO:0043968; GO:0045296; GO:0045893; GO:0045995; GO:0050821; GO:0051117; GO:0051301; GO:0051726; GO:0060382; GO:0070062; GO:0071339; GO:0090263; GO:0097255; GO:0101031; GO:0120293; GO:1904507; GO:1904874; GO:1905168; GO:1990062; GO:1990904; GO:2000779 ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; DNA helicase activity [GO:0003678]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713] GDVHKKK 0.98454 -2.7234 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6279 12.8991 12.4511 12.5375 12.8759 12.374 0 17.0279 0 12.7034 0 12.7855 12.711 12.8487 12.487 0 0 0 0 0 0 0 0 0 0 12.7578 12.3728 12.1501 0 0 12.2894 12.4854 12.0073 12.5499 12.5414 13.5947 13.8427 13.9285 0 0 16.6419 0 0 0 0 0 0 0 0 12.3197 0 0 14.245 0 10.3016 0 0 14.1254 0 0 0 0 12.9955 0 0 0 0 0 12.0654 12.5441 16.0661 0 0 15.9631 14.0885 15.9917 0 0 0 15.9268 15.9866 0 15.8668 0 0 0 15.4901 0 14.6124 14.3108 14.5572 13.5905 0 0 0 0 0 12.3955 14.7918 15.6315 15.0676 15.2963 14.3975 0 0 0 0 13.5866 15.2541 0 15.1448 14.8097 19.3351 0 0 0 0 13.5513 0 0 0 0 13.5852 0 13.8778 14.1026 0 0 0 11.5762 0 0 0 18.8178 14.4905 0 0 0 0 0 12.6174 0 0 0 0 0 0 0 0 0 0 0 14.8306 0 0 0 0 14.7352 0 0 0 0 14.7559 0 0 0 0 Q9Y426 C2CD2_HUMAN C2 domain-containing protein 2 (Transmembrane protein 24-like) C2CD2 C21orf25 C21orf258 TMEM24L Homo sapiens (Human) cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0005829; GO:0016021 AHELKLLVR 0.98454 -2.7255 0 0 0 0 0 0 11.4056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87781 0 0 0 11.1041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2734 0 0 0 0 13.4583 0 0 13.9799 0 0 0 0 0 0 11.7817 0 0 12.0188 16.4089 0 11.9534 0 0 0 0 12.1944 0 0 0 0 0 0 0 0 0 0 0 0 11.6515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXZ2 DDX43_HUMAN "Probable ATP-dependent RNA helicase DDX43, EC 3.6.4.13 (Cancer/testis antigen 13, CT13) (DEAD box protein 43) (DEAD box protein HAGE) (Helical antigen)" DDX43 HAGE Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] FKAHQQKR 0.98455 -1.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UDX5 MTFP1_HUMAN "Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein, MTP18)" MTFP1 MTP18 HSPC242 My022 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; response to muscle activity [GO:0014850] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; response to muscle activity [GO:0014850] GO:0000266; GO:0005739; GO:0005743; GO:0006915; GO:0014850; GO:0016021 WPLAVRK 0.98455 -1.5354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3985 0 13.8223 0 13.1159 14.3495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0247 0 13.2145 0 0 0 0 0 0 13.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3826 0 0 0 0 0 0 0 0 0 0 0 11.7382 0 0 0 0 0 12.6073 0 11.1901 0 0 11.7207 0 0 Q1HG44 DOXA2_HUMAN Dual oxidase maturation factor 2 (Dual oxidase activator 2) DUOXA2 Homo sapiens (Human) hydrogen peroxide metabolic process [GO:0042743]; positive regulation of cell motility [GO:2000147]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; protein localization [GO:0008104]; protein maturation [GO:0051604]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of cell motility [GO:2000147]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; protein localization [GO:0008104]; protein maturation [GO:0051604]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0016021; GO:0019899; GO:0031252; GO:0042743; GO:0045177; GO:0050727; GO:0051604; GO:2000147; GO:2000609 enzyme binding [GO:0019899] QAALPDLK 0.98456 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08185 CBG_HUMAN "Corticosteroid-binding globulin, CBG (Serpin A6) (Transcortin)" SERPINA6 CBG Homo sapiens (Human) glucocorticoid metabolic process [GO:0008211]; negative regulation of endopeptidase activity [GO:0010951] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; steroid binding [GO:0005496]; glucocorticoid metabolic process [GO:0008211]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005496; GO:0005576; GO:0005615; GO:0008211; GO:0010951; GO:0070062 serine-type endopeptidase inhibitor activity [GO:0004867]; steroid binding [GO:0005496] SSKVVHK 0.98457 -1.5454 0 0 0 0 0 0 0 0 0 14.3487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51810 GP143_HUMAN G-protein coupled receptor 143 (Ocular albinism type 1 protein) GPR143 OA1 Homo sapiens (Human) calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; eye pigment biosynthetic process [GO:0006726]; G protein-coupled receptor signaling pathway [GO:0007186]; melanosome localization [GO:0032400]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of calcium-mediated signaling [GO:0050848]; regulation of melanosome organization [GO:1903056]; regulation of melanosome transport [GO:1902908]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0004930; GO:0005737; GO:0005765; GO:0005794; GO:0005886; GO:0006726; GO:0007165; GO:0007186; GO:0007601; GO:0016020; GO:0016021; GO:0016324; GO:0032400; GO:0032402; GO:0032438; GO:0033162; GO:0035240; GO:0035584; GO:0035643; GO:0042470; GO:0048015; GO:0050848; GO:0072544; GO:0072545; GO:1902908; GO:1903056 dopamine binding [GO:0035240]; G protein-coupled receptor activity [GO:0004930]; L-DOPA binding [GO:0072544]; L-DOPA receptor activity [GO:0035643]; tyrosine binding [GO:0072545] AFHALCLGSGGLRLALGLLQLLPGR 0.98457 -3.0234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0027 0 0 0 0 0 0 0 0 0 0 11.2479 0 0 0 0 0 12.0145 0 0 0 0 11.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1381 0 0 12.2309 0 0 0 0 0 0 0 10.4353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4547 0 0 0 0 0 0 0 11.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GTZ2 CC196_HUMAN Putative coiled-coil domain-containing protein 196 (Long intergenic non-protein coding RNA 238) CCDC196 C14orf53 LINC00238 NCRNA00238 Homo sapiens (Human) KMEWVKYQEQNNILQNDFHGK 0.98458 -1.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0928 0 0 0 A5YM69 ARG35_HUMAN Rho guanine nucleotide exchange factor 35 (Rho guanine nucleotide exchange factor 5-like protein) ARHGEF35 ARHGEF5L Homo sapiens (Human) EKLLSVL 0.98458 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUB4 CT141_HUMAN Uncharacterized protein C20orf141 C20orf141 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 TRLCLPR 0.98458 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60413 KR10C_HUMAN Keratin-associated protein 10-12 (High sulfur keratin-associated protein 10.12) (Keratin-associated protein 10.12) (Keratin-associated protein 18-12) (Keratin-associated protein 18.12) KRTAP10-12 KAP10.12 KAP18-12 KRTAP10.12 KRTAP18-12 KRTAP18.12 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 PVCRPAR 0.98459 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5392 0 0 14.7521 0 0 0 0 0 0 14.2349 0 0 0 0 0 0 14.2274 0 14.6093 0 0 0 0 0 0 0 14.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2096 Q16654 PDK4_HUMAN "[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 4)" PDK4 PDHK4 Homo sapiens (Human) cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of bone resorption [GO:0045124]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]; response to starvation [GO:0042594] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of bone resorption [GO:0045124]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885]; response to starvation [GO:0042594] GO:0004672; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0006006; GO:0006468; GO:0006885; GO:0008286; GO:0009267; GO:0010510; GO:0010565; GO:0010906; GO:0042304; GO:0042593; GO:0042594; GO:0045124; GO:0046320; GO:0071398; GO:0072593; GO:2000811 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] HYQMSSEADDWCIPSR 0.98459 -3.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3047 12.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3296 0 0 Q8N2C3 DEPD4_HUMAN DEP domain-containing protein 4 DEPDC4 Homo sapiens (Human) intracellular signal transduction [GO:0035556] intracellular signal transduction [GO:0035556] GO:0035556 GVHLCQVLMNHKVFEPVGMK 0.98459 -3.0579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4539 0 0 0 0 0 11.4109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1984 0 0 0 0 0 0 0 13.4897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCJ0 FBX25_HUMAN F-box only protein 25 FBXO25 FBX25 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567] GO:0000151; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0016567; GO:0019005 actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842] DHFRNDTNTQSFYREK 0.98459 -3.0529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8622 0 0 0 11.0156 0 0 0 0 0 0 0 0 14.9821 0 0 0 0 0 0 0 0 12.5878 0 0 0 0 13.8376 13.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8258 14.2915 0 0 0 0 0 0 0 15.8305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91452 0 0 0 0 0 0 0 0 0 P47897 SYQ_HUMAN "Glutamine--tRNA ligase, EC 6.1.1.18 (Glutaminyl-tRNA synthetase, GlnRS)" QARS1 QARS Homo sapiens (Human) "brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418]" aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991] "aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418]" GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0006469; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234 ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] AFIHWVSQPLMCEVR 0.9846 -2.1739 12.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3259 0 12.6755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9205 0 0 0 0 0 0 0 0 0 11.6577 0 0 0 0 0 0 0 0 14.9541 14.5784 13.2721 0 11.6121 14.0234 0 0 0 0 0 0 0 0 0 12.6213 0 0 12.4583 0 0 11.7567 0 0 0 13.5337 0 13.3028 12.291 0 0 14.2973 12.4196 0 12.3367 0 13.4552 0 0 0 0 10.8676 0 0 0 0 13.2118 0 0 0 0 0 0 0 0 0 11.0904 0 0 0 0 0 0 0 12.912 13.1398 0 0 13.0285 0 14.1858 0 0 0 0 0 13.5169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6331 0 0 0 0 0 0 0 0 0 13.9482 0 13.3648 Q8N1Q1 CAH13_HUMAN "Carbonic anhydrase 13, EC 4.2.1.1 (Carbonate dehydratase XIII) (Carbonic anhydrase XIII, CA-XIII)" CA13 Homo sapiens (Human) one-carbon metabolic process [GO:0006730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myelin sheath [GO:0043209]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730] GO:0004089; GO:0005737; GO:0005829; GO:0006730; GO:0008270; GO:0016836; GO:0043209; GO:0043231 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] EVKYDSSLRPLSIK 0.9846 -2.5404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GW9 SYMM_HUMAN "Methionine--tRNA ligase, mitochondrial, EC 6.1.1.10 (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase, MtMetRS)" MARS2 Homo sapiens (Human) methionyl-tRNA aminoacylation [GO:0006431]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; methionyl-tRNA aminoacylation [GO:0006431]; tRNA aminoacylation for protein translation [GO:0006418] GO:0004825; GO:0005524; GO:0005759; GO:0006418; GO:0006431 ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825] FYGHPCPFEGR 0.9846 -3.0609 0 0 0 0 0 0 0 0 0 0 0 13.5106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.897 0 0 0 0 0 0 0 0 0 10.2212 0 0 0 0 0 0 0 0 0 0 0 0 14.9003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9303 0 0 11.6868 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9336 0 0 0 0 13.476 0 10.4792 0 14.4577 0 0 0 14.166 0 0 0 0 0 0 0 0 13.6941 0 14.7628 14.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.771 0 0 0 0 0 0 0 0 0 13.3464 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0V9 LMA2L_HUMAN "VIP36-like protein (Lectin mannose-binding 2-like, LMAN2-like protein)" LMAN2L VIPL PSEC0028 UNQ368/PRO704 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein folding [GO:0006457]; protein transport [GO:0015031] GO:0000139; GO:0005537; GO:0005789; GO:0005793; GO:0005794; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0015031; GO:0016021; GO:0030134; GO:0046872 mannose binding [GO:0005537]; metal ion binding [GO:0046872] DRMQPGPVFGNMDK 0.9846 -3.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3906 11.9902 0 13.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7504 0 0 0 0 0 0 0 0 18.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4M9 EHD1_HUMAN "EH domain-containing protein 1 (PAST homolog 1, hPAST1) (Testilin)" EHD1 PAST PAST1 CDABP0131 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659] ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038] ciliary pocket membrane [GO:0020018]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein homooligomerization [GO:0051260]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659] GO:0005509; GO:0005524; GO:0005525; GO:0005769; GO:0005811; GO:0005886; GO:0006886; GO:0006897; GO:0010008; GO:0010886; GO:0010976; GO:0016020; GO:0016197; GO:0020018; GO:0030139; GO:0031095; GO:0031175; GO:0031267; GO:0031901; GO:0032456; GO:0034383; GO:0042632; GO:0042802; GO:0043231; GO:0045296; GO:0048471; GO:0051260; GO:0055038; GO:0060271; GO:0061512; GO:0070062; GO:0072659; GO:1901741; GO:1990090; GO:2001137 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] ARLAKVHAYIISSLK 0.9846 -3.0666 0 0 10.5975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2036 13.3261 0 0 0 0 12.452 0 12.8415 12.0106 0 0 0 0 0 0 0 0 0 0 0 12.5804 0 0 14.4398 0 0 0 0 0 13.1547 13.4525 0 0 0 12.8214 0 0 0 0 14.2024 14.279 0 0 0 0 0 13.8605 0 0 0 0 13.5534 0 0 13.9068 14.5718 13.7294 0 0 15.434 0 11.8675 0 15.3561 0 0 0 0 14.0565 14.592 13.8923 0 0 15.2006 0 14.0441 0 11.9303 0 0 0 0 0 14.4412 14.5556 0 0 0 0 0 0 10.7616 0 0 0 0 0 0 0 14.1012 0 0 0 0 0 0 0 0 12.7993 0 13.1412 13.5341 13.6069 0 0 0 0 14.7694 0 0 0 12.0709 0 0 0 P59826 BPIB3_HUMAN "BPI fold-containing family B member 3 (Ligand-binding protein RYA3) (Long palate, lung and nasal epithelium carcinoma-associated protein 3)" BPIFB3 C20orf185 LPLUNC3 Homo sapiens (Human) innate immune response [GO:0045087] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lipid binding [GO:0008289]; innate immune response [GO:0045087] GO:0005576; GO:0005737; GO:0008289; GO:0045087 lipid binding [GO:0008289] APAKVPPKK 0.98461 -3.0772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.244 0 0 0 14.1971 0 0 0 14.0321 0 0 0 15.0354 0 0 0 15.4678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.547 0 0 0 0 0 0 0 0 0 12.357 0 14.798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6336 0 0 0 13.8038 12.9817 0 0 0 0 14.3424 12.2574 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7927 0 0 0 0 0 0 0 14.2438 0 0 0 0 0 14.3263 0 0 0 0 0 0 0 0 13.5559 0 0 0 0 0 0 14.0262 0 0 0 0 0 0 13.6693 0 0 14.0226 0 Q12972 PP1R8_HUMAN "Nuclear inhibitor of protein phosphatase 1, NIPP-1 (Protein phosphatase 1 regulatory inhibitor subunit 8) [Includes: Activator of RNA decay, EC 3.1.4.- (ARD-1) ]" PPP1R8 ARD1 NIPP1 Homo sapiens (Human) cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; negative regulation of protein dephosphorylation [GO:0035308]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ribonuclease E activity [GO:0008995]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; negative regulation of protein dephosphorylation [GO:0035308]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380] GO:0003677; GO:0003723; GO:0003729; GO:0004519; GO:0004865; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0006401; GO:0008283; GO:0008380; GO:0008995; GO:0016607; GO:0035308 DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ribonuclease E activity [GO:0008995]; RNA binding [GO:0003723] LIEKLIIDEK 0.98461 -2.3319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1432 0 0 12.5099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7643 0 0 0 0 11.2739 0 11.4318 0 0 12.2376 0 11.2667 0 0 0 0 0 0 0 0 11.3553 0 11.9855 0 17.5178 0 0 0 0 0 17.5983 0 0 0 0 0 0 18.922 0 0 18.8458 0 0 18.0294 0 17.9877 0 0 0 0 0 18.2683 18.1795 0 0 0 0 0 0 0 18.568 18.7014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9248 0 0 0 17.4986 0 0 0 0 0 17.5214 0 0 0 18.2015 18.3001 0 0 0 0 11.9886 0 0 0 0 0 0 0 0 13.7746 0 12.0868 11.9211 0 12.4671 0 0 0 0 0 0 0 0 12.3543 0 0 0 0 0 0 0 0 11.7768 0 0 Q9BRC7 PLCD4_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4, hPLCD4, EC 3.1.4.11 (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4, PLC-delta-4)" PLCD4 Homo sapiens (Human) acrosome reaction [GO:0007340]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phospholipase C activity [GO:0004435]; acrosome reaction [GO:0007340]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; small GTPase mediated signal transduction [GO:0007264] GO:0001965; GO:0004435; GO:0005085; GO:0005509; GO:0005634; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0007340; GO:0016042; GO:0046488; GO:0048015 calcium ion binding [GO:0005509]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phospholipase C activity [GO:0004435] AQTLLIQVISGQQLPK 0.98461 -3.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4521 13.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15408 FOSL2_HUMAN "Fos-related antigen 2, FRA-2" FOSL2 FRA2 Homo sapiens (Human) cell death [GO:0008219]; keratinocyte development [GO:0003334]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell death [GO:0008219]; keratinocyte development [GO:0003334]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003334; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008219; GO:0045944; GO:0048146; GO:0090575 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" LAAAKCR 0.98462 -3.7745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N801 STPG4_HUMAN "Protein STPG4 (Gonad-specific expression gene protein, GSE) (Sperm-tail PG-rich repeat-containing protein 4)" STPG4 C2orf61 Homo sapiens (Human) C-5 methylation of cytosine [GO:0090116]; chromatin organization [GO:0006325]; DNA demethylation of male pronucleus [GO:0044727]; positive regulation of DNA demethylation [GO:1901537] cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male germ cell nucleus [GO:0001673]; male pronucleus [GO:0001940]; nucleus [GO:0005634] cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male germ cell nucleus [GO:0001673]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; C-5 methylation of cytosine [GO:0090116]; chromatin organization [GO:0006325]; DNA demethylation of male pronucleus [GO:0044727]; positive regulation of DNA demethylation [GO:1901537] GO:0001673; GO:0001939; GO:0001940; GO:0003682; GO:0005634; GO:0005737; GO:0006325; GO:0042393; GO:0042585; GO:0044727; GO:0090116; GO:1901537 chromatin binding [GO:0003682]; histone binding [GO:0042393] DKPRPSPSTLVDK 0.98462 -3.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9M5 TM102_HUMAN "Transmembrane protein 102 (Common beta-chain associated protein, CBAP)" TMEM102 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of cell adhesion [GO:0045785]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to cytokine [GO:0034097]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; apoptotic process [GO:0006915]; positive regulation of cell adhesion [GO:0045785]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to cytokine [GO:0034097]; signal transduction [GO:0007165] GO:0005739; GO:0005886; GO:0006915; GO:0007165; GO:0009986; GO:0010820; GO:0016021; GO:0032991; GO:0034097; GO:0042981; GO:0045785; GO:0050730; GO:1901028; GO:2000406 ARIPAPLLQAHAAAQALLRPLVAGTR 0.98462 -3.2694 0 0 0 0 0 0 0 11.6995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4079 12.0977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1768 0 0 0 18.8164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4513 0 18.6227 0 0 0 0 0 0 0 18.0919 0 0 15.3144 0 0 0 0 0 0 0 0 0 0 0 15.7056 0 0 11.9504 11.7933 0 0 0 0 0 0 0 0 0 0 0 0 14.018 0 0 0 0 13.1571 0 0 0 12.8071 11.0373 12.8748 13.2107 13.0688 0 13.1935 0 0 11.7838 0 0 0 0 0 13.413 0 0 0 0 Q92485 ASM3B_HUMAN "Acid sphingomyelinase-like phosphodiesterase 3b, ASM-like phosphodiesterase 3b, EC 3.1.4.-" SMPDL3B ASML3B ASMLPD Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]" GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0031225; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062 "hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]" HHRVIAGQFFGHHHTDSFR 0.98462 -3.2745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IF1 AJUBA_HUMAN LIM domain-containing protein ajuba AJUBA JUB Homo sapiens (Human) "calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell cycle [GO:0007049]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; glycerophospholipid biosynthetic process [GO:0046474]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lamellipodium assembly [GO:0030032]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of hippo signaling [GO:0035331]; negative regulation of kinase activity [GO:0033673]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of cellular response to hypoxia [GO:1900037]; regulation of GTPase activity [GO:0043087]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; wound healing, spreading of epidermal cells [GO:0035313]" adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] "adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; actin filament binding [GO:0051015]; alpha-catenin binding [GO:0045294]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell cycle [GO:0007049]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; glycerophospholipid biosynthetic process [GO:0046474]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lamellipodium assembly [GO:0030032]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of hippo signaling [GO:0035331]; negative regulation of kinase activity [GO:0033673]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of cellular response to hypoxia [GO:1900037]; regulation of GTPase activity [GO:0043087]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0000122; GO:0000932; GO:0001666; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005925; GO:0006355; GO:0007010; GO:0007049; GO:0007249; GO:0008104; GO:0016339; GO:0030027; GO:0030032; GO:0030334; GO:0031328; GO:0031334; GO:0033673; GO:0035195; GO:0035313; GO:0035331; GO:0043087; GO:0043123; GO:0043406; GO:0045294; GO:0046474; GO:0046872; GO:0048041; GO:0051015; GO:1900037; GO:2000637 actin filament binding [GO:0051015]; alpha-catenin binding [GO:0045294]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] DYHFECYHCEDCR 0.98462 -2.3353 0 0 13.6535 0 0 0 13.3055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.411 0 0 0 0 0 0 0 0 0 11.3924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8919 14.8112 13.4074 13.5868 0 13.6495 14.0861 17.2152 0 0 15.0801 13.3271 0 0 0 11.5492 0 0 0 0 0 11.9976 13.456 0 11.9692 0 0 13.5272 0 0 14.0071 0 0 0 14.3611 0 0 13.5751 0 0 0 0 0 14.1915 0 0 0 0 0 0 13.6321 0 14.005 13.4418 0 0 0 0 0 0 0 0 0 0 0 14.05 0 0 0 0 12.0885 13.4529 0 13.9399 0 0 0 0 0 12.9292 0 11.1475 0 0 0 13.267 0 0 0 0 0 0 0 0 0 0 0 0 11.1775 0 14.6801 0 0 0 0 0 0 0 Q99469 STAC_HUMAN SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein) STAC STAC1 Homo sapiens (Human) cellular response to heat [GO:0034605]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; T-tubule [GO:0030315] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; T-tubule [GO:0030315]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; cellular response to heat [GO:0034605]; positive regulation of cation channel activity [GO:2001259]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009] GO:0003009; GO:0005829; GO:0007165; GO:0030315; GO:0031234; GO:0034605; GO:0044325; GO:0046872; GO:1901387; GO:1903078; GO:2001259 metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325] EVMPIACGNKVDPVYETLR 0.98462 -3.7728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6216 0 0 0 0 0 0 0 0 0 0 12.2786 0 0 14.1963 12.7886 13.2818 13.7693 0 0 0 0 0 0 14.4227 0 13.1183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A3KFT3 OR2M5_HUMAN Olfactory receptor 2M5 OR2M5 OR2M5P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KVLGKGK 0.98463 -3.7023 0 0 0 0 0 0 0 0 11.8786 11.7154 11.5325 0 0 0 0 0 12.1964 12.3941 11.9108 0 12.2909 0 0 0 0 12.0025 0 0 0 0 0 11.1494 10.5741 0 0 0 0 0 0 0 0 0 12.1768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3935 0 0 0 12.6203 13.4726 0 12.1348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CW20 LIMS4_HUMAN LIM and senescent cell antigen-like-containing domain protein 4 (LIM and senescent cell antigen-like-containing domain protein 3-like) LIMS4 LIMS3L Homo sapiens (Human) cellular anatomical entity [GO:0110165] cellular anatomical entity [GO:0110165]; metal ion binding [GO:0046872] GO:0046872; GO:0110165 metal ion binding [GO:0046872] HSDVKVYKEFCDFYAK 0.98463 -3.7855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2153 0 0 0 0 0 0 12.7179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15104 GLNA_HUMAN "Glutamine synthetase, GS, EC 6.3.1.2 (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL, EC 2.3.1.225)" GLUL GLNS Homo sapiens (Human) "ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]" axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791] "axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; ammonia assimilation cycle [GO:0019676]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of insulin secretion [GO:0032024]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254]" GO:0000287; GO:0001525; GO:0004356; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005886; GO:0006538; GO:0006542; GO:0008283; GO:0009267; GO:0009749; GO:0010594; GO:0016595; GO:0018345; GO:0019676; GO:0019706; GO:0030145; GO:0032024; GO:0032991; GO:0042254; GO:0042802; GO:0043204; GO:0043209; GO:0043679; GO:0045503; GO:0050679; GO:0051968; GO:0070062; GO:0097386; GO:1903670; GO:1904749 ATP binding [GO:0005524]; dynein light chain binding [GO:0045503]; glutamate binding [GO:0016595]; glutamate-ammonia ligase activity [GO:0004356]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] LSKRHQYHIR 0.98463 -1.5047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8285 13.8673 0 0 0 14.7229 0 14.6611 0 14.4509 0 0 0 14.5814 13.9989 0 0 14.4036 0 0 0 0 0 0 13.1914 13.0579 0 13.8168 0 13.4257 13.4029 0 0 0 0 13.6787 0 13.6349 13.5402 0 0 0 0 0 0 13.4569 0 0 19.1443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46379 BAG6_HUMAN "Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6, BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe)" BAG6 BAT3 G3 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001822; GO:0002429; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0006620; GO:0006915; GO:0007130; GO:0007283; GO:0007420; GO:0010498; GO:0016020; GO:0018393; GO:0030101; GO:0030154; GO:0030324; GO:0030433; GO:0030544; GO:0031593; GO:0031625; GO:0031647; GO:0032435; GO:0042771; GO:0042802; GO:0043022; GO:0043066; GO:0043231; GO:0045861; GO:0045995; GO:0050821; GO:0051787; GO:0061857; GO:0070059; GO:0070062; GO:0070628; GO:0071712; GO:0071816; GO:0071818; GO:1904294; GO:1904378; GO:1904379; GO:1990381 Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381] LQVVLEHMPVGPDAILRYVR 0.98463 -3.0946 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9057 0 0 0 0 0 0 0 0 0 0 0 16.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0437 0 12.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52824 DGKQ_HUMAN "Diacylglycerol kinase theta, DAG kinase theta, DGKtheta, EC 2.7.1.107 (Diglyceride kinase theta, DGK-theta)" DGKQ DAGK4 Homo sapiens (Human) cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493] GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007186; GO:0007205; GO:0008277; GO:0010628; GO:0010629; GO:0010801; GO:0012506; GO:0016363; GO:0016607; GO:0018105; GO:0019900; GO:0019933; GO:0030168; GO:0030297; GO:0033198; GO:0035556; GO:0043274; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050731; GO:0051591; GO:0070161; GO:0070493; GO:0070528; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903432; GO:2000064; GO:2000182 ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; DNA-binding transcription factor binding [GO:0140297]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] ALPRAQEVLK 0.98463 -3.0926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2Q7 LRR70_HUMAN Leucine-rich repeat-containing protein 70 (Synleurin) LRRC70 UNQ1891/PRO4337 Homo sapiens (Human) positive regulation of response to cytokine stimulus [GO:0060760] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; positive regulation of response to cytokine stimulus [GO:0060760] GO:0005886; GO:0005887; GO:0060760 ILNLSFNNLTALHPRVLK 0.98463 -3.7769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6235 0 0 0 0 0 0 12.6751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7609 0 0 0 14.5555 0 0 0 14.3386 0 13.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5H1 PCDG2_HUMAN "Protocadherin gamma-A2, PCDH-gamma-A2" PCDHGA2 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] KSHLIFPQPNYADTLISQESCEKK 0.98463 -3.7794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7153 0 0 14.0519 0 13.6667 0 0 0 0 0 0 0 15.2035 0 0 0 13.9547 0 15.1748 0 0 0 13.3825 15.2293 15.34 15.7741 0 0 0 0 15.321 0 15.4435 0 0 0 0 0 0 0 0 0 0 0 0 14.5513 0 0 0 0 14.4071 14.5302 0 0 0 14.7462 0 0 0 0 0 0 0 13.8242 0 0 0 13.4822 0 0 0 0 0 0 0 0 0 0 14.1619 0 0 0 0 0 0 0 0 0 0 0 0 13.547 0 0 0 0 14.1206 0 0 0 0 0 0 0 Q6P3R8 NEK5_HUMAN "Serine/threonine-protein kinase Nek5, EC 2.7.11.1 (Never in mitosis A-related kinase 5, NimA-related protein kinase 5)" NEK5 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0046872; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DRPSINSILKR 0.98464 -3.7048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5859 0 0 0 0 0 12.9762 0 0 0 0 0 13.8907 0 0 0 0 0 0 13.1801 0 12.7688 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3491 0 0 0 0 0 11.1472 15.7301 0 0 0 0 14.2046 0 13.647 0 0 0 0 0 13.8614 14.4383 14.8893 0 14.1632 0 0 0 0 14.3123 14.5594 0 0 0 0 14.8656 0 0 0 12.7585 13.3613 13.6414 0 13.6954 12.7885 0 0 0 0 0 0 0 0 13.5836 14.537 0 0 15.3917 0 0 0 0 0 0 12.8394 0 0 0 0 0 0 15.2855 0 0 0 0 0 0 0 0 15.6421 0 0 0 0 0 15.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5395 0 0 0 0 0 0 0 12.0882 0 0 0 Q76LX8 ATS13_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 13, ADAM-TS 13, ADAM-TS13, ADAMTS-13, EC 3.4.24.87 (von Willebrand factor-cleaving protease, vWF-CP, vWF-cleaving protease)" ADAMTS13 C9orf8 UNQ6102/PRO20085 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; extracellular matrix organization [GO:0030198]; glycoprotein metabolic process [GO:0009100]; integrin-mediated signaling pathway [GO:0007229]; peptide catabolic process [GO:0043171]; platelet activation [GO:0030168]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amine [GO:0014075]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; extracellular matrix organization [GO:0030198]; glycoprotein metabolic process [GO:0009100]; integrin-mediated signaling pathway [GO:0007229]; peptide catabolic process [GO:0043171]; platelet activation [GO:0030168]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to amine [GO:0014075]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] GO:0004222; GO:0005178; GO:0005509; GO:0005615; GO:0005788; GO:0006508; GO:0007160; GO:0007229; GO:0008237; GO:0008270; GO:0009100; GO:0009636; GO:0009986; GO:0014075; GO:0016485; GO:0030163; GO:0030168; GO:0030198; GO:0031012; GO:0035864; GO:0043171; GO:0071222; GO:0071346; GO:0071353; GO:0071356 calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] CQVCGGDNSTCSPR 0.98464 -3.105 0 0 0 0 0 0 0 0 12.5339 0 0 0 0 12.9126 0 0 0 0 13.9277 13.6388 0 12.0764 0 0 0 0 0 12.7827 10.7265 0 0 0 0 0 0 0 0 0 12.0362 0 0 11.2224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6325 11.6755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1732 0 0 0 0 12.0103 0 0 0 0 0 12.265 0 0 0 12.101 13.0464 0 0 0 0 0 0 0 11.674 0 0 0 0 13.9948 0 0 0 0 0 0 0 0 0 0 0 11.8968 0 0 0 11.463 0 0 0 13.4444 0 0 0 0 0 12.3106 12.5061 0 12.0482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9093 0 0 14.2791 0 12.2478 14.2497 13.9048 0 0 16.8821 0 0 13.0494 14.4447 0 14.1585 0 0 0 13.704 12.1338 0 0 0 0 Q8N9P6 CI163_HUMAN Uncharacterized protein C9orf163 C9orf163 Homo sapiens (Human) EGVISVPR 0.98464 -2.7218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9612 0 0 0 0 14.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2159 0 0 0 0 15.8589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75525 KHDR3_HUMAN "KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein T-Star) (Sam68-like mammalian protein 2, SLM-2) (Sam68-like phosphotyrosine protein)" KHDRBS3 SALP SLM2 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0017124; GO:0019904; GO:0032991; GO:0042802; GO:0048024 identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124] GVYRDQPYGRY 0.98465 -2.7366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6402 0 0 0 14.6914 0 0 0 0 0 0 14.5055 13.0131 12.7067 0 0 0 0 0 13.5651 0 0 13.3708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0907 0 0 0 0 0 0 0 12.1232 0 0 0 0 0 0 0 14.8961 0 0 0 0 0 0 0 0 0 0 0 0 12.1539 0 0 0 0 0 15.0716 0 0 0 11.2531 0 Q6STE5 SMRD3_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 (60 kDa BRG-1/Brm-associated factor subunit C) (BRG1-associated factor 60C, BAF60C)" SMARCD3 BAF60C Homo sapiens (Human) "cardiac right ventricle formation [GO:0003219]; chromatin remodeling [GO:0006338]; muscle cell differentiation [GO:0042692]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein binding [GO:0043393]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]" brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]; cardiac right ventricle formation [GO:0003219]; chromatin remodeling [GO:0006338]; muscle cell differentiation [GO:0042692]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein binding [GO:0043393]; regulation of transcription by RNA polymerase II [GO:0006357]; secondary heart field specification [GO:0003139]" GO:0000785; GO:0001221; GO:0002052; GO:0003139; GO:0003219; GO:0003407; GO:0003712; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0030374; GO:0035060; GO:0042692; GO:0043393; GO:0045582; GO:0045597; GO:0045663; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140297; GO:2000045; GO:2000781; GO:2000819 DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221] ILPQRIR 0.98465 -1.5164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4C7 STX19_HUMAN Syntaxin-19 STX19 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0005484; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0008021; GO:0012505; GO:0016021; GO:0031201; GO:0031629; GO:0048278; GO:0048787 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] CKTFILR 0.98465 -1.516 0 0 0 0 13.2798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4404 14.5678 13.5481 14.0192 14.0333 0 0 0 12.3298 0 0 0 0 0 0 0 13.1433 0 0 13.1141 0 12.9482 0 0 0 0 0 0 0 0 0 13.5891 12.6483 0 0 13.4512 0 0 0 0 0 12.9671 0 0 12.6618 13.7096 0 12.6241 0 13.2167 0 13.2401 13.033 0 12.2426 0 12.6562 0 0 12.9384 13.5032 13.7378 13.3197 0 13.1021 0 13.4261 0 0 12.8006 12.36 0 0 13.6029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4662 0 0 13.4037 0 0 0 0 0 0 0 Q7Z572 SPT21_HUMAN Spermatogenesis-associated protein 21 SPATA21 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] KVLSILSRLK 0.98466 -3.0162 0 0 0 0 0 0 0 0 0 0 0 10.9021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63833 0 0 0 0 0 0 0 0 0 0 0 0 11.6571 0 0 10.3616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9589 0 0 0 0 0 11.0046 0 0 0 14.4298 0 0 0 0 0 0 0 14.3617 0 0 0 0 0 0 0 0 0 0 0 13.0254 0 0 0 0 0 12.0401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGX0 O11L1_HUMAN Olfactory receptor 11L1 OR11L1 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0070062 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] EAVRKVMR 0.98466 -3.018 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0327 0 0 0 0 0 0 0 0 0 11.3187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5376 13.317 13.4006 0 0 0 0 13.5719 13.9264 0 13.851 0 0 0 0 0 0 0 0 0 13.9793 0 0 13.5119 0 0 13.2959 0 0 0 0 0 0 0 0 0 0 13.2117 0 0 13.2835 0 0 0 0 0 13.1585 0 0 0 13.4774 13.2261 0 0 0 13.0272 0 0 13.9547 0 13.7146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8684 0 0 0 0 0 0 0 0 0 0 Q8WUR7 CO040_HUMAN UPF0235 protein C15orf40 C15orf40 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 GCVTIAIHAKPGSK 0.98466 -1.5349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZR5 ELOV4_HUMAN "Elongation of very long chain fatty acids protein 4, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4, ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4)" ELOVL4 Homo sapiens (Human) "fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176] "endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid biosynthetic process [GO:0006633]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" GO:0005783; GO:0006633; GO:0006636; GO:0008020; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0102337; GO:0102756 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; fatty acid elongase activity [GO:0009922]; G protein-coupled photoreceptor activity [GO:0008020]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756] GVEYLDTVFFILRK 0.98466 -3.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.537 0 0 0 12.1965 0 0 0 0 15.5895 0 0 0 0 0 0 0 15.7406 0 12.3727 0 0 0 0 0 0 0 13.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9924 0 0 0 0 0 0 0 0 0 0 11.3909 0 0 0 0 0 0 A0PJZ3 GXLT2_HUMAN "Glucoside xylosyltransferase 2, EC 2.4.2.42 (Glycosyltransferase 8 domain-containing protein 4)" GXYLT2 GLT8D4 Homo sapiens (Human) O-glycan processing [GO:0016266] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252]; O-glycan processing [GO:0016266]" GO:0016021; GO:0016266; GO:0035252; GO:0140563 "UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252]" AAALLLLALAALLLALLSLR 0.98467 -3.0225 0 0 0 0 9.65067 0 0 0 0 0 0 12.7068 0 0 0 0 0 11.4983 0 12.454 0 11.5662 0 12.8819 9.42211 0 0 0 12.4181 0 0 0 0 11.2318 12.8215 0 12.4659 0 0 0 0 0 0 0 0 0 0 0 12.4412 0 0 0 0 13.0264 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9836 0 0 0 15.8512 10.7329 0 0 0 12.1433 0 0 13.4035 12.8274 0 13.9633 14.4007 13.5153 14.3516 14.4038 13.6235 14.5263 11.3689 0 0 10.5728 0 0 0 0 12.8608 0 0 13.4663 13.2013 0 0 0 13.1898 0 13.2181 0 13.708 0 0 0 0 12.5093 13.0837 0 11.6111 0 0 14.1265 14.1094 11.0183 16.3432 0 0 11.4705 12.0279 15.0159 15.3498 12.2744 15.2006 0 0 0 0 11.8205 0 0 0 0 12.8721 11.6926 0 14.5587 0 15.0269 12.3639 0 14.1279 15.0717 10.3707 0 0 0 0 0 13.2305 13.3112 0 0 0 0 12.3794 11.7607 0 0 0 11.3657 12.371 0 16.2781 11.4872 16.1669 0 9.68585 0 13.3281 0 0 Q96T55 KCNKG_HUMAN "Potassium channel subfamily K member 16 (2P domain potassium channel Talk-1) (TWIK-related alkaline pH-activated K(+) channel 1, TALK-1)" KCNK16 TALK1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; stabilization of membrane potential [GO:0030322] GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0015271; GO:0022841; GO:0030322; GO:0034765; GO:0071805 outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] HYISVYR 0.98467 -3.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BX79 STRA6_HUMAN Receptor for retinol uptake STRA6 (Retinol-binding protein receptor STRA6) (Stimulated by retinoic acid gene 6 protein homolog) STRA6 PP14296 UNQ3126/PRO10282/PRO19578 Homo sapiens (Human) adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; response to retinoic acid [GO:0032526]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import into cell [GO:0071939]; vocal learning [GO:0042297] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023]; adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; response to retinoic acid [GO:0032526]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import into cell [GO:0071939]; vocal learning [GO:0042297] GO:0001568; GO:0001822; GO:0003184; GO:0003281; GO:0005886; GO:0005887; GO:0007507; GO:0007612; GO:0007631; GO:0016918; GO:0019841; GO:0030324; GO:0030325; GO:0030540; GO:0032526; GO:0032991; GO:0034632; GO:0034633; GO:0038023; GO:0042297; GO:0043010; GO:0043583; GO:0043585; GO:0048286; GO:0048520; GO:0048546; GO:0048566; GO:0048589; GO:0048745; GO:0048844; GO:0050890; GO:0050905; GO:0060322; GO:0060323; GO:0060325; GO:0060426; GO:0060539; GO:0060900; GO:0061029; GO:0061038; GO:0061143; GO:0061156; GO:0061205; GO:0071939; GO:0097070 retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023] QEVVELVK 0.98468 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2598 0 11.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6967 0 0 12.9469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14415 AT1B2_HUMAN "Sodium/potassium-transporting ATPase subunit beta-2 (Adhesion molecule in glia, AMOG) (Sodium/potassium-dependent ATPase subunit beta-2)" ATP1B2 Homo sapiens (Human) cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-substrate adhesion [GO:0031589]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; lateral ventricle development [GO:0021670]; membrane repolarization [GO:0086009]; motor behavior [GO:0061744]; negative regulation of glial cell migration [GO:1903976]; neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration [GO:0021944]; photoreceptor cell maintenance [GO:0045494]; plasma membrane bounded cell projection organization [GO:0120036]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein stabilization [GO:0050821]; retina homeostasis [GO:0001895]; sodium ion export across plasma membrane [GO:0036376]; third ventricle development [GO:0021678]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; astrocyte projection [GO:0097449]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890] apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; astrocyte projection [GO:0097449]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-substrate adhesion [GO:0031589]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; lateral ventricle development [GO:0021670]; membrane repolarization [GO:0086009]; motor behavior [GO:0061744]; negative regulation of glial cell migration [GO:1903976]; neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration [GO:0021944]; photoreceptor cell maintenance [GO:0045494]; plasma membrane bounded cell projection organization [GO:0120036]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein stabilization [GO:0050821]; retina homeostasis [GO:0001895]; sodium ion export across plasma membrane [GO:0036376]; third ventricle development [GO:0021678]; transport across blood-brain barrier [GO:0150104] GO:0001671; GO:0001895; GO:0001917; GO:0005737; GO:0005886; GO:0005890; GO:0006883; GO:0009897; GO:0010976; GO:0016020; GO:0016324; GO:0016328; GO:0021670; GO:0021678; GO:0021944; GO:0030007; GO:0030674; GO:0031253; GO:0031589; GO:0032781; GO:0036376; GO:0044298; GO:0045494; GO:0046982; GO:0050821; GO:0051117; GO:0061744; GO:0071944; GO:0086009; GO:0086064; GO:0097449; GO:0097450; GO:0098984; GO:0120036; GO:0150104; GO:1901018; GO:1903278; GO:1903288; GO:1903976; GO:1990573 ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674] FAGRVAFK 0.98469 -3.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6926 0 0 0 0 0 0 0 0 0 0 0 0 11.9772 0 0 0 0 0 13.6761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3869 0 0 14.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1D5 CF107_HUMAN Cilia- and flagella-associated protein 107 CFAP107 C1orf158 Homo sapiens (Human) axonemal microtubule [GO:0005879] axonemal microtubule [GO:0005879] GO:0005879 QRQLTPK 0.98469 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96F86 EDC3_HUMAN "Enhancer of mRNA-decapping protein 3 (LSM16 homolog) (YjeF N-terminal domain-containing protein 2, YjeF_N2, hYjeF_N2) (YjeF domain-containing protein 1)" EDC3 LSM16 YJDC YJEFN2 PP844 Homo sapiens (Human) deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; P-body assembly [GO:0033962] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; P-body [GO:0000932] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; P-body [GO:0000932]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; P-body assembly [GO:0033962] GO:0000932; GO:0003729; GO:0005829; GO:0016020; GO:0031087; GO:0033962; GO:0036464; GO:0042802 identical protein binding [GO:0042802]; mRNA binding [GO:0003729] HNSWSSSSR 0.98469 -3.0512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3366 0 0 0 0 0 0 0 0 0 0 0 0 17.7012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JXX5 CK094_HUMAN Uncharacterized protein C11orf94 C11orf94 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AGLSLFLHLILAVALLRSQPLR 0.9847 -2.5392 0 0 0 0 0 0 0 0 0 0 11.3105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8537 13.2684 13.9527 0 0 0 0 11.9006 0 0 0 0 0 13.1361 0 0 0 0 0 0 0 0 0 13.1373 0 0 0 0 0 12.0382 0 0 0 0 0 0 0 13.1572 0 12.8614 0 0 13.5511 0 13.09 0 12.899 12.81 0 12.2889 0 0 0 0 0 11.8593 0 0 0 0 0 13.0993 12.8538 0 12.8473 0 0 0 0 15.3146 0 0 0 12.4379 0 0 0 0 0 12.8962 0 0 0 0 0 0 0 0 0 12.9475 0 0 0 0 0 0 11.1898 P18433 PTPRA_HUMAN "Receptor-type tyrosine-protein phosphatase alpha, Protein-tyrosine phosphatase alpha, R-PTP-alpha, EC 3.1.3.48" PTPRA PTPA PTPRL2 Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0005925; GO:0006468; GO:0006470; GO:0007229; GO:0008286; GO:0016020; GO:0043235; GO:0050804; GO:0051893; GO:0070062; GO:0098685; GO:0099699 protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] DLLVTNTR 0.9847 -2.9563 0 0 0 14.4662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.999 0 0 0 0 0 13.7 10.9246 0 0 0 0 0 12.0177 0 0 0 0 0 0 0 0 15.6787 0 0 15.9579 15.828 0 0 0 0 15.8598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2954 11.7962 0 0 0 0 0 0 0 0 0 0 0 0 15.4884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1015 0 0 0 0 0 0 0 0 12.3656 0 12.8965 0 0 0 0 17.7268 0 13.038 0 0 0 0 0 0 0 0 0 0 0 0 17.8004 0 0 0 0 0 12.5802 0 0 0 0 0 0 11.0545 11.5085 12.8176 0 0 0 0 10.8144 0 0 0 P25791 RBTN2_HUMAN "Rhombotin-2 (Cysteine-rich protein TTG-2) (LIM domain only protein 2, LMO-2) (T-cell translocation protein 2)" LMO2 RBTN2 RBTNL1 RHOM2 TTG2 Homo sapiens (Human) cellular response to thyroid hormone stimulus [GO:0097067]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; cellular response to thyroid hormone stimulus [GO:0097067]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001221; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0042802; GO:0043425; GO:0045944; GO:0046872; GO:0061629; GO:0097067; GO:0140297 bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221] MSSAIER 0.9847 -1.4845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6392 0 0 0 0 0 13.8444 0 0 0 14.2583 13.1067 13.9561 0 0 0 0 13.7441 12.803 13.1108 0 0 0 13.0958 12.925 0 0 0 0 12.1522 0 13.7943 0 0 0 0 0 0 13.3761 0 13.3989 0 0 13.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0P670 SPEM2_HUMAN Uncharacterized protein SPEM2 SPEM2 C17orf74 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CCNHQQRPQNYRQIPHSHSVFR 0.9847 -2.9543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4018 0 0 0 0 15.0644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16533 SNPC1_HUMAN "snRNA-activating protein complex subunit 1, SNAPc subunit 1 (Proximal sequence element-binding transcription factor subunit gamma, PSE-binding factor subunit gamma, PTF subunit gamma) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit, SNAPc 43 kDa subunit)" SNAPC1 SNAP43 Homo sapiens (Human) snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; snRNA-activating protein complex [GO:0019185]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; sequence-specific DNA binding [GO:0043565]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] GO:0000995; GO:0005654; GO:0005730; GO:0016251; GO:0019185; GO:0042795; GO:0042796; GO:0043565 RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; sequence-specific DNA binding [GO:0043565] FEDFTELWRNMK 0.9847 -1.4795 0 0 0 0 0 0 0 0 0 0 0 0 12.5273 0 0 0 0 0 12.8486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7681 0 0 0 0 13.3368 0 0 0 0 0 0 0 0 0 15.0213 14.3342 11.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9235 0 0 0 0 0 0 0 0 0 0 0 14.2499 0 0 0 0 0 0 0 0 0 0 Q7KYR7 BT2A1_HUMAN Butyrophilin subfamily 2 member A1 BTN2A1 BT2.1 BTF1 Homo sapiens (Human) lipid metabolic process [GO:0006629]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; lipid metabolic process [GO:0006629]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0005102; GO:0005886; GO:0005887; GO:0006629; GO:0009897; GO:0050852 signaling receptor binding [GO:0005102] ESFASGK 0.9847 -2.9556 0 0 0 0 0 0 0 0 0 0 0 0 12.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.61 0 0 0 13.4784 0 13.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 14.047 0 0 Q8NFZ3 NLGNY_HUMAN "Neuroligin-4, Y-linked, Neuroligin Y" NLGN4Y KIAA0951 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625] "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]" "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; chemical synaptic transmission [GO:0007268]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]" GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007612; GO:0009986; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0050804; GO:0050839; GO:0070161; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098839; GO:0098983; GO:0098985; GO:0099054; GO:0099060 cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] DQLYLHIGLKPRVR 0.9847 -1.4802 0 0 0 0 0 0 0 10.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4718 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1Y0 ATG5_HUMAN Autophagy protein 5 (APG5-like) (Apoptosis-specific protein) ATG5 APG5L ASP Homo sapiens (Human) aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chaperone-mediated autophagy [GO:0061684]; establishment of localization in cell [GO:0051649]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; mucus secretion [GO:0070254]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; blood vessel remodeling [GO:0001974]; C-terminal protein lipidation [GO:0006501]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chaperone-mediated autophagy [GO:0061684]; establishment of localization in cell [GO:0051649]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; mucus secretion [GO:0070254]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of defense response to virus [GO:0050687]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015] GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005737; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006995; GO:0009410; GO:0009620; GO:0010040; GO:0010659; GO:0010667; GO:0016020; GO:0016236; GO:0016567; GO:0019883; GO:0030424; GO:0030670; GO:0031397; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0035973; GO:0039689; GO:0042311; GO:0043687; GO:0044233; GO:0044804; GO:0045060; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0051649; GO:0055015; GO:0060047; GO:0060548; GO:0061684; GO:0061739; GO:0070254; GO:0070257; GO:0071500; GO:1901096; GO:1902017; GO:1902617; GO:1904973; GO:2000378; GO:2000619 IYQTTTERPFIQKLFR 0.9847 -1.4819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7119 0 0 0 0 14.216 0 Q14957 NMDE3_HUMAN "Glutamate receptor ionotropic, NMDA 2C, GluN2C (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C, NMDAR2C, NR2C)" GRIN2C NMDAR2C Homo sapiens (Human) brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; long-term synaptic potentiation [GO:0060291]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; protein localization to postsynaptic membrane [GO:1903539]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611] anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; long-term synaptic potentiation [GO:0060291]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; protein localization to postsynaptic membrane [GO:1903539]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611] GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007215; GO:0007420; GO:0009611; GO:0015276; GO:0017146; GO:0022849; GO:0033058; GO:0038023; GO:0042177; GO:0045211; GO:0048167; GO:0048168; GO:0050885; GO:0060079; GO:0060291; GO:0070161; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:1903539; GO:1904315 glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ARTQRLLR 0.98471 -1.4878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6421 0 0 0 0 0 12.8973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6026 0 0 0 0 12.9261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5646 0 0 13.3468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXN9 WDR82_HUMAN WD repeat-containing protein 82 WDR82 SWD2 TMEM113 WDR82A UNQ9342/PRO34047 Homo sapiens (Human) "DNA-templated transcription, termination [GO:0006353]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; lncRNA catabolic process [GO:0110064]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of lncRNA transcription [GO:0140744]; nuclear RNA surveillance [GO:0071027]" chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188] "chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; DNA-templated transcription, termination [GO:0006353]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; lncRNA catabolic process [GO:0110064]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of lncRNA transcription [GO:0140744]; nuclear RNA surveillance [GO:0071027]" GO:0000785; GO:0003682; GO:0005730; GO:0006353; GO:0032785; GO:0035097; GO:0048188; GO:0051568; GO:0071027; GO:0072357; GO:0080182; GO:0110064; GO:0140744 chromatin binding [GO:0003682] LILISTNGSFIR 0.98471 -3.771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7H5 PAF1_HUMAN "RNA polymerase II-associated factor 1 homolog, hPAF1 (Pancreatic differentiation protein 2)" PAF1 PD2 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] GO:0000122; GO:0000993; GO:0001711; GO:0003682; GO:0005654; GO:0005737; GO:0006368; GO:0006378; GO:0010390; GO:0016020; GO:0016055; GO:0016593; GO:0019827; GO:0030054; GO:0031062; GO:0031442; GO:0033523; GO:0034504; GO:0045638; GO:0071222; GO:1902808 chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993] AARDKEEIFGSDADSEDDADSDDEDR 0.98471 -3.2618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3066 0 11.1601 9.82977 0 12.5062 0 0 0 0 10.6422 0 12.4016 0 0 10.7185 0 0 0 0 9.89095 0 0 11.2509 0 0 9.715 0 0 0 0 0 0 11.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8969 12.4281 0 0 0 0 0 13.8968 15.3768 0 0 0 0 0 0 0 14.1145 0 0 15.3577 13.2295 0 13.0354 14.8561 0 0 14.949 0 15.7697 16.9395 16.0173 0 0 14.7398 0 0 15.5822 0 0 0 0 0 15.4917 13.1828 0 0 0 0 0 0 13.1721 0 0 14.8055 0 11.2046 13.1632 0 0 9.82515 0 0 0 12.2848 0 0 0 0 0 0 0 13.2566 12.4277 0 0 0 0 0 0 0 0 0 0 0 12.589 0 14.3559 0 0 11.7405 0 0 12.82 0 13.7458 0 11.4652 0 0 0 0 0 0 0 0 0 0 0 0 12.8763 0 0 Q96F45 ZN503_HUMAN Zinc finger protein 503 ZNF503 NOLZ1 Homo sapiens (Human) "G1 to G0 transition involved in cell differentiation [GO:0070315]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neural precursor cell proliferation [GO:0061351]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; G1 to G0 transition involved in cell differentiation [GO:0070315]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neural precursor cell proliferation [GO:0061351]" GO:0005634; GO:0008285; GO:0010629; GO:0045892; GO:0046872; GO:0061351; GO:0070315 metal ion binding [GO:0046872] LPIKVLK 0.98471 -1.5454 0 0 0 0 0 0 0 0 18.9588 18.9976 18.9807 19.0348 19.0206 19.0738 19.0655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8856 19.1422 19.0409 19.2083 0 19.1194 11.9123 19.0785 11.7972 19.1027 19.147 11.8493 19.1765 0 11.6554 0 0 12.2844 11.5134 19.1983 0 0 0 0 0 0 17.6594 17.792 17.4672 17.5345 0 0 0 0 0 16.257 17.6368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.735 20.0638 0 0 19.9611 19.1868 18.3844 19.0233 19.1192 0 0 13.5846 13.6637 13.7128 0 0 0 0 0 0 0 0 0 Q96SL8 FIZ1_HUMAN Flt3-interacting zinc finger protein 1 (Zinc finger protein 798) FIZ1 ZNF798 Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468] GO:0000785; GO:0001934; GO:0003713; GO:0005634; GO:0005737; GO:0006468; GO:0030971; GO:0045944; GO:0046872; GO:0061629 metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] FDHGRELAAHWAAHTDVK 0.98471 -2.5446 0 0 0 0 13.2331 12.8373 14.3098 13.2627 0 11.3151 12.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.069 12.1209 0 0 0 0 0 12.6515 0 0 0 0 0 13.0904 13.9302 0 14.2742 0 0 0 0 0 0 13.0729 0 12.6168 0 14.113 0 0 12.2947 12.6346 12.112 0 16.5155 0 0 13.1516 0 0 12.2983 13.6945 13.5841 0 0 0 13.0182 0 0 0 13.3362 14.5427 13.368 13.4666 13.588 14.3675 13.9213 13.967 13.8091 13.6505 13.8264 13.6414 0 0 0 0 14.2998 0 0 0 15.2833 0 17.1901 13.915 13.3716 0 10.9015 0 0 0 12.1795 0 10.7746 0 11.7112 0 0 13.7715 0 13.6796 0 12.8075 0 0 0 0 0 0 0 13.5355 13.8209 0 0 0 0 0 13.006 0 0 0 0 0 0 Q9H9P2 CHODL_HUMAN Chondrolectin (Transmembrane protein MT75) CHODL C21orf68 PRED12 UNQ872/PRO1890 Homo sapiens (Human) muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of axonogenesis [GO:0050772] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of axonogenesis [GO:0050772] GO:0005737; GO:0005789; GO:0005813; GO:0005829; GO:0007399; GO:0007517; GO:0016021; GO:0030246; GO:0048471; GO:0050772 carbohydrate binding [GO:0030246] KESGMEV 0.98471 -2.5442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1311 0 0 0 0 0 0 0 0 0 0 13.1727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX46 ADPRS_HUMAN "ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3, EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3, EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase, EC 3.2.2.-)" ADPRS ADPRHL2 ARH3 Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290]" cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; base-excision repair, gap-filling [GO:0006287]; cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290]" GO:0000287; GO:0004553; GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0006281; GO:0006287; GO:0016604; GO:0060546; GO:0061463; GO:0071451; GO:0090734; GO:0140290; GO:0140292 "ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]" ALVQSLLAKEAFDEVDMAHRFAQEYK 0.98471 -2.1732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9832 12.4163 0 0 12.8884 0 0 0 0 0 0 12.4505 0 0 0 0 0 0 0 0 0 0 0 0 0 12.992 0 0 0 0 0 0 0 11.9334 0 0 0 0 0 0 0 0 0 0 14.3427 0 0 0 0 0 0 0 0 0 11.7273 0 0 0 0 0 0 11.6464 0 0 0 0 0 11.3194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPP2 IQEC3_HUMAN IQ motif and SEC7 domain-containing protein 3 IQSEC3 KIAA1110 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] anchoring junction [GO:0070161]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629] anchoring junction [GO:0070161]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] GO:0005085; GO:0005654; GO:0005829; GO:0014069; GO:0030036; GO:0032012; GO:0045211; GO:0060077; GO:0070161; GO:0098690; GO:0098982; GO:0099629 guanyl-nucleotide exchange factor activity [GO:0005085] ELVVGIYERIQQKELK 0.98471 -1.4874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.278 0 0 0 13.8326 13.6411 0 0 0 13.2322 0 0 0 0 0 12.823 0 0 0 0 13.1304 0 0 0 0 0 0 0 0 12.8781 0 0 10.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6839 12.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1398 0 0 0 14.6683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6839 0 0 P0C874 S31D3_HUMAN Spermatogenesis-associated protein 31D3 (Protein FAM75D3) SPATA31D3 FAM75D3 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 DPLPPQPVSPLDSK 0.98472 -3.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2635 0 0 0 0 14.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4283 0 0 0 0 0 11.9904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2584 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8027 0 0 0 P12319 FCERA_HUMAN "High affinity immunoglobulin epsilon receptor subunit alpha (Fc-epsilon RI-alpha, FcERI) (IgE Fc receptor subunit alpha)" FCER1A FCE1A Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; regulation of immune response [GO:0050776] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; IgE binding [GO:0019863]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; regulation of immune response [GO:0050776] GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0009986; GO:0019863; GO:0050776 IgE binding [GO:0019863]; transmembrane signaling receptor activity [GO:0004888] GFRLLNPHPK 0.98472 -2.3326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9186 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8638 0 0 0 13.6381 13.7836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7289 14.4255 0 0 0 13.341 0 0 13.1303 0 0 0 0 0 0 0 0 0 0 0 12.6789 0 0 14.2009 0 0 12.6702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HYK3 COQ5_HUMAN "2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial, EC 2.1.1.201 (Ubiquinone biosynthesis methyltransferase COQ5)" COQ5 Homo sapiens (Human) methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142] "extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ubiquinone biosynthesis complex [GO:0110142]; 2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0043430]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]" GO:0005743; GO:0005759; GO:0006744; GO:0008168; GO:0031314; GO:0032259; GO:0032991; GO:0043333; GO:0043430; GO:0110142 "2-decaprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0043430]; 2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity [GO:0043333]; methyltransferase activity [GO:0008168]" DMIEDAGFHK 0.98472 -3.7768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.851 0 0 0 0 0 0 0 0 0 0 13.4887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BY9 SARAF_HUMAN "Store-operated calcium entry-associated regulatory factor, SARAF, SOCE-associated regulatory factor (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66)" SARAF TMEM66 XTP3 HSPC035 NPD003 PSEC0019 UNQ1967/PRO4499 Homo sapiens (Human) calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion transport [GO:0006816]; regulation of store-operated calcium entry [GO:2001256] GO:0005783; GO:0006816; GO:0030176; GO:0140268; GO:2001256 ALTLHYDRYTTSRR 0.98472 -2.3307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0162 0 0 0 12.5664 0 0 0 0 0 14.0069 0 0 0 0 0 0 0 10.4786 0 14.1965 0 0 0 0 13.3534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5201 13.5875 0 0 0 13.0329 0 0 12.8999 12.4875 0 0 0 0 0 0 0 0 0 0 12.2196 0 0 0 0 13.045 0 0 0 11.7194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6995 12.933 13.6573 0 0 0 0 0 0 Q9BQ67 GRWD1_HUMAN Glutamate-rich WD repeat-containing protein 1 GRWD1 GRWD KIAA1942 WDR28 Homo sapiens (Human) DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; ribosome biogenesis [GO:0042254] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; ribosome biogenesis [GO:0042254] GO:0003682; GO:0003688; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006260; GO:0006334; GO:0006337; GO:0032991; GO:0042254; GO:0042393 chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; RNA binding [GO:0003723] MHNLHGTK 0.98472 -2.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.7811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6195 13.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4732 0 13.7939 13.9568 0 0 0 0 0 0 0 0 0 0 0 14.6682 0 0 0 0 0 0 0 0 0 0 0 0 13.8732 0 0 0 0 11.2416 14.3808 0 0 0 0 0 0 0 0 0 11.7233 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6V7 DDX49_HUMAN "Probable ATP-dependent RNA helicase DDX49, EC 3.6.4.13 (DEAD box protein 49)" DDX49 Homo sapiens (Human) positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0006364; GO:0016887; GO:0030307; GO:0044357 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] EKVEETLK 0.98472 -1.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0464 0 0 0 0 0 0 0 11.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15509 CSF2R_HUMAN "Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, GM-CSF-R-alpha, GMCSFR-alpha, GMR-alpha (CDw116) (CD antigen CD116)" CSF2RA CSF2R CSF2RY Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; positive regulation of leukocyte proliferation [GO:0070665]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023]; cytokine-mediated signaling pathway [GO:0019221]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; positive regulation of leukocyte proliferation [GO:0070665]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259] GO:0004896; GO:0005576; GO:0005886; GO:0005887; GO:0006468; GO:0007259; GO:0009897; GO:0019221; GO:0019955; GO:0030526; GO:0038023; GO:0038157; GO:0043235; GO:0070665 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023] EEVLTVKEIT 0.98473 -3.2752 0 0 11.6417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.916 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P84090 ERH_HUMAN Enhancer of rudimentary homolog ERH Homo sapiens (Human) cell cycle [GO:0007049]; nucleobase-containing compound metabolic process [GO:0006139]; pyrimidine nucleoside metabolic process [GO:0006213] methylosome [GO:0034709]; midbody [GO:0030496]; nucleus [GO:0005634] methylosome [GO:0034709]; midbody [GO:0030496]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; nucleobase-containing compound metabolic process [GO:0006139]; pyrimidine nucleoside metabolic process [GO:0006213] GO:0003723; GO:0005634; GO:0006139; GO:0006213; GO:0007049; GO:0008327; GO:0030496; GO:0034709 methyl-CpG binding [GO:0008327]; RNA binding [GO:0003723] ADTQTYQPYNK 0.98473 -3.7854 0 0 0 0 0 0 0 0 0 0 14.7098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2814 0 0 0 11.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0091 0 0 0 0 0 0 0 0 0 0 0 11.6951 0 13.0337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1845 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13956 CNCG_HUMAN "Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma, GMP-PDE gamma, EC 3.1.4.35" PDE6H Homo sapiens (Human) positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601] photoreceptor outer segment membrane [GO:0042622] "photoreceptor outer segment membrane [GO:0042622]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of MAPK cascade [GO:0043410]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" GO:0004857; GO:0007601; GO:0030553; GO:0042622; GO:0043410; GO:0045742; GO:0045745; GO:0047555; GO:0050896 "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; enzyme inhibitor activity [GO:0004857]" KGPPKFK 0.98473 -3.7835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9682 0 0 0 0 Q8IVN8 SBSPO_HUMAN Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin) SBSPON C8orf84 RPESP Homo sapiens (Human) collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] GO:0005576; GO:0062023 ACPARPCFVGEWSPWSGCADQCKPTTR 0.98473 -3.0921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7172 12.6382 0 0 0 0 0 0 0 0 Q96AN5 TM143_HUMAN Transmembrane protein 143 TMEM143 UNQ5922/PRO19813 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] GO:0005739; GO:0016021 LPPAERR 0.98473 -3.0923 0 0 0 0 0 0 0 0 0 0 0 0 12.6093 0 0 0 0 0 0 0 12.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1631 0 0 0 12.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.761 0 0 13.8618 0 0 0 14.9183 13.9079 0 0 0 0 0 0 0 0 14.4533 0 0 0 0 0 16.458 12.2461 0 14.7033 0 0 0 14.3722 14.791 14.346 0 14.0049 0 0 0 0 14.1536 0 14.4045 13.9533 13.9862 13.9032 0 14.498 14.8919 14.7768 14.7662 14.1795 13.4822 13.9749 14.3686 0 0 0 0 0 0 14.0029 0 14.9614 14.7391 0 0 13.7279 0 0 0 0 0 0 0 0 0 0 11.8567 0 0 0 14.2374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0916 0 0 0 0 0 0 0 0 Q99676 ZN184_HUMAN Zinc finger protein 184 ZNF184 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AFRHCSSLAQHQK 0.98473 -3.7019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3887 0 0 0 0 0 0 0 0 0 0 10.2088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8987 0 0 0 0 0 0 0 11.3165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1057 0 0 0 0 0 0 0 0 0 14.0108 12.7435 0 0 0 0 0 11.102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9184 0 0 0 0 0 13.6947 14.4696 0 0 0 0 0 0 0 0 0 0 12.5308 0 0 0 0 0 0 14.3475 0 0 0 0 0 0 Q9NYJ7 DLL3_HUMAN "Delta-like protein 3 (Drosophila Delta homolog 3, Delta3)" DLL3 Homo sapiens (Human) cell differentiation [GO:0030154]; compartment pattern specification [GO:0007386]; negative regulation of neurogenesis [GO:0050768]; Notch signaling pathway [GO:0007219]; paraxial mesoderm development [GO:0048339]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; cell differentiation [GO:0030154]; compartment pattern specification [GO:0007386]; negative regulation of neurogenesis [GO:0050768]; Notch signaling pathway [GO:0007219]; paraxial mesoderm development [GO:0048339]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756] GO:0001501; GO:0001756; GO:0005112; GO:0005509; GO:0007219; GO:0007386; GO:0016021; GO:0030154; GO:0048339; GO:0050768 calcium ion binding [GO:0005509]; Notch binding [GO:0005112] ACANGGTCVEGGGAHRCSCALGFGGRDCR 0.98473 -3.2774 0 0 0 0 0 0 0 0 0 0 0 11.7081 0 0 0 0 0 0 11.2816 0 11.1255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0484 0 0 0 0 0 0 0 0 14.9053 0 12.8709 13.0146 14.8651 15.3865 12.3179 12.6485 0 0 0 0 0 16.0451 13.272 0 12.9909 0 0 0 0 0 0 0 0 0 12.4416 0 14.4426 13.9775 10.9397 0 15.3051 13.3817 11.3245 14.9721 13.7799 0 0 12.9786 0 0 0 0 15.6067 0 0 0 0 0 13.8461 0 15.3974 15.4353 0 0 0 15.9132 0 14.6259 0 0 13.8549 0 12.3834 0 0 14.5316 0 15.5436 0 10.4002 12.2829 0 0 0 0 0 14.7003 0 0 0 0 0 0 0 14.0404 0 0 0 0 12.0782 0 0 0 13.0612 0 13.2936 12.2016 14.3562 0 11.6812 0 0 0 Q9UKQ2 ADA28_HUMAN "Disintegrin and metalloproteinase domain-containing protein 28, ADAM 28, EC 3.4.24.- (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II, eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L, MDC-L)" ADAM28 ADAM23 MDCL Homo sapiens (Human) proteolysis [GO:0006508]; spermatogenesis [GO:0007283] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] GO:0004175; GO:0004222; GO:0005576; GO:0005739; GO:0005886; GO:0006508; GO:0007283; GO:0008237; GO:0016021; GO:0046872 endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] ATFQCALGECCEK 0.98473 -1.4958 0 0 0 0 0 0 13.2712 0 0 0 0 0 0 12.0684 0 0 0 0 13.4814 0 10.247 0 12.2298 0 0 0 0 12.793 0 10.4401 0 0 0 0 0 0 0 0 0 10.5295 0 0 0 0 13.6298 0 0 10.2695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0301 15.9684 0 0 0 0 0 0 0 0 0 11.5262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6882 0 0 12.8014 0 0 0 0 0 0 0 0 0 11.2274 0 0 13.3029 0 0 0 0 0 11.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7871 0 0 0 0 0 11.9518 0 0 10.7538 0 0 0 11.5913 0 0 12.9489 13.1021 0 13.8296 0 13.7051 0 0 0 0 0 0 0 13.6353 0 0 Q9Y303 NAGA_HUMAN "N-acetylglucosamine-6-phosphate deacetylase, GlcNAc 6-P deacetylase, EC 3.5.1.25 (Amidohydrolase domain-containing protein 2)" AMDHD2 CGI-14 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] GO:0005634; GO:0005829; GO:0005975; GO:0006046; GO:0006048; GO:0008448; GO:0019262; GO:0046872; GO:0047419 metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448] SHEVIRALTAR 0.98473 -3.091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75575 RPC9_HUMAN "DNA-directed RNA polymerase III subunit RPC9, RNA polymerase III subunit C9 (Calcitonin gene-related peptide-receptor component protein, CGRP-RCP, CGRP-receptor component protein, CGRPRCP, HsC17)" CRCP Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuropeptide signaling pathway [GO:0007218]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; DNA polymerase III complex [GO:0009360]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase III complex [GO:0005666] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; DNA polymerase III complex [GO:0009360]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase III complex [GO:0005666]; calcitonin gene-related peptide receptor activity [GO:0001635]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuropeptide signaling pathway [GO:0007218]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384] GO:0000166; GO:0001635; GO:0001669; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0005886; GO:0006383; GO:0006384; GO:0007218; GO:0009360; GO:0045087; GO:0051607 calcitonin gene-related peptide receptor activity [GO:0001635]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166] AEKLQLLNHR 0.98474 -3.1034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17022 ZNF18_HUMAN Zinc finger protein 18 (Heart development-specific gene 1 protein) (Zinc finger protein 535) (Zinc finger protein KOX11) (Zinc finger protein with KRAB and SCAN domains 6) ZNF18 HDSG1 KOX11 ZKSCAN6 ZNF535 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AEDSQFSESDAALQEELSSPETAR 0.98474 -1.5044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1681 0 0 14.3144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4204 0 0 0 0 0 0 13.5929 13.9077 0 13.9315 0 0 0 0 0 11.8102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SI9 CEI_HUMAN Protein CEI (Coordinated expression to IRXA2 protein) C5orf38 CEI Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 ALRFVLSK 0.98474 -2.7203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8585 0 0 0 0 0 0 0 0 0 17.5062 0 0 0 0 0 14.2161 13.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6791 0 16.7175 0 0 0 13.709 0 0 0 0 0 0 0 0 0 0 0 0 16.6945 0 0 0 0 13.7679 13.5861 0 0 14.6634 0 0 0 13.7715 0 16.7263 0 0 0 0 0 0 16.1345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0587 0 0 0 0 0 0 0 Q8N8X9 MB213_HUMAN Protein mab-21-like 3 MAB21L3 C1orf161 Homo sapiens (Human) CFQVMRHLKEDIWCPGNR 0.98474 -2.3451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG41 NPB_HUMAN "Neuropeptide B (Preproprotein L7, hPPL7) [Cleaved into: Neuropeptide B-23, NPB23, hL7; Neuropeptide B-29, NPB29, hL7C ]" NPB PPL7 PPNPB Homo sapiens (Human) feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] GO:0001664; GO:0005576; GO:0007186; GO:0007218; GO:0007631 G protein-coupled receptor binding [GO:0001664] AADCLAA 0.98474 -3.1001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZI1 IRX2_HUMAN Iroquois-class homeodomain protein IRX-2 (Homeodomain protein IRXA2) (Iroquois homeobox protein 2) IRX2 IRXA2 Homo sapiens (Human) cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell development [GO:0048468]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; proximal/distal pattern formation involved in metanephric nephron development [GO:0072272]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of loop of Henle identity [GO:0072086]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0030182; GO:0043565; GO:0048468; GO:0072086; GO:0072272 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" AGDPLCESGSECKDK 0.98474 3.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7692 0 0 0 0 0 0 0 0 0 0 0 0 10.7773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3424 0 0 0 0 0 11.5392 0 0 0 0 0 13.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3391 0 0 0 0 0 14.2033 14.1518 0 0 12.2482 0 0 0 0 0 0 0 10.4245 0 0 0 0 11.1584 0 0 0 12.2631 0 0 0 10.4983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6137 0 0 10.7386 0 11.2355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5623 0 0 0 0 0 0 0 0 0 0 0 0 0 11.865 P62081 RS7_HUMAN 40S ribosomal protein S7 (Small ribosomal subunit protein eS7) RPS7 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural crest cell differentiation [GO:0014033]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural crest cell differentiation [GO:0014033]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0001843; GO:0002181; GO:0003723; GO:0003730; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0010628; GO:0014033; GO:0016020; GO:0019901; GO:0022626; GO:0022627; GO:0032040; GO:0032991; GO:0042274; GO:0045202; GO:0048027; GO:0050821; GO:1902255; GO:1904667; GO:1990904; GO:1990948; GO:2000059 mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] AIIIFVPVPQLK 0.98476 -3.0156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6787 12.2094 0 0 0 0 0 0 0 0 0 0 0 12.1189 0 0 0 0 0 0 0 0 0 12.4601 0 0 0 0 0 0 0 10.8877 0 0 0 0 0 0 0 0 12.1556 0 0 0 0 0 0 0 0 0 0 0 13.1291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.73196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.18306 0 0 0 10.5626 0 Q6PML9 ZNT9_HUMAN "Zinc transporter 9, ZnT-9 (Human embryonic lung protein, HuEL) (Solute carrier family 30 member 9)" SLC30A9 C4orf1 HUEL Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; cellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; zinc ion transport [GO:0006829] GO:0003682; GO:0005634; GO:0005783; GO:0005856; GO:0006289; GO:0006829; GO:0006882; GO:0008324; GO:0016021; GO:0016922; GO:0030374; GO:0031410; GO:0045944 cation transmembrane transporter activity [GO:0008324]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374] CRAAACNPSDR 0.98476 -2.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5775 0 0 10.5713 0 0 0 10.8813 0 0 0 12.2883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7271 0 0 0 0 0 0 0 0 0 0 0 0 11.7842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8747 0 0 0 0 0 0 0 0 0 0 0 0 12.0586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8012 0 0 0 0 0 Q86Z23 C1QL4_HUMAN "Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11, C1q/TNF-related protein 11)" C1QL4 CTRP11 Homo sapiens (Human) ERK1 and ERK2 cascade [GO:0070371]; fibroblast proliferation [GO:0048144]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147] collagen trimer [GO:0005581]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast proliferation [GO:0048144]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147] GO:0005581; GO:0005615; GO:0042802; GO:0045599; GO:0048144; GO:0048147; GO:0070371; GO:0070373 identical protein binding [GO:0042802] CRMVCDPHGPR 0.98476 -2.1297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.19795 0 0 0 0 0 0 0 0 0 0 0 0 9.58193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3221 0 0 0 0 0 11.577 0 0 0 0 0 0 0 0 0 11.1671 0 11.2491 0 12.59 0 0 0 0 0 0 0 0 13.0881 0 0 0 10.7855 0 10.3194 0 0 12.6505 0 13.2926 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4876 0 13.4305 0 0 0 0 13.3562 0 12.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFJ8 BHE22_HUMAN "Class E basic helix-loop-helix protein 22, bHLHe22 (Class B basic helix-loop-helix protein 5, bHLHb5) (Trinucleotide repeat-containing gene 20 protein)" BHLHE22 BHLHB5 TNRC20 Homo sapiens (Human) neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0046983; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ALRLNINAR 0.98476 -2.1285 0 0 0 9.44386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0341 0 0 0 0 10.3348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8495 0 0 0 10.7023 11.1292 0 0 0 0 0 0 0 0 0 0 0 14.768 0 0 0 0 0 0 0 0 0 0 12.7175 0 0 0 0 0 0 13.1813 0 0 11.3983 0 0 0 13.4093 0 0 0 0 0 0 0 0 12.4931 0 0 0 0 0 0 0 0 12.7589 0 0 12.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0267 0 13.3849 0 0 0 0 E9PAV3 NACAM_HUMAN "Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form, skNAC)" NACA Homo sapiens (Human) protein targeting to membrane [GO:0006612] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; DNA binding [GO:0003677]; unfolded protein binding [GO:0051082]; protein targeting to membrane [GO:0006612] GO:0003677; GO:0005634; GO:0005737; GO:0005854; GO:0006612; GO:0051082 DNA binding [GO:0003677]; unfolded protein binding [GO:0051082] AKQSRSEK 0.98477 -2.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4867 0 0 16.9347 0 0 0 15.5081 0 16.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2478 0 0 0 0 14.7286 0 0 0 0 15.9883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9726 0 0 0 0 0 0 0 0 0 0 13.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6661 0 0 0 11.094 0 0 0 10.7436 0 0 0 0 11.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14155 ARHG7_HUMAN Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85) ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 Homo sapiens (Human) ephrin receptor signaling pathway [GO:0048013]; focal adhesion assembly [GO:0048041]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; negative regulation of microtubule nucleation [GO:1905833]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of GTPase activity [GO:0043547]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; gamma-tubulin binding [GO:0043015]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; ephrin receptor signaling pathway [GO:0048013]; focal adhesion assembly [GO:0048041]; Golgi organization [GO:0007030]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; negative regulation of microtubule nucleation [GO:1905833]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of GTPase activity [GO:0043547]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of GTP binding [GO:1904424]; signal transduction [GO:0007165] GO:0001726; GO:0005085; GO:0005737; GO:0005813; GO:0005829; GO:0005925; GO:0005938; GO:0007030; GO:0007165; GO:0007399; GO:0010763; GO:0019901; GO:0030027; GO:0030032; GO:0032991; GO:0035556; GO:0043005; GO:0043015; GO:0043025; GO:0043065; GO:0043547; GO:0048013; GO:0048041; GO:0097431; GO:0098794; GO:1900026; GO:1904424; GO:1905833; GO:2000394 gamma-tubulin binding [GO:0043015]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901] KELELQILTEAIRNWEGDDIK 0.98477 -1.5301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4325 0 0 0 0 0 0 0 0 0 0 17.9206 0 17.4414 17.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1934 0 0 0 0 0 0 0 13.6028 0 15.3699 0 0 0 0 0 12.8833 0 0 0 13.4345 0 15.0265 14.7264 13.5861 0 0 13.1902 11.2055 0 14.3493 0 15.2293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1623 0 10.6449 0 0 0 0 13.262 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3274 0 0 0 14.8866 0 0 0 14.2227 0 0 0 13.5689 0 0 0 13.1082 0 0 17.9768 0 0 20.5646 0 0 0 0 0 17.1424 0 0 O43508 TNF12_HUMAN "Tumor necrosis factor ligand superfamily member 12 (APO3 ligand) (TNF-related weak inducer of apoptosis, TWEAK) [Cleaved into: Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form ]" TNFSF12 APO3L DR3LG UNQ181/PRO207 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; endothelial cell migration [GO:0043542]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein catabolic process [GO:0045732]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; endothelial cell migration [GO:0043542]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein catabolic process [GO:0045732]; signal transduction [GO:0007165] GO:0001525; GO:0001938; GO:0005102; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0006915; GO:0006955; GO:0007165; GO:0030154; GO:0043542; GO:0045732; GO:0045766; GO:0048018; GO:0048471; GO:0097190; GO:0097191; GO:2001238 cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] AVYLKLDLLVDGVLALR 0.98478 -1.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6669 0 0 0 0 13.2239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1858 0 0 0 14.0579 13.999 14.013 13.9411 13.8974 13.7983 13.9457 0 0 0 0 15.4468 0 0 0 0 0 13.7491 13.6677 0 14.168 0 13.7005 13.9567 0 14.7526 0 14.3233 0 0 0 14.016 13.6984 14.1809 14.2944 0 0 0 14.2567 14.1832 0 14.3527 0 0 0 14.688 0 0 0 14.7294 0 14.0408 0 0 0 0 0 0 0 0 0 14.506 0 0 0 0 19.6521 0 0 0 14.433 0 0 0 0 0 0 0 0 0 14.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2936 0 0 0 0 0 0 0 0 P61421 VA0D1_HUMAN "V-type proton ATPase subunit d 1, V-ATPase subunit d 1 (32 kDa accessory protein) (V-ATPase 40 kDa accessory protein) (V-ATPase AC39 subunit, p39) (Vacuolar proton pump subunit d 1)" ATP6V0D1 ATP6D VPATPD Homo sapiens (Human) brain development [GO:0007420]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034] "apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; protein-containing complex binding [GO:0044877]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; brain development [GO:0007420]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]" GO:0000220; GO:0005765; GO:0005769; GO:0006879; GO:0007034; GO:0007035; GO:0007420; GO:0008021; GO:0010008; GO:0016020; GO:0016241; GO:0016324; GO:0016471; GO:0030665; GO:0030670; GO:0033181; GO:0036295; GO:0043679; GO:0044877; GO:0046961; GO:0060271; GO:0070062; GO:1902600 "protein-containing complex binding [GO:0044877]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" SIAELVPK 0.98478 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5996 0 0 0 0 0 0 14.9502 0 14.7068 15.2064 0 0 0 0 0 0 0 0 15.0968 0 0 0 14.9464 0 0 0 15.0726 0 14.6751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3719 0 0 18.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGD2 OR4K2_HUMAN Olfactory receptor 4K2 (Olfactory receptor OR14-15) OR4K2 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] HHSSRGSSK 0.98478 -1.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7912 12.4856 0 11.6905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8617 0 0 0 0 0 0 Q9UFV1 TBC29_HUMAN Putative TBC1 domain family member 29 TBC1D29P TBC1D29 Homo sapiens (Human) SLYEETNK 0.98478 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H8 ZN510_HUMAN Zinc finger protein 510 ZNF510 KIAA0972 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" KAILSDHQR 0.98478 -2.7553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4867 0 0 0 0 0 0 0 13.8522 0 0 12.7736 0 0 0 0 0 0 0 14.8777 13.5731 0 0 13.0653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9422 0 13.0918 13.0437 12.6818 13.5051 0 0 0 0 0 0 15.0372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1948 13.139 0 0 0 0 0 0 0 0 11.7668 0 0 13.2399 0 0 0 0 0 0 0 0 14.705 0 0 9.98157 0 14.7088 0 0 0 0 0 14.2075 13.3099 0 0 0 0 0 0 0 Q5VU57 CBPC6_HUMAN "Cytosolic carboxypeptidase 6, EC 3.4.17.24 (ATP/GTP-binding protein-like 4) (Protein deglutamylase CCP6)" AGBL4 CCP6 Homo sapiens (Human) anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958] GO:0004181; GO:0005794; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0008285; GO:0015631; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607; GO:0098957; GO:0098958; GO:0120222; GO:1904115; GO:2000060 metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] EEDIYQFAYCYPYTYTRFQHYLDSLQKR 0.98479 -2.9533 12.9235 0 13.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7555 0 0 16.5302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4707 0 0 0 0 11.85 0 0 0 0 0 0 14.4672 0 0 10.6187 0 0 0 13.9538 12.6034 Q8IWE4 DCNL3_HUMAN "DCN1-like protein 3, DCNL3 (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3) (Squamous cell carcinoma-related oncogene 3)" DCUN1D3 SCCRO3 Homo sapiens (Human) negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225] GO:0000151; GO:0005634; GO:0005737; GO:0005886; GO:0010225; GO:0010332; GO:0010564; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0051443; GO:0097602; GO:2000134; GO:2000434; GO:2000435; GO:2000436 cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182] EIAIALWK 0.98479 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92979 NEP1_HUMAN "Ribosomal RNA small subunit methyltransferase NEP1, EC 2.1.1.- (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)" EMG1 C2F Homo sapiens (Human) blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364] GO:0001824; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006364; GO:0017126; GO:0019843; GO:0032040; GO:0042274; GO:0042802; GO:0070037; GO:0070475 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843] ERSGGEQAQDWDALPPKR 0.98479 -2.1493 0 0 0 0 0 0 0 0 11.8584 0 0 13.2716 13.5541 0 0 0 0 0 11.131 0 0 0 0 0 0 0 11.8772 0 0 0 0 0 0 0 0 0 0 0 0 11.2773 0 0 0 0 0 11.9619 0 10.9703 0 0 10.8704 0 11.5123 11.0765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9709 12.9956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4594 0 0 13.3872 0 0 0 0 0 0 0 0 0 0 0 12.8546 0 13.3192 13.3276 0 0 0 0 0 0 0 12.797 0 0 0 0 0 0 0 0 0 0 0 10.9443 0 13.2251 0 0 0 0 0 0 0 0 13.6357 0 0 13.2344 0 0 13.3828 14.2677 13.2802 14.6992 15.0355 13.1134 14.5594 0 13.3958 0 13.2238 12.6827 12.2672 12.8311 0 13.4528 0 14.0578 Q9BZC1 CELF4_HUMAN "CUGBP Elav-like family member 4, CELF-4 (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4)" CELF4 BRUNOL4 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; embryo development ending in birth or egg hatching [GO:0009792]; excitatory postsynaptic potential [GO:0060079]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; mRNA splice site selection [GO:0006376]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of retina development in camera-type eye [GO:1902866]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; embryo development ending in birth or egg hatching [GO:0009792]; excitatory postsynaptic potential [GO:0060079]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; mRNA splice site selection [GO:0006376]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of retina development in camera-type eye [GO:1902866]" GO:0000380; GO:0000381; GO:0000900; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0007281; GO:0009792; GO:0036002; GO:0042835; GO:0048025; GO:0048026; GO:0060079; GO:0090394; GO:0098794; GO:1902866; GO:1990904 BRE binding [GO:0042835]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] LFIGQIPR 0.98479 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4114 12.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3607 17.3863 0 14.8134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4209 0 0 0 0 0 14.9802 0 0 15.0138 0 0 0 0 0 0 0 0 0 15.3105 14.9267 0 0 0 0 0 0 0 0 15.0395 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7085 0 18.0858 0 0 0 0 0 0 14.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSD7 RL3R1_HUMAN "Relaxin-3 receptor 1, RLN3 receptor 1 (G protein-coupled receptor SALPR) (G-protein coupled receptor GPCR135) (Relaxin family peptide receptor 3) (Somatostatin- and angiotensin-like peptide receptor)" RXFP3 GPCR135 RLN3R1 SALPR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytokinesis [GO:0032467] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007218; GO:0008528; GO:0032467 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930] ALCVWIWALAALASLPSAIFSTTVK 0.98479 -3.0502 0 0 0 0 0 0 0 0 0 0 13.2607 0 0 0 11.8407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7878 12.6036 11.685 0 0 0 0 0 12.6193 12.3368 0 0 0 0 0 0 0 0 12.982 0 0 0 0 0 0 0 0 11.4544 0 0 0 13.5881 0 0 0 0 0 13.7684 0 0 0 0 0 0 0 0 13.5008 0 0 12.8208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5287 0 0 15.8512 14.1154 0 0 0 0 0 0 0 Q01955 CO4A3_HUMAN Collagen alpha-3(IV) chain (Goodpasture antigen) [Cleaved into: Tumstatin ] COL4A3 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; response to glucose [GO:0009749]; sensory perception of sound [GO:0007605] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; structural molecule activity [GO:0005198]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endothelial cell apoptotic process [GO:0072577]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; response to glucose [GO:0009749]; sensory perception of sound [GO:0007605] GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005783; GO:0005788; GO:0006919; GO:0007155; GO:0007166; GO:0007605; GO:0008015; GO:0008191; GO:0008285; GO:0009749; GO:0016525; GO:0030020; GO:0030198; GO:0031012; GO:0032836; GO:0038063; GO:0043231; GO:0062023; GO:0072577; GO:1905563 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metalloendopeptidase inhibitor activity [GO:0008191]; structural molecule activity [GO:0005198] DKGQCFCDGAK 0.9848 -2.9542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7826 0 14.5838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0914 0 0 0 0 0 14.6944 0 0 15.9388 0 0 0 0 0 0 13.9693 0 0 0 13.4023 0 0 14.9198 0 0 0 12.2996 14.7795 0 0 14.8491 0 0 0 0 0 0 0 0 0 14.5085 0 0 0 0 14.1485 0 14.7869 14.1854 0 13.6976 0 10.7819 14.5319 13.6303 0 0 14.6374 0 13.6218 0 0 16.9117 0 15.1336 0 13.8445 0 0 13.2518 0 0 0 0 0 0 0 0 0 14.6489 0 14.1622 17.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4134 16.4029 14.0061 14 0 0 0 0 0 Q8IZL9 CDK20_HUMAN "Cyclin-dependent kinase 20, EC 2.7.11.22 (CDK-activating kinase p42, CAK-kinase p42) (Cell cycle-related kinase) (Cell division protein kinase 20) (Cyclin-dependent protein kinase H) (Cyclin-kinase-activating kinase p42)" CDK20 CCRK CDCH Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic skeletal system development [GO:0048706]; floor plate formation [GO:0021508]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; protein phosphorylation [GO:0006468]; regulation of protein maturation [GO:1903317]; roof of mouth development [GO:0060021] cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; cell cycle [GO:0007049]; cell division [GO:0051301]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic skeletal system development [GO:0048706]; floor plate formation [GO:0021508]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; protein phosphorylation [GO:0006468]; regulation of protein maturation [GO:1903317]; roof of mouth development [GO:0060021] GO:0001843; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005929; GO:0006468; GO:0007049; GO:0021508; GO:0031076; GO:0048706; GO:0051301; GO:0060021; GO:0061512; GO:0106310; GO:1901621; GO:1903317; GO:1990403 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] HVETGEIVALKKVALR 0.9848 -3.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0587 0 0 0 0 0 0 0 0 0 11.2577 0 0 0 0 0 0 0 0 13.3188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWV3 CDAC1_HUMAN "Cytidine and dCMP deaminase domain-containing protein 1, EC 3.5.4.5 (Cytidine deaminase) (Testis development protein NYD-SP15)" CDADC1 Homo sapiens (Human) cytidine deamination [GO:0009972]; DNA cytosine deamination [GO:0070383] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytidine deaminase activity [GO:0004126]; importin-alpha family protein binding [GO:0061676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; DNA cytosine deamination [GO:0070383] GO:0004126; GO:0005634; GO:0005737; GO:0008270; GO:0009972; GO:0042803; GO:0061676; GO:0070383 cytidine deaminase activity [GO:0004126]; importin-alpha family protein binding [GO:0061676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] ADISYMR 0.9848 -2.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6 12.1595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2622 0 0 0 0 0 0 0 13.6926 0 13.7559 0 0 14.6915 0 13.4906 0 0 14.9386 0 0 14.5289 0 0 0 0 15.0777 0 14.9898 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4366 0 0 0 0 14.2872 0 15.3486 0 0 0 0 0 0 0 0 0 0 0 0 12.001 0 0 0 0 0 0 15.3451 0 0 0 0 0 0 0 12.0815 14.1079 0 0 0 0 0 0 0 0 16.4636 0 0 0 0 18.0491 0 0 0 0 0 0 0 11.5379 0 0 0 0 0 0 0 15.2463 0 0 0 17.7157 0 Q9NYK5 RM39_HUMAN "39S ribosomal protein L39, mitochondrial, L39mt, MRP-L39 (39S ribosomal protein L5, mitochondrial, L5mt, MRP-L5) (Mitochondrial large ribosomal subunit protein mL39)" MRPL39 C21orf92 MRPL5 RPML5 MSTP003 PRED22 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543] GO:0000166; GO:0003723; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 nucleotide binding [GO:0000166]; RNA binding [GO:0003723] ALRLWLVAPGGGIKWR 0.9848 -2.5374 0 0 0 0 0 0 0 0 14.7288 15.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0756 0 0 13.2681 0 0 0 13.7618 0 0 13.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1661 0 0 0 13.3907 0 0 0 0 0 13.9458 0 0 0 0 0 0 0 0 0 0 13.9322 0 0 Q9Y2J2 E41L3_HUMAN "Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1, DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed ]" EPB41L3 DAL1 KIAA0987 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cytoskeletal protein-membrane anchor activity [GO:0106006]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360] GO:0001558; GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006915; GO:0008360; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659; GO:0106006 actin binding [GO:0003779]; cytoskeletal protein-membrane anchor activity [GO:0106006]; structural constituent of cytoskeleton [GO:0005200] AAKRLWK 0.9848 -2.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4818 0 0 13.388 10.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7102 0 0 0 0 0 0 0 0 0 0 0 14.2855 13.2616 13.0134 13.1496 11.5838 0 0 0 16.7078 0 0 13.0958 0 0 0 0 0 0 13.3945 16.7791 13.2105 12.8305 0 0 0 0 12.9528 0 13.1009 0 0 13.4493 0 0 0 0 16.2006 0 15.9955 0 0 0 0 0 0 0 13.0682 0 13.1045 0 13.2148 0 14.1458 0 0 13.9453 13.1054 0 12.8126 0 0 0 12.4442 0 0 0 12.8644 0 0 0 0 0 14.0385 0 0 0 0 15.3343 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0307 10.2388 0 0 0 12.0753 0 0 0 0 P55197 AF10_HUMAN Protein AF-10 (ALL1-fused gene from chromosome 10 protein) MLLT10 AF10 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0031491; GO:0032991; GO:0042393; GO:0045944; GO:0046872 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491] CELCPHK 0.98481 -3.2612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0179 0 11.3587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0507 0 12.7369 12.3712 12.1905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2929 0 0 0 0 0 13.7293 0 0 0 0 0 0 0 0 0 0 0 0 11.7809 0 0 0 0 0 14.0558 0 14.9799 0 0 0 0 0 14.2702 0 0 0 0 10.9073 0 0 14.2319 0 13.0555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99677 LPAR4_HUMAN "Lysophosphatidic acid receptor 4, LPA receptor 4, LPA-4 (G-protein coupled receptor 23) (P2Y purinoceptor 9, P2Y9) (P2Y5-like receptor) (Purinergic receptor 9)" LPAR4 GPR23 LPA4 P2RY9 Homo sapiens (Human) positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0004930; GO:0005886; GO:0005887; GO:0016604; GO:0035025; GO:0035727; GO:0043231; GO:0051482; GO:0070915 G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid binding [GO:0035727]; lysophosphatidic acid receptor activity [GO:0070915] IFYNFNR 0.98481 -3.2616 0 0 0 0 0 0 13.0344 0 0 0 0 0 0 14.0493 0 0 0 0 0 0 0 0 0 0 0 0 12.6021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NEY8 PRXD1_HUMAN Putative prolyl-tRNA synthetase associated domain-containing protein 1 (PrdX deacylase domain-containing protein 1) (Prolyl-tRNA synthetase associated domain-containing protein 1 pseudogene) PRORSD1P NCRNA00117 PRDXDD1P Homo sapiens (Human) aminoacyl-tRNA editing activity [GO:0002161] GO:0002161 aminoacyl-tRNA editing activity [GO:0002161] NLFLKDKK 0.98482 -2.7041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75069 TMCC2_HUMAN Transmembrane and coiled-coil domains protein 2 (Cerebral protein 11) TMCC2 KIAA0481 hucep-11 Homo sapiens (Human) amyloid precursor protein metabolic process [GO:0042982] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; amyloid precursor protein metabolic process [GO:0042982] GO:0005783; GO:0005789; GO:0012505; GO:0016021; GO:0042982 AAIDHLHQKILKITEQIK 0.98482 -1.4855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2574 0 0 0 0 0 0 12.5127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3028 0 0 0 0 0 0 0 0 0 0 18.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9712 0 0 0 0 0 11.357 0 0 0 P0CB38 PAB4L_HUMAN "Polyadenylate-binding protein 4-like, PABP-4-like, Poly(A)-binding protein 4-like" PABPC4L Homo sapiens (Human) cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] ALDTMNFDIIK 0.98482 -2.7086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5658 0 0 12.5249 0 0 0 0 0 11.8748 11.5701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.711 0 12.5321 14.1836 0 0 0 0 0 12.3922 14.5265 14.4081 0 13.2818 11.0327 0 11.0053 0 0 0 0 0 0 0 0 14.0798 0 10.6633 0 0 0 0 0 0 0 0 0 0 0 0 12.449 0 0 10.7129 18.4588 0 14.873 13.9351 0 0 0 0 13.1952 0 0 0 10.2189 0 0 0 0 11.2327 0 0 0 0 0 0 13.9948 0 0 0 0 12.786 0 0 0 0 0 0 0 14.0199 0 0 0 0 0 0 0 17.4755 0 0 0 0 16.9956 0 0 0 0 0 0 0 19.1822 0 17.7904 0 16.55 0 0 0 14.0423 0 0 13.7701 0 14.6841 0 0 12.0581 0 0 0 0 12.9316 0 0 0 0 P13521 SCG2_HUMAN "Secretogranin-2 (Chromogranin-C) (Secretogranin II, SgII) [Cleaved into: Secretoneurin, SN; Manserin ]" SCG2 CHGC Homo sapiens (Human) angiogenesis [GO:0001525]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; protein secretion [GO:0009306] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; angiogenesis [GO:0001525]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; protein secretion [GO:0009306] GO:0000165; GO:0001525; GO:0001937; GO:0001938; GO:0005125; GO:0005615; GO:0005788; GO:0006954; GO:0009306; GO:0030141; GO:0035556; GO:0042056; GO:0043542; GO:0048245; GO:0050918; GO:0050930; GO:0098992; GO:2000352; GO:2001237 chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125] ATRLFEKPLDSQSIYQLIEISR 0.98482 -2.1707 0 0 0 0 0 0 0 0 0 0 0 0 12.1876 0 0 0 0 0 0 0 0 0 0 0 14.6025 0 12.6885 0 0 0 0 0 0 12.7891 0 12.754 0 0 10.4547 0 0 0 0 0 0 0 0 0 0 12.9664 14.8231 0 13.3879 13.6291 0 13.8767 0 0 0 0 0 0 0 0 0 12.6776 0 0 0 0 0 0 11.0208 0 0 0 0 0 12.5243 0 0 0 14.1879 12.6897 0 0 0 14.0212 0 13.6693 13.8473 13.6693 13.5319 13.2442 12.999 0 0 0 13.5583 0 0 0 0 0 0 0 0 18.2164 12.9809 0 0 0 0 13.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5577 0 0 0 0 0 0 0 0 0 0 0 0 13.7706 0 0 0 0 13.4826 13.2664 0 0 0 12.847 13.8525 0 0 0 0 0 0 0 13.0883 14.279 0 0 0 0 0 0 0 14.229 0 13.7334 0 0 Q5H9T9 FSCB_HUMAN Fibrous sheath CABYR-binding protein FSCB C14orf155 Homo sapiens (Human) negative regulation of protein sumoylation [GO:0033234] sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228] sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]; calcium ion binding [GO:0005509]; negative regulation of protein sumoylation [GO:0033234] GO:0005509; GO:0033234; GO:0035686; GO:0097228 calcium ion binding [GO:0005509] KHMAIPK 0.98482 -2.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2697 14.0863 0 0 0 0 0 0 0 0 0 0 0 0 16.4325 0 16.6957 0 17.3728 17.359 17.0089 14.5548 0 14.5886 0 16.7998 0 0 0 0 0 0 0 0 0 0 14.6975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96R45 OR2A7_HUMAN Olfactory receptor 2A7 (Olfactory receptor OR7-18) OR2A7 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] VLGVERAL 0.98482 -2.1721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6388 14.3264 0 14.3925 0 0 0 14.245 0 13.9084 0 0 13.8025 0 0 0 0 0 0 0 0 0 14.0148 0 0 14.3904 0 14.2383 12.8614 0 13.981 0 14.558 0 0 14.5625 0 0 0 0 12.7066 14.2223 14.1195 13.9592 0 0 0 13.7104 0 0 14.3318 14.0017 0 0 0 0 14.2007 0 0 0 0 0 0 0 14.3662 0 14.0615 0 0 0 0 0 0 0 0 0 0 0 12.097 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5V0 ZN706_HUMAN Zinc finger protein 706 ZNF706 HSPC038 PNAS-113 Homo sapiens (Human) "negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of translation [GO:0006417]" GO:0005634; GO:0005737; GO:0006417; GO:0045892; GO:0046872; GO:1902455 metal ion binding [GO:0046872] MARGQQK 0.98482 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6G3 RM42_HUMAN "39S ribosomal protein L42, mitochondrial, L42mt, MRP-L42 (39S ribosomal protein L31, mitochondrial, L31mt, MRP-L31) (Mitochondrial large ribosomal subunit protein mL42)" MRPL42 MRPL31 MRPS32 RPML31 HSPC204 PTD007 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0005763; GO:0005886; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] CRKNLNPPK 0.98482 -3.7018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7581 0 0 0 0 0 0 0 0 0 0 0 12.1898 0 0 12.7802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2694 0 0 0 0 0 0 0 0 12.3346 0 0 0 0 13.0092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6337 14.2499 14.1734 0 0 0 0 12.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96013 PAK4_HUMAN "Serine/threonine-protein kinase PAK 4, EC 2.7.11.1 (p21-activated kinase 4, PAK-4)" PAK4 KIAA1142 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; cytoskeleton organization [GO:0007010]; dendritic spine development [GO:0060996]; intracellular signal transduction [GO:0035556]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; cadherin binding involved in cell-cell adhesion [GO:0098641]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; cytoskeleton organization [GO:0007010]; dendritic spine development [GO:0060996]; intracellular signal transduction [GO:0035556]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] GO:0001558; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005912; GO:0005925; GO:0006468; GO:0006915; GO:0007010; GO:0007049; GO:0007165; GO:0016477; GO:0035556; GO:0043408; GO:0045766; GO:0060996; GO:0071407; GO:0098641; GO:0106310; GO:2000352 ATP binding [GO:0005524]; cadherin binding involved in cell-cell adhesion [GO:0098641]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DNLPPRLK 0.98483 -3.2788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62987 RL40_HUMAN Ubiquitin-60S ribosomal protein L40 (CEP52) (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (Large ribosomal subunit protein eL40) ] UBA52 UBCEP2 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; cytoplasmic translation [GO:0002181]; modification-dependent protein catabolic process [GO:0019941]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; translation [GO:0006412] GO:0002181; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005741; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006412; GO:0010008; GO:0016567; GO:0019941; GO:0022625; GO:0022626; GO:0022627; GO:0030666; GO:0031386; GO:0031625; GO:0031982; GO:0036211; GO:0070062 protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625] CYARLHPRAVNCR 0.98483 -3.7901 0 0 0 0 0 0 0 0 13.1022 0 0 0 0 12.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6548 0 0 0 0 12.6872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0042 0 14.0839 0 0 0 13.6509 0 0 0 0 0 0 0 0 14.1193 0 0 17.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9125 0 0 15.2707 0 0 0 0 0 0 0 0 0 0 0 0 12.4825 0 12.5179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7761 0 0 0 0 0 Q6PIF2 SYCE2_HUMAN Synaptonemal complex central element protein 2 (Central element synaptonemal complex protein 1) SYCE2 CESC1 Homo sapiens (Human) cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694]; nucleoplasm [GO:0005654] central element [GO:0000801]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130] GO:0000801; GO:0005654; GO:0005694; GO:0007130; GO:0051301 IIQEKLQEFTQK 0.98483 -1.4865 0 0 0 0 0 0 0 0 0 0 0 0 10.8542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTP7 FAP24_HUMAN Fanconi anemia core complex-associated protein 24 (Fanconi anemia-associated protein of 24 kDa) FAAP24 C19orf40 Homo sapiens (Human) interstrand cross-link repair [GO:0036297] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297] GO:0000785; GO:0003677; GO:0003682; GO:0005654; GO:0036297; GO:0043231; GO:0043240; GO:0071821 chromatin binding [GO:0003682]; DNA binding [GO:0003677] EPSKNPLLGKK 0.98483 -3.0905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8549 0 0 0 0 0 0 0 14.3255 0 0 0 15.3056 14.031 14.3252 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8094 0 0 0 0 0 0 0 0 0 Q9Y3E7 CHMP3_HUMAN "Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24, hVps24)" CHMP3 CGI149 NEDF VPS24 CGI-149 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of cytokinesis [GO:0032467]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of endosome size [GO:0051036]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] "amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin-specific protease binding [GO:1990381]; apoptotic process [GO:0006915]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of cytokinesis [GO:0032467]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of endosome size [GO:0051036]; regulation of mitotic spindle assembly [GO:1901673]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076]" GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005546; GO:0005643; GO:0005765; GO:0005769; GO:0005770; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006915; GO:0006997; GO:0007080; GO:0010824; GO:0015031; GO:0016236; GO:0019076; GO:0030496; GO:0031210; GO:0031410; GO:0031468; GO:0032467; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0042802; GO:0043162; GO:0044790; GO:0045324; GO:0046761; GO:0051036; GO:0051258; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904930; GO:1990381; GO:2000641 "identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ubiquitin-specific protease binding [GO:1990381]" EMRVVDRQIR 0.98483 -1.4903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4135 0 0 0 A6NP11 ZN716_HUMAN Zinc finger protein 716 ZNF716 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKSFNCSSTLTR 0.98484 -2.7198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9281 0 0 0 0 0 11.1624 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6647 0 0 0 0 0 0 13.5728 0 0 0 0 0 0 0 0 0 0 10.705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75940 SPF30_HUMAN Survival of motor neuron-related-splicing factor 30 (30 kDa splicing factor SMNrp) (SMN-related protein) (Survival motor neuron domain-containing protein 1) SMNDC1 SMNR SPF30 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]" Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0006915; GO:0015030; GO:0016607 RNA binding [GO:0003723] AQRIKELEQER 0.98484 -1.4958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNZ2 NSF1C_HUMAN NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47) NSFL1C UBXN2C Homo sapiens (Human) autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730]; lipid binding [GO:0008289]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0000045; GO:0000132; GO:0005634; GO:0005694; GO:0005737; GO:0005795; GO:0005815; GO:0005829; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0046604; GO:0061025; GO:1904780; GO:1990730 lipid binding [GO:0008289]; ubiquitin binding [GO:0043130] EHGAVAVER 0.98484 -1.495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75325 LRRN2_HUMAN Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5) LRRN2 GAC1 LRRN5 UNQ256/PRO293 Homo sapiens (Human) cell adhesion [GO:0007155]; signal transduction [GO:0007165] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; signal transduction [GO:0007165] GO:0005615; GO:0007155; GO:0007165; GO:0016021; GO:0031012; GO:0038023 signaling receptor activity [GO:0038023] ALGDRPGLIAILALAVLLLAAGLAAHLGTGQPR 0.98485 -2.3492 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9295 0 0 0 0 0 0 0 0 0 0 0 0 12.688 0 11.925 12.5621 0 0 0 13.395 0 12.4681 0 12.5128 0 0 0 0 0 13.8982 12.7667 0 0 0 11.7047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6155 0 0 0 11.1828 0 0 0 0 0 0 12.8566 0 0 0 0 0 0 0 13.0226 11.8092 0 0 0 0 11.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1838 11.7515 0 0 0 0 14.3315 12.7726 0 0 0 13.525 0 0 12.121 0 0 0 0 0 0 0 11.1578 0 0 0 0 12.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2521 0 0 0 0 0 0 0 0 0 0 0 10.9037 0 0 10.9056 0 0 0 0 0 0 Q9BX95 SGPP1_HUMAN "Sphingosine-1-phosphate phosphatase 1, SPPase1, Spp1, hSPP1, hSPPase1, EC 3.1.3.- (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1, SPP-1)" SGPP1 SPP1 Homo sapiens (Human) ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; phospholipid dephosphorylation [GO:0046839]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; phospholipid dephosphorylation [GO:0046839]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670] GO:0005789; GO:0005886; GO:0006668; GO:0006670; GO:0016020; GO:0016021; GO:0030148; GO:0035621; GO:0042392; GO:0045616; GO:0045682; GO:0046839; GO:0070780; GO:0097191; GO:0097193 dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392] AEAPLAGDPRLR 0.98485 -2.3572 0 0 0 0 0 0 12.3052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8055 0 14.3782 0 13.643 0 0 0 0 0 0 0 0 13.9722 0 0 0 14.1355 0 13.5834 12.0971 0 0 14.1857 10.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2116 0 0 0 0 0 0 0 0 14.825 14.7633 14.2869 13.3366 0 12.393 14.8255 0 0 0 0 0 0 16.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.906 0 0 14.7752 0 0 0 0 0 0 0 0 0 14.5537 0 0 0 0 0 0 0 14.6 0 0 14.7729 0 14.7888 0 0 0 0 0 11.6047 12.2045 0 0 0 0 14.4574 14.6948 0 0 0 0 0 0 0 11.3826 0 0 0 0 0 0 0 0 0 0 0 10.7561 11.521 0 0 0 0 0 0 0 0 0 9.73742 0 Q8NFA0 UBP32_HUMAN "Ubiquitin carboxyl-terminal hydrolase 32, EC 3.4.19.12 (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32)" USP32 USP10 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006511; GO:0016020; GO:0016579 calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843] AFTSEEELGENEMYYCSKCK 0.98486 -3.0155 0 0 0 0 0 0 0 0 0 0 10.2993 0 0 0 0 11.8264 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5582 14.7305 0 0 0 0 10.7899 0 0 0 0 0 0 12.1372 0 10.4359 0 0 0 0 0 0 0 14.1273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9524 0 0 11.8648 12.6241 0 0 12.6189 0 0 12.3563 0 14.1918 0 16.4638 0 13.1705 0 0 0 13.2979 13.5059 14.5887 10.7176 11.3513 0 16.1254 0 0 11.7738 0 14.9211 13.9004 0 0 14.864 14.1262 0 0 11.6955 0 0 13.0331 0 0 11.6826 13.6807 0 0 12.4401 0 0 0 0 0 0 0 0 0 0 10.4369 12.2141 0 14.7676 14.6103 12.707 0 0 0 11.9234 11.4946 11.4598 0 0 9.52233 0 0 0 0 13.6571 13.6891 11.4772 0 0 0 0 11.9148 0 0 0 0 12.7679 0 0 0 13.8031 0 0 0 11.5961 0 0 0 0 0 12.1347 11.2007 13.8896 0 Q8NH93 OR1L3_HUMAN "Olfactory receptor 1L3 (Olfactory receptor 9-D, OR9-D) (Olfactory receptor OR9-28)" OR1L3 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GLQKLINKIK 0.98486 -2.1228 0 0 0 0 0 0 0 0 13.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4252 0 0 0 0 0 0 0 11.5896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0097 0 0 0 0 0 0 0 0 0 0 0 12.9172 11.7596 0 0 0 0 0 0 11.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9566 0 0 0 0 11.8681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1596 0 0 0 0 0 0 0 12.5298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0112 0 0 0 0 0 0 0 Q8TCT9 HM13_HUMAN "Minor histocompatibility antigen H13, EC 3.4.23.- (Intramembrane protease 1, IMP-1, IMPAS-1, hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase)" HM13 H13 IMP1 PSL3 SPP MSTP086 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; regulation of heme oxygenase activity [GO:0061960]; signal peptide processing [GO:0006465]" cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] "cell surface [GO:0009986]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; regulation of heme oxygenase activity [GO:0061960]; signal peptide processing [GO:0006465]" GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0006465; GO:0008233; GO:0009986; GO:0016020; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0061960; GO:0071458; GO:0071556; GO:1904211 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]" FDISLKKNTHTYFYTSFAAYIFGLGLTIFIMHIFK 0.98486 -2.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.32 0 0 0 0 11.1611 0 0 0 0 0 0 0 0 0 14.4251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0796 0 0 0 13.9287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RE9 ZN300_HUMAN Zinc finger protein 300 ZNF300 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0016604; GO:0043565; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" AFAKKSQLIVHQR 0.98486 -1.5038 0 0 0 0 0 0 0 0 0 0 13.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7422 12.3523 14.4491 0 13.4736 0 12.7921 11.7036 0 0 0 0 0 14.1842 13.8704 13.6518 0 0 0 0 10.4569 0 12.8858 13.1594 15.0744 13.2707 13.684 0 0 12.5336 15.9663 0 12.3654 0 0 0 12.8236 0 0 0 0 0 14.5214 0 0 11.0047 0 0 0 0 0 0 0 0 0 12.9593 0 13.386 0 12.3611 0 0 12.5935 0 0 0 0 0 0 0 0 0 13.2781 0 0 0 12.115 0 12.108 12.5904 0 13.9633 0 0 0 9.34401 0 10.6812 0 0 11.6112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0V1 TM168_HUMAN Transmembrane protein 168 TMEM168 Homo sapiens (Human) integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] GO:0016021; GO:0030133 LDTLIEWWR 0.98486 -2.3605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1053 0 0 12.4723 0 0 0 0 11.4833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8256 0 0 14.7812 0 0 14.6376 0 14.4509 13.6542 0 0 0 0 14.4425 0 0 0 0 0 0 0 15.2325 0 15.9701 0 0 0 0 0 16.157 10.9086 16.0256 0 0 12.9299 0 0 0 0 16.602 15.8659 0 0 0 0 14.7131 14.7219 0 0 16.6982 12.5895 0 16.4189 15.865 15.1493 0 15.6465 0 0 0 0 0 14.5369 14.7556 0 14.8571 0 0 15.4304 0 0 0 0 0 15.4204 14.7951 0 0 0 0 0 0 0 0 0 0 12.1985 0 0 0 0 14.2324 14.1582 0 0 0 0 0 0 0 Q99819 GDIR3_HUMAN "Rho GDP-dissociation inhibitor 3, Rho GDI 3 (Rho-GDI gamma)" ARHGDIG Homo sapiens (Human) blastocyst hatching [GO:0001835]; negative regulation of cell adhesion [GO:0007162]; regulation of protein localization [GO:0032880]; Rho protein signal transduction [GO:0007266] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094]; blastocyst hatching [GO:0001835]; negative regulation of cell adhesion [GO:0007162]; regulation of protein localization [GO:0032880]; Rho protein signal transduction [GO:0007266] GO:0001835; GO:0005094; GO:0005096; GO:0005829; GO:0005886; GO:0007162; GO:0007266; GO:0016020; GO:0031410; GO:0032880 GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094] EGVDYRVK 0.98487 -2.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3517 0 0 0 0 0 0 0 0 0 12.9345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47813 IF1AX_HUMAN "Eukaryotic translation initiation factor 1A, X-chromosomal, eIF-1A X isoform (Eukaryotic translation initiation factor 4C, eIF-4C)" EIF1AX EIF1A EIF4C Homo sapiens (Human) translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413]" GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006413; GO:0008135 "RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" AYGELPEHAK 0.98489 -2.6914 14.1021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWV6 ENPP7_HUMAN "Ectonucleotide pyrophosphatase/phosphodiesterase family member 7, E-NPP 7, NPP-7, EC 3.1.4.12 (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase, Alk-SMase)" ENPP7 UNQ3077/PRO9912 Homo sapiens (Human) fatty acid homeostasis [GO:0055089]; glycosphingolipid metabolic process [GO:0006687]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; fatty acid homeostasis [GO:0055089]; glycosphingolipid metabolic process [GO:0006687]; lipid digestion [GO:0044241]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of sphingomyelin catabolic process [GO:2000755]; regulation of intestinal lipid absorption [GO:1904729]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] GO:0004767; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0006684; GO:0006685; GO:0006687; GO:0008081; GO:0008156; GO:0008270; GO:0008285; GO:0016020; GO:0044241; GO:0045797; GO:0055089; GO:1904729; GO:2000304; GO:2000755 phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270] FPNFTFR 0.98489 -3.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.458 0 0 0 0 0 0 0 0 0 11.2038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUM7 NPAS4_HUMAN "Neuronal PAS domain-containing protein 4, Neuronal PAS4 (Class E basic helix-loop-helix protein 79, bHLHe79) (HLH-PAS transcription factor NXF) (PAS domain-containing protein 10)" NPAS4 BHLHE79 NXF PASD10 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]" chromatin [GO:0000785]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; postsynapse [GO:0098794]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; cellular response to corticosterone stimulus [GO:0071386]; excitatory postsynaptic potential [GO:0060079]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; long-term memory [GO:0007616]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]; social behavior [GO:0035176]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0007612; GO:0007614; GO:0007616; GO:0030154; GO:0032228; GO:0035176; GO:0044877; GO:0045944; GO:0046982; GO:0048167; GO:0060079; GO:0060080; GO:0071386; GO:0098794; GO:1904862 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CRFNTSKSLR 0.98489 -1.5286 0 0 0 0 0 0 0 0 0 12.0224 12.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8588 0 0 0 0 0 0 0 0 11.8792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2983 0 0 0 0 0 0 0 0 0 0 0 12.5025 0 0 12.4092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0498 10.6445 0 0 0 0 0 11.9882 0 0 0 0 0 0 12.1594 0 0 0 0 0 0 11.8755 0 0 0 0 13.9085 0 0 0 13.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7433 0 0 0 12.5676 0 O43155 FLRT2_HUMAN Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2) FLRT2 KIAA0405 UNQ232/PRO265 Homo sapiens (Human) axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222] cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein-macromolecule adaptor activity [GO:0030674]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222] GO:0003007; GO:0005104; GO:0005615; GO:0005789; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0008543; GO:0030674; GO:0031012; GO:0043005; GO:0045202; GO:0045499; GO:0051965; GO:0061343; GO:0070062; GO:0071711; GO:2001222 chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein-macromolecule adaptor activity [GO:0030674] CDRNFVYCNER 0.9849 -3.7708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.28005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2331 0 0 11.5922 0 0 0 0 0 0 0 0 0 0 0 0 11.5959 0 0 0 11.3728 0 0 0 0 0 0 0 0 0 13.2571 0 0 14.2422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2052 10.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0023 0 0 0 0 0 0 0 P49802 RGS7_HUMAN "Regulator of G-protein signaling 7, RGS7" RGS7 Homo sapiens (Human) brain development [GO:0007420]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to amphetamine [GO:0001975]; response to cold [GO:0009409]; response to ethanol [GO:0045471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; brain development [GO:0007420]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to amphetamine [GO:0001975]; response to cold [GO:0009409]; response to ethanol [GO:0045471] GO:0001965; GO:0001975; GO:0003924; GO:0005096; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007420; GO:0008277; GO:0009409; GO:0009968; GO:0031681; GO:0032991; GO:0035556; GO:0043005; GO:0043547; GO:0045121; GO:0045471; GO:1901381 G-protein alpha-subunit binding [GO:0001965]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] EPSQQRVK 0.9849 -2.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9533 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5024 16.7423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3632 0 0 0 0 14.5624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5746 0 0 Q8N0U8 VKORL_HUMAN "Vitamin K epoxide reductase complex subunit 1-like protein 1, VKORC1-like protein 1, EC 1.17.4.4" VKORC1L1 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]; cellular response to oxidative stress [GO:0034599]; peptidyl-glutamic acid carboxylation [GO:0017187]; vitamin K metabolic process [GO:0042373] GO:0005783; GO:0005789; GO:0016021; GO:0017187; GO:0034599; GO:0042373; GO:0047057; GO:0048038 quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057] MAAPVLLR 0.9849 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75594 PGRP1_HUMAN "Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short, PGRP-S)" PGLYRP1 PGLYRP PGRP TNFSF3L SBBI68 UNQ639/PRO1269 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253] GO:0005576; GO:0008270; GO:0008745; GO:0009253; GO:0016019; GO:0016045; GO:0031640; GO:0032689; GO:0032827; GO:0035580; GO:0042834; GO:0045087; GO:0050728; GO:0050830; GO:0051701; GO:0061844; GO:0070062; GO:0097013; GO:1904724 N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; zinc ion binding [GO:0008270] NVQHYHMK 0.98491 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8262 0 0 0 0 0 0 0 0 13.789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01566 IFN10_HUMAN "Interferon alpha-10, IFN-alpha-10 (Interferon alpha-6L) (Interferon alpha-C, LeIF C)" IFNA10 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132] ITLYLIER 0.98491 -1.4751 0 0 0 0 0 0 0 0 0 13.5335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1271 0 0 0 0 0 0 13.495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2389 0 0 0 0 0 0 0 0 0 0 14.1242 0 0 0 0 0 0 13.1076 0 0 12.7832 0 0 0 0 0 0 0 0 12.9983 13.6267 0 12.7893 0 0 0 0 0 12.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P84085 ARF5_HUMAN ADP-ribosylation factor 5 ARF5 Homo sapiens (Human) "intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" GO:0003924; GO:0005525; GO:0005794; GO:0005886; GO:0006886; GO:0006890; GO:0016192; GO:0048471; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924] MLQEDELR 0.98491 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15760 GPR19_HUMAN Probable G-protein coupled receptor 19 (GPR-NGA) GPR19 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0005929; GO:0007186 G protein-coupled receptor activity [GO:0004930] ETFCMSSMK 0.98491 -3.6962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.972 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1892 11.0142 0 11.3313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9902 0 0 0 0 0 0 0 0 0 12.9934 0 0 14.3787 0 0 13.8638 13.6324 11.8878 13.5089 0 14.7 0 13.3824 0 0 0 0 0 0 0 14.045 0 0 0 0 0 0 0 13.9794 0 13.6518 0 0 0 0 0 0 0 0 0 0 0 0 11.4164 0 0 0 0 0 0 13.637 0 12.3175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WT6 TRI69_HUMAN "E3 ubiquitin-protein ligase TRIM69, EC 2.3.2.27 (RFP-like domain-containing protein trimless) (RING finger protein 36) (RING-type E3 ubiquitin transferase TRIM69) (Tripartite motif-containing protein 69)" TRIM69 RNF36 HSD-34 HSD34 Homo sapiens (Human) apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016567; GO:0016607; GO:0042802; GO:0046872; GO:0061630 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] DITTLLHSLEQGMK 0.98491 -3.6949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NC44 RETR2_HUMAN Reticulophagy regulator 2 RETREG2 C2orf17 FAM134A MAG2 Homo sapiens (Human) collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; reticulophagy [GO:0061709] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; reticulophagy [GO:0061709] GO:0005783; GO:0007029; GO:0016021; GO:0030574; GO:0061709; GO:0140506 endoplasmic reticulum-autophagosome adaptor activity [GO:0140506] LATTLWLR 0.98491 -1.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13627 DYR1A_HUMAN "Dual specificity tyrosine-phosphorylation-regulated kinase 1A, EC 2.7.12.1 (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog, MNBH, hMNB)" DYRK1A DYRK MNB MNBH Homo sapiens (Human) "amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006468; GO:0007399; GO:0007623; GO:0008092; GO:0015631; GO:0016607; GO:0018105; GO:0018107; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0033120; GO:0034205; GO:0036289; GO:0038083; GO:0042802; GO:0043518; GO:0043621; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0050321; GO:0090312; GO:0106310; GO:1990904 actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631] GVSLNLTRK 0.98492 -2.1685 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0481 0 0 0 0 0 0 0 11.1366 0 0 0 0 0 0 0 12.5939 10.2723 0 0 0 0 0 0 0 11.8097 0 11.1406 13.0591 11.3022 0 0 0 0 0 0 0 11.0466 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3645 0 0 10.6684 0 0 0 0 0 0 11.4266 0 0 0 0 0 13.5914 0 0 12.8136 0 0 0 0 12.9871 0 0 12.982 0 0 0 0 16.1261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0472 0 12.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4858 13.3892 0 14.0549 0 0 13.0401 12.668 12.7302 0 0 14.2816 0 0 0 14.8511 0 0 0 0 0 0 0 0 0 Q8NE00 TM104_HUMAN Transmembrane protein 104 TMEM104 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IYLAIFTLLLGPFTFFDVQKTK 0.98492 -3.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4556 0 0 0 0 Q9BYR8 KRA31_HUMAN Keratin-associated protein 3-1 (High sulfur keratin-associated protein 3.1) (Keratin-associated protein 3.1) KRTAP3-1 KAP3.1 KRTAP3.1 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0045095 structural molecule activity [GO:0005198] MYCCALR 0.98492 -3.7008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBW5 BIN2_HUMAN Bridging integrator 2 (Breast cancer-associated protein 1) BIN2 BRAP1 Homo sapiens (Human) "cell chemotaxis [GO:0060326]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]" anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell projection [GO:0042995]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; secretory granule lumen [GO:0034774] "anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell projection [GO:0042995]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; podosome [GO:0002102]; secretory granule lumen [GO:0034774]; phospholipid binding [GO:0005543]; cell chemotaxis [GO:0060326]; phagocytosis, engulfment [GO:0006911]; plasma membrane tubulation [GO:0097320]; podosome assembly [GO:0071800]" GO:0001891; GO:0002102; GO:0005543; GO:0005576; GO:0005886; GO:0005938; GO:0006911; GO:0034774; GO:0042995; GO:0060326; GO:0070161; GO:0071800; GO:0097320; GO:1904813 phospholipid binding [GO:0005543] AQEKVLQK 0.98492 -2.1703 0 0 0 0 0 0 0 0 0 12.0922 0 15.1671 0 0 0 0 0 0 0 0 11.9276 0 0 0 11.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9104 0 0 13.4774 0 0 0 0 0 14.3872 15.1303 0 0 13.2879 0 0 0 15.1234 0 0 12.9821 0 0 0 0 0 0 0 0 0 13.2426 0 0 0 0 0 14.7119 0 13.6367 0 0 0 16.0506 0 0 0 14.8726 0 13.2624 0 0 0 0 13.5557 13.6143 0 0 0 13.6508 0 0 0 14.7919 0 0 0 0 13.8474 0 0 0 0 0 0 0 0 0 13.8474 0 0 0 0 13.4529 15.2818 0 0 13.6994 0 0 0 0 0 13.6499 0 15.5674 13.5536 0 0 0 0 0 P42126 ECI1_HUMAN "Enoyl-CoA delta isomerase 1, mitochondrial, EC 5.3.3.8 (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase, D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)" ECI1 DCI Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; fatty acid beta-oxidation [GO:0006635]" GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0016863 "delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]" ALVASVRVPARVLLR 0.98493 -2.7117 0 0 0 0 0 0 0 0 0 0 11.1562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5816 10.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.31818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1194 0 0 Q02790 FKBP4_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP4, PPIase FKBP4, EC 5.2.1.8 (51 kDa FK506-binding protein, FKBP51) (52 kDa FK506-binding protein, 52 kDa FKBP, FKBP-52) (59 kDa immunophilin, p59) (FK506-binding protein 4, FKBP-4) (FKBP59) (HSP-binding immunophilin, HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed ]" FKBP4 FKBP52 Homo sapiens (Human) androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex localization [GO:0031503]; steroid hormone receptor complex assembly [GO:0006463] axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; nuclear glucocorticoid receptor binding [GO:0035259]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein-containing complex localization [GO:0031503]; steroid hormone receptor complex assembly [GO:0006463] GO:0000413; GO:0003723; GO:0003755; GO:0005524; GO:0005525; GO:0005528; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0006457; GO:0006463; GO:0006825; GO:0007566; GO:0010977; GO:0030521; GO:0030674; GO:0030850; GO:0031072; GO:0031111; GO:0031115; GO:0031503; GO:0032767; GO:0032991; GO:0035259; GO:0043025; GO:0044295; GO:0046661; GO:0048156; GO:0048471; GO:0051219; GO:0061077; GO:0070062 ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; nuclear glucocorticoid receptor binding [GO:0035259]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156] EGKYKQALLQYK 0.98493 -3.0905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2945 13.4703 13.4039 0 13.4243 0 13.1963 13.4289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4415 13.1817 14.09 13.2129 13.1244 12.8232 12.7625 13.8087 13.9278 13.6134 0 12.3893 0 0 0 0 0 10.3599 0 0 0 0 0 0 0 0 0 0 0 13.4997 0 13.8361 12.5119 13.4185 13.8114 0 0 0 0 13.7837 0 0 13.0863 0 0 0 0 13.4471 0 0 0 0 0 0 0 0 0 0 14.4837 0 13.1636 0 14.9662 0 0 0 0 13.2463 0 0 0 13.459 0 0 0 13.7622 0 0 0 0 0 0 0 0 0 0 0 13.6544 0 13.9319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0273 0 0 15.0335 0 0 0 0 0 0 0 0 0 0 0 13.8728 14.5234 0 0 0 0 15.249 12.9804 0 0 0 0 14.6661 0 0 Q149M9 NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 NWD1 Homo sapiens (Human) negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628] cytosol [GO:0005829]; nucleolus [GO:0005730] cytosol [GO:0005829]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628] GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088 ATP binding [GO:0005524] ATLSGCHK 0.98493 -2.3263 0 0 0 0 0 0 0 0 13.4748 0 0 0 0 0 0 12.9683 13.5036 0 13.5075 13.7261 0 0 0 0 13.4112 14.3807 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5248 0 13.6292 14.1506 0 14.3894 0 0 0 0 0 0 0 13.0894 0 12.9194 12.905 0 0 0 13.9118 0 0 0 0 0 0 0 0 0 18.8349 11.2869 0 0 12.1832 0 0 12.9493 0 0 0 0 0 12.5813 12.9659 18.8554 18.7638 0 12.621 0 0 12.0156 0 14.5084 12.9585 12.8385 13.4727 0 11.7892 0 0 12.3355 0 0 0 0 13.5934 0 0 0 0 14.0401 12.8156 0 13.0703 14.9737 13.8357 0 0 0 12.9748 12.0693 0 13.2409 0 12.8046 0 13.6603 14.3768 0 0 11.7703 0 0 0 0 15.2861 0 11.7608 0 13.0782 14.2369 0 12.9872 0 0 0 0 0 0 0 0 0 12.7809 0 0 0 0 13.4916 0 0 0 12.8156 0 13.3256 12.7287 0 12.5174 0 0 0 0 0 13.3856 0 0 0 0 13.2789 14.0708 0 Q9Y3B4 SF3B6_HUMAN "Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit, SF3B14a) (Spliceosome-associated protein, 14-kDa) (Splicing factor 3b, subunit 6, 14kDa)" SF3B6 SAP14 SF3B14 SF3B14A CGI-110 HSPC175 HT006 Homo sapiens (Human) "blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0001825; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0071011; GO:0071013; GO:1903241 mRNA binding [GO:0003729]; RNA binding [GO:0003723] ANIRLPPEVNRILYIR 0.98493 -2.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9736 0 0 0 0 0 0 P98198 AT8B2_HUMAN "Phospholipid-transporting ATPase ID, EC 7.6.2.1 (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2)" ATP8B2 ATPID KIAA1137 Homo sapiens (Human) Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; Golgi organization [GO:0007030]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] AQHRCMRR 0.98494 -2.5507 0 0 0 0 0 0 0 0 0 0 0 12.3233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.701 0 0 0 0 12.9077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3968 0 0 0 0 0 0 11.8517 0 0 0 0 0 0 12.0943 0 14.1127 0 Q8IZU2 WDR17_HUMAN WD repeat-containing protein 17 WDR17 Homo sapiens (Human) DAHSFLSDICMFRWHTHQKGK 0.98494 -2.7195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.008 0 0 0 0 0 0 0 0 0 0 0 12.561 0 0 0 0 0 13.2636 0 0 11.0484 12.1053 0 0 0 0 0 0 0 0 0 12.8957 0 0 0 0 0 0 0 0 0 11.3926 0 0 0 0 0 0 10.5935 0 0 0 0 0 0 0 12.4317 12.0166 0 0 10.9962 14.2925 0 11.6806 0 0 0 0 0 11.4378 12.433 0 0 0 0 0 0 12.5236 12.925 0 0 0 11.1717 0 11.4812 12.2695 13.9833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1125 0 0 0 0 0 0 0 12.9948 0 Q8N3H0 TAFA2_HUMAN Chemokine-like protein TAFA-2 TAFA2 FAM19A2 Homo sapiens (Human) memory [GO:0007613]; visual learning [GO:0008542] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; receptor ligand activity [GO:0048018]; memory [GO:0007613]; visual learning [GO:0008542] GO:0005615; GO:0005634; GO:0005737; GO:0007613; GO:0008542; GO:0048018 receptor ligand activity [GO:0048018] ATKGKLLIIIFIVTLWGK 0.98494 -3.8016 0 0 0 0 0 12.1028 0 0 0 10.7126 0 0 0 11.1917 0 0 0 0 0 0 0 0 11.115 0 0 0 0 11.6148 0 0 0 0 0 0 0 0 0 0 11.1417 0 0 0 0 0 0 0 0 0 11.0198 0 0 0 0 0 13.88 0 0 0 0 0 0 0 0 0 0 10.7651 0 0 0 0 11.2812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1272 0 0 0 0 15.2225 12.8582 14.2655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8455 12.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0898 0 0 0 12.6851 11.8942 0 0 12.3921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.262 0 0 0 0 12.1436 0 0 0 0 0 0 0 0 0 0 Q8N584 TT39C_HUMAN "Tetratricopeptide repeat protein 39C, TPR repeat protein 39C" TTC39C C18orf17 Homo sapiens (Human) cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474] cilium assembly [GO:0060271]; otolith morphogenesis [GO:0032474] GO:0032474; GO:0060271 GRALLLQAK 0.98494 -2.5466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7031 0 0 0 0 0 11.9982 13.1149 13.4173 0 0 0 14.4282 15.7981 15.3076 14.3355 14.6337 15.6813 15.0065 14.7383 0 15.2312 13.8555 15.2788 16.0993 15.5843 0 15.4225 14.5415 16.1795 12.6852 15.6686 15.6824 14.8468 13.9789 15.1785 0 13.4926 13.4886 15.9631 12.8104 0 14.7709 14.3483 0 0 0 0 14.9313 14.8951 14.7279 0 14.0784 14.622 14.9938 0 14.1983 13.9878 14.9956 0 0 0 0 0 0 13.5895 0 13.4198 0 0 0 13.7415 13.1182 0 0 0 0 0 0 0 0 14.2148 0 0 0 0 0 0 0 13.1072 0 12.8893 0 0 0 0 13.8785 0 0 0 0 0 0 0 0 Q8WYA1 BMAL2_HUMAN "Aryl hydrocarbon receptor nuclear translocator-like protein 2 (Basic-helix-loop-helix-PAS protein MOP9) (Brain and muscle ARNT-like 2) (CYCLE-like factor, CLIF) (Class E basic helix-loop-helix protein 6, bHLHe6) (Member of PAS protein 9) (PAS domain-containing protein 9)" ARNTL2 BHLHE6 BMAL2 CLIF MOP9 PASD9 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; CLOCK-BMAL transcription complex [GO:1990513]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0007623; GO:0009649; GO:0032922; GO:0034751; GO:0042753; GO:0045893; GO:0045944; GO:0046983; GO:0070888; GO:1990513 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AVLQSKEKILTDSYK 0.98494 -2.552 0 0 0 0 0 0 0 0 0 0 0 12.1074 12.2852 0 0 12.3412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4487 0 0 10.5043 0 0 0 0 0 13.0731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9009 0 12.3621 0 14.5116 0 0 0 0 0 0 13.1853 0 0 0 0 13.4961 0 0 0 0 0 0 0 0 0 10.1809 0 0 0 0 0 0 11.8904 0 0 0 0 0 12.836 0 0 0 0 0 0 0 13.2707 0 0 0 0 0 0 0 0 13.8015 0 14.8155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1539 0 0 11.6612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5572 0 11.822 0 0 0 0 0 0 0 0 0 13.5851 0 0 0 0 0 Q9UHF4 I20RA_HUMAN "Interleukin-20 receptor subunit alpha, IL-20 receptor subunit alpha, IL-20R-alpha, IL-20RA (Cytokine receptor class-II member 8) (Cytokine receptor family 2 member 8, CRF2-8) (IL-20R1) (ZcytoR7)" IL20RA UNQ681/PRO1315 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of bone resorption [GO:0045124] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interleukin-20 binding [GO:0042015]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; regulation of bone resorption [GO:0045124] GO:0004896; GO:0005886; GO:0005887; GO:0019221; GO:0042015; GO:0045124; GO:2001244 cytokine receptor activity [GO:0004896]; interleukin-20 binding [GO:0042015] APGRPALRPLPLPPLLLLLLAAPWGR 0.98494 -3.8013 0 0 0 0 0 0 0 0 0 13.4489 0 0 10.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3464 13.4278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4434 0 0 0 0 0 0 0 12.4543 11.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3997 0 0 11.6806 0 0 0 0 0 12.0193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.234 0 0 0 0 0 0 11.4192 0 0 0 0 0 0 0 0 0 0 0 0 11.082 0 0 0 0 0 0 0 11.5806 0 13.8708 P25021 HRH2_HUMAN "Histamine H2 receptor, H2R, HH2R (Gastric receptor I)" HRH2 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; immune response [GO:0006955]; positive regulation of vasoconstriction [GO:0045907]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; immune response [GO:0006955]; positive regulation of vasoconstriction [GO:0045907]" GO:0001696; GO:0004969; GO:0004993; GO:0005886; GO:0005887; GO:0006955; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0045907 G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] ITITVVLAVLILITVAGNVVVCLAVGLNRR 0.98495 -2.6507 0 0 0 0 0 0 0 0 0 0 13.4546 0 13.0862 0 12.4725 0 0 0 0 11.4084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9588 14.1311 13.1397 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8347 12.8432 0 0 0 0 0 0 13.4192 15.2683 13.4976 0 0 0 0 0 0 0 13.2681 14.2277 0 0 0 13.8158 13.4022 0 13.6938 14.1683 13.5881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6084 13.1228 15.2861 0 0 0 0 12.3426 0 14.8666 0 0 0 0 0 0 0 13.0045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2837 0 0 12.2781 0 Q92621 NU205_HUMAN Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292 structural constituent of nuclear pore [GO:0017056] DDMIHQLPLLTEKQYIATIHSRLQDSQLWK 0.98495 -2.3491 0 0 0 0 0 0 0 0 0 13.2671 12.7539 12.7874 12.7401 0 0 0 12.9773 0 13.4062 0 0 0 0 0 12.8901 0 0 0 11.1961 0 12.3619 12.4257 12.8042 0 11.8195 0 0 12.6197 0 14.0694 0 12.7639 13.1447 0 0 0 13.5054 12.2501 0 0 12.5637 0 12.1131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6504 0 0 0 0 0 0 0 0 0 12.5424 0 0 0 0 0 0 0 0 0 0 0 13.582 14.0612 0 0 0 0 0 0 0 15.8435 0 0 14.9864 0 0 10.7918 0 0 0 0 0 0 14.9209 0 0 0 0 0 0 0 12.3449 0 0 0 0 14.1115 0 0 0 12.7172 14.6881 15.1368 0 0 0 0 0 0 12.7498 0 0 0 0 0 0 0 0 0 13.5335 0 0 0 0 0 0 0 0 13.5895 13.4872 0 0 0 13.3597 13.372 13.7919 13.8808 0 13.3222 13.4812 0 13.5332 13.426 12.8739 12.4138 0 0 0 0 0 0 0 A0A0C4DH68 KV224_HUMAN Immunoglobulin kappa variable 2-24 IGKV2-24 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 FSGVPDR 0.98496 -2.1187 0 0 0 0 0 0 0 0 0 10.8887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88059 0 0 0 0 16.5026 0 0 0 0 0 11.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9996 0 0 0 0 P25787 PSA2_HUMAN Proteasome subunit alpha type-2 (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3) PSMA2 HC3 PSC3 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]" GO:0000502; GO:0000932; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0009615; GO:0010498; GO:0019773; GO:0034774; GO:0043161; GO:0070062; GO:1904813 KQKSILYDER 0.98496 -2.5628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1566 0 12.4066 0 0 0 0 0 0 0 0 0 0 12.6822 0 13.4181 12.5686 0 0 0 0 0 0 0 12.0118 0 0 18.5254 0 0 13.9288 14.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4259 13.1612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0696 0 0 0 0 0 0 Q5VWM3 PRA18_HUMAN PRAME family member 18 PRAMEF18 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 DQALAISVLDELPR 0.98496 -3.0154 0 0 0 11.0749 0 0 0 0 0 0 0 0 0 0 12.3533 0 0 0 0 10.8185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0577 13.4836 13.6982 10.3123 0 0 0 0 12.2781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8669 0 0 0 11.9432 13.0025 0 12.6493 0 0 0 12.789 10.7444 0 0 0 12.535 0 0 0 0 14.3731 0 0 0 13.6138 0 12.1347 0 0 0 0 0 11.2682 0 0 0 0 0 0 0 0 15.0216 0 0 12.5238 0 0 0 0 0 0 0 0 0 0 0 12.0222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3111 0 0 0 0 0 0 0 0 0 0 10.7839 12.2684 0 0 0 0 0 0 0 11.6177 0 0 0 0 12.4854 0 Q8IYT4 KATL2_HUMAN "Katanin p60 ATPase-containing subunit A-like 2, Katanin p60 subunit A-like 2, EC 5.6.1.1 (p60 katanin-like 2)" KATNAL2 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013] GO:0000922; GO:0005524; GO:0005737; GO:0005819; GO:0005874; GO:0008017; GO:0008568; GO:0015630; GO:0016853; GO:0016887; GO:0031122; GO:0051013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568] EAAMRPVR 0.98496 -2.9128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0529 0 0 11.8384 13.4552 0 0 0 0 0 0 0 0 0 0 0 0 0 14.604 0 0 0 0 0 0 0 0 0 14.0055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3953 0 0 0 0 0 14.8519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7M2 ZN283_HUMAN Zinc finger protein 283 (Zinc finger protein HZF19) ZNF283 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSRGYQLTQHQK 0.98496 -2.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93052 LPP_HUMAN Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma) LPP Homo sapiens (Human) cell-cell adhesion [GO:0098609] cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609] GO:0001725; GO:0005634; GO:0005829; GO:0005886; GO:0005925; GO:0046872; GO:0098609 metal ion binding [GO:0046872] FAPVVAPK 0.98496 -2.3564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.418 0 0 0 0 0 0 0 0 15.8403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9207 0 0 10.1692 0 0 0 0 0 0 0 0 13.5926 0 0 0 13.9307 13.7041 11.7106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2123 11.8 0 0 0 0 0 18.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.851 0 0 0 0 0 0 0 0 11.8444 0 0 0 0 0 0 0 18.2755 11.1691 0 0 0 0 0 17.9703 0 Q9HD42 CHM1A_HUMAN "Charged multivesicular body protein 1a (Chromatin-modifying protein 1a, CHMP1a) (Vacuolar protein sorting-associated protein 46-1, Vps46-1, hVps46-1)" CHMP1A CHMP1 KIAA0047 PCOLN3 PRSM1 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000421; GO:0000776; GO:0000794; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005769; GO:0005771; GO:0005815; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007076; GO:0007080; GO:0008237; GO:0008270; GO:0010629; GO:0010824; GO:0012505; GO:0015031; GO:0016192; GO:0016363; GO:0019904; GO:0030496; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0045324; GO:0046761; GO:0051301; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904903; GO:1904930 identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] DDTLFQLK 0.98496 -2.3519 0 0 0 0 0 0 0 0 11.2102 11.333 12.5499 11.1932 0 11.6708 0 0 10.6414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5596 0 0 0 0 10.5039 0 0 0 0 0 0 0 0 0 0 9.97312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0783 0 0 0 0 0 0 0 0 0 12.9192 13.0616 12.7611 12.7647 12.457 13.4476 12.434 0 17.6637 13.0018 0 0 0 0 0 0 0 0 12.8535 0 12.3721 0 0 Q9P0T7 TMEM9_HUMAN "Proton-transporting V-type ATPase complex assembly regulator TMEM9, v-ATPase assembly regulator TMEM9 (Dermal papilla-derived protein 4) (Transmembrane protein 9, Protein TMEM9)" TMEM9 DERP4 TMEM9A HSPC186 PSEC0012 UNQ631/PRO1248 Homo sapiens (Human) endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176] integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585] integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585]; endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176] GO:0005764; GO:0005765; GO:0005770; GO:0007042; GO:0015031; GO:0015630; GO:0016021; GO:0032585; GO:0042176; GO:0043231; GO:0045171; GO:0048388; GO:0070070; GO:0072686; GO:0090263 ANTVLERVEGAQQRWK 0.98496 -2.3543 0 0 0 0 0 0 0 0 0 12.8383 0 12.4316 0 0 0 0 0 12.5745 0 0 12.0007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3246 0 0 0 0 0 0 0 14.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95278 EPM2A_HUMAN "Laforin, EC 3.1.3.-, EC 3.1.3.16, EC 3.1.3.48 (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase, LAFPTPase)" EPM2A Homo sapiens (Human) autophagosome assembly [GO:0000045]; calcium ion transport [GO:0006816]; carbohydrate phosphorylation [GO:0046835]; dephosphorylation [GO:0016311]; glial cell proliferation [GO:0014009]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; habituation [GO:0046959]; L-glutamate transmembrane transport [GO:0015813]; mitochondrion organization [GO:0007005]; negative regulation of cell cycle [GO:0045786]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phosphatase activity [GO:0010923]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphorylated carbohydrate dephosphorylation [GO:0046838]; positive regulation of macroautophagy [GO:0016239]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of cell growth [GO:0001558]; regulation of glycogen (starch) synthase activity [GO:2000465]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein import into nucleus [GO:0042306]; regulation of protein kinase activity [GO:0045859]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein ubiquitination [GO:0031396]; regulation of ubiquitin protein ligase activity [GO:1904666]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; carbohydrate phosphatase activity [GO:0019203]; glycogen (starch) synthase activity [GO:0004373]; glycogen binding [GO:2001069]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; starch binding [GO:2001070]; autophagosome assembly [GO:0000045]; calcium ion transport [GO:0006816]; carbohydrate phosphorylation [GO:0046835]; dephosphorylation [GO:0016311]; glial cell proliferation [GO:0014009]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; habituation [GO:0046959]; L-glutamate transmembrane transport [GO:0015813]; mitochondrion organization [GO:0007005]; negative regulation of cell cycle [GO:0045786]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phosphatase activity [GO:0010923]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphorylated carbohydrate dephosphorylation [GO:0046838]; positive regulation of macroautophagy [GO:0016239]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of cell growth [GO:0001558]; regulation of glycogen (starch) synthase activity [GO:2000465]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein import into nucleus [GO:0042306]; regulation of protein kinase activity [GO:0045859]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein ubiquitination [GO:0031396]; regulation of ubiquitin protein ligase activity [GO:1904666]; Wnt signaling pathway [GO:0016055] GO:0000045; GO:0001558; GO:0004373; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005977; GO:0005978; GO:0006470; GO:0006816; GO:0007005; GO:0008138; GO:0010629; GO:0010923; GO:0014009; GO:0015813; GO:0016055; GO:0016239; GO:0016311; GO:0016791; GO:0017018; GO:0019203; GO:0030246; GO:0030425; GO:0031396; GO:0033137; GO:0035305; GO:0035335; GO:0042306; GO:0042803; GO:0043161; GO:0043204; GO:0045786; GO:0045859; GO:0046835; GO:0046838; GO:0046959; GO:0046983; GO:0061136; GO:0098556; GO:1903076; GO:1904666; GO:2000465; GO:2001069; GO:2001070 carbohydrate binding [GO:0030246]; carbohydrate phosphatase activity [GO:0019203]; glycogen (starch) synthase activity [GO:0004373]; glycogen binding [GO:2001069]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; starch binding [GO:2001070] AQEDFFQK 0.98497 -3.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3012 14.4569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30926 ACHB4_HUMAN Neuronal acetylcholine receptor subunit beta-4 CHRNB4 Homo sapiens (Human) "behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of smooth muscle contraction [GO:0006940]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; neuronal action potential [GO:0019228]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of smooth muscle contraction [GO:0006940]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]" GO:0005231; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006939; GO:0006940; GO:0007165; GO:0007268; GO:0007271; GO:0007626; GO:0015276; GO:0015464; GO:0016021; GO:0019228; GO:0022848; GO:0030594; GO:0034220; GO:0035095; GO:0035579; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046928; GO:0050877; GO:0051899; GO:0051971; GO:0060084; GO:0070161; GO:0070821; GO:0098981; GO:1904315 acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] IVPPTSLDVPLIGK 0.98497 -2.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4662 0 0 0 0 0 0 11.9494 12.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03405 UPAR_HUMAN "Urokinase plasminogen activator surface receptor, U-PAR, uPAR (Monocyte activation antigen Mo3) (CD antigen CD87)" PLAUR MO3 UPAR Homo sapiens (Human) blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of cell adhesion [GO:0030155]; regulation of fibrinolysis [GO:0051917]; regulation of plasminogen activation [GO:0010755]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; urokinase plasminogen activator signaling pathway [GO:0038195] anchored component of membrane [GO:0031225]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine-type endopeptidase complex [GO:1905370]; specific granule membrane [GO:0035579] anchored component of membrane [GO:0031225]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine-type endopeptidase complex [GO:1905370]; specific granule membrane [GO:0035579]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; urokinase plasminogen activator receptor activity [GO:0030377]; blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of cell adhesion [GO:0030155]; regulation of fibrinolysis [GO:0051917]; regulation of plasminogen activation [GO:0010755]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; urokinase plasminogen activator signaling pathway [GO:0038195] GO:0001934; GO:0005102; GO:0005576; GO:0005788; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006935; GO:0007165; GO:0007596; GO:0009986; GO:0010755; GO:0016021; GO:0019898; GO:0019899; GO:0019904; GO:0030155; GO:0030162; GO:0030377; GO:0031225; GO:0034112; GO:0035579; GO:0038023; GO:0038195; GO:0042995; GO:0043066; GO:0043388; GO:0045742; GO:0051917; GO:0090200; GO:0098637; GO:1905370; GO:2001243; GO:2001268 enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; urokinase plasminogen activator receptor activity [GO:0030377] GCATASMCQHAHLGDAFSMNHIDVSCCTK 0.98497 -2.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9743 0 0 0 0 0 13.5021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13177 PAK2_HUMAN "Serine/threonine-protein kinase PAK 2, EC 2.7.11.1 (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2, PAK-2) (p58) [Cleaved into: PAK-2p27, p27; PAK-2p34, p34 (C-t-PAK2) ]" PAK2 Homo sapiens (Human) adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cardiac muscle hypertrophy [GO:0003300]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendritic spine development [GO:0060996]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of growth [GO:0040008]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; small GTPase binding [GO:0031267]; adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cardiac muscle hypertrophy [GO:0003300]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendritic spine development [GO:0060996]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of growth [GO:0040008]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0002223; GO:0003300; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006469; GO:0006915; GO:0007165; GO:0014069; GO:0016310; GO:0018105; GO:0019901; GO:0030141; GO:0030296; GO:0031267; GO:0034333; GO:0035556; GO:0040008; GO:0042802; GO:0043066; GO:0043408; GO:0045296; GO:0046777; GO:0048010; GO:0048471; GO:0050731; GO:0050770; GO:0051493; GO:0051497; GO:0060996; GO:0070830; GO:0071407; GO:0071560; GO:0098978; GO:0106310; GO:0150105; GO:2001238; GO:2001271 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; small GTPase binding [GO:0031267] DPLSANHSLK 0.98497 -3.4097 0 0 0 0 0 0 0 10.6248 13.7806 0 0 0 10.9945 0 0 0 0 13.0079 0 0 0 0 0 0 0 0 0 0 0 11.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1877 0 10.8964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6739 0 0 14.2741 12.8523 13.6446 0 0 0 0 0 0 13.6433 0 0 0 0 0 0 0 0 11.5399 0 11.2934 0 14.0966 10.4764 0 0 0 0 0 0 0 13.5394 11.7154 0 0 12.0216 0 0 0 0 0 0 0 0 0 13.4866 0 0 0 14.6181 13.4824 0 0 0 13.3856 0 13.6974 14.5589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2719 0 0 0 0 0 0 0 0 14.3305 0 11.3001 0 0 Q8N5L8 RP25L_HUMAN "Ribonuclease P protein subunit p25-like protein, RNase P protein subunit-like p25 (Rpp25-like protein)" RPP25L C9orf23 Homo sapiens (Human) tRNA 5'-leader removal [GO:0001682] nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172] nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; RNA binding [GO:0003723]; tRNA 5'-leader removal [GO:0001682] GO:0000172; GO:0001682; GO:0003723; GO:0005634 RNA binding [GO:0003723] IRNLLGLALGR 0.98497 -1.4989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9751 0 0 0 0 0 0 0 Q96HD9 ACY3_HUMAN "N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming), EC 3.5.1.114 (Acylase III) (Aminoacylase-3, ACY-3) (Aspartoacylase-2) (Hepatitis C virus core-binding protein 1, HCBP1, HCV core-binding protein 1)" ACY3 ASPA2 Homo sapiens (Human) apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" GO:0004046; GO:0005829; GO:0016324; GO:0016788; GO:0016811; GO:0042802; GO:0046872; GO:0070062 "aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" HLQLQYPELSCQVFLYQRSGEESYNLDSVAK 0.98497 -1.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0261 0 0 0 0 0 0 0 0 0 0 0 0 13.5005 0 0 0 11.6347 0 0 0 0 11.8313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99895 CTRC_HUMAN "Chymotrypsin-C, EC 3.4.21.2 (Caldecrin)" CTRC CLCR Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cobalamin metabolic process [GO:0009235]; proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; cellular calcium ion homeostasis [GO:0006874]; cobalamin metabolic process [GO:0009235]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508; GO:0006874; GO:0008233; GO:0009235 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] KKPVVYTR 0.98497 -1.5034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0H0 INT2_HUMAN "Integrator complex subunit 2, Int2" INTS2 KIAA1287 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034243; GO:0034472 ETSSSVLWQMR 0.98497 -3.4069 0 0 0 0 0 0 10.3658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1912 0 12.2742 0 13.8554 14.7674 0 0 0 0 0 0 0 0 13.7688 0 11.2203 13.6798 0 0 0 0 13.3693 0 0 0 0 12.8886 14.8694 0 12.5543 14.6877 0 14.2421 14.5276 0 13.4221 0 14.4297 11.5891 14.4674 14.2952 0 11.7898 15.0066 0 13.6239 14.0409 17.3725 13.817 0 15.3437 14.5997 14.1546 15.3144 12.5805 15.294 0 14.1959 14.0566 14.6593 15.2718 14.9044 14.7758 0 15.6304 0 14.1088 12.7613 14.6265 14.299 14.4541 14.6092 14.4272 13.6964 14.0487 14.5621 14.4898 0 13.5285 14.329 0 0 0 14.0846 13.5666 13.8964 13.1125 13.4932 0 15.1688 0 0 0 0 0 0 0 0 11.6154 0 0 0 0 0 13.8293 15.0827 0 15.1822 0 0 0 0 0 O14920 IKKB_HUMAN "Inhibitor of nuclear factor kappa-B kinase subunit beta, I-kappa-B-kinase beta, IKK-B, IKK-beta, IkBKB, EC 2.7.11.10 (I-kappa-B kinase 2, IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta, NFKBIKB) (Serine/threonine protein kinase IKBKB, EC 2.7.11.1)" IKBKB IKKB Homo sapiens (Human) "antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cellular response to tumor necrosis factor [GO:0071356]; cortical actin cytoskeleton organization [GO:0030866]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of phosphorylation [GO:0042325]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to virus [GO:0009615]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; membrane raft [GO:0045121]; nucleus [GO:0005634] "CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459]; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent [GO:0002479]; cellular response to tumor necrosis factor [GO:0071356]; cortical actin cytoskeleton organization [GO:0030866]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of phosphorylation [GO:0042325]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to virus [GO:0009615]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0002223; GO:0002479; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0008384; GO:0008385; GO:0009615; GO:0009898; GO:0010803; GO:0018105; GO:0019901; GO:0030866; GO:0033209; GO:0035509; GO:0035631; GO:0038095; GO:0042325; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0045121; GO:0045893; GO:0045944; GO:0046982; GO:0050852; GO:0051092; GO:0051403; GO:0070498; GO:0071356; GO:0072659; GO:0097110; GO:0106310; GO:1903140; GO:1903347; GO:1990459 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459] EDCNRLQQGQR 0.98498 -2.1382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0046 0 0 0 0 11.0391 0 0 0 0 0 11.5862 0 0 0 0 0 0 0 0 12.0828 0 0 0 11.5626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6596 0 0 0 13.3916 0 15.8157 0 0 0 0 0 0 0 0 14.0218 0 0 0 10.8022 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6007 0 0 0 12.663 12.1356 0 10.673 0 13.4991 0 0 0 0 0 0 0 0 12.1136 0 11.8757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2183 0 0 0 11.169 0 0 0 0 0 0 0 0 0 0 0 11.8676 0 0 0 0 0 0 0 0 0 0 11.6571 0 0 Q15303 ERBB4_HUMAN "Receptor tyrosine-protein kinase erbB-4, EC 2.7.10.1 (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain, 4ICD, E4ICD (s80HER4) ]" ERBB4 HER4 Homo sapiens (Human) "cardiac muscle tissue regeneration [GO:0061026]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; central nervous system morphogenesis [GO:0021551]; embryonic pattern specification [GO:0009880]; ERBB2-ERBB4 signaling pathway [GO:0038135]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; heart development [GO:0007507]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; olfactory bulb interneuron differentiation [GO:0021889]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214] "basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; epidermal growth factor receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; GABA receptor binding [GO:0050811]; neuregulin receptor activity [GO:0038131]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase activity [GO:0004713]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cardiac muscle tissue regeneration [GO:0061026]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; central nervous system morphogenesis [GO:0021551]; embryonic pattern specification [GO:0009880]; ERBB2-ERBB4 signaling pathway [GO:0038135]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; heart development [GO:0007507]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; olfactory bulb interneuron differentiation [GO:0021889]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0000976; GO:0001755; GO:0001934; GO:0004713; GO:0004714; GO:0005006; GO:0005154; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0007399; GO:0007416; GO:0007507; GO:0007595; GO:0008284; GO:0008285; GO:0009880; GO:0009925; GO:0014068; GO:0016323; GO:0016477; GO:0018108; GO:0021551; GO:0021889; GO:0030296; GO:0030334; GO:0033674; GO:0038130; GO:0038131; GO:0038135; GO:0038138; GO:0042531; GO:0042803; GO:0043066; GO:0043235; GO:0043552; GO:0043653; GO:0044214; GO:0045165; GO:0045211; GO:0045893; GO:0046427; GO:0046777; GO:0050811; GO:0060045; GO:0060644; GO:0060749; GO:0061026; GO:0070374; GO:0071364; GO:0072046; GO:0098978; GO:0098982; GO:0099056; GO:0099061; GO:2000010 ATP binding [GO:0005524]; epidermal growth factor receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; GABA receptor binding [GO:0050811]; neuregulin receptor activity [GO:0038131]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase activity [GO:0004713]; transcription cis-regulatory region binding [GO:0000976]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] ACPSSKMEVEENGIK 0.98498 -2.3751 0 0 0 0 0 0 0 0 10.5675 13.5184 0 0 0 0 0 0 0 0 0 0 0 10.0403 0 0 0 0 0 0 0 0 0 0 0 0 11.9823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7617 15.4491 0 11.6004 16.8216 0 0 0 0 12.0354 0 0 13.8629 12.6536 13.9884 14.4596 10.9524 0 13.6367 14.094 13.383 12.0425 11.6954 0 0 0 0 12.432 0 0 15.4979 11.8888 0 0 16.1445 0 22.6358 14.1858 0 0 0 0 0 0 15.4149 23.1067 22.666 0 12.0808 12.6128 0 0 0 0 0 0 0 0 0 0 0 0 12.2554 0 0 13.2897 12.7104 13.2294 0 0 10.5609 0 0 0 0 0 11.0794 0 11.9689 0 0 0 0 0 0 0 13.6664 0 0 15.8599 0 0 13.1289 13.9189 0 16.499 0 0 0 0 0 12.7002 0 0 14.0063 0 0 0 0 0 0 19.7899 0 11.5089 19.2476 0 19.1602 11.3397 14.3313 0 0 0 0 0 18.299 0 0 18.4074 Q5SZQ8 CELF3_HUMAN "CUGBP Elav-like family member 3, CELF-3 (Bruno-like protein 1) (CAG repeat protein 4) (CUG-BP- and ETR-3-like factor 3) (ELAV-type RNA-binding protein 1, ETR-1) (Expanded repeat domain protein CAG/CTG 4) (RNA-binding protein BRUNOL-1) (Trinucleotide repeat-containing gene 4 protein)" CELF3 BRUNOL1 CAGH4 ERDA4 TNRC4 Homo sapiens (Human) "flagellated sperm motility [GO:0030317]; mRNA splice site selection [GO:0006376]; ncRNA transcription [GO:0098781]; nuclear body organization [GO:0030575]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 7SK snRNA binding [GO:0097322]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; flagellated sperm motility [GO:0030317]; mRNA splice site selection [GO:0006376]; ncRNA transcription [GO:0098781]; nuclear body organization [GO:0030575]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]" GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0007283; GO:0008380; GO:0016604; GO:0030317; GO:0030575; GO:0036002; GO:0048026; GO:0097322; GO:0098781; GO:1990904 7SK snRNA binding [GO:0097322]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] MKEPDAIK 0.98498 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7W0 ZN618_HUMAN Zinc finger protein 618 ZNF618 KIAA1952 Homo sapiens (Human) positive regulation of chromatin binding [GO:0035563] chromatin [GO:0000785]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] chromatin [GO:0000785]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator binding [GO:0001221]; positive regulation of chromatin binding [GO:0035563] GO:0000785; GO:0001221; GO:0003677; GO:0003700; GO:0005634; GO:0005721; GO:0035563; GO:0042802; GO:0046872 DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator binding [GO:0001221] ATAAESAFSRR 0.98498 -2.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7849 0 0 0 0 0 0 0 13.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUJ5 PWP2B_HUMAN PWWP domain-containing protein 2B PWWP2B PWWP2 Homo sapiens (Human) negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex binding [GO:0120325]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161] GO:0005634; GO:0005654; GO:0032968; GO:0035067; GO:0120161; GO:0120325; GO:1901675; GO:2000616 NuRD complex binding [GO:0120325] ADCASESACSSDSLDEAR 0.98498 -3.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5777 0 0 0 0 0 0 13.6549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2872 0 11.7799 0 0 0 0 13.47 0 0 0 14.6268 13.9204 0 0 13.83 0 13.4802 13.2693 0 0 0 0 0 12.1588 0 13.8831 0 13.0558 0 0 0 0 0 12.3884 12.0067 0 13.3912 0 0 0 0 0 0 12.2936 0 0 0 0 0 14.5826 13.0637 14.9556 0 0 14.5226 12.6887 0 0 13.9842 0 0 0 0 0 14.9206 0 14.413 0 13.3805 0 0 13.292 0 0 0 0 0 0 0 0 13.9099 0 13.8161 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.948 0 0 0 0 0 0 0 0 Q99684 GFI1_HUMAN Zinc finger protein Gfi-1 (Growth factor independent protein 1) (Zinc finger protein 163) GFI1 ZNF163 Homo sapiens (Human) "cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]" nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to lipopolysaccharide [GO:0071222]; hemopoiesis [GO:0030097]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; viral process [GO:0016032]" GO:0000083; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0010956; GO:0010957; GO:0010977; GO:0016032; GO:0016363; GO:0016604; GO:0017053; GO:0030097; GO:0032088; GO:0034121; GO:0045892; GO:0046872; GO:0051569; GO:0070105; GO:0071222; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ICGKSFK 0.98498 -2.7523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60841 IF2P_HUMAN "Eukaryotic translation initiation factor 5B, eIF-5B, EC 3.6.5.3 (Translation initiation factor IF-2)" EIF5B IF2 KIAA0741 Homo sapiens (Human) regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006413; GO:0006446; GO:0046872 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] AEATLKLLQAQGVEVPSKDSLPK 0.98499 -3.0481 11.893 0 0 10.6138 0 0 0 17.0141 10.0749 0 0 0 0 13.2261 9.54894 0 0 0 0 0 0 0 11.9155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3701 0 0 0 0 0 0 16.3626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 9.52115 11.9013 0 0 0 0 0 0 0 13.3429 0 0 12.3359 0 0 11.9492 14.2728 11.288 0 0 0 0 12.9117 10.9244 13.4731 0 12.4041 14.4714 12.085 12.1503 12.0444 0 14.3153 0 10.166 0 13.0301 0 12.4089 0 12.1646 0 0 11.9248 0 0 13.2469 14.5351 18.9594 0 12.6014 12.6102 0 0 0 0 11.9058 0 0 0 0 0 0 0 12.1953 0 0 11.9681 0 0 0 0 0 0 0 14.3567 12.6366 0 0 0 0 0 0 0 13.2357 10.6579 0 12.0504 0 12.2143 14.4609 0 10.9794 0 0 0 0 0 10.5566 12.339 0 0 0 0 0 0 10.8135 0 0 0 0 0 0 O94919 ENDD1_HUMAN "Endonuclease domain-containing 1 protein, EC 3.1.30.-" ENDOD1 KIAA0830 Homo sapiens (Human) innate immune response [GO:0045087] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; innate immune response [GO:0045087] GO:0003676; GO:0004519; GO:0005576; GO:0005829; GO:0016020; GO:0045087; GO:0046872; GO:0070062 endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676] AICRVLSIPVR 0.98499 -2.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6956 0 0 0 0 0 0 0 13.7694 0 16.2444 16.0276 14.9249 14.0524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9397 0 0 0 0 13.5926 0 0 0 13.8695 0 0 0 12.8426 0 0 0 13.0926 12.7705 12.4177 0 0 0 0 0 0 0 0 0 0 0 0 11.971 0 11.7679 0 0 0 0 0 0 12.9663 0 14.686 0 0 0 12.7421 0 0 12.0822 0 0 12.626 0 0 0 0 0 13.896 0 0 13.5217 0 0 0 0 11.7515 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6496 11.1158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8969 0 0 0 0 0 0 P0C6A0 ZGLP1_HUMAN "GATA-type zinc finger protein 1 (GATA-like protein 1, GLP-1)" ZGLP1 GLP1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000122; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0007283; GO:0008270; GO:0043565; GO:0045944; GO:0048599 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]" CASCRTQRTPLWR 0.98499 -2.5189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0356 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1432 0 15.1179 13.3154 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6062 14.5815 14.7407 0 0 0 0 0 14.0247 0 0 0 14.3894 0 14.3572 14.3207 14.2447 14.3829 15.0248 0 0 0 0 15.0072 0 0 0 0 14.0094 11.6444 13.6986 13.7811 0 0 0 0 14.3394 14.0691 0 0 0 14.2208 13.2892 0 13.6784 0 0 0 13.7569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.036 13.8585 0 0 0 0 0 0 Q14135 VGLL4_HUMAN "Transcription cofactor vestigial-like protein 4, Vgl-4" VGLL4 KIAA0121 Homo sapiens (Human) "negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell growth [GO:0030308]; negative regulation of hippo signaling [GO:0035331]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein catabolic process [GO:0045732]" nucleus [GO:0005634] "nucleus [GO:0005634]; transcription coactivator binding [GO:0001223]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell growth [GO:0030308]; negative regulation of hippo signaling [GO:0035331]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of protein catabolic process [GO:0045732]" GO:0001223; GO:0005634; GO:0030178; GO:0030308; GO:0035331; GO:0045732; GO:0045892; GO:0060044 transcription coactivator binding [GO:0001223] AASLVHADDEK 0.98499 -2.6896 0 0 0 0 0 0 0 0 0 0 15.2992 0 0 0 0 0 0 0 0 11.5367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9819 0 0 0 14.0754 13.9318 0 0 14.3791 0 0 0 0 0 0 0 0 0 0 0 13.9152 0 13.7885 0 0 0 0 0 0 0 0 0 0 13.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0914 0 0 0 0 0 0 0 0 Q8N8P6 YX004_HUMAN Putative uncharacterized protein FLJ39060 Homo sapiens (Human) ELRISHWPNECIR 0.98499 -2.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5619 0 0 0 0 0 0 0 0 0 0 Q96GI7 FA89A_HUMAN Protein FAM89A FAM89A C1orf153 Homo sapiens (Human) GGPGGGGAR 0.985 -3.431 11.8253 11.616 0 0 0 13.4522 0 0 0 10.6436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9333 0 0 0 0 0 0 0 11.8136 0 0 0 0 0 0 0 0 0 0 0 12.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8235 0 0 12.9897 12.8048 0 0 0 0 11.3826 0 0 0 0 0 11.9302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L21 RL10L_HUMAN 60S ribosomal protein L10-like (Large ribosomal subunit protein uL16-like) RPL10L Homo sapiens (Human) cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412] cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ribosome [GO:0005840] cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; ribosomal large subunit assembly [GO:0000027]; spermatogenesis [GO:0007283]; translation [GO:0006412] GO:0000027; GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0005840; GO:0005844; GO:0006412; GO:0007141; GO:0007283; GO:0016020; GO:0022625; GO:0030154 structural constituent of ribosome [GO:0003735] LHPFHVIR 0.985 -2.6962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5999 0 0 14.3423 0 13.063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PG2 M4A10_HUMAN Membrane-spanning 4-domains subfamily A member 10 (CD20 antigen-like 7) MS4A10 CD20L7 MS4A9 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166] GO:0005886; GO:0007166; GO:0016021 DLFLESPFESPIWR 0.985 -3.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3118 11.8016 0 0 0 12.185 0 0 15.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5754 0 0 0 0 0 0 11.0137 0 0 0 0 0 0 0 0 15.3682 0 0 0 0 0 0 0 0 0 0 0 0 12.461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.272 0 0 0 0 0 0 0 0 0 Q99612 KLF6_HUMAN Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9) KLF6 BCD1 COPEB CPBP ST12 Homo sapiens (Human) "B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0030183; GO:0043231; GO:0045893; GO:0045944; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CHFNGCRK 0.985 -1.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0876 0 0 13.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVA6 FICD_HUMAN "Protein adenylyltransferase FICD, EC 2.7.7.n1 (AMPylator FICD) (De-AMPylase FICD, EC 3.1.4.-) (FIC domain-containing protein) (Huntingtin yeast partner E) (Huntingtin-interacting protein 13, HIP-13) (Huntingtin-interacting protein E)" FICD HIP13 HYPE UNQ3041/PRO9857 Homo sapiens (Human) negative regulation of GTPase activity [GO:0034260]; protein adenylylation [GO:0018117]; protein deadenylylation [GO:0044602]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] integral component of endoplasmic reticulum membrane [GO:0030176] integral component of endoplasmic reticulum membrane [GO:0030176]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein adenylylhydrolase activity [GO:0044603]; protein adenylyltransferase activity [GO:0070733]; protein homodimerization activity [GO:0042803]; negative regulation of GTPase activity [GO:0034260]; protein adenylylation [GO:0018117]; protein deadenylylation [GO:0044602]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] GO:0005524; GO:0006986; GO:0018117; GO:0030176; GO:0030544; GO:0034260; GO:0034976; GO:0042802; GO:0042803; GO:0044602; GO:0044603; GO:0051087; GO:0070733; GO:1903894 ATP binding [GO:0005524]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein adenylylhydrolase activity [GO:0044603]; protein adenylyltransferase activity [GO:0070733]; protein homodimerization activity [GO:0042803] CTSPSTELSITSRGATLLVAKTK 0.985 -3.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7402 0 0 0 0 10.5812 0 0 12.4547 0 0 0 0 15.5003 15.978 0 0 0 14.9286 0 0 0 14.611 0 0 0 0 0 0 0 0 13.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZJ7 GPR62_HUMAN "G-protein coupled receptor 62 (G-protein coupled receptor GPCR8, hGPCR8) (G-protein coupled receptor KPG_005)" GPR62 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate-mediated signaling [GO:0048016]; positive regulation of cAMP-mediated signaling [GO:0043950] endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; arrestin family protein binding [GO:1990763]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate-mediated signaling [GO:0048016]; positive regulation of cAMP-mediated signaling [GO:0043950] GO:0004930; GO:0005768; GO:0005886; GO:0007186; GO:0007189; GO:0010008; GO:0016021; GO:0042802; GO:0043235; GO:0043950; GO:0048016; GO:1990763 arrestin family protein binding [GO:1990763]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802] LSILPPLRPRLPGGK 0.985 -1.5277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.036 0 12.1896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6805 0 11.3372 0 0 13.388 13.983 0 13.9253 10.2802 0 0 0 0 11.6534 0 0 0 14.3778 0 14.0599 0 0 0 0 0 11.6382 0 14.271 0 13.8626 13.6687 0 13.8498 0 13.7932 0 0 0 0 0 0 0 0 0 0 0 13.4521 0 0 13.0724 0 0 0 18.0912 0 13.2862 0 0 0 0 13.2755 0 0 0 0 13.9719 0 0 0 13.9951 0 0 0 0 11.2911 0 0 0 0 0 0 13.8347 13.5622 0 15.2742 12.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4015 0 0 Q9HA38 ZMAT3_HUMAN Zinc finger matrin-type protein 3 (Zinc finger protein WIG-1) (p53-activated gene 608 protein) ZMAT3 PAG608 WIG1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; protein transport [GO:0015031]; regulation of growth [GO:0040008] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; protein transport [GO:0015031]; regulation of growth [GO:0040008] GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0006915; GO:0006974; GO:0008270; GO:0015031; GO:0040008 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] ILLQHAVLPPPKQPSPSPPMSVATRSTGTLQLPPQK 0.985 -2.7004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6571 0 0 0 0 0 0 0 0 0 0 12.9772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5Y9 SCNAA_HUMAN "Sodium channel protein type 10 subunit alpha (Peripheral nerve sodium channel 3, PN3, hPN3) (Sodium channel protein type X subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.8)" SCN10A Homo sapiens (Human) AV node cell action potential [GO:0086016]; bundle of His cell action potential [GO:0086043]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; clathrin complex [GO:0071439]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; clathrin complex [GO:0071439]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of presynaptic membrane [GO:0099056]; voltage-gated sodium channel complex [GO:0001518]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; AV node cell action potential [GO:0086016]; bundle of His cell action potential [GO:0086043]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of ion transmembrane transport [GO:0034765]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725] GO:0001518; GO:0002027; GO:0005244; GO:0005248; GO:0007600; GO:0019228; GO:0019233; GO:0030424; GO:0034765; GO:0035725; GO:0042475; GO:0044325; GO:0055117; GO:0060371; GO:0070062; GO:0071439; GO:0086010; GO:0086016; GO:0086043; GO:0098978; GO:0099056 transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] ALKTVSVIPGLK 0.985 -2.1485 0 0 0 10.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8196 0 0 0 12.084 0 0 0 11.0717 0 0 0 0 11.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.392 10.1399 0 0 0 12.7908 0 12.9688 0 0 15.0612 0 0 12.244 0 0 0 0 13.9773 0 0 0 0 0 0 0 0 0 14.3171 0 12.993 0 14.7662 0 0 0 14.8071 0 12.6284 0 0 0 0 14.0585 0 0 0 13.9113 14.0692 0 0 13.7343 0 0 0 0 0 0 15.129 15.8227 14.959 14.3202 0 0 11.7039 0 13.3625 0 14.3907 16.7756 16.0878 0 16.8959 14.9883 0 0 0 0 15.7087 13.7058 0 0 0 0 11.9679 0 0 0 0 0 0 0 0 0 0 0 0 11.128 12.4508 0 13.7359 16.3462 16.3774 0 12.3359 0 0 0 A0A1W2PPG7 GBG14_HUMAN Putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 GNG14 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] heterotrimeric G-protein complex [GO:0005834] heterotrimeric G-protein complex [GO:0005834]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0005834; GO:0007186; GO:0031681 G-protein beta-subunit binding [GO:0031681] EKKPYAIL 0.98501 -2.7041 0 0 0 0 0 0 0 0 0 0 12.0549 0 0 11.8222 11.5162 0 0 0 0 11.4156 0 0 0 0 0 0 0 0 0 0 0 14.6035 0 0 0 0 0 0 0 0 0 0 0 0 0 11.621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.19 0 0 0 0 0 0 0 0 0 13.5813 13.2879 13.326 13.4355 13.4152 0 0 13.2514 14.0027 13.2618 13.2815 0 0 13.11 0 0 0 0 0 0 13.4993 0 0 B1AH88 TSPOB_HUMAN Putative peripheral benzodiazepine receptor-related protein TSPO PBRS Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] GO:0005739; GO:0005829; GO:0043231 DCSCTSR 0.98501 -3.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5929 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7457 0 11.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04201 MAS_HUMAN Proto-oncogene Mas MAS1 MAS Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; G protein-coupled receptor signaling pathway [GO:0007186]; hippocampus development [GO:0021766]; male gonad development [GO:0008584]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; protein kinase C signaling [GO:0070528]; regulation of inflammatory response [GO:0050727]; response to activity [GO:0014823]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; angiotensin receptor activity [GO:0001595]; angiotensin type II receptor activity [GO:0004945]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; G protein-coupled receptor signaling pathway [GO:0007186]; hippocampus development [GO:0021766]; male gonad development [GO:0008584]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; protein kinase C signaling [GO:0070528]; regulation of inflammatory response [GO:0050727]; response to activity [GO:0014823]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283] GO:0001595; GO:0001933; GO:0004930; GO:0004945; GO:0005886; GO:0005887; GO:0007186; GO:0007250; GO:0007283; GO:0008284; GO:0008584; GO:0009410; GO:0009986; GO:0014823; GO:0021766; GO:0034698; GO:0042277; GO:0045740; GO:0050727; GO:0060732; GO:0070528 angiotensin receptor activity [GO:0001595]; angiotensin type II receptor activity [GO:0004945]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277] AVIIFIAILSFLVFTPLMLVSSTILVVK 0.98501 -3.4359 0 0 0 0 0 0 0 0 0 0 0 11.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0801 0 0 0 12.5749 0 0 14.5115 0 0 0 0 0 0 0 14.981 16.5537 15.5893 0 14.6501 15.981 14.0311 0 14.5926 14.4186 13.8725 14.2371 14.1853 0 0 13.2662 0 14.3152 13.6833 14.1671 16.8147 0 15.6494 15.369 16.7546 13.8152 11.9032 0 14.6276 0 0 0 0 0 0 13.4385 13.3183 13.9996 0 11.6302 16.4919 0 15.0017 0 14.4941 14.5593 0 0 0 0 0 0 0 0 0 0 14.7231 13.7878 0 0 0 0 0 12.0717 12.5468 12.1098 16.3778 0 0 12.6115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6711 0 0 0 11.509 11.7004 13.5427 0 0 P06731 CEAM5_HUMAN "Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen, CEA) (Meconium antigen 100) (CD antigen CD66e)" CEACAM5 CEA Homo sapiens (Human) apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; homotypic cell-cell adhesion [GO:0034109]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myotube differentiation [GO:0010832] GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007156; GO:0007157; GO:0009986; GO:0010832; GO:0016323; GO:0016324; GO:0031225; GO:0034109; GO:0034235; GO:0042802; GO:0042803; GO:0043066; GO:0070062; GO:2000811 GPI anchor binding [GO:0034235]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] EVLLLVHNLPQHLFGYSWYK 0.98501 -3.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9376 0 0 0 0 0 0 0 0 0 0 0 11.4478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9553 13.586 0 0 0 0 0 0 0 0 12.5194 0 0 0 13.2625 0 0 0 0 12.6174 0 13.4163 0 0 0 0 0 0 0 0 0 12.8576 0 13.2614 0 0 13.2718 0 12.7348 13.0554 0 0 0 13.6663 13.9987 12.7206 0 0 0 0 0 0 0 14.1116 0 0 0 0 0 14.0881 13.69 0 13.8789 13.8293 0 12.7474 0 0 13.1137 0 0 0 0 0 0 0 0 0 0 13.6922 12.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV22 NSE1_HUMAN "Non-structural maintenance of chromosomes element 1 homolog, Non-SMC element 1 homolog, EC 2.3.2.27" NSMCE1 HSPC333 HSPC337 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; postreplication repair [GO:0006301]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; postreplication repair [GO:0006301]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" GO:0000724; GO:0000781; GO:0004842; GO:0005634; GO:0005654; GO:0006301; GO:0016925; GO:0030915; GO:0032204; GO:0043231; GO:0046872; GO:0046983; GO:0061630; GO:2001022 metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] FVQNKWLIEK 0.98501 -2.1512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2284 0 0 12.4281 0 13.0659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7998 10.6945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4238 0 0 0 12.5392 15.1149 0 0 0 0 0 0 13.2256 0 0 0 0 12.8232 0 0 0 0 0 0 0 0 0 13.7475 13.4982 13.1944 0 0 0 0 0 13.0915 13.9425 0 0 0 0 0 0 0 0 0 0 0 0 13.5609 13.3489 14.6041 0 14.0452 0 0 0 0 0 14.643 0 0 0 0 13.7607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4525 0 Q9BTV6 DPH7_HUMAN "Diphthine methyltransferase, EC 3.1.1.97 (Diphthamide biosynthesis protein 7) (WD repeat-containing protein 85)" DPH7 C9orf112 WDR85 Homo sapiens (Human) peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; diphthine methylesterase activity [GO:0061685]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] GO:0005737; GO:0017183; GO:0061685 diphthine methylesterase activity [GO:0061685] EDNDGEGHAR 0.98501 -2.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1154 0 0 0 0 0 0 0 0 0 0 0 12.452 0 0 0 0 0 0 0 0 0 12.1068 0 0 0 0 0 0 0 0 12.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0003 0 11.4995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZA8 PC11Y_HUMAN "Protocadherin-11 Y-linked, Protocadherin-11 (Protocadherin on the Y chromosome, PCDH-Y) (Protocadherin prostate cancer, Protocadherin-PC) (Protocadherin-22)" PCDH11Y PCDH11 PCDH22 PCDHY Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283] integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225] integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007283; GO:0030177; GO:0061827; GO:0097225 calcium ion binding [GO:0005509] ADDVDSDGNR 0.98501 -3.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2478 0 0 11.7406 0 0 0 0 0 0 0 0 0 11.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6872 0 0 14.5251 12.0815 12.223 0 0 0 0 0 0 0 0 13.3212 0 0 0 0 0 14.9179 0 0 0 0 0 0 12.4016 0 0 0 0 13.3534 15.382 15.3768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1152 0 0 0 0 0 0 0 0 0 12.4926 0 0 12.8884 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NSI1 AR26L_HUMAN Putative ankyrin repeat domain-containing protein 26-like protein ANKRD26P1 Homo sapiens (Human) GQGPSCSFTGCWCCR 0.98502 -3.0889 0 0 0 0 0 0 15.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.208 0 0 0 0 12.1799 13.7102 0 11.919 12.4646 0 0 0 0 0 0 11.6299 0 11.4857 0 0 0 0 0 0 0 0 12.9573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0372 0 0 0 0 0 0 0 13.3533 0 0 0 0 0 0 0 0 0 0 0 10.9133 0 0 12.1614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60779 S19A2_HUMAN "Thiamine transporter 1, ThTr-1, ThTr1 (Solute carrier family 19 member 2) (Thiamine carrier 1, TC1)" SLC19A2 THT1 TRMA Homo sapiens (Human) thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085] GO:0005886; GO:0008517; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934 folic acid transmembrane transporter activity [GO:0008517]; thiamine transmembrane transporter activity [GO:0015234] AAAAAATVLLRTARVR 0.98503 -2.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6753 0 0 0 10.7856 0 14.0127 0 14.6856 0 14.5475 0 0 0 0 0 0 0 0 0 0 0 0 12.6104 0 0 12.7383 0 0 0 0 0 0 0 13.2124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8208 12.4388 14.3975 0 0 13.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5754 0 13.4014 0 0 13.6331 13.4807 0 0 0 0 0 11.3029 0 0 0 0 0 0 0 0 0 0 P54826 GAS1_HUMAN "Growth arrest-specific protein 1, GAS-1" GAS1 Homo sapiens (Human) cell cycle [GO:0007049]; cell fate commitment [GO:0045165]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; developmental growth [GO:0048589]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; regulation of apoptotic process [GO:0042981]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589] anchored component of plasma membrane [GO:0046658]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell fate commitment [GO:0045165]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; developmental growth [GO:0048589]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein processing [GO:0010955]; regulation of apoptotic process [GO:0042981]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of smoothened signaling pathway [GO:0008589] GO:0005886; GO:0007049; GO:0008589; GO:0010955; GO:0016021; GO:0035924; GO:0042981; GO:0045165; GO:0045930; GO:0046658; GO:0048589; GO:0060628 GPALEDCDCAQDENCKSTK 0.98503 -3.8012 0 0 0 0 0 0 0 9.76515 12.5812 0 0 0 13.7248 0 0 0 0 0 0 12.5403 0 0 0 10.8595 0 0 0 0 0 0 0 12.8363 0 0 0 12.7072 0 13.7041 0 0 13.7093 0 0 0 0 0 0 0 0 0 0 0 13.5259 13.0311 12.9943 12.4368 0 0 11.3271 11.0056 0 0 0 0 0 0 0 11.5819 0 0 0 14.9689 0 13.9146 12.9477 13.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.395 0 16.1396 0 0 0 15.1877 0 14.9897 0 13.7794 0 13.0007 0 0 12.1448 14.0411 0 0 12.6385 0 0 0 0 13.1894 0 0 12.9872 12.7585 12.9178 0 0 0 0 12.1443 0 0 12.3659 16.1634 0 0 0 0 0 0 11.7744 0 16.9082 15.238 15.0512 16.3931 16.3545 16.6705 16.2162 16.6785 16.5449 16.227 16.5615 15.5556 14.7525 17.2284 17.7597 12.6905 0 0 0 16.1176 0 15.3354 0 0 Q04725 TLE2_HUMAN "Transducin-like enhancer protein 2 (Enhancer of split groucho-like protein 2, ESG2)" TLE2 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" GO:0003714; GO:0005615; GO:0005634; GO:0005654; GO:0005667; GO:0005925; GO:0007165; GO:0009887; GO:0016055; GO:0016604; GO:0045892; GO:0090090 transcription corepressor activity [GO:0003714] DLVDSPASLASSLGSPLPRAK 0.98503 -2.3256 0 0 0 0 0 0 0 0 0 0 15.3088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6507 0 0 0 0 0 0 14.682 14.9327 0 14.2929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4824 16.3234 0 15.9717 0 0 16.5516 0 16.4093 14.2255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5G6 PCDG7_HUMAN "Protocadherin gamma-A7, PCDH-gamma-A7" PCDHGA7 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] AAQPRGGDYR 0.98503 -3.0902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3877 0 0 12.6494 0 0 0 0 0 0 0 0 0 12.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6693 13.8646 0 0 0 0 13.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P71 NECA3_HUMAN N-terminal EF-hand calcium-binding protein 3 (Amyloid-beta A4 protein-binding family A member 2-binding protein) (Nek2-interacting protein 1) (Neuronal calcium-binding protein 3) (X11L-binding protein 51) NECAB3 APBA2BP NIP1 SYTIP2 XB51 Homo sapiens (Human) protein metabolic process [GO:0019538]; protein secretion [GO:0009306]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; protein metabolic process [GO:0019538]; protein secretion [GO:0009306]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] GO:0000137; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0009306; GO:0019538; GO:0042984 calcium ion binding [GO:0005509] AVGPGPHK 0.98504 -2.7191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9578 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1626 0 0 0 13.3157 12.8454 9.80449 0 0 12.1876 0 12.6425 11.782 12.6294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9639 0 0 0 0 0 0 14.9635 0 0 0 0 16.0106 0 13.9421 0 0 0 0 0 14.0878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRS2 RIOK1_HUMAN "Serine/threonine-protein kinase RIO1, EC 2.7.11.1, EC 3.6.3.- (RIO kinase 1)" RIOK1 RIO1 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490]; phosphorylation [GO:0016310]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274] "cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; phosphorylation [GO:0016310]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]" GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016310; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234 ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ARELYLQVIQYMR 0.98504 -2.7103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7951 0 0 0 12.7075 0 0 0 0 0 0 13.7867 0 0 14.5892 0 0 0 0 0 0 0 0 0 0 0 0 12.8894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2658 0 0 0 14.22 0 0 0 0 0 0 0 0 0 0 0 11.8284 0 0 0 0 0 14.3229 0 0 0 14.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0904 0 14.2524 0 Q9UQC9 CLCA2_HUMAN "Calcium-activated chloride channel regulator 2, EC 3.4.-.- (Calcium-activated chloride channel family member 2, hCLCA2) (Calcium-activated chloride channel protein 3, CaCC-3, hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form ]" CLCA2 CACC3 Homo sapiens (Human) cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] anchoring junction [GO:0070161]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; basal plasma membrane [GO:0009925]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell adhesion [GO:0007155]; ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0007155; GO:0009925; GO:0015276; GO:0030054; GO:0031965; GO:0034220; GO:0046872; GO:0070161 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; ligand-gated ion channel activity [GO:0015276]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] ILIPATWK 0.98504 -2.9938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1328 0 13.5233 0 0 0 0 0 0 11.4462 0 0 13.3453 13.4893 14.1829 0 0 13.2537 0 0 0 0 0 0 0 12.9865 0 0 0 0 0 0 0 13.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5223 0 0 0 15.7487 0 0 0 0 0 0 14.1195 13.9861 13.2935 0 12.9637 12.5157 11.5727 0 12.6748 0 0 0 12.4693 13.2917 14.0199 0 0 0 0 0 13.5075 0 13.1513 0 0 0 0 0 0 0 0 13.5405 0 0 0 0 0 0 0 13.1848 13.3283 0 0 0 0 0 0 0 0 0 12.4772 0 0 0 0 C9JTQ0 ANR63_HUMAN Ankyrin repeat domain-containing protein 63 ANKRD63 Homo sapiens (Human) LLLEQGAAVNLRDER 0.98505 -2.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.04 0 0 0 0 0 0 0 12.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7187 0 0 0 0 0 0 0 0 0 14.186 0 0 0 0 0 0 12.7013 0 0 0 0 0 0 0 0 0 12.6238 0 0 0 0 0 0 0 0 12.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14522 PTPRT_HUMAN "Receptor-type tyrosine-protein phosphatase T, R-PTP-T, EC 3.1.3.48 (Receptor-type tyrosine-protein phosphatase rho, RPTP-rho)" PTPRT KIAA0283 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007156; GO:0007165; GO:0007169; GO:0008013; GO:0009986; GO:0016021; GO:0016790; GO:0019903; GO:0030336; GO:0035335; GO:0042803; GO:0045294; GO:0045295; GO:0045296; GO:0051393; GO:0070097; GO:0071354; GO:0097677; GO:1904893; GO:1990264 alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] ARQLTLQWEPFGYAVTR 0.98505 -2.9987 0 0 0 0 0 0 0 0 0 0 12.9411 0 0 14.5093 0 0 0 0 0 12.5731 0 0 0 0 12.3157 0 0 0 12.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3235 11.9617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.079 0 0 0 0 0 0 0 15.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9986 0 0 0 0 0 0 0 0 0 13.7124 0 0 0 0 0 0 0 0 0 0 15.0158 0 0 0 0 0 0 0 13.8565 0 12.1447 0 0 P52803 EFNA5_HUMAN "Ephrin-A5 (AL-1) (EPH-related receptor tyrosine kinase ligand 7, LERK-7)" EFNA5 EPLG7 LERK7 Homo sapiens (Human) axon guidance [GO:0007411]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to forskolin [GO:1904322]; collateral sprouting [GO:0048668]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; nervous system development [GO:0007399]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell morphogenesis [GO:0022604]; regulation of cell-cell adhesion [GO:0022407]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of microtubule cytoskeleton organization [GO:0070507]; retinal ganglion cell axon guidance [GO:0031290]; synaptic membrane adhesion [GO:0099560] adherens junction [GO:0005912]; anchored component of external side of plasma membrane [GO:0031362]; basement membrane [GO:0005604]; caveola [GO:0005901]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; anchored component of external side of plasma membrane [GO:0031362]; basement membrane [GO:0005604]; caveola [GO:0005901]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; neurotrophin TRKA receptor binding [GO:0005168]; neurotrophin TRKB receptor binding [GO:0005169]; neurotrophin TRKC receptor binding [GO:0005170]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; axon guidance [GO:0007411]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to forskolin [GO:1904322]; collateral sprouting [GO:0048668]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; nervous system development [GO:0007399]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell morphogenesis [GO:0022604]; regulation of cell-cell adhesion [GO:0022407]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of microtubule cytoskeleton organization [GO:0070507]; retinal ganglion cell axon guidance [GO:0031290]; synaptic membrane adhesion [GO:0099560] GO:0001934; GO:0005168; GO:0005169; GO:0005170; GO:0005604; GO:0005886; GO:0005901; GO:0005912; GO:0007399; GO:0007411; GO:0022407; GO:0022604; GO:0030297; GO:0031290; GO:0031362; GO:0032956; GO:0043087; GO:0045499; GO:0046875; GO:0048013; GO:0048668; GO:0048672; GO:0050731; GO:0051893; GO:0051965; GO:0061178; GO:0070507; GO:0071372; GO:0098982; GO:0099560; GO:1900025; GO:1904322 chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; neurotrophin TRKA receptor binding [GO:0005168]; neurotrophin TRKB receptor binding [GO:0005169]; neurotrophin TRKC receptor binding [GO:0005170]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] GFKRWECNR 0.98505 -3.0034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.152 11.3567 11.9536 0 0 0 0 11.0308 0 0 0 0 0 0 0 0 0 0 12.4024 0 10.7712 0 0 0 0 0 0 0 0 0 11.8284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3269 0 0 0 0 0 0 0 0 10.619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8482 0 0 0 0 0 0 0 0 Q86YR5 GPSM1_HUMAN G-protein-signaling modulator 1 (Activator of G-protein signaling 3) GPSM1 AGS3 Homo sapiens (Human) cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239] GO:0000132; GO:0000139; GO:0001965; GO:0005092; GO:0005789; GO:0005829; GO:0005886; GO:0007399; GO:0016239; GO:0030154; GO:0032991; GO:0034260; GO:1905098 G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092] ASEFYER 0.98505 -3.0026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1608 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7344 0 0 0 0 0 11.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.96292 0 0 0 0 0 0 0 0 0 0 14.1769 0 0 0 0 0 0 0 0 0 10.6922 13.2577 0 0 0 0 0 0 13.1517 0 0 0 0 0 0 0 12.8879 9.51394 0 0 0 0 0 0 0 0 0 10.3142 0 10.6925 0 0 0 13.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 0 0 0 0 0 0 A2RUU4 COLL1_HUMAN Colipase-like protein 1 CLPSL1 C6orf127 Homo sapiens (Human) digestion [GO:0007586]; lipid catabolic process [GO:0016042]; response to food [GO:0032094] extracellular region [GO:0005576] extracellular region [GO:0005576]; enzyme activator activity [GO:0008047]; digestion [GO:0007586]; lipid catabolic process [GO:0016042]; response to food [GO:0032094] GO:0005576; GO:0007586; GO:0008047; GO:0016042; GO:0032094 enzyme activator activity [GO:0008047] APDNCESHCAEK 0.98506 -2.9155 0 0 0 0 0 0 0 0 0 11.4794 0 0 14.3171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0114 10.4834 14.0962 0 10.513 0 14.7383 15.8758 0 0 0 0 0 0 10.2642 0 0 0 0 0 0 0 13.7153 0 0 0 11.9145 0 0 0 0 0 0 0 14.6175 11.64 0 0 14.5533 14.8621 0 0 0 0 0 0 0 0 0 0 15.0803 14.3998 0 0 0 0 0 0 0 13.7953 0 0 0 0 11.2482 0 0 14.2591 0 0 13.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.273 0 0 0 0 13.4873 0 0 P51692 STA5B_HUMAN Signal transducer and activator of transcription 5B STAT5B Homo sapiens (Human) activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; erythrocyte differentiation [GO:0030218]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; mitotic cell cycle [GO:0000278]; myeloid cell apoptotic process [GO:0033028]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; natural killer cell proliferation [GO:0001787]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of myeloid cell apoptotic process [GO:0033033]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; erythrocyte differentiation [GO:0030218]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; mitotic cell cycle [GO:0000278]; myeloid cell apoptotic process [GO:0033028]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; natural killer cell proliferation [GO:0001787]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of myeloid cell apoptotic process [GO:0033033]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366]" GO:0000278; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001553; GO:0001779; GO:0001787; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0006952; GO:0007259; GO:0007565; GO:0007595; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030183; GO:0030218; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0032870; GO:0033028; GO:0033033; GO:0033077; GO:0035259; GO:0040014; GO:0040018; GO:0042104; GO:0042127; GO:0042267; GO:0042448; GO:0042492; GO:0042802; GO:0042803; GO:0043029; GO:0043434; GO:0045579; GO:0045588; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0050798; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0090575; GO:0097531 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ATIISEQQAKSLLK 0.98506 -2.5622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5909 0 0 0 0 0 0 15.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3Y1 FBXW8_HUMAN F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8) (F-box only protein 29) FBXW8 FBW6 FBW8 FBX29 FBXO29 FBXW6 Homo sapiens (Human) cell population proliferation [GO:0008283]; Golgi organization [GO:0007030]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription factor catabolic process [GO:1901485]; protein ubiquitination [GO:0016567]; spongiotrophoblast layer development [GO:0060712] Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005] Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; cell population proliferation [GO:0008283]; Golgi organization [GO:0007030]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription factor catabolic process [GO:1901485]; protein ubiquitination [GO:0016567]; spongiotrophoblast layer development [GO:0060712] GO:0005794; GO:0005829; GO:0007030; GO:0008283; GO:0016567; GO:0019005; GO:0031467; GO:0048471; GO:0050775; GO:0060712; GO:0060716; GO:1901485 ILVYSLEAGRR 0.98506 -3.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7429 0 0 0 0 13.5255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3831 0 12.4252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2467 0 0 11.1413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6874 0 0 0 0 0 11.4608 0 0 13.7489 0 0 0 12.4119 0 0 0 0 0 13.1949 0 0 0 0 0 0 11.3724 0 Q96DM1 PGBD4_HUMAN PiggyBac transposable element-derived protein 4 PGBD4 Homo sapiens (Human) AQISLQKIKPVFDFLVNK 0.98506 -2.9125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0608 0 0 0 0 0 0 0 0 0 12.3382 0 0 0 0 0 0 10.8128 0 0 0 10.6153 0 0 14.2633 14.0301 14.1856 11.2658 16.178 13.7998 0 0 11.0227 13.9323 0 0 0 0 0 12.8493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087WWA1 P3URF_HUMAN PIK3R3 upstream open reading frame protein P3R3URF Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854] phosphatidylinositol 3-kinase complex [GO:0005942] phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] GO:0005942; GO:0046854; GO:0046935 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935] GPSRLVR 0.98507 -2.9256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.251 0 0 17.6283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GU71 C97D2_HUMAN Uncharacterized protein CFAP97D2 (CFAP97 domain-containing protein 2) CFAP97D2 Homo sapiens (Human) APLTFRHLHLK 0.98507 -2.7413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7688 0 0 0 0 0 0 0 16.2245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75581 LRP6_HUMAN "Low-density lipoprotein receptor-related protein 6, LRP-6" LRP6 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] "cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" GO:0001933; GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006469; GO:0007204; GO:0007268; GO:0009986; GO:0014029; GO:0014033; GO:0016021; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0044335; GO:0044340; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0051091; GO:0060070; GO:0071397; GO:0071542; GO:0071901; GO:0071936; GO:0072659; GO:0090118; GO:0090244; GO:0098609; GO:1904928; GO:1904948; GO:1904953; GO:1990851; GO:1990909 coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] AVVVNPEK 0.98507 -2.9231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6951 0 0 0 0 0 0 0 0 14.3054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9292 0 0 0 0 0 0 0 0 10.3055 0 0 0 0 0 0 0 0 0 0 0 14.0084 0 0 14.1769 0 0 0 0 0 0 14.3947 0 0 14.4338 0 0 0 0 0 0 0 0 14.3381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01833 PIGR_HUMAN "Polymeric immunoglobulin receptor, PIgR, Poly-Ig receptor (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component ]" PIGR Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc receptor signaling pathway [GO:0038093]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; receptor clustering [GO:0043113]; retina homeostasis [GO:0001895] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory IgA immunoglobulin complex [GO:0071751] azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory IgA immunoglobulin complex [GO:0071751]; polymeric immunoglobulin receptor activity [GO:0001792]; transmembrane signaling receptor activity [GO:0004888]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc receptor signaling pathway [GO:0038093]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; receptor clustering [GO:0043113]; retina homeostasis [GO:0001895] GO:0001580; GO:0001792; GO:0001895; GO:0002415; GO:0004888; GO:0005615; GO:0005886; GO:0005887; GO:0007173; GO:0035577; GO:0038093; GO:0043113; GO:0043235; GO:0070062; GO:0071751 polymeric immunoglobulin receptor activity [GO:0001792]; transmembrane signaling receptor activity [GO:0004888] ADAAPDEKVLDSGFR 0.98507 -2.1175 0 0 0 0 0 0 0 0 10.8312 0 11.1042 0 0 0 0 0 0 0 12.2057 0 14.58 0 0 0 0 0 12.289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8562 0 0 0 11.1297 12.3494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7248 12.6089 12.6295 0 0 12.5347 0 16.6841 16.5797 0 17.8138 11.3766 17.4073 0 16.0845 16.6382 16.1561 17.1915 12.9835 0 16.6646 16.6227 0 0 16.0547 14.4725 0 15.0897 0 16.5896 17.3113 0 13.9461 14.2832 13.9204 12.6461 0 0 16.9751 15.9418 15.768 14.9177 0 0 13.8449 11.288 15.9281 16.3045 14.4218 0 15.2206 14.6204 14.8198 15.7949 13.3487 13.1659 12.9677 0 0 0 13.4151 13.8449 14.6568 0 0 12.8474 14.84 12.2621 13.1928 0 0 0 0 0 11.1319 12.0151 0 0 12.9038 0 15.3318 0 14.6684 0 0 12.7514 0 0 14.7573 14.0877 0 0 11.5106 12.4345 12.6558 0 14.2986 13.6478 0 13.1665 0 11.606 13.4441 0 0 P04217 A1BG_HUMAN Alpha-1B-glycoprotein (Alpha-1-B glycoprotein) A1BG Homo sapiens (Human) blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774] GO:0005576; GO:0005615; GO:0031093; GO:0034774; GO:0062023; GO:0070062; GO:0072562; GO:1904813 GVTFLLRR 0.98507 -2.9167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15882 CHIN_HUMAN "N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin, NC) (Rho GTPase-activating protein 2)" CHN1 ARHGAP2 CHN Homo sapiens (Human) ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; positive regulation of GTPase activity [GO:0043547]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; positive regulation of GTPase activity [GO:0043547]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005096; GO:0005829; GO:0008045; GO:0043087; GO:0043547; GO:0046872; GO:0046875; GO:0048013; GO:0050770; GO:0051056 ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] ENEQIPKYEKIHNFK 0.98507 -2.8329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0415 13.0928 0 13.1726 0 0 0 0 0 0 15.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.34 0 0 0 0 0 Q8N0U4 F185A_HUMAN Protein FAM185A FAM185A Homo sapiens (Human) ARLPCHLAVR 0.98507 -2.1209 0 0 0 0 0 0 0 0 0 0 16.0112 15.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N159 NAGS_HUMAN "N-acetylglutamate synthase, mitochondrial, EC 2.3.1.1 (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form ]" NAGS Homo sapiens (Human) arginine biosynthetic process [GO:0006526]; glutamate metabolic process [GO:0006536]; urea cycle [GO:0000050] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; methione N-acyltransferase activity [GO:0103045]; arginine biosynthetic process [GO:0006526]; glutamate metabolic process [GO:0006536]; urea cycle [GO:0000050] GO:0000050; GO:0004042; GO:0005739; GO:0005759; GO:0006526; GO:0006536; GO:0103045 acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; methione N-acyltransferase activity [GO:0103045] GGTGGAR 0.98507 -3.412 19.7466 19.6529 19.3861 0 0 0 18.9718 0 0 0 0 0 0 0 0 11.9565 0 0 0 0 0 0 11.9751 19.3648 12.4495 12.0642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1708 0 0 12.2544 0 0 0 0 10.0828 12.4283 12.5606 0 10.8816 0 0 0 10.1114 0 9.90504 0 0 0 0 0 0 0 13.733 0 0 0 0 0 0 19.6042 19.6696 19.6912 16.3449 0 0 0 16.4833 0 0 0 13.6185 0 0 0 0 15.1154 13.9528 0 15.2152 0 0 16.5113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9795 0 0 13.9076 12.9678 0 0 0 13.7124 13.6976 0 0 0 16.652 17.0006 0 13.4596 10.942 0 13.288 0 0 0 0 13.7128 0 0 0 13.6761 0 19.8276 19.899 16.275 19.8932 13.6037 0 0 0 0 0 10.8424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91386 0 0 15.8833 Q8NEM1 ZN680_HUMAN Zinc finger protein 680 ZNF680 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSLFSILSKHK 0.98507 -2.9207 0 0 0 0 0 0 0 0 0 10.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8818 13.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3016 0 0 16.5467 0 0 0 11.1191 16.3406 0 11.6915 0 0 12.3837 0 17.0236 0 0 10.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 11.335 0 0 0 0 0 0 0 0 13.5944 0 0 11.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.665 0 0 0 0 0 0 0 0 0 11.2062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0243 0 Q969L4 LSM10_HUMAN U7 snRNA-associated Sm-like protein LSm10 LSM10 Homo sapiens (Human) mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380] Cajal body [GO:0015030]; cytoplasmic U snRNP body [GO:0071254]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683] Cajal body [GO:0015030]; cytoplasmic U snRNP body [GO:0071254]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; U7 snRNP [GO:0005683]; histone pre-mRNA DCP binding [GO:0071208]; U7 snRNA binding [GO:0071209]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; RNA splicing [GO:0008380] GO:0005654; GO:0005683; GO:0006398; GO:0008380; GO:0015030; GO:0016604; GO:0071208; GO:0071209; GO:0071254; GO:1900087 histone pre-mRNA DCP binding [GO:0071208]; U7 snRNA binding [GO:0071209] NVRYVHIPDDVNITSTIEQQLQIIHRVR 0.98507 -1.4945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3619 13.3784 13.9332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RF0 SNX18_HUMAN Sorting nexin-18 (SH3 and PX domain-containing protein 3B) SNX18 SH3PXD3B Homo sapiens (Human) cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] "cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]" GO:0000281; GO:0005546; GO:0005886; GO:0006897; GO:0015031; GO:0016197; GO:0031234; GO:0031410; GO:0035091; GO:0036089; GO:0043547; GO:0055038; GO:0070062; GO:0097320; GO:2000786 "phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" ALRARALYDFR 0.98507 -2.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWH6 RPAP1_HUMAN RNA polymerase II-associated protein 1 RPAP1 KIAA1403 Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366] DNA-directed RNA polymerase complex [GO:0000428]; nucleus [GO:0005634] DNA-directed RNA polymerase complex [GO:0000428]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleotidyltransferase activity [GO:0016779]; transcription by RNA polymerase II [GO:0006366] GO:0000428; GO:0003677; GO:0005634; GO:0006366; GO:0016779 DNA binding [GO:0003677]; nucleotidyltransferase activity [GO:0016779] EDEDEDEECPAGK 0.98507 -1.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4022 11.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8787 0 13.1151 0 0 13.163 0 12.4099 14.2053 12.9986 0 0 14.1483 0 0 0 13.2042 0 0 0 0 0 0 12.4286 12.7974 0 0 13.3946 14.0207 0 13.8929 13.3818 0 12.7839 0 14.2707 13.5992 0 13.8991 13.6163 0 14.5916 14.356 0 0 14.5864 14.2259 0 14.9066 0 14.1429 0 0 0 13.0868 12.8043 0 0 0 0 0 0 0 14.0326 0 0 0 13.2983 0 12.9459 0 0 0 13.3731 0 13.2956 0 0 0 13.9972 14.7623 13.744 0 0 0 0 0 0 0 0 11.8052 0 0 0 0 0 0 0 0 14.492 0 0 0 16.5695 0 0 Q9C0A0 CNTP4_HUMAN Contactin-associated protein-like 4 (Cell recognition molecule Caspr4) CNTNAP4 CASPR4 KIAA1763 Homo sapiens (Human) "cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]" anchoring junction [GO:0070161]; cell projection [GO:0042995]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734] "anchoring junction [GO:0070161]; cell projection [GO:0042995]; integral component of membrane [GO:0016021]; presynaptic membrane [GO:0042734]; cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]" GO:0007155; GO:0016021; GO:0032225; GO:0032228; GO:0042734; GO:0042995; GO:0070161; GO:2000821 ARLFLLINSGEAK 0.98507 -3.4068 0 0 0 11.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0411 0 0 14.0463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0062 0 0 0 0 0 0 0 0 16.0548 11.8045 0 0 0 13.8173 0 0 13.4658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0554 0 0 13.6245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1071 0 0 0 0 0 0 0 0 0 0 0 0 16.2753 0 0 0 12.9884 0 0 0 0 0 0 0 12.8874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL51 HCN2_HUMAN "Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2, BCNG-2)" HCN2 BCNG2 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0005887; GO:0007267; GO:0008076; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0042802; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086091; GO:0098719; GO:0098855; GO:0098907; GO:1990573; GO:2001257 cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] DARGGGGR 0.98507 -2.1215 0 0 0 0 0 0 0 0 13.2057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0308 0 0 0 0 0 0 0 0 0 11.8347 13.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9YNA8 GAK19_HUMAN "Endogenous retrovirus group K member 19 Gag polyprotein (HERV-K(C19) Gag protein) (HERV-K_19q11 provirus ancestral Gag polyprotein, Gag polyprotein)" ERVK-19 Homo sapiens (Human) viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032] GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032 nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] ACDGMGGAMHK 0.98507 -2.9186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95931 CBX7_HUMAN Chromobox protein homolog 7 CBX7 Homo sapiens (Human) chromatin organization [GO:0006325]; developmental process involved in reproduction [GO:0003006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to xenobiotic stimulus [GO:0009410] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin organization [GO:0006325]; developmental process involved in reproduction [GO:0003006]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to xenobiotic stimulus [GO:0009410] GO:0000122; GO:0000785; GO:0003006; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0009410; GO:0031519; GO:0032968; GO:0035102 EAQAAEGFFR 0.98508 -2.3749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1993 11.1233 0 0 0 0 0 0 0 0 13.4001 0 13.196 12.335 0 0 0 11.1649 0 0 0 0 0 0 15.8659 0 0 0 13.6208 13.6779 0 0 0 0 0 0 0 0 0 13.1443 0 0 14.191 0 0 14.2696 0 17.0139 0 0 0 14.0136 0 14.9909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.026 0 0 0 14.0555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.434 0 0 0 0 0 0 14.2945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26374 RAE2_HUMAN "Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2, REP-2)" CHML REP2 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192] GO:0005092; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005968; GO:0006886; GO:0007264; GO:0016192; GO:0018344; GO:0031267 GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] LFTPYTETEINEEELTKPR 0.98508 -2.3705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4483 0 0 15.4536 0 0 0 13.7703 0 0 0 0 0 0 14.1698 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3841 13.6093 0 14.0479 0 0 13.895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52961 NAR1_HUMAN "GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1, EC 2.4.2.31 (ADP-ribosyltransferase C2 and C3 toxin-like 1, ARTC1) (Mono(ADP-ribosyl)transferase 1) (CD antigen CD296)" ART1 Homo sapiens (Human) peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] GO:0003950; GO:0005886; GO:0006471; GO:0009986; GO:0018120; GO:0031225; GO:0033017; GO:0106274 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274] IYLRALGK 0.98508 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13253 NOGG_HUMAN Noggin NOG Homo sapiens (Human) atrial cardiac muscle tissue morphogenesis [GO:0055009]; axial mesoderm development [GO:0048318]; BMP signaling pathway involved in heart development [GO:0061312]; cartilage development [GO:0051216]; cell differentiation in hindbrain [GO:0021533]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal system development [GO:0048706]; endocardial cushion morphogenesis [GO:0003203]; endoderm formation [GO:0001706]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; exploration behavior [GO:0035640]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060825]; heart trabecula morphogenesis [GO:0061384]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; membranous septum morphogenesis [GO:0003149]; mesoderm formation [GO:0001707]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell migration [GO:0030336]; negative regulation of cytokine activity [GO:0060302]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural plate morphogenesis [GO:0001839]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of transcription by RNA polymerase II [GO:0045944]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; prostatic bud formation [GO:0060513]; regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000313]; regulation of neuronal synaptic plasticity [GO:0048168]; short-term synaptic potentiation [GO:1990926]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; somite development [GO:0061053]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; ureteric bud formation [GO:0060676]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; visual learning [GO:0008542]; wound healing [GO:0042060] extracellular region [GO:0005576]; extracellular space [GO:0005615]; presynapse [GO:0098793] extracellular region [GO:0005576]; extracellular space [GO:0005615]; presynapse [GO:0098793]; cytokine binding [GO:0019955]; protein homodimerization activity [GO:0042803]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; axial mesoderm development [GO:0048318]; BMP signaling pathway involved in heart development [GO:0061312]; cartilage development [GO:0051216]; cell differentiation in hindbrain [GO:0021533]; cranial skeletal system development [GO:1904888]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal system development [GO:0048706]; endocardial cushion morphogenesis [GO:0003203]; endoderm formation [GO:0001706]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; exploration behavior [GO:0035640]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060825]; heart trabecula morphogenesis [GO:0061384]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; membranous septum morphogenesis [GO:0003149]; mesoderm formation [GO:0001707]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell migration [GO:0030336]; negative regulation of cytokine activity [GO:0060302]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural plate morphogenesis [GO:0001839]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of transcription by RNA polymerase II [GO:0045944]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; prostatic bud formation [GO:0060513]; regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000313]; regulation of neuronal synaptic plasticity [GO:0048168]; short-term synaptic potentiation [GO:1990926]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; somite development [GO:0061053]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; ureteric bud formation [GO:0060676]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; visual learning [GO:0008542]; wound healing [GO:0042060] GO:0000122; GO:0001501; GO:0001649; GO:0001701; GO:0001706; GO:0001707; GO:0001837; GO:0001839; GO:0001843; GO:0003149; GO:0003151; GO:0003203; GO:0003223; GO:0005576; GO:0005615; GO:0007224; GO:0007399; GO:0008045; GO:0008542; GO:0009953; GO:0010628; GO:0010629; GO:0019955; GO:0021510; GO:0021533; GO:0021983; GO:0030336; GO:0030514; GO:0035019; GO:0035640; GO:0042060; GO:0042474; GO:0042733; GO:0042803; GO:0045668; GO:0045944; GO:0048168; GO:0048318; GO:0048570; GO:0048706; GO:0048712; GO:0048863; GO:0050673; GO:0050679; GO:0051216; GO:0055009; GO:0060044; GO:0060173; GO:0060272; GO:0060291; GO:0060302; GO:0060325; GO:0060394; GO:0060412; GO:0060425; GO:0060513; GO:0060676; GO:0060825; GO:0061037; GO:0061053; GO:0061312; GO:0061384; GO:0061626; GO:0090090; GO:0090190; GO:0090193; GO:0098793; GO:0099171; GO:1904888; GO:1905006; GO:1990926; GO:2000313; GO:2001234 cytokine binding [GO:0019955]; protein homodimerization activity [GO:0042803] PSGAMPSEIK 0.98508 -2.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3172 0 0 0 0 0 0 0 0 0 0 12.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1244 0 0 12.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVL8 YP033_HUMAN Putative uncharacterized protein FLJ42384 Homo sapiens (Human) LVGRASPR 0.98508 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8737 0 0 0 0 14.0208 0 0 0 0 19.3385 0 0 0 0 19.649 0 0 0 0 0 0 0 0 0 0 19.7841 0 0 0 0 0 0 0 0 0 0 0 14.7194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4658 0 0 0 0 0 0 0 0 15.6366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDX5 ACMSD_HUMAN "2-amino-3-carboxymuconate-6-semialdehyde decarboxylase, EC 4.1.1.45 (Picolinate carboxylase)" ACMSD Homo sapiens (Human) negative regulation of quinolinate biosynthetic process [GO:1904985]; picolinic acid biosynthetic process [GO:1905004]; regulation of 'de novo' NAD biosynthetic process from tryptophan [GO:1905012]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]; picolinic acid biosynthetic process [GO:1905004]; regulation of 'de novo' NAD biosynthetic process from tryptophan [GO:1905012]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569] GO:0001760; GO:0005737; GO:0005829; GO:0006569; GO:0008270; GO:0016787; GO:0016831; GO:0019748; GO:1904985; GO:1905004; GO:1905012 aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270] ENCWDPEVR 0.98508 -2.3701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3569 0 11.9621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1491 0 0 0 11.3486 0 0 0 12.7832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3336 0 13.3444 0 0 0 0 0 13.806 0 0 0 0 0 0 0 0 0 15.1138 0 0 0 0 0 0 13.7528 0 0 0 0 0 0 11.6002 0 0 0 0 0 0 0 0 10.7072 0 0 0 0 0 0 0 0 12.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EL1 INKA1_HUMAN "PAK4-inhibitor INKA1 (Induced in neural crest by AP2-alpha protein homolog, HInca) (Inka box actin regulator 1)" INKA1 C3orf54 FAM212A Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291] GO:0005634; GO:0005737; GO:0019901; GO:0030291 protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291] FAALMSCR 0.98508 -3.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SZ5 AEDO_HUMAN "2-aminoethanethiol dioxygenase, EC 1.13.11.19 (Cysteamine dioxygenase)" ADO C10orf22 Homo sapiens (Human) cellular response to hypoxia [GO:0071456] cytosol [GO:0005829] cytosol [GO:0005829]; cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506]; cellular response to hypoxia [GO:0071456] GO:0005506; GO:0005829; GO:0047800; GO:0071456 cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506] IARQACLTFR 0.98508 -2.3696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8211 13.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5791 0 0 17.3357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8352 0 17.7708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRG2 SH23A_HUMAN SH2 domain-containing protein 3A (Novel SH2-containing protein 1) SH2D3A NSP1 UNQ175/PRO201 Homo sapiens (Human) JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264] GO:0001784; GO:0005085; GO:0007254; GO:0007264; GO:0033138 guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784] AAALRGLVELALALR 0.98508 -3.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.888 0 0 0 0 0 0 0 0 0 10.4987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4589 0 0 0 0 0 0 13.4106 0 13.3049 11.5454 0 0 0 17.7008 14.3624 14.4204 0 0 0 0 0 14.1314 0 14.4991 0 0 0 0 0 0 13.1693 12.7563 13.9261 13.1013 0 0 0 12.692 12.9638 13.1374 0 0 12.3689 0 12.8363 13.0311 13.1481 0 0 0 0 0 0 0 0 13.2789 0 14.3238 12.4781 0 15.9226 12.4644 0 12.6558 17.1879 17.2746 0 0 11.1152 0 13.1127 0 15.2748 0 13.0221 0 14.1795 11.8876 12.8176 0 0 0 12.6493 0 13.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0084 16.6651 13.2781 0 0 0 0 0 0 Q9NXE8 CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25) CWC25 CCDC49 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006 KIKELLQMSLEK 0.98508 -2.7514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9028 0 12.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6018 0 0 0 13.595 0 0 0 0 0 12.7454 0 13.5194 0 13.6047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7389 0 0 14.738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.26 0 0 0 0 0 0 P02753 RET4_HUMAN "Retinol-binding protein 4 (Plasma retinol-binding protein, PRBP, RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176) ]" RBP4 PRO2222 Homo sapiens (Human) cardiac muscle tissue development [GO:0048738]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to retinoic acid [GO:0032526]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; visual perception [GO:0007601] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; cardiac muscle tissue development [GO:0048738]; embryonic organ morphogenesis [GO:0048562]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; female genitalia morphogenesis [GO:0048807]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; lung development [GO:0030324]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion [GO:0032024]; response to retinoic acid [GO:0032526]; retinol metabolic process [GO:0042572]; retinol transport [GO:0034633]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; visual perception [GO:0007601] GO:0001654; GO:0002639; GO:0005576; GO:0005615; GO:0006094; GO:0007507; GO:0007601; GO:0016918; GO:0019841; GO:0030277; GO:0030324; GO:0032024; GO:0032526; GO:0034632; GO:0034633; GO:0042572; GO:0042593; GO:0048562; GO:0048706; GO:0048738; GO:0048807; GO:0060044; GO:0060059; GO:0060065; GO:0060068; GO:0060157; GO:0060347; GO:0070062 retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632] FSGTWYAMAK 0.98509 -3.7694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7V8 DC8L2_HUMAN DDB1- and CUL4-associated factor 8-like protein 2 (WD repeat-containing protein 42C) DCAF8L2 WDR42C Homo sapiens (Human) Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737] GO:0005737; GO:0080008 AATELTGLKKVIK 0.98509 -3.7691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.16 0 0 0 0 0 12.8146 0 0 0 0 0 0 0 0 12.5892 0 0 0 0 0 0 13.5716 0 12.4068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17927 CR1_HUMAN Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35) CR1 C3BR Homo sapiens (Human) "ATP export [GO:1904669]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; immune complex clearance by erythrocytes [GO:0002435]; negative regulation of activation of membrane attack complex [GO:0001971]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of cytolysis [GO:0045918]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of T cell proliferation [GO:0042130]; plasma membrane organization [GO:0007009]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of serine-type endopeptidase activity [GO:1900005]" cell surface [GO:0009986]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667] "cell surface [GO:0009986]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667]; complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618]; ATP export [GO:1904669]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement receptor mediated signaling pathway [GO:0002430]; immune complex clearance by erythrocytes [GO:0002435]; negative regulation of activation of membrane attack complex [GO:0001971]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of cytolysis [GO:0045918]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of T cell proliferation [GO:0042130]; plasma membrane organization [GO:0007009]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of serine-type endopeptidase activity [GO:1900005]" GO:0001618; GO:0001851; GO:0001855; GO:0001861; GO:0001970; GO:0001971; GO:0002430; GO:0002435; GO:0002638; GO:0004877; GO:0005615; GO:0005856; GO:0005886; GO:0005887; GO:0006957; GO:0006958; GO:0007009; GO:0008284; GO:0009986; GO:0030667; GO:0032689; GO:0032703; GO:0042130; GO:0044853; GO:0045591; GO:0045916; GO:0045918; GO:0045957; GO:0045959; GO:0070062; GO:0101003; GO:1900004; GO:1900005; GO:1900099; GO:1904669 complement component C3b binding [GO:0001851]; complement component C3b receptor activity [GO:0004877]; complement component C4b binding [GO:0001855]; complement component C4b receptor activity [GO:0001861]; virus receptor activity [GO:0001618] EISYTCDPHPDR 0.98509 -2.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1764 0 0 0 0 0 0 13.7807 0 0 0 16.0904 0 14.8841 12.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.636 0 0 15.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7303 0 0 0 0 0 0 0 P18065 IBP2_HUMAN "Insulin-like growth factor-binding protein 2, IBP-2, IGF-binding protein 2, IGFBP-2" IGFBP2 BP2 IBP2 Homo sapiens (Human) aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of activated T cell proliferation [GO:0042104]; regulation of growth [GO:0040008]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of activated T cell proliferation [GO:0042104]; regulation of growth [GO:0040008]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007565; GO:0007568; GO:0007584; GO:0009410; GO:0009612; GO:0010226; GO:0016324; GO:0031410; GO:0031994; GO:0031995; GO:0032355; GO:0032526; GO:0032870; GO:0040008; GO:0042104; GO:0043567; GO:0043627; GO:0051384; GO:0070062; GO:0090090 insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102] EPGCGCCSVCAR 0.98509 -3.7693 0 0 0 0 0 0 0 13.1058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.206 0 0 0 0 0 0 0 0 0 0 0 12.2675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1075 0 0 0 0 13.4506 12.3503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6453 0 0 0 0 0 0 0 12.692 0 0 0 0 0 0 0 0 0 0 0 0 10.3375 0 0 0 0 0 0 0 0 0 0 0 0 11.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6107 13.5166 0 0 0 0 0 0 12.4674 0 0 0 0 13.7272 0 12.301 0 0 0 0 0 0 0 0 Q6NXN4 D19P1_HUMAN "Putative C-mannosyltransferase DPY19L2P1, EC 2.4.1.- (Dpy-19-like protein 2 pseudogene 1) (Protein dpy-19 homolog 2-like 1)" DPY19L2P1 Homo sapiens (Human) spermatid development [GO:0007286] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; spermatid development [GO:0007286] GO:0007286; GO:0016021; GO:0016757 glycosyltransferase activity [GO:0016757] FHLYPEVIIAAWYR 0.98509 -1.4984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8481 15.4794 0 11.8894 0 0 0 0 18.7638 13.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0961 0 10.7345 0 0 0 13.2508 0 13.4102 14.9578 12.9432 0 0 0 12.3835 0 0 0 0 0 0 0 13.1642 0 14.6044 0 0 0 0 0 0 0 0 0 0 13.541 14.36 13.3606 0 0 0 0 13.939 13.3365 0 0 13.6607 13.0356 0 0 14.1954 14.5779 0 0 0 0 10.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1523 0 0 0 0 0 0 0 0 Q8NCR3 MFI_HUMAN Protein MFI (Mitochondrial fission factor interactor) MFI C11orf65 Homo sapiens (Human) negative regulation of mitochondrial fission [GO:0090258]; negative regulation of protein targeting to mitochondrion [GO:1903215] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of protein targeting to mitochondrion [GO:1903215] GO:0005741; GO:0005829; GO:0090258; GO:1903215 FPPDIYYKIFTHR 0.98509 -2.1375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2916 0 0 0 13.6284 0 0 0 0 0 0 0 0 0 0 0 0 13.8426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8971 0 0 0 15.2229 0 0 0 0 0 0 0 12.2967 0 0 18.6333 0 0 0 0 0 0 0 14.6756 0 0 0 0 0 0 0 0 15.4279 0 0 0 0 0 0 0 0 0 12.6026 0 0 0 0 0 12.596 0 0 0 0 0 0 0 0 15.0372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7604 0 0 0 14.724 0 Q9NXR1 NDE1_HUMAN "Nuclear distribution protein nudE homolog 1, NudE" NDE1 NUDE Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; vesicle transport along microtubule [GO:0047496] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; vesicle transport along microtubule [GO:0047496] GO:0000132; GO:0000776; GO:0001764; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0007405; GO:0008017; GO:0016020; GO:0016477; GO:0019904; GO:0021987; GO:0031616; GO:0032154; GO:0042802; GO:0045202; GO:0047496; GO:0051298; GO:0051301; GO:0051303; GO:0051642 identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904] AIKDQLQK 0.98509 -2.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2307 13.2169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6678 0 0 0 0 0 0 0 0 0 0 15.1389 0 0 0 0 0 0 0 0 0 0 0 0 11.8819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NH21 SERC4_HUMAN Serine incorporator 4 SERINC4 Homo sapiens (Human) phospholipid biosynthetic process [GO:0008654] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; phospholipid biosynthetic process [GO:0008654] GO:0008654; GO:0016020; GO:0016021 AGPSPGTSLGLAQQHSGGSSVLVK 0.9851 -3.688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8719 12.0665 11.5631 0 0 13.4353 0 0 14.7075 0 0 9.2396 0 0 0 0 14.9117 0 0 0 0 0 0 0 0 0 0 0 0 11.224 0 0 0 0 0 14.1109 0 0 10.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4814 0 14.9272 0 14.2933 0 0 0 0 0 0 0 0 13.6701 0 0 0 0 0 0 0 0 13.714 0 15.1069 14.3829 0 0 0 0 0 0 0 0 13.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1281 O60684 IMA7_HUMAN Importin subunit alpha-7 (Karyopherin subunit alpha-6) KPNA6 IPOA7 Homo sapiens (Human) entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079] cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral life cycle [GO:1903902]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079] GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006607; GO:0008139; GO:0016020; GO:0019079; GO:0042564; GO:0043657; GO:0045944; GO:0060135; GO:0061608; GO:0075506; GO:1900017; GO:1903902 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] AQIQAVIDANIFPVLIEILQKAEFR 0.9851 -2.9523 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3544 0 0 12.9202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.417 0 0 0 0 12.7895 12.592 0 13.7108 0 0 12.6835 0 0 0 0 0 0 0 0 0 0 0 P61550 ENVT1_HUMAN "Endogenous retrovirus group S71 member 1 Env polyprotein (Envelope polyprotein) (HERV-T Env protein) (HERV-T_19q13.11 provirus ancestral Env polyprotein) [Includes: Surface protein, SU; Transmembrane protein, TM ]" ERVS71-1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ENLDRHQQER 0.9851 -3.4339 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9584 0 0 11.019 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4683 10.4721 13.0161 0 0 0 0 0 13.3723 0 0 13.4486 0 0 10.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.94055 0 10.8509 11.3245 0 0 0 0 13.818 0 0 0 0 0 0 0 0 0 0 14.7586 0 0 0 14.6418 0 0 0 14.6931 0 0 0 0 0 0 9.99831 0 0 0 0 0 0 12.0227 0 0 0 0 0 0 11.2292 0 0 0 0 0 0 0 0 0 10.9401 0 0 0 0 0 0 0 0 0 0 0 0 13.3761 10.7746 0 0 0 0 0 0 0 0 0 15.3186 0 0 0 0 0 11.8779 11.4408 0 0 10.4073 11.3717 0 10.8851 0 13.7012 0 0 14.447 0 0 0 0 0 0 0 0 0 0 0 11.2383 0 0 Q7RTS3 PTF1A_HUMAN "Pancreas transcription factor 1 subunit alpha (Class A basic helix-loop-helix protein 29, bHLHa29) (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48) (p48 DNA-binding subunit of transcription factor PTF1, PTF1-p48)" PTF1A BHLHA29 PTF1P48 Homo sapiens (Human) "amacrine cell differentiation [GO:0035881]; cerebellum development [GO:0021549]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; neuron fate commitment [GO:0048663]; pancreas development [GO:0031016]; regulation of neural retina development [GO:0061074]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina layer formation [GO:0010842]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; amacrine cell differentiation [GO:0035881]; cerebellum development [GO:0021549]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; neuron fate commitment [GO:0048663]; pancreas development [GO:0031016]; regulation of neural retina development [GO:0061074]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina layer formation [GO:0010842]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0009888; GO:0010842; GO:0021549; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0046983; GO:0048384; GO:0048663; GO:0061074; GO:0070888; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" MQSINDAFEGLR 0.9851 -3.4308 0 0 0 0 0 0 0 11.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.099 0 0 0 0 0 0 0 0 0 0 12.4505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0649 0 0 0 0 0 0 0 0 0 0 13.5814 0 0 0 12.6175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7236 0 0 0 12.3576 12.4053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6724 0 0 Q7Z6J2 GRASP_HUMAN "Protein TAMALIN (General receptor for phosphoinositides 1-associated scaffold protein, GRP1-associated scaffold protein)" TAMALIN GRASP Homo sapiens (Human) "protein localization [GO:0008104]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]" anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] "anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; protein localization [GO:0008104]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]" GO:0005886; GO:0007165; GO:0008104; GO:0014069; GO:0030165; GO:0031267; GO:0042802; GO:0045211; GO:0048471; GO:0070161; GO:0098685; GO:0098978; GO:0099152 identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267] ALAVSGGTLPRRK 0.9851 -3.6913 0 12.5094 0 13.1449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6571 14.5241 0 14.5157 0 14.2947 0 0 0 0 0 0 15.2663 0 0 0 0 0 0 0 0 0 0 0 14.7876 14.7658 0 0 0 0 0 15.0758 0 0 0 14.4214 0 0 0 0 0 0 14.3687 0 14.725 14.1225 0 0 0 14.6485 16.7033 0 14.3785 0 0 0 0 0 14.3439 15.1038 0 0 0 14.5084 0 0 0 0 0 0 0 15.0424 0 0 0 14.4036 0 0 15.0317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4459 0 Q8WWY8 LIPH_HUMAN "Lipase member H, LIPH, EC 3.1.1.- (LPD lipase-related protein) (Membrane-associated phosphatidic acid-selective phospholipase A1-alpha, mPA-PLA1 alpha) (Phospholipase A1 member B)" LIPH LPDLR MPAPLA1 PLA1B Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620]; fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433] GO:0004465; GO:0004620; GO:0005615; GO:0005886; GO:0006633; GO:0006654; GO:0008201; GO:0016042; GO:0016298; GO:0019433 heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620] CDHQRSVYLYLSSLRESCTITAYPCDSYQDYR 0.9851 -2.5153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.516 0 0 0 10.9279 0 0 0 0 0 13.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9556 0 0 0 0 0 12.8588 13.5963 13.7957 0 0 11.1988 0 0 0 0 0 0 15.2741 14.5399 15.6303 12.7104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7554 12.9116 0 0 0 0 0 12.8277 0 0 0 12.2092 0 0 0 0 0 0 0 0 11.9512 0 0 0 0 0 0 0 0 0 0 0 12.7608 0 0 0 Q9H8N7 ZN395_HUMAN "Zinc finger protein 395 (HD-regulating factor 2, HDRF-2) (Huntington disease gene regulatory region-binding protein 2, HD gene regulatory region-binding protein 2, HDBP-2) (Papillomavirus regulatory factor 1, PRF-1) (Papillomavirus-binding factor)" ZNF395 HDBP2 PBF Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0016607; GO:0045944; GO:0046872 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LGKRSLLGAR 0.9851 -2.6947 0 0 0 0 13.2769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPJ3 ACO13_HUMAN "Acyl-coenzyme A thioesterase 13, Acyl-CoA thioesterase 13, EC 3.1.2.- (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase, EC 3.1.2.2) (Thioesterase superfamily member 2, THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed ]" ACOT13 THEM2 HT012 PNAS-27 Homo sapiens (Human) lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; spindle [GO:0005819] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617]; metal ion binding [GO:0046872]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289] GO:0005634; GO:0005759; GO:0005819; GO:0005829; GO:0006629; GO:0016290; GO:0046872; GO:0047617; GO:0051289; GO:0102991; GO:0120163 acyl-CoA hydrolase activity [GO:0047617]; metal ion binding [GO:0046872]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] ARNFERVLGK 0.9851 -2.1403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15105 SMAD7_HUMAN "Mothers against decapentaplegic homolog 7, MAD homolog 7, Mothers against DPP homolog 7 (Mothers against decapentaplegic homolog 8, MAD homolog 8, Mothers against DPP homolog 8) (SMAD family member 7, SMAD 7, Smad7, hSMAD7)" SMAD7 MADH7 MADH8 Homo sapiens (Human) adherens junction assembly [GO:0034333]; anatomical structure morphogenesis [GO:0009653]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 type immune response [GO:2000317]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte hypertrophy [GO:1903043]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; protein-containing complex localization [GO:0031503]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of cardiac muscle contraction [GO:0055117]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; response to laminar fluid shear stress [GO:0034616]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular septum morphogenesis [GO:0060412] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; activin binding [GO:0048185]; beta-catenin binding [GO:0008013]; collagen binding [GO:0005518]; DNA binding [GO:0003677]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; transcription regulator inhibitor activity [GO:0140416]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; adherens junction assembly [GO:0034333]; anatomical structure morphogenesis [GO:0009653]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 type immune response [GO:2000317]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte hypertrophy [GO:1903043]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; protein-containing complex localization [GO:0031503]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of cardiac muscle contraction [GO:0055117]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; response to laminar fluid shear stress [GO:0034616]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular septum morphogenesis [GO:0060412] GO:0000122; GO:0000785; GO:0001650; GO:0001657; GO:0002725; GO:0003677; GO:0005518; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007179; GO:0008013; GO:0009653; GO:0010717; GO:0010719; GO:0010801; GO:0010944; GO:0017015; GO:0022409; GO:0030154; GO:0030279; GO:0030336; GO:0030509; GO:0030512; GO:0030514; GO:0031397; GO:0031398; GO:0031503; GO:0031625; GO:0032436; GO:0032925; GO:0032991; GO:0033137; GO:0034333; GO:0034616; GO:0034713; GO:0043433; GO:0046872; GO:0048185; GO:0048844; GO:0050821; GO:0051444; GO:0055010; GO:0055117; GO:0060373; GO:0060389; GO:0060394; GO:0060395; GO:0060412; GO:0070411; GO:0071144; GO:0071560; GO:0140416; GO:1902731; GO:1903043; GO:1990830; GO:2000317; GO:2000320 activin binding [GO:0048185]; beta-catenin binding [GO:0008013]; collagen binding [GO:0005518]; DNA binding [GO:0003677]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; transcription regulator inhibitor activity [GO:0140416]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625] APGGEDEEEGAGGGGGGGELRGEGATDSR 0.98511 -3.4356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9261 10.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31939 PUR9_HUMAN "Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase, ATIC) [Cleaved into: Bifunctional purine biosynthesis protein ATIC, N-terminally processed ] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase, EC 2.1.2.3 (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase, AICAR formyltransferase) (AICAR transformylase); Inosine 5'-monophosphate cyclohydrolase, IMP cyclohydrolase, EC 3.5.4.10 (IMP synthase) (Inosinicase) ]" ATIC PURH OK/SW-cl.86 Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside metabolic process [GO:0009116]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654] GO:0003360; GO:0003937; GO:0004643; GO:0005829; GO:0005886; GO:0006139; GO:0006177; GO:0006189; GO:0009116; GO:0010035; GO:0016020; GO:0021549; GO:0021987; GO:0031100; GO:0042803; GO:0044208; GO:0045296; GO:0046452; GO:0046654; GO:0070062; GO:0097294; GO:0098761 cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803] EWVEKLTEVSISSDAFFPFR 0.98511 -3.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.927 9.98883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.591 0 0 0 0 0 0 0 0 0 0 0 11.9764 0 0 0 0 0 11.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P85299 PRR5_HUMAN "Proline-rich protein 5 (Protein observed with Rictor-1, Protor-1)" PRR5 PROTOR1 PP610 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; TORC2 signaling [GO:0038203] cytosol [GO:0005829]; TORC2 complex [GO:0031932] cytosol [GO:0005829]; TORC2 complex [GO:0031932]; cell cycle [GO:0007049]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; TORC2 signaling [GO:0038203] GO:0001934; GO:0005829; GO:0006468; GO:0007010; GO:0007049; GO:0014065; GO:0014068; GO:0016310; GO:0030307; GO:0031669; GO:0031932; GO:0038203; GO:0043066 GMVILRDK 0.98511 -2.9636 0 0 0 0 0 0 0 0 0 0 0 0 10.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13360 ZN177_HUMAN Zinc finger protein 177 ZNF177 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] blood microparticle [GO:0072562]; nucleus [GO:0005634] "blood microparticle [GO:0072562]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872; GO:0072562; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AFIFQSSLKKHMR 0.98511 -3.4424 0 0 0 0 0 0 0 0 0 13.5453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7998 0 11.1613 0 0 0 0 0 0 0 0 0 0 0 0 10.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1387 0 0 13.8214 0 0 0 0 0 0 0 11.6645 0 0 0 0 0 11.2987 0 0 0 0 0 11.7563 0 12.0872 0 0 0 0 0 19.244 10.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0899 0 0 0 0 0 0 0 0 0 11.189 0 11.5311 0 0 11.5782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUA9 MROH5_HUMAN Maestro heat-like repeat family member 5 MROH5 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ARAHILPWVDNIVSR 0.98511 -3.4428 0 11.3617 0 0 0 0 0 0 0 0 12.301 0 13.0103 0 0 12.8122 0 0 0 13.0307 0 0 0 0 0 0 0 0 0 0 0 0 12.928 13.4204 0 0 0 11.8762 0 13.5069 0 0 11.8179 0 0 0 0 0 0 0 14.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5119 0 0 0 0 0 0 0 13.7283 11.1452 0 0 10.3085 11.8393 0 0 0 0 0 0 0 0 0 0 0 0 12.6301 0 0 0 13.8345 11.851 0 0 0 0 0 0 13.2434 0 0 13.076 10.783 11.9247 0 11.3199 0 0 0 0 12.6015 0 0 14.3297 0 0 0 0 0 0 12.8695 14.0934 0 0 12.9367 0 0 0 13.5483 0 0 14.4153 0 9.90781 13.0123 0 0 12.7623 14.315 0 0 11.7548 0 0 0 0 0 0 0 0 0 0 11.0181 0 0 12.9888 0 0 12.7667 0 0 0 0 0 0 12.3994 0 0 13.044 13.6881 0 0 Q99798 ACON_HUMAN "Aconitate hydratase, mitochondrial, Aconitase, EC 4.2.1.3 (Citrate hydro-lyase)" ACO2 Homo sapiens (Human) citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099]" GO:0001889; GO:0003994; GO:0005506; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006101; GO:0006102; GO:0035900; GO:0047780; GO:0051538; GO:0051539 "3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron ion binding [GO:0005506]" APYSLLVTRLQKALGVR 0.98511 -2.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2119 0 0 0 13.5567 0 0 13.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.222 0 0 0 0 0 0 0 13.2515 0 0 0 0 14.5618 0 0 0 0 0 0 0 0 0 0 0 13.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY49 PECR_HUMAN "Peroxisomal trans-2-enoyl-CoA reductase, TERP, EC 1.3.1.38 (2,4-dienoyl-CoA reductase-related protein, DCR-RP) (HPDHase) (Short chain dehydrogenase/reductase family 29C member 1) (pVI-ARL)" PECR SDR29C1 PRO1004 Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; phytol metabolic process [GO:0033306] cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; phytol metabolic process [GO:0033306] GO:0005102; GO:0005739; GO:0005777; GO:0005778; GO:0005829; GO:0006633; GO:0019166; GO:0033306 signaling receptor binding [GO:0005102]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166] ASWAKGRSYLAPGLLQGQVAIVTGGATGIGK 0.98511 -2.1473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYS8 LRRC2_HUMAN Leucine-rich repeat-containing protein 2 LRRC2 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] GO:0004722; GO:0005737; GO:0007165; GO:0043231 protein serine/threonine phosphatase activity [GO:0004722] EQTHLREWYISNTLIQIIPTYIQLFQAMR 0.98511 -2.9634 0 0 0 0 0 0 0 0 0 0 0 14.7883 13.8801 0 0 0 0 0 0 0 15.0737 0 0 0 14.311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2425 13.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9927 0 0 0 16.1996 13.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H082 RB33B_HUMAN Ras-related protein Rab-33B RAB33B Homo sapiens (Human) "autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]" endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; presynapse [GO:0098793] "endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]" GO:0000045; GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005796; GO:0006891; GO:0015031; GO:0017157; GO:0032482; GO:0034067; GO:0048705; GO:0098793; GO:1903358; GO:1903434; GO:2000156 GTP binding [GO:0005525]; GTPase activity [GO:0003924] KSMVQHYYR 0.98511 -2.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULR0 ISY1_HUMAN Pre-mRNA-splicing factor ISY1 homolog ISY1 KIAA1160 Homo sapiens (Human) "generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006] "catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000350; GO:0000389; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0071006; GO:0071013; GO:0071014; GO:0071020 RNA binding [GO:0003723] IRDLNDEINKLLR 0.98511 -3.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5505 0 12.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7151 12.7258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Y8 S23IP_HUMAN SEC23-interacting protein (p125) SEC23IP MSTP053 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886] COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; RNA binding [GO:0003723]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886] GO:0003723; GO:0004620; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0012507; GO:0030134; GO:0043231; GO:0046872 metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; RNA binding [GO:0003723] AVLIPHHKGRK 0.98511 -2.1485 0 0 0 0 12.8124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.439 0 0 0 0 12.4746 12.1446 0 0 0 0 0 13.4515 0 0 13.1198 0 0 13.7377 12.7125 0 0 0 0 0 0 0 0 11.3819 0 0 0 0 0 0 0 0 0 0 0 12.6603 11.8185 0 13.7407 14.1683 0 13.1984 12.9503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1183 12.7567 0 11.9099 0 11.7518 11.6471 0 0 0 0 0 0 0 0 12.8911 13.1837 0 0 0 0 0 0 11.7852 0 0 11.3457 0 0 0 14.0528 0 0 13.3533 0 0 0 0 0 0 0 0 A6NJT0 UNC4_HUMAN Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1) UNCX UNCX4.1 Homo sapiens (Human) cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468]" GO:0000785; GO:0000981; GO:0001502; GO:0005634; GO:0007389; GO:0010468; GO:0021516; GO:0021889; GO:0035726; GO:0045595; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GAAGLPK 0.98512 -3.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.222 0 0 0 0 12.5134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8689 0 0 0 0 0 0 0 0 0 12.8906 0 0 0 0 P08243 ASNS_HUMAN "Asparagine synthetase [glutamine-hydrolyzing], EC 6.3.5.4 (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase)" ASNS TS11 Homo sapiens (Human) asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931] cytosol [GO:0005829] cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; asparagine biosynthetic process [GO:0006529]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931] GO:0004066; GO:0005524; GO:0005829; GO:0006529; GO:0006541; GO:0042149; GO:0043066; GO:0045931; GO:0070981 asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524] EILWRPK 0.98512 -3.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3328 0 0 0 0 12.2336 0 10.7003 10.9516 0 0 0 11.8413 0 0 0 0 16.8017 0 15.9184 14.0031 0 0 0 0 0 0 0 0 0 0 0 0 13.3482 0 11.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9499 12.0336 12.2134 0 0 0 0 0 12.0968 0 10.2411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3769 0 0 0 0 0 0 Q13277 STX3_HUMAN Syntaxin-3 STX3 STX3A Homo sapiens (Human) exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; neuron projection development [GO:0031175]; organelle membrane fusion [GO:0090174]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of gene expression [GO:0010468]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] apical plasma membrane [GO:0016324]; azurophil granule [GO:0042582]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; vacuole [GO:0005773]; zymogen granule membrane [GO:0042589] apical plasma membrane [GO:0016324]; azurophil granule [GO:0042582]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; vacuole [GO:0005773]; zymogen granule membrane [GO:0042589]; arachidonic acid binding [GO:0050544]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; neuron projection development [GO:0031175]; organelle membrane fusion [GO:0090174]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of gene expression [GO:0010468]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0001750; GO:0001917; GO:0005484; GO:0005634; GO:0005773; GO:0005886; GO:0005911; GO:0006886; GO:0006887; GO:0006906; GO:0008021; GO:0008284; GO:0010468; GO:0012505; GO:0016021; GO:0016324; GO:0030027; GO:0030425; GO:0030426; GO:0031175; GO:0031201; GO:0031629; GO:0042470; GO:0042581; GO:0042582; GO:0042589; GO:0043005; GO:0045785; GO:0048278; GO:0048787; GO:0050544; GO:0050921; GO:0060291; GO:0070062; GO:0090174; GO:0098685; GO:0098794; GO:0098967; GO:0098978; GO:1903078; GO:2000010 arachidonic acid binding [GO:0050544]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] DDLEQLTTEIKKR 0.98512 -3.0876 0 12.8371 0 0 0 0 12.5388 0 0 0 0 0 13.8006 0 13.62 0 0 12.0536 0 0 15.1532 0 0 13.7766 13.2412 0 0 0 0 11.5729 0 0 14.3111 0 13.9853 0 0 15.2601 13.131 14.5857 0 0 14.2679 0 0 0 0 0 0 0 0 12.8549 0 0 13.5317 0 11.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7325 0 0 11.8181 0 0 0 15.1521 0 0 0 0 0 0 0 0 0 0 15.7934 0 0 12.6657 0 0 0 0 0 15.0607 0 15.6728 0 13.545 0 11.5009 0 14.4276 14.6606 14.1878 13.9988 14.7503 0 15.0235 15.6547 13.9668 15.2763 14.1044 13.8145 0 12.1826 0 0 15.1008 0 15.8993 14.2574 13.806 0 0 0 14.5175 0 14.1069 14.7425 15.9225 0 0 13.8804 11.3158 13.8426 11.5494 11.4447 0 10.9449 0 0 0 0 0 0 14.7912 0 0 0 0 0 0 12.1141 14.6528 14.6321 0 0 0 0 0 0 0 0 0 0 13.6381 0 13.3238 14.1699 0 11.9797 0 Q16690 DUS5_HUMAN "Dual specificity protein phosphatase 5, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase hVH3)" DUSP5 VH3 Homo sapiens (Human) dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of MAPK cascade [GO:0043409]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of MAPK cascade [GO:0043409]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470] GO:0000165; GO:0001706; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0008138; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0017018; GO:0035335; GO:0035970; GO:0043409; GO:0070371 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] LREESAAR 0.98512 -3.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0727 0 0 0 0 12.4089 0 0 0 12.5017 0 0 0 0 0 0 0 0 0 13.3569 0 13.9229 12.3117 13.0915 12.2005 0 0 0 0 0 0 0 0 0 0 0 0 11.8772 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7547 0 13.6818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFJ9 BBS1_HUMAN Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; motile cilium [GO:0031514] axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601] GO:0000226; GO:0001764; GO:0005113; GO:0005119; GO:0005813; GO:0005829; GO:0005930; GO:0007601; GO:0007608; GO:0008594; GO:0009566; GO:0016358; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0034451; GO:0034464; GO:0042048; GO:0042445; GO:0043001; GO:0044255; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0051219; GO:0060170; GO:0060271; GO:0060296; GO:0061351; GO:0061512; GO:0061629; GO:1905515 patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; smoothened binding [GO:0005119] AFQTDLYLLR 0.98512 -2.1544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1945 0 12.9419 0 0 0 0 0 0 12.8375 12.3924 0 11.3944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2026 12.9937 13.0668 0 0 12.7931 0 0 0 13.361 0 0 0 15.3162 0 13.2712 0 13.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5089 0 0 0 0 0 0 0 0 0 0 0 12.8438 0 0 0 0 0 0 0 0 0 0 11.8989 0 0 0 0 0 0 0 0 0 0 0 12.2908 0 0 0 0 0 0 0 11.6218 0 0 0 Q9NUL5 SHFL_HUMAN "Shiftless antiviral inhibitor of ribosomal frameshifting protein, SFL, SHFL (Interferon-regulated antiviral protein, IRAV) (Repressor of yield of DENV protein, RyDEN)" SHFL C19orf66 FLJ11286 IRAV RYDEN SFL Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of viral genome replication [GO:0045071]; regulation of translational termination [GO:0006449]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342]; viral translational frameshifting [GO:0075523] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translational frameshifting [GO:2001125]; negative regulation of viral genome replication [GO:0045071]; regulation of translational termination [GO:0006449]; response to interferon-beta [GO:0035456]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342]; viral translational frameshifting [GO:0075523] GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0034340; GO:0034341; GO:0034342; GO:0035456; GO:0042802; GO:0043022; GO:0045071; GO:0045087; GO:0051607; GO:0075523; GO:1990825; GO:2001125 identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] ILPPRWDRDPDR 0.98512 -2.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4391 0 0 0 13.4746 0 0 0 0 0 12.3417 0 12.6999 0 12.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5597 0 0 0 0 0 0 14.0085 0 0 0 0 0 0 14.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5571 0 0 0 0 0 13.3632 0 0 0 13.3259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43155 CACP_HUMAN "Carnitine O-acetyltransferase, Carnitine acetylase, EC 2.3.1.137, EC 2.3.1.7 (Carnitine acetyltransferase, CAT, CrAT)" CRAT CAT1 Homo sapiens (Human) "carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process, CoA-linked [GO:0019254]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty acid metabolic process [GO:0051791]; short-chain fatty acid metabolic process [GO:0046459]" GO:0003997; GO:0004092; GO:0005739; GO:0005743; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0008458; GO:0019254; GO:0033540; GO:0046459; GO:0051791 acyl-CoA oxidase activity [GO:0003997]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine O-octanoyltransferase activity [GO:0008458] AHQDALPRLPVPPLQQSLDHYLK 0.98513 -3.2824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2898 14.2122 0 13.4868 0 0 0 0 0 10.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5477 0 11.5224 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1681 0 0 0 0 0 0 0 0 0 0 0 0 12.0296 14.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6656 0 Q00056 HXA4_HUMAN Homeobox protein Hox-A4 (Homeobox protein Hox-1.4) (Homeobox protein Hox-1D) HOXA4 HOX1D Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0009952; GO:0016604; GO:0048704; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GGASPGR 0.98513 -3.2853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0S4 C27C1_HUMAN "Cytochrome P450 27C1, EC 1.14.19.53 (All-trans retinol 3,4-desaturase)" CYP27C1 Homo sapiens (Human) retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] "intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 11-cis retinal binding [GO:0005502]; 11-cis-retinal 3,4-desaturase activity [GO:0061899]; all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinal binding [GO:0005503]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]" GO:0001972; GO:0004497; GO:0005502; GO:0005503; GO:0005506; GO:0005739; GO:0020037; GO:0031966; GO:0042572; GO:0042573; GO:0042574; GO:0043231; GO:0061896; GO:0061897; GO:0061898; GO:0061899; GO:1904768 "11-cis retinal binding [GO:0005502]; 11-cis-retinal 3,4-desaturase activity [GO:0061899]; all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinal binding [GO:0005503]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972]" ANMESWREYR 0.98513 -3.8012 0 0 0 0 0 0 0 0 0 0 11.8299 0 0 0 0 0 0 0 0 0 0 0 12.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.814 0 0 14.8508 0 0 12.7317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7666 0 0 0 0 0 0 0 0 0 14.9098 0 0 0 0 0 0 0 14.6354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IS14 IF5AL_HUMAN "Eukaryotic translation initiation factor 5A-1-like, eIF-5A-1-like, eIF-5A1-like (Eukaryotic initiation factor 5A isoform 1-like)" EIF5AL1 Homo sapiens (Human) mRNA transport [GO:0051028]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643] endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031] GO:0003723; GO:0003746; GO:0005643; GO:0005789; GO:0015031; GO:0043022; GO:0045901; GO:0045905; GO:0051028 ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] GWPCKIVEMSASKTGK 0.98513 -2.1669 0 0 0 0 0 0 0 0 0 0 13.6017 0 14.0514 14.6329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UU9 TKN4_HUMAN "Tachykinin-4 (Preprotachykinin-C, PPT-C) [Cleaved into: Endokinin-A, EKA; Endokinin-A/B, EKA/B; Endokinin-C, EKC ]" TAC4 Homo sapiens (Human) detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of sensory perception of pain [GO:1904058]; regulation of blood pressure [GO:0008217]; regulation of sensory perception of pain [GO:0051930]; tachykinin receptor signaling pathway [GO:0007217] extracellular space [GO:0005615] extracellular space [GO:0005615]; receptor ligand activity [GO:0048018]; substance K receptor binding [GO:0031837]; substance P receptor binding [GO:0031835]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of sensory perception of pain [GO:1904058]; regulation of blood pressure [GO:0008217]; regulation of sensory perception of pain [GO:0051930]; tachykinin receptor signaling pathway [GO:0007217] GO:0003085; GO:0005615; GO:0006954; GO:0007204; GO:0007217; GO:0008217; GO:0031835; GO:0031837; GO:0048018; GO:0050965; GO:0051930; GO:1902093; GO:1904057; GO:1904058 receptor ligand activity [GO:0048018]; substance K receptor binding [GO:0031837]; substance P receptor binding [GO:0031835] PLIQPRR 0.98513 -3.2873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4799 0 0 0 0 0 11.6361 0 0 0 0 0 0 0 0 Q9BXI2 ORNT2_HUMAN Mitochondrial ornithine transporter 2 (Solute carrier family 25 member 2) SLC25A2 ORNT2 Homo sapiens (Human) mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; L-ornithine transmembrane transporter activity [GO:0000064]; transmembrane transporter activity [GO:0022857]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] GO:0000050; GO:0000064; GO:0005739; GO:0005743; GO:0016021; GO:0022857; GO:1990575 L-ornithine transmembrane transporter activity [GO:0000064]; transmembrane transporter activity [GO:0022857] CRLQTMYEMEMSGK 0.98513 -3.8045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1015 0 0 0 0 0 0 0 0 0 0 0 13.8466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGN4 CLM8_HUMAN "CMRF35-like molecule 8, CLM-8 (CD300 antigen-like family member A) (CMRF-35-H9, CMRF35-H9) (CMRF35-H) (IRC1/IRC2) (Immunoglobulin superfamily member 12, IgSF12) (Inhibitory receptor protein 60, IRp60) (NK inhibitory receptor) (CD antigen CD300a)" CD300A CMRF35H IGSF12 HSPC083 Homo sapiens (Human) "cell adhesion [GO:0007155]; immune system process [GO:0002376]; negative regulation of activation of Janus kinase activity [GO:1902569]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of eosinophil activation [GO:1902567]; negative regulation of eosinophil migration [GO:2000417]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034125]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of NK T cell activation [GO:0051134]; negative regulation of phagocytosis, engulfment [GO:0060101]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; regulation of T cell receptor signaling pathway [GO:0050856]" extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] "extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; immune system process [GO:0002376]; negative regulation of activation of Janus kinase activity [GO:1902569]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of eosinophil activation [GO:1902567]; negative regulation of eosinophil migration [GO:2000417]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034125]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of NK T cell activation [GO:0051134]; negative regulation of phagocytosis, engulfment [GO:0060101]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; regulation of T cell receptor signaling pathway [GO:0050856]" GO:0001786; GO:0002376; GO:0004888; GO:0005886; GO:0007155; GO:0008429; GO:0016020; GO:0016021; GO:0030889; GO:0032516; GO:0033007; GO:0034125; GO:0038023; GO:0043305; GO:0043407; GO:0048147; GO:0050856; GO:0050859; GO:0051134; GO:0060101; GO:0070062; GO:0070821; GO:0101003; GO:1902564; GO:1902567; GO:1902569; GO:2000417 phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] EEEPDSDYSVIRK 0.98513 -2.1557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7124 0 0 0 0 0 19.3881 0 0 0 0 0 14.1158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6445 0 0 0 0 0 0 0 0 0 0 0 14.1232 0 0 0 0 0 0 14.1305 0 19.1501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49589 SYCC_HUMAN "Cysteine--tRNA ligase, cytoplasmic, EC 6.1.1.16 (Cysteinyl-tRNA synthetase, CysRS)" CARS1 CARS Homo sapiens (Human) cysteinyl-tRNA aminoacylation [GO:0006423] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423] GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0005829; GO:0006423; GO:0042802; GO:0042803; GO:0046872 ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049] ADSSGQQGKGRR 0.98514 -2.3248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1178 0 0 0 0 0 11.9327 0 0 0 0 0 13.0262 0 0 0 0 0 0 0 0 0 12.1642 0 0 0 0 0 0 0 0 0 12.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5XKE5 K2C79_HUMAN "Keratin, type II cytoskeletal 79 (Cytokeratin-79, CK-79) (Keratin-6-like, Keratin-6L) (Keratin-79, K79) (Type-II keratin Kb38)" KRT79 K6L KB38 KRT6L Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; enzyme binding [GO:0019899]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005829; GO:0019899; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0070062 enzyme binding [GO:0019899]; structural constituent of skin epidermis [GO:0030280] AEAEAWYQTK 0.98514 -3.8061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVF5 KCTD4_HUMAN BTB/POZ domain-containing protein KCTD4 KCTD4 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 HNSLEDTDQGKNCK 0.98514 -2.9909 0 0 0 0 12.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9015 0 0 0 11.4296 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7671 0 0 0 0 0 10.8016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0415 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7B7 CG069_HUMAN Putative uncharacterized protein PKD1L1-AS1 (PKD1L1 antisense RNA 1) PKD1L1-AS1 C7orf69 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GFHFCIWIIFLLPPPCKK 0.98514 -2.9863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6878 13.2156 0 0 14.953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY97 B3GN2_HUMAN "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2, EC 2.4.1.149 (Beta-1,3-N-acetylglucosaminyltransferase 1, BGnT-1, Beta-1,3-Gn-T1, Beta3Gn-T1) (Beta-1,3-galactosyltransferase 7, Beta-1,3-GalTase 7, Beta3Gal-T7, Beta3GalT7, b3Gal-T7) (Beta-3-Gx-T7) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 7) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, BGnT-2, Beta-1,3-Gn-T2, Beta-1,3-N-acetylglucosaminyltransferase 2, Beta3Gn-T2) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 7)" B3GNT2 B3GALT7 B3GNT1 Homo sapiens (Human) axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; sensory perception of smell [GO:0007608] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; sensory perception of smell [GO:0007608]" GO:0000139; GO:0007411; GO:0007608; GO:0008194; GO:0008457; GO:0008499; GO:0008532; GO:0016021; GO:0016266; GO:0016757; GO:0018146; GO:0030311; GO:1990830 "beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" DFLLYLR 0.98515 -2.7175 0 11.7287 0 0 0 10.4511 0 0 11.9169 14.8762 15.1893 13.5615 14.207 15.5872 15.8194 12.2301 15.6327 11.6935 14.5105 16.3348 16.7979 0 16.2852 0 14.9757 16.5012 17.0287 17.0632 15.7531 15.7194 15.0716 0 14.8427 13.1096 0 12.4119 0 12.8382 14.0449 13.1023 12.2638 16.1087 15.9308 16.5156 15.5631 16.287 15.9743 15.9912 16.3025 16.1985 15.8637 15.3516 12.8876 14.4097 16.7784 15.8576 0 0 16.1817 11.8334 14.5408 14.5947 15.0497 14.2567 11.5622 0 0 0 0 13.5047 12.9139 0 0 0 13.2755 0 0 12.4938 0 14.5767 12.8255 13.9862 0 0 0 0 0 13.6209 0 0 0 0 0 0 0 13.2881 13.1704 13.4205 0 13.0484 0 0 0 15.1638 14.5731 0 0 12.8313 0 13.5891 0 16.1989 0 0 0 17.9415 0 17.9545 12.7407 0 0 0 0 13.1421 14.2882 13.4862 11.1815 13.8799 0 0 0 12.6373 13.1963 13.3852 12.3657 0 0 0 0 0 0 0 0 0 0 0 16.4201 12.4721 16.3497 0 12.7691 12.2666 0 0 0 0 13.6177 14.1466 0 0 0 13.4002 14.1319 0 15.1793 12.7166 12.6822 14.8878 13.0586 13.0261 0 0 12.822 0 0 14.0735 0 15.2178 16.8446 0 P22001 KCNA3_HUMAN Potassium voltage-gated channel subfamily A member 3 (HGK5) (HLK3) (HPCN3) (Voltage-gated K(+) channel HuKIII) (Voltage-gated potassium channel subunit Kv1.3) KCNA3 HGK5 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] axon [GO:0030424]; calyx of Held [GO:0044305]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] axon [GO:0030424]; calyx of Held [GO:0044305]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005244; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0015271; GO:0016021; GO:0030424; GO:0034765; GO:0044305; GO:0045121; GO:0051260; GO:0071805; GO:0098978; GO:0099055; GO:0099056 delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249] EDEGFLR 0.98515 -3.3957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0B4J1U4 TRGV5_HUMAN T cell receptor gamma variable 5 TRGV5 TCRGV5 Homo sapiens (Human) adaptive immune response [GO:0002250]; innate immune response [GO:0045087] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087] GO:0002250; GO:0009897; GO:0042101; GO:0045087 RWALLVLLAFLSPASQK 0.98516 -3.0119 0 0 0 0 0 0 12.9963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40926 MDHM_HUMAN "Malate dehydrogenase, mitochondrial, EC 1.1.1.37" MDH2 Homo sapiens (Human) aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099] GO:0003723; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0006094; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0009060; GO:0016020; GO:0030060; GO:0043621; GO:0046554; GO:0070062 L-malate dehydrogenase activity [GO:0030060]; malate dehydrogenase (NADP+) activity [GO:0046554]; protein self-association [GO:0043621]; RNA binding [GO:0003723] EGVVECSFVK 0.98516 -2.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.709 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5584 13.476 13.4074 0 0 0 14.3287 0 0 14.5711 0 0 0 0 14.4596 0 0 0 0 0 0 0 16.0786 0 0 0 0 0 14.8233 0 0 15.157 0 0 0 0 0 15.204 0 14.5056 0 0 12.4242 0 13.8245 14.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2491 14.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5305 13.3405 14.0742 13.5902 0 0 0 0 0 0 Q07002 CDK18_HUMAN "Cyclin-dependent kinase 18, EC 2.7.11.22 (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3)" CDK18 PCTAIRE3 PCTK3 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] GO:0000083; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] IFMFQLLRGLAYCHHR 0.98516 -3.4057 0 0 0 0 0 0 0 0 0 12.2587 11.7192 0 12.0423 0 0 0 0 0 11.6516 0 0 0 0 0 0 0 0 0 0 0 11.7452 0 12.6259 0 0 11.424 0 0 0 0 11.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9071 0 0 0 0 0 0 0 13.2881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4159 13.3884 13.5098 13.2613 0 0 0 0 0 13.6924 0 0 16.1344 0 0 0 0 0 13.5232 0 0 0 0 Q96HJ3 CCD34_HUMAN Coiled-coil domain-containing protein 34 (Renal carcinoma antigen NY-REN-41) CCDC34 RAMA3 L15 Homo sapiens (Human) FQEWLENAKHK 0.98516 -2.9124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAT1 PMGT2_HUMAN "Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2, POMGnT2, EC 2.4.1.312 (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)" POMGNT2 AGO61 C3orf39 EOGTL GTDC2 Homo sapiens (Human) neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; protein O-GlcNAc transferase activity [GO:0097363]; neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0008375; GO:0016021; GO:0016757; GO:0035269; GO:0097363 acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; protein O-GlcNAc transferase activity [GO:0097363] EARCQASVHGASEARLTVSWQIPWNLK 0.98517 -3.4154 0 11.8268 0 0 0 0 12.0226 0 0 0 0 0 0 0 0 0 13.8112 0 0 0 0 12.2959 0 13.3329 0 0 0 0 0 0 0 0 0 0 0 12.3124 0 0 0 0 0 0 0 0 0 0 12.2288 0 0 14.8644 14.2356 0 13.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8557 16.3708 17.2676 14.5992 15.6551 16.3393 0 18.0388 15.0677 15.2282 15.9806 15.571 16.152 15.8548 16.3468 15.5735 19.1682 16.609 19.7696 19.7316 12.5513 16.4302 18.5929 15.006 15.9088 17.2231 15.5053 14.5255 17.3103 15.2704 16.0281 18.1817 16.2091 15.4785 15.7984 15.8738 16.1454 15.2355 16.2802 14.8372 16.038 15.5278 15.8937 16.0388 15.5494 0 16.4927 16.0077 15.61 15.3425 15.5081 14.2669 14.8312 14.2325 15.2211 14.4354 16.1464 15.736 15.8188 15.2191 16.2808 13.8371 13.8223 18.5832 18.593 11.2241 16.0286 15.0825 15.8909 15.8571 0 13.6033 0 15.6339 14.1264 16.8188 0 14.3731 15.0477 17.8466 15.6586 0 0 14.6165 19.043 14.2015 0 19.1408 0 0 16.0143 0 0 0 13.8814 0 0 0 0 13.3429 0 14.1155 0 0 0 13.7071 14.5826 13.2337 0 0 0 0 14.8493 12.2024 Q01664 TFAP4_HUMAN "Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41, bHLHc41)" TFAP4 BHLHC41 Homo sapiens (Human) "cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0006978; GO:0008285; GO:0010629; GO:0017053; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837; GO:2001269 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" AVIVKPVR 0.98517 -3.8414 12.5306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2709 0 0 0 0 0 0 14.0414 0 0 0 12.806 0 0 12.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4194 15.0923 0 12.8428 0 0 0 0 0 0 0 14.0134 0 14.0685 14.0009 0 0 0 0 0 0 12.6839 0 12.505 0 13.9535 13.0223 13.6771 0 11.2591 0 0 0 0 0 11.641 11.6602 0 0 0 0 0 11.7633 0 0 12.8805 0 0 0 0 0 0 0 0 0 14.7976 0 0 0 0 13.4022 0 0 0 0 12.3888 0 13.2707 0 0 0 10.9261 0 0 0 0 0 11.7522 0 0 12.844 13.1701 12.9089 0 0 0 0 0 11.429 0 0 0 0 13.8402 0 0 0 0 0 0 0 0 0 Q86UN2 R4RL1_HUMAN "Reticulon-4 receptor-like 1 (Nogo receptor-like 2) (Nogo-66 receptor homolog 2) (Nogo-66 receptor-related protein 3, NgR3)" RTN4RL1 NGRH2 NGRL2 Homo sapiens (Human) axon regeneration [GO:0031103]; corpus callosum development [GO:0022038]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977] anchored component of plasma membrane [GO:0046658]; cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; signaling receptor activity [GO:0038023]; axon regeneration [GO:0031103]; corpus callosum development [GO:0022038]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron projection development [GO:0010977] GO:0005576; GO:0005615; GO:0005886; GO:0008201; GO:0009986; GO:0010977; GO:0022038; GO:0031012; GO:0031103; GO:0035374; GO:0038023; GO:0042995; GO:0043204; GO:0045121; GO:0046658; GO:0048681; GO:0070062 chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; signaling receptor activity [GO:0038023] GHPHGPR 0.98517 -3.4136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8457 0 0 0 0 0 12.6469 11.8517 10.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2607 10.7202 0 0 0 12.5706 12.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1293 10.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6561 0 0 0 0 0 0 0 0 14.0857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5M1 ATPF2_HUMAN ATP synthase mitochondrial F1 complex assembly factor 2 (ATP12 homolog) ATPAF2 ATP12 LP3663 Homo sapiens (Human) mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton-transporting ATP synthase complex assembly [GO:0043461] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton-transporting ATP synthase complex assembly [GO:0043461] GO:0005739; GO:0005829; GO:0016607; GO:0033615; GO:0043461 FYQNVSITQGEGGFEINLDHR 0.98517 -2.9247 0 0 0 0 0 0 0 0 0 0 14.8393 0 13.6536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C0HLV8 MP31_HUMAN PTEN upstream open reading frame MP31 (Micropeptide 31) Homo sapiens (Human) lactate oxidation [GO:0019516] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; lactate oxidation [GO:0019516] GO:0005739; GO:0019516 LRSVLSSR 0.98518 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09471 GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit alpha GNAO1 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dopamine receptor signaling pathway [GO:0007212]; muscle contraction [GO:0006936] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; dopamine receptor signaling pathway [GO:0007212]; muscle contraction [GO:0006936] GO:0001664; GO:0003924; GO:0005525; GO:0005834; GO:0005886; GO:0006936; GO:0007188; GO:0007212; GO:0031683; GO:0031821; GO:0031852; GO:0046872; GO:0051430 corticotropin-releasing hormone receptor 1 binding [GO:0051430]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852] AALERSK 0.98518 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2738 14.1678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12766 HMGX3_HUMAN HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF) HMGXB3 KIAA0194 SMF Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] CPTCGNFLGGK 0.98518 -1.5489 12.2301 0 0 0 0 0 0 0 0 0 0 0 13.4839 0 0 13.244 12.6877 0 0 12.9442 14.9626 14.6571 13.6029 0 13.3939 14.5923 0 13.5441 0 0 0 0 0 0 0 0 11.9283 0 0 0 0 0 0 13.3322 13.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9186 0 0 0 0 12.9752 0 14.1103 0 14.2547 13.7993 0 0 0 0 0 0 0 0 0 12.0702 12.4779 0 12.2277 0 0 14.9033 0 0 0 0 0 0 0 0 0 0 12.5338 0 13.9522 0 0 0 0 0 0 0 0 0 13.1035 13.5637 0 0 0 0 14.9526 0 0 0 15.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1214 0 Q15327 ANKR1_HUMAN Ankyrin repeat domain-containing protein 1 (Cardiac ankyrin repeat protein) (Cytokine-inducible gene C-193 protein) (Cytokine-inducible nuclear protein) ANKRD1 C193 CARP HA1A2 Homo sapiens (Human) "cardiac muscle tissue morphogenesis [GO:0055008]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of protein secretion [GO:0050714]; protein kinase C signaling [GO:0070528]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; I band [GO:0031674]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; I band [GO:0031674]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; p53 binding [GO:0002039]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cardiac muscle tissue morphogenesis [GO:0055008]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of protein secretion [GO:0050714]; protein kinase C signaling [GO:0070528]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; sarcomere organization [GO:0045214]; skeletal muscle cell differentiation [GO:0035914]" GO:0001650; GO:0002039; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006357; GO:0031432; GO:0031674; GO:0035914; GO:0035994; GO:0042826; GO:0043065; GO:0043517; GO:0045214; GO:0050714; GO:0055008; GO:0061629; GO:0070412; GO:0070528; GO:0071222; GO:0071260; GO:0071347; GO:0071356; GO:0071466; GO:0071560; GO:2000279 DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; p53 binding [GO:0002039]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; titin binding [GO:0031432]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] EAELKKK 0.98518 -2.1155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSA8 YS025_HUMAN Putative uncharacterized protein FLJ45684 Homo sapiens (Human) IPPVRTVR 0.98518 -2.9267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XS5 ANGL5_HUMAN Angiopoietin-related protein 5 (Angiopoietin-like protein 5) ANGPTL5 UNQ5795/PRO19600 Homo sapiens (Human) collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] GO:0005615; GO:0062023 DESKSNDTVCKEDCEESCDVK 0.98518 -3.0332 0 12.2167 0 0 0 0 0 0 0 0 0 12.0142 0 11.8686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2159 0 12.6716 0 0 0 0 13.0184 13.8762 0 0 12.333 0 13.6931 13.5854 0 0 0 13.2519 0 0 0 0 0 0 0 0 0 0 0 12.2232 0 0 11.3296 0 0 0 0 0 12.6616 0 0 0 0 11.3903 12.7967 13.3951 0 0 0 0 0 14.6953 0 0 0 0 0 0 0 10.7293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3937 11.2971 0 0 14.8933 16.0176 18.4163 12.6574 0 0 0 0 0 0 0 0 Q9BQG2 NUD12_HUMAN "NAD-capped RNA hydrolase NUDT12, DeNADding enzyme NUDT12, EC 3.6.1.- (NADH pyrophosphatase NUDT12, EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12, Nudix motif 12)" NUDT12 Homo sapiens (Human) circadian regulation of gene expression [GO:0032922]; methylguanosine-cap decapping [GO:0110156]; mRNA catabolic process [GO:0006402]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742] cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; methylguanosine-cap decapping [GO:0110156]; mRNA catabolic process [GO:0006402]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD catabolic process [GO:0019677]; NAD-cap decapping [GO:0110155]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742] GO:0000210; GO:0000287; GO:0005634; GO:0005737; GO:0005777; GO:0005782; GO:0006402; GO:0006734; GO:0006742; GO:0008270; GO:0019677; GO:0032922; GO:0034356; GO:0035529; GO:0110153; GO:0110155; GO:0110156; GO:1990174 magnesium ion binding [GO:0000287]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; phosphodiesterase decapping endonuclease activity [GO:1990174]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; zinc ion binding [GO:0008270] AIAHQLIKHWIR 0.98518 -3.6785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2726 0 0 0 0 0 0 0 0 13.4633 13.6446 0 0 0 0 0 0 0 14.4204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7898 0 13.3807 12.7378 13.1416 0 0 16.2672 0 0 0 0 0 0 0 0 0 0 0 0 12.4914 0 0 0 0 0 12.1518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9961 0 0 Q9Y5A7 NUB1_HUMAN NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18) NUB1 NYREN18 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005654; GO:0005730; GO:0005829; GO:0006511; GO:0016567; GO:0032436; GO:0034341; GO:0034612; GO:2000058 AQKKYLQAK 0.98518 -2.3696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6399 0 0 0 0 0 0 13.9633 0 0 0 0 14.0253 0 0 0 0 0 13.4925 0 0 0 0 0 0 0 0 0 0 0 12.1496 0 0 0 0 0 0 0 0 0 13.0003 0 0 0 0 0 0 0 0 12.9535 13.392 10.8003 0 0 12.6556 0 12.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8348 0 0 0 0 0 0 0 P54289 CA2D1_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1 ] CACNA2D1 CACNL2A CCHL2A MHS3 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to amyloid-beta [GO:1904646]; membrane depolarization during bundle of His cell action potential [GO:0086048]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] extracellular exosome [GO:0070062]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcoplasmic reticulum [GO:0016529]; voltage-gated calcium channel complex [GO:0005891] extracellular exosome [GO:0070062]; L-type voltage-gated calcium channel complex [GO:1990454]; sarcoplasmic reticulum [GO:0016529]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to amyloid-beta [GO:1904646]; membrane depolarization during bundle of His cell action potential [GO:0086048]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of calcium ion transport [GO:0051924]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] GO:0005245; GO:0005891; GO:0006816; GO:0016529; GO:0045933; GO:0046872; GO:0051924; GO:0060307; GO:0060402; GO:0061577; GO:0070062; GO:0070588; GO:0086002; GO:0086048; GO:0086091; GO:0098703; GO:0098903; GO:1901843; GO:1902514; GO:1904646; GO:1990454 metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] ANCNKIIMLFTDGGEERAQEIFNK 0.98519 -3.0468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2009 0 0 0 15.2779 11.0059 14.2683 0 0 0 0 0 0 11.5664 0 11.4929 16.3242 0 0 0 0 14.7944 14.6539 0 0 0 14.7883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6412 0 0 0 12.9045 0 0 0 0 0 0 0 0 0 0 19.1358 0 0 0 0 0 0 0 0 0 0 10.3802 0 0 0 0 0 0 0 0 0 0 0 13.8871 0 0 0 0 12.121 0 12.9378 0 0 0 0 0 14.7656 0 0 0 0 0 0 0 0 Q15428 SF3A2_HUMAN "Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62, SAP 62)" SF3A2 SAP62 Homo sapiens (Human) "mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]" GO:0000245; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0010976; GO:0016607; GO:0071004; GO:0071005; GO:0071013; GO:1903241 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] AAKEAKEAPAQPAPEK 0.98519 -2.7511 0 0 0 0 0 0 0 0 0 0 0 0 12.3492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9579 0 0 0 0 0 0 0 0 0 0 0 12.7863 0 0 0 0 0 0 0 0 0 0 0 0 12.4845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IPW1 CK071_HUMAN Uncharacterized protein C11orf71 C11orf71 Homo sapiens (Human) nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0016604 EPDGRGR 0.98519 -3.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9432 0 0 0 0 0 0 0 0 0 14.1515 0 0 0 12.9294 0 0 0 0 0 0 0 0 14.715 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2658 0 0 0 0 0 0 0 14.2825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7J5 DPPA2_HUMAN Developmental pluripotency-associated protein 2 (Pluripotent embryonic stem cell-related gene 1 protein) DPPA2 PESCRG1 Homo sapiens (Human) system development [GO:0048731] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; system development [GO:0048731] GO:0003682; GO:0005634; GO:0005654; GO:0048731 chromatin binding [GO:0003682] ARLQRSYEMNER 0.98519 -3.7688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0531 0 0 0 0 0 0 0 0 0 0 13.912 0 0 0 13.3906 0 0 0 0 12.6055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9319 0 12.4669 0 0 13.8708 0 0 0 0 13.6572 0 14.4503 0 0 0 0 0 13.7243 0 13.7223 14.2782 0 15.1093 0 15.2165 0 0 0 0 0 14.8657 13.5505 12.9266 13.9001 13.1489 0 0 0 0 0 0 13.0402 14.0205 13.6247 13.6331 12.8351 0 0 0 0 0 0 0 0 12.9618 0 0 0 0 13.7677 13.8574 0 14.4996 0 12.7918 14.0428 14.2048 0 0 0 0 14.7231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1453 0 0 0 0 0 0 0 14.2435 13.8028 13.8475 14.1286 0 0 0 0 0 0 0 0 0 0 14.0223 0 0 Q8NGC5 OR6J1_HUMAN Olfactory receptor 6J1 (Olfactory receptor 6J2) OR6J1 OR6J2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVLRSRLSSNK 0.98519 -2.3746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4501 13.978 14.9104 13.8107 13.4138 12.9213 0 0 0 13.0005 13.3435 0 13.2714 13.2727 13.7814 13.6462 0 0 0 0 0 14.5141 0 0 0 13.776 13.344 13.3278 13.5182 13.6162 13.3829 0 0 15.7627 13.461 0 0 0 0 0 13.4937 0 0 13.9161 14.1357 0 0 13.7382 0 0 13.19 13.9577 0 0 0 0 0 0 0 13.5934 0 0 0 13.5442 13.6828 13.1166 0 13.9574 13.9448 13.4488 13.9674 0 13.8734 0 0 0 0 0 0 13.8426 0 13.5415 0 0 0 0 0 12.3791 0 13.6905 13.7962 0 0 0 0 0 0 13.1968 0 0 0 0 0 0 0 0 13.5252 0 0 0 0 0 0 0 0 Q9GZR1 SENP6_HUMAN "Sentrin-specific protease 6, EC 3.4.22.- (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6)" SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; protein desumoylation [GO:0016926]; protein modification by small protein removal [GO:0070646]; protein sumoylation [GO:0016925]; regulation of kinetochore assembly [GO:0090234]; regulation of spindle assembly [GO:0090169] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016925; GO:0016926; GO:0070139; GO:0070646; GO:0090169; GO:0090234 SUMO-specific endopeptidase activity [GO:0070139] CLTHLEDLQR 0.98519 -2.5 0 0 0 10.7381 0 0 0 0 0 0 0 0 0 0 0 13.4468 9.38965 12.6987 0 0 0 0 0 0 0 0 12.6727 0 12.2502 0 0 12.9629 0 0 0 0 0 0 0 0 13.9933 0 0 0 14.8214 0 0 0 11.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0264 0 13.9028 14.3969 12.0767 0 12.1509 0 0 0 11.0656 11.4706 0 0 0 0 0 0 18.0716 0 0 0 11.5191 0 0 15.0329 0 0 14.4615 0 0 0 0 0 0 0 0 0 0 0 11.2884 0 10.0444 0 0 12.5775 0 0 0 11.3473 11.7181 0 0 0 0 0 0 0 0 0 11.369 16.4214 13.7078 11.0075 0 0 0 0 0 12.0044 13.1101 0 0 0 0 0 0 0 14.8195 10.6804 0 12.6917 0 0 15.4255 0 0 0 0 0 0 0 0 0 14.8401 0 0 0 0 0 0 0 0 10.7306 0 15.3084 13.8268 15.3438 0 0 0 0 0 0 Q14117 DPYS_HUMAN "Dihydropyrimidinase, DHP, DHPase, EC 3.5.2.2 (Dihydropyrimidine amidohydrolase) (Hydantoinase)" DPYS Homo sapiens (Human) CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212] GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0042802; GO:0046050; GO:0046079; GO:0051219; GO:0070062 dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270] DLYMVTDLELYEAFSRCK 0.9852 -3.6903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4639 0 13.6325 12.2614 12.4121 12.904 0 14.0708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9595 0 0 13.7957 0 0 0 0 0 12.9964 0 13.241 0 0 0 0 0 0 0 0 0 0 0 0 13.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8292 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16644 MAPK3_HUMAN "MAP kinase-activated protein kinase 3, MAPK-activated protein kinase 3, MAPKAP kinase 3, MAPKAP-K3, MAPKAPK-3, MK-3, EC 2.7.11.1 (Chromosome 3p kinase, 3pK)" MAPKAPK3 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; macropinocytosis [GO:0044351]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0002224; GO:0004674; GO:0004683; GO:0004708; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0009931; GO:0018105; GO:0032496; GO:0034097; GO:0035556; GO:0044351; GO:0046777; GO:0048010; GO:0051019; GO:0106310 ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] QLIRLLLK 0.9852 -2.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5214 0 0 0 0 0 0 12.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VWT5 FYB2_HUMAN "FYN-binding protein 2 (Activation-dependent, raft-recruited ADAP-like phosphoprotein)" FYB2 ARAP C1orf168 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852] immunological synapse [GO:0001772]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] immunological synapse [GO:0001772]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; cell adhesion mediated by integrin [GO:0033627]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852] GO:0001772; GO:0005886; GO:0007229; GO:0033627; GO:0045121; GO:0050852; GO:0072659 EVPKLNYSSSLASSSEENRELYEDVYK 0.9852 -3.4298 0 0 0 0 0 0 0 0 11.8931 0 0 0 13.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.556 0 0 0 0 0 0 11.8016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0375 0 0 0 13.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCD6 PHOP2_HUMAN "Pyridoxal phosphate phosphatase PHOSPHO2, EC 3.1.3.74" PHOSPHO2 Homo sapiens (Human) metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pyridoxal phosphatase activity [GO:0033883] GO:0016791; GO:0033883; GO:0046872 metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pyridoxal phosphatase activity [GO:0033883] VVLIEFVDK 0.9852 -2.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZQ6 NPFF1_HUMAN Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022) NPFFR1 GPR147 NPFF1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0008188; GO:0042277 G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277] CIVHPFR 0.9852 -2.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6224 0 0 0 0 0 0 12.7476 0 0 0 0 12.9166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.93 0 0 0 0 12.838 0 0 0 0 15.5738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2041 0 0 0 0 14.4996 0 0 0 13.9223 14.6504 0 0 0 14.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6705 0 0 0 0 0 0 0 12.5196 0 13.5033 0 11.8858 14.7003 14.601 0 0 0 0 13.3305 0 0 O14929 HAT1_HUMAN "Histone acetyltransferase type B catalytic subunit, EC 2.3.1.48 (Histone acetyltransferase 1)" HAT1 KAT1 Homo sapiens (Human) chromosome organization [GO:0051276]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; subtelomeric heterochromatin assembly [GO:0031509] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromosome organization [GO:0051276]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; subtelomeric heterochromatin assembly [GO:0031509]" GO:0000781; GO:0000785; GO:0004402; GO:0005634; GO:0005654; GO:0005739; GO:0006335; GO:0006336; GO:0006475; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043967; GO:0051276 H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393] DFVLVKLCQDLPCFSR 0.98521 -2.9629 0 0 0 0 0 0 0 0 0 0 0 11.9997 0 0 0 0 0 0 0 0 0 0 11.8569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2279 0 0 0 0 0 0 0 0 0 0 0 0 11.4921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5435 11.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11216 PYGB_HUMAN "Glycogen phosphorylase, brain form, EC 2.4.1.1" PYGB Homo sapiens (Human) glycogen catabolic process [GO:0005980] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen catabolic process [GO:0005980] GO:0005576; GO:0005737; GO:0005980; GO:0008184; GO:0016020; GO:0030170; GO:0035578; GO:0070062; GO:0102250; GO:0102499 glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499] AKPLTDSEK 0.98521 -2.6987 0 0 0 0 0 0 0 0 0 0 13.2809 0 0 0 0 0 0 0 15.5165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9207 0 0 14.1896 0 0 13.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18428 LBP_HUMAN "Lipopolysaccharide-binding protein, LBP" LBP Homo sapiens (Human) acute-phase response [GO:0006953]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil chemotaxis [GO:0030593]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of tumor necrosis factor production [GO:0032720]; neutrophil chemotaxis [GO:0030593]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496] GO:0001530; GO:0002232; GO:0002281; GO:0005102; GO:0005576; GO:0005615; GO:0006953; GO:0006968; GO:0008228; GO:0009986; GO:0015920; GO:0016020; GO:0030593; GO:0031663; GO:0032490; GO:0032496; GO:0032720; GO:0032722; GO:0032755; GO:0032757; GO:0032760; GO:0033036; GO:0034145; GO:0043032; GO:0045087; GO:0045919; GO:0050829; GO:0050830; GO:0060265; GO:0070062; GO:0070891; GO:0071222; GO:0071223; GO:0071723; GO:0090023 lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102] ALPSILLALLLTSTPEALGANPGLVARITDK 0.98521 -2.5271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8489 0 13.9073 14.9228 0 0 0 0 0 18.05 0 0 0 0 0 15.074 0 0 0 0 0 0 0 0 13.474 0 0 0 0 0 11.7747 0 0 0 0 0 0 0 0 0 11.8624 12.1154 0 14.338 0 0 0 0 0 0 0 0 0 0 0 12.4038 0 0 0 0 11.5533 14.5693 0 0 11.1879 0 0 0 0 0 0 0 0 0 0 0 11.3517 0 0 0 0 11.8867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.312 0 10.8858 0 14.399 0 Q6P9H4 CNKR3_HUMAN "Connector enhancer of kinase suppressor of ras 3, Connector enhancer of KSR 3 (CNK homolog protein 3, CNK3) (CNKSR family member 3) (Maguin-like protein)" CNKSR3 MAGI1 Homo sapiens (Human) negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765] GO:0005737; GO:0010765; GO:0016324; GO:0033137; GO:0070373; GO:2000651 ALLAWLDR 0.98521 -2.521 14.8867 0 12.1409 0 0 0 0 0 0 0 0 0 0 0 0 14.011 0 13.6736 13.327 13.6658 0 13.4824 0 14.7973 13.4776 0 12.9797 13.0562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9612 0 0 0 0 0 0 0 0 0 0 0 0 14.7247 0 14.6469 14.3468 15.6176 15.6152 15.2549 14.5072 0 15.2648 0 14.9038 14.5425 0 14.3151 0 14.4123 15.6278 14.9208 15.896 15.4042 0 14.0095 15.381 14.9425 14.5728 14.3458 16.9512 0 0 13.9155 0 14.4783 14.4937 15.1879 0 0 0 0 0 0 0 14.7145 14.4263 13.9519 14.4809 14.1034 0 14.3708 0 0 14.2489 0 15.3204 0 0 14.5868 14.2947 0 15.431 16.4824 14.2895 0 14.4522 0 0 15.9885 15.925 14.2932 14.3022 0 14.6676 0 0 14.7203 14.5299 0 0 0 0 14.5332 0 14.6728 0 14.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4857 0 16.0637 13.6327 0 0 0 0 0 Q96M42 CU129_HUMAN Putative uncharacterized protein encoded by LINC00479 LINC00479 C21orf129 PRED76 Homo sapiens (Human) KSGSTGNICSVMLNVATGCVR 0.98521 -2.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3548 0 0 0 0 0 0 0 0 0 0 0 0 13.9813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4308 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9464 18.5331 17.9815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9748 0 0 0 0 0 18.0496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95990 F107A_HUMAN Actin-associated protein FAM107A (Down-regulated in renal cell carcinoma 1) (Protein TU3A) FAM107A DRR1 TU3A Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; stress fiber [GO:0001725]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cell cycle [GO:0007049]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to nutrient levels [GO:0031669]; cognition [GO:0050890]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of long-term synaptic potentiation [GO:1900272]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein stability [GO:0031647] GO:0001558; GO:0001725; GO:0003779; GO:0005634; GO:0005737; GO:0005925; GO:0007049; GO:0015629; GO:0016607; GO:0030041; GO:0030335; GO:0031398; GO:0031647; GO:0031669; GO:0032587; GO:0032956; GO:0043005; GO:0045202; GO:0050890; GO:0051017; GO:0051895; GO:0070507; GO:0071385; GO:1900272; GO:2000134 actin binding [GO:0003779] LLNPVKASR 0.98522 -3.0869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7288 0 0 0 0 0 0 0 0 0 0 0 0 13.6003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1007 P0DMS8 AA3R_HUMAN Adenosine receptor A3 ADORA3 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; regulation of heart contraction [GO:0008016]; regulation of norepinephrine secretion [GO:0014061]; response to wounding [GO:0009611]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; activation of adenylate cyclase activity [GO:0007190]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; regulation of heart contraction [GO:0008016]; regulation of norepinephrine secretion [GO:0014061]; response to wounding [GO:0009611]; signal transduction [GO:0007165] GO:0001609; GO:0001973; GO:0004930; GO:0005886; GO:0005887; GO:0006954; GO:0007165; GO:0007186; GO:0007190; GO:0008016; GO:0008285; GO:0009611; GO:0014061; GO:0030336; GO:0032088; GO:0042734; GO:0045202 G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930] IWLALGLCWLVSFLVGLTPMFGWNMK 0.98522 -3.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6491 0 0 0 0 0 0 0 14.2383 0 13.1016 0 0 12.5418 0 0 12.7241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9275 13.3355 0 0 12.8343 0 0 0 0 12.6523 0 13.1418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TZ20 OR2G6_HUMAN Olfactory receptor 2G6 OR2G6 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] MEETNNSSEK 0.98522 -2.7888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXE6 ARMC6_HUMAN Armadillo repeat-containing protein 6 ARMC6 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] cytosol [GO:0005829] cytosol [GO:0005829]; hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244; GO:0005829 AHPQKAGVQK 0.98522 -3.0844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VX2 COMD7_HUMAN COMM domain-containing protein 7 COMMD7 C20orf92 Homo sapiens (Human) "negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" cytoplasmic vesicle [GO:0031410] "cytoplasmic vesicle [GO:0031410]; NF-kappaB binding [GO:0051059]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0031410; GO:0032088; GO:0033209; GO:0045892; GO:0051059 NF-kappaB binding [GO:0051059] SIVKSLLLVPNGALK 0.98522 -2.1472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1675 10.8455 0 0 0 0 0 0 0 0 0 13.2178 16.413 0 13.7644 0 0 0 0 0 0 0 0 0 12.3639 11.7958 0 0 0 0 0 0 0 11.2187 0 0 0 10.7173 15.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1048 12.1654 10.4708 11.9965 0 11.1554 0 0 0 0 10.833 0 11.3733 0 0 0 0 0 0 0 0 0 0 0 13.2521 0 0 0 0 0 0 17.0701 0 0 0 0 0 11.656 10.833 11.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8718 0 0 0 0 0 0 0 0 0 0 Q99943 PLCA_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase alpha, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 1, 1-AGP acyltransferase 1, 1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha, LPAAT-alpha) (Protein G15)" AGPAT1 G15 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961] GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0016024 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841] EISTDGR 0.98522 -3.7122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2909 0 0 0 0 0 0 0 15.3412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIX4 KCNG1_HUMAN Potassium voltage-gated channel subfamily G member 1 (Voltage-gated potassium channel subunit Kv6.1) (kH2) KCNG1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259] GO:0005249; GO:0005251; GO:0005267; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0051260; GO:0071805; GO:1902259 delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249] ALRILYVMRLAR 0.98522 -3.7982 0 0 0 0 0 11.5361 0 0 0 0 0 0 11.8402 12.1073 0 0 0 0 0 0 0 0 0 10.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7808 0 0 0 0 0 0 0 0 0 0 11.3221 0 15.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1355 Q9Y5V3 MAGD1_HUMAN Melanoma-associated antigen D1 (MAGE tumor antigen CCF) (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog) MAGED1 NRAGE PP2250 PRO2292 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of MAP kinase activity [GO:0043406]; protein localization to nucleus [GO:0034504]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713]; circadian regulation of gene expression [GO:0032922]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of MAP kinase activity [GO:0043406]; protein localization to nucleus [GO:0034504]; regulation of apoptotic process [GO:0042981]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0003713; GO:0005634; GO:0005737; GO:0005886; GO:0006355; GO:0032922; GO:0032991; GO:0034504; GO:0042752; GO:0042802; GO:0042981; GO:0043406; GO:0050680; GO:0090190; GO:1900181; GO:2001235 identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713] DVALLQER 0.98522 -2.616 0 0 0 0 0 0 0 0 9.52158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5244 0 0 0 0 0 0 0 15.6957 0 0 0 0 0 12.7582 0 12.422 0 0 0 12.8555 0 0 0 0 13.349 0 0 0 0 0 13.0675 0 0 0 0 0 0 0 0 0 0 14.8182 0 0 12.7669 0 0 11.8825 0 0 15.4418 12.5438 0 0 16.9171 0 0 0 0 0 0 11.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 14.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UM47 NOTC3_HUMAN "Neurogenic locus notch homolog protein 3, Notch 3 [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain ]" NOTCH3 Homo sapiens (Human) artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000122; GO:0000139; GO:0005509; GO:0005576; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0007219; GO:0007411; GO:0009986; GO:0014016; GO:0015629; GO:0016021; GO:0019899; GO:0030900; GO:0038023; GO:0042802; GO:0043235; GO:0045296; GO:0045665; GO:0045944; GO:0048661; GO:0048663; GO:0048844; GO:0072104 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] AGGTCSSDGMGFHCTCPPGVQGR 0.98523 -2.1535 14.1696 0 0 13.5388 0 13.2033 0 14.8789 15.989 15.8869 16.1408 16.3652 15.7957 0 16.3336 0 14.5728 15.7073 15.8723 0 15.8526 0 16.5014 0 0 15.6664 15.1112 15.7175 15.7647 16.1026 14.3949 14.3749 0 0 11.6077 0 14.3977 0 13.9258 14.0303 13.4071 14.8602 15.1255 0 14.5325 0 0 0 11.9705 0 0 0 0 11.7186 12.1688 0 10.741 0 0 0 10.5714 0 0 0 0 0 0 0 0 12.8402 0 13.2728 14.7587 13.5468 13.5879 16.2796 16.073 14.8593 13.6597 15.297 0 12.3093 0 0 0 14.726 0 0 0 13.5677 13.753 12.4588 14.9109 14.9334 13.6005 13.121 11.8052 0 0 11.3513 15.0173 13.5845 15.2461 0 0 14.4761 0 11.6485 0 0 0 15.8935 13.9642 14.633 0 14.4089 14.896 0 13.9235 0 13.8721 14.4878 12.4067 13.481 13.3458 10.5519 13.8257 15.1233 14.222 14.6893 0 14.1494 16.255 16.2311 15.5815 0 0 15.0621 0 0 0 13.0244 14.6014 11.121 14.9446 0 0 12.1675 0 12.8703 11.5269 14.9011 0 0 0 11.5241 0 0 14.0942 13.2332 14.7231 15.0713 10.2153 0 14.7874 14.3959 13.9351 13.5142 14.7662 0 0 0 14.9657 12.6133 12.8879 13.8815 0 14.8889 13.8804 0 O95866 G6B_HUMAN Megakaryocyte and platelet inhibitory receptor G6b (Protein G6b) MPIG6B C6orf25 G6B G6B-B Homo sapiens (Human) blood coagulation [GO:0007596]; erythrocyte differentiation [GO:0030218]; integrin-mediated signaling pathway [GO:0007229]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; negative regulation of signal transduction [GO:0009968]; platelet formation [GO:0030220] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; blood coagulation [GO:0007596]; erythrocyte differentiation [GO:0030218]; integrin-mediated signaling pathway [GO:0007229]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; negative regulation of signal transduction [GO:0009968]; platelet formation [GO:0030220] GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007229; GO:0007596; GO:0008201; GO:0009968; GO:0016021; GO:0030218; GO:0030219; GO:0030220; GO:0035855 heparin binding [GO:0008201] FAPLVKTEPQR 0.98523 -3.2853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3409 14.3265 0 13.7984 0 13.9981 0 0 14.7385 0 0 0 0 0 0 13.7256 0 0 0 0 10.992 0 10.7379 0 0 0 0 0 0 13.9609 0 0 0 0 13.5529 0 0 0 0 10.7925 14.294 0 0 0 11.3899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7642 0 0 12.6905 0 0 0 0 0 0 0 0 0 0 13.3818 0 0 0 0 0 0 0 A0A075B6L6 TVB73_HUMAN Probable non-functional T cell receptor beta variable 7-3 TRBV7-3 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 DRFFAVR 0.98524 -3.3829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4QN01 CJ040_HUMAN Putative uncharacterized protein encoded by LINC01553 LINC01553 C10orf40 Homo sapiens (Human) ERSTQLRR 0.98524 -2.8971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NNY8 UBP27_HUMAN "Ubiquitin carboxyl-terminal hydrolase 27, EC 3.4.19.12 (Deubiquitinating enzyme 27) (Ubiquitin carboxyl-terminal hydrolase 22-like) (Ubiquitin thioesterase 27) (Ubiquitin-specific-processing protease 27) (X-linked ubiquitin carboxyl-terminal hydrolase 27)" USP27X USP22L USP27 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of apoptotic process [GO:0043065]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0043065; GO:0045087; GO:0050821; GO:0051607; GO:0060340; GO:0061578; GO:0070536; GO:0071108; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578] CGSCQSYQESTKQLTMNK 0.98524 -2.1604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8719 0 14.0251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15539 RGS5_HUMAN "Regulator of G-protein signaling 5, RGS5" RGS5 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0003924; GO:0005096; GO:0005829; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0043231 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] DSLPRFVR 0.98524 -2.1583 0 0 0 17.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9215 11.3455 0 0 0 10.1401 0 0 0 0 0 0 0 14.1585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1801 0 0 0 0 14.2064 0 0 11.2998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1641 0 0 0 13.7117 0 0 0 11.2983 0 0 0 0 0 0 0 0 O95264 5HT3B_HUMAN "5-hydroxytryptamine receptor 3B, 5-HT3-B, 5-HT3B (Serotonin receptor 3B)" HTR3B Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0009986; GO:0022850; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0098662; GO:1904315; GO:1904602 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ARIVFKTSVLVGYTVFR 0.98524 -2.9861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51993 FUT6_HUMAN "4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6, EC 2.4.1.152 (Fucosyltransferase 6) (Fucosyltransferase VI, Fuc-TVI, FucT-VI) (Galactoside 3-L-fucosyltransferase)" FUT6 FCT3A Homo sapiens (Human) ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; glycosphingolipid biosynthetic process [GO:0006688]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; glycosphingolipid biosynthetic process [GO:0006688]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0005576; GO:0005794; GO:0006486; GO:0006487; GO:0006493; GO:0006672; GO:0006688; GO:0008417; GO:0009312; GO:0016021; GO:0017083; GO:0032580; GO:0036065; GO:0036071; GO:0042355; GO:0046920; GO:0070062 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] DLARYLQELDK 0.98524 -3.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.856 0 0 0 0 0 0 0 0 0 0 11.011 0 0 0 0 0 0 0 0 11.2604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7556 0 P61565 ENK21_HUMAN "Endogenous retrovirus group K member 21 Env polyprotein (EnvK1 protein) (Envelope polyprotein) (HERV-K_12q14.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERVK-21 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198] GO:0005198; GO:0005886; GO:0016021 structural molecule activity [GO:0005198] HPSEMQRK 0.98524 -2.9894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78412 IRX6_HUMAN Iroquois-class homeodomain protein IRX-6 (Homeodomain protein IRXB3) (Iroquois homeobox protein 6) IRX6 IRX7 IRXB3 Homo sapiens (Human) "cell development [GO:0048468]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0030182; GO:0045893; GO:0048468 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGLAAPR 0.98524 -3.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1222 0 0 0 0 0 0 13.4035 0 0 0 Q6P3S1 DEN1B_HUMAN DENN domain-containing protein 1B (Connecdenn 2) (Protein FAM31B) DENND1B C1orf218 FAM31B Homo sapiens (Human) endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852] GO:0005085; GO:0005829; GO:0006897; GO:0015031; GO:0016607; GO:0030136; GO:0031267; GO:0032456; GO:0043231; GO:0043547; GO:0050776; GO:0050852; GO:1901981; GO:2000553 guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267] HLPPSPRKR 0.98524 -2.6334 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.567 0 12.5216 0 0 0 13.751 13.925 0 0 0 0 14.1674 14.0783 13.5736 14.0942 0 0 0 0 13.4346 0 13.6167 12.8696 0 0 0 0 0 0 0 0 0 0 0 0 14.1626 13.6413 0 0 13.7447 14.3151 0 0 0 0 0 0 13.6835 13.6001 0 12.6484 0 0 0 0 0 11.4434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1954 0 0 14.2704 0 0 0 0 0 0 0 0 0 0 0 12.0959 0 0 0 0 0 0 13.2031 0 0 0 0 0 0 0 Q8N6M9 ZFN2A_HUMAN AN1-type zinc finger protein 2A ZFAND2A Homo sapiens (Human) cellular response to arsenic-containing substance [GO:0071243]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; zinc ion binding [GO:0008270]; cellular response to arsenic-containing substance [GO:0071243]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047] GO:0000502; GO:0005634; GO:0005737; GO:0005783; GO:0008270; GO:0032436; GO:0043161; GO:0045047; GO:0071243 zinc ion binding [GO:0008270] CDACKQDFCK 0.98524 -3.2911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.324 11.5595 0 0 0 11.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IL0 COA8_HUMAN "Cytochrome c oxidase assembly factor 8, COA8 (Apoptogenic protein 1, mitochondrial, APOP-1)" COA8 APOP1 APOPT1 C14orf153 Homo sapiens (Human) intrinsic apoptotic signaling pathway [GO:0097193]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; protein stabilization [GO:0050821]; response to reactive oxygen species [GO:0000302] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrion [GO:0005739] matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrion [GO:0005739]; intrinsic apoptotic signaling pathway [GO:0097193]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of cytochrome-c oxidase activity [GO:1904960]; protein stabilization [GO:0050821]; response to reactive oxygen species [GO:0000302] GO:0000302; GO:0005739; GO:0033617; GO:0050821; GO:0097193; GO:0099617; GO:1903427; GO:1904960 TFLPPLCR 0.98524 -2.1578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6794 0 0 0 0 0 0 0 0 0 14.5646 13.9267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28289 TMOD1_HUMAN "Tropomodulin-1 (Erythrocyte tropomodulin, E-Tmod)" TMOD1 D9S57E TMOD Homo sapiens (Human) actin filament organization [GO:0007015]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694] actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865] actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694] GO:0003779; GO:0005523; GO:0005829; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0008344; GO:0016020; GO:0030016; GO:0030017; GO:0030239; GO:0030863; GO:0051015; GO:0051694; GO:0070307 actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523] APTGPFK 0.98525 -3.3891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9676 0 17.7391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VDD7 BRME1_HUMAN Break repair meiotic recombinase recruitment factor 1 (Pre-T/NK cell-associated protein 3B3) BRME1 C19orf57 Homo sapiens (Human) double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; spermatogenesis [GO:0007283] chromosome [GO:0005694] chromosome [GO:0005694]; double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; spermatogenesis [GO:0007283] GO:0005694; GO:0007144; GO:0007283; GO:1990918 AADGGHR 0.98525 -3.3939 0 0 0 0 0 0 0 0 0 14.2856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96C11 FGGY_HUMAN "FGGY carbohydrate kinase domain-containing protein (D-ribulokinase FGGY, EC 2.7.1.47)" FGGY Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; D-ribulokinase activity [GO:0019150]; carbohydrate phosphorylation [GO:0046835]; neuron cellular homeostasis [GO:0070050]; pentose metabolic process [GO:0019321] GO:0005737; GO:0019150; GO:0019321; GO:0046835; GO:0070050 D-ribulokinase activity [GO:0019150] ATGVTAR 0.98525 -3.3998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9907 0 0 0 0 12.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3986 0 0 0 0 0 0 0 0 0 13.8025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYT3 STK33_HUMAN "Serine/threonine-protein kinase 33, EC 2.7.11.1" STK33 Homo sapiens (Human) mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; mitotic DNA damage checkpoint signaling [GO:0044773]; protein autophosphorylation [GO:0046777] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0044773; GO:0046777; GO:0048471; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DNFDMCSSSFTSSK 0.98525 -2.7167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4066 0 0 0 0 0 0 0 0 0 0 10.6274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0526 0 0 10.2053 0 0 0 15.8221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6942 11.7181 0 0 0 0 0 16.383 13.011 0 0 0 12.9041 0 0 0 12.5428 0 0 0 0 0 0 13.4165 0 11.209 0 0 0 0 0 0 0 0 12.9592 0 0 12.509 0 0 0 0 0 12.8968 0 0 0 12.4392 0 0 13.6869 0 0 0 0 0 0 0 0 0 0 12.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4794 0 0 0 0 0 0 0 0 0 0 0 P69892 HBG2_HUMAN Hemoglobin subunit gamma-2 (Gamma-2-globin) (Hb F Ggamma) (Hemoglobin gamma-2 chain) (Hemoglobin gamma-G chain) HBG2 Homo sapiens (Human) carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942] blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833] blood microparticle [GO:0072562]; cytosol [GO:0005829]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942] GO:0005344; GO:0005829; GO:0005833; GO:0010942; GO:0015670; GO:0015671; GO:0019825; GO:0020037; GO:0031721; GO:0031838; GO:0042744; GO:0043177; GO:0046872; GO:0072562; GO:0098869 heme binding [GO:0020037]; hemoglobin alpha binding [GO:0031721]; metal ion binding [GO:0046872]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] ATITSLWGK 0.98526 -2.9118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74015 0 10.1347 0 0 0 10.7669 0 0 0 0 11.1562 0 0 0 0 10.3431 0 0 0 0 9.85978 0 0 0 0 0 0 10.5559 0 0 0 0 0 0 0 0 0 0 0 0 15.8653 15.5902 14.9714 12.1453 14.0202 0 0 0 0 17.3168 17.7111 18.394 0 10.8308 13.1299 0 12.0893 12.802 0 0 14.7298 0 11.9655 0 0 0 0 0 0 0 0 0 9.93799 0 13.5022 0 0 14.643 0 13.1177 12.3628 0 0 12.6018 0 0 0 0 0 12.357 12.8643 11.9865 12.0284 0 0 0 14.2811 0 0 0 0 0 0 0 11.529 0 0 13.604 12.1279 0 11.1625 11.7059 0 0 0 0 0 0 0 11.1311 0 13.1305 0 0 11.7044 0 0 0 0 0 0 0 13.8455 0 0 14.3391 0 0 0 A5PLK6 RGSL_HUMAN Regulator of G-protein signaling protein-like RGSL1 RGSL RGSL2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GLLTWLEKCRLPFFCK 0.98526 -2.6471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9931 12.6644 0 0 0 0 0 0 0 13.6542 0 0 0 0 15.5254 13.5199 0 0 0 15.7743 0 14.1015 15.6282 15.7688 15.6265 15.8743 14.9561 15.1671 0 0 14.5969 13.9636 0 14.4249 0 15.5884 14.4826 14.102 13.0929 0 0 0 0 0 14.5324 14.6796 13.8213 0 0 0 0 0 13.2618 13.3267 0 12.6376 0 11.8593 0 0 0 0 13.5389 0 0 0 0 0 0 0 0 0 0 12.9778 0 0 0 0 0 0 0 0 10.7543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6891 0 12.4553 0 0 0 0 0 0 0 0 0 Q04724 TLE1_HUMAN "Transducin-like enhancer protein 1 (E(Sp1) homolog) (Enhancer of split groucho-like protein 1, ESG1)" TLE1 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; negative regulation of anoikis [GO:2000811]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]" GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0007165; GO:0009887; GO:0010628; GO:0016055; GO:0030178; GO:0042802; GO:0043124; GO:0045892; GO:0090090; GO:0140297; GO:1990907; GO:2000811 DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714] HVYTGGK 0.98526 -3.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWU4 CF089_HUMAN Bombesin receptor-activated protein C6orf89 (Amfion) C6orf89 BRAP UNQ177/PRO203 Homo sapiens (Human) epithelial cell proliferation [GO:0050673]; positive regulation of cell cycle [GO:0045787]; positive regulation of histone deacetylase activity [GO:1901727]; wound healing [GO:0042060] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; epithelial cell proliferation [GO:0050673]; positive regulation of cell cycle [GO:0045787]; positive regulation of histone deacetylase activity [GO:1901727]; wound healing [GO:0042060] GO:0000139; GO:0005730; GO:0005737; GO:0005886; GO:0016021; GO:0030496; GO:0042060; GO:0045787; GO:0050673; GO:1901727 FERLHPLVIK 0.98526 -3.0108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QF0 RAB3I_HUMAN "Rab-3A-interacting protein, Rab3A-interacting protein (Rabin-3) (SSX2-interacting protein)" RAB3IP RABIN8 Homo sapiens (Human) ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of filopodium assembly [GO:0051490]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi to plasma membrane transport vesicle [GO:0070319]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proximal dendrite [GO:1990635] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi to plasma membrane transport vesicle [GO:0070319]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proximal dendrite [GO:1990635]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of filopodium assembly [GO:0051490]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612] GO:0005085; GO:0005634; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0006612; GO:0006887; GO:0006893; GO:0030027; GO:0033365; GO:0036064; GO:0042802; GO:0048471; GO:0051020; GO:0051490; GO:0060271; GO:0070319; GO:0097711; GO:1990635 GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802] ASAVECGGPKKCALTGQSK 0.98526 -2.911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3991 13.9983 0 14.6925 14.5134 12.1098 14.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15550 KDM6A_HUMAN "Lysine-specific demethylase 6A, EC 1.14.11.68 (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)" KDM6A UTX Homo sapiens (Human) chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; regulation of gene expression [GO:0010468] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; histone H3-K4 methylation [GO:0051568]; regulation of gene expression [GO:0010468] GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0051568; GO:0071557; GO:0071558 chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] CYLNATRSK 0.98527 -2.8309 11.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7289 12.9053 0 13.0868 17.161 0 0 11.4698 0 0 0 14.8869 12.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5742 0 0 14.9559 0 0 13.9103 0 14.5126 14.0883 0 0 15.0298 0 0 13.5158 11.4447 14.9031 0 0 12.8237 0 0 0 0 0 12.4348 12.503 0 0 0 0 0 14.0901 0 0 0 0 0 0 13.4635 0 0 0 0 0 0 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5017 0 13.6896 0 0 0 0 18.7357 0 0 0 0 12.076 0 18.5497 0 0 0 0 0 0 9.5308 0 0 0 0 0 0 10.0771 0 9.72744 P08603 CFAH_HUMAN Complement factor H (H factor 1) CFH HF HF1 HF2 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of complement-dependent cytotoxicity [GO:1903659]" blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370] "blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; complement component C3b binding [GO:0001851]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of complement-dependent cytotoxicity [GO:1903659]" GO:0001851; GO:0005576; GO:0005615; GO:0006508; GO:0006956; GO:0006957; GO:0008201; GO:0030449; GO:0030451; GO:0042802; GO:0043395; GO:0070062; GO:0072562; GO:1903659; GO:1905370 complement component C3b binding [GO:0001851]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] CLGEKWSHPPSCIK 0.98527 -2.1053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3245 11.1726 0 13.647 0 0 0 12.3775 0 0 0 0 0 0 0 0 0 0 11.5158 0 15.1075 0 0 0 0 0 0 0 0 0 0 11.0582 0 0 0 0 11.5611 0 0 0 0 0 12.3152 0 0 11.4109 0 0 0 0 0 0 0 12.5994 0 0 0 0 0 0 0 0 0 0 11.4973 0 0 0 0 0 0 11.4 0 0 14.6647 14.2476 14.0979 14.6499 0 0 0 0 0 0 0 13.8227 0 0 0 0 11.2971 0 0 0 0 0 0 P78509 RELN_HUMAN "Reelin, EC 3.4.21.-" RELN Homo sapiens (Human) "associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; interneuron migration [GO:1904936]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; proteolysis [GO:0006508]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of NMDA receptor activity [GO:2000310]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]; associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; interneuron migration [GO:1904936]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; proteolysis [GO:0006508]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of neuron differentiation [GO:0045664]; regulation of neuron migration [GO:2001222]; regulation of NMDA receptor activity [GO:2000310]; regulation of synaptic activity [GO:0060025]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]" GO:0000904; GO:0001764; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007155; GO:0007411; GO:0007417; GO:0007420; GO:0007616; GO:0007626; GO:0008236; GO:0008306; GO:0010001; GO:0010976; GO:0014068; GO:0016358; GO:0018108; GO:0021511; GO:0021517; GO:0021766; GO:0021800; GO:0021819; GO:0030425; GO:0031012; GO:0032008; GO:0032793; GO:0035418; GO:0038026; GO:0043005; GO:0045664; GO:0045860; GO:0046872; GO:0048265; GO:0050731; GO:0050795; GO:0050804; GO:0051057; GO:0051968; GO:0060025; GO:0060291; GO:0061003; GO:0061098; GO:0070325; GO:0070326; GO:0090129; GO:0097114; GO:0097119; GO:0097120; GO:0097477; GO:0110157; GO:1900273; GO:1902078; GO:1904936; GO:2000310; GO:2000463; GO:2000969; GO:2001222 lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326] APSNVSTIIHILYLPEDAK 0.98527 -3.6758 0 0 0 0 0 0 0 0 0 0 0 0 12.8937 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4959 0 12.973 12.5774 10.3242 0 0 0 0 0 0 0 0 0 0 12.2235 0 12.4119 0 0 0 0 0 0 0 0 13.8628 13.5152 0 13.8943 12.764 0 0 11.5144 0 0 0 0 0 0 0 0 0 0 0 0 13.1605 0 0 12.9325 0 0 0 0 14.8083 0 12.1505 0 0 0 0 14.1466 0 0 11.8863 0 0 0 0 0 0 0 0 13.7863 13.3386 0 12.1726 15.2431 0 0 0 0 14.3388 0 0 13.4906 0 13.011 14.1985 0 0 0 0 0 0 14.4624 0 0 0 0 12.4412 14.405 0 14.2847 14.0437 0 12.705 0 0 0 0 0 0 0 0 0 13.242 0 0 0 0 11.4845 0 10.8916 13.2541 0 0 0 0 0 12.5567 13.2037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99567 NUP88_HUMAN Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88) NUP88 Homo sapiens (Human) mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056] GO:0000055; GO:0000056; GO:0000278; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0017056 structural constituent of nuclear pore [GO:0017056] EEGEHIREMVK 0.98527 -2.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7555 0 13.7021 0 0 0 0 0 0 0 0 12.9464 15.3827 0 0 0 0 0 0 0 14.0471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRR8 GPTC1_HUMAN G patch domain-containing protein 1 (Evolutionarily conserved G-patch domain-containing protein) GPATCH1 ECGP GPATC1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0005634; GO:0071013 RNA binding [GO:0003723] IYPPPELPRDYR 0.98527 -2.8323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8365 0 0 13.7744 0 0 0 14.1081 0 14.4453 0 13.8941 14.0383 0 14.0444 10.9546 0 0 0 0 0 0 14.5317 0 15.6682 11.9762 13.4654 0 14.699 0 0 0 0 14.0203 0 0 0 15.1473 0 14.8411 14.2535 11.6122 0 13.8905 0 13.7726 12.9725 0 14.5561 15.0015 0 0 14.2452 13.7299 0 13.6582 0 10.9298 0 14.8379 15.0484 0 14.2704 0 0 14.3413 0 0 0 0 0 0 0 14.7534 14.2459 14.2942 0 0 0 0 0 0 0 0 9.73939 0 0 0 0 0 0 13.9551 14.7498 15.2119 14.0639 0 0 0 0 0 Q9UM21 MGT4A_HUMAN "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A, EC 2.4.1.145 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa, GlcNAc-T IVa, GnT-IVa, N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form ]" MGAT4A Homo sapiens (Human) glyoxylate metabolic process [GO:0046487]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; peroxisome [GO:0005777] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; peroxisome [GO:0005777]; acetylglucosaminyltransferase activity [GO:0008375]; alanine-glyoxylate transaminase activity [GO:0008453]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; glyoxylate metabolic process [GO:0046487]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082]" GO:0000139; GO:0005777; GO:0005783; GO:0005788; GO:0005793; GO:0005795; GO:0006486; GO:0006487; GO:0006491; GO:0008375; GO:0008453; GO:0008454; GO:0016021; GO:0019082; GO:0042803; GO:0046487; GO:0046872; GO:0070062 "acetylglucosaminyltransferase activity [GO:0008375]; alanine-glyoxylate transaminase activity [GO:0008453]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]" DAKHCDR 0.98527 -3.8411 0 0 0 0 0 0 0 0 0 13.2449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3575 14.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01571 IFN17_HUMAN "Interferon alpha-17, IFN-alpha-17 (Interferon alpha-88) (Interferon alpha-I', LeIF I) (Interferon alpha-T)" IFNA17 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0009615; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132] ITLYLTEKK 0.98528 -2.671 0 0 0 0 0 0 0 0 11.1037 11.7931 0 0 11.0682 0 0 0 11.8155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9664 0 0 0 0 0 0 0 10.4824 0 0 0 0 0 0 0 10.4848 0 0 10.787 0 0 0 0 0 0 0 0 0 0 10.5796 0 0 0 0 0 0 11.1638 0 0 0 13.5238 0 0 13.2421 0 0 0 0 12.9335 13.1743 0 0 0 11.7146 0 0 11.2146 11.3659 12.2292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8459 0 13.3684 0 0 0 0 10.6937 0 0 0 13.553 0 12.7204 0 0 13.3146 0 12.7739 0 0 0 0 0 0 13.0237 0 0 0 0 0 0 0 13.3483 0 0 0 0 13.5388 0 0 0 0 0 0 0 11.538 0 0 0 0 0 12.6979 0 0 0 0 12.3616 0 0 0 0 12.8631 0 0 P0DTF9 PTIP2_HUMAN PTTG1IP family member 2 PTTG1IP2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ACKKYCFPYFGCR 0.98528 -2.1154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3121 0 0 0 0 0 11.362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1757 0 0 0 0 13.4476 0 0 12.939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8286 0 0 0 0 0 0 0 0 0 13.1705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20936 RASA1_HUMAN "Ras GTPase-activating protein 1, GAP, GTPase-activating protein, RasGAP (Ras p21 protein activator) (p120GAP)" RASA1 GAP RASA Homo sapiens (Human) blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of GTPase activity [GO:0043547]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of GTPase activity [GO:0043547]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] GO:0000281; GO:0001570; GO:0001726; GO:0001784; GO:0001953; GO:0003924; GO:0005096; GO:0005102; GO:0005737; GO:0005829; GO:0005886; GO:0007162; GO:0007165; GO:0008360; GO:0019870; GO:0030833; GO:0035556; GO:0043066; GO:0043524; GO:0043547; GO:0046580; GO:0048013; GO:0048514; GO:0051020; GO:0051252 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102] FEITLSNKTK 0.98528 -2.1143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8797 12.7649 0 0 0 0 13.4677 0 12.8737 0 0 0 0 0 0 0 0 0 11.9523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7349 0 0 0 0 0 0 0 0 0 0 0 0 0 P32297 ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 CHRNA3 NACHRA3 Homo sapiens (Human) "acetylcholine receptor signaling pathway [GO:0095500]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]" GO:0005231; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007171; GO:0007268; GO:0007271; GO:0007399; GO:0007626; GO:0014056; GO:0014069; GO:0015276; GO:0015464; GO:0016021; GO:0016607; GO:0022848; GO:0030425; GO:0030594; GO:0034220; GO:0035095; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0050877; GO:0051899; GO:0060079; GO:0060084; GO:0070161; GO:0095500; GO:1904315; GO:1905144 acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] EGYPCQDGMCGYCHHR 0.98528 -2.7442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1515 0 0 0 11.2301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0614 0 0 0 0 0 0 0 0 0 12.7007 0 0 0 11.7792 0 0 0 0 0 0 0 0 0 0 0 14.7139 12.5669 14.059 0 0 0 14.2948 0 0 13.6247 0 0 0 0 10.6773 11.7705 0 0 0 0 0 0 0 0 11.8791 0 0 11.6547 0 0 0 0 0 0 0 0 0 0 0 0 14.035 0 0 0 0 0 0 0 0 0 0 14.3208 14.172 12.5394 11.6197 0 0 0 0 0 12.3404 0 0 0 12.6627 12.3808 0 0 0 0 0 0 0 0 0 11.5117 0 0 12.387 0 13.6362 0 0 Q7Z4M0 RE114_HUMAN Meiotic recombination protein REC114 REC114 C15orf60 Homo sapiens (Human) DNA recombination [GO:0006310]; meiotic cell cycle [GO:0051321] DNA recombination [GO:0006310]; meiotic cell cycle [GO:0051321] GO:0006310; GO:0051321 ATESQGKDSAKSVPR 0.98528 -3.7671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SE8 NPM2_HUMAN Nucleoplasmin-2 NPM2 Homo sapiens (Human) blastocyst development [GO:0001824]; chromatin remodeling [GO:0006338]; oocyte differentiation [GO:0009994]; positive regulation of DNA replication [GO:0045740]; positive regulation of meiotic nuclear division [GO:0045836]; regulation of exit from mitosis [GO:0007096]; single fertilization [GO:0007338] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723]; blastocyst development [GO:0001824]; chromatin remodeling [GO:0006338]; oocyte differentiation [GO:0009994]; positive regulation of DNA replication [GO:0045740]; positive regulation of meiotic nuclear division [GO:0045836]; regulation of exit from mitosis [GO:0007096]; single fertilization [GO:0007338] GO:0000785; GO:0001824; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0007096; GO:0007338; GO:0009994; GO:0042393; GO:0045740; GO:0045836 chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723] QSCRLLLHTICLGEKAK 0.98528 -3.6836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BPU6 DPYL5_HUMAN "Dihydropyrimidinase-related protein 5, DRP-5 (CRMP3-associated molecule, CRAM) (Collapsin response mediator protein 5, CRMP-5) (UNC33-like phosphoprotein 6, ULIP-6)" DPYSL5 CRMP5 ULIP6 Homo sapiens (Human) axon guidance [GO:0007411]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; signal transduction [GO:0007165] cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; microtubule binding [GO:0008017]; axon guidance [GO:0007411]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; signal transduction [GO:0007165]" GO:0005829; GO:0007165; GO:0007399; GO:0007411; GO:0008017; GO:0016810; GO:0030425; GO:0032991; GO:0043025; GO:0050774 "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; microtubule binding [GO:0008017]" EMGTPLADTPTRPVTR 0.98528 -3.6779 0 0 0 0 14.5124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.038 13.1559 14.4914 13.288 13.9772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUP7 TRM13_HUMAN "tRNA:m(4)X modification enzyme TRM13 homolog, EC 2.1.1.225 (Coiled-coil domain-containing protein 76)" TRMT13 CCDC76 Homo sapiens (Human) tRNA methylation [GO:0030488] metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488] GO:0008175; GO:0030488; GO:0046872; GO:0106050 metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175] HLKKCNSR 0.98528 -3.7648 0 0 0 0 0 0 0 0 16.9062 0 0 0 0 0 0 0 12.3193 0 0 0 12.2523 0 0 0 0 0 0 0 0 0 0 0 0 16.576 16.5678 16.5622 0 15.3994 16.6766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9543 0 0 0 0 0 0 0 0 0 0 0 0 12.2787 0 0 13.1532 0 0 0 0 0 13.5373 0 0 17.904 0 0 0 0 0 0 0 0 0 12.8307 0 0 0 0 0 0 0 0 0 0 16.8818 17.3966 17.1331 0 16.3981 0 0 12.8606 0 12.1451 0 0 0 12.3932 12.9401 0 0 0 0 0 0 0 16.4265 0 0 0 16.1194 0 0 0 15.9241 15.5282 0 0 0 0 0 0 0 0 0 0 14.4568 16.2795 0 19.1798 16.1485 0 17.0375 0 0 0 0 15.2933 15.6125 0 0 0 0 0 0 15.8691 0 0 0 0 14.5342 Q9UBL9 P2RX2_HUMAN "P2X purinoceptor 2, P2X2 (ATP receptor) (Purinergic receptor)" P2RX2 P2X2 Homo sapiens (Human) behavioral response to pain [GO:0048266]; detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [GO:0003029]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; peristalsis [GO:0030432]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; sensory perception of sound [GO:0007605]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; urinary bladder smooth muscle contraction [GO:0014832] apical plasma membrane [GO:0016324]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; purinergic nucleotide receptor activity [GO:0001614]; behavioral response to pain [GO:0048266]; detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [GO:0003029]; neuromuscular junction development [GO:0007528]; neuromuscular synaptic transmission [GO:0007274]; peristalsis [GO:0030432]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; sensory perception of sound [GO:0007605]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; urinary bladder smooth muscle contraction [GO:0014832] GO:0001614; GO:0001666; GO:0002931; GO:0003029; GO:0004931; GO:0005524; GO:0005639; GO:0005886; GO:0005887; GO:0007274; GO:0007528; GO:0007605; GO:0009743; GO:0010524; GO:0014832; GO:0015276; GO:0016324; GO:0030432; GO:0033198; GO:0042802; GO:0043025; GO:0043235; GO:0048266; GO:0048741; GO:0050850; GO:0050909; GO:0098794 ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; purinergic nucleotide receptor activity [GO:0001614] AVQLLILLYFVWYVFIVQKSYQESETGPESSIITKVK 0.98528 -3.4225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7003 0 10.7601 0 0 0 0 14.2777 0 0 0 0 14.4938 14.6208 0 0 0 0 0 0 0 0 11.9338 0 11.4187 0 0 0 0 13.5723 14.5259 0 13.1984 0 0 0 0 0 0 0 0 0 0 0 12.9462 0 0 0 0 0 0 0 0 0 0 0 10.7889 0 0 0 0 0 0 0 11.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKX7 NUP50_HUMAN Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50) NUP50 NPAP60L PRO1146 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606] GO:0005635; GO:0005643; GO:0005654; GO:0006606; GO:0006913; GO:0031965; GO:0051028 EKGIGTLHLK 0.98528 -2.4425 0 0 0 0 0 0 0 0 0 0 17.2728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9792 0 0 16.0969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8121 0 14.9292 14.6222 14.7214 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92502 STAR8_HUMAN "StAR-related lipid transfer protein 8 (Deleted in liver cancer 3 protein, DLC-3) (START domain-containing protein 8, StARD8) (START-GAP3)" STARD8 DLC3 KIAA0189 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165] focal adhesion [GO:0005925] focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; regulation of Rho protein signal transduction [GO:0035023]; signal transduction [GO:0007165] GO:0005096; GO:0005925; GO:0007165; GO:0008289; GO:0030036; GO:0035023 GTPase activator activity [GO:0005096]; lipid binding [GO:0008289] APDGHPLRLWKASTEVAAPPAVVLHR 0.98529 -3.0448 0 0 0 0 0 0 0 0 12.4271 0 0 0 0 0 0 0 0 0 0 0 0 14.2836 0 14.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2698 14.3853 18.8444 15.6657 18.6352 14.5236 0 14.916 16.1797 16.203 15.8153 19.0044 15.396 15.8884 14.3615 0 18.3967 13.9057 12.5027 15.0417 14.1042 14.3805 14.4703 18.8453 14.9915 14.9694 15.234 14.49 0 14.6005 14.4274 0 16.241 14.8352 18.9254 0 0 13.0083 0 14.0142 14.0629 0 0 14.7272 0 0 15.1854 12.9177 0 0 0 14.9123 18.0298 13.85 0 14.0604 0 14.1255 14.1598 14.2548 15.9748 13.3392 12.5461 14.1467 0 0 14.7195 14.2125 15.0631 18.7347 13.9604 0 0 11.324 13.8812 0 15.6673 14.0426 0 0 0 0 0 11.0806 0 0 0 12.9753 14.164 14.2005 0 0 0 0 0 9.65189 0 0 0 0 0 0 0 0 0 0 15.2684 0 0 0 0 0 0 0 O14756 H17B6_HUMAN "17-beta-hydroxysteroid dehydrogenase type 6, 17-beta-HSD 6, 17-beta-HSD6, EC 1.1.1.105, EC 1.1.1.209, EC 1.1.1.239, EC 1.1.1.53, EC 1.1.1.62 (3-alpha->beta-hydroxysteroid epimerase, 3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 6)" HSD17B6 RODH SDR9C6 Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; brexanolone catabolic process [GO:0062175]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231] "early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; brexanolone catabolic process [GO:0062175]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]" GO:0003824; GO:0004745; GO:0005783; GO:0006702; GO:0006710; GO:0008202; GO:0009055; GO:0016229; GO:0016491; GO:0031901; GO:0042572; GO:0043231; GO:0044594; GO:0047023; GO:0047024; GO:0047035; GO:0047044; GO:0047045; GO:0062175 "17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; catalytic activity [GO:0003824]; electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" EAPKHIKETYGQQYFDALYNIMK 0.98529 -3.4263 0 14.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6359 0 0 0 13.4071 12.6364 0 0 0 0 0 0 0 0 12.6381 13.4981 12.4152 0 0 0 0 0 14.789 0 0 14.2656 0 0 0 0 0 0 0 0 0 0 0 14.1863 0 0 0 0 11.8578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1477 0 0 0 0 0 0 0 0 0 0 0 13.4982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35711 SOX5_HUMAN Transcription factor SOX-5 SOX5 Homo sapiens (Human) asymmetric neuroblast division [GO:0055059]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; asymmetric neuroblast division [GO:0055059]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001502; GO:0002062; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0032332; GO:0045165; GO:0051216; GO:0055059; GO:0061036; GO:0071560; GO:2000741 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" GSNEPHIKRPMNAFMVWAK 0.98529 -2.3668 0 0 0 0 12.1537 0 0 0 0 0 0 0 0 0 0 0 10.8704 0 0 0 0 0 0 0 0 10.4656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1388 0 0 0 0 0 0 12.606 0 0 0 0 12.8614 0 0 0 0 0 12.4638 12.6943 11.6266 0 12.7179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.026 12.1469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55073 IOD3_HUMAN "Thyroxine 5-deiodinase, EC 1.21.99.3 (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)" DIO3 ITDI3 TXDI3 Homo sapiens (Human) brown fat cell proliferation [GO:0070342]; hormone biosynthetic process [GO:0042446]; positive regulation of multicellular organism growth [GO:0040018]; response to hypoxia [GO:0001666]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798]; brown fat cell proliferation [GO:0070342]; hormone biosynthetic process [GO:0042446]; positive regulation of multicellular organism growth [GO:0040018]; response to hypoxia [GO:0001666]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403] GO:0001666; GO:0004800; GO:0005886; GO:0010008; GO:0016021; GO:0033798; GO:0040018; GO:0042403; GO:0042404; GO:0042446; GO:0043231; GO:0046549; GO:0070342; GO:0097474 thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798] LVTKYQR 0.98529 -3.8569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1563 0 13.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5I0G3 MDH1B_HUMAN "Putative malate dehydrogenase 1B, EC 1.1.1.-" MDH1B Homo sapiens (Human) malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099] L-malate dehydrogenase activity [GO:0030060]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099] GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060 L-malate dehydrogenase activity [GO:0030060] IAHNIIAVALGVEGEAKAILARK 0.98529 -2.4982 0 0 0 0 0 0 0 0 0 0 0 0 13.5948 0 0 0 0 14.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6771 0 14.5305 0 0 0 0 0 0 0 0 0 0 0 9.87642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4133 0 0 0 12.8406 0 0 0 0 15.5841 0 13.1319 0 0 0 13.066 0 0 0 15.2155 0 0 0 0 0 0 0 0 12.7207 0 0 0 0 12.6491 0 0 0 13.2687 0 0 0 0 0 0 0 13.7942 0 0 0 0 13.7389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6246 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7449 12.9804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMV5 P4R3C_HUMAN Protein PPP4R3C (SMEK homolog 3) (Serine/threonine-protein phosphatase 4 regulatory subunit 3C) PPP4R3C PPP4R3CP SMEK3P Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289] nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; protein dephosphorylation [GO:0006470] GO:0005654; GO:0006470; GO:0006974; GO:0030289; GO:0072542 protein phosphatase activator activity [GO:0072542] CELLFFFKELCSFSQALQPQSK 0.98529 -3.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85577 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2438 0 0 0 14.6869 0 0 0 0 0 0 11.0026 0 0 0 0 0 12.5455 0 0 0 0 0 0 10.8833 0 0 0 0 16.0552 0 0 0 0 0 0 0 0 0 0 10.6164 12.594 0 0 0 0 0 0 0 0 0 0 12.0148 0 0 0 0 0 0 11.2286 0 0 14.6313 0 0 0 0 0 0 0 0 0 12.8081 0 0 0 0 0 0 0 0 0 0 0 0 10.5907 0 Q8N1N4 K2C78_HUMAN "Keratin, type II cytoskeletal 78 (Cytokeratin-78, CK-78) (Keratin-5b) (Keratin-78, K78) (Type-II keratin Kb40)" KRT78 K5B KB40 Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005615; GO:0005829; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0070062 structural constituent of skin epidermis [GO:0030280] FLEQQNK 0.98529 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3347 0 0 0 0 0 0 0 0 0 0 0 15.7783 0 0 0 0 0 15.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92935 EXTL1_HUMAN "Exostosin-like 1, EC 2.4.1.224 (Exostosin-L) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein)" EXTL1 EXTL Homo sapiens (Human) protein glycosylation [GO:0006486]; skeletal system development [GO:0001501] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; protein glycosylation [GO:0006486]; skeletal system development [GO:0001501] GO:0001501; GO:0005789; GO:0005794; GO:0006486; GO:0008375; GO:0015020; GO:0016021; GO:0016757; GO:0050508 acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757] LRLDPVLFK 0.98529 -2.369 0 0 12.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6392 0 0 0 0 0 0 0 0 12.5578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3608 11.1172 0 0 13.0015 0 0 0 0 0 0 0 11.4401 0 0 0 0 0 0 0 0 0 0 0 0 12.9514 0 0 0 0 0 0 0 0 0 0 12.5573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8216 0 0 0 0 0 13.1441 0 0 12.5925 12.2373 0 0 0 0 0 0 11.1782 0 0 0 Q9C0F1 CEP44_HUMAN "Centrosomal protein of 44 kDa, Cep44 (HBV PreS1-transactivated protein 3, PS1TP3)" CEP44 KIAA1712 Homo sapiens (Human) centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098] GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0007099; GO:0008017; GO:0010457; GO:0030496 microtubule binding [GO:0008017] IPSQQRK 0.98529 -2.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4453 0 0 0 0 0 0 0 0 17.4614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9422 0 0 0 0 0 0 16.8832 0 0 Q9H310 RHBG_HUMAN "Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein, Rh family type B glycoprotein, Rh type B glycoprotein)" RHBG Homo sapiens (Human) ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; transepithelial ammonium transport [GO:0070634] anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spectrin-associated cytoskeleton [GO:0014731] anchored component of plasma membrane [GO:0046658]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spectrin-associated cytoskeleton [GO:0014731]; ammonium transmembrane transporter activity [GO:0008519]; ankyrin binding [GO:0030506]; ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; transepithelial ammonium transport [GO:0070634] GO:0005886; GO:0005887; GO:0008519; GO:0014731; GO:0016323; GO:0030506; GO:0030659; GO:0046658; GO:0070634; GO:0072488; GO:0097272 ammonium transmembrane transporter activity [GO:0008519]; ankyrin binding [GO:0030506] LQLPLLCLFLQGATAVLFAVFVR 0.98529 -3.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A5PLN9 TPC13_HUMAN Trafficking protein particle complex subunit 13 TRAPPC13 C5orf44 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005829; GO:0006888; GO:0006901; GO:0099022; GO:1990071; GO:1990072 AGIIKGVTVIGKLDIVWK 0.9853 -2.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2991 0 0 0 0 13.0332 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1128 0 0 0 0 0 0 0 0 11.4144 0 0 0 0 0 0 13.9709 13.0884 11.692 0 0 0 0 0 0 0 0 0 0 10.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7996 0 0 0 0 0 0 0 0 0 0 0 16.1713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B2RXH4 BTBDI_HUMAN BTB/POZ domain-containing protein 18 BTBD18 Homo sapiens (Human) cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spermatogenesis [GO:0007283] GO:0005634; GO:0007141; GO:0007283; GO:0010529; GO:0030154; GO:0032968; GO:1990511 EEGPQENNR 0.9853 -2.6872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91461 0 0 13.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7827 0 0 0 0 0 10.3896 0 0 0 9.61561 0 0 0 O00626 CCL22_HUMAN C-C motif chemokine 22 (CC chemokine STCP-1) (MDC(1-69)) (Macrophage-derived chemokine) (Small-inducible cytokine A22) (Stimulated T-cell chemotactic protein 1) [Cleaved into: MDC(3-69); MDC(5-69); MDC(7-69) ] CCL22 MDC SCYA22 A-152E5.1 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; response to virus [GO:0009615]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; response to virus [GO:0009615]; signal transduction [GO:0007165] GO:0002548; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0009615; GO:0030593; GO:0031640; GO:0043547; GO:0048020; GO:0048247; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009] LPLRVVK 0.9853 -1.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0035 16.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0351 0 0 0 0 0 15.8095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7235 0 17.7782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7031 0 0 0 0 17.6942 0 0 0 0 0 0 17.5962 0 0 0 0 0 Q04756 HGFA_HUMAN "Hepatocyte growth factor activator, HGF activator, HGFA, EC 3.4.21.- [Cleaved into: Hepatocyte growth factor activator short chain; Hepatocyte growth factor activator long chain ]" HGFAC Homo sapiens (Human) blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638] GO:0004252; GO:0005576; GO:0005615; GO:0005791; GO:0005829; GO:0006508; GO:0007596; GO:0008236; GO:0031638 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] DCGTEKCFDETRYEYLEGGDR 0.9853 -1.5465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4939 0 0 0 0 0 0 0 0 0 0 0 12.4998 0 0 0 0 0 0 12.3428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.9053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4028 0 Q16581 C3AR_HUMAN "C3a anaphylatoxin chemotactic receptor, C3AR, C3a-R" C3AR1 AZ3B C3R1 HNFAG09 Homo sapiens (Human) blood circulation [GO:0008015]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular endothelial growth factor production [GO:0010575] azurophil granule membrane [GO:0035577]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; complement component C3a receptor activity [GO:0004876]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; blood circulation [GO:0008015]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular endothelial growth factor production [GO:0010575] GO:0002430; GO:0004875; GO:0004876; GO:0004930; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0007186; GO:0007200; GO:0007204; GO:0008015; GO:0010575; GO:0010759; GO:0035577; GO:0035579; GO:0045766; GO:0051482; GO:0090023 complement component C3a receptor activity [GO:0004876]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930] PIWCQNHR 0.9853 -2.9501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6175 0 0 0 0 0 0 0 0 12.5066 0 0 12.5922 0 0 0 0 0 13.1612 0 0 0 0 0 0 0 0 0 11.6844 0 0 P60604 UB2G2_HUMAN "Ubiquitin-conjugating enzyme E2 G2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2)" UBE2G2 UBC7 Homo sapiens (Human) "cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to interferon-beta [GO:0035458]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0030433; GO:0035458; GO:0042802; GO:0061631; GO:0070936; GO:1904153 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] EQFYKIAKQIVQK 0.98531 -2.5131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0466 0 0 0 0 0 0 0 13.2552 0 0 0 0 0 0 13.1779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0733 0 0 11.4859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC71 MIEAP_HUMAN Mitochondria-eating protein (Spermatogenesis-associated protein 18) SPATA18 MIEAP Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695] GO:0005737; GO:0005739; GO:0005741; GO:0006974; GO:0035694; GO:0035695; GO:0042802; GO:0043231 identical protein binding [GO:0042802] FSDSYSQAR 0.98531 -3.7928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6729 0 13.8519 0 0 0 0 13.1446 0 0 0 0 13.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6067 12.0411 0 14.7061 13.0218 0 0 0 0 0 0 0 11.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8578 0 0 Q9ULZ2 STAP1_HUMAN "Signal-transducing adaptor protein 1, STAP-1 (BCR downstream-signaling protein 1) (Docking protein BRDG1) (Stem cell adaptor protein 1)" STAP1 BRDG1 Homo sapiens (Human) "cellular response to lipopolysaccharide [GO:0071222]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of microglial cell migration [GO:1904140]; negative regulation of phosphorylation [GO:0042326]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of phagocytosis, engulfment [GO:0060100]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; macrophage colony-stimulating factor receptor binding [GO:0005157]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activator activity [GO:0030296]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of microglial cell migration [GO:1904140]; negative regulation of phosphorylation [GO:0042326]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell mediated cytotoxicity [GO:1904151]; positive regulation of phagocytosis, engulfment [GO:0060100]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001784; GO:0005068; GO:0005157; GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0007169; GO:0010628; GO:0010760; GO:0019901; GO:0030296; GO:0032991; GO:0035591; GO:0042326; GO:0043231; GO:0050861; GO:0060100; GO:0071222; GO:1900028; GO:1902227; GO:1903980; GO:1904140; GO:1904151; GO:2000251 macrophage colony-stimulating factor receptor binding [GO:0005157]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase activator activity [GO:0030296]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] EATEMLQK 0.98531 -2.0481 0 0 0 0 0 0 0 0 12.0866 0 0 0 12.2797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6868 11.9396 0 0 0 0 10.8298 0 0 0 0 0 0 0 0 0 14.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1411 0 0 0 0 0 0 0 0 0 12.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2601 0 0 0 0 0 12.4133 0 0 0 0 0 0 0 0 0 0 0 11.9493 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3068 0 0 0 0 0 0 0 0 0 0 0 12.6315 0 0 12.5193 14.2589 0 0 0 0 0 0 0 14.5239 0 12.2185 0 0 13.747 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RUR9 C144A_HUMAN Coiled-coil domain-containing protein 144A CCDC144A KIAA0565 Homo sapiens (Human) CPSVSPSMPENQSATK 0.98532 -2.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9118 0 0 17.7794 0 0 0 0 0 0 0 0 12.3456 0 0 0 11.1689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6466 0 0 0 O60245 PCDH7_HUMAN "Protocadherin-7 (Brain-heart protocadherin, BH-Pcdh)" PCDH7 BHPCDH Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0031092 calcium ion binding [GO:0005509] AVDGGDPPR 0.98532 -2.5268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3871 0 0 0 0 0 12.9951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7125 0 0 0 0 15.2726 0 0 0 0 0 15.1235 0 14.4885 0 14.6033 0 0 0 0 14.3566 14.1154 0 0 0 0 0 13.68 14.4034 0 14.0055 0 0 0 0 0 0 0 0 0 0 13.5171 0 0 13.5057 0 0 0 0 14.9675 0 0 0 0 0 0 0 0 0 0 0 0 13.696 12.9843 14.5676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.341 0 0 11.9595 0 0 0 0 0 0 0 0 0 0 0 0 13.8359 0 0 0 0 0 0 0 0 0 O95977 S1PR4_HUMAN "Sphingosine 1-phosphate receptor 4, S1P receptor 4, S1P4 (Endothelial differentiation G-protein coupled receptor 6) (Sphingosine 1-phosphate receptor Edg-6, S1P receptor Edg-6)" S1PR4 EDG6 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of metabolic process [GO:0019222] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of metabolic process [GO:0019222] GO:0004930; GO:0005737; GO:0005739; GO:0005886; GO:0005887; GO:0006955; GO:0007186; GO:0007189; GO:0007202; GO:0007204; GO:0008289; GO:0019222; GO:0038036 G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036] APRPAAR 0.98532 -3.4554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8264 0 11.9773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P3W6 NBPFA_HUMAN Neuroblastoma breakpoint family member 10 NBPF10 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723] GO:0003723; GO:0005737 RNA binding [GO:0003723] CYSTPSGCLELCDSCQPYR 0.98532 -2.7881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1829 0 0 0 10.7829 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9478 0 0 12.5849 0 12.8665 0 0 0 15.6757 11.7338 0 0 0 0 0 0 0 0 18.0873 17.9939 0 11.9515 0 0 0 0 0 0 0 11.4748 0 12.1295 0 0 10.2009 0 12.3531 17.563 0 15.0863 18.9057 0 0 0 0 0 0 0 11.689 14.5872 0 0 0 0 0 11.5357 0 0 0 0 0 11.6998 0 12.3104 0 0 0 0 16.9804 16.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6172 0 11.3248 0 0 0 0 0 0 0 0 14.7368 0 0 0 0 0 0 0 0 Q8IYS8 BD1L2_HUMAN Biorientation of chromosomes in cell division protein 1-like 2 (Biorientation of chromosomes in cell division protein 1 pseudogene) (Protein FAM44C) BOD1L2 BOD1P FAM44C Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of phosphoprotein phosphatase activity [GO:0032515] centrosome [GO:0005813]; cytoplasm [GO:0005737]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of phosphoprotein phosphatase activity [GO:0032515] GO:0000922; GO:0000940; GO:0004864; GO:0005737; GO:0005813; GO:0005876; GO:0007049; GO:0032515; GO:0051301; GO:0051721 protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864] ASGGGGPINPASLPPGDPQLIAIIVGQLK 0.98532 -2.7849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7575 14.2991 14.329 0 13.6673 0 0 0 0 14.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5122 0 0 0 0 0 0 0 14.3558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBA6 GOGA5_HUMAN Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein) GOLGA5 RETII RFG5 PIG31 Homo sapiens (Human) "Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0016021; GO:0030133; GO:0031267; GO:0031985; GO:0042803; GO:0048193 protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] ATRILQSK 0.98532 -2.5267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2884 0 11.0902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9781 0 0 0 0 0 0 14.5231 0 0 0 0 0 0 0 13.6333 14.027 0 10.7616 0 18.7274 0 0 13.5066 13.1942 0 0 0 0 0 0 0 10.2674 0 13.8219 0 0 0 0 0 0 0 0 0 10.912 12.4405 0 0 0 0 0 0 12.9874 0 0 0 0 0 0 0 0 16.7671 0 0 0 0 0 0 11.8356 0 11.0322 0 0 0 0 0 0 14.2821 17.888 0 0 0 0 0 0 11.4179 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7362 0 0 0 0 Q96AG4 LRC59_HUMAN "Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34, p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed ]" LRRC59 PRO1855 Homo sapiens (Human) positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; positive regulation of Ras protein signal transduction [GO:0046579]; signal transduction [GO:0007165] GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0007165; GO:0016020; GO:0016021; GO:0042645; GO:0045296; GO:0046579 cadherin binding [GO:0045296]; RNA binding [GO:0003723] EANQAPKSKSGSR 0.98532 -2.1463 0 0 0 0 0 11.5147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4221 0 0 0 0 0 0 0 13.3059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3799 0 0 0 0 0 11.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JJ6 JPH4_HUMAN "Junctophilin-4, JP-4 (Junctophilin-like 1 protein)" JPH4 JPHL1 KIAA1831 Homo sapiens (Human) calcium ion transport into cytosol [GO:0060402]; learning [GO:0007612]; neuromuscular process controlling balance [GO:0050885]; regulation of cytokine production [GO:0001817]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic plasticity [GO:0048167] dendritic shaft [GO:0043198]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] dendritic shaft [GO:0043198]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; calcium ion transport into cytosol [GO:0060402]; learning [GO:0007612]; neuromuscular process controlling balance [GO:0050885]; regulation of cytokine production [GO:0001817]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of store-operated calcium entry [GO:2001256]; regulation of synaptic plasticity [GO:0048167] GO:0001817; GO:0005789; GO:0005790; GO:0005886; GO:0007612; GO:0014701; GO:0016021; GO:0030314; GO:0043198; GO:0048167; GO:0050885; GO:0060314; GO:0060402; GO:2001256 EGLGVER 0.98532 -3.6288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0399 0 0 0 0 0 0 0 0 0 0 0 14.5716 0 0 0 0 0 0 0 0 0 0 0 0 15.3502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9804 12.1579 10.6471 0 0 0 0 0 0 0 0 0 0 0 11.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SR6 ZN382_HUMAN "Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1, KS1) (Multiple zinc finger and krueppel-associated box protein KS1)" ZNF382 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] KSNLIRHQK 0.98532 -2.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2831 0 11.1258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5101 14.2165 0 14.9592 0 0 0 0 0 0 0 0 11.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5276 16.9708 13.7096 0 14.4503 0 0 0 0 0 12.1039 0 12.536 11.2527 0 0 10.9697 13.6666 0 0 0 0 0 0 0 0 0 0 15.0122 0 0 0 0 0 0 0 0 0 12.547 0 0 13.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5259 0 0 0 0 0 0 0 13.7353 0 0 0 0 0 0 14.2198 0 0 0 0 0 0 0 0 0 Q99811 PRRX2_HUMAN "Paired mesoderm homeobox protein 2 (Paired-related homeobox protein 2, PRX-2)" PRRX2 PMX2 PRX2 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EPSGGSSGSEAAPQDGECPSPGR 0.98532 -2.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXR5 TLR10_HUMAN Toll-like receptor 10 (CD antigen CD290) TLR10 UNQ315/PRO358 Homo sapiens (Human) immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine production [GO:0001817]; toll-like receptor 10 signaling pathway [GO:0034166]; toll-like receptor signaling pathway [GO:0002224] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of inflammatory response [GO:0050729]; regulation of cytokine production [GO:0001817]; toll-like receptor 10 signaling pathway [GO:0034166]; toll-like receptor signaling pathway [GO:0002224]" GO:0001817; GO:0002224; GO:0002755; GO:0004888; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0016020; GO:0034166; GO:0038023; GO:0042802; GO:0043235; GO:0045087; GO:0050135; GO:0050729; GO:0061809 "identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]" AYLEWPKDRR 0.98532 -3.7159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2421 0 0 0 0 0 0 13.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6242 0 0 0 0 0 0 0 0 13.8872 14.3403 0 0 0 0 0 0 14.6696 0 14.0195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5383 0 0 0 0 0 0 0 0 0 0 0 11.5108 0 15.8025 0 0 15.1277 13.9421 12.4252 0 0 14.6259 0 0 13.0635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4727 0 0 0 16.4062 14.5147 15.3856 0 0 0 13.6263 0 0 16.6304 0 0 Q9HBQ8 GGA2B_HUMAN Putative golgin subfamily A member 2B (Golgin subfamily A member 2-like protein 1) GOLGA2P5 GOLGA2B GOLGA2L1 PP1757 Homo sapiens (Human) Golgi organization [GO:0007030]; spindle assembly [GO:0051225] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030]; spindle assembly [GO:0051225] GO:0000137; GO:0005801; GO:0007030; GO:0032580; GO:0051225 GEGEAAGAGVACGRLQQVA 0.98532 -2.7041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8507 0 11.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0658 13.703 0 0 0 0 0 0 0 0 0 0 14.4133 0 0 0 0 0 0 0 0 0 0 12.7901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2966 12.6461 0 0 0 0 0 0 0 0 12.6999 12.692 0 0 0 0 0 0 0 0 0 0 A2IDD5 CCD78_HUMAN Coiled-coil domain-containing protein 78 (hsCCDC78) CCDC78 C16orf25 JFP10 Homo sapiens (Human) cell projection organization [GO:0030030]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; skeletal muscle contraction [GO:0003009] centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529] centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; cell projection organization [GO:0030030]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; skeletal muscle contraction [GO:0003009] GO:0003009; GO:0005737; GO:0005814; GO:0016529; GO:0030030; GO:0042383; GO:0048471; GO:0098535; GO:0098536 LQLQLKKLK 0.98533 -3.8118 0 0 0 0 0 0 0 0 0 0 0 13.4891 13.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0528 0 0 0 0 0 0 0 0 0 0 11.2574 0 0 11.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8916 14.0704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5578 0 0 0 0 0 0 12.4933 0 0 0 0 0 0 11.936 0 0 0 14.8984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.164 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NHM9 MOXD2_HUMAN "Putative DBH-like monooxygenase protein 2, EC 1.14.17.- (DBH-like monooxygenase protein 2 pseudogene)" MOXD2P MOXD2 Homo sapiens (Human) dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] extracellular space [GO:0005615]; secretory granule membrane [GO:0030667] extracellular space [GO:0005615]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0030667; GO:0042420; GO:0042421 copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500] AHDLLFR 0.98533 -3.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.772 13.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8946 0 0 0 13.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07919 QCR6_HUMAN "Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)" UQCRH Homo sapiens (Human) "aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]" mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]" GO:0005739; GO:0005743; GO:0005746; GO:0005750; GO:0006119; GO:0006122; GO:0008121; GO:0009060; GO:0045333 ubiquinol-cytochrome-c reductase activity [GO:0008121] EQCEQLEK 0.98533 -2.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51811 XK_HUMAN Endoplasmic reticulum membrane adapter protein XK (Kell complex 37 kDa component) (Kx antigen) (Membrane transport protein XK) (XK-related protein 1) XK XKR1 XRG1 Homo sapiens (Human) amino acid transport [GO:0006865]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; amino acid transport [GO:0006865]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; myelination [GO:0042552]; regulation of axon diameter [GO:0031133]; regulation of cell size [GO:0008361]; skeletal muscle fiber development [GO:0048741] GO:0005789; GO:0005886; GO:0006865; GO:0006874; GO:0008361; GO:0010961; GO:0016021; GO:0030674; GO:0031133; GO:0042552; GO:0048741 protein-macromolecule adaptor activity [GO:0030674] CFCWACR 0.98533 -2.8929 0 0 0 0 0 0 0 0 14.5204 0 14.0251 13.9661 0 0 0 0 0 12.0614 0 0 0 0 0 0 0 0 0 0 0 0 13.4077 0 13.5982 13.3526 14.3352 14.1346 0 0 0 0 13.8641 0 13.6956 12.1729 0 0 0 13.7631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5848 0 0 0 0 0 0 0 0 0 0 13.215 0 12.7835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.171 0 0 0 0 12.2019 0 0 0 0 0 12.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8729 0 0 0 0 11.743 0 0 13.3607 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68DX3 FRPD2_HUMAN FERM and PDZ domain-containing protein 2 (PDZ domain-containing protein 4) (PDZ domain-containing protein 5C) FRMPD2 PDZD5C PDZK4 PDZK5C Homo sapiens (Human) bicellular tight junction assembly [GO:0070830] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; 1-phosphatidylinositol binding [GO:0005545]; bicellular tight junction assembly [GO:0070830] GO:0005545; GO:0005737; GO:0005856; GO:0005923; GO:0016323; GO:0070830 1-phosphatidylinositol binding [GO:0005545] AIREAQWGQNR 0.98533 -3.8153 0 0 0 12.4395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1372 0 12.7383 0 0 0 0 0 0 0 0 0 0 12.7841 0 0 0 0 0 0 12.5597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7279 15.3808 0 0 0 0 0 0 0 0 0 0 11.2219 0 0 12.408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7049 0 11.0976 0 0 0 0 0 0 0 14.1724 0 0 0 0 0 0 0 0 0 0 0 0 13.8885 0 0 0 0 0 0 13.8714 0 0 16.4465 Q6UWY5 OLFL1_HUMAN Olfactomedin-like protein 1 OLFML1 UNQ564/PRO1126 Homo sapiens (Human) signal transduction [GO:0007165] extracellular space [GO:0005615] extracellular space [GO:0005615]; signal transduction [GO:0007165] GO:0005615; GO:0007165 MLLPGGVGR 0.98533 -3.8093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3561 0 0 0 0 11.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4138 0 0 0 0 0 0 0 0 0 0 0 11.9935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L3B6 CD37L_HUMAN Hsp90 co-chaperone Cdc37-like 1 (Hsp90-associating relative of Cdc37) CDC37L1 CDC37B HARC Homo sapiens (Human) protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0005576; GO:0005737; GO:0005829; GO:0006457; GO:0031072; GO:0031089; GO:0050821; GO:0051082; GO:0051087 chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082] AQTAVSELRQR 0.98533 -3.7241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5084 12.295 0 0 10.5792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2584 0 0 0 0 0 0 11.8699 0 0 0 14.7887 0 11.5002 0 0 0 0 0 0 0 0 13.7596 12.0957 0 0 13.9079 0 0 0 0 0 0 11.6681 0 0 0 0 13.1728 0 0 0 12.5691 0 12.0745 0 0 0 0 0 0 0 0 11.7872 0 0 0 0 0 0 0 11.5763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7381 0 0 0 0 0 0 0 0 12.9385 0 0 0 0 0 0 0 11.4924 0 0 0 0 0 0 0 0 0 0 0 0 12.4441 Q8NAJ2 CI106_HUMAN Putative uncharacterized protein encoded by LINC02913 LINC02913 C9orf106 Homo sapiens (Human) GCNLRGGR 0.98533 -2.6169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92777 SYN2_HUMAN Synapsin-2 (Synapsin II) SYN2 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091] GO:0005524; GO:0005886; GO:0007268; GO:0007269; GO:0014069; GO:0017156; GO:0030672; GO:0031201; GO:0042802; GO:0045202; GO:0070161; GO:0097091; GO:0098685; GO:0098978 ATP binding [GO:0005524]; identical protein binding [GO:0042802] AYMRTSISGNWK 0.98533 -2.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1058 0 0 0 12.0479 0 9.16214 0 0 0 0 0 0 0 0 0 14.6971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSB4 KRT82_HUMAN "Keratin, type II cuticular Hb2 (Keratin-82, K82) (Type II hair keratin Hb2) (Type-II keratin Kb22)" KRT82 KRTHB2 Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005829; GO:0030280; GO:0031424; GO:0045095; GO:0045109 structural constituent of skin epidermis [GO:0030280] CGSQSFSSYSAVMPRMVTHYAVSK 0.98533 -3.6344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.861 0 0 0 0 0 13.6333 14.1592 12.5624 14.5263 0 13.4662 0 0 0 0 0 0 0 0 9.43494 0 0 0 0 0 0 0 0 0 0 12.9592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F5H4A9 CC080_HUMAN Uncharacterized membrane protein C3orf80 C3orf80 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CCKLPLHAFLDNVGWFVR 0.98534 -3.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4586 0 0 0 0 0 0 0 0 0 0 12.4563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3565 12.3398 0 0 0 0 0 0 0 15.7874 16.5426 0 15.2439 0 0 0 0 0 0 0 12.2718 0 0 0 0 15.6649 0 0 13.3475 0 0 0 0 0 13.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6459 0 0 0 0 0 0 0 0 0 0 0 0 15.1343 15.1133 0 0 0 0 0 0 16.0716 0 0 0 0 0 0 0 0 0 0 0 11.1874 0 0 0 0 0 0 0 0 0 0 13.1717 0 0 0 0 0 0 0 0 0 0 0 Q09FC8 ZN415_HUMAN Zinc finger protein 415 ZNF415 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001650; GO:0005634; GO:0005737; GO:0006357; GO:0015630; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNECDRSFSR 0.98534 -3.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0547 0 0 11.8377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4009 0 0 0 0 0 0 11.8405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15119 PDK2_HUMAN "[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 2, PDH kinase 2, PDKII)" PDK2 PDHK2 Homo sapiens (Human) cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885] GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005967; GO:0006006; GO:0006111; GO:0006468; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0050848; GO:0072332 ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] NAMRATVESHESSLILPPIK 0.98534 -2.6283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5919 0 10.1435 0 0 0 0 0 0 0 0 0 11.8143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5682 0 13.5035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.432 0 0 0 0 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9413 13.4384 0 0 0 0 0 Q2VWP7 PRTG_HUMAN Protogenin (Protein Shen-Dan) PRTG Homo sapiens (Human) negative regulation of neurogenesis [GO:0050768] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; negative regulation of neurogenesis [GO:0050768] GO:0005615; GO:0005886; GO:0016021; GO:0038023; GO:0042802; GO:0050768 identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] ANTSSSIFLHWRR 0.98534 -2.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4324 0 0 16.6219 10.8709 0 0 0 0 0 0 0 0 0 13.9146 0 0 0 0 0 0 0 0 12.408 13.6079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5954 0 0 0 12.0872 0 0 0 0 0 0 0 0 0 13.6381 0 13.0689 11.7081 0 0 0 12.546 0 0 0 0 13.6348 0 13.1236 13.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9009 0 0 0 0 13.2385 0 0 0 0 0 0 0 0 0 0 0 0 13.1731 0 0 0 0 0 11.6534 0 0 0 0 0 12.8754 0 0 11.723 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3388 0 Q53EQ6 TIGD5_HUMAN Tigger transposable element-derived protein 5 TIGD5 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] GDRVTVLLAANLTGSHK 0.98534 -3.8175 0 0 0 0 0 0 0 0 13.5868 0 13.9108 0 0 0 0 0 0 0 0 0 0 12.3197 0 0 0 0 0 0 0 0 11.6894 9.96896 0 0 0 0 0 0 0 0 0 0 0 14.4924 0 0 0 0 0 0 13.4276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2232 0 0 0 0 11.6016 0 0 0 0 0 12.8768 12.4365 0 12.7657 16.3567 0 0 0 14.2991 0 0 0 0 15.1848 0 0 0 0 0 15.2599 13.0296 0 0 0 0 14.9448 0 0 0 15.1428 0 0 0 0 11.7487 0 0 0 0 0 0 0 0 0 0 0 12.6606 0 0 0 0 0 0 13.5292 13.0029 0 13.0783 0 0 0 0 0 0 12.5189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2949 0 0 0 0 0 14.2436 0 0 0 0 0 0 0 Q5T2D3 OTUD3_HUMAN "OTU domain-containing protein 3, EC 3.4.19.12" OTUD3 KIAA0459 Homo sapiens (Human) negative regulation of protein kinase B signaling [GO:0051898]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type deubiquitinase activity [GO:0004843]; negative regulation of protein kinase B signaling [GO:0051898]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821] GO:0004843; GO:0005737; GO:0005829; GO:0016579; GO:0035871; GO:0044313; GO:0050821; GO:0051898; GO:0071108; GO:1990167 cysteine-type deubiquitinase activity [GO:0004843] ELHIAYR 0.98534 -2.6286 0 0 0 0 0 0 0 0 0 0 0 11.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N594 MPND_HUMAN "MPN domain-containing protein, EC 3.4.-.-" MPND Homo sapiens (Human) chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508] histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508] GO:0003713; GO:0006338; GO:0006508; GO:0042393; GO:0045944; GO:0046872; GO:0070122; GO:0140492 histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; transcription coactivator activity [GO:0003713] AAPEPLSPAGGAGEEAPEEDEDEAEAEDPERPNAGAGGGR 0.98534 -3.2909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCY6 MSD4_HUMAN Myb/SANT-like DNA-binding domain-containing protein 4 (Myb/SANT-like DNA-binding domain containing 4 with coiled-coils) MSANTD4 KIAA1826 DC25 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 DRLQFLK 0.98534 -3.8188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4386 0 0 0 0 15.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6962 13.346 13.4173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGC4 O10G3_HUMAN Olfactory receptor 10G3 (Olfactory receptor OR14-40) OR10G3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LALKRMLR 0.98534 -2.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3339 0 0 12.4935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6796 Q8TE99 PXYP1_HUMAN "2-phosphoxylose phosphatase 1, EC 3.1.3.- (Acid phosphatase-like protein 2) (Xylosyl phosphatase) (epididymis luminal protein 124)" PXYLP1 ACPL2 HEL124 XYLP UNQ370/PRO706 Homo sapiens (Human) chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dephosphorylation [GO:0016311]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909] GO:0000139; GO:0005794; GO:0006024; GO:0010909; GO:0016021; GO:0016311; GO:0016791; GO:0050650 phosphatase activity [GO:0016791] HKLLPNDWSADQLYLETTGKSR 0.98534 -3.3794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4276 0 0 0 13.9136 0 0 12.3752 0 0 0 0 0 0 0 0 0 0 14.1735 0 0 0 0 0 0 14.1026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0929 0 0 0 0 0 0 14.132 0 0 0 Q9BUH6 PAXX_HUMAN Protein PAXX (Paralog of XRCC4 and XLF) (XRCC4-like small protein) PAXX C9orf142 XLS Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303] cytoplasm [GO:0005737]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] cytoplasm [GO:0005737]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; DNA polymerase binding [GO:0070182]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303] GO:0005634; GO:0005654; GO:0005737; GO:0006303; GO:0006974; GO:0035861; GO:0042802; GO:0042803; GO:0060090; GO:0070182; GO:0070419 DNA polymerase binding [GO:0070182]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803] ALTLGLAKRVWSLER 0.98534 -3.2915 0 0 0 0 0 0 0 0 0 12.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1955 0 0 0 0 0 0 14.9693 14.491 14.5393 0 0 0 14.3782 0 15.0755 12.2171 0 13.6093 12.1792 0 0 0 0 0 14.3667 0 0 0 0 0 0 0 0 0 0 0 0 14.0122 13.7749 0 13.498 0 14.8435 0 0 13.383 0 0 0 14.7467 0 0 0 0 14.3339 0 0 0 0 0 14.565 0 0 0 0 0 0 14.3582 0 0 0 0 0 0 0 0 0 0 0 14.6296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.477 0 0 0 0 0 0 0 Q9C0B5 ZDHC5_HUMAN "Palmitoyltransferase ZDHHC5, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 5, DHHC-5) (Zinc finger protein 375)" ZDHHC5 KIAA1748 ZNF375 Homo sapiens (Human) innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345] anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; synapse [GO:0045202]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345] GO:0005886; GO:0006869; GO:0016020; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0030425; GO:0045087; GO:0045202; GO:0045335; GO:0062208; GO:0070161; GO:1903078; GO:1905171 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] AEEDEDKEDDFR 0.98534 -3.823 0 0 0 0 0 0 0 0 0 0 0 0 12.604 12.8349 0 0 0 0 0 0 0 0 11.103 0 0 0 0 12.3911 0 0 0 12.8259 12.3287 0 0 0 0 0 0 12.0492 0 0 13.2538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5351 0 12.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8773 0 0 0 0 0 0 0 0 13.2363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4531 0 0 0 0 0 0 0 0 0 13.1218 0 0 12.3605 0 12.7553 0 0 0 0 0 0 0 14.559 0 0 0 0 0 0 0 0 12.7313 12.6177 0 12.6333 14.3226 12.924 0 0 0 0 0 0 0 12.4324 0 0 0 0 0 0 0 0 0 12.8642 Q9H5U6 ZCHC4_HUMAN "rRNA N6-adenosine-methyltransferase ZCCHC4, EC 2.1.1.- (Zinc finger CCHC domain-containing protein 4)" ZCCHC4 Homo sapiens (Human) positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; zinc ion binding [GO:0008270]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167] GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0008988; GO:0031167; GO:0045727; GO:1904047 nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; zinc ion binding [GO:0008270] HGCFICGELDHKR 0.98534 -3.8206 0 0 11.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7119 0 0 0 0 0 10.7964 0 0 0 0 0 12.2319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0884 0 0 0 0 0 0 0 0 0 0 0 0 10.36 0 14.8897 0 0 0 0 12.4741 13.1117 0 11.8153 0 11.4802 0 0 0 14.0314 0 0 0 0 0 0 0 0 12.1468 0 0 0 13.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.201 0 0 0 0 0 0 0 0 0 14.3896 0 0 0 0 0 10.9899 0 0 0 0 0 0 0 0 0 0 12.6016 P41143 OPRD_HUMAN "Delta-type opioid receptor, D-OR-1, DOR-1" OPRD1 OPRD Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cellular response to toxic substance [GO:0097237]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; negative regulation of gene expression [GO:0010629]; negative regulation of protein-containing complex assembly [GO:0031333]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of sensory perception of pain [GO:0051930]" axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; spine apparatus [GO:0097444] "axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal dense core vesicle [GO:0098992]; plasma membrane [GO:0005886]; spine apparatus [GO:0097444]; G protein-coupled enkephalin receptor activity [GO:0038046]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hypoxia [GO:0071456]; cellular response to toxic substance [GO:0097237]; eating behavior [GO:0042755]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; negative regulation of gene expression [GO:0010629]; negative regulation of protein-containing complex assembly [GO:0031333]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of sensory perception of pain [GO:0051930]" GO:0004930; GO:0004985; GO:0005886; GO:0005887; GO:0006955; GO:0007186; GO:0007187; GO:0007193; GO:0007200; GO:0007218; GO:0008344; GO:0010629; GO:0030285; GO:0031226; GO:0031333; GO:0032590; GO:0032793; GO:0033138; GO:0033612; GO:0038003; GO:0038046; GO:0042277; GO:0042755; GO:0042923; GO:0043005; GO:0043679; GO:0045121; GO:0051881; GO:0051924; GO:0051930; GO:0071363; GO:0071456; GO:0097237; GO:0097444; GO:0098992; GO:0099056; GO:0099061 G protein-coupled enkephalin receptor activity [GO:0038046]; G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; receptor serine/threonine kinase binding [GO:0033612] AREATAR 0.98535 -2.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0636 13.1505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8841 0 0 0 0 0 0 0 0 11.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41439 FOLR3_HUMAN "Folate receptor gamma, FR-gamma (Folate receptor 3)" FOLR3 Homo sapiens (Human) cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; folic acid binding [GO:0005542]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] GO:0005542; GO:0005576; GO:0007155; GO:0007342; GO:0015884; GO:0016020; GO:0019898; GO:0031362; GO:0035036; GO:0035580; GO:0038023; GO:1904724 folic acid binding [GO:0005542]; signaling receptor activity [GO:0038023] KERILNVPLCK 0.98535 -2.6317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5639 0 0 13.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9814 0 P55771 PAX9_HUMAN Paired box protein Pax-9 PAX9 Homo sapiens (Human) "anatomical structure development [GO:0048856]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; face morphogenesis [GO:0060325]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; cellular response to growth factor stimulus [GO:0071363]; endoderm development [GO:0007492]; face morphogenesis [GO:0060325]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0005730; GO:0006357; GO:0007492; GO:0042476; GO:0042481; GO:0045892; GO:0048856; GO:0060325; GO:0071363; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" IGNLAQQGHYDSYK 0.98535 -2.6333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6733 0 0 0 0 13.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58483 0 0 0 13.8282 0 0 0 12.6862 0 0 0 0 0 0 0 0 0 0 13.3021 0 13.074 13.9523 0 0 0 0 0 0 0 0 0 0 0 11.0082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15785 TOM34_HUMAN "Mitochondrial import receptor subunit TOM34, hTom34 (Translocase of outer membrane 34 kDa subunit)" TOMM34 URCC3 Homo sapiens (Human) protein targeting to mitochondrion [GO:0006626] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; heat shock protein binding [GO:0031072]; protein targeting to mitochondrion [GO:0006626] GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0016020; GO:0016021; GO:0031072; GO:0043231 heat shock protein binding [GO:0031072] LKLPSIPLVPVSAQK 0.98535 -3.3889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9706 0 0 15.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1074 0 0 0 0 0 Q8NGL2 OR5L1_HUMAN Olfactory receptor 5L1 (OST262) (Olfactory receptor OR11-151) OR5L1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] MGSAEGR 0.98535 -3.2947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JT2 S45A3_HUMAN Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein) SLC45A3 PCANAP6 PRST Homo sapiens (Human) hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119]; hexose transmembrane transport [GO:0008645]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; regulation of oligodendrocyte differentiation [GO:0048713]; sucrose transport [GO:0015770] GO:0005886; GO:0008506; GO:0008645; GO:0010907; GO:0015770; GO:0016020; GO:0016021; GO:0045723; GO:0048713; GO:0051119 sucrose:proton symporter activity [GO:0008506]; sugar transmembrane transporter activity [GO:0051119] LHQLCCRMPR 0.98535 -2.9893 0 0 0 0 0 0 0 0 14.0981 0 0 12.4714 0 0 0 0 0 0 14.1156 0 0 0 0 0 0 13.7795 0 0 0 0 0 0 0 0 14.5545 0 0 0 0 0 0 0 12.174 0 0 0 0 0 0 0 0 0 13.7628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4402 0 0 15.4533 15.2444 0 0 12.6135 0 0 0 0 0 12.5967 0 13.2222 0 13.9253 14.5266 0 0 0 11.3267 0 0 0 0 0 13.7841 15.9812 0 0 0 14.0295 0 0 0 0 13.3099 0 14.5054 0 0 0 0 0 0 0 0 0 13.4213 0 0 13.6714 0 0 0 0 0 0 14.8627 0 0 0 15.458 0 0 0 0 12.6456 0 16.1442 0 0 0 14.3801 15.0052 11.5701 0 0 0 0 0 0 0 0 15.2253 0 0 0 0 0 0 14.0706 0 0 0 0 0 0 15.7951 13.0425 0 Q99460 PSMD1_HUMAN 26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112) PSMD1 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176] "azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]" "azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]" GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008540; GO:0016020; GO:0022624; GO:0030234; GO:0031625; GO:0034515; GO:0035578; GO:0042176; GO:0043161 enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625] DQTLKMIKILSGEMAIELHLQFLIR 0.98535 -3.3926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1814 0 0 0 0 0 0 0 0 0 0 0 0 11.7914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.938 0 0 12.1613 0 0 12.3144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4364 0 0 0 0 0 0 0 0 0 10.7905 0 0 0 0 0 0 0 0 0 0 0 0 12.1544 0 0 0 0 0 0 0 Q9BWM5 ZN416_HUMAN Zinc finger protein 416 ZNF416 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFGSKSTLVR 0.98535 -2.1612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9976 0 0 13.3659 0 11.6701 0 0 0 0 0 0 0 17.8535 0 0 12.2766 0 0 13.8108 0 0 0 18.3229 0 13.1433 15.0621 0 0 0 0 0 12.1249 0 0 0 0 13.73 0 0 0 0 0 0 0 0 0 14.6225 0 0 14.87 0 13.2889 13.9123 0 13.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.707 0 0 0 0 0 0 0 0 Q9UBL3 ASH2L_HUMAN Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein) ASH2L ASH2L1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627] euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627] GO:0000791; GO:0000976; GO:0005634; GO:0005654; GO:0006325; GO:0006974; GO:0008013; GO:0008284; GO:0030097; GO:0035097; GO:0043627; GO:0044665; GO:0044666; GO:0045944; GO:0046872; GO:0048188; GO:0051568; GO:0071339 beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976] ASHGVRKGAWYFEITVDEMPPDTAAR 0.98535 -3.3934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2524 0 0 0 0 0 0 0 0 0 0 9.36205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7413 0 0 0 0 0 0 0 0 0 10.4203 0 0 0 0 0 0 9.24389 0 0 0 0 0 0 11.0274 0 13.9297 10.4435 14.2765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3106 0 0 0 0 0 0 0 0 0 0 0 0 12.9638 0 0 0 0 0 0 0 0 13.8812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41279 M3K8_HUMAN "Mitogen-activated protein kinase kinase kinase 8, EC 2.7.11.25 (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2, TPL-2)" MAP3K8 COT ESTF Homo sapiens (Human) cell cycle [GO:0007049]; MAPK cascade [GO:0000165]; protein phosphorylation [GO:0006468]; T cell costimulation [GO:0031295] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; MAPK cascade [GO:0000165]; protein phosphorylation [GO:0006468]; T cell costimulation [GO:0031295] GO:0000165; GO:0000287; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0031295; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DLRGTEIYMSPEVILCRGHSTK 0.98536 -2.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3042 0 0 0 0 0 0 0 0 13.1398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49913 CAMP_HUMAN "Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein, CAP-18, hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37 ]" CAMP CAP18 FALL39 HSD26 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; modulation of process of another organism [GO:0035821]; neutrophil activation [GO:0042119]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein phosphorylation [GO:0001934]; response to yeast [GO:0001878] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; lipopolysaccharide binding [GO:0001530]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptidoglycan [GO:0071224]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; killing by host of symbiont cells [GO:0051873]; modulation of process of another organism [GO:0035821]; neutrophil activation [GO:0042119]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of protein phosphorylation [GO:0001934]; response to yeast [GO:0001878] GO:0001530; GO:0001878; GO:0001934; GO:0002227; GO:0002544; GO:0005576; GO:0005615; GO:0008284; GO:0019731; GO:0019732; GO:0032757; GO:0035580; GO:0035821; GO:0042119; GO:0042581; GO:0042742; GO:0042995; GO:0045087; GO:0045766; GO:0050829; GO:0050830; GO:0051838; GO:0051873; GO:0061844; GO:0070062; GO:0071222; GO:0071224; GO:0071347; GO:0071354; GO:0071356; GO:1904724 lipopolysaccharide binding [GO:0001530] IVQRIKDFLR 0.98536 -2.6452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.141 0 12.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9175 0 0 0 12.9253 0 P52594 AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein) AGFG1 HRB RAB RIP Homo sapiens (Human) acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289] GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0031410; GO:0043231; GO:0045109; GO:0046872 DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] CFDCDQR 0.98536 -3.4048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92540 SMG7_HUMAN "Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog, hSMG-7)" SMG7 C1orf16 EST1C KIAA0250 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]" GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0035303; GO:0042162; GO:0045111; GO:0051721; GO:0070034 protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] CTLEKLQETGK 0.98536 -2.643 0 0 0 0 0 0 0 0 0 0 0 0 11.6955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8693 0 0 0 0 0 0 0 0 0 0 0 10.1543 0 0 0 0 0 0 0 0 0 12.3961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92791 SC65_HUMAN Endoplasmic reticulum protein SC65 (Leprecan-like protein 4) (Nucleolar autoantigen No55) (Prolyl 3-hydroxylase family member 4) (Synaptonemal complex protein SC65) P3H4 LEPREL4 NOL55 SC65 Homo sapiens (Human) bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]; synaptonemal complex assembly [GO:0007130] catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; synaptonemal complex [GO:0000795] catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]; bone remodeling [GO:0046849]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; peptidyl-lysine hydroxylation [GO:0017185]; synaptonemal complex assembly [GO:0007130] GO:0000794; GO:0000795; GO:0005730; GO:0005783; GO:0007130; GO:0017185; GO:0030199; GO:0032964; GO:0043231; GO:0046849; GO:1902494 ESARYLEAALRLHR 0.98536 -3.402 0 0 0 0 0 0 0 0 0 12.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2317 0 0 0 0 0 0 0 0 0 0 0 0 13.9332 0 0 0 0 0 0 0 0 0 0 0 13.8585 0 0 0 0 0 0 0 0 12.2579 0 0 0 0 0 0 0 11.9437 0 0 0 0 13.4855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ29 DOCK9_HUMAN "Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1, Zizimin-1)" DOCK9 KIAA1058 ZIZ1 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005829; GO:0007264; GO:0012505; GO:0016020; GO:0043547; GO:0045296 cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085] ADMCAALCYEILKCCNSK 0.98536 -3.8404 15.0577 0 0 0 0 0 0 0 0 0 13.2095 0 0 11.4026 0 0 0 0 11.725 0 0 0 0 0 0 0 0 11.6638 10.0436 0 0 0 0 0 0 12.1356 0 0 0 0 10.0751 0 0 0 12.0629 0 0 0 0 0 0 0 13.6148 13.4139 13.2616 12.0951 0 0 0 0 0 0 0 0 0 12.0552 14.3517 14.0138 15.3208 14.9342 14.4674 14.8962 15.0603 0 13.1267 13.683 13.4531 0 14.0489 0 13.2545 12.1469 0 0 16.5261 16.0944 12.7901 13.5734 13.7808 0 14.7925 15.015 13.2477 0 0 0 14.8378 0 0 13.7501 13.6015 0 0 0 0 11.9587 13.8333 13.4853 15.8077 0 13.9296 0 0 13.1784 0 0 0 0 0 12.3852 13.7728 14.4486 13.8992 14.3147 14.2993 13.8988 0 14.4298 0 14.657 14.516 14.697 0 14.059 14.4057 13.9438 12.9741 13.3848 14.7665 13.2805 0 15.1506 0 15.2688 0 14.2546 13.8128 0 0 13.2555 14.8898 13.5914 0 0 11.7628 0 14.4236 0 0 0 0 0 0 0 15.2301 0 11.5248 13.0835 0 0 0 13.8272 14.2671 0 0 14.7726 0 14.2545 0 0 Q9NYS0 KBRS1_HUMAN "NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1, Kappa B-Ras protein 1, KappaB-Ras1)" NKIRAS1 KBRAS1 Homo sapiens (Human) I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129] GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0007249; GO:0010803; GO:0032484; GO:0032794; GO:0043129; GO:0048286 GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924] GNSNSEN 0.98536 -3.4033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9133 0 0 0 0 0 13.6979 0 13.4078 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9522 0 0 0 0 0 0 0 O14863 ZNT4_HUMAN "Zinc transporter 4, ZnT-4 (Solute carrier family 30 member 4)" SLC30A4 ZNT4 Homo sapiens (Human) regulation of sequestering of zinc ion [GO:0061088]; response to toxic substance [GO:0009636]; response to zinc ion [GO:0010043]; zinc ion homeostasis [GO:0055069]; zinc ion transmembrane transport [GO:0071577] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; regulation of sequestering of zinc ion [GO:0061088]; response to toxic substance [GO:0009636]; response to zinc ion [GO:0010043]; zinc ion homeostasis [GO:0055069]; zinc ion transmembrane transport [GO:0071577] GO:0005385; GO:0005737; GO:0005765; GO:0005770; GO:0005886; GO:0009636; GO:0010008; GO:0010043; GO:0016021; GO:0031902; GO:0055069; GO:0061088; GO:0071577 zinc ion transmembrane transporter activity [GO:0005385] FTFGFHR 0.98537 -3.6749 10.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5773 0 0 0 0 12.6498 13.1774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2379 0 0 0 0 P16520 GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (Transducin beta chain 3) GNB3 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of blood pressure [GO:0008217]; regulation of cholesterol metabolic process [GO:0090181]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression [GO:0010468]; regulation of glucose metabolic process [GO:0010906]; regulation of hormone metabolic process [GO:0032350]; regulation of phospholipid metabolic process [GO:1903725]; regulation of triglyceride metabolic process [GO:0090207] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; signaling receptor complex adaptor activity [GO:0030159]; spectrin binding [GO:0030507]; cell volume homeostasis [GO:0006884]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of blood pressure [GO:0008217]; regulation of cholesterol metabolic process [GO:0090181]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression [GO:0010468]; regulation of glucose metabolic process [GO:0010906]; regulation of hormone metabolic process [GO:0032350]; regulation of phospholipid metabolic process [GO:1903725]; regulation of triglyceride metabolic process [GO:0090207] GO:0003924; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0006884; GO:0007186; GO:0008217; GO:0010468; GO:0010906; GO:0030159; GO:0030425; GO:0030507; GO:0032350; GO:0044297; GO:0045598; GO:0051020; GO:0070062; GO:0090181; GO:0090207; GO:1903725 GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; signaling receptor complex adaptor activity [GO:0030159]; spectrin binding [GO:0030507] KACADVTLAELVSGLEVVGR 0.98537 -3.7642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9661 12.2749 0 0 11.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17050 NAGAB_HUMAN "Alpha-N-acetylgalactosaminidase, EC 3.2.1.49 (Alpha-galactosidase B)" NAGA Homo sapiens (Human) carbohydrate catabolic process [GO:0016052]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lysosome [GO:0005764] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; protein homodimerization activity [GO:0042803]; carbohydrate catabolic process [GO:0016052]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311] GO:0004557; GO:0005737; GO:0005764; GO:0008456; GO:0009311; GO:0016052; GO:0016139; GO:0019377; GO:0042803; GO:0046477; GO:0070062 alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; protein homodimerization activity [GO:0042803] CNINCDEDPK 0.98537 -3.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0011 0 0 0 0 0 13.0146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0212 0 0 0 0 0 0 Q3SY46 KR133_HUMAN Keratin-associated protein 13-3 KRTAP13-3 KAP13.3 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 GCQETCWRPNSCQTLCVESSPCHTSCYYPR 0.98537 -3.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.732 0 0 12.4196 0 0 0 0 0 0 0 0 0 0 0 0 11.7105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1262 11.8947 0 0 0 0 0 12.3233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4548 Q5VWZ2 LYPL1_HUMAN "Lysophospholipase-like protein 1, EC 3.1.2.22" LYPLAL1 Homo sapiens (Human) protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084] GO:0002084; GO:0004622; GO:0005737; GO:0005829; GO:0008474; GO:0052689 carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474] FHSFPNVYHELSK 0.98537 -3.6763 0 0 0 0 0 0 0 0 12.0774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3239 Q86TP1 PRUN1_HUMAN "Exopolyphosphatase PRUNE1, EC 3.6.1.1 (Drosophila-related expressed sequence 17, DRES-17, DRES17) (HTcD37) (Protein prune homolog 1, hPrune)" PRUNE1 PRUNE Homo sapiens (Human) regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631]; regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767] GO:0004309; GO:0004427; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0015631; GO:0016791; GO:0031113; GO:0046872; GO:0050767 exopolyphosphatase activity [GO:0004309]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631] AALQESR 0.98537 -2.8306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8216 0 16.6128 14.381 0 0 0 0 0 0 0 0 0 16.5804 16.6626 17.4138 0 0 0 0 0 0 0 0 0 17.0199 0 17.9937 17.4375 15.6628 16.8708 15.4206 17.9141 15.1877 14.7466 15.2977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6789 0 18.7557 14.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VW0 SESD1_HUMAN SEC14 domain and spectrin repeat-containing protein 1 (Huntingtin-interacting protein-like protein) (Protein Solo) SESTD1 SOLO Homo sapiens (Human) negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878] intermediate filament cytoskeleton [GO:0045111] "intermediate filament cytoskeleton [GO:0045111]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]" GO:0005546; GO:0010314; GO:0032266; GO:0043325; GO:0045111; GO:0070273; GO:0070300; GO:0080025; GO:1904878 "phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]" AQWGIGDSIRASQALQQK 0.98537 -3.7633 0 0 0 0 0 0 0 0 0 0 10.9572 0 0 0 11.376 0 0 0 12.5031 0 0 0 0 0 0 0 0 10.662 0 0 0 0 0 0 0 0 0 0 13.172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6618 0 13.5986 15.838 0 0 0 13.608 14.8939 15.3044 14.8956 14.5277 14.4932 13.602 0 0 13.4916 0 13.4066 13.6721 13.8177 14.2791 13.6496 0 0 14.1494 0 0 0 0 0 13.3362 0 0 0 0 0 14.2599 12.9712 13.6659 0 14.0531 13.9657 0 0 0 0 0 0 0 0 13.8906 0 13.3529 0 0 0 14.2146 0 13.311 0 13.5791 14.0382 0 0 15.1007 13.2742 0 13.3159 15.0133 13.6233 0 0 0 0 0 0 14.1488 0 13.292 0 14.9853 13.8324 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6486 13.6549 13.2477 0 0 13.1433 14.3233 0 0 0 0 0 0 0 0 0 Q96IW7 SC22A_HUMAN Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2) SEC22A SEC22L2 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031] GO:0005484; GO:0005789; GO:0006888; GO:0015031; GO:0016021 SNAP receptor activity [GO:0005484] KLAQLPDR 0.98537 -2.4343 0 0 0 14.7905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99523 SORT_HUMAN "Sortilin (100 kDa NT receptor) (Glycoprotein 95, Gp95) (Neurotensin receptor 3, NT3, NTR3)" SORT1 Homo sapiens (Human) endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of lipoprotein lipase activity [GO:0051005]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; post-Golgi vesicle-mediated transport [GO:0006892]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140] "cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of lipoprotein lipase activity [GO:0051005]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; post-Golgi vesicle-mediated transport [GO:0006892]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050]" GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006622; GO:0006892; GO:0006895; GO:0006897; GO:0007186; GO:0007218; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016021; GO:0016050; GO:0019899; GO:0030136; GO:0030140; GO:0030379; GO:0031410; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0051005; GO:0090160; GO:1905394 "enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394]" DITDLINNTFIRTEFGMAIGPENSGK 0.98537 -2.5618 0 0 0 0 0 0 0 0 0 0 0 0 12.0056 0 0 0 0 0 0 0 0 13.3894 11.8395 0 0 0 0 0 0 0 11.0935 0 0 0 0 0 0 0 0 0 0 0 12.8914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6839 0 0 0 13.2755 0 0 10.9811 0 0 0 0 0 0 0 0 0 0 15.6279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2982 10.4232 0 0 0 0 14.2139 0 0 0 13.2305 0 0 0 12.0983 0 0 0 0 13.3876 14.1204 0 11.8922 0 0 0 13.7703 0 0 0 0 0 0 0 0 0 0 12.0234 0 13.364 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5187 0 0 0 0 0 12.8613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKI2 BORG2_HUMAN Cdc42 effector protein 3 (Binder of Rho GTPases 2) (MSE55-related Cdc42-binding protein) CDC42EP3 BORG2 CEP3 Homo sapiens (Human) positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; cytoskeletal regulatory protein binding [GO:0005519]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165] GO:0005519; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0007266; GO:0008360; GO:0012505; GO:0015629; GO:0030838; GO:0031274 cytoskeletal regulatory protein binding [GO:0005519] HTIHIGK 0.98537 -3.6766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9522 13.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2921 0 0 0 0 0 0 0 0 0 0 0 0 0 13.174 0 0 12.2936 12.8731 0 0 0 0 0 0 0 0 0 13.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75419 CDC45_HUMAN Cell division control protein 45 homolog (PORC-PI-1) CDC45 CDC45L CDC45L2 UNQ374/PRO710 Homo sapiens (Human) DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; DNA replication preinitiation complex [GO:0031261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication preinitiation complex assembly [GO:1902977] GO:0000076; GO:0000727; GO:0003682; GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006268; GO:0006270; GO:0031261; GO:0036064; GO:0071162; GO:1902977 chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697] DEEEDEEHSGNDSDGSEPSEK 0.98538 -2.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7095 0 0 13.3536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1597 0 0 12.8539 0 0 0 13.8117 0 0 14.9763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3099 0 0 0 13.1395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10144 GRAB_HUMAN "Granzyme B, EC 3.4.21.79 (C11) (CTLA-1) (Cathepsin G-like 1, CTSGL1) (Cytotoxic T-lymphocyte proteinase 2, Lymphocyte protease) (Fragmentin-2) (Granzyme-2) (Human lymphocyte protein, HLP) (SECT) (T-cell serine protease 1-3E)" GZMB CGL1 CSPB CTLA1 GRB Homo sapiens (Human) apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; cytolysis [GO:0019835]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of translation [GO:0017148]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269] GO:0001772; GO:0004252; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0008236; GO:0016020; GO:0017148; GO:0019835; GO:0042267; GO:0043231; GO:0044194; GO:0051603; GO:0070269; GO:0140507; GO:1900740 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] ADAGEIIGGHEAK 0.98538 -2.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.808 0 0 0 0 0 0 0 0 0 14.3584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3332 0 0 0 0 0 0 16.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.805 0 0 0 0 10.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8108 0 0 0 0 0 10.1302 0 0 0 0 0 0 0 0 0 0 14.4142 14.2538 0 13.9512 13.9145 0 13.6327 0 11.808 13.4042 0 0 0 0 0 0 0 0 0 0 14.1551 0 14.864 P35268 RL22_HUMAN "60S ribosomal protein L22 (EBER-associated protein, EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15) (Large ribosomal subunit protein eL22)" RPL22 Homo sapiens (Human) "alpha-beta T cell differentiation [GO:0046632]; cytoplasmic translation [GO:0002181]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; alpha-beta T cell differentiation [GO:0046632]; cytoplasmic translation [GO:0002181]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; translation [GO:0006412]" GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0008201; GO:0022625; GO:0022626; GO:0042802; GO:0045182; GO:0046632; GO:0070062; GO:0098793; GO:0098978; GO:0099577; GO:1990904 heparin binding [GO:0008201]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182] APVKKLVVK 0.98538 -3.419 0 0 0 12.7051 13.5285 13.0898 14.3461 13.6957 16.7907 14.6402 16.4492 15.8534 16.687 14.9604 15.4277 14.3784 0 13.9017 13.929 0 14.5214 0 13.8736 0 15.5809 0 14.3626 0 15.1429 14.8838 14.4571 15.6614 0 0 14.1217 0 0 0 13.8044 0 14.657 14.6 16.2292 0 0 13.8166 12.8127 13.9593 0 14.5949 0 12.8179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2775 0 0 0 0 0 0 0 0 0 0 0 13.2869 13.0006 10.4737 0 0 0 0 0 0 11.192 0 0 0 0 0 0 0 0 0 0 15.5102 0 0 0 13.3015 0 0 0 0 0 0 0 0 0 0 0 13.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1705 0 0 0 0 0 0 0 0 0 15.3226 0 0 13.5294 0 0 0 0 0 0 13.7266 0 0 0 0 0 0 13.9633 13.4748 0 0 12.3969 13.5678 P38571 LICH_HUMAN "Lysosomal acid lipase/cholesteryl ester hydrolase, Acid cholesteryl ester hydrolase, LAL, EC 3.1.1.13 (Cholesteryl esterase) (Lipase A) (Sterol esterase)" LIPA Homo sapiens (Human) cell morphogenesis [GO:0000902]; epithelial cell proliferation [GO:0050673]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; macrophage homeostasis [GO:0061519]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771] cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; epithelial cell proliferation [GO:0050673]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; macrophage homeostasis [GO:0061519]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771] GO:0000902; GO:0001650; GO:0004771; GO:0005654; GO:0005764; GO:0005829; GO:0006954; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0034383; GO:0043202; GO:0043231; GO:0048771; GO:0048873; GO:0050673; GO:0061519 lipase activity [GO:0016298]; sterol esterase activity [GO:0004771] EFLPQSAFLK 0.98538 -3.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6164 0 0 0 0 0 0 0 0 0 0 11.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8209 0 0 0 0 0 14.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9526 0 0 0 0 0 0 0 0 12.5667 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51608 MECP2_HUMAN "Methyl-CpG-binding protein 2, MeCp-2 protein, MeCp2" MECP2 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; gene expression [GO:0010467]; glial cell proliferation [GO:0014009]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; Notch signaling pathway [GO:0007219]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; trans-synaptic signaling by BDNF [GO:0099191]; ventricular system development [GO:0021591]; visual learning [GO:0008542]" centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794] "centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]; adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular biogenic amine metabolic process [GO:0006576]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; gene expression [GO:0010467]; glial cell proliferation [GO:0014009]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin assembly [GO:0031507]; histone acetylation [GO:0016573]; histone methylation [GO:0016571]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000820]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; Notch signaling pathway [GO:0007219]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA methylation [GO:1905643]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to hypoxia [GO:0001666]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; startle response [GO:0001964]; synapse assembly [GO:0007416]; trans-synaptic signaling by BDNF [GO:0099191]; ventricular system development [GO:0021591]; visual learning [GO:0008542]" GO:0000122; GO:0000792; GO:0001662; GO:0001666; GO:0001964; GO:0001976; GO:0002087; GO:0003677; GO:0003682; GO:0003700; GO:0003714; GO:0003723; GO:0003729; GO:0005615; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006020; GO:0006349; GO:0006541; GO:0006576; GO:0007052; GO:0007219; GO:0007416; GO:0007585; GO:0007616; GO:0008104; GO:0008211; GO:0008284; GO:0008327; GO:0008344; GO:0008542; GO:0009791; GO:0010385; GO:0010467; GO:0010629; GO:0010971; GO:0014009; GO:0016358; GO:0016525; GO:0016571; GO:0016573; GO:0019230; GO:0019233; GO:0019904; GO:0021549; GO:0021591; GO:0031507; GO:0032048; GO:0035176; GO:0035197; GO:0042551; GO:0043524; GO:0043537; GO:0045892; GO:0045944; GO:0046470; GO:0047485; GO:0050432; GO:0051151; GO:0051707; GO:0060079; GO:0060252; GO:0060291; GO:0090063; GO:0098794; GO:0099191; GO:1900114; GO:1905643; GO:1990841; GO:2000820 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714] KPGSVVAAAAAEAKK 0.98538 -2.1067 0 0 0 0 0 0 0 0 12.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.874 0 0 0 0 13.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7679 0 0 0 12.2968 0 0 14.3228 13.1042 0 0 0 0 0 0 0 0 0 0 13.3729 15.6789 0 14.3949 12.3736 0 0 0 0 0 12.1206 0 0 11.8841 0 0 0 0 0 0 0 14.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57764 GSDMD_HUMAN "Gasdermin-D (Gasdermin domain-containing protein 1) [Cleaved into: Gasdermin-D, N-terminal, GSDMD-NT, hGSDMD-NTD; Gasdermin-D, C-terminal, GSDMD-CT, hGSDMD-CTD ]" GSDMD DFNA5L GSDMDC1 FKSG10 Homo sapiens (Human) cellular response to extracellular stimulus [GO:0031668]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pore complex assembly [GO:0046931]; pore formation in membrane of another organism [GO:0035915]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-18 production [GO:0032741]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cardiolipin binding [GO:1901612]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]; cellular response to extracellular stimulus [GO:0031668]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pore complex assembly [GO:0046931]; pore formation in membrane of another organism [GO:0035915]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-18 production [GO:0032741]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]" GO:0001786; GO:0005546; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0016021; GO:0022829; GO:0031668; GO:0032731; GO:0032732; GO:0032741; GO:0035580; GO:0035915; GO:0042742; GO:0045087; GO:0046931; GO:0050829; GO:0050830; GO:0051260; GO:0070269; GO:0070273; GO:0070300; GO:0072559; GO:1901612; GO:1904724; GO:1904813 "cardiolipin binding [GO:1901612]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]" ELCQLLLEGLEGVLR 0.98538 -3.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5918 0 0 0 0 0 0 0 0 0 15.45 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0861 0 0 0 0 0 0 0 0 0 0 0 Q01638 ILRL1_HUMAN "Interleukin-1 receptor-like 1, EC 3.2.2.6 (Protein ST2)" IL1RL1 DER4 ST2 T1 Homo sapiens (Human) immune response [GO:0006955]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of T-helper 1 type immune response [GO:0002826]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of macrophage activation [GO:0043032]; signal transduction [GO:0007165] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interleukin-1 receptor activity [GO:0004908]; interleukin-33 binding [GO:0002113]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; immune response [GO:0006955]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of T-helper 1 type immune response [GO:0002826]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of macrophage activation [GO:0043032]; signal transduction [GO:0007165]" GO:0002113; GO:0002114; GO:0002826; GO:0004896; GO:0004908; GO:0005576; GO:0005829; GO:0005886; GO:0005925; GO:0006955; GO:0007165; GO:0009897; GO:0016021; GO:0032689; GO:0032722; GO:0032754; GO:0043032; GO:0050135; GO:0050729; GO:0061809 "cytokine receptor activity [GO:0004896]; interleukin-1 receptor activity [GO:0004908]; interleukin-33 binding [GO:0002113]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]" DEQGFSLFPVIGAPAQNEIKEVEIGK 0.98538 -2.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4183 0 0 12.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9987 0 0 0 0 0 0 0 0 0 9.67423 0 0 0 0 0 0 0 0 0 10.3624 0 0 0 0 0 0 0 0 0 0 0 0 0 12.497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3B726 RPA43_HUMAN DNA-directed RNA polymerase I subunit RPA43 (DNA-directed RNA polymerase I subunit F) (Twist neighbor protein) POLR1F TWISTNB Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription, initiation [GO:0006352]" nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] "nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA-templated transcription, initiation [GO:0006352]" GO:0005654; GO:0005736; GO:0006352; GO:1990830 HIALSPR 0.98538 -2.4385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWR7 ENPP6_HUMAN "Glycerophosphocholine cholinephosphodiesterase ENPP6, GPC-Cpde, EC 3.1.4.-, EC 3.1.4.38 (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6, E-NPP 6, NPP-6)" ENPP6 UNQ1889/PRO4334 Homo sapiens (Human) choline metabolic process [GO:0019695]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; choline metabolic process [GO:0019695]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629] GO:0005576; GO:0005886; GO:0006629; GO:0008081; GO:0008889; GO:0019695; GO:0031225; GO:0046475; GO:0046872; GO:0047390; GO:0070062 glycerophosphocholine cholinephosphodiesterase activity [GO:0047390]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081] ADLAAIYHER 0.98538 -3.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2213 0 12.9326 12.3372 0 0 0 11.8351 0 0 13.5612 0 0 0 0 12.8451 12.3237 0 0 12.4079 0 0 0 0 0 0 11.6694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2293 0 14.5214 13.7056 0 0 0 0 0 0 14.6213 0 12.6374 14.0626 13.5823 0 12.5723 0 0 0 0 0 0 0 0 0 0 0 12.8595 14.9762 12.5218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4738 13.9216 12.1693 0 0 0 0 0 0 14.7817 0 0 0 0 15.0389 14.9847 0 0 14.0626 0 0 14.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1086 0 0 0 0 0 0 0 0 12.3828 0 11.8058 0 0 0 15.5788 0 0 0 0 14.6402 0 0 0 11.4564 0 0 0 0 0 0 0 0 0 Q7L5A3 F214B_HUMAN Protein FAM214B FAM214B KIAA1539 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 ELKRGPGLGAR 0.98538 -2.4425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7909 0 0 0 0 0 11.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.008 0 0 0 0 0 0 0 0 0 0 12.5133 0 0 15.7226 14.0975 0 0 0 13.2886 0 0 13.5792 0 13.0803 0 12.6626 0 0 12.4133 0 0 14.5093 0 0 0 0 0 0 0 13.3198 0 0 0 0 0 13.8319 0 0 14.3602 0 12.6788 0 0 0 13.2172 12.5135 0 14.1621 0 13.6887 0 13.4401 0 14.4055 13.0954 0 14.117 0 13.1339 0 12.7393 13.2068 0 0 13.1319 13.4831 12.831 11.9117 0 0 0 0 0 0 13.1055 0 0 12.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZM8 NDEL1_HUMAN "Nuclear distribution protein nudE-like 1, Protein Nudel (Mitosin-associated protein 1)" NDEL1 EOPA MITAP1 NUDEL Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron projection extension [GO:1990138]; nuclear membrane disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of intracellular protein transport [GO:0033157]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021] axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron projection extension [GO:1990138]; nuclear membrane disassembly [GO:0051081]; positive regulation of axon extension [GO:0045773]; positive regulation of axon regeneration [GO:0048680]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of intracellular protein transport [GO:0033157]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496] GO:0000132; GO:0000776; GO:0001833; GO:0005635; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007020; GO:0007059; GO:0007100; GO:0008017; GO:0008021; GO:0008090; GO:0008286; GO:0010975; GO:0016477; GO:0021799; GO:0021955; GO:0031252; GO:0032418; GO:0033157; GO:0042802; GO:0043014; GO:0043203; GO:0043547; GO:0044877; GO:0045773; GO:0047496; GO:0048487; GO:0048680; GO:0051081; GO:0051303; GO:0051642; GO:0060052; GO:0060053; GO:0070012; GO:0090630; GO:0090724; GO:0140650; GO:1900029; GO:1904115; GO:1990138 alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; oligopeptidase activity [GO:0070012]; protein-containing complex binding [GO:0044877] ERQQEVTR 0.98538 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3234 0 15.9717 0 0 0 0 15.3395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5J5 PHLA3_HUMAN Pleckstrin homology-like domain family A member 3 (TDAG51/Ipl homolog 1) PHLDA3 TIH1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of apoptotic process [GO:0043065] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]; anatomical structure morphogenesis [GO:0009653]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of apoptotic process [GO:0043065]" GO:0005546; GO:0005547; GO:0005737; GO:0005886; GO:0009653; GO:0010314; GO:0032266; GO:0042771; GO:0043065; GO:0043325; GO:0051898; GO:0080025 "phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]" GTGGRPK 0.98538 -3.6864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.048 14.0526 14.0983 14.1262 13.9959 14.0782 13.4098 13.2471 13.3855 0 0 0 0 13.4915 0 0 0 0 0 0 11.8642 10.8466 0 0 0 10.9902 0 0 0 0 0 0 0 12.3939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6937 0 0 0 0 0 0 0 0 0 11.9755 11.7955 0 0 0 0 0 10.7683 0 0 0 0 0 0 0 0 11.6325 0 0 0 0 12.2736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17213 BPI_HUMAN "Bactericidal permeability-increasing protein, BPI (CAP 57)" BPI Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of macrophage activation [GO:0043031]; negative regulation of tumor necrosis factor production [GO:0032720] azurophil granule lumen [GO:0035578]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; specific granule lumen [GO:0035580] azurophil granule lumen [GO:0035578]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; lipopolysaccharide binding [GO:0001530]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of macrophage activation [GO:0043031]; negative regulation of tumor necrosis factor production [GO:0032720] GO:0001530; GO:0005576; GO:0005615; GO:0010494; GO:0016020; GO:0019731; GO:0031663; GO:0032715; GO:0032717; GO:0032720; GO:0035578; GO:0035580; GO:0043031; GO:0045087; GO:0050829; GO:0061844; GO:0070062; GO:0071222 lipopolysaccharide binding [GO:0001530] MRENMAR 0.98539 -3.4271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25786 PSA1_HUMAN "Proteasome subunit alpha type-1 (30 kDa prosomal protein, PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)" PSMA1 HC2 NU PROS30 PSC2 Homo sapiens (Human) immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]" "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; lipopolysaccharide binding [GO:0001530]; RNA binding [GO:0003723]; immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005839; GO:0005844; GO:0010498; GO:0019773; GO:0043161; GO:0070062 lipopolysaccharide binding [GO:0001530]; RNA binding [GO:0003723] HMSEFMECNLNELVKHGLRALR 0.98539 -2.4982 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8788 0 0 13.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26012 ITB8_HUMAN Integrin beta-8 ITGB8 Homo sapiens (Human) cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ganglioside metabolic process [GO:0001573]; hard palate development [GO:0060022]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; negative regulation of gene expression [GO:0010629]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; extracellular matrix protein binding [GO:1990430]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ganglioside metabolic process [GO:0001573]; hard palate development [GO:0060022]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; negative regulation of gene expression [GO:0010629]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570] GO:0001570; GO:0001573; GO:0005178; GO:0005886; GO:0005925; GO:0006955; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008305; GO:0009615; GO:0009986; GO:0010628; GO:0010629; GO:0016477; GO:0033627; GO:0034686; GO:0038023; GO:0045766; GO:0051216; GO:0060022; GO:0060674; GO:0061520; GO:0070062; GO:1901388; GO:1990430 extracellular matrix protein binding [GO:1990430]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023] CASSNAASCARCLALGPECGWCVQEDFISGGSRSER 0.98539 -3.426 0 0 0 0 0 0 0 0 0 0 10.6381 0 0 0 0 0 0 0 0 0 13.7788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.59 0 0 0 0 0 0 0 13.4743 13.8927 0 0 0 0 10.9704 0 0 0 14.3833 0 0 12.353 0 12.498 0 0 0 0 0 12.5885 0 0 12.473 0 0 0 0 12.2568 0 0 0 14.1947 0 0 0 0 0 0 11.5884 14.0248 0 0 0 12.0347 0 0 0 0 0 0 0 0 14.4462 0 0 0 0 0 0 14.516 13.5376 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2965 11.6741 0 12.4301 0 0 0 0 0 12.2953 0 11.661 0 10.3796 0 0 0 0 0 0 0 0 0 12.3967 10.406 0 0 0 0 12.3618 P62487 RPB7_HUMAN "DNA-directed RNA polymerase II subunit RPB7, RNA polymerase II subunit B7 (DNA-directed RNA polymerase II subunit G) (RNA polymerase II 19 kDa subunit, RPB19)" POLR2G RPB7 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]" "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000291; GO:0000932; GO:0003697; GO:0003727; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0006367; GO:0031369; GO:0045948; GO:0060213 single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369] AIVFRPFK 0.98539 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0865 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUH2 CREG2_HUMAN Protein CREG2 (Cellular repressor of E1A-stimulated genes 2) CREG2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] GO:0005615; GO:0005783; GO:0005794 AGAARAR 0.98539 -2.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2795 0 14.9051 14.581 0 0 14.5011 0 0 14.5171 0 0 0 0 14.3696 0 0 0 0 0 0 0 0 0 0 12.0551 0 12.5436 15.2725 11.6055 16.0481 11.4932 0 0 0 14.3371 15.384 15.2719 16.6065 15.3205 14.721 15.5465 15.3012 14.5512 15.2792 14.52 14.8701 12.4513 12.8582 13.9542 0 0 0 0 0 12.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.811 0 0 0 0 0 0 0 0 0 0 0 0 14.328 14.7107 15.4126 16.2767 14.0243 14.5149 15.5915 13.5907 0 0 0 0 0 0 0 14.7422 0 14.5947 0 0 Q8TF47 ZFP90_HUMAN "Zinc finger protein 90 homolog, Zfp-90 (Zinc finger protein 756)" ZFP90 KIAA1954 ZNF756 Homo sapiens (Human) "negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0043392; GO:0045893; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFSQSSSLIQHERTHTGEKPYECNECGR 0.98539 -3.0439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9498 0 0 0 0 0 0 0 0 0 0 0 10.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GA3 LTV1_HUMAN Protein LTV1 homolog LTV1 C6orf93 Homo sapiens (Human) ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]" GO:0000056; GO:0005634; GO:0005654; GO:0005829; GO:0030688; GO:0042274 EKWDCESICSTYSNLYNHPQLIKYQPK 0.98539 -2.6724 0 0 0 0 0 0 0 0 0 12.4606 0 13.032 0 12.7639 0 0 12.8656 14.3725 13.1555 0 0 0 0 0 14.9849 0 11.4943 13.3393 0 0 0 11.4671 0 0 0 0 0 0 0 0 11.5763 14.0498 0 0 13.5467 13.7037 0 13.7137 0 13.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5073 0 0 0 0 0 0 0 0 11.9069 0 0 0 0 0 0 0 16.7358 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3045 0 15.9561 14.5883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0258 14.5874 0 0 0 0 0 0 0 0 0 0 0 12.4961 0 0 0 12.8423 0 14.6672 0 0 0 0 0 0 0 0 14.2879 13.4033 13.2654 13.1046 13.0991 13.2252 0 0 13.4752 13.1105 14.3542 0 0 13.0503 14.077 0 0 0 0 0 16.5851 0 12.0794 0 Q96JY6 PDLI2_HUMAN PDZ and LIM domain protein 2 (PDZ-LIM protein mystique) PDLIM2 PP6345 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; filamentous actin [GO:0031941]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; filamentous actin [GO:0031941]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] GO:0001725; GO:0003779; GO:0005634; GO:0005912; GO:0007507; GO:0030018; GO:0030036; GO:0030864; GO:0031005; GO:0031625; GO:0031941; GO:0032036; GO:0046872; GO:0051371; GO:0061061 actin binding [GO:0003779]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625] ALATPPK 0.98539 -2.7481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9191 15.9185 0 13.6593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQP3 TENN_HUMAN "Tenascin-N, TN-N (Tenascin-W, TN-W)" TNN TNW Homo sapiens (Human) axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733] CA3 pyramidal cell dendrite [GO:0097442]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; hippocampal mossy fiber expansion [GO:1990026]; neuronal cell body [GO:0043025]; tenascin complex [GO:0090733]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; axonogenesis [GO:0007409]; cell-matrix adhesion [GO:0007160]; dendrite self-avoidance [GO:0070593]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of neuron migration [GO:2001223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection extension [GO:1990138]; osteoblast development [GO:0002076]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of bone development [GO:1903010]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of smooth muscle tissue development [GO:1905899] GO:0002076; GO:0005178; GO:0005615; GO:0007160; GO:0007409; GO:0009986; GO:0010976; GO:0030155; GO:0030334; GO:0033689; GO:0042802; GO:0043025; GO:0045668; GO:0062023; GO:0070593; GO:0090733; GO:0097442; GO:1903010; GO:1903672; GO:1905240; GO:1905899; GO:1990026; GO:1990138; GO:2001223 identical protein binding [GO:0042802]; integrin binding [GO:0005178] EFWLGLDK 0.98539 -2.114 10.1417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85323 0 0 0 0 0 0 0 0 11.6746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8969 0 0 0 11.3974 0 0 0 0 0 17.1612 0 0 11.8933 0 11.406 0 11.4472 0 0 0 0 0 0 0 0 12.0509 0 0 11.6031 0 0 0 0 0 12.28 0 0 0 0 0 9.8037 0 0 0 0 10.9146 0 0 0 0 0 0 13.2733 0 0 10.8367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60895 RAMP2_HUMAN "Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2, CRLR activity-modifying protein 2)" RAMP2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adherens junction assembly [GO:0034333]; adrenomedullin receptor signaling pathway [GO:1990410]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; bicellular tight junction assembly [GO:0070830]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of vascular permeability [GO:0043116]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; sprouting angiogenesis [GO:0002040]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] adrenomedullin receptor complex [GO:1903143]; amylin receptor complex 2 [GO:0150057]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] adrenomedullin receptor complex [GO:1903143]; amylin receptor complex 2 [GO:0150057]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; coreceptor activity [GO:0015026]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adherens junction assembly [GO:0034333]; adrenomedullin receptor signaling pathway [GO:1990410]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; bicellular tight junction assembly [GO:0070830]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of vascular permeability [GO:0043116]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; sprouting angiogenesis [GO:0002040]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0001605; GO:0002040; GO:0005737; GO:0005764; GO:0005886; GO:0005887; GO:0005905; GO:0006816; GO:0006886; GO:0007186; GO:0007189; GO:0007507; GO:0008217; GO:0008277; GO:0009986; GO:0010628; GO:0015026; GO:0015031; GO:0031623; GO:0032870; GO:0034333; GO:0035924; GO:0043116; GO:0043235; GO:0045766; GO:0070830; GO:0070831; GO:0072659; GO:0097084; GO:0097647; GO:0150057; GO:1903143; GO:1990409; GO:1990410; GO:2000352; GO:2001214 adrenomedullin binding [GO:1990409]; adrenomedullin receptor activity [GO:0001605]; coreceptor activity [GO:0015026] DQMDPIEKDWCDWAMISR 0.9854 -2.9501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5887 0 0 0 0 0 11.8317 0 0 0 0 0 0 0 16.0081 0 15.281 0 0 0 0 0 0 0 15.3827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1296 0 0 0 0 14.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0H9 SRCN1_HUMAN "SRC kinase signaling inhibitor 1 (SNAP-25-interacting protein, SNIP) (p130Cas-associated protein) (p140Cap)" SRCIN1 KIAA1684 P140 SNIP Homo sapiens (Human) exocytosis [GO:0006887]; negative regulation of protein secretion [GO:0050709]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synapse [GO:0045202]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; exocytosis [GO:0006887]; negative regulation of protein secretion [GO:0050709]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0005737; GO:0006887; GO:0014069; GO:0015629; GO:0019901; GO:0019904; GO:0030027; GO:0030175; GO:0030334; GO:0030424; GO:0030425; GO:0034446; GO:0043025; GO:0045202; GO:0050709; GO:0061001; GO:0061098; GO:0061099; GO:0070161; GO:0098793 protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] AHFPGLQSKMR 0.9854 -2.6871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0331 0 0 0 0 0 0 0 9.82988 0 0 0 13.7351 15.8618 10.4588 10.839 13.5434 0 0 0 14.6461 0 0 14.189 0 0 14.449 11.3061 13.9031 13.9935 0 0 11.3937 0 0 0 0 0 0 12.8998 0 14.7585 0 0 0 0 12.7665 12.1782 0 0 13.0881 0 12.2738 14.1025 0 0 14.339 13.4289 0 13.3505 0 0 12.9434 13.3112 0 0 0 0 0 0 14.6801 12.6618 0 10.4817 11.493 0 0 0 0 11.9851 0 0 0 11.699 11.3514 0 0 13.2436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75578 ITA10_HUMAN Integrin alpha-10 ITGA10 UNQ468/PRO827 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] external side of plasma membrane [GO:0009897]; integrin alpha10-beta1 complex [GO:0034680]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integrin alpha10-beta1 complex [GO:0034680]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] GO:0005178; GO:0005518; GO:0005886; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0033627; GO:0034680; GO:0046872; GO:0098609; GO:0098639 collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872] ACEAGRVTR 0.98541 -3.6227 0 0 0 10.2788 0 0 0 0 10.6633 0 0 0 0 0 0 0 0 0 0 0 9.77489 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8829 0 0 10.6544 0 0 0 0 0 0 0 13.8837 0 13.4841 0 13.5244 0 0 0 0 0 0 12.6867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4864 0 10.9732 0 0 0 0 10.7749 12.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1525 0 0 0 0 0 0 0 0 P23975 SC6A2_HUMAN "Sodium-dependent noradrenaline transporter (Norepinephrine transporter, NET) (Solute carrier family 6 member 2)" SLC6A2 NAT1 NET1 SLC6A5 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725] GO:0003779; GO:0005326; GO:0005328; GO:0005330; GO:0005334; GO:0005886; GO:0005887; GO:0006836; GO:0007268; GO:0008504; GO:0009410; GO:0009986; GO:0015844; GO:0015874; GO:0016020; GO:0032809; GO:0035725; GO:0042734; GO:0043005; GO:0043014; GO:0045121; GO:0046872; GO:0048265; GO:0048487; GO:0051583; GO:0051620; GO:0070050 actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334] ARKTAELLVVK 0.98541 -2.0459 0 12.3 12.8193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3559 13.0076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2582 0 15.4524 0 0 0 0 0 0 0 0 0 0 0 0 11.2565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9898 16.7041 0 0 0 0 0 0 0 0 0 0 0 14.7838 0 0 0 0 0 14.5503 13.4193 0 0 14.4554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27540 ARNT_HUMAN "Aryl hydrocarbon receptor nuclear translocator, ARNT protein (Class E basic helix-loop-helix protein 2, bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta, HIF-1-beta, HIF1-beta)" ARNT BHLHE2 Homo sapiens (Human) cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666] aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; embryonic placenta development [GO:0001892]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001666; GO:0001892; GO:0001938; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010575; GO:0016604; GO:0017162; GO:0030154; GO:0030949; GO:0033235; GO:0034751; GO:0042803; GO:0043565; GO:0043619; GO:0045648; GO:0045821; GO:0045944; GO:0046886; GO:0046982; GO:0061629; GO:0090575; GO:1990837 "aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" CDDDQMSNDK 0.98541 -3.6202 11.6763 10.8798 0 0 0 0 0 0 0 0 0 0 14.954 13.5464 0 14.2459 0 0 0 0 12.5764 0 0 0 0 0 0 12.7603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4063 0 0 0 0 12.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7558 0 0 0 13.2224 0 0 0 10.8643 0 0 0 0 0 0 0 12.8587 0 0 13.5067 0 0 0 0 0 14.5112 0 0 13.3799 13.6262 0 0 0 0 0 0 14.6378 0 0 0 0 0 0 14.2318 0 0 0 0 0 0 0 0 0 0 11.463 11.8176 14.6007 0 0 0 0 13.2879 0 13.0376 0 0 13.5038 0 0 0 0 0 15.2418 0 0 0 0 0 0 0 13.8059 0 0 14.0216 0 0 0 14.5627 0 13.5222 0 12.6881 0 14.1773 13.4091 0 0 0 0 0 0 Q07960 RHG01_HUMAN Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP) ARHGAP1 CDC42GAP RHOGAP1 Homo sapiens (Human) endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572] GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0007266; GO:0010008; GO:0016197; GO:0017124; GO:0031267; GO:0033572; GO:0045296; GO:0048471; GO:0051056; GO:0070062; GO:2001136 cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] ALYIVHPTMFIKTLLILFK 0.98541 -2.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7176 0 12.1418 0 0 0 0 0 0 0 0 0 11.6833 0 0 0 0 0 11.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5077 0 0 0 0 0 0 0 0 0 0 15.768 0 0 0 13.8196 0 0 0 0 0 0 12.6562 0 0 0 0 0 9.90445 14.6628 0 0 0 12.7898 0 0 0 0 0 0 0 0 0 0 0 0 12.0998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9711 13.3502 0 0 0 0 12.5375 0 0 0 0 0 0 10.1506 0 15.2078 12.2034 0 Q2NL67 PARP6_HUMAN "Protein mono-ADP-ribosyltransferase PARP6, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 17, ARTD17) (Poly [ADP-ribose] polymerase 6, PARP-6)" PARP6 Homo sapiens (Human) positive regulation of dendrite morphogenesis [GO:0050775]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] GO:0003950; GO:0006471; GO:0050775; GO:0070213; GO:0140289; GO:1990404 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404] KFRAGLSIFSPIPK 0.98541 -2.7699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9732 14.1827 0 0 14.4356 0 0 0 0 0 0 0 0 13.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.518 0 13.975 0 0 0 0 0 0 0 14.1951 0 0 0 0 0 0 0 0 0 0 0 12.9424 0 0 13.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L1W4 LRC8D_HUMAN "Volume-regulated anion channel subunit LRRC8D (Leucine-rich repeat-containing protein 5) (Leucine-rich repeat-containing protein 8D, HsLRRC8D)" LRRC8D LRRC5 UNQ213/PRO239 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular glucose homeostasis [GO:0001678]; cellular response to osmotic stress [GO:0071470]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular glucose homeostasis [GO:0001678]; cellular response to osmotic stress [GO:0071470]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] GO:0001678; GO:0005225; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015734; GO:0015810; GO:0016020; GO:0016021; GO:0034214; GO:0034702; GO:0071470; GO:0098656 volume-sensitive anion channel activity [GO:0005225] DQVVCLPVLPSPVNSKAHTPPGNAEVTTNIPK 0.98541 -2.5108 0 0 0 0 0 10.1993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2434 12.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9599 0 0 0 15.6048 0 13.18 14.1172 0 14.3186 0 0 11.4105 0 0 15.6491 0 0 11.5833 0 12.917 12.0081 0 0 0 0 16.256 12.9374 0 14.0857 0 0 11.82 0 0 0 0 0 0 0 0 0 11.07 0 14.4555 0 0 0 0 13.8953 13.0457 13.803 0 13.7178 12.957 0 0 0 0 13.6164 0 0 16.0811 12.1498 14.0043 0 0 0 0 12.6992 13.1246 12.7662 0 0 0 10.6742 0 0 0 0 0 14.2743 0 13.4021 0 0 0 0 0 13.4112 0 0 0 0 0 0 0 11.2215 0 0 0 0 0 0 0 0 11.7484 0 Q86X24 HORM1_HUMAN "HORMA domain-containing protein 1 (Cancer/testis antigen 46, CT46) (Newborn ovary HORMA protein)" HORMAD1 NOHMA Homo sapiens (Human) blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] chromosome [GO:0005694]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; blastocyst development [GO:0001824]; meiotic cell cycle [GO:0051321]; meiotic DNA double-strand break formation [GO:0042138]; meiotic recombination checkpoint signaling [GO:0051598]; meiotic sister chromatid cohesion [GO:0051177]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] GO:0000795; GO:0001824; GO:0005634; GO:0005694; GO:0007130; GO:0007283; GO:0042138; GO:0048477; GO:0051177; GO:0051321; GO:0051598; GO:0060629 ASILLIRK 0.98541 -2.5906 0 0 0 0 0 0 0 0 0 0 0 0 10.5715 0 0 0 0 0 0 0 0 0 0 11.258 0 10.9848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.632 0 14.5296 0 0 0 0 18.9421 18.6787 14.4818 0 0 0 0 0 0 0 11.8001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8179 0 0 0 15.3699 0 0 0 0 0 0 12.0558 0 0 0 0 0 0 0 0 0 10.9994 11.7951 0 0 0 0 0 0 0 0 11.5533 Q8N831 TSYL6_HUMAN "Testis-specific Y-encoded-like protein 6, TSPY-like protein 6" TSPYL6 Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0042393 chromatin binding [GO:0003682]; histone binding [GO:0042393] EPVEIPR 0.98541 -3.6209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5852 0 0 0 12.5328 0 12.4055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBG4 AT2L1_HUMAN "Ethanolamine-phosphate phospho-lyase, EC 4.2.3.2 (Alanine--glyoxylate aminotransferase 2-like 1)" ETNPPL AGXT2L1 Homo sapiens (Human) mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] GO:0005759; GO:0008483; GO:0030170; GO:0050459 ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] CELYSKR 0.98541 -3.7928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8994 13.8622 13.3527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9832 0 0 0 0 0 0 0 0 13.1303 0 0 0 13.9732 0 13.7972 13.5634 13.9058 14.0297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9738 14.1536 0 0 0 0 0 0 0 0 0 0 0 12.4461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H3BRN8 PIRC2_HUMAN Piercer of microtubule wall 2 protein PIERCE2 C15orf65 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368] axonemal microtubule [GO:0005879] axonemal microtubule [GO:0005879]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368] GO:0003341; GO:0005879; GO:0007368; GO:0035082 ATGFYQNNTLNTAPDR 0.98542 -3.4535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60858 TRI13_HUMAN "E3 ubiquitin-protein ligase TRIM13, EC 2.3.2.27 (B-cell chronic lymphocytic leukemia tumor suppressor Leu5) (Leukemia-associated protein 5) (Putative tumor suppressor RFP2) (RING finger protein 77) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13)" TRIM13 LEU5 RFP2 RNF77 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; endoplasmic reticulum mannose trimming [GO:1904380]; innate immune response [GO:0045087]; negative regulation of viral transcription [GO:0032897]; positive regulation of cell death [GO:0010942]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; response to gamma radiation [GO:0010332]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; endoplasmic reticulum mannose trimming [GO:1904380]; innate immune response [GO:0045087]; negative regulation of viral transcription [GO:0032897]; positive regulation of cell death [GO:0010942]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; response to gamma radiation [GO:0010332]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0003713; GO:0004842; GO:0005737; GO:0005789; GO:0008270; GO:0009653; GO:0010332; GO:0010942; GO:0016021; GO:0016239; GO:0016567; GO:0030433; GO:0032897; GO:0043123; GO:0043161; GO:0044322; GO:0044790; GO:0045087; GO:0051092; GO:0051865; GO:0061630; GO:0097038; GO:1904380 transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] EFFEKLQHTLDQK 0.98542 -3.6342 0 0 0 0 0 0 0 0 0 0 0 0 12.8307 0 0 11.3286 12.4409 0 0 0 0 0 0 12.3909 0 0 0 0 12.5888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4472 0 0 0 0 0 0 0 0 0 12.4076 0 0 0 0 0 0 0 14.9818 0 0 0 0 0 0 0 0 12.6589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5469 0 0 0 0 0 0 0 0 0 0 11.6434 0 0 0 0 0 0 0 0 0 13.748 0 0 0 0 0 13.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75628 REM1_HUMAN GTP-binding protein REM 1 (GTPase-regulating endothelial cell sprouting) (Rad and Gem-like GTP-binding protein 1) REM1 GES REM Homo sapiens (Human) negative regulation of high voltage-gated calcium channel activity [GO:1901842] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842] GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005886; GO:1901842 calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] ARRFLAR 0.98542 -3.7156 0 0 0 0 0 0 0 0 0 0 0 0 11.3179 0 0 0 0 0 0 0 0 0 0 0 10.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6253 0 0 0 0 0 0 0 0 0 0 0 Q14532 K1H2_HUMAN "Keratin, type I cuticular Ha2 (Hair keratin, type I Ha2) (Keratin-32, K32)" KRT32 HHA2 HKA2 KRTHA2 Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0030855; GO:0045109; GO:0070062 structural molecule activity [GO:0005198] LAADDFR 0.98542 -2.5258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0N8 SL9C1_HUMAN "Sodium/hydrogen exchanger 10 (Na(+)/H(+) exchanger 10, NHE-10) (Solute carrier family 9 member 10) (Solute carrier family 9 member C1) (Sperm-specific Na(+)/H(+) exchanger, sNHE)" SLC9C1 SLC9A10 Homo sapiens (Human) cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719]; spermatogenesis [GO:0007283] GO:0005216; GO:0005886; GO:0007283; GO:0015385; GO:0015386; GO:0016021; GO:0030154; GO:0030317; GO:0031514; GO:0051453; GO:0071805; GO:0098719 ion channel activity [GO:0005216]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] DATSTKYKSVCCTFQHFQELTK 0.98542 -2.703 0 0 0 16.1196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7485 0 0 0 0 0 0 0 0 12.9912 0 0 0 0 0 12.3761 0 0 0 0 0 0 0 0 0 0 0 0 10.8674 0 0 0 13.7761 14.827 0 0 13.954 0 0 0 13.879 0 0 13.5347 12.3167 0 0 0 0 0 0 0 0 12.774 0 12.2878 0 0 0 14.9449 13.2952 0 11.0041 0 0 0 0 14.4851 10.8285 11.9442 13.1227 10.7759 0 0 13.0064 12.3281 13.5174 12.0697 14.5318 15.16 0 14.3676 13.2762 0 17.2681 0 13.8326 0 0 16.1003 0 16.6234 12.68 0 15.3368 0 0 0 15.3067 13.8942 11.8322 11.8721 12.5327 13.2198 11.7932 11.1759 0 14.3274 0 0 14.1117 0 13.6856 0 0 0 0 0 12.2822 0 0 0 0 10.9798 13.0958 0 16.6015 0 0 0 0 0 0 15.2184 0 0 0 12.7859 0 0 0 Q5GLZ8 HERC4_HUMAN "Probable E3 ubiquitin-protein ligase HERC4, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4)" HERC4 KIAA1593 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; ubiquitin protein ligase activity [GO:0061630]; cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630 ubiquitin protein ligase activity [GO:0061630] IFNSFLHTALKVLEILHRVNEK 0.98542 -2.9665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1142 0 0 0 0 0 0 0 0 0 0 0 16.1465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5193 0 0 11.0006 0 11.7167 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8119 11.9285 18.1801 12.6847 0 16.5907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8373 0 0 0 0 14.8549 0 14.4315 0 10.9461 0 0 0 0 0 0 0 13.3562 0 0 0 0 12.3071 0 0 0 0 0 0 Q8NGM9 OR8D4_HUMAN Olfactory receptor 8D4 (Olfactory receptor OR11-275) OR8D4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] KISLSPG 0.98542 -3.7232 0 0 0 0 13.7868 13.5169 0 13.5569 0 0 0 0 0 0 0 0 0 0 0 0 13.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2494 0 0 0 0 0 0 0 0 0 13.93 0 0 0 0 0 0 0 0 0 14.3301 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969H6 POP5_HUMAN "Ribonuclease P/MRP protein subunit POP5, hPop5" POP5 AD-008 HSPC004 x0003 Homo sapiens (Human) rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033] multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172] multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033] GO:0000172; GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0005730; GO:0006364; GO:0008033; GO:0030681; GO:0033204 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204] SVTRSCLLEEEEESGEEAAEAME 0.98542 -2.7806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.157 0 0 0 14.9325 0 0 0 0 0 0 15.8051 0 0 0 0 0 0 14.9462 0 0 0 0 14.9442 15.0159 14.8131 14.5299 14.8855 15.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7531 14.8641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0739 0 0 0 0 0 0 0 0 0 0 14.7928 0 A6NGH8 ANR61_HUMAN Ankyrin repeat domain-containing protein 61 ANKRD61 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 LLGAGVSCIR 0.98543 -2.3962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5613 0 0 11.9173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2597 0 0 0 0 0 0 0 0 14.0069 0 0 0 0 0 13.268 0 0 0 14.5114 0 0 0 0 O43173 SIA8C_HUMAN "Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase, EC 2.4.99.- (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C, SIAT8-C) (Sialyltransferase St8Sia III, ST8SiaIII)" ST8SIA3 SIAT8C Homo sapiens (Human) ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]" GO:0000139; GO:0001574; GO:0003828; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009100; GO:0009311; GO:0016021; GO:0033691; GO:0042802; GO:1990743 "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; identical protein binding [GO:0042802]; sialic acid binding [GO:0033691]; sialyltransferase activity [GO:0008373]" ENIFTTPKYASPGAPRMYMFHAGFR 0.98543 -2.9798 0 0 0 0 0 0 0 0 0 0 0 0 10.57 0 0 0 0 0 0 0 0 0 0 11.0431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9221 0 0 0 0 10.9733 0 12.2413 0 0 0 0 0 0 11.6688 0 0 0 0 0 0 0 13.5965 0 0 0 0 0 0 0 0 0 0 13.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6857 0 0 0 0 0 0 0 0 0 0 0 0 11.4596 0 0 0 0 0 0 0 0 13.6342 0 0 0 11.4365 0 0 0 O75530 EED_HUMAN "Polycomb protein EED, hEED (Embryonic ectoderm development protein) (WD protein associating with integrin cytoplasmic tails 1, WAIT-1)" EED Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; spinal cord development [GO:0021510]" chromosome [GO:0005694]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; transcription corepressor binding [GO:0001222]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; spinal cord development [GO:0021510]" GO:0000122; GO:0001222; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0008047; GO:0021510; GO:0035098; GO:0042054; GO:0042802; GO:0045892 chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; transcription corepressor binding [GO:0001222] DIHRNYVDCVR 0.98543 -3.6368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DPA3 SNH28_HUMAN "Putative uncharacterized protein SNHG28 (Small nucleolar RNA host gene 2) (VSIG8 overlapping transcript protein, VSIG8-OT1)" SNHG28 C1orf204 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] ALPSPDCPGLRTTGEQMQKLLLK 0.98543 -2.7872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0438 0 0 0 0 0 0 0 12.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3599 P24752 THIL_HUMAN "Acetyl-CoA acetyltransferase, mitochondrial, EC 2.3.1.9 (Acetoacetyl-CoA thiolase) (T2)" ACAT1 ACAT MAT Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA catabolic process [GO:0046356]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; coenzyme A biosynthetic process [GO:0015937]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; isoleucine catabolic process [GO:0006550]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; liver development [GO:0001889]; metanephric proximal convoluted tubule development [GO:0072229]; propionyl-CoA biosynthetic process [GO:1902860]; response to hormone [GO:0009725]; response to organic cyclic compound [GO:0014070]; response to starvation [GO:0042594] GO:0001889; GO:0003985; GO:0005739; GO:0005759; GO:0006085; GO:0006550; GO:0006635; GO:0007420; GO:0009725; GO:0014070; GO:0015936; GO:0015937; GO:0016453; GO:0019899; GO:0030955; GO:0042594; GO:0042802; GO:0046356; GO:0046952; GO:0060612; GO:0070062; GO:0072229; GO:0120225; GO:1902224; GO:1902860 acetyl-CoA C-acetyltransferase activity [GO:0003985]; C-acetyltransferase activity [GO:0016453]; coenzyme A binding [GO:0120225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955] PTLKEVVIVSATRTPIGSFLGSLSLLPATK 0.98543 -3.3772 0 0 0 0 0 0 0 0 0 0 11.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8802 0 0 0 0 0 0 0 0 0 0 14.0122 14.0923 14.0699 13.8797 14.1084 0 0 0 0 13.8227 0 0 0 13.3222 0 0 0 0 0 0 0 0 0 0 12.6747 0 12.6742 0 0 10.1529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3756 0 0 0 0 11.7656 0 0 0 0 0 0 0 0 0 0 0 0 10.2779 0 12.6046 11.9287 12.5025 0 0 0 0 0 0 0 0 0 P48739 PIPNB_HUMAN "Phosphatidylinositol transfer protein beta isoform, PI-TP-beta, PtdIns transfer protein beta, PtdInsTP beta" PITPNB Homo sapiens (Human) "lipid metabolic process [GO:0006629]; nucleus organization [GO:0006997]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338]; lipid metabolic process [GO:0006629]; nucleus organization [GO:0006997]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005737; GO:0005789; GO:0005794; GO:0006629; GO:0006890; GO:0006997; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0120019; GO:0140338 phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338] KELANSPDCPQMCAYK 0.98543 -2.7903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0369 0 0 12.0681 0 0 0 0 0 0 0 0 13.8515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13887 KLF5_HUMAN "Krueppel-like factor 5 (Basic transcription element-binding protein 2, BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2)" KLF5 BTEB2 CKLF IKLF Homo sapiens (Human) angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816] chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; cell-cell signaling via exosome [GO:0099156]; cellular response to leukemia inhibitory factor [GO:1990830]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0046872; GO:0060576; GO:0061586; GO:0099156; GO:1902895; GO:1990830; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CTWEGCDWR 0.98543 -2.8816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0203 11.5569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4937 0 0 0 0 0 0 0 0 12.0869 0 0 0 0 0 0 0 0 0 0 0 12.6845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXD5 SE6L2_HUMAN Seizure 6-like protein 2 SEZ6L2 PSK UNQ1903/PRO4349 Homo sapiens (Human) regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0043025; GO:0060074; GO:0090036 FEAFEEDR 0.98543 -2.9761 0 0 0 0 0 0 0 0 0 0 13.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5655 12.9591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0083 12.743 0 0 14.5308 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4376 0 0 0 0 0 0 0 0 0 0 0 0 12.6137 12.7461 0 0 0 0 0 0 0 11.7086 0 11.2769 0 0 0 0 0 10.3716 0 0 0 0 11.9671 16.3656 0 0 0 0 0 0 0 0 11.0729 0 0 0 0 0 11.144 0 0 0 0 0 0 0 0 11.9919 0 0 0 0 0 0 11.5854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6XZB0 LIPI_HUMAN "Lipase member I, LIPI, EC 3.1.1.- (Cancer/testis antigen 17, CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta, mPA-PLA1 beta)" LIPI LPDL PRED5 Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620]; fatty acid biosynthetic process [GO:0006633]; lipid catabolic process [GO:0016042]; phosphatidic acid biosynthetic process [GO:0006654]; triglyceride catabolic process [GO:0019433] GO:0004465; GO:0004620; GO:0005615; GO:0005886; GO:0006633; GO:0006654; GO:0008201; GO:0016042; GO:0016298; GO:0019433 heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; phospholipase activity [GO:0004620] AVHLFMASLETNCNFISFPCRSYK 0.98543 -2.8807 0 0 0 11.2313 0 0 0 0 0 0 0 15.4502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2796 0 0 0 0 0 15.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8944 12.8398 0 15.6767 0 0 0 0 0 0 14.303 0 0 0 0 0 14.2095 0 15.7141 11.9531 0 0 0 0 14.8252 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2495 0 14.1501 14.4407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6613 0 0 0 0 0 0 0 0 0 13.0407 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE86 MCU_HUMAN "Calcium uniporter protein, mitochondrial, HsMCU (Coiled-coil domain-containing protein 109A)" MCU C10orf42 CCDC109A Homo sapiens (Human) actin filament reorganization [GO:0090527]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein complex oligomerization [GO:0051259] calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament reorganization [GO:0090527]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein complex oligomerization [GO:0051259] GO:0005262; GO:0005739; GO:0005743; GO:0006851; GO:0015292; GO:0019722; GO:0031305; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0051259; GO:0051560; GO:0051561; GO:0090023; GO:0090141; GO:0090527; GO:1990246 calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292] CQFTLKPISDSVGVFLR 0.98543 -2.1444 0 0 0 0 11.1212 0 13.0471 13.9728 15.7655 15.5663 15.4098 15.5346 16.5555 15.2431 0 13.7571 0 0 12.5314 12.7124 0 0 0 0 14.9157 0 0 0 12.7738 14.9092 15.2237 0 15.5554 0 0 0 14.8884 0 0 0 0 15.2137 15.561 15.0851 0 14.9747 15.3167 13.9765 0 0 15.8741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5587 15.5396 14.0988 14.5846 11.7105 17.6435 17.1939 17.7556 0 0 0 0 16.6826 16.9729 15.5939 0 0 0 0 0 0 16.4078 0 0 0 0 15.8943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6438 0 0 0 0 10.0437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2567 0 0 12.2471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGG6 OR8BC_HUMAN Olfactory receptor 8B12 (Olfactory receptor OR11-317) OR8B12 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] PLSILPLEQGK 0.98543 -3.6377 0 0 0 0 13.5424 0 0 0 11.2098 0 11.4838 11.4051 0 0 0 0 13.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4585 0 0 0 0 0 0 0 12.8767 0 12.7997 0 12.3304 0 0 0 0 0 0 14.0801 0 0 13.423 12.7574 0 0 0 0 0 0 0 0 0 0 12.7718 12.8605 0 0 0 0 0 11.8601 14.0447 0 0 0 0 0 0 15.2002 0 0 0 13.867 0 14.4904 0 0 13.3354 12.7988 0 0 13.4156 12.7619 0 0 0 0 0 0 0 0 13.585 13.4019 0 0 0 0 12.4772 0 0 0 0 0 12.663 14.2869 0 14.6608 0 13.9486 11.3261 0 0 0 0 0 0 11.9072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NI29 FBX27_HUMAN F-box only protein 27 (F-box/G-domain protein 5) FBXO27 FBG5 FBX27 Homo sapiens (Human) glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; glycoprotein catabolic process [GO:0006516]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005737; GO:0005829; GO:0006516; GO:0016567; GO:0019005; GO:0030433; GO:0031146 HDSGCMYR 0.98543 -3.3791 0 0 0 0 0 0 0 0 0 16.7133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99727 TIMP4_HUMAN "Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4, TIMP-4)" TIMP4 Homo sapiens (Human) central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; Notch signaling pathway [GO:0007219]; ovulation cycle [GO:0042698]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcomere [GO:0030017] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcomere [GO:0030017]; metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020]; central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; Notch signaling pathway [GO:0007219]; ovulation cycle [GO:0042698]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; response to organic substance [GO:0010033]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410] GO:0002020; GO:0005615; GO:0007219; GO:0007417; GO:0008191; GO:0009410; GO:0009725; GO:0010033; GO:0010951; GO:0030017; GO:0031012; GO:0032496; GO:0034097; GO:0042698; GO:0043434; GO:0046872; GO:0051045 metal ion binding [GO:0046872]; metalloendopeptidase inhibitor activity [GO:0008191]; protease binding [GO:0002020] MLRYEIK 0.98543 -2.6122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5426 0 0 0 0 0 0 0 0 0 0 0 0 11.9353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYL1 SAM10_HUMAN "Sterile alpha motif domain-containing protein 10, SAM domain-containing protein 10" SAMD10 C20orf136 Homo sapiens (Human) transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasmic side of plasma membrane [GO:0009898] cytoplasmic side of plasma membrane [GO:0009898]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0007169; GO:0009898 ALLRLNAEK 0.98543 -2.8865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1722 14.892 0 0 0 0 0 0 15.0195 0 0 0 0 0 0 0 0 14.4962 0 0 0 0 0 0 15.1101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9405 17.6206 17.4626 17.156 0 17.2205 16.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6942 0 0 0 15.9328 0 0 0 0 0 0 0 0 0 14.1323 0 0 0 0 13.895 13.3701 15.7731 0 0 0 16.0361 0 16.0556 16.1726 15.3051 14.115 0 0 0 0 0 14.5918 0 0 0 14.5653 0 0 0 0 15.92 15.1461 0 0 0 0 0 14.6676 0 0 0 0 0 0 0 0 0 0 0 0 14.3262 13.0034 0 0 0 0 0 0 0 0 Q9NWQ4 GPT2L_HUMAN G patch domain-containing protein 2-like GPATCH2L C14orf118 KIAA1152 Homo sapiens (Human) CSPAHCSAR 0.98543 -3.3792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4945 0 0 11.6699 12.0126 0 0 0 0 0 0 13.4089 0 0 0 0 0 0 13.1225 0 0 0 0 0 17.5045 13.8717 13.8145 13.4919 0 0 0 0 0 0 0 15.5534 0 0 0 0 0 0 0 0 11.036 12.5448 0 0 13.8725 0 0 0 0 0 12.5776 0 0 0 0 0 0 0 0 0 0 0 12.7141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7674 0 0 0 0 0 0 0 0 0 0 12.7225 10.5116 0 0 0 12.4514 13.0032 0 0 0 0 0 0 Q9UHN1 DPOG2_HUMAN "DNA polymerase subunit gamma-2, mitochondrial (DNA polymerase gamma accessory 55 kDa subunit, p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta)" POLG2 MTPOLB Homo sapiens (Human) DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; in utero embryonic development [GO:0001701]; mitochondrial DNA replication [GO:0006264]; mitochondrion morphogenesis [GO:0070584]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; respiratory electron transport chain [GO:0022904] cytoplasm [GO:0005737]; gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; gamma DNA polymerase complex [GO:0005760]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; DNA-directed DNA polymerase activity [GO:0003887]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; in utero embryonic development [GO:0001701]; mitochondrial DNA replication [GO:0006264]; mitochondrion morphogenesis [GO:0070584]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; respiratory electron transport chain [GO:0022904] GO:0001701; GO:0003690; GO:0003887; GO:0005737; GO:0005739; GO:0005759; GO:0005760; GO:0006261; GO:0006264; GO:0006281; GO:0022904; GO:0030337; GO:0042645; GO:0042802; GO:0070182; GO:0070584; GO:1900264 DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; DNA-directed DNA polymerase activity [GO:0003887]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802] DTTMKEMMHISKLK 0.98543 -2.7926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0965 14.0429 13.5587 0 0 0 0 0 0 0 0 0 0 0 14.3322 13.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8377 0 0 0 0 0 14.1537 0 0 0 0 12.9885 0 0 0 0 0 12.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1635 Q7Z6K1 THAP5_HUMAN THAP domain-containing protein 5 THAP5 Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; cell cycle [GO:0007049]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0000785; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0007049; GO:0045786; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protease binding [GO:0002020] EQQTLGRLK 0.98544 -3.8259 0 0 0 0 0 10.5897 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9069 0 0 12.2252 0 0 0 0 0 12.2605 0 12.1065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2008 0 0 0 0 0 13.0318 0 12.3042 0 0 0 0 0 0 0 0 0 0 0 12.7354 12.8852 11.2949 0 0 0 0 0 12.0851 14.2016 14.5912 0 13.6758 14.5088 0 0 0 14.2063 0 0 0 0 0 0 0 12.192 0 0 13.5047 0 0 0 0 0 0 0 0 0 11.9079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3147 0 0 Q8N729 NPW_HUMAN "Neuropeptide W (Preproprotein L8, hPPL8) [Cleaved into: Neuropeptide W-23, NPW23, hL8; Neuropeptide W-30, NPW30, hL8C ]" NPW PPL8 PPNPW Homo sapiens (Human) feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] GO:0001664; GO:0005576; GO:0007186; GO:0007218; GO:0007631 G protein-coupled receptor binding [GO:0001664] AAAGPLAR 0.98544 -2.7974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1705 0 0 0 0 0 0 11.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8024 0 0 0 0 0 0 0 0 0 0 0 11.9281 13.2858 10.6139 0 0 0 0 0 0 0 0 0 11.607 0 0 0 0 0 0 0 0 0 0 10.5931 0 0 0 0 0 0 13.2649 0 0 0 0 0 12.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0393 0 0 0 13.7552 0 0 0 0 0 0 0 0 0 0 11.6438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H987 SYP2L_HUMAN Synaptopodin 2-like protein SYNPO2L Homo sapiens (Human) heart morphogenesis [GO:0003007]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; heart morphogenesis [GO:0003007]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; sarcomere organization [GO:0045214] GO:0003007; GO:0003779; GO:0005634; GO:0005654; GO:0005829; GO:0015629; GO:0016607; GO:0030018; GO:0030054; GO:0032233; GO:0035025; GO:0045214; GO:0051496 actin binding [GO:0003779] AGSRASEGQGSGLGGQLSEVSGR 0.98544 -2.9848 0 0 0 9.96039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.796 0 0 0 13.2718 0 11.6656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5224 0 13.9538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8718 0 0 0 0 0 0 0 0 15.1647 10.7032 0 0 0 0 0 0 14.4355 0 0 0 14.572 0 0 13.6817 15.5519 0 16.1103 14.4122 0 0 12.1973 15.516 15.1249 13.6962 0 0 0 0 15.4845 12.9363 14.1925 14.151 14.203 13.9169 14.0375 14.6713 0 14.2492 0 0 0 13.6817 13.462 0 13.4631 0 0 0 0 13.3139 0 0 13.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8296 0 0 0 0 11.0176 0 0 0 0 0 0 13.6957 0 14.753 0 0 0 0 0 0 Q9NZW5 PALS2_HUMAN "Protein PALS2 (MAGUK p55 subfamily member 6) (Membrane protein, palmitoylated 6) (Veli-associated MAGUK 1, VAM-1)" PALS2 MPP6 VAM1 Homo sapiens (Human) protein-containing complex assembly [GO:0065003] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex assembly [GO:0065003] GO:0005886; GO:0005911; GO:0016020; GO:0065003; GO:0070062 DWDNSGPFCGTISSK 0.98544 -2.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0624 0 0 0 0 0 0 0 13.8378 0 0 15.0721 0 0 0 0 13.6437 0 13.6261 0 0 0 0 0 0 14.4763 14.8609 0 0 0 0 0 0 0 14.0692 0 15.0986 0 0 0 0 0 0 0 14.141 14.4217 0 0 0 12.9285 0 0 14.62 0 0 0 0 0 13.9844 0 0 0 0 0 0 0 0 0 0 0 14.0282 0 0 0 0 0 0 13.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5151 0 0 0 0 0 0 0 0 Q00G26 PLIN5_HUMAN Perilipin-5 (Lipid storage droplet protein 5) PLIN5 LSDP5 OXPAT PAT-1 Homo sapiens (Human) lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; mitochondrion localization [GO:0051646]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of lipase activity [GO:0060192]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of lipase activity [GO:0060193]; positive regulation of lipid storage [GO:0010884]; positive regulation of sequestering of triglyceride [GO:0010890]; positive regulation of triglyceride biosynthetic process [GO:0010867] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; lipase binding [GO:0035473]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; mitochondrion localization [GO:0051646]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of lipase activity [GO:0060192]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of lipase activity [GO:0060193]; positive regulation of lipid storage [GO:0010884]; positive regulation of sequestering of triglyceride [GO:0010890]; positive regulation of triglyceride biosynthetic process [GO:0010867] GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0010867; GO:0010884; GO:0010890; GO:0010897; GO:0019915; GO:0031999; GO:0032000; GO:0034389; GO:0035359; GO:0035473; GO:0042802; GO:0043231; GO:0051646; GO:0060192; GO:0060193; GO:2000378 identical protein binding [GO:0042802]; lipase binding [GO:0035473] AWEAEHR 0.98545 -3.2945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75389 0 0 0 0 0 0 10.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0918 0 0 0 0 0 11.1478 0 0 0 0 0 0 0 0 0 0 0 9.99251 0 0 0 Q9BUI4 RPC3_HUMAN "DNA-directed RNA polymerase III subunit RPC3, RNA polymerase III subunit C3 (DNA-directed RNA polymerase III subunit C) (RNA polymerase III 62 kDa subunit, RPC62)" POLR3C Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription, DNA-templated [GO:0006351]" GO:0003697; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0006359; GO:0032728; GO:0045087; GO:0045089; GO:0051607 DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697] CARIFRLVLQK 0.98545 -2.6313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3621 0 0 0 0 0 13.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3992 0 0 14.9726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUK6 MSTO1_HUMAN Protein misato homolog 1 MSTO1 LST005 SLTP005 Homo sapiens (Human) mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005] GO:0005737; GO:0005741; GO:0005829; GO:0007005; GO:0048311 LILMDLK 0.98545 -2.4121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9688 13.2778 0 13.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6717 0 0 0 0 0 0 0 Q68DD2 PA24F_HUMAN "Cytosolic phospholipase A2 zeta, cPLA2-zeta, EC 3.1.1.4 (Phospholipase A2 group IVF)" PLA2G4F Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; cellular response to organic cyclic compound [GO:0071407]; glycerophospholipid catabolic process [GO:0046475]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; prostaglandin biosynthetic process [GO:0001516] cytosol [GO:0005829]; mitochondrion [GO:0005739]; ruffle membrane [GO:0032587]; vesicle [GO:0031982] cytosol [GO:0005829]; mitochondrion [GO:0005739]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; cellular response to antibiotic [GO:0071236]; cellular response to organic cyclic compound [GO:0071407]; glycerophospholipid catabolic process [GO:0046475]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; prostaglandin biosynthetic process [GO:0001516] GO:0001516; GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005739; GO:0005829; GO:0008970; GO:0031982; GO:0032587; GO:0036148; GO:0046475; GO:0047498; GO:0050482; GO:0071236; GO:0071407 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] AVDLILSFDYSLEAPFEVLK 0.98546 -2.4161 0 0 0 12.6147 0 0 0 0 14.009 16.9499 0 12.9147 0 0 0 12.7722 11.245 0 0 0 13.1951 0 0 0 12.1878 0 12.1484 0 0 0 0 0 16.8671 15.4193 16.4363 14.7555 14.0818 16.2095 14.682 17.4114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6488 16.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2598 14.4992 12.676 0 0 0 0 0 12.2239 12.1127 0 0 0 12.0632 0 0 0 14.1446 13.093 12.4118 0 0 0 0 0 0 0 0 0 0 0 12.0422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9042 0 12.5449 12.4115 12.7738 0 0 13.3411 13.6788 0 0 0 0 0 11.6293 12.4567 12.2755 0 11.5679 0 12.1538 0 0 0 0 0 0 0 0 0 0 0 19.0699 18.9167 17.3941 17.0581 0 18.0308 18.2151 18.2854 18.3222 0 0 0 0 0 12.1782 0 0 0 13.0203 0 12.437 0 0 P17035 ZNF28_HUMAN Zinc finger protein 28 (Zinc finger protein KOX24) ZNF28 KOX24 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFAYNSYLAKHSIIHTGEKPYK 0.98546 -2.9027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5087 0 0 0 13.1916 0 0 0 12.1482 0 0 0 12.0014 0 0 0 0 0 0 0 0 0 0 0 0 12.1482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0014 0 0 0 P29016 CD1B_HUMAN T-cell surface glycoprotein CD1b (CD antigen CD1b) CD1B Homo sapiens (Human) "adaptive immune response [GO:0002250]; antigen processing and presentation, endogenous lipid antigen via MHC class Ib [GO:0048006]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; positive regulation of T cell mediated cytotoxicity [GO:0001916]" cell surface [GO:0009986]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; endogenous lipid antigen binding [GO:0030883]; exogenous lipid antigen binding [GO:0030884]; lipopeptide binding [GO:0071723]; adaptive immune response [GO:0002250]; antigen processing and presentation, endogenous lipid antigen via MHC class Ib [GO:0048006]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; positive regulation of T cell mediated cytotoxicity [GO:0001916]" GO:0001916; GO:0002250; GO:0005615; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0009897; GO:0009986; GO:0010008; GO:0016021; GO:0030883; GO:0030884; GO:0043231; GO:0048006; GO:0048007; GO:0071723 endogenous lipid antigen binding [GO:0030883]; exogenous lipid antigen binding [GO:0030884]; lipopeptide binding [GO:0071723] NPTSIGSIVLAIIVPSLLLLLCLALWYMRRR 0.98546 -2.4199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6576 12.4361 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9903 0 0 0 0 0 0 13.3659 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35900 K1C20_HUMAN "Keratin, type I cytoskeletal 20 (Cytokeratin-20, CK-20) (Keratin-20, K20) (Protein IT)" KRT20 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of protein secretion [GO:0050708] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural constituent of cytoskeleton [GO:0005200]; apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of protein secretion [GO:0050708] GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005882; GO:0006915; GO:0009267; GO:0030855; GO:0045109; GO:0050708 structural constituent of cytoskeleton [GO:0005200] DYSAYYRQIEELR 0.98546 -3.7609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0094 10.1731 0 0 0 0 0 9.66658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9541 0 0 0 0 0 0 0 0 11.763 11.8339 0 0 0 0 15.0263 0 14.8591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0855 0 0 0 0 0 0 0 10.6031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2983 0 0 0 0 14.0987 0 0 0 0 0 13.7458 0 11.5839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8965 Q15345 LRC41_HUMAN Leucine-rich repeat-containing protein 41 (Protein Muf1) LRRC41 MUF1 PP7759 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016567; GO:0042802 identical protein binding [GO:0042802] AIVRALPLLR 0.98546 -2.8239 0 0 0 0 0 0 0 0 12.9234 0 0 0 0 0 12.768 0 0 0 0 0 0 0 0 0 0 9.2845 12.2366 0 0 0 0 0 0 9.71999 0 0 0 0 0 12.2331 0 0 0 0 0 0 0 10.2193 0 0 0 0 12.5742 0 12.2096 0 0 0 12.3759 0 13.5153 0 13.6208 11.9845 0 13.143 0 0 0 0 9.78785 0 12.1573 0 12.817 13.496 0 12.4608 0 0 0 0 0 0 0 13.1687 0 0 13.9138 0 0 0 0 0 13.6766 0 14.203 0 0 14.4517 0 0 0 0 0 13.6728 0 0 0 0 15.737 15.6874 15.0384 0 0 11.0607 0 0 16.1295 16.896 0 13.9754 0 0 0 14.3627 0 0 0 0 0 15.8781 11.526 0 0 12.1452 0 0 17.4604 0 0 0 0 0 14.4714 0 0 0 12.7443 0 16.9605 0 16.2807 0 0 11.8663 0 13.7762 0 0 13.0963 0 0 13.7599 0 0 0 14.7743 0 0 0 0 0 0 0 13.7984 10.9954 13.6954 0 0 Q68G74 LHX8_HUMAN "LIM/homeobox protein Lhx8, LIM homeobox protein 8" LHX8 Homo sapiens (Human) female gonad development [GO:0008585]; forebrain neuron development [GO:0021884]; learning or memory [GO:0007611]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; female germ cell nucleus [GO:0001674]; nucleus [GO:0005634] "chromatin [GO:0000785]; female germ cell nucleus [GO:0001674]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; female gonad development [GO:0008585]; forebrain neuron development [GO:0021884]; learning or memory [GO:0007611]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001674; GO:0005634; GO:0006357; GO:0007611; GO:0008585; GO:0021884; GO:0030182; GO:0042475; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GNVYHLACFACFSCK 0.98546 -3.8404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0558 0 0 0 0 0 0 13.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YL7 PDPN_HUMAN "Podoplanin (Aggrus) (Glycoprotein 36, Gp36) (PA2.26 antigen) (T1-alpha, T1A) [Cleaved into: 29kDa cytosolic podoplanin intracellular domain, PICD ]" PDPN GP36 PSEC0003 PSEC0025 Homo sapiens (Human) "actin-mediated cell contraction [GO:0070252]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; lung development [GO:0030324]; lymph node development [GO:0048535]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of platelet aggregation [GO:1901731]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of myofibroblast contraction [GO:1904328]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; response to hyperoxia [GO:0055093]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319]" anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge of lamellipodium [GO:0061851]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; tetraspanin-enriched microdomain [GO:0097197] "anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge of lamellipodium [GO:0061851]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; tetraspanin-enriched microdomain [GO:0097197]; chaperone binding [GO:0051087]; chemokine binding [GO:0019956]; signaling receptor binding [GO:0005102]; actin-mediated cell contraction [GO:0070252]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; lung development [GO:0030324]; lymph node development [GO:0048535]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of platelet aggregation [GO:1901731]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of myofibroblast contraction [GO:1904328]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; response to hyperoxia [GO:0055093]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319]" GO:0000902; GO:0001726; GO:0001946; GO:0005102; GO:0005739; GO:0005829; GO:0005886; GO:0005887; GO:0007266; GO:0008285; GO:0008360; GO:0010718; GO:0016020; GO:0016323; GO:0016324; GO:0016477; GO:0019956; GO:0030027; GO:0030054; GO:0030168; GO:0030175; GO:0030324; GO:0030335; GO:0031258; GO:0031410; GO:0031527; GO:0031528; GO:0032587; GO:0042995; GO:0043066; GO:0044319; GO:0045121; GO:0048535; GO:0051087; GO:0055093; GO:0060838; GO:0061851; GO:0070161; GO:0070252; GO:0090091; GO:0097197; GO:0098609; GO:1900024; GO:1901731; GO:1904328; GO:2000392 chaperone binding [GO:0051087]; chemokine binding [GO:0019956]; signaling receptor binding [GO:0005102] DGLSTVTLVGIIVGVLLAIGFIGAIIVVVMR 0.98546 -2.4206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.983 0 0 0 0 0 0 0 0 0 0 11.8933 0 11.4685 0 0 11.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4656 0 0 0 0 13.8677 13.6766 11.6295 0 0 0 0 0 0 0 0 0 12.2622 0 0 0 0 0 0 0 11.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3932 0 0 0 0 0 0 0 0 0 0 13.0015 0 13.3688 0 0 0 0 0 0 13.2153 0 0 0 0 0 0 0 0 11.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N292 GAPT_HUMAN "Protein GAPT (Growth factor receptor-bound protein 2-binding adapter protein, transmembrane)" GAPT C5orf29 Homo sapiens (Human) B cell homeostasis [GO:0001782]; B cell proliferation involved in immune response [GO:0002322] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; B cell homeostasis [GO:0001782]; B cell proliferation involved in immune response [GO:0002322] GO:0001782; GO:0002322; GO:0005794; GO:0005886; GO:0016021; GO:0043231 FTLPRFLQR 0.98546 -2.6429 0 13.3662 0 0 0 12.1845 0 0 0 0 0 0 0 0 0 13.3285 0 0 0 0 0 0 0 0 0 0 0 12.9645 0 0 0 0 0 0 0 0 0 0 0 13.3569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3J3 HROB_HUMAN Homologous recombination OB-fold protein HROB C17orf53 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725] nucleus [GO:0005634]; site of DNA damage [GO:0090734] nucleus [GO:0005634]; site of DNA damage [GO:0090734]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725] GO:0000725; GO:0000731; GO:0003697; GO:0005634; GO:0006974; GO:0007292; GO:0036297; GO:0048232; GO:0090734 single-stranded DNA binding [GO:0003697] DPSCFLCTYSIVMVLRK 0.98546 -2.4227 0 0 0 0 0 11.0948 0 0 0 0 12.8988 14.4982 13.1466 14.1605 13.0707 0 0 13.6138 0 0 0 0 0 0 0 0 13.6261 13.7554 13.0555 0 12.6304 0 0 12.0798 0 0 12.3594 0 0 12.2421 0 0 0 13.0756 0 0 0 0 0 12.7729 10.6433 12.2938 0 0 0 12.2791 0 0 0 0 0 0 0 0 0 0 16.0036 17.8729 14.8605 15.4807 15.0585 14.5675 16.778 16.2139 16.5471 14.4851 15.8242 15.5029 16.4758 13.2675 16.6317 0 13.8947 13.456 0 0 13.5491 13.7627 14.5707 15.5613 15.177 15.1863 16.146 13.8985 14.695 0 0 0 16.43 0 0 0 0 0 0 0 13.7546 14.9589 14.7289 14.7543 13.6177 14.7457 14.4965 15.0875 13.5928 14.8321 0 13.7807 16.2541 14.8238 13.5787 14.8285 13.8768 0 0 0 13.7662 0 0 0 16.5369 17.8219 0 0 13.6482 14.2387 0 13.9343 0 0 13.7826 13.5106 14.8225 16.5471 0 0 15.7292 14.854 14.0669 0 15.5834 15.8644 15.816 13.8044 0 17.3675 14.76 14.6984 13.5726 0 14.9612 0 14.8342 0 14.4997 15.3639 14.1899 15.7693 0 0 0 0 0 0 13.2617 0 15.2804 13.7139 15.4688 0 Q8NC54 KCT2_HUMAN Keratinocyte-associated transmembrane protein 2 KCT2 C5orf15 HTGN29 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GPAQAKLLPGSAIQALVGLARPLVLALLLVSAALSSVVSR 0.98546 -2.4186 0 13.9869 0 0 14.2699 0 0 11.3114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4932 0 0 0 0 0 0 0 0 12.3113 0 0 0 0 0 0 0 0 0 0 11.8033 0 0 0 0 0 0 0 0 11.6161 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5715 11.6844 0 12.053 0 0 0 0 13.2785 0 0 0 0 0 0 0 0 0 11.9387 14.1555 0 0 0 0 11.4065 0 0 0 0 0 14.8575 0 0 11.4734 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9234 0 0 0 0 0 0 0 0 0 11.3234 0 0 0 11.3179 11.3184 0 0 0 0 0 0 13.0272 0 Q9UDY6 TRI10_HUMAN Tripartite motif-containing protein 10 (B30-RING finger protein) (RING finger protein 9) TRIM10 RFB30 RNF9 Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0030218; GO:0045087; GO:0046597; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CETRKCR 0.98546 -2.9048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15258 RER1_HUMAN Protein RER1 RER1 Homo sapiens (Human) "positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]" cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; plasma membrane [GO:0005886]; acetylcholine receptor binding [GO:0033130]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]" GO:0005783; GO:0005793; GO:0005794; GO:0005886; GO:0006621; GO:0006890; GO:0009986; GO:0030173; GO:0033130; GO:0071340; GO:1903078 acetylcholine receptor binding [GO:0033130] PFIRRLPEFK 0.98547 -2.4245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75071 EFC14_HUMAN EF-hand calcium-binding domain-containing protein 14 EFCAB14 KIAA0494 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] EKLQLISALTNK 0.98547 -3.7626 0 0 0 0 0 0 0 0 0 11.7429 0 0 0 0 0 0 0 0 0 13.061 16.6499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0194 0 0 0 0 0 0 0 0 10.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0299 0 0 0 0 17.5281 0 14.2746 0 0 0 0 0 0 0 0 0 0 0 0 12.2015 0 0 0 0 0 0 0 0 13.2419 0 0 0 0 0 0 17.3672 0 0 0 0 0 0 0 0 0 0 0 0 12.7324 13.3001 0 0 0 0 0 0 0 0 0 0 0 0 12.4965 0 0 0 0 0 0 0 0 0 P55198 AF17_HUMAN Protein AF-17 (ALL1-fused gene from chromosome 17 protein) MLLT6 AF17 Homo sapiens (Human) "histone H3-K79 methylation [GO:0034729]; negative regulation of histone H3-K79 methylation [GO:2001161]; negative regulation of urine volume [GO:0035811]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal potassium excretion [GO:0036359]; renal sodium excretion [GO:0035812]; renal water absorption [GO:0070295]" nucleus [GO:0005634] "nucleus [GO:0005634]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone H3-K79 methylation [GO:0034729]; negative regulation of histone H3-K79 methylation [GO:2001161]; negative regulation of urine volume [GO:0035811]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; renal potassium excretion [GO:0036359]; renal sodium excretion [GO:0035812]; renal water absorption [GO:0070295]" GO:0005634; GO:0006355; GO:0006357; GO:0010765; GO:0031491; GO:0034729; GO:0035811; GO:0035812; GO:0036359; GO:0042393; GO:0045944; GO:0046872; GO:0070295; GO:2001161 histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491] CELCPHK 0.98547 -2.8243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2031 0 0 0 0 0 0 0 12.0254 0 0 0 0 0 0 0 0 0 0 0 13.8675 0 0 0 0 0 0 0 0 0 0 0 0 11.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14442 PIGH_HUMAN "Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (Phosphatidylinositol-glycan biosynthesis class H protein, PIG-H)" PIGH Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; protein modification process [GO:0036211] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; catalytic activity [GO:0003824]; GPI anchor biosynthetic process [GO:0006506]; protein modification process [GO:0036211] GO:0000506; GO:0003824; GO:0005783; GO:0005789; GO:0006506; GO:0036211 catalytic activity [GO:0003824] EDERSFSDICGGR 0.98547 -3.8472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53T59 H1BP3_HUMAN "HCLS1-binding protein 3 (HS1-binding protein 3, HSP1BP-3)" HS1BP3 Homo sapiens (Human) regulation of apoptotic process [GO:0042981] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; phosphatidylinositol binding [GO:0035091]; regulation of apoptotic process [GO:0042981] GO:0005739; GO:0005783; GO:0035091; GO:0042981 phosphatidylinositol binding [GO:0035091] AVFNEILR 0.98547 -2.5601 0 0 0 0 0 0 0 0 0 0 0 0 12.2959 0 0 0 0 12.5281 11.4851 0 12.776 0 0 11.669 12.5954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1411 14.0303 0 0 0 0 0 10.0395 11.2908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.362 13.6939 15.818 15.4089 15.1692 15.6859 15.177 0 13.2343 16.3764 12.8964 0 0 0 0 0 0 13.161 13.9581 12.9419 14.0262 14.0031 13.0438 14.3963 12.8921 0 0 14.0303 16.3273 0 0 0 0 14.284 14.3761 14.6953 13.6583 15.0725 12.9449 0 12.9364 14.0611 12.8186 12.8562 14.0485 0 12.9516 14.1031 12.6037 12.9839 14.5983 0 14.4783 14.461 0 15.1722 12.8762 14.6225 14.5328 13.2814 15.6245 14.3068 0 13.2892 14.8205 13.9399 13.9204 14.8577 0 13.7994 12.9133 12.7283 13.9056 14.2564 0 0 0 0 0 13.8483 0 13.3608 12.6942 12.979 0 0 0 0 14.4895 0 0 0 0 0 0 0 0 0 0 13.0297 14.1584 13.1656 0 0 0 0 0 0 Q69YZ2 T200B_HUMAN Transmembrane protein 200B (Transmembrane protein TTMA) (Two transmembrane domain-containing family member B) TMEM200B TTMB Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GTSPVPSVR 0.98547 -3.682 15.2741 0 0 0 0 0 0 14.9349 0 0 0 0 0 0 12.7784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7398 0 13.1133 0 0 0 0 0 0 0 0 0 0 0 0 15.723 0 0 0 15.3549 15.3478 14.8751 13.5241 14.6956 15.8911 15.6713 16.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6548 0 0 0 14.4585 0 0 0 14.5057 0 0 0 0 0 0 0 0 13.4248 0 0 0 0 0 10.3061 12.8003 13.2982 0 0 0 0 0 0 13.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5873 0 Q8IXK0 PHC2_HUMAN "Polyhomeotic-like protein 2, hPH2 (Early development regulatory protein 2)" PHC2 EDR2 PH2 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] "heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007283; GO:0008270; GO:0031519; GO:0035102; GO:0042393; GO:0042802; GO:0045892 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] EVAPGEK 0.98547 -2.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4061 0 14.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7274 12.0958 0 0 12.6544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4Y2 EFC4A_HUMAN "EF-hand calcium-binding domain-containing protein 4A (Calcium release-activated calcium channel regulator 2B, CRAC channel regulator 2B) (Calcium release-activated channel regulator 2B)" CRACR2B EFCAB4A Homo sapiens (Human) regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] GO:0002115; GO:0005509; GO:0005737; GO:2001256 calcium ion binding [GO:0005509] AVRTLWARLQR 0.98547 -2.4253 0 0 0 0 0 0 0 0 0 0 12.2622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9098 0 0 0 0 0 0 0 0 13.4548 0 0 0 0 0 0 14.4431 15.152 14.7422 0 0 14.8438 0 0 0 13.3071 0 0 0 0 0 0 0 0 0 0 12.144 0 0 0 14.9312 0 0 15.3383 0 0 0 0 0 14.1605 14.1206 13.7751 0 0 0 0 0 0 0 0 0 17.1963 0 0 0 0 0 0 12.8426 14.9853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1988 0 0 0 0 0 0 0 0 0 11.7481 15.0968 0 0 0 0 0 0 0 0 9.8129 0 0 0 0 0 0 0 0 14.3396 0 13.1049 0 0 0 0 11.2597 0 Q9BYW1 GTR11_HUMAN "Solute carrier family 2, facilitated glucose transporter member 11 (Glucose transporter type 11, GLUT-11)" SLC2A11 GLUT11 Homo sapiens (Human) fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; monosaccharide transmembrane transport [GO:0015749] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; sugar transmembrane transporter activity [GO:0051119]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; monosaccharide transmembrane transport [GO:0015749] GO:0005353; GO:0005355; GO:0005654; GO:0005886; GO:0005887; GO:0008645; GO:0015149; GO:0015749; GO:0015755; GO:0016020; GO:0030054; GO:0051119; GO:1904659 fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; sugar transmembrane transporter activity [GO:0051119] ALRRLIQGR 0.98547 -2.4295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2274 0 12.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2113 0 0 0 0 0 0 0 0 Q9H4L7 SMRCD_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1, EC 3.6.4.12 (ATP-dependent helicase 1, hHEL1)" SMARCAD1 KIAA1122 Homo sapiens (Human) chromatin remodeling [GO:0006338]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018] heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; ubiquitin binding [GO:0043130]; chromatin remodeling [GO:0006338]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]" GO:0000018; GO:0000729; GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0008094; GO:0016887; GO:0035861; GO:0043130; GO:0043596; GO:0051304; GO:0070932; GO:0070933; GO:0140658 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; ubiquitin binding [GO:0043130]" CEDISNKLTK 0.98547 -3.5929 0 0 14.3257 0 12.4322 11.0749 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0667 12.4515 15.6367 0 0 0 0 0 10.0193 0 0 0 0 0 0 0 0 0 0 0 12.7624 11.2319 15.9798 0 14.5615 11.723 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2919 0 0 0 0 0 11.8605 0 11.9132 0 0 0 0 0 0 0 0 13.9177 0 10.9107 0 0 0 12.2919 11.3192 12.6317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6584 0 12.0619 0 0 0 0 0 0 0 0 0 15.0409 0 0 0 0 0 11.9408 0 11.1747 0 0 10.4301 0 0 0 0 12.1123 0 0 0 0 0 0 0 0 0 0 0 14.7267 0 0 0 Q9UER7 DAXX_HUMAN "Death domain-associated protein 6 (Daxx, hDaxx) (ETS1-associated protein 1, EAP1) (Fas death domain-associated protein)" DAXX BING2 DAP6 Homo sapiens (Human) "androgen receptor signaling pathway [GO:0030521]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; chromatin remodeling [GO:0006338]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; JNK cascade [GO:0007254]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of neuron death [GO:1901216]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]; nuclear androgen receptor binding [GO:0050681]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sumo-dependent protein binding [GO:0140037]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin protein ligase binding [GO:0031625]; androgen receptor signaling pathway [GO:0030521]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to heat [GO:0034605]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; chromatin remodeling [GO:0006338]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; JNK cascade [GO:0007254]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of neuron death [GO:1901216]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000775; GO:0001934; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006334; GO:0006338; GO:0006355; GO:0007254; GO:0008625; GO:0010468; GO:0010629; GO:0016604; GO:0016605; GO:0019899; GO:0019901; GO:0030295; GO:0030521; GO:0031072; GO:0031396; GO:0031625; GO:0034605; GO:0034620; GO:0042393; GO:0042803; GO:0042981; GO:0045860; GO:0045892; GO:0047485; GO:0050681; GO:0061629; GO:0071276; GO:0071280; GO:0072738; GO:0140037; GO:0140416; GO:1901216; GO:1903936 enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]; nuclear androgen receptor binding [GO:0050681]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sumo-dependent protein binding [GO:0140037]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin protein ligase binding [GO:0031625] AHSAKKK 0.98547 -2.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0953 0 0 0 0 0 0 12.7463 0 0 0 0 0 0 0 0 0 0 12.4018 0 0 0 0 12.7962 0 0 0 0 0 0 0 0 0 14.7715 0 0 0 0 0 0 0 0 13.0006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2154 0 0 0 0 0 0 0 0 13.953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2613 0 0 0 0 0 0 0 0 0 12.5072 0 0 0 0 Q9Y6Q5 AP1M2_HUMAN AP-1 complex subunit mu-2 (AP-mu chain family member mu1B) (Adaptor protein complex AP-1 subunit mu-2) (Adaptor-related protein complex 1 subunit mu-2) (Clathrin assembly protein complex 1 mu-2 medium chain 2) (Golgi adaptor HA1/AP1 adaptin mu-2 subunit) (Mu-adaptin 2) (Mu1B-adaptin) AP1M2 Homo sapiens (Human) basolateral protein secretion [GO:0110010]; protein targeting [GO:0006605]; vesicle targeting [GO:0006903]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin adaptor activity [GO:0035615]; basolateral protein secretion [GO:0110010]; protein targeting [GO:0006605]; vesicle targeting [GO:0006903]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005765; GO:0005829; GO:0006605; GO:0006903; GO:0016192; GO:0030121; GO:0030136; GO:0030659; GO:0031410; GO:0032588; GO:0035615; GO:0043231; GO:0110010 clathrin adaptor activity [GO:0035615] HSNLYLVATTSK 0.98547 -2.0901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2699 12.7243 0 0 13.5067 0 0 0 0 0 0 0 0 0 10.9002 12.7515 12.9727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.265 0 13.8595 0 0 13.4791 0 13.899 15.3218 0 15.0379 14.1539 0 0 0 0 15.3528 0 0 0 0 0 0 15.5203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9174 0 0 0 0 0 0 0 0 0 0 0 P18858 DNLI1_HUMAN "DNA ligase 1, EC 6.5.1.1 (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)" LIG1 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; mismatch repair [GO:0006298]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; lagging strand elongation [GO:0006273]; mismatch repair [GO:0006298]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]" GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006281; GO:0006284; GO:0006287; GO:0006298; GO:0006310; GO:0009653; GO:0043231; GO:0046872; GO:0051301; GO:0071897; GO:1903461 ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; metal ion binding [GO:0046872] IIPVLLEHGLERLPEHCKLSPGIPLK 0.98548 -3.5052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.465 11.6453 11.4847 0 11.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7431 0 0 0 0 14.2938 0 12.3653 0 0 0 13.4488 0 12.5194 13.9769 14.7641 12.6093 0 14.4025 14.7026 0 13.4126 0 0 13.2747 0 15.1453 15.4594 14.3246 0 13.7024 0 13.3117 14.3072 0 13.8985 13.8804 0 0 0 0 0 14.8864 0 15.4116 14.0332 0 0 0 12.9355 12.5981 0 0 12.6603 16.6516 14.987 13.3841 0 14.0083 0 14.0115 14.2059 13.9054 15.0676 0 14.5584 14.2518 0 12.7659 0 12.9706 0 16.9663 16.7172 0 14.201 11.0424 13.4946 13.4252 13.338 0 12.4395 0 0 0 0 13.3991 0 0 14.2177 0 0 12.7219 0 0 0 0 0 0 0 0 10.6297 0 0 0 0 0 0 15.4639 0 10.8827 13.6231 0 0 0 0 P37231 PPARG_HUMAN "Peroxisome proliferator-activated receptor gamma, PPAR-gamma (Nuclear receptor subfamily 1 group C member 3)" PPARG NR1C3 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; epithelial cell differentiation [GO:0030855]; fatty acid metabolic process [GO:0006631]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; long-chain fatty acid transport [GO:0015909]; macrophage derived foam cell differentiation [GO:0010742]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of connective tissue replacement involved in inflammatory response wound healing [GO:1904597]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; placenta development [GO:0001890]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of gene expression [GO:0010628]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of blood pressure [GO:0008217]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cholesterol transporter activity [GO:0060694]; regulation of circadian rhythm [GO:0042752]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipid [GO:0033993]; response to nutrient [GO:0007584]; retinoic acid receptor signaling pathway [GO:0048384]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; white fat cell differentiation [GO:0050872]" chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; alpha-actinin binding [GO:0051393]; arachidonic acid binding [GO:0050544]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LBD domain binding [GO:0050693]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; peptide binding [GO:0042277]; prostaglandin receptor activity [GO:0004955]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; epithelial cell differentiation [GO:0030855]; fatty acid metabolic process [GO:0006631]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; long-chain fatty acid transport [GO:0015909]; macrophage derived foam cell differentiation [GO:0010742]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of connective tissue replacement involved in inflammatory response wound healing [GO:1904597]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; placenta development [GO:0001890]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of gene expression [GO:0010628]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of blood pressure [GO:0008217]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cholesterol transporter activity [GO:0060694]; regulation of circadian rhythm [GO:0042752]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipid [GO:0033993]; response to nutrient [GO:0007584]; retinoic acid receptor signaling pathway [GO:0048384]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; white fat cell differentiation [GO:0050872]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001227; GO:0001890; GO:0003677; GO:0003682; GO:0003690; GO:0003700; GO:0004879; GO:0004955; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006629; GO:0006631; GO:0006919; GO:0007165; GO:0007584; GO:0008022; GO:0008217; GO:0008270; GO:0009755; GO:0010628; GO:0010629; GO:0010742; GO:0010745; GO:0010862; GO:0010875; GO:0010887; GO:0010888; GO:0010891; GO:0015909; GO:0016525; GO:0019216; GO:0019899; GO:0030154; GO:0030224; GO:0030509; GO:0030512; GO:0030514; GO:0030855; GO:0032869; GO:0033993; GO:0035357; GO:0042277; GO:0042593; GO:0042752; GO:0042789; GO:0042802; GO:0042953; GO:0043231; GO:0043235; GO:0043388; GO:0043407; GO:0043537; GO:0043565; GO:0043621; GO:0045087; GO:0045165; GO:0045600; GO:0045668; GO:0045892; GO:0045893; GO:0045923; GO:0045944; GO:0046965; GO:0048384; GO:0048469; GO:0048511; GO:0048662; GO:0050544; GO:0050692; GO:0050693; GO:0050728; GO:0050872; GO:0051091; GO:0051393; GO:0055088; GO:0060336; GO:0060391; GO:0060392; GO:0060394; GO:0060694; GO:0060965; GO:0070165; GO:0070412; GO:0070888; GO:0071404; GO:0071456; GO:0090258; GO:0090575; GO:0097677; GO:0140297; GO:1900076; GO:1902894; GO:1902895; GO:1903243; GO:1903845; GO:1904179; GO:1904597; GO:1904706; GO:1904893; GO:1905461; GO:1905563; GO:1905599; GO:2000272 "alpha-actinin binding [GO:0051393]; arachidonic acid binding [GO:0050544]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LBD domain binding [GO:0050693]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; peptide binding [GO:0042277]; prostaglandin receptor activity [GO:0004955]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" ASGFHYGVHACEGCKGFFRR 0.98548 -2.4332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8539 0 0 0 0 15.7347 0 0 15.1232 0 0 0 14.8355 0 0 12.1817 0 0 0 0 0 12.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0504 0 0 0 0 0 12.7896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2673 0 0 0 0 13.6042 Q8N4Z0 RAB42_HUMAN Ras-related protein Rab-42 RAB42 Homo sapiens (Human) Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265] GO:0003924; GO:0005525; GO:0005886; GO:0007265; GO:0019003 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] ALQLRAGPR 0.98548 -3.8653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6749 0 15.8381 0 16.7035 15.9062 15.3068 15.4414 0 0 15.6253 15.0896 15.4371 15.1806 0 15.3719 0 0 0 0 0 0 0 0 14.5757 14.0097 0 0 0 0 15.0589 0 0 0 0 0 0 0 13.3959 0 0 0 0 0 0 0 13.272 0 13.1283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LD1 SGCZ_HUMAN "Zeta-sarcoglycan, Zeta-SG (ZSG1)" SGCZ Homo sapiens (Human) cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; membrane organization [GO:0061024]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cardiac muscle tissue development [GO:0048738]; heart contraction [GO:0060047]; membrane organization [GO:0061024]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001] GO:0005737; GO:0005856; GO:0016012; GO:0016021; GO:0042383; GO:0046716; GO:0048738; GO:0055001; GO:0060047; GO:0061024 CLYFFVLLLLVTMIVNLAMTIWILK 0.98548 -3.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0091 0 0 0 0 0 0 0 0 0 0 0 0 11.8121 0 0 0 0 0 Q9H0R8 GBRL1_HUMAN "Gamma-aminobutyric acid receptor-associated protein-like 1 (Early estrogen-regulated protein) (GABA(A) receptor-associated protein-like 1) (Glandular epithelial cell protein 1, GEC-1)" GABARAPL1 GEC1 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; glycophagy [GO:0061723]; macroautophagy [GO:0016236] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; glycophagy [GO:0061723]; macroautophagy [GO:0016236] GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005783; GO:0005794; GO:0005829; GO:0005874; GO:0006995; GO:0016236; GO:0030659; GO:0030957; GO:0031625; GO:0048487; GO:0050811; GO:0061723 beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625] ARVPDLDK 0.98548 -3.4248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H244 P2Y12_HUMAN "P2Y purinoceptor 12, P2Y12 (ADP-glucose receptor, ADPG-R) (P2T(AC)) (P2Y(AC)) (P2Y(cyc)) (P2Y12 platelet ADP receptor, P2Y(ADP)) (SP1999)" P2RY12 HORK3 Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell projection organization [GO:0030030]; cellular response to ATP [GO:0071318]; cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration [GO:0021808]; establishment of localization in cell [GO:0051649]; G protein-coupled receptor signaling pathway [GO:0007186]; hemostasis [GO:0007599]; ion transport [GO:0006811]; lamellipodium assembly [GO:0030032]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of chemotaxis [GO:0050921]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; positive regulation of ion transport [GO:0043270]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of ruffle assembly [GO:1900029]; regulation of chemotaxis [GO:0050920]; regulation of microglial cell migration [GO:1904139]; response to axon injury [GO:0048678]; substrate-dependent cell migration, cell extension [GO:0006930]; visual system development [GO:0150063]" cell body membrane [GO:0044298]; cell projection membrane [GO:0031253]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886] "cell body membrane [GO:0044298]; cell projection membrane [GO:0031253]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled ADP receptor activity [GO:0001621]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell projection organization [GO:0030030]; cellular response to ATP [GO:0071318]; cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration [GO:0021808]; establishment of localization in cell [GO:0051649]; G protein-coupled receptor signaling pathway [GO:0007186]; hemostasis [GO:0007599]; ion transport [GO:0006811]; lamellipodium assembly [GO:0030032]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of chemotaxis [GO:0050921]; positive regulation of integrin activation by cell surface receptor linked signal transduction [GO:0033626]; positive regulation of ion transport [GO:0043270]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of ruffle assembly [GO:1900029]; regulation of chemotaxis [GO:0050920]; regulation of microglial cell migration [GO:1904139]; response to axon injury [GO:0048678]; substrate-dependent cell migration, cell extension [GO:0006930]; visual system development [GO:0150063]" GO:0001609; GO:0001621; GO:0005085; GO:0005886; GO:0006811; GO:0006930; GO:0007186; GO:0007193; GO:0007200; GO:0007202; GO:0007599; GO:0009986; GO:0016021; GO:0019722; GO:0021808; GO:0030030; GO:0030032; GO:0030168; GO:0031224; GO:0031253; GO:0033626; GO:0033630; GO:0035585; GO:0043270; GO:0043552; GO:0044298; GO:0045028; GO:0048678; GO:0050920; GO:0050921; GO:0051649; GO:0051897; GO:0070527; GO:0071318; GO:0150063; GO:1900029; GO:1904139; GO:1904141 G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled ADP receptor activity [GO:0001621]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; guanyl-nucleotide exchange factor activity [GO:0005085] ELYRSYVRTR 0.98548 -3.8567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0518 0 14.9906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2D2 S35A3_HUMAN UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3) SLC35A3 Homo sapiens (Human) carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine metabolic process [GO:0006047]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; UDP-N-acetylglucosamine metabolic process [GO:0006047]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569] GO:0000139; GO:0005459; GO:0005462; GO:0005794; GO:0006047; GO:0008643; GO:0030173; GO:1990569 UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] CSLRALNR 0.98548 -2.438 0 0 0 0 12.3862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0003 0 0 0 12.6492 0 0 0 0 0 0 0 0 14.0599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9868 0 0 0 0 0 0 0 0 0 0 0 0 0 O96007 MOC2B_HUMAN "Molybdopterin synthase catalytic subunit, EC 2.8.1.12 (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B, MOCS2B) (Molybdopterin-synthase large subunit, MPT synthase large subunit)" MOCS2 MCBPE MOCO1 Homo sapiens (Human) Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] GO:0005654; GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366; GO:0032324 molybdopterin synthase activity [GO:0030366] DVINFTAEK 0.98549 -2.4877 0 0 0 0 0 0 0 0 0 0 11.5664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.047 10.9831 0 0 0 0 0 0 0 0 0 0 13.3519 0 0 0 0 14.5913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7W6 CC172_HUMAN Coiled-coil domain-containing protein 172 CCDC172 C10orf96 Homo sapiens (Human) cytoplasm [GO:0005737]; sperm midpiece [GO:0097225] cytoplasm [GO:0005737]; sperm midpiece [GO:0097225] GO:0005737; GO:0097225 ENVKIEISDLENQANMLKSEMK 0.98549 -2.1028 0 0 11.1906 0 0 0 0 11.8805 0 0 0 0 0 0 0 0 0 0 13.4511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2552 0 10.0696 0 0 0 0 0 0 12.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6697 0 0 13.6457 0 0 0 0 0 0 0 0 13.1415 0 14.8268 9.89206 14.3475 0 15.7892 0 0 14.3151 0 12.4636 0 0 13.3496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4151 0 0 0 0 0 0 0 0 0 0 0 10.4075 13.9399 0 0 0 12.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T5D7 ZN684_HUMAN Zinc finger protein 684 ZNF684 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AFIKKSHLLR 0.98549 -2.9341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7067 0 0 0 0 0 0 0 0 0 0 12.5465 13.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7508 0 11.1306 0 0 0 0 12.2365 0 0 0 0 0 0 0 0 0 13.1565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NW29 RWDD4_HUMAN RWD domain-containing protein 4 (Protein FAM28A) RWDD4 FAM28A RWDD4A Homo sapiens (Human) EQLSKAQKR 0.98549 -2.9411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3339 0 12.5107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1845 0 0 0 0 0 0 0 0 0 0 0 0 11.4263 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6I5 SPT12_HUMAN Spermatogenesis-associated protein 12 (Spermatogenesis-related protein 5) SPATA12 SRG5 Homo sapiens (Human) MSSSALTCGSTLEKSGDTWEMKALDSSR 0.98549 -2.1045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9607 0 0 0 0 0 0 0 0 11.8875 0 0 0 0 0 0 0 0 0 0 0 12.0688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7867 11.5876 0 0 11.5274 0 0 0 13.9318 13.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9024 0 0 0 0 13.1244 0 0 12.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9498 0 0 0 0 10.977 0 Q8N9F7 GDPD1_HUMAN "Lysophospholipase D GDPD1, EC 3.1.4.- (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1)" GDPD1 GDE4 Homo sapiens (Human) glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291] GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0016021; GO:0046475; GO:0046872; GO:0048471; GO:0070291 lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081] ALFDHLTAR 0.98549 -3.0405 0 14.0441 10.7484 0 0 0 0 0 13.3527 13.8244 0 12.8148 12.9144 12.2781 0 0 0 0 0 0 0 0 12.0969 0 0 0 13.0711 12.1 13.0264 13.3833 13.8916 13.6378 13.494 0 12.9484 0 13.3696 12.9138 0 0 0 13.44 0 0 13.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2314 0 9.39926 15.0365 14.5342 0 0 18.0563 0 0 0 19.2332 14.2659 0 0 13.6375 0 0 15.1427 0 14.6462 12.6391 0 0 0 0 0 14.9462 14.2747 0 0 0 0 0 0 12.8197 0 0 13.065 0 0 0 0 0 12.1256 0 0 0 12.2013 0 0 0 0 0 10.7929 0 0 14.5563 0 12.7253 0 0 0 10.7166 0 0 0 0 0 13.2636 13.2236 0 15.1168 0 0 0 14.4259 14.4315 0 0 13.5145 12.6228 0 12.7489 0 13.4616 0 0 13.4677 0 0 0 0 Q8TBH0 ARRD2_HUMAN Arrestin domain-containing protein 2 ARRDC2 PP2703 Homo sapiens (Human) protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; protein transport [GO:0015031] GO:0005737; GO:0005886; GO:0015031; GO:0031410 AVVASLAGEPVGPGQRALWQGRALR 0.98549 -2.4863 0 0 0 0 0 12.3172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.941 0 0 0 0 0 0 13.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5494 0 0 0 0 0 0 0 12.7137 0 0 0 0 0 0 0 0 0 0 15.1808 0 0 0 0 0 0 0 0 0 0 0 12.5334 0 12.8164 0 0 13.1188 12.2153 10.9046 14.226 0 0 0 0 0 13.0472 10.9085 0 0 0 0 0 0 0 14.0613 0 0 0 0 0 0 12.0049 0 0 0 0 0 11.6664 0 0 12.6197 0 0 0 0 0 0 0 Q96EX1 SIM12_HUMAN Small integral membrane protein 12 SMIM12 C1orf212 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AVLNRNR 0.98549 -2.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.9549 0 0 0 0 0 0 0 0 0 0 0 0 19.0934 0 18.7397 0 0 0 0 0 0 20.2225 0 0 0 0 0 16.8378 19.2545 19.3109 18.7385 0 19.3873 0 0 0 0 0 0 0 0 20.2964 19.1816 19.7084 18.9144 Q96R72 OR4K3_HUMAN Olfactory receptor 4K3 (Olfactory receptor OR14-14) OR4K3 OR4K3P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] SRKTDHTP 0.98549 -2.7473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9383 0 0 0 0 0 0 0 0 11.0956 0 0 0 0 10.684 0 0 0 0 0 0 0 0 0 0 0 11.1382 0 0 0 0 0 0 0 10.6132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0677 0 0 0 0 0 0 11.3085 0 12.2771 0 0 0 0 0 12.3355 0 0 0 0 0 0 0 0 12.2973 0 0 0 0 0 0 0 0 0 0 0 0 12.85 15.1729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5089 0 0 0 11.9492 0 0 14.2095 0 0 0 13.6049 0 0 0 12.7657 Q9H0C8 ILKAP_HUMAN "Integrin-linked kinase-associated serine/threonine phosphatase 2C, ILKAP, EC 3.1.3.16" ILKAP Homo sapiens (Human) protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein dephosphorylation [GO:0006470] GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0017018; GO:0046872 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018] LANKAVQR 0.98549 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UC06 ZNF70_HUMAN Zinc finger protein 70 (Zinc finger protein N27C7-1) ZNF70 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076] "cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005737; GO:0006357; GO:0043076; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFSQSSHLLRHQIIHTGEKPYECR 0.98549 -2.7478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GVG4 CC194_HUMAN Coiled-coil domain-containing protein 194 CCDC194 Homo sapiens (Human) AEPGPEPGR 0.9855 -2.9497 0 0 0 0 0 11.9669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0638 0 0 13.3684 0 0 0 0 0 0 0 0 0 0 0 11.8574 0 0 0 0 0 0 0 0 0 0 P0C7U1 ASA2B_HUMAN Putative inactive neutral ceramidase B (ASAH2-like protein) (Putative inactive N-acylsphingosine amidohydrolase 2B) (Putative inactive non-lysosomal ceramidase B) ASAH2B ASAH2C ASAH2L Homo sapiens (Human) ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512] extracellular region [GO:0005576] extracellular region [GO:0005576]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512] GO:0005576; GO:0017040; GO:0042759; GO:0046512; GO:0046514 N-acylsphingosine amidohydrolase activity [GO:0017040] FYWHKGLLGLSNATVEWHIPDTAQPGIYR 0.9855 -2.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDY8 TMM52_HUMAN Transmembrane protein 52 TMEM52 UNQ3048/PRO9864 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ARGPLAAR 0.9855 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9007 0 0 12.3505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.954 0 13.8569 14.0016 14.1184 14.0523 14.3467 18.6103 0 0 0 0 0 0 0 0 0 13.5077 0 0 19.8605 0 0 13.042 0 0 0 0 0 13.3174 12.8932 0 0 12.8136 0 0 0 0 0 0 0 0 0 0 0 0 12.9259 0 14.5318 0 0 0 0 0 0 0 0 0 0 0 13.4107 0 19.0844 0 0 13.3786 0 0 0 0 0 0 0 15.066 0 0 0 18.8781 18.8647 0 0 0 0 0 0 13.0838 0 0 0 0 17.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.037 0 0 0 0 0 0 14.4937 0 Q8NEE0 KLAS1_HUMAN Putative uncharacterized protein KLHL30-AS1 (KLHL30 antisense RNA 1) KLHL30-AS1 C2orf19 Homo sapiens (Human) VELSKELR 0.9855 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LM5 CD045_HUMAN Uncharacterized protein C4orf45 C4orf45 Homo sapiens (Human) ASKPPKLPK 0.9855 -2.1099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPF2 CHSTB_HUMAN "Carbohydrate sulfotransferase 11, EC 2.8.2.5 (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1, C4S-1, C4ST-1, C4ST1)" CHST11 Homo sapiens (Human) apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146]; apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050659 chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146] FLFVREPFER 0.9855 -2.497 0 0 0 0 0 0 0 0 0 0 0 0 16.2811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6239 0 0 0 0 0 0 0 0 0 0 12.7349 12.968 0 0 12.7126 18.9221 11.8935 0 0 0 0 0 0 0 0 0 0 0 0 14.0103 0 0 Q9UJC3 HOOK1_HUMAN "Protein Hook homolog 1, h-hook1, hHK1" HOOK1 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi organization [GO:0007030]; lysosome organization [GO:0007040]; manchette assembly [GO:1905198]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] GO:0003779; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0007030; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0030705; GO:0031122; GO:0042802; GO:0042803; GO:0045022; GO:0051959; GO:0070695; GO:1905198; GO:1905719 actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] ADTLAFEMK 0.9855 -2.1127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8686 0 0 0 0 13.7995 0 0 0 0 0 0 0 11.5094 0 0 0 0 0 0 0 0 14.8381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3056 0 0 0 0 0 0 13.3573 0 0 0 0 12.6232 0 0 13.1951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5P3 RAI2_HUMAN Retinoic acid-induced protein 2 RAI2 Homo sapiens (Human) animal organ development [GO:0048513]; embryo development ending in birth or egg hatching [GO:0009792] nucleus [GO:0005634] nucleus [GO:0005634]; animal organ development [GO:0048513]; embryo development ending in birth or egg hatching [GO:0009792] GO:0005634; GO:0009792; GO:0048513 ALVTVPAPSILNPPAESQSGMALK 0.9855 -3.6184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8974 0 0 0 0 0 13.6659 0 13.9845 0 0 0 0 0 0 0 0 0 0 15.3428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0013 0 0 0 0 0 13.0177 0 0 0 12.268 0 0 0 14.411 0 0 14.5762 0 0 0 0 11.7528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3333 0 0 13.1844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.819 0 0 0 0 0 0 0 0 0 0 0 11.1861 0 0 0 0 0 0 0 11.9227 0 0 0 0 0 0 Q5T1A1 DCST2_HUMAN DC-STAMP domain-containing protein 2 DCST2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AIARKTK 0.98551 -2.5091 14.1238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7015 0 17.3353 0 0 0 13.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2979 0 0 0 0 0 0 0 0 12.442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0663 0 0 0 0 0 0 12.4799 0 0 12.9236 0 0 0 0 0 0 0 0 0 0 0 0 12.5491 0 0 0 0 0 0 0 0 0 0 0 15.077 0 0 0 0 0 0 13.7949 Q6UXI9 NPNT_HUMAN Nephronectin (Preosteoblast EGF-like repeat protein with MAM domain) (Protein EGFL6-like) NPNT EGFL6L POEM UNQ295/PRO334 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to tumor necrosis factor [GO:0071356]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; pilomotor reflex [GO:0097195]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; smooth muscle contractile fiber [GO:0030485] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; smooth muscle contractile fiber [GO:0030485]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to tumor necrosis factor [GO:0071356]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; pilomotor reflex [GO:0097195]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657] GO:0001657; GO:0001658; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0007160; GO:0007179; GO:0010694; GO:0010811; GO:0016020; GO:0030198; GO:0030485; GO:0030511; GO:0033631; GO:0045184; GO:0045669; GO:0045944; GO:0045987; GO:0051145; GO:0062023; GO:0070062; GO:0070374; GO:0071356; GO:0097195 calcium ion binding [GO:0005509]; integrin binding [GO:0005178] CKCHPGYAGK 0.98551 -2.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64147 0 0 0 0 0 0 0 Q86XP1 DGKH_HUMAN "Diacylglycerol kinase eta, DAG kinase eta, EC 2.7.1.107 (Diglyceride kinase eta, DGK-eta)" DGKH Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of catalytic activity [GO:0043086]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; SAM domain binding [GO:0032093]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of catalytic activity [GO:0043086]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] GO:0003951; GO:0004143; GO:0005524; GO:0005737; GO:0005768; GO:0005886; GO:0006654; GO:0007205; GO:0015629; GO:0019900; GO:0030168; GO:0032093; GO:0032991; GO:0035556; GO:0042802; GO:0043086; GO:0043231; GO:0046339; GO:0046473; GO:0046834; GO:0046872 ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; SAM domain binding [GO:0032093] AVKPREIMLR 0.98551 -2.6858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NB12 SMYD1_HUMAN "Histone-lysine N-methyltransferase SMYD1, EC 2.1.1.354 (SET and MYND domain-containing protein 1)" SMYD1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; skeletal muscle cell differentiation [GO:0035914] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; skeletal muscle cell differentiation [GO:0035914] GO:0003677; GO:0003714; GO:0005634; GO:0005737; GO:0006338; GO:0007507; GO:0010831; GO:0018024; GO:0034968; GO:0035914; GO:0045663; GO:0046872 DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] CGQCKFAHYCDR 0.98551 -3.4494 0 0 0 0 0 11.8201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5434 0 0 0 0 0 0 0 0 0 0 0 13.2066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4188 0 0 0 0 0 0 0 0 0 13.8941 0 12.0852 0 12.0993 0 14.1234 0 0 15.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3079 0 13.1529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC12 RDH11_HUMAN "Retinol dehydrogenase 11, EC 1.1.1.300 (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1, RalR1) (Short chain dehydrogenase/reductase family 7C member 1)" RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82 Homo sapiens (Human) adaptation of rhodopsin mediated signaling [GO:0016062]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; photoreceptor inner segment [GO:0001917]; 11-cis-retinol dehydrogenase activity [GO:0102354]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; adaptation of rhodopsin mediated signaling [GO:0016062]; cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]" GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0016021; GO:0016062; GO:0016616; GO:0033721; GO:0042572; GO:0042574; GO:0052650; GO:0102354; GO:0110095 "11-cis-retinol dehydrogenase activity [GO:0102354]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" EIQTTTGNQQVLVRK 0.98551 -2.7696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S21 RB40C_HUMAN Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3) RAB40C RARL RASL8C Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0043231; GO:0072659 GTP binding [GO:0005525]; GTPase activity [GO:0003924] AIVSCTPVHLIDKLPLPVTIKSHLK 0.98551 -2.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5561 13.2001 0 0 0 0 0 0 Q9NS66 GP173_HUMAN Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3) GPR173 SREB3 Homo sapiens (Human) negative regulation of neuron migration [GO:2001223]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; negative regulation of neuron migration [GO:2001223]; signal transduction [GO:0007165] GO:0004930; GO:0004968; GO:0005886; GO:0007165; GO:0016021; GO:2001223 G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968] ANDTLGFMLMLAVLMAATHAVYGKLLLFEYR 0.98551 -3.4477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4356 0 0 0 0 0 0 0 0 0 0 13.8711 12.3393 0 0 0 0 0 0 0 0 0 0 0 0 12.6007 0 0 0 0 0 0 0 0 0 13.4486 0 0 0 0 0 11.9968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1463 0 0 0 12.7756 0 0 0 0 0 0 0 0 0 11.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3668 0 0 0 0 0 0 0 0 11.8185 0 0 0 0 0 Q9NVH0 EXD2_HUMAN "Exonuclease 3'-5' domain-containing protein 2, EC 3.1.11.1 (3'-5' exoribonuclease EXD2, EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2)" EXD2 C14orf114 EXDL2 Homo sapiens (Human) DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; replication fork processing [GO:0031297] GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0008852; GO:0016021; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090305; GO:0090734 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; exodeoxyribonuclease I activity [GO:0008852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310] HFPIEMK 0.98551 -3.6281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9709 0 0 9.65496 0 0 0 14.004 0 0 13.309 0 0 0 0 14.0516 14.5837 0 0 0 16.1541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4728 0 0 0 0 0 0 0 0 0 0 0 15.1978 15.0532 0 0 11.7853 15.4657 0 14.8209 10.2349 0 0 0 0 0 0 0 0 0 0 0 15.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9542 13.0999 0 0 0 0 0 0 A7E2U8 CD047_HUMAN UPF0602 protein C4orf47 C4orf47 Chr4_1746 Homo sapiens (Human) 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881] GO:0005813; GO:0005881; GO:0097731 LLKGAPFKLNLHPR 0.98552 -2.446 0 0 0 0 0 0 0 0 0 0 0 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4683 0 0 12.2355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3109 11.6405 0 0 11.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60759 CYTIP_HUMAN "Cytohesin-interacting protein (Cytohesin binder and regulator, CYBR) (Cytohesin-associated scaffolding protein, CASP) (Cytohesin-binding protein HE, Cbp HE) (Pleckstrin homology Sec7 and coiled-coil domains-binding protein)" CYTIP PSCDBP Homo sapiens (Human) regulation of cell adhesion [GO:0030155] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleoplasm [GO:0005654]; regulation of cell adhesion [GO:0030155] GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005938; GO:0030155 KQLLKFIPGLHR 0.98552 -3.7224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7106 0 0 0 11.2507 0 0 0 0 0 13.2071 0 0 0 15.0798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4691 0 0 14.9591 0 0 0 0 0 0 P43686 PRS6B_HUMAN "26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7, TBP-7)" PSMC4 MIP224 TBP7 Homo sapiens (Human) blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508] "cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; synapse [GO:0045202]" "cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]" GO:0000502; GO:0001824; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0008540; GO:0016020; GO:0016234; GO:0016887; GO:0022624; GO:0031597; GO:0036402; GO:0043161; GO:0045202 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402] ELLKPNASVALHK 0.98552 -3.6331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2347 0 0 13.5632 0 0 0 0 0 0 0 0 10.6831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5823 0 0 0 0 0 0 15.24 0 0 14.5435 0 14.4555 14.7162 0 15.8958 0 15.0272 0 0 15.1541 0 0 14.4671 0 0 0 0 14.4754 14.7788 13.6219 0 0 0 0 0 14.6788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4AE62 GTDC1_HUMAN Glycosyltransferase-like domain-containing protein 1 (Mannosyltransferase-like protein Xa) (Mat-Xa) GTDC1 Homo sapiens (Human) glycosyltransferase activity [GO:0016757] GO:0016757 glycosyltransferase activity [GO:0016757] ILYFHENQLIYPVKK 0.98552 -2.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2845 0 0 0 0 0 0 0 0 Q6UY13 YB003_HUMAN Putative uncharacterized protein UNQ5830/PRO19650/PRO19816 UNQ5830/PRO19650/PRO19816 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AILMLSLQLILLLIPSISHEAHK 0.98552 -2.7774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0486 0 0 0 0 0 0 0 0 12.7417 0 12.0222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7163 0 0 0 0 0 0 0 0 Q7Z769 S35E3_HUMAN Solute carrier family 35 member E3 (Bladder cancer-overexpressed gene 1 protein) SLC35E3 BLOV1 UNQ3043/PRO9859 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; nucleotide-sugar transmembrane transporter activity [GO:0005338] GO:0005338; GO:0005794; GO:0015297; GO:0016021 antiporter activity [GO:0015297]; nucleotide-sugar transmembrane transporter activity [GO:0005338] IAAGLLFNLLVSICIVFLNK 0.98552 -2.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.463 Q9H114 CSTL1_HUMAN Cystatin-like 1 (RCET11) CSTL1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869] GO:0004869; GO:0005576 cysteine-type endopeptidase inhibitor activity [GO:0004869] NPLLLLIALVLSAK 0.98552 -3.6315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.215 0 14.9119 0 10.5674 0 0 0 0 0 0 0 0 0 0 12.4657 0 0 0 0 0 0 0 0 0 0 12.5869 0 0 0 0 0 0 0 0 0 0 0 0 11.5098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0796 O14874 BCKD_HUMAN "[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial, EC 2.7.11.4 (Branched-chain alpha-ketoacid dehydrogenase kinase, BCKD-kinase, BCKDHKIN)" BCKDK Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; negative regulation of cellular amino acid metabolic process [GO:0045763]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; regulation of glucose metabolic process [GO:0010906] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; negative regulation of cellular amino acid metabolic process [GO:0045763]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; regulation of glucose metabolic process [GO:0010906] GO:0004674; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0005947; GO:0006468; GO:0009063; GO:0009083; GO:0010906; GO:0016301; GO:0016310; GO:0045763; GO:0047323 [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] HIEDEKLVRYFLDK 0.98553 -2.8805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8996 0 12.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2277 0 0 0 0 0 0 0 13.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6713 0 0 0 0 0 0 0 13.574 0 0 0 0 13.5229 0 0 13.1686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3281 0 0 0 0 0 0 0 O60902 SHOX2_HUMAN Short stature homeobox protein 2 (Homeobox protein Og12X) (Paired-related homeobox protein SHOT) SHOX2 OG12X SHOT Homo sapiens (Human) cardiac pacemaker cell differentiation [GO:0060920]; cardiac right atrium morphogenesis [GO:0003213]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte development [GO:0002063]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal joint morphogenesis [GO:0060272]; mesenchymal cell proliferation [GO:0010463]; muscle tissue morphogenesis [GO:0060415]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; osteoblast differentiation [GO:0001649]; positive regulation of axonogenesis [GO:0050772]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of chondrocyte differentiation [GO:0032330]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; sinoatrial node development [GO:0003163]; sinoatrial valve development [GO:0003172]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; cardiac pacemaker cell differentiation [GO:0060920]; cardiac right atrium morphogenesis [GO:0003213]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte development [GO:0002063]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal joint morphogenesis [GO:0060272]; mesenchymal cell proliferation [GO:0010463]; muscle tissue morphogenesis [GO:0060415]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; osteoblast differentiation [GO:0001649]; positive regulation of axonogenesis [GO:0050772]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of chondrocyte differentiation [GO:0032330]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; sinoatrial node development [GO:0003163]; sinoatrial valve development [GO:0003172]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089]" GO:0000122; GO:0000785; GO:0000981; GO:0001501; GO:0001649; GO:0002027; GO:0002053; GO:0002063; GO:0003163; GO:0003172; GO:0003213; GO:0005634; GO:0006357; GO:0007224; GO:0007399; GO:0010463; GO:0032330; GO:0035115; GO:0045880; GO:0048557; GO:0048743; GO:0050772; GO:0060272; GO:0060351; GO:0060415; GO:0060920; GO:0060931; GO:0072089; GO:1990837; GO:2000172; GO:2000648 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" AKKHAAALGL 0.98553 -2.6113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2799 15.466 0 14.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7999 14.9684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8244 0 0 0 0 0 0 0 15.0908 0 0 14.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53RD9 FBLN7_HUMAN "Fibulin-7, FIBL-7" FBLN7 TM14 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of biomineralization [GO:0110151] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; positive regulation of biomineralization [GO:0110151] GO:0005509; GO:0005615; GO:0005925; GO:0007155; GO:0008201; GO:0031012; GO:0043395; GO:0110151 calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201] CICPPGRTGNR 0.98553 -3.6404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3966 0 14.5981 0 0 0 0 0 0 0 0 0 0 0 0 13.974 0 0 0 14.5113 0 13.8275 0 13.5633 13.6186 0 0 0 0 0 0 0 0 0 14.023 0 0 0 13.4935 0 0 0 0 13.692 0 0 0 0 0 0 14.5992 0 15.1963 0 0 0 0 0 14.384 13.7927 0 0 14.6822 0 0 0 0 0 0 13.712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1804 0 0 0 13.4467 0 0 0 0 0 0 Q7Z7G1 CLNK_HUMAN Cytokine-dependent hematopoietic cell linker (Mast cell immunoreceptor signal transducer) CLNK MIST Homo sapiens (Human) intracellular signal transduction [GO:0035556]; mast cell degranulation [GO:0043303]; negative regulation of natural killer cell activation [GO:0032815]; positive regulation of natural killer cell cytokine production [GO:0002729]; regulation of cell death [GO:0010941]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; mast cell granule [GO:0042629]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; mast cell granule [GO:0042629]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; mast cell degranulation [GO:0043303]; negative regulation of natural killer cell activation [GO:0032815]; positive regulation of natural killer cell cytokine production [GO:0002729]; regulation of cell death [GO:0010941]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0002729; GO:0005737; GO:0007169; GO:0010941; GO:0032815; GO:0032991; GO:0035556; GO:0042629; GO:0043303; GO:0044877 protein-containing complex binding [GO:0044877] GHSDDDYDDPELR 0.98553 -2.8759 0 0 0 0 0 0 0 0 0 12.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3267 0 0 0 0 0 0 0 0 0 15.2743 0 0 0 0 0 0 15.8842 0 0 15.4251 0 0 0 0 0 0 0 13.101 0 0 0 0 0 12.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6157 0 0 0 0 0 12.4056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0106 0 15.3516 0 0 0 0 0 0 0 0 0 0 11.2508 0 13.6651 0 0 0 0 0 0 11.1946 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YL5 TDRP_HUMAN Testis development-related protein (Protein INM01) TDRP C8orf42 Homo sapiens (Human) spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0043231 MWKLGRGR 0.98553 -3.3769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.529 0 0 0 0 0 0 16.3625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92945 FUBP2_HUMAN "Far upstream element-binding protein 2, FUSE-binding protein 2 (KH type-splicing regulatory protein, KSRP) (p75)" KHSRP FUBP2 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006397; GO:0008380; GO:0010468; GO:0010586; GO:0010989; GO:0016020; GO:0035925; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345 DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] AINQQTGAFVEISRQLPPNGDPNFKLFIIR 0.98553 -2.6099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6811 0 0 0 0 0 0 0 0 0 0 Q9BWS9 CHID1_HUMAN "Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein, SI-CLP)" CHID1 GL008 PSEC0104 SB139 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016] GO:0005576; GO:0005615; GO:0005634; GO:0005764; GO:0005770; GO:0005802; GO:0005975; GO:0008061; GO:0016020; GO:0043202; GO:0045087; GO:0070062; GO:0070492; GO:1900016 chitin binding [GO:0008061]; oligosaccharide binding [GO:0070492] HAKGLHIVPR 0.98553 -3.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7819 0 0 0 0 0 0 0 0 0 0 0 11.8096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5843 0 13.3066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7143 0 0 0 0 0 0 0 0 0 0 12.0648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NNW7 TRXR2_HUMAN "Thioredoxin reductase 2, mitochondrial, EC 1.8.1.9 (Selenoprotein Z, SelZ) (TR-beta) (Thioredoxin reductase TR3)" TXNRD2 KIAA1652 TRXR2 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; response to hyperoxia [GO:0055093]; response to oxygen radical [GO:0000305]; response to selenium ion [GO:0010269]; response to xenobiotic stimulus [GO:0009410] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; response to hyperoxia [GO:0055093]; response to oxygen radical [GO:0000305]; response to selenium ion [GO:0010269]; response to xenobiotic stimulus [GO:0009410] GO:0000305; GO:0004791; GO:0005739; GO:0005759; GO:0005829; GO:0009410; GO:0010269; GO:0030424; GO:0030425; GO:0042803; GO:0043025; GO:0044877; GO:0045454; GO:0050660; GO:0055093 flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; thioredoxin-disulfide reductase activity [GO:0004791] KVKYFNIK 0.98553 -2.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2A4 ABI3_HUMAN "ABI gene family member 3 (New molecule including SH3, Nesh)" ABI3 NESH Homo sapiens (Human) defense response to tumor cell [GO:0002357]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of cellular senescence [GO:2000774]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of postsynaptic density assembly [GO:0099151] cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209] cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; defense response to tumor cell [GO:0002357]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of cellular senescence [GO:2000774]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of postsynaptic density assembly [GO:0099151] GO:0002357; GO:0005737; GO:0010593; GO:0014069; GO:0016020; GO:0017124; GO:0030027; GO:0030334; GO:0031209; GO:0042802; GO:0043197; GO:0043198; GO:0051015; GO:0061001; GO:0099151; GO:1900028; GO:1903077; GO:2000249; GO:2000774 actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124] AELQQLQEFEIPTGR 0.98553 -2.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1932 0 0 0 0 0 0 0 13.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4575 0 0 0 0 0 0 0 0 0 0 0 0 0 P20290 BTF3_HUMAN "Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta, NAC-beta) (RNA polymerase B transcription factor 3)" BTF3 NACB OK/SW-cl.8 Homo sapiens (Human) negative regulation of protein localization to endoplasmic reticulum [GO:1905551]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; negative regulation of protein localization to endoplasmic reticulum [GO:1905551]; protein transport [GO:0015031] GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005854; GO:0015031; GO:0042788; GO:1905551 RNA binding [GO:0003723] GGTRGQEPQMK 0.98554 -2.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21549 AGT1_HUMAN "Alanine--glyoxylate aminotransferase, AGT, EC 2.6.1.44 (Serine--pyruvate aminotransferase, SPT, EC 2.6.1.51)" AGXT AGT1 SPAT Homo sapiens (Human) "glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; L-serine metabolic process [GO:0006563]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; L-serine metabolic process [GO:0006563]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]" GO:0004760; GO:0005777; GO:0005782; GO:0005829; GO:0006563; GO:0007219; GO:0008453; GO:0008483; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042802; GO:0042803; GO:0042853; GO:0043231; GO:0043621; GO:0046487; GO:0046724 alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; transaminase activity [GO:0008483] LLVTPPKALLK 0.98554 -3.2937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4106 0 0 0 0 10.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.941 0 11.7243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0575 0 0 0 0 0 0 13.6265 0 0 0 0 12.7851 0 0 0 13.3142 0 0 0 0 0 0 0 12.8333 0 0 0 0 0 0 0 0 0 12.8854 0 0 0 0 0 0 13.7948 12.7887 0 13.193 0 0 0 0 0 0 0 0 0 12.4814 0 0 0 0 0 0 13.8293 0 0 0 0 13.1797 13.2547 12.9566 0 0 0 12.0343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2307 0 0 0 0 0 0 13.5352 P40227 TCPZ_HUMAN "T-complex protein 1 subunit zeta, TCP-1-zeta (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)" CCT6A CCT6 CCTZ Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0003723; GO:0005524; GO:0005737; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0016887; GO:0032212; GO:0044183; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:0071987; GO:0140662; GO:1904851; GO:1904871; GO:1904874 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987] AAVKTLNPK 0.98554 -2.8918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.046 0 0 0 0 0 0 0 0 0 0 0 0 12.3959 0 0 0 0 0 12.1558 0 0 0 0 0 12.9349 0 0 0 0 0 0 0 0 0 0 0 0 13.4982 12.5761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3324 13.3083 0 0 0 0 0 0 11.7548 16.4803 0 14.783 P52907 CAZA1_HUMAN F-actin-capping protein subunit alpha-1 (CapZ alpha-1) CAPZA1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]; protein-containing complex assembly [GO:0065003] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell junction assembly [GO:0034329]; protein-containing complex assembly [GO:0065003] GO:0003779; GO:0005576; GO:0005829; GO:0005856; GO:0008290; GO:0015629; GO:0030036; GO:0034329; GO:0045296; GO:0051015; GO:0051016; GO:0065003; GO:0070062; GO:0071203 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296] ILSYKIGKEMQNA 0.98554 -3.2944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.495 0 0 13.2583 0 0 0 0 0 13.9557 0 0 13.4196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8788 0 0 0 0 0 13.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.208 0 0 0 Q15170 TCAL1_HUMAN "Transcription elongation factor A protein-like 1, TCEA-like protein 1 (Nuclear phosphoprotein p21/SIIR) (Transcription elongation factor S-II protein-like 1)" TCEAL1 SIIR Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; WW domain binding [GO:0050699] GO:0005634; GO:0005654; GO:0050699 WW domain binding [GO:0050699] HKLEEGSFKER 0.98554 -2.9796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3267 0 0 Q96EY1 DNJA3_HUMAN "DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1, hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)" DNAJA3 HCA57 TID1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077] GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043124; GO:0043154; GO:0043231; GO:0044877; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0070161; GO:0071340; GO:0090398; GO:0106137; GO:0140297 ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082] ALLTLRPGVSLTGTK 0.98554 -2.3943 0 0 10.6919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9283 0 0 0 0 0 0 0 0 0 0 0 11.6937 0 0 0 0 0 Q9BPX7 CG025_HUMAN UPF0415 protein C7orf25 C7orf25 Homo sapiens (Human) ALRLVASSKINSR 0.98554 -2.9829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5332 0 0 0 0 0 0 16.8896 0 0 0 14.0923 15.1603 0 0 0 0 0 0 0 0 15.9094 0 0 0 0 0 0 0 0 0 0 0 0 15.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6434 0 0 0 0 0 0 14.6601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQW5 PRDM7_HUMAN "Histone-lysine N-methyltransferase PRDM7, EC 2.1.1.- (PR domain zinc finger protein 7) (PR domain-containing protein 7) ([histone H3]-lysine4 N-methyltransferase PRDM7)" PRDM7 PFM4 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; recombination hotspot binding [GO:0010844]; chromatin organization [GO:0006325]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0005694; GO:0006325; GO:0006355; GO:0010468; GO:0010844; GO:0010845; GO:0042800; GO:0046975; GO:0080182 histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; recombination hotspot binding [GO:0010844] EEWAEMGDWEKTRYR 0.98554 -2.9814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0448 0 0 12.894 0 0 0 0 0 0 0 0 0 0 12.4806 0 0 0 0 0 0 0 0 0 0 0 0 13.3219 0 0 0 0 0 0 0 0 11.8478 0 0 0 12.8867 0 0 0 0 0 0 0 12.8694 0 0 0 0 0 0 0 0 0 0 12.7249 12.3766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUR5 TMTC1_HUMAN "Protein O-mannosyl-transferase TMTC1, EC 2.4.1.109 (Transmembrane and TPR repeat-containing protein 1)" TMTC1 ARG99 Homo sapiens (Human) protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; protein O-linked mannosylation [GO:0035269]; RNA processing [GO:0006396] GO:0000030; GO:0004169; GO:0005783; GO:0006396; GO:0016021; GO:0035269 dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] GNQLREQNLLDK 0.98555 -2.6269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7618 0 10.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5457 0 15.1247 11.4246 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5315 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUM0 NU133_HUMAN Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] GO:0000776; GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0016020; GO:0016973; GO:0017056; GO:0021915; GO:0022008; GO:0031080; GO:0031965; GO:0048339; GO:0061053; GO:0072006 structural constituent of nuclear pore [GO:0017056] ANYEYYVQGQI 0.98555 -3.8363 0 0 0 0 0 0 0 0 0 0 10.2646 0 0 0 11.691 0 0 0 0 0 10.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4982 0 0 0 0 0 0 0 0 0 0 0 0 12.9981 0 0 0 0 0 0 12.8708 0 0 0 0 13.8678 0 0 0 0 0 0 0 0 14.1522 14.8633 0 0 0 0 0 15.3249 0 13.0449 13.6807 16.1999 15.4748 14.1649 15.1186 14.2628 13.3483 0 0 0 0 0 0 12.0584 0 14.2802 10.8666 0 0 14.8745 14.0769 0 12.789 0 0 0 0 0 0 0 0 0 14.4542 0 0 0 0 0 0 14.3728 15.1131 0 0 13.9355 0 0 12.9976 11.7375 0 0 0 0 0 0 0 12.4036 0 0 0 0 0 0 0 0 0 0 12.5695 0 0 12.927 0 0 12.6543 0 0 0 0 0 0 0 0 0 14.0133 0 0 0 0 0 12.562 9.99563 Q8WW32 HMGB4_HUMAN High mobility group protein B4 HMGB4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0005634; GO:0005694; GO:0006357; GO:0008301 "DNA binding, bending [GO:0008301]" ARYQEEMMNYVGK 0.98555 -3.8401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65259 0 0 0 0 0 0 0 0 0 0 0 Q9NQ38 ISK5_HUMAN "Serine protease inhibitor Kazal-type 5 (Lympho-epithelial Kazal-type-related inhibitor, LEKTI) [Cleaved into: Hemofiltrate peptide HF6478; Hemofiltrate peptide HF7665 ]" SPINK5 Homo sapiens (Human) cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; epidermal cell differentiation [GO:0009913]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antibacterial peptide production [GO:0002787]; negative regulation of immune response [GO:0050777]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572]; regulation of cell adhesion [GO:0030155]; regulation of T cell differentiation [GO:0045580]; regulation of timing of anagen [GO:0051884] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; epidermal cell differentiation [GO:0009913]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antibacterial peptide production [GO:0002787]; negative regulation of immune response [GO:0050777]; negative regulation of serine-type endopeptidase activity [GO:1900004]; negative regulation of serine-type peptidase activity [GO:1902572]; regulation of cell adhesion [GO:0030155]; regulation of T cell differentiation [GO:0045580]; regulation of timing of anagen [GO:0051884] GO:0002787; GO:0004867; GO:0005576; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005938; GO:0007417; GO:0009913; GO:0016525; GO:0030154; GO:0030155; GO:0030198; GO:0030855; GO:0035315; GO:0043231; GO:0045580; GO:0048471; GO:0050777; GO:0051884; GO:0097209; GO:1900004; GO:1902572 serine-type endopeptidase inhibitor activity [GO:0004867] ARHLARAPK 0.98555 -2.8053 0 0 0 0 0 0 0 0 0 0 0 11.4165 0 10.9877 11.4923 13.9027 0 14.1206 11.9507 13.6569 12.0637 0 0 0 0 14.1827 12.5281 0 0 14.0834 11.8652 0 14.4708 0 0 0 0 12.2007 11.8336 12.9967 0 12.4406 14.4331 14.295 12.4959 0 10.1179 13.8202 0 0 0 13.1569 13.5157 12.2368 13.7887 13.5719 11.7919 0 0 0 0 0 12.6212 13.1351 0 0 0 0 0 0 0 0 11.2778 0 14.2663 13.9177 13.3288 0 12.1047 0 0 13.1119 13.8211 14.6512 13.861 14.9901 14.4619 13.0838 14.0487 0 12.6587 12.3314 0 13.4415 17.7435 13.604 0 11.7109 14.4009 0 0 0 12.9368 11.7696 14.8065 13.6029 14.332 0 0 13.5072 14.9973 0 13.5919 13.4165 0 0 12.9827 0 0 0 0 0 13.14 14.9433 0 0 13.5042 0 0 0 0 0 0 0 0 0 0 14.8077 12.1089 12.3796 11.9163 0 0 12.1617 0 0 0 12.2167 0 14.222 11.4269 0 0 0 0 0 0 0 14.7613 0 11.5909 0 0 0 0 12.2051 15.3087 0 0 0 0 0 0 12.9309 0 13.9898 0 10.5366 0 14.0652 Q9NQ89 CL004_HUMAN Protein C12orf4 C12orf4 Homo sapiens (Human) regulation of mast cell degranulation [GO:0043304] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; regulation of mast cell degranulation [GO:0043304] GO:0005737; GO:0043304 EREFVYK 0.98555 -2.6309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7465 0 0 12.5163 11.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5562 0 0 13.3319 0 0 0 0 0 0 14.1704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7981 0 0 0 0 0 0 0 0 0 0 14.182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8834 0 0 0 0 12.3532 0 0 0 0 0 0 0 0 0 A0A1B0GVD1 F237B_HUMAN Protein FAM237B FAM237B Homo sapiens (Human) MCFATRR 0.98556 -2.9002 0 0 0 0 0 0 0 0 0 0 16.8358 0 0 0 0 0 11.679 14.0729 14.4491 0 0 0 11.0289 0 0 0 0 14.1568 0 0 11.1286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5097 16.4832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60359 CCG3_HUMAN "Voltage-dependent calcium channel gamma-3 subunit (Neuronal voltage-gated calcium channel gamma-3 subunit) (Transmembrane AMPAR regulatory protein gamma-3, TARP gamma-3)" CACNG3 Homo sapiens (Human) "calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]" AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; voltage-gated calcium channel complex [GO:0005891] "AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; somatodendritic compartment [GO:0036477]; voltage-gated calcium channel complex [GO:0005891]; channel regulator activity [GO:0016247]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of AMPA receptor activity [GO:2000311]; transmission of nerve impulse [GO:0019226]" GO:0005245; GO:0005886; GO:0005891; GO:0006605; GO:0006816; GO:0008104; GO:0016247; GO:0019226; GO:0030165; GO:0030425; GO:0030666; GO:0032281; GO:0035255; GO:0036477; GO:0051968; GO:0060076; GO:0098685; GO:0098839; GO:0098943; GO:0098970; GO:0098978; GO:0099061; GO:0099590; GO:0099645; GO:2000311; GO:2000969 channel regulator activity [GO:0016247]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; voltage-gated calcium channel activity [GO:0005245] HQQLRAKSHSEFLK 0.98556 -3.8467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51157 RAB28_HUMAN Ras-related protein Rab-28 RAB28 Homo sapiens (Human) intracellular protein transport [GO:0006886]; toxin transport [GO:1901998] ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; toxin transport [GO:1901998] GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0019003; GO:0035253; GO:0036064; GO:1901998 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] QTIGLDFFLRRITLPGNLNVTLQIWDIGGQTIGGK 0.98556 -3.5814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9284 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14686 NCOA6_HUMAN "Nuclear receptor coactivator 6 (Activating signal cointegrator 2, ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250, NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein, PPAR-interacting protein, PRIP) (Thyroid hormone receptor-binding protein)" NCOA6 AIB3 KIAA0181 RAP250 TRBP Homo sapiens (Human) "brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; histone H3-K4 methylation [GO:0051568]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]" cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA-templated transcription, initiation [GO:0006352]; heart development [GO:0007507]; histone H3-K4 methylation [GO:0051568]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to hormone [GO:0009725]" GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006352; GO:0006974; GO:0007420; GO:0007507; GO:0009725; GO:0019899; GO:0030099; GO:0030331; GO:0030374; GO:0035097; GO:0043231; GO:0044666; GO:0045893; GO:0045944; GO:0046965; GO:0046966; GO:0051568 chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713] GKVDKIGQILLTK 0.98556 -2.6399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1635 0 0 0 0 0 0 0 0 0 14.16 0 0 0 0 13.8277 0 0 13.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RM4 CC142_HUMAN Coiled-coil domain-containing protein 142 CCDC142 PSEC0243 Homo sapiens (Human) AVLLRLHR 0.98556 -2.4121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.791 11.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8029 0 0 0 0 0 0 0 0 0 0 12.5299 0 0 0 0 12.2011 0 0 0 0 12.2087 12.3766 0 0 0 0 0 0 0 0 0 0 0 12.825 0 12.9073 0 0 0 0 11.1537 0 0 0 0 0 0 0 0 0 0 0 0 12.8617 0 0 0 0 13.6556 0 0 0 13.9269 0 0 0 0 0 12.9186 0 0 0 0 0 0 0 0 0 13.3183 0 0 0 14.9917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5461 0 14.448 0 Q6NV75 GP153_HUMAN Probable G-protein coupled receptor 153 (G-protein coupled receptor PGR1) GPR153 PGR1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930] PLQEDKMQYLQVPPTR 0.98556 -3.6746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXT6 TAPT1_HUMAN Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor) TAPT1 CMVFR Homo sapiens (Human) cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; growth hormone-releasing hormone receptor activity [GO:0016520]; cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724] GO:0001503; GO:0005654; GO:0005813; GO:0005829; GO:0014032; GO:0016021; GO:0016520; GO:0030030; GO:0030176; GO:0035437; GO:0036064; GO:0045724; GO:0048706; GO:0051216; GO:0061036; GO:1903012 growth hormone-releasing hormone receptor activity [GO:0016520] FNDITADVYSEYR 0.98556 -2.6366 0 0 0 0 11.5554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6815 0 0 0 0 0 0 11.7508 0 11.2954 0 0 0 0 0 0 0 0 0 10.8714 0 0 0 0 0 0 0 0 0 0 12.0878 0 0 12.5104 0 0 0 0 0 14.0679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3016 0 0 0 11.8892 12.5425 0 0 0 12.3925 0 0 0 0 10.2846 0 0 0 0 0 0 0 14.273 0 0 0 0 0 0 11.2392 0 13.5649 0 13.4372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8653 0 0 0 0 0 0 0 Q7RTX0 TS1R3_HUMAN Taste receptor type 1 member 3 (Sweet taste receptor T1R3) TAS1R3 T1R3 TR3 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sweet taste receptor complex [GO:1903767] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sweet taste receptor complex [GO:1903767]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917] GO:0001582; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008527; GO:0016021; GO:0050916; GO:0050917; GO:1903767 G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] FSSNGLLWALAMK 0.98556 -2.6411 0 0 0 0 0 0 0 0 11.7744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1987 0 0 0 0 0 0 0 0 0 0 10.7394 0 0 0 13.8236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4628 0 0 0 0 0 0 0 0 0 0 12.8023 10.5453 0 11.3512 0 0 0 0 13.2221 0 0 0 0 0 0 0 0 0 0 0 13.6983 0 0 0 0 0 0 0 0 0 0 0 0 11.0535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDX6 CGAT1_HUMAN "Chondroitin sulfate N-acetylgalactosaminyltransferase 1, CsGalNAcT-1, EC 2.4.1.174 (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1, Beta4GalNAcT-1)" CSGALNACT1 CHGN GALNACT1 UNQ656/PRO1287 Homo sapiens (Human) "chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]" Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] "Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; proteoglycan biosynthetic process [GO:0030166]; UDP-glucuronate metabolic process [GO:0046398]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]" GO:0000139; GO:0008376; GO:0008955; GO:0015014; GO:0015020; GO:0019276; GO:0030166; GO:0030173; GO:0030206; GO:0030210; GO:0032580; GO:0046398; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050653 acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronosyltransferase activity [GO:0015020]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; peptidoglycan glycosyltransferase activity [GO:0008955] DFGFGMTCQYR 0.98556 -2.8145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5672 0 0 12.9957 0 0 0 12.611 0 0 0 14.3773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6935 13.901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7628 13.712 13.7598 0 0 0 11.7635 0 Q9Y573 IPP_HUMAN "Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide, IPP) (Kelch-like protein 27)" IPP KLHL27 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0015629 actin binding [GO:0003779] AADSPFSSDKHAQLILAQINKMR 0.98556 -2.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4947 0 0 0 0 0 0 0 13.1862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.649 0 0 0 0 12.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVW6 ARI3B_HUMAN "AT-rich interactive domain-containing protein 3B, ARID domain-containing protein 3B (Bright and dead ringer protein) (Bright-like protein)" ARID3B BDP DRIL2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0045944 DNA binding [GO:0003677] MEPLQQQQQQQQQQQKQPHLAPLQMDAREK 0.98557 -3.8506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9247 0 0 0 0 0 12.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6545 0 0 0 0 0 0 12.206 12.1101 11.6378 0 0 0 17.263 0 11.5753 0 11.2351 11.5511 0 0 0 0 0 0 0 10.3862 12.8908 0 0 0 13.042 0 0 0 0 0 0 0 0 12.6202 0 17.4542 0 0 0 0 0 16.5421 13.496 12.1012 0 0 0 0 0 0 0 12.7139 13.0843 13.6015 0 0 0 11.238 0 13.3313 0 13.1091 0 0 0 0 0 0 0 0 17.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6259 0 0 0 0 0 0 0 Q96JW4 S41A2_HUMAN Solute carrier family 41 member 2 SLC41A2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095] GO:0005886; GO:0015095; GO:0016021 magnesium ion transmembrane transporter activity [GO:0015095] FLNLLLSMVPVIYQK 0.98557 -3.8559 10.5865 0 0 0 0 0 11.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.485 12.7286 16.9258 12.3157 0 0 0 0 0 0 0 0 0 12.1927 0 0 0 0 0 0 0 0 0 14.8507 13.4027 15.201 0 0 12.4995 13.5336 13.1054 12.7105 0 0 0 0 0 0 0 18.2785 0 0 0 0 14.8035 14.3238 0 14.9379 0 17.8981 11.8987 11.8465 0 14.7082 15.3098 13.923 14.1078 14.4122 0 0 15.4993 14.9012 14.6544 14.0359 15.7532 0 0 0 0 0 0 0 0 14.4661 13.6214 0 11.8667 12.1586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60931 CTNS_HUMAN Cystinosin CTNS Homo sapiens (Human) adult walking behavior [GO:0007628]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; cognition [GO:0050890]; glutathione metabolic process [GO:0006749]; grooming behavior [GO:0007625]; ion transport [GO:0006811]; L-cystine transport [GO:0015811]; lens development in camera-type eye [GO:0002088]; long-term memory [GO:0007616]; melanin biosynthetic process [GO:0042438]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; regulation of melanin biosynthetic process [GO:0048021]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; L-cystine transmembrane transporter activity [GO:0015184]; solute:proton symporter activity [GO:0015295]; adult walking behavior [GO:0007628]; ATP metabolic process [GO:0046034]; brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; cognition [GO:0050890]; glutathione metabolic process [GO:0006749]; grooming behavior [GO:0007625]; ion transport [GO:0006811]; L-cystine transport [GO:0015811]; lens development in camera-type eye [GO:0002088]; long-term memory [GO:0007616]; melanin biosynthetic process [GO:0042438]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; regulation of melanin biosynthetic process [GO:0048021]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] GO:0002088; GO:0005764; GO:0005765; GO:0005770; GO:0005774; GO:0005886; GO:0006520; GO:0006749; GO:0006811; GO:0007420; GO:0007616; GO:0007625; GO:0007628; GO:0008542; GO:0010730; GO:0010918; GO:0015031; GO:0015184; GO:0015295; GO:0015811; GO:0016021; GO:0033162; GO:0042438; GO:0042470; GO:0043231; GO:0045111; GO:0046034; GO:0048021; GO:0050890; GO:0055085; GO:0070062; GO:1904263 L-cystine transmembrane transporter activity [GO:0015184]; solute:proton symporter activity [GO:0015295] IRNWLTIFILFPLKLVEK 0.98557 -3.855 0 0 0 0 0 0 0 0 10.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1159 0 0 0 0 0 0 0 11.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7911 12.8293 0 0 0 0 0 0 0 0 0 11.7591 0 0 0 10.6971 0 0 0 0 14.0202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.691 0 0 0 0 0 0 0 0 0 0 0 11.9816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5665 0 0 0 0 0 0 0 0 0 0 0 0 P19021 AMD_HUMAN "Peptidyl-glycine alpha-amidating monooxygenase, PAM [Includes: Peptidylglycine alpha-hydroxylating monooxygenase, PHM, EC 1.14.17.3; Peptidyl-alpha-hydroxyglycine alpha-amidating lyase, EC 4.3.2.5 (Peptidylamidoglycolate lyase, PAL) ]" PAM Homo sapiens (Human) central nervous system development [GO:0007417]; fatty acid primary amide biosynthetic process [GO:0062112]; heart development [GO:0007507]; lactation [GO:0007595]; limb development [GO:0060173]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in female pregnancy [GO:0060135]; odontogenesis [GO:0042476]; ovulation cycle process [GO:0022602]; peptide amidation [GO:0001519]; protein amidation [GO:0018032]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein secretion [GO:0050708]; regulation of transcription by RNA polymerase II [GO:0006357]; response to copper ion [GO:0046688]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; toxin metabolic process [GO:0009404] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; fatty acid primary amide biosynthetic process [GO:0062112]; heart development [GO:0007507]; lactation [GO:0007595]; limb development [GO:0060173]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in female pregnancy [GO:0060135]; odontogenesis [GO:0042476]; ovulation cycle process [GO:0022602]; peptide amidation [GO:0001519]; protein amidation [GO:0018032]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein secretion [GO:0050708]; regulation of transcription by RNA polymerase II [GO:0006357]; response to copper ion [GO:0046688]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; toxin metabolic process [GO:0009404] GO:0001519; GO:0001666; GO:0001676; GO:0004504; GO:0004598; GO:0005507; GO:0005509; GO:0005576; GO:0005802; GO:0005886; GO:0006357; GO:0007417; GO:0007507; GO:0007595; GO:0008270; GO:0009268; GO:0009404; GO:0009410; GO:0009986; GO:0010043; GO:0016020; GO:0016021; GO:0018032; GO:0019901; GO:0022602; GO:0030658; GO:0030667; GO:0031418; GO:0032355; GO:0032956; GO:0042476; GO:0042802; GO:0043005; GO:0043204; GO:0046688; GO:0048471; GO:0050708; GO:0051384; GO:0060135; GO:0060173; GO:0062112; GO:0070062 calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] ASMDTVHHMLLFGCNMPSSTGSYWFCDEGTCTDK 0.98557 -3.5913 0 0 0 0 11.9929 0 0 0 14.211 0 0 14.0383 0 0 13.5223 0 0 0 0 0 0 13.8367 0 0 0 12.9349 0 0 0 11.9639 0 0 0 0 0 0 12.003 0 0 0 0 12.5527 0 0 0 0 0 14.5084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8469 0 0 0 0 0 0 0 12.8238 14.1435 0 0 12.8395 14.4107 11.8062 0 0 0 0 12.6583 0 0 12.9843 13.4719 0 0 0 12.7952 13.5576 0 0 0 0 0 0 0 0 0 0 0 12.3365 11.0829 0 0 0 0 0 0 0 13.1285 0 0 0 0 14.9835 14.1677 13.6371 0 12.5959 0 13.5788 0 0 0 0 0 0 0 14.5882 12.4823 11.8993 0 0 0 12.6545 0 12.3674 12.5932 12.0822 0 0 0 0 10.565 0 0 12.5396 0 14.0724 13.5021 0 0 0 0 13.1285 Q13033 STRN3_HUMAN Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen) STRN3 GS2NA SG2NA Homo sapiens (Human) "negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estradiol [GO:0032355]" GO:0000122; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0030425; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0043025; GO:0044877; GO:0045892; GO:0045944; GO:0051721; GO:0070016; GO:0090443 armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] LPCICTYNGDKK 0.98557 -3.5034 0 0 0 0 0 0 10.445 10.7433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5728 0 0 0 0 0 0 0 0 0 0 0 0 16.3519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.024 0 0 0 0 0 0 0 0 0 9.72535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.474 0 12.0271 0 0 0 14.542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7325 0 0 0 12.1147 0 0 0 12.1021 0 11.9346 0 0 0 12.0281 0 0 0 0 0 0 0 0 0 0 0 12.1964 0 0 0 0 0 0 0 18.4113 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5564 0 0 0 0 0 0 0 0 20.5646 0 0 0 0 0 0 0 0 Q13164 MK07_HUMAN "Mitogen-activated protein kinase 7, MAP kinase 7, MAPK 7, EC 2.7.11.24 (Big MAP kinase 1, BMK-1) (Extracellular signal-regulated kinase 5, ERK-5)" MAPK7 BMK1 ERK5 PRKM7 Homo sapiens (Human) calcineurin-NFAT signaling cascade [GO:0033173]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of angiogenesis [GO:0045765]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; calcineurin-NFAT signaling cascade [GO:0033173]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to transforming growth factor beta stimulus [GO:0071560]; intracellular signal transduction [GO:0035556]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of inflammatory response [GO:0050728]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of response to cytokine stimulus [GO:0060761]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of angiogenesis [GO:0045765]; signal transduction [GO:0007165] GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0016605; GO:0018105; GO:0019933; GO:0030154; GO:0033173; GO:0034115; GO:0035556; GO:0036003; GO:0045765; GO:0045944; GO:0050728; GO:0051019; GO:0051247; GO:0051344; GO:0060761; GO:0070301; GO:0070885; GO:0071363; GO:0071499; GO:0071560; GO:0106310; GO:1902176; GO:2000352; GO:2001240 ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; mitogen-activated protein kinase binding [GO:0051019]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ELKILKHFK 0.98557 -3.5045 0 0 0 0 0 0 0 0 13.5037 0 0 0 0 0 0 12.613 12.8188 0 10.9218 0 0 0 12.466 0 0 0 0 12.7088 12.7514 12.9031 0 0 0 0 0 0 0 0 13.108 12.7212 12.3171 0 0 12.8629 12.3808 0 0 0 0 0 0 0 0 0 0 0 0 13.8385 12.9478 0 0 0 0 12.7144 13.0639 0 0 0 10.8559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.671 0 0 0 0 0 0 0 0 0 15.1683 0 0 0 0 0 0 0 14.7581 0 0 0 0 0 0 0 16.4454 0 0 14.9291 0 10.2354 0 0 0 0 0 12.2245 0 0 0 0 0 0 0 0 0 11.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5061 0 0 0 14.3667 14.5228 0 0 0 0 0 0 0 0 0 Q2MV58 TECT1_HUMAN Tectonic-1 TCTN1 TECT1 UNQ9369/PRO34160 Homo sapiens (Human) central nervous system interneuron axonogenesis [GO:0021956]; cilium assembly [GO:0060271]; dorsal/ventral neural tube patterning [GO:0021904]; in utero embryonic development [GO:0001701]; neural tube formation [GO:0001841]; protein localization to ciliary transition zone [GO:1904491]; regulation of smoothened signaling pathway [GO:0008589]; somatic motor neuron differentiation [GO:0021523]; telencephalon development [GO:0021537] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; MKS complex [GO:0036038] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; MKS complex [GO:0036038]; central nervous system interneuron axonogenesis [GO:0021956]; cilium assembly [GO:0060271]; dorsal/ventral neural tube patterning [GO:0021904]; in utero embryonic development [GO:0001701]; neural tube formation [GO:0001841]; protein localization to ciliary transition zone [GO:1904491]; regulation of smoothened signaling pathway [GO:0008589]; somatic motor neuron differentiation [GO:0021523]; telencephalon development [GO:0021537] GO:0001701; GO:0001841; GO:0005615; GO:0005829; GO:0005856; GO:0008589; GO:0016020; GO:0021523; GO:0021537; GO:0021904; GO:0021956; GO:0036038; GO:0060271; GO:1904491 LTGALPCQLVAQK 0.98557 -3.5021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8016 0 0 0 0 0 12.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4292 0 0 0 12.6358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WR6 CQ064_HUMAN Uncharacterized protein C17orf64 C17orf64 Homo sapiens (Human) FISLFSELEAKQLR 0.98557 -2.6424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8756 0 0 12.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2587 0 0 0 0 0 0 0 11.158 13.3119 0 0 11.8485 0 12.0608 10.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0748 0 0 0 0 0 0 0 0 12.9762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8Z3 PRR26_HUMAN Putative uncharacterized protein DIP2C-AS1 (DIP2C antisense RNA 1) (Proline-rich protein 26) DIP2C-AS1 C10orf108 PRR26 Homo sapiens (Human) ARDHGARGCGPR 0.98557 -3.5028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY12 SCAPE_HUMAN "S phase cyclin A-associated protein in the endoplasmic reticulum, S phase cyclin A-associated protein in the ER (Zinc finger protein 291)" SCAPER KIAA1454 ZNF291 MSTP063 Homo sapiens (Human) antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] EKLREEK 0.98557 -3.5875 0 0 0 0 0 15.6908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2165 0 0 0 0 0 0 0 10.943 0 0 0 0 0 0 0 0 0 0 13.1183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5108 0 13.449 0 0 15.6722 0 11.9277 0 0 0 15.1594 0 0 17.4854 0 0 11.5311 0 11.3448 13.8195 0 0 0 0 0 0 0 14.8228 12.4663 12.9298 0 0 0 0 0 16.1947 0 12.9764 0 0 0 0 14.9204 0 0 0 13.1407 0 13.3029 0 0 13.4831 0 0 0 0 13.5919 0 0 0 0 0 0 0 17.2713 0 13.1302 0 12.5197 0 0 12.3424 0 11.7726 13.1228 11.5005 13.332 0 0 13.0147 0 13.1486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9644 0 0 16.1271 0 0 0 Q9Y2C3 B3GT5_HUMAN "Beta-1,3-galactosyltransferase 5, Beta-1,3-GalTase 5, Beta3Gal-T5, Beta3GalT5, b3Gal-T5, EC 2.4.1.- (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)" B3GALT5 Homo sapiens (Human) lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; response to bacterium [GO:0009617] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; lipid metabolic process [GO:0006629]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; response to bacterium [GO:0009617]" GO:0000139; GO:0005783; GO:0005794; GO:0006486; GO:0006629; GO:0008194; GO:0008499; GO:0009312; GO:0009617; GO:0016021; GO:0016757 "glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" FSVCLFR 0.98557 -3.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1789 0 0 0 0 0 0 0 0 0 10.4916 0 0 0 0 0 0 0 0 0 11.5478 0 0 0 0 0 0 0 11.1094 0 0 0 0 0 0 0 11.6143 11.6245 0 12.6099 11.4929 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1407 12.3184 0 0 0 0 15.0317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6G5 COMDA_HUMAN COMM domain-containing protein 10 COMMD10 HSPC305 PTD002 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] GO:0005654; GO:0005737 AVSLINAIDTGRFPRLLTR 0.98557 -2.8228 0 10.0503 0 0 0 0 11.203 0 0 0 0 0 0 13.1584 0 0 0 12.8602 0 11.6691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.407 0 0 0 0 0 0 12.9302 0 0 0 0 0 0 14.2961 0 0 0 0 0 14.1619 13.3691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1662 0 0 0 0 0 0 0 0 0 0 0 10.28 0 0 0 0 0 0 0 0 0 0 0 0 13.5056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75360 PROP1_HUMAN "Homeobox protein prophet of Pit-1, PROP-1 (Pituitary-specific homeodomain factor)" PROP1 Homo sapiens (Human) apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; hypophysis morphogenesis [GO:0048850]; hypothalamus cell differentiation [GO:0021979]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357]; somatotropin secreting cell differentiation [GO:0060126] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cell migration [GO:0016477]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; hypophysis morphogenesis [GO:0048850]; hypothalamus cell differentiation [GO:0021979]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357]; somatotropin secreting cell differentiation [GO:0060126]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001568; GO:0003682; GO:0005634; GO:0005667; GO:0006357; GO:0006915; GO:0007417; GO:0008013; GO:0008022; GO:0009953; GO:0016477; GO:0021979; GO:0043066; GO:0048850; GO:0060126; GO:1990837 "beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" KGRVGSNLLPER 0.98558 -2.0892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14500 KCJ12_HUMAN "ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2, IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12)" KCNJ12 IRK2 KCNJN1 Homo sapiens (Human) muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005886; GO:0006813; GO:0006936; GO:0008016; GO:0016021; GO:0031224; GO:0034765; GO:0051289; GO:1990573 inward rectifier potassium channel activity [GO:0005242] CRNRFVK 0.98558 -3.8764 0 0 0 0 0 0 0 0 14.72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2428 0 0 13.0241 0 0 0 0 13.446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15061 WDR43_HUMAN WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog) WDR43 KIAA0007 UTP5 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation regulator activity [GO:0003711]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" GO:0000462; GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0034243; GO:0045943; GO:2000036; GO:2000234 RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation regulator activity [GO:0003711] DEDVEEEDEDAEGKDEENGEDR 0.98558 -3.8703 0 0 0 0 0 0 0 0 0 0 13.2975 12.159 0 0 9.93908 0 0 0 0 12.7782 0 0 0 0 12.2237 0 11.6647 0 12.0385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0928 0 0 0 0 11.2108 0 13.4694 0 14.324 12.8981 0 11.9336 0 0 15.6286 0 12.3039 0 0 0 0 11.9836 0 0 12.324 11.8563 0 14.4934 13.0866 0 0 0 12.0416 0 15.9403 0 0 11.8603 0 13.7242 11.5812 12.8831 0 0 13.7747 0 0 13.2833 0 0 0 0 0 0 0 0 0 0 13.8841 0 14.141 0 0 0 0 0 13.4665 0 13.6947 0 0 0 0 0 0 0 0 12.0815 0 0 0 15.1819 0 0 0 0 11.3047 0 0 0 0 0 0 14.2101 0 12.1521 0 0 0 0 0 0 0 0 13.6052 13.279 0 11.6816 0 12.7748 0 0 Q16236 NF2L2_HUMAN "Nuclear factor erythroid 2-related factor 2, NF-E2-related factor 2, NFE2-related factor 2, Nrf-2 (HEBP1) (Nuclear factor, erythroid derived 2, like 2)" NFE2L2 NRF2 Homo sapiens (Human) aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to copper ion [GO:0071280]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of innate immune response [GO:0045088]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lithium ion [GO:0010226] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; aflatoxin catabolic process [GO:0046223]; aging [GO:0007568]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to copper ion [GO:0071280]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of embryonic development [GO:0045995]; regulation of innate immune response [GO:0045088]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lithium ion [GO:0010226]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006357; GO:0006954; GO:0007568; GO:0010226; GO:0010499; GO:0010628; GO:0010667; GO:0010976; GO:0016567; GO:0019904; GO:0030194; GO:0030968; GO:0032993; GO:0034599; GO:0036003; GO:0036091; GO:0036499; GO:0042149; GO:0043161; GO:0043536; GO:0043565; GO:0045088; GO:0045454; GO:0045766; GO:0045944; GO:0045995; GO:0046223; GO:0046326; GO:0061419; GO:0061629; GO:0070301; GO:0071280; GO:0071356; GO:0071466; GO:0071498; GO:0071499; GO:0090575; GO:0140467; GO:1902037; GO:1902176; GO:1903071; GO:1903206; GO:1903788; GO:1904385; GO:1904753; GO:2000121; GO:2000352; GO:2000379 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]" DELRAKALHIPFPVEK 0.98558 -2.0942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3138 0 15.0995 0 0 0 0 0 0 15.2374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0664 0 0 0 0 14.7646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6725 0 0 0 0 0 0 0 0 0 Q5JVF3 PCID2_HUMAN PCI domain-containing protein 2 (CSN12-like protein) PCID2 HT004 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of histone exchange [GO:1900049]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]" cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] "cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription, DNA-templated [GO:0045893]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of histone exchange [GO:1900049]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0043066; GO:0043488; GO:0044615; GO:0045579; GO:0045893; GO:0048536; GO:0070390; GO:0090267; GO:1900049; GO:1905457; GO:2000117 double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723] CQTVIVQSFLRAFQAHK 0.98558 -3.8741 0 11.5868 0 0 0 0 0 15.8131 15.8701 16.0138 15.3921 14.1451 13.7582 14.4144 15.7807 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9343 15.5058 13.1809 16.0375 15.9973 15.9478 16.6447 0 16.2604 16.3671 15.4719 15.5026 12.6227 15.7449 15.7527 14.5619 0 0 13.6103 0 0 0 0 0 0 0 12.3476 0 0 10.7811 0 0 11.1958 0 12.1309 0 0 0 0 0 0 0 15.628 0 0 0 0 0 0 0 0 0 16.1601 0 17.6194 0 0 0 0 0 0 0 12.5194 14.4304 0 13.2396 0 0 0 0 14.3335 0 0 0 0 0 0 14.6798 0 0 14.5813 0 0 0 0 0 12.1508 15.2803 13.6334 0 0 14.9847 0 0 0 0 0 14.9696 0 0 0 0 14.229 0 13.8043 0 11.9756 12.9614 12.2869 13.3722 0 0 13.8254 12.47 12.8497 0 0 0 0 15.6074 15.5192 0 14.3592 15.0995 0 0 0 0 13.7656 0 13.3105 13.6884 0 0 13.3902 13.1502 0 0 0 0 13.6011 0 0 13.9746 0 14.6929 13.229 0 0 0 11.7771 14.1776 Q8IWT6 LRC8A_HUMAN "Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A, HsLRRC8A) (Swelling protein 1)" LRRC8A KIAA1437 LRRC8 SWELL1 UNQ221/PRO247 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; anion transport [GO:0006820]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular glucose homeostasis [GO:0001678]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transport [GO:0015734] cell surface [GO:0009986]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; anion transport [GO:0006820]; aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular glucose homeostasis [GO:0001678]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transport [GO:0015734] GO:0001678; GO:0002329; GO:0005225; GO:0005886; GO:0005887; GO:0006820; GO:0006884; GO:0006970; GO:0007283; GO:0009986; GO:0015734; GO:0015810; GO:0016020; GO:0016021; GO:0032024; GO:0034214; GO:0034702; GO:0042802; GO:0045663; GO:0098656; GO:0140360; GO:0140361; GO:1902476; GO:1905103 cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225] ALHIKFTDIKEIPLWIYSLK 0.98558 -2.8293 0 0 0 0 0 11.0347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7547 0 0 12.6292 0 0 0 12.8381 0 0 0 0 0 11.6672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1234 0 0 0 0 0 0 0 0 0 0 0 0 11.1452 0 0 0 0 12.2549 16.0446 11.5552 15.7427 0 0 0 15.3746 14.6157 0 14.698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4314 0 0 0 0 0 12.372 0 0 0 0 0 0 0 0 15.2168 0 16.421 15.1206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6514 0 0 0 14.9266 0 0 13.5231 0 11.2943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91546 0 0 0 0 0 0 0 0 0 0 0 10.4732 0 13.0694 0 0 0 0 0 0 Q9NZL3 ZN224_HUMAN "Zinc finger protein 224 (Bone marrow zinc finger 2, BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22)" ZNF224 BMZF2 KOX22 ZNF233 ZNF255 ZNF27 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0017053; GO:0031965; GO:0043565; GO:0045892; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" APCLLKHERLHSGEK 0.98558 -3.8643 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6317 0 0 0 0 10.5313 0 0 12.8976 10.6677 0 0 10.1453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5052 0 16.5696 16.2391 0 0 0 0 0 13.4319 0 12.749 0 0 14.1501 0 12.9932 0 0 14.5947 0 0 0 14.8977 14.9763 0 14.5552 13.7534 13.866 0 0 0 0 0 14.4269 12.6011 0 0 0 0 0 0 0 14.6517 0 14.7983 11.989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 14.0669 0 12.0317 0 0 0 0 0 0 12.8612 14.1739 0 11.1312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0237 0 0 0 0 0 0 0 Q9Y2K2 SIK3_HUMAN "Serine/threonine-protein kinase SIK3, EC 2.7.11.1 (Salt-inducible kinase 3, SIK-3) (Serine/threonine-protein kinase QSK)" SIK3 KIAA0999 QSK L19 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468] GO:0000226; GO:0000287; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0006468; GO:0035556; GO:0050321; GO:0106310; GO:1904263; GO:1904515 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] GNFAVVKRATHLVTK 0.98558 -2.4332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2986 0 16.0746 0 0 0 16.1548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3422 O60315 ZEB2_HUMAN "Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1, SMADIP1) (Zinc finger homeobox protein 1b)" ZEB2 KIAA0569 SIP1 ZFHX1B ZFX1B HRIHFB2411 Homo sapiens (Human) anatomical structure development [GO:0048856]; developmental pigmentation [GO:0048066]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of melanosome organization [GO:1903056]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure development [GO:0048856]; developmental pigmentation [GO:0048066]; melanocyte migration [GO:0097324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of melanosome organization [GO:1903056]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007399; GO:0019208; GO:0030511; GO:0043565; GO:0045636; GO:0045944; GO:0046872; GO:0048023; GO:0048066; GO:0048856; GO:0090263; GO:0097324; GO:1903056 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; phosphatase regulator activity [GO:0019208]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" CGKRFSHSGSYSQHMNHR 0.98559 -2.5722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99067 11.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0933 0 14.9239 12.8816 0 12.6244 0 0 0 0 0 0 0 0 0 0 0 0 13.0036 0 0 12.3056 0 0 11.2522 0 13.8475 12.3446 13.5798 0 0 0 0 0 0 0 0 0 0 0 11.2573 12.7318 0 0 12.806 11.4745 0 0 0 0 0 0 12.2673 0 0 0 0 0 0 12.8486 0 0 12.8102 0 0 0 0 0 13.1626 15.3283 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9295 0 0 0 0 0 0 0 0 0 0 12.14 0 11.8128 12.3649 0 0 0 0 0 12.1432 0 0 0 0 0 0 0 0 O94779 CNTN5_HUMAN "Contactin-5 (Neural recognition molecule NB-2, hNB-2)" CNTN5 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605] anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886] anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; presynapse assembly [GO:0099054]; sensory perception of sound [GO:0007605] GO:0005576; GO:0005886; GO:0007411; GO:0007420; GO:0007605; GO:0030424; GO:0098609; GO:0098632; GO:0098982; GO:0099026; GO:0099054 cell-cell adhesion mediator activity [GO:0098632] ENKRIAILPDGSLR 0.98559 -2.5729 0 0 0 0 0 0 11.1102 12.0042 0 12.229 0 0 0 0 0 0 0 0 10.93 0 0 0 13.2606 0 0 0 13.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65666 0 15.1982 12.4852 0 0 0 14.7908 0 0 14.5809 0 15.2461 0 0 14.7318 0 0 0 14.2238 14.515 0 0 0 0 0 15.5654 0 15.0773 14.3763 0 0 0 14.7255 0 0 15.0249 0 0 15.6094 0 14.174 0 0 0 0 0 0 0 14.9469 13.2703 0 0 0 0 13.6049 0 0 0 0 0 0 0 0 0 0 0 9.2395 0 0 0 16.7281 0 0 0 0 0 0 18.0463 14.212 0 0 0 10.8021 0 0 0 10.9425 0 0 0 0 0 0 0 0 13.7649 0 0 0 12.3501 0 0 Q15743 OGR1_HUMAN "Ovarian cancer G-protein coupled receptor 1, OGR-1 (G-protein coupled receptor 68) (GPR12A) (Sphingosylphosphorylcholine receptor)" GPR68 OGR1 Homo sapiens (Human) cellular response to pH [GO:0071467]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; monocyte differentiation [GO:0030224]; negative regulation of monocyte differentiation [GO:0045656]; osteoclast development [GO:0036035]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of osteoclast development [GO:2001206] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cellular response to pH [GO:0071467]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; monocyte differentiation [GO:0030224]; negative regulation of monocyte differentiation [GO:0045656]; osteoclast development [GO:0036035]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of osteoclast development [GO:2001206] GO:0004930; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0030073; GO:0030224; GO:0035774; GO:0036035; GO:0045656; GO:0071467; GO:2001206 G protein-coupled receptor activity [GO:0004930] AREAYPLGAPEASGKSGAQGEEPELLTK 0.98559 -2.6688 0 0 0 0 0 0 0 0 0 0 13.7698 0 0 0 0 0 0 0 0 0 0 0 10.9238 0 0 0 0 0 0 0 0 0 0 13.3918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9275 0 0 0 0 0 0 0 0 0 12.2679 12.7034 12.7497 0 0 0 0 0 0 0 0 0 0 14.49 0 13.9589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2537 0 12.1236 0 0 0 0 0 13.5747 0 0 0 0 0 0 0 0 0 0 11.0503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P461 ACSM6_HUMAN "Acyl-coenzyme A synthetase ACSM6, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 6)" ACSM6 C10orf129 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] GO:0004321; GO:0005524; GO:0005525; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0031956; GO:0046872; GO:0047760 ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872] DVLDQWSQLEKDGLR 0.98559 -2.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WA6 BPHL_HUMAN "Valacyclovir hydrolase, VACVase, Valacyclovirase, EC 3.1.-.- (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein, Bph-rp) (Breast epithelial mucin-associated antigen, MCNAA)" BPHL MCNAA Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; alpha-amino-acid esterase activity [GO:0047658]; cellular amino acid metabolic process [GO:0006520]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0047658 alpha-amino-acid esterase activity [GO:0047658] DAKDAVDLMKALK 0.98559 -2.9389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7252 0 0 0 0 0 0 0 0 0 0 10.9924 0 0 0 0 0 0 0 0 0 11.9792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6401 0 0 0 0 0 0 17.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4598 0 0 11.6891 0 0 0 0 0 0 0 0 0 0 12.0198 13.7755 0 0 0 12.8843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5539 0 0 0 0 0 12.5813 0 0 0 0 0 0 0 11.5764 0 0 0 0 12.5122 0 0 0 0 0 0 0 Q8TAT5 NEIL3_HUMAN "Endonuclease 8-like 3, EC 3.2.2.-, EC 4.2.99.18 (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3)" NEIL3 Homo sapiens (Human) "base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; depurination [GO:0045007]; interstrand cross-link repair [GO:0036297]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; MCM complex binding [GO:1904931]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; depurination [GO:0045007]; interstrand cross-link repair [GO:0036297]" GO:0000405; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0005634; GO:0005654; GO:0005694; GO:0006284; GO:0006285; GO:0008270; GO:0019104; GO:0036297; GO:0045007; GO:0140078; GO:1904931 bubble DNA binding [GO:0000405]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; MCM complex binding [GO:1904931]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] ALRIHFGMKGFIMINPLEYK 0.98559 -2.9408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5103 0 0 0 0 0 0 0 0 0 14.9203 13.828 14.9483 14.0075 15.1397 0 0 0 0 0 15.0423 0 0 0 0 0 0 14.3221 0 13.4105 0 0 0 13.5731 0 0 0 0 0 0 0 0 0 0 0 0 0 13.662 13.9885 0 0 13.7916 0 15.4389 16.3016 0 14.772 14.4763 0 0 0 13.6995 15.0643 0 0 0 14.043 15.4806 0 0 0 0 12.5704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9974 12.4166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5615 0 0 0 0 0 0 Q96F63 CCD97_HUMAN Coiled-coil domain-containing protein 97 CCDC97 Homo sapiens (Human) DEEERYFDEEEPEDAPSPELDGD 0.98559 -2.4834 0 0 10.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8397 0 0 11.2211 0 0 11.9607 0 0 0 0 0 0 0 0 0 0 0 12.8533 0 0 0 0 0 0 0 0 0 0 0 0 13.6274 13.5904 0 0 0 0 0 0 0 0 0 13.7777 0 13.9244 0 0 0 0 0 0 0 13.0877 12.2753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3745 14.1648 0 0 13.8139 0 12.3609 0 0 0 13.3523 13.1494 0 0 0 0 0 0 0 0 13.127 13.2254 0 0 0 0 13.5074 0 13.5761 0 0 0 0 10.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9596 0 0 0 0 0 0 Q99828 CIB1_HUMAN "Calcium and integrin-binding protein 1, CIB (Calcium- and integrin-binding protein, CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein, KIP) (SNK-interacting protein 2-28, SIP2-28)" CIB1 CIB KIP PRKDCIP Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163] apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163] GO:0000287; GO:0001525; GO:0001933; GO:0001934; GO:0001954; GO:0002931; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005886; GO:0006302; GO:0006915; GO:0006974; GO:0007026; GO:0007113; GO:0007155; GO:0007286; GO:0008284; GO:0008285; GO:0008427; GO:0010977; GO:0016020; GO:0016324; GO:0030027; GO:0030220; GO:0030291; GO:0030307; GO:0030335; GO:0030424; GO:0030426; GO:0031122; GO:0031267; GO:0031982; GO:0032433; GO:0032587; GO:0033630; GO:0038163; GO:0042127; GO:0042383; GO:0043005; GO:0043025; GO:0043066; GO:0043085; GO:0043204; GO:0043495; GO:0044325; GO:0045653; GO:0048471; GO:0051092; GO:0051301; GO:0051302; GO:0051898; GO:0070062; GO:0070374; GO:0070886; GO:0071356; GO:0071363; GO:0071902; GO:0071944; GO:0090050; GO:0090314; GO:0097191; GO:1900026; GO:1903078; GO:1990090; GO:2000256 calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] IFDFDDDGTLNREDLSRLVNCLTGEGEDTR 0.98559 -2.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2798 11.6059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYF3 FA53C_HUMAN Protein FAM53C FAM53C C5orf6 Homo sapiens (Human) protein import into nucleus [GO:0006606] nucleus [GO:0005634] nucleus [GO:0005634]; protein import into nucleus [GO:0006606] GO:0005634; GO:0006606 LPVPPAPPSKRHCR 0.98559 -3.0388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A98 TIP39_HUMAN "Tuberoinfundibular peptide of 39 residues, TIP39 (Parathyroid hormone 2)" PTH2 TIP39 TIPF39 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218] GO:0005576; GO:0007218 AWADPATPRPRR 0.9856 -2.8554 0 0 0 9.82249 10.4758 0 0 0 0 0 0 10.8695 9.94603 0 0 13.4354 0 0 10.9217 0 16.2838 0 0 11.6991 0 0 0 0 0 0 0 0 10.4667 0 0 12.9092 0 0 0 0 0 0 13.2262 0 12.8212 0 10.6582 12.8095 0 0 0 0 0 0 0 12.132 0 0 0 0 0 0 0 0 0 0 0 16.8718 0 0 0 12.7431 17.5315 0 12.0707 11.6312 0 12.2752 0 0 0 18.2002 18.2798 0 11.9717 14.1384 12.1233 17.8733 17.9613 12.5682 0 0 10.691 14.5813 13.9628 0 13.4015 17.846 0 18.2683 13.6669 0 0 0 17.6861 0 13.9787 0 18.5597 0 19.375 0 0 17.6533 0 18.4858 0 0 0 0 0 17.4265 0 14.356 17.9548 0 17.4491 17.3576 0 0 14.3647 11.1824 0 0 0 0 15.0081 0 0 18.1927 0 13.6939 0 0 0 0 12.6182 13.4473 9.78375 0 13.2502 0 13.94 0 0 0 0 0 10.7364 0 0 0 12.6662 0 0 0 0 12.3348 0 0 0 0 0 0 0 0 0 0 0 0 O00178 GTPB1_HUMAN "GTP-binding protein 1, G-protein 1, GP-1, GP1" GTPBP1 Homo sapiens (Human) GTP metabolic process [GO:0046039]; immune response [GO:0006955]; positive regulation of mRNA catabolic process [GO:0061014]; signal transduction [GO:0007165]; translational elongation [GO:0006414] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; immune response [GO:0006955]; positive regulation of mRNA catabolic process [GO:0061014]; signal transduction [GO:0007165]; translational elongation [GO:0006414] GO:0000177; GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0006955; GO:0007165; GO:0016020; GO:0046039; GO:0061014 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] AAAAAAR 0.9856 -3.3417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1346 15.6108 15.2103 14.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.63 0 0 0 0 0 12.8695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1999 0 0 0 0 0 0 15.4896 14.5959 0 0 0 0 0 0 11.6838 13.1496 15.8386 0 11.1522 0 0 14.347 0 0 0 0 12.1437 0 17.0583 0 0 P98196 AT11A_HUMAN "Phospholipid-transporting ATPase IH, EC 7.6.2.1 (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A)" ATP11A ATPIH ATPIS KIAA1021 Homo sapiens (Human) in utero embryonic development [GO:0001701]; phospholipid translocation [GO:0045332]; positive regulation of myotube differentiation [GO:0010831] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; in utero embryonic development [GO:0001701]; phospholipid translocation [GO:0045332]; positive regulation of myotube differentiation [GO:0010831] GO:0000287; GO:0001701; GO:0005524; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0010831; GO:0016020; GO:0016887; GO:0035579; GO:0043231; GO:0045332; GO:0055037; GO:0070821; GO:0090555; GO:0090556; GO:0140326; GO:0140346; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] AADTIEALQKAGIKVWVLTGDK 0.9856 -2.8523 0 0 0 0 0 0 0 0 0 13.5614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4834 0 0 0 0 0 13.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4944 0 15.2163 0 0 0 0 0 0 0 12.7071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2028 0 13.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.971 0 0 Q3LXA3 TKFC_HUMAN "Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase, DHA kinase, EC 2.7.1.28, EC 2.7.1.29 (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing), EC 4.6.1.15 (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase) ]" TKFC DAK Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088] GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0019563; GO:0034012; GO:0039534; GO:0044262; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062 ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354] AAGDGDCGTTHSR 0.9856 -2.6832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4407 0 0 13.5424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6JVE9 LCN8_HUMAN Epididymal-specific lipocalin-8 LCN8 LCN5 Homo sapiens (Human) response to hormone [GO:0009725] extracellular region [GO:0005576] extracellular region [GO:0005576]; small molecule binding [GO:0036094]; response to hormone [GO:0009725] GO:0005576; GO:0009725; GO:0036094 small molecule binding [GO:0036094] FAFPGHR 0.9856 -2.4964 0 0 0 0 0 0 0 0 0 13.0412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0527 0 0 0 13.3541 0 0 13.5451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6332 0 0 0 0 0 0 0 0 13.5139 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5425 0 0 0 0 13.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7001 13.0848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1X6 CH082_HUMAN UPF0598 protein C8orf82 C8orf82 Homo sapiens (Human) AGGVGLVRSALAFELSACFEYGPGAPALPSHVRWQGR 0.9856 -3.6167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8108 13.4179 0 0 0 0 0 0 0 0 14.4887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5B4 RIC3_HUMAN Protein RIC-3 (Resistant to inhibitor of cholinesterase 3) RIC3 UNQ720/PRO1385 Homo sapiens (Human) "positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; protein-containing complex assembly [GO:0065003]; synaptic transmission, cholinergic [GO:0007271]" endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202] "endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; protein folding chaperone [GO:0044183]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; protein-containing complex assembly [GO:0065003]; synaptic transmission, cholinergic [GO:0007271]" GO:0000139; GO:0005789; GO:0007204; GO:0007271; GO:0016021; GO:0033130; GO:0034394; GO:0043005; GO:0043025; GO:0043231; GO:0044183; GO:0045202; GO:0065003; GO:2000010 acetylcholine receptor binding [GO:0033130]; protein folding chaperone [GO:0044183] EEWSQDFK 0.9856 -2.9492 0 0 0 0 12.4841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9304 10.7832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5183 0 0 0 0 0 0 0 0 0 0 0 13.4319 0 0 0 0 13.4405 0 13.817 15.426 14.2397 14.1943 0 14.3222 14.0274 14.2166 0 0 11.1387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4674 0 0 0 0 0 13.685 13.3633 0 0 0 14.409 0 0 0 13.7066 0 0 0 0 0 0 14.1439 0 0 0 0 0 13.7185 0 0 0 0 0 0 12.7082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2329 0 15.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8463 0 0 0 0 0 13.4107 Q8N6U8 GP161_HUMAN G-protein coupled receptor 161 (G-protein coupled receptor RE2) GPR161 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] ciliary membrane [GO:0060170]; cilium [GO:0005929]; endocytic vesicle membrane [GO:0030666]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; recycling endosome [GO:0055037] ciliary membrane [GO:0060170]; cilium [GO:0005929]; endocytic vesicle membrane [GO:0030666]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; recycling endosome [GO:0055037]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621] GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0016021; GO:0030666; GO:0043005; GO:0055037; GO:0060170; GO:0097386; GO:1901621 G protein-coupled receptor activity [GO:0004930] EPFVQRQR 0.9856 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCD5 NT5C_HUMAN "5'(3')-deoxyribonucleotidase, cytosolic type, EC 3.1.3.- (Cytosolic 5',3'-pyrimidine nucleotidase) (Deoxy-5'-nucleotidase 1, dNT-1)" NT5C DNT1 UMPH2 Homo sapiens (Human) allantoin metabolic process [GO:0000255]; dCMP catabolic process [GO:0006249]; dephosphorylation [GO:0016311]; dGMP catabolic process [GO:0046055]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; IMP catabolic process [GO:0006204]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; UMP catabolic process [GO:0046050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; pyrimidine nucleotide binding [GO:0019103]; allantoin metabolic process [GO:0000255]; dCMP catabolic process [GO:0006249]; dephosphorylation [GO:0016311]; dGMP catabolic process [GO:0046055]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; IMP catabolic process [GO:0006204]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; UMP catabolic process [GO:0046050] GO:0000255; GO:0005634; GO:0005737; GO:0005829; GO:0006204; GO:0006249; GO:0008252; GO:0008253; GO:0009223; GO:0016311; GO:0019103; GO:0042802; GO:0046050; GO:0046055; GO:0046074; GO:0046079; GO:0046872; GO:0050483; GO:0070062 5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; pyrimidine nucleotide binding [GO:0019103] IILTRDKTVVLGDLLIDDK 0.9856 -2.0999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB90 RRAGC_HUMAN "Ras-related GTP-binding protein C, Rag C, RagC, EC 3.6.5.- (GTPase-interacting protein 2) (TIB929)" RRAGC Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription, DNA-templated [GO:0006351]" GO:0000287; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006351; GO:0006915; GO:0007264; GO:0008104; GO:0008380; GO:0009267; GO:0010506; GO:0019003; GO:0032006; GO:0032008; GO:0034198; GO:0043200; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:1903432; GO:1990131 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982] ILLMGLRR 0.9856 -3.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P241 AT10D_HUMAN "Phospholipid-transporting ATPase VD, EC 7.6.2.1 (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D)" ATP10D ATPVD KIAA1487 Homo sapiens (Human) cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; cation transport [GO:0006812]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006812; GO:0016021; GO:0016887; GO:0034220; GO:0045332; GO:0140326; GO:0140351; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287] AGIKIWMLTGDK 0.9856 -3.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6184 0 0 12.2183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1875 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8238 0 0 13.3359 0 0 0 13.8662 14.3191 0 13.9664 0 13.8105 0 0 11.2315 0 0 0 0 0 0 0 0 12.3679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.49 14.324 0 14.311 0 0 14.5078 0 0 14.2043 0 0 14.0054 15.2901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UET6 TRM7_HUMAN "Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase, EC 2.1.1.205 (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1)" FTSJ1 JM23 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; RNA methylation [GO:0001510]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128] GO:0001510; GO:0002128; GO:0002181; GO:0005737; GO:0005829; GO:0006400; GO:0008173; GO:0008175; GO:0009020; GO:0030488; GO:0052666 RNA methyltransferase activity [GO:0008173]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175] DVYYRLAK 0.9856 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JE40 PATL2_HUMAN "Protein PAT1 homolog 2 (PAT1-like protein 2) (Protein PAT1 homolog a, Pat1a, hPat1a)" PATL2 Homo sapiens (Human) deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962] GO:0000290; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0010607; GO:0017148; GO:0033962 RNA binding [GO:0003723] ALVARLLPFLPQDQAVTILLAITHHLPLLVR 0.98561 -2.6846 0 0 0 0 0 0 0 0 0 0 0 14.9841 0 0 0 0 0 0 0 0 0 0 12.8946 0 0 0 13.2603 0 13.6572 14.1839 0 12.2818 0 14.2898 13.4658 0 12.1749 0 14.4599 0 14.2202 13.2776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.094 0 0 0 0 0 0 0 0 14.3215 0 0 0 14.4375 0 0 0 0 0 13.769 13.992 14.0088 0 0 0 13.7665 0 13.7159 0 0 0 0 0 0 13.9763 15.204 13.6879 12.9311 0 0 0 0 13.4606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0005 0 0 13.9887 0 14.2027 13.9853 13.6059 0 0 13.8811 0 0 0 0 14.7309 0 13.8992 0 0 0 0 0 11.1096 0 0 0 0 0 11.4813 0 0 13.2653 11.7686 0 0 0 0 0 0 0 0 0 12.0692 P11117 PPAL_HUMAN "Lysosomal acid phosphatase, LAP, EC 3.1.3.2" ACP2 Homo sapiens (Human) dephosphorylation [GO:0016311]; lysosome organization [GO:0007040] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; acid phosphatase activity [GO:0003993]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]; lysosome organization [GO:0007040] GO:0003993; GO:0005764; GO:0005765; GO:0007040; GO:0016020; GO:0016021; GO:0016311; GO:0016791; GO:0043202; GO:0070062 acid phosphatase activity [GO:0003993]; phosphatase activity [GO:0016791] AALLQLLLGVNLVVMPPTRAR 0.98561 -2.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0337 12.9629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9154 0 0 0 0 0 0 0 0 0 12.1554 11.4695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2051 13.3449 0 0 12.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 P21754 ZP3_HUMAN "Zona pellucida sperm-binding protein 3 (Sperm receptor) (ZP3A/ZP3B) (Zona pellucida glycoprotein 3, Zp-3) (Zona pellucida protein C) [Cleaved into: Processed zona pellucida sperm-binding protein 3 ]" ZP3 ZP3A ZP3B ZPC Homo sapiens (Human) "binding of sperm to zona pellucida [GO:0007339]; blastocyst formation [GO:0001825]; egg coat formation [GO:0035803]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte development [GO:0048599]; positive regulation of acrosomal vesicle exocytosis [GO:2000368]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of antral ovarian follicle growth [GO:2000388]; positive regulation of humoral immune response [GO:0002922]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type IV hypersensitivity [GO:0001809]" collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acrosin binding [GO:0032190]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018]; structural constituent of egg coat [GO:0035804]; binding of sperm to zona pellucida [GO:0007339]; blastocyst formation [GO:0001825]; egg coat formation [GO:0035803]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte development [GO:0048599]; positive regulation of acrosomal vesicle exocytosis [GO:2000368]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of antral ovarian follicle growth [GO:2000388]; positive regulation of humoral immune response [GO:0002922]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type IV hypersensitivity [GO:0001809]" GO:0001809; GO:0001825; GO:0002455; GO:0002687; GO:0002922; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0007339; GO:0016021; GO:0030246; GO:0031012; GO:0032190; GO:0032729; GO:0032753; GO:0035803; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0050729; GO:0062023; GO:2000344; GO:2000360; GO:2000368; GO:2000386; GO:2000388 acrosin binding [GO:0032190]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018]; structural constituent of egg coat [GO:0035804] LMEENWNAEK 0.98561 -3.627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4806 0 0 0 0 15.4982 0 0 0 0 0 10.1128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0796 0 0 0 0 0 0 0 0 0 0 13.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3992 0 0 12.8932 0 0 0 0 0 0 0 0 0 0 P50416 CPT1A_HUMAN "Carnitine O-palmitoyltransferase 1, liver isoform, CPT1-L, EC 2.3.1.21 (Carnitine O-palmitoyltransferase I, liver isoform, CPT I, CPTI-L) (Carnitine palmitoyltransferase 1A)" CPT1A CPT1 Homo sapiens (Human) carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641] GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0009410; GO:0009437; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031307; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045471; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698 carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698] AGNAIHAILLYRRK 0.98561 -2.5888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2668 0 0 0 0 0 0 13.4018 13.6739 0 0 0 0 0 0 0 0 0 0 P58304 VSX2_HUMAN Visual system homeobox 2 (Ceh-10 homeodomain-containing homolog) (Homeobox protein CHX10) VSX2 CHX10 HOX10 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007601; GO:0050896; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ENSIAVLR 0.98561 -2.1124 0 0 0 0 0 0 0 0 0 0 14.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7136 13.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5145 0 0 0 0 0 13.8589 0 0 0 0 11.0874 0 0 0 12.8385 0 0 0 0 11.2846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5983 0 0 10.1633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59543 T2R20_HUMAN "Taste receptor type 2 member 20 (Taste receptor type 2 member 49, T2R49) (Taste receptor type 2 member 56, T2R56)" TAS2R20 TAS2R49 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930] AKSVVLVIVLGSLFFLVCHLVMK 0.98561 -3.4521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.45882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3711 0 0 0 0 0 0 0 0 0 10.1342 0 0 0 11.8952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UP52 TFR2_HUMAN "Transferrin receptor protein 2, TfR2" TFR2 Homo sapiens (Human) acute-phase response [GO:0006953]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; endocytic iron import into cell [GO:0140298]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; positive regulation of endocytosis [GO:0045807]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein maturation [GO:1903319]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; response to iron ion [GO:0010039]; transferrin transport [GO:0033572] cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; co-receptor binding [GO:0039706]; transferrin receptor activity [GO:0004998]; acute-phase response [GO:0006953]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; endocytic iron import into cell [GO:0140298]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; positive regulation of endocytosis [GO:0045807]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein maturation [GO:1903319]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; response to iron ion [GO:0010039]; transferrin transport [GO:0033572] GO:0004998; GO:0005886; GO:0005887; GO:0006826; GO:0006879; GO:0006898; GO:0006953; GO:0009897; GO:0010039; GO:0031410; GO:0033572; GO:0039706; GO:0045807; GO:0045944; GO:0055072; GO:0071281; GO:0090277; GO:0140298; GO:1903319; GO:1990712 co-receptor binding [GO:0039706]; transferrin receptor activity [GO:0004998] ARGVDPVGRLLLVR 0.98561 -3.722 0 0 0 0 0 0 0 0 9.16699 0 0 0 0 13.326 13.8756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6833 0 0 0 0 0 0 0 0 0 0 0 10.9865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4618 0 0 0 0 0 0 0 14.9895 14.3081 0 0 0 0 0 0 0 0 0 0 13.7278 14.4407 0 0 13.0379 0 13.2259 14.2839 0 0 0 0 0 0 13.799 0 0 0 0 12.6471 0 0 0 0 0 0 0 0 12.9898 0 0 0 13.0907 0 0 12.8111 13.1241 0 0 0 12.935 12.3922 0 14.6374 0 0 14.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5504 0 12.8365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75608 LYPA1_HUMAN "Acyl-protein thioesterase 1, APT-1, hAPT1, EC 3.1.2.- (Lysophospholipase 1) (Lysophospholipase I, LPL-I, LysoPLA I) (Palmitoyl-protein hydrolase, EC 3.1.2.22)" LYPLA1 APT1 LPL1 Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; fatty acid metabolic process [GO:0006631]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084] GO:0002084; GO:0004620; GO:0004622; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006631; GO:0008474; GO:0016298; GO:0031965; GO:0042997; GO:0052689; GO:0070062 carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620] ASFPQGPIGGANR 0.98562 -2.8689 0 0 0 0 0 0 0 0 0 0 11.6607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9841 10.6449 0 10.2767 0 0 0 0 14.2008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3009 0 0 14.1128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.37265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9371 0 0 0 0 12.3048 0 0 0 0 0 0 11.4959 0 0 11.8716 0 0 11.0763 11.0029 0 0 0 0 0 15.6174 0 0 0 0 0 0 0 0 0 0 0 0 11.5787 0 0 0 0 12.3062 0 0 0 O94892 ZN432_HUMAN Zinc finger protein 432 ZNF432 KIAA0798 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LIEHQRTHTGEKPYICNECGK 0.98562 -2.5075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5251 0 0 0 0 0 0 0 0 12.6097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7594 11.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.607 O95478 NSA2_HUMAN Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1) NSA2 TINP1 HUSSY-29 Homo sapiens (Human) maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470] "nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]" GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0030687 RNA binding [GO:0003723] FIRPMGLRFK 0.98562 -3.4638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.657 0 0 0 0 0 10.5855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2873 0 0 0 0 0 0 13.9821 13.6478 14.3514 0 0 0 0 0 0 0 0 14.7991 0 0 0 0 13.1446 0 0 0 0 0 14.1893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.08273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6726 11.8998 0 10.1638 0 0 0 0 0 P06239 LCK_HUMAN "Tyrosine-protein kinase Lck, EC 2.7.10.2 (Leukocyte C-terminal Src kinase, LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK)" LCK Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; Fc-gamma receptor signaling pathway [GO:0038094]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular zinc ion homeostasis [GO:0006882]; Fc-gamma receptor signaling pathway [GO:0038094]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein phosphorylation [GO:0006468]; regulation of lymphocyte activation [GO:0051249]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0000242; GO:0001772; GO:0001784; GO:0004713; GO:0004715; GO:0004722; GO:0005102; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0006882; GO:0006919; GO:0007169; GO:0008022; GO:0009410; GO:0016004; GO:0018108; GO:0019901; GO:0019903; GO:0030097; GO:0030154; GO:0030168; GO:0030217; GO:0031234; GO:0031295; GO:0034116; GO:0035556; GO:0038083; GO:0038094; GO:0042169; GO:0042608; GO:0042609; GO:0042610; GO:0042802; GO:0043274; GO:0043548; GO:0045087; GO:0045121; GO:0050852; GO:0050853; GO:0050862; GO:0050870; GO:0050900; GO:0051117; GO:0051209; GO:0051249; GO:0070062; GO:1903039; GO:2001244 ATP binding [GO:0005524]; ATPase binding [GO:0051117]; CD4 receptor binding [GO:0042609]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase binding [GO:0043548]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608] ERPEDRPTFDYLR 0.98562 -3.4611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1413 0 11.2215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7717 0 0 0 0 P49683 PRLHR_HUMAN "Prolactin-releasing peptide receptor, PrRP receptor, PrRPR (G-protein coupled receptor 10) (hGR3)" PRLHR GPR10 GR3 Homo sapiens (Human) feeding behavior [GO:0007631]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone metabolic process [GO:0042445] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; feeding behavior [GO:0007631]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone metabolic process [GO:0042445] GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0007565; GO:0007631; GO:0008188; GO:0042445; GO:0042923; GO:0043005 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983] GLIVLLYSVVVVVGLVGNCLLVLVIAR 0.98562 -2.777 10.9308 0 11.0534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0849 0 0 0 0 0 0 0 11.6534 0 0 0 0 0 0 0 0 0 0 0 0 11.4654 0 12.6402 0 11.3919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.784 11.4999 0 0 0 14.6337 0 0 14.2701 12.7251 0 0 0 10.8984 0 13.5494 0 0 0 0 13.6361 0 13.4861 0 0 13.4366 0 0 0 0 13.7916 0 0 0 0 12.3385 13.8603 13.8685 13.8599 0 0 0 12.5674 0 0 13.9939 0 0 0 0 11.2584 0 14.1156 0 14.0367 0 0 0 13.1542 0 0 0 0 13.78 0 0 0 0 0 0 0 0 0 0 12.9418 11.3212 0 12.784 0 14.4099 12.5155 11.7432 0 0 0 11.3112 0 0 0 0 0 10.8684 0 11.674 0 0 0 0 0 11.698 0 13.5261 0 0 0 0 0 0 0 0 12.3694 P51858 HDGF_HUMAN "Hepatoma-derived growth factor, HDGF (High mobility group protein 1-like 2, HMG-1L2)" HDGF HMG1L2 Homo sapiens (Human) cellular response to interleukin-7 [GO:0098761]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]; cellular response to interleukin-7 [GO:0098761]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]" GO:0000122; GO:0000166; GO:0000978; GO:0001222; GO:0001227; GO:0003690; GO:0003712; GO:0003714; GO:0003723; GO:0003779; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007165; GO:0008083; GO:0008201; GO:0015631; GO:0017053; GO:0034504; GO:0043524; GO:0045944; GO:0051781; GO:0062023; GO:0098761 "actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]" FGKPNKR 0.98562 -2.7795 0 0 0 0 0 0 0 0 0 0 16.9665 0 16.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXS2 DRC2_HUMAN Dynein regulatory complex subunit 2 (Coiled-coil domain-containing protein 65) (Testis development protein NYD-SP28) CCDC65 DRC2 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352] GO:0003352; GO:0005858; GO:0005930; GO:0031514; GO:0036064; GO:0060271; GO:0060285; GO:0070286 AAFETLQVK 0.98562 -3.3744 0 0 0 10.9865 0 0 11.8033 0 10.7943 0 11.2203 0 0 0 0 0 0 0 12.1842 0 11.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3582 0 0 0 0 0 0 0 14.7682 0 0 0 0 14.3831 15.8985 0 0 0 0 15.0637 0 15.5557 0 0 0 0 0 13.1789 0 11.6894 14.1463 0 0 12.9028 0 0 13.1519 0 0 13.9376 0 14.456 0 15.3744 0 15.8817 0 13.0175 0 0 13.0607 13.8759 0 13.8324 0 0 14.2195 0 0 0 0 12.8867 13.3907 13.4689 15.9186 12.6991 0 0 0 12.6312 0 0 0 14.4439 13.7033 0 0 13.0002 0 0 0 0 0 12.4557 14.6803 11.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5456 0 0 0 0 0 0 Q96BH1 RNF25_HUMAN "E3 ubiquitin-protein ligase RNF25, EC 2.3.2.27 (RING finger protein 25) (RING-type E3 ubiquitin transferase RNF25)" RNF25 Homo sapiens (Human) positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005634; GO:0005829; GO:0016567; GO:0046872; GO:0051059; GO:0051092; GO:0061630 metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AMLDPPK 0.98562 -3.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09417 DHPR_HUMAN "Dihydropteridine reductase, EC 1.5.1.34 (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1)" QDPR DHPR SDR33C1 Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; dihydrobiopterin metabolic process [GO:0051066]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 6,7-dihydropteridine reductase activity [GO:0004155]; electron transfer activity [GO:0009055]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; cellular amino acid metabolic process [GO:0006520]; dihydrobiopterin metabolic process [GO:0051066]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729]" GO:0004155; GO:0005737; GO:0005829; GO:0006520; GO:0006559; GO:0006729; GO:0009055; GO:0051066; GO:0070062; GO:0070402; GO:0070404 "6,7-dihydropteridine reductase activity [GO:0004155]; electron transfer activity [GO:0009055]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]" TELTPAYF 0.98563 -2.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8363 0 0 12.3856 0 0 0 0 0 0 0 0 0 0 13.0073 0 13.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30153 2AAA_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha) PPP2R1A Homo sapiens (Human) "apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]" "chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]" "chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; ceramide metabolic process [GO:0006672]; chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell growth [GO:0030308]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of DNA replication [GO:0006275]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; regulation of transcription, DNA-templated [GO:0006355]; regulation of Wnt signaling pathway [GO:0030111]; response to organic substance [GO:0010033]; RNA splicing [GO:0008380]; second-messenger-mediated signaling [GO:0019932]" GO:0000159; GO:0000775; GO:0004722; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006275; GO:0006355; GO:0006470; GO:0006672; GO:0006915; GO:0007059; GO:0007143; GO:0008380; GO:0010033; GO:0015630; GO:0016020; GO:0016328; GO:0019888; GO:0019932; GO:0030111; GO:0030155; GO:0030308; GO:0030425; GO:0040008; GO:0042532; GO:0043005; GO:0043025; GO:0043409; GO:0045595; GO:0046982; GO:0051232; GO:0051306; GO:0051754; GO:0065003; GO:0070062; GO:0070262; GO:0098978; GO:1903538; GO:1990405; GO:2001241 protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722] AAASHKVK 0.98563 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.072 19.7943 0 0 0 0 0 14.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.029 0 0 0 0 0 0 0 0 0 0 0 0 P38484 INGR2_HUMAN "Interferon gamma receptor 2, IFN-gamma receptor 2, IFN-gamma-R2 (Interferon gamma receptor accessory factor 1, AF-1) (Interferon gamma receptor beta-chain, IFN-gamma-R-beta) (Interferon gamma transducer 1)" IFNGR2 IFNGT1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; microglial cell activation [GO:0001774]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; response to virus [GO:0009615] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interferon-gamma receptor activity [GO:0004906]; cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; microglial cell activation [GO:0001774]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; response to virus [GO:0009615] GO:0000139; GO:0001774; GO:0004896; GO:0004906; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007166; GO:0009615; GO:0019221; GO:0030659; GO:0051607; GO:0060333; GO:0098586; GO:1904783 cytokine receptor activity [GO:0004896]; interferon-gamma receptor activity [GO:0004906] DDVWDSVSIISFPEK 0.98563 -2.4486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6687 11.4386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7526 15.1153 12.1049 0 12.6252 0 0 13.638 0 14.1122 14.4642 12.4793 0 0 0 0 0 0 0 12.4907 0 11.2697 0 0 0 0 0 9.89967 11.8835 13.2037 0 0 0 12.9562 10.9774 11.5608 0 0 13.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.086 0 0 0 0 0 0 15.4642 0 0 0 0 0 15.6243 0 11.8786 0 15.3562 15.7026 11.7559 0 0 0 0 12.5434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8142 11.4198 0 Q7Z736 PKHH3_HUMAN "Pleckstrin homology domain-containing family H member 3, PH domain-containing family H member 3" PLEKHH3 Homo sapiens (Human) signal transduction [GO:0007165] cytoskeleton [GO:0005856]; extracellular space [GO:0005615] cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; signal transduction [GO:0007165] GO:0005615; GO:0005856; GO:0007165 ALAALRLQSLQR 0.98563 -2.387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.282 0 13.1353 0 15.3616 12.2513 0 0 0 0 0 0 0 13.946 0 0 0 12.9005 11.2577 0 0 0 0 0 12.532 0 0 12.8426 0 0 0 0 14.6506 0 0 14.9238 0 14.8301 0 0 15.4359 0 13.7153 13.5543 14.4013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3831 0 0 0 0 15.6681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2319 0 0 0 11.8984 0 0 0 Q8IZF7 AGRF2_HUMAN Adhesion G-protein coupled receptor F2 (G-protein coupled receptor 111) (G-protein coupled receptor PGR20) ADGRF2 GPR111 PGR20 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] AIVRISKNIAILTPLLGLTWGFGVATVIDDR 0.98563 -2.9756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6218 0 0 0 0 0 10.3394 0 0 0 12.607 0 12.3003 0 12.2317 0 13.0391 0 0 0 13.1035 0 0 0 0 0 14.3185 0 0 11.7757 13.5798 11.8796 10.6232 0 0 11.9462 0 11.8008 0 0 0 13.5664 0 0 0 0 0 14.7359 0 0 0 13.6128 12.2505 12.4388 0 12.3347 14.5907 11.3898 11.379 0 0 12.7504 0 10.4181 14.1582 0 0 12.184 10.9984 0 0 0 0 0 0 0 0 15.1345 0 13.0016 0 12.5572 0 13.069 0 0 0 0 0 15.2333 0 0 10.2801 13.3405 11.5078 0 0 10.9519 0 13.4101 0 0 0 0 0 11.4678 0 0 0 0 0 10.0371 0 0 0 0 0 10.5692 0 0 0 0 0 0 0 0 0 0 11.98 0 0 0 0 11.1685 11.531 0 0 0 0 Q8NFI3 ENASE_HUMAN "Cytosolic endo-beta-N-acetylglucosaminidase, ENGase, EC 3.2.1.96" ENGASE Homo sapiens (Human) protein deglycosylation [GO:0006517]; protein folding [GO:0006457] cytosol [GO:0005829] "cytosol [GO:0005829]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; protein deglycosylation [GO:0006517]; protein folding [GO:0006457]" GO:0004553; GO:0005829; GO:0006457; GO:0006517; GO:0033925 "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]" DFFQNQDKFWGR 0.98563 -2.9736 0 0 0 0 0 0 0 0 0 0 0 0 11.9482 0 11.9458 11.4335 0 12.5654 0 0 0 17.4954 0 0 0 0 0 0 12.0677 0 0 0 11.4972 13.782 0 0 0 0 12.2119 0 12.7801 0 0 0 12.7495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5389 0 0 0 14.1644 12.6446 12.77 12.7266 14.7047 13.689 0 0 0 0 13.1382 0 0 0 0 0 13.3542 0 0 13.3826 0 0 0 13.6308 0 0 0 0 13.2454 0 0 0 0 14.1074 0 0 0 0 13.821 0 0 0 0 0 0 0 0 13.2351 13.8108 16.1026 13.5413 13.7571 0 13.1368 0 0 0 0 0 0 13.7052 0 14.3231 0 13.7835 0 0 0 0 0 13.222 0 0 0 0 0 0 0 0 0 0 0 15.0647 0 0 0 0 0 0 0 0 0 0 0 13.0616 14.706 0 0 0 0 0 0 0 Q92585 MAML1_HUMAN "Mastermind-like protein 1, Mam-1" MAML1 KIAA0200 Homo sapiens (Human) atrioventricular node cell development [GO:0060928]; atrioventricular node development [GO:0003162]; myoblast differentiation [GO:0045445]; Notch signaling pathway [GO:0007219]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; protein phosphorylation [GO:0006468] intracellular membrane-bounded organelle [GO:0043231]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] intracellular membrane-bounded organelle [GO:0043231]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptide antigen binding [GO:0042605]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; atrioventricular node cell development [GO:0060928]; atrioventricular node development [GO:0003162]; myoblast differentiation [GO:0045445]; Notch signaling pathway [GO:0007219]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; protein phosphorylation [GO:0006468] GO:0002193; GO:0003162; GO:0003713; GO:0005634; GO:0005654; GO:0006468; GO:0007219; GO:0007221; GO:0010831; GO:0016607; GO:0019901; GO:0042605; GO:0043231; GO:0045445; GO:0045944; GO:0060928 peptide antigen binding [GO:0042605]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713] HHSTCEAR 0.98563 -2.6094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.671 0 0 0 14.0246 13.7624 14.011 0 13.3364 13.399 0 0 0 0 0 12.9861 13.4323 0 0 13.9867 0 0 0 0 0 0 13.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.329 0 0 12.2554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1037 0 0 0 0 0 0 0 Q96FN5 KIF12_HUMAN Kinesin-like protein KIF12 KIF12 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0070062 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] DLAQNEQRILAQQVHALERR 0.98563 -2.0423 0 0 0 0 0 0 0 0 0 12.205 0 12.1557 0 12.0715 12.6501 12.2634 12.2413 12.1667 0 0 0 0 0 0 0 0 0 0 0 12.5092 0 0 0 12.5775 12.3437 0 0 0 11.6061 0 0 12.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5585 0 0 14.0726 0 0 0 14.1914 14.2578 14.4713 14.515 0 0 0 0 14.3591 0 0 0 0 Q9UJ90 KCNE5_HUMAN Potassium voltage-gated channel subfamily E regulatory beta subunit 5 (AMME syndrome candidate gene 2 protein) (Potassium channel subunit beta MiRP4) (Potassium voltage-gated channel subfamily E member 1-like protein) KCNE5 AMMECR2 KCNE1L Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle contraction [GO:0060048]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cation channel activity [GO:2001257]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005] plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle contraction [GO:0060048]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cation channel activity [GO:2001257]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0005249; GO:0005886; GO:0008016; GO:0008076; GO:0015459; GO:0044325; GO:0060048; GO:0060306; GO:0060307; GO:0060372; GO:0086005; GO:0086011; GO:0086014; GO:0086091; GO:0097623; GO:0098915; GO:1901379; GO:1901380; GO:1901381; GO:1902260; GO:1903765; GO:2001257 potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] LLLELHHR 0.98563 -2.0443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43609 SPY1_HUMAN "Protein sprouty homolog 1, Spry-1" SPRY1 Homo sapiens (Human) animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; organ induction [GO:0001759]; ureteric bud development [GO:0001657] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; organ induction [GO:0001759]; ureteric bud development [GO:0001657] GO:0000132; GO:0001656; GO:0001657; GO:0001759; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0008285; GO:0010719; GO:0030512; GO:0034260; GO:0040037; GO:0043407; GO:0046580; GO:0048513; GO:0051387; GO:0060449; GO:0060940; GO:0070371; GO:0070373; GO:1902747 NSNTVYCK 0.98564 -2.8907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2536 0 0 0 0 0 0 0 0 0 0 0 0 11.2892 18.1871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21854 CD72_HUMAN B-cell differentiation antigen CD72 (Lyb-2) (CD antigen CD72) CD72 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155] GO:0004888; GO:0005102; GO:0005886; GO:0005887; GO:0007155; GO:0030246 carbohydrate binding [GO:0030246]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888] LSNMENR 0.98564 -2.3881 0 0 0 0 0 0 0 0 0 11.8509 0 0 13.2374 0 0 0 0 0 0 0 0 0 0 0 10.9863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 11.359 0 0 0 0 0 0 0 0 0 0 0 0 11.5267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4751 13.7073 0 0 0 0 0 11.8905 0 0 0 0 0 0 0 0 0 0 0 Q92890 UFD1_HUMAN "Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1, UB fusion protein 1)" UFD1 UFD1L Homo sapiens (Human) "ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; ER-associated misfolded protein catabolic process [GO:0071712]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030433; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0071712 cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593] GIPNYEFK 0.98564 -3.8357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0H5 RGAP1_HUMAN "Rac GTPase-activating protein 1 (Male germ cell RacGap, MgcRacGAP) (Protein CYK4 homolog, CYK4, HsCYK-4)" RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272] acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233] "acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272]" GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008272; GO:0019901; GO:0030496; GO:0031234; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0046872; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149 "alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]" DCRVVSHPECR 0.98564 -3.8397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1594 0 0 0 13.8424 12.7733 0 15.2346 0 13.102 13.4276 0 0 0 0 13.1435 0 0 13.4542 13.4718 13.1784 0 0 0 0 12.2147 0 0 12.7817 0 0 0 0 0 0 0 12.2795 0 0 0 0 0 0 0 0 0 0 12.7026 0 0 0 0 0 0 0 0 0 16.6413 0 0 0 0 0 0 12.6149 0 0 0 0 0 0 12.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0713 0 0 0 0 Q9UQ05 KCNH4_HUMAN "Potassium voltage-gated channel subfamily H member 4 (Brain-specific eag-like channel 2, BEC2) (Ether-a-go-go-like potassium channel 1, ELK channel 1, ELK1) (Voltage-gated potassium channel subunit Kv12.3)" KCNH4 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0034765; GO:0042391; GO:0071805 voltage-gated potassium channel activity [GO:0005249] ANNNVFEPKPSVPEYKVASVGGSR 0.98564 -2.3894 0 0 0 0 0 0 0 0 0 0 14.7321 0 11.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.773 0 0 0 0 0 13.6359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6039 0 0 0 0 0 0 0 0 0 0 0 12.5712 0 12.0036 0 0 0 0 0 0 0 0 0 14.0799 0 0 0 0 13.1309 0 0 0 0 0 0 0 0 0 0 Q9Y2G1 MYRF_HUMAN "Myelin regulatory factor, EC 3.4.-.- (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal ]" MYRF C11orf9 KIAA0954 MRF Homo sapiens (Human) "central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]" cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]; central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]" GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0008233; GO:0014003; GO:0016021; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0042802; GO:0043565; GO:0045893; GO:0048709 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]" AGSVPHK 0.98564 -2.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6962 13.4502 12.9412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0046 0 0 0 0 0 0 0 0 0 0 12.8153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MPS7 YDJC_HUMAN "Carbohydrate deacetylase, EC 3.5.1.-" YDJC Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] deacetylase activity [GO:0019213]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975] GO:0000287; GO:0005975; GO:0019213 deacetylase activity [GO:0019213]; magnesium ion binding [GO:0000287] EELEAQLSCFR 0.98565 -3.7562 0 14.0081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0675 0 15.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1521 0 0 0 0 0 0 0 0 0 13.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3138 0 0 0 0 0 0 15.0064 13.4593 0 13.6948 0 0 0 0 0 0 0 0 0 0 15.9734 19.761 14.227 15.2717 15.2329 15.0121 19.7433 15.095 0 0 0 0 13.3099 0 0 0 0 0 18.795 0 0 0 0 0 14.7133 19.5569 0 0 0 0 0 0 13.5581 0 0 19.5574 0 17.8615 0 0 20.2474 0 0 0 0 19.6407 0 13.2532 0 0 12.8974 0 0 0 0 0 0 18.8811 0 0 0 0 18.1976 12.9569 0 14.8956 0 13.3507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3601 0 0 0 0 0 0 O14628 ZN195_HUMAN Zinc finger protein 195 ZNF195 ZNFP104 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CEECGRVFMWFSDITKHK 0.98565 -3.6718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6661 0 0 0 0 0 0 0 0 14.3912 14.3587 13.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4119 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3368 0 0 0 0 0 0 0 0 0 0 13.5774 13.0578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2705 0 0 0 0 12.423 0 0 0 11.5143 0 0 0 0 0 0 0 0 P0C672 TSN19_HUMAN "Tetraspanin-19, Tspan-19" TSPAN19 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887] GO:0005887 DKPEDITK 0.98565 -2.6266 0 0 0 0 0 11.4884 0 0 0 0 0 0 0 0 0 10.7162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2204 0 0 0 0 0 0 0 0 0 0 13.0486 0 12.4198 0 0 0 9.86189 0 0 13.7326 0 0 0 0 0 0 12.3787 0 0 0 0 14.2777 0 0 0 13.6722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4113 0 14.4874 0 0 13.6865 0 0 0 0 14.9952 0 0 0 0 0 0 0 0 0 0 14.2277 0 0 0 0 12.9678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6076 0 13.5473 0 0 0 Q01718 ACTHR_HUMAN "Adrenocorticotropic hormone receptor, ACTH receptor, ACTH-R (Adrenocorticotropin receptor) (Melanocortin receptor 2, MC2-R)" MC2R ACTHR Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of metabolic process [GO:0019222]" cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; corticotropin receptor activity [GO:0004978]; G protein-coupled receptor activity [GO:0004930]; melanocortin receptor activity [GO:0004977]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of metabolic process [GO:0019222]" GO:0004930; GO:0004977; GO:0004978; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007189; GO:0019222 corticotropin receptor activity [GO:0004978]; G protein-coupled receptor activity [GO:0004930]; melanocortin receptor activity [GO:0004977] ILENILIILR 0.98565 -2.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2Y0W8 S4A8_HUMAN Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3) SLC4A8 KIAA0739 NBC NBC3 NDCBE1 Homo sapiens (Human) bicarbonate transport [GO:0015701]; chloride transmembrane transport [GO:1902476]; ion homeostasis [GO:0050801]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber [GO:0097457]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; symmetric synapse [GO:0032280]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber [GO:0097457]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; symmetric synapse [GO:0032280]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; chloride transmembrane transport [GO:1902476]; ion homeostasis [GO:0050801]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion transmembrane transport [GO:0035725]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0005452; GO:0005886; GO:0008021; GO:0008510; GO:0015081; GO:0015106; GO:0015108; GO:0015301; GO:0015701; GO:0016020; GO:0016021; GO:0022857; GO:0030425; GO:0032279; GO:0032280; GO:0032809; GO:0035725; GO:0042391; GO:0042734; GO:0043005; GO:0043195; GO:0043679; GO:0050801; GO:0050804; GO:0051453; GO:0055085; GO:0097386; GO:0097457; GO:0098793; GO:0098978; GO:0150104; GO:1902476; GO:2000302 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857] FLFILLGPVGKGQQYHEIGRSMATIMTDEIFHDVAYK 0.98565 -2.805 0 0 0 0 0 0 0 0 0 0 13.4759 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1047 0 9.79578 0 11.8567 0 0 0 0 0 0 12.2526 0 0 0 11.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2789 0 14.2712 11.5975 13.0255 12.3252 11.9254 0 0 0 0 0 0 0 0 11.0637 0 0 0 0 0 0 12.287 12.9619 0 0 0 0 0 0 11.5017 14.7382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4191 0 0 0 12.5793 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1676 0 0 0 0 0 0 0 13.5441 0 0 0 0 0 0 0 0 0 0 0 0 14.1148 0 0 0 0 0 0 15.25 0 0 0 14.7923 0 0 0 0 0 0 11.3359 12.602 0 13.4774 0 0 0 0 0 0 0 11.7594 0 10.5229 0 0 13.2186 0 0 0 0 0 0 0 Q7RTV5 PXL2C_HUMAN Peroxiredoxin-like 2C (AhpC/TSA antioxidant enzyme domain-containing protein 1) (Thioredoxin-like protein AAED1) PRXL2C AAED1 C9orf21 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycolytic process [GO:0045821] antioxidant activity [GO:0016209]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycolytic process [GO:0045821] GO:0016209; GO:0045821; GO:0070374 antioxidant activity [GO:0016209] AVVVFVR 0.98565 -3.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBI6 XXLT1_HUMAN "Xyloside xylosyltransferase 1, EC 2.4.2.62 (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)" XXYLT1 C3orf21 PSEC0251 Homo sapiens (Human) O-glycan processing [GO:0016266] integral component of endoplasmic reticulum membrane [GO:0030176] "integral component of endoplasmic reticulum membrane [GO:0030176]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560]; O-glycan processing [GO:0016266]" GO:0000287; GO:0016266; GO:0030145; GO:0030176; GO:0035252; GO:0140560 "magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560]" CKVIFHDVAVLTDKLFPIVEAMQK 0.98565 -3.2988 0 0 0 0 0 0 0 0 0 0 11.7174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3624 0 0 0 0 12.0977 10.5959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3977 0 12.5258 0 11.7867 0 0 0 12.2428 0 0 0 15.5085 0 0 0 0 0 0 0 0 0 14.6149 0 0 0 0 0 0 0 0 0 0 0 0 13.4463 0 0 0 0 0 0 13.2064 0 0 12.5257 0 0 12.4993 0 0 0 13.5634 0 0 0 0 0 12.4733 12.4945 0 0 0 12.3437 0 12.9495 0 13.4259 13.0422 0 0 0 0 0 12.3696 0 14.2331 0 0 0 0 14.2114 0 0 0 0 0 0 0 0 0 11.8969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYA0 IFT81_HUMAN "Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1, CDV-1)" IFT81 CDV1 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542; GO:0120316 tubulin binding [GO:0015631] EECLQEESRYHYTNCMIKNLEVQLR 0.98565 -3.7582 0 13.772 0 0 0 0 14.4552 14.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6066 0 0 0 0 0 0 0 0 0 11.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.49428 0 0 0 0 0 13.0942 15.4509 14.8599 13.3807 0 0 0 0 13.3749 0 0 0 12.8497 0 0 0 13.7676 0 14.0166 0 0 0 0 0 0 0 12.1103 0 0 0 0 0 12.0725 0 0 0 0 0 0 0 0 0 14.4434 0 0 0 0 14.2608 13.2586 0 0 0 0 0 0 0 0 0 0 12.3375 0 0 0 0 0 0 0 0 0 0 0 13.78 10.4081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZV5 SELN_HUMAN "Selenoprotein N, SelN" SELENON SELN SEPN1 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; cellular response to caffeine [GO:0071313]; cellular response to oxidative stress [GO:0034599]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; multicellular organismal response to stress [GO:0033555]; positive regulation of response to oxidative stress [GO:1902884]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; respiratory system process [GO:0003016]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; skeletal muscle fiber development [GO:0048741]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; calcium ion binding [GO:0005509]; oxidoreductase activity [GO:0016491]; calcium ion homeostasis [GO:0055074]; cellular response to caffeine [GO:0071313]; cellular response to oxidative stress [GO:0034599]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; multicellular organismal response to stress [GO:0033555]; positive regulation of response to oxidative stress [GO:1902884]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; respiratory system process [GO:0003016]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; skeletal muscle fiber development [GO:0048741]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834] GO:0003016; GO:0005509; GO:0005789; GO:0007005; GO:0014816; GO:0014834; GO:0014858; GO:0014873; GO:0016491; GO:0033555; GO:0034599; GO:0048286; GO:0048741; GO:0055074; GO:0060314; GO:0071313; GO:1902884 calcium ion binding [GO:0005509]; oxidoreductase activity [GO:0016491] ARSLALLGALLAAAAAAAVR 0.98565 -2.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.581 0 0 0 0 0 0 0 13.0289 0 0 0 0 11.4179 0 0 0 0 0 12.6965 0 0 0 0 0 0 0 14.6809 15.0212 14.8883 0 0 14.7026 0 11.1797 0 14.8159 0 0 0 0 0 13.9483 0 15.021 14.1048 10.5807 0 0 0 0 13.5941 0 0 0 0 0 0 0 0 0 0 0 13.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGI9 AAKG3_HUMAN "5'-AMP-activated protein kinase subunit gamma-3, AMPK gamma3, AMPK subunit gamma-3" PRKAG3 AMPKG3 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of protein serine/threonine kinase activity [GO:0071900]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873] GO:0004679; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005978; GO:0006096; GO:0006468; GO:0006633; GO:0014873; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0031669; GO:0035556; GO:0042149; GO:0050790; GO:0071900 AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] DLAVVLETAPILTALDIFVDR 0.98565 -3.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2161 0 0 0 0 0 12.0839 0 0 0 11.6644 0 12.7768 0 0 0 0 0 0 0 0 0 0 0 0 0 12.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9907 0 0 11.6257 0 0 0 0 0 0 0 0 0 0 0 12.7367 0 0 0 0 0 0 0 0 12.591 0 0 0 0 0 0 0 0 11.9782 0 0 0 12.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3157 0 0 0 0 O60269 GRIN2_HUMAN "G protein-regulated inducer of neurite outgrowth 2, GRIN2" GPRIN2 KIAA0514 Homo sapiens (Human) neuron projection development [GO:0031175] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; neuron projection development [GO:0031175] GO:0005886; GO:0031175 ASGPKAR 0.98566 -2.9002 0 0 0 0 0 0 0 0 0 16.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3323 0 0 0 0 0 0 0 0 0 0 11.6533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3234 0 0 0 0 12.9851 0 0 0 0 0 0 0 0 0 12.5918 0 15.2759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3337 0 0 0 0 0 0 0 0 0 0 O95479 G6PE_HUMAN "GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase, GDH, EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase, EC 1.1.1.363); 6-phosphogluconolactonase, 6PGL, EC 3.1.1.31 ]" H6PD GDH Homo sapiens (Human) "glucose metabolic process [GO:0006006]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of cortisol biosynthetic process [GO:2000064]; response to alcohol [GO:0097305]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate binding [GO:0030246]; glucose 1-dehydrogenase (NAD+) activity [GO:0047934]; glucose 1-dehydrogenase (NADP+) activity [GO:0047935]; glucose 1-dehydrogenase [NAD(P)] activity [GO:0047936]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of cortisol biosynthetic process [GO:2000064]; response to alcohol [GO:0097305]" GO:0004345; GO:0005739; GO:0005783; GO:0005788; GO:0006006; GO:0009051; GO:0017057; GO:0030246; GO:0047934; GO:0047935; GO:0047936; GO:0050661; GO:0097305; GO:2000064 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate binding [GO:0030246]; glucose 1-dehydrogenase (NAD+) activity [GO:0047934]; glucose 1-dehydrogenase (NADP+) activity [GO:0047935]; glucose 1-dehydrogenase [NAD(P)] activity [GO:0047936]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661] DQNRKALDGLWNR 0.98566 -3.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.004 0 0 0 0 0 0 P42772 CDN2B_HUMAN "Cyclin-dependent kinase 4 inhibitor B (Multiple tumor suppressor 2, MTS-2) (p14-INK4b) (p15-INK4b, p15INK4B)" CDKN2B MTS2 Homo sapiens (Human) aging [GO:0007568]; cell cycle [GO:0007049]; cellular response to extracellular stimulus [GO:0031668]; cellular response to nutrient [GO:0031670]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; liver development [GO:0001889]; megakaryocyte differentiation [GO:0030219]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of phosphorylation [GO:0042326]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to cytokine [GO:0034097]; response to organic cyclic compound [GO:0014070]; spleen development [GO:0048536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]; aging [GO:0007568]; cell cycle [GO:0007049]; cellular response to extracellular stimulus [GO:0031668]; cellular response to nutrient [GO:0031670]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; liver development [GO:0001889]; megakaryocyte differentiation [GO:0030219]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of phosphorylation [GO:0042326]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to cytokine [GO:0034097]; response to organic cyclic compound [GO:0014070]; spleen development [GO:0048536] GO:0000079; GO:0001889; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007568; GO:0008285; GO:0014070; GO:0019901; GO:0030219; GO:0030511; GO:0030858; GO:0031668; GO:0031670; GO:0034097; GO:0042326; GO:0048536; GO:0050680; GO:0060253; GO:0070316; GO:0071560; GO:0090398; GO:2000045; GO:2000134 cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901] PVHDAAR 0.98566 -2.8078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2455 0 0 0 0 0 0 11.7434 0 0 0 0 0 0 0 0 0 0 0 0 0 10.699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08426 ECHP_HUMAN "Peroxisomal bifunctional enzyme, PBE, PBFE (L-bifunctional protein, LBP) (Multifunctional enzyme 1, MFE1) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase, EC 4.2.1.17, EC 5.3.3.8; 3-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.35 ]" EHHADH ECHD Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] "cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; enzyme binding [GO:0019899]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]" GO:0003857; GO:0004165; GO:0004300; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0016508; GO:0016509; GO:0016863; GO:0019899; GO:0033540; GO:0070403 "3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; enzyme binding [GO:0019899]; intramolecular oxidoreductase activity, transposing C=C bonds [GO:0016863]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]" CLYSLINEAFR 0.98566 -3.8506 0 0 0 0 0 13.051 0 0 13.0605 0 0 11.0787 12.9073 10.5336 0 0 0 10.2801 10.9774 0 0 0 0 0 11.1668 0 0 0 0 0 0 10.5491 0 0 12.0235 12.2119 0 0 0 0 0 0 0 0 0 0 0 0 10.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7124 11.9033 0 0 0 0 0 0 12.0271 0 0 0 0 14.2228 12.6688 0 0 0 0 0 13.0469 0 0 13.6134 13.5758 14.4487 0 15.5628 15.704 0 0 0 0 11.997 13.728 13.0874 0 0 0 0 0 0 0 13.1754 0 12.55 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2474 14.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6679 0 0 12.3692 11.4568 0 0 0 0 0 0 0 0 Q5TC12 ATPF1_HUMAN ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog) ATPAF1 ATP11 Homo sapiens (Human) mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] GO:0005739; GO:0033615 AAVVVAAAGGAGPAVLQVAGLYRGLCAVR 0.98566 -2.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7016 0 0 0 0 0 0 0 0 0 0 12.2779 0 0 11.9015 0 11.8175 0 0 0 0 0 13.8439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9247 0 0 0 0 Q8IWA5 CTL2_HUMAN Choline transporter-like protein 2 (Solute carrier family 44 member 2) SLC44A2 CTL2 PSEC0210 Homo sapiens (Human) choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; choline transport [GO:0015871]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; transmembrane transport [GO:0055085] GO:0005739; GO:0005765; GO:0005886; GO:0006656; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0022857; GO:0035579; GO:0043123; GO:0055085; GO:0070062 choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857] GEFCGQKGTK 0.98566 -3.5854 0 11.6772 0 0 11.9856 0 12.644 0 12.9789 0 0 0 12.9609 0 0 0 0 0 0 0 0 0 12.1241 0 0 0 12.7475 0 0 0 13.0539 0 0 0 13.0732 0 0 0 0 0 0 0 10.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7384 13.5425 0 0 0 0 0 0 14.8294 0 0 15.1076 14.9375 16.6276 0 15.5247 0 0 14.7252 13.2312 0 13.3829 12.1785 0 12.4972 14.8516 12.1708 15.3938 0 13.6063 0 0 0 0 11.3485 0 0 12.5945 0 0 14.6525 12.9423 0 0 0 15.4695 0 13.7946 0 15.601 0 0 15.7324 0 10.482 0 14.651 0 12.3062 15.6168 0 14.6333 0 0 0 0 0 16.0389 15.9527 16.028 16.3417 0 0 15.0521 0 15.2638 11.8206 13.2085 0 0 12.4017 0 0 0 0 15.413 15.9808 0 0 0 0 0 0 0 11.2015 0 0 0 0 0 12.4069 0 0 0 0 13.5378 14.4337 0 0 0 0 13.9082 Q8N398 VW5B2_HUMAN von Willebrand factor A domain-containing protein 5B2 VWA5B2 Homo sapiens (Human) DNEQLALRGGAETTADR 0.98566 -3.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2624 0 0 0 0 0 0 0 0 11.9132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6323 0 0 0 0 0 0 14.498 14.9521 14.6382 14.7156 0 13.585 0 0 0 13.3566 0 0 0 0 0 0 0 0 13.5094 13.5121 0 0 0 14.6519 14.5316 13.8074 0 0 0 0 13.7901 0 13.7836 0 13.9697 0 0 0 0 13.841 13.6842 13.7559 14.4605 13.7947 0 13.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8556 0 0 0 0 0 0 0 0 13.9037 0 12.9903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2961 0 13.7886 11.816 0 0 0 0 0 0 0 Q96N76 HUTU_HUMAN "Urocanate hydratase, Urocanase, EC 4.2.1.49 (Imidazolonepropionate hydrolase)" UROC1 Homo sapiens (Human) histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] cytosol [GO:0005829] cytosol [GO:0005829]; urocanate hydratase activity [GO:0016153]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] GO:0005829; GO:0006548; GO:0016153; GO:0019556; GO:0019557 urocanate hydratase activity [GO:0016153] ILYSDQKGRVAIAVAINQAIACR 0.98566 -2.8073 0 0 0 0 0 0 0 0 12.7575 12.0368 12.189 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8546 0 0 12.0053 0 12.1302 12.161 12.2905 0 0 0 0 0 0 0 0 11.9217 0 12.0006 0 0 0 0 0 0 0 0 0 0 12.1827 0 0 0 0 0 0 0 0 0 14.0766 14.2581 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5092 0 0 0 0 0 0 0 0 0 0 0 0 12.1478 0 0 0 0 0 0 12.7538 13.8578 0 0 12.0908 0 0 0 0 0 0 0 0 14.2729 13.1133 0 0 0 0 0 12.7479 0 0 0 0 0 13.3086 13.3042 0 0 12.8676 0 0 0 0 0 0 0 13.6376 0 0 0 12.6913 0 0 0 0 0 0 15.204 0 18.0597 0 0 0 0 0 0 0 14.2998 0 0 0 14.4153 13.3882 14.3078 14.6755 18.087 14.5396 14.474 14.3019 14.3606 14.3409 0 0 0 0 0 0 14.591 0 0 Q9H4I9 EMRE_HUMAN "Essential MCU regulator, mitochondrial (Single-pass membrane protein with aspartate-rich tail 1, mitochondrial)" SMDT1 C22orf32 EMRE Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851] GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006851; GO:0031305; GO:0036444; GO:0051560; GO:1990246 MASGAAR 0.98566 -3.8483 0 0 0 0 0 0 11.3074 0 18.5896 0 0 18.3258 0 18.3105 18.339 0 0 0 0 0 0 0 0 10.4599 0 0 0 0 0 0 0 18.5222 0 0 0 0 0 0 18.53 18.5607 18.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3697 0 0 0 0 0 0 19.5559 0 0 0 12.2922 0 0 19.6201 19.6451 0 19.5817 0 15.2369 0 19.5101 0 0 0 0 0 0 19.5752 19.5175 0 Q9NX08 COMD8_HUMAN COMM domain-containing protein 8 COMMD8 MDS022 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 LALSSDK 0.98566 -2.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6552 0 0 0 0 0 0 0 0 0 0 0 0 16.0162 0 Q9P2K3 RCOR3_HUMAN REST corepressor 3 RCOR3 KIAA1343 Homo sapiens (Human) "histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000118; GO:0003714; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0016575; GO:0045892 transcription corepressor activity [GO:0003714] EGNTEQPVQTSKIGLGRR 0.98566 4.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3427 0 0 0 0 0 0 0 0 0 9.91355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7899 0 0 0 0 0 10.0052 0 12.9247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4507 0 0 0 0 0 0 0 0 0 11.464 0 0 0 0 0 11.5465 0 0 0 0 0 11.4881 0 0 0 13.371 12.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3354 0 0 0 0 11.1044 0 Q9ULI3 HEG1_HUMAN Protein HEG homolog 1 HEG1 KIAA1237 Homo sapiens (Human) cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222] cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue growth [GO:0055017]; cell-cell junction assembly [GO:0007043]; endothelial cell morphogenesis [GO:0001886]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; multicellular organism growth [GO:0035264]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; pericardium development [GO:0060039]; positive regulation of fibroblast growth factor production [GO:0090271]; post-embryonic development [GO:0009791]; protein localization to cell junction [GO:1902414]; regulation of body fluid levels [GO:0050878]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular septum development [GO:0003281]; ventricular trabecula myocardium morphogenesis [GO:0003222] GO:0001570; GO:0001701; GO:0001886; GO:0001945; GO:0003017; GO:0003209; GO:0003222; GO:0003281; GO:0005509; GO:0005576; GO:0005911; GO:0007043; GO:0007507; GO:0009791; GO:0009897; GO:0016021; GO:0030324; GO:0035024; GO:0035264; GO:0048845; GO:0050878; GO:0055017; GO:0060039; GO:0090271; GO:1902414; GO:1905709; GO:2000299 calcium ion binding [GO:0005509] ASPRASRWPPPLLLLLLPLLLLPPAAPGTR 0.98566 -2.8086 0 11.3338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2075 0 0 0 0 0 0 0 0 0 12.8074 0 0 0 0 13.1288 0 0 11.5737 0 13.6128 0 0 9.89083 0 0 0 0 0 0 0 0 0 0 12.3084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.99 0 0 0 0 0 12.558 0 15.3196 0 15.7405 0 0 0 0 0 12.2533 0 0 13.664 0 0 13.6384 0 16.352 0 0 0 0 0 0 0 0 12.3452 0 0 0 0 0 0 12.5204 0 0 11.5305 12.6213 11.0682 0 0 0 0 0 0 0 0 11.8442 0 0 12.4272 12.3144 13.8661 0 0 12.2477 0 12.7071 0 0 12.4892 14.6144 11.9269 0 0 11.4399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.905 11.9502 13.381 0 13.5493 0 0 0 0 15.0437 0 0 0 0 0 11.6012 0 O94991 SLIK5_HUMAN SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11) SLITRK5 KIAA0918 LRRC11 Homo sapiens (Human) adult behavior [GO:0030534]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; circulatory system development [GO:0072359]; dendrite morphogenesis [GO:0048813]; grooming behavior [GO:0007625]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; striatum development [GO:0021756] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]; adult behavior [GO:0030534]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; circulatory system development [GO:0072359]; dendrite morphogenesis [GO:0048813]; grooming behavior [GO:0007625]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; striatum development [GO:0021756] GO:0005886; GO:0007268; GO:0007409; GO:0007625; GO:0009410; GO:0016021; GO:0021756; GO:0030534; GO:0043235; GO:0043588; GO:0045202; GO:0048813; GO:0051965; GO:0072359; GO:1905606 EGNSVEDYKDLHELK 0.98567 -2.6394 0 0 0 0 0 0 0 0 0 0 0 13.4995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.991 0 0 0 0 0 0 0 0 0 0 12.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0007 0 0 0 0 0 13.2627 0 0 0 0 0 0 0 0 0 0 13.9895 0 15.0777 0 0 0 0 0 0 0 14.7186 0 0 0 0 0 0 13.0591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8591 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0366 0 0 0 0 0 0 0 0 0 0 Q7L7V1 DHX32_HUMAN "Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32, EC 3.6.4.13 (DEAD/H box 32) (DEAD/H helicase-like protein 1, DHLP1) (DEAH box protein 32) (HuDDX32)" DHX32 DDX32 Homo sapiens (Human) mitochondrion [GO:0005739]; spliceosomal complex [GO:0005681] mitochondrion [GO:0005739]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0005739; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] KVYNPRIR 0.98567 -2.6424 0 0 0 12.5041 0 0 12.2515 0 0 0 0 0 0 0 12.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7978 0 0 0 0 0 0 0 12.6848 0 0 12.4467 0 0 0 0 12.4623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0102 0 0 0 0 0 0 0 0 0 0 0 0 14.6628 11.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6179 0 0 0 13.9163 0 0 0 0 0 0 0 0 0 0 0 0 12.8415 0 0 0 0 0 0 12.1177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.941 0 0 0 0 0 0 12.2364 0 0 0 0 0 0 Q8IWD5 MFS6L_HUMAN Major facilitator superfamily domain-containing protein 6-like MFSD6L FP7072 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 ATLLRKLSR 0.98567 -3.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57228 0 0 0 0 0 0 0 0 0 0 0 9.81092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5215 0 0 0 0 0 0 14.2801 0 0 0 0 0 0 0 14.8219 0 15.0121 0 0 0 0 0 0 0 0 0 14.3105 0 0 0 0 0 0 0 14.2639 0 14.3392 0 0 0 13.7137 0 0 0 0 0 0 0 0 13.4202 0 0 0 0 0 0 0 0 14.1726 12.6197 11.3996 0 11.675 0 0 0 0 0 13.9373 0 12.1265 0 0 Q969S0 S35B4_HUMAN UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4) (YEA4 homolog) SLC35B4 YEA4 PSEC0055 Homo sapiens (Human) carbohydrate transport [GO:0008643]; regulation of gluconeogenesis [GO:0006111]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464]; carbohydrate transport [GO:0008643]; regulation of gluconeogenesis [GO:0006111]; UDP-N-acetylglucosamine transmembrane transport [GO:1990569]; UDP-xylose transmembrane transport [GO:0015790] GO:0000139; GO:0005462; GO:0005464; GO:0005783; GO:0005794; GO:0006111; GO:0008643; GO:0015790; GO:0022857; GO:0030173; GO:0030176; GO:1990569 transmembrane transporter activity [GO:0022857]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; UDP-xylose transmembrane transporter activity [GO:0005464] GVFILTTECASLTVTLVVTLR 0.98567 -2.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRJ7 PCDBG_HUMAN "Protocadherin beta-16, PCDH-beta-16 (Protocadherin-3X)" PCDHB16 KIAA1621 PCDH3X Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] EIGWMHNR 0.98567 -3.8703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9503 11.9004 0 0 0 11.2295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.843 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4731 0 0 0 12.8023 0 Q14393 GAS6_HUMAN "Growth arrest-specific protein 6, GAS-6 (AXL receptor tyrosine kinase ligand)" GAS6 AXLLG Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme-linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fibroblast apoptotic process [GO:0044346]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; myeloid cell apoptotic process [GO:0033028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]" cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093] "cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activator activity [GO:0030296]; protein-macromolecule adaptor activity [GO:0030674]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme-linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fibroblast apoptotic process [GO:0044346]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; myeloid cell apoptotic process [GO:0033028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]" GO:0001764; GO:0001786; GO:0001934; GO:0001961; GO:0003104; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0006468; GO:0006909; GO:0007165; GO:0007167; GO:0007596; GO:0009267; GO:0010628; GO:0010804; GO:0018105; GO:0019064; GO:0019079; GO:0030296; GO:0030674; GO:0030971; GO:0031093; GO:0031100; GO:0031589; GO:0032008; GO:0032148; GO:0032689; GO:0032692; GO:0032715; GO:0032720; GO:0032825; GO:0033028; GO:0033033; GO:0033138; GO:0035457; GO:0035754; GO:0040008; GO:0043027; GO:0043066; GO:0043154; GO:0043277; GO:0043433; GO:0043491; GO:0044346; GO:0045860; GO:0045892; GO:0046718; GO:0046813; GO:0046827; GO:0048018; GO:0048146; GO:0050766; GO:0051897; GO:0061098; GO:0070062; GO:0070168; GO:0070374; GO:0070588; GO:0071307; GO:0071333; GO:0071363; GO:0071466; GO:0072659; GO:0085029; GO:0097028; GO:0097241; GO:1900142; GO:2000270; GO:2000352; GO:2000510; GO:2000533; GO:2000669 calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activator activity [GO:0030296]; protein-macromolecule adaptor activity [GO:0030674]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] AVPLSVALVDYHSTKKLK 0.98568 -2.6585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8453 14.1261 0 0 0 12.4848 0 0 0 0 0 14.9085 0 0 0 0 0 0 0 0 14.0117 12.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.017 0 0 0 0 0 0 0 13.5193 Q8N635 MEIOB_HUMAN "Meiosis-specific with OB domain-containing protein, EC 3.1.-.-" MEIOB C16orf73 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis I [GO:0007144]; fertilization [GO:0009566]; homologous chromosome pairing at meiosis [GO:0007129]; male meiotic nuclear division [GO:0007140]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000712; GO:0000724; GO:0003682; GO:0003697; GO:0005634; GO:0005694; GO:0005737; GO:0007129; GO:0007140; GO:0007144; GO:0008310; GO:0009566 chromatin binding [GO:0003682]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; single-stranded DNA binding [GO:0003697] ANSFAARIFTTLSDLQTNMANLK 0.98568 -3.8722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2193 0 0 0 0 0 0 0 0 0 0 0 0 13.2692 0 0 0 0 0 0 0 0 10.9795 0 0 0 12.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6871 0 0 0 13.1554 14.2488 14.1674 0 0 0 0 0 13.1058 13.85 0 13.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5523 0 0 13.1224 0 0 0 0 0 13.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3558 0 0 0 0 0 Q8NGK9 OR5DG_HUMAN Olfactory receptor 5D16 (Olfactory receptor OR11-154) OR5D16 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] VASVFYTVVIPLLNPLIYSLRNK 0.98568 -3.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE96 DQX1_HUMAN "ATP-dependent RNA helicase DQX1, EC 3.6.4.12 (DEAQ box polypeptide 1)" DQX1 Homo sapiens (Human) spliceosomal complex [GO:0005681] spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723] GO:0003678; GO:0003723; GO:0005524; GO:0005681; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723] GFQKGQVTVTQPYPLAAR 0.98568 -3.6082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4086 13.5757 0 0 0 0 0 0 0 12.8563 0 0 0 15.2485 0 14.9307 0 0 0 0 0 0 0 0 0 11.0875 11.9887 0 0 0 0 0 14.2324 0 0 0 0 0 0 0 0 0 14.2571 14.2195 0 0 0 0 0 0 13.1626 13.0895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6G9 DC1L1_HUMAN "Cytoplasmic dynein 1 light intermediate chain 1, LIC1 (Dynein light chain A, DLC-A) (Dynein light intermediate chain 1, cytosolic)" DYNC1LI1 DNCLI1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267] GO:0000226; GO:0000776; GO:0000922; GO:0003723; GO:0005524; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005886; GO:0007018; GO:0007049; GO:0016020; GO:0019003; GO:0030667; GO:0045504; GO:0051301; GO:0090267; GO:0101003 ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; RNA binding [GO:0003723] AEDNFEDIITK 0.98568 -2.8285 0 0 0 0 0 0 0 0 15.3434 15.2067 15.2722 14.4952 12.9067 15.8251 15.1545 0 0 0 14.592 0 0 0 0 0 0 0 0 0 14.4606 0 10.5892 14.9097 14.5405 15.939 0 14.757 0 15.5825 13.9307 0 0 14.431 14.2406 0 0 10.7645 0 0 15.0393 14.8487 14.9527 0 0 0 0 0 12.7112 0 0 0 12.1521 0 0 0 11.2068 0 0 0 0 0 0 0 0 0 0 0 0 12.3653 0 0 11.7099 0 0 0 0 0 0 0 0 12.8786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7628 0 0 0 0 0 0 13.0682 0 0 0 0 0 0 0 12.3315 0 0 13.183 0 13.6945 12.5191 11.9805 12.5832 0 0 0 0 0 0 0 0 13.2367 0 0 0 0 0 0 0 0 0 13.375 0 12.9806 12.6896 0 14.915 0 14.5196 0 0 14.1172 0 15.0274 12.1494 0 0 0 14.533 0 13.5056 13.8162 0 0 0 0 0 0 B5MCY1 TDR15_HUMAN Tudor domain-containing protein 15 TDRD15 Homo sapiens (Human) P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] P granule [GO:0043186] P granule [GO:0043186]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] GO:0030719; GO:0034587; GO:0043186 AAIDYFK 0.98569 -2.4331 0 0 0 0 0 11.9239 0 11.1996 0 12.3844 9.67737 13.9485 11.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0283 0 11.1452 12.7828 0 12.0903 0 0 0 0 0 0 12.5577 0 0 0 0 11.7794 0 0 11.2881 0 11.3523 11.7663 0 0 0 0 0 0 0 0 0 10.6648 0 0 0 11.8725 0 0 0 11.0955 0 12.6926 11.4927 11.977 12.4057 11.9669 11.2607 12.6827 0 12.6831 17.2742 0 14.6357 13.4481 13.101 0 0 11.5902 0 13.5008 12.2745 13.8616 10.9029 0 0 16.427 13.4379 11.8728 11.4326 13.7357 12.2021 12.4085 13.6552 0 0 0 12.0862 13.9747 11.9517 12.3399 0 12.9089 12.4245 12.3836 12.7466 13.3462 13.1235 0 0 13.603 13.3415 12.1775 13.8255 13.3953 12.4449 12.5511 12.4715 13.0841 11.7408 13.3038 12.899 0 12.2254 12.9121 0 13.1881 13.9697 11.2186 0 0 13.1586 0 11.5465 13.0594 13.6012 0 11.7754 14.4494 0 0 10.9005 0 0 0 0 0 0 13.5259 0 0 15.1119 0 10.6696 14.8821 0 0 11.5405 0 13.3053 14.6819 14.4609 0 0 0 0 12.9583 0 O60239 3BP5_HUMAN "SH3 domain-binding protein 5, SH3BP-5 (SH3 domain-binding protein that preferentially associates with BTK)" SH3BP5 SAB Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099]; signal transduction [GO:0007165] GO:0004860; GO:0005085; GO:0005654; GO:0005737; GO:0005739; GO:0007165; GO:0016604; GO:0017124; GO:0030659; GO:0035556; GO:0061099 guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; SH3 domain binding [GO:0017124] ATQDFQR 0.98569 -3.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2658 14.8382 14.6747 0 0 0 0 14.7013 0 13.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75821 EIF3G_HUMAN "Eukaryotic translation initiation factor 3 subunit G, eIF3g (Eukaryotic translation initiation factor 3 RNA-binding subunit, eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44)" EIF3G EIF3S4 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] GO:0001732; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0048471; GO:0075525 RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] CVTSELLK 0.98569 -2.6687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3643 0 0 0 12.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DI83 NARR_HUMAN "Ras-related protein Rab-34, isoform NARR (Nine amino-acid residue-repeats)" RAB34 NARR Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730] GO:0005730 ARVILGSPRPR 0.98569 -2.4825 0 9.88171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3907 0 0 0 0 0 12.5643 0 0 12.5614 0 10.1883 0 0 12.3779 0 0 0 15.5893 0 0 0 0 0 13.5108 13.6515 0 13.0779 0 14.3827 0 13.6472 0 12.9988 0 11.4717 0 0 0 0 0 0 0 0 0 0 12.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9045 0 0 14.6902 0 0 0 14.2866 0 0 0 13.4833 13.6752 0 0 0 13.4752 0 0 0 0 0 14.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2W9 RM21_HUMAN "39S ribosomal protein L21, mitochondrial, L21mt, MRP-L21 (Mitochondrial large ribosomal subunit protein bL21m)" MRPL21 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] HHAEVVKK 0.98569 -2.9387 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2681 0 12.1275 12.8785 12.6327 13.8951 0 0 0 0 10.4961 0 0 0 0 13.9537 0 0 0 0 0 0 0 0 0 14.4682 0 0 0 0 11.5972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.87 0 0 0 0 0 0 0 0 0 0 0 11.6824 0 0 13.239 0 0 0 0 11.1374 0 0 0 0 14.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0326 0 0 0 0 0 0 0 0 Q8IZ52 CHSS2_HUMAN "Chondroitin sulfate synthase 2, EC 2.4.1.175, EC 2.4.1.226 (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor, ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2)" CHPF CSS2 UNQ651/PRO1281 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206] cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759] cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206] GO:0000139; GO:0005759; GO:0005829; GO:0008376; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510 acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] DPVHMYQLHK 0.98569 -3.6097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5545 0 12.7766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5282 0 0 0 14.1718 0 0 0 16.5026 0 0 0 0 17.975 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4911 0 0 0 0 0 0 0 0 12.089 0 0 Q8NI60 COQ8A_HUMAN "Atypical kinase COQ8A, mitochondrial, EC 2.7.-.- (Chaperone activity of bc1 complex-like, Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)" COQ8A ADCK3 CABC1 PP265 Homo sapiens (Human) phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744] extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744] GO:0005524; GO:0005739; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0031314; GO:0043531 ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301] AMFEEAYSNYCKR 0.98569 -3.3416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5391 0 0 0 0 0 0 0 0 0 0 0 0 Q96IG2 FXL20_HUMAN F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like) FBXL20 FBL2 Homo sapiens (Human) "behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]" cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685] "cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; behavioral fear response [GO:0001662]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]" GO:0001662; GO:0005829; GO:0019005; GO:0031146; GO:0098685; GO:0098793; GO:0098978; GO:0099575; GO:2000300 FCRCCIIL 0.98569 -3.6109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J94 PIWL1_HUMAN "Piwi-like protein 1, EC 3.1.26.-" PIWIL1 HIWI Homo sapiens (Human) "gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186] "chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" GO:0003723; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0007286; GO:0010529; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0035093; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:1905538 endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] AIMIEVDDR 0.98569 -2.0941 0 0 0 0 0 0 0 0 0 0 0 10.3814 0 0 0 0 0 0 0 0 15.0866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78459 15.1051 0 0 0 0 0 0 0 0 15.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7332 0 0 14.8475 18.2307 0 0 0 0 0 13.2315 0 13.5179 0 0 0 0 0 0 0 0 0 0 0 11.9445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8476 0 0 0 0 0 0 15.078 0 0 0 0 0 0 0 0 12.5348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4378 14.4416 0 0 0 0 0 0 13.1654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QS3 ARX_HUMAN Homeobox protein ARX (Aristaless-related homeobox) ARX Homo sapiens (Human) axon guidance [GO:0007411]; cell proliferation in forebrain [GO:0021846]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex tangential migration [GO:0021800]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; enteric nervous system development [GO:0048484]; epithelial cell fate commitment [GO:0072148]; globus pallidus development [GO:0021759]; lipid digestion [GO:0044241]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; axon guidance [GO:0007411]; cell proliferation in forebrain [GO:0021846]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex tangential migration [GO:0021800]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; enteric nervous system development [GO:0048484]; epithelial cell fate commitment [GO:0072148]; globus pallidus development [GO:0021759]; lipid digestion [GO:0044241]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0005634; GO:0006357; GO:0007411; GO:0010628; GO:0021759; GO:0021800; GO:0021831; GO:0021846; GO:0021853; GO:0035265; GO:0044241; GO:0046622; GO:0048484; GO:0050678; GO:0072148; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ALLKEPRR 0.98569 -2.0889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2032 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57077 M3KCL_HUMAN MAP3K7 C-terminal-like protein (TAK1-like protein) MAP3K7CL C21orf7 TAK1L Homo sapiens (Human) cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634] GO:0005634; GO:0005829 KEITLLEQRK 0.9857 -2.9488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1469 0 13.6174 13.3058 0 13.5454 0 0 0 0 0 0 0 0 0 0 0 13.1323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2525 0 0 0 0 0 Q15435 PP1R7_HUMAN Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22) PPP1R7 SDS22 Homo sapiens (Human) positive regulation of protein dephosphorylation [GO:0035307] chromosome [GO:0005694]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164] chromosome [GO:0005694]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; enzyme regulator activity [GO:0030234]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of protein dephosphorylation [GO:0035307] GO:0000164; GO:0004865; GO:0005634; GO:0005694; GO:0005737; GO:0019888; GO:0030234; GO:0035307; GO:0070062 enzyme regulator activity [GO:0030234]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865] IEGFEVLKKVK 0.9857 -2.8486 0 0 0 14.2945 13.6657 0 0 0 0 0 0 0 0 0 0 14.3245 11.4631 13.6588 14.5585 0 13.2697 0 12.8388 0 10.2382 0 11.206 12.9966 0 0 0 0 0 0 0 0 0 0 0 0 12.4071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2117 0 0 0 12.9092 16.2122 0 13.9801 13.1128 0 0 12.572 14.2174 13.6008 0 13.1963 13.8517 0 12.6201 0 14.0884 0 0 12.5948 13.9388 11.9818 13.4269 0 12.831 0 0 12.1947 13.8442 0 15.0954 0 13.923 0 0 0 0 0 0 0 0 0 13.2705 0 13.6602 15.6046 13.2167 0 0 0 0 0 0 0 0 0 0 0 0 10.0794 0 12.912 0 0 0 0 0 0 15.049 0 15.773 0 0 0 0 12.7881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7456 0 0 0 9.72344 9.68506 0 0 Q7RTX1 TS1R1_HUMAN Taste receptor type 1 member 1 (G-protein coupled receptor 70) TAS1R1 GPR70 T1R1 TR1 GM148 Homo sapiens (Human) sensory perception of umami taste [GO:0050917] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; sensory perception of umami taste [GO:0050917] GO:0004930; GO:0005886; GO:0005887; GO:0008527; GO:0016021; GO:0050917 G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] AFSMSSAYNAYR 0.9857 -2.8497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5593 0 0 0 0 0 14.7424 0 0 11.2599 0 0 0 14.9672 0 13.9767 0 0 0 0 13.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8741 13.3347 0 0 0 12.3707 0 0 0 0 12.0842 11.9625 0 12.8245 12.7075 0 0 0 0 0 0 0 11.9962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0343 12.8001 13.7477 0 0 13.0698 0 0 0 0 0 0 0 0 0 0 0 11.3104 0 0 0 0 0 0 0 0 0 Q86SG2 ANR23_HUMAN Ankyrin repeat domain-containing protein 23 (Diabetes-related ankyrin repeat protein) (Muscle ankyrin repeat protein 3) ANKRD23 DARP Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; regulation of sarcomere organization [GO:0060297]; response to muscle stretch [GO:0035994] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; I band [GO:0031674]; nucleoplasm [GO:0005654] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; I band [GO:0031674]; nucleoplasm [GO:0005654]; titin binding [GO:0031432]; fatty acid metabolic process [GO:0006631]; regulation of sarcomere organization [GO:0060297]; response to muscle stretch [GO:0035994] GO:0005654; GO:0005829; GO:0006631; GO:0015629; GO:0031432; GO:0031674; GO:0035994; GO:0060297 titin binding [GO:0031432] GGHLVILKQLLNQGARVNAR 0.9857 -2.6786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8254 0 0 0 0 11.1635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNN5 FAF1_HUMAN "FAS-associated factor 1, hFAF1 (UBX domain-containing protein 12) (UBX domain-containing protein 3A)" FAF1 UBXD12 UBXN3A CGI-03 Homo sapiens (Human) apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent ERAD pathway [GO:0030433] CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005634; GO:0005635; GO:0005654; GO:0005783; GO:0005829; GO:0006915; GO:0007253; GO:0008219; GO:0010942; GO:0019887; GO:0019901; GO:0019904; GO:0030155; GO:0030433; GO:0031072; GO:0031265; GO:0031334; GO:0031625; GO:0034098; GO:0042176; GO:0043065; GO:0043130; GO:0043161; GO:0045732; GO:0045740; GO:0048471; GO:0051059; GO:1902043; GO:1990917 heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] HQLWEGWPTSATDDSMCLAESGLSYPCHR 0.9857 -2.8519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7092 0 0 0 0 13.5823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7671 0 0 0 0 0 0 0 0 0 0 0 0 12.5246 0 0 0 0 0 0 0 0 0 0 0 12.3017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75489 NDUS3_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial, EC 7.1.1.2 (Complex I-30kD, CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)" NDUFS3 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762]" mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762]" GO:0003954; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0009055; GO:0009060; GO:0016604; GO:0021762; GO:0030308; GO:0031966; GO:0032981; GO:0042776; GO:0072593; GO:2001243 electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954] GILGASALTRGTGRPSVLLLPVR 0.98571 -2.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.861 Q7Z5L2 R3HCL_HUMAN Coiled-coil domain-containing protein R3HCC1L (Growth inhibition and differentiation-related protein 88) (Putative mitochondrial space protein 32.1) (R3H and coiled-coil domain-containing protein 1-like) R3HCC1L C10orf28 GIDRP88 Homo sapiens (Human) HEPDGEAFEDK 0.98571 -2.8553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N556 AFAP1_HUMAN "Actin filament-associated protein 1 (110 kDa actin filament-associated protein, AFAP-110)" AFAP1 AFAP Homo sapiens (Human) regulation of cytoskeleton organization [GO:0051493]; regulation of signal transduction [GO:0009966] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; regulation of cytoskeleton organization [GO:0051493]; regulation of signal transduction [GO:0009966] GO:0003779; GO:0005829; GO:0005925; GO:0009966; GO:0015629; GO:0017124; GO:0042169; GO:0051493 actin binding [GO:0003779]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124] APEYITSNYDSDAMSSSYESYDEEEEDGK 0.98571 -2.4963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6147 17.5456 17.4414 0 17.2919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2722 0 0 0 0 0 0 0 0 0 0 12.8933 0 13.3829 0 0 12.7247 0 11.7993 0 0 0 0 0 0 0 0 0 11.8662 0 14.7997 19.018 0 14.7199 0 0 0 0 0 0 0 14.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5677 0 0 0 0 0 0 0 0 0 20.496 0 0 0 0 0 0 0 Q8NDD1 CA131_HUMAN Uncharacterized protein C1orf131 C1orf131 cPERP-A Homo sapiens (Human) chromosome [GO:0005694] chromosome [GO:0005694]; RNA binding [GO:0003723] GO:0003723; GO:0005694 RNA binding [GO:0003723] AIMLGAKPPKK 0.98571 -3.9151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1969 13.0373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4571 0 12.9035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0201 0 14.1552 0 13.6477 0 0 0 0 0 13.8887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG50 RDM1_HUMAN RAD52 motif-containing protein 1 (RAD52 homolog B) RDM1 RAD52B Homo sapiens (Human) Cajal body [GO:0015030]; cytosol [GO:0005829]; nucleolus [GO:0005730]; PML body [GO:0016605] Cajal body [GO:0015030]; cytosol [GO:0005829]; nucleolus [GO:0005730]; PML body [GO:0016605]; DNA binding [GO:0003677]; RNA binding [GO:0003723] GO:0003677; GO:0003723; GO:0005730; GO:0005829; GO:0015030; GO:0016605 DNA binding [GO:0003677]; RNA binding [GO:0003723] AAHRAQK 0.98571 -3.9142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.682 12.9498 0 0 0 0 14.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6338 14.8385 0 0 0 0 0 0 0 0 0 13.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWU1 CDK19_HUMAN "Cyclin-dependent kinase 19, EC 2.7.11.22 (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase)" CDK19 CDC2L6 CDK11 KIAA1028 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cellular response to lipopolysaccharide [GO:0071222]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; protein phosphorylation [GO:0006468] GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006468; GO:0008353; GO:0016592; GO:0043065; GO:0048471; GO:0050729; GO:0071222; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] KPMQLPR 0.98571 -2.6844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2225 0 0 0 0 13.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZV5 WWTR1_HUMAN WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) "cilium assembly [GO:0060271]; glomerulus development [GO:0032835]; heart process [GO:0003015]; hippo signaling [GO:0035329]; kidney morphogenesis [GO:0060993]; mesenchymal cell differentiation [GO:0048762]; multicellular organism growth [GO:0035264]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription, DNA-templated [GO:0006355]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; tissue homeostasis [GO:0001894]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cilium assembly [GO:0060271]; glomerulus development [GO:0032835]; heart process [GO:0003015]; hippo signaling [GO:0035329]; kidney morphogenesis [GO:0060993]; mesenchymal cell differentiation [GO:0048762]; multicellular organism growth [GO:0035264]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription, DNA-templated [GO:0006355]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; stem cell division [GO:0017145]; tissue homeostasis [GO:0001894]" GO:0000122; GO:0001649; GO:0001894; GO:0001933; GO:0003015; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006355; GO:0006469; GO:0008284; GO:0010718; GO:0016567; GO:0016604; GO:0017145; GO:0031146; GO:0032835; GO:0035264; GO:0035329; GO:0042803; GO:0045599; GO:0045669; GO:0045944; GO:0048762; GO:0060271; GO:0060390; GO:0060993; GO:0072307; GO:0090090; GO:1900182 protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] EPDSGSHSR 0.98571 -2.5834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9147 13.0001 0 0 0 12.2681 0 0 0 0 0 12.5608 13.3116 12.9316 0 0 0 0 0 13.9209 0 15.0174 0 0 Q9H5J8 TAF1D_HUMAN "TATA box-binding protein-associated factor RNA polymerase I subunit D (RNA polymerase I-specific TBP-associated factor 41 kDa, TAFI41) (TATA box-binding protein-associated factor 1D, TBP-associated factor 1D) (Transcription initiation factor SL1/TIF-IB subunit D)" TAF1D JOSD3 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" centriolar satellite [GO:0034451]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668] "centriolar satellite [GO:0034451]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0005654; GO:0005668; GO:0005730; GO:0005829; GO:0006355; GO:0034451; GO:0042802; GO:0072686 DNA binding [GO:0003677]; identical protein binding [GO:0042802] LKYEHHLK 0.98571 -2.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9424 0 0 0 0 0 0 0 0 0 0 A6PVC2 TTLL8_HUMAN "Protein monoglycylase TTLL8, EC 6.3.2.- (Tubulin--tyrosine ligase-like protein 8)" TTLL8 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126] "axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]" GO:0003341; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0030317; GO:0036126; GO:0046872; GO:0060271; GO:0070735; GO:0070736 "ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]" ARGPSAMPDPAQGPPSPALQRDLGLK 0.98572 -3.3744 0 0 0 15.5929 0 0 0 0 0 0 0 0 0 10.713 0 0 0 0 0 0 0 11.54 0 0 0 0 0 0 0 0 11.9554 0 0 0 0 0 0 0 0 0 0 12.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2392 0 0 0 0 13.8913 0 0 0 0 0 0 12.2433 0 0 0 12.9552 14.0444 14.7979 14.0185 0 13.5415 0 0 0 15.2229 17.6704 0 0 14.6017 0 0 16.7066 0 0 12.1503 0 17.4474 14.5878 0 15.8148 0 17.3813 14.4476 0 13.4293 0 0 0 13.9214 0 16.4384 0 0 14.7728 0 15.6982 15.7 14.6398 16.091 16.5508 14.1921 16.3923 16.4079 14.7051 16.3464 13.4054 0 15.0797 15.3507 0 0 0 0 0 15.9044 15.9181 0 13.6392 0 15.2113 13.9976 12.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9802 0 0 0 0 0 0 0 14.2733 0 0 0 12.5795 0 O43402 EMC8_HUMAN ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B) EMC8 C16orf2 C16orf4 COX4AL COX4NB FAM158B NOC4 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0016020; GO:0045050; GO:0071816; GO:0072546 CRDPHHDYCEDWPEAQR 0.98572 -3.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23415 GLRA1_HUMAN Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit) GLRA1 Homo sapiens (Human) "acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; inhibitory postsynaptic potential [GO:0060080]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; muscle contraction [GO:0006936]; negative regulation of transmission of nerve impulse [GO:0051970]; nervous system process [GO:0050877]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuropeptide signaling pathway [GO:0007218]; positive regulation of acrosome reaction [GO:2000344]; regulation of membrane potential [GO:0042391]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; response to alcohol [GO:0097305]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]" GO:0001964; GO:0002087; GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0006936; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007601; GO:0007628; GO:0008270; GO:0009897; GO:0016021; GO:0016594; GO:0016934; GO:0019228; GO:0030425; GO:0030594; GO:0030977; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0043025; GO:0043200; GO:0043204; GO:0043231; GO:0045202; GO:0045211; GO:0050877; GO:0050884; GO:0051970; GO:0060012; GO:0060013; GO:0060077; GO:0060080; GO:0070161; GO:0071230; GO:0071294; GO:0071361; GO:0097305; GO:0098690; GO:1902476; GO:1904315; GO:2000344 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; taurine binding [GO:0030977]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; zinc ion binding [GO:0008270] DLRYCTK 0.98572 -2.873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3275 0 0 0 0 12.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6359 0 0 13.8772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6822 0 0 0 0 0 12.7012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1638 0 13.3783 0 P63215 GBG3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 GNG3 GNGT3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration [GO:0007204] cell body [GO:0044297]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cell body [GO:0044297]; dendrite [GO:0030425]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0003924; GO:0005834; GO:0005886; GO:0007186; GO:0007204; GO:0014069; GO:0030425; GO:0031681; GO:0044297 G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924] IEASLCRIKVSK 0.98572 -2.8722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1007 0 0 0 0 0 0 15.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7055 12.6231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1822 0 0 0 0 0 0 0 0 13.2463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16394 EXT1_HUMAN "Exostosin-1, EC 2.4.1.224, EC 2.4.1.225 (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1) (Putative tumor suppressor protein EXT1)" EXT1 Homo sapiens (Human) "antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; chondroitin sulfate metabolic process [GO:0030204]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification [GO:0001503]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; TNFSF11-mediated signaling pathway [GO:0071847]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; synapse [GO:0045202] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; chondroitin sulfate metabolic process [GO:0030204]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification [GO:0001503]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; TNFSF11-mediated signaling pathway [GO:0071847]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]" GO:0000139; GO:0001501; GO:0001503; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007165; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0014033; GO:0015012; GO:0015014; GO:0015020; GO:0016021; GO:0016757; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030176; GO:0030199; GO:0030204; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0033692; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042328; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0071847; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1904888; GO:1990823 acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CDRDNTEYEK 0.98572 -3.6445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6043 0 0 0 12.2426 14.3934 0 0 12.3965 0 0 0 0 0 0 0 0 0 0 15.1978 15.7766 0 0 0 0 17.0399 11.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1091 14.8349 15.1221 15.4186 13.5888 0 12.3363 13.2863 0 12.5629 12.5026 0 0 13.2074 0 0 15.4174 0 14.7962 13.9117 14.9578 14.2208 0 13.4847 12.9786 14.7105 0 15.3686 0 13.7764 14.3612 14.3053 16.2788 15.1467 0 13.4305 12.9385 0 14.3346 15.2303 15.2249 12.8512 14.4241 0 13.6321 14.9197 13.6891 14.2598 15.0947 0 0 0 13.3645 0 0 0 12.7225 12.607 13.1491 13.8665 13.539 14.9859 12.8775 14.5482 14.2588 0 0 14.3271 12.6862 13.0336 14.2367 14.1034 15.9414 0 0 0 13.3954 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3511 0 0 0 0 0 0 14.3077 14.1156 14.2064 14.9706 0 0 0 0 0 Q2TAM9 TUSC1_HUMAN "Tumor suppressor candidate gene 1 protein (TSG-9, TSG9)" TUSC1 Homo sapiens (Human) GSCCGGDGAADGR 0.98572 -2.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0215 0 0 0 0 0 Q496J9 SV2C_HUMAN Synaptic vesicle glycoprotein 2C SV2C KIAA1054 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857]; chemical synaptic transmission [GO:0007268]; neurotransmitter transport [GO:0006836] GO:0005886; GO:0006836; GO:0007268; GO:0008021; GO:0016021; GO:0022857; GO:0030285; GO:0030672; GO:0043005; GO:0070161 transmembrane transporter activity [GO:0022857] ARGQPEK 0.98572 -2.7758 0 0 0 0 0 0 0 0 14.995 14.5378 14.7143 0 14.0663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9433 0 0 12.4581 13.4621 13.5259 13.5344 13.7936 12.2403 13.7542 13.6565 0 0 0 14.2085 0 0 13.5587 0 14.7353 13.4383 0 13.6841 11.3233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9397 0 0 0 0 0 0 0 12.358 0 0 0 12.9402 15.2238 0 0 0 0 0 0 10.9174 0 0 0 13.9666 0 0 0 0 0 0 0 0 0 0 0 0 15.3387 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4181 0 0 0 0 12.8494 0 14.6322 0 0 0 0 13.7185 0 0 14.1577 12.9421 0 0 0 13.256 13.1657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1861 Q68CR1 SE1L3_HUMAN "Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3, Sel-1L3)" SEL1L3 KIAA0746 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 FIIPLKEWFR 0.98572 -2.8687 13.076 0 11.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3974 11.4174 0 13.3624 0 0 12.8665 12.5948 0 12.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1433 0 0 0 0 0 0 0 0 0 0 12.1598 13.6022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5171 0 0 13.311 0 0 0 0 14.25 0 0 0 14.7986 0 12.647 0 12.2497 0 0 0 0 0 0 0 0 0 0 14.6109 0 13.0672 0 0 0 0 0 0 0 12.9261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1918 0 0 0 12.9434 0 0 0 0 0 0 0 13.1498 14.3191 0 12.8326 0 14.0762 0 0 0 0 0 0 12.3862 0 13.8068 0 Q92560 BAP1_HUMAN "Ubiquitin carboxyl-terminal hydrolase BAP1, EC 3.4.19.12 (BRCA1-associated protein 1) (Cerebral protein 6)" BAP1 KIAA0272 hucep-6 Homo sapiens (Human) "chromatin organization [GO:0006325]; common myeloid progenitor cell proliferation [GO:0035726]; erythrocyte maturation [GO:0043249]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; leukocyte proliferation [GO:0070661]; macrophage homeostasis [GO:0061519]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; myeloid cell apoptotic process [GO:0033028]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cellular homeostasis [GO:0070050]; neutrophil differentiation [GO:0030223]; nucleate erythrocyte differentiation [GO:0043363]; platelet morphogenesis [GO:0036344]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; response to inorganic substance [GO:0010035]; thrombocyte differentiation [GO:0002574]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cysteine-type deubiquitinase activity [GO:0004843]; peptidase activity [GO:0008233]; chromatin organization [GO:0006325]; common myeloid progenitor cell proliferation [GO:0035726]; erythrocyte maturation [GO:0043249]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; leukocyte proliferation [GO:0070661]; macrophage homeostasis [GO:0061519]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; monoubiquitinated protein deubiquitination [GO:0035520]; myeloid cell apoptotic process [GO:0033028]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron cellular homeostasis [GO:0070050]; neutrophil differentiation [GO:0030223]; nucleate erythrocyte differentiation [GO:0043363]; platelet morphogenesis [GO:0036344]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of inflammatory response [GO:0050727]; response to inorganic substance [GO:0010035]; thrombocyte differentiation [GO:0002574]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000278; GO:0001558; GO:0001701; GO:0001894; GO:0002574; GO:0003682; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006511; GO:0008233; GO:0008285; GO:0010035; GO:0010467; GO:0016579; GO:0030223; GO:0031490; GO:0033028; GO:0035517; GO:0035520; GO:0035522; GO:0035726; GO:0036211; GO:0036344; GO:0043249; GO:0043363; GO:0045892; GO:0050727; GO:0051726; GO:0061484; GO:0061519; GO:0070050; GO:0070661; GO:0071108; GO:1900015; GO:1903955 chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cysteine-type deubiquitinase activity [GO:0004843]; peptidase activity [GO:0008233] EVVEATDSREK 0.98572 -3.9157 0 0 0 0 0 0 0 15.1862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3214 0 0 0 0 0 0 13.1183 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6764 0 12.7145 0 14.0202 0 0 12.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3825 0 0 0 13.3802 0 14.209 11.9782 12.594 0 0 0 0 13.7575 0 13.5652 0 0 11.8434 0 0 0 0 0 0 0 0 10.7929 0 0 0 0 0 0 0 0 0 0 13.4742 0 Q96KP6 TNIP3_HUMAN "TNFAIP3-interacting protein 3 (A20-binding inhibitor of NF-kappa-B activation 3, ABIN-3) (Listeria-induced gene protein)" TNIP3 ABIN3 LIND Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 4 signaling pathway [GO:0034142] cytosol [GO:0005829] cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 4 signaling pathway [GO:0034142] GO:0002756; GO:0005829; GO:0006357; GO:0006954; GO:0031593; GO:0034142; GO:0043124; GO:0071222 polyubiquitin modification-dependent protein binding [GO:0031593] EKLEKQLK 0.98572 -3.4604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBR2 CATZ_HUMAN "Cathepsin Z, EC 3.4.18.1 (Cathepsin P) (Cathepsin X)" CTSZ Homo sapiens (Human) angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of protein binding [GO:0032091]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of neuron death [GO:1901214] cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580] cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of protein binding [GO:0032091]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of neuron death [GO:1901214] GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0010757; GO:0030134; GO:0031410; GO:0032091; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1901214; GO:1904813 carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] GPGWRPLLLLVLLAGAAQGGLYFRR 0.98572 -2.5854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43439 MTG8R_HUMAN Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85) CBFA2T2 EHT MTGR1 Homo sapiens (Human) "intestinal epithelial cell differentiation [GO:0060575]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron projection development [GO:0010976]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron projection development [GO:0010976]; transcription, DNA-templated [GO:0006351]" GO:0000122; GO:0003714; GO:0005634; GO:0006351; GO:0010976; GO:0010977; GO:0045746; GO:0045892; GO:0046872; GO:0060575 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] ELLHCAR 0.98573 -2.6053 0 0 0 0 0 12.6356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0061 0 0 0 0 0 0 0 0 0 0 12.2215 14.0755 0 0 13.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5321 0 0 0 0 0 0 0 0 0 0 12.8743 0 0 0 0 0 0 0 13.7924 0 0 0 0 0 0 0 13.2791 0 0 0 0 0 P16389 KCNA2_HUMAN Potassium voltage-gated channel subfamily A member 2 (NGK1) (Voltage-gated K(+) channel HuKIV) (Voltage-gated potassium channel HBK5) (Voltage-gated potassium channel subunit Kv1.2) KCNA2 Homo sapiens (Human) "neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]" axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] "axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]" GO:0005249; GO:0005251; GO:0005267; GO:0005789; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0014059; GO:0015271; GO:0016021; GO:0019228; GO:0019233; GO:0019894; GO:0021633; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0034765; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045188; GO:0051260; GO:0071805; GO:0097623; GO:0099056 delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249] IIAIVSVMVILISIVSFCLETLPIFR 0.98573 -3.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YG0 TMM42_HUMAN Transmembrane protein 42 TMEM42 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AERPGPPGGAVSATAYPDTPAEFPPHLQAGAMR 0.98573 -2.5989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5169 0 0 0 12.6481 0 13.3514 13.689 13.9135 0 0 0 12.0064 0 0 0 0 0 0 0 13.7929 0 14.0507 13.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4902 0 12.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1904 0 0 0 0 0 13.62 0 0 14.1657 0 14.3581 0 13.4393 0 0 0 0 0 13.5288 0 0 0 0 Q6UX98 ZDH24_HUMAN "Probable palmitoyltransferase ZDHHC24, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 24)" ZDHHC24 UNQ2528/PRO6027 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706 protein-cysteine S-palmitoyltransferase activity [GO:0019706] GVMLAGR 0.98573 -2.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN92 DUTL_HUMAN "Putative inactive deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323, dUTPase-like protein" Homo sapiens (Human) dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081] dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081] GO:0000287; GO:0004170; GO:0006226; GO:0046081 dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287] AIILSKLTQEQK 0.98573 -2.9736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3174 0 0 0 0 0 0 0 0 0 0 0 13.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9933 0 0 0 0 0 0 0 0 0 0 0 13.7113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XR8 CEP57_HUMAN "Centrosomal protein of 57 kDa, Cep57 (FGF2-interacting protein) (Testis-specific protein 57) (Translokin)" CEP57 KIAA0092 TSP57 Homo sapiens (Human) fibroblast growth factor receptor signaling pathway [GO:0008543]; microtubule anchoring [GO:0034453]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; microtubule anchoring [GO:0034453]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286] GO:0005634; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034453; GO:0042803; GO:0043015; GO:0051260 fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] ANQITKVR 0.98573 -3.7427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0803 0 0 0 0 14.5442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3363 10.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6886 0 0 0 0 0 0 0 14.5344 19.1672 11.1804 0 13.5463 0 0 0 0 12.0542 14.1485 0 11.2366 13.9647 0 19.7447 0 0 0 0 16.8983 0 0 0 0 0 0 0 0 0 0 0 0 12.1197 0 0 11.6668 0 0 10.7205 0 0 0 0 0 0 13.2412 0 0 0 0 0 0 0 0 10.9541 0 12.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.001 0 0 0 0 0 0 0 0 13.1129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBC4 CT203_HUMAN Uncharacterized protein C20orf203 C20orf203 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 GLRAPAGR 0.98573 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBQ7 GRHPR_HUMAN "Glyoxylate reductase/hydroxypyruvate reductase, EC 1.1.1.79, EC 1.1.1.81" GRHPR GLXR MSTP035 Homo sapiens (Human) carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP+) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803]; carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487] GO:0005737; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:1902494 carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP+) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803] AADCEVEQWDSDEPIPAKELER 0.98573 -3.6461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1884 0 0 0 0 0 0 13.9996 0 0 0 0 12.9693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75800 ZMY10_HUMAN Zinc finger MYND domain-containing protein 10 (Protein BLu) ZMYND10 BLU LUCA12.4 Homo sapiens (Human) cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]; protein localization to cilium [GO:0061512] apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293] apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein folding chaperone [GO:0044183]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505]; protein localization to cilium [GO:0061512] GO:0003341; GO:0005737; GO:0016324; GO:0034451; GO:0036158; GO:0036159; GO:0044183; GO:0044458; GO:0046872; GO:0060090; GO:0061512; GO:0120293; GO:1905505 metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein folding chaperone [GO:0044183] CQNEWYCCR 0.98574 -3.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23142 FBLN1_HUMAN "Fibulin-1, FIBL-1" FBLN1 PP213 Homo sapiens (Human) "blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]" basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]" GO:0001933; GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0007162; GO:0007566; GO:0008022; GO:0010628; GO:0016504; GO:0030198; GO:0031012; GO:0042802; GO:0044877; GO:0048146; GO:0062023; GO:0070051; GO:0070062; GO:0070373; GO:0071635; GO:0071953; GO:0072378; GO:1900025; GO:1904188; GO:1904237; GO:2000146; GO:2000647 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] CCHCCLLGR 0.98574 -2.3873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0216 0 0 0 0 11.5354 0 0 0 0 0 0 0 0 0 0 0 12.3298 0 0 0 0 0 0 0 0 0 0 0 0 12.2619 11.3346 0 0 0 0 0 0 0 0 0 0 14.6518 0 0 0 0 0 0 0 0 15.124 0 14.295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3147 0 0 0 13.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12837 PO4F2_HUMAN "POU domain, class 4, transcription factor 2 (Brain-specific homeobox/POU domain protein 3B, Brain-3B, Brn-3B)" POU4F2 BRN3B Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to cytokine stimulus [GO:0071345]; cellular response to estradiol stimulus [GO:0071392]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxygen levels [GO:0071453]; dorsal root ganglion development [GO:1990791]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; MAPK cascade [GO:0000165]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell differentiation [GO:0045596]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell differentiation [GO:0045597]; positive regulation of glucose import [GO:0046326]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]" GO:0000122; GO:0000165; GO:0000785; GO:0000791; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0002039; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0007283; GO:0007411; GO:0007507; GO:0007605; GO:0010666; GO:0016607; GO:0030182; GO:0030520; GO:0031290; GO:0032869; GO:0043068; GO:0043433; GO:0045596; GO:0045597; GO:0045672; GO:0045773; GO:0045944; GO:0046326; GO:0048675; GO:0050885; GO:0051090; GO:0060041; GO:0071345; GO:0071392; GO:0071453; GO:0072332; GO:0090259; GO:1902870; GO:1904178; GO:1990791; GO:1990841; GO:2000679 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IAAIAEKLDLKK 0.98574 -2.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7669 0 0 0 0 0 13.5726 0 0 0 0 0 13.6676 14.8528 13.7788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7182 13.8643 0 14.4081 14.383 0 0 0 11.8786 0 0 0 14.3523 0 13.028 0 0 Q16549 PCSK7_HUMAN "Proprotein convertase subtilisin/kexin type 7, EC 3.4.21.- (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7, PC7) (Proprotein convertase 8, PC8, hPC8) (Subtilisin/kexin-like protease PC7)" PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) peptide hormone processing [GO:0016486]; protein processing [GO:0016485] integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485] GO:0004252; GO:0005802; GO:0008233; GO:0016020; GO:0016485; GO:0016486; GO:0030173 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] DVQHIIVFTATRYEDRR 0.98574 -2.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.196 0 0 12.2519 0 0 0 0 0 10.0093 0 0 0 0 0 0 0 11.5279 0 0 0 0 0 0 0 0 0 15.5754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UL3 GPAT4_HUMAN "Glycerol-3-phosphate acyltransferase 4, EC 2.3.1.15 (1-acylglycerol-3-phosphate O-acyltransferase 6, 1-AGP acyltransferase 6, 1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta, LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7, TSARG7)" GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432] GO:0002071; GO:0003841; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006654; GO:0006656; GO:0007595; GO:0008610; GO:0016020; GO:0016021; GO:0016024; GO:0019432; GO:0040014; GO:0046339; GO:0102420 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420] LYMKSLLK 0.98574 -2.0423 0 0 0 0 0 0 0 0 0 0 11.8725 0 0 0 0 0 0 0 0 0 0 0 0 11.4964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0452 12.8798 0 12.9148 0 0 0 0 13.5434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5605 0 0 0 0 0 0 0 13.1156 0 0 0 Q96EB6 SIR1_HUMAN "NAD-dependent protein deacetylase sirtuin-1, hSIRT1, EC 2.3.1.286 (NAD-dependent protein deacylase sirtuin-1, EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1, hSIR2) [Cleaved into: SirtT1 75 kDa fragment, 75SirT1 ]" SIRT1 SIR2L1 Homo sapiens (Human) "angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone methylation [GO:0031062]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]" chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553] "chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein lysine deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone methylation [GO:0031062]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]" GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004407; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005677; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006325; GO:0006346; GO:0006476; GO:0006642; GO:0006974; GO:0006979; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0008022; GO:0008284; GO:0009267; GO:0010629; GO:0010824; GO:0010875; GO:0010883; GO:0010906; GO:0014068; GO:0016239; GO:0016567; GO:0016575; GO:0016605; GO:0016922; GO:0017136; GO:0018394; GO:0019213; GO:0019899; GO:0030225; GO:0030308; GO:0030512; GO:0031062; GO:0031065; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032071; GO:0032088; GO:0032868; GO:0032922; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0034983; GO:0035356; GO:0035358; GO:0042127; GO:0042149; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043280; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0050872; GO:0051019; GO:0051097; GO:0051152; GO:0051574; GO:0051898; GO:0055089; GO:0060766; GO:0060907; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0070932; GO:0071356; GO:0071441; GO:0071456; GO:0071479; GO:0071900; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140297; GO:0160012; GO:1900034; GO:1900113; GO:1901215; GO:1901984; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000480; GO:2000481; GO:2000619; GO:2000655; GO:2000757; GO:2000773; GO:2000774 bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein lysine deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] DEVDLLIVIGSSLK 0.98574 -2.4529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2721 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4659 0 0 0 0 0 0 12.7151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3129 0 0 0 0 0 0 12.698 0 0 0 0 0 0 12.844 0 0 0 13.3369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2182 0 0 0 A6NKT7 RGPD3_HUMAN RanBP2-like and GRIP domain-containing protein 3 RGPD3 RGP3 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006607; GO:0050790 AAKLFPGSPAIYKLK 0.98575 -2.6254 0 0 0 0 0 0 0 0 14.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35612 ADDB_HUMAN Beta-adducin (Erythrocyte adducin subunit beta) ADD2 ADDB Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; synapse assembly [GO:0007416] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069] cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; synapse assembly [GO:0007416] GO:0003779; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0007416; GO:0008290; GO:0014069; GO:0019901; GO:0030036; GO:0030097; GO:0030507; GO:0031410; GO:0032092; GO:0042803; GO:0044853; GO:0046982; GO:0050900; GO:0050901; GO:0051015; GO:0051016; GO:0051017; GO:0065003 actin binding [GO:0003779]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200] CKISSVYR 0.98575 -3.7551 0 0 11.2435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0217 0 0 0 0 0 0 0 0 0 0 11.9185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56545 CTBP2_HUMAN "C-terminal-binding protein 2, CtBP2" CTBP2 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic vesicle docking [GO:0016081]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]" anchoring junction [GO:0070161]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; transcription repressor complex [GO:0017053] "anchoring junction [GO:0070161]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; nuclear retinoic acid receptor binding [GO:0042974]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural constituent of presynaptic active zone [GO:0098882]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic vesicle docking [GO:0016081]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]" GO:0000122; GO:0001221; GO:0001222; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0008285; GO:0016081; GO:0016616; GO:0017053; GO:0019079; GO:0019901; GO:0035563; GO:0042802; GO:0042974; GO:0044877; GO:0045892; GO:0045944; GO:0048386; GO:0050872; GO:0051287; GO:0070161; GO:0098684; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0099523; GO:0140297; GO:1990830 "chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; nuclear retinoic acid receptor binding [GO:0042974]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural constituent of presynaptic active zone [GO:0098882]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]" ALAQALKEGRIR 0.98575 -2.8001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4729 0 0 13.7273 15.7905 14.7998 16.2497 11.9895 0 0 0 0 0 0 13.5452 0 0 0 0 0 0 0 0 0 0 0 0 11.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS72 PEAK3_HUMAN Protein PEAK3 PEAK3 C19orf35 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360] actin cytoskeleton [GO:0015629]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; focal adhesion [GO:0005925]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360] GO:0004672; GO:0005925; GO:0006468; GO:0008360; GO:0015629; GO:0032956; GO:0043621 protein kinase activity [GO:0004672]; protein self-association [GO:0043621] ACRLRTPGSLSTNPEPLPPPLPK 0.98575 -3.5806 0 0 16.0825 0 0 10.3348 0 0 0 0 0 0 0 12.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9944 11.9637 0 0 0 0 0 0 0 0 0 13.2497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.181 0 0 0 0 0 0 13.0418 15.9817 0 11.6002 0 0 0 13.701 0 0 0 0 0 0 0 0 0 0 0 0 16.1634 0 11.9555 0 12.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0712 0 0 0 0 0 0 0 11.5971 13.6656 13.9021 0 0 0 14.4149 0 12.8772 0 12.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.378 0 0 0 0 0 Q8IW70 T151B_HUMAN Transmembrane protein 151B (Transmembrane protein 193) TMEM151B C6orf137 TMEM193 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 SCLWRSR 0.98575 -2.6247 0 0 0 0 0 0 0 0 0 0 15.3931 0 0 0 0 0 0 0 0 0 0 0 11.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5674 0 0 0 0 0 Q96CW9 NTNG2_HUMAN Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic specialization assembly [GO:0098698]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888] anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic specialization assembly [GO:0098698]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888] GO:0005576; GO:0005886; GO:0007409; GO:0009887; GO:0009888; GO:0010975; GO:0016477; GO:0030424; GO:0034446; GO:0043256; GO:0046658; GO:0050804; GO:0070831; GO:0098685; GO:0098698; GO:0098978; GO:0099029; GO:0099560; GO:0150011; GO:1905606; GO:2001222 APGAAPRPATLLGCLLLLGLAARLGR 0.98575 -2.0501 0 0 0 0 0 0 0 0 0 0 0 11.2395 11.7402 0 0 11.6865 0 11.3866 0 0 0 0 0 0 0 0 0 0 0 13.9163 0 0 0 0 0 0 0 0 11.785 13.6138 0 0 0 0 0 0 0 12.9425 0 0 0 11.5392 0 0 11.6632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0612 0 0 0 0 12.7802 0 0 0 0 0 0 13.3424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1964 13.5349 0 0 12.0355 0 0 0 12.2837 12.6904 0 0 0 13.124 11.1276 0 0 11.9561 13.3018 0 9.81986 11.226 12.9902 0 0 0 0 0 0 0 13.8844 13.8133 0 0 0 0 0 0 0 0 0 0 0 10.3711 0 0 0 0 0 0 0 0 0 13.8106 0 0 0 11.8871 0 12.502 0 0 0 12.7312 0 12.5336 12.1658 0 13.0183 0 9.736 0 0 0 0 0 0 0 0 0 Q99583 MNT_HUMAN "Max-binding protein MNT (Class D basic helix-loop-helix protein 3, bHLHd3) (Myc antagonist MNT) (Protein ROX)" MNT BHLHD3 ROX Homo sapiens (Human) cellular senescence [GO:0090398]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular senescence [GO:0090398]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0003700; GO:0005654; GO:0006357; GO:0006366; GO:0046983; GO:0051726; GO:0090398; GO:2001234 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EPAPLPSR 0.98575 -2.0498 0 0 0 13.9796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8654 0 0 0 15.2786 0 14.0863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.359 0 0 0 0 0 0 0 0 0 0 10.5975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9405 13.1538 0 0 0 0 0 18.4065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NCL7 AN33B_HUMAN Ankyrin repeat domain-containing protein 33B ANKRD33B Homo sapiens (Human) ASLLPLQRLRR 0.98576 -2.4037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.332 0 15.2467 14.3941 14.8561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95045 UPP2_HUMAN "Uridine phosphorylase 2, UPase 2, UrdPase 2, EC 2.4.2.3" UPP2 Homo sapiens (Human) dCMP catabolic process [GO:0006249]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108] cytosol [GO:0005829]; type III intermediate filament [GO:0045098] cytosol [GO:0005829]; type III intermediate filament [GO:0045098]; deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; dCMP catabolic process [GO:0006249]; nucleoside metabolic process [GO:0009116]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108] GO:0004850; GO:0005829; GO:0006218; GO:0006249; GO:0009116; GO:0042802; GO:0044206; GO:0045098; GO:0046108; GO:0047847 deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850] AFALFMHK 0.98576 -2.0579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5703 0 0 15.808 0 0 0 0 0 0 0 15.9717 0 0 0 0 0 15.5938 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4929 13.9103 0 0 13.2023 0 0 0 11.9727 0 0 13.923 0 14.0034 0 14.0024 0 0 12.965 0 0 0 0 0 0 12.5981 0 12.7202 13.7987 0 0 14.351 0 13.7932 13.882 13.5858 0 0 0 0 0 0 0 0 0 0 0 0 10.8833 0 0 0 0 0 0 0 0 16.7528 0 0 0 0 0 0 0 0 11.0649 0 0 0 0 0 0 0 0 0 O95678 K2C75_HUMAN "Keratin, type II cytoskeletal 75 (Cytokeratin-75, CK-75) (Keratin-6 hair follicle, hK6hf) (Keratin-75, K75) (Type II keratin-K6hf) (Type-II keratin Kb18)" KRT75 K6HF KB18 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; structural molecule activity [GO:0005198]; hematopoietic progenitor cell differentiation [GO:0002244]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0001533; GO:0002244; GO:0005198; GO:0005829; GO:0005882; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0070062 structural constituent of skin epidermis [GO:0030280]; structural molecule activity [GO:0005198] AQYEDIANR 0.98576 -3.5854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8415 0 0 0 0 12.4058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.304 0 0 0 0 0 0 P32519 ELF1_HUMAN ETS-related transcription factor Elf-1 (E74-like factor 1) ELF1 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of T cell receptor signaling pathway [GO:0050860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001817; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045893; GO:0045944; GO:0050860; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AVSRLWGK 0.98576 -2.4065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5132 0 0 0 Q7Z6G3 NECA2_HUMAN "N-terminal EF-hand calcium-binding protein 2, EF-hand calcium-binding protein 2 (Neuronal calcium-binding protein 2) (Synaptotagmin-interacting protein 2, Stip-2)" NECAB2 EFCBP2 Homo sapiens (Human) negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of protein localization to membrane [GO:1905477]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; A2A adenosine receptor binding [GO:0031687]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; type 5 metabotropic glutamate receptor binding [GO:0031802]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of protein localization to membrane [GO:1905477]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] GO:0005509; GO:0005737; GO:0005886; GO:0030424; GO:0030425; GO:0031687; GO:0031802; GO:0042802; GO:0042984; GO:0060168; GO:0070374; GO:1900451; GO:1904021; GO:1905477 A2A adenosine receptor binding [GO:0031687]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; type 5 metabotropic glutamate receptor binding [GO:0031802] FLLKETANQIQSLLSSVESAVEAIEEQTSQLRQNHIK 0.98576 -2.8035 0 0 0 0 0 0 0 0 0 9.64989 0 0 0 0 0 0 0 0 12.2743 0 0 0 0 0 0 0 0 0 0 0 0 10.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0204 0 0 0 0 0 0 0 0 12.262 0 0 0 0 0 0 11.6563 0 13.4803 0 15.6652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9588 0 0 0 0 0 0 0 0 0 0 0 12.1902 0 0 0 0 0 0 0 0 0 10.0307 0 0 0 0 0 0 0 0 11.3411 0 0 0 0 10.3785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6974 0 0 13.6154 0 0 0 0 0 0 12.2936 0 0 0 0 0 0 0 Q8IV13 CCNJL_HUMAN Cyclin-J-like protein CCNJL Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0016538; GO:0044772 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] ELKLPTFRAHSPLLK 0.98576 -2.8994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3176 0 0 0 0 0 0 18.0171 0 0 0 0 0 0 0 0 0 0 0 0 12.7087 0 0 0 0 0 0 10.7051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N412 STPG2_HUMAN Sperm-tail PG-rich repeat-containing protein 2 STPG2 C4orf37 Homo sapiens (Human) DQQQNYCSFIPRLYEIIVLQEKK 0.98576 -2.8078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.684 0 9.54728 0 11.6246 0 0 0 0 0 0 12.3206 0 0 0 0 12.919 0 0 0 0 0 0 0 12.5874 0 0 0 0 0 0 0 12.2198 0 0 12.8225 0 0 0 13.0372 0 13.0766 0 0 0 0 12.0769 0 12.4717 0 12.6686 0 0 13.5473 12.559 0 12.7323 0 0 0 0 13.6134 0 14.055 12.6862 0 0 13.6327 0 0 0 12.4276 12.8028 12.541 0 0 0 13.3284 0 0 13.5793 0 12.2044 0 12.4817 12.6991 0 0 0 0 0 0 0 12.6318 0 0 0 0 0 0 0 0 0 0 12.4707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5855 0 0 0 0 0 Q8NBZ7 UXS1_HUMAN "UDP-glucuronic acid decarboxylase 1, EC 4.1.1.35 (UDP-glucuronate decarboxylase 1, UGD, UXS-1)" UXS1 UNQ2538/PRO6079 Homo sapiens (Human) D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040]; D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320] GO:0005737; GO:0016021; GO:0032580; GO:0033320; GO:0042732; GO:0042802; GO:0042803; GO:0048040; GO:0070062; GO:0070403; GO:1902494 identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040] ALLRLVSAVNR 0.98576 -2.0593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8054 0 0 0 0 0 0 0 0 0 0 0 0 16.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AV8 E2F7_HUMAN "Transcription factor E2F7, E2F-7" E2F7 Homo sapiens (Human) "chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]" chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; chorionic trophoblast cell differentiation [GO:0060718]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; hepatocyte differentiation [GO:0070365]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokinesis [GO:0032466]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0006357; GO:0008285; GO:0016607; GO:0030330; GO:0032466; GO:0032877; GO:0042802; GO:0045944; GO:0060707; GO:0060718; GO:0070365; GO:0071930; GO:0090575; GO:1990837; GO:2000134 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EVNCLTLKDLISPRQPR 0.98576 -2.4105 0 0 0 0 0 0 0 0 0 0 14.3134 0 0 0 0 0 0 0 10.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0011 0 0 0 0 0 0 0 10.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7X2 CA115_HUMAN Uncharacterized protein C1orf115 C1orf115 Homo sapiens (Human) 9+0 non-motile cilium [GO:0097731]; integral component of membrane [GO:0016021] 9+0 non-motile cilium [GO:0097731]; integral component of membrane [GO:0016021] GO:0016021; GO:0097731 NVGKVIIKGCR 0.98576 -2.4076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20393 NR1D1_HUMAN "Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1, EAR-1)" NR1D1 EAR1 HREV THRAL Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; glycogen biosynthetic process [GO:0005978]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal protein catabolic process [GO:0010498]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of fat cell differentiation [GO:0045598]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to leptin [GO:0044321]" anchoring junction [GO:0070161]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "anchoring junction [GO:0070161]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian temperature homeostasis [GO:0060086]; glycogen biosynthetic process [GO:0005978]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of bile acid biosynthetic process [GO:0070859]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasomal protein catabolic process [GO:0010498]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of circadian sleep/wake cycle [GO:0042749]; regulation of fat cell differentiation [GO:0045598]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of lipid metabolic process [GO:0019216]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to leptin [GO:0044321]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0001678; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005978; GO:0008270; GO:0009755; GO:0010498; GO:0016604; GO:0019216; GO:0020037; GO:0030154; GO:0030425; GO:0031648; GO:0032922; GO:0034144; GO:0042632; GO:0042749; GO:0042752; GO:0043124; GO:0043197; GO:0044321; GO:0045598; GO:0045892; GO:0045893; GO:0045944; GO:0050728; GO:0060086; GO:0061178; GO:0061469; GO:0061889; GO:0070161; GO:0070859; GO:0070888; GO:0071222; GO:0071347; GO:0071356; GO:0120163; GO:0150079; GO:1903979; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]" ALRALVLKNR 0.98577 -2.4117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8758 0 0 0 0 0 0 15.7544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6SZW1 SARM1_HUMAN "NAD(+) hydrolase SARM1, NADase SARM1, hSARM1, EC 3.2.2.6 (NADP(+) hydrolase SARM1, EC 3.2.2.-) (Sterile alpha and Armadillo repeat protein) (Sterile alpha and TIR motif-containing protein 1) (Sterile alpha motif domain-containing protein 2, MyD88-5, SAM domain-containing protein 2) (Tir-1 homolog, HsTIR)" SARM1 KIAA0524 SAMD2 SARM Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202] "anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of mitochondrial outer membrane [GO:0031315]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; synapse [GO:0045202]; identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; NAD catabolic process [GO:0019677]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; nervous system development [GO:0007399]; positive regulation of neuron death [GO:1901216]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; signal transduction [GO:0007165]" GO:0003953; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0007165; GO:0007399; GO:0009749; GO:0019677; GO:0030154; GO:0030424; GO:0030425; GO:0031315; GO:0034128; GO:0035591; GO:0042802; GO:0043523; GO:0045087; GO:0045202; GO:0048678; GO:0048814; GO:0050135; GO:0061809; GO:0070161; GO:1901214; GO:1901216 "identical protein binding [GO:0042802]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling adaptor activity [GO:0035591]" CMQDHDCK 0.98577 -3.5097 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1308 0 0 14.5092 0 14.5718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6206 13.7409 13.7186 0 0 0 0 15.1909 0 0 0 0 13.6589 0 13.541 14.7363 0 12.2807 14.6038 0 0 0 14.6171 0 0 0 0 0 0 0 13.1433 15.0059 0 0 13.8536 14.9453 12.3275 0 0 13.7459 15.1942 13.9048 14.2928 0 16.0996 0 0 0 0 13.5412 12.9607 0 0 0 13.9129 13.3055 0 0 0 14.4335 0 13.5854 0 15.5159 0 16.1002 15.7731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3848 0 14.5277 11.3639 0 0 0 0 0 16.1142 13.9496 0 14.5835 0 14.8869 0 Q6WBX8 RAD9B_HUMAN "Cell cycle checkpoint control protein RAD9B (DNA repair exonuclease rad9 homolog B, hRAD9B)" RAD9B Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573] checkpoint clamp complex [GO:0030896]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] checkpoint clamp complex [GO:0030896]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573] GO:0000076; GO:0005634; GO:0005654; GO:0006281; GO:0030896; GO:0031573; GO:0071479 ASDSEEDMNNVCCR 0.98577 -1.5513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8877 0 0 0 0 0 0 0 11.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.903 0 0 0 12.9893 0 0 0 11.0513 0 0 0 0 0 0 12.8679 0 0 0 0 0 0 0 13.8384 0 0 0 0 0 0 15.5907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.88 0 0 11.5073 0 0 0 0 0 0 13.3271 12.6724 0 10.7995 0 0 0 11.3234 0 0 11.3169 0 0 0 0 0 0 0 0 11.978 12.9503 0 0 0 0 0 0 Q8N910 CO056_HUMAN Putative uncharacterized protein PAK6-AS1 (PAK6 antisense RNA 1) PAK6-AS1 C15orf56 Homo sapiens (Human) GAARVGR 0.98577 -3.5108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3449 15.4229 0 0 0 0 15.6861 0 0 15.4029 0 0 14.1275 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9843 0 0 14.2709 14.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9611 0 0 17.1669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2204 15.8588 0 0 0 0 0 0 0 13.0532 0 0 16.3998 0 0 0 0 0 0 0 17.0092 0 0 15.2321 0 15.6681 15.3133 0 15.4711 0 0 0 0 0 0 0 0 0 0 0 0 15.7522 12.3678 0 0 13.3914 0 0 0 0 0 0 0 0 14.2824 16.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3763 0 0 0 0 0 0 0 0 0 0 Q8NH55 O52E5_HUMAN Olfactory receptor 52E5 OR52E5 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IFHNNSVRQ 0.98577 -2.069 0 0 0 0 0 0 0 0 0 11.1794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2671 0 12.025 0 0 0 0 0 0 0 0 0 12.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5759 0 12.754 0 0 0 0 0 0 0 0 0 0 0 0 14.8522 0 0 0 0 0 13.3475 0 0 0 0 0 0 0 0 0 0 0 0 12.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6815 0 13.6786 13.6322 0 13.9077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7365 0 13.6184 0 0 0 0 0 12.8849 0 0 0 0 0 0 0 0 0 0 13.2388 13.9595 13.8934 12.9147 12.7515 14.0295 0 0 12.8433 13.0386 13.2016 12.8017 12.7659 13.0386 12.5481 0 0 0 12.8957 0 13.8324 0 0 Q9ULT0 TTC7A_HUMAN "Tetratricopeptide repeat protein 7A, TPR repeat protein 7A" TTC7A KIAA1140 TTC7 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; hemopoiesis [GO:0030097]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cellular iron ion homeostasis [GO:0006879]; hemopoiesis [GO:0030097]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005737; GO:0005886; GO:0006879; GO:0030097; GO:0046854; GO:0072659 DGSFGEGLTMK 0.98577 -2.0604 0 0 0 0 0 0 0 0 0 12.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0192 0 0 0 0 0 0 13.6592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8245 0 0 13.4625 0 16.616 0 0 13.7918 0 0 0 0 0 0 12.9945 0 0 0 0 0 0 0 0 P18054 LOX12_HUMAN "Polyunsaturated fatty acid lipoxygenase ALOX12, EC 1.13.11.- (Arachidonate (12S)-lipoxygenase, 12S-LOX, 12S-lipoxygenase, EC 1.13.11.31) (Arachidonate (15S)-lipoxygenase, EC 1.13.11.33) (Linoleate (13S)-lipoxygenase) (Lipoxin synthase 12-LO, EC 3.3.2.-) (Platelet-type lipoxygenase 12)" ALOX12 12LO LOG12 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559]" GO:0004052; GO:0005506; GO:0005737; GO:0005829; GO:0005886; GO:0006629; GO:0010656; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019395; GO:0033559; GO:0034440; GO:0042383; GO:0042554; GO:0043651; GO:0047977; GO:0050473; GO:0051122; GO:0061436; GO:0070062; GO:0090331; GO:1901751; GO:2001303; GO:2001306 "arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]" DDLPPNMR 0.98578 -2.8276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3259 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2619 0 0 0 0 0 0 0 0 14.8167 0 0 0 0 0 0 0 0 13.3807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0917 12.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8361 0 P24001 IL32_HUMAN "Interleukin-32, IL-32 (Natural killer cells protein 4) (Tumor necrosis factor alpha-inducing factor)" IL32 NK4 TAIF Homo sapiens (Human) cell adhesion [GO:0007155]; defense response [GO:0006952]; immune response [GO:0006955]; negative regulation of viral life cycle [GO:1903901]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of type III interferon production [GO:0034346] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020] cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; cytokine activity [GO:0005125]; cell adhesion [GO:0007155]; defense response [GO:0006952]; immune response [GO:0006955]; negative regulation of viral life cycle [GO:1903901]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of type III interferon production [GO:0034346] GO:0005125; GO:0005615; GO:0005829; GO:0006952; GO:0006955; GO:0007155; GO:0010628; GO:0016020; GO:0034346; GO:1903901; GO:1905636 cytokine activity [GO:0005125] ERDGLRCR 0.98578 -3.8804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P39877 PA2G5_HUMAN "Phospholipase A2 group V, EC 3.1.1.4 (PLA2-10) (Phosphatidylcholine 2-acylhydrolase 5)" PLA2G5 Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid metabolic process [GO:0006631]; leukotriene biosynthetic process [GO:0019370]; low-density lipoprotein particle remodeling [GO:0034374]; phagosome-lysosome fusion [GO:0090385]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid metabolic process [GO:0006644]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of immune complex clearance by monocytes and macrophages [GO:0090265]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagosome maturation [GO:1905164]; positive regulation of phospholipase activity [GO:0010518] early phagosome [GO:0032009]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] early phagosome [GO:0032009]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-independent phospholipase A2 activity [GO:0047499]; phospholipid binding [GO:0005543]; arachidonic acid secretion [GO:0050482]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid metabolic process [GO:0006631]; leukotriene biosynthetic process [GO:0019370]; low-density lipoprotein particle remodeling [GO:0034374]; phagosome-lysosome fusion [GO:0090385]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid metabolic process [GO:0006644]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of immune complex clearance by monocytes and macrophages [GO:0090265]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagosome maturation [GO:1905164]; positive regulation of phospholipase activity [GO:0010518] GO:0005509; GO:0005543; GO:0005576; GO:0005794; GO:0005886; GO:0006631; GO:0006644; GO:0010518; GO:0010744; GO:0019370; GO:0032009; GO:0032010; GO:0034374; GO:0034638; GO:0035965; GO:0047498; GO:0047499; GO:0050482; GO:0050766; GO:0055037; GO:0070374; GO:0090265; GO:0090385; GO:1903028; GO:1905036; GO:1905164 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-independent phospholipase A2 activity [GO:0047499]; phospholipid binding [GO:0005543] DGTDWCCWAHDHCYGR 0.98578 -3.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9574 0 0 0 0 0 0 0 0 0 0 0 0 13.633 0 0 0 0 0 0 0 0 10.3301 0 0 0 0 0 0 0 0 0 13.0433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78368 KC1G2_HUMAN "Casein kinase I isoform gamma-2, CKI-gamma 2, EC 2.7.11.1" CSNK1G2 CK1G2 Homo sapiens (Human) endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; Wnt signaling pathway [GO:0016055] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0006897; GO:0007165; GO:0016020; GO:0016055; GO:0018105; GO:0030148; GO:0090263; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] IGCGNFGELRLGK 0.98578 -2.0744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8551 0 0 0 0 0 12.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9572 0 14.2053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5788 0 0 13.0968 0 0 0 0 0 0 0 0 0 0 12.5262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06732 ZN33B_HUMAN Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2) ZNF33B KOX2 ZNF11B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHTGEKSCQCNECGK 0.98578 -3.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7314 0 0 0 0 0 0 0 13.8171 0 0 0 0 0 14.6062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9899 13.3383 0 0 0 12.8615 0 Q8NFW8 NEUA_HUMAN "N-acylneuraminate cytidylyltransferase, EC 2.7.7.43 (CMP-N-acetylneuraminic acid synthase, CMP-NeuNAc synthase)" CMAS Homo sapiens (Human) N-acetylneuraminate metabolic process [GO:0006054] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acetylneuraminate metabolic process [GO:0006054] GO:0005634; GO:0005654; GO:0006054; GO:0008781; GO:0016020 N-acylneuraminate cytidylyltransferase activity [GO:0008781] DAIGISLLKKSGIEVR 0.98578 -2.8272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95947 0 0 0 0 0 0 0 13.1755 0 0 0 11.5931 12.8314 15.57 0 0 0 0 0 13.3541 0 0 0 12.9038 16.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8302 0 11.7008 0 0 0 0 12.3372 0 0 0 0 0 0 0 0 0 0 0 10.9067 0 11.5987 0 0 0 0 0 0 0 0 0 0 16.2283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6842 0 0 0 0 0 0 0 Q8WWL2 SPIR2_HUMAN "Protein spire homolog 2, Spir-2" SPIRE2 KIAA1832 SPIR2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0003779; GO:0005829; GO:0005856; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030041; GO:0030659; GO:0032154; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0048193; GO:0051295; GO:0051639; GO:0070649; GO:2000781 actin binding [GO:0003779] ALDWGLDESEER 0.98578 -3.8859 0 0 0 0 0 0 0 0 0 12.8769 13.6867 0 14.8191 0 0 0 0 16.88 0 12.2715 12.2512 0 0 0 0 0 0 0 11.83 0 14.7159 11.7836 0 0 0 11.1967 0 0 0 0 0 14.7827 14.447 13.6123 0 0 0 0 0 0 0 0 0 13.9569 17.1639 13.1739 0 0 0 0 16.4334 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2364 12.3218 12.3054 0 12.6563 0 13.6646 0 14.2884 0 13.643 15.6026 15.2136 14.1054 0 12.6573 0 0 13.7083 0 0 14.4645 0 0 15.6574 13.6766 14.1194 12.938 0 14.38 14.3247 0 12.9644 12.7389 14.5863 0 13.1738 0 0 0 14.9262 14.0545 13.2518 0 14.7422 13.0921 0 15.2096 0 13.6439 0 13.1368 13.0918 14.106 0 12.0605 0 13.5647 0 0 12.2536 0 0 12.9153 13.2312 13.1496 16.0552 13.3322 0 12.9875 0 0 0 12.6158 12.6603 0 13.7078 12.9511 0 13.9875 14.4271 14.899 0 12.8801 0 0 0 0 0 0 0 0 0 0 12.2041 0 11.4235 0 0 13.1524 0 0 0 12.7667 0 12.6297 Q9HAP6 LIN7B_HUMAN "Protein lin-7 homolog B, Lin-7B, hLin7B (Mammalian lin-seven protein 2, MALS-2) (Vertebrate lin-7 homolog 2, Veli-2, hVeli2)" LIN7B MALS2 VELI2 UNQ3116/PRO10200 Homo sapiens (Human) exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031] GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0015031; GO:0016323; GO:0019904; GO:0030165; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361 L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904] FCSAIREVYEQLYDTLDITGSAEIR 0.98578 -2.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2344 0 0 0 0 0 0 0 0 0 13.0291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02086 SP2_HUMAN Transcription factor Sp2 SP2 KIAA0048 Homo sapiens (Human) immune response [GO:0006955]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; immune response [GO:0006955]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0006357; GO:0006955; GO:0035264; GO:0042826; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" HSAAILR 0.98579 -3.3395 0 0 0 0 0 9.03645 0 0 11.7477 0 0 0 0 0 0 0 0 11.5956 12.8006 11.6188 12.4876 0 11.4156 11.702 15.4077 0 12.0584 12.1244 12.238 0 0 11.6117 0 0 0 0 11.8694 0 0 12.3078 0 0 0 0 0 12.4229 0 11.1549 0 13.6225 0 11.241 0 10.9541 11.3765 0 0 0 0 0 0 0 0 0 0 0 0 13.2301 0 13.9642 10.1596 13.3744 0 0 0 13.0749 12.8923 0 12.9096 0 0 0 13.2194 0 0 0 0 0 0 18.6624 0 14.1723 0 0 0 0 18.4316 0 0 13.5136 0 12.5701 12.9863 0 14.7492 12.7966 13.9941 13.6227 11.8468 0 13.8966 14.1266 14.2312 13.171 12.7819 12.8537 0 0 12.6158 0 12.6451 0 0 12.1825 12.8481 13.8911 12.3584 13.5832 0 13.1194 13.4002 12.5598 0 13.3315 0 18.6361 12.5406 13.2704 0 19.2047 0 12.0661 0 18.0532 13.6494 13.5889 0 14.5017 18.5127 0 13.4752 0 0 0 13.5265 11.4803 16.028 0 0 0 14.3215 14.108 14.6977 0 13.4686 14.151 14.1415 13.6959 13.9586 0 0 13.3446 0 13.214 16 12.551 0 13.7393 0 0 Q14140 SRTD2_HUMAN "SERTA domain-containing protein 2 (Transcriptional regulator interacting with the PHD-bromodomain 2, TRIP-Br2)" SERTAD2 KIAA0127 TRIPBR2 Homo sapiens (Human) negative regulation of cell growth [GO:0030308] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; negative regulation of cell growth [GO:0030308] GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030308 transcription coactivator activity [GO:0003713] FDEHEDGLEGK 0.98579 -2.6649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4273 0 0 0 0 0 0 0 12.7192 0 0 0 0 0 11.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1481 0 0 0 0 0 0 0 0 0 14.1185 11.7354 14.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JUW0 KRBX4_HUMAN KRAB domain-containing protein 4 (KRAB box domain-containing protein 4) KRBOX4 ZNF673 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" "regulation of transcription, DNA-templated [GO:0006355]" GO:0006355 ESQDKLPWQAAFIGK 0.98579 -3.6157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3763 12.2336 0 0 0 11.9982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SZD4 GLYL3_HUMAN "Glycine N-acyltransferase-like protein 3, EC 2.3.1.13 (Acyl-CoA:glycine-N-acyltransferase-like protein 3)" GLYATL3 C6orf140 Homo sapiens (Human) lipid metabolic process [GO:0006629] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; lipid metabolic process [GO:0006629] GO:0005739; GO:0006629; GO:0016410; GO:0047961 glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410] LLILEKMLK 0.98579 -2.6621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3382 12.4984 0 0 0 12.7901 0 0 0 0 0 0 0 0 0 14.152 0 0 0 0 0 0 0 0 0 0 12.3479 12.0797 12.2041 0 12.3568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92904 0 0 0 0 12.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13987 CD59_HUMAN "CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor, HRF-20, HRF20) (MAC-inhibitory protein, MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor, MACIF) (Membrane inhibitor of reactive lysis, MIRL) (Protectin) (CD antigen CD59)" CD59 MIC11 MIN1 MIN2 MIN3 MSK21 Homo sapiens (Human) blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of activation of membrane attack complex [GO:0001971]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659] anchored component of external side of plasma membrane [GO:0031362]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]; vesicle [GO:0031982] anchored component of external side of plasma membrane [GO:0031362]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; complement binding [GO:0001848]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of activation of membrane attack complex [GO:0001971]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659] GO:0000139; GO:0001848; GO:0001971; GO:0005615; GO:0005789; GO:0005886; GO:0005925; GO:0007166; GO:0007596; GO:0009986; GO:0012507; GO:0016020; GO:0030133; GO:0030449; GO:0031362; GO:0031982; GO:0033116; GO:0035579; GO:0070062; GO:0070821; GO:1903659 complement binding [GO:0001848] ENELTYYCCK 0.9858 -1.5673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52209 6PGD_HUMAN "6-phosphogluconate dehydrogenase, decarboxylating, EC 1.1.1.44" PGD PGDH Homo sapiens (Human) "D-gluconate catabolic process [GO:0046177]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]" cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate catabolic process [GO:0046177]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]" GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0046177; GO:0050661; GO:0070062 NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616] GGCIIRSVFLGK 0.9858 -2.9462 0 14.3184 12.6141 0 13.703 0 11.3217 0 11.7164 0 10.5285 0 13.3126 0 0 0 0 0 10.3374 10.809 0 11.6188 0 0 10.1857 0 0 0 0 0 0 11.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2085 12.7043 0 0 12.1378 11.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.176 15.2712 14.5906 0 14.8983 11.7391 0 13.5492 0 14.3515 0 15.2791 12.051 0 0 0 0 15.3079 12.0761 13.1945 0 0 14.2481 0 0 14.3048 12.0436 13.6629 0 0 0 15.5403 0 14.9986 14.4204 0 13.489 0 0 14.8497 14.8602 0 13.9233 16.0742 13.9976 0 13.6735 13.8767 11.2553 13.9224 14.9428 14.8964 11.9709 0 11.1103 12.0687 0 14.0174 11.2336 14.1829 11.4681 16.1006 14.2379 15.8569 14.8591 0 15.3285 16.0741 16.0651 15.814 10.8334 16.2074 0 15.8408 0 15.1719 0 0 0 0 12.7223 13.4658 13.561 0 13.0113 12.7109 9.94582 13.7436 13.099 0 13.4516 0 13.0228 0 0 0 12.8156 13.0674 15.7282 14.9475 15.937 13.8385 0 0 13.8593 0 0 Q07444 NKG2E_HUMAN NKG2-E type II integral membrane protein (NK cell receptor E) (NKG2-E-activating NK receptor) KLRC3 NKG2E Homo sapiens (Human) cellular defense response [GO:0006968]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of natural killer cell activation [GO:0032814]; stimulatory C-type lectin receptor signaling pathway [GO:0002223] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888]; cellular defense response [GO:0006968]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of natural killer cell activation [GO:0032814]; stimulatory C-type lectin receptor signaling pathway [GO:0002223] GO:0002223; GO:0004888; GO:0005887; GO:0006968; GO:0009897; GO:0030246; GO:0032814; GO:0045954 carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888] DSDHAERNCAMLHVRGLISDQCGSSR 0.9858 -3.9091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YD7 F90A1_HUMAN Protein FAM90A1 FAM90A1 Homo sapiens (Human) ALLHIFSR 0.9858 -2.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8653 0 0 0 0 0 0 0 0 12.8953 12.3803 13.346 0 0 14.0738 0 13.4922 0 11.2161 0 0 0 14.1252 12.7117 0 0 0 12.3536 0 12.1425 0 0 0 14.7865 12.6726 0 0 0 14.4387 14.8913 0 13.4128 13.1388 14.5078 12.9401 15.2131 14.2588 0 0 0 12.4972 13.676 0 0 0 0 0 0 0 13.2578 13.3009 13.3243 0 0 0 0 0 0 0 0 0 13.3699 0 0 12.9384 12.2902 14.3971 0 13.1956 14.2853 13.937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1077 12.5511 0 0 0 0 Q8IYI6 EXOC8_HUMAN Exocyst complex component 8 (Exocyst complex 84 kDa subunit) EXOC8 Homo sapiens (Human) endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell leading edge [GO:0031252]; cytosol [GO:0005829]; exocyst [GO:0000145]; growth cone [GO:0030426]; late endosome [GO:0005770]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; extracellular matrix disassembly [GO:0022617]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0005770; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0007032; GO:0008104; GO:0015031; GO:0016020; GO:0016241; GO:0022617; GO:0030426; GO:0031252; GO:0031267; GO:0035091; GO:0048471; GO:0090148; GO:0090522 phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267] AAAVHTAIRQLRIEGATLLYIHK 0.9858 -2.4331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6705 0 0 0 0 0 0 0 10.6209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1913 16.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9943 0 0 0 0 0 0 0 0 0 0 0 0 10.2427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAT6 NPL4_HUMAN "Nuclear protein localization protein 4 homolog, Protein NPL4" NPLOC4 KIAA1499 NPL4 Homo sapiens (Human) "Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0030433; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0039536; GO:0042175; GO:0043130; GO:0044877; GO:0046872; GO:0051117; GO:0070530 ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] CVHCVPLEPFDEDYLNHLEPPVKHMSFHAYIR 0.9858 -2.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9147 0 0 0 0 0 0 10.0434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7533 0 0 0 0 0 0 11.4959 12.6934 12.1903 12.6328 15.0004 13.3339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5302 0 0 11.9942 13.4124 14.1528 0 0 0 12.8695 0 0 13.6109 0 0 0 0 0 14.1684 0 0 0 0 Q8TF05 PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 PPP4R1 MEG1 PP4R1 Homo sapiens (Human) protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] protein phosphatase 4 complex [GO:0030289] protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0006468; GO:0006470; GO:0007165; GO:0019888; GO:0030289 protein phosphatase regulator activity [GO:0019888] ACAECFMAVSCATCQEIR 0.9858 -2.6659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.07197 0 0 0 0 0 15.3208 14.859 0 14.518 0 0 11.316 0 0 0 0 0 0 15.8925 0 0 11.3852 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1718 0 0 10.1662 0 0 0 0 0 0 0 0 0 12.8734 0 0 0 0 0 0 0 0 0 11.0528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7005 0 0 14.3122 11.4803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6209 0 0 0 11.898 0 0 0 0 0 0 0 0 Q92902 HPS1_HUMAN BLOC-3 complex member HPS1 (Hermansky-Pudlak syndrome 1 protein) HPS1 HPS Homo sapiens (Human) intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosome [GO:0005764] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosome [GO:0005764]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] GO:0005085; GO:0005737; GO:0005764; GO:0005829; GO:0007040; GO:0007601; GO:0016192; GO:0031085; GO:0031410; GO:0046907; GO:0046983; GO:0050896; GO:0060155; GO:1903232 guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983] GPLAAFVKTKVWSLIQLAR 0.9858 -2.0882 0 0 0 0 0 0 0 0 0 0 11.474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3182 0 0 15.1749 0 0 0 0 13.9995 13.3174 0 14.3742 0 13.5901 0 14.784 13.7864 15.0968 14.2342 13.0132 0 0 0 0 15.5378 14.3712 0 0 0 0 0 0 12.6473 12.4647 13.6563 0 0 14.5003 14.3949 14.0739 14.0314 0 0 13.6608 12.0891 13.3775 0 14.4078 0 0 0 14.3633 0 0 0 13.8469 0 0 0 15.5723 0 0 15.2298 13.9074 0 13.3215 0 12.965 0 0 0 0 0 0 0 0 0 0 14.9834 15.3232 0 12.7689 0 0 0 0 0 12.5916 0 0 0 0 0 0 0 14.5439 0 0 14.7249 0 0 0 0 0 P06401 PRGR_HUMAN "Progesterone receptor, PR (Nuclear receptor subfamily 3 group C member 3)" PGR NR3C3 Homo sapiens (Human) cell-cell signaling [GO:0007267]; glandular epithelial cell maturation [GO:0002071]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lung alveolus development [GO:0048286]; negative regulation of gene expression [GO:0010629]; ovulation from ovarian follicle [GO:0001542]; paracrine signaling [GO:0038001]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748] chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; glandular epithelial cell maturation [GO:0002071]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lung alveolus development [GO:0048286]; negative regulation of gene expression [GO:0010629]; ovulation from ovarian follicle [GO:0001542]; paracrine signaling [GO:0038001]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]" GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001542; GO:0002071; GO:0003677; GO:0003707; GO:0004879; GO:0005102; GO:0005496; GO:0005654; GO:0005741; GO:0005829; GO:0006357; GO:0007165; GO:0007267; GO:0008270; GO:0010628; GO:0010629; GO:0019899; GO:0030518; GO:0038001; GO:0042802; GO:0045944; GO:0048286; GO:0050678; GO:0050847; GO:0051117; GO:0060748 "ATPase binding [GO:0051117]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" CCQAGMVLGGRKFK 0.98581 -2.4955 0 0 0 0 0 0 0 0 0 0 13.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4897 0 0 0 0 0 0 0 0 0 0 0 0 13.4567 0 10.8549 0 13.4679 0 0 13.4524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54793 ARSF_HUMAN "Arylsulfatase F, ASF, EC 3.1.6.1" ARSF Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005788; GO:0046872; GO:0070062 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] EAISFLER 0.98581 -2.578 0 11.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9768 0 12.2818 0 0 0 0 0 0 0 12.255 0 0 12.6426 0 0 0 0 0 0 0 0 0 12.043 13.2061 0 0 0 0 12.2841 0 0 0 14.0041 12.4931 0 12.8753 0 0 0 0 12.4504 11.5154 0 0 0 0 0 0 0 12.4214 13.6806 12.8393 12.8259 0 0 0 0 0 0 12.5658 0 12.562 0 0 11.8655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7341 0 0 0 0 0 0 Q08AM6 VAC14_HUMAN Protein VAC14 homolog (Tax1-binding protein 2) VAC14 TAX1BP2 TRX Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; PAS complex [GO:0070772] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; PAS complex [GO:0070772]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of kinase activity [GO:0033674]; signal transduction [GO:0007165] GO:0000139; GO:0000306; GO:0005783; GO:0005829; GO:0006661; GO:0007165; GO:0010008; GO:0031901; GO:0031902; GO:0033674; GO:0038023; GO:0042802; GO:0043231; GO:0070772 identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023] DIVTESNKFDLVSFIPLLRER 0.98581 -2.8541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1646 0 0 11.7159 11.2721 0 0 0 15.583 0 0 12.6517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1249 12.1152 16.6991 16.4894 0 0 0 0 0 0 0 11.3234 15.2924 15.7248 0 0 0 0 0 0 16.5583 0 14.7499 0 16.3186 0 0 0 0 0 16.539 0 17.5134 0 16.4893 0 0 0 0 0 0 16.57 16.3087 0 16.543 16.5633 0 0 0 0 0 13.3602 16.5675 16.6826 0 12.4514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6837 17.2633 0 0 0 0 0 0 0 0 0 0 0 0 11.8439 0 0 0 0 0 0 0 0 0 0 0 Q10588 BST1_HUMAN "ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2, EC 3.2.2.6 (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1, BST-1) (Cyclic ADP-ribose hydrolase 2, cADPr hydrolase 2) (CD antigen CD157)" BST1 Homo sapiens (Human) humoral immune response [GO:0006959]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cellular extravasation [GO:0002691]; regulation of inflammatory response [GO:0050727]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of neutrophil chemotaxis [GO:0090022]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of superoxide metabolic process [GO:0090322]; signal transduction [GO:0007165] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; uropod [GO:0001931] "anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; uropod [GO:0001931]; ADP-ribosyl cyclase activity [GO:0061811]; cyclic ADP-ribose hydrolase [GO:0061812]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]; humoral immune response [GO:0006959]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell-matrix adhesion [GO:0001952]; regulation of cellular extravasation [GO:0002691]; regulation of inflammatory response [GO:0050727]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of neutrophil chemotaxis [GO:0090022]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of superoxide metabolic process [GO:0090322]; signal transduction [GO:0007165]" GO:0001931; GO:0001952; GO:0002691; GO:0003953; GO:0005576; GO:0005886; GO:0006959; GO:0007165; GO:0008284; GO:0016740; GO:0016849; GO:0019898; GO:0030890; GO:0031225; GO:0032956; GO:0035579; GO:0050135; GO:0050727; GO:0050730; GO:0050848; GO:0061809; GO:0061811; GO:0061812; GO:0070062; GO:0090022; GO:0090322; GO:2001044 "ADP-ribosyl cyclase activity [GO:0061811]; cyclic ADP-ribose hydrolase [GO:0061812]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]" AAQGCAASRLLQLLLQLLLLLLLLAAGGAR 0.98581 -2.8552 0 0 0 0 0 0 0 0 14.121 0 14.5062 15.1469 0 0 0 0 0 11.3413 0 12.0977 0 0 16.4922 0 0 13.6296 0 13.0687 13.7519 14.2994 14.0483 0 0 13.8026 14.5012 15.0668 14.3125 15.1978 0 13.974 14.694 0 13.7628 0 0 10.748 0 0 14.4776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0481 0 0 0 0 13.9924 0 0 0 0 0 0 12.7742 0 0 0 14.1175 0 0 0 0 0 0 0 12.1401 0 0 0 0 0 0 0 11.6374 14.1997 0 12.2492 0 0 0 12.6268 0 0 0 0 0 0 13.9399 0 0 15.8576 0 0 0 0 0 0 18.2073 0 11.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9238 0 0 0 0 0 0 0 10.9084 0 0 0 0 0 0 11.2138 15.4746 13.519 0 0 12.1653 14.7587 0 0 0 14.7415 14.6221 0 13.4223 0 0 11.5518 0 14.124 13.4295 14.4633 0 10.1459 Q13158 FADD_HUMAN FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity) FADD MORT1 GIG3 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; behavioral response to cocaine [GO:0048148]; cellular response to mechanical stimulus [GO:0071260]; death-inducing signaling complex assembly [GO:0071550]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; innate immune response [GO:0045087]; kidney development [GO:0001822]; lymph node development [GO:0048535]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of activation-induced cell death of T cells [GO:0070236]; negative regulation of necroptotic process [GO:0060546]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; response to morphine [GO:0043278]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; TRAIL-activated apoptotic signaling pathway [GO:0036462]" CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ripoptosome [GO:0097342] "CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ripoptosome [GO:0097342]; caspase binding [GO:0089720]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; receptor serine/threonine kinase binding [GO:0033612]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; behavioral response to cocaine [GO:0048148]; cellular response to mechanical stimulus [GO:0071260]; death-inducing signaling complex assembly [GO:0071550]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; innate immune response [GO:0045087]; kidney development [GO:0001822]; lymph node development [GO:0048535]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of activation-induced cell death of T cells [GO:0070236]; negative regulation of necroptotic process [GO:0060546]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000454]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; response to morphine [GO:0043278]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; TRAIL-activated apoptotic signaling pathway [GO:0036462]" GO:0001822; GO:0001916; GO:0002020; GO:0002821; GO:0005123; GO:0005164; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0008625; GO:0031264; GO:0031265; GO:0032729; GO:0032757; GO:0032760; GO:0032813; GO:0033077; GO:0033612; GO:0035877; GO:0036462; GO:0042104; GO:0042802; GO:0043005; GO:0043029; GO:0043065; GO:0043123; GO:0043278; GO:0044297; GO:0044877; GO:0045087; GO:0045121; GO:0045651; GO:0045862; GO:0045944; GO:0048148; GO:0048535; GO:0048536; GO:0048538; GO:0051607; GO:0060340; GO:0060546; GO:0070236; GO:0071260; GO:0071550; GO:0089720; GO:0097049; GO:0097190; GO:0097191; GO:0097192; GO:0097202; GO:0097342; GO:0097527; GO:2000454; GO:2001238 caspase binding [GO:0089720]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; receptor serine/threonine kinase binding [GO:0033612]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813] DLQNRSGAMSPMSWNSDASTSEAS 0.98581 -3.9141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14749 GNMT_HUMAN "Glycine N-methyltransferase, EC 2.1.1.20" GNMT Homo sapiens (Human) glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein modification process [GO:0036211]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052] cytosol [GO:0005829] cytosol [GO:0005829]; folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; protein modification process [GO:0036211]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052] GO:0005542; GO:0005829; GO:0005977; GO:0006111; GO:0006555; GO:0006730; GO:0016594; GO:0017174; GO:0032259; GO:0036211; GO:0042802; GO:0046498; GO:0046500; GO:0051289; GO:1901052; GO:1904047 folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047] AWLLGLLR 0.98581 -2.4918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9645 0 0 Q86YB7 ECHD2_HUMAN "Enoyl-CoA hydratase domain-containing protein 2, mitochondrial" ECHDC2 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635] GO:0004300; GO:0005739; GO:0006635 enoyl-CoA hydratase activity [GO:0004300] ALAQEILPQAPIAVRLGK 0.98581 -2.5778 0 0 0 0 0 0 0 0 0 0 13.6441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4878 0 0 16.0339 0 0 0 0 11.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEA6 GLIS3_HUMAN Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515) GLIS3 ZNF515 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSRLENLK 0.98581 -3.4594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9766 0 12.5974 0 0 0 0 11.9776 0 0 0 0 0 0 0 0 0 0 0 0 13.9886 0 0 0 0 13.6887 0 0 0 0 0 0 0 0 12.8512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5741 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAK5 GABP2_HUMAN "GA-binding protein subunit beta-2, GABP subunit beta-2, GABPB-2" GABPB2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000976; GO:0005634; GO:0042802; GO:0045944 identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976] DVVELLIK 0.98581 -3.9178 14.2918 0 0 0 14.232 0 14.8555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1102 0 0 0 14.9227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8522 14.4562 13.7108 0 0 0 0 0 0 0 0 0 0 12.6757 0 12.7143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92781 RDH5_HUMAN "Retinol dehydrogenase 5, EC 1.1.1.209, EC 1.1.1.315, EC 1.1.1.53 (11-cis retinol dehydrogenase, 11-cis RDH, 11-cis RoDH) (9-cis retinol dehydrogenase, 9cRDH) (Short chain dehydrogenase/reductase family 9C member 5)" RDH5 HSD17B9 RDH1 SDR9C5 Homo sapiens (Human) response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601] cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; steroid dehydrogenase activity [GO:0016229]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601]" GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0016021; GO:0016229; GO:0016491; GO:0042572; GO:0042803; GO:0043231; GO:0044297; GO:0047023; GO:0047044; GO:0050896 "androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; steroid dehydrogenase activity [GO:0016229]" CLEHALTARHPRTR 0.98581 -2.0986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5005 0 0 0 0 0 15.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8691 0 0 0 0 0 0 12.4284 13.0347 0 0 0 0 0 0 0 0 0 0 0 15.4198 0 0 0 0 0 0 0 0 0 0 0 0 12.0218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6517 Q96BM1 ANKR9_HUMAN Ankyrin repeat domain-containing protein 9 ANKRD9 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; cellular copper ion homeostasis [GO:0006878]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] GO:0005829; GO:0006878; GO:0016567; GO:0031410; GO:0031466; GO:0043161; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] AMQVLVTAISPGR 0.98581 -2.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8678 0 0 0 12.6634 0 0 0 0 0 0 0 12.6954 0 0 0 0 0 0 11.8917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5097 0 0 0 0 0 0 0 0 12.5009 0 0 0 11.6877 0 0 0 0 0 0 0 12.6723 0 13.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.907 0 0 14.0955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRA0 SPHK2_HUMAN "Sphingosine kinase 2, SK 2, SPK 2, EC 2.7.1.91" SPHK2 SK2 Homo sapiens (Human) blood vessel development [GO:0001568]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; histone binding [GO:0042393]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; small GTPase binding [GO:0031267]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036]; blood vessel development [GO:0001568]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; female pregnancy [GO:0007565]; histone H2A-K5 acetylation [GO:0043977]; histone H2B-K12 acetylation [GO:0043980]; negative regulation of cell growth [GO:0030308]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of histone deacetylation [GO:0031064]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ATP biosynthetic process [GO:2001169]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670] GO:0000786; GO:0001568; GO:0001727; GO:0002720; GO:0003951; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0006665; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008283; GO:0008284; GO:0008481; GO:0016020; GO:0016310; GO:0017050; GO:0030148; GO:0030308; GO:0031064; GO:0031267; GO:0032736; GO:0032755; GO:0032760; GO:0033008; GO:0038036; GO:0042393; GO:0043065; GO:0043122; GO:0043231; GO:0043306; GO:0043977; GO:0043980; GO:0045815; GO:0046512; GO:0090037; GO:0090280; GO:1901726; GO:1903426; GO:1904628; GO:1904959; GO:2000304; GO:2000617; GO:2001169 ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; histone binding [GO:0042393]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; small GTPase binding [GO:0031267]; sphinganine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036] AFRLEPLTPR 0.98581 -2.0961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4798 0 0 0 0 0 0 0 0 0 10.0547 0 0 0 0 0 0 13.22 10.5541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3953 0 0 0 0 0 0 0 0 0 0 14.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9263 0 0 0 0 0 0 0 0 0 0 0 0 10.5299 0 0 0 0 0 0 0 0 0 0 0 0 11.1468 0 0 0 0 0 0 0 0 12.2911 0 0 0 0 0 0 13.7011 14.0509 0 0 0 0 0 0 11.5081 0 0 0 O14977 AZIN1_HUMAN "Antizyme inhibitor 1, AZI, AZI1 (Ornithine decarboxylase antizyme inhibitor)" AZIN1 OAZI OAZIN Homo sapiens (Human) negative regulation of protein catabolic process [GO:0042177]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine biosynthetic process from ornithine [GO:0033387] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ornithine decarboxylase activator activity [GO:0042978]; ornithine decarboxylase activity [GO:0004586]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of polyamine transmembrane transport [GO:1902269]; putrescine biosynthetic process from ornithine [GO:0033387] GO:0004586; GO:0005634; GO:0005737; GO:0005829; GO:0033387; GO:0042177; GO:0042978; GO:1902269 ornithine decarboxylase activator activity [GO:0042978]; ornithine decarboxylase activity [GO:0004586] HLLECAKELDVQIIGVK 0.98582 -3.7365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1239 0 0 13.7658 13.5075 13.6327 13.6117 0 14.25 13.2728 13.1175 13.183 0 0 13.0186 0 0 0 0 0 14.7451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7186 0 0 0 0 0 0 12.6238 0 0 0 0 0 0 0 0 12.909 12.6191 0 0 0 0 0 0 13.3937 0 13.9386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05093 CP17A_HUMAN "Steroid 17-alpha-hydroxylase/17,20 lyase, EC 1.14.14.19 (17-alpha-hydroxyprogesterone aldolase, EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17, Cytochrome P450c17) (Steroid 17-alpha-monooxygenase)" CYP17A1 CYP17 S17AH Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025] axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508]; androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202] GO:0004508; GO:0005506; GO:0005783; GO:0005789; GO:0006694; GO:0006702; GO:0006704; GO:0007548; GO:0008202; GO:0019825; GO:0020037; GO:0030424; GO:0042446; GO:0042448; GO:0043025; GO:0047442 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508] HGHMHNNFFK 0.98582 -3.3741 0 0 0 0 0 0 13.2679 0 0 0 0 0 0 0 0 0 0 12.5756 0 0 0 0 0 0 0 0 0 13.4041 0 0 0 0 13.567 0 0 0 0 0 0 13.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1096 0 14.6004 0 13.1078 0 0 0 0 0 0 14.833 0 0 0 0 13.9805 12.6918 0 0 0 13.8117 14.4866 0 0 0 0 0 0 0 0 0 0 14.3026 0 0 0 12.6114 0 0 0 0 0 0 0 0 0 0 13.7664 11.2416 0 0 15.3879 0 13.98 10.8988 0 10.5019 15.5173 0 0 0 0 0 0 0 0 10.2158 0 0 12.9999 0 0 14.9863 0 0 0 0 0 0 14.4941 0 0 0 0 12.6959 0 11.9854 0 0 0 0 0 0 0 12.6397 13.8545 0 0 0 0 0 0 0 0 9.87667 0 0 0 0 0 0 0 0 Q6ZVL6 K154L_HUMAN UPF0606 protein KIAA1549L KIAA1549L C11orf41 C11orf69 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FSIAKGLTQALRK 0.98582 -3.3695 0 0 0 0 0 0 0 0 14.89 0 11.1966 0 0 0 0 0 0 0 0 0 0 0 0 13.0422 0 14.9262 0 0 14.5069 0 0 0 0 0 0 0 14.2648 0 0 0 0 0 0 0 0 0 0 0 0 14.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9488 0 10.6402 0 0 0 11.5036 14.636 15.0456 0 0 16.7087 16.5465 12.0472 0 14.6992 0 0 15.9577 10.4599 14.2264 0 0 0 14.8069 14.1821 11.4647 14.9184 14.5986 0 0 0 11.2178 0 14.698 14.457 12.9017 0 15.6355 0 0 0 0 0 0 0 13.6457 0 0 0 14.5313 14.5071 0 0 11.0242 12.7763 0 0 0 0 14.9554 0 0 12.8991 0 12.3068 0 0 0 0 10.5618 12.3893 14.6479 0 0 0 0 12.4107 0 14.7538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0735 0 0 0 0 0 11.8498 0 0 Q8IYV9 IZUM1_HUMAN "Izumo sperm-egg fusion protein 1 (Oocyte binding/fusion factor, OBF) (Sperm-specific protein izumo)" IZUMO1 Homo sapiens (Human) cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heterotypic cell-cell adhesion [GO:0034113]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; heterotypic cell-cell adhesion [GO:0034113]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] GO:0002080; GO:0005102; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0016021; GO:0034113; GO:0035036; GO:0042802; GO:0042803; GO:0086080 identical protein binding [GO:0042802]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] CGVMLQTLIWCK 0.98582 -2.5817 0 0 0 0 0 0 0 0 0 11.5468 0 0 0 0 12.4779 11.5843 0 0 0 0 0 0 12.7617 0 0 0 0 0 0 0 0 12.2595 11.7757 0 0 0 0 11.626 11.041 0 0 0 0 13.2048 0 0 0 0 11.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9F9 ARP5_HUMAN "Actin-related protein 5, hARP5 (Sarcoma antigen NY-SAR-16)" ACTR5 ARP5 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of transcription, DNA-templated [GO:0006355]; UV-damage excision repair [GO:0070914]" cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of transcription, DNA-templated [GO:0006355]; UV-damage excision repair [GO:0070914]" GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0006302; GO:0006310; GO:0006338; GO:0006355; GO:0031011; GO:0033044; GO:0045893; GO:0051726; GO:0060382; GO:0070914 DWALNHLDDNEVWITRK 0.98582 -2.8683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9923 0 0 0 0 0 0 0 0 12.1456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.962 0 0 0 0 0 0 0 0 0 0 0 O60732 MAGC1_HUMAN "Melanoma-associated antigen C1 (Cancer/testis antigen 7.1, CT7.1) (MAGE-C1 antigen)" MAGEC1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 AHSEVIK 0.98583 -3.7405 0 0 14.2932 0 12.8415 0 15.9839 14.0138 11.0435 0 0 0 0 0 0 0 0 13.4935 0 11.4708 0 12.443 14.5232 13.3999 0 15.2325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2158 0 0 0 11.4189 0 11.6523 0 0 0 0 0 0 0 0 0 0 14.7156 0 0 0 0 13.1529 0 10.5543 13.6233 11.8949 15.185 12.3328 13.7614 14.8725 14.8792 0 11.8467 0 0 0 0 13.3187 0 13.3194 14.0968 0 13.0202 14.2932 13.3134 14.4144 0 13.0678 13.3922 11.1785 0 0 0 13.6778 13.9361 0 0 0 13.7499 13.8714 10.2907 0 0 10.1503 0 14.272 0 0 15.1032 14.0622 13.7648 14.2908 0 0 0 10.9832 0 15.2136 0 0 0 12.9181 13.3283 14.3034 0 13.0731 14.6541 0 13.6578 14.0163 13.9367 14.361 0 14.0434 14.4057 11.7738 0 0 14.6726 13.3295 0 10.3149 14.4655 14.1796 14.0781 14.0323 12.5794 0 0 0 11.4814 0 0 0 0 0 0 10.7262 0 0 0 14.5809 0 0 14.4619 0 0 12.7509 15.6009 0 Q16518 RPE65_HUMAN "Retinoid isomerohydrolase, EC 3.1.1.64 (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase, EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase)" RPE65 Homo sapiens (Human) cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of gene expression [GO:0010468]; retina homeostasis [GO:0001895]; retina morphogenesis in camera-type eye [GO:0060042]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776]; zeaxanthin biosynthetic process [GO:1901827] cell body [GO:0044297]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cell body [GO:0044297]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]; cellular response to electrical stimulus [GO:0071257]; circadian rhythm [GO:0007623]; detection of light stimulus involved in visual perception [GO:0050908]; insulin receptor signaling pathway [GO:0008286]; neural retina development [GO:0003407]; regulation of gene expression [GO:0010468]; retina homeostasis [GO:0001895]; retina morphogenesis in camera-type eye [GO:0060042]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]; vitamin A metabolic process [GO:0006776]; zeaxanthin biosynthetic process [GO:1901827]" GO:0001523; GO:0001786; GO:0001895; GO:0003407; GO:0004744; GO:0005634; GO:0005789; GO:0005886; GO:0006776; GO:0007601; GO:0007623; GO:0008286; GO:0010468; GO:0016020; GO:0016702; GO:0016853; GO:0031210; GO:0042574; GO:0044297; GO:0046872; GO:0050251; GO:0050908; GO:0052884; GO:0052885; GO:0060042; GO:0071257; GO:1901612; GO:1901827 "all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity [GO:0052884]; cardiolipin binding [GO:1901612]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; retinal isomerase activity [GO:0004744]; retinol isomerase activity [GO:0050251]" FIRTDAYVRAMTEK 0.98583 -2.8742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6893 0 0 0 11.9749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5634 0 12.2609 0 0 0 14.7031 0 0 12.5894 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9439 0 0 0 14.3854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q495Z4 ASAS1_HUMAN Putative uncharacterized protein ASB16-AS1 (ASB16 antisense RNA 1) (ASB16 antisense gene protein 1) ASB16-AS1 C17orf65 Homo sapiens (Human) GPRNAAAAR 0.98583 -3.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6312 0 0 0 0 0 0 9.8978 0 0 0 0 0 0 0 0 0 0 0 0 9.39051 0 13.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3858 14.4117 14.0756 0 0 0 0 13.2951 0 0 0 0 13.9197 0 0 0 0 13.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.327 11.9342 0 0 0 0 0 0 14.0717 11.3218 0 0 0 0 0 0 0 0 0 11.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G163 FBX43_HUMAN F-box only protein 43 (Endogenous meiotic inhibitor 2) FBXO43 EMI2 Homo sapiens (Human) meiotic cell cycle [GO:0051321]; negative regulation of meiotic nuclear division [GO:0045835]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; meiotic cell cycle [GO:0051321]; negative regulation of meiotic nuclear division [GO:0045835]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088] GO:0005634; GO:0007088; GO:0016567; GO:0045835; GO:0046872; GO:0051321 metal ion binding [GO:0046872] DFCSTSSFQDSGYNELK 0.98583 -2.6032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.673 0 0 0 0 14.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JQC9 AKAP4_HUMAN "A-kinase anchor protein 4, AKAP-4 (A-kinase anchor protein 82 kDa, AKAP 82, hAKAP82) (Major sperm fibrous sheath protein, HI) (Protein kinase A-anchoring protein 4, PRKA4)" AKAP4 AKAP82 Homo sapiens (Human) establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; flagellated sperm motility [GO:0030317]; protein localization [GO:0008104]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; Z disc [GO:0030018] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; Z disc [GO:0030018]; protein kinase A binding [GO:0051018]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; flagellated sperm motility [GO:0030317]; protein localization [GO:0008104]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] GO:0005634; GO:0005737; GO:0005856; GO:0005952; GO:0007165; GO:0007178; GO:0007338; GO:0008104; GO:0030018; GO:0030317; GO:0031514; GO:0035686; GO:0045184; GO:0048471; GO:0051018; GO:0051649; GO:0097224; GO:0097225; GO:0097228; GO:0097229; GO:0120316 protein kinase A binding [GO:0051018] CEDPCEGENKCSEPR 0.98583 -3.7483 0 0 0 0 0 0 0 12.3762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5313 0 0 0 0 0 0 13.7344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3822 0 0 0 0 14.6875 14.3737 14.5166 13.4472 0 13.6928 0 0 0 0 0 0 12.8655 0 0 12.827 0 0 0 10.4945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2794 0 0 0 0 13.0208 11.1628 0 0 0 0 0 0 0 0 0 0 0 11.9912 0 0 0 0 0 0 0 0 0 0 14.0957 13.5806 0 13.6486 15.357 0 0 0 0 0 0 0 12.1201 14.3273 0 13.4847 13.3394 13.3476 13.3587 13.0238 0 0 0 0 0 12.858 0 0 0 13.4813 0 14.1126 0 0 0 0 0 0 0 Q9H3S4 TPK1_HUMAN "Thiamin pyrophosphokinase 1, hTPK1, EC 2.7.6.2 (Placental protein 20, PP20) (Thiamine pyrophosphokinase 1)" TPK1 Homo sapiens (Human) phosphorylation [GO:0016310]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; phosphorylation [GO:0016310]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772] GO:0004788; GO:0005524; GO:0005829; GO:0006772; GO:0009229; GO:0016301; GO:0016310; GO:0030975; GO:0042802 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788] HLWNKALLR 0.98583 -3.8348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRA1 PDGFC_HUMAN "Platelet-derived growth factor C, PDGF-C (Fallotein) (Spinal cord-derived growth factor, SCDGF) (VEGF-E) [Cleaved into: Platelet-derived growth factor C, latent form, PDGFC latent form; Platelet-derived growth factor C, receptor-binding form, PDGFC receptor-binding form ]" PDGFC SCDGF UNQ174/PRO200 Homo sapiens (Human) activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ morphogenesis [GO:0009887]; bone development [GO:0060348]; cellular response to amino acid stimulus [GO:0071230]; central nervous system development [GO:0007417]; digestive tract development [GO:0048565]; embryonic organ development [GO:0048568]; fibroblast proliferation [GO:0048144]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ morphogenesis [GO:0009887]; bone development [GO:0060348]; cellular response to amino acid stimulus [GO:0071230]; central nervous system development [GO:0007417]; digestive tract development [GO:0048565]; embryonic organ development [GO:0048568]; fibroblast proliferation [GO:0048144]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] GO:0000139; GO:0005161; GO:0005576; GO:0005615; GO:0005634; GO:0005788; GO:0005829; GO:0005886; GO:0007171; GO:0007417; GO:0008083; GO:0008284; GO:0009887; GO:0009986; GO:0014068; GO:0030335; GO:0031954; GO:0042803; GO:0043406; GO:0048008; GO:0048144; GO:0048146; GO:0048565; GO:0048568; GO:0050730; GO:0051781; GO:0060348; GO:0070062; GO:0070374; GO:0070851; GO:0071230; GO:0120162 growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803] AFVFGRK 0.98583 -3.8293 0 0 0 0 0 0 0 0 0 0 12.1145 0 12.294 12.064 0 0 12.0703 10.4527 0 0 0 0 10.5987 0 0 0 0 0 10.9872 0 0 0 0 0 0 0 0 0 0 0 16.619 11.4013 0 0 10.9073 10.783 0 17.0089 0 14.7286 10.7617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8723 0 0 0 14.0642 13.6071 0 0 0 14.3467 0 0 0 0 13.9443 0 13.5511 15.6955 0 0 0 13.3039 0 0 0 0 0 0 12.9406 0 0 0 0 0 0 0 12.7603 0 0 13.2347 12.7437 0 14.3203 0 13.1097 0 0 0 13.2398 0 12.8862 0 0 0 0 13.1207 0 13.6976 0 0 0 13.8426 0 0 0 0 0 0 0 0 0 0 0 0 16.0179 12.5305 11.631 0 0 0 0 0 11.5821 16.6226 0 0 0 0 0 0 11.1322 13.9909 0 0 0 0 13.623 0 0 O75529 TAF5L_HUMAN "TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L, TAF5L (PCAF-associated factor 65 beta, PAF65-beta)" TAF5L PAF65B Homo sapiens (Human) "histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" cytoplasmic ribonucleoprotein granule [GO:0036464]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "cytoplasmic ribonucleoprotein granule [GO:0036464]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; transcription coactivator activity [GO:0003713]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0000123; GO:0000124; GO:0003713; GO:0005634; GO:0006282; GO:0006355; GO:0006357; GO:0006366; GO:0016573; GO:0016607; GO:0033276; GO:0035521; GO:0035522; GO:0036464; GO:0043484; GO:0043966; GO:0045893; GO:1904672 transcription coactivator activity [GO:0003713] ILRGHCGPVYSTR 0.98584 -1.5952 0 0 0 0 0 0 0 0 0 0 0 0 10.6263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6554 0 11.4806 0 0 0 0 0 0 0 0 0 0 11.3462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7995 0 10.4806 10.483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22830 HEMH_HUMAN "Ferrochelatase, mitochondrial, EC 4.99.1.1 (Heme synthase) (Protoheme ferro-lyase)" FECH Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to light stimulus [GO:0009416] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; protein homodimerization activity [GO:0042803]; generation of precursor metabolites and energy [GO:0006091]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX metabolic process [GO:0046501]; response to light stimulus [GO:0009416]" GO:0004325; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006783; GO:0008198; GO:0009416; GO:0042803; GO:0046501; GO:0051537 "2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; ferrous iron binding [GO:0008198]; protein homodimerization activity [GO:0042803]" IGGGSPIK 0.98584 -2.6048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42336 PK3CA_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, PI3-kinase subunit alpha, PI3K-alpha, PI3Kalpha, PtdIns-3-kinase subunit alpha, EC 2.7.1.137, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha, PtdIns-3-kinase subunit p110-alpha, p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA, EC 2.7.11.1)" PIK3CA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cell migration [GO:0016477]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; hypomethylation of CpG island [GO:0044029]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of genetic imprinting [GO:2000653]; regulation of multicellular organism growth [GO:0040014]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]" GO:0001525; GO:0001889; GO:0001944; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006006; GO:0006909; GO:0007173; GO:0010592; GO:0010629; GO:0014065; GO:0014704; GO:0014823; GO:0014870; GO:0016020; GO:0016242; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030027; GO:0030036; GO:0030168; GO:0030295; GO:0030835; GO:0031295; GO:0032008; GO:0033138; GO:0035004; GO:0035005; GO:0035994; GO:0036092; GO:0038028; GO:0038084; GO:0040014; GO:0043201; GO:0043276; GO:0043457; GO:0043491; GO:0043524; GO:0043542; GO:0043560; GO:0044029; GO:0046854; GO:0046934; GO:0048015; GO:0048471; GO:0048661; GO:0050852; GO:0051897; GO:0052742; GO:0052812; GO:0055119; GO:0060048; GO:0060612; GO:0071333; GO:0071464; GO:0071548; GO:0086003; GO:0097009; GO:0106310; GO:0110053; GO:1903544; GO:2000270; GO:2000653; GO:2000811 "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]" DFLWSHRHYCVTIPEILPKLLLSVK 0.98584 -2.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4007 0 0 0 0 0 0 0 11.115 0 0 0 0 0 0 0 0 13.0395 0 0 0 0 0 0 13.4413 0 0 0 0 0 0 0 0 14.3684 0 0 0 0 0 0 0 0 0 0 0 12.8387 0 0 0 0 0 0 13.5239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8657 0 0 12.994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5603 0 0 0 0 0 0 10.689 0 0 0 0 0 0 0 0 0 0 P78537 BL1S1_HUMAN "Biogenesis of lysosome-related organelles complex 1 subunit 1, BLOC-1 subunit 1 (GCN5-like protein 1) (Protein RT14)" BLOC1S1 BLOS1 GCN5L1 RT14 Homo sapiens (Human) aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; neuron projection development [GO:0031175]; organelle transport along microtubule [GO:0072384]; peptidyl-lysine acetylation [GO:0018394]; platelet dense granule organization [GO:0060155]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; neuron projection development [GO:0031175]; organelle transport along microtubule [GO:0072384]; peptidyl-lysine acetylation [GO:0018394]; platelet dense granule organization [GO:0060155]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] GO:0005615; GO:0005758; GO:0005759; GO:0005765; GO:0005769; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0032438; GO:0048490; GO:0051036; GO:0060155; GO:0062196; GO:0072384; GO:0098574; GO:0099078; GO:1904115 LLKEHQAK 0.98584 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1208 0 0 0 0 0 0 0 0 0 0 0 13.6324 0 0 0 0 0 0 0 0 0 0 Q07654 TFF3_HUMAN "Trefoil factor 3 (Intestinal trefoil factor, hITF) (Polypeptide P1.B, hP1.B)" TFF3 ITF TFI Homo sapiens (Human) maintenance of gastrointestinal epithelium [GO:0030277]; regulation of glucose metabolic process [GO:0010906] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; maintenance of gastrointestinal epithelium [GO:0030277]; regulation of glucose metabolic process [GO:0010906] GO:0005576; GO:0005615; GO:0010906; GO:0030141; GO:0030277; GO:0042802 identical protein binding [GO:0042802] ECNNRGCCFDSR 0.98584 -3.7533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9572 0 0 0 0 0 0 11.8527 13.5853 0 0 0 13.7502 13.4988 0 0 10.6628 10.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2851 0 0 0 0 0 0 0 0 0 0 0 0 12.2841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0885 0 0 0 0 0 0 0 0 0 14.7625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53FA7 QORX_HUMAN "Quinone oxidoreductase PIG3, EC 1.6.5.5 (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3, Protein PIG3) (p53-induced gene 3 protein)" TP53I3 PIG3 Homo sapiens (Human) NADP metabolic process [GO:0006739] cytosol [GO:0005829] "cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]" GO:0003960; GO:0005829; GO:0006739; GO:0016651; GO:0042803; GO:0048038; GO:0070402 "NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]" IVLELPQ 0.98584 -3.7527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4836 0 14.2728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2475 18.288 0 0 14.4977 15.4784 0 0 15.6085 15.6799 14.8476 17.9229 14.2902 16.2518 15.5683 14.8929 14.8745 14.3877 0 0 14.7518 15.675 14.2423 15.6996 14.4979 14.946 14.6097 14.3664 16.6267 14.4081 0 14.4324 14.8367 15.9144 16.465 14.6334 0 0 0 15.7696 19.0017 15.1458 19.72 15.8519 15.8213 0 16.3201 16.6963 15.7821 14.9214 14.1217 15.6818 15.8016 14.5891 16.5061 14.5994 14.8915 15.966 0 14.3534 15.1129 0 16.6859 0 15.4438 16.1537 14.9719 15.596 14.8749 14.8489 14.6316 14.4453 16.4459 14.4605 14.5537 0 15.327 15.8977 0 12.7773 14.0314 13.2554 16.2637 0 15.4505 0 16.3167 16.1161 14.9373 14.0973 0 0 0 0 0 0 13.2579 0 0 0 0 0 0 0 0 0 16.3284 14.3374 15.8182 0 0 0 16.249 0 Q5HYL7 TM196_HUMAN Transmembrane protein 196 TMEM196 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LASYEQR 0.98584 -2.3818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.649 0 0 9.84015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0954 10.7411 0 10.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.609 0 0 0 10.2283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2778 0 11.7691 0 0 12.2116 12.1412 0 10.8445 0 0 0 0 0 0 0 0 0 0 0 13.3782 0 0 Q96BD6 SPSB1_HUMAN "SPRY domain-containing SOCS box protein 1, SSB-1" SPSB1 SSB1 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0043161; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] RSVRLALGR 0.98584 -3.6694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZU0 CF062_HUMAN Uncharacterized protein C6orf62 (HBV X-transactivated gene 12 protein) (HBV XAg-transactivated protein 12) C6orf62 XTP12 Nbla00237 Homo sapiens (Human) ATIFKLCSICLYLPQEQLTHWAVGTIEDHLR 0.98584 -2.0363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6646 0 0 0 0 0 0 0 0 0 0 0 14.832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJ70 NAGK_HUMAN "N-acetyl-D-glucosamine kinase, N-acetylglucosamine kinase, EC 2.7.1.59 (GlcNAc kinase)" NAGK Homo sapiens (Human) N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262] GO:0005524; GO:0005829; GO:0006044; GO:0006051; GO:0019262; GO:0045127; GO:0070062 ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127] CRFAGFCR 0.98584 -3.754 0 0 0 0 12.7603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2607 0 0 0 O75394 RM33_HUMAN "39S ribosomal protein L33, mitochondrial, L33mt, MRP-L33 (Mitochondrial large ribosomal subunit protein bL33m)" MRPL33 C2orf1 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 structural constituent of ribosome [GO:0003735] LTLLHYDPVVKQRVLFVEK 0.98585 -2.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0493 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE65 ZN738_HUMAN Zinc finger protein 738 ZNF738 Homo sapiens (Human) "protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0006355; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] DSFQKVILR 0.98585 -2.0413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTR2 DUS19_HUMAN "Dual specificity protein phosphatase 19, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity phosphatase TS-DSP1) (Low molecular weight dual specificity phosphatase 3, LMW-DSP3) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1, SAPK pathway-regulating phosphatase 1)" DUSP19 DUSP17 LMWDSP3 SKRP1 Homo sapiens (Human) negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; protein dephosphorylation [GO:0006470]; regulation of MAP kinase activity [GO:0043405] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; myosin phosphatase activity [GO:0017018]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; protein dephosphorylation [GO:0006470]; regulation of MAP kinase activity [GO:0043405] GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0006469; GO:0006470; GO:0008138; GO:0008579; GO:0017018; GO:0030295; GO:0031435; GO:0043405; GO:0043410; GO:0043507; GO:0043508; GO:0045860; GO:0046329; GO:0046330 JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; myosin phosphatase activity [GO:0017018]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] AFSRNNLR 0.98585 -3.5799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9J302 CD051_HUMAN Uncharacterized protein C4orf51 C4orf51 Homo sapiens (Human) CDSESKVCSSEDSEADRYSDYGWGGPSSPFN 0.98586 -2.0524 0 0 0 0 0 0 0 0 0 0 0 0 13.7382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1836 0 0 0 0 0 0 0 0 13.8331 0 0 0 0 0 0 0 14.032 0 0 11.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4975 0 0 0 12.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95838 GLP2R_HUMAN "Glucagon-like peptide 2 receptor, GLP-2 receptor, GLP-2-R, GLP-2R" GLP2R Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell population proliferation [GO:0008284] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell population proliferation [GO:0008284] GO:0004930; GO:0004967; GO:0005886; GO:0007166; GO:0007188; GO:0008284; GO:0008528; GO:0016021; GO:0017046 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046] CSLWAPGRPFLTLVLLVSIKQVTGSLLEETTR 0.98586 -2.8022 17.442 18.1414 18.0042 0 0 17.0112 16.8989 0 0 13.188 0 0 0 0 0 0 0 0 16.6207 0 19.9393 12.1124 18.1521 14.6445 16.4639 19.7184 19.9516 16.3044 0 10.1755 0 0 0 0 0 0 0 12.7749 0 0 0 0 0 0 15.8603 0 0 0 0 12.4129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4537 13.3343 17.9902 0 13.4988 0 0 14.7881 19.2449 12.5621 18.6108 12.9011 18.6955 18.6699 18.7243 18.2638 18.1712 18.1137 18.2505 12.7168 18.0647 18.7273 0 18.6062 20.5642 14.1896 18.7906 14.2672 18.5566 0 0 0 18.7869 13.5499 15.5308 0 18.4853 0 18.3664 18.4765 19.2677 11.6558 18.4181 12.2264 18.3868 0 0 20.3204 0 18.3273 20.8435 18.4502 14.3024 20.8242 18.3354 15.2869 15.5782 0 0 20.8263 12.4141 18.5345 13.509 0 18.2613 0 18.2055 13.8555 20.601 20.8208 18.3427 20.8178 20.8196 20.5675 14.4453 20.7585 20.523 15.6976 20.5553 0 20.746 18.1428 14.0809 0 18.816 0 18.1594 0 17.9909 18.1243 15.2766 0 10.8455 0 0 0 0 0 0 0 0 0 0 0 0 13.9064 20.5304 12.0922 18.0429 0 17.1213 0 20.3189 0 P0DN24 CC086_HUMAN Uncharacterized protein C3orf86 C3orf86 Homo sapiens (Human) PALAPPSK 0.98586 -2.0513 12.7015 0 0 0 13.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6518 0 13.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8571 0 0 0 13.5109 0 0 0 0 14.0649 0 0 0 15.4173 0 14.2114 13.76 0 0 13.9599 14.0925 0 0 0 0 14.3791 14.3036 0 0 0 14.7104 14.7154 0 0 0 0 0 14.2723 0 15.8366 0 13.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3776 15.4173 0 0 0 0 0 0 Q8NDG6 TDRD9_HUMAN "ATP-dependent RNA helicase TDRD9, EC 3.6.4.13 (Tudor domain-containing protein 9)" TDRD9 C14orf75 Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547] cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0010529; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:0071547 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ALLATALSPPGLSDIERTILLLK 0.98586 -3.5854 0 0 0 0 0 0 9.52691 0 11.3458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1083 0 12.1057 0 0 0 0 0 0 12.5102 12.3621 12.8944 0 0 13.4896 0 0 0 0 0 0 0 10.0293 0 0 0 0 0 0 0 0 0 0 16.0854 11.0116 0 0 17.9396 0 14.3261 18.1011 0 10.8617 0 0 0 12.2365 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3065 0 12.0042 0 0 13.6257 0 0 0 0 0 0 13.2646 0 12.7507 11.6143 0 0 0 0 0 0 0 0 0 0 0 0 9.48075 0 12.6726 0 0 0 0 0 0 0 0 12.2403 0 0 11.3334 0 0 0 0 0 0 0 0 12.9384 0 0 0 0 0 0 0 0 A6NFY7 SDHF1_HUMAN "Succinate dehydrogenase assembly factor 1, mitochondrial, SDH assembly factor 1, SDHAF1 (LYR motif-containing protein 8)" SDHAF1 LYRM8 Homo sapiens (Human) mitochondrial respiratory chain complex II assembly [GO:0034553] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; mitochondrial respiratory chain complex II assembly [GO:0034553] GO:0005654; GO:0005739; GO:0005759; GO:0034553 GKPGAEARVR 0.98587 -3.5086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0805 0 11.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02652 APOA2_HUMAN "Apolipoprotein A-II, Apo-AII, ApoA-II (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II, ProapoA-II; Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76)) ]" APOA2 Homo sapiens (Human) acute inflammatory response [GO:0002526]; animal organ regeneration [GO:0031100]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; diacylglycerol catabolic process [GO:0046340]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol import [GO:0060621]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of cholesterol transporter activity [GO:0060695]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of lipase activity [GO:0060192]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phospholipid catabolic process [GO:0009395]; phospholipid efflux [GO:0033700]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of phagocytosis [GO:0050766]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein stability [GO:0031647]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to xenobiotic stimulus [GO:0009410]; reverse cholesterol transport [GO:0043691]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle remodeling [GO:0034370] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein receptor binding [GO:0034190]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; acute inflammatory response [GO:0002526]; animal organ regeneration [GO:0031100]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; diacylglycerol catabolic process [GO:0046340]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol import [GO:0060621]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of cholesterol transporter activity [GO:0060695]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of lipase activity [GO:0060192]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phospholipid catabolic process [GO:0009395]; phospholipid efflux [GO:0033700]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of phagocytosis [GO:0050766]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein stability [GO:0031647]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to xenobiotic stimulus [GO:0009410]; reverse cholesterol transport [GO:0043691]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle remodeling [GO:0034370] GO:0002526; GO:0002719; GO:0005102; GO:0005319; GO:0005543; GO:0005576; GO:0005769; GO:0005788; GO:0005829; GO:0006641; GO:0006656; GO:0008035; GO:0008203; GO:0008289; GO:0009395; GO:0009410; GO:0009749; GO:0010903; GO:0015485; GO:0018158; GO:0018206; GO:0019899; GO:0030300; GO:0030301; GO:0031072; GO:0031100; GO:0031210; GO:0031647; GO:0032375; GO:0032757; GO:0033344; GO:0033700; GO:0034190; GO:0034361; GO:0034364; GO:0034366; GO:0034370; GO:0034374; GO:0034375; GO:0034380; GO:0034384; GO:0042157; GO:0042627; GO:0042632; GO:0042803; GO:0043627; GO:0043691; GO:0046340; GO:0046982; GO:0050766; GO:0050821; GO:0050995; GO:0050996; GO:0051384; GO:0055102; GO:0060192; GO:0060228; GO:0060621; GO:0060695; GO:0070062; GO:0070653; GO:0072562; GO:0120020; GO:1905920 apolipoprotein receptor binding [GO:0034190]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] EQLTPLIK 0.98587 -2.4076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5599 0 0 0 0 0 0 0 0 11.3278 0 0 0 0 0 0 0 0 0 0 Q8IZF4 AGRG5_HUMAN Adhesion G-protein coupled receptor G5 (G-protein coupled receptor 114) (G-protein coupled receptor PGR27) ADGRG5 GPR114 PGR27 UNQ2524/PRO6017 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] DACKTRPR 0.98587 -2.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0471 0 0 0 0 0 0 0 0 0 0 12.416 0 0 0 0 0 0 0 0 0 0 0 0 12.6539 0 0 12.2231 0 0 0 0 0 11.3725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4018 0 0 Q96S37 S22AC_HUMAN "Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter, RST) (Urate anion exchanger 1)" SLC22A12 OATL4 URAT1 UNQ6453/PRO34004 Homo sapiens (Human) cellular homeostasis [GO:0019725]; cellular response to insulin stimulus [GO:0032869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; response to xenobiotic stimulus [GO:0009410]; urate metabolic process [GO:0046415]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143]; cellular homeostasis [GO:0019725]; cellular response to insulin stimulus [GO:0032869]; organic anion transport [GO:0015711]; renal urate salt excretion [GO:0097744]; response to xenobiotic stimulus [GO:0009410]; urate metabolic process [GO:0046415]; urate transport [GO:0015747] GO:0005886; GO:0009410; GO:0015143; GO:0015711; GO:0015747; GO:0016021; GO:0016324; GO:0019725; GO:0030165; GO:0031526; GO:0032869; GO:0046415; GO:0070062; GO:0097744 PDZ domain binding [GO:0030165]; urate transmembrane transporter activity [GO:0015143] PHQCRRFR 0.98587 -2.4091 0 0 0 0 0 0 0 0 0 0 0 12.0771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7437 0 0 11.4948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2874 0 14.541 13.6466 0 0 0 0 0 0 12.5059 0 0 0 16.6066 15.875 13.4746 16.1319 0 0 0 0 13.7487 14.0268 13.559 13.9395 13.7771 0 13.2375 0 13.0507 14.3602 13.5002 0 14.9217 14.3579 0 0 0 14.3745 15.7645 14.6192 0 14.0227 14.1124 0 0 0 0 0 0 0 0 0 0 0 0 12.5899 13.3146 0 12.9858 0 0 0 0 0 0 0 0 0 0 0 14.6163 0 0 0 15.0835 15.6194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9152 0 0 0 0 0 0 Q9UKV8 AGO2_HUMAN "Protein argonaute-2, Argonaute2, hAgo2, EC 3.1.26.n2 (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2, eIF-2C 2, eIF2C 2) (PAZ Piwi domain protein, PPD) (Protein slicer)" AGO2 EIF2C2 Homo sapiens (Human) "gene silencing by RNA [GO:0031047]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]; gene silencing by RNA [GO:0031047]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing by RNA [GO:0035194]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]; translation [GO:0006412]" GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003743; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006412; GO:0008022; GO:0009791; GO:0010501; GO:0010586; GO:0010628; GO:0016020; GO:0016442; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0035194; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0036464; GO:0042985; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090624; GO:0090625; GO:0098808; GO:1900153; GO:1901165; GO:1990904 "core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]" DAGMPIQGQPCFCKYAQGADSVEPMFR 0.98587 -2.0574 0 0 12.7423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5657 0 0 0 13.1933 0 0 0 0 0 0 0 12.4069 0 0 0 0 0 11.8654 0 0 0 0 0 14.1056 0 0 0 0 0 0 0 13.6509 0 0 0 0 0 0 12.6992 0 11.8709 0 13.6578 0 0 14.8343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8345 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2476 0 11.6047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10632 CP2C8_HUMAN "Cytochrome P450 2C8, EC 1.14.14.1 (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase)" CYP2C8 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0002933; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0005886; GO:0006082; GO:0006805; GO:0008202; GO:0008210; GO:0008392; GO:0008395; GO:0008401; GO:0016712; GO:0019373; GO:0020037; GO:0034875; GO:0042178; GO:0042572; GO:0042573; GO:0042759; GO:0043231; GO:0046456; GO:0070330; GO:0070989; GO:0097267; GO:0101020 "arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]" DQNFLTLMKR 0.98588 -3.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4907 0 0 13.5813 0 0 0 0 0 13.1543 0 0 0 0 0 0 0 0 0 0 13.1471 0 0 0 0 0 0 0 0 0 0 0 0 12.9853 0 0 0 0 0 0 10.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7865 0 0 14.2929 0 0 0 13.9335 0 0 10.3917 0 0 13.9185 14.5848 12.0641 0 0 0 0 13.7646 0 0 16.0909 13.0466 0 0 14.3489 0 0 0 0 15.2841 0 0 0 13.983 13.3922 14.0916 0 0 0 13.9807 0 0 0 0 0 0 0 12.8449 0 0 15.0724 0 0 0 0 13.8172 0 13.0691 0 0 0 0 0 0 0 12.7121 0 0 16.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8891 12.5381 15.8082 12.2833 0 0 0 0 13.5777 14.0571 0 11.5351 0 11.412 0 0 Q06323 PSME1_HUMAN "Proteasome activator complex subunit 1 (11S regulator complex subunit alpha, REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein, IGUP I-5111) (Proteasome activator 28 subunit alpha, PA28a, PA28alpha)" PSME1 IFI5111 Homo sapiens (Human) antigen processing and presentation of exogenous antigen [GO:0019884]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; antigen processing and presentation of exogenous antigen [GO:0019884]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136] GO:0000502; GO:0005654; GO:0005737; GO:0005829; GO:0008537; GO:0010950; GO:0019884; GO:0061133; GO:0061136; GO:0070062; GO:2000045 endopeptidase activator activity [GO:0061133] DIRLMVMEIRNAYAVLYDIILK 0.98588 -2.827 8.93943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6617 14.2529 0 0 0 0 0 0 0 0 0 0 0 0 13.1813 12.838 0 0 15.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5108 0 0 0 0 0 0 0 14.9414 0 14.0671 0 0 0 0 0 0 13.7876 15.1321 0 12.3685 0 0 0 0 0 0 0 0 11.8604 0 0 0 0 0 0 14.2742 0 14.8263 10.0983 0 14.4952 0 14.5801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1564 0 0 0 0 0 0 0 15.0803 0 0 0 0 0 Q15615 OR4D1_HUMAN Olfactory receptor 4D1 (Olfactory receptor 4D3) (Olfactory receptor TPCR16) OR4D1 OR4D3 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005887; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] CLVICRE 0.98588 -3.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PH85 DCNL2_HUMAN "DCN1-like protein 2, DCNL2 (DCUN1 domain-containing protein 2) (Defective in cullin neddylation protein 1-like protein 2)" DCUN1D2 C13orf17 DCUN1L2 Homo sapiens (Human) positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434] GO:0000151; GO:0005634; GO:0005737; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000434; GO:2000436 cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182] AATQCEFSRKEFLDGMTELGCDSMEK 0.98588 -2.0663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5302 0 0 0 0 0 0 0 0 14.6662 0 0 0 13.758 0 12.311 12.2538 0 0 0 12.1731 14.5939 0 0 0 0 13.7283 0 14.4939 10.7082 0 0 0 0 0 11.2062 13.7232 10.3541 0 0 0 0 0 0 13.6786 0 0 13.6195 12.9981 14.3671 0 14.2023 0 0 0 0 14.0823 14.2935 0 0 0 0 0 14.4699 0 13.4049 14.0573 11.8643 0 12.5482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.388 0 0 0 0 0 0 0 0 0 13.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV04 TB10C_HUMAN Carabin (TBC1 domain family member 10C) TBC1D10C Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; B cell activation [GO:0042113]; calcineurin-NFAT signaling cascade [GO:0033173]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; B cell activation [GO:0042113]; calcineurin-NFAT signaling cascade [GO:0033173]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005096; GO:0005829; GO:0005886; GO:0016020; GO:0031527; GO:0033173; GO:0042113; GO:0042147; GO:0050869; GO:0070371; GO:0070373; GO:0070885; GO:0090630; GO:0101003 GTPase activator activity [GO:0005096] IVVQPPEEPR 0.98588 -3.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7794 14.5239 14.9237 14.474 14.3605 0 0 0 14.3188 12.1411 14.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9325 11.9855 0 0 14.1609 0 0 14.6363 0 0 0 13.7189 0 13.4774 13.6478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5902 12.6922 0 13.0524 0 0 0 0 0 0 13.0669 0 12.7416 0 14.5884 13.1002 13.4789 0 0 0 0 0 13.014 0 0 0 0 0 0 0 0 0 0 0 0 12.8278 0 0 12.7001 0 0 0 0 13.064 0 0 0 0 0 0 0 0 Q9NWT8 AKIP_HUMAN "Aurora kinase A-interacting protein, AURKA-interacting protein (28S ribosomal protein S38, mitochondrial, MRP-S38) (Mitochondrial small ribosomal subunit protein mS38)" AURKAIP1 AIP AKIP MRPS38 Homo sapiens (Human) mitochondrial translation [GO:0032543]; mRNA processing [GO:0006397]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of proteolysis [GO:0045862] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitochondrial translation [GO:0032543]; mRNA processing [GO:0006397]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of proteolysis [GO:0045862] GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0006397; GO:0032543; GO:0043231; GO:0045839; GO:0045862 DLRRIWLK 0.98588 -3.5149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4339 0 0 0 0 0 0 0 0 0 12.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25789 PSA4_HUMAN Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L) PSMA4 HC9 PSC9 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0043161; GO:0043231; GO:0070062 ENGKTVIRVLK 0.98589 -3.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5058 0 0 0 0 0 12.2505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAP4 LMO3_HUMAN "LIM domain only protein 3, LMO-3 (Neuronal-specific transcription factor DAT1) (Rhombotin-3)" LMO3 RBTN3 RBTNL2 RHOM3 Homo sapiens (Human) negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003713; GO:0005634; GO:0005737; GO:0035360; GO:0045600; GO:0045944; GO:0046872; GO:0070373; GO:0140297; GO:2000324 DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713] ALDKYWHEDCLKCACCDCR 0.98589 -3.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7481 0 0 0 0 0 0 0 0 0 11.8346 10.5209 0 13.7395 0 13.5589 13.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1141 14.0663 0 0 0 0 0 0 0 0 12.0542 0 0 0 0 0 0 13.7794 0 0 0 14.525 0 0 0 0 0 0 0 0 0 13.5059 0 0 0 0 0 0 0 14.1172 0 0 12.2729 0 0 0 0 9.82126 0 0 14.4039 14.7519 0 0 0 0 O14792 HS3S1_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 1, EC 2.8.2.23 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1, 3-OST-1, Heparan sulfate 3-O-sulfotransferase 1, h3-OST-1)" HS3ST1 3OST 3OST1 Homo sapiens (Human) glycosaminoglycan biosynthetic process [GO:0006024] Golgi lumen [GO:0005796] Golgi lumen [GO:0005796]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146]; glycosaminoglycan biosynthetic process [GO:0006024] GO:0005796; GO:0006024; GO:0008146; GO:0008467 [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; sulfotransferase activity [GO:0008146] AALLLGAVLLVAQPQLVPSR 0.9859 -2.0823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.336 0 0 0 0 0 0 0 0 0 0 14.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.772 12.0188 0 0 0 10.3412 0 0 0 0 10.6212 0 0 11.3132 13.2379 0 14.2015 0 0 15.1476 15.0846 14.9737 0 0 11.7873 13.5445 13.4257 11.5848 12.6781 12.7947 14.2302 0 11.551 11.4549 14.1372 13.4701 12.2188 0 0 0 0 12.5633 11.6309 0 0 13.6239 0 14.3183 11.8553 0 11.4406 0 11.4644 0 0 14.1789 10.9146 0 0 0 0 11.3788 0 0 13.6198 0 0 0 0 0 0 0 0 14.4271 13.0651 0 0 0 0 12.7816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43921 EFNA2_HUMAN "Ephrin-A2 (EPH-related receptor tyrosine kinase ligand 6, LERK-6) (HEK7 ligand, HEK7-L)" EFNA2 EPLG6 LERK6 Homo sapiens (Human) axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]; olfactory bulb development [GO:0021772]; osteoclast differentiation [GO:0030316] anchored component of membrane [GO:0031225]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; axon guidance [GO:0007411]; bone remodeling [GO:0046849]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]; olfactory bulb development [GO:0021772]; osteoclast differentiation [GO:0030316] GO:0005886; GO:0007267; GO:0007411; GO:0021772; GO:0030316; GO:0031225; GO:0031594; GO:0043204; GO:0046849; GO:0046875; GO:0048013 ephrin receptor binding [GO:0046875] APAQRPLLPLLLLLLPLPPPPFAR 0.9859 -2.0836 0 0 0 0 0 0 0 0 9.9497 0 0 13.3411 0 13.4776 0 0 12.3563 0 0 0 0 0 0 10.7521 0 0 15.0872 0 0 14.0098 0 0 0 0 0 0 0 0 10.611 0 0 11.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4124 0 12.885 0 0 10.8193 0 0 13.4311 0 0 0 11.4091 12.7644 0 13.0968 0 16.4438 13.5986 12.9491 0 0 0 12.0372 0 0 0 14.9622 15.706 0 15.2764 0 0 0 0 14.529 0 13.4261 0 0 0 11.5746 14.6714 12.2188 14.7908 0 12.7375 12.3809 0 14.0558 0 0 0 12.4522 14.2134 0 12.7249 0 0 0 0 0 0 0 0 0 0 14.0788 15.2804 15.5677 14.5965 14.1947 14.6463 14.5307 0 0 13.7676 0 0 13.5432 0 0 12.9981 11.5383 0 14.3252 0 0 0 0 0 0 0 0 0 0 0 0 11.6292 0 0 0 0 0 0 0 14.0326 0 13.5811 0 0 0 15.0472 0 P14784 IL2RB_HUMAN "Interleukin-2 receptor subunit beta, IL-2 receptor subunit beta, IL-2R subunit beta, IL-2RB (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75, p75) (CD antigen CD122)" IL2RB IL15RB Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; positive regulation of phagocytosis [GO:0050766]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-2 receptor complex [GO:0005893]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-2 receptor complex [GO:0005893]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; interleukin-2 binding [GO:0019976]; interleukin-2 receptor activity [GO:0004911]; cytokine-mediated signaling pathway [GO:0019221]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; positive regulation of phagocytosis [GO:0050766]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] GO:0004896; GO:0004911; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0005893; GO:0007165; GO:0009897; GO:0009986; GO:0016020; GO:0019221; GO:0019976; GO:0030101; GO:0035723; GO:0038110; GO:0042010; GO:0043066; GO:0050766; GO:0065003 cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; interleukin-2 binding [GO:0019976]; interleukin-2 receptor activity [GO:0004911] NTGPWLKK 0.9859 -3.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68CR7 LRC66_HUMAN Leucine-rich repeat-containing protein 66 LRRC66 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FPLLKVLILQR 0.9859 -2.4803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7021 13.7824 13.7836 0 11.707 0 0 0 0 0 0 11.3253 15.6358 0 17.1838 0 0 15.4115 0 0 0 0 13.5473 0 0 0 0 0 0 14.2016 0 13.6149 0 0 0 0 0 12.9554 0 0 0 0 11.3394 0 0 13.2665 13.6606 15.3531 0 12.3055 0 0 0 12.454 0 0 0 14.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.866 12.6008 0 0 0 0 0 0 12.0452 0 0 0 0 0 0 0 0 0 0 0 0 12.5113 0 0 0 0 0 0 0 13.4774 0 0 14.2161 0 0 0 0 0 Q7L0R7 RNF44_HUMAN RING finger protein 44 RNF44 KIAA1100 Homo sapiens (Human) protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567] GO:0016567; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LGDAKPRGLTK 0.9859 -3.9134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DU3 SLAF6_HUMAN "SLAM family member 6 (Activating NK receptor) (NK-T-B-antigen, NTB-A) (CD antigen CD352)" SLAMF6 KALI UNQ6123/PRO20080 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; innate immune response [GO:0045087]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540] GO:0005886; GO:0009897; GO:0016021; GO:0032729; GO:0032740; GO:0042110; GO:0045087; GO:0045954; GO:0070062; GO:0072540 AQISTKTSAK 0.9859 -2.0873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6639 0 12.9738 0 0 0 0 0 0 0 0 0 0 15.6769 0 0 13.5777 0 14.9625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8395 14.0235 0 0 0 0 0 0 13.9141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0669 0 0 0 11.6126 15.2684 14.7015 0 0 14.4754 15.4429 13.0173 12.2552 0 0 0 0 0 13.9388 0 14.1166 0 0 Q9H4Y5 GSTO2_HUMAN "Glutathione S-transferase omega-2, GSTO-2, EC 2.5.1.18 (Glutathione S-transferase omega 2-2, GSTO 2-2) (Glutathione-dependent dehydroascorbate reductase, EC 1.8.5.1) (Monomethylarsonic acid reductase, MMA(V) reductase, EC 1.20.4.2)" GSTO2 Homo sapiens (Human) cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; xenobiotic metabolic process [GO:0006805] GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0006805; GO:0016491; GO:0019852; GO:0042802; GO:0045174; GO:0050610; GO:0070062; GO:0071243 glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491] ARQKMLLELFCK 0.9859 -3.3488 0 0 0 0 0 0 0 0 0 9.54257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1213 0 0 0 0 0 0 0 0 0 0 0 0 17.7422 0 0 18.0681 0 17.9799 0 0 13.5047 17.3989 15.0868 14.7083 12.3321 0 0 0 0 0 13.5659 0 0 15.6669 16.7979 15.477 0 0 0 14.2355 0 13.0924 17.1198 0 14.5707 14.8653 15.4703 13.3904 0 0 16.1021 14.5476 0 0 0 15.4408 0 0 13.5023 12.0562 0 0 14.4902 0 0 0 0 0 0 0 14.8038 0 0 0 0 0 0 0 15.1136 0 16.1381 0 0 0 14.8557 17.0056 12.1401 0 0 0 0 0 0 0 11.8111 0 0 12.2925 0 0 12.7174 11.279 0 14.6721 0 0 0 0 13.4424 0 P51511 MMP15_HUMAN "Matrix metalloproteinase-15, MMP-15, EC 3.4.24.- (Membrane-type matrix metalloproteinase 2, MT-MMP 2, MTMMP2) (Membrane-type-2 matrix metalloproteinase, MT2-MMP, MT2MMP) (SMCP-2)" MMP15 Homo sapiens (Human) collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein modification process [GO:0036211]; proteolysis [GO:0006508]; response to estradiol [GO:0032355] extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein modification process [GO:0036211]; proteolysis [GO:0006508]; response to estradiol [GO:0032355] GO:0004222; GO:0005886; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0032355; GO:0035987; GO:0036211; GO:0070006 enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] CGVPDQFGVRVK 0.98591 -3.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2133 0 0 0 0 0 0 0 10.8446 0 0 0 0 0 0 0 0 0 0 0 14.0698 0 13.1477 0 0 0 0 0 14.0059 0 0 0 12.9824 0 0 10.9981 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14032 BAAT_HUMAN "Bile acid-CoA:amino acid N-acyltransferase, BACAT, BAT, EC 2.3.1.65 (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase, EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase, EC 3.1.2.2)" BAAT Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; acyltransferase activity [GO:0016746]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530] GO:0001889; GO:0002152; GO:0005777; GO:0005782; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016290; GO:0016410; GO:0016746; GO:0019530; GO:0031100; GO:0033882; GO:0047617; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817; GO:0102991 acyl-CoA hydrolase activity [GO:0047617]; acyltransferase activity [GO:0016746]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain acyl-CoA hydrolase activity [GO:0052816]; medium-chain acyl-CoA hydrolase activity [GO:0052815]; myristoyl-CoA hydrolase activity [GO:0102991]; N-acyltransferase activity [GO:0016410]; palmitoyl-CoA hydrolase activity [GO:0016290]; very long chain acyl-CoA hydrolase activity [GO:0052817] AHAEQAIGQLKRHGK 0.98591 -3.3687 0 0 0 0 12.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9304 0 12.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9612 0 0 0 0 0 0 12.3881 0 0 0 0 0 0 0 0 0 0 12.5968 0 0 0 0 0 0 0 12.0815 0 0 0 0 10.4747 0 0 0 0 0 0 0 0 0 0 0 13.9763 0 0 13.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5771 0 0 0 0 11.489 0 0 12.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 Q717R9 CYS1_HUMAN Cystin-1 (Cilia-associated protein) CYS1 Homo sapiens (Human) ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] GO:0005829; GO:0005856; GO:0005929; GO:0060170 MGSGSSR 0.98591 -3.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.413 0 0 0 0 11.0394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8978 Q8IUD6 RN135_HUMAN "E3 ubiquitin-protein ligase RNF135, EC 2.3.2.27 (RIG-I E3 ubiquitin ligase, REUL) (RING finger protein 135) (RING finger protein leading to RIG-I activation, Riplet) (RING-type E3 ubiquitin transferase RNF135)" RNF135 L13 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; free ubiquitin chain polymerization [GO:0010994]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; protein homooligomerization [GO:0051260]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; RIG-I signaling pathway [GO:0039529] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RIG-I binding [GO:0039552]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; antiviral innate immune response [GO:0140374]; free ubiquitin chain polymerization [GO:0010994]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; protein homooligomerization [GO:0051260]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; RIG-I signaling pathway [GO:0039529] GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0010494; GO:0010994; GO:0016567; GO:0032728; GO:0039529; GO:0039552; GO:0042802; GO:0043021; GO:0045087; GO:0045088; GO:0046872; GO:0051260; GO:0061630; GO:0070534; GO:0140374; GO:1990904 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RIG-I binding [GO:0039552]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] TMDSCCVEWK 0.98591 -1.5672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE63 HIPK4_HUMAN "Homeodomain-interacting protein kinase 4, EC 2.7.11.1" HIPK4 Homo sapiens (Human) histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of signal transduction by p53 class mediator [GO:1901796] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; histone phosphorylation [GO:0016572]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of signal transduction by p53 class mediator [GO:1901796] GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0016572; GO:0018105; GO:0018107; GO:0046777; GO:0106310; GO:1901796 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] AQGLPPR 0.98591 -2.577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7083 0 0 14.7164 14.5472 13.518 12.8531 0 0 0 0 0 0 0 0 14.7242 0 0 14.132 0 0 0 0 0 0 13.6834 0 0 0 0 0 0 12.8677 14.0764 0 0 0 0 0 0 0 0 0 0 14.318 14.3028 0 0 14.1631 14.0784 12.8352 0 13.3085 0 0 0 0 0 14.8109 0 0 0 0 0 0 0 0 0 0 0 0 12.4237 0 0 0 0 0 0 0 0 12.3227 0 0 0 0 0 0 15.7245 0 0 0 0 0 13.1311 0 0 0 0 0 0 Q9UBF8 PI4KB_HUMAN "Phosphatidylinositol 4-kinase beta, PI4K-beta, PI4Kbeta, PtdIns 4-kinase beta, EC 2.7.1.67 (NPIK) (PI4K92) (PI4KIII)" PI4KB PIK4CB Homo sapiens (Human) lysosome organization [GO:0007040]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum membrane [GO:0030867] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum membrane [GO:0030867]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742]; lysosome organization [GO:0007040]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165] GO:0000139; GO:0004430; GO:0005524; GO:0005737; GO:0005741; GO:0005768; GO:0005794; GO:0005829; GO:0006661; GO:0006898; GO:0007040; GO:0007165; GO:0016020; GO:0016310; GO:0030867; GO:0046854; GO:0048015; GO:0048471; GO:0052742; GO:0071889 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; phosphatidylinositol kinase activity [GO:0052742] CLDDPPAQIREEEDEMGAAVASGTAK 0.98591 -3.9175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.105 13.7704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.905 11.7566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3074 0 0 0 0 0 O43572 AKA10_HUMAN "A-kinase anchor protein 10, mitochondrial, AKAP-10 (Dual specificity A kinase-anchoring protein 2, D-AKAP-2) (Protein kinase A-anchoring protein 10, PRKA10)" AKAP10 Homo sapiens (Human) protein localization [GO:0008104]; signal transduction [GO:0007165] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein kinase A binding [GO:0051018]; protein localization [GO:0008104]; signal transduction [GO:0007165] GO:0005739; GO:0005829; GO:0005886; GO:0007165; GO:0008104; GO:0032991; GO:0051018 protein kinase A binding [GO:0051018] GAGPSPR 0.98592 -3.7381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1697 0 12.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.901 0 0 0 0 0 0 O95707 RPP29_HUMAN "Ribonuclease P protein subunit p29, hPOP4" POP4 RPP29 Homo sapiens (Human) rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682] multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P complex [GO:0030677] multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P complex [GO:0030677]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682] GO:0000172; GO:0001682; GO:0004526; GO:0005654; GO:0005730; GO:0006364; GO:0030677; GO:0030681; GO:0033204 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204] ADLHGAIISVTKSK 0.98592 -3.7348 0 0 0 0 0 0 10.5303 0 12.1416 12.1388 0 11.8761 0 0 12.3252 0 0 0 0 0 0 0 0 0 0 12.6161 0 0 0 0 0 12.5662 0 11.0205 0 0 12.833 12.7036 12.2594 12.304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2701 0 0 0 0 14.4085 0 0 0 0 14.8313 0 14.3075 12.6488 0 0 0 0 0 0 0 0 0 P48735 IDHP_HUMAN "Isocitrate dehydrogenase [NADP], mitochondrial, IDH, EC 1.1.1.42 (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)" IDH2 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; carbohydrate metabolic process [GO:0005975]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099] GO:0000287; GO:0004450; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0005975; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287; GO:0070062 isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287] EKLILPHVDIQLKYFDLGLPNR 0.98592 -3.4696 11.1783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0233 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1861 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4359 0 0 0 0 10.8032 0 0 0 0 0 11.7333 0 12.8762 0 0 0 13.0874 0 0 13.0292 0 0 0 11.552 0 0 0 0 13.0715 13.4124 0 0 0 13.1723 0 0 0 0 0 12.9862 0 0 14.4307 13.748 12.7553 12.3364 0 0 0 14.8324 12.4977 0 0 0 11.8907 0 0 0 0 0 0 0 0 0 12.53 0 13.0624 0 0 0 11.8774 0 0 0 0 0 0 0 0 13.4625 0 13.9435 0 0 0 0 0 14.0078 0 0 0 0 0 0 0 0 0 0 0 13.122 0 0 0 0 0 0 P52756 RBM5_HUMAN RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9) RBM5 H37 LUCA15 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0006396; GO:0006915; GO:0008285; GO:0043065; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] DDRDERESR 0.98592 -3.833 0 10.9671 0 0 0 0 0 0 11.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9239 0 12.6808 15.2314 0 0 0 0 0 0 0 12.5483 0 0 0 0 12.3637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7384 12.8195 0 0 12.9537 0 0 0 0 0 0 12.1411 0 0 0 12.8841 0 0 0 0 0 0 0 0 0 0 0 13.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.243 0 0 11.9122 0 12.9258 0 0 0 0 0 0 0 0 0 0 0 0 13.2108 0 12.3093 0 Q02338 BDH_HUMAN "D-beta-hydroxybutyrate dehydrogenase, mitochondrial, EC 1.1.1.30 (3-hydroxybutyrate dehydrogenase, BDH) (Short chain dehydrogenase/reductase family 9C member 1)" BDH1 BDH SDR9C1 Homo sapiens (Human) steroid metabolic process [GO:0008202] intracellular membrane-bounded organelle [GO:0043231]; matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] intracellular membrane-bounded organelle [GO:0043231]; matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; steroid metabolic process [GO:0008202] GO:0003858; GO:0005739; GO:0005759; GO:0008202; GO:0016229; GO:0016491; GO:0043231; GO:0099617 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229] LATRLSRPLSR 0.98592 -2.4944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8517 0 0 0 13.6066 13.7351 13.2955 0 0 0 0 13.8314 14.0001 0 0 0 0 0 0 0 0 18.8126 0 0 0 0 0 0 0 0 0 0 0 13.2109 14.1358 13.8458 0 0 0 0 0 16.5905 0 0 0 0 0 0 0 0 0 0 0 13.5887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14526 HIC1_HUMAN "Hypermethylated in cancer 1 protein, Hic-1 (Zinc finger and BTB domain-containing protein 29)" HIC1 ZBTB29 Homo sapiens (Human) "intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008630; GO:0016055; GO:0030178; GO:0042826; GO:0043517; GO:0043565; GO:0046872; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AAEVLSQGAHLAAGPDGRTIDRFSPT 0.98592 -2.8681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7824 0 13.0835 13.7911 0 14.843 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8582 0 14.4904 0 0 0 0 0 0 0 0 0 0 0 11.1667 0 0 0 0 0 0 0 0 0 13.1484 0 0 0 0 13.3485 0 14.0956 0 0 0 0 0 13.7905 0 11.4924 14.0886 13.1853 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9283 0 0 0 0 0 0 11.0938 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6403 0 10.726 0 0 0 0 0 Q15208 STK38_HUMAN "Serine/threonine-protein kinase 38, EC 2.7.11.1 (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1)" STK38 NDR1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-serine phosphorylation [GO:0018105]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468] GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0018105; GO:0031435; GO:0035556; GO:0036211; GO:0043407; GO:0045296; GO:0106310 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DIKPDNLLLDSKGHVK 0.98592 -3.65 0 0 0 0 0 0 0 0 0 14.5186 14.0264 14.1932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0244 0 0 0 0 13.5875 14.1527 0 0 0 0 0 14.4143 14.3851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2582 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3224 14.3859 14.1833 0 0 0 14.1659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3168 0 0 14.2043 0 0 0 0 0 0 0 0 0 0 0 0 14.4166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.488 0 0 0 0 14.2306 0 0 0 0 12.5915 Q92800 EZH1_HUMAN "Histone-lysine N-methyltransferase EZH1, EC 2.1.1.356 (ENX-2) (Enhancer of zeste homolog 1)" EZH1 KIAA0388 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 trimethylation [GO:0098532]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; subtelomeric heterochromatin assembly [GO:0031509] "chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; transcription corepressor activity [GO:0003714]; anatomical structure morphogenesis [GO:0009653]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; hippocampus development [GO:0021766]; histone H3-K27 trimethylation [GO:0098532]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; subtelomeric heterochromatin assembly [GO:0031509]" GO:0000122; GO:0000781; GO:0000792; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006338; GO:0009653; GO:0021766; GO:0031507; GO:0031509; GO:0035098; GO:0045944; GO:0046976; GO:0098532 chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; transcription corepressor activity [GO:0003714] CFKYDCFLHPFHATPNVYK 0.98592 -2.098 0 0 0 0 0 0 0 0 0 0 0 11.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2198 0 0 0 0 0 11.3858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3958 0 0 0 0 0 0 0 0 0 0 0 0 12.5228 0 0 0 15.5683 14.9113 0 0 0 0 0 0 0 13.5335 0 0 0 0 0 0 14.3211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3258 0 0 0 14.7197 13.7597 13.6919 12.7642 0 11.2492 11.1539 0 13.819 0 13.7568 13.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5695 0 0 0 0 0 0 0 13.4539 0 12.5514 0 0 0 0 0 Q969P5 FBX32_HUMAN "F-box only protein 32 (Atrogin-1) (Muscle atrophy F-box protein, MAFbx)" FBXO32 Homo sapiens (Human) cellular response to dexamethasone stimulus [GO:0071549]; protein ubiquitination [GO:0016567]; response to denervation involved in regulation of muscle adaptation [GO:0014894] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018]; cellular response to dexamethasone stimulus [GO:0071549]; protein ubiquitination [GO:0016567]; response to denervation involved in regulation of muscle adaptation [GO:0014894] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0014894; GO:0016567; GO:0019005; GO:0030018; GO:0071549 FNYVVRLLELIAK 0.98592 -2.8669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9439 0 10.3061 14.254 13.5672 0 0 0 0 0 0 0 0 0 0 12.3348 0 12.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.796 0 13.3704 13.6656 0 0 0 0 0 0 12.6907 0 0 13.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4658 0 0 0 0 0 0 0 Q96B86 RGMA_HUMAN Repulsive guidance molecule A (RGM domain family member A) RGMA RGM Homo sapiens (Human) BMP signaling pathway [GO:0030509]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of axon regeneration [GO:0048681]; negative regulation of receptor binding [GO:1900121]; neural tube closure [GO:0001843]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; coreceptor activity [GO:0015026]; transferrin receptor binding [GO:1990459]; BMP signaling pathway [GO:0030509]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of axon regeneration [GO:0048681]; negative regulation of receptor binding [GO:1900121]; neural tube closure [GO:0001843]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510] GO:0001843; GO:0005783; GO:0005886; GO:0006509; GO:0009986; GO:0015026; GO:0030509; GO:0030510; GO:0031175; GO:0031225; GO:0043547; GO:0045944; GO:0048681; GO:0051044; GO:1900121; GO:1990459 coreceptor activity [GO:0015026]; transferrin receptor binding [GO:1990459] CNSEFWSATSGSHAPASDDTPEFCAALR 0.98592 -3.7402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4462 0 0 0 10.8445 0 0 0 11.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5633 0 0 0 0 0 0 0 0 0 0 0 11.5706 0 0 13.7762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7505 0 0 0 0 0 0 0 12.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3404 0 0 11.6948 0 0 0 0 0 0 0 11.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9049 13.6043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1093 12.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CK0 ZN653_HUMAN Zinc finger protein 653 (67 kDa zinc finger protein) (Zinc finger protein Zip67) ZNF653 ZIP67 Homo sapiens (Human) extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular region [GO:0005576]; nucleus [GO:0005634] extracellular region [GO:0005576]; nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of nucleic acid-templated transcription [GO:1903507]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0003712; GO:0003714; GO:0005576; GO:0005634; GO:0006357; GO:0046872; GO:0050682; GO:0140297; GO:1900116; GO:1903507 AF-2 domain binding [GO:0050682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] RFEKLDSVK 0.98592 -1.5688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1599 0 0 13.8577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5057 12.3463 0 0 0 12.623 0 0 0 0 0 0 0 0 0 0 0 0 14.6034 0 0 0 0 0 0 0 12.8131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99619 SPSB2_HUMAN "SPRY domain-containing SOCS box protein 2, SSB-2 (Gene-rich cluster protein C9)" SPSB2 GRCC9 SSB2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; intracellular signal transduction [GO:0035556]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0035556; GO:0043161; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] DCSENIEVK 0.98592 -1.572 0 0 0 0 0 0 0 0 0 0 11.3841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7715 0 0 0 0 0 0 0 13.2777 0 13.3425 13.3726 0 0 0 0 0 12.357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2044 0 0 0 0 0 0 Q9NXC5 MIO_HUMAN GATOR complex protein MIOS (Missing oocyte meiosis regulator homolog) MIOS Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein-containing complex localization [GO:0031503] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein-containing complex localization [GO:0031503] GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0030054; GO:0031503; GO:0032008; GO:0034198; GO:0061700; GO:1904262; GO:1904263 ADFSVLIWDICSKYTPDIVPMEKVK 0.98592 -3.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9512 0 0 0 0 0 0 11.2864 0 0 0 0 0 0 0 0 0 11.1111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZP5 O5AC2_HUMAN Olfactory receptor 5AC2 (HSA1) OR5AC2 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] KVMHALR 0.98592 -3.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3A4 RRP7A_HUMAN Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14) RRP7A CGI-96 Homo sapiens (Human) blastocyst formation [GO:0001825]; cilium disassembly [GO:0061523]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit assembly [GO:0000028]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364] centrosome [GO:0005813]; cilium [GO:0005929]; CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456] centrosome [GO:0005813]; cilium [GO:0005929]; CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; cilium disassembly [GO:0061523]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit assembly [GO:0000028]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364] GO:0000028; GO:0001825; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005929; GO:0006364; GO:0032545; GO:0034456; GO:0042254; GO:0061523; GO:1902570 RNA binding [GO:0003723] IPSPLGYAAIPIK 0.98592 -2.8662 0 0 0 11.3431 11.0447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2095 0 0 0 11.6131 11.5907 0 0 11.6238 0 0 0 0 0 0 0 0 0 0 0 11.139 0 0 0 0 11.3154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.009 0 0 10.9923 0 0 15.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4327 0 0 15.5263 0 0 0 0 0 11.7108 0 11.9712 0 14.8797 11.8323 0 0 0 14.6341 14.4021 0 0 0 0 0 15.6059 0 0 0 12.0882 0 0 13.4232 0 0 0 0 0 0 0 0 12.4776 0 0 0 0 0 11.9566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.238 0 11.6279 0 0 0 0 0 13.4131 0 0 0 0 0 0 0 Q9Y5E2 PCDB7_HUMAN "Protocadherin beta-7, PCDH-beta-7" PCDHB7 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DSGNNGK 0.98592 -3.3694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3359 0 12.3421 0 0 0 12.4872 0 12.4279 0 0 0 0 12.0282 0 0 12.0642 0 0 0 0 11.4852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0253 13.8171 12.9636 0 0 0 0 0 12.8724 13.1812 11.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4125 Q9Y6K9 NEMO_HUMAN "NF-kappa-B essential modulator, NEMO (FIP-3) (IkB kinase-associated protein 1, IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma, I-kappa-B kinase subunit gamma, IKK-gamma, IKKG, IkB kinase subunit gamma) (NF-kappa-B essential modifier)" IKBKG FIP3 NEMO Homo sapiens (Human) anoikis [GO:0043276]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; establishment of vesicle localization [GO:0051650]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of neuron death [GO:1901215]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to virus [GO:0009615]; T cell receptor signaling pathway [GO:0050852] cytoplasm [GO:0005737]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; ubiquitin protein ligase binding [GO:0031625]; anoikis [GO:0043276]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; establishment of vesicle localization [GO:0051650]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of neuron death [GO:1901215]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; response to virus [GO:0009615]; T cell receptor signaling pathway [GO:0050852] GO:0000151; GO:0000922; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006954; GO:0006955; GO:0006974; GO:0007249; GO:0008385; GO:0009615; GO:0016239; GO:0019904; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043122; GO:0043123; GO:0043276; GO:0045087; GO:0045944; GO:0046872; GO:0046982; GO:0050852; GO:0050862; GO:0051092; GO:0051650; GO:0065003; GO:0070530; GO:0072686; GO:1901215; GO:1990450; GO:1990459 identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; ubiquitin protein ligase binding [GO:0031625] CQYQAPDMDTLQIHVMECIE 0.98592 -3.8288 0 0 0 0 0 0 0 0 0 0 0 10.7277 12.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.99166 0 0 0 0 0 0 0 0 0 13.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6021 0 0 0 11.4647 0 12.8778 12.5007 13.0094 14.0764 0 14.1337 0 0 0 14.5426 16.9898 0 0 0 0 0 0 0 0 0 16.3765 0 0 11.6539 0 13.7139 0 0 0 0 12.3403 0 0 0 0 0 15.7635 0 0 11.6749 0 0 0 0 12.8023 0 0 10.7001 0 12.7624 0 0 0 0 0 0 0 0 0 11.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4864 0 0 0 0 0 0 0 0 0 0 0 A8MTL9 HMSD_HUMAN Serpin-like protein HMSD (Minor histocompatibility protein HMSD) (Minor histocompatibility serpin domain-containing protein) HMSD Homo sapiens (Human) activation of immune response [GO:0002253] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; activation of immune response [GO:0002253] GO:0002253; GO:0004867; GO:0005615 serine-type endopeptidase inhibitor activity [GO:0004867] GFQSLLVAINR 0.98593 -1.5832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5926 0 0 10.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5019 0 0 0 0 0 0 0 0 0 0 0 0 O15397 IPO8_HUMAN "Importin-8, Imp8 (Ran-binding protein 8, RanBP8)" IPO8 RANBP8 Homo sapiens (Human) protein import into nucleus [GO:0006606]; signal transduction [GO:0007165] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606]; signal transduction [GO:0007165] GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0007165; GO:0031267 small GTPase binding [GO:0031267] DEDEELWQEDPYEYIR 0.98593 -3.6561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0377 0 0 0 0 0 0 0 0 12.4261 0 0 0 0 0 0 0 0 0 0 0 0 11.0365 0 0 0 0 12.0296 0 0 0 0 0 0 0 10.6597 0 0 0 0 0 0 0 0 0 0 0 0 0 14.981 13.8987 14.5377 14.1 13.9858 14.0104 0 0 0 0 10.9055 12.6004 0 12.7579 12.7912 0 0 0 0 14.1861 0 0 0 0 0 0 0 14.6008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4406 12.3252 0 0 0 14.8718 10.4363 0 0 0 0 0 15.3739 0 0 0 0 14.9683 0 0 0 0 0 0 14.8335 0 0 0 0 0 0 0 0 0 0 11.5071 0 0 0 13.5287 0 0 10.7611 0 0 0 0 13.1758 0 0 0 Q02543 RL18A_HUMAN 60S ribosomal protein L18a (Large ribosomal subunit protein eL20) RPL18A Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] IKFPLPHR 0.98593 -3.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07021 C1QBP_HUMAN "Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP, C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33, SF2AP32)" C1QBP GC1QBP HABP1 SF2P32 Homo sapiens (Human) "apoptotic process [GO:0006915]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; adrenergic receptor binding [GO:0031690]; complement component C1q complex binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380]" GO:0000122; GO:0001849; GO:0003714; GO:0003729; GO:0005080; GO:0005540; GO:0005615; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006397; GO:0006915; GO:0006955; GO:0006958; GO:0008134; GO:0008380; GO:0009986; GO:0014065; GO:0016020; GO:0030449; GO:0030984; GO:0031690; GO:0032689; GO:0032695; GO:0039534; GO:0039536; GO:0042256; GO:0043065; GO:0045087; GO:0045785; GO:0048025; GO:0048786; GO:0050687; GO:0051897; GO:0070131; GO:0090023; GO:0097177; GO:0098978; GO:0098982; GO:1900026; GO:1901165; GO:2000510 adrenergic receptor binding [GO:0031690]; complement component C1q complex binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] GPCACGCGCGSLHTDGDK 0.98593 -3.4766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6538 0 0 0 0 0 0 0 0 0 0 0 0 0 15.436 0 15.2668 0 0 0 0 0 0 0 0 0 0 0 0 9.97298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5129 0 0 0 0 0 0 0 0 0 0 0 13.4676 12.8441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.216 0 0 0 0 0 0 Q5QGT7 RTP2_HUMAN Receptor-transporting protein 2 (3CxxC-type zinc finger protein 2) RTP2 Z3CXXC2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; olfactory receptor binding [GO:0031849]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] GO:0001580; GO:0005886; GO:0006612; GO:0009986; GO:0016021; GO:0031849; GO:0051205 olfactory receptor binding [GO:0031849] EQCYEEDGGQYR 0.98593 -3.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y694 S22A7_HUMAN "Solute carrier family 22 member 7 (Novel liver transporter) (Organic anion transporter 2, hOAT2)" SLC22A7 NLT OAT2 Homo sapiens (Human) organic anion transport [GO:0015711]; xenobiotic metabolic process [GO:0006805] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; organic anion transport [GO:0015711]; xenobiotic metabolic process [GO:0006805] GO:0005886; GO:0005887; GO:0006805; GO:0015301; GO:0015347; GO:0015711; GO:0016020; GO:0016323 anion:anion antiporter activity [GO:0015301]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] LLVYLSVR 0.98593 -3.7476 0 0 0 0 0 0 0 0 0 0 0 0 10.6699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1946 0 12.5659 0 0 0 11.6477 0 13.6769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.789 11.1613 0 0 0 0 0 0 0 0 0 0 0 11.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7682 0 0 0 0 0 11.9111 G2XKQ0 SUMO5_HUMAN "Small ubiquitin-related modifier 5, SUMO-5 (SUMO1 pseudogene 1) (Ubiquitin-like 2) (Ubiquitin-like 6)" SUMO1P1 SUMO5 UBL2 UBL6 Homo sapiens (Human) PML body organization [GO:0030578]; protein sumoylation [GO:0016925] nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein tag [GO:0031386]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]; PML body organization [GO:0030578]; protein sumoylation [GO:0016925] GO:0005634; GO:0008134; GO:0016925; GO:0030578; GO:0031386; GO:0042802; GO:0044389 identical protein binding [GO:0042802]; protein tag [GO:0031386]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389] VKMTTPLK 0.98594 -2.4457 0 0 0 0 0 12.7368 0 0 0 0 0 0 0 0 0 13.1113 12.8752 0 14.1215 13.4242 12.7468 0 0 0 13.1475 0 13.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7827 0 0 0 0 0 0 0 0 0 0 13.0764 13.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4959 0 0 0 0 0 14.0566 0 0 0 0 0 0 0 0 14.6901 0 0 15.7846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.671 14.7083 0 0 0 0 0 0 0 14.5446 0 0 0 0 14.5387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3172 0 0 0 0 0 14.3523 0 14.4193 14.5169 0 0 0 0 0 Q6UX52 IL40_HUMAN "Protein IL-40 (Interleukin-40, IL-40)" C17orf99 IL40 UNQ464/PRO809 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; mature B cell differentiation involved in immune response [GO:0002313]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; regulation of immune response [GO:0050776] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; cytokine activity [GO:0005125]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; mature B cell differentiation involved in immune response [GO:0002313]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; regulation of immune response [GO:0050776] GO:0002250; GO:0002313; GO:0004888; GO:0005125; GO:0005615; GO:0005887; GO:0007166; GO:0050776; GO:2000558 cytokine activity [GO:0005125]; transmembrane signaling receptor activity [GO:0004888] AREEEITPVVSIAYKVLEVFPK 0.98594 -3.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XZ4 SPAS2_HUMAN Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr) SPATS2 SCR59 SPATA10 Nbla00526 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723] GO:0003723; GO:0005737; GO:0005829 RNA binding [GO:0003723] RGGQGYR 0.98594 -3.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0429 0 0 0 0 0 13.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1419 0 0 14.3863 0 14.6025 0 0 13.1016 0 0 0 12.9686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8506 0 Q8IVF7 FMNL3_HUMAN "Formin-like protein 3 (Formin homology 2 domain-containing protein 3) (WW domain-binding protein 3, WBP-3)" FMNL3 FHOD3 FRL2 KIAA2014 WBP3 Homo sapiens (Human) angiogenesis [GO:0001525]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360] GO:0001525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0008360; GO:0016477; GO:0030866; GO:0031267; GO:0032794; GO:0043231; GO:0051015 actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267] ALKNSRLVSQK 0.98594 -3.6693 0 0 0 0 0 0 0 0 0 13.9619 0 0 15.458 0 10.3907 0 13.4065 0 0 13.4457 11.9787 12.976 13.5732 0 14.103 14.1971 10.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1748 0 0 17.7684 0 14.6063 0 0 17.8794 15.965 17.9441 16.3218 17.9725 15.611 15.9028 14.9252 0 0 0 0 13.6709 15.1528 13.7983 15.0089 15.8312 14.6502 14.8264 15.3272 15.5908 14.2322 13.9639 13.6974 0 11.1799 15.2192 15.0202 0 0 14.7373 13.9927 16.6022 14.8913 15.2258 16.4282 15.6929 0 14.7544 14.9122 14.9714 17.3216 17.3981 16.8184 15.4114 15.8042 15.8375 15.6742 15.4666 15.2715 14.9774 14.3787 14.2313 0 15.5429 15.8043 15.5001 14.1732 15.0417 14.0241 14.6865 14.482 17.187 14.6239 16.3151 13.6014 14.4021 15.5734 15.0219 14.0314 15.7198 15.21 14.2803 0 0 0 11.4681 15.9807 13.2998 14.7245 14.7102 13.1229 14.4997 0 0 0 14.094 0 0 0 0 0 0 0 10.8653 0 0 14.2257 15.4057 0 14.2997 0 0 0 11.4687 0 Q8N8E2 ZN513_HUMAN Zinc finger protein 513 ZNF513 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] GO:0000976; GO:0003677; GO:0005634; GO:0007601; GO:0010468; GO:0045944; GO:0046872; GO:0050896; GO:0060041 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976] AVHTDSS 0.98594 -3.5798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.726 12.4235 0 0 12.1543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5082 0 0 0 0 0 0 0 0 0 0 11.0891 0 0 0 0 0 0 0 0 0 12.2574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42681 TXK_HUMAN "Tyrosine-protein kinase TXK, EC 2.7.10.2 (Protein-tyrosine kinase 4) (Resting lymphocyte kinase)" TXK PTK4 RLK Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246] GO:0001819; GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0007202; GO:0007229; GO:0010468; GO:0010543; GO:0032729; GO:0042246; GO:0045944; GO:0046777; GO:0050852; GO:0060335 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] KPLPPLPPSEVAEEK 0.98595 -3.5846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7262 0 19.724 13.0248 0 0 0 0 11.8917 0 11.5541 0 11.9901 0 0 0 10.7782 12.055 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1452 0 12.3121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1302 0 0 0 12.5146 0 0 0 0 0 0 11.7095 0 0 0 0 0 0 10.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02763 TIE2_HUMAN "Angiopoietin-1 receptor, EC 2.7.10.1 (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2, hTIE2) (p140 TEK) (CD antigen CD202b)" TEK TIE2 VMCM VMCM1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001525; GO:0001934; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] CSCNNGEMCDR 0.98595 -2.4523 0 0 0 0 0 0 0 0 12.9657 14.5318 12.6005 13.9607 12.6382 14.0823 13.9679 15.0532 13.8888 15.9801 15.0397 15.5921 14.2055 0 15.2465 0 15.7033 14.3202 15.2886 15.7391 12.8626 14.7338 0 12.7439 0 12.7463 11.5646 13.0022 0 0 0 0 12.7724 15.0475 12.9807 12.8484 15.3699 16.316 13.629 0 16.8858 0 14.4594 12.8731 16.8364 0 0 12.1805 0 16.3024 0 0 0 0 13.9633 0 0 0 0 0 12.9673 0 0 0 11.5542 0 0 0 0 0 0 0 12.1196 12.6369 0 0 0 0 0 0 19.3567 19.0835 19.9222 0 19.1888 15.5615 0 19.2092 0 13.7777 0 13.2321 13.8743 0 14.7068 0 15.7147 0 14.9128 0 0 0 0 16.3789 0 14.8505 12.8011 19.3486 12.9147 15.2743 16.4026 0 15.2576 0 0 12.5922 11.7498 0 0 0 13.5511 13.2248 13.9587 13.5814 12.0968 0 13.4926 0 0 10.601 0 0 0 0 0 12.8866 0 0 12.3816 15.7921 0 0 10.8944 0 12.8826 15.637 14.9475 19.3386 15.0442 0 14.5002 0 11.3735 0 14.6462 14.8338 0 14.1984 0 14.9416 14.4995 14.392 14.4747 11.462 0 0 15.7271 0 0 0 14.4532 0 Q86XQ3 CTSR3_HUMAN "Cation channel sperm-associated protein 3, CatSper3 (Ca(v)-like protein) (One-repeat calcium channel-like protein)" CATSPER3 Homo sapiens (Human) establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; voltage-gated calcium channel activity [GO:0005245]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240] GO:0001669; GO:0005245; GO:0005783; GO:0005886; GO:0006814; GO:0030317; GO:0031514; GO:0034765; GO:0036128; GO:0048240; GO:0051649 voltage-gated calcium channel activity [GO:0005245] ELMLEQQEMLMGEKQVILQR 0.98595 -2.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0128 0 0 13.3075 0 0 0 0 0 0 0 0 14.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3869 0 0 0 0 14.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5162 0 15.0569 0 0 0 0 0 0 0 Q8NGT2 O13J1_HUMAN Olfactory receptor 13J1 (Olfactory receptor OR9-2) OR13J1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LPFCGHHVVSHFTCKILAVLK 0.98595 -2.0403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2267 0 0 0 10.0455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AZ1 EFMT3_HUMAN "EEF1A lysine methyltransferase 3, EC 2.1.1.- (Hepatocellular carcinoma-associated antigen 557a) (Methyltransferase-like protein 21B) (Protein-lysine methyltransferase METTL21B) (eEF1A-KMT3)" EEF1AKMT3 FAM119B HCA557A METTL21B Homo sapiens (Human) peptidyl-lysine methylation [GO:0018022] centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022] GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005829; GO:0008168; GO:0016279; GO:0018022; GO:0031072; GO:0032991 heat shock protein binding [GO:0031072]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279] ARHREPR 0.98595 -1.5943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1672 12.7913 0 0 11.6026 13.1014 13.4785 0 13.6248 0 0 0 13.8474 12.8167 0 12.8893 0 0 0 0 0 0 0 0 0 0 0 0 13.6071 13.0096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4842 10.5188 0 0 0 0 0 0 12.5279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3577 11.3782 0 0 0 0 0 14.9321 14.6626 15.3319 0 0 0 0 0 12.004 0 0 13.6553 0 0 0 0 0 0 0 0 12.3699 0 0 0 12.6153 0 12.6298 0 0 0 0 0 0 13.1724 0 0 0 0 0 0 0 0 0 0 0 12.2779 0 0 0 0 0 0 0 0 0 0 0 0 11.879 0 0 0 13.8302 0 0 0 13.8256 0 0 0 0 0 0 0 0 0 0 0 Q96CV9 OPTN_HUMAN "Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7, HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein, TFIIIA-IntP)" OPTN FIP2 GLC1E HIP7 HYPL NRP Homo sapiens (Human) autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to unfolded protein [GO:0034620]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of receptor recycling [GO:0001920]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy [GO:0010508]; positive regulation of xenophagy [GO:1904417]; protein localization to Golgi apparatus [GO:0034067]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein C-terminus binding [GO:0008022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; autophagy [GO:0006914]; cell death [GO:0008219]; cellular response to unfolded protein [GO:0034620]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of receptor recycling [GO:0001920]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy [GO:0010508]; positive regulation of xenophagy [GO:1904417]; protein localization to Golgi apparatus [GO:0034067]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165] GO:0000139; GO:0001920; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005794; GO:0005802; GO:0005829; GO:0006914; GO:0007030; GO:0007165; GO:0008022; GO:0008219; GO:0010508; GO:0030674; GO:0031267; GO:0031593; GO:0034067; GO:0034620; GO:0042802; GO:0043001; GO:0043122; GO:0043124; GO:0045087; GO:0046872; GO:0048471; GO:0050829; GO:0055038; GO:0061734; GO:0070530; GO:0090161; GO:1904417 identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein C-terminus binding [GO:0008022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] AQMEVYCSDFHAER 0.98595 -2.0408 0 10.2509 0 0 0 0 0 0 0 0 12.9908 0 12.3687 0 0 0 10.8191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9993 0 0 0 0 0 0 0 0 12.8445 13.7875 14.0069 0 0 0 0 0 12.9879 0 13.8393 13.2214 13.5179 0 0 0 0 0 0 0 15.0834 0 0 0 0 0 0 0 11.3203 0 0 0 10.6501 0 0 0 0 0 0 0 0 0 0 0 12.1477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3414 12.5448 0 15.0028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2826 0 0 0 0 Q99928 GBRG3_HUMAN Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) GABRG3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0009410; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0070161; GO:0098794; GO:0098982; GO:0099699; GO:1902476; GO:1902711; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] APKLLLLLCLFSGLHAR 0.98595 -2.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.424 0 0 0 0 0 0 0 11.8537 0 12.1165 0 0 0 0 0 0 0 0 10.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8954 0 13.3957 0 0 0 0 0 0 0 13.5173 10.1901 0 17.2644 0 13.9705 0 0 0 14.1565 13.7253 0 0 0 0 0 0 12.8557 0 14.0963 0 0 0 0 0 0 0 0 0 0 12.3171 0 0 0 0 0 0 0 0 0 13.1166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1945 12.7073 0 0 12.5257 0 0 0 0 10.6524 0 0 0 0 0 0 0 0 0 0 0 12.9311 0 11.588 0 12.5483 0 0 0 0 0 0 13.0274 0 0 0 Q9UN70 PCDGK_HUMAN "Protocadherin gamma-C3, PCDH-gamma-C3 (Protocadherin-2) (Protocadherin-43, PC-43)" PCDHGC3 PCDH2 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; synapse organization [GO:0050808] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; synapse organization [GO:0050808] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0016020; GO:0016339; GO:0043524; GO:0050808 calcium ion binding [GO:0005509] EQKKNLTFYLLLSLILVSVGFVVTVFGVIIFK 0.98595 -2.0352 0 0 0 0 0 0 0 0 12.5873 0 10.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3877 0 0 0 0 0 0 0 0 0 0 10.5326 0 10.0662 0 10.7171 0 0 0 0 0 0 0 10.4042 0 0 0 0 0 0 0 0 10.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7926 13.1156 12.831 0 0 0 0 0 0 12.7613 0 0 0 0 0 0 15.3955 0 0 0 0 0 0 13.6619 12.8424 0 0 0 0 0 0 0 0 0 12.2481 0 0 0 0 0 12.9663 0 0 0 0 0 0 0 0 0 0 0 12.0558 13.2875 0 0 12.2987 14.2037 12.7439 12.7889 0 12.8061 0 0 0 12.1381 12.9624 0 0 0 0 12.5685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2334 0 0 0 0 0 0 0 12.4699 0 0 0 0 0 0 Q13613 MTMR1_HUMAN "Myotubularin-related protein 1 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTMR1 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]" GO:0004438; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0042803; GO:0046856; GO:0052629; GO:0060304 "phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]" DPHFILDVPLGVISR 0.98597 -3.6075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9506 15.1536 0 15.5642 14.9538 0 12.6338 0 14.4817 0 14.445 0 0 0 14.5226 0 0 14.7458 0 0 0 0 0 0 0 0 14.0047 0 0 14.0475 0 13.9605 0 14.0856 0 0 0 0 13.8977 0 0 14.0837 0 0 0 0 0 0 0 0 0 0 0 13.6826 13.0793 0 0 0 13.5069 12.6285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4017 0 0 0 0 0 0 0 0 0 0 0 0 13.0014 0 0 0 0 0 O75251 NDUS7_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial, EC 7.1.1.2 (Complex I-20kD, CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)" NDUFS7 Homo sapiens (Human) "aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; protease binding [GO:0002020]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0002020; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0008137; GO:0009060; GO:0015990; GO:0016655; GO:0032981; GO:0042776; GO:0043005; GO:0043025; GO:0046872; GO:0048038; GO:0051539; GO:0097060 "4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; protease binding [GO:0002020]; quinone binding [GO:0048038]" AVLSAPGLRGFRILGLR 0.98598 -2.0537 0 0 0 0 0 0 0 0 9.58477 0 0 0 0 0 0 0 0 0 0 12.4733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2868 15.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7254 0 0 12.5677 12.8716 0 12.5609 0 0 0 0 0 0 0 11.3319 0 0 12.9135 0 0 0 13.6744 0 13.441 13.4842 0 0 0 0 0 0 0 0 0 0 0 12.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0057 0 0 0 0 0 P35754 GLRX1_HUMAN "Glutaredoxin-1 (Thioltransferase-1, TTase-1)" GLRX GRX Homo sapiens (Human) nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of membrane potential [GO:0045838]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein deglutathionylation [GO:0080058] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione disulfide oxidoreductase activity [GO:0015038]; glutathione oxidoreductase activity [GO:0097573]; glutathione-disulfide reductase (NADPH) activity [GO:0004362]; protein N-terminus binding [GO:0047485]; nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of membrane potential [GO:0045838]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein deglutathionylation [GO:0080058] GO:0004362; GO:0005634; GO:0005739; GO:0005829; GO:0015038; GO:0015949; GO:0045838; GO:0047485; GO:0070062; GO:0080058; GO:0097573; GO:2000651 glutathione disulfide oxidoreductase activity [GO:0015038]; glutathione oxidoreductase activity [GO:0097573]; glutathione-disulfide reductase (NADPH) activity [GO:0004362]; protein N-terminus binding [GO:0047485] IQPGKVVVFIK 0.98598 -2.0529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5775 0 0 0 0 0 P12525 MYCP1_HUMAN Putative myc-like protein MYCLP1 (Protein L-Myc-2) (V-myc myelocytomatosis viral oncogene homolog pseudogene 1) MYCLP1 MYCL1P1 MYCL2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0046983 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]" PVIIAVRADLLDPR 0.98599 -3.9066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6189 0 0 0 0 0 0 0 0 0 12.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VAK6 LMOD3_HUMAN "Leiomodin-3 (Leiomodin, fetal form)" LMOD3 Homo sapiens (Human) actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of skeletal muscle fiber development [GO:0048743]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of skeletal muscle fiber development [GO:0048743]; skeletal muscle fiber development [GO:0048741]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] GO:0003785; GO:0005523; GO:0005737; GO:0005856; GO:0005865; GO:0006936; GO:0006941; GO:0007015; GO:0030016; GO:0030239; GO:0030240; GO:0031430; GO:0045010; GO:0048741; GO:0048743; GO:0051694 actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523] DVIKTLKPVPR 0.98599 -3.9031 0 0 0 0 0 0 0 13.2516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1923 0 12.7333 13.9158 12.7659 0 12.3241 0 12.4411 13.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0637 0 0 0 0 0 13.5719 14.5508 0 0 0 14.2831 0 0 12.6619 13.325 0 0 0 0 13.7661 0 0 0 0 0 0 13.7469 0 0 13.0305 0 0 0 0 0 14.0663 12.8863 0 0 12.5549 14.0408 0 0 12.8202 0 12.8146 13.0935 12.2488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6172 0 0 0 0 0 0 0 0 12.6071 0 0 0 0 0 0 0 Q9BXJ8 TACAN_HUMAN Ion channel TACAN (Transmembrane protein 120A) (Transmembrane protein induced by tumor necrosis factor alpha) TMEM120A TACAN TMPIT Homo sapiens (Human) detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; fat cell differentiation [GO:0045444]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; fat cell differentiation [GO:0045444]; ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260] GO:0005216; GO:0005637; GO:0005886; GO:0016020; GO:0016021; GO:0034220; GO:0045444; GO:0050966; GO:0051260; GO:0051291 ion channel activity [GO:0005216] EWQVLMCGFPFLLLFLGNFFTTLR 0.98599 -2.0661 0 0 0 0 0 0 0 0 0 11.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5492 0 0 0 0 0 0 0 0 0 12.0232 0 0 0 0 13.8704 0 13.7333 0 0 0 0 0 0 0 16.1891 0 0 0 0 0 14.6768 0 12.7029 0 12.9113 0 0 0 0 0 0 0 0 0 13.251 12.8422 0 13.1928 0 0 13.3576 0 0 0 0 0 0 0 0 0 15.151 13.0112 0 0 0 0 0 0 0 0 0 0 0 14.5417 0 0 0 0 14.6464 0 0 0 12.4536 11.8882 0 0 0 0 0 0 0 0 12.7596 0 0 0 0 0 0 0 0 12.5556 0 0 0 0 0 0 0 0 0 0 Q9HC24 LFG4_HUMAN Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein) TMBIM4 GAAP LFG4 CGI-119 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of calcium-mediated signaling [GO:0050848] GO:0000139; GO:0005795; GO:0006915; GO:0016020; GO:0016021; GO:0043066; GO:0050848 MADPDPR 0.98599 -3.9082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP94 S39A2_HUMAN "Zinc transporter ZIP2 (6A1) (Eti-1) (Solute carrier family 39 member 2) (Zrt- and Irt-like protein 2, ZIP-2, hZIP2)" SLC39A2 ZIP2 Homo sapiens (Human) zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] GO:0005385; GO:0005886; GO:0005887; GO:0006829; GO:0016020; GO:0031410; GO:0036464; GO:0071577 zinc ion transmembrane transporter activity [GO:0005385] GHHRLVLR 0.98599 -2.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2519 0 0 11.8226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4659 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHD4 CIDEB_HUMAN Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B) CIDEB Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; bile acid signaling pathway [GO:0038183]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of cell death [GO:0010942]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; response to nutrient levels [GO:0031667] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; bile acid signaling pathway [GO:0038183]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of cell death [GO:0010942]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; response to nutrient levels [GO:0031667] GO:0005829; GO:0006915; GO:0008630; GO:0010942; GO:0031667; GO:0038183; GO:0042802; GO:0042981; GO:0048471; GO:0090200; GO:0097194; GO:0097202 identical protein binding [GO:0042802] GLTAATR 0.98599 -3.9117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2564 0 0 0 0 13.5941 0 0 0 0 0 0 13.0318 0 0 0 0 0 0 0 0 0 0 0 P14406 CX7A2_HUMAN "Cytochrome c oxidase subunit 7A2, mitochondrial (Cytochrome c oxidase subunit VIIa-liver/heart, Cytochrome c oxidase subunit VIIa-L, Cytochrome c oxidase subunit VIIaL)" COX7A2 COX7AL Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]" integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751] "integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751]; oxidoreductase activity [GO:0016491]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]" GO:0002082; GO:0005746; GO:0005751; GO:0006123; GO:0016021; GO:0016491; GO:0031966; GO:0045333; GO:0097250 oxidoreductase activity [GO:0016491] MLRNLLALR 0.986 -1.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6KB66 K2C80_HUMAN "Keratin, type II cytoskeletal 80 (Cytokeratin-80, CK-80) (Keratin-80, K80) (Type-II keratin Kb20)" KRT80 KB20 Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005737; GO:0005829; GO:0005882; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0045111 structural constituent of skin epidermis [GO:0030280] EEMKALNDK 0.986 -3.3484 0 0 0 0 0 0 0 0 0 0 0 10.2246 0 0 0 0 11.5762 12.4214 0 11.3583 0 0 10.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6362 0 0 0 11.4783 0 13.9684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8156 0 0 0 12.3788 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5601 13.4424 12.835 13.9079 0 0 0 0 0 0 0 0 0 11.3736 0 11.8024 13.481 10.7295 0 13.4094 14.6076 13.0437 11.8913 14.0142 12.6075 13.5017 11.9049 0 0 0 0 0 0 0 12.6401 0 12.1656 0 12.2688 0 14.5447 14.4743 0 0 0 0 0 0 13.0811 0 0 0 0 10.7268 13.6101 13.8992 12.8431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L42 KCNH8_HUMAN "Potassium voltage-gated channel subfamily H member 8 (ELK1, hElk1) (Ether-a-go-go-like potassium channel 3, ELK channel 3, ELK3) (Voltage-gated potassium channel subunit Kv12.1)" KCNH8 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0071805 voltage-gated potassium channel activity [GO:0005249] DFIRVHHLPQQLK 0.986 -2.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 13.335 0 0 0 12.1195 0 0 0 13.735 0 0 0 12.6591 0 0 0 0 0 13.792 0 0 10.8243 0 0 0 0 10.9627 14.2742 0 0 0 0 12.6167 0 13.7549 0 0 12.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0501 10.0796 0 0 0 0 0 0 0 0 0 0 13.7306 0 11.541 12.9108 11.1241 17.0526 0 13.0925 13.0526 14.0709 0 0 0 0 0 0 11.9221 13.679 0 14.0049 15.0409 0 0 0 0 0 13.266 0 0 0 12.6871 0 13.9682 14.1628 14.2509 0 11.9411 13.6089 10.0796 0 0 0 13.3117 0 13.4264 13.4512 13.5479 0 12.9132 10.566 0 14.0494 10.1891 0 14.2075 12.8982 0 0 12.9873 14.1759 14.0953 14.1336 0 0 0 14.2082 14.1412 0 0 0 0 11.0699 10.6383 0 0 10.2682 0 13.2458 0 0 0 0 13.6684 0 0 10.6988 0 0 0 0 0 0 12.9155 0 13.7657 0 0 10.9908 0 Q99675 CGRF1_HUMAN Cell growth regulator with RING finger domain protein 1 (Cell growth regulatory gene 19 protein) (RING finger protein 197) CGRRF1 CGR19 RNF197 Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285] endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285] GO:0005654; GO:0005783; GO:0007049; GO:0008285; GO:0030308; GO:0043231; GO:0046872 metal ion binding [GO:0046872] TYKLSCR 0.986 -2.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8328 0 0 0 0 0 0 0 0 0 0 O75712 CXB3_HUMAN "Gap junction beta-3 protein (Connexin-31, Cx31)" GJB3 CX31 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; skin development [GO:0043588]; spermatogenesis [GO:0007283] cell junction [GO:0030054]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] cell junction [GO:0030054]; connexin complex [GO:0005922]; cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; skin development [GO:0043588]; spermatogenesis [GO:0007283] GO:0001701; GO:0001890; GO:0005243; GO:0005737; GO:0005921; GO:0005922; GO:0007267; GO:0007283; GO:0016021; GO:0030054; GO:0043231; GO:0043588; GO:0071300 gap junction channel activity [GO:0005243] IWLSVVFVFR 0.98601 -2.0836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5821 13.1235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19634 SL9A1_HUMAN "Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1, NHE-1) (Solute carrier family 9 member 1)" SLC9A1 APNH1 NHE1 Homo sapiens (Human) cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; protein-macromolecule adaptor activity [GO:0030674]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; neuron death [GO:0070997]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863]" GO:0005516; GO:0005546; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0006811; GO:0006883; GO:0006885; GO:0009986; GO:0010447; GO:0010613; GO:0010882; GO:0014704; GO:0015299; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0016477; GO:0030011; GO:0030027; GO:0030307; GO:0030315; GO:0030346; GO:0030674; GO:0032869; GO:0035794; GO:0035994; GO:0036376; GO:0043065; GO:0043066; GO:0045121; GO:0045760; GO:0045944; GO:0048306; GO:0048471; GO:0048863; GO:0051259; GO:0051453; GO:0051492; GO:0051893; GO:0051930; GO:0055007; GO:0060090; GO:0070062; GO:0070417; GO:0070886; GO:0070997; GO:0071236; GO:0071257; GO:0071260; GO:0071456; GO:0071468; GO:0071805; GO:0071872; GO:0086003; GO:0086036; GO:0086040; GO:0086092; GO:0090533; GO:0098719; GO:0098735; GO:1902600; GO:1903281 "calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; protein-macromolecule adaptor activity [GO:0030674]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]; solute:proton antiporter activity [GO:0015299]" DQFIIAYGGLR 0.98601 -1.5587 0 0 0 0 0 0 0 0 14.6707 0 0 0 14.4399 0 0 0 13.232 0 0 0 0 0 0 0 0 0 11.5367 0 0 12.9604 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7726 11.8612 0 13.9175 0 0 0 0 0 14.1345 0 0 0 0 0 0 14.9841 11.7167 0 13.2621 0 14.2442 0 14.2915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9136 0 0 12.9734 0 0 0 0 0 0 0 0 12.2105 0 0 0 0 0 0 0 0 13.4227 0 0 15.2089 0 0 13.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TAL8 QRIC1_HUMAN Transcriptional regulator QRICH1 (Glutamine-rich protein 1) QRICH1 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; response to endoplasmic reticulum stress [GO:0034976]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endoplasmic reticulum unfolded protein response [GO:0030968]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; response to endoplasmic reticulum stress [GO:0034976]" GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0030968; GO:0034976; GO:0036499; GO:0043065; GO:0045893; GO:0070059; GO:0140467 DNA binding [GO:0003677] ARSVPQHRMK 0.98601 -3.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3195 12.4569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4219 13.803 13.3254 0 0 0 0 0 14.3453 13.8166 13.675 0 14.2562 13.5996 13.8609 0 13.5825 0 0 0 0 0 13.2554 13.4985 0 0 14.5768 0 17.1234 0 0 0 0 0 11.671 0 0 0 0 0 14.7331 0 0 0 13.5159 14.1502 0 0 0 13.9991 14.0286 13.9586 13.7337 0 0 13.85 13.4529 0 0 13.8907 13.3853 0 0 0 0 0 0 0 13.739 13.4455 0 0 13.783 0 0 13.4934 13.6314 12.9986 0 13.9828 13.4651 0 11.7453 0 0 0 0 0 0 0 15.9397 0 0 0 0 0 0 0 0 11.7608 0 0 0 0 0 0 0 11.2829 13.4179 0 0 12.4615 0 0 Q96EY7 PTCD3_HUMAN "Pentatricopeptide repeat domain-containing protein 3, mitochondrial (28S ribosomal protein S39, mitochondrial, MRP-S39) (Mitochondrial small ribosomal subunit protein mS39) (Transformation-related gene 15 protein, TRG-15)" PTCD3 MRPS39 TRG15 Homo sapiens (Human) mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417] GO:0003723; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0005829; GO:0005886; GO:0006417; GO:0019843; GO:0032543; GO:0043024 ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] DPDDDKFFQSAMSICSSLR 0.98601 -2.48 0 0 0 12.8937 12.6984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2786 0 13.7867 0 14.5375 0 12.9783 0 0 0 0 0 0 14.047 0 13.5852 13.803 0 0 0 0 0 12.9511 13.4542 0 0 0 0 13.29 0 0 0 13.2085 13.3993 0 13.1865 0 0 0 0 0 14.0665 13.6699 0 0 13.6249 13.7295 13.9748 0 0 0 0 13.6143 13.8673 0 0 13.5693 0 13.7037 15.7819 0 0 13.8586 0 14.3107 0 13.4007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HY7 DHTK1_HUMAN "2-oxoadipate dehydrogenase complex component E1, E1a, OADC-E1, OADH-E1, EC 1.2.4.- (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase, Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)" DHTKD1 KIAA1630 Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hematopoietic progenitor cell differentiation [GO:0002244]; tricarboxylic acid cycle [GO:0006099] GO:0002244; GO:0004591; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0030976 oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976] ATRLAFEYQRQFR 0.98601 -3.7334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXG8 SPZ1_HUMAN Spermatogenic leucine zipper protein 1 (Testis-specific protein 1) (Testis-specific protein NYD-TSP1) SPZ1 TSP1 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] GO:0003677; GO:0003700; GO:0005634; GO:0005737 DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] HELEEQVK 0.98601 -3.5518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2568 0 0 12.6294 0 0 0 14.4267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZT2 OGFR_HUMAN "Opioid growth factor receptor, OGFr (Protein 7-60) (Zeta-type opioid receptor)" OGFR Homo sapiens (Human) regulation of cell growth [GO:0001558] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; opioid growth factor receptor activity [GO:0140625]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005634; GO:0005737; GO:0016020; GO:0140625 opioid growth factor receptor activity [GO:0140625] AGEAAELQDAEVESSAKSGK 0.98601 -3.5531 0 0 0 11.4273 0 0 0 0 14.5163 0 0 0 0 0 14.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4026 15.4965 12.4638 0 15.3058 15.2396 0 0 0 14.8624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1299 12.76 0 12.9264 0 0 0 0 0 0 0 0 0 0 12.0978 0 0 14.023 0 0 0 12.1099 0 0 0 0 14.8643 0 0 0 0 0 0 11.8781 0 0 0 0 11.9452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.55 0 0 0 0 0 0 0 0 0 0 0 0 12.8521 0 0 0 0 0 0 0 0 12.9476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WY91 THAP4_HUMAN "Peroxynitrite isomerase THAP4, EC 5.99.-.- (Ferric Homo sapiens nitrobindin, Hs-Nb(III)) (THAP domain-containing protein 4)" THAP4 CGI-36 PP238 Homo sapiens (Human) nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570] GO:0003677; GO:0005634; GO:0005737; GO:0006570; GO:0020037; GO:0042126; GO:0042802; GO:0046872; GO:0062213; GO:0070026 DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213] EPIDRKR 0.98602 -3.4743 0 0 0 0 12.1382 0 0 0 0 0 0 0 0 0 0 0 10.8171 0 0 0 0 0 0 0 0 0 0 0 11.6026 0 0 11.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4632 0 0 0 0 0 0 0 0 14.1129 0 0 0 0 0 0 0 0 12.4231 13.4451 0 0 0 14.2573 0 0 0 13.76 0 0 0 0 13.9423 0 0 0 0 19.8745 0 0 0 0 0 11.5494 0 0 0 0 12.1508 0 0 0 0 0 19.8922 0 0 0 0 0 0 12.7412 0 0 13.8266 0 12.8959 0 0 0 0 0 0 0 13.4472 13.6472 0 10.745 0 0 0 0 0 0 0 0 0 0 0 19.8931 0 0 0 11.512 0 11.7245 0 0 0 0 Q96A26 F162A_HUMAN "Protein FAM162A (E2-induced gene 5 protein) (Growth and transformation-dependent protein, HGTD-P)" FAM162A C3orf28 E2IG5 DC16 FWP001 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to hypoxia [GO:0071456]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of release of cytochrome c from mitochondria [GO:0090200] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to hypoxia [GO:0071456]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of release of cytochrome c from mitochondria [GO:0090200] GO:0005739; GO:0005829; GO:0006919; GO:0016021; GO:0031966; GO:0043065; GO:0051402; GO:0071456; GO:0090200 ILIWSGRFK 0.98602 -1.5661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZD4 AHSP_HUMAN Alpha-hemoglobin-stabilizing protein (Erythroid differentiation-related factor) (Erythroid-associated factor) AHSP EDRF ERAF Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; hemopoiesis [GO:0030097]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; hemoglobin complex [GO:0005833] cytoplasm [GO:0005737]; hemoglobin complex [GO:0005833]; hemoglobin binding [GO:0030492]; unfolded protein binding [GO:0051082]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; hemopoiesis [GO:0030097]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0005737; GO:0005833; GO:0006457; GO:0020027; GO:0030097; GO:0030218; GO:0030492; GO:0050821; GO:0051082 hemoglobin binding [GO:0030492]; unfolded protein binding [GO:0051082] ALLKANK 0.98602 -1.5671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBD5 ORC3_HUMAN Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo) ORC3 LATHEO ORC3L Homo sapiens (Human) DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; glial cell proliferation [GO:0014009]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]; DNA replication origin binding [GO:0003688]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; glial cell proliferation [GO:0014009]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275]" GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005654; GO:0005656; GO:0005664; GO:0006260; GO:0006270; GO:0006275; GO:0014009; GO:0016604; GO:0031261; GO:0061351 DNA replication origin binding [GO:0003688] FIRAVSELELLGFIKPTK 0.98602 -2.8666 12.063 0 0 0 0 0 0 11.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6692 0 0 14.9865 0 0 0 0 13.6547 14.7705 0 0 15.6014 0 0 0 12.5703 0 0 0 0 0 0 13.1625 0 14.0423 0 0 0 0 0 0 0 0 0 0 15.6342 14.222 13.3442 0 0 0 0 0 0 12.1086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7749 14.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75208 COQ9_HUMAN "Ubiquinone biosynthesis protein COQ9, mitochondrial" COQ9 C16orf49 HSPC326 PSEC0129 Homo sapiens (Human) "mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744]" mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142] "mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744]" GO:0005739; GO:0005743; GO:0006120; GO:0006744; GO:0008289; GO:0042803; GO:0110142 lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803] AFHASAVGLR 0.98603 -3.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2413 11.7185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6026 0 0 0 0 0 12.4588 12.6266 0 0 0 0 0 11.957 0 0 0 0 0 0 0 12.4355 0 0 12.1894 0 0 0 0 0 11.718 0 0 11.3432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95149 SPN1_HUMAN Snurportin-1 (RNA U transporter 1) SNUPN RNUT1 SPN1 Homo sapiens (Human) protein import into nucleus [GO:0006606]; RNA import into nucleus [GO:0006404]; snRNA import into nucleus [GO:0061015] cytosol [GO:0005829]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339]; protein import into nucleus [GO:0006606]; RNA import into nucleus [GO:0006404]; snRNA import into nucleus [GO:0061015] GO:0000339; GO:0005643; GO:0005654; GO:0005829; GO:0006404; GO:0006606; GO:0042564; GO:0061015; GO:0061608 nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339] FYWMHSKLPEEEGLGEKTK 0.98603 -3.4883 11.1932 0 0 0 0 0 0 0 0 12.9049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2781 0 0 0 0 14.7495 0 0 0 12.9329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05DH4 FHI1A_HUMAN "FHF complex subunit HOOK interacting protein 1A, FHIP1A (FTS and Hook-interacting protein like, FHIP-L)" FHIP1A FAM160A1 Homo sapiens (Human) protein localization to perinuclear region of cytoplasm [GO:1905719] protein localization to perinuclear region of cytoplasm [GO:1905719] GO:1905719 DNSDPFHSEPKEPK 0.98603 -2.0976 0 0 0 0 0 0 12.3397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5297 11.8854 11.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.723 0 0 0 0 0 0 0 0 0 13.124 0 0 0 12.4977 12.7042 0 0 0 12.7934 12.0645 12.8767 0 0 0 0 0 12.6643 0 0 0 0 0 0 12.2491 0 0 0 0 0 0 13.2892 13.3907 13.5543 13.4875 13.3514 0 0 0 0 0 14.3729 0 0 0 0 0 0 0 0 0 14.4048 0 0 14.0805 13.452 13.838 0 0 0 0 13.3754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08379 GOGA2_HUMAN "Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein, GM130) (GM130 autoantigen) (Golgin-95)" GOLGA2 Homo sapiens (Human) asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225] GO:0000137; GO:0000139; GO:0000922; GO:0005794; GO:0005801; GO:0005874; GO:0006486; GO:0006888; GO:0007020; GO:0007030; GO:0007098; GO:0008017; GO:0008356; GO:0010507; GO:0015031; GO:0019901; GO:0019905; GO:0030134; GO:0032091; GO:0032580; GO:0033116; GO:0042802; GO:0045296; GO:0051225; GO:0051289; GO:0060050; GO:0061676; GO:0072686; GO:0090161; GO:0090166; GO:0090306; GO:0090307 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905] EGESEDLASRLQYSR 0.98603 -1.5716 0 0 0 0 11.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5792 0 0 0 0 0 0 0 0 0 0 14.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7596 0 12.3589 0 0 0 0 0 0 15.7905 0 0 0 0 14.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14139 UBE4A_HUMAN "Ubiquitin conjugation factor E4 A, EC 2.3.2.27 (RING-type E3 ubiquitin transferase E4 A)" UBE4A KIAA0126 Homo sapiens (Human) protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0030433; GO:0034450 ubiquitin-ubiquitin ligase activity [GO:0034450] DLELCQILLYAYLDILLYFTRQKDMAK 0.98603 -1.5686 0 0 0 0 0 0 0 0 0 0 0 11.8786 0 0 0 0 0 0 0 0 12.3893 0 0 0 0 11.9673 10.0153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.215 13.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4186 0 0 14.7427 0 0 0 0 0 0 13.1395 13.6163 0 0 0 0 0 0 0 0 11.0528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GX9 MTNB_HUMAN "Methylthioribulose-1-phosphate dehydratase, MTRu-1-P dehydratase, EC 4.2.1.109 (APAF1-interacting protein, hAPIP)" APIP CGI-29 Homo sapiens (Human) apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372] GO:0005737; GO:0005829; GO:0006915; GO:0008270; GO:0019284; GO:0019509; GO:0042802; GO:0043066; GO:0046570; GO:0051289; GO:0070269; GO:0070372 identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270] EGDCCSR 0.98603 -3.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5581 12.3335 0 0 0 0 0 0 12.5645 0 0 0 0 0 0 0 11.1178 0 9.25552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.87249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2126 13.1043 0 0 12.2867 0 9.56037 0 0 0 0 0 0 14.0936 0 11.193 0 13.3593 0 0 0 0 0 0 12.2621 0 0 0 0 12.9016 0 0 0 0 0 0 0 0 0 0 0 0 13.8555 0 0 0 13.2401 0 10.6624 0 0 0 0 0 13.2109 0 12.9017 0 0 0 0 13.6763 13.7475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3031 10.2984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRD0 FBX8_HUMAN F-box only protein 8 (F-box/SEC7 protein FBS) FBXO8 FBS FBX8 DC10 UNQ1877/PRO4320 Homo sapiens (Human) regulation of ARF protein signal transduction [GO:0032012]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin ligase complex [GO:0000151] ubiquitin ligase complex [GO:0000151]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of ARF protein signal transduction [GO:0032012]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0005085; GO:0006511; GO:0032012 guanyl-nucleotide exchange factor activity [GO:0005085] EIAKFIFCTR 0.98603 -3.4846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4669 12.6567 0 0 0 0 0 0 0 0 0 0 0 0 10.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9399 0 0 12.6813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPQ9 TNR6B_HUMAN Trinucleotide repeat-containing gene 6B protein TNRC6B KIAA1093 Homo sapiens (Human) "gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" GO:0000932; GO:0003723; GO:0005654; GO:0005829; GO:0031047; GO:0035195; GO:0035278; GO:0060213; GO:1900153 RNA binding [GO:0003723] EREDSWK 0.98603 -3.4772 0 0 0 0 0 0 0 0 0 0 0 12.2858 0 12.8012 12.4574 0 13.5365 0 10.7093 0 0 0 0 0 12.6813 13.0284 13.4115 0 0 12.3368 0 0 0 11.5946 11.9764 0 12.3813 0 0 12.9606 13.2137 0 0 0 12.3032 0 13.3291 12.5106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.401 0 0 0 0 0 15.4057 0 0 0 0 0 14.0159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3335 14.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5272 0 0 0 10.2175 0 11.0509 0 0 0 0 0 0 0 12.5643 Q9Y6I4 UBP3_HUMAN "Ubiquitin carboxyl-terminal hydrolase 3, EC 3.4.19.12 (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3)" USP3 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; mitotic cell cycle [GO:0000278]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000278; GO:0000785; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006325; GO:0006511; GO:0008270; GO:0016578; GO:0031647; GO:0036464; GO:0042393; GO:0090543 cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] FDPFLDLSLDIPSQFR 0.98603 -3.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1638 0 0 0 0 0 0 0 0 0 0 12.311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.097 0 0 0 0 11.9886 14.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60870 KIN17_HUMAN "DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein homolog)" KIN BTCD KIN17 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397] GO:0003677; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0016363; GO:0032991; GO:0043231; GO:0046872 DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] CHCMSESHQR 0.98604 -3.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0511 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2207 0 0 12.7303 13.2614 12.7073 0 0 0 0 0 11.6108 12.9042 12.8401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.817 0 0 0 0 0 0 13.1538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2674 0 0 0 0 0 0 0 0 0 0 0 10.6212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7754 0 0 0 0 0 0 0 Q13153 PAK1_HUMAN "Serine/threonine-protein kinase PAK 1, EC 2.7.11.1 (Alpha-PAK) (p21-activated kinase 1, PAK-1) (p65-PAK)" PAK1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060] actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018] actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; microtubule organizing center [GO:0005815]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060] GO:0001726; GO:0001934; GO:0002223; GO:0004672; GO:0004674; GO:0005518; GO:0005524; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006338; GO:0006468; GO:0006887; GO:0006915; GO:0006974; GO:0008284; GO:0014704; GO:0016310; GO:0016477; GO:0030018; GO:0030027; GO:0030335; GO:0030424; GO:0030425; GO:0031116; GO:0031532; GO:0031965; GO:0032587; GO:0032956; GO:0032991; GO:0033138; GO:0033148; GO:0035556; GO:0038096; GO:0042060; GO:0042802; GO:0043015; GO:0043408; GO:0043507; GO:0046777; GO:0048012; GO:0048013; GO:0048754; GO:0048812; GO:0050770; GO:0051496; GO:0060244; GO:0090063; GO:0106310 ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ELLQHQFLKIAKPLSSLTPLIAAAK 0.98604 -3.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NET5 NFAM1_HUMAN NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1) NFAM1 CNAIP Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of B cell differentiation [GO:0045577]; signal transduction [GO:0007165] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of B cell differentiation [GO:0045577]; signal transduction [GO:0007165] GO:0001819; GO:0004888; GO:0005886; GO:0006954; GO:0007165; GO:0016021; GO:0030183; GO:0035556; GO:0035577; GO:0045121; GO:0045577; GO:0050853; GO:0050861; GO:0051091 transmembrane signaling receptor activity [GO:0004888] ALPGLPRPPGLPAAPWLLLGVLLLPGTLR 0.98604 -1.5742 0 0 0 0 12.6662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2091 0 0 0 0 0 14.2021 0 0 13.0359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969T9 WBP2_HUMAN "WW domain-binding protein 2, WBP-2" WBP2 Homo sapiens (Human) "cellular response to estrogen stimulus [GO:0071391]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570]" GO:0000785; GO:0000978; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0030331; GO:0031490; GO:0032570; GO:0033148; GO:0043627; GO:0045815; GO:0045893; GO:0045944; GO:0050847; GO:0071169; GO:0071391; GO:0071442 chromatin DNA binding [GO:0031490]; nuclear estrogen receptor binding [GO:0030331]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713] VIFLSKGK 0.98604 -2.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96D31 CRCM1_HUMAN Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A) ORAI1 CRACM1 TMEM142A Homo sapiens (Human) adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279]; adaptive immune response [GO:0002250]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; mammary gland epithelium development [GO:0061180]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115] GO:0002115; GO:0002250; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0015279; GO:0016020; GO:0016323; GO:0034704; GO:0042802; GO:0044853; GO:0045121; GO:0045762; GO:0051924; GO:0051928; GO:0061180; GO:0070509; GO:0070588 calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; store-operated calcium channel activity [GO:0015279] FLPLKKQPGQPR 0.98604 -3.5008 0 0 0 0 0 0 0 0 0 12.0363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1207 0 0 0 0 13.2412 0 0 0 12.7637 0 0 0 0 0 12.1442 0 0 0 0 0 0 0 0 0 0 0 12.1544 0 0 0 13.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0423 0 0 0 0 0 0 0 0 0 0 0 0 12.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14815 CAN9_HUMAN "Calpain-9, EC 3.4.22.- (Digestive tract-specific calpain) (New calpain 4, nCL-4) (Protein CG36)" CAPN9 NCL4 Homo sapiens (Human) digestion [GO:0007586]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508] GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007586 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] ITHSSGQSFEQMR 0.98605 -1.5817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ98 TTY12_HUMAN Putative transcript Y 12 protein TTTY12 TTY12 Homo sapiens (Human) MIDPETR 0.98605 -2.0341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96039 13.1942 0 0 0 0 0 0 O95727 CRTAM_HUMAN Cytotoxic and regulatory T-cell molecule (Class-I MHC-restricted T-cell-associated molecule) (CD antigen CD355) CRTAM Homo sapiens (Human) "adaptive immune response [GO:0002250]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; detection of tumor cell [GO:0002355]; establishment of T cell polarity [GO:0001768]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of activated T cell proliferation [GO:0046007]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of CD8-positive, alpha-beta T cell activation [GO:2001185]; regulation of T cell activation [GO:0050863]; regulation of T cell differentiation [GO:0045580]" immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; cell recognition [GO:0008037]; detection of stimulus [GO:0051606]; detection of tumor cell [GO:0002355]; establishment of T cell polarity [GO:0001768]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of activated T cell proliferation [GO:0046007]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; regulation of CD8-positive, alpha-beta T cell activation [GO:2001185]; regulation of T cell activation [GO:0050863]; regulation of T cell differentiation [GO:0045580]" GO:0001768; GO:0001772; GO:0001819; GO:0002250; GO:0002355; GO:0002860; GO:0005102; GO:0005886; GO:0007157; GO:0008037; GO:0016021; GO:0032729; GO:0042802; GO:0045580; GO:0045954; GO:0046007; GO:0050863; GO:0051606; GO:0097021; GO:2001185 identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] AHVIWKK 0.98606 -2.0378 0 0 0 0 0 0 0 0 15.3271 14.5753 14.1925 0 11.7159 14.1033 14.8878 13.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0275 0 0 14.998 0 0 0 0 0 14.4122 0 0 15.1699 0 15.2537 0 10.9186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5895 0 0 0 0 12.6432 12.8202 0 0 0 0 0 0 13.6577 0 13.4232 14.0267 0 0 0 0 12.9043 0 0 0 0 0 0 11.8661 0 11.9257 11.8926 0 0 11.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8489 0 13.7432 11.8731 0 0 0 0 0 0 0 12.3187 0 0 0 0 0 0 12.6737 0 0 12.4801 0 0 0 0 13.0959 0 0 12.0161 0 0 0 0 0 0 0 0 0 13.0941 0 0 0 0 0 11.6133 0 16.1959 16.1898 0 0 0 16.272 15.9982 0 0 0 0 0 0 0 0 0 0 Q70UQ0 IKIP_HUMAN "Inhibitor of nuclear factor kappa-B kinase-interacting protein, I kappa-B kinase-interacting protein, IKBKB-interacting protein, IKK-interacting protein" IKBIP IKIP Homo sapiens (Human) response to X-ray [GO:0010165] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; response to X-ray [GO:0010165] GO:0005783; GO:0005789; GO:0010165; GO:0016020; GO:0016021 EIAFLSEKISNLTIVQAEIKDIK 0.98606 -1.5941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.505 0 0 0 0 0 0 14.0653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.0281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4762 0 12.4841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1032 0 0 0 0 0 0 0 12.9229 0 0 13.2473 0 0 0 0 0 13.2043 0 15.07 0 0 0 0 0 0 0 15.4709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5396 10.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75626 PRDM1_HUMAN "PR domain zinc finger protein 1, EC 2.1.1.- (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1, PRDI-BF1, PRDI-binding factor 1)" PRDM1 BLIMP1 Homo sapiens (Human) adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; histone arginine methylation [GO:0034969]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; response to radiation [GO:0009314]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; aorta development [GO:0035904]; artery morphogenesis [GO:0048844]; cell fate commitment [GO:0045165]; coronary vasculature development [GO:0060976]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; germ cell development [GO:0007281]; heart valve development [GO:0003170]; histone arginine methylation [GO:0034969]; innate immune response [GO:0045087]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; maternal placenta development [GO:0001893]; morphogenesis of a branching structure [GO:0001763]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; regulation of extrathymic T cell differentiation [GO:0033082]; regulation of gene expression [GO:0010468]; regulation of natural killer cell differentiation [GO:0032823]; regulation of NK T cell differentiation [GO:0051136]; regulation of transcription by RNA polymerase II [GO:0006357]; response to radiation [GO:0009314]; sebum secreting cell proliferation [GO:1990654]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281]" GO:0000122; GO:0000978; GO:0001227; GO:0001763; GO:0001822; GO:0001893; GO:0002250; GO:0003170; GO:0003281; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007281; GO:0008168; GO:0009314; GO:0009791; GO:0010467; GO:0010468; GO:0010628; GO:0010629; GO:0032823; GO:0033082; GO:0034969; GO:0035904; GO:0042127; GO:0042462; GO:0042826; GO:0045087; GO:0045165; GO:0046872; GO:0048844; GO:0051136; GO:0060576; GO:0060707; GO:0060976; GO:1990654; GO:1990837; GO:1990841 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CNSSTVRFQGLAEGTK 0.98607 -3.6065 9.57833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8154 0 11.6137 0 0 0 9.77322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1478 0 0 0 0 0 13.6098 13.9705 13.3896 0 14.9211 0 13.8309 0 12.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6015 0 0 0 0 0 0 0 0 0 10.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0815 11.3715 0 0 0 0 0 0 0 0 0 0 14.278 0 0 0 0 0 14.9416 0 0 0 0 0 0 0 0 0 0 0 0 14.3688 0 0 0 0 P09661 RU2A_HUMAN "U2 small nuclear ribonucleoprotein A', U2 snRNP A'" SNRPA1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] "catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0071005; GO:0071007; GO:0071013; GO:1903241 RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620] GKRGAQLAK 0.98607 -3.8903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1306 0 0 0 0 0 0 0 0 0 12.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8108 0 0 0 0 0 0 0 0 0 0 0 11.8961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00742 FA10_HUMAN "Coagulation factor X, EC 3.4.21.6 (Stuart factor) (Stuart-Prower factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain ]" F10 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intrinsic component of external side of plasma membrane [GO:0031233]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370] "endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intrinsic component of external side of plasma membrane [GO:0031233]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" GO:0004252; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0007596; GO:0016020; GO:0030335; GO:0031233; GO:0031638; GO:0051897; GO:0072377; GO:1905370 calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; serine-type endopeptidase activity [GO:0004252] DGDQCETSPCQNQGK 0.98608 -3.5188 0 0 0 0 0 0 0 11.3266 0 0 0 0 0 11.4726 0 14.0244 0 0 13.7775 0 0 0 0 0 0 0 0 12.2081 0 10.9394 11.0719 0 0 0 0 0 0 0 0 0 0 0 9.96042 0 0 0 0 0 0 0 0 12.1276 0 0 0 13.116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0285 13.6051 14.8839 0 0 14.885 0 11.7393 0 0 0 13.3538 0 15.2659 0 10.7874 0 13.2683 0 0 0 0 0 13.2646 0 0 15.1464 0 0 0 13.3688 11.3507 0 14.0069 0 0 0 0 0 0 0 0 0 0 14.0014 0 0 0 0 0 13.8657 0 0 0 0 13.8448 0 0 0 0 0 0 0 16.0284 0 0 0 13.0568 0 0 0 0 0 0 12.8974 14.8602 16.1224 0 0 0 0 13.5739 13.6497 12.8136 0 0 0 0 14.5237 11.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TAL5 SMTL2_HUMAN Smoothelin-like protein 2 SMTNL2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; positive regulation of vasoconstriction [GO:0045907] filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815] filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; positive regulation of vasoconstriction [GO:0045907] GO:0005523; GO:0005815; GO:0008157; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0045907 protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523] GQSLDHDEASESEMR 0.98608 -3.5223 0 0 0 0 13.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2108 0 0 13.4952 0 0 0 0 0 0 0 0 0 12.9051 0 0 0 0 0 0 12.781 0 0 13.2169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M243 CCD27_HUMAN Coiled-coil domain-containing protein 27 CCDC27 Homo sapiens (Human) DARCPEWKPHQK 0.98609 3.0305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9413 0 12.2043 0 0 0 0 0 0 0 0 0 0 0 11.7118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7727 0 0 0 0 0 13.7401 0 0 0 0 14.2387 0 0 0 0 0 0 14.8259 0 0 0 16.0456 0 14.2513 0 0 0 0 0 12.4414 0 0 12.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4993 0 0 0 0 0 0 11.0834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2701 0 0 0 0 0 0 0 0 0 0 13.6516 0 0 P21810 PGS1_HUMAN Biglycan (Bone/cartilage proteoglycan I) (PG-S1) BGN SLRR1A Homo sapiens (Human) articular cartilage development [GO:0061975]; bone development [GO:0060348]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; sarcolemma [GO:0042383]; transport vesicle [GO:0030133]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800] GO:0005201; GO:0005539; GO:0005576; GO:0005615; GO:0005796; GO:0009986; GO:0019800; GO:0030021; GO:0030133; GO:0031012; GO:0042383; GO:0043202; GO:0050840; GO:0060348; GO:0061975; GO:0062023; GO:0070062 extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539] IHDNRIRK 0.9861 -2.0646 0 0 0 0 0 11.4029 12.1845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08AF3 SLFN5_HUMAN Schlafen family member 5 SLFN5 Homo sapiens (Human) cell differentiation [GO:0030154] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; cell differentiation [GO:0030154] GO:0005524; GO:0005634; GO:0030154 ATP binding [GO:0005524] AKRHLYILK 0.9861 -3.5435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3584 0 0 0 0 0 0 0 0 12.1523 0 0 0 13.5531 0 0 0 0 0 0 13.0048 0 0 0 0 0 0 0 13.3261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0131 0 0 0 0 0 0 0 0 0 0 12.7736 0 0 0 0 0 14.9614 0 0 0 0 0 0 13.5846 0 13.5344 0 0 0 0 0 0 0 0 13.7857 0 13.2351 12.8347 0 Q9P0J6 RM36_HUMAN "39S ribosomal protein L36, mitochondrial, L36mt, MRP-L36 (BRCA1-interacting protein 1) (Mitochondrial large ribosomal subunit protein bL36m)" MRPL36 BRIP1 Homo sapiens (Human) mitochondrial translation [GO:0032543]; ribosome biogenesis [GO:0042254]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosome biogenesis [GO:0042254]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0016604; GO:0032543; GO:0042254 structural constituent of ribosome [GO:0003735] GAAPVAVEPGAAVRSLLSPGLLPHLLPALGFKNK 0.9861 -3.5408 0 0 0 0 0 0 0 0 0 14.087 14.9936 0 0 14.2113 0 0 0 12.2414 0 0 0 0 0 0 0 0 0 0 12.6292 0 0 0 14.3043 0 14.1216 0 0 0 0 0 13.3989 0 0 0 0 0 13.0645 0 0 0 0 0 9.99591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5405 0 0 0 0 0 0 0 0 0 0 12.9405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4612 0 0 0 0 0 0 0 0 0 0 13.6448 0 0 0 0 0 0 0 0 0 0 0 0 15.1288 0 0 0 0 0 0 0 0 0 12.5206 13.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2889 0 13.8694 0 0 P0DM35 M1BL1_HUMAN Metallothionein 1H-like protein 1 MT1HL1 Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; detoxification of copper ion [GO:0010273] GO:0005634; GO:0005737; GO:0006882; GO:0010273; GO:0046872; GO:0071276; GO:0071280; GO:0071294 metal ion binding [GO:0046872] GASEKCSCCA 0.98611 3.0292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.406 0 0 0 10.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.231 0 0 0 0 P62258 1433E_HUMAN "14-3-3 protein epsilon, 14-3-3E" YWHAE Homo sapiens (Human) cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; neuron migration [GO:0001764]; positive regulation of protein export from nucleus [GO:0046827]; protein localization [GO:0008104]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane repolarization [GO:0060306]; regulation of mitotic cell cycle [GO:0007346]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; calcium channel regulator activity [GO:0005246]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; neuron migration [GO:0001764]; positive regulation of protein export from nucleus [GO:0046827]; protein localization [GO:0008104]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane repolarization [GO:0060306]; regulation of mitotic cell cycle [GO:0007346]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762] GO:0000165; GO:0001764; GO:0003064; GO:0003723; GO:0005246; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0007346; GO:0008104; GO:0015459; GO:0016020; GO:0019899; GO:0019903; GO:0019904; GO:0021762; GO:0021766; GO:0021987; GO:0023026; GO:0031625; GO:0034504; GO:0034605; GO:0035556; GO:0042470; GO:0042802; GO:0042826; GO:0044325; GO:0045296; GO:0046827; GO:0046982; GO:0050815; GO:0051219; GO:0051480; GO:0060306; GO:0070062; GO:0086013; GO:0086091; GO:0097110; GO:1901016; GO:1901020; GO:1902309; GO:1905913 cadherin binding [GO:0045296]; calcium channel regulator activity [GO:0005246]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] ASWRIISSIEQK 0.98611 -1.6275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6583 12.5549 12.6041 13.5487 14.6301 0 0 0 13.5773 0 0 0 0 0 0 13.3995 0 0 11.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12982 BNIP2_HUMAN BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 BNIP2 NIP2 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to oxygen-glucose deprivation [GO:0090649] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; response to oxygen-glucose deprivation [GO:0090649] GO:0005096; GO:0005509; GO:0005635; GO:0005730; GO:0005737; GO:0005829; GO:0006915; GO:0043066; GO:0043231; GO:0048471; GO:0090649 calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096] CYQQIDR 0.98611 -3.3671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4258 14.1684 13.1981 0 0 0 0 0 0 0 0 0 0 9.88287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMY6 WDR88_HUMAN WD repeat-containing protein 88 (PQQ repeat and WD repeat-containing protein) WDR88 PQWD Homo sapiens (Human) AVGLKLKQCER 0.98611 -3.7321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1363 0 0 0 0 13.2456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7645 13.3411 0 0 0 0 0 14.4669 0 0 0 0 0 0 0 14.3339 0 0 0 0 0 0 0 0 0 13.5416 0 0 13.4173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0649 14.0177 13.3691 0 14.175 0 0 Q7KZ85 SPT6H_HUMAN "Transcription elongation factor SPT6, hSPT6 (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein, Tat-CT2 protein)" SUPT6H KIAA0162 SPT6H Homo sapiens (Human) blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0010793; GO:0031491; GO:0032968; GO:0034728; GO:0042393; GO:0042789; GO:0045191; GO:0050684; GO:0051028; GO:0051147; GO:0061086 DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723] AKLNITPTKK 0.98611 -2.4775 0 0 0 0 0 0 0 0 10.2087 0 0 0 0 0 10.8362 0 0 0 0 12.4995 0 0 0 0 0 12.01 12.2451 0 0 0 0 0 9.79123 0 0 11.7756 0 0 0 0 12.6926 11.6349 0 0 0 0 12.0191 0 0 12.9524 0 11.6321 0 0 0 10.7222 0 0 0 0 0 0 0 0 0 0 0 12.0077 0 0 0 0 0 13.7766 14.6857 12.7365 12.1814 0 12.2974 0 0 13.6621 0 13.0572 10.144 14.3257 13.0271 0 13.0488 13.4502 13.1473 13.1464 0 0 12.86 12.9406 0 0 13.1492 14.2695 14.0576 12.9389 0 14.0444 13.8463 12.566 0 0 11.9179 12.1476 12.2008 12.5937 13.6261 0 15.4098 0 0 13.3522 12.259 0 15.1343 0 0 14.8475 13.9438 13.2973 14.2992 14.61 15.0601 14.8413 0 14.8847 11.6548 0 0 0 12.3925 0 0 0 0 13.607 11.7007 0 14.3745 15.7569 0 12.2058 10.8387 0 0 11.5389 12.8472 12.2187 0 0 12.8373 0 0 17.4815 0 0 11.2533 13.8034 0 12.8133 0 13.0026 0 0 0 10.7007 13.2577 14.0423 0 0 12.6437 0 13.2068 0 Q99747 SNAG_HUMAN "Gamma-soluble NSF attachment protein, SNAP-gamma (N-ethylmaleimide-sensitive factor attachment protein gamma)" NAPG SNAPG Homo sapiens (Human) intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; SNARE complex [GO:0031201] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; SNARE complex [GO:0031201]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003] GO:0005483; GO:0005739; GO:0005765; GO:0005794; GO:0006886; GO:0006891; GO:0019905; GO:0031201; GO:0050821; GO:0061025; GO:0065003; GO:0070062 soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905] AAQKINEGLEHLAK 0.98611 -3.5517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9285 0 0 0 0 0 0 0 0 0 0 11.7656 0 0 10.7839 0 0 0 0 0 0 0 0 0 0 13.633 0 0 0 0 0 15.6288 13.7229 0 0 10.8653 0 0 10.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2164 0 0 0 0 0 0 11.2594 0 0 0 0 0 0 0 0 0 13.3767 0 0 0 0 0 0 0 0 B6A8C7 TARM1_HUMAN "T-cell-interacting, activating receptor on myeloid cells protein 1 (OSCAR-like transcript-2 protein, OLT-2)" TARM1 Homo sapiens (Human) "adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; negative regulation of CD4-positive, alpha-beta T cell activation [GO:2000515]" integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; negative regulation of CD4-positive, alpha-beta T cell activation [GO:2000515]" GO:0002250; GO:0005886; GO:0016021; GO:0034987; GO:0035579; GO:0045087; GO:0070821; GO:2000515 immunoglobulin receptor binding [GO:0034987] GTVTAGGRVTLQCQKR 0.98612 -1.5575 0 0 0 0 0 0 0 0 12.9879 0 0 0 0 0 0 0 0 13.4123 0 0 0 0 12.6448 0 0 13.6623 13.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6973 14.8228 0 0 0 0 0 0 14.5836 0 0 0 0 16.4293 0 0 0 14.8738 0 0 0 0 0 14.7861 0 0 0 0 0 0 13.0465 0 15.4939 0 0 0 0 0 0 0 0 15.2987 0 13.8953 0 12.8043 0 0 0 0 15.2049 0 0 15.8868 0 0 0 0 0 14.5784 12.0665 14.9514 0 0 12.6619 0 0 15.0244 0 13.8812 0 13.4033 14.2948 0 0 12.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3308 0 0 0 0 0 0 0 0 P21964 COMT_HUMAN "Catechol O-methyltransferase, EC 2.1.1.6" COMT Homo sapiens (Human) catecholamine catabolic process [GO:0042424]; cellular response to phosphate starvation [GO:0016036]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259]; neurotransmitter catabolic process [GO:0042135] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; catechol O-methyltransferase activity [GO:0016206]; L-dopa O-methyltransferase activity [GO:0102084]; magnesium ion binding [GO:0000287]; methyltransferase activity [GO:0008168]; O-methyltransferase activity [GO:0008171]; orcinol O-methyltransferase activity [GO:0102938]; catecholamine catabolic process [GO:0042424]; cellular response to phosphate starvation [GO:0016036]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; lipid metabolic process [GO:0006629]; methylation [GO:0032259]; neurotransmitter catabolic process [GO:0042135] GO:0000287; GO:0005829; GO:0005886; GO:0006629; GO:0008168; GO:0008171; GO:0016020; GO:0016021; GO:0016036; GO:0016206; GO:0030424; GO:0030425; GO:0032259; GO:0032502; GO:0042135; GO:0042417; GO:0042420; GO:0042424; GO:0043231; GO:0070062; GO:0102084; GO:0102938 catechol O-methyltransferase activity [GO:0016206]; L-dopa O-methyltransferase activity [GO:0102084]; magnesium ion binding [GO:0000287]; methyltransferase activity [GO:0008168]; O-methyltransferase activity [GO:0008171]; orcinol O-methyltransferase activity [GO:0102938] GPGSEAGP 0.98612 -1.5553 0 0 0 0 0 0 0 0 0 0 0 0 12.3618 12.9397 0 0 0 0 0 12.495 0 0 0 0 0 0 0 0 0 0 0 12.7983 0 12.5219 12.8528 13.3134 0 12.7836 0 0 0 0 0 10.9805 12.6739 12.4333 0 0 0 0 0 11.4452 9.74836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6362 0 0 0 0 0 0 0 0 11.8782 0 0 0 0 14.5918 13.6065 0 0 13.9811 0 0 14.4861 10.6561 0 12.5525 15.2861 14.6616 15.6457 0 13.8514 13.7982 0 14.7615 0 0 13.8397 0 14.7523 13.8892 13.6389 13.7053 15.27 0 13.4156 15.8294 15.4045 14.4381 12.1851 12.8638 0 0 0 13.461 13.771 0 0 0 0 14.3832 14.4607 0 0 0 13.3778 0 0 0 0 0 0 0 13.2614 13.2147 0 11.303 11.548 0 0 13.0465 0 0 0 0 13.4432 0 12.4473 11.4087 15.173 15.2184 14.3589 13.4751 11.952 15.0035 0 15.3444 13.358 14.2062 13.4038 13.9904 13.1714 0 0 14.1834 0 13.64 0 0 0 0 13.2089 0 0 P29966 MARCS_HUMAN "Myristoylated alanine-rich C-kinase substrate, MARCKS (Protein kinase C substrate, 80 kDa protein, light chain, 80K-L protein, PKCSL)" MARCKS MACS PRKCSL Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; mitochondrion organization [GO:0007005]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; response to endoplasmic reticulum stress [GO:0034976] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; germinal vesicle [GO:0042585]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; germinal vesicle [GO:0042585]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; mitochondrion organization [GO:0007005]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; response to endoplasmic reticulum stress [GO:0034976] GO:0005080; GO:0005516; GO:0005737; GO:0005813; GO:0005886; GO:0005925; GO:0005938; GO:0006915; GO:0007005; GO:0007015; GO:0007417; GO:0015629; GO:0021915; GO:0022008; GO:0032432; GO:0034976; GO:0042585; GO:0042802; GO:0051015; GO:0051017; GO:0051764; GO:0070062 actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080] EELQANGSAPAADK 0.98612 -1.5559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2G4 MAP10_HUMAN Microtubule-associated protein 10 (Microtubule regulator of 120 KDa) MAP10 KIAA1383 MTR120 Homo sapiens (Human) cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]; regulation of microtubule-based process [GO:0032886] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431] centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; microtubule binding [GO:0008017]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467]; regulation of microtubule-based process [GO:0032886] GO:0005813; GO:0005881; GO:0008017; GO:0030496; GO:0031122; GO:0032467; GO:0032886; GO:0051256; GO:0051301; GO:0097431; GO:1990023 microtubule binding [GO:0008017] AECDNVGSVENGK 0.98612 -3.6596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7118 0 0 0 0 0 0 0 0 0 0 0 0 9.98242 0 0 9.95444 0 0 0 0 0 0 0 0 0 0 0 11.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6262 14.7332 0 0 13.4977 0 0 0 0 0 13.2596 0 0 0 0 0 0 11.8135 0 0 13.1257 0 11.3313 12.8356 0 0 12.449 0 0 0 11.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5303 0 0 0 0 0 0 0 12.8819 0 0 0 10.274 0 0 12.7737 0 0 0 0 0 0 12.366 0 9.53898 0 0 0 0 0 0 0 12.6665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2462 0 11.9215 0 0 0 Q9Y2U8 MAN1_HUMAN Inner nuclear membrane protein Man1 (LEM domain-containing protein 3) LEMD3 MAN1 Homo sapiens (Human) negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; regulation of intracellular signal transduction [GO:1902531] integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; chromatin DNA binding [GO:0031490]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; regulation of intracellular signal transduction [GO:1902531] GO:0005637; GO:0005639; GO:0006998; GO:0016020; GO:0016021; GO:0030512; GO:0030514; GO:0031490; GO:0031965; GO:0032926; GO:1902531 chromatin DNA binding [GO:0031490] DGAVEDEEGEGEDGEER 0.98612 -3.5665 0 0 0 0 0 0 0 10.5603 0 10.5445 0 10.389 0 0 0 0 0 0 0 0 0 0 12.948 0 0 0 0 13.0081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0558 0 0 0 0 0 0 0 0 0 0 13.5354 14.3507 0 0 14.9175 14.3831 14.6863 14.699 0 14.3342 14.1902 0 0 11.8959 0 0 0 0 15.2899 14.2362 15.7219 0 0 0 0 0 11.9 0 0 0 0 0 0 0 0 0 13.5418 0 13.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4588 0 0 0 0 0 0 0 0 0 12.5897 0 0 0 12.2678 0 0 0 0 0 0 0 12.3433 0 0 0 0 0 0 0 0 0 0 0 0 14.8821 0 0 0 14.2651 0 P37268 FDFT_HUMAN "Squalene synthase, SQS, SS, EC 2.5.1.21 (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase 1)" FDFT1 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; steroid biosynthetic process [GO:0006694] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; steroid biosynthetic process [GO:0006694] GO:0004310; GO:0005783; GO:0005789; GO:0006694; GO:0006695; GO:0016021; GO:0045338; GO:0046872; GO:0051996 farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996] DYLEDQQGGR 0.98613 -3.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86X55 CARM1_HUMAN "Histone-arginine methyltransferase CARM1, EC 2.1.1.319 (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4)" CARM1 PRMT4 Homo sapiens (Human) "aging [GO:0007568]; chromatin organization [GO:0006325]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of dendrite development [GO:2000171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor coactivator activity [GO:0030374]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; aging [GO:0007568]; chromatin organization [GO:0006325]; histone H3-R17 methylation [GO:0034971]; histone H3-R2 methylation [GO:0034970]; histone methylation [GO:0016571]; negative regulation of dendrite development [GO:2000171]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of mRNA binding [GO:1902415]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]" GO:0000976; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0007568; GO:0008013; GO:0008276; GO:0008284; GO:0008469; GO:0016274; GO:0016571; GO:0030374; GO:0033146; GO:0034970; GO:0034971; GO:0035242; GO:0035642; GO:0042054; GO:0045600; GO:0051591; GO:0070577; GO:1902415; GO:2000171 beta-catenin binding [GO:0008013]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor coactivator activity [GO:0030374]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] ILMAKSVK 0.98613 -3.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.066 0 0 18.0935 0 0 0 0 0 0 13.8803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8063 0 0 0 0 0 0 0 13.1899 0 0 0 0 Q8TDU9 RL3R2_HUMAN "Relaxin-3 receptor 2, RLN3 receptor 2 (G-protein coupled receptor 100) (G-protein coupled receptor GPCR142) (Insulin-like peptide INSL5 receptor) (Relaxin family peptide receptor 4)" RXFP4 GPCR142 GPR100 RLN3R2 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253] GO:0005886; GO:0005887; GO:0007218; GO:0008528; GO:2000253 G protein-coupled peptide receptor activity [GO:0008528] LCLLRFPSR 0.98613 -3.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9407 0 0 0 0 12.8417 0 0 0 0 12.2957 0 13.4954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1581 0 0 0 0 0 0 14.2594 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8147 0 0 12.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1533 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4897 0 0 0 0 0 0 0 0 0 0 0 Q9H4E7 DEFI6_HUMAN "Differentially expressed in FDCP 6 homolog, DEF-6 (IRF4-binding protein)" DEF6 IBP Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport to the plasma membrane [GO:0098876] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport to the plasma membrane [GO:0098876] GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0016020; GO:0030175; GO:0048471; GO:0051056; GO:0098876 guanyl-nucleotide exchange factor activity [GO:0005085] IKELEEMQQR 0.98613 -3.6635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5325 0 0 0 0 10.9432 0 0 0 0 12.2062 0 0 0 0 0 0 0 0 0 11.3688 0 0 0 11.7161 0 0 0 0 12.8954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.547 0 0 13.0831 0 0 0 0 0 0 0 0 12.2924 0 12.0671 0 0 0 0 0 0 0 13.0999 0 0 0 0 14.9098 0 0 13.2217 0 0 0 0 0 0 0 0 0 10.1438 0 0 12.2942 0 0 0 0 0 0 0 0 12.0496 13.7674 0 0 0 0 13.9328 0 0 0 0 0 0 0 0 0 0 0 14.9642 0 0 0 0 13.2663 0 0 0 13.7844 0 12.4121 11.8607 12.7032 14.3285 14.6148 0 14.0177 0 11.9115 0 12.5839 13.424 15.6883 13.4116 15.4267 0 11.8032 13.0442 0 12.2083 0 0 P23769 GATA2_HUMAN Endothelial transcription factor GATA-2 (GATA-binding protein 2) GATA2 Homo sapiens (Human) "brown fat cell differentiation [GO:0050873]; cell differentiation in hindbrain [GO:0021533]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; glandular epithelial cell maturation [GO:0002071]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transcription by RNA polymerase II [GO:0006366]; urogenital system development [GO:0001655]; vascular wound healing [GO:0061042]; ventral spinal cord interneuron differentiation [GO:0021514]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; brown fat cell differentiation [GO:0050873]; cell differentiation in hindbrain [GO:0021533]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; central nervous system neuron development [GO:0021954]; cochlea development [GO:0090102]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; definitive hemopoiesis [GO:0060216]; embryonic placenta development [GO:0001892]; eosinophil fate commitment [GO:0035854]; GABAergic neuron differentiation [GO:0097154]; glandular epithelial cell maturation [GO:0002071]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; homeostasis of number of cells within a tissue [GO:0048873]; inner ear morphogenesis [GO:0042472]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of gene expression [GO:0010629]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of forebrain neuron differentiation [GO:2000977]; regulation of histone acetylation [GO:0035065]; regulation of primitive erythrocyte differentiation [GO:0010725]; response to lipid [GO:0033993]; semicircular canal development [GO:0060872]; somatic stem cell population maintenance [GO:0035019]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transcription by RNA polymerase II [GO:0006366]; urogenital system development [GO:0001655]; vascular wound healing [GO:0061042]; ventral spinal cord interneuron differentiation [GO:0021514]" GO:0000122; GO:0000978; GO:0000981; GO:0001221; GO:0001223; GO:0001228; GO:0001655; GO:0001709; GO:0001764; GO:0001892; GO:0002071; GO:0002244; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006366; GO:0006909; GO:0007204; GO:0008270; GO:0010628; GO:0010629; GO:0010725; GO:0021514; GO:0021533; GO:0021902; GO:0021954; GO:0033993; GO:0035019; GO:0035065; GO:0035854; GO:0042472; GO:0043306; GO:0043536; GO:0045165; GO:0045599; GO:0045648; GO:0045650; GO:0045654; GO:0045666; GO:0045746; GO:0045766; GO:0045944; GO:0048873; GO:0050766; GO:0050873; GO:0060100; GO:0060129; GO:0060216; GO:0060872; GO:0061042; GO:0061351; GO:0061484; GO:0061629; GO:0070345; GO:0070742; GO:0090050; GO:0090102; GO:0097154; GO:1901533; GO:1902895; GO:1903444; GO:1903589; GO:1990837; GO:2000178; GO:2000352; GO:2000977 "C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" ARSCSEGR 0.98614 -3.4962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12931 TRAP1_HUMAN "Heat shock protein 75 kDa, mitochondrial, HSP 75 (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein, TRAP-1)" TRAP1 HSP75 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386] cell periphery [GO:0071944]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cell periphery [GO:0071944]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386] GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0071944; GO:1901856; GO:1903427; GO:1903751 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082] AGTRNIYYLCAPNRHLAEHSPYYEAMK 0.98614 -1.6496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.959 0 0 0 0 12.7062 0 0 0 0 0 0 13.8152 0 0 0 11.8166 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2156 0 0 0 0 0 0 14.405 0 11.0377 0 0 0 0 13.6193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3756 0 0 0 0 0 0 0 0 0 0 0 14.1254 0 0 0 0 0 0 0 0 0 0 0 11.1586 0 0 0 14.1506 0 0 0 0 0 0 0 14.1594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14596 NBR1_HUMAN Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B) NBR1 1A13B KIAA0049 M17S2 MIG19 Homo sapiens (Human) macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872] autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235] autophagosome [GO:0005776]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; phagophore assembly site [GO:0000407]; receptor complex [GO:0043235]; mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; macroautophagy [GO:0016236]; negative regulation of osteoblast differentiation [GO:0045668]; regulation of bone mineralization [GO:0030500]; regulation of stress-activated MAPK cascade [GO:0032872] GO:0000407; GO:0005654; GO:0005758; GO:0005764; GO:0005770; GO:0005776; GO:0005778; GO:0005829; GO:0008270; GO:0016020; GO:0016236; GO:0016604; GO:0030500; GO:0031430; GO:0032872; GO:0043130; GO:0043231; GO:0043235; GO:0045668; GO:0051019 mitogen-activated protein kinase binding [GO:0051019]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] DVLVPCLK 0.98614 -3.4987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60598 0 0 0 0 0 0 14.2562 0 0 0 0 0 0 11.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8374 0 0 0 0 0 0 0 0 0 0 0 12.2528 0 12.3192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9601 0 0 0 Q5XG92 EST4A_HUMAN "Carboxylesterase 4A, EC 3.1.1.-" CES4A CES8 UNQ440/PRO873 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689] GO:0005576; GO:0052689 carboxylic ester hydrolase activity [GO:0052689] FPLNRQAMRK 0.98614 -1.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHV4 NEDD1_HUMAN "Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1, NEDD-1)" NEDD1 Homo sapiens (Human) cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278] apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278] GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301 gamma-tubulin binding [GO:0043015] HLKYSLFKK 0.98614 -2.0972 0 13.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4895 0 0 0 0 0 0 0 0 11.5107 0 0 0 0 0 0 11.1829 0 0 0 0 0 0 0 12.4719 0 11.6736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5662 0 0 0 13.1599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6775 0 0 0 0 10.78 Q9Y237 PIN4_HUMAN "Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4, EC 5.2.1.8 (Parvulin-14, Par14, hPar14) (Parvulin-17, Par17, hPar17) (Peptidyl-prolyl cis-trans isomerase Pin4, PPIase Pin4) (Peptidyl-prolyl cis/trans isomerase EPVH, hEPVH) (Rotamase Pin4)" PIN4 Homo sapiens (Human) rRNA processing [GO:0006364] chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819] chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]; bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003677; GO:0003681; GO:0003690; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005759; GO:0005819; GO:0006364; GO:0030684 bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723] GGGNAVKVR 0.98616 -1.5812 0 0 0 0 0 0 0 0 15.1126 0 0 15.3417 0 15.3014 15.9063 13.3471 13.924 0 13.9765 12.2919 14.6799 13.6858 12.5603 0 14.3736 14.179 14.1949 0 13.8303 15.4983 13.5877 15.4054 13.2774 15.6679 15.4766 15.1364 14.4546 15.2278 15.3786 15.0632 0 13.1267 14.2458 14.3344 0 14.596 14.4223 16.0462 15.0353 15.1901 14.6599 0 13.1738 0 13.899 13.4895 13.5946 13.9448 12.8557 13.0282 13.1702 14.1673 13.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6559 15.6782 0 0 0 0 0 0 0 0 13.0098 14.8925 16.5884 16.1816 16.1429 14.9213 0 13.9364 16.2615 14.3421 0 14.2548 14.2493 0 19.4184 0 0 0 0 16.22 0 0 0 0 P0DMU3 F231L_HUMAN FAM231A/C-like protein LOC102723383 Homo sapiens (Human) EEGTFWTERVGQER 0.98616 -3.5965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV87 CNPD1_HUMAN Protein CNPPD1 (Cyclin Pas1/PHO80 domain-containing protein 1) CNPPD1 C2orf24 CDABP0125 CGI-57 Homo sapiens (Human) regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000307; GO:0005634; GO:0016021; GO:0016538; GO:0019901 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] AAPSPIRRLQK 0.98616 -3.3098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9443 0 0 12.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1861 0 0 0 0 12.3566 0 0 12.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NVV9 ADAM5_HUMAN "Putative disintegrin and metalloproteinase domain-containing protein 5 (Putative transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein II, tMDC II)" ADAM5 ADAM5P TMDC2 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155] GO:0007155; GO:0007339 DETFVQDGSMCGPDMYCFEMHCK 0.98617 -3.8999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6485 0 13.6397 0 0 0 0 0 0 0 0 14.7112 0 0 0 14.9797 0 14.5405 0 0 0 0 14.8793 0 0 0 0 0 0 0 11.483 0 0 0 0 0 0 0 0 15.273 0 15.215 0 14.9312 0 0 13.0881 11.4426 13.5587 14.055 0 0 14.0221 0 0 0 0 13.1618 0 0 0 15.046 0 15.4175 0 12.9528 11.5857 11.3299 0 0 0 0 15.4584 15.1028 0 0 14.8919 0 0 0 0 0 0 0 0 0 15.3988 14.6988 0 14.9818 0 10.0604 0 13.3358 0 0 0 0 0 0 10.2523 0 15.2071 0 0 0 15.2538 0 0 0 0 0 0 0 14.2504 0 0 0 11.5822 0 0 0 0 14.1741 0 0 14.2627 0 0 0 0 0 0 0 0 0 13.9262 14.1161 11.7402 0 0 0 Q96ES6 MFSD3_HUMAN Major facilitator superfamily domain-containing protein 3 MFSD3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; solute:proton symporter activity [GO:0015295] GO:0015295; GO:0016021 solute:proton symporter activity [GO:0015295] GKLLPLAGLYLVQGLPYGLQSGLLPVLLR 0.98617 -3.8946 0 0 0 0 0 0 0 0 0 0 12.1338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7908 0 11.1097 0 0 11.5864 0 0 11.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8978 0 0 0 0 0 0 0 0 11.9013 0 0 13.0494 0 0 0 12.722 13.4924 12.7159 13.5779 0 14.4686 13.8953 11.1612 13.8603 12.3007 0 14.671 14.1345 0 0 13.4844 0 0 0 0 0 13.3559 13.7082 0 13.4651 0 13.9164 0 0 13.9888 0 0 0 0 0 14.0756 0 14.2235 13.7375 0 12.5294 0 0 0 0 0 14.7212 0 0 0 13.7722 0 0 0 0 14.4276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9791 0 0 0 0 0 0 0 0 0 0 0 12.9028 0 0 14.6909 0 0 13.8936 0 0 0 0 0 Q9H211 CDT1_HUMAN "DNA replication factor Cdt1 (Double parked homolog, DUP)" CDT1 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated DNA replication [GO:2000104]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated DNA replication [GO:2000105]; positive regulation of protein localization to kinetochore [GO:1905342]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708] kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; kinetochore organization [GO:0051383]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated DNA replication [GO:2000104]; negative regulation of protein localization to kinetochore [GO:1905341]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated DNA replication [GO:2000105]; positive regulation of protein localization to kinetochore [GO:1905342]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication origin binding [GO:1902595]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708] GO:0000076; GO:0000278; GO:0000776; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0007059; GO:0016604; GO:0030174; GO:0031334; GO:0033044; GO:0033262; GO:0035563; GO:0045740; GO:0045786; GO:0051301; GO:0051315; GO:0051383; GO:0070182; GO:0071163; GO:0072708; GO:1902426; GO:1902595; GO:1905341; GO:1905342; GO:2000104; GO:2000105 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182] FRQERSVPTFK 0.98617 -3.9008 0 0 0 0 0 0 0 0 14.8816 13.816 14.2416 13.7423 14.3859 0 14.0728 0 0 0 0 0 0 0 0 0 0 12.7722 0 0 12.6723 0 14.3944 0 12.6845 0 0 0 0 14.279 14.5341 0 14.8283 13.7378 13.9296 12.7262 12.7621 13.3669 0 0 12.5464 13.1391 12.3494 0 0 0 0 0 0 10.1695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5636 0 13.2126 14.464 0 14.0229 13.8139 0 13.7082 0 13.1939 13.5015 14.0462 13.0493 12.9946 13.6661 0 13.4942 13.6262 0 14.4126 0 10.5493 11.528 16.6556 12.6337 17.9452 0 0 0 0 13.8711 13.927 12.1566 13.9541 0 0 0 0 0 14.2676 0 14.5042 0 0 0 0 0 14.021 14.2668 0 13.1426 12.9942 11.5796 15.0849 14.3114 13.0166 14.4924 13.4202 14.112 13.8079 0 0 0 13.1278 0 0 0 0 13.9645 0 0 0 0 14.0275 0 0 13.8641 0 0 14.2302 13.8863 0 0 13.3651 0 13.2362 0 0 0 0 0 0 0 12.3195 0 0 12.1244 10.6897 14.0263 0 0 0 12.3041 0 0 P08514 ITA2B_HUMAN "Integrin alpha-IIb (GPalpha IIb, GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2 ]" ITGA2B GP2B ITGAB Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] blood microparticle [GO:0072562]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] blood microparticle [GO:0072562]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] GO:0001525; GO:0005178; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0031092; GO:0033627; GO:0042802; GO:0046872; GO:0050840; GO:0070062; GO:0072562; GO:0098609 extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; metal ion binding [GO:0046872] AIPIWWVLVGVLGGLLLLTILVLAMWK 0.98618 -3.5212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0389 0 0 0 0 0 0 11.5491 0 13.8019 0 0 12.294 0 0 0 0 0 11.2881 0 0 0 0 0 0 0 0 0 0 0 0 10.8456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8197 0 0 0 0 12.8339 9.7034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6156 0 10.9602 0 0 0 11.7596 10.2454 0 0 13.0006 0 12.8783 11.5332 0 Q9NUC0 SRTD4_HUMAN SERTA domain-containing protein 4 SERTAD4 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 ITYFKRK 0.98618 -3.5252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7294 0 0 12.2738 0 0 0 0 0 0 0 0 0 0 0 0 13.19 0 0 13.0518 0 13.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4842 0 0 0 0 0 0 0 0 13.9857 0 0 0 0 0 0 0 0 12.7654 0 0 0 0 0 0 13.8745 0 0 12.9578 0 0 12.9328 12.0129 0 0 0 0 12.1351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0264 12.4652 12.1267 0 0 0 0 12.6704 0 Q9Y575 ASB3_HUMAN "Ankyrin repeat and SOCS box protein 3, ASB-3" ASB3 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein localization to T-tubule [GO:0036371]; protein ubiquitination [GO:0016567]; regulation of cardiac muscle contraction [GO:0055117] cytosol [GO:0005829]; T-tubule [GO:0030315] cytosol [GO:0005829]; T-tubule [GO:0030315]; intracellular signal transduction [GO:0035556]; protein localization to T-tubule [GO:0036371]; protein ubiquitination [GO:0016567]; regulation of cardiac muscle contraction [GO:0055117] GO:0005829; GO:0016567; GO:0030315; GO:0035556; GO:0036371; GO:0055117 LLLRKGANK 0.98618 -1.5934 0 0 0 17.391 0 0 0 0 0 0 12.3249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2218 0 0 P55268 LAMB2_HUMAN "Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta, S-LAM beta)" LAMB2 LAMS Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric podocyte development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric podocyte development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005788; GO:0007411; GO:0007528; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0014044; GO:0016477; GO:0031594; GO:0034446; GO:0043083; GO:0043256; GO:0043260; GO:0045785; GO:0048677; GO:0051149; GO:0060041; GO:0062023; GO:0070062; GO:0070831; GO:0072249; GO:0072274; GO:0098637; GO:0110011; GO:2001046 extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] ARGPTCNEFTGQCHCR 0.98619 -3.5405 0 0 0 12.4427 0 0 0 0 13.1606 10.8934 12.6632 0 0 12.8774 0 11.148 0 14.5137 14.7727 0 11.7752 13.3004 15.3995 0 15.6221 14.0426 0 13.6354 14.3582 0 0 11.3488 10.8273 15.6555 12.5298 0 12.3742 10.9267 0 15.3724 15.6477 0 0 0 15.5525 15.666 0 0 0 0 10.3907 0 0 0 0 0 0 0 0 0 0 11.8707 0 0 0 0 12.1934 0 0 10.9615 0 0 13.8305 14.0363 0 0 0 15.1082 15.0616 15.047 0 13.5184 0 0 0 13.5636 18.9812 15.1614 13.6966 14.9978 11.4199 15.4407 14.7847 13.5634 14.304 12.1409 18.5762 12.0705 17.9449 11.3683 15.4107 0 0 0 13.6185 14.9409 17.4174 0 0 0 0 12.8453 11.5091 0 0 13.7974 0 14.6664 0 0 0 17.4895 14.7159 0 0 0 14.6417 14.6764 0 15.379 0 15.6131 14.8796 14.9144 0 14.0869 12.8952 15.5238 0 15.659 15.1621 0 0 16.107 15.3049 10.7306 0 15.1457 0 0 12.6798 0 0 0 10.3296 0 17.1747 0 11.8662 0 12.4958 19.9415 0 0 0 0 15.461 17.3386 11.9458 16.3025 0 0 15.1623 14.7928 14.809 0 17.8209 12.8204 0 0 P01834 IGKC_HUMAN Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI) IGKC Homo sapiens (Human) "adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; retina homeostasis [GO:0001895]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgD immunoglobulin complex [GO:0071738]; IgE immunoglobulin complex [GO:0071742]; IgG immunoglobulin complex [GO:0071735]; IgM immunoglobulin complex [GO:0071753]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]" "blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; IgA immunoglobulin complex [GO:0071745]; IgD immunoglobulin complex [GO:0071738]; IgE immunoglobulin complex [GO:0071742]; IgG immunoglobulin complex [GO:0071735]; IgM immunoglobulin complex [GO:0071753]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; retina homeostasis [GO:0001895]" GO:0001895; GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871; GO:0070062; GO:0071735; GO:0071738; GO:0071742; GO:0071745; GO:0071753; GO:0072562 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] SFNRGEC 0.9862 -3.5482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5497 14.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5UCC4 EMC10_HUMAN ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1) EMC10 C19orf63 INM02 UNQ764/PRO1556 Homo sapiens (Human) angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of p38MAPK cascade [GO:1900745]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0001525; GO:0001938; GO:0005576; GO:0005789; GO:0010595; GO:0016021; GO:0030176; GO:0045050; GO:0045766; GO:0071816; GO:0072546; GO:1900745 AAASAGATRLLLLLLMAVAAPSR 0.9862 -3.5408 0 0 0 0 0 0 0 9.10297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1441 0 0 0 0 0 0 0 0 0 0 0 10.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0662 0 0 0 0 0 0 0 0 0 0 13.4101 0 0 11.9934 0 0 12.3969 0 11.9235 0 0 0 0 0 0 0 0 0 0 0 14.852 0 0 12.4769 0 0 11.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2269 P17540 KCRS_HUMAN "Creatine kinase S-type, mitochondrial, EC 2.7.3.2 (Basic-type mitochondrial creatine kinase, Mib-CK) (Sarcomeric mitochondrial creatine kinase, S-MtCK)" CKMT2 Homo sapiens (Human) muscle contraction [GO:0006936]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; muscle contraction [GO:0006936]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310] GO:0004111; GO:0005524; GO:0005739; GO:0005743; GO:0006936; GO:0016301; GO:0016310; GO:0046314 ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301] FSKILENLRLQK 0.98621 -3.3657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2293 0 0 0 0 0 0 0 14.9031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8426 0 0 0 0 0 0 0 14.9647 0 0 0 0 0 0 13.4477 0 0 0 0 14.3777 0 0 0 0 0 0 0 0 0 0 0 0 14.8131 0 0 0 0 0 0 0 0 0 12.7433 0 0 0 0 0 0 Q5T5A8 LCE3C_HUMAN Late cornified envelope protein 3C (Late envelope protein 15) (Small proline-rich-like epidermal differentiation complex protein 3A) LCE3C LEP15 SPRL3A Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; keratinization [GO:0031424]; killing of cells of another organism [GO:0031640] defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; keratinization [GO:0031424]; killing of cells of another organism [GO:0031640] GO:0031424; GO:0031640; GO:0050829; GO:0050830 CPPKSPAQCLPPPSSDCALSSGGCGPSSESGCCLSHHRHFR 0.98621 -3.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4096 0 0 0 10.7781 0 0 0 0 10.9675 0 0 11.8139 0 0 0 0 9.38478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9923 0 0 11.62 0 12.318 0 0 0 13.1995 0 0 13.7619 12.2748 0 0 0 0 0 0 12.7532 0 0 0 0 13.8272 0 0 0 0 0 12.6163 0 0 0 0 11.0332 0 0 11.7275 12.4488 0 0 12.4848 0 12.3376 12.8237 0 0 0 12.7125 14.7596 13.8216 12.9413 0 13.4387 13.4074 0 0 0 0 0 0 0 0 11.9498 0 0 13.0319 0 0 14.3004 12.7303 0 0 12.6163 0 0 0 0 0 0 0 0 11.3628 0 0 0 0 0 0 0 0 0 13.1665 0 0 0 0 0 0 Q15582 BGH3_HUMAN "Transforming growth factor-beta-induced protein ig-h3, Beta ig-h3 (Kerato-epithelin) (RGD-containing collagen-associated protein, RGD-CAP)" TGFBI BIGH3 Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0050896; GO:0062023; GO:0070062 cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178] ALFVRLLALALALALGPAATLAGPAKSPYQLVLQHSR 0.98622 -2.4774 0 0 0 0 0 0 0 0 12.0105 12.2031 0 11.3168 0 14.0191 0 13.4324 0 11.8119 0 0 0 0 12.8505 0 0 0 13.1907 12.0494 0 0 0 0 0 0 0 11.424 12.94 0 11.8336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7601 0 0 0 13.118 12.7689 0 0 0 0 0 11.8024 0 0 0 0 0 0 0 0 0 13.6618 0 13.7062 0 0 0 0 0 0 14.1681 13.444 0 0 11.9362 11.0862 0 0 0 0 0 0 13.7966 0 0 0 0 12.4339 0 0 13.6964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5868 0 0 0 0 0 0 0 0 12.9823 13.0093 0 0 15.2847 11.9894 0 0 0 0 0 14.157 0 0 0 0 14.2639 0 0 0 0 0 0 0 0 12.824 0 0 0 0 14.3224 0 0 0 0 11.8822 Q96AJ9 VTI1A_HUMAN Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2) VTI1A Homo sapiens (Human) "autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882]" autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] "autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882]" GO:0000139; GO:0000149; GO:0005484; GO:0005768; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0006896; GO:0006906; GO:0006914; GO:0008021; GO:0012507; GO:0016021; GO:0016236; GO:0030136; GO:0031201; GO:0031902; GO:0032588; GO:0042147; GO:0043025; GO:0043231; GO:0044306; GO:0048280; GO:0048471; GO:0050882; GO:0090161 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] EIPPQSRGMYSNRMR 0.98622 -1.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1487 0 0 0 16.2478 0 0 0 16.0553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0635 0 0 0 0 0 0 13.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0165 0 0 0 0 11.0972 0 0 0 0 11.5261 0 0 0 0 0 0 0 0 0 0 10.1189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0114 17.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2901 0 0 0 0 0 0 0 12.0667 0 0 11.131 0 0 0 Q13409 DC1I2_HUMAN "Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic, DH IC-2)" DYNC1I2 DNCI2 DNCIC2 Homo sapiens (Human) microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970] GO:0003777; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0010970; GO:0030286; GO:0031982; GO:0045503; GO:0045504 dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777] DEENDSK 0.98623 -3.5745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99952 PTN18_HUMAN "Tyrosine-protein phosphatase non-receptor type 18, EC 3.1.3.48 (Brain-derived phosphatase)" PTPN18 BDP1 Homo sapiens (Human) blastocyst formation [GO:0001825]; negative regulation of ERBB signaling pathway [GO:1901185]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; blastocyst formation [GO:0001825]; negative regulation of ERBB signaling pathway [GO:1901185]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470] GO:0001825; GO:0004725; GO:0004726; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0035335; GO:1901185 non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] PENVRKNR 0.98623 -3.5773 0 0 0 0 0 0 0 0 11.7502 0 0 0 0 0 12.3921 0 12.0993 12.2546 0 0 0 0 0 0 0 0 12.5245 0 12.1175 0 0 12.4369 0 12.5546 0 0 0 0 0 0 0 0 0 12.8157 0 0 0 12.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6835 0 0 0 0 0 14.0827 0 0 0 0 0 0 0 0 0 0 14.2529 0 0 P30419 NMT1_HUMAN "Glycylpeptide N-tetradecanoyltransferase 1, EC 2.3.1.97 (Myristoyl-CoA:protein N-myristoyltransferase 1, HsNMT1, NMT 1, Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1) (Protein-lysine myristoyltransferase NMT1, EC 2.3.1.-)" NMT1 NMT Homo sapiens (Human) cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of rhodopsin mediated signaling pathway [GO:0022400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030]; cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; N-terminal protein myristoylation [GO:0006499]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; regulation of rhodopsin mediated signaling pathway [GO:0022400] GO:0001701; GO:0004379; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006499; GO:0018008; GO:0018030; GO:0019107; GO:0019898; GO:0022400; GO:0042180; GO:1900740 glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030] ADESETAVK 0.98625 -1.6496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEF2 CJ105_HUMAN Uncharacterized protein C10orf105 C10orf105 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 HGRPTVPR 0.98625 -1.5646 0 0 0 0 11.5715 0 0 10.5176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5012 0 0 0 0 0 0 0 0 0 0 12.8625 0 12.941 0 0 10.6139 0 0 0 0 12.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1037 0 0 11.7385 0 0 0 0 0 0 0 0 11.1817 0 0 0 0 0 0 0 0 0 0 0 12.5938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6523 0 0 0 0 0 0 0 0 0 12.3752 0 0 0 0 0 11.4521 10.9563 0 0 0 0 11.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PJW6 TM223_HUMAN Transmembrane protein 223 TMEM223 Homo sapiens (Human) nervous system development [GO:0007399] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nervous system development [GO:0007399] GO:0005739; GO:0007399; GO:0016021 GEVPAMLPLKVK 0.98626 -3.3141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95573 ACSL3_HUMAN "Fatty acid CoA ligase Acsl3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3, LACS 3) (Long-chain-fatty-acid--CoA ligase 3, EC 6.2.1.3) (Medium-chain acyl-CoA ligase Acsl3, EC 6.2.1.2)" ACSL3 ACS3 FACL3 LACS3 Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; palmitoyl-CoA ligase activity [GO:0090433]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006631; GO:0016020; GO:0016021; GO:0019901; GO:0019904; GO:0030182; GO:0031956; GO:0034379; GO:0035336; GO:0035338; GO:0042998; GO:0044539; GO:0047676; GO:0048471; GO:0051047; GO:0090433; GO:2001247 arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; palmitoyl-CoA ligase activity [GO:0090433]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] DIVSLVPRLR 0.98626 -1.6508 0 0 0 0 0 0 10.6935 0 0 0 0 0 0 0 0 0 13.1056 0 0 0 12.0024 0 0 0 0 0 0 13.4794 0 0 0 0 0 0 0 0 0 12.4028 0 0 0 0 0 13.3167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3669 0 0 0 0 0 0 0 0 0 0 0 12.2878 0 12.8331 0 0 0 0 0 0 16.1807 0 0 0 0 0 0 0 0 0 12.8717 0 0 0 0 0 0 13.2499 0 13.4831 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7128 0 0 0 0 0 0 0 0 0 0 0 11.5821 0 0 0 0 0 0 12.5211 0 0 0 0 0 0 0 0 0 0 11.2204 0 0 0 0 15.5712 0 0 0 0 0 0 0 13.2157 0 0 0 0 0 0 P09234 RU1C_HUMAN "U1 small nuclear ribonucleoprotein C, U1 snRNP C, U1-C, U1C" SNRPC Homo sapiens (Human) "mRNA 5'-splice site recognition [GO:0000395]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" Cajal body [GO:0015030]; commitment complex [GO:0000243]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] "Cajal body [GO:0015030]; commitment complex [GO:0000243]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" GO:0000243; GO:0000387; GO:0000395; GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005685; GO:0008270; GO:0015030; GO:0030627; GO:0042803; GO:0071004 mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] ENVKDYYQKWMEEQAQSLIDK 0.98626 -3.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13416 ORC2_HUMAN Origin recognition complex subunit 2 ORC2 ORC2L Homo sapiens (Human) DNA replication initiation [GO:0006270]; negative regulation of transcription by RNA polymerase II [GO:0000122] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; inner kinetochore [GO:0000939]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; inner kinetochore [GO:0000939]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; DNA replication origin binding [GO:0003688]; DNA replication initiation [GO:0006270]; negative regulation of transcription by RNA polymerase II [GO:0000122]" GO:0000122; GO:0000781; GO:0000792; GO:0000808; GO:0000939; GO:0003688; GO:0005634; GO:0005654; GO:0005664; GO:0005813; GO:0006270; GO:0016020 DNA replication origin binding [GO:0003688] DVQESLK 0.98626 -3.6011 0 0 0 0 0 0 0 0 15.4527 0 0 15.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6363 0 0 0 0 15.2995 0 0 15.4616 0 0 0 14.5485 13.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2159 0 0 0 0 0 0 0 0 0 14.3149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0974 0 0 0 0 0 0 0 0 Q86Y34 AGRG3_HUMAN Adhesion G protein-coupled receptor G3 (G-protein coupled receptor 97) (G-protein coupled receptor PGR26) ADGRG3 GPR97 PGR26 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; regulation of cell migration [GO:0030334] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; regulation of cell migration [GO:0030334] GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0030183; GO:0030334; GO:0032792; GO:0035579; GO:1901223 G protein-coupled receptor activity [GO:0004930] ATPRGLGALLLLLLLPTSGQEK 0.98626 -3.6021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1713 0 0 0 0 0 0 0 12.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5282 0 0 0 0 10.8957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.258 0 15.0769 14.2239 0 0 0 0 0 0 0 0 0 0 0 15.1484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4916 13.6704 0 0 0 0 0 0 0 0 0 13.1902 0 0 0 0 0 0 13.6927 14.1244 0 13.9726 0 0 0 14.1546 0 13.5687 0 0 0 0 0 0 0 0 0 0 0 0 Q8N365 CIART_HUMAN "Circadian-associated transcriptional repressor (ChIP-derived repressor of network oscillator, Chrono) (Computationally highlighted repressor of the network oscillator)" CIART C1orf51 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634]; PML body [GO:0016605] "nucleus [GO:0005634]; PML body [GO:0016605]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; circadian regulation of gene expression [GO:0032922]; locomotor rhythm [GO:0045475]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0000978; GO:0005634; GO:0016605; GO:0032922; GO:0045475; GO:0045892; GO:0070888 E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] PSPGPIR 0.98626 -1.6541 0 0 0 0 0 0 0 10.7243 15.2735 14.7077 11.7449 14.4668 10.9112 0 13.378 15.9401 0 0 0 0 0 0 0 0 13.4175 0 0 13.0743 0 11.0727 0 10.8362 13.8804 11.9861 12.1518 13.1432 14.2636 14.4747 0 13.7184 12.0648 13.5238 0 0 11.0439 13.4925 10.4991 13.8243 13.6153 13.5463 11.7072 13.6636 0 0 13.7288 0 14.0636 0 13.2653 12.8361 0 12.206 0 0 0 11.4262 14.613 14.746 0 0 0 0 13.4239 13.1619 14.2885 14.3162 0 14.7013 13.9616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2777 0 0 0 0 0 14.2858 0 0 0 0 14.3647 14.2568 0 0 14.9971 0 0 14.1398 14.1541 0 0 0 0 14.0531 14.3083 0 0 0 14.5636 0 0 0 0 0 0 14.1629 0 14.2397 0 0 0 0 0 0 0 0 14.1647 0 14.3773 14.4248 15.116 0 0 0 0 0 0 0 14.0504 14.8071 12.7335 15.5113 15.0617 15.4352 13.3592 16.0819 15.9306 15.4728 13.5762 15.4875 13.3089 15.6091 15.0453 14.948 0 0 0 13.6865 16.0918 0 15.8446 13.9714 0 Q8WUS8 D42E1_HUMAN "Short-chain dehydrogenase/reductase family 42E member 1, EC 1.1.1.-" SDR42E1 HSPC105 Homo sapiens (Human) steroid biosynthetic process [GO:0006694] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid biosynthetic process [GO:0006694]" GO:0003854; GO:0006694; GO:0016021; GO:0016616 "3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" FVYGDPR 0.98626 -3.8943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92911 SC5A5_HUMAN "Sodium/iodide cotransporter, Na(+)/I(-) cotransporter (Sodium-iodide symporter, Na(+)/I(-) symporter) (Solute carrier family 5 member 5)" SLC5A5 NIS Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; iodide transmembrane transport [GO:1904200]; iodide transport [GO:0015705]; ion transport [GO:0006811]; sodium ion transport [GO:0006814]; thyroid hormone generation [GO:0006590]; transport across blood-brain barrier [GO:0150104] extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; iodide transmembrane transporter activity [GO:0015111]; sodium:iodide symporter activity [GO:0008507]; symporter activity [GO:0015293]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; iodide transmembrane transport [GO:1904200]; iodide transport [GO:0015705]; ion transport [GO:0006811]; sodium ion transport [GO:0006814]; thyroid hormone generation [GO:0006590]; transport across blood-brain barrier [GO:0150104] GO:0005634; GO:0005886; GO:0006590; GO:0006811; GO:0006814; GO:0008507; GO:0015111; GO:0015293; GO:0015705; GO:0016021; GO:0070062; GO:0071320; GO:0071371; GO:0150104; GO:1903561; GO:1904200 iodide transmembrane transporter activity [GO:0015111]; sodium:iodide symporter activity [GO:0008507]; symporter activity [GO:0015293] GPEELPTGNK 0.98626 -1.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5985 11.9392 14.7906 0 12.4522 0 0 0 0 0 0 0 14.3235 0 0 11.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5249 0 0 13.3361 0 0 0 0 0 0 0 0 0 0 0 0 12.952 12.5162 0 0 11.3427 11.5001 0 0 0 11.7412 0 0 0 11.5139 0 0 12.5891 0 0 0 0 11.4839 0 0 0 0 0 0 0 14.1015 0 12.7398 0 0 0 0 0 0 12.3311 13.5305 0 0 12.4399 0 0 0 11.2551 0 11.6294 0 0 12.9777 0 0 0 0 Q96GD0 PLPP_HUMAN "Chronophin, EC 3.1.3.16, EC 3.1.3.74 (Pyridoxal phosphate phosphatase, PLP phosphatase)" PDXP CIN PLP PLPP Homo sapiens (Human) actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; protein dephosphorylation [GO:0006470]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]; glycerol-3-phosphatase activity [GO:0043136]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; pyridoxal phosphatase activity [GO:0033883]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; protein dephosphorylation [GO:0006470]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088] GO:0000287; GO:0004721; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0006470; GO:0007088; GO:0016311; GO:0016791; GO:0017018; GO:0030836; GO:0031072; GO:0031247; GO:0031258; GO:0032361; GO:0032465; GO:0032587; GO:0033883; GO:0042803; GO:0043136; GO:0071318 glycerol-3-phosphatase activity [GO:0043136]; heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; pyridoxal phosphatase activity [GO:0033883] ARPELALR 0.98626 -3.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6R7 WDCP_HUMAN WD repeat and coiled-coil-containing protein WDCP C2orf44 PP384 Homo sapiens (Human) protein complex oligomerization [GO:0051259] kinase binding [GO:0019900]; protein complex oligomerization [GO:0051259] GO:0019900; GO:0051259 kinase binding [GO:0019900] AVLLCDGK 0.98626 -3.3098 0 0 0 0 0 0 14.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3907 0 0 0 0 0 0 0 0 0 0 15.0916 0 0 0 0 0 0 0 0 0 0 0 13.8883 0 0 0 0 0 0 14.8103 0 11.2238 0 0 0 0 0 10.3608 0 0 0 0 0 13.4118 0 0 12.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8923 0 0 0 0 0 0 0 0 0 10.2159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0086 0 0 Q9H9V9 JMJD4_HUMAN "2-oxoglutarate and iron-dependent oxygenase JMJD4, EC 1.14.11.- (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4)" JMJD4 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; peptidyl-lysine 4-dioxygenase activity [GO:0106156]; sequence-specific DNA binding [GO:0043565]; negative regulation of gene expression [GO:0010629]; positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126] GO:0005634; GO:0005737; GO:0010629; GO:0016706; GO:0018126; GO:0043565; GO:0045905; GO:0046872; GO:0106156 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; peptidyl-lysine 4-dioxygenase activity [GO:0106156]; sequence-specific DNA binding [GO:0043565] DYITYWK 0.98626 -3.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3493 0 0 0 0 17.0872 0 0 0 16.8132 0 0 13.8273 0 12.0308 0 10.8595 0 12.6698 0 15.1305 0 14.1335 16.9963 0 0 0 0 0 11.8761 12.3404 0 11.7145 0 11.137 0 0 0 0 0 0 0 0 18.5206 0 0 0 0 15.943 16.8113 0 15.6086 0 14.9758 0 14.8772 15.0821 15.2855 15.2645 14.839 0 15.4139 0 15.5495 15.2861 15.4115 15.2194 15.4965 0 0 0 0 0 15.9413 0 16.2656 0 0 17.396 17.8787 0 0 13.9491 0 0 15.4262 0 0 0 0 0 15.7003 16.2947 15.7354 17.3454 16.2068 16.1305 0 0 16.7078 16.7494 0 0 15.6832 0 0 0 16.2224 16.0752 0 15.305 15.6576 0 0 0 15.7638 0 15.1805 0 16.4773 0 15.854 16.896 15.5383 15.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1761 0 15.8693 0 0 0 0 0 0 0 A8MYB1 TMC5B_HUMAN Transmembrane and coiled-coil domain-containing protein 5B TMCO5B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CWYKYFQYLTFMVLVFIR 0.98627 -2.0314 0 0 0 0 0 0 0 0 0 0 0 0 13.052 0 0 0 0 0 0 0 11.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.994 0 12.7134 0 0 0 0 0 0 0 12.31 14.4381 14.357 0 14.1954 0 0 0 0 14.3142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48061 SDF1_HUMAN "Stromal cell-derived factor 1, SDF-1, hSDF-1 (C-X-C motif chemokine 12) (Intercrine reduced in hepatomas, IRH, hIRH) (Pre-B cell growth-stimulating factor, PBSF) [Cleaved into: SDF-1-beta(3-72); SDF-1-alpha(3-67) ]" CXCL12 SDF1 SDF1A SDF1B Homo sapiens (Human) adult locomotory behavior [GO:0008344]; animal organ regeneration [GO:0031100]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cellular calcium ion homeostasis [GO:0006874]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; integrin activation [GO:0033622]; killing of cells of another organism [GO:0031640]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neuron migration [GO:0001764]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T cell migration [GO:2000406]; regulation of actin polymerization or depolymerization [GO:0008064]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]; telencephalon cell migration [GO:0022029] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; CXCR chemokine receptor binding [GO:0045236]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]; adult locomotory behavior [GO:0008344]; animal organ regeneration [GO:0031100]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cellular calcium ion homeostasis [GO:0006874]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; integrin activation [GO:0033622]; killing of cells of another organism [GO:0031640]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neuron migration [GO:0001764]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T cell migration [GO:2000406]; regulation of actin polymerization or depolymerization [GO:0008064]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]; telencephalon cell migration [GO:0022029] GO:0001666; GO:0001764; GO:0001938; GO:0005102; GO:0005178; GO:0005576; GO:0005634; GO:0005737; GO:0006874; GO:0006935; GO:0006952; GO:0006955; GO:0007155; GO:0007165; GO:0007186; GO:0007411; GO:0008009; GO:0008015; GO:0008064; GO:0008083; GO:0008344; GO:0009314; GO:0009408; GO:0009615; GO:0009897; GO:0010818; GO:0022029; GO:0030335; GO:0031100; GO:0031640; GO:0033603; GO:0033622; GO:0038146; GO:0042379; GO:0043434; GO:0045236; GO:0045666; GO:0045785; GO:0048842; GO:0050930; GO:0050965; GO:0050966; GO:0060326; GO:0061844; GO:0062023; GO:0070062; GO:0070098; GO:0090026; GO:0090280; GO:1902230; GO:1903237; GO:1990478; GO:1990869; GO:2000406; GO:2000669 chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; CXCR chemokine receptor binding [GO:0045236]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102] HLKILNTPNCALQIVAR 0.98627 -1.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4896 0 0 0 0 13.8027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3462 0 0 0 0 0 0 0 11.6149 0 0 0 0 13.2976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02809 PLOD1_HUMAN "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, EC 1.14.11.4 (Lysyl hydroxylase 1, LH1)" PLOD1 LLH PLOD Homo sapiens (Human) epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666] catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867] catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; epidermis development [GO:0008544]; peptidyl-lysine hydroxylation [GO:0017185]; response to hypoxia [GO:0001666] GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0008475; GO:0008544; GO:0017185; GO:0030867; GO:0031418; GO:0070062; GO:1902494 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475] ELLKKFR 0.98627 -1.5787 0 0 0 0 0 0 11.5887 0 0 11.8431 0 0 0 0 0 0 0 0 13.2485 0 14.9103 0 0 0 12.0019 0 15.0428 0 0 0 0 0 0 12.3726 0 0 0 0 0 0 11.1697 11.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.214 15.5026 0 0 0 0 0 14.4821 0 0 13.4506 12.245 0 0 12.5887 13.3906 0 0 0 0 0 0 0 13.0227 0 0 0 13.3613 16.989 0 13.8192 16.6417 0 14.1147 0 12.9838 0 0 0 0 0 13.3902 0 14.3436 16.8611 0 0 0 0 14.1276 0 0 0 0 14.2858 0 15.1787 0 0 0 14.0118 0 16.4336 13.5136 0 12.8709 0 0 0 12.7244 0 0 0 0 0 0 0 0 14.1927 0 0 13.8946 13.972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2532 13.1613 0 0 0 0 0 0 Q14C87 T132D_HUMAN "Transmembrane protein 132D (Mature oligodendrocytes transmembrane protein, Mature OL transmembrane protein)" TMEM132D HBE120 KIAA1944 MOLT Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AIFATAVAQELLQRPK 0.98627 -2.0328 0 0 0 0 0 0 0 0 0 0 0 15.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4251 0 14.6083 0 0 16.1978 0 16.2178 16.5601 16.5804 0 0 17.1953 0 0 0 0 0 0 0 0 17.0199 18.19 18.365 0 16.8113 16.8482 16.9788 16.95 15.1877 16.1551 16.3494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2644 0 0 0 13.2415 0 0 0 0 16.6017 0 0 0 11.4568 0 0 14.2221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5NDL2 EOGT_HUMAN "EGF domain-specific O-linked N-acetylglucosamine transferase, EC 2.4.1.255 (Extracellular O-linked N-acetylglucosamine transferase)" EOGT AER61 C3orf64 EOGT1 Homo sapiens (Human) protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; glycosyltransferase activity [GO:0016757]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; protein O-GlcNAcylation via threonine [GO:0097370]; protein O-linked glycosylation [GO:0006493] GO:0005788; GO:0006493; GO:0016262; GO:0016757; GO:0097363; GO:0097370 glycosyltransferase activity [GO:0016757]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363] DGKIRVTILAR 0.98627 -3.3179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.548 0 0 13.4556 0 0 0 0 0 13.1727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CM8 ACSF2_HUMAN "Medium-chain acyl-CoA ligase ACSF2, mitochondrial, EC 6.2.1.2" ACSF2 UNQ493/PRO1009 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] GO:0004467; GO:0005524; GO:0005759; GO:0006631; GO:0006637; GO:0031956; GO:0047760 ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956] DGEETTVEEIK 0.98627 -3.8992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.855 0 0 0 0 0 0 0 15.0411 0 0 14.0577 0 0 0 0 0 0 11.5579 0 0 0 0 14.2852 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1839 0 0 0 0 0 0 0 11.2783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60928 KCJ13_HUMAN "Inward rectifier potassium channel 13 (Inward rectifier K(+) channel Kir7.1) (Potassium channel, inwardly rectifying subfamily J member 13)" KCNJ13 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005886; GO:0006813; GO:0016021; GO:0034765; GO:1990573 inward rectifier potassium channel activity [GO:0005242] MDSSNCK 0.98628 -3.3326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8479 0 0 0 0 0 0 0 0 0 11.6847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8958 0 0 0 0 0 0 0 0 0 14.5902 0 0 0 0 0 0 0 0 0 0 0 0 Q96RI1 NR1H4_HUMAN "Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14, RXR-interacting protein 14)" NR1H4 BAR FXR HRR1 RIP14 Homo sapiens (Human) "bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; cell differentiation [GO:0030154]; cell-cell junction assembly [GO:0007043]; cellular glucose homeostasis [GO:0001678]; cellular response to bile acid [GO:1903413]; cellular response to fatty acid [GO:0071398]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organonitrogen compound [GO:0071417]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; defense response to bacterium [GO:0042742]; fatty acid homeostasis [GO:0055089]; histone H3-R17 methylation [GO:0034971]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular bile acid receptor signaling pathway [GO:0038185]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of apoptotic process [GO:0043066]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; nitrogen catabolite activation of transcription from RNA polymerase II promoter [GO:0001080]; Notch signaling pathway [GO:0007219]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of ammonia assimilation cycle [GO:2001250]; positive regulation of glutamate metabolic process [GO:2000213]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of phosphatidic acid biosynthetic process [GO:1905695]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of cholesterol metabolic process [GO:0090181]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of urea metabolic process [GO:0034255]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235] "chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]; bile acid binding [GO:0032052]; bile acid receptor activity [GO:0038181]; chenodeoxycholic acid binding [GO:1902122]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; cell differentiation [GO:0030154]; cell-cell junction assembly [GO:0007043]; cellular glucose homeostasis [GO:0001678]; cellular response to bile acid [GO:1903413]; cellular response to fatty acid [GO:0071398]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organonitrogen compound [GO:0071417]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; defense response to bacterium [GO:0042742]; fatty acid homeostasis [GO:0055089]; histone H3-R17 methylation [GO:0034971]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular bile acid receptor signaling pathway [GO:0038185]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of apoptotic process [GO:0043066]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; nitrogen catabolite activation of transcription from RNA polymerase II promoter [GO:0001080]; Notch signaling pathway [GO:0007219]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of ammonia assimilation cycle [GO:2001250]; positive regulation of glutamate metabolic process [GO:2000213]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of phosphatidic acid biosynthetic process [GO:1905695]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of cholesterol metabolic process [GO:0090181]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of urea metabolic process [GO:0034255]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000791; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001080; GO:0001221; GO:0001228; GO:0001678; GO:0003700; GO:0004879; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0006954; GO:0007043; GO:0007219; GO:0008206; GO:0008270; GO:0010804; GO:0010903; GO:0010988; GO:0016922; GO:0030154; GO:0030522; GO:0032052; GO:0032088; GO:0032689; GO:0032692; GO:0032703; GO:0032715; GO:0032720; GO:0032740; GO:0034142; GO:0034162; GO:0034255; GO:0034971; GO:0035356; GO:0035774; GO:0038181; GO:0038183; GO:0038185; GO:0042632; GO:0042742; GO:0043066; GO:0043124; GO:0043235; GO:0043565; GO:0045087; GO:0045893; GO:0045944; GO:0046628; GO:0046965; GO:0050728; GO:0055089; GO:0061178; GO:0070857; GO:0071222; GO:0071398; GO:0071417; GO:0071638; GO:0090181; GO:1902122; GO:1903413; GO:1904179; GO:1905695; GO:2000213; GO:2001250 "bile acid binding [GO:0032052]; bile acid receptor activity [GO:0038181]; chenodeoxycholic acid binding [GO:1902122]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" ASGYHYNALTCEGCK 0.98628 -3.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8033 0 0 0 0 0 11.7618 0 0 0 0 0 0 0 0 12.9419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8497 0 11.1722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4199 0 0 0 0 0 11.7771 0 0 0 11.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9928 14.1376 13.225 0 0 0 0 0 0 0 0 13.9033 0 13.0378 0 12.3213 0 0 0 12.832 0 0 0 11.2932 0 0 0 0 12.212 10.8491 0 0 0 0 0 0 0 0 0 0 0 12.952 0 12.2408 0 12.2467 0 0 0 0 0 13.9715 0 0 0 11.8479 12.4143 15.9646 15.4351 0 0 0 0 0 0 0 0 12.6343 0 10.3214 0 0 0 0 0 0 0 14.5858 0 0 0 0 Q9BRP4 PAAF1_HUMAN Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71) PAAF1 WDR71 Homo sapiens (Human) proteasome complex [GO:0000502] proteasome complex [GO:0000502] GO:0000502 APVQVIHR 0.98628 -1.5811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4E1 WAC2C_HUMAN "WASH complex subunit 2C (Vaccinia virus penetration factor, VPEF)" WASHC2C FAM21C KIAA0592 VPEF Homo sapiens (Human) "endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; negative regulation of barbed-end actin filament capping [GO:2000813]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203] "cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; negative regulation of barbed-end actin filament capping [GO:2000813]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005546; GO:0005547; GO:0005730; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0010314; GO:0015031; GO:0016197; GO:0031901; GO:0032266; GO:0032456; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0043325; GO:0070273; GO:0071203; GO:0080025; GO:1900024; GO:1901981; GO:1905394; GO:2000813 "phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]" EVDLIPKVQEAVNYGLQVLDSAFEQLDIK 0.98628 -3.5265 0 0 0 0 0 0 0 0 14.3235 0 0 0 13.2476 0 14.3819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2966 14.0459 15.0365 0 0 0 0 0 13.7653 14.4471 0 0 14.7472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VGE8 ZN816_HUMAN Zinc finger protein 816 ZNF816 ZNF816A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECDNVYIR 0.98629 -3.5391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0974 0 0 0 0 0 0 0 0 0 12.0804 0 0 0 0 0 0 0 12.2248 0 0 14.2317 0 0 14.3708 14.6797 0 14.1872 0 0 0 11.0604 0 0 0 0 0 0 0 0 0 0 0 13.7507 13.9984 14.6491 0 0 0 11.9408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3432 0 0 0 0 0 0 12.6556 0 0 0 0 0 0 0 12.0266 0 0 0 0 0 0 0 0 0 14.0318 13.1665 0 0 0 0 0 0 0 Q96I15 SCLY_HUMAN "Selenocysteine lyase, hSCL, EC 4.4.1.16" SCLY SCL Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; selenocysteine catabolic process [GO:0016261] catalytic complex [GO:1902494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] catalytic complex [GO:1902494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]; vitamin B6 binding [GO:0070279]; cellular amino acid metabolic process [GO:0006520]; selenocysteine catabolic process [GO:0016261] GO:0005794; GO:0005829; GO:0006520; GO:0009000; GO:0016261; GO:0016597; GO:0016740; GO:0042803; GO:0070279; GO:1902494 amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740]; vitamin B6 binding [GO:0070279] AAELVTQNCEAYEAHMR 0.98629 -1.591 0 0 0 0 0 0 0 0 0 11.9903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1592 0 0 0 0 0 0 0 0 0 0 0 0 0 14.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZM4 ULBP3_HUMAN "UL16-binding protein 3 (ALCAN-gamma) (NKG2D ligand 3, N2DL-3, NKG2DL3) (Retinoic acid early transcript 1N)" ULBP3 N2DL3 RAET1N Homo sapiens (Human) natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267] anchored component of plasma membrane [GO:0046658]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267] GO:0005615; GO:0005886; GO:0009897; GO:0030101; GO:0042267; GO:0046658; GO:0046703 natural killer cell lectin-like receptor binding [GO:0046703] DCKSWLR 0.98629 -3.9244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9L3 I20L2_HUMAN "Interferon-stimulated 20 kDa exonuclease-like 2, EC 3.1.-.-" ISG20L2 HSD-38 HSD38 Homo sapiens (Human) ribosome biogenesis [GO:0042254] nucleolus [GO:0005730]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254] GO:0000175; GO:0003723; GO:0004527; GO:0005634; GO:0005730; GO:0042254 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723] AAVSWLTPAPSKK 0.98629 -3.9253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5077 0 12.3018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8815 0 0 0 0 0 0 0 0 0 11.2983 0 0 0 12.6144 0 0 9.84911 0 0 12.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5541 0 0 13.6558 0 0 14.5861 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15025 TNIP1_HUMAN "TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1, ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1, Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein, VAN, hVAN)" TNIP1 KIAA0113 NAF1 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; glycoprotein biosynthetic process [GO:0009101]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral genome replication [GO:0045071]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; translation [GO:0006412] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; glycoprotein biosynthetic process [GO:0009101]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral genome replication [GO:0045071]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; translation [GO:0006412] GO:0002755; GO:0005654; GO:0005829; GO:0006357; GO:0006412; GO:0006952; GO:0006954; GO:0007159; GO:0009101; GO:0042802; GO:0043124; GO:0045071; GO:0045944; GO:0050729; GO:0051019; GO:0070373; GO:0071222; GO:1903003 identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019] DEEKAREALR 0.9863 -3.5498 0 12.4779 0 12.0557 12.6352 0 0 0 13.2423 0 0 0 12.4977 0 0 12.7102 0 0 0 13.3856 0 13.4114 14.2298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0274 0 0 0 0 0 13.42 0 0 0 0 14.6693 0 0 0 0 0 0 0 0 0 0 0 12.506 0 0 13.212 0 0 0 13.7192 0 0 14.7741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.322 0 0 0 0 0 0 14.4073 13.8741 0 0 0 0 0 0 13.4325 0 0 0 0 0 0 0 12.2134 0 0 0 0 0 13.3792 0 0 0 14.1354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7312 0 0 0 0 0 0 0 0 Q9Y615 ACL7A_HUMAN Actin-like protein 7A (Actin-like-7-alpha) ACTL7A Homo sapiens (Human) acrosome assembly [GO:0001675]; single fertilization [GO:0007338] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dynactin complex [GO:0005869]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dynactin complex [GO:0005869]; Golgi apparatus [GO:0005794]; male germ cell nucleus [GO:0001673]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; structural constituent of cytoskeleton [GO:0005200]; acrosome assembly [GO:0001675]; single fertilization [GO:0007338] GO:0001669; GO:0001673; GO:0001675; GO:0005200; GO:0005634; GO:0005737; GO:0005794; GO:0005856; GO:0005869; GO:0007338; GO:0031514; GO:0032991 structural constituent of cytoskeleton [GO:0005200] ETFVGQELNNTNVHLKLVNPLR 0.9863 -3.9262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6275 0 0 0 0 0 0 0 11.5988 0 0 0 0 0 0 0 0 0 11.1722 0 0 0 0 0 0 0 0 14.0851 0 0 0 0 0 0 0 12.3542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94864 ST65G_HUMAN "STAGA complex 65 subunit gamma (Adenocarcinoma antigen ART1) (SPTF-associated factor 65 gamma, STAF65gamma) (Suppressor of Ty 7-like)" SUPT7L KIAA0764 Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; maintenance of protein location in nucleus [GO:0051457]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone H3 acetylation [GO:0043966]; maintenance of protein location in nucleus [GO:0051457]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]" GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0046982; GO:0051457 protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713] DYHSYMLQISK 0.98631 -3.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6187 0 12.7234 0 0 0 0 0 0 12.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1448 0 0 0 0 0 0 0 13.5799 0 0 P20309 ACM3_HUMAN Muscarinic acetylcholine receptor M3 CHRM3 Homo sapiens (Human) "acetylcholine receptor signaling pathway [GO:0095500]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; positive regulation of smooth muscle contraction [GO:0045987]; protein modification process [GO:0036211]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of vascular associated smooth muscle contraction [GO:0003056]; saliva secretion [GO:0046541]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" anchoring junction [GO:0070161]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; phosphatidylinositol phospholipase C activity [GO:0004435]; signaling receptor activity [GO:0038023]; acetylcholine receptor signaling pathway [GO:0095500]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; calcium-mediated signaling [GO:0019722]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; positive regulation of smooth muscle contraction [GO:0045987]; protein modification process [GO:0036211]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of vascular associated smooth muscle contraction [GO:0003056]; saliva secretion [GO:0046541]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]" GO:0003056; GO:0004435; GO:0004993; GO:0005789; GO:0005886; GO:0005887; GO:0006939; GO:0007165; GO:0007186; GO:0007187; GO:0007197; GO:0007213; GO:0007268; GO:0007399; GO:0009925; GO:0016323; GO:0016907; GO:0019722; GO:0030425; GO:0030594; GO:0032412; GO:0036211; GO:0038023; GO:0042166; GO:0045202; GO:0045211; GO:0045987; GO:0046541; GO:0070161; GO:0095500 acetylcholine binding [GO:0042166]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; phosphatidylinositol phospholipase C activity [GO:0004435]; signaling receptor activity [GO:0038023] FALKTRSQITK 0.98631 -1.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29279 CCN2_HUMAN "CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8, IBP-8, IGF-binding protein 8, IGFBP-8)" CCN2 CTGF HCS24 IGFBP8 Homo sapiens (Human) aging [GO:0007568]; angiogenesis [GO:0001525]; calcium ion transmembrane import into cytosol [GO:0097553]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]; aging [GO:0007568]; angiogenesis [GO:0001525]; calcium ion transmembrane import into cytosol [GO:0097553]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894] GO:0001502; GO:0001503; GO:0001525; GO:0001894; GO:0001934; GO:0001968; GO:0002062; GO:0005178; GO:0005520; GO:0005576; GO:0005615; GO:0005801; GO:0005829; GO:0005886; GO:0005938; GO:0007155; GO:0007160; GO:0007165; GO:0007229; GO:0007568; GO:0008022; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008544; GO:0009611; GO:0009749; GO:0010628; GO:0010629; GO:0010942; GO:0016477; GO:0030324; GO:0031012; GO:0032330; GO:0032355; GO:0032967; GO:0034059; GO:0035556; GO:0035988; GO:0043200; GO:0043280; GO:0043434; GO:0045597; GO:0046330; GO:0048471; GO:0050867; GO:0051385; GO:0051496; GO:0060452; GO:0060548; GO:0070278; GO:0070318; GO:0070374; GO:0070542; GO:0071897; GO:0072593; GO:0097553 fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022] CCEEWVCDEPK 0.98631 -3.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4219 0 0 13.1474 0 0 0 0 12.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6616 0 0 12.1443 0 0 14.2458 0 0 0 0 0 0 10.4077 0 0 0 0 0 0 0 13.2644 0 0 0 0 0 0 0 0 0 0 10.6371 0 11.9777 9.58943 11.9436 0 0 Q13115 DUS4_HUMAN "Dual specificity protein phosphatase 4, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2, MAP kinase phosphatase 2, MKP-2)" DUSP4 MKP2 VH2 Homo sapiens (Human) dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; endoderm formation [GO:0001706]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] GO:0001706; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0017018; GO:0043409; GO:0070373; GO:1990439 MAP kinase serine/threonine phosphatase activity [GO:1990439]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] CLLLDCR 0.98632 -2.4755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1072 0 0 0 0 0 12.4538 0 0 0 12.6475 12.8635 0 13.3344 0 0 0 0 0 0 0 0 0 12.2663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0717 0 0 0 0 13.4576 0 0 0 0 0 0 0 0 0 0 0 17.3847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6106 0 0 17.6503 0 0 0 0 0 12.5184 0 0 0 0 0 0 12.7824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2877 0 13.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7R7 CA185_HUMAN Uncharacterized protein C1orf185 C1orf185 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DEPQLATK 0.98632 -3.5661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1775 0 0 0 0 0 0 0 0 0 0 0 0 0 13.076 0 0 0 0 0 0 0 0 0 0 0 0 13.131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VG3 IFTAP_HUMAN Intraflagellar transport-associated protein (Protein HEPIS) IFTAP C11orf74 NWC Homo sapiens (Human) acrosome reaction [GO:0007340]; spermatogenesis [GO:0007283] 9+0 non-motile cilium [GO:0097731]; cytosol [GO:0005829] 9+0 non-motile cilium [GO:0097731]; cytosol [GO:0005829]; intraciliary transport particle A binding [GO:0120160]; acrosome reaction [GO:0007340]; spermatogenesis [GO:0007283] GO:0005829; GO:0007283; GO:0007340; GO:0097731; GO:0120160 intraciliary transport particle A binding [GO:0120160] DTSPDLEK 0.98632 -1.6155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LK0 CEP19_HUMAN "Centrosomal protein of 19 kDa, Cep19" CEP19 C3orf34 HSD5 Homo sapiens (Human) "cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]" centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922] "centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]" GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712 IRQRIMPVR 0.98632 -2.4765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35070 BTC_HUMAN "Probetacellulin [Cleaved into: Betacellulin, BTC ]" BTC Homo sapiens (Human) cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell apoptotic process [GO:1904019]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB4-ERBB4 signaling pathway [GO:0038138]; negative regulation of epithelial cell apoptotic process [GO:1904036]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of mitotic nuclear division [GO:0045840] clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell apoptotic process [GO:1904019]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB4-ERBB4 signaling pathway [GO:0038138]; negative regulation of epithelial cell apoptotic process [GO:1904036]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of mitotic nuclear division [GO:0045840] GO:0005154; GO:0005576; GO:0005615; GO:0005886; GO:0007173; GO:0008083; GO:0008283; GO:0008284; GO:0016021; GO:0030297; GO:0030669; GO:0038134; GO:0038138; GO:0045741; GO:0045840; GO:0048018; GO:0051781; GO:1904019; GO:1904036 epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] CERVDLFYLRGDR 0.98633 -1.6246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22415 USF1_HUMAN "Upstream stimulatory factor 1 (Class B basic helix-loop-helix protein 11, bHLHb11) (Major late transcription factor 1)" USF1 BHLHB11 USF Homo sapiens (Human) carbon catabolite regulation of transcription [GO:0045990]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; response to hypoxia [GO:0001666]; response to UV [GO:0009411] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; carbon catabolite regulation of transcription [GO:0045990]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]" GO:0000430; GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0001666; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0009411; GO:0019086; GO:0019899; GO:0019901; GO:0032869; GO:0042593; GO:0042802; GO:0042803; GO:0042826; GO:0043425; GO:0043565; GO:0044877; GO:0045944; GO:0045990; GO:0046982; GO:0051918; GO:0055088; GO:1990837 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AQHNEVER 0.98634 -1.6268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64953 0 0 0 0 0 0 0 0 10.8277 0 0 0 0 0 0 0 0 0 0 0 10.0802 0 0 0 0 10.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7295 0 0 0 0 0 0 0 11.5841 11.3327 0 0 0 0 17.1041 0 13.2651 0 0 0 0 0 0 13.8 0 10.7232 10.3635 0 0 0 16.5175 12.6273 0 0 0 0 0 0 0 0 0 0 0 0 12.8459 0 0 0 0 0 0 0 12.0708 17.4127 0 0 0 0 12.1294 11.4054 12.1426 0 0 0 11.198 0 10.8844 0 12.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0973 0 11.5546 11.5583 0 0 0 0 0 10.2869 P52597 HNRPF_HUMAN "Heterogeneous nuclear ribonucleoprotein F, hnRNP F (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed ]" HNRNPF HNRPF Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]" GO:0000398; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006396; GO:0016020; GO:0017025; GO:0043484; GO:0071013; GO:1990904 RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; TBP-class protein binding [GO:0017025] DRANMQHR 0.98634 -1.6247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1232 0 0 0 0 0 0 0 0 0 0 0 0 11.9384 0 0 0 P05362 ICAM1_HUMAN "Intercellular adhesion molecule 1, ICAM-1 (Major group rhinovirus receptor) (CD antigen CD54)" ICAM1 Homo sapiens (Human) adhesion of symbiont to host [GO:0044406]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of endothelial barrier [GO:0061028]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of leukocyte mediated cytotoxicity [GO:0001910]; regulation of ruffle assembly [GO:1900027]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]; T cell antigen processing and presentation [GO:0002457]; T cell extravasation [GO:0072683] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adhesion of symbiont to host [GO:0044406]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of endothelial barrier [GO:0061028]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of leukocyte mediated cytotoxicity [GO:0001910]; regulation of ruffle assembly [GO:1900027]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291]; T cell antigen processing and presentation [GO:0002457]; T cell extravasation [GO:0072683] GO:0001618; GO:0001772; GO:0001910; GO:0002291; GO:0002457; GO:0002693; GO:0004888; GO:0005178; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007157; GO:0007159; GO:0009897; GO:0009986; GO:0016020; GO:0022614; GO:0033627; GO:0038023; GO:0044406; GO:0045121; GO:0046813; GO:0050900; GO:0061028; GO:0062023; GO:0070062; GO:0070374; GO:0071333; GO:0072683; GO:1900027; GO:1902042; GO:1904646; GO:1990830; GO:2000352 integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] CQVEGGAPR 0.98635 -3.3071 0 0 0 0 0 14.2421 15.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6364 12.384 12.9115 12.4336 0 0 0 15.8374 13.6342 12.4788 18.2993 0 0 0 0 13.2661 0 13.2865 17.795 0 13.2495 0 0 16.8064 0 0 12.0835 12.3808 0 0 0 0 11.3471 0 11.7203 0 13.6667 0 0 0 0 0 0 0 14.5498 0 0 12.4992 13.782 0 17.6527 13.5594 14.0361 13.7531 0 14.0252 0 0 11.9782 0 12.9892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4048 0 13.8475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9885 0 0 0 0 0 Q8WYJ6 SEPT1_HUMAN Septin-1 (LARP) (Peanut-like protein 3) (Serologically defined breast cancer antigen NY-BR-24) SEPTIN1 DIFF6 PNUTL3 SEPT1 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021] cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157] GO:0003924; GO:0005525; GO:0005815; GO:0005940; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030496; GO:0031105; GO:0032153; GO:0042802; GO:0060090; GO:0061640 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] AGGVMDK 0.98636 -1.6486 0 0 0 0 0 11.0065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7721 0 0 0 0 0 0 0 0 0 0 0 0 17.1058 0 12.6149 0 11.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTP6 ZBED2_HUMAN Zinc finger BED domain-containing protein 2 ZBED2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0045618; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" EKEVLRR 0.98636 -3.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2928 0 14.0062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00625 PIR_HUMAN "Pirin, EC 1.13.11.24 (Probable quercetin 2,3-dioxygenase PIR, Probable quercetinase)" PIR Homo sapiens (Human) digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366]" GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0007586; GO:0008127; GO:0030224; GO:0046872 "metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]" DPKRSHFVLIAGEPLR 0.98637 -1.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WB0 ZC3C1_HUMAN "Zinc finger C3HC-type protein 1 (Nuclear-interacting partner of ALK, hNIPA) (Nuclear-interacting partner of anaplastic lymphoma kinase)" ZC3HC1 NIPA HSPC216 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005654; GO:0007049; GO:0008270; GO:0016567; GO:0019901; GO:0031965; GO:0051301; GO:2001240 protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] AAPCEGQAFAVGVEK 0.98637 -3.3293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5157 0 0 15.4009 0 Q8TF42 UBS3B_HUMAN "Ubiquitin-associated and SH3 domain-containing protein B, EC 3.1.3.48 (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1, STS-1) (T-cell ubiquitin ligand 2, TULA-2) (Tyrosine-protein phosphatase STS1/TULA2)" UBASH3B KIAA1959 STS1 Homo sapiens (Human) collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279] GO:0004725; GO:0005634; GO:0005737; GO:0006469; GO:0009968; GO:0031625; GO:0035335; GO:0038063; GO:0042802; GO:0043393; GO:0045670; GO:0045671; GO:0045779; GO:0051219; GO:0051279; GO:0070527; GO:0090331 identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625] CLFVCRHGERMDVVFGK 0.98637 -1.6492 0 0 0 0 0 0 0 0 0 0 0 12.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EX3 DC2I2_HUMAN Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34) DYNC2I2 WDR34 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; filopodium [GO:0030175] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018] GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005868; GO:0005929; GO:0005930; GO:0007018; GO:0030175; GO:0035721; GO:0036064; GO:0042073; GO:0045503; GO:0045504; GO:0060271; GO:0097014; GO:0097542 dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] CSLAAGEAALTR 0.98637 -1.5622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9586 0 0 0 0 0 0 0 0 0 0 0 0 12.8859 0 0 0 0 0 0 0 0 11.9556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ52 CNTN6_HUMAN "Contactin-6 (Neural recognition molecule NB-3, hNB-3)" CNTN6 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747] anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886] anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747] GO:0005886; GO:0007155; GO:0007156; GO:0007219; GO:0007411; GO:0007417; GO:0030424; GO:0045747; GO:0070593; GO:0098632; GO:0098688; GO:0099026 cell-cell adhesion mediator activity [GO:0098632] ERTVITVPPSK 0.98637 -3.3241 0 0 0 0 0 0 0 0 0 0 12.3911 0 11.1096 11.0849 0 0 11.2374 0 0 0 0 9.94191 0 0 11.0667 0 0 0 12.2017 0 0 12.2802 0 0 0 0 0 0 8.69213 0 0 12.3608 0 0 0 0 0 0 0 0 0 0 0 0 12.8453 0 0 11.5836 0 0 0 0 0 10.253 0 0 10.4397 12.3572 0 10.9482 0 10.9648 0 0 0 13.407 0 0 15.0825 12.5707 14.4045 0 18.3115 13.1494 0 0 0 13.7036 0 12.7972 0 0 13.0925 13.6762 0 0 0 12.9246 11.8848 0 0 0 12.1719 0 0 0 0 12.9063 0 14.5574 0 0 14.0332 0 0 12.3069 0 11.8482 14.2417 0 13.9229 0 14.4501 0 12.5 12.3777 0 0 0 0 0 15.0779 14.1773 0 13.7296 15.4295 0 14.6568 14.4934 0 0 0 16.2388 14.0052 0 0 0 0 0 0 0 0 12.404 13.3411 0 0 0 13.973 0 0 0 0 13.5283 13.6263 0 0 13.1148 0 0 0 0 11.5436 0 13.8165 14.0868 0 0 0 14.0594 0 O95125 ZN202_HUMAN Zinc finger protein 202 (Zinc finger protein with KRAB and SCAN domains 10) ZNF202 ZKSCAN10 Homo sapiens (Human) lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleolus [GO:0005730] "chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005694; GO:0005730; GO:0006357; GO:0006629; GO:0016604; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EALIRLR 0.98638 -3.5296 0 0 12.9594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1263 0 0 0 0 11.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16594 TAF9_HUMAN "Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit, TAFII-31, TAFII31) (Transcription initiation factor TFIID 32 kDa subunit, TAFII-32, TAFII32)" TAF9 TAF2G TAFII31 Homo sapiens (Human) "box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to interleukin-1 [GO:0070555]; response to L-glutamate [GO:1902065]; RNA polymerase II preinitiation complex assembly [GO:0051123]" MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; box C/D snoRNP assembly [GO:0000492]; cellular response to DNA damage stimulus [GO:0006974]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to interleukin-1 [GO:0070555]; response to L-glutamate [GO:1902065]; RNA polymerase II preinitiation complex assembly [GO:0051123]" GO:0000124; GO:0000492; GO:0000976; GO:0002039; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006355; GO:0006357; GO:0006468; GO:0006974; GO:0016251; GO:0016573; GO:0032435; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043066; GO:0043484; GO:0043966; GO:0045893; GO:0045944; GO:0046982; GO:0050821; GO:0051117; GO:0051123; GO:0060261; GO:0060760; GO:0070555; GO:0070742; GO:0070761; GO:0071339; GO:0140297; GO:1902065; GO:1902166 ATPase binding [GO:0051117]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] EDDDDDDDDDDDYDNL 0.98638 -2.0308 0 0 0 0 0 0 0 0 0 13.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6323 0 12.3518 12.189 0 12.1013 12.2226 13.0077 0 13.7419 0 13.9497 0 0 0 0 0 0 0 0 0 0 0 10.8817 0 0 0 10.56 0 0 0 0 0 0 0 0 12.4502 14.0369 0 9.98513 0 13.5682 0 0 0 0 0 0 0 0 11.4812 0 0 0 11.6317 0 0 13.1558 13.5745 0 0 12.0833 0 0 0 0 12.1 0 0 0 0 0 0 11.2609 0 0 0 12.3137 0 0 11.6378 11.0547 0 0 0 0 0 0 0 0 10.6323 0 0 0 0 0 13.9872 0 11.3339 11.3323 10.8055 0 14.4168 11.3215 0 12.8158 0 0 0 0 Q6ZS92 YD022_HUMAN Putative uncharacterized protein FLJ45721 Homo sapiens (Human) EGSVIGK 0.98638 -3.5277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YT5 S13A5_HUMAN "Solute carrier family 13 member 5 (Na(+)/citrate cotransporter, NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter)" SLC13A5 NACT Homo sapiens (Human) alpha-ketoglutarate transport [GO:0015742]; anion transmembrane transport [GO:0098656]; cellular response to lithium ion [GO:0071285]; citrate transport [GO:0015746]; fumarate transport [GO:0015741]; oxaloacetate transport [GO:0015729]; succinate transport [GO:0015744] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; identical protein binding [GO:0042802]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; alpha-ketoglutarate transport [GO:0015742]; anion transmembrane transport [GO:0098656]; cellular response to lithium ion [GO:0071285]; citrate transport [GO:0015746]; fumarate transport [GO:0015741]; oxaloacetate transport [GO:0015729]; succinate transport [GO:0015744] GO:0005343; GO:0005654; GO:0005829; GO:0005886; GO:0015137; GO:0015141; GO:0015729; GO:0015741; GO:0015742; GO:0015744; GO:0015746; GO:0016021; GO:0017153; GO:0042802; GO:0071285; GO:0098656 citrate transmembrane transporter activity [GO:0015137]; identical protein binding [GO:0042802]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141] IALRTLLWVGAKPAR 0.98638 -3.331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0333 0 0 0 0 0 0 0 11.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3841 0 0 0 15.0674 13.522 12.8281 13.8365 13.8543 13.2711 0 0 14.5222 13.8357 13.8369 0 0 13.114 0 14.4254 0 14.0018 0 0 0 13.5079 14.831 0 0 0 0 0 13.1487 0 13.7061 0 13.6569 0 13.7788 12.1253 0 13.5893 13.929 0 0 0 13.4375 0 13.138 0 13.926 0 0 14.6195 13.2081 0 13.4684 0 0 0 0 0 0 13.4167 0 0 11.4761 0 0 0 0 11.6019 13.3502 0 0 0 0 0 0 0 11.6664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7S6 ARI2O_HUMAN Uncharacterized protein ARIH2OS (Ariadne-2 homolog opposite strand protein) ARIH2OS C3orf71 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IGAKRQR 0.98638 -2.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4647 14.6988 0 0 0 0 0 0 0 0 0 13.3122 0 0 0 0 0 0 0 19.4751 0 15.2358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2743 0 0 0 0 0 0 0 0 0 0 0 15.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBC0 HNF6_HUMAN "Hepatocyte nuclear factor 6, HNF-6 (One cut domain family member 1) (One cut homeobox 1)" ONECUT1 HNF6 HNF6A Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cilium assembly [GO:0060271]; endoderm development [GO:0007492]; epithelial cell development [GO:0002064]; glucose metabolic process [GO:0006006]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spleen development [GO:0048536]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type B pancreatic cell differentiation [GO:0003309]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cilium assembly [GO:0060271]; endoderm development [GO:0007492]; epithelial cell development [GO:0002064]; glucose metabolic process [GO:0006006]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; Notch signaling pathway [GO:0007219]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spleen development [GO:0048536]; transforming growth factor beta receptor signaling pathway [GO:0007179]; type B pancreatic cell differentiation [GO:0003309]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0003309; GO:0003310; GO:0003311; GO:0003682; GO:0005634; GO:0006006; GO:0006355; GO:0006357; GO:0007179; GO:0007219; GO:0007492; GO:0009653; GO:0016477; GO:0030183; GO:0030335; GO:0030512; GO:0045165; GO:0045944; GO:0048536; GO:0060271; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ETFRRMWK 0.98638 -3.5283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8549 0 0 0 0 0 0 0 0 0 12.6751 0 0 0 0 0 0 0 12.5844 13.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y261 FOXA2_HUMAN "Hepatocyte nuclear factor 3-beta, HNF-3-beta, HNF-3B (Forkhead box protein A2) (Transcription factor 3B, TCF-3B)" FOXA2 HNF3B TCF3B Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chromatin organization [GO:0006325]; dopaminergic neuron differentiation [GO:0071542]; endocrine pancreas development [GO:0031018]; negative regulation of detection of glucose [GO:2000971]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of blood coagulation [GO:0030193]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-6 [GO:0070741]" cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chromatin organization [GO:0006325]; dopaminergic neuron differentiation [GO:0071542]; endocrine pancreas development [GO:0031018]; negative regulation of detection of glucose [GO:2000971]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of transcription from RNA polymerase II promoter by glucose [GO:0061987]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; regulation of blood coagulation [GO:0030193]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357]; response to interleukin-6 [GO:0070741]" GO:0000432; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001708; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0008344; GO:0009653; GO:0010719; GO:0019904; GO:0030054; GO:0030154; GO:0030193; GO:0031018; GO:0033132; GO:0040019; GO:0043433; GO:0045893; GO:0045944; GO:0061178; GO:0061987; GO:0070741; GO:0071542; GO:0090009; GO:1990837; GO:2000049; GO:2000543; GO:2000971 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GGLGELK 0.98638 -3.3319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8939 0 0 0 0 0 0 0 0 11.8825 0 0 0 0 0 0 0 0 13.9799 14.055 0 0 0 0 0 0 0 0 0 0 Q01814 AT2B2_HUMAN "Plasma membrane calcium-transporting ATPase 2, PMCA2, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2)" ATP2B2 PMCA2 Homo sapiens (Human) brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of sound [GO:0007605] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; sensory perception of sound [GO:0007605] GO:0003407; GO:0005388; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006874; GO:0007420; GO:0007605; GO:0008022; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030182; GO:0032591; GO:0032809; GO:0034220; GO:0035254; GO:0043231; GO:0045121; GO:0046872; GO:0051480; GO:0070062; GO:0070161; GO:0098688; GO:0098839; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:1903779; GO:1905056; GO:1905059 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905059]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; protein C-terminus binding [GO:0008022] DRDEMVKK 0.98639 -1.5807 12.6585 0 0 0 11.3451 0 0 0 0 10.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0137 0 0 10.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3842 0 10.2682 0 13.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7822 13.5872 0 0 0 12.7784 0 16.0799 15.4395 15.2121 15.5706 15.756 0 15.2345 15.9025 15.6323 15.2718 0 0 12.9329 15.1848 0 0 0 0 0 15.1234 0 16.0236 15.7381 0 15.1791 15.4586 0 15.5849 0 0 0 14.7631 15.1222 16.0096 15.4017 0 12.8171 0 14.8656 15.3497 14.94 0 0 15.789 15.0483 0 14.7482 0 0 0 14.8753 13.833 0 15.0351 14.8207 0 14.4962 15.4667 0 14.2524 14.2811 14.6945 15.1905 14.9355 0 0 0 0 0 14.0642 13.8128 0 0 13.6589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9432 13.462 0 0 0 0 0 Q719H9 KCTD1_HUMAN BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1) KCTD1 C18orf5 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]" GO:0003714; GO:0005634; GO:0005654; GO:0008134; GO:0042802; GO:0045892; GO:0051260 identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] RTPRVPSVIR 0.98639 -1.5793 0 0 0 0 0 0 0 0 0 12.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.429 0 0 11.6084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6108 0 15.8181 0 0 0 0 0 0 0 13.9721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHH9 ATLA2_HUMAN "Atlastin-2, EC 3.6.5.- (ADP-ribosylation factor-like protein 6-interacting protein 2, ARL-6-interacting protein 2, Aip-2)" ATL2 ARL6IP2 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260] GO:0003924; GO:0005525; GO:0005783; GO:0007029; GO:0007030; GO:0016020; GO:0016021; GO:0042802; GO:0051260; GO:0098826; GO:1990809 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] DIDEDFK 0.98639 -3.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZJ5 E2AK3_HUMAN "Eukaryotic translation initiation factor 2-alpha kinase 3, EC 2.7.11.1 (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase, HsPEK)" EIF2AK3 PEK PERK Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501] GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006468; GO:0006919; GO:0006983; GO:0007029; GO:0010575; GO:0010628; GO:0010998; GO:0016020; GO:0017148; GO:0018105; GO:0019722; GO:0019899; GO:0019903; GO:0030176; GO:0030282; GO:0030968; GO:0031018; GO:0031642; GO:0032055; GO:0032057; GO:0034198; GO:0034976; GO:0036492; GO:0036499; GO:0042149; GO:0042802; GO:0045943; GO:0046777; GO:0048009; GO:0048471; GO:0051879; GO:0060734; GO:0070417; GO:0106310; GO:1900182; GO:1902235; GO:1990737 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AISPGLLVRALLLLLLLLGLAAR 0.98639 -3.9274 0 0 0 0 0 0 0 0 0 13.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1191 0 0 0 0 0 0 0 10.9383 0 0 0 0 0 0 0 0 0 0 13.0409 0 0 0 10.1775 0 0 13.072 0 0 0 0 0 0 0 0 0 0 9.50239 0 0 14.8062 13.6701 0 0 0 0 15.8332 17.2488 0 13.5991 16.2796 15.4167 10.1221 0 12.2894 11.958 14.4244 0 15.4957 14.3372 0 0 13.4067 13.4014 15.1332 12.9555 13.3536 13.6509 15.4257 0 0 12.8814 12.8519 14.8183 14.4065 15.1538 0 0 14.4033 13.3791 0 0 14.4206 0 0 14.6796 13.3714 15.0566 13.9127 15.8837 0 14.5339 14.6695 14.0144 0 0 14.1494 0 0 13.6554 15.2908 15.2982 0 15.1734 13.6157 16.2089 13.4649 14.5602 12.449 0 15.0105 19.8484 15.0043 14.6079 13.7447 15.6716 13.82 14.5298 14.0339 15.5469 13.2822 13.09 0 11.1277 0 14.85 14.7651 15.2811 14.6172 16.2629 0 0 11.0007 0 0 0 0 11.2178 0 0 10.727 0 0 0 15.7921 0 10.741 12.2528 0 11.4447 0 0 0 Q9Y2T1 AXIN2_HUMAN "Axin-2 (Axin-like protein, Axil) (Axis inhibition protein 2) (Conductin)" AXIN2 Homo sapiens (Human) bone mineralization [GO:0030282]; cell death [GO:0008219]; cell development [GO:0048468]; cellular response to dexamethasone stimulus [GO:0071549]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; intramembranous ossification [GO:0001957]; maintenance of DNA repeat elements [GO:0043570]; mRNA stabilization [GO:0048255]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of cell death [GO:0010942]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chondrocyte development [GO:0061181]; regulation of mismatch repair [GO:0032423]; secondary heart field specification [GO:0003139]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; bone mineralization [GO:0030282]; cell death [GO:0008219]; cell development [GO:0048468]; cellular response to dexamethasone stimulus [GO:0071549]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; intramembranous ossification [GO:0001957]; maintenance of DNA repeat elements [GO:0043570]; mRNA stabilization [GO:0048255]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of cell death [GO:0010942]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of chondrocyte development [GO:0061181]; regulation of mismatch repair [GO:0032423]; secondary heart field specification [GO:0003139]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055] GO:0001649; GO:0001756; GO:0001934; GO:0001957; GO:0003139; GO:0003413; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0008013; GO:0008104; GO:0008219; GO:0008285; GO:0010718; GO:0010942; GO:0016055; GO:0019899; GO:0019901; GO:0030282; GO:0030877; GO:0031625; GO:0032423; GO:0032436; GO:0033687; GO:0033689; GO:0042476; GO:0043161; GO:0043570; GO:0045600; GO:0045668; GO:0045860; GO:0048255; GO:0048468; GO:0060090; GO:0061181; GO:0070411; GO:0070602; GO:0071549; GO:0072089; GO:0090090; GO:2000054 beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625] ASPDSPLTRWTKSLHSLLGDQDGAYLFR 0.98639 -3.5387 0 0 0 10.3323 0 0 0 0 0 0 0 0 0 0 0 0 11.1426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.27 0 0 0 0 0 0 13.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6592 0 0 0 0 0 0 0 0 0 0 0 0 11.0011 0 0 11.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.302 0 0 0 0 0 0 0 0 0 12.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7579 12.9625 0 0 0 13.747 0 0 0 0 13.8064 0 0 0 13.4384 0 0 0 0 0 0 0 0 0 Q9ULD6 INTU_HUMAN Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6) INTU KIAA1284 PDZD6 PDZK6 Homo sapiens (Human) cell division [GO:0051301]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; intraciliary transport [GO:0042073]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to organelle [GO:0033365]; regulation of cilium assembly [GO:1902017]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192] cell surface [GO:0009986]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] cell surface [GO:0009986]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cell division [GO:0051301]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; hair follicle morphogenesis [GO:0031069]; intraciliary transport [GO:0042073]; keratinocyte differentiation [GO:0030216]; limb development [GO:0060173]; motile cilium assembly [GO:0044458]; negative regulation of cell division [GO:0051782]; negative regulation of keratinocyte proliferation [GO:0010839]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to organelle [GO:0033365]; regulation of cilium assembly [GO:1902017]; regulation of ossification [GO:0030278]; regulation of smoothened signaling pathway [GO:0008589]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord dorsal/ventral patterning [GO:0021513]; tongue morphogenesis [GO:0043587]; vesicle-mediated transport [GO:0016192] GO:0001736; GO:0005737; GO:0005814; GO:0005929; GO:0007224; GO:0007399; GO:0008589; GO:0009986; GO:0010839; GO:0016192; GO:0021513; GO:0021915; GO:0030216; GO:0030278; GO:0031069; GO:0031514; GO:0033365; GO:0035869; GO:0036064; GO:0042073; GO:0042733; GO:0043587; GO:0044458; GO:0045880; GO:0051301; GO:0051782; GO:0060021; GO:0060173; GO:0060271; GO:1902017; GO:1905515 AKEQLKLLEVLVGIIHQTK 0.9864 -3.3586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0244 0 0 0 0 0 12.0203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8428 12.9131 0 0 11.1703 0 0 0 0 0 14.5678 16.0913 15.4499 14.8761 16.499 0 11.3974 0 14.891 14.2418 14.1807 0 16.0382 0 0 14.4526 13.7738 13.7907 0 0 11.4438 11.6934 13.5797 13.3019 0 0 0 0 12.007 0 14.2509 14.9634 0 0 13.4322 0 0 0 14.8667 0 0 0 0 0 14.4068 12.7249 13.4865 0 0 0 11.3306 0 0 13.4357 0 13.1626 0 0 0 13.5889 13.1538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6404 0 0 0 0 0 0 0 0 0 O15116 LSM1_HUMAN U6 snRNA-associated Sm-like protein LSm1 (Cancer-associated Sm-like) (Small nuclear ribonuclear CaSm) LSM1 CASM Homo sapiens (Human) "deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; neuron differentiation [GO:0030182]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; neuron differentiation [GO:0030182]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; stem cell population maintenance [GO:0019827]" GO:0000290; GO:0000339; GO:0000375; GO:0000932; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016070; GO:0019827; GO:0030182; GO:0045665; GO:0071044; GO:1990726 RNA binding [GO:0003723]; RNA cap binding [GO:0000339] HLVLLRDGR 0.9864 -1.588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8873 16.7758 0 0 0 17.4362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P03956 MMP1_HUMAN "Interstitial collagenase, EC 3.4.24.7 (Fibroblast collagenase) (Matrix metalloproteinase-1, MMP-1) [Cleaved into: 22 kDa interstitial collagenase; 27 kDa interstitial collagenase ]" MMP1 CLG Homo sapiens (Human) cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508] GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0006508; GO:0008233; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0031334; GO:0071492 endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] ADVDHAIEK 0.9864 -3.3526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16849 PTPRN_HUMAN "Receptor-type tyrosine-protein phosphatase-like N, R-PTP-N (Islet cell antigen 512, ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment, ICA512-NTF; ICA512-transmembrane fragment, ICA512-TMF; ICA512-cleaved cytosolic fragment, ICA512-CCF ]" PTPRN ICA3 ICA512 Homo sapiens (Human) dense core granule maturation [GO:1990502]; insulin secretion [GO:0030073]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; luteinization [GO:0001553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; regulation of secretion [GO:0051046]; response to reactive oxygen species [GO:0000302] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; spectrin binding [GO:0030507]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]; dense core granule maturation [GO:1990502]; insulin secretion [GO:0030073]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; luteinization [GO:0001553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; regulation of secretion [GO:0051046]; response to reactive oxygen species [GO:0000302] GO:0000302; GO:0001553; GO:0005634; GO:0005768; GO:0005886; GO:0008134; GO:0016021; GO:0030073; GO:0030141; GO:0030507; GO:0030658; GO:0035773; GO:0043025; GO:0043204; GO:0043679; GO:0044389; GO:0045202; GO:0045944; GO:0051046; GO:0070161; GO:1904692; GO:1990502 spectrin binding [GO:0030507]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389] IKLKVESSPSR 0.9864 -3.3537 0 0 0 0 0 0 14.116 0 0 0 0 0 0 0 0 0 0 11.1612 0 0 11.537 0 0 0 10.5523 0 0 0 0 0 0 0 0 0 0 10.2751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3434 12.4365 0 0 0 0 0 0 0 14.9456 0 0 13.1868 0 0 0 0 0 0 0 0 0 14.1066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2537 13.0509 0 0 0 0 0 12.3058 0 11.8569 0 0 0 12.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1604 0 0 15.746 0 0 0 0 0 0 Q96RU8 TRIB1_HUMAN "Tribbles homolog 1, TRB-1 (G-protein-coupled receptor-induced gene 2 protein, GIG-2) (SKIP1)" TRIB1 C8FW GIG2 TRB1 Homo sapiens (Human) JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; JNK cascade [GO:0007254]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405]; response to lipopolysaccharide [GO:0032496] GO:0004860; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0007254; GO:0014912; GO:0031434; GO:0031625; GO:0031665; GO:0032436; GO:0032496; GO:0043405; GO:0043433; GO:0045645; GO:0045651; GO:0045659; GO:0048662; GO:0055106; GO:0061629 mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106] ALCIHTGRELRCK 0.9864 -3.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7142 13.867 0 13.5139 13.5141 0 0 0 0 0 0 0 0 0 0 15.4005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8563 0 0 0 0 0 0 13.3619 0 0 14.2575 0 0 0 14.7062 0 0 0 0 0 0 13.8145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5P4 CERT_HUMAN "Ceramide transfer protein, hCERT (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein, GPBP) (START domain-containing protein 11, StARD11) (StAR-related lipid transfer protein 11)" CERT1 CERT COL4A3BP STARD11 Homo sapiens (Human) cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; ceramide transfer activity [GO:0120017]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol-4-phosphate binding [GO:0070273]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; lipid homeostasis [GO:0055088]; mitochondrion morphogenesis [GO:0070584]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165] GO:0000902; GO:0001701; GO:0003007; GO:0005654; GO:0005739; GO:0005789; GO:0005794; GO:0005829; GO:0006672; GO:0006936; GO:0006955; GO:0007029; GO:0007165; GO:0008283; GO:0016301; GO:0034976; GO:0035621; GO:0035627; GO:0042802; GO:0055088; GO:0070273; GO:0070584; GO:0097001; GO:0120009; GO:0120012; GO:0120017; GO:1902387; GO:1902388 ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; ceramide transfer activity [GO:0120017]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol-4-phosphate binding [GO:0070273] EYPKFLKR 0.9864 -1.5853 0 0 0 0 0 0 0 0 11.1384 0 0 10.6599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.398 0 0 0 0 11.1035 10.9338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3931 0 14.5681 0 0 0 0 0 0 0 0 10.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1647 0 0 0 0 0 0 0 0 0 12.3729 0 0 0 10.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0666 0 0 0 0 0 0 0 13.2169 0 13.0674 0 0 0 0 0 0 12.5858 12.8313 0 12.6001 0 0 0 0 0 0 12.991 0 0 P49910 ZN165_HUMAN "Zinc finger protein 165 (Cancer/testis antigen 53, CT53) (LD65) (Zinc finger and SCAN domain-containing protein 7)" ZNF165 ZPF165 ZSCAN7 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CYECNECGKSFAESSDLTRHR 0.98641 -3.5566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7002 9.93905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6532 0 0 0 0 0 14.3868 0 0 0 13.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.778 0 11.8977 0 0 0 0 0 0 0 0 0 0 13.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0222 0 0 0 0 0 0 0 Q86YI8 PHF13_HUMAN "PHD finger protein 13 (Survival time-associated PHD finger protein in ovarian cancer 1, SPOC1)" PHF13 Homo sapiens (Human) cell division [GO:0051301]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell division [GO:0051301]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076] GO:0000278; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0007059; GO:0007076; GO:0035064; GO:0046872; GO:0051301 chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] DSDAPGK 0.98641 -2.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4391 0 0 0 0 0 0 0 0 0 0 13.6585 0 0 0 0 13.2477 15.8819 0 0 0 16.0381 0 0 0 0 0 0 0 0 15.0841 12.6376 0 0 14.3716 0 13.8446 0 13.335 0 13.7426 13.3149 0 0 13.4522 0 0 0 12.4359 14.0671 0 0 0 13.5579 0 13.8998 0 0 0 0 0 13.6459 15.8826 14.0011 0 12.8538 14.004 0 0 0 0 12.0403 0 0 0 0 0 13.5725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9201 0 0 0 0 0 0 0 Q92752 TENR_HUMAN "Tenascin-R, TN-R (Janusin) (Restrictin)" TNR Homo sapiens (Human) "associative learning [GO:0008306]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; synaptic transmission, glutamatergic [GO:0035249]; telencephalon cell migration [GO:0022029]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; perineuronal net [GO:0072534]; Schaffer collateral - CA1 synapse [GO:0098685]; tenascin complex [GO:0090733]; signaling receptor binding [GO:0005102]; associative learning [GO:0008306]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; locomotory exploration behavior [GO:0035641]; long-term synaptic potentiation [GO:0060291]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of synaptic transmission [GO:0050805]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of cell migration [GO:0030334]; synapse organization [GO:0050808]; synaptic transmission, glutamatergic [GO:0035249]; telencephalon cell migration [GO:0022029]" GO:0005102; GO:0005576; GO:0005615; GO:0007155; GO:0007158; GO:0007411; GO:0008306; GO:0009986; GO:0022029; GO:0022408; GO:0030198; GO:0030334; GO:0035249; GO:0035641; GO:0045121; GO:0048677; GO:0048692; GO:0050805; GO:0050808; GO:0050885; GO:0051968; GO:0051971; GO:0060291; GO:0062023; GO:0072534; GO:0090733; GO:0098685; GO:0098978 signaling receptor binding [GO:0005102] CANGTCLCEEGYVGEDCGQRQCLNACSGR 0.98641 -3.5656 11.0249 0 12.7662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4543 0 0 0 0 0 0 13.2002 14.5425 0 13.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3647 0 0 0 0 0 0 0 0 0 0 0 14.5986 0 0 0 0 0 0 0 0 0 0 0 0 12.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7314 0 0 0 0 0 10.9068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H714 PACER_HUMAN "Protein associated with UVRAG as autophagy enhancer, Pacer (Protein Rubicon-like)" RUBCNL C13orf18 KIAA0226L Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagosome-endosome fusion [GO:0061910]; autophagosome-lysosome fusion [GO:0061909]; lipid metabolic process [GO:0006629]; regulation of glycogen metabolic process [GO:0070873]; regulation of lipid metabolic process [GO:0019216] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome maturation [GO:0097352]; autophagosome-endosome fusion [GO:0061910]; autophagosome-lysosome fusion [GO:0061909]; lipid metabolic process [GO:0006629]; regulation of glycogen metabolic process [GO:0070873]; regulation of lipid metabolic process [GO:0019216] GO:0000421; GO:0006629; GO:0010314; GO:0019216; GO:0031410; GO:0032266; GO:0043231; GO:0061909; GO:0061910; GO:0070273; GO:0070873; GO:0097352; GO:1901981 phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] GLLAPLLK 0.98642 -3.5735 0 0 0 10.0243 10.6356 0 10.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.156 0 0 0 10.2384 0 0 0 0 0 0 0 15.9831 0 15.9398 9.14371 0 0 0 0 0 0 0 0 0 0 9.0955 0 0 0 13.3171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4705 0 0 0 0 0 11.0314 0 15.2638 14.217 11.0309 14.6218 14.5628 13.1777 13.1232 13.9007 15.3075 15.3681 14.5781 13.2295 0 13.0441 15.1122 13.7272 15.2484 11.3992 17.2466 13.9883 14.0253 12.3757 12.1033 14.6309 12.286 15.4242 15.2039 13.7815 14.0876 0 14.5939 12.2772 14.7177 14.1628 14.3703 14.0972 0 13.648 11.6748 12.3644 15.9766 13.2014 0 12.2583 11.6491 13.7818 14.955 14.3486 14.2256 12.488 12.9789 13.8996 0 14.3937 12.4721 13.0198 13.0144 12.6662 0 13.1844 14.7269 12.5494 0 14.08 12.016 10.4083 0 12.9641 13.4675 0 10.8886 10.7149 12.4626 0 0 0 0 0 14.3105 0 10.3055 0 0 0 11.5364 0 10.7262 0 0 0 12.9098 0 0 13.2095 0 0 0 12.6899 16.2806 0 9.7149 13.5527 0 0 0 A8MUN3 YQ048_HUMAN Putative uncharacterized protein ENSP00000381830 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 HYKREAK 0.98642 -1.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15813 CD1D_HUMAN Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d) CD1D Homo sapiens (Human) "antigen processing and presentation, endogenous lipid antigen via MHC class Ib [GO:0048006]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; detection of bacterium [GO:0016045]; heterotypic cell-cell adhesion [GO:0034113]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; T cell selection [GO:0045058]" basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] "basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-2-microglobulin binding [GO:0030881]; cell adhesion molecule binding [GO:0050839]; endogenous lipid antigen binding [GO:0030883]; exogenous lipid antigen binding [GO:0030884]; histone binding [GO:0042393]; lipid antigen binding [GO:0030882]; lipopeptide binding [GO:0071723]; antigen processing and presentation, endogenous lipid antigen via MHC class Ib [GO:0048006]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; detection of bacterium [GO:0016045]; heterotypic cell-cell adhesion [GO:0034113]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; T cell selection [GO:0045058]" GO:0001916; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0009897; GO:0009986; GO:0010008; GO:0016045; GO:0016323; GO:0030881; GO:0030882; GO:0030883; GO:0030884; GO:0034113; GO:0042102; GO:0042393; GO:0045058; GO:0045087; GO:0045089; GO:0048006; GO:0048007; GO:0050839; GO:0071723 beta-2-microglobulin binding [GO:0030881]; cell adhesion molecule binding [GO:0050839]; endogenous lipid antigen binding [GO:0030883]; exogenous lipid antigen binding [GO:0030884]; histone binding [GO:0042393]; lipid antigen binding [GO:0030882]; lipopeptide binding [GO:0071723] GCLLFLLLWALLQAWGSAEVPQR 0.98642 -3.5699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14257 RCN2_HUMAN "Reticulocalbin-2 (Calcium-binding protein ERC-55) (E6-binding protein, E6BP)" RCN2 ERC55 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleolus [GO:0005730] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleolus [GO:0005730]; calcium ion binding [GO:0005509] GO:0005509; GO:0005730; GO:0005783; GO:0005788 calcium ion binding [GO:0005509] DRFVNDYDKDNDGR 0.98642 -3.5717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8598 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2015 0 0 0 0 0 0 0 12.3329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2765 12.8555 0 0 0 0 0 0 0 0 0 0 0 Q6P4R8 NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G) NFRKB INO80G Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" GO:0000723; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 DNA binding [GO:0003677]; protease binding [GO:0002020] ALQQKPK 0.98642 -2.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0895 0 11.9933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3767 0 14.2424 13.5975 0 0 0 0 0 14.2869 0 14.4453 0 14.9355 11.2088 12.619 0 14.4726 0 0 12.6709 13.4984 0 14.8613 14.5627 13.8098 12.1324 14.6104 14.5395 0 0 13.4842 13.5026 0 13.6106 0 0 13.8335 0 12.7944 0 14.6034 14.9079 15.4681 0 13.9728 0 13.6303 15.0276 0 0 0 15.7321 12.148 13.9318 0 0 0 15.1803 13.461 15.7223 0 13.917 14.0475 0 0 0 0 0 0 14.3787 13.7511 0 0 0 0 0 0 0 0 0 0 0 0 15 14.235 13.6039 12.9497 0 0 0 0 0 12.001 0 0 0 0 0 0 0 0 0 0 0 15.0969 12.0267 14.2847 13.3716 0 0 0 0 Q8NC67 NETO2_HUMAN Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2) NETO2 BTCL2 UNQ1926/PRO4401 Homo sapiens (Human) regulation of kainate selective glutamate receptor activity [GO:2000312] integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069] integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; ionotropic glutamate receptor binding [GO:0035255]; regulation of kainate selective glutamate receptor activity [GO:2000312] GO:0014069; GO:0016021; GO:0035255; GO:2000312 ionotropic glutamate receptor binding [GO:0035255] AGVFEQITKTHGTIIGITSGIVLVLLIISILVQVK 0.98642 -3.5699 0 0 0 0 0 0 0 0 0 12.57 0 0 0 0 0 0 0 0 0 13.1608 0 0 0 13.416 0 0 0 0 11.5599 0 12.8039 0 0 0 0 11.624 0 0 11.8474 9.78238 0 0 0 0 0 0 0 0 12.8405 0 12.7089 12.8586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0804 14.6935 0 0 0 0 0 0 14.2323 0 12.5014 0 0 0 0 0 0 13.4057 0 0 0 0 0 0 13.6185 0 0 0 13.5996 0 13.9487 0 14.0966 0 13.8134 13.3504 13.0724 0 0 0 0 14.0754 0 0 13.7984 0 0 12.5351 0 13.7715 13.7227 0 13.4095 10.9489 0 0 13.0705 0 12.5032 0 0 0 13.4299 0 13.1482 13.1288 0 11.8544 0 0 12.5693 11.2178 0 0 0 0 14.2988 0 11.7399 13.341 12.3115 0 12.867 0 10.8884 0 11.3608 11.0014 11.5951 0 11.5023 0 0 0 0 0 0 0 13.03 13.6651 0 0 0 0 0 12.0578 P11169 GTR3_HUMAN "Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain, GLUT-3)" SLC2A3 GLUT3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; galactose transmembrane transport [GO:0015757]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; monosaccharide transmembrane transport [GO:0015749]; transport across blood-brain barrier [GO:0150104] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell projection [GO:0042995]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; galactose transmembrane transporter activity [GO:0005354]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; galactose transmembrane transport [GO:0015757]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; monosaccharide transmembrane transport [GO:0015749]; transport across blood-brain barrier [GO:0150104] GO:0005354; GO:0005355; GO:0005536; GO:0005886; GO:0005887; GO:0005975; GO:0015149; GO:0015749; GO:0015757; GO:0016020; GO:0016021; GO:0019852; GO:0030667; GO:0033300; GO:0035579; GO:0042995; GO:0043204; GO:0046323; GO:0055056; GO:0070062; GO:0070821; GO:0070837; GO:0098708; GO:0101003; GO:0150104; GO:1904659 D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; galactose transmembrane transporter activity [GO:0005354]; glucose binding [GO:0005536]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149] IIKEFINK 0.98643 -1.6059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8279 0 0 0 0 0 0 0 0 14.2503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5339 0 0 0 0 0 0 14.2762 12.9402 0 0 0 0 0 0 0 13.7333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6388 13.4413 0 0 0 0 0 Q8TB03 CX038_HUMAN Uncharacterized protein CXorf38 CXorf38 Homo sapiens (Human) ARQFQPQCQVCAEWKR 0.98644 -1.6149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3899 0 15.1808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3021 0 14.1261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1555 0 0 0 0 0 0 0 0 0 0 0 18.5905 Q5VT66 MARC1_HUMAN "Mitochondrial amidoxime-reducing component 1, mARC1, EC 1.7.-.- (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1, MOSC domain-containing protein 1, Moco sulfurase C-terminal domain-containing protein 1)" MTARC1 MARC1 MOSC1 Homo sapiens (Human) cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958] "integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]; cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]" GO:0005739; GO:0005741; GO:0006809; GO:0008940; GO:0016021; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809; GO:1903958 "molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]" EPLETLKSYRQCDPSER 0.98645 -1.6238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1V8 CJ085_HUMAN Uncharacterized protein encoded by LINC01561 LINC01561 C10orf85 Homo sapiens (Human) ASSELPNR 0.98645 -3.3056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPC2 KCNK9_HUMAN "Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2, Two pore K(+) channel KT3.2)" KCNK9 TASK3 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322] GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0008021; GO:0015271; GO:0022841; GO:0030322; GO:0071805; GO:1990573 outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] AEEIRIKGK 0.98645 -3.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9166 0 0 0 0 0 0 0 0 0 0 0 0 13.8048 0 0 0 0 0 0 0 0 0 11.2063 12.8174 0 0 0 0 0 0 0 0 14.5688 0 0 0 0 0 0 0 0 0 0 13.0985 0 0 0 12.3904 0 0 0 0 0 0 12.3884 0 11.916 0 0 0 0 0 0 13.2889 13.012 12.9579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9256 12.5019 0 0 0 11.6659 0 0 Q9NRF8 PYRG2_HUMAN "CTP synthase 2, EC 6.3.4.2 (CTP synthetase 2) (UTP--ammonia ligase 2)" CTPS2 Homo sapiens (Human) 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220] cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220] GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006220; GO:0006241; GO:0006541; GO:0019856; GO:0042802; GO:0044210; GO:0097268 ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802] LGIRRTVFK 0.98645 -3.3052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9944 12.6044 0 12.8841 0 0 0 0 0 0 0 0 0 12.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1632 0 14.6813 0 0 0 0 0 0 0 0 0 0 13.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5729 0 0 0 10.8794 0 0 0 0 0 12.403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15286 RAB35_HUMAN Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C) RAB35 RAB1C RAY Homo sapiens (Human) antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] "anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192]" GO:0000281; GO:0003924; GO:0005525; GO:0005546; GO:0005829; GO:0005886; GO:0005905; GO:0008104; GO:0010008; GO:0015031; GO:0016192; GO:0016197; GO:0019003; GO:0019882; GO:0030669; GO:0031175; GO:0031253; GO:0032456; GO:0032482; GO:0036010; GO:0042470; GO:0045171; GO:0045334; GO:0048227; GO:0055038; GO:0070062; GO:0098993; GO:1990090 "GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" DYDHLFKLLIIGDSGVGKSSLLLR 0.98646 -1.6369 0 0 0 0 0 0 0 0 0 0 0 0 11.2434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2611 0 13.7903 0 0 0 13.7638 0 13.8682 0 0 0 0 13.117 12.9534 0 0 0 0 0 13.0453 0 12.3898 0 0 0 0 0 0 0 0 0 0 0 11.0766 0 0 0 0 0 12.7509 12.7221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P587 FAHD1_HUMAN "Acylpyruvase FAHD1, mitochondrial, EC 3.7.1.5 (Fumarylacetoacetate hydrolase domain-containing protein 1, FAH domain-containing protein 1) (Oxaloacetate decarboxylase, OAA decarboxylase, EC 4.1.1.112) (YisK-like protein)" FAHD1 C16orf36 YISKL Homo sapiens (Human) cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948] GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621 acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948] DVQDECKK 0.98646 -1.6324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WV83 S35F5_HUMAN "Solute carrier family 35 member F5 (Hepatitis C virus NS5A-transactivated protein 3, HCV NS5A-transactivated protein 3)" SLC35F5 NS5ATP3 UNQ2545/PRO6097 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LSRMSYPVK 0.98646 -3.3131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29317 EPHA2_HUMAN "Ephrin type-A receptor 2, EC 2.7.10.1 (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK)" EPHA2 ECK Homo sapiens (Human) activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; axon guidance [GO:0007411]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of protein kinase B signaling [GO:0051898]; neural tube development [GO:0021915]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160] cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; virus receptor activity [GO:0001618]; activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; axon guidance [GO:0007411]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; negative regulation of protein kinase B signaling [GO:0051898]; neural tube development [GO:0021915]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570] GO:0001501; GO:0001570; GO:0001618; GO:0001649; GO:0002043; GO:0004714; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0005925; GO:0006954; GO:0007155; GO:0007169; GO:0007411; GO:0008630; GO:0009986; GO:0010591; GO:0014028; GO:0016477; GO:0016525; GO:0019838; GO:0021915; GO:0030027; GO:0030216; GO:0030316; GO:0030335; GO:0031256; GO:0031258; GO:0032587; GO:0032682; GO:0033598; GO:0033628; GO:0033674; GO:0036342; GO:0043005; GO:0043235; GO:0043491; GO:0043535; GO:0045296; GO:0045765; GO:0046058; GO:0046849; GO:0048013; GO:0048320; GO:0048870; GO:0050830; GO:0051898; GO:0060035; GO:0060326; GO:0060444; GO:0070160; GO:0070309; GO:0070372; GO:0070848; GO:0072659; GO:0090630; GO:1901491; GO:1903078; GO:1903348; GO:1904238 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; virus receptor activity [GO:0001618] DCNSFPGGASSCK 0.98647 -3.329 0 10.4674 0 0 0 10.6567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8245 0 11.6377 0 0 0 0 13.1007 0 0 13.2245 0 0 0 13.7865 13.819 0 15.1472 0 12.1303 0 11.5693 0 0 11.8376 13.5216 0 0 0 0 13.3117 0 0 0 0 13.4252 0 11.9145 12.3087 0 0 15.0314 0 0 13.8102 13.5548 0 0 12.0572 0 13.3957 0 0 0 0 0 13.9432 13.847 0 0 12.3165 0 14.1755 12.0739 0 0 0 0 0 0 0 0 0 0 0 0 11.7429 12.35 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9524 0 0 0 0 0 0 0 0 12.8121 0 13.1923 0 0 0 0 0 0 Q99463 NPY6R_HUMAN "Putative neuropeptide Y receptor type 6, NPY6-R (NPY Y1-like receptor) (Putative pancreatic polypeptide receptor 2, PP2)" NPY6R NPY1RL Y2B Homo sapiens (Human) integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188] GO:0005886; GO:0008188; GO:0016021; GO:0042923; GO:0043005 neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188] INTMLISIVVTFGACWLPR 0.98647 -1.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1904 0 14.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1M4 DB127_HUMAN "Beta-defensin 127 (Beta-defensin 27, DEFB-27) (Defensin, beta 127)" DEFB127 C20orf73 DEFB27 UNQ1956/PRO6071 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087; GO:0050829; GO:0061844 MGLFMIIAILLFQKPTVTEQLKK 0.98647 -3.3251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00182 LEG9_HUMAN "Galectin-9, Gal-9 (Ecalectin) (Tumor antigen HOM-HD-21)" LGALS9 Homo sapiens (Human) "cellular response to interferon-gamma [GO:0071346]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; maternal process involved in female pregnancy [GO:0060135]; natural killer cell tolerance induction [GO:0002519]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine production [GO:0032682]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of tumor necrosis factor production [GO:0032720]; p38MAPK cascade [GO:0038066]; positive regulation of activated T cell autonomous cell death [GO:0070241]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response [GO:0032834]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral entry into host cell [GO:0046598]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]" collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634] "collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; disaccharide binding [GO:0048030]; enzyme binding [GO:0019899]; galactose binding [GO:0005534]; galactoside binding [GO:0016936]; cellular response to interferon-gamma [GO:0071346]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; maternal process involved in female pregnancy [GO:0060135]; natural killer cell tolerance induction [GO:0002519]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine production [GO:0032682]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of tumor necrosis factor production [GO:0032720]; p38MAPK cascade [GO:0038066]; positive regulation of activated T cell autonomous cell death [GO:0070241]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response [GO:0032834]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral entry into host cell [GO:0046598]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]" GO:0002519; GO:0005534; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006935; GO:0006954; GO:0007565; GO:0010628; GO:0010629; GO:0016936; GO:0019899; GO:0030246; GO:0032496; GO:0032682; GO:0032689; GO:0032720; GO:0032729; GO:0032731; GO:0032733; GO:0032735; GO:0032736; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032834; GO:0038066; GO:0043123; GO:0043305; GO:0045953; GO:0046007; GO:0046598; GO:0048030; GO:0051092; GO:0060135; GO:0062023; GO:0070241; GO:0070371; GO:0070374; GO:0070555; GO:0071346; GO:0071636; GO:0071639; GO:0098586; GO:1901224; GO:2000510; GO:2000562; GO:2000563; GO:2000670; GO:2001190; GO:2001200; GO:2001269 carbohydrate binding [GO:0030246]; disaccharide binding [GO:0048030]; enzyme binding [GO:0019899]; galactose binding [GO:0005534]; galactoside binding [GO:0016936] KTHMPFQK 0.98648 -1.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2822 12.348 12.1977 0 0 10.9227 12.2154 0 0 0 0 0 0 0 0 0 11.9698 0 12.6777 0 0 0 0 12.6644 0 12.5806 0 0 0 0 0 0 0 10.9867 0 0 0 0 11.7968 12.8352 11.7307 0 0 0 11.0943 0 0 0 11.9004 0 0 0 12.7982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3911 0 0 0 0 0 0 0 0 0 10.9511 0 0 0 0 0 0 0 0 0 10.3686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14796 SH21B_HUMAN "SH2 domain-containing protein 1B (EWS/FLI1-activated transcript 2, EAT-2)" SH2D1B EAT2 Homo sapiens (Human) adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; leukocyte activation involved in immune response [GO:0002366]; positive regulation of innate immune response [GO:0045089]; positive regulation of natural killer cell mediated immunity [GO:0002717]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966] cytosol [GO:0005829] cytosol [GO:0005829]; protein-macromolecule adaptor activity [GO:0030674]; adaptive immune response [GO:0002250]; innate immune response [GO:0045087]; leukocyte activation involved in immune response [GO:0002366]; positive regulation of innate immune response [GO:0045089]; positive regulation of natural killer cell mediated immunity [GO:0002717]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966] GO:0002250; GO:0002366; GO:0002717; GO:0005829; GO:0009966; GO:0030674; GO:0045087; GO:0045089; GO:0050731; GO:0050776 protein-macromolecule adaptor activity [GO:0030674] DSESIPGVLCLCVSFKNIVYTYRIFR 0.98648 -2.0247 0 0 0 0 0 0 0 0 0 11.8965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.354 0 0 0 0 0 0 10.6146 0 0 0 0 0 0 0 0 0 12.6903 0 12.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4463 0 0 0 0 0 0 0 0 0 0 13.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4596 0 0 12.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N96 SPT13_HUMAN "Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2, Asef2)" SPATA13 Homo sapiens (Human) cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; cell migration [GO:0016477]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005654; GO:0005737; GO:0005829; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0030334; GO:0032587; GO:0042802; GO:0046847; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802] DICEGYIRQCR 0.98648 -3.5381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2478 0 0 0 12.102 0 0 0 0 0 0 0 0 0 0 0 10.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0436 0 0 0 0 0 0 0 0 0 0 15.4151 0 0 0 0 0 0 0 0 0 0 12.2156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99436 PSB7_HUMAN "Proteasome subunit beta type-7, EC 3.4.25.1 (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z)" PSMB7 Z Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0004175; GO:0004298; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0016604; GO:0019774; GO:0034774; GO:0043161; GO:1904813 endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298] GYKLPKVR 0.98648 -1.6484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8869 13.5619 0 14.1689 0 0 0 0 13.5184 14.588 13.5469 14.5301 14.5153 13.5071 14.4338 13.2424 13.557 0 12.9624 0 0 0 13.2185 0 0 0 0 12.8555 12.3136 0 0 0 0 14.4704 13.3584 14.3088 0 17.533 14.1093 13.3578 0 13.0414 13.248 13.6599 14.8706 0 14.4679 13.5265 13.7542 13.3147 13.4059 0 13.563 0 13.5591 11.7914 0 14.7531 13.7466 0 13.3132 14.0307 13.1879 0 13.5874 14.2104 14.0944 0 0 0 12.9896 0 13.3829 13.5155 0 13.114 13.4598 14.3551 13.3494 12.7718 0 0 0 0 14.1701 0 0 0 12.9878 13.1346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4193 12.8676 13.5977 0 0 0 0 0 Q13561 DCTN2_HUMAN "Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit, DCTN-50) (p50 dynamitin)" DCTN2 DCTN50 Homo sapiens (Human) melanosome transport [GO:0032402]; microtubule-based process [GO:0007017]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; melanosome transport [GO:0032402]; microtubule-based process [GO:0007017]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539] GO:0000776; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005874; GO:0007017; GO:0007052; GO:0007080; GO:0016020; GO:0019901; GO:0030286; GO:0030426; GO:0030507; GO:0031982; GO:0032402; GO:0042802; GO:0070062; GO:0071539 identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507] DKRVGTK 0.98649 -2.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0803 0 0 0 14.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSF8 BTBDA_HUMAN BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1) BTBD10 GMRP1 Homo sapiens (Human) negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; negative regulation of neuron death [GO:1901215]; positive regulation of phosphorylation [GO:0042327]; type B pancreatic cell proliferation [GO:0044342] GO:0001650; GO:0005654; GO:0005737; GO:0042327; GO:0044342; GO:1901215 DVAKSVLKER 0.98649 -1.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4626 0 0 0 0 0 0 14.4589 0 0 11.2257 0 0 0 0 0 0 0 13.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8638 0 0 13.3001 0 0 0 O43704 ST1B1_HUMAN "Sulfotransferase 1B1, ST1B1, EC 2.8.2.1 (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase)" SULT1B1 ST1B2 SULT1B2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cellular biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805] GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006576; GO:0006805; GO:0008146; GO:0009812; GO:0018958; GO:0030855; GO:0042403; GO:0050427; GO:0051923 aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] FDAIYETEMSKTALQFR 0.9865 -1.6589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5658 0 0 0 0 0 13.963 14.2612 14.1655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6398 0 0 0 0 0 14.7365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6911 0 Q09470 KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1) KCNA1 Homo sapiens (Human) cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; potassium channel activity [GO:0005267]; potassium ion transmembrane transporter activity [GO:0015079]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964] GO:0001964; GO:0005249; GO:0005251; GO:0005267; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0006813; GO:0006937; GO:0007268; GO:0007405; GO:0008076; GO:0008104; GO:0009986; GO:0010644; GO:0010960; GO:0015079; GO:0016021; GO:0016324; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0044305; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0097718; GO:0098978; GO:0099055; GO:0099056; GO:0099508; GO:1903818; GO:1905030 delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; potassium channel activity [GO:0005267]; potassium ion transmembrane transporter activity [GO:0015079]; voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249] GEQATSLAILRVIRLVR 0.9865 -3.3638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6262 0 13.1404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8216 0 0 P54803 GALC_HUMAN "Galactocerebrosidase, GALCERase, EC 3.2.1.46 (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase)" GALC Homo sapiens (Human) galactosylceramide catabolic process [GO:0006683]; glycosphingolipid metabolic process [GO:0006687]; myelination [GO:0042552] lysosomal lumen [GO:0043202]; lysosome [GO:0005764] lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683]; glycosphingolipid metabolic process [GO:0006687]; myelination [GO:0042552] GO:0004336; GO:0005764; GO:0006683; GO:0006687; GO:0042552; GO:0043202 galactosylceramidase activity [GO:0004336] AEWLLSASWQR 0.98651 -3.5655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCR6 SMRP1_HUMAN Spermatid-specific manchette-related protein 1 (Ciliated bronchial epithelial protein 1) (Testis development protein NYD-SP22) SMRP1 C9orf24 CBE1 Homo sapiens (Human) cell differentiation [GO:0030154]; protein-containing complex assembly [GO:0065003]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; manchette [GO:0002177]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; manchette [GO:0002177]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; cell differentiation [GO:0030154]; protein-containing complex assembly [GO:0065003]; spermatogenesis [GO:0007283] GO:0002177; GO:0005634; GO:0005654; GO:0005829; GO:0007283; GO:0030154; GO:0043014; GO:0048471; GO:0065003 alpha-tubulin binding [GO:0043014] CGCVDPLPGRLPFHGYESACSGRHYCLR 0.98651 -2.4615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6475 0 0 0 12.1223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9455 10.6911 0 0 0 0 12.5568 13.6358 0 12.4657 13.4984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2451 0 11.8642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0692 13.6504 0 12.6405 13.3185 14.1339 13.454 14.1278 13.3986 0 13.6679 0 0 0 0 0 13.2292 0 13.368 0 0 0 0 O43257 ZNHI1_HUMAN Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet) ZNHIT1 CGBP1 ZNFN4A1 Homo sapiens (Human) "histone exchange [GO:0043486]; intestinal stem cell homeostasis [GO:0036335]; muscle cell differentiation [GO:0042692]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of lymphoid progenitor cell differentiation [GO:1905458]; regulation of histone exchange [GO:1900049]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] "nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; intestinal stem cell homeostasis [GO:0036335]; muscle cell differentiation [GO:0042692]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of lymphoid progenitor cell differentiation [GO:1905458]; regulation of histone exchange [GO:1900049]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000786; GO:0000812; GO:0005634; GO:0005654; GO:0006355; GO:0031491; GO:0036335; GO:0042393; GO:0042692; GO:0043486; GO:0046872; GO:1900049; GO:1902164; GO:1905458 histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491] MVEKKTSVR 0.98652 -1.5909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6279 0 0 0 16.0194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZQ5 SELH_HUMAN "Selenoprotein H, SelH" SELENOH C11orf31 SELH Homo sapiens (Human) Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; RNA binding [GO:0003723] GO:0003723; GO:0005794 RNA binding [GO:0003723] LKFPEPQEVVEELK 0.98652 -1.6766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4244 11.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0799 0 0 0 0 0 0 0 13.3515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3233 0 12.8587 0 0 0 0 13.3791 0 0 0 13.1628 0 0 19.5533 0 0 0 0 0 0 0 0 0 0 13.7936 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7994 0 0 0 0 0 0 13.7954 13.6431 0 0 0 0 0 0 0 Q9HBH1 DEFM_HUMAN "Peptide deformylase, mitochondrial, EC 3.5.1.88 (Polypeptide deformylase)" PDF PDF1A Homo sapiens (Human) co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; positive regulation of cell population proliferation [GO:0008284]; translation [GO:0006412] GO:0005739; GO:0006412; GO:0008284; GO:0018206; GO:0031365; GO:0042586; GO:0043686; GO:0046872 metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586] ALRQMEPFPLR 0.98652 -1.6776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2541 0 14.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15053 K0040_HUMAN Uncharacterized protein KIAA0040 KIAA0040 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LLQMEKR 0.98653 -2.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7012 0 13.0432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUH3 RBM45_HUMAN "RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1, RB-1) (RNA-binding motif protein 45)" RBM45 DRB1 DRBP1 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0007399; GO:0030154; GO:0042802; GO:1990904 identical protein binding [GO:0042802]; RNA binding [GO:0003723] AILAEPK 0.98653 -1.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6154 14.2899 0 0 0 0 15.3935 0 14.4942 0 0 14.5877 12.7627 15.3853 0 0 0 0 0 0 0 13.9537 14.3272 0 0 0 0 13.5999 0 0 0 0 0 0 0 0 0 16.8348 0 15.5033 0 0 0 16.7244 14.294 0 14.4665 14.4539 13.4229 0 0 0 0 0 14.5003 14.488 16.3395 0 17.2552 0 0 0 0 16.2316 0 0 0 13.8171 0 14.3892 0 0 0 0 0 14.6798 0 0 14.4873 14.3381 0 0 14.185 17.3764 14.2842 0 14.2078 0 0 0 0 0 0 0 0 0 0 0 0 13.6741 0 0 14.2123 0 0 0 14.7215 0 15.9464 0 Q9UH92 MLX_HUMAN "Max-like protein X (Class D basic helix-loop-helix protein 13, bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4)" MLX BHLHD13 TCFL4 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" PQTLREIVIGVLHQLK 0.98654 -1.6038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.01 0 15.472 0 15.8205 0 0 0 16.2695 16.1997 15.9187 15.5421 14.973 15.3405 0 0 16.9018 0 0 0 0 0 0 0 0 12.0811 14.7847 0 0 0 0 0 0 0 0 0 0 13.3476 0 15.5637 0 0 0 0 0 0 0 P08962 CD63_HUMAN "CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3, LAMP-3) (Lysosome integral membrane protein 1, Limp1) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30, Tspan-30) (CD antigen CD63)" CD63 MLA1 TSPAN30 Homo sapiens (Human) cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746] "azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]" "azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]" GO:0002092; GO:0005615; GO:0005654; GO:0005765; GO:0005886; GO:0005887; GO:0007160; GO:0009986; GO:0010008; GO:0015031; GO:0016477; GO:0031088; GO:0031226; GO:0031902; GO:0031904; GO:0032585; GO:0035577; GO:0035646; GO:0042470; GO:0043231; GO:0048757; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046 CCGAANYTDWEK 0.98655 -1.6137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYT0 PLEK2_HUMAN Pleckstrin-2 PLEK2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]" GO:0005737; GO:0005856; GO:0005886; GO:0031258; GO:0031532; GO:0032266; GO:0035556; GO:0043325; GO:0080025; GO:0120034 "phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]" AEWIEAIKKLT 0.98655 -1.6122 0 0 0 0 0 13.2744 12.9717 0 0 0 0 0 12.6572 0 0 0 0 11.8406 0 0 0 0 0 0 0 0 0 0 12.1976 11.9082 12.5309 13.1556 0 0 13.056 0 0 0 0 0 0 0 13.8685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.407 0 13.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.984 13.492 11.4911 0 13.3787 12.9277 0 13.4552 0 0 0 0 0 0 0 0 0 0 0 0 14.3927 14.0421 13.1444 0 0 0 0 0 0 11.5794 0 0 0 0 0 14.7571 0 0 0 0 0 0 0 0 0 0 0 0 12.6759 0 0 0 0 0 A2RTY3 HEAT9_HUMAN Protein HEATR9 (HEAT repeat-containing protein 9) HEATR9 C17orf66 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244 ALRMLVK 0.98656 -1.6213 0 0 0 16.2423 0 0 0 10.9748 0 12.9535 14.1928 11.9805 0 12.4804 0 15.7819 18.0251 12.8744 18.4441 11.0783 12.7431 0 0 0 0 13.4222 0 16.2625 11.3768 12.6983 12.8956 12.3242 12.6616 0 0 12.4212 0 0 12.3815 0 16.2514 0 11.4241 0 16.3361 16.2866 16.4572 16.3437 16.3916 12.4318 16.3147 12.9681 18.4198 0 18.5367 18.5276 18.3458 0 13.1804 0 0 12.7237 13.1271 0 11.1789 0 14.6485 14.0476 0 0 0 0 0 0 0 9.44603 13.5671 0 0 0 0 0 0 0 0 0 9.91607 0 0 0 0 0 0 13.6853 14.1667 14.1064 0 13.6942 9.37402 0 0 0 0 0 0 0 0 0 0 15.3037 0 12.7555 9.39227 0 0 0 0 13.7737 13.4793 0 14.5854 0 0 0 0 18.9892 0 0 0 0 0 0 0 0 0 17.1424 17.0258 0 0 15.6015 0 0 0 16.7568 19.1263 12.9577 0 0 17.0864 11.5225 0 0 11.3293 0 0 16.924 14.1627 0 0 9.71601 14.3955 19.1905 12.8562 0 0 17.4813 0 14.1906 14.3312 15.3048 15.5602 0 0 0 16.7307 14.4227 0 14.5124 17.4729 19.5067 Q6P1Q0 LTMD1_HUMAN LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2) LETMD1 Homo sapiens (Human) mitochondrion organization [GO:0007005]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; mitochondrion organization [GO:0007005]; regulation of inflammatory response [GO:0050727]; regulation of phagocytosis [GO:0050764] GO:0005654; GO:0005730; GO:0005739; GO:0005741; GO:0005743; GO:0007005; GO:0016021; GO:0043022; GO:0050727; GO:0050764 ribosome binding [GO:0043022] ALAKLGIGQLTAQEVK 0.98656 -1.6237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9769 Q8IVU1 IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule) IGDCC3 PUNC Homo sapiens (Human) cell-cell adhesion [GO:0098609]; neuromuscular process controlling balance [GO:0050885] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cell-cell adhesion [GO:0098609]; neuromuscular process controlling balance [GO:0050885] GO:0005887; GO:0050885; GO:0098609 AVQRAASPRR 0.98656 -1.6231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94905 ERLN2_HUMAN "Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2, SPFH domain-containing protein 2)" ERLIN2 C8orf2 SPFH2 UNQ2441/PRO5003/PRO9924 Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933]; ubiquitin-dependent ERAD pathway [GO:0030433] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0008203; GO:0015485; GO:0016021; GO:0030433; GO:0031625; GO:0032933; GO:0032991; GO:0045121; GO:0045540; GO:0045541; GO:0045717 cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625] ADAECYTAMK 0.98658 -1.64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.918 0 0 0 0 12.9671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01826 SATB1_HUMAN DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1) SATB1 Homo sapiens (Human) chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003690; GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0006357; GO:0016363; GO:0016604; GO:0016605; GO:0043565 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]" AKVSQALFAKVAATK 0.98658 -3.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2997 0 0 0 0 0 0 0 0 10.9189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8453 0 11.6669 13.0078 0 0 0 0 14.9574 0 0 0 0 0 0 0 0 0 0 0 0 16.8488 0 0 13.7611 13.4754 0 0 12.0557 0 0 0 14.0411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7958 0 0 0 0 0 0 0 14.4851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2NL68 PRSR3_HUMAN Proline and serine-rich protein 3 PROSER3 C19orf55 Homo sapiens (Human) AELSRQKR 0.98658 -1.6413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N609 TR1L1_HUMAN Translocating chain-associated membrane protein 1-like 1 TRAM1L1 Homo sapiens (Human) "protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" integral component of endoplasmic reticulum membrane [GO:0030176] "integral component of endoplasmic reticulum membrane [GO:0030176]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" GO:0006616; GO:0030176; GO:0045048 GISLWAIVFILGR 0.98658 -3.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3253 14.2432 0 0 13.742 0 0 0 0 0 0 0 0 0 0 0 12.663 0 0 13.1955 0 0 0 12.9355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LR5 UB2E2_HUMAN "Ubiquitin-conjugating enzyme E2 E2, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2)" UBE2E2 UBCH8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087 ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] AEHDRMAR 0.98658 -1.6394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7102 0 0 0 0 12.6126 15.8523 14.5171 0 13.7713 0 14.6202 12.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9206 0 14.0547 0 13.2549 0 0 0 0 0 0 0 0 0 0 14.2049 14.0581 0 0 12.9628 0 0 0 13.5674 13.8161 0 0 13.6678 0 0 13.4021 0 0 0 0 14.738 0 14.0023 14.6893 0 0 0 15.0125 14.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8993 0 13.1441 0 0 0 0 0 P02788 TRFL_HUMAN "Lactotransferrin, Lactoferrin, EC 3.4.21.- (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H, Lfcin-H; Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C ]" LTF GIG12 LF Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of membrane potential [GO:0045837]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680]; retina homeostasis [GO:0001895] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of membrane potential [GO:0045837]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680]; retina homeostasis [GO:0001895] GO:0001503; GO:0001530; GO:0001817; GO:0001895; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045087; GO:0045669; GO:0045837; GO:0048525; GO:0050829; GO:0050830; GO:0051092; GO:0051673; GO:0055037; GO:0055072; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000117; GO:2000308; GO:2001205 cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252] DEYELLCPDNTRK 0.98659 -1.6446 0 0 0 0 0 0 0 0 0 11.4545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6366 0 0 0 0 0 0 0 0 0 0 0 0 12.3496 0 0 11.3523 0 0 0 0 0 0 0 0 11.7858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1919 13.7209 0 0 0 14.0842 13.7274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1426 0 0 0 0 0 11.931 0 0 0 0 0 0 12.6213 0 0 0 0 0 0 0 0 0 0 0 0 13.0889 0 0 0 14.9266 Q86WC4 OSTM1_HUMAN Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit) OSTM1 GL HSPC019 UNQ6098/PRO21201 Homo sapiens (Human) osteoclast differentiation [GO:0030316]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765] chloride channel complex [GO:0034707]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; osteoclast differentiation [GO:0030316]; transepithelial chloride transport [GO:0030321] GO:0005765; GO:0005829; GO:0030316; GO:0030321; GO:0034707 LILPKRLK 0.98659 -1.6483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99959 PKP2_HUMAN Plakophilin-2 PKP2 Homo sapiens (Human) bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cardiac conduction [GO:0086019]; desmosome assembly [GO:0002159]; desmosome organization [GO:0002934]; heart development [GO:0007507]; intermediate filament bundle assembly [GO:0045110]; maintenance of animal organ identity [GO:0048496]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; ventricular cardiac muscle cell action potential [GO:0086005]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; intermediate filament binding [GO:0019215]; molecular adaptor activity [GO:0060090]; protein kinase C binding [GO:0005080]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling involved in cardiac conduction [GO:0086019]; desmosome assembly [GO:0002159]; desmosome organization [GO:0002934]; heart development [GO:0007507]; intermediate filament bundle assembly [GO:0045110]; maintenance of animal organ identity [GO:0048496]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; ventricular cardiac muscle cell action potential [GO:0086005]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0001533; GO:0002159; GO:0002934; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005882; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007507; GO:0010765; GO:0014704; GO:0016021; GO:0017080; GO:0019215; GO:0030054; GO:0030057; GO:0044325; GO:0045110; GO:0045294; GO:0045296; GO:0048496; GO:0055010; GO:0060090; GO:0072659; GO:0086002; GO:0086005; GO:0086019; GO:0086064; GO:0086073; GO:0086083; GO:0086091; GO:0098609; GO:0098911 alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; intermediate filament binding [GO:0019215]; molecular adaptor activity [GO:0060090]; protein kinase C binding [GO:0005080]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325] NMSSAGADGRKAMR 0.98659 -2.0237 0 12.3109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4538 0 0 13.3411 0 0 12.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3778 0 0 0 0 0 0 13.9398 0 0 0 0 0 0 0 12.6554 0 10.1489 12.4493 13.4668 0 0 0 0 0 0 0 0 0 14.7988 0 14.0671 14.4732 0 0 0 0 0 0 11.6304 0 0 0 13.1933 0 14.2816 0 11.359 0 13.3042 12.5476 0 0 0 0 0 11.898 14.5442 13.4041 13.6164 13.5687 0 14.5937 0 0 0 0 0 0 12.2825 0 0 0 0 13.4761 0 0 0 0 0 0 0 0 0 14.3813 0 11.0902 0 0 12.4657 0 0 14.5259 0 12.5918 0 0 0 0 0 0 0 0 13.1517 0 0 0 0 11.8449 0 0 0 0 0 0 0 0 12.6177 14.2241 0 0 0 0 0 13.1234 0 0 14.385 0 0 0 0 0 0 0 0 0 0 0 0 10.6941 0 0 Q8N118 CP4X1_HUMAN "Cytochrome P450 4X1, EC 1.14.14.- (CYPIVX1)" CYP4X1 UNQ1929/PRO4404 Homo sapiens (Human) lipid metabolic process [GO:0006629] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; anandamide 14,15 epoxidase activity [GO:0062189]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lipid metabolic process [GO:0006629]" GO:0005506; GO:0005789; GO:0006629; GO:0016021; GO:0020037; GO:0062189 "anandamide 14,15 epoxidase activity [GO:0062189]; heme binding [GO:0020037]; iron ion binding [GO:0005506]" EFSWLETRWAR 0.98661 -3.9475 0 0 0 0 0 0 0 0 0 0 13.386 0 0 0 0 0 0 0 0 0 0 13.165 0 13.1407 0 0 13.595 0 0 0 9.87123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8967 14.8884 13.4488 0 14.4435 0 0 0 12.8722 0 0 0 16.958 13.5109 0 0 0 12.5904 0 0 15.2307 0 0 13.0292 14.1729 9.79722 14.998 13.6987 0 0 0 0 0 13.5512 13.0712 0 0 0 0 0 0 0 0 13.2763 0 12.526 12.1827 0 0 0 0 0 13.7823 0 0 16.7676 0 0 13.1527 13.0815 0 12.8887 13.7479 13.0695 0 0 12.691 0 0 0 0 0 0 0 12.6239 12.8254 0 0 0 12.3119 0 0 0 0 11.8712 0 0 0 12.4428 0 0 0 0 0 0 0 0 12.5468 0 0 0 0 12.2621 0 O95822 DCMC_HUMAN "Malonyl-CoA decarboxylase, mitochondrial, MCD, EC 4.1.1.9" MLYCD Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931] GO:0002931; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006085; GO:0006633; GO:0006637; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046321; GO:0050080; GO:2001294 identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080] AMDELLRR 0.98662 -2.4615 14.2309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1524 0 0 0 0 0 13.4776 0 0 13.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2055 11.3414 0 0 0 0 0 0 0 0 0 13.8325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1376 0 0 0 0 0 0 0 0 0 0 Q96DB2 HDA11_HUMAN "Histone deacetylase 11, HD11, EC 3.5.1.98" HDAC11 Homo sapiens (Human) chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; oligodendrocyte development [GO:0014003] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; oligodendrocyte development [GO:0014003] GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0014003; GO:0016575; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407] FAKQAIR 0.98663 -2.4742 0 0 0 0 0 0 0 0 0 12.2921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6178 0 0 0 0 14.8643 0 14.6849 13.5738 13.9288 13.2051 14.2338 0 0 13.2625 0 14.8562 0 0 0 0 0 0 13.902 0 0 0 0 0 0 0 0 0 12.7023 0 13.9008 0 0 12.9172 13.676 14.1409 0 15.0203 0 13.9749 0 0 0 0 13.7335 13.2649 0 0 13.3505 0 14.5315 12.3102 0 0 0 0 13.9586 14.1205 13.4781 0 14.861 14.7559 12.6905 0 11.5706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9406 0 0 0 0 0 0 Q9NPI0 TM138_HUMAN Transmembrane protein 138 TMEM138 HSPC196 HSPC198 Homo sapiens (Human) cilium assembly [GO:0060271] cilium [GO:0005929]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774] cilium [GO:0005929]; integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; cilium assembly [GO:0060271] GO:0005774; GO:0005929; GO:0016021; GO:0060271 KEFMQVR 0.98665 -1.6036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7096 0 0 0 12.6042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1187 0 0 0 0 0 0 0 0 0 11.2265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4921 13.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TEC6 H37_HUMAN Histone H3-7 H3-7 H3-2 HIST2H3PS2 Homo sapiens (Human) nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] ARTKQTAR 0.98667 -1.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAA5 LR75A_HUMAN Leucine-rich repeat-containing protein 75A (Leucine-rich repeat-containing protein FAM211A) LRRC75A C17orf76 FAM211A Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AGDKAGRAGAGMPPYHR 0.98667 -1.6142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0334 0 0 0 17.8914 0 0 0 0 0 0 0 0 0 0 0 0 0 12.614 0 0 0 0 0 0 0 0 0 0 14.114 0 0 0 0 0 0 14.0673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3577 15.3855 0 14.2392 0 0 0 0 0 0 0 0 16.0309 14.3971 0 0 0 13.8434 0 0 0 0 0 Q9H967 WDR76_HUMAN WD repeat-containing protein 76 WDR76 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; regulation of DNA damage checkpoint [GO:2000001] heterochromatin [GO:0000792]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] heterochromatin [GO:0000792]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; cellular response to DNA damage stimulus [GO:0006974]; regulation of DNA damage checkpoint [GO:2000001] GO:0000792; GO:0003677; GO:0005634; GO:0006974; GO:0019899; GO:0090734; GO:2000001 DNA binding [GO:0003677]; enzyme binding [GO:0019899] IPLLTTIRHNTFTGR 0.98667 -1.6148 0 0 0 11.0454 14.4152 0 13.4273 0 0 0 0 0 0 0 0 0 0 0 0 10.2172 0 0 0 0 0 10.0028 13.105 0 0 10.4605 0 0 0 0 0 11.1009 0 0 0 10.5726 0 0 0 0 0 0 0 10.723 0 9.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3496 12.1277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6721 13.633 14.5565 0 0 0 0 15.9092 14.7695 13.2999 14.6387 15.0908 0 11.6848 0 0 0 12.8798 12.2107 0 15.0661 11.3977 14.0405 0 0 0 0 15.1731 12.9163 0 14.8337 0 0 14.1002 13.4722 0 12.272 14.5476 12.6269 13.9776 13.3387 0 0 0 11.8407 14.5728 10.7591 15.1366 0 11.6736 0 0 0 0 0 12.9302 0 0 12.6658 14.2331 0 12.4058 12.8712 14.8803 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5267 0 0 12.0394 13.2849 13.7803 0 0 0 0 0 Q9H6K4 OPA3_HUMAN Optic atrophy 3 protein OPA3 Homo sapiens (Human) regulation of lipid metabolic process [GO:0019216]; response to stimulus [GO:0050896]; visual perception [GO:0007601] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; regulation of lipid metabolic process [GO:0019216]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005739; GO:0007601; GO:0019216; GO:0050896 MRIMGFR 0.98668 -3.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0513 0 0 0 0 0 0 0 0 0 0 13.2147 13.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3056 0 0 0 Q5SYB0 FRPD1_HUMAN FERM and PDZ domain-containing protein 1 (FERM domain-containing protein 2) FRMPD1 FRMD2 KIAA0967 Homo sapiens (Human) establishment of protein localization to membrane [GO:0090150]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; establishment of protein localization to membrane [GO:0090150]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0005829; GO:0005856; GO:0005886; GO:0008277; GO:0032991; GO:0090150 CTSGVPKSSFLTEEK 0.98669 -3.9314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1132 0 0 0 0 0 12.6246 0 13.1647 12.9109 0 0 11.6654 0 0 0 0 12.6149 0 0 0 0 0 0 15.3328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4635 12.9765 0 12.7399 13.0906 0 0 0 12.0509 0 14.734 0 0 0 0 0 0 0 0 0 0 0 0 12.6014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.717 0 0 13.6015 0 0 11.9848 0 0 11.827 11.906 0 10.7479 0 11.8856 0 11.3048 0 0 0 15.3488 0 0 Q96AE7 TTC17_HUMAN "Tetratricopeptide repeat protein 17, TPR repeat protein 17" TTC17 Homo sapiens (Human) actin filament polymerization [GO:0030041]; cilium organization [GO:0044782] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782] GO:0005737; GO:0005829; GO:0005886; GO:0015629; GO:0030041; GO:0044782 ALHFSSRHNK 0.9867 -1.6405 0 0 0 0 0 0 0 0 12.3794 0 0 0 0 0 0 0 0 0 0 10.6339 0 0 0 11.8551 0 0 0 0 0 0 0 0 0 11.2875 0 0 0 0 0 0 14.1133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5707 15.3092 15.7484 12.1568 14.3349 15.8968 17.1189 15.9324 0 0 15.3337 0 0 0 12.273 0 12.7382 16.3806 0 12.4601 13.4778 15.2198 14.7057 0 13.3504 12.5776 0 14.6302 0 14.3801 0 12.3136 0 14.8225 0 12.9001 0 0 11.9193 0 0 12.858 0 0 0 0 0 0 0 15.9219 13.646 0 14.4142 0 0 0 0 0 0 0 0 0 0 0 14.0024 0 0 0 0 0 0 0 9.86716 0 0 0 0 0 0 0 0 12.3007 0 0 0 0 0 0 0 0 0 0 0 15.3669 0 0 12.1707 0 0 0 0 Q9H270 VPS11_HUMAN "Vacuolar protein sorting-associated protein 11 homolog, hVPS11 (RING finger protein 108)" VPS11 RNF108 PP3476 Homo sapiens (Human) autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein ubiquitination [GO:0016567]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904] GO:0000166; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0008333; GO:0016567; GO:0019904; GO:0019905; GO:0030136; GO:0030139; GO:0030674; GO:0030897; GO:0031647; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0045732; GO:0046872; GO:0048284; GO:0061630; GO:1902115; GO:1903955; GO:2000643 metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630] DRKVSPK 0.9867 -3.9475 0 0 0 0 13.5661 13.0987 0 0 0 0 0 0 0 0 0 12.1459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3784 0 0 9.90494 0 12.9283 0 0 0 0 0 0 13.4081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.917 0 0 0 0 0 12.9246 0 0 0 0 0 0 16.9206 11.7338 0 0 13.8463 0 0 0 0 0 0 0 0 17.1713 17.2378 12.3027 16.038 0 12.2433 11.7695 0 0 0 11.566 0 0 11.1368 0 0 0 0 0 0 13.6225 0 0 0 0 0 0 13.3859 17.4033 0 0 0 0 0 0 0 0 15.137 0 0 14.4298 0 0 12.6175 16.7106 12.7113 0 0 15.6721 0 15.6151 0 0 0 0 0 0 0 0 12.1078 13.4892 13.5947 0 0 0 0 0 0 0 12.2657 0 0 0 0 13.2169 11.4375 0 0 0 0 0 0 0 0 O96011 PX11B_HUMAN "Peroxisomal membrane protein 11B (Peroxin-11B) (Peroxisomal biogenesis factor 11B) (Protein PEX11 homolog beta, PEX11-beta)" PEX11B Homo sapiens (Human) peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; regulation of peroxisome size [GO:0044375]; signal transduction [GO:0007165] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; regulation of peroxisome size [GO:0044375]; signal transduction [GO:0007165] GO:0005654; GO:0005739; GO:0005777; GO:0005778; GO:0005779; GO:0005829; GO:0007031; GO:0007165; GO:0016020; GO:0016559; GO:0032991; GO:0042802; GO:0042803; GO:0043231; GO:0044375 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] AVHLSDVVLRFCITVSHLNR 0.98672 -2.461 0 0 0 9.93737 0 0 11.187 12.7756 0 0 13.5359 0 0 0 14.1843 0 0 0 0 0 13.1315 0 12.9207 0 0 0 0 12.4143 0 0 13.3056 0 0 0 13.5314 0 0 0 13.9867 13.99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5738 13.2508 13.2113 0 0 12.5897 12.3339 11.6006 0 0 0 0 0 0 0 12.2818 14.2026 0 11.6472 0 0 0 0 0 12.4758 0 14.488 14.9777 14.0989 13.1466 0 12.2681 12.4333 0 0 0 0 0 0 0 0 12.3755 0 0 0 0 0 12.7871 13.8119 0 0 0 12.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4517 0 0 0 0 0 0 0 14.1483 0 0 0 0 13.4819 13.5708 0 0 0 0 0 0 0 0 0 0 13.0782 12.3388 0 0 0 0 0 0 0 0 12.9441 12.9166 0 0 0 0 0 0 Q8N699 MYCT1_HUMAN Myc target protein 1 (Myc target in myeloid cells protein 1) MYCT1 MTLC MTMC1 Homo sapiens (Human) hematopoietic stem cell homeostasis [GO:0061484] intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; hematopoietic stem cell homeostasis [GO:0061484] GO:0005654; GO:0043231; GO:0061484 ASAPISQWSSSRR 0.98673 -2.4717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCT8 SPP2A_HUMAN "Signal peptide peptidase-like 2A, SPP-like 2A, SPPL2a, EC 3.4.23.- (Intramembrane protease 3, IMP-3) (Presenilin-like protein 2)" SPPL2A IMP3 PSL2 PSEC0147 Homo sapiens (Human) membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803] extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]" GO:0005765; GO:0005770; GO:0005886; GO:0006509; GO:0010803; GO:0016020; GO:0030660; GO:0031293; GO:0031902; GO:0033619; GO:0042500; GO:0042803; GO:0043231; GO:0050776; GO:0070062; GO:0071458; GO:0071556 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]" ILIAFISYK 0.98674 -2.4723 0 0 0 0 0 0 0 0 13.8157 13.0397 13.2533 13.9418 0 14.2081 13.6464 14.4499 13.4621 12.9724 14.0681 0 0 0 0 0 0 0 0 12.9956 13.4079 0 0 0 0 14.0508 13.9676 0 13.4499 14.8015 14.0319 11.7871 13.0333 0 0 0 12.7442 0 0 13.5174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6306 0 0 0 0 0 0 0 0 0 0 0 0 17.9024 0 0 14.8146 13.0816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1204 0 0 0 0 0 0 0 0 0 14.5875 14.9905 0 15.3771 14.8549 0 0 0 0 0 14.9766 0 13.9452 0 17.4887 0 0 0 0 0 14.8814 0 0 Q9UI15 TAGL3_HUMAN "Transgelin-3 (Neuronal protein 22, NP22) (Neuronal protein NP25)" TAGLN3 NP25 Homo sapiens (Human) central nervous system development [GO:0007417]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoskeleton [GO:0005856]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; nucleus [GO:0005634]; central nervous system development [GO:0007417]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005856; GO:0007417 DDGCYRGEPSWFHR 0.98675 -1.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3649 0 0 11.6644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FF7 MISP3_HUMAN Uncharacterized protein MISP3 (MISP family member 3) MISP3 Homo sapiens (Human) DIEREAHR 0.98679 -3.9423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1039 0 0 0 0 0 11.5115 11.9843 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9587 13.3252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0762 0 11.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01100 FOS_HUMAN "Protein c-Fos (Cellular oncogene fos) (Fos proto-oncogene, AP-1 transcription factor subunit) (G0/G1 switch regulatory protein 7) (Proto-oncogene c-Fos) (Transcription factor AP-1 subunit c-Fos)" FOS G0S7 Homo sapiens (Human) "aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hypoxia [GO:0071456]; cellular response to prolactin [GO:1990646]; cellular response to reactive oxygen species [GO:0034614]; conditioned taste aversion [GO:0001661]; DNA methylation [GO:0006306]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; nervous system development [GO:0007399]; osteoclast differentiation [GO:0030316]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976] "chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; aging [GO:0007568]; cellular response to cadmium ion [GO:0071276]; cellular response to calcium ion [GO:0071277]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hypoxia [GO:0071456]; cellular response to prolactin [GO:1990646]; cellular response to reactive oxygen species [GO:0034614]; conditioned taste aversion [GO:0001661]; DNA methylation [GO:0006306]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; nervous system development [GO:0007399]; osteoclast differentiation [GO:0030316]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to gravity [GO:0009629]; response to immobilization stress [GO:0035902]; response to light stimulus [GO:0009416]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle cell differentiation [GO:0035914]; sleep [GO:0030431]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000785; GO:0000976; GO:0000978; GO:0000979; GO:0000981; GO:0001221; GO:0001228; GO:0001661; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006306; GO:0006357; GO:0006366; GO:0006954; GO:0007179; GO:0007399; GO:0007565; GO:0007568; GO:0009409; GO:0009410; GO:0009416; GO:0009629; GO:0009636; GO:0016020; GO:0030316; GO:0030431; GO:0031668; GO:0032496; GO:0032570; GO:0032993; GO:0034097; GO:0034614; GO:0035902; GO:0035914; GO:0035976; GO:0035994; GO:0042802; GO:0043005; GO:0044877; GO:0045672; GO:0045893; GO:0045944; GO:0051412; GO:0051591; GO:0060395; GO:0061629; GO:0070412; GO:0071276; GO:0071277; GO:0071456; GO:0090575; GO:0140467; GO:1901216; GO:1902895; GO:1990646; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]" NKMAAAK 0.9868 -3.9453 0 0 0 0 11.2251 0 11.1352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2311 0 0 13.1241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6416 0 0 13.2169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H0 DLGP4_HUMAN "Disks large-associated protein 4, DAP-4 (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4, SAPAP-4)" DLGAP4 DAP4 KIAA0964 SAPAP4 Homo sapiens (Human) regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572] cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] GO:0005886; GO:0023052; GO:0031594; GO:0060090; GO:0098962; GO:0098978; GO:0098981; GO:0099572 molecular adaptor activity [GO:0060090] ARGESPGR 0.9868 -3.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2767 0 0 0 0 0 0 14.5981 0 14.0543 0 0 0 0 0 0 0 15.4937 11.8559 14.6347 12.1814 0 0 0 12.8401 0 0 0 0 0 0 15.5205 12.9532 12.6043 0 0 0 0 0 0 0 13.6584 0 0 0 0 0 0 0 0 0 0 0 0 13.87 0 0 0 13.4561 11.9143 14.5435 0 0 12.0209 14.2144 0 0 0 0 13.3435 0 14.9068 0 13.3635 0 0 0 0 0 14.8419 14.1046 0 0 0 13.1028 0 15.3045 0 0 0 12.9038 0 10.7988 0 0 0 0 0 14.4312 13.2615 0 10.735 0 0 0 14.8335 0 13.4951 0 0 0 10.9591 0 13.2675 0 0 0 0 0 0 0 P0C263 SBK2_HUMAN "Serine/threonine-protein kinase SBK2, EC 2.7.11.1 (SH3-binding domain kinase family member 2) (Sugen kinase 69, SgK069)" SBK2 SGK069 Homo sapiens (Human) MAPK cascade [GO:0000165]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; MAPK cascade [GO:0000165]; protein phosphorylation [GO:0006468] GO:0000165; GO:0004674; GO:0004708; GO:0005524; GO:0006468; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AEVDELYEEVR 0.98683 -2.4602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3641 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60279 SUSD5_HUMAN Sushi domain-containing protein 5 SUSD5 KIAA0527 Homo sapiens (Human) cell adhesion [GO:0007155]; Notch signaling pathway [GO:0007219] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; Notch signaling pathway [GO:0007219] GO:0005540; GO:0007155; GO:0007219; GO:0016021 hyaluronic acid binding [GO:0005540] DEAEAHIDYEDNFPDDR 0.98684 -2.4723 0 0 0 0 0 0 0 10.3193 0 0 0 12.2306 0 14.2201 0 14.9242 0 0 11.075 0 0 0 0 0 0 15.1693 11.5803 0 15.0536 0 0 12.1113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2842 15.1264 0 0 12.9439 0 13.1674 0 0 0 0 0 0 0 0 0 0 15.306 0 13.1944 14.604 0 0 0 0 0 11.9726 0 0 0 0 0 0 0 0 0 0 12.4536 14.3884 0 0 0 0 0 0 0 0 13.4754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1653 0 13.5492 0 0 Q8NGY3 OR6K3_HUMAN Olfactory receptor 6K3 (Olfactory receptor OR1-18) OR6K3 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] NKDMNNAIKK 0.98686 -1.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8668 0 10.8502 0 0 0 0 14.0475 0 14.9229 14.7778 0 13.7911 0 0 0 0 0 15.5391 11.9398 15.9543 15.136 15.0309 14.058 14.8388 13.4112 13.1885 14.2861 15.3031 0 0 14.4439 15.1908 14.7147 13.1105 0 14.0615 14.9823 0 0 13.7587 13.8338 15.0559 0 0 0 14.8573 11.9943 0 0 0 0 0 0 14.2513 14.2811 0 0 0 0 0 14.7274 0 0 0 14.0656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.836 0 0 11.2505 0 13.8693 0 12.9677 0 14.3604 12.8693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7325 0 0 0 0 O15069 NACAD_HUMAN NAC-alpha domain-containing protein 1 NACAD KIAA0363 Homo sapiens (Human) protein targeting to membrane [GO:0006612] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]; unfolded protein binding [GO:0051082]; protein targeting to membrane [GO:0006612] GO:0005634; GO:0005737; GO:0005854; GO:0006612; GO:0051082 unfolded protein binding [GO:0051082] AKQSRSEK 0.98687 -3.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6XR72 ZNT10_HUMAN "Zinc transporter 10, ZnT-10 (Manganese transporter SLC30A10) (Solute carrier family 30 member 10)" SLC30A10 ZNT10 ZNT8 Homo sapiens (Human) cellular response to angiotensin [GO:1904385]; cellular zinc ion homeostasis [GO:0006882]; detoxification of zinc ion [GO:0010312]; epidermal growth factor receptor signaling pathway [GO:0007173]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; negative regulation of cellular senescence [GO:2000773]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cellular response to manganese ion [GO:1905802]; regulation of zinc ion transport [GO:0071579]; zinc ion transmembrane transport [GO:0071577] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]; cellular response to angiotensin [GO:1904385]; cellular zinc ion homeostasis [GO:0006882]; detoxification of zinc ion [GO:0010312]; epidermal growth factor receptor signaling pathway [GO:0007173]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; negative regulation of cellular senescence [GO:2000773]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of cellular response to manganese ion [GO:1905802]; regulation of zinc ion transport [GO:0071579]; zinc ion transmembrane transport [GO:0071577] GO:0005384; GO:0005385; GO:0005769; GO:0005794; GO:0005886; GO:0006828; GO:0006882; GO:0007173; GO:0010312; GO:0016021; GO:0043524; GO:0055037; GO:0070374; GO:0071421; GO:0071577; GO:0071579; GO:1903427; GO:1904385; GO:1905802; GO:2000773 manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385] IIATLHIKYPK 0.98688 -3.9377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4762 0 0 0 0 0 0 14.2982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5763 0 0 0 0 0 0 0 0 0 0 0 0 0 P49639 HXA1_HUMAN Homeobox protein Hox-A1 (Homeobox protein Hox-1F) HOXA1 HOX1F Homo sapiens (Human) abducens nerve formation [GO:0021599]; anatomical structure morphogenesis [GO:0009653]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; cognition [GO:0050890]; embryonic neurocranium morphogenesis [GO:0048702]; inner ear development [GO:0048839]; neuromuscular process [GO:0050905]; optokinetic behavior [GO:0007634]; outer ear morphogenesis [GO:0042473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal formation [GO:0060876]; sensory perception of sound [GO:0007605] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; abducens nerve formation [GO:0021599]; anatomical structure morphogenesis [GO:0009653]; artery development [GO:0060840]; artery morphogenesis [GO:0048844]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; cognition [GO:0050890]; embryonic neurocranium morphogenesis [GO:0048702]; inner ear development [GO:0048839]; neuromuscular process [GO:0050905]; optokinetic behavior [GO:0007634]; outer ear morphogenesis [GO:0042473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of behavior [GO:0050795]; regulation of transcription by RNA polymerase II [GO:0006357]; semicircular canal formation [GO:0060876]; sensory perception of sound [GO:0007605]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007605; GO:0007634; GO:0009653; GO:0021599; GO:0042473; GO:0042802; GO:0043565; GO:0045944; GO:0048702; GO:0048839; GO:0048844; GO:0050795; GO:0050890; GO:0050905; GO:0060840; GO:0060876; GO:0090102; GO:0090103; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" NPPKTGK 0.98689 -3.9423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1989 0 13.1034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9968 0 15.0052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6714 0 0 0 0 Q969G5 CAVN3_HUMAN "Caveolae-associated protein 3 (Cavin-3) (Protein kinase C delta-binding protein) (Serum deprivation response factor-related gene product that binds to C-kinase, hSRBC)" CAVIN3 PRKCDBP SRBC Homo sapiens (Human) circadian regulation of gene expression [GO:0032922]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of fermentation [GO:1901003]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; circadian regulation of gene expression [GO:0032922]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of fermentation [GO:1901003]; negative regulation of protein kinase B signaling [GO:0051898]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] GO:0005080; GO:0005737; GO:0005829; GO:0005901; GO:0030866; GO:0032922; GO:0032991; GO:0051898; GO:0070374; GO:1901003 protein kinase C binding [GO:0005080] ALSGRKGPAAPPPTPVK 0.98689 -3.9451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.67825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSG1 ZNF2_HUMAN Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661) ZNF2 ZNF661 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006357; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CQESVTFEDVAVVFTDEEWSR 0.98689 -3.9445 0 0 11.0341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.781 0 0 0 11.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2992 0 0 0 0 12.4094 0 0 0 0 0 0 0 0 0 0 17.4428 0 18.2243 14.7848 0 14.2384 14.3203 0 0 15.3018 14.9978 14.4788 0 0 0 0 0 0 15.2374 14.8831 0 14.4448 0 14.1709 0 0 14.6074 14.4506 0 0 13.8353 0 0 0 10.7936 0 0 0 0 0 0 14.2706 0 0 0 13.8037 0 0 0 0 0 12.9575 12.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4818 0 0 12.3513 0 0 0 13.8977 0 0 0 0 0 0 0 0 A6NH11 GLTD2_HUMAN Glycolipid transfer protein domain-containing protein 2 GLTPD2 Homo sapiens (Human) ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009] cytosol [GO:0005829] cytosol [GO:0005829]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009] GO:0005829; GO:0035627; GO:0120009; GO:1902387; GO:1902388 ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388] EAFTKVTDLEARVHGPDAEHYWSLVAMAAWER 0.9869 -1.7016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9644 0 12.0189 0 0 0 0 0 0 0 0 0 0 0 0 11.3366 0 14.9111 10.7448 0 13.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ICH7 ASPH2_HUMAN "Aspartate beta-hydroxylase domain-containing protein 2, EC 1.14.11.-" ASPHD2 Homo sapiens (Human) peptidyl-amino acid modification [GO:0018193] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; peptidyl-amino acid modification [GO:0018193] GO:0016020; GO:0016021; GO:0018193; GO:0046872; GO:0051213 dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872] YSWSGMGR 0.9869 -2.0207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6738 0 0 0 0 0 0 0 P07766 CD3E_HUMAN T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e) CD3E T3E Homo sapiens (Human) "adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; apoptotic signaling pathway [GO:0097190]; calcium-mediated signaling [GO:0019722]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell surface receptor signaling pathway [GO:0007166]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell activation [GO:0046629]; negative regulation of gene expression [GO:0010629]; negative regulation of smoothened signaling pathway [GO:0045879]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal complex assembly [GO:0007172]; smoothened signaling pathway [GO:0007224]; T cell activation [GO:0042110]; T cell anergy [GO:0002870]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" alpha-beta T cell receptor complex [GO:0042105]; cell body [GO:0044297]; cell-cell junction [GO:0005911]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] "alpha-beta T cell receptor complex [GO:0042105]; cell body [GO:0044297]; cell-cell junction [GO:0005911]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; alpha-beta T cell activation [GO:0046631]; apoptotic signaling pathway [GO:0097190]; calcium-mediated signaling [GO:0019722]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell surface receptor signaling pathway [GO:0007166]; cerebellum development [GO:0021549]; dendrite development [GO:0016358]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell activation [GO:0046629]; negative regulation of gene expression [GO:0010629]; negative regulation of smoothened signaling pathway [GO:0045879]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of T cell anergy [GO:0002669]; positive regulation of T cell proliferation [GO:0042102]; positive thymic T cell selection [GO:0045059]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal complex assembly [GO:0007172]; smoothened signaling pathway [GO:0007224]; T cell activation [GO:0042110]; T cell anergy [GO:0002870]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001772; GO:0001954; GO:0002250; GO:0002669; GO:0002870; GO:0004888; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005911; GO:0007166; GO:0007169; GO:0007172; GO:0007186; GO:0007224; GO:0009897; GO:0010628; GO:0010629; GO:0016358; GO:0017124; GO:0018108; GO:0019722; GO:0019901; GO:0021549; GO:0030159; GO:0031295; GO:0032729; GO:0032743; GO:0032753; GO:0033634; GO:0035739; GO:0042101; GO:0042102; GO:0042105; GO:0042106; GO:0042110; GO:0042608; GO:0042802; GO:0042981; GO:0043197; GO:0044297; GO:0045059; GO:0045060; GO:0045879; GO:0046629; GO:0046631; GO:0050731; GO:0050850; GO:0050852; GO:0065003; GO:0097190; GO:2000563 identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor complex adaptor activity [GO:0030159]; T cell receptor binding [GO:0042608]; transmembrane signaling receptor activity [GO:0004888] AKAKPVTR 0.98693 -2.4596 14.7445 14.0081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7291 9.27547 0 0 0 0 10.7469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6825 0 0 0 0 11.1655 0 0 0 0 0 0 0 0 0 0 0 16.3138 0 16.3966 0 16.461 0 14.992 0 18.6904 18.7003 18.6623 0 0 13.0972 10.9951 0 0 11.3263 13.1502 0 0 0 0 13.4337 0 0 12.2981 0 12.0063 0 0 12.8494 0 0 0 0 0 0 12.7421 0 12.4033 0 0 0 0 0 13.1652 0 0 13.093 0 11.9941 0 0 12.2048 0 0 12.5741 0 0 0 12.4805 12.8167 0 0 0 0 12.7073 0 0 12.2699 0 12.9793 12.9782 0 12.4592 0 13.2209 11.5335 0 0 0 0 0 0 0 13.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08034 CXB1_HUMAN "Gap junction beta-1 protein (Connexin-32, Cx32) (GAP junction 28 kDa liver protein)" GJB1 CX32 Homo sapiens (Human) cell-cell signaling [GO:0007267]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; nervous system development [GO:0007399]; purine ribonucleotide transport [GO:0015868] connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328] connexin complex [GO:0005922]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; cell-cell signaling [GO:0007267]; epididymis development [GO:1905867]; gap junction assembly [GO:0016264]; nervous system development [GO:0007399]; purine ribonucleotide transport [GO:0015868] GO:0005243; GO:0005789; GO:0005922; GO:0007267; GO:0007399; GO:0015868; GO:0016021; GO:0016264; GO:0016328; GO:0042802; GO:1905867 gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802] DILRRSPGTGAGLAEK 0.98693 -2.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.44 0 0 0 0 0 0 0 0 0 0 10.3335 0 14.3214 0 0 0 0 0 0 0 11.3832 0 0 0 0 0 0 0 0 0 0 0 13.8234 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7596 14.0482 0 0 0 0 0 0 0 0 13.7298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2143 0 0 11.6629 0 0 0 0 0 0 14.0818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15080 NCF4_HUMAN "Neutrophil cytosol factor 4, NCF-4 (Neutrophil NADPH oxidase factor 4) (SH3 and PX domain-containing protein 4) (p40-phox, p40phox)" NCF4 SH3PXD4 Homo sapiens (Human) phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; phosphatidylinositol-3-phosphate binding [GO:0032266]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554] GO:0005737; GO:0005829; GO:0005886; GO:0006909; GO:0010008; GO:0016020; GO:0016176; GO:0032010; GO:0032266; GO:0042554; GO:0043020; GO:0045730 phosphatidylinositol-3-phosphate binding [GO:0032266]; superoxide-generating NADPH oxidase activator activity [GO:0016176] GFTSHFVFVIEVKTK 0.98693 -2.4574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94782 UBP1_HUMAN "Ubiquitin carboxyl-terminal hydrolase 1, EC 3.4.19.12 (Deubiquitinating enzyme 1, hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment ]" USP1 Homo sapiens (Human) monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; response to UV [GO:0009411]; skeletal system development [GO:0001501]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001501; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006282; GO:0006511; GO:0008233; GO:0009411; GO:0016579; GO:0019985; GO:0035520 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233] CFAASGLEFDCYGGGLSK 0.98697 -1.6718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0063 0 15.3441 12.7746 0 0 0 0 0 0 15.5402 14.6605 15.2334 14.3665 0 15.2001 0 0 0 0 0 0 11.6082 11.2055 0 0 0 0 15.103 0 15.2819 0 15.5002 11.2613 0 0 15.5119 15.4922 0 0 15.7423 0 0 0 15.4762 0 15.9301 0 13.4118 0 15.6013 0 14.3285 15.7914 13.5052 15.6649 15.3175 15.3948 0 0 0 0 15.4785 15.7323 12.9281 12.8615 0 0 15.6283 15.4849 15.5284 0 0 13.6104 0 12.8364 0 0 0 0 0 0 0 15.5344 15.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3151 0 0 0 13.3571 0 0 P18847 ATF3_HUMAN "Cyclic AMP-dependent transcription factor ATF-3, cAMP-dependent transcription factor ATF-3 (Activating transcription factor 3)" ATF3 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; endoplasmic reticulum unfolded protein response [GO:0030968]; gluconeogenesis [GO:0006094]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061394]; skeletal muscle cell differentiation [GO:0035914] CHOP-ATF3 complex [GO:1990622]; chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "CHOP-ATF3 complex [GO:1990622]; chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cellular response to amino acid starvation [GO:0034198]; endoplasmic reticulum unfolded protein response [GO:0030968]; gluconeogenesis [GO:0006094]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance [GO:0061394]; skeletal muscle cell differentiation [GO:0035914]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006094; GO:0006357; GO:0008284; GO:0010628; GO:0030968; GO:0034198; GO:0035914; GO:0042802; GO:0042803; GO:0045944; GO:0046982; GO:0061394; GO:0070373; GO:0090575; GO:1903984; GO:1990440; GO:1990622; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" AQNGRTPEDERNLFIQQIK 0.98697 -1.6658 0 0 0 0 11.2639 0 12.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7385 0 0 13.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04671 P_HUMAN P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog) OCA2 D15S12 P Homo sapiens (Human) cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; L-tyrosine transmembrane transporter activity [GO:0005302]; cell population proliferation [GO:0008283]; eye pigment biosynthetic process [GO:0006726]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; spermatid development [GO:0007286] GO:0005302; GO:0005737; GO:0005765; GO:0005789; GO:0006726; GO:0007286; GO:0008283; GO:0010008; GO:0016021; GO:0030318; GO:0033162; GO:0042438 L-tyrosine transmembrane transporter activity [GO:0005302] EEHIVVELTQADALGSRWRR 0.98697 -1.6666 0 0 0 0 0 0 10.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1499 10.8775 0 0 0 0 0 0 0 0 0 10.6204 10.6231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWD3 RTL8A_HUMAN Retrotransposon Gag-like protein 8A (Mammalian retrotransposon derived protein 8A) RTL8A CXX1B FAM127B MAR8A Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730] GO:0005730 ALLAGPLRPAARR 0.98698 -3.9414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIA0 CYH4_HUMAN "Cytohesin-4 (PH, SEC7 and coiled-coil domain-containing protein 4)" CYTH4 CYT4 PSCD4 Homo sapiens (Human) regulation of ARF protein signal transduction [GO:0032012] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; regulation of ARF protein signal transduction [GO:0032012] GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0008289; GO:0032012; GO:0034451; GO:0045171 guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] ASITRVPFYDLVSTRK 0.98698 -3.9375 0 0 0 0 0 0 0 0 0 0 10.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0586 0 0 0 0 0 0 0 0 0 0 12.4731 0 0 0 13.2912 0 13.7822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6326 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5717 0 0 0 0 0 0 0 0 0 14.6835 0 0 0 0 0 P80723 BASP1_HUMAN Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22) BASP1 NAP22 Homo sapiens (Human) "diaphragm development [GO:0060539]; gonad development [GO:0008406]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; negative regulation of transcription, DNA-templated [GO:0045892]; podocyte differentiation [GO:0072112]; positive regulation of heart growth [GO:0060421]; positive regulation of metanephric ureteric bud development [GO:2001076]; substantia nigra development [GO:0021762]; thorax and anterior abdomen determination [GO:0007356]" cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; vesicle [GO:0031982] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; vesicle [GO:0031982]; protein domain specific binding [GO:0019904]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; diaphragm development [GO:0060539]; gonad development [GO:0008406]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchyme development [GO:0072075]; negative regulation of transcription, DNA-templated [GO:0045892]; podocyte differentiation [GO:0072112]; positive regulation of heart growth [GO:0060421]; positive regulation of metanephric ureteric bud development [GO:2001076]; substantia nigra development [GO:0021762]; thorax and anterior abdomen determination [GO:0007356]" GO:0000785; GO:0000976; GO:0003714; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0007356; GO:0008406; GO:0016363; GO:0016605; GO:0016607; GO:0019904; GO:0021762; GO:0030054; GO:0030426; GO:0031982; GO:0045892; GO:0060231; GO:0060421; GO:0060539; GO:0070062; GO:0072075; GO:0072112; GO:2001076 protein domain specific binding [GO:0019904]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] ETPAATEAPSSTPKAQGPAASAEEPK 0.98699 -1.6816 14.1585 0 11.9975 0 15.3786 15.5302 12.5902 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3983 13.3334 0 13.9405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0456 0 0 15.8535 18.9951 0 16.0878 16.2464 14.1124 19.141 13.3159 19.4166 19.375 0 0 14.5028 0 0 0 0 0 0 15.6167 0 15.5857 0 0 0 14.9963 15.1003 13.5773 18.1955 0 15.3611 15.3989 0 0 0 0 20.493 0 0 15.2731 0 0 0 0 0 0 0 15.6873 0 15.4393 15.5431 15.4938 11.5247 0 12.421 0 15.2815 15.3488 14.9943 20.3877 19.4042 19.5224 15.6958 20.452 12.7555 0 15.5639 13.3584 15.3031 14.2503 15.1232 14.4968 14.4109 15.4793 14.743 15.0456 16.2515 15.8338 0 14.811 0 19.3624 16.4105 15.9821 13.9718 15.0207 12.0711 0 0 0 0 0 0 0 0 0 12.347 0 0 12.1955 0 0 15.6481 13.0301 14.243 14.6649 0 15.4793 12.2908 15.0439 0 Q14197 ICT1_HUMAN "Peptidyl-tRNA hydrolase ICT1, mitochondrial, EC 3.1.1.29 (39S ribosomal protein L58, mitochondrial, MRP-L58) (Digestion substraction 1, DS-1) (Immature colon carcinoma transcript 1 protein) (Mitochondrial large ribosomal subunit protein mL62)" MRPL58 DS1 ICT1 Homo sapiens (Human) mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]; mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126]" GO:0004045; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005762; GO:0005886; GO:0016150; GO:0032543; GO:0070126 "aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity, codon nonspecific [GO:0016150]" DMITEASQTPKEPTKEDVK 0.98699 -1.6811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0384 0 0 0 0 0 0 0 0 0 0 0 15.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1498 0 12.4762 0 12.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ26 YS006_HUMAN Putative uncharacterized protein PP6455 PP6455 Homo sapiens (Human) SGAAETALLVR 0.98699 -2.0172 0 0 0 0 14.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 13.697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5F7 PCDGL_HUMAN "Protocadherin gamma-C4, PCDH-gamma-C4" PCDHGC4 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; synapse organization [GO:0050808] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; synapse organization [GO:0050808] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0043524; GO:0050808 calcium ion binding [GO:0005509] EKQSDYR 0.98699 -3.9502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0766 0 0 0 11.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0551 0 0 0 0 0 0 0 14.479 0 0 0 0 15.4968 0 0 0 0 0 0 13.6796 0 14.1155 14.3465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8953 0 0 0 0 14.3277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.983 0 15.0601 0 0 0 0 0 0 0 0 0 11.3407 0 0 0 0 0 0 0 0 0 0 0 0 11.5305 0 Q96KD3 GAR1B_HUMAN Golgi associated RAB2 interactor protein 1B (Testis development protein NYD-SP18) GARIN1B FAM137A FAM71F1 Homo sapiens (Human) acrosome assembly [GO:0001675]; acrosome reaction [GO:0007340] Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; acrosome assembly [GO:0001675]; acrosome reaction [GO:0007340] GO:0001675; GO:0005794; GO:0007340 EDSIPCTCDLRWR 0.987 -3.9603 0 0 0 0 0 0 0 0 0 0 0 0 13.3408 0 0 0 0 0 12.3912 0 0 0 0 0 0 0 0 0 0 0 0 12.5324 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2917 0 0 0 0 14.7308 14.273 0 13.7765 0 0 0 0 13.0484 0 12.1275 0 0 0 12.9057 12.7563 0 13.3706 14.9343 14.5551 0 0 0 14.1116 0 11.4836 0 0 15.8947 12.9809 11.5056 12.1837 0 0 0 13.251 13.4361 0 0 0 0 13.1899 0 15.0156 0 0 15.2989 0 0 0 0 0 13.4788 0 12.4965 10.2295 0 0 0 15.4048 0 0 0 0 0 0 0 0 0 0 0 0 12.8123 0 0 0 0 12.8883 13.0472 13.7279 0 0 0 0 0 0 0 0 14.3298 0 0 0 0 0 0 15.3875 0 0 0 0 0 13.8537 0 O43929 ORC4_HUMAN Origin recognition complex subunit 4 ORC4 ORC4L Homo sapiens (Human) DNA replication initiation [GO:0006270] "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; DNA replication initiation [GO:0006270]" GO:0000166; GO:0000781; GO:0000808; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005730; GO:0005829; GO:0006270 ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166] FSHRQIHLMNSFGFPQYVKIFK 0.98701 -1.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8739 0 0 0 14.3795 0 0 0 0 0 0 0 0 15.1537 0 0 14.2302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0464 0 0 0 0 0 Q9Y664 KPTN_HUMAN KICSTOR complex protein kaptin (Actin-associated protein 2E4) KPTN Homo sapiens (Human) actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462] KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420] KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462] GO:0005765; GO:0007015; GO:0030027; GO:0032420; GO:0034198; GO:0042149; GO:0051015; GO:0061462; GO:0098871; GO:0140007; GO:1904262 actin filament binding [GO:0051015] GVHILQHSLIQASELVLTRLR 0.98701 -1.7002 0 0 0 0 0 0 13.6522 0 0 0 0 0 0 0 0 0 0 0 0 10.1805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7923 0 0 0 12.8482 0 0 0 0 0 17.5577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.459 0 13.3304 12.4959 0 0 0 0 0 0 12.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JW98 CAHM4_HUMAN Calcium homeostasis modulator protein 4 (Protein FAM26D) CALHM4 C6orf78 FAM26D UNQ6481/PRO21277 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261] GO:0005261; GO:0005887 cation channel activity [GO:0005261] ISPLECK 0.98704 -2.4596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4086 0 0 0 0 0 0 11.7738 0 0 0 0 0 0 0 12.2965 0 0 0 0 Q9UK99 FBX3_HUMAN F-box only protein 3 FBXO3 FBX3 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis [GO:0006508] GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0006508 ubiquitin-protein transferase activity [GO:0004842] ACQLDSRYWR 0.98707 -3.9373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3983 0 0 0 0 13.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8694 0 13.0366 0 O43559 FRS3_HUMAN "Fibroblast growth factor receptor substrate 3, FGFR substrate 3 (FGFR-signaling adaptor SNT2) (Suc1-associated neurotrophic factor target 2, SNT-2)" FRS3 Homo sapiens (Human) fibroblast growth factor receptor signaling pathway [GO:0008543]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; fibroblast growth factor receptor binding [GO:0005104]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; fibroblast growth factor receptor signaling pathway [GO:0008543]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005068; GO:0005104; GO:0005737; GO:0005886; GO:0007165; GO:0007169; GO:0008543; GO:0042802 fibroblast growth factor receptor binding [GO:0005104]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] FVLGPTPARR 0.98708 -1.6626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0598 0 0 0 11.4995 0 11.2052 0 0 13.8034 0 0 0 0 0 0 0 0 0 12.4993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3607 0 10.6889 14.9139 0 0 0 0 0 0 0 0 0 0 0 P22570 ADRO_HUMAN "NADPH:adrenodoxin oxidoreductase, mitochondrial, AR, Adrenodoxin reductase, EC 1.18.1.6 (Ferredoxin--NADP(+) reductase, Ferredoxin reductase)" FDXR ADXR Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491]; cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744] GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006744; GO:0008203; GO:0015039; GO:0016491 ferredoxin-NADP+ reductase activity [GO:0004324]; NADPH-adrenodoxin reductase activity [GO:0015039]; oxidoreductase activity [GO:0016491] AALGVLRQSRVK 0.98708 -1.663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6098 0 0 0 0 0 13.7582 0 13.0592 0 13.4206 13.5524 13.9095 12.5638 0 0 0 14.1232 0 0 12.7013 0 0 0 0 14.9579 0 0 0 0 0 0 0 0 12.8493 0 0 0 0 0 0 13.2527 0 0 0 14.4551 0 0 0 0 13.0845 15.7815 0 13.9565 0 0 0 0 12.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3694 0 0 0 0 13.5468 0 0 0 0 0 0 0 0 0 0 0 0 17.2686 12.1152 0 17.1423 11.9299 12.6355 0 0 11.8298 0 17.2195 0 0 Q9NZN4 EHD2_HUMAN EH domain-containing protein 2 (PAST homolog 2) EHD2 PAST2 Homo sapiens (Human) cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659] caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] caveola [GO:0005901]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]; cilium assembly [GO:0060271]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659] GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0010008; GO:0015630; GO:0016197; GO:0016787; GO:0019898; GO:0019904; GO:0030139; GO:0030866; GO:0032456; GO:0042802; GO:0043231; GO:0045171; GO:0048471; GO:0055038; GO:0060271; GO:0070062; GO:0072659; GO:0097320; GO:1901741; GO:2001137 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904] EMPSVFGKENKK 0.98708 -1.6657 0 0 0 0 0 0 0 0 0 13.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5652 0 0 0 0 0 0 0 13.8195 0 0 11.3237 0 0 13.4192 13.0075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6725 0 0 0 14.0368 12.691 0 0 0 0 11.6937 0 0 0 0 0 0 0 0 0 12.6255 0 0 0 13.1107 13.6413 0 0 0 0 12.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5238 0 0 0 0 13.1652 0 0 0 0 0 0 0 0 0 0 0 12.6998 0 0 0 0 0 0 0 0 P0DJI9 SAA2_HUMAN "Serum amyloid A-2 protein, SAA2 [Cleaved into: Amyloid A2 protein, AA2 ]" SAA2 Homo sapiens (Human) acute-phase response [GO:0006953] extracellular exosome [GO:0070062]; high-density lipoprotein particle [GO:0034364] extracellular exosome [GO:0070062]; high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953] GO:0006953; GO:0034364; GO:0070062 DMWRAYSDMR 0.98709 -2.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9711 0 13.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49407 ARRB1_HUMAN Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2) ARRB1 ARR1 Homo sapiens (Human) G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000139; GO:0000785; GO:0001664; GO:0001934; GO:0002031; GO:0002092; GO:0003713; GO:0004857; GO:0005096; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005905; GO:0006357; GO:0006511; GO:0007165; GO:0008134; GO:0015031; GO:0016567; GO:0016604; GO:0030659; GO:0031143; GO:0031397; GO:0031410; GO:0031625; GO:0031701; GO:0032088; GO:0032715; GO:0032717; GO:0035025; GO:0035066; GO:0043149; GO:0043161; GO:0045746; GO:0045944; GO:0070374; GO:0090240; GO:1990763 angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625] AFCAENLEEK 0.98709 -1.6708 0 0 0 0 0 0 0 0 0 12.8016 12.5579 0 12.2161 0 0 0 0 11.1115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.521 0 0 0 0 0 0 0 0 11.1206 10.426 0 0 0 12.5673 14.4111 0 0 14.4678 14.6789 0 14.6382 0 13.8551 13.9377 0 0 0 14.6822 0 17.9935 0 0 0 0 0 0 0 12.6278 0 0 0 10.5942 13.3908 0 0 9.22415 0 0 0 0 0 0 0 0 0 0 0 0 12.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1452 0 0 0 0 9.37749 10.9068 0 0 0 0 0 0 0 13.3202 0 0 0 0 12.6833 13.2629 0 0 13.4621 0 0 0 0 0 0 0 0 0 0 0 0 P50995 ANX11_HUMAN "Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50, CAP-50)" ANXA11 ANX11 Homo sapiens (Human) cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592] azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819] azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; specific granule [GO:0042581]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592] GO:0003723; GO:0005509; GO:0005544; GO:0005635; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006909; GO:0008429; GO:0016020; GO:0023026; GO:0030496; GO:0032506; GO:0042470; GO:0042581; GO:0042582; GO:0044548; GO:0045335; GO:0048306; GO:0051592; GO:0062023; GO:0070062 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548] AMKGFGTDEQAIIDCLGSRSNK 0.98709 -3.9523 0 0 0 0 0 0 0 0 0 0 12.2465 0 12.0937 0 0 0 0 12.3835 12.5151 0 0 0 0 0 0 0 0 12.1045 0 0 12.0174 0 0 0 0 0 0 0 11.1656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8951 0 14.8389 12.6331 0 0 14.8305 0 0 0 13.7836 14.4832 13.3911 14.4206 0 0 0 13.2631 14.7708 13.4513 14.1774 0 0 0 0 0 0 0 0 0 13.5195 0 0 0 0 14.5218 0 0 0 0 0 0 0 0 0 12.9929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.596 0 0 0 0 0 0 12.1826 0 0 0 12.3128 0 0 P62913 RL11_HUMAN 60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5) RPL11 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of protein binding [GO:0032092]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; protein-containing complex [GO:0032991]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of protein binding [GO:0032092]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0000027; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0006605; GO:0008097; GO:0010628; GO:0016020; GO:0022625; GO:0022626; GO:0031625; GO:0032092; GO:0032435; GO:0032991; GO:0034504; GO:0042273; GO:0042788; GO:0050821; GO:0070062; GO:1901796; GO:1902255; GO:1904667; GO:1990948; GO:2000059; GO:2000435 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] EEAMRWFQQK 0.98709 -2.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78337 PITX1_HUMAN Pituitary homeobox 1 (Hindlimb-expressed homeobox protein backfoot) (Homeobox protein PITX1) (Paired-like homeodomain transcription factor 1) PITX1 BFT PTX1 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; branchiomeric skeletal muscle development [GO:0014707]; cartilage development [GO:0051216]; embryonic hindlimb morphogenesis [GO:0035116]; myoblast fate commitment [GO:0048625]; negative regulation of transcription, DNA-templated [GO:0045892]; pituitary gland development [GO:0021983]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; branchiomeric skeletal muscle development [GO:0014707]; cartilage development [GO:0051216]; embryonic hindlimb morphogenesis [GO:0035116]; myoblast fate commitment [GO:0048625]; negative regulation of transcription, DNA-templated [GO:0045892]; pituitary gland development [GO:0021983]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0009653; GO:0014707; GO:0021983; GO:0035116; GO:0045892; GO:0048625; GO:0051216; GO:0061629; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" DTCNSSLASLRLK 0.98709 -3.9573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRD1 FBX6_HUMAN F-box only protein 6 (F-box protein that recognizes sugar chains 2) (F-box/G-domain protein 2) FBXO6 FBG2 FBS2 FBX6 Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; glycoprotein catabolic process [GO:0006516]; proteolysis [GO:0006508]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum quality control compartment [GO:0044322]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum quality control compartment [GO:0044322]; SCF ubiquitin ligase complex [GO:0019005]; carbohydrate binding [GO:0030246]; ubiquitin protein ligase activity [GO:0061630]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; glycoprotein catabolic process [GO:0006516]; proteolysis [GO:0006508]; response to unfolded protein [GO:0006986]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000077; GO:0005737; GO:0005829; GO:0006281; GO:0006508; GO:0006516; GO:0006986; GO:0019005; GO:0030246; GO:0030433; GO:0031146; GO:0044322; GO:0061630 carbohydrate binding [GO:0030246]; ubiquitin protein ligase activity [GO:0061630] ADCGCTYQLK 0.98709 -1.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGV2 NDRG3_HUMAN Protein NDRG3 (N-myc downstream-regulated gene 3 protein) NDRG3 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] GO:0005737; GO:0007165; GO:0007283; GO:0030154; GO:0030308; GO:0070062 GLPKGNR 0.98709 -3.9536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3977 0 0 0 0 0 0 0 13.0772 0 0 0 0 0 0 0 0 0 0 12.392 0 0 Q7Z5L7 PODN_HUMAN Podocan PODN SLRR5A UNQ293/PRO332 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285] GO:0005518; GO:0005615; GO:0005737; GO:0008285; GO:0030336; GO:0062023 collagen binding [GO:0005518] AFEHLTNLNYLYLANNKLTLAPR 0.9871 -2.0168 0 0 0 0 0 0 0 0 11.4584 0 11.6626 0 0 15.5107 14.6463 0 0 11.2489 0 0 13.5864 0 10.784 0 0 0 0 11.9009 0 12.0431 10.7248 0 11.2724 0 0 12.3163 0 0 0 0 0 0 0 0 12.8426 0 10.4987 0 0 0 0 0 0 0 0 0 10.4693 0 0 0 0 0 0 0 0 0 11.1173 0 0 11.2541 14.2197 0 0 13.4965 0 0 0 13.0432 0 15.2673 12.8942 0 0 14.072 15.8968 0 12.3413 14.366 13.4034 13.4297 14.1632 0 15.5128 14.5084 11.1256 14.0471 0 15.5132 12.3265 12.7502 14.2887 14.3379 14.9761 14.6182 14.6557 13.3735 0 14.1542 12.6532 0 0 14.9757 13.3129 15.21 0 0 14.1247 0 0 10.7633 0 0 0 12.0582 0 15.6768 12.4693 15.6782 14.2564 15.1526 12.7502 13.5405 0 12.6982 0 14.3808 15.3789 0 0 12.8294 0 0 0 13.9749 0 15.0705 0 0 12.3369 0 0 11.1509 10.7192 14.1477 15.418 15.3529 0 0 0 0 12.6538 12.5692 0 0 0 12.6583 16.2335 12.6586 0 13.9 0 0 0 15.3637 0 0 0 0 12.6891 0 Q8IZ13 ZBED8_HUMAN Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8) ZBED8 Buster3 C5orf54 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 ASGQILMEFETMK 0.9871 -3.9592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6427 0 0 0 0 0 12.595 12.2272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7548 0 0 0 0 0 0 0 12.8031 13.3116 0 0 12.668 0 0 11.8546 0 0 0 0 0 0 0 0 0 11.0953 0 0 0 0 0 0 0 0 0 11.5367 15.2601 0 0 0 0 0 12.435 0 15.232 0 0 15.8011 0 0 0 0 15.7947 0 11.6815 0 12.7136 10.2691 0 0 0 0 0 0 0 0 0 0 0 0 15.2384 0 0 0 0 13.9432 15.5799 0 0 0 16.3083 16.3891 0 0 0 0 0 0 0 0 0 0 0 0 16.0015 12.978 15.6189 0 0 0 0 13.8757 0 0 12.9471 0 0 0 0 0 16.2702 0 16.2542 0 0 0 0 0 0 0 0 12.6425 0 10.5977 0 0 0 0 0 15.8059 0 0 0 0 0 15.187 0 O95190 OAZ2_HUMAN "Ornithine decarboxylase antizyme 2, AZ2, ODC-Az 2" OAZ2 Homo sapiens (Human) negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ornithine decarboxylase inhibitor activity [GO:0008073]; negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732] GO:0005634; GO:0005737; GO:0005829; GO:0006595; GO:0006596; GO:0008073; GO:0045732; GO:0090316; GO:1902268 ornithine decarboxylase inhibitor activity [GO:0008073] APLLKTFSFLGFEIVR 0.98711 -1.6824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35998 PRS7_HUMAN 26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) PSMC2 MSS1 Homo sapiens (Human) osteoblast differentiation [GO:0001649]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; osteoblast differentiation [GO:0001649]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000502; GO:0000932; GO:0001649; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008540; GO:0016020; GO:0016887; GO:0022624; GO:0034774; GO:0036402; GO:0036464; GO:0043161; GO:1901800; GO:1904813 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402] DFLEAVNKVIK 0.98712 -1.6964 0 0 0 0 0 0 0 0 0 0 0 10.1295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3107 0 0 0 0 0 0 12.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2322 0 0 12.9444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4257 12.8512 14.3305 14.3635 11.6866 0 0 0 0 0 0 13.9337 0 0 0 0 0 0 0 0 0 0 0 13.2684 0 0 0 0 0 0 14.2091 0 0 0 0 12.0435 0 0 0 0 0 0 0 0 0 0 11.195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PGQ7 BORA_HUMAN "Protein aurora borealis, HsBora" BORA C13orf34 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein localization [GO:0032880] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein localization [GO:0032880] GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007088; GO:0019901; GO:0032147; GO:0032880; GO:0051301; GO:0060236; GO:0072687 protein kinase binding [GO:0019901] CWMKTASPFQCSSP 0.98717 -3.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10721 KIT_HUMAN "Mast/stem cell growth factor receptor Kit, SCFR, EC 2.7.10.1 (Piebald trait protein, PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117)" KIT SCFR Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cellular response to thyroid hormone stimulus [GO:0097067]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of developmental process [GO:0051093]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reproductive process [GO:2000242]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; protein autophosphorylation [GO:0046777]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; signal transduction [GO:0007165]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual learning [GO:0008542] acrosomal vesicle [GO:0001669]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] acrosomal vesicle [GO:0001669]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton reorganization [GO:0031532]; B cell differentiation [GO:0030183]; cell chemotaxis [GO:0060326]; cellular response to thyroid hormone stimulus [GO:0097067]; cytokine-mediated signaling pathway [GO:0019221]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; digestive tract development [GO:0048565]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation [GO:0050673]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; Fc receptor signaling pathway [GO:0038093]; germ cell migration [GO:0008354]; glycosphingolipid metabolic process [GO:0006687]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell migration [GO:0035701]; hemopoiesis [GO:0030097]; immature B cell differentiation [GO:0002327]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; lamellipodium assembly [GO:0030032]; lymphoid progenitor cell differentiation [GO:0002320]; male gonad development [GO:0008584]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; mast cell proliferation [GO:0070662]; megakaryocyte development [GO:0035855]; melanocyte adhesion [GO:0097326]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of developmental process [GO:0051093]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reproductive process [GO:2000242]; ovarian follicle development [GO:0001541]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of colon smooth muscle contraction [GO:1904343]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of pyloric antrum smooth muscle contraction [GO:0120072]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; protein autophosphorylation [GO:0046777]; regulation of bile acid metabolic process [GO:1904251]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; response to cadmium ion [GO:0046686]; signal transduction [GO:0007165]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; T cell differentiation [GO:0030217]; tongue development [GO:0043586]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; visual learning [GO:0008542] GO:0001541; GO:0001650; GO:0001669; GO:0002020; GO:0002244; GO:0002318; GO:0002320; GO:0002327; GO:0002551; GO:0002732; GO:0004713; GO:0004714; GO:0005020; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0006687; GO:0006954; GO:0007165; GO:0007169; GO:0007283; GO:0007286; GO:0008354; GO:0008360; GO:0008542; GO:0008584; GO:0009897; GO:0009898; GO:0010863; GO:0014068; GO:0019221; GO:0019827; GO:0019955; GO:0030032; GO:0030097; GO:0030183; GO:0030217; GO:0030218; GO:0030318; GO:0030335; GO:0031274; GO:0031532; GO:0032765; GO:0033674; GO:0035019; GO:0035162; GO:0035234; GO:0035556; GO:0035701; GO:0035855; GO:0038093; GO:0038109; GO:0038162; GO:0042127; GO:0042169; GO:0042531; GO:0042803; GO:0043069; GO:0043235; GO:0043303; GO:0043406; GO:0043410; GO:0043473; GO:0043552; GO:0043586; GO:0045747; GO:0046427; GO:0046686; GO:0046777; GO:0046872; GO:0048103; GO:0048170; GO:0048565; GO:0048863; GO:0050673; GO:0050910; GO:0051091; GO:0051093; GO:0060326; GO:0060374; GO:0070662; GO:0070668; GO:0097067; GO:0097324; GO:0097326; GO:0120072; GO:1904251; GO:1904343; GO:1904349; GO:1905065; GO:2000242 ATP binding [GO:0005524]; cytokine binding [GO:0019955]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; stem cell factor receptor activity [GO:0005020]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] EDNDTLVR 0.98719 -3.962 0 0 0 0 0 0 0 0 0 0 0 0 14.6344 11.4111 0 0 0 0 0 0 11.3881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9731 0 0 0 12.6078 0 13.9146 0 0 0 0 0 0 0 11.9954 0 0 0 16.0518 11.582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8763 0 0 0 0 0 0 0 0 11.8465 0 0 11.7311 0 0 0 0 0 13.0943 13.2247 0 0 0 0 0 0 0 0 11.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCE9 ANO8_HUMAN Anoctamin-8 (Transmembrane protein 16H) ANO8 KIAA1623 TMEM16H Homo sapiens (Human) chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum lumen [GO:0005788]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular calcium activated chloride channel activity [GO:0005229]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005229; GO:0005788; GO:0005886; GO:0006821; GO:0016021; GO:0034220; GO:0055085 intracellular calcium activated chloride channel activity [GO:0005229] ALLGLLSLRR 0.98719 -3.956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0171 0 0 10.7231 12.7057 0 11.0447 11.0081 0 0 0 0 0 0 12.339 0 0 0 0 0 0 0 0 12.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6653 13.2373 0 0 0 0 0 13.616 0 12.5499 13.5887 0 12.746 0 12.4846 12.3616 13.8198 12.4292 13.7186 0 0 13.788 13.4333 12.02 0 14.3147 0 0 0 0 11.6045 0 13.841 12.2612 14.9775 13.7469 0 11.6297 0 13.4909 11.4362 13.1235 15.2256 14.7471 0 14.1921 13.7073 13.1857 0 0 0 14.0904 0 11.6743 14.6722 0 0 0 11.6862 0 14.5283 0 13.4014 10.9091 0 0 12.8248 0 0 0 14.071 13.133 11.8558 0 0 0 0 0 0 12.7129 0 12.7624 0 0 12.8009 0 0 0 0 12.6749 0 0 0 0 0 0 0 12.6711 0 0 0 0 12.1304 0 0 0 0 13.515 15.146 0 0 P51160 PDE6C_HUMAN "Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha', EC 3.1.4.35 (cGMP phosphodiesterase 6C)" PDE6C PDEA2 Homo sapiens (Human) "phototransduction, visible light [GO:0007603]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]" plasma membrane [GO:0005886] "plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; phototransduction, visible light [GO:0007603]; retinal cone cell development [GO:0046549]; signal transduction [GO:0007165]; visual perception [GO:0007601]" GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0007603; GO:0030553; GO:0046549; GO:0046872; GO:0047555 "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]" AAEDSGGGDDKKSK 0.9872 -1.6693 0 0 0 0 0 0 0 0 0 0 14.0166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3772 10.1149 0 0 0 0 0 0 0 0 0 0 0 0 9.97169 0 0 0 0 0 0 13.1235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7626 0 14.6612 0 0 0 0 0 0 13.5106 0 13.3593 12.5545 0 0 0 0 0 0 0 13.1913 0 0 0 0 0 0 13.0678 0 0 13.8361 0 0 13.2529 0 0 0 0 14.451 0 0 0 12.693 14.8028 0 14.4939 13.6543 0 0 0 13.1039 0 14.9331 15.0899 0 0 0 0 0 0 0 0 0 0 13.2826 13.3185 0 0 13.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1462 13.0874 0 13.3229 0 13.7744 0 0 0 0 0 12.008 13.1156 0 0 0 0 0 Q8N7U9 CQ054_HUMAN Putative uncharacterized protein encoded by LINC00469 LINC00469 C17orf54 Homo sapiens (Human) NIHQAKECEK 0.9872 -2.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6X4 F169A_HUMAN "Soluble lamin-associated protein of 75 kDa, SLAP75 (Protein FAM169A)" FAM169A KIAA0888 Homo sapiens (Human) nuclear inner membrane [GO:0005637] nuclear inner membrane [GO:0005637] GO:0005637 FQDSEFSSSQGEDEK 0.9872 -1.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2469 11.9127 0 0 13.0255 0 0 0 0 0 0 18.9141 0 0 0 0 11.5523 12.7071 0 0 0 0 0 0 0 0 0 13.3371 0 0 14.065 0 0 0 0 0 0 0 0 0 0 14.9037 0 0 0 0 0 0 0 0 0 0 0 13.2844 0 0 0 0 0 0 0 15.0827 0 0 11.9172 0 12.0418 12.5672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3149 0 0 0 0 0 0 P53672 CRBA2_HUMAN Beta-crystallin A2 (Beta-A2 crystallin) CRYBA2 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] identical protein binding [GO:0042802]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] GO:0002088; GO:0005212; GO:0007601; GO:0042802 identical protein binding [GO:0042802]; structural constituent of eye lens [GO:0005212] GDYPRWSAWSGSSSHNSNQLLSFR 0.98723 -1.6909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4775 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2981 0 0 11.8645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JRS4 O10J3_HUMAN Olfactory receptor 10J3 OR10J3 OR10J3P Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] CSAQSRGAKNSVSLMK 0.98723 -1.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PF15 KLH35_HUMAN Kelch-like protein 35 KLHL35 Homo sapiens (Human) EDRWSLR 0.98726 -1.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3487 0 0 0 0 0 12.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14146 URB2_HUMAN Unhealthy ribosome biogenesis protein 2 homolog URB2 KIAA0133 Homo sapiens (Human) regulation of signal transduction by p53 class mediator [GO:1901796]; ribosome biogenesis [GO:0042254] aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730] aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosome biogenesis [GO:0042254] GO:0005730; GO:0016235; GO:0030496; GO:0042254; GO:1901796 ACPQIVTALTLLNR 0.98728 -3.9567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6792 0 15.3304 0 0 0 13.737 15.5455 14.9502 0 14.6946 0 0 14.7847 14.5769 14.4703 0 0 0 0 0 0 0 0 0 0 12.1984 9.84317 0 0 0 0 0 13.456 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9822 0 0 0 12.0474 0 0 0 0 0 13.0363 0 0 0 0 0 0 12.6081 0 0 12.3049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GX56 TRDV1_HUMAN T cell receptor delta variable 1 TRDV1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955]; innate immune response [GO:0045087] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955]; innate immune response [GO:0045087] GO:0002250; GO:0005615; GO:0006955; GO:0042101; GO:0045087 EMIFLIR 0.98729 -3.9636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08247 SYPH_HUMAN Synaptophysin (Major synaptic vesicle protein p38) SYP Homo sapiens (Human) cellular response to organic substance [GO:0071310]; endocytosis [GO:0006897]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle membrane organization [GO:0048499] anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; SH2 domain binding [GO:0042169]; cellular response to organic substance [GO:0071310]; endocytosis [GO:0006897]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle membrane organization [GO:0048499] GO:0006897; GO:0008021; GO:0015485; GO:0016188; GO:0030285; GO:0030672; GO:0031594; GO:0042169; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0043621; GO:0048168; GO:0048169; GO:0048172; GO:0048471; GO:0048488; GO:0048499; GO:0048786; GO:0060076; GO:0070161; GO:0071310; GO:0098685; GO:2000300; GO:2000474 cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; SH2 domain binding [GO:0042169] DPVTSGLNTSVVFGFLNLVLWVGNLWFVFKETGWAAPFLR 0.98731 -2.0094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3659 13.7441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0737 0 0 14.8696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1556 0 0 12.945 0 0 0 0 13.884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60323 NANO3_HUMAN "Nanos homolog 3, NOS-3" NANOS3 NOS3 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; germ cell development [GO:0007281]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of cell cycle [GO:0051726]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic signaling pathway [GO:0097190]; germ cell development [GO:0007281]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; regulation of cell cycle [GO:0051726]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283]" GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006417; GO:0007281; GO:0007283; GO:0008270; GO:0010494; GO:0017148; GO:0048471; GO:0048477; GO:0051726; GO:0097190; GO:1900153; GO:2001234 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] TQDTGHRR 0.98732 -2.0163 0 0 0 0 0 0 0 0 0 0 14.8833 0 0 15.1104 14.8712 0 17.6969 0 0 0 16.8422 0 0 0 15.223 0 0 0 0 0 0 0 0 0 0 0 0 14.794 0 0 16.3519 16.2178 0 0 16.6626 0 0 0 14.4216 0 0 0 17.6147 17.5456 17.4414 17.0199 0 18.365 0 17.3485 16.1005 16.8149 16.8221 15.2745 16.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3274 0 0 0 0 0 0 0 0 0 0 17.3094 0 0 0 0 0 0 0 0 17.7195 0 0 0 20.5686 0 0 0 0 0 0 Q13461 FOXE3_HUMAN "Forkhead box protein E3 (Forkhead-related protein FKHL12) (Forkhead-related transcription factor 8, FREAC-8)" FOXE3 FKHL12 FREAC8 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell development [GO:0048468]; cell differentiation [GO:0030154]; ciliary body morphogenesis [GO:0061073]; cornea development in camera-type eye [GO:0061303]; epithelial cell proliferation [GO:0050673]; eye development [GO:0001654]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lens fiber cell differentiation [GO:1902747]; positive regulation of lens epithelial cell proliferation [GO:2001111]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; trabecular meshwork development [GO:0002930]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell development [GO:0048468]; cell differentiation [GO:0030154]; ciliary body morphogenesis [GO:0061073]; cornea development in camera-type eye [GO:0061303]; epithelial cell proliferation [GO:0050673]; eye development [GO:0001654]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lens fiber cell differentiation [GO:1902747]; positive regulation of lens epithelial cell proliferation [GO:2001111]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; trabecular meshwork development [GO:0002930]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001654; GO:0002088; GO:0002930; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0006366; GO:0009653; GO:0030154; GO:0042789; GO:0043066; GO:0043565; GO:0048468; GO:0050673; GO:0051726; GO:0061072; GO:0061073; GO:0061303; GO:1902747; GO:2001111 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" FITERFAFYR 0.98734 -1.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4214 0 0 0 0 0 0 10.8549 0 0 0 11.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SGD2 PPM1L_HUMAN "Protein phosphatase 1L, EC 3.1.3.16 (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon, PP2C-epsilon)" PPM1L PP2CE Homo sapiens (Human) MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; sphingolipid biosynthetic process [GO:0030148]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; sphingolipid biosynthetic process [GO:0030148]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] GO:0000165; GO:0004722; GO:0005789; GO:0006470; GO:0007178; GO:0016021; GO:0017018; GO:0030148; GO:0046872; GO:0070062 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] IEDTMTLLSLLGRIMRYFLLR 0.98734 -1.688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6631 19.2387 13.8565 13.9155 14.2688 0 0 0 0 13.6608 15.0729 0 0 0 13.5826 0 0 0 0 0 13.3999 0 0 0 0 0 0 0 0 0 14.7069 0 0 0 14.5116 14.0626 0 0 0 0 14.3184 0 14.9403 0 0 0 0 14.8452 0 0 13.7232 0 0 14.6482 0 0 0 0 14.859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYW2 TA2R8_HUMAN "Taste receptor type 2 member 8, T2R8 (Taste receptor family B member 5, TRB5)" TAS2R8 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580] GO:0001580; GO:0004930; GO:0005886; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] DPSTEVHVR 0.98734 -1.6908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6025 0 0 15.1642 0 0 12.7364 0 14.7295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1399 0 0 0 0 0 0 0 0 12.6392 0 12.198 0 0 0 0 0 0 0 0 0 11.8932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3169 0 0 0 0 0 Q96A19 C102A_HUMAN Coiled-coil domain-containing protein 102A CCDC102A Homo sapiens (Human) myosin complex [GO:0016459] myosin complex [GO:0016459] GO:0016459 AAQMEKTMR 0.98737 -1.9675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8109 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5029 13.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15537 XLRS1_HUMAN Retinoschisin (X-linked juvenile retinoschisis protein) RS1 XLRS1 Homo sapiens (Human) adaptation of rhodopsin mediated signaling [GO:0016062]; cell adhesion [GO:0007155]; eye development [GO:0001654]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601] extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917] "extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylserine binding [GO:0001786]; adaptation of rhodopsin mediated signaling [GO:0016062]; cell adhesion [GO:0007155]; eye development [GO:0001654]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601]" GO:0001654; GO:0001786; GO:0001917; GO:0005615; GO:0007155; GO:0007601; GO:0010842; GO:0016062; GO:0019897; GO:0043325; GO:0051260; GO:0098984 "phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylserine binding [GO:0001786]" ARLNSQGFGCAWLSK 0.98738 -1.9746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8311 0 0 0 11.0574 0 0 0 0 0 0 0 0 0 0 0 0 11.027 0 0 0 0 0 0 0 15.2347 14.4092 0 0 0 14.9075 16.5606 0 0 12.7073 0 0 0 0 0 0 0 0 0 13.7016 0 0 0 0 11.0918 0 0 0 0 0 0 0 0 0 12.3847 0 0 0 0 0 12.3656 0 0 0 0 11.0922 0 0 0 0 0 0 0 13.3108 0 0 0 0 0 12.42 0 0 0 0 0 0 0 0 0 13.5784 0 0 0 0 0 0 0 16.2112 0 0 0 0 0 0 0 0 13.1859 0 0 0 0 0 0 0 0 11.1113 0 0 0 0 0 0 0 0 P00750 TPA_HUMAN "Tissue-type plasminogen activator, t-PA, t-plasminogen activator, tPA, EC 3.4.21.68 (Alteplase) (Reteplase) [Cleaved into: Tissue-type plasminogen activator chain A; Tissue-type plasminogen activator chain B ]" PLAT Homo sapiens (Human) "blood coagulation [GO:0007596]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to luteinizing hormone stimulus [GO:0071373]; fibrinolysis [GO:0042730]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of proteolysis [GO:0045861]; plasminogen activation [GO:0031639]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ovulation [GO:0060279]; prevention of polyspermy [GO:0060468]; protein modification process [GO:0036211]; proteolysis [GO:0006508]; regulation of synaptic plasticity [GO:0048167]; response to cAMP [GO:0051591]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]; synaptic transmission, glutamatergic [GO:0035249]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]" apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle [GO:0098992]; perisynaptic space [GO:0099544]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; serine protease inhibitor complex [GO:0097180] "apical part of cell [GO:0045177]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle [GO:0098992]; perisynaptic space [GO:0099544]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; serine protease inhibitor complex [GO:0097180]; phosphoprotein binding [GO:0051219]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; blood coagulation [GO:0007596]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to luteinizing hormone stimulus [GO:0071373]; fibrinolysis [GO:0042730]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of proteolysis [GO:0045861]; plasminogen activation [GO:0031639]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ovulation [GO:0060279]; prevention of polyspermy [GO:0060468]; protein modification process [GO:0036211]; proteolysis [GO:0006508]; regulation of synaptic plasticity [GO:0048167]; response to cAMP [GO:0051591]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; smooth muscle cell migration [GO:0014909]; synaptic transmission, glutamatergic [GO:0035249]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]" GO:0001666; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0005737; GO:0006508; GO:0007596; GO:0009986; GO:0010757; GO:0014909; GO:0031639; GO:0035249; GO:0036211; GO:0042730; GO:0045177; GO:0045861; GO:0048008; GO:0048167; GO:0051219; GO:0051591; GO:0051918; GO:0060279; GO:0060468; GO:0070062; GO:0070542; GO:0071372; GO:0071373; GO:0071549; GO:0097180; GO:0098685; GO:0098794; GO:0098978; GO:0098992; GO:0099183; GO:0099544 phosphoprotein binding [GO:0051219]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102] FLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYR 0.98738 -3.9635 0 0 0 0 0 0 0 0 0 0 0 12.1221 0 0 0 0 0 0 0 0 0 0 13.8069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7797 0 0 0 0 0 0 14.3184 13.2045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1187 0 16.1475 14.925 0 12.8484 0 15.8482 0 0 0 0 0 0 0 0 0 14.9276 16.0471 0 13.3624 0 0 0 12.9206 14.7422 15.4103 0 14.3643 0 13.7661 0 0 0 14.0938 14.5644 0 0 0 0 0 0 14.5325 13.3569 13.5238 0 0 0 13.063 13.9014 13.4286 0 0 13.9028 13.5727 0 13.9759 0 13.311 0 0 14.9519 0 0 0 0 0 0 0 0 0 0 11.648 0 0 0 0 0 0 0 0 0 0 0 0 14.6198 0 0 0 14.0114 14.3286 0 13.8161 0 0 0 0 0 O75783 RHBL1_HUMAN "Rhomboid-related protein 1, RRP, EC 3.4.21.105 (Rhomboid-like protein 1)" RHBDL1 RHBDL Homo sapiens (Human) proteolysis [GO:0006508]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; signal transduction [GO:0007165] GO:0004252; GO:0005887; GO:0006508; GO:0007165; GO:0016020 serine-type endopeptidase activity [GO:0004252] AIANGQRALPR 0.98739 -3.9668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2384 0 0 0 0 Q6PDB4 ZN880_HUMAN Zinc finger protein 880 ZNF880 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDECGKDFTR 0.9874 -1.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5035 0 0 0 0 0 0 0 11.5824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2673 0 11.3039 0 0 0 0 0 0 0 11.8738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9227 14.2819 13.6273 13.2799 0 0 11.9893 0 0 13.0894 0 0 0 0 0 0 0 0 0 12.6155 0 0 0 0 0 0 0 0 12.6419 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0841 0 0 0 0 0 0 0 11.0788 0 0 0 0 0 0 0 0 0 0 Q9Y5Q5 CORIN_HUMAN "Atrial natriuretic peptide-converting enzyme, EC 3.4.21.- (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment ]" CORIN CRN TMPRSS10 Homo sapiens (Human) female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] GO:0003050; GO:0004175; GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0007565; GO:0008217; GO:0009986; GO:0015629; GO:0016021; GO:0016486; GO:0016604; GO:0035813; GO:1903779 endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] ADDNNMGNGCSQK 0.9874 -1.9904 0 0 0 0 0 0 0 0 12.3428 0 0 0 0 0 0 0 12.3557 0 0 0 9.65868 12.3651 0 0 0 0 11.7928 11.1163 12.1464 0 0 0 0 0 0 0 10.8563 0 0 0 0 0 0 0 11.3343 0 0 0 11.7214 11.1852 0 0 11.0291 11.7351 0 0 0 0 0 0 0 0 0 0 0 0 14.2866 0 0 0 0 0 12.9627 0 12.3914 12.2246 13.7952 0 9.5748 13.0489 0 10.466 15.2695 15.2488 12.5008 0 11.6534 0 0 0 15.2719 12.0716 15.8418 15.4107 12.1 0 10.0949 12.6927 14.2117 10.6644 0 13.2782 0 11.1551 15.4478 11.6677 12.0383 13.6741 11.5388 0 12.2658 13.8817 12.1476 14.013 13.7869 12.2662 12.6381 13.3726 11.0406 13.1671 0 11.8491 0 0 0 0 12.0004 0 12.8332 0 12.323 12.9792 10.504 0 0 12.4161 12.3639 11.8146 0 0 0 0 12.6304 0 13.2399 0 0 12.8426 0 0 0 0 0 11.9713 0 12.1357 0 0 0 0 10.5559 0 0 10.9855 0 13.0478 10.3412 0 0 0 0 0 0 0 0 11.4437 0 0 11.9137 14.0043 O95711 LY86_HUMAN "Lymphocyte antigen 86, Ly-86 (Protein MD-1)" LY86 MD1 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666] extracellular space [GO:0005615] extracellular space [GO:0005615]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666] GO:0005615; GO:0006954; GO:0031663; GO:0031666; GO:0045087 FGIILREDIK 0.98742 -2.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q29983 MICA_HUMAN "MHC class I polypeptide-related sequence A, MIC-A" MICA PERB11.1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; gamma-delta T cell activation [GO:0046629]; immune response to tumor cell [GO:0002418]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; response to heat [GO:0009408]; T cell mediated cytotoxicity [GO:0001913] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; cellular response to DNA damage stimulus [GO:0006974]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; gamma-delta T cell activation [GO:0046629]; immune response to tumor cell [GO:0002418]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; response to heat [GO:0009408]; T cell mediated cytotoxicity [GO:0001913] GO:0001913; GO:0002418; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006974; GO:0009408; GO:0009897; GO:0009986; GO:0019835; GO:0032815; GO:0042267; GO:0042742; GO:0045953; GO:0046629; GO:0046703; GO:0051607 natural killer cell lectin-like receptor binding [GO:0046703] CRAKPQGQWAEDVLGNK 0.98742 -2.0088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4597 0 0 0 0 Q5MJ68 SPDYC_HUMAN "Speedy protein C (Rapid inducer of G2/M progression in oocytes C, RINGO C, hSpy/Ringo C)" SPDYC Homo sapiens (Human) cell cycle [GO:0007049]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; cell cycle [GO:0007049]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0005634; GO:0005737; GO:0007049; GO:0019901; GO:0045737 protein kinase binding [GO:0019901] IFPKPPAR 0.98743 -2.0163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFP4 MDGA1_HUMAN "MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein, GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3)" MDGA1 MAMDC3 Homo sapiens (Human) brain development [GO:0007420]; cerebral cortex radially oriented cell migration [GO:0021799]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; spinal cord association neuron differentiation [GO:0021527] anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; brain development [GO:0007420]; cerebral cortex radially oriented cell migration [GO:0021799]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; spinal cord association neuron differentiation [GO:0021527] GO:0001764; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0007399; GO:0007420; GO:0021527; GO:0021799; GO:0046658; GO:0098982; GO:0099179; GO:1905606 AENGVGVPAIKSIR 0.98743 -2.0111 0 0 0 0 0 0 0 0 0 0 0 10.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3458 0 0 0 0 0 12.6011 0 13.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.559 0 0 0 0 0 0 0 0 0 0 13.7342 0 0 0 0 0 0 0 0 12.6582 0 0 0 0 0 0 0 12.4913 0 0 0 0 0 0 0 0 0 0 0 0 12.8876 Q9H347 UBQL3_HUMAN Ubiquilin-3 UBQLN3 Homo sapiens (Human) cellular response to stress [GO:0033554]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829] cytosol [GO:0005829]; polyubiquitin modification-dependent protein binding [GO:0031593]; cellular response to stress [GO:0033554]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005829; GO:0006511; GO:0031593; GO:0032434; GO:0033554 polyubiquitin modification-dependent protein binding [GO:0031593] AHPDQLVLIFAGK 0.98746 -1.6875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28476 GBRR2_HUMAN Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor) GABRR2 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007601; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:0098982; GO:1902476; GO:1902711; GO:1904315 chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] LAFYSSTGWYNRLYINFTLR 0.98747 3.0315 0 11.1916 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8499 0 0 0 0 0 0 0 14.0485 0 0 12.8741 0 0 0 0 0 0 0 13.7609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0813 13.3795 13.1472 0 0 0 0 0 Q52M75 CE027_HUMAN Putative uncharacterized protein encoded by LINC01554 (Protein FIS) LINC01554 C5orf27 Homo sapiens (Human) LMSSREVGLR 0.98748 -1.9666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHH9 IP6K2_HUMAN "Inositol hexakisphosphate kinase 2, InsP6 kinase 2, InsP6K2, EC 2.7.4.- (P(i)-uptake stimulator, PiUS)" IP6K2 IHPK2 TCCCIA00113 Homo sapiens (Human) cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphate ion transport [GO:0006817]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065] cell junction [GO:0030054]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol diphosphate tetrakisphosphate kinase activity [GO:0052839]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; kinase activity [GO:0016301]; cellular response to flavonoid [GO:1905396]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cell growth [GO:0030308]; phosphate ion transport [GO:0006817]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]" GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006817; GO:0016301; GO:0016310; GO:0030054; GO:0030308; GO:0032958; GO:0043065; GO:0043647; GO:0046854; GO:0052836; GO:0052839; GO:0097243; GO:1905396 "ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol diphosphate tetrakisphosphate kinase activity [GO:0052839]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; kinase activity [GO:0016301]" CHQQQLQRMK 0.98748 -1.9672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7161 0 0 0 0 0 14.8625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3033 13.4285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4263 13.3834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L190 SYCE3_HUMAN "Synaptonemal complex central element protein 3 (Testis highly expressed gene 2 protein, THEG-2)" SYCE3 C22orf41 THEG2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694]; nucleus [GO:0005634] central element [GO:0000801]; chromosome [GO:0005694]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] GO:0000801; GO:0005634; GO:0005694; GO:0006915; GO:0007130; GO:0007131; GO:0007283; GO:0035234; GO:0043065; GO:0051094; GO:0051301; GO:2000243 MDDADPEERNYDNMLK 0.98749 -3.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3218 0 0 0 0 0 12.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0Z6 TTC5_HUMAN "Tetratricopeptide repeat protein 5, TPR repeat protein 5 (Stress-responsive activator of p300, Protein Strap)" TTC5 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003677; GO:0003682; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410; GO:0043022; GO:0045944; GO:0061014 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022] ASSNPDLHLNR 0.98749 -3.9675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3345 0 0 0 0 0 0 0 0 0 Q6P9A2 GLT18_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 18, EC 2.4.1.41 (Polypeptide GalNAc transferase 18, GalNAc-T18) (Polypeptide GalNAc transferase-like protein 4, GalNAc-T-like protein 4, pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4)" GALNT18 GALNTL4 Homo sapiens (Human) protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] ALRKQLQCK 0.98751 -1.9899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5481 0 0 0 0 0 0 0 0 0 0 0 0 0 13.041 0 0 0 0 0 0 0 0 12.4446 0 15.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7863 0 0 0 0 0 0 14.2567 0 0 0 0 12.8904 0 14.2581 0 13.9376 0 0 0 0 0 0 0 0 12.7936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6TDU7 DNAI7_HUMAN "Dynein axonemal intermediate chain 7 (Cancer susceptibility candidate gene 1 protein, Protein CASC1) (Cilia and flagella associated protein 94) (Lung adenoma susceptibility 1-like protein) (Protein phosphatase 1 regulatory subunit 54)" DNAI7 CASC1 CFAP94 LAS1 PPP1R54 Homo sapiens (Human) axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017] GO:0005858; GO:0005929; GO:0005930; GO:0008017; GO:0048487 beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017] DDVKNVEK 0.98752 -1.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5709 0 0 0 0 0 9.40931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7577 13.3399 0 11.6797 14.3967 14.4774 0 0 0 0 0 0 12.8799 0 12.0795 0 0 0 0 13.3295 13.2764 13.6221 0 0 0 0 14.1999 17.1169 15.4741 14.5548 14.9981 11.3539 0 0 0 14.6909 13.1706 14.3655 14.8811 0 0 0 12.5283 0 0 0 0 0 0 0 13.8004 0 0 0 13.2059 13.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8J6 ZN615_HUMAN Zinc finger protein 615 ZNF615 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFAHLSILVKHR 0.98752 -1.999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0282 0 0 0 0 0 0 0 0 0 0 0 0 14.7116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTS6 SETD7_HUMAN "Histone-lysine N-methyltransferase SETD7, EC 2.1.1.364 (Histone H3-K4 methyltransferase SETD7, H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9)" SETD7 KIAA1717 KMT7 SET7 SET9 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; histone lysine methylation [GO:0034968]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; heterochromatin organization [GO:0070828]; histone lysine methylation [GO:0034968]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription, DNA-templated [GO:0006355]" GO:0002039; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0006974; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0051570; GO:0070828 chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279] FGPIKCIR 0.98752 -2.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92628 K0232_HUMAN Uncharacterized protein KIAA0232 KIAA0232 Homo sapiens (Human) ATP binding [GO:0005524] GO:0005524 ATP binding [GO:0005524] AIRISPRTHFR 0.98752 -1.9961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.445 0 0 0 11.4297 0 0 12.9822 0 0 0 0 0 0 0 0 13.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8472 0 0 0 0 0 0 0 0 0 13.2068 0 0 0 0 0 0 13.9115 0 0 0 0 13.7258 15.1741 0 13.4828 0 0 0 13.5143 0 0 0 0 0 14.2473 0 0 0 11.5965 0 0 0 0 0 0 0 0 14.7423 0 0 0 12.5798 0 0 0 0 0 0 12.1525 0 0 0 0 0 12.4995 0 12.6479 13.3143 0 13.3008 0 0 0 0 13.0425 0 0 0 14.4728 0 0 0 0 12.6125 0 12.7888 0 0 13.0811 13.2861 0 0 0 0 13.0014 0 0 0 11.6936 0 0 0 0 0 11.9091 0 0 0 12.9421 0 0 Q9H4H8 FA83D_HUMAN Protein FAM83D (Spindle protein CHICA) FAM83D C20orf129 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; epithelial to mesenchymal transition [GO:0001837]; metaphase plate congression [GO:0051310]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; protein localization to mitotic spindle [GO:1902480]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle [GO:0005819]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; epithelial to mesenchymal transition [GO:0001837]; metaphase plate congression [GO:0051310]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; protein localization to mitotic spindle [GO:1902480]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein catabolic process [GO:0042176]; regulation of TOR signaling [GO:0032006]; signal transduction [GO:0007165] GO:0001837; GO:0005737; GO:0005819; GO:0005829; GO:0007165; GO:0008017; GO:0008283; GO:0015630; GO:0016477; GO:0019894; GO:0019901; GO:0032006; GO:0042176; GO:0045171; GO:0051301; GO:0051310; GO:0070372; GO:0072686; GO:0097431; GO:1902480; GO:1902808 kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] DVALYPSYQ 0.98752 -2.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0461 0 14.2093 0 0 0 0 0 14.0666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5209 0 0 0 0 0 0 0 13.7823 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4333 0 0 0 0 0 0 0 0 0 0 0 0 13.4498 14.8958 0 0 0 0 0 0 0 0 16.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6866 0 0 0 0 0 0 0 16.5051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1865 0 12.158 0 0 O14548 COX7R_HUMAN "Cytochrome c oxidase subunit 7A-related protein, mitochondrial (COX7a-related protein) (Cytochrome c oxidase subunit VIIa-related protein) (EB1)" COX7A2L COX7AR COX7RP Homo sapiens (Human) "mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]" mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] "mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; cytochrome-c oxidase activity [GO:0004129]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]" GO:0002082; GO:0004129; GO:0005730; GO:0005739; GO:0005743; GO:0005746; GO:0005751; GO:0006123; GO:0097250 cytochrome-c oxidase activity [GO:0004129] VPELQKFFQK 0.98753 -2.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75306 NDUS2_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial, EC 7.1.1.2 (Complex I-49kD, CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)" NDUFS2 Homo sapiens (Human) "aerobic respiration [GO:0009060]; cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxygen sensor activity [GO:0019826]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; aerobic respiration [GO:0009060]; cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006979; GO:0008137; GO:0009055; GO:0009060; GO:0019826; GO:0022008; GO:0031625; GO:0032981; GO:0042063; GO:0042775; GO:0042776; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0061351; GO:0071453 "4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxygen sensor activity [GO:0019826]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]" GVAAQVLRPGAGVRLPIQPSR 0.98753 -2.0082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0717 0 0 0 0 0 0 0 0 0 0 16.3846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5799 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6344 0 0 0 0 0 0 0 0 0 0 0 12.3272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13492 PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) PICALM CALM Homo sapiens (Human) "amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192]" cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982] "cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156]; amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001540; GO:0005545; GO:0005546; GO:0005634; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0006900; GO:0007409; GO:0007611; GO:0008021; GO:0009986; GO:0010629; GO:0016020; GO:0016185; GO:0016188; GO:0016192; GO:0016197; GO:0030097; GO:0030100; GO:0030132; GO:0030136; GO:0030276; GO:0031224; GO:0031267; GO:0031623; GO:0031982; GO:0032050; GO:0032880; GO:0035459; GO:0042734; GO:0043025; GO:0043231; GO:0043547; GO:0045211; GO:0045296; GO:0045334; GO:0045893; GO:0048156; GO:0048261; GO:0048268; GO:0048471; GO:0048813; GO:0050750; GO:0055072; GO:0065003; GO:0070381; GO:0072583; GO:0097418; GO:0097494; GO:0097753; GO:0098894; GO:0150093; GO:1901216; GO:1902004; GO:1902959; GO:1902961; GO:1902963; GO:1903077; GO:1905224; GO:2000009; GO:2000369 "1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156]" DSTAASR 0.98754 -2.0146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60393 NOBOX_HUMAN Homeobox protein NOBOX NOBOX Homo sapiens (Human) oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; oogenesis [GO:0048477]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0048477 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" LIPLVSGKRELTR 0.98757 -1.6864 0 0 0 0 0 12.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4361 13.5371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4503 0 0 0 0 0 0 0 P58005 SESN3_HUMAN "Sestrin-3, EC 1.11.1.-" SESN3 SEST3 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC2 complex [GO:0031932] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glucose homeostasis [GO:0042593]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031]; response to insulin [GO:0032868]; TORC2 signaling [GO:0038203]" GO:0005634; GO:0005737; GO:0016239; GO:0016684; GO:0031932; GO:0032868; GO:0034198; GO:0038203; GO:0042149; GO:0042593; GO:0046626; GO:0051896; GO:0070728; GO:0071233; GO:1901031; GO:1904262; GO:1990253 "leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]" AITRHLT 0.98759 -1.965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7275 12.4842 12.9925 12.5878 12.5079 12.926 12.8222 0 0 0 12.8462 12.503 12.7545 12.6458 12.5589 0 16.3056 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4554 0 12.5161 12.5521 12.5188 12.442 0 12.3896 12.4465 12.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2605 13.3042 0 0 13.2371 13.0752 0 0 0 13.0037 13.1706 0 13.1713 0 13.9626 13.7653 0 0 0 0 14.549 14.4858 0 11.77 0 0 14.3709 0 0 14.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0819 0 0 0 0 0 0 0 0 14.1518 0 19.029 0 14.5016 14.0423 0 0 0 0 0 0 0 0 0 O15259 NPHP1_HUMAN Nephrocystin-1 (Juvenile nephronophthisis 1 protein) NPHP1 NPH1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization involved in establishment of planar polarity [GO:0090251]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632] GO:0005198; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0005912; GO:0005923; GO:0005929; GO:0007165; GO:0007632; GO:0016020; GO:0030030; GO:0030036; GO:0031514; GO:0032391; GO:0048515; GO:0060041; GO:0090251; GO:0098609; GO:1903348 structural molecule activity [GO:0005198] GEILLVIEKK 0.9876 -1.9796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3421 0 0 0 0 0 0 0 0 0 0 12.4934 0 13.0485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7667 0 0 0 0 0 0 0 0 13.707 0 0 14.5747 13.7182 14.2897 0 0 0 13.9865 0 0 0 0 12.9467 0 0 0 0 0 0 0 13.0464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1473 0 0 11.8533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6602 0 0 0 0 0 0 0 0 0 0 Q5T681 CJ062_HUMAN Uncharacterized protein C10orf62 C10orf62 Homo sapiens (Human) ETSECPSDKDK 0.98762 -1.9892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0041 0 0 0 0 0 0 0 0 14.6168 0 0 0 0 0 0 0 12.8022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQQ3 GORS1_HUMAN "Golgi reassembly-stacking protein 1 (Golgi peripheral membrane protein p65) (Golgi phosphoprotein 5, GOLPH5) (Golgi reassembly-stacking protein of 65 kDa, GRASP65)" GORASP1 GOLPH5 GRASP65 Homo sapiens (Human) establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; negative regulation of dendrite morphogenesis [GO:0050774]; protein N-linked glycosylation [GO:0006487]; protein transport [GO:0015031] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; metal ion binding [GO:0046872]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; negative regulation of dendrite morphogenesis [GO:0050774]; protein N-linked glycosylation [GO:0006487]; protein transport [GO:0015031] GO:0000139; GO:0005794; GO:0005801; GO:0006487; GO:0007030; GO:0015031; GO:0033116; GO:0046872; GO:0050774; GO:0061951 metal ion binding [GO:0046872] ALLKANVEKPVK 0.98763 -1.9958 0 0 0 0 0 0 0 0 0 0 0 0 10.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQF2 JIP1_HUMAN "C-Jun-amino-terminal kinase-interacting protein 1, JIP-1, JNK-interacting protein 1 (Islet-brain 1, IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1)" MAPK8IP1 IB1 JIP1 PRKM8IP Homo sapiens (Human) "JUN phosphorylation [GO:0007258]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; JUN phosphorylation [GO:0007258]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of JNK cascade [GO:0046328]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]" GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007258; GO:0016192; GO:0019894; GO:0019901; GO:0030425; GO:0031966; GO:0043025; GO:0043508; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243 kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] AIFRFVPR 0.98763 -1.9979 0 0 0 10.4116 0 0 0 0 0 0 0 0 0 12.4081 0 0 0 0 0 0 0 0 0 0 12.6501 0 13.8637 0 0 0 0 0 0 0 0 13.9115 0 13.7154 14.0331 0 0 0 0 0 13.9588 0 0 10.5532 12.4642 0 0 0 0 0 0 0 0 0 0 0 10.242 0 0 0 0 0 0 0 0 0 12.6206 0 0 0 12.2832 0 13.6229 0 0 0 0 12.516 0 0 14.8356 14.8 13.7569 0 13.0278 0 12.9182 0 0 0 12.6444 0 13.2752 14.7172 0 0 12.3611 12.9272 0 0 15.4159 0 14.2148 0 0 11.2534 13.1345 12.6657 12.8776 13.2836 0 0 0 0 0 0 14.8243 14.9127 14.8295 0 13.4074 13.6274 12.6775 0 0 12.9976 13.9644 12.2752 13.0346 0 0 0 12.5569 13.3191 0 0 0 0 12.7227 13.1521 0 12.0606 0 12.3986 0 0 0 0 0 0 13.6658 14.1958 0 14.9074 0 0 0 0 10.9601 13.9537 0 14.1347 0 14.2299 0 0 0 0 0 0 0 0 0 0 0 0 P23582 ANFC_HUMAN C-type natriuretic peptide [Cleaved into: CNP-22; CNP-29; CNP-53 ] NPPC CNP2 Homo sapiens (Human) cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; meiotic cell cycle [GO:0051321]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of multicellular organism growth [GO:0040014]; regulation of smooth muscle cell proliferation [GO:0048660]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410] extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141] extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; meiotic cell cycle [GO:0051321]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of multicellular organism growth [GO:0040014]; regulation of smooth muscle cell proliferation [GO:0048660]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410] GO:0001503; GO:0001666; GO:0003418; GO:0003419; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0006182; GO:0006457; GO:0007168; GO:0008285; GO:0009410; GO:0009791; GO:0010753; GO:0019934; GO:0030141; GO:0032966; GO:0032991; GO:0040014; GO:0045471; GO:0045669; GO:0048660; GO:0051321; GO:0051427; GO:0051447; GO:1900194; GO:2000279 hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102] IGSMSGLGC 0.98768 -3.9811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNA5 FRRS1_HUMAN "Ferric-chelate reductase 1, EC 1.-.-.- (Stromal cell-derived receptor 2, SDR-2)" FRRS1 SDFR2 SDR2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]; cellular iron ion homeostasis [GO:0006879]" GO:0006879; GO:0016021; GO:0016722; GO:0046872 "metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]" FCIRSPLNCDPEK 0.98768 -3.9787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9811 0 0 0 0 0 0 0 0 0 0 0 14.3752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10828 THB_HUMAN Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) THRB ERBA2 NR1A2 THR1 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to thyroid hormone stimulus [GO:0097067]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of female receptivity [GO:0007621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; sensory perception of sound [GO:0007605]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription, DNA-templated [GO:0006351]; type I pneumocyte differentiation [GO:0060509]" chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid hormone binding [GO:0070324]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to thyroid hormone stimulus [GO:0097067]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of female receptivity [GO:0007621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; retinal cone cell apoptotic process [GO:0097474]; retinal cone cell development [GO:0046549]; sensory perception of sound [GO:0007605]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription, DNA-templated [GO:0006351]; type I pneumocyte differentiation [GO:0060509]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001223; GO:0002154; GO:0002157; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006351; GO:0007605; GO:0007621; GO:0008016; GO:0008050; GO:0008270; GO:0009755; GO:0016604; GO:0019899; GO:0030154; GO:0031490; GO:0042789; GO:0045944; GO:0046549; GO:0060509; GO:0070324; GO:0090575; GO:0097067; GO:0097474; GO:1990837 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid hormone binding [GO:0070324]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" ATGYHYRCITCEGCK 0.98769 -3.9819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6W3E5 GDPD4_HUMAN "Glycerophosphodiester phosphodiesterase domain-containing protein 4, EC 3.1.-.- (Glycerophosphodiester phosphodiesterase 6) (UgpQ)" GDPD4 GDE6 UGPQ Homo sapiens (Human) lipid metabolic process [GO:0006629] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629] GO:0006629; GO:0008889; GO:0016020; GO:0016021; GO:0046872 glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872] ERARNQSIPTLADLLTLAEK 0.9877 -1.9644 0 0 0 0 0 0 0 0 0 0 0 0 10.264 0 12.0355 0 0 0 0 0 10.353 0 0 0 13.0236 12.3738 0 0 0 0 10.5035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9584 0 0 12.3619 12.3635 0 0 0 0 0 0 0 0 0 0 12.053 0 0 0 0 0 0 14.3327 13.2132 12.9156 0 11.4447 11.8477 0 13.3229 0 14.1573 0 0 0 0 14.5201 12.6884 0 14.1618 0 10.0703 14.3068 15.6295 15.4605 0 0 0 0 0 17.0483 0 14.6728 15.3848 0 0 0 0 12.3006 15.8407 16.5317 14.5561 0 0 0 15.514 13.2838 0 0 15.8584 15.7898 14.7027 14.4885 14.2877 0 0 0 15.2044 0 0 13.7927 10.4276 12.7089 13.2667 15.5295 15.3521 16.5812 16.3905 15.9116 16.0218 0 15.5625 16.3347 16.4299 15.326 15.6434 0 0 12.2911 11.8163 14.786 0 0 14.9559 16.329 0 0 0 0 0 12.06 0 0 0 0 0 0 0 0 0 14.4287 14.3583 14.9285 14.8956 0 0 13.7401 14.5269 0 Q8NA58 PNDC1_HUMAN "Poly(A)-specific ribonuclease PNLDC1, EC 3.1.13.4 (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1, HsPNLDC1)" PNLDC1 Homo sapiens (Human) "blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA biosynthetic process [GO:1990511]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA biosynthetic process [GO:1990511]; spermatogenesis [GO:0007283]" GO:0000175; GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005737; GO:0005783; GO:0005789; GO:0007283; GO:0016021; GO:0046872; GO:1990511 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723] DEGVVVK 0.9877 -1.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4391 0 0 0 0 0 14.2811 0 0 0 0 0 0 0 0 0 13.4381 0 0 0 0 14.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1681 0 0 0 15.7864 0 0 0 0 0 0 12.7047 0 11.6653 0 13.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6758 0 0 0 12.2709 0 0 0 0 0 0 0 0 0 11.6947 0 0 14.3903 0 15.3661 0 11.9709 14.9526 11.5007 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0C9 UBE2O_HUMAN "(E3-independent) E2 ubiquitin-conjugating enzyme, EC 2.3.2.24 (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa, Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O)" UBE2O KIAA1734 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of apoptotic process [GO:0043066]; positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0003723; GO:0004842; GO:0004869; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0043066; GO:0061630; GO:0061631; GO:0070534 ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ELKEAIKILESLK 0.9877 -3.998 0 0 0 0 0 0 0 0 15.1577 13.6034 13.6108 13.4172 14.6412 0 13.3024 13.1817 0 0 0 12.6629 0 0 0 0 0 0 11.3116 0 12.4147 11.5556 12.444 0 12.5481 0 12.6177 12.9508 0 12.4983 13.8025 0 12.6496 12.3224 12.6172 12.4042 11.2747 12.3893 0 12.2811 13.1892 0 0 0 0 0 0 0 0 0 15.6328 0 0 0 0 14.6254 0 0 0 0 12.3287 0 11.4202 0 0 0 0 0 0 0 0 0 12.751 0 0 0 0 0 0 0 0 0 0 0 0 13.7268 0 0 0 0 0 0 0 0 0 0 0 0 12.776 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8197 0 11.404 0 0 0 14.9779 0 0 14.3253 13.6847 0 0 0 0 0 13.3401 0 0 0 0 0 0 0 0 0 0 14.9177 0 0 0 0 0 0 0 0 13.0829 14.8936 0 14.7868 14.7599 14.9347 14.9208 14.9332 18.6598 18.8895 0 14.7371 18.5494 0 15.3715 0 0 0 13.4998 19.0715 12.2694 14.7882 0 0 P17174 AATC_HUMAN "Aspartate aminotransferase, cytoplasmic, cAspAT, EC 2.6.1.1, EC 2.6.1.3 (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic, cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)" GOT1 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine transaminase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; cellular response to insulin stimulus [GO:0032869]; fatty acid homeostasis [GO:0055089]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114]; Notch signaling pathway [GO:0007219]; oxaloacetate metabolic process [GO:0006107]; response to glucocorticoid [GO:0051384] GO:0004069; GO:0004609; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006103; GO:0006107; GO:0006114; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0007219; GO:0019550; GO:0019551; GO:0030170; GO:0032869; GO:0047801; GO:0051384; GO:0055089; GO:0070062 L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine transaminase activity [GO:0047801]; phosphatidylserine decarboxylase activity [GO:0004609]; pyridoxal phosphate binding [GO:0030170] APPSVFAEVPQAQPVLVFKLTADFREDPDPR 0.98773 -1.9891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3598 14.9591 0 15.8198 0 0 0 13.4045 0 11.5133 0 0 0 0 0 0 0 0 0 0 15.7054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3458 0 0 0 0 0 0 0 14.9847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21579 SYT1_HUMAN "Synaptotagmin-1 (Synaptotagmin I, SytI) (p65)" SYT1 SVP65 SYT Homo sapiens (Human) "brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; detection of calcium ion [GO:0005513]; fast, calcium ion-dependent exocytosis of neurotransmitter [GO:0098746]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of synaptic transmission [GO:0050806]; protein heterooligomerization [GO:0051291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of regulated secretory pathway [GO:1903305]; regulation of synaptic transmission, glutamatergic [GO:0051966]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle endocytosis [GO:0048488]; synchronous neurotransmitter secretion [GO:0071911]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192]" anchoring junction [GO:0070161]; axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; axon [GO:0030424]; chromaffin granule membrane [GO:0042584]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-sculpted acetylcholine transport vesicle membrane [GO:0060201]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; clathrin-sculpted monoamine transport vesicle membrane [GO:0070083]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; brain development [GO:0007420]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; detection of calcium ion [GO:0005513]; fast, calcium ion-dependent exocytosis of neurotransmitter [GO:0098746]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903235]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of synaptic transmission [GO:0050806]; protein heterooligomerization [GO:0051291]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of exocytosis [GO:0017157]; regulation of regulated secretory pathway [GO:1903305]; regulation of synaptic transmission, glutamatergic [GO:0051966]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle endocytosis [GO:0048488]; synchronous neurotransmitter secretion [GO:0071911]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001786; GO:0005509; GO:0005513; GO:0005516; GO:0005544; GO:0005546; GO:0005737; GO:0005794; GO:0005886; GO:0007268; GO:0007269; GO:0007420; GO:0008021; GO:0008022; GO:0014059; GO:0016192; GO:0017075; GO:0017156; GO:0017157; GO:0017158; GO:0019905; GO:0030154; GO:0030276; GO:0030285; GO:0030348; GO:0030424; GO:0030669; GO:0030672; GO:0031045; GO:0033603; GO:0042584; GO:0042734; GO:0042802; GO:0043005; GO:0044306; GO:0046982; GO:0048278; GO:0048306; GO:0048488; GO:0048791; GO:0050750; GO:0050806; GO:0051291; GO:0051966; GO:0060076; GO:0060201; GO:0060203; GO:0061202; GO:0061669; GO:0061891; GO:0070083; GO:0070161; GO:0070382; GO:0071277; GO:0071911; GO:0098686; GO:0098746; GO:0098978; GO:0099502; GO:1903235; GO:1903305; GO:1903861 "calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]" FETKVHRK 0.98778 -4.202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5M9Q1 NKAPL_HUMAN NKAP-like protein NKAPL C6orf194 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell differentiation [GO:0030154]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] GO:0003682; GO:0005634; GO:0007283; GO:0010468; GO:0030154 chromatin binding [GO:0003682] CSSWDGCSR 0.98778 -4.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7948 0 12.3866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.063 11.0917 0 0 0 0 10.7383 0 0 0 0 0 0 0 0 9.57962 0 0 0 0 0 0 0 0 0 0 14.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8757 0 0 11.2609 0 16.3232 0 0 0 0 15.2608 14.0255 0 0 14.0067 0 0 0 0 0 0 0 0 13.4834 0 0 0 0 0 0 0 0 13.2509 13.2531 13.8155 0 0 0 0 0 0 0 0 0 0 0 10.2259 0 0 0 10.9773 0 0 0 0 0 13.8484 0 10.0771 0 0 14.4201 0 13.1118 0 0 0 0 0 0 13.4324 14.5052 0 0 13.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7935 0 0 0 0 0 0 0 0 0 10.0366 0 Q8IZ07 AN13A_HUMAN Ankyrin repeat domain-containing protein 13A (Protein KE03) ANKRD13A ANKRD13 Homo sapiens (Human) negative regulation of protein localization to endosome [GO:1905667]; negative regulation of receptor internalization [GO:0002091] cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin-dependent protein binding [GO:0140036]; negative regulation of protein localization to endosome [GO:1905667]; negative regulation of receptor internalization [GO:0002091] GO:0002091; GO:0005737; GO:0005770; GO:0005886; GO:0048471; GO:0140036; GO:1905667 ubiquitin-dependent protein binding [GO:0140036] IEIPLFHVLNAR 0.98778 -3.9754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.385 0 0 0 0 0 0 0 11.6241 0 0 0 0 0 0 12.65 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5908 0 0 0 0 0 0 0 0 0 0 0 0 11.7855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93091 RNAS6_HUMAN "Ribonuclease K6, RNase K6, EC 3.1.27.-" RNASE6 RNS6 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis [GO:0090501] GO:0003676; GO:0004519; GO:0004540; GO:0005576; GO:0005615; GO:0005764; GO:0006401; GO:0006952; GO:0019731; GO:0031410; GO:0045087; GO:0050829; GO:0050830; GO:0051607; GO:0061844; GO:0090501 endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540] FFIVACDPPQKSDPPYKLVPVHLDSIL 0.98778 -3.9863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.231 12.2163 0 0 0 18.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P270 SLAI2_HUMAN SLAIN motif-containing protein 2 SLAIN2 KIAA1458 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116] GO:0005813; GO:0005829; GO:0007020; GO:0015630; GO:0031116; GO:0031122 DDSWKDGCY 0.98778 -3.9781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8503 0 0 0 0 13.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43790 KRT86_HUMAN "Keratin, type II cuticular Hb6 (Hair keratin K2.11) (Keratin-86, K86) (Type II hair keratin Hb6) (Type-II keratin Kb26)" KRT86 KRTHB6 Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular space [GO:0005615]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular space [GO:0005615]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005615; GO:0005829; GO:0030280; GO:0031424; GO:0045095; GO:0045109 structural constituent of skin epidermis [GO:0030280] FLEQQNK 0.98779 -3.9953 0 0 10.3756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2722 0 14.0885 0 12.7097 0 0 12.6364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4202 0 0 0 11.7191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7213 11.7503 0 12.911 14.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1897 14.4426 0 Q8IYX7 SAXO1_HUMAN Stabilizer of axonemal microtubules 1 SAXO1 C9orf138 FAM154A Homo sapiens (Human) cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821] GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417 microtubule binding [GO:0008017] CICELCSCGR 0.98779 -3.996 0 0 13.7073 0 13.6928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2993 0 0 0 0 0 0 0 0 0 14.611 14.6985 14.6431 0 0 0 0 0 0 17.4472 17.5741 0 16.2189 0 0 21.5013 0 21.383 0 0 20.9168 0 13.4264 0 18.2103 18.74 18.6727 0 13.9627 0 21.4362 0 0 0 17.8056 0 0 15.6264 16.7441 18.283 17.4125 0 0 0 16.3974 0 0 15.7219 18.2733 11.8646 0 0 16.3791 0 0 0 18.0305 18.2247 18.3881 12.4565 19.0979 18.8461 18.548 17.5737 0 0 18.1487 18.0021 12.9642 18.6648 0 18.1899 0 17.7511 0 18.4296 0 17.7833 17.992 17.4381 0 0 0 0 14.8837 15.4835 0 16.0781 17.2192 17.5916 0 0 0 11.3338 0 0 0 0 0 0 0 0 0 0 0 18.8905 18.8182 14.2561 0 0 16.1619 0 14.0972 0 Q14314 FGL2_HUMAN Fibroleukin (Fibrinogen-like protein 2) (pT49) FGL2 Homo sapiens (Human) negative regulation of defense response to virus [GO:0050687]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of macrophage antigen processing and presentation [GO:0002617]; negative regulation of memory T cell differentiation [GO:0043381]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; ficolin-1-rich granule lumen [GO:1904813] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; ficolin-1-rich granule lumen [GO:1904813]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; negative regulation of defense response to virus [GO:0050687]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of macrophage antigen processing and presentation [GO:0002617]; negative regulation of memory T cell differentiation [GO:0043381]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] GO:0002291; GO:0002605; GO:0002617; GO:0005102; GO:0005576; GO:0005577; GO:0005615; GO:0008233; GO:0043381; GO:0050687; GO:0062023; GO:0070062; GO:1904813 peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102] AKDVCPVRLESR 0.9878 -3.9973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3108 0 0 0 0 0 0 13.2041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6408 14.9909 0 0 0 0 0 0 0 14.9065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96TC7 RMD3_HUMAN "Regulator of microtubule dynamics protein 3, RMD-3, hRMD-3 (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51)" RMDN3 FAM82A2 FAM82C PTPIP51 hucep-10 UNQ3122/PRO10274 Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; organelle membrane contact site [GO:0044232]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; organelle membrane contact site [GO:0044232]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874] GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005876; GO:0006874; GO:0006915; GO:0008017; GO:0016021; GO:0030154; GO:0044232; GO:0045171; GO:0097431 microtubule binding [GO:0008017] DSDKESEDGEDEVSCETVK 0.9878 -3.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4946 0 0 0 0 0 0 0 0 0 0 0 13.3703 0 12.7917 14.1991 0 13.1795 0 11.3223 0 0 0 0 0 0 0 0 0 0 0 12.621 11.852 0 0 0 0 13.2286 13.5545 13.4659 0 0 0 0 0 0 0 0 0 0 12.4206 0 0 0 0 0 0 0 0 0 13.9288 0 13.8171 0 0 0 0 0 0 0 0 0 0 0 0 13.0807 0 13.6169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7463 0 0 0 O95163 ELP1_HUMAN "Elongator complex protein 1, ELP1 (IkappaB kinase complex-associated protein, IKK complex-associated protein) (p150)" ELP1 IKAP IKBKAP Homo sapiens (Human) regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; protein self-association [GO:0043621]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098] GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0033588; GO:0043621 protein self-association [GO:0043621]; tRNA binding [GO:0000049] AIGHLSK 0.98781 -4.1108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.025 16.0167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4733 0 0 0 0 0 0 0 15.2734 0 0 0 0 0 0 0 12.8765 0 12.7746 0 0 0 14.3884 14.7122 0 13.276 13.2739 12.6219 13.4025 13.4709 14.8409 12.7875 12.4422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.18 0 0 0 0 0 0 0 0 18.6296 0 0 0 0 0 0 0 15.4446 12.4191 0 13.6528 0 14.0959 0 0 12.2536 0 0 0 14.5083 0 0 0 0 0 14.3465 14.0261 15.4136 14.654 0 17.3667 11.9788 0 10.3849 19.1087 0 0 11.2764 17.2954 17.5379 0 0 0 Q969Q6 P2R3C_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C) PPP2R3C C14orf10 G5PR Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; activation of protein kinase activity [GO:0032147]; B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029] GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0030865; GO:0032147; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900 metal ion binding [GO:0046872] AVFLQRK 0.98781 -1.9638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6182 0 0 0 0 0 0 0 0 12.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9783 0 0 0 0 0 0 0 0 0 0 11.36 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6633 0 0 0 0 0 0 0 0 0 0 11.6083 0 0 0 0 0 0 0 0 0 12.86 0 0 0 12.7611 0 0 0 0 0 0 0 12.7735 0 0 0 0 0 12.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8702 0 0 0 0 0 0 P08581 MET_HUMAN "Hepatocyte growth factor receptor, HGF receptor, EC 2.7.10.1 (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor, SF receptor) (Tyrosine-protein kinase Met)" MET Homo sapiens (Human) branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; hepatocyte growth factor receptor activity [GO:0005008]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of kinase activity [GO:0033674]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001886; GO:0001889; GO:0004713; GO:0004714; GO:0005008; GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0006909; GO:0007165; GO:0007166; GO:0007169; GO:0007399; GO:0009925; GO:0009986; GO:0010507; GO:0016021; GO:0016477; GO:0017154; GO:0019903; GO:0030182; GO:0031016; GO:0031116; GO:0033674; GO:0035024; GO:0042802; GO:0043235; GO:0045944; GO:0048754; GO:0050918; GO:0051497; GO:0051897; GO:0061436; GO:0070495; GO:0071526; GO:1901299; GO:1905098; GO:2001028 ATP binding [GO:0005524]; hepatocyte growth factor receptor activity [GO:0005008]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] ATFPEDQFPNSSQNGSCR 0.98782 -4.1179 0 0 0 0 0 0 0 0 0 11.1877 11.2552 0 10.8138 10.9635 0 0 0 0 0 0 0 0 11.835 0 0 0 11.0486 0 0 0 0 0 0 0 11.1152 0 0 0 0 0 11.0843 0 0 0 0 0 0 0 0 0 0 12.3148 12.536 0 14.6484 0 0 0 0 0 12.3342 12.3014 11.8569 0 10.1757 0 10.5309 0 0 0 0 0 12.0366 0 0 0 11.4205 0 0 0 0 14.0825 0 12.6004 0 17.0958 12.7055 0 0 0 0 13.1834 0 0 0 12.5701 0 17.6298 0 0 11.3153 10.9036 0 0 0 0 13.1805 0 0 0 0 0 13.1167 12.0452 0 0 0 0 0 0 0 0 14.8755 11.5378 11.7339 12.864 0 12.3111 11.9266 0 0 12.3224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4012 0 0 0 0 0 11.6644 0 0 0 0 11.1959 13.4276 0 0 0 12.1577 12.3603 11.6321 0 0 11.259 10.7214 0 0 11.5034 0 0 0 0 0 0 0 A0A0B4J274 TVA20_HUMAN T cell receptor alpha variable 20 TRAV20 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 LKATLTKK 0.98783 -1.9797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7625 0 0 0 0 0 0 0 0 0 0 0 0 13.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15297 PPM1D_HUMAN "Protein phosphatase 1D, EC 3.1.3.16 (Protein phosphatase 2C isoform delta, PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1)" PPM1D WIP1 Homo sapiens (Human) "cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; heterochromatin assembly [GO:0031507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; myosin phosphatase activity [GO:0017018]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; G2/M transition of mitotic cell cycle [GO:0000086]; heterochromatin assembly [GO:0031507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]" GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006306; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0017018; GO:0030330; GO:0031507; GO:0035970; GO:0045814; GO:0046872; GO:0051019; GO:0060260 metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; myosin phosphatase activity [GO:0017018]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722] DDFVRAVEVTQDHK 0.98783 -1.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5672 15.174 15.0989 17.0112 13.7457 16.2487 15.077 0 0 0 16.4197 0 16.3453 14.3798 0 0 16.3943 18.1082 11.2372 12.7101 0 0 0 0 0 0 0 12.7608 0 0 0 0 13.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12277 KCRB_HUMAN "Creatine kinase B-type, EC 2.7.3.2 (Brain creatine kinase, B-CK) (Creatine kinase B chain) (Creatine phosphokinase B-type, CPK-B)" CKB CKBB Homo sapiens (Human) cellular chloride ion homeostasis [GO:0030644]; cerebellum development [GO:0021549]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]; substantia nigra development [GO:0021762] cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634] cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; ubiquitin protein ligase binding [GO:0031625]; cellular chloride ion homeostasis [GO:0030644]; cerebellum development [GO:0021549]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310]; substantia nigra development [GO:0021762] GO:0004111; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005829; GO:0016301; GO:0016310; GO:0021549; GO:0021762; GO:0030425; GO:0030644; GO:0031625; GO:0043025; GO:0046314; GO:0070062 ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; ubiquitin protein ligase binding [GO:0031625] LLIEMEQR 0.98784 -1.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXP2 GAR1A_HUMAN Golgi associated RAB2 interactor protein 1A GARIN1A FAM137B FAM71F2 Homo sapiens (Human) acrosome assembly [GO:0001675] Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; acrosome assembly [GO:0001675] GO:0001675; GO:0005794 GLSITTK 0.98784 -1.9881 0 0 0 0 0 9.08438 0 0 0 0 0 0 0 0 0 0 0 0 12.8875 0 0 0 0 0 0 0 0 12.2313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1336 0 13.5286 0 0 0 0 15.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9A6 LRC40_HUMAN Leucine-rich repeat-containing protein 40 LRRC40 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] GO:0004722; GO:0005737; GO:0007165; GO:0016020; GO:0043231 protein serine/threonine phosphatase activity [GO:0004722] HLNSILVLDLRDNKLK 0.98787 -3.9754 0 0 0 0 0 0 0 0 0 0 0 0 12.7353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7112 12.9343 0 0 0 12.933 0 0 0 0 0 0 12.7747 0 0 0 12.8598 0 0 0 12.723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12967 GNDS_HUMAN "Ral guanine nucleotide dissociation stimulator, RalGDS (Ral guanine nucleotide exchange factor, RalGEF)" RALGDS KIAA1308 RGF Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] brush border [GO:0005903]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] brush border [GO:0005903]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] GO:0005085; GO:0005634; GO:0005829; GO:0005886; GO:0005903; GO:0007265; GO:0030695; GO:0043547 GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085] KVQLHHGGNKGQR 0.98789 -3.9958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6744 0 0 0 12.8421 0 12.0281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7238 0 0 0 14.824 0 15.2592 12.6981 0 0 0 0 0 14.9594 15.0371 0 15.1503 14.9786 0 16.6563 0 15.0333 0 12.0958 15.2966 0 15.0744 0 0 14.7638 0 0 0 0 15.3017 13.5669 0 0 0 0 0 0 17.0766 0 0 16.6639 0 15.105 0 0 0 0 15.1808 15.3923 0 0 0 15.3507 0 0 0 0 0 15.4892 0 0 0 0 14.5831 0 0 0 0 0 0 0 14.9712 0 0 15.9401 15.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9365 0 0 14.4687 0 15.5242 0 0 0 Q14520 HABP2_HUMAN "Hyaluronan-binding protein 2, EC 3.4.21.- (Factor VII-activating protease) (Factor seven-activating protease, FSAP) (Hepatocyte growth factor activator-like protein) (Plasma hyaluronan-binding protein) [Cleaved into: Hyaluronan-binding protein 2 50 kDa heavy chain; Hyaluronan-binding protein 2 50 kDa heavy chain alternate form; Hyaluronan-binding protein 2 27 kDa light chain; Hyaluronan-binding protein 2 27 kDa light chain alternate form ]" HABP2 HGFAL PHBP Homo sapiens (Human) cell adhesion [GO:0007155]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; cell adhesion [GO:0007155]; proteolysis [GO:0006508] GO:0004252; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0006508; GO:0007155; GO:0008233 calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] FLNWIKATIK 0.98789 -3.9951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1927 0 0 0 0 0 0 0 0 10.1881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8503 0 0 0 0 0 16.9845 0 0 0 0 0 0 0 0 0 0 14.5245 0 0 0 13.8194 0 0 0 0 0 0 12.3815 0 0 0 0 0 0 0 Q9UPQ4 TRI35_HUMAN "E3 ubiquitin-protein ligase TRIM35, EC 2.3.2.27 (Hemopoietic lineage switch protein 5)" TRIM35 HLS5 KIAA1098 Homo sapiens (Human) apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790] GO:0005634; GO:0005737; GO:0006915; GO:0008270; GO:0016567; GO:0043065; GO:0044790; GO:0045087; GO:0045930; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AFWAMRR 0.98789 -4.0028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1394 0 0 0 0 0 Q14469 HES1_HUMAN "Transcription factor HES-1 (Class B basic helix-loop-helix protein 39, bHLHb39) (Hairy and enhancer of split 1) (Hairy homolog) (Hairy-like protein, hHL)" HES1 BHLHB39 HL HRY Homo sapiens (Human) "adenohypophysis development [GO:0021984]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; BMP signaling pathway [GO:0030509]; Cajal-Retzius cell differentiation [GO:0021870]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hindbrain morphogenesis [GO:0021575]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreatic A cell differentiation [GO:0003310]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to organic cyclic compound [GO:0014070]; response to thyroid hormone [GO:0097066]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; stomach neuroendocrine cell differentiation [GO:0061102]; T cell proliferation [GO:0042098]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; adenohypophysis development [GO:0021984]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; artery morphogenesis [GO:0048844]; ascending aorta morphogenesis [GO:0035910]; BMP signaling pathway [GO:0030509]; Cajal-Retzius cell differentiation [GO:0021870]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cell adhesion [GO:0007155]; cell fate determination [GO:0001709]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to fatty acid [GO:0071398]; cellular response to interleukin-1 [GO:0071347]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cochlea development [GO:0090102]; comma-shaped body morphogenesis [GO:0072049]; common bile duct development [GO:0061009]; embryonic heart tube morphogenesis [GO:0003143]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glomerulus vasculature development [GO:0072012]; hindbrain morphogenesis [GO:0021575]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell stereocilium organization [GO:0060122]; labyrinthine layer blood vessel development [GO:0060716]; lateral inhibition [GO:0046331]; liver development [GO:0001889]; lung development [GO:0030324]; metanephric nephron tubule morphogenesis [GO:0072282]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of calcium ion import [GO:0090281]; negative regulation of cell fate determination [GO:1905934]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pancreatic A cell differentiation [GO:2000227]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of stomach neuroendocrine cell differentiation [GO:0061106]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oculomotor nerve development [GO:0021557]; outflow tract morphogenesis [GO:0003151]; pancreatic A cell differentiation [GO:0003310]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle, embryonic [GO:0045977]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of fat cell differentiation [GO:0045598]; regulation of neurogenesis [GO:0050767]; regulation of protein-containing complex assembly [GO:0043254]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; renal interstitial fibroblast development [GO:0072141]; response to alkaloid [GO:0043279]; response to organic cyclic compound [GO:0014070]; response to thyroid hormone [GO:0097066]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; somatic stem cell population maintenance [GO:0035019]; stomach neuroendocrine cell differentiation [GO:0061102]; T cell proliferation [GO:0042098]; telencephalon development [GO:0021537]; thymus development [GO:0048538]; trochlear nerve development [GO:0021558]; ureteric bud morphogenesis [GO:0060675]; vascular associated smooth muscle cell development [GO:0097084]; ventricular septum development [GO:0003281]; ventricular septum morphogenesis [GO:0060412]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0001709; GO:0001889; GO:0003143; GO:0003151; GO:0003266; GO:0003281; GO:0003310; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007399; GO:0008284; GO:0008432; GO:0009952; GO:0010628; GO:0010629; GO:0010977; GO:0014070; GO:0016363; GO:0016477; GO:0021537; GO:0021555; GO:0021557; GO:0021558; GO:0021575; GO:0021861; GO:0021870; GO:0021984; GO:0030324; GO:0030509; GO:0030513; GO:0030901; GO:0032991; GO:0035019; GO:0035881; GO:0035910; GO:0042098; GO:0042102; GO:0042491; GO:0042531; GO:0042803; GO:0042826; GO:0043254; GO:0043279; GO:0043388; GO:0043398; GO:0043433; GO:0043565; GO:0044877; GO:0045598; GO:0045608; GO:0045665; GO:0045747; GO:0045892; GO:0045944; GO:0045977; GO:0046331; GO:0046425; GO:0046427; GO:0048469; GO:0048538; GO:0048667; GO:0048711; GO:0048715; GO:0048844; GO:0050678; GO:0050767; GO:0051087; GO:0060122; GO:0060164; GO:0060253; GO:0060412; GO:0060675; GO:0060716; GO:0061009; GO:0061102; GO:0061106; GO:0061309; GO:0061626; GO:0061629; GO:0065003; GO:0070888; GO:0071347; GO:0071356; GO:0071398; GO:0071820; GO:0072012; GO:0072049; GO:0072050; GO:0072141; GO:0072282; GO:0090102; GO:0090162; GO:0090281; GO:0097066; GO:0097084; GO:0097150; GO:1902870; GO:1905934; GO:1990090; GO:1990837; GO:2000227; GO:2000737; GO:2000974; GO:2000978 "chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; HLH domain binding [GO:0043398]; JUN kinase binding [GO:0008432]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]" LGSQAGEAAK 0.9879 -4.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5486 0 0 0 0 0 0 0 0 0 0 0 0 Q6GMV3 PTRD1_HUMAN "Putative peptidyl-tRNA hydrolase PTRHD1, EC 3.1.1.29 (Peptidyl-tRNA hydrolase domain-containing protein 1)" PTRHD1 C2orf79 Homo sapiens (Human) aminoacyl-tRNA hydrolase activity [GO:0004045] GO:0004045 aminoacyl-tRNA hydrolase activity [GO:0004045] GVGPAFR 0.9879 -4.1092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IEG0 SNR48_HUMAN "U11/U12 small nuclear ribonucleoprotein 48 kDa protein, U11/U12 snRNP 48 kDa protein, U11/U12-48K" SNRNP48 C6orf151 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]; metal ion binding [GO:0046872]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0005654; GO:0005689; GO:0005829; GO:0006397; GO:0008380; GO:0046872 metal ion binding [GO:0046872] EEEDEMYNPEFFYENVK 0.9879 -4.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04695 K1C17_HUMAN "Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17, CK-17) (Keratin-17, K17)" KRT17 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; positive regulation of cell growth [GO:0030307]; positive regulation of hair follicle development [GO:0051798]; positive regulation of translation [GO:0045727] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; positive regulation of cell growth [GO:0030307]; positive regulation of hair follicle development [GO:0051798]; positive regulation of translation [GO:0045727] GO:0001533; GO:0005198; GO:0005829; GO:0005856; GO:0030307; GO:0030855; GO:0031069; GO:0031424; GO:0045095; GO:0045109; GO:0045111; GO:0045727; GO:0051798 structural molecule activity [GO:0005198] ADLEMQIENLK 0.98791 -4.119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2768 0 0 0 0 0 9.9678 0 0 0 0 10.7878 0 0 0 0 10.8906 0 0 0 0 0 0 0 0 0 0 10.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1263 0 0 0 0 0 0 0 0 0 0 12.5881 0 0 0 0 13.5137 0 13.3254 0 0 0 0 14.2281 0 0 0 0 0 0 0 13.5551 0 0 0 0 0 0 12.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6508 0 0 0 0 0 10.8467 0 0 0 0 10.5171 0 0 0 0 0 0 0 0 11.5344 0 0 0 0 0 0 0 0 12.2804 11.2125 0 0 0 0 0 0 0 0 0 0 0 0 O00423 EMAL1_HUMAN "Echinoderm microtubule-associated protein-like 1, EMAP-1, HuEMAP-1" EML1 EMAP1 EMAPL EMAPL1 Homo sapiens (Human) brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405] GO:0000226; GO:0002244; GO:0005509; GO:0005829; GO:0005874; GO:0005875; GO:0007052; GO:0007405; GO:0007420; GO:0008017; GO:0015631; GO:0048471; GO:0097431; GO:1990023 calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631] ARPLMQTLPLR 0.98792 -1.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3541 13.3815 13.2252 14.0806 14.2514 16.9232 0 13.7476 0 14.3194 13.6659 13.8344 0 13.3159 13.3737 13.36 0 0 0 0 0 0 0 0 0 0 13.5184 0 0 0 0 0 13.3008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4548 11.15 0 0 0 16.5227 0 0 12.0792 0 0 0 0 0 0 0 0 12.7628 13.4495 0 0 0 0 0 0 0 0 0 13.4276 11.523 13.3659 0 15.4058 0 0 0 14.8424 14.1257 17.5531 0 0 12.4184 0 0 0 0 13.0662 0 0 0 13.4498 13.0737 13.0248 0 0 0 17.6345 0 0 0 0 0 0 0 0 10.3223 0 17.5247 9.76886 0 0 0 0 0 0 12.691 0 0 0 0 0 0 0 0 0 14.1645 14.2403 0 14.4113 14.1809 0 13.592 0 14.1993 0 0 0 0 14.4791 0 0 Q569G3 CE047_HUMAN Uncharacterized protein C5orf47 C5orf47 Homo sapiens (Human) FGSHQCSGVLQLGGR 0.98792 -1.9598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.145 0 0 0 11.6103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A5PLL7 PDES1_HUMAN "Plasmanylethanolamine desaturase, EC 1.14.19.77 (Plasmanylethanolamine desaturase 1) (Transmembrane protein 189)" PEDS1 KUA PDES TMEM189 Homo sapiens (Human) ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631] GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0016021; GO:0016491; GO:0050207 oxidoreductase activity [GO:0016491]; plasmanylethanolamine desaturase activity [GO:0050207] ELAALYSPGK 0.98794 -1.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5168 0 11.6145 0 11.2996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3943 0 0 0 0 0 14.4295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBF4 ZCRB1_HUMAN "Zinc finger CCHC-type and RNA-binding motif-containing protein 1 (U11/U12 small nuclear ribonucleoprotein 31 kDa protein, U11/U12 snRNP 31 kDa protein, U11/U12-31K)" ZCRB1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" GO:0000398; GO:0003723; GO:0005654; GO:0005689; GO:0005829; GO:0008270; GO:0008380 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] IEEEQKKWK 0.98795 -1.9878 12.6162 13.6987 0 0 0 0 0 0 0 0 0 0 0 12.4694 0 0 0 0 0 10.0314 0 11.8013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1364 0 0 0 0 0 0 0 0 0 17.507 17.7232 0 0 0 0 0 0 0 18.2977 0 0 0 11.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9579 0 0 0 0 0 17.205 0 0 0 0 0 0 0 17.2315 0 0 0 0 0 0 13.1362 0 0 0 0 0 14.1506 0 0 0 0 17.7526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6399 0 0 0 0 0 0 0 13.9026 0 Q9NVH1 DJC11_HUMAN DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401] MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] GO:0001401; GO:0005654; GO:0005739; GO:0005741; GO:0007007; GO:0016607; GO:0042407; GO:0140275 LIIKPYLR 0.98795 -1.9871 0 0 0 0 0 0 0 0 0 0 11.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5605 0 0 0 0 11.9329 0 0 0 0 0 12.4743 0 0 0 0 0 0 13.0313 0 0 0 0 0 0 0 12.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4662 0 0 0 0 0 0 0 0 12.3677 0 0 0 0 0 0 0 0 0 14.1021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3301 0 13.521 O60353 FZD6_HUMAN "Frizzled-6, Fz-6, hFz6" FZD6 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; embryonic nail plate morphogenesis [GO:0035880]; establishment of body hair planar orientation [GO:0048105]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; midbrain morphogenesis [GO:1904693]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; platelet activation [GO:0030168]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; embryonic nail plate morphogenesis [GO:0035880]; establishment of body hair planar orientation [GO:0048105]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; midbrain morphogenesis [GO:1904693]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; platelet activation [GO:0030168]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001843; GO:0001942; GO:0004930; GO:0005789; GO:0005886; GO:0005887; GO:0009986; GO:0016021; GO:0016324; GO:0016327; GO:0017147; GO:0030168; GO:0030659; GO:0031625; GO:0033278; GO:0035567; GO:0035880; GO:0042472; GO:0042813; GO:0043433; GO:0048105; GO:0060070; GO:0060071; GO:0090090; GO:1904693 G protein-coupled receptor activity [GO:0004930]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] KHYKPSSHK 0.98796 -4.1995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5375 0 0 0 0 0 0 0 0 0 0 0 0 11.4021 12.4485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16452 EPB42_HUMAN "Protein 4.2, P4.2 (Erythrocyte membrane protein band 4.2, Erythrocyte protein 4.2)" EPB42 E42P Homo sapiens (Human) cell morphogenesis [GO:0000902]; erythrocyte maturation [GO:0043249]; hemoglobin metabolic process [GO:0020027]; iron ion homeostasis [GO:0055072]; peptide cross-linking [GO:0018149]; regulation of cell shape [GO:0008360]; spleen development [GO:0048536] cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural constituent of cytoskeleton [GO:0005200]; cell morphogenesis [GO:0000902]; erythrocyte maturation [GO:0043249]; hemoglobin metabolic process [GO:0020027]; iron ion homeostasis [GO:0055072]; peptide cross-linking [GO:0018149]; regulation of cell shape [GO:0008360]; spleen development [GO:0048536] GO:0000902; GO:0003810; GO:0005200; GO:0005524; GO:0005856; GO:0005886; GO:0008360; GO:0018149; GO:0020027; GO:0030863; GO:0043249; GO:0048536; GO:0055072 ATP binding [GO:0005524]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; structural constituent of cytoskeleton [GO:0005200] APSSLPLR 0.98798 -3.9927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9817 0 0 0 0 0 11.6451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4534 0 0 0 13.4156 0 0 0 0 0 0 0 13.63 14.4601 14.1318 0 0 0 0 0 0 0 0 15.353 0 0 0 0 14.3732 0 0 0 0 0 0 13.5857 12.2503 0 0 0 0 0 13.3787 0 13.7125 14.7514 0 0 0 0 13.9427 14.6529 15.7621 0 0 14.8666 0 0 15.4025 15.0038 0 0 12.1376 0 0 0 0 0 12.1087 0 0 15.6986 13.8484 14.4998 0 13.6572 0 0 0 0 0 12.5629 0 13.7387 13.8226 0 14.591 11.3485 15.1086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1455 0 0 0 14.2107 0 0 0 0 0 Q96AP7 ESAM_HUMAN Endothelial cell-selective adhesion molecule ESAM UNQ220/PRO246 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; protein localization [GO:0008104]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of actin filament polymerization [GO:0030833] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cell-cell adhesion mediator activity [GO:0098632]; bicellular tight junction assembly [GO:0070830]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of blood-brain barrier [GO:0035633]; protein localization [GO:0008104]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of actin filament polymerization [GO:0030833] GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007156; GO:0008104; GO:0016021; GO:0030833; GO:0032991; GO:0035633; GO:0070830; GO:0098609; GO:0098632; GO:2000249 cell-cell adhesion mediator activity [GO:0098632] EDAIAPR 0.98798 -3.9947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25929 NPY1R_HUMAN "Neuropeptide Y receptor type 1, NPY1-R" NPY1R NPYR NPYY1 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose metabolic process [GO:0006006]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; sensory perception of pain [GO:0019233]" integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose metabolic process [GO:0006006]; locomotory behavior [GO:0007626]; outflow tract morphogenesis [GO:0003151]; regulation of blood pressure [GO:0008217]; regulation of multicellular organism growth [GO:0040014]; sensory perception of pain [GO:0019233]" GO:0001601; GO:0001602; GO:0003151; GO:0004983; GO:0005886; GO:0005887; GO:0006006; GO:0007187; GO:0007193; GO:0007626; GO:0007631; GO:0008188; GO:0008217; GO:0019233; GO:0040014; GO:0042923; GO:0043005 neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983]; pancreatic polypeptide receptor activity [GO:0001602]; peptide YY receptor activity [GO:0001601] HQLIINPR 0.98799 -4.0024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4398 12.8439 12.78 0 0 0 0 0 0 13.4548 0 0 0 0 0 0 0 0 0 0 12.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0235 0 0 0 0 0 0 0 0 0 0 0 0 13.1621 0 0 0 0 0 0 P35442 TSP2_HUMAN Thrombospondin-2 THBS2 TSP2 Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965] GO:0005509; GO:0005576; GO:0005604; GO:0007155; GO:0008201; GO:0016525; GO:0031091; GO:0051965; GO:0062023 calcium ion binding [GO:0005509]; heparin binding [GO:0008201] CDNCPYVHNPAQIDTDNNGEGDACSVDIDGDDVFNER 0.988 -4.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1098 0 0 0 0 0 0 0 0 0 14.3937 0 0 0 0 0 0 0 0 0 0 10.7611 10.5228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.252 13.177 0 0 0 12.3721 0 0 0 0 14.3844 0 0 0 0 0 0 13.3368 0 0 0 0 0 13.7482 15.0994 14.4492 0 0 0 0 0 0 0 0 0 0 0 0 0 11.42 0 0 0 0 0 17.025 0 0 15.9559 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7884 0 0 0 0 0 0 0 0 0 13.9688 0 15.1349 0 0 12.1808 0 10.3863 12.8704 0 0 0 0 0 0 0 0 0 10.8343 0 0 0 0 0 0 0 0 0 Q04771 ACVR1_HUMAN "Activin receptor type-1, EC 2.7.11.30 (Activin receptor type I, ACTR-I) (Activin receptor-like kinase 2, ALK-2) (Serine/threonine-protein kinase receptor R1, SKR1) (TGF-B superfamily receptor type I, TSR-I)" ACVR1 ACVRLK2 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; regulation of skeletal muscle tissue development [GO:0048641]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]; ventricular septum morphogenesis [GO:0060412]" activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; peptidyl-threonine phosphorylation [GO:0018107]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of ossification [GO:0030278]; regulation of skeletal muscle tissue development [GO:0048641]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; urogenital system development [GO:0001655]; ventricular septum morphogenesis [GO:0060412]" GO:0001569; GO:0001655; GO:0001701; GO:0001702; GO:0001707; GO:0001755; GO:0002526; GO:0003143; GO:0003181; GO:0003183; GO:0003203; GO:0003274; GO:0003289; GO:0004672; GO:0004674; GO:0004675; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0007179; GO:0007281; GO:0007368; GO:0007507; GO:0009953; GO:0009968; GO:0010862; GO:0016361; GO:0017046; GO:0018107; GO:0030278; GO:0030335; GO:0030501; GO:0030509; GO:0032924; GO:0032926; GO:0042803; GO:0043235; GO:0045177; GO:0045296; GO:0045669; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048641; GO:0050431; GO:0050731; GO:0051145; GO:0060037; GO:0060389; GO:0060412; GO:0060923; GO:0061312; GO:0061445; GO:0070724; GO:0071363; GO:0071385; GO:0071773; GO:1905007; GO:1990782; GO:2000017; GO:2000134; GO:2001237 "activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]" DEKSWFR 0.988 -4.1089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13394 MB211_HUMAN "Putative nucleotidyltransferase MAB21L1, EC 2.7.7.- (Protein mab-21-like 1)" MAB21L1 CAGR1 Nbla00126 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; eye development [GO:0001654]; positive regulation of cell population proliferation [GO:0008284] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; eye development [GO:0001654]; positive regulation of cell population proliferation [GO:0008284] GO:0001654; GO:0005524; GO:0005525; GO:0005634; GO:0008283; GO:0008284; GO:0009653; GO:0016779; GO:0043010; GO:0046872 ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779] DRYVVQITPAFKCTGIWPR 0.988 -1.9382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2119 0 13.2736 0 0 0 14.1445 12.7932 12.8763 0 11.6826 0 0 0 0 0 0 0 11.9723 0 0 0 11.1972 0 13.6264 14.095 0 14.0033 13.6879 14.0009 13.2816 13.5205 0 0 0 0 0 0 0 0 14.7554 13.7831 0 0 14.1877 0 0 0 0 14.093 0 0 12.432 0 0 14.6735 0 0 0 13.7924 14.7323 0 14.8985 0 0 0 0 13.6057 12.9086 0 0 14.1317 0 13.7819 0 13.7687 13.5475 0 0 13.3617 0 0 12.604 0 0 0 12.7255 0 0 0 0 0 0 0 12.2034 13.8027 0 0 0 0 0 0 0 0 0 13.9576 0 13.5607 0 13.0885 0 0 0 0 Q14264 ENR1_HUMAN "Endogenous retrovirus group 3 member 1 Env polyprotein (ERV-3 envelope protein, ERV3 envelope protein) (ERV3-1 envelope protein) (Envelope polyprotein) (HERV-R envelope protein, ERV-R envelope protein) (HERV-R_7q21.2 provirus ancestral Env polyprotein) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERV3-1 ERV3 Homo sapiens (Human) EITAKIQKLAHIPVQTWK 0.988 -4.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6035 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4131 0 Q5M8T2 S35D3_HUMAN Solute carrier family 35 member D3 (Fringe connection-like protein 1) SLC35D3 FRCL1 Homo sapiens (Human) carbohydrate transport [GO:0008643]; energy homeostasis [GO:0097009]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462]; carbohydrate transport [GO:0008643]; energy homeostasis [GO:0097009]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527] GO:0005461; GO:0005462; GO:0005463; GO:0005769; GO:0005783; GO:0005794; GO:0008643; GO:0015297; GO:0016021; GO:0032527; GO:0070863; GO:0097009 antiporter activity [GO:0015297]; UDP-glucuronic acid transmembrane transporter activity [GO:0005461]; UDP-N-acetylgalactosamine transmembrane transporter activity [GO:0005463]; UDP-N-acetylglucosamine transmembrane transporter activity [GO:0005462] GRVLGISVAIAHGVFSGSLNILLK 0.98803 -1.9591 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9763 11.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2002 0 0 0 0 0 10.9146 0 0 0 0 14.4868 0 10.1623 0 0 19.2588 0 14.6249 0 19.4237 0 0 0 0 0 0 14.2104 18.776 19.2055 0 0 0 17 0 0 0 12.9364 0 12.9212 12.2546 15.0219 0 9.92806 15.4318 0 12.7453 0 0 15.9894 0 0 0 0 16.7566 0 0 0 0 0 0 0 0 15.4102 14.2781 0 0 0 0 0 0 0 0 0 0 14.7571 0 0 0 12.4304 0 0 0 0 0 0 0 0 12.7337 0 12.1382 0 0 0 0 0 14.5573 14.2195 13.4831 0 0 0 12.4091 0 13.0674 11.3591 11.7735 0 0 0 0 0 0 P32745 SSR3_HUMAN "Somatostatin receptor type 3, SS-3-R, SS3-R, SS3R, SST3 (SSR-28)" SSTR3 Homo sapiens (Human) "cell-cell signaling [GO:0007267]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated apoptotic signaling pathway [GO:0008628]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]" ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] "ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; signaling receptor binding [GO:0005102]; somatostatin receptor activity [GO:0004994]; cell-cell signaling [GO:0007267]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated apoptotic signaling pathway [GO:0008628]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]" GO:0004930; GO:0004994; GO:0005102; GO:0005737; GO:0005886; GO:0005887; GO:0005929; GO:0007187; GO:0007218; GO:0007267; GO:0007283; GO:0008285; GO:0008628; GO:0021549; GO:0030900; GO:0042277; GO:0042594; GO:0042923; GO:0043005; GO:0060170; GO:0071385; GO:0071392; GO:0097730 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; signaling receptor binding [GO:0005102]; somatostatin receptor activity [GO:0004994] QGFRRVLLR 0.98805 -4.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9933 0 0 0 0 0 0 0 0 0 0 0 0 0 14.563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9279 12.1398 0 0 0 11.4783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4652 0 0 0 0 0 0 0 0 0 9.90346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5239 0 0 0 11.7248 0 0 0 0 0 0 18.0054 0 0 0 0 13.2906 0 0 9.96265 0 0 0 0 0 0 0 0 0 0 0 11.3073 0 0 0 0 0 12.1765 11.5122 0 0 0 0 0 0 0 0 0 Q13342 SP140_HUMAN "Nuclear body protein SP140 (Lymphoid-restricted homolog of Sp100, LYSp100) (Nuclear autoantigen Sp-140) (Speckled 140 kDa)" SP140 LYSP100 Homo sapiens (Human) defense response [GO:0006952]; regulation of transcription by RNA polymerase II [GO:0006357] fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PML body [GO:0016605] "fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; defense response [GO:0006952]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0001650; GO:0003677; GO:0005634; GO:0005739; GO:0006357; GO:0006952; GO:0016605; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" AAQKRVR 0.98805 -4.1937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7858 12.8705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.287 0 0 0 0 0 0 0 0 11.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4112 0 0 0 0 0 17.757 0 14.8929 0 14.445 14.3326 14.8377 0 0 14.4831 0 0 0 13.8537 0 0 0 0 14.0154 0 0 13.8041 0 0 0 0 0 0 0 18.3685 0 0 14.5147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3478 0 0 0 13.4276 12.8691 0 0 0 0 0 0 0 13.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03111 ENL_HUMAN Protein ENL (YEATS domain-containing protein 1) MLLT1 ENL LTG19 YEATS1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of protein kinase activity [GO:0006469]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; fibrillar center [GO:0001650]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] cytosol [GO:0005829]; fibrillar center [GO:0001650]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; histone binding [GO:0042393]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; negative regulation of protein kinase activity [GO:0006469]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0001650; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0006469; GO:0008023; GO:0016573; GO:0032783; GO:0035267; GO:0042393 histone binding [GO:0042393] EEKAPPPK 0.98806 -4.1985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7577 0 0 0 0 0 0 0 0 0 0 11.2656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6331 0 0 0 0 0 0 0 0 0 15.4536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8949 0 0 0 0 0 0 0 0 13.9527 0 0 0 0 Q9Y5U5 TNR18_HUMAN Tumor necrosis factor receptor superfamily member 18 (Activation-inducible TNFR family receptor) (Glucocorticoid-induced TNFR-related protein) (CD antigen CD357) TNFRSF18 AITR GITR UNQ319/PRO364 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tumor necrosis factor receptor activity [GO:0005031]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165] GO:0002687; GO:0005031; GO:0005576; GO:0005886; GO:0005887; GO:0006915; GO:0007165; GO:0009897; GO:0042531; GO:0043066; GO:0045785 tumor necrosis factor receptor activity [GO:0005031] CCRVHTTRCCR 0.98806 -1.9877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95561 CA105_HUMAN Uncharacterized protein C1orf105 C1orf105 Homo sapiens (Human) ASFENCMSYR 0.98807 -3.992 0 0 0 0 0 0 0 13.1267 0 0 0 0 0 0 15.0081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0345 0 0 0 10.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0215 0 0 13.8498 0 0 0 0 0 0 0 12.355 0 14.2067 14.7306 0 0 0 0 0 12.0435 0 12.134 11.704 0 0 13.2528 0 0 0 0 12.6035 0 0 0 0 0 12.3379 0 0 0 0 0 0 0 11.8887 0 0 0 0 0 13.2088 0 0 15.1413 0 0 0 0 0 0 0 0 0 0 0 0 14.8398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5599 0 0 0 0 11.7479 0 0 0 0 Q96P20 NLRP3_HUMAN "NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1, CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)" NLRP3 C1orf7 CIAS1 NALP3 PYPAF1 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; peptidoglycan binding [GO:0042834]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; pyroptosis [GO:0070269]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165] GO:0000139; GO:0002221; GO:0002674; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006915; GO:0006952; GO:0006954; GO:0007165; GO:0007231; GO:0009595; GO:0032088; GO:0032691; GO:0032731; GO:0032753; GO:0042802; GO:0042834; GO:0043280; GO:0043565; GO:0044546; GO:0045087; GO:0045630; GO:0045944; GO:0050727; GO:0050728; GO:0050729; GO:0051092; GO:0070269; GO:0071222; GO:0072559; GO:0098586; GO:0140297; GO:1901223; GO:2000553 ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; peptidoglycan binding [GO:0042834]; sequence-specific DNA binding [GO:0043565] AMDYFPKIEINLSTRMDHMVSSFCIENCHR 0.98807 -3.9911 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6467 0 0 0 0 0 0 0 0 0 0 0 13.0122 0 12.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4233 0 0 14.9807 0 0 13.7556 0 0 0 0 0 0 0 13.9342 0 0 0 13.318 0 0 0 0 14.5927 0 0 0 0 14.7832 0 0 0 0 0 0 15.2553 0 0 0 0 0 0 0 0 0 0 0 12.2586 0 12.8153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0971 0 14.7315 0 0 0 0 0 0 0 0 14.9694 0 0 0 0 0 14.63 14.8903 0 0 0 0 0 0 0 Q9NSE4 SYIM_HUMAN "Isoleucine--tRNA ligase, mitochondrial, EC 6.1.1.5 (Isoleucyl-tRNA synthetase, IleRS)" IARS2 Homo sapiens (Human) isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006428; GO:0032543 aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] DQLGGWFQSSLLTSVAARKR 0.98807 -3.9905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8282 0 0 0 0 0 0 0 13.9214 0 0 0 0 0 0 0 0 14.0341 0 0 0 0 0 14.835 0 0 12.0813 0 0 0 0 0 0 0 0 0 0 0 13.8881 0 0 10.5088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0852 0 0 0 0 0 12.4982 0 0 0 0 0 0 0 0 0 12.6108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1596 14.5845 0 0 0 0 A0A0A0MS02 TRGV1_HUMAN Probable non-functional T cell receptor gamma variable TRGV1 Homo sapiens (Human) adaptive immune response [GO:0002250] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0009897; GO:0042101 SNWNLRLQNLIK 0.98809 -4.0044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5742 0 0 0 0 0 0 0 0 0 0 13.7015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7655 0 0 0 0 0 0 0 0 0 11.2475 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0288 0 0 0 0 0 0 0 0 0 0 0 0 12.5975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31749 AKT1_HUMAN "RAC-alpha serine/threonine-protein kinase, EC 2.7.11.1 (Protein kinase B, PKB) (Protein kinase B alpha, PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)" AKT1 PKB RAC Homo sapiens (Human) "activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to cadmium ion [GO:0071276]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]" cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lamellipodium [GO:0030027]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982] "cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; lamellipodium [GO:0030027]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; carbohydrate transport [GO:0008643]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to cadmium ion [GO:0071276]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by protein phosphorylation [GO:0100002]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; NIK/NF-kappaB signaling [GO:0038061]; nitric oxide biosynthetic process [GO:0006809]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]" GO:0001649; GO:0001893; GO:0001934; GO:0001938; GO:0002042; GO:0003376; GO:0004672; GO:0004674; GO:0004712; GO:0005516; GO:0005524; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0005886; GO:0005911; GO:0005978; GO:0005979; GO:0006006; GO:0006417; GO:0006468; GO:0006469; GO:0006606; GO:0006809; GO:0006924; GO:0006954; GO:0006979; GO:0007165; GO:0007173; GO:0007186; GO:0007249; GO:0007281; GO:0008283; GO:0008284; GO:0008286; GO:0008637; GO:0008643; GO:0009408; GO:0010467; GO:0010507; GO:0010595; GO:0010628; GO:0010629; GO:0010748; GO:0010761; GO:0010763; GO:0010765; GO:0010907; GO:0010918; GO:0010951; GO:0010975; GO:0014065; GO:0015630; GO:0016242; GO:0016301; GO:0016310; GO:0016567; GO:0018105; GO:0018107; GO:0019221; GO:0019899; GO:0019901; GO:0030027; GO:0030154; GO:0030235; GO:0030307; GO:0030334; GO:0031234; GO:0031295; GO:0031397; GO:0031641; GO:0031663; GO:0031929; GO:0031982; GO:0031999; GO:0032079; GO:0032091; GO:0032094; GO:0032287; GO:0032436; GO:0032869; GO:0032991; GO:0033138; GO:0034405; GO:0034614; GO:0035556; GO:0035655; GO:0035924; GO:0036064; GO:0036294; GO:0038061; GO:0042593; GO:0042802; GO:0042803; GO:0042981; GO:0043066; GO:0043154; GO:0043161; GO:0043276; GO:0043325; GO:0043488; GO:0043491; GO:0043536; GO:0045429; GO:0045600; GO:0045725; GO:0045737; GO:0045746; GO:0045861; GO:0045893; GO:0045944; GO:0046326; GO:0046622; GO:0046777; GO:0046889; GO:0048009; GO:0048266; GO:0048661; GO:0051000; GO:0051091; GO:0051146; GO:0051247; GO:0060079; GO:0060416; GO:0060644; GO:0060709; GO:0060716; GO:0070141; GO:0070848; GO:0071276; GO:0071356; GO:0071364; GO:0071380; GO:0071889; GO:0071901; GO:0072655; GO:0072656; GO:0090201; GO:0097011; GO:0097194; GO:0098794; GO:0099104; GO:0100002; GO:0106310; GO:0140052; GO:1900087; GO:1900182; GO:1901215; GO:1901796; GO:1902176; GO:1903038; GO:1903078; GO:1903721; GO:1990090; GO:1990418; GO:2000010; GO:2000074; GO:2000402; GO:2001240 "14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]" DLKLENLMLDK 0.98809 -4.1075 0 0 0 0 12.3553 11.4366 0 0 0 0 0 0 0 0 14.7814 0 0 0 0 0 0 0 12.3323 0 0 13.5613 0 0 14.0603 0 0 0 0 0 0 0 0 0 0 13.5087 14.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8413 16.7524 13.0883 0 0 0 0 0 0 0 13.8638 0 16.4008 0 0 13.8149 14.4596 14.1184 11.1578 13.3955 14.4265 0 13.0239 15.0555 0 0 0 14.1617 14.5624 0 13.8078 13.5174 14.6308 0 13.4345 14.7739 13.3788 14.3878 14.8714 11.6497 12.4681 13.6242 14.4579 13.7976 15.0127 14.729 0 0 13.852 0 0 0 15.1346 0 0 0 0 12.2338 0 13.7297 11.3862 0 14.6789 12.1333 0 13.4748 0 0 0 0 0 0 0 13.5655 0 14.2948 0 13.0575 0 0 0 11.0156 0 0 0 10.2741 0 0 13.2678 0 0 0 0 13.6631 13.5755 13.6102 13.9918 0 0 0 14.7584 0 Q96DA0 ZG16B_HUMAN Zymogen granule protein 16 homolog B ZG16B UNQ773/PRO1567 Homo sapiens (Human) retina homeostasis [GO:0001895] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; retina homeostasis [GO:0001895] GO:0001895; GO:0005615; GO:0030246; GO:0070062 carbohydrate binding [GO:0030246] GMVMYTSK 0.98809 -4.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3L3 3BP1_HUMAN SH3 domain-binding protein 1 SH3BP1 Homo sapiens (Human) "actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament depolymerization [GO:0030834]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of Rac protein signal transduction [GO:0035020]; regulation of small GTPase mediated signal transduction [GO:0051056]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]" adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; phagocytic cup [GO:0001891] "adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; semaphorin receptor binding [GO:0030215]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; cell migration [GO:0016477]; establishment of epithelial cell apical/basal polarity [GO:0045198]; filopodium assembly [GO:0046847]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; positive regulation of GTPase activity [GO:0043547]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament depolymerization [GO:0030834]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of Rac protein signal transduction [GO:0035020]; regulation of small GTPase mediated signal transduction [GO:0051056]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]" GO:0001891; GO:0005096; GO:0005634; GO:0005829; GO:0005912; GO:0005923; GO:0006911; GO:0007015; GO:0016477; GO:0017124; GO:0030027; GO:0030215; GO:0030834; GO:0031252; GO:0032956; GO:0034329; GO:0035020; GO:0043535; GO:0043547; GO:0045198; GO:0046847; GO:0051056; GO:0051058; GO:0071526; GO:0097178 GTPase activator activity [GO:0005096]; semaphorin receptor binding [GO:0030215]; SH3 domain binding [GO:0017124] DVLQPLSR 0.98809 -4.0092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5085 0 0 12.804 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7538 0 0 0 15.1247 14.0728 14.2292 0 0 0 0 0 0 0 0 12.581 0 0 0 0 0 0 13.1892 0 12.3096 0 12.3821 0 0 12.9404 13.0992 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0714 0 0 0 0 0 0 0 12.332 0 0 0 0 0 0 0 0 0 0 0 11.7759 0 0 12.083 0 0 0 0 0 0 12.1848 0 0 0 0 0 0 0 0 0 0 11.6073 10.9712 0 Q8WXJ9 ASB17_HUMAN "Ankyrin repeat and SOCS box protein 17, ASB-17" ASB17 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 DYVQDRSCNLALIWR 0.9881 -4.1255 11.1083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1852 0 0 12.0413 0 0 0 0 14.2549 0 0 0 14.6353 0 0 12.3937 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.826 0 0 12.3372 0 0 0 0 12.8744 13.7813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0948 11.9539 0 0 0 0 0 13.6137 0 12.3885 13.3404 0 13.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7777 0 0 0 0 0 0 12.9502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.326 0 0 11.1176 0 0 0 Q9Y2G8 DJC16_HUMAN DnaJ homolog subfamily C member 16 DNAJC16 KIAA0962 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AYEILSNEEKR 0.9881 -4.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2143 0 0 0 0 0 0 12.6551 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6448 0 0 0 0 0 0 0 11.1405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8909 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9725 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12236 ADT3_HUMAN "ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2, ANT 2) (Adenine nucleotide translocator 3, ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed ]" SLC25A6 AAC3 ANT3 CDABP0051 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP:ADP antiporter activity [GO:0005471]; apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029] GO:0005471; GO:0005634; GO:0005739; GO:0005743; GO:0005744; GO:0006915; GO:0016020; GO:0016021; GO:0140021; GO:1901029; GO:1990544 ATP:ADP antiporter activity [GO:0005471] DFLAGGIAAAISKTAVAPIERVK 0.98811 -4.136 0 0 0 0 0 0 0 0 0 0 0 11.9425 0 13.0273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7524 0 0 13.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6526 0 0 0 0 0 0 0 11.6326 0 0 0 13.4115 0 0 0 0 0 0 0 0 0 0 0 0 0 15.711 14.951 10.8052 0 0 13.4146 14.7862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4033 0 0 14.5296 0 13.7607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2144 0 0 0 15.8296 0 0 0 0 12.3774 0 0 12.336 0 0 0 0 0 0 0 0 0 0 10 0 0 0 0 0 0 0 0 14.2374 0 0 0 0 0 13.8179 0 0 12.9851 0 0 0 P0C7T7 FMAS1_HUMAN Putative uncharacterized protein FRMD6-AS1 (FRMD6 antisense RNA 1) (FRMD6 antisense gene protein 1) FRMD6-AS1 C14orf82 Homo sapiens (Human) GGVDHGDQGLSPCCGDGGAR 0.98812 -1.9399 0 0 0 0 0 0 0 0 11.8741 0 13.8614 0 0 0 12.2605 0 0 0 0 0 0 0 0 0 0 0 12.9135 0 13.611 0 0 0 0 10.2146 12.5664 11.7717 13.0822 0 12.7456 12.2442 0 13.1302 0 13.2865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3929 0 0 0 0 0 0 0 14.6146 14.6119 14.6231 14.4682 12.6678 0 14.0884 0 0 0 0 13.6446 0 0 0 0 P23141 EST1_HUMAN "Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase, ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1, CE-1, hCE-1, EC 3.1.1.1) (Cholesteryl ester hydrolase, CEH, EC 3.1.1.13) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1, EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase, REH) (Serine esterase 1) (Triacylglycerol hydrolase, TGH)" CES1 CES2 SES1 Homo sapiens (Human) cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]; cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691] GO:0004771; GO:0005737; GO:0005783; GO:0005788; GO:0005811; GO:0005829; GO:0006695; GO:0008203; GO:0009636; GO:0010875; GO:0010887; GO:0016042; GO:0030855; GO:0042632; GO:0043691; GO:0047374; GO:0051791; GO:0052689; GO:0070857; GO:0071397; GO:0071404; GO:0080030; GO:0090122; GO:0090205; GO:0120188 carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771] DAGAPTYMYEFQYR 0.98812 -1.9408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.50492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2499 0 0 0 0 0 0 0 0 15.2415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.063 0 0 0 0 0 0 0 0 0 0 0 0 14.1577 14.0835 0 0 0 0 0 0 0 11.7596 0 0 0 0 0 13.2233 0 0 0 14.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6VUC0 AP2E_HUMAN "Transcription factor AP-2-epsilon, AP2-epsilon (Activating enhancer-binding protein 2-epsilon)" TFAP2E Homo sapiens (Human) anatomical structure development [GO:0048856]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0042127; GO:0042802; GO:0048856; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" CLRERLEK 0.98813 -1.9549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3C6 ATG9A_HUMAN Autophagy-related protein 9A (APG9-like 1) (mATG9) ATG9A APG9L1 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; bone morphogenesis [GO:0060349]; late nucleophagy [GO:0044805]; positive regulation of necrotic cell death [GO:0010940]; protein localization to phagophore assembly site [GO:0034497] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; phospholipid scramblase activity [GO:0017128]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; bone morphogenesis [GO:0060349]; late nucleophagy [GO:0044805]; positive regulation of necrotic cell death [GO:0010940]; protein localization to phagophore assembly site [GO:0034497] GO:0000045; GO:0000139; GO:0000407; GO:0000422; GO:0005739; GO:0005768; GO:0005770; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0010940; GO:0016020; GO:0016021; GO:0017128; GO:0031902; GO:0031966; GO:0034045; GO:0034497; GO:0043231; GO:0044805; GO:0055037; GO:0055038; GO:0060349 phospholipid scramblase activity [GO:0017128] AVFILEELLSPIVTPLILIFCLRPR 0.98813 -1.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.859 13.9126 13.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7803 0 0 0 0 0 0 0 0 0 0 12.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6929 0 0 12.7358 0 0 0 0 0 0 0 0 0 13.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00124 UBXN8_HUMAN "UBX domain-containing protein 8 (Reproduction 8 protein, Rep-8 protein) (UBX domain-containing protein 6)" UBXN8 D8S2298E REP8 UBXD6 Homo sapiens (Human) single fertilization [GO:0007338]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; single fertilization [GO:0007338]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000151; GO:0005654; GO:0005730; GO:0005783; GO:0007338; GO:0030176; GO:0030433; GO:0030674; GO:0043130 protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130] DFLLLCGRILLLLALLTLIISVTTSWLNSFK 0.98814 -4.1842 0 0 0 0 0 0 0 0 0 0 0 0 11.9786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2431 0 11.6959 0 0 0 0 0 0 0 0 0 0 0 13.0784 0 0 0 0 0 0 10.4282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.628 0 13.191 0 0 14.307 14.2033 15.2014 15.5991 0 13.5196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7986 0 0 0 0 0 0 0 0 12.7804 0 0 12.9481 0 0 0 0 0 0 0 0 0 0 12.327 0 0 0 0 0 0 0 0 0 0 0 11.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0042 0 0 0 0 0 0 0 0 O15213 WDR46_HUMAN WD repeat-containing protein 46 (WD repeat-containing protein BING4) WDR46 BING4 C6orf11 FP221 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0032040 RNA binding [GO:0003723] ELRPQRPK 0.98814 -4.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95801 TTC4_HUMAN "Tetratricopeptide repeat protein 4, TPR repeat protein 4" TTC4 My044 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457] GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879 Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879] DVRKANLK 0.98814 -1.9549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4781 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4552 0 13.5534 13.3699 13.4715 0 0 0 0 0 0 0 0 0 13.4097 0 0 0 0 0 0 0 0 0 0 14.8244 0 0 0 0 0 0 0 12.7895 0 0 0 0 0 0 0 0 0 0 0 0 12.4552 12.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWV1 LAX1_HUMAN Lymphocyte transmembrane adapter 1 (Linker for activation of X cells) (Membrane-associated adapter protein LAX) LAX1 LAX Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell activation [GO:0042113]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; lymphocyte activation [GO:0046649]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of T cell activation [GO:0050868] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; adaptive immune response [GO:0002250]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell activation [GO:0042113]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; lymphocyte activation [GO:0046649]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of T cell activation [GO:0050868] GO:0002250; GO:0005794; GO:0005829; GO:0005886; GO:0006955; GO:0016020; GO:0016021; GO:0019901; GO:0035556; GO:0042113; GO:0042169; GO:0043407; GO:0046649; GO:0050851; GO:0050868 protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169] AKNIYDILPWRQEDLGR 0.98814 -1.9591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88108 0 0 0 0 0 0 0 0 0 0 0 10.4202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4439 0 0 0 0 0 0 0 0 12.4084 13.9614 0 0 0 0 0 0 12.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8203 14.1016 0 0 0 0 0 0 0 0 0 0 11.5713 0 0 0 0 0 0 0 0 0 0 14.9642 0 0 0 0 0 0 0 0 13.1092 0 0 0 13.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UF12 HYPDH_HUMAN "Hydroxyproline dehydrogenase, HYPDH, EC 1.5.5.3 (Kidney and liver proline oxidase 1, HsPOX1) (Probable proline dehydrogenase 2, EC 1.5.5.2) (Probable proline oxidase 2)" PRODH2 HSPOX1 HYPDH Homo sapiens (Human) proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]" GO:0004657; GO:0005739; GO:0005743; GO:0006562; GO:0010133; GO:0016645; GO:0071949 "FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-NH group of donors [GO:0016645]; proline dehydrogenase activity [GO:0004657]" DAEAAHR 0.98814 -4.1869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3684 0 0 0 0 0 0 0 0 0 0 0 0 0 P52952 NKX25_HUMAN Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E) NKX2-5 CSX NKX2.5 NKX2E Homo sapiens (Human) "adult heart development [GO:0007512]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle cell development [GO:0055014]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; atrioventricular node development [GO:0003162]; bundle of His development [GO:0003166]; cardiac conduction system development [GO:0003161]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube development [GO:0035050]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription via serum response element binding [GO:0010735]; positive regulation of transcription, DNA-templated [GO:0045893]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adult heart development [GO:0007512]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle cell development [GO:0055014]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; atrioventricular node development [GO:0003162]; bundle of His development [GO:0003166]; cardiac conduction system development [GO:0003161]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube development [GO:0035050]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription via serum response element binding [GO:0010735]; positive regulation of transcription, DNA-templated [GO:0045893]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0001570; GO:0001947; GO:0003007; GO:0003148; GO:0003161; GO:0003162; GO:0003166; GO:0003168; GO:0003180; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0007512; GO:0008284; GO:0010628; GO:0010667; GO:0010735; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0035050; GO:0042803; GO:0043066; GO:0043565; GO:0045666; GO:0045823; GO:0045892; GO:0045893; GO:0045944; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055007; GO:0055008; GO:0055013; GO:0055014; GO:0055015; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0090090; GO:0090575; GO:1903779; GO:1904019; GO:1904036; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" RIAVPVLVR 0.98815 -4.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8911 0 0 13.8459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3169 0 0 0 0 0 0 0 0 0 0 0 0 0 12.036 0 0 0 0 0 0 0 0 0 12.7685 0 0 0 17.93 0 14.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q765I0 UTS2B_HUMAN "Urotensin-2B (Urotensin II-related peptide) (Urotensin IIB, U-IIB, UIIB) (Urotensin-2 domain-containing protein)" UTS2B URP UTS2D Homo sapiens (Human) blood vessel diameter maintenance [GO:0097746]; regulation of blood pressure [GO:0008217] extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; blood vessel diameter maintenance [GO:0097746]; regulation of blood pressure [GO:0008217] GO:0001664; GO:0005179; GO:0005576; GO:0008217; GO:0097746 G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179] ACFWKYCV 0.98815 -4.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXT6 M10L1_HUMAN "RNA helicase Mov10l1, EC 3.6.4.13 (Moloney leukemia virus 10-like protein 1, MOV10-like protein 1)" MOV10L1 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546] cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA methylation involved in gamete generation [GO:0043046]; germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA metabolic process [GO:0034587]; post-transcriptional gene silencing by RNA [GO:0035194]; spermatogenesis [GO:0007283] GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043046; GO:0043186; GO:0071546 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ALLIVLGNPHVLVR 0.98815 -4.1966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9306 0 12.1884 0 0 0 0 0 0 9.35425 11.5391 0 0 0 0 0 10.855 0 0 0 11.262 0 0 0 0 0 0 0 0 0 0 0 12.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5151 14.3072 0 0 0 0 11.6001 0 17.1298 0 0 14.4416 0 0 0 0 0 0 0 0 14.4861 0 13.1674 0 15.1666 10.8272 0 0 13.8005 0 0 0 13.5794 11.4809 14.054 0 10.1017 12.6009 0 12.0963 0 0 0 0 0 0 0 14.1494 0 0 0 15.3708 0 0 0 0 10.8623 0 0 0 0 0 15.2114 0 16.0427 15.6366 15.6467 15.4203 0 0 15.7654 0 0 15.1576 14.1279 11.0199 15.2001 0 15.3965 15.2386 12.8178 15.3814 0 15.0351 14.5871 0 10.6624 0 0 0 0 0 0 0 0 0 9.64008 0 12.82 10.4359 0 14.2458 0 13.5549 14.0521 14.5003 14.4754 0 0 13.1309 0 0 13.2658 A0A1W2PRP0 FOXL3_HUMAN Forkhead box protein L3 FOXL3 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EGPRGPR 0.98816 -3.9902 0 0 12.3232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.373 0 0 0 0 0 13.6976 0 0 0 12.1984 13.0103 0 11.4811 13.649 0 0 0 0 0 0 0 0 0 0 0 0 11.4372 0 0 0 0 0 0 0 10.6688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2016 0 Q5BKX8 CAVN4_HUMAN Caveolae-associated protein 4 (Muscle-related coiled-coil protein) (Muscle-restricted coiled-coil protein) CAVIN4 MURC Homo sapiens (Human) cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of Rho protein signal transduction [GO:0035023] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of Rho protein signal transduction [GO:0035023] GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007517; GO:0010468; GO:0016528; GO:0030018; GO:0030154; GO:0035023; GO:0042383; GO:0045944 CPTSLSVVKDR 0.98816 -4.2069 0 0 0 0 0 0 0 0 0 12.4865 0 0 11.7555 0 0 0 0 0 0 0 0 0 11.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4622 0 0 11.4537 13.5215 0 0 0 13.6563 0 12.5567 0 0 0 0 0 14.9921 11.6325 0 0 0 0 0 12.5245 0 12.6196 0 0 11.6421 0 0 0 0 0 0 0 13.1104 0 0 0 0 0 0 0 0 0 0 12.1623 13.0911 0 0 0 0 0 0 13.4013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0641 0 11.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0569 0 0 0 0 0 0 0 0 0 0 0 13.2725 0 0 0 14.2378 0 0 13.7915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4222 0 0 Q8NBI3 DRAXI_HUMAN Draxin (Dorsal inhibitory axon guidance protein) (Dorsal repulsive axon guidance protein) (Neucrin) DRAXIN C1orf187 PSEC0258 UNQ3119/PRO10268 Homo sapiens (Human) anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; commissural neuron differentiation in spinal cord [GO:0021528]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; hippocampal neuron apoptotic process [GO:0110088]; negative regulation of axon extension [GO:0030517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; Wnt signaling pathway [GO:0016055] extracellular region [GO:0005576] extracellular region [GO:0005576]; anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; commissural neuron differentiation in spinal cord [GO:0021528]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; hippocampal neuron apoptotic process [GO:0110088]; negative regulation of axon extension [GO:0030517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; Wnt signaling pathway [GO:0016055] GO:0005576; GO:0007411; GO:0016055; GO:0021516; GO:0021528; GO:0021960; GO:0030517; GO:0030900; GO:0090090; GO:0110088; GO:0110091 CFDDCMCVEGLR 0.98816 -1.7083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7062 0 0 0 0 0 0 11.132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3986 0 0 0 0 0 0 12.3287 0 0 12.5478 0 0 11.5846 0 0 12.2418 0 0 12.9644 0 0 0 0 0 0 0 0 14.0696 0 0 0 0 13.7042 12.8034 0 0 0 0 0 0 0 0 0 11.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9884 0 0 0 0 0 0 0 12.5831 0 0 12.5521 0 0 11.75 0 0 0 0 0 11.7027 0 0 0 0 0 13.9568 0 0 0 0 13.3573 0 0 0 0 12.1464 0 0 0 9.92585 0 0 0 0 0 11.3539 0 0 D3DTV9 PRAC2_HUMAN "Putative protein PRAC2 (Prostate, rectum and colon expressed gene protein 2)" PRAC2 C17orf93 HOXB-AS5 HOXB13-AS1 NCRNA00253 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 PVAPRTMK 0.98817 -4.0908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C024 NUDT7_HUMAN "Peroxisomal coenzyme A diphosphatase NUDT7, EC 3.6.1.- (Nucleoside diphosphate-linked moiety X motif 7, Nudix motif 7)" NUDT7 Homo sapiens (Human) acetyl-CoA catabolic process [GO:0046356]; brown fat cell differentiation [GO:0050873]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; nucleoside diphosphate metabolic process [GO:0009132]; propionyl-CoA catabolic process [GO:1902859]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acetyl-CoA hydrolase activity [GO:0003986]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; snoRNA binding [GO:0030515]; acetyl-CoA catabolic process [GO:0046356]; brown fat cell differentiation [GO:0050873]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; nucleoside diphosphate metabolic process [GO:0009132]; propionyl-CoA catabolic process [GO:1902859]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289] GO:0000287; GO:0003986; GO:0005777; GO:0005782; GO:0005829; GO:0009132; GO:0010945; GO:0015938; GO:0030145; GO:0030515; GO:0036114; GO:0044580; GO:0046356; GO:0050873; GO:1901289; GO:1902858; GO:1902859; GO:2001294 acetyl-CoA hydrolase activity [GO:0003986]; CoA pyrophosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; snoRNA binding [GO:0030515] FINHIFEYTNPEDGVTYQIK 0.98817 -4.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CS3 FAF2_HUMAN FAS-associated factor 2 (Protein ETEA) (UBX domain-containing protein 3B) (UBX domain-containing protein 8) FAF2 ETEA KIAA0887 UBXD8 UBXN3B Homo sapiens (Human) "lipid droplet organization [GO:0034389]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] "azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; lipid droplet organization [GO:0034389]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0005576; GO:0005783; GO:0005811; GO:0006986; GO:0030433; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035578; GO:0043130; GO:0055102 lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625] FALRFIR 0.98817 -4.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKG9 OCTC_HUMAN "Peroxisomal carnitine O-octanoyltransferase, COT, EC 2.3.1.137" CROT COT Homo sapiens (Human) carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791] GO:0005777; GO:0005782; GO:0005829; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015908; GO:0015936; GO:0033540; GO:0043231; GO:0051791 carnitine O-octanoyltransferase activity [GO:0008458] AQYLREASDLQIAAYAFTSFGKK 0.98817 -4.0939 0 0 0 0 0 0 0 0 12.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3775 0 12.3257 0 0 0 0 0 0 12.2231 0 0 0 0 11.8718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3685 0 12.7712 0 0 13.0119 0 12.8181 13.3261 0 12.0365 0 0 0 0 0 0 0 0 0 11.7601 13.6253 11.9323 0 0 0 0 12.9613 0 0 0 0 10.3975 14.1925 14.3828 14.71 0 0 0 0 13.9991 0 0 0 11.7535 0 0 0 0 0 0 11.8092 0 0 0 14.24 13.0379 0 0 0 12.332 0 0 0 13.2596 0 0 13.8961 13.0876 0 0 0 0 0 0 0 14.5353 0 0 0 0 0 0 0 0 0 12.7399 0 0 0 12.5468 0 0 0 0 0 0 0 0 0 0 0 13.4564 0 0 0 12.0056 13.2441 P54868 HMCS2_HUMAN "Hydroxymethylglutaryl-CoA synthase, mitochondrial, HMG-CoA synthase, EC 2.3.3.10 (3-hydroxy-3-methylglutaryl coenzyme A synthase)" HMGCS2 Homo sapiens (Human) "acetyl-CoA metabolic process [GO:0006084]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fatty acid [GO:0071398]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; ketone body biosynthetic process [GO:0046951]; kidney development [GO:0001822]; liver development [GO:0001889]; lung development [GO:0030324]; midgut development [GO:0007494]; multicellular organismal response to stress [GO:0033555]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to growth hormone [GO:0060416]; response to linoleic acid [GO:0070543]; response to metal ion [GO:0010038]; response to monosaccharide [GO:0034284]; response to nutrient [GO:0007584]; response to prostaglandin F [GO:0034696]; response to starvation [GO:0042594]; response to temperature stimulus [GO:0009266]; response to testosterone [GO:0033574]; response to triglyceride [GO:0034014]; response to xenobiotic stimulus [GO:0009410]" mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; identical protein binding [GO:0042802]; acetyl-CoA metabolic process [GO:0006084]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; cellular response to fatty acid [GO:0071398]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; ketone body biosynthetic process [GO:0046951]; kidney development [GO:0001822]; liver development [GO:0001889]; lung development [GO:0030324]; midgut development [GO:0007494]; multicellular organismal response to stress [GO:0033555]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to growth hormone [GO:0060416]; response to linoleic acid [GO:0070543]; response to metal ion [GO:0010038]; response to monosaccharide [GO:0034284]; response to nutrient [GO:0007584]; response to prostaglandin F [GO:0034696]; response to starvation [GO:0042594]; response to temperature stimulus [GO:0009266]; response to testosterone [GO:0033574]; response to triglyceride [GO:0034014]; response to xenobiotic stimulus [GO:0009410]" GO:0001822; GO:0001889; GO:0004421; GO:0005739; GO:0005759; GO:0006084; GO:0006695; GO:0007420; GO:0007494; GO:0007584; GO:0009266; GO:0009410; GO:0010038; GO:0010142; GO:0030324; GO:0032869; GO:0033555; GO:0033574; GO:0033762; GO:0034014; GO:0034284; GO:0034696; GO:0042594; GO:0042802; GO:0045471; GO:0046951; GO:0051591; GO:0060416; GO:0060612; GO:0070543; GO:0071222; GO:0071230; GO:0071385; GO:0071398 hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; identical protein binding [GO:0042802] ALLKASQDMFDKK 0.98818 -4.1069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD07 RAE1E_HUMAN "Retinoic acid early transcript 1E (Lymphocyte effector toxicity activation ligand) (NKG2D ligand 4, N2DL-4, NKG2DL4) (RAE-1-like transcript 4) (UL16-binding protein 4)" RAET1E LETAL N2DL4 ULBP4 UNQ1867/PRO4303 Homo sapiens (Human) natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954] GO:0005615; GO:0005886; GO:0009897; GO:0016021; GO:0042267; GO:0045954; GO:0046703 natural killer cell lectin-like receptor binding [GO:0046703] CTGASWQFATNGEK 0.98818 -4.0084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1383 0 0 0 0 11.0052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9502 0 0 0 0 0 0 Q8WVC6 DCAKD_HUMAN Dephospho-CoA kinase domain-containing protein DCAKD Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937] membrane [GO:0016020] membrane [GO:0016020]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; coenzyme A biosynthetic process [GO:0015937] GO:0004140; GO:0005524; GO:0015937; GO:0016020 ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140] ETFKYFLRGYR 0.98818 -4.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4331 0 0 0 11.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2923 0 0 0 0 0 0 0 0 13.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9848 0 0 0 0 0 0 0 0 12.9229 0 0 0 13.2915 0 0 0 0 0 0 0 0 0 0 0 0 13.0978 0 0 0 0 13.2255 13.564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99733 NP1L4_HUMAN "Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2, NAP-2)" NAP1L4 NAP2 Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0003723; GO:0005634; GO:0005737; GO:0006334; GO:0031491; GO:0042393; GO:0051082 chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] FYEEVHDLER 0.98818 -4.1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2533 0 0 0 0 0 0 0 0 0 0 0 0 11.8228 0 0 0 0 0 0 0 11.7642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8503 0 O14618 CCS_HUMAN Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone) CCS Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; positive regulation of oxidoreductase activity [GO:0051353]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035]; cellular response to oxidative stress [GO:0034599]; positive regulation of oxidoreductase activity [GO:0051353]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801] GO:0005507; GO:0005634; GO:0005737; GO:0005829; GO:0006801; GO:0015035; GO:0015680; GO:0019430; GO:0034599; GO:0045296; GO:0051353 cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035] GGHPLSK 0.98819 -4.1149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9919 0 0 12.2147 0 0 0 0 0 0 0 0 0 0 0 10.7685 0 0 0 0 0 0 0 0 0 0 13.4715 0 0 0 12.7822 0 0 0 0 0 0 0 0 12.4605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8062 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49AA0 ZFP69_HUMAN Zinc finger protein 69 homolog (Zinc finger protein 642) ZFP69 ZNF642 Homo sapiens (Human) lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0006629; GO:0019216; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AYLTHHQRIHTGER 0.98819 -1.7337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3519 0 0 0 0 0 0 12.7952 0 0 13.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0756 0 0 0 13.4255 0 12.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.488 0 0 0 0 0 0 0 14.122 0 0 0 0 0 0 0 0 14.0056 0 0 0 0 0 0 0 0 13.1525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8076 0 0 0 0 12.6468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969K3 RNF34_HUMAN "E3 ubiquitin-protein ligase RNF34, EC 2.3.2.27 (Caspase regulator CARP1) (Caspases-8 and -10-associated RING finger protein 1, CARP-1) (FYVE-RING finger protein Momo) (Human RING finger homologous to inhibitor of apoptosis protein, hRFI) (RING finger protein 34) (RING finger protein RIFF) (RING-type E3 ubiquitin transferase RNF34)" RNF34 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cellular response to cold [GO:0070417]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of oxygen metabolic process [GO:2000374]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006915; GO:0012505; GO:0016567; GO:0016604; GO:0016607; GO:0031625; GO:0035872; GO:0043161; GO:0046872; GO:0061630; GO:0070417; GO:0070936; GO:1901796; GO:1901797; GO:1901981; GO:1902042; GO:2000374; GO:2001271 metal ion binding [GO:0046872]; p53 binding [GO:0002039]; phosphatidylinositol phosphate binding [GO:1901981]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] KKHVCCDCK 0.9882 -4.1348 0 0 0 0 0 0 0 0 13.773 0 0 12.2276 0 13.6686 12.9224 13.7485 0 0 0 0 0 0 0 0 0 0 0 12.639 0 0 0 0 0 13.5985 0 0 0 12.8824 13.1952 13.7297 0 0 13.0897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9994 0 0 0 0 0 0 0 13.5844 14.188 0 0 0 0 0 0 0 0 0 0 13.2397 0 0 0 12.7704 0 0 14.267 0 13.3682 0 0 0 0 0 0 14.121 0 0 0 0 0 10.7715 13.9622 0 0 0 0 0 12.5426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.426 0 0 0 0 12.1478 14.1695 0 0 13.3523 12.9204 14.09 12.5301 0 0 0 14.2758 0 14.0837 0 0 Q96K80 ZC3HA_HUMAN Zinc finger CCCH domain-containing protein 10 ZC3H10 ZC3HDC10 Homo sapiens (Human) "negative regulation of miRNA maturation [GO:1903799]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of miRNA maturation [GO:1903799]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" GO:0000381; GO:0003723; GO:0005654; GO:0005737; GO:0010608; GO:0035198; GO:0046872; GO:1903799 metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] KTGELPPRLR 0.9882 -4.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7M1 AGRD2_HUMAN Adhesion G-protein coupled receptor D2 (G-protein coupled receptor 144) (G-protein coupled receptor PGR24) ADGRD2 GPR144 PGR24 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] HPLKAPA 0.98822 -1.932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7453 0 0 0 17.7883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KQV3 ZN792_HUMAN Zinc finger protein 792 ZNF792 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LFSQSSSLNSHRRLHTGER 0.98823 -4.1829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JU00 DRC5_HUMAN "Dynein regulatory complex subunit 5 (T-complex-associated testis-expressed protein 1, Tcte-1)" TCTE1 DRC5 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018] GO:0005737; GO:0005856; GO:0007018; GO:0030317; GO:0036126 DCGMNFEWNLFLFTYR 0.98823 -1.9336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43396 TXNL1_HUMAN Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) TXNL1 TRP32 TXL TXNL Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; thioredoxin-disulfide reductase activity [GO:0004791] GO:0000502; GO:0004791; GO:0005634; GO:0005737; GO:0005829; GO:0015036 disulfide oxidoreductase activity [GO:0015036]; thioredoxin-disulfide reductase activity [GO:0004791] AGCECLNESDEHGFDNCLR 0.98824 -1.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6915 0 0 0 0 0 0 0 12.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0295 0 0 0 0 0 15.839 0 0 13.8067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWB6 TEX14_HUMAN Inactive serine/threonine-protein kinase TEX14 (Protein kinase-like protein SgK307) (Sugen kinase 307) (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein) TEX14 SGK307 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; midbody [GO:0030496]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; intercellular bridge organization [GO:0043063]; male meiotic nuclear division [GO:0007140]; mitotic sister chromatid separation [GO:0051306]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; protein phosphorylation [GO:0006468] GO:0000776; GO:0004672; GO:0005524; GO:0005737; GO:0006468; GO:0007094; GO:0007140; GO:0008608; GO:0019901; GO:0030496; GO:0032091; GO:0032466; GO:0043063; GO:0045171; GO:0051301; GO:0051306; GO:0070062; GO:1990830 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901] DSLETSR 0.98824 -1.9503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0635 15.5543 0 0 0 0 14.8918 12.6291 0 0 0 0 12.6983 12.9254 12.5924 0 0 0 0 0 13.073 0 0 0 16.1128 0 0 0 0 0 0 13.1566 0 12.1065 12.801 0 12.153 12.3771 0 0 12.9767 0 0 12.3302 0 13.6756 0 0 14.3159 0 13.6475 0 13.9079 13.3323 13.9264 0 13.8984 0 0 14.9383 0 0 0 14.212 0 13.7756 0 0 0 12.6057 0 0 14.1388 0 0 0 0 0 0 0 0 0 0 0 13.1938 11.9499 0 0 0 0 0 0 0 0 0 0 0 0 12.8362 13.4818 0 0 0 0 0 0 16.366 13.618 13.9874 0 0 0 0 0 Q8IXJ6 SIR2_HUMAN "NAD-dependent protein deacetylase sirtuin-2, EC 2.3.1.286 (NAD-dependent protein defatty-acylase sirtuin-2, EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2)" SIRT2 SIR2L SIR2L2 Homo sapiens (Human) "autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; mitotic nuclear membrane reassembly [GO:0007084]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; NLRP3 inflammasome complex assembly [GO:0044546]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; subtelomeric heterochromatin assembly [GO:0031509]; tubulin deacetylation [GO:0090042]" "centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]" "centriole [GO:0005814]; centrosome [GO:0005813]; chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular lipid catabolic process [GO:0044242]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to oxidative stress [GO:0034599]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; innate immune response [GO:0045087]; meiotic cell cycle [GO:0051321]; mitotic nuclear membrane reassembly [GO:0007084]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; negative regulation of transcription, DNA-templated [GO:0045892]; NLRP3 inflammasome complex assembly [GO:0044546]; peptidyl-lysine deacetylation [GO:0034983]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein kinase B signaling [GO:0043491]; rDNA heterochromatin assembly [GO:0000183]; regulation of cell cycle [GO:0051726]; regulation of exit from mitosis [GO:0007096]; regulation of myelination [GO:0031641]; regulation of phosphorylation [GO:0042325]; response to redox state [GO:0051775]; substantia nigra development [GO:0021762]; subtelomeric heterochromatin assembly [GO:0031509]; tubulin deacetylation [GO:0090042]" GO:0000122; GO:0000183; GO:0000781; GO:0000792; GO:0003682; GO:0003950; GO:0004407; GO:0005634; GO:0005677; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006471; GO:0006476; GO:0006914; GO:0007084; GO:0007096; GO:0008270; GO:0008285; GO:0010507; GO:0010801; GO:0014065; GO:0016575; GO:0017136; GO:0021762; GO:0022011; GO:0030426; GO:0030496; GO:0031507; GO:0031509; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0035035; GO:0035729; GO:0042177; GO:0042325; GO:0042826; GO:0042903; GO:0043130; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0043491; GO:0044224; GO:0044242; GO:0044546; GO:0045087; GO:0045599; GO:0045836; GO:0045843; GO:0045892; GO:0045944; GO:0046970; GO:0048012; GO:0048471; GO:0051301; GO:0051321; GO:0051726; GO:0051775; GO:0051781; GO:0051987; GO:0061428; GO:0061433; GO:0070403; GO:0070446; GO:0070932; GO:0070933; GO:0071219; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140297; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:1900226; GO:1900425; GO:2000378; GO:2000777 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] APLSTPR 0.98824 -1.9529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0568 0 0 0 0 0 0 11.8461 0 0 0 0 0 0 0 0 10.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3337 0 0 0 0 14.6188 0 14.1294 0 0 0 0 0 0 0 0 12.4324 0 0 0 0 0 0 0 10.9928 0 0 0 0 0 0 0 0 0 0 14.0511 0 0 0 0 0 11.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4973 0 14.7862 0 0 14.9372 0 10.8748 0 0 0 14.4159 0 0 0 0 0 0 0 0 0 0 0 13.9036 0 0 13.9388 0 0 0 13.6702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JB3 HIC2_HUMAN "Hypermethylated in cancer 2 protein, Hic-2 (HIC1-related gene on chromosome 22 protein) (Hic-3) (Zinc finger and BTB domain-containing protein 30)" HIC2 HRG22 KIAA1020 ZBTB30 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0008022; GO:0045892; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GDMGPDMELPSHSK 0.98824 -1.9522 11.3971 0 0 0 0 0 0 0 0 0 12.225 0 13.289 11.5329 12.1357 0 0 0 0 12.2625 0 0 0 0 13.4947 11.8711 11.9941 0 0 0 12.9789 0 11.4674 0 0 0 0 0 0 0 0 11.968 0 0 0 11.5062 0 0 12.5202 13.0331 0 0 0 0 0 0 15.8055 0 15.1215 0 13.4299 0 0 13.8891 13.4942 0 0 0 0 0 0 0 0 0 12.5456 0 0 0 13.3784 0 13.3207 14.0152 0 14.7461 0 0 15.0019 0 15.3551 14.4274 15.8037 14.7862 0 14.5731 13.4853 14.0493 0 15.4201 14.3391 14.7422 14.8612 14.6686 0 0 0 15.4573 14.5425 15.1618 15.7345 13.8098 15.1826 0 13.8548 0 13.5788 0 13.5942 13.7744 0 14.7115 14.5181 15.2087 15.1777 15.5916 15.621 15.5726 13.8995 0 15.2628 13.0801 15.4735 13.4742 13.7039 0 13.6844 14.9685 14.8829 13.1749 15.9524 14.7613 14.7256 15.1202 14.868 15.7157 15.0997 0 14.6903 0 0 0 13.2186 0 14.7122 13.924 13.9108 13.877 0 14.338 14.5186 13.5595 14.1827 14.2505 14.2606 14.4115 18.0879 14.4081 18.1206 18.1427 0 0 14.0312 15.3788 0 0 0 0 0 18.2868 0 0 P59666 DEF3_HUMAN "Neutrophil defensin 3 (Defensin, alpha 3) (HNP-3, HP-3, HP3) [Cleaved into: HP 3-56; Neutrophil defensin 2 (HNP-2, HP-2, HP2) ]" DEFA3 DEF3 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; intracellular estrogen receptor signaling pathway [GO:0030520]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; protein homodimerization activity [GO:0042803]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; innate immune response in mucosa [GO:0002227]; intracellular estrogen receptor signaling pathway [GO:0030520]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673] GO:0002227; GO:0005576; GO:0005615; GO:0005796; GO:0019731; GO:0030520; GO:0031640; GO:0035578; GO:0042803; GO:0050829; GO:0050830; GO:0050832; GO:0051607; GO:0051673; GO:0061844; GO:0070062; GO:0071222 protein homodimerization activity [GO:0042803] NMDCYCR 0.98825 -4.2093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8941 0 0 14.0363 12.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5003 0 0 11.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3333 0 0 0 0 12.0418 0 0 0 0 0 0 0 0 0 0 11.7328 0 12.506 0 0 0 0 0 0 0 0 0 0 11.3932 0 0 0 0 0 13.0379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4926 12.1238 0 0 0 0 0 0 13.2556 0 0 11.8473 0 O43189 PHF1_HUMAN "PHD finger protein 1, Protein PHF1, hPHF1 (Polycomb-like protein 1, hPCl1)" PHF1 PCL1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription corepressor binding [GO:0001222]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0006325; GO:0006355; GO:0006974; GO:0035064; GO:0035861; GO:0042802; GO:0046872; GO:0061086; GO:0061087; GO:1990226 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription corepressor binding [GO:0001222] FYEFECCVCR 0.98826 -4.0881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.798 P10124 SRGN_HUMAN "Serglycin (Hematopoietic proteoglycan core protein) (Platelet proteoglycan core protein, P.PG) (Secretory granule proteoglycan core protein)" SRGN PRG PRG1 Homo sapiens (Human) apoptotic process [GO:0006915]; biomineral tissue development [GO:0031214]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; maintenance of granzyme B location in T cell secretory granule [GO:0033382]; maintenance of protease location in mast cell secretory granule [GO:0033373]; mast cell secretory granule organization [GO:0033364]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine production [GO:0001818]; protein processing [GO:0016485]; secretory granule organization [GO:0033363]; T cell secretory granule organization [GO:0033371] cytolytic granule [GO:0044194]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mast cell granule [GO:0042629]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141] cytolytic granule [GO:0044194]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mast cell granule [GO:0042629]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]; apoptotic process [GO:0006915]; biomineral tissue development [GO:0031214]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; maintenance of granzyme B location in T cell secretory granule [GO:0033382]; maintenance of protease location in mast cell secretory granule [GO:0033373]; mast cell secretory granule organization [GO:0033364]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine production [GO:0001818]; protein processing [GO:0016485]; secretory granule organization [GO:0033363]; T cell secretory granule organization [GO:0033371] GO:0001818; GO:0005576; GO:0005615; GO:0005794; GO:0006915; GO:0016485; GO:0030141; GO:0030502; GO:0031093; GO:0031214; GO:0033363; GO:0033364; GO:0033371; GO:0033373; GO:0033382; GO:0042629; GO:0044194; GO:0140507 LVLALALILVLESSVQGYPTRR 0.98827 -4.1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3337 0 0 0 0 0 0 0 0 11.1278 0 0 11.1398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBR4 LHX3_HUMAN "LIM/homeobox protein Lhx3, LIM homeobox protein 3" LHX3 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; inner ear development [GO:0048839]; lung development [GO:0030324]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prolactin secreting cell differentiation [GO:0060127]; regulation of transcription by RNA polymerase II [GO:0006357]; somatotropin secreting cell differentiation [GO:0060126]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron cell fate specification [GO:0021520]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; ventral spinal cord interneuron specification [GO:0021521]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; inner ear development [GO:0048839]; lung development [GO:0030324]; medial motor column neuron differentiation [GO:0021526]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prolactin secreting cell differentiation [GO:0060127]; regulation of transcription by RNA polymerase II [GO:0006357]; somatotropin secreting cell differentiation [GO:0060126]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron cell fate specification [GO:0021520]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; ventral spinal cord interneuron specification [GO:0021521]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001890; GO:0005634; GO:0005667; GO:0006357; GO:0006915; GO:0008045; GO:0009887; GO:0021520; GO:0021521; GO:0021526; GO:0021527; GO:0030182; GO:0030324; GO:0043066; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0048839; GO:0060126; GO:0060127; GO:0060129; GO:0061629 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]" HWHSKCLK 0.98827 -4.1059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1909 0 0 0 0 0 0 0 0 0 10.5649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3336 0 15.9594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4N8 P4HA3_HUMAN "Prolyl 4-hydroxylase subunit alpha-3, 4-PH alpha-3, EC 1.14.11.2 (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3)" P4HA3 UNQ711/PRO1374 Homo sapiens (Human) peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401] GO:0004656; GO:0005506; GO:0005783; GO:0005788; GO:0018401; GO:0031418 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656] ALAPERRLLGLLR 0.98828 -4.0187 0 0 0 0 0 0 0 0 0 11.4559 0 0 0 0 0 0 0 0 10.2674 0 0 0 0 0 0 0 0 0 10.3008 0 0 0 12.0238 0 0 0 0 0 10.7845 11.5398 0 0 12.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2664 0 0 0 0 0 0 0 0 13.2188 0 0 12.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2456 12.2587 0 0 0 0 0 0 0 0 0 12.8348 16.9125 0 0 0 0 0 13.6434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.445 0 0 0 11.8578 0 12.5475 11.6334 0 0 0 15.6879 0 0 0 13.0384 0 13.0265 0 0 0 0 0 0 0 0 12.6193 13.6566 14.5424 14.4153 13.8557 14.8163 0 13.7664 0 0 0 0 0 0 0 0 0 12.9827 0 0 0 0 0 0 Q96SK2 TM209_HUMAN Transmembrane protein 209 TMEM209 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 APLIPTLNTIVQYLDLTPNQEYLFER 0.98828 -4.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13304 GPR17_HUMAN "Uracil nucleotide/cysteinyl leukotriene receptor, UDP/CysLT receptor (G-protein coupled receptor 17) (P2Y-like receptor) (R12)" GPR17 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930]; receptor serine/threonine kinase binding [GO:0033612]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0002862; GO:0004930; GO:0004950; GO:0005886; GO:0005887; GO:0007186; GO:0033612; GO:0035025; GO:0048709; GO:0051482 chemokine receptor activity [GO:0004950]; G protein-coupled receptor activity [GO:0004930]; receptor serine/threonine kinase binding [GO:0033612] SHGASCATQRILALANR 0.98829 -4.1317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SP6 GP149_HUMAN Probable G-protein coupled receptor 149 (G-protein coupled receptor PGR10) GPR149 PGR10 Homo sapiens (Human) antral ovarian follicle growth [GO:0001547]; negative regulation of ovulation [GO:0060280]; neuropeptide signaling pathway [GO:0007218]; preantral ovarian follicle growth [GO:0001546] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; antral ovarian follicle growth [GO:0001547]; negative regulation of ovulation [GO:0060280]; neuropeptide signaling pathway [GO:0007218]; preantral ovarian follicle growth [GO:0001546] GO:0001546; GO:0001547; GO:0004930; GO:0005887; GO:0007218; GO:0042277; GO:0042923; GO:0043005; GO:0060280 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277] ATLLVSYNFYTMHR 0.98829 -4.1333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7366 15.927 0 0 0 0 0 0 0 0 14.2105 14.8338 14.5448 0 0 0 14.3304 16.3344 0 0 0 13.169 0 0 14.663 12.4794 0 13.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1016 0 0 0 0 0 0 0 0 0 13.6773 0 0 0 0 0 0 0 0 0 0 0 13.9777 0 0 0 14.15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4832 Q8N1C3 GBRG1_HUMAN Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) GABRG1 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050811; GO:0050877; GO:0051932; GO:0060078; GO:0070161; GO:0098794; GO:1902476; GO:1902711; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] DCASFFCCFEDCR 0.9883 -4.0447 13.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6177 0 0 0 0 11.8155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8806 0 0 0 0 0 0 0 0 0 12.2894 0 0 0 0 0 0 0 12.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95236 APOL3_HUMAN "Apolipoprotein L3 (Apolipoprotein L-III, ApoL-III) (TNF-inducible protein CG12-1, CG12_1)" APOL3 Homo sapiens (Human) inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; inflammatory response [GO:0006954]; lipoprotein metabolic process [GO:0042157]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005319; GO:0005576; GO:0005737; GO:0006954; GO:0008289; GO:0016020; GO:0042157; GO:0043123 lipid binding [GO:0008289]; lipid transporter activity [GO:0005319] AIRQARAR 0.98831 -1.7372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5006 17.7361 0 0 14.0555 14.3665 0 14.4754 14.4696 0 0 0 14.7478 0 0 0 14.908 14.1752 0 14.5053 14.2534 14.2345 0 0 0 0 0 14.3036 13.1858 14.3471 14.889 0 13.9117 0 13.8313 0 14.4184 14.3154 14.5837 14.3912 14.6869 0 15.2215 15.1676 0 13.8833 14.3836 0 13.7975 15.1345 13.8035 14.1546 0 15.2605 13.3274 0 0 0 0 15.3472 0 13.5511 14.6282 14.4328 0 0 0 0 0 0 0 0 13.8887 0 0 19.1337 14.0828 0 0 0 0 0 0 0 0 0 13.8522 0 0 0 0 0 0 0 0 14.514 0 0 0 0 0 0 Q3ZCU0 GVQW3_HUMAN Protein GVQW3 (GVQW motif-containing protein 3) GVQW3 Homo sapiens (Human) DLVCSNR 0.98831 -4.0479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYR2 SMYD4_HUMAN "SET and MYND domain-containing protein 4, EC 2.1.1.-" SMYD4 KIAA1936 Homo sapiens (Human) heart development [GO:0007507]; methylation [GO:0032259] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; heart development [GO:0007507]; methylation [GO:0032259] GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0032259; GO:0042826; GO:0046872 histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168] DSDAPLFYREEGNKK 0.98831 -4.1719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.537 0 12.7442 0 0 14.875 0 0 0 0 0 0 0 0 0 13.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5875 0 0 0 0 0 0 0 0 0 0 0 12.4521 0 0 0 0 0 0 14.2933 0 0 10.7974 0 0 0 0 15.2191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6518 0 0 0 0 0 P20592 MX2_HUMAN Interferon-induced GTP-binding protein Mx2 (Interferon-regulated resistance GTP-binding protein MxB) (Myxovirus resistance protein 2) (p78-related protein) MX2 Homo sapiens (Human) defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear pore [GO:0005643]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615] GO:0003924; GO:0005525; GO:0005634; GO:0005643; GO:0005737; GO:0005829; GO:0005874; GO:0006952; GO:0008017; GO:0009615; GO:0015031; GO:0016020; GO:0035455; GO:0045087; GO:0046822; GO:0051028; GO:0051607; GO:0051726 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017] CRGQQEITNR 0.98832 -4.1791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6953 0 0 12.0254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3145 0 0 0 0 0 0 0 0 0 Q96GC9 VMP1_HUMAN Vacuole membrane protein 1 (Transmembrane protein 49) VMP1 TDC1 TMEM49 HSPC292 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; autophagy [GO:0006914]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; embryo implantation [GO:0007566]; Golgi organization [GO:0007030]; lipoprotein transport [GO:0042953]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; organelle localization by membrane tethering [GO:0140056]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896] autophagosome membrane [GO:0000421]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; phagophore assembly site [GO:0000407]; plasma membrane [GO:0005886] autophagosome membrane [GO:0000421]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; phagophore assembly site [GO:0000407]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; autophagy [GO:0006914]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; embryo implantation [GO:0007566]; Golgi organization [GO:0007030]; lipoprotein transport [GO:0042953]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; organelle localization by membrane tethering [GO:0140056]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896] GO:0000045; GO:0000407; GO:0000421; GO:0005730; GO:0005783; GO:0005789; GO:0005886; GO:0006914; GO:0007030; GO:0007566; GO:0012505; GO:0016020; GO:0016021; GO:0016240; GO:0017128; GO:0033116; GO:0034329; GO:0042953; GO:0098609; GO:0140056; GO:1901896; GO:1990456 phospholipid scramblase activity [GO:0017128] AIIKMHIQK 0.98832 -4.1864 0 0 0 0 0 0 0 9.97714 0 0 0 0 0 0 0 0 0 0 0 0 11.6598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0596 0 0 0 0 0 0 0 11.3166 0 0 0 0 0 0 0 0 11.507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0596 11.4666 0 0 0 0 0 12.6057 14.8021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8393 0 13.0935 0 0 0 0 0 0 0 0 0 0 P43355 MAGA1_HUMAN "Melanoma-associated antigen 1 (Antigen MZ2-E) (Cancer/testis antigen 1.1, CT1.1) (MAGE-1 antigen)" MAGEA1 MAGE1 MAGE1A Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; histone deacetylase binding [GO:0042826]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005737; GO:0005886; GO:0042826; GO:0045746 histone deacetylase binding [GO:0042826] AEMLESVIK 0.98833 -1.9318 0 0 0 0 0 14.3335 0 0 0 12.7102 0 0 0 0 0 0 0 12.8744 0 0 0 0 0 0 0 15.0229 0 0 13.4839 0 0 0 13.9913 0 0 0 12.6505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9931 0 0 0 0 0 0 15.1959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5337 0 0 0 0 0 0 0 10.7473 0 0 0 0 11.358 0 0 0 0 0 0 16.3209 13.2769 0 0 0 11.9533 0 0 0 0 0 11.2708 15.3693 0 0 0 0 0 0 0 0 0 11.671 12.9636 0 12.5362 0 0 0 12.2577 0 12.1141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2907 0 0 0 11.0341 0 Q6UDR6 SPIT4_HUMAN Kunitz-type protease inhibitor 4 SPINT4 C20orf137 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576 serine-type endopeptidase inhibitor activity [GO:0004867] CETFVFSGCNGNLNNFK 0.98833 -1.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5129 0 0 0 0 0 0 0 0 0 12.9702 0 0 0 0 0 0 0 0 13.2085 0 0 0 12.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2734 0 0 0 0 0 0 12.5584 0 0 0 0 0 Q13702 RAPSN_HUMAN "43 kDa receptor-associated protein of the synapse, RAPsyn (43 kDa postsynaptic protein) (Acetylcholine receptor-associated 43 kDa protein) (RING finger protein 205)" RAPSN RNF205 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; establishment of protein localization to postsynaptic membrane [GO:1903540]; motor neuron apoptotic process [GO:0097049]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; regulation of postsynaptic membrane organization [GO:1901626]; synaptic transmission, cholinergic [GO:0007271]" anchoring junction [GO:0070161]; centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634] "anchoring junction [GO:0070161]; centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; acetylcholine receptor binding [GO:0033130]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; protein-membrane adaptor activity [GO:0043495]; chemical synaptic transmission [GO:0007268]; establishment of protein localization to postsynaptic membrane [GO:1903540]; motor neuron apoptotic process [GO:0097049]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; regulation of postsynaptic membrane organization [GO:1901626]; synaptic transmission, cholinergic [GO:0007271]" GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0007268; GO:0007271; GO:0031594; GO:0033130; GO:0035255; GO:0043495; GO:0046872; GO:0070161; GO:0097049; GO:0099634; GO:1900075; GO:1901626; GO:1903540; GO:2000673 acetylcholine receptor binding [GO:0033130]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; protein-membrane adaptor activity [GO:0043495] ALESFEK 0.98834 -1.9325 0 0 0 0 0 9.58457 0 0 0 0 0 0 0 0 0 0 0 0 13.0819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5895 0 0 0 0 0 0 0 0 0 0 0 11.2226 0 0 0 0 0 0 0 11.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5491 0 0 0 0 0 0 0 0 0 0 0 11.9115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96015 DNAL4_HUMAN Dynein axonemal light chain 4 DNAL4 Homo sapiens (Human) microtubule-based movement [GO:0007018] cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886] cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] GO:0003777; GO:0005737; GO:0005874; GO:0005886; GO:0005929; GO:0007018; GO:0030286; GO:0042802 identical protein binding [GO:0042802]; microtubule motor activity [GO:0003777] LQTFPLVR 0.98835 -1.9499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35237 SPB6_HUMAN "Serpin B6 (Cytoplasmic antiproteinase, CAP) (Peptidase inhibitor 6, PI-6) (Placental thrombin inhibitor)" SERPINB6 PI6 PTI Homo sapiens (Human) cellular response to osmotic stress [GO:0071470]; negative regulation of endopeptidase activity [GO:0010951]; sensory perception of sound [GO:0007605] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine protease inhibitor complex [GO:0097180]; tertiary granule membrane [GO:0070821] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine protease inhibitor complex [GO:0097180]; tertiary granule membrane [GO:0070821]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cellular response to osmotic stress [GO:0071470]; negative regulation of endopeptidase activity [GO:0010951]; sensory perception of sound [GO:0007605] GO:0002020; GO:0004867; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007605; GO:0010951; GO:0030667; GO:0062023; GO:0070062; GO:0070821; GO:0071470; GO:0097180; GO:0101003 protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] ENTEERLFK 0.98835 -4.0872 0 0 0 0 0 0 13.975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5465 0 12.9353 13.1316 0 0 0 0 0 0 0 0 0 0 16.1213 0 18.9695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80024 0 18.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49720 PSB3_HUMAN Proteasome subunit beta type-3 (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain) PSMB3 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0043161; GO:0070062 DAVSGMGVIVHIIEK 0.98835 -4.0829 0 0 0 0 0 0 0 0 0 0 13.7905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0185 0 0 0 0 0 0 0 0 0 0 0 P63124 VPK04_HUMAN "Endogenous retrovirus group K member 104 Pro protein (HERV-K104 Pro protein) (HERV-K_5q13.3 provirus ancestral Pro protein, EC 3.4.23.50) (Protease) (Proteinase, PR)" HERV-K104 Homo sapiens (Human) proteolysis [GO:0006508] aspartic-type endopeptidase activity [GO:0004190]; nucleic acid binding [GO:0003676]; proteolysis [GO:0006508] GO:0003676; GO:0004190; GO:0006508 aspartic-type endopeptidase activity [GO:0004190]; nucleic acid binding [GO:0003676] MGYIPGK 0.98835 -4.0854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3103 0 0 0 0 0 0 17.6152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14593 ZN273_HUMAN Zinc finger protein 273 (Zinc finger protein HZF9) ZNF273 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSTLTEHK 0.98836 -4.101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8676 0 0 0 0 0 13.8478 12.7297 11.1515 0 12.6788 0 0 0 0 0 0 0 0 0 13.34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8793 0 0 0 10.5392 0 0 0 0 0 13.2403 13.8667 13.0271 0 12.8325 0 0 0 13.0141 0 13.1788 14.7149 14.0444 13.1057 13.7438 15.5302 0 12.6472 0 0 0 0 14.0298 13.7718 0 13.405 0 0 0 0 0 11.3683 0 13.1798 0 14.217 14.9076 0 0 13.9721 13.7408 0 13.6518 14.1799 13.6391 0 0 14.579 0 0 0 14.1227 0 0 0 0 13.3576 0 0 13.8927 14.0546 14.0265 0 0 0 0 0 0 14.7448 0 14.9809 14.1987 0 0 0 14.7972 0 13.1826 0 15.6487 0 0 0 0 0 14.3601 0 0 13.5772 14.2625 0 0 0 0 0 0 0 0 0 13.525 0 0 0 0 0 14.2718 0 0 0 0 0 0 0 0 Q10981 FUT2_HUMAN "Galactoside alpha-(1,2)-fucosyltransferase 2 (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (SE2) (Secretor blood group alpha-2-fucosyltransferase) (Secretor factor, Se) (Type 1 galactoside alpha-(1,2)-fucosyltransferase FUT2, EC 2.4.1.69) (Type 2 galactoside alpha-(1,2)-fucosyltransferase FUT2, EC 2.4.1.344)" FUT2 SEC2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; glycolipid metabolic process [GO:0006664]; L-fucose catabolic process [GO:0042355]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; regulation of cell adhesion [GO:0030155]; regulation of endothelial cell proliferation [GO:0001936] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-(1,2)-fucosyltransferase activity [GO:0031127]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; glycolipid metabolic process [GO:0006664]; L-fucose catabolic process [GO:0042355]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; regulation of cell adhesion [GO:0030155]; regulation of endothelial cell proliferation [GO:0001936]" GO:0000139; GO:0001936; GO:0005794; GO:0005975; GO:0006486; GO:0006664; GO:0008107; GO:0008417; GO:0009312; GO:0016021; GO:0030155; GO:0031127; GO:0032580; GO:0036065; GO:0042355; GO:0070062 "alpha-(1,2)-fucosyltransferase activity [GO:0031127]; fucosyltransferase activity [GO:0008417]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]" YLQQALDWFR 0.98838 -1.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16637 SMN_HUMAN Survival motor neuron protein (Component of gems 1) (Gemin-1) SMN1 SMN SMNT; SMN2 SMNC Homo sapiens (Human) "DNA-templated transcription, termination [GO:0006353]; nervous system development [GO:0007399]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018] "axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; DNA-templated transcription, termination [GO:0006353]; nervous system development [GO:0007399]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" GO:0000245; GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006353; GO:0007399; GO:0015030; GO:0016604; GO:0030018; GO:0030424; GO:0032797; GO:0034719; GO:0036464; GO:0042802; GO:0043005; GO:0043204; GO:0097504 identical protein binding [GO:0042802]; RNA binding [GO:0003723] NGDICETSGK 0.98838 -1.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N130 NPT2C_HUMAN "Sodium-dependent phosphate transport protein 2C, Sodium-phosphate transport protein 2C (Na(+)-dependent phosphate cotransporter 2C) (Sodium/inorganic phosphate cotransporter IIC) (Sodium/phosphate cotransporter 2C, Na(+)/Pi cotransporter 2C, NaPi-2c) (Solute carrier family 34 member 3)" SLC34A3 NPT2C NPTIIC Homo sapiens (Human) cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]; sodium-dependent phosphate transport [GO:0044341] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium ion transport [GO:0006814]; sodium-dependent phosphate transport [GO:0044341] GO:0005436; GO:0005886; GO:0005903; GO:0006814; GO:0006817; GO:0016021; GO:0016324; GO:0030643; GO:0031526; GO:0031982; GO:0044341 sodium:phosphate symporter activity [GO:0005436] AQAPDILK 0.98838 -4.0208 0 0 0 0 0 0 0 0 0 11.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1657 0 0 0 0 12.8156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3141 0 0 0 0 0 0 0 0 0 O95497 VNN1_HUMAN "Pantetheinase, EC 3.5.1.92 (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1, Vanin-1)" VNN1 Homo sapiens (Human) acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979] anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pantetheine hydrolase activity [GO:0017159]; acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979] GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015939; GO:0016021; GO:0017159; GO:0031225; GO:0033089; GO:0035577; GO:0045087; GO:0098609; GO:1902177 pantetheine hydrolase activity [GO:0017159] DLCCHLSYK 0.98839 -4.1408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5226 0 0 0 0 0 14.3476 0 0 0 0 0 0 14.1635 0 0 0 0 0 0 0 0 0 13.2725 0 13.8592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13425 SNTB2_HUMAN "Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3, SNT3) (Syntrophin-like, SNTL)" SNTB2 D16S2531E SNT2B2 SNTL Homo sapiens (Human) cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] GO:0003723; GO:0003779; GO:0005198; GO:0005516; GO:0005654; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0005925; GO:0016010; GO:0016020; GO:0030658; GO:0032991; GO:0045202 actin binding [GO:0003779]; calmodulin binding [GO:0005516]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] EVSLGCMLNGQEVR 0.98839 -4.1489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3156 0 0 0 0 0 0 0 Q9H8S5 CCNP_HUMAN Cyclin-P (Cyclin N-terminal domain-containing protein 2) CCNP CNTD2 Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0016538; GO:0044772; GO:0097124 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] AELLRAER 0.98839 -4.1475 0 0 0 0 0 0 0 0 10.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0462 0 12.3866 0 0 0 0 0 11.5763 13.2345 0 0 0 0 0 0 0 0 0 0 0 0 12.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P45379 TNNT2_HUMAN "Troponin T, cardiac muscle, TnTc (Cardiac muscle troponin T, cTnT)" TNNT2 Homo sapiens (Human) actin crosslink formation [GO:0051764]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of ATP-dependent activity [GO:0032780]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of heart contraction [GO:0008016]; regulation of muscle filament sliding speed [GO:0032972]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cardiac myofibril [GO:0097512]; cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861] cardiac myofibril [GO:0097512]; cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; troponin complex [GO:0005861]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; tropomyosin binding [GO:0005523]; troponin C binding [GO:0030172]; troponin I binding [GO:0031013]; actin crosslink formation [GO:0051764]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; negative regulation of ATP-dependent activity [GO:0032780]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of heart contraction [GO:0008016]; regulation of muscle filament sliding speed [GO:0032972]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0003779; GO:0005523; GO:0005829; GO:0005861; GO:0005865; GO:0006936; GO:0008016; GO:0030017; GO:0030049; GO:0030172; GO:0030674; GO:0031013; GO:0032780; GO:0032781; GO:0032972; GO:0042802; GO:0044877; GO:0045214; GO:0051592; GO:0051764; GO:0055010; GO:0060048; GO:0097512; GO:1990584 actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; tropomyosin binding [GO:0005523]; troponin C binding [GO:0030172]; troponin I binding [GO:0031013] AEEDEEEEEAKEAEDGPMEESK 0.9884 -4.0465 0 0 0 0 0 0 0 10.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.661 0 0 0 0 0 0 0 0 0 13.343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0043 15.0885 0 0 0 0 0 0 0 0 0 0 0 0 13.0225 13.6713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RG1 KCD19_HUMAN BTB/POZ domain-containing protein KCTD19 KCTD19 Homo sapiens (Human) protein homooligomerization [GO:0051260] protein homooligomerization [GO:0051260] GO:0051260 AITAKVVSLANRLWTLHISPK 0.9884 -4.1701 0 0 0 0 0 0 0 0 11.135 0 0 0 14.5747 15.1104 0 0 0 0 16.9607 0 14.7038 0 0 0 0 0 0 0 0 0 10.9824 0 0 0 0 0 0 0 0 16.1978 0 0 0 0 0 10.6361 0 17.1535 0 14.2832 0 0 0 17.7743 17.4414 17.0199 0 0 0 0 0 0 0 14.8866 15.0511 0 11.1828 0 0 0 0 13.5701 0 0 0 0 0 0 0 17.2274 0 0 0 0 11.0801 0 0 0 0 0 0 0 0 0 11.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4731 17.0316 0 0 0 0 0 0 0 0 16.443 0 0 0 0 0 0 0 0 10.5654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7528 0 0 0 13.9044 0 10.2434 0 0 0 0 0 0 0 0 10.7288 10.7566 0 0 0 0 Q643R3 LPCT4_HUMAN "Lysophospholipid acyltransferase LPCAT4 (1-acylglycerol-3-phosphate O-acyltransferase 7, 1-AGP acyltransferase 7, 1-AGPAT 7) (1-acylglycerophosphocholine O-acyltransferase, EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase, EC 2.3.1.n6) (1-alkenylglycerophosphoethanolamine O-acyltransferase, EC 2.3.1.121) (1-alkylglycerophosphocholine O-acetyltransferase, EC 2.3.1.67) (Acyltransferase-like 3) (Lysophosphatidylcholine acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase 2, EC 2.3.1.n7) (Plasmalogen synthase)" LPCAT4 AGPAT7 AYTL3 LPEAT2 Homo sapiens (Human) phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 1-alkenylglycerophosphoethanolamine O-acyltransferase activity [GO:0047166]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644] GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047166; GO:0047184; GO:0047192; GO:0071617; GO:0106262; GO:0106263 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 1-alkenylglycerophosphoethanolamine O-acyltransferase activity [GO:0047166]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617] KALLKFK 0.9884 -4.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2218 0 0 0 0 0 0 10.1032 0 0 0 0 0 0 0 12.9285 0 0 0 0 0 0 0 0 12.1395 0 0 0 0 13.6769 0 13.8165 0 13.1276 12.4679 0 0 0 0 0 0 0 0 0 0 13.5406 0 0 0 0 0 0 12.0746 13.4946 0 0 12.8825 13.0081 0 0 0 0 0 0 0 0 0 0 0 0 9.22388 0 12.5157 13.5595 0 0 0 0 0 0 0 12.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0305 0 0 0 0 0 0 0 11.2691 0 0 0 11.1775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11309 PIM1_HUMAN "Serine/threonine-protein kinase pim-1, EC 2.7.11.1" PIM1 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular detoxification [GO:1990748]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cellular detoxification [GO:1990748]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561]" GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0008134; GO:0022898; GO:0030145; GO:0043024; GO:0043066; GO:0043433; GO:0043539; GO:0045737; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:0071902; GO:0090336; GO:0106310; GO:1902033; GO:1905062; GO:1990748 ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134] HCHNCGVLHR 0.98841 -4.1785 0 0 0 0 0 0 0 0 0 11.0699 0 12.9778 0 0 0 0 0 13.4238 0 0 0 0 0 0 0 0 11.6481 0 0 0 0 12.7087 0 0 0 0 0 0 0 11.9558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8345 0 12.2068 0 0 0 0 0 0 0 0 0 0 12.0116 0 0 0 0 15.9815 0 14.3571 0 15.459 0 15.8751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7744 0 0 15.8291 15.7344 0 0 0 15.7206 15.1354 15.4632 0 15.7973 15.4449 0 0 15.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4148 0 0 0 0 0 0 15.182 0 0 0 0 0 0 0 Q96EE4 CC126_HUMAN Coiled-coil domain-containing protein 126 CCDC126 UNQ786/PRO1605 Homo sapiens (Human) extracellular region [GO:0005576]; membrane [GO:0016020] extracellular region [GO:0005576]; membrane [GO:0016020] GO:0005576; GO:0016020 FFTISRK 0.98841 -1.7211 0 12.5891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMV7 LEKR1_HUMAN Protein LEKR1 LEKR1 Homo sapiens (Human) QSYIFRLCFC 0.98842 -1.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4333 0 0 0 0 0 0 0 0 0 Q96B02 UBE2W_HUMAN "Ubiquitin-conjugating enzyme E2 W, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme, EC 2.3.2.25) (N-terminus-conjugating E2) (Ubiquitin carrier protein W) (Ubiquitin-conjugating enzyme 16, UBC-16) (Ubiquitin-protein ligase W)" UBE2W UBC16 Homo sapiens (Human) cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006513; GO:0006515; GO:0031625; GO:0043161; GO:0061631; GO:0070979; GO:0071218 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] TKWWYHDDTC 0.98842 -1.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP66 HM20A_HUMAN High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1) HMG20A HMGX1 HMGXB1 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0010468; GO:0033234; GO:0042802; GO:0045665 DNA binding [GO:0003677]; identical protein binding [GO:0042802] YMKELEQYQK 0.98842 -1.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2459 0 0 0 11.7711 0 0 0 0 0 0 0 Q13202 DUS8_HUMAN "Dual specificity protein phosphatase 8, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase hVH-5)" DUSP8 C11orf81 VH5 Homo sapiens (Human) dephosphorylation [GO:0016311]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0008330; GO:0016311; GO:0016791; GO:0017017; GO:0017018; GO:0043409 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] KLASLLR 0.98843 -1.7369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9733 0 0 11.7786 0 0 12.2511 12.4734 0 0 0 0 0 0 0 0 0 0 11.2017 0 0 0 0 0 0 0 11.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T66 NMNA3_HUMAN "Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3, NMN/NaMN adenylyltransferase 3 (Nicotinamide-nucleotide adenylyltransferase 3, NMN adenylyltransferase 3) (Nicotinate-nucleotide adenylyltransferase 3, NaMN adenylyltransferase 3, EC 2.7.7.18) (Pyridine nucleotide adenylyltransferase 3, PNAT-3, EC 2.7.7.1)" NMNAT3 FKSG76 Homo sapiens (Human) NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; NAD biosynthetic process [GO:0009435]; nucleotide biosynthetic process [GO:0009165] GO:0000309; GO:0004515; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0009165; GO:0009435 ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515] HHHSKLLR 0.98843 -1.9136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15372 EIF3H_HUMAN "Eukaryotic translation initiation factor 3 subunit H, eIF3h (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit)" EIF3H EIF3S3 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0008237; GO:0016020; GO:0016282; GO:0032435; GO:0033290; GO:0042788; GO:0070062; GO:0070122; GO:0071541; GO:0140492 isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] GKGKGGSGDSAVK 0.98844 -1.9293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5615 0 0 0 0 0 0 0 0 10.7076 0 0 0 0 0 0 0 0 0 0 12.7145 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5447 0 0 0 0 0 12.9384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7828 0 0 0 0 P04626 ERBB2_HUMAN "Receptor tyrosine-protein kinase erbB-2, EC 2.7.10.1 (Metastatic lymph node gene 19 protein, MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)" ERBB2 HER2 MLN19 NEU NGL Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERBB2-ERBB4 signaling pathway [GO:0038135]; heart development [GO:0007507]; immature T cell proliferation in thymus [GO:0033080]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine phosphorylation [GO:0018108]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of microtubule-based process [GO:0032886]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; ERBB3:ERBB2 complex [GO:0038143]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; ERBB3:ERBB2 complex [GO:0038143]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase I core binding [GO:0001042]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERBB2-ERBB4 signaling pathway [GO:0038135]; heart development [GO:0007507]; immature T cell proliferation in thymus [GO:0033080]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine phosphorylation [GO:0018108]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of microtubule-based process [GO:0032886]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] GO:0001042; GO:0001934; GO:0004713; GO:0004714; GO:0004888; GO:0005524; GO:0005634; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0007166; GO:0007167; GO:0007169; GO:0007422; GO:0007507; GO:0007528; GO:0008022; GO:0008045; GO:0008284; GO:0009925; GO:0010008; GO:0014065; GO:0016021; GO:0016323; GO:0016324; GO:0018108; GO:0019903; GO:0030182; GO:0030307; GO:0032886; GO:0033080; GO:0033088; GO:0033674; GO:0035556; GO:0038133; GO:0038134; GO:0038135; GO:0038143; GO:0042060; GO:0042552; GO:0042802; GO:0043125; GO:0043209; GO:0043235; GO:0043406; GO:0043410; GO:0043547; GO:0044214; GO:0045727; GO:0045765; GO:0045785; GO:0045943; GO:0046777; GO:0046982; GO:0048471; GO:0048709; GO:0050679; GO:0070372; GO:0071363; GO:0071364; GO:0090314 ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase I core binding [GO:0001042]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888] ASPLTSIISAVVGILLVVVLGVVFGILIK 0.98844 -1.9268 0 13.281 12.7637 0 0 0 0 0 0 0 11.2479 11.1007 13.6681 0 0 0 0 0 0 10.5137 0 0 0 0 0 0 0 0 0 0 0 0 13.1851 0 0 12.0482 0 0 0 9.91253 10.4842 0 0 0 0 0 12.5464 0 13.179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4009 0 12.7893 14.4797 0 11.012 14.5986 12.8566 11.5334 0 0 13.4398 14.9753 0 13.8309 12.7442 0 0 0 0 0 13.7964 12.8585 13.7465 13.896 14.3784 15.909 0 0 0 15.0771 0 0 14.6445 11.4384 0 14.7717 13.6357 0 12.518 13.509 13.437 0 13.6314 0 0 13.3916 0 0 0 0 0 0 0 0 15.1307 0 0 0 13.1107 12.6574 0 13.5825 12.8558 0 0 0 0 0 0 0 0 0 14.1589 0 0 0 14.1343 0 11.4857 12.3098 0 0 0 13.242 12.2216 13.2591 0 0 0 0 12.5522 0 0 0 11.9878 0 0 0 0 0 0 0 Q6DKI7 PVRIG_HUMAN "Transmembrane protein PVRIG (CD112 receptor, CD112R) (Poliovirus receptor-related immunoglobulin domain-containing protein)" PVRIG C7orf15 Homo sapiens (Human) negative regulation of T cell receptor signaling pathway [GO:0050860] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatase binding [GO:0019902]; signaling receptor activity [GO:0038023]; negative regulation of T cell receptor signaling pathway [GO:0050860] GO:0005886; GO:0016021; GO:0019902; GO:0038023; GO:0050860 phosphatase binding [GO:0019902]; signaling receptor activity [GO:0038023] ADLAGILGVSGVLLFGCVYLLHLLR 0.98844 -1.9301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2973 15.1541 0 0 0 0 0 0 0 0 0 0 15.1966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49903 SPS1_HUMAN "Selenide, water dikinase 1, EC 2.7.9.3 (Selenium donor protein 1) (Selenophosphate synthase 1)" SEPHS1 SELD SPS SPS1 Homo sapiens (Human) phosphorylation [GO:0016310]; protein modification process [GO:0036211]; selenocysteine biosynthetic process [GO:0016260] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]; phosphorylation [GO:0016310]; protein modification process [GO:0036211]; selenocysteine biosynthetic process [GO:0016260]" GO:0004756; GO:0005524; GO:0005525; GO:0005737; GO:0005886; GO:0016260; GO:0016310; GO:0031965; GO:0036211; GO:0042802; GO:0042803; GO:0046872; GO:0046982 "ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; selenide, water dikinase activity [GO:0004756]" VMPLIIQGFK 0.98845 -1.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RI0 PAR4_HUMAN "Proteinase-activated receptor 4, PAR-4 (Coagulation factor II receptor-like 3) (Thrombin receptor-like 3)" F2RL3 PAR4 Homo sapiens (Human) blood coagulation [GO:0007596]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of Rho protein signal transduction [GO:0035025]; response to wounding [GO:0009611]; signal transduction [GO:0007165] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; thrombin-activated receptor activity [GO:0015057]; blood coagulation [GO:0007596]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of Rho protein signal transduction [GO:0035025]; response to wounding [GO:0009611]; signal transduction [GO:0007165] GO:0004930; GO:0005576; GO:0005886; GO:0005887; GO:0007165; GO:0007200; GO:0007596; GO:0009611; GO:0015057; GO:0030168; GO:0035025; GO:0051281; GO:0051482; GO:0060155 G protein-coupled receptor activity [GO:0004930]; thrombin-activated receptor activity [GO:0015057] ARALRGR 0.98845 -4.0978 0 0 0 0 0 0 14.4585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00266 METK1_HUMAN "S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, EC 2.5.1.6 (Methionine adenosyltransferase 1, MAT 1) (Methionine adenosyltransferase I/III, MAT-I/III)" MAT1A AMS1 MATA1 Homo sapiens (Human) methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; S-adenosylmethionine biosynthetic process [GO:0006556] cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269] cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; S-adenosylmethionine biosynthetic process [GO:0006556] GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0009087; GO:0042802; GO:0046872; GO:0048269; GO:0051289 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478] LNARMADLR 0.98846 -4.1004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T750 XP32_HUMAN Skin-specific protein 32 XP32 C1orf68 Homo sapiens (Human) epidermis development [GO:0008544] epidermis development [GO:0008544] GO:0008544 CPAPCQTTYVKCPTPCQTYVK 0.98846 -1.9432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2965 0 0 0 11.6799 0 0 0 0 11.8605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6511 0 0 0 0 0 0 0 0 0 0 13.2052 0 0 12.6235 0 0 13.5992 0 13.8136 0 0 0 0 0 0 0 0 12.0482 0 0 10.688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3632 0 13.2645 12.1076 0 0 0 0 0 13.7367 0 0 13.8208 0 0 0 13.5657 0 12.3923 11.9119 0 0 13.4727 0 0 0 0 0 0 0 0 0 0 0 0 12.6164 0 11.0131 0 0 0 0 0 0 0 13.7011 0 0 0 14.9149 13.6879 0 12.8103 0 0 0 10.8701 0 0 0 0 P01282 VIP_HUMAN "VIP peptides [Cleaved into: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide, VIP (Vasoactive intestinal polypeptide) ]" VIP Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; body fluid secretion [GO:0007589]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; epinephrine secretion [GO:0048242]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; learning or memory [GO:0007611]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epinephrine secretion [GO:0032812]; positive regulation of penile erection [GO:0060406]; positive regulation of protein catabolic process [GO:0045732]; prolactin secretion [GO:0070459]; regulation of protein localization [GO:0032880]; regulation of sensory perception of pain [GO:0051930]; response to yeast [GO:0001878] extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204] extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; body fluid secretion [GO:0007589]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; epinephrine secretion [GO:0048242]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; learning or memory [GO:0007611]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epinephrine secretion [GO:0032812]; positive regulation of penile erection [GO:0060406]; positive regulation of protein catabolic process [GO:0045732]; prolactin secretion [GO:0070459]; regulation of protein localization [GO:0032880]; regulation of sensory perception of pain [GO:0051930]; response to yeast [GO:0001878] GO:0001878; GO:0001938; GO:0005179; GO:0005184; GO:0005576; GO:0007186; GO:0007189; GO:0007200; GO:0007589; GO:0007611; GO:0008284; GO:0019731; GO:0019732; GO:0032812; GO:0032880; GO:0043005; GO:0043066; GO:0043204; GO:0043267; GO:0045087; GO:0045732; GO:0048242; GO:0048255; GO:0048662; GO:0050829; GO:0050830; GO:0051428; GO:0051930; GO:0060406; GO:0061844; GO:0070459 hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428] AQLLVLLTLLSVLFSQTSAWPLYRAPSALRLGDR 0.98847 -4.0238 10.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4179 13.2009 0 11.3787 0 0 0 12.3227 0 0 0 12.069 12.4506 0 0 0 0 13.9871 0 0 0 0 0 12.7729 13.5606 0 0 0 12.9027 12.6356 0 0 0 0 0 0 0 0 0 0 0 12.4344 0 0 0 0 0 0 12.8238 0 0 13.0281 0 13.25 0 0 14.1833 14.4335 0 0 11.6641 0 0 0 13.1046 0 13.1092 13.1935 0 0 0 0 0 0 0 0 0 0 0 0 13.4247 0 0 14.3782 13.6094 0 0 11.5375 0 0 0 0 0 0 0 0 12.4463 0 0 0 0 0 0 0 0 0 0 0 0 Q92928 RAB1C_HUMAN "Putative Ras-related protein Rab-1C, hRab1c, EC 3.6.5.2" RAB1C Homo sapiens (Human) autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; intracellular protein transport [GO:0006886] GO:0000045; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0006886; GO:0016020 G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] MNPGYDCLFK 0.98849 -1.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0F7 ARL6_HUMAN ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein) ARL6 BBS3 Homo sapiens (Human) cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; protein localization to cilium [GO:0061512]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; protein localization to cilium [GO:0061512]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055] GO:0003924; GO:0005525; GO:0005543; GO:0005737; GO:0005879; GO:0005886; GO:0005929; GO:0005930; GO:0006612; GO:0006886; GO:0007368; GO:0007601; GO:0015630; GO:0016020; GO:0016055; GO:0016192; GO:0030117; GO:0032402; GO:0046872; GO:0051258; GO:0060271; GO:0061512; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] GLLDRLSVLLGLKK 0.98849 -4.1432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9303 0 0 0 0 14.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMX2 OAZ3_HUMAN "Ornithine decarboxylase antizyme 3, AZ3, ODC-Az 3" OAZ3 Homo sapiens (Human) negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ornithine decarboxylase inhibitor activity [GO:0008073]; negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732]; spermatogenesis [GO:0007283] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006596; GO:0007283; GO:0008073; GO:0045732; GO:0072562; GO:0090316; GO:1902268 ornithine decarboxylase inhibitor activity [GO:0008073] PSVYSLSYIK 0.98849 -1.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06865 HEXA_HUMAN "Beta-hexosaminidase subunit alpha, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit alpha, Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha)" HEXA Homo sapiens (Human) adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; maintenance of location in cell [GO:0051651]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] azurophil granule [GO:0042582]; beta-N-acetylhexosaminidase complex [GO:1905379]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; adult walking behavior [GO:0007628]; carbohydrate metabolic process [GO:0005975]; cell morphogenesis involved in neuron differentiation [GO:0048667]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; lysosome organization [GO:0007040]; maintenance of location in cell [GO:0051651]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; sensory perception of sound [GO:0007605]; sexual reproduction [GO:0019953]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395] GO:0001501; GO:0004563; GO:0005764; GO:0005829; GO:0005975; GO:0006024; GO:0006689; GO:0007040; GO:0007605; GO:0007628; GO:0008375; GO:0016020; GO:0019915; GO:0019953; GO:0030203; GO:0042552; GO:0042582; GO:0043202; GO:0043231; GO:0046982; GO:0048667; GO:0050884; GO:0050885; GO:0051651; GO:0060395; GO:0070062; GO:0102148; GO:1905379 acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982] EDIPVNYMKELELVTK 0.9885 -4.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5037 13.2939 0 0 12.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5067 11.7256 0 11.36 12.8969 12.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4281 0 0 0 11.8252 0 0 0 0 0 0 0 11.9852 0 0 0 0 0 0 0 0 0 0 0 0 11.7094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24534 EF1B_HUMAN "Elongation factor 1-beta, EF-1-beta" EEF1B2 EEF1B EF1B Homo sapiens (Human) translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414] GO:0003746; GO:0005085; GO:0005737; GO:0005829; GO:0005853; GO:0006414 guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746] AKKPALVAK 0.9885 -1.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2VPB7 AP5B1_HUMAN "AP-5 complex subunit beta-1 (Adaptor-related protein complex 5 beta subunit, Beta5)" AP5B1 PP1030 Homo sapiens (Human) endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0005765; GO:0005770; GO:0015031; GO:0016192; GO:0016197; GO:0030119; GO:0044599 ALLRAGVRGGLVDLLQVLAR 0.9885 -4.1685 0 13.4856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9727 0 0 0 0 0 0 10.972 0 0 0 11.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8388 13.0352 0 0 0 13.1734 13.1693 14.3993 0 13.2226 14.8242 0 13.0675 13.4555 0 0 12.2919 13.3822 13.2766 0 0 11.303 11.1117 0 0 0 0 12.6636 10.965 12.8442 13.1466 0 0 0 12.3401 12.147 0 0 11.9148 0 12.2922 0 13.6312 0 13.27 0 13.1801 12.3129 0 0 0 12.8913 12.4892 0 13.0925 0 12.8153 0 0 0 0 11.2032 12.5963 0 0 12.2766 0 0 0 12.2091 0 0 11.9764 0 0 0 0 0 0 0 0 0 0 0 0 10.8858 0 0 0 10.8109 0 0 0 0 0 11.3312 0 0 0 0 0 11.1401 0 0 0 0 10.8565 0 Q5XUX1 FBXW9_HUMAN F-box/WD repeat-containing protein 9 (F-box and WD-40 domain-containing protein 9) FBXW9 FBW9 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 AGPALLK 0.9885 -4.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3355 13.2052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4961 0 0 0 0 0 0 0 14.272 0 14.2476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1481 0 Q8NBV8 SYT8_HUMAN "Synaptotagmin-8 (Synaptotagmin VIII, SytVIII)" SYT8 Homo sapiens (Human) calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] acrosomal vesicle [GO:0001669]; axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] acrosomal vesicle [GO:0001669]; axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001669; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030672; GO:0031045; GO:0048488; GO:0048791; GO:0070382; GO:0071277 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] EVDRMLALQPR 0.9885 -4.1774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.152 0 0 0 0 0 0 0 14.2933 14.3208 0 0 0 0 13.5291 0 0 0 0 0 0 0 13.9949 0 0 0 0 0 0 0 0 0 0 0 0 14.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BD0 SO4A1_HUMAN "Solute carrier organic anion transporter family member 4A1, OATP4A1 (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1, OATP-RP1, OATPRP1, POAT) (Organic anion-transporting polypeptide E, OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12)" SLCO4A1 OATP1 OATP4A1 OATPE SLC21A12 Homo sapiens (Human) sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; sodium-independent organic anion transport [GO:0043252] GO:0005886; GO:0005887; GO:0015347; GO:0015349; GO:0043252 sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] CVRDPQRSFALGIQWIVVR 0.98852 -1.7209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VTL7 FNDC7_HUMAN Fibronectin type III domain-containing protein 7 FNDC7 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GSANYSTDLYGSK 0.98854 -1.9118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8478 0 0 0 0 0 10.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NL08 O6C75_HUMAN Olfactory receptor 6C75 OR6C75 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ERVTLSKGVAVLNTSVAPLLNPFIYTLR 0.98855 -1.9242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EE01 CENPW_HUMAN "Centromere protein W, CENP-W (Cancer-up-regulated gene 2 protein)" CENPW C6orf173 CUG2 Homo sapiens (Human) cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome organization [GO:0051276]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278] "chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; chromosome organization [GO:0051276]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]" GO:0000278; GO:0000775; GO:0000776; GO:0003677; GO:0005654; GO:0005730; GO:0007059; GO:0016363; GO:0034080; GO:0046982; GO:0051276; GO:0051301; GO:0051382 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] ALSTIVSQRKQIK 0.98855 -1.9176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NL0 RUN3B_HUMAN "RUN domain-containing protein 3B (Rap2-binding protein 9) (Rap2-interacting protein 9, RPIP-9)" RUNDC3B RPIB9 RPIP9 Homo sapiens (Human) AWIRVALMEK 0.98855 -1.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.802 0 0 0 13.5141 0 0 0 0 14.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.709 0 0 0 0 0 0 13.8474 0 14.4248 14.192 0 0 0 0 14.2483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2723 0 Q96S55 WRIP1_HUMAN "ATPase WRNIP1, EC 3.6.1.- (Werner helicase-interacting protein 1)" WRNIP1 WHIP Homo sapiens (Human) DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated DNA replication initiation [GO:0030174] membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated DNA replication initiation [GO:0030174] GO:0000731; GO:0003677; GO:0005524; GO:0005634; GO:0006261; GO:0006282; GO:0008047; GO:0016020; GO:0016887; GO:0017116; GO:0030174; GO:0042802; GO:0045087; GO:0046872; GO:0048471 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116] AGLNGLQLAVLAR 0.98855 -1.9148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3973 0 15.2419 0 0 0 0 0 0 12.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H410 DSN1_HUMAN Kinetochore-associated protein DSN1 homolog DSN1 C20orf172 MIS13 Homo sapiens (Human) cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nuclear MIS12/MIND complex [GO:0000818]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nuclear MIS12/MIND complex [GO:0000818]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] GO:0000070; GO:0000444; GO:0000776; GO:0000818; GO:0001650; GO:0005576; GO:0005654; GO:0005730; GO:0005829; GO:0016604; GO:0031617; GO:0035578; GO:0051301 SISVDLAESK 0.98855 -1.7476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPH0 PPA6_HUMAN "Lysophosphatidic acid phosphatase type 6, EC 3.1.3.2 (Acid phosphatase 6, lysophosphatidic) (Acid phosphatase-like protein 1) (PACPL1)" ACP6 ACPL1 LPAP UNQ205/PRO231 Homo sapiens (Human) dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311]; hematopoietic progenitor cell differentiation [GO:0002244]; lysobisphosphatidic acid metabolic process [GO:2001311]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644] GO:0002244; GO:0003993; GO:0005737; GO:0005739; GO:0005759; GO:0006644; GO:0006654; GO:0016311; GO:0016791; GO:0052642; GO:2001311 acid phosphatase activity [GO:0003993]; lysophosphatidic acid phosphatase activity [GO:0052642]; phosphatase activity [GO:0016791] LKMVQVVFR 0.98855 -1.7483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7231 0 0 0 0 0 0 0 0 0 13.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8783 0 0 0 14.7278 12.8643 0 0 0 0 0 13.4698 0 14.6304 0 0 0 14.4514 0 0 0 0 0 0 15.5088 0 12.9027 0 11.6244 12.7338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1005 0 0 0 0 Q9Y275 TN13B_HUMAN "Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator, BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1, TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form ]" TNFSF13B BAFF BLYS TALL1 TNFSF20 ZTNF4 UNQ401/PRO738 Homo sapiens (Human) B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; germinal center formation [GO:0002467]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; germinal center formation [GO:0002467]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0001782; GO:0002467; GO:0002636; GO:0005102; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005925; GO:0007165; GO:0016021; GO:0030183; GO:0030890; GO:0031295; GO:0031296; GO:0033209; GO:0042098; GO:0042100; GO:0042102; GO:0043231; GO:0048018; GO:0048471 cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] MDDSTEREQSR 0.98855 -4.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5286 0 0 Q9UQC2 GAB2_HUMAN GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100) GAB2 KIAA0571 Homo sapiens (Human) osteoclast differentiation [GO:0030316]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mast cell degranulation [GO:0043306]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; osteoclast differentiation [GO:0030316]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mast cell degranulation [GO:0043306]; signal transduction [GO:0007165]" GO:0005068; GO:0005547; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0008284; GO:0030316; GO:0035591; GO:0043306; GO:0043325; GO:0048015 "phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]" KAKPTPLDLR 0.98857 -1.9431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6319 13.4548 14.3697 0 0 0 0 0 0 0 13.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1173 0 0 0 14.4762 14.7022 0 0 0 14.4748 0 0 0 15.8539 0 0 0 0 0 0 0 17.5624 Q6XYQ8 SYT10_HUMAN "Synaptotagmin-10 (Synaptotagmin X, SytX)" SYT10 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192] exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] "exocytic vesicle [GO:0070382]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030658; GO:0042803; GO:0045202; GO:0045956; GO:0046982; GO:0070382; GO:0071277 "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" AIEPAIK 0.98858 -4.0422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMB5 T184A_HUMAN Transmembrane protein 184A TMEM184A Homo sapiens (Human) cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; heparin binding [GO:0008201] GO:0005768; GO:0005886; GO:0008201; GO:0016021; GO:0030658; GO:0030659; GO:0030667; GO:0031901; GO:0048471 heparin binding [GO:0008201] AVIFLSFWQGLLLAILER 0.98858 -4.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8705 0 0 0 0 0 0 0 13.7046 13.5646 0 0 0 0 0 0 0 0 0 0 0 11.6458 0 0 0 0 0 12.0739 0 0 0 0 0 0 0 0 0 0 11.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0494 0 0 0 0 0 0 0 0 0 0 0 10.9018 0 0 0 0 0 0 0 Q9H112 CST11_HUMAN Cystatin-11 CST11 CST8L Homo sapiens (Human) androgen receptor signaling pathway [GO:0030521]; defense response to Gram-negative bacterium [GO:0050829]; killing of cells of another organism [GO:0031640] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm head [GO:0061827] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm head [GO:0061827]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; androgen receptor signaling pathway [GO:0030521]; defense response to Gram-negative bacterium [GO:0050829]; killing of cells of another organism [GO:0031640] GO:0004869; GO:0005576; GO:0005634; GO:0005737; GO:0030521; GO:0031640; GO:0036126; GO:0050829; GO:0061827 cysteine-type endopeptidase inhibitor activity [GO:0004869] ESDDKYHFR 0.98858 -4.1571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4919 0 0 10.9238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2406 0 0 0 0 0 0 13.4295 13.2936 0 0 0 0 0 0 0 0 0 0 0 0 14.1904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3381 0 0 12.5528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4715 0 0 0 0 0 0 0 0 0 11.768 0 0 0 14.7754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NEN9 CX065_HUMAN Uncharacterized protein CXorf65 CXorf65 Homo sapiens (Human) FIFIKHGDNQQFLVNTNCAVVVLLYYIRSK 0.98859 -4.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C0E4 RB40L_HUMAN Ras-related protein Rab-40A-like (Ras-like GTPase) RAB40AL RLGP Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] cytoplasm [GO:0005737]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular signal transduction [GO:0035556]; protein localization to plasma membrane [GO:0072659]; protein ubiquitination [GO:0016567] GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005768; GO:0005886; GO:0008021; GO:0016567; GO:0035556; GO:0043231; GO:0072659 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IEEHAPGVPKILVGNRLHLAFK 0.98859 -4.1681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1932 0 12.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6489 0 0 0 0 0 0 0 0 0 0 0 14.4014 0 14.1771 0 14.1755 0 0 0 0 0 14.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2062 0 0 0 13.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35523 CLCN1_HUMAN "Chloride channel protein 1, ClC-1 (Chloride channel protein, skeletal muscle)" CLCN1 CLC1 Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; muscle contraction [GO:0006936]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; muscle contraction [GO:0006936]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765] GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0006936; GO:0019227; GO:0034707; GO:0034765; GO:0042383; GO:0042803; GO:1902476 protein homodimerization activity [GO:0042803]; voltage-gated chloride channel activity [GO:0005247] AFVAKVVALTAGLGSGIPVGK 0.98859 -4.0496 0 13.0657 0 0 13.5606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.158 0 12.6634 0 0 0 0 0 15.0414 0 0 0 0 0 11.9728 0 0 0 0 10.2676 0 0 0 0 0 0 0 P51814 ZNF41_HUMAN Zinc finger protein 41 ZNF41 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HQKMHSGEKR 0.98859 -4.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8048 0 0 0 0 0 0 0 0 0 0 10.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6648 0 0 12.2684 14.7834 0 0 0 11.8339 0 0 14.1036 0 0 0 11.9363 0 0 0 0 0 0 13.2939 0 0 0 0 12.3587 0 0 0 14.1133 16.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2435 0 0 13.6721 0 0 0 0 0 14.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9663 0 12.6719 12.5256 12.7785 13.438 12.8889 13.574 0 0 0 0 0 0 0 0 0 0 0 0 A6NFK2 GRCR2_HUMAN Glutaredoxin domain-containing cysteine-rich protein 2 (GRXCR1-like protein) (Glutaredoxin domain-containing cysteine-rich protein 1-like protein) GRXCR2 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; protein localization to organelle [GO:0033365]; sensory perception of sound [GO:0007605] microvillus [GO:0005902]; stereocilium base [GO:0120044]; stereocilium shaft [GO:0120043] microvillus [GO:0005902]; stereocilium base [GO:0120044]; stereocilium shaft [GO:0120043]; auditory receptor cell stereocilium organization [GO:0060088]; protein localization to organelle [GO:0033365]; sensory perception of sound [GO:0007605] GO:0005902; GO:0007605; GO:0033365; GO:0060088; GO:0120043; GO:0120044 CPACNENGLQPCQICNQ 0.9886 -1.7713 0 0 0 0 0 0 0 0 0 0 12.9069 12.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0366 0 0 0 0 0 0 16.8456 16.7044 16.9139 16.8439 16.7344 16.6773 16.5721 16.9116 0 17.0463 16.6015 16.3837 16.1875 16.2092 0 0 0 13.0151 0 0 13.3316 12.9702 0 0 0 0 13.4493 0 0 0 12.305 12.8988 0 0 0 13.3911 0 13.2503 0 0 0 12.8975 0 0 14.3358 0 0 13.0434 0 0 0 0 0 0 13.7644 13.3974 13.0708 0 0 0 12.8988 0 12.6903 13.9792 13.1143 0 0 0 13.4668 0 0 0 0 0 0 0 17.0257 13.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUS0 CS085_HUMAN Uncharacterized protein C19orf85 C19orf85 Homo sapiens (Human) ALQPRRTR 0.98861 -1.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C5Z0 H2AB2_HUMAN "Histone H2A-Bbd type 2/3 (H2A Barr body-deficient, H2A.Bbd)" H2AB2 H2AFB2; H2AB3 H2ABBD H2AFB H2AFB3 Homo sapiens (Human) mRNA processing [GO:0006397]; nucleosome assembly [GO:0006334] euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634] euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; mRNA processing [GO:0006397]; nucleosome assembly [GO:0006334] GO:0000786; GO:0000791; GO:0003677; GO:0005634; GO:0006334; GO:0006397; GO:0030527; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] EGHYAQR 0.98861 -1.7745 0 0 0 0 0 0 14.1509 0 0 0 0 0 0 0 0 10.5984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.699 0 11.8231 14.0308 14.0402 14.3004 0 0 0 0 11.7852 0 0 0 0 0 0 0 0 0 0 0 13.1491 0 0 0 0 0 14.1278 12.4388 0 0 0 0 0 0 0 0 0 0 10.4989 0 13.8214 14.1442 0 10.5285 0 0 0 13.5887 13.7912 0 0 11.5877 0 13.6167 0 0 12.6006 13.8367 0 14.7165 0 12.6856 0 0 0 14.3051 0 0 0 0 0 11.5929 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0052 0 0 0 0 0 0 12.5257 0 0 0 0 0 0 0 Q8IY22 CMIP_HUMAN "C-Maf-inducing protein, c-Mip (Truncated c-Maf-inducing protein, Tc-Mip)" CMIP KIAA1694 TCMIP Homo sapiens (Human) in utero embryonic development [GO:0001701] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; in utero embryonic development [GO:0001701] GO:0001701; GO:0005654; GO:0005829 DQWFHSLQWK 0.98861 -4.0773 0 0 0 0 0 0 0 0 0 0 0 0 0 11.686 0 0 0 0 0 11.0019 0 0 0 0 0 0 11.0768 10.9599 10.7883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7265 0 0 0 0 0 0 0 0 12.3199 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8843 13.1648 0 0 13.7132 0 14.1542 0 0 14.7257 13.3896 14.1591 16.645 13.9989 14.8917 0 13.7788 12.6587 15.7768 14.4841 16.7566 12.9996 0 0 14.904 0 15.61 14.8879 0 16.1329 16.0511 14.9771 15.2927 13.9528 11.9228 13.6821 0 0 0 0 0 12.5049 16.5943 16.4924 12.2695 0 12.5565 0 0 0 0 0 13.0443 13.4049 13.7863 0 15.8388 0 12.7493 0 15.9568 14.149 0 0 0 0 12.8517 12.9034 15.6501 0 16.1085 14.882 15.9203 16.6234 0 0 12.1583 15.1453 0 14.2148 15.1671 13.401 0 0 0 12.0822 0 12.9056 13.0585 0 13.3264 0 0 0 9.40427 13.8651 0 0 12.7156 12.4818 13.3494 12.3325 13.1485 0 0 15.7946 12.7299 12.5538 0 0 0 13.9633 15.0296 0 P14138 EDN3_HUMAN "Endothelin-3, ET-3 (Preproendothelin-3, PPET3)" EDN3 Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; establishment of localization in cell [GO:0051649]; inositol phosphate-mediated signaling [GO:0048016]; melanocyte differentiation [GO:0030318]; neural crest cell migration [GO:0001755]; neutrophil chemotaxis [GO:0030593]; peptide hormone secretion [GO:0030072]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; potassium ion transmembrane transport [GO:0071805]; regulation of developmental pigmentation [GO:0048070]; regulation of gene expression [GO:0010468]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; signal transduction [GO:0007165]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; axon extension [GO:0048675]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; establishment of localization in cell [GO:0051649]; inositol phosphate-mediated signaling [GO:0048016]; melanocyte differentiation [GO:0030318]; neural crest cell migration [GO:0001755]; neutrophil chemotaxis [GO:0030593]; peptide hormone secretion [GO:0030072]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; potassium ion transmembrane transport [GO:0071805]; regulation of developmental pigmentation [GO:0048070]; regulation of gene expression [GO:0010468]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; signal transduction [GO:0007165]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] GO:0001755; GO:0002690; GO:0003100; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0006874; GO:0007165; GO:0007166; GO:0007267; GO:0007411; GO:0008015; GO:0008283; GO:0008284; GO:0010460; GO:0010468; GO:0010961; GO:0014826; GO:0019229; GO:0030072; GO:0030318; GO:0030593; GO:0031708; GO:0042310; GO:0043406; GO:0045597; GO:0045840; GO:0046887; GO:0048016; GO:0048070; GO:0048675; GO:0051649; GO:0060585; GO:0071805; GO:1901381 endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102] CTCFTYK 0.98862 -4.0807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1371 0 0 0 0 0 13.3025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6781 0 0 0 0 0 0 0 0 12.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01970 PLCB3_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3, PLC-beta-3)" PLCB3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of systemic arterial blood pressure [GO:0003073] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of systemic arterial blood pressure [GO:0003073] GO:0003073; GO:0004435; GO:0004629; GO:0005509; GO:0005516; GO:0005634; GO:0005829; GO:0007186; GO:0016020; GO:0016042; GO:0032991; GO:0045296; GO:0046488; GO:0048015; GO:0099524 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629] DTRTGRYAR 0.98862 -1.7098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3078 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1263 0 0 0 15.3127 0 0 0 0 0 0 14.8791 0 0 0 0 0 0 0 0 0 14.0868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8793 0 0 0 0 0 13.3692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43283 M3K13_HUMAN "Mitogen-activated protein kinase kinase kinase 13, EC 2.7.11.25 (Leucine zipper-bearing kinase) (Mixed lineage kinase, MLK)" MAP3K13 LZK Homo sapiens (Human) JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon extension [GO:0045773]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; IkappaB kinase complex binding [GO:0106137]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon extension [GO:0045773]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005737; GO:0006468; GO:0007254; GO:0014042; GO:0016020; GO:0018105; GO:0019899; GO:0019901; GO:0042802; GO:0042803; GO:0043507; GO:0043539; GO:0045773; GO:0046777; GO:0046872; GO:0051092; GO:0051403; GO:0106137; GO:0106310; GO:0150012; GO:1905492 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; IkappaB kinase complex binding [GO:0106137]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674] AYSTDYK 0.98863 -4.2152 0 14.4793 0 0 0 0 0 0 0 0 0 11.7688 0 0 0 10.8621 0 0 0 0 0 11.9458 0 12.229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.413 0 0 0 0 0 0 0 0 0 13.7639 0 0 0 0 0 0 13.2717 0 0 0 0 0 0 0 11.8181 13.1003 0 0 12.896 0 0 0 0 0 0 0 0 0 0 13.4247 0 0 0 0 0 0 0 0 0 0 0 0 12.7425 12.5041 0 0 17.0772 0 0 0 0 0 0 0 0 0 12.2672 15.9199 0 14.1803 0 0 13.7363 12.0317 0 0 12.9068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1486 0 0 0 0 0 0 12.1634 0 0 15.3753 0 0 0 0 0 0 Q15617 OR8G1_HUMAN Olfactory receptor 8G1 (Olfactory receptor OR11-281) (Olfactory receptor TPCR25) OR8G1 OR8G1P Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] DVHVSLKK 0.98863 -1.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y255 PRLD1_HUMAN "PRELI domain-containing protein 1, mitochondrial (25 kDa protein of relevant evolutionary and lymphoid interest) (Px19-like protein)" PRELID1 PRELI CGI-106 SBBI12 Homo sapiens (Human) apoptotic process [GO:0006915]; intermembrane lipid transfer [GO:0120009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; apoptotic process [GO:0006915]; intermembrane lipid transfer [GO:0120009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid transport [GO:0015914]; positive regulation of cellular respiration [GO:1901857]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of membrane lipid distribution [GO:0097035]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of T cell differentiation [GO:0045580] GO:0005654; GO:0005739; GO:0005758; GO:0006915; GO:0010917; GO:0010950; GO:0015914; GO:0032991; GO:0043066; GO:0045580; GO:0051881; GO:0070234; GO:0090201; GO:0097035; GO:0120009; GO:1901857; GO:2001140 AKETALAATEKAK 0.98863 -1.7203 0 0 11.0959 0 0 0 15.5687 0 0 0 0 0 0 0 0 0 0 12.6359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4214 0 0 0 0 0 0 0 0 0 0 0 0 13.1003 0 0 0 0 0 0 0 0 0 0 0 O75829 CNMD_HUMAN "Leukocyte cell-derived chemotaxin 1 (Chondromodulin) [Cleaved into: Chondrosurfactant protein, CH-SP; Chondromodulin-1 (Chondromodulin-I, ChM-I) ]" CNMD CHMI LECT1 MYETS1 Homo sapiens (Human) cartilage development [GO:0051216]; cell differentiation [GO:0030154]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; proteoglycan metabolic process [GO:0006029]; skeletal system development [GO:0001501] endomembrane system [GO:0012505]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; proteoglycan metabolic process [GO:0006029]; skeletal system development [GO:0001501] GO:0001501; GO:0001937; GO:0005576; GO:0006029; GO:0012505; GO:0016021; GO:0016525; GO:0030154; GO:0051216 ARIPEVGAVTK 0.98864 -1.7291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0143 0 12.8274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7248 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 12.883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DV77 TPRX2_HUMAN Tetrapeptide repeat homeobox protein 2 TPRX2 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] QERTVYTESQQKVLEFYFQK 0.98865 -1.9111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8942 0 0 0 0 11.7353 0 0 12.4255 0 0 0 0 0 0 13.2574 13.3953 0 0 0 0 0 0 0 0 0 0 0 0 11.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7969 0 0 0 0 0 12.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MPY1 GBRR3_HUMAN Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor) GABRR3 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:1902476; GO:1902711; GO:1904315 chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; protein domain specific binding [GO:0019904]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] FPLDTQNCSLELESYAYNEDDLMLYWKHGNK 0.98866 -4.0273 0 0 0 0 0 0 0 0 0 0 12.7581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3626 0 0 0 0 0 0 0 0 0 14.2743 0 0 0 0 0 11.9528 12.9526 0 0 0 0 0 0 10.994 0 0 0 16.409 0 0 13.1567 0 13.5559 0 0 0 0 9.76548 0 0 13.6942 0 0 0 0 13.0512 0 0 0 12.0376 0 0 13.1137 0 0 0 0 0 13.6359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4333 0 13.3252 0 0 0 0 0 0 0 13.1865 12.4735 0 13.7177 0 0 0 0 P59537 T2R43_HUMAN "Taste receptor type 2 member 43, T2R43 (Taste receptor type 2 member 52, T2R52)" TAS2R43 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001580; GO:0004930; GO:0005886; GO:0007186; GO:0008527; GO:0016021; GO:0031514; GO:0033038; GO:0060170 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] FSYPSIHPFILIWGNKKLK 0.98866 -1.7452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4132 0 0 0 0 0 0 13.2907 0 0 11.9181 0 0 0 0 0 0 0 13.2834 0 0 0 0 0 0 0 9.96311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5838 0 0 0 0 0 0 0 13.3614 0 14.9588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9433 0 0 0 0 0 14.6195 0 12.1098 0 0 0 0 0 0 0 0 13.1365 14.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0537 14.025 Q86U37 CN023_HUMAN Uncharacterized protein encoded by LINC01551 LINC01551 C14orf23 Homo sapiens (Human) LLDRFLSLSR 0.98866 -1.7404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9569 0 0 16.458 0 0 14.6917 0 0 0 0 0 0 0 0 0 14.6992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43829 ZBT14_HUMAN "Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog, Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog, ZF5, Zfp-5, hZF5)" ZBTB14 ZFP161 ZNF478 Homo sapiens (Human) "cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001822; GO:0003170; GO:0003279; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0016235; GO:0043565; GO:0045892; GO:0046872; GO:0060976; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" EQIACQACGK 0.98868 -1.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13433 S39A6_HUMAN "Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6, ZIP-6)" SLC39A6 LIV1 ZIP6 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] GO:0005385; GO:0005783; GO:0005886; GO:0005887; GO:0006882; GO:0009986; GO:0031258; GO:0071577; GO:0071578 zinc ion transmembrane transporter activity [GO:0005385] ARKLSVILILTFALSVTNPLHELK 0.98868 -4.1632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3582 0 0 0 0 0 0 11.9688 0 0 0 0 0 12.965 13.8323 0 0 0 0 0 0 0 12.0191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8831 0 0 13.0722 13.4531 0 0 0 0 0 0 0 0 0 0 0 13.6536 0 0 11.9616 0 10.8597 0 0 0 0 0 0 0 0 0 0 0 12.6975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9936 0 13.1255 0 0 0 0 0 Q9BTK6 PAGR1_HUMAN "PAXIP1-associated glutamate-rich protein 1 (Glutamate-rich coactivator interacting with SRC1, GAS) (PAXIP1-associated protein 1) (PTIP-associated protein 1)" PAGR1 C16orf53 PA1 Homo sapiens (Human) DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; nuclear estrogen receptor binding [GO:0030331]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005634; GO:0006281; GO:0006310; GO:0030331; GO:0033148; GO:0035097; GO:0044666; GO:0045944; GO:0051568; GO:1902808 nuclear estrogen receptor binding [GO:0030331] AEDEGEGGR 0.98868 -4.1551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.753 0 0 0 0 0 0 0 13.2217 0 0 12.9342 0 0 0 0 0 0 0 0 0 0 0 12.5661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60811 PRAM2_HUMAN PRAME family member 2 PRAMEF2 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 FTSVFLR 0.98869 -4.0559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93973 0 0 0 0 0 0 0 0 0 0 0 0 13.0927 0 12.9935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1598 0 0 0 0 13.4169 13.4698 0 13.3461 13.3531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55089 UCN1_HUMAN Urocortin UCN Homo sapiens (Human) "activation of protein kinase A activity [GO:0034199]; aerobic respiration [GO:0009060]; associative learning [GO:0008306]; drinking behavior [GO:0042756]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric emptying [GO:0035483]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell size [GO:0045792]; negative regulation of feeding behavior [GO:2000252]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; pancreatic juice secretion [GO:0030157]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell growth [GO:0030307]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of DNA replication [GO:0045740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of vascular permeability [GO:0043117]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to auditory stimulus [GO:0010996]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to oxidative stress [GO:0006979]; response to pain [GO:0048265]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; startle response [GO:0001964]; vasodilation [GO:0042311]" axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; perikaryon [GO:0043204]; varicosity [GO:0043196] "axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; perikaryon [GO:0043204]; varicosity [GO:0043196]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; corticotropin-releasing hormone receptor 2 binding [GO:0051431]; histone deacetylase inhibitor activity [GO:0046811]; neuropeptide hormone activity [GO:0005184]; activation of protein kinase A activity [GO:0034199]; aerobic respiration [GO:0009060]; associative learning [GO:0008306]; drinking behavior [GO:0042756]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; gastric emptying [GO:0035483]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell size [GO:0045792]; negative regulation of feeding behavior [GO:2000252]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; pancreatic juice secretion [GO:0030157]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell growth [GO:0030307]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of DNA replication [GO:0045740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of vascular permeability [GO:0043117]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to auditory stimulus [GO:0010996]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to oxidative stress [GO:0006979]; response to pain [GO:0048265]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; startle response [GO:0001964]; vasodilation [GO:0042311]" GO:0001964; GO:0005184; GO:0005576; GO:0006954; GO:0006979; GO:0007186; GO:0007218; GO:0007565; GO:0007605; GO:0008306; GO:0009060; GO:0010629; GO:0010996; GO:0030157; GO:0030307; GO:0030425; GO:0031175; GO:0032099; GO:0032355; GO:0032755; GO:0032967; GO:0033138; GO:0034199; GO:0035176; GO:0035483; GO:0042311; GO:0042756; GO:0043066; GO:0043117; GO:0043196; GO:0043204; GO:0043679; GO:0043950; GO:0045727; GO:0045740; GO:0045776; GO:0045792; GO:0045944; GO:0046811; GO:0046888; GO:0048265; GO:0051384; GO:0051430; GO:0051431; GO:0051461; GO:0051966; GO:0060452; GO:0060455; GO:0060547; GO:0090280; GO:1901215; GO:2000252; GO:2000987 corticotropin-releasing hormone receptor 1 binding [GO:0051430]; corticotropin-releasing hormone receptor 2 binding [GO:0051431]; histone deacetylase inhibitor activity [GO:0046811]; neuropeptide hormone activity [GO:0005184] ALLLLLAERFPRR 0.9887 -4.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.934 0 0 0 0 0 11.8887 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8796 0 0 11.5298 0 0 13.0055 0 0 13.4929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.715 0 12.0169 0 0 0 0 0 0 0 0 0 11.5473 0 0 0 12.8838 0 0 0 0 0 0 0 11.0839 0 0 0 13.8071 0 0 0 13.912 0 0 13.0332 0 0 0 0 0 0 14.3235 0 0 0 0 0 0 11.3153 0 10.8306 11.2388 0 0 0 0 0 0 0 14.4456 0 11.702 0 0 0 0 0 0 13.5759 0 0 0 0 0 0 0 11.4652 0 0 12.1699 12.6313 0 12.9322 0 0 0 0 0 0 12.3104 0 0 0 0 0 0 0 0 0 0 12.1682 0 0 0 0 Q68DY9 ZN772_HUMAN Zinc finger protein 772 ZNF772 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASLIRHWKIHTGER 0.9887 -4.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8315 0 0 11.6247 0 0 0 0 0 9.67243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3736 0 0 0 0 0 0 0 0 0 0 11.5692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNE0 EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR (Anhidrotic ectodysplasin receptor 1) (Downless homolog) (EDA-A1 receptor) (Ectodermal dysplasia receptor) (Ectodysplasin-A receptor) EDAR DL Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; salivary gland cavitation [GO:0060662] apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; salivary gland cavitation [GO:0060662] GO:0001942; GO:0004888; GO:0005886; GO:0006915; GO:0008544; GO:0010628; GO:0016021; GO:0030154; GO:0038023; GO:0042475; GO:0043123; GO:0043473; GO:0045177; GO:0046330; GO:0060662; GO:1901224 signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] ELSGQGHLATALIIAMSTIFIMAIAIVLIIMFYILKTK 0.9887 -4.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5084 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P33121 ACSL1_HUMAN "Long-chain-fatty-acid--CoA ligase 1, EC 6.2.1.3 (Acyl-CoA synthetase 1, ACS1) (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1, LACS 1) (Long-chain acyl-CoA synthetase 2, LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase, EC 6.2.1.24)" ACSL1 FACL1 FACL2 LACS LACS1 LACS2 Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178] GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0007584; GO:0008610; GO:0010747; GO:0014070; GO:0015908; GO:0016020; GO:0016021; GO:0019432; GO:0033211; GO:0034201; GO:0035338; GO:0042178; GO:0044539; GO:0047676; GO:0050197; GO:0070251; GO:0071902; GO:0090434; GO:0120162 arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251] AELSLVFVDK 0.98871 -1.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6272 0 12.5645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4816 0 0 0 0 0 0 0 0 0 12.1187 0 0 0 0 0 0 0 0 Q8TBY9 CF251_HUMAN Cilia- and flagella-associated protein 251 (WD repeat-containing protein 66) CFAP251 WDR66 Homo sapiens (Human) cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317] axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317] GO:0003341; GO:0005930; GO:0030317; GO:0031514; GO:0036126 FYDHTLSIVNWYSHLKLGAIR 0.98871 -1.7703 0 0 0 0 0 0 0 0 0 10.4601 11.7949 0 0 0 0 13.8835 14.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2976 0 0 0 10.2767 0 0 12.6449 12.1138 0 0 0 0 0 0 0 0 15.8692 0 14.5022 14.1093 14.3573 0 12.1337 13.5641 12.1663 13.0842 12.1514 11.3286 0 0 0 11.2307 0 0 0 0 0 0 0 0 12.4037 0 0 0 0 0 0 0 0 0 0 0 12.2203 0 0 0 0 0 0 13.9049 11.3253 0 0 0 0 0 0 0 0 0 0 0 15.5003 0 0 0 16.1426 0 0 0 0 0 0 0 0 0 0 13.1423 0 11.7416 0 0 0 0 0 0 0 0 0 0 0 12.4035 0 0 0 12.0893 0 0 14.9951 0 0 0 0 13.3369 0 0 0 0 0 0 0 0 0 0 13.2196 13.9472 15.3472 13.5467 14.492 0 13.3229 0 0 0 0 0 15.7785 0 14.7281 0 0 O00233 PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27) PSMD9 Homo sapiens (Human) "negative regulation of insulin secretion [GO:0046676]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome regulatory particle assembly [GO:0070682]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]; bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713]; negative regulation of insulin secretion [GO:0046676]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome regulatory particle assembly [GO:0070682]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0032024; GO:0043425; GO:0045893; GO:0046676; GO:0070682 bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713] HQLRLVPTR 0.98872 -4.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4193 0 0 0 0 13.5922 0 13.9045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.763 0 0 0 0 0 0 0 0 0 0 0 14.7714 0 0 0 0 0 0 0 0 P55273 CDN2D_HUMAN Cyclin-dependent kinase 4 inhibitor D (p19-INK4d) CDKN2D Homo sapiens (Human) autophagic cell death [GO:0048102]; cell cycle [GO:0007049]; DNA synthesis involved in DNA repair [GO:0000731]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of phosphorylation [GO:0042326]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to retinoic acid [GO:0032526]; response to UV [GO:0009411]; response to vitamin D [GO:0033280]; sensory perception of sound [GO:0007605] cyclin D2-CDK4 complex [GO:0097129]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin D2-CDK4 complex [GO:0097129]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901]; autophagic cell death [GO:0048102]; cell cycle [GO:0007049]; DNA synthesis involved in DNA repair [GO:0000731]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of phosphorylation [GO:0042326]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; response to retinoic acid [GO:0032526]; response to UV [GO:0009411]; response to vitamin D [GO:0033280]; sensory perception of sound [GO:0007605] GO:0000079; GO:0000731; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007605; GO:0008285; GO:0009411; GO:0019901; GO:0030308; GO:0032526; GO:0033280; GO:0042326; GO:0043154; GO:0048102; GO:0097129; GO:1902230; GO:1902807; GO:2000045 cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase binding [GO:0019901] ELVHPDALNR 0.98873 -1.7722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6685 12.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43665 RGS10_HUMAN "Regulator of G-protein signaling 10, RGS10" RGS10 Homo sapiens (Human) G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0001965; GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007213; GO:0008277; GO:0009968; GO:0043547; GO:0045202 G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] AVSRLSRK 0.98874 -1.7163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6731 0 0 13.8165 13.9869 13.9682 14.2346 0 13.9988 0 0 0 0 13.3373 0 0 13.8812 13.7958 0 13.7095 0 13.9139 13.7389 0 0 0 0 13.5583 0 0 0 0 0 0 13.0621 0 0 0 0 0 0 0 13.3625 13.453 0 13.2275 0 0 13.3966 0 13.7887 0 13.386 13.6494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8013 13.7178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28069 PIT1_HUMAN "Pituitary-specific positive transcription factor 1, PIT-1 (Growth hormone factor 1, GHF-1)" POU1F1 GHF1 PIT1 Homo sapiens (Human) "adenohypophysis development [GO:0021984]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lncRNA binding [GO:0106222]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; adenohypophysis development [GO:0021984]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0008285; GO:0021984; GO:0045944; GO:0061629; GO:0106222; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lncRNA binding [GO:0106222]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" RTTISIAAK 0.98875 -1.7202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7247 13.471 12.357 13.6036 0 0 12.9389 0 12.7306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.261 0 0 0 0 0 0 0 14.9768 0 0 0 0 0 0 0 0 0 0 0 0 17.1978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54727 RD23B_HUMAN "UV excision repair protein RAD23 homolog B, HR23B, hHR23B (XP-C repair-complementing complex 58 kDa protein, p58)" RAD23B Homo sapiens (Human) cellular response to interleukin-7 [GO:0098761]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283] GO:0000502; GO:0000978; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006289; GO:0007283; GO:0031593; GO:0032434; GO:0043130; GO:0043161; GO:0070628; GO:0071942; GO:0098761; GO:0140612 damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130] ALKEKIESEK 0.98875 -1.7243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54317 LIPR2_HUMAN "Pancreatic lipase-related protein 2, PL-RP2 (Cytotoxic T lymphocyte lipase) (Galactolipase, EC 3.1.1.26) (Triacylglycerol lipase, EC 3.1.1.3)" PNLIPRP2 PLRP2 Homo sapiens (Human) galactolipid catabolic process [GO:0019376]; lipid catabolic process [GO:0016042]; lipid digestion [GO:0044241]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; triglyceride catabolic process [GO:0019433]; triglyceride metabolic process [GO:0006641] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; 1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; galactolipid catabolic process [GO:0019376]; lipid catabolic process [GO:0016042]; lipid digestion [GO:0044241]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; triglyceride catabolic process [GO:0019433]; triglyceride metabolic process [GO:0006641] GO:0004620; GO:0004806; GO:0005509; GO:0005576; GO:0005615; GO:0006641; GO:0009395; GO:0016020; GO:0016042; GO:0016298; GO:0019376; GO:0019433; GO:0031410; GO:0034638; GO:0043005; GO:0044241; GO:0047372; GO:0047714; GO:0102549 1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity [GO:0102549]; acylglycerol lipase activity [GO:0047372]; calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipase activity [GO:0016298]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806] AEDSWPSDMCK 0.98876 -1.911 0 0 0 0 0 0 0 0 11.5533 11.2706 11.1115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8816 0 0 0 12.3731 13.4003 0 0 0 0 13.3444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6722 0 0 16.4284 0 0 0 0 0 0 0 0 0 13.6183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2668 0 0 0 0 20.5944 0 0 0 0 0 0 0 0 0 0 0 0 12.7167 0 14.3727 0 0 0 0 0 0 13.3281 0 0 0 0 0 0 11.5251 0 0 12.2134 12.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0145 Q9UKP6 UR2R_HUMAN "Urotensin-2 receptor, UR-2-R (G-protein coupled receptor 14) (Urotensin II receptor, UR-II-R)" UTS2R GPR14 Homo sapiens (Human) blood circulation [GO:0008015]; blood vessel diameter maintenance [GO:0097746]; neuropeptide signaling pathway [GO:0007218]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; urotensin II receptor activity [GO:0001604]; blood circulation [GO:0008015]; blood vessel diameter maintenance [GO:0097746]; neuropeptide signaling pathway [GO:0007218]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] GO:0001604; GO:0004930; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0008015; GO:0008217; GO:0008528; GO:0016020; GO:0097746 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; urotensin II receptor activity [GO:0001604] AYLTLLFATSIAGPGLLIGLLYAR 0.98876 -4.0301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5559 0 12.0072 14.7121 0 13.621 11.9245 0 0 0 0 0 15.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1327 0 0 0 0 15.4073 11.7425 0 0 0 15.2104 0 0 0 0 0 0 0 0 0 0 0 0 14.3154 0 0 10.8025 15.9407 0 0 0 0 0 0 0 0 12.0291 0 0 0 0 0 0 0 0 12.6111 0 0 0 0 0 0 0 0 0 11.4962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2328 12.2759 0 0 12.0615 0 0 0 0 0 0 0 0 0 0 0 P49902 5NTC_HUMAN "Cytosolic purine 5'-nucleotidase, EC 3.1.3.5, EC 3.1.3.99 (Cytosolic 5'-nucleotidase II, cN-II) (Cytosolic IMP/GMP-specific 5'-nucleotidase) (Cytosolic nucleoside phosphotransferase 5'N, EC 2.7.1.77) (High Km 5'-nucleotidase)" NT5C2 NT5B NT5CP PNT5 Homo sapiens (Human) adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP catabolic process [GO:0006204]; IMP metabolic process [GO:0046040]; nucleotide phosphorylation [GO:0046939] cytosol [GO:0005829] cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; XMP 5'-nucleosidase activity [GO:0106411]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP catabolic process [GO:0006204]; IMP metabolic process [GO:0046040]; nucleotide phosphorylation [GO:0046939] GO:0000255; GO:0005524; GO:0005829; GO:0006204; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046085; GO:0046872; GO:0046939; GO:0050146; GO:0050483; GO:0050484; GO:0106411 5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; XMP 5'-nucleosidase activity [GO:0106411] AAHVLMPHESTVEHTHVDINEMESPLATRNR 0.98877 -4.038 0 0 0 0 10.2454 0 0 0 11.9842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.852 0 0 0 0 0 12.4568 0 0 13.9461 0 0 0 0 0 0 0 10.7247 0 0 0 0 0 0 0 11.3786 12.0997 0 0 0 12.2828 0 11.4236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3986 0 0 0 15.4786 0 0 0 0 0 0 0 0 0 0 0 0 14.4863 0 0 0 0 0 12.7931 0 0 0 0 0 11.9525 0 13.56 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9887 12.5197 0 0 0 0 0 0 0 0 0 12.2828 12.7693 0 0 0 12.2343 0 0 Q15006 EMC2_HUMAN "ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35, TPR repeat protein 35)" EMC2 KIAA0103 TTC35 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406] cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005737; GO:0005783; GO:0005789; GO:0042406; GO:0045050; GO:0071816; GO:0072546 ILQEDPTNTAAR 0.98877 -1.911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.645 0 0 0 0 0 0 13.3567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW24 TEKT4_HUMAN Tektin-4 TEKT4 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] GO:0005634; GO:0005879; GO:0015630; GO:0036126; GO:0060271; GO:0060294 ALDATEVPFSITTDNLQCRERR 0.98877 -4.1605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.688 12.9614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7271 0 12.2336 0 0 0 0 0 0 0 0 0 0 0 11.9738 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4198 0 0 0 0 0 0 0 0 0 0 14.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6339 0 0 0 0 0 0 0 13.426 13.2563 0 0 0 0 0 0 0 0 0 13.604 0 0 0 13.4303 0 0 0 0 0 0 Q9UIJ7 KAD3_HUMAN "GTP:AMP phosphotransferase AK3, mitochondrial, EC 2.7.4.10 (Adenylate kinase 3, AK 3) (Adenylate kinase 3 alpha-like 1)" AK3 AK3L1 AK6 AKL3L Homo sapiens (Human) ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; phosphorylation [GO:0016310]; UTP metabolic process [GO:0046051] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; phosphorylation [GO:0016310]; UTP metabolic process [GO:0046051] GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0016310; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899 ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside triphosphate adenylate kinase activity [GO:0046899] GTEIGVLAK 0.98877 -4.0414 0 0 0 0 0 0 0 0 13.5874 13.6316 0 15.6591 0 0 0 0 0 0 0 13.2639 0 0 12.468 0 0 0 0 12.7482 0 0 13.7134 13.6873 16.8068 0 14.6942 0 13.8892 13.8052 0 0 0 0 0 0 0 12.6706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6233 13.7424 0 0 0 16.8124 0 0 0 0 13.4574 0 0 0 0 0 0 0 0 0 0 13.9694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1398 0 0 0 0 0 13.6359 0 0 0 0 12.8447 0 13.3803 0 12.8416 13.8301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9131 0 0 0 0 0 0 0 0 18.1909 18.9144 Q5T7N8 F27D1_HUMAN Protein FAM27D1 FAM27D1 Homo sapiens (Human) ADPQQQKR 0.98878 -4.0593 0 0 0 0 0 0 0 0 12.8293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0182 0 0 0 0 0 0 0 11.4598 0 0 0 0 11.2619 0 0 11.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7653 0 0 0 0 0 0 0 0 0 0 15.1702 0 0 11.8806 0 0 0 13.809 0 0 Q9Y337 KLK5_HUMAN "Kallikrein-5, EC 3.4.21.- (Kallikrein-like protein 2, KLK-L2) (Stratum corneum tryptic enzyme)" KLK5 SCTE UNQ570/PRO1132 Homo sapiens (Human) amelogenesis [GO:0097186]; cornification [GO:0070268]; epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proteolysis [GO:0006508] cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; amelogenesis [GO:0097186]; cornification [GO:0070268]; epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proteolysis [GO:0006508] GO:0002803; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0006508; GO:0008233; GO:0008236; GO:0008544; GO:0022617; GO:0030141; GO:0045745; GO:0070268; GO:0097186; GO:0097209 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] RCEDAYPR 0.98878 -1.7448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00110 OVOL3_HUMAN Putative transcription factor ovo-like protein 3 OVOL3 Homo sapiens (Human) epidermal cell differentiation [GO:0009913]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; epidermal cell differentiation [GO:0009913]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009913; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFLVRSRR 0.98879 -4.0672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28827 PTPRM_HUMAN "Receptor-type tyrosine-protein phosphatase mu, Protein-tyrosine phosphatase mu, R-PTP-mu, EC 3.1.3.48" PTPRM PTPRL1 Homo sapiens (Human) homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165] GO:0001937; GO:0004725; GO:0005001; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0006470; GO:0007156; GO:0007165; GO:0009410; GO:0010596; GO:0010842; GO:0016525; GO:0030027; GO:0031175; GO:0031290; GO:0042802; GO:0045296; GO:0048471 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] CAEGYGFK 0.98879 -4.0615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4871 0 0 0 0 0 0 0 0 0 0 10.934 0 0 0 0 0 0 0 0 0 0 12.4831 0 0 0 11.6455 0 0 0 0 0 0 0 0 0 0 0 12.792 0 0 0 12.2167 0 0 14.0753 0 0 0 0 0 0 0 0 0 10.9277 0 12.8988 0 0 0 0 0 0 0 0 0 0 11.9047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1425 0 0 0 0 0 0 0 0 0 0 Q8J025 APCD1_HUMAN Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein) APCDD1 DRAPC1 FP7019 Homo sapiens (Human) astrocyte cell migration [GO:0043615]; hair follicle development [GO:0001942]; negative regulation of Wnt signaling pathway [GO:0030178]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; Wnt signaling pathway [GO:0016055] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]; astrocyte cell migration [GO:0043615]; hair follicle development [GO:0001942]; negative regulation of Wnt signaling pathway [GO:0030178]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; Wnt signaling pathway [GO:0016055] GO:0001942; GO:0005886; GO:0005887; GO:0016055; GO:0017147; GO:0030178; GO:0042487; GO:0042802; GO:0043615 identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147] EENGCECTK 0.98879 -4.0661 0 0 0 0 0 0 0 0 0 0 13.6965 0 15.1292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4802 0 0 0 0 11.662 13.3451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0521 0 0 0 0 0 0 0 0 13.8471 0 0 0 0 13.3112 0 0 0 0 0 0 0 0 0 13.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N888 BCOR2_HUMAN Putative BCoR-like protein 2 (BCL-6 corepressor pseudogene 1) (BCL-6 corepressor-like protein 2) BCORP1 BCORL2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003714; GO:0005634 transcription corepressor activity [GO:0003714] VLSNNASSQK 0.98879 -1.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3765 0 0 0 12.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5H8 PCDA3_HUMAN "Protocadherin alpha-3, PCDH-alpha-3" PCDHA3 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] HRLLVLVK 0.98879 -1.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6Y2X3 DJC14_HUMAN "DnaJ homolog subfamily C member 14 (DnaJ protein homolog 3) (Dopamine receptor-interacting protein of 78 kDa, DRIP78) (Human DnaJ protein 3, hDj-3)" DNAJC14 DRIP78 HDJ3 Homo sapiens (Human) protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dopamine receptor binding [GO:0050780]; protein transport [GO:0015031] GO:0005789; GO:0015031; GO:0016020; GO:0016021; GO:0050780 dopamine receptor binding [GO:0050780] EAMNTMMCSRCQGK 0.9888 -4.0757 0 0 0 0 0 0 0 0 0 13.1971 0 0 0 0 0 0 0 0 0 0 12.3465 0 0 13.2209 0 0 0 0 0 0 0 0 0 0 13.3465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5802 0 0 0 0 15.0162 0 0 0 0 0 0 14.4957 15.0938 0 0 0 0 11.9893 0 0 0 13.4564 0 14.7508 11.6586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3536 0 0 0 0 0 0 0 0 0 0 0 14.439 0 12.7856 0 0 0 0 13.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6705 0 14.3027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.96 0 0 0 12.5565 0 0 0 0 0 Q9BRV3 SWET1_HUMAN "Sugar transporter SWEET1, HsSWEET1 (RAG1-activating protein 1) (Solute carrier family 50 member 1) (Stromal cell protein)" SLC50A1 RAG1AP1 SCP Homo sapiens (Human) carbohydrate transport [GO:0008643]; hexose transmembrane transport [GO:0008645] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucoside transmembrane transporter activity [GO:0042947]; sugar transmembrane transporter activity [GO:0051119]; carbohydrate transport [GO:0008643]; hexose transmembrane transport [GO:0008645] GO:0000139; GO:0005794; GO:0005886; GO:0008643; GO:0008645; GO:0012505; GO:0016021; GO:0042947; GO:0051119 glucoside transmembrane transporter activity [GO:0042947]; sugar transmembrane transporter activity [GO:0051119] NYWLLQT 0.9888 -4.0807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CL83 ST3L1_HUMAN Putative STAG3-like protein 1 (Stromal antigen 3-like protein 1) STAG3L1 Homo sapiens (Human) sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; cohesin complex [GO:0008278]; nucleus [GO:0005634] chromatin [GO:0000785]; cohesin complex [GO:0008278]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; sister chromatid cohesion [GO:0007062] GO:0000785; GO:0003682; GO:0005634; GO:0007062; GO:0008278 chromatin binding [GO:0003682] EVRVKCVK 0.98882 -4.2368 0 0 10.5852 13.7736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1308 0 0 0 13.2121 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3769 0 0 0 14.963 0 15.01 0 0 14.1914 15.1069 13.6203 15.4332 14.1443 0 13.9069 0 0 0 13.7872 13.6184 13.2998 0 0 12.9948 0 0 12.6737 0 0 0 0 0 0 14.8573 0 0 0 0 0 0 12.6828 0 13.4359 0 0 0 0 0 13.5417 0 0 0 0 14.4935 0 14.4343 0 0 0 0 0 0 0 0 0 0 0 0 14.9948 0 0 0 12.6381 0 13.2672 0 15.4593 13.1049 0 0 0 0 13.3577 13.3254 0 15.1199 0 0 0 17.0932 0 0 0 Q8NA03 FSIP1_HUMAN Fibrous sheath-interacting protein 1 FSIP1 HSD10 Homo sapiens (Human) CLLDECILKQKSIIK 0.98882 -1.7676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1584 0 0 12.9338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5643 0 0 0 0 12.2769 12.8262 0 0 0 0 0 0 12.3473 0 0 0 0 0 0 0 11.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UFW8 CGBP1_HUMAN "CGG triplet repeat-binding protein 1, CGG-binding protein 1 (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein)" CGGBP1 CGGBP Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]" GO:0000122; GO:0003690; GO:0005634; GO:0005654; GO:0010468; GO:0040029; GO:0042802; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802] FVVTAPPARNR 0.98883 -1.7702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.43 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6469 0 0 0 0 0 0 0 13.6575 0 0 0 12.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3468 0 0 0 0 12.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5788 Q14993 COJA1_HUMAN Collagen alpha-1(XIX) chain (Collagen alpha-1(Y) chain) COL19A1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; extracellular matrix organization [GO:0030198]; skeletal muscle tissue development [GO:0007519]; skeletal system development [GO:0001501] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; extracellular matrix organization [GO:0030198]; skeletal muscle tissue development [GO:0007519]; skeletal system development [GO:0001501] GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0007155; GO:0007519; GO:0030154; GO:0030198; GO:0030674; GO:0031012; GO:0062023; GO:0098609 extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674] CNPEDCLYPVSHAHQRTGGN 0.98886 -4.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2461 0 0 14.9514 15.0138 15.1926 0 0 14.8938 0 0 0 14.918 0 0 0 0 0 12.801 0 13.4381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5657 0 0 0 0 0 0 0 0 0 Q7Z3S7 CA2D4_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-4 (Voltage-gated calcium channel subunit alpha-2/delta-4) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-4; Voltage-dependent calcium channel subunit delta-4 ] CACNA2D4 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of ion transmembrane transport [GO:0034765] voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport [GO:0070588]; detection of light stimulus involved in visual perception [GO:0050908]; regulation of ion transmembrane transport [GO:0034765] GO:0005245; GO:0005891; GO:0034765; GO:0046872; GO:0050908; GO:0070588 metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] FSEDMENMLR 0.98886 -4.038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8627 0 0 13.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y584 TIM22_HUMAN Mitochondrial import inner membrane translocase subunit Tim22 (Testis-expressed protein 4) TIMM22 TEX4 TIM22 Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320]; protein transporter activity [GO:0140318]; protein insertion into mitochondrial inner membrane [GO:0045039] GO:0005743; GO:0008320; GO:0016021; GO:0030943; GO:0042721; GO:0045039; GO:0140318 mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320]; protein transporter activity [GO:0140318] AMESCAFK 0.98886 -1.7158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75396 SC22B_HUMAN "Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa, ERS-24, ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1)" SEC22B SEC22L1 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of autophagosome assembly [GO:1902902]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280]" endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133] "endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of autophagosome assembly [GO:1902902]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280]" GO:0000139; GO:0005484; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0012507; GO:0015031; GO:0016021; GO:0030133; GO:0030670; GO:0031201; GO:0033116; GO:0042470; GO:0045732; GO:0048280; GO:1902902 SNAP receptor activity [GO:0005484] DLQQYQSQAKQLFRK 0.98887 -1.9045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.956 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0594 0 14.7437 14.1948 14.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14142 TRI14_HUMAN Tripartite motif-containing protein 14 TRIM14 KIAA0129 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] GO:0000209; GO:0003713; GO:0005654; GO:0005737; GO:0005741; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0032897; GO:0042803; GO:0043123; GO:0045087; GO:0045335; GO:0046596; GO:0051091; GO:0051092; GO:0061630 protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ANAESSKTWLKGK 0.98887 -1.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8276 0 0 0 0 0 0 0 0 0 0 0 0 13.3989 0 13.2757 12.625 12.0763 0 0 0 0 0 0 13.1542 0 0 0 12.9392 0 0 0 0 0 0 12.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7409 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0255 0 0 12.0254 0 0 0 0 0 0 0 Q96HS1 PGAM5_HUMAN "Serine/threonine-protein phosphatase PGAM5, mitochondrial, EC 3.1.3.16 (Bcl-XL-binding protein v68) (Phosphoglycerate mutase family member 5)" PGAM5 Homo sapiens (Human) macroautophagy [GO:0016236]; necroptotic process [GO:0070266]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of mitochondrial fission [GO:0090141] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; macroautophagy [GO:0016236]; necroptotic process [GO:0070266]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of mitochondrial fission [GO:0090141] GO:0004722; GO:0005096; GO:0005739; GO:0005741; GO:0016021; GO:0016236; GO:0016791; GO:0017018; GO:0035970; GO:0044877; GO:0070266; GO:0090141; GO:0120163 GTPase activator activity [GO:0005096]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877] EGAPIEPDPPVSHWK 0.98887 -1.9056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9238 0 11.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6229 12.9062 13.5011 0 0 13.8274 0 0 0 0 0 17.0237 0 0 0 0 0 0 0 13.7316 12.9129 12.3513 0 0 0 0 0 13.7358 0 0 0 12.9506 0 13.4531 0 13.8563 0 0 14.0077 0 13.3109 13.2704 0 13.8338 0 14.3232 13.4547 0 13.6453 12.7343 12.9171 0 13.6617 0 13.2642 12.9428 13.5539 0 13.1528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3614 13.5272 0 13.6083 13.6583 13.4244 0 0 0 13.1904 0 0 0 0 0 0 0 0 Q9BYX7 ACTBM_HUMAN Putative beta-actin-like protein 3 (Kappa-actin) (POTE ankyrin domain family member K) POTEKP ACTBL3 FKSG30 Homo sapiens (Human) actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] actin filament [GO:0005884]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973] GO:0005524; GO:0005576; GO:0005829; GO:0005884; GO:0070062; GO:0098973 ATP binding [GO:0005524]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973] AGFAGDDAPQAVFPSIVGRPRHQGMMEGMHQK 0.98887 -1.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5151 0 0 0 0 0 0 0 0 0 0 13.2791 Q6ZW49 PAXI1_HUMAN PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein) PAXIP1 PAXIP1L PTIP CAGF28 Homo sapiens (Human) "adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]" chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adipose tissue development [GO:0060612]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]" GO:0000416; GO:0001570; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0010212; GO:0016363; GO:0030330; GO:0031398; GO:0035066; GO:0035097; GO:0043433; GO:0043542; GO:0044666; GO:0045830; GO:0048304; GO:0051568; GO:0051571; GO:0060261; GO:0060612; GO:0060717; GO:1902749; GO:2001022 AHVSPLFK 0.98888 -4.0658 0 0 0 0 0 0 0 0 14.1778 12.6515 12.6896 0 0 0 11.7921 11.2104 12.3647 0 0 0 0 0 0 0 0 0 11.7373 0 0 0 0 0 0 0 0 0 0 0 14.7689 0 0 0 0 0 0 11.8607 12.3097 0 0 0 0 0 12.0002 0 0 0 10.6832 0 0 0 0 0 0 0 0 12.4021 11.1222 0 0 0 0 13.233 0 0 0 0 9.88906 0 0 0 0 0 0 16.522 0 12.6422 0 0 0 0 13.769 0 13.2874 0 0 0 0 0 0 0 0 0 13.5103 14.1261 13.6962 0 0 0 0 11.8583 0 13.2995 12.3427 0 0 0 0 0 0 0 0 0 13.1616 14.386 13.2737 0 0 0 0 0 0 12.6807 0 0 12.5543 0 0 0 0 0 0 0 0 0 0 0 0 15.6266 0 0 0 12.1156 0 13.3247 10.6064 0 13.7671 0 12.972 0 12.5746 12.4807 13.0264 13.2116 13.0091 14.4089 0 12.4334 12.8505 12.2464 12.7645 0 0 0 0 11.7913 0 15.0203 0 0 Q8IZU9 KIRR3_HUMAN Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3 ] KIRREL3 KIAA1867 NEPH2 UNQ5923/PRO4502/PRO19814 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416] axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; cell adhesion molecule binding [GO:0050839]; cell-cell adhesion [GO:0098609]; glomerulus morphogenesis [GO:0072102]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inter-male aggressive behavior [GO:0002121]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; synapse assembly [GO:0007416] GO:0001764; GO:0002121; GO:0005576; GO:0005886; GO:0005887; GO:0005911; GO:0007156; GO:0007416; GO:0008021; GO:0016021; GO:0021740; GO:0021766; GO:0030097; GO:0030424; GO:0030425; GO:0043198; GO:0048812; GO:0050839; GO:0072102; GO:0098609 cell adhesion molecule binding [GO:0050839] GEFQQDSVLKQLEVLK 0.98888 -4.0615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYK1 CNTP5_HUMAN Contactin-associated protein-like 5 (Cell recognition molecule Caspr5) CNTNAP5 CASPR5 Homo sapiens (Human) cell adhesion [GO:0007155] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155] GO:0005886; GO:0007155; GO:0016021 DVISLKFK 0.98888 -1.9107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.817 0 0 13.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3279 0 0 0 10.8816 0 12.0331 0 0 0 0 0 0 0 10.4024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0504 0 14.2216 10.9267 0 0 0 0 15.0992 0 0 0 0 0 Q9UJW2 TINAG_HUMAN "Tubulointerstitial nephritis antigen, TIN-Ag" TINAG Homo sapiens (Human) cell adhesion [GO:0007155]; proteolysis [GO:0006508] basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764] basement membrane [GO:0005604]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166]; cell adhesion [GO:0007155]; proteolysis [GO:0006508] GO:0000166; GO:0004197; GO:0005604; GO:0005615; GO:0005764; GO:0006508; GO:0007155 cysteine-type endopeptidase activity [GO:0004197]; nucleotide binding [GO:0000166] AIFQGQYCRNFGCCEDR 0.98888 -4.067 0 0 0 0 13.3918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2223 0 0 0 12.7105 0 0 0 11.7495 0 0 12.2597 0 0 0 0 0 0 0 0 14.4146 0 0 14.6029 11.1295 0 0 0 0 14.2129 0 0 0 12.6344 0 0 0 0 0 0 11.728 0 0 13.5697 13.0075 0 15.0466 0 12.6626 13.2194 0 13.168 0 0 14.9585 0 0 0 0 0 0 0 0 0 13.5956 0 14.5208 13.7205 0 0 13.5669 13.4078 13.4167 0 13.3656 0 0 0 0 12.2664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7594 0 14.5191 0 0 0 0 0 0 Q99614 TTC1_HUMAN "Tetratricopeptide repeat protein 1, TPR repeat protein 1" TTC1 TPR1 Homo sapiens (Human) protein folding [GO:0006457] cytosol [GO:0005829]; peroxisomal membrane [GO:0005778] cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] GO:0005778; GO:0005829; GO:0006457; GO:0051082 unfolded protein binding [GO:0051082] AILRRAELYEK 0.98889 -1.7447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5298 0 0 0 0 0 0 0 11.0831 11.2754 0 0 0 0 0 0 0 0 0 0 11.9795 0 11.3035 0 0 0 0 0 9.47553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7353 0 0 0 0 10.7345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1476 0 0 14.5835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.214 0 0 0 0 10.6236 0 0 0 0 0 0 0 0 0 0 0 0 13.7762 0 0 0 0 0 0 0 0 11.5196 0 0 0 0 0 0 0 0 0 0 10.8061 0 0 0 0 0 0 13.5252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6753 0 0 0 0 0 0 13.3436 0 Q86Z20 CC125_HUMAN Coiled-coil domain-containing protein 125 (Protein kenae) CCDC125 KENAE Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of cell motility [GO:2000146]; negative regulation of Rho protein signal transduction [GO:0035024] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; activation of GTPase activity [GO:0090630]; negative regulation of cell motility [GO:2000146]; negative regulation of Rho protein signal transduction [GO:0035024] GO:0005737; GO:0035024; GO:0042802; GO:0090630; GO:2000146 identical protein binding [GO:0042802] ATSHTQAVLQK 0.98891 -4.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8801 0 10.8225 0 0 12.9575 0 14.1435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8996 12.0318 0 13.6254 0 0 0 0 0 0 0 0 12.2107 0 0 0 0 0 0 0 0 0 13.628 0 14.7429 12.84 0 0 0 11.5177 0 0 11.3298 0 11.6025 0 0 0 0 0 0 0 0 0 12.4362 0 0 0 0 0 11.717 0 0 0 0 0 0 0 0 0 0 0 0 0 11.031 0 0 0 0 0 0 0 0 0 10.7276 0 15.8517 0 0 0 0 0 0 0 16.2205 0 0 11.9772 0 0 18.112 0 0 0 0 0 0 0 0 0 0 0 11.1728 0 0 0 P11168 GTR2_HUMAN "Solute carrier family 2, facilitated glucose transporter member 2 (Glucose transporter type 2, liver, GLUT-2)" SLC2A2 GLUT2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; galactose transmembrane transport [GO:0015757]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; monosaccharide transmembrane transport [GO:0015749] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; galactose transmembrane transporter activity [GO:0005354]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; carbohydrate metabolic process [GO:0005975]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; galactose transmembrane transport [GO:0015757]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; monosaccharide transmembrane transport [GO:0015749] GO:0005353; GO:0005354; GO:0005355; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0005911; GO:0005975; GO:0015149; GO:0015749; GO:0015755; GO:0015757; GO:0016020; GO:0016324; GO:0033300; GO:0046323; GO:0055056; GO:0070837; GO:1904659 D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; galactose transmembrane transporter activity [GO:0005354]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149] AKQSLKR 0.98892 -4.2508 0 0 0 0 0 0 0 0 17.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0F5 RNF38_HUMAN "E3 ubiquitin-protein ligase RNF38, EC 2.3.2.27 (RING finger protein 38) (RING-type E3 ubiquitin transferase RNF38)" RNF38 Homo sapiens (Human) male gonad development [GO:0008584]; protein ubiquitination [GO:0016567] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; male gonad development [GO:0008584]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005654; GO:0008584; GO:0016567; GO:0036126; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LGEAKPRGLTK 0.98892 -4.2521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0137 0 12.817 0 0 0 0 12.931 0 0 0 0 0 0 0 13.276 0 0 0 0 0 0 0 0 0 0 0 0 13.2653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBM0 VEZA_HUMAN Vezatin VEZT Homo sapiens (Human) cell-cell adhesion [GO:0098609] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609] GO:0001669; GO:0002142; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0016021; GO:0017022; GO:0060171; GO:0098609 myosin binding [GO:0017022] LATLYMLK 0.98894 -1.7672 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9742 0 0 0 0 0 0 0 0 0 0 0 9.95257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7084 0 0 0 0 0 0 0 0 10.8536 0 12.5134 0 0 0 0 0 0 0 0 0 12.6819 0 0 0 0 0 0 12.6115 0 0 0 0 12.7957 13.8048 0 0 0 0 0 13.2343 0 0 0 0 13.4685 0 12.4349 12.3924 0 0 0 0 13.6575 0 0 0 0 12.5041 0 12.5701 0 0 0 0 0 0 0 0 0 0 12.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3947 0 0 0 0 0 0 12.7913 0 0 11.6988 0 0 0 0 9.86821 0 0 0 0 0 0 0 11.8133 0 0 12.2025 0 0 0 Q8NEB5 PLPP5_HUMAN "Phospholipid phosphatase 5, EC 3.1.3.4, EC 3.1.3.81 (Phosphatidic acid phosphatase type 2 domain-containing protein 1B)" PLPP5 DPPL1 HTPAP PPAPDC1B Homo sapiens (Human) phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; diacylglycerol diphosphate phosphatase activity [GO:0000810]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644] GO:0000810; GO:0005737; GO:0005886; GO:0006644; GO:0008195; GO:0016021; GO:0046839 diacylglycerol diphosphate phosphatase activity [GO:0000810]; phosphatidate phosphatase activity [GO:0008195] CFPDGLAHSDLMCTGDK 0.98895 -4.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5062 13.9081 13.5781 13.256 13.2302 0 0 0 0 13.2982 0 0 0 0 13.4215 0 13.7928 0 14.422 0 0 0 0 11.5903 13.3525 0 0 0 13.3214 0 0 0 0 0 12.4042 0 0 0 0 0 13.1914 0 0 0 0 0 12.1398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4428 0 0 0 0 0 0 0 0 0 0 Q5JTC6 AMER1_HUMAN "APC membrane recruitment protein 1, Amer1 (Protein FAM123B) (Wilms tumor gene on the X chromosome protein)" AMER1 FAM123B WTX Homo sapiens (Human) adipose tissue development [GO:0060612]; bone development [GO:0060348]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; beta-catenin destruction complex binding [GO:1904713]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; adipose tissue development [GO:0060612]; bone development [GO:0060348]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]" GO:0005546; GO:0005829; GO:0005886; GO:0008013; GO:0016055; GO:0016604; GO:0031398; GO:0043231; GO:0045732; GO:0060348; GO:0060612; GO:0060828; GO:0072161; GO:0090090; GO:0090263; GO:1904713 "beta-catenin binding [GO:0008013]; beta-catenin destruction complex binding [GO:1904713]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" EAYTREAYGR 0.98896 -1.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9625 0 0 14.1267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWF3 SCIMP_HUMAN "SLP adapter and CSK-interacting membrane protein (SLP65/SLP76, Csk-interacting membrane protein)" SCIMP C17orf87 UNQ5783/PRO16090 Homo sapiens (Human) cellular response to molecule of fungal origin [GO:0071226]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of stress-activated MAPK cascade [GO:0032874]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123] filopodium [GO:0030175]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; receptor complex [GO:0043235]; ruffle [GO:0001726]; tetraspanin-enriched microdomain [GO:0097197]; uropod membrane [GO:0031259] filopodium [GO:0030175]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; receptor complex [GO:0043235]; ruffle [GO:0001726]; tetraspanin-enriched microdomain [GO:0097197]; uropod membrane [GO:0031259]; molecular adaptor activity [GO:0060090]; cellular response to molecule of fungal origin [GO:0071226]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of stress-activated MAPK cascade [GO:0032874]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor TLR1:TLR2 signaling pathway [GO:0038123] GO:0001726; GO:0001772; GO:0002720; GO:0002732; GO:0016020; GO:0016021; GO:0030175; GO:0031256; GO:0031259; GO:0031666; GO:0032735; GO:0032755; GO:0032874; GO:0034138; GO:0034142; GO:0034154; GO:0038123; GO:0043235; GO:0045335; GO:0060090; GO:0070374; GO:0071226; GO:0097197 molecular adaptor activity [GO:0060090] WEIAKPLKHK 0.98896 -1.7801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7219 0 0 0 0 0 0 0 0 12.8523 0 0 0 0 0 0 0 18.4454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17844 DDX5_HUMAN "Probable ATP-dependent RNA helicase DDX5, EC 3.6.4.13 (DEAD box protein 5) (RNA helicase p68)" DDX5 G17P1 HELR HLR1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of miRNA maturation [GO:1903800]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of miRNA maturation [GO:1903800]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]" GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0030509; GO:0030520; GO:0030521; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045445; GO:0045667; GO:0046332; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1903800; GO:1990841; GO:1990904; GO:2001014 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332] FEKNFYQEHPDLAR 0.98897 -1.7146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3867 0 0 15.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVZ3 NECP2_HUMAN "Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2, NECAP-2)" NECAP2 Homo sapiens (Human) endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0005905; GO:0006897; GO:0015031; GO:0016192; GO:0030125 IPPRATNRGYR 0.98898 -1.9072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7234 0 0 0 0 0 0 0 0 13.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8552 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2461 0 0 0 0 0 0 0 0 12.1872 0 12.3933 0 0 0 0 0 0 15.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JB6 LOXL4_HUMAN "Lysyl oxidase homolog 4, EC 1.4.3.- (Lysyl oxidase-like protein 4) (Lysyl oxidase-related protein C)" LOXL4 LOXC Homo sapiens (Human) collagen fibril organization [GO:0030199]; peptidyl-lysine oxidation [GO:0018057] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; peptidyl-lysine oxidation [GO:0018057] GO:0004720; GO:0005044; GO:0005507; GO:0005615; GO:0016020; GO:0018057; GO:0030199; GO:0043235; GO:0062023; GO:0070062 copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044] DPKSRLK 0.98899 -1.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4269 11.5591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGU5 HMGX4_HUMAN HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG) HMGXB4 HMG2L1 HMGBCG Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] NURF complex [GO:0016589] NURF complex [GO:0016589]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] GO:0003677; GO:0008333; GO:0016055; GO:0016589; GO:0030178; GO:0042802 DNA binding [GO:0003677]; identical protein binding [GO:0042802] AYDDSVK 0.989 -4.2281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49748 ACADV_HUMAN "Very long-chain specific acyl-CoA dehydrogenase, mitochondrial, VLCAD, EC 1.3.8.9" ACADVL VLCAD Homo sapiens (Human) energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659] GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031314; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181 acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099] EKITAFVVERGFGGITHGPPEK 0.98901 -4.2422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.016 0 0 0 0 0 15.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0341 12.9018 0 0 0 0 0 0 0 13.2955 0 0 0 0 13.1849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TAA0 TTC22_HUMAN "Tetratricopeptide repeat protein 22, TPR repeat protein 22" TTC22 Homo sapiens (Human) AIEIAKNQPPILNRLAK 0.98901 -4.2468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NA42 ZN383_HUMAN Zinc finger protein 383 ZNF383 HSD17 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005654; GO:0005737; GO:0006357; GO:0031965; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] FFSCGSHVTR 0.98901 -1.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4281 0 0 12.0359 0 0 0 12.0168 0 0 0 12.1105 0 12.2702 0 0 0 0 13.7213 13.0618 0 0 0 0 0 0 0 12.5333 0 0 0 0 0 11.2369 0 0 0 0 0 0 0 12.0539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96G91 P2Y11_HUMAN "P2Y purinoceptor 11, P2Y11" P2RY11 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; neuronal signal transduction [GO:0023041]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled ATP receptor activity [GO:0045031]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; activation of adenylate cyclase activity [GO:0007190]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; defense response [GO:0006952]; G protein-coupled receptor signaling pathway [GO:0007186]; neuronal signal transduction [GO:0023041]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] GO:0005886; GO:0005887; GO:0006952; GO:0007186; GO:0007190; GO:0007200; GO:0019722; GO:0023041; GO:0030594; GO:0038023; GO:0045031; GO:0071318 G protein-coupled ATP receptor activity [GO:0045031]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023] DSWNPEDAK 0.98901 -4.2434 0 0 0 0 0 0 0 0 0 0 0 11.4305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7219 0 0 0 0 14.2614 0 0 0 0 0 0 0 0 0 0 0 12.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60704 TPST2_HUMAN "Protein-tyrosine sulfotransferase 2, EC 2.8.2.20 (Tyrosylprotein sulfotransferase 2, TPST-2)" TPST2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; peptidyl-tyrosine sulfation [GO:0006478] GO:0000139; GO:0005783; GO:0005794; GO:0006478; GO:0008146; GO:0008476; GO:0016021; GO:0042803; GO:0050427 protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146] IIPRVLAMR 0.98902 -4.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0977 0 0 0 0 0 0 0 12.9315 0 0 0 0 14.2686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0303 0 0 0 14.3951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13797 PLST_HUMAN Plastin-3 (T-plastin) PLS3 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348] GO:0005509; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0032432; GO:0051015; GO:0051017; GO:0051639; GO:0060348 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509] DEMATTQISKDELDELK 0.98902 -1.7489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5365 0 0 0 0 0 0 0 0 0 13.1056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31785 IL2RG_HUMAN "Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma, IL-2 receptor subunit gamma, IL-2R subunit gamma, IL-2RG) (gammaC) (p64) (CD antigen CD132)" IL2RG Homo sapiens (Human) "CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; cytokine-mediated signaling pathway [GO:0019221]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; mature B cell differentiation [GO:0002335]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T cell differentiation in thymus [GO:0033089]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]" cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; interleukin-2 binding [GO:0019976]; CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; cytokine-mediated signaling pathway [GO:0019221]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; mature B cell differentiation [GO:0002335]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0032831]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T cell differentiation in thymus [GO:0033089]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]" GO:0002335; GO:0002361; GO:0004896; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0006955; GO:0007165; GO:0009897; GO:0009986; GO:0010467; GO:0010628; GO:0016020; GO:0019221; GO:0019955; GO:0019976; GO:0032831; GO:0033077; GO:0033089; GO:0035723; GO:0035771; GO:0038110; GO:0038111; GO:0042010; GO:0043235; GO:0045579; GO:0050766 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; interleukin-2 binding [GO:0019976] FSLPSVDGQK 0.98902 -1.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5637 12.4342 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5249 13.6223 13.7087 12.9084 0 13.1679 12.7515 0 0 0 0 12.6984 0 0 0 0 0 0 0 0 12.5291 0 0 0 0 0 0 0 0 0 0 0 0 13.7572 0 13.4173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95182 NDUA7_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a, CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a)" NDUFA7 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0003735; GO:0005739; GO:0005743; GO:0005747; GO:0005761; GO:0006120; GO:0008137; GO:0009060; GO:0032543; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735] KAVTPAPPIK 0.98903 -1.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4382 12.7902 0 13.1608 0 0 14.0692 0 13.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.659 14.1142 0 0 0 0 0 14.4903 15.3363 0 0 0 0 0 0 0 0 0 14.9457 0 0 14.1919 0 0 0 0 14.3221 0 0 0 0 14.2737 0 0 15.1647 0 0 15.7092 0 15.595 0 0 0 0 0 13.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0621 0 0 0 0 14.9604 0 15.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY57 YAF2_HUMAN YY1-associated factor 2 YAF2 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0045892; GO:0045893; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] GMSRSSSPR 0.98903 -1.7504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7162 0 0 0 0 0 0 0 0 0 12.4766 12.6877 0 0 11.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0751 0 0 0 11.9832 0 12.1232 0 0 0 0 0 0 0 0 0 0 11.6695 0 11.6455 0 0 0 13.9452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0523 0 0 0 0 10.5097 0 0 0 0 Q9BU89 DOHH_HUMAN "Deoxyhypusine hydroxylase, hDOHH, EC 1.14.99.29 (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1)" DOHH HLRC1 Homo sapiens (Human) peptidyl-lysine modification to peptidyl-hypusine [GO:0008612] cytosol [GO:0005829] cytosol [GO:0005829]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612] GO:0005506; GO:0005829; GO:0008612; GO:0016491; GO:0019135 deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491] FRALFTLR 0.98904 -1.7627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13646 K1C13_HUMAN "Keratin, type I cytoskeletal 13 (Cytokeratin-13, CK-13) (Keratin-13, K13)" KRT13 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of translation in response to stress [GO:0043555] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nucleus [GO:0005634]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of translation in response to stress [GO:0043555] GO:0005198; GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0030855; GO:0043555; GO:0045095; GO:0045109; GO:0045111; GO:0070062 structural molecule activity [GO:0005198] ALEEANADLEVK 0.98905 -4.0352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30566 PUR8_HUMAN "Adenylosuccinate lyase, ADSL, ASL, EC 4.3.2.2 (Adenylosuccinase, ASase)" ADSL AMPS Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; aerobic respiration [GO:0009060]; AMP biosynthetic process [GO:0006167]; AMP salvage [GO:0044209]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to starvation [GO:0042594] cytosol [GO:0005829]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; protein-containing complex [GO:0032991]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity [GO:0070626]; identical protein binding [GO:0042802]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; aerobic respiration [GO:0009060]; AMP biosynthetic process [GO:0006167]; AMP salvage [GO:0044209]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]" GO:0001666; GO:0004018; GO:0005829; GO:0006164; GO:0006167; GO:0006177; GO:0006189; GO:0007584; GO:0009060; GO:0014850; GO:0032991; GO:0042594; GO:0042802; GO:0044208; GO:0044209; GO:0070626; GO:0097294 "(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity [GO:0070626]; identical protein binding [GO:0042802]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]" CCLWIQDLCMDLQNLK 0.98905 -1.8677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4927 14.4073 0 0 0 0 0 0 0 0 0 0 0 15.0694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8866 0 0 0 0 0 0 0 0 12.9363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13045 FLII_HUMAN Protein flightless-1 homolog FLII FLIL Homo sapiens (Human) actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; myofibril assembly [GO:0030239] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; myofibril assembly [GO:0030239]" GO:0003779; GO:0005546; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005903; GO:0005925; GO:0008154; GO:0015629; GO:0030239; GO:0034451; GO:0051014; GO:0051015; GO:0051016 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AAEWYNIDFSLQNQLR 0.98905 -1.7665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5456 13.7474 0 0 0 0 0 17.5456 0 0 0 0 0 0 0 15.4206 0 0 0 0 0 0 12.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2424 0 0 0 0 0 0 0 0 0 0 0 0 18.0881 0 0 13.4932 0 0 0 0 0 0 0 12.8166 0 0 0 0 0 0 0 0 13.1604 0 0 12.1299 0 0 20.0566 0 0 0 0 0 0 0 0 12.7221 0 0 0 0 0 0 0 11.9539 12.9435 12.4724 11.2393 0 0 0 0 0 0 0 0 11.4618 12.0538 0 0 0 0 0 0 0 0 0 0 10.594 0 0 13.1665 0 0 0 20.5069 11.6461 12.1582 0 0 0 0 0 Q9H306 MMP27_HUMAN "Matrix metalloproteinase-27, MMP-27, EC 3.4.24.-" MMP27 UNQ2503/PRO5992 Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extrinsic component of endoplasmic reticulum membrane [GO:0042406] extracellular matrix [GO:0031012]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] GO:0004222; GO:0006508; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0042406 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] AHSGGIK 0.98905 -1.7671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1516 0 0 0 0 11.3653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3253 0 0 0 0 0 11.6661 0 0 0 0 0 0 0 0 0 0 13.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2078 0 0 0 0 0 12.3211 0 0 0 0 0 0 0 0 0 0 0 0 13.6296 0 0 0 0 Q9NZH0 GPC5B_HUMAN "G-protein coupled receptor family C group 5 member B (A-69G12.1) (Retinoic acid-induced gene 2 protein, RAIG-2)" GPRC5B RAIG2 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein tyrosine kinase activity [GO:0061098] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein tyrosine kinase activity [GO:0061098] GO:0001664; GO:0004930; GO:0005615; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0009986; GO:0016021; GO:0019901; GO:0030295; GO:0030659; GO:0043123; GO:0043231; GO:0043235; GO:0045666; GO:0050729; GO:0060907; GO:0061098; GO:0070062; GO:0090263 G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] AHQVLTFLLLFVITSVASENASTSR 0.98905 -4.0358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5625 0 0 0 0 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0501 13.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2787 13.9207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH37 OR4C3_HUMAN Olfactory receptor 4C3 (Olfactory receptor OR11-98) OR4C3 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NMALFYGILTPMLNPLIYTLRNEEVK 0.98907 -1.7771 0 0 0 0 0 0 0 0 14.4027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7618 12.5539 14.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.868 0 14.8793 14.4136 0 0 14.8314 12.3323 12.4067 0 0 0 0 0 14.8762 0 14.9367 10.6027 0 P48047 ATPO_HUMAN "ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein, OSCP)" ATP5PO ATP5O ATPO Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600]" GO:0000274; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005886; GO:0006754; GO:0015986; GO:0042776; GO:0045261; GO:0046933; GO:1902600 "proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]" CFSTSVVRPFAK 0.98909 -1.9071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8883 0 0 0 0 0 0 18.9243 0 0 0 0 0 11.6678 0 0 0 0 0 0 0 18.1729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0726 14.4757 0 0 0 0 0 0 0 0 13.726 12.3277 0 0 Q15884 F1892_HUMAN Protein FAM189A2 (Protein X123) FAM189A2 C9orf61 X123 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AHKLPSRR 0.98909 -1.9023 0 0 0 0 0 14.0212 0 11.1562 0 0 0 0 0 0 0 0 13.4439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3558 0 0 0 0 0 0 12.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.485 0 0 0 0 0 0 0 0 0 12.775 0 0 13.6712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP59 S40A1_HUMAN Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1) SLC40A1 FPN1 IREG1 SLC11A3 MSTP079 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; establishment of localization in cell [GO:0051649]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]; transcription by RNA polymerase II [GO:0006366] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; apoptotic process [GO:0006915]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; establishment of localization in cell [GO:0051649]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen trabecula formation [GO:0060345]; transcription by RNA polymerase II [GO:0006366] GO:0002260; GO:0003158; GO:0005381; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0006366; GO:0006879; GO:0006915; GO:0008021; GO:0015093; GO:0016021; GO:0016323; GO:0017046; GO:0034395; GO:0034755; GO:0042802; GO:0043066; GO:0045944; GO:0046872; GO:0051649; GO:0055072; GO:0060345; GO:0060586; GO:1903988 ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron ion transmembrane transporter activity [GO:0005381]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046] KENQANTSVV 0.98909 -1.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX01 TXN4B_HUMAN Thioredoxin-like protein 4B (Dim1-like protein) TXNL4B DIM2 DLP Homo sapiens (Human) "cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0007049; GO:0046540 SFLLPKLTSKK 0.98909 -1.7144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6S1 AZI2_HUMAN "5-azacytidine-induced protein 2 (NF-kappa-B-activating kinase-associated protein 1, Nak-associated protein 1, Nap1) (TILP)" AZI2 NAP1 TBKBP2 Homo sapiens (Human) defense response to virus [GO:0051607]; dendritic cell differentiation [GO:0097028]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cell cycle [GO:0000278]; T cell activation [GO:0042110]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; serine/threonine protein kinase complex [GO:1902554]; defense response to virus [GO:0051607]; dendritic cell differentiation [GO:0097028]; dendritic cell proliferation [GO:0044565]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cell cycle [GO:0000278]; T cell activation [GO:0042110]; type I interferon signaling pathway [GO:0060337] GO:0000278; GO:0005737; GO:0007249; GO:0042110; GO:0044565; GO:0051607; GO:0060337; GO:0097028; GO:1902554 AYHAYREVCIDR 0.9891 -4.2262 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91807 0 0 0 0 12.8387 0 12.6651 0 13.1142 0 0 12.9197 0 0 13.1695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7199 11.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.923 10.6812 0 0 0 0 12.2802 0 0 12.2382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4282 0 0 0 0 0 0 0 0 0 0 12.0645 0 0 0 0 0 0 0 0 0 14.479 0 0 0 9.6057 11.64 0 0 0 13.8352 0 0 0 0 0 13.6015 0 14.0231 0 11.5215 H7BZ55 CRCC2_HUMAN Ciliary rootlet coiled-coil protein 2 CROCC2 Homo sapiens (Human) AARALQK 0.98911 -4.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5872 12.8229 0 0 12.195 0 0 0 0 11.2901 0 13.3432 0 16.801 0 0 0 0 0 0 0 0 12.2807 0 13.3117 10.5494 0 0 0 0 0 0 12.806 0 0 0 0 0 0 0 0 0 0 12.7639 0 0 0 0 13.1237 14.518 0 0 0 0 0 13.4605 0 11.6808 0 0 0 0 0 0 11.1252 0 0 0 0 13.1003 11.655 11.1612 0 0 0 0 0 0 0 0 0 0 13.6049 0 13.7691 0 10.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7614 0 0 11.2301 0 11.1199 Q92973 TNPO1_HUMAN "Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein, MIP)" TNPO1 KPNB2 MIP1 TRN Homo sapiens (Human) protein import into nucleus [GO:0006606] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606] GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006606; GO:0008139; GO:0031267; GO:0061608; GO:0070062 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] ATVGILITTIASK 0.98911 -4.2525 0 0 0 0 0 0 9.60735 0 11.9661 14.7476 0 0 0 12.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8513 14.7848 0 0 14.5917 13.057 15.1007 12.4466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1254 0 0 0 0 0 0 0 11.8046 13.985 14.2969 13.5211 13.544 14.2524 14.3971 0 14.5473 13.188 0 0 10.7661 0 15.4114 0 0 15.5993 0 15.8679 0 19.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6969 0 19.2783 14.8019 0 0 0 0 0 0 12.2507 0 12.8892 13.5543 14.7403 0 0 0 14.4636 14.1558 0 0 0 10.7965 14.3424 0 14.6583 0 13.8009 0 14.8842 0 0 0 0 0 0 0 0 0 14.6479 0 0 0 15.7485 19.3857 0 0 0 0 0 13.6128 0 0 0 13.1716 0 0 13.4493 11.0417 0 0 0 0 0 12.5616 0 16.8456 13.6526 0 Q9BV38 WDR18_HUMAN WD repeat-containing protein 18 WDR18 Homo sapiens (Human) DNA-templated DNA replication [GO:0006261]; rRNA processing [GO:0006364] dynein axonemal particle [GO:0120293]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rix1 complex [GO:0097344] dynein axonemal particle [GO:0120293]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rix1 complex [GO:0097344]; DNA-templated DNA replication [GO:0006261]; rRNA processing [GO:0006364] GO:0005654; GO:0005656; GO:0005730; GO:0006261; GO:0006364; GO:0097344; GO:0120293 NLRKINR 0.98911 -4.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4499 0 0 0 0 0 0 0 0 0 0 0 0 14.673 0 0 0 0 0 0 0 0 Q8NDH6 ICA1L_HUMAN Islet cell autoantigen 1-like protein (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein) ICA1L ALS2CR14 ALS2CR15 Homo sapiens (Human) regulation of transport [GO:0051049] Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; protein domain specific binding [GO:0019904]; regulation of transport [GO:0051049] GO:0005794; GO:0019904; GO:0051049 protein domain specific binding [GO:0019904] KVQMQVRNSK 0.98914 -1.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0942 0 0 0 0 0 0 0 0 13.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6DRA6 H2B2D_HUMAN Putative histone H2B type 2-D (H2B-clustered histone 19 pseudogene) H2BC19P HIST2H2BD Homo sapiens (Human) nucleosome assembly [GO:0006334] nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; nucleosome assembly [GO:0006334] GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0030527; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AVTKAQKK 0.98915 -1.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2Z9 COQ6_HUMAN "Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, EC 1.14.13.- (Coenzyme Q10 monooxygenase 6)" COQ6 CGI-10 Homo sapiens (Human) ubiquinone biosynthetic process [GO:0006744] cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142] "cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142]; 2-octaprenyl-6-methoxyphenol hydroxylase activity [GO:0008681]; 4-hydroxy-3-all-trans-hexaprenylbenzoate oxygenase activity [GO:0106364]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; ubiquinone biosynthetic process [GO:0006744]" GO:0005739; GO:0005743; GO:0005794; GO:0006744; GO:0008681; GO:0016491; GO:0016709; GO:0031314; GO:0042995; GO:0071949; GO:0106364; GO:0110142 "2-octaprenyl-6-methoxyphenol hydroxylase activity [GO:0008681]; 4-hydroxy-3-all-trans-hexaprenylbenzoate oxygenase activity [GO:0106364]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]" ILLLEAGPK 0.98915 -4.3106 0 0 0 0 0 0 0 14.3967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6002 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6875 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0384 0 12.3042 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8925 0 0 0 0 0 13.0666 0 0 0 0 12.4201 15.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2138 P06748 NPM_HUMAN "Nucleophosmin, NPM (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)" NPM1 NPM Homo sapiens (Human) "cell volume homeostasis [GO:0006884]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; regulation of cell growth [GO:0001558]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome assembly [GO:0042255]; rRNA export from nucleus [GO:0006407]; signal transduction [GO:0007165]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; granular component [GO:0001652]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; spindle pole centrosome [GO:0031616] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; granular component [GO:0001652]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; spindle pole centrosome [GO:0031616]; chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein N-terminus binding [GO:0047485]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]; cell volume homeostasis [GO:0006884]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; regulation of cell growth [GO:0001558]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome assembly [GO:0042255]; rRNA export from nucleus [GO:0006407]; signal transduction [GO:0007165]" GO:0000055; GO:0000056; GO:0001046; GO:0001558; GO:0001652; GO:0003682; GO:0003713; GO:0003723; GO:0004860; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005925; GO:0006281; GO:0006334; GO:0006338; GO:0006407; GO:0006884; GO:0006886; GO:0006913; GO:0007098; GO:0007165; GO:0008104; GO:0008284; GO:0008285; GO:0010824; GO:0010825; GO:0010826; GO:0015934; GO:0015935; GO:0016020; GO:0016607; GO:0019843; GO:0019901; GO:0030957; GO:0031398; GO:0031616; GO:0032071; GO:0032991; GO:0032993; GO:0034644; GO:0042255; GO:0042273; GO:0042274; GO:0042393; GO:0042803; GO:0043023; GO:0043024; GO:0043066; GO:0043516; GO:0044387; GO:0045727; GO:0045860; GO:0045893; GO:0045944; GO:0046599; GO:0047485; GO:0048025; GO:0050821; GO:0051059; GO:0051082; GO:0051092; GO:0060699; GO:0060735; GO:0090398; GO:0140297; GO:1902629; GO:1902751; GO:1904751; GO:1990904 chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein N-terminus binding [GO:0047485]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082] FINYVKNCFR 0.98916 -1.8671 0 0 0 11.4988 0 0 0 12.2735 0 0 0 0 0 0 0 0 18.3375 13.718 14.2577 13.6587 13.8324 0 13.8033 0 14.4168 14.1187 0 0 0 13.5405 0 0 0 0 0 0 0 12.431 0 0 0 0 13.7003 13.3493 13.7436 14.0402 13.7895 0 14.0027 13.9715 13.9183 14.0368 18.6739 0 14.2797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4001 0 13.247 0 0 13.1969 0 0 0 0 0 0 0 0 0 15.5748 0 12.5286 0 15.7321 0 0 0 15.373 0 12.6488 0 0 0 0 0 19.2008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4944 0 13.7404 0 0 0 0 0 0 0 19.3809 0 0 0 0 0 15.611 0 15.2538 15.5003 15.3156 15.4257 15.2183 15.1833 0 0 15.3838 0 0 12.3983 19.0926 19.2571 15.2652 0 0 0 0 Q15019 SEPT2_HUMAN "Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5, NEDD-5)" SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 Homo sapiens (Human) cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283] GO:0000776; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005886; GO:0005930; GO:0005940; GO:0007224; GO:0007283; GO:0008021; GO:0008104; GO:0015629; GO:0015630; GO:0017157; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0032391; GO:0042802; GO:0045171; GO:0045296; GO:0060090; GO:0060170; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730 cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] ADTLTLK 0.98916 -1.7665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7723 11.9798 11.8714 14.623 14.7569 0 0 14.172 14.3115 0 0 14.3328 0 0 0 0 0 0 0 0 13.2932 0 13.1699 0 0 14.0977 0 0 0 0 0 0 0 0 0 0 12.9081 0 0 0 0 0 0 0 0 12.7417 0 0 0 13.3824 0 0 0 13.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.318 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXN1 ASPN_HUMAN "Asporin (Periodontal ligament-associated protein 1, PLAP-1)" ASPN PLAP1 SLRR1C UNQ215/PRO241 Homo sapiens (Human) bone mineralization [GO:0030282]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; response to fluoride [GO:1902617] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; bone mineralization [GO:0030282]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; response to fluoride [GO:1902617] GO:0005509; GO:0005518; GO:0005615; GO:0030282; GO:0030512; GO:0031012; GO:0042995; GO:0062023; GO:0070171; GO:1902617 calcium ion binding [GO:0005509]; collagen binding [GO:0005518] DMEDTDDDDDDDDDDDDDDEDNSLFPTR 0.98916 -1.7651 11.2175 0 0 0 0 0 0 0 16.4885 16.3193 0 16.4168 0 0 0 0 0 13.163 0 0 0 0 0 0 0 0 13.007 0 0 0 0 0 16.9963 0 17.0965 0 16.9332 12.4187 0 14.2134 0 0 0 0 0 0 0 0 0 0 0 12.1032 0 0 11.0025 0 0 0 16.432 0 0 0 15.7886 0 0 0 0 0 13.2665 12.8813 0 0 0 0 12.502 14.67 12.1627 0 0 13.279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7985 0 0 0 0 12.5176 0 0 0 13.9389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5024 0 0 0 0 13.7491 0 0 0 0 0 0 12.1615 0 11.8269 0 0 0 0 0 0 13.0095 0 0 0 14.5504 14.061 12.6012 0 14.8606 13.089 0 14.3151 14.6927 0 13.3744 17.8653 0 0 0 0 14.087 0 0 14.9219 0 0 0 11.3724 O60671 RAD1_HUMAN "Cell cycle checkpoint protein RAD1, hRAD1, EC 3.1.11.2 (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein)" RAD1 REC1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint signaling [GO:0051598]; substantia nigra development [GO:0021762] checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] checkpoint clamp complex [GO:0030896]; chromosome [GO:0005694]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint signaling [GO:0051598]; substantia nigra development [GO:0021762] GO:0000077; GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006974; GO:0008408; GO:0008853; GO:0021762; GO:0030896; GO:0043231; GO:0051598; GO:0071479 3'-5' exonuclease activity [GO:0008408]; damaged DNA binding [GO:0003684]; exodeoxyribonuclease III activity [GO:0008853] ALVLSCK 0.98917 -1.8715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3961 0 0 0 0 0 0 0 0 13.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0861 13.1885 0 0 0 11.0221 0 0 0 0 0 11.4136 0 0 0 0 13.4836 0 0 0 12.9298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5393 11.4955 0 0 0 0 0 0 0 0 0 11.6959 13.3018 0 0 0 0 0 0 12.559 0 13.4025 0 0 0 0 0 0 0 0 12.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9297 0 P17813 EGLN_HUMAN Endoglin (CD antigen CD105) ENG END Homo sapiens (Human) "artery morphogenesis [GO:0048844]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; atrioventricular canal morphogenesis [GO:1905222]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; detection of hypoxia [GO:0070483]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; extracellular matrix constituent secretion [GO:0070278]; extracellular matrix disassembly [GO:0022617]; heart looping [GO:0001947]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of phosphorylation [GO:0042325]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to corticosteroid [GO:0031960]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" cell surface [GO:0009986]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell surface [GO:0009986]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; galactose binding [GO:0005534]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transmembrane signaling receptor activity [GO:0004888]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; artery morphogenesis [GO:0048844]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; atrioventricular canal morphogenesis [GO:1905222]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in endocardial cushion formation [GO:0003273]; cell motility [GO:0048870]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; detection of hypoxia [GO:0070483]; dorsal aorta morphogenesis [GO:0035912]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; extracellular matrix constituent secretion [GO:0070278]; extracellular matrix disassembly [GO:0022617]; heart looping [GO:0001947]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell differentiation [GO:1905065]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of phosphorylation [GO:0042325]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to corticosteroid [GO:0031960]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]; venous blood vessel morphogenesis [GO:0048845]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]" GO:0000122; GO:0001569; GO:0001570; GO:0001666; GO:0001837; GO:0001934; GO:0001937; GO:0001947; GO:0003084; GO:0003148; GO:0003198; GO:0003203; GO:0003208; GO:0003209; GO:0003222; GO:0003273; GO:0004888; GO:0005024; GO:0005114; GO:0005534; GO:0005539; GO:0005615; GO:0005886; GO:0005925; GO:0006355; GO:0007155; GO:0007179; GO:0009410; GO:0009897; GO:0009986; GO:0010628; GO:0010629; GO:0010862; GO:0015026; GO:0016021; GO:0016477; GO:0016604; GO:0017015; GO:0022009; GO:0022617; GO:0030155; GO:0030336; GO:0030509; GO:0030512; GO:0030513; GO:0031953; GO:0031960; GO:0032967; GO:0034713; GO:0035912; GO:0042060; GO:0042127; GO:0042325; GO:0042802; GO:0042803; GO:0043235; GO:0045766; GO:0045944; GO:0048185; GO:0048745; GO:0048844; GO:0048845; GO:0048870; GO:0050431; GO:0051001; GO:0051897; GO:0055009; GO:0060326; GO:0060348; GO:0060394; GO:0070278; GO:0070483; GO:0071260; GO:0072563; GO:0097084; GO:1905007; GO:1905065; GO:1905222 activin binding [GO:0048185]; coreceptor activity [GO:0015026]; galactose binding [GO:0005534]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transmembrane signaling receptor activity [GO:0004888]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114] KELVAHLK 0.98917 -1.8723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15814 IGLL1_HUMAN Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b) IGLL1 IGL1 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; membrane [GO:0016020]" "endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunoglobulin complex, circulating [GO:0042571]; membrane [GO:0016020]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0005576; GO:0005783; GO:0006910; GO:0006911; GO:0006955; GO:0006958; GO:0009897; GO:0016020; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] QRWPLLLLGLAVVTHGLLR 0.98919 -1.7826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49SQ1 GPR33_HUMAN Probable G-protein coupled receptor 33 GPR33 Homo sapiens (Human) complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; complement receptor mediated signaling pathway [GO:0002430]; inflammatory response [GO:0006954]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0002430; GO:0004875; GO:0004930; GO:0005886; GO:0006954; GO:0007200; GO:0007204; GO:0016021 complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930] FLLGFLLPFFIIIFCYER 0.98919 -1.7822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4631 0 0 0 0 0 0 0 14.2811 0 13.909 0 0 0 0 0 14.569 0 0 0 0 0 0 0 0 0 0 0 0 15.5525 0 15.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4N8 KIF2B_HUMAN Kinesin-like protein KIF2B KIF2B Homo sapiens (Human) cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; regulation of chromosome segregation [GO:0051983] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle [GO:0005819] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; regulation of chromosome segregation [GO:0051983] GO:0000776; GO:0003777; GO:0005524; GO:0005730; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0015630; GO:0016887; GO:0045171; GO:0051301; GO:0051310; GO:0051983; GO:0072686 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ENYWVTVEWVEKAVK 0.98919 -4.2257 0 0 0 0 0 0 0 0 0 0 0 11.2912 0 0 10.207 0 13.696 0 11.3833 11.5186 0 0 0 10.7112 0 0 11.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2501 0 0 0 0 0 0 0 0 16.3135 16.242 16.3001 14.134 14.9603 0 16.2059 14.4494 17.3575 17.1773 16.4149 16.7633 16.3666 16.5145 12.3978 16.0351 15.6424 15.6252 15.3361 12.5394 16.9968 0 16.2885 15.6823 16.3774 15.2032 14.2499 14.4635 15.0763 16.16 16.4551 14.396 13.9055 0 15.1621 15.0311 13.0906 14.7784 0 16.047 16.2883 14.3766 16.7607 14.8564 0 15.0821 16.3864 14.9425 15.0014 12.5454 0 14.9763 14.0186 0 11.3492 12.4753 12.306 12.2471 14.9268 14.0204 15.419 14.0275 15.7948 15.7709 0 12.457 15.0022 14.0084 15.7083 0 15.1179 11.7367 0 15.4026 0 14.4747 15.3131 15.1887 12.411 14.5127 14.7405 12.1973 0 0 14.3868 14.9283 15.7862 15.813 16.0411 12.8193 0 0 0 0 0 0 0 0 0 0 0 0 11.3391 0 0 14.7837 0 14.5588 13.6497 12.4058 0 0 14.8144 13.3801 Q96FK6 WDR89_HUMAN WD repeat-containing protein 89 WDR89 C14orf150 MSTP050 Homo sapiens (Human) CWDARVAR 0.9892 -4.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1231 0 0 0 14.8849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5577 0 12.6632 0 0 0 0 0 0 0 13.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6279 0 0 0 0 0 0 0 0 0 0 0 12.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUQ3 TXLNG_HUMAN "Gamma-taxilin (Environmental lipopolysaccharide-responding gene protein) (Factor inhibiting ATF4-mediated transcription, FIAT) (Lipopolysaccharide-specific response protein 5)" TXLNG CXorf15 ELRG LSR5 Homo sapiens (Human) cell cycle [GO:0007049]; regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564] cytosol [GO:0005829]; nuclear membrane [GO:0031965] cytosol [GO:0005829]; nuclear membrane [GO:0031965]; DNA-binding transcription factor binding [GO:0140297]; syntaxin binding [GO:0019905]; cell cycle [GO:0007049]; regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564] GO:0005829; GO:0007049; GO:0010564; GO:0019905; GO:0030500; GO:0031965; GO:0051726; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; syntaxin binding [GO:0019905] HKELQQQLVDAK 0.9892 -1.9011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9794 11.6935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1544 0 0 0 0 0 0 0 0 0 0 11.8047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3569 0 0 0 0 0 0 0 Q9Y5H9 PCDA2_HUMAN "Protocadherin alpha-2, PCDH-alpha-2" PCDHA2 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634] endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005634; GO:0005783; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] ASSIRRGR 0.9892 -1.8987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5324 0 0 0 0 0 0 0 0 0 0 13.6057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PJZ0 A20A5_HUMAN Putative ankyrin repeat domain-containing protein 20A5 (Ankyrin repeat domain-containing protein 20A5 pseudogene) ANKRD20A5P ANKRD20A5 Homo sapiens (Human) IRYSELQKIHK 0.98921 -5.7866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05108 CP11A_HUMAN "Cholesterol side-chain cleavage enzyme, mitochondrial, EC 1.14.15.6 (CYPXIA1) (Cholesterol desmolase) (Cytochrome P450 11A1) (Cytochrome P450(scc))" CYP11A1 CYP11A Homo sapiens (Human) C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; sterol metabolic process [GO:0016125]; vitamin D metabolic process [GO:0042359] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; sterol metabolic process [GO:0016125]; vitamin D metabolic process [GO:0042359] GO:0005506; GO:0005739; GO:0005743; GO:0005759; GO:0006700; GO:0006704; GO:0008203; GO:0008386; GO:0016125; GO:0020037; GO:0034650; GO:0042359; GO:0071375 cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506] DFVSVLHRRIK 0.98921 -4.2537 0 0 0 0 0 0 0 0 0 0 0 13.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3811 0 0 0 0 0 0 0 0 0 0 0 14.7052 0 0 0 13.0768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0764 13.8622 0 0 0 0 0 14.4113 0 0 0 11.3064 13.8628 12.7174 17.831 17.8497 0 0 0 0 0 0 0 0 0 0 17.2667 0 0 0 0 0 0 0 0 16.2818 13.3116 0 0 0 0 0 0 0 0 0 0 15.4029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1308 0 0 0 0 0 0 Q5JVX7 CA141_HUMAN Uncharacterized protein C1orf141 C1orf141 Homo sapiens (Human) AISKIKEDK 0.98921 4.4267 0 0 0 0 0 0 0 0 0 0 0 0 11.1757 0 0 0 0 0 11.3202 0 0 0 0 0 0 0 0 0 0 11.1195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3808 0 0 0 0 0 0 0 0 0 0 11.5204 0 0 0 0 11.923 0 0 12.1848 0 0 0 0 12.8257 0 13.7036 0 0 0 0 0 13.7206 11.9686 0 0 12.1892 0 0 0 0 0 0 0 0 11.6344 10.7045 0 0 10.7841 0 0 0 12.089 16.152 0 0 0 12.2594 0 0 0 0 0 0 0 0 12.1204 0 0 0 11.7142 13.4898 0 0 0 11.8689 0 0 13.0567 0 0 0 0 0 0 0 11.6711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1881 0 0 0 0 11.5836 14.3882 0 0 12.7482 0 0 0 0 0 0 0 0 Q8WXD2 SCG3_HUMAN "Secretogranin-3 (Secretogranin III, SgIII)" SCG3 UNQ2502/PRO5990 Homo sapiens (Human) protein localization to secretory granule [GO:0033366] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; RNA binding [GO:0003723]; protein localization to secretory granule [GO:0033366] GO:0003723; GO:0005576; GO:0005788; GO:0030658; GO:0030667; GO:0033366; GO:0034774 RNA binding [GO:0003723] EDYDLSK 0.98924 -4.3102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5075 0 15.9045 14.9044 0 0 0 0 0 0 0 0 0 0 0 0 13.8747 0 0 0 0 0 0 13.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9052 0 0 0 14.2851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6528 0 0 0 0 0 0 0 Q92546 RGP1_HUMAN RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog) RGP1 KIAA0258 Homo sapiens (Human) "negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] HQESCLHTTR 0.98924 -4.3084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5752 0 0 0 0 0 0 13.2765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1419 12.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9736 0 12.974 0 0 0 0 0 0 0 0 0 11.0501 0 0 0 12.3116 0 0 0 0 0 0 0 0 0 0 Q9H091 ZMY15_HUMAN Zinc finger MYND domain-containing protein 15 ZMYND15 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]" cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673] "cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatid development [GO:0007286]" GO:0001673; GO:0005737; GO:0007286; GO:0042826; GO:0045892; GO:0046872 histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872] ADWQRCPDDVSHR 0.98924 -4.3085 0 0 12.8063 0 0 0 11.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3815 0 0 0 0 0 0 0 0 0 0 0 13.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7991 0 0 0 0 0 0 0 0 0 11.8549 0 0 15.45 0 12.0547 12.5419 13.3404 0 0 0 17.1991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0521 0 16.8149 0 0 0 0 15.9291 0 0 0 16.6531 16.6485 16.3535 0 0 0 0 0 14.7165 14.0795 0 15.0286 16.4235 0 0 0 0 0 0 16.7515 0 16.6654 14.2376 0 14.6055 0 16.7073 0 14.918 0 17.2282 0 17.3844 0 15.7093 0 10.5609 0 0 0 14.1421 0 0 0 0 0 0 0 0 10.5327 16.4029 0 0 0 0 0 15.0161 0 Q5SWL7 PRA14_HUMAN PRAME family member 14 PRAMEF14 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 CHHSMSDNELEGR 0.98925 -4.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4404 12.0053 0 0 0 0 12.343 0 0 0 0 0 0 11.9021 0 0 0 0 0 0 12.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8737 0 0 0 13.6172 14.7754 13.152 0 0 0 0 0 0 0 0 0 0 0 11.3016 0 0 0 14.1686 0 0 11.7118 0 0 0 0 0 0 0 0 0 15.7293 0 0 0 12.6826 0 14.4682 0 0 0 0 0 0 13.9506 0 0 0 0 15.1512 14.0081 14.2372 0 0 14.337 0 0 12.5037 0 0 0 10.4434 0 0 0 0 0 0 0 0 0 12.773 0 12.5965 0 0 0 0 0 13.4058 0 0 0 13.7469 0 0 13.0791 13.7652 0 0 0 0 0 13.2375 0 11.9934 Q9UHM6 OPN4_HUMAN Melanopsin (Opsin-4) OPN4 MOP Homo sapiens (Human) cellular response to light stimulus [GO:0071482]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; thermotaxis [GO:0043052]; visual perception [GO:0007601] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; detection of temperature stimulus involved in thermoception [GO:0050960]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; thermotaxis [GO:0043052]; visual perception [GO:0007601] GO:0005502; GO:0005886; GO:0005887; GO:0007186; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016021; GO:0030424; GO:0030425; GO:0042752; GO:0043052; GO:0043204; GO:0048511; GO:0050960; GO:0071482; GO:0097381; GO:1990384; GO:1990913 11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020] AYTMLLCCFVFFLPLLIIIYCYIFIFRAIRETGR 0.98925 -4.323 0 0 0 0 0 0 10.807 0 0 0 18.6156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4276 0 0 0 12.2129 0 12.9824 0 0 0 0 0 0 0 0 0 0 11.609 0 0 0 0 13.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0491 0 0 0 16.9738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCU1 CC197_HUMAN Uncharacterized protein CCDC197 (Coiled-coil domain-containing protein 197) CCDC197 C14orf48 LINC00521 Homo sapiens (Human) HKLFEDYLIK 0.98926 -1.7532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8372 0 13.1319 0 0 0 0 0 0 0 0 0 0 0 0 13.3855 0 0 0 0 0 0 0 0 15.4928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75298 RTN2_HUMAN "Reticulon-2 (Neuroendocrine-specific protein-like 1, NSP-like protein 1) (Neuroendocrine-specific protein-like I, NSP-like protein I, NSPLI)" RTN2 NSPL1 Homo sapiens (Human) gene expression [GO:0010467]; intracellular protein transmembrane transport [GO:0065002]; negative regulation of amyloid-beta formation [GO:1902430]; regulation of glucose import [GO:0046324] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intermediate filament [GO:0005882]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; terminal cisterna [GO:0014802]; Z disc [GO:0030018] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intermediate filament [GO:0005882]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; gene expression [GO:0010467]; intracellular protein transmembrane transport [GO:0065002]; negative regulation of amyloid-beta formation [GO:1902430]; regulation of glucose import [GO:0046324] GO:0005783; GO:0005789; GO:0005882; GO:0009986; GO:0010467; GO:0014802; GO:0030018; GO:0030176; GO:0030315; GO:0033017; GO:0046324; GO:0065002; GO:1902430 EFSEEDEEETTSQDWGTPR 0.98927 -1.7663 0 0 0 0 0 0 0 0 13.5143 0 0 11.5637 0 0 0 0 0 13.742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.957 0 0 0 0 0 0 0 0 0 0 0 0 12.9176 0 0 0 0 0 0 0 0 0 0 0 11.919 0 0 0 0 0 0 13.3045 14.0147 0 0 0 13.1688 0 0 0 0 0 0 0 12.9574 0 0 10.5209 12.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6758 0 0 0 0 0 0 14.2675 0 0 14.4627 0 12.5024 0 11.6891 0 0 0 0 0 0 0 0 0 0 0 0 11.4546 0 0 0 0 0 0 0 0 O76014 KRT37_HUMAN "Keratin, type I cuticular Ha7 (Hair keratin, type I Ha7) (Keratin-37, K37)" KRT37 HHA7 HKA7 KRTHA7 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109; GO:0070062 structural molecule activity [GO:0005198] LAADDFR 0.98927 -1.7615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP92 RT30_HUMAN "39S ribosomal protein S30, mitochondrial, MRP-S30, S30mt (Mitochondrial large ribosomal subunit protein mL65) (Mitochondrial large ribosomal subunit protein mS30) (Programmed cell death protein 9)" MRPS30 PDCD9 BM-047 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006915; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] CWRPLLR 0.98927 -1.7645 0 0 0 0 0 0 0 0 13.6034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2579 0 12.7937 0 0 0 0 0 0 0 13.286 0 0 0 0 0 0 0 0 0 0 14.3141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0797 14.8668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9796 14.7353 14.0583 0 0 0 10.7456 0 0 0 0 0 0 0 0 0 0 0 0 12.6684 0 0 0 0 0 0 0 Q5SNT2 TM201_HUMAN Transmembrane protein 201 (Spindle-associated membrane protein 1) TMEM201 NET5 SAMP1 Homo sapiens (Human) centrosome localization [GO:0051642]; fibroblast migration [GO:0010761]; nuclear envelope organization [GO:0006998]; nuclear migration along microtubule [GO:0030473]; protein localization to nuclear envelope [GO:0090435] cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922]; actin filament binding [GO:0051015]; lamin binding [GO:0005521]; centrosome localization [GO:0051642]; fibroblast migration [GO:0010761]; nuclear envelope organization [GO:0006998]; nuclear migration along microtubule [GO:0030473]; protein localization to nuclear envelope [GO:0090435] GO:0000922; GO:0005521; GO:0005635; GO:0005639; GO:0005737; GO:0006998; GO:0010761; GO:0030473; GO:0031965; GO:0051015; GO:0051642; GO:0090435 actin filament binding [GO:0051015]; lamin binding [GO:0005521] CNHHQTTK 0.98928 -4.2254 0 0 0 0 0 0 0 0 0 0 12.2085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1938 0 0 0 0 12.7825 14.6233 0 0 0 0 0 13.9601 0 0 0 0 0 0 11.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9372 0 12.6775 0 0 0 0 0 0 0 0 0 14.3109 0 0 0 0 0 0 0 10.8454 0 0 0 0 0 0 0 0 0 0 10.6669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WU08 ST32A_HUMAN "Serine/threonine-protein kinase 32A, EC 2.7.11.1 (Yet another novel kinase 1)" STK32A YANK1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] GO:0004674; GO:0005524; GO:0005886; GO:0018105; GO:0035556; GO:0046872; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ETQITTMAGTK 0.98928 -1.8669 0 0 0 0 0 0 0 10.9012 0 0 0 0 12.1434 0 0 0 0 0 0 0 0 13.73 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5914 0 0 0 0 0 0 0 0 0 0 0 13.5025 0 0 0 0 0 14.0542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5885 0 0 14.6821 0 0 0 0 0 0 0 0 0 14.4187 0 0 0 0 0 13.4944 0 0 0 0 14.5533 14.1685 0 13.7781 0 0 0 14.7363 14.5505 0 0 0 0 12.4557 0 13.7942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H1 ST38L_HUMAN "Serine/threonine-protein kinase 38-like, EC 2.7.11.1 (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2)" STK38L KIAA0965 NDR2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128] GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0015629; GO:0016020; GO:0018105; GO:0035556; GO:0051128; GO:0106310 actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AERDILVEADGAWVVKMFYSFQDK 0.98929 -1.8737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56373 P2RX3_HUMAN "P2X purinoceptor 3, P2X3 (ATP receptor) (Purinergic receptor)" P2RX3 Homo sapiens (Human) behavioral response to formalin induced pain [GO:0061368]; cellular response to ATP [GO:0071318]; establishment of localization in cell [GO:0051649]; inorganic cation transmembrane transport [GO:0098662]; neuromuscular synaptic transmission [GO:0007274]; neuronal action potential [GO:0019228]; peristalsis [GO:0030432]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of sensory perception of pain [GO:1904058]; protein homotrimerization [GO:0070207]; regulation of synaptic plasticity [GO:0048167]; response to carbohydrate [GO:0009743]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sensory perception of taste [GO:0050909]; signal transduction [GO:0007165]; urinary bladder smooth muscle contraction [GO:0014832] dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; Schaffer collateral - CA1 synapse [GO:0098685]; terminal bouton [GO:0043195] dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; Schaffer collateral - CA1 synapse [GO:0098685]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; purinergic nucleotide receptor activity [GO:0001614]; behavioral response to formalin induced pain [GO:0061368]; cellular response to ATP [GO:0071318]; establishment of localization in cell [GO:0051649]; inorganic cation transmembrane transport [GO:0098662]; neuromuscular synaptic transmission [GO:0007274]; neuronal action potential [GO:0019228]; peristalsis [GO:0030432]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of sensory perception of pain [GO:1904058]; protein homotrimerization [GO:0070207]; regulation of synaptic plasticity [GO:0048167]; response to carbohydrate [GO:0009743]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; sensory perception of taste [GO:0050909]; signal transduction [GO:0007165]; urinary bladder smooth muscle contraction [GO:0014832] GO:0001614; GO:0001666; GO:0004931; GO:0005524; GO:0005639; GO:0005791; GO:0005794; GO:0005886; GO:0005887; GO:0007165; GO:0007274; GO:0009408; GO:0009409; GO:0009612; GO:0009743; GO:0010524; GO:0014832; GO:0019228; GO:0030432; GO:0042802; GO:0043025; GO:0043195; GO:0043197; GO:0043235; GO:0045121; GO:0048167; GO:0050850; GO:0050909; GO:0051649; GO:0061368; GO:0070207; GO:0071318; GO:0098662; GO:0098685; GO:0098686; GO:0099056; GO:1904058 ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; purinergic nucleotide receptor activity [GO:0001614] SSVSPGYNFR 0.98931 -1.8948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VTH9 DNAI4_HUMAN Dynein axonemal intermediate chain 4 (WD repeat-containing protein 78) DNAI4 WDR78 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; motile cilium [GO:0031514] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; motile cilium [GO:0031514]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018] GO:0002244; GO:0003341; GO:0005858; GO:0005930; GO:0007018; GO:0031514; GO:0045503; GO:0045504; GO:0070286; GO:0120293 dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] CSCSYNEQYLDTYRGHKGPVYK 0.98931 -4.2703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2652 0 0 0 0 0 0 0 0 0 0 10.8031 0 0 0 0 0 0 0 12.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIY3 RWD2A_HUMAN RWD domain-containing protein 2A RWDD2A RWDD2 Homo sapiens (Human) EALPPKIEFVITLQIEEPKVK 0.98933 -4.3073 0 0 0 0 0 0 0 0 0 0 13.9451 0 0 0 0 0 0 0 0 0 0 0 12.9432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9452 0 0 0 0 11.8689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9382 0 0 0 0 0 0 0 11.4857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SRI9 MANEA_HUMAN "Glycoprotein endo-alpha-1,2-mannosidase, Endo-alpha mannosidase, Endomannosidase, hEndo, EC 3.2.1.130 (Mandaselin)" MANEA Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]" GO:0000139; GO:0004559; GO:0004569; GO:0005794; GO:0016021 "alpha-mannosidase activity [GO:0004559]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]" IAKNYPQGR 0.98934 -4.3171 0 0 0 0 0 0 0 0 0 13.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9251 12.0576 0 9.90112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NC0 ZMAT2_HUMAN Zinc finger matrin-type protein 2 ZMAT2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003677; GO:0005634; GO:0008270; GO:0046540; GO:0071005 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] AEEDLTFEEDDEMAAVMGFSGFGSTKKSY 0.98934 -4.3146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1219 0 0 0 0 0 0 0 10.2247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2342 0 0 0 0 12.1602 0 0 12.7457 0 0 0 0 13.3404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6138 13.3161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGF9 OR4X2_HUMAN Olfactory receptor 4X2 (Olfactory receptor OR11-105) OR4X2 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LWIRTLRLNEK 0.98937 -5.7866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2386 0 0 0 0 13.3895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3506 0 0 0 0 0 Q9UNW9 NOVA2_HUMAN RNA-binding protein Nova-2 (Astrocytic NOVA1-like RNA-binding protein) (Neuro-oncological ventral antigen 2) NOVA2 ANOVA NOVA3 Homo sapiens (Human) "central nervous system neuron development [GO:0021954]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron differentiation [GO:0030182]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; central nervous system neuron development [GO:0021954]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron differentiation [GO:0030182]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of axon guidance [GO:1902667]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]" GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0010468; GO:0021954; GO:0030182; GO:0051252; GO:0120163; GO:1902667; GO:1990825 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825] EPEAPDSRKR 0.98938 -1.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0666 0 0 0 0 0 11.613 0 0 0 0 0 0 0 0 0 0 11.1671 0 0 0 0 0 0 0 0 13.3978 0 0 0 0 0 0 0 10.9306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.375 0 0 0 0 0 0 0 0 0 0 12.0855 0 0 0 0 0 0 0 0 0 0 0 Q7RTV0 PHF5A_HUMAN "PHD finger-like domain-containing protein 5A, PHD finger-like domain protein 5A (Splicing factor 3B-associated 14 kDa protein, SF3b14b)" PHF5A Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]" nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription, DNA-templated [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011; GO:1903241 DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] KQAGVAIGR 0.9894 -1.8736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DX5 ASB9_HUMAN "Ankyrin repeat and SOCS box protein 9, ASB-9" ASB9 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; intracellular signal transduction [GO:0035556]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567] GO:0005739; GO:0005829; GO:0016567; GO:0035556; GO:0045732 ITKLVLPEDLK 0.9894 -4.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7743 0 0 0 0 11.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NNX1 TUFT1_HUMAN Tuftelin TUFT1 Homo sapiens (Human) bone mineralization [GO:0030282]; intracellular signal transduction [GO:0035556]; odontogenesis [GO:0042476] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; structural constituent of tooth enamel [GO:0030345]; bone mineralization [GO:0030282]; intracellular signal transduction [GO:0035556]; odontogenesis [GO:0042476] GO:0005576; GO:0005737; GO:0030282; GO:0030345; GO:0035556; GO:0042476 structural constituent of tooth enamel [GO:0030345] AKTENPGSIRISK 0.9894 -4.2703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2238 0 0 0 0 0 0 0 0 0 17.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5744 0 0 0 0 0 0 0 0 0 0 14.0619 0 0 0 0 0 0 0 0 0 0 0 0 14.8302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQZ6 ZC4H2_HUMAN Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127) ZC4H2 HCA127 KIAA1166 Homo sapiens (Human) nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; noradrenergic neuron development [GO:0003358]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; protein monoubiquitination [GO:0006513]; regulation of transcription regulatory region DNA binding [GO:2000677]; spinal cord motor neuron differentiation [GO:0021522] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; noradrenergic neuron development [GO:0003358]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; protein monoubiquitination [GO:0006513]; regulation of transcription regulatory region DNA binding [GO:2000677]; spinal cord motor neuron differentiation [GO:0021522] GO:0003358; GO:0005634; GO:0005737; GO:0006513; GO:0007399; GO:0007528; GO:0021522; GO:0032991; GO:0043025; GO:0045211; GO:0045666; GO:0046872; GO:0051091; GO:0070161; GO:2000677 metal ion binding [GO:0046872] ADEQEIMCK 0.9894 -1.8747 0 0 0 0 0 0 0 0 0 0 0 0 9.6828 0 0 0 0 0 0 0 0 0 0 0 13.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8967 11.6879 0 0 11.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8952 0 0 0 0 0 0 0 11.9518 0 0 0 0 0 0 0 0 12.0634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9998 11.8591 0 0 0 0 0 0 0 Q96SL4 GPX7_HUMAN "Glutathione peroxidase 7, GPx-7, GSHPx-7, EC 1.11.1.9 (CL683)" GPX7 GPX6 UNQ469/PRO828 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599] GO:0004096; GO:0004601; GO:0004602; GO:0005576; GO:0005783; GO:0005788; GO:0034599 catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601] AVNIRGK 0.98941 -4.2927 0 0 0 0 0 0 0 0 0 0 13.7003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1075 0 0 14.4059 0 14.3006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4798 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6124 0 P18846 ATF1_HUMAN "Cyclic AMP-dependent transcription factor ATF-1, cAMP-dependent transcription factor ATF-1 (Activating transcription factor 1) (Protein TREB36)" ATF1 Homo sapiens (Human) cAMP-mediated signaling [GO:0019933]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cobalt ion [GO:0032025]; response to purine-containing compound [GO:0014074] ATF1-ATF4 transcription factor complex [GO:1990590]; ATF4-CREB1 transcription factor complex [GO:1990589]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "ATF1-ATF4 transcription factor complex [GO:1990590]; ATF4-CREB1 transcription factor complex [GO:1990589]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cAMP-mediated signaling [GO:0019933]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cobalt ion [GO:0032025]; response to purine-containing compound [GO:0014074]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0010976; GO:0014074; GO:0019933; GO:0032025; GO:0042802; GO:0044877; GO:0045740; GO:0045944; GO:0046982; GO:0065003; GO:0090575; GO:1990589; GO:1990590 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AHGILARRPSYR 0.98942 -1.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.413 0 0 0 17.2535 15.9659 0 0 16.4207 0 0 0 0 0 0 0 0 0 12.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50226 ST1A2_HUMAN "Sulfotransferase 1A2, ST1A2, EC 2.8.2.1 (Aryl sulfotransferase 2) (Phenol sulfotransferase 2) (Phenol-sulfating phenol sulfotransferase 2, P-PST 2)" SULT1A2 STP2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine biosynthetic process [GO:0009309]; catecholamine metabolic process [GO:0006584]; ethanol catabolic process [GO:0006068]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine biosynthetic process [GO:0009309]; catecholamine metabolic process [GO:0006584]; ethanol catabolic process [GO:0006068]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006584; GO:0006805; GO:0008146; GO:0008202; GO:0009309; GO:0018958; GO:0047894; GO:0050427; GO:0051923 aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; sulfotransferase activity [GO:0008146] ELIQDISR 0.98942 -1.8948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0876 0 12.2064 0 0 0 0 0 15.2766 0 0 0 0 0 0 13.9198 0 0 0 0 17.0491 0 0 0 0 0 0 0 0 14.2052 0 0 0 0 0 0 14.7164 16.7508 15.8412 0 0 0 0 0 13.7184 0 14.7075 0 0 0 0 0 0 0 0 14.0566 0 0 0 0 0 0 0 0 0 0 0 14.7153 0 0 0 0 0 0 0 0 0 0 0 15.2638 0 0 0 0 0 0 0 16.0098 14.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3255 0 0 0 0 P62826 RAN_HUMAN "GTP-binding nuclear protein Ran, EC 3.6.5.- (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)" RAN ARA24 OK/SW-cl.81 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; DNA metabolic process [GO:0006259]; GTP metabolic process [GO:0046039]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nucleolus [GO:1902570]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]; viral process [GO:0016032] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; RNA nuclear export complex [GO:0042565] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; RNA nuclear export complex [GO:0042565]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; DNA metabolic process [GO:0006259]; GTP metabolic process [GO:0046039]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nucleolus [GO:1902570]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]; viral process [GO:0016032] GO:0000054; GO:0000055; GO:0000056; GO:0000070; GO:0000278; GO:0000287; GO:0003682; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0005829; GO:0006259; GO:0006606; GO:0006611; GO:0007052; GO:0016020; GO:0016032; GO:0019003; GO:0030036; GO:0030496; GO:0032092; GO:0032991; GO:0035281; GO:0042307; GO:0042470; GO:0042565; GO:0045296; GO:0046039; GO:0046982; GO:0051301; GO:0055037; GO:0061015; GO:0070062; GO:1902570 cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] SNYNFEK 0.98942 -4.3069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99616 CCL13_HUMAN "C-C motif chemokine 13 (CK-beta-10) (Monocyte chemoattractant protein 4) (Monocyte chemotactic protein 4, MCP-4) (NCC-1) (Small-inducible cytokine A13) [Cleaved into: C-C motif chemokine 13, long chain; C-C motif chemokine 13, medium chain; C-C motif chemokine 13, short chain ]" CCL13 MCP4 NCC1 SCYA13 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165] GO:0002548; GO:0005102; GO:0005576; GO:0005615; GO:0006874; GO:0006935; GO:0006954; GO:0007010; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0008360; GO:0030593; GO:0031640; GO:0043547; GO:0048020; GO:0048245; GO:0048247; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102] AVIFRTKLGK 0.98943 -4.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5134 0 0 0 0 13.5182 0 0 0 0 14.198 14.6175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9554 0 0 0 12.4797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15283 RASA2_HUMAN "Ras GTPase-activating protein 2 (GTPase-activating protein 1m, GAP1m)" RASA2 GAP1M RASGAP Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0035556; GO:0043087; GO:0046580; GO:0046872; GO:0048471 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] DAIYTIPVK 0.98945 -5.784 0 0 0 0 0 0 0 0 0 0 0 0 11.2556 0 0 0 11.8602 12.2082 0 0 0 0 0 0 11.8427 0 0 0 11.907 11.5603 0 11.8607 11.9328 11.6198 0 0 11.8091 0 0 0 11.0358 0 0 0 12.2561 0 0 0 0 0 0 0 0 0 13.2528 0 12.5155 0 0 11.9302 11.4042 0 0 11.2178 10.3941 0 0 0 0 0 0 13.0509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0018 0 0 0 0 0 0 13.2193 0 0 0 0 12.7095 0 0 0 0 14.0468 0 0 13.5569 0 0 0 0 11.6611 0 0 11.8347 0 0 0 11.8594 0 0 0 14.1812 12.7859 0 12.0918 0 0 0 14.0178 0 0 0 0 0 0 0 0 14.0631 0 0 0 0 0 13.152 13.6152 14.0185 14.0753 0 0 0 14.8032 13.2129 13.5948 0 0 0 0 0 0 14.3646 13.4824 0 0 0 0 11.0579 0 13.384 0 0 Q16854 DGUOK_HUMAN "Deoxyguanosine kinase, mitochondrial, EC 2.7.1.113 (Deoxyadenosine kinase, mitochondrial, EC 2.7.1.76)" DGUOK DGK Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; dAMP salvage [GO:0106383]; dGTP metabolic process [GO:0046070]; guanosine metabolic process [GO:0008617]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of neuron projection development [GO:0010977]; protein phosphorylation [GO:0006468]; purine deoxyribonucleoside metabolic process [GO:0046122] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; deoxyadenosine kinase activity [GO:0004136]; deoxyguanosine kinase activity [GO:0004138]; deoxynucleoside kinase activity [GO:0019136]; ATP biosynthetic process [GO:0006754]; dAMP salvage [GO:0106383]; dGTP metabolic process [GO:0046070]; guanosine metabolic process [GO:0008617]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of neuron projection development [GO:0010977]; protein phosphorylation [GO:0006468]; purine deoxyribonucleoside metabolic process [GO:0046122] GO:0004136; GO:0004138; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006468; GO:0006754; GO:0008617; GO:0010977; GO:0019136; GO:0042775; GO:0046070; GO:0046122; GO:0106383 ATP binding [GO:0005524]; deoxyadenosine kinase activity [GO:0004136]; deoxyguanosine kinase activity [GO:0004138]; deoxynucleoside kinase activity [GO:0019136] KPVQIFERSVYSDR 0.98945 -5.7844 0 0 0 0 0 0 0 0 0 11.9837 0 0 0 0 0 0 0 0 0 0 0 0 11.3177 0 11.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7876 15.6344 0 16.7941 17.1869 14.5699 16.5926 13.8493 13.6565 0 0 0 14.8805 0 0 0 13.5342 0 0 16.2049 14.97 0 0 0 0 0 0 13.9898 14.0551 0 0 13.8539 0 0 0 0 0 0 12.9127 0 0 0 13.6542 0 0 0 0 13.6558 0 0 0 13.448 13.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7819 0 14.3328 0 0 0 0 0 0 0 0 0 0 0 P26441 CNTF_HUMAN "Ciliary neurotrophic factor, CNTF" CNTF Homo sapiens (Human) astrocyte activation [GO:0048143]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; muscle organ morphogenesis [GO:0048644]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of photoreceptor cell differentiation [GO:0046533]; neuron development [GO:0048666]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of retinal cell programmed cell death [GO:0046668]; retinal rod cell differentiation [GO:0060221]; signal transduction [GO:0007165]; tyrosine phosphorylation of STAT protein [GO:0007260] axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-6 receptor binding [GO:0005138]; protein-containing complex binding [GO:0044877]; astrocyte activation [GO:0048143]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; muscle organ morphogenesis [GO:0048644]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of photoreceptor cell differentiation [GO:0046533]; neuron development [GO:0048666]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of retinal cell programmed cell death [GO:0046668]; retinal rod cell differentiation [GO:0060221]; signal transduction [GO:0007165]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0005125; GO:0005127; GO:0005138; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007260; GO:0008083; GO:0008284; GO:0010628; GO:0030424; GO:0042531; GO:0043524; GO:0044877; GO:0046533; GO:0046668; GO:0048143; GO:0048644; GO:0048666; GO:0048680; GO:0060221; GO:0070120 ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-6 receptor binding [GO:0005138]; protein-containing complex binding [GO:0044877] RDLCSRSIWLAR 0.98949 -4.2727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4785 0 0 0 0 0 0 0 12.8163 0 0 0 0 0 0 0 0 0 0 0 12.6637 0 11.9145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0676 0 0 0 0 0 13.0487 14.8433 13.9114 0 13.4598 0 0 14.1272 0 0 0 0 14.3641 13.9012 0 0 0 0 13.8154 0 14.3379 14.1522 15.4012 0 0 0 0 0 0 16.7241 15.225 14.1752 0 0 0 0 0 0 14.0151 0 0 0 0 0 0 0 0 0 0 14.0816 0 14.611 14.8666 0 14.0857 15.0593 0 0 14.4274 13.7803 0 14.1561 0 13.1578 0 14.19 0 0 13.776 0 0 0 0 0 0 0 0 0 0 0 0 14.1476 14.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52333 JAK3_HUMAN "Tyrosine-protein kinase JAK3, EC 2.7.10.2 (Janus kinase 3, JAK-3) (Leukocyte janus kinase, L-JAK)" JAK3 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; innate immune response [GO:0045087]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; intracellular signal transduction [GO:0035556]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL production [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; innate immune response [GO:0045087]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; intracellular signal transduction [GO:0035556]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL production [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0002250; GO:0002731; GO:0004713; GO:0004715; GO:0005126; GO:0005131; GO:0005524; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007167; GO:0007204; GO:0007259; GO:0007260; GO:0018108; GO:0019221; GO:0019903; GO:0030154; GO:0030183; GO:0030218; GO:0032693; GO:0032695; GO:0035556; GO:0035771; GO:0038110; GO:0042104; GO:0042981; GO:0043029; GO:0045087; GO:0045221; GO:0045626; GO:0046425; GO:0050868; GO:0051770; GO:0051928; GO:0060397; GO:0070232; GO:0070244; GO:0070669; GO:0070670; GO:0070672; GO:0071104 ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713] GCETHAFTAHPEGKHHSLSFS 0.98949 -1.7604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92548 0 0 0 10.2668 0 0 0 0 0 0 0 0 0 0 0 14.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8258 0 0 12.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.429 0 0 0 0 0 0 0 0 0 0 0 12.3909 12.6803 0 0 0 Q8IZP2 ST134_HUMAN Putative protein FAM10A4 (Suppression of tumorigenicity 13 pseudogene 4) ST13P4 FAM10A4 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; protein dimerization activity [GO:0046983] GO:0005737; GO:0046983; GO:0070062 protein dimerization activity [GO:0046983] ADEPSSEESDLEIDK 0.98949 -4.2686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.526 15.8767 0 0 0 0 15.682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JN0 LCOR_HUMAN "Ligand-dependent corepressor, LCoR (Mblk1-related protein 2)" LCOR C10orf12 KIAA1795 MLR2 Homo sapiens (Human) cellular response to estradiol stimulus [GO:0071392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; nuclear estrogen receptor binding [GO:0030331]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; ubiquitin-specific protease binding [GO:1990381]; cellular response to estradiol stimulus [GO:0071392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0001222; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0030331; GO:0042826; GO:0071392; GO:1990226; GO:1990381 DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; nuclear estrogen receptor binding [GO:0030331]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; ubiquitin-specific protease binding [GO:1990381] KLRAILPK 0.98949 -1.7597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2638 13.9166 0 0 12.885 0 12.0018 0 0 0 0 0 0 14.8456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.374 12.2924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1623 0 14.1378 0 0 14.3231 0 0 0 0 0 14.3603 0 0 0 12.9116 0 0 0 0 9.99859 0 0 0 0 14.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3986 0 0 O94956 SO2B1_HUMAN "Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B, OATP-B) (Organic anion transporter polypeptide-related protein 2, OATP-RP2, OATPRP2) (Solute carrier family 21 member 9)" SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805] GO:0005886; GO:0005887; GO:0006805; GO:0008514; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016324; GO:0042167; GO:0043252; GO:0055085; GO:0150104 bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] EARTKESR 0.9895 -1.8659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.855 12.467 12.4741 13.3066 12.6525 12.4572 0 0 0 0 0 0 0 0 0 13.0861 0 13.0306 0 0 0 0 0 12.6395 13.3856 13.6892 0 0 13.4315 0 0 0 0 13.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1055 14.0581 0 0 13.3432 0 13.6886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4212 0 0 0 13.8625 0 0 0 13.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13258 PD2R_HUMAN "Prostaglandin D2 receptor, PGD receptor, PGD2 receptor (Prostanoid DP receptor)" PTGDR Homo sapiens (Human) adenosine metabolic process [GO:0046085]; cellular response to prostaglandin D stimulus [GO:0071799]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; male sex determination [GO:0030238]; mast cell degranulation [GO:0043303]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; sleep [GO:0030431] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; prostaglandin D receptor activity [GO:0004956]; prostaglandin J receptor activity [GO:0001785]; adenosine metabolic process [GO:0046085]; cellular response to prostaglandin D stimulus [GO:0071799]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; male sex determination [GO:0030238]; mast cell degranulation [GO:0043303]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; sleep [GO:0030431] GO:0001785; GO:0004956; GO:0005886; GO:0006954; GO:0007186; GO:0007204; GO:0016021; GO:0030238; GO:0030431; GO:0043303; GO:0046085; GO:0071799 prostaglandin D receptor activity [GO:0004956]; prostaglandin J receptor activity [GO:0001785] AYYGAFKDVKEK 0.9895 -4.2913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FH0 BORC8_HUMAN BLOC-1-related complex subunit 8 (MEF2B neighbor) BORCS8 MEF2BNB Homo sapiens (Human) heart development [GO:0007507]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574] BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; heart development [GO:0007507]; lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196] GO:0007507; GO:0032418; GO:0051036; GO:0062196; GO:0072384; GO:0098574; GO:0099078 SVEGLLK 0.9895 -4.2826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRR3 PGAP4_HUMAN Post-GPI attachment to proteins factor 4 (Post-GPI attachment to proteins GalNAc transferase 4) (Transmembrane protein 246) PGAP4 C9orf125 TMEM246 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; GPI anchor biosynthetic process [GO:0006506] GO:0000139; GO:0006506; GO:0016021; GO:0016757 glycosyltransferase activity [GO:0016757] ARFSEPHLRDALYLK 0.9895 -1.8647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2358 0 0 0 0 12.6004 0 0 14.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6682 0 0 0 0 0 14.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3582 12.7151 14.5035 0 0 0 0 12.4161 12.5303 0 0 0 0 0 0 0 12.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y263 PLAP_HUMAN "Phospholipase A-2-activating protein, PLA2P, PLAP" PLAA PLAP Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; nervous system development [GO:0007399]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]; phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; nervous system development [GO:0007399]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] GO:0005634; GO:0005737; GO:0006644; GO:0006693; GO:0006954; GO:0007165; GO:0007399; GO:0010992; GO:0016005; GO:0016236; GO:0032430; GO:0043130; GO:0043161; GO:0043162; GO:0045202; GO:0070062; GO:0070161; GO:0071222; GO:1900045; GO:1903423; GO:1903861; GO:2001224 phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130] LTEDDLILLEKILSLICNSSSEKPTVQQLQILWK 0.98951 -4.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6203 0 0 0 0 0 0 0 0 0 0 0 0 12.8216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0088 0 0 0 0 0 0 11.9348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00268 TAF4_HUMAN "Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit, TAF(II)130, TAFII-130, TAFII130) (Transcription initiation factor TFIID 135 kDa subunit, TAF(II)135, TAFII-135, TAFII135)" TAF4 TAF2C TAF2C1 TAF4A TAFII130 TAFII135 Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" chromatin [GO:0000785]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "chromatin [GO:0000785]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000785; GO:0001541; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006468; GO:0017162; GO:0032991; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043966; GO:0045893; GO:0046982; GO:0051123; GO:0060261; GO:0071339 aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] DETFLLQAPLQRRILEIGK 0.98953 -1.8943 0 0 0 0 0 0 0 0 0 0 0 13.2417 0 0 0 0 12.5463 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZU64 CFA65_HUMAN Cilia- and flagella-associated protein 65 (Coiled-coil domain-containing protein 108) CFAP65 CCDC108 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; RNA binding [GO:0003723]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288] GO:0001669; GO:0002080; GO:0003723; GO:0005737; GO:0005886; GO:0007288; GO:0016021; GO:0030317; GO:0036126; GO:0097225 RNA binding [GO:0003723] CAQLLVSIKHK 0.98953 -1.7839 0 0 11.6757 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9754 0 0 11.7688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7211 0 0 0 0 13.282 13.0171 11.9701 0 0 17.3347 15.392 16.6088 0 0 0 0 0 0 0 0 0 0 10.7708 0 0 0 11.6104 0 0 0 12.4912 0 0 0 14.1531 0 0 0 10.7752 13.5005 12.952 0 0 0 0 0 14.1401 12.8008 0 0 0 0 11.9916 0 0 0 0 0 0 0 0 0 12.529 0 12.8777 0 0 0 0 10.7478 0 0 13.5136 0 14.2157 0 0 0 0 0 14.8676 0 0 0 0 0 0 0 13.5954 0 0 0 0 0 0 0 0 0 0 12.4276 0 0 0 0 0 0 0 0 0 0 Q8TE67 ES8L3_HUMAN "Epidermal growth factor receptor kinase substrate 8-like protein 3, EPS8-like protein 3 (Epidermal growth factor receptor pathway substrate 8-related protein 3, EPS8-related protein 3)" EPS8L3 EPS8R3 Homo sapiens (Human) positive regulation of ruffle assembly [GO:1900029]; regulation of hair cycle [GO:0042634]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; positive regulation of ruffle assembly [GO:1900029]; regulation of hair cycle [GO:0042634]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] GO:0003779; GO:0005737; GO:0005886; GO:0007266; GO:0032587; GO:0035023; GO:0042634; GO:1900029 actin binding [GO:0003779] ALEEELEQRPR 0.98954 -5.7976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23381 SYWC_HUMAN "Tryptophan--tRNA ligase, cytoplasmic, EC 6.1.1.2 (Interferon-induced protein 53, IFP53) (Tryptophanyl-tRNA synthetase, TrpRS, hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS ]" WARS1 IFI53 WARS WRS Homo sapiens (Human) angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tryptophanyl-tRNA aminoacylation [GO:0006436] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tryptophanyl-tRNA aminoacylation [GO:0006436] GO:0001525; GO:0001933; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0010835; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062 ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830] ALIEVLQPLIAEHQARR 0.98958 -4.2685 0 0 0 0 0 0 0 10.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.736 0 0 10.6312 0 0 0 0 0 0 14.4851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5MCW4 ZN569_HUMAN Zinc finger protein 569 ZNF569 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFPRIASLALHMR 0.98958 -4.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5704 0 0 0 13.5236 0 11.4058 0 0 0 0 0 0 12.9336 0 13.3226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8176 13.4742 0 0 0 0 0 0 0 0 13.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7277 12.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0331 0 0 0 0 0 0 0 0 Q96QH2 PRAM_HUMAN "PML-RARA-regulated adapter molecule 1, PRAM, PRAM-1" PRAM1 Homo sapiens (Human) integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; regulation of neutrophil degranulation [GO:0043313]; T cell receptor signaling pathway [GO:0050852] plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; regulation of neutrophil degranulation [GO:0043313]; T cell receptor signaling pathway [GO:0050852] GO:0005886; GO:0007229; GO:0008289; GO:0019901; GO:0032991; GO:0043313; GO:0050852; GO:0072659 lipid binding [GO:0008289]; protein kinase binding [GO:0019901] FPQLGATPFPR 0.98958 -4.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2985 0 13.7953 0 0 0 0 0 0 0 0 11.7974 0 0 0 0 12.013 0 0 0 0 0 0 0 0 0 0 11.5823 0 12.2971 12.8031 0 0 0 0 0 13.8378 0 13.8557 0 0 0 0 0 12.8426 0 11.9452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.926 0 0 12.2605 0 0 0 0 0 0 0 0 0 0 0 0 A6NJ64 NPIB2_HUMAN Putative nuclear pore complex-interacting protein family member B2 NPIPB2 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 DVITLRR 0.98959 -4.2803 0 0 0 0 0 0 0 0 0 0 0 12.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6626 0 15.6519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4 0 0 0 13.8853 11.6747 0 0 0 0 0 0 0 0 0 0 0 0 12.9886 0 0 0 0 0 0 12.9565 0 0 0 0 0 0 0 12.5309 0 0 0 12.7605 0 0 0 0 0 0 0 0 15.6423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.009 0 0 0 0 0 0 0 0 0 0 0 0 Q5MJ09 SPXN3_HUMAN "Sperm protein associated with the nucleus on the X chromosome N3 (Nuclear-associated protein SPAN-Xn3, SPANX-N3) (SPANX family member N3)" SPANXN3 Homo sapiens (Human) DLDSSEGSSQEDEDLGLSEGSSQDSGED 0.98959 -4.2876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5648 0 0 0 0 0 0 0 0 0 0 0 13.6881 0 0 0 0 0 0 0 0 0 0 0 13.1582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2943 14.2806 0 0 14.555 0 0 14.4892 0 0 0 0 12.6007 0 0 14.1443 0 0 0 0 0 13.4956 0 0 0 0 0 0 0 14.4297 0 11.7941 0 0 14.6409 0 0 13.4915 0 0 15.3441 14.7634 0 14.1076 0 0 0 0 0 0 14.4703 0 0 0 0 0 0 0 0 0 15.0363 0 0 14.8449 0 0 0 14.6999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBX7 KLK11_HUMAN "Kallikrein-11, hK11, EC 3.4.21.- (Hippostasin) (Serine protease 20) (Trypsin-like protease) [Cleaved into: Kallikrein-11 inactive chain 1; Kallikrein-11 inactive chain 2 ]" KLK11 PRSS20 TLSP UNQ649/PRO1279 Homo sapiens (Human) proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0005794; GO:0006508; GO:0008236; GO:0030141; GO:0070062 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] ILQLILLALATGLVGGETR 0.98959 -4.2854 0 0 0 0 13.4605 0 0 13.3844 0 0 0 0 12.4693 0 12.526 0 14.7451 14.3312 14.57 13.7575 0 0 0 0 14.9651 0 14.0659 0 15.606 15.0418 0 14.6485 11.5675 14.8952 13.7518 0 14.0344 14.5824 0 0 0 15.6852 15.4511 0 14.8644 16.4515 14.4719 16.3894 15.3005 0 14.6502 0 10.0278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.521 0 0 0 0 0 14.4322 0 15.2115 0 0 13.9824 0 0 0 13.1653 0 0 0 0 15.591 0 0 0 14.4616 0 0 15.1482 0 0 0 0 0 12.3956 0 15.7056 0 15.4372 15.661 12.5562 0 13.9319 15.29 0 0 0 0 0 0 15.1294 13.6124 0 0 0 0 0 0 0 0 14.83 14.4152 0 12.8626 14.1825 15.144 0 14.7231 15.449 13.6478 14.5899 0 15.3057 14.6809 15.2371 0 0 0 0 0 0 14.0288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3507 14.0398 0 0 0 0 0 0 0 0 Q13882 PTK6_HUMAN "Protein-tyrosine kinase 6, EC 2.7.10.2 (Breast tumor kinase) (Tyrosine-protein kinase BRK)" PTK6 BRK Homo sapiens (Human) cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ERBB2 signaling pathway [GO:0038128]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of growth [GO:0045926]; negative regulation of protein tyrosine kinase activity [GO:0061099]; positive regulation of cell cycle [GO:0045787]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0001726; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007169; GO:0007260; GO:0010976; GO:0016477; GO:0016604; GO:0030154; GO:0031234; GO:0038128; GO:0042531; GO:0042802; GO:0045087; GO:0045742; GO:0045787; GO:0045926; GO:0046777; GO:0060575; GO:0061099; GO:0071300 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] DPEQRPCFK 0.9896 -4.3034 0 0 0 0 0 0 0 0 0 11.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3045 0 0 0 13.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP95 FGF20_HUMAN "Fibroblast growth factor 20, FGF-20" FGF20 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear auditory receptor cell differentiation [GO:0042491]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopaminergic neuron differentiation [GO:1904340]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell migration [GO:0030334]; regulation of dopamine secretion [GO:0014059]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparan sulfate proteoglycan binding [GO:0043395]; receptor-receptor interaction [GO:0090722]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear auditory receptor cell differentiation [GO:0042491]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopaminergic neuron differentiation [GO:1904340]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell migration [GO:0030334]; regulation of dopamine secretion [GO:0014059]; signal transduction [GO:0007165] GO:0001934; GO:0005102; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0014059; GO:0030154; GO:0030334; GO:0042491; GO:0043395; GO:0043524; GO:0060043; GO:0070374; GO:0090722; GO:1904340 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparan sulfate proteoglycan binding [GO:0043395]; receptor-receptor interaction [GO:0090722]; signaling receptor binding [GO:0005102] GGPGAAQLAHLHGILRR 0.9896 -1.7582 0 0 0 0 0 0 0 0 0 0 11.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5229 0 0 0 0 0 0 0 0 0 0 11.7866 0 11.3696 0 0 0 0 11.9935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVJ2 ARL8B_HUMAN "ADP-ribosylation factor-like protein 8B, EC 3.6.5.2 (ADP-ribosylation factor-like protein 10C) (Novel small G protein indispensable for equal chromosome segregation 1)" ARL8B ARL10C GIE1 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; antigen processing and presentation following phagocytosis [GO:0002747]; antigen processing and presentation of polysaccharide antigen via MHC class II [GO:0002505]; autophagosome-lysosome fusion [GO:0061909]; calcium ion regulated lysosome exocytosis [GO:1990927]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; endosomal transport [GO:0016197]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; viral exocytosis [GO:0046754] anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; midbody [GO:0030496]; spindle midzone [GO:0051233]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; midbody [GO:0030496]; spindle midzone [GO:0051233]; synapse [GO:0045202]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; antigen processing and presentation following phagocytosis [GO:0002747]; antigen processing and presentation of polysaccharide antigen via MHC class II [GO:0002505]; autophagosome-lysosome fusion [GO:0061909]; calcium ion regulated lysosome exocytosis [GO:1990927]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; endosomal transport [GO:0016197]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; viral exocytosis [GO:0046754] GO:0001778; GO:0002505; GO:0002747; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0007049; GO:0007059; GO:0008089; GO:0015031; GO:0016020; GO:0016197; GO:0019003; GO:0030496; GO:0031902; GO:0032418; GO:0042267; GO:0043014; GO:0045202; GO:0046754; GO:0048487; GO:0051233; GO:0051301; GO:0061909; GO:0070062; GO:0070161; GO:0090117; GO:0090385; GO:0101004; GO:1902774; GO:1904115; GO:1990927 alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] EKIEASRNELHNLLDK 0.9896 -4.2942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1056 0 0 0 0 0 0 0 0 0 0 15.2606 0 13.5111 14.8315 0 0 14.7305 0 13.8645 0 0 0 14.2638 0 0 0 12.3258 0 0 0 0 14.1273 0 0 0 0 0 13.2834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6726 0 0 0 0 0 0 0 12.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0J9YX94 PMA6F_HUMAN Paraneoplastic antigen Ma6F PNMA6F PNMA6BL Homo sapiens (Human) ARPSEALQDTLRR 0.98961 -1.863 0 0 0 13.0776 0 10.7921 0 0 13.9812 0 0 13.0876 0 12.4745 12.7474 0 0 0 12.6356 0 0 0 0 12.1612 13.4222 12.2782 10.3121 12.1039 0 0 0 0 0 12.9687 13.9908 11.905 0 0 0 12.6002 12.3715 10.3058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7309 0 0 0 0 0 0 0 0 12.8083 0 0 0 0 0 0 0 0 15.1157 0 0 0 14.2994 13.8429 12.5362 14.9328 0 0 14.7581 14.0296 0 0 14.8096 13.9296 14.4918 0 0 0 0 0 0 15.011 14.6389 14.0403 14.459 0 0 13.3407 0 13.3916 13.3323 14.3724 0 14.0629 0 0 0 0 13.5309 0 13.7776 12.2625 0 14.537 0 13.7668 12.7235 15.5982 0 13.7621 0 13.5196 13.5637 13.8733 0 12.8321 0 12.5903 0 0 0 0 14.1008 0 13.1936 13.2758 13.0282 13.1278 0 0 0 0 12.6842 13.0103 14.5884 14.459 12.9977 14.6302 14.0347 0 0 0 0 0 0 0 Q9NXE4 NSMA3_HUMAN "Sphingomyelin phosphodiesterase 4, EC 3.1.4.12 (Neutral sphingomyelinase 3, nSMase-3, nSMase3) (Neutral sphingomyelinase III)" SMPD4 KIAA1418 SKNY Homo sapiens (Human) cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcolemma [GO:0042383]; trans-Golgi network [GO:0005802] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcolemma [GO:0042383]; trans-Golgi network [GO:0005802]; metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685] GO:0000139; GO:0004767; GO:0005635; GO:0005640; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0006685; GO:0007029; GO:0016021; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356 metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290] HLLSPVGRR 0.98961 -5.7824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0333 0 0 0 0 0 0 0 0 0 15.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1992 0 0 17.5626 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6503 0 14.8832 0 0 0 0 0 0 0 0 0 0 17.5784 0 0 0 0 0 0 13.9409 0 0 0 0 0 0 0 0 17.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5GFL6 VWA2_HUMAN "von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen, AMACO) (Colon cancer secreted protein 2, CCSP-2)" VWA2 AMACO Homo sapiens (Human) calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626] GO:0005509; GO:0005604; GO:0005615; GO:0007161; GO:0042802; GO:0046626; GO:0062023; GO:0070062 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] CRDGWEGPHCENR 0.98962 -5.7974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8294 0 0 0 11.6823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3628 0 0 0 0 0 0 0 0 0 0 0 0 11.8821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9981 0 0 0 0 0 0 0 12.1934 0 0 11.5011 0 0 0 12.9362 0 0 0 0 0 0 0 0 0 13.7276 0 0 0 0 12.3647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2153 0 0 0 0 0 0 0 0 Q93034 CUL5_HUMAN "Cullin-5, CUL-5 (Vasopressin-activated calcium-mobilizing receptor 1, VACM-1)" CUL5 VACM1 Homo sapiens (Human) ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734] Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734]; calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000082; GO:0004842; GO:0005262; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031466; GO:0031625; GO:0038023; GO:0038128; GO:0090734; GO:0097193 calcium channel activity [GO:0005262]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] AYIVEWRK 0.98962 -5.7958 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0578 13.1138 13.4161 14.8985 0 12.4312 12.5516 0 11.9277 0 13.3088 0 0 12.5252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8358 0 0 0 12.9974 0 0 0 0 0 0 11.2822 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8872 0 13.8271 12.603 0 14.9075 0 0 14.1401 0 15.0362 15.5655 14.8639 13.7558 15.0382 0 0 0 0 0 0 0 0 0 0 0 13.2663 0 0 0 0 0 0 13.1241 14.5974 13.8098 12.7284 13.8179 14.4261 0 0 13.9979 0 0 0 0 0 0 13.9454 0 15.2461 0 0 14.3665 13.7622 12.883 14.1115 13.164 13.9564 13.783 0 14.9542 13.644 0 12.8058 13.8857 12.7365 0 0 0 13.6539 10.6411 0 13.4653 0 14.7016 13.0826 0 0 0 0 0 0 0 12.0109 0 0 0 0 13.6829 0 0 0 10.8322 0 0 12.1127 0 0 0 0 0 0 0 0 12.161 12.0901 12.4074 0 0 13.3426 0 0 0 O94805 ACL6B_HUMAN "Actin-like protein 6B (53 kDa BRG1-associated factor B) (Actin-related protein Baf53b) (ArpNalpha) (BRG1-associated factor 53B, BAF53B)" ACTL6B ACTL6 BAF53B Homo sapiens (Human) chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; histone H4 acetylation [GO:0043967]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; dendrite development [GO:0016358]; histone H4 acetylation [GO:0043967]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510] GO:0000776; GO:0000785; GO:0003682; GO:0003713; GO:0005200; GO:0005634; GO:0006325; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0016358; GO:0016363; GO:0016514; GO:0016586; GO:0021510; GO:0030071; GO:0035060; GO:0035267; GO:0042551; GO:0043967; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0070316; GO:0071565; GO:0140092; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin binding [GO:0003682]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713] EPVREGAPPNWKK 0.98964 -1.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.805 0 0 0 0 0 0 0 0 0 0 0 13.1684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3551 0 0 P09619 PGFRB_HUMAN "Platelet-derived growth factor receptor beta, PDGF-R-beta, PDGFR-beta, EC 2.7.10.1 (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1, PDGFR-1) (CD antigen CD140b)" PDGFRB PDGFR PDGFR1 Homo sapiens (Human) aging [GO:0007568]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in coronary angiogenesis [GO:0060981]; cell migration involved in vasculogenesis [GO:0035441]; glycosaminoglycan biosynthetic process [GO:0006024]; inner ear development [GO:0048839]; lung growth [GO:0060437]; male gonad development [GO:0008584]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerular capillary formation [GO:0072277]; metanephric glomerular mesangial cell proliferation involved in metanephros development [GO:0072262]; metanephric mesenchymal cell migration [GO:0035789]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; smooth muscle cell chemotaxis [GO:0071670]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; phosphatidylinositol 3-kinase binding [GO:0043548]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor activity [GO:0005017]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; aging [GO:0007568]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; cardiac myofibril assembly [GO:0055003]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell migration involved in coronary angiogenesis [GO:0060981]; cell migration involved in vasculogenesis [GO:0035441]; glycosaminoglycan biosynthetic process [GO:0006024]; inner ear development [GO:0048839]; lung growth [GO:0060437]; male gonad development [GO:0008584]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerular capillary formation [GO:0072277]; metanephric glomerular mesangial cell proliferation involved in metanephros development [GO:0072262]; metanephric mesenchymal cell migration [GO:0035789]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton organization [GO:0032956]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to fluid shear stress [GO:0034405]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; smooth muscle cell chemotaxis [GO:0071670]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] GO:0001525; GO:0004713; GO:0004714; GO:0004992; GO:0005017; GO:0005019; GO:0005102; GO:0005161; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0006024; GO:0007165; GO:0007169; GO:0007568; GO:0008284; GO:0008584; GO:0009636; GO:0009986; GO:0010863; GO:0014068; GO:0014911; GO:0016020; GO:0016324; GO:0016477; GO:0018108; GO:0019838; GO:0019899; GO:0019901; GO:0030335; GO:0031226; GO:0031410; GO:0032355; GO:0032516; GO:0032526; GO:0032956; GO:0032967; GO:0033674; GO:0034405; GO:0035025; GO:0035441; GO:0035789; GO:0035791; GO:0035793; GO:0035909; GO:0038085; GO:0038091; GO:0042060; GO:0042542; GO:0043065; GO:0043066; GO:0043202; GO:0043231; GO:0043235; GO:0043406; GO:0043548; GO:0043552; GO:0043627; GO:0045840; GO:0046488; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048661; GO:0048839; GO:0050921; GO:0055003; GO:0055093; GO:0060326; GO:0060437; GO:0060981; GO:0061298; GO:0070374; GO:0071670; GO:0072075; GO:0072262; GO:0072277; GO:0072278; GO:0072284; GO:0090280; GO:2000379; GO:2000491; GO:2000573 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; phosphatidylinositol 3-kinase binding [GO:0043548]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor activity [GO:0005017]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085] AEAEDSFL 0.98964 -1.8869 0 0 0 0 0 0 0 0 0 10.7912 0 0 0 0 0 0 10.9762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9976 0 13.9426 0 0 13.2821 13.7363 0 17.2548 14.0506 14.8905 0 0 16.3477 0 11.6489 0 15.1343 0 0 15.7448 12.9843 0 14.1089 16.8892 13.1313 0 12.6103 0 0 16.2443 0 0 14.0506 11.9432 0 13.4519 14.3609 0 0 0 10.7548 12.316 11.7574 0 0 0 0 0 13.5281 13.7556 0 14.7996 0 13.761 13.198 0 14.1601 13.2992 0 13.3301 0 0 14.1648 0 0 0 0 0 0 13.0134 0 0 0 0 0 0 0 0 13.2843 0 0 0 0 0 0 0 0 0 0 0 0 0 13.358 11.456 0 11.994 0 0 0 13.4489 0 0 0 0 0 0 10.6079 P0CF75 EBLN1_HUMAN "Endogenous Bornavirus-like nucleoprotein 1 (Endogenous Borna-like N element-1, EBLN-1)" EBLN1 Homo sapiens (Human) ALLSVGVSK 0.98964 -4.3562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3818 0 14.7814 14.746 0 0 0 0 0 0 11.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0934 0 0 14.1136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0677 0 0 0 0 0 0 0 0 0 0 0 Q9C009 FOXQ1_HUMAN "Forkhead box protein Q1 (HNF-3/forkhead-like protein 1, HFH-1) (Hepatocyte nuclear factor 3 forkhead homolog 1)" FOXQ1 HFH1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; hair follicle morphogenesis [GO:0031069]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; hair follicle morphogenesis [GO:0031069]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0009653; GO:0030154; GO:0031069; GO:0043524; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GPAAGGAHLYCPLR 0.98964 -1.8938 0 0 0 0 0 0 0 0 0 0 0 15.3753 13.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5658 0 16.5104 16.6437 0 0 0 15.0291 15.1439 0 16.5453 0 0 0 0 0 0 0 0 0 0 0 0 10.1731 0 0 0 0 0 0 0 14.9772 0 0 0 0 13.3261 0 12.5855 0 0 0 0 0 0 12.2922 0 12.5661 12.4808 0 0 12.5399 0 0 0 0 0 0 12.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9585 12.6953 0 0 12.7057 0 0 0 0 12.6812 13.1393 0 0 12.8038 0 0 0 0 0 0 12.5697 0 12.5332 0 0 12.7742 0 0 0 0 0 0 0 0 0 0 0 13.1851 0 0 0 0 0 0 0 12.8314 0 0 13.2316 0 20.2225 20.0076 0 0 17.9216 0 18.7586 19.203 0 0 0 0 0 0 11.8418 0 0 0 0 0 0 19.1816 19.0885 18.9144 O42043 ENK18_HUMAN "Endogenous retrovirus group K member 18 Env polyprotein (Envelope polyprotein) (HERV-K(C1a) envelope protein) (HERV-K110 envelope protein) (HERV-K18 envelope protein) (HERV-K18 superantigen) (HERV-K_1q23.3 provirus ancestral Env polyprotein) (IDDMK1,2 22 envelope protein) (IDDMK1,2 22 superantigen) [Cleaved into: Surface protein, SU; Transmembrane protein, TM ]" ERVK-18 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198] GO:0005198; GO:0005886; GO:0016021 structural molecule activity [GO:0005198] DSDIENGP 0.98965 -5.8347 0 0 12.2809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2604 0 0 12.944 0 0 0 0 0 0 0 0 0 0 0 10.9636 0 0 0 0 0 0 0 0 0 0 0 12.7418 13.276 0 0 0 0 0 0 0 0 0 0 0 0 10.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.822 0 0 0 0 0 Q8WWX8 SC5AB_HUMAN "Sodium/myo-inositol cotransporter 2, Na(+)/myo-inositol cotransporter 2 (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2, SMIT2) (Solute carrier family 5 member 11)" SLC5A11 KST1 SLGTX SMIT2 Homo sapiens (Human) apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]; regulation of transporter activity [GO:0032409] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166]; apoptotic process [GO:0006915]; myo-inositol transport [GO:0015798]; regulation of transporter activity [GO:0032409] GO:0005412; GO:0005886; GO:0006915; GO:0015166; GO:0015798; GO:0016021; GO:0032409 glucose:sodium symporter activity [GO:0005412]; polyol transmembrane transporter activity [GO:0015166] EDAFHIFR 0.98968 -4.2782 11.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8595 0 0 13.8032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1591 0 0 0 0 0 0 0 0 0 0 0 14.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDW4 ST7L_HUMAN Suppressor of tumorigenicity 7 protein-like (ST7-related protein) ST7L ST7R Homo sapiens (Human) negative regulation of cell growth [GO:0030308] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; negative regulation of cell growth [GO:0030308] GO:0016021; GO:0030308 ERLRAGLAGTGASLWFVAGLGLLYALR 0.98969 -5.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6941 0 0 0 0 0 0 0 0 0 0 10.8518 0 14.459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.068 0 0 0 10.7378 0 0 0 0 0 10.1719 0 0 0 0 0 12.7971 0 0 11.2461 0 0 0 0 0 0 0 0 0 0 11.106 0 0 0 0 0 0 12.1193 0 0 0 0 0 0 0 0 11.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9A5 CNO10_HUMAN CCR4-NOT transcription complex subunit 10 CNOT10 Homo sapiens (Human) gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] GO:0000289; GO:0005634; GO:0005829; GO:0006402; GO:0016020; GO:0017148; GO:0030014; GO:0031047 CMFWNNLGCIHFAMSKHNLGIFYFKK 0.98969 -5.6414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1755 0 0 0 0 0 0 12.7542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8189 0 0 0 0 11.1424 0 0 0 0 0 0 0 0 0 0 11.3408 0 13.0921 0 13.5205 0 0 0 0 0 0 0 0 0 0 0 14.3968 0 0 0 0 0 0 0 11.4118 0 0 0 0 0 0 0 0 0 P14555 PA2GA_HUMAN "Phospholipase A2, membrane associated, EC 3.1.1.4 (GIIC sPLA2) (Group IIA phospholipase A2) (Non-pancreatic secretory phospholipase A2, NPS-PLA2) (Phosphatidylcholine 2-acylhydrolase 2A)" PLA2G2A PLA2B PLA2L RASF-A Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; intestinal stem cell homeostasis [GO:0036335]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phospholipid metabolic process [GO:0006644]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; regulation of neutrophil activation [GO:1902563] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]; arachidonic acid secretion [GO:0050482]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; intestinal stem cell homeostasis [GO:0036335]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phospholipid metabolic process [GO:0006644]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; regulation of neutrophil activation [GO:1902563] GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0005741; GO:0005783; GO:0005789; GO:0005886; GO:0006644; GO:0006954; GO:0010744; GO:0016042; GO:0019835; GO:0030141; GO:0034374; GO:0036335; GO:0046337; GO:0046470; GO:0046473; GO:0047498; GO:0048471; GO:0050482; GO:0050729; GO:0050830; GO:0070062; GO:0070374; GO:1902563 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543] DATDRCCVTHDCCYK 0.9897 -5.782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3961 0 0 0 0 13.1221 0 0 0 0 0 0 0 15.4113 0 0 12.3979 0 0 0 0 0 0 0 0 0 0 0 10.5473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0898 0 0 0 0 0 0 0 0 0 0 0 0 10.5918 0 10.778 0 0 0 0 0 13.6982 Q14BN4 SLMAP_HUMAN "Sarcolemmal membrane-associated protein, Sarcolemmal-associated protein" SLMAP KIAA1601 SLAP UNQ1847/PRO3577 Homo sapiens (Human) muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150] integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790] integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150] GO:0005790; GO:0005815; GO:0005887; GO:0006936; GO:0042383; GO:0072659; GO:1900825; GO:1902305; GO:1905150 AELERWRK 0.98971 -5.6702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7965 0 11.9253 0 11.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0781 0 0 0 0 0 0 0 0 0 0 13.2031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.728 0 0 0 0 0 0 0 0 0 12.3901 0 0 0 0 0 0 0 0 0 0 11.8744 0 0 0 0 0 0 0 11.6392 0 0 0 0 0 0 0 Q4G0I0 CSMT1_HUMAN Protein CCSMST1 CCSMST1 C16orf91 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DRAHPAAEEEDDPDR 0.98971 -5.6678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1382 0 0 0 11.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9787 0 0 0 0 0 0 0 0 0 13.5983 0 0 13.8081 0 0 0 0 0 0 0 13.3853 10.9941 0 13.0692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1669 0 0 0 0 0 Q6IMN6 CAPR2_HUMAN Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (Gastric cancer multidrug resistance-associated protein) (Protein EEG-1) (RNA granule protein 140) CAPRIN2 C1QDC1 EEG1 KIAA1873 RNG140 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003723; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0017148; GO:0030154; GO:0030308; GO:0032092; GO:0033138; GO:0043235; GO:0045944; GO:0046872; GO:0050775; GO:0061003; GO:0090263 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102] LITNSYR 0.98971 -5.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8715 11.8368 0 0 0 11.7219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4493 0 0 0 17.3337 15.8423 0 16.0209 0 0 0 0 13.8535 0 0 16.2482 0 0 14.2255 0 0 0 0 0 0 10.9984 0 0 0 0 0 0 0 0 0 0 0 0 17.177 0 0 0 0 13.2138 0 0 0 13.4384 0 0 0 0 0 13.2586 0 0 0 0 0 0 14.6732 0 0 0 0 0 0 0 18.3752 0 0 0 0 0 0 13.4029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14833 GRM4_HUMAN "Metabotropic glutamate receptor 4, mGluR4" GRM4 GPRC1D MGLUR4 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neurotransmitter secretion [GO:0007269]; positive regulation of MAPK cascade [GO:0043410]; regulation of neuron apoptotic process [GO:0043523]; regulation of synaptic transmission, glutamatergic [GO:0051966]" cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793] "cytoplasmic vesicle [GO:0031410]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; neurotransmitter secretion [GO:0007269]; positive regulation of MAPK cascade [GO:0043410]; regulation of neuron apoptotic process [GO:0043523]; regulation of synaptic transmission, glutamatergic [GO:0051966]" GO:0001640; GO:0004930; GO:0005886; GO:0005887; GO:0007196; GO:0007216; GO:0007268; GO:0007269; GO:0008066; GO:0031410; GO:0043410; GO:0043523; GO:0051966; GO:0098793 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066] GMPCCWHCEPCTGYQYQVDR 0.98972 -1.8628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.208 0 0 10.7388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4452 12.237 12.409 0 0 0 0 0 11.2192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1296 0 0 0 0 14.132 0 14.9986 0 0 11.1375 0 0 15.1419 0 0 0 11.3917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2584 0 0 0 0 0 0 0 0 13.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5133 0 0 0 0 0 0 Q8N8E1 MAAS1_HUMAN Putative uncharacterized protein encoded by MAPKAPK5-AS1 (MAPKAPK5 antisense RNA 1) (MAPKAPK5 antisense gene protein 1) MAPKAPK5-AS1 C12orf47 Homo sapiens (Human) APGPRGDGQQPPLGTGGDEDPGAGSASAGGSR 0.98972 -4.3463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8829 0 0 0 0 0 0 0 0 0 0 Q9H1B4 NXF5_HUMAN "Nuclear RNA export factor 5 (TAP-like protein 1, TAPL-1)" NXF5 TAPL1 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA transport [GO:0050658] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA transport [GO:0050658] GO:0003723; GO:0005634; GO:0005737; GO:0006406; GO:0016973; GO:0050658 RNA binding [GO:0003723] FDPDLMGRDIDIILNRR 0.98972 -1.7579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14713 ITBP1_HUMAN "Integrin beta-1-binding protein 1 (Integrin cytoplasmic domain-associated protein 1, ICAP-1)" ITGB1BP1 ICAP1 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; biomineral tissue development [GO:0031214]; blood vessel diameter maintenance [GO:0097746]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; Notch signaling pathway [GO:0007219]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of GTPase activity [GO:0043087]; regulation of integrin-mediated signaling pathway [GO:2001044]; tube formation [GO:0035148] cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GDP-dissociation inhibitor activity [GO:0005092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; activation of protein kinase B activity [GO:0032148]; biomineral tissue development [GO:0031214]; blood vessel diameter maintenance [GO:0097746]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; Notch signaling pathway [GO:0007219]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of GTPase activity [GO:0043087]; regulation of integrin-mediated signaling pathway [GO:2001044]; tube formation [GO:0035148] GO:0001726; GO:0002043; GO:0005092; GO:0005178; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006469; GO:0006933; GO:0007160; GO:0007219; GO:0007229; GO:0008284; GO:0008285; GO:0010595; GO:0010764; GO:0016020; GO:0016477; GO:0016604; GO:0019901; GO:0030027; GO:0030154; GO:0031214; GO:0032091; GO:0032148; GO:0033622; GO:0033628; GO:0034451; GO:0035148; GO:0035556; GO:0035924; GO:0043087; GO:0043113; GO:0044344; GO:0045747; GO:0045944; GO:0048471; GO:0051451; GO:0051496; GO:0051781; GO:0051894; GO:0051895; GO:0051897; GO:0070373; GO:0071944; GO:0072659; GO:0090051; GO:0090314; GO:0090315; GO:0097746; GO:1900025; GO:2001044 GDP-dissociation inhibitor activity [GO:0005092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901] HALYLIIRMVCYDDGLGAGKSLLALK 0.98973 -4.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0665 0 0 0 0 0 0 0 0 0 0 0 0 12.2471 0 0 0 0 0 0 0 0 0 0 13.2705 0 0 0 13.222 0 0 0 0 0 0 0 0 0 13.2316 0 0 0 0 12.8181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15034 RIMB2_HUMAN "RIMS-binding protein 2, RIM-BP2" RIMBP2 KIAA0318 RBP2 Homo sapiens (Human) neuromuscular synaptic transmission [GO:0007274] anchoring junction [GO:0070161]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; plasma membrane [GO:0005886]; synapse [GO:0045202]; neuromuscular synaptic transmission [GO:0007274] GO:0005886; GO:0007274; GO:0045202; GO:0070161 CRSESDMENER 0.98973 -4.3525 0 0 0 0 0 0 0 0 12.2657 11.8232 11.8549 0 11.3558 10.9932 0 0 0 0 0 0 0 0 0 0 0 11.2952 0 12.1284 0 12.4641 12.4875 0 11.7414 0 11.8995 0 10.9944 0 0 0 0 0 12.473 0 10.1536 0 12.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0156 0 0 13.7898 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7156 0 0 0 0 0 0 11.5337 0 0 0 0 0 0 0 0 0 0 0 0 12.1047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1097 0 0 0 0 10.0318 0 0 11.2929 0 0 0 0 0 0 0 0 O15405 TOX3_HUMAN TOX high mobility group box family member 3 (CAG trinucleotide repeat-containing gene F9 protein) (Trinucleotide repeat-containing gene 9 protein) TOX3 CAGF9 TNRC9 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0031490; GO:0042803; GO:0042981; GO:0043524; GO:0045944; GO:0051219 chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713] AAPDSGK 0.98973 -4.3557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5797 0 0 0 0 0 0 0 11.7564 0 0 12.0938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 O43763 TLX2_HUMAN T-cell leukemia homeobox protein 2 (Homeobox protein Hox-11L1) (Neural crest homeobox protein) TLX2 HOX11L1 NCX Homo sapiens (Human) animal organ development [GO:0048513]; enteric nervous system development [GO:0048484]; mesoderm formation [GO:0001707]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ development [GO:0048513]; enteric nervous system development [GO:0048484]; mesoderm formation [GO:0001707]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001707; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0048484; GO:0048513; GO:0050774; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AGRLLLHLQQDALPRPLR 0.98973 -4.3507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.851 0 0 0 0 11.2172 0 11.9966 0 0 0 0 0 0 0 0 0 0 0 12.3908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2801 0 0 0 11.2288 14.77 0 0 0 11.1187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5944 0 0 0 0 11.3394 0 0 0 0 O95954 FTCD_HUMAN "Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase, FTCD) (LCHC1) [Includes: Glutamate formimidoyltransferase, EC 2.1.2.5 (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase, EC 4.3.1.4 (Formiminotetrahydrofolate cyclodeaminase) ]" FTCD Homo sapiens (Human) cytoskeleton organization [GO:0007010]; folic acid-containing compound metabolic process [GO:0006760]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; glutamate formimidoyltransferase activity [GO:0030409]; microtubule binding [GO:0008017]; cytoskeleton organization [GO:0007010]; folic acid-containing compound metabolic process [GO:0006760]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] GO:0000139; GO:0005542; GO:0005737; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005829; GO:0005886; GO:0006760; GO:0007010; GO:0008017; GO:0019556; GO:0019557; GO:0030409; GO:0030412; GO:0030868; GO:0070062 folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; glutamate formimidoyltransferase activity [GO:0030409]; microtubule binding [GO:0008017] KFLIAFNINLLGTK 0.98973 -5.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0286 0 0 11.1349 0 0 0 0 0 0 0 0 0 12.428 0 0 0 0 0 0 11.4359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8924 0 0 0 0 0 12.2596 10.951 0 0 0 0 0 0 0 0 11.8579 0 0 0 0 0 0 0 0 12.8446 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9595 0 0 0 0 12.6973 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13426 XRCC4_HUMAN "DNA repair protein XRCC4, hXRCC4 (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus, XRCC4/C ]" XRCC4 Homo sapiens (Human) DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; positive regulation of ligase activity [GO:0051351]; positive regulation of phosphatidylserine exposure on apoptotic cell surface [GO:1905782]; protein localization to site of double-strand break [GO:1990166]; response to X-ray [GO:0010165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; positive regulation of ligase activity [GO:0051351]; positive regulation of phosphatidylserine exposure on apoptotic cell surface [GO:1905782]; protein localization to site of double-strand break [GO:1990166]; response to X-ray [GO:0010165] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005958; GO:0006302; GO:0006303; GO:0008022; GO:0010165; GO:0032807; GO:0033152; GO:0035861; GO:0042802; GO:0051103; GO:0051351; GO:0070419; GO:0070975; GO:1905782; GO:1990166 FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022] EALETDLYK 0.98973 -5.8345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WY41 NANO1_HUMAN "Nanos homolog 1, NOS-1 (EC_Rep1a)" NANOS1 NOS1 Homo sapiens (Human) "cell migration [GO:0016477]; cerebellar neuron development [GO:0098749]; epithelial cell migration [GO:0010631]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell growth [GO:0001558]; tissue homeostasis [GO:0001894]" cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; cerebellar neuron development [GO:0098749]; epithelial cell migration [GO:0010631]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell growth [GO:0001558]; tissue homeostasis [GO:0001894]" GO:0001558; GO:0001894; GO:0003729; GO:0005737; GO:0008270; GO:0010608; GO:0010631; GO:0016477; GO:0017148; GO:0030371; GO:0048471; GO:0048477; GO:0098749; GO:1900153 mRNA binding [GO:0003729]; translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270] AVDGEPR 0.98973 -4.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96R06 SPAG5_HUMAN "Sperm-associated antigen 5 (Astrin) (Deepest) (Mitotic spindle-associated protein p126, MAP126)" SPAG5 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of spindle orientation [GO:0051294]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of metaphase plate congression [GO:0090235]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604] centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of spindle orientation [GO:0051294]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of metaphase plate congression [GO:0090235]; spindle organization [GO:0007051] GO:0000070; GO:0000776; GO:0005737; GO:0005829; GO:0007051; GO:0007059; GO:0008017; GO:0016604; GO:0030496; GO:0032388; GO:0034451; GO:0035253; GO:0035371; GO:0036064; GO:0051294; GO:0051301; GO:0051988; GO:0071539; GO:0072686; GO:0090235; GO:0097431; GO:1905832 microtubule binding [GO:0008017] DTVENLTAKLASTIADNQEQDLEKTR 0.98973 -4.3561 10.4885 0 0 0 0 0 0 0 12.4071 0 0 13.8487 17.9137 12.7841 18.0384 17.7733 17.5895 12.9897 0 0 0 0 11.8284 0 0 0 13.724 17.6383 13.0425 15.587 0 0 0 0 12.4603 12.8374 12.5162 17.7477 0 14.0866 17.6803 0 0 12.5568 17.7573 0 0 17.7923 0 17.8452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0143 0 0 0 0 0 0 0 0 0 12.4379 0 0 0 0 0 0 10.4815 0 0 0 14.6715 0 0 11.9395 15.0411 0 0 10.9528 0 13.3817 0 0 12.5101 0 0 0 0 0 0 0 0 0 0 0 12.833 14.7887 0 0 0 18.5664 0 0 0 0 0 0 0 0 0 0 11.5917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0692 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7357 0 12.6155 0 0 0 18.611 0 18.5812 13.5552 0 0 0 13.0543 13.452 0 12.5537 0 0 0 0 18.5653 0 0 Q9BX67 JAM3_HUMAN "Junctional adhesion molecule C, JAM-C (JAM-2) (Junctional adhesion molecule 3, JAM-3) [Cleaved into: Soluble form of JAM-C, sJAM-C ]" JAM3 UNQ859/PRO1868 Homo sapiens (Human) adaptive immune response [GO:0002250]; adherens junction assembly [GO:0034333]; angiogenesis [GO:0001525]; apical protein localization [GO:0045176]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of cell polarity [GO:0030010]; granulocyte migration [GO:0097530]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte migration involved in inflammatory response [GO:0002523]; maintenance of blood-brain barrier [GO:0035633]; myelination [GO:0042552]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of integrin activation [GO:0033624]; neutrophil homeostasis [GO:0001780]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of membrane permeability [GO:1905710]; protein localization to cell junction [GO:1902414]; protein localization to cell surface [GO:0034394]; regulation of actin cytoskeleton organization by cell-cell adhesion [GO:0090138]; regulation of neutrophil chemotaxis [GO:0090022]; spermatid development [GO:0007286]; transmission of nerve impulse [GO:0019226] bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160] bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; cell-cell adhesion mediator activity [GO:0098632]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; adaptive immune response [GO:0002250]; adherens junction assembly [GO:0034333]; angiogenesis [GO:0001525]; apical protein localization [GO:0045176]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of cell polarity [GO:0030010]; granulocyte migration [GO:0097530]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte migration involved in inflammatory response [GO:0002523]; maintenance of blood-brain barrier [GO:0035633]; myelination [GO:0042552]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of integrin activation [GO:0033624]; neutrophil homeostasis [GO:0001780]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of membrane permeability [GO:1905710]; protein localization to cell junction [GO:1902414]; protein localization to cell surface [GO:0034394]; regulation of actin cytoskeleton organization by cell-cell adhesion [GO:0090138]; regulation of neutrophil chemotaxis [GO:0090022]; spermatid development [GO:0007286]; transmission of nerve impulse [GO:0019226] GO:0001525; GO:0001780; GO:0002250; GO:0002318; GO:0002523; GO:0002693; GO:0005178; GO:0005615; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0005911; GO:0005923; GO:0007160; GO:0007286; GO:0016477; GO:0019226; GO:0030010; GO:0030057; GO:0031941; GO:0033010; GO:0033624; GO:0033629; GO:0034113; GO:0034333; GO:0034394; GO:0035633; GO:0042552; GO:0042803; GO:0043220; GO:0044291; GO:0045176; GO:0046982; GO:0070160; GO:0090022; GO:0090138; GO:0097241; GO:0097530; GO:0098609; GO:0098632; GO:0098636; GO:1902414; GO:1905710 cell-cell adhesion mediator activity [GO:0098632]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CEVVARNDRK 0.98974 -5.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5535 0 17.1331 16.5616 16.0769 0 15.9548 0 13.5744 0 14.2324 0 0 13.2897 0 0 0 0 0 0 0 0 0 0 15.4023 0 0 15.4516 0 14.7629 14.7909 15.3079 0 15.8962 15.7112 0 0 0 0 0 0 0 14.7064 14.7491 15.6939 0 14.8411 13.7144 0 0 0 0 13.0909 14.8205 15.4857 0 0 0 15.8388 0 15.5951 15.3626 15.2825 0 0 0 14.4269 0 15.4131 0 0 15.6687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0634 15.1712 15.1139 0 0 0 15.4871 0 Q6ZNG0 ZN620_HUMAN Zinc finger protein 620 ZNF620 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ECGKGLSSDTALIQHQR 0.98975 -1.8849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2794 14.984 0 0 0 0 0 14.4116 0 0 0 11.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1094 0 0 0 12.4173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5411 11.8057 0 0 0 0 0 0 0 0 0 0 0 13.2634 0 13.5868 0 14.2359 0 0 0 0 0 0 0 Q8N6T7 SIR6_HUMAN "NAD-dependent protein deacylase sirtuin-6, EC 2.3.1.- (NAD-dependent protein deacetylase sirtuin-6, EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6, EC 2.4.2.-) (Regulatory protein SIR2 homolog 6, hSIRT6) (SIR2-like protein 6)" SIRT6 SIR2L6 Homo sapiens (Human) "base-excision repair [GO:0006284]; cardiac muscle cell differentiation [GO:0055007]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; glucose homeostasis [GO:0042593]; histone H3 deacetylation [GO:0070932]; ketone biosynthetic process [GO:0042181]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transposition [GO:0010529]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription factor catabolic process [GO:1901485]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]; response to UV [GO:0009411]; subtelomeric heterochromatin assembly [GO:0031509]" "chromatin [GO:0000785]; chromosome, subtelomeric region [GO:0099115]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]" "chromatin [GO:0000785]; chromosome, subtelomeric region [GO:0099115]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; deacetylase activity [GO:0019213]; DNA damage sensor activity [GO:0140612]; histone deacetylase activity [GO:0004407]; lncRNA binding [GO:0106222]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent histone deacetylase activity (H3-K56 specific) [GO:0140765]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803]; TORC2 complex binding [GO:1904841]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cardiac muscle cell differentiation [GO:0055007]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; glucose homeostasis [GO:0042593]; histone H3 deacetylation [GO:0070932]; ketone biosynthetic process [GO:0042181]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transposition [GO:0010529]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription factor catabolic process [GO:1901485]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]; response to UV [GO:0009411]; subtelomeric heterochromatin assembly [GO:0031509]" GO:0000122; GO:0000785; GO:0003684; GO:0003714; GO:0003950; GO:0004407; GO:0005634; GO:0005654; GO:0005721; GO:0005783; GO:0006284; GO:0006302; GO:0006471; GO:0006476; GO:0008270; GO:0008285; GO:0008340; GO:0009411; GO:0010529; GO:0010569; GO:0017136; GO:0019213; GO:0019216; GO:0031490; GO:0031491; GO:0031508; GO:0031509; GO:0031648; GO:0032024; GO:0032206; GO:0032922; GO:0034244; GO:0034979; GO:0035861; GO:0042181; GO:0042308; GO:0042593; GO:0042752; GO:0042803; GO:0043231; GO:0045600; GO:0045721; GO:0045814; GO:0045820; GO:0046325; GO:0046827; GO:0046969; GO:0048146; GO:0050994; GO:0051697; GO:0055007; GO:0070403; GO:0070932; GO:0090734; GO:0097372; GO:0099115; GO:0106222; GO:0106274; GO:0120162; GO:0120187; GO:0140612; GO:0140765; GO:0140773; GO:0140774; GO:1901485; GO:1902732; GO:1904841; GO:1905555; GO:1905564; GO:1990404; GO:2000648; GO:2000738; GO:2000773; GO:2000781 chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; deacetylase activity [GO:0019213]; DNA damage sensor activity [GO:0140612]; histone deacetylase activity [GO:0004407]; lncRNA binding [GO:0106222]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent histone deacetylase activity (H3-K56 specific) [GO:0140765]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803]; TORC2 complex binding [GO:1904841]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] ALPPLPR 0.98975 -1.8926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8894 0 0 0 0 0 0 0 0 0 0 0 13.5488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7378 0 0 0 0 0 0 0 0 12.3986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PE3 INP4A_HUMAN "Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase, EC 3.1.3.66)" INPP4A Homo sapiens (Human) inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165]" GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0007165; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0031965; GO:0034597; GO:0043647; GO:0052828; GO:0055038; GO:0070161 "inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]" FPTTDGNHLR 0.98975 -1.8893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.177 0 10.6216 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4905 0 13.9932 13.5111 15.1711 0 16.928 10.6844 0 0 0 0 0 0 0 0 0 0 0 0 10.201 0 12.8513 14.313 0 0 13.8989 0 0 0 0 0 0 14.1852 0 0 0 0 0 0 0 0 13.4729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.399 0 0 0 0 0 0 0 12.9061 0 0 0 13.0653 0 12.7376 13.8168 13.3509 13.8073 0 0 0 0 0 0 0 14.2661 0 12.2403 0 0 Q99439 CNN2_HUMAN "Calponin-2 (Calponin H2, smooth muscle) (Neutral calponin)" CNN2 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cellular response to mechanical stimulus [GO:0071260]; cytoskeleton organization [GO:0007010]; establishment of localization in cell [GO:0051649]; hemopoiesis [GO:0030097]; macrophage migration [GO:1905517]; negative regulation of macrophage migration [GO:1905522]; negative regulation of phagocytosis [GO:0050765]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; regulation of actin filament-based process [GO:0032970]; regulation of leukocyte proliferation [GO:0070663]; wound healing [GO:0042060] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; stress fiber [GO:0001725]; tertiary granule lumen [GO:1904724] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; stress fiber [GO:0001725]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; actomyosin structure organization [GO:0031032]; cellular response to mechanical stimulus [GO:0071260]; cytoskeleton organization [GO:0007010]; establishment of localization in cell [GO:0051649]; hemopoiesis [GO:0030097]; macrophage migration [GO:1905517]; negative regulation of macrophage migration [GO:1905522]; negative regulation of phagocytosis [GO:0050765]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; regulation of actin filament-based process [GO:0032970]; regulation of leukocyte proliferation [GO:0070663]; wound healing [GO:0042060] GO:0001725; GO:0003779; GO:0005516; GO:0005576; GO:0005856; GO:0005911; GO:0005925; GO:0006909; GO:0007010; GO:0010628; GO:0016020; GO:0030097; GO:0031032; GO:0032970; GO:0035580; GO:0042060; GO:0045296; GO:0050765; GO:0051649; GO:0070663; GO:0071260; GO:1904724; GO:1905517; GO:1905522 actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516] LQPGSVPK 0.98975 -1.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1785 0 15.131 0 0 0 0 0 14.0736 0 14.2842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7894 15.1013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9638 0 0 0 0 0 13.0444 0 0 0 0 0 0 0 Q9P2U8 VGLU2_HUMAN "Vesicular glutamate transporter 2, VGluT2 (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6)" SLC17A6 DNPI VGLUT2 Homo sapiens (Human) "anion transport [GO:0006820]; hyaloid vascular plexus regression [GO:1990384]; ion transport [GO:0006811]; L-glutamate import [GO:0051938]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; membrane potential driven uniporter activity [GO:0022810]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; hyaloid vascular plexus regression [GO:1990384]; ion transport [GO:0006811]; L-glutamate import [GO:0051938]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]" GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0006811; GO:0006820; GO:0015386; GO:0016021; GO:0022810; GO:0022857; GO:0030285; GO:0030672; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0070161; GO:0098700; GO:1990384 chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; membrane potential driven uniporter activity [GO:0022810]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857] EEFVQGEVQDSHSYK 0.98975 -5.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3329 17.3482 0 0 15.7157 15.3214 15.6415 0 0 16.7775 16.652 16.7197 0 0 0 0 0 15.9014 15.6611 0 0 0 0 0 0 0 0 0 0 0 0 17.761 0 17.747 0 0 17.0435 0 0 0 0 0 0 17.1823 0 17.1681 0 0 10.8509 0 0 0 17.5729 0 17.5787 0 0 0 0 0 0 0 0 0 0 15.602 0 0 0 0 17.4118 10.2059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.22 14.5967 0 0 0 16.132 0 Q86VS8 HOOK3_HUMAN "Protein Hook homolog 3, h-hook3, hHK3" HOOK3 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005829; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719 dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] AKSVIRTLDPK 0.98976 -19.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3773 0 0 0 0 0 11.4006 0 0 0 0 0 0 0 0 0 0 11.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8978 18.4181 0 0 0 13.2915 0 11.8009 0 0 0 0 18.4149 18.4986 19.4124 0 0 0 0 12.5741 0 0 0 12.0508 0 11.9045 0 0 0 0 0 0 0 0 12.3317 0 0 0 0 0 12.6499 11.9187 12.2322 12.9916 18.1751 12.2063 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9332 0 18.5188 11.7796 0 18.4349 0 0 0 13.1468 12.7905 13.2059 13.2633 12.2154 0 0 12.0189 11.7136 0 0 0 11.5276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3044 0 0 0 0 0 0 Q8TB22 SPT20_HUMAN "Spermatogenesis-associated protein 20 (Sperm-specific protein 411, Ssp411)" SPATA20 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] extracellular region [GO:0005576] extracellular region [GO:0005576]; carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005576; GO:0005975; GO:0007283; GO:0030154 ALSAQQQTLKQIVICGDRQAK 0.98976 -5.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.933 0 12.0389 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1608 0 0 0 14.6068 0 0 0 0 0 0 13.2159 14.8038 0 0 14.5562 11.757 12.9269 0 0 0 14.5845 18.3774 0 0 18.4588 0 0 0 0 0 0 0 13.4073 0 0 0 0 12.6821 10.889 0 13.049 12.1982 13.5801 11.8292 12.6428 14.5615 15.4794 11.9916 0 0 0 12.5674 11.8341 0 0 0 13.6942 0 0 0 0 0 11.2307 13.3408 11.5187 0 0 12.3604 14.3325 0 0 0 0 0 0 15.8023 0 0 0 0 0 12.5603 0 19.1898 0 0 0 0 0 0 0 0 0 0 0 12.7931 0 0 0 0 0 0 0 0 0 0 12.6309 0 Q9C0J1 B3GN4_HUMAN "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4, EC 2.4.1.149 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, BGnT-4, Beta-1,3-Gn-T4, Beta-1,3-N-acetylglucosaminyltransferase 4, Beta3Gn-T4)" B3GNT4 UNQ1898/PRO4344 Homo sapiens (Human) keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" GO:0000139; GO:0008194; GO:0008457; GO:0008499; GO:0008532; GO:0016021; GO:0016266; GO:0016757; GO:0018146; GO:0030311 "beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" DTFLLLAIK 0.98976 -5.7565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8783 0 0 0 0 0 0 12.9139 13.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8868 0 0 0 0 0 0 0 12.3382 0 0 0 0 0 0 0 0 0 0 0 12.9034 11.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0655 0 0 0 0 0 12.2398 0 0 0 0 0 0 12.7495 0 0 13.2133 13.0457 0 12.0365 0 0 0 0 0 12.303 0 0 0 0 0 0 12.4064 0 0 0 Q9P278 FNIP2_HUMAN Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932] GO:0000122; GO:0001932; GO:0005737; GO:0005765; GO:0005829; GO:0006468; GO:0008630; GO:0031334; GO:0033138; GO:0034451; GO:0042030; GO:0051087 ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087] CCQGSSSVSSSSSSSISSHSSSGGSSHHAK 0.98976 -19.595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8073 0 0 0 0 12.5269 0 0 0 0 0 0 0 0 0 0 0 12.6915 12.8299 0 14.2222 14.7191 0 0 0 0 0 0 0 12.3092 0 0 0 0 0 0 0 0 12.9608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8893 0 0 0 0 0 0 O14733 MP2K7_HUMAN "Dual specificity mitogen-activated protein kinase kinase 7, MAP kinase kinase 7, MAPKK 7, EC 2.7.12.2 (JNK-activating kinase 2) (MAPK/ERK kinase 7, MEK 7) (Stress-activated protein kinase kinase 4, SAPK kinase 4, SAPKK-4, SAPKK4) (c-Jun N-terminal kinase kinase 2, JNK kinase 2, JNKK 2)" MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of motor neuron apoptotic process [GO:2000671]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of motor neuron apoptotic process [GO:2000671]; response to heat [GO:0009408]; response to osmotic stress [GO:0006970]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]" GO:0000165; GO:0000287; GO:0004707; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0006970; GO:0007165; GO:0007254; GO:0008022; GO:0008545; GO:0009408; GO:0009411; GO:0009611; GO:0019899; GO:0019901; GO:0019903; GO:0031435; GO:0032212; GO:0034612; GO:0038095; GO:0043507; GO:0043525; GO:0045893; GO:0046330; GO:0051403; GO:0051973; GO:0070374; GO:0071222; GO:0071347; GO:0072709; GO:0090398; GO:0106310; GO:1904355; GO:2000671 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; JUN kinase kinase activity [GO:0008545]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein tyrosine kinase activity [GO:0004713] ALYYLKEKHGVIHR 0.98977 -5.6412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7394 0 0 0 0 14.4995 0 0 0 12.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5695 0 0 0 0 0 0 0 0 0 0 0 0 16.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2119 0 0 O75061 AUXI_HUMAN "Putative tyrosine-protein phosphatase auxilin, EC 3.1.3.48 (DnaJ homolog subfamily C member 6)" DNAJC6 KIAA0473 Homo sapiens (Human) clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; dephosphorylation [GO:0016311]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle uncoating [GO:0016191] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; vesicle [GO:0031982]; clathrin binding [GO:0030276]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; dephosphorylation [GO:0016311]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle uncoating [GO:0016191] GO:0004725; GO:0005737; GO:0005829; GO:0014069; GO:0016191; GO:0016311; GO:0017124; GO:0030276; GO:0031982; GO:0043231; GO:0072318; GO:0072583; GO:0098793; GO:2000369 clathrin binding [GO:0030276]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] EYRVQDGK 0.98977 -5.7697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.026 0 0 0 0 0 0 0 9.75766 0 0 9.97613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.079 0 0 0 0 0 9.85081 P12081 HARS1_HUMAN "Histidine--tRNA ligase, cytoplasmic, EC 6.1.1.21 (Histidyl-tRNA synthetase, HisRS)" HARS1 HARS HRS Homo sapiens (Human) histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418] GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006412; GO:0006418; GO:0006427; GO:0032543; GO:0042802; GO:0042803 ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] FVLKTPK 0.98977 -5.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4607 0 0 0 0 12.5836 0 0 12.6124 0 13.7302 12.5561 0 0 0 12.3149 0 0 0 0 0 0 0 0 0 0 12.7223 0 12.6152 13.7803 0 0 0 0 0 12.7484 0 0 0 0 0 15.5195 0 15.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5548 13.2122 0 12.6689 0 0 0 0 0 0 0 12.2445 13.6857 0 0 13.3364 0 0 0 13.5537 13.8702 0 0 13.4797 13.522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9396 13.7053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3139 0 0 0 0 0 Q5T0W9 FA83B_HUMAN Protein FAM83B FAM83B C6orf143 Homo sapiens (Human) cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165] GO:0005154; GO:0005737; GO:0007165; GO:0007173; GO:0008283; GO:0016020; GO:0019901; GO:0036312; GO:0036313 epidermal growth factor receptor binding [GO:0005154]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901] AHLLTIKETIR 0.98977 -5.6254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3848 0 0 0 0 0 0 0 0 0 0 0 0 13.1042 0 0 0 0 0 0 0 0 0 0 0 0 14.2539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3278 0 0 0 0 0 0 0 0 0 0 13.6407 0 12.6719 0 0 15.4682 0 0 0 15.4385 0 15.4993 0 0 11.0028 15.5814 0 0 0 0 15.6475 0 0 0 0 0 13.7491 15.5529 0 0 0 0 0 0 0 0 13.0522 0 12.6533 15.4024 0 0 14.3838 0 0 0 0 0 0 0 0 0 12.9663 13.0373 0 0 0 0 0 0 15.0893 0 0 0 0 0 0 0 10.7448 Q6ZNW5 GDPP1_HUMAN "GDP-D-glucose phosphorylase 1, EC 2.7.7.78" GDPGP1 C15orf58 Homo sapiens (Human) glucose metabolic process [GO:0006006] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006] GO:0000166; GO:0005085; GO:0005737; GO:0006006; GO:0016779; GO:0016787; GO:0080048 GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779] GVQRRPPQTIK 0.98977 -5.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6203 0 0 0 0 0 0 12.8811 0 0 12.3917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7038 0 0 0 0 0 0 0 0 0 0 0 0 12.4713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEJ9 NGDN_HUMAN "Neuroguidin (Centromere accumulated nuclear protein 1, CANu1) (EIF4E-binding protein)" NGDN C14orf120 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]" "axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]" "axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]" GO:0000462; GO:0000775; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006417; GO:0030175; GO:0030424; GO:0030425; GO:0032040 RNA binding [GO:0003723] LKYQIDKLIK 0.98979 -4.3018 0 0 0 0 0 11.2026 0 0 0 0 13.1892 0 0 0 0 12.6651 0 0 0 0 12.4589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5103 12.7474 11.956 0 0 0 0 11.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1259 0 12.0273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8283 0 0 0 0 0 0 0 12.881 0 0 0 0 13.5981 0 0 0 0 13.2939 0 0 0 0 0 13.4328 0 0 0 0 0 0 0 0 0 0 13.5126 0 0 0 0 13.2892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8058 0 0 0 0 0 0 0 0 14.9952 0 0 0 0 Q96KB5 TOPK_HUMAN "Lymphokine-activated killer T-cell-originated protein kinase, EC 2.7.12.2 (Cancer/testis antigen 84, CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase, SPK) (T-LAK cell-originated protein kinase)" PBK TOPK Homo sapiens (Human) cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0000278; GO:0001933; GO:0004674; GO:0004706; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0018105; GO:0032435; GO:0032873; GO:0034644; GO:0038066; GO:0043161; GO:0050728; GO:0106310; GO:1904291 ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] RLMDEAKILK 0.98979 -5.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LZ2 MAGBA_HUMAN Melanoma-associated antigen B10 (MAGE-B10 antigen) MAGEB10 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 AHAETSK 0.98979 -5.6755 0 0 12.5317 18.1561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6063 0 11.4405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7474 0 0 0 0 0 0 0 0 0 0 0 0 13.9131 0 13.9001 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7813 0 0 0 11.6732 0 0 12.4378 0 0 12.4021 0 0 0 10.54 12.3838 0 0 0 0 0 13.3941 0 0 13.7224 0 0 0 11.7882 0 0 14.1093 0 13.2319 0 12.283 0 12.1124 0 0 13.723 0 0 0 0 12.3642 0 0 0 14.2198 0 0 0 0 0 0 14.2209 13.9305 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2672 0 0 0 14.3547 0 0 0 0 0 0 0 0 0 0 15.2825 Q9NR22 ANM8_HUMAN "Protein arginine N-methyltransferase 8, EC 2.1.1.319 (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4)" PRMT8 HRMT1L3 HRMT1L4 Homo sapiens (Human) "histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]" anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; plasma membrane [GO:0005886] "anchored component of the cytoplasmic side of the plasma membrane [GO:0098753]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of protein binding [GO:0043393]" GO:0005886; GO:0006479; GO:0008469; GO:0008757; GO:0016571; GO:0018216; GO:0019899; GO:0019919; GO:0035241; GO:0035242; GO:0042802; GO:0042803; GO:0043393; GO:0051260; GO:0098753; GO:1904047 enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] ANHLDNIITIFK 0.98979 -4.2998 0 0 0 0 0 0 0 0 0 0 0 0 10.9533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5461 0 0 0 11.5628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.305 0 11.1208 0 0 0 0 0 0 0 0 0 13.2357 0 16.2124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3567 0 0 0 0 0 0 0 0 0 11.765 0 0 0 0 12.8124 0 0 0 11.139 0 0 0 13.2367 0 0 0 0 0 12.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17025 ZN182_HUMAN Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14) ZNF182 KOX14 ZNF21 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EKSKLIIHQR 0.9898 -19.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3748 0 0 0 11.1237 0 0 0 0 0 0 15.2022 0 0 0 0 0 0 13.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYG6 LRC56_HUMAN Leucine-rich repeat-containing protein 56 LRRC56 Homo sapiens (Human) cell projection organization [GO:0030030] cilium [GO:0005929] cilium [GO:0005929]; cell projection organization [GO:0030030] GO:0005929; GO:0030030 ALEVASR 0.9898 -4.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1187 0 0 0 O75355 ENTP3_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 3, NTPDase 3, EC 3.6.1.5 (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3, Ecto-ATPDase 3, Ecto-ATPase 3) (Ecto-apyrase 3) (HB6)" ENTPD3 CD39L3 Homo sapiens (Human) nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143] GO:0004382; GO:0005524; GO:0005886; GO:0009134; GO:0009143; GO:0016020; GO:0016021; GO:0017110; GO:0017111; GO:0045134; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134] ACHDQETCSFDGVYQPK 0.98981 -4.3458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0136 0 0 0 0 0 0 12.5965 0 0 0 0 13.2685 0 0 0 0 0 0 0 0 0 0 0 0 12.5516 0 0 0 0 0 12.5569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3195 0 0 0 0 0 0 0 0 0 0 0 12.9866 0 0 13.3018 0 0 0 0 0 14.4253 0 0 0 0 0 0 12.4542 0 0 0 12.801 0 0 0 12.2826 0 0 0 12.3728 0 0 0 0 0 0 0 0 0 0 0 13.3294 0 0 0 0 11.8048 13.1236 0 0 Q4KWH8 PLCH1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1, EC 3.1.4.11 (Phosphoinositide phospholipase C-eta-1) (Phospholipase C-eta-1, PLC-eta-1) (Phospholipase C-like protein 3, PLC-L3)" PLCH1 KIAA1069 PLCL3 Homo sapiens (Human) lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0043231; GO:0048015; GO:0050429 calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; phosphatidylinositol phospholipase C activity [GO:0004435] AHQVVQQKSEQFMIYNQK 0.98981 -19.578 0 0 0 0 0 0 0 0 15.4228 0 0 0 15.1157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.918 0 14.0189 0 12.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7575 0 0 0 13.1822 0 0 0 0 0 0 0 0 0 15.024 13.7614 0 0 0 13.1679 13.4468 14.352 0 0 16.9702 14.1038 14.3129 0 0 15.9102 0 12.6428 0 0 0 12.9609 14.8048 0 0 0 0 0 0 13.2767 15.1407 0 0 0 0 0 0 0 14.6001 14.5805 0 11.0857 0 0 0 0 10.2934 0 14.0539 0 13.1411 13.0435 0 0 0 13.7276 13.119 12.4617 0 16.4394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.592 0 0 12.8084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5572 Q8TC44 POC1B_HUMAN POC1 centriolar protein homolog B (Pix1) (Proteome of centriole protein 1B) (WD repeat-containing protein 51B) POC1B WDR51B Homo sapiens (Human) cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; retina homeostasis [GO:0001895] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; cell population proliferation [GO:0008283]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; retina homeostasis [GO:0001895] GO:0000922; GO:0001895; GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008283; GO:0036064; GO:0060271 DRTVRLWIPDK 0.98981 -5.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0656 0 0 0 0 13.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2773 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD26 GOPC_HUMAN "Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (Fused in glioblastoma) (PDZ protein interacting specifically with TC10, PIST)" GOPC CAL FIG Homo sapiens (Human) apical protein localization [GO:0045176]; cytoplasmic sequestering of CFTR protein [GO:0043004]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein transport [GO:0015031] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; trans-Golgi network transport vesicle [GO:0030140] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; trans-Golgi network transport vesicle [GO:0030140]; identical protein binding [GO:0042802]; transmembrane transporter binding [GO:0044325]; apical protein localization [GO:0045176]; cytoplasmic sequestering of CFTR protein [GO:0043004]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein transport [GO:0015031] GO:0000139; GO:0005737; GO:0005765; GO:0005794; GO:0005886; GO:0006888; GO:0006893; GO:0010360; GO:0014069; GO:0015031; GO:0016020; GO:0030140; GO:0030425; GO:0030660; GO:0032991; GO:0042802; GO:0043004; GO:0044325; GO:0045176; GO:0070161; GO:2000009 identical protein binding [GO:0042802]; transmembrane transporter binding [GO:0044325] DTKHKEAVTILSQQR 0.98981 -5.8236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.995 0 0 0 12.7294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1826 0 0 0 0 Q9NXP7 GIN1_HUMAN "Gypsy retrotransposon integrase-like protein 1, GIN-1 (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein)" GIN1 TGIN1 ZH2C2 Homo sapiens (Human) DNA integration [GO:0015074] nucleic acid binding [GO:0003676]; DNA integration [GO:0015074] GO:0003676; GO:0015074 nucleic acid binding [GO:0003676] EKKLFYVGK 0.98981 -5.8314 0 0 14.0186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8203 0 0 11.6024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2278 0 0 12.5741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGM3 DMBT1_HUMAN "Deleted in malignant brain tumors 1 protein (Glycoprotein 340, Gp-340) (Hensin) (Salivary agglutinin, SAG) (Surfactant pulmonary-associated D-binding protein)" DMBT1 GP340 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; extracellular matrix binding [GO:0050840]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of bacterial lipoprotein [GO:0042494]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] GO:0001530; GO:0003677; GO:0005044; GO:0005576; GO:0005615; GO:0005737; GO:0006898; GO:0006952; GO:0015031; GO:0019898; GO:0030670; GO:0030855; GO:0031012; GO:0035375; GO:0038187; GO:0042494; GO:0042589; GO:0043152; GO:0045087; GO:0048306; GO:0050829; GO:0050830; GO:0050840; GO:0051607; GO:0061844; GO:0070062; GO:0070891; GO:1904399 calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; extracellular matrix binding [GO:0050840]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375] CKMVVCR 0.98981 -19.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0451 0 0 0 0 0 0 Q9Y267 S22AE_HUMAN "Solute carrier family 22 member 14 (Organic cation transporter-like 4, ORCTL-4)" SLC22A14 OCTL2 ORCTL4 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240] integral component of mitochondrial inner membrane [GO:0031305]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] integral component of mitochondrial inner membrane [GO:0031305]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; riboflavin transmembrane transporter activity [GO:0032217]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240] GO:0005886; GO:0030317; GO:0031305; GO:0032217; GO:0048240; GO:0097228 riboflavin transmembrane transporter activity [GO:0032217] KTIPSNLLDELQLPRK 0.98981 -5.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.933 0 12.0502 0 0 0 0 0 0 0 0 0 0 0 0 11.6014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9273 0 0 0 0 0 12.2279 0 0 0 12.0453 0 0 0 0 0 0 0 13.7326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8828 0 11.414 0 0 0 0 0 0 0 0 0 0 11.7932 0 0 13.3362 0 0 12.7705 0 0 14.0303 0 0 0 0 0 0 0 0 0 12.2045 0 0 0 0 0 0 0 13.393 12.8134 0 0 0 0 0 11.9797 0 0 0 0 0 0 0 0 0 0 10.9215 0 0 0 O43593 HAIR_HUMAN "Lysine-specific demethylase hairless, EC 1.14.11.65 ([histone H3]-dimethyl-L-lysine(9) demethylase hairless)" HR Homo sapiens (Human) histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006357; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0140683 chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] AGPGLRKGLGLPLSPVR 0.98982 -19.614 0 0 11.8577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.578 0 0 0 14.1115 0 0 0 0 0 0 0 0 0 11.2437 0 0 0 0 0 0 0 0 0 0 0 0 12.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8329 0 0 0 0 13.1007 0 0 0 0 0 16.1757 0 0 0 0 0 0 11.3741 0 0 0 0 0 0 0 0 0 0 0 10.8952 0 0 0 11.1304 11.1275 0 0 0 12.9895 0 0 13.5259 0 0 0 0 0 0 11.4094 14.1217 0 0 0 15.126 0 0 0 0 10.7319 9.56904 0 0 0 0 0 0 0 0 0 0 13.599 0 0 0 11.4411 13.6626 0 0 11.969 0 0 0 0 0 0 13.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7732 9.28709 0 0 0 0 0 P35916 VGFR3_HUMAN "Vascular endothelial growth factor receptor 3, VEGFR-3, EC 2.7.10.1 (Fms-like tyrosine kinase 4, FLT-4) (Tyrosine-protein kinase receptor FLT4)" FLT4 VEGFR3 Homo sapiens (Human) blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021]; blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; lymphangiogenesis [GO:0001946]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944] GO:0001934; GO:0001938; GO:0001944; GO:0001945; GO:0001946; GO:0002040; GO:0002244; GO:0003016; GO:0004714; GO:0005021; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0010575; GO:0010595; GO:0018108; GO:0019838; GO:0019903; GO:0033674; GO:0035924; GO:0038084; GO:0042803; GO:0043066; GO:0043235; GO:0043410; GO:0046330; GO:0046777; GO:0048010; GO:0048286; GO:0048514; GO:0060312; GO:0070374; GO:0090037 ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021] ALMSELKILIHIGNHLNVVNLLGACTK 0.98982 -19.607 0 0 0 0 0 0 0 0 0 0 10.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.32717 0 0 0 0 0 0 10.6187 0 0 0 0 12.4983 0 0 0 0 0 0 0 0 0 0 15.4388 0 15.072 0 15.3067 14.4648 14.3221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0799 0 0 0 10.6738 0 0 0 0 0 0 13.6421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1834 0 0 0 0 0 0 0 0 Q8N9Y4 F181A_HUMAN Protein FAM181A FAM181A C14orf152 HSD-31 HSD31 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DVDGLGQKVCR 0.98982 -4.3555 0 0 0 0 0 0 0 0 0 11.9706 0 0 12.6605 0 0 0 0 0 0 0 0 0 11.6168 0 0 0 0 0 0 0 11.6914 11.6661 0 0 0 0 0 0 0 0 0 0 0 9.88978 0 0 0 0 0 0 0 0 0 0 0 10.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0634 0 0 0 0 0 16.1064 0 0 0 0 11.5403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T37 RBM15_HUMAN RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15) RBM15 OTT OTT1 Homo sapiens (Human) "branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]" nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]" GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674 mRNA binding [GO:0003729]; RNA binding [GO:0003723] DGWSLDRDR 0.98982 -19.634 0 0 0 0 0 0 0 0 14.0561 0 0 14.8737 15.0784 0 13.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5581 10.3028 0 14.5951 0 0 0 0 0 0 14.0213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1396 0 0 0 0 0 12.8633 14.4638 0 13.0355 0 13.1232 0 0 13.6672 12.8363 12.9721 13.1871 13.7733 14.3028 0 12.9667 15.1283 0 12.8616 12.0975 0 0 0 0 0 11.9551 0 0 14.1463 12.7977 0 0 13.1171 0 0 0 15.5723 13.7481 13.4286 12.2052 0 0 0 0 0 0 0 12.3752 11.6888 0 14.2287 12.3119 0 0 0 13.172 0 0 0 0 0 0 0 0 12.3621 0 0 0 0 0 14.1072 0 12.3775 12.8436 11.4267 0 0 0 0 0 0 0 0 12.1172 13.8584 0 13.3038 0 0 15.0231 0 Q9H9Q4 NHEJ1_HUMAN Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor) NHEJ1 XLF Homo sapiens (Human) B cell differentiation [GO:0030183]; central nervous system development [GO:0007417]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; positive regulation of ligase activity [GO:0051351]; response to ionizing radiation [GO:0010212]; T cell differentiation [GO:0030217] DNA ligase IV complex [GO:0032807]; fibrillar center [GO:0001650]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] DNA ligase IV complex [GO:0032807]; fibrillar center [GO:0001650]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; DNA end binding [GO:0045027]; DNA polymerase binding [GO:0070182]; B cell differentiation [GO:0030183]; central nervous system development [GO:0007417]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; positive regulation of ligase activity [GO:0051351]; response to ionizing radiation [GO:0010212]; T cell differentiation [GO:0030217] GO:0001650; GO:0005634; GO:0005654; GO:0006303; GO:0007417; GO:0010212; GO:0030183; GO:0030217; GO:0032807; GO:0033152; GO:0035861; GO:0045027; GO:0051103; GO:0051351; GO:0070182; GO:0070419 DNA end binding [GO:0045027]; DNA polymerase binding [GO:0070182] PQLSKVKR 0.98982 -1.8511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40617 ARL4A_HUMAN ADP-ribosylation factor-like protein 4A ARL4A ARL4 Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brown fat cell differentiation [GO:0050873]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0050873 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IKVTLGNSK 0.98983 -5.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0612 0 0 0 0 0 0 0 0 0 0 15.2662 0 0 0 0 0 0 0 0 0 0 14.483 0 14.1968 0 0 0 0 0 0 0 11.7489 0 0 0 0 15.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8224 14.2072 0 0 0 0 0 0 0 0 0 0 Q8TCJ2 STT3B_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, Oligosaccharyl transferase subunit STT3B, STT3-B, EC 2.4.99.18 (Source of immunodominant MHC-associated peptides homolog)" STT3B SIMP Homo sapiens (Human) co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0004579; GO:0005783; GO:0005789; GO:0006487; GO:0006516; GO:0006986; GO:0008250; GO:0016020; GO:0016021; GO:0018279; GO:0030433; GO:0032991; GO:0034998; GO:0043686; GO:0043687; GO:0046872 dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872] AEPSAPESK 0.98983 -1.8623 0 0 0 0 0 0 0 0 11.8096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2587 13.0068 0 0 14.7174 14.9211 14.7494 0 0 12.9283 0 14.2344 14.0346 0 13.2061 0 0 13.3516 0 0 0 13.497 0 0 0 0 0 12.1042 0 0 0 0 0 0 0 0 13.6861 0 0 0 0 0 0 0 13.3855 0 0 0 13.1923 0 0 0 11.3792 0 13.057 0 0 0 0 0 0 0 13.1631 0 0 0 0 0 0 0 0 0 0 11.6104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.264 0 0 0 0 0 0 0 0 13.4708 13.0832 0 0 14.0641 0 0 0 0 Q8IVP9 ZN547_HUMAN Zinc finger protein 547 ZNF547 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CSKCGILFMER 0.98984 -5.7565 0 0 0 0 0 0 0 0 0 0 0 0 12.0277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1192 0 0 0 0 0 0 0 10.6679 0 0 0 0 0 0 0 0 0 0 17.1121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9626 0 0 0 0 0 0 0 0 0 11.2858 0 0 0 0 0 0 0 0 0 11.1232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1055 0 13.1439 0 13.4087 12.4356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYY8 FAKD2_HUMAN "FAST kinase domain-containing protein 2, mitochondrial" FASTKD2 KIAA0971 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA processing [GO:0000963]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA processing [GO:0006396] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; apoptotic process [GO:0006915]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA processing [GO:0000963]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA processing [GO:0006396] GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0006396; GO:0006915; GO:0019843; GO:0032543; GO:0035770; GO:0042645; GO:0044528; GO:0070131; GO:1902775 RNA binding [GO:0003723]; rRNA binding [GO:0019843] DAPIALK 0.98984 -19.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7389 0 0 10.7098 0 0 0 0 0 0 12.4091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.728 0 0 0 0 0 11.7308 0 0 13.2593 0 0 13.0377 0 0 0 0 0 0 0 12.6576 0 14.8855 0 12.85 0 0 0 0 0 0 0 0 11.9419 13.4475 0 0 0 0 0 11.1533 0 0 0 0 0 0 0 0 0 13.2869 13.3954 0 0 13.2278 0 12.8195 0 0 0 0 0 0 0 0 0 12.9741 13.0115 12.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4074 0 0 0 0 0 0 15.4395 0 15.4146 15.9852 0 15.1025 0 0 13.802 14.1278 0 0 0 0 12.6649 12.655 0 0 0 0 0 0 A6NJI9 LRC72_HUMAN Leucine-rich repeat-containing protein 72 LRRC72 Homo sapiens (Human) ASETALQSSR 0.98985 -5.6189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4745 0 0 0 0 11.7471 0 0 0 13.1715 0 0 0 13.3994 0 0 0 0 0 0 0 0 0 0 12.4588 0 0 0 0 0 0 0 0 0 0 12.4731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49321 NASP_HUMAN "Nuclear autoantigenic sperm protein, NASP" NASP Homo sapiens (Human) blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574] GO:0000082; GO:0000785; GO:0001824; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006334; GO:0006335; GO:0006336; GO:0008584; GO:0015031; GO:0032991; GO:0033574; GO:0034080; GO:0042393; GO:0043486; GO:0044877 histone binding [GO:0042393]; protein-containing complex binding [GO:0044877] EEQMKEGEETEGSEEDDKENDK 0.98985 -5.6241 0 0 0 0 0 0 0 0 0 11.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3784 0 0 0 14.9227 0 12.8382 0 0 0 0 15.0129 14.7924 0 0 0 0 0 14.7639 0 0 0 15.0585 Q86T82 UBP37_HUMAN "Ubiquitin carboxyl-terminal hydrolase 37, EC 3.4.19.12 (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37)" USP37 KIAA1594 Homo sapiens (Human) cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; regulation of DNA replication [GO:0006275]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006275; GO:0006511; GO:0016579; GO:0019901; GO:0035871; GO:0051301; GO:0071108 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein kinase binding [GO:0019901] AMTDPSR 0.98985 -19.476 0 0 0 0 0 0 0 0 0 0 0 0 13.7414 0 0 0 0 0 0 0 0 0 0 0 13.8765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6686 0 0 13.3587 0 11.9009 0 0 0 11.7228 10.6936 0 0 9.5701 9.34523 0 0 0 0 0 13.1856 0 0 0 0 0 0 13.431 0 0 0 0 0 0 0 13.4022 11.4872 11.8069 12.8157 14.4222 0 13.8825 13.7945 0 0 0 0 13.457 0 0 12.3791 0 0 13.9706 0 11.4778 11.7762 0 0 14.11 0 0 0 16.1387 0 0 11.5436 0 0 0 0 0 13.5164 0 14.9493 13.6766 0 0 0 13.0101 10.9953 0 13.5035 0 9.92827 0 15.2499 14.0741 10.9976 0 0 0 0 10.67 0 0 14.544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8229 0 0 0 0 15.9429 0 0 0 14.2227 0 0 13.8253 0 Q8N5G0 SIM20_HUMAN "Small integral membrane protein 20 (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 7 kDa, MITRAC7) [Cleaved into: Phoenixin-14, PNX-14; Phoenixin-20, PNX-20 ]" SMIM20 C4orf52 MITRAC7 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial cytochrome c oxidase assembly [GO:0033617] GO:0005576; GO:0005743; GO:0016021; GO:0033617 PLMRLEEYK 0.98985 -5.7666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFA2 NOXO1_HUMAN NADPH oxidase organizer 1 (NADPH oxidase regulatory protein) (Nox organizer 1) (Nox-organizing protein 1) (SH3 and PX domain-containing protein 5) NOXO1 P41NOX SH3PXD5 Homo sapiens (Human) extracellular matrix disassembly [GO:0022617]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554] cytoplasm [GO:0005737]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phospholipid binding [GO:0005543]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; extracellular matrix disassembly [GO:0022617]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554] GO:0005543; GO:0005737; GO:0005886; GO:0010310; GO:0016176; GO:0019899; GO:0022617; GO:0035091; GO:0042554; GO:0043020; GO:0060263 enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phospholipid binding [GO:0005543]; superoxide-generating NADPH oxidase activator activity [GO:0016176] GLARLQLLETYSRR 0.98985 -5.6226 0 0 0 0 0 0 0 0 0 0 11.7142 0 0 0 0 0 0 0 0 10.4117 0 0 0 0 0 0 0 0 0 12.5498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9782 0 11.4216 0 12.4599 0 11.5098 0 0 0 12.4041 0 0 0 13.1811 0 0 0 0 0 0 11.925 0 0 11.8624 0 0 0 0 0 0 0 11.4761 0 0 13.4557 12.1906 0 0 13.6949 11.0025 12.5531 0 0 0 13.4534 0 12.2398 0 0 0 0 0 0 0 12.9159 0 0 13.7211 0 0 16.7765 0 13.9973 15.0324 0 15.1227 13.0719 0 0 11.4425 0 0 0 0 0 0 0 0 0 12.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4576 12.6139 0 0 0 0 0 0 0 Q9HBH5 RDH14_HUMAN "Retinol dehydrogenase 14, EC 1.1.1.300 (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4)" RDH14 PAN2 SDR7C4 UNQ529/PRO1072 Homo sapiens (Human) osteoblast differentiation [GO:0001649] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 11-cis-retinol dehydrogenase activity [GO:0102354]; NADP-retinol dehydrogenase activity [GO:0052650]; osteoblast differentiation [GO:0001649] GO:0001649; GO:0005634; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0052650; GO:0102354 11-cis-retinol dehydrogenase activity [GO:0102354]; NADP-retinol dehydrogenase activity [GO:0052650] AFCQEMLQEEPR 0.98985 -5.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5285 13.4631 0 0 0 0 0 0 0 0 0 0 0 0 11.464 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49841 GSK3B_HUMAN "Glycogen synthase kinase-3 beta, GSK-3 beta, EC 2.7.11.26 (Serine/threonine-protein kinase GSK3B, EC 2.7.11.1)" GSK3B Homo sapiens (Human) beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; regulation of synaptic vesicle exocytosis [GO:2000300]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082] axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909] axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625]; beta-catenin destruction complex disassembly [GO:1904886]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation [GO:1905240]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neuron death [GO:1901215]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron death [GO:1901216]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; regulation of synaptic vesicle exocytosis [GO:2000300]; signal transduction [GO:0007165]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082] GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007165; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010629; GO:0010822; GO:0010975; GO:0016301; GO:0018105; GO:0018107; GO:0019082; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032436; GO:0032515; GO:0032886; GO:0034236; GO:0034452; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043161; GO:0043547; GO:0045597; GO:0045719; GO:0045724; GO:0045732; GO:0046777; GO:0046825; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060079; GO:0061629; GO:0070507; GO:0070885; GO:0071109; GO:0071300; GO:0090090; GO:0097191; GO:0097192; GO:0098794; GO:0098978; GO:0106027; GO:0106310; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1901215; GO:1901216; GO:1901984; GO:1902042; GO:1903566; GO:1904339; GO:1904646; GO:1904781; GO:1904886; GO:1905240; GO:1990909; GO:2000077; GO:2000300; GO:2000466; GO:2000740 ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625] EMNPNYTEFKFPQIK 0.98986 -1.883 0 0 0 0 0 0 0 0 13.3799 0 14.6382 0 13.2621 0 0 13.3963 14.3292 0 13.1501 12.4376 0 0 13.2302 0 13.1135 13.1394 13.1456 0 13.5522 13.6637 0 0 0 0 14.9539 0 13.3544 13.044 0 0 0 0 0 14.7144 0 0 0 13.4799 0 13.7842 0 14.1291 13.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2861 0 0 0 0 0 0 13.8681 0 0 0 0 12.7699 0 0 13.9784 0 0 0 0 0 13.9724 13.9294 13.6496 13.3927 14.2268 0 0 13.4066 0 0 0 15.1826 0 14.5528 0 0 12.4012 0 0 0 11.01 12.6385 0 0 14.9471 0 11.0103 0 0 0 0 0 0 0 0 12.4012 0 0 13.8346 0 0 0 13.1045 0 0 0 14.0574 12.9006 14.6752 13.6423 0 0 0 0 0 0 14.3207 0 13.4506 0 0 0 0 0 0 0 12.464 0 0 0 0 0 0 0 0 0 13.4293 0 0 0 0 0 0 0 15.2767 13.8805 0 0 0 0 0 0 0 Q7Z404 TMC4_HUMAN Transmembrane channel-like protein 4 TMC4 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381] GO:0005887; GO:0008381; GO:0070062 mechanosensitive ion channel activity [GO:0008381] EGLRSLQPWAWTLK 0.98986 -5.638 0 10.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0626 0 0 0 12.3001 13.7134 0 0 0 0 14.8434 0 0 0 0 0 10.9347 11.4599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6118 0 13.267 0 0 0 16.3658 12.617 0 12.0824 0 0 0 0 0 0 0 15.3378 13.4277 0 0 0 0 0 12.6358 0 0 0 12.7654 0 11.551 13.2656 0 0 13.9686 14.3455 0 11.926 0 0 0 0 12.9317 12.1067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JP2 MY15B_HUMAN Unconventional myosin-XVB (Myosin XVBP) (Unconventional myosin-15B) MYO15B KIAA1783 MYO15BP Homo sapiens (Human) cytoplasm [GO:0005737]; myosin complex [GO:0016459] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] GO:0003774; GO:0005524; GO:0005737; GO:0016459 ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] APLQLGPSSSIKEK 0.98986 -5.6397 0 0 0 0 0 0 0 0 0 0 10.2992 0 0 0 0 0 17.6969 17.3926 0 0 0 15.5974 11.3832 0 0 15.2719 0 13.9204 0 0 0 0 0 0 0 0 0 10.8312 0 0 0 0 0 0 12.9722 17.4138 0 0 14.4216 0 14.299 12.8136 0 18.6644 17.4414 0 17.3349 16.2254 0 0 15.7217 0 0 0 15.2451 16.1976 0 11.2283 0 0 0 0 0 0 0 0 0 10.621 0 0 10.6155 12.1216 12.8096 0 0 0 14.9434 0 12.5516 0 10.9148 0 0 0 0 0 0 0 17.5809 0 0 0 15.3213 14.5118 0 0 0 0 0 0 0 12.2898 0 0 0 0 0 11.1387 0 0 0 0 0 0 0 0 10.1887 13.2432 0 0 0 12.1817 0 0 0 0 0 0 0 0 11.2242 0 0 0 0 0 0 13.719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9006 11.8664 0 0 0 0 0 11.8436 15.1451 0 0 0 0 0 9.96498 Q9BX69 CARD6_HUMAN Caspase recruitment domain-containing protein 6 CARD6 Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981] apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981] GO:0006915; GO:0042981 EWDLLMFLGEAAIER 0.98986 -19.575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0072 0 0 13.3451 0 0 0 12.1317 0 0 0 0 0 0 0 0 0 10.0344 13.2694 0 13.7922 0 0 0 0 0 0 13.8436 12.9353 12.5354 0 0 0 11.8545 0 13.051 0 13.7503 0 0 12.7851 0 13.7209 0 14.1393 12.289 0 0 0 12.012 12.6318 0 12.1744 11.84 12.5694 0 0 12.1918 0 0 11.9476 0 0 12.6384 0 0 0 0 0 0 0 12.2586 13.3354 0 0 11.4209 0 0 0 0 0 0 14.8789 13.7487 0 0 0 0 0 11.3677 0 0 0 0 0 0 0 0 0 0 0 0 10.913 14.4097 0 0 Q9NQ69 LHX9_HUMAN "LIM/homeobox protein Lhx9, LIM homeobox protein 9" LHX9 Homo sapiens (Human) "cell population proliferation [GO:0008283]; dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; female gonad development [GO:0008585]; gonad morphogenesis [GO:0035262]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell population proliferation [GO:0008283]; dorsal spinal cord interneuron anterior axon guidance [GO:0097380]; female gonad development [GO:0008585]; gonad morphogenesis [GO:0035262]; male gonad development [GO:0008584]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0008283; GO:0008584; GO:0008585; GO:0030182; GO:0035262; GO:0045892; GO:0046872; GO:0097380; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AEDNSCPFR 0.98986 -5.7758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3838 9.96181 0 0 0 0 0 0 0 10.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4386 0 12.3404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.30305 0 10.7933 0 0 0 0 14.325 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6153 12.37 0 0 0 11.9143 0 0 0 0 0 0 0 0 10.8203 0 0 0 0 0 0 0 0 0 0 0 9.30868 0 0 0 0 0 10.8158 0 0 0 0 0 0 0 0 10.7595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS39 RED2_HUMAN "Double-stranded RNA-specific editase B2, EC 3.5.-.- (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2)" ADARB2 ADAR3 RED2 Homo sapiens (Human) adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; mRNA processing [GO:0006397]; RNA processing [GO:0006396] GO:0003723; GO:0003725; GO:0003726; GO:0003727; GO:0004000; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0008251; GO:0046872 adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; tRNA-specific adenosine deaminase activity [GO:0008251] EDSERSIFVR 0.98986 -19.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9321 0 0 0 0 0 11.7423 0 13.9163 14.6653 15.2232 16.3514 14.3902 13.9631 14.9087 13.9484 15.0506 0 0 0 0 0 14.7142 15.644 0 0 16.3133 16.6791 15.563 18.1272 15.5911 14.5429 16.9659 16.1904 15.7362 15.1343 13.9536 15.1526 16.3457 15.9985 18.4323 15.1247 14.2029 15.7445 0 14.6824 15.6239 16.9302 14.243 14.0989 15.8531 18.1364 0 12.0956 13.801 0 15.8574 15.2261 16.087 14.0425 15.3274 14.129 14.4416 16.1347 15.4809 13.805 14.7574 15.5925 13.7162 0 13.7293 15.0449 15.0839 15.9218 14.3934 15.6564 15.3155 15.8362 13.8413 13.669 13.7484 0 0 0 0 0 13.4715 0 14.541 14.1995 0 0 0 0 0 0 0 11.5174 0 0 0 14.8896 0 0 0 14.7896 15.9456 0 0 0 0 14.6642 13.7101 0 P12532 KCRU_HUMAN "Creatine kinase U-type, mitochondrial, EC 2.7.3.2 (Acidic-type mitochondrial creatine kinase, Mia-CK) (Ubiquitous mitochondrial creatine kinase, U-MtCK)" CKMT1A CKMT; CKMT1B CKMT Homo sapiens (Human) phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301]; phosphocreatine biosynthetic process [GO:0046314]; phosphorylation [GO:0016310] GO:0004111; GO:0005524; GO:0005739; GO:0005743; GO:0016301; GO:0016310; GO:0046314 ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; kinase activity [GO:0016301] AGPFSRLLSARPGLR 0.98987 -19.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5504 0 0 0 0 0 0 0 0 11.6344 0 0 0 0 0 0 0 0 0 15.4279 15.577 0 0 0 0 0 0 0 14.2943 0 0 0 0 0 0 12.9587 13.7964 0 0 0 0 0 0 0 0 0 0 11.6432 0 13.5681 13.4451 0 15.872 12.3016 0 0 0 13.3512 0 0 15.7281 0 0 0 0 0 0 0 0 14.196 13.9159 0 0 12.2372 13.2853 0 0 0 0 0 0 0 0 0 0 0 0 14.2728 0 14.4213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3358 0 13.2143 0 0 0 0 0 0 P83110 HTRA3_HUMAN "Serine protease HTRA3, EC 3.4.21.- (High-temperature requirement factor A3) (Pregnancy-related serine protease)" HTRA3 PRSP Homo sapiens (Human) negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; proteolysis [GO:0006508] GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0008236; GO:0030512; GO:0030514; GO:0042802 endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] FIGIRMR 0.98987 -19.59 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3607 0 0 0 0 0 0 0 0 14.5928 14.5952 0 10.8408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8435 13.4253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7583 0 0 0 0 0 0 14.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15697 ZN174_HUMAN Zinc finger protein 174 (AW-1) (Zinc finger and SCAN domain-containing protein 8) ZNF174 ZSCAN8 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001650; GO:0003700; GO:0005634; GO:0006357; GO:0016604; GO:0042803; GO:0043565; GO:0045892; GO:0046872; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" LSPHHWEK 0.98987 -19.63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4868 0 0 0 0 14.3079 13.9394 10.7858 0 0 0 0 0 0 0 10.543 0 0 0 11.7196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96476 0 0 0 0 0 0 0 0 0 0 0 13.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16891 MIC60_HUMAN MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89) IMMT HMP MIC60 MINOS2 PIG4 PIG52 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; neuron cellular homeostasis [GO:0070050] membrane [GO:0016020]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; SAM complex [GO:0001401] membrane [GO:0016020]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; RNA binding [GO:0003723]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; neuron cellular homeostasis [GO:0070050] GO:0001401; GO:0003723; GO:0005739; GO:0005743; GO:0005758; GO:0007007; GO:0016020; GO:0042407; GO:0044284; GO:0051560; GO:0061617; GO:0070050; GO:0140275 RNA binding [GO:0003723] DAMENEMRTQLRR 0.98987 -19.605 0 0 0 11.8377 10.0331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4206 0 0 0 12.0994 0 0 0 0 0 11.8948 0 0 12.3087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T4F4 ZFY27_HUMAN Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27) ZFYVE27 SPG33 Homo sapiens (Human) endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] GO:0005654; GO:0005783; GO:0005829; GO:0016192; GO:0030176; GO:0030424; GO:0030425; GO:0031175; GO:0032584; GO:0042802; GO:0043231; GO:0043621; GO:0045773; GO:0046872; GO:0048011; GO:0055038; GO:0071782; GO:0071787; GO:0072659 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein self-association [GO:0043621] ARLPDSELMR 0.98987 -19.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1226 0 0 0 0 0 0 0 13.0183 0 0 10.3082 0 0 0 0 12.9057 0 0 13.7829 0 0 0 13.5416 10.4158 12.2068 0 0 0 0 0 0 0 0 0 0 0 9.93236 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9241 9.1632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2923 0 0 0 0 14.3316 14.1412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2583 0 0 Q7L014 DDX46_HUMAN "Probable ATP-dependent RNA helicase DDX46, EC 3.6.4.13 (DEAD box protein 46) (PRP5 homolog)" DDX46 KIAA0801 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686] "Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0015030; GO:0016020; GO:0016607; GO:0016887; GO:1903241 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ASYPCMSLHGGIDQYDRDSIINDFK 0.98987 -19.606 0 0 0 0 0 0 0 0 0 11.49 0 0 0 0 0 0 0 0 0 11.4352 0 0 0 0 11.8022 10.8096 0 10.5504 0 12.583 0 0 0 12.928 12.4529 12.6483 0 0 0 0 11.9299 0 0 0 0 0 0 0 0 0 0 11.2146 0 0 0 0 0 0 12.5926 0 0 0 0 0 0 11.9193 0 12.5954 10.699 0 0 0 14.1902 0 0 13.4823 0 12.2357 0 0 0 11.8234 0 0 0 0 0 0 0 0 0 0 0 0 12.0389 0 0 13.3383 0 0 0 0 0 0 0 0 0 0 0 11.8407 12.2481 0 0 11.7821 0 0 0 0 0 0 0 0 0 0 0 11.9002 0 11.7429 0 0 0 12.4814 13.4135 13.248 11.627 0 0 0 0 0 0 0 13.4202 0 0 0 0 0 0 0 0 0 0 12.0981 0 0 12.3256 12.899 0 0 0 0 0 0 0 0 0 0 10.9926 13.7471 13.356 0 0 0 12.0719 0 0 0 12.7193 0 Q8N878 FRMD1_HUMAN FERM domain-containing protein 1 FRMD1 Homo sapiens (Human) positive regulation of hippo signaling [GO:0035332] cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856] cytoplasmic side of apical plasma membrane [GO:0098592]; cytoskeleton [GO:0005856]; positive regulation of hippo signaling [GO:0035332] GO:0005856; GO:0035332; GO:0098592 ARHLYYCHLK 0.98987 -19.616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7588 0 14.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96K21 ANCHR_HUMAN "Abscission/NoCut checkpoint regulator, ANCHR (MLL partner containing FYVE domain) (Zinc finger FYVE domain-containing protein 19)" ZFYVE19 ANCHR MPFYVE Homo sapiens (Human) abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466] GO:0005737; GO:0005813; GO:0009838; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0046872; GO:0051301; GO:0090543 metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266] CAGCDGDLFCAR 0.98987 -19.626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2773 13.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6426 0 0 0 0 0 0 0 0 Q96NR7 WWAS2_HUMAN Putative uncharacterized protein WWC2-AS2 (WWC2 antisense RNA 2) (WWC2 antisense gene protein 2) WWC2-AS2 C4orf38 Homo sapiens (Human) KLLVPGLPCLVRGGWPWTR 0.98987 -5.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.807 0 0 0 14.1756 0 14.0206 13.7105 0 0 0 14.9791 0 0 0 0 0 0 14.1706 0 0 14.7341 13.7364 14.9935 0 0 0 0 0 0 0 14.4182 0 14.5558 0 14.5619 13.9044 0 0 0 0 14.2986 0 14.2282 13.8341 0 13.9119 0 0 0 14.945 14.0425 0 0 0 13.5773 13.4067 0 0 0 0 0 0 13.8023 0 14.4444 0 0 0 0 0 13.4522 0 0 0 0 0 0 0 13.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4375 13.8511 0 0 0 0 0 0 0 Q99435 NELL2_HUMAN Protein kinase C-binding protein NELL2 (NEL-like protein 2) (Nel-related protein 2) NELL2 NRP2 Homo sapiens (Human) fertilization [GO:0009566]; neuron cellular homeostasis [GO:0070050] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]; fertilization [GO:0009566]; neuron cellular homeostasis [GO:0070050] GO:0005080; GO:0005509; GO:0005576; GO:0005737; GO:0008201; GO:0009566; GO:0070050 calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080] DGYHDNGMFSPSGESCEDIDECGTGR 0.98987 -5.6626 9.74393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5112 0 0 0 0 0 0 0 0 11.8957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0181 0 0 0 0 0 11.7774 12.5645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9314 0 0 0 13.2912 0 0 11.4914 13.9067 0 0 0 0 0 0 11.5932 0 0 13.6686 12.5931 0 0 0 0 14.5442 0 0 11.3786 0 14.1215 0 0 0 0 0 12.7303 0 0 0 0 0 0 11.7683 0 0 0 0 0 0 0 0 0 0 0 12.3243 0 13.4533 0 0 0 0 0 13.5005 13.3337 0 0 0 13.8315 0 15.2696 14.2576 0 0 14.2175 0 11.9261 0 0 0 11.876 14.1741 12.779 10.807 12.9957 0 0 0 11.2538 0 0 12.1833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09132 SRP19_HUMAN "Signal recognition particle 19 kDa protein, SRP19" SRP19 Homo sapiens (Human) "cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" "cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006617; GO:0008312; GO:0016604; GO:0048500 7S RNA binding [GO:0008312]; RNA binding [GO:0003723] EWNRDVQYR 0.98988 -4.2992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52737 ZN136_HUMAN Zinc finger protein 136 ZNF136 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DQNIKDHYK 0.98988 -5.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72649 0 0 0 0 13.8424 0 0 0 0 0 0 0 0 0 0 0 0 11.5425 0 0 0 0 0 0 0 0 0 0 0 0 13.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6179 0 0 0 0 0 0 0 0 0 0 11.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3115 0 0 0 0 0 0 0 0 0 Q9H015 S22A4_HUMAN "Solute carrier family 22 member 4 (Ergothioneine transporter, ET transporter) (Organic cation/carnitine transporter 1)" SLC22A4 ETT OCTN1 UT2H Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293]; amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; carnitine metabolic process [GO:0009437]; carnitine transport [GO:0015879]; organic cation transport [GO:0015695]; quaternary ammonium group transport [GO:0015697]; sodium ion transport [GO:0006814]; triglyceride metabolic process [GO:0006641]; xenobiotic transport [GO:0042908] GO:0000166; GO:0005524; GO:0005739; GO:0005886; GO:0005887; GO:0006641; GO:0006814; GO:0007589; GO:0008513; GO:0009437; GO:0015171; GO:0015226; GO:0015293; GO:0015491; GO:0015651; GO:0015695; GO:0015697; GO:0015879; GO:0016324; GO:0030165; GO:0042908; GO:0089718 amino acid transmembrane transporter activity [GO:0015171]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; cation:cation antiporter activity [GO:0015491]; nucleotide binding [GO:0000166]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; secondary active organic cation transmembrane transporter activity [GO:0008513]; symporter activity [GO:0015293] AFILDLFR 0.98988 -5.8149 0 0 0 0 0 0 0 0 0 0 14.0944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0827 0 0 0 0 0 0 0 0 0 0 0 12.4394 0 0 0 0 0 0 0 10.3567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2R6 RERE_HUMAN Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634] histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942] GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0046872; GO:0048755; GO:0048813 chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] ALQRLVKK 0.98988 -19.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7261 0 12.275 0 13.3415 0 0 11.7571 0 11.4251 0 0 12.3489 12.2214 0 0 0 0 0 0 12.1141 0 12.561 13.3655 0 12.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0946 0 13.1649 0 16.6668 0 0 0 16.7322 16.6436 14.054 13.0148 16.805 13.3008 16.9643 14.1724 0 0 9.79593 13.0197 0 13.0669 0 13.2105 13.2731 0 0 0 0 0 13.5162 0 17.9091 0 13.6868 12.0349 14.6884 0 0 0 0 0 14.097 0 0 14.8202 0 13.5344 15.0919 0 9.79593 0 14.4334 0 15.3729 13.6922 0 14.8741 0 0 14.3405 13.8721 14.2729 0 0 14.2441 15.4418 14.6583 13.5564 13.2952 0 0 12.98 13.5926 15.476 15.6076 12.9099 15.1408 0 0 13.6315 0 0 0 15.4079 13.6526 13.1585 13.4607 14.4136 0 12.4464 12.8138 12.0468 0 0 0 0 0 0 13.8217 0 0 0 0 12.4714 0 17.0429 0 13.0525 13.0159 0 0 0 14.878 P40426 PBX3_HUMAN Pre-B-cell leukemia transcription factor 3 (Homeobox protein PBX3) PBX3 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; animal organ morphogenesis [GO:0009887]; anterior compartment pattern formation [GO:0007387]; brain development [GO:0007420]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; posterior compartment specification [GO:0007388]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult locomotory behavior [GO:0008344]; animal organ morphogenesis [GO:0009887]; anterior compartment pattern formation [GO:0007387]; brain development [GO:0007420]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; posterior compartment specification [GO:0007388]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0002087; GO:0005634; GO:0005667; GO:0006357; GO:0007387; GO:0007388; GO:0007420; GO:0007585; GO:0008344; GO:0009887; GO:0021516; GO:0048568; GO:0048666 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AKLTQIR 0.98989 -19.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1677 0 12.5296 0 13.4828 0 0 0 0 0 0 0 0 17.2969 0 0 0 9.9993 0 0 0 0 0 0 0 0 0 12.2493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.956 0 0 0 0 0 0 0 0 0 0 13.6536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0874 0 0 0 0 0 Q155Q3 DIXC1_HUMAN "Dixin (Coiled-coil protein DIX1, Coiled-coil-DIX1) (DIX domain-containing protein 1)" DIXDC1 CCD1 KIAA1735 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex development [GO:0021695]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507] axon terminus [GO:0043679]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991] axon terminus [GO:0043679]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cerebellar cortex development [GO:0021695]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0003779; GO:0005829; GO:0005856; GO:0005925; GO:0019904; GO:0021695; GO:0021799; GO:0021869; GO:0030177; GO:0031435; GO:0032956; GO:0032991; GO:0043015; GO:0043025; GO:0043679; GO:0045665; GO:0046330; GO:0050772; GO:0060070; GO:0070507 actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904] DWRPGSPGTYLETSWEEQLLEQQEYLEKEMEEAK 0.98989 -5.8217 0 0 0 0 0 0 0 0 0 0 0 0 10.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2177 0 0 13.9556 11.6574 0 0 0 13.6761 13.9688 13.0151 12.6876 0 0 0 0 0 0 0 13.8995 0 0 0 0 13.6678 0 0 0 0 14.8173 13.0915 0 0 14.0976 0 0 0 0 0 0 12.0201 0 0 14.3095 0 0 0 0 14.1206 0 0 14.8352 0 0 0 12.4496 15.214 14.2088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.309 13.8393 0 0 0 0 0 0 0 Q8N461 FXL16_HUMAN F-box/LRR-repeat protein 16 (F-box and leucine-rich repeat protein 16) FBXL16 C16orf22 FBL16 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0005829; GO:0019005; GO:0031146 KGVKAMSLK 0.98989 -5.829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.705 0 12.8424 13.0856 0 0 13.3098 0 0 0 13.0133 0 12.8245 0 0 0 0 12.9005 0 0 0 0 0 14.611 0 0 0 0 0 0 0 12.9065 13.0121 0 12.854 0 13.0775 0 0 0 0 0 0 0 13.3253 0 0 0 13.2178 12.8031 12.9213 0 0 0 0 0 13.4234 12.7231 0 0 0 13.2935 13.029 12.7168 13.076 13.0558 0 12.6853 0 12.8379 12.8461 0 0 0 0 0 0 13.4278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9816 0 0 0 0 0 Q99933 BAG1_HUMAN "BAG family molecular chaperone regulator 1, BAG-1 (Bcl-2-associated athanogene 1)" BAG1 HAP Homo sapiens (Human) apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821] GO:0000774; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007166; GO:0016020; GO:0031625; GO:0043066; GO:0050821; GO:0051085; GO:0051087 adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625] AQRGGAR 0.98989 -19.4 11.7667 0 0 0 0 15.4723 15.512 0 0 0 0 0 0 0 12.7829 0 11.9366 0 0 0 0 13.9394 0 0 0 0 0 0 0 0 0 0 0 0 14.4065 0 0 0 0 0 0 0 0 0 12.3572 0 0 0 12.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8581 0 0 0 0 0 0 0 0 0 0 12.3947 0 0 14.6222 0 14.8739 0 15.3235 0 0 0 0 14.8055 0 14.8016 0 14.6295 0 0 0 0 14.81 12.9137 0 0 0 0 15.8387 14.683 14.6014 0 0 0 0 0 14.7757 0 0 13.7758 0 0 0 0 0 14.1843 14.6788 0 14.7567 14.7319 14.6742 12.7181 0 0 0 14.724 0 0 0 0 0 0 0 0 0 0 0 11.7387 0 13.7276 0 14.0472 0 0 0 0 0 14.8405 14.3995 0 0 13.9694 0 0 0 0 0 0 0 12.2355 0 0 0 0 0 0 0 0 0 14.9486 0 0 14.7017 13.4949 Q9NS75 CLTR2_HUMAN "Cysteinyl leukotriene receptor 2, CysLTR2 (G-protein coupled receptor GPCR21, hGPCR21) (G-protein coupled receptor HG57) (HPN321)" CYSLTR2 CYSLT2 CYSLT2R PSEC0146 Homo sapiens (Human) cellular response to glucagon stimulus [GO:0071377]; immune response [GO:0006955]; neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; guanyl-nucleotide exchange factor activity [GO:0005085]; leukotriene receptor activity [GO:0004974]; cellular response to glucagon stimulus [GO:0071377]; immune response [GO:0006955]; neuropeptide signaling pathway [GO:0007218] GO:0001631; GO:0004974; GO:0005085; GO:0005886; GO:0005887; GO:0006955; GO:0007218; GO:0008528; GO:0071377 cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; guanyl-nucleotide exchange factor activity [GO:0005085]; leukotriene receptor activity [GO:0004974] IMSYSLYVNMYSSIYFLTVLSVVR 0.98989 -5.8301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5818 0 0 0 0 0 0 0 0 0 0 0 13.2122 0 0 0 0 0 0 0 0 0 0 17.2968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52198 RND2_HUMAN Rho-related GTP-binding protein RhoN (Rho family GTPase 2) (Rho-related GTP-binding protein Rho7) (Rnd2) RND2 ARHN RHO7 Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; plasma membrane [GO:0005886] acrosomal membrane [GO:0002080]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; early endosome [GO:0005769]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; collateral sprouting [GO:0048668]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of collateral sprouting [GO:0048672]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] GO:0002080; GO:0003924; GO:0005525; GO:0005769; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0016477; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0047485; GO:0048668; GO:0048672 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485] GHRQLRR 0.9899 -4.3357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZT07 TBCD9_HUMAN TBC1 domain family member 9 (TBC1 domain family member 9A) TBC1D9 KIAA0882 TBC1D9A Homo sapiens (Human) activation of GTPase activity [GO:0090630] calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0005509; GO:0090630 calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096] DDGEAMTVLGRYLDSVTNK 0.9899 -5.8439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6644 0 11.8871 0 0 0 0 0 0 13.0998 0 0 0 0 0 0 0 0 15.6912 0 0 0 12.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4974 0 0 0 10.9965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4064 0 13.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8731 0 0 0 0 0 12.1602 0 0 Q86X83 COMD2_HUMAN COMM domain-containing protein 2 COMMD2 HSPC042 My004 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 IAVEFLRR 0.9899 -5.7142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9327 0 0 0 0 0 0 0 11.8185 0 0 0 0 0 0 0 0 0 0 0 0 11.6127 0 0 0 0 0 0 13.7799 0 0 0 0 0 0 0 0 0 13.0144 0 0 0 0 0 0 0 19.3497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2196 11.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9364 0 0 0 0 12.7183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9T2 CX042_HUMAN Putative uncharacterized protein CXorf42 (NF-kappa-B-activating protein pseudogene 1) NKAPP1 CXorf42 Homo sapiens (Human) EASGSGR 0.9899 -5.8462 0 0 0 0 0 0 0 11.3485 12.2931 12.1949 12.2882 11.9362 0 0 0 0 0 0 0 0 0 0 0 0 11.803 0 0 0 0 0 11.9812 11.2681 11.509 0 11.5476 0 12.5654 11.7989 0 0 11.462 0 0 0 11.7277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.398 13.0478 14.4578 15.8171 0 0 0 0 14.3183 12.6694 12.8967 13.2881 0 0 12.4675 0 14.685 0 12.9344 0 0 11.9278 0 0 0 0 0 12.9653 13.6864 0 0 0 0 0 0 0 0 13.829 14.7632 0 12.9963 0 14.751 13.4209 10.3218 0 13.2259 0 0 13.0939 0 0 13.3844 13.5359 0 0 13.9583 13.5527 0 0 13.808 0 0 14.8173 0 14.3711 0 13.5778 12.6793 14.4127 15.4081 0 0 0 0 0 0 0 0 0 0 0 0 12.3942 0 0 0 0 0 0 0 0 0 13.4521 12.9852 0 0 12.1929 0 0 0 0 0 0 0 0 14.5742 0 12.9708 0 0 0 11.2281 Q8TA94 ZN563_HUMAN Zinc finger protein 563 ZNF563 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CKICGKAFVYPSVCQR 0.9899 -19.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.716 0 12.5942 0 0 0 0 0 0 13.3963 0 0 15.907 0 13.2473 0 0 0 0 0 0 0 0 13.6994 0 0 0 13.2659 0 12.5467 12.6966 13.2913 0 0 0 0 0 0 0 0 0 12.9811 0 0 0 0 0 0 0 0 0 0 11.9666 0 11.7338 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2507 0 0 0 0 0 0 0 0 0 0 11.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3937 0 0 0 0 0 0 Q9BQI4 CCDC3_HUMAN "Coiled-coil domain-containing protein 3 (Fat/vessel-derived secretory protein, Favine)" CCDC3 Homo sapiens (Human) lipid biosynthetic process [GO:0008610]; negative regulation of gene expression [GO:0010629]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid biosynthetic process [GO:0046889] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid biosynthetic process [GO:0008610]; negative regulation of gene expression [GO:0010629]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid biosynthetic process [GO:0046889] GO:0005576; GO:0005783; GO:0008610; GO:0010629; GO:0010804; GO:0045600; GO:0045833; GO:0046889; GO:0051055 ACQLPSEWR 0.9899 -4.3366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7345 0 0 0 0 0 0 0 11.2397 0 0 0 0 0 11.5112 0 0 0 11.3461 0 0 12.076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8289 0 0 0 0 0 0 0 0 0 0 0 12.876 0 0 0 0 0 0 0 11.7965 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8127 0 0 12.2254 13.025 0 0 11.4033 0 0 0 0 0 Q9BV81 EMC6_HUMAN ER membrane protein complex subunit 6 (Transmembrane protein 93) EMC6 TMEM93 Homo sapiens (Human) autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of omegasome membrane [GO:0097631] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of omegasome membrane [GO:0097631]; autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0000045; GO:0005789; GO:0016021; GO:0030176; GO:0045050; GO:0071816; GO:0072546; GO:0097631 AGRRWNK 0.9899 -4.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5318 0 0 0 0 0 0 0 0 18.1903 0 0 18.2212 0 0 0 0 0 0 0 0 0 0 18.21 0 0 0 0 0 0 0 10.3845 0 0 0 10.3975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7196 0 0 0 0 0 0 0 0 0 Q9NSB8 HOME2_HUMAN "Homer protein homolog 2, Homer-2 (Cupidin)" HOMER2 Homo sapiens (Human) behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605] anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426] anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; synaptic receptor adaptor activity [GO:0030160]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605] GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035256; GO:0035584; GO:0043229; GO:0045177; GO:0048148; GO:0048875; GO:0070161; GO:0070885; GO:0098978; GO:2001256 actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; synaptic receptor adaptor activity [GO:0030160] AHVFQIDPNTKKNWMPASK 0.9899 -5.7186 0 0 0 0 0 0 0 0 0 0 14.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3366 0 0 0 0 0 0 0 0 11.7513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.553 0 0 O00159 MYO1C_HUMAN "Unconventional myosin-Ic (Myosin I beta, MMI-beta, MMIb)" MYO1C Homo sapiens (Human) actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; chromatin remodeling [GO:0006338]; mRNA transport [GO:0051028]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of histone acetylation [GO:0035066]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; B-WICH complex [GO:0110016]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461] actin cytoskeleton [GO:0015629]; B-WICH complex [GO:0110016]; basal plasma membrane [GO:0009925]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nuclear body [GO:0016604]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium membrane [GO:0060171]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cellular response to interferon-gamma [GO:0071346]; chromatin remodeling [GO:0006338]; mRNA transport [GO:0051028]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of histone acetylation [GO:0035066]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein targeting to membrane [GO:0006612]; regulation of bicellular tight junction assembly [GO:2000810]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0001726; GO:0005102; GO:0005516; GO:0005524; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0006338; GO:0006612; GO:0007015; GO:0008022; GO:0009925; GO:0015629; GO:0016020; GO:0016328; GO:0016461; GO:0016604; GO:0030050; GO:0030335; GO:0030659; GO:0031267; GO:0031941; GO:0035066; GO:0038089; GO:0045121; GO:0045335; GO:0045943; GO:0045944; GO:0045945; GO:0051015; GO:0051028; GO:0060171; GO:0070062; GO:0071346; GO:0090314; GO:0110016; GO:1900078; GO:1900748; GO:2000810 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] AKNGHLAVVAPR 0.98991 -5.7289 0 0 0 0 0 0 0 0 11.5474 0 0 0 0 0 0 0 11.8052 0 0 0 0 0 12.246 0 11.9742 12.9573 0 0 0 0 0 0 0 0 0 11.4261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8853 0 0 0 0 0 0 0 13.9865 0 13.5033 0 0 0 14.4254 0 0 16.9064 0 0 13.0429 0 13.9686 0 0 0 0 0 0 13.5637 13.1239 0 0 0 0 16.231 0 0 0 0 0 12.3648 12.4943 12.1603 0 0 11.6813 0 0 0 16.5685 16.3318 0 0 0 0 12.7484 0 0 0 14.3504 15.5122 0 0 0 0 0 0 0 12.4261 0 12.265 14.0853 0 0 0 0 0 0 0 0 0 0 0 0 11.6818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94910 AGRL1_HUMAN "Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1, CIRL-1) (Latrophilin-1) (Lectomedin-2)" ADGRL1 KIAA0821 LEC2 LPHN1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129] anchoring junction [GO:0070161]; axon [GO:0030424]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; positive regulation of synapse maturation [GO:0090129] GO:0004930; GO:0005886; GO:0005887; GO:0007157; GO:0007166; GO:0007186; GO:0007189; GO:0014069; GO:0016021; GO:0016524; GO:0030246; GO:0030424; GO:0030426; GO:0035584; GO:0042734; GO:0043005; GO:0045202; GO:0050839; GO:0070161; GO:0090129 carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524] ACWLRVDNYFIWSFIGPVSFVIVVNLVFLMVTLHK 0.98991 -19.567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8277 0 0 0 14.9503 0 0 10.5751 0 0 11.5775 0 0 0 0 0 11.855 0 0 13.6564 0 0 0 0 14.7546 0 11.5082 0 0 0 12.3107 0 11.287 0 0 0 0 14.6172 11.3518 10.9163 0 13.5684 0 0 14.2541 11.6302 0 0 0 0 0 0 0 0 12.322 14.3754 11.322 13.8729 0 0 0 0 0 0 0 0 0 0 0 11.1995 0 0 0 0 0 0 0 0 0 0 11.6683 0 0 0 0 13.2471 O95873 CF047_HUMAN Uncharacterized protein C6orf47 (Protein G4) C6orf47 G4 Homo sapiens (Human) FLRRLGGWLPR 0.98991 -4.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8896 0 0 0 13.7393 0 0 0 15.0757 13.4574 0 0 0 13.3088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3487 0 0 0 0 0 0 14.8128 0 0 13.8655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41212 ETV6_HUMAN "Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1, Tel)" ETV6 TEL TEL1 Homo sapiens (Human) cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; vitellogenesis [GO:0007296] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of transcription by RNA polymerase II [GO:0006357]; vitellogenesis [GO:0007296]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0071425; GO:0097152 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ALRHYYKLNIIR 0.98991 -5.7226 0 0 0 0 0 0 0 0 0 10.7244 0 0 0 0 0 0 0 10.8618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6059 0 0 15.1074 0 11.8865 0 0 0 0 12.9493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8838 0 0 12.7343 0 0 0 12.2938 0 0 0 0 0 0 0 0 0 0 0 15.4772 0 0 0 0 0 0 0 0 13.3935 0 0 0 0 0 0 0 0 0 0 0 P42701 I12R1_HUMAN "Interleukin-12 receptor subunit beta-1, IL-12 receptor subunit beta-1, IL-12R subunit beta-1, IL-12R-beta-1, IL-12RB1 (IL-12 receptor beta component) (CD antigen CD212)" IL12RB1 IL12R IL12RB Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cellular response to interferon-gamma [GO:0071346]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; signal transduction [GO:0007165] GO:0001916; GO:0002230; GO:0002827; GO:0004896; GO:0005886; GO:0006955; GO:0007165; GO:0009897; GO:0019221; GO:0019955; GO:0032729; GO:0032740; GO:0032819; GO:0035722; GO:0038155; GO:0042022; GO:0042102; GO:0042104; GO:0043235; GO:0043382; GO:0046427; GO:0051142; GO:0071346; GO:0072536; GO:2000318; GO:2000330 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896] CCYFAAGSATR 0.98991 -5.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2S7 PDIP2_HUMAN "Polymerase delta-interacting protein 2 (38 kDa DNA polymerase delta interaction protein, p38)" POLDIP2 PDIP38 POLD4 HSPC017 Homo sapiens (Human) error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; mitotic spindle assembly [GO:0090307]; negative regulation of macroautophagy [GO:0016242]; positive regulation of actin filament binding [GO:1904531]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; vascular associated smooth muscle cell proliferation [GO:1990874] cell-cell junction [GO:0005911]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; error-free translesion synthesis [GO:0070987]; mitochondrion morphogenesis [GO:0070584]; mitotic spindle assembly [GO:0090307]; negative regulation of macroautophagy [GO:0016242]; positive regulation of actin filament binding [GO:1904531]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; vascular associated smooth muscle cell proliferation [GO:1990874] GO:0003677; GO:0005634; GO:0005739; GO:0005759; GO:0005886; GO:0005911; GO:0016242; GO:0030496; GO:0042645; GO:0045931; GO:0051894; GO:0070584; GO:0070987; GO:0072686; GO:0090307; GO:1903490; GO:1904531; GO:1990874; GO:2001108 DNA binding [GO:0003677] AACTARR 0.98991 -5.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1476 11.8248 0 0 0 0 0 0 0 0 0 0 0 0 13.3432 0 13.5927 0 13.3486 12.965 0 0 0 13.6569 0 15.9593 0 0 0 12.811 0 0 0 0 0 0 14.1283 15.117 12.7445 0 0 0 0 0 0 0 13.1103 0 0 0 13.841 13.7434 0 13.5838 13.6827 14.097 0 14.0446 0 14.0782 0 0 0 0 0 0 11.8359 0 0 0 0 0 0 13.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8617 0 0 0 0 0 0 0 0 P34741 SDC2_HUMAN "Syndecan-2, SYND2 (Fibroglycan) (Heparan sulfate proteoglycan core protein, HSPG) (CD antigen CD362)" SDC2 HSPG1 Homo sapiens (Human) cell migration [GO:0016477]; dendrite morphogenesis [GO:0048813]; regulation of dendrite morphogenesis [GO:0048814] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; cell migration [GO:0016477]; dendrite morphogenesis [GO:0048813]; regulation of dendrite morphogenesis [GO:0048814] GO:0005788; GO:0005796; GO:0005886; GO:0009986; GO:0016021; GO:0016477; GO:0030165; GO:0042802; GO:0043202; GO:0048813; GO:0048814; GO:0062023 identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165] APTKEFYA 0.98992 -5.7379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4673 0 0 0 0 0 0 0 0 0 0 11.0787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PJG2 MDEAS_HUMAN Mitotic deacetylase-associated SANT domain protein (ELM2 and SANT domain-containing protein 1) MIDEAS C14orf117 C14orf43 ELMSAN1 Homo sapiens (Human) "histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000118; GO:0003677; GO:0003714; GO:0005654; GO:0005667; GO:0006357; GO:0016575; GO:0045892 DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714] AGGPQLDRYVR 0.98992 -19.578 0 0 0 0 0 0 0 0 0 0 0 10.9324 11.0397 0 0 0 0 0 0 0 10.4073 0 0 10.5071 0 0 0 0 0 0 0 10.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.667 0 0 12.9902 0 0 0 0 0 0 0 0 0 0 0 11.6081 0 0 0 12.997 12.6259 13.3986 13.8354 13.8234 0 0 14.353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8738 0 15.1578 15.2873 13.7057 13.7995 11.2447 15.2623 0 0 15.785 0 0 0 12.339 0 0 0 0 0 0 0 0 12.9092 15.6039 0 0 0 0 0 0 0 0 0 0 14.6062 0 0 0 14.5166 0 14.0371 14.5884 0 0 14.2346 13.5839 12.8818 0 0 13.1541 0 0 0 0 0 0 0 0 0 15.1489 0 0 14.5937 0 0 0 0 Q9H694 BICC1_HUMAN "Protein bicaudal C homolog 1, Bic-C" BICC1 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of canonical Wnt signaling pathway [GO:0090090] GO:0001822; GO:0003723; GO:0005737; GO:0007368; GO:0007507; GO:0090090 RNA binding [GO:0003723] EDVKEAK 0.98992 -19.575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.218 0 0 17.362 0 0 12.7841 14.1713 14.0695 0 0 0 0 0 0 0 0 0 0 14.6023 0 13.4196 0 0 13.7845 13.8136 15.0129 0 0 0 13.6842 0 0 0 0 0 0 0 0 0 0 0 12.8517 0 0 0 0 0 0 0 0 13.4475 0 0 0 0 16.4894 0 0 0 14.7334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.979 0 0 0 0 0 0 12.7211 0 O15381 NVL_HUMAN "Nuclear valosin-containing protein-like, NVLp, Nuclear VCP-like protein" NVL NVL2 Homo sapiens (Human) positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364] GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723] ALGLVTPAGVLLAGPPGCGKTLLAK 0.98993 -19.331 15.0802 0 0 0 12.6325 0 11.2285 0 0 11.0307 0 11.2054 0 0 0 0 0 0 11.929 0 13.894 0 12.1058 0 0 11.4168 0 11.1916 0 11.3784 0 0 0 11.7631 0 0 0 10.7083 0 0 0 12.639 0 0 12.4963 14.0192 0 12.2938 0 12.9541 13.956 17.1934 16.8474 14.0658 13.7648 13.6414 11.8224 0 0 0 0 0 10.8218 10.8163 0 11.487 0 10.0268 0 10.1547 0 0 0 0 13.9195 10.7749 0 13.3633 13.1484 13.9981 0 14.448 13.462 14.3133 15.8971 14.7289 15.4271 13.5463 14.1887 14.6336 16.1714 16.2245 16.6191 16.5243 14.6047 16.2871 14.3767 15.8522 16.499 0 0 13.9592 0 0 14.9455 15.0125 0 0 9.43221 0 14.2321 0 15.2946 15.7408 16.2378 15.794 13.7279 15.8082 16.7418 15.2069 14.3537 16.3308 16.6063 15.4596 16.7866 16.3386 15.2468 15.9757 15.5763 15.1729 15.6944 15.2713 16.4757 17.931 17.6563 18.1205 18.4585 18.5671 18.0878 17.6047 15.9649 18.1298 18.4536 18.8114 18.719 17.7917 18.6504 13.5031 14.6124 0 16.2318 15.3149 0 15.071 15.2181 15.0733 13.6774 12.8786 13.2711 0 0 0 0 15.5389 0 14.1925 0 13.0484 12.5147 13.2995 0 15.0469 15.1906 0 13.1638 14.178 0 13.0407 14.4621 0 O76013 KRT36_HUMAN "Keratin, type I cuticular Ha6 (Hair keratin, type I Ha6) (Keratin-36, K36)" KRT36 HHA6 HKA6 KRTHA6 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of keratinocyte differentiation [GO:0045616] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; regulation of keratinocyte differentiation [GO:0045616] GO:0005829; GO:0005856; GO:0030280; GO:0030855; GO:0045095; GO:0045109; GO:0045111; GO:0045616; GO:0070062 structural constituent of skin epidermis [GO:0030280] CDLERQNQEYQVLLDVKAR 0.98993 -5.6212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DKV0 S31C1_HUMAN Putative spermatogenesis-associated protein 31C1 (Protein FAM75C1) SPATA31C1 FAM75C1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 ECPRGLEETWDLLSQLQSLLGPHLEK 0.98993 -19.325 0 0 0 0 0 0 0 0 11.7626 13.2799 12.1762 12.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1182 0 0 13.0299 0 13.1989 0 0 12.8594 12.0508 11.7235 0 0 12.0053 13.2014 0 12.1675 0 0 0 12.8955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8628 0 0 0 0 0 0 0 0 0 0 0 0 14.8272 0 0 0 0 0 0 0 0 0 0 0 0 12.2884 0 0 0 0 0 0 12.4303 0 0 13.8509 0 12.5219 0 12.3918 12.2283 0 13.1556 0 0 0 0 13.3095 0 0 0 0 0 0 13.3504 13.2946 0 0 15.2327 12.9147 0 0 0 0 0 0 11.9995 0 0 0 0 13.4225 14.1621 0 0 0 0 0 0 0 14.5957 0 0 0 0 0 11.862 0 0 0 13.6439 0 13.6639 0 13.9177 10.6689 0 14.1838 0 13.6243 0 12.855 12.3655 0 0 0 0 0 0 0 0 0 0 P49221 TGM4_HUMAN "Protein-glutamine gamma-glutamyltransferase 4, EC 2.3.2.13 (Fibrinoligase) (Prostate transglutaminase) (Prostate-specific transglutaminase) (Transglutaminase P, TG(P), TGP, TGase P) (Transglutaminase-4, TGase-4)" TGM4 Homo sapiens (Human) peptide cross-linking [GO:0018149] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149] GO:0003810; GO:0005737; GO:0005794; GO:0018149; GO:0046872; GO:0062023; GO:0070062 metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] AMCAMMSFEK 0.98993 -19.343 0 0 0 10.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7321 0 0 0 0 0 0 10.9799 0 0 0 0 0 0 0 0 0 0 0 11.6307 0 0 0 0 0 0 0 12.0619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4735 0 0 0 0 13.1672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.747 14.8265 0 14.676 0 0 0 0 0 14.8788 14.9326 0 0 0 0 0 12.499 0 0 0 0 0 0 0 12.8435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55084 ECHB_HUMAN "Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase, EC 2.3.1.155, EC 2.3.1.16 (Acetyl-CoA acyltransferase) (Beta-ketothiolase) ]" HADHB MSTP029 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467] endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; lncRNA binding [GO:0106222]; RNA binding [GO:0003723]; cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467] GO:0003723; GO:0003857; GO:0003985; GO:0003988; GO:0004300; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0010467; GO:0016507; GO:0042645; GO:0050633; GO:0071222; GO:0106222 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; lncRNA binding [GO:0106222]; RNA binding [GO:0003723] LKPAFIK 0.98993 -5.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5783 0 0 0 0 19.5174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5794 12.8279 13.0749 0 0 0 0 0 0 0 0 0 0 9.86205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9081 0 0 0 0 0 0 0 0 0 0 0 13.5006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.462 0 0 0 0 0 0 0 0 0 0 P55773 CCL23_HUMAN "C-C motif chemokine 23 (CK-beta-8, CKB-8) (Macrophage inflammatory protein 3, MIP-3) (Myeloid progenitor inhibitory factor 1, MPIF-1) (Small-inducible cytokine A23) [Cleaved into: CCL23(19-99); CCL23(22-99); CCL23(27-99); CCL23(30-99) ]" CCL23 MIP3 MPIF1 SCYA23 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] GO:0002548; GO:0005576; GO:0005615; GO:0006874; GO:0006935; GO:0006954; GO:0006955; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0008201; GO:0008285; GO:0030593; GO:0031726; GO:0043547; GO:0048020; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:2001264 CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; chemokine activity [GO:0008009]; heparin binding [GO:0008201] FHATSADCCISYTPR 0.98993 -5.6186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SQS8 CJ120_HUMAN Uncharacterized protein C10orf120 C10orf120 Homo sapiens (Human) CLTYHGNDRKSFLPAK 0.98993 -5.616 13.1288 11.7978 0 0 0 12.6948 0 0 0 14.2435 15.7329 12.9843 0 0 0 13.4215 11.3077 13.4397 0 11.9038 13.1373 0 0 0 13.6443 13.0434 13.87 0 12.5694 0 0 16.4391 13.8343 0 13.0602 0 0 12.4849 13.5868 0 13.8886 0 13.9281 0 13.6223 14.3378 14.3423 0 10.6973 12.6356 0 0 0 0 0 0 17.2919 17.9937 0 0 16.8407 17.4998 0 15.1743 0 15.2131 0 13.6838 0 0 0 0 0 12.1662 0 16.0487 0 0 0 0 0 0 15.0628 15.7358 15.1384 0 14.8853 14.3723 13.9974 15.7829 15.558 0 0 14.5947 0 17.2199 16.6111 16.0913 0 13.685 0 14.9319 0 14.9185 13.8872 13.735 13.1299 15.0156 15.178 0 0 0 0 0 0 0 0 14.3704 14.3811 15.0206 13.5335 0 15.5325 0 0 15.5784 0 14.0844 15.0646 0 0 15.828 12.6525 13.4543 0 0 13.1553 0 13.2929 12.5757 12.6934 0 0 15.236 14.4384 0 0 0 17.3977 0 0 12.7947 12.0329 10.9679 14.0959 13.9616 0 0 12.6065 10.8242 0 0 0 15.132 0 0 0 0 0 0 0 13.7435 12.8859 0 16.0477 0 11.0274 0 17.1214 11.021 Q86UW1 OSTA_HUMAN "Organic solute transporter subunit alpha, OST-alpha (Solute carrier family 51 subunit alpha)" SLC51A OSTA Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782] GO:0005789; GO:0005886; GO:0015125; GO:0015721; GO:0016021; GO:0016323; GO:0032782; GO:0032991; GO:0042803; GO:0046982 bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] ALGPVELALTSILTLLALGSIAIFLEDAVYLYK 0.98993 -5.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5797 0 0 0 15.3507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.995 0 0 0 0 12.2689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7371 0 0 0 0 0 0 14.0378 0 14.2302 0 0 0 0 0 0 15.2547 14.4025 0 0 0 0 0 0 0 0 15.601 15.6238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3K6 BOLA2_HUMAN BolA-like protein 2 BOLA2 BOLA2A My016; BOLA2B Homo sapiens (Human) [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428] cytoplasm [GO:0005737]; cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; iron-sulfur cluster binding [GO:0051536]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]" GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0016226; GO:0044571; GO:0045454; GO:0051536; GO:0051537; GO:0055072; GO:0097428; GO:1990229 "2 iron, 2 sulfur cluster binding [GO:0051537]; iron-sulfur cluster binding [GO:0051536]" ELSAEYLREK 0.98993 -5.7663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRN7 ADPPT_HUMAN "L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase, EC 2.7.8.7 (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase, AASD-PPT) (LYS5 ortholog)" AASDHPPT CGI-80 HAH-P HSPC223 x0005 Homo sapiens (Human) 10-formyltetrahydrofolate catabolic process [GO:0009258]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939]; protein maturation [GO:0051604] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939]; protein maturation [GO:0051604] GO:0000287; GO:0005829; GO:0008897; GO:0009258; GO:0015939; GO:0019878; GO:0051604; GO:0070062 holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287] AEWLLAVRSIQPEEK 0.98993 -5.7563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9558 0 0 10.6111 0 0 0 0 0 0 0 14.1147 15.3476 0 15.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2396 0 0 0 0 11.5511 0 0 0 0 0 0 0 O75127 PTCD1_HUMAN "Pentatricopeptide repeat-containing protein 1, mitochondrial" PTCD1 KIAA0632 Homo sapiens (Human) mitochondrial translation [GO:0032543]; tRNA 3'-end processing [GO:0042780] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; mitochondrial translation [GO:0032543]; tRNA 3'-end processing [GO:0042780] GO:0000049; GO:0003723; GO:0005739; GO:0005759; GO:0032543; GO:0042780 RNA binding [GO:0003723]; tRNA binding [GO:0000049] ALLPVLAK 0.98994 -5.7735 0 0 0 0 0 0 0 0 0 0 16.2122 0 0 16.2042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2881 0 0 13.456 0 0 10.3647 0 0 0 11.2695 0 0 0 14.0362 13.5817 0 0 13.2131 12.6956 0 0 0 13.3035 14.0202 12.1951 0 0 0 0 0 10.5068 0 14.5108 15.5868 0 0 0 0 13.3821 0 0 0 0 11.2055 0 0 0 0 9.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9556 13.6407 0 0 0 0 0 0 0 0 0 17.5484 0 0 0 11.1485 0 12.8172 12.8288 12.365 0 0 0 0 0 0 0 17.686 0 0 0 0 Q05639 EF1A2_HUMAN "Elongation factor 1-alpha 2, EF-1-alpha-2 (Eukaryotic elongation factor 1 A-2, eEF1A-2) (Statin-S1)" EEF1A2 EEF1AL STN Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid kinase activity [GO:0090218]; regulation of chaperone-mediated autophagy [GO:1904714]; translation [GO:0006412]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; eukaryotic translation elongation factor 1 complex [GO:0005853]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; eukaryotic translation elongation factor 1 complex [GO:0005853]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid kinase activity [GO:0090218]; regulation of chaperone-mediated autophagy [GO:1904714]; translation [GO:0006412]; translational elongation [GO:0006414]" GO:0003746; GO:0003924; GO:0005525; GO:0005737; GO:0005853; GO:0006412; GO:0006414; GO:0008135; GO:0019901; GO:0043065; GO:0045202; GO:0090218; GO:0098574; GO:1904714 "GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]" EAAEMGK 0.98994 -19.388 0 0 0 0 0 0 0 0 0 11.7727 0 0 0 11.3065 11.6539 0 0 0 0 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8882 0 0 0 0 0 12.3173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9822 0 0 0 0 0 0 0 0 0 0 0 0 12.8122 0 0 0 13.1268 0 0 0 14.1165 0 0 0 0 0 0 0 0 0 0 0 0 12.9629 0 13.0059 0 0 0 0 0 0 0 0 13.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M1K9 ZN423_HUMAN "Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein, hOAZ) (Smad- and Olf-interacting zinc finger protein)" ZNF423 KIAA0760 NPHP14 OAZ Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cilium [GO:0061512]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0007219; GO:0007399; GO:0030154; GO:0030513; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0061512; GO:0120163 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" AEQSPVSSDVEVSSPKR 0.98994 -5.6374 0 0 0 10.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6197 0 0 0 0 10.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2395 0 12.1589 0 0 0 0 12.0207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2224 0 0 0 0 0 0 0 0 0 0 0 0 Q99755 PI51A_HUMAN "Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha, PIP5K1-alpha, PtdIns(4)P-5-kinase 1 alpha, EC 2.7.1.68 (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha, PIP5KIalpha)" PIP5K1A Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; phosphorylation [GO:0016310]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165] cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; phosphorylation [GO:0016310]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165]" GO:0000285; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006650; GO:0006661; GO:0006909; GO:0007165; GO:0008654; GO:0010761; GO:0014066; GO:0016308; GO:0016310; GO:0016477; GO:0016607; GO:0019900; GO:0030027; GO:0030216; GO:0031532; GO:0032587; GO:0046854; GO:0048041; GO:0052810; GO:0052812; GO:0060326; GO:0072659; GO:0090630; GO:0097178 "1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]" FMCNTVFKKIPLK 0.98994 -1.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQI0 DDX4_HUMAN "Probable ATP-dependent RNA helicase DDX4, EC 3.6.4.13 (DEAD box protein 4) (Vasa homolog)" DDX4 VASA Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; flagellated sperm motility [GO:0030317]; gamete generation [GO:0007276]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007276; GO:0007283; GO:0010529; GO:0016887; GO:0030154; GO:0030317; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0048471; GO:0071546; GO:0071547; GO:1990511 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] DHFMKSGFASGRNFGNR 0.98994 -5.7807 0 0 0 0 0 0 0 0 0 0 12.7309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8946 0 11.9935 0 0 0 0 0 0 13.819 11.5679 11.1375 13.2436 11.2176 0 0 15.0351 9.78573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9607 0 0 0 0 12.3893 0 0 0 11.793 10.9178 12.5182 0 0 0 0 0 0 10.3287 0 0 0 0 0 0 0 0 0 17.7274 17.8275 17.4219 0 12.1796 0 0 0 11.9613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7304 12.6684 0 0 0 0 0 0 0 12.1702 0 0 0 0 0 0 0 12.5491 0 0 0 0 13.8834 0 0 12.673 0 0 0 0 0 Q16706 MA2A1_HUMAN "Alpha-mannosidase 2, EC 3.2.1.114 (Golgi alpha-mannosidase II, AMan II, Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)" MAN2A1 MANA2 Homo sapiens (Human) in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]; viral protein processing [GO:0019082] cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]; viral protein processing [GO:0019082]" GO:0000139; GO:0001701; GO:0001889; GO:0004559; GO:0004572; GO:0005797; GO:0005801; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0007005; GO:0007033; GO:0007585; GO:0016020; GO:0016021; GO:0016799; GO:0019082; GO:0030246; GO:0042803; GO:0046872; GO:0048286; GO:0050769; GO:0060042; GO:0070062 "alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]" DDHYWSGYFTSR 0.98995 -1.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8232 11.231 0 0 0 0 0 0 0 0 0 0 0 0 12.1377 0 0 0 0 13.5311 0 0 11.2655 12.3398 0 0 11.6792 0 0 0 0 11.2489 0 0 0 0 11.1836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6819 0 0 0 0 0 0 0 0 0 0 13.1534 0 0 0 0 0 0 0 0 0 0 12.9593 16.016 13.9573 14.0588 13.6499 0 0 0 0 15.7537 0 12.4879 0 13.7217 0 0 15.6135 0 0 0 0 13.3997 0 0 0 0 0 0 0 0 0 0 0 11.2939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0854 0 0 0 13.1925 0 0 0 13.8529 14.2613 0 0 13.6747 13.729 0 0 0 0 0 13.7184 0 11.3 0 13.4405 0 0 Q6ZQY3 GADL1_HUMAN "Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase, ADC, HuADC, EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase, CSADC, HuCSADC, EC 4.1.1.29) (Glutamate decarboxylase-like protein 1)" GADL1 Homo sapiens (Human) carboxylic acid metabolic process [GO:0019752] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752] GO:0004068; GO:0004782; GO:0005737; GO:0005829; GO:0016831; GO:0019752; GO:0030170 aspartate 1-decarboxylase activity [GO:0004068]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782] AASFLGIGTENVCFVETDGR 0.98995 -5.6617 0 0 0 0 0 0 0 0 13.8922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1895 0 0 0 0 0 0 0 0 0 0 0 0 14.9605 0 0 0 0 13.1634 0 0 0 0 0 0 13.9035 0 0 0 13.1358 0 0 0 0 0 0 13.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.628 0 0 0 0 0 0 0 0 0 0 13.1445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0883 0 0 12.8158 12.7156 13.0289 0 13.0061 12.958 0 12.665 0 0 0 0 0 0 0 0 0 13.8376 0 0 Q8IXV7 KLD8B_HUMAN Kelch domain-containing protein 8B KLHDC8B FP17659 Homo sapiens (Human) mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813] cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496] cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813] GO:0005737; GO:0005829; GO:0030496; GO:0045171; GO:0098813; GO:0110070; GO:0140014; GO:1902410 AGAAAVVLGK 0.98995 -5.6634 0 0 0 0 12.8335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9412 9.34194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5802 14.7079 0 0 14.5008 14.1964 13.8103 0 0 15.1826 0 0 0 0 0 0 0 14.6408 0 0 0 0 15.2681 14.9622 14.855 0 13.8295 0 0 0 0 15.8132 14.6541 13.9485 14.7169 0 0 0 0 0 0 0 14.1219 0 14.3782 0 0 0 14.4166 0 13.9448 14.3153 14.6818 0 0 14.1103 0 0 0 0 0 0 14.291 0 0 14.2935 14.0531 14.1794 0 0 14.1577 0 14.2466 0 0 0 13.9388 0 0 0 10.7978 0 0 0 11.2217 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9063 14.0903 0 0 0 0 0 0 Q96CP6 ASTRA_HUMAN Protein Aster-A (GRAM domain-containing protein 1A) GRAMD1A KIAA1533 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366] GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006914; GO:0015485; GO:0016021; GO:0031227; GO:0031234; GO:0031410; GO:0032366; GO:0032934; GO:0044232; GO:0071397; GO:0120015; GO:0120020; GO:0140268 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015] QPWSLVKSLIEK 0.98995 -5.6611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1508 11.4232 0 0 0 0 11.2242 0 0 0 13.0734 0 0 15.759 0 0 0 0 0 15.8811 0 0 0 0 0 0 0 0 0 0 0 11.8181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0581 0 0 0 0 0 0 Q96FN4 CPNE2_HUMAN Copine-2 (Copine II) CPNE2 Homo sapiens (Human) cellular response to calcium ion [GO:0071277] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cellular response to calcium ion [GO:0071277] GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0046872; GO:0070062; GO:0071277 calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] ETLAKAVLAELPQQVVQYFKHK 0.98995 -5.6636 0 0 0 0 0 0 0 0 0 0 0 0 15.5572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.012 0 0 0 0 0 0 0 0 0 0 0 0 13.7872 0 0 0 0 0 0 0 0 0 0 0 15.2396 0 0 0 16.2627 0 0 0 0 0 0 14.6889 0 14.3959 0 0 0 0 0 0 11.7231 0 0 0 0 13.8883 0 0 15.5437 0 14.715 14.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9501 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8031 0 0 0 0 0 0 0 0 0 0 0 Q9NX63 MIC19_HUMAN MICOS complex subunit MIC19 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 3) CHCHD3 MIC19 MINOS3 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053] extracellular exosome [GO:0070062]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; SAM complex [GO:0001401] extracellular exosome [GO:0070062]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; SAM complex [GO:0001401]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053] GO:0001401; GO:0005634; GO:0005739; GO:0005743; GO:0007007; GO:0008053; GO:0019902; GO:0042407; GO:0044284; GO:0060090; GO:0061617; GO:0070062; GO:0140275 molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902] GGTTSTR 0.98995 -19.47 0 0 0 0 0 0 0 0 0 12.339 12.3902 0 0 0 0 11.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.556 0 0 0 0 0 12.8114 0 0 0 12.7943 12.1549 0 12.4388 11.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97599 0 0 0 0 12.5881 0 0 0 0 0 0 0 0 0 0 11.8536 0 0 12.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3599 0 0 0 0 0 0 13.8327 0 12.7213 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3613 0 0 0 14.6362 0 13.2048 13.1325 0 0 0 0 14.079 0 0 0 0 Q9NY74 ETAA1_HUMAN Ewing's tumor-associated antigen 1 (Ewing's tumor-associated antigen 16) ETAA1 ETAA16 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; protein serine/threonine kinase activator activity [GO:0043539]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of DNA damage checkpoint [GO:2000001]; replication fork processing [GO:0031297] GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0031297; GO:0043539; GO:0043596; GO:0071902; GO:2000001 protein serine/threonine kinase activator activity [GO:0043539] AKISCTK 0.98995 -19.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8698 13.2374 13.1155 0 12.5141 0 0 13.9789 14.6991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.987 13.4315 0 0 0 0 0 0 0 0 0 0 13.3856 0 0 0 12.5584 0 0 12.7696 0 0 0 0 0 0 0 0 0 0 11.041 0 0 0 0 0 0 0 0 13.2129 11.1611 11.1057 0 11.2533 0 0 0 0 0 13.6342 13.4027 0 13.1389 0 0 0 13.0485 0 0 0 0 0 0 0 0 P08833 IBP1_HUMAN "Insulin-like growth factor-binding protein 1, IBP-1, IGF-binding protein 1, IGFBP-1 (Placental protein 12, PP12)" IGFBP1 IBP1 Homo sapiens (Human) aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of cell growth [GO:0030307]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; tissue regeneration [GO:0042246] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of cell growth [GO:0030307]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; tissue regeneration [GO:0042246] GO:0005102; GO:0005520; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0007165; GO:0007568; GO:0008286; GO:0030307; GO:0031994; GO:0031995; GO:0042246; GO:0043567; GO:0090090 insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102] ALHVTNIK 0.98996 -5.8132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1167 14.9961 0 0 0 0 13.2144 0 13.7863 13.6159 12.9129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8828 0 0 12.8682 11.9204 11.4432 0 0 0 0 0 0 0 0 0 0 0 12.2515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5597 0 0 0 0 0 0 0 0 0 11.9927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29274 AA2AR_HUMAN Adenosine receptor A2a ADORA2A ADORA2 Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; biomineralization [GO:0110148]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inflammatory response [GO:0050728]; negative regulation of locomotion [GO:0040013]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription, DNA-templated [GO:0006355]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]" axolemma [GO:0030673]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786] "axolemma [GO:0030673]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; alpha-actinin binding [GO:0051393]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; biomineralization [GO:0110148]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inflammatory response [GO:0050728]; negative regulation of locomotion [GO:0040013]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of calcium ion transport [GO:0051924]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription, DNA-templated [GO:0006355]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]" GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0004930; GO:0005882; GO:0005886; GO:0005887; GO:0006355; GO:0006469; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007186; GO:0007188; GO:0007189; GO:0007205; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0009410; GO:0010035; GO:0012505; GO:0014049; GO:0014057; GO:0014061; GO:0014069; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0035249; GO:0035810; GO:0035815; GO:0040013; GO:0042311; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043154; GO:0043524; GO:0044877; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0097190; GO:0098978; GO:0099055; GO:0099056; GO:0110148; GO:1900273; GO:2000300; GO:2001235 alpha-actinin binding [GO:0051393]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802] AAGTSAR 0.98996 -19.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5424 0 13.9393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7664 0 0 0 0 0 Q58A45 PAN3_HUMAN "PAN2-PAN3 deadenylation complex subunit PAN3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3, PAN deadenylation complex subunit 3)" PAN3 Homo sapiens (Human) "mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein phosphorylation [GO:0006468]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251] "cytosol [GO:0005829]; P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein phosphorylation [GO:0006468]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]" GO:0000289; GO:0000932; GO:0004672; GO:0005524; GO:0005829; GO:0006397; GO:0006468; GO:0008143; GO:0010606; GO:0031251; GO:0046872; GO:0090503 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; protein kinase activity [GO:0004672] AKNPIGCLADRCK 0.98996 -19.563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1657 0 0 0 0 0 0 0 0 0 0 10.9506 0 0 12.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8533 12.4404 12.9208 0 0 0 0 12.0193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5841 0 0 0 0 11.4766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4513 10.5349 0 0 0 12.9762 0 0 0 0 0 0 0 0 0 0 13.7835 0 0 12.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0696 0 0 0 14.4988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9013 0 0 0 0 0 0 Q9UPW8 UN13A_HUMAN Protein unc-13 homolog A (Munc13-1) UNC13A KIAA1032 Homo sapiens (Human) "cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" anchoring junction [GO:0070161]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; cell differentiation [GO:0030154]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; neurotransmitter secretion [GO:0007269]; positive regulation of dendrite extension [GO:1903861]; presynaptic dense core vesicle exocytosis [GO:0099525]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007269; GO:0007528; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030154; GO:0030672; GO:0031594; GO:0035249; GO:0042734; GO:0043005; GO:0043195; GO:0048786; GO:0051966; GO:0061789; GO:0070161; GO:0098831; GO:0099011; GO:0099525; GO:1903861 calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075] DHMVREEAK 0.98996 -5.8009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6203 16.5789 16.6594 0 0 0 0 0 0 0 0 0 0 11.4106 0 0 0 0 11.7057 0 0 12.1189 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6203 0 0 0 0 0 0 0 0 0 0 0 0 12.3724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7994 0 0 0 12.6772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7625 0 0 0 0 14.8615 0 15.9144 0 0 0 0 0 0 14.1805 14.3899 13.7566 18.2489 0 14.4491 0 18.6863 0 0 0 15.1615 0 0 0 0 0 0 0 0 0 0 P24588 AKAP5_HUMAN "A-kinase anchor protein 5, AKAP-5 (A-kinase anchor protein 79 kDa, AKAP 79) (H21) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein)" AKAP5 AKAP79 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287] anchoring junction [GO:0070161]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; protein serine/threonine phosphatase complex [GO:0008287]; adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; calmodulin binding [GO:0005516]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of protein kinase A signaling [GO:0010738]; signal transduction [GO:0007165] GO:0005516; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0007194; GO:0007268; GO:0008179; GO:0008287; GO:0009898; GO:0010738; GO:0014069; GO:0017124; GO:0030346; GO:0031698; GO:0032590; GO:0034237; GO:0035254; GO:0043197; GO:0045121; GO:0045762; GO:0050811; GO:0051018; GO:0060076; GO:0060090; GO:0070161; GO:0070886; GO:0097110; GO:0098837; GO:1900273; GO:1901387; GO:1903078; GO:1905665; GO:1905751 adenylate cyclase binding [GO:0008179]; beta-2 adrenergic receptor binding [GO:0031698]; calmodulin binding [GO:0005516]; GABA receptor binding [GO:0050811]; glutamate receptor binding [GO:0035254]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124] ASMLCFKRR 0.98997 -5.8189 0 0 0 0 0 0 0 0 0 0 12.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5088 0 0 0 0 17.5672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3641 0 0 0 0 12.3957 0 0 0 0 0 0 0 0 14.4811 0 0 0 0 11.8348 0 P82673 RT35_HUMAN "28S ribosomal protein S35, mitochondrial, MRP-S35, S35mt (28S ribosomal protein S28, mitochondrial, MRP-S28, S28mt) (Mitochondrial small ribosomal subunit protein mS35)" MRPS35 MRPS28 HDCMD11P MDS023 PSEC0213 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ARVVVLRVK 0.98997 -5.8186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0892 14.3751 0 0 0 0 0 12.6618 0 12.6746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1124 14.4357 0 0 0 0 0 0 0 11.612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1347 0 0 0 0 0 0 0 0 0 15.3525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3648 0 0 0 0 11.3132 0 0 0 P82914 RT15_HUMAN "28S ribosomal protein S15, mitochondrial, MRP-S15, S15mt (Mitochondrial small ribosomal subunit protein uS15m)" MRPS15 RPMS15 DC37 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] FPFNQWGLQPR 0.98997 -5.8206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9327 0 0 0 0 0 0 0 14.8625 0 0 0 0 0 0 0 9.77975 0 0 0 0 0 0 0 0 13.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6468 14.0909 0 0 0 0 12.8717 0 0 0 0 0 13.9719 0 0 0 0 0 0 0 0 12.7323 16.5573 0 0 11.1024 0 0 0 0 0 0 0 0 0 0 12.0454 11.8728 0 0 0 0 14.0932 0 0 0 0 0 0 0 0 0 0 0 0 13.9917 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13588 GRAP_HUMAN GRB2-related adapter protein GRAP Homo sapiens (Human) cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793] anchoring junction [GO:0070161]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; cell-cell signaling [GO:0007267]; Ras protein signal transduction [GO:0007265]; regulation of MAPK cascade [GO:0043408]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165] GO:0001784; GO:0005154; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007267; GO:0007605; GO:0008180; GO:0043408; GO:0070161; GO:0098793 epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784] GDTLKILNMEDDQNWYK 0.98997 -19.574 0 0 0 0 0 11.7461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2984 0 0 0 13.2777 0 12.8605 14.1672 12.7313 0 0 0 0 0 13.888 0 0 0 0 0 0 0 0 0 0 13.5887 0 11.4714 14.7335 0 0 0 0 13.1144 0 12.437 11.1577 0 0 0 13.0065 0 0 0 13.052 13.124 0 13.9018 0 0 0 0 0 0 0 0 0 0 0 13.0741 0 0 0 0 13.286 0 0 0 0 13.0079 0 0 0 0 0 0 13.3048 0 0 0 12.14 0 0 13.3235 13.7832 15.6858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4315 0 0 13.4308 0 0 0 0 0 Q9BWT6 MND1_HUMAN Meiotic nuclear division protein 1 homolog MND1 GAJ Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; reciprocal meiotic recombination [GO:0007131] nucleus [GO:0005634] nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; homologous chromosome pairing at meiosis [GO:0007129]; reciprocal meiotic recombination [GO:0007131] GO:0003690; GO:0005634; GO:0007129; GO:0007131 double-stranded DNA binding [GO:0003690] ALHARKHK 0.98997 -1.882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3243 0 0 0 0 0 0 0 0 11.32 11.183 0 0 0 12.4951 0 0 0 0 0 0 0 0 0 0 0 0 12.1553 0 0 0 13.0033 0 0 0 13.2826 11.8484 12.9748 0 0 0 0 0 12.0893 13.6511 0 0 0 0 0 0 0 13.5988 0 0 0 0 0 0 13.2854 12.6667 13.4165 0 0 17.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H628 RERGL_HUMAN "Ras-related and estrogen-regulated growth inhibitor-like protein, EC 3.6.5.2 (RERG/Ras-like protein)" RERGL Homo sapiens (Human) G protein activity [GO:0003925]; GTP binding [GO:0005525] GO:0003925; GO:0005525 G protein activity [GO:0003925]; GTP binding [GO:0005525] ALIYRIR 0.98997 -19.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0996 0 0 0 14.3363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0334 12.9152 0 12.8491 12.9101 0 0 0 0 0 12.2937 0 0 0 P23526 SAHH_HUMAN "Adenosylhomocysteinase, AdoHcyase, EC 3.3.1.1 (S-adenosyl-L-homocysteine hydrolase)" AHCY SAHH Homo sapiens (Human) chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian sleep/wake cycle [GO:0042745]; one-carbon metabolic process [GO:0006730]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353] GO:0001666; GO:0002439; GO:0004013; GO:0005634; GO:0005829; GO:0006730; GO:0007584; GO:0019510; GO:0030554; GO:0033353; GO:0042470; GO:0042745; GO:0042802; GO:0043005; GO:0051287; GO:0070062 adenosylhomocysteinase activity [GO:0004013]; adenyl nucleotide binding [GO:0030554]; identical protein binding [GO:0042802]; NAD binding [GO:0051287] YPQLLPGIR 0.98998 -5.7139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6582 0 0 0 0 0 0 Q14166 TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12) TTLL12 KIAA0153 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; regulation of mitotic cell cycle [GO:0007346] GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0007346; GO:0015631; GO:0030496; GO:0045087; GO:0060339; GO:1990889 ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631] EDVGKVK 0.98998 -19.323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1049 0 0 0 0 0 0 0 0 10.0093 0 0 0 0 13.3322 0 12.6188 0 0 0 0 13.5828 0 13.4858 0 0 0 0 0 0 0 13.8731 0 0 0 0 0 0 14.092 12.8393 0 0 0 13.9179 12.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1171 0 0 0 0 0 0 0 0 0 0 12.5806 0 13.2416 0 0 0 0 0 0 0 0 0 12.6978 0 0 0 0 0 Q8N543 OGFD1_HUMAN "Prolyl 3-hydroxylase OGFOD1, EC 1.14.11.- (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog) (uS12 prolyl 3-hydroxylase)" OGFOD1 KIAA1612 TPA1 Homo sapiens (Human) cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063] GO:0005506; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0019511; GO:0031418; GO:0031543; GO:0031544; GO:0034063 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543] ECMKLFR 0.98998 -19.341 0 0 0 0 0 0 10.7834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4411 0 0 13.0593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H553 ALG2_HUMAN "Alpha-1,3/1,6-mannosyltransferase ALG2, EC 2.4.1.132, EC 2.4.1.257 (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)" ALG2 UNQ666/PRO1298 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation [GO:0006486]; response to calcium ion [GO:0051592] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein glycosylation [GO:0006486]; response to calcium ion [GO:0051592]" GO:0000033; GO:0004378; GO:0005634; GO:0005737; GO:0005789; GO:0006486; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0046982; GO:0047485; GO:0048306; GO:0048471; GO:0051592; GO:0102704 "alpha-1,3-mannosyltransferase activity [GO:0000033]; calcium-dependent protein binding [GO:0048306]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]" DSFLKRLYR 0.98998 -5.8433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9364 0 0 0 0 9.93097 10.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0857 0 0 0 0 0 0 0 0 0 13.8328 0 0 0 0 0 0 12.031 0 14.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6889 0 0 0 13.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3073 0 0 0 0 0 0 0 11.5174 0 0 0 0 0 12.1336 0 0 11.9229 0 11.1567 12.7368 13.2496 0 0 0 0 0 0 0 14.315 13.4226 0 0 0 Q9P035 HACD3_HUMAN "Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3, EC 4.2.1.134 (3-hydroxyacyl-CoA dehydratase 3, HACD3) (Butyrate-induced protein 1, B-ind1, hB-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1)" HACD3 BIND1 PTPLAD1 Homo sapiens (Human) fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rac protein signal transduction [GO:0016601]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; fatty acid elongation [GO:0030497]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; JNK cascade [GO:0007254]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rac protein signal transduction [GO:0016601]; Rho protein signal transduction [GO:0007266]; small GTPase mediated signal transduction [GO:0007264]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] GO:0005096; GO:0005783; GO:0005925; GO:0007249; GO:0007254; GO:0007264; GO:0007266; GO:0016601; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0031965; GO:0042761; GO:0045070; GO:0046726; GO:0102158; GO:0102343; GO:0102344; GO:0102345 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158] ELYLRVELSDVQNPAISITENVLHFK 0.98998 -5.8425 0 0 0 0 0 0 0 10.0756 0 0 0 0 0 0 0 0 0 0 0 0 11.9457 0 0 0 0 0 0 0 0 0 0 0 13.9668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4323 0 15.2925 13.4704 0 0 0 0 0 0 0 0 0 12.3797 0 0 0 0 13.3088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NKB5 PCX2_HUMAN Pecanex-like protein 2 (Pecanex homolog protein 2) PCNX2 KIAA0435 PCNXL2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DNCSQEKKEEILENEK 0.98999 -19.36 12.075 12.4381 14.0787 0 10.8675 0 13.116 0 9.94882 0 0 0 0 0 14.1215 0 0 0 0 0 12.7223 0 0 13.182 0 0 0 0 0 0 0 0 16.6616 0 0 0 0 0 0 0 0 0 0 0 0 0 13.942 0 12.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8727 0 0 0 0 0 0 10.8813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4678 0 11.814 0 0 0 0 0 0 0 0 0 12.9119 0 0 0 0 0 0 10.99 0 0 0 0 0 0 12.541 0 0 0 0 12.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4433 0 0 0 0 0 0 0 0 0 0 0 0 H3BPM6 MKROS_HUMAN MKRN2 opposite strand protein (MKRN2 antisense RNA 1) (MKRN2 antisense gene protein 1) MKRN2OS C3orf83 MKRN2-AS1 Homo sapiens (Human) FNHCEKYIYSFSVPQCCPLCQQDLGSRK 0.98999 -5.7222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5891 0 0 0 0 0 0 0 0 0 0 0 12.9834 0 0 0 0 0 0 0 0 0 12.8685 0 0 0 0 0 0 15.4448 14.2551 0 0 0 0 0 0 0 0 0 0 0 0 13.5132 0 0 0 14.5912 15.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0585 0 0 0 0 0 0 0 0 14.8019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43293 DAPK3_HUMAN "Death-associated protein kinase 3, DAP kinase 3, EC 2.7.11.1 (DAP-like kinase, Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase, ZIP-kinase)" DAPK3 ZIPK Homo sapiens (Human) "apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-gamma [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of myosin II filament organization [GO:0043519]; regulation of smooth muscle contraction [GO:0006940]; regulation of transcription, DNA-templated [GO:0006355]" GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006355; GO:0006468; GO:0006915; GO:0006940; GO:0007088; GO:0007346; GO:0008140; GO:0008360; GO:0010506; GO:0016605; GO:0017148; GO:0030335; GO:0031267; GO:0035556; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043519; GO:0043522; GO:0046777; GO:0051893; GO:0071346; GO:0090263; GO:0097190; GO:0106310; GO:2000145; GO:2000249 ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] DFIRRLLVK 0.98999 -5.7288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5373 0 0 0 12.3282 0 12.516 0 0 0 11.44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2144 13.1441 0 14.2883 0 14.0613 0 0 12.8273 13.4197 0 0 0 13.0604 13.0612 0 0 12.953 0 0 0 0 17.7782 12.9569 0 12.7877 0 0 0 0 0 13.5271 14.6346 13.4066 11.9176 12.2314 0 0 0 12.8513 14.9064 14.5048 13.1168 13.6155 13.8852 0 11.4951 13.5961 13.4435 0 0 0 13.7786 13.7941 13.9819 14.7422 13.5676 14.1959 0 0 0 0 0 0 0 14.7737 13.5137 0 13.1749 0 0 0 0 0 0 0 13.2437 13.6826 14.1866 14.1448 13.1426 0 0 0 0 0 0 0 0 12.5577 0 0 12.8604 0 0 0 0 12.0575 14.3374 13.4598 0 0 0 0 0 P0C0L5 CO4B_HUMAN Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain ] C4B CO4 CPAMD3; C4B_2 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; detection of molecule of bacterial origin [GO:0032490]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; opsonization [GO:0008228]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]" anchoring junction [GO:0070161]; axon [GO:0030424]; blood microparticle [GO:0072562]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139]; synapse [GO:0045202] "anchoring junction [GO:0070161]; axon [GO:0030424]; blood microparticle [GO:0072562]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139]; synapse [GO:0045202]; carbohydrate binding [GO:0030246]; complement binding [GO:0001848]; endopeptidase inhibitor activity [GO:0004866]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; detection of molecule of bacterial origin [GO:0032490]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; opsonization [GO:0008228]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]" GO:0001848; GO:0004866; GO:0005576; GO:0005601; GO:0005615; GO:0005886; GO:0006954; GO:0006956; GO:0006958; GO:0008228; GO:0030246; GO:0030424; GO:0030425; GO:0032490; GO:0045087; GO:0045202; GO:0050778; GO:0070062; GO:0070161; GO:0072562; GO:0106139; GO:1903028; GO:2000427 carbohydrate binding [GO:0030246]; complement binding [GO:0001848]; endopeptidase inhibitor activity [GO:0004866] ASCRLRLEPGK 0.98999 -5.7246 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5305 0 0 0 0 0 0 0 11.4587 12.3976 11.1595 12.6092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9219 0 0 12.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7474 0 11.0417 0 0 0 0 0 0 13.4039 0 13.8401 13.1475 13.9529 0 0 0 0 0 0 0 0 0 12.9063 0 0 0 0 0 0 0 13.5122 0 14.4905 0 11.4294 0 0 0 12.8287 12.8036 13.3214 13.9881 13.7708 0 11.7063 0 0 13.5361 13.8884 0 0 12.9674 12.3647 0 13.9612 0 13.9509 0 0 0 0 11.5135 0 12.301 14.4502 0 12.1378 12.964 0 0 13.9915 14.2061 14.943 0 0 13.3842 12.7695 13.4751 0 0 0 0 12.4746 0 0 13.709 13.1646 12.1763 0 0 12.0074 0 0 0 0 0 0 0 0 13.9614 0 0 0 13.901 12.8806 13.2939 0 0 0 0 0 0 Q15329 E2F5_HUMAN "Transcription factor E2F5, E2F-5" E2F5 Homo sapiens (Human) cell projection organization [GO:0030030]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell projection organization [GO:0030030]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001216; GO:0001650; GO:0003700; GO:0005654; GO:0005730; GO:0006357; GO:0030030; GO:0043231; GO:0046983; GO:0051726; GO:0090575 "DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ERELDQQK 0.98999 -4.3353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8034 0 0 0 0 14.8044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q32P28 P3H1_HUMAN "Prolyl 3-hydroxylase 1, EC 1.14.11.7 (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1, Leprecan-1)" P3H1 GROS1 LEPRE1 PSEC0109 Homo sapiens (Human) bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of protein secretion [GO:0050708] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of protein secretion [GO:0050708] GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0008285; GO:0010976; GO:0016020; GO:0018126; GO:0019797; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:0070062; GO:1901874 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797] AALRALRLR 0.98999 -19.705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5222 0 0 0 0 0 0 0 0 0 0 0 0 13.9792 0 15.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.993 0 12.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7414 0 0 0 0 0 0 Q5VWP3 MLIP_HUMAN "Muscular LMNA-interacting protein (Cardiac Isl1-interacting protein, CIP) (Muscular-enriched A-type laminin-interacting protein)" MLIP C6orf142 Cip Homo sapiens (Human) negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcolemma [GO:0042383] nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nucleus [GO:0005634]; PML body [GO:0016605]; sarcolemma [GO:0042383]; lamin binding [GO:0005521]; transcription corepressor activity [GO:0003714]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000122; GO:0003714; GO:0005521; GO:0005634; GO:0005635; GO:0010614; GO:0016605; GO:0031981; GO:0042383; GO:0045944; GO:1903243 lamin binding [GO:0005521]; transcription corepressor activity [GO:0003714] ILLKKEEEVYEPNPFSK 0.98999 -5.7178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.372 0 0 13.0376 0 0 13.3904 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6185 0 0 15.9872 0 0 0 0 0 0 0 0 0 0 0 13.0424 0 0 0 0 0 0 0 0 0 0 13.5015 12.6548 0 0 0 0 0 14.409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86U44 MTA70_HUMAN "N6-adenosine-methyltransferase catalytic subunit, EC 2.1.1.348 (Methyltransferase-like protein 3, hMETTL3) (N6-adenosine-methyltransferase 70 kDa subunit, MT-A70)" METTL3 MTA70 Homo sapiens (Human) "adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]" GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006382; GO:0006397; GO:0006402; GO:0006974; GO:0007283; GO:0007623; GO:0008168; GO:0008173; GO:0009048; GO:0016422; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0080009; GO:0098508; GO:1902036; GO:1903679; GO:1904047 methyltransferase activity [GO:0008168]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047] AQVQEFCDYGTKEECMK 0.98999 -4.3364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9022 0 0 0 0 0 0 0 14.2666 0 0 0 14.2356 14.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9995 15.0139 15.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8664 14.1743 0 0 0 0 0 0 0 0 9.70302 14.8206 0 0 0 0 0 0 0 14.6929 0 14.6223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2181 0 14.9044 0 0 0 0 0 0 0 0 0 0 14.692 14.147 0 0 12.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZL2 MAML2_HUMAN "Mastermind-like protein 2, Mam-2" MAML2 KIAA1819 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221] GO:0003713; GO:0005634; GO:0005654; GO:0007219; GO:0007221; GO:0016607; GO:0045944 transcription coactivator activity [GO:0003713] ARIAVCR 0.98999 -19.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9324 0 0 0 0 0 0 0 0 0 0 15.1776 0 0 0 0 0 0 0 12.4699 0 0 0 0 0 0 0 0 0 0 14.452 0 0 0 0 14.4068 0 15.9288 0 13.9691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5F7 NKAP_HUMAN NF-kappa-B-activating protein NKAP Homo sapiens (Human) "granulocyte differentiation [GO:0030851]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; regulation of gene expression [GO:0010468]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; RNA binding [GO:0003723]; granulocyte differentiation [GO:0030851]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; regulation of gene expression [GO:0010468]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]" GO:0000122; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0007219; GO:0010468; GO:0030851; GO:0031490; GO:0033077; GO:0035019; GO:0045892; GO:0046638; GO:0071425 chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; RNA binding [GO:0003723] HKKYSEDSDSDSDSETDSSDEDNK 0.98999 -4.3338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80014 0 0 0 10.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0867 12.7335 0 0 0 0 0 11.3255 0 11.4119 0 0 0 0 0 0 13.3061 0 12.1798 12.4321 0 11.2265 0 0 0 0 0 0 11.7652 15.304 0 13.6603 12.4673 0 12.2926 0 11.0192 11.4282 0 13.7281 0 0 0 14.2419 0 12.7776 0 0 0 13.5252 0 13.6115 0 11.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3985 0 13.4638 0 0 12.4607 0 0 0 0 0 12.4668 0 0 0 0 0 0 11.4931 0 11.1173 0 0 0 0 0 11.3449 0 0 0 11.4162 10.302 0 0 0 0 Q8TAD8 SNIP1_HUMAN Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1) SNIP1 Homo sapiens (Human) "I-kappaB kinase/NF-kappaB signaling [GO:0007249]; miRNA processing [GO:0035196]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription by RNA polymerase II [GO:0006357]; U2-type prespliceosome assembly [GO:1903241]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; miRNA processing [GO:0035196]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription by RNA polymerase II [GO:0006357]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005686; GO:0005829; GO:0006357; GO:0007249; GO:0035196; GO:0071005; GO:1903241 mRNA binding [GO:0003729]; RNA binding [GO:0003723] DDEDEEEEEEVSDS 0.98999 -19.387 0 0 0 0 0 0 0 0 11.6561 0 0 11.9043 9.54603 0 0 0 11.0395 0 0 0 0 0 11.0032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6879 0 0 0 11.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1422 0 0 0 0 0 10.9471 0 0 0 0 0 0 0 0 0 11.6996 Q9NPA0 EMC7_HUMAN ER membrane protein complex subunit 7 EMC7 C11orf3 C15orf24 HT022 UNQ905/PRO1926 Homo sapiens (Human) protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021] EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005789; GO:0016021; GO:0030176; GO:0030246; GO:0045050; GO:0071816; GO:0072546 carbohydrate binding [GO:0030246] AVVPGVK 0.98999 -20.068 0 0 0 0 0 0 10.0404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4679 0 11.7484 0 0 0 0 0 0 0 0 0 12.4352 0 0 0 0 0 0 0 0 0 0 10.9495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSE2 CISH_HUMAN "Cytokine-inducible SH2-containing protein, CIS (CIS-1) (Protein G18) (Suppressor of cytokine signaling, SOCS)" CISH G18 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005829; GO:0005886; GO:0005942; GO:0007205; GO:0009968; GO:0016567; GO:0035556; GO:0046854; GO:0046935 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935] LVADVDCLPLPRR 0.98999 -19.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2VCK2 DCD2B_HUMAN Doublecortin domain-containing protein 2B DCDC2B Homo sapiens (Human) intracellular signal transduction [GO:0035556] microtubule [GO:0005874]; microtubule organizing center [GO:0005815] microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; intracellular signal transduction [GO:0035556] GO:0005815; GO:0005874; GO:0035556 LHYLPHR 0.99 -5.7364 11.5028 0 0 13.2024 13.5078 12.8265 12.6516 0 0 0 0 0 0 0 0 0 0 17.8749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1738 0 0 0 0 19.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5627 0 0 0 0 0 0 0 19.517 0 0 0 14.3184 0 0 0 14.7821 19.1747 0 19.3028 0 0 0 0 0 0 19.1338 0 14.0897 0 0 0 13.8872 0 19.2197 0 0 0 0 16.4532 0 0 14.4795 0 0 0 14.3718 0 0 0 0 0 19.2582 19.6275 13.9126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4448 0 14.2738 14.0548 0 0 0 0 0 A8MQ14 ZN850_HUMAN Zinc finger protein 850 ZNF850 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRCPSQLSQHK 0.99 -4.3383 0 0 0 0 0 0 0 0 0 0 11.0622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4769 0 0 0 0 10.3103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1163 12.2022 0 0 0 0 0 0 0 0 0 12.9317 16.0967 0 0 0 0 0 0 0 0 13.2582 0 0 0 0 0 0 0 0 0 0 0 13.9589 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2245 0 11.0075 0 14.1282 0 0 0 0 0 0 13.4493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7766 12.1068 0 0 0 0 0 0 0 0 13.2129 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6 0 0 0 0 0 0 0 0 0 0 O95271 TNKS1_HUMAN "Poly [ADP-ribose] polymerase tankyrase-1, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 5, ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1, EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1, TANK1)" TNKS PARP5A PARPL TIN1 TINF1 TNKS1 Homo sapiens (Human) "cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]" GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0007052; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0018105; GO:0018107; GO:0031965; GO:0032210; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051225; GO:0051301; GO:0051973; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:1904355; GO:1904357; GO:1904743; GO:1904908; GO:1990404 histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; zinc ion binding [GO:0008270] AVLTGEYK 0.99 -19.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0231 0 0 0 12.9789 13.5765 0 0 14.1565 0 0 12.4012 13.4111 13.8078 11.4707 0 13.314 14.7777 0 13.6865 0 0 0 0 0 0 11.0883 0 0 0 0 0 14.0709 0 13.0245 11.9712 14.8305 14.8006 0 0 15.597 0 12.5743 12.9078 0 0 0 0 0 14.0279 14.5191 14.275 0 13.1407 0 0 0 13.9343 0 0 0 0 14.1708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43026 GDF5_HUMAN "Growth/differentiation factor 5, GDF-5 (Bone morphogenetic protein 14, BMP-14) (Cartilage-derived morphogenetic protein 1, CDMP-1) (Lipopolysaccharide-associated protein 4, LAP-4, LPS-associated protein 4) (Radotermin)" GDF5 BMP14 CDMP1 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; chondrocyte differentiation [GO:0002062]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; chondrocyte differentiation [GO:0002062]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0002062; GO:0005125; GO:0005576; GO:0005615; GO:0005886; GO:0007179; GO:0007267; GO:0008083; GO:0009612; GO:0010862; GO:0030326; GO:0030509; GO:0030513; GO:0032331; GO:0032332; GO:0035136; GO:0035137; GO:0036122; GO:0040014; GO:0042802; GO:0043524; GO:0043932; GO:0045666; GO:0050680; GO:0060390; GO:0060395; GO:0060591; GO:0097152; GO:2001054 BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802] AGSVPSSFLLK 0.99 -19.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2942 0 0 13.117 0 0 0 0 0 0 0 14.8136 0 13.3565 0 0 0 0 12.1534 0 0 0 0 14.763 13.0277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5191 0 0 0 0 14.0204 11.4937 0 0 13.277 0 13.576 0 0 0 0 0 0 13.8801 0 13.2556 14.7521 15.1032 0 17.9625 13.0927 14.8105 0 13.3355 0 15.7292 0 0 0 0 12.8516 0 0 16.6226 0 0 13.0369 0 0 0 0 0 0 0 13.6722 12.9861 0 0 17.0793 0 0 0 13.6388 12.9362 13.1968 0 0 0 0 0 0 0 0 0 0 0 12.7755 13.0103 0 13.2959 0 0 16.8017 12.7529 0 14.4031 0 0 0 12.7686 0 0 0 11.9407 0 13.1436 0 18.2059 0 0 0 0 0 0 0 0 0 13.4387 0 11.3344 0 14.9287 0 0 0 0 12.3099 0 Q14524 SCN5A_HUMAN Sodium channel protein type 5 subunit alpha (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5) (hH1) SCN5A Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell communication [GO:0086067]; brainstem development [GO:0003360]; bundle of His cell action potential [GO:0086043]; cardiac conduction system development [GO:0003161]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cerebellum development [GO:0021549]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of action potential [GO:0045760]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; SA node cell action potential [GO:0086015]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]; ventricular cardiac muscle cell action potential [GO:0086005] caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018] caveola [GO:0005901]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; nitric-oxide synthase binding [GO:0050998]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in AV node cell action potential [GO:0086060]; voltage-gated sodium channel activity involved in bundle of His cell action potential [GO:0086061]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; voltage-gated sodium channel activity involved in SA node cell action potential [GO:0086063]; atrial cardiac muscle cell action potential [GO:0086014]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell communication [GO:0086067]; brainstem development [GO:0003360]; bundle of His cell action potential [GO:0086043]; cardiac conduction system development [GO:0003161]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cardiac ventricle development [GO:0003231]; cellular response to calcium ion [GO:0071277]; cerebellum development [GO:0021549]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of action potential [GO:0045760]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; SA node cell action potential [GO:0086015]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; telencephalon development [GO:0021537]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0001518; GO:0002027; GO:0003161; GO:0003231; GO:0003360; GO:0005244; GO:0005248; GO:0005516; GO:0005654; GO:0005730; GO:0005783; GO:0005886; GO:0005901; GO:0006814; GO:0009986; GO:0010765; GO:0014704; GO:0014894; GO:0016021; GO:0016328; GO:0017134; GO:0019228; GO:0019899; GO:0019901; GO:0019904; GO:0021537; GO:0021549; GO:0030018; GO:0030315; GO:0030506; GO:0031625; GO:0035725; GO:0042383; GO:0042475; GO:0044325; GO:0045760; GO:0048471; GO:0050679; GO:0050998; GO:0051899; GO:0060048; GO:0060307; GO:0060371; GO:0060372; GO:0060373; GO:0071277; GO:0086002; GO:0086004; GO:0086005; GO:0086006; GO:0086010; GO:0086012; GO:0086014; GO:0086015; GO:0086016; GO:0086043; GO:0086045; GO:0086046; GO:0086047; GO:0086048; GO:0086060; GO:0086061; GO:0086062; GO:0086063; GO:0086067; GO:0086091; GO:0097110; GO:0098912; GO:1902305 ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; nitric-oxide synthase binding [GO:0050998]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in AV node cell action potential [GO:0086060]; voltage-gated sodium channel activity involved in bundle of His cell action potential [GO:0086061]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; voltage-gated sodium channel activity involved in SA node cell action potential [GO:0086063] AFRRHLLQR 0.99 -19.427 0 0 0 0 0 0 0 0 0 13.5932 14.6881 0 0 0 0 0 13.8444 0 0 10.7517 0 0 0 0 0 0 0 0 12.7937 0 0 0 0 0 0 0 0 12.8998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5289 0 0 0 0 0 0 0 0 0 0 12.5076 0 14.8703 13.9501 0 0 14.1626 14.9954 0 0 0 13.7888 14.3506 0 13.5099 0 11.5483 13.9222 0 12.3503 0 0 0 12.9474 0 0 0 0 14.1328 0 0 0 13.2518 14.6717 0 0 0 0 14.3862 12.8053 13.6616 0 0 0 0 13.8477 0 0 0 0 0 14.5737 0 0 13.327 0 0 13.431 0 0 11.0801 0 0 14.3041 0 0 0 0 0 13.3089 0 0 0 0 10.6722 0 11.9543 0 0 0 0 11.2584 0 0 0 0 0 0 12.6503 0 0 0 0 0 0 0 0 0 11.3585 0 Q14721 KCNB1_HUMAN "Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1, DRK1, h-DRK1) (Voltage-gated potassium channel subunit Kv2.1)" KCNB1 Homo sapiens (Human) action potential [GO:0001508]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; clustering of voltage-gated potassium channels [GO:0045163]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; response to axon injury [GO:0048678]; response to L-glutamate [GO:1902065]; vesicle docking involved in exocytosis [GO:0006904] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proximal dendrite [GO:1990635]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proximal dendrite [GO:1990635]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; clustering of voltage-gated potassium channels [GO:0045163]; glucose homeostasis [GO:0042593]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of insulin secretion [GO:0046676]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of protein targeting to membrane [GO:0090314]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of action potential [GO:0098900]; regulation of ion transmembrane transport [GO:0034765]; regulation of motor neuron apoptotic process [GO:2000671]; response to axon injury [GO:0048678]; response to L-glutamate [GO:1902065]; vesicle docking involved in exocytosis [GO:0006904] GO:0000149; GO:0001508; GO:0005249; GO:0005251; GO:0005783; GO:0005886; GO:0006904; GO:0007215; GO:0008076; GO:0009986; GO:0010701; GO:0015271; GO:0016021; GO:0016324; GO:0016328; GO:0030424; GO:0030425; GO:0031669; GO:0032590; GO:0032809; GO:0033605; GO:0034765; GO:0042383; GO:0042593; GO:0043204; GO:0044325; GO:0045163; GO:0045211; GO:0045956; GO:0046676; GO:0046982; GO:0047485; GO:0048471; GO:0048678; GO:0051260; GO:0070161; GO:0071277; GO:0071333; GO:0071805; GO:0072659; GO:0090314; GO:0097623; GO:0098900; GO:1900454; GO:1902065; GO:1990635; GO:2000671 delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] DEDDTKFK 0.99 -19.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7855 0 0 0 0 0 12.5219 12.1267 11.6743 0 13.4939 0 0 13.1866 0 0 0 0 12.9519 0 0 12.5662 11.2889 0 0 13.7266 0 11.1846 11.0434 0 0 0 0 0 0 0 0 0 0 0 0 12.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4088 0 0 0 0 13.0763 12.4402 12.3753 0 0 0 0 13.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15645 PCH2_HUMAN "Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein, 16E1-BP, HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13, TR-interacting protein 13, TRIP-13)" TRIP13 PCH2 Homo sapiens (Human) double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; transcription by RNA polymerase II [GO:0006366] chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint signaling [GO:0051598]; mitotic spindle assembly checkpoint signaling [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; transcription by RNA polymerase II [GO:0006366] GO:0001556; GO:0001673; GO:0003712; GO:0005524; GO:0005634; GO:0005694; GO:0006302; GO:0006366; GO:0007094; GO:0007130; GO:0007131; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0016887; GO:0042802; GO:0048477; GO:0051598 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; transcription coregulator activity [GO:0003712] ALAQKLTIRLSSR 0.99 -4.3422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0X2 SPG16_HUMAN Sperm-associated antigen 16 protein (Pf20 protein homolog) SPAG16 PF20 Homo sapiens (Human) axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288] axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126] axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288] GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716 DFHRMHHK 0.99 -19.456 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3051 15.9745 0 0 12.7499 0 0 0 10.9644 14.9313 14.8814 0 0 0 0 0 0 0 0 0 0 0 0 12.9441 0 0 0 0 0 0 0 0 0 0 0 0 12.4276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8T0 AKTIP_HUMAN AKT-interacting protein (Ft1) (Fused toes protein homolog) AKTIP FTS Homo sapiens (Human) apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] GO:0000209; GO:0001934; GO:0005634; GO:0005829; GO:0005886; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0032092; GO:0045022; GO:0061631; GO:0070695; GO:1905719 ubiquitin conjugating enzyme activity [GO:0061631] EKMLTQK 0.99 -19.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8382 0 12.3686 0 12.6076 0 0 12.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6745 0 0 12.7262 0 0 0 0 12.4363 0 12.0273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1077 0 0 0 13.6541 0 13.364 13.4232 14.9096 13.5155 0 0 0 0 0 0 0 14.1481 0 0 13.8002 0 13.5695 0 0 13.445 0 14.4973 0 0 0 0 0 0 0 14.5913 0 0 0 0 0 14.143 0 14.6189 0 14.0715 0 0 14.3691 0 0 0 0 0 0 0 0 13.9027 0 14.349 14.5256 0 0 0 14.1343 0 0 0 0 0 0 0 0 13.9171 0 15.3851 13.9179 0 0 0 0 14.0942 13.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6411 14.0202 0 0 0 0 0 Q9NVM6 DJC17_HUMAN DnaJ homolog subfamily C member 17 DNAJC17 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; spliceosomal complex disassembly [GO:0000390]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681] cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; spliceosomal complex disassembly [GO:0000390]; toxin transport [GO:1901998] GO:0000122; GO:0000390; GO:0003723; GO:0005681; GO:0005737; GO:1901998 RNA binding [GO:0003723] DVLLRLLQK 0.99 -19.43 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7768 0 0 0 0 0 0 10.1744 0 0 0 12.0969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4644 0 12.8232 0 0 0 0 18.6437 0 0 0 0 0 0 0 0 0 0 0 0 13.9224 0 0 0 12.982 0 0 0 0 12.6131 0 11.6709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RN3 FA98C_HUMAN Protein FAM98C FAM98C Homo sapiens (Human) tRNA-splicing ligase complex [GO:0072669] tRNA-splicing ligase complex [GO:0072669] GO:0072669 ADLSCLVPATSVAVRRGTCCAINK 0.99001 -5.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4723 0 0 0 0 12.8312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6414 0 0 0 0 0 0 0 0 0 12.3 0 0 14.6117 0 0 0 0 0 0 12.4764 0 0 14.0455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4504 0 0 0 0 13.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N987 NECA1_HUMAN "N-terminal EF-hand calcium-binding protein 1, EF-hand calcium-binding protein 1 (Neuronal calcium-binding protein 1)" NECAB1 EFCBP1 Homo sapiens (Human) blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984] GO:0001835; GO:0005509; GO:0005654; GO:0005737; GO:0005829; GO:0042802; GO:0042984 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] AMGKTKK 0.99001 -19.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2512 0 0 0 0 0 0 12.9459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6585 Q96JZ2 HSH2D_HUMAN "Hematopoietic SH2 domain-containing protein, Hematopoietic SH2 protein (Adaptor in lymphocytes of unknown function X)" HSH2D ALX Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; signal transduction [GO:0007165] GO:0005634; GO:0005737; GO:0007165 ALSSQESK 0.99001 -5.7658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7001 0 0 0 0 0 0 0 0 0 0 0 0 12.4989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.056 12.745 0 0 0 0 10.9431 15.0339 0 0 0 0 0 0 0 15.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.896 0 0 13.2277 0 0 0 0 0 13.4134 0 0 0 0 0 0 0 0 12.7469 0 0 0 13.429 0 0 0 0 0 0 0 13.2129 0 13.0758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0448 0 Q9H1X1 RSPH9_HUMAN Radial spoke head protein 9 homolog RSPH9 C6orf206 MRPS18AL1 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; kinocilium [GO:0060091]; motile cilium [GO:0031514] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458]; radial spoke assembly [GO:0062177] GO:0003341; GO:0005930; GO:0031514; GO:0035082; GO:0044458; GO:0060091; GO:0060294; GO:0062177; GO:0097729; GO:1904158 ASLLTSLMLVKR 0.99001 -5.7538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4991 0 Q9HAQ2 KIF9_HUMAN Kinesin-like protein KIF9 KIF9 Homo sapiens (Human) extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; sperm flagellum [GO:0036126]; vesicle [GO:0031982] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; sperm flagellum [GO:0036126]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801] GO:0002102; GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0036126; GO:0042802; GO:0071801; GO:1901317; GO:1903008 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ALQQVFRMIEERPTHAITVR 0.99001 -19.508 0 0 0 0 0 0 0 0 0 10.524 0 11.2553 0 0 0 0 0 0 0 0 0 0 9.70732 12.7919 0 0 0 0 0 10.6218 11.8267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0829 0 0 0 0 13.7176 0 0 13.0981 0 12.3603 0 0 12.1909 0 0 0 12.6905 0 11.9118 11.85 0 15.0472 16.9517 13.603 0 0 0 17.5124 0 0 0 0 0 0 0 0 0 15.0225 0 0 0 0 0 0 0 0 0 13.2945 0 0 0 0 0 14.6708 14.0831 12.9555 0 0 13.7695 0 0 0 0 0 0 0 13.0687 14.1223 0 0 13.5164 0 0 0 0 16.0716 14.0736 13.9545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKJ3 GPTC8_HUMAN G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723] AEPSISYSCNPLYFDFK 0.99001 -19.559 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1952 0 0 0 0 0 0 0 0 11.6472 12.2469 11.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6782 11.9371 0 0 0 0 10.5119 0 0 15.1092 10.9959 15.8458 0 0 0 13.556 0 12.8695 12.632 13.1305 0 0 0 0 0 0 0 0 0 0 13.1165 0 0 0 13.0891 0 14.3006 15.4677 13.5386 13.8891 13.0584 13.4581 13.9035 13.9421 13.2279 16.9161 0 14.0411 11.9182 11.995 12.9793 14.5627 14.2858 13.6428 19.3694 0 0 13.8361 13.368 14.7387 0 13.1739 0 12.9342 0 0 11.4023 13.2711 0 0 15.9841 0 0 0 15.2155 0 0 0 0 0 19.1047 11.0149 0 0 0 0 0 0 0 15.9917 12.8422 13.8629 13.0837 0 15.4607 0 0 12.2748 0 11.2551 0 12.5515 0 0 0 14.371 0 14.4193 13.5025 15.5344 0 11.3055 13.1522 0 14.2312 13.7028 0 0 0 13.0735 15.9215 13.8071 0 0 14.742 0 13.8755 0 0 0 15.2707 0 13.0466 15.084 0 Q6NX45 ZN774_HUMAN Zinc finger protein 774 ZNF774 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNDCGESFSQSSDLIK 0.99002 -5.7661 0 0 0 0 0 0 11.0362 0 0 0 0 0 0 0 0 0 0 11.5276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.526 0 0 0 0 0 0 0 10.9392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.163 0 0 0 0 0 0 0 0 0 0 0 11.7808 0 0 0 0 0 0 0 0 0 0 0 13.0397 0 0 13.8659 0 0 0 12.9073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6212 12.0676 0 0 0 0 0 0 0 11.9364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P6B1 ERIC5_HUMAN Glutamate-rich protein 5 ERICH5 C8orf47 Homo sapiens (Human) EDAPAAEGKKK 0.99002 -5.6371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY77 PDIP3_HUMAN "Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein, p46) (S6K1 Aly/REF-like target, SKAR)" POLDIP3 KIAA1649 PDIP46 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727 mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723] ARLVHPGVAEVVFVK 0.99002 -19.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82404 0 0 10.5298 12.8921 0 0 0 0 0 0 A4GXA9 EME2_HUMAN "Probable crossover junction endonuclease EME2, EC 3.1.22.-" EME2 Homo sapiens (Human) double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596] endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000712; GO:0003677; GO:0004519; GO:0006302; GO:0031297; GO:0031573; GO:0043596; GO:0048476; GO:1905347 DNA binding [GO:0003677]; endonuclease activity [GO:0004519] AAAEALRLLRPEQVLK 0.99003 -5.6598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5739 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9304 0 0 12.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1688 0 0 0 0 0 13.5489 0 0 0 13.7095 13.6641 0 0 0 0 0 0 0 0 0 0 0 0 O75390 CISY_HUMAN "Citrate synthase, mitochondrial, EC 2.3.3.1 (Citrate (Si)-synthase)" CS Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099] GO:0003723; GO:0004108; GO:0005634; GO:0005739; GO:0005759; GO:0005975; GO:0006099; GO:0006101; GO:0070062 citrate (Si)-synthase activity [GO:0004108]; RNA binding [GO:0003723] AYAQGISRTKYWELIYEDSMDLIAK 0.99003 -19.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1671 0 0 0 0 0 0 0 0 0 0 0 12.7292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9399 0 14.4249 14.6131 13.5066 13.9201 0 0 0 0 0 0 13.1251 0 13.0449 0 0 13.4603 13.0066 0 0 0 15.4421 13.7425 0 0 0 0 10.5882 13.0087 0 0 0 0 0 0 0 0 0 12.6506 0 12.6029 0 0 0 0 0 0 12.4171 0 0 13.4391 0 0 0 0 12.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0873 0 11.7417 13.4206 0 0 0 0 0 0 P42768 WASP_HUMAN "Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein, WASp)" WAS IMD2 Homo sapiens (Human) actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110] GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146; GO:2000601 actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] AIHSSDEGEDQAGDEDEDDEWDD 0.99003 -19.322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0171 0 0 0 0 0 0 13.792 0 12.2743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9965 0 0 15.7043 0 11.7403 0 0 12.7016 0 0 14.4798 0 0 0 0 0 12.8542 0 0 0 0 0 0 0 0 0 12.7927 13.4477 0 11.9146 0 11.7253 0 0 0 0 0 0 0 15.1997 0 0 13.2721 0 0 0 15.3693 0 0 13.9413 0 0 0 0 0 12.6372 0 0 0 0 0 0 15.483 14.1741 12.9187 0 0 0 0 0 0 0 13.0539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9059 12.2376 11.3059 0 0 12.8409 0 0 0 0 0 0 Q6EKJ0 GTD2B_HUMAN "General transcription factor II-I repeat domain-containing protein 2B, GTF2I repeat domain-containing protein 2B (Transcription factor GTF2IRD2-beta)" GTF2IRD2B Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" GO:0000981; GO:0003677; GO:0005634; GO:0005654 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" DSQWDSVLHIAT 0.99003 -19.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7669 11.8969 15.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.763 0 0 11.0381 0 0 0 0 0 0 0 12.8987 0 0 0 0 12.4197 13.3902 0 13.1346 0 14.1494 12.6792 14.0639 0 0 12.2702 9.33943 0 0 0 11.2323 0 0 0 0 0 0 0 14.6287 0 0 13.3652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7371 0 0 0 0 0 13.4257 0 0 0 0 0 0 0 0 0 0 10.8517 0 0 0 9.81336 0 13.4987 0 0 0 0 0 15.3401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9407 0 0 0 0 0 10.1233 Q9NZZ3 CHMP5_HUMAN "Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2) (Vacuolar protein sorting-associated protein 60, Vps60, hVps60)" CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding [GO:0046755]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding [GO:0046755]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000421; GO:0000776; GO:0001778; GO:0001919; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0010824; GO:0015031; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0043162; GO:0045296; GO:0046755; GO:0046761; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071222; GO:0071225; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904903; GO:1904930 cadherin binding [GO:0045296] ALRVLKQK 0.99003 -19.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00270 GPR31_HUMAN "12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor, 12-(S)-HETE receptor, 12-HETER (G-protein coupled receptor 31) (GPR31/12-HETER)" GPR31 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of inflammatory response [GO:0050728]; positive regulation of immune response [GO:0050778]; response to acidic pH [GO:0010447]; response to ischemia [GO:0002931]; response to molecule of bacterial origin [GO:0002237] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; arachidonic acid binding [GO:0050544]; bioactive lipid receptor activity [GO:0045125]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of inflammatory response [GO:0050728]; positive regulation of immune response [GO:0050778]; response to acidic pH [GO:0010447]; response to ischemia [GO:0002931]; response to molecule of bacterial origin [GO:0002237] GO:0002237; GO:0002931; GO:0004930; GO:0005886; GO:0005887; GO:0006629; GO:0007186; GO:0010447; GO:0045125; GO:0050544; GO:0050728; GO:0050778 arachidonic acid binding [GO:0050544]; bioactive lipid receptor activity [GO:0045125]; G protein-coupled receptor activity [GO:0004930] VFHTLRGK 0.99004 -19.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6732 0 0 0 0 0 12.6435 0 13.4893 13.4388 0 0 0 0 0 0 0 0 0 0 12.3681 0 0 0 0 0 0 0 13.3346 0 0 0 0 11.6441 0 0 0 0 0 0 0 0 11.8461 0 0 0 0 0 10.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60645 EXOC3_HUMAN Exocyst complex component 3 (Exocyst complex component Sec6) EXOC3 SEC6 SEC6L1 Homo sapiens (Human) exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667] cytosol [GO:0005829]; exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; cadherin binding [GO:0045296]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000149; GO:0000281; GO:0005794; GO:0005829; GO:0006887; GO:0006904; GO:0015031; GO:0030426; GO:0030496; GO:0030667; GO:0042734; GO:0045296; GO:0048471; GO:0051601; GO:0090148; GO:0090522 cadherin binding [GO:0045296]; SNARE binding [GO:0000149] DIVVPSLNVAKLLK 0.99004 -19.715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.066 0 0 0 0 0 0 0 0 14.0107 0 0 0 0 14.6623 0 0 0 0 0 15.9605 0 0 0 0 0 0 0 0 0 15.0157 0 0 0 15.1311 0 0 0 0 0 0 0 0 11.6157 0 0 0 0 0 13.4255 0 0 0 0 11.3034 11.075 0 0 0 0 0 0 0 0 0 0 0 0 14.0816 0 15.1702 0 0 0 0 0 0 0 0 0 14.931 0 0 0 0 15.1718 0 0 0 0 0 0 0 19.0518 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6067 12.577 0 0 0 15.3237 0 P32926 DSG3_HUMAN "Desmoglein-3 (130 kDa pemphigus vulgaris antigen, PVA) (Cadherin family member 6)" DSG3 CDHF6 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0001533; GO:0005509; GO:0005829; GO:0005886; GO:0005911; GO:0007156; GO:0016021; GO:0030057; GO:0070062; GO:0098609 calcium ion binding [GO:0005509] EQASSYR 0.99004 -19.387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0433 15.1588 14.7986 12.2037 14.7753 0 15.2831 14.5628 0 0 15.335 11.528 0 14.5052 0 10.7098 13.7668 0 0 0 9.78467 0 14.2272 13.5791 0 10.8497 14.2027 14.8639 16.0942 15.6876 15.9801 0 13.8205 14.243 0 0 14.2053 0 16.3403 0 13.9878 14.1961 14.1848 14.0119 0 0 0 13.7856 13.9629 0 12.1598 0 13.6479 0 0 0 0 0 0 0 0 0 0 0 14.3009 0 0 0 0 14.8524 0 0 0 0 0 0 12.9699 14.1279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35498 SCN1A_HUMAN Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) SCN1A NAC1 SCN1 Homo sapiens (Human) adult walking behavior [GO:0007628]; cardiac muscle cell action potential involved in contraction [GO:0086002]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of localization in cell [GO:0051649]; membrane depolarization during action potential [GO:0086010]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; axon initial segment [GO:0043194]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018] axon [GO:0030424]; axon initial segment [GO:0043194]; intercalated disc [GO:0014704]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; adult walking behavior [GO:0007628]; cardiac muscle cell action potential involved in contraction [GO:0086002]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of localization in cell [GO:0051649]; membrane depolarization during action potential [GO:0086010]; neuromuscular process controlling posture [GO:0050884]; neuronal action potential [GO:0019228]; neuronal action potential propagation [GO:0019227]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0005654; GO:0005886; GO:0006814; GO:0007628; GO:0014704; GO:0016604; GO:0019227; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0033268; GO:0034765; GO:0035725; GO:0043025; GO:0043194; GO:0050884; GO:0050966; GO:0051649; GO:0086002; GO:0086010 voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] AKDVGSENDFADDEHSTFEDNESR 0.99004 -20.085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6644 0 0 0 0 0 0 0 14.2555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.707 0 0 0 0 0 0 0 0 0 0 0 0 14.202 0 0 0 0 0 0 13.3824 0 0 11.1326 0 12.603 11.0303 13.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9497 0 0 0 0 12.6071 0 0 0 P37288 V1AR_HUMAN "Vasopressin V1a receptor, V1aR (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor)" AVPR1A AVPR1 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; blood circulation [GO:0008015]; calcium-mediated signaling [GO:0019722]; cellular response to water deprivation [GO:0042631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; multicellular organism aging [GO:0010259]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537]; transport across blood-brain barrier [GO:0150104] endocytic vesicle [GO:0030139]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endocytic vesicle [GO:0030139]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000]; activation of phospholipase C activity [GO:0007202]; blood circulation [GO:0008015]; calcium-mediated signaling [GO:0019722]; cellular response to water deprivation [GO:0042631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; multicellular organism aging [GO:0010259]; myotube differentiation [GO:0014902]; negative regulation of female receptivity [GO:0007621]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of heart rate [GO:0010460]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to corticosterone [GO:0051412]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]; telencephalon development [GO:0021537]; transport across blood-brain barrier [GO:0150104] GO:0001992; GO:0002125; GO:0003084; GO:0004930; GO:0005000; GO:0005080; GO:0005768; GO:0005886; GO:0005887; GO:0006091; GO:0007186; GO:0007202; GO:0007204; GO:0007621; GO:0007625; GO:0008015; GO:0008284; GO:0010259; GO:0010460; GO:0014049; GO:0014902; GO:0017046; GO:0019722; GO:0021537; GO:0030139; GO:0030307; GO:0031394; GO:0031894; GO:0032849; GO:0035176; GO:0035815; GO:0042277; GO:0042631; GO:0042711; GO:0042713; GO:0043084; GO:0045907; GO:0051412; GO:0051970; GO:0150104 G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; V1A vasopressin receptor binding [GO:0031894]; vasopressin receptor activity [GO:0005000] GPDWLCR 0.99004 -19.371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4361 0 14.1112 0 0 0 14.2064 13.9762 0 12.7066 14.0998 14.6291 0 12.7468 0 12.8199 12.6387 0 11.1347 11.2456 0 0 0 0 13.9865 11.7571 10.9931 0 0 14.2344 0 0 0 0 0 0 0 0 0 0 0 0 11.784 0 0 0 0 13.7836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6749 0 13.8736 0 0 0 0 0 0 0 10.1749 0 0 0 0 0 0 13.3934 0 0 0 0 0 0 0 0 0 0 0 0 Q14156 EFR3A_HUMAN Protein EFR3 homolog A (Protein EFR3-like) EFR3A KIAA0143 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005829; GO:0005886; GO:0046854; GO:0072659 AIDTSGMEEQEK 0.99004 -20.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0508 12.7377 0 0 10.5954 0 0 0 0 0 10.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1046 0 11.7837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5623 0 0 0 15.2592 0 0 0 0 0 0 13.5366 13.7408 0 0 14.1293 16.0874 13.4171 0 0 0 0 12.8408 11.0353 0 0 15.2861 13.9962 12.6842 13.0514 13.2293 13.6095 12.4572 0 0 13.2326 13.1331 0 12.7152 0 0 0 12.2068 0 0 0 0 13.4587 13.9542 12.8567 13.0661 13.1862 13.1083 12.9218 0 13.1262 0 13.4366 0 13.1619 0 0 11.6193 14.1209 0 12.7275 14.9513 12.9904 0 0 0 0 0 0 12.8948 0 13.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8768 0 0 0 0 0 0 Q5XXA6 ANO1_HUMAN Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2) ANO1 DOG1 ORAOV2 TAOS2 TMEM16A Homo sapiens (Human) cation transport [GO:0006812]; cellular response to heat [GO:0034605]; cellular response to peptide [GO:1901653]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; glial cell projection elongation [GO:0106091]; iodide transport [GO:0015705]; ion transmembrane transport [GO:0034220]; mucus secretion [GO:0070254]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; protein localization to membrane [GO:0072657]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated chloride channel activity [GO:0005247]; cation transport [GO:0006812]; cellular response to heat [GO:0034605]; cellular response to peptide [GO:1901653]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; glial cell projection elongation [GO:0106091]; iodide transport [GO:0015705]; ion transmembrane transport [GO:0034220]; mucus secretion [GO:0070254]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; protein localization to membrane [GO:0072657]; transmembrane transport [GO:0055085] GO:0005102; GO:0005227; GO:0005229; GO:0005247; GO:0005254; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006821; GO:0007200; GO:0015111; GO:0015705; GO:0016324; GO:0034220; GO:0034605; GO:0034707; GO:0035774; GO:0042802; GO:0042803; GO:0045121; GO:0046872; GO:0050965; GO:0055085; GO:0070062; GO:0070254; GO:0072657; GO:0106091; GO:1901653; GO:1902476 calcium activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; identical protein binding [GO:0042802]; intracellular calcium activated chloride channel activity [GO:0005229]; iodide transmembrane transporter activity [GO:0015111]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; voltage-gated chloride channel activity [GO:0005247] EKVLMVELFMR 0.99004 -19.72 0 0 0 0 0 0 12.7502 12.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0165 0 0 0 13.2085 0 0 0 0 0 0 0 12.4264 0 11.4662 0 0 12.688 0 0 0 0 12.1814 0 0 0 0 13.1267 0 0 0 0 0 0 0 0 11.3971 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6299 0 0 0 0 0 0 0 0 0 0 0 11.855 13.0898 0 0 0 15.0648 0 15.0499 16.1087 0 0 17.4021 0 0 0 0 0 0 14.2891 0 0 0 0 0 0 0 13.5169 0 0 0 14.5381 0 0 12.3239 0 14.4103 13.802 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6991 0 0 15.4085 0 0 0 0 0 13.9421 0 15.4418 0 0 0 0 0 0 0 13.5626 0 0 0 12.6947 0 0 0 11.5788 13.9119 0 12.5333 12.6675 0 0 12.7544 0 0 0 0 14.6567 0 0 12.8534 Q6V1P9 PCD23_HUMAN Protocadherin-23 (Cadherin-27) (Cadherin-like protein CDHJ) (Cadherin-like protein VR8) (Protein dachsous homolog 2) (Protocadherin PCDHJ) DCHS2 CDH27 CDHJ PCDH23 PCDHJ Homo sapiens (Human) condensed mesenchymal cell proliferation [GO:0072137]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nephron development [GO:0072006] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; condensed mesenchymal cell proliferation [GO:0072137]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nephron development [GO:0072006] GO:0005509; GO:0005886; GO:0007156; GO:0016021; GO:0072006; GO:0072137 calcium ion binding [GO:0005509] APVGKLLLLPGR 0.99004 -19.693 0 0 0 0 0 0 11.0033 11.7819 11.9226 13.9601 12.7162 11.9982 10.8563 12.0535 0 0 13.0669 11.1134 0 0 0 0 12.4942 0 0 0 0 0 0 0 0 0 11.6668 12.4949 11.6858 12.0998 13.8615 0 11.6748 10.8894 12.1793 0 0 10.7355 11.5988 0 0 13.5071 0 0 0 0 0 0 0 10.2642 0 0 0 0 0 0 0 0 0 0 0 0 14.3975 11.8979 0 0 0 0 0 13.9209 11.7029 0 0 11.9212 16.0022 0 15.7427 13.5058 15.1195 0 15.1353 0 14.1218 0 14.2499 0 0 0 0 13.5716 14.7332 0 15.1618 14.3543 0 12.8309 11.7081 14.77 13.3119 13.1555 0 14.2917 0 0 14.5386 13.3869 0 0 0 0 0 0 0 14.2145 12.0723 0 0 0 13.967 14.7939 0 12.9248 0 0 0 0 0 0 13.2436 0 0 0 13.3544 13.8368 0 0 0 10.8626 0 0 0 13.6219 0 17.0422 0 13.3292 13.2254 15.8473 12.7727 13.2294 11.2793 13.0286 13.4651 14.0063 12.2739 13.3684 0 12.9596 0 12.3893 13.5454 14.3579 14.3364 0 11.9409 0 0 0 10.1101 13.645 0 13.2075 0 14.3163 Q7Z2T5 TRM1L_HUMAN "TRMT1-like protein, EC 2.1.1.-" TRMT1L C1orf25 TRM1L MSTP070 Homo sapiens (Human) behavior [GO:0007610]; tRNA N2-guanine methylation [GO:0002940] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; behavior [GO:0007610]; tRNA N2-guanine methylation [GO:0002940] GO:0000049; GO:0002940; GO:0003723; GO:0004809; GO:0005634; GO:0007610; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049] GPTSADETAK 0.99004 -19.336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5709 0 0 0 0 0 0 11.2468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2499 0 0 0 0 0 0 0 0 0 13.3681 0 0 0 14.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4608 0 0 0 0 14.5068 0 0 0 0 0 0 0 0 14.4123 0 0 0 0 0 0 0 0 0 Q8IWZ6 BBS7_HUMAN Bardet-Biedl syndrome 7 protein (BBS2-like protein 1) BBS7 BBS2L1 Homo sapiens (Human) brain development [GO:0007420]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; digestive tract morphogenesis [GO:0048546]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; limb development [GO:0060173]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; visual perception [GO:0007601] axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750] axoneme [GO:0005930]; BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; brain development [GO:0007420]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; digestive tract morphogenesis [GO:0048546]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; limb development [GO:0060173]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; visual perception [GO:0007601] GO:0001654; GO:0001750; GO:0001947; GO:0005634; GO:0005813; GO:0005829; GO:0005930; GO:0006357; GO:0007224; GO:0007368; GO:0007420; GO:0007601; GO:0008104; GO:0015031; GO:0016020; GO:0032402; GO:0032436; GO:0034464; GO:0036064; GO:0043005; GO:0045444; GO:0046907; GO:0048546; GO:0051877; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GFTKRGK 0.99004 -19.718 0 0 12.0626 0 0 0 0 0 13.4303 0 0 0 0 0 0 12.5437 0 0 12.9851 12.1232 12.8778 0 0 12.0903 0 0 12.5134 0 0 0 0 0 0 0 14.7727 12.1745 0 0 12.863 0 0 0 14.9893 12.6042 11.6544 12.0164 0 12.4044 0 0 0 0 13.7931 0 12.5683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9974 0 15.2316 0 0 0 14.665 0 15.7935 0 14.772 0 0 0 0 0 14.8366 14.2774 12.381 14.4174 0 0 16.005 12.5106 14.5358 0 0 0 16.2278 0 0 14.2481 15.3247 13.5677 0 0 15.2758 0 16.2033 0 0 0 0 11.6558 0 0 0 0 0 0 0 0 0 0 14.5882 0 14.4186 15.7754 0 0 0 14.2098 0 0 15.2344 0 0 0 0 15.2225 0 0 0 0 0 0 0 13.9267 0 0 14.8502 0 0 14.3987 0 0 0 13.7817 0 0 13.6375 13.0833 13.6315 0 0 14.0856 0 0 13.9298 0 14.7995 0 14.7132 0 0 13.3899 0 0 0 0 Q9P2H5 UBP35_HUMAN "Ubiquitin carboxyl-terminal hydrolase 35, EC 3.4.19.12 (Deubiquitinating enzyme 35) (Ubiquitin thioesterase 35) (Ubiquitin-specific-processing protease 35)" USP35 KIAA1372 USP34 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] EERTEKEEVGEEEESTR 0.99004 -19.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0573 0 0 0 0 0 0 0 0 0 0 0 0 12.4715 0 0 0 0 0 0 0 0 11.8606 0 12.0415 0 0 12.717 0 10.7764 0 0 0 13.0535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.973 0 0 0 0 0 11.8842 0 0 0 0 0 0 0 13.3041 0 0 0 0 12.2625 0 0 12.2302 0 13.1971 14.0326 0 0 0 13.9783 0 0 0 0 0 14.6311 0 0 0 0 11.9295 0 0 0 11.6534 11.8821 0 0 14.9212 0 0 0 0 0 0 12.4923 15.0181 0 14.3706 0 14.1927 0 0 13.5649 13.6309 0 13.2284 11.9108 0 0 13.292 0 12.7613 0 0 0 0 0 13.8515 0 0 13.2243 0 0 0 0 11.2701 0 0 16.5248 0 0 0 12.0182 0 0 0 0 0 0 0 0 0 14.6815 13.4278 0 0 0 O00629 IMA3_HUMAN "Importin subunit alpha-3 (Importin alpha Q1, Qip1) (Karyopherin subunit alpha-4)" KPNA4 QIP1 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606] cytosol [GO:0005829]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606] GO:0005634; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0031965; GO:0042564; GO:0061608 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] DEHLLKR 0.99005 -19.421 0 0 0 11.0634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0952 0 0 0 0 0 11.0455 0 0 13.1 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8027 0 0 0 0 0 0 0 0 14.1644 0 0 12.2273 0 0 0 0 0 0 0 0 0 0 12.7881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2924 12.4718 0 0 0 0 0 0 0 0 0 12.9058 0 0 0 0 12.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4071 0 0 0 0 0 11.7084 O14511 NRG2_HUMAN "Pro-neuregulin-2, membrane-bound isoform, Pro-NRG2 [Cleaved into: Neuregulin-2, NRG-2 (Divergent of neuregulin-1, DON-1) (Neural- and thymus-derived activator for ERBB kinases, NTAK) ]" NRG2 NTAK Homo sapiens (Human) animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165] GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0007165; GO:0007399; GO:0008083; GO:0016021; GO:0035556; GO:0048513 growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102] CSSYSDSSSSSSER 0.99005 -19.41 0 0 0 0 0 0 0 0 13.7212 0 0 12.8716 12.644 0 11.619 0 0 0 0 0 0 10.929 0 0 0 11.0811 0 0 0 0 0 0 0 0 11.3872 0 0 0 0 0 13.328 0 0 10.7832 0 11.7287 0 0 12.6165 0 0 11.6749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4834 0 13.6381 0 0 12.3822 0 0 0 0 0 12.8639 0 12.4489 0 12.6991 0 0 0 11.4862 0 13.3315 0 12.0577 12.9863 0 0 13.7214 13.6012 0 12.1733 0 0 0 0 0 13.3476 0 12.6044 13.3343 13.8216 0 0 0 0 13.5452 0 0 12.5068 0 0 0 0 11.785 0 0 0 0 0 13.054 0 0 13.0436 0 12.2573 13.8367 13.9467 0 12.6551 12.1734 0 0 0 0 0 14.6078 0 0 14.7757 0 0 11.8665 12.0874 13.5243 0 14.0604 12.1406 13.5921 13.0377 0 13.3529 0 11.3941 0 0 0 0 0 O94804 STK10_HUMAN "Serine/threonine-protein kinase 10, EC 2.7.11.1 (Lymphocyte-oriented kinase)" STK10 LOK Homo sapiens (Human) cell cycle [GO:0007049]; lymphocyte aggregation [GO:0071593]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of lymphocyte migration [GO:2000401] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; lymphocyte aggregation [GO:0071593]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of lymphocyte migration [GO:2000401] GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007049; GO:0035579; GO:0042802; GO:0042803; GO:0046777; GO:0070062; GO:0071593; GO:0106310; GO:2000401 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALDESHNQNLK 0.99005 -21.006 0 0 13.3306 0 0 10.1566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7636 0 0 0 0 0 0 0 0 0 0 0 11.8899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5541 0 14.1912 14.5117 0 14.1269 13.6486 14.5474 14.7717 0 13.4391 12.7448 0 0 0 0 0 0 0 0 0 10.841 0 0 0 0 13.3362 0 13.4737 0 0 0 0 0 0 11.1297 0 0 0 14.3811 0 0 14.2359 0 0 0 0 0 0 0 0 0 0 13.4192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1531 0 0 0 0 13.3868 0 13.7221 14.147 0 0 0 13.7085 0 0 0 0 11.708 0 0 0 0 0 0 0 0 0 0 0 12.9856 0 12.9926 0 0 13.7619 0 0 12.3203 12.8902 12.6812 Q64ET8 FRG2_HUMAN Protein FRG2 (FSHD region gene 2 protein) FRG2 FRG2A Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 AGNSTAGSEPESSSYRENCR 0.99005 -5.8184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6554 12.9264 0 0 0 12.9172 0 12.3747 12.3358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.338 0 0 0 0 0 0 0 0 0 0 10.8691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IE81 JADE1_HUMAN Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17) JADE1 KIAA1807 PHF17 Homo sapiens (Human) "apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000123; GO:0001558; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0006275; GO:0006355; GO:0006357; GO:0006915; GO:0016570; GO:0016607; GO:0030308; GO:0036064; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0051726; GO:0090090; GO:2000134; GO:2000278 metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713] ALRLPEEVVDFLYQYWK 0.99005 -19.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.513 0 0 0 0 0 0 0 13.9956 0 0 0 0 0 0 0 0 0 0 0 13.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1323 0 13.8584 13.8146 17.7361 12.8804 13.6668 14.2342 13.4868 12.7523 0 0 0 13.5817 15.4196 13.4684 0 13.7352 16.0651 13.4535 0 0 0 0 0 0 0 0 13.7097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6232 0 0 0 0 0 0 0 0 14.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9975 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1533 0 0 0 0 0 0 0 0 Q6ZNG9 KRBA2_HUMAN KRAB-A domain-containing protein 2 KRBA2 Homo sapiens (Human) "DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]" "nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003676; GO:0006355; GO:0015074 nucleic acid binding [GO:0003676] AEIGADRSDMDDDMDPTPEASEPSTSQGTSGLLCW 0.99005 -1.8505 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9585 0 0 0 0 0 0 0 0 0 0 0 13.5589 13.4728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4499 0 14.5252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8715 0 14.0777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8893 0 14.1018 14.2763 0 0 0 0 0 0 13.776 0 0 0 0 0 0 0 13.0395 0 0 0 0 0 0 13.1214 0 0 0 13.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZQX7 LIAT1_HUMAN Protein LIAT1 (Ligand of ATE1 protein) LIAT1 C17orf97 Homo sapiens (Human) protein arginylation [GO:0016598] protein arginylation [GO:0016598] GO:0016598 DGSSSHR 0.99005 -21.003 0 0 0 11.5576 0 0 0 0 0 0 0 0 13.6191 0 0 0 0 0 0 0 0 0 0 14.0046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3098 0 14.8247 14.6037 14.8191 14.6012 0 0 15.0248 0 10.1682 0 0 0 0 0 0 15.7453 0 15.0457 0 0 14.7983 0 15.1339 0 0 0 0 15.1241 0 11.8559 0 0 0 0 0 0 0 0 0 0 0 14.5011 14.8988 0 0 15.1264 0 15.1399 15.8885 0 0 0 14.879 0 0 0 0 14.9734 0 15.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4883 0 0 0 0 10.5455 0 10.9076 0 0 0 0 0 0 0 0 15.0109 0 0 0 0 0 0 0 Q8WTT2 NOC3L_HUMAN "Nucleolar complex protein 3 homolog, NOC3 protein homolog (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)" NOC3L AD24 C10orf117 FAD24 Homo sapiens (Human) DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444] mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444] GO:0003682; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006270; GO:0016607; GO:0045444 chromatin binding [GO:0003682]; RNA binding [GO:0003723] ALAFIKRLCTLALHVLPNSSIGILATTR 0.99005 -19.455 11.2504 15.0738 13.861 0 12.6622 13.5064 0 12.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0774 0 15.2692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1882 0 0 10.9957 14.5485 14.7328 14.3107 0 13.8506 19.3604 12.8016 0 0 0 0 19.9508 19.9503 15.5092 0 0 0 0 0 13.7292 0 0 17.7124 17.4742 17.1923 19.6878 13.4186 19.6526 0 0 15.8093 0 0 0 13.4486 19.9052 0 14.3246 0 0 0 0 0 0 0 19.6717 0 0 13.4562 13.4325 0 0 14.3981 19.4892 19.6068 19.5863 19.5856 19.6355 19.4599 0 0 13.5956 0 19.8846 0 0 13.63 16.3053 0 0 0 0 0 0 19.6076 0 0 19.652 0 0 10.8978 14.5325 0 11.8325 0 0 0 0 0 0 0 0 0 0 0 13.8661 0 0 19.543 0 0 14.6371 0 0 14.5021 0 Q99640 PMYT1_HUMAN "Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase, EC 2.7.11.1 (Myt1 kinase)" PKMYT1 MYT1 Homo sapiens (Human) G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088] GO:0000079; GO:0000086; GO:0000139; GO:0000278; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006468; GO:0007088; GO:0016020; GO:0016301; GO:0046872; GO:0051321; GO:0106310 ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ATAEALLALPVLR 0.99005 -5.8202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99836 MYD88_HUMAN Myeloid differentiation primary response protein MyD88 MYD88 Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; establishment of endothelial intestinal barrier [GO:0090557]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; induced systemic resistance [GO:0009682]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; leukocyte activation involved in inflammatory response [GO:0002269]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil-mediated killing of bacterium [GO:0070944]; phagocytosis [GO:0006909]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000338]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil migration [GO:1902622]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to molecule of fungal origin [GO:0002238]; response to organic cyclic compound [GO:0014070]; response to peptidoglycan [GO:0032494]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor 8 signaling pathway [GO:0034158]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; interleukin-1 receptor binding [GO:0005149]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; Toll binding [GO:0005121]; Toll-like receptor binding [GO:0035325]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; establishment of endothelial intestinal barrier [GO:0090557]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; induced systemic resistance [GO:0009682]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; leukocyte activation involved in inflammatory response [GO:0002269]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil-mediated killing of bacterium [GO:0070944]; phagocytosis [GO:0006909]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000338]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil migration [GO:1902622]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to molecule of fungal origin [GO:0002238]; response to organic cyclic compound [GO:0014070]; response to peptidoglycan [GO:0032494]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor 8 signaling pathway [GO:0034158]; type I interferon signaling pathway [GO:0060337] GO:0002238; GO:0002269; GO:0002283; GO:0002755; GO:0005121; GO:0005123; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006909; GO:0006915; GO:0007165; GO:0007166; GO:0007249; GO:0007254; GO:0008063; GO:0009682; GO:0010008; GO:0010628; GO:0014069; GO:0014070; GO:0014075; GO:0016064; GO:0031663; GO:0032481; GO:0032494; GO:0032722; GO:0032731; GO:0032740; GO:0032747; GO:0032755; GO:0032757; GO:0032760; GO:0032991; GO:0034158; GO:0035325; GO:0042742; GO:0042802; GO:0042832; GO:0043123; GO:0043200; GO:0043621; GO:0045087; GO:0045471; GO:0046330; GO:0048661; GO:0050671; GO:0050727; GO:0050830; GO:0051092; GO:0051607; GO:0060337; GO:0060907; GO:0070498; GO:0070555; GO:0070935; GO:0070944; GO:0070976; GO:0071222; GO:0071260; GO:0090557; GO:0140052; GO:1900017; GO:1900227; GO:1902622; GO:2000338; GO:2000341 death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; interleukin-1 receptor binding [GO:0005149]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; Toll binding [GO:0005121]; Toll-like receptor binding [GO:0035325] FALSLSPGAHQK 0.99005 -19.437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6334 12.2921 0 14.005 0 0 0 0 0 12.55 0 0 0 0 0 0 0 0 0 0 0 12.5802 0 0 0 0 0 0 0 0 0 0 0 0 11.5625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3178 0 0 0 0 0 Q9BRX2 PELO_HUMAN "Protein pelota homolog, EC 3.1.-.-" PELO CGI-17 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome organization [GO:0051276]; endoderm development [GO:0007492]; inner cell mass cell proliferation [GO:0001833]; mesenchymal to epithelial transition [GO:0060231]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of translation [GO:0006417]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome organization [GO:0051276]; endoderm development [GO:0007492]; inner cell mass cell proliferation [GO:0001833]; mesenchymal to epithelial transition [GO:0060231]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of translation [GO:0006417]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; stem cell population maintenance [GO:0019827]" GO:0001833; GO:0004519; GO:0005634; GO:0005737; GO:0006417; GO:0007049; GO:0007492; GO:0019827; GO:0030513; GO:0032790; GO:0046872; GO:0051276; GO:0051301; GO:0060231; GO:0070481; GO:0070651; GO:0070966; GO:0071025 endonuclease activity [GO:0004519]; metal ion binding [GO:0046872] AAGEVKALDDFYKMLQHEPDR 0.99005 -19.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2367 0 0 0 0 0 0 0 14.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6531 0 10.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5074 0 0 0 0 0 0 0 0 0 0 16.8848 Q9BZ71 PITM3_HUMAN "Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3, PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1, NIR-1)" PITPNM3 NIR1 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661] cell body [GO:0044297]; cell projection [GO:0042995]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cell body [GO:0044297]; cell projection [GO:0042995]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phospholipase activity [GO:0004620]; receptor tyrosine kinase binding [GO:0030971]; phosphatidylinositol biosynthetic process [GO:0006661] GO:0004620; GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008289; GO:0008526; GO:0012505; GO:0016020; GO:0030134; GO:0030971; GO:0042995; GO:0044297 calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phospholipase activity [GO:0004620]; receptor tyrosine kinase binding [GO:0030971] AHFPAALGHILIK 0.99005 -21.017 0 0 0 11.3166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.441 0 0 0 0 0 0 0 0 0 0 0 12.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3332 0 0 0 0 0 0 0 0 13.9341 0 0 0 0 0 11.2647 0 0 0 11.8449 0 0 0 0 0 0 10.0821 13.9187 10.6684 0 0 0 0 0 0 0 13.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0468 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5243 0 0 0 0 0 0 0 0 0 0 0 Q9H1K1 ISCU_HUMAN "Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)" ISCU NIFUN Homo sapiens (Human) "cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; molecular adaptor activity [GO:0060090]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of iron ion import across plasma membrane [GO:1904439]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]" GO:0005506; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006879; GO:0008198; GO:0016226; GO:0051537; GO:0060090; GO:1902958; GO:1904234; GO:1904439; GO:1990229 "2 iron, 2 sulfur cluster binding [GO:0051537]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; molecular adaptor activity [GO:0060090]" AALADYK 0.99005 -1.8557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9631 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7971 0 0 0 0 0 16.1785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYV8 T2R14_HUMAN "Taste receptor type 2 member 14, T2R14 (Taste receptor family B member 1, TRB1)" TAS2R14 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001580; GO:0004930; GO:0005886; GO:0007186; GO:0008527; GO:0016021; GO:0033038 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] ILTALAISR 0.99005 -5.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8146 11.6585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8656 0 0 0 0 0 0 0 0 0 12.2724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6962 0 P01042 KNG1_HUMAN "Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen, HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor ]" KNG1 BDK KNG Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of proteolysis [GO:0045861]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; vasodilation [GO:0042311] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of proteolysis [GO:0045861]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; vasodilation [GO:0042311] GO:0004866; GO:0004869; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006954; GO:0007162; GO:0007204; GO:0007596; GO:0008201; GO:0008270; GO:0010951; GO:0030195; GO:0031093; GO:0031640; GO:0042311; GO:0043065; GO:0045861; GO:0061844; GO:0062023; GO:0070062; GO:0072562 cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] DFVQPPTK 0.99006 -19.503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7624 0 0 0 0 0 0 13.8088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4909 0 0 0 0 0 0 0 16.0347 0 0 14.6565 0 0 0 0 0 0 0 13.4635 0 13.3222 0 0 0 0 0 0 0 12.7003 0 0 0 0 0 0 0 0 14.1525 0 0 0 0 14.1829 0 0 0 0 0 13.9505 0 0 0 0 0 0 0 0 0 12.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2103 0 0 0 0 0 0 0 0 0 0 0 P78556 CCL20_HUMAN "C-C motif chemokine 20 (Beta-chemokine exodus-1) (CC chemokine LARC) (Liver and activation-regulated chemokine) (Macrophage inflammatory protein 3 alpha, MIP-3-alpha) (Small-inducible cytokine A20) [Cleaved into: CCL20(1-67); CCL20(1-64); CCL20(2-70) ]" CCL20 LARC MIP3A SCYA20 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; signal transduction [GO:0007165]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR6 chemokine receptor binding [GO:0031731]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; signal transduction [GO:0007165]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679] GO:0002548; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0030593; GO:0031640; GO:0031731; GO:0035584; GO:0042742; GO:0043547; GO:0048020; GO:0048247; GO:0060326; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0072678; GO:0072679; GO:2000406 CCR chemokine receptor binding [GO:0048020]; CCR6 chemokine receptor binding [GO:0031731]; chemokine activity [GO:0008009] LLSKKVK 0.99006 -5.6952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9918 0 0 0 0 0 0 0 0 14.4247 0 0 0 0 0 0 0 0 0 10.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15814 TBCC_HUMAN "Tubulin-specific chaperone C (Tubulin-folding cofactor C, CFC)" TBCC Homo sapiens (Human) post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; chaperone binding [GO:0051087]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] GO:0003924; GO:0005737; GO:0005829; GO:0005856; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015631; GO:0032391; GO:0051087 chaperone binding [GO:0051087]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631] DAASSTK 0.99006 -19.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2031 0 0 0 Q2KHR2 RFX7_HUMAN DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2) RFX7 RFXDC2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LCTKSPRK 0.99006 -19.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0622 0 0 0 0 0 0 13.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.227 14.2074 0 0 0 0 0 0 0 0 0 12.3551 0 12.8766 0 0 0 0 0 0 0 0 12.6982 0 0 0 0 0 0 0 0 0 0 11.9882 0 0 11.9895 0 0 0 12.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXC1 AEGP_HUMAN Apical endosomal glycoprotein (MAM domain-containing protein 4) MAMDC4 AEGP UNQ3001/PRO9742 Homo sapiens (Human) protein transport [GO:0015031] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein transport [GO:0015031] GO:0005794; GO:0015031; GO:0016021 DCSDEAQCGYHGASPTLGAPFACDFEQDPCGWR 0.99006 -5.6945 0 0 0 0 0 0 0 0 0 13.6847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6552 0 0 0 0 0 0 0 0 0 11.2152 0 0 0 0 12.8938 0 0 0 0 0 0 0 12.6309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0022 0 0 Q86Y38 XYLT1_HUMAN "Xylosyltransferase 1, EC 2.4.2.26 (Peptide O-xylosyltransferase 1) (Xylosyltransferase I, XT-I, XylT-I)" XYLT1 XT1 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166] GO:0000137; GO:0000139; GO:0005615; GO:0006024; GO:0015012; GO:0016021; GO:0030158; GO:0030166; GO:0030203; GO:0030206; GO:0043931; GO:0046872; GO:0048706; GO:0050650 metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158] CQYKHIVDWCGCSPNDFKPQDFHR 0.99006 -1.8606 0 14.1035 0 13.19 12.9251 13.8932 13.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7202 0 12.8941 0 0 0 0 0 0 0 0 0 13.8217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6915 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8253 0 0 0 13.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5215 0 14.6423 12.6752 0 0 0 0 12.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9033 0 0 0 0 0 0 0 12.211 0 0 0 0 0 0 0 13.9801 0 0 0 0 0 0 Q9NWV8 BABA1_HUMAN BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex) BABAM1 C19orf62 MERIT40 NBA1 HSPC142 Homo sapiens (Human) cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; hematopoietic stem cell proliferation [GO:0071425]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; hematopoietic stem cell proliferation [GO:0071425]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0010212; GO:0016604; GO:0044818; GO:0045739; GO:0051301; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0071425 EEEMSWK 0.99006 -19.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.284 0 0 0 0 13.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8819 13.5341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6837 0 0 0 0 0 0 13.6175 12.2714 0 0 0 0 13.5828 0 0 0 14.9795 0 0 0 0 0 0 12.7021 0 0 0 0 0 0 0 13.738 0 0 0 0 12.7675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5X4 NR2E3_HUMAN Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor) NR2E3 PNR RNR Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; eye photoreceptor cell development [GO:0042462]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual perception [GO:0007601]" GO:0000122; GO:0000978; GO:0001228; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007165; GO:0007601; GO:0007602; GO:0008270; GO:0008283; GO:0008285; GO:0010628; GO:0030154; GO:0042462; GO:0043565; GO:0045944; GO:0048856; GO:0060041 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]" ETRPTALMSSTVAAAAPAAGAASRK 0.99006 -5.7028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5994 0 0 0 11.5753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6637 0 0 0 0 10.0094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9448 0 13.9321 0 0 0 0 12.7094 13.1235 12.9841 0 11.5307 0 0 14.4192 0 13.5833 13.665 0 13.4446 0 0 0 0 0 0 14.4569 0 15.4385 0 0 13.8379 0 14.3624 0 13.167 0 0 13.7456 0 13.9927 13.6222 13.6206 0 0 13.8358 0 0 14.9764 0 13.6546 13.7502 0 0 14.1221 0 0 0 13.8957 0 13.1448 0 13.7358 13.8739 13.2551 13.6723 0 0 0 13.8285 0 0 0 15.4152 13.2528 13.5207 0 13.7353 15.3763 0 0 12.548 14.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4633 13.8134 0 0 0 0 0 O95196 CSPG5_HUMAN Chondroitin sulfate proteoglycan 5 (Acidic leucine-rich EGF-like domain-containing brain protein) (Neuroglycan C) CSPG5 CALEB NGC Homo sapiens (Human) "axon regeneration [GO:0031103]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; glial cell projection elongation [GO:0106091]; intracellular transport [GO:0046907]; nervous system development [GO:0007399]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of growth [GO:0040008]; regulation of synaptic vesicle exocytosis [GO:2000300]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]" anchoring junction [GO:0070161]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; synapse [GO:0045202] "anchoring junction [GO:0070161]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; synapse [GO:0045202]; growth factor activity [GO:0008083]; axon regeneration [GO:0031103]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; glial cell projection elongation [GO:0106091]; intracellular transport [GO:0046907]; nervous system development [GO:0007399]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of growth [GO:0040008]; regulation of synaptic vesicle exocytosis [GO:2000300]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]" GO:0000139; GO:0005576; GO:0005789; GO:0005794; GO:0005796; GO:0005887; GO:0007010; GO:0007399; GO:0008083; GO:0009986; GO:0016020; GO:0016021; GO:0030660; GO:0031103; GO:0040008; GO:0043202; GO:0045202; GO:0046907; GO:0048858; GO:0070161; GO:0098978; GO:0098982; GO:0099055; GO:0099550; GO:0106091; GO:1900026; GO:2000300 growth factor activity [GO:0008083] DLASSENGTECR 0.99007 -5.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7133 0 0 10.5079 0 0 0 15.3248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.898 14.4526 0 0 0 14.3641 12.7375 0 13.3058 13.2578 12.7337 11.4519 0 13.8689 0 0 0 13.7528 0 0 0 12.963 12.0543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5807 0 0 0 0 0 0 P49842 STK19_HUMAN "Serine/threonine-protein kinase 19, EC 2.7.11.1 (Protein G11) (Protein RP1)" STK19 G11 RP1 Homo sapiens (Human) positive regulation of Ras protein signal transduction [GO:0046579]; protein phosphorylation [GO:0006468] nuclear speck [GO:0016607]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; positive regulation of Ras protein signal transduction [GO:0046579]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0016607; GO:0031267; GO:0046579; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] ELLLSELLGRR 0.99007 -5.8514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1085 0 0 0 15.0462 0 0 0 0 13.253 0 0 0 0 0 0 0 0 0 14.4164 0 13.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.666 0 0 0 0 0 0 12.3986 0 12.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9411 0 0 0 12.9001 0 0 0 0 Q8IZA0 K319L_HUMAN "Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor, AAVR)" KIAA0319L AAVR KIAA1837 PP791 Homo sapiens (Human) neuron migration [GO:0001764] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; neuron migration [GO:0001764] GO:0000139; GO:0001764; GO:0005730; GO:0005794; GO:0005886; GO:0016020; GO:0016021; GO:0031410 DYSGEMEGK 0.99007 -5.7173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7608 11.5897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4298 0 0 15.7525 15.7779 0 0 0 0 0 0 0 0 12.4593 0 0 0 0 13.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0168 0 12.7816 0 0 0 0 0 0 0 0 0 0 0 0 12.6077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVG3 TRI62_HUMAN "E3 ubiquitin-protein ligase TRIM62, EC 2.3.2.27 (Tripartite motif-containing protein 62)" TRIM62 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of viral transcription [GO:0032897]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K27-linked ubiquitination [GO:0044314]; protein ubiquitination [GO:0016567]; regulation of viral entry into host cell [GO:0046596]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of viral transcription [GO:0032897]; positive regulation of antifungal innate immune response [GO:1905036]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K27-linked ubiquitination [GO:0044314]; protein ubiquitination [GO:0016567]; regulation of viral entry into host cell [GO:0046596]; viral release from host cell [GO:0019076] GO:0003713; GO:0004842; GO:0005737; GO:0005829; GO:0008270; GO:0010719; GO:0016567; GO:0019076; GO:0032897; GO:0042802; GO:0043123; GO:0044314; GO:0045087; GO:0046596; GO:0051091; GO:0051092; GO:0061630; GO:1905036 identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ALLCFFCDEPALHEQHQVTGIDDAFDELQRELK 0.99007 -5.7131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3316 0 13.2742 0 11.3391 0 12.5176 12.8431 0 0 12.1078 11.4599 12.1424 12.2372 12.1939 14.2597 0 11.2536 0 0 0 0 0 0 0 0 0 0 12.2662 0 0 0 0 0 0 0 0 0 15.7498 0 0 0 0 0 0 0 0 0 11.2687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3801 0 Q9H1M3 DB129_HUMAN "Beta-defensin 129 (Beta-defensin 29, DEFB-29) (Defensin, beta 129)" DEFB129 C20orf87 DEFB29 UNQ5794/PRO19599 Homo sapiens (Human) defense response to bacterium [GO:0042742] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742] GO:0005576; GO:0042742 DHCNVDEK 0.99007 -19.557 0 0 0 0 0 0 0 0 12.6627 11.3128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5108 10.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2186 0 0 0 0 0 11.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.072 0 0 12.642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4281 0 0 0 0 0 0 0 0 0 0 13.2143 11.9914 0 0 0 0 0 0 0 0 0 0 11.807 0 0 0 0 0 0 12.732 0 11.2886 0 0 0 11.1751 11.7511 0 0 12.6735 0 0 0 12.7881 0 0 12.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D2B8 PM2P1_HUMAN "Putative postmeiotic segregation increased 2-like protein 1 (PMS2-related protein 2) (Postmeiotic segregation increased 2-like protein 13) (Postmeiotic segregation increased 2-like protein 6) (Postmeiotic segregation increased 2-like protein 8) (Postmeiotic segregation increased protein 3, hPMS3) (Postmeiotic segregation increased protein 8) (Putative postmeiotic segregation increased 2 pseudogene 1)" PMS2P1 PMS2L1 PMS2L13 PMS2L6 PMS2L8 PMS3 PMS8 PMSR2 Homo sapiens (Human) mismatch repair [GO:0006298]; phosphorylation [GO:0016310]; somatic hypermutation of immunoglobulin genes [GO:0016446] mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389] mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; kinase activity [GO:0016301]; mismatch repair [GO:0006298]; phosphorylation [GO:0016310]; somatic hypermutation of immunoglobulin genes [GO:0016446] GO:0006298; GO:0016301; GO:0016310; GO:0016446; GO:0016887; GO:0032300; GO:0032389; GO:0140664 ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; kinase activity [GO:0016301] AESSSTEPAK 0.99008 -5.7363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.551 0 0 0 0 11.8868 0 0 15.4478 0 0 0 0 0 0 0 0 0 12.2807 14.9418 0 0 0 0 0 0 0 14.9769 0 0 0 0 0 13.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3865 15.3557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48382 RFX5_HUMAN DNA-binding protein RFX5 (Regulatory factor X 5) RFX5 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0043231; GO:0043565; GO:0045348; GO:0045944; GO:0090575; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" APRSLIPPIPVSPPILAPR 0.99008 -19.67 0 11.0783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.176 0 0 0 0 13.0745 0 0 0 0 0 0 0 0 12.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9685 0 0 0 0 0 0 0 0 0 10.2557 0 0 14.3074 0 0 0 0 0 0 15.4992 0 0 0 0 0 0 0 0 0 0 13.8825 0 0 0 0 0 0 0 0 0 0 0 15.6858 0 0 0 0 0 0 0 0 0 0 13.212 0 0 0 13.6316 14.0457 0 0 0 12.6495 14.4931 0 0 12.0559 0 0 0 0 0 0 11.7891 14.0776 0 0 0 0 0 0 12.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.918 14.6715 0 0 0 Q7Z3Z3 PIWL3_HUMAN Piwi-like protein 3 PIWIL3 Homo sapiens (Human) cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; piRNA binding [GO:0034584]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] GO:0003723; GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007283; GO:0030154; GO:0031047; GO:0034584; GO:0043186; GO:0051321 endoribonuclease activity [GO:0004521]; piRNA binding [GO:0034584]; RNA binding [GO:0003723] ITYIDYYRQQHK 0.99008 -19.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3708 0 0 0 0 0 0 0 13.3512 17.3588 13.9866 0 0 0 14.2393 14.8646 0 0 11.8317 0 0 0 0 0 12.9413 0 12.0367 0 0 12.79 0 0 0 0 0 0 0 0 0 0 0 13.0448 0 0 0 0 0 12.8446 0 13.7241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1392 0 13.8709 0 0 0 0 0 13.237 0 0 0 0 0 0 13.5118 0 0 13.4667 0 0 0 0 0 Q93073 SBP2L_HUMAN "Selenocysteine insertion sequence-binding protein 2-like, SECIS-binding protein 2-like" SECISBP2L KIAA0256 Homo sapiens (Human) selenocysteine incorporation [GO:0001514] ribonucleoprotein complex [GO:1990904] ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514] GO:0001514; GO:0003723; GO:0003730; GO:0035368; GO:0043021; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368] CVIISPNCEK 0.99008 -19.992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1368 0 0 0 0 0 0 0 0 0 0 0 12.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1938 0 15.1029 0 0 0 14.8582 0 0 0 0 0 0 0 0 0 0 0 0 15.2734 0 0 0 14.1146 0 0 15.0499 0 0 14.9305 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2438 0 0 0 15.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.691 0 0 15.284 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AT1 K1143_HUMAN Uncharacterized protein KIAA1143 KIAA1143 Homo sapiens (Human) AEIKAAK 0.99008 -19.987 0 0 0 0 0 0 0 0 0 0 0 0 13.3685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8144 14.3897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2881 Q9UPS6 SET1B_HUMAN "Histone-lysine N-methyltransferase SETD1B, EC 2.1.1.364 (Lysine N-methyltransferase 2G) (SET domain-containing protein 1B, hSET1B)" SETD1B KIAA1076 KMT2G SET1B Homo sapiens (Human) chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182] chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; Set1C/COMPASS complex [GO:0048188] chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; Set1C/COMPASS complex [GO:0048188]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182] GO:0003723; GO:0005654; GO:0005694; GO:0006325; GO:0016607; GO:0018024; GO:0035097; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0080182; GO:0097692 histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723] ATVDGVLLVVLKELK 0.99008 -20.006 0 0 0 0 0 0 11.847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4504 0 0 0 0 0 0 0 0 11.4571 0 0 0 0 0 0 0 11.0778 0 0 0 13.3497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8207 0 13.086 14.011 14.4214 13.0226 0 0 0 0 14.5215 12.0243 12.2646 14.3111 14.6975 0 15.411 15.0715 14.9497 14.5866 14.0495 0 13.2743 0 15.1802 0 10.9524 15.5533 13.5253 0 0 13.3509 0 0 13.5946 0 11.9175 0 0 0 12.28 12.8831 13.9563 0 0 0 0 12.724 13.9588 12.3525 12.0392 11.7519 12.4094 0 15.111 0 11.9719 13.3994 0 0 0 0 0 0 0 0 14.4305 14.0226 0 0 0 12.1228 0 0 12.094 0 0 0 13.7967 13.6991 0 0 0 0 13.9825 0 0 0 0 0 0 0 0 0 0 12.0938 0 0 0 0 12.6118 13.3315 0 0 0 11.9973 0 A2CJ06 DYTN_HUMAN Dystrotelin DYTN Homo sapiens (Human) synaptic signaling [GO:0099536] plasma membrane [GO:0005886]; synapse [GO:0045202] plasma membrane [GO:0005886]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; synaptic signaling [GO:0099536] GO:0005886; GO:0008270; GO:0045202; GO:0099536 zinc ion binding [GO:0008270] CLNFDICQMCFLSGLHSK 0.99009 -20.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14525 ASTN1_HUMAN Astrotactin-1 ASTN1 ASTN KIAA0289 Homo sapiens (Human) locomotory behavior [GO:0007626]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764] clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204] clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; locomotory behavior [GO:0007626]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764] GO:0001764; GO:0005768; GO:0007158; GO:0007626; GO:0009897; GO:0016021; GO:0030136; GO:0043204 AAGECLCYEGYMK 0.99009 -5.7536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7065 0 0 0 16.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.625 0 0 0 0 0 0 12.0482 0 0 0 0 16.7815 0 0 0 0 0 0 0 0 0 0 0 0 15.5863 0 0 0 0 0 0 0 0 10.5002 0 15.4236 0 0 0 0 0 0 0 0 0 0 0 0 11.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2954 0 0 0 13.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43639 NCK2_HUMAN "Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2, Nck-2) (SH2/SH3 adaptor protein NCK-beta)" NCK2 GRB4 Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]; cytoskeletal anchor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110] GO:0001771; GO:0001784; GO:0005737; GO:0005783; GO:0005829; GO:0007015; GO:0007165; GO:0007172; GO:0007173; GO:0007176; GO:0008093; GO:0008285; GO:0012506; GO:0014069; GO:0016477; GO:0030032; GO:0030159; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0042102; GO:0042110; GO:0044877; GO:0045944; GO:0048013; GO:0060996; GO:0097110; GO:1902237; GO:1903898; GO:1903912; GO:1990441 cytoskeletal anchor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159] LWLLDDSKTWWR 0.99009 -5.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4271 0 0 0 0 0 0 0 0 0 0 0 12.1339 0 0 0 0 0 0 0 12.8309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7453 0 0 0 0 0 0 0 0 13.9908 0 0 0 0 0 0 0 0 0 0 0 0 13.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0862 0 0 P0DPK5 H3Y2_HUMAN Histone H3.X (Histone H3.Y2) H3Y2 Homo sapiens (Human) nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] ARTKQTAR 0.99009 -20.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.743 0 0 0 0 15.3916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9864 0 0 0 0 0 0 0 0 0 0 0 13.1231 13.3277 0 0 0 0 11.209 13.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1 0 13.2266 0 0 0 14.0429 0 P21802 FGFR2_HUMAN "Fibroblast growth factor receptor 2, FGFR-2, EC 2.7.10.1 (K-sam, KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)" FGFR2 BEK KGFR KSAM Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060] cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of smoothened signaling pathway [GO:0008589]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060] GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001837; GO:0002053; GO:0003148; GO:0003149; GO:0003416; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0005938; GO:0006915; GO:0007169; GO:0007267; GO:0007409; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009791; GO:0009880; GO:0009887; GO:0009986; GO:0010518; GO:0010839; GO:0016020; GO:0016021; GO:0016331; GO:0017134; GO:0018108; GO:0021769; GO:0021847; GO:0021860; GO:0022612; GO:0030177; GO:0030282; GO:0030324; GO:0030855; GO:0030901; GO:0030916; GO:0031069; GO:0031410; GO:0032496; GO:0032808; GO:0033674; GO:0033688; GO:0035265; GO:0035602; GO:0035603; GO:0035604; GO:0035607; GO:0042060; GO:0042472; GO:0042476; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0045165; GO:0045471; GO:0045667; GO:0045787; GO:0045944; GO:0046777; GO:0048286; GO:0048333; GO:0048557; GO:0048562; GO:0048565; GO:0048568; GO:0048608; GO:0048661; GO:0048701; GO:0048705; GO:0048730; GO:0048755; GO:0048762; GO:0050679; GO:0051150; GO:0051781; GO:0055010; GO:0060045; GO:0060076; GO:0060174; GO:0060348; GO:0060349; GO:0060442; GO:0060445; GO:0060449; GO:0060463; GO:0060484; GO:0060501; GO:0060512; GO:0060523; GO:0060527; GO:0060529; GO:0060595; GO:0060601; GO:0060615; GO:0060664; GO:0060667; GO:0060670; GO:0060688; GO:0060915; GO:0060916; GO:0070372; GO:0070374; GO:0071300; GO:0071560; GO:0090263 ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] DLSDLVSEMEMMK 0.99009 -19.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1263 0 0 12.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5729 0 0 0 0 12.5711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.104 0 0 13.5218 12.7608 0 0 0 0 0 0 0 0 0 0 0 11.5507 0 0 0 0 0 0 0 0 0 0 13.1443 0 0 0 0 0 0 0 0 0 16.4938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6864 0 P50914 RL14_HUMAN 60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14) RPL14 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0042273; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ADINTKWAATRWAK 0.99009 -19.692 0 0 0 0 0 0 0 0 0 0 11.57 13.7506 0 13.8865 13.3542 13.3778 0 13.3764 13.7838 0 13.4936 11.9545 13.9642 0 0 0 0 0 0 13.6043 0 0 0 12.7192 0 13.5672 13.3277 0 13.1975 0 12.2554 0 0 14.0501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.058 11.4879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2248 0 0 0 0 0 0 13.2018 13.221 12.8685 12.7476 0 0 0 0 12.2586 0 0 0 0 12.4587 0 0 0 12.4221 0 13.0412 12.5267 0 0 0 11.4228 0 0 0 0 0 0 0 0 0 0 10.9341 14.3877 0 0 0 0 0 0 0 0 0 14.9177 0 12.3589 14.8786 0 0 12.0128 0 0 0 0 0 0 P51451 BLK_HUMAN "Tyrosine-protein kinase Blk, EC 2.7.10.2 (B lymphocyte kinase) (p55-Blk)" BLK Homo sapiens (Human) B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; dendritic cell differentiation [GO:0097028]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of mast cell proliferation [GO:0070667]; neuron projection development [GO:0031175]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein binding [GO:0032092]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of mast cell degranulation [GO:0043304]; regulation of platelet aggregation [GO:0090330]; tolerance induction to self antigen [GO:0002513]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; dendritic cell differentiation [GO:0097028]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of mast cell proliferation [GO:0070667]; neuron projection development [GO:0031175]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein binding [GO:0032092]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of mast cell degranulation [GO:0043304]; regulation of platelet aggregation [GO:0090330]; tolerance induction to self antigen [GO:0002513]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0002431; GO:0002513; GO:0002576; GO:0002902; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005829; GO:0006974; GO:0007169; GO:0018108; GO:0030154; GO:0030889; GO:0031175; GO:0031234; GO:0032024; GO:0032092; GO:0035556; GO:0043304; GO:0045087; GO:0050853; GO:0050855; GO:0070667; GO:0090330; GO:0097028; GO:2000670 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] ALQHERLVRLYAVVTK 0.99009 -19.378 0 0 0 0 10.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1986 0 0 0 0 13.3467 13.4093 0 0 0 0 0 0 12.7879 0 0 0 0 12.0865 0 0 0 12.8513 0 12.4874 13.1977 13.0569 12.9342 14.4242 0 14.4883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.156 0 0 0 12.4192 0 0 0 0 0 12.723 13.2886 14.0137 13.2516 0 14.096 14.2726 11.0643 0 12.5282 0 0 0 0 0 12.9427 0 0 0 0 0 0 0 13.3436 0 14.4332 13.1127 12.9661 0 0 14.4928 13.8056 0 0 13.5147 0 0 0 13.0088 0 0 0 0 0 0 0 0 0 12.6138 12.5365 0 13.7724 0 0 0 0 0 0 0 0 0 10.8684 0 14.3842 0 0 13.2211 14.1419 10.7936 0 0 0 0 0 0 14.0942 0 0 0 0 0 0 0 0 0 0 0 0 9.81506 0 12.0235 Q3ZCQ8 TIM50_HUMAN Mitochondrial import inner membrane translocase subunit TIM50 TIMM50 TIM50 PRO1512 Homo sapiens (Human) intracellular protein transport [GO:0006886]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]; release of cytochrome c from mitochondria [GO:0001836] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; interleukin-2 receptor binding [GO:0005134]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; intracellular protein transport [GO:0006886]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]; release of cytochrome c from mitochondria [GO:0001836] GO:0001836; GO:0003723; GO:0004721; GO:0004722; GO:0004725; GO:0005134; GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0006470; GO:0006886; GO:0007006; GO:0016021; GO:0016607; GO:0030150; GO:0043021 interleukin-2 receptor binding [GO:0005134]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] LEQEEQQR 0.99009 -19.72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.641 0 0 13.0413 0 0 0 0 0 13.8017 12.8371 13.2036 0 12.6129 0 0 12.5094 0 0 0 0 0 0 0 0 0 11.8676 11.9082 0 0 0 0 0 0 0 0 15.1138 0 0 12.0103 13.6001 0 13.6165 0 0 12.0341 0 12.4274 0 0 0 13.4311 0 0 0 0 0 0 0 0 12.5204 0 12.9221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8854 0 0 0 13.272 0 0 Q5HY64 FA47C_HUMAN Putative protein FAM47C FAM47C Homo sapiens (Human) AFVEEVEAQLMTK 0.99009 -19.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TDH0 DDI2_HUMAN "Protein DDI1 homolog 2, EC 3.4.23.-" DDI2 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647] GO:0004190; GO:0005654; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0043130; GO:0072711; GO:0097752 aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130] LLTVYCVR 0.99009 -19.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0096 0 0 0 0 12.8533 0 12.08 13.3888 0 0 0 13.6102 0 0 0 0 13.2113 12.8971 0 0 0 13.1659 0 0 0 0 0 0 0 0 0 0 10.734 0 9.78467 11.6233 0 0 0 0 0 0 0 0 13.6396 0 12.5882 14.2868 0 0 12.1686 13.0251 13.5591 12.9564 11.9279 14.105 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5438 0 0 0 0 0 0 12.4973 13.5003 14.7111 0 0 0 0 0 11.8809 12.7677 12.6784 0 13.6514 0 11.7231 0 0 0 0 0 0 15.313 0 0 0 0 Q93009 UBP7_HUMAN "Ubiquitin carboxyl-terminal hydrolase 7, EC 3.4.19.12 (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7)" USP7 HAUSP Homo sapiens (Human) "histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gluconeogenesis [GO:0006111]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]" chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991] "chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase binding [GO:0031625]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gluconeogenesis [GO:0006111]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006111; GO:0006283; GO:0006511; GO:0008022; GO:0010216; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031625; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0035616; GO:0042752; GO:0048511; GO:0050821; GO:0051090; GO:0070536; GO:0101005; GO:1901537; GO:1901796; GO:1904353; GO:1905279; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase binding [GO:0031625] ASGKLRLLEIVSYK 0.99009 -5.7512 0 0 0 0 0 0 0 0 0 0 13.4453 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7157 13.3205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5013 0 0 0 0 0 11.4775 0 0 0 0 0 0 0 0 13.0483 0 0 12.9153 14.523 0 13.7632 13.3142 0 0 13.9995 0 0 0 14.4143 0 0 12.5117 0 0 0 13.6618 14.821 10.7969 0 0 0 0 13.7574 0 0 0 0 0 0 0 0 0 0 0 12.6959 0 0 0 0 13.6125 0 0 0 0 12.1696 0 0 15.1452 0 0 13.144 0 0 0 13.318 0 0 11.8738 0 0 12.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9234 0 0 0 0 0 0 13.788 0 0 0 0 Q9H0D6 XRN2_HUMAN "5'-3' exoribonuclease 2, EC 3.1.13.- (DHM1-like protein, DHP protein)" XRN2 Homo sapiens (Human) "DNA catabolic process, exonucleolytic [GO:0000738]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]" aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process, exonucleolytic [GO:0000738]; hippocampus development [GO:0021766]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA catabolic process [GO:0006401]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283]" GO:0000175; GO:0000738; GO:0000956; GO:0001147; GO:0003723; GO:0004518; GO:0004534; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006396; GO:0006397; GO:0006401; GO:0007283; GO:0008409; GO:0016020; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0046872; GO:0060041 3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147] DDEDSFR 0.99009 -19.319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0008 0 14.3867 0 0 0 0 14.1316 0 0 0 0 0 0 0 0 0 0 0 0 15.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5913 0 0 0 0 0 13.4163 0 0 0 0 0 0 0 0 12.5521 0 12.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.93 Q9NQ55 SSF1_HUMAN "Suppressor of SWI4 1 homolog, Ssf-1 (Brix domain-containing protein 3) (Peter Pan homolog)" PPAN BXDC3 SSF1 Homo sapiens (Human) ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] "nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]" GO:0000027; GO:0003723; GO:0005634; GO:0005730; GO:0006364; GO:0019843; GO:0030687 RNA binding [GO:0003723]; rRNA binding [GO:0019843] AQRQAQQAQNVQR 0.99009 -19.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3341 0 0 0 0 0 0 0 0 0 0 0 0 11.409 10.2495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7433 0 0 0 0 0 13.1003 0 12.9673 0 16.0173 0 0 11.2336 0 0 0 0 0 0 0 0 0 0 0 11.1139 0 12.8965 0 13.8703 14.2074 14.1738 0 0 12.9133 0 12.2821 12.6869 0 0 0 14.0212 0 0 0 0 0 0 0 0 13.8859 0 12.5397 0 0 0 0 13.4898 12.8155 12.5995 0 0 0 13.5405 0 15.5486 12.7694 0 0 0 0 12.5558 12.2321 0 17.3091 0 0 0 0 0 0 13.3599 13.2488 0 0 0 12.0344 0 0 0 0 11.6927 0 0 0 0 12.0429 0 0 14.4334 0 0 0 0 0 0 0 Q9NZU7 CABP1_HUMAN "Calcium-binding protein 1, CaBP1 (Calbrain) (Caldendrin)" CABP1 Homo sapiens (Human) negative regulation of protein import into nucleus [GO:0042308]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to stimulus [GO:0050896]; visual perception [GO:0007601] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; enzyme inhibitor activity [GO:0004857]; nuclear localization sequence binding [GO:0008139]; negative regulation of protein import into nucleus [GO:0042308]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0000139; GO:0004857; GO:0005246; GO:0005509; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0007601; GO:0008139; GO:0014069; GO:0042308; GO:0048306; GO:0048471; GO:0050896; GO:0070161; GO:1901385 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; enzyme inhibitor activity [GO:0004857]; nuclear localization sequence binding [GO:0008139] DKDGYINCRDLGNCMR 0.99009 -5.613 0 0 0 0 11.5133 0 0 13.5174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2916 0 0 0 0 0 14.6179 14.8026 0 0 0 0 0 0 0 0 0 0 13.8995 13.3351 13.1888 0 0 0 0 0 0 0 0 0 0 0 15.3518 0 0 0 0 0 0 0 0 14.0209 0 0 0 0 0 14.2371 12.1654 13.1655 0 0 13.6178 0 14.3228 0 0 0 12.8045 14.1698 13.7705 13.8052 12.4559 0 0 0 0 0 0 13.276 13.2998 14.0381 0 0 0 11.9673 14.9925 0 11.7477 0 0 0 0 0 0 0 0 13.2486 14.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9554 13.6827 0 14.5728 13.1203 0 0 0 0 0 Q9UBD0 HSFX1_HUMAN "Heat shock transcription factor, X-linked" HSFX1 LW-1; HSFX2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0006357 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IFSAKRLVSILNK 0.99009 -4.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0445 0 0 0 10.1489 Q9ULV8 CBLC_HUMAN "E3 ubiquitin-protein ligase CBL-C, EC 2.3.2.27 (RING finger protein 57) (RING-type E3 ubiquitin transferase CBL-C) (SH3-binding protein CBL-3) (SH3-binding protein CBL-C) (Signal transduction protein CBL-C)" CBLC CBL3 RNF57 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of MAP kinase activity [GO:0043407]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] membrane raft [GO:0045121]; plasma membrane [GO:0005886] membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of MAP kinase activity [GO:0043407]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001784; GO:0005154; GO:0005509; GO:0005886; GO:0006511; GO:0007165; GO:0007166; GO:0007175; GO:0008270; GO:0016567; GO:0017124; GO:0030971; GO:0042059; GO:0043407; GO:0045121; GO:0061630 calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DVKIEPCGHLLCSCCLAAWQHSDSQTCPFCR 0.99009 -20.066 0 12.7011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1376 0 0 0 0 0 0 13.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6767 0 0 0 0 0 0 0 13.0094 0 12.1139 0 0 0 0 0 0 0 0 13.4803 0 0 12.3691 0 0 0 0 0 0 0 13.7399 0 0 0 0 0 0 0 0 0 0 13.2781 0 0 0 0 12.9115 0 0 0 0 0 0 0 0 0 0 16.2989 0 0 0 0 0 0 0 13.5177 0 0 0 0 0 0 0 0 14.1585 0 0 0 0 0 13.3195 0 A0A075B6I1 LV460_HUMAN Immunoglobulin lambda variable 4-60 IGLV4-60 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 APRYLMK 0.9901 -19.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5191 0 0 0 0 0 0 13.2723 0 0 0 0 0 0 0 0 0 0 0 0 11.5394 0 0 11.962 0 0 0 0 0 0 0 12.2156 0 0 0 0 0 0 0 12.3118 0 12.6633 0 0 0 12.3404 0 0 0 12.9418 0 0 0 0 0 0 0 13.5908 0 0 0 0 0 12.4291 0 0 0 0 0 0 0 0 0 0 0 0 11.4483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15446 RPA34_HUMAN "DNA-directed RNA polymerase I subunit RPA34 (A34.5) (Antisense to ERCC-1 protein, ASE-1) (CD3-epsilon-associated protein, CD3E-associated protein) (DNA-directed RNA polymerase I subunit G) (RNA polymerase I-associated factor PAF49)" POLR1G ASE1 CAST CD3EAP PAF49 Homo sapiens (Human) rRNA transcription [GO:0009303]; transcription by RNA polymerase I [GO:0006360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase I transcription regulator complex [GO:0000120] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase I transcription regulator complex [GO:0000120]; RNA binding [GO:0003723]; rRNA transcription [GO:0009303]; transcription by RNA polymerase I [GO:0006360]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0000120; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005736; GO:0005739; GO:0005829; GO:0006360; GO:0007169; GO:0009303 RNA binding [GO:0003723] ATPGSTKK 0.9901 -5.7621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0421 0 0 0 12.7458 0 0 0 0 0 0 0 0 0 14.8773 0 0 0 0 0 0 0 0 0 0 0 13.0541 13.2531 0 0 0 0 0 0 13.2945 0 0 14.8336 14.467 0 0 0 0 0 0 12.8623 0 0 0 0 0 0 0 14.639 0 0 0 0 0 19.0937 0 0 0 13.0956 13.659 0 13.4947 0 0 0 0 0 0 0 0 0 0 0 12.7186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4155 0 0 0 0 0 0 0 Q5K651 SAMD9_HUMAN "Sterile alpha motif domain-containing protein 9, SAM domain-containing protein 9" SAMD9 C7orf5 DRIF1 KIAA2004 OEF1 Homo sapiens (Human) endosomal vesicle fusion [GO:0034058] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058] GO:0005737; GO:0005829; GO:0034058; GO:0043231 DEHEGETGNWFSPFIEALHK 0.9901 -19.408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.959 0 12.1386 12.7974 0 0 0 0 15.7128 0 0 0 0 0 0 0 0 0 0 0 12.1422 0 0 0 0 0 0 0 0 0 0 0 0 11.3808 0 0 0 0 0 0 0 0 0 0 17.9815 0 0 0 0 0 0 0 0 0 0 14.8852 10.7572 11.3269 0 11.4662 0 0 18.6623 0 0 0 15.558 0 0 15.336 14.0805 0 15.2108 0 0 0 0 14.4225 14.6986 0 0 0 0 0 13.9982 14.1677 13.962 12.0895 17.2915 0 0 13.4691 14.1154 13.2073 0 14.4139 0 0 0 0 16.0171 0 14.7654 0 0 0 0 0 0 13.176 15.7445 14.4199 20.6012 13.3722 0 0 0 15.3989 19.6407 0 14.4288 0 13.1758 0 0 15.1827 13.344 0 19.099 0 18.9323 0 0 0 12.8615 0 13.3914 11.2267 15.153 0 0 0 0 0 0 0 0 12.8331 0 0 13.5119 14.3419 0 0 10.6602 0 0 14.8598 15.0711 0 13.3829 14.155 0 0 13.0134 Q5R372 RBG1L_HUMAN Rab GTPase-activating protein 1-like RABGAP1L HHL KIAA0471 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880] GO:0005096; GO:0005634; GO:0005769; GO:0005794; GO:0006897; GO:0015031; GO:0031267; GO:0032880; GO:0090630 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] FYFKLKQGIEK 0.9901 -5.7639 0 0 0 12.2362 12.397 0 12.8377 12.17 0 0 0 0 10.7611 0 0 0 0 14.1679 14.0684 13.6331 14.1336 15.2927 13.8803 13.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3206 0 0 0 0 0 0 0 0 13.6203 0 0 0 0 0 13.8336 13.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9844 14.3453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7215 0 0 0 0 0 0 0 12.1518 11.5508 0 0 0 15.2257 15.0924 14.9166 0 0 0 0 0 0 0 0 0 0 16.0898 0 17.016 0 0 0 0 0 0 0 0 0 0 0 14.5972 0 0 0 14.8156 0 0 0 0 0 0 11.2211 15.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1908 0 0 0 0 0 0 0 0 0 0 0 0 15.7281 0 0 0 0 0 0 0 0 0 0 Q92786 PROX1_HUMAN "Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1, PROX-1)" PROX1 Homo sapiens (Human) "acinar cell differentiation [GO:0090425]; aorta smooth muscle tissue morphogenesis [GO:0060414]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; blood vessel endothelial cell differentiation [GO:0060837]; brain development [GO:0007420]; branching involved in pancreas morphogenesis [GO:0061114]; cerebellar granule cell differentiation [GO:0021707]; circadian rhythm [GO:0007623]; dentate gyrus development [GO:0021542]; dorsal spinal cord development [GO:0021516]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endocardium formation [GO:0060214]; epithelial cell migration [GO:0010631]; hepatocyte cell migration [GO:0002194]; hepatocyte differentiation [GO:0070365]; hepatocyte proliferation [GO:0072574]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lens placode formation involved in camera-type eye formation [GO:0046619]; liver development [GO:0001889]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; olfactory placode formation [GO:0030910]; otic placode formation [GO:0043049]; pancreas development [GO:0031016]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle checkpoint [GO:1901978]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of forebrain neuron differentiation [GO:2000979]; positive regulation of heart growth [GO:0060421]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle thin filament assembly [GO:0030240]; transcription by RNA polymerase II [GO:0006366]; venous blood vessel morphogenesis [GO:0048845]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; acinar cell differentiation [GO:0090425]; aorta smooth muscle tissue morphogenesis [GO:0060414]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; blood vessel endothelial cell differentiation [GO:0060837]; brain development [GO:0007420]; branching involved in pancreas morphogenesis [GO:0061114]; cerebellar granule cell differentiation [GO:0021707]; circadian rhythm [GO:0007623]; dentate gyrus development [GO:0021542]; dorsal spinal cord development [GO:0021516]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endocardium formation [GO:0060214]; epithelial cell migration [GO:0010631]; hepatocyte cell migration [GO:0002194]; hepatocyte differentiation [GO:0070365]; hepatocyte proliferation [GO:0072574]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; lens fiber cell morphogenesis [GO:0070309]; lens placode formation involved in camera-type eye formation [GO:0046619]; liver development [GO:0001889]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; lymphatic endothelial cell fate commitment [GO:0060838]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuronal stem cell population maintenance [GO:0097150]; olfactory placode formation [GO:0030910]; otic placode formation [GO:0043049]; pancreas development [GO:0031016]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle checkpoint [GO:1901978]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of forebrain neuron differentiation [GO:2000979]; positive regulation of heart growth [GO:0060421]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle thin filament assembly [GO:0030240]; transcription by RNA polymerase II [GO:0006366]; venous blood vessel morphogenesis [GO:0048845]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001822; GO:0001889; GO:0001938; GO:0001946; GO:0002088; GO:0002194; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0007405; GO:0007406; GO:0007420; GO:0007623; GO:0008284; GO:0008285; GO:0010468; GO:0010595; GO:0010631; GO:0016922; GO:0021516; GO:0021542; GO:0021707; GO:0021915; GO:0030240; GO:0030324; GO:0030910; GO:0031016; GO:0031667; GO:0042752; GO:0043049; GO:0043433; GO:0045071; GO:0045737; GO:0045787; GO:0045892; GO:0045944; GO:0046619; GO:0048664; GO:0048845; GO:0050692; GO:0050693; GO:0055005; GO:0055009; GO:0055010; GO:0060042; GO:0060059; GO:0060214; GO:0060298; GO:0060412; GO:0060414; GO:0060421; GO:0060836; GO:0060837; GO:0060838; GO:0061114; GO:0070309; GO:0070365; GO:0070858; GO:0072574; GO:0090425; GO:0097150; GO:1901978; GO:1990837; GO:2000179; GO:2000979 "DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; LBD domain binding [GO:0050693]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ALNMHYNK 0.9901 -21.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3711 0 11.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0735 0 0 0 0 0 0 0 13.6354 0 0 0 0 0 12.3498 12.8321 0 0 0 0 0 0 0 0 12.9806 0 0 13.5775 0 13.1801 0 13.4781 0 13.1958 0 12.8844 0 14.348 0 0 0 13.2182 0 0 0 0 10.9944 0 0 0 0 0 0 0 0 0 12.9337 0 0 0 12.7918 0 0 0 0 0 0 0 11.0176 0 0 0 0 0 13.9335 0 0 0 0 0 0 0 0 0 0 0 12.6098 0 0 0 0 13.2319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1093 0 0 14.085 0 0 0 0 Q9NWC5 TM45A_HUMAN Transmembrane protein 45A (DNA polymerase-transactivated protein 4) (Dermal papilla-derived protein 7) TMEM45A DERP7 DNAPTP4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 NAEREQESEEEM 0.9901 -5.636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IX07 FOG1_HUMAN "Zinc finger protein ZFPM1 (Friend of GATA protein 1, FOG-1, Friend of GATA 1) (Zinc finger protein 89A) (Zinc finger protein multitype 1)" ZFPM1 FOG1 ZFN89A Homo sapiens (Human) atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cardiac muscle tissue morphogenesis [GO:0055008]; cell differentiation [GO:0030154]; definitive erythrocyte differentiation [GO:0060318]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; mitral valve formation [GO:0003192]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of mast cell differentiation [GO:0060377]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive erythrocyte differentiation [GO:0060319]; regulation of chemokine production [GO:0032642]; regulation of definitive erythrocyte differentiation [GO:0010724]; T-helper cell lineage commitment [GO:0002295]; tricuspid valve formation [GO:0003195]; ventricular septum morphogenesis [GO:0060412] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cardiac muscle tissue morphogenesis [GO:0055008]; cell differentiation [GO:0030154]; definitive erythrocyte differentiation [GO:0060318]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; heart development [GO:0007507]; megakaryocyte development [GO:0035855]; megakaryocyte differentiation [GO:0030219]; mitral valve formation [GO:0003192]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of mast cell differentiation [GO:0060377]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive erythrocyte differentiation [GO:0060319]; regulation of chemokine production [GO:0032642]; regulation of definitive erythrocyte differentiation [GO:0010724]; T-helper cell lineage commitment [GO:0002295]; tricuspid valve formation [GO:0003195]; ventricular septum morphogenesis [GO:0060412] GO:0000122; GO:0000785; GO:0002295; GO:0003151; GO:0003181; GO:0003192; GO:0003195; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0007507; GO:0010724; GO:0017053; GO:0030154; GO:0030218; GO:0030219; GO:0030220; GO:0030851; GO:0032091; GO:0032642; GO:0032713; GO:0032729; GO:0035162; GO:0035855; GO:0045599; GO:0045944; GO:0046872; GO:0055008; GO:0060318; GO:0060319; GO:0060377; GO:0060412; GO:0060413; GO:0061629 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] APPGPAR 0.99011 -5.6501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.253 0 0 0 12.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5141 0 0 0 0 0 0 0 0 0 0 0 0 14.0704 0 0 0 0 0 0 0 0 13.0234 0 0 0 0 13.0107 0 0 13.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8445 0 0 0 0 0 0 0 0 0 0 14.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5821 0 0 0 13.4308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2003 0 0 0 13.6705 0 0 0 0 12.9017 Q8NEC5 CTSR1_HUMAN "Cation channel sperm-associated protein 1, CatSper1, hCatSper" CATSPER1 Homo sapiens (Human) calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of ion transmembrane transport [GO:0034765]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of ion transmembrane transport [GO:0034765]; spermatogenesis [GO:0007283] GO:0005227; GO:0005245; GO:0005886; GO:0006816; GO:0007283; GO:0030154; GO:0030317; GO:0034765; GO:0036128; GO:0060296; GO:0097228 calcium activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245] EEGQFQK 0.99011 -21.05 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4107 0 0 0 0 0 0 0 0 11.8377 0 0 0 0 10.2288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4547 0 0 0 12.6706 0 12.5218 13.1104 0 0 0 0 0 0 0 0 0 0 14.9797 0 12.0328 15.8322 13.7287 0 0 0 0 13.7116 0 0 11.7717 0 15.022 0 0 0 0 13.7245 0 14.0709 0 0 0 0 0 0 0 0 13.1296 0 0 0 10.7792 0 0 0 0 0 12.4319 12.9629 13.6987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1791 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BP3 PPWD1_HUMAN "Peptidylprolyl isomerase domain and WD repeat-containing protein 1, EC 5.2.1.8 (Spliceosome-associated cyclophilin)" PPWD1 KIAA0073 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]" catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein peptidyl-prolyl isomerization [GO:0000413]" GO:0000398; GO:0000413; GO:0003755; GO:0005654; GO:0016018; GO:0016604; GO:0071013 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] AAESGSDFQQR 0.99011 -5.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8235 0 14.6622 0 0 0 0 0 0 0 0 0 0 0 0 14.6471 0 0 0 0 13.7257 0 12.3755 0 12.1468 0 12.3908 0 0 0 0 0 0 0 0 12.3708 0 0 0 0 0 0 0 13.4448 0 12.9943 0 0 13.0249 0 0 0 12.7176 0 13.9579 0 11.4237 0 0 0 0 12.8544 0 0 0 0 0 0 0 0 13.1557 0 12.0293 0 0 0 0 0 12.2516 0 0 0 0 0 0 12.9462 0 0 0 0 0 0 0 0 0 0 0 Q96CU9 FXRD1_HUMAN "FAD-dependent oxidoreductase domain-containing protein 1, EC 1.-.-.-" FOXRED1 FP634 Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005737; GO:0005739; GO:0005743; GO:0005747; GO:0016491; GO:0032981 oxidoreductase activity [GO:0016491] FYLGEKIQENNII 0.99011 -5.6544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7851 14.9739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2606 0 0 0 0 0 0 0 0 0 0 0 0 13.3585 0 0 13.6193 13.4771 13.0924 12.7584 0 0 13.1597 0 0 12.5104 13.1119 0 0 13.2591 12.2682 0 0 0 0 0 0 0 0 0 0 12.9223 0 0 0 0 0 11.764 11.8224 0 0 0 0 11.9454 0 0 0 0 0 0 0 11.1746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7839 0 11.9745 0 0 0 14.6905 P10074 TZAP_HUMAN "Telomere zinc finger-associated protein, TZAP (Krueppel-related zinc finger protein 3, hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855)" ZBTB48 HKR3 TZAP ZNF855 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]" "chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]" GO:0000781; GO:0000976; GO:0000978; GO:0003691; GO:0003700; GO:0005634; GO:0006357; GO:0010833; GO:0042802; GO:0045893; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976] AKHRNER 0.99012 -19.539 0 0 0 0 0 0 0 0 10.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3415 13.4267 14.1802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1355 0 0 0 0 0 0 15.132 0 15.0409 0 0 0 13.9188 0 13.3051 13.7113 13.313 13.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4935 0 0 14.7493 0 0 0 0 0 0 0 0 0 0 0 12.8721 14.7485 0 0 0 0 0 0 0 13.4875 0 14.8867 0 0 0 0 0 0 0 0 0 13.3955 0 0 0 0 0 0 0 0 0 14.7296 0 0 0 0 0 0 P60228 EIF3E_HUMAN "Eukaryotic translation initiation factor 3 subunit E, eIF3e (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48)" EIF3E EIF3S6 INT6 Homo sapiens (Human) "formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; negative regulation of translational initiation [GO:0045947]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" GO:0000184; GO:0001732; GO:0003723; GO:0003743; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016020; GO:0016282; GO:0016605; GO:0033290; GO:0045296; GO:0045727; GO:0045947; GO:0047485; GO:0070062; GO:0071540; GO:1902416 cadherin binding [GO:0045296]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] HLVFPLLEFLSVKEIYNEKELLQGK 0.99012 -5.656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2171 0 0 0 0 0 0 16.2491 0 0 0 0 0 0 0 14.9789 14.2104 0 14.4 15.3186 14.7579 14.57 13.8131 0 0 0 0 0 14.8202 0 14.2484 0 13.8816 13.7087 0 14.4223 0 15.3618 14.5141 0 14.4635 0 14.2934 13.7699 0 11.7093 0 0 0 14.0867 13.6559 13.7982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4584 0 0 0 0 0 0 0 0 0 12.7672 0 0 0 0 12.9139 0 0 0 0 13.7804 14.0458 0 0 0 0 0 0 Q08ER8 ZN543_HUMAN Zinc finger protein 543 ZNF543 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGKAFR 0.99012 -5.6584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPF5 DMAP1_HUMAN "DNA methyltransferase 1-associated protein 1, DNMAP1, DNMT1-associated protein 1" DMAP1 KIAA1425 Homo sapiens (Human) "DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]; response to ethanol [GO:0045471]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]; response to ethanol [GO:0045471]" GO:0000122; GO:0000786; GO:0000812; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0006355; GO:0016573; GO:0035267; GO:0040008; GO:0042307; GO:0042981; GO:0043486; GO:0043967; GO:0043968; GO:0045471; GO:0045892; GO:0045893; GO:0051726; GO:0061629; GO:1905168; GO:2000779 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] HRHEALAR 0.99012 -19.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1193 0 0 13.3184 0 12.7274 0 0 0 13.979 16.1781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHD8 SEPT9_HUMAN "Septin-9 (MLL septin-like fusion protein MSF-A, MLL septin-like fusion protein) (Ovarian/Breast septin, Ov/Br septin) (Septin D1)" SEPTIN9 KIAA0991 MSF SEPT9 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104] GO:0001725; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005930; GO:0005940; GO:0008104; GO:0015629; GO:0015630; GO:0031105; GO:0032153; GO:0045296; GO:0048471; GO:0060090; GO:0061640; GO:0097730; GO:1902857 cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] AMKQGFEFNIMVVGQSGLGKSTLINTLFK 0.99012 -19.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6172 0 0 10.036 0 0 0 0 0 0 0 12.0787 0 0 0 0 0 0 10.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1457 11.7454 0 0 15.4298 0 13.8264 12.8573 0 0 0 0 12.8357 0 14.0761 14.2091 15.6452 0 12.4616 0 13.3034 14.1558 13.4213 0 0 14.6112 13.4391 13.1393 0 0 0 0 0 0 0 14.5416 0 13.6899 0 12.9024 10.938 0 0 15.4273 13.0999 14.2293 0 13.5803 0 12.9007 13.5288 12.5733 0 0 12.456 0 12.5977 0 0 12.2223 0 0 11.7204 0 13.7897 10.8338 0 0 0 0 12.8259 10.9497 0 0 0 0 0 13.7084 12.57 12.3968 12.5953 12.0236 12.5688 14.1716 11.5916 12.9785 12.9502 12.3427 11.8653 12.318 11.8285 13.4539 0 13.6522 11.9651 0 14.4708 0 11.8686 0 0 A0A1B0GVH7 IQCM_HUMAN IQ domain-containing protein M IQCM Homo sapiens (Human) AFYDWRGFVLTR 0.99013 -19.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1842 11.6342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3961 0 0 0 11.6013 0 0 0 0 0 0 0 0 0 10.9802 0 0 0 0 13.1362 0 12.2519 0 0 0 0 0 14.7039 16.2632 0 0 0 16.3728 0 17.3528 16.5545 16.7133 15.9259 16.0493 16.8039 16.4783 16.6904 16.2464 15.9095 16.1539 16.3909 16.2946 16.0437 16.4528 16.3245 17.5218 0 0 0 13.4126 0 0 0 14.3306 0 0 0 0 0 0 15.8378 0 0 16.7739 0 0 0 12.5644 0 0 12.2541 0 0 0 0 13.1601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2608 0 0 0 12.5183 0 0 0 0 0 15.9132 16.1911 0 0 0 10.1438 12.5126 9.91453 0 12.2674 0 0 0 0 0 O43301 HS12A_HUMAN Heat shock 70 kDa protein 12A HSPA12A KIAA0417 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524] GO:0005524; GO:0005634; GO:0005737; GO:0070062 ATP binding [GO:0005524] IFGEDFIEQFKIK 0.99013 -19.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0407 0 0 0 0 12.5446 0 11.8011 11.7316 11.8027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0758 0 11.6335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5774 0 14.502 0 16.175 15.1247 14.6639 15.5864 14.9474 0 14.0252 17.155 14.667 14.1303 16.6188 15.1143 14.4583 14.127 14.9826 14.4362 14.1127 0 0 16.0281 0 14.9606 14.0296 0 0 0 14.8807 14.2859 13.0712 14.2538 15.0796 14.5897 0 0 13.769 0 14.4848 15.3285 0 0 15.9735 13.8027 0 0 13.8178 14.4048 15.5249 0 0 0 13.9324 0 13.5427 14.9023 0 13.5886 13.7613 0 0 0 0 14.3128 0 13.8378 15.2393 16.2197 15.6781 15.3549 13.9243 13.5977 0 0 13.6079 0 0 14.1042 15.4948 0 13.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7879 16.17 14.1263 0 0 0 0 12.1184 Q08E93 F27E3_HUMAN Protein FAM27E3 FAM27E3 Homo sapiens (Human) ENGRHTHTYTHRHTHR 0.99013 -19.303 0 0 0 0 12.1887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7557 0 0 0 0 0 0 13.1017 0 0 0 13.6432 0 0 0 0 0 0 12.7089 0 0 0 0 0 0 12.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6M2 FBX33_HUMAN F-box only protein 33 FBXO33 FBX33 Homo sapiens (Human) positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] SCF ubiquitin ligase complex [GO:0019005] SCF ubiquitin ligase complex [GO:0019005]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0016567; GO:0019005; GO:0031146; GO:0031398 ASASCSHWR 0.99013 -19.989 0 0 0 0 0 0 0 0 12.5501 12.6735 13.0299 12.5446 0 12.6229 0 12.3547 0 0 0 0 0 0 12.9129 0 0 12.405 0 13.0294 0 12.1536 12.5422 0 12.4195 12.356 0 12.5642 0 12.6529 12.3197 0 12.3197 0 12.3686 12.584 12.448 12.5803 11.8246 12.4886 13.3266 0 0 0 13.2494 12.9359 13.3467 13.2572 12.7557 14.401 14.1412 13.3707 12.7037 0 12.2554 13.2268 14.2056 14.7716 0 0 0 0 0 0 0 0 0 10.3112 0 0 0 0 0 13.5243 0 0 13.272 0 0 0 0 0 0 12.6807 0 0 0 0 14.5193 16.6803 0 11.4476 0 13.6681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0031 0 0 0 0 0 0 12.0159 15.3155 0 0 12.7636 0 12.8405 0 0 0 13.1204 0 0 0 0 0 0 0 15.5361 0 0 0 0 0 0 0 0 0 15.8347 0 0 0 0 0 0 14.1783 0 0 0 0 0 0 0 14.2669 0 0 0 0 0 0 0 Q8NDP4 ZN439_HUMAN Zinc finger protein 439 ZNF439 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ACECQEYGPKPWK 0.99013 -19.667 0 0 0 0 0 0 0 0 0 0 0 10.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 11.774 0 12.9856 0 0 0 0 10.0157 0 10.8345 0 0 0 0 0 0 10.9812 12.6437 13.2769 0 0 0 0 0 0 0 0 0 0 0 0 10.215 0 0 0 0 0 0 0 0 0 13.3523 0 13.3365 0 0 0 0 0 10.7712 0 14.1547 0 0 0 12.9951 0 0 0 14.1474 14.5902 14.7908 0 0 0 0 0 13.9019 11.4764 12.3206 0 0 0 13.8815 0 14.6103 12.773 0 12.8664 15.0317 0 13.0721 0 0 14.139 0 0 0 0 0 11.8366 0 0 0 0 0 0 0 0 12.7788 0 12.6626 0 14.7671 0 0 0 0 0 14.8532 14.8132 0 0 0 0 0 13.2361 0 0 0 0 0 13.7707 0 0 13.8321 0 0 0 10.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9432 0 0 0 0 0 0 0 Q9NRN9 METL5_HUMAN "rRNA N6-adenosine-methyltransferase METTL5, EC 2.1.1.- (Methyltransferase-like protein 5)" METTL5 DC3 HSPC133 Homo sapiens (Human) positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863] anchoring junction [GO:0070161]; cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793] anchoring junction [GO:0070161]; cell projection [GO:0042995]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; stem cell differentiation [GO:0048863] GO:0003676; GO:0005634; GO:0008988; GO:0016740; GO:0031167; GO:0042995; GO:0045727; GO:0048863; GO:0070161; GO:0098793; GO:0098794; GO:1904047 nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740] AAEWKIKIDIIAELR 0.99013 -5.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9133 13.9399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75901 RASF9_HUMAN "Ras association domain-containing protein 9 (PAM COOH-terminal interactor protein 1, P-CIP1) (Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor)" RASSF9 PAMCI PCIP1 Homo sapiens (Human) endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; protein targeting [GO:0006605]; signal transduction [GO:0007165] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; recycling endosome [GO:0055037]; trans-Golgi network transport vesicle membrane [GO:0012510]; endosomal transport [GO:0016197]; intracellular transport [GO:0046907]; protein targeting [GO:0006605]; signal transduction [GO:0007165] GO:0005768; GO:0005829; GO:0006605; GO:0007165; GO:0012510; GO:0016197; GO:0046907; GO:0055037; GO:0070062 AGLKIHSHLSGIQKEIK 0.99014 -5.6944 0 0 0 0 0 0 0 0 10.6274 0 0 0 0 0 0 12.9047 0 0 0 0 0 0 0 0 0 0 0 9.64294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7224 0 14.7725 0 0 12.983 0 0 0 0 0 0 0 0 0 0 12.1138 0 0 0 0 0 0 0 11.7237 0 0 0 12.6769 0 13.0251 0 0 0 0 0 13.3817 13.2884 0 0 0 0 0 0 12.5257 0 0 0 0 12.2292 0 0 0 0 13.8696 0 0 0 0 12.9717 0 0 0 0 0 0 0 14.1829 0 0 0 0 0 0 15.7403 0 15.1843 12.1992 0 0 12.2106 11.2518 0 0 0 11.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.638 0 15.5742 P11047 LAMC1_HUMAN "Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma, S-LAM gamma)" LAMC1 LAMB2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of cell adhesion [GO:0045785]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005615; GO:0005788; GO:0007155; GO:0007492; GO:0009887; GO:0009888; GO:0016477; GO:0022617; GO:0031581; GO:0034446; GO:0035633; GO:0043259; GO:0043260; GO:0045785; GO:0050679; GO:0051149; GO:0062023; GO:0065003; GO:0070062; GO:0098637; GO:0110011; GO:2001046 extracellular matrix structural constituent [GO:0005201] ATAESASECLPCDCNGR 0.99014 -5.7015 10.7184 0 0 0 0 0 0 0 0 11.8886 13.4852 14.2845 11.9144 12.6608 11.8525 0 0 0 0 0 0 0 0 0 13.2322 13.2881 13.5124 0 13.9554 12.9698 13.3719 12.9963 13.6543 0 0 0 12.4281 0 12.4252 0 13.7277 0 16.9283 0 11.014 13.1456 0 0 0 12.6767 14.5886 0 0 0 0 0 13.2222 0 0 15.5219 0 0 0 14.6975 0 0 13.5923 0 12.7802 0 0 10.6721 11.0466 0 0 13.8199 0 12.6948 0 11.5323 13.7818 14.5865 0 14.6717 0 0 14.4584 14.027 0 11.8144 0 14.4291 0 0 14.1114 12.6061 11.7228 12.6658 0 12.5921 0 14.146 13.9882 12.0868 0 12.5225 0 11.795 13.1093 0 0 0 0 0 0 0 0 12.2909 12.4983 13.003 0 0 0 12.7323 11.8652 0 0 13.1195 13.9597 11.7969 0 0 12.1032 0 0 14.3501 13.5166 0 11.9388 13.2996 13.8204 0 12.9899 0 0 0 0 0 14.1783 0 9.45057 0 0 10.867 13.3205 12.1676 0 0 0 0 13.2516 15.379 17.4383 0 0 0 12.1291 0 0 14.9978 10.6937 12.1659 11.7146 10.9327 0 0 0 0 0 12.125 Q16760 DGKD_HUMAN "Diacylglycerol kinase delta, DAG kinase delta, EC 2.7.1.107 (130 kDa diacylglycerol kinase) (Diglyceride kinase delta, DGK-delta)" DGKD KIAA0145 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; signal transduction [GO:0007165] GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007173; GO:0007205; GO:0010033; GO:0015031; GO:0019900; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046834; GO:0046872; GO:0046982; GO:0090038; GO:2000370 ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] AYEKTTESSEESEVMAKK 0.99014 -19.308 0 0 0 0 0 0 0 0 14.3857 0 0 0 0 13.5143 14.6786 0 0 14.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0253 0 16.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6839 0 0 0 0 0 0 12.9945 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0832 0 13.0489 0 0 0 0 0 0 13.2212 0 0 0 0 0 0 0 0 0 0 0 0 13.5185 0 0 0 0 0 16.2555 0 0 0 0 0 0 0 0 0 0 0 15.9669 0 0 0 0 0 0 0 0 0 0 Q67FW5 B3GNL_HUMAN "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1, BGnT-like protein 1, Beta1,3-N-acetylglucosaminyltransferase-like protein 1, Beta3Gn-T-like protein 1, Beta3GnTL1, EC 2.4.1.- (Beta-1,3-N-acetylglucosaminyltransferase 8, BGnT-8, Beta-1,3-Gn-T8, Beta3Gn-T8)" B3GNTL1 B3GNT8 Homo sapiens (Human) glycosyltransferase activity [GO:0016757] GO:0016757 glycosyltransferase activity [GO:0016757] GFYCHEDSQER 0.99014 -19.691 0 0 14.0827 0 0 11.6331 0 0 0 0 0 0 12.6591 0 0 0 12.2051 12.6479 0 0 0 0 0 12.5865 0 0 0 12.4794 0 0 0 0 0 0 0 0 0 12.4397 0 0 0 0 0 0 12.5838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0297 0 0 0 10.351 0 0 13.7054 13.0509 13.6409 0 0 0 0 0 0 0 0 0 0 14.1312 13.3332 12.3722 0 0 10.8995 0 0 0 12.6004 0 0 11.8776 0 0 0 0 0 0 0 0 0 0 0 14.6019 0 12.4498 0 15.8477 0 0 0 0 0 0 12.7192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IFG1 O52E8_HUMAN Olfactory receptor 52E8 (Olfactory receptor OR11-54) OR52E8 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FGLGNISLLLLDVILIILSYVR 0.99014 -19.317 0 0 0 0 0 0 0 0 0 0 10.5735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8812 0 0 0 0 0 0 0 0 13.8993 0 0 0 0 10.3397 11.9664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.859 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0105 0 0 0 0 0 10.0558 10.522 0 0 0 0 0 11.1126 0 0 0 0 0 0 0 0 0 11.4687 0 0 12.8025 0 0 0 0 0 0 0 0 0 0 10.4669 0 0 0 0 0 12.4131 10.974 0 0 0 0 0 0 0 0 Q8IUZ0 LRC49_HUMAN "Leucine-rich repeat-containing protein 49 (Centriolar satellite-associated tubulin polyglutamylase complex regulator 2) (Tubulin polyglutamylase complex subunit 4, PGs4)" LRRC49 CSTPP2 Homo sapiens (Human) outer dynein arm assembly [GO:0036158] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; outer dynein arm assembly [GO:0036158] GO:0005737; GO:0005815; GO:0005874; GO:0036158 LISILGDAR 0.99014 -20.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6735 0 13.7957 13.181 13.3093 0 0 13.2607 0 0 0 0 0 0 0 0 0 0 0 13.2525 13.3749 0 0 13.2264 0 0 0 13.2691 0 13.4975 0 0 0 0 0 0 0 0 0 13.4607 0 13.0687 0 0 0 0 0 0 0 12.4481 0 0 0 0 0 0 13.0836 0 0 0 0 0 0 0 0 14.5411 0 0 Q96PP8 GBP5_HUMAN "Guanylate-binding protein 5, EC 3.6.5.- (GBP-TA antigen) (GTP-binding protein 5, GBP-5) (Guanine nucleotide-binding protein 5)" GBP5 UNQ2427/PRO4987 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; inflammatory response [GO:0006954]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein homotetramerization [GO:0051289]; protein localization to Golgi apparatus [GO:0034067]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; inflammatory response [GO:0006954]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein homotetramerization [GO:0051289]; protein localization to Golgi apparatus [GO:0034067]; response to bacterium [GO:0009617] GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0006954; GO:0009617; GO:0016020; GO:0031410; GO:0032731; GO:0032741; GO:0034067; GO:0042802; GO:0042803; GO:0045089; GO:0048471; GO:0051289; GO:0071346; GO:1900017; GO:1900227 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] AIAHYDQQMGQK 0.99014 -20.102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9424 0 0 0 12.1472 0 0 0 0 0 0 0 0 12.8168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0949 0 0 0 0 12.2922 0 0 0 0 0 0 0 0 0 0 0 0 0 12.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2047 0 0 0 0 0 0 0 0 0 0 0 13.0431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.78 15.7494 0 0 0 0 0 0 0 0 0 0 0 0 Q96TA1 NIBA2_HUMAN "Protein Niban 2 (Meg-3) (Melanoma invasion by ERK, MINERVA) (Niban-like protein 1) (Protein FAM129B)" NIBAN2 C9orf88 FAM129B Homo sapiens (Human) "axon guidance [GO:0007411]; cell differentiation [GO:0030154]; gonadotropin secretion [GO:0032274]; hypomethylation of CpG island [GO:0044029]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of embryonic development [GO:0040019]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]" adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; gonadotropin secretion [GO:0032274]; hypomethylation of CpG island [GO:0044029]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of embryonic development [GO:0040019]; positive regulation of skeletal muscle fiber development [GO:0048743]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0007411; GO:0008285; GO:0016525; GO:0030154; GO:0030948; GO:0032274; GO:0040019; GO:0043066; GO:0044029; GO:0045296; GO:0045746; GO:0045892; GO:0045893; GO:0048743; GO:0070062; GO:2000279; GO:2000679 cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713] EELCKSIQRVLER 0.99014 -20.095 0 0 12.1677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1368 0 14.534 0 0 0 0 10.4439 0 0 0 0 0 14.8283 0 0 0 0 13.6415 0 0 0 0 14.4926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4431 0 0 0 12.4629 0 0 0 0 0 0 0 0 0 0 0 12.8069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2054 0 0 0 0 0 0 0 0 11.5035 0 15.2905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTA9 WAC_HUMAN WW domain-containing adapter protein with coiled-coil WAC KIAA1844 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone monoubiquitination [GO:0010390]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]" GO:0000993; GO:0003682; GO:0005634; GO:0005654; GO:0005681; GO:0006325; GO:0006974; GO:0010390; GO:0010506; GO:0016239; GO:0016607; GO:0031571; GO:0032435; GO:0045893; GO:0071894; GO:1904263 chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993] EWLEREQR 0.99014 -19.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9349 0 0 12.9327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2277 0 12.6816 0 0 0 0 0 0 0 0 0 0 12.7153 0 0 0 0 0 13.1589 0 0 0 0 0 13.2419 0 0 0 0 0 0 0 13.2496 0 0 0 0 0 0 0 0 0 0 0 0 13.0727 0 0 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3026 0 Q9H9B1 EHMT1_HUMAN "Histone-lysine N-methyltransferase EHMT1, EC 2.1.1.-, EC 2.1.1.367 (Euchromatic histone-lysine N-methyltransferase 1, Eu-HMTase1) (G9a-like protein 1, GLP, GLP1) (Histone H3-K9 methyltransferase 5, H3-K9-HMTase 5) (Lysine N-methyltransferase 1D)" EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone H3-K9 methylation [GO:0051567]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; regulation of histone H3-K9 methylation [GO:0051570]" chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone H3-K9 methylation [GO:0051567]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; regulation of histone H3-K9 methylation [GO:0051570]" GO:0000122; GO:0000785; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006306; GO:0006325; GO:0008168; GO:0008270; GO:0016279; GO:0016571; GO:0016604; GO:0018024; GO:0018026; GO:0018027; GO:0045892; GO:0045995; GO:0046974; GO:0046976; GO:0051567; GO:0051570; GO:0070742; GO:0120162 C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] AQKMDGESEEEQESVDTGEEEEGGDESDLSSESSIK 0.99014 -19.736 0 12.9303 0 0 0 0 0 0 0 11.785 0 12.095 0 0 0 0 0 0 0 0 11.298 0 0 0 11.6785 11.1291 0 0 0 0 0 0 0 0 13.5746 0 12.1034 0 0 0 0 0 0 0 0 14.1219 0 0 0 0 0 12.9412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7729 0 13.2237 0 0 0 0 0 11.9852 0 0 0 12.2447 16.2994 0 12.8131 13.6462 15.5037 0 0 0 0 0 15.1629 11.9968 16.1593 11.872 11.9082 0 12.9947 11.2094 0 13.6215 13.0117 12.4708 12.1376 12.4933 0 13.2945 15.9983 16.294 13.1907 13.5049 0 14.9574 14.9642 0 0 0 14.469 0 11.6729 13.8816 14.6679 14.2273 0 13.1376 16.9845 13.21 12.6023 0 0 13.7142 0 0 0 0 0 0 0 0 0 11.0476 14.8846 0 12.577 0 0 11.4514 0 0 0 0 12.6539 12.5704 0 0 0 0 13.9578 0 0 0 0 17.0013 0 12.4981 0 P07900 HS90A_HUMAN "Heat shock protein HSP 90-alpha, EC 3.6.4.10 (Heat shock 86 kDa, HSP 86, HSP86) (Lipopolysaccharide-associated protein 2, LAP-2, LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)" HSP90AA1 HSP90A HSPC1 HSPCA Homo sapiens (Human) activation of innate immune response [GO:0002218]; axon extension [GO:0048675]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; cellular response to virus [GO:0098586]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; mitochondrial transport [GO:0006839]; neuron migration [GO:0001764]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; regulation of apoptotic process [GO:0042981]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004] apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524] apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTP binding [GO:0005525]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; Rho GDP-dissociation inhibitor binding [GO:0051022]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134]; activation of innate immune response [GO:0002218]; axon extension [GO:0048675]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; cellular response to virus [GO:0098586]; central nervous system neuron axonogenesis [GO:0021955]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; establishment of cell polarity [GO:0030010]; mitochondrial transport [GO:0006839]; neuron migration [GO:0001764]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomerase activity [GO:0051973]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; regulation of apoptotic process [GO:0042981]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004] GO:0001764; GO:0001934; GO:0002134; GO:0002135; GO:0002218; GO:0002230; GO:0003009; GO:0003723; GO:0003729; GO:0005524; GO:0005525; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006839; GO:0006986; GO:0007004; GO:0009408; GO:0009409; GO:0009410; GO:0009651; GO:0009986; GO:0010592; GO:0010659; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0017098; GO:0019903; GO:0021955; GO:0023026; GO:0030010; GO:0030235; GO:0030911; GO:0031396; GO:0031526; GO:0031625; GO:0032273; GO:0032564; GO:0032728; GO:0032880; GO:0032991; GO:0033138; GO:0034605; GO:0034774; GO:0042026; GO:0042220; GO:0042307; GO:0042470; GO:0042802; GO:0042803; GO:0042826; GO:0042981; GO:0043025; GO:0043202; GO:0043209; GO:0043254; GO:0043335; GO:0043627; GO:0044183; GO:0044294; GO:0044295; GO:0044325; GO:0045040; GO:0045429; GO:0045732; GO:0045793; GO:0046677; GO:0048156; GO:0048471; GO:0048675; GO:0050821; GO:0051020; GO:0051022; GO:0051082; GO:0051131; GO:0051897; GO:0051973; GO:0060452; GO:0061684; GO:0062023; GO:0070062; GO:0070182; GO:0071682; GO:0097110; GO:0097226; GO:0097524; GO:0097718; GO:0098586; GO:1902949; GO:1904813; GO:1905323; GO:1990782 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTP binding [GO:0005525]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; Rho GDP-dissociation inhibitor binding [GO:0051022]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134] EMLQQSKILKVIR 0.99015 -5.708 0 0 0 0 0 0 10.1819 0 14.6295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3375 0 0 0 0 0 0 0 0 0 13.6968 0 0 0 0 0 0 0 0 0 0 0 0 13.8832 0 0 0 13.5846 0 0 11.4764 0 0 0 14.2711 0 14.6977 0 0 0 0 0 0 0 0 0 13.2611 0 0 0 0 0 0 0 0 11.8995 0 0 0 0 0 0 0 0 0 0 0 0 13.8095 0 0 0 13.4297 11.1549 11.1132 0 14.8748 14.0179 14.6048 0 0 0 11.371 0 0 12.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3439 0 0 0 0 0 P30532 ACHA5_HUMAN Neuronal acetylcholine receptor subunit alpha-5 CHRNA5 NACHRA5 Homo sapiens (Human) "behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; dopaminergic synapse [GO:0098691]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" GO:0005231; GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0015276; GO:0015464; GO:0022848; GO:0030594; GO:0034220; GO:0035094; GO:0035095; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051899; GO:0070161; GO:0098691; GO:1904315; GO:2000300 acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] AARGSGPR 0.99015 -5.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1858 0 0 0 0 0 0 0 0 0 10.589 10.6718 0 15.3518 0 0 0 11.9011 0 0 0 0 0 0 12.1592 0 0 0 0 0 0 0 0 13.3666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7419 0 0 0 0 0 0 0 0 0 0 12.5445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5136 0 0 0 0 0 0 0 13.9122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2614 0 0 0 0 0 0 0 0 0 13.2101 0 0 0 P47914 RL29_HUMAN 60S ribosomal protein L29 (Cell surface heparin-binding protein HIP) (Large ribosomal subunit protein eL29) RPL29 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; embryo implantation [GO:0007566]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; cadherin binding [GO:0045296]; heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; embryo implantation [GO:0007566]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0007566; GO:0008201; GO:0016020; GO:0022625; GO:0022626; GO:0045296 cadherin binding [GO:0045296]; heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] FAKKHNK 0.99015 -5.8509 0 0 0 0 0 0 0 0 0 17.2165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6718 0 0 0 14.318 0 0 0 0 0 12.1725 0 0 0 0 0 0 0 0 0 11.942 0 0 0 0 0 0 0 0 0 0 0 0 14.5038 0 0 0 0 0 0 0 12.0065 0 12.0256 0 0 0 0 0 0 0 0 0 0 0 14.2618 0 0 0 17.3758 0 0 0 0 0 0 0 0 0 13.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2993 0 0 0 18.2196 12.861 0 0 12.2786 0 0 0 0 0 0 0 15.7761 0 0 0 0 0 Q12788 TBL3_HUMAN Transducin beta-like protein 3 (WD repeat-containing protein SAZD) TBL3 SAZD Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]" 90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]" GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0030686; GO:0032040; GO:0034511 RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] ALGLAISLDRPHTVLTVIQAIRR 0.99015 -19.381 0 0 0 0 0 0 0 11.7513 0 0 13.8995 0 0 0 0 0 0 0 0 0 0 11.794 0 0 0 0 0 0 0 0 0 0 10.7886 0 0 0 12.2561 0 0 0 11.3923 0 0 0 10.7061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4919 0 0 12.884 0 0 0 0 11.6724 11.0265 0 0 14.0003 13.4101 0 0 0 13.4234 0 0 14.6354 0 11.9201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5626 0 14.6485 0 0 0 0 13.9288 0 0 0 0 0 0 0 0 0 0 12.9021 13.5848 0 0 0 12.8273 12.5513 0 0 0 0 0 0 12.4974 0 12.3279 0 0 0 0 0 12.3638 0 0 0 12.1824 0 11.8691 0 0 0 0 0 0 0 0 0 13.0295 0 0 0 0 0 13.5366 0 0 0 0 0 0 0 0 0 0 0 0 Q32MQ0 ZN750_HUMAN Zinc finger protein 750 ZNF750 Homo sapiens (Human) cell differentiation [GO:0030154]; epidermis development [GO:0008544]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000122; GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0008544; GO:0010719; GO:0030154; GO:0045944; GO:0046872; GO:1990841 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KAKLQDTAR 0.99015 -19.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5626 0 0 0 0 0 0 0 0 0 0 0 0 13.2877 0 0 0 0 0 0 0 13.5122 0 0 0 13.645 12.0065 0 0 0 0 13.8648 0 0 0 0 11.6891 0 0 12.9438 12.8138 12.4943 12.7086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6AI39 BICRL_HUMAN BRD4-interacting chromatin-remodeling complex-associated protein-like (Glioma tumor suppressor candidate region gene 1 protein-like) BICRAL GLTSCR1L KIAA0240 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; GBAF complex [GO:0140288]; SWI/SNF complex [GO:0016514] "chromatin [GO:0000785]; GBAF complex [GO:0140288]; SWI/SNF complex [GO:0016514]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:1902459 PAAKQLTK 0.99015 -5.7173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6GQQ9 OTU7B_HUMAN "OTU domain-containing protein 7B, EC 3.4.19.12 (Cellular zinc finger anti-NF-kappa-B protein, Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne)" OTUD7B ZA20D1 Homo sapiens (Human) adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947; GO:1900181; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; zinc ion binding [GO:0008270] ALYALMEK 0.99015 -19.777 0 0 0 0 0 0 0 0 0 12.6989 0 0 0 0 9.21177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89175 0 0 0 0 0 0 0 0 0 11.689 0 0 0 0 0 0 0 0 12.3813 0 0 0 0 14.8151 0 0 0 0 13.8886 0 0 10.6428 10.4202 0 0 0 0 0 0 0 0 0 0 0 11.8456 0 0 0 0 0 0 0 0 12.8008 0 0 0 0 0 0 0 12.515 0 0 13.4601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1271 0 0 0 0 14.4831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VF2 IGFN1_HUMAN Immunoglobulin-like and fibronectin type III domain-containing protein 1 (EEF1A2-binding protein 1) (KY-interacting protein 1) IGFN1 EEF1A2BP1 KYIP1 Homo sapiens (Human) homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018] nucleus [GO:0005634]; synapse [GO:0045202]; Z disc [GO:0030018]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] GO:0005634; GO:0007156; GO:0007416; GO:0010842; GO:0030018; GO:0045202 APPAPKKK 0.99015 -21.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1253 0 0 0 0 0 0 0 0 13.7738 0 0 0 0 0 0 0 0 0 0 0 14.1384 0 0 0 14.2098 0 0 0 0 0 0 0 0 0 0 0 0 14.5837 0 0 0 0 0 0 0 0 0 0 13.0588 0 0 0 0 0 0 0 0 0 0 0 13.7663 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5362 0 0 0 0 14.3913 0 0 0 0 0 0 Q96MG2 JSPR1_HUMAN "Junctional sarcoplasmic reticulum protein 1 (Junctional-face membrane protein of 45 kDa homolog, JP-45)" JSRP1 JP45 Homo sapiens (Human) regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; skeletal muscle contraction [GO:0003009] sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017] sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; skeletal muscle contraction [GO:0003009] GO:0003009; GO:0016529; GO:0033017; GO:0060314 AAREPREALPQR 0.99015 -20.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9853 15.1896 14.7609 15.1379 0 0 0 14.623 15.2561 0 0 0 0 0 0 0 0 0 0 13.2793 0 0 12.2767 0 0 0 13.5158 0 0 0 13.1428 0 13.345 14.1159 14.9653 0 13.9353 0 0 13.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0231 0 0 0 0 0 11.2647 0 0 13.2279 0 13.0646 0 0 0 0 13.0025 0 0 0 0 0 11.5156 0 Q9NZJ7 MTCH1_HUMAN Mitochondrial carrier homolog 1 (Presenilin-associated protein) MTCH1 PSAP CGI-64 UNQ1871/PRO4314 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; neuronal ion channel clustering [GO:0045161]; positive regulation of apoptotic process [GO:0043065]; regulation of signal transduction [GO:0009966] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; neuronal ion channel clustering [GO:0045161]; positive regulation of apoptotic process [GO:0043065]; regulation of signal transduction [GO:0009966] GO:0005739; GO:0005741; GO:0006915; GO:0006919; GO:0009966; GO:0016020; GO:0016021; GO:0043065; GO:0045161 CMVQFVGREAK 0.99015 -19.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53814 SMTN_HUMAN Smoothelin SMTN SMSMO Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; actin cytoskeleton organization [GO:0030036]; muscle organ development [GO:0007517]; smooth muscle contraction [GO:0006939] GO:0003779; GO:0005737; GO:0005815; GO:0005856; GO:0006939; GO:0007517; GO:0008307; GO:0015629; GO:0030036; GO:0031941 actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] AALRELR 0.99016 -21.046 0 0 0 12.75 0 0 0 0 0 0 0 13.5664 0 0 0 13.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6904 0 0 0 0 9.86614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2754 0 0 15.5508 0 0 13.9434 0 12.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 13.02 0 0 0 0 0 0 0 0 0 0 0 12.9876 0 14.5179 13.8164 0 0 0 0 8.98866 0 13.1279 0 0 0 0 0 13.7599 0 13.4157 13.3994 0 15.4369 15.377 0 0 0 13.6969 0 0 0 14.9365 0 0 0 0 0 0 14.9591 0 0 0 0 0 0 0 0 0 0 13.9482 16.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0489 0 0 13.4069 0 0 0 0 Q6IA69 NADE_HUMAN "Glutamine-dependent NAD(+) synthetase, EC 6.3.5.1 (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase)" NADSYN1 Homo sapiens (Human) 'de novo' NAD biosynthetic process [GO:0034627]; NAD biosynthetic process [GO:0009435] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; 'de novo' NAD biosynthetic process [GO:0034627]; NAD biosynthetic process [GO:0009435] GO:0003952; GO:0004359; GO:0005524; GO:0005737; GO:0005829; GO:0009435; GO:0034627 ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952] ILTTCYMASK 0.99016 -5.7358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4761 11.1819 11.8031 0 0 11.3772 13.0509 12.2235 12.5604 13.6069 0 11.8641 13.5337 10.9201 0 0 0 0 0 0 0 0 0 0 0 11.4816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6617 0 0 0 0 0 15.0399 15.0452 0 14.8284 0 0 0 0 0 0 0 0 14.003 0 0 0 14.9798 0 14.9872 15.9766 0 0 0 0 0 0 14.1319 15.164 0 14.306 0 0 16.24 14.1312 15.8721 0 11.5245 0 0 14.0827 13.8944 0 12.3198 14.2604 14.2184 0 0 0 14.3819 0 0 14.5359 14.0417 0 14.2344 0 0 0 0 16.8189 0 14.285 0 14.4077 0 0 14.1253 14.0463 0 0 0 13.8303 0 0 0 10.3852 14.3571 14.0004 11.3546 14.1163 13.7768 13.9364 13.3239 0 0 0 0 0 0 0 0 13.4204 0 0 0 0 13.0499 14.6348 0 14.4436 13.9357 0 0 0 0 0 Q96BZ8 LENG1_HUMAN Leukocyte receptor cluster member 1 LENG1 Homo sapiens (Human) ALQEGQPEEDETDDR 0.99016 -19.881 0 0 0 0 0 0 0 0 0 11.2003 0 11.0316 0 11.3363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7487 0 0 0 0 0 0 13.6712 13.69 0 0 12.9552 12.7582 0 0 15.6755 13.315 0 13.5626 13.6312 13.6755 12.6518 0 0 0 11.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5145 0 0 0 0 12.2383 0 12.793 0 0 0 0 0 0 0 0 0 0 0 12.3713 0 0 0 0 0 0 0 0 0 0 0 0 0 11.64 0 0 0 0 12.5114 12.0116 0 0 0 0 0 0 0 11.5002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96I27 ZN625_HUMAN Zinc finger protein 625 ZNF625 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ALMCLSLYLIHK 0.99016 -1.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9044 0 0 0 11.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1595 0 0 0 0 0 0 Q9NR77 PXMP2_HUMAN Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane protein) PXMP2 PMP22 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991] GO:0005737; GO:0005739; GO:0005778; GO:0005829; GO:0016020; GO:0016021; GO:0032991 AATSGILSALGNFLAQMIEKKR 0.99016 -21.05 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3329 0 0 12.5752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3403 0 0 0 12.5615 12.3671 0 0 0 0 13.7567 0 13.8405 0 12.6616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5912 0 0 16.8015 12.3458 13.0909 0 0 0 12.4162 12.6993 0 0 0 0 0 0 0 0 13.4272 13.5083 14.3594 12.8914 0 15.2055 0 0 0 0 12.9891 14.6871 12.9694 14.1868 13.3957 14.2475 0 0 0 14.6532 0 0 0 0 0 0 0 0 0 0 0 0 14.5407 0 0 0 12.6417 0 0 0 0 0 0 0 0 0 0 13.7809 0 0 0 0 0 0 0 14.4387 0 0 13.5751 0 0 P08648 ITA5_HUMAN Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain ] ITGA5 FNRA Homo sapiens (Human) "angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]" alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202] "alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0001525; GO:0001618; GO:0001726; GO:0005154; GO:0005161; GO:0005178; GO:0005783; GO:0005794; GO:0005886; GO:0005925; GO:0007044; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007229; GO:0007565; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0010811; GO:0023035; GO:0030335; GO:0030949; GO:0031410; GO:0031589; GO:0033627; GO:0033631; GO:0034113; GO:0034674; GO:0035313; GO:0035987; GO:0043184; GO:0045202; GO:0046872; GO:0050731; GO:0071062; GO:0098609; GO:1903672; GO:2000811 epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618] AEGSYGVPLWIIILAILFGLLLLGLLIYILYKLGFFK 0.99017 -19.538 0 0 0 0 0 0 0 0 16.472 15.7477 0 0 0 0 13.1 0 0 0 0 13.1089 0 0 0 0 0 0 0 10.932 0 10.6207 0 0 10.2437 11.2006 0 10.5083 0 13.5528 0 0 0 0 0 0 0 0 11.8597 0 0 0 12.2303 0 0 12.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6101 0 11.6741 0 12.6409 0 12.9397 0 0 0 0 0 0 14.7448 0 14.3488 13.6723 0 0 0 0 13.4587 0 0 15.9621 0 0 0 0 0 13.2163 0 0 0 11.1255 0 0 0 0 13.4375 0 0 0 0 0 0 0 12.3311 10.9919 11.1412 0 14.9125 12.8112 0 12.4564 0 0 0 0 0 0 13.3192 0 0 0 13.4631 13.6028 0 0 0 12.736 11.953 0 13.4966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.691 0 15.9192 0 0 0 0 0 13.0709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08887 IL6RA_HUMAN "Interleukin-6 receptor subunit alpha, IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA (IL-6R 1) (Membrane glycoprotein 80, gp80) (CD antigen CD126) [Cleaved into: Soluble interleukin-6 receptor subunit alpha, sIL6R ]" IL6R Homo sapiens (Human) acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573] apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803]; acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573] GO:0002384; GO:0002446; GO:0002548; GO:0002690; GO:0004896; GO:0004915; GO:0004921; GO:0005576; GO:0005615; GO:0005886; GO:0005896; GO:0006953; GO:0008284; GO:0009897; GO:0010536; GO:0010573; GO:0016324; GO:0019221; GO:0019899; GO:0019955; GO:0019970; GO:0019981; GO:0031018; GO:0032717; GO:0032722; GO:0032755; GO:0032966; GO:0034097; GO:0042531; GO:0042803; GO:0043235; GO:0043410; GO:0045669; GO:0048661; GO:0050731; GO:0050829; GO:0050830; GO:0070102; GO:0070110; GO:0070119; GO:0070120; GO:0072126; GO:0072540; GO:0097191; GO:1901731 ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803] PAAGSHPSR 0.99017 -5.7444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4839 0 0 0 0 0 0 0 0 12.4875 0 0 15.0692 0 0 13.4274 0 0 0 0 0 0 0 0 0 0 0 0 12.2496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59025 RTP1_HUMAN Receptor-transporting protein 1 (3CxxC-type zinc finger protein 1) RTP1 Z3CXXC1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; olfactory receptor binding [GO:0031849]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] GO:0001580; GO:0005886; GO:0006612; GO:0009986; GO:0016021; GO:0031849; GO:0051205 olfactory receptor binding [GO:0031849] LRCPALHLPSLSVFSLRWK 0.99017 -5.7433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15654 TRIP6_HUMAN "Thyroid receptor-interacting protein 6, TR-interacting protein 6, TRIP-6 (Opa-interacting protein 1, OIP-1) (Zyxin-related protein 1, ZRP-1)" TRIP6 OIP1 Homo sapiens (Human) chordate embryonic development [GO:0043009]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA binding [GO:0003723]; chordate embryonic development [GO:0043009]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165] GO:0001725; GO:0003723; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007165; GO:0019900; GO:0030335; GO:0043009; GO:0046872; GO:0046966; GO:0048041; GO:1901224 interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA binding [GO:0003723] CEECGLLLSSEGECQGCYPLDGHILCK 0.99017 -1.8601 0 0 0 0 0 0 0 0 0 13.3442 0 0 0 0 0 0 12.92 0 0 0 0 0 0 0 12.5202 0 0 0 11.2204 0 0 0 0 0 0 0 0 0 13.1708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4062 11.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2392 0 0 0 13.9134 0 0 0 0 0 14.0895 0 0 12.8225 0 0 0 0 0 0 0 0 0 12.253 0 12.7669 0 0 0 0 0 12.5834 0 0 0 0 0 0 0 0 0 0 0 0 12.0618 0 12.6433 0 0 0 0 0 12.4473 14.0213 0 Q5VZE5 NAA35_HUMAN "N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)" NAA35 EGAP MAK10 Homo sapiens (Human) N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659] GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006474; GO:0017196; GO:0031417; GO:0043066; GO:0048659 ASVDDDDSGWELSMPEKMEK 0.99017 -19.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4034 0 0 0 0 0 12.1101 13.107 14.9808 0 15.7209 0 0 0 0 0 0 12.5642 0 0 13.5322 0 0 12.3663 14.8852 0 0 12.5508 0 12.3219 0 0 12.2561 0 15.1275 13.9317 0 11.3838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9817 11.6818 0 0 0 0 0 0 0 0 12.2304 16.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7901 0 12.7206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6178 0 0 13.5242 0 0 0 0 0 0 0 0 0 0 0 12.5324 0 0 0 0 0 0 12.8776 0 0 0 12.5577 11.845 0 0 16.6673 0 0 0 0 0 0 0 13.6997 0 0 13.1283 0 12.4261 0 0 0 0 12.6706 12.4469 12.4326 0 12.4365 10.5693 0 0 0 0 0 12.4432 0 Q9HA92 RSAD1_HUMAN "Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (Putative heme chaperone)" RSAD1 Homo sapiens (Human) porphyrin-containing compound biosynthetic process [GO:0006779] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]" GO:0004109; GO:0005737; GO:0005739; GO:0006779; GO:0020037; GO:0046872; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; heme binding [GO:0020037]; metal ion binding [GO:0046872]" ALPGARAR 0.99017 -19.9 12.0342 0 0 0 0 12.7228 0 0 0 0 0 0 0 0 0 11.9629 0 0 0 0 0 12.5861 0 12.8197 0 0 0 13.1497 0 0 12.5584 0 10.7702 13.3256 0 0 0 0 0 0 0 0 0 0 13.1657 0 10.7851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8229 0 0 0 13.3907 0 0 0 12.6544 0 0 0 0 0 13.6989 0 0 14.1799 0 0 13.0425 0 0 0 0 12.6515 0 0 15.6734 0 0 0 13.0794 0 0 0 0 0 15.3248 0 0 0 15.6131 0 0 0 0 0 12.8191 0 0 0 14.2473 13.1969 0 0 14.3527 0 14.7163 0 0 0 0 13.2131 0 0 13.5253 0 0 0 0 0 0 0 0 15.2312 12.2766 0 0 0 0 0 0 0 0 0 0 0 0 12.133 0 0 0 0 0 0 0 15.1804 0 P30740 ILEU_HUMAN "Leukocyte elastase inhibitor, LEI (Monocyte/neutrophil elastase inhibitor, EI, M/NEI) (Peptidase inhibitor 2, PI-2) (Serpin B1)" SERPINB1 ELANH2 MNEI PI2 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; type B pancreatic cell proliferation [GO:0044342] collagen-containing extracellular matrix [GO:0062023]; cytolytic granule [GO:0044194]; cytoplasmic ribonucleoprotein granule [GO:0036464]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774] collagen-containing extracellular matrix [GO:0062023]; cytolytic granule [GO:0044194]; cytoplasmic ribonucleoprotein granule [GO:0036464]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; type B pancreatic cell proliferation [GO:0044342] GO:0004867; GO:0005576; GO:0005615; GO:0005769; GO:0010951; GO:0016020; GO:0030414; GO:0032691; GO:0034774; GO:0036464; GO:0044194; GO:0044342; GO:0062023; GO:0070062 peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867] DIFISKIVHK 0.99018 -5.6129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51854 TKTL1_HUMAN "Transketolase-like protein 1, EC 2.2.1.1 (Transketolase 2, TK 2) (Transketolase-related protein)" TKTL1 TKR TKT2 Homo sapiens (Human) glucose catabolic process [GO:0006007]; thiamine metabolic process [GO:0006772] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; glucose catabolic process [GO:0006007]; thiamine metabolic process [GO:0006772] GO:0004802; GO:0005634; GO:0005829; GO:0006007; GO:0006772; GO:0030976; GO:0046872 metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802] AEFPEEARPDR 0.99018 -19.985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6718 0 0 0 11.2554 0 11.5058 0 0 0 0 0 11.6385 0 0 0 11.4272 12.8767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3668 12.3656 0 0 0 0 0 0 0 0 0 0 0 0 14.4199 14.1624 14.1153 0 14.53 0 14.8091 13.7632 13.9961 14.3427 0 0 0 0 0 0 0 0 0 16.9731 0 13.8117 0 0 0 0 13.2201 13.3692 13.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13319 CD5R2_HUMAN "Cyclin-dependent kinase 5 activator 2, CDK5 activator 2 (Cyclin-dependent kinase 5 regulatory subunit 2) (p39) (p39I)" CDK5R2 NCK5AI Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cerebellum development [GO:0021549]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; neuron migration [GO:0001764]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; superior olivary nucleus maturation [GO:0021722] cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein kinase 5 complex [GO:0016533] cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein kinase 5 complex [GO:0016533]; actin binding [GO:0003779]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; axon guidance [GO:0007411]; brain development [GO:0007420]; cerebellum development [GO:0021549]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; neuron migration [GO:0001764]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; superior olivary nucleus maturation [GO:0021722] GO:0000079; GO:0001764; GO:0003779; GO:0005737; GO:0005886; GO:0007411; GO:0007420; GO:0008289; GO:0016020; GO:0016533; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030426; GO:0043005; GO:0045956; GO:0061575 actin binding [GO:0003779]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901] LIQRLSPQMLR 0.99018 -4.342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4483 0 0 0 0 0 12.6616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV53 DEN1C_HUMAN DENN domain-containing protein 1C (Connecdenn 3) (Protein FAM31C) DENND1C FAM31C Homo sapiens (Human) endocytic recycling [GO:0032456]; endocytosis [GO:0006897] centrosome [GO:0005813]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897] GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0006897; GO:0030136; GO:0032456; GO:0043231; GO:1901981 guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981] APALPSRSDR 0.99018 -19.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1453 0 11.4743 0 0 0 0 0 12.5992 0 0 0 0 0 0 0 0 0 0 0 12.0364 0 0 0 0 0 0 15.7117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7306 0 0 0 0 0 0 12.4798 13.8644 0 15.0059 0 0 0 13.499 14.187 0 14.7758 16.2227 14.561 12.8623 15.1715 13.7848 14.1163 0 13.9135 14.7705 14.3133 0 14.7578 14.0708 15.6139 16.2882 13.5434 13.4714 13.8049 0 0 0 0 13.6893 0 13.6506 0 0 0 13.7328 12.6939 0 14.7221 11.9875 0 0 0 0 12.6182 0 12.6068 0 0 0 13.9722 0 0 0 0 12.5695 13.421 0 0 14.0124 14.2595 0 0 0 0 14.1994 10.8354 14.3723 0 14.0722 0 13.4429 0 0 0 10.4693 0 11.3905 13.6012 0 0 0 0 0 0 0 0 13.2138 0 15.8062 0 0 0 0 0 0 0 0 0 13.3062 12.1052 14.2151 0 Q8TB24 RIN3_HUMAN Ras and Rab interactor 3 (Ras interaction/interference protein 3) RIN3 Homo sapiens (Human) endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165] GO:0002091; GO:0005085; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006897; GO:0007165; GO:0030139; GO:0030424; GO:0030425; GO:0031267; GO:0031410; GO:0031982; GO:0043025; GO:0060755; GO:0097494 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] ADTQAQALCAQCAEKFAVER 0.99018 -20 0 0 0 0 0 0 0 0 0 0 12.8141 13.6829 13.5518 0 0 0 0 0 12.521 0 0 0 0 0 0 0 12.3449 12.4526 0 0 0 12.7668 0 12.7902 0 0 12.7202 12.4036 0 12.1993 10.3295 13.2443 0 12.3881 0 0 0 0 12.1867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.929 0 14.0311 0 0 14.5469 0 0 14.3156 13.6168 0 0 13.539 0 0 0 13.6978 0 12.1596 0 0 13.9663 0 0 0 0 0 12.5545 0 0 12.1204 13.5745 0 0 0 0 13.6561 0 0 0 0 10.1119 14.3621 0 0 0 0 0 0 10.904 0 0 0 12.8138 0 0 14.0441 13.6821 0 0 0 0 0 0 0 13.5136 13.2724 12.0336 10.6587 0 0 0 0 0 0 0 0 0 0 0 14.3289 11.5546 0 12.4831 0 0 0 0 12.4515 0 0 14.7654 0 13.8076 0 14.2266 15.4188 13.8189 14.0431 0 0 0 0 0 13.5602 0 0 0 13.9743 0 13.7938 11.9484 0 O75170 PP6R2_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2) PPP6R2 KIAA0685 PP6R2 SAPS2 Homo sapiens (Human) regulation of phosphoprotein phosphatase activity [GO:0043666] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; regulation of phosphoprotein phosphatase activity [GO:0043666] GO:0005634; GO:0005829; GO:0019888; GO:0019903; GO:0043231; GO:0043666 protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] AGPAIPTPAVSSALAVAVPLGPIMAVTAAPAMVATLGTVTK 0.99019 -19.298 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8558 0 0 0 0 0 0 11.6505 11.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5573 0 0 0 14.0698 15.3869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.195 0 0 0 12.4144 0 16.3171 0 0 0 0 0 0 12.4643 0 0 13.2592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC36 SUN5_HUMAN SUN domain-containing protein 5 (Sad1 and UNC84 domain-containing protein 5) (Sperm-associated antigen 4-like protein) (Testis and spermatogenesis-related gene 4 protein) SUN5 SPAG4L TSARG4 Homo sapiens (Human) nuclear envelope organization [GO:0006998]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; sperm connecting piece [GO:0097224] Golgi apparatus [GO:0005794]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; sperm connecting piece [GO:0097224]; protein-membrane adaptor activity [GO:0043495]; nuclear envelope organization [GO:0006998]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] GO:0005635; GO:0005637; GO:0005639; GO:0005794; GO:0006998; GO:0007283; GO:0007286; GO:0034993; GO:0043495; GO:0097224 protein-membrane adaptor activity [GO:0043495] EEVFLGAFQFQPENIIQMFPLQNQPARAFSAVKVK 0.99019 -19.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.81756 13.0571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4612 0 0 0 0 0 0 0 10.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0815 0 0 0 0 0 14.4682 14.7899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NX9 DACH2_HUMAN "Dachshund homolog 2, Dach2" DACH2 Homo sapiens (Human) development of primary female sexual characteristics [GO:0046545]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; development of primary female sexual characteristics [GO:0046545]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005667; GO:0006357; GO:0046545 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AEPLYSTPR 0.99019 -20.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4528 0 0 0 0 0 0 0 0 0 0 0 13.587 0 0 0 0 0 0 0 0 13.4969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0727 0 0 0 0 0 0 0 0 0 0 11.3218 0 0 0 0 0 0 0 0 0 12.4961 0 0 0 0 0 0 13.459 0 0 0 Q96T68 SETB2_HUMAN "Histone-lysine N-methyltransferase SETDB2, EC 2.1.1.366 (Chronic lymphocytic leukemia deletion region gene 8 protein) (Lysine N-methyltransferase 1F) (SET domain bifurcated 2)" SETDB2 C13orf4 CLLD8 KMT1F Homo sapiens (Human) "cell division [GO:0051301]; chromosome segregation [GO:0007059]; heart looping [GO:0001947]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; left/right axis specification [GO:0070986]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]" chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; heart looping [GO:0001947]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; left/right axis specification [GO:0070986]; mitotic cell cycle [GO:0000278]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]" GO:0000278; GO:0001947; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0008270; GO:0010629; GO:0018024; GO:0045892; GO:0046974; GO:0051301; GO:0051567; GO:0070828; GO:0070986; GO:0090309 DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; zinc ion binding [GO:0008270] AYNLTNFSSMFTDSCDCSEGCIDITK 0.99019 -20.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.877 0 12.0157 0 0 0 0 0 0 0 0 11.6326 11.6272 0 0 0 0 0 0 12.0862 0 0 0 0 0 11.2215 0 0 11.8232 12.1595 12.55 12.6813 0 9.95245 11.5877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.253 14.9114 14.2779 13.6792 14.3444 18.6075 12.674 0 0 0 0 0 16.5359 0 13.3525 0 0 16.0225 15.6079 15.8854 16.1315 0 0 0 16.2345 14.7228 0 14.8456 15.1119 0 0 14.5699 15.6478 14.4249 14.0812 14.5962 15.5241 16.478 0 14.565 15.7881 0 0 14.7222 14.047 14.9533 0 14.1506 0 14.5227 14.5681 0 0 14.907 0 0 0 11.4581 0 0 0 0 14.4261 12.2589 14.4335 0 13.9246 0 15.2717 0 0 0 0 0 0 0 13.731 0 0 0 15.0892 14.028 0 0 0 0 0 12.9997 13.6868 0 0 0 0 0 0 13.6827 13.9467 13.5969 13.6834 0 0 0 13.4225 14.8281 0 A8MPP1 D11L8_HUMAN "Putative ATP-dependent RNA helicase DDX11-like protein 8, EC 3.6.4.13 (DEAD/H box protein 11-like 8)" DDX11L8 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139] nucleolus [GO:0005730]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; establishment of sister chromatid cohesion [GO:0034085]; nucleobase-containing compound metabolic process [GO:0006139] GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006139; GO:0016887; GO:0032508; GO:0034085 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] DLVDRLKVEQAR 0.9902 -20.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5844 0 0 0 0 0 0 10.7237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.402 0 0 0 0 13.4221 13.3025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3389 0 0 0 0 0 12.9192 11.8696 0 0 11.9733 0 0 0 0 0 0 12.618 0 0 0 0 0 0 0 0 0 0 14.4276 0 0 0 0 0 0 0 0 18.1697 0 0 0 0 0 0 0 11.1844 0 0 12.0381 0 10.7815 0 0 0 15.3867 0 0 0 0 0 0 0 0 O60333 KIF1B_HUMAN "Kinesin-like protein KIF1B, Klp" KIF1B KIAA0591 KIAA1448 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; neuromuscular synaptic transmission [GO:0007274]; neuron-neuron synaptic transmission [GO:0007270]; vesicle-mediated transport [GO:0016192] GO:0003777; GO:0005524; GO:0005739; GO:0005871; GO:0005874; GO:0005875; GO:0006915; GO:0007018; GO:0007270; GO:0007274; GO:0008017; GO:0008021; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0019894; GO:0030424; GO:0030425; GO:0030659; GO:0030705; GO:0031410; GO:0043005; GO:0070161; GO:1904115 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] DLLNPKNK 0.9902 -19.745 0 0 0 0 0 0 0 0 0 11.9441 11.8709 0 0 0 0 0 0 0 0 15.6395 0 0 0 0 0 0 0 0 0 11.7404 12.6371 0 0 0 0 0 0 0 0 0 0 0 12.222 0 0 12.9146 11.9424 0 0 0 0 11.1186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4549 0 0 0 0 0 0 0 12.8614 13.2829 0 13.9627 0 0 0 15.5983 0 0 15.2987 13.0105 13.4018 0 0 13.9645 0 13.75 14.5231 16.1422 0 14.1304 0 0 0 0 0 9.69596 15.1331 0 0 0 0 0 0 16.2598 0 0 0 0 0 10.8184 0 0 0 16.1735 0 15.2991 0 14.8465 0 0 0 0 0 0 0 0 0 0 13.7318 0 0 0 0 0 0 16.1607 0 14.2823 0 13.5934 0 11.4773 14.5916 0 16.9442 13.4629 0 14.2128 14.4435 0 0 13.1299 14.3959 0 12.6678 0 0 0 0 0 13.128 13.5073 0 0 0 0 0 14.164 14.4681 12.7588 P61160 ARP2_HUMAN Actin-related protein 2 (Actin-like protein 2) ACTR2 ARP2 Homo sapiens (Human) Arp2/3 complex-mediated actin nucleation [GO:0034314]; associative learning [GO:0008306]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to trichostatin A [GO:0035984]; cilium assembly [GO:0060271]; cytosolic transport [GO:0016482]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; spindle localization [GO:0051653] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; podosome core [GO:0061825]; postsynaptic density [GO:0014069]; site of double-strand break [GO:0035861] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; podosome core [GO:0061825]; postsynaptic density [GO:0014069]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; associative learning [GO:0008306]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cellular response to trichostatin A [GO:0035984]; cilium assembly [GO:0060271]; cytosolic transport [GO:0016482]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471]; response to immobilization stress [GO:0035902]; spindle localization [GO:0051653] GO:0003779; GO:0005200; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005885; GO:0005925; GO:0007163; GO:0008306; GO:0008356; GO:0010592; GO:0014069; GO:0015629; GO:0016020; GO:0016344; GO:0016482; GO:0030027; GO:0030478; GO:0033206; GO:0034314; GO:0035578; GO:0035861; GO:0035902; GO:0035984; GO:0045471; GO:0045944; GO:0051653; GO:0060271; GO:0061003; GO:0061825; GO:0070062; GO:0071346; GO:1904813; GO:1905168 actin binding [GO:0003779]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200] DITRYLIKLLLLR 0.9902 -20.979 0 0 0 14.3064 11.3644 0 0 0 0 0 13.4807 0 0 0 0 0 0 0 0 0 0 0 13.3144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.527 0 13.5304 13.767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8534 0 0 14.3987 0 0 0 0 0 0 0 13.9 12.8401 0 16.3055 13.9204 14.7173 13.5633 0 14.9261 13.9388 15.0324 16.4938 14.9778 0 14.775 14.9377 15.444 15.0742 0 13.7356 0 0 0 13.6331 0 14.018 14.0058 0 0 14.6908 13.6693 0 15.7437 0 0 0 0 0 14.509 10.5302 13.6468 0 0 0 14.0691 10.3925 0 0 13.9657 15.3088 13.9189 11.2787 0 0 0 14.6364 0 0 0 0 0 14.4747 14.8901 0 0 13.8722 13.5885 0 0 0 12.4531 14.2798 0 14.6908 0 13.6037 13.6821 14.4635 0 0 15.3081 11.4767 0 0 0 12.1854 0 0 0 13.468 0 0 0 0 0 0 0 0 0 0 0 0 Q1RMZ1 SAMTR_HUMAN "S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog, EC 2.1.1.-)" BMT2 C7orf60 SAMTOR Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262] cytosol [GO:0005829] cytosol [GO:0005829]; methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047]; cellular response to amino acid starvation [GO:0034198]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262] GO:0005829; GO:0008168; GO:0032259; GO:0034198; GO:1904047; GO:1904262 methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047] EPGAGGR 0.9902 -5.6519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9557 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.149 12.3615 0 0 0 0 0 0 0 12.2051 0 0 0 11.1562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3512 0 0 0 0 0 0 0 11.1671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8703 0 0 0 Q8N8Z6 DCBD1_HUMAN "Discoidin, CUB and LCCL domain-containing protein 1" DCBLD1 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; signaling receptor activity [GO:0038023] GO:0005887; GO:0038023 signaling receptor activity [GO:0038023] AAGRGLLALLLAVSAPLR 0.9902 -21.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0047 0 0 0 13.3945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4842 0 0 0 0 0 0 0 0 10.0516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5477 0 0 0 0 10.5427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6558 0 0 0 0 0 0 13.2521 0 0 0 0 0 14.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4033 0 14.6267 Q8WXA9 SREK1_HUMAN "Splicing regulatory glutamine/lysine-rich protein 1 (Serine/arginine-rich-splicing regulatory protein 86, SRrp86) (Splicing factor, arginine/serine-rich 12) (Splicing regulatory protein 508, SRrp508)" SREK1 SFRS12 SRRP86 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0016607 RNA binding [GO:0003723] EHNKEPDSSVSK 0.9902 -20.973 0 0 0 14.1157 0 13.5446 14.2771 14.1323 12.5334 12.359 12.2442 12.4043 12.6297 0 12.6679 12.4195 12.5605 0 0 0 0 13.8842 14.4638 0 0 0 0 12.7425 12.4015 0 12.6299 12.5003 12.56 10.4516 12.6647 12.7894 12.7868 12.6259 12.6736 12.5274 0 12.0304 11.8412 12.4764 0 13.098 0 0 13.1303 0 10.9409 0 0 12.3726 14.556 14.5188 0 0 0 0 13.3975 0 0 0 0 0 0 0 0 0 11.9541 0 0 0 14.2784 0 12.7934 12.4382 0 0 16.973 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1223 15.3771 0 0 0 0 0 0 11.2013 0 0 0 0 0 0 0 14.2487 0 0 15.3723 0 0 0 0 13.2595 0 0 0 0 0 0 13.3872 12.974 13.2663 0 0 0 0 0 12.9768 0 0 17.7747 13.3005 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4772 0 0 0 0 0 14.3682 14.4623 14.4385 14.3571 14.0489 0 0 14.9811 0 14.519 14.5182 14.0021 13.9925 14.2608 0 15.3375 0 0 14.368 0 0 0 0 Q9BQ04 RBM4B_HUMAN RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30) RBM4B RBM30 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]" GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0005730; GO:0005829; GO:0006417; GO:0007623; GO:0008270; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DRSPLRR 0.9902 -5.6523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2071 13.0333 0 13.0689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0212 0 0 0 0 0 0 0 0 0 0 15.0683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.002 0 13.5333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9676 0 0 0 0 0 0 0 Q9UBI9 HDC_HUMAN "Headcase protein homolog, hHDC" HECA HDC Homo sapiens (Human) negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323] GO:0005634; GO:0005737; GO:0016020; GO:0030323; GO:0045930 FCSCRCGQGHLK 0.9902 -21.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1627 15.1872 16.6141 13.7078 0 14.0084 15.1281 0 14.9592 0 15.0311 15.8786 0 0 15.2753 15.2037 0 11.4878 15.8144 0 0 0 13.9853 0 0 0 0 0 0 12.7617 0 0 0 0 0 0 0 0 0 0 0 0 11.7184 12.5507 0 10.6768 0 0 0 0 0 0 11.6236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9005 0 11.6367 0 0 0 0 0 0 0 12.997 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJX4 APC5_HUMAN "Anaphase-promoting complex subunit 5, APC5 (Cyclosome subunit 5)" ANAPC5 APC5 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0005829; GO:0007049; GO:0007346; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979 protein phosphatase binding [GO:0019903] DSDLLHWKHSLSELIDISIAQKTAIWR 0.9902 -20.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4777 0 13.1813 13.3071 0 0 0 12.9597 0 0 0 0 0 0 13.9351 13.1896 0 0 0 0 0 0 0 0 0 15.8327 0 0 0 0 0 0 13.9256 0 13.8661 0 13.1965 0 0 0 0 0 0 0 0 0 0 0 0 14.9742 0 15.2758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5031 0 0 0 0 0 15.1045 0 0 0 0 0 0 0 0 0 0 13.6003 0 0 0 0 0 0 0 Q9Y6F1 PARP3_HUMAN "Protein mono-ADP-ribosyltransferase PARP3, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 3, ARTD3) (DNA ADP-ribosyltransferase PARP3, EC 2.4.2.-) (IRT1) (NAD(+) ADP-ribosyltransferase 3, ADPRT-3) (Poly [ADP-ribose] polymerase 3, PARP-3, hPARP-3) (Poly[ADP-ribose] synthase 3, pADPRT-3)" PARP3 ADPRT3 ADPRTL3 Homo sapiens (Human) DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723] centriole [GO:0005814]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861] centriole [GO:0005814]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of isotype switching [GO:0045829]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to site of double-strand break [GO:1990166]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723] GO:0000723; GO:0003824; GO:0003950; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006281; GO:0006302; GO:0006471; GO:0016604; GO:0030592; GO:0035861; GO:0045171; GO:0045829; GO:0051106; GO:0060236; GO:0070212; GO:0070213; GO:0140289; GO:0140294; GO:1905662; GO:1990166; GO:1990404; GO:2001034 catalytic activity [GO:0003824]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404] FFTCWNR 0.9902 -20.111 0 0 0 0 0 0 0 15.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8175 15.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9639 13.9222 13.9785 0 14.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5646 0 13.0634 0 14.0553 0 0 0 13.8948 0 14.1291 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5256 0 0 0 0 13.9454 0 0 13.9056 0 14.0578 0 14.2371 0 13.5011 0 13.4543 0 0 0 0 13.7043 14.023 0 13.5718 13.8032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.773 0 0 0 13.8256 0 Q9Y6W6 DUS10_HUMAN "Dual specificity protein phosphatase 10, EC 3.1.3.16, EC 3.1.3.48 (Mitogen-activated protein kinase phosphatase 5, MAP kinase phosphatase 5, MKP-5)" DUSP10 MKP5 Homo sapiens (Human) dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; oligodendrocyte differentiation [GO:0048709]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; stress-activated MAPK cascade [GO:0051403] GO:0002819; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0008330; GO:0008432; GO:0010633; GO:0016311; GO:0016607; GO:0016791; GO:0017017; GO:0017018; GO:0030336; GO:0032496; GO:0033549; GO:0035970; GO:0043409; GO:0043508; GO:0044387; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0048715; GO:0050680; GO:0051403; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042; GO:1990264 JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/threonine phosphatase activity [GO:0008330] GLFNYKR 0.9902 -20.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.402 0 0 10.7984 0 0 0 13.6676 0 0 0 0 0 11.53 0 0 0 0 0 0 0 0 0 0 0 0 14.0718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4244 0 0 0 0 0 0 0 0 0 0 0 0 14.2744 15.3426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4683 0 0 0 0 0 0 0 0 0 0 0 A8MTB9 CEA18_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 18 CEACAM18 Homo sapiens (Human) GYRTVVALDK 0.99021 -5.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7782 0 0 0 0 11.2323 13.1906 0 0 0 0 0 0 12.2063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2432 0 0 0 0 0 0 0 0 0 0 0 0 11.1559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6827 0 0 18.5965 0 O60320 F1891_HUMAN Protein FAM189A1 (Transmembrane protein 228) FAM189A1 KIAA0574 TMEM228 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PAALPRSLSR 0.99021 -21.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7034 0 12.168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4072 0 0 0 0 P15907 SIAT1_HUMAN "Beta-galactoside alpha-2,6-sialyltransferase 1, Alpha 2,6-ST 1, EC 2.4.99.1 (B-cell antigen CD75) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (ST6Gal I, ST6GalI) (Sialyltransferase 1)" ST6GAL1 SIAT1 Homo sapiens (Human) humoral immune response [GO:0006959]; N-acetylneuraminate metabolic process [GO:0006054]; negative regulation of chemotaxis [GO:0050922]; negative regulation of macrophage apoptotic process [GO:2000110]; O-glycan processing [GO:0016266]; positive regulation of mononuclear cell proliferation [GO:0032946]; protein N-linked glycosylation via asparagine [GO:0018279]; protein sialylation [GO:1990743]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; response to ethanol [GO:0045471]; sialylation [GO:0097503]; viral protein processing [GO:0019082] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373]; humoral immune response [GO:0006959]; N-acetylneuraminate metabolic process [GO:0006054]; negative regulation of chemotaxis [GO:0050922]; negative regulation of macrophage apoptotic process [GO:2000110]; O-glycan processing [GO:0016266]; positive regulation of mononuclear cell proliferation [GO:0032946]; protein N-linked glycosylation via asparagine [GO:0018279]; protein sialylation [GO:1990743]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; response to ethanol [GO:0045471]; sialylation [GO:0097503]; viral protein processing [GO:0019082]" GO:0000138; GO:0000139; GO:0003835; GO:0005576; GO:0005783; GO:0005794; GO:0005797; GO:0006054; GO:0006959; GO:0008373; GO:0016021; GO:0016266; GO:0018279; GO:0019082; GO:0032580; GO:0032946; GO:0042803; GO:0045471; GO:0050922; GO:0097503; GO:1900024; GO:1990743; GO:2000110 "beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373]" FSAEALRCHLR 0.99021 -21.054 0 0 0 0 0 9.79448 0 0 20.1812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0821 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8344 15.4537 0 0 0 0 13.3361 18.418 18.4531 0 0 13.5442 0 18.3228 0 0 14.174 15.1594 0 0 11.2352 0 0 0 0 0 0 0 0 0 0 13.647 0 0 0 0 0 0 0 0 0 0 12.7362 10.418 0 16.3545 0 18.7842 0 0 0 0 0 0 0 0 0 0 0 11.3193 0 0 10.3607 0 0 0 10.2209 0 0 0 0 0 0 0 0 0 12.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58505 CU058_HUMAN Uncharacterized protein C21orf58 C21orf58 Homo sapiens (Human) ALPPALQDPPHVPPRVPR 0.99021 -5.6806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.56 14.7666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5234 0 0 0 0 0 0 0 0 0 0 0 0 11.8112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.748 0 0 0 0 0 0 0 0 13.1819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5ST30 SYVM_HUMAN "Valine--tRNA ligase, mitochondrial, EC 6.1.1.9 (Valyl-tRNA synthetase, ValRS) (Valyl-tRNA synthetase-like)" VARS2 KIAA1885 VARS2L VARSL Homo sapiens (Human) valyl-tRNA aminoacylation [GO:0006438] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438] GO:0002161; GO:0004832; GO:0005524; GO:0005739; GO:0005829; GO:0006438 aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832] DIISGVEMQVLQEKLR 0.99021 -21.042 0 0 0 0 0 0 0 0 13.8181 14.2642 0 15.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9766 14.0377 14.1057 0 0 0 0 0 12.2284 0 13.1391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4757 0 0 0 0 0 0 0 0 13.5774 0 0 0 11.0977 0 0 0 0 0 0 0 0 0 14.4491 0 0 13.8174 0 13.9462 0 0 0 0 13.5612 13.7118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0907 0 0 0 0 0 0 0 0 12.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5481 Q8NFQ5 BPIB6_HUMAN BPI fold-containing family B member 6 (Bactericidal/permeability-increasing protein-like 3) BPIFB6 BPIL3 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; lipid binding [GO:0008289] GO:0005576; GO:0008289 lipid binding [GO:0008289] LLSLSRK 0.99021 -19.519 12.2177 0 0 18.528 0 0 0 0 16.0568 12.4012 12.5557 18.3955 11.1117 18.4 0 0 0 0 0 0 0 0 0 0 0 10.9817 0 12.5226 10.5123 19.3404 12.5483 19.3624 12.8447 19.4112 12.6764 12.269 12.2728 19.4661 10.6587 0 19.4489 12.4195 10.7618 0 10.9564 10.8729 0 11.1682 12.8729 13.3383 12.0797 0 0 0 0 0 19.3068 19.6269 19.3974 0 0 0 18.3324 0 18.4077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3957 0 0 15.009 11.264 0 0 0 0 0 0 0 0 0 10.6319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7714 0 0 0 0 0 0 0 0 0 13.645 0 13.4484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5755 0 0 0 11.0412 0 18.557 18.5699 0 0 0 0 13.3711 13.61 0 0 0 18.9784 19.1695 19.4217 Q9UJT9 FBXL7_HUMAN F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7) FBXL7 FBL6 FBL7 KIAA0840 Homo sapiens (Human) cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000086; GO:0000151; GO:0000209; GO:0000278; GO:0005813; GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0031146; GO:0051301 GLYTIAQCCPELRR 0.99021 -5.8109 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.029 0 11.0722 0 0 0 0 0 0 0 0 0 0 0 11.9562 0 0 0 0 0 13.6862 0 0 0 0 0 0 14.9604 0 0 0 0 0 0 0 0 0 11.4496 0 0 0 0 0 14.3678 0 11.113 0 0 14.0862 0 0 0 0 14.3761 0 0 11.03 14.4949 0 14.2384 0 14.426 0 0 0 11.329 14.4821 0 0 0 13.9155 0 13.9065 0 0 0 0 0 13.8842 14.3574 0 14.0173 0 10.4047 0 0 11.5796 14.1554 0 0 0 10.8888 14.7569 14.0524 0 11.3227 0 0 13.7484 0 0 0 0 0 0 0 0 0 Q9UKA4 AKA11_HUMAN "A-kinase anchor protein 11, AKAP-11 (A-kinase anchor protein 220 kDa, AKAP 220, hAKAP220) (Protein kinase A-anchoring protein 11, PRKA11)" AKAP11 AKAP220 KIAA0629 Homo sapiens (Human) cortical actin cytoskeleton organization [GO:0030866]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; renal water homeostasis [GO:0003091] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; cortical actin cytoskeleton organization [GO:0030866]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; renal water homeostasis [GO:0003091] GO:0003091; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0008104; GO:0008157; GO:0030866; GO:0034237; GO:0035556; GO:0036010; GO:0051018 protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157] DCVPECK 0.99021 -19.88 0 0 0 0 0 0 15.1227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5959 0 0 0 0 0 0 12.1804 0 11.9632 0 0 11.629 0 0 0 0 0 0 0 0 0 13.3723 0 0 10.9517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8181 0 0 0 0 0 12.2774 12.3003 0 0 0 0 0 0 0 0 0 0 0 0 13.1099 0 0 0 0 0 0 0 12.4023 0 0 0 0 0 0 0 0 0 15.4972 0 15.2811 12.7853 0 15.2409 0 0 0 0 0 0 11.726 0 0 0 0 0 0 12.857 12.1824 13.6309 0 0 0 0 0 0 0 12.5765 0 0 0 13.0163 0 13.2515 0 0 0 0 0 13.0081 13.6223 11.8912 0 0 0 0 0 0 0 0 13.735 0 0 11.9548 0 10.6865 0 0 0 0 0 10.7479 0 11.9457 0 0 0 0 0 0 0 G9CGD6 CNIPF_HUMAN CNK3/IPCEF1 fusion protein CNK3/IPCEF1 Homo sapiens (Human) positive regulation of cellular response to hepatocyte growth factor stimulus [GO:2001114]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; positive regulation of cellular response to hepatocyte growth factor stimulus [GO:2001114]; regulation of signal transduction [GO:0009966] GO:0005737; GO:0009966; GO:0016020; GO:2001114 ALLAWLDR 0.99022 -19.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0843 0 11.0904 0 12.8054 13.6361 0 0 0 0 11.6492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6244 10.5828 0 0 12.4799 9.91313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5417 14.39 14.47 15.7876 14.8414 0 12.2838 0 16.324 16.7975 14.5798 15.2746 15.2499 15.8734 16.5491 15.4574 15.8173 14.0969 14.5477 13.2391 0 13.2802 0 14.7635 14.8238 15.3462 0 15.8649 13.7789 14.8168 14.3307 0 14.6459 15.3102 15.2172 14.824 15.3602 15.4005 15.3087 15.4065 15.8036 15.3979 13.7553 14.1035 14.5512 0 15.3109 15.3695 15.3457 15.7314 14.7557 14.7859 14.6303 16.4386 16.8907 15.0742 13.7401 13.8191 15.5725 17.4897 16.0287 14.4905 14.9462 14.7827 14.7543 13.4027 14.5007 13.9257 16.1529 0 14.6512 13.5606 13.9918 14.7275 14.8841 15.5627 15.4836 13.1394 15.5461 13.6391 15.2824 0 11.8987 0 15.7965 0 0 15.7261 0 14.2347 0 13.0514 0 0 0 0 12.284 14.0811 0 0 0 12.8488 0 0 0 14.9248 15.4664 16.1186 15.6008 0 0 12.934 0 0 A1A4G5 LNP1_HUMAN Leukemia NUP98 fusion partner 1 LNP1 NP3 Homo sapiens (Human) CRSHVRDYR 0.99022 -19.535 0 0 0 0 0 0 0 0 0 0 12.8763 11.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0265 0 0 0 12.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6753 0 0 0 0 0 0 0 0 0 0 0 0 12.384 0 0 0 0 0 0 0 12.0451 0 0 0 0 0 0 0 0 0 12.9031 12.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0114 0 0 0 11.7136 0 0 11.4885 0 0 0 0 0 11.025 0 0 0 0 0 0 0 0 0 0 0 12.2038 0 12.1197 0 0 0 0 0 0 0 0 11.5188 0 0 0 11.4983 0 0 0 0 0 Q9UN37 VPS4A_HUMAN "Vacuolar protein sorting-associated protein 4A, EC 3.6.4.6 (Protein SKD2) (VPS4-1, hVPS4)" VPS4A VPS4 Homo sapiens (Human) abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear membrane reassembly [GO:0007084]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase plate congression [GO:0007080]; mitotic nuclear membrane reassembly [GO:0007084]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] GO:0000916; GO:0000922; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005774; GO:0005813; GO:0005829; GO:0005886; GO:0006622; GO:0006900; GO:0006914; GO:0006997; GO:0006998; GO:0007033; GO:0007080; GO:0007084; GO:0008022; GO:0009838; GO:0010008; GO:0016192; GO:0016197; GO:0016236; GO:0016887; GO:0019076; GO:0019904; GO:0030496; GO:0031468; GO:0031902; GO:0032367; GO:0032466; GO:0032880; GO:0034058; GO:0036258; GO:0039702; GO:0043162; GO:0044877; GO:0044878; GO:0046761; GO:0048471; GO:0051301; GO:0060548; GO:0061640; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0072319; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:0140545; GO:1903076; GO:1903543; GO:1903774; GO:1904896; GO:1904903; GO:1904949 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] AEKLKDYLR 0.99022 -19.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2504 0 0 0 0 0 0 0 0 0 11.7517 11.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3733 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3836 0 0 0 0 0 14.869 0 0 0 0 0 0 0 0 14.3939 0 0 0 0 0 0 0 0 0 0 0 11.252 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43597 SPY2_HUMAN "Protein sprouty homolog 2, Spry-2" SPRY2 Homo sapiens (Human) animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung growth [GO:0060437]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule end [GO:1990752]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule end [GO:1990752]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase inhibitor activity [GO:0030291]; animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung growth [GO:0060437]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; sensory perception of sound [GO:0007605] GO:0000132; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007605; GO:0008285; GO:0008543; GO:0010628; GO:0010719; GO:0010801; GO:0015629; GO:0015630; GO:0016020; GO:0016525; GO:0019901; GO:0030291; GO:0030335; GO:0030512; GO:0031345; GO:0031397; GO:0032587; GO:0033138; GO:0034260; GO:0035924; GO:0040037; GO:0042472; GO:0043066; GO:0043407; GO:0043539; GO:0045165; GO:0046580; GO:0048513; GO:0051387; GO:0051897; GO:0060437; GO:0060449; GO:0070371; GO:0070373; GO:0070374; GO:1900747; GO:1902747; GO:1990752; GO:1990830 protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase inhibitor activity [GO:0030291] CEDCGKCK 0.99023 -5.7009 0 0 0 0 0 0 0 0 0 0 0 14.6677 0 0 0 0 0 13.721 13.6829 0 0 0 13.5494 0 0 0 13.0445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6479 10.1503 0 13.9731 13.4512 0 14.5287 0 14.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4421 15.3515 14.0714 14.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7167 0 0 14.4416 15.3155 13.5411 0 0 0 0 0 0 14.5928 0 15.2892 0 14.5205 14.731 0 0 0 14.6111 15.5985 0 0 0 14.7243 14.092 14.2811 0 0 0 0 14.1167 14.6153 14.4465 15.4247 15.1754 13.5591 0 0 14.2078 0 14.2007 15.3883 0 0 0 0 0 0 13.8377 13.5915 13.9663 0 14.2169 0 0 0 0 0 0 0 13.7927 0 0 0 0 0 0 0 0 0 13.7018 0 0 0 0 0 13.6121 0 Q2M3C7 SPKAP_HUMAN A-kinase anchor protein SPHKAP (SPHK1-interactor and AKAP domain-containing protein) (Sphingosine kinase type 1-interacting protein) SPHKAP KIAA1678 SKIP Homo sapiens (Human) cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; protein kinase A binding [GO:0051018] GO:0005737; GO:0005739; GO:0051018 protein kinase A binding [GO:0051018] ASSCESIPEEDSEAR 0.99023 -19.984 0 0 0 0 0 0 0 0 0 10.2985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9168 0 0 0 0 0 13.7004 0 13.6361 0 0 0 0 0 12.9919 0 0 0 0 11.9111 0 0 0 12.0255 0 0 0 0 11.9296 13.9957 0 0 0 0 12.4448 13.168 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4521 12.7616 13.5723 0 13.9625 13.8754 0 0 0 0 0 0 0 0 0 0 0 14.6359 0 0 13.5155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0632 12.4321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9342 0 0 0 11.8884 0 11.7126 0 0 0 Q8WUJ3 CEMIP_HUMAN "Cell migration-inducing and hyaluronan-binding protein, EC 3.2.1.35" CEMIP KIAA1199 Homo sapiens (Human) hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415]; hyaluronan biosynthetic process [GO:0030213]; hyaluronan catabolic process [GO:0030214]; positive regulation of cell migration [GO:0030335]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; sensory perception of sound [GO:0007605] GO:0004415; GO:0005540; GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005886; GO:0005905; GO:0007605; GO:0010800; GO:0030213; GO:0030214; GO:0030335; GO:0030665; GO:0032050; GO:0045334; GO:0046923; GO:0051281; GO:0090314; GO:1900020 clathrin heavy chain binding [GO:0032050]; ER retention sequence binding [GO:0046923]; hyaluronic acid binding [GO:0005540]; hyalurononglucosaminidase activity [GO:0004415] AKIFQVVPIPVVKK 0.99023 -19.998 0 0 0 0 0 10.5741 0 0 0 8.98778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2087 0 13.685 12.2933 12.675 12.8682 0 0 0 13.5628 0 0 0 0 0 0 0 12.3417 13.27 14.3154 12.2869 13.9805 0 0 0 11.8732 12.5923 0 0 0 0 13.1876 12.9488 0 0 0 0 0 0 0 0 0 0 0 0 12.2137 0 0 0 0 13.5695 14.1063 0 0 13.2664 0 0 0 0 13.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5077 0 0 0 0 0 0 0 P50990 TCPQ_HUMAN "T-complex protein 1 subunit theta, TCP-1-theta (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)" CCT8 C21orf112 CCTQ KIAA0002 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998] azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199] azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cadherin binding [GO:0045296]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998] GO:0002199; GO:0005524; GO:0005576; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0005929; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0034774; GO:0035578; GO:0044183; GO:0044297; GO:0045111; GO:0045296; GO:0046931; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:0140662; GO:1901998; GO:1904813; GO:1904851; GO:1904871; GO:1904874 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cadherin binding [GO:0045296]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] DWDDDQND 0.99024 -19.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0275 0 10.6255 0 0 14.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.262 0 0 0 0 0 0 0 0 0 0 0 0 13.6823 0 0 0 0 0 0 0 0 11.1825 0 0 0 0 0 0 0 0 12.3708 0 0 0 0 11.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 11.223 0 0 11.425 0 0 0 12.6317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8157 0 0 11.9843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0347 0 0 0 0 0 0 0 10.2663 0 13.0646 0 0 13.6 0 0 0 0 12.655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2723 Q13349 ITAD_HUMAN Integrin alpha-D (ADB2) (CD11 antigen-like family member D) (Leukointegrin alpha D) (CD antigen CD11d) ITGAD Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229] GO:0005178; GO:0005886; GO:0006955; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0033627; GO:0034113; GO:0046872; GO:0098609 integrin binding [GO:0005178]; metal ion binding [GO:0046872] GNLSFGWVR 0.99024 -19.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4673 0 0 0 0 0 14.8965 0 11.8067 0 0 0 0 0 0 0 0 0 0 13.0769 13.1892 15.5665 12.2335 15.3337 0 0 0 13.9046 0 0 0 0 0 0 0 0 0 14.6698 0 0 0 0 0 12.9113 0 0 10.9059 0 0 0 0 11.6832 0 0 13.4805 0 13.6364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IPM2 IQCE_HUMAN IQ domain-containing protein E IQCE KIAA1023 Homo sapiens (Human) limb morphogenesis [GO:0035108] ciliary membrane [GO:0060170]; cilium [GO:0005929] ciliary membrane [GO:0060170]; cilium [GO:0005929]; limb morphogenesis [GO:0035108] GO:0005929; GO:0035108; GO:0060170 AFHKPPPTSPKSPYLSK 0.99024 -20.023 0 0 0 0 0 0 0 0 0 0 11.7618 0 0 0 0 0 11.6925 11.5036 0 0 0 0 0 0 0 0 0 12.8189 11.3115 0 0 0 0 0 0 0 0 13.4911 0 10.5836 0 0 0 0 11.3228 0 0 0 13.2986 13.4449 0 0 0 11.5518 13.6355 0 0 0 14.3746 0 12.6306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8074 0 0 0 0 0 0 0 0 0 11.6947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8543 0 0 0 0 12.4262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7859 0 15.1484 0 0 0 0 0 0 0 0 14.8116 0 0 13.8556 13.5074 13.7524 0 14.6787 13.7778 14.4471 12.7697 13.2929 14.6077 14.5358 0 0 0 0 14.6095 0 0 14.3525 0 0 Q7Z3K3 POGZ_HUMAN Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635) POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003 Homo sapiens (Human) cell division [GO:0051301]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell division [GO:0051301]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006310; GO:0007064; GO:0010468; GO:0045944; GO:0046872; GO:0051301; GO:0051382; GO:1905168 DNA binding [GO:0003677]; metal ion binding [GO:0046872] ADTDLFMECEEEELEPWQK 0.99024 -20.044 0 12.3702 0 0 0 0 0 0 13.7616 0 0 0 0 14.656 13.7549 0 0 0 0 0 0 0 12.0596 0 0 0 13.9501 13.9456 0 0 0 14.0161 0 13.0123 0 0 0 0 0 0 0 0 0 0 0 0 9.83393 0 14.0528 0 0 0 9.94291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3635 0 12.7946 0 12.2317 13.0433 0 0 0 13.3768 0 13.2144 0 0 0 0 0 0 12.807 0 0 11.1434 0 0 0 13.2472 0 0 13.3628 0 0 9.86675 0 0 0 0 0 14.7143 0 0 12.8402 0 0 0 0 13.9945 0 12.2059 14.036 0 0 0 0 0 0 0 0 13.7797 0 0 0 0 0 0 0 0 0 13.1123 13.6861 13.7369 0 0 0 0 12.7077 0 14.7545 0 0 0 0 0 0 0 0 0 0 12.2143 0 0 0 13.757 0 0 0 11.9739 0 0 0 0 0 0 0 Q7Z4T8 GLTL5_HUMAN "Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 (Polypeptide GalNAc transferase 15, GalNAc-T15, pp-GaNTase 15) (Protein-UDP acetylgalactosaminyltransferase 15) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 15)" GALNTL5 GALNT15 Homo sapiens (Human) spermatid development [GO:0007286] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; metal ion binding [GO:0046872]; spermatid development [GO:0007286] GO:0005794; GO:0007286; GO:0016021; GO:0031902; GO:0046872 metal ion binding [GO:0046872] DMDFWGR 0.99024 -19.297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.86953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9401 0 0 0 12.5221 11.4858 11.4293 0 0 0 0 11.2688 0 0 0 0 0 0 0 0 0 11.8903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6092 0 0 0 12.173 0 0 0 0 0 0 0 12.2895 0 0 0 0 0 0 0 0 0 0 11.0541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0122 0 0 0 0 0 0 0 13.9447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEQ8 PIGO_HUMAN "GPI ethanolamine phosphate transferase 3, EC 2.-.-.- (Phosphatidylinositol-glycan biosynthesis class O protein, PIG-O)" PIGO UNQ632/PRO1249 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506] GO:0005789; GO:0006506; GO:0016020; GO:0016021; GO:0051377 mannose-ethanolamine phosphotransferase activity [GO:0051377] AVAGLAASGLALLLWKPVTVLVK 0.99024 -19.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5436 0 15.1266 15.3387 0 0 0 0 0 0 0 12.1807 14.7027 12.5326 14.2326 0 12.7511 0 0 0 0 0 0 0 0 0 0 12.8772 0 0 13.8864 0 0 0 0 11.2001 0 0 0 0 14.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.001 0 0 0 0 14.8387 0 15.1548 13.4789 15.0175 0 14.3011 0 0 11.7617 0 0 13.5704 0 13.8388 0 0 0 0 0 13.6599 0 0 0 0 13.1294 0 0 0 14.3107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX68 XKR5_HUMAN XK-related protein 5 XKR5 XRG5 UNQ2754/PRO6493 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] GO:0005886; GO:0016020; GO:0016021; GO:0043652; GO:0070782; GO:1902742 GTGGQQR 0.99025 -20.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWF9 CCD83_HUMAN Coiled-coil domain-containing protein 83 CCDC83 HSD9 Homo sapiens (Human) DFKDYVNLGPLGVK 0.99025 -20.965 0 0 0 0 0 0 0 0 14.9605 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0176 0 0 0 0 0 0 0 0 0 0 0 10.9154 0 0 0 0 0 0 13.9934 0 0 0 11.3255 0 0 0 0 0 15.4032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6848 0 14.0995 0 0 0 11.7074 0 0 0 0 0 0 0 0 0 11.5441 11.4462 0 0 0 0 12.9446 0 0 0 0 13.7842 0 0 0 0 0 0 0 0 0 0 0 13.344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2193 0 0 0 Q96RU2 UBP28_HUMAN "Ubiquitin carboxyl-terminal hydrolase 28, EC 3.4.19.12 (Deubiquitinating enzyme 28) (Ubiquitin thioesterase 28) (Ubiquitin-specific-processing protease 28)" USP28 KIAA1515 Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; protein deubiquitination [GO:0016579]; Ras protein signal transduction [GO:0007265]; regulation of protein stability [GO:0031647]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; protein deubiquitination [GO:0016579]; Ras protein signal transduction [GO:0007265]; regulation of protein stability [GO:0031647]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000077; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0007265; GO:0008283; GO:0010212; GO:0016579; GO:0016604; GO:0031647; GO:0032991; GO:0034644; GO:0042771 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] DSYGGLR 0.99025 -19.789 0 0 0 0 0 0 0 0 0 0 11.4324 0 0 0 0 0 10.8205 0 0 0 0 0 0 0 0 11.2262 0 0 0 11.5971 0 0 0 0 0 0 0 10.3963 0 0 0 0 0 0 0 10.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.462 0 0 0 0 0 0 0 15.6377 0 0 0 0 0 0 0 0 11.3273 0 0 0 0 0 0 0 0 0 12.0884 11.5729 11.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5634 0 0 0 0 0 0 0 0 0 0 0 11.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBX8 LGR6_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 6 LGR6 UNQ6427/PRO21331 VTS20631 Homo sapiens (Human) axon guidance [GO:0007411]; bone regeneration [GO:1990523]; G protein-coupled receptor signaling pathway [GO:0007186]; negative chemotaxis [GO:0050919]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; bone regeneration [GO:1990523]; G protein-coupled receptor signaling pathway [GO:0007186]; negative chemotaxis [GO:0050919]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055] GO:0004888; GO:0005886; GO:0005887; GO:0007186; GO:0007411; GO:0008201; GO:0016055; GO:0016500; GO:0030177; GO:0030335; GO:0031982; GO:0032588; GO:0048495; GO:0050919; GO:0090263; GO:1990523 heparin binding [GO:0008201]; protein-hormone receptor activity [GO:0016500]; Roundabout binding [GO:0048495]; transmembrane signaling receptor activity [GO:0004888] ASGQWEAEDLHLDDEESSK 0.99025 -20.97 0 0 0 0 0 0 11.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2593 0 0 16.6203 0 0 12.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.848 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3967 0 0 0 0 0 0 0 17.5623 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1921 17.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8046 0 0 0 17.7147 0 0 0 18.7069 0 0 0 0 13.1742 0 0 0 0 0 0 0 P0CAP1 MYZAP_HUMAN "Myocardial zonula adherens protein (GRINL1A upstream protein, Gup)" MYZAP MYOZAP Homo sapiens (Human) intracellular signal transduction [GO:0035556] anchoring junction [GO:0070161]; cortical actin cytoskeleton [GO:0030864]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; I band [GO:0031674]; Z disc [GO:0030018] anchoring junction [GO:0070161]; cortical actin cytoskeleton [GO:0030864]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; I band [GO:0031674]; Z disc [GO:0030018]; intracellular signal transduction [GO:0035556] GO:0030018; GO:0030864; GO:0031234; GO:0031674; GO:0035556; GO:0070161 DVRATLEK 0.99026 -21.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4529 0 0 0 0 0 12.4858 0 12.5983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3437 0 0 0 0 11.3744 0 0 0 0 0 0 0 0 0 14.1155 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8322 0 0 0 0 0 0 Q07699 SCN1B_HUMAN Sodium channel subunit beta-1 SCN1B Homo sapiens (Human) axon guidance [GO:0007411]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; corticospinal neuron axon guidance [GO:0021966]; locomotion [GO:0040011]; membrane depolarization [GO:0051899]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; node of Ranvier [GO:0033268]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; node of Ranvier [GO:0033268]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062]; axon guidance [GO:0007411]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; corticospinal neuron axon guidance [GO:0021966]; locomotion [GO:0040011]; membrane depolarization [GO:0051899]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transport [GO:0010765]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725] GO:0001518; GO:0005244; GO:0005248; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007411; GO:0010765; GO:0010976; GO:0014704; GO:0017080; GO:0019227; GO:0019871; GO:0021966; GO:0030315; GO:0033268; GO:0035725; GO:0040011; GO:0043204; GO:0044325; GO:0051899; GO:0060048; GO:0060307; GO:0060371; GO:0061337; GO:0086002; GO:0086006; GO:0086012; GO:0086047; GO:0086062; GO:0086091; GO:2000649 sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; voltage-gated sodium channel activity involved in Purkinje myocyte action potential [GO:0086062] ILCISCK 0.99026 -5.6128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UY14 ATL4_HUMAN "ADAMTS-like protein 4, ADAMTSL-4 (Thrombospondin repeat-containing protein 1)" ADAMTSL4 TSRC1 PP1396 UNQ2803/PRO34012 Homo sapiens (Human) apoptotic process [GO:0006915]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; apoptotic process [GO:0006915]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065] GO:0002020; GO:0002064; GO:0005576; GO:0005614; GO:0005788; GO:0006915; GO:0030198; GO:0042802; GO:0043065; GO:0062023; GO:0070285 identical protein binding [GO:0042802]; protease binding [GO:0002020] EACDMGPCTTAWFHSDWSSK 0.99026 -21.038 0 0 0 12.8342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9234 0 0 0 12.0352 0 0 0 0 12.4672 13.7644 12.5187 12.8956 12.6763 0 11.7105 12.3238 12.5481 0 0 12.5937 13.0631 11.8151 0 0 14.7558 12.5681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5207 0 0 0 0 0 13.6306 0 12.5475 11.9124 0 0 0 0 0 0 0 11.9213 12.6348 0 13.0936 0 0 0 12.7006 0 13.0402 0 10.5188 0 0 0 0 0 12.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 10.732 0 0 13.5963 0 0 12.974 0 0 0 12.7147 0 Q96BY6 DOC10_HUMAN Dedicator of cytokinesis protein 10 (Zizimin-3) DOCK10 KIAA0694 ZIZ3 Homo sapiens (Human) B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; B cell homeostasis [GO:0001782]; dendritic spine morphogenesis [GO:0060997]; marginal zone B cell differentiation [GO:0002315]; positive regulation of GTPase activity [GO:0043547]; regulation of cell migration [GO:0030334]; small GTPase mediated signal transduction [GO:0007264] GO:0001782; GO:0002315; GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0030334; GO:0043197; GO:0043547; GO:0060997; GO:0070062; GO:0070161 guanyl-nucleotide exchange factor activity [GO:0005085] APSPEVSDFFSILDVCLQNFRYLGKR 0.99026 -21.064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1385 0 0 0 0 10.4266 0 0 11.2476 0 0 0 0 0 0 0 13.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.69 0 0 0 0 0 0 0 0 17.6196 13.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9671 13.3109 11.2978 0 15.164 0 0 0 0 0 0 0 0 15.2509 14.8967 0 13.4223 16.5641 14.1897 12.1566 14.1472 0 0 14.7076 0 0 0 0 0 0 11.2439 0 0 0 0 0 0 0 0 0 13.3731 0 15.6804 0 13.5341 0 0 0 0 0 0 0 0 12.7985 0 0 14.2066 0 0 0 18.1119 0 0 0 0 15.2651 0 13.0177 0 0 0 0 0 0 0 0 0 0 15.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4019 0 0 0 0 0 Q9BRZ2 TRI56_HUMAN "E3 ubiquitin-protein ligase TRIM56, EC 2.3.2.27 (RING finger protein 109) (Tripartite motif-containing protein 56)" TRIM56 RNF109 Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340]" GO:0000785; GO:0003723; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0008270; GO:0032479; GO:0032728; GO:0034340; GO:0045087; GO:0045893; GO:0051607; GO:0060340; GO:0061630; GO:0070534 RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AAAAFAR 0.99026 -19.872 0 0 0 11.3857 11.5189 0 0 0 0 0 0 0 0 0 13.6347 0 0 13.6833 0 13.6134 0 13.4964 12.766 0 0 0 0 10.8981 0 0 0 0 0 0 14.1658 0 0 0 14.0955 0 0 0 0 13.8042 0 11.7014 0 0 0 0 0 0 0 0 13.2994 0 13.2447 13.9464 13.7699 13.6694 12.3416 12.4445 11.7941 0 0 0 0 0 0 0 0 0 0 0 14.716 0 14.9235 14.7799 16.0535 15.034 14.7334 0 13.4715 14.3159 0 11.2475 13.9184 14.618 0 14.808 14.7573 14.6477 0 0 14.5938 14.8858 14.5178 0 0 14.8293 0 0 14.9083 0 0 0 13.1255 14.7322 0 0 0 0 14.5705 13.2176 0 0 12.4536 0 0 15.1122 14.8951 0 0 15.6435 0 13.0825 0 14.3927 15.01 0 0 0 15.6973 14.7161 0 14.3133 0 0 0 0 0 13.3115 14.1734 14.2235 0 13.1412 14.3006 0 0 0 14.8545 13.9782 13.2046 14.3086 14.9781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.784 0 14.7706 0 0 14.2644 14.8386 0 Q9NVP4 DZAN1_HUMAN Double zinc ribbon and ankyrin repeat-containing protein 1 DZANK1 C20orf12 C20orf84 Homo sapiens (Human) eye photoreceptor cell development [GO:0042462] metal ion binding [GO:0046872]; eye photoreceptor cell development [GO:0042462] GO:0042462; GO:0046872 metal ion binding [GO:0046872] ALIAEPR 0.99026 -19.858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1734 0 0 0 0 0 0 0 0 0 0 0 0 12.4307 0 0 0 0 12.0723 0 0 0 0 14.8874 11.2993 0 0 10.6745 0 0 0 0 0 0 0 0 0 0 12.0824 0 0 0 0 0 0 11.7039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UI46 DNAI1_HUMAN Dynein axonemal intermediate chain 1 (Axonemal dynein intermediate chain 1) DNAI1 Homo sapiens (Human) cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] 9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157] 9+2 motile cilium [GO:0097729]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0003351; GO:0003774; GO:0005576; GO:0005813; GO:0005856; GO:0005874; GO:0005929; GO:0007018; GO:0007368; GO:0007507; GO:0008286; GO:0030317; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0097729; GO:0120293 cytoskeletal motor activity [GO:0003774]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] GHIISLK 0.99026 -21.034 0 0 0 0 0 0 15.8543 0 0 0 11.8128 0 12.2192 0 0 0 0 0 0 0 0 0 0 14.7122 0 0 0 0 9.68764 0 0 0 0 0 0 0 0 0 0 0 0 0 13.027 0 0 12.6728 0 0 0 0 0 0 13.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0272 0 0 16.464 16.3075 13.0536 0 0 16.2131 0 16.3942 0 16.4581 0 18.2535 18.415 0 18.262 13.4384 0 0 0 0 0 0 0 16.7602 0 0 0 0 0 0 0 14.2318 0 0 17.0029 0 0 16.7223 0 0 13.5911 0 0 0 0 16.697 0 0 0 14.2976 0 13.3931 13.6299 14.4706 0 0 16.6767 16.8931 12.8658 12.8406 0 16.6734 0 0 0 0 0 0 12.9978 0 0 0 0 0 0 0 0 0 0 0 12.5505 0 0 13.7195 16.9609 0 0 0 0 0 0 0 13.7519 0 14.7258 0 0 0 0 0 0 0 0 0 13.9056 0 0 0 0 Q8IXK2 GLT12_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 12, EC 2.4.1.41 (Polypeptide GalNAc transferase 12, GalNAc-T12, pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12)" GALNT12 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] ALANSVR 0.99027 -19.895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8281 0 0 0 0 0 9.16022 0 0 0 0 0 13.3714 0 0 0 0 12.0404 0 0 0 0 0 0 10.8684 0 0 0 0 0 0 0 14.739 0 0 0 0 0 11.1443 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5854 17.4827 16.916 17.6137 17.461 16.1839 16.6593 16.6955 15.3081 13.9965 13.5073 15.4323 13.1033 11.2204 0 0 12.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1503 0 0 14.1944 11.3301 0 0 13.4996 13.2497 14.5245 13.5767 14.1118 0 14.8044 0 0 14.1064 12.6603 14.6234 15.0685 14.8611 14.5572 14.7855 0 13.3803 13.9095 14.167 13.5901 0 13.2989 0 0 10.498 13.9854 0 0 0 0 0 0 13.6562 0 14.2541 13.3086 0 14.6051 0 14.7389 0 14.4291 13.1098 0 0 13.5452 0 14.3643 10.8595 11.9228 0 10.7158 12.8592 12.6747 0 0 0 10.8158 0 0 0 0 0 0 0 0 0 0 0 0 11.1475 0 0 13.1679 10.1602 O60232 ZNRD2_HUMAN Protein ZNRD2 (Autoantigen p27) (Sjoegren syndrome/scleroderma autoantigen 1) (Zinc ribbon domain-containing protein 2) ZNRD2 SSSCA1 Homo sapiens (Human) cell division [GO:0051301]; mitotic cell cycle [GO:0000278] cell division [GO:0051301]; mitotic cell cycle [GO:0000278] GO:0000278; GO:0051301 ERQDRISR 0.99027 -1.8434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60688 YPEL1_HUMAN Protein yippee-like 1 YPEL1 FKSG3 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] GO:0005634; GO:0046872 metal ion binding [GO:0046872] EGKFIIELAHMIKDNGWE 0.99027 -1.8412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94915 FRYL_HUMAN Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) FRYL AF4P12 KIAA0826 Homo sapiens (Human) cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; site of polarized growth [GO:0030427] cell cortex [GO:0005938]; site of polarized growth [GO:0030427]; cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175] GO:0000902; GO:0005938; GO:0030427; GO:0031175 AAQTTIETAIHSLIETLK 0.99027 -19.522 0 0 0 0 0 0 0 0 0 0 0 0 12.1827 0 0 0 0 0 0 11.0227 0 0 0 0 0 0 0 0 0 0 12.9784 0 0 0 0 0 0 0 11.3784 0 0 14.0076 0 0 0 0 14.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2213 0 0 0 0 16.9035 14.0877 0 0 0 0 12.1767 0 11.9256 0 0 0 11.4797 14.6777 0 0 0 13.2214 0 12.8593 0 16.3147 0 0 0 12.309 0 0 0 13.5505 0 12.2634 0 12.7312 0 13.1792 0 13.1288 11.6599 0 13.5105 11.1237 14.3164 0 12.2845 13.418 0 0 0 0 13.2777 0 0 13.1224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9764 13.2658 0 12.1804 14.8827 12.3084 0 14.9234 16.0525 0 0 0 0 0 0 0 12.6657 13.6933 14.0573 14.3832 0 12.8748 0 0 0 0 15.2683 0 0 13.9659 0 0 0 0 0 0 0 0 0 0 0 Q16534 HLF_HUMAN Hepatic leukemia factor HLF Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; skeletal muscle cell differentiation [GO:0035914]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003690; GO:0005634; GO:0005654; GO:0006357; GO:0035914; GO:0043565; GO:0045944; GO:0048511; GO:0090575; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" FSEEELK 0.99027 -19.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2672 14.5201 0 0 0 0 0 0 14.4842 0 0 0 0 0 14.3036 0 0 14.2896 0 0 0 0 0 0 0 0 0 0 14.3538 0 0 0 0 0 0 0 0 0 0 0 13.5687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.164 0 0 0 0 12.3283 0 Q53GQ0 DHB12_HUMAN "Very-long-chain 3-oxoacyl-CoA reductase, EC 1.1.1.330 (17-beta-hydroxysteroid dehydrogenase 12, 17-beta-HSD 12) (3-ketoacyl-CoA reductase, KAR) (Estradiol 17-beta-dehydrogenase 12, EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 1)" HSD17B12 SDR12C1 Homo sapiens (Human) estrogen biosynthetic process [GO:0006703]; extracellular matrix organization [GO:0030198]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; fatty acid elongase complex [GO:0009923]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; fatty acid elongase complex [GO:0009923]; integral component of membrane [GO:0016021]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-fatty-acyl-CoA reductase activity [GO:0050062]; oxidoreductase activity [GO:0016491]; estrogen biosynthetic process [GO:0006703]; extracellular matrix organization [GO:0030198]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0001968; GO:0005518; GO:0005783; GO:0005789; GO:0006633; GO:0006703; GO:0008201; GO:0009923; GO:0010811; GO:0016021; GO:0016491; GO:0016509; GO:0030198; GO:0031012; GO:0035338; GO:0044594; GO:0050062; GO:0102339; GO:0102340; GO:0102341; GO:0102342 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-fatty-acyl-CoA reductase activity [GO:0050062]; oxidoreductase activity [GO:0016491] AHYLKKTK 0.99027 -1.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53SF7 COBL1_HUMAN Cordon-bleu protein-like 1 COBLL1 KIAA0977 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296] GO:0003785; GO:0045296; GO:0070062 actin monomer binding [GO:0003785]; cadherin binding [GO:0045296] APSPPSK 0.99027 -19.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8038 0 0 0 0 0 0 0 0 13.2023 0 0 0 0 0 0 0 0 11.4716 0 0 0 0 0 0 0 0 0 0 16.7547 0 0 12.8937 0 0 0 14.5542 17.3353 12.107 0 0 0 12.7093 0 0 0 0 0 0 0 0 0 12.9357 0 0 0 0 0 15.4115 12.6649 13.4252 0 0 12.4086 0 0 14.4725 0 0 0 0 0 0 12.7429 12.9611 0 0 0 0 0 0 0 0 0 0 0 12.7984 0 0 14.846 0 12.5729 0 14.0022 13.3078 13.2113 0 0 12.2732 14.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3194 15.7655 0 0 0 0 0 11.4499 0 0 17.6524 0 14.6295 18.9267 0 0 0 0 0 0 17.8777 0 13.117 0 0 0 0 0 0 Q8IVW8 SPNS2_HUMAN Sphingosine-1-phosphate transporter SPNS2 (Protein spinster homolog 2) SPNS2 Homo sapiens (Human) B cell homeostasis [GO:0001782]; bone development [GO:0060348]; lipid transport [GO:0006869]; lymph node development [GO:0048535]; lymphocyte migration [GO:0072676]; regulation of eye pigmentation [GO:0048073]; regulation of humoral immune response [GO:0002920]; regulation of T cell migration [GO:2000404]; sensory perception of sound [GO:0007605]; sphingolipid biosynthetic process [GO:0030148]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell homeostasis [GO:0043029] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sphingolipid transporter activity [GO:0046624]; transmembrane transporter activity [GO:0022857]; B cell homeostasis [GO:0001782]; bone development [GO:0060348]; lipid transport [GO:0006869]; lymph node development [GO:0048535]; lymphocyte migration [GO:0072676]; regulation of eye pigmentation [GO:0048073]; regulation of humoral immune response [GO:0002920]; regulation of T cell migration [GO:2000404]; sensory perception of sound [GO:0007605]; sphingolipid biosynthetic process [GO:0030148]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell homeostasis [GO:0043029] GO:0001782; GO:0002920; GO:0003376; GO:0005886; GO:0006869; GO:0007605; GO:0010008; GO:0016020; GO:0016021; GO:0022857; GO:0030148; GO:0043029; GO:0046624; GO:0048073; GO:0048535; GO:0060348; GO:0072676; GO:2000404 sphingolipid transporter activity [GO:0046624]; transmembrane transporter activity [GO:0022857] QAAGDWHWALRVSPVLGMITGTLILILVPATKR 0.99027 -1.8442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0U7 CA087_HUMAN Uncharacterized protein C1orf87 C1orf87 Homo sapiens (Human) AAADLRK 0.99027 -19.886 0 0 0 0 0 0 0 0 13.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8552 0 0 0 0 0 0 12.4271 0 11.7209 0 10.5447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7808 0 0 0 0 0 0 12.5968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3F8 MILK1_HUMAN "MICAL-like protein 1 (Molecule interacting with Rab13, MIRab13)" MICALL1 KIAA1668 MIRAB13 Homo sapiens (Human) endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458] extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038] extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; neuron projection development [GO:0031175]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis [GO:0006898]; slow endocytic recycling [GO:0032458] GO:0005770; GO:0006612; GO:0006897; GO:0006898; GO:0019898; GO:0031175; GO:0031267; GO:0031902; GO:0032456; GO:0032458; GO:0036010; GO:0042802; GO:0045296; GO:0046872; GO:0055038; GO:0070300; GO:0097320 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidic acid binding [GO:0070300]; small GTPase binding [GO:0031267] ATKGSKPVR 0.99027 -19.53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7633 0 12.0888 0 0 0 13.8891 13.675 0 13.5428 14.395 0 0 0 14.0928 13.4773 14.2026 14.4882 13.7451 14.3318 13.6816 14.6035 13.9745 14.379 14.7707 0 14.4466 13.7561 13.6999 0 13.7133 0 13.7339 0 0 0 0 16.5115 13.9614 0 0 16.6661 0 0 0 0 14.1691 0 13.7988 14.5394 0 0 14.1648 13.0941 13.519 13.1904 13.4225 0 14.2812 13.9687 0 13.7293 0 0 0 0 0 0 14.7222 13.4305 14.7273 0 14.2212 0 13.3042 14.808 14.7537 13.7214 13.8274 15.0038 14.3915 13.8932 0 15.0336 13.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3791 14.7789 15.3665 14.131 0 0 0 0 0 Q8TBZ0 CC110_HUMAN "Coiled-coil domain-containing protein 110 (Cancer/testis antigen 52, CT52) (Cancer/testis antigen KM-HN-1)" CCDC110 KMHN1 Homo sapiens (Human) cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] GO:0005654; GO:0005794; GO:0005856 FENSISRLTEDKILLENYVR 0.99027 -19.534 0 0 0 0 0 0 0 0 11.9723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.39036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5521 0 0 0 0 0 0 0 0 0 0 0 14.9066 0 16.0756 0 0 16.4465 0 0 14.7916 0 12.6604 15.8414 0 15.017 0 13.1117 16.8208 0 0 14.1726 0 0 0 14.7268 15.2713 0 11.3472 10.8951 0 0 0 0 0 0 0 0 0 0 0 0 12.5731 0 11.5055 0 0 0 0 0 0 12.1847 0 0 0 0 0 0 12.3067 0 0 0 0 0 0 0 0 0 0 0 16.1242 11.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9599 0 0 0 10.7713 0 0 0 0 0 0 0 Q96B67 ARRD3_HUMAN "Arrestin domain-containing protein 3 (TBP-2-like inducible membrane protein, TLIMP)" ARRDC3 KIAA1376 Homo sapiens (Human) fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; skin development [GO:0043588] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; heat generation [GO:0031649]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein transport [GO:0015031]; skin development [GO:0043588] GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005886; GO:0015031; GO:0031649; GO:0031651; GO:0031699; GO:0043588; GO:0051443; GO:0060613; GO:0071878; GO:0090327; GO:0120163 beta-3 adrenergic receptor binding [GO:0031699] MVLGKVK 0.99027 -1.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8893 0 0 0 0 17.158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.317 0 0 0 0 0 0 0 0 0 0 0 14.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6895 12.4821 14.583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4858 0 0 0 12.7208 0 0 0 0 0 13.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 13.425 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0I1 MTMRC_HUMAN "Myotubularin-related protein 12 (Inactive phosphatidylinositol 3-phosphatase 12) (Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit, 3-PAP, 3-phosphatase adapter protein)" MTMR12 KIAA1682 PIP3AP Homo sapiens (Human) phosphatidylinositol dephosphorylation [GO:0046856]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol dephosphorylation [GO:0046856]; toxin transport [GO:1901998] GO:0004438; GO:0005737; GO:0005829; GO:0016529; GO:0019208; GO:0030017; GO:0046856; GO:1901998 phosphatase regulator activity [GO:0019208]; phosphatidylinositol-3-phosphatase activity [GO:0004438] DLRVFQFCLR 0.99027 -19.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5981 0 0 0 0 0 0 11.8535 13.6778 0 0 0 14.255 13.405 13.3602 0 0 0 0 13.3343 12.9428 0 0 12.5385 0 11.4737 0 0 0 0 0 12.3648 0 0 0 0 14.7474 0 12.4073 0 0 13.0405 0 0 0 0 0 11.2437 0 0 0 0 0 0 0 0 11.9847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2909 12.9108 0 0 0 0 0 0 12.3524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60285 NUAK1_HUMAN "NUAK family SNF1-like kinase 1, EC 2.7.11.1 (AMPK-related protein kinase 5, ARK5) (Omphalocele kinase 1)" NUAK1 ARK5 KIAA0537 OMPHK1 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of signal transduction by p53 class mediator [GO:1901796] GO:0001650; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006974; GO:0007155; GO:0015630; GO:0030155; GO:0035507; GO:0035556; GO:0042127; GO:0042149; GO:0046872; GO:0106310; GO:1901796; GO:2000772 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GELYDYISER 0.99028 -1.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6524 12.5948 0 0 0 12.078 0 0 0 0 0 0 11.3985 0 11.5848 0 0 0 0 0 0 14.4937 0 13.3299 14.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1192 0 0 0 12.1516 0 0 0 12.4337 12.511 0 11.0354 0 0 0 15.2528 13.8548 0 0 0 0 0 0 0 11.963 0 0 12.3083 0 0 0 0 11.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8321 0 0 0 0 0 0 0 P35228 NOS2_HUMAN "Nitric oxide synthase, inducible, EC 1.14.13.39 (Hepatocyte NOS, HEP-NOS) (Inducible NO synthase, Inducible NOS, iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)" NOS2 NOS2A Homo sapiens (Human) arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response in mucosa [GO:0002227]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of leukocyte mediated cytotoxicity [GO:0001912]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cellular respiration [GO:0043457]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801] cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; arginine binding [GO:0034618]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tetrahydrobiopterin binding [GO:0034617]; arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response in mucosa [GO:0002227]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of leukocyte mediated cytotoxicity [GO:0001912]; prostaglandin secretion [GO:0032310]; regulation of cell population proliferation [GO:0042127]; regulation of cellular respiration [GO:0043457]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of insulin secretion [GO:0050796]; response to bacterium [GO:0009617]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; superoxide metabolic process [GO:0006801] GO:0001666; GO:0001912; GO:0002227; GO:0004517; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0005886; GO:0006527; GO:0006801; GO:0006809; GO:0006954; GO:0007263; GO:0007623; GO:0009617; GO:0009725; GO:0010181; GO:0010629; GO:0012506; GO:0016491; GO:0018119; GO:0020037; GO:0030863; GO:0031284; GO:0032310; GO:0032496; GO:0032755; GO:0032757; GO:0034617; GO:0034618; GO:0042127; GO:0042177; GO:0042742; GO:0042803; GO:0043457; GO:0045454; GO:0045776; GO:0046872; GO:0048471; GO:0050660; GO:0050661; GO:0050796; GO:0050829; GO:0051712; GO:0071222; GO:0071346; GO:0071466; GO:1900015 arginine binding [GO:0034618]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; tetrahydrobiopterin binding [GO:0034617] AKGILTCRSK 0.99028 -21.811 0 0 0 0 0 0 0 0 0 0 12.2553 0 0 0 0 0 0 0 0 0 0 0 0 11.197 0 0 10.4166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0949 0 0 0 0 0 13.401 0 0 0 0 12.5135 13.1611 12.7401 13.6312 0 0 14.3813 13.1558 13.757 0 0 0 12.8761 0 13.8092 14.9067 0 0 0 0 14.9241 13.2621 13.1214 12.6863 0 0 12.7441 12.9335 13.2445 14.2983 13.4318 0 14.7763 0 0 0 0 13.9337 14.3918 12.8677 14.046 0 0 0 13.1248 0 15.0388 0 0 12.7416 12.8466 13.7876 0 14.1608 12.7487 0 13.7683 13.0398 13.9928 0 0 14.4071 14.1292 0 13.3841 0 14.8212 13.2698 0 0 0 13.6736 0 0 0 13.0705 13.2794 0 0 0 12.4839 0 0 0 0 14.2506 0 0 0 0 0 0 0 0 13.3254 0 14.7848 0 13.8566 0 0 0 Q14CB8 RHG19_HUMAN Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19) ARHGAP19 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0043231; GO:0051056 GTPase activator activity [GO:0005096] APAYIRECAR 0.99028 -19.943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3836 0 0 0 0 0 11.4344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5212 0 0 12.8458 10.9379 0 0 0 0 0 0 0 0 0 0 0 0 12.0169 0 0 0 0 0 0 0 0 0 0 0 11.7895 0 Q92804 RBP56_HUMAN "TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor, TAF(II)68, TAFII68) (RNA-binding protein 56)" TAF15 RBP56 TAF2N Homo sapiens (Human) "mRNA stabilization [GO:0048255]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; mRNA stabilization [GO:0048255]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA splicing [GO:0008380]" GO:0003677; GO:0003712; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0008380; GO:0045893; GO:0046872; GO:0048255 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] GGFQGRGGDPK 0.99028 -21.793 0 0 0 0 0 10.0352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.114 0 0 0 0 0 0 0 0 0 0 0 12.3613 0 0 0 0 0 0 0 0 0 0 0 0 11.7849 0 0 0 0 0 0 0 0 0 0 0 14.5713 0 0 0 0 13.0682 0 13.0673 0 10.7829 0 0 0 0 0 0 11.6177 0 12.8639 0 0 0 0 0 12.4348 0 0 0 0 12.8455 0 0 0 0 11.8706 0 13.5974 13.3857 0 0 0 0 0 12.91 0 0 0 12.4002 0 0 13.4232 0 0 0 0 0 0 0 0 13.2614 0 12.8824 12.783 0 0 0 0 12.5727 0 0 0 0 13.7179 0 0 0 0 0 0 0 0 0 0 14.0301 0 0 10.9741 13.0918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1124 12.7064 0 0 0 0 0 0 P13727 PRG2_HUMAN "Bone marrow proteoglycan, BMPG (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein, EMBP, MBP (Pregnancy-associated major basic protein) ]" PRG2 MBP Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; immune response [GO:0006955]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of macrophage cytokine production [GO:0010936]; positive regulation of interleukin-4 production [GO:0032753] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; transport vesicle [GO:0030133] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; transport vesicle [GO:0030133]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; heparin binding [GO:0008201]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; immune response [GO:0006955]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of macrophage cytokine production [GO:0010936]; positive regulation of interleukin-4 production [GO:0032753] GO:0002215; GO:0005576; GO:0006955; GO:0008201; GO:0010936; GO:0030021; GO:0030133; GO:0030246; GO:0032693; GO:0032753; GO:0042742; GO:0062023; GO:0070062; GO:1904813 carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; heparin binding [GO:0008201] KLPLLLALLFGAVSALHLR 0.99029 -5.8096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.996 0 0 0 0 0 13.6315 0 0 0 0 0 0 14.7075 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4405 0 0 0 0 0 0 0 0 0 0 0 0 10.6539 0 0 0 0 0 0 0 0 0 0 11.4555 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0269 0 0 0 0 14.4939 0 0 0 0 0 0 0 0 14.428 0 0 0 0 0 0 0 0 12.7933 0 0 0 0 0 0 0 13.3397 0 13.043 0 0 0 0 0 0 0 0 0 0 0 12.687 0 14.9366 14.1447 0 0 0 0 0 0 12.3762 12.8836 0 0 14.1332 15.1467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35125 UBP6_HUMAN "Ubiquitin carboxyl-terminal hydrolase 6, EC 3.4.19.12 (Deubiquitinating enzyme 6) (Proto-oncogene TRE-2) (Ubiquitin thioesterase 6) (Ubiquitin-specific-processing protease 6)" USP6 HRP1 TRE2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; protein deubiquitination [GO:0016579]; protein modification process [GO:0036211]; regulation of vesicle-mediated transport [GO:0060627]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] cytoplasm [GO:0005737]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calmodulin binding [GO:0005516]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; GTPase activator activity [GO:0005096]; nucleic acid binding [GO:0003676]; activation of GTPase activity [GO:0090630]; protein deubiquitination [GO:0016579]; protein modification process [GO:0036211]; regulation of vesicle-mediated transport [GO:0060627]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0003676; GO:0004197; GO:0004843; GO:0005096; GO:0005516; GO:0005737; GO:0005764; GO:0005886; GO:0006511; GO:0016579; GO:0036211; GO:0055037; GO:0060627; GO:0090630 calmodulin binding [GO:0005516]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; GTPase activator activity [GO:0005096]; nucleic acid binding [GO:0003676] HLRASTK 0.99029 -19.69 10.7958 0 0 0 0 0 0 0 14.3115 0 11.5274 0 12.3468 0 0 0 12.3314 11.9981 0 0 0 0 0 0 11.6385 0 11.6534 0 11.6962 0 0 11.2455 0 0 0 0 0 0 12.1414 10.923 0 0 12.4964 0 0 12.8472 0 0 0 14.1899 14.2297 0 12.6139 0 0 13.3744 0 12.855 0 0 0 0 0 11.3028 0 0 13.2154 0 0 12.9224 12.4463 0 0 14.1845 0 0 0 0 0 0 0 11.3657 0 12.9038 0 0 0 0 13.7698 0 14.7912 0 13.499 12.3817 0 0 0 0 0 0 0 0 0 0 10.7085 0 0 0 0 0 0 13.8802 0 0 0 0 0 13.0443 13.2694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7703 11.01 0 0 0 0 12.9389 13.4448 14.3385 0 0 0 0 0 0 0 0 14.332 13.6041 0 0 13.6402 0 13.7959 14.5355 14.2704 14.3691 0 14.5707 16.2304 14.5017 13.6093 13.1366 0 0 0 12.3905 0 13.8562 0 0 P47989 XDH_HUMAN "Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase, XD, EC 1.17.1.4; Xanthine oxidase, XO, EC 1.17.3.2 (Xanthine oxidoreductase, XOR) ]" XDH XDHA Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115] cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529] "cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115]" GO:0000255; GO:0001933; GO:0001937; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0006147; GO:0006148; GO:0006149; GO:0006154; GO:0006157; GO:0006161; GO:0006196; GO:0006204; GO:0006919; GO:0007595; GO:0009114; GO:0009115; GO:0010629; GO:0016226; GO:0016491; GO:0016529; GO:0042803; GO:0043546; GO:0045602; GO:0046038; GO:0046055; GO:0046059; GO:0050660; GO:0051537; GO:0051898; GO:0070674; GO:0070675; GO:0071949; GO:1900745; GO:1900747; GO:2000379; GO:2001213 "2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]" DCPNKKAIYASK 0.99029 -20.036 0 0 0 0 0 0 0 0 0 0 10.6255 0 0 0 0 0 0 0 10.5404 0 0 11.778 0 0 0 12.2389 0 0 0 11.7765 0 0 0 0 0 11.2189 0 0 0 0 0 0 14.4785 13.886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2639 13.2641 0 0 13.6234 0 0 0 0 0 13.5794 13.703 12.4926 0 0 13.2191 0 0 0 11.0958 12.7094 0 0 13.1771 12.4898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.577 0 0 0 0 0 0 0 0 0 12.1785 0 0 0 0 0 12.8357 0 0 15.3156 0 13.0091 0 0 14.9719 12.9466 0 0 0 0 0 0 0 14.6118 0 0 0 0 13.9366 0 10.5649 12.9318 0 0 0 12.4469 0 0 0 0 0 0 13.0316 0 0 0 0 13.103 0 10.9705 0 12.9761 P56192 SYMC_HUMAN "Methionine--tRNA ligase, cytoplasmic, EC 6.1.1.10 (Methionyl-tRNA synthetase, MetRS)" MARS1 MARS Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418] GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006431; GO:0009303; GO:0016020; GO:0017101; GO:0036120; GO:0070062; GO:0071364; GO:1901838 ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049] AGMFVSK 0.99029 -19.275 0 0 0 0 10.1141 0 0 0 14.6341 14.586 0 0 0 0 0 0 0 0 11.8798 0 0 0 0 0 0 10.8784 0 0 0 0 0 11.4775 0 0 0 0 14.5127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4607 0 12.0107 0 0 0 0 0 0 0 0 0 0 0 11.4856 0 0 0 0 0 12.4058 0 0 0 0 13.3615 0 0 0 0 0 0 0 0 14.6387 0 0 0 14.9381 0 0 0 0 0 0 14.5927 0 0 0 14.9906 0 0 13.8512 0 0 0 0 0 0 0 0 0 0 0 13.7694 0 0 0 0 0 0 0 0 13.836 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4013 12.8309 12.4128 11.8031 0 0 0 0 12.5893 0 13.34 0 12.4555 0 14.8778 0 0 0 0 13.6963 14.7501 12.498 0 0 Q15276 RABE1_HUMAN Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17) RABEP1 RAB5EP RABPT5 RABPT5A Homo sapiens (Human) apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0005096; GO:0005768; GO:0005769; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0031901; GO:0032991; GO:0042803; GO:0043231; GO:0055037; GO:0061025; GO:1903441 growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] AIATVSENTK 0.99029 -19.662 12.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0885 13.5651 12.5942 0 0 0 0 0 11.5929 0 0 0 0 0 0 0 0 0 0 0 0 13.3011 10.9703 0 0 0 0 0 0 11.8886 12.7263 12.5646 0 0 0 12.0888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5813 0 0 0 0 0 0 0 0 0 12.7531 10.7076 0 11.5166 0 13.9974 14.0714 0 13.4148 13.4862 0 12.5667 14.2054 0 0 13.7145 0 13.9769 0 12.4067 12.9105 13.6497 16.8296 0 0 15.4129 14.9234 14.9385 0 13.4494 13.7719 13.6191 14.1976 0 13.7867 13.3224 12.2277 0 12.8624 12.8149 13.7587 13.2222 12.7555 0 12.7465 0 0 0 0 13.7002 0 12.7527 0 0 0 14.3476 13.1199 0 0 14.2097 14.1347 0 0 0 0 0 12.1787 12.7927 0 0 0 0 14.2715 12.6735 14.3108 0 13.7674 12.9556 12.6514 12.989 13.5908 13.9543 0 0 10.3206 15.4221 13.5643 13.3556 0 0 14.0431 0 14.0146 0 12.5994 12.997 0 15.7761 13.1403 0 13.6594 0 0 Q7Z3D6 GLUCM_HUMAN "D-glutamate cyclase, mitochondrial, EC 4.2.1.48" DGLUCY C14orf159 UNQ2439/PRO5000 Homo sapiens (Human) glutamate metabolic process [GO:0006536] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; D-glutamate cyclase activity [GO:0047820]; glutamate metabolic process [GO:0006536] GO:0005759; GO:0006536; GO:0047820 D-glutamate cyclase activity [GO:0047820] ELESMIGIDPGNRGIGHLLCK 0.99029 -19.289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3911 0 0 0 0 0 0 0 0 0 0 0 0 15.3527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9411 0 0 Q9ULH7 MRTFB_HUMAN "Myocardin-related transcription factor B, MRTF-B (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2)" MRTFB KIAA1243 MKL2 Homo sapiens (Human) muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145] nucleus [GO:0005634] nucleus [GO:0005634]; cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713]; muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145] GO:0003713; GO:0005634; GO:0007517; GO:0045296; GO:0045844; GO:0045944; GO:0051145; GO:1902895 cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713] DPPRYEEAIKQTR 0.99029 -20.043 0 0 0 0 0 0 0 0 12.996 0 0 0 0 9.50716 0 12.7491 9.5343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0859 0 11.7447 0 0 0 0 13.2767 0 0 0 0 0 0 0 0 0 0 0 11.6349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2672 9.62174 0 0 0 0 0 0 0 0 0 0 0 0 13.9565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0236 0 0 0 0 0 0 0 0 0 14.2244 0 0 0 0 16.8714 0 0 0 0 0 0 13.5126 0 0 0 10.198 0 0 13.4119 14.1443 0 0 0 0 0 0 0 0 0 0 0 0 10.9253 0 0 0 0 0 0 0 0 12.7499 12.6298 0 0 0 12.725 0 0 18.1871 14.4764 0 14.5261 14.3385 0 12.882 12.4313 12.9506 18.1427 0 0 11.2382 0 0 0 0 13.9892 12.9391 0 0 0 Q9H583 HEAT1_HUMAN "HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed ]" HEATR1 BAP28 UTP10 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]" 90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455] "90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]" GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0045943; GO:2000234 RNA binding [GO:0003723]; snoRNA binding [GO:0030515] APKSFPK 0.9903 -19.794 11.2496 0 12.6469 0 0 0 11.2019 0 14.0555 13.9293 0 15.3164 13.5626 11.7839 12.1061 13.919 12.9855 12.3081 0 0 12.7877 0 12.5317 0 0 0 13.4042 0 13.5671 14.0701 13.1402 12.2854 12.9584 12.6177 0 0 9.8864 11.5733 16.4905 12.2917 12.3737 12.6631 11.5241 14.6568 12.7108 12.6034 12.6844 12.7328 14.6521 13.7209 12.5594 0 0 0 0 0 0 0 0 0 0 10.257 0 0 0 0 14.7381 13.8896 14.4282 13.6146 0 13.5535 0 12.118 15.6498 15.0307 15.614 16.3937 14.5982 14.7015 14.5146 12.8409 16.4391 15.017 16.8681 0 15.5557 14.9476 14.7396 0 15.9571 13.9289 16.2639 15.3763 16.8046 16.3528 16.1124 15.5899 15.1988 14.8877 14.5696 14.8527 15.25 13.0448 12.7256 16.4883 16.8687 15.5554 13.8559 14.8085 15.44 0 16.8083 13.543 13.8507 14.4186 15.2038 14.604 13.5348 15.2482 14.2422 15.3791 12.7235 14.8306 14.9152 15.8508 15.41 16.3171 16.0744 14.201 14.2427 16.2145 15.6906 16.275 15.2007 17.0523 14.6414 16.1111 16.0509 16.3501 15.4036 15.8247 14.0621 15.8144 15.605 0 16.0372 14.097 0 0 15.7404 14.9087 0 13.1027 16.0156 15.7726 13.2536 0 13.4284 12.203 13.07 13.4277 11.9787 0 0 0 0 0 14.3363 12.8003 14.1043 15.8006 13.7501 12.558 14.819 14.2077 12.8636 0 15.5155 12.2476 O00255 MEN1_HUMAN Menin MEN1 SCG2 Homo sapiens (Human) "brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; phosphoprotein binding [GO:0051219]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; Y-form DNA binding [GO:0000403]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose stimulus [GO:0071333]; cellular response to peptide hormone stimulus [GO:0071375]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to gamma radiation [GO:0010332]; response to transforming growth factor beta [GO:0071559]; response to UV [GO:0009411]; type B pancreatic cell differentiation [GO:0003309]" GO:0000122; GO:0000165; GO:0000278; GO:0000400; GO:0000403; GO:0000781; GO:0000785; GO:0000976; GO:0001933; GO:0002076; GO:0003309; GO:0003682; GO:0003690; GO:0005634; GO:0005654; GO:0005737; GO:0005788; GO:0005829; GO:0006281; GO:0006325; GO:0006357; GO:0006974; GO:0007420; GO:0008285; GO:0009411; GO:0010332; GO:0010812; GO:0016363; GO:0017053; GO:0030511; GO:0030674; GO:0032092; GO:0032154; GO:0032925; GO:0032991; GO:0035097; GO:0043433; GO:0044665; GO:0045668; GO:0045736; GO:0045786; GO:0045892; GO:0045944; GO:0046329; GO:0046697; GO:0047485; GO:0050680; GO:0051219; GO:0051568; GO:0051974; GO:0061469; GO:0070412; GO:0071333; GO:0071339; GO:0071375; GO:0071559; GO:1902807 chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; phosphoprotein binding [GO:0051219]; protein N-terminus binding [GO:0047485]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; Y-form DNA binding [GO:0000403] AAQKTLFPLRSIDDVVR 0.9903 -5.6803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.508 0 11.8673 0 0 0 0 0 0 0 0 0 0 0 0 13.1558 17.87 0 14.1513 13.6812 0 0 0 0 0 11.2495 0 0 15.0876 13.0914 12.389 0 0 0 12.9476 14.1236 0 0 0 14.7732 0 0 0 0 0 0 0 13.2886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95071 UBR5_HUMAN "E3 ubiquitin-protein ligase UBR5, EC 2.3.2.26 (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog, hHYD) (Progestin-induced protein)" UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779] GO:0000209; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0016020; GO:0032991; GO:0034450; GO:0042307; GO:0043130; GO:0048471; GO:0050847; GO:0061630; GO:0070936; GO:0090263; GO:1901315; GO:2000779; GO:2000780 RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270] AMNQQTTLDTPQLERKR 0.9903 -20.124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9375 0 0 13.2702 0 12.8704 0 0 0 0 11.9289 0 13.1716 0 0 0 0 0 0 11.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6573 0 15.8821 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6939 0 0 11.7925 0 0 17.0032 16.3727 16.5585 0 16.1664 16.0015 0 12.416 0 0 12.8292 0 17.1263 17.6396 18.2173 18.375 0 0 0 14.9532 15.0048 0 0 12.8627 15.7824 0 12.8103 0 0 0 0 0 12.7058 0 0 0 14.5087 12.9237 12.6512 0 14.5119 0 15.3593 14.9365 0 14.8728 0 0 12.1549 13.2365 0 0 0 0 0 12.7136 12.5568 0 13.4489 13.6735 11.0955 14.1917 0 0 0 0 0 0 0 14.2668 0 0 12.5112 0 0 0 0 13.8905 14.1366 13.4095 14.1543 10.9256 13.7418 0 0 0 0 0 14.3724 14.5804 12.2373 0 16.2574 0 0 0 0 0 0 0 13.9882 0 0 14.0598 0 12.8173 10.6547 0 0 P80303 NUCB2_HUMAN Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1 ] NUCB2 NEFA Homo sapiens (Human) negative regulation of appetite [GO:0032099]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; negative regulation of appetite [GO:0032099]; small GTPase mediated signal transduction [GO:0007264] GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005615; GO:0005635; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0032099; GO:0070062 calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085] EELQRQHDQLEAQKLEYHQVIQQMEQK 0.9903 -5.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.167 0 0 0 0 0 0 0 11.4065 0 0 0 0 0 0 0 0 0 0 0 11.8111 0 16.5234 0 13.2157 12.974 0 0 0 13.1546 11.2398 0 0 0 0 11.3898 0 0 0 0 0 0 12.8735 0 11.7784 0 10.8113 13.2402 16.8366 15.33 0 0 0 13.5367 12.3866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2642 0 0 0 0 0 0 0 11.2179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9004 0 Q8TEZ7 PAQR8_HUMAN "Membrane progestin receptor beta, mPR beta (Lysosomal membrane protein in brain 1) (Membrane progesterone P4 receptor beta) (Membrane progesterone receptor beta) (Progesterone and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member VIII)" PAQR8 C6orf33 LMPB1 MPRB Homo sapiens (Human) oogenesis [GO:0048477]; response to steroid hormone [GO:0048545] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nuclear steroid receptor activity [GO:0003707]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]; oogenesis [GO:0048477]; response to steroid hormone [GO:0048545] GO:0003707; GO:0005496; GO:0005794; GO:0005886; GO:0016021; GO:0038023; GO:0048477; GO:0048545 nuclear steroid receptor activity [GO:0003707]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496] QEIFLQR 0.9903 -20.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBJ2 ABCD2_HUMAN "ATP-binding cassette sub-family D member 2, EC 3.1.2.-, EC 7.6.2.- (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein, hALDR)" ABCD2 ALD1 ALDL1 ALDR ALDRP Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0007031; GO:0009617; GO:0015910; GO:0016021; GO:0016887; GO:0032000; GO:0042626; GO:0042760; GO:0042803; GO:0043217; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1903427; GO:1990535; GO:2001280 ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] ALADQMNLILSKRLWYIMIEQFLMK 0.9903 -20.125 0 0 0 0 0 0 0 0 0 10.6481 0 0 0 0 0 0 0 13.2933 0 0 0 0 10.7035 12.0673 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3863 0 0 0 0 0 0 13.2733 0 12.1411 11.6868 0 0 0 0 0 0 14.056 0 0 0 0 0 0 0 0 0 0 14.426 0 0 0 0 0 0 13.2767 0 0 0 13.3333 0 14.1567 0 0 0 14.0175 0 0 0 0 0 0 0 0 0 13.8646 0 0 0 0 0 0 0 0 14.4752 0 12.3814 0 13.1144 0 0 0 0 13.7914 0 0 0 0 0 0 0 0 12.1702 0 0 0 0 0 0 0 0 10.4873 12.539 0 0 0 0 11.9964 0 0 0 0 12.8828 14.1931 0 0 0 14.9974 0 14.9286 0 0 O75113 N4BP1_HUMAN "NEDD4-binding protein 1, N4BP1, EC 3.1.-.-" N4BP1 KIAA0615 Homo sapiens (Human) cellular response to UV [GO:0034644]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of viral genome replication [GO:0045071]; regulation of innate immune response [GO:0045088] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ubiquitin binding [GO:0043130]; cellular response to UV [GO:0034644]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of viral genome replication [GO:0045071]; regulation of innate immune response [GO:0045088] GO:0001818; GO:0003729; GO:0004540; GO:0005634; GO:0005730; GO:0005829; GO:0016605; GO:0031397; GO:0032435; GO:0034644; GO:0043130; GO:0045071; GO:0045087; GO:0045088 mRNA binding [GO:0003729]; ribonuclease activity [GO:0004540]; ubiquitin binding [GO:0043130] AELLEQSRGRIEGLFGVSLAVLGALGAEEPLPAR 0.99031 -21.119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.164 0 0 0 0 0 0 0 0 11.8944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1601 0 12.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5531 12.6454 11.8355 0 0 0 12.521 0 12.3007 0 0 0 0 0 11.9492 0 0 0 0 11.3668 0 0 0 0 0 0 12.3998 0 0 0 0 0 0 0 10.0107 0 0 0 13.495 0 0 0 0 0 13.9156 14.0688 0 0 0 0 0 0 0 0 13.3115 0 0 0 0 0 0 0 0 0 0 0 0 12.8816 0 0 0 13.4297 12.4214 0 0 0 14.5005 0 0 0 0 P62249 RS16_HUMAN 40S ribosomal protein S16 (Small ribosomal subunit protein uS9) RPS16 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]" GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0015935; GO:0016020; GO:0022626; GO:0022627; GO:0042274; GO:0070062; GO:1990830 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EIKDILIQYDRTLLVADPR 0.99031 -5.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7849 13.2437 13.9344 12.9139 13.1438 13.2841 0 0 0 0 0 14.5001 0 13.9375 13.6878 0 14.6696 13.6272 0 0 13.7827 0 0 0 13.7209 0 0 0 0 0 14.2813 0 0 0 14.3033 0 0 0 0 0 0 0 0 15.0064 0 0 13.9506 0 0 13.9622 0 14.6979 14.2599 14.582 0 0 0 0 0 0 0 15.0604 0 14.4864 14.8128 0 0 0 0 0 0 13.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6JBY9 CPZIP_HUMAN CapZ-interacting protein (Protein kinase substrate CapZIP) (RCSD domain-containing protein 1) RCSD1 CAPZIP Homo sapiens (Human) cellular hyperosmotic response [GO:0071474]; skeletal muscle contraction [GO:0003009] actin filament [GO:0005884] actin filament [GO:0005884]; actin filament binding [GO:0051015]; cellular hyperosmotic response [GO:0071474]; skeletal muscle contraction [GO:0003009] GO:0003009; GO:0005884; GO:0051015; GO:0071474 actin filament binding [GO:0051015] EQAAAAK 0.99031 -21.059 0 0 0 0 0 0 0 0 0 0 13.0724 11.2446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1713 11.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.763 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3425 0 0 0 0 10.5962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2561 0 0 0 0 0 12.4825 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XJ1 GA2L3_HUMAN GAS2-like protein 3 (Growth arrest-specific protein 2-like 3) GAS2L3 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; microtubule cytoskeleton organization [GO:0000226] GO:0000226; GO:0003779; GO:0005737; GO:0005874; GO:0005884; GO:0008017; GO:0008093; GO:0015629; GO:0015630; GO:0030036; GO:0051015; GO:0051764 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017] DADSGDK 0.99031 -19.86 0 0 0 0 0 0 0 0 0 0 0 0 0 14.177 0 0 0 0 0 0 0 0 12.7371 12.7939 0 0 0 0 0 0 0 0 13.1849 12.0819 12.4618 0 0 0 0 0 0 11.5847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2605 0 0 0 0 0 0 0 0 13.4961 14.7664 0 14.791 14.5161 15.6411 0 15.6274 0 0 0 15.7476 0 0 13.4936 0 0 14.6788 0 0 12.683 0 0 0 0 13.2304 0 0 0 0 0 0 0 0 0 13.8357 0 0 0 0 0 0 14.0901 0 15.4609 0 0 0 0 13.8067 0 0 0 14.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4892 12.558 0 13.6539 0 0 0 0 0 0 0 0 0 0 0 Q8TF45 ZN418_HUMAN Zinc finger protein 418 ZNF418 KIAA1956 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGKFFSSLLEHRR 0.99031 -19.822 0 0 0 0 0 0 12.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3174 0 0 0 0 0 0 0 10.7025 0 0 0 0 0 0 0 9.89055 0 0 0 0 0 0 0 0 0 0 11.9742 0 0 0 0 0 0 0 0 0 0 10.5251 0 0 0 0 0 0 0 0 0 0 10.7082 0 0 0 0 0 10.1445 0 0 11.9921 17.1409 0 10.1876 0 0 0 16.7568 0 0 16.6563 0 15.2292 0 0 0 0 0 0 0 0 0 14.138 13.6542 0 0 0 0 0 12.5133 0 0 0 0 11.1444 11.9201 0 0 0 0 0 0 0 0 11.7367 13.0675 10.9136 0 0 0 0 0 11.167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6928 0 0 0 0 0 9.33311 0 0 0 0 11.1053 0 0 0 0 Q96PQ6 ZN317_HUMAN Zinc finger protein 317 ZNF317 KIAA1588 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AYGRSCHLIAHK 0.99031 -21.033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6012 0 0 0 0 10.4847 0 0 0 0 0 0 0 0 0 0 13.0029 0 0 0 0 0 12.9528 0 0 0 0 0 0 13.0454 0 16.6471 0 0 0 0 0 0 0 0 0 0 0 13.6671 0 0 0 0 0 0 0 0 0 0 0 13.5676 0 0 12.1615 0 0 0 0 0 0 0 0 0 12.3342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVC5 ASHWN_HUMAN Ashwin C2orf49 Homo sapiens (Human) "embryonic morphogenesis [GO:0048598]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; embryonic morphogenesis [GO:0048598]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0005634; GO:0005654; GO:0005737; GO:0006388; GO:0048598; GO:0072669 LKRAAPK 0.99031 -19.852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1231 0 0 0 0 0 0 12.99 12.446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1343 0 0 0 0 0 0 0 0 0 12.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H808 TLE6_HUMAN Transducin-like enhancer protein 6 TLE6 Homo sapiens (Human) actin filament organization [GO:0007015]; embryonic process involved in female pregnancy [GO:0060136]; endoplasmic reticulum localization [GO:0051643]; establishment of spindle localization [GO:0051293]; mitochondrion localization [GO:0051646]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333]; transcription regulator complex [GO:0005667] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; subcortical maternal complex [GO:0106333]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; actin filament organization [GO:0007015]; embryonic process involved in female pregnancy [GO:0060136]; endoplasmic reticulum localization [GO:0051643]; establishment of spindle localization [GO:0051293]; mitochondrion localization [GO:0051646]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of embryonic development [GO:0040019]; regulation of cell division [GO:0051302] GO:0000122; GO:0003714; GO:0005634; GO:0005667; GO:0005737; GO:0005938; GO:0007015; GO:0032991; GO:0040019; GO:0051293; GO:0051302; GO:0051643; GO:0051646; GO:0060136; GO:0090090; GO:0106333 transcription corepressor activity [GO:0003714] CWDQRTIMKPLEYQFK 0.99031 -21.09 0 0 0 0 0 0 0 0 0 12.6576 0 11.9508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1607 0 0 14.5854 0 0 0 13.9635 13.2003 0 13.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5064 0 0 13.2503 0 0 0 0 0 0 13.0492 0 0 0 0 0 0 0 0 0 0 0 Q9NXL6 SIDT1_HUMAN SID1 transmembrane family member 1 SIDT1 Homo sapiens (Human) RNA transport [GO:0050658] integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033]; RNA transport [GO:0050658] GO:0003725; GO:0005764; GO:0005886; GO:0015485; GO:0016021; GO:0050658; GO:0051033 cholesterol binding [GO:0015485]; double-stranded RNA binding [GO:0003725]; RNA transmembrane transporter activity [GO:0051033] AAITLQKK 0.99031 -19.863 0 0 10.9409 0 0 15.732 15.8973 0 12.4043 0 0 12.1821 12.2907 12.4765 0 0 0 10.6866 11.8789 0 0 17.2284 0 17.2333 12.1965 0 0 0 0 0 0 12.6695 0 0 12.7266 0 12.2364 0 12.1961 0 0 0 0 0 12.4448 0 0 0 0 0 0 0 11.632 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1709 14.8814 14.9369 15.9437 17.8543 13.7122 18.0475 14.6928 15.4197 13.7424 13.6231 18.6408 14.4462 14.2751 14.7438 15.3626 12.5616 0 14.8156 18.2619 13.4451 12.1737 18.6837 0 18.5466 18.6946 15.2762 18.5824 13.1005 18.5583 18.9707 18.6614 13.7329 18.5621 18.4908 18.574 14.6843 18.4199 0 12.0994 0 12.6691 14.7636 18.4331 13.0888 18.3234 12.8092 18.3615 18.3348 0 0 0 18.3331 12.3234 11.6094 18.4067 18.2777 0 18.2741 14.309 18.2858 14.7268 18.3001 18.247 13.9576 18.3653 11.6143 18.2672 18.296 14.3626 0 0 13.8595 0 10.5375 14.0058 18.229 18.1243 18.1586 18.0996 0 14.6813 0 18.2154 0 18.0358 0 0 13.7998 0 18.1248 14.2061 12.7183 14.1404 0 0 14.0008 14.1765 12.6707 13.0277 14.1217 0 13.8521 13.8495 12.846 18.0713 14.4402 17.9542 13.9162 0 14.6401 10.7146 14.0277 0 O15480 MAGB3_HUMAN Melanoma-associated antigen B3 (MAGE-B3 antigen) MAGEB3 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 AHAETSK 0.99032 -19.864 0 0 0 0 0 0 0 0 0 0 0 0 13.235 0 0 0 0 13.0138 0 0 0 0 12.01 13.5882 0 12.4852 0 0 0 0 0 0 0 0 12.0424 0 0 0 0 0 0 0 0 0 12.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5449 14.6175 0 0 0 0 0 0 15.0626 13.4642 13.9163 12.7701 0 15.4328 12.8449 13.3426 0 16.9728 16.2842 16.9038 17.0159 16.7507 16.742 17.0135 15.4388 15.0887 14.4479 16.2953 17.0547 13.6347 18.1134 17.0518 15.6077 16.5326 15.1253 17.2565 13.8277 17.1428 16.3886 14.8975 16.2108 15.8516 16.0879 15.9681 16.6586 0 15.9888 16.9932 15.0211 14.8788 16.1614 0 15.6288 15.4095 15.8355 0 16.2203 16.6184 17.3596 15.7293 16.8931 15.273 16.6844 16.1785 16.6433 16.3196 13.3273 14.2362 16.6698 16.0028 16.1719 16.5565 16.4593 15.1658 17.0608 16.0755 16.3708 15.9252 16.8349 15.1422 16.1655 11.6257 14.8388 0 16.3365 15.8672 11.8937 14.3933 15.3144 0 14.9227 0 0 0 0 0 10.6872 0 10.5446 0 0 0 0 0 0 17.0074 16.0091 15.0814 15.7073 0 15.8545 11.8711 12.4058 0 P17030 ZNF25_HUMAN Zinc finger protein 25 (Zinc finger protein KOX19) ZNF25 KOX19 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ACECKECGK 0.99032 -21.141 0 0 10.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7265 0 0 0 0 0 0 0 0 0 0 0 11.1935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2952 10.9831 0 11.2038 0 0 0 0 0 0 0 0 12.5065 12.2074 0 0 0 0 0 18.8499 0 11.8541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1405 0 0 0 0 12.2063 0 0 0 0 0 0 0 12.8474 13.6553 0 13.2394 0 0 0 0 0 0 0 0 0 0 13.1939 0 0 0 0 0 0 0 0 0 12.6933 14.349 0 0 0 0 P17735 ATTY_HUMAN "Tyrosine aminotransferase, TAT, EC 2.6.1.5 (L-tyrosine:2-oxoglutarate aminotransferase)" TAT Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572] GO:0004838; GO:0005739; GO:0005829; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548 amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170] IQEFCEQHYHCAEGSQEECDK 0.99032 -19.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5813 0 0 0 0 0 0 0 0 0 0 0 11.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5807 0 0 0 0 0 0 0 0 0 0 11.0128 0 0 0 0 0 13.8994 0 0 0 0 13.2206 0 0 11.0945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0484 0 0 0 0 0 0 11.4409 0 0 0 0 10.9476 0 0 10.998 0 0 0 P61201 CSN2_HUMAN "COP9 signalosome complex subunit 2, SGN2, Signalosome subunit 2 (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15, TR-interacting protein 15, TRIP-15)" COPS2 CSN2 TRIP15 Homo sapiens (Human) inner cell mass cell proliferation [GO:0001833]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; protein phosphorylation [GO:0006468]; regulation of protein neddylation [GO:2000434]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell proliferation [GO:0001834] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; inner cell mass cell proliferation [GO:0001833]; negative regulation of nucleic acid-templated transcription [GO:1903507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; protein phosphorylation [GO:0006468]; regulation of protein neddylation [GO:2000434]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell proliferation [GO:0001834] GO:0000122; GO:0000338; GO:0001833; GO:0001834; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0006468; GO:0007165; GO:0008180; GO:0030182; GO:0035914; GO:0045116; GO:1903507; GO:2000434 transcription corepressor activity [GO:0003714] AALSSFQKVLELEGEK 0.99032 -19.925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8358 0 0 0 0 0 0 0 0 0 0 0 12.4209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5182 0 0 12.0682 13.4698 0 11.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6265 0 0 0 0 0 12.3013 0 0 0 0 0 0 0 0 Q7Z614 SNX20_HUMAN "Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1, SLIC-1)" SNX20 SLIC1 Homo sapiens (Human) protein transport [GO:0015031] early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein transport [GO:0015031]" GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981 "phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AGQYPRALELLLRVLPLQEK 0.99032 -19.929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0245 12.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XL3 ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) ANKLE2 KIAA0692 LEM4 Homo sapiens (Human) cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790] GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0030176; GO:0035307; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721 protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888] AFSTREDAEK 0.99032 -19.529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0511 0 0 0 0 0 0 0 0 13.9067 0 0 0 0 0 0 0 0 0 0 0 0 13.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99707 METH_HUMAN "Methionine synthase, MS, EC 2.1.1.13 (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase)" MTR Homo sapiens (Human) axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678] cytosol [GO:0005829] cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; pteridine-containing compound metabolic process [GO:0042558]; response to axon injury [GO:0048678] GO:0005829; GO:0007399; GO:0008270; GO:0008705; GO:0009086; GO:0009235; GO:0031103; GO:0031419; GO:0032259; GO:0042558; GO:0048678; GO:0071732 cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270] AYHLLVK 0.99032 -21.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7981 0 0 0 14.571 13.5291 0 0 0 0 0 0 0 13.9079 0 0 0 0 0 0 13.6259 14.5542 13.676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2997 0 0 0 0 0 0 0 11.8776 14.6628 0 0 0 0 13.4937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7631 0 0 0 0 0 0 0 13.7499 0 13.8189 0 0 0 0 0 0 Q9UBM7 DHCR7_HUMAN "7-dehydrocholesterol reductase, 7-DHC reductase, EC 1.3.1.21 (Delta7-sterol reductase) (Sterol Delta(7)-reductase) (Sterol reductase SR-2)" DHCR7 D7SR Homo sapiens (Human) brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; regulation of cholesterol biosynthetic process [GO:0045540]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; 7-dehydrocholesterol reductase activity [GO:0047598]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; sterol delta7 reductase activity [GO:0009918]; brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; regulation of cholesterol biosynthetic process [GO:0045540]; sterol biosynthetic process [GO:0016126]" GO:0005640; GO:0005783; GO:0005789; GO:0006695; GO:0009918; GO:0016020; GO:0016126; GO:0016132; GO:0016627; GO:0030176; GO:0033489; GO:0033490; GO:0045540; GO:0047598; GO:0050661 "7-dehydrocholesterol reductase activity [GO:0047598]; NADP binding [GO:0050661]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; sterol delta7 reductase activity [GO:0009918]" CLIWGRK 0.99032 -21.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5657 0 0 0 11.5372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4444 0 0 0 12.8272 13.0382 0 0 13.1235 0 13.0139 0 0 13.9772 0 0 13.6723 0 0 0 0 12.5938 0 12.4942 13.2097 0 0 0 0 0 0 0 0 0 12.9732 0 0 0 0 12.6565 0 13.3031 0 0 13.7965 0 12.9063 13.4745 13.224 13.1112 0 0 0 13.6362 13.4901 0 14.5489 0 12.7022 0 0 0 13.0188 12.9703 13.6219 14.5319 0 0 0 0 0 0 14.043 14.9855 0 13.0288 13.5465 14.437 0 0 14.4747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8571 0 0 0 0 0 0 0 0 13.1894 0 0 12.6182 10.7441 0 0 Q9UP95 S12A4_HUMAN "Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1, hKCC1)" SLC12A4 KCC1 Homo sapiens (Human) ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] GO:0005765; GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0008519; GO:0015379; GO:0016020; GO:0019901; GO:0045202; GO:0055064; GO:0055075; GO:0140157; GO:1902476; GO:1990573 ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901] CTTAAHLALLVPK 0.99032 -19.93 0 0 0 0 0 0 0 0 0 13.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2612 0 0 0 0 0 0 0 0 11.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.063 10.2097 0 0 0 0 0 0 0 0 0 0 0 0 14.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2681 P46459 NSF_HUMAN "Vesicle-fusing ATPase, EC 3.6.4.6 (N-ethylmaleimide-sensitive fusion protein, NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)" NSF Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001921; GO:0005524; GO:0005765; GO:0005794; GO:0005795; GO:0005829; GO:0005886; GO:0006813; GO:0006886; GO:0006887; GO:0006891; GO:0014069; GO:0016192; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030165; GO:0035255; GO:0035494; GO:0043001; GO:0043198; GO:0044877; GO:0045026; GO:0045732; GO:0046872; GO:0140545 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075] AAQSTAMNR 0.99033 -21.81 0 0 0 11.1404 0 10.8759 0 11.2765 0 13.6749 0 0 0 0 0 0 0 12.8101 0 0 12.363 13.616 13.8873 12.2252 0 0 0 13.7713 11.4181 10.319 12.5432 10.9991 13.3263 0 0 12.8517 13.6497 0 0 0 0 14.3823 11.5919 0 10.9764 0 0 0 0 13.7675 0 12.928 0 14.2723 0 0 0 0 0 0 0 0 0 0 0 0 14.7413 13.5124 0 13.7364 0 0 13.4571 13.8133 15.1711 0 14.806 14.8683 15.5068 14.2045 15.3034 16.4481 15.3621 0 15.8848 16.1048 15.7689 0 0 12.2404 13.6937 12.0917 0 14.9518 14.4746 15.9998 0 15.6164 0 15.9757 15.1659 14.6436 15.2143 14.2629 14.9096 16.1719 15.0101 0 14.5997 16.1566 15.0218 0 16.1362 15.4358 0 16.1628 16.0162 14.9729 14.6777 16.1276 16.4509 15.7596 15.7268 15.2693 16.418 15.8947 15.3918 15.2074 14.772 15.3047 15.3733 15.6101 14.5224 14.9861 15.9857 16.0852 15.9182 15.5234 12.9462 12.882 15.4187 16.1281 17.1331 16.0416 16.287 16.9103 14.7785 13.1679 12.1332 17.4155 16.0208 14.5547 14.3902 13.2454 15.7854 14.9105 15.3218 0 0 14.3332 0 14.5338 0 0 0 0 0 0 0 12.9028 13.9217 15.4788 15.126 15.9993 15.1617 0 0 0 15.812 11.9008 P29083 T2EA_HUMAN "General transcription factor IIE subunit 1 (General transcription factor IIE 56 kDa subunit) (Transcription initiation factor IIE subunit alpha, TFIIE-alpha)" GTF2E1 TF2E1 Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; transcription preinitiation complex [GO:0097550] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription open complex formation at RNA polymerase II promoter [GO:0001113] GO:0001113; GO:0005634; GO:0005654; GO:0005669; GO:0005673; GO:0005829; GO:0006366; GO:0006367; GO:0016251; GO:0046872; GO:0097550 metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251] ALLIHEKK 0.99033 -21.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5971 12.7936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8281 0 0 0 0 0 0 14.9814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4524 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7693 12.6638 0 0 0 0 0 0 0 0 0 0 13.2087 13.5688 0 0 13.7543 0 13.8135 0 0 0 0 0 0 0 0 0 11.9932 0 0 0 0 13.9017 0 0 0 0 0 0 0 0 0 14.2187 0 0 0 0 0 0 0 0 0 15.2925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3563 Q68BL8 OLM2B_HUMAN Olfactomedin-like protein 2B (Photomedin-2) OLFML2B Homo sapiens (Human) extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] GO:0005615; GO:0007165; GO:0030198; GO:0031012; GO:0042802; GO:0050840 extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802] AMSEGSDCQCK 0.99033 -19.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8408 11.31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86T03 PP4P1_HUMAN "Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase, Type 1 PtdIns-4,5-P2 4-Ptase, EC 3.1.3.78 (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)" PIP4P1 C14orf9 TMEM55B Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to sterol depletion [GO:0006991] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to sterol depletion [GO:0006991]" GO:0005654; GO:0005765; GO:0005886; GO:0006644; GO:0006991; GO:0008203; GO:0016021; GO:0030670; GO:0031902; GO:0032418; GO:0034597; GO:0046856; GO:0070070; GO:1901796; GO:1904263 "phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]" NAPPGKK 0.99033 -19.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1788 0 13.7773 14.0035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0812 0 0 0 0 0 0 0 12.2867 0 11.9037 13.0102 0 0 0 0 0 0 0 0 0 12.5408 13.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9191 0 0 0 13.4733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0658 0 0 0 11.6921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVT5 KSR1_HUMAN "Kinase suppressor of Ras 1, EC 2.7.11.1" KSR1 KSR Homo sapiens (Human) cAMP-mediated signaling [GO:0019933]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cAMP-mediated signaling [GO:0019933]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006468; GO:0007165; GO:0007265; GO:0008022; GO:0016020; GO:0019933; GO:0032587; GO:0032991; GO:0042127; GO:0043231; GO:0043405; GO:0043410; GO:0046872; GO:0071889; GO:0106310 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DSRFNFPAAYFIHHR 0.99033 -19.943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7695 0 0 0 0 0 0 19.9582 0 0 0 0 12.5254 0 0 0 0 0 0 12.5432 0 0 11.5128 0 0 12.1868 0 0 0 13.7658 0 0 0 0 14.0923 0 0 0 0 0 11.5798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1861 13.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXF6 RFIP5_HUMAN "Rab11 family-interacting protein 5, Rab11-FIP5 (Gamma-SNAP-associated factor 1, Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11)" RAB11FIP5 GAF1 KIAA0857 RIP11 Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008] centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658] centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]; gamma-tubulin binding [GO:0043015]; small GTPase binding [GO:0031267]; cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008] GO:0000139; GO:0005739; GO:0005741; GO:0005769; GO:0005794; GO:0030141; GO:0030658; GO:0031267; GO:0031901; GO:0034451; GO:0035773; GO:0043015; GO:0043231; GO:0045055; GO:0045335; GO:0055037; GO:0055038; GO:0070164; GO:0071468; GO:2000008 gamma-tubulin binding [GO:0043015]; small GTPase binding [GO:0031267] AKGFFLRNK 0.99033 -19.934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1677 0 0 0 0 0 0 0 0 11.7804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5372 0 0 0 0 0 0 14.4404 13.6048 0 0 10.9241 0 0 0 0 0 0 0 0 0 12.9261 13.7447 0 0 12.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.102 0 0 0 0 0 0 0 0 13.1146 0 0 0 0 0 0 O14578 CTRO_HUMAN "Citron Rho-interacting kinase, CRIK, EC 2.7.11.1 (Serine/threonine-protein kinase 21)" CIT CRIK KIAA0949 STK21 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; transcription coactivator binding [GO:0001223]; actomyosin structure organization [GO:0031032]; G2/M transition of mitotic cell cycle [GO:0000086]; generation of neurons [GO:0048699]; Golgi organization [GO:0007030]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; negative regulation of hippo signaling [GO:0035331]; neuron apoptotic process [GO:0051402]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cytokinesis [GO:0032467]; regulation of actin polymerization or depolymerization [GO:0008064] GO:0000086; GO:0000278; GO:0000281; GO:0001223; GO:0001889; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007030; GO:0008064; GO:0016020; GO:0017124; GO:0018107; GO:0019901; GO:0030165; GO:0030291; GO:0030496; GO:0031032; GO:0031985; GO:0032154; GO:0032467; GO:0035331; GO:0043025; GO:0046872; GO:0048699; GO:0051402; GO:0097110; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; transcription coactivator binding [GO:0001223] AALESQLR 0.99034 -19.271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9998 0 13.3041 0 0 0 0 0 0 0 0 0 14.2169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6264 12.8574 0 12.449 13.2507 12.8205 0 0 0 0 11.2512 0 13.5127 0 11.2181 0 0 10.2527 0 0 0 0 14.1252 0 13.9389 0 12.9622 15.208 0 15.5941 0 0 0 0 14.9378 0 10.69 0 0 14.9991 0 0 0 0 0 0 0 0 0 0 0 14.4615 0 12.3002 0 0 14.5038 0 0 13.8354 0 0 12.5242 0 14.6651 0 14.3849 13.7084 0 0 14.2622 0 12.6317 0 11.9738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5422 0 0 0 0 13.1849 12.062 0 0 0 0 13.1271 16.8412 0 16.9474 12.6866 16.9684 17.0565 0 0 0 0 12.6136 0 0 0 0 12.8936 16.8119 14.0861 0 12.0958 0 O95294 RASL1_HUMAN RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein) RASAL1 RASAL Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0030154; GO:0035556; GO:0043087; GO:0046580; GO:0046872; GO:0071277; GO:1903861 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] AALGPLGP 0.99034 -19.287 0 11.7754 0 14.6778 0 12.7328 15.4428 0 10.9084 12.0764 0 11.8301 12.215 11.9251 12.2698 0 0 0 13.2154 13.2157 0 0 14.022 0 0 0 0 0 0 11.9164 12.2102 12.2092 12.4006 0 0 0 0 11.8405 0 0 0 12.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.938 0 11.4045 0 0 0 0 0 0 0 0 0 0 0 0 14.1538 0 14.0547 15.8534 15.4543 0 0 0 0 0 0 0 0 0 0 0 17.7338 0 16.7248 15.3249 15.7451 0 0 0 15.0541 0 0 16.7048 0 10.6724 0 14.1509 0 0 0 0 0 0 11.1865 15.7776 0 0 0 0 15.4539 13.6659 0 0 0 0 0 14.2339 0 0 0 0 0 0 12.5983 0 0 0 0 0 13.3382 0 0 0 0 0 0 0 0 0 0 14.3209 0 13.7221 0 0 0 0 13.3333 0 11.8884 0 14.9098 0 0 0 0 0 0 0 15.4839 0 Q3B7T1 EDRF1_HUMAN Erythroid differentiation-related factor 1 EDRF1 C10orf137 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" nucleus [GO:0005634] "nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0005634; GO:0045893 AAHLEEFHYQTK 0.99034 -19.28 14.4822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2144 11.741 12.0117 12.844 0 0 0 0 11.4192 0 11.8402 11.3681 10.8434 11.8384 0 11.6577 0 0 0 0 0 0 12.0399 11.9829 0 0 0 11.1568 0 0 0 12.3048 0 0 0 0 0 0 0 0 12.5643 0 0 0 0 0 0 0 0 0 13.1055 0 14.4622 0 0 0 0 0 0 0 0 0 0 15.6335 13.6145 0 0 0 0 0 0 0 0 14.446 13.6648 0 0 12.9119 0 0 0 0 0 0 13.5551 9.78098 0 0 0 0 0 13.735 0 0 13.4519 0 12.764 0 0 0 13.368 0 14.125 0 0 0 10.2867 0 0 0 0 0 14.952 15.4893 14.1513 12.7495 0 0 0 0 0 13.6279 13.7325 0 14.7312 0 0 0 0 0 15.2438 0 0 0 13.6275 0 0 14.5516 14.2014 14.1685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6722 0 12.694 0 0 0 12.3125 12.8969 0 10.7853 Q8NB78 KDM1B_HUMAN "Lysine-specific histone demethylase 2, EC 1.14.99.66 (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 1B)" KDM1B AOF1 C6orf193 LSD2 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genomic imprinting [GO:0006349] nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genomic imprinting [GO:0006349] GO:0000122; GO:0000786; GO:0003682; GO:0005634; GO:0005654; GO:0006349; GO:0008270; GO:0016491; GO:0032452; GO:0034720; GO:0042393; GO:0043046; GO:0044030; GO:0045944; GO:0050660; GO:0071949; GO:0140682 chromatin binding [GO:0003682]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] IGGRVWDDK 0.99034 -19.662 0 0 0 0 0 0 0 0 0 16.0928 14.1004 16.3415 0 0 0 0 11.0351 14.009 0 16.8715 0 0 11.0272 0 16.1896 13.8171 0 0 15.5168 13.0161 0 0 11.1216 0 15.5096 0 15.2811 11.0207 0 17.6062 17.113 14.7466 13.2808 0 17.344 16.6892 18.0619 18.7219 11.3848 16.4737 0 17.4022 16.4136 14.4461 17.017 16.8539 17.7683 16.3661 16.9563 16.8457 13.7938 15.6894 17.089 15.3971 16.7872 16.397 12.4124 0 0 0 12.8021 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9401 14.435 14.4633 14.0174 0 0 0 0 0 0 0 15.3116 0 0 0 0 0 13.6522 13.3838 0 0 0 11.7431 12.7249 0 11.2737 0 13.2473 0 11.0522 14.5495 18.3972 0 0 0 0 12.5249 0 0 12.4987 0 13.0369 0 13.1548 12.985 14.0022 12.916 12.7088 0 12.1624 0 0 0 14.1327 0 0 11.7616 0 0 0 0 0 0 11.6812 0 0 0 0 0 0 0 15.2952 19.0206 12.6583 0 0 0 12.7522 17.8419 13.7558 13.9415 15.0558 17.9238 11.5072 16.7699 13.8231 16.388 13.1384 13.0321 0 0 14.2808 0 0 0 0 Q93084 AT2A3_HUMAN "Sarcoplasmic/endoplasmic reticulum calcium ATPase 3, SERCA3, SR Ca(2+)-ATPase 3, EC 7.2.2.10 (Calcium pump 3)" ATP2A3 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; organelle membrane [GO:0031090]; platelet dense tubular network membrane [GO:0031095]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; transmembrane transporter binding [GO:0044325]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; ion transmembrane transport [GO:0034220]; negative regulation of receptor binding [GO:1900121]; regulation of cardiac conduction [GO:1903779]; transport across blood-brain barrier [GO:0150104] GO:0005388; GO:0005524; GO:0005783; GO:0005789; GO:0006816; GO:0006874; GO:0006919; GO:0008656; GO:0015085; GO:0015662; GO:0016021; GO:0016529; GO:0016887; GO:0030899; GO:0031090; GO:0031095; GO:0031965; GO:0033017; GO:0034220; GO:0044325; GO:0046872; GO:0070059; GO:0070588; GO:0150104; GO:1900121; GO:1903515; GO:1903779 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-dependent ATPase activity [GO:0030899]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; transmembrane transporter binding [GO:0044325] AIYSNMK 0.99034 -19.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2486 13.2089 0 12.2773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.617 0 0 0 0 0 0 0 0 0 0 0 0 12.6957 0 Q9H159 CAD19_HUMAN Cadherin-19 CDH19 CDH7L2 UNQ478/PRO941 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] MDRELQDEYWVIIQAK 0.99034 -20.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6922 0 0 0 0 0 0 0 0 14.8373 0 0 18.5023 0 0 13.0901 0 0 13.9758 13.5624 0 0 0 0 15.9175 0 0 0 0 0 0 0 10.0327 0 0 0 0 0 0 0 0 12.7593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.548 14.7723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6996 0 0 0 0 0 0 0 0 13.2361 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3F6 BACD3_HUMAN "BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3, hBACURD3 (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10)" KCTD10 ULR061 MSTP028 Homo sapiens (Human) negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005112; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260 identical protein binding [GO:0042802]; Notch binding [GO:0005112] IHIKRPDDR 0.99034 -5.612 0 0 0 0 0 0 0 0 0 0 0 0 10.7147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8403 15.7751 15.3837 15.6407 0 15.0713 0 14.0255 0 15.2869 14.8328 14.2653 0 0 0 14.3143 0 0 0 0 0 0 0 0 0 0 0 0 14.6818 0 0 0 0 0 15.3458 15.075 15.1878 0 0 0 15.2276 0 15.7496 0 14.5669 15.7857 0 0 13.9466 14.7848 0 0 0 0 0 15.759 0 0 15.3401 15.4939 15.6917 15.3325 15.7667 15.3632 0 15.5075 15.3364 15.2471 15.2286 15.2929 0 0 15.3249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2883 0 0 0 0 14.869 0 0 15.2394 0 0 0 0 0 Q08881 ITK_HUMAN "Tyrosine-protein kinase ITK/TSK, EC 2.7.10.2 (Interleukin-2-inducible T-cell kinase, IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk)" ITK EMT LYK Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; gamma-delta T cell activation [GO:0046629]; intracellular signal transduction [GO:0035556]; NK T cell differentiation [GO:0001865]; positive regulation of cytokine production [GO:0001819]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; activation of phospholipase C activity [GO:0007202]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; gamma-delta T cell activation [GO:0046629]; intracellular signal transduction [GO:0035556]; NK T cell differentiation [GO:0001865]; positive regulation of cytokine production [GO:0001819]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852] GO:0001819; GO:0001865; GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0006968; GO:0007165; GO:0007202; GO:0035556; GO:0042110; GO:0046629; GO:0046872; GO:0050852; GO:0050853 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] EGAFMVR 0.99035 -20.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0598 13.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4997 0 0 0 12.9223 0 0 0 0 0 12.6551 0 0 0 0 0 0 0 0 0 0 14.3519 0 0 12.2797 12.7082 0 0 13.4834 0 13.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4023 0 0 0 0 0 0 0 0 12.14 0 0 12.9609 0 12.8667 0 0 0 0 0 0 11.8584 0 0 12.448 0 12.9028 0 0 14.3471 13.7667 0 0 12.494 13.174 0 0 0 Q9UL03 INT6_HUMAN "Integrator complex subunit 6, Int6 (DBI-1) (Protein DDX26) (Protein deleted in cancer 1, DICE1)" INTS6 DBI1 DDX26 DDX26A Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transmembrane signaling receptor activity [GO:0004888]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0004888; GO:0005634; GO:0005654; GO:0015629; GO:0016180; GO:0032039; GO:0034243; GO:0034472 transmembrane signaling receptor activity [GO:0004888] AQIMKEIR 0.99035 -20.962 0 0 0 0 0 0 12.7706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4744 13.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0867 0 14.1337 0 0 0 0 0 0 0 0 0 12.5055 0 0 15.6381 15.2763 0 13.5174 0 0 14.1407 0 0 13.4118 15.9378 12.8331 0 14.8847 0 0 0 0 0 0 13.3366 12.187 0 14.5091 0 0 0 0 0 0 0 0 0 16.4524 0 0 14.0511 13.1867 0 15.4842 0 0 14.6815 0 16.1658 0 0 14.9305 14.5226 0 0 0 0 14.2237 0 0 0 13.6514 13.8411 13.8219 0 0 0 0 0 12.6849 14.149 0 14.0159 0 12.4559 0 0 0 0 11.9673 0 11.2646 0 11.9817 0 12.9471 0 0 0 0 0 0 0 0 13.9209 0 0 0 0 0 O14514 AGRB1_HUMAN "Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40, Vstat40; Vasculostatin-120, Vstat120 ]" ADGRB1 BAI1 Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]" cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]" GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016021; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428 G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786] AACQMLCR 0.99036 -21.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0347 11.9432 13.0599 0 0 0 0 0 11.451 0 14.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1096 0 14.181 12.1525 13.7034 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0152 0 0 11.9777 0 13 0 0 0 13.1834 0 0 12.2844 15.9084 0 0 0 0 0 12.9531 0 0 0 0 14.3949 0 0 12.3042 0 12.8186 13.335 0 12.7669 0 0 0 0 0 12.3536 0 0 14.4092 0 11.8886 10.5652 0 0 11.8822 0 0 0 0 0 0 12.4555 0 12.5138 11.26 14.5521 10.9788 15.6487 12.7136 0 0 0 14.0738 12.3804 0 0 0 0 10.6175 11.9471 0 0 11.4832 0 0 0 0 0 12.7361 0 0 0 0 12.4978 0 11.9885 0 0 0 0 0 0 0 Q5M775 CYTSB_HUMAN "Cytospin-B (Nuclear structure protein 5, NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1)" SPECC1 CYTSB NSP5 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824] apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654] apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824] GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177 HLRTPSTK 0.99036 -21.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0766 0 0 0 0 0 0 0 0 13.85 0 14.0944 13.7642 13.765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5916 0 0 0 0 13.9263 14.056 0 0 0 0 13.97 13.9313 0 0 13.7972 0 0 0 0 0 0 0 0 0 13.6957 13.9133 14.105 0 14.1166 14.105 0 0 14.2503 0 0 0 13.963 0 0 14.6892 12.7224 0 0 0 0 14.6341 0 0 0 0 0 0 0 0 13.825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8287 12.6289 0 14.0925 0 14.324 0 0 0 0 0 0 0 0 Q8TC76 F110B_HUMAN Protein FAM110B FAM110B C8orf72 Homo sapiens (Human) cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739] GO:0005739; GO:0005815; GO:0005829 FFNYCGLDPEELENLGMENFAR 0.99036 -19.799 0 0 0 0 0 0 0 0 0 0 0 0 13.5525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.574 0 0 0 0 0 12.7946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0549 0 0 0 14.9436 0 0 0 13.4486 11.8961 0 0 0 0 0 14.6473 14.3173 0 0 13.7503 13.5453 0 13.4239 14.4676 0 0 10.0066 0 0 0 12.1948 12.909 0 0 0 0 0 0 14.1286 0 0 0 0 10.3934 0 0 0 0 13.5393 0 0 0 0 0 0 0 0 0 0 13.1452 0 0 0 0 0 0 0 0 0 0 10.4613 0 0 0 12.0934 12.504 11.217 12.3364 0 0 0 13.3218 0 0 13.0354 0 0 0 13.2623 0 0 13.7349 0 0 0 14.3645 0 0 0 0 0 0 0 0 Q96EG1 ARSG_HUMAN "Arylsulfatase G, ASG, EC 3.1.6.1 (N-sulfoglucosamine-3-sulfatase, EC 3.1.6.15)" ARSG KIAA1001 UNQ839/PRO1777 Homo sapiens (Human) sulfur compound metabolic process [GO:0006790] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lysosome [GO:0005764] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889]; sulfur compound metabolic process [GO:0006790] GO:0004065; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0006790; GO:0033889; GO:0046872 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-sulfoglucosamine-3-sulfatase activity [GO:0033889] MASEGMR 0.99036 -19.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.26078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7132 0 0 0 0 0 0 0 Q9BV73 CP250_HUMAN "Centrosome-associated protein CEP250 (250 kDa centrosomal protein, Cep250) (Centrosomal Nek2-associated protein 1, C-Nap1) (Centrosomal protein 2)" CEP250 CEP2 CNAP1 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; mitotic cell cycle [GO:0000278]; non-motile cilium assembly [GO:1905515]; positive regulation of protein localization to centrosome [GO:1904781]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of centriole-centriole cohesion [GO:0030997] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; protein-containing complex [GO:0032991]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; mitotic cell cycle [GO:0000278]; non-motile cilium assembly [GO:1905515]; positive regulation of protein localization to centrosome [GO:1904781]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of centriole-centriole cohesion [GO:0030997] GO:0000278; GO:0001750; GO:0001917; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0008022; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030997; GO:0032991; GO:0033365; GO:0036064; GO:0048471; GO:0050908; GO:0060271; GO:0070062; GO:1904781; GO:1905515 protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] AAAVKLSALNEALALDKVGLNQQLLQLEEENQSVCSR 0.99036 -19.85 0 0 0 0 0 0 0 0 13.7646 13.6774 0 0 14.8466 13.5194 14.6559 0 0 13.1325 14.3108 0 0 0 14.1359 0 0 0 0 0 12.1163 13.5519 0 0 14.9488 0 13.7264 13.6435 15.7475 12.611 14.8702 11.2671 13.7794 12.9355 0 11.2729 0 0 14.1044 13.8777 0 0 0 0 0 0 13.6636 0 0 12.8893 0 0 0 0 0 0 0 12.254 0 13.3208 0 0 0 0 0 0 0 12.7193 0 0 0 11.4815 0 0 0 0 0 13.1501 0 0 0 0 12.7533 14.8872 0 15.8925 0 0 14.1057 0 14.3817 0 0 0 0 0 0 0 0 0 0 15.2374 13.8223 13.7577 12.4775 0 0 0 0 0 0 15.3215 0 0 13.2884 0 0 0 0 0 13.1726 0 0 12.6515 13.0087 0 12.9981 0 14.4146 0 13.6726 0 0 0 0 13.8386 12.9289 0 0 14.8915 0 0 0 0 0 12.6133 15.1824 0 0 0 15.2221 11.5646 13.5914 0 0 12.8946 0 0 12.3859 0 0 12.9645 0 0 0 0 0 0 0 13.4924 0 0 Q9UPN9 TRI33_HUMAN "E3 ubiquitin-protein ligase TRIM33, EC 2.3.2.27 (Ectodermin homolog) (RET-fused gene 7 protein, Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma, TIF1-gamma) (Tripartite motif-containing protein 33)" TRIM33 KIAA1113 RFG7 TIF1G Homo sapiens (Human) "negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]" GO:0000122; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0008270; GO:0016567; GO:0017015; GO:0030514; GO:0045892; GO:0070410; GO:0070412 co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CPVCRQECR 0.99036 -19.822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2913 0 0 0 11.5192 0 0 0 14.412 0 12.8373 0 0 0 15.303 0 0 0 12.7584 0 0 0 0 0 0 0 10.3933 0 0 0 0 0 0 0 0 10.769 0 13.5434 0 0 0 0 11.8474 12.9399 0 0 14.1753 9.56371 11.7957 0 12.6515 13.5585 0 0 0 0 0 0 0 0 0 0 12.3617 0 0 0 0 0 0 0 0 0 0 0 11.5109 0 0 0 11.6309 12.9471 13.4693 0 0 0 0 11.9708 0 0 0 14.4251 0 0 11.7148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5277 0 0 0 0 0 14.6784 O00461 GOLI4_HUMAN "Golgi integral membrane protein 4 (Golgi integral membrane protein, cis, GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa, Golgi phosphoprotein of 130 kDa)" GOLIM4 GIMPC GOLPH4 GPP130 Homo sapiens (Human) cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133] cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133] GO:0000139; GO:0005794; GO:0005796; GO:0005801; GO:0010008; GO:0016020; GO:0016021; GO:0030133; GO:0030139; GO:0032580 EHQEALHQQRLQGHLLRQQEQQQQQVAR 0.99037 -19.919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5949 0 0 0 0 0 0 0 0 0 0 11.1452 0 0 0 11.6067 0 0 0 0 0 0 0 0 16.0882 15.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1306 0 0 0 0 0 12.3381 0 0 0 0 0 0 12.3444 12.1571 0 0 0 12.4842 0 0 0 0 11.8904 0 0 0 11.4386 0 0 0 0 0 0 0 O15552 FFAR2_HUMAN Free fatty acid receptor 2 (G-protein coupled receptor 43) FFAR2 FFA2 GPCR43 GPR43 Homo sapiens (Human) cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to fatty acid [GO:0071398]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipid storage [GO:0019915]; mucosal immune response [GO:0002385]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-8 production [GO:0032757]; regulation of acute inflammatory response [GO:0002673]; regulation of peptide hormone secretion [GO:0090276] cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell projection [GO:0042995]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cellular response to fatty acid [GO:0071398]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipid storage [GO:0019915]; mucosal immune response [GO:0002385]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-8 production [GO:0032757]; regulation of acute inflammatory response [GO:0002673]; regulation of peptide hormone secretion [GO:0090276] GO:0002232; GO:0002385; GO:0002673; GO:0002720; GO:0002752; GO:0002879; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008289; GO:0019915; GO:0032722; GO:0032757; GO:0042593; GO:0042995; GO:0045444; GO:0071398; GO:0090276 G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289] AFVGRIRQPQPAPVHILLLSLTLADLLLLLLLPFK 0.99037 -1.8279 0 0 0 0 0 0 0 12.0216 0 0 12.2285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.666 14.4118 0 13.6957 0 0 0 0 14.1861 0 0 0 12.9792 0 0 0 13.6445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3317 0 0 0 0 0 0 0 0 0 13.6554 0 13.5481 0 0 0 0 13.5383 0 12.8737 0 0 0 13.0516 0 14.1316 0 0 0 13.0753 13.7496 12.3535 0 0 0 0 0 13.1147 11.6537 0 12.3488 0 0 0 0 13.1673 0 0 0 13.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9574 0 0 0 O75366 AVIL_HUMAN Advillin (p92) AVIL Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005] "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480]" GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" HFMAIFK 0.99037 -20.27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5939 0 0 0 0 0 0 0 0 0 15.9731 0 16.4619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3535 0 0 0 0 0 0 11.0278 0 10.9486 0 0 11.6184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8133 0 0 0 0 0 0 0 0 0 0 12.6925 0 0 0 0 0 0 0 0 0 0 0 0 11.3966 12.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16885 PLCG2_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV, PLC-IV) (Phospholipase C-gamma-2, PLC-gamma-2)" PLCG2 Homo sapiens (Human) "activation of store-operated calcium channel activity [GO:0032237]; antifungal innate immune response [GO:0061760]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cellular response to calcium ion [GO:0071277]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; Fc-epsilon receptor signaling pathway [GO:0038095]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of receptor internalization [GO:0002092]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; programmed cell death [GO:0012501]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of lipid metabolic process [GO:0019216]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]; Wnt signaling pathway [GO:0016055]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]; activation of store-operated calcium channel activity [GO:0032237]; antifungal innate immune response [GO:0061760]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cellular response to calcium ion [GO:0071277]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; Fc-epsilon receptor signaling pathway [GO:0038095]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of receptor internalization [GO:0002092]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; programmed cell death [GO:0012501]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of lipid metabolic process [GO:0019216]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]; Wnt signaling pathway [GO:0016055]" GO:0001775; GO:0001784; GO:0001878; GO:0002092; GO:0002223; GO:0002224; GO:0002281; GO:0002316; GO:0002732; GO:0004435; GO:0004629; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0009395; GO:0010628; GO:0010634; GO:0012501; GO:0016055; GO:0019216; GO:0019722; GO:0019901; GO:0030168; GO:0030183; GO:0031663; GO:0032237; GO:0032481; GO:0032587; GO:0032733; GO:0032735; GO:0032743; GO:0032747; GO:0032755; GO:0032760; GO:0032959; GO:0035556; GO:0038095; GO:0043069; GO:0043122; GO:0043410; GO:0048471; GO:0048678; GO:0050731; GO:0050850; GO:0050852; GO:0050853; GO:0051091; GO:0051092; GO:0051209; GO:0060100; GO:0060907; GO:0061760; GO:0070062; GO:0070884; GO:0071277; GO:0071396; GO:0097110; GO:0097708; GO:0140031; GO:0150078; GO:1900227; GO:1902808; GO:1903428; GO:1903721; GO:1990782; GO:1990858 phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110] AVKSGFRSVPLK 0.99037 -21.75 0 0 0 0 0 0 0 0 0 0 0 0 11.5431 0 0 0 0 0 0 10.8303 0 0 11.2193 12.3639 12.4933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8882 0 11.8679 0 0 0 0 0 0 0 0 10.9687 0 0 0 0 0 0 0 0 0 0 0 0 13.3604 13.7871 0 0 0 0 0 0 13.1174 0 0 14.3202 0 0 11.1694 14.164 0 0 0 0 0 12.2732 0 0 13.448 0 13.7495 0 0 0 0 0 0 12.5704 13.2416 13.9053 0 13.7184 0 13.1641 13.3004 0 0 13.5949 0 0 15.5576 0 13.1015 0 0 13.2304 14.4437 0 0 0 0 0 13.026 13.5037 0 11.4289 0 0 11.6484 0 0 0 0 14.0086 0 14.6371 13.1892 13.9667 12.692 13.895 10.7852 0 0 13.752 0 0 0 13.0707 11.8208 12.6281 13.2581 0 0 0 0 0 11.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4605 10.5803 11.9756 0 12.6298 0 0 Q5FWF5 ESCO1_HUMAN "N-acetyltransferase ESCO1, EC 2.3.1.- (CTF7 homolog 1) (Establishment factor-like protein 1, EFO1, EFO1p, hEFO1) (Establishment of cohesion 1 homolog 1, ECO1 homolog 1, ESO1 homolog 1)" ESCO1 EFO1 KIAA1911 Homo sapiens (Human) mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270]; mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275] GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0007064; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733 acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270] CNSHLEITIPKDLK 0.99037 -21.139 0 0 0 0 0 0 0 0 13.1938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6748 0 0 0 0 0 0 0 0 0 12.1177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0006 0 0 0 0 0 0 0 0 0 0 15.9603 11.6047 0 0 0 0 0 0 0 11.9603 10.8855 0 0 13.9138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5219 0 12.3191 0 0 0 0 0 0 0 0 0 0 12.0348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3265 0 12.0624 0 11.991 0 11.7657 0 0 0 0 0 0 0 0 0 0 0 0 12.2759 0 0 0 0 0 Q9BZ95 NSD3_HUMAN "Histone-lysine N-methyltransferase NSD3, EC 2.1.1.370, EC 2.1.1.371 (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1, WHSC1-like protein 1)" NSD3 WHSC1L1 DC28 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone methylation [GO:0016571]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulator activator activity [GO:0140537]; chromatin organization [GO:0006325]; histone methylation [GO:0016571]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016571; GO:0018024; GO:0045893; GO:0046872; GO:0046975; GO:0140537; GO:2001255 histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulator activator activity [GO:0140537] CPQHCCSACSMEK 0.99037 -19.529 0 0 0 0 0 0 0 0 14.2284 10.6595 0 12.896 14.0015 12.7735 13.1149 12.9549 12.7754 0 12.4932 12.4846 0 0 12.8481 0 12.7875 13.2398 13.0873 12.6154 12.8344 13.0558 0 0 0 0 0 0 0 0 0 0 12.492 0 13.4264 0 0 13.7772 13.7321 0 0 0 0 0 11.8207 11.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6886 0 0 0 11.019 14.1418 0 11.8551 0 0 0 0 0 0 0 0 12.9487 0 0 0 11.1639 0 11.8187 11.6262 0 0 0 9.65227 0 0 0 0 0 0 0 11.7093 0 0 11.21 0 0 9.91661 0 0 0 0 0 0 0 13.2481 0 0 0 0 12.4767 0 0 0 11.3282 0 0 0 0 0 0 0 0 11.7429 18.4454 0 0 11.6135 0 0 0 0 0 0 0 0 18.0777 18.4882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9096 0 0 0 0 0 0 0 0 0 0 0 Q9P015 RM15_HUMAN "39S ribosomal protein L15, mitochondrial, L15mt, MRP-L15 (Mitochondrial large ribosomal subunit protein uL15m)" MRPL15 HSPC145 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to leukemia inhibitory factor [GO:1990830]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543; GO:1990830 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] DELFKMLCTR 0.99037 -19.925 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8845 10.4627 0 0 0 0 0 13.2716 0 12.9653 0 12.5962 12.9173 0 0 15.187 13.7044 0 0 12.1957 0 0 0 0 0 0 12.1439 0 13.9248 14.1412 0 11.6717 12.2004 11.987 13.2177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6735 0 0 0 0 0 0 0 0 0 14.2972 0 0 0 0 0 0 0 0 14.7389 14.7461 13.2547 14.3434 14.2394 14.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2374 0 16.0725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5237 0 0 0 12.5824 0 0 0 0 13.4786 0 0 0 0 0 0 0 0 0 0 12.9245 0 0 0 12.8736 0 0 13.721 0 0 12.5776 0 12.6117 0 0 0 0 0 0 0 0 14.7911 0 0 0 Q9Y5X1 SNX9_HUMAN "Sorting nexin-9 (SH3 and PX domain-containing protein 1, Protein SDP1) (SH3 and PX domain-containing protein 3A)" SNX9 SH3PX1 SH3PXD3A Homo sapiens (Human) cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; protein-containing complex assembly [GO:0065003]; receptor-mediated endocytosis [GO:0006898] clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802] clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; protein-containing complex assembly [GO:0065003]; receptor-mediated endocytosis [GO:0006898] GO:0000281; GO:0001726; GO:0005545; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0006898; GO:0016197; GO:0030136; GO:0030659; GO:0030838; GO:0031234; GO:0031410; GO:0031625; GO:0032437; GO:0035091; GO:0036089; GO:0042802; GO:0042803; GO:0043547; GO:0045296; GO:0045860; GO:0051044; GO:0060988; GO:0065003; GO:0070062; GO:0071933; GO:0097320 1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625] AMDDGVK 0.99037 -21.127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0944 0 0 0 0 13.4803 0 0 0 0 0 0 0 0 0 0 13.1353 0 0 12.7847 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1991 0 0 14.907 0 0 13.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14829 PPE1_HUMAN "Serine/threonine-protein phosphatase with EF-hands 1, PPEF-1, EC 3.1.3.16 (Protein phosphatase with EF calcium-binding domain, PPEF) (Serine/threonine-protein phosphatase 7, PP7)" PPEF1 PPEF PPP7C Homo sapiens (Human) detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; detection of stimulus involved in sensory perception [GO:0050906]; protein dephosphorylation [GO:0006470] GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0006470; GO:0017018; GO:0030145; GO:0050906 calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] DHDTDSK 0.99038 -21.808 0 0 0 13.0955 0 0 0 0 15.9511 0 15.6109 0 0 0 0 0 0 13.7841 0 15.2219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7332 0 0 0 9.5498 0 0 0 0 11.8747 0 0 11.362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8309 0 0 13.3375 0 0 13.6036 0 0 0 14.4144 0 0 0 0 0 13.6541 0 0 13.9028 0 0 0 0 0 0 0 13.8894 12.6815 12.7159 12.9287 0 0 0 0 0 0 0 12.6222 0 0 0 14.0942 0 12.5568 0 12.4056 0 0 0 13.1536 0 0 0 0 0 0 12.563 13.1923 13.349 13.6603 0 0 13.7953 13.4848 0 13.043 13.7749 0 13.5188 0 0 0 0 0 0 0 0 0 13.9357 0 14.2187 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5783 0 0 0 0 0 0 0 0 0 11.2216 P13010 XRCC5_HUMAN "X-ray repair cross-complementing protein 5, EC 3.6.4.- (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit, CTC85, CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen, TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))" XRCC5 G22P2 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to chromosome, telomeric region [GO:0070198]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to xenobiotic stimulus [GO:0009410]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to chromosome, telomeric region [GO:0070198]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to xenobiotic stimulus [GO:0009410]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]" GO:0000723; GO:0000725; GO:0000781; GO:0000783; GO:0000976; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007420; GO:0008022; GO:0008047; GO:0008094; GO:0009410; GO:0016020; GO:0016787; GO:0022008; GO:0031625; GO:0032040; GO:0032204; GO:0032212; GO:0032991; GO:0032993; GO:0034462; GO:0034511; GO:0034774; GO:0042162; GO:0043085; GO:0043564; GO:0044877; GO:0045027; GO:0045087; GO:0045860; GO:0045892; GO:0048660; GO:0050769; GO:0051973; GO:0060218; GO:0070198; GO:0070418; GO:0070419; GO:0071398; GO:0071425; GO:0071475; GO:0071480; GO:0071481; GO:0090734; GO:1904430; GO:1990830; GO:1990904 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]" EDGSGDR 0.99038 -5.6865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0126 0 0 0 0 11.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0464 0 0 0 0 0 0 0 13.5916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1157 P15144 AMPN_HUMAN "Aminopeptidase N, AP-N, hAPN, EC 3.4.11.2 (Alanyl aminopeptidase) (Aminopeptidase M, AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13)" ANPEP APN CD13 PEPN Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] GO:0001525; GO:0001618; GO:0004177; GO:0005615; GO:0005737; GO:0005765; GO:0005793; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0009897; GO:0016021; GO:0030154; GO:0030667; GO:0038023; GO:0042277; GO:0043171; GO:0070006; GO:0070062 aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] AALACSK 0.99038 -19.948 0 0 0 0 0 0 0 0 0 0 10.9924 0 0 11.2486 0 0 0 0 0 0 0 0 0 0 0 11.2584 0 0 0 0 0 0 0 0 0 0 0 0 11.9922 0 0 0 0 0 0 0 0 0 12.5403 0 0 0 0 0 11.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9387 0 0 13.0465 12.4343 0 0 0 0 0 0 0 0 0 0 0 0 0 13.341 12.8651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0592 0 0 0 0 0 0 0 0 12.2156 0 0 0 0 0 0 0 0 12.5768 0 0 0 0 0 0 0 0 13.7629 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4513 0 0 0 0 0 0 12.2789 0 0 0 0 11.1328 0 0 0 0 0 0 0 0 0 P43360 MAGA6_HUMAN "Melanoma-associated antigen 6 (Cancer/testis antigen 1.6, CT1.6) (MAGE-6 antigen) (MAGE3B antigen)" MAGEA6 MAGE6 Homo sapiens (Human) negative regulation of autophagy [GO:0010507]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0010507; GO:0042826 histone deacetylase binding [GO:0042826] EGDCAPEEK 0.99038 -5.6846 0 0 0 0 11.4503 0 0 0 9.92975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8584 0 0 0 10.5481 0 0 0 0 0 0 0 0 0 0 0 0 12.0121 0 11.1092 0 0 11.8667 0 0 0 0 0 0 10.8301 0 0 0 0 0 0 0 0 0 0 0 0 10.7704 0 0 0 0 0 0 0 10.5894 0 0 0 0 0 0 0 0 11.5058 0 0 0 0 0 0 0 0 11.3427 0 0 11.9358 0 0 11.2672 0 0 0 0 0 10.6367 0 11.0281 0 0 0 0 0 0 0 0 0 10.9364 0 0 0 0 11.1641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1017 0 0 11.9002 0 0 0 0 0 0 12.949 10.2349 0 0 0 0 11.2133 0 0 13.4271 0 0 0 P55287 CAD11_HUMAN "Cadherin-11 (OSF-4) (Osteoblast cadherin, OB-cadherin)" CDH11 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; ossification [GO:0001503]; skeletal system development [GO:0001501] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; corticospinal tract morphogenesis [GO:0021957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; ossification [GO:0001503]; skeletal system development [GO:0001501] GO:0000902; GO:0001501; GO:0001503; GO:0005509; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0021957; GO:0034332; GO:0045296; GO:0050804; GO:0070062; GO:0098685; GO:0098742; GO:0098978 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] DTFDDDS 0.99038 -21.791 0 0 0 0 0 0 0 0 0 12.1675 0 0 0 0 0 0 0 0 10.9798 14.4027 11.6651 0 0 0 0 0 0 0 0 0 0 0 0 10.2683 10.8255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8725 0 0 12.0669 0 0 0 0 0 0 12.4612 0 0 0 0 10.1805 0 0 0 0 0 0 0 0 0 0 0 0 12.0474 12.4557 12.5864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14507 EP3A_HUMAN "Epididymal secretory protein E3-alpha (Human epididymis-specific protein 3-alpha, HE3-alpha)" EDDM3A FAM12A HE3A Homo sapiens (Human) sperm displacement [GO:0007321] extracellular space [GO:0005615] extracellular space [GO:0005615]; sperm displacement [GO:0007321] GO:0005615; GO:0007321 EALKGKSFHMFIYSLWFK 0.99038 -1.8407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8349 0 0 0 11.8349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4266 0 13.5239 0 0 0 13.1723 13.5506 0 0 0 0 0 0 0 0 0 0 0 12.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6847 0 0 0 0 0 0 0 13.203 13.0827 13.584 0 0 0 0 0 13.1024 0 0 0 0 0 0 0 13.5765 0 0 0 13.5382 13.7871 0 0 13.012 13.1894 13.3348 0 10.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVB6 CTF18_HUMAN "Chromosome transmission fidelity protein 18 homolog, hCTF18 (CHL12)" CHTF18 C16orf41 CTF18 Homo sapiens (Human) cell cycle [GO:0007049]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Ctf18 RFC-like complex [GO:0031390]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0007049; GO:0016020; GO:0016887; GO:0031390; GO:0032508; GO:1900264 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677] ATPQALLLDALCLLLDILAPK 0.99038 -21.792 0 0 0 0 0 0 0 0 0 0 0 10.0988 0 0 0 14.9823 14.4112 0 0 0 14.2447 0 14.2541 0 0 0 14.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7573 12.3559 0 0 0 0 0 0 0 0 12.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.604 0 11.3381 0 13.6007 0 0 0 11.2021 0 0 0 0 18.7052 0 19.2299 0 19.2174 0 13.1485 0 14.5872 19.4859 21.0303 0 0 0 0 0 0 14.6082 12.7601 0 0 0 0 0 0 0 17.786 12.7176 0 0 0 0 0 0 13.1355 0 12.0618 15.0845 12.8282 0 0 0 0 0 0 13.243 11.3073 0 13.4263 0 0 11.7627 0 15.8015 0 0 0 0 14.1258 17.5774 0 0 0 0 0 0 0 0 13.691 0 17.3819 0 12.0164 17.2543 0 17.1229 0 0 0 0 0 12.6494 13.5166 0 13.6734 0 0 0 0 0 0 0 Q9H3G5 CPVL_HUMAN "Probable serine carboxypeptidase CPVL, EC 3.4.16.- (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein, VCP-like protein, hVLP)" CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) proteolysis [GO:0006508] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis [GO:0006508] GO:0004185; GO:0006508; GO:0070062 serine-type carboxypeptidase activity [GO:0004185] EDTVQSVK 0.99038 -5.6849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.49 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBH9 MKNK2_HUMAN "MAP kinase-interacting serine/threonine-protein kinase 2, EC 2.7.11.1 (MAP kinase signal-integrating kinase 2, MAPK signal-integrating kinase 2, Mnk2)" MKNK2 GPRK7 MNK2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to arsenic-containing substance [GO:0071243]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell surface receptor signaling pathway [GO:0007166]; cellular response to arsenic-containing substance [GO:0071243]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417] GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006417; GO:0006468; GO:0007166; GO:0009931; GO:0016604; GO:0016605; GO:0018105; GO:0030097; GO:0035556; GO:0046777; GO:0046872; GO:0071243; GO:0097192; GO:0106310 ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CGSDCGWDR 0.99038 -21.807 0 0 0 0 0 0 0 0 10.5816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5751 14.7012 0 0 11.7688 13.48 0 0 0 0 0 0 0 0 0 0 10.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2977 12.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKD2 MRT4_HUMAN mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4) MRTO4 C1orf33 MRT4 Homo sapiens (Human) nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]" GO:0000027; GO:0000956; GO:0003723; GO:0005730; GO:0005737; GO:0006364; GO:0030687; GO:0042273 RNA binding [GO:0003723] GVVTLLSDYEVCKEGDVLTPEQARVLK 0.99038 -21.803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2A7 NCKP1_HUMAN "Nck-associated protein 1, NAP 1 (Membrane-associated protein HEM-2) (p125Nap1)" NCKAP1 HEM2 KIAA0587 NAP1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; cortical actin cytoskeleton organization [GO:0030866]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601] GO:0000902; GO:0001726; GO:0005829; GO:0005925; GO:0006915; GO:0007417; GO:0010592; GO:0016021; GO:0016477; GO:0016601; GO:0030027; GO:0030031; GO:0030838; GO:0030866; GO:0031209; GO:0031258; GO:0031941; GO:0048812; GO:0070062; GO:2000601 FLRSALK 0.99038 -19.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7496 11.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4796 0 11.347 0 0 0 0 0 0 0 13.902 0 0 0 0 0 0 12.3358 0 0 0 0 0 0 0 0 0 13.0031 0 0 14.7377 0 0 11.8355 0 0 0 0 0 0 0 0 0 0 0 0 13.4895 B4DS77 SHSA9_HUMAN Protein shisa-9 SHISA9 Homo sapiens (Human) regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of short-term neuronal synaptic plasticity [GO:0048172] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of short-term neuronal synaptic plasticity [GO:0048172] GO:0008328; GO:0014069; GO:0030165; GO:0032281; GO:0032591; GO:0045202; GO:0045211; GO:0048172; GO:0070161; GO:0098962; GO:0098978; GO:0099061; GO:2000311 PDZ domain binding [GO:0030165] ALADVMR 0.99039 -19.285 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6312 0 0 0 0 0 0 0 0 0 12.0985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8494 0 0 0 0 0 0 0 0 0 0 12.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9407 11.5743 0 0 0 14.1493 0 0 15.0183 13.2311 0 0 0 0 0 11.7214 0 0 0 0 O95159 ZFPL1_HUMAN Zinc finger protein-like 1 (Zinc finger protein MCG4) ZFPL1 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]" Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]; vesicle-mediated transport [GO:0016192]" GO:0003677; GO:0005634; GO:0005794; GO:0006355; GO:0008270; GO:0016021; GO:0016192 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] AGLLLLLGLLGFLALLALMSRLGR 0.99039 -19.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1582 19.1532 0 13.7856 0 14.6485 0 0 0 13.7581 13.4645 0 0 11.0814 0 13.3954 14.2208 0 0 0 0 0 14.1244 0 14.2287 0 13.9892 0 0 0 14.2014 0 0 0 0 0 0 13.7961 14.2194 0 12.9328 0 0 14.0333 0 0 0 0 0 0 0 0 13.9231 0 0 0 0 0 11.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7094 0 0 0 0 0 0 P98194 AT2C1_HUMAN "Calcium-transporting ATPase type 2C member 1, ATPase 2C1, EC 7.2.2.10 (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1, SPCA1)" ATP2C1 KIAA1347 PMR1L HUSSY-28 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; trans-Golgi network membrane organization [GO:0098629] cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]; actin cytoskeleton reorganization [GO:0031532]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; ion transmembrane transport [GO:0034220]; manganese ion transport [GO:0006828]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; trans-Golgi network membrane organization [GO:0098629] GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0015662; GO:0016020; GO:0016021; GO:0016339; GO:0016887; GO:0030026; GO:0030145; GO:0030173; GO:0031532; GO:0032468; GO:0032472; GO:0032580; GO:0033106; GO:0034220; GO:0042998; GO:0043123; GO:0046872; GO:0070588; GO:0098629; GO:0140613 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613] AEYPFSSEQKWMAVK 0.99039 -19.266 0 0 0 0 0 0 0 0 0 0 10.1918 0 0 0 0 0 0 0 0 0 12.3946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0593 0 11.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3478 Q8TEW0 PARD3_HUMAN "Partitioning defective 3 homolog, PAR-3, PARD-3 (Atypical PKC isotype-specific-interacting protein, ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha)" PARD3 PAR3 PAR3A Homo sapiens (Human) asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; tight junction [GO:0070160] "adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]" GO:0000226; GO:0005546; GO:0005547; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007049; GO:0007155; GO:0007163; GO:0007205; GO:0007409; GO:0008104; GO:0008356; GO:0010801; GO:0012505; GO:0016324; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0033269; GO:0035091; GO:0043296; GO:0045197; GO:0051660; GO:0065003; GO:0070160; GO:0070830; GO:0090162; GO:0120157 "phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AEHENLFR 0.99039 -19.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4414 11.512 0 12.4772 12.4048 12.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.809 13.0234 0 0 0 0 0 14.3531 13.3647 0 0 12.7722 13.7593 12.8952 14.1482 14.3347 0 0 0 0 0 0 0 0 0 0 0 12.0892 12.514 13.013 13.9357 0 0 0 0 0 13.444 0 0 0 0 0 12.3539 0 12.9848 0 11.8942 14.2594 14.324 13.324 0 12.8131 0 0 0 0 0 13.1766 0 0 0 0 0 0 0 0 0 0 14.2067 0 0 0 0 0 0 0 0 0 13.247 0 0 0 0 12.9757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6257 0 Q9Y2J0 RP3A_HUMAN Rabphilin-3A (Exophilin-1) RPH3A KIAA0985 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; extrinsic component of synaptic vesicle membrane [GO:0098850]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; extrinsic component of synaptic vesicle membrane [GO:0098850]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669]" GO:0005509; GO:0005544; GO:0005546; GO:0005829; GO:0006886; GO:0006887; GO:0008021; GO:0008270; GO:0008430; GO:0017158; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070161; GO:0070679; GO:0098850; GO:1901981 "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]" CGVETNNRLHSVWLCKICIEQR 0.99039 -5.6923 0 0 0 0 0 0 0 0 0 13.8902 14.2003 0 14.0058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7814 0 13.9724 0 0 0 12.1371 0 0 0 0 0 0 0 0 14.0269 14.1236 0 0 0 0 0 0 0 0 12.9429 11.4949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5361 14.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1067 0 0 12.8167 13.3305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0324 0 0 0 0 0 0 14.6369 13.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B1ANS9 WDR64_HUMAN WD repeat-containing protein 64 WDR64 Homo sapiens (Human) DVIKSIVKIPHLDLLITATQK 0.9904 -20.954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6409 10.894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0051 13.7186 0 0 14.4403 0 13.4868 0 13.9635 13.8058 0 0 14.3137 0 0 0 0 0 0 0 0 0 0 0 0 12.6989 0 0 0 0 0 0 0 0 0 0 0 12.8318 10.8291 0 0 0 0 0 0 12.8727 0 0 10.8983 13.3016 0 0 0 14.6933 12.315 12.9412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4878 0 12.3035 0 0 0 0 0 0 0 0 0 0 0 0 12.3203 0 0 0 0 0 P46781 RS9_HUMAN 40S ribosomal protein S9 (Small ribosomal subunit protein uS4) RPS9 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0008284; GO:0015935; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0045182; GO:0045202; GO:0045903; GO:0070062; GO:1990904 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182] GQGGAGAGDDEEED 0.9904 -20.962 0 0 0 0 9.57749 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3 0 0 0 0 0 0 0 0 13.7913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6054 0 0 0 0 0 0 0 14.0386 12.9766 0 0 13.0057 12.656 0 0 14.3833 0 0 0 14.816 15.1903 0 0 0 0 0 0 0 15.4206 0 0 13.4765 13.1487 0 14.314 13.5006 13.3759 0 13.2164 0 14.3187 13.3588 0 0 0 0 0 0 0 0 11.2801 0 0 0 13.8539 12.4747 14.7725 14.0404 0 12.8165 0 0 0 11.8503 0 15.488 0 0 0 0 0 0 0 11.9701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.923 0 0 12.7092 0 0 Q32MK0 MYLK3_HUMAN "Myosin light chain kinase 3, EC 2.7.11.18 (Cardiac-MyBP-C-associated Ca/CaM kinase, Cardiac-MLCK)" MYLK3 MLCK Homo sapiens (Human) cardiac myofibril assembly [GO:0055003]; cellular response to interleukin-1 [GO:0071347]; positive regulation of sarcomere organization [GO:0060298]; protein phosphorylation [GO:0006468]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain kinase activity [GO:0004687]; cardiac myofibril assembly [GO:0055003]; cellular response to interleukin-1 [GO:0071347]; positive regulation of sarcomere organization [GO:0060298]; protein phosphorylation [GO:0006468]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769] GO:0002528; GO:0004683; GO:0004687; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0015629; GO:0045214; GO:0048769; GO:0055003; GO:0060298; GO:0071347 ATP binding [GO:0005524]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain kinase activity [GO:0004687] EPGEESQK 0.9904 -20.138 0 0 0 0 0 0 0 0 0 0 0 11.9364 0 13.2758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1633 0 0 0 0 0 0 0 0 13.8432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0918 0 0 16.3878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1522 15.465 0 13.9792 13.8399 0 0 0 13.8145 0 0 14.0494 0 0 0 0 0 0 13.8909 0 0 Q6P5X5 CV039_HUMAN UPF0545 protein C22orf39 C22orf39 Homo sapiens (Human) KHILVWAPR 0.9904 -5.8634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43236 SEPT4_HUMAN "Septin-4 (Bradeion beta) (Brain protein H5) (CE5B3 beta) (Cell division control-related protein 2, hCDCREL-2) (Peanut-like protein 2)" SEPTIN4 C17orf47 PNUTL2 SEP4 SEPT4 hucep-7 Homo sapiens (Human) apoptotic process [GO:0006915]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515] anchoring junction [GO:0070161]; axon [GO:0030424]; cell division site [GO:0032153]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; axon [GO:0030424]; cell division site [GO:0032153]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; apoptotic process [GO:0006915]; cytoskeleton-dependent cytokinesis [GO:0061640]; flagellated sperm motility [GO:0030317]; hematopoietic stem cell homeostasis [GO:0061484]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein ubiquitination [GO:0031398]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; regulation of exocytosis [GO:0017157]; spermatid differentiation [GO:0048515] GO:0000287; GO:0001764; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005654; GO:0005739; GO:0005741; GO:0005829; GO:0005940; GO:0006915; GO:0008021; GO:0008104; GO:0015630; GO:0017157; GO:0030317; GO:0030424; GO:0030425; GO:0031105; GO:0031398; GO:0032153; GO:0042802; GO:0042981; GO:0043065; GO:0043204; GO:0048515; GO:0060090; GO:0061484; GO:0061640; GO:0070161; GO:0097227; GO:2001244 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198] ALHQRVNIVPILAK 0.99041 -19.821 0 0 0 0 0 0 0 0 0 0 11.7832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.789 0 0 0 0 0 0 0 0 0 0 12.1654 12.8082 0 0 0 0 0 0 0 0 0 0 12.0004 0 O95155 UBE4B_HUMAN "Ubiquitin conjugation factor E4 B, EC 2.3.2.27 (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2)" UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) granzyme-mediated apoptotic signaling pathway [GO:0008626]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0008626; GO:0009411; GO:0019899; GO:0030433; GO:0034450; GO:0043161 enzyme binding [GO:0019899]; ubiquitin-ubiquitin ligase activity [GO:0034450] AEIDYSDAPDEFR 0.99041 -20.179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2335 0 0 0 0 0 0 0 0 0 0 0 10.484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8892 0 0 0 0 0 0 0 13.3836 0 0 0 0 0 0 0 13.3884 0 13.0579 13.1507 0 14.2488 0 13.6015 0 13.7357 0 0 0 0 0 0 0 0 12.982 0 0 0 0 12.8406 0 0 0 11.9604 0 0 0 0 0 0 10.7884 0 0 0 11.5284 0 0 0 13.4402 0 13.5726 0 12.7889 13.2932 13.0255 0 0 0 13.3848 13.6902 13.0583 13.4608 0 0 0 0 0 0 0 0 13.4851 0 0 0 0 0 0 0 11.3689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86Y97 KMT5C_HUMAN "Histone-lysine N-methyltransferase KMT5C (Lysine N-methyltransferase 5C) (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2, Su(var)4-20 homolog 2, Suv4-20h2) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B, EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B, EC 2.1.1.361)" KMT5C SUV420H2 PP7130 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830] "condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]" "condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]" GO:0000779; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0006281; GO:0006325; GO:0018024; GO:0034772; GO:0034773; GO:0042393; GO:0042799; GO:0045830; GO:0046872; GO:1904047; GO:2001034 chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] ALTLGGWTARYFQSR 0.99041 -19.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5163 0 14.6733 0 0 0 0 0 0 0 13.0366 0 0 0 0 0 0 0 0 11.9411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1007 0 0 0 0 0 0 0 0 0 0 0 0 14.1481 0 0 0 0 0 0 0 0 14.1691 0 0 11.0678 0 0 14.5427 0 0 0 0 0 0 0 0 0 0 14.2342 0 0 0 0 0 0 0 0 0 0 13.3516 0 0 0 0 0 0 0 13.7705 13.4198 0 10.4214 0 0 0 0 0 Q8N9B5 JMY_HUMAN Junction-mediating and -regulatory protein JMY Homo sapiens (Human) 'de novo' actin filament nucleation [GO:0070060]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357] autophagosome membrane [GO:0000421]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] autophagosome membrane [GO:0000421]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endomembrane system [GO:0012505]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; microtubule binding [GO:0008017]; transcription coactivator activity [GO:0003713]; 'de novo' actin filament nucleation [GO:0070060]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to starvation [GO:0009267]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000421; GO:0003713; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006281; GO:0006357; GO:0008017; GO:0009267; GO:0012505; GO:0031252; GO:0031410; GO:0034314; GO:0043065; GO:0051091; GO:0070060; GO:0070358; GO:0071933; GO:0072332 actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; microtubule binding [GO:0008017]; transcription coactivator activity [GO:0003713] DEVVYYDTYESMEAMLEKEEMAASAYLQR 0.99041 -20.577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8412 0 0 0 0 0 0 11.6135 0 0 0 0 0 0 0 0 11.6429 0 11.3908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6833 0 12.8586 0 14.7681 0 13.3574 12.4138 0 0 14.2956 0 12.9431 0 0 0 0 0 12.9711 0 0 0 14.1186 0 0 0 13.7186 0 0 0 0 0 0 17.1513 12.7337 0 0 0 14.4569 0 13.6015 0 0 0 0 0 0 14.7097 13.6416 13.4159 0 0 13.7556 0 0 19.1309 13.5798 12.1848 13.5963 0 0 13.1645 0 13.6832 0 13.3559 12.1565 0 15.317 13.4535 0 12.5555 12.7018 0 0 0 0 13.3407 0 13.3297 0 14.5199 0 14.5778 0 0 0 0 0 0 14.5974 13.3914 13.623 13.7997 13.8774 0 0 0 0 13.4881 0 0 0 13.2404 10.8187 13.6855 0 0 Q8TBY8 PMFBP_HUMAN "Polyamine-modulated factor 1-binding protein 1, PMF-1-binding protein" PMFBP1 Homo sapiens (Human) spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; sperm connecting piece [GO:0097224] cytoplasm [GO:0005737]; sperm connecting piece [GO:0097224]; spermatogenesis [GO:0007283] GO:0005737; GO:0007283; GO:0097224 EDEVILYEEEMGNHNENTGEK 0.99041 -20.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0386 0 0 0 0 0 0 0 0 0 0 0 0 11.4886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0756 0 14.5143 0 0 0 0 12.5523 12.0227 0 0 0 0 0 0 0 0 0 0 0 12.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9083 0 0 0 0 0 0 14.2256 0 0 0 0 0 0 0 0 0 0 0 0 14.6963 0 0 0 0 0 0 0 0 0 0 0 11.7554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92785 REQU_HUMAN "Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D, BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)" DPF2 BAF45D REQ UBID4 Homo sapiens (Human) "apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006338; GO:0006357; GO:0006915; GO:0007399; GO:0016514; GO:0030071; GO:0042393; GO:0043231; GO:0045892; GO:0045944; GO:0046872; GO:0062072; GO:0070316; GO:0070577; GO:0071565; GO:0097190; GO:1902459; GO:1905454; GO:2000045; GO:2000781; GO:2000819 H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] CCNICGTSENDDQLLFCDDCDR 0.99041 -20.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5727 0 13.2938 0 16.49 12.2739 0 15.0086 12.5334 14.1508 0 0 14.4725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2074 0 12.2528 14.5131 0 0 0 12.1327 12.1366 12.007 0 0 0 0 0 0 0 0 0 0 11.6511 0 0 0 0 14.0036 0 13.9389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1554 14.7425 13.2938 11.8967 0 12.2517 0 0 0 0 13.1446 0 0 12.6732 0 0 0 0 0 12.1666 13.4463 0 12.4135 0 13.2872 15.1092 11.0682 0 0 15.6147 0 0 0 0 0 0 0 0 0 12.5823 12.2411 12.2695 0 12.8613 0 10.1989 0 12.8058 0 0 17.4349 0 0 11.8061 0 0 17.3808 0 17.3436 0 0 0 0 10.644 0 0 0 0 0 0 0 0 0 15.1509 0 13.2719 0 0 15.6871 0 0 16.1763 0 0 0 0 0 0 15.9408 0 0 13.1343 0 10.9524 Q5VWX1 KHDR2_HUMAN "KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1, SLM-1, hSLM-1)" KHDRBS2 SLM1 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]" GO:0000381; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024 mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124] FQGSDGK 0.99042 -21.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4701 0 0 0 0 15.1689 16.901 0 0 0 0 0 16.5236 0 16.6736 0 0 0 16.4065 0 0 0 0 0 0 16.712 0 16.1334 0 0 0 0 0 0 0 0 0 0 16.2505 0 16.4948 0 0 14.3362 0 0 0 0 0 0 0 0 0 0 0 0 16.081 0 15.7629 0 0 0 0 0 0 15.9841 0 15.9232 0 9.9621 0 0 15.8856 0 15.361 15.133 0 15.0531 15.4728 10.4672 15.8631 0 0 0 0 0 0 0 0 0 0 0 12.4934 0 0 0 0 15.6451 0 0 0 0 0 0 Q8NBP0 TTC13_HUMAN "Tetratricopeptide repeat protein 13, TPR repeat protein 13" TTC13 PSEC0076 Homo sapiens (Human) AEILSPLGR 0.99042 -21.746 0 0 0 0 0 0 0 0 0 0 0 13.0405 0 0 0 0 0 15.1226 10.049 0 13.6209 0 0 0 14.2365 0 0 0 11.7538 0 0 0 0 0 11.5087 14.3329 0 0 0 0 13.5564 0 0 0 0 0 0 13.7367 0 0 0 0 11.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7921 0 0 0 0 11.955 13.0274 0 14.5322 0 0 0 11.818 0 0 12.2966 0 0 11.5346 15.1527 0 12.8639 0 0 13.4365 0 0 0 0 11.3818 0 12.1882 0 0 12.8212 14.8489 11.3465 15.343 0 14.7812 12.595 0 0 12.6847 15.2218 0 0 0 13.0247 13.0397 13.0484 13.291 13.8633 16.2068 0 13.3375 0 0 0 11.4078 14.0345 12.5738 11.9969 13.0368 13.4802 0 0 12.4969 15.1443 0 0 0 0 13.0427 0 12.5539 12.9628 12.4266 0 0 0 0 12.0903 11.024 12.3959 0 0 0 0 0 13.618 13.7831 0 15.2966 11.1235 0 0 13.1868 0 0 12.7557 0 0 13.0334 15.6766 15.6219 0 0 11.2224 0 13.9805 14.0063 13.6029 0 Q8WX94 NALP7_HUMAN "NACHT, LRR and PYD domains-containing protein 7 (Nucleotide-binding oligomerization domain protein 12) (PYRIN-containing APAF1-like protein 3)" NLRP7 NALP7 NOD12 PYPAF3 Homo sapiens (Human) cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of aspartic-type peptidase activity [GO:1905246]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of protein processing [GO:0010955]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of aspartic-type peptidase activity [GO:1905246]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of protein processing [GO:0010955]; regulation of inflammatory response [GO:0050727] GO:0005524; GO:0005737; GO:0010955; GO:0019828; GO:0019966; GO:0032691; GO:0042802; GO:0050727; GO:0071222; GO:0071347; GO:0089720; GO:1900016; GO:1905246 aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966] CMLDWTDCNLSPTLRYAFYLSCKELSR 0.99042 -19.841 0 0 0 0 0 0 0 0 0 12.7917 0 0 0 0 0 0 0 12.9123 12.4244 14.3781 0 0 0 0 0 0 0 12.5669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6038 0 0 0 0 0 0 0 0 0 0 0 10.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4436 14.0079 14.1026 0 10.8908 0 0 0 0 14.1748 14.2558 0 0 0 14.314 13.0135 0 12.7471 0 0 0 0 10.373 0 0 0 0 12.9777 14.5377 0 11.9178 11.1695 0 0 0 0 0 0 0 0 0 13.1652 0 0 0 0 13.7963 13.9793 13.5376 0 0 0 0 0 0 0 0 0 10.0243 0 0 0 0 0 14.0913 13.3464 0 13.5891 14.9511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8946 0 0 0 0 13.2397 13.7241 Q96PE6 ZIM3_HUMAN Zinc finger imprinted 3 (Zinc finger protein 657) ZIM3 ZNF657 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GVECDGSKK 0.99042 -21.735 0 10.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7076 0 0 0 0 0 0 10.9781 0 0 13.5446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0067 0 0 0 0 0 0 0 0 0 0 0 0 12.832 0 0 0 0 0 0 12.1215 0 0 13.7964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3523 0 0 13.3577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1678 0 0 14.7211 0 0 13.8154 14.1695 14.0947 0 13.0565 0 12.4334 0 0 0 0 0 0 0 0 0 14.0552 0 0 0 0 12.0286 0 0 0 11.5285 0 0 0 0 0 0 0 0 0 17.6673 0 0 0 12.4851 Q9NQW8 CNGB3_HUMAN "Cyclic nucleotide-gated cation channel beta-3 (Cone photoreceptor cGMP-gated channel subunit beta) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-3, CNG channel beta-3)" CNGB3 Homo sapiens (Human) cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; signal transduction [GO:0007165]; visual perception [GO:0007601] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495] intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0001750; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0007165; GO:0007601; GO:0017071; GO:0030553; GO:0044877; GO:0098655; GO:1902495 cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877] ASLARLLKLK 0.99042 -20.27 0 0 0 17.3582 0 0 0 0 13.7513 0 13.8819 13.6739 0 0 13.9028 0 0 0 0 0 0 12.2885 14.7948 10.9551 14.1555 0 15.148 0 0 0 0 13.4414 0 0 0 0 0 0 13.16 0 0 0 0 0 14.0562 0 0 0 0 0 0 0 0 0 12.1467 0 14.9712 15.2813 0 0 0 0 0 14.5498 13.9925 0 0 0 17.8985 13.2939 0 17.8253 0 17.4903 14.3199 18.5001 17.4634 13.9229 0 13.57 16.6355 0 0 17.0964 0 0 16.5076 0 0 14.8 13.4284 0 0 0 0 0 0 0 16.6929 17.0617 13.5985 0 0 0 0 14.7272 0 0 14.7375 17.1321 0 0 13.9235 14.6595 13.6259 13.5428 14.6928 13.8346 16.6561 13.8716 16.3807 16.533 16.4828 13.5597 0 13.9592 13.3651 0 16.191 13.405 13.7261 13.3829 0 16.5923 14.4452 0 14.7671 12.9877 13.4549 0 14.0419 0 13.1325 13.8711 0 16.3235 13.6623 0 0 0 15.9476 15.781 0 13.243 0 0 0 15.8024 0 0 0 15.3031 0 0 15.0326 14.604 15.0188 0 12.5907 0 15.8052 0 0 16.391 0 15.0481 15.713 14.9114 0 0 Q9NV66 TYW1_HUMAN "S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1, EC 4.1.3.44 (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein)" TYW1 RSAFD1 Homo sapiens (Human) wybutosine biosynthetic process [GO:0031591] "4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]; wybutosine biosynthetic process [GO:0031591]" GO:0010181; GO:0031591; GO:0046872; GO:0051539; GO:0102521 "4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]" AMITPALREALTK 0.99042 -21.71 0 0 0 0 0 0 0 0 13.3336 0 0 0 12.2939 12.1775 0 0 0 12.9412 0 0 0 0 0 0 0 0 0 0 0 0 12.6391 0 0 0 0 0 13.3733 13.1193 0 0 0 12.067 0 0 0 0 0 0 0 12.6172 0 13.4127 12.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9812 0 0 0 0 0 0 0 15.4507 0 0 0 0 15.2615 0 0 0 14.0957 0 0 0 14.9775 0 0 0 0 0 0 0 0 0 13.0683 11.3657 0 14.1446 0 0 13.4966 13.0421 0 15.7505 0 0 11.38 13.559 0 0 0 0 0 0 0 14.2555 0 0 0 0 0 10.6274 0 13.3892 0 15.7204 13.7296 13.3761 15.3073 0 15.9639 15.5707 0 0 13.3187 13.9775 15.2832 0 15.4407 13.44 15.8202 0 0 0 0 0 14.062 0 0 0 0 0 0 0 0 0 0 0 0 13.6937 0 14.7917 0 0 0 0 16.0804 15.4164 15.2391 15.5221 0 0 0 14.7254 0 Q9P212 PLCE1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, EC 3.1.4.11 (Pancreas-enriched phospholipase C) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1, PLC-epsilon-1)" PLCE1 KIAA1516 PLCE PPLC Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate-mediated signaling [GO:0048016]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267]; calcium-mediated signaling [GO:0019722]; cytoskeleton organization [GO:0007010]; diacylglycerol biosynthetic process [GO:0006651]; epidermal growth factor receptor signaling pathway [GO:0007173]; glomerulus development [GO:0032835]; heart development [GO:0007507]; inositol phosphate-mediated signaling [GO:0048016]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265]; regulation of cell growth [GO:0001558]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein kinase activity [GO:0045859]; regulation of Ras protein signal transduction [GO:0046578]; regulation of smooth muscle contraction [GO:0006940] GO:0000139; GO:0001558; GO:0004435; GO:0004629; GO:0005085; GO:0005829; GO:0005886; GO:0006651; GO:0006940; GO:0007010; GO:0007173; GO:0007200; GO:0007204; GO:0007265; GO:0007507; GO:0008277; GO:0010592; GO:0016042; GO:0019722; GO:0019899; GO:0030027; GO:0031267; GO:0032835; GO:0043410; GO:0045859; GO:0046578; GO:0046872; GO:0048015; GO:0048016 enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; small GTPase binding [GO:0031267] ELIDLQPLIQFPEEVASILMEQEQTIYRR 0.99043 -21.791 0 0 0 0 16.1381 14.5633 15.4523 14.36 12.8653 0 0 13.445 0 0 0 0 11.697 12.9545 9.34915 14.342 13.2986 12.5013 13.1498 13.9573 14.1165 12.0389 14.0018 0 13.8418 13.6725 13.9612 0 0 0 10.5788 10.3635 0 0 0 12.1201 12.8072 14.4531 13.8412 12.2775 13.6116 13.5935 14.2401 0 14.0791 0 11.9341 11.7302 0 0 0 0 11.2904 0 0 0 0 0 0 0 0 0 14.9465 14.1446 14.7467 12.9972 0 10.5445 13.8127 14.4487 13.9642 16.0555 16.1954 15.7274 15.3493 16.0244 14.1959 15.5586 16.3189 15.6897 14.9273 15.119 14.7792 16.267 14.8581 14.5975 15.9186 16.02 15.244 15.2125 14.6612 15.7544 15.251 15.7359 14.0991 15.1945 15.3204 14.9944 15.9056 14.9875 15.5963 15.4692 16.1779 15.5575 15.2614 16.4035 16.2175 12.2856 15.5901 16.4909 14.4803 15.7492 15.5829 16.3804 15.8446 15.0752 16.2779 11.8539 16.294 14.9003 15.3685 14.9043 14.8176 14.9708 15.8553 15.6404 13.2389 14.5138 16.4334 15.892 15.5754 14.9978 14.3147 15.9286 15.929 15.6368 13.9349 15.704 15.3596 16.2526 14.9453 15.0017 14.1358 14.0793 13.5723 0 16.5486 13.0993 12.055 13.9185 14.6121 15.1128 14.3134 0 0 0 0 0 13.9298 13.229 14.3992 14.1551 13.3894 12.7422 11.4579 0 12.6716 15.5386 14.9941 15.5731 14.8725 13.7054 14.4656 11.4456 0 0 P24593 IBP5_HUMAN "Insulin-like growth factor-binding protein 5, IBP-5, IGF-binding protein 5, IGFBP-5" IGFBP5 IBP5 Homo sapiens (Human) aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to organic cyclic compound [GO:0071407]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; lung alveolus development [GO:0048286]; mammary gland involution [GO:0060056]; negative regulation of cell migration [GO:0030336]; negative regulation of growth [GO:0045926]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of skeletal muscle hypertrophy [GO:1904205]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cell growth [GO:0001558]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; response to growth hormone [GO:0060416]; signal transduction [GO:0007165]; striated muscle cell differentiation [GO:0051146]; type B pancreatic cell proliferation [GO:0044342] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; fibronectin binding [GO:0001968]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; aging [GO:0007568]; cellular response to cAMP [GO:0071320]; cellular response to organic cyclic compound [GO:0071407]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; hair follicle morphogenesis [GO:0031069]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; lung alveolus development [GO:0048286]; mammary gland involution [GO:0060056]; negative regulation of cell migration [GO:0030336]; negative regulation of growth [GO:0045926]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of skeletal muscle hypertrophy [GO:1904205]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cell growth [GO:0001558]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; response to growth hormone [GO:0060416]; signal transduction [GO:0007165]; striated muscle cell differentiation [GO:0051146]; type B pancreatic cell proliferation [GO:0044342] GO:0001558; GO:0001649; GO:0001968; GO:0005576; GO:0005615; GO:0005788; GO:0007165; GO:0007565; GO:0007568; GO:0014912; GO:0016942; GO:0017148; GO:0030336; GO:0031069; GO:0031994; GO:0031995; GO:0035556; GO:0042567; GO:0042593; GO:0043567; GO:0043568; GO:0043569; GO:0044342; GO:0045668; GO:0045926; GO:0048009; GO:0048286; GO:0048662; GO:0051146; GO:0051897; GO:0060056; GO:0060416; GO:0071320; GO:0071407; GO:1901862; GO:1904205; GO:1904707; GO:1904754 fibronectin binding [GO:0001968]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995] EPGCGCCMTCALAEGQSCGVYTER 0.99043 -21.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.456 0 0 0 12.7003 0 0 12.481 0 0 0 0 0 0 0 0 0 0 12.8192 13.3083 11.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5727 12.4831 0 0 0 0 10.8645 0 11.8057 0 10.9578 0 0 0 0 13.0637 13.4855 0 13.0832 0 12.4429 0 0 0 0 0 0 0 0 0 0 0 0 12.7274 0 0 0 0 0 0 12.2315 0 0 0 0 0 0 0 0 0 0 0 11.1468 0 0 12.4524 0 12.5015 13.2323 0 0 0 0 0 0 0 0 0 0 0 0 12.3545 0 0 0 0 0 0 0 0 0 13.4439 0 0 0 0 0 0 0 0 0 0 0 13.604 0 16.4723 13.4163 0 0 0 13.7985 0 0 0 0 13.5958 14.6759 0 0 0 10.6144 0 11.0923 Q03431 PTH1R_HUMAN "Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor, PTH/PTHr receptor) (Parathyroid hormone 1 receptor, PTH1 receptor)" PTH1R PTHR PTHR1 Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; chondrocyte differentiation [GO:0002062]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; in utero embryonic development [GO:0001701]; negative regulation of cell population proliferation [GO:0008285]; osteoblast development [GO:0002076]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; skeletal system development [GO:0001501]" apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; chondrocyte differentiation [GO:0002062]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; in utero embryonic development [GO:0001701]; negative regulation of cell population proliferation [GO:0008285]; osteoblast development [GO:0002076]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; skeletal system development [GO:0001501]" GO:0001501; GO:0001701; GO:0002062; GO:0002076; GO:0004991; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0007166; GO:0007186; GO:0007187; GO:0007188; GO:0007189; GO:0007200; GO:0008283; GO:0008284; GO:0008285; GO:0008528; GO:0016323; GO:0016324; GO:0017046; GO:0030282; GO:0042803; GO:0043235; GO:0043621; GO:0045453; GO:0048469; GO:0060732 G protein-coupled peptide receptor activity [GO:0008528]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621] AQAQCEK 0.99043 -19.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1319 0 0 0 0 0 0 12.056 0 0 0 0 0 12.0658 0 0 12.0922 0 0 0 0 0 0 0 0 0 11.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6705 0 0 0 12.2969 13.6718 0 15.9528 0 0 0 0 0 0 0 13.4485 0 0 0 0 0 0 12.551 0 0 11.1444 0 0 0 12.5762 12.4752 0 12.3157 0 0 0 0 0 13.1939 12.4683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8239 0 0 13.1389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7816 0 0 0 0 0 12.5009 12.7113 12.8517 0 12.8802 Q08174 PCDH1_HUMAN "Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42, PC42)" PCDH1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005654; GO:0005730; GO:0005886; GO:0005887; GO:0005911; GO:0007155; GO:0007156; GO:0007267; GO:0007399; GO:0030054; GO:0043231 calcium ion binding [GO:0005509] AVDGGVPPR 0.99043 -19.947 0 0 0 0 0 0 0 0 0 0 0 0 11.5272 10.3994 0 0 0 13.8445 13.8983 13.2998 0 10.7429 0 0 13.5726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8761 0 0 0 0 0 0 0 0 0 0 11.28 0 0 12.5312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8838 0 0 11.4736 0 0 0 0 0 0 13.7824 0 0 0 0 0 0 0 0 0 14.4978 0 0 0 0 14.6733 14.5658 0 0 0 0 10.778 0 12.8342 0 0 14.2946 16.3025 12.9213 0 0 15.3532 14.104 0 0 0 12.4268 0 0 0 0 0 0 13.4455 0 0 0 0 0 14.0141 0 12.3356 0 0 0 0 0 0 0 0 13.0157 0 0 0 0 11.9343 0 0 0 0 11.5022 0 0 0 0 0 0 0 11.2533 0 10.8872 0 17.5487 0 10.2789 0 0 0 0 0 0 11.2601 Q14790 CASP8_HUMAN "Caspase-8, CASP-8, EC 3.4.22.61 (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE, FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog, MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10 ]" CASP8 MCH5 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; TRAIL-activated apoptotic signaling pathway [GO:0036462] caspase complex [GO:0008303]; CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ripoptosome [GO:0097342] caspase complex [GO:0008303]; CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; TRAIL-activated apoptotic signaling pathway [GO:0036462] GO:0001525; GO:0001817; GO:0004197; GO:0005123; GO:0005164; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0006508; GO:0006915; GO:0006919; GO:0007507; GO:0008233; GO:0008234; GO:0008303; GO:0008625; GO:0009409; GO:0010803; GO:0030101; GO:0030225; GO:0031264; GO:0031265; GO:0031625; GO:0032025; GO:0032355; GO:0032496; GO:0032731; GO:0032991; GO:0034612; GO:0035877; GO:0036462; GO:0042110; GO:0042113; GO:0042802; GO:0043005; GO:0043065; GO:0043123; GO:0043124; GO:0044297; GO:0044877; GO:0045088; GO:0045121; GO:0045471; GO:0045651; GO:0045862; GO:0046677; GO:0051603; GO:0060546; GO:0060715; GO:0070269; GO:0071260; GO:0071407; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097200; GO:0097202; GO:0097264; GO:0097342; GO:1901216 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625] DALMLFQR 0.99043 -19.956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JY77 GASP1_HUMAN "G-protein coupled receptor-associated sorting protein 1, GASP-1" GPRASP1 GASP KIAA0443 Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172] GO:0005634; GO:0005829; GO:0008333; GO:1990172 CRFMAGAEETNNK 0.99043 -21.783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9581 0 0 0 0 0 0 0 0 0 0 0 13.8069 0 0 0 0 13.8458 0 0 0 0 0 0 0 0 10.8825 0 0 0 0 0 0 0 0 0 0 0 13.5758 0 0 0 0 12.6022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3468 0 11.2351 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3586 0 0 0 0 0 0 0 0 13.2694 0 0 0 0 0 0 12.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6484 0 0 Q5SW24 DACT2_HUMAN Dapper homolog 2 (Dapper antagonist of catenin 2) DACT2 C6orf116 PP13671 Homo sapiens (Human) epithelial cell morphogenesis [GO:0003382]; hematopoietic progenitor cell differentiation [GO:0002244]; inner medullary collecting duct development [GO:0072061]; negative regulation of cell adhesion [GO:0007162]; negative regulation of nodal signaling pathway [GO:1900108]; skin development [GO:0043588] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; transcription factor binding [GO:0008134]; epithelial cell morphogenesis [GO:0003382]; hematopoietic progenitor cell differentiation [GO:0002244]; inner medullary collecting duct development [GO:0072061]; negative regulation of cell adhesion [GO:0007162]; negative regulation of nodal signaling pathway [GO:1900108]; skin development [GO:0043588] GO:0002244; GO:0003382; GO:0005080; GO:0005737; GO:0007162; GO:0008013; GO:0008134; GO:0043588; GO:0051018; GO:0070097; GO:0072061; GO:1900108 beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; transcription factor binding [GO:0008134] ALPADTGLQK 0.99043 -21.773 0 0 0 0 0 0 0 0 0 0 12.3056 0 0 0 0 0 12.3393 0 16.8971 0 0 0 0 0 0 12.1677 0 0 0 0 0 0 12.2203 0 0 0 0 0 0 0 0 0 11.9049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5402 0 0 0 0 0 19.4229 0 0 0 0 0 0 0 0 13.0789 0 0 17.8025 0 0 0 0 0 0 0 16.7032 0 0 0 0 0 0 0 18.6725 0 12.825 0 0 0 0 0 0 0 14.1102 0 0 0 0 14.9358 0 0 0 0 0 0 0 0 0 17.0456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2498 0 0 0 0 0 0 11.3523 0 12.4454 0 0 13.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCQ5 FBX15_HUMAN F-box only protein 15 FBXO15 FBX15 Homo sapiens (Human) cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] GO:0005829; GO:0019005 IFGLGWAIILKEK 0.99043 -5.6117 0 0 0 0 0 0 12.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1708 13.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2435 0 0 0 12.6347 13.7091 14.4139 0 0 13.7241 0 0 0 0 0 0 0 13.3851 0 0 0 0 0 0 0 0 12.3733 12.6453 0 0 0 0 0 13.4914 0 13.9179 0 0 0 0 0 0 0 0 13.9719 0 0 0 0 0 0 0 0 0 15.4007 13.9119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.814 13.7802 14.2465 0 0 0 0 0 0 Q9NRM0 GTR9_HUMAN "Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9, GLUT-9) (Urate transporter)" SLC2A9 GLUT9 Homo sapiens (Human) fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; monosaccharide transmembrane transport [GO:0015749]; urate metabolic process [GO:0046415]; urate transport [GO:0015747] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate:proton symporter activity [GO:0005351]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; monosaccharide transmembrane transport [GO:0015749]; urate metabolic process [GO:0046415]; urate transport [GO:0015747] GO:0005351; GO:0005353; GO:0005355; GO:0005886; GO:0005887; GO:0008645; GO:0015143; GO:0015149; GO:0015747; GO:0015749; GO:0015755; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0046415; GO:1904659 carbohydrate:proton symporter activity [GO:0005351]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143] AFYNESWER 0.99043 -20.818 0 0 0 0 0 0 0 0 11.1563 0 0 0 0 0 0 0 0 0 0 10.4459 0 0 12.8558 0 12.0209 0 0 0 0 10.6139 0 0 0 0 0 13.817 0 0 0 0 0 0 0 0 0 0 0 12.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2244 0 0 0 0 0 0 0 0 0 14.6997 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1937 0 14.2495 0 0 0 0 0 0 14.3971 12.7848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1496 14.8276 14.0989 0 13.8637 13.5925 13.8357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1685 0 0 0 0 0 0 0 0 0 0 0 0 12.0782 0 0 0 0 0 0 12.7969 13.3738 0 Q9UJF2 NGAP_HUMAN Ras GTPase-activating protein nGAP (RAS protein activator-like 2) RASAL2 NGAP Homo sapiens (Human) adipose tissue development [GO:0060612]; gene expression [GO:0010467]; multicellular organism growth [GO:0035264]; regulation of GTPase activity [GO:0043087]; regulation of protein activation cascade [GO:2000257]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; adipose tissue development [GO:0060612]; gene expression [GO:0010467]; multicellular organism growth [GO:0035264]; regulation of GTPase activity [GO:0043087]; regulation of protein activation cascade [GO:2000257]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749]; signal transduction [GO:0007165] GO:0002021; GO:0005096; GO:0005829; GO:0007165; GO:0009749; GO:0010467; GO:0035264; GO:0043087; GO:0060612; GO:2000257 GTPase activator activity [GO:0005096] EEYMAFMNDFLEHEWGGMK 0.99043 -19.976 0 0 0 0 13.3966 14.0313 0 0 0 0 0 0 0 0 14.0649 0 0 0 11.102 0 0 0 0 13.0383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8906 0 15.0923 0 0 0 0 15.1386 0 15.4842 15.7843 0 0 0 0 0 0 0 0 0 0 11.6248 0 0 0 0 0 15.0343 0 0 14.5882 0 12.6306 0 0 0 0 0 14.6834 14.3975 15.4891 0 0 0 0 12.1281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3233 0 11.0166 18.6289 0 0 0 0 0 13.1104 15.5764 0 0 0 0 15.5394 0 14.6202 15.2727 0 0 0 0 15.8354 15.9379 0 14.1536 0 0 14.6584 10.6874 0 0 0 0 0 0 13.1396 0 0 12.754 12.8549 0 15.0864 14.0189 11.777 0 0 0 0 0 0 0 O75912 DGKI_HUMAN "Diacylglycerol kinase iota, DAG kinase iota, DGK-iota, EC 2.7.1.107" DGKI Homo sapiens (Human) "diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]" anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]" GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007205; GO:0014069; GO:0030168; GO:0030424; GO:0030672; GO:0032991; GO:0035556; GO:0043197; GO:0045202; GO:0046339; GO:0046834; GO:0046872; GO:0051966; GO:0070161; GO:0097060 ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951] AACQRNR 0.99044 -19.258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6837 0 0 0 0 0 0 0 0 0 0 11.8782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4386 0 0 0 0 0 0 0 16.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0128 11.7894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94989 ARHGF_HUMAN "Rho guanine nucleotide exchange factor 15 (Ephexin-5, E5) (Vsm-RhoGEF)" ARHGEF15 KIAA0915 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of synapse maturation [GO:2000297]; positive regulation of stress fiber assembly [GO:0051496]; regulation of catalytic activity [GO:0050790]; regulation of small GTPase mediated signal transduction [GO:0051056]; retina vasculature morphogenesis in camera-type eye [GO:0061299] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; negative regulation of synapse maturation [GO:2000297]; positive regulation of stress fiber assembly [GO:0051496]; regulation of catalytic activity [GO:0050790]; regulation of small GTPase mediated signal transduction [GO:0051056]; retina vasculature morphogenesis in camera-type eye [GO:0061299] GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0030425; GO:0050790; GO:0051056; GO:0051496; GO:0061299; GO:0090630; GO:2000297 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] ADVNGEREAPLTGSGSQENGAPDAGLACPPCCPCVCHTTR 0.99044 -20.924 0 11.248 0 23.9723 0 0 11.6885 0 12.0669 10.6031 12.8466 13.3457 10.5522 0 0 0 0 0 0 0 10.0444 16.301 0 16.0802 0 0 0 0 12.5164 9.49857 0 12.5413 0 0 12.603 0 13.2208 0 0 12.9018 0 14.0507 0 0 12.5945 0 12.1758 0 0 0 0 0 0 12.8556 0 0 9.78416 11.339 0 0 0 0 0 0 12.1937 12.1246 14.292 9.68965 0 0 13.3707 12.0992 0 10.8232 13.5319 13.9629 13.4932 11.3304 17.1407 12.1201 17.0809 0 13.9222 13.9586 17.5365 15.8089 15.934 17.9213 16.1123 17.4605 0 17.801 17.4642 14.5419 17.8849 15.8352 16.4249 17.278 17.2964 17.21 17.0817 17.0486 13.6976 16.8424 16.0427 17.131 15.0401 15.8647 13.576 15.031 15.408 0 16.226 14.8678 15.1106 13.8232 0 13.1686 15.0118 13.1406 13.3072 13.8624 13.3997 14.7607 14.6697 14.7156 15.4194 16.9354 15.4242 13.1601 14.8684 17.1115 14.3088 14.406 12.8515 15.7205 14.1149 14.7814 14.2536 14.5062 13.4759 12.7762 13.2614 12.855 15.5869 14.3009 0 12.0667 0 17.56 0 0 14.2801 16.7627 10.3683 12.9917 12.9882 0 13.7416 14.2737 13.0227 12.7193 12.8329 13.2863 12.733 0 16.1217 13.5778 11.7419 0 0 14.6472 14.3442 14.2754 0 0 0 12.7275 0 16.802 P48436 SOX9_HUMAN Transcription factor SOX-9 SOX9 Homo sapiens (Human) "anterior head development [GO:0097065]; aortic valve morphogenesis [GO:0003180]; astrocyte fate commitment [GO:0060018]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; bronchus cartilage development [GO:0060532]; cAMP-mediated signaling [GO:0019933]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell proliferation involved in heart morphogenesis [GO:0061323]; cell-cell adhesion [GO:0098609]; cellular response to BMP stimulus [GO:0071773]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to heparin [GO:0071504]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte hypertrophy [GO:0003415]; chromatin remodeling [GO:0006338]; cochlea morphogenesis [GO:0090103]; cytoskeleton organization [GO:0007010]; endocardial cushion morphogenesis [GO:0003203]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in prostatic bud elongation [GO:0060517]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix assembly [GO:0085029]; glandular epithelial cell differentiation [GO:0002067]; glial cell fate specification [GO:0021780]; growth plate cartilage chondrocyte growth [GO:0003430]; hair follicle development [GO:0001942]; Harderian gland development [GO:0070384]; heart development [GO:0007507]; heart valve development [GO:0003170]; heart valve formation [GO:0003188]; heart valve morphogenesis [GO:0003179]; intestinal epithelial cell differentiation [GO:0060575]; intestinal epithelial structure maintenance [GO:0060729]; intrahepatic bile duct development [GO:0035622]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung smooth muscle development [GO:0061145]; male germ-line sex determination [GO:0019100]; male gonad development [GO:0008584]; mammary gland development [GO:0030879]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of bone mineralization [GO:0030502]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of gene expression [GO:0010629]; negative regulation of immune system process [GO:0002683]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell fate specification [GO:0014036]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord development [GO:0030903]; nucleosome assembly [GO:0006334]; oligodendrocyte differentiation [GO:0048709]; otic vesicle formation [GO:0030916]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of male gonad development [GO:2000020]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein kinase B signaling [GO:0043491]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in lung morphogenesis [GO:0061046]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle process [GO:0010564]; regulation of cell population proliferation [GO:0042127]; regulation of cell proliferation involved in tissue homeostasis [GO:0060784]; regulation of epithelial cell proliferation involved in lung morphogenesis [GO:2000794]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; response to fatty acid [GO:0070542]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; trachea cartilage development [GO:0060534]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]; ureter morphogenesis [GO:0072197]; ureter smooth muscle cell differentiation [GO:0072193]; ureter urothelium development [GO:0072190]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; pre-mRNA intronic binding [GO:0097157]; protein kinase A catalytic subunit binding [GO:0034236]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior head development [GO:0097065]; aortic valve morphogenesis [GO:0003180]; astrocyte fate commitment [GO:0060018]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; bronchus cartilage development [GO:0060532]; cAMP-mediated signaling [GO:0019933]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell fate specification [GO:0001708]; cell proliferation involved in heart morphogenesis [GO:0061323]; cell-cell adhesion [GO:0098609]; cellular response to BMP stimulus [GO:0071773]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to heparin [GO:0071504]; cellular response to interleukin-1 [GO:0071347]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte hypertrophy [GO:0003415]; chromatin remodeling [GO:0006338]; cochlea morphogenesis [GO:0090103]; cytoskeleton organization [GO:0007010]; endocardial cushion morphogenesis [GO:0003203]; endocrine pancreas development [GO:0031018]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in prostatic bud elongation [GO:0060517]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; extracellular matrix assembly [GO:0085029]; glandular epithelial cell differentiation [GO:0002067]; glial cell fate specification [GO:0021780]; growth plate cartilage chondrocyte growth [GO:0003430]; hair follicle development [GO:0001942]; Harderian gland development [GO:0070384]; heart development [GO:0007507]; heart valve development [GO:0003170]; heart valve formation [GO:0003188]; heart valve morphogenesis [GO:0003179]; intestinal epithelial cell differentiation [GO:0060575]; intestinal epithelial structure maintenance [GO:0060729]; intrahepatic bile duct development [GO:0035622]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung smooth muscle development [GO:0061145]; male germ-line sex determination [GO:0019100]; male gonad development [GO:0008584]; mammary gland development [GO:0030879]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of bone mineralization [GO:0030502]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of gene expression [GO:0010629]; negative regulation of immune system process [GO:0002683]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell fate specification [GO:0014036]; neuron fate specification [GO:0048665]; Notch signaling pathway [GO:0007219]; notochord development [GO:0030903]; nucleosome assembly [GO:0006334]; oligodendrocyte differentiation [GO:0048709]; otic vesicle formation [GO:0030916]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of male gonad development [GO:2000020]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein kinase B signaling [GO:0043491]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of branching involved in lung morphogenesis [GO:0061046]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle process [GO:0010564]; regulation of cell population proliferation [GO:0042127]; regulation of cell proliferation involved in tissue homeostasis [GO:0060784]; regulation of epithelial cell proliferation involved in lung morphogenesis [GO:2000794]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; response to fatty acid [GO:0070542]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; trachea cartilage development [GO:0060534]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]; ureter morphogenesis [GO:0072197]; ureter smooth muscle cell differentiation [GO:0072193]; ureter urothelium development [GO:0072190]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001501; GO:0001502; GO:0001658; GO:0001708; GO:0001837; GO:0001894; GO:0001934; GO:0001942; GO:0002009; GO:0002053; GO:0002062; GO:0002067; GO:0002683; GO:0003170; GO:0003179; GO:0003180; GO:0003188; GO:0003203; GO:0003413; GO:0003415; GO:0003430; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006334; GO:0006338; GO:0006357; GO:0006366; GO:0006468; GO:0007010; GO:0007165; GO:0007173; GO:0007219; GO:0007283; GO:0007507; GO:0008013; GO:0008284; GO:0008584; GO:0010463; GO:0010564; GO:0010628; GO:0010629; GO:0010634; GO:0014032; GO:0014036; GO:0014068; GO:0019100; GO:0019933; GO:0021780; GO:0030155; GO:0030279; GO:0030282; GO:0030502; GO:0030850; GO:0030857; GO:0030858; GO:0030879; GO:0030903; GO:0030916; GO:0031018; GO:0032331; GO:0032332; GO:0032808; GO:0032991; GO:0034236; GO:0034504; GO:0035019; GO:0035622; GO:0042127; GO:0042981; GO:0043066; GO:0043425; GO:0043491; GO:0043565; GO:0045662; GO:0045668; GO:0045732; GO:0045892; GO:0045893; GO:0045944; GO:0046322; GO:0046533; GO:0048665; GO:0048709; GO:0050679; GO:0050680; GO:0051216; GO:0060008; GO:0060009; GO:0060018; GO:0060041; GO:0060070; GO:0060174; GO:0060221; GO:0060441; GO:0060509; GO:0060517; GO:0060532; GO:0060534; GO:0060575; GO:0060729; GO:0060784; GO:0061036; GO:0061046; GO:0061138; GO:0061145; GO:0061323; GO:0065003; GO:0070168; GO:0070371; GO:0070384; GO:0070542; GO:0071260; GO:0071300; GO:0071347; GO:0071364; GO:0071504; GO:0071560; GO:0071773; GO:0072034; GO:0072089; GO:0072190; GO:0072193; GO:0072197; GO:0072289; GO:0085029; GO:0090090; GO:0090103; GO:0090184; GO:0090190; GO:0097065; GO:0097152; GO:0097157; GO:0098609; GO:1901203; GO:1902732; GO:1902894; GO:1904864; GO:1990837; GO:2000020; GO:2000138; GO:2000648; GO:2000741; GO:2000794; GO:2001054 "beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; pre-mRNA intronic binding [GO:0097157]; protein kinase A catalytic subunit binding [GO:0034236]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" FPVCIREAVSQVLK 0.99044 -20.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0P641 CB080_HUMAN Uncharacterized protein C2orf80 C2orf80 Homo sapiens (Human) AAAYARK 0.99044 -19.263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6222 13.7893 0 11.5295 0 13.8222 0 0 0 17.2927 15.0264 0 13.8572 14.0805 16.9853 0 14.0114 0 0 10.896 0 0 0 14.5741 0 0 0 16.9418 12.171 0 0 0 0 14.4198 13.9775 0 13.5524 0 0 13.8452 17.0231 0 0 14.4858 0 0 0 11.0481 0 0 0 0 0 0 0 0 0 0 0 0 13.5561 0 0 0 0 0 0 0 0 0 0 13.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SXZ3 ZN718_HUMAN Zinc finger protein 718 ZNF718 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNQSSTLNLHK 0.99044 -20.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3024 0 0 0 0 0 0 0 0 0 12.2957 0 0 0 0 0 0 0 0 12.2048 0 0 0 0 0 0 0 0 10.1838 0 10.9088 0 0 0 0 0 12.6945 0 0 0 0 15.0928 0 0 0 0 0 13.0441 0 18.42 16.2768 0 0 0 0 11.6296 0 0 12.7902 0 0 0 0 0 19.0506 0 0 13.1238 0 0 0 0 14.1227 14.3228 13.1393 0 0 0 0 12.214 0 0 0 9.48977 0 0 12.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VWI1 TCRGL_HUMAN Transcription elongation regulator 1-like protein TCERG1L Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; RNA polymerase binding [GO:0070063]; transcription coregulator activity [GO:0003712] GO:0003712; GO:0005634; GO:0070063 RNA polymerase binding [GO:0070063]; transcription coregulator activity [GO:0003712] DGDKEDK 0.99044 -19.261 0 0 0 12.3486 0 0 0 0 0 0 11.1203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7973 0 0 10.0331 0 0 0 13.518 0 0 0 0 0 13.1876 0 0 0 0 0 0 0 0 0 0 0 0 12.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9725 0 0 0 0 0 0 0 0 12.6573 11.6517 0 0 0 12.7886 10.7691 0 0 0 0 13.4306 0 0 0 0 14.2123 0 0 12.5507 0 0 0 0 0 0 0 11.7244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8736 0 0 0 0 0 0 0 0 Q9NYW8 RBAK_HUMAN "RB-associated KRAB zinc finger protein (RB-associated KRAB repressor, hRBaK) (Zinc finger protein 769)" RBAK ZNF769 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0045892 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" FHHRSAFNSHQR 0.99044 -20.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.137 0 9.57503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.626 14.7217 13.0885 0 0 0 12.3342 12.436 0 0 0 0 0 0 13.4156 0 0 0 0 0 0 0 15.4232 13.445 0 0 13.6367 12.2124 0 13.9462 13.1948 12.9051 11.3915 0 0 0 0 14.9193 0 0 0 14.3555 0 0 0 0 0 13.2102 0 14.6509 0 0 12.7168 12.7523 12.5635 0 12.2754 0 13.3004 13.3132 12.9976 17.9754 0 0 0 0 0 12.6743 0 14.3573 0 12.7967 0 0 0 13.6795 0 12.1404 0 0 0 0 0 0 13.6217 0 0 0 0 0 0 12.4302 0 11.791 0 0 0 13.134 0 0 0 11.177 0 0 P22301 IL10_HUMAN "Interleukin-10, IL-10 (Cytokine synthesis inhibitory factor, CSIF)" IL10 Homo sapiens (Human) "aging [GO:0007568]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to lipopolysaccharide [GO:0071222]; chronic inflammatory response to antigenic stimulus [GO:0002439]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; endothelial cell apoptotic process [GO:0072577]; hemopoiesis [GO:0030097]; leukocyte chemotaxis [GO:0030595]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chronic inflammatory response to antigenic stimulus [GO:0002875]; negative regulation of cytokine activity [GO:0060302]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myeloid dendritic cell activation [GO:0030886]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of gene expression [GO:0010468]; regulation of isotype switching [GO:0045191]; regulation of response to wounding [GO:1903034]; regulation of synapse organization [GO:0050807]; response to activity [GO:0014823]; response to carbon monoxide [GO:0034465]; response to glucocorticoid [GO:0051384]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to molecule of bacterial origin [GO:0002237]; response to xenobiotic stimulus [GO:0009410]; type 2 immune response [GO:0042092]" extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-10 receptor binding [GO:0005141]; protein dimerization activity [GO:0046983]; aging [GO:0007568]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to lipopolysaccharide [GO:0071222]; chronic inflammatory response to antigenic stimulus [GO:0002439]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; endothelial cell apoptotic process [GO:0072577]; hemopoiesis [GO:0030097]; leukocyte chemotaxis [GO:0030595]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chronic inflammatory response to antigenic stimulus [GO:0002875]; negative regulation of cytokine activity [GO:0060302]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myeloid dendritic cell activation [GO:0030886]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of gene expression [GO:0010468]; regulation of isotype switching [GO:0045191]; regulation of response to wounding [GO:1903034]; regulation of synapse organization [GO:0050807]; response to activity [GO:0014823]; response to carbon monoxide [GO:0034465]; response to glucocorticoid [GO:0051384]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to molecule of bacterial origin [GO:0002237]; response to xenobiotic stimulus [GO:0009410]; type 2 immune response [GO:0042092]" GO:0001818; GO:0001819; GO:0001938; GO:0002237; GO:0002439; GO:0002639; GO:0002719; GO:0002875; GO:0002904; GO:0005125; GO:0005141; GO:0005576; GO:0005615; GO:0007253; GO:0007568; GO:0008083; GO:0008285; GO:0009410; GO:0010468; GO:0010507; GO:0014823; GO:0014854; GO:0030097; GO:0030183; GO:0030595; GO:0030886; GO:0030889; GO:0032687; GO:0032689; GO:0032692; GO:0032695; GO:0032701; GO:0032715; GO:0032717; GO:0032720; GO:0032868; GO:0034115; GO:0034116; GO:0034465; GO:0035729; GO:0042092; GO:0042100; GO:0042130; GO:0042742; GO:0042832; GO:0043032; GO:0043066; GO:0043524; GO:0045019; GO:0045191; GO:0045347; GO:0045348; GO:0045787; GO:0045893; GO:0045930; GO:0045944; GO:0046427; GO:0046983; GO:0050728; GO:0050807; GO:0051045; GO:0051091; GO:0051384; GO:0060302; GO:0060670; GO:0071222; GO:0071392; GO:0071650; GO:0072577; GO:0097421; GO:1900100; GO:1902895; GO:1903034; GO:1903208; GO:1903672; GO:1904057; GO:1904706; GO:1904707; GO:2000273 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-10 receptor binding [GO:0005141]; protein dimerization activity [GO:0046983] FLPCENK 0.99045 -20.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2154 0 0 0 0 0 0 0 0 0 0 0 12.8938 0 0 0 0 0 0 0 0 0 13.2194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.383 12.7028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0689 0 13.0108 0 0 14.0805 0 0 0 0 0 0 14.4704 0 0 0 0 0 0 0 0 0 0 13.1478 13.9799 0 0 P31751 AKT2_HUMAN "RAC-beta serine/threonine-protein kinase, EC 2.7.11.1 (Protein kinase Akt-2) (Protein kinase B beta, PKB beta) (RAC-PK-beta)" AKT2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; activation of GTPase activity [GO:0090630]; carbohydrate transport [GO:0008643]; cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165] GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0005978; GO:0006006; GO:0006417; GO:0007165; GO:0008284; GO:0008286; GO:0008643; GO:0010748; GO:0010907; GO:0010918; GO:0018105; GO:0030334; GO:0030335; GO:0031340; GO:0032000; GO:0032287; GO:0032587; GO:0032869; GO:0032991; GO:0035556; GO:0036211; GO:0043066; GO:0043231; GO:0045444; GO:0045725; GO:0046326; GO:0046872; GO:0051726; GO:0060644; GO:0065002; GO:0071486; GO:0072659; GO:0090314; GO:0090630; GO:0097473; GO:0106310; GO:2000147 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FFLSINWQDVVQKKLLPPFK 0.99045 -1.7912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4083 0 0 0 14.4172 0 0 0 0 14.0559 13.9425 13.9845 0 0 0 13.8884 0 0 0 14.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07075 AMPE_HUMAN "Glutamyl aminopeptidase, EAP, EC 3.4.11.7 (Aminopeptidase A, AP-A) (Differentiation antigen gp160) (CD antigen CD249)" ENPEP Homo sapiens (Human) angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; glomerulus development [GO:0032835]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; signal transduction [GO:0007165] GO:0001525; GO:0002003; GO:0003081; GO:0004177; GO:0005737; GO:0005765; GO:0005886; GO:0005887; GO:0005903; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0008283; GO:0009897; GO:0016324; GO:0016477; GO:0031410; GO:0032835; GO:0042277; GO:0043171; GO:0045177; GO:0070006; GO:0070062 aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] DTNLIKTQDVFTVIRYISYNSYGK 0.99045 -20.948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0899 11.0304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5521 0 0 0 0 0 0 0 0 0 0 0 0 13.8967 0 0 0 0 0 0 0 0 0 0 0 14.9125 0 0 13.2815 0 0 0 0 15.6385 0 16.6361 0 0 0 16.1251 0 0 0 0 14.8581 14.9277 0 0 0 14.5887 0 14.5911 15.4779 0 0 0 14.9147 0 0 13.574 0 14.4112 0 0 0 14.4513 12.5851 0 0 0 0 14.399 0 0 0 15.0835 14.3837 0 0 0 0 0 0 14.0163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2871 0 0 0 14.7718 0 0 0 0 0 P11171 EPB41_HUMAN "Protein 4.1, P4.1 (4.1R) (Band 4.1) (EPB4.1) (Erythrocyte membrane protein band 4.1)" EPB41 E41P Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of calcium ion transport [GO:0051924]; regulation of cell shape [GO:0008360]; regulation of intestinal absorption [GO:1904478] basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731] basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731]; 1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of calcium ion transport [GO:0051924]; regulation of cell shape [GO:0008360]; regulation of intestinal absorption [GO:1904478] GO:0003779; GO:0005200; GO:0005516; GO:0005545; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007049; GO:0008022; GO:0008360; GO:0014731; GO:0016323; GO:0016604; GO:0030036; GO:0030054; GO:0030507; GO:0030863; GO:0030866; GO:0031032; GO:0032092; GO:0032991; GO:0045171; GO:0047485; GO:0051219; GO:0051301; GO:0051924; GO:0072686; GO:1904478; GO:1904778 1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200] ELEEKVMELHK 0.99046 -20.18 13.9049 0 13.6003 14.3985 0 0 0 14.5534 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8761 0 15.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3704 16.3138 16.4629 16.3966 16.3662 16.461 15.1596 14.992 15.0064 18.6755 18.7003 18.6623 18.1563 16.7954 17.5868 22.6371 0 22.5629 0 0 0 19.8607 0 20.8265 14.0692 0 0 16.4245 20.0953 20.5616 21.4994 15.93 20.2977 19.1313 18.9826 18.5994 17.5749 0 17.9827 19.625 18.8405 18.035 17.5981 17.1554 13.2971 19.6529 19.5738 19.7933 19.5932 0 18.4442 0 19.0046 18.8947 15.5098 19.5743 0 20.8812 14.6697 17.8615 20.8314 20.5944 20.2474 18.3055 18.9136 19.0443 19.9498 19.6407 14.9542 15.0722 0 19.8415 18.8637 17.9217 19.1923 19.912 19.4991 19.1174 0 18.9073 18.5628 0 0 0 18.2364 18.1978 0 19.6889 20.4356 18.1388 0 0 0 15.6084 0 0 0 0 0 0 0 0 0 0 0 13.9062 16.6621 0 0 0 0 0 0 0 P29122 PCSK6_HUMAN "Proprotein convertase subtilisin/kexin type 6, EC 3.4.21.- (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4, SPC4) (Subtilisin/kexin-like protease PACE4)" PCSK6 PACE4 Homo sapiens (Human) "determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of BMP signaling pathway [GO:0030510]; regulation of lipoprotein lipase activity [GO:0051004]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; nerve growth factor binding [GO:0048406]; serine-type endopeptidase activity [GO:0004252]; determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of BMP signaling pathway [GO:0030510]; regulation of lipoprotein lipase activity [GO:0051004]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]" GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007354; GO:0007368; GO:0008201; GO:0009100; GO:0009986; GO:0016020; GO:0016485; GO:0016486; GO:0030510; GO:0032902; GO:0032940; GO:0048406; GO:0051004; GO:0062023 endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; nerve growth factor binding [GO:0048406]; serine-type endopeptidase activity [GO:0004252] AEGQWTLEIQDLPSQVR 0.99046 -19.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3998 0 0 0 0 0 0 0 0 0 12.9811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.3347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.874 0 0 0 14.8072 11.1578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.517 0 14.9351 0 0 0 0 0 0 0 11.3854 0 0 0 0 0 0 0 0 0 13.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5152 0 0 0 0 0 12.6463 0 0 11.931 0 12.5094 12.8251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5681 0 0 Q13285 STF1_HUMAN "Steroidogenic factor 1, SF-1, STF-1, hSF-1 (Adrenal 4-binding protein) (Fushi tarazu factor homolog 1) (Nuclear receptor subfamily 5 group A member 1) (Steroid hormone receptor Ad4BP)" NR5A1 AD4BP FTZF1 SF1 Homo sapiens (Human) adrenal gland development [GO:0030325]; calcineurin-mediated signaling [GO:0097720]; female gonad development [GO:0008585]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; maintenance of protein location in nucleus [GO:0051457]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; multicellular organism aging [GO:0010259]; negative regulation of female gonad development [GO:2000195]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary sex determination [GO:0007538]; regulation of steroid biosynthetic process [GO:0050810]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gonadotropin-releasing hormone [GO:0097210]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; tissue development [GO:0009888]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; adrenal gland development [GO:0030325]; calcineurin-mediated signaling [GO:0097720]; female gonad development [GO:0008585]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; maintenance of protein location in nucleus [GO:0051457]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; multicellular organism aging [GO:0010259]; negative regulation of female gonad development [GO:2000195]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary sex determination [GO:0007538]; regulation of steroid biosynthetic process [GO:0050810]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gonadotropin-releasing hormone [GO:0097210]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; tissue development [GO:0009888]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001553; GO:0003677; GO:0003682; GO:0004879; GO:0005543; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007530; GO:0007538; GO:0008270; GO:0008584; GO:0008585; GO:0009755; GO:0009888; GO:0010259; GO:0010628; GO:0019899; GO:0030238; GO:0030325; GO:0033327; GO:0042445; GO:0043565; GO:0045944; GO:0050810; GO:0051457; GO:0060008; GO:0090575; GO:0097210; GO:0097720; GO:1990837; GO:2000020; GO:2000195 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" ARILGCLQEPTK 0.99046 -20.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2096 0 0 0 0 0 0 0 0 11.3375 0 0 0 0 0 12.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2396 13.4993 13.4819 0 13.227 13.5512 0 0 0 0 10.4723 0 0 0 0 0 0 0 10.0972 0 0 12.1051 12.8893 0 0 0 0 13.1222 0 0 0 0 0 0 0 13.3536 0 0 0 10.7056 0 0 0 0 0 0 0 0 0 0 0 13.2384 0 0 10.4188 0 0 0 0 13.5775 13.6609 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6694 13.1386 10.1184 0 0 0 10.0828 0 0 0 10.3193 0 12.5731 0 10.8961 0 0 12.2842 0 0 0 0 9.88215 0 0 0 0 0 0 0 0 12.0569 0 Q15434 RBMS2_HUMAN "RNA-binding motif, single-stranded-interacting protein 2 (Suppressor of CDC2 with RNA-binding motif 3)" RBMS2 SCR3 Homo sapiens (Human) RNA processing [GO:0006396] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA processing [GO:0006396] GO:0003723; GO:0003730; GO:0005634; GO:0005829; GO:0006396; GO:0008143; GO:0008266; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] AILDKTTNKCK 0.99046 -20.15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9914 0 0 0 0 0 0 0 13.8557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3155 0 0 0 14.1257 0 0 0 0 0 0 0 0 0 0 0 13.461 0 0 0 0 0 0 0 0 0 Q6PIU1 KCNV1_HUMAN Potassium voltage-gated channel subfamily V member 1 (Neuronal potassium channel alpha subunit HNKA) (Voltage-gated potassium channel subunit Kv8.1) KCNV1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; ion channel inhibitor activity [GO:0008200]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0008200; GO:0015459; GO:0016021; GO:0034765; GO:0045171; GO:0051260; GO:0071805 ion channel inhibitor activity [GO:0008200]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249] FLCVRDR 0.99046 -20.169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.81654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2359 0 0 0 0 0 0 0 0 10.4837 0 0 0 0 0 0 0 0 0 0 0 11.487 0 0 0 9.27994 0 0 0 0 0 15.5507 11.6342 0 12.6646 0 0 0 0 0 0 0 0 0 0 15.2284 0 0 0 14.4614 14.8637 0 15.0107 0 0 0 0 14.0411 12.5723 0 12.5914 0 11.9427 12.6979 10.6799 13.2033 10.5957 11.7742 0 0 12.5575 0 0 0 0 0 11.5044 0 0 13.1338 10.4346 0 0 13.1155 0 0 0 12.1119 0 0 0 0 0 11.9427 0 0 0 0 0 0 9.92107 0 0 0 0 0 0 0 14.9704 0 0 0 0 14.5195 0 11.3122 0 10.6811 0 0 0 11.0999 0 0 9.35854 0 0 0 0 0 0 9.83851 0 0 0 0 0 15.3585 0 0 14.7649 0 0 0 0 Q86WI1 PKHL1_HUMAN "Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1, PKHD1-like protein 1)" PKHD1L1 Homo sapiens (Human) immune response [GO:0006955]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; stereocilium coat [GO:0120234]; stereocilium tip [GO:0032426] cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; stereocilium coat [GO:0120234]; stereocilium tip [GO:0032426]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]; sensory perception of sound [GO:0007605] GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016021; GO:0032426; GO:0038023; GO:0120234 signaling receptor activity [GO:0038023] AGERILILQEAVTWK 0.99046 -19.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4139 0 0 9.89406 0 0 0 0 0 0 0 0 0 0 12.2527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8376 14.2591 13.8 13.638 14.328 0 14.6181 0 16.4431 0 0 0 17.6521 13.3875 0 0 12.9413 14.0647 14.3971 15.1736 15.6166 0 0 0 0 14.3001 0 14.0723 0 0 14.5069 0 0 14.1949 0 0 0 0 14.518 13.582 14.7146 14.4349 12.7063 0 0 13.7103 0 0 14.1674 14.1526 0 14.0797 13.6796 15.7585 14.4005 13.1482 0 14.0884 0 13.7771 0 15.4011 13.7871 0 13.9968 0 14.6321 12.2048 0 0 0 0 0 0 0 0 0 14.7951 0 0 0 0 0 0 0 0 0 11.7666 0 0 0 0 0 0 12.0724 0 0 0 13.7066 0 0 0 0 0 14.2195 0 Q86XE3 MICU3_HUMAN "Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2)" MICU3 EFHA2 Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560] mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246] mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560] GO:0005509; GO:0005743; GO:0036444; GO:0051560; GO:1990246 calcium ion binding [GO:0005509] AVAEAAWRR 0.99046 -20.594 0 0 0 0 0 0 0 0 0 0 0 13.1792 0 13.9337 0 0 0 0 0 0 0 0 0 0 0 0 12.3317 0 0 0 0 0 0 0 0 0 0 12.7969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9164 0 0 0 0 0 0 0 12.5832 0 0 0 13.2814 0 0 15.0582 16.3818 0 0 0 0 0 0 0 13.0531 0 0 0 0 0 0 0 0 0 0 13.2159 13.1868 0 0 0 0 0 0 0 0 0 0 0 0 13.8953 0 13.8475 0 0 0 13.2912 0 0 0 12.7948 0 0 0 0 13.5366 0 0 0 0 0 0 16.0004 15.7602 0 0 0 0 13.5464 0 0 0 0 0 0 0 0 0 0 0 0 0 12.646 0 0 0 0 0 0 0 0 0 13.9256 0 0 0 0 0 0 0 Q8TCT1 PHOP1_HUMAN "Phosphoethanolamine/phosphocholine phosphatase, EC 3.1.3.75" PHOSPHO1 Homo sapiens (Human) bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; regulation of bone mineralization [GO:0030500] cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010] cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462]; bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; endochondral ossification [GO:0001958]; regulation of bone mineralization [GO:0030500] GO:0001958; GO:0005829; GO:0016462; GO:0016791; GO:0030282; GO:0030500; GO:0031012; GO:0035630; GO:0046872; GO:0052731; GO:0052732; GO:0065010 metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphocholine phosphatase activity [GO:0052731]; phosphoethanolamine phosphatase activity [GO:0052732]; pyrophosphatase activity [GO:0016462] AEPSSFR 0.99046 -19.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0779 0 0 0 0 0 0 0 0 0 0 13.8295 0 0 0 0 13.2544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4707 14.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9284 13.2505 13.616 0 0 14.2054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3975 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5952 0 0 0 0 0 0 0 0 0 0 0 0 12.5782 0 0 15.0849 0 0 0 0 0 0 0 0 13.6978 0 0 0 0 0 0 0 0 0 0 0 0 12.6086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9717 0 13.5565 0 0 0 0 0 Q96JG8 MAGD4_HUMAN Melanoma-associated antigen D4 (MAGE-D4 antigen) (MAGE-E1 antigen) MAGED4 KIAA1859 MAGED4A MAGEE1; MAGED4B Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 AAAAAAR 0.99046 -20.176 0 0 0 0 0 0 9.25519 0 0 0 0 0 0 12.4743 0 0 12.3664 0 0 0 0 0 0 12.7237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5238 0 0 0 0 0 0 17.1321 0 0 14.1257 11.2807 0 0 13.2504 0 17.2372 0 0 0 12.7368 13.3611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.671 16.7 0 0 0 0 0 16.1365 0 0 0 0 17.2247 0 0 0 0 0 0 0 0 0 0 0 0 12.5519 11.8927 0 0 14.123 0 0 0 0 12.3794 0 0 0 0 0 12.0299 0 0 0 0 0 0 0 12.9819 0 0 0 0 0 Q9BW27 NUP85_HUMAN Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup75) (Nucleoporin Nup85) (Pericentrin-1) NUP85 NUP75 PCNT1 Homo sapiens (Human) "lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]" cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819] "cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; structural constituent of nuclear pore [GO:0017056]; lamellipodium assembly [GO:0030032]; macrophage chemotaxis [GO:0048246]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nucleocytoplasmic transport [GO:0006913]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]" GO:0000776; GO:0005635; GO:0005643; GO:0005654; GO:0005819; GO:0005829; GO:0006406; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0030032; GO:0031080; GO:0031965; GO:0045893; GO:0048246; GO:0072006 structural constituent of nuclear pore [GO:0017056] DAAFATLVSDRFLRDYCER 0.99046 -20.556 9.57675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8371 0 0 0 0 0 10.8525 0 0 0 0 0 0 0 0 0 13.3871 12.9654 12.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5475 0 0 0 0 0 0 0 15.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4167 14.0405 0 0 0 0 0 0 0 13.056 12.2073 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9842 0 0 16.2904 12.591 0 0 0 0 0 0 0 0 11.0516 0 0 0 0 0 0 11.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.605 Q9NQC7 CYLD_HUMAN "Ubiquitin carboxyl-terminal hydrolase CYLD, EC 3.4.19.12 (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD)" CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) cell cycle [GO:0007049]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cysteine-type deubiquitinase activity [GO:0004843]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0006511; GO:0007049; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0019901; GO:0031234; GO:0032088; GO:0032480; GO:0036064; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0060544; GO:0061578; GO:0070064; GO:0070266; GO:0070423; GO:0070507; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242 cysteine-type deubiquitinase activity [GO:0004843]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270] DFKLFKK 0.99046 -20.163 11.278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1423 0 0 0 13.2426 0 0 0 12.6504 11.9537 0 0 0 0 0 0 0 0 0 0 0 11.6889 0 12.9302 0 12.8315 0 11.787 0 0 11.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1861 0 13.2752 13.4571 15.26 13.7779 0 13.2856 13.3787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6817 0 0 11.1764 0 0 15.9976 0 0 Q9Y623 MYH4_HUMAN "Myosin-4 (Myosin heavy chain 2b, MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb, MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal)" MYH4 Homo sapiens (Human) actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017] muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049] GO:0000146; GO:0003725; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0016460; GO:0016887; GO:0030016; GO:0030017; GO:0030048; GO:0030049; GO:0032982; GO:0046034; GO:0051015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; double-stranded RNA binding [GO:0003725]; microfilament motor activity [GO:0000146] AIVQSREGGK 0.99046 -19.821 0 0 0 0 0 0 0 0 12.1618 0 0 0 0 0 0 0 0 12.3335 0 12.5706 0 0 0 0 12.7251 11.3831 12.8893 0 0 11.7026 0 12.6933 0 0 0 0 13.1013 13.9214 13.6806 0 0 12.1461 12.7938 0 0 12.8621 13.1258 11.6099 0 0 0 0 0 0 11.0564 0 0 0 10.4121 0 0 10.1517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6377 0 0 0 0 15.821 15.2774 13.7659 0 15.9263 0 14.4439 0 14.41 0 17.4362 13.1638 0 13.5199 0 12.6449 0 12.392 13.2453 0 12.0202 0 0 13.1408 0 0 12.8256 0 0 0 0 14.2222 0 0 0 0 14.3148 0 13.4922 0 13.028 12.9693 0 14.0394 13.9939 12.8322 13.1076 0 0 0 0 11.5507 0 0 13.4547 0 0 0 0 0 0 13.6411 0 0 0 14.4846 0 0 0 14.0984 13.5988 0 12.4699 11.3874 0 0 14.1126 13.0147 14.3788 14.0231 0 13.8653 13.7116 0 0 14.5448 0 0 12.7762 0 13.779 0 0 0 11.0353 13.9477 0 0 Q9Y6A5 TACC3_HUMAN Transforming acidic coiled-coil-containing protein 3 (ERIC-1) TACC3 ERIC1 Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236] GO:0000226; GO:0000922; GO:0005737; GO:0005829; GO:0007052; GO:0007091; GO:0008283; GO:0021987; GO:0034451; GO:0043231; GO:0051301; GO:0060236; GO:0072686; GO:1902850 FEKQKEVIEGYR 0.99046 -20.609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3187 15.3224 0 0 0 12.1942 15.5555 15.5812 13.5092 15.292 15.2329 17.3511 15.6012 15.9305 15.4965 14.9881 12.7988 0 12.9386 13.4504 15.2345 0 0 0 0 0 0 0 0 0 0 0 0 13.9767 0 0 0 0 0 0 0 0 0 0 0 13.5161 0 0 0 0 0 0 0 0 0 0 12.8107 0 13.759 0 0 0 0 0 0 0 14.978 0 0 0 0 0 0 0 0 12.3959 0 14.2438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.102 14.1335 13.8322 0 13.3493 0 0 15.1248 0 0 0 0 0 0 12.3735 15.704 15.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3941 0 0 13.4907 0 O15020 SPTN2_HUMAN "Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)" SPTBN2 KIAA0302 SCA5 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091] apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; parallel fiber to Purkinje cell synapse [GO:0098688]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; postsynaptic spectrin-associated cytoskeleton [GO:0099189]; presynapse [GO:0098793]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult behavior [GO:0030534]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; multicellular organism growth [GO:0035264]; postsynapse organization [GO:0099173]; synapse assembly [GO:0007416]; vesicle-mediated transport [GO:0016192] GO:0003779; GO:0005200; GO:0005543; GO:0005615; GO:0005829; GO:0005886; GO:0007416; GO:0008091; GO:0016192; GO:0016324; GO:0021692; GO:0030036; GO:0030054; GO:0030534; GO:0030864; GO:0033010; GO:0035264; GO:0042995; GO:0043025; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0098688; GO:0098793; GO:0098918; GO:0098978; GO:0099173; GO:0099189 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phospholipid binding [GO:0005543]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of synapse [GO:0098918] ADRFSSCIDMGKELLAR 0.99047 -19.84 0 0 0 0 0 0 0 0 0 11.4936 0 11.7623 0 12.0912 14.0353 14.9255 14.6211 15.0209 15.3194 12.8605 13.2883 13.3174 15.4513 13.8978 12.7806 15.243 15.3622 13.961 14.8384 0 0 12.1546 0 11.7568 0 0 0 0 0 11.1396 11.8835 13.2642 14.3255 13.1818 10.8871 14.1937 0 13.2199 13.8331 13.2695 13.7554 13.4891 13.7213 0 0 15.5258 0 0 0 0 14.4649 0 12.3623 11.5847 0 0 0 0 0 0 0 0 0 12.1048 0 0 13.3505 12.7115 0 14.0069 14.1104 14.0219 18.6848 18.3459 15.8815 13.9201 18.7994 17.6028 16.4004 13.9187 16.3278 15.6571 15.8725 17.0347 0 0 16.8829 17.9007 0 0 0 0 13.3927 14.135 12.9608 13.6802 17.5716 16.3848 13.6979 14.6211 16.2635 16.7839 16.1585 15.9599 15.311 17.0014 0 0 13.3975 15.1112 14.2034 14.5059 12.9501 16.8066 16.5029 0 16.7903 0 12.9659 16.5277 0 12.1849 13.481 13.1843 17.1927 14.9001 16.8477 16.2447 16.5233 15.8195 16.4547 14.3671 0 16.9555 16.351 0 17.715 13.78 17.5841 10.774 13.6449 0 17.6602 17.046 13.4057 16.5793 12.2313 14.3871 13.6489 0 13.324 14.0311 13.4083 14.0865 0 14.2776 11.4429 14.1935 12.3048 0 12.3878 14.0919 16.9649 16.8669 16.4857 13.8195 16.9623 0 16.7936 0 A6NN14 ZN729_HUMAN Zinc finger protein 729 ZNF729 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECAKAF 0.99047 -21.705 0 0 0 0 0 0 0 0 12.0284 11.869 0 12.3695 0 12.6775 12.5727 0 12.3257 12.6096 12.2902 0 0 0 12.8676 0 12.5236 0 11.5792 0 0 0 11.3366 0 0 11.6431 0 11.7339 0 12.4403 0 0 11.3309 0 0 0 0 0 0 11.3507 0 0 0 0 0 0 0 0 0 0 14.8472 0 13.076 0 12.9541 0 0 12.8549 0 0 0 0 0 0 0 0 12.6754 0 0 12.6315 15.8162 0 0 14.6342 13.0205 13.2479 0 0 0 15.335 13.5555 12.6049 0 13.8025 12.6819 0 0 0 0 0 0 0 14.0978 13.4897 0 0 0 0 11.7251 0 12.6414 0 0 14.3569 12.9326 12.7977 0 0 13.115 0 0 0 0 0 13.2244 0 0 0 0 14.1767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1269 0 13.8001 0 11.4932 0 0 11.7505 0 0 0 0 0 0 14.5345 0 0 0 0 0 0 14.8028 14.6091 0 0 13.8671 12.8088 0 12.7083 0 0 0 0 12.3708 0 0 13.4014 0 A6NNM8 TTL13_HUMAN "Tubulin polyglutamylase TTLL13, EC 6.3.2.- (Tubulin tyrosine ligase like 13) (Tubulin tyrosine ligase-like family member 13 pseudogene) (Tubulin--tyrosine ligase-like protein 13)" TTLL13 TTLL13P Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874] cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] AAQMCGLKEVGEDEEWTLYWTDCAVSLERVMDMK 0.99047 -5.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3894 11.272 0 0 0 0 0 0 15.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6331 0 0 0 12.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6319 0 0 0 0 0 0 0 0 0 0 10.9401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5RL73 RBM48_HUMAN RNA-binding protein 48 RBM48 C7orf64 HSPC304 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; RNA binding [GO:0003723] GO:0003723; GO:0005654 RNA binding [GO:0003723] DHYVTKK 0.99047 -20.268 0 0 0 0 0 0 0 0 0 0 0 12.897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3464 0 0 0 0 0 0 10.7636 0 0 0 0 0 0 0 0 0 0 0 0 11.4984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VV63 ATRN1_HUMAN Attractin-like protein 1 ATRNL1 KIAA0534 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; integral component of membrane [GO:0016021] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005604; GO:0007186; GO:0009887; GO:0009888; GO:0016021; GO:0016477; GO:0030246; GO:0034446 carbohydrate binding [GO:0030246] CHVRNEQICNK 0.99047 -5.689 0 0 0 0 0 0 0 11.3442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1365 0 0 0 0 11.3125 0 0 0 0 0 0 11.6813 10.9307 0 0 0 0 0 0 0 0 0 0 0 0 11.6013 0 0 0 0 12.5747 0 0 0 0 0 0 0 0 0 0 0 0 11.6884 0 0 0 0 0 0 0 0 12.1398 0 0 12.0351 0 0 0 0 0 0 11.559 12.1554 0 0 0 0 0 0 0 0 0 0 0 0 12.7675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8363 0 0 11.0951 10.2297 0 0 0 0 0 0 0 0 0 0 12.8131 0 0 0 11.2489 0 0 0 0 Q9Y5X0 SNX10_HUMAN Sorting nexin-10 SNX10 Homo sapiens (Human) bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; gastric acid secretion [GO:0001696]; intracellular protein transport [GO:0006886]; osteoclast differentiation [GO:0030316]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; ruffle assembly [GO:0097178]; tooth eruption [GO:0044691]; vesicle organization [GO:0016050] apical cytoplasm [GO:0090651]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extrinsic component of endosome membrane [GO:0031313]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; secretory granule [GO:0030141] apical cytoplasm [GO:0090651]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extrinsic component of endosome membrane [GO:0031313]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; secretory granule [GO:0030141]; 1-phosphatidylinositol binding [GO:0005545]; ATPase binding [GO:0051117]; phosphatidylinositol phosphate binding [GO:1901981]; bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; gastric acid secretion [GO:0001696]; intracellular protein transport [GO:0006886]; osteoclast differentiation [GO:0030316]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; ruffle assembly [GO:0097178]; tooth eruption [GO:0044691]; vesicle organization [GO:0016050] GO:0001696; GO:0005545; GO:0005634; GO:0005768; GO:0005783; GO:0005815; GO:0006886; GO:0006897; GO:0007032; GO:0016050; GO:0019725; GO:0030141; GO:0030316; GO:0031313; GO:0035630; GO:0044691; GO:0045453; GO:0051117; GO:0055074; GO:0060271; GO:0061512; GO:0071539; GO:0090651; GO:0097178; GO:1901981; GO:1990830 1-phosphatidylinositol binding [GO:0005545]; ATPase binding [GO:0051117]; phosphatidylinositol phosphate binding [GO:1901981] EDFWHSYIDYEICIHTNSMCFTMKTSCVR 0.99047 -5.6862 0 0 0 0 0 13.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.873 11.2422 0 0 0 0 0 13.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.66 14.6937 0 0 0 15.1488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3789 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0359 15.2773 0 O15534 PER1_HUMAN "Period circadian protein homolog 1, hPER1 (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui)" PER1 KIAA0482 PER RIGUI Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; histone H3 acetylation [GO:0043966]; histone H3 deacetylation [GO:0070932]; histone H4 acetylation [GO:0043967]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of circadian rhythm [GO:0042752]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of hair cycle [GO:0042634]; regulation of p38MAPK cascade [GO:1900744]; regulation of sodium ion transport [GO:0002028]; response to cAMP [GO:0051591]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock [GO:0009649]; entrainment of circadian clock by photoperiod [GO:0043153]; histone H3 acetylation [GO:0043966]; histone H3 deacetylation [GO:0070932]; histone H4 acetylation [GO:0043967]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of circadian rhythm [GO:0042752]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of hair cycle [GO:0042634]; regulation of p38MAPK cascade [GO:1900744]; regulation of sodium ion transport [GO:0002028]; response to cAMP [GO:0051591]" GO:0000122; GO:0000976; GO:0000978; GO:0001222; GO:0002028; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007623; GO:0009649; GO:0010608; GO:0019900; GO:0031490; GO:0031625; GO:0032922; GO:0042634; GO:0042752; GO:0043124; GO:0043153; GO:0043966; GO:0043967; GO:0045892; GO:0045944; GO:0046329; GO:0051591; GO:0070888; GO:0070932; GO:0097167; GO:0140297; GO:1900015; GO:1900744; GO:2000323 chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] CASSSSYTTSSASDDDR 0.99048 -20.803 0 0 0 0 11.5232 0 0 0 0 0 0 0 0 0 0 12.6533 12.0898 13.1211 11.9819 13.0749 13.9978 0 12.7052 0 13.6917 0 14.3966 0 0 0 12.7427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7711 11.969 0 11.2802 0 0 0 0 0 0 0 0 0 0 14.4832 0 0 12.1604 18.1784 0 18.0935 0 17.933 13.635 0 0 0 13.8876 13.8138 13.7347 13.7638 0 0 14.5531 0 17.4463 0 0 13.7512 13.9247 13.6523 0 0 16.7281 0 0 0 13.637 0 14.6289 17.1585 0 14.3367 0 16.9418 0 0 0 14.1609 14.3902 16.9547 14.0283 0 15.0001 0 0 16.9706 13.5951 0 0 14.9559 14.228 17.8735 0 16.1218 15.796 0 13.4712 14.6211 0 0 14.9634 0 14.7873 15.7515 14.3453 17.0042 14.4972 15.2543 16.7344 0 16.372 16.7865 13.4844 13.1698 0 0 0 0 0 0 13.2099 15.8291 0 13.7204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7913 17.8972 13.6072 0 0 0 0 0 0 P15259 PGAM2_HUMAN "Phosphoglycerate mutase 2, EC 5.4.2.11, EC 5.4.2.4 (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M, PGAM-M)" PGAM2 PGAMM Homo sapiens (Human) canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; phosphoglycerate mutase activity [GO:0004619]; canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; Notch signaling pathway [GO:0007219]; response to mercury ion [GO:0046689]; spermatogenesis [GO:0007283]; striated muscle contraction [GO:0006941]" GO:0004082; GO:0004619; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0006941; GO:0007219; GO:0007283; GO:0016787; GO:0042802; GO:0046538; GO:0046689; GO:0061621; GO:0070062 "2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; phosphoglycerate mutase activity [GO:0004619]" HYGGLTGLNK 0.99048 -5.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7649 0 0 0 0 0 0 0 13.3318 0 12.5942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P68402 PA1B2_HUMAN "Platelet-activating factor acetylhydrolase IB subunit alpha2, EC 3.1.1.47 (PAF acetylhydrolase 30 kDa subunit, PAF-AH 30 kDa subunit) (PAF-AH subunit beta, PAFAH subunit beta)" PAFAH1B2 PAFAHB Homo sapiens (Human) brain development [GO:0007420]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; ficolin-1-rich granule lumen [GO:1904813]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; ficolin-1-rich granule lumen [GO:1904813]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283] GO:0001650; GO:0003847; GO:0005576; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006629; GO:0007283; GO:0007420; GO:0008247; GO:0016042; GO:0016239; GO:0034774; GO:0042803; GO:0044877; GO:0046982; GO:0047179; GO:0070062; GO:1904813 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] HVLWRLK 0.99048 -1.8278 0 0 11.1684 0 0 0 0 0 0 0 0 0 0 13.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6357 0 16.244 0 0 0 0 0 0 0 0 0 16.2013 13.7933 0 0 0 0 0 11.7229 0 13.2139 0 0 0 0 0 0 0 0 0 0 0 0 10.8907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6522 0 0 11.9946 0 0 0 0 0 11.6146 0 0 11.6329 0 0 13.5678 0 0 0 0 14.0796 0 0 0 13.9742 0 0 0 0 13.643 0 0 0 10.8844 0 11.5298 0 0 0 0 0 0 Q12904 AIMP1_HUMAN "Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2, EMAP-2 (Endothelial monocyte-activating polypeptide II, EMAP-II) (Small inducible cytokine subfamily E member 1) ]" AIMP1 EMAP2 SCYE1 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412] GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0042803; GO:0050900; GO:0051020; GO:0070094 cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049] AILQATLR 0.99048 -19.965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0968 15.7155 0 13.5387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16478 GRIK5_HUMAN "Glutamate receptor ionotropic, kainate 5, GluK5 (Excitatory amino acid receptor 2, EAA2) (Glutamate receptor KA-2, KA2)" GRIK5 GRIK2 Homo sapiens (Human) "cellular response to glucose stimulus [GO:0071333]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; kainate selective glutamate receptor complex [GO:0032983]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; terminal bouton [GO:0043195]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to glucose stimulus [GO:0071333]; establishment of localization in cell [GO:0051649]; excitatory postsynaptic potential [GO:0060079]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of neuron apoptotic process [GO:0043525]; protein retention in ER lumen [GO:0006621]; receptor clustering [GO:0043113]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; synaptic transmission, glutamatergic [GO:0035249]" GO:0005654; GO:0005783; GO:0005886; GO:0006621; GO:0008066; GO:0015276; GO:0015277; GO:0017124; GO:0030165; GO:0030425; GO:0031630; GO:0032983; GO:0035249; GO:0038023; GO:0042802; GO:0043113; GO:0043195; GO:0043204; GO:0043525; GO:0045211; GO:0050804; GO:0051649; GO:0060079; GO:0070161; GO:0071333; GO:0098686; GO:0098978; GO:0099056; GO:0099061; GO:1904315 glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] HAVSCRK 0.99048 -21.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.188 0 0 0 0 13.8971 0 13.6898 0 13.6314 13.0977 0 0 0 0 0 0 0 0 0 0 0 11.3572 0 11.9214 0 0 13.7957 0 0 0 0 12.317 0 0 10.4939 13.9569 0 0 0 15.7045 0 14.1207 0 0 0 0 13.0406 0 0 0 0 0 0 0 0 0 0 15.8133 0 0 0 0 0 0 0 12.3107 12.0459 0 0 0 15.4392 0 0 0 0 0 0 0 0 14.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4702 0 0 0 0 0 0 0 0 Q641Q2 WAC2A_HUMAN WASH complex subunit 2A WASHC2A FAM21A FAM21B Homo sapiens (Human) "endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203] "cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol phosphate binding [GO:1901981]; retromer complex binding [GO:1905394]; endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0071203; GO:1901981; GO:1905394 phosphatidylinositol phosphate binding [GO:1901981]; retromer complex binding [GO:1905394] EEEESDEDFAHHSDNEQNR 0.99048 -1.8271 0 0 0 11.9941 11.6049 0 0 0 0 0 0 0 0 0 0 0 12.5473 0 0 0 0 0 0 0 0 12.6606 12.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1175 0 0 0 0 13.5895 13.9078 0 12.0272 0 0 15.1229 0 0 0 0 0 12.1981 0 0 0 0 0 0 0 0 0 0 0 0 12.6631 0 0 0 0 11.3337 0 0 0 0 0 0 14.59 0 0 0 0 13.3444 0 0 0 11.8013 0 0 13.6076 0 0 0 0 13.7095 0 0 0 0 14.2398 0 0 0 12.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3622 0 0 0 0 0 0 0 0 0 0 0 10.2015 11.7022 Q6P3S6 FBX42_HUMAN F-box only protein 42 (Just one F-box and Kelch domain-containing protein) FBXO42 FBX42 JFK KIAA1332 Homo sapiens (Human) SCF ubiquitin ligase complex [GO:0019005] SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase-substrate adaptor activity [GO:1990756] GO:0019005; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] APLSPSLNSR 0.99048 -20.801 0 0 0 0 0 0 0 0 11.3119 0 0 0 10.923 0 0 10.6026 0 0 0 0 0 10.8633 0 0 0 0 10.6382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4684 0 12.747 0 0 0 11.9978 0 0 0 0 0 0 12.1474 0 0 0 0 0 12.5969 0 12.6571 0 0 0 0 0 0 0 0 13.5747 13.9236 15.9412 14.5521 14.7765 14.7036 15.9532 15.059 14.7181 0 0 0 13.3202 0 0 0 12.8756 0 0 0 0 0 13.7785 0 0 14.42 14.178 14.9208 0 14.1121 12.5241 11.7779 12.3815 0 12.6381 13.3112 15.9582 12.5778 0 0 0 12.8504 0 0 0 0 0 0 0 0 12.7757 13.4807 12.5314 12.6415 0 0 13.6745 0 0 12.6854 13.4171 0 0 0 0 12.6963 0 0 0 13.6908 14.1121 0 13.5141 0 0 13.0572 0 12.6203 0 13.6352 12.6891 14.5034 0 0 12.4168 0 0 13.0979 12.7766 0 0 0 0 Q86W26 NAL10_HUMAN "NACHT, LRR and PYD domains-containing protein 10 (Nucleotide-binding oligomerization domain protein 8)" NLRP10 NALP10 NOD8 PYNOD Homo sapiens (Human) adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 type immune response [GO:2000318]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897] cytoplasm [GO:0005737]; extrinsic component of plasma membrane [GO:0019897]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTPase activity [GO:0003924]; adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 type immune response [GO:2000318]; regulation of inflammatory response [GO:0050727] GO:0002250; GO:0002827; GO:0003924; GO:0005524; GO:0005737; GO:0006954; GO:0016887; GO:0019897; GO:0032730; GO:0032755; GO:0032757; GO:0045087; GO:0050727; GO:0050729; GO:0050829; GO:0050832; GO:1900426; GO:2000318 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTPase activity [GO:0003924] EASTGKGRGTEETPK 0.99048 -19.97 0 9.85803 13.1935 14.8924 14.2424 15.2315 13.7434 13.2064 0 0 11.852 0 0 10.6292 0 0 13.4454 0 0 0 0 0 0 0 0 0 12.2047 14.2118 0 0 0 0 10.7437 0 0 0 0 0 0 0 9.73855 0 0 0 0 0 10.9923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8891 0 0 0 14.6485 0 0 0 0 0 0 0 0 11.309 12.9851 0 0 0 0 0 0 0 0 12.9455 11.5273 0 0 0 12.8318 0 0 0 0 0 0 0 0 11.3197 12.8112 13.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0007 0 0 10.6937 12.9654 12.874 0 0 13.3912 0 13.1363 0 0 0 14.4776 0 0 0 13.0331 0 11.9082 0 0 0 14.3093 0 0 0 0 0 11.6634 0 12.3696 12.9096 13.2538 0 0 12.7486 13.1645 12.8162 0 0 13.7079 14.0086 13.0082 10.5592 0 0 14.4271 0 0 0 0 13.2594 0 0 Q9NR19 ACSA_HUMAN "Acetyl-coenzyme A synthetase, cytoplasmic, EC 6.2.1.1 (Acetate--CoA ligase) (Acetyl-CoA synthetase, ACS, AceCS) (Acetyl-CoA synthetase 1, AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase, EC 6.2.1.17)" ACSS2 ACAS2 Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; lipid biosynthetic process [GO:0008610] GO:0003987; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006069; GO:0006085; GO:0008610; GO:0016208; GO:0019427; GO:0050218 acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218] FETTYFK 0.99048 -20.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1136 10.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKV5 AMFR_HUMAN "E3 ubiquitin-protein ligase AMFR, EC 2.3.2.36 (Autocrine motility factor receptor, AMF receptor) (RING finger protein 45) (gp78)" AMFR RNF45 Homo sapiens (Human) aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450]; aging [GO:0007568]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of protein binding [GO:0032092]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006511; GO:0007165; GO:0007568; GO:0007611; GO:0016020; GO:0016021; GO:0016055; GO:0016567; GO:0030176; GO:0030425; GO:0030426; GO:0030433; GO:0030674; GO:0030968; GO:0032092; GO:0032991; GO:0034450; GO:0036513; GO:0038023; GO:0042802; GO:0043025; GO:0043130; GO:0044322; GO:0046872; GO:0048471; GO:0051087; GO:0051865; GO:0061630; GO:0070936; GO:0090090; GO:1904288; GO:1904380; GO:1990381; GO:2000638 BAT3 complex binding [GO:1904288]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450] FWNFIFYK 0.99048 -19.974 0 0 0 0 0 0 0 11.1333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9591 0 0 0 0 0 0 0 0 0 0 0 0 11.3055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8896 10.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7068 0 0 0 0 13.583 0 13.8101 0 12.4166 0 0 0 0 0 0 12.3646 0 0 0 0 0 0 0 0 0 0 0 13.3432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.537 0 0 0 0 13.7619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMX5 NENF_HUMAN "Neudesin (Cell immortalization-related protein 2) (Neuron-derived neurotrophic factor) (Protein GIG47) (Secreted protein of unknown function, SPUF protein)" NENF CIR2 SPUF Homo sapiens (Human) MAPK cascade [GO:0000165]; negative regulation of appetite [GO:0032099]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; growth factor activity [GO:0008083]; metal ion binding [GO:0046872]; MAPK cascade [GO:0000165]; negative regulation of appetite [GO:0032099]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410] GO:0000165; GO:0005615; GO:0005739; GO:0005783; GO:0008083; GO:0012505; GO:0016020; GO:0032099; GO:0043410; GO:0046872; GO:1901215 growth factor activity [GO:0008083]; metal ion binding [GO:0046872] LRPLAALALVLALAPGLPTAR 0.99048 -4.8117 0 0 0 0 0 11.9879 0 11.1113 0 12.8902 11.4693 0 12.8799 0 0 0 13.5607 0 0 12.9736 13.0661 0 0 0 0 0 0 0 12.4287 11.3285 0 0 12.3826 0 11.6826 0 0 0 12.2658 0 12.4727 0 0 0 0 12.9424 0 11.7302 0 0 0 0 0 12.207 0 13.0425 0 11.8834 11.0276 10.7899 0 0 0 0 0 10.7925 14.7166 0 16.7978 0 0 0 0 14.6834 0 0 0 0 0 15.2688 0 0 14.539 0 0 0 0 0 0 0 11.7608 0 0 13.5734 0 0 11.5093 0 0 13.9212 13.9589 0 0 15.1547 0 0 0 11.3611 0 0 0 0 14.1124 14.3673 0 0 0 0 0 14.874 0 0 15.3726 14.0487 0 0 0 0 0 14.3155 13.8452 11.8129 0 10.9819 0 0 0 0 0 15.5615 0 0 0 0 0 12.8754 13.5308 12.9657 14.5167 0 14.2453 0 0 0 13.5892 0 0 11.8646 0 12.3878 0 0 13.4108 0 0 0 0 0 0 0 0 14.4839 0 0 0 0 0 0 0 0 A8MT70 ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 ZBBX Homo sapiens (Human) cilium movement [GO:0003341] motile cilium [GO:0031514] motile cilium [GO:0031514]; metal ion binding [GO:0046872]; cilium movement [GO:0003341] GO:0003341; GO:0031514; GO:0046872 metal ion binding [GO:0046872] DFLNLCLRNSSTYYK 0.99049 -20.916 0 0 10.0676 0 0 0 0 0 13.1517 0 0 0 0 0 11.6107 13.6317 13.7153 14.4893 15.3537 12.8594 14.8161 10.7112 15.708 15.4482 14.2945 12.4643 14.7256 13.1951 11.6922 0 0 0 0 12.8995 0 0 0 0 0 0 11.6149 0 0 0 0 0 0 13.4391 10.7289 0 11.5947 12.0784 11.1525 11.086 0 13.4307 0 0 0 0 0 0 0 0 0 0 18.3928 17.0999 18.6514 18.2377 18.2397 17.7739 18.1266 15.445 18.0005 18.1627 17.7843 17.802 17.5182 17.6677 17.7717 14.3896 15.251 14.1305 0 15.9161 15.0871 16.8863 16.3888 16.5394 17.1129 15.3733 14.5872 16.593 15.598 15.3267 14.5665 14.8726 13.0075 16.9334 16.4254 16.5595 0 15.7537 16.9941 16.158 17.2818 16.5867 17.2348 16.2699 15.9512 0 16.6239 17.3278 15.2618 16.5526 16.8061 17.1513 14.5071 16.7235 16.4494 16.8144 16.3675 15.7931 15.0731 17.2907 16.6933 17.275 15.6517 17.3071 16.9364 16.5158 16.7137 15.8531 17.1492 17.0188 16.0973 16.6763 16.7748 16.1937 12.9082 15.7379 15.3351 16.289 16.3364 16.5381 15.6058 14.2045 0 14.3536 13.6939 15.8381 0 16.3183 15.2832 16.0105 16.7276 0 13.8754 0 12.9939 0 0 0 0 15.9937 0 0 13.2205 14.1978 14.9224 15.3744 16.4867 16.8915 15.5335 0 0 0 0 0 A8MX76 CAN14_HUMAN "Calpain-14, EC 3.4.22.- (Calcium-activated neutral proteinase 14, CANP 14)" CAPN14 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508] GO:0004198; GO:0005509; GO:0005737; GO:0006508 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] EIEDQNERQDEFFTKFFEK 0.99049 -19.257 0 0 0 0 14.7237 10.1183 15.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80345 0 0 0 11.7022 0 0 0 0 11.4627 0 0 0 0 0 0 0 0 0 0 0 9.8005 0 0 0 0 0 0 0 0 0 15.1689 0 0 0 0 11.09 11.5846 14.6825 0 0 16.2788 0 0 0 0 0 13.0359 0 0 10.9726 14.0319 14.8575 14.206 0 0 12.6844 16.1644 0 12.1156 0 0 0 0 12.1483 12.082 0 11.9432 12.9057 0 0 12.4127 11.8873 0 13.7399 12.8481 12.706 14.4072 14.8151 0 0 13.6536 0 13.6797 0 17.2909 14.3518 12.7123 0 11.8501 0 0 0 14.2814 0 0 0 13.638 14.0543 12.718 13.6356 12.7498 0 0 11.9826 0 0 14.1886 0 0 0 0 11.7766 15.4795 0 11.833 0 0 0 10.9173 0 11.3597 0 0 0 0 0 0 0 0 14.6789 0 12.7171 12.1332 0 0 11.9416 0 P02489 CRYAA_HUMAN "Alpha-crystallin A chain (Heat shock protein beta-4, HspB4) [Cleaved into: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162) ]" CRYAA CRYA1 HSPB4 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intracellular transport [GO:0032387]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intracellular transport [GO:0032387]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; visual perception [GO:0007601] GO:0002088; GO:0005198; GO:0005212; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007601; GO:0009408; GO:0032387; GO:0032991; GO:0042026; GO:0042802; GO:0043066; GO:0046872; GO:0050821; GO:0051082 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082] QDDHGYISREFHR 0.99049 -5.8644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6551 12.1161 12.8974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8276 0 0 0 0 13.3076 0 0 0 0 0 0 0 0 0 12.9225 0 0 0 0 0 0 0 12.7299 0 0 0 12.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15198 PGFRL_HUMAN "Platelet-derived growth factor receptor-like protein, PDGFR-like protein (PDGF receptor beta-like tumor suppressor)" PDGFRL PRLTS Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019] GO:0004992; GO:0005019; GO:0005576 platelet activating factor receptor activity [GO:0004992]; platelet-derived growth factor beta-receptor activity [GO:0005019] GELFVPSPSYFDVVYLNPDRQAVVPCR 0.99049 -5.8811 0 0 0 0 11.9966 0 0 0 0 0 0 0 0 0 18.1248 14.4273 18.4071 17.4859 15.5965 14.1138 19.7541 13.6884 15.1263 13.416 0 18.8109 19.2759 16.2501 14.3335 0 18.8586 0 0 0 0 0 0 13.9012 0 0 0 0 19.0201 0 0 19.0944 19.0379 19.1418 10.7288 0 0 13.7167 13.6676 12.1666 0 0 0 0 0 0 12.7969 0 0 0 0 0 0 0 0 0 13.8967 0 0 0 0 0 0 0 0 0 0 0 0 12.6788 0 12.8702 0 14.0641 13.2196 0 19.2493 13.1276 0 0 14.2964 0 16.1687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1458 0 0 0 0 0 0 0 0 0 10.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.347 0 19.3531 0 0 19.3485 19.3187 0 0 19.1345 0 0 0 12.9273 0 0 19.6162 19.6444 0 Q2TAK8 PWP3A_HUMAN "PWWP domain-containing DNA repair factor 3A, PWWP3A (Mutated melanoma-associated antigen 1, MUM-1) (PWWP domain-containing protein MUM1) (Protein expandere)" PWWP3A EXPAND1 MUM1 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA repair [GO:0006281] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; chromatin organization [GO:0006325]; DNA repair [GO:0006281] GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0031491 nucleosome binding [GO:0031491] ADAKYVLCR 0.99049 -20.838 0 0 0 0 0 0 0 0 10.2193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5657 0 0 10.2773 0 0 0 0 0 0 0 0 0 0 0 10.7153 0 0 0 0 0 0 0 0 0 10.516 0 0 0 0 0 0 11.6393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3167 0 13.3593 0 13.1592 0 0 14.1111 0 0 0 0 0 0 0 11.2964 12.8584 13.2396 0 12.4543 0 0 0 0 10.7351 11.0897 13.6035 0 0 12.7832 12.6575 0 0 0 0 0 12.5684 15.5093 12.737 12.7488 12.683 0 0 12.4868 0 0 13.0345 12.5362 13.807 0 15.8702 0 0 0 0 0 11.0937 0 13.244 0 0 12.3087 11.452 0 0 0 0 0 0 0 12.1791 12.4482 11.146 0 13.8555 12.3829 12.3861 0 13.1605 0 0 13.7331 13.2112 12.4909 0 0 0 0 0 0 0 Q4G0J3 LARP7_HUMAN "La-related protein 7 (La ribonucleoprotein domain family member 7, hLARP7) (P-TEFb-interaction protein for 7SK stability, PIP7S)" LARP7 HDCMA18P Homo sapiens (Human) "box C/D RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]" 7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532] "7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; box C/D RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]" GO:0000122; GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0030532; GO:0032897; GO:0034244; GO:0048024; GO:0097322; GO:0120259; GO:1904871; GO:1905382; GO:1990438; GO:1990904 7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] ASMASLK 0.99049 -20.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6052 0 0 0 0 0 0 0 0 12.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7027 0 0 13.859 0 13.3208 14.2224 0 13.1274 0 0 0 0 0 0 14.3081 0 13.576 13.1461 12.9658 13.1979 0 13.3192 0 14.9644 12.9784 13.4547 0 0 0 0 0 0 0 13.8032 0 0 0 0 0 0 13.239 0 13.8515 0 12.9667 12.0279 0 13.216 0 0 0 0 0 13.6572 0 0 0 0 0 14.092 0 0 12.4344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5285 0 0 0 0 0 Q9BQI3 E2AK1_HUMAN "Eukaryotic translation initiation factor 2-alpha kinase 1, EC 2.7.11.1 (Heme-controlled repressor, HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor, hHRI) (Hemin-sensitive initiation factor 2-alpha kinase)" EIF2AK1 HRI KIAA1369 PRO1362 Homo sapiens (Human) acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; iron ion homeostasis [GO:0055072]; macrophage differentiation [GO:0030225]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translational initiation by iron [GO:0045993]; phagocytosis [GO:0006909]; protein autophosphorylation [GO:0046777]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of eIF2 alpha phosphorylation by heme [GO:0010999]; response to iron ion starvation [GO:1990641] GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005737; GO:0006909; GO:0008285; GO:0010999; GO:0020037; GO:0030225; GO:0042803; GO:0045993; GO:0046501; GO:0046777; GO:0046986; GO:0051649; GO:0055072; GO:0106310; GO:0140467; GO:0140468; GO:1990641 ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] AITHLMR 0.99049 -20.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0647 12.1793 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7153 0 0 0 11.3387 0 0 0 0 0 0 0 11.3454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0444 0 0 0 0 0 0 0 0 14.6876 14.4001 14.2676 0 0 0 0 0 13.1297 13.576 0 13.0653 0 0 0 0 0 14.1413 0 0 0 0 12.1366 0 0 0 13.9856 0 0 0 0 11.6702 12.8429 0 0 0 0 0 0 0 0 0 12.389 0 0 0 13.0607 0 0 0 0 0 0 11.7982 0 0 0 12.4012 14.2116 12.3893 12.5619 14.3965 0 12.765 0 13.0995 13.136 0 0 0 13.4101 0 0 0 0 0 12.6828 0 0 Q9Y6R4 M3K4_HUMAN "Mitogen-activated protein kinase kinase kinase 4, EC 2.7.11.25 (MAP three kinase 1) (MAPK/ERK kinase kinase 4, MEK kinase 4, MEKK 4)" MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225] GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0006468; GO:0010225; GO:0010468; GO:0019100; GO:0032212; GO:0035556; GO:0043507; GO:0046872; GO:0048471; GO:0051973; GO:0060718; GO:0106310; GO:1900745; GO:1904355 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310] AMDLPSFEPAFLVLCRVLLNVIHECLKLR 0.99049 -20.924 0 0 0 0 0 0 0 0 0 12.5803 12.7191 0 12.4262 12.2121 0 13.4778 13.2531 12.5621 13.8333 0 0 13.0301 12.2754 12.7993 12.3287 14.0791 0 0 0 13.4658 13.2067 11.8254 0 0 0 12.9339 12.653 0 13.3226 12.9941 13.2074 13.5736 0 0 0 12.1074 11.0051 13.595 0 0 0 13.4327 0 13.5807 0 13.1324 0 0 0 0 11.9027 12.2534 12.5423 0 0 0 0 0 0 0 0 0 13.3418 12.9164 0 0 0 0 0 0 0 0 0 14.1116 0 0 13.8431 0 0 0 0 0 0 0 0 16.3218 0 0 0 0 0 0 0 0 0 0 14.3609 0 0 11.6242 14.2204 0 0 0 13.268 15.954 0 12.3908 0 0 0 0 0 0 0 0 13.5022 14.689 0 0 0 0 0 0 12.8815 0 0 0 15.8618 0 0 15.6405 0 0 14.3454 0 10.7114 0 0 0 0 0 0 12.9139 10.48 0 0 12.3017 0 0 0 0 0 0 0 11.6695 0 0 0 0 12.0237 0 14.5318 0 0 0 0 0 0 0 O95932 TGM3L_HUMAN "Protein-glutamine gamma-glutamyltransferase 6, EC 2.3.2.13 (Transglutaminase Y, TGY, TGase Y) (Transglutaminase-3-like, TGase-3-like) (Transglutaminase-6, TG6, TGase-6)" TGM6 TGM3L Homo sapiens (Human) peptide cross-linking [GO:0018149] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149] GO:0003810; GO:0005737; GO:0018149; GO:0046872 metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] ERVYSNTKK 0.9905 -20.943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6928 0 0 0 0 0 0 0 0 0 0 13.7839 13.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2736 13.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42356 PI4KA_HUMAN "Phosphatidylinositol 4-kinase alpha, PI4-kinase alpha, PI4K-alpha, PtdIns-4-kinase alpha, EC 2.7.1.67 (Phosphatidylinositol 4-Kinase III alpha)" PI4KA PIK4 PIK4CA Homo sapiens (Human) modulation by host of viral process [GO:0044788]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; reorganization of cellular membranes to establish viral sites of replication [GO:0140754]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; modulation by host of viral process [GO:0044788]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; reorganization of cellular membranes to establish viral sites of replication [GO:0140754]; signal transduction [GO:0007165] GO:0004430; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006661; GO:0007165; GO:0016020; GO:0016301; GO:0016310; GO:0030660; GO:0044788; GO:0045296; GO:0046854; GO:0048015; GO:0052742; GO:0070062; GO:0140754 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742] APYLAKFK 0.9905 -20.93 0 0 0 0 0 0 0 13.8498 0 12.0105 13.8022 11.6257 0 11.3909 12.6832 13.8868 0 11.6925 13.1148 12.3323 0 0 0 0 12.5016 0 13.2349 0 11.4661 11.9892 11.6881 12.1383 0 13.1435 0 0 13.19 0 0 11.5762 12.8902 14.1093 11.4232 13.4658 0 0 0 11.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9991 0 11.8856 22.7973 0 0 0 0 0 0 0 0 0 15.4581 15.6019 0 0 0 13.5347 13.464 0 0 16.4183 0 0 0 14.2887 0 0 0 0 0 0 15.635 0 0 0 0 14.3505 0 0 0 0 0 11.4039 0 15.1544 0 12.689 14.0001 14.3957 0 11.5972 0 0 14.8821 0 15.4889 0 13.5728 0 15.4995 0 15.2239 14.9916 0 13.629 15.0117 14.2197 13.7241 12.4968 0 13.0254 0 15.6998 13.9111 11.88 13.6926 0 14.7737 0 0 0 14.7856 0 0 0 12.9678 0 12.889 13.9837 14.3123 0 0 14.7351 0 0 0 0 0 12.0167 0 0 13.3146 0 0 0 13.63 0 Q9P267 MBD5_HUMAN Methyl-CpG-binding domain protein 5 (Methyl-CpG-binding protein MBD5) MBD5 KIAA1461 Homo sapiens (Human) glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; regulation of behavior [GO:0050795]; regulation of multicellular organism growth [GO:0040014] chromocenter [GO:0010369]; chromosome [GO:0005694]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromocenter [GO:0010369]; chromosome [GO:0005694]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; glucose homeostasis [GO:0042593]; nervous system development [GO:0007399]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; regulation of behavior [GO:0050795]; regulation of multicellular organism growth [GO:0040014] GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0007399; GO:0010369; GO:0030496; GO:0040014; GO:0042593; GO:0050795; GO:0060399; GO:0070062 chromatin binding [GO:0003682] GLTSWPGKLVR 0.9905 -20.947 0 0 0 0 0 0 0 0 16.2069 0 0 0 0 0 0 0 17.3304 0 0 0 16.8044 0 16.2195 0 0 0 0 14.7098 0 14.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8061 14.5174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5018 0 0 0 0 0 0 0 0 0 13.4661 13.0231 0 0 14.6111 0 0 0 0 0 0 13.9819 0 12.9908 0 0 0 0 0 18.5281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1689 0 0 0 0 0 0 0 0 0 20.6453 0 0 0 0 0 0 0 0 19.9749 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1745 0 0 0 0 15.1834 0 13.2391 0 0 0 14.033 0 0 20.7556 0 0 0 0 0 18.1909 18.932 P41743 KPCI_HUMAN "Protein kinase C iota type, EC 2.7.11.13 (Atypical protein kinase C-lambda/iota, PRKC-lambda/iota, aPKC-lambda/iota) (nPKC-iota)" PRKCI DXS1179E Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to insulin stimulus [GO:0032869]; cytoskeleton organization [GO:0007010]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; protein targeting to membrane [GO:0006612]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; secretion [GO:0046903]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005923; GO:0006468; GO:0006612; GO:0007010; GO:0007015; GO:0010976; GO:0015630; GO:0016192; GO:0016324; GO:0016477; GO:0018105; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0035556; GO:0042462; GO:0043066; GO:0043220; GO:0043524; GO:0045171; GO:0045197; GO:0045216; GO:0045747; GO:0046326; GO:0046872; GO:0046903; GO:0048194; GO:0051092; GO:0060252; GO:0061024; GO:0070062; GO:0070160; GO:0070555; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AHCAICTDR 0.99051 -20.14 0 0 0 0 0 0 0 0 0 0 0 10.3073 0 10.37 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4718 0 0 0 0 0 0 0 0 0 0 12.1695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6783 0 0 0 0 0 0 0 0 0 0 0 15.0874 13.4615 16.1037 0 14.3702 0 0 14.3257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6824 0 0 0 0 0 0 12.8609 0 0 0 0 0 0 0 0 0 0 13.6044 0 0 0 0 0 0 11.2801 0 0 0 0 13.1635 12.1603 0 0 0 14.0579 0 10.805 0 0 0 0 0 0 0 0 0 0 0 0 11.5782 0 0 12.1325 0 0 0 12.8374 0 14.8263 P47928 ID4_HUMAN "DNA-binding protein inhibitor ID-4 (Class B basic helix-loop-helix protein 27, bHLHb27) (Inhibitor of DNA binding 4) (Inhibitor of differentiation 4)" ID4 BHLHB27 Homo sapiens (Human) "astrocyte differentiation [GO:0048708]; cell differentiation [GO:0030154]; central nervous system myelination [GO:0022010]; cerebral cortex neuron differentiation [GO:0021895]; circadian regulation of gene expression [GO:0032922]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; hippocampus development [GO:0021766]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast proliferation [GO:0007405]; osteoblast differentiation [GO:0001649]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland stromal morphogenesis [GO:0060741]; protein localization [GO:0008104]; seminal vesicle morphogenesis [GO:0061682]; stem cell proliferation [GO:0072089]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; astrocyte differentiation [GO:0048708]; cell differentiation [GO:0030154]; central nervous system myelination [GO:0022010]; cerebral cortex neuron differentiation [GO:0021895]; circadian regulation of gene expression [GO:0032922]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; hippocampus development [GO:0021766]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast proliferation [GO:0007405]; osteoblast differentiation [GO:0001649]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland stromal morphogenesis [GO:0060741]; protein localization [GO:0008104]; seminal vesicle morphogenesis [GO:0061682]; stem cell proliferation [GO:0072089]" GO:0000082; GO:0000122; GO:0001649; GO:0002052; GO:0005634; GO:0005654; GO:0005737; GO:0007405; GO:0008104; GO:0010628; GO:0021766; GO:0021895; GO:0022010; GO:0030154; GO:0032922; GO:0045444; GO:0045599; GO:0045665; GO:0045892; GO:0045944; GO:0046983; GO:0048708; GO:0048712; GO:0048715; GO:0060740; GO:0060741; GO:0061629; GO:0061682; GO:0072089; GO:0140416; GO:2000648 protein dimerization activity [GO:0046983]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416] CKAAEAAADEPALCLQCDMNDCYSR 0.99051 -5.6116 0 0 0 0 0 0 0 0 10.9334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6486 0 0 0 0 0 0 0 0 0 0 0 10.5725 0 0 0 0 0 0 0 0 0 0 13.0986 0 0 0 0 0 0 0 0 0 11.3263 0 0 11.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8366 0 Q8WU90 ZC3HF_HUMAN Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4) ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181]; positive regulation of GTPase activity [GO:0043547] GO:0002181; GO:0003723; GO:0005634; GO:0005829; GO:0019221; GO:0043547; GO:0045296; GO:0046872 cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] AGKALVISGR 0.99051 -20.57 0 0 0 0 0 0 0 0 0 0 13.3161 12.3805 0 0 0 0 0 0 0 0 15.2788 0 0 0 0 11.1324 0 0 0 0 0 0 11.6342 0 0 0 9.76296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2894 0 13.8521 0 13.5044 0 14.0993 13.9918 0 0 0 0 0 0 0 0 0 15.0667 0 13.5234 0 0 0 0 0 10.5309 0 0 0 0 0 0 13.9388 13.5036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8411 0 0 0 0 0 14.0485 0 0 0 0 0 12.0275 0 0 0 0 0 0 0 0 0 0 10.348 0 13.3632 0 0 Q96A59 MALD3_HUMAN MARVEL domain-containing protein 3 MARVELD3 MRVLDC3 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; protein localization to cell junction [GO:1902414]; response to osmotic stress [GO:0006970] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of JNK cascade [GO:0046329]; protein localization to cell junction [GO:1902414]; response to osmotic stress [GO:0006970] GO:0005737; GO:0005923; GO:0006970; GO:0010633; GO:0016021; GO:0031410; GO:0031435; GO:0045216; GO:0046329; GO:0050680; GO:0070830; GO:1902414 mitogen-activated protein kinase kinase kinase binding [GO:0031435] DGNRDRNR 0.99051 -20.539 0 0 0 0 0 0 10.3677 10.6932 0 0 0 0 0 0 0 0 0 0 12.9844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.383 0 0 0 0 0 0 0 0 0 14.8113 0 10.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3246 0 0 0 0 13.438 0 0 0 0 0 0 0 0 0 0 0 0 11.2505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2782 0 0 0 0 Q9BUE6 ISCA1_HUMAN "Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 2) (Iron-sulfur assembly protein IscA, hIscA)" ISCA1 HBLD2 GK004 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]" GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0046872; GO:0051537; GO:0097428 "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]" AALTLTPSAVNKIKQLLK 0.99051 -20.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0371 0 0 12.5983 0 0 0 0 0 0 0 0 0 0 0 12.195 0 0 0 0 0 0 0 0 0 0 0 11.0625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3911 0 0 0 0 12.8923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.594 0 0 0 0 13.6152 0 0 0 0 0 0 14.0258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.874 13.1116 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWF2 TRAIP_HUMAN "E3 ubiquitin-protein ligase TRAIP, EC 2.3.2.27 (RING finger protein 206) (TRAF-interacting protein)" TRAIP RNF206 TRIP Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297]; signal transduction [GO:0007165] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of DNA damage [GO:0090734] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of DNA damage [GO:0090734]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; replication fork processing [GO:0031297]; signal transduction [GO:0007165] GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006915; GO:0006974; GO:0007165; GO:0010804; GO:0016567; GO:0031297; GO:0032088; GO:0032688; GO:0042802; GO:0046872; GO:0048471; GO:0061630; GO:0090734; GO:0106300 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] FIQPTDTVMIRPLPVK 0.99051 -20.167 0 0 0 0 0 0 0 0 12.93 12.5839 0 0 0 11.7458 0 0 0 0 11.9549 0 0 0 0 0 10.2771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1826 0 0 0 0 0 0 0 0 0 12.5236 0 13.221 0 0 0 0 0 0 0 12.9683 12.5882 0 0 0 0 0 12.8575 0 11.1373 0 0 11.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9379 0 0 0 0 12.7323 0 0 0 12.0319 0 0 10.946 0 0 0 0 0 0 0 11.8286 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7938 12.462 11.8821 0 0 0 13.2698 0 0 0 0 0 12.151 0 0 0 0 11.2224 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZQ2 SHP1L_HUMAN Testicular spindle-associated protein SHCBP1L (SHC SH2 domain-binding protein 1-like protein) SHCBP1L C1orf14 Homo sapiens (Human) cell differentiation [GO:0030154]; male meiosis cytokinesis [GO:0007112]; positive regulation of chromosome organization [GO:2001252]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; meiotic spindle [GO:0072687] cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; cell differentiation [GO:0030154]; male meiosis cytokinesis [GO:0007112]; positive regulation of chromosome organization [GO:2001252]; spermatogenesis [GO:0007283] GO:0005737; GO:0007112; GO:0007283; GO:0030154; GO:0072687; GO:2001252 DKWLGVWKTNPSVFFVK 0.99051 -19.813 0 0 0 0 0 0 0 0 0 0 0 12.8008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6339 0 0 0 0 0 0 0 0 0 0 11.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1294 12.1561 0 0 12.7913 0 0 13.4844 13.1901 12.9272 0 0 0 12.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0711 0 14.1807 0 0 0 0 0 0 0 0 0 14.7103 0 0 0 0 0 0 Q9H2J4 PDCL3_HUMAN "Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1, VIAF-1)" PDCL3 PhLP2A VIAF1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]; protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730] GO:0001525; GO:0001938; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006457; GO:0006915; GO:0010628; GO:0030036; GO:0032991; GO:0043184; GO:0044183; GO:0045766; GO:0048471; GO:0050730; GO:0050821; GO:0061077; GO:0097356; GO:1903645; GO:2000059 protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184] DSDSEGD 0.99051 -20.546 0 0 0 0 0 0 0 0 0 0 11.9314 0 11.7655 0 0 0 0 12.2506 0 0 0 0 0 0 0 11.9272 0 12.0663 0 0 0 0 0 0 0 0 0 0 0 10.9247 0 0 0 0 0 0 0 0 11.3661 0 10.5424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1272 13.2008 0 0 0 0 0 0 10.3332 0 0 14.5843 0 0 0 0 0 14.5935 0 14.5974 0 14.7668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1498 0 14.4809 0 0 0 0 0 0 0 0 0 0 0 14.1101 0 14.1624 0 14.0972 0 12.0446 0 0 0 0 0 0 14.4257 13.661 15.5773 0 0 0 0 0 14.1364 14.8525 0 13.1683 12.9581 15.6002 13.0606 0 0 0 0 0 0 15.2728 0 0 Q9H4A3 WNK1_HUMAN "Serine/threonine-protein kinase WNK1, EC 2.7.11.1 (Erythrocyte 65 kDa protein, p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1, hWNK1)" WNK1 HSN2 KDP KIAA0344 PRKWNK1 Homo sapiens (Human) cation homeostasis [GO:0055080]; cellular chloride ion homeostasis [GO:0030644]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; potassium ion homeostasis [GO:0055075]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; T cell receptor signaling pathway [GO:0050852] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cation homeostasis [GO:0055080]; cellular chloride ion homeostasis [GO:0030644]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; potassium ion homeostasis [GO:0055075]; protein phosphorylation [GO:0006468]; regulation of cation transmembrane transport [GO:1904062]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; T cell receptor signaling pathway [GO:0050852] GO:0002028; GO:0003084; GO:0004672; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006811; GO:0007165; GO:0010766; GO:0010820; GO:0016020; GO:0018105; GO:0018107; GO:0019869; GO:0019870; GO:0019901; GO:0019902; GO:0030295; GO:0030644; GO:0032991; GO:0033633; GO:0034115; GO:0034260; GO:0035556; GO:0035725; GO:0038116; GO:0048666; GO:0050801; GO:0050852; GO:0055075; GO:0055080; GO:0090188; GO:0090263; GO:0097022; GO:0106310; GO:1903038; GO:1903288; GO:1904062; GO:1990869; GO:2000651 ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DAMNLSGR 0.99051 -20.147 0 0 0 0 0 0 0 0 12.9968 12.9015 0 0 0 0 12.5369 0 0 11.784 0 0 11.8105 0 0 0 0 0 0 0 0 0 11.6519 13.0588 13.3085 12.683 11.6015 0 13.2873 12.6182 13.4184 12.7359 11.3305 0 13.3518 0 13.2903 13.5314 14.2661 0 0 11.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2602 0 0 13.0976 0 0 0 0 0 0 0 0 0 13.5297 0 0 0 13.403 14.7784 0 0 13.6395 0 13.3325 0 14.0333 13.5384 0 0 12.6748 0 0 12.8601 13.4542 11.3289 0 0 0 12.4108 0 0 0 12.9694 13.4738 13.6006 0 12.6711 0 0 13.5697 0 0 0 15.0027 12.4405 0 12.9173 0 12.7341 0 0 13.2234 14.6125 15.1145 0 0 12.3353 0 12.8996 0 0 0 13.4525 14.3796 0 12.4634 14.0251 13.2017 15.2729 0 19.9753 13.5415 13.5087 14.9222 13.9887 14.1146 13.4029 0 13.8797 0 0 13.9606 0 15.0013 0 0 Q9P0P8 MRES1_HUMAN Mitochondrial transcription rescue factor 1 MTRES1 C6orf203 HSPC230 Homo sapiens (Human) regulation of mitochondrial transcription [GO:1903108]; rescue of stalled ribosome [GO:0072344] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; regulation of mitochondrial transcription [GO:1903108]; rescue of stalled ribosome [GO:0072344] GO:0000049; GO:0003723; GO:0005739; GO:0005759; GO:0043023; GO:0072344; GO:1903108 ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; tRNA binding [GO:0000049] AMASVKLLAGVLRK 0.99051 -20.589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8604 0 0 0 0 0 0 0 0 0 0 0 0 12.948 0 0 0 15.0515 13.7451 13.368 13.4951 0 0 0 0 0 0 0 0 0 0 0 0 13.4596 0 0 0 0 0 0 0 13.5745 11.9726 13.7923 0 0 0 0 0 0 0 14.2795 0 0 0 0 0 12.7344 0 0 0 0 0 0 13.5619 0 14.8716 0 0 0 15.0454 14.2536 0 0 0 13.6001 0 0 11.5987 0 11.3301 0 14.5021 0 0 0 0 13.3478 13.2884 0 0 0 0 0 0 0 0 0 0 0 0 13.9866 13.6595 0 12.0482 14.0561 13.0296 0 14.2039 0 0 0 0 P02746 C1QB_HUMAN Complement C1q subcomponent subunit B C1QB Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; synapse pruning [GO:0098883]" blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; complement component C1 complex [GO:0005602]; complement component C1q complex [GO:0062167]; extracellular region [GO:0005576]; postsynapse [GO:0098794]; synapse [GO:0045202] "blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; complement component C1 complex [GO:0005602]; complement component C1q complex [GO:0062167]; extracellular region [GO:0005576]; postsynapse [GO:0098794]; synapse [GO:0045202]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; synapse pruning [GO:0098883]" GO:0005576; GO:0005581; GO:0005602; GO:0006956; GO:0006958; GO:0045087; GO:0045202; GO:0062023; GO:0062167; GO:0072562; GO:0098794; GO:0098883 ATQKIAFSATRTINVPLR 0.99052 -20.638 0 0 11.6435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7711 13.6508 13.4227 0 12.7494 0 0 0 13.992 0 0 0 0 0 0 0 0 0 0 0 0 13.65 0 0 13.4256 0 0 0 13.0994 0 0 0 0 0 0 0 14.1007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.438 0 13.13 0 0 0 0 0 13.0824 13.0436 0 14.3602 0 13.6153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35713 SOX18_HUMAN Transcription factor SOX-18 SOX18 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; embryonic heart tube development [GO:0035050]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; establishment of endothelial barrier [GO:0061028]; hair cycle process [GO:0022405]; hair follicle development [GO:0001942]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription, DNA-templated [GO:0006355]; stem cell fate specification [GO:0048866]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cell differentiation [GO:0030154]; cell maturation [GO:0048469]; embryonic heart tube development [GO:0035050]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; establishment of endothelial barrier [GO:0061028]; hair cycle process [GO:0022405]; hair follicle development [GO:0001942]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription, DNA-templated [GO:0006355]; stem cell fate specification [GO:0048866]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001570; GO:0001701; GO:0001942; GO:0001944; GO:0001946; GO:0001947; GO:0003151; GO:0005634; GO:0005667; GO:0006355; GO:0009653; GO:0022405; GO:0030154; GO:0035050; GO:0043534; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0048866; GO:0060214; GO:0060836; GO:0060956; GO:0061028; GO:0072091; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" MLGKAWK 0.99052 -21.652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3234 0 0 0 0 0 0 0 14.9332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3288 12.9022 0 0 0 0 0 0 0 0 12.2183 0 0 0 0 0 0 0 0 13.1336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36871 PGM1_HUMAN "Phosphoglucomutase-1, PGM 1, EC 5.4.2.2 (Glucose phosphomutase 1)" PGM1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] GO:0000287; GO:0004614; GO:0005576; GO:0005737; GO:0005829; GO:0005975; GO:0006006; GO:0006094; GO:0006096; GO:0070062; GO:1904724; GO:1904813 magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614] EAIQLIARIAAANGIGR 0.99052 -20.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9897 0 14.2686 0 0 11.2151 0 0 0 0 0 0 0 0 11.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8997 0 15.5226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0925 0 0 0 0 0 0 0 0 0 0 0 0 11.8407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46092 CCR10_HUMAN "C-C chemokine receptor type 10, C-C CKR-10, CC-CKR-10, CCR-10 (G-protein coupled receptor 2)" CCR10 GPR2 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0004930; GO:0005783; GO:0005886; GO:0005887; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0009986; GO:0016493; GO:0019722; GO:0019957; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; G protein-coupled receptor activity [GO:0004930] ADVQAFSR 0.99052 -21.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6967 0 0 0 0 0 0 0 11.0825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2094 0 0 0 13.9231 0 0 0 0 0 0 0 0 13.8998 15.6779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2365 0 Q13795 ARFRP_HUMAN "ADP-ribosylation factor-related protein 1, ARF-related protein 1, ARP" ARFRP1 ARP1 Homo sapiens (Human) "gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; signal transduction [GO:0007165]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; signal transduction [GO:0007165]" GO:0003924; GO:0005525; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0007165; GO:0007369; GO:0016020; GO:0032588; GO:0034067; GO:0042147; GO:0043001 GTP binding [GO:0005525]; GTPase activity [GO:0003924] NVHRPPR 0.99052 -20.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6085 0 0 0 0 0 12.9681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49AG3 ZBED5_HUMAN Zinc finger BED domain-containing protein 5 (Transposon-derived Buster1 transposase-like protein) ZBED5 Buster1 Homo sapiens (Human) DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AVDGKIAEAVTLIK 0.99052 -21.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2222 0 0 0 13.847 11.9241 0 0 13.4069 13.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTT4 SSX8_HUMAN Putative protein SSX8 SSX8P SSX8 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 DPEEDDE 0.99052 -21.698 14.6253 0 14.172 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6581 13.2835 13.1621 13.2939 0 11.1565 13.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.78 11.6124 0 0 0 0 0 19.6331 0 0 0 0 17.4736 0 16.8516 17.8446 17.7113 17.7148 17.7803 17.5484 17.6331 13.4747 16.1124 0 0 0 0 0 17.7653 17.3661 0 0 0 0 0 0 0 0 17.8203 17.9794 0 0 0 17.6354 0 17.1937 17.2328 0 0 12.0165 12.126 0 0 0 0 0 17.3824 17.3222 0 17.4628 0 17.5718 0 0 17.5702 0 0 0 17.4037 0 0 0 0 12.5385 0 11.1385 17.0445 10.9442 0 0 0 15.0914 0 0 0 16.4942 0 16.6726 16.3661 0 0 0 0 0 0 0 0 0 0 0 13.0002 0 0 0 0 0 0 12.6903 0 0 13.3229 12.9714 9.99308 Q8IVF5 TIAM2_HUMAN "Rho guanine nucleotide exchange factor TIAM2 (SIF and TIAM1-like exchange factor) (T-lymphoma invasion and metastasis-inducing protein 2, TIAM-2)" TIAM2 KIAA2016 STEF Homo sapiens (Human) activation of GTPase activity [GO:0090630]; positive regulation of axonogenesis [GO:0050772]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; synapse [GO:0045202] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; positive regulation of axonogenesis [GO:0050772]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005096; GO:0005829; GO:0007264; GO:0016020; GO:0030027; GO:0030175; GO:0030426; GO:0043204; GO:0045202; GO:0050772; GO:0051056; GO:0070062; GO:0090630 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] AFLDARNPTKQHSSTLESYLIK 0.99052 -21.705 0 16.4336 0 0 0 0 0 0 14.4477 0 0 0 0 0 0 0 0 10.7707 0 12.4968 0 0 0 0 12.3914 0 11.5236 11.6486 0 0 0 0 0 0 0 0 0 0 11.7034 0 0 0 13.3149 0 12.8346 0 0 13.2534 0 10.2614 11.4272 0 0 0 0 0 0 0 0 0 0 10.8506 0 0 0 0 0 0 0 0 0 0 12.5544 13.3741 0 0 0 0 13.2723 14.0782 13.4405 0 0 0 15.5203 13.3147 0 13.8044 0 0 0 12.6834 0 12.9762 12.3017 0 0 0 0 12.2882 0 0 14.0921 14.4316 14.1409 0 0 0 0 14.1548 14.4791 0 0 0 0 0 14.9592 0 0 14.947 15.9997 0 0 14.9737 15.1472 13.7122 12.6078 0 12.9368 12.4078 0 12.7959 0 13.0993 0 0 13.8993 11.9761 14.8459 0 13.8792 0 0 0 12.86 0 15.8078 0 0 0 13.9899 0 0 13.2551 13.0464 13.1291 13.1409 19.3904 10.8872 0 11.1117 0 0 10.6172 0 0 0 12.5802 0 10.757 11.7741 12.4736 11.8285 12.6445 0 0 0 0 0 0 Q96L03 SPT17_HUMAN Spermatogenesis-associated protein 17 SPATA17 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calmodulin binding [GO:0005516] GO:0005516; GO:0005737 calmodulin binding [GO:0005516] AYIRHLNR 0.99052 -21.632 0 0 0 14.0581 0 0 0 0 12.6202 0 0 0 0 0 0 15.0697 12.3813 14.6039 0 0 12.5653 0 11.9629 0 0 0 0 14.5989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9789 0 0 0 0 0 0 0 0 0 0 0 0 15.8412 0 0 0 0 0 0 0 11.8688 0 13.3226 0 0 0 14.6396 0 0 0 0 14.8941 15.0746 0 0 12.4031 0 0 0 0 16.6359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7913 14.4625 0 0 17.7147 0 14.8066 12.4325 0 13.5035 0 0 0 0 0 13.0365 0 0 13.7099 0 0 0 0 14.3832 13.345 0 0 15.2844 0 13.3273 12.9986 13.1653 13.0417 0 0 0 0 13.5914 0 15.5401 0 14.4163 0 0 0 0 0 0 0 16.9049 0 15.4594 14.1853 0 0 0 0 0 0 0 0 14.2277 0 0 13.3277 0 13.2341 0 13.6157 13.3464 12.935 0 0 0 0 0 Q96PL5 ERMAP_HUMAN "Erythroid membrane-associated protein, hERMAP (Radin blood group antigen) (Scianna blood group antigen)" ERMAP RD SC Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0005102; GO:0005794; GO:0005829; GO:0005886; GO:0009897; GO:0016021; GO:0050852 signaling receptor binding [GO:0005102] DGKDQDEDLMPEYK 0.99052 -20.653 0 0 0 0 0 0 0 0 0 0 0 11.5882 10.9334 0 0 0 0 0 13.7992 0 0 10.9397 0 12.1779 0 12.3559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5382 0 0 0 0 0 0 0 0 13.9776 11.643 13.9269 14.7866 14.4831 14.0481 0 14.4148 0 0 0 0 0 0 0 0 13.955 13.6577 0 0 0 0 0 0 0 0 14.3887 13.8672 0 0 14.0221 13.9947 0 13.9278 0 14.1614 0 0 0 0 14.3113 0 0 0 0 14.3891 12.8149 0 0 14.7581 12.8627 13.9011 14.5413 14.089 0 13.9633 0 0 12.1149 14.288 0 0 0 14.4763 14.5076 0 13.9768 13.7612 14.0513 14.1577 14.0276 14.2218 0 0 0 13.6712 14.0467 0 0 0 14.4173 0 11.7489 0 0 0 0 0 0 0 13.2839 0 0 0 0 11.1764 0 0 0 13.7436 12.8225 0 0 0 0 Q9Y3M9 ZN337_HUMAN Zinc finger protein 337 ZNF337 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CAERGQDFSR 0.99052 -21.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9178 13.9851 0 0 12.8057 0 0 0 0 0 0 0 14.9813 0 0 0 12.9318 11.8001 12.8758 12.5302 12.9061 13.2385 12.3281 0 0 13.6494 0 0 13.5384 0 0 13.3451 0 0 0 14.9699 0 14.2437 13.3379 0 11.6965 13.2797 13.9087 12.6856 14.0027 0 14.1877 13.1977 0 12.4171 0 12.6395 0 0 10.7117 0 13.4788 0 14.3433 13.2574 13.9371 0 11.9828 0 0 0 13.464 0 0 15.0723 13.2384 13.4406 0 0 0 0 0 0 13.2958 0 0 15.1594 14.0314 0 0 0 0 0 0 0 0 0 17.0334 0 0 0 0 0 0 0 0 0 14.0435 0 0 0 0 0 O75643 U520_HUMAN "U5 small nuclear ribonucleoprotein 200 kDa helicase, EC 3.6.4.13 (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein, U5-200KD)" SNRNP200 ASCC3L1 HELIC2 KIAA0788 Homo sapiens (Human) "cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]" GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] EIGKHINMDGTINVDDFK 0.99053 -20.266 0 0 0 0 13.3115 0 0 0 0 0 13.121 0 0 0 0 0 13.0731 0 0 0 0 0 14.5224 0 0 0 0 12.8852 0 0 0 0 0 0 0 0 0 0 0 0 10.1443 0 0 0 0 11.7181 0 0 0 0 0 0 0 13.7631 13.6093 10.198 0 0 0 0 0 0 0 0 0 0 0 11.146 0 0 11.6739 0 0 0 0 0 0 0 0 11.4054 0 0 13.3373 0 13.2925 13.3375 15.8424 15.8853 16.6683 15.6471 0 15.5476 18.4126 16.8582 0 0 0 0 0 13.9744 0 14.7488 13.8437 15.5665 0 0 12.1192 13.0041 12.581 0 0 10.8216 0 0 0 13.6108 0 0 0 0 0 0 0 0 0 16.1604 0 0 12.5215 0 10.3237 0 0 0 0 0 15.9706 0 0 11.5992 0 0 0 0 12.857 0 0 13.1061 0 0 0 0 12.1405 0 11.3887 0 0 0 0 0 0 0 0 15.4704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13596 SNX1_HUMAN Sorting nexin-1 SNX1 Homo sapiens (Human) "early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; positive regulation of protein catabolic process [GO:0045732]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; vesicle [GO:0031982]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; positive regulation of protein catabolic process [GO:0045732]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005154; GO:0005158; GO:0005737; GO:0005764; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0010008; GO:0016020; GO:0030027; GO:0030904; GO:0030905; GO:0031623; GO:0031901; GO:0031982; GO:0032991; GO:0034498; GO:0035091; GO:0042147; GO:0042802; GO:0042803; GO:0043231; GO:0045296; GO:0045732; GO:0046982; GO:0072673; GO:1990459; GO:1990460 cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459] DEILEWESR 0.99053 -4.6166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0246 0 0 12.83 0 0 0 0 11.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5783 12.7923 0 0 0 13.0047 13.3955 0 0 0 0 14.087 0 0 0 0 0 13.3691 0 0 0 0 0 0 0 13.5884 0 14.5342 0 0 12.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9328 0 0 12.0276 0 0 0 0 13.1743 13.6271 0 0 13.2748 0 0 0 0 0 13.7821 0 0 0 0 0 0 0 0 0 0 0 14.3525 0 13.5831 0 0 0 13.0659 0 0 0 0 0 0 0 0 0 0 Q76FK4 NOL8_HUMAN Nucleolar protein 8 (Nucleolar protein Nop132) NOL8 C9orf34 NOP132 Homo sapiens (Human) protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364] chromosome [GO:0005694]; nucleolus [GO:0005730] chromosome [GO:0005694]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364] GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:1902570 RNA binding [GO:0003723] DDQGNPQK 0.99053 -21.826 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0713 10.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0121 0 13.9754 0 0 0 0 0 0 12.5562 0 0 0 0 12.8035 13.6451 0 0 0 0 0 0 0 0 0 11.7635 0 0 0 0 0 0 0 11.7179 12.1162 0 0 0 0 12.2614 0 10.3916 0 0 0 0 0 9.63229 14.582 13.583 0 13.4063 0 0 12.847 15.8589 15.5034 0 0 12.9278 0 0 0 0 0 13.3046 12.4381 0 0 0 0 0 0 11.8741 0 14.4445 11.5411 0 0 16.4315 0 11.4971 11.0506 0 0 0 0 0 0 0 12.5599 14.2636 11.3427 0 0 0 0 0 0 0 0 0 0 13.195 0 0 13.3549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9915 0 14.2769 13.4475 10.5209 0 0 0 13.3904 0 0 10.8587 0 0 0 0 0 0 0 0 Q9BTY7 HGH1_HUMAN Protein HGH1 homolog HGH1 C8orf30A C8orf30B FAM203A FAM203B Homo sapiens (Human) AFLLDPDRCVVQRLLPLTQYPDSSVR 0.99053 -20.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8049 0 12.2661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0304 0 0 14.3316 14.881 0 0 0 0 0 0 0 12.6608 0 0 0 0 0 13.807 0 0 0 0 0 0 0 13.5075 0 0 0 0 12.8801 0 0 0 13.2329 0 0 0 0 0 0 0 13.0186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2846 0 0 0 0 0 0 0 0 12.2992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2201 0 0 0 0 0 0 12.765 0 0 0 0 10.2908 Q9H1E3 NUCKS_HUMAN Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1) NUCKS1 NUCKS JC7 Homo sapiens (Human) cellular glucose homeostasis [GO:0001678]; cellular response to X-ray [GO:0071481]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; gene conversion [GO:0035822]; interstrand cross-link repair [GO:0036297]; modulation by host of RNA binding by virus [GO:1990968]; modulation by host of viral genome replication [GO:0044827]; modulation by host of viral RNA-binding transcription factor activity [GO:1990969]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of insulin receptor signaling pathway [GO:0046626]; replication fork processing [GO:0031297] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; cellular glucose homeostasis [GO:0001678]; cellular response to X-ray [GO:0071481]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; gene conversion [GO:0035822]; interstrand cross-link repair [GO:0036297]; modulation by host of RNA binding by virus [GO:1990968]; modulation by host of viral genome replication [GO:0044827]; modulation by host of viral RNA-binding transcription factor activity [GO:1990969]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of insulin receptor signaling pathway [GO:0046626]; replication fork processing [GO:0031297] GO:0000724; GO:0000785; GO:0001678; GO:0003682; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006275; GO:0006325; GO:0031297; GO:0035822; GO:0036297; GO:0043923; GO:0044827; GO:0044829; GO:0045944; GO:0046626; GO:0046628; GO:0060382; GO:0071481; GO:0140297; GO:1990968; GO:1990969 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] DDSHSAEDSEDEK 0.99053 -21.828 0 0 0 0 0 0 0 0 0 11.5954 0 12.9004 0 0 11.1983 13.5948 0 0 0 11.4045 14.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5995 0 0 0 12.0781 11.3393 0 0 13.1987 10.4501 0 0 0 0 0 0 0 0 0 0 9.79586 0 0 0 0 0 0 0 0 0 0 0 11.81 13.4717 13.3651 0 13.263 13.3815 0 0 13.041 14.6916 0 0 0 13.8687 11.9254 12.244 0 14.265 15.763 15.1708 14.244 0 15.8547 0 0 0 15.2603 12.7336 0 0 16.2745 0 14.3233 0 15.9241 0 15.2722 16.1899 0 0 0 11.3397 11.6165 0 13.6397 0 0 12.1389 17.085 13.7092 12.3396 13.4291 14.1936 0 0 10.9438 14.9718 15.1357 0 15.3924 13.9051 0 15.9165 13.882 0 15.1423 0 11.7189 0 0 0 13.5675 15.0023 13.9092 15.1829 12.8405 0 0 11.9125 11.7262 0 12.5352 0 0 0 0 0 13.9151 13.7522 11.5339 0 0 0 0 10.8193 0 11.8059 12.5042 12.8425 0 0 0 0 0 12.5759 0 0 13.7636 13.3232 11.4434 0 0 0 0 Q9NPJ8 NXT2_HUMAN NTF2-related export protein 2 (Protein p15-2) NXT2 BM-025 DC9 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606] cytosol [GO:0005829]; nuclear pore central transport channel [GO:0044613]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; nuclear pore central transport channel [GO:0044613]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606] GO:0005654; GO:0005829; GO:0006606; GO:0006913; GO:0042272; GO:0044613; GO:0048471; GO:0051028 ATSLDFK 0.99053 -20.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1548 11.0571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.536 0 0 12.5595 0 0 0 0 0 0 0 0 0 0 10.6702 0 Q9NZM5 NOP53_HUMAN "Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (Protein interacting with carboxyl terminus 1, PICT-1) (p60)" NOP53 GLT GLTSCR2 PICT1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006364; GO:0006974; GO:0007095; GO:0008097; GO:0014067; GO:0031333; GO:0032435; GO:0032436; GO:0039535; GO:0042802; GO:0042981; GO:0043231; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901796; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723] EVRRAQAR 0.99053 -21.839 0 0 0 0 14.4053 16.0974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4751 18.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3799 18.3329 0 0 0 18.1254 0 18.0954 17.9791 18.0281 18.3161 18.4149 0 19.4124 0 0 0 0 12.533 0 0 0 0 0 13.188 0 0 0 0 19.6841 0 0 18.403 0 0 14.112 0 0 0 0 0 0 0 0 0 0 18.7319 0 0 0 0 0 0 0 0 18.6588 0 0 0 18.3836 18.4875 0 0 0 0 18.412 0 0 0 0 15.1996 0 0 0 0 0 0 0 0 0 0 0 18.7242 18.6953 0 18.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y467 SALL2_HUMAN "Sal-like protein 2 (Zinc finger protein 795) (Zinc finger protein SALL2) (Zinc finger protein Spalt-2, Sal-2, hSal2)" SALL2 KIAA0360 SAL2 ZNF795 Homo sapiens (Human) eye development [GO:0001654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; eye development [GO:0001654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0005634; GO:0006357; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AVEPKNK 0.99053 -20.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7646 0 0 0 0 0 0 0 0 0 0 0 0 15.4035 0 14.7244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60826 CCD22_HUMAN Coiled-coil domain-containing protein 22 CCDC22 CXorf37 JM1 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; cullin family protein binding [GO:0097602]; cellular copper ion homeostasis [GO:0006878]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031] GO:0005654; GO:0005768; GO:0005829; GO:0006878; GO:0006893; GO:0007253; GO:0015031; GO:0032456; GO:0043123; GO:0043124; GO:0097602; GO:2000060 cullin family protein binding [GO:0097602] AQRQRLQK 0.99054 -4.622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8446 0 0 0 11.4674 0 0 0 0 0 0 17.2516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7557 0 0 0 0 0 0 0 0 0 0 P57737 CORO7_HUMAN "Coronin-7, Crn7 (70 kDa WD repeat tumor rejection antigen homolog)" CORO7 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; positive regulation of hippo signaling [GO:0035332]; protein transport [GO:0015031] GO:0000139; GO:0003779; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0007015; GO:0007030; GO:0015031; GO:0016020; GO:0016021; GO:0016477; GO:0030010; GO:0030041; GO:0031410; GO:0035332; GO:0051015 actin binding [GO:0003779]; actin filament binding [GO:0051015] ASQSTQAHENSRDSR 0.99054 -19.257 0 0 0 0 0 0 0 0 0 13.753 0 0 0 15.0838 0 14.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.858 0 0 14.186 0 0 0 0 0 14.6459 0 0 13.0075 0 11.5822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0388 0 0 0 0 15.0915 0 0 0 0 13.3725 13.3749 0 0 0 13.5164 14.6473 0 0 0 0 0 12.8335 0 12.5786 0 0 0 0 0 12.857 12.9035 13.0986 11.5703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5651 0 0 0 0 13.3693 0 0 0 13.9648 0 13.3547 10.228 14.7932 0 0 0 0 15.1516 0 0 0 0 0 14.2843 0 15.6091 0 0 0 0 0 0 10.9437 0 0 13.6873 0 0 0 0 14.592 0 0 0 0 Q08AH1 ACSM1_HUMAN "Acyl-coenzyme A synthetase ACSM1, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 1) (Benzoate--CoA ligase, EC 6.2.1.25) (Butyrate--CoA ligase 1) (Butyryl-coenzyme A synthetase 1) (Lipoate-activating enzyme) (Middle-chain acyl-CoA synthetase 1) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-B)" ACSM1 BUCS1 LAE MACS1 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; benzoate metabolic process [GO:0018874]; butyrate metabolic process [GO:0019605]; cholesterol homeostasis [GO:0042632]; energy derivation by oxidation of organic compounds [GO:0015980]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; xenobiotic metabolic process [GO:0006805] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; long-chain fatty acid-CoA ligase activity [GO:0004467]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; benzoate metabolic process [GO:0018874]; butyrate metabolic process [GO:0019605]; cholesterol homeostasis [GO:0042632]; energy derivation by oxidation of organic compounds [GO:0015980]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; xenobiotic metabolic process [GO:0006805] GO:0004321; GO:0004467; GO:0005524; GO:0005525; GO:0005759; GO:0006633; GO:0006637; GO:0006805; GO:0015645; GO:0015980; GO:0016405; GO:0018858; GO:0018874; GO:0019395; GO:0019605; GO:0042632; GO:0046872; GO:0047760; GO:0070062; GO:0072562; GO:0102391 ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; GTP binding [GO:0005525]; long-chain fatty acid-CoA ligase activity [GO:0004467]; metal ion binding [GO:0046872] DILYRLQLSKAK 0.99054 -20.897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4226 0 0 0 0 0 0 0 0 0 0 13.3469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0241 0 10.4101 0 13.577 0 0 0 0 12.6618 0 0 0 0 14.6178 0 0 14.6527 0 13.3207 13.7196 14.5323 0 0 0 17.046 16.5862 0 0 13.5184 16.104 15.9181 0 16.7337 12.9038 0 0 13.8007 13.4298 14.3507 0 13.1239 13.5207 0 0 0 10.9236 12.9731 15.3835 15.5362 0 16.3551 16.1364 16.1847 16.4108 15.8077 15.9827 0 15.4025 0 15.0798 14.7728 0 0 0 14.4344 13.0429 15.2056 0 13.4735 12.7562 14.3991 14.8137 0 0 12.6151 0 0 0 0 13.2258 13.7199 0 0 13.1135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.185 12.978 0 0 0 0 Q6IC98 GRAM4_HUMAN GRAM domain-containing protein 4 (Death-inducing protein) GRAMD4 DIP KIAA0767 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] GO:0005739; GO:0005789; GO:0006915; GO:0016021; GO:0031966; GO:0034164; GO:0043280 EETNAEMLRQELDR 0.99054 -20.854 0 0 0 10.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4785 0 0 0 0 0 0 0 0 0 12.8412 0 0 0 0 12.7625 0 0 14.273 0 0 0 0 12.942 0 12.3562 14.4546 0 0 0 0 12.8756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9479 14.1796 0 0 0 0 13.2851 0 0 0 0 13.4067 14.2388 0 0 13.5388 0 0 12.9872 0 0 0 0 0 0 0 0 0 0 0 13.2513 0 14.4649 0 0 0 14.1908 0 0 0 0 0 0 0 0 13.5636 0 0 0 14.0606 0 0 0 0 0 11.2714 Q92664 TF3A_HUMAN "Transcription factor IIIA, TFIIIA" GTF3A Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383] GO:0003677; GO:0005634; GO:0005654; GO:0006383; GO:0008097; GO:0009303; GO:0042273; GO:0046872 5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] AFIRDYHLSRHILTHTGEK 0.99054 -4.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6209 0 0 10.9742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9752 0 0 0 0 0 0 0 10.6688 0 0 0 0 0 0 0 0 0 13.3782 0 0 11.6127 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0C4 SEM4C_HUMAN Semaphorin-4C SEMA4C KIAA1739 SEMAI UNQ5855/PRO34487 Homo sapiens (Human) axon guidance [GO:0007411]; cell migration in hindbrain [GO:0021535]; cerebellum development [GO:0021549]; muscle cell differentiation [GO:0042692]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of cell migration [GO:0030335]; positive regulation of stress-activated MAPK cascade [GO:0032874]; semaphorin-plexin signaling pathway [GO:0071526] anchoring junction [GO:0070161]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; cell migration in hindbrain [GO:0021535]; cerebellum development [GO:0021549]; muscle cell differentiation [GO:0042692]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of cell migration [GO:0030335]; positive regulation of stress-activated MAPK cascade [GO:0032874]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0001843; GO:0005615; GO:0005887; GO:0007411; GO:0014069; GO:0021535; GO:0021549; GO:0030215; GO:0030335; GO:0030672; GO:0032874; GO:0042692; GO:0045499; GO:0048843; GO:0050919; GO:0070161; GO:0071526; GO:0098839 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] APLENLGLVWLAVVALGAVCLVLLLLVLSLR 0.99054 -20.813 0 0 0 0 10.1021 0 12.2777 0 13.5118 12.9592 0 14.6262 13.3662 0 0 0 12.1325 0 0 0 0 0 0 12.7209 9.8765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9298 0 0 0 0 0 0 0 0 0 0 0 11.0043 0 0 0 0 0 0 0 0 0 0 0 12.0753 13.7253 13.2796 0 0 0 0 0 0 0 0 0 13.7722 0 0 0 15.4735 14.7848 16.0701 14.2577 13.9081 14.7265 16.734 14.7804 0 16.2325 0 15.7476 16.1445 14.1621 16.4391 16.2032 13.6026 15.443 14.93 14.3024 14.6753 0 15.8044 15.6489 0 14.7711 13.9682 11.5701 14.0924 0 13.0869 15.5636 16.0072 0 13.608 0 0 12.7248 0 15.0405 0 13.3691 15.2737 0 0 13.5467 0 12.0507 0 13.013 11.4975 13.3947 0 14.5757 13.4569 14.4647 0 13.4177 13.3849 14.8595 13.6912 12.5265 13.7898 13.5819 0 12.8353 13.9189 14.0716 0 0 14.457 0 0 13.0678 14.7299 0 0 0 12.76 0 0 0 13.962 0 0 0 14.8734 0 0 15.1095 13.9429 13.5832 10.7909 11.6205 0 12.4585 0 0 Q6ICB4 SESQ2_HUMAN "Sesquipedalian-2, Ses2 (27 kDa inositol polyphosphate phosphatase interacting protein B, IPIP27B) (PH domain-containing endocytic trafficking adaptor 2)" PHETA2 FAM109B Homo sapiens (Human) "endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]" clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] "clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; protein homodimerization activity [GO:0042803]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037 protein homodimerization activity [GO:0042803] CEEQDRP 0.99055 -20.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0149 0 0 0 0 0 0 Q7L311 ARMX2_HUMAN "Armadillo repeat-containing X-linked protein 2 (ARM protein lost in epithelial cancers on chromosome X 2, Protein ALEX2)" ARMCX2 ALEX2 KIAA0512 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] GO:0005739; GO:0005741; GO:0016021 KVLALLQK 0.99055 -20.479 0 0 0 0 0 11.8884 0 0 10.8316 0 16.6104 16.6938 0 0 0 0 0 0 0 0 0 0 9.31951 0 0 0 0 0 0 0 0 0 0 0 16.1287 0 0 0 16.1266 15.9557 0 0 13.3588 0 0 0 0 15.9804 0 0 15.9709 0 0 0 15.8043 0 0 0 0 0 0 0 0 0 0 15.009 0 0 10.3756 0 0 14.2347 0 0 0 0 0 0 0 0 12.4484 0 0 0 0 13.0262 12.8444 14.5732 0 0 0 0 14.1657 0 0 0 0 0 0 0 0 15.3678 0 13.7385 12.7471 0 0 0 13.2205 0 0 10.4075 15.415 0 0 0 0 0 0 0 0 13.9259 0 12.0686 0 0 0 13.1306 0 0 0 0 0 14.8215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4135 0 0 11.0456 0 0 14.4116 0 0 0 17.3215 17.1115 0 0 0 0 17.0614 0 0 0 17.112 0 0 0 0 0 0 13.4426 0 16.8946 0 0 Q8N4M1 CTL3_HUMAN Choline transporter-like protein 3 (Solute carrier family 44 member 3) SLC44A3 CTL3 UNQ558/PRO1115 Homo sapiens (Human) phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085] GO:0005886; GO:0006656; GO:0015220; GO:0016020; GO:0016021; GO:0022857; GO:0055085 choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857] CVLGFAIVSTGITAVLLVLIFVLRK 0.99055 -20.475 0 12.0965 0 0 0 12.2061 11.9747 0 0 0 0 0 0 0 0 0 0 0 0 12.4658 0 0 0 0 0 0 0 0 13.8021 0 0 0 0 12.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9635 0 0 0 0 0 0 12.7623 0 0 0 0 0 0 0 0 0 0 14.0232 0 11.7599 0 0 0 0 0 0 0 0 0 0 0 0 13.6833 14.1359 0 0 0 0 0 13.3127 0 0 0 14.2472 0 0 0 0 0 13.0579 0 0 0 0 0 12.6196 0 0 0 0 0 13.4511 0 0 14.2928 0 0 0 0 0 13.0018 10.752 13.0511 0 0 0 0 0 0 13.8681 0 0 0 13.9655 0 13.5846 0 15.3611 0 13.4608 14.0481 0 13.1538 14.4427 13.2586 13.3652 0 0 0 11.1517 0 0 0 14.9031 0 0 0 0 0 0 0 0 0 0 0 11.8059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1197 Q9BS91 S35A5_HUMAN Probable UDP-sugar transporter protein SLC35A5 (Solute carrier family 35 member A5) SLC35A5 UNQ164/PRO190 Homo sapiens (Human) carbohydrate transport [GO:0008643] integral component of Golgi membrane [GO:0030173] integral component of Golgi membrane [GO:0030173]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; carbohydrate transport [GO:0008643] GO:0008643; GO:0015165; GO:0030173 pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165] DHQSRNLK 0.99055 -5.9806 0 0 0 0 0 0 0 0 10.4995 0 0 0 0 0 0 0 0 0 0 0 10.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7959 0 0 0 0 0 0 0 0 0 0 11.9773 0 10.514 0 0 0 0 0 13.2588 11.2681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00458 IFRD1_HUMAN Interferon-related developmental regulator 1 (Nerve growth factor-inducible protein PC4) IFRD1 Homo sapiens (Human) muscle cell differentiation [GO:0042692]; myoblast fate determination [GO:0007518]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706] nucleus [GO:0005634]; sarcoplasm [GO:0016528] nucleus [GO:0005634]; sarcoplasm [GO:0016528]; muscle cell differentiation [GO:0042692]; myoblast fate determination [GO:0007518]; negative regulation of axon extension [GO:0030517]; negative regulation of collateral sprouting [GO:0048671]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle tissue development [GO:0014706] GO:0005634; GO:0007518; GO:0014706; GO:0016528; GO:0030517; GO:0042692; GO:0043403; GO:0048671 HRAKVDK 0.99056 -20.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15516 CLOCK_HUMAN "Circadian locomoter output cycles protein kaput, hCLOCK, EC 2.3.1.48 (Class E basic helix-loop-helix protein 8, bHLHe8)" CLOCK BHLHE8 KIAA0334 Homo sapiens (Human) "cellular response to ionizing radiation [GO:0071479]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage checkpoint signaling [GO:0000077]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of transcription, DNA-templated [GO:0045892]; photoperiodism [GO:0009648]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein acetylation [GO:0006473]; regulation of circadian rhythm [GO:0042752]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]" chromatin [GO:0000785]; chromatoid body [GO:0033391]; chromosome [GO:0005694]; CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; chromatoid body [GO:0033391]; chromosome [GO:0005694]; CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone acetyltransferase activity [GO:0004402]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to ionizing radiation [GO:0071479]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage checkpoint signaling [GO:0000077]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of transcription, DNA-templated [GO:0045892]; photoperiodism [GO:0009648]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein acetylation [GO:0006473]; regulation of circadian rhythm [GO:0042752]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]" GO:0000077; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005829; GO:0006355; GO:0006357; GO:0006473; GO:0007165; GO:0007283; GO:0007623; GO:0009648; GO:0031490; GO:0032922; GO:0033391; GO:0042634; GO:0042752; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050729; GO:0050796; GO:0051092; GO:0051775; GO:0070888; GO:0071479; GO:1990513; GO:1990837; GO:2000074; GO:2000323 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone acetyltransferase activity [GO:0004402]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" GQQWIWLQTHYYITYHQWNSR 0.99056 -1.7911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8373 0 0 0 0 0 0 0 0 0 12.8868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8563 0 0 0 0 0 0 0 0 0 0 0 0 12.5255 0 13.2835 0 0 12.407 0 12.1189 11.5751 0 0 12.1058 12.2196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1799 0 0 11.4222 0 0 0 13.6789 P01286 SLIB_HUMAN "Somatoliberin (Growth hormone-releasing factor, GRF) (Growth hormone-releasing hormone, GHRH) (Somatocrinin) (Somatorelin) (Sermorelin)" GHRH GHRF Homo sapiens (Human) "adenohypophysis development [GO:0021984]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; growth hormone secretion [GO:0030252]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, REM sleep [GO:0046005]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; response to food [GO:0032094]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; terminal bouton [GO:0043195] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; terminal bouton [GO:0043195]; growth hormone-releasing hormone activity [GO:0016608]; growth hormone-releasing hormone receptor binding [GO:0031770]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]; adenohypophysis development [GO:0021984]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; growth hormone secretion [GO:0030252]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, REM sleep [GO:0046005]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; response to food [GO:0032094]" GO:0005184; GO:0005576; GO:0005615; GO:0007189; GO:0007267; GO:0008284; GO:0016608; GO:0021984; GO:0030252; GO:0031770; GO:0032094; GO:0040018; GO:0043195; GO:0043204; GO:0043568; GO:0046005; GO:0051428; GO:0060124 growth hormone-releasing hormone activity [GO:0016608]; growth hormone-releasing hormone receptor binding [GO:0031770]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428] KVLGQLSAR 0.99056 -5.987 0 0 0 0 0 0 0 0 0 0 11.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6009 0 13.4685 14.733 0 0 0 0 0 0 0 0 16.6382 0 0 16.6577 0 0 0 0 0 0 0 0 0 15.3723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7569 0 0 0 0 0 0 0 0 0 0 0 0 Q92613 JADE3_HUMAN Protein Jade-3 (Jade family PHD finger protein 3) (PHD finger protein 16) JADE3 KIAA0215 PHF16 Homo sapiens (Human) histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654] histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000123; GO:0005654; GO:0006275; GO:0006357; GO:0016570; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0051726; GO:2000278 metal ion binding [GO:0046872] IIAEKVKDVLFIR 0.99056 -20.537 0 16.0315 0 12.7751 0 0 0 13.1008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93074 MED12_HUMAN "Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component, ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component, Trap230) (Trinucleotide repeat-containing gene 11 protein)" MED12 ARC240 CAGH45 HOPA KIAA0192 TNRC11 TRAP230 Homo sapiens (Human) "axis elongation involved in somitogenesis [GO:0090245]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; oligodendrocyte development [GO:0014003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; Schwann cell development [GO:0014044]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; axis elongation involved in somitogenesis [GO:0090245]; embryonic brain development [GO:1990403]; embryonic neurocranium morphogenesis [GO:0048702]; endoderm development [GO:0007492]; heart development [GO:0007507]; neural tube closure [GO:0001843]; oligodendrocyte development [GO:0014003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; Schwann cell development [GO:0014044]; somatic stem cell population maintenance [GO:0035019]; spinal cord development [GO:0021510]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0000151; GO:0000978; GO:0001843; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0007492; GO:0007507; GO:0008013; GO:0008022; GO:0014003; GO:0014044; GO:0016020; GO:0016592; GO:0019904; GO:0021510; GO:0030374; GO:0035019; GO:0036342; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0048702; GO:0060071; GO:0060261; GO:0061630; GO:0090245; GO:1990403 beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] AMVVAKLLEK 0.99056 -20.167 0 0 0 0 9.98556 0 0 0 14.1124 10.18 16.5471 0 0 11.8754 14.0837 0 0 0 0 14.0527 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3167 17.152 13.327 0 12.9796 0 13.5281 13.0439 0 0 0 13.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.877 12.7054 0 12.4172 12.6534 0 12.4324 12.8219 12.9257 0 0 0 12.8632 13.4488 0 0 16.7415 0 15.0037 16.9125 16.735 15.2457 16.4336 16.7247 0 0 16.6962 0 14.0751 14.6945 16.5305 0 0 14.9486 14.2214 13.7938 13.8735 0 13.5516 0 0 11.5212 13.5937 14.9235 10.3679 0 15.2322 14.2365 12.6297 0 13.3302 14.9096 0 15.7844 13.8936 13.8017 10.9661 13.0654 14.4221 0 0 12.4338 0 0 13.2236 0 0 14.0832 13.3585 0 0 15.0182 14.3149 0 0 0 0 0 13.5064 0 14.5198 0 0 0 12.4209 14.2715 0 12.6556 0 0 0 0 0 0 0 0 0 0 13.1789 0 0 0 0 14.2133 14.3531 0 13.3365 0 12.476 12.5218 0 0 0 14.3113 Q969J2 ZKSC4_HUMAN Zinc finger protein with KRAB and SCAN domains 4 (P373c6.1) (Zinc finger protein 307) (Zinc finger protein 427) ZKSCAN4 ZNF307 ZNF427 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRRNSHLLR 0.99056 -20.587 0 0 0 0 0 0 0 0 0 0 0 10.3939 0 0 0 12.6683 0 0 0 0 12.1982 0 0 0 0 0 0 12.6172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5346 0 0 10.0573 0 11.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5663 0 0 0 0 0 0 0 0 14.0083 13.7197 0 0 0 13.8315 15.3058 14.2426 14.3213 0 0 14.6681 0 0 0 14.055 12.9435 0 0 11.1109 0 0 0 0 0 11.3315 0 13.3368 0 13.2114 13.1702 13.8615 0 0 13.4019 13.3209 0 0 0 0 0 0 0 13.0899 0 0 0 0 0 11.4488 0 0 0 0 0 0 11.2067 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6059 0 0 0 0 Q99558 M3K14_HUMAN "Mitogen-activated protein kinase kinase kinase 14, EC 2.7.11.25 (NF-kappa-beta-inducing kinase, HsNIK) (Serine/threonine-protein kinase NIK)" MAP3K14 NIK Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; MAPK cascade [GO:0000165]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; MAPK cascade [GO:0000165]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein phosphorylation [GO:0006468] GO:0000165; GO:0001650; GO:0004672; GO:0004674; GO:0004704; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0007249; GO:0038061; GO:0043123; GO:0043231; GO:0051607; GO:0071260; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] IFIAGSK 0.99056 -20.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0349 0 15.751 13.0422 0 0 12.8011 13.309 12.9467 12.571 0 0 0 13.2191 0 0 0 0 0 0 13.4098 0 0 0 0 0 0 13.9291 0 0 13.7275 0 0 13.2316 0 0 0 0 0 0 0 0 0 0 15.1133 0 13.3115 14.5264 13.4846 0 0 0 0 12.8469 0 0 0 0 0 0 0 0 12.9181 13.3269 0 0 0 13.6911 0 13.1239 13.6683 0 0 11.12 10.7334 0 11.077 0 0 0 0 0 0 13.901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4245 0 0 0 0 0 0 13.2685 12.1185 0 0 0 0 0 B4DU55 ZN879_HUMAN Zinc finger protein 879 ZNF879 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSQSSALIQHQRIHTGEKPYK 0.99057 -5.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4479 0 0 12.4731 0 0 0 0 0 11.9705 0 13.7128 0 0 0 0 0 0 0 0 0 0 13.8626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4135 12.6656 0 13.429 0 0 0 13.5422 0 0 0 0 0 0 0 12.7088 0 0 0 13.2322 0 0 15.8599 0 12.8722 0 13.6466 13.3654 0 13.3144 0 0 0 0 0 0 0 0 0 0 12.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.82 0 0 0 0 12.9535 0 0 0 12.9648 0 0 0 0 0 12.5188 0 0 14.1173 0 12.7867 0 11.702 0 0 0 0 0 0 0 0 0 0 0 0 11.2085 15.0439 0 0 0 0 0 0 0 14.6605 0 11.3241 0 15.1178 O43497 CAC1G_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1) CACNA1G KIAA1123 Homo sapiens (Human) AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; sinoatrial node development [GO:0003163] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; voltage-gated sodium channel activity [GO:0005248]; AV node cell action potential [GO:0086016]; AV node cell to bundle of His cell signaling [GO:0086027]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; cardiac muscle cell action potential involved in contraction [GO:0086002]; chemical synaptic transmission [GO:0007268]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during SA node cell action potential [GO:0086046]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to nickel cation [GO:0010045]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; sinoatrial node development [GO:0003163] GO:0001518; GO:0003163; GO:0005248; GO:0005737; GO:0005886; GO:0005891; GO:0007268; GO:0008332; GO:0010045; GO:0019228; GO:0034765; GO:0042391; GO:0043005; GO:0045202; GO:0045956; GO:0060371; GO:0070509; GO:0070588; GO:0086002; GO:0086010; GO:0086015; GO:0086016; GO:0086018; GO:0086027; GO:0086045; GO:0086046; GO:0086056; GO:0086059; GO:0086091; GO:0097110 low voltage-gated calcium channel activity [GO:0008332]; scaffold protein binding [GO:0097110]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; voltage-gated sodium channel activity [GO:0005248] ARLPACCLER 0.99057 -21.189 0 0 0 0 0 0 0 0 11.8844 0 0 0 0 12.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6814 13.2268 14.0753 12.6614 0 0 0 0 0 10.7805 0 0 0 12.713 0 11.3382 0 0 0 0 0 0 0 0 12.3259 0 0 11.8165 12.2561 11.8486 11.8916 12.1911 12.4224 12.7983 0 0 18.3971 18.3903 0 18.1018 18.1468 17.0794 10.8919 0 13.3589 10.3619 15.4972 0 0 19.023 0 0 0 14.2056 16.34 12.0508 0 12.9837 18.8863 0 18.8376 0 14.9093 13.1267 15.0482 0 0 0 0 0 0 12.8437 13.3945 13.4128 0 0 13.0474 12.3167 0 0 0 14.0637 0 18.8774 0 18.6965 19.1663 18.8041 12.7688 13.0411 0 14.6492 14.6332 14.5888 0 12.244 12.1528 13.5494 14.0107 0 14.3173 15.3296 0 0 12.2396 11.6425 0 13.0005 0 0 0 9.89303 13.8345 0 15.5796 0 14.4912 0 13.1743 11.3992 0 0 0 0 13.8129 0 0 0 0 0 0 0 13.7273 13.1472 0 13.0427 0 0 0 0 0 0 0 13.0364 14.604 12.8781 0 0 11.3881 P21439 MDR3_HUMAN "Phosphatidylcholine translocator ABCB4, EC 7.6.2.1 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (P-glycoprotein 3)" ABCB4 MDR3 PGY3 Homo sapiens (Human) bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557]; transmembrane transport [GO:0055085] GO:0005524; GO:0005548; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0006629; GO:0015629; GO:0016020; GO:0016021; GO:0016324; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0042910; GO:0045121; GO:0045332; GO:0046581; GO:0055085; GO:0055088; GO:0061092; GO:0070062; GO:0090554; GO:0090555; GO:0140359; GO:1901557; GO:1903413; GO:2001140 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; phospholipid transporter activity [GO:0005548]; xenobiotic transmembrane transporter activity [GO:0042910] AGEILTRRLR 0.99057 -21.166 0 0 0 0 14.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2452 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6308 14.6438 0 0 0 0 0 0 0 0 14.9224 0 14.4856 0 0 0 0 13.4312 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8372 0 0 0 0 0 0 0 0 0 0 0 0 P53420 CO4A4_HUMAN Collagen alpha-4(IV) chain COL4A4 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836] GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0032836; GO:0062023 extracellular matrix structural constituent [GO:0005201] DCSVCHCVPEK 0.99057 -21.623 0 0 0 0 0 0 0 9.86555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4501 15.3365 0 13.6218 14.8197 0 0 0 0 12.8092 0 0 0 10.0444 0 0 0 13.4049 13.3677 13.3585 0 14.7871 11.4638 10.3474 0 0 0 14.4982 0 0 0 0 13.1035 0 0 0 13.695 14.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0845 0 0 0 0 0 0 0 0 0 0 11.0012 0 0 0 0 0 0 0 0 11.2667 10.6971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1424 0 11.9192 Q008S8 ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like (Lung-specific F-box and DH domain-containing protein) (Putative guanine nucleotide exchange factor LFDH) ECT2L C6orf91 LFDH Homo sapiens (Human) cellular anatomical entity [GO:0110165] cellular anatomical entity [GO:0110165]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0110165 guanyl-nucleotide exchange factor activity [GO:0005085] ARVVRELLQSER 0.99057 -19.812 0 0 0 0 0 0 0 0 12.9253 13.471 13.2805 13.532 0 13.9432 13.4831 13.3759 0 0 0 0 0 0 0 0 0 0 0 0 12.408 0 13.5419 12.4304 0 13.7837 12.6249 13.1104 13.1114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3336 0 0 0 0 0 0 0 0 0 0 0 0 15.5494 0 0 0 0 13.1803 0 0 12.9771 13.4263 0 0 0 14.3469 14.6703 0 0 0 0 0 0 0 14.4254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9524 0 16.9386 16.1093 15.9144 13.4776 0 0 15.897 0 0 0 12.6726 15.8658 0 0 0 0 0 0 0 0 0 Q14738 2A5D_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta) PPP2R5D Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] GO:0000159; GO:0004721; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0007165; GO:0007399; GO:0019888; GO:0035307; GO:0072542 phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] ELQKLPALK 0.99057 -21.69 0 0 11.0296 0 0 0 0 0 0 0 0 0 0 0 0 11.5782 0 12.106 0 0 0 0 0 0 0 0 0 0 0 0 13.1978 0 0 0 0 0 0 0 17.1993 0 0 0 0 0 0 12.0218 0 0 0 0 12.3884 0 0 0 12.9583 0 0 0 0 0 11.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2329 0 0 0 0 0 0 0 0 13.2589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1316 0 0 0 0 0 0 0 13.9491 0 0 0 14.4662 0 0 0 0 11.7366 0 13.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4212 0 0 0 0 0 0 0 0 0 13.9732 0 0 11.2052 0 0 0 0 11.7713 Q6QNY1 BL1S2_HUMAN "Biogenesis of lysosome-related organelles complex 1 subunit 2, BLOC-1 subunit 2 (Centrosome-associated protein)" BLOC1S2 BLOS2 CEAP Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; microtubule nucleation [GO:0007020]; mitochondrial outer membrane permeabilization [GO:0097345]; neuron projection development [GO:0031175]; organelle transport along microtubule [GO:0072384]; platelet dense granule organization [GO:0060155]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]" axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; centrosome [GO:0005813]; cytoplasmic side of lysosomal membrane [GO:0098574]; gamma-tubulin complex [GO:0000930]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; centrosome [GO:0005813]; cytoplasmic side of lysosomal membrane [GO:0098574]; gamma-tubulin complex [GO:0000930]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; gamma-tubulin binding [GO:0043015]; protein C-terminus binding [GO:0008022]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; microtubule nucleation [GO:0007020]; mitochondrial outer membrane permeabilization [GO:0097345]; neuron projection development [GO:0031175]; organelle transport along microtubule [GO:0072384]; platelet dense granule organization [GO:0060155]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196]" GO:0000930; GO:0005634; GO:0005739; GO:0005813; GO:0007020; GO:0008022; GO:0008089; GO:0008284; GO:0008625; GO:0016197; GO:0031083; GO:0031175; GO:0032418; GO:0032438; GO:0043015; GO:0045893; GO:0048490; GO:0051036; GO:0060155; GO:0062196; GO:0072384; GO:0097345; GO:0098574; GO:0099078; GO:1904115 gamma-tubulin binding [GO:0043015]; protein C-terminus binding [GO:0008022] KLEAKYK 0.99057 -4.8105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3491 13.6526 0 14.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2065 13.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L5N7 PCAT2_HUMAN "Lysophosphatidylcholine acyltransferase 2, LPC acyltransferase 2, LPCAT-2, LysoPC acyltransferase 2, EC 2.3.1.23 (1-acylglycerol-3-phosphate O-acyltransferase 11, 1-AGP acyltransferase 11, 1-AGPAT 11, EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase, EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase, EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase, Acetyl-CoA:lyso-PAF acetyltransferase, Lyso-PAF acetyltransferase, LysoPAFAT) (Acyltransferase-like 1) (Lysophosphatidic acid acyltransferase alpha, LPAAT-alpha)" LPCAT2 AGPAT11 AYTL1 Homo sapiens (Human) membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200]; membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663] GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016021; GO:0036151; GO:0047144; GO:0047159; GO:0047184; GO:0047192; GO:0050200; GO:0061024 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200] KITQTALKFLGR 0.99057 -4.8087 0 0 0 0 11.2155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5699 12.3404 0 0 0 0 0 0 0 9.607 0 12.2873 0 0 0 0 0 13.2218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.656 12.9883 0 0 13.4824 0 0 13.0184 0 0 13.2322 0 0 0 0 0 14.553 0 0 0 0 0 12.1083 0 0 0 12.9048 0 0 13.2243 0 0 0 0 0 0 12.9918 13.6416 14.7037 13.0867 0 0 0 0 0 0 0 0 14.6104 0 13.5828 0 13.1286 13.1035 0 14.7755 0 0 0 0 0 0 13.5983 0 14.8386 0 13.6617 0 10.7775 0 0 0 0 10.4736 0 0 0 11.3058 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VE0 MYPOP_HUMAN "Myb-related transcription factor, partner of profilin (Myb-related protein p42POP) (Partner of profilin)" MYPOP P42POP Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0042802 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ELAGTLRQGLAK 0.99057 -21.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2423 0 0 0 13.4413 0 0 0 0 0 0 0 13.4526 0 14.255 0 0 0 0 0 0 13.73 0 0 0 0 13.618 0 13.7271 0 0 12.9265 0 0 12.9881 0 0 15.3938 0 15.2943 10.5005 0 0 0 0 0 0 0 0 14.5832 0 0 0 14.0975 0 15.5394 0 0 0 0 0 0 0 13.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0862 15.0285 0 0 0 0 0 0 Q8WWK9 CKAP2_HUMAN Cytoskeleton-associated protein 2 (CTCL tumor antigen se20-10) (Tumor- and microtubule-associated protein) CKAP2 LB1 TMAP Homo sapiens (Human) apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000281; GO:0000922; GO:0005737; GO:0005813; GO:0005874; GO:0006915; GO:0007026; GO:0015630; GO:0045944; GO:0072686 DPTHDVK 0.99057 -21.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1615 11.0273 11.4306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3651 0 0 0 0 0 0 0 0 0 0 0 14.6339 0 0 0 14.091 11.3138 0 0 0 13.3098 14.113 12.3914 0 0 0 0 0 0 0 0 0 0 12.4676 0 13.908 0 0 0 0 14.5748 15.3408 0 12.7525 12.3488 0 0 0 0 0 14.9997 0 12.3755 14.6227 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0157 0 0 0 0 12.1819 13.0489 0 0 0 0 0 0 0 14.2008 14.471 0 0 0 0 0 0 0 13.511 0 0 0 13.7077 0 0 0 0 0 0 0 0 0 Q99547 MPH6_HUMAN M-phase phosphoprotein 6 MPHOSPH6 MPP6 Homo sapiens (Human) maturation of 5.8S rRNA [GO:0000460] cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460] GO:0000178; GO:0000460; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829 RNA binding [GO:0003723] AKKMFLK 0.99057 -21.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0129 0 0 0 0 12.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7327 14.1852 14.1367 14.146 0 0 0 0 0 0 0 0 0 0 14.0341 0 0 14.1538 0 14.1124 13.9809 14.0581 0 0 13.8348 0 0 0 0 0 14.3299 0 0 13.585 14.1749 13.4102 0 14.0066 0 14.1369 12.5072 13.6872 13.5722 12.9593 13.9094 14.1924 13.4666 0 14.3922 13.1055 0 0 0 13.9576 0 0 0 14.003 14.0866 0 13.9311 0 13.5902 0 13.6357 0 0 0 13.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5942 0 0 0 0 0 Q9BPZ7 SIN1_HUMAN "Target of rapamycin complex 2 subunit MAPKAP1, TORC2 subunit MAPKAP1 (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1, SAPK-interacting protein 1, mSIN1)" MAPKAP1 MIP1 SIN1 Homo sapiens (Human) cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Ras protein signal transduction [GO:0046580]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932] "cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Ras protein signal transduction [GO:0046580]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203]" GO:0005546; GO:0005547; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007010; GO:0016310; GO:0019901; GO:0021762; GO:0030307; GO:0031267; GO:0031410; GO:0031669; GO:0031932; GO:0033138; GO:0038203; GO:0043066; GO:0043325; GO:0046580; GO:0070300; GO:0080025; GO:1900407 "phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]" EILLKAVKR 0.99057 -5.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYT8 NEUL_HUMAN "Neurolysin, mitochondrial, EC 3.4.24.16 (Angiotensin-binding protein) (Microsomal endopeptidase, MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase)" NLN AGTBP KIAA1226 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; regulation of gluconeogenesis [GO:0006111]; regulation of skeletal muscle fiber differentiation [GO:1902809] extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; mitochondrial intermembrane space [GO:0005758]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; regulation of gluconeogenesis [GO:0006111]; regulation of skeletal muscle fiber differentiation [GO:1902809] GO:0004222; GO:0005576; GO:0005758; GO:0005886; GO:0006111; GO:0006508; GO:0006518; GO:0007186; GO:0042277; GO:0046872; GO:1902809 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277] CCIPETRRR 0.99057 -5.8594 0 0 0 0 13.3404 0 13.6778 0 0 0 13.1412 0 0 0 0 0 10.2715 0 0 0 0 12.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1817 0 0 13.2985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8936 13.8644 0 0 0 0 0 0 0 0 0 12.0791 16.5145 13.747 0 11.842 17.4679 0 0 0 11.592 17.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0211 0 0 0 0 0 0 15.4535 0 15.0659 0 0 0 0 0 0 0 0 0 14.3357 0 0 0 0 0 0 0 14.2127 0 0 13.2502 0 0 0 14.6454 15.723 16.3492 0 15.0275 0 15.4969 14.6734 0 0 0 0 0 0 17.0039 0 0 14.5474 14.8274 0 0 0 0 15.2007 15.6454 15.1089 14.6772 0 14.6194 0 0 0 0 0 0 13.3288 0 0 0 0 O60885 BRD4_HUMAN Bromodomain-containing protein 4 (Protein HUNK1) BRD4 HUNK1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of inflammatory response [GO:0050727]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000083; GO:0000785; GO:0000794; GO:0002039; GO:0003682; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0006338; GO:0006355; GO:0006974; GO:0008353; GO:0010971; GO:0019899; GO:0032968; GO:0043123; GO:0043922; GO:0045893; GO:0045944; GO:0050727; GO:0070577; GO:0099122; GO:0106140; GO:1901407; GO:2000002; GO:2001255 chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] AAALPPKPAR 0.99058 -20.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5967 0 0 0 0 0 0 0 0 0 0 10.7411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5295 10.9654 12.965 13.0348 0 17.3959 0 14.4303 0 12.3384 0 12.9019 0 0 0 0 0 0 0 0 12.9555 12.5595 0 0 17.6417 0 0 0 13.4967 0 14.8022 17.6521 0 13.3625 0 0 14.9578 13.2559 0 0 13.6241 0 12.997 14.4891 0 13.6622 12.392 13.1178 13.4944 13.5338 14.6981 14.445 14.0608 0 0 17.3982 12.4025 12.8792 13.5608 0 0 14.0817 0 0 0 14.3707 12.9311 0 0 0 12.1171 12.494 0 0 0 0 0 12.2929 0 0 14.2794 0 14.6194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0211 11.8389 13.7388 0 0 0 0 0 O76054 S14L2_HUMAN "SEC14-like protein 2 (Alpha-tocopherol-associated protein, TAP, hTAP) (Squalene transfer protein) (Supernatant protein factor, SPF)" SEC14L2 C22orf6 KIAA1186 KIAA1658 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cholesterol biosynthetic process [GO:0045540]" GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008431; GO:0045540; GO:0045893; GO:0070062 phospholipid binding [GO:0005543]; vitamin E binding [GO:0008431] APKLFPVAYNLIKPFLSEDTR 0.99058 -20.264 0 9.56792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.75 0 0 0 0 10.4483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7929 0 0 0 0 0 0 13.3245 11.5833 12.5568 0 0 13.4941 14.6946 0 13.4429 13.9136 12.2074 0 0 0 0 0 14.0949 0 12.4134 0 12.2602 0 0 0 0 0 0 0 0 0 0 12.3576 0 0 12.357 0 0 0 0 0 0 0 13.3833 0 13.6056 14.1141 0 0 12.6314 0 0 0 0 0 0 0 0 0 0 12.7583 13.0896 0 13.5321 13.521 14.7479 0 0 13.6991 12.9607 0 13.974 0 0 0 0 0 0 0 0 0 0 11.0867 0 0 0 0 0 0 0 0 0 0 11.9688 0 0 0 0 0 13.327 13.8613 0 0 0 0 0 0 P05015 IFN16_HUMAN "Interferon alpha-16, IFN-alpha-16 (Interferon alpha-WA)" IFNA16 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005132; GO:0005576; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0043330; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132] ITLYLMGKK 0.99058 -5.8809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5A7 TAFA5_HUMAN Chemokine-like protein TAFA-5 TAFA5 FAM19A5 UNQ5208/PRO34524 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular wound healing [GO:0061044] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular wound healing [GO:0061044] GO:0001664; GO:0005125; GO:0005615; GO:0005737; GO:0007186; GO:0048018; GO:0061044; GO:1904706; GO:1904753 cytokine activity [GO:0005125]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018] ARPACVDAR 0.99058 -20.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4662 0 0 0 0 0 13.2739 0 0 0 0 11.476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6134 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89414 0 0 13.1626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3783 0 0 0 0 0 0 0 0 0 14.0841 13.8767 14.183 13.9067 0 0 0 0 13.6161 0 0 0 0 12.8384 0 0 13.1355 13.1707 0 0 0 0 0 0 13.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1162 0 0 0 0 0 0 0 0 0 0 13.3674 0 0 0 0 Q9GZU2 PEG3_HUMAN Paternally-expressed gene 3 protein (Zinc finger and SCAN domain-containing protein 24) PEG3 KIAA0287 ZSCAN24 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357] autophagosome [GO:0005776]; nucleus [GO:0005634] "autophagosome [GO:0005776]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005776; GO:0006357; GO:0006915; GO:0010468; GO:0045944; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DKFYECR 0.99058 -21.208 0 0 0 0 0 0 0 0 0 0 11.8636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3254 12.5375 0 0 0 0 0 10.4975 0 0 0 0 0 0 11.0776 11.8394 10.958 0 12.5809 12.4339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2879 0 0 0 0 0 0 0 10.9106 11.3053 0 0 0 0 0 16.0748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8675 11.8362 0 0 0 0 0 0 0 13.5281 11.5811 0 0 0 12.4768 0 0 0 0 12.1023 0 12.3229 0 0 0 0 0 0 0 0 0 0 0 0 11.4303 0 0 0 0 0 0 0 14.1364 0 0 11.6103 0 12.1663 0 12.4162 13.2761 0 0 0 0 0 0 10.8849 0 0 0 0 0 0 0 0 0 0 12.438 0 0 14.051 12.3463 0 0 Q9UBS9 SUCO_HUMAN SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1) SUCO C1orf9 CH1 OPT SLP1 Homo sapiens (Human) ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850] GO:0001503; GO:0005737; GO:0005791; GO:0016020; GO:0016021; GO:0030867; GO:0032967; GO:0045669; GO:0046850 CFSSYDDMNLK 0.99058 -20.281 0 0 0 13.6704 0 14.9508 12.696 0 0 0 14.7039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6728 0 0 0 15.4518 0 0 0 12.3268 12.9445 15.0892 17.0469 0 0 14.4763 14.7057 15.2161 15.8073 15.2466 15.4085 15.1606 16.3459 15.7548 15.4572 0 0 0 12.6949 0 0 12.6145 12.3714 0 12.4021 0 15.3812 12.1329 0 0 12.5311 15.688 14.5493 0 0 0 0 0 0 0 12.5042 0 11.7921 12.7765 12.653 0 13.6594 12.7723 0 0 14.5359 0 14.0205 0 13.9632 12.415 0 0 0 0 12.0668 0 0 0 12.9296 0 11.3695 0 0 0 0 0 0 0 14.2935 0 0 0 0 0 0 0 14.1874 0 0 13.4776 0 0 0 10.6623 0 0 0 0 14.1917 0 0 0 0 Q9Y2T5 GPR52_HUMAN G-protein coupled receptor 52 GPR52 Homo sapiens (Human) cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; phototransduction [GO:0007602]; response to xenobiotic stimulus [GO:0009410] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; phototransduction [GO:0007602]; response to xenobiotic stimulus [GO:0009410] GO:0004930; GO:0005887; GO:0007186; GO:0007602; GO:0007626; GO:0008020; GO:0009410; GO:0071482 G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930] EINDRRAR 0.99058 -20.795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4005 13.6764 14.3671 14.201 13.4306 13.6897 12.9002 10.9312 12.9003 0 0 0 0 0 0 0 0 11.9546 0 0 0 0 0 0 0 0 0 13.0325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14843 FFAR3_HUMAN Free fatty acid receptor 3 (G-protein coupled receptor 41) FFAR3 GPR41 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to fatty acid [GO:0071398]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; mucosal immune response [GO:0002385]; negative regulation of blood pressure [GO:0045776]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of hormone biosynthetic process [GO:0046885]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of norepinephrine secretion [GO:0014061]; regulation of peptide hormone secretion [GO:0090276] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to fatty acid [GO:0071398]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; mucosal immune response [GO:0002385]; negative regulation of blood pressure [GO:0045776]; positive regulation of acute inflammatory response to non-antigenic stimulus [GO:0002879]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of hormone biosynthetic process [GO:0046885]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of norepinephrine secretion [GO:0014061]; regulation of peptide hormone secretion [GO:0090276] GO:0002385; GO:0002720; GO:0002879; GO:0004930; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007193; GO:0008289; GO:0014061; GO:0032722; GO:0045776; GO:0046626; GO:0046885; GO:0071398; GO:0090276 G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289] GGSHRRQR 0.99059 -1.8297 0 0 0 0 0 0 0 0 0 0 0 0 11.1075 11.7605 0 0 0 0 0 0 0 14.557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4689 0 0 0 0 12.8594 0 0 0 0 0 0 0 0 0 0 0 14.5847 0 14.9306 0 0 14.6332 14.5853 0 0 0 15.3651 13.9557 0 0 0 0 11.3266 14.0266 0 0 0 14.2978 0 0 12.9674 0 12.7707 0 0 13.8658 0 13.8972 0 12.9045 0 14.63 0 0 0 0 0 0 0 0 0 15.1403 0 0 0 13.1617 0 0 0 0 0 0 0 0 0 0 12.2551 0 0 0 0 0 0 0 0 0 10.7871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9776 0 0 Q06730 ZN33A_HUMAN "Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain, ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31)" ZNF33A KIAA0065 KOX31 ZNF11 ZNF11A ZNF33 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFYQKSQLTQHQR 0.99059 -5.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1744 0 0 11.5913 0 0 13.7824 0 0 0 0 0 11.6389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4879 0 0 0 13.5008 0 0 0 0 0 13.1936 0 0 0 0 0 14.2837 15.188 0 0 0 15.8982 14.1478 10.2862 0 11.5424 12.5223 0 15.0692 15.3287 0 0 0 14.5095 0 0 10.7742 0 0 0 0 0 0 0 12.3964 0 0 0 0 0 15.0351 14.5121 0 14.4809 15.3484 10.5762 14.9828 14.9233 14.8706 16.37 0 0 0 0 0 0 0 14.8749 0 15.7875 0 0 0 15.5578 15.7993 0 14.9381 0 14.6378 14.7142 0 14.1188 0 0 14.2312 0 0 0 0 0 12.5857 12.5861 0 0 0 0 0 11.4912 10.6705 0 0 16.7004 0 0 14.7556 0 0 0 0 14.7734 0 0 0 0 14.2448 0 0 12.5964 Q7L211 ABHDD_HUMAN "Protein ABHD13, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 13, Abhydrolase domain-containing protein 13)" ABHD13 C13orf6 Homo sapiens (Human) protein depalmitoylation [GO:0002084] dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020] dendrite cytoplasm [GO:0032839]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084] GO:0002084; GO:0008474; GO:0016020; GO:0016021; GO:0032839 palmitoyl-(protein) hydrolase activity [GO:0008474] EKSWMLWNFVER 0.99059 -20.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8096 0 0 15.1278 0 0 0 0 0 0 0 0 11.8592 0 0 0 0 0 0 0 0 0 0 0 12.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4364 0 13.4454 0 0 0 0 13.7153 0 0 0 13.0371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4482 0 13.497 13.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6508 0 0 0 0 0 0 0 0 0 12.8796 14.0498 0 0 0 13.7674 0 0 0 0 0 0 0 13.1762 0 0 14.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9749 0 0 0 13.756 0 0 0 12.428 13.0598 0 0 0 0 0 Q7Z2F6 KRBX5_HUMAN KRAB domain-containing protein 5 KRBOX5 ZNF720 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" "regulation of transcription, DNA-templated [GO:0006355]" GO:0006355 KLIEASFQK 0.99059 -5.6064 0 0 0 0 13.1 0 0 0 0 0 0 14.3723 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.757 0 0 0 0 0 0 0 0 0 0 0 0 15.6819 0 0 0 15.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6905 0 0 0 0 0 0 0 0 14.518 0 0 0 0 0 0 0 0 15.3266 0 15.4391 0 0 Q7Z3H4 SAMD7_HUMAN "Sterile alpha motif domain-containing protein 7, SAM domain-containing protein 7" SAMD7 Homo sapiens (Human) "negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0005737; GO:0010629; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393] KTLSFPIR 0.99059 -19.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.509 0 0 0 0 0 0 0 0 0 0 0 0 9.94244 11.5825 0 0 0 0 0 0 0 0 0 0 0 12.7776 0 0 13.6858 0 0 13.1412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.126 12.8831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXA3 RUFY2_HUMAN RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related) RUFY2 KIAA1537 RABIP4R Homo sapiens (Human) regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100] GO:0005634; GO:0005737; GO:0005768; GO:0017124; GO:0030100; GO:0046872 metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124] ANLLNMAKLSIK 0.99059 -20.891 0 0 0 9.99464 0 0 0 0 0 10.7614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3115 0 0 0 0 0 0 0 0 11.2051 0 0 14.6353 0 0 0 0 0 0 0 11.4967 13.4387 0 0 0 0 0 0 0 13.2209 0 13.9497 0 0 0 13.0868 0 0 0 14.1323 13.5378 15.1154 13.5048 13.6883 10.8283 0 13.077 14.3559 0 0 0 13.0911 11.8402 11.1523 13.4494 13.6006 0 12.0073 13.5072 0 0 12.3671 13.561 0 0 0 0 0 0 0 0 12.8102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.338 0 0 0 0 0 Q4U2R8 S22A6_HUMAN "Solute carrier family 22 member 6 (Organic anion transporter 1, hOAT1) (PAH transporter, hPAHT) (Renal organic anion transporter 1, hROAT1)" SLC22A6 OAT1 PAHT Homo sapiens (Human) alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to organic cyclic compound [GO:0014070]; sodium-independent organic anion transport [GO:0043252] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; alpha-ketoglutarate transport [GO:0015742]; organic anion transport [GO:0015711]; renal tubular secretion [GO:0097254]; response to organic cyclic compound [GO:0014070]; sodium-independent organic anion transport [GO:0043252] GO:0005452; GO:0005886; GO:0005887; GO:0005901; GO:0008514; GO:0014070; GO:0015301; GO:0015347; GO:0015711; GO:0015742; GO:0016323; GO:0031404; GO:0032991; GO:0042802; GO:0043252; GO:0070062; GO:0097254 anion:anion antiporter activity [GO:0015301]; chloride ion binding [GO:0031404]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] EAGIYPR 0.9906 -20.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4686 13.3187 0 0 12.9975 0 0 0 13.1597 13.0406 12.7643 0 11.9597 0 0 0 0 0 0 0 13.209 0 0 Q8IVS8 GLCTK_HUMAN "Glycerate kinase, EC 2.7.1.31 (HBeAg-binding protein 4)" GLYCTK HBEBP4 LP5910 Homo sapiens (Human) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerate kinase activity [GO:0008887]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; protein phosphorylation [GO:0006468] GO:0005524; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0006468; GO:0008887; GO:0061624 ATP binding [GO:0005524]; glycerate kinase activity [GO:0008887] AAALQVLPRLARAPLHPLLWR 0.9906 -1.8379 0 0 0 0 0 0 0 0 12.4588 12.1749 12.1507 12.7701 11.7995 0 12.4559 0 0 0 0 0 0 0 0 0 0 12.1928 0 0 0 0 12.7336 0 0 0 0 0 12.3716 0 0 0 0 0 0 0 0 0 0 11.2393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8969 0 0 0 0 0 0 13.7161 0 0 0 0 0 13.6507 0 0 13.431 0 13.9174 13.7286 14.0111 0 13.8236 13.6842 13.3745 0 13.5779 13.4873 14.0345 0 0 0 0 0 0 13.5757 0 13.993 0 0 Q8NCG7 DGLB_HUMAN "Diacylglycerol lipase-beta, DAGL-beta, DGL-beta, EC 3.1.1.116 (KCCR13L) (PUFA-specific triacylglycerol lipase, EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta)" DAGLB Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; endocannabinoid signaling pathway [GO:0071926]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727] GO:0001516; GO:0004806; GO:0005654; GO:0005737; GO:0005765; GO:0005886; GO:0007405; GO:0010898; GO:0016021; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0042136; GO:0046872; GO:0047372; GO:0050727; GO:0071926 acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806] CYAFSPPR 0.9906 -20.476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.351 12.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0941 0 0 0 9.90109 0 0 0 0 0 0 0 13.1598 0 0 0 0 0 0 0 0 10.1127 0 0 0 0 0 12.9254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2905 0 0 0 0 0 0 12.322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07359 GP1BA_HUMAN "Platelet glycoprotein Ib alpha chain, GP-Ib alpha, GPIb-alpha, GPIbA, Glycoprotein Ibalpha (Antigen CD42b-alpha) (CD antigen CD42b) [Cleaved into: Glycocalicin ]" GP1BA Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; fibrinolysis [GO:0042730]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of platelet activation [GO:0010572]; regulation of blood coagulation [GO:0030193]; release of sequestered calcium ion into cytosol [GO:0051209]" anchored component of external side of plasma membrane [GO:0031362]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "anchored component of external side of plasma membrane [GO:0031362]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; thrombin-activated receptor activity [GO:0015057]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; fibrinolysis [GO:0042730]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of platelet activation [GO:0010572]; regulation of blood coagulation [GO:0030193]; release of sequestered calcium ion into cytosol [GO:0051209]" GO:0000902; GO:0005615; GO:0005886; GO:0005887; GO:0007155; GO:0007166; GO:0007596; GO:0007597; GO:0009986; GO:0010572; GO:0015057; GO:0016020; GO:0030168; GO:0030193; GO:0031012; GO:0031362; GO:0035855; GO:0042730; GO:0051209; GO:0070062; GO:0070527; GO:1903238; GO:1990779 thrombin-activated receptor activity [GO:0015057] AWLLFLRGSLPTFRSSLFLWVR 0.99061 -4.6062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8747 13.3264 0 0 0 0 0 0 0 0 0 0 12.9903 13.1382 0 0 13.1946 0 0 0 0 13.1179 0 0 0 0 0 0 0 0 10.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2007 0 15.1353 0 0 P33981 TTK_HUMAN "Dual specificity protein kinase TTK, EC 2.7.12.1 (Phosphotyrosine picked threonine-protein kinase, PYT)" TTK MPS1 MPS1L1 Homo sapiens (Human) chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]; spindle organization [GO:0007051] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; chromosome segregation [GO:0007059]; chromosome separation [GO:0051304]; female meiosis chromosome segregation [GO:0016321]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein localization to meiotic spindle midzone [GO:1903096]; spindle organization [GO:0007051] GO:0000776; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0007051; GO:0007052; GO:0007059; GO:0007094; GO:0008284; GO:0010862; GO:0016020; GO:0016321; GO:0018105; GO:0018107; GO:0033316; GO:0034501; GO:0042802; GO:0043515; GO:0046777; GO:0051304; GO:0106310; GO:1903096 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] GAVPLEMLEIALRNLNLQK 0.99061 -20.509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5965 0 0 0 0 10.9374 0 10.2184 0 0 0 0 0 0 0 0 0 0 0 0 16.2732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2081 0 0 10.9032 0 0 0 0 0 0 0 0 19.094 10.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4746 0 0 0 0 0 0 0 0 0 0 0 0 P52566 GDIR2_HUMAN "Rho GDP-dissociation inhibitor 2, Rho GDI 2 (Ly-GDI) (Rho-GDI beta)" ARHGDIB GDIA2 GDID4 RAP1GN1 Homo sapiens (Human) negative regulation of trophoblast cell migration [GO:1901164]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; Rho GDP-dissociation inhibitor activity [GO:0005094]; small GTPase binding [GO:0031267]; negative regulation of trophoblast cell migration [GO:1901164]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] GO:0003924; GO:0005094; GO:0005096; GO:0005737; GO:0005829; GO:0005856; GO:0007266; GO:0016020; GO:0031267; GO:0031410; GO:0035023; GO:0070062; GO:1901164; GO:2000249 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; Rho GDP-dissociation inhibitor activity [GO:0005094]; small GTPase binding [GO:0031267] APNVVVTR 0.99061 -20.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8349 0 0 0 0 0 0 11.8094 0 0 0 0 0 0 0 0 0 0 11.3116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4902 0 0 0 0 14.7998 10.9738 0 0 0 0 0 0 11.5722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0453 0 0 0 0 0 0 0 0 11.7596 0 0 11.0622 0 11.8267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6505 0 A5PKW4 PSD1_HUMAN "PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6, Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1)" PSD EFA6 EFA6A KIAA2011 PSD1 TYL Homo sapiens (Human) neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]; signal transduction [GO:0007165] "cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]" "cleavage furrow [GO:0032154]; dendritic spine [GO:0043197]; extrinsic component of postsynaptic endosome membrane [GO:0098999]; postsynaptic density, intracellular component [GO:0099092]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; neuron projection development [GO:0031175]; regulation of ARF protein signal transduction [GO:0032012]; signal transduction [GO:0007165]" GO:0005085; GO:0005543; GO:0007165; GO:0031175; GO:0032012; GO:0032154; GO:0032587; GO:0043197; GO:0098999; GO:0099092 guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543] AMASELR 0.99062 -19.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.581 0 0 0 9.64521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8927 0 0 0 0 0 0 0 0 14.0348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6509 0 0 13.5719 13.7484 0 0 12.4148 0 0 0 0 0 0 0 0 10.404 0 0 0 13.3907 0 0 0 13.9554 13.5464 0 13.2404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0103 0 0 0 0 0 0 0 13.9489 0 0 0 0 0 0 0 0 0 0 11.6905 0 0 0 O15350 P73_HUMAN Tumor protein p73 (p53-like transcription factor) (p53-related protein) TP73 P73 Homo sapiens (Human) "cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; mismatch repair [GO:0006298]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein tetramerization [GO:0051262]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410]" cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; mismatch repair [GO:0006298]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein tetramerization [GO:0051262]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001228; GO:0001822; GO:0002039; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006298; GO:0006357; GO:0006974; GO:0007049; GO:0007346; GO:0008285; GO:0008630; GO:0009410; GO:0010243; GO:0010468; GO:0019901; GO:0030054; GO:0042771; GO:0042802; GO:0043065; GO:0043231; GO:0043410; GO:0045665; GO:0045893; GO:0045944; GO:0046872; GO:0048714; GO:0051262; GO:0051726; GO:0060044; GO:0061629; GO:0097371; GO:0140297; GO:1901248 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]" CPNHELGR 0.99062 -21.189 0 0 0 0 0 0 0 0 0 0 0 0 12.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6354 0 0 0 0 0 0 0 0 0 12.8447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7864 11.6155 0 0 0 12.6757 12.3555 0 14.4793 16.0376 15.9336 0 15.7351 12.5177 11.8337 12.3058 0 0 0 0 0 0 0 0 0 0 0 0 12.1168 0 0 12.6049 0 14.627 0 14.2827 0 0 12.9323 13.1811 14.1834 14.3916 0 0 11.8108 0 12.2916 13.9184 0 0 0 0 0 0 0 0 0 0 11.0973 0 0 0 0 14.1022 0 0 0 0 0 14.407 13.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 12.044 12.1418 14.5256 0 11.9222 0 0 0 0 0 0 11.6654 0 13.2149 0 0 0 0 0 0 0 0 12.563 0 0 0 0 P16333 NCK1_HUMAN "Cytoplasmic protein NCK1 (NCK adaptor protein 1, Nck-1) (SH2/SH3 adaptor protein NCK-alpha)" NCK1 NCK Homo sapiens (Human) "actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]" cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506] "cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to other organism [GO:0051707]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]" GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007165; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0033137; GO:0035591; GO:0036493; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0051707; GO:0060548; GO:0070262; GO:0071074; GO:1902237; GO:1903676; GO:1903679; GO:1903898; GO:1903912; GO:1990441 cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159] ETVYCIGQR 0.99062 -21.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6341 0 0 0 0 0 14.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.763 0 0 0 0 0 0 0 0 0 0 0 0 15.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31249 HXD3_HUMAN Homeobox protein Hox-D3 (Homeobox protein Hox-4A) HOXD3 HOX1D HOX4A Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; cell-matrix adhesion [GO:0007160]; embryonic skeletal system morphogenesis [GO:0048704]; glossopharyngeal nerve morphogenesis [GO:0021615]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]" aggresome [GO:0016235]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cartilage development [GO:0051216]; cell-matrix adhesion [GO:0007160]; embryonic skeletal system morphogenesis [GO:0048704]; glossopharyngeal nerve morphogenesis [GO:0021615]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0007160; GO:0007219; GO:0009952; GO:0010628; GO:0016235; GO:0016604; GO:0021615; GO:0030878; GO:0045666; GO:0045944; GO:0048704; GO:0051216; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" NSCATAGESCEDK 0.99062 -4.6161 0 0 0 0 0 0 0 0 0 0 0 10.9109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5894 0 0 13.1431 0 0 13.1662 0 11.4575 0 0 13.0002 0 14.8562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5633 0 0 0 0 13.6543 0 0 0 0 0 0 0 0 0 0 0 15.4737 0 0 0 0 0 0 12.353 13.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7455 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6638 0 0 0 0 0 0 12.1988 0 0 0 0 0 14.1982 0 0 0 0 0 14.7546 11.8108 0 0 0 12.0141 0 0 0 0 0 11.7691 0 0 P80404 GABT_HUMAN "4-aminobutyrate aminotransferase, mitochondrial, EC 2.6.1.19 ((S)-3-amino-2-methylpropionate transaminase, EC 2.6.1.22) (GABA aminotransferase, GABA-AT) (Gamma-amino-N-butyrate transaminase, GABA transaminase, GABA-T) (L-AIBAT)" ABAT GABAT Homo sapiens (Human) aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005] 4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410] GO:0001666; GO:0005739; GO:0005759; GO:0007568; GO:0007620; GO:0007626; GO:0009410; GO:0009448; GO:0009449; GO:0009450; GO:0010039; GO:0014053; GO:0021549; GO:0030170; GO:0031652; GO:0032024; GO:0032144; GO:0032145; GO:0033602; GO:0034386; GO:0035094; GO:0035640; GO:0042135; GO:0042802; GO:0043005; GO:0045471; GO:0045776; GO:0045964; GO:0046872; GO:0047298; GO:0048148; GO:0051536; GO:0070474; GO:0090331; GO:0097151; GO:1902722; GO:1904450 (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145] ALLTGLLDLQARYPQFISR 0.99062 -20.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1584 0 0 0 0 0 0 0 0 9.92107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9658 0 0 0 0 0 0 0 0 15.2888 0 0 0 0 0 0 10.6359 0 10.9262 0 10.8271 11.0059 0 0 11.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8445 0 11.6684 0 0 0 0 0 0 0 12.4679 0 0 0 0 11.4966 0 0 0 0 0 0 0 0 0 0 0 0 10.3171 0 11.5439 0 0 10.9774 0 Q14527 HLTF_HUMAN "Helicase-like transcription factor, EC 2.3.2.27, EC 3.6.4.- (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3)" HLTF HIP116A RNF80 SMARCA3 SNF2L3 ZBU1 Homo sapiens (Human) DNA repair [GO:0006281]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767]" GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006281; GO:0008094; GO:0008270; GO:0016020; GO:0016363; GO:0016567; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0061630; GO:0090575; GO:0140658 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]" AVLDLESERRWVLTGTPIQNSLK 0.99062 -21.174 0 0 0 0 0 0 0 0 0 0 11.1665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2078 0 0 0 0 0 0 0 0 0 13.4581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1501 0 0 0 0 0 0 0 0 0 0 0 0 13.259 0 0 0 0 15.6355 0 13.4189 0 0 14.0052 0 0 0 14.9461 0 0 0 0 13.6647 0 14.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5402 0 0 0 13.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5935 0 0 0 13.0358 0 0 0 13.4002 0 14.3373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.671 0 Q2VWA4 SKOR2_HUMAN "SKI family transcriptional corepressor 2 (Functional Smad-suppressing element on chromosome 18, Fussel-18) (LBX1 corepressor 1-like protein) (Ladybird homeobox corepressor 1-like protein)" SKOR2 CORL2 FUSSEL18 Homo sapiens (Human) "negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0030512; GO:0030514; GO:0046332; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]" CSYCNMYFSPNK 0.99062 -20.197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0044 0 0 0 0 0 0 0 0 10.7313 0 0 0 0 0 0 0 0 0 0 13.5949 0 0 0 0 0 0 0 0 11.8759 0 0 0 0 12.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A65 EXOC4_HUMAN Exocyst complex component 4 (Exocyst complex component Sec8) EXOC4 KIAA1699 SEC8 SEC8L1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; paraxial mesoderm formation [GO:0048341]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; plasma membrane [GO:0005886]; synapse [GO:0045202]; PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; paraxial mesoderm formation [GO:0048341]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0006887; GO:0006893; GO:0006904; GO:0007268; GO:0015031; GO:0016020; GO:0016241; GO:0030165; GO:0031267; GO:0032584; GO:0035748; GO:0045202; GO:0047485; GO:0048341; GO:0090148; GO:0090522; GO:0090543 PDZ domain binding [GO:0030165]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267] IPETVKAIIERLEQELK 0.99062 -21.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4922 0 0 0 0 0 0 0 0 13.5362 0 0 0 0 0 0 13.7744 0 0 12.4197 0 0 13.9332 0 13.4422 14.9932 14.2872 13.9472 0 0 0 0 13.4045 11.8258 0 13.5689 0 12.2488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9402 0 0 0 0 0 0 0 0 0 0 0 0 12.5236 0 13.4648 0 12.7837 0 0 0 0 0 0 0 0 0 13.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6822 11.7553 0 0 0 12.5866 0 14.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5657 0 0 0 0 0 14.0122 0 0 0 0 0 13.8997 0 13.4378 0 14.4165 0 0 14.3413 0 14.1466 0 13.6064 0 0 Q9BSD7 NTPCR_HUMAN "Cancer-related nucleoside-triphosphatase, NTPase, EC 3.6.1.15 (Nucleoside triphosphate phosphohydrolase)" NTPCR C1orf57 Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTPase activity [GO:0003924]; nucleoside-triphosphatase activity [GO:0017111]; RNA binding [GO:0003723] GO:0003723; GO:0003924; GO:0005524; GO:0016020; GO:0016887; GO:0017111 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTPase activity [GO:0003924]; nucleoside-triphosphatase activity [GO:0017111]; RNA binding [GO:0003723] GKPLALVEEIR 0.99062 -4.6146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7463 0 0 0 0 0 0 0 0 0 0 13.8738 14.551 0 0 0 0 13.9004 0 0 14.2674 0 0 0 0 0 0 0 0 14.5721 14.4182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8367 12.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4475 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRE2 TSH2_HUMAN "Teashirt homolog 2 (Ovarian cancer-related protein 10-2, OVC10-2) (Zinc finger protein 218)" TSHZ2 C20orf17 TSH2 ZNF218 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" CMFCGDSFDSLQDLSVHMIKTKHYQK 0.99062 -21.622 11.4048 10.9955 0 0 15.2864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2009 0 13.3266 0 0 0 0 0 0 0 0 11.7697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.525 14.7915 14.9272 14.9128 0 14.9828 0 0 0 14.8333 14.5666 14.5678 14.5562 0 0 15.7655 12.1531 0 0 15.1112 15.0713 14.82 0 0 0 14.931 14.8774 0 0 19.013 15.1882 0 0 0 14.9948 0 0 0 0 0 0 0 0 15.3293 0 15.5739 16.2633 0 0 15.8922 0 15.0572 0 15.3327 15.1202 15.1189 0 0 15.1544 16.9896 15.221 0 11.9271 0 0 0 0 0 15.1231 0 15.2365 0 0 0 15.2017 0 15.4531 15.0582 0 0 15.5121 15.5114 15.6353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6021 0 0 0 11.019 15.1945 0 Q9P0K7 RAI14_HUMAN Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14) RAI14 KIAA1334 NORPEG Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0001650; GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005938; GO:0007283; GO:0030154; GO:0070161 actin binding [GO:0003779] EKENIQTLLKSK 0.99062 -4.6156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.001 0 11.7798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0305 0 12.7172 0 0 10.8568 12.0124 12.8818 11.9907 11.8441 12.8561 0 0 0 0 0 0 0 0 0 14.5652 12.0539 12.4113 0 11.7587 12.3934 0 0 0 13.2922 11.7548 0 12.2133 12.834 0 12.0641 13.4361 12.4693 0 0 0 0 0 11.8284 0 0 0 0 0 0 0 12.0774 0 0 0 0 0 0 0 0 0 0 0 14.7 0 0 0 0 0 0 0 0 13.6878 0 14.6872 0 0 0 0 0 0 Q9Y6H3 ATP23_HUMAN "Mitochondrial inner membrane protease ATP23 homolog, EC 3.4.24.- (Ku70-binding protein 3) (XRCC6-binding protein 1)" ATP23 KUB3 XRCC6BP1 Homo sapiens (Human) double-strand break repair via nonhomologous end joining [GO:0006303]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] cell junction [GO:0030054]; cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extrinsic component of mitochondrial inner membrane [GO:0031314]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytosol [GO:0005829]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extrinsic component of mitochondrial inner membrane [GO:0031314]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; DNA-dependent protein kinase activity [GO:0004677]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; double-strand break repair via nonhomologous end joining [GO:0006303]; mitochondrial protein processing [GO:0034982]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] GO:0004222; GO:0004677; GO:0005829; GO:0005886; GO:0005958; GO:0006303; GO:0030054; GO:0031314; GO:0033615; GO:0034982; GO:0043231; GO:0046872 DNA-dependent protein kinase activity [GO:0004677]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AHVDWFTNIRHLACSEVR 0.99062 -4.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13598 ICAM2_HUMAN "Intercellular adhesion molecule 2, ICAM-2 (CD antigen CD102)" ICAM2 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609] cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; uropod [GO:0001931] cleavage furrow [GO:0032154]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; uropod [GO:0001931]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609] GO:0001931; GO:0005178; GO:0005886; GO:0005887; GO:0005902; GO:0007155; GO:0016020; GO:0032154; GO:0098609 integrin binding [GO:0005178] MGTYGVR 0.99063 -20.715 0 0 0 0 0 0 0 0 0 13.6397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3801 0 0 14.429 0 0 0 0 0 0 0 0 0 0 0 12.7746 0 13.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03252 LMNB2_HUMAN Lamin-B2 LMNB2 LMN2 Homo sapiens (Human) heterochromatin assembly [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435] intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965] intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; heterochromatin assembly [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435] GO:0005200; GO:0005635; GO:0005652; GO:0005882; GO:0006998; GO:0007097; GO:0031507; GO:0031965; GO:0042802; GO:0051664; GO:0090435 identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200] AASAAREELK 0.99063 -4.6198 0 0 10.6831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6196 19.0199 0 18.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7698 0 18.8492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8372 0 0 0 12.1481 0 0 0 0 0 0 0 0 0 0 19.4939 19.6616 0 19.6025 19.4814 19.5983 19.7472 12.4094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8484 0 0 0 12.3587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4284 11.452 0 0 19.5443 0 19.4996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2926 0 13.7413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13905 RPGF1_HUMAN Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G) RAPGEF1 GRF2 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005085; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0007165; GO:0007169; GO:0007265; GO:0007399; GO:0010976; GO:0017124; GO:0032486; GO:0038180; GO:0043231; GO:0043547; GO:0061028; GO:0071320; GO:1901888; GO:1990090 guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124] DLVLYCEAFLTTYRTFISPEELIKK 0.99063 -20.261 0 0 0 0 0 0 0 12.7306 15.6531 11.4674 12.472 11.86 0 0 9.61908 0 0 0 0 0 9.45794 0 0 0 15.153 0 0 0 0 11.318 12.2978 12.0567 11.9031 10.9731 11.6332 11.9612 12.686 0 12.2321 0 0 12.37 12.1455 0 0 0 12.3027 0 10.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7274 13.9218 0 0 0 0 0 0 0 0 12.5895 0 0 0 0 0 11.3634 0 15.634 0 0 0 0 0 0 0 12.9218 0 0 0 0 11.2063 0 0 0 0 0 0 12.9517 0 11.9723 0 12.4802 0 12.5648 0 0 0 14.2178 0 0 0 0 0 0 0 14.2855 0 0 10.9917 0 0 0 0 0 11.0761 13.5686 0 0 0 0 0 12.5496 0 0 0 0 0 0 0 0 0 14.9316 0 0 0 0 0 0 0 0 14.725 0 0 0 0 0 16.5234 0 0 0 12.0828 0 0 0 0 12.8351 0 0 0 0 Q5F1R6 DJC21_HUMAN DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3) DNAJC21 DNAJA5 Homo sapiens (Human) protein folding [GO:0006457] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ribosome [GO:0005840]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; protein folding [GO:0006457] GO:0003723; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0006457; GO:0008270 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] AMEKENK 0.99063 -21.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2036 0 0 0 0 14.7465 0 0 0 0 0 0 0 11.6739 11.5846 0 0 0 0 0 0 0 0 0 0 0 14.6897 0 0 0 0 0 0 0 0 0 0 10.3778 13.5409 12.6721 0 0 0 11.383 0 0 0 0 0 0 0 0 0 12.9082 0 0 0 0 12.2329 0 12.6464 0 12.8284 12.6264 0 13.4223 0 0 0 0 0 0 0 0 0 0 11.9579 13.375 0 12.4448 0 0 0 0 12.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.939 0 12.6915 0 0 0 0 0 0 0 Q6BDS2 URFB1_HUMAN UHRF1-binding protein 1 (ICBP90-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1) UHRF1BP1 C6orf107 Homo sapiens (Human) histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] GO:0042802; GO:0042826 histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802] AGIIKKQILK 0.99063 -21.283 0 14.4313 0 0 0 0 0 0 0 0 10.6921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2126 0 0 11.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8612 0 0 0 0 0 0 0 0 0 0 12.105 0 12.0639 0 0 0 0 0 0 0 12.6308 0 0 11.2943 0 0 0 0 0 0 14.9551 13.7458 17.9914 0 0 0 0 0 12.291 0 13.4786 0 0 0 11.7701 0 11.4947 0 0 0 0 0 0 0 0 0 0 0 14.5288 0 0 12.3859 0 14.7455 0 0 14.6805 0 0 0 0 0 0 0 12.8894 0 0 0 0 0 0 0 0 Q6P9H5 GIMA6_HUMAN "GTPase IMAP family member 6 (Immunity-associated nucleotide 2 protein, IAN-2, hIAN2) (Immunity-associated nucleotide 6 protein, IAN-6, hIAN6)" GIMAP6 IAN2 IAN6 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; GTP binding [GO:0005525] GO:0005525; GO:0005829 GTP binding [GO:0005525] CLLGKADL 0.99063 -20.787 0 0 0 0 10.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91458 0 0 0 0 0 0 0 0 0 0 0 10.9021 0 0 0 0 0 0 0 0 0 0 0 0 10.5198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV45 UN5CL_HUMAN UNC5C-like protein (Protein unc-5 homolog C-like) (ZU5 and death domain-containing protein) UNC5CL ZUD Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; netrin receptor activity [GO:0005042]; peptidase activity [GO:0008233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330] GO:0005042; GO:0005737; GO:0008233; GO:0016020; GO:0016021; GO:0043123; GO:0046330 netrin receptor activity [GO:0005042]; peptidase activity [GO:0008233] GPCQLFDFNGAR 0.99063 -20.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0958 13.1887 13.676 13.3537 13.5546 12.9827 13.5729 13.6603 13.7798 13.1742 12.6817 13.0977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0763 0 0 0 0 12.6711 0 12.7192 11.8131 0 0 0 0 0 0 0 0 0 0 0 0 12.2534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.573 0 0 0 11.4202 0 0 0 0 12.6183 0 12.4296 0 0 0 0 0 0 Q8WVJ2 NUDC2_HUMAN NudC domain-containing protein 2 NUDCD2 Homo sapiens (Human) protein folding [GO:0006457] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] GO:0000776; GO:0000922; GO:0005737; GO:0005815; GO:0005829; GO:0006457; GO:0015630; GO:0045171; GO:0051082; GO:0072686 unfolded protein binding [GO:0051082] MVRIVLTK 0.99063 -5.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7857 0 0 0 0 0 0 0 0 0 0 0 0 12.4636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3775 0 0 0 13.497 0 0 0 0 0 0 0 13.3073 0 13.3648 0 0 0 0 0 0 0 0 0 0 0 0 Q96C57 CSTOS_HUMAN Protein CUSTOS CUSTOS C12orf43 Homo sapiens (Human) negative regulation of Wnt signaling pathway [GO:0030178]; Spemann organizer formation [GO:0060061]; Wnt signaling pathway [GO:0016055] nuclear envelope [GO:0005635] nuclear envelope [GO:0005635]; negative regulation of Wnt signaling pathway [GO:0030178]; Spemann organizer formation [GO:0060061]; Wnt signaling pathway [GO:0016055] GO:0005635; GO:0016055; GO:0030178; GO:0060061 EPAKAKVQK 0.99063 -5.9761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UF56 FXL17_HUMAN F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13) FBXL17 FBL17 FBX13 FBXO13 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of smoothened signaling pathway [GO:0008589]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006515; GO:0007399; GO:0008589; GO:0014033; GO:0016567; GO:0019005; GO:0031146; GO:0043153; GO:0043161; GO:0051726 CCSWCRRR 0.99063 -21.289 0 0 0 0 0 0 0 0 14.3009 0 14.2631 0 0 13.9644 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.359 11.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8806 0 0 0 12.3141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4171 0 0 0 0 10.3753 0 0 0 0 0 12.8571 0 0 0 0 0 12.9797 0 0 0 0 12.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7727 0 0 14.1891 0 0 0 0 0 0 0 0 0 0 13.0546 0 0 13.9879 0 0 0 0 12.3285 Q9UKX5 ITA11_HUMAN Integrin alpha-11 ITGA11 MSTP018 Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen-activated signaling pathway [GO:0038065]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; osteoblast differentiation [GO:0001649]; substrate-dependent cell migration [GO:0006929] external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha11-beta1 complex [GO:0034681]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha11-beta1 complex [GO:0034681]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen-activated signaling pathway [GO:0038065]; integrin-mediated signaling pathway [GO:0007229]; muscle organ development [GO:0007517]; osteoblast differentiation [GO:0001649]; substrate-dependent cell migration [GO:0006929] GO:0001649; GO:0005178; GO:0005518; GO:0005886; GO:0005925; GO:0006929; GO:0007155; GO:0007160; GO:0007229; GO:0007517; GO:0008305; GO:0009897; GO:0016020; GO:0033627; GO:0034681; GO:0038064; GO:0038065; GO:0046872; GO:0098609; GO:0098639 collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; integrin binding [GO:0005178]; metal ion binding [GO:0046872] AKAKVAFR 0.99063 -20.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4489 0 13.3302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2698 0 0 11.7782 0 0 0 0 0 0 0 13.2343 13.9143 19.7402 0 14.9058 0 17.8088 14.2811 0 13.9024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1002 0 13.016 19.7179 0 0 0 10.9577 0 12.7284 0 13.7038 12.6057 0 14.0205 14.3009 12.916 0 0 13.5911 0 14.014 14.762 0 14.1756 0 0 0 13.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.706 0 0 0 0 12.7084 0 0 14.7447 0 0 0 0 0 0 0 0 0 14.1978 0 14.7262 0 0 0 0 0 Q9Y4R8 TELO2_HUMAN "Telomere length regulation protein TEL2 homolog (Protein clk-2 homolog, hCLK2)" TELO2 KIAA0683 Homo sapiens (Human) positive regulation of DNA damage checkpoint [GO:2000003]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006]; telomere maintenance via telomerase [GO:0007004] "ASTRA complex [GO:0070209]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078]" "ASTRA complex [GO:0070209]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT complex [GO:0110078]; Hsp90 protein binding [GO:0051879]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]; positive regulation of DNA damage checkpoint [GO:2000003]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006]; telomere maintenance via telomerase [GO:0007004]" GO:0000781; GO:0005634; GO:0005737; GO:0005829; GO:0007004; GO:0016020; GO:0016604; GO:0019901; GO:0031931; GO:0031932; GO:0032006; GO:0034399; GO:0042162; GO:0044877; GO:0050821; GO:0051879; GO:0060090; GO:0070209; GO:0071902; GO:0110078; GO:1904263; GO:1904515; GO:2000003 Hsp90 protein binding [GO:0051879]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162] AVLICLAQLGEPELR 0.99063 -21.292 0 0 0 17.2627 0 0 0 0 14.549 12.9578 12.8384 0 0 0 14.2725 13.6431 12.9681 12.4121 0 13.508 15.3204 0 0 0 0 0 0 0 12.7135 0 0 10.4286 12.1203 13.0969 0 15.1349 12.1908 0 0 13.8144 13.4898 12.4485 0 15.7858 0 0 0 0 0 0 0 0 15.7546 0 0 0 15.3421 11.9038 0 0 0 0 0 0 10.7393 0 0 0 0 12.8111 0 0 0 0 0 0 0 13.0683 14.706 14.9661 0 14.813 14.7335 17.5555 14.2486 12.7618 17.1829 0 0 0 0 0 15.8158 15.0982 14.5036 17.307 12.4072 16.9629 0 0 0 0 17.1285 0 17.0104 17.4029 0 11.4988 0 13.6701 0 11.8696 17.1632 14.5755 0 13.7345 11.8476 0 0 0 0 0 0 0 0 14.7691 0 14.4735 0 15.4921 13.8122 0 15.3111 0 0 0 12.5845 14.8841 0 0 14.082 17.2067 17.393 0 0 0 17.3006 17.3412 17.2982 12.9381 0 0 0 17.1628 17.2181 12.3194 17.479 13.5476 17.0076 14.88 12.5356 15.3251 12.1833 12.4534 0 0 0 0 0 0 11.6917 17.2654 0 0 16.6653 14.7358 0 12.1454 17.4147 0 Q9Y4U1 MMAC_HUMAN "Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase, EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating), EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein, MMACHC)" MMACHC Homo sapiens (Human) cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749] GO:0005737; GO:0005829; GO:0006749; GO:0009235; GO:0016491; GO:0016740; GO:0031419; GO:0032451; GO:0033787; GO:0042803; GO:0043295; GO:0070988; GO:0071949 cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740] EPKVAELKQK 0.99063 -20.302 0 0 9.21483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.594 0 0 0 0 12.7063 0 0 0 0 0 0 0 0 12.3288 0 0 0 0 0 0 0 0 0 0 10.6793 12.4676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9453 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9295 0 12.403 0 0 0 12.3919 0 0 0 13.4981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14753 OVOL1_HUMAN "Putative transcription factor Ovo-like 1, hOvo1" OVOL1 Homo sapiens (Human) "epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; meiotic cell cycle phase transition [GO:0044771]; mesoderm development [GO:0007498]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; epidermal cell differentiation [GO:0009913]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; keratinocyte proliferation [GO:0043616]; kidney development [GO:0001822]; meiotic cell cycle phase transition [GO:0044771]; mesoderm development [GO:0007498]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of meiotic cell cycle phase transition [GO:1901994]; negative regulation of stem cell proliferation [GO:2000647]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]; spermatogenesis [GO:0007283]; stem cell proliferation [GO:0072089]" GO:0000978; GO:0000981; GO:0001227; GO:0001822; GO:0005634; GO:0006357; GO:0007283; GO:0007498; GO:0009913; GO:0010839; GO:0043588; GO:0043616; GO:0044771; GO:0046872; GO:0051729; GO:0072089; GO:1901994; GO:1990837; GO:2000647 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" HMKCHNDVKR 0.99064 -20.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9824 14.8663 14.3157 13.1992 13.692 0 13.8005 0 0 13.7025 0 0 0 0 0 0 0 0 0 0 0 0 11.9101 0 0 0 0 0 0 0 0 14.3542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5098 10.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51813 BMX_HUMAN "Cytoplasmic tyrosine-protein kinase BMX, EC 2.7.10.2 (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase, ETK) (NTK38)" BMX Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; phosphatidylinositol biosynthetic process [GO:0006661]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; phosphatidylinositol biosynthetic process [GO:0006661]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006468; GO:0006661; GO:0006915; GO:0007155; GO:0007165; GO:0007498; GO:0032587; GO:0035556; GO:0046777; GO:0046872; GO:0050853 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] EGAFMVR 0.99064 -5.9804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08495 DEMA_HUMAN Dematin (Dematin actin-binding protein) (Erythrocyte membrane protein band 4.9) DMTN DMT EPB49 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament capping [GO:0051693]; actin filament reorganization [GO:0090527]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cytoskeleton organization [GO:0007010]; erythrocyte development [GO:0048821]; lamellipodium assembly [GO:0030032]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing [GO:0090303]; protein secretion by platelet [GO:0070560]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell projection membrane [GO:0031253]; cortical cytoskeleton [GO:0030863]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; spectrin-associated cytoskeleton [GO:0014731] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell projection membrane [GO:0031253]; cortical cytoskeleton [GO:0030863]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein self-association [GO:0043621]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament capping [GO:0051693]; actin filament reorganization [GO:0090527]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cytoskeleton organization [GO:0007010]; erythrocyte development [GO:0048821]; lamellipodium assembly [GO:0030032]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of blood coagulation [GO:0030194]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing [GO:0090303]; protein secretion by platelet [GO:0070560]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591] GO:0003779; GO:0005102; GO:0005829; GO:0005884; GO:0005886; GO:0007010; GO:0008360; GO:0010591; GO:0010763; GO:0010801; GO:0010812; GO:0012505; GO:0014069; GO:0014731; GO:0015629; GO:0030032; GO:0030036; GO:0030194; GO:0030507; GO:0030863; GO:0031095; GO:0031253; GO:0031410; GO:0032956; GO:0033137; GO:0035584; GO:0035585; GO:0043621; GO:0048471; GO:0048821; GO:0050732; GO:0051015; GO:0051017; GO:0051489; GO:0051693; GO:0051895; GO:0065003; GO:0070560; GO:0071277; GO:0071320; GO:0090303; GO:0090315; GO:0090527; GO:1900025; GO:1900026; GO:1901731; GO:2001046 actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein self-association [GO:0043621]; signaling receptor binding [GO:0005102]; spectrin binding [GO:0030507] GAEEEEEEEDDDSGEEMK 0.99064 -19.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1484 0 0 0 0 0 0 0 0 0 0 13.4098 0 0 0 0 0 0 0 0 0 0 0 0 12.9451 0 14.5191 0 0 0 0 0 0 0 9.66008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9801 0 0 0 0 0 0 0 14.1506 15.2912 0 15.2126 0 0 0 0 0 0 15.2871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8214 0 15.3163 0 14.7847 14.7336 0 0 0 0 0 0 14.9514 15.413 0 0 0 0 0 0 14.8621 0 0 0 0 0 15.3748 0 0 10.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7257 0 0 0 0 0 0 0 0 0 11.5488 0 0 0 0 0 0 13.9935 0 14.945 0 0 0 0 0 Q8IVQ6 ZDH21_HUMAN "Palmitoyltransferase ZDHHC21, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 21, DHHC-21) (Zinc finger DHHC domain-containing protein 21)" ZDHHC21 Homo sapiens (Human) adrenergic receptor signaling pathway [GO:0071875]; hair follicle development [GO:0001942]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of leukocyte adhesion to arterial endothelial cell [GO:1904997]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of vascular associated smooth muscle contraction [GO:0003056]; sebaceous gland development [GO:0048733] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; adrenergic receptor signaling pathway [GO:0071875]; hair follicle development [GO:0001942]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of leukocyte adhesion to arterial endothelial cell [GO:1904997]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of vascular associated smooth muscle contraction [GO:0003056]; sebaceous gland development [GO:0048733] GO:0000139; GO:0001942; GO:0003056; GO:0005783; GO:0005794; GO:0005886; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0048733; GO:0050999; GO:0071875; GO:1903140; GO:1904997 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] ILWFIPFR 0.99064 -5.9852 0 0 0 0 0 0 0 0 0 0 12.0971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0613 13.324 0 0 0 0 0 12.4411 12.1851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2189 0 0 0 0 13.2667 0 13.0353 0 0 13.5825 14.1771 0 0 12.5399 13.1785 0 0 0 0 0 13.0802 0 0 0 0 0 13.2889 0 13.3518 0 0 0 0 0 0 0 0 0 0 0 0 12.2372 0 0 0 0 12.8714 0 0 0 0 15.1647 15.2361 0 0 0 0 0 0 0 15.2557 0 0 12.6956 0 0 0 0 0 0 0 Q8IX18 DHX40_HUMAN "Probable ATP-dependent RNA helicase DHX40, EC 3.6.4.13 (DEAH box protein 40) (Protein PAD)" DHX40 DDX40 ARG147 Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] CLCAGYFK 0.99064 -20.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7508 0 0 0 0 0 0 0 0 0 0 0 10.0334 0 0 9.92904 14.39 0 0 0 0 0 0 0 0 0 9.99067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7884 12.882 0 14.0443 0 0 0 0 0 14.0259 0 13.9966 0 11.0331 0 0 0 0 0 12.8555 0 0 0 0 0 12.4349 0 0 11.742 0 12.4048 14.6813 0 0 0 13.749 0 0 0 12.2879 12.546 0 0 0 0 0 0 13.1482 0 0 0 13.827 13.6992 12.311 12.483 13.2627 0 0 12.2573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.73 0 0 0 0 0 0 0 12.44 0 0 0 0 0 0 11.8117 0 13.2377 Q96K76 UBP47_HUMAN "Ubiquitin carboxyl-terminal hydrolase 47, EC 3.4.19.12 (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47)" USP47 Homo sapiens (Human) "base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to xenobiotic stimulus [GO:0009410]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to xenobiotic stimulus [GO:0009410]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006284; GO:0006511; GO:0006974; GO:0008630; GO:0009410; GO:0010972; GO:0016579; GO:0019005; GO:0030307; GO:0031647; GO:0034644; GO:0035520; GO:0043066; GO:0043154; GO:0045892; GO:0071987; GO:0090263; GO:0101005; GO:1902230 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987] AGGDSGNVDDDCER 0.99064 -20.891 0 0 0 0 0 0 0 0 0 15.3057 0 0 15.4368 16.8495 15.6821 0 0 0 0 10.8003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9712 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6726 0 0 0 0 0 0 0 15.0437 0 0 0 0 0 0 0 14.5861 0 12.2883 0 0 0 0 13.2102 16.5105 16.1163 0 0 16.1127 0 15.6422 0 0 16.3411 0 0 0 0 12.7035 0 0 0 0 0 0 0 0 12.3628 0 0 17.0778 18.1938 0 13.9693 16.27 16.7029 0 0 14.3245 0 16.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3336 0 0 0 0 0 15.2285 0 0 0 0 13.7892 0 0 0 11.0904 0 15.1323 0 Q9P109 GCNT4_HUMAN "Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4, EC 2.4.1.102 (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3, C2GnT3)" GCNT4 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; neutrophil homeostasis [GO:0001780]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; inter-male aggressive behavior [GO:0002121]; kidney morphogenesis [GO:0060993]; neutrophil homeostasis [GO:0001780]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; thyroid hormone metabolic process [GO:0042403]; tissue morphogenesis [GO:0048729]" GO:0000139; GO:0001780; GO:0002121; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0008375; GO:0016021; GO:0016266; GO:0042403; GO:0048729; GO:0060993 "acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]" FTYHHELRR 0.99064 -5.982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0254 0 0 13.2741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8797 12.6379 0 0 0 12.1298 0 11.4887 0 11.2259 13.782 12.5775 0 12.1917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0062 0 0 15.4947 0 0 0 12.98 15.0319 0 12.9206 0 0 0 0 0 0 0 0 13.9103 0 0 0 0 0 0 0 0 0 0 0 14.9865 0 0 13.9512 0 14.0778 0 0 0 15.1162 0 0 0 13.763 0 13.0266 0 13.4073 0 13.7413 12.9728 13.4902 13.2614 14.3912 0 0 0 0 0 0 0 0 15.3957 14.4657 14.2473 0 12.6914 14.1201 0 13.4362 12.7919 12.3363 0 11.7546 0 0 0 12.5384 0 0 13.7853 0 0 0 0 0 0 0 0 12.4764 0 0 0 14.9795 0 0 0 0 0 12.8307 0 0 12.7313 0 0 O75446 SAP30_HUMAN Histone deacetylase complex subunit SAP30 (30 kDa Sin3-associated polypeptide) (Sin3 corepressor complex subunit SAP30) (Sin3-associated polypeptide p30) SAP30 Homo sapiens (Human) "modulation by host of symbiont transcription [GO:0052472]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]" histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580] "histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; modulation by host of symbiont transcription [GO:0052472]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]" GO:0000118; GO:0000122; GO:0003677; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006355; GO:0016580; GO:0030336; GO:0030512; GO:0035914; GO:0046872; GO:0052472; GO:1902455; GO:1902459 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] RIQKSISQK 0.99065 -5.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63244 RACK1_HUMAN "Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein, HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed) ]" RACK1 GNB2L1 HLC7 PIG21 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle [GO:0007049]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cytoplasmic translation [GO:0002181]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; IRE1-RACK1-PP2A complex [GO:1990630]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; IRE1-RACK1-PP2A complex [GO:1990630]; midbody [GO:0030496]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; small ribosomal subunit [GO:0015935]; BH3 domain binding [GO:0051434]; cadherin binding [GO:0045296]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cell cycle [GO:0007049]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cytoplasmic translation [GO:0002181]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of translation [GO:0017148]; negative regulation of Wnt signaling pathway [GO:0030178]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]; rhythmic process [GO:0048511] GO:0001891; GO:0001934; GO:0002181; GO:0003723; GO:0005080; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006919; GO:0007049; GO:0007369; GO:0008200; GO:0008656; GO:0010629; GO:0015935; GO:0016567; GO:0017148; GO:0019899; GO:0019903; GO:0022627; GO:0030178; GO:0030292; GO:0030308; GO:0030332; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032091; GO:0032436; GO:0032880; GO:0033137; GO:0035591; GO:0042169; GO:0042803; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043473; GO:0043547; GO:0045296; GO:0045879; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051343; GO:0051434; GO:0051726; GO:0051898; GO:0051901; GO:0060090; GO:0070062; GO:0071333; GO:0071363; GO:0072344; GO:1900102; GO:1903208; GO:1990630; GO:2000114; GO:2000543; GO:2001244 BH3 domain binding [GO:0051434]; cadherin binding [GO:0045296]; cyclin binding [GO:0030332]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102] DETNYGIPQRALR 0.99065 -20.436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5137 0 0 0 0 0 0 16.9129 0 0 0 0 0 16.1756 15.7068 0 15.0054 0 0 0 14.7252 0 14.3727 0 14.4649 16.1908 0 14.6781 0 14.4335 0 0 0 0 0 0 14.7735 0 0 0 0 0 0 0 0 0 0 14.5397 0 0 14.6289 0 0 0 0 0 0 14.1052 0 14.3158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1862 0 0 0 0 0 0 Q2TAA2 IAH1_HUMAN "Isoamyl acetate-hydrolyzing esterase 1 homolog, EC 3.1.-.-" IAH1 Homo sapiens (Human) lipid catabolic process [GO:0016042] hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lipid catabolic process [GO:0016042] GO:0016042; GO:0016787; GO:0042802 hydrolase activity [GO:0016787]; identical protein binding [GO:0042802] IILPRLIRK 0.99065 -5.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IF99 O10K2_HUMAN Olfactory receptor 10K2 (Olfactory receptor OR1-4) OR10K2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IVRRTISLL 0.99065 -5.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUX3 TGRM2_HUMAN TOG array regulator of axonemal microtubules protein 2 (Crescerin-2) TOGARAM2 FAM179A Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; regulation of cellular component organization [GO:0051128] cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; regulation of cellular component organization [GO:0051128] GO:0000226; GO:0005815; GO:0005876; GO:0005881; GO:0005929; GO:0008017; GO:0051128; GO:0072686; GO:0090307 microtubule binding [GO:0008017] APRTRLAR 0.99065 -20.46 0 0 0 0 0 0 12.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1219 0 11.1191 0 0 0 0 0 15.6081 0 0 0 0 0 0 0 0 13.7375 0 0 14.8364 14.4027 12.9165 0 10.4575 0 14.3929 0 0 0 14.3905 14.1163 0 0 0 15.0143 13.2922 0 0 0 0 0 12.2869 0 0 0 0 0 0 0 13.7142 15.5183 0 0 14.1633 0 0 0 16.0943 14.2923 0 14.3973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5148 0 0 15.0316 0 0 17.4495 0 13.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7837 0 0 0 0 0 0 13.2271 Q96JG6 VPS50_HUMAN Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50) VPS50 CCDC132 KIAA1861 Homo sapiens (Human) endocytic recycling [GO:0032456]; protein transport [GO:0015031] EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037] EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; SNARE binding [GO:0000149]; endocytic recycling [GO:0032456]; protein transport [GO:0015031] GO:0000149; GO:0015031; GO:0016020; GO:0032456; GO:0048471; GO:0055037; GO:0070062; GO:1990745 SNARE binding [GO:0000149] ALMQLDFQQFLMK 0.99065 -20.459 0 0 0 0 0 0 0 0 15.8867 14.6647 14.6978 13.167 14.584 14.7948 14.0943 11.2702 13.2183 0 0 10.6157 0 0 12.5134 0 11.5706 0 9.96867 11.4476 11.874 13.7112 12.9122 0 13.8222 12.3696 12.0436 0 13.5097 13.7383 12.1415 11.7423 0 12.6356 0 0 0 0 13.9419 15.0617 0 12.9635 0 0 0 11.2574 0 0 0 0 0 0 0 0 10.046 0 0 0 13.6007 0 0 0 0 0 0 0 0 0 0 12.0171 14.108 12.7651 0 0 0 0 15.7994 12.4369 14.5341 0 11.2997 0 14.8871 14.2046 14.704 0 0 12.0293 14.3393 14.6799 14.5781 0 13.2644 0 0 0 0 13.1727 0 14.5838 0 0 14.6215 0 14.521 12.7314 0 0 14.3865 0 13.4803 13.4987 0 0 13.6584 0 0 10.632 14.9992 0 14.4961 14.5938 13.8367 14.2071 13.691 14.6962 0 12.9225 0 13.9595 12.0878 11.0937 0 0 0 13.0474 0 10.9336 0 0 0 0 0 12.5906 13.5222 0 0 14.9689 0 13.6487 10.0143 0 13.6536 0 13.0598 0 11.6255 0 0 0 0 0 0 0 0 12.6077 14.6155 0 0 12.9378 0 0 Q9HCB6 SPON1_HUMAN Spondin-1 (F-spondin) (Vascular smooth muscle cell growth-promoting factor) SPON1 KIAA0762 VSGP Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein binding [GO:0032092]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein binding [GO:0032092]; positive regulation of protein processing [GO:0010954]; protein processing [GO:0016485] GO:0005201; GO:0005615; GO:0005788; GO:0007155; GO:0010954; GO:0016485; GO:0031012; GO:0032092; GO:0046872; GO:0050693; GO:1902430; GO:1902993 extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872] CMLPECPIDCELTEWSQWSECNK 0.99065 -20.472 0 0 0 0 0 0 0 0 0 0 13.8467 0 0 13.2179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6922 0 0 0 13.1228 0 0 0 0 0 0 0 0 0 13.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4015 0 0 0 0 0 10.7059 0 11.8329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3049 14.124 0 0 0 0 0 0 0 0 14.188 14.1824 0 0 0 14.4675 0 0 0 0 0 0 0 13.346 0 0 0 0 0 0 0 0 0 Q9NWW7 CB042_HUMAN Uncharacterized protein C2orf42 C2orf42 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654 FFCSCQTLK 0.99065 -20.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0987 0 0 0 0 0 0 0 0 13.4186 0 0 0 0 0 0 13.8276 0 0 0 0 13.3078 0 0 0 0 0 0 0 0 0 0 0 11.9796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8175 0 12.7917 0 0 0 0 12.737 15.4472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0465 0 0 0 0 0 14.7109 13.5383 0 14.9065 0 0 0 0 14.5982 0 0 0 0 0 0 0 10.6209 0 0 0 0 O60259 KLK8_HUMAN "Kallikrein-8, hK8, EC 3.4.21.118 (Neuropsin, NP) (Ovasin) (Serine protease 19) (Serine protease TADG-14) (Tumor-associated differentially expressed gene 14 protein)" KLK8 NRPN PRSS19 TADG14 UNQ283/PRO322 Homo sapiens (Human) cell death [GO:0008219]; keratinocyte proliferation [GO:0043616]; memory [GO:0007613]; negative regulation of axon regeneration [GO:0048681]; negative regulation of myelination [GO:0031642]; neuron projection morphogenesis [GO:0048812]; proteolysis [GO:0006508]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; serine protease inhibitor complex [GO:0097180] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase activity [GO:0004252]; cell death [GO:0008219]; keratinocyte proliferation [GO:0043616]; memory [GO:0007613]; negative regulation of axon regeneration [GO:0048681]; negative regulation of myelination [GO:0031642]; neuron projection morphogenesis [GO:0048812]; proteolysis [GO:0006508]; regulation of synapse organization [GO:0050807]; response to wounding [GO:0009611] GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0006508; GO:0007613; GO:0008219; GO:0009611; GO:0030141; GO:0031642; GO:0043616; GO:0048681; GO:0048812; GO:0050807; GO:0097180 serine-type endopeptidase activity [GO:0004252] PRPRAAK 0.99066 -20.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8264 13.9006 0 0 13.1898 0 13.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53GL7 PAR10_HUMAN "Protein mono-ADP-ribosyltransferase PARP10, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 10, ARTD10) (Poly [ADP-ribose] polymerase 10, PARP-10)" PARP10 Homo sapiens (Human) NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]; translesion synthesis [GO:0019985]; viral protein processing [GO:0019082] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of viral genome replication [GO:0045071]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212]; regulation of chromatin assembly [GO:0010847]; translesion synthesis [GO:0019985]; viral protein processing [GO:0019082] GO:0003714; GO:0003950; GO:0005634; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006471; GO:0010629; GO:0010847; GO:0019082; GO:0019985; GO:0032088; GO:0034356; GO:0045071; GO:0048147; GO:0070212; GO:0070213; GO:0070530; GO:0140289; GO:0140297; GO:1900045; GO:1990404 DNA-binding transcription factor binding [GO:0140297]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; transcription corepressor activity [GO:0003714] ALVQLPKPLSEADVRVLEEQAQNLGLEGTLVSLAR 0.99066 -20.498 0 0 0 0 10.9618 0 0 0 0 0 14.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.236 0 0 10.9511 0 0 0 0 0 0 0 0 15.9439 12.8894 13.0258 12.9226 0 0 0 0 0 0 0 11.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3078 0 13.1713 0 0 0 0 0 0 0 13.7829 0 0 15.4532 16.1405 0 12.7427 12.641 12.5367 16.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.736 0 0 0 0 0 0 0 0 0 0 0 12.6236 0 0 0 0 0 0 0 12.6534 0 0 0 16.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1696 12.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VWG9 TAF3_HUMAN "Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit, TAF(II)140, TAF140, TAFII-140, TAFII140)" TAF3 Homo sapiens (Human) maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123] male germ cell nucleus [GO:0001673]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] male germ cell nucleus [GO:0001673]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulator inhibitor activity [GO:0140416]; maintenance of protein location in nucleus [GO:0051457]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0000122; GO:0001673; GO:0002039; GO:0005634; GO:0005654; GO:0005669; GO:0006468; GO:0016251; GO:0031965; GO:0042789; GO:0043433; GO:0046872; GO:0046982; GO:0051123; GO:0051457; GO:0060261; GO:0140416 metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription regulator inhibitor activity [GO:0140416] EDKMKAPAPPLVLPPK 0.99066 -20.49 0 0 0 0 0 0 0 0 0 0 0 10.2228 0 0 0 14.2025 11.905 0 0 0 0 0 0 0 0 0 0 0 0 0 11.629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6768 12.6504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8486 0 0 0 13.5188 13.7007 13.7976 0 0 0 13.8983 0 0 0 0 0 0 0 0 0 12.9247 0 0 0 15.1854 0 0 Q86XT2 VP37D_HUMAN Vacuolar protein sorting-associated protein 37D (ESCRT-I complex subunit VPS37D) (Williams-Beuren syndrome chromosomal region 24 protein) VPS37D WBSCR24 Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902] endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702] GO:0000813; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0070062; GO:0090148 EVAENCADK 0.99066 -5.8789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWC9 CC106_HUMAN Coiled-coil domain-containing protein 106 CCDC106 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 AFEHHRVDR 0.99066 -20.507 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2396 0 0 0 11.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4763 0 0 0 0 0 0 15.3909 0 0 0 0 0 0 0 0 0 0 12.6577 0 0 0 12.9099 0 0 0 0 0 0 0 0 12.0922 0 0 0 0 0 0 0 0 13.5765 0 0 0 0 0 13.3707 0 0 0 13.4775 13.7149 13.9707 13.9475 0 14.5911 0 0 0 0 11.8967 13.0788 0 0 0 14.6165 14.074 0 13.2614 13.7115 0 0 0 0 13.4397 10.8521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3496 14.3023 0 0 13.373 0 0 0 13.4564 0 Q9H9E3 COG4_HUMAN "Conserved oligomeric Golgi complex subunit 4, COG complex subunit 4 (Component of oligomeric Golgi complex 4)" COG4 Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; identical protein binding [GO:0042802]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0000301; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0042802; GO:0048213; GO:0070085 identical protein binding [GO:0042802] AAVIFADTLTLLFEGIAR 0.99066 -4.808 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2504 0 0 0 0 0 11.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0522 0 0 14.6017 0 0 0 14.7642 0 0 11.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5263 0 0 0 0 0 12.8744 0 0 0 13.2371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0136 0 13.5755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX24 NHP2_HUMAN H/ACA ribonucleoprotein complex subunit 2 (Nucleolar protein family A member 2) (snoRNP protein NHP2) NHP2 NOLA2 HSPC286 Homo sapiens (Human) cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004] "box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]" "box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U3 snoRNA binding [GO:0034511]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; rRNA pseudouridine synthesis [GO:0031118]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]" GO:0000454; GO:0000469; GO:0000470; GO:0000781; GO:0003723; GO:0003730; GO:0005654; GO:0005697; GO:0005732; GO:0007004; GO:0031118; GO:0031120; GO:0031429; GO:0034511; GO:0034513; GO:0070034; GO:0072589; GO:0090661; GO:1904874 box H/ACA snoRNA binding [GO:0034513]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U3 snoRNA binding [GO:0034511] EVQKFVNK 0.99066 -20.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4558 0 0 0 0 0 0 0 0 0 0 0 14.6308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2L6 FRM4B_HUMAN FERM domain-containing protein 4B (GRP1-binding protein GRSP1) FRMD4B GRSP1 KIAA1013 Homo sapiens (Human) establishment of epithelial cell polarity [GO:0090162] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; ruffle [GO:0001726] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; ruffle [GO:0001726]; establishment of epithelial cell polarity [GO:0090162] GO:0001726; GO:0005615; GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0090162 ACVHKGQIEVESETIFK 0.99066 -20.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0966 0 0 0 0 13.9276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5871 0 0 0 0 0 11.2721 0 11.8102 0 11.506 0 0 0 0 0 0 0 0 0 16.8926 16.9537 0 16.1057 14.6495 14.929 0 14.5053 0 14.2172 15.1206 15.6826 15.6162 14.737 15.4011 0 0 0 13.0618 13.769 0 0 13.7593 0 0 14.8099 15.0467 14.4049 13.6092 0 0 0 14.0527 0 0 14.7083 15.8894 14.9452 14.9123 0 0 13.8707 0 0 0 0 14.2124 12.1383 14.3628 14.4251 0 14.9617 14.6841 0 14.7049 19.0527 14.8414 15.2961 0 14.9612 19.0004 14.7389 14.6233 15.3341 0 0 15.0138 0 0 14.2229 13.1098 11.7679 13.2067 0 0 0 0 0 14.9751 14.6291 12.8763 0 13.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1988 0 0 0 0 0 0 0 13.1703 0 0 P01701 LV151_HUMAN Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64) IGLV1-51 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062 antigen binding [GO:0003823] LLIYDNNKR 0.99067 -5.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19878 NCF2_HUMAN "Neutrophil cytosol factor 2, NCF-2 (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)" NCF2 NOXA2 P67PHOX Homo sapiens (Human) cellular defense response [GO:0006968]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; membrane [GO:0016020]; NADPH oxidase complex [GO:0043020]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; cellular defense response [GO:0006968]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] GO:0001669; GO:0005829; GO:0005886; GO:0006801; GO:0006909; GO:0006968; GO:0008022; GO:0009055; GO:0016020; GO:0016175; GO:0016176; GO:0031267; GO:0032010; GO:0042554; GO:0043020; GO:0045087; GO:0045730 electron transfer activity [GO:0009055]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activator activity [GO:0016176] AMECVWKQK 0.99067 -20.213 0 10.7205 0 0 0 0 0 0 0 0 0 0 0 13.7289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1331 0 0 0 0 0 0 0 14.8115 0 13.6583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9483 0 0 0 0 14.1163 0 14.4119 0 0 0 0 0 14.5951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51816 AFF2_HUMAN "AF4/FMR2 family member 2 (Protein FMR-2, FMR2P) (Protein Ox19)" AFF2 FMR2 OX19 Homo sapiens (Human) brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] nuclear speck [GO:0016607] nuclear speck [GO:0016607]; G-quadruplex RNA binding [GO:0002151]; brain development [GO:0007420]; learning or memory [GO:0007611]; mRNA processing [GO:0006397]; negative regulation of gene expression [GO:0010629]; nuclear speck organization [GO:0035063]; regulation of gene expression [GO:0010468]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] GO:0002151; GO:0006397; GO:0007420; GO:0007611; GO:0008380; GO:0010468; GO:0010629; GO:0016607; GO:0035063; GO:0043484 G-quadruplex RNA binding [GO:0002151] DLFDFFRDWDLEQQCHYEQDRSALK 0.99067 -21.668 0 0 0 0 0 13.5916 13.6902 0 0 0 0 0 0 0 0 0 0 0 16.3867 0 0 0 14.2427 0 0 0 0 0 0 11.9617 0 0 0 0 0 15.5043 0 0 0 0 0 0 0 12.5047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5249 10.9848 13.5204 0 0 0 0 13.499 12.9961 0 15.8158 14.8384 14.6469 0 0 13.7986 0 13.4499 0 0 0 0 0 0 0 0 0 0 13.1875 0 0 13.8268 0 0 0 0 0 0 13.1564 0 11.3046 0 0 14.3906 0 0 0 14.1738 0 0 14.2762 0 0 0 0 0 13.1619 0 0 0 0 0 0 0 0 15.0526 13.1661 13.2344 0 13.5445 14.3474 0 0 0 13.1016 0 13.3682 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3573 13.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2331 0 0 0 0 0 15.3968 Q5FWF6 ZN789_HUMAN Zinc finger protein 789 ZNF789 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHDCGKCFR 0.99067 -20.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8553 0 0 0 0 0 0 13.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1776 0 16.2742 0 0 13.354 0 0 0 13.6926 0 0 0 0 0 0 0 13.1883 0 0 0 0 0 0 13.5108 13.253 13.2633 11.1304 0 0 0 12.0894 13.2986 0 13.9044 0 0 0 0 0 0 0 0 0 0 12.4595 0 0 0 0 10.5669 0 0 0 0 11.6629 0 0 0 0 0 0 0 0 0 0 0 11.5025 0 0 0 0 12.0783 0 0 0 0 0 12.9397 0 Q7Z5P9 MUC19_HUMAN "Mucin-19, MUC-19" MUC19 Homo sapiens (Human) extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] GO:0005576; GO:0005796; GO:0005886 ACAEKETYIVGWR 0.99067 -21.188 16.2488 0 0 0 0 0 0 0 0 0 0 10.8691 0 0 0 13.0521 0 13.1541 0 12.6782 0 12.7316 0 0 0 0 0 0 12.7887 12.7987 0 0 0 14.0032 0 0 0 0 0 11.0575 11.8834 0 0 9.79247 0 0 0 12.0029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3017 0 0 0 0 0 0 0 0 0 11.3699 15.0204 14.2983 12.8377 0 14.6579 0 16.2015 0 13.9501 13.1528 16.2466 0 15.6945 0 0 15.726 14.4896 0 15.172 15.6103 14.7272 0 15.4951 14.1545 13.8413 0 14.6265 0 15.7711 15.799 12.1745 16.3032 11.0626 13.2994 0 14.5758 11.7971 0 14.6424 0 0 0 0 13.6243 0 12.6026 15.4484 0 12.7599 15.4545 15.3801 13.5352 11.3092 12.478 0 0 0 0 0 12.1369 0 0 14.1361 15.1589 0 11.9264 0 11.3588 0 0 0 0 0 0 0 13.2457 14.4296 0 15.4512 15.7797 15.4964 13.0883 14.8047 0 0 13.8326 0 0 0 15.3535 14.2516 12.4032 0 0 0 0 11.9727 12.0193 0 0 14.1238 14.1888 0 13.7125 Q96NE9 FRMD6_HUMAN FERM domain-containing protein 6 (Willin) FRMD6 C14orf31 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; protein localization [GO:0008104]; regulation of actin filament-based process [GO:0032970] apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886] apical junction complex [GO:0043296]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; protein localization [GO:0008104]; regulation of actin filament-based process [GO:0032970] GO:0003383; GO:0005737; GO:0005856; GO:0005886; GO:0008104; GO:0031032; GO:0032970; GO:0043296 GKDYILKHIPNMHK 0.99067 -19.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6612 0 0 10.8544 0 12.4044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2723 0 0 0 12.4797 0 0 0 0 0 13.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2516 0 0 0 0 0 0 13.0945 0 0 0 0 0 10.6757 0 0 0 0 0 0 0 0 9.27605 0 14.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8W2 CF155_HUMAN Putative uncharacterized protein encoded by LINC00472 LINC00472 C6orf155 Homo sapiens (Human) PQIPATCEPGK 0.99067 -21.685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.424 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3153 0 0 0 0 11.1031 0 0 0 0 10.3339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULV4 COR1C_HUMAN Coronin-1C (Coronin-3) (hCRNN4) CORO1C CRN2 CRNN4 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202]; actin filament binding [GO:0051015]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165] GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016477; GO:0016600; GO:0030017; GO:0030027; GO:0031267; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394 actin filament binding [GO:0051015]; small GTPase binding [GO:0031267] CEPIIMTVPR 0.99067 -21.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6534 12.317 0 13.8651 0 0 0 13.1919 0 0 0 0 0 0 13.453 0 0 0 13.4556 0 0 0 0 0 0 0 12.9607 13.9494 15.8792 0 0 14.768 14.2415 0 0 0 0 0 14.495 0 12.3216 0 0 0 0 12.4974 0 14.1541 0 14.9104 0 13.3691 0 14.1536 0 12.9836 0 0 0 0 14.7083 0 0 0 0 13.5696 0 0 0 0 0 13.1703 0 0 0 0 0 0 0 14.1345 0 0 0 0 0 0 0 0 0 0 13.3939 12.4788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Y1 CMTA1_HUMAN Calmodulin-binding transcription activator 1 CAMTA1 KIAA0833 MSTP023 Homo sapiens (Human) neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003690; GO:0003712; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0035307; GO:0043565; GO:0045944; GO:0050885; GO:0070886 double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712] CSSLPKERHR 0.99067 -21.682 0 0 9.82418 11.3703 0 0 0 0 0 0 0 0 13.1066 0 0 0 11.2174 0 0 0 0 0 0 0 10.5672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.998 12.4882 0 0 0 13.6329 0 12.5399 0 0 0 0 0 0 0 0 0 0 13.8022 10.905 0 0 0 0 0 0 0 0 0 0 0 0 11.18 0 11.0108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3668 12.0896 0 0 0 14.0381 16.0368 0 0 0 0 0 0 0 0 0 0 0 0 13.7041 0 0 0 0 0 0 0 0 11.1349 0 0 0 0 0 0 0 0 0 11.261 0 0 0 0 13.4101 0 0 0 12.3148 0 0 0 0 13.6425 Q8N5P1 ZC3H8_HUMAN Zinc finger CCCH domain-containing protein 8 ZC3H8 ZC3HDC8 Homo sapiens (Human) "apoptotic process [GO:0006915]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase III [GO:0045945]; response to antibiotic [GO:0046677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; T cell homeostasis [GO:0043029]" Cajal body [GO:0015030]; chromatin [GO:0000785]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023] "Cajal body [GO:0015030]; chromatin [GO:0000785]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; apoptotic process [GO:0006915]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase III [GO:0045945]; response to antibiotic [GO:0046677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; T cell homeostasis [GO:0043029]" GO:0000785; GO:0000791; GO:0001162; GO:0001227; GO:0003723; GO:0005634; GO:0005654; GO:0006915; GO:0008023; GO:0015030; GO:0016604; GO:0033085; GO:0035363; GO:0042795; GO:0042796; GO:0043029; GO:0045892; GO:0045945; GO:0046677; GO:0046872; GO:0070245 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]" AGHKNGK 0.99068 -20.295 0 0 0 0 0 0 0 0 0 0 13.8559 0 13.2034 0 13.3529 16.8338 13.2711 12.199 12.0815 0 16.7102 0 0 0 0 13.3247 0 13.3578 13.2634 13.4253 13.3591 0 0 0 0 0 0 13.3853 13.2288 13.1433 0 0 13.1573 16.3996 0 0 13.2624 0 13.2647 15.0503 13.2566 16.4827 0 0 11.9734 13.1944 0 0 0 0 0 0 0 0 0 0 0 0 13.1328 12.8728 10.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5968 0 0 0 0 0 0 0 0 0 0 13.3238 13.1516 0 0 0 0 0 0 0 18.3055 0 0 0 0 0 0 0 0 0 0 0 0 19.1789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3139 0 19.2403 0 0 0 0 0 0 0 0 19.02 0 0 0 0 0 0 0 0 0 0 13.7905 13.5718 14.6091 13.624 13.3761 14.525 13.3771 0 15.4384 0 15.2341 13.3696 15.1157 0 0 0 19.0254 15.1509 0 15.2355 0 9.54026 O75603 GCM2_HUMAN "Chorion-specific transcription factor GCMb, hGCMb (GCM motif protein 2) (Glial cells missing homolog 2)" GCM2 GCMB Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cellular phosphate ion homeostasis [GO:0030643]; gliogenesis [GO:0042063]; parathyroid gland development [GO:0060017]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular calcium ion homeostasis [GO:0006874]; cellular phosphate ion homeostasis [GO:0030643]; gliogenesis [GO:0042063]; parathyroid gland development [GO:0060017]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0006366; GO:0006874; GO:0030643; GO:0042063; GO:0043565; GO:0046872; GO:0060017; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ARLKQQK 0.99068 -21.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7846 0 0 0 0 0 0 0 0 10.6691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9316 0 0 16.9387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95391 SLU7_HUMAN "Pre-mRNA-splicing factor SLU7, hSlu7" SLU7 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0000380; GO:0000386; GO:0000389; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0006886; GO:0008270; GO:0008380; GO:0016020; GO:0016607; GO:0030532; GO:0030628; GO:0034605; GO:0043231; GO:0071013 pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270] DHNSEDEDEDK 0.99068 -20.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7628 13.3966 0 0 13.1423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7345 0 13.8104 0 0 0 0 0 0 13.3934 13.1196 12.528 0 0 12.7434 0 13.0301 0 0 0 13.1099 0 0 13.442 0 13.3115 0 0 0 12.0466 0 0 0 11.4974 0 12.4839 0 0 0 11.5384 0 13.143 0 0 0 0 0 0 0 15.395 13.8427 0 0 0 0 0 0 0 0 0 13.254 0 0 0 0 10.6753 0 0 0 0 0 0 12.3236 0 0 0 0 0 0 0 0 0 0 0 12.7917 0 O95567 CV031_HUMAN Uncharacterized protein C22orf31 C22orf31 Homo sapiens (Human) LVLRRQLK 0.99068 -1.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0926 0 12.1779 0 0 0 0 0 0 13.6193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3352 0 14.2104 0 0 0 0 0 0 0 13.7877 0 0 0 0 0 0 0 0 0 13.9276 0 13.5127 0 0 0 0 0 0 14.2829 13.3183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0927 0 0 0 P39059 COFA1_HUMAN Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV) ] COL15A1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] collagen type XV trimer [GO:0005582]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005582; GO:0005615; GO:0005788; GO:0007155; GO:0007165; GO:0016021; GO:0030020; GO:0030198; GO:0031012; GO:0062023; GO:0070062 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] ADFQCFK 0.99068 -21.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3009 0 0 0 0 0 0 0 0 0 0 14.2418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41222 PTGDS_HUMAN "Prostaglandin-H2 D-isomerase, EC 5.3.99.2 (Beta-trace protein) (Cerebrin-28) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase, L-PGDS) (Prostaglandin-D2 synthase, PGD2 synthase, PGDS, PGDS2)" PTGDS PDS Homo sapiens (Human) "cyclooxygenase pathway [GO:0019371]; gene expression [GO:0010467]; mast cell degranulation [GO:0043303]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to glucocorticoid [GO:0051384]" endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791] "endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; fatty acid binding [GO:0005504]; prostaglandin-D synthase activity [GO:0004667]; retinoid binding [GO:0005501]; small molecule binding [GO:0036094]; cyclooxygenase pathway [GO:0019371]; gene expression [GO:0010467]; mast cell degranulation [GO:0043303]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to glucocorticoid [GO:0051384]" GO:0001516; GO:0004667; GO:0005501; GO:0005504; GO:0005576; GO:0005615; GO:0005789; GO:0005791; GO:0005794; GO:0010467; GO:0019371; GO:0031965; GO:0036094; GO:0043303; GO:0045187; GO:0048471; GO:0051384; GO:0070062; GO:2000255 fatty acid binding [GO:0005504]; prostaglandin-D synthase activity [GO:0004667]; retinoid binding [GO:0005501]; small molecule binding [GO:0036094] GPGEDFR 0.99068 -20.715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51786 ZN157_HUMAN Zinc finger protein 157 (Zinc finger protein HZF22) ZNF157 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ARLIEHQR 0.99068 -20.3 0 0 0 0 0 0 0 0 0 0 0 0 12.0317 0 11.8372 10.6679 0 0 0 0 0 0 16.0432 0 0 11.5588 0 0 10.9715 0 12.4689 0 0 0 11.1103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5787 0 0 0 0 13.3723 0 0 0 0 0 0 0 0 13.2685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7483 0 10.5095 0 0 0 0 0 0 0 0 0 11.9583 0 0 0 0 0 0 0 0 0 0 0 0 12.867 0 0 0 0 10.2668 0 0 0 0 0 0 0 0 0 0 0 0 12.593 0 0 12.4561 0 0 0 0 0 0 0 0 0 0 0 0 12.8863 0 13.9342 Q5SY80 CTSRE_HUMAN "Cation channel sperm-associated auxiliary subunit epsilon, CatSper-epsilon, CatSperepsilon" CATSPERE C1orf101 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240] CatSper complex [GO:0036128]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240] GO:0030317; GO:0036128; GO:0048240; GO:0097228 ACPIAQK 0.99068 -5.6108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3792 0 0 0 0 0 0 12.7771 0 0 0 0 0 0 11.7338 0 0 0 0 0 0 0 0 12.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5014 0 0 0 0 0 0 0 13.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VUJ9 DRC8_HUMAN Dynein regulatory complex protein 8 (EF-hand calcium-binding domain-containing protein 2) EFCAB2 DRC8 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm principal piece [GO:0097228] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm principal piece [GO:0097228]; calcium ion binding [GO:0005509] GO:0005509; GO:0005737; GO:0005856; GO:0097228 calcium ion binding [GO:0005509] DHHTMTVLWGTQEIIVAEFHKKIK 0.99068 -5.9291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2836 11.8462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2894 13.1169 0 0 0 0 0 0 0 0 0 0 12.1958 0 12.9166 0 13.6531 0 0 0 0 12.5563 0 0 0 0 0 0 0 12.9595 13.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6591 0 0 0 0 0 0 0 12.5585 0 Q6P087 RUSD3_HUMAN "Mitochondrial mRNA pseudouridine synthase RPUSD3, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 3)" RPUSD3 Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131] GO:0000455; GO:0003723; GO:0005739; GO:0005759; GO:0006397; GO:0009982; GO:0035770; GO:0070131 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] FWSGWRR 0.99068 -20.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1082 0 0 0 0 0 0 0 0 0 0 0 16.3441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1712 0 0 0 0 14.2438 0 0 Q8N2R8 FA43A_HUMAN Protein FAM43A FAM43A PP7298 Homo sapiens (Human) IWSKSEAGRQGTK 0.99068 -21.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0549 0 0 0 0 12.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6002 0 0 Q9BSC4 NOL10_HUMAN Nucleolar protein 10 NOL10 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" nucleolus [GO:0005730]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0003723; GO:0005730; GO:0032040 RNA binding [GO:0003723] AQRVQLKK 0.99068 -21.204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3528 12.6538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2929 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0665 0 0 0 0 0 0 0 14.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9903 15.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ19 ANR60_HUMAN Ankyrin repeat domain-containing protein 60 ANKRD60 C20orf86 Homo sapiens (Human) LEETGEMFR 0.99068 -1.7932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNY5 ZN232_HUMAN Zinc finger protein 232 (Zinc finger and SCAN domain-containing protein 11) ZNF232 ZSCAN11 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0043231; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DHECSECGK 0.99068 -21.281 0 0 0 0 0 0 0 0 0 12.6193 0 0 0 12.0438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6704 0 0 11.6473 0 0 0 0 12.2678 0 0 0 0 0 0 0 12.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5B0 CTDP1_HUMAN "RNA polymerase II subunit A C-terminal domain phosphatase, EC 3.1.3.16 (TFIIF-associating CTD phosphatase)" CTDP1 FCP1 Homo sapiens (Human) cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368] centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription elongation from RNA polymerase II promoter [GO:0006368] GO:0000922; GO:0001096; GO:0004721; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006368; GO:0006470; GO:0008420; GO:0010458; GO:0017018; GO:0030496; GO:0030957; GO:0032991; GO:0043231; GO:0043923; GO:0051233; GO:0051301; GO:0061052; GO:0070940 myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096] ESSNEDEGSSSEADEMAK 0.99068 -21.279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4438 0 0 0 0 12.9991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43818 U3IP2_HUMAN "U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein, U3 snoRNP-associated 55 kDa protein, U3-55K)" RRP9 RNU3IP2 U355K Homo sapiens (Human) rRNA processing [GO:0006364] box C/D RNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] box C/D RNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364] GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0031428; GO:0032040; GO:0034511 RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511] ECCVTAGGR 0.99069 -20.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8778 0 0 12.3215 0 13.5315 0 0 0 0 12.6922 0 11.8248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6101 0 14.6916 17.5775 0 0 0 18.0797 0 0 18.3576 17.3704 18.4741 18.582 13.1455 0 0 12.6941 13.7007 13.3745 0 13.3134 0 13.1749 0 13.3574 0 18.2934 17.9972 0 0 15.3558 0 12.7196 0 0 18.3623 12.683 18.2155 0 12.7038 0 0 0 0 17.5448 0 17.6457 12.583 17.8074 13.3865 13.6632 17.9361 13.4116 17.7085 0 14.5025 13.3326 0 17.6678 0 16.7269 0 0 17.6479 0 17.6347 16.0584 0 12.7817 17.5147 0 0 17.4887 0 13.3068 13.9984 0 0 16.2627 0 12.2126 0 0 0 0 17.2373 16.6822 0 0 12.1691 0 0 0 0 0 12.3346 0 0 0 0 0 0 0 0 0 17.0814 13.1774 0 0 0 0 0 O76081 RGS20_HUMAN "Regulator of G-protein signaling 20, RGS20 (Gz-selective GTPase-activating protein, G(z)GAP, Gz-GAP) (Regulator of G-protein signaling Z1) (Regulator of Gz-selective protein signaling 1)" RGS20 RGSZ1 ZGAP1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005802; GO:0005886; GO:0007186; GO:0008277; GO:0009968 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] ARIIYEDYISILSPK 0.99069 -20.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1678 0 14.198 0 0 0 0 14.7514 0 0 0 0 0 0 0 0 12.6144 0 0 0 0 0 0 0 11.8852 13.0485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3211 0 0 13.4914 0 12.889 13.5566 12.2689 0 14.6452 0 13.6257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1852 13.5961 13.9895 0 0 0 0 0 0 0 13.5072 0 0 0 0 0 14.6057 0 0 0 14.358 0 11.9506 12.6359 14.4833 0 12.8181 0 13.5963 13.6255 0 0 0 0 0 0 13.4193 0 0 0 13.7092 0 0 0 0 0 0 0 0 0 0 14.382 0 0 0 0 0 14.2125 13.3396 13.7573 0 14.5267 13.656 0 0 0 Q02318 CP27A_HUMAN "Sterol 26-hydroxylase, mitochondrial, EC 1.14.15.15 (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)" CYP27A1 CYP27 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125]" GO:0005506; GO:0005739; GO:0005743; GO:0005759; GO:0006699; GO:0006707; GO:0008203; GO:0008395; GO:0016125; GO:0020037; GO:0030343; GO:0031073; GO:0036378; GO:0047103; GO:0047748; GO:0047749 "3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]" DFAHMPLLKAVLK 0.99069 -20.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5704 0 13.766 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0742 0 0 0 0 0 13.5401 0 12.1267 0 0 12.736 0 14.1011 0 11.4618 0 13.3151 0 0 13.7126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.554 Q5TC82 RC3H1_HUMAN "Roquin-1, Roquin, EC 2.3.2.27 (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) (RING finger protein 198)" RC3H1 KIAA2025 RNF198 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932] "cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0006511; GO:0008270; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0061630; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628 CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] DEDSSLMQLKEEFR 0.99069 -21.857 0 0 0 0 0 0 0 0 0 0 0 0 11.6115 0 0 0 0 0 11.8388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7874 0 0 0 0 0 0 0 13.2521 0 13.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9933 0 0 0 0 0 0 0 0 0 0 0 13.7542 13.7793 0 0 0 0 0 0 0 0 13.8362 0 0 0 0 13.4486 0 13.2224 13.7211 13.5699 0 12.0514 11.9182 13.3504 0 0 0 0 0 15.302 0 13.6019 0 0 Q8TCU5 NMD3A_HUMAN "Glutamate receptor ionotropic, NMDA 3A, GluN3A (N-methyl-D-aspartate receptor subtype 3A, NMDAR3A, NR3A) (NMDAR-L)" GRIN3A KIAA1973 Homo sapiens (Human) calcium ion transport [GO:0006816]; dendrite development [GO:0016358]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of dendritic spine development [GO:0061000]; prepulse inhibition [GO:0060134]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to ethanol [GO:0045471]; rhythmic process [GO:0048511] anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium channel activity [GO:0005262]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein phosphatase 2A binding [GO:0051721]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; calcium ion transport [GO:0006816]; dendrite development [GO:0016358]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of dendritic spine development [GO:0061000]; prepulse inhibition [GO:0060134]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to ethanol [GO:0045471]; rhythmic process [GO:0048511] GO:0004972; GO:0005262; GO:0005789; GO:0005886; GO:0006816; GO:0015276; GO:0016020; GO:0016021; GO:0016358; GO:0016594; GO:0017146; GO:0035235; GO:0038023; GO:0042165; GO:0042802; GO:0043005; GO:0043025; GO:0045202; GO:0045471; GO:0048511; GO:0051721; GO:0060134; GO:0061000; GO:0070161; GO:0098978; GO:0099061; GO:1904315; GO:2000300 calcium channel activity [GO:0005262]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein phosphatase 2A binding [GO:0051721]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] CCYGYCIDLLEKIAEDMNFDFDLYIVGDGK 0.99069 -20.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3491 0 0 0 0 0 0 0 0 0 0 0 0 0 13.395 0 0 13.5377 0 0 0 0 0 0 0 0 0 0 13.7273 0 0 14.3311 0 14.3309 0 0 0 0 0 0 0 14.2661 0 0 0 0 0 0 0 0 0 0 0 12.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNF0 PACN2_HUMAN "Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II, SdpII)" PACSIN2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100] caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587] caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100] GO:0005543; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005911; GO:0005925; GO:0007010; GO:0008092; GO:0016607; GO:0019898; GO:0030036; GO:0030100; GO:0032587; GO:0036010; GO:0042802; GO:0043231; GO:0045296; GO:0045806; GO:0048858; GO:0050804; GO:0055038; GO:0070062; GO:0070300; GO:0070836; GO:0072584; GO:0097320; GO:0098978 cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543] ALYDYEGQEHDELSFK 0.99069 -20.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7003 0 0 0 0 0 0 0 9.89579 0 0 12.5439 0 0 0 0 0 0 0 13.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.268 0 0 0 0 0 0 0 0 0 0 0 11.8387 0 0 0 0 0 0 0 0 11.6606 0 0 0 0 0 0 0 0 0 C9J1S8 TR49D_HUMAN Tripartite motif-containing protein 49D (Tripartite motif-containing protein 49-like protein) (Tripartite motif-containing protein 49D1) (Tripartite motif-containing protein 49D2) TRIM49D1 TRIM49L TRIM49L1; TRIM49D2 TRIM49D2P Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] MPAFHHEEEKHNLEMLKK 0.9907 -1.8245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9961 12.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6923 0 0 0 0 0 11.678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17405 ASM_HUMAN "Sphingomyelin phosphodiesterase, EC 3.1.4.12, EC 3.1.4.3 (Acid sphingomyelinase, aSMase)" SMPD1 ASM Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060] endolysosome [GO:0036019]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886] "endolysosome [GO:0036019]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphatidylcholine phospholipase C activity [GO:0034480]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; termination of signal transduction [GO:0023021]; viral entry into host cell [GO:0046718]; wound healing [GO:0042060]" GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006684; GO:0006685; GO:0006687; GO:0007165; GO:0007399; GO:0008081; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034480; GO:0034612; GO:0034644; GO:0035307; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043407; GO:0045807; GO:0046513; GO:0046718; GO:0061750; GO:0070062; GO:0070555; GO:0071277 "acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphatidylcholine phospholipase C activity [GO:0034480]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]" KEPNVAR 0.9907 -20.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9427 0 0 0 0 0 0 0 0 0 0 0 13.3257 13.0758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4901 0 0 0 0 0 0 13.7193 0 13.3313 0 0 0 0 0 0 0 0 0 0 0 0 10.7483 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9158 0 0 0 0 0 0 P20023 CR2_HUMAN "Complement receptor type 2, Cr2 (Complement C3d receptor) (Epstein-Barr virus receptor, EBV receptor) (CD antigen CD21)" CR2 C3DR Homo sapiens (Human) "B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; negative regulation of complement activation, classical pathway [GO:0045959]" extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; complement binding [GO:0001848]; complement receptor activity [GO:0004875]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; negative regulation of complement activation, classical pathway [GO:0045959]" GO:0001618; GO:0001848; GO:0003677; GO:0004875; GO:0004888; GO:0005615; GO:0005886; GO:0006955; GO:0006957; GO:0006958; GO:0016021; GO:0030183; GO:0042100; GO:0042803; GO:0043235; GO:0045959; GO:0070062 complement binding [GO:0001848]; complement receptor activity [GO:0004875]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] CPNPEVK 0.9907 -20.442 9.96665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6285 0 0 0 0 0 0 0 0 11.0424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2035 0 0 0 0 0 0 0 0 0 14.1665 15.2545 15.6729 15.2362 14.5375 14.1654 15.2193 15.7136 15.1273 14.9151 15.9157 0 0 0 13.8158 0 0 0 13.5311 0 16.0369 0 14.196 0 15.4843 13.4394 0 0 0 0 0 0 0 0 0 0 0 0 0 13.452 0 12.5592 0 0 0 13.3219 12.1196 0 0 0 0 0 0 0 0 0 0 0 12.3456 0 0 12.9652 0 0 0 0 0 0 0 0 12.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5096 0 0 0 0 0 0 11.3245 0 P23634 AT2B4_HUMAN "Plasma membrane calcium-transporting ATPase 4, PMCA4, EC 7.2.2.10 (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4)" ATP2B4 ATP2B2 MXRA1 Homo sapiens (Human) calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832] GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0010751; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019829; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0033138; GO:0034220; GO:0036126; GO:0036487; GO:0043005; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0050998; GO:0051001; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0099059; GO:0140199; GO:0150104; GO:1900082; GO:1901660; GO:1902083; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145; GO:2000481 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080] AVKVPKK 0.9907 -19.251 11.8703 12.9447 0 0 12.5991 0 14.7127 13.9449 0 0 0 0 0 0 0 12.6951 12.336 14.2677 14.3759 17.2065 15.2632 0 14.3056 0 12.959 0 15.151 0 0 13.4079 11.807 0 0 0 14.2136 0 0 0 0 0 13.5416 0 0 0 0 0 0 0 0 0 0 11.9801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4616 0 12.9909 0 13.9008 0 11.2448 0 0 0 0 14.0274 14.5419 13.5223 15.2816 0 14.4512 0 0 0 0 0 13.339 0 14.6166 13.9994 14.4051 13.3229 14.0128 15.1984 14.3974 14.1573 13.658 0 0 0 14.0304 0 12.5751 12.537 12.9624 15.4124 0 15.6577 15.2884 18.9919 13.9973 15.2564 15.5889 14.5953 15.5991 16.2855 15.1796 16.5062 14.5359 14.4053 15.2199 15.4056 15.0779 0 15.2194 12.3991 14.8296 13.8972 13.2648 0 14.158 15.975 0 15.2889 15.1813 13.5499 14.2965 14.9994 0 15.5526 15.9159 12.458 15.2433 14.1916 14.1372 0 0 0 14.7766 0 0 0 13.594 13.8033 0 0 0 0 14.1014 14.1185 0 0 0 15.0379 0 14.1555 0 0 13.1027 14.6241 15.2496 14.6115 15.6315 0 0 0 0 14.737 P47870 GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) GABRB2 Homo sapiens (Human) "cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; ion transmembrane transport [GO:0034220]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005254; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0007605; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043524; GO:0045202; GO:0050877; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0070161; GO:0071420; GO:0090102; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315; GO:1904862 chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GPQRQKK 0.9907 -20.446 0 0 0 0 0 0 0 0 0 0 0 11.0449 0 0 0 0 0 0 0 0 0 0 10.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1055 0 0 0 0 0 0 0 0 0 0 0 0 12.5231 0 0 0 0 0 11.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0215 0 0 0 0 0 0 0 0 0 0 0 0 10.4532 0 0 0 0 0 0 0 0 0 0 0 14.7152 0 0 0 0 0 0 0 12.8829 0 0 0 0 12.7324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6461 0 0 0 0 0 0 0 0 0 0 11.7747 0 0 0 0 0 0 0 0 0 Q8IWV8 UBR2_HUMAN "E3 ubiquitin-protein ligase UBR2, EC 2.3.2.27 (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)" UBR2 C6orf133 KIAA0349 Homo sapiens (Human) cellular response to leucine [GO:0071233]; heterochromatin assembly [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; heterochromatin assembly [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596 leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DFMEDDHER 0.9907 -19.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5943 0 0 0 12.4499 13.0034 13.2962 0 11.931 13.5122 13.0725 0 11.5796 0 0 0 0 13.2857 13.4779 0 12.9858 0 0 0 0 0 0 0 0 0 0 0 0 0 10.751 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9944 13.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6P7 I22R1_HUMAN "Interleukin-22 receptor subunit alpha-1, IL-22 receptor subunit alpha-1, IL-22R-alpha-1, IL-22RA1 (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9, CRF2-9) (ZcytoR11)" IL22RA1 IL22R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; interferon receptor activity [GO:0004904]; interleukin-20 binding [GO:0042015]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829] GO:0004896; GO:0004904; GO:0005886; GO:0005887; GO:0019221; GO:0042015; GO:0050829 cytokine receptor activity [GO:0004896]; interferon receptor activity [GO:0004904]; interleukin-20 binding [GO:0042015] GLALTVQWES 0.9907 -1.8267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9L7 YV006_HUMAN Putative uncharacterized protein FLJ36925 Homo sapiens (Human) GHKSRGR 0.9907 -20.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1759 12.0463 0 12.0575 0 0 0 10.7711 0 0 0 0 0 0 13.1189 0 0 0 0 9.70387 0 0 0 0 0 0 0 10.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXA6 TSSK6_HUMAN "Testis-specific serine/threonine-protein kinase 6, TSK-6, TSSK-6, Testis-specific kinase 6, EC 2.7.11.1 (Cancer/testis antigen 72, CT72) (Serine/threonine-protein kinase SSTK) (Small serine/threonine kinase)" TSSK6 SSTK FKSG82 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; sperm DNA condensation [GO:0035092] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; sperm DNA condensation [GO:0035092] GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0018105; GO:0035092; GO:0035556; GO:0044877; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] FLPRELSILR 0.9907 -1.8263 0 15.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTJ5 SAC1_HUMAN "Phosphatidylinositol-3-phosphatase SAC1, EC 3.1.3.64 (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein)" SACM1L KIAA0851 SAC1 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0006661; GO:0016021; GO:0016791; GO:0034596; GO:0043812; GO:0046856; GO:0140268 phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812] ECKNMRWDR 0.9907 -4.6057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90866 0 0 0 0 0 0 0 12.6233 0 0 11.8287 14.1053 0 10.9343 12.1577 0 0 9.99534 0 0 0 0 13.0361 13.1793 15.0073 11.3214 0 0 0 0 14.1151 12.6455 0 0 0 0 0 0 10.6833 0 0 0 12.7087 14.471 0 0 13.5088 13.808 13.7146 13.7827 0 14.3134 13.4445 14.8512 0 0 0 0 0 0 0 11.1419 0 12.5913 0 0 0 0 0 13.3826 0 12.6033 12.7312 0 0 0 0 0 14.7842 0 13.1799 12.07 0 14.1784 13.2545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2981 0 14.4866 0 0 0 0 0 Q9P275 UBP36_HUMAN "Ubiquitin carboxyl-terminal hydrolase 36, EC 3.4.19.12 (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36)" USP36 KIAA1453 Homo sapiens (Human) histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0003723; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007000; GO:0016242; GO:0016578; GO:0016579; GO:0016607; GO:0031647; GO:0042981; GO:0050821; GO:1903146; GO:1903955; GO:2000232 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723] ACLNGCAKLDRQTQATTLVHQIFGGYLR 0.9907 -20.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7725 0 0 0 17.1147 0 0 17.3757 0 0 17.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.214 0 0 0 0 0 0 0 0 0 0 0 0 10.9508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2045 0 11.8307 0 0 0 0 15.6039 0 0 0 0 0 0 0 0 0 0 14.4193 0 0 0 0 0 0 0 13.0703 0 0 0 0 0 14.0698 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7687 0 0 0 0 0 0 0 Q9ULM0 PKHH1_HUMAN "Pleckstrin homology domain-containing family H member 1, PH domain-containing family H member 1" PLEKHH1 KIAA1200 Homo sapiens (Human) cytoskeleton [GO:0005856] cytoskeleton [GO:0005856] GO:0005856 ATQISNMPFMDESSGSDDDCSSQASFRISVPSSESR 0.9907 -20.435 0 0 0 0 0 0 0 11.1303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.115 0 0 0 0 12.1817 13.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5183 0 13.5015 0 0 0 0 12.7575 0 13.0567 0 0 12.5416 0 0 0 17.9094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6907 0 13.9096 0 14.4391 0 0 16.3704 0 0 0 0 0 14.165 0 0 0 0 13.3239 0 0 10.9346 0 0 17.6157 12.4577 0 0 0 0 0 0 13.4415 0 0 0 0 0 0 0 0 0 0 0 0 10.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2926 0 0 11.6061 0 0 0 0 14.2774 0 0 0 0 0 O14775 GNB5_HUMAN Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5) GNB5 Homo sapiens (Human) dark adaptation [GO:1990603]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; presynapse [GO:0098793] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; presynapse [GO:0098793]; chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; signaling receptor complex adaptor activity [GO:0030159]; dark adaptation [GO:1990603]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0007165; GO:0007186; GO:0007212; GO:0030159; GO:0031682; GO:0036367; GO:0043547; GO:0051087; GO:0098793; GO:1901386; GO:1902773; GO:1990603 chaperone binding [GO:0051087]; G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; signaling receptor complex adaptor activity [GO:0030159] ALRPVFK 0.99071 -4.6195 0 0 0 0 0 0 0 12.8431 13.7757 13.1564 12.6866 0 0 0 17.7092 0 0 12.572 12.5688 0 0 0 0 0 0 0 12.6408 12.3893 0 12.0681 0 12.5083 0 0 11.9409 12.6724 0 0 0 0 12.1126 0 0 0 0 0 12.5529 0 0 0 0 0 0 0 0 13.6222 0 0 0 0 0 0 0 11.1652 0 0 0 0 0 0 0 13.2079 0 0 0 0 0 0 0 12.1591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.251 0 0 0 18.9617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4308 14.2331 14.6313 14.4865 19.473 0 0 0 0 13.7228 0 0 0 0 0 0 0 O60306 AQR_HUMAN "RNA helicase aquarius, EC 3.6.4.13 (Intron-binding protein of 160 kDa, IBP160)" AQR KIAA0560 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] AAPAQPK 0.99071 -1.8325 12.4671 11.7008 0 9.08791 11.6548 0 0 0 0 0 0 0 0 9.78016 0 0 0 0 0 0 11.8478 13.2609 0 13.4289 0 0 0 0 0 0 0 0 12.1455 0 0 0 12.5036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2461 0 0 12.2861 13.4488 0 0 12.8324 0 13.9616 14.0462 0 0 0 0 13.1398 13.2609 0 12.9386 0 0 13.7543 13.2876 0 12.9201 13.3735 0 0 0 13.7755 0 0 13.0554 13.3088 13.7713 14.1392 12.7501 0 0 0 14.6536 14.7328 13.6986 0 0 0 0 16.3642 0 0 0 0 0 15.3114 0 14.3389 17.1034 16.7816 14.6263 0 0 13.3125 12.0885 14.5373 0 13.7263 13.0347 14.772 0 15.9575 0 14.7735 14.7451 0 0 0 13.886 15.9965 0 0 12.2446 16.4898 10.1227 0 0 0 0 0 0 0 0 0 0 12.85 0 0 0 0 12.4232 0 14.7888 0 15.818 0 0 0 Q14765 STAT4_HUMAN Signal transducer and activator of transcription 4 STAT4 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0006952; GO:0007259; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0045944; GO:0090575 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GRLSALPFADILRDYK 0.99071 -4.6081 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.377 0 0 0 0 0 0 0 0 0 0 0 13.062 0 9.82302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9894 13.7386 12.412 0 0 12.5135 0 0 0 0 0 0 0 0 0 0 0 0 13.0035 0 0 13.6509 0 0 0 0 0 0 0 0 13.5745 0 0 0 0 0 0 12.2883 0 0 0 0 14.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8701 0 0 0 0 0 0 0 13.0193 0 Q8IUC6 TCAM1_HUMAN "TIR domain-containing adapter molecule 1, TICAM-1 (Proline-rich, vinculin and TIR domain-containing protein B) (Putative NF-kappa-B-activating protein 502H) (Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta, MyD88-3, TIR domain-containing adapter protein inducing IFN-beta)" TICAM1 PRVTIRB TRIF Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; B cell proliferation [GO:0042100]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein-containing complex assembly [GO:0043254]; response to exogenous dsRNA [GO:0043330]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739]; ripoptosome [GO:0097342] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739]; ripoptosome [GO:0097342]; protein kinase binding [GO:0019901]; apoptotic signaling pathway [GO:0097190]; B cell proliferation [GO:0042100]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein-containing complex assembly [GO:0043254]; response to exogenous dsRNA [GO:0043330]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] GO:0002281; GO:0002735; GO:0005739; GO:0005776; GO:0005829; GO:0006809; GO:0006954; GO:0007249; GO:0010008; GO:0010508; GO:0010628; GO:0019901; GO:0030890; GO:0031398; GO:0031663; GO:0032092; GO:0032722; GO:0032728; GO:0032755; GO:0032760; GO:0032816; GO:0035666; GO:0042100; GO:0043123; GO:0043254; GO:0043330; GO:0045087; GO:0045429; GO:0051092; GO:0051607; GO:0060907; GO:0071222; GO:0097190; GO:0097342; GO:0140052; GO:1900017 protein kinase binding [GO:0019901] FYNFVILHAR 0.99071 -20.507 0 12.2975 0 0 0 0 12.1749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9634 15.0716 14.8391 13.7356 14.6225 0 13.5951 13.6008 13.3836 14.8284 14.025 0 0 14.1942 13.954 0 0 0 0 0 14.3845 0 13.7727 14.3373 0 13.8388 15.0014 0 0 0 13.6991 12.0267 0 0 0 15.3498 0 0 15.4879 14.1298 13.8806 14.9629 14.1709 0 14.6287 0 15.2358 0 0 0 0 0 0 15.1339 0 0 0 0 0 14.3445 0 13.4385 0 0 12.0242 12.5356 13.5537 15.803 0 14.5742 14.3077 0 0 0 0 13.6761 0 0 13.5871 14.0128 0 13.4349 0 0 0 11.8895 0 0 14.2994 0 13.2923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9553 13.4119 0 0 0 0 Q8IVD9 NUDC3_HUMAN NudC domain-containing protein 3 NUDCD3 KIAA1068 Homo sapiens (Human) cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; unfolded protein binding [GO:0051082]; cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793] GO:0005737; GO:0005868; GO:0006457; GO:0051082; GO:0060271; GO:1905793 unfolded protein binding [GO:0051082] ENYTWSQDYTDLEVR 0.99071 -4.6144 0 0 0 0 0 0 0 0 12.3549 0 0 0 11.2302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4972 0 0 0 0 0 0 0 0 0 12.8219 0 14.8913 0 0 0 0 0 0 12.555 0 0 0 0 0 0 12.463 0 12.8147 0 0 0 13.3841 0 0 0 0 0 0 0 0 0 0 0 11.8546 0 0 0 12.2668 0 0 0 13.9655 0 0 0 0 0 0 0 10.7013 12.2563 0 0 0 11.6531 0 12.2095 0 0 0 12.0014 0 0 0 0 0 0 14.2294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXF0 SRS12_HUMAN "Serine/arginine-rich splicing factor 12 (35 kDa SR repressor protein, SRrp35) (Splicing factor, arginine/serine-rich 13B) (Splicing factor, arginine/serine-rich 19)" SRSF12 SFRS13B SFRS19 SRRP35 Homo sapiens (Human) "mRNA 5'-splice site recognition [GO:0000395]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; mRNA 5'-splice site recognition [GO:0000395]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000244; GO:0000381; GO:0000395; GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0016607; GO:0048025; GO:0050733; GO:0051082 RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082] FSYSQSKSR 0.99071 -20.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4459 0 12.8101 0 0 0 0 0 0 0 0 13.3075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DG6 CMBL_HUMAN "Carboxymethylenebutenolidase homolog, EC 3.1.-.-" CMBL Homo sapiens (Human) xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; xenobiotic metabolic process [GO:0006805] GO:0005829; GO:0006805; GO:0016787; GO:0070062 hydrolase activity [GO:0016787] EDCSPADKPYIDEAR 0.99071 -5.9752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.586 0 0 0 0 0 0 0 0 0 13.9243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99593 TBX5_HUMAN "T-box transcription factor TBX5, T-box protein 5" TBX5 Homo sapiens (Human) "atrial septum morphogenesis [GO:0060413]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; atrioventricular valve morphogenesis [GO:0003181]; bundle of His cell to Purkinje myocyte communication by electrical coupling [GO:0086054]; bundle of His development [GO:0003166]; cardiac left ventricle formation [GO:0003218]; cardiac muscle cell proliferation [GO:0060038]; cell fate specification [GO:0001708]; cell migration involved in coronary vasculogenesis [GO:0060980]; cell-cell signaling [GO:0007267]; cell-cell signaling involved in cardiac conduction [GO:0086019]; embryonic forelimb morphogenesis [GO:0035115]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion development [GO:0003197]; forelimb morphogenesis [GO:0035136]; heart development [GO:0007507]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pattern specification process [GO:0007389]; pericardium development [GO:0060039]; positive regulation of cardiac conduction [GO:1903781]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node development [GO:0003163]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; atrial septum morphogenesis [GO:0060413]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; atrioventricular valve morphogenesis [GO:0003181]; bundle of His cell to Purkinje myocyte communication by electrical coupling [GO:0086054]; bundle of His development [GO:0003166]; cardiac left ventricle formation [GO:0003218]; cardiac muscle cell proliferation [GO:0060038]; cell fate specification [GO:0001708]; cell migration involved in coronary vasculogenesis [GO:0060980]; cell-cell signaling [GO:0007267]; cell-cell signaling involved in cardiac conduction [GO:0086019]; embryonic forelimb morphogenesis [GO:0035115]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion development [GO:0003197]; forelimb morphogenesis [GO:0035136]; heart development [GO:0007507]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pattern specification process [GO:0007389]; pericardium development [GO:0060039]; positive regulation of cardiac conduction [GO:1903781]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node development [GO:0003163]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001708; GO:0002009; GO:0003163; GO:0003166; GO:0003167; GO:0003181; GO:0003197; GO:0003218; GO:0003281; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006366; GO:0007267; GO:0007389; GO:0007507; GO:0008285; GO:0010719; GO:0030324; GO:0030326; GO:0030336; GO:0032991; GO:0032993; GO:0035115; GO:0035136; GO:0043565; GO:0045893; GO:0045944; GO:0051891; GO:0060038; GO:0060039; GO:0060044; GO:0060045; GO:0060371; GO:0060413; GO:0060928; GO:0060929; GO:0060980; GO:0061629; GO:0072513; GO:0086019; GO:0086054; GO:1901846; GO:1903598; GO:1903781 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]" LTNNHLDPFGHIILNSMHK 0.99071 -1.8369 0 0 0 0 0 0 0 15.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.708 0 0 0 12.584 0 17.0523 0 17.1922 0 0 0 0 17.1461 0 0 0 0 0 0 0 0 17.7374 0 17.5283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6821 0 14.2338 0 0 0 0 0 17.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5003 0 17.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXY0 MAK16_HUMAN Protein MAK16 homolog (NNP78) (Protein RBM13) MAK16 RBM13 Homo sapiens (Human) maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470] "intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]" GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0030687; GO:0043231 RNA binding [GO:0003723] ALEQIDENLIYWPRFIR 0.99071 -20.489 0 0 0 0 11.4918 0 0 0 0 0 0 0 12.7893 0 0 0 11.9313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5236 0 0 0 0 0 0 0 0 0 0 0 11.5718 0 0 0 0 12.607 0 0 0 0 0 0 0 0 0 16.108 0 0 0 0 0 0 0 0 15.2719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2038 0 0 0 0 0 0 0 0 13.4227 0 0 0 0 0 0 0 10.602 0 12.7268 10.4138 0 0 0 0 0 0 0 0 10.439 0 0 12.7454 0 9.31025 0 0 0 0 0 0 0 0 0 0 14.8605 0 0 0 0 0 0 0 0 0 0 Q9NXF7 DCA16_HUMAN DDB1- and CUL4-associated factor 16 DCAF16 C4orf30 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567] GO:0005654; GO:0016567; GO:0080008 LEPIPEWPPLASCGVPPFQKPLTSPSR 0.99071 -5.9783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9443 0 0 0 0 0 0 0 0 0 0 0 0 11.9629 0 11.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6483 0 0 0 0 0 0 0 14.7416 14.926 0 0 0 0 0 14.2329 0 0 0 13.5755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0969 0 0 13.6069 13.4836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2928 0 0 0 0 0 0 0 13.2448 0 0 0 Q9UFC0 LRWD1_HUMAN "Leucine-rich repeat and WD repeat-containing protein 1 (Centromere protein 33, CENP-33) (Origin recognition complex-associated protein, ORC-associated protein, ORCA)" LRWD1 CENP-33 ORCA Homo sapiens (Human) chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; DNA replication initiation [GO:0006270]; establishment of protein localization to chromatin [GO:0071169]" GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005654; GO:0005664; GO:0005721; GO:0005730; GO:0005737; GO:0005815; GO:0006270; GO:0006325; GO:0008327; GO:0035064; GO:0043231; GO:0071169 chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064] DVRYGPESLSEFTQWRVR 0.99071 -1.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9375 0 0 0 0 0 0 14.4012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4555 0 0 0 0 0 0 0 0 12.8421 0 0 0 0 0 13.3417 0 0 0 0 14.327 0 0 13.2725 0 0 0 0 0 0 0 12.9782 13.1455 0 13.2866 0 0 0 0 0 12.946 0 0 12.6378 0 14.3593 0 0 0 0 13.8848 0 13.1476 0 13.7122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9357 0 0 0 0 0 0 0 0 0 12.8174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13867 BLMH_HUMAN "Bleomycin hydrolase, BH, BLM hydrolase, BMH, EC 3.4.22.40" BLMH Homo sapiens (Human) homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] GO:0000209; GO:0004177; GO:0004180; GO:0004197; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008234; GO:0009410; GO:0009636; GO:0042802; GO:0043418; GO:0070062 aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802] CWIFSCLNVMR 0.99072 -5.9795 0 0 0 0 0 0 0 0 12.75 0 0 0 12.9381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7401 0 11.7887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8365 0 0 12.5563 0 0 0 0 0 0 0 0 0 14.0928 0 0 16.2842 13.12 0 0 12.4567 13.1295 13.3446 13.5221 14.4111 13.5839 0 0 0 12.4785 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4994 0 0 12.4763 12.0072 13.2475 0 0 0 0 0 0 0 0 0 0 0 0 14.4173 0 0 0 0 0 0 0 0 0 13.5748 0 0 0 0 13.2082 13.4046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBB5 KLDC4_HUMAN Kelch domain-containing protein 4 KLHDC4 Homo sapiens (Human) DVDKGTR 0.99072 -20.21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVR3 TPC14_HUMAN Trafficking protein particle complex subunit 14 (Microtubule-associated protein 11) TRAPPC14 C7orf43 MAP11 Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of cell population proliferation [GO:0042127] centriolar satellite [GO:0034451]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; TRAPPII protein complex [GO:1990071] centriolar satellite [GO:0034451]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; TRAPPII protein complex [GO:1990071]; alpha-tubulin binding [GO:0043014]; cilium assembly [GO:0060271]; regulation of cell population proliferation [GO:0042127] GO:0005886; GO:0030496; GO:0034451; GO:0042127; GO:0043014; GO:0043231; GO:0060271; GO:0072686; GO:1990071 alpha-tubulin binding [GO:0043014] AITPPVASPVGRPLYLPPDK 0.99072 -5.9923 0 0 0 0 0 0 0 0 0 0 13.0925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.377 0 0 0 0 0 0 0 0 0 11.7787 0 0 0 14.2219 14.4696 0 0 13.5016 0 0 0 0 0 0 0 0 13.7378 0 14.2593 0 11.7223 0 0 0 0 0 12.45 0 0 0 13.8646 13.6653 0 0 0 0 13.9456 0 0 0 13.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7865 0 13.9566 14.0533 0 0 0 0 0 14.0338 0 13.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EK9 KTI12_HUMAN Protein KTI12 homolog KTI12 SBBI81 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098] ATP binding [GO:0005524]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0005524; GO:0006357 ATP binding [GO:0005524] NRWDRPLFTLVGLEEPLPLAGIR 0.99072 -5.9863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4579 0 0 0 0 0 0 12.5701 12.6942 0 15.1263 0 0 14.458 14.3867 0 0 0 13.068 0 0 0 0 0 14.0436 0 15.6592 15.3886 0 0 14.6518 0 14.8548 0 0 15.2594 0 0 12.3692 0 0 15.009 0 0 0 0 0 0 16.1095 0 0 0 0 0 0 15.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PN7 TREF1_HUMAN Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132) TRERF1 BCAR2 RAPA TREP132 Homo sapiens (Human) "cellular response to progesterone stimulus [GO:0071393]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear progesterone receptor binding [GO:0033142]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; cellular response to progesterone stimulus [GO:0071393]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0016575; GO:0030374; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050847; GO:0071393 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear progesterone receptor binding [GO:0033142]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714] GAFGEQFDAK 0.99072 -20.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9772 0 0 0 0 0 0 11.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0258 11.8566 0 0 0 0 13.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4885 14.1666 0 14.5854 14.6501 0 0 0 0 13.3982 0 0 0 0 0 12.7204 13.0251 0 0 0 0 0 0 0 0 0 0 0 15.4632 0 0 14.4255 0 0 14.6729 0 0 0 0 0 0 0 12.8729 0 0 0 0 14.7378 0 15.4597 0 0 0 0 0 13.6885 0 0 13.6233 13.3902 0 0 14.1061 0 0 14.0178 0 12.5362 0 0 12.2963 12.853 14.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2549 0 13.1377 0 0 0 0 0 0 0 14.3076 0 0 0 0 0 14.5119 0 0 14.4073 0 0 0 0 Q96PY6 NEK1_HUMAN "Serine/threonine-protein kinase Nek1, EC 2.7.11.1 (Never in mitosis A-related kinase 1, NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55)" NEK1 KIAA1901 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468] GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007049; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] AEDNEAKWKR 0.99072 -20.22 0 0 0 0 0 0 0 0 0 11.1289 0 0 0 0 0 0 0 0 0 11.1648 0 0 10.7002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4306 0 0 13.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9905 0 0 0 0 11.8382 0 13.05 0 0 0 0 0 0 0 0 0 13.373 0 0 0 0 12.08 11.0922 0 13.4081 0 0 16.8703 14.1067 0 0 13.4569 0 0 13.9661 0 0 0 0 0 0 14.0631 12.5568 0 0 0 0 0 0 12.8142 0 0 0 0 13.3311 0 0 13.6843 0 0 0 0 12.5832 0 0 12.0368 0 10.9428 0 0 0 0 13.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2085 0 0 0 0 0 0 0 16.4486 13.9588 0 0 0 Q9Y2K7 KDM2A_HUMAN "Lysine-specific demethylase 2A, EC 1.14.11.27 (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)" KDM2A CXXC8 FBL11 FBL7 FBXL11 JHDM1A KIAA1004 Homo sapiens (Human) chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription by competitive promoter binding [GO:0010944]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 demethylation [GO:0070544]; negative regulation of transcription by competitive promoter binding [GO:0010944]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003712; GO:0005654; GO:0005694; GO:0006303; GO:0006325; GO:0006357; GO:0006482; GO:0008270; GO:0010944; GO:0032452; GO:0032922; GO:0042752; GO:0045322; GO:0051864; GO:0070544; GO:0140680 histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] ACVQGECGVCHYCR 0.99072 -21.612 0 0 0 0 0 0 0 0 0 0 0 12.0358 0 0 0 0 0 0 0 0 0 0 14.0666 13.7399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5337 0 0 0 12.147 0 13.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1073 14.8642 14.4121 0 0 11.9174 0 16.2489 0 0 0 0 14.1505 17.2774 0 11.4643 0 12.8155 0 0 0 0 0 0 0 13.7521 0 0 0 0 0 0 0 0 0 0 0 15.3402 14.1084 0 0 10.9114 0 0 0 14.8335 0 0 0 0 0 0 0 13.5707 0 0 11.5817 0 12.0759 12.3312 11.4315 0 12.6896 0 0 0 0 0 12.1371 0 0 0 0 11.8221 12.9509 0 0 0 12.5959 0 11.7263 0 12.4288 0 0 0 0 11.1214 14.4923 16.1646 0 12.5628 0 0 11.3647 0 15.9344 13.8253 12.0514 11.4953 A7XYQ1 SOBP_HUMAN Sine oculis-binding protein homolog (Jackson circler protein 1) SOBP JXC1 Homo sapiens (Human) animal organ development [GO:0048513]; cochlea development [GO:0090102]; cognition [GO:0050890]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184]; animal organ development [GO:0048513]; cochlea development [GO:0090102]; cognition [GO:0050890]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605] GO:0005634; GO:0007605; GO:0007626; GO:0032184; GO:0042472; GO:0046872; GO:0048513; GO:0050890; GO:0090102 metal ion binding [GO:0046872]; SUMO polymer binding [GO:0032184] ARLHNVIHRALHAHVK 0.99073 -20.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1228 0 0 0 0 0 O75970 MPDZ_HUMAN Multiple PDZ domain protein (Multi-PDZ domain protein 1) MPDZ MUPP1 Homo sapiens (Human) apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; protein C-terminus binding [GO:0008022] GO:0005737; GO:0005923; GO:0008022; GO:0014069; GO:0016324; GO:0016327; GO:0030425 protein C-terminus binding [GO:0008022] ATGVIVK 0.99073 -21.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.637 12.1073 0 12.6229 0 0 14.5465 0 13.4315 12.1292 11.818 12.9524 12.7487 0 12.5346 11.8593 12.5489 0 12.2802 0 0 0 0 0 0 12.0736 12.9872 12.2906 12.4974 11.8524 0 13.854 0 12.6731 0 0 18.7833 0 0 0 0 0 0 0 0 0 17.7868 0 0 0 0 0 0 12.267 0 0 0 0 12.9184 0 0 0 0 0 0 0 0 0 11.8667 0 15.335 14.997 15.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8776 12.9652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0774 0 0 0 0 0 0 0 0 0 0 15.298 0 0 0 0 15.1644 O95260 ATE1_HUMAN "Arginyl-tRNA--protein transferase 1, Arginyltransferase 1, R-transferase 1, EC 2.3.2.8 (Arginine-tRNA--protein transferase 1)" ATE1 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598] GO:0004057; GO:0005634; GO:0005737; GO:0010498; GO:0016598 arginyltransferase activity [GO:0004057] CRPLQFQPSK 0.99073 -20.312 0 0 0 0 0 0 0 0 0 14.0348 0 0 13.2916 0 0 0 0 0 0 10.8289 0 0 0 0 0 13.1852 12.0659 13.279 14.8474 14.8815 14.4123 0 14.7304 0 13.927 0 13.9527 0 0 0 0 0 12.8088 0 0 0 0 0 0 12.6137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8491 0 0 0 0 0 13.7622 0 0 11.9061 0 11.5836 11.2491 0 0 0 0 0 0 0 0 12.9809 0 0 0 13.1775 0 0 0 0 12.311 0 0 0 0 0 0 9.95107 0 0 0 12.3898 13.7857 0 0 0 0 13.4947 0 0 0 13.5848 0 0 0 9.54257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5434 0 0 0 0 10.634 0 12.1116 0 0 0 0 9.93035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22794 EVI2A_HUMAN "Protein EVI2A (Ecotropic viral integration site 2A protein homolog, EVI-2A)" EVI2A EVDA EVI2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane signaling receptor activity [GO:0004888] GO:0004888; GO:0016021 transmembrane signaling receptor activity [GO:0004888] LTNKQIG 0.99073 -20.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P83369 LSM11_HUMAN U7 snRNA-associated Sm-like protein LSm11 LSM11 Homo sapiens (Human) mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin organization [GO:1902275] histone pre-mRNA 3'end processing complex [GO:0071204]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; U7 snRNP [GO:0005683] histone pre-mRNA 3'end processing complex [GO:0071204]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; U7 snRNP [GO:0005683]; U7 snRNA binding [GO:0071209]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; regulation of chromatin organization [GO:1902275] GO:0005634; GO:0005654; GO:0005683; GO:0005697; GO:0006398; GO:0016604; GO:0071204; GO:0071209; GO:1900087; GO:1902275 U7 snRNA binding [GO:0071209] GARSAGAGSPARPPSPR 0.99073 -21.258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7684 12.7284 13.5803 10.8881 0 0 0 0 0 0 0 0 0 0 0 0 12.4288 0 0 0 0 12.8357 0 0 0 0 0 13.493 0 0 13.0002 0 0 0 0 0 11.3331 0 0 0 0 0 0 0 12.841 0 14.8626 0 0 0 0 0 0 0 0 0 0 13.4534 0 0 12.4988 0 0 0 0 10.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08050 FOXM1_HUMAN "Forkhead box protein M1 (Forkhead-related protein FKHL16) (Hepatocyte nuclear factor 3 forkhead homolog 11, HFH-11, HNF-3/fork-head homolog 11) (M-phase phosphoprotein 2) (MPM-2 reactive phosphoprotein 2) (Transcription factor Trident) (Winged-helix factor from INS-1 cells)" FOXM1 FKHL16 HFH11 MPP2 WIN Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of Ras protein signal transduction [GO:0046578]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of Ras protein signal transduction [GO:0046578]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000086; GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001558; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006357; GO:0006978; GO:0008284; GO:0019901; GO:0032873; GO:0042127; GO:0045892; GO:0045893; GO:0045944; GO:0046578; GO:0051726; GO:2000377; GO:2000781 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" PLILKRR 0.99073 -20.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1554 0 0 0 0 0 0 0 0 0 13.8894 0 0 0 0 0 0 0 0 0 0 0 0 0 15.12 0 0 12.6558 0 0 0 0 15.0493 15.4368 15.3612 0 0 0 0 14.8701 0 14.9014 0 13.0057 0 0 0 0 15.0479 0 0 15.3142 0 14.9339 0 0 15.6372 14.8382 0 15.0615 15.0299 0 14.913 0 0 14.8106 0 14.8164 12.5167 15.0668 0 14.9544 14.6133 0 15.2141 11.3198 0 0 0 0 0 0 0 0 0 0 13.9209 0 0 0 0 0 0 0 0 0 10.7306 0 0 0 0 0 0 0 0 12.0559 12.4375 13.9547 0 0 0 Q75N03 HAKAI_HUMAN "E3 ubiquitin-protein ligase Hakai, EC 2.3.2.27 (Casitas B-lineage lymphoma-transforming sequence-like protein 1, c-Cbl-like protein 1) (RING finger protein 188) (RING-type E3 ubiquitin transferase Hakai)" CBLL1 HAKAI RNF188 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; mRNA methylation [GO:0080009]; negative regulation of cell adhesion [GO:0007162]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell-cell adhesion [GO:0098609]; mRNA methylation [GO:0080009]; negative regulation of cell adhesion [GO:0007162]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155] GO:0000151; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0007162; GO:0016567; GO:0016607; GO:0030155; GO:0030335; GO:0036396; GO:0042802; GO:0045807; GO:0046872; GO:0061630; GO:0080009; GO:0098609 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] IPIKLISK 0.99073 -21.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0089 0 0 0 14.5578 0 0 0 0 0 15.1795 15.7376 15.4582 16.1585 0 15.3628 0 0 0 15.2299 15.4092 0 16.155 10.2891 16.0131 0 0 0 0 0 14.4897 0 0 0 0 0 0 0 0 0 0 16.316 0 0 0 16.141 0 0 13.2801 0 0 0 0 0 0 0 0 0 0 16.0265 15.7327 0 0 0 15.1881 15.2671 15.1329 0 0 15.2329 0 0 0 0 12.6637 0 0 0 0 15.4464 13.7093 10.5751 0 0 0 0 11.5231 0 0 0 0 0 0 12.765 0 15.256 0 0 0 12.9796 0 0 0 Q7LC44 ARC_HUMAN "Activity-regulated cytoskeleton-associated protein, hArc (Activity-regulated gene 3.1 protein homolog, ARC/ARG3.1, Arg3.1)" ARC KIAA0278 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; endoderm development [GO:0007492]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; mRNA transport [GO:0051028]; positive regulation of AMPA receptor activity [GO:2000969]; protein homooligomerization [GO:0051260]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated intercellular transport [GO:0110077] acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular vesicle [GO:1903561]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic endosome [GO:0098845] acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular vesicle [GO:1903561]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic endosome [GO:0098845]; mRNA binding [GO:0003729]; anterior/posterior pattern specification [GO:0009952]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; endoderm development [GO:0007492]; learning [GO:0007612]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; mRNA transport [GO:0051028]; positive regulation of AMPA receptor activity [GO:2000969]; protein homooligomerization [GO:0051260]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated intercellular transport [GO:0110077] GO:0001669; GO:0003729; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006897; GO:0007010; GO:0007492; GO:0007612; GO:0007616; GO:0009952; GO:0015629; GO:0016477; GO:0022604; GO:0031901; GO:0043025; GO:0043197; GO:0045121; GO:0048168; GO:0050804; GO:0051028; GO:0051260; GO:0060291; GO:0060997; GO:0061001; GO:0070161; GO:0071598; GO:0098839; GO:0098845; GO:0098978; GO:0099149; GO:0110077; GO:1900271; GO:1900452; GO:1903561; GO:2000969 mRNA binding [GO:0003729] ELDLPQKQGEPLDQFLWR 0.99073 -20.71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1436 0 0 0 14.5149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.243 0 0 13.1175 0 0 0 0 12.4759 0 0 0 0 0 0 13.0137 12.5413 0 0 0 0 0 11.5968 0 0 0 0 0 0 0 0 Q8WYL5 SSH1_HUMAN "Protein phosphatase Slingshot homolog 1, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 1, SSH-1L, hSSH-1L)" SSH1 KIAA1298 SSH1L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; regulation of cellular protein metabolic process [GO:0032268] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902]; cellular response to ATP [GO:0071318]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470]; regulation of cellular protein metabolic process [GO:0032268] GO:0000902; GO:0003779; GO:0004721; GO:0004725; GO:0005737; GO:0005856; GO:0005886; GO:0006470; GO:0008138; GO:0017018; GO:0030027; GO:0030036; GO:0030496; GO:0030837; GO:0032154; GO:0032268; GO:0071318 actin binding [GO:0003779]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] ETPKVLPKSLLLK 0.99073 -20.693 0 0 13.5073 0 0 0 0 0 0 12.6133 0 12.2464 0 13.7777 0 0 0 0 0 0 0 0 0 0 0 0 13.3437 12.5637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1692 0 0 0 17.8057 13.7505 15.6274 0 0 0 0 13.7095 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5594 0 0 0 0 0 0 0 17.4225 0 0 0 0 17.4152 0 0 12.8601 14.0546 0 13.1312 0 12.3307 0 0 0 0 0 0 0 0 0 0 13.37 0 0 0 0 0 0 0 0 13.4733 12.9836 13.5909 0 0 0 13.8725 0 0 0 0 0 12.5026 0 13.9374 0 0 0 0 0 0 0 0 0 0 0 0 12.85 0 0 0 13.0395 0 0 0 0 0 0 0 0 0 0 Q96Q91 B3A4_HUMAN "Anion exchange protein 4, AE 4, Anion exchanger 4 (Sodium bicarbonate cotransporter 5) (Solute carrier family 4 member 9)" SLC4A9 AE4 SBC5 Homo sapiens (Human) bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] GO:0005452; GO:0005886; GO:0008510; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0022857; GO:0045177; GO:0050801; GO:0051453; GO:0055085 anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857] EQRLTGLVVFILTGASIFLAPVLK 0.99073 -20.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.053 0 0 0 0 0 0 0 0 10.8588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9824 12.6772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW82 WDR70_HUMAN WD repeat-containing protein 70 WDR70 Homo sapiens (Human) regulation of DNA double-strand break processing [GO:1903775] nucleus [GO:0005634]; site of double-strand break [GO:0035861] nucleus [GO:0005634]; site of double-strand break [GO:0035861]; enzyme binding [GO:0019899]; regulation of DNA double-strand break processing [GO:1903775] GO:0005634; GO:0019899; GO:0035861; GO:1903775 enzyme binding [GO:0019899] GAKLCVVK 0.99073 -20.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6008 0 0 0 0 0 13.3857 0 0 0 0 0 0 0 0 0 0 12.4957 0 14.3186 0 0 13.0606 0 0 0 14.3939 15.0873 0 0 0 0 0 0 0 0 0 12.3858 0 0 0 0 0 0 0 0 0 0 0 0 13.7438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1641 0 13.9501 0 Q9Y3R5 DOP2_HUMAN Protein dopey-2 DOP1B C21orf5 DOPEY2 KIAA0933 Homo sapiens (Human) cognition [GO:0050890]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; cognition [GO:0050890]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum organization [GO:0007029]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0007029; GO:0009880; GO:0015031; GO:0031901; GO:0050890; GO:0070062 ALQSNLRYSLLPRR 0.99073 -21.276 0 0 0 0 9.70323 0 0 0 11.3153 0 13.0166 0 0 0 0 0 0 0 0 0 11.0931 0 0 0 0 0 11.8913 0 0 11.56 0 10.645 0 13.9884 0 0 12.239 0 0 0 0 11.6147 0 0 0 0 0 0 0 0 0 0 0 11.1292 0 0 0 10.6865 0 0 0 0 0 0 0 0 14.4626 15.808 12.9445 14.8483 13.7614 13.8487 13.8823 12.7352 14.5116 0 13.2398 0 13.3742 0 13.0024 0 13.1618 0 13.0604 14.5652 16.8871 16.4376 16.3118 14.9814 0 16.6781 0 11.4673 0 11.9792 16.8135 16.0655 0 11.6156 0 15.4198 11.1347 11.5385 0 0 12.7848 12.6285 0 13.181 0 0 10.0473 15.9059 16.2712 0 14.4301 14.5517 13.9762 13.0045 13.8748 13.1536 13.7209 13.1618 15.8097 17.0772 14.7192 14.6889 0 14.9826 0 11.9307 0 0 13.7587 13.9744 0 0 0 0 13.614 0 14.3125 14.236 14.817 0 14.3146 0 0 15.4582 0 0 13.3002 0 12.8108 0 0 0 0 0 0 0 10.4195 0 0 0 0 0 0 12.4443 0 13.7627 12.4409 0 13.4756 13.3515 0 0 0 0 O15296 LX15B_HUMAN "Polyunsaturated fatty acid lipoxygenase ALOX15B (15-lipoxygenase 2, 15-LOX-2) (Arachidonate 15-lipoxygenase B, 15-LOX-B, EC 1.13.11.33) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb, EC 1.13.11.-)" ALOX15B Homo sapiens (Human) apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; endocannabinoid signaling pathway [GO:0071926]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; phospholipid metabolic process [GO:0006644]; positive regulation of chemokine production [GO:0032722]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostate gland development [GO:0030850]; regulation of epithelial cell differentiation [GO:0030856] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; arachidonate 15-lipoxygenase activity [GO:0050473]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; linoleate 9S-lipoxygenase activity [GO:1990136]; lipid binding [GO:0008289]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; endocannabinoid signaling pathway [GO:0071926]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; phospholipid metabolic process [GO:0006644]; positive regulation of chemokine production [GO:0032722]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; prostate gland development [GO:0030850]; regulation of epithelial cell differentiation [GO:0030856]" GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006629; GO:0006644; GO:0006915; GO:0008285; GO:0008289; GO:0010744; GO:0016020; GO:0016165; GO:0016702; GO:0019369; GO:0019372; GO:0019898; GO:0030336; GO:0030850; GO:0030856; GO:0032722; GO:0034440; GO:0035360; GO:0036403; GO:0043651; GO:0045618; GO:0045786; GO:0045926; GO:0050473; GO:0051122; GO:0070062; GO:0071926; GO:1901696; GO:1990136; GO:2001303 "arachidonate 15-lipoxygenase activity [GO:0050473]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; linoleate 9S-lipoxygenase activity [GO:1990136]; lipid binding [GO:0008289]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]" ELQAWVR 0.99074 -4.6715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3994 0 0 0 0 0 0 0 0 0 12.7445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9217 0 14.9596 13.77 0 0 13.44 13.9087 0 13.5881 15.7635 12.9055 13.744 0 0 13.1397 0 13.1663 0 0 0 0 11.3075 0 12.8149 0 0 0 0 0 0 0 0 0 0 11.1281 0 0 0 0 11.5672 0 0 0 0 0 0 0 0 0 0 0 15.4032 0 15.3931 12.7585 0 0 0 0 0 0 0 0 0 0 12.8728 0 0 0 0 0 12.5954 12.7637 0 0 0 0 0 0 0 0 0 0 0 0 11.321 0 0 10.944 0 0 12.7405 0 13.7527 0 0 0 P07384 CAN1_HUMAN "Calpain-1 catalytic subunit, EC 3.4.22.52 (Calcium-activated neutral proteinase 1, CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain, muCANP)" CAPN1 CANPL1 PIG30 Homo sapiens (Human) mammary gland involution [GO:0060056]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]; mammary gland involution [GO:0060056]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264] GO:0001533; GO:0004198; GO:0005509; GO:0005576; GO:0005737; GO:0005739; GO:0005764; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0008233; GO:0008284; GO:0016020; GO:0016241; GO:0032801; GO:0050790; GO:0060056; GO:0070062; GO:0097264; GO:1904813; GO:2000310 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233] DLGPNSSK 0.99074 -5.5892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6506 0 0 0 13.9111 13.7076 13.786 0 0 0 0 11.364 0 0 0 0 13.1495 13.2575 0 0 0 0 0 0 0 13.4521 0 13.6003 0 0 0 13.1594 14.6792 0 13.2343 13.8403 0 0 0 0 0 0 0 13.3369 0 0 0 0 13.5209 0 0 0 0 0 13.3332 0 0 0 0 0 0 0 0 13.4329 0 0 0 0 13.5833 0 0 0 0 14.2239 0 13.4843 0 0 0 0 0 0 0 0 11.8509 0 0 10.8846 0 0 0 0 0 0 0 14.1396 0 0 0 0 0 0 0 0 0 P10275 ANDR_HUMAN Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) AR DHTR NR3C4 Homo sapiens (Human) "activation of prostate induction by androgen receptor signaling pathway [GO:0060520]; androgen receptor signaling pathway [GO:0030521]; animal organ formation [GO:0048645]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to testosterone stimulus [GO:0071394]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell morphogenesis [GO:0003382]; epithelial cell proliferation [GO:0050673]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular receptor signaling pathway [GO:0030522]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; Leydig cell differentiation [GO:0033327]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; male somatic sex determination [GO:0019102]; mammary gland alveolus development [GO:0060749]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland growth [GO:0060736]; regulation of developmental growth [GO:0048638]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; androgen binding [GO:0005497]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; POU domain binding [GO:0070974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; activation of prostate induction by androgen receptor signaling pathway [GO:0060520]; androgen receptor signaling pathway [GO:0030521]; animal organ formation [GO:0048645]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to testosterone stimulus [GO:0071394]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell morphogenesis [GO:0003382]; epithelial cell proliferation [GO:0050673]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular receptor signaling pathway [GO:0030522]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; Leydig cell differentiation [GO:0033327]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; male somatic sex determination [GO:0019102]; mammary gland alveolus development [GO:0060749]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland growth [GO:0060736]; regulation of developmental growth [GO:0048638]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000165; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001091; GO:0001223; GO:0001228; GO:0001701; GO:0003073; GO:0003382; GO:0003682; GO:0003700; GO:0004879; GO:0005102; GO:0005496; GO:0005497; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006366; GO:0007165; GO:0007267; GO:0007283; GO:0007338; GO:0008013; GO:0008270; GO:0008284; GO:0008285; GO:0008584; GO:0010628; GO:0016607; GO:0019102; GO:0019899; GO:0030518; GO:0030520; GO:0030521; GO:0030522; GO:0032991; GO:0033148; GO:0033327; GO:0035264; GO:0042327; GO:0043410; GO:0043568; GO:0045597; GO:0045720; GO:0045726; GO:0045893; GO:0045944; GO:0045945; GO:0048009; GO:0048638; GO:0048645; GO:0048808; GO:0050673; GO:0050680; GO:0051092; GO:0051117; GO:0060520; GO:0060571; GO:0060599; GO:0060736; GO:0060740; GO:0060742; GO:0060748; GO:0060749; GO:0060769; GO:0061629; GO:0070974; GO:0071383; GO:0071391; GO:0071394; GO:0072520; GO:1903076; GO:2001237 "androgen binding [GO:0005497]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; nuclear receptor activity [GO:0004879]; POU domain binding [GO:0070974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" DYYNFPLALAGPPPPPPPPHPHARIK 0.99074 -20.886 0 0 0 0 0 0 0 0 0 0 0 0 9.48392 0 0 0 0 0 0 0 10.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6227 0 0 14.7858 0 0 12.7439 14.6577 0 0 0 0 16.0237 0 0 0 0 0 0 11.7701 0 0 0 0 0 10.2476 0 0 0 0 0 0 0 11.3943 0 0 0 0 0 0 0 0 0 0 0 11.164 0 0 0 0 0 0 0 0 9.87731 12.8112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.694 0 0 0 0 0 0 0 0 0 14.8286 0 0 0 0 0 0 0 0 15.4241 12.2074 0 0 0 0 14.1555 P20794 MAK_HUMAN "Serine/threonine-protein kinase MAK, EC 2.7.11.1 (Male germ cell-associated kinase)" MAK Homo sapiens (Human) cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] axoneme [GO:0005930]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] GO:0001750; GO:0001917; GO:0003713; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0005930; GO:0006468; GO:0007283; GO:0030154; GO:0030496; GO:0031514; GO:0032391; GO:0035556; GO:0042073; GO:0045494; GO:0046777; GO:0046872; GO:0060271; GO:0072686; GO:0106310; GO:1902856; GO:1905515 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713] ENLYQLMK 0.99074 -20.401 0 0 0 0 0 0 0 0 13.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1012 0 0 0 12.2374 0 0 0 0 0 0 12.3497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0304 0 0 0 0 0 14.5621 0 0 0 13.6958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9747 0 0 13.1365 0 0 0 0 0 12.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2458 Q15059 BRD3_HUMAN Bromodomain-containing protein 3 (RING3-like protein) BRD3 KIAA0043 RING3L Homo sapiens (Human) "chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0003682; GO:0005634; GO:0006338; GO:0006355; GO:0006357; GO:0070577 chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577] ATRLAELQEQLK 0.99074 -5.8766 0 0 0 0 0 0 0 13.0277 0 0 0 0 0 0 0 0 0 0 0 12.1455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7414 12.8415 13.882 0 0 0 15.3503 0 0 12.896 0 0 0 0 12.5658 12.5448 13.9585 0 0 12.8042 0 0 0 0 0 13.4475 13.9101 0 0 0 0 0 13.7826 0 13.9226 13.7041 13.1675 0 0 0 0 14.0967 14.7011 0 13.2715 12.9022 13.7945 15.475 12.6609 12.8747 0 0 13.6488 13.7128 14.8969 15.4948 14.5082 11.375 14.6699 0 0 0 15.0612 0 13.9116 13.5804 14.38 0 0 14.1395 0 0 14.1158 0 0 0 14.3465 14.3151 12.3203 0 14.0501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7234 15.1622 14.2725 13.4516 0 0 0 0 0 Q16566 KCC4_HUMAN "Calcium/calmodulin-dependent protein kinase type IV, CaMK IV, EC 2.7.11.17 (CaM kinase-GR)" CAMK4 CAMK CAMK-GR CAMKIV Homo sapiens (Human) "adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165]" GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0018105; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0046777; GO:0070062; GO:0098794; GO:0098978; GO:0106310 ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310] GTQKPYALKVLK 0.99074 -20.315 0 0 0 0 0 0 0 0 11.9621 0 12.9477 12.9515 14.4431 13.0745 12.331 0 0 0 0 0 0 0 0 0 0 13.2596 11.7817 0 13.6976 13.9009 0 0 12.7818 0 0 0 13.2299 0 0 0 0 11.344 0 14.3749 0 0 12.1306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6945 0 0 0 0 0 0 0 0 0 13.3934 0 12.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0707 0 0 13.9731 13.6634 0 0 0 0 0 0 12.7259 13.6837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5694 12.0137 13.7576 0 0 13.3112 12.2769 13.4215 15.0131 11.2409 0 0 0 Q2VPK5 CTU2_HUMAN Cytoplasmic tRNA 2-thiolation protein 2 (Cytosolic thiouridylase subunit 2) CTU2 C16orf84 NCS2 Homo sapiens (Human) protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] cytosol [GO:0005829]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; protein-containing complex [GO:0032991]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] GO:0000049; GO:0002098; GO:0002143; GO:0005829; GO:0016779; GO:0016783; GO:0032447; GO:0032991; GO:0034227 nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049] AMLGKNR 0.99074 -19.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8408 0 0 0 14.1305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9831 0 0 0 0 0 0 0 0 0 0 15.3155 0 14.5211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q75T13 PGAP1_HUMAN "GPI inositol-deacylase, EC 3.1.-.- (Post-GPI attachment to proteins factor 1, hPGAP1)" PGAP1 UNQ3024/PRO9822 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185]; anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605]" GO:0005783; GO:0005789; GO:0006505; GO:0006888; GO:0007605; GO:0009880; GO:0009948; GO:0015031; GO:0016021; GO:0016255; GO:0016788; GO:0021871; GO:0050185; GO:1902953 "hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185]" EAKPYKVDPFVIIIK 0.99074 -4.804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6856 0 0 0 0 0 15.4206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4996 0 13.6364 0 0 0 0 0 0 0 14.2737 0 0 0 0 0 0 0 0 0 0 0 13.9436 0 0 0 0 0 0 0 13.0609 0 0 0 0 0 14.4322 13.8502 0 0 0 0 13.7152 13.6274 14.318 14.0145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5583 0 13.7616 0 0 0 0 0 Q86XU0 ZN677_HUMAN Zinc finger protein 677 ZNF677 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CTECGKAFTER 0.99074 -5.5894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2716 0 14.6286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4233 0 0 0 0 0 0 12.7938 0 0 14.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3603 0 0 0 0 0 0 0 0 0 Q9Y6S9 RPKL1_HUMAN "Ribosomal protein S6 kinase-like 1, EC 2.7.11.1" RPS6KL1 Homo sapiens (Human) protein phosphorylation [GO:0006468] ribosome [GO:0005840] ribosome [GO:0005840]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005840; GO:0006468; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EAVKLKITK 0.99074 -5.8882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NCS6 CB072_HUMAN Uncharacterized protein C2orf72 C2orf72 Homo sapiens (Human) ASSLAAR 0.99075 -4.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0887 0 0 0 0 0 0 0 0 P08588 ADRB1_HUMAN "Beta-1 adrenergic receptor (Beta-1 adrenoreceptor, Beta-1 adrenoceptor)" ADRB1 ADRB1R B1AR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]" early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] "early endosome [GO:0005769]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-2A adrenergic receptor binding [GO:0031694]; beta-adrenergic receptor activity [GO:0004939]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled receptor activity [GO:0004930]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; fear response [GO:0042596]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to cold [GO:0009409]" GO:0001996; GO:0001997; GO:0002024; GO:0002025; GO:0004930; GO:0004939; GO:0004940; GO:0005085; GO:0005769; GO:0005886; GO:0005887; GO:0007190; GO:0009409; GO:0030165; GO:0031649; GO:0031694; GO:0040015; GO:0042596; GO:0043547; GO:0045187; GO:0046982; GO:0050873; GO:0071880; GO:0098685; GO:0099579; GO:0120162 alpha-2A adrenergic receptor binding [GO:0031694]; beta-adrenergic receptor activity [GO:0004939]; beta1-adrenergic receptor activity [GO:0004940]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled receptor activity [GO:0004930]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982] EAQKQVKK 0.99075 -19.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5101 0 0 0 0 0 0 0 14.3053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5974 0 0 12.4989 12.2306 12.0045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2235 0 0 15.0971 0 0 0 0 0 0 12.0172 12.9005 0 0 0 0 11.9175 0 0 0 0 0 12.1324 0 0 12.5445 0 0 0 0 0 0 0 0 Q92737 RSLAA_HUMAN "Ras-like protein family member 10A, EC 3.6.5.2 (Ras-like protein RRP22) (Ras-related protein on chromosome 22)" RASL10A RRP22 Homo sapiens (Human) small GTPase mediated signal transduction [GO:0007264] nucleolus [GO:0005730]; plasma membrane [GO:0005886] nucleolus [GO:0005730]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0003925; GO:0005525; GO:0005730; GO:0005886; GO:0007264 G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] ALRQRIAETR 0.99075 -5.8929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0699 0 14.3868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2214 0 0 0 0 0 13.0944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6252 0 Q9UFB7 ZBT47_HUMAN Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651) ZBTB47 KIAA1190 ZNF651 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DMPFTCETCGK 0.99075 -5.8896 0 0 0 0 0 0 0 0 0 0 0 14.2763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4138 0 0 0 0 11.8855 0 0 0 0 0 0 0 0 0 0 0 14.7605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1247 0 0 0 14.6539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.145 0 0 13.5818 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5F1 PCDBC_HUMAN "Protocadherin beta-12, PCDH-beta-12" PCDHB12 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] ALDYEER 0.99075 -20.439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5405 A0A1B0GVG6 TEX54_HUMAN Testis-expressed protein 54 TEX54 Homo sapiens (Human) EEESEDGREDETTDTQRGPR 0.99076 -23.446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5283 0 16.5486 0 0 0 0 0 0 0 16.3598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6626 0 13.5686 13.9218 0 0 11.2018 0 0 0 0 0 0 0 0 0 0 0 0 0 O15021 MAST4_HUMAN "Microtubule-associated serine/threonine-protein kinase 4, EC 2.7.11.1" MAST4 KIAA0303 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0007010; GO:0018105; GO:0035556; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AWAPGGK 0.99076 -20.485 14.9937 0 14.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7355 0 0 13.1758 0 0 0 0 0 13.696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1653 0 0 13.7908 14.4424 12.0166 0 15.5992 0 0 0 12.8674 16.2689 12.8094 0 0 14.0439 13.9377 0 0 14.5234 0 0 0 0 14.8661 0 12.7519 11.4739 12.7538 0 14.888 0 0 14.7539 0 0 0 14.1072 0 0 0 0 0 0 0 0 11.8368 14.2906 0 0 0 0 0 0 0 14.4742 12.6097 13.434 13.7982 0 12.6743 14.6327 0 14.1602 0 13.9152 0 0 0 14.1556 14.5032 14.1459 0 0 0 0 0 13.8615 0 13.7805 0 0 0 12.3771 12.238 0 0 0 0 0 0 0 14.252 14.6511 0 0 0 0 0 0 0 0 11.4369 0 11.5665 12.8241 0 0 O75346 ZN253_HUMAN "Zinc finger protein 253 (Bone marrow zinc finger 1, BMZF-1) (Zinc finger protein 411)" ZNF253 BMZF1 ZNF411 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0045892; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CRECGKAFNHSTTLFSHEK 0.99076 -20.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2186 0 0 15.1568 11.7397 12.7739 0 0 0 0 0 0 0 0 0 12.2268 0 0 0 0 0 0 0 0 13.7696 0 0 0 0 0 13.9292 11.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0953 0 0 0 13.4215 0 13.6959 0 0 0 13.2426 0 14.352 0 0 0 15.3832 0 13.1677 13.9753 0 0 12.8578 0 0 0 12.7965 0 0 0 0 0 0 13.3939 13.1798 0 0 0 0 0 0 0 12.3122 0 0 0 10.1113 0 0 0 0 0 0 0 0 0 0 0 0 13.1704 O95858 TSN15_HUMAN "Tetraspanin-15, Tspan-15 (Tetraspan NET-7) (Transmembrane 4 superfamily member 15)" TSPAN15 NET7 TM4SF15 UNQ677/PRO1311 Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] cell junction [GO:0030054]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] cell junction [GO:0030054]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; enzyme binding [GO:0019899]; negative regulation of Notch signaling pathway [GO:0045746]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604] GO:0005788; GO:0005829; GO:0005886; GO:0005887; GO:0009986; GO:0016604; GO:0019899; GO:0030054; GO:0031902; GO:0043231; GO:0045746; GO:0051604; GO:0072659; GO:0097197 enzyme binding [GO:0019899] CCGGEDYR 0.99076 -5.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7637 0 0 0 0 0 13.1958 0 0 0 0 13.8872 0 0 0 11.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9V3 WSDU1_HUMAN "WD repeat, SAM and U-box domain-containing protein 1" WDSUB1 WDSAM1 Homo sapiens (Human) ubiquitin-protein transferase activity [GO:0004842] GO:0004842 ubiquitin-protein transferase activity [GO:0004842] IESLGLRSKVLR 0.99076 -5.6104 0 0 0 0 0 0 0 0 0 0 11.5235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1037 0 0 0 0 0 11.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99758 ABCA3_HUMAN "Phospholipid-transporting ATPase ABCA3, EC 7.6.2.1 (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3, ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3, EC 7.6.2.2) [Cleaved into: 150 Kda mature form ]" ABCA3 ABC3 Homo sapiens (Human) lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019]; lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016021; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140 ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019] AVLRQLALLLWK 0.99076 -20.532 0 0 0 0 0 0 0 0 15.2189 0 0 0 0 0 0 0 0 0 14.5241 0 0 0 0 0 0 0 0 0 0 0 0 11.3361 0 0 0 0 0 10.4021 0 0 0 0 0 0 0 0 0 0 0 13.1659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2354 0 0 13.7857 0 0 0 0 0 0 10.6615 0 12.2494 0 0 0 0 0 16.9206 0 0 13.9412 0 10.8668 0 0 14.6569 11.9552 12.0435 10.8496 0 0 0 0 0 0 0 0 14.0222 17.6788 0 0 0 0 0 0 12.0709 0 14.4403 14.0913 13.036 17.2723 10.3825 0 10.8077 0 0 16.8007 12.64 13.2903 0 0 0 13.0722 13.024 0 0 0 0 0 0 0 11.2491 11.7719 0 12.9306 0 12.5843 12.3105 11.9595 0 0 0 0 0 11.8391 11.5326 0 12.0693 0 0 0 0 0 0 12.0316 0 0 14.4755 0 0 0 0 11.2342 0 0 0 16.6605 0 0 0 0 0 0 0 Q9Y485 DMXL1_HUMAN "DmX-like protein 1, X-like 1 protein" DMXL1 XL1 Homo sapiens (Human) vacuolar acidification [GO:0007035] RAVE complex [GO:0043291] RAVE complex [GO:0043291]; vacuolar acidification [GO:0007035] GO:0007035; GO:0043291 AKAILSHLVK 0.99076 -21.507 0 0 0 0 0 0 0 0 12.7716 12.5442 0 0 0 0 12.2698 12.0091 0 0 0 0 0 0 0 0 0 0 14.0707 0 12.4086 12.1631 0 12.3532 0 12.659 0 0 12.6502 12.4541 0 12.3077 0 0 0 0 0 13.7617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.957 0 0 0 0 12.6005 0 0 0 0 0 0 17.4541 0 0 0 0 0 0 18.9286 0 0 11.7338 14.2746 0 0 0 18.3645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9764 0 0 0 0 0 0 12.4515 0 18.5955 0 0 0 0 12.6442 0 0 12.2305 0 0 13.449 0 0 19.0506 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7199 0 0 0 0 0 0 15.1132 0 0 11.4295 0 0 0 0 0 0 0 15.0712 13.026 0 0 0 10.8739 11.785 0 0 18.298 0 13.0071 O75054 IGSF3_HUMAN "Immunoglobulin superfamily member 3, IgSF3 (Glu-Trp-Ile EWI motif-containing protein 3, EWI-3)" IGSF3 EWI3 KIAA0466 Homo sapiens (Human) lacrimal gland development [GO:0032808] cell surface [GO:0009986]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; lacrimal gland development [GO:0032808] GO:0009986; GO:0016021; GO:0032808 DGGVQWGDR 0.99077 -20.672 0 0 0 0 0 0 0 0 14.543 14.4988 14.1244 15.7983 14.3265 14.33 15.2077 13.1659 13.6188 12.7974 0 0 10.2888 0 0 13.2768 13.23 13.0521 0 13.9852 14.8394 13.3106 14.5968 14.5373 0 13.9266 14.3907 0 13.5017 0 13.9797 15.0609 14.5342 14.1106 13.246 13.1928 13.2397 13.7527 13.6021 14.7618 14.42 14.5474 0 13.576 0 14.5043 14.4726 14.4511 15.0019 14.3937 0 13.8244 14.2543 14.988 15.1504 15.7985 14.2173 12.1888 0 12.8291 0 14.5344 14.5561 0 10.7915 0 0 15.9764 14.28 0 16.3098 0 14.5712 16.2702 14.1384 14.5212 14.9927 13.178 13.2831 12.9622 14.0011 13.2942 13.4547 0 13.1743 13.5501 15.8915 0 14.838 0 13.1193 13.4972 15.4223 13.1662 15.5217 0 15.6036 15.5608 13.2005 16.2399 14.9049 15.2948 13.0018 0 13.0279 12.8635 15.2257 0 15.5157 14.4638 14.5848 12.5283 0 0 15.1321 14.1385 0 15.923 14.6043 15.4006 0 13.1153 10.1728 14.1146 14.1221 10.5088 12.3799 0 15.5292 0 15.5251 0 15.9536 0 13.9175 0 15.5566 0 16.7505 0 0 14.9524 17.8855 15.5131 14.9191 14.5808 14.5192 0 13.4642 13.5981 0 14.1846 14.2049 0 14.9352 14.8167 0 0 0 14.93 14.1901 0 0 0 0 16.0375 0 13.5126 0 0 14.6395 0 Q8IUY3 GRM2A_HUMAN GRAM domain-containing protein 2A GRAMD2A GRAMD2 Homo sapiens (Human) endoplasmic reticulum-plasma membrane tethering [GO:0061817]; regulation of store-operated calcium entry [GO:2001256] extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232] "extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; regulation of store-operated calcium entry [GO:2001256]" GO:0005546; GO:0016021; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:2001256 "phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" CGREGITLNK 0.99077 -5.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6033 0 0 0 0 0 0 0 10.9146 0 0 0 12.4562 0 16.4627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3719 0 0 0 0 11.0343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5844 0 0 0 0 10.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1623 0 0 0 0 0 0 0 0 0 Q9P2S6 ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 (Testis-specific ankyrin-like protein 1) (Zinc finger MYND domain-containing protein 13) ANKMY1 TSAL1 ZMYND13 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] AELIPSHRMKK 0.99077 -5.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8198 0 0 0 0 0 0 9.29536 0 0 0 0 0 0 0 0 9.98142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.294 0 0 13.1263 13.1559 0 0 0 0 15.0283 0 0 0 0 0 15.0162 0 0 0 0 0 0 0 14.3438 0 0 0 0 0 0 0 0 14.3382 0 12.4038 0 0 0 0 0 15.1257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3868 0 0 0 0 Q9NZ43 USE1_HUMAN Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31) USE1 USE1L MDS032 Homo sapiens (Human) "lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]" GO:0005484; GO:0005783; GO:0005789; GO:0006890; GO:0007041; GO:0015031; GO:0016021; GO:0030163; GO:0031201; GO:0032940 SNAP receptor activity [GO:0005484] AASRLELNLVRLLSR 0.99078 -20.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6647 0 0 0 0 0 0 12.6856 0 0 0 0 12.7801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9865 0 0 0 0 0 0 0 0 0 0 13.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3511 0 0 0 0 0 0 0 0 0 15.3838 0 0 0 0 0 0 O94885 SASH1_HUMAN SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) SASH1 KIAA0790 PEPE1 Homo sapiens (Human) positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044] GO:0000209; GO:0001965; GO:0005737; GO:0008022; GO:0010595; GO:0010632; GO:0019901; GO:0031435; GO:0031666; GO:0032991; GO:0043507; GO:0045766; GO:0060090; GO:1900044; GO:1900745; GO:1901224; GO:1902498 G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901] DSGCYESSENLENGKTRK 0.99079 -21.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7976 14.9517 0 0 11.0918 0 0 0 0 0 0 0 0 0 0 0 14.6876 0 0 14.2658 0 0 0 0 10.4041 0 14.502 0 13.7245 0 0 0 0 0 13.9345 0 0 0 0 13.1336 0 0 0 0 0 0 16.4088 0 14.7213 0 0 0 0 13.527 0 0 0 0 0 0 13.1056 0 12.6682 0 0 0 14.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.872 13.8437 0 13.5678 0 0 14.2501 14.4316 14.4844 0 14.7001 15.1083 0 13.9257 0 0 0 0 0 0 0 0 10.9471 P78369 CLD10_HUMAN "Claudin-10 (Oligodendrocyte-specific protein-like, OSP-like)" CLDN10 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269] GO:0005198; GO:0005737; GO:0005886; GO:0005923; GO:0006811; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0043269; GO:0070830 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] TTNPSKQFDK 0.99079 -1.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04637 IF4G1_HUMAN "Eukaryotic translation initiation factor 4 gamma 1, eIF-4-gamma 1, eIF-4G 1, eIF-4G1 (p220)" EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; lung development [GO:0030324]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; neuron differentiation [GO:0030182]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular macromolecule biosynthetic process [GO:0034645]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; lung development [GO:0030324]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; negative regulation of neuron death [GO:1901215]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; neuron differentiation [GO:0030182]; positive regulation of cell death [GO:0010942]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of polysome binding [GO:1905696]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412]; translational initiation [GO:0006413]" GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0010801; GO:0010942; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0030324; GO:0031369; GO:0031669; GO:0033138; GO:0034645; GO:0035278; GO:0036493; GO:0042802; GO:0045471; GO:0045666; GO:0051247; GO:0060090; GO:0060964; GO:0080135; GO:0097009; GO:0098794; GO:1900087; GO:1901215; GO:1905537; GO:1905606; GO:1905612; GO:1905696 "ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]" ARTPATK 0.99079 -21.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.401 0 0 0 0 0 0 0 0 0 0 12.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3645 0 12.5019 0 0 11.0633 0 0 11.2092 0 11.8197 0 0 0 0 0 0 0 16.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9474 0 0 0 0 0 0 0 0 0 0 13.4681 0 0 0 0 0 0 18.4134 0 0 0 0 0 0 0 12.1983 0 0 0 11.6726 0 0 0 0 0 0 0 0 0 0 0 11.1141 0 0 13.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6905 0 0 0 0 0 0 0 12.8842 0 0 0 0 0 0 0 Q12768 WASC5_HUMAN WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin) WASHC5 KIAA0196 Homo sapiens (Human) actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; lysosome organization [GO:0007040]; meiotic spindle assembly [GO:0090306]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; regulation of actin nucleation [GO:0051125]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of vesicle size [GO:0097494] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; lysosome organization [GO:0007040]; meiotic spindle assembly [GO:0090306]; oocyte maturation [GO:0001556]; polar body extrusion after meiotic divisions [GO:0040038]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; regulation of actin nucleation [GO:0051125]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of vesicle size [GO:0097494] GO:0001556; GO:0005654; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0007032; GO:0007040; GO:0015031; GO:0016197; GO:0030041; GO:0031503; GO:0031901; GO:0034315; GO:0040038; GO:0051125; GO:0071203; GO:0090306; GO:0097494; GO:0140285 ALLADIEAHYQDPSLPYPK 0.99079 -5.975 0 0 0 0 0 0 0 0 0 12.5413 12.5597 12.3241 12.7496 0 14.9289 0 0 0 0 0 0 0 0 0 0 0 0 12.5445 0 12.4256 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9737 0 11.9419 0 0 0 0 0 0 0 0 0 0 0 0 11.1506 0 0 0 0 0 0 0 0 0 0 0 14.3302 0 0 0 13.2938 13.5293 14.3886 0 14.9826 0 0 0 0 0 0 0 13.4952 13.6439 0 14.907 0 0 0 13.7417 14.2093 0 0 13.3569 0 0 13.3327 0 0 0 12.0805 15.2406 13.685 13.5476 13.05 0 14.5541 0 0 14.1338 0 11.8491 0 0 0 15.9117 0 13.5392 0 0 13.5169 14.2432 13.3173 12.3974 0 12.8063 13.759 14.4495 14.2821 0 0 0 0 12.6103 15.0648 0 0 0 0 14.7226 0 0 0 0 0 0 0 0 12.2728 0 0 13.3596 0 13.5687 13.5079 0 13.3969 13.241 13.6584 13.1753 13.1434 0 13.5109 13.0997 0 13.4685 0 0 14.8492 0 0 0 14.5185 0 0 0 Q1W209 ESRG_HUMAN "Embryonic stem cell-related gene protein, hES cell-related gene protein" ESRG HESRG Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 IHLRPQVLRPTSPR 0.99079 -5.9736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMQ8 LMTK1_HUMAN "Serine/threonine-protein kinase LMTK1, EC 2.7.11.1 (Apoptosis-associated tyrosine kinase, AATYK) (Brain apoptosis-associated tyrosine kinase) (CDK5-binding protein) (Lemur tyrosine kinase 1) (p35-binding protein, p35BP)" AATK AATYK KIAA0641 LMR1 LMTK1 Homo sapiens (Human) brain development [GO:0007420]; peptidyl-tyrosine autophosphorylation [GO:0038083]; protein phosphorylation [GO:0006468] integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; brain development [GO:0007420]; peptidyl-tyrosine autophosphorylation [GO:0038083]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0006468; GO:0007420; GO:0016021; GO:0038083; GO:0048471; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] DSAYFSDLEAEAEATSGPEK 0.99079 -5.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5229 0 0 0 0 0 0 0 0 0 0 11.9899 0 0 0 0 0 0 0 0 0 0 0 0 14.3922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7935 0 0 0 0 0 0 0 0 Q8IWU2 LMTK2_HUMAN "Serine/threonine-protein kinase LMTK2, EC 2.7.11.1 (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase, hBREK) (CDK5/p35-regulated kinase, CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2)" LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2 Homo sapiens (Human) axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037] cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; axonogenesis [GO:0007409]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001881; GO:0004674; GO:0004864; GO:0005524; GO:0005769; GO:0005794; GO:0005829; GO:0005887; GO:0006468; GO:0007169; GO:0007409; GO:0016021; GO:0018105; GO:0018107; GO:0030426; GO:0032456; GO:0033572; GO:0033674; GO:0043025; GO:0043235; GO:0045022; GO:0046777; GO:0048471; GO:0055037; GO:0070853; GO:0106310 ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CINSESSTDEEGGGFEWDDDFSPDPFMSK 0.99079 -19.216 0 0 0 0 0 0 0 0 0 0 0 12.7781 0 13.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4371 0 0 0 0 0 0 0 14.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4834 0 12.0435 0 0 14.7421 13.9063 0 0 0 0 0 0 0 0 12.3457 0 0 0 11.2148 0 0 0 0 0 0 0 12.8724 0 0 0 0 0 0 12.9332 12.6981 0 0 11.5251 0 16.1196 0 0 0 0 0 0 10.4107 0 0 0 Q8WYQ5 DGCR8_HUMAN Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8) DGCR8 C22orf12 DGCRK6 LP4941 Homo sapiens (Human) primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091] GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0014069; GO:0016604; GO:0020037; GO:0031053; GO:0042802; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0072091; GO:0140517 double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517] HAPAVRK 0.99079 -21.326 0 0 0 11.9264 0 0 11.7224 0 0 0 0 0 0 0 0 12.2599 0 0 12.3002 0 0 0 11.7737 0 0 0 0 0 0 12.5855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5896 11.8498 14.8413 14.4766 11.5706 0 14.452 0 19.1799 0 0 19.2771 0 0 0 0 0 0 0 13.0856 0 0 0 0 0 0 13.1074 0 0 13.1553 14.2676 0 0 0 15.0979 16.9163 0 0 0 0 0 0 16.3561 16.0256 0 0 0 0 17.091 0 0 0 0 0 0 0 0 0 0 15.8457 0 11.4754 0 0 0 0 15.8217 15.5894 0 0 16.5736 16.0541 0 0 0 0 0 15.1224 15.1934 0 15.8607 0 14.6678 14.2486 0 0 0 0 12.3224 0 0 12.4492 0 0 0 0 0 0 0 0 13.737 0 0 0 0 0 0 Q9Y448 SKAP_HUMAN "Small kinetochore-associated protein, SKAP (Kinetochore-localized astrin-binding protein, Kinastrin) (Kinetochore-localized astrin/SPAG5-binding protein) (TRAF4-associated factor 1)" KNSTRN C15orf23 SKAP TRAF4AF1 HSD11 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; chromosome segregation [GO:0007059]; microtubule cytoskeleton organization [GO:0000226]; mitotic sister chromatid segregation [GO:0000070]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; spindle pole [GO:0000922]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; chromosome segregation [GO:0007059]; microtubule cytoskeleton organization [GO:0000226]; mitotic sister chromatid segregation [GO:0000070]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; spindle organization [GO:0007051] GO:0000070; GO:0000226; GO:0000776; GO:0000922; GO:0001726; GO:0005634; GO:0005737; GO:0005815; GO:0005886; GO:0007051; GO:0007059; GO:0016477; GO:0034451; GO:0035371; GO:0042803; GO:0051010; GO:0051301; GO:0051988; GO:0071364; GO:0072686 microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803] DCGQDRR 0.99079 -20.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0876 0 0 0 0 0 0 0 0 0 0 9.88419 0 0 0 10.5489 0 0 0 0 0 0 10.3339 0 0 0 10.5094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13888 TF2H2_HUMAN "General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit, BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit)" GTF2H2 BTF2P44 Homo sapiens (Human) G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270]; G protein-coupled receptor internalization [GO:0002031]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA helicase activity [GO:1905776]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0000438; GO:0000439; GO:0002031; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006289; GO:0006357; GO:0006366; GO:0006367; GO:0008270; GO:0009411; GO:0016251; GO:0016607; GO:0047485; GO:1905776 protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270] AKYCELPVECKICGLTLVSAPHLAR 0.9908 -19.244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4613 11.0365 0 0 0 0 0 0 0 0 11.0072 0 0 0 0 10.476 0 0 0 0 10.167 0 0 0 0 0 0 9.85248 0 0 0 0 0 0 0 0 0 0 14.7029 13.101 0 0 0 0 0 0 11.1517 0 0 0 0 0 0 0 0 15.8917 0 0 0 0 0 12.6258 0 0 0 0 0 0 0 0 0 0 13.1024 0 0 0 0 0 0 0 13.5821 0 0 11.1144 0 0 0 0 0 0 0 14.1091 0 14.4028 0 13.6962 0 0 0 0 11.5161 0 14.3208 14.0178 0 14.3386 0 0 0 0 0 0 0 0 14.1772 0 0 0 0 13.3791 0 0 0 0 0 0 0 0 0 0 14.9406 0 0 0 0 0 11.5371 0 0 0 0 0 0 0 Q14693 LPIN1_HUMAN "Phosphatidate phosphatase LPIN1, EC 3.1.3.4 (Lipin-1)" LPIN1 KIAA0188 Homo sapiens (Human) animal organ regeneration [GO:0031100]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of myelination [GO:0031642]; negative regulation of phosphatidate phosphatase activity [GO:1903741]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; animal organ regeneration [GO:0031100]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of myelination [GO:0031642]; negative regulation of phosphatidate phosphatase activity [GO:1903741]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidic acid metabolic process [GO:0046473]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432]; triglyceride mobilization [GO:0006642] GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005783; GO:0005789; GO:0005829; GO:0006642; GO:0006654; GO:0007077; GO:0008195; GO:0009062; GO:0019432; GO:0031100; GO:0031642; GO:0031965; GO:0032869; GO:0044255; GO:0045740; GO:0045944; GO:0046473; GO:0120162; GO:1903741 phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] DDNMNTSEDEDMFPIEMSSDEAMELLESSR 0.9908 -4.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2173 13.9451 13.4038 0 0 0 0 0 0 0 0 0 11.5354 0 0 0 0 0 10.4091 0 0 0 0 13.8473 0 0 0 13.2504 0 0 14.5722 14.554 0 0 0 0 0 0 0 11.4331 0 14.5136 0 0 14.0471 10.8254 0 0 0 10.7093 12.6272 0 0 0 0 14.3236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3227 0 0 0 Q8NDL9 CBPC5_HUMAN "Cytosolic carboxypeptidase-like protein 5, EC 3.4.17.-, EC 3.4.17.24 (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5)" AGBL5 CCP5 Homo sapiens (Human) C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0045171; GO:0051607; GO:0072686 metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] EPRSQDRR 0.9908 -19.241 0 0 0 0 0 0 0 0 0 12.9357 0 0 0 0 0 0 12.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0922 11.3739 0 0 0 0 0 0 0 0 0 12.1672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3537 0 0 0 0 0 0 11.7699 0 13.2234 0 0 0 0 0 12.8599 0 12.2996 0 0 0 11.6638 0 0 0 0 0 0 14.4508 13.9045 11.6707 0 0 Q96J42 TXD15_HUMAN Thioredoxin domain-containing protein 15 TXNDC15 C5orf14 UNQ335/PRO534 Homo sapiens (Human) cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of membrane [GO:0016021] ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0005929; GO:0016021; GO:0045880; GO:0060170; GO:0060271 ILNMSQDLMDFLNPNGSDCTLVLFYTPWCR 0.9908 -19.233 0 12.9381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.557 0 0 0 0 0 0 0 0 0 10.654 0 0 0 0 11.4494 0 0 0 0 0 0 10.8804 0 0 0 0 0 0 0 11.7804 0 0 0 0 11.4965 0 0 0 0 0 0 14.5501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2716 0 11.893 0 0 0 0 0 0 13.8465 0 0 0 0 11.8188 12.1736 0 0 0 0 0 0 0 0 0 13.9376 14.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 12.206 0 14.442 14.7278 15.0484 0 0 0 0 0 12.7279 0 12.9148 0 12.0417 0 0 0 0 0 14.3004 13.2978 0 0 0 0 0 0 0 Q9NWU5 RM22_HUMAN "39S ribosomal protein L22, mitochondrial, L22mt, MRP-L22 (39S ribosomal protein L25, mitochondrial, L25mt, MRP-L25) (Mitochondrial large ribosomal subunit protein uL22m)" MRPL22 MRPL25 RPML25 HSPC158 Homo sapiens (Human) mitochondrial translation [GO:0032543]; ribosome assembly [GO:0042255] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosome assembly [GO:0042255] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0015934; GO:0032543; GO:0042255 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AAAVLGQLGALWIHNLR 0.9908 -19.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8591 0 13.8393 0 0 0 0 13.4198 0 14.0019 0 0 0 0 0 0 0 12.1445 0 0 12.1665 0 0 0 0 13.6194 0 0 12.151 14.9215 11.8287 0 0 0 10.7489 0 0 0 0 0 0 13.5941 0 14.0633 0 0 19.3628 0 0 0 0 0 13.3578 0 0 0 0 0 0 0 0 0 14.4626 0 0 0 0 0 14.0022 0 0 0 0 13.3849 0 14.6502 0 0 0 17.7828 0 0 0 0 0 15.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0892 O95757 HS74L_HUMAN "Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Heat-shock protein family A member 4-like protein, HSPA4-like protein) (Osmotic stress protein 94)" HSPA4L APG1 OSP94 Homo sapiens (Human) protein folding [GO:0006457]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986] GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986; GO:0140662 ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662] CTPACISLGSR 0.99081 -21.516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3581 14.0856 0 0 13.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2635 0 12.8526 0 0 0 15.2747 0 13.6666 13.7783 12.1827 0 13.5928 0 0 0 0 0 0 0 0 0 13.2555 13.025 0 0 0 0 0 0 0 0 15.0111 13.3707 13.1483 13.1376 0 13.7627 0 12.1807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0083 11.7022 12.8863 11.8526 14.6203 0 0 0 0 12.5208 13.0264 0 18.9451 11.5466 0 0 0 13.292 13.2628 14.6599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1515 0 0 0 13.2789 0 P0DJR0 GIMD1_HUMAN GTPase IMAP family member GIMD1 (GIMAP family P-loop NTPase domain-containing protein 1) GIMD1 Homo sapiens (Human) GTP binding [GO:0005525] GO:0005525 GTP binding [GO:0005525] TLLNSIQHK 0.99081 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23193 TCEA1_HUMAN Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005730; GO:0006351; GO:0006366; GO:0006368; GO:0008270; GO:0045944 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] ISNLKDAK 0.99081 -21.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8794 0 0 0 0 0 0 0 0 0 0 0 13.8357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1148 12.9422 0 0 0 0 0 0 0 14.3726 0 0 0 0 0 0 0 0 0 0 0 11.6587 0 0 0 0 10.3193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62995 TRA2B_HUMAN "Transformer-2 protein homolog beta, TRA-2 beta, TRA2-beta, hTRA2-beta (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)" TRA2B SFRS10 Homo sapiens (Human) "cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]" nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681] "nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005637; GO:0005654; GO:0005681; GO:0019904; GO:0021796; GO:0032991; GO:0036002; GO:0042802; GO:0043484; GO:0048026; GO:0071333; GO:1990403 identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] AAQDRDQIYR 0.99081 -21.497 0 9.37306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1131 0 0 0 0 10.9796 0 0 0 0 0 12.3337 11.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7365 14.1183 14.6829 0 0 0 0 0 0 0 0 0 10.9338 0 14.9269 14.8957 0 0 0 13.1645 0 13.478 0 0 0 13.8187 0 14.9655 14.4012 13.9226 0 14.6692 13.9889 0 14.6468 0 0 0 0 0 14.8154 11.4185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0813 0 0 14.4565 12.4977 13.7606 0 0 0 0 0 0 0 13.3312 0 0 12.1321 11.89 0 0 0 0 0 10.9739 0 0 0 0 0 10.9569 0 14.0349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14D33 RTP5_HUMAN Receptor-transporting protein 5 (3CxxC-type zinc finger protein 5) (CXXC-type zinc finger protein 11) RTP5 C2orf85 CXXC11 Z3CXXC5 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; olfactory receptor binding [GO:0031849]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] GO:0001580; GO:0006612; GO:0016021; GO:0031849; GO:0051205 olfactory receptor binding [GO:0031849] DAVAEVAEGNGK 0.99081 -5.9934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3728 17.359 17.0089 0 0 0 0 0 16.1269 0 0 0 15.7153 0 16.4746 15.404 16.308 16.0587 15.2744 15.617 15.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3395 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15842 KCNJ8_HUMAN "ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1)" KCNJ8 Homo sapiens (Human) defense response to virus [GO:0051607]; heart development [GO:0007507]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; transport across blood-brain barrier [GO:0150104] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076] inward rectifying potassium channel [GO:0008282]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; voltage-gated potassium channel complex [GO:0008076]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; defense response to virus [GO:0051607]; heart development [GO:0007507]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; transport across blood-brain barrier [GO:0150104] GO:0001822; GO:0005242; GO:0005524; GO:0005739; GO:0005886; GO:0006813; GO:0007507; GO:0008076; GO:0008282; GO:0015272; GO:0017098; GO:0019829; GO:0030016; GO:0031004; GO:0032496; GO:0034765; GO:0042383; GO:0043330; GO:0051607; GO:0071805; GO:0098662; GO:0098915; GO:0150104; GO:1902282; GO:1990573 ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; sulfonylurea receptor binding [GO:0017098]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282] DRLPKAR 0.99081 -5.9922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JSQ8 KHDCL_HUMAN Putative KHDC1-like protein KHDC1L Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919] GO:0003723; GO:0005737; GO:0006919 RNA binding [GO:0003723] AVGTSALSK 0.99081 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YW0 PLCZ1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1, EC 3.1.4.11 (Phosphoinositide phospholipase C-zeta-1) (Phospholipase C-zeta-1, PLC-zeta-1) (Testis-development protein NYD-SP27)" PLCZ1 Homo sapiens (Human) calcium ion transport [GO:0006816]; egg activation [GO:0007343]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in egg activation [GO:0060470] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; sperm head [GO:0061827] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; sperm head [GO:0061827]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]; calcium ion transport [GO:0006816]; egg activation [GO:0007343]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in egg activation [GO:0060470]" GO:0004435; GO:0005509; GO:0005546; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006816; GO:0007204; GO:0007343; GO:0010314; GO:0016042; GO:0032266; GO:0045120; GO:0048015; GO:0048471; GO:0060470; GO:0061827 "calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-5-phosphate binding [GO:0010314]" AIAFEIIQKYEPIEEVRK 0.99081 -23.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4389 0 0 0 0 0 0 0 0 0 0 12.0462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3472 0 0 0 0 0 0 0 0 0 0 12.6888 12.7324 0 0 0 0 12.9861 0 12.7283 12.6748 0 13.7255 0 0 0 0 0 0 0 0 13.0608 0 0 11.2658 0 0 0 0 0 0 0 0 0 0 0 12.6145 11.65 0 0 0 0 0 0 0 0 12.7771 0 12.892 0 0 0 0 0 10.6782 Q9GZU3 TM39B_HUMAN Transmembrane protein 39B TMEM39B Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 DLDHRFS 0.99081 -20.525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1091 0 0 0 12.4095 0 0 12.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3885 0 0 0 0 0 13.6869 15.5747 0 11.4652 14.2978 12.3692 15.8871 10.3047 0 0 0 9.89435 0 0 0 0 10.36 0 0 0 0 15.771 0 0 0 0 0 0 0 12.7581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99393 0 0 10.7842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H596 DUS21_HUMAN "Dual specificity protein phosphatase 21, EC 3.1.3.16, EC 3.1.3.48 (Low molecular weight dual specificity phosphatase 21, LMW-DSP21)" DUSP21 LMWDSP21 Homo sapiens (Human) peptidyl-tyrosine dephosphorylation [GO:0035335] cytoplasm [GO:0005737]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; protein tyrosine phosphatase activity [GO:0004725]; peptidyl-tyrosine dephosphorylation [GO:0035335] GO:0004725; GO:0005634; GO:0005737; GO:0005759; GO:0017017; GO:0017018; GO:0031314; GO:0035335 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; protein tyrosine phosphatase activity [GO:0004725] LFNNNTVR 0.99081 -4.6429 0 10.2811 0 0 0 0 0 0 13.7071 10.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5983 0 0 13.0563 0 0 9.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7807 0 0 0 0 0 0 0 0 0 0 0 16.1747 0 0 0 11.4557 11.8407 0 10.6204 12.2363 0 10.6095 9.53984 0 0 0 0 12.2178 12.9421 0 0 0 0 0 0 0 11.204 0 0 0 13.0492 13.2373 12.1594 12.37 12.5756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3723 13.9443 0 0 0 10.8934 0 0 10.7658 0 0 0 0 0 0 0 0 0 10.2997 0 9.94898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8153 0 0 13.0259 9.87015 A6NHC0 CAN8_HUMAN "Calpain-8, EC 3.4.22.53 (New calpain 2, nCL-2) (Stomach-specific M-type calpain)" CAPN8 NCL2 Homo sapiens (Human) digestion [GO:0007586]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508] GO:0004198; GO:0005509; GO:0005737; GO:0005794; GO:0006508; GO:0007586 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] ILLNEAFSKR 0.99082 -5.5791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8195 0 16.8598 0 0 13.2638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5253 0 0 0 0 0 0 0 0 14.2876 0 0 13.7822 0 0 0 13.3411 0 0 0 0 0 0 0 0 0 0 0 13.2222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DOX4 IGE_HUMAN Immunoglobulin epsilon heavy chain (Immunoglobulin epsilon heavy chain ND) Homo sapiens (Human) adaptive immune response [GO:0002250] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250] GO:0002250; GO:0005576; GO:0005886; GO:0019814 DWIEGETYQCRVTHPHLPR 0.99082 -20.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2547 12.1563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8721 0 0 0 0 0 0 13.8618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1528 0 0 14.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBB1 LNX1_HUMAN "E3 ubiquitin-protein ligase LNX, EC 2.3.2.27 (Ligand of Numb-protein X 1) (Numb-binding protein 1) (PDZ domain-containing RING finger protein 2) (RING-type E3 ubiquitin transferase LNX)" LNX1 LNX PDZRN2 UNQ574/PRO1136 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005737; GO:0006511; GO:0030165; GO:0042802; GO:0046872 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842] ALSVLRRTK 0.99082 -21.607 0 0 0 12.0148 0 0 0 0 0 0 0 13.2197 0 0 0 0 0 0 0 10.4019 0 0 0 0 0 0 0 0 0 13.3082 13.4578 0 13.6644 14.2217 0 0 0 0 0 11.8423 0 13.0866 0 0 13.07 13.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0944 0 0 0 0 0 0 0 0 0 0 11.6537 0 0 11.4235 0 0 0 0 0 0 0 10.7659 0 0 0 0 14.4763 0 0 0 0 0 0 13.5898 0 16.0921 0 0 0 0 0 0 0 0 0 0 0 0 10.1525 0 0 0 0 0 0 0 0 0 13.3848 13.0213 0 0 0 0 0 0 0 0 0 0 14.6021 13.7304 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9065 0 0 0 13.8233 9.78834 0 0 0 0 0 0 Q96EE3 SEH1_HUMAN Nucleoporin SEH1 (GATOR complex protein SEH1) (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein) SEH1L SEC13L SEH1 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of TORC1 signaling [GO:1904262]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; defense response to Gram-positive bacterium [GO:0050830]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of TORC1 signaling [GO:1904262]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503] GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005765; GO:0005829; GO:0006913; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0031503; GO:0032008; GO:0034198; GO:0035859; GO:0050830; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904262; GO:1904263 structural molecule activity [GO:0005198] DVRIFTLK 0.99082 -5.8856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3923 0 0 0 0 0 13.8297 13.1322 0 0 0 0 0 0 0 0 12.0677 0 0 0 0 0 13.3957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5222 0 0 0 0 0 0 0 0 13.8889 0 0 11.7539 0 0 0 0 0 0 12.0008 0 16.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LX8 ZN597_HUMAN Zinc finger protein 597 ZNF597 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CSDDGDNFFSFSK 0.99082 -5.8699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3178 0 0 0 12.9053 0 0 0 13.421 0 14.6899 0 13.921 13.4695 0 14.7586 0 0 13.2553 0 13.3659 13.5265 0 0 0 0 12.8721 12.0817 0 13.0837 12.5349 12.8023 0 13.3556 13.227 0 0 0 0 0 0 0 0 0 13.793 0 0 0 0 0 13.5844 13.7931 14.377 13.7849 13.4909 0 0 13.0905 15.0047 0 0 0 0 13.9608 13.8258 12.2549 15.12 13.7159 12.0914 0 0 0 13.7056 13.669 13.7221 13.6886 0 0 0 13.6426 0 13.6805 0 0 13.6272 13.7127 0 0 0 0 0 0 0 0 0 0 0 0 13.9632 13.6052 0 13.7648 13.7946 0 13.0246 13.1772 13.0013 0 0 0 0 0 0 0 Q96P70 IPO9_HUMAN "Importin-9, Imp9 (Ran-binding protein 9, RanBP9)" IPO9 IMP9 KIAA1192 RANBP9 HSPC273 Homo sapiens (Human) proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267]; proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606] GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0016020; GO:0031144; GO:0031267; GO:0042393; GO:0061608; GO:0140713 histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] AAAEEQIK 0.99082 -5.876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2294 0 19.1589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95147 DUS14_HUMAN "Dual specificity protein phosphatase 14, EC 3.1.3.16, EC 3.1.3.48 (MKP-1-like protein tyrosine phosphatase, MKP-L) (Mitogen-activated protein kinase phosphatase 6, MAP kinase phosphatase 6, MKP-6)" DUSP14 MKP6 Homo sapiens (Human) protein dephosphorylation [GO:0006470] MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]; protein dephosphorylation [GO:0006470] GO:0003723; GO:0004725; GO:0006470; GO:0017017; GO:0017018 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723] ARRPVIR 0.99083 -20.251 0 0 0 0 11.0543 0 11.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7368 0 0 0 0 0 0 0 0 10.6067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4429 0 0 0 0 0 14.3047 13.9347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.366 13.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5584 0 0 0 0 0 14.2568 0 14.3673 0 0 14.834 0 0 14.6246 0 0 0 14.732 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2314 0 0 10.8199 0 0 0 0 13.033 0 0 0 14.9723 0 0 0 P0DUH7 HRURF_HUMAN Protein HRURF (HR upstream open reading frame protein) HRURF U2HR Homo sapiens (Human) regulation of translation [GO:0006417] regulation of translation [GO:0006417] GO:0006417 AQPTASAQK 0.99083 -1.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52943 CRIP2_HUMAN "Cysteine-rich protein 2, CRP-2 (Protein ESP1)" CRIP2 CRP2 Homo sapiens (Human) hemopoiesis [GO:0030097]; positive regulation of cell population proliferation [GO:0008284] cell cortex [GO:0005938] cell cortex [GO:0005938]; zinc ion binding [GO:0008270]; hemopoiesis [GO:0030097]; positive regulation of cell population proliferation [GO:0008284] GO:0005938; GO:0008270; GO:0008284; GO:0030097 zinc ion binding [GO:0008270] DWHKFCLKCER 0.99083 -1.8368 0 0 0 10.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6868 0 14.8431 0 0 0 0 13.7911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7433 0 0 0 0 0 0 0 14.4391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53801 PTTG_HUMAN "Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor, PBF, PTTG-binding factor)" PTTG1IP C21orf1 C21orf3 Homo sapiens (Human) "negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; p53 binding [GO:0002039]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]" GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0006606; GO:0016020; GO:0016021; GO:0031398; GO:0043518; GO:0070062; GO:1902254 p53 binding [GO:0002039] HDEIRKK 0.99083 -20.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1491 0 0 0 0 12.9286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6033 0 0 0 0 0 0 13.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15554 TERF2_HUMAN Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein) TERF2 TRBF2 TRF2 Homo sapiens (Human) "anterograde axonal transport of messenger ribonucleoprotein complex [GO:0099087]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; in utero embryonic development [GO:0001701]; negative regulation of beta-galactosidase activity [GO:1903770]; negative regulation of cellular senescence [GO:2000773]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of gene expression [GO:0010629]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomere single strand break repair [GO:1903824]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; RNA-templated DNA biosynthetic process [GO:0006278]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]" "axon cytoplasm [GO:1904115]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]" "axon cytoplasm [GO:1904115]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]; anterograde axonal transport of messenger ribonucleoprotein complex [GO:0099087]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; in utero embryonic development [GO:0001701]; negative regulation of beta-galactosidase activity [GO:1903770]; negative regulation of cellular senescence [GO:2000773]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of gene expression [GO:0010629]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomere single strand break repair [GO:1903824]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; RNA-templated DNA biosynthetic process [GO:0006278]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]" GO:0000723; GO:0000781; GO:0000783; GO:0001673; GO:0001701; GO:0003691; GO:0005634; GO:0005654; GO:0006278; GO:0007049; GO:0008022; GO:0010628; GO:0010629; GO:0016233; GO:0016604; GO:0019899; GO:0031627; GO:0031848; GO:0032204; GO:0032205; GO:0032206; GO:0032208; GO:0032210; GO:0032211; GO:0032214; GO:0042162; GO:0042803; GO:0044877; GO:0051000; GO:0061820; GO:0070187; GO:0070198; GO:0090398; GO:0098505; GO:0099087; GO:1903770; GO:1903824; GO:1904115; GO:1904354; GO:1904357; GO:1904430; GO:1905778; GO:1905839; GO:2000773 double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162] DIMQALLVRPLGK 0.99083 -4.7893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5815 0 10.7713 0 0 0 0 10.3071 0 11.7619 0 0 11.3427 0 11.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9344 0 14.9119 0 0 0 0 0 0 0 0 0 0 0 0 12.1488 0 12.2694 0 0 13.9595 12.5816 0 13.6947 0 12.8456 0 0 0 0 0 0 0 15.8072 14.1823 0 0 0 11.9814 0 0 0 0 0 0 14.0822 0 12.4959 0 0 0 0 0 13.787 0 0 0 0 0 0 0 0 13.7467 0 0 0 0 0 0 0 0 12.2879 0 13.143 0 15.3908 0 0 0 11.7832 0 13.5118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1629 0 0 0 0 0 0 Q5VU65 P210L_HUMAN Nuclear pore membrane glycoprotein 210-like (Nucleoporin 210 kDa-like) (Nucleoporin Nup210-like) NUP210L Homo sapiens (Human) integral component of membrane [GO:0016021]; nuclear pore [GO:0005643] integral component of membrane [GO:0016021]; nuclear pore [GO:0005643] GO:0005643; GO:0016021 ALKDGVVVINASLTSIIYQNKDIQPIK 0.99083 -21.227 0 0 0 0 0 10.9187 0 0 0 14.902 0 13.4849 12.6566 12.1032 12.6425 0 0 0 16.9717 0 13.1072 0 0 0 0 11.4106 0 0 12.1365 13.8846 16.8216 16.3399 11.4082 0 13.2956 0 12.3114 0 0 0 0 12.4267 12.1885 12.0528 0 0 12.3352 0 0 0 0 0 0 0 17.4414 0 17.2919 0 16.6384 16.8113 16.6502 17.5492 0 0 0 15.3994 0 0 0 14.5819 0 9.4664 0 0 0 14.9426 12.8025 14.9862 12.3368 16.0251 0 0 14.0397 0 11.8859 0 0 0 0 0 0 13.8644 11.9637 0 0 14.3556 0 15.0235 13.5547 0 0 0 0 15.3114 0 0 14.0393 0 0 0 14.424 13.2214 14.2582 14.9234 13.0368 0 0 15.1047 16.3393 0 0 0 11.5004 0 16.2248 15.3071 0 12.8867 15.451 15.2598 14.4124 13.9985 11.6393 0 13.1487 12.2582 0 15.8534 0 13.6987 0 13.7621 0 12.8324 13.6459 0 0 0 0 0 0 0 0 0 11.4002 0 15.414 13.7183 10.7259 17.7528 13.2353 0 0 0 0 12.6853 0 14.5688 14.0435 0 0 20.5703 12.8755 0 0 0 0 0 0 14.7103 Q6P444 MTFR2_HUMAN Mitochondrial fission regulator 2 (DUF729 domain-containing protein 1) MTFR2 DUFD1 FAM54A Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] GO:0000266; GO:0005739; GO:0007005; GO:0009060 LRAIERSPGGR 0.99083 -4.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1613 0 0 0 0 0 0 0 0 0 0 16.1923 0 0 0 0 0 0 0 0 0 0 14.2208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P9A3 ZN549_HUMAN Zinc finger protein 549 ZNF549 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFIHKKR 0.99083 -4.8079 0 0 0 0 0 0 0 0 11.9049 13.0516 0 0 0 0 0 0 11.1278 0 0 11.9746 0 14.6563 0 0 0 0 0 0 0 0 0 12.8856 0 0 11.3473 0 0 0 12.2661 0 0 0 0 0 0 0 14.0742 14.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3117 13.2976 0 0 14.3506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4287 0 0 0 0 15.9849 0 0 14.7198 0 0 0 13.8543 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3747 0 0 0 0 0 0 15.0133 15.0709 0 0 0 12.1248 0 0 0 0 0 0 14.8273 12.3074 0 0 14.5754 0 14.5658 0 Q6UXU4 GSG1L_HUMAN "Germ cell-specific gene 1-like protein, GSG1-like protein" GSG1L UNQ5831/PRO19651 Homo sapiens (Human) regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] GO:0005886; GO:0070161; GO:0098685; GO:0098978; GO:0099061; GO:0099149; GO:2000311 CRSFIDLAPASEK 0.99083 -5.5875 0 0 0 0 0 0 0 0 0 0 12.9565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3399 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4693 Q6ZNG1 ZN600_HUMAN Zinc finger protein 600 ZNF600 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFACHSYLAK 0.99083 -5.8871 0 14.3749 13.3752 14.2939 11.9486 13.1677 0 15.7997 0 12.4768 0 0 0 0 0 0 0 0 0 12.6172 0 13.5774 0 12.5887 0 0 0 12.503 0 0 0 0 12.5157 12.8005 0 0 0 0 12.4502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8148 0 0 0 0 15.7739 0 0 0 0 16.2476 13.771 15.628 0 14.5464 14.4974 0 13.5701 0 18.7385 0 0 0 12.4086 0 14.9851 15.0979 0 0 0 0 0 0 0 0 13.3768 0 0 13.6191 13.7003 0 14.44 12.6448 13.2812 0 0 13.8197 13.2883 0 0 13.8816 0 0 0 15.6245 14.82 13.3584 13.3558 14.2986 13.7816 0 0 13.7416 13.9367 0 0 0 14.8389 12.85 0 13.2499 0 0 0 0 14.551 0 0 13.3629 0 0 0 0 0 13.2598 12.3608 13.567 13.9169 0 0 0 0 14.3658 0 14.5551 0 14.6846 0 0 0 0 0 0 0 14.5432 12.2376 0 0 13.614 0 0 0 Q8TAA9 VANG1_HUMAN "Vang-like protein 1 (Loop-tail protein 2 homolog, LPP2) (Strabismus 2) (Van Gogh-like protein 1)" VANGL1 STB2 Homo sapiens (Human) "pigmentation [GO:0043473]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; pigmentation [GO:0043473]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0005886; GO:0016021; GO:0016328; GO:0043473; GO:0060071 AMIAAAAR 0.99083 -5.888 0 0 0 0 0 0 12.6237 0 0 0 0 0 0 0 0 0 10.7791 0 0 0 0 12.3273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1973 0 0 0 0 0 0 0 0 0 0 0 12.7081 0 0 0 0 16.1778 0 0 0 0 13.5989 0 12.7725 0 0 0 0 0 12.1045 0 0 12.5354 0 0 0 0 16.3 0 0 13.3937 0 0 16.3993 0 0 11.9655 0 0 0 0 0 12.0823 0 0 0 13.2349 0 0 0 0 11.8956 0 14.4463 13.6458 13.3617 0 0 0 0 0 0 0 13.859 11.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7855 0 0 0 0 0 0 0 0 0 0 0 Q8TF21 ANR24_HUMAN Ankyrin repeat domain-containing protein 24 ANKRD24 KIAA1981 Homo sapiens (Human) AALEQAREDLR 0.99083 -4.6694 0 0 0 0 0 10.7489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8028 17.7129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZK4 OR2H1_HUMAN "Olfactory receptor 2H1 (Hs6M1-16) (OLFR42A-9004.14/9026.2) (Olfactory receptor 2H6) (Olfactory receptor 2H8) (Olfactory receptor 6-2, OR6-2) (Olfactory receptor OR6-32)" OR2H1 OR2H6 OR2H8 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] INSATAWRK 0.99083 -21.235 0 0 0 0 0 0 13.3164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6U8 ALG9_HUMAN "Alpha-1,2-mannosyltransferase ALG9, EC 2.4.1.259, EC 2.4.1.261 (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)" ALG9 DIBD1 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]" GO:0000026; GO:0000030; GO:0005789; GO:0006487; GO:0006488; GO:0016020; GO:0016021; GO:0052918; GO:0052926 "alpha-1,2-mannosyltransferase activity [GO:0000026]; dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052926]; dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0052918]; mannosyltransferase activity [GO:0000030]" FHVQNLGHPYWLTLAPMYIWFIIFFIQPHK 0.99083 -4.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8685 0 0 0 0 0 0 0 0 0 0 0 11.273 0 0 0 0 0 0 0 0 0 0 0 0 13.8008 0 0 0 0 0 0 0 0 0 0 0 0 13.2215 0 0 0 16.0118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1304 0 0 13.2352 0 0 0 0 0 14.0698 0 0 0 14.3235 0 0 0 0 0 0 0 0 0 13.2364 0 13.5881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9S0 NANOG_HUMAN "Homeobox protein NANOG (Homeobox transcription factor Nanog, hNanog)" NANOG Homo sapiens (Human) "cell differentiation [GO:0030154]; endodermal cell fate specification [GO:0001714]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell differentiation [GO:0030154]; endodermal cell fate specification [GO:0001714]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]" GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001714; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0006357; GO:0010468; GO:0019827; GO:0030154; GO:0035019; GO:0043231; GO:0045595; GO:0045944; GO:1990837; GO:2000648 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" RWQKNNWPK 0.99083 -5.5973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15056 SYNJ2_HUMAN "Synaptojanin-2, EC 3.1.3.36 (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2)" SYNJ2 KIAA0348 Homo sapiens (Human) brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; membrane organization [GO:0061024]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; synaptic vesicle endocytosis [GO:0048488] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793] "anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; membrane organization [GO:0061024]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; synaptic vesicle endocytosis [GO:0048488]" GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005856; GO:0005886; GO:0006661; GO:0007420; GO:0017124; GO:0034596; GO:0042995; GO:0043813; GO:0045121; GO:0046855; GO:0046856; GO:0048471; GO:0048488; GO:0052629; GO:0061024; GO:0070161; GO:0098793 "phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]" AAERPSHRK 0.99084 -20.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5717 0 0 0 0 0 0 0 0 13.9584 0 0 0 0 0 0 0 0 0 0 12.1604 0 0 0 12.4956 0 0 0 0 0 0 0 0 12.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7561 15.1507 0 0 0 0 0 0 14.0136 0 0 11.1499 0 13.703 12.9537 0 0 14.1451 0 0 0 13.3507 0 0 14.8199 13.86 0 0 0 0 0 0 14.2498 0 0 14.5262 0 0 0 0 12.791 0 0 0 13.671 0 0 0 14.18 0 0 13.1563 12.9846 13.5572 0 0 0 0 13.4175 0 0 0 16.9181 11.423 17.0255 14.4149 0 0 0 14.8118 16.3644 0 13.4741 0 11.9472 11.4215 0 0 13.9942 0 0 0 0 0 14.8607 0 0 0 14.5144 0 0 0 0 0 0 0 0 0 14.1442 0 0 0 0 0 0 0 0 13.8828 0 0 0 0 0 P17014 ZNF12_HUMAN "Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3, GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3)" ZNF12 GIOT3 KOX3 ZNF325 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0045892; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AYECYECGK 0.99084 -21.319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1702 0 0 0 0 0 0 0 0 0 0 0 0 11.2337 0 0 0 0 0 10.8315 0 0 0 0 0 0 0 0 0 9.79007 0 0 0 0 0 0 0 0 10.8351 0 0 0 0 0 0 0 0 0 0 13.5911 15.1173 12.9774 0 0 0 14.2942 0 0 0 0 0 0 0 14.3647 13.6869 13.8703 14.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.051 0 0 0 0 0 0 0 0 0 0 0 0 10.3085 0 0 0 0 0 0 13.2745 0 10.8328 0 0 0 0 0 0 0 13.2903 0 0 0 0 0 14.1065 0 0 0 0 11.1055 0 11.6099 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9563 0 0 0 0 0 P62253 UB2G1_HUMAN "Ubiquitin-conjugating enzyme E2 G1, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed ]" UBE2G1 UBE2G Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0031625; GO:0043161; GO:0061631; GO:0070062; GO:0070534; GO:0070936 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] AHLTFPK 0.99084 -20.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01813 PFKAP_HUMAN "ATP-dependent 6-phosphofructokinase, platelet type, ATP-PFK, PFK-P, EC 2.7.1.11 (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C, PFK-C) (Phosphohexokinase)" PFKP PFKF Homo sapiens (Human) "canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]" 6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] "6-phosphofructokinase complex [GO:0005945]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877]; canonical glycolysis [GO:0061621]; cellular response to leukemia inhibitory factor [GO:1990830]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]" GO:0003872; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005945; GO:0006002; GO:0016020; GO:0016208; GO:0030388; GO:0042802; GO:0044877; GO:0045296; GO:0046872; GO:0048029; GO:0061621; GO:0070062; GO:0070095; GO:1990830 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; protein-containing complex binding [GO:0044877] EARGRGK 0.99084 -21.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1046 0 0 0 0 0 0 0 0 0 12.9239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9307 0 0 0 11.8193 0 0 0 0 0 0 0 0 0 0 0 12.6063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PI26 SHQ1_HUMAN Protein SHQ1 homolog SHQ1 Homo sapiens (Human) box H/ACA snoRNP assembly [GO:0000493]; negative regulation of rRNA processing [GO:2000233]; positive regulation of apoptotic process [GO:0043065]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; ribonucleoprotein complex assembly [GO:0022618] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; unfolded protein binding [GO:0051082]; box H/ACA snoRNP assembly [GO:0000493]; negative regulation of rRNA processing [GO:2000233]; positive regulation of apoptotic process [GO:0043065]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; ribonucleoprotein complex assembly [GO:0022618] GO:0000493; GO:0005654; GO:0005737; GO:0005829; GO:0022618; GO:0043065; GO:0051082; GO:1904874; GO:2000233 unfolded protein binding [GO:0051082] AYRDTIKILQLGK 0.99084 -19.168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1552 0 0 12.1466 12.6011 0 0 13.1746 0 0 0 0 0 0 0 0 0 0 13.5286 0 0 0 12.6763 0 0 0 0 0 0 0 0 0 0 11.2711 0 0 0 0 11.8821 0 0 0 0 0 0 0 0 0 0 0 12.7798 0 0 0 12.4513 13.6832 13.3219 13.3222 14.729 14.1746 14.3695 14.0736 0 0 12.2237 0 0 0 0 0 0 0 13.7578 0 0 0 0 0 12.8126 0 0 13.2123 0 0 0 12.7711 0 15.2892 13.3396 0 13.1305 13.6815 12.9843 0 0 0 0 0 15.5798 13.214 0 12.1847 13.1283 13.3697 0 13.4211 14.1532 12.6453 0 11.9843 0 0 14.8275 12.9515 12.7286 0 14.3349 14.9359 14.607 0 0 13.7653 0 13.3511 14.9141 0 12.4585 13.667 0 0 0 0 0 0 0 14.2182 0 14.5343 0 0 0 0 13.5143 0 0 0 0 12.3333 0 0 12.7757 0 0 0 12.1366 13.8957 14.5196 0 0 0 0 0 Q6UVK1 CSPG4_HUMAN Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan) CSPG4 MCSP Homo sapiens (Human) angiogenesis [GO:0001525]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; tissue remodeling [GO:0048771] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; lysosomal lumen [GO:0043202]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901]; angiogenesis [GO:0001525]; glial cell migration [GO:0008347]; intracellular signal transduction [GO:0035556]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; tissue remodeling [GO:0048771] GO:0001525; GO:0001726; GO:0005576; GO:0005654; GO:0005796; GO:0005886; GO:0005887; GO:0005925; GO:0006929; GO:0008347; GO:0009986; GO:0015026; GO:0016324; GO:0019901; GO:0031258; GO:0035556; GO:0043202; GO:0043410; GO:0048008; GO:0048771; GO:0050731; GO:0062023; GO:0070062; GO:0097178 coreceptor activity [GO:0015026]; protein kinase binding [GO:0019901] APLEVPQALGR 0.99084 -20.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.082 0 0 12.2561 11.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6521 13.3882 0 0 0 0 13.0051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7796 0 0 0 0 0 0 0 14.8284 0 0 0 0 0 0 0 11.3259 0 0 0 0 11.3896 0 0 0 0 11.6701 0 0 15.6521 0 0 0 Q7L804 RFIP2_HUMAN "Rab11 family-interacting protein 2, Rab11-FIP2 (NRip11)" RAB11FIP2 KIAA0941 Homo sapiens (Human) establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669] cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038] cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; establishment of cell polarity [GO:0030010]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; phagocytosis [GO:0006909]; positive regulation of GTPase activity [GO:0043547]; regulated exocytosis [GO:0045055]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669] GO:0001891; GO:0005654; GO:0005768; GO:0006909; GO:0019901; GO:0030010; GO:0030659; GO:0031267; GO:0035669; GO:0035773; GO:0042802; GO:0042803; GO:0042995; GO:0043231; GO:0043547; GO:0045055; GO:0055038 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] FATLPRKK 0.99084 -21.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9139 0 0 0 11.7812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9929 17.8366 0 0 0 0 0 0 0 15.2647 0 0 0 0 0 0 0 0 15.3861 15.6363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1061 13.2665 0 0 0 0 0 0 0 14.8355 0 0 0 14.5084 0 0 12.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWS1 PARI_HUMAN "PCNA-interacting partner, PARI (PARP-1 binding protein) (PARP1-binding protein, PARPBP)" PARPBP C12orf48 PARI Homo sapiens (Human) DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042] GO:0000785; GO:0003677; GO:0005654; GO:0005737; GO:0006281; GO:2000042 DNA binding [GO:0003677] CRALTSNCENYNTVSPSQLLDFLSGK 0.99084 -5.6101 0 0 0 0 0 0 10.156 0 0 0 0 0 0 0 0 11.6688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8249 0 0 0 0 0 0 0 0 0 0 0 9.29287 0 0 0 0 15.8977 0 0 15.9544 0 0 0 0 0 0 0 0 0 0 11.7748 0 0 0 12.6261 0 0 0 0 10.5685 12.7475 13.2949 0 0 0 0 0 0 0 0 0 11.4098 0 0 0 0 0 0 0 0 0 0 0 12.7339 0 0 0 12.8388 0 0 12.5596 0 0 0 0 0 0 0 0 12.332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1949 0 0 0 0 0 0 0 0 Q9Y6F8 CDY1_HUMAN "Testis-specific chromodomain protein Y 1, EC 2.3.1.48" CDY1 CDY1A; CDY1B Homo sapiens (Human) spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; spermatogenesis [GO:0007283] GO:0003714; GO:0004402; GO:0005634; GO:0007283; GO:0035064 histone acetyltransferase activity [GO:0004402]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714] ALVRCNIK 0.99084 -21.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2905 0 0 0 0 0 0 0 0 0 0 12.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6868 0 0 0 0 0 0 0 0 0 0 0 0 10.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HN2 SAHH3_HUMAN "Adenosylhomocysteinase 3, AdoHcyase 3, EC 3.3.1.1 (IP(3)Rs binding protein released with IP(3) 2, IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2)" AHCYL2 KIAA0828 Homo sapiens (Human) one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353] GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005 hydrolase activity [GO:0016787] EIEIAEQEMPALMALRK 0.99085 -19.231 0 0 0 0 16.2241 0 0 0 0 0 11.9328 0 12.7883 0 0 0 0 0 10.8166 0 0 13.1445 0 12.7294 0 0 0 0 0 0 0 11.904 0 0 0 0 0 0 0 0 0 10.6497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4515 0 16.4712 16.361 10.2297 0 0 0 16.2107 0 16.2131 0 16.3942 16.4084 0 0 18.2535 0 18.5602 18.3734 18.6151 16.8978 16.8125 0 13.6777 0 0 0 13.2856 0 17.2534 17.6675 0 0 0 0 0 16.7448 16.6499 12.1415 0 0 0 11.8439 0 0 15.5666 0 0 0 0 11.4547 0 0 0 11.8483 0 10.8884 0 17.6881 16.7863 0 0 0 16.7441 16.7532 0 16.784 16.7912 0 0 16.6968 16.9349 0 0 12.553 0 11.7523 12.0857 16.4562 12.2638 11.7779 11.4863 0 16.8223 16.739 0 16.8736 11.631 16.8687 16.5558 0 0 0 0 0 0 0 0 0 0 0 15.0345 14.8217 14.8408 0 0 13.0534 0 0 0 0 10.8221 0 Q15628 TRADD_HUMAN "Tumor necrosis factor receptor type 1-associated DEATH domain protein, TNFR1-associated DEATH domain protein (TNFRSF1A-associated via death domain)" TRADD Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of hair follicle development [GO:0051798]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]; death domain binding [GO:0070513]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of hair follicle development [GO:0051798]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0002947; GO:0005068; GO:0005164; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006915; GO:0007165; GO:0008625; GO:0019900; GO:0030335; GO:0031264; GO:0033209; GO:0042802; GO:0043065; GO:0043123; GO:0043235; GO:0044877; GO:0045121; GO:0050729; GO:0051092; GO:0051798; GO:0070513; GO:0071356; GO:0097191; GO:1901224 death domain binding [GO:0070513]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; tumor necrosis factor receptor binding [GO:0005164] KVGRSLQR 0.99085 -19.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5669 0 0 0 12.8416 0 14.8971 0 0 11.185 0 0 0 14.8162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4728 12.4177 0 0 0 0 0 0 0 0 0 0 0 0 Q16877 F264_HUMAN "6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4, 6PF-2-K/Fru-2,6-P2ase 4, PFK/FBPase 4 (6PF-2-K/Fru-2,6-P2ase testis-type isozyme) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]" PFKFB4 Homo sapiens (Human) "fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]" cytosol [GO:0005829] "cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]" GO:0003873; GO:0004331; GO:0005524; GO:0005829; GO:0006000; GO:0006003 "6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]" DSDEATEDFMR 0.99085 -5.9268 0 0 0 0 0 0 0 0 0 0 0 0 12.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3621 0 0 0 0 0 0 0 0 0 Q96BT1 CC049_HUMAN Putative uncharacterized protein C3orf49 C3orf49 Homo sapiens (Human) EESSSDSDMGFHESQQNQKSNLKTK 0.99085 -19.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1887 0 12.7308 0 0 0 0 0 0 10.7568 0 0 0 0 0 0 0 0 0 0 12.2982 0 0 0 0 0 0 0 13.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7559 13.2695 13.995 0 0 0 0 0 0 0 0 0 14.0856 13.7313 0 0 0 0 0 0 0 0 0 0 14.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0191 0 11.5622 0 0 0 0 0 14.6055 0 0 0 0 0 0 0 0 0 0 0 14.2686 12.2934 0 0 0 0 0 13.9177 0 0 0 0 12.242 0 14.5755 0 0 0 0 0 0 13.7149 0 0 0 0 0 12.6401 0 Q9NQC3 RTN4_HUMAN "Reticulon-4 (Foocen) (Neurite outgrowth inhibitor, Nogo protein) (Neuroendocrine-specific protein, NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5)" RTN4 KIAA0886 NOGO My043 SP1507 Homo sapiens (Human) apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; brain development [GO:0007420]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; neuron differentiation [GO:0030182]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334] anchoring junction [GO:0070161]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; brain development [GO:0007420]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; neuron differentiation [GO:0030182]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334] GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0007420; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030176; GO:0030182; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0043005; GO:0045296; GO:0045766; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0070161; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0120078; GO:1902430; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213 cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625] EEYADFK 0.99085 -19.227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2181 13.4114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL62 TRPC5_HUMAN "Short transient receptor potential channel 5, TrpC5 (Transient receptor protein 5, TRP-5, hTRP-5, hTRP5)" TRPC5 TRP5 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630] calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] "calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630]" GO:0003779; GO:0005262; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007204; GO:0007399; GO:0008284; GO:0010800; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045121; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:1902630 "actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" ALASPSLIALSSEDPILTAFRLGWELKELSK 0.99085 -19.218 0 0 0 0 0 0 11.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1839 0 0 0 0 11.0469 0 0 0 0 0 0 11.3944 0 0 0 0 0 0 0 0 0 0 15.503 15.6184 13.8761 13.9105 0 14.0024 13.5657 12.2695 0 12.4694 0 0 14.388 12.5802 0 0 18.2329 14.2207 12.5639 0 0 0 0 0 0 0 16.0787 0 0 0 0 0 0 0 0 20.0455 20.426 20.6211 20.2343 19.8198 19.6932 19.0088 19.7176 14.3834 0 0 0 17.3266 0 0 0 0 0 0 0 13.3619 0 0 13.1457 13.931 19.0797 12.85 0 17.6792 13.8691 17.0583 10.8903 16.0645 0 18.266 0 0 13.3235 0 13.1572 0 0 13.3775 0 0 13.4346 14.977 0 0 16.8172 0 0 0 13.6527 0 14.4286 0 15.64 13.1107 11.2494 14.4529 0 0 13.3211 0 13.0886 13.5531 0 18.0786 16.1639 13.3455 14.2781 14.108 14.6353 0 14.0736 0 13.7993 12.9382 0 0 16.4769 16.1765 16.5329 0 0 12.716 15.0619 14.5591 0 14.237 13.0042 0 O96006 ZBED1_HUMAN "E3 SUMO-protein ligase ZBED1, EC 2.3.2.- (DNA replication-related element-binding factor) (Putative Ac-like transposable element) (Zinc finger BED domain-containing protein 1) (dREF homolog)" ZBED1 ALTE DREF hDREF KIAA0785 TRAMP Homo sapiens (Human) "negative regulation by host of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autosumoylation [GO:1990466]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005813; GO:0006355; GO:0006357; GO:0016605; GO:0019789; GO:0031965; GO:0042802; GO:0043565; GO:0044828; GO:0045944; GO:0046872; GO:0046983; GO:0061665; GO:1990466; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]" AKSKVWK 0.99086 -21.495 0 0 0 0 0 0 0 0 12.0033 0 0 0 0 0 0 0 0 0 0 0 12.5151 0 0 0 0 0 0 0 0 11.7849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6566 0 0 0 0 0 0 0 14.2772 0 13.1707 0 0 0 0 0 13.7954 12.2322 13.0823 13.3451 11.3533 14.3026 0 0 14.7905 0 0 0 0 0 0 0 14.4712 0 0 0 0 0 0 0 0 11.7337 0 0 15.1781 0 0 0 12.1586 0 0 13.9684 0 0 0 0 0 0 12.8881 13.3016 0 0 0 0 0 0 0 0 14.6529 0 0 0 14.3021 0 14.35 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0336 0 0 0 0 0 0 0 0 0 12.396 0 0 0 Q6UW63 PLGT2_HUMAN "Protein O-glucosyltransferase 2, EC 2.4.1.- (Endoplasmic reticulum resident protein 58, ER protein 58, ERp58) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2, EC 2.4.2.-)" POGLUT2 EP58 KDELC1 UNQ1910/PRO4357 Homo sapiens (Human) protein O-linked glycosylation via serine [GO:0018242] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788]; nucleoplasm [GO:0005654]; EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242] GO:0005654; GO:0005788; GO:0005829; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527; GO:0140561; GO:0140562 EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252] DLAHFPAVDPEKIAVEIPKR 0.99086 -23.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3576 0 0 0 0 0 0 0 0 0 0 10.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9786 Q9P2G9 KLHL8_HUMAN Kelch-like protein 8 KLHL8 KIAA1378 Homo sapiens (Human) protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleoplasm [GO:0005654] Cul3-RING ubiquitin ligase complex [GO:0031463]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005654; GO:0006511; GO:0016567; GO:0031463 AFAESHNR 0.99086 -20.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7146 0 0 11.1805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5517 0 0 0 0 0 0 0 0 0 11.9811 0 0 0 13.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6176 0 0 0 0 0 0 0 0 0 13.3468 0 0 0 0 0 0 0 0 0 Q9UI40 NCKX2_HUMAN Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2) SLC24A2 NCKX2 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; phototransduction [GO:0007602]; potassium ion transmembrane transport [GO:0071805]; sodium ion transmembrane transport [GO:0035725]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; phototransduction [GO:0007602]; potassium ion transmembrane transport [GO:0071805]; sodium ion transmembrane transport [GO:0035725]; visual perception [GO:0007601]" GO:0001917; GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007601; GO:0007602; GO:0008273; GO:0015293; GO:0034220; GO:0035725; GO:0036368; GO:0060291; GO:0060292; GO:0070509; GO:0070588; GO:0071486; GO:0071805; GO:0098703 "calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]" ASILHKIAKK 0.99086 -21.522 0 0 0 0 0 0 0 0 0 0 0 11.8533 0 0 0 0 0 0 0 0 0 0 13.6898 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6535 14.519 0 0 0 0 0 0 12.0373 0 0 0 0 13.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5047 0 0 0 0 0 0 0 0 0 0 14.9066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2708 0 0 0 0 11.4663 10.4633 10.6983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4079 12.2402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0V3 RBFA_HUMAN "Putative ribosome-binding factor A, mitochondrial" RBFA C18orf22 Homo sapiens (Human) rRNA processing [GO:0006364] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; rRNA processing [GO:0006364] GO:0005739; GO:0006364 DERDNFVQNDFR 0.99087 -5.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N163 CCAR2_HUMAN "Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein, DBC-1, DBC.1) (NET35) (p30 DBC)" CCAR2 DBC1 KIAA1967 Homo sapiens (Human) "cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000993; GO:0003723; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005819; GO:0006355; GO:0006397; GO:0006974; GO:0007049; GO:0008380; GO:0009411; GO:0016055; GO:0019899; GO:0030308; GO:0030374; GO:0031647; GO:0032435; GO:0032784; GO:0042752; GO:0043065; GO:0043086; GO:0043653; GO:0044609; GO:0045892; GO:0048511; GO:0090263; GO:0090311; GO:1902230; GO:2000003 enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993] GRLPQLGEK 0.99087 -21.603 0 0 0 0 0 0 0 0 0 0 11.782 11.6714 11.2484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7171 0 0 0 10.9579 0 13.7728 12.9363 0 0 0 0 0 12.6066 12.0872 11.4052 14.7198 14.679 14.7174 0 12.6192 14.7267 0 15.111 0 15.2016 0 0 14.9559 14.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6599 13.1504 0 13.3833 0 11.8687 0 0 12.4724 16.8978 16.8728 0 16.7835 0 0 0 0 0 0 15.1402 0 0 0 0 0 0 0 0 0 16.6369 0 14.4142 0 16.5568 16.7248 16.7937 16.1205 12.5037 15.4257 16.6813 13.6033 0 12.073 0 16.9353 0 12.8959 0 0 11.7115 0 0 0 0 0 0 0 0 0 0 0 16.978 0 16.8574 17.7078 0 0 14.3968 0 17.1943 0 17.3694 12.1999 0 13.6177 12.7738 0 16.5594 17.1547 17.2383 0 0 15.0613 17.5866 15.1218 17.2853 13.4257 15.6134 17.2717 13.431 15.7598 17.7056 18.0604 17.0893 13.2659 0 14.7363 16.9253 0 13.0358 0 17.3762 Q96EK4 THA11_HUMAN THAP domain-containing protein 11 THAP11 HRIHFB2206 Homo sapiens (Human) cell population proliferation [GO:0008283]; electron transport chain [GO:0022900]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of androgen receptor activity [GO:2000825]; regulation of mitochondrial transcription [GO:1903108]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; electron transport chain [GO:0022900]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of androgen receptor activity [GO:2000825]; regulation of mitochondrial transcription [GO:1903108]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003677; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0008283; GO:0022900; GO:0030182; GO:0043524; GO:1903108; GO:2000825 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" DRLLAMAVIR 0.99087 -5.9668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4103 0 0 0 0 0 11.7732 0 0 0 16.619 0 0 0 0 0 14.7664 0 0 0 0 0 0 0 0 0 13.5864 0 0 0 0 P00450 CERU_HUMAN "Ceruloplasmin, EC 1.16.3.1 (Ferroxidase)" CP Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] GO:0004322; GO:0005507; GO:0005576; GO:0005615; GO:0005765; GO:0005788; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0016491; GO:0051087; GO:0055072; GO:0070062; GO:0072562 chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491] DIASGLIGPLIICKK 0.99088 -21.226 0 0 0 0 0 0 0 0 13.3095 0 13.3863 13.4255 0 13.3999 13.2128 0 13.1249 0 13.1682 0 13.2955 0 0 0 0 0 0 0 0 0 9.92967 13.6136 0 0 0 13.4286 0 0 13.011 0 13.5254 13.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7207 0 0 10.9482 0 0 0 0 11.2383 14.0976 0 0 0 0 0 11.8296 0 0 0 0 0 0 12.2364 0 0 13.7178 0 0 14.2755 0 0 0 0 0 13.0761 0 0 12.8998 0 0 12.0725 14.9088 0 0 0 0 0 12.4319 0 0 0 0 0 0 0 13.4043 0 0 0 13.062 0 11.6052 0 0 0 0 0 0 0 0 0 0 11.538 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3501 0 0 0 0 0 14.2533 0 0 18.2584 0 0 0 13.8389 0 0 0 0 17.8769 0 0 0 0 0 P13945 ADRB3_HUMAN "Beta-3 adrenergic receptor (Beta-3 adrenoreceptor, Beta-3 adrenoceptor)" ADRB3 ADRB3R B3AR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; brown fat cell differentiation [GO:0050873]; carbohydrate metabolic process [GO:0005975]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; generation of precursor metabolites and energy [GO:0006091]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]" integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; aging [GO:0007568]; brown fat cell differentiation [GO:0050873]; carbohydrate metabolic process [GO:0005975]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; energy reserve metabolic process [GO:0006112]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; generation of precursor metabolites and energy [GO:0006091]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]" GO:0002024; GO:0002025; GO:0004930; GO:0004939; GO:0005634; GO:0005886; GO:0005887; GO:0005975; GO:0006091; GO:0006112; GO:0007187; GO:0007188; GO:0007190; GO:0007568; GO:0009409; GO:0015052; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0046677; GO:0050873; GO:0051379; GO:0051380; GO:0071880; GO:0120162 beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803] LDGASWGVS 0.99088 -20.247 0 0 0 0 0 0 0 0 0 0 9.61809 0 0 0 0 10.3402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7477 0 0 0 0 0 0 0 0 0 0 11.7687 0 0 0 0 11.7949 11.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8259 0 0 0 0 0 13.158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92598 HS105_HUMAN Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) HSPH1 HSP105 HSP110 KIAA0201 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986] GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662 adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662] DVSGKMNR 0.99088 -20.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7207 0 0 13.105 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2X9 S12A5_HUMAN "Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2, hKCC2) (Neuronal K-Cl cotransporter)" SLC12A5 KCC2 KIAA1176 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040] cell periphery [GO:0071944]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202] cell periphery [GO:0071944]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular ion homeostasis [GO:0006873]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular pH reduction [GO:0051452]; ion transport [GO:0006811]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040] GO:0005886; GO:0005887; GO:0006811; GO:0006873; GO:0006884; GO:0006971; GO:0007268; GO:0007612; GO:0008519; GO:0009410; GO:0015108; GO:0015379; GO:0016021; GO:0019901; GO:0030644; GO:0032590; GO:0035264; GO:0040040; GO:0043005; GO:0043025; GO:0043204; GO:0045202; GO:0051452; GO:0055064; GO:0055075; GO:0060996; GO:0071944; GO:1902476; GO:1990573 ammonium transmembrane transporter activity [GO:0008519]; chloride transmembrane transporter activity [GO:0015108]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901] FALVFLGCVILSILAIYAGVIK 0.99088 -20.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7761 0 0 0 0 0 0 0 0 0 0 11.0384 0 0 0 0 0 0 0 0 0 0 0 0 11.8764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.082 0 11.9562 0 11.0157 0 0 0 0 0 14.594 0 0 0 12.0563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGG8 PCARE_HUMAN Photoreceptor cilium actin regulator PCARE C2orf71 Homo sapiens (Human) photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0005929; GO:0007601; GO:0035845; GO:0050896; GO:0120199; GO:1903546 DGEVLLQEVR 0.99089 -19.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1854 17.3304 0 0 0 16.8158 0 0 0 0 0 0 0 0 0 0 0 0 13.6107 14.2191 0 0 0 0 13.1916 14.4972 0 0 0 0 0 0 10.8082 0 0 10.5557 13.9221 0 0 0 0 11.799 0 0 0 0 0 0 0 0 0 0 0 0 11.2016 0 0 10.4611 0 0 12.2143 0 0 0 0 0 0 16.4293 0 0 0 0 0 10.484 12.9492 15.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0428 0 0 0 0 0 0 0 0 11.9288 0 0 0 0 0 0 0 0 0 0 0 0 10.5255 0 0 0 13.7309 0 0 0 0 0 0 11.66 0 13.2558 0 0 0 0 0 0 0 0 12.6753 13.225 10.9915 0 13.0027 0 0 0 13.0225 0 0 0 0 0 0 0 0 0 0 0 14.108 0 0 0 0 0 0 P00519 ABL1_HUMAN "Tyrosine-protein kinase ABL1, EC 2.7.10.2 (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)" ABL1 ABL JTK7 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cell-cell adhesion [GO:0098609]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; DN4 thymocyte differentiation [GO:1904157]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron death [GO:0070997]; neuron differentiation [GO:0030182]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; podocyte apoptotic process [GO:1903210]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein localization to cytoplasmic microtubule plus-end [GO:1904518]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]" actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cell-cell adhesion [GO:0098609]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; DN4 thymocyte differentiation [GO:1904157]; DNA conformation change [GO:0071103]; DNA damage induced protein phosphorylation [GO:0006975]; endocytosis [GO:0006897]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron death [GO:0070997]; neuron differentiation [GO:0030182]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; podocyte apoptotic process [GO:1903210]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein localization to cytoplasmic microtubule plus-end [GO:1904518]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of T cell differentiation [GO:0045580]; regulation of transcription, DNA-templated [GO:0006355]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]" GO:0000278; GO:0000287; GO:0000400; GO:0000405; GO:0001726; GO:0001784; GO:0001843; GO:0001922; GO:0001934; GO:0002322; GO:0002333; GO:0003677; GO:0003713; GO:0003785; GO:0004515; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006298; GO:0006355; GO:0006468; GO:0006897; GO:0006914; GO:0006974; GO:0006975; GO:0006979; GO:0007173; GO:0007204; GO:0007229; GO:0007249; GO:0008022; GO:0008306; GO:0008630; GO:0009410; GO:0009791; GO:0010506; GO:0010595; GO:0015629; GO:0016301; GO:0016604; GO:0017124; GO:0018108; GO:0019905; GO:0021587; GO:0022408; GO:0030035; GO:0030036; GO:0030041; GO:0030100; GO:0030145; GO:0030155; GO:0030182; GO:0030425; GO:0030426; GO:0030509; GO:0030514; GO:0030516; GO:0031113; GO:0031965; GO:0032489; GO:0032729; GO:0032743; GO:0032956; GO:0032991; GO:0033690; GO:0034446; GO:0034599; GO:0034976; GO:0035791; GO:0036211; GO:0038083; GO:0038096; GO:0038189; GO:0038191; GO:0042169; GO:0042770; GO:0042981; GO:0043025; GO:0043065; GO:0043123; GO:0043124; GO:0043525; GO:0043542; GO:0043621; GO:0045580; GO:0045907; GO:0045930; GO:0045931; GO:0045944; GO:0046632; GO:0046777; GO:0046875; GO:0048146; GO:0048471; GO:0048536; GO:0048538; GO:0050731; GO:0050798; GO:0050852; GO:0050853; GO:0050885; GO:0051015; GO:0051019; GO:0051281; GO:0051353; GO:0051444; GO:0051496; GO:0051649; GO:0051726; GO:0051882; GO:0051894; GO:0060020; GO:0060563; GO:0070064; GO:0070097; GO:0070301; GO:0070371; GO:0070373; GO:0070374; GO:0070997; GO:0071103; GO:0071222; GO:0071560; GO:0071871; GO:0071901; GO:0072359; GO:0090050; GO:0090398; GO:0098609; GO:0098794; GO:1900006; GO:1900026; GO:1900272; GO:1900275; GO:1901300; GO:1902036; GO:1903055; GO:1903210; GO:1903351; GO:1903905; GO:1904157; GO:1904518; GO:1904528; GO:1904531; GO:1905244; GO:1905555; GO:1990051; GO:1990837; GO:2000096; GO:2000145; GO:2000249; GO:2000251; GO:2000352; GO:2000406; GO:2000773; GO:2001020 actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713] AGENRSDQVTR 0.99089 -20.32 0 0 0 0 0 10.268 0 0 0 0 0 0 13.1219 13.154 0 0 0 0 13.6344 0 0 0 0 0 0 0 0 0 0 11.1432 0 0 0 0 0 0 0 13.1847 0 0 0 0 14.0471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8693 0 0 0 0 0 0 0 0 0 0 0 12.8559 0 0 16.1068 14.5295 0 13.5451 0 0 13.9654 0 13.2341 0 0 0 0 0 12.8306 0 0 0 11.9318 0 0 0 0 14.1398 0 0 0 0 12.6934 0 0 0 0 14.2554 14.0297 13.0005 0 0 13.5581 11.5424 0 13.1612 12.0919 12.7455 0 14.3846 0 0 0 0 0 14.0789 14.5077 0 0 0 0 0 0 0 11.8572 0 0 0 12.5629 0 0 0 12.1729 0 0 0 12.2786 12.6424 13.3625 14.935 0 0 0 0 0 0 0 0 0 0 11.7426 0 0 0 0 0 12.495 0 13.4284 0 0 0 0 P46779 RL28_HUMAN 60S ribosomal protein L28 (Large ribosomal subunit protein eL28) RPL28 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0030425; GO:0036464; GO:0044297; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ARNSFRYNGLIHR 0.99089 -20.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3455 0 12.2159 0 13.4376 0 0 12.6715 0 10.8913 10.0488 0 0 13.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8105 13.8746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01804 OTUD4_HUMAN "OTU domain-containing protein 4, EC 3.4.19.12 (HIV-1-induced protein HIN-1)" OTUD4 HIN-1 KIAA1046 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein K48-linked deubiquitination [GO:1903093] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; Lys63-specific deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; innate immune response [GO:0045087]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein K48-linked deubiquitination [GO:1903093] GO:0003723; GO:0004843; GO:0005634; GO:0005829; GO:0016579; GO:0034122; GO:0045087; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:1901537; GO:1903093; GO:2000660 cysteine-type deubiquitinase activity [GO:0004843]; Lys63-specific deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723] FFFNLGVK 0.99089 -20.379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3312 13.8119 0 0 0 0 0 11.6829 0 0 0 0 0 0 0 0 13.3946 0 0 0 0 0 0 0 0 14.2646 0 0 0 13.7773 0 0 0 0 0 12.5133 0 15.5059 0 13.704 13.8488 0 0 13.5185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0841 0 0 Q14D04 MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 (Protein melted) VEPH1 KIAA1692 VEPH Homo sapiens (Human) negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; phosphatidylinositol-5-phosphate binding [GO:0010314]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of signal transduction [GO:0009966] GO:0005886; GO:0009966; GO:0010314; GO:0030512; GO:0060392 phosphatidylinositol-5-phosphate binding [GO:0010314] DEDTPHAKIASDIMSCILQNYNR 0.99089 -19.167 0 0 0 0 0 0 0 0 0 0 12.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3898 0 12.8449 0 0 0 0 0 0 0 11.896 0 0 0 0 0 11.7571 12.1563 0 0 0 0 11.9182 0 0 0 0 0 0 0 0 0 0 19.3974 0 18.3694 0 0 18.3862 0 0 11.431 0 0 0 0 0 0 0 14.5204 0 14.9128 13.1828 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2901 0 0 0 0 0 15.301 0 0 0 0 0 0 0 0 0 0 0 13.6169 0 0 0 0 0 0 0 0 0 0 0 12.3372 0 0 0 14.1017 12.1019 0 0 14.2571 0 0 13.0719 15.4385 0 0 0 13.8558 13.2806 0 12.2277 13.1813 0 0 0 0 0 0 0 0 0 0 0 0 13.0571 0 0 0 0 18.5178 0 0 13.493 18.5983 13.786 15.0636 14.058 14.1001 0 0 0 15.6189 0 0 0 14.602 0 12.8425 0 0 Q5H8A4 PIGG_HUMAN "GPI ethanolamine phosphate transferase 2, EC 2.-.-.- (GPI7 homolog, hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein, PIG-G)" PIGG GPI7 UNQ1930/PRO4405 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254]" GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016254; GO:0016780; GO:0030176; GO:0051267 "CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]" DPGFEQFK 0.99089 -21.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5684 0 0 0 0 0 0 0 0 0 0 0 14.018 0 12.8635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6834 0 0 12.7978 13.9414 0 0 0 10.7686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7943 0 0 0 0 0 0 13.2996 0 0 0 0 0 0 0 0 0 14.6989 0 0 0 0 0 0 0 0 Q5TBA9 FRY_HUMAN Protein furry homolog FRY C13orf14 Homo sapiens (Human) cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] cell cortex [GO:0005938]; microtubule organizing center [GO:0005815]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922] cell cortex [GO:0005938]; microtubule organizing center [GO:0005815]; site of polarized growth [GO:0030427]; spindle pole [GO:0000922]; enzyme inhibitor activity [GO:0004857]; cell morphogenesis [GO:0000902]; negative regulation of tubulin deacetylation [GO:1904428]; neuron projection development [GO:0031175] GO:0000902; GO:0000922; GO:0004857; GO:0005815; GO:0005938; GO:0030427; GO:0031175; GO:1904428 enzyme inhibitor activity [GO:0004857] DLAIDFIFSLVLIEVLK 0.99089 -20.354 0 0 0 0 0 13.3418 14.8068 13.2154 0 11.6562 0 0 0 0 0 0 0 0 0 12.5658 0 0 0 0 0 0 0 0 0 0 10.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0835 10.7948 0 0 0 0 13.7789 0 14.102 0 0 0 0 0 12.868 12.6964 0 0 13.3811 0 16.7662 0 0 15.2316 0 0 0 0 0 0 14.3865 14.2968 13.5895 0 11.7606 10.4646 0 0 12.2724 0 0 11.9253 0 0 0 0 0 0 0 11.377 0 0 0 0 0 0 13.805 0 0 0 0 0 0 0 14.2513 0 15.0795 0 0 0 0 0 0 0 0 0 0 13.1865 0 0 12.9177 0 0 0 0 0 13.3235 0 0 0 13.3405 0 0 0 13.3671 0 12.5629 0 0 0 15.9021 0 12.4601 12.9571 0 12.7865 0 Q6W2J9 BCOR_HUMAN "BCL-6 corepressor, BCoR" BCOR KIAA1575 Homo sapiens (Human) "blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]" BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H2A monoubiquitination [GO:0035518]; negative regulation of bone mineralization [GO:0030502]; negative regulation of histone H3-K36 methylation [GO:0000415]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001]" GO:0000122; GO:0000415; GO:0000976; GO:0000977; GO:0001835; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007507; GO:0030502; GO:0031072; GO:0035518; GO:0042476; GO:0042826; GO:0045892; GO:0051572; GO:0060021; GO:0065001; GO:0070171; GO:0140261; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] AEAKGNR 0.99089 -19.158 0 0 0 0 0 0 0 0 0 12.4425 12.4621 0 0 0 12.1657 0 0 12.4984 0 0 0 9.16895 0 0 0 0 11.3156 11.6051 0 0 0 0 0 13.7922 0 0 0 0 0 0 0 0 0 10.6537 0 0 0 0 12.05 13.0715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7422 0 15.466 0 0 0 14.5256 13.4848 11.5738 0 13.2717 0 12.7206 14.2041 0 0 13.1926 12.461 14.4389 0 0 0 0 12.6774 14.9685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6211 0 0 0 11.9311 0 0 11.626 13.2599 13.8349 11.571 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8435 13.7463 0 0 0 13.8817 0 0 0 14.7474 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1759 13.4552 12.9078 0 12.8953 0 12.9719 0 0 12.8424 0 0 0 0 16.8165 13.9721 0 0 0 Q6XUX3 DUSTY_HUMAN "Dual serine/threonine and tyrosine protein kinase, EC 2.7.12.1 (Dusty protein kinase, Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496, SgK496)" DSTYK KIAA0472 RIP5 RIPK5 SGK496 HDCMD38P Homo sapiens (Human) cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] DLQITPKRLEYTR 0.99089 -4.6128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7846 12.381 11.8605 12.5016 0 0 0 0 0 12.551 12.4452 0 0 12.5401 12.7181 0 0 0 0 0 0 0 0 0 0 0 0 12.1427 12.0964 0 0 0 0 0 0 0 0 0 0 10.9705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0616 0 0 0 0 12.5446 0 0 0 0 0 0 0 0 12.802 13.1795 0 14.0012 0 12.6346 0 0 0 13.8226 0 0 0 0 0 0 0 0 0 0 0 11.0671 0 0 0 0 11.66 0 0 0 0 13.6218 0 0 0 0 0 13.2335 13.6366 0 0 13.4648 0 0 0 0 0 0 0 0 0 13.6063 0 0 0 0 0 0 0 0 0 0 12.3621 0 0 0 13.2664 0 0 13.1441 13.3959 0 0 0 0 17.4429 0 0 0 0 0 0 0 0 Q7Z2V1 TNT_HUMAN Protein TNT C16orf82 Homo sapiens (Human) LTGPAHSTK 0.99089 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2619 0 0 13.2615 0 0 0 12.6244 0 12.8292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5225 0 13.7607 0 0 0 0 0 0 Q8IVF6 AN18A_HUMAN Ankyrin repeat domain-containing protein 18A ANKRD18A KIAA2015 Homo sapiens (Human) AEREVIVREFQEELVDHLK 0.99089 -20.338 0 0 0 0 0 12.3558 0 0 0 0 0 0 12.5259 0 0 0 0 0 11.6881 0 0 0 0 0 0 0 0 0 0 12.4213 0 0 0 12.7642 0 0 9.68804 0 0 0 0 0 0 0 0 0 11.8398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3183 10.6626 0 14.0762 0 0 0 0 0 0 0 0 0 0 0 0 13.327 14.5868 15.4863 0 14.2735 0 13.2951 0 0 14.5834 11.2623 14.6785 14.2662 0 0 0 13.5487 0 0 0 0 0 0 0 0 14.6359 13.4397 15.1062 13.4201 0 13.7078 16.5615 13.6037 15.0479 13.9548 14.4666 14.5793 0 15.1389 0 0 13.5232 0 13.4713 0 0 14.0951 0 12.7312 0 13.2596 0 0 0 0 13.6055 13.5046 0 13.6542 0 0 0 0 0 11.7266 11.9699 14.7218 14.1221 0 0 0 0 0 0 0 13.3387 13.9103 0 0 0 0 0 13.2668 0 13.405 0 0 0 0 0 0 Q8ND56 LS14A_HUMAN "Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein, AlphaSNBP) (RNA-associated protein 55A, hRAP55, hRAP55A)" LSM14A C19orf13 FAM61A RAP55 RAP55A Homo sapiens (Human) mitotic spindle assembly [GO:0090307]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; RIG-I signaling pathway [GO:0039529]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitotic spindle [GO:0072686]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; messenger ribonucleoprotein complex [GO:1990124]; mitotic spindle [GO:0072686]; P-body [GO:0000932]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mitotic spindle assembly [GO:0090307]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; RIG-I signaling pathway [GO:0039529]; stress granule assembly [GO:0034063] GO:0000932; GO:0003690; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0005737; GO:0005829; GO:0010494; GO:0017148; GO:0033962; GO:0034063; GO:0036464; GO:0039529; GO:0060340; GO:0072686; GO:0090307; GO:1990124 double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] AGENQEHR 0.99089 -20.37 0 0 0 0 0 0 0 0 0 0 0 12.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4674 0 0 0 0 0 0 0 0 0 11.6914 0 0 0 0 10.4782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3804 0 0 0 0 0 0 0 0 0 0 0 12.3544 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1177 0 0 0 0 14.9699 0 0 0 12.0156 0 14.3709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3595 0 0 0 0 0 0 0 13.4035 0 0 0 0 0 0 0 12.2831 0 0 0 0 0 0 0 0 0 Q8TAP9 MPLKI_HUMAN M-phase-specific PLK1-interacting protein (TTD non-photosensitive 1 protein) MPLKIP C7orf11 TTDN1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0007049; GO:0030496; GO:0043231; GO:0051301 PYGSSHSPR 0.99089 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBZ3 WDR20_HUMAN WD repeat-containing protein 20 (Protein DMR) WDR20 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 ATEGGGK 0.99089 -4.3634 0 0 0 0 0 0 0 0 18.9079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4464 13.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3103 13.3565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.1635 20.1888 20.1885 0 20.1552 20.1805 0 20.209 0 20.1448 20.1533 20.1262 20.1055 0 20.1268 0 0 0 0 20.1772 0 20.1525 0 20.1383 Q9H9D4 ZN408_HUMAN Zinc finger protein 408 (PR domain zinc finger protein 17) ZNF408 PFM14 PRDM17 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRQRGNLR 0.99089 -19.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2965 0 10.3697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7761 0 11.2801 0 0 0 12.5137 0 0 0 11.5414 0 0 0 0 0 0 0 12.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.084 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9665 0 0 0 0 0 0 0 0 0 0 15.27 Q9HC56 PCDH9_HUMAN Protocadherin-9 PCDH9 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887] cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030426; GO:0044291 calcium ion binding [GO:0005509] CPSSTGFHIQENEESHYESQRR 0.99089 -21.306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1335 0 0 0 0 12.6291 0 0 0 0 0 14.2373 0 0 0 0 0 0 15.4861 0 12.6426 13.4789 0 0 0 0 0 15.2459 0 0 0 0 0 13.5762 0 0 0 0 0 0 0 0 0 0 0 0 13.0698 0 0 0 0 10.6495 0 0 13.2345 12.6685 0 0 11.4552 0 0 0 0 12.9199 10.5412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4248 0 0 13.1583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8632 0 0 0 0 0 0 0 0 0 0 0 Q9UKE5 TNIK_HUMAN "TRAF2 and NCK-interacting protein kinase, EC 2.7.11.1" TNIK KIAA0551 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; response to organonitrogen compound [GO:0010243]; Wnt signaling pathway [GO:0016055] "apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037]" "apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of dendrite morphogenesis [GO:0048814]; regulation of MAPK cascade [GO:0043408]; response to organonitrogen compound [GO:0010243]; Wnt signaling pathway [GO:0016055]" GO:0000165; GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007010; GO:0010243; GO:0016055; GO:0016324; GO:0030033; GO:0031532; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048812; GO:0048814; GO:0055037; GO:0070062; GO:0072659; GO:0098793; GO:0098978; GO:0099092; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALFLIPRNPAPRLK 0.99089 -20.386 0 0 0 10.7205 0 0 0 0 0 10.4978 0 0 15.2613 14.2574 0 0 0 0 0 0 0 0 0 0 0 0 14.3618 0 0 0 0 0 0 0 0 0 0 0 0 14.5259 0 0 13.7102 13.7792 12.6823 12.7971 0 12.7946 11.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4354 0 0 15.1725 0 0 0 0 0 0 12.896 14.8107 12.4457 14.0642 0 0 0 11.29 0 13.8768 13.1617 0 14.7101 13.7621 13.4077 14.8809 15.3678 15.2814 15.6739 14.3497 0 14.2127 12.6529 0 14.1952 12.844 14.6712 0 0 13.2237 12.885 0 13.0029 13.7606 0 0 13.0116 14.3509 13.5807 14.58 0 14.2737 15.0896 14.4622 11.3406 0 11.5915 0 0 0 13.6423 0 13.0037 0 0 11.5342 0 12.2055 0 13.4316 0 0 0 0 12.8569 13.6297 0 15.8466 0 0 0 0 11.7143 0 14.0314 11.6936 13.3228 0 14.5646 0 0 11.7817 0 0 0 0 11.6911 0 12.1711 0 0 0 0 0 0 0 0 0 10.5403 0 0 0 0 0 Q9Y6Q1 CAN6_HUMAN "Calpain-6 (Calpain-like protease X-linked) (Calpamodulin, CalpM)" CAPN6 CALPM CANPX Homo sapiens (Human) microtubule bundle formation [GO:0001578]; regulation of cytoskeleton organization [GO:0051493] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; spindle microtubule [GO:0005876]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; microtubule binding [GO:0008017]; microtubule bundle formation [GO:0001578]; regulation of cytoskeleton organization [GO:0051493] GO:0001578; GO:0004198; GO:0005737; GO:0005876; GO:0008017; GO:0048471; GO:0051493 calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; microtubule binding [GO:0008017] DLRTYRR 0.99089 -20.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6989 0 14.513 13.3414 0 0 0 11.3786 0 12.2973 0 0 13.3805 0 0 13.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9627 0 10.1158 0 0 0 0 0 0 14.3139 12.5549 0 0 0 0 0 14.2633 14.1128 11.4247 12.3755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2208 0 0 0 0 0 0 0 0 O14645 IDLC_HUMAN "Axonemal dynein light intermediate polypeptide 1 (Inner dynein arm light chain, axonemal) (hp28)" DNALI1 Homo sapiens (Human) 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293]; dynein complex [GO:0030286]; filopodium [GO:0030175]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293]; dynein complex [GO:0030286]; filopodium [GO:0030175]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504] GO:0005737; GO:0005929; GO:0005930; GO:0030175; GO:0030286; GO:0031514; GO:0036126; GO:0045504; GO:0097729; GO:0120293 dynein heavy chain binding [GO:0045504] DLERQVNEQK 0.9909 -4.6417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.485 0 0 0 0 14.4353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8356 13.8011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.29 0 0 0 0 0 0 0 0 0 0 0 0 14.8016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43184 ADA12_HUMAN "Disintegrin and metalloproteinase domain-containing protein 12, ADAM 12, EC 3.4.24.- (Meltrin-alpha)" ADAM12 MLTN UNQ346/PRO545 Homo sapiens (Human) cell adhesion [GO:0007155]; myoblast fusion [GO:0007520]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; SH3 domain binding [GO:0017124]; cell adhesion [GO:0007155]; myoblast fusion [GO:0007520]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508] GO:0004222; GO:0005576; GO:0005654; GO:0005886; GO:0006508; GO:0007155; GO:0007520; GO:0008237; GO:0016021; GO:0017124; GO:0045766; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; SH3 domain binding [GO:0017124] CGNRFVEEGEECDCGEPEECMNRCCNATTCTLK 0.9909 -21.384 0 0 0 0 0 0 0 13.3315 0 0 0 0 0 12.8908 13.5851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9934 0 0 11.7083 11.4189 0 0 12.1249 0 0 0 12.4503 0 0 12.985 10.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1047 0 0 13.1813 0 0 0 0 0 18.2304 0 0 11.9489 0 0 0 0 0 12.4925 13.0342 12.0165 0 0 0 0 0 0 12.9221 0 0 0 0 0 12.7116 12.6438 0 0 0 0 0 12.6431 0 0 0 0 0 0 0 12.8842 0 0 12.7425 0 0 0 0 0 0 0 0 11.5097 0 0 0 12.8655 0 13.8626 0 0 12.663 0 0 0 0 0 0 12.9861 0 0 13.5146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2013 0 13.9928 0 0 0 0 0 0 0 0 0 0 0 0 0 O43918 AIRE_HUMAN "Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein, APECED protein)" AIRE APECED Homo sapiens (Human) "central tolerance induction to self antigen [GO:0002509]; humoral immune response [GO:0006959]; immune response [GO:0006955]; negative thymic T cell selection [GO:0045060]; peripheral T cell tolerance induction [GO:0002458]; positive regulation of chemokine production [GO:0032722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of thymocyte migration [GO:2000410]; regulation of transcription, DNA-templated [GO:0006355]; thymus epithelium morphogenesis [GO:0097536]; transcription by RNA polymerase II [GO:0006366]" cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; central tolerance induction to self antigen [GO:0002509]; humoral immune response [GO:0006959]; immune response [GO:0006955]; negative thymic T cell selection [GO:0045060]; peripheral T cell tolerance induction [GO:0002458]; positive regulation of chemokine production [GO:0032722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of thymocyte migration [GO:2000410]; regulation of transcription, DNA-templated [GO:0006355]; thymus epithelium morphogenesis [GO:0097536]; transcription by RNA polymerase II [GO:0006366]" GO:0000977; GO:0001673; GO:0001674; GO:0002458; GO:0002509; GO:0003682; GO:0005634; GO:0005737; GO:0006355; GO:0006366; GO:0006955; GO:0006959; GO:0008270; GO:0016604; GO:0032722; GO:0042393; GO:0042802; GO:0045060; GO:0045182; GO:0045893; GO:0045944; GO:0097536; GO:2000410 chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270] ALVPPPR 0.9909 -19.212 12.3315 0 11.5992 0 11.4626 0 12.2368 0 0 14.4648 0 14.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4721 0 0 0 0 0 0 0 14.0589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3806 0 0 0 0 0 0 0 0 0 0 14.4174 0 0 0 14.0813 13.7376 14.1402 14.6925 16.0161 15.3008 14.0898 15.435 0 14.904 14.8374 13.988 0 14.7123 13.2801 0 13.5851 0 0 0 11.5727 0 0 12.9737 14.4856 13.7187 0 0 0 0 13.6018 13.745 0 0 0 0 0 14.7298 0 0 0 0 0 0 0 0 10.8727 0 0 0 14.7619 0 0 0 0 0 0 11.7895 0 11.2015 0 14.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3593 0 0 14.0131 0 14.4558 0 0 0 0 0 0 0 P17027 ZNF23_HUMAN Zinc finger protein 23 (Zinc finger protein 359) (Zinc finger protein 612) (Zinc finger protein KOX16) ZNF23 KOX16 ZNF359 ZNF612 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GKLIQHQR 0.9909 -5.876 0 11.9867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4467 0 0 0 0 0 0 0 0 13.0716 13.2877 12.9199 0 0 0 0 0 0 0 0 0 12.3275 0 0 0 0 0 0 0 0 11.5306 0 0 0 0 0 0 0 0 0 0 0 13.1597 0 0 0 0 0 12.3754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25092 GUC2C_HUMAN "Guanylyl cyclase C, GC-C, EC 4.6.1.2 (Heat-stable enterotoxin receptor, STA receptor, hSTAR) (Intestinal guanylate cyclase)" GUCY2C GUC2C STAR Homo sapiens (Human) cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of cell population proliferation [GO:0042127]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165] GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005789; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0009636; GO:0015643; GO:0016021; GO:0016941; GO:0017046; GO:0035556; GO:0042127 ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; toxic substance binding [GO:0015643] ELEVYLLVK 0.9909 -20.397 0 0 0 0 0 0 0 0 0 11.409 10.6665 11.6487 13.0119 17.0422 11.3487 0 0 11.5495 0 0 0 0 0 0 0 0 0 0 0 13.2071 0 0 0 0 0 0 0 16.4993 0 16.2865 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4378 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3651 0 0 0 0 0 11.8022 10.9463 12.9476 0 0 0 12.5361 0 13.6487 0 17.2217 0 0 0 14.9089 0 0 0 0 0 0 0 12.2506 0 12.2461 0 0 0 0 0 0 0 0 0 0 15.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6326 0 0 0 14.5163 0 12.0923 0 13.8893 10.36 0 0 0 0 0 0 0 0 0 0 17.3228 0 13.3791 0 0 0 12.6225 0 0 12.049 0 13.5071 0 0 0 0 0 0 0 0 11.4138 0 0 0 0 0 12.1435 18.5082 14.5109 13.8391 0 14.4457 0 0 0 0 0 Q14722 KCAB1_HUMAN "Voltage-gated potassium channel subunit beta-1, EC 1.1.1.- (K(+) channel subunit beta-1) (Kv-beta-1)" KCNAB1 KCNA1B Homo sapiens (Human) negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion transport [GO:0006813]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; potassium ion transport [GO:0006813]; regulation of delayed rectifier potassium channel activity [GO:1902259]; regulation of potassium ion transmembrane transport [GO:1901379] GO:0004033; GO:0005249; GO:0005829; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0019904; GO:0031234; GO:0034705; GO:0044224; GO:0044325; GO:0070402; GO:1901379; GO:1902259; GO:1902260; GO:1903817 aldo-keto reductase (NADP) activity [GO:0004033]; NADPH binding [GO:0070402]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] AETERGLSR 0.9909 -4.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1793 0 0 0 0 13.2972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9558 0 0 11.5219 Q17R60 IMPG1_HUMAN "Interphotoreceptor matrix proteoglycan 1 (Interphotoreceptor matrix proteoglycan of 150 kDa, IPM-150) (Sialoprotein associated with cones and rods)" IMPG1 IPM150 SPACR Homo sapiens (Human) extracellular matrix organization [GO:0030198]; visual perception [GO:0007601] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; chondroitin sulfate binding [GO:0035374]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]; extracellular matrix organization [GO:0030198]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0005201; GO:0005540; GO:0005576; GO:0007601; GO:0008201; GO:0030198; GO:0031012; GO:0033165; GO:0035374 chondroitin sulfate binding [GO:0035374]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540] ALEQQFTQLLVPYLRSNLTGFK 0.9909 -5.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1141 0 0 12.1221 0 0 0 0 0 0 0 14.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7837 0 0 0 13.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4776 0 0 0 0 17.5094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2007 0 12.7846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3ZCX4 ZN568_HUMAN Zinc finger protein 568 ZNF568 Homo sapiens (Human) "embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; embryonic placenta morphogenesis [GO:0060669]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001701; GO:0005634; GO:0006357; GO:0045892; GO:0046872; GO:0060669 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" EKQSNEFGK 0.9909 -5.8745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1445 0 0 13.3055 14.4315 14.7919 15.2429 14.1322 10.2171 14.2305 14.9337 0 11.9302 14.2875 10.7036 11.8986 0 12.9727 16.1941 14.8304 0 10.6571 12.9199 0 0 0 0 11.0075 0 11.6811 0 0 13.0511 11.1501 0 0 0 0 0 0 0 0 0 0 11.2398 0 0 0 0 0 0 0 0 0 0 0 0 9.70726 0 0 13.143 0 0 0 0 14.1075 12.5058 11.5281 0 0 0 12.7704 11.7687 0 0 0 0 11.5568 0 0 0 0 0 0 0 0 0 10.6861 0 0 0 12.2494 12.3029 12.0189 0 12.0132 0 0 0 0 0 0 Q6MZT1 R7BP_HUMAN Regulator of G-protein signaling 7-binding protein (R7 family-binding protein) RGS7BP R7BP Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078] anchored component of postsynaptic density membrane [GO:0099031]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794] anchored component of postsynaptic density membrane [GO:0099031]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of postsynaptic membrane potential [GO:0060078] GO:0005634; GO:0005737; GO:0007186; GO:0009968; GO:0030424; GO:0043005; GO:0043198; GO:0043204; GO:0044327; GO:0060078; GO:0098794; GO:0098978; GO:0099026; GO:0099031 EPGGGTK 0.9909 -4.6331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7599 0 0 0 0 0 0 0 0 10.4974 0 0 0 0 9.86683 0 0 0 0 0 0 0 0 0 0 10.3873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6579 0 0 0 0 0 0 11.5166 0 0 0 0 0 0 0 0 0 0 0 11.8972 11.7802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBF2 NHLC2_HUMAN NHL repeat-containing protein 2 NHLRC2 Homo sapiens (Human) cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093] cytosol [GO:0005829]; extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093] GO:0005576; GO:0005829; GO:0031093 IGIKLYK 0.9909 -21.394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4713 0 0 0 0 0 0 0 0 14.603 0 0 0 0 0 0 10.6556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW07 ZN358_HUMAN Zinc finger protein 358 ZNF358 Homo sapiens (Human) embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; embryonic forelimb morphogenesis [GO:0035115]; neural tube development [GO:0021915]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0019827; GO:0021915; GO:0035115; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] PYRCPDCGK 0.9909 -5.5783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9103 0 0 0 0 0 0 0 0 0 0 0 11.3457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2304 0 0 0 0 0 11.2226 0 0 0 0 0 0 11.7445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKK9 NUDT5_HUMAN "ADP-sugar pyrophosphatase, EC 3.6.1.13 (8-oxo-dGDP phosphatase, EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5, EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5, Nudix motif 5, hNUDT5) (YSA1H)" NUDT5 NUDIX5 HSPC115 Homo sapiens (Human) ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693] GO:0000287; GO:0005634; GO:0005829; GO:0006338; GO:0006753; GO:0009117; GO:0009191; GO:0016779; GO:0019144; GO:0019303; GO:0019693; GO:0030515; GO:0042802; GO:0042803; GO:0044715; GO:0044716; GO:0047631; GO:0055086; GO:0070062; GO:1990966 8-oxo-dGDP phosphatase activity [GO:0044715]; 8-oxo-GDP phosphatase activity [GO:0044716]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515] LEKTTYMDPTGK 0.9909 -4.6442 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2968 0 0 0 0 0 0 0 0 0 0 0 10.5162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 12.823 0 12.8325 0 0 0 0 0 0 13.0314 0 0 0 0 0 0 0 13.049 0 13.3089 0 0 13.0998 0 0 0 0 0 0 0 12.8068 0 0 0 0 13.0229 0 0 0 0 0 12.0774 0 0 0 0 0 0 0 11.0019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07949 RET_HUMAN "Proto-oncogene tyrosine-protein kinase receptor Ret, EC 2.7.10.1 (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment ]" RET CDHF12 CDHR16 PTC RET51 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]" axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] "axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; axon guidance [GO:0007411]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription, DNA-templated [GO:0045893]; posterior midgut development [GO:0007497]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657]" GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0005887; GO:0006468; GO:0006919; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030335; GO:0030424; GO:0030425; GO:0033141; GO:0033619; GO:0033630; GO:0033674; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045121; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:2001241 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] AKATSGAAGLRLLLLLLLPLLGK 0.99091 -4.6633 0 0 0 0 0 0 0 0 0 0 0 10.4651 0 0 0 0 0 10.6996 0 0 0 0 0 0 0 0 12.3375 10.5659 0 0 12.0397 0 0 0 0 0 0 0 0 0 0 0 11.5192 0 0 0 0 0 12.568 0 0 0 0 0 11.087 0 0 0 0 0 0 0 0 0 0 0 13.6062 0 13.7204 13.428 13.2205 0 0 12.207 13.2301 0 0 0 14.8329 0 0 0 15.3042 0 13.7455 15.0588 14.5357 13.2374 12.0461 0 0 12.607 0 0 12.5318 0 11.6545 13.2086 0 12.0188 0 0 0 13.8128 0 0 12.1991 0 16.0314 0 15.1586 0 13.848 0 0 0 14.3141 14.0807 0 13.2032 0 0 13.8469 0 0 13.5506 12.368 15.041 12.3818 0 11.3695 12.3926 10.4815 14.4915 14.382 0 0 0 0 0 0 12.0191 0 13.4872 11.4596 13.2602 0 0 0 10.9799 12.8204 14.5347 12.6488 0 0 10.1757 0 0 0 0 0 12.5878 14.7432 13.3863 0 0 0 0 0 11.633 0 0 0 12.931 14.8887 0 0 0 0 0 P11234 RALB_HUMAN "Ras-related protein Ral-B, EC 3.6.5.2" RALB Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to starvation [GO:0009267]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; Ras protein signal transduction [GO:0007265]; regulation of exocyst assembly [GO:0001928]; regulation of exocyst localization [GO:0060178]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; midbody [GO:0030496]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; midbody [GO:0030496]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to starvation [GO:0009267]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; Ras protein signal transduction [GO:0007265]; regulation of exocyst assembly [GO:0001928]; regulation of exocyst localization [GO:0060178]; signal transduction [GO:0007165] GO:0001928; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005886; GO:0006915; GO:0007049; GO:0007165; GO:0007265; GO:0009267; GO:0019003; GO:0030496; GO:0031625; GO:0032091; GO:0032092; GO:0051117; GO:0051301; GO:0060178; GO:0070062; GO:0071360; GO:0071902; GO:2000786 ATPase binding [GO:0051117]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625] ANVDKVFFDLMREIR 0.99091 -5.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62805 H4_HUMAN Histone H4 H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4-16 HIST4H4 Homo sapiens (Human) "DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]; protein localization to CENP-A containing chromatin [GO:0061644]; telomere organization [GO:0032200]" "CENP-A containing nucleosome [GO:0043505]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "CENP-A containing nucleosome [GO:0043505]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]; protein localization to CENP-A containing chromatin [GO:0061644]; telomere organization [GO:0032200]" GO:0000228; GO:0000781; GO:0000786; GO:0003677; GO:0003723; GO:0005576; GO:0005634; GO:0005654; GO:0006334; GO:0006335; GO:0006336; GO:0006352; GO:0016020; GO:0019904; GO:0030527; GO:0032200; GO:0032991; GO:0043505; GO:0045653; GO:0046982; GO:0061644; GO:0070062 DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] DAVTYTEHAKR 0.99091 -4.7885 11.5151 12.2588 11.9723 0 0 0 0 0 0 11.863 0 0 0 0 11.596 0 0 0 11.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4676 11.7069 0 0 0 0 0 10.0278 0 0 0 12.3626 0 0 11.9449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0761 0 13.4752 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6024 14.2981 0 0 13.3573 0 0 0 0 13.673 13.7305 0 0 0 0 13.0335 0 12.4171 0 0 0 14.2266 14.0691 0 0 0 0 0 0 0 12.6212 13.6982 0 0 13.2215 13.134 0 13.7753 13.4472 12.8079 0 0 0 0 0 0 0 0 0 12.3355 0 0 0 0 0 0 0 12.2375 0 0 0 0 0 0 12.2637 0 0 0 10.6074 0 0 0 0 0 0 0 0 0 12.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8899 0 Q15436 SC23A_HUMAN "Protein transport protein Sec23A, hSec23A (SEC23-related protein A)" SEC23A Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659] GO:0000139; GO:0005096; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012507; GO:0019898; GO:0030127; GO:0048471; GO:0070971; GO:0072659; GO:0090110 GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] FLQPVQK 0.99091 -21.552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9715 0 0 0 0 0 12.1845 0 12.5876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3247 0 13.8737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6319 0 0 0 0 15.9871 0 0 0 11.7202 0 0 0 0 0 0 0 0 13.2443 0 0 0 0 0 0 12.7341 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8607 0 0 0 0 0 0 0 0 0 13.278 0 12.6262 11.6748 13.1443 12.7869 0 0 0 0 0 13.5021 0 0 11.8276 0 0 0 12.6312 0 0 0 0 0 12.8477 12.4875 0 0 0 0 0 0 0 12.3417 0 12.6668 0 0 Q15599 NHRF2_HUMAN "Na(+)/H(+) exchange regulatory cofactor NHE-RF2, NHERF-2 (NHE3 kinase A regulatory protein E3KARP) (SRY-interacting protein 1, SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2) (Tyrosine kinase activator protein 1, TKA-1)" SLC9A3R2 NHERF2 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003] apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003] GO:0005102; GO:0005634; GO:0005886; GO:0005925; GO:0008013; GO:0008022; GO:0012505; GO:0016324; GO:0019902; GO:0031799; GO:0031800; GO:0042802; GO:0043495; GO:0045296; GO:0065003; GO:0070062; GO:0072659 beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; type 2 metabotropic glutamate receptor binding [GO:0031799]; type 3 metabotropic glutamate receptor binding [GO:0031800] ELRPRLCHLR 0.99091 -23.436 0 0 0 0 0 0 0 0 0 0 13.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9492 0 0 0 0 0 0 0 0 0 0 0 0 10.8675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.649 0 0 0 0 0 0 0 0 0 0 0 0 13.4883 0 0 0 0 0 0 0 0 12.9635 12.7553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3205 12.4574 0 0 0 0 10.4604 0 0 Q15648 MED1_HUMAN "Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component, ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein, PBP, PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component, Trap220) (Thyroid receptor-interacting protein 2, TR-interacting protein 2, TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A)" MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 Homo sapiens (Human) "androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G0 to G1 transition [GO:0045023]; hematopoietic stem cell differentiation [GO:0060218]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; LBD domain binding [GO:0050693]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; G0 to G1 transition [GO:0045023]; hematopoietic stem cell differentiation [GO:0060218]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; RNA polymerase II preinitiation complex assembly [GO:0051123]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; ventricular trabecula myocardium morphogenesis [GO:0003222]" GO:0000122; GO:0000902; GO:0001223; GO:0001525; GO:0001889; GO:0001892; GO:0002088; GO:0002154; GO:0003222; GO:0003406; GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006590; GO:0006606; GO:0006702; GO:0007420; GO:0007595; GO:0010628; GO:0010839; GO:0016020; GO:0016592; GO:0016922; GO:0030216; GO:0030224; GO:0030331; GO:0030374; GO:0030518; GO:0031100; GO:0032968; GO:0033148; GO:0035050; GO:0035116; GO:0035162; GO:0035357; GO:0035729; GO:0035855; GO:0042789; GO:0042809; GO:0042974; GO:0042975; GO:0043066; GO:0044877; GO:0045023; GO:0045444; GO:0045618; GO:0045648; GO:0045665; GO:0045893; GO:0045944; GO:0046966; GO:0048821; GO:0048822; GO:0050693; GO:0051123; GO:0060218; GO:0060261; GO:0060335; GO:0060744; GO:0060745; GO:0060750; GO:0070318; GO:0070562; GO:0070847; GO:0071364; GO:0071383; GO:0097067; GO:0140297; GO:1990841; GO:2000347; GO:2001141 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; LBD domain binding [GO:0050693]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] FYAALPGQQHCYFLNK 0.99091 -23.471 0 0 0 0 0 0 0 0 0 13.7546 13.2244 0 0 0 13.8998 0 14.0264 0 0 0 0 0 13.9521 0 0 0 14.104 0 0 14.2103 0 12.6873 0 14.5633 12.0558 14.6275 11.7275 0 0 0 0 0 0 13.8359 11.9051 0 0 13.9827 0 0 0 0 0 0 0 0 0 0 0 0 9.86578 0 0 0 0 0 0 0 0 0 0 0 0 13.5772 0 0 0 0 15.2961 0 0 12.7802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1594 0 0 12.5418 0 14.8673 0 0 0 0 16.8205 0 0 0 0 0 16.2141 0 0 0 0 14.8923 0 0 16.456 0 16.0648 0 0 0 0 9.92096 0 0 0 0 0 0 0 0 0 0 0 0 0 14.543 0 0 0 0 0 17.1823 0 0 13.9875 12.7316 0 13.6011 0 13.8871 0 0 13.623 0 12.9585 0 0 0 11.1665 0 0 13.8188 0 0 13.1595 0 15.0694 0 Q2VY69 ZN284_HUMAN Zinc finger protein 284 ZNF284 ZNF284L Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDTCSNSFGQR 0.99091 -5.5965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2805 0 0 0 0 0 0 0 0 0 10.5859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6741 10.3911 0 0 0 0 0 0 13.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8284 0 0 0 0 12.9357 0 0 0 0 0 0 0 0 13.1227 12.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUQ1 RINT1_HUMAN "RAD50-interacting protein 1 (RAD50 interactor 1, HsRINT-1, RINT-1)" RINT1 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] "cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939 ATVKFWHKILK 0.99091 -21.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5827 0 0 0 0 0 0 0 0 12.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0274 0 13.9918 0 0 0 0 0 12.831 0 0 0 0 0 0 0 0 12.579 0 12.3814 0 12.5738 0 12.5066 12.3197 0 0 0 0 0 0 12.4923 0 13.8262 12.7615 0 0 0 0 12.9356 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6138 0 0 0 13.5927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7637 0 0 0 0 0 0 0 0 11.3195 12.3779 0 0 0 0 0 10.6475 0 0 0 13.0654 0 0 0 12.7635 0 0 0 0 0 0 0 0 Q76L83 ASXL2_HUMAN Putative Polycomb group protein ASXL2 (Additional sex combs-like protein 2) ASXL2 ASXH2 KIAA1685 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517] nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]; animal organ morphogenesis [GO:0009887]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003677; GO:0003682; GO:0005654; GO:0009887; GO:0035360; GO:0035517; GO:0042975; GO:0045600; GO:0045944; GO:0046872 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975] AEIPLNEQTTLSKENYLFTRGQTFDEK 0.99091 -1.803 0 0 0 0 11.0437 0 0 0 12.7548 0 0 0 0 0 0 0 0 0 10.3352 0 0 0 0 13.4077 0 0 0 0 0 0 0 0 0 0 0 0 12.1327 0 0 0 12.0437 0 0 0 0 0 11.9657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0144 11.7516 0 0 13.8111 0 15.3207 0 14.0535 14.2031 0 14.3576 0 0 0 0 14.0238 13.138 0 13.9784 0 0 0 13.2326 15.5562 14.911 0 0 11.092 14.8364 13.8255 0 12.4467 0 0 0 0 0 13.475 0 0 14.4743 12.8747 13.3034 0 0 0 13.2305 12.5574 0 0 11.4833 0 12.1733 13.5456 0 12.8904 0 0 13.3245 13.4159 0 12.7499 0 12.7662 0 0 11.3578 0 11.7001 0 0 0 0 0 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 11.6392 0 0 0 0 0 0 0 13.425 0 0 0 14.4237 10.8873 11.9026 11.462 Q7Z3Z4 PIWL4_HUMAN Piwi-like protein 4 PIWIL4 HIWI2 PIWI Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; epithelial structure maintenance [GO:0010669]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; piP-body [GO:0071547]; piRNA binding [GO:0034584]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; epithelial structure maintenance [GO:0010669]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatogenesis [GO:0007283] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006417; GO:0007283; GO:0010529; GO:0010669; GO:0030154; GO:0031047; GO:0034584; GO:0034587; GO:0043046; GO:0043186; GO:0051321; GO:0071547 piRNA binding [GO:0034584]; RNA binding [GO:0003723] DGTEITYVDYYK 0.99091 -5.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8674 0 0 0 12.6155 0 0 12.111 0 0 0 0 0 0 0 0 0 0 0 11.9554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0787 0 11.1986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UR1 NOXA1_HUMAN "NADPH oxidase activator 1, NOX activator 1 (Antigen NY-CO-31) (NCF2-like protein) (P67phox-like factor) (p51-nox)" NOXA1 P51NOX Homo sapiens (Human) regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020] cytosol [GO:0005829]; NADPH oxidase complex [GO:0043020]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of respiratory burst [GO:0060263]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] GO:0005829; GO:0006801; GO:0010310; GO:0016176; GO:0017124; GO:0019899; GO:0031267; GO:0042554; GO:0042802; GO:0043020; GO:0060263 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; superoxide-generating NADPH oxidase activator activity [GO:0016176] CTSTAYQEQR 0.99091 -21.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0257 0 10.245 0 0 0 0 11.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VP3 PACS2_HUMAN "Phosphofurin acidic cluster sorting protein 2, PACS-2 (PACS1-like protein)" PACS2 KIAA0602 PACS1L Homo sapiens (Human) apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; transmembrane transporter binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659] GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0032469; GO:0034497; GO:0044325; GO:0072659; GO:1990456 transmembrane transporter binding [GO:0044325] ELISVVIAVKMQGSKR 0.99091 -5.8993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4172 0 11.861 12.2894 12.5149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4163 0 13.007 0 11.9099 0 14.312 12.9798 14.3006 0 0 0 12.4355 0 0 0 13.6897 0 0 0 0 0 0 0 0 11.6399 0 0 0 0 0 13.5902 0 0 0 0 0 15.0956 0 0 16.3174 0 0 0 0 0 0 0 0 0 0 12.2223 0 10.6684 11.1632 11.7956 0 0 0 0 0 0 0 0 12.6791 0 13.3756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8343 0 0 0 0 0 0 0 0 0 0 Q8N474 SFRP1_HUMAN "Secreted frizzled-related protein 1, FRP-1, sFRP-1 (Secreted apoptosis-related protein 2, SARP-2)" SFRP1 FRP FRP1 SARP2 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of angiogenesis [GO:0045765]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147]; BMP signaling pathway [GO:0030509]; bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cellular response to BMP stimulus [GO:0071773]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heparin [GO:0071504]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin D [GO:0071305]; cellular response to X-ray [GO:0071481]; convergent extension involved in somitogenesis [GO:0090246]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad development [GO:0008585]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; male gonad development [GO:0008584]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone remodeling [GO:0046851]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000080]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000054]; neural crest cell fate commitment [GO:0014034]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of angiogenesis [GO:0045765]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell cycle process [GO:0010564]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; somatic stem cell population maintenance [GO:0035019]; stromal-epithelial cell signaling involved in prostate gland development [GO:0044345]; ureteric bud development [GO:0001657]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" GO:0001649; GO:0001657; GO:0001954; GO:0002244; GO:0003402; GO:0004197; GO:0005109; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0008201; GO:0008284; GO:0008285; GO:0008584; GO:0008585; GO:0009267; GO:0009410; GO:0009950; GO:0009986; GO:0010564; GO:0010629; GO:0010719; GO:0010975; GO:0014034; GO:0014070; GO:0017147; GO:0030177; GO:0030178; GO:0030279; GO:0030307; GO:0030308; GO:0030316; GO:0030336; GO:0030509; GO:0030514; GO:0033689; GO:0035019; GO:0042802; GO:0043065; GO:0043066; GO:0043508; GO:0043547; GO:0044344; GO:0044345; GO:0045578; GO:0045600; GO:0045668; GO:0045671; GO:0045765; GO:0045880; GO:0045892; GO:0045893; GO:0046676; GO:0046851; GO:0048147; GO:0048546; GO:0050679; GO:0050680; GO:0050732; GO:0051496; GO:0051894; GO:0060070; GO:0060218; GO:0060346; GO:0060527; GO:0060687; GO:0060766; GO:0062023; GO:0070062; GO:0071305; GO:0071347; GO:0071356; GO:0071363; GO:0071380; GO:0071391; GO:0071392; GO:0071456; GO:0071481; GO:0071504; GO:0071542; GO:0071560; GO:0071773; GO:0090090; GO:0090179; GO:0090244; GO:0090246; GO:0090263; GO:0097191; GO:1902043; GO:1904956; GO:2000041; GO:2000052; GO:2000054; GO:2000080; GO:2000270; GO:2000271 cysteine-type endopeptidase activity [GO:0004197]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147] DLKKLVLYLK 0.99091 -1.8009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HE8 TMM80_HUMAN Transmembrane protein 80 TMEM80 Homo sapiens (Human) non-motile cilium assembly [GO:1905515] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; non-motile cilium assembly [GO:1905515] GO:0016021; GO:0035869; GO:1905515 GPRGCRDR 0.99091 -1.7996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.395 15.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4265 0 0 0 14.1585 0 0 0 0 0 11.6791 0 0 0 0 0 0 0 0 0 10.9586 0 0 0 0 0 0 0 0 0 0 0 15.2405 0 0 0 0 0 0 0 0 0 0 0 14.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4456 0 0 0 0 0 0 0 0 0 0 0 Q9H2B2 SYT4_HUMAN "Synaptotagmin-4 (Synaptotagmin IV, SytIV)" SYT4 KIAA1342 Homo sapiens (Human) "calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; dense core granule cytoskeletal transport [GO:0099519]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of vesicle fusion [GO:0031338]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]" astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; dense core granule membrane [GO:0032127]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; integral component of Golgi membrane [GO:0030173]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of synaptic vesicle membrane [GO:0030285]; microvesicle [GO:1990742]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] "astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; dense core granule membrane [GO:0032127]; exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; integral component of Golgi membrane [GO:0030173]; integral component of neuronal dense core vesicle membrane [GO:0099066]; integral component of synaptic vesicle membrane [GO:0030285]; microvesicle [GO:1990742]; neuronal cell body [GO:0043025]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; dense core granule cytoskeletal transport [GO:0099519]; memory [GO:0007613]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of protein secretion [GO:0050709]; negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO:1905433]; negative regulation of short-term neuronal synaptic plasticity [GO:0048174]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dense core granule exocytosis [GO:1905415]; positive regulation of glutamate secretion [GO:0014049]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of endocytosis [GO:0030100]; regulation of presynaptic dense core granule exocytosis [GO:0099161]; regulation of vesicle fusion [GO:0031338]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0006906; GO:0007269; GO:0007613; GO:0014049; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0030100; GO:0030154; GO:0030173; GO:0030276; GO:0030285; GO:0030424; GO:0030425; GO:0031338; GO:0032127; GO:0033604; GO:0043025; GO:0045202; GO:0045955; GO:0045956; GO:0048174; GO:0048471; GO:0050709; GO:0070382; GO:0071277; GO:0097449; GO:0098978; GO:0098992; GO:0099066; GO:0099161; GO:0099183; GO:0099519; GO:1903861; GO:1905415; GO:1905433; GO:1990742; GO:2000301 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] EICDYPR 0.99091 -5.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9842 14.3928 13.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5I1 SUV92_HUMAN "Histone-lysine N-methyltransferase SUV39H2, EC 2.1.1.355 (Histone H3-K9 methyltransferase 2, H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2, Su(var)3-9 homolog 2)" SUV39H2 KMT1B Homo sapiens (Human) "cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; S-adenosyl-L-methionine binding [GO:1904047]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" GO:0000122; GO:0000775; GO:0000785; GO:0000976; GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0007049; GO:0008270; GO:0018024; GO:0030154; GO:0034968; GO:0036123; GO:0036124; GO:0042754; GO:0045892; GO:0046974; GO:0048511; GO:0071456; GO:1904047 histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; S-adenosyl-L-methionine binding [GO:1904047]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] CQCGPDCPNR 0.99091 -1.7981 0 0 0 0 0 11.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2909 0 0 0 0 0 0 0 0 0 11.3832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXF8 ZDHC7_HUMAN "Palmitoyltransferase ZDHHC7, EC 2.3.1.225 (Acyltransferase ZDHHC7, EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 7, DHHC-7)" ZDHHC7 Homo sapiens (Human) glucose import in response to insulin stimulus [GO:0044381]; negative regulation of catabolic process [GO:0009895]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; polarized epithelial cell differentiation [GO:0030859]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of Fas signaling pathway [GO:1902044]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein localization to cell-cell junction [GO:0150106]; regulation of protein localization to plasma membrane [GO:1903076] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; glucose import in response to insulin stimulus [GO:0044381]; negative regulation of catabolic process [GO:0009895]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; polarized epithelial cell differentiation [GO:0030859]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of Fas signaling pathway [GO:1902044]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein localization to cell-cell junction [GO:0150106]; regulation of protein localization to plasma membrane [GO:1903076] GO:0000139; GO:0005654; GO:0005783; GO:0005794; GO:0006612; GO:0008277; GO:0009895; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0030859; GO:0044381; GO:0140439; GO:0150106; GO:1902044; GO:1903076 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] CCCIKPER 0.99091 -4.7853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.008 0 0 0 0 14.4323 15.1187 0 14.4783 0 0 0 14.6663 13.7926 0 0 0 12.9909 0 0 0 13.9259 0 0 0 0 0 0 0 0 0 14.2461 0 0 0 0 0 0 0 0 0 12.9526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKT8 FBXW2_HUMAN F-box/WD repeat-containing protein 2 (F-box and WD-40 domain-containing protein 2) (Protein MD6) FBXW2 FBW2 FWD2 Homo sapiens (Human) protein modification process [GO:0036211]; proteolysis [GO:0006508] cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; protein modification process [GO:0036211]; proteolysis [GO:0006508] GO:0004842; GO:0005829; GO:0006508; GO:0036211 ubiquitin-protein transferase activity [GO:0004842] RDFLKLLPLELSFYLLK 0.99091 -21.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0024 0 0 14.3624 14.0707 13.364 14.2666 18.0735 13.1895 13.0449 0 0 0 0 0 0 0 0 0 12.6952 0 12.1053 0 0 0 13.0496 13.2486 17.4849 0 0 0 0 0 0 0 13.4838 0 0 0 17.2293 12.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.709 0 0 0 0 0 0 0 0 0 0 Q9UPS8 ANR26_HUMAN Ankyrin repeat domain-containing protein 26 ANKRD26 KIAA1074 Homo sapiens (Human) negative regulation of fat cell differentiation [GO:0045599] centrosome [GO:0005813] centrosome [GO:0005813]; negative regulation of fat cell differentiation [GO:0045599] GO:0005813; GO:0045599 ARDECSRLQDK 0.99091 -5.5869 0 0 0 0 0 0 0 0 12.879 0 0 12.9647 13.7811 0 0 0 0 0 0 11.16 0 0 16.7032 0 0 0 0 0 0 11.8481 0 0 0 0 15.0807 0 11.2801 0 12.5486 0 0 0 13.5505 0 16.6117 0 0 0 0 0 0 0 0 0 0 0 13.6796 0 0 0 0 11.4505 12.4092 0 0 0 0 0 0 12.7324 0 0 0 0 0 0 14.592 0 0 0 14.9216 0 12.9371 13.4522 0 0 13.6095 13.9576 0 13.4475 0 0 13.1043 0 0 0 15.3118 0 0 0 0 0 0 0 0 0 13.1859 18.3789 0 12.3366 0 0 14.5492 0 0 0 13.6493 0 0 0 0 0 14.8677 0 13.0698 0 13.3671 0 0 0 0 12.9068 12.0944 0 18.2918 0 0 13.9371 0 0 13.7588 0 11.7405 0 0 0 0 0 10.5425 0 0 0 0 0 0 0 0 0 0 0 0 14.0531 0 0 0 0 0 0 0 0 13.8243 12.9893 13.62 10.724 0 0 0 12.7984 0 0 O15041 SEM3E_HUMAN Semaphorin-3E SEMA3E KIAA0331 SEMAH Homo sapiens (Human) axon guidance [GO:0007411]; branching involved in blood vessel morphogenesis [GO:0001569]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sprouting angiogenesis [GO:0002040]; synapse organization [GO:0050808] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; receptor ligand activity [GO:0048018]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; branching involved in blood vessel morphogenesis [GO:0001569]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sprouting angiogenesis [GO:0002040]; synapse organization [GO:0050808] GO:0001569; GO:0001755; GO:0001953; GO:0002040; GO:0005576; GO:0005615; GO:0005887; GO:0007411; GO:0008360; GO:0014068; GO:0016525; GO:0021828; GO:0030215; GO:0030335; GO:0043524; GO:0045499; GO:0048018; GO:0048843; GO:0050808; GO:0050919; GO:0071526; GO:2000249 chemorepellent activity [GO:0045499]; receptor ligand activity [GO:0048018]; semaphorin receptor binding [GO:0030215] DDEEDRHHR 0.99092 -4.8019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7337 0 11.1268 0 0 9.56411 0 0 12.9342 0 13.3802 0 0 0 0 13.2828 14.5259 10.0218 14.2928 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4432 0 0 11.0106 0 8.91913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94367 13.2916 9.99152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0473 P05204 HMGN2_HUMAN Non-histone chromosomal protein HMG-17 (High mobility group nucleosome-binding domain-containing protein 2) HMGN2 HMG17 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; chromatin organization [GO:0006325]; killing of cells of another organism [GO:0031640] chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; chromatin organization [GO:0006325]; killing of cells of another organism [GO:0031640] GO:0000785; GO:0003682; GO:0003723; GO:0005615; GO:0005634; GO:0005737; GO:0006325; GO:0031492; GO:0031640; GO:0061844 chromatin binding [GO:0003682]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723] ADAGKEGNNPAENGDAK 0.99092 -5.9178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1486 0 11.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4482 0 0 0 0 12.7984 0 0 0 0 P22692 IBP4_HUMAN "Insulin-like growth factor-binding protein 4, IBP-4, IGF-binding protein 4, IGFBP-4" IGFBP4 IBP4 Homo sapiens (Human) inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] GO:0000165; GO:0001558; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0006954; GO:0007165; GO:0010906; GO:0031994; GO:0031995; GO:0043410; GO:0043567; GO:0043568; GO:0044342; GO:0090090 insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102] DEGDHPNNSFSPCSAHDR 0.99092 -5.8996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1278 0 0 0 0 0 0 0 0 11.9717 0 0 0 0 0 0 0 13.868 0 14.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14192 FHL2_HUMAN "Four and a half LIM domains protein 2, FHL-2 (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3, SLIM-3)" FHL2 DRAL SLIM3 Homo sapiens (Human) atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015] GO:0000122; GO:0001649; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0046872; GO:0055014; GO:0055015; GO:0060347; GO:0070885 bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] DLSYKDRHWHEACFHCSQCR 0.99092 -5.6019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7359 0 12.828 0 13.5491 0 0 13.9959 13.7208 0 12.9468 0 0 0 0 0 0 0 0 0 13.4045 14.7308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4557 0 12.9238 0 0 14.5606 0 0 0 0 0 0 12.8067 12.949 0 0 0 0 12.8583 0 0 13.2488 0 0 0 0 0 0 0 0 14.501 13.6865 0 0 0 0 0 0 12.1949 11.0224 0 14.8388 0 0 0 11.4838 0 0 0 13.9254 15.2223 0 0 0 12.9342 0 0 0 0 0 0 14.9636 0 12.9345 0 0 0 0 14.1511 0 15.0805 0 0 0 13.9748 10.6573 0 0 0 0 13.3354 0 0 0 0 0 14.059 0 0 0 0 0 0 13.3879 0 0 0 14.4834 0 0 0 10.7225 0 0 Q15800 MSMO1_HUMAN "Methylsterol monooxygenase 1, EC 1.14.18.9 (C-4 methylsterol oxidase) (Sterol-C4-methyl oxidase)" MSMO1 DESP4 ERG25 SC4MOL Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; fatty acid metabolic process [GO:0006631]; steroid metabolic process [GO:0008202]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; cholesterol biosynthetic process [GO:0006695]; fatty acid metabolic process [GO:0006631]; steroid metabolic process [GO:0008202]; sterol biosynthetic process [GO:0016126] GO:0000254; GO:0005506; GO:0005783; GO:0005789; GO:0005886; GO:0006631; GO:0006695; GO:0008202; GO:0016020; GO:0016021; GO:0016126; GO:0016491 C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491] LLHHKRIYK 0.99092 -5.5973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JWF2 GNAS1_HUMAN "Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein, XLalphas)" GNAS GNAS1 Homo sapiens (Human) adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; developmental growth [GO:0048589]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; sensory perception of chemical stimulus [GO:0007606] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; bone development [GO:0060348]; developmental growth [GO:0048589]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; sensory perception of chemical stimulus [GO:0007606] GO:0001664; GO:0003924; GO:0005159; GO:0005525; GO:0005829; GO:0005834; GO:0007188; GO:0007189; GO:0007191; GO:0007606; GO:0010856; GO:0016020; GO:0016324; GO:0031683; GO:0031698; GO:0031748; GO:0031852; GO:0035255; GO:0046872; GO:0048589; GO:0051430; GO:0060348; GO:0070062; GO:0070527; GO:0120162 adenylate cyclase activator activity [GO:0010856]; beta-2 adrenergic receptor binding [GO:0031698]; corticotropin-releasing hormone receptor 1 binding [GO:0051430]; D1 dopamine receptor binding [GO:0031748]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; insulin-like growth factor receptor binding [GO:0005159]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mu-type opioid receptor binding [GO:0031852] AASAAPASGARR 0.99092 -23.528 0 0 0 0 0 0 0 0 0 0 0 12.6312 0 0 11.8144 0 0 0 0 0 0 0 0 12.9541 0 0 0 0 12.7422 13.4733 13.3125 13.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1577 10.6591 0 0 0 0 0 15.6706 0 0 0 0 0 0 0 0 0 0 0 11.2883 0 0 13.2339 0 11.2429 0 0 0 0 13.358 0 0 13.8054 13.9099 0 0 0 0 10.9948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7572 0 0 0 15.2262 11.9879 0 14.4055 13.0121 0 0 0 0 0 0 0 0 0 15.4808 0 13.3673 0 0 0 0 0 13.2553 0 13.7836 0 0 0 15.7606 10.765 0 0 0 16.1933 0 0 0 0 0 0 0 0 0 0 0 10.5645 0 0 13.9991 0 0 0 10.807 14.6572 14.168 0 Q7Z422 SZRD1_HUMAN SUZ domain-containing protein 1 (Putative MAPK-activating protein PM18/PM20/PM22) SZRD1 C1orf144 Homo sapiens (Human) MEDEEVAESWEEAADSGEIDR 0.99092 -5.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WN2 IFNE_HUMAN "Interferon epsilon, IFN-epsilon (Interferon epsilon-1)" IFNE IFNE1 UNQ360/PRO655 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337] GO:0002250; GO:0002286; GO:0002323; GO:0005125; GO:0005132; GO:0005615; GO:0006959; GO:0019221; GO:0030183; GO:0033141; GO:0042100; GO:0042742; GO:0043330; GO:0051607; GO:0060337; GO:0098586 cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132] HFFGTVLVLLASTTIFSLDLK 0.99092 -5.6039 13.5631 0 12.3339 0 0 0 0 14.3628 0 0 0 0 0 12.6984 0 12.9554 13.1534 13.4013 15.0454 0 15.1738 12.7028 14.0859 14.4503 0 0 13.5229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5912 0 0 0 0 0 15.3859 0 0 0 13.3032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9436 0 0 0 12.848 12.7423 14.6071 14.1658 16.0289 14.2338 14.6143 17.4135 14.5549 16.8418 15.0976 16.972 14.4894 0 14.3313 14.3266 14.3315 0 0 17.0783 0 0 15.8285 17.8613 14.7604 0 15.6579 15.7011 14.18 16.8084 15.3705 15.4524 14.8669 15.2218 14.4462 0 15.8535 15.7948 14.57 16.984 17.0463 16.2003 16.4776 0 0 14.4053 0 15.0297 0 14.5659 14.7307 16.4991 0 14.684 14.254 16.4596 14.7112 0 14.7701 14.8361 16.4606 16.2536 0 14.7144 14.348 14.2617 15.1042 14.7023 14.5532 0 14.6053 15.3041 0 0 15.3808 0 16.1164 0 15.7402 17.1156 15.9071 14.5987 15.4338 15.3271 14.7803 0 0 0 0 11.8896 0 0 0 14.5305 0 0 0 0 14.0924 11.489 15.014 15.5281 14.5045 0 0 12.2191 14.584 0 Q8TB69 ZN519_HUMAN Zinc finger protein 519 ZNF519 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNRRSTLTQHQIIHTR 0.99092 -5.9041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6722 0 13.0872 0 0 0 0 13.7186 0 0 0 0 0 0 0 0 0 0 0 12.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3178 0 0 0 0 0 13.5362 0 0 0 0 0 0 0 0 0 0 0 13.0749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5726 0 0 0 0 0 0 0 0 0 0 0 Q8TE77 SSH3_HUMAN "Protein phosphatase Slingshot homolog 3, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 3, SSH-3L, hSSH-3L)" SSH3 SSH3L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470] GO:0003779; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0006470; GO:0008138; GO:0017018; GO:0030036; GO:0030837 actin binding [GO:0003779]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] EEPGPRPR 0.99092 -1.8202 0 0 0 0 10.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2463 0 0 0 0 0 0 0 0 0 0 0 12.0318 0 0 0 0 0 0 0 0 0 0 13.235 13.7122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0516 0 0 0 0 0 0 0 11.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CX6 LRC58_HUMAN Leucine-rich repeat-containing protein 58 LRRC58 Homo sapiens (Human) CGGVYFDCCVR 0.99092 -5.6059 0 0 13.6888 0 0 11.5083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6071 0 0 14.2883 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7582 0 0 0 0 0 0 0 Q9H7T9 AUNIP_HUMAN "Aurora kinase A and ninein-interacting protein, AIBp" AUNIP C1orf135 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; spindle organization [GO:0007051] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; spindle pole [GO:0000922]; damaged DNA binding [GO:0003684]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; spindle organization [GO:0007051] GO:0000724; GO:0000922; GO:0003684; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0090734; GO:2001033 damaged DNA binding [GO:0003684] SVSSHTESQINKESK 0.99092 -1.8207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3327 0 0 0 0 0 0 0 0 12.3796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00548 DLL1_HUMAN "Delta-like protein 1 (Drosophila Delta homolog 1, Delta1, H-Delta-1)" DLL1 UNQ146/PRO172 Homo sapiens (Human) astrocyte development [GO:0014002]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; myeloid cell differentiation [GO:0030099]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; nephron development [GO:0072006]; neuroepithelial cell differentiation [GO:0060563]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957]; astrocyte development [GO:0014002]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cerebellar molecular layer formation [GO:0021688]; cerebellar Purkinje cell layer structural organization [GO:0021693]; clathrin-dependent endocytosis [GO:0072583]; compartment pattern specification [GO:0007386]; determination of left/right symmetry [GO:0007368]; endothelial tip cell fate specification [GO:0097102]; energy homeostasis [GO:0097009]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; lateral inhibition [GO:0046331]; left/right axis specification [GO:0070986]; loop of Henle development [GO:0072070]; marginal zone B cell differentiation [GO:0002315]; myeloid cell differentiation [GO:0030099]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; nephron development [GO:0072006]; neuroepithelial cell differentiation [GO:0060563]; neuron fate specification [GO:0048665]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; organ growth [GO:0035265]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; proximal/distal pattern formation [GO:0009954]; regulation of blood pressure [GO:0008217]; regulation of cell adhesion [GO:0030155]; regulation of cell division [GO:0051302]; regulation of growth [GO:0040008]; regulation of neurogenesis [GO:0050767]; regulation of skeletal muscle tissue growth [GO:0048631]; regulation of somitogenesis [GO:0014807]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746]; retina development in camera-type eye [GO:0060041]; retina morphogenesis in camera-type eye [GO:0060042]; skeletal muscle tissue growth [GO:0048630]; skin epidermis development [GO:0098773]; somite specification [GO:0001757]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; type B pancreatic cell development [GO:0003323] GO:0001709; GO:0001756; GO:0001757; GO:0001947; GO:0002085; GO:0002315; GO:0003323; GO:0005112; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0005912; GO:0007219; GO:0007368; GO:0007386; GO:0008217; GO:0008284; GO:0008285; GO:0009954; GO:0010628; GO:0014002; GO:0014807; GO:0016324; GO:0021510; GO:0021688; GO:0021693; GO:0030097; GO:0030099; GO:0030154; GO:0030155; GO:0030857; GO:0030957; GO:0031410; GO:0032693; GO:0034351; GO:0035265; GO:0040008; GO:0042491; GO:0045121; GO:0045596; GO:0045605; GO:0045608; GO:0045611; GO:0045638; GO:0045662; GO:0045665; GO:0045746; GO:0045747; GO:0045807; GO:0045944; GO:0046331; GO:0048630; GO:0048631; GO:0048633; GO:0048665; GO:0050767; GO:0051302; GO:0060041; GO:0060042; GO:0060563; GO:0060853; GO:0070986; GO:0072006; GO:0072014; GO:0072070; GO:0072583; GO:0097009; GO:0097102; GO:0097110; GO:0097150; GO:0098773; GO:1900746; GO:1903672; GO:2000726 calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; scaffold protein binding [GO:0097110]; Tat protein binding [GO:0030957] ADFHGDHSADK 0.99093 -5.9234 0 0 0 0 0 0 0 0 0 0 0 0 9.78375 0 0 0 0 0 10.699 10.9953 0 0 0 0 0 0 0 0 11.26 0 0 0 0 10.8373 0 0 0 0 0 0 0 0 0 10.7552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0657 11.9501 0 0 0 0 11.7982 0 13.5227 0 12.8906 0 0 0 0 0 12.7685 0 0 0 0 12.9845 0 0 0 0 0 0 0 0 10.7543 0 0 12.3428 0 0 13.221 0 0 0 0 11.0612 12.8459 0 0 0 0 0 0 0 0 15.592 0 0 0 0 12.9712 0 12.8355 0 0 0 0 0 0 13.0533 0 0 0 11.9772 0 0 0 0 0 0 0 0 12.5034 0 0 9.29572 12.6747 0 0 0 0 0 0 0 0 0 12.9962 0 0 0 0 0 0 0 0 0 13.3378 0 0 0 0 0 0 0 O60296 TRAK2_HUMAN Trafficking kinesin-binding protein 2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 3 protein) TRAK2 ALS2CR3 KIAA0549 Homo sapiens (Human) anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport of mitochondrion [GO:0098972]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; anterograde axonal transport of mitochondrion [GO:0098957]; anterograde dendritic transport of mitochondrion [GO:0098972]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein targeting [GO:0006605]; vesicle transport along microtubule [GO:0047496] GO:0005102; GO:0005737; GO:0005739; GO:0005769; GO:0005829; GO:0005886; GO:0006605; GO:0017022; GO:0022008; GO:0030425; GO:0031410; GO:0032839; GO:0047496; GO:0048311; GO:0050811; GO:0098957; GO:0098972; GO:1904115 GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102] LSLRRQNYLSEK 0.99093 -4.8198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3541 0 0 0 0 0 0 0 0 0 0 0 0 11.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9574 0 0 0 0 0 0 0 0 0 0 0 P26440 IVD_HUMAN "Isovaleryl-CoA dehydrogenase, mitochondrial, IVD, EC 1.3.8.4 (Butyryl-CoA dehydrogenase, EC 1.3.8.1)" IVD Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552] GO:0003995; GO:0004085; GO:0005654; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0033539; GO:0042802; GO:0050660 acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isovaleryl-CoA dehydrogenase activity [GO:0008470] IPAANILGHENK 0.99093 -20.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4356 0 0 0 0 0 0 0 0 0 0 0 13.8576 0 0 0 0 0 0 12.6407 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7087 0 0 0 12.8876 0 0 0 0 0 15.3874 0 0 11.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5897 0 0 0 0 0 0 0 0 Q02641 CACB1_HUMAN "Voltage-dependent L-type calcium channel subunit beta-1, CAB1 (Calcium channel voltage-dependent subunit beta 1)" CACNB1 CACNLB1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of voltage-gated calcium channel activity [GO:1901385] plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of voltage-gated calcium channel activity [GO:1901385] GO:0005245; GO:0005886; GO:0005891; GO:0007268; GO:0007528; GO:0008331; GO:0042383; GO:0045202; GO:0045933; GO:0070588; GO:1901385; GO:1902514; GO:1904646 high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245] EKYNNDWWIGRLVK 0.99093 -5.9251 0 0 0 0 11.6103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.862 0 12.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.207 0 0 0 0 0 0 0 0 12.3896 0 0 0 0 0 0 0 0 0 13.6406 0 0 0 0 0 13.1532 0 0 0 0 0 17.5334 16.4956 0 17.4786 0 14.714 14.8717 0 14.4553 15.1931 0 0 0 0 0 0 0 12.0261 0 15.0324 0 0 14.0289 0 17.4349 0 0 0 0 16.2513 0 0 15.0105 0 0 14.5901 0 0 15.4835 0 0 0 0 0 16.0105 17.3672 0 0 0 0 0 13.6076 15.2045 0 0 0 0 0 13.1278 11.5581 11.5701 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2235 0 0 0 0 0 0 13.5664 Q03393 PTPS_HUMAN "6-pyruvoyl tetrahydrobiopterin synthase, PTP synthase, PTPS, EC 4.2.3.12" PTS Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; central nervous system development [GO:0007417]; tetrahydrobiopterin biosynthetic process [GO:0006729] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; central nervous system development [GO:0007417]; tetrahydrobiopterin biosynthetic process [GO:0006729] GO:0003874; GO:0005737; GO:0005739; GO:0005829; GO:0006520; GO:0006729; GO:0007417; GO:0042802; GO:0046872 6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] STEGGGR 0.99093 -5.9333 0 0 0 0 0 0 0 0 0 12.689 0 11.1117 12.2704 0 0 0 12.5449 0 0 0 0 0 0 0 0 0 0 0 0 10.4748 0 12.4217 0 0 0 10.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5026 0 0 0 0 0 0 0 0 0 0 0 11.8128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2613 0 12.4227 0 0 0 0 0 0 0 0 0 0 12.3165 13.7936 12.723 0 0 11.5043 0 0 12.8082 0 0 0 0 0 0 0 0 0 0 11.5694 0 0 11.2182 11.977 0 0 0 10.8157 0 11.9675 12.4043 0 0 0 0 12.4425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3452 0 0 13.6437 0 0 0 11.1562 0 Q13332 PTPRS_HUMAN "Receptor-type tyrosine-protein phosphatase S, R-PTP-S, EC 3.1.3.48 (Receptor-type tyrosine-protein phosphatase sigma, R-PTP-sigma)" PTPRS Homo sapiens (Human) negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560] anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of synaptic vesicle membrane [GO:0030285]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; synaptic membrane adhesion [GO:0099560] GO:0004721; GO:0004725; GO:0005829; GO:0005886; GO:0005887; GO:0006470; GO:0008201; GO:0010977; GO:0030285; GO:0030424; GO:0030426; GO:0030517; GO:0032687; GO:0032688; GO:0034164; GO:0035335; GO:0035374; GO:0043204; GO:0043395; GO:0048671; GO:0048681; GO:0061000; GO:0070062; GO:0070161; GO:0099061; GO:0099560 chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725] CHQYWPAERSAR 0.99093 -1.8229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9135 0 0 0 0 0 0 0 0 0 0 0 0 12.1362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQL6 FERM1_HUMAN Fermitin family homolog 1 (Kindlerin) (Kindlin syndrome protein) (Kindlin-1) (Unc-112-related protein 1) FERMT1 C20orf42 KIND1 URP1 Homo sapiens (Human) "basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; establishment of epithelial cell polarity [GO:0090162]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of timing of anagen [GO:0051886]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of integrin activation [GO:0033625]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]" cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587] "cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; establishment of epithelial cell polarity [GO:0090162]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte migration [GO:0051546]; keratinocyte proliferation [GO:0043616]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of timing of anagen [GO:0051886]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of integrin activation [GO:0033625]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]" GO:0001954; GO:0005178; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0007155; GO:0007160; GO:0007229; GO:0010629; GO:0030054; GO:0030055; GO:0030511; GO:0032587; GO:0033625; GO:0033630; GO:0042308; GO:0043616; GO:0051015; GO:0051546; GO:0051886; GO:0071636; GO:0071711; GO:0071944; GO:0090090; GO:0090162; GO:1903691; GO:2000647 actin filament binding [GO:0051015]; integrin binding [GO:0005178] CDHENQYAQWMAACMLASK 0.99093 -20.241 0 10.8455 0 0 12.9243 0 13.9052 0 18.3467 0 0 18.3955 0 0 0 18.7026 0 0 14.0381 0 0 0 0 13.4778 0 13.9054 19.5985 19.2649 19.2521 0 0 19.3556 19.4014 19.4112 0 19.4317 0 19.4538 0 0 0 0 19.498 0 0 19.5661 19.5504 0 19.5174 19.5276 19.5388 0 0 18.9821 19.4055 19.3659 19.3068 0 19.3974 0 0 0 0 0 0 0 0 0 0 12.6624 0 0 11.0701 0 13.2253 0 0 12.0799 0 13.5625 0 13.5746 0 0 0 0 0 0 0 0 12.9389 13.8225 0 0 13 0 13.7233 14.9035 0 14.3892 13.4286 0 14.3466 14.2807 15.6 14.2209 0 0 0 0 18.573 0 0 0 0 13.4622 13.4323 0 13.878 15.1705 13.2945 0 0 0 14.7645 0 15.0354 0 14.3785 14.0018 12.9827 0 0 13.1491 0 0 0 0 0 0 0 13.4305 0 13.6242 13.3949 14.1727 0 0 0 0 0 13.0504 0 0 0 0 0 18.5058 18.5892 18.5178 18.5609 0 18.5456 0 18.6423 18.6178 0 0 0 18.462 18.4294 0 12.889 12.8687 13.8242 0 0 0 0 0 Q9BXA7 TSSK1_HUMAN "Testis-specific serine/threonine-protein kinase 1, TSK-1, TSK1, TSSK-1, Testis-specific kinase 1, EC 2.7.11.1 (Serine/threonine-protein kinase 22A)" TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0018105; GO:0031514; GO:0035556; GO:0044877; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] FHQLSLAIK 0.99093 -4.8225 0 10.6352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0666 0 0 0 14.5401 14.515 0 0 0 0 0 0 10.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7159 0 0 0 13.6644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7337 0 0 0 0 0 0 0 Q9Y366 IFT52_HUMAN Intraflagellar transport protein 52 homolog (Protein NGD5 homolog) IFT52 C20orf9 NGD5 CGI-53 Homo sapiens (Human) cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224] GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0008022; GO:0009953; GO:0010839; GO:0030992; GO:0031514; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042733; GO:0043616; GO:0044292; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:1905515 protein C-terminus binding [GO:0008022] ARLAQITNK 0.99093 -5.9263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5761 12.0261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4165 12.691 0 0 0 0 13.5723 0 0 0 0 0 0 13.5103 0 0 0 0 0 0 0 0 13.5639 13.6131 0 0 0 0 0 0 0 0 0 0 0 13.8147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4189 0 0 0 13.1739 0 Q9Y6K8 KAD5_HUMAN "Adenylate kinase isoenzyme 5, AK 5, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 5)" AK5 Homo sapiens (Human) ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220] GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0006172; GO:0006173; GO:0009142; GO:0009220; GO:0034451; GO:0046034 adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550] EELASESER 0.99093 -5.934 0 0 0 0 0 0 0 0 0 13.767 0 0 0 0 0 0 0 0 0 0 0 12.7183 0 0 0 0 0 12.5435 0 0 0 0 0 0 13.0567 0 0 11.9488 0 0 0 0 0 0 13.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8333 0 0 12.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0741 0 0 0 0 A0A075B767 PAL4H_HUMAN "Peptidyl-prolyl cis-trans isomerase A-like 4H, PPIase A-like 4H, EC 5.2.1.8" PPIAL4H Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018; GO:0043231 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] FDDENLIR 0.99094 -19.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.234 0 0 11.4639 0 0 0 12.1278 0 0 0 0 16.9076 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3112 0 0 0 0 0 0 0 12.5246 0 12.2838 11.5771 0 12.242 10.327 0 0 0 0 0 0 0 0 12.3645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2932 0 0 0 0 0 0 0 0 P10636 TAU_HUMAN "Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau, PHF-tau)" MAPT MAPTL MTBT1 TAU Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; axon development [GO:0061564]; axonal transport [GO:0098930]; axonal transport of mitochondrion [GO:0019896]; cell-cell signaling [GO:0007267]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; central nervous system neuron development [GO:0021954]; cytoplasmic microtubule organization [GO:0031122]; generation of neurons [GO:0048699]; internal protein amino acid acetylation [GO:0006475]; intracellular distribution of mitochondria [GO:0048312]; learning or memory [GO:0007611]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of gene expression [GO:0010629]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of tubulin deacetylation [GO:1904428]; neurofibrillary tangle assembly [GO:1902988]; neuron projection development [GO:0031175]; plus-end-directed organelle transport along microtubule [GO:0072386]; positive regulation of axon extension [GO:0045773]; positive regulation of diacylglycerol kinase activity [GO:1905689]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of superoxide anion generation [GO:0032930]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular response to heat [GO:1900034]; regulation of chromosome organization [GO:0033044]; regulation of long-term synaptic depression [GO:1900452]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of mitochondrial fission [GO:0090140]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; rRNA metabolic process [GO:0016072]; stress granule assembly [GO:0034063]; supramolecular fiber organization [GO:0097435]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; main axon [GO:0044304]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477]; tubulin complex [GO:0045298] axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; main axon [GO:0044304]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477]; tubulin complex [GO:0045298]; actin binding [GO:0003779]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; dynactin binding [GO:0034452]; enzyme binding [GO:0019899]; histone-dependent DNA binding [GO:0099077]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; single-stranded DNA binding [GO:0003697]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; axon development [GO:0061564]; axonal transport [GO:0098930]; axonal transport of mitochondrion [GO:0019896]; cell-cell signaling [GO:0007267]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; central nervous system neuron development [GO:0021954]; cytoplasmic microtubule organization [GO:0031122]; generation of neurons [GO:0048699]; internal protein amino acid acetylation [GO:0006475]; intracellular distribution of mitochondria [GO:0048312]; learning or memory [GO:0007611]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of gene expression [GO:0010629]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of tubulin deacetylation [GO:1904428]; neurofibrillary tangle assembly [GO:1902988]; neuron projection development [GO:0031175]; plus-end-directed organelle transport along microtubule [GO:0072386]; positive regulation of axon extension [GO:0045773]; positive regulation of diacylglycerol kinase activity [GO:1905689]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of superoxide anion generation [GO:0032930]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular response to heat [GO:1900034]; regulation of chromosome organization [GO:0033044]; regulation of long-term synaptic depression [GO:1900452]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of mitochondrial fission [GO:0090140]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; rRNA metabolic process [GO:0016072]; stress granule assembly [GO:0034063]; supramolecular fiber organization [GO:0097435]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] GO:0000226; GO:0001774; GO:0003677; GO:0003680; GO:0003690; GO:0003697; GO:0003723; GO:0003779; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0005886; GO:0006475; GO:0006919; GO:0007267; GO:0007416; GO:0007611; GO:0007613; GO:0008017; GO:0010288; GO:0010506; GO:0010629; GO:0010917; GO:0015630; GO:0016072; GO:0016607; GO:0017124; GO:0019896; GO:0019899; GO:0019901; GO:0021954; GO:0030424; GO:0030425; GO:0030426; GO:0030673; GO:0030674; GO:0031110; GO:0031113; GO:0031116; GO:0031122; GO:0031175; GO:0032930; GO:0033044; GO:0033673; GO:0034063; GO:0034185; GO:0034399; GO:0034452; GO:0034605; GO:0034614; GO:0035091; GO:0036464; GO:0036477; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043565; GO:0044297; GO:0044304; GO:0045121; GO:0045298; GO:0045773; GO:0046785; GO:0048143; GO:0048167; GO:0048312; GO:0048699; GO:0050808; GO:0050848; GO:0051087; GO:0051258; GO:0051260; GO:0051721; GO:0051879; GO:0061564; GO:0070507; GO:0071813; GO:0072386; GO:0090140; GO:0090258; GO:0097386; GO:0097418; GO:0097435; GO:0098930; GO:0099077; GO:0099609; GO:1900034; GO:1900452; GO:1901216; GO:1902474; GO:1902936; GO:1902988; GO:1903748; GO:1903829; GO:1904115; GO:1904428; GO:1905689; GO:1990000; GO:1990090; GO:1990416; GO:2001020 actin binding [GO:0003779]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; dynactin binding [GO:0034452]; enzyme binding [GO:0019899]; histone-dependent DNA binding [GO:0099077]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; single-stranded DNA binding [GO:0003697] GADGKTK 0.99094 -19.154 0 0 0 0 0 0 0 0 15.1579 19.9399 19.915 19.9166 19.8825 19.8971 14.3394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7834 19.8132 19.787 19.7959 19.8344 19.7011 19.7261 19.6905 19.7466 0 0 0 0 0 0 0 0 0 0 0 11.5276 0 12.709 11.1568 0 0 0 18.9212 16.256 11.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1161 0 15.0421 0 0 0 0 0 0 16.5507 15.7521 16.1342 15.7178 13.8115 0 14.1567 0 0 14.4459 14.6709 13.7794 0 12.7181 0 16.3709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8 0 0 0 0 0 0 14.2845 13.3911 0 0 11.764 0 0 0 0 0 13.2406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3093 12.1342 0 0 11.0978 12.2628 0 0 0 0 0 17.063 20.2812 20.1396 20.2183 16.1062 20.5964 20.3615 17.9533 17.845 20.2336 20.2948 20.0881 20.1112 0 0 0 0 0 17.4924 0 13.4433 0 20.2104 P82094 TMF1_HUMAN "TATA element modulatory factor, TMF (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa)" TMF1 ARA160 Homo sapiens (Human) acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289] GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030374; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845 DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374] EDYLRHEIGELQQR 0.99094 -20.377 0 0 0 0 0 0 0 0 13.5525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8859 14.8245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4323 14.2526 0 0 0 0 14.3625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01433 AMPD2_HUMAN "AMP deaminase 2, EC 3.5.4.6 (AMP deaminase isoform L)" AMPD2 Homo sapiens (Human) AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] cytosol [GO:0005829] cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0042802; GO:0046033; GO:0046872; GO:0052652; GO:0097009 AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] CKEIAEELFTRSLAESELR 0.99094 -1.8353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9008 0 0 12.66 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1216 0 0 0 0 0 0 0 Q6IS24 GLT17_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 17, EC 2.4.1.41 (Polypeptide GalNAc transferase-like protein 3, GalNAc-T-like protein 3, pp-GaNTase-like protein 3) (Protein-UDP acetylgalactosaminyltransferase-like protein 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3) (Williams-Beuren syndrome chromosomal region 17 protein)" GALNT17 WBSCR17 Homo sapiens (Human) protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] MASLRRVK 0.99094 -19.149 0 0 14.9657 0 0 0 0 0 0 0 0 13.3712 0 0 15.8738 0 0 0 0 0 16.5072 0 11.4981 0 11.1615 11.9224 0 0 10.4449 0 15.2365 0 0 0 0 0 0 0 15.5915 0 0 15.4339 16.8274 16.7627 0 17.3728 17.359 17.0089 13.3832 0 0 16.9557 0 0 0 15.0705 0 0 0 0 0 0 0 0 0 0 10.1824 0 0 14.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2779 18.6197 19.5791 0 0 0 0 0 12.1486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1705 13.4732 0 13.5988 0 0 0 0 18.2247 0 11.9109 0 0 0 13.7351 11.4451 0 0 0 0 0 10.183 11.1605 0 17.2547 0 0 0 0 13.1022 0 17.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4873 0 0 0 0 0 0 0 0 11.8107 15.651 12.8402 0 0 15.7879 17.3536 14.6034 0 0 0 Q6PJW8 CNST_HUMAN Consortin CNST C1orf71 Homo sapiens (Human) positive regulation of Golgi to plasma membrane protein transport [GO:0042998] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; connexin binding [GO:0071253]; phosphatase binding [GO:0019902]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] GO:0005802; GO:0005886; GO:0016020; GO:0016021; GO:0019902; GO:0030133; GO:0032991; GO:0042998; GO:0043231; GO:0071253 connexin binding [GO:0071253]; phosphatase binding [GO:0019902] DDQLNKETEDYLNSLLEGCLK 0.99094 -19.166 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6619 0 0 0 0 12.4422 0 0 0 12.7575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8552 0 0 12.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0153 12.9235 0 0 0 0 13.6757 0 0 0 16.5335 Q8NEZ3 WDR19_HUMAN WD repeat-containing protein 19 (Intraflagellar transport 144 homolog) WDR19 IFT144 KIAA1638 Homo sapiens (Human) cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to ciliary membrane [GO:1903441]; protein-containing complex assembly [GO:0065003]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] GO:0000902; GO:0001701; GO:0001750; GO:0005737; GO:0005856; GO:0005929; GO:0008406; GO:0030326; GO:0030991; GO:0031076; GO:0031514; GO:0032391; GO:0035721; GO:0042471; GO:0048701; GO:0050877; GO:0055123; GO:0060271; GO:0060830; GO:0060831; GO:0061055; GO:0065003; GO:0097542; GO:0097730; GO:1903441 DCGAILENMKQFSEAAQLYEKGLYYDK 0.99094 -19.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4763 0 0 10.1843 0 0 0 12.3359 12.6098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8017 0 0 0 0 0 0 11.9545 0 0 12.787 0 0 0 0 0 12.491 0 0 0 0 0 0 0 0 14.8726 0 0 0 0 0 0 13.4019 12.3039 0 0 12.5246 0 0 0 0 0 0 0 0 0 0 15.4155 0 0 0 0 0 0 0 11.4189 0 12.5055 0 0 0 0 0 0 0 0 0 12.7414 13.2919 0 13.2426 0 10.7244 0 12.4343 0 0 0 0 0 0 0 0 0 0 13.2004 0 0 0 0 0 0 0 0 0 0 0 0 14.4177 0 0 0 11.4105 0 0 0 0 0 0 0 0 Q96BF6 NACC2_HUMAN "Nucleus accumbens-associated protein 2, NAC-2 (BTB/POZ domain-containing protein 14A) (Repressor with BTB domain and BEN domain)" NACC2 BTBD14A NAC2 RBB Homo sapiens (Human) "negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [GO:1900477]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein homooligomerization [GO:0051260]; protein-containing complex localization [GO:0031503]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [GO:1900477]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein homooligomerization [GO:0051260]; protein-containing complex localization [GO:0031503]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005730; GO:0005739; GO:0006357; GO:0008285; GO:0031503; GO:0042803; GO:0042826; GO:0044877; GO:0045892; GO:0051260; GO:1900477; GO:1902231 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASGSYAVQEK 0.99094 -19.173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3563 0 0 0 0 0 0 0 0 0 0 11.9214 0 0 0 10.1072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.299 10.6334 0 0 0 0 0 0 15.5962 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.671 0 0 0 0 11.2453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5414 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5B8 NDK7_HUMAN "Nucleoside diphosphate kinase 7, NDK 7, NDP kinase 7, EC 2.7.4.6 (nm23-H7)" NME7 Homo sapiens (Human) CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] axonemal microtubule [GO:0005879]; centrosome [GO:0005813]; cytosol [GO:0005829] axonemal microtubule [GO:0005879]; centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] GO:0004550; GO:0005524; GO:0005813; GO:0005829; GO:0005879; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0046872 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550] AGEIIEIINK 0.99094 -20.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.674 0 0 0 11.6814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9286 0 0 0 0 0 0 0 0 0 0 0 0 0 15.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23352 KALM_HUMAN Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein) ANOS1 ADMLX KAL KAL1 KALIG1 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182] GO:0004867; GO:0005201; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0007155; GO:0007411; GO:0008201; GO:0009986; GO:0030182; GO:0031012 extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] ASGFAAACVESCEVDNECSGVK 0.99095 -5.9648 0 0 0 0 0 0 0 0 0 0 0 12.9114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6421 0 0 0 0 0 0 13.1337 0 0 0 0 16.181 0 0 0 12.8211 15.9094 0 18.1409 0 0 0 16.5163 0 13.9784 0 15.2142 0 0 0 0 0 0 0 0 0 17.9536 13.5454 0 0 0 0 0 0 0 0 0 0 0 0 15.1216 17.9688 0 0 0 17.9631 0 17.8926 0 0 0 0 0 0 17.897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6272 0 0 16.0773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31948 STIP1_HUMAN "Stress-induced-phosphoprotein 1, STI1 (Hsc70/Hsp90-organizing protein, Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)" STIP1 Homo sapiens (Human) cellular response to interleukin-7 [GO:0098761]; protein folding [GO:0006457] chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chaperone complex [GO:0101031]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; protein folding [GO:0006457] GO:0003723; GO:0005634; GO:0005794; GO:0005829; GO:0006457; GO:0030544; GO:0032991; GO:0051879; GO:0098761; GO:0101031; GO:0120293 Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; RNA binding [GO:0003723] CMMAQYNRHDSPEDVK 0.99095 -21.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7759 0 0 0 0 0 0 0 0 0 0 0 10.6474 0 0 0 0 0 11.9482 0 0 13.1868 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3708 0 0 0 0 13.6852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4557 P49760 CLK2_HUMAN "Dual specificity protein kinase CLK2, EC 2.7.12.1 (CDC-like kinase 2)" CLK2 Homo sapiens (Human) negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0010212; GO:0016604; GO:0016607; GO:0018108; GO:0042802; GO:0043484; GO:0045721; GO:0046777; GO:0106310 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] DRGDAYYDTDYRHSYEYQR 0.99095 -21.378 0 0 0 0 11.6587 0 0 11.2023 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4882 0 0 0 0 0 0 10.0724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9011 13.0425 13.5663 14.0736 15.239 0 11.6395 0 0 0 0 0 0 0 0 0 0 0 0 11.3741 0 0 0 0 0 0 0 0 0 0 0 13.8649 0 0 15.4638 0 0 0 0 0 0 13.8802 0 0 0 15.1768 0 15.7818 0 11.068 0 0 12.0155 15.9121 15.3899 11.9888 15.3755 15.3846 0 0 0 16.201 0 0 0 0 15.1507 0 0 0 0 0 0 0 0 16.1285 0 0 0 0 14.3845 15.611 14.9778 0 0 14.0256 0 0 0 0 0 10.8819 13.4767 14.9754 0 0 13.4778 14.1244 0 0 0 0 0 0 0 0 0 0 0 0 11.3124 0 0 14.2132 0 0 0 10.6537 0 0 0 0 0 13.6157 0 12.5596 0 12.9138 0 0 0 0 0 0 P62906 RL10A_HUMAN "60S ribosomal protein L10a (CSA-19) (Large ribosomal subunit protein uL1) (Neural precursor cell expressed developmentally down-regulated protein 6, NEDD-6)" RPL10A NEDD6 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; response to ethanol [GO:0045471]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; response to ethanol [GO:0045471]; translation [GO:0006412] GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0045471; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ILGPGLNK 0.99095 -21.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2969 13.6742 0 0 13.1596 0 0 0 0 0 0 0 0 0 0 15.2056 0 0 15.4261 0 0 0 0 0 14.4822 0 0 15.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5827 0 14.2109 13.4602 13.144 0 0 0 0 14.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6019 0 0 0 13.0236 0 0 0 0 0 0 0 0 0 0 0 12.1558 0 0 0 0 0 0 12.749 0 0 0 0 0 Q14696 MESD_HUMAN LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61) MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369 Homo sapiens (Human) mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750]; mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055] GO:0001503; GO:0005783; GO:0005886; GO:0006457; GO:0006909; GO:0007498; GO:0016055; GO:0034394; GO:0042802; GO:0050750; GO:1904395 identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750] DYNDADMAR 0.99095 -21.373 0 0 0 0 0 8.87845 0 0 13.7996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.788 0 0 0 14.7731 0 0 0 0 0 13.7127 0 0 0 0 0 15.1505 0 14.2303 0 13.5787 0 0 0 15.1607 0 15.1484 14.6686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9186 0 0 0 0 0 0 0 0 0 0 14.6788 0 0 0 13.9282 14.6744 0 0 14.6828 14.7376 14.4773 0 0 0 0 0 0 0 0 0 Q15438 CYH1_HUMAN "Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1)" CYTH1 D17S811E PSCD1 Homo sapiens (Human) establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008289; GO:0016192; GO:0030155; GO:0031234; GO:0032012; GO:0090162 guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] DQVIKACK 0.99095 -21.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7688 11.6332 0 0 0 0 0 0 0 0 0 0 14.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4835 0 0 13.7849 0 0 0 0 0 0 13.4709 15.2291 0 0 0 0 0 0 0 13.1065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4057 0 0 0 13.341 13.2765 0 0 0 0 13.2777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0874 0 0 0 0 0 0 0 0 0 0 0 0 Q330K2 NDUF6_HUMAN "NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)" NDUFAF6 C8orf38 Homo sapiens (Human) biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981 AFPAFLQTVSLEDFLKKIQR 0.99095 -4.6001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5693 0 0 0 0 0 0 0 0 0 14.712 0 0 0 0 15.0288 0 11.8253 0 0 0 0 0 0 14.9256 0 15.1468 15.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9159 0 0 0 0 0 0 0 0 0 0 0 0 14.9081 0 13.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NT04 TIGD7_HUMAN Tigger transposable element-derived protein 7 TIGD7 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] ELFSEWFFQNFVPEVR 0.99095 -20.392 0 0 0 0 0 0 0 0 11.8704 0 0 0 0 0 11.7682 0 0 0 0 0 0 0 0 0 0 0 12.366 11.4213 12.3593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2691 13.7945 13.799 14.2083 14.1051 0 13.8466 17.6373 13.0818 13.5682 15.0974 13.1112 13.1661 0 15.0022 13.8329 0 0 0 0 0 0 0 0 0 11.6639 12.4554 13.3531 0 0 0 0 0 0 15.0211 0 13.4726 13.6595 0 13.8951 13.9872 0 0 13.2374 0 0 0 15.2402 13.3078 13.5983 0 13.0188 14.0836 0 0 12.244 15.3234 12.8486 12.82 13.0293 0 0 11.4683 14.0107 0 13.6247 17.2864 13.3042 0 0 13.2119 14.4054 13.9031 15.3244 0 0 0 11.6005 0 0 0 0 14.0262 0 13.1097 14.463 12.4364 0 0 0 9.67689 0 0 0 11.4618 12.4647 0 0 11.5642 0 0 0 11.3119 0 0 0 0 13.3132 12.4664 0 0 0 0 0 Q7L1S5 CHST9_HUMAN "Carbohydrate sulfotransferase 9, EC 2.8.2.- (GalNAc-4-O-sulfotransferase 2, GalNAc-4-ST2, GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2)" CHST9 UNQ2549/PRO6175 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030203; GO:0030206; GO:0042446; GO:0047756 chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] ILYCEVPK 0.99095 -19.179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0515 12.6182 0 11.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7092 0 0 0 0 0 0 15.7063 0 0 12.4504 0 0 0 0 0 0 0 10.2497 0 0 11.5872 0 0 0 0 14.5552 0 0 0 0 0 0 0 0 10.8041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6684 0 0 13.4486 13.8441 0 0 0 0 Q8N3U4 STAG2_HUMAN Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2) STAG2 SA2 Homo sapiens (Human) cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; establishment of meiotic sister chromatid cohesion [GO:0034089]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]" GO:0000775; GO:0000785; GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0007062; GO:0008278; GO:0016020; GO:0016363; GO:0034089; GO:0034991; GO:0051301; GO:0090307; GO:0097431 chromatin binding [GO:0003682] AICIEEIGIWMKMYSDAFLNDSYLKYVGWTMHDK 0.99095 -21.409 0 0 0 0 0 0 0 0 0 0 0 18.5778 0 0 11.2482 0 0 0 0 0 0 0 0 0 10.003 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3336 0 0 0 0 0 0 0 0 11.5514 0 0 0 0 11.0188 14.3816 12.108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7078 13.584 0 0 0 0 0 0 0 0 13.0662 0 0 0 0 0 0 13.2736 0 0 0 0 0 0 14.3694 0 10.5483 0 0 0 12.641 0 0 0 14.4502 0 0 0 0 13.8155 0 0 0 0 0 0 0 0 11.9495 0 11.0523 0 0 0 0 0 0 0 0 13.2939 12.4228 0 0 0 0 0 0 0 0 0 0 0 0 16.2014 0 0 0 0 0 11.9758 0 0 18.9838 12.1337 0 0 13.3089 0 0 11.1482 0 0 0 0 11.7328 0 0 0 0 0 Q9C0F0 ASXL3_HUMAN Putative Polycomb group protein ASXL3 (Additional sex combs-like protein 3) ASXL3 KIAA1713 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of transcription by RNA polymerase II [GO:0045944] PR-DUB complex [GO:0035517] PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975]; animal organ morphogenesis [GO:0009887]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003677; GO:0003682; GO:0009887; GO:0035517; GO:0042975; GO:0045944; GO:0046872; GO:0051055 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; peroxisome proliferator activated receptor binding [GO:0042975] AHLFQTSK 0.99095 -20.395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0466 0 0 0 0 0 0 0 0 0 0 15.5526 0 0 0 0 0 0 0 0 12.9768 0 0 13.4161 0 0 0 0 0 12.9095 0 14.3419 14.6617 13.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4224 0 16.0272 13.7361 0 12.9725 0 13.9243 0 0 0 0 0 12.2959 14.2139 0 0 0 0 12.0336 0 0 13.9494 0 12.9237 0 0 14.7058 0 0 14.3529 0 0 0 0 14.5716 0 0 0 0 0 14.4802 11.3468 0 0 0 13.537 13.8408 0 0 11.2837 0 0 0 0 0 0 0 0 0 13.9727 0 13.8382 0 0 0 0 11.5826 0 14.769 14.3727 0 0 0 0 0 0 14.9511 0 0 0 11.2664 0 0 0 0 0 0 0 0 0 0 11.9913 0 0 15.8496 0 0 0 11.5117 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2T7 YBOX2_HUMAN "Y-box-binding protein 2 (Contrin) (DNA-binding protein C, Dbpc) (Germ cell-specific Y-box-binding protein) (MSY2 homolog)" YBX2 CSDA3 MSY2 Homo sapiens (Human) oocyte development [GO:0048599]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; translational attenuation [GO:0009386] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; oocyte development [GO:0048599]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; translational attenuation [GO:0009386] GO:0003676; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0006366; GO:0007283; GO:0009386; GO:0010468; GO:0048599; GO:0120162 DNA binding [GO:0003677]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723] NNPRKFLR 0.99095 -21.405 0 0 0 0 0 0 0 0 0 13.5565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.327 13.7554 13.5897 0 12.561 0 13.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3662 0 0 0 0 0 13.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1176 0 0 0 0 Q9Y6A4 CFA20_HUMAN Cilia- and flagella-associated protein 20 (Basal body up-regulated protein 22) (Transcription factor IIB) CFAP20 BUG22 C16orf80 GTL3 Homo sapiens (Human) cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular exosome [GO:0070062]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; extracellular exosome [GO:0070062]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] GO:0003723; GO:0005654; GO:0005814; GO:0005879; GO:0005929; GO:0018095; GO:0031514; GO:0036064; GO:0060271; GO:0060296; GO:0070062; GO:2000147; GO:2000253 RNA binding [GO:0003723] KYFTFEVQVLDDK 0.99095 -19.211 0 0 0 12.9871 14.4585 0 0 0 0 0 0 0 0 0 0 0 13.3382 0 11.9717 10.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3294 0 0 0 0 0 10.5489 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2246 0 0 0 0 0 0 0 0 0 13.8155 14.1066 11.6131 0 0 0 0 12.8815 18.1895 12.8565 11.5279 0 0 0 0 14.8935 0 0 0 0 0 0 13.8524 10.8662 0 0 13.4366 0 0 0 0 0 11.0881 0 0 0 0 0 13.4119 0 0 10.0181 11.0373 0 0 0 13.0229 0 0 14.3273 0 0 0 0 0 0 0 13.1306 0 0 13.4914 0 0 0 0 0 11.8147 0 0 14.1595 12.1032 0 12.0729 0 0 0 0 0 12.685 0 0 0 0 0 0 0 0 0 0 0 0 13.002 0 10.3783 0 0 12.8474 0 11.852 0 0 13.4851 0 P48509 CD151_HUMAN "CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3, PETA-3) (Tetraspanin-24, Tspan-24) (CD antigen CD151)" CD151 TSPAN24 Homo sapiens (Human) "cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]" basement membrane [GO:0005604]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "basement membrane [GO:0005604]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]" GO:0005178; GO:0005604; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0009986; GO:0016020; GO:0016477; GO:0030335; GO:0042098; GO:0044319; GO:0045807 integrin binding [GO:0005178] GEFNEKK 0.99096 -21.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.502 0 11.2034 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0736 0 0 0 0 0 0 0 0 0 0 10.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0692 0 P78332 RBM6_HUMAN RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3) RBM6 DEF3 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]" GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0006396 DNA binding [GO:0003677]; RNA binding [GO:0003723] ANIGGHR 0.99096 -21.48 0 0 0 0 0 0 0 0 0 0 11.4382 0 11.6502 0 0 0 0 0 18.2782 0 0 0 0 0 18.3327 0 0 18.3417 0 11.5084 0 0 0 0 0 0 0 0 0 0 0 0 11.3808 0 0 0 0 0 13.607 13.732 13.2304 0 12.7848 12.5081 18.1357 18.1601 18.1081 17.9815 9.82482 0 0 0 0 0 0 0 0 12.1529 0 12.3901 19.8033 0 19.8232 0 0 0 13.8077 0 13.9923 12.83 0 0 0 14.4537 0 12.1253 0 19.3617 19.3599 19.3718 0 0 0 0 0 0 12.5916 12.5455 0 11.4636 11.5476 17.5593 12.6341 0 0 0 11.8974 19.1707 0 19.2303 13.4691 19.2107 0 11.0606 12.9345 12.4813 12.0008 19.1512 11.5107 19.1184 14.1027 0 13.0711 0 0 12.4572 14.6127 0 0 0 12.4438 12.2555 13.9425 0 0 0 0 14.6894 12.8604 13.9455 14.3857 0 0 19.0141 0 13.3486 19.002 0 0 0 0 0 0 0 0 14.194 16.5843 12.2732 0 0 0 12.6113 11.5857 0 0 12.3363 0 0 12.0372 12.6119 18.8592 14.1918 12.1928 0 12.7805 12.2291 0 0 0 12.8976 Q5VT98 PRA20_HUMAN PRAME family member 20 PRAMEF20 PRAMEF21 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 KLKMLGMLFHNIR 0.99096 -21.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0943 0 0 0 0 13.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q63HK3 ZKSC2_HUMAN Zinc finger protein with KRAB and SCAN domains 2 (Zinc finger protein 694) ZKSCAN2 ZNF694 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AVVHQRPFVGK 0.99096 -23.484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4434 0 0 13.4157 13.5166 0 14.5848 0 9.30854 13.7708 0 0 0 0 13.8903 13.4112 14.8038 0 0 0 0 0 0 11.1475 0 0 0 0 13.348 0 0 0 0 0 0 0 0 0 0 0 13.8903 0 0 0 11.4655 0 12.1916 11.8213 0 0 11.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7001 0 0 10.6062 0 0 11.0341 11.7655 Q7M4L6 SHF_HUMAN SH2 domain-containing adapter protein F SHF Homo sapiens (Human) apoptotic process [GO:0006915] phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915] GO:0001784; GO:0006915 phosphotyrosine residue binding [GO:0001784] AFAVDIKVIK 0.99096 -23.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0819 0 0 0 0 13.772 0 17.3957 11.7772 0 14.1198 0 14.8876 0 0 0 14.4708 14.4064 18.4887 14.129 13.9431 0 0 0 0 0 0 0 12.1798 0 0 12.4719 0 0 0 0 0 0 0 0 0 0 15.221 0 0 14.5726 0 12.9063 0 13.8438 0 0 0 0 13.4616 13.3744 0 0 0 0 0 16.0351 15.2613 12.2608 0 0 0 12.8066 0 0 0 14.0954 0 0 0 0 0 0 0 14.1834 13.9312 0 0 0 14.1124 0 0 0 13.9353 13.5041 0 0 14.2549 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXX5 T183A_HUMAN Transmembrane protein 183A TMEM183A C1orf37 Homo sapiens (Human) regulation of protein stability [GO:0031647] integral component of membrane [GO:0016021]; SCF ubiquitin ligase complex [GO:0019005] integral component of membrane [GO:0016021]; SCF ubiquitin ligase complex [GO:0019005]; regulation of protein stability [GO:0031647] GO:0016021; GO:0019005; GO:0031647 CLLFWCR 0.99096 -23.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4485 0 0 0 0 0 0 18.3679 0 0 0 0 0 0 0 0 18.6995 13.1378 13.5493 13.7456 0 0 0 0 0 0 12.8898 0 15.5226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3918 0 0 12.6822 0 0 0 0 12.1706 0 0 14.2103 0 0 12.9107 0 0 0 0 0 0 0 0 0 0 0 13.9825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AY3 FKB10_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP10, PPIase FKBP10, EC 5.2.1.8 (65 kDa FK506-binding protein, 65 kDa FKBP, FKBP-65) (FK506-binding protein 10, FKBP-10) (Immunophilin FKBP65) (Rotamase)" FKBP10 FKBP65 PSEC0056 Homo sapiens (Human) aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; protein folding [GO:0006457]; wound healing [GO:0042060] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; aorta morphogenesis [GO:0035909]; collagen fibril organization [GO:0030199]; extracellular matrix assembly [GO:0085029]; in utero embryonic development [GO:0001701]; peptidyl-lysine hydroxylation [GO:0017185]; peptidyl-proline modification [GO:0018208]; protein folding [GO:0006457]; wound healing [GO:0042060] GO:0001701; GO:0003755; GO:0005509; GO:0005528; GO:0005758; GO:0005783; GO:0005788; GO:0006457; GO:0016020; GO:0017185; GO:0018208; GO:0030199; GO:0035909; GO:0042060; GO:0085029 calcium ion binding [GO:0005509]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] EVQMGDFVR 0.99096 -21.578 0 0 0 0 0 0 0 0 0 0 0 12.011 0 0 0 0 0 11.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6937 0 0 11.4498 10.7339 0 0 0 0 0 12.6644 0 0 0 0 0 0 0 0 0 0 11.0137 0 0 0 0 0 0 0 0 11.4373 0 0 0 0 0 0 0 10.5753 0 0 0 0 12.1923 0 13.5488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7294 0 0 0 0 0 0 0 0 0 0 12.5597 0 11.753 10.3489 0 11.4544 0 0 12.7007 0 10.6713 10.7142 0 0 12.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3924 0 0 0 0 0 10.9006 0 0 12.6095 12.8962 0 0 0 12.6395 16.2236 16.568 12.5734 0 0 0 0 15.2259 0 0 0 15.28 0 0 11.3783 0 0 0 14.1837 0 13.9499 13.7087 0 Q9UBW7 ZMYM2_HUMAN Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198) ZMYM2 FIM RAMP ZNF198 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605] "cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0005634; GO:0005829; GO:0008270; GO:0016605; GO:0031624; GO:0045892 ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] CDCCKSQGTLK 0.99096 -21.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.956 0 0 0 0 0 0 11.9354 12.8646 10.5849 0 12.3034 10.0425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9685 0 12.1426 13.6867 0 0 12.4301 0 0 0 15.4859 0 11.6904 0 0 15.1948 0 0 13.7557 0 0 0 11.136 12.418 13.5599 0 0 12.969 0 0 0 14.0375 0 0 14.7309 13.9626 0 0 13.1002 11.1447 0 0 0 0 0 0 0 12.5816 0 0 0 0 0 0 0 0 0 0 13.9497 0 12.3352 0 0 0 0 0 12.4021 12.4852 0 0 0 0 11.0511 0 0 12.3219 11.9879 0 0 0 0 0 0 12.6596 0 0 0 0 0 0 0 0 13.0603 0 0 0 13.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2119 0 0 11.0309 Q9Y446 PKP3_HUMAN Plakophilin-3 PKP3 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; desmosome assembly [GO:0002159]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; protein localization to plasma membrane [GO:0072659] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; desmosome assembly [GO:0002159]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; protein localization to plasma membrane [GO:0072659] GO:0001533; GO:0002159; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0010628; GO:0019899; GO:0030054; GO:0030057; GO:0045294; GO:0045296; GO:0050839; GO:0072659; GO:0098609; GO:0098641; GO:1902373; GO:1990124 alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cadherin binding involved in cell-cell adhesion [GO:0098641]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899] HATGAMR 0.99096 -21.491 0 0 10.1404 0 0 0 0 0 11.092 11.4024 0 11.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6755 0 0 0 0 11.6484 0 11.1791 0 0 10.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6123 0 0 0 0 0 14.3894 0 13.9724 0 0 0 0 15.2032 0 0 0 15.3941 15.6178 14.471 14.8778 14.5906 14.7202 15.8542 15.0582 15.2014 15.8136 0 11.4298 0 14.7285 0 13.9721 0 14.1497 11.0081 10.2527 13.7304 0 0 0 13.99 15.863 15.6184 13.7099 0 13.9412 0 0 0 14.0891 0 13.8185 13.7578 0 13.3397 13.8259 0 16.2052 16.1336 12.7962 0 0 13.3945 11.7921 0 0 0 14.5681 13.3652 13.8388 0 15.7125 0 0 0 15.9243 11.6822 0 0 0 0 11.6656 13.4319 0 0 11.1592 0 0 12.6688 11.6673 12.1637 0 0 0 12.4453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95989 NUDT3_HUMAN "Diphosphoinositol polyphosphate phosphohydrolase 1, DIPP-1, EC 3.6.1.52 (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 1, EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 3, Nudix motif 3)" NUDT3 DIPP DIPP1 Homo sapiens (Human) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; cell-cell signaling [GO:0007267]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diadenosine polyphosphate catabolic process [GO:0015961]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; RNA decapping [GO:0110154] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287]; adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; cell-cell signaling [GO:0007267]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diadenosine polyphosphate catabolic process [GO:0015961]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; RNA decapping [GO:0110154] GO:0000287; GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0007267; GO:0008486; GO:0015961; GO:0034431; GO:0034432; GO:0050072; GO:0052840; GO:0052842; GO:0071543; GO:0071544; GO:0110154; GO:1901907; GO:1901909; GO:1901911 bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; m7G(5')pppN diphosphatase activity [GO:0050072]; magnesium ion binding [GO:0000287] EVCEEAGVK 0.99097 -5.9959 0 0 0 0 0 0 0 10.6992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28799 GRN_HUMAN "Progranulin, PGRN (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda, GP88, Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor, PCDGF) (Proepithelin, PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E) ]" GRN Homo sapiens (Human) astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165] GO:0002265; GO:0002282; GO:0003723; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007165; GO:0008083; GO:0010595; GO:0016020; GO:0030335; GO:0035578; GO:0043524; GO:0043525; GO:0045766; GO:0048680; GO:0050679; GO:0050727; GO:0050821; GO:0051087; GO:0060266; GO:0070062; GO:0106016; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1905247; GO:1905673 chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723] CAARGTK 0.99097 -21.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2351 0 0 0 0 0 0 0 15.8505 0 0 0 0 0 0 11.0164 0 0 0 0 0 0 10.2359 0 0 0 0 0 0 0 0 8.6249 0 0 0 9.48418 0 0 0 0 0 0 0 0 11.4633 0 0 12.3856 0 13.7816 0 13.9937 12.8553 12.8542 13.6854 13.0309 11.5991 13.6732 0 11.5207 0 0 0 0 11.4014 0 0 0 11.2205 0 0 12.0158 0 15.024 14.7018 0 0 0 11.8276 0 12.9796 0 14.3161 14.6268 0 0 0 0 13.9898 0 11.2377 0 12.1352 13.1509 12.248 0 14.4546 0 0 0 0 0 0 0 14.478 0 0 11.904 0 11.7445 14.3319 14.2368 0 0 0 0 0 0 0 0 12.8268 14.8141 0 11.0116 0 0 11.4593 0 14.5392 0 0 0 15.2182 18.2143 0 0 13.9894 0 18.6863 0 18.6984 0 12.3298 0 0 0 11.0942 0 0 0 18.1308 0 0 P41252 SYIC_HUMAN "Isoleucine--tRNA ligase, cytoplasmic, EC 6.1.1.5 (Isoleucyl-tRNA synthetase, IRS, IleRS)" IARS1 IARS Homo sapiens (Human) isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418] GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062 aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049] DADKSIIRTLK 0.99097 -21.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7553 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3043 0 0 0 0 13.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3608 0 11.4428 11.4193 12.0287 0 0 0 0 14.4848 0 14.3154 12.5496 0 0 12.1115 0 0 0 0 0 15.0219 12.4247 0 0 0 0 0 11.9 0 0 0 0 10.9635 0 0 12.5559 0 0 0 0 13.169 0 11.9053 0 0 0 12.7536 12.3798 0 0 0 0 0 0 12.8358 0 0 0 0 0 0 13.1321 0 0 0 0 0 0 0 0 0 0 0 12.6611 12.478 0 0 0 0 11.2277 0 0 0 0 0 0 11.3425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0178 Q86VI1 EX3L1_HUMAN Exocyst complex component 3-like protein (Protein Jiangli) EXOC3L1 EXOC3L Homo sapiens (Human) exocyst localization [GO:0051601]; exocytosis [GO:0006887]; peptide hormone secretion [GO:0030072] exocyst [GO:0000145]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] exocyst [GO:0000145]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; peptide hormone secretion [GO:0030072] GO:0000145; GO:0000149; GO:0006887; GO:0030072; GO:0030133; GO:0030141; GO:0051601 SNARE binding [GO:0000149] DWRQRCLR 0.99097 -23.515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3495 0 0 0 0 0 13.2357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3283 0 0 0 0 12.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15079 SNPH_HUMAN Syntaphilin SNPH KIAA0374 Homo sapiens (Human) neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; presynapse [GO:0098793] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; presynapse [GO:0098793]; syntaxin-1 binding [GO:0017075]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; synaptic vesicle docking [GO:0016081] GO:0005737; GO:0005739; GO:0005881; GO:0007269; GO:0016021; GO:0016081; GO:0017075; GO:0030182; GO:0043005; GO:0070161; GO:0098793 syntaxin-1 binding [GO:0017075] AMSLPGSR 0.99098 -5.5783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3205 0 0 0 0 0 0 0 0 0 0 14.1653 0 13.4528 0 0 0 0 0 0 13.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7014 0 0 0 0 0 0 10.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15143 ARC1B_HUMAN Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC) ARPC1B ARC41 Homo sapiens (Human) Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; tubulobulbar complex [GO:0036284] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; tubulobulbar complex [GO:0036284]; actin binding [GO:0003779]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627] GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005885; GO:0005925; GO:0015629; GO:0030833; GO:0032355; GO:0034314; GO:0036284; GO:0043627; GO:0044877; GO:0070062 actin binding [GO:0003779]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200] CRIFSAYIK 0.99098 -4.363 0 0 0 10.2501 0 0 0 0 0 0 0 0 11.7146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6734 11.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5178 0 0 9.51661 0 0 0 16.0203 0 0 0 0 0 0 13.8768 0 0 0 0 0 0 0 0 0 9.81033 12.8468 0 12.5871 0 0 0 0 14.8438 13.553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12524 MYCL_HUMAN "Protein L-Myc (Class E basic helix-loop-helix protein 38, bHLHe38) (Protein L-Myc-1) (V-myc myelocytomatosis viral oncogene homolog)" MYCL BHLHE38 LMYC MYCL1 Homo sapiens (Human) regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0003677; GO:0005654; GO:0005694; GO:0006357; GO:0045607; GO:0046983 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]" DQVPTLASCSKAPKVVILSK 0.99098 -20.244 0 0 0 0 0 12.2618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6167 0 0 0 0 0 0 0 14.1158 13.061 0 0 14.0266 14.9134 0 13.478 0 12.6552 14.5737 15.4124 15.1545 0 15.1444 0 0 0 0 0 0 0 0 0 15.4582 0 14.395 14.6159 0 15.5566 0 0 0 0 14.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1422 0 14.1076 15.5119 0 0 0 0 0 0 0 0 0 0 15.8196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8938 0 13.4499 0 0 0 0 0 P20264 PO3F3_HUMAN "POU domain, class 3, transcription factor 3 (Brain-specific homeobox/POU domain protein 1, Brain-1, Brn-1) (Octamer-binding protein 8, Oct-8) (Octamer-binding transcription factor 8, OTF-8)" POU3F3 BRN1 OTF8 Homo sapiens (Human) "central nervous system development [GO:0007417]; cerebral cortex radially oriented cell migration [GO:0021799]; chemical homeostasis [GO:0048878]; forebrain ventricular zone progenitor cell division [GO:0021869]; metanephric ascending thin limb development [GO:0072218]; metanephric DCT cell differentiation [GO:0072240]; metanephric loop of Henle development [GO:0072236]; metanephric macula densa development [GO:0072227]; metanephric thick ascending limb development [GO:0072233]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; urea transmembrane transport [GO:0071918]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; central nervous system development [GO:0007417]; cerebral cortex radially oriented cell migration [GO:0021799]; chemical homeostasis [GO:0048878]; forebrain ventricular zone progenitor cell division [GO:0021869]; metanephric ascending thin limb development [GO:0072218]; metanephric DCT cell differentiation [GO:0072240]; metanephric loop of Henle development [GO:0072236]; metanephric macula densa development [GO:0072227]; metanephric thick ascending limb development [GO:0072233]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; urea transmembrane transport [GO:0071918]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007417; GO:0008284; GO:0010628; GO:0021799; GO:0021869; GO:0042803; GO:0043066; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048878; GO:0071837; GO:0071918; GO:0072218; GO:0072227; GO:0072233; GO:0072236; GO:0072240 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GDPSSVK 0.99098 -20.227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8309 13.9079 0 0 0 0 0 0 13.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2396 0 0 0 0 0 13.742 0 0 13.3615 0 0 0 0 0 0 0 0 0 0 0 0 12.9429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P3W2 DJC24_HUMAN DnaJ homolog subfamily C member 24 (CSL-type zinc finger-containing protein 3) (Diphthamide biosynthesis protein 4) DNAJC24 DPH4 ZCSL3 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]; positive regulation of ATP-dependent activity [GO:0032781] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATPase activator activity [GO:0001671]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270]; chaperone-mediated protein folding [GO:0061077]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]; positive regulation of ATP-dependent activity [GO:0032781] GO:0001671; GO:0005737; GO:0005856; GO:0008198; GO:0008270; GO:0017183; GO:0032781; GO:0061077 ATPase activator activity [GO:0001671]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270] LILMYHPDK 0.99098 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0689 12.167 0 0 0 0 0 0 0 0 0 13.7097 14.1855 14.5618 13.5762 0 0 0 0 0 0 14.0687 0 0 0 0 14.0818 14.2438 0 0 0 0 13.4387 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0411 14.1549 0 0 0 13.3181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8ND90 PNMA1_HUMAN Paraneoplastic antigen Ma1 (37 kDa neuronal protein) (Neuron- and testis-specific protein 1) PNMA1 MA1 Homo sapiens (Human) inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of apoptotic process [GO:0043065] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of apoptotic process [GO:0043065] GO:0002437; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0043065 AMTLLEDWCR 0.99098 -4.6123 0 0 0 11.238 0 0 0 0 0 0 0 0 0 0 0 0 12.7108 12.4788 0 0 0 0 0 0 13.7632 0 0 0 0 0 0 0 0 0 13.4634 0 0 0 0 0 14.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1738 0 0 14.749 0 0 0 0 0 0 0 0 Q96KP1 EXOC2_HUMAN Exocyst complex component 2 (Exocyst complex component Sec5) EXOC2 SEC5 SEC5L1 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0019901; GO:0031267; GO:0047485; GO:0090148; GO:0090522; GO:0090543; GO:2000535 protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267] GSSFQSGR 0.99098 -20.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6594 0 0 0 0 0 0 0 11.1974 0 12.9437 0 0 0 0 0 0 0 0 13.8666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.775 0 0 Q9BZ11 ADA33_HUMAN "Disintegrin and metalloproteinase domain-containing protein 33, ADAM 33, EC 3.4.24.-" ADAM33 C20orf153 UNQ873/PRO1891 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0004222; GO:0006508; GO:0008270; GO:0016021 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] CSWGCRR 0.99098 -20.229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9369 0 12.8676 0 0 12.4347 0 0 11.8086 0 0 12.0477 12.2548 13.3099 12.4833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2879 0 0 0 12.3042 12.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7447 13.3973 13.8305 13.6069 0 0 0 13.1696 13.1423 12.6531 13.8577 14.301 14.8083 14.9491 0 0 0 13.779 0 0 17.6985 16.2857 16.9918 14.3795 14.6785 17.994 15.4863 13.7929 13.9537 0 13.6939 0 15.1437 13.5847 13.399 0 0 13.1324 14.0258 14.2407 14.7573 15.0588 14.5654 13.6995 0 0 0 11.7757 14.7267 13.4062 13.8542 14.0833 0 0 13.512 14.8784 0 14.0369 15.0765 0 15.8039 13.7292 15.1949 14.5688 13.8739 13.786 15.3589 15.4423 14.2869 14.9672 14.9711 12.6075 14.1807 0 13.9273 0 13.8013 0 14.019 0 13.6594 0 0 0 14.3934 0 13.7238 0 0 14.797 0 0 0 0 0 11.248 0 13.3305 15.0837 0 0 15.1878 0 0 14.6727 14.0337 13.6316 14.997 13.743 0 0 0 0 O00560 SDCB1_HUMAN "Syntenin-1 (Melanoma differentiation-associated protein 9, MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18, TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1)" SDCBP MDA9 SYCL Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]" adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] "adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]" GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008022; GO:0008093; GO:0008284; GO:0010718; GO:0010862; GO:0016020; GO:0019838; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0032435; GO:0035556; GO:0035578; GO:0042043; GO:0042327; GO:0042470; GO:0042802; GO:0044877; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046875; GO:0046982; GO:0047485; GO:0050839; GO:0070062; GO:0072562; GO:0099054; GO:1903543; GO:1903553; GO:1903561 "cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]" RAEIKQGIR 0.99099 -5.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14964 HGS_HUMAN Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110) HGS HRS Homo sapiens (Human) endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; membrane invagination [GO:0010324]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; receptor internalization [GO:0031623]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; phagocytic vesicle lumen [GO:0097013] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; ESCRT-0 complex [GO:0033565]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; phagocytic vesicle lumen [GO:0097013]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; membrane invagination [GO:0010324]; multivesicular body assembly [GO:0036258]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; receptor internalization [GO:0031623]; regulation of MAP kinase activity [GO:0043405]; regulation of protein catabolic process [GO:0042176]; signal transduction [GO:0007165] GO:0005764; GO:0005768; GO:0005769; GO:0005829; GO:0006622; GO:0007165; GO:0008285; GO:0010324; GO:0010628; GO:0010642; GO:0016197; GO:0016236; GO:0016525; GO:0019904; GO:0030948; GO:0031623; GO:0031901; GO:0032456; GO:0032585; GO:0033565; GO:0035091; GO:0036258; GO:0042176; GO:0043130; GO:0043328; GO:0043405; GO:0044389; GO:0046426; GO:0046872; GO:0070062; GO:0072657; GO:0090148; GO:0097013; GO:1903543 metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389] CSSKYSTIPK 0.99099 -5.582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6656 0 14.2819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8855 0 0 0 0 0 0 0 15.5261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYB4 PEX5R_HUMAN "PEX5-related protein (PEX2-related protein) (PEX5-like protein) (Peroxin-5-related protein) (Peroxisome biogenesis factor 5-like) (Tetratricopeptide repeat-containing Rab8b-interacting protein, Pex5Rp, TRIP8b)" PEX5L PEX5R PXR2 Homo sapiens (Human) "protein import into peroxisome matrix, docking [GO:0016560]; regulation of cAMP-mediated signaling [GO:0043949]" cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; receptor complex [GO:0043235] "cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; receptor complex [GO:0043235]; intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome targeting sequence binding [GO:0000268]; small GTPase binding [GO:0031267]; protein import into peroxisome matrix, docking [GO:0016560]; regulation of cAMP-mediated signaling [GO:0043949]" GO:0000268; GO:0005052; GO:0005221; GO:0005778; GO:0005829; GO:0016560; GO:0031267; GO:0043235; GO:0043949 intracellular cyclic nucleotide activated cation channel activity [GO:0005221]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome targeting sequence binding [GO:0000268]; small GTPase binding [GO:0031267] GHPMAER 0.99099 -19.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0504 0 0 0 0 0 0 0 0 0 12.2304 0 0 0 13.7056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7805 0 0 13.4226 0 0 13.0951 0 0 0 0 0 0 0 0 0 0 0 13.5015 0 14.1246 14.4619 13.9644 0 0 0 0 0 0 12.7605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7262 0 0 0 0 0 0 0 Q8NB14 UBP38_HUMAN "Ubiquitin carboxyl-terminal hydrolase 38, EC 3.4.19.12 (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38)" USP38 KIAA1891 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] EWFLFNDSR 0.99099 -20.348 0 0 0 0 0 0 0 0 12.3821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9652 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6123 13.0425 0 12.7752 0 0 12.5122 0 0 0 0 0 0 0 13.9481 0 0 0 13.6669 13.5658 0 0 0 0 0 0 11.9136 12.1732 0 0 0 0 0 0 0 13.1005 0 0 0 15.1716 12.9682 0 0 0 0 14.3138 12.4691 0 0 0 11.2007 0 0 0 0 13.6299 0 0 0 15.3647 0 0 0 0 0 0 13.4066 0 0 0 0 0 0 11.6992 13.7463 0 0 0 0 0 13.8591 0 0 0 0 0 0 0 0 12.5389 12.4702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.883 0 9.86847 Q9HAB8 PPCS_HUMAN "Phosphopantothenate--cysteine ligase, EC 6.3.2.51 (Phosphopantothenoylcysteine synthetase, PPC synthetase)" PPCS COAB Homo sapiens (Human) acetyl-CoA biosynthetic process [GO:0006085]; coenzyme A biosynthetic process [GO:0015937]; heart process [GO:0003015] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphopantothenate--cysteine ligase activity [GO:0004632]; protein homodimerization activity [GO:0042803]; acetyl-CoA biosynthetic process [GO:0006085]; coenzyme A biosynthetic process [GO:0015937]; heart process [GO:0003015] GO:0003015; GO:0004632; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0015937; GO:0042802; GO:0042803 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphopantothenate--cysteine ligase activity [GO:0004632]; protein homodimerization activity [GO:0042803] KALEIYQHQVVVANILESRQSFVFIVTK 0.99099 -5.5826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.96 0 13.7014 0 13.2438 0 0 0 13.9135 0 0 0 0 13.248 0 13.6222 13.2496 0 13.7073 0 0 10.8764 0 0 0 0 0 0 0 12.8041 0 0 0 0 0 0 0 0 0 0 0 0 0 12.276 0 0 14.4431 0 12.687 0 0 0 0 13.5652 0 0 0 0 12.8522 0 0 12.4958 0 0 0 0 0 0 0 0 0 12.511 0 0 0 0 0 12.9434 11.9645 0 0 0 0 0 17.0631 0 11.0583 0 0 0 0 0 0 0 10.9238 0 0 0 0 0 0 0 Q9Y2I1 NISCH_HUMAN "Nischarin (Imidazoline receptor 1, I-1, IR1) (Imidazoline receptor antisera-selected protein, hIRAS) (Imidazoline-1 receptor, I1R) (Imidazoline-1 receptor candidate protein, I-1 receptor candidate protein, I1R candidate protein)" NISCH IRAS KIAA0975 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601] GO:0005178; GO:0005654; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006915; GO:0015630; GO:0016020; GO:0016601; GO:0019901; GO:0030036; GO:0030336; GO:0035091; GO:0042802; GO:0043231; GO:0045171; GO:0055037 identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901] DLEVYLQK 0.99099 -19.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3936 0 12.2235 0 0 0 0 0 12.0691 0 0 0 11.6057 0 0 0 0 12.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1174 0 0 0 0 0 0 0 15.5753 14.6866 0 0 0 0 0 0 0 0 10.4529 0 0 0 0 0 0 0 12.3663 12.9183 12.5416 0 14.2223 0 10.6561 0 0 0 0 10.1417 0 0 0 14.7082 14.8782 12.6739 0 11.5013 0 0 14.3566 11.7926 13.0881 13.1757 0 0 0 11.6872 0 13.7216 0 13.1935 13.3562 0 0 0 14.4666 0 12.4726 0 0 14.1539 0 13.54 13.0837 0 0 0 15.2268 14.0001 0 12.9748 15.218 0 14.118 0 0 11.4947 0 0 12.4696 0 0 0 0 0 12.7738 0 0 0 0 0 0 0 0 0 13.8969 0 0 0 0 0 0 0 P23467 PTPRB_HUMAN "Receptor-type tyrosine-protein phosphatase beta, Protein-tyrosine phosphatase beta, R-PTP-beta, EC 3.1.3.48 (Vascular endothelial protein tyrosine phosphatase, VE-PTP)" PTPRB PTPB Homo sapiens (Human) angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; glial cell migration [GO:0008347]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cadherin binding [GO:0045296]; protein C-terminus binding [GO:0008022]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311]; glial cell migration [GO:0008347]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470] GO:0001525; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0008022; GO:0008347; GO:0016311; GO:0035579; GO:0043235; GO:0045296; GO:0070821; GO:1990264 cadherin binding [GO:0045296]; protein C-terminus binding [GO:0008022]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] CDPTQQKFCDGPLK 0.991 -21.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0837 0 0 0 0 0 0 0 0 12.7068 11.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8879 0 0 0 0 0 0 0 0 0 0 0 0 10.7352 0 14.1579 0 0 0 14.5149 0 0 0 0 13.9804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7251 0 0 0 0 13.6083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63010 AP2B1_HUMAN AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit) AP2B1 ADTB2 CLAPB1 Homo sapiens (Human) aorta development [GO:0035904]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin adaptor complex [GO:0030131]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] AP-2 adaptor complex [GO:0030122]; clathrin adaptor complex [GO:0030131]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; clathrin binding [GO:0030276]; signal sequence binding [GO:0005048]; aorta development [GO:0035904]; clathrin-dependent endocytosis [GO:0072583]; coronary vasculature development [GO:0060976]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; synaptic vesicle endocytosis [GO:0048488]; ventricular septum development [GO:0003281]; vesicle-mediated transport [GO:0016192] GO:0001822; GO:0003281; GO:0005048; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0016020; GO:0016192; GO:0030122; GO:0030131; GO:0030276; GO:0030666; GO:0030669; GO:0035904; GO:0036020; GO:0045334; GO:0048488; GO:0060976; GO:0072583; GO:0098793; GO:0098794; GO:0098884; GO:0098978 clathrin binding [GO:0030276]; signal sequence binding [GO:0005048] APEVSQYIYQVYDSILKN 0.991 -4.6628 13.6872 0 12.5434 13.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1717 0 0 0 0 0 0 0 0 0 0 0 0 0 10.446 0 11.7764 11.1515 0 0 11.5161 0 0 14.0565 0 0 0 0 0 0 12.2971 0 0 12.3768 0 0 0 0 0 0 0 12.448 0 0 0 0 0 12.3288 0 0 12.1992 12.9504 0 0 0 12.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8932 0 11.653 0 0 0 12.135 0 0 16.73 16.8489 0 0 0 0 9.80147 10.2221 0 0 0 12.8043 13.4398 0 11.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5763 0 0 0 0 0 0 0 11.5719 0 0 0 0 13.8149 0 0 0 11.9604 12.0189 0 P80162 CXCL6_HUMAN "C-X-C motif chemokine 6 (Chemokine alpha 3, CKA-3) (Granulocyte chemotactic protein 2, GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1; Small-inducible cytokine B6, N-processed variant 2; Small-inducible cytokine B6, N-processed variant 3 ]" CXCL6 GCP2 SCYB6 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165] GO:0001776; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007267; GO:0008009; GO:0008201; GO:0030593; GO:0032642; GO:0042119; GO:0042742; GO:0045236; GO:0061844; GO:0070098; GO:0070951; GO:0071222 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201] NGKQVCLDPEAPFLKK 0.991 -5.8947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.547 12.8897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P82980 RET5_HUMAN "Retinol-binding protein 5 (Cellular retinol-binding protein III, CRBP-III) (HRBPiso)" RBP5 Homo sapiens (Human) fatty acid transport [GO:0015908] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; fatty acid transport [GO:0015908] GO:0005501; GO:0005504; GO:0005634; GO:0005829; GO:0015908; GO:0016918; GO:0019841; GO:0070062 fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841] IALLLKPDK 0.991 -5.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9012 0 11.909 0 0 0 11.573 0 12.9473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1494 0 0 0 0 0 13.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3455 0 0 0 0 0 0 13.3076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8776 0 Q1W6H9 F110C_HUMAN Protein FAM110C FAM110C Homo sapiens (Human) positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cell projection assembly [GO:0060491] cell cortex [GO:0005938]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922] cell cortex [GO:0005938]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of cell projection assembly [GO:0060491] GO:0000922; GO:0005634; GO:0005815; GO:0005874; GO:0005938; GO:0030335; GO:0043014; GO:0051897; GO:0060491 alpha-tubulin binding [GO:0043014] APAPVAR 0.991 -21.376 0 0 0 0 0 0 0 0 0 9.66489 0 0 0 0 0 0 0 0 0 11.7216 0 0 0 0 0 0 0 9.81149 0 0 0 0 0 0 0 15.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.948 14.039 14.9779 15.6189 13.8971 14.046 13.5682 20.5541 0 15.3829 0 14.0534 14.4998 0 0 0 0 0 0 14.467 0 0 0 0 0 0 13.1819 0 0 0 0 14.6589 0 13.9998 13.8689 14.0993 0 0 13.5209 0 0 14.858 0 0 15.3774 15.2956 0 13.3433 14.9306 14.8991 0 14.3861 13.9772 14.0444 14.2736 19.1244 13.9951 13.9349 0 0 0 0 14.5837 0 13.7707 0 0 0 0 14.1586 0 0 13.5694 11.3109 0 0 14.017 0 0 13.425 14.3601 13.5937 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3525 12.9239 0 14.2205 0 0 0 0 0 14.0866 0 Q3ZAQ7 VMA21_HUMAN Vacuolar ATPase assembly integral membrane protein VMA21 (Myopathy with excessive autophagy protein) VMA21 MEAX XMEA Homo sapiens (Human) regulation of ATP-dependent activity [GO:0043462]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; integral component of membrane [GO:0016021]; lysosome [GO:0005764] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; regulation of ATP-dependent activity [GO:0043462]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072] GO:0005764; GO:0005789; GO:0012507; GO:0016021; GO:0033116; GO:0043462; GO:0070072 QWREGKQD 0.991 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5D862 FILA2_HUMAN "Filaggrin-2, FLG-2 (Intermediate filament-associated and psoriasis-susceptibility protein, Ifapsoriasin)" FLG2 IFPS Homo sapiens (Human) cell adhesion [GO:0007155]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; transition metal ion binding [GO:0046914]; cell adhesion [GO:0007155]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436] GO:0001533; GO:0005198; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0007155; GO:0036457; GO:0046914; GO:0048730; GO:0061436; GO:1904724 calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; transition metal ion binding [GO:0046914] CRHGSNSR 0.991 -21.371 0 0 0 0 0 11.8441 0 0 13.8858 0 13.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5225 0 0 0 10.4027 0 0 0 0 13.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6485 0 0 0 0 0 0 0 0 0 10.0991 0 0 0 0 0 0 0 10.4109 0 0 0 0 0 13.576 13.9597 0 0 0 0 0 13.2367 0 0 0 13.0255 13.3042 13.2837 12.5599 0 0 0 0 0 0 13.1417 13.8674 0 14.088 13.452 0 0 0 0 0 0 0 0 12.4155 12.9828 0 0 0 0 0 0 12.7489 13.0357 13.3116 0 13.0493 13.2942 0 12.8948 12.2 0 0 0 0 0 11.139 0 0 0 13.0936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.183 0 0 0 0 0 0 15.8383 13.111 0 12.4928 0 0 0 0 0 0 0 0 0 0 0 14.1975 0 Q5VT99 LRC38_HUMAN Leucine-rich repeat-containing protein 38 (BK channel auxiliary gamma subunit LRRC38) LRRC38 Homo sapiens (Human) positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805] integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076] integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]; potassium channel activator activity [GO:0099104]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805] GO:0005249; GO:0005887; GO:0008076; GO:0044325; GO:0071805; GO:0099104; GO:1903818 potassium channel activator activity [GO:0099104]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] CAPNKDAEDEDEDK 0.991 -5.9037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7967 0 12.2174 11.8804 0 0 13.2785 0 12.2517 10.7394 11.5775 0 0 16.1539 0 0 13.0597 0 11.4041 0 11.1369 0 0 13.2347 0 13.6091 0 10.6361 11.5044 0 0 0 12.5929 12.8063 0 0 0 0 0 16.1257 12.227 12.1838 12.7523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0665 0 0 0 0 0 9.02929 0 0 0 0 0 0 0 0 0 Q86SU0 ILDR1_HUMAN Immunoglobulin-like domain-containing receptor 1 (Angulin-2) ILDR1 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; peptide hormone secretion [GO:0030072]; positive regulation of peptide hormone secretion [GO:0090277]; protein localization to tricellular tight junction [GO:0061833]; regulation of RNA splicing [GO:0043484]; response to fatty acid [GO:0070542]; tricellular tight junction assembly [GO:1904274] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; high-density lipoprotein particle receptor activity [GO:0070506]; identical protein binding [GO:0042802]; cellular response to leukemia inhibitory factor [GO:1990830]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; peptide hormone secretion [GO:0030072]; positive regulation of peptide hormone secretion [GO:0090277]; protein localization to tricellular tight junction [GO:0061833]; regulation of RNA splicing [GO:0043484]; response to fatty acid [GO:0070542]; tricellular tight junction assembly [GO:1904274] GO:0005829; GO:0005886; GO:0005923; GO:0010669; GO:0016020; GO:0016021; GO:0030072; GO:0032991; GO:0042802; GO:0043484; GO:0051649; GO:0061689; GO:0061833; GO:0070160; GO:0070506; GO:0070542; GO:0090277; GO:1904274; GO:1990830 high-density lipoprotein particle receptor activity [GO:0070506]; identical protein binding [GO:0042802] DSSHSGR 0.991 -21.368 0 0 0 0 0 0 0 0 12.8711 0 0 12.1105 0 0 0 0 12.5376 0 12.2438 12.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1349 0 0 0 0 0 12.2239 0 0 0 0 0 0 0 13.6125 0 0 16.4783 0 0 0 0 0 0 0 15.767 0 0 0 0 0 0 0 13.5825 0 0 0 0 0 10.8389 14.6783 0 0 0 0 0 15.471 13.5299 0 13.7492 0 0 0 0 14.613 0 0 14.7323 0 0 13.2212 14.4104 14.2473 14.7542 0 0 0 0 0 12.7221 0 14.2249 0 0 0 0 0 0 0 0 12.6783 0 0 0 0 0 13.0869 0 0 0 0 0 0 0 0 12.2741 0 0 0 0 0 0 0 0 0 13.8384 14.6769 0 0 0 0 14.8559 0 Q8NGE5 O10A7_HUMAN Olfactory receptor 10A7 (Olfactory receptor OR12-6) OR10A7 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IIITILRMSSATGR 0.991 -5.6007 0 0 0 0 0 0 0 0 10.4339 0 0 14.9604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7803 0 0 0 0 0 0 0 0 14.9305 15.1749 0 0 0 13.521 0 0 0 0 14.0709 14.5308 13.495 10.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHG7 SVIP_HUMAN Small VCP/p97-interacting protein SVIP Homo sapiens (Human) "negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly [GO:1904240]; positive regulation of autophagy [GO:0010508]; positive regulation of protein lipidation [GO:1903061]" anchored component of membrane [GO:0031225]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum membrane [GO:0030868]; tertiary granule membrane [GO:0070821] "anchored component of membrane [GO:0031225]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; smooth endoplasmic reticulum membrane [GO:0030868]; tertiary granule membrane [GO:0070821]; ATPase binding [GO:0051117]; protein self-association [GO:0043621]; negative regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903070]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly [GO:1904240]; positive regulation of autophagy [GO:0010508]; positive regulation of protein lipidation [GO:1903061]" GO:0000139; GO:0005789; GO:0005886; GO:0010508; GO:0030667; GO:0030868; GO:0031225; GO:0031333; GO:0043621; GO:0051117; GO:0070062; GO:0070821; GO:1903061; GO:1903070; GO:1904153; GO:1904240 ATPase binding [GO:0051117]; protein self-association [GO:0043621] LAEAAERRQK 0.991 -5.9057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF27 AGA11_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11, AGAP-11 (Centaurin-gamma-like protein KIAA1975)" AGAP11 KIAA1975 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630] GO:0003924; GO:0005096; GO:0046872; GO:0090630 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] AIPIKQGMLLK 0.991 -4.7852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4479 0 0 0 13.3276 0 0 0 0 14.2561 0 0 0 0 12.8193 0 0 14.2852 0 14.6125 15.9291 0 0 0 15.1189 15.623 0 0 14.6908 0 14.2178 0 0 0 0 15.6129 0 0 12.4475 0 0 14.3296 0 14.3283 14.3695 14.7746 0 0 0 11.3096 16.7197 0 0 14.4167 15.2289 0 0 14.5471 0 0 0 14.3751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6206 13.8015 13.8753 0 0 0 0 15.4837 0 Q8WUY1 THEM6_HUMAN Protein THEM6 (Mesenchymal stem cell protein DSCD75) (Thioesterase superfamily member 6) THEM6 C8orf55 PSEC0098 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 FRQHLLGTSPERVVQHLCQR 0.991 -5.9041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5892 0 0 0 0 0 0 0 0 13.4762 0 0 0 0 0 0 0 Q8WYP3 RIN2_HUMAN Ras and Rab interactor 2 (Ras association domain family 4) (Ras inhibitor JC265) (Ras interaction/interference protein 2) RIN2 RASSF4 Homo sapiens (Human) endocytosis [GO:0006897]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endocytic vesicle [GO:0030139] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005096; GO:0005829; GO:0006897; GO:0007264; GO:0010595; GO:0030139; GO:0030695; GO:0031267; GO:1904906; GO:2001214 GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] AELHSRPQPHIFHFVYKR 0.991 -21.403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9945 0 0 13.7102 0 0 0 0 0 0 13.958 0 0 0 0 0 0 13.6717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92641 0 0 13.3519 0 0 14.5085 0 0 0 0 0 0 0 0 12.6355 0 12.1359 0 0 0 14.6592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2853 0 13.7187 11.1338 0 0 0 0 0 0 0 12.0252 9.38061 12.9559 0 0 0 0 0 0 0 0 0 0 0 15.159 0 0 0 0 0 0 0 15.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2173 Q96Q11 TRNT1_HUMAN "CCA tRNA nucleotidyltransferase 1, mitochondrial, EC 2.7.7.72 (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)" TRNT1 CGI-47 Homo sapiens (Human) mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 5'-3' RNA polymerase activity [GO:0034062]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA cytidylyltransferase activity [GO:0016437]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-end processing [GO:0042780]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033] GO:0000049; GO:0001680; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0008033; GO:0016437; GO:0034062; GO:0042780; GO:0052927; GO:0052928; GO:0052929; GO:1990180 5'-3' RNA polymerase activity [GO:0034062]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA cytidylyltransferase activity [GO:0016437] DELLSYIKKT 0.991 -5.9108 0 0 0 0 10.6343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9523 0 0 0 0 13.2646 0 0 0 0 0 12.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2243 13.1391 0 0 0 0 12.4408 12.9268 0 13.8765 0 0 14.3133 15.0272 0 13.4722 0 0 11.09 12.8422 0 0 0 0 0 12.5726 14.3117 0 0 12.7979 0 0 14.4438 0 13.9788 12.7944 12.8377 0 0 0 0 0 0 14.2901 11.979 0 0 0 0 0 0 0 0 14.6483 0 0 0 0 0 13.3895 13.5814 0 0 12.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6535 Q99102 MUC4_HUMAN "Mucin-4, MUC-4 (Ascites sialoglycoprotein, ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1, ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2, ASGP-2) ]" MUC4 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; maintenance of gastrointestinal epithelium [GO:0030277]; regulation of signaling receptor activity [GO:0010469] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982] "extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent, lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; maintenance of gastrointestinal epithelium [GO:0030277]; regulation of signaling receptor activity [GO:0010469]" GO:0005176; GO:0005615; GO:0005796; GO:0005886; GO:0005887; GO:0007160; GO:0010469; GO:0016020; GO:0030197; GO:0030277; GO:0031012; GO:0031982; GO:0070062 "ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent, lubricant activity [GO:0030197]" DVTALNVSTLK 0.991 -19.185 12.3459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6995 0 0 0 0 0 0 0 0 0 13.6032 0 0 0 0 0 0 0 0 0 13.1037 0 0 14.593 0 0 0 0 0 0 0 12.9409 0 0 0 0 12.3388 0 0 0 0 0 0 14.6995 0 0 0 0 0 15.3048 0 0 0 0 12.6545 0 0 0 0 0 0 0 0 14.905 0 0 12.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6046 12.0073 0 0 0 0 0 0 0 0 0 0 0 0 16.3033 10.925 0 0 0 12.6833 0 0 0 0 0 0 0 Q9BTU6 P4K2A_HUMAN "Phosphatidylinositol 4-kinase type 2-alpha, EC 2.7.1.67 (Phosphatidylinositol 4-kinase type II-alpha)" PI4K2A Homo sapiens (Human) endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310] anchoring junction [GO:0070161]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802] anchoring junction [GO:0070161]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310] GO:0000139; GO:0000287; GO:0004430; GO:0005524; GO:0005739; GO:0005765; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0016310; GO:0030425; GO:0031224; GO:0031410; GO:0031901; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0045121; GO:0046854; GO:0070161 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287] DLEEDLYELFK 0.991 -19.208 0 0 0 0 0 0 0 0 11.4903 0 0 0 0 0 0 0 0 0 0 0 11.7837 0 0 0 0 0 0 0 0 0 0 0 12.0539 0 0 0 0 0 0 0 0 11.8541 0 0 0 0 0 0 0 0 0 11.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7568 0 13.5741 0 0 0 0 0 0 0 0 0 0 13.1656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4902 0 0 0 0 0 0 0 0 0 0 12.7841 0 0 0 0 0 0 0 0 14.564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0444 0 0 0 0 0 0 0 0 11.4861 10.4793 0 11.3819 Q06033 ITIH3_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H3, ITI heavy chain H3, ITI-HC3, Inter-alpha-inhibitor heavy chain 3 (Serum-derived hyaluronan-associated protein, SHAP)" ITIH3 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] GO:0004866; GO:0004867; GO:0005576; GO:0030212; GO:0031089; GO:0070062 endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] AVNRADTAK 0.99101 -23.5 0 11.9507 0 0 0 0 0 0 0 0 13.218 0 0 12.77 0 0 0 0 0 0 11.1304 0 0 0 0 0 0 0 11.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7973 0 0 0 12.2507 0 0 0 11.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6601 0 0 0 0 0 9.99915 0 13.7412 0 13.9236 0 0 0 0 0 0 16.8604 17.1987 17.0718 0 0 0 16.9972 14.6798 15.5943 14.4213 0 0 0 0 12.8548 14.4423 0 13.2989 0 0 0 14.1106 0 0 0 0 0 12.7146 0 14.6021 15.0407 15.1922 15.2493 0 0 0 13.4491 12.6723 0 0 14.1488 13.3271 0 0 13.6523 10.751 13.8758 14.2293 9.59755 0 13.8033 0 14.3394 13.3633 14.7516 0 0 9.95439 0 14.3385 0 0 0 0 0 11.4041 0 0 0 0 10.8157 0 14.0895 0 0 0 0 0 0 14.3249 0 12.2051 0 0 13.0402 13.6965 13.0695 14.1218 0 14.1428 0 0 0 13.2444 0 0 Q53F39 MPPE1_HUMAN "Metallophosphoesterase 1, EC 3.1.-.- (Post-GPI attachment to proteins factor 5)" MPPE1 PGAP5 PP579 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506] cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; GPI anchor biosynthetic process [GO:0006506] GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0006506; GO:0006888; GO:0016021; GO:0030145; GO:0033116; GO:0034235; GO:0062050; GO:0070971 GPI anchor binding [GO:0034235]; GPI-mannose ethanolamine phosphate phosphodiesterase activity [GO:0062050]; manganese ion binding [GO:0030145] FEKVFSSERLFSWK 0.99101 -5.9227 0 0 0 0 0 0 0 0 0 0 13.9063 0 0 0 14.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6887 0 0 0 0 0 0 14.3759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N782 ZN525_HUMAN Zinc finger protein 525 ZNF525 KIAA1979 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNYSSLLRKHQIIHLGEK 0.99101 -5.9178 0 0 0 0 12.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4032 0 0 0 0 0 12.8293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2225 0 0 0 0 0 0 0 10.074 0 0 0 0 0 15.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8866 14.1454 0 0 0 0 0 0 0 13.5299 0 0 0 0 0 0 0 0 13.8611 0 Q8TCB6 O51E1_HUMAN Olfactory receptor 51E1 (D-GPCR) (G-protein coupled receptor 164) (Olfactory receptor 52A3) (Prostate-overexpressed G protein-coupled receptor) (Prostate-specific G protein-coupled receptor 2) OR51E1 GPR164 OR51E1P OR52A3P POGR PSGR2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IGVAAVVRGAALMAPLPVFIK 0.99101 -4.7997 0 0 11.8397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5033 0 10.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1494 0 0 0 0 0 0 0 14.7167 0 14.6829 0 14.3771 0 0 14.9262 0 0 0 0 0 13.7765 14.1189 14.4717 0 0 13.4428 13.5907 0 0 0 13.1357 13.2579 0 0 0 10.9692 0 0 0 0 0 12.3587 12.7518 12.6714 0 0 14.1187 0 0 0 13.7825 0 13.7241 0 0 0 0 0 0 0 12.1304 0 0 0 0 0 0 13.4415 0 0 0 0 0 0 13.9385 11.9407 0 0 14.1064 0 0 0 0 0 0 0 0 13.9194 0 0 0 13.7697 0 0 0 15.083 0 0 12.7511 0 0 12.7777 0 0 Q92918 M4K1_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 1, EC 2.7.11.1 (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1, MEK kinase kinase 1, MEKKK 1)" MAP4K1 HPK1 Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007254; GO:0008283; GO:0008349; GO:0016020; GO:0018105; GO:0035556; GO:0043410; GO:0046777; GO:0106310; GO:1904628 ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DKVSGDLVALKMVK 0.99101 -23.364 0 0 0 0 0 11.9314 0 0 0 0 0 0 0 0 0 0 8.9062 0 0 0 0 11.9647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2559 13.2026 0 0 0 0 0 12.2705 0 0 16.4021 0 0 0 0 0 0 0 0 12.624 0 12.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8958 12.971 0 0 0 0 0 11.8628 0 0 0 0 12.7374 0 0 0 0 13.0181 0 0 13.3146 0 0 12.641 0 0 0 13.3168 0 0 0 0 0 0 0 0 0 0 0 0 12.335 0 0 0 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2625 0 Q96DX7 TRI44_HUMAN Tripartite motif-containing protein 44 (Protein DIPB) TRIM44 DIPB Homo sapiens (Human) "negative regulation of protein K48-linked ubiquitination [GO:0061944]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]" GO:0001961; GO:0002230; GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045893; GO:0050821; GO:0061630; GO:0061944; GO:1901224 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AEGDEEGPSGASEEEDT 0.99101 -23.513 0 0 10.1324 0 0 0 0 0 0 0 12.4097 0 0 0 0 11.2638 0 0 0 0 0 0 11.5413 0 0 0 0 0 10.3329 11.8354 0 0 0 0 0 0 11.1521 0 0 0 0 0 10.6086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4722 11.6086 0 10.8559 0 0 0 0 0 0 0 0 0 0 0 0 11.2815 0 0 0 11.2063 11.167 10.9653 0 11.3934 10.6369 0 0 11.4952 0 0 11.6389 0 0 0 0 0 0 0 0 0 0 10.3045 0 0 12.5877 0 11.8923 12.4923 0 0 12.4476 0 0 0 0 0 0 0 0 10.7485 0 0 0 0 0 10.854 9.52113 0 0 0 12.4419 0 0 0 0 9.56411 0 11.5965 11.9218 0 0 0 0 10.1685 0 0 0 0 0 10.9592 10.1536 12.0668 0 13.6453 0 0 12.8885 0 12.6566 0 12.8501 12.2705 0 0 0 0 0 0 0 0 0 11.0778 Q96P26 5NT1B_HUMAN "Cytosolic 5'-nucleotidase 1B, cN1B, EC 3.1.3.5 (Autoimmune infertility-related protein) (Cytosolic 5'-nucleotidase IB, cN-IB)" NT5C1B AIRP FKSG85 Homo sapiens (Human) adenosine metabolic process [GO:0046085]; purine nucleotide catabolic process [GO:0006195] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; XMP 5'-nucleosidase activity [GO:0106411]; adenosine metabolic process [GO:0046085]; purine nucleotide catabolic process [GO:0006195] GO:0000166; GO:0000287; GO:0005634; GO:0005829; GO:0006195; GO:0008253; GO:0046085; GO:0106411 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; XMP 5'-nucleosidase activity [GO:0106411] CCPFQGHSSCRR 0.99101 -23.378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0675 0 0 0 0 12.5621 12.5918 12.3028 0 0 0 0 0 12.8146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3062 0 0 0 0 0 0 0 0 Q9BRU2 TCAL7_HUMAN "Transcription elongation factor A protein-like 7, TCEA-like protein 7 (Transcription elongation factor S-II protein-like 7)" TCEAL7 Homo sapiens (Human) "negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; WW domain binding [GO:0050699]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0005634; GO:0005654; GO:0032088; GO:0045892; GO:0050699 WW domain binding [GO:0050699] EGDEMER 0.99101 -21.475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWT7 CAR10_HUMAN "Caspase recruitment domain-containing protein 10 (CARD-containing MAGUK protein 3, Carma 3)" CARD10 CARMA3 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981] CBM complex [GO:0032449]; cytoplasm [GO:0005737] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; CARD domain binding [GO:0050700]; signaling receptor complex adaptor activity [GO:0030159]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981] GO:0005737; GO:0007250; GO:0030159; GO:0032449; GO:0042981; GO:0050700; GO:0065003; GO:0090051; GO:1900182 CARD domain binding [GO:0050700]; signaling receptor complex adaptor activity [GO:0030159] ACQSFHEALEAWAK 0.99101 -23.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6968 0 0 0 0 0 0 0 0 0 12.3335 0 12.7434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3957 0 0 0 0 0 0 0 0 0 0 13.0079 12.9271 0 0 0 0 0 17.1734 15.8366 16.5611 0 15.7996 0 0 0 0 0 0 0 16.0018 14.4317 0 13.2161 13.1779 0 0 0 0 0 0 0 0 11.0442 0 0 0 0 12.6227 0 0 14.5751 0 0 12.5302 0 12.4547 0 14.1677 0 0 0 0 0 0 0 0 0 12.9548 0 0 0 13.2779 15.1506 0 0 0 11.3388 0 0 0 0 0 0 0 0 0 13.0038 0 0 10.8194 0 0 0 0 0 0 0 0 0 13.5989 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0C2 TB182_HUMAN 182 kDa tankyrase-1-binding protein TNKS1BP1 KIAA1741 TAB182 Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004] adherens junction [GO:0005912]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair [GO:0006302]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein autophosphorylation [GO:0031954]; telomere maintenance via telomerase [GO:0007004] GO:0000289; GO:0000792; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006302; GO:0007004; GO:0010800; GO:0019899; GO:0030014; GO:0031954; GO:0033138; GO:0044877; GO:0045296; GO:0071479; GO:0071532 ankyrin repeat binding [GO:0071532]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877] AETTQAR 0.99101 -21.536 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6693 0 12.9377 0 0 0 0 0 12.2648 0 11.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6385 17.0098 14.3335 13.9034 0 0 0 15.1906 0 13.4962 14.3961 14.8785 0 0 17.3329 0 0 0 0 0 0 0 15.071 0 13.7881 0 0 13.4581 16.0726 0 14.6154 0 0 14.5108 12.6756 12.9249 0 12.3447 0 0 15.4143 13.7932 0 13.5915 12.8656 15.3633 0 12.3482 14.6907 13.9633 13.2803 13.7908 13.9614 13.1312 15.0524 15.1378 12.8264 13.5085 14.1637 14.242 15.1029 0 15.792 13.105 13.3254 15.5235 13.5171 0 0 0 14.9116 0 16.0089 15.8006 0 15.0943 15.1603 13.8053 12.8291 0 14.2251 13.0172 0 0 15.6132 0 0 0 12.4995 15.646 14.2504 0 0 0 0 0 0 0 11.5496 12.1079 0 0 0 0 0 0 0 13.5068 13.2279 0 14.9766 0 0 12.1385 Q9HDC5 JPH1_HUMAN "Junctophilin-1, JP-1 (Junctophilin type 1)" JPH1 JP1 Homo sapiens (Human) calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; structural constituent of muscle [GO:0008307]; calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314] GO:0005654; GO:0005789; GO:0005886; GO:0007517; GO:0008307; GO:0014701; GO:0016021; GO:0016529; GO:0030018; GO:0030314; GO:0060314; GO:0060402 structural constituent of muscle [GO:0008307] ADAADQAALAAR 0.99101 -23.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6165 0 0 0 0 0 0 0 0 0 0 0 20.7764 0 0 10.0326 15.9371 14.526 14.6054 14.8569 14.6499 0 14.2884 0 0 0 0 0 0 13.3333 0 0 0 11.896 13.9028 0 0 0 0 0 0 0 12.3865 0 0 0 0 0 0 0 14.4757 0 0 0 0 10.3281 0 0 0 0 0 12.3008 0 13.4306 12.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7094 11.1557 0 11.4827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4601 0 0 0 Q9UGC6 RGS17_HUMAN "Regulator of G-protein signaling 17, RGS17" RGS17 RGSZ2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968] GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005886; GO:0007186; GO:0009968; GO:0043005; GO:0045202; GO:0070161 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] KVIEEKAR 0.99101 -5.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9262 0 0 0 0 0 0 0 0 0 0 0 11.2939 0 0 0 0 0 0 11.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2958 11.1318 0 0 0 0 0 0 0 0 0 0 0 0 12.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9694 0 0 11.9435 0 0 0 13.15 0 0 0 0 0 0 0 14.4538 0 0 Q9UMF0 ICAM5_HUMAN "Intercellular adhesion molecule 5, ICAM-5 (Telencephalin)" ICAM5 TLCN TLN Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] GO:0005178; GO:0005886; GO:0005887; GO:0006909; GO:0007155; GO:0098609 integrin binding [GO:0005178] AEAWPPAQISWR 0.99101 -21.578 0 0 0 0 0 0 0 0 0 11.1503 0 0 0 0 0 0 0 0 0 0 13.2325 0 12.2796 0 0 12.7867 0 12.3061 0 0 0 0 0 0 12.4133 0 0 13.5747 0 0 0 0 0 0 0 12.3237 12.8137 0 0 0 0 13.2392 14.3904 16.1824 16.0256 16.4886 16.5375 16.7934 15.9424 15.7906 15.1945 14.1729 15.4632 15.3178 16.0218 14.5506 0 13.2178 13.0751 0 0 0 0 0 14.6241 0 0 0 0 0 13.1804 0 16.5937 14.0009 0 0 13.6885 13.7584 13.7868 12.362 0 0 13.9829 0 0 13.7429 0 0 0 11.7469 13.3351 0 14.0617 13.3473 0 0 0 12.7125 0 13.1522 14.3503 14.9687 12.0346 13.1612 0 0 11.9881 0 0 12.6788 15.5031 0 0 0 0 16.4861 17.1172 13.3533 15.9539 0 0 0 0 0 0 13.1541 0 16.8446 0 0 0 0 0 0 0 0 0 0 0 0 12.2365 0 0 0 13.5417 0 14.6073 14.8474 0 0 0 13.2545 14.9361 14.8915 13.8514 15.3354 15.592 14.1901 0 0 0 16.538 0 0 14.5974 14.8108 0 14.5444 15.3742 0 O96017 CHK2_HUMAN "Serine/threonine-protein kinase Chk2, EC 2.7.11.1 (CHK2 checkpoint homolog) (Cds1 homolog, Hucds1, hCds1) (Checkpoint kinase 2)" CHEK2 CDS1 CHK2 RAD53 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; thymocyte apoptotic process [GO:0070242]" cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cell division [GO:0051301]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; thymocyte apoptotic process [GO:0070242]" GO:0000077; GO:0000086; GO:0001934; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0006978; GO:0008630; GO:0016605; GO:0018105; GO:0019901; GO:0030163; GO:0031573; GO:0031625; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0070242; GO:0071466; GO:0071480; GO:0090307; GO:0090399; GO:0106310; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625] KLLVVDPK 0.99102 -4.8174 0 0 0 0 0 0 0 0 14.5992 0 13.8698 13.2322 14.8169 11.7134 13.3129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1769 12.9059 13.1523 11.4892 15.3412 0 12.8394 13.1969 0 12.7711 0 0 0 0 0 0 0 13.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42892 ECE1_HUMAN "Endothelin-converting enzyme 1, ECE-1, EC 3.4.24.71" ECE1 Homo sapiens (Human) axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492] early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093] early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of endosome membrane [GO:0031302]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492] GO:0001921; GO:0003100; GO:0004175; GO:0004222; GO:0005765; GO:0005768; GO:0005769; GO:0005886; GO:0007186; GO:0007507; GO:0008270; GO:0009897; GO:0010814; GO:0010815; GO:0010816; GO:0016020; GO:0016021; GO:0016485; GO:0016486; GO:0017046; GO:0019229; GO:0031302; GO:0031982; GO:0033093; GO:0034959; GO:0035050; GO:0042447; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0070062; GO:0097492; GO:1902287 endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] AQVYYRACMNETR 0.99102 -5.9403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3425 0 0 0 0 0 0 0 0 11.1757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60153 RNAS9_HUMAN Inactive ribonuclease-like protein 9 RNASE9 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830] extracellular region [GO:0005576] extracellular region [GO:0005576]; nucleic acid binding [GO:0003676]; defense response to Gram-positive bacterium [GO:0050830] GO:0003676; GO:0005576; GO:0050830 nucleic acid binding [GO:0003676] FFSTGPARPPTK 0.99102 -1.8019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3096 0 13.2378 0 0 0 0 0 0 0 0 17.1325 0 0 0 0 0 P62820 RAB1A_HUMAN "Ras-related protein Rab-1A, EC 3.6.5.2 (YPT1-related protein)" RAB1A RAB1 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]; virion assembly [GO:0019068] cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; transport vesicle membrane [GO:0030658] cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; transport vesicle membrane [GO:0030658]; cadherin binding [GO:0045296]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]; virion assembly [GO:0019068] GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005783; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0016192; GO:0016477; GO:0019068; GO:0030252; GO:0030658; GO:0032402; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0045296; GO:0047496; GO:0070062; GO:0090110; GO:1903020 cadherin binding [GO:0045296]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] LLVGNKCDLTTKK 0.99102 -4.8189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4826 0 0 0 0 0 0 0 0 0 0 13.3899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6YHK3 CD109_HUMAN CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109) CD109 CPAMD7 Homo sapiens (Human) hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; protein phosphorylation [GO:0006468]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; protein phosphorylation [GO:0006468]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089] GO:0001933; GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0006468; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0031225; GO:0043616; GO:0045616; GO:0050431; GO:0061045; GO:0072089; GO:0072675; GO:2000647 serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431] EKALSFMRQGYQR 0.99102 -5.9436 0 0 14.3621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6199 11.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7609 0 0 0 0 0 0 0 14.1501 0 0 13.8159 0 12.4021 0 0 14.5351 0 13.2436 0 0 14.9485 12.8343 0 0 0 0 0 0 0 0 0 16.1962 0 16.3677 0 13.3802 0 0 0 0 0 0 12.7198 0 0 0 0 0 0 15.84 14.7363 0 13.9776 14.8013 0 13.7095 0 13.4622 0 0 13.7049 0 0 0 15.321 0 0 0 15.7126 0 13.6425 13.5064 0 0 13.3344 0 0 0 0 0 0 0 0 0 13.6284 0 0 19.5107 0 0 19.4624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULZ9 MMP17_HUMAN "Matrix metalloproteinase-17, MMP-17, EC 3.4.24.- (Membrane-type matrix metalloproteinase 4, MT-MMP 4, MTMMP4) (Membrane-type-4 matrix metalloproteinase, MT4-MMP, MT4MMP)" MMP17 MT4MMP Homo sapiens (Human) collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; drinking behavior [GO:0042756]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] GO:0001822; GO:0004222; GO:0005576; GO:0005886; GO:0006508; GO:0008047; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0042756; GO:0070006 enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] AARGPGPPPPGPGLSR 0.99102 -4.8234 0 0 0 0 0 0 0 0 0 0 0 13.0641 10.3606 0 0 0 0 13.8912 0 0 0 0 0 0 0 0 0 0 12.6927 0 0 0 0 0 0 0 0 13.3032 0 0 0 0 0 0 0 0 11.4946 0 0 0 0 0 0 10.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4555 0 0 0 0 11.2294 0 0 0 0 15.2075 0 0 0 11.6732 15.6051 0 13.7248 0 0 0 0 0 0 0 0 0 0 0 0 14.3382 0 0 0 0 10.481 17.1056 0 0 0 9.17268 12.9994 0 0 0 0 0 0 0 0 0 0 0 0 15.4349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7789 0 0 15.9217 0 10.4532 0 0 0 0 0 0 0 0 0 0 10.8702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6616 0 0 0 P62277 RS13_HUMAN 40S ribosomal protein S13 (Small ribosomal subunit protein uS15) RPS13 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; negative regulation of RNA splicing [GO:0033119]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; negative regulation of RNA splicing [GO:0033119]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0022626; GO:0022627; GO:0033119; GO:0048027; GO:0070062; GO:0070181 mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735] IHRLARYYK 0.99103 -20.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2599 0 12.8622 0 0 0 0 0 0 0 0 0 0 0 14.8759 0 0 0 0 0 0 0 0 0 13.3051 0 13.7071 0 0 0 0 13.4007 0 0 0 0 0 0 14.1307 0 0 13.6004 0 0 0 0 0 0 0 0 0 0 0 14.515 0 0 0 0 0 12.4267 0 0 0 12.4051 0 0 0 0 0 0 0 0 0 0 0 0 11.702 0 0 0 0 0 0 0 0 0 0 0 0 15.0451 10.9611 Q5T7W7 TSTD2_HUMAN Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 (Rhodanese domain-containing protein 2) TSTD2 C9orf97 PP4189 Homo sapiens (Human) AFALFVK 0.99103 -20.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8466 0 12.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0177 0 0 0 0 0 0 0 0 0 0 12.9808 0 0 0 0 0 13.1911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 0 0 0 14.496 0 0 0 0 0 0 0 0 0 0 0 0 10.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92934 BAD_HUMAN "Bcl2-associated agonist of cell death, BAD (Bcl-2-binding component 6) (Bcl-2-like protein 8, Bcl2-L-8) (Bcl-xL/Bcl-2-associated death promoter) (Bcl2 antagonist of cell death)" BAD BBC6 BCL2L8 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; ADP metabolic process [GO:0046031]; apoptotic process [GO:0006915]; ATP metabolic process [GO:0046034]; cellular response to chromate [GO:0071247]; cellular response to hypoxia [GO:0071456]; cellular response to lipid [GO:0071396]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cerebral cortex development [GO:0021987]; cytokine-mediated signaling pathway [GO:0019221]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of granulosa cell apoptotic process [GO:1904710]; positive regulation of insulin secretion [GO:0032024]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902220]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of mitochondrial membrane permeability [GO:0046902]; release of cytochrome c from mitochondria [GO:0001836]; response to amino acid [GO:0043200]; response to benzene [GO:1901423]; response to calcium ion [GO:0051592]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to oleic acid [GO:0034201]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 14-3-3 protein binding [GO:0071889]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; ADP metabolic process [GO:0046031]; apoptotic process [GO:0006915]; ATP metabolic process [GO:0046034]; cellular response to chromate [GO:0071247]; cellular response to hypoxia [GO:0071456]; cellular response to lipid [GO:0071396]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cerebral cortex development [GO:0021987]; cytokine-mediated signaling pathway [GO:0019221]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of granulosa cell apoptotic process [GO:1904710]; positive regulation of insulin secretion [GO:0032024]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902220]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of mitochondrial membrane permeability [GO:0046902]; release of cytochrome c from mitochondria [GO:0001836]; response to amino acid [GO:0043200]; response to benzene [GO:1901423]; response to calcium ion [GO:0051592]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to oleic acid [GO:0034201]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]; type B pancreatic cell proliferation [GO:0044342] GO:0001836; GO:0005543; GO:0005739; GO:0005741; GO:0005829; GO:0006007; GO:0006915; GO:0006919; GO:0007283; GO:0008289; GO:0008625; GO:0008630; GO:0008656; GO:0009410; GO:0009749; GO:0010508; GO:0010918; GO:0019221; GO:0019901; GO:0019903; GO:0021987; GO:0030346; GO:0032024; GO:0032355; GO:0032570; GO:0033133; GO:0033574; GO:0034201; GO:0035774; GO:0042542; GO:0042593; GO:0043065; GO:0043200; GO:0043280; GO:0043422; GO:0044342; GO:0045471; GO:0045579; GO:0045582; GO:0045862; GO:0046031; GO:0046034; GO:0046902; GO:0046931; GO:0050679; GO:0051384; GO:0051592; GO:0071247; GO:0071260; GO:0071316; GO:0071396; GO:0071456; GO:0071889; GO:0090200; GO:0097191; GO:0097192; GO:0097193; GO:0097202; GO:1901216; GO:1901423; GO:1902220; GO:1904710; GO:2000078 14-3-3 protein binding [GO:0071889]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903] GSSAPSQ 0.99103 -20.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08047 SP1_HUMAN Transcription factor Sp1 SP1 TSFP1 Homo sapiens (Human) "cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; cellular response to insulin stimulus [GO:0032869]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]" GO:0000785; GO:0000791; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008022; GO:0010628; GO:0017053; GO:0032869; GO:0032993; GO:0033194; GO:0035035; GO:0042802; GO:0042803; GO:0042826; GO:0043425; GO:0043536; GO:0043565; GO:0043923; GO:0045766; GO:0045893; GO:0045944; GO:0046872; GO:0048511; GO:0061629; GO:0071837; GO:0140297; GO:1902004; GO:1904828; GO:1905564; GO:1990837 "bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]" EACTCPYCKDSEGR 0.99104 -1.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1354 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4257 0 0 0 13.0239 12.76 0 0 0 0 0 0 0 14.4801 0 0 0 12.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8856 0 0 12.3904 0 0 0 0 0 12.0996 0 0 0 0 0 0 0 0 0 0 0 0 11.3914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18031 PTN1_HUMAN "Tyrosine-protein phosphatase non-receptor type 1, EC 3.1.3.48 (Protein-tyrosine phosphatase 1B, PTP-1B)" PTPN1 PTP1B Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; actin cytoskeleton reorganization [GO:0031532]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338] GO:0003723; GO:0004725; GO:0004726; GO:0005158; GO:0005737; GO:0005759; GO:0005769; GO:0005783; GO:0005829; GO:0006470; GO:0008270; GO:0008286; GO:0009966; GO:0009968; GO:0019899; GO:0019901; GO:0030061; GO:0030100; GO:0030948; GO:0030968; GO:0030971; GO:0031532; GO:0032991; GO:0033157; GO:0034620; GO:0035335; GO:0035791; GO:0036498; GO:0043407; GO:0043507; GO:0045296; GO:0046627; GO:0046875; GO:0051721; GO:0060338; GO:0060397; GO:0061098; GO:0070373; GO:0097443; GO:0098554; GO:1902202; GO:1902236; GO:1903896; GO:1903898; GO:1990264; GO:2000646 cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] CREFFPNHQWVKEETQEDK 0.99104 -19.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6986 0 0 11.745 0 0 0 12.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0427 0 0 12.3853 0 0 0 0 11.5482 0 0 0 13.6457 0 0 12.4067 0 0 0 0 0 0 11.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3575 0 0 0 0 0 0 14.9239 0 0 0 11.4352 0 12.525 0 0 0 0 0 0 0 12.1269 0 0 0 0 0 0 0 0 0 P21108 PRPS3_HUMAN "Ribose-phosphate pyrophosphokinase 3, EC 2.7.6.1 (Phosphoribosyl pyrophosphate synthase 1-like 1, PRPS1-like 1) (Phosphoribosyl pyrophosphate synthase III, PRS-III)" PRPS1L1 PRPS3 PRPSL Homo sapiens (Human) 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; male gonad development [GO:0008584]; phosphorylation [GO:0016310]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; male gonad development [GO:0008584]; phosphorylation [GO:0016310]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156] GO:0000287; GO:0002189; GO:0004749; GO:0005524; GO:0005737; GO:0006015; GO:0006164; GO:0008584; GO:0009156; GO:0016301; GO:0016310; GO:0042803 ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749] FSNQETCVEIDESVR 0.99104 -5.9644 0 0 0 0 0 11.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3705 12.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7104 0 0 0 0 0 13.5 0 0 0 0 0 0 12.014 0 0 0 0 0 0 0 13.1849 0 0 0 0 0 14.5444 0 0 0 0 14.8416 14.0237 11.9614 0 14.5534 11.9487 0 0 0 13.7594 0 0 0 0 0 0 0 0 0 11.6955 0 12.7897 14.5356 0 0 0 0 0 0 0 0 14.9141 0 0 0 0 0 0 12.8864 0 0 0 13.481 0 0 0 0 0 0 0 0 0 0 0 12.7856 11.5869 0 0 0 0 0 0 0 0 11.1972 0 0 12.4165 0 0 0 0 0 0 0 0 0 0 0 13.8509 Q5GH76 XKR4_HUMAN "XK-related protein 4, hXKR4 [Cleaved into: XK-related protein 4, processed form ]" XKR4 KIAA1889 XRG4 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] GO:0005886; GO:0016020; GO:0016021; GO:0017128; GO:0043652; GO:0070782; GO:1902742 phospholipid scramblase activity [GO:0017128] IDLFRNR 0.99104 -21.905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.704 11.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.774 0 0 13.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QU1 PCD15_HUMAN Protocadherin-15 PCDH15 USH1F Homo sapiens (Human) cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; synapse [GO:0045202] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear development [GO:0048839]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] GO:0001750; GO:0005509; GO:0005576; GO:0005615; GO:0005887; GO:0007155; GO:0007156; GO:0007605; GO:0032420; GO:0045202; GO:0045494; GO:0048839; GO:0050953; GO:0050957 calcium ion binding [GO:0005509] EKIQRLWSQSVSLPR 0.99104 -19.114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9261 12.068 0 0 0 0 11.6837 12.2973 0 12.5795 0 0 12.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1042 0 0 0 11.5783 0 0 10.8593 0 0 0 0 0 0 0 13.1027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9358 0 0 0 0 0 0 0 0 12.5813 13.0819 0 0 0 13.6387 15.6178 0 14.2937 13.1056 0 0 12.92 0 13.6117 0 0 0 0 15.0536 0 0 0 13.116 0 0 0 0 14.9571 13.6489 13.2853 0 0 0 0 0 0 0 0 14.5914 15.5803 13.4314 13.235 13.497 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7762 11.7306 0 12.8916 0 0 0 0 13.5264 0 0 0 14.4733 0 Q9UPE1 SRPK3_HUMAN "SRSF protein kinase 3, EC 2.7.11.1 (Muscle-specific serine kinase 1, MSSK-1) (Serine/arginine-rich protein-specific kinase 3, SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23)" SRPK3 MSSK1 STK23 Homo sapiens (Human) cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; muscle tissue development [GO:0060537]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; skeletal muscle tissue development [GO:0007519]; spliceosomal complex assembly [GO:0000245] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; muscle tissue development [GO:0060537]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; skeletal muscle tissue development [GO:0007519]; spliceosomal complex assembly [GO:0000245] GO:0000245; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007519; GO:0030154; GO:0035556; GO:0050684; GO:0060537; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CKIIHTDIK 0.99104 -19.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2956 11.6301 0 0 0 0 0 13.7503 0 14.0043 0 0 0 0 0 0 0 11.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0057 13.0831 0 0 0 0 0 17.9158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6274 0 0 0 14.2365 0 14.5739 0 0 0 0 0 0 0 13.4754 0 0 0 13.9542 0 0 0 0 11.7029 0 0 13.9585 13.6794 0 0 0 0 0 11.9787 13.7514 0 0 Q9Y228 T3JAM_HUMAN TRAF3-interacting JNK-activating modulator (TRAF3-interacting protein 3) TRAF3IP3 T3JAM Homo sapiens (Human) Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] GO:0000139; GO:0005741; GO:0005765; GO:0005886; GO:0016021 AQHPQAR 0.99104 -19.137 0 0 0 0 0 0 0 0 0 12.5954 0 0 12.9168 0 17.1559 0 16.9439 0 0 0 0 14.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5726 11.9389 0 0 0 0 11.8228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4563 13.9468 13.7359 13.8173 0 14.1157 0 12.8185 0 0 0 0 0 0 0 0 0 0 0 0 15.8417 16.0494 0 0 0 12.9507 0 0 13.2936 0 0 0 0 0 0 12.7904 0 0 0 0 16.0833 15.1243 0 15.7064 18.5033 13.7367 0 0 0 0 0 0 0 0 0 14.8502 18.415 19.2888 18.6293 0 18.5022 0 0 0 12.017 0 0 0 0 14.3536 14.801 0 0 0 13.2978 13.2622 18.9997 18.5786 15.2051 0 12.642 18.5114 0 0 0 0 0 0 0 0 15.5924 0 0 12.9977 11.4634 0 0 0 0 0 0 0 0 0 0 0 12.3439 18.6223 0 0 0 0 15.2495 0 O00193 SMAP_HUMAN Small acidic protein SMAP C11orf58 Homo sapiens (Human) DAKSNYK 0.99105 -5.9957 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0998 0 12.0485 0 0 12.1964 12.1434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0689 12.7172 14.3028 0 12.9655 0 0 13.445 0 0 0 0 0 0 0 0 12.604 0 13.0631 0 0 0 0 13.1377 0 0 0 12.8582 12.6226 0 0 0 0 0 0 0 0 12.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1735 0 0 0 11.6868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7025 0 0 0 12.182 0 0 13.74 0 0 0 0 12.2362 0 0 0 13.7197 O15294 OGT1_HUMAN "UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit, EC 2.4.1.255 (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit, OGT)" OGT Homo sapiens (Human) "apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; hemopoiesis [GO:0030097]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitophagy [GO:0000423]; negative regulation of cell migration [GO:0030336]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of proteolysis [GO:0045862]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of necroptotic process [GO:0060544]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]" cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580] "cell projection [GO:0042995]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; acetylglucosaminyltransferase activity [GO:0008375]; chromatin DNA binding [GO:0031490]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; hemopoiesis [GO:0030097]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitophagy [GO:0000423]; negative regulation of cell migration [GO:0030336]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of proteolysis [GO:0045862]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of necroptotic process [GO:0060544]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; signal transduction [GO:0007165]" GO:0000122; GO:0000123; GO:0000423; GO:0005547; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006357; GO:0006493; GO:0006915; GO:0007165; GO:0007584; GO:0008375; GO:0016262; GO:0016485; GO:0016580; GO:0017122; GO:0030097; GO:0030336; GO:0030512; GO:0031397; GO:0031490; GO:0031966; GO:0032435; GO:0032868; GO:0032922; GO:0032991; GO:0035020; GO:0042995; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045862; GO:0045893; GO:0045944; GO:0046626; GO:0048015; GO:0051571; GO:0060544; GO:0061087; GO:0080182; GO:0097363; GO:0120162; GO:1900095; GO:1902455; GO:1902459 "acetylglucosaminyltransferase activity [GO:0008375]; chromatin DNA binding [GO:0031490]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]" GKVWKQR 0.99105 -4.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3742 0 13.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5314 15.0354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9052 14.8939 0 0 0 0 0 0 14.6353 0 14.8859 0 0 0 0 0 0 0 14.6107 0 14.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4696 0 0 0 14.5539 0 P31641 SC6A6_HUMAN Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6) SLC6A6 Homo sapiens (Human) alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; gamma-aminobutyric acid import [GO:0051939]; import across plasma membrane [GO:0098739]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of cell differentiation [GO:0045597]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microvillus membrane [GO:0031528]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; microvillus membrane [GO:0031528]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369]; alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; gamma-aminobutyric acid import [GO:0051939]; import across plasma membrane [GO:0098739]; modulation of chemical synaptic transmission [GO:0050804]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; positive regulation of cell differentiation [GO:0045597]; positive regulation of necrotic cell death [GO:0010940]; sodium ion transmembrane transport [GO:0035725]; taurine transport [GO:0015734]; transport across blood-brain barrier [GO:0150104] GO:0005283; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0005887; GO:0006836; GO:0006865; GO:0010940; GO:0015171; GO:0015185; GO:0015734; GO:0016021; GO:0016323; GO:0016324; GO:0022858; GO:0030425; GO:0031528; GO:0032328; GO:0035725; GO:0043025; GO:0045597; GO:0050804; GO:0051939; GO:0071705; GO:0089718; GO:0098739; GO:0098797; GO:0098982; GO:0099055; GO:0150104 alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369] EGATPYNSR 0.99105 -5.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8802 0 0 0 0 0 0 0 0 0 0 10.014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8881 10.3036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2099 0 12.0299 0 0 0 0 14.8137 0 0 0 0 0 10.0893 11.2235 0 12.0992 0 0 0 0 0 0 0 10.9172 0 0 0 0 0 12.7097 0 0 0 0 12.7031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8047 0 0 0 0 11.8616 0 12.183 10.6128 0 0 0 0 0 11.6636 0 0 0 0 0 0 0 0 11.3716 13.1001 0 11.4311 0 11.498 0 0 0 0 0 0 0 0 14.2308 0 10.6748 0 0 0 11.4322 0 0 0 0 P54840 GYS2_HUMAN "Glycogen [starch] synthase, liver, EC 2.4.1.11" GYS2 Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; response to glucose [GO:0009749] cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ectoplasm [GO:0043265] "cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ectoplasm [GO:0043265]; glycogen (starch) synthase activity [GO:0004373]; glycogen synthase activity, transferring glucose-1-phosphate [GO:0061547]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; response to glucose [GO:0009749]" GO:0004373; GO:0005737; GO:0005829; GO:0005856; GO:0005938; GO:0005978; GO:0006091; GO:0009749; GO:0030864; GO:0043265; GO:0061547 "glycogen (starch) synthase activity [GO:0004373]; glycogen synthase activity, transferring glucose-1-phosphate [GO:0061547]" FGKKLYDALLR 0.99105 -4.6032 0 10.7007 11.3565 0 0 0 0 0 0 0 0 13.7647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.743 0 0 12.0687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V42 F124A_HUMAN Protein FAM124A FAM124A Homo sapiens (Human) FYQLILRR 0.99105 -21.366 0 10.9294 16.3895 0 0 13.5749 0 16.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.041 0 0 0 0 0 0 12.7063 0 0 0 11.656 14.753 0 0 0 0 0 0 11.9469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0641 0 0 0 0 0 14.4814 0 11.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6545 0 14.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAQ2 SMRC2_HUMAN "SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170, BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)" SMARCC2 BAF170 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 histone binding [GO:0042393]; transcription coactivator activity [GO:0003713] AAASATR 0.99105 -23.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.06315 0 0 0 0 0 0 10.1924 0 0 0 0 0 0 0 0 0 0 0 10.233 0 0 0 0 0 0 0 0 0 10.3086 0 0 0 0 0 0 12.332 0 0 0 13.0567 12.8193 13.2669 0 12.6262 0 0 0 0 0 10.6517 0 0 0 0 0 0 0 0 0 0 13.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9629 0 0 0 0 0 0 0 0 0 0 0 13.1918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5709 0 0 0 13.0014 13.1499 0 0 13.5929 0 0 0 0 0 0 0 0 0 Q96C00 ZBTB9_HUMAN Zinc finger and BTB domain-containing protein 9 ZBTB9 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000977; GO:0005634; GO:0006357; GO:0042802; GO:0046872 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] FAVKPKR 0.99105 -23.36 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3157 16.3437 16.1766 13.7358 16.0024 14.4993 15.1719 15.0766 15.6123 16.2397 15.7379 15.3228 14.7989 14.2075 15.535 13.6426 0 15.8852 12.7065 0 15.7479 13.0026 0 15.0763 14.1997 15.181 13.1872 0 15.8755 0 0 0 13.6591 14.8195 13.572 15.743 0 16.1841 15.0116 14.7741 13.0092 15.9377 15.7728 12.9401 13.577 0 0 13.3498 0 12.83 13.5064 13.4298 16.1493 14.1767 13.0889 14.1167 0 10.9506 0 13.1902 13.3914 14.8354 14.5879 14.2398 13.3994 13.9951 13.5865 14.6112 12.707 13.0733 13.5607 0 0 13.5256 0 0 13.3621 13.9705 12.7293 15.5781 14.0852 0 0 0 13.1587 14.5581 0 14.1394 0 0 12.9311 0 0 12.7557 0 0 0 0 12.7965 0 0 0 0 0 0 0 13.444 0 0 0 0 0 0 0 Q9ULX6 AKP8L_HUMAN "A-kinase anchor protein 8-like, AKAP8-like protein (Helicase A-binding protein 95, HAP95) (Homologous to AKAP95 protein, HA95) (Neighbor of A-kinase-anchoring protein 95, Neighbor of AKAP95)" AKAP8L NAKAP NAKAP95 HRIHFB2018 Homo sapiens (Human) cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear membrane disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear membrane disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380] GO:0000785; GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005737; GO:0006397; GO:0007076; GO:0008380; GO:0010793; GO:0016363; GO:0016605; GO:0016607; GO:0017151; GO:0031065; GO:0034237; GO:0042826; GO:0044839; GO:0045944; GO:0046872; GO:0051081; GO:1990904 DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723] AQGWARDAR 0.99105 -19.207 12.8989 0 0 0 0 0 10.9793 0 0 11.2331 0 0 0 12.9794 0 12.4583 0 12.7339 0 0 0 0 0 0 0 0 12.5689 0 11.321 0 0 0 0 0 0 12.7106 0 0 0 0 0 0 0 0 0 0 0 12.1333 0 0 0 12.3833 0 0 10.6199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9274 0 11.9179 0 0 0 0 0 0 0 0 0 14.2517 0 0 0 0 0 0 0 12.1478 0 0 11.215 0 0 0 13.4574 0 0 0 0 0 0 0 0 0 0 0 0 11.6847 0 0 0 11.7426 0 0 0 0 0 0 14.2157 0 0 0 0 13.4564 0 0 12.6923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0125 0 0 O75477 ERLN1_HUMAN "Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1) (Protein KE04) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1, SPFH domain-containing protein 1)" ERLIN1 C10orf69 KE04 KEO4 SPFH1 Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005783; GO:0005789; GO:0008203; GO:0015485; GO:0016021; GO:0030433; GO:0031625; GO:0032933; GO:0032991; GO:0045121; GO:0045540; GO:0045541; GO:0045717 cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625] DLNLMAPGLTIQAVRVTKPK 0.99106 -21.474 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5714 0 0 0 0 0 0 0 0 11.3017 0 0 10.911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7936 0 0 0 13.5303 13.7141 0 12.9533 0 0 14.1327 13.8512 0 0 0 13.198 0 0 0 14.4462 0 13.8929 14.115 14.2622 14.756 14.9605 14.9067 0 0 0 0 16.5817 16.5288 15.3369 15.3684 14.7569 0 15.9509 15.508 14.7067 15.9151 0 15.454 0 0 16.5107 11.1193 15.1646 0 15.2291 14.277 0 0 15.9342 14.8753 15.7666 16.132 14.7592 14.8896 16.0689 0 14.2046 0 14.8868 0 15.0412 14.2298 14.5789 15.5758 14.1281 14.7547 15.2481 13.9762 15.5281 13.9337 0 14.9491 16.055 12.3814 0 0 0 13.3651 12.2281 12.6102 13.7031 13.2161 13.6435 0 12.7835 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3399 14.1842 14.2769 14.0784 0 0 0 12.9095 0 P0CG40 SP9_HUMAN Transcription factor Sp9 SP9 Homo sapiens (Human) embryonic limb morphogenesis [GO:0030326]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic limb morphogenesis [GO:0030326]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030326; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ATCDCPNCQEAER 0.99106 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5H9M0 PWP3B_HUMAN "PWWP domain-containing DNA repair factor 3B, PWWP3B (Mutated melanoma-associated antigen 1-like protein 1, MUM1-like protein 1) (PWWP domain-containing protein MUM1L1)" PWWP3B MUM1L1 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 AREDYSESIDWCISLICDYRVR 0.99106 -5.5747 0 0 0 0 0 0 0 0 0 0 12.2699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4616 12.6259 0 0 0 0 0 0 12.2946 0 13.314 0 0 0 0 0 0 0 0 13.1557 0 0 0 0 0 0 0 0 0 0 0 0 14.8418 0 0 12.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4301 0 0 0 0 0 0 15.0143 12.9053 0 0 12.4595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6086 13.2636 0 0 0 0 0 0 0 Q6ZT98 TTLL7_HUMAN "Tubulin polyglutamylase TTLL7, EC 6.3.2.- (Testis development protein NYD-SP30) (Tubulin--tyrosine ligase-like protein 7)" TTLL7 Homo sapiens (Human) cell differentiation [GO:0030154]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; protein polyglutamylation [GO:0018095] cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; perikaryon [GO:0043204] cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; perikaryon [GO:0043204]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; cell differentiation [GO:0030154]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; protein polyglutamylation [GO:0018095] GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0007399; GO:0015631; GO:0018095; GO:0030154; GO:0030425; GO:0043014; GO:0043204; GO:0046872; GO:0048487; GO:0070740 alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] DFLARNMTK 0.99106 -23.421 0 0 0 0 0 11.6588 0 0 0 12.2081 11.4812 12.0446 0 0 0 0 0 0 0 0 11.367 0 0 0 0 0 13.4486 0 0 0 0 0 11.4138 10.8561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2099 0 0 0 0 13.2269 0 13.8951 11.1279 0 0 0 0 12.1225 0 17.3341 13.9373 0 0 0 0 0 0 13.4441 11.5242 0 12.2442 16.8064 0 0 0 0 0 0 13.5305 13.1221 14.104 11.8047 0 0 14.3593 0 0 0 0 12.5629 12.5789 10.9277 12.4884 11.3477 12.2946 14.04 0 0 0 0 0 0 0 16.433 10.9893 0 0 0 0 0 0 0 14.5341 11.9441 13.1867 0 0 12.0279 0 0 0 0 0 0 0 0 11.7925 14.4837 0 11.4247 11.9339 11.2601 12.0216 13.6279 11.4303 0 13.246 0 0 0 0 0 0 12.9965 12.3161 0 0 0 0 0 11.4369 11.6371 0 11.8566 Q969W1 ZDH16_HUMAN "Palmitoyltransferase ZDHHC16, EC 2.3.1.225 (Abl-philin 2) (Zinc finger DHHC domain-containing protein 16, DHHC-16)" ZDHHC16 APH2 UNQ2570/PRO6258 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; eye development [GO:0001654]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537] GO:0001654; GO:0005789; GO:0005794; GO:0006915; GO:0006974; GO:0007507; GO:0016021; GO:0016409; GO:0018345; GO:0019706; GO:0021537 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] GLVQRWRYGK 0.99106 -23.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4134 0 0 0 0 0 11.9526 0 0 0 0 0 0 0 12.2183 0 0 0 0 0 0 0 0 0 0 11.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3599 0 0 0 12.7894 0 0 13.9145 12.8609 14.5762 0 0 0 15.0888 0 0 0 0 0 0 0 0 0 0 0 0 14.6556 0 0 0 0 0 0 14.8969 0 13.521 0 0 0 0 0 15.6648 0 14.4726 0 0 0 0 0 0 13.4517 12.2549 0 0 0 0 0 0 0 0 12.9898 0 14.1093 12.6616 13.5467 0 0 0 0 0 0 0 11.4171 13.0147 0 0 0 0 0 0 0 13.4367 0 0 0 0 13.6684 13.7652 14.2527 0 12.7627 0 12.7936 0 0 0 13.0322 0 0 0 11.2297 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0V3 SH3B4_HUMAN SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein) SH3BP4 BOG25 EHB10 TTP Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; endocytosis [GO:0006897]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of GTPase activity [GO:0034260]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; cellular response to amino acid stimulus [GO:0071230]; endocytosis [GO:0006897]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of GTPase activity [GO:0034260]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790] GO:0005092; GO:0005634; GO:0005737; GO:0005905; GO:0006897; GO:0008285; GO:0010508; GO:0030136; GO:0030308; GO:0031267; GO:0032007; GO:0034260; GO:0042802; GO:0050790; GO:0061462; GO:0070062; GO:0071230 GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] ASEQAKVVRGFQLK 0.99106 -23.427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3594 0 0 0 12.4147 12.7265 0 0 0 0 13.1707 11.5232 0 0 0 0 0 0 0 11.6109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0192 0 0 0 0 0 0 11.4844 0 0 0 0 0 0 0 0 0 0 14.3078 14.5124 12.5697 0 0 0 15.5701 12.9428 0 0 0 0 0 15.2553 13.9895 0 0 0 0 0 12.9851 14.1615 14.5874 14.4781 13.1398 0 0 13.7287 14.2391 0 14.4831 0 0 0 13.7048 13.81 0 13.9257 0 14.4033 14.3415 15.3429 0 15.0989 0 0 0 13.1284 12.9364 0 13.9071 13.8412 0 0 14.0349 0 15.7477 0 13.6575 0 15.0116 0 12.6675 0 12.025 12.9941 0 15.7127 0 15.5467 13.3365 0 0 14.8414 0 0 0 0 14.7993 0 0 0 0 0 14.5373 0 14.1654 0 0 13.7991 14.9259 0 0 0 0 E5RQL4 FONG_HUMAN Formiminotransferase N-terminal subdomain-containing protein (Formiminotransferase-cyclodeaminase N-terminal-like protein) FTCDNL1 FONG Homo sapiens (Human) folic acid binding [GO:0005542]; transferase activity [GO:0016740] GO:0005542; GO:0016740 folic acid binding [GO:0005542]; transferase activity [GO:0016740] KQLGWFTRR 0.99107 -5.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43670 ZN207_HUMAN "BUB3-interacting and GLEBS motif-containing protein ZNF207, BuGZ, hBuGZ (Zinc finger protein 207)" ZNF207 BUGZ Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983] GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008608; GO:0046785; GO:0046872; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047 DNA binding [GO:0003677]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; RNA binding [GO:0003723] CHICHKK 0.99107 -4.6123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23368 MAOM_HUMAN "NAD-dependent malic enzyme, mitochondrial, NAD-ME, EC 1.1.1.38 (Malic enzyme 2)" ME2 Homo sapiens (Human) malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090]; regulation of NADP metabolic process [GO:1902031] GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0009055; GO:0043231; GO:0046872; GO:0051287; GO:1902031 electron transfer activity [GO:0009055]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948] AVVVTDGER 0.99107 -23.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8848 0 0 0 0 0 0 0 0 0 13.3606 0 0 0 12.4178 0 13.3009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1972 0 13.9781 0 13.0307 13.3504 0 0 0 0 0 0 0 13.1989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7716 0 0 0 0 0 0 14.2496 0 0 0 0 0 13.4299 0 13.8999 12.301 0 13.7557 0 13.9097 0 0 12.46 0 0 0 0 0 0 0 0 0 Q8IZC6 CORA1_HUMAN Collagen alpha-1(XXVII) chain COL27A1 KIAA1870 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte development [GO:0003431] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte development [GO:0003431] GO:0003431; GO:0005201; GO:0005576; GO:0005583; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] GDPGLSPGK 0.99107 -23.535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6882 0 0 0 0 14.7018 0 14.7398 16.2761 0 0 0 0 14.0639 11.6108 12.5378 0 11.6408 15.1635 0 0 0 0 10.5201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7732 0 15.1396 0 0 0 0 0 0 0 13.0887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7874 0 0 0 11.8727 0 0 0 0 0 0 0 0 13.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1206 0 0 0 12.6201 0 0 0 0 0 0 0 0 0 0 0 12.6302 0 0 0 0 15.1588 0 0 14.0865 0 0 0 0 0 0 0 11.8043 0 0 11.6593 0 0 0 0 0 12.4299 12.5753 0 0 0 0 12.6027 0 0 0 12.6915 0 13.1341 0 11.9201 Q8N135 LGI4_HUMAN Leucine-rich repeat LGI family member 4 (LGI1-like protein 3) (Leucine-rich glioma-inactivated protein 4) LGI4 LGIL3 UNQ6515/PRO21485 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; glial cell proliferation [GO:0014009]; myelination in peripheral nervous system [GO:0022011]; neuron maturation [GO:0042551]; regulation of myelination [GO:0031641] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; adult locomotory behavior [GO:0008344]; glial cell proliferation [GO:0014009]; myelination in peripheral nervous system [GO:0022011]; neuron maturation [GO:0042551]; regulation of myelination [GO:0031641] GO:0005576; GO:0005615; GO:0008344; GO:0014009; GO:0022011; GO:0031641; GO:0042551 FLFAACFK 0.99107 -5.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3229 0 0 12.0908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2129 0 11.9502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1763 0 0 0 0 14.212 0 0 0 0 0 0 0 0 0 0 0 0 0 B2RXF5 ZBT42_HUMAN Zinc finger and BTB domain-containing protein 42 ZBTB42 Homo sapiens (Human) muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006357; GO:0007517; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EKPHACRWCER 0.99108 -4.6356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9328 0 0 0 0 12.9489 0 0 0 0 0 0 0 0 0 0 0 14.4156 0 13.1607 0 0 0 0 0 0 0 15.2841 0 0 0 0 0 0 0 0 0 0 0 0 13.9309 0 0 0 0 0 12.9935 13.7662 0 14.4665 0 0 0 0 13.0277 0 0 0 0 0 12.5533 13.8886 0 0 0 12.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4439 13.1287 0 0 0 0 11.4401 0 0 P23443 KS6B1_HUMAN "Ribosomal protein S6 kinase beta-1, S6K-beta-1, S6K1, EC 2.7.11.1 (70 kDa ribosomal protein S6 kinase 1, P70S6K1, p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha, p70 S6 kinase alpha, p70 S6K-alpha, p70 S6KA)" RPS6KB1 STK14A Homo sapiens (Human) aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929] anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929] GO:0000082; GO:0001662; GO:0003009; GO:0004672; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0007165; GO:0007281; GO:0007568; GO:0007584; GO:0007616; GO:0009408; GO:0009410; GO:0009611; GO:0009612; GO:0009636; GO:0009749; GO:0009986; GO:0014732; GO:0014878; GO:0014911; GO:0016477; GO:0018105; GO:0030165; GO:0031667; GO:0031929; GO:0032496; GO:0032869; GO:0033574; GO:0033762; GO:0034612; GO:0042277; GO:0042802; GO:0043005; GO:0043066; GO:0043201; GO:0043491; GO:0044539; GO:0045202; GO:0045471; GO:0045727; GO:0045931; GO:0045948; GO:0046324; GO:0046627; GO:0048015; GO:0048471; GO:0048633; GO:0048661; GO:0051721; GO:0070161; GO:0071346; GO:0071363; GO:0071549; GO:0106310; GO:2001237 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] DLLKKLLK 0.99108 -4.6382 0 0 0 0 0 0 0 0 0 12.3575 12.3427 11.2646 12.6521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1081 0 12.2098 0 0 0 11.3577 0 0 0 0 0 0 0 0 10.5322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3997 13.3904 0 0 0 13.4192 13.5188 0 0 0 0 0 0 0 16.1837 15.0438 0 0 0 0 0 0 0 13.2835 0 0 0 0 0 14.5142 0 0 0 0 0 14.425 0 0 0 0 0 0 0 0 0 13.522 0 0 0 0 0 12.2559 12.0204 12.43 0 0 12.7907 0 0 0 0 0 0 12.082 0 0 0 0 0 12.7813 13.739 0 0 14.7492 0 15.0314 0 14.8804 0 14.8089 0 0 12.6782 0 0 0 0 14.3058 0 14.9371 0 0 P60321 NANO2_HUMAN "Nanos homolog 2, NOS-2" NANOS2 NOS2 Homo sapiens (Human) "germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; germ-line stem cell population maintenance [GO:0030718]; mRNA catabolic process [GO:0006402]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of translation [GO:0017148]; oogenesis [GO:0048477]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; spermatogenesis [GO:0007283]" GO:0000932; GO:0003729; GO:0005634; GO:0005737; GO:0006402; GO:0007283; GO:0008270; GO:0017148; GO:0030718; GO:0045835; GO:0048471; GO:0048477; GO:1900153 mRNA binding [GO:0003729]; zinc ion binding [GO:0008270] NSAGRRVK 0.99108 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VH5 LRRT3_HUMAN Leucine-rich repeat transmembrane neuronal protein 3 LRRTM3 UNQ803/PRO1693 Homo sapiens (Human) positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054] anchoring junction [GO:0070161]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061] anchoring junction [GO:0070161]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054] GO:0005615; GO:0031012; GO:0051965; GO:0070161; GO:0098978; GO:0099054; GO:0099061; GO:1902004 IIAGSVALFLSVLVILLVIYVSWK 0.99108 -4.767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0417 0 0 0 0 0 0 0 11.6995 0 0 0 0 0 0 0 0 0 0 0 0 12.2716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98641 0 0 0 0 0 0 0 0 13.1401 0 0 0 0 0 0 0 0 15.003 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5535 0 14.8964 0 0 0 0 0 0 15.3988 14.3869 14.5415 14.4574 0 0 11.2577 0 0 0 0 0 0 0 0 0 0 14.7925 14.8491 0 12.2395 0 14.5606 14.3151 14.413 0 14.2195 14.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5456 0 0 12.6329 12.3004 11.4617 0 0 0 0 0 0 13.1701 0 0 0 0 11.1514 0 0 0 0 11.8213 15.2538 14.7824 0 0 0 11.6684 0 Q9BRP8 PYM1_HUMAN Partner of Y14 and mago (PYM homolog 1 exon junction complex-associated factor) (Protein wibg homolog) PYM1 PYM WIBG Homo sapiens (Human) "exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" GO:0000184; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0030054; GO:0035145; GO:0043022; GO:0045727; GO:1903259 ribosome binding [GO:0043022]; RNA binding [GO:0003723] YVKFFKSK 0.99108 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H425 CA198_HUMAN Uncharacterized protein C1orf198 C1orf198 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 FPGLRGPTGQKVVR 0.99108 -5.9097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0729 0 0 0 0 0 0 0 Q9H8K7 PAAT_HUMAN "ATPase PAAT, EC 3.6.1.- (Protein associated with ABC transporters, PAAT)" PAAT C10orf88 Homo sapiens (Human) cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] GO:0005737; GO:0005739; GO:0016887; GO:0042802 ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] HYDSGER 0.99108 -20.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3869 0 0 0 0 0 0 0 0 13.0657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4119 0 0 0 12.8636 0 O75937 DNJC8_HUMAN DnaJ homolog subfamily C member 8 (Splicing protein spf31) DNAJC8 SPF31 HSPC315 HSPC331 Homo sapiens (Human) cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544] GO:0005634; GO:0005654; GO:0005829; GO:0030544; GO:0045171 Hsp70 protein binding [GO:0030544] AFEAVDK 0.99109 -21.898 0 0 0 0 0 0 0 0 0 0 0 10.0764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7714 0 0 0 0 0 0 0 0 12.9035 0 0 0 0 0 0 0 14.7991 0 0 0 12.9956 0 0 0 0 0 12.143 0 0 0 0 0 0 0 0 0 0 0 0 9.9678 0 0 0 0 0 0 0 0 0 0 14.0287 10.0764 0 0 0 14.2604 0 0 0 0 0 0 0 13.4605 0 0 0 0 0 0 0 0 13.9975 14.5867 0 0 0 0 0 0 0 0 0 11.2804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10523 ARRS_HUMAN "S-arrestin (48 kDa protein) (Retinal S-antigen, S-AG) (Rod photoreceptor arrestin)" SAG Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor internalization [GO:0002031]; rhodopsin mediated signaling pathway [GO:0016056] cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytosol [GO:0005829]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor internalization [GO:0002031]; rhodopsin mediated signaling pathway [GO:0016056] GO:0001664; GO:0001750; GO:0001917; GO:0002031; GO:0002046; GO:0004864; GO:0005829; GO:0007166; GO:0016020; GO:0016056; GO:0051219 G protein-coupled receptor binding [GO:0001664]; opsin binding [GO:0002046]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864] DAGEAEEGK 0.99109 -5.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0425 0 13.9238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5461 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5065 0 0 0 0 0 0 0 0 0 13.6402 12.399 0 0 0 0 0 0 0 0 0 0 13.8389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1803 0 0 0 0 0 0 0 13.214 0 0 0 0 0 13.5299 0 0 0 0 0 0 0 0 0 0 0 0 13.1671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P39900 MMP12_HUMAN "Macrophage metalloelastase, MME, EC 3.4.24.65 (Macrophage elastase, ME, hME) (Matrix metalloproteinase-12, MMP-12)" MMP12 HME Homo sapiens (Human) "bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]" cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; response to amyloid-beta [GO:1904645]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0000122; GO:0001046; GO:0004175; GO:0004222; GO:0004252; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1904645; GO:1904905 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] DRFFWLK 0.99109 -21.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56748 CLD8_HUMAN Claudin-8 CLDN8 UNQ779/PRO1573 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] GO:0005198; GO:0005783; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016323; GO:0016327; GO:0016338; GO:0042802; GO:0070830 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] CTRCTGDNEK 0.99109 -4.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3065 0 0 0 0 0 0 0 0 0 0 13.8098 0 0 0 0 0 0 0 0 0 0 0 14.0098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00536 CDK16_HUMAN "Cyclin-dependent kinase 16, EC 2.7.11.22 (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1)" CDK16 PCTAIRE1 PCTK1 Homo sapiens (Human) exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283] anchoring junction [GO:0070161]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; spermatogenesis [GO:0007283] GO:0000083; GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006887; GO:0007283; GO:0008021; GO:0010508; GO:0015630; GO:0030252; GO:0031175; GO:0031234; GO:0043005; GO:0061178; GO:0070161; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GKSKLTDNLVALK 0.99109 -4.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9643 0 0 0 0 0 0 0 13.1958 0 0 15.5866 0 0 0 0 0 0 0 0 0 0 15.5107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14324 MYPC2_HUMAN "Myosin-binding protein C, fast-type, Fast MyBP-C (C-protein, skeletal muscle fast isoform)" MYBPC2 MYBPCF Homo sapiens (Human) cell adhesion [GO:0007155] cytosol [GO:0005829]; myosin filament [GO:0032982] cytosol [GO:0005829]; myosin filament [GO:0032982]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell adhesion [GO:0007155] GO:0003779; GO:0005829; GO:0007155; GO:0008307; GO:0032982 actin binding [GO:0003779]; structural constituent of muscle [GO:0008307] ADKKTMEWFNVYER 0.99109 -19.122 0 14.1698 0 0 0 0 0 0 0 0 0 0 13.5386 12.7604 0 0 0 12.7411 0 14.4156 0 0 0 14.5895 0 12.7571 0 0 0 0 0 0 17.1469 0 0 0 0 16.6796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5465 0 17.3491 0 16.473 0 0 0 0 0 11.4498 0 0 0 0 0 12.7051 0 0 0 0 0 14.1335 0 0 0 0 0 0 0 13.151 12.9897 13.4549 0 0 0 0 0 13.4682 0 0 0 0 0 13.3497 0 0 0 0 0 0 0 0 0 0 0 0 13.3055 0 0 0 13.9111 0 0 0 0 0 0 13.9382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0276 0 13.924 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3687 0 13.6768 15.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3785 0 Q15928 ZN141_HUMAN Zinc finger protein 141 ZNF141 D4S90 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; limb morphogenesis [GO:0035108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; limb morphogenesis [GO:0035108]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0006366; GO:0009653; GO:0035108; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EPYNVKIHK 0.99109 -21.345 0 0 0 0 0 0 0 10.2854 0 0 0 0 0 0 0 0 0 0 0 16.5815 0 0 0 0 0 0 0 0 16.8378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9767 0 16.9722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7258 0 0 0 10.1809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2418 10.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2162 0 0 0 0 0 0 0 13.2474 0 0 0 11.7674 0 0 0 0 13.1914 0 0 0 0 0 0 15.1857 0 0 0 0 0 12.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.485 0 0 0 0 0 0 0 0 0 Q3ZCT8 KBTBC_HUMAN Kelch repeat and BTB domain-containing protein 12 (Kelch domain-containing protein 6) KBTBD12 KLHDC6 Homo sapiens (Human) EESILDLVLRWVNHNKELR 0.99109 -5.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4284 0 0 0 0 0 0 0 0 0 0 12.2143 0 0 13.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7977 0 0 0 0 13.7794 0 0 14.4853 0 0 13.5069 0 0 0 0 0 12.2036 0 0 10.7581 0 0 15.161 15.2958 0 0 0 0 12.9902 0 0 12.9866 0 0 0 14.8239 0 0 15.1775 14.7147 14.1876 0 13.721 15.6951 15.2571 16.525 14.6163 0 0 0 0 14.4995 15.3924 14.3446 13.7374 0 14.9476 0 0 0 0 0 14.6904 0 14.7331 0 0 14.8223 14.4318 14.8678 0 14.5793 0 0 0 0 14.4684 0 0 0 0 0 0 14.6004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UX71 PXDC2_HUMAN Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein) PLXDC2 TEM7R UNQ2514/PRO6003 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CGPCVSSQIGFNCSWCSK 0.99109 -21.917 0 0 0 0 0 0 0 0 12.7437 13.1948 13.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4211 13.5833 11.7707 0 12.6273 0 13.3465 0 11.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1283 0 0 0 12.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9856 0 0 12.905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7272 0 0 0 0 0 14.0307 14.2155 12.8776 15.2067 0 0 13.4735 0 0 14.2671 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVT2 MISP_HUMAN Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein) MISP C19orf21 Homo sapiens (Human) cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776] actin filament [GO:0005884]; cell cortex [GO:0005938]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616] actin filament [GO:0005884]; cell cortex [GO:0005938]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; actin filament binding [GO:0051015]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic spindle assembly [GO:0090307]; organelle localization [GO:0051640]; regulation of protein localization to cell cortex [GO:1904776] GO:0000132; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0016477; GO:0031616; GO:0043231; GO:0051015; GO:0051301; GO:0051640; GO:0051660; GO:0090307; GO:1904776 actin filament binding [GO:0051015] AQQGVQRQGVSYSVHAYTGQPSPR 0.99109 -4.6626 15.4427 16.3417 16.038 14.8718 15.8886 15.7105 16.0288 16.7054 0 0 0 12.7316 13.633 0 0 0 0 0 0 0 0 15.8761 0 15.7128 0 0 0 0 11.07 0 0 0 0 13.8623 13.1463 0 0 0 0 12.9808 0 13.183 0 0 0 0 0 0 0 0 0 0 0 13.474 0 0 13.4018 13.1922 0 12.2799 0 0 0 0 12.1674 0 16.3704 16.3138 16.2411 16.3966 16.3662 16.461 15.635 15.2227 15.0064 18.684 18.7003 18.6623 13.9834 13.9645 18.0608 22.6389 22.8668 22.5606 21.399 20.4142 0 19.9411 13.2494 20.8538 14.9507 15.1419 15.8186 15.1764 20.0053 20.6865 21.5128 14.5003 20.2824 19.0725 19.0295 18.567 19.261 20.3746 19.7937 19.6434 18.8989 18.0775 17.5194 17.1414 17.3749 19.8058 21.0113 20.1074 19.6129 0 18.4442 0 18.3937 18.8728 0 20.4513 14.8428 20.8942 0 18.019 20.8341 20.6042 20.2532 19.8386 19.979 19.0303 19.9465 19.6407 14.6257 15.0108 0 19.8676 19.9572 18.1196 19.0837 19.9392 19.5466 19.099 0 18.8811 18.5772 11.6512 0 0 18.2597 0 18.107 20.4745 20.4279 0 0 0 0 0 0 0 13.8286 0 0 0 0 13.7447 0 0 0 14.8259 16.1934 14.8246 14.9711 0 14.118 0 0 0 Q8NE79 POPD1_HUMAN "Blood vessel epicardial substance, hBVES (Popeye domain-containing protein 1, Popeye protein 1)" BVES POP1 POPDC1 Homo sapiens (Human) cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; structural molecule activity [GO:0005198]; cell migration involved in heart development [GO:0060973]; epithelial cell-cell adhesion [GO:0090136]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of endocytic recycling [GO:2001135]; regulation of GTPase activity [GO:0043087]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; response to ischemia [GO:0002931]; sinoatrial node cell development [GO:0060931]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking [GO:0048278]; vesicle-mediated transport [GO:0016192] GO:0001921; GO:0002027; GO:0002244; GO:0002931; GO:0005198; GO:0005886; GO:0005901; GO:0005923; GO:0007507; GO:0007517; GO:0007519; GO:0008360; GO:0016021; GO:0016192; GO:0016328; GO:0030054; GO:0030552; GO:0031253; GO:0034446; GO:0040017; GO:0042383; GO:0042391; GO:0043087; GO:0048278; GO:0051146; GO:0060931; GO:0060973; GO:0090136; GO:2001135 cAMP binding [GO:0030552]; structural molecule activity [GO:0005198] ELSGMYR 0.99109 -19.114 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1968 0 0 0 0 0 Q8NGK1 O51G1_HUMAN Olfactory receptor 51G1 (Olfactory receptor 51G3) (Olfactory receptor OR11-29) OR51G1 OR51G3P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KFQFIKSLR 0.99109 -5.9216 0 0 11.6269 0 0 0 15.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0018 11.9532 0 0 0 0 0 0 0 0 15.159 0 0 0 12.9535 0 11.1208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.664 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8095 0 0 0 13.4261 0 0 0 0 0 13.8149 15.6235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4671 0 0 0 0 0 0 0 0 0 Q8WZA0 LZIC_HUMAN Protein LZIC (Leucine zipper and CTNNBIP1 domain-containing protein) (Leucine zipper and ICAT homologous domain-containing protein) LZIC Homo sapiens (Human) beta-catenin binding [GO:0008013] GO:0008013 beta-catenin binding [GO:0008013] EELDTDEYEETK 0.99109 -19.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.355 0 0 0 0 0 0 0 0 11.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5942 0 0 0 0 0 0 12.9431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5387 0 0 0 0 12.7797 0 0 0 0 11.1645 0 0 0 0 Q9P253 VPS18_HUMAN "Vacuolar protein sorting-associated protein 18 homolog, hVPS18" VPS18 KIAA1475 Homo sapiens (Human) autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; protein ubiquitination [GO:0016567]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718] actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynapse [GO:0098793] actin filament [GO:0005884]; AP-3 adaptor complex [GO:0030123]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; presynapse [GO:0098793]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; organelle fusion [GO:0048284]; protein ubiquitination [GO:0016567]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle exocytosis [GO:2000300]; vacuole organization [GO:0007033]; vesicle docking involved in exocytosis [GO:0006904]; viral entry into host cell [GO:0046718] GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0005884; GO:0006886; GO:0006904; GO:0006914; GO:0007032; GO:0007033; GO:0007040; GO:0008333; GO:0016567; GO:0019905; GO:0030123; GO:0030136; GO:0030674; GO:0030897; GO:0031902; GO:0033147; GO:0033263; GO:0034058; GO:0035542; GO:0046718; GO:0046872; GO:0048284; GO:0061630; GO:0098793; GO:0098978; GO:2000300 actin binding [GO:0003779]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; syntaxin binding [GO:0019905]; ubiquitin protein ligase activity [GO:0061630] EAICSSLK 0.99109 -21.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8313 17.2495 0 0 0 17.3151 16.6141 0 0 0 0 17.7273 14.5814 0 0 0 0 0 0 0 0 0 0 14.8698 0 0 17.4809 0 0 0 0 0 0 0 0 0 14.2323 0 0 0 0 0 0 0 0 0 12.3161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2134 0 13.1479 0 0 0 0 0 0 12.9021 0 13.1016 0 0 0 0 0 0 0 0 0 13.0116 0 0 O14639 ABLM1_HUMAN "Actin-binding LIM protein 1, abLIM-1 (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin)" ABLIM1 ABLIM KIAA0059 LIMAB1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; visual perception [GO:0007601] GO:0001725; GO:0003779; GO:0005737; GO:0007010; GO:0007601; GO:0009887; GO:0015629; GO:0030027; GO:0030032; GO:0046872; GO:0051015; GO:0060271 actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872] CKSCGKVLTGEYISK 0.9911 -5.9462 0 0 0 0 0 0 0 0 0 0 0 13.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6595 0 11.7936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2182 0 0 0 0 0 0 0 0 12.4594 15.7444 0 15.1371 0 0 0 0 14.5264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0428 0 0 0 0 0 0 0 14.0276 0 0 12.7766 0 0 0 0 0 0 0 17.5468 0 12.9312 0 0 0 0 0 0 0 0 0 0 0 12.7293 0 0 0 0 0 0 0 12.1083 0 0 13.9302 0 0 0 0 0 0 0 0 0 0 0 12.8329 0 0 0 0 0 0 0 0 0 13.3085 0 12.3695 0 0 12.6592 0 P22492 H1T_HUMAN Histone H1t (Testicular H1 histone) H1-6 H1FT H1T HIST1H1T Homo sapiens (Human) cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283] nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; spermatogenesis [GO:0007283] GO:0000786; GO:0003690; GO:0005634; GO:0006334; GO:0007283; GO:0030154; GO:0030261; GO:0030527; GO:0031492; GO:0045910 double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527] KLVLSRDSK 0.9911 -21.366 13.3903 0 13.2567 0 0 16.9644 16.9195 0 0 0 0 12.1911 0 0 0 12.5538 0 0 0 0 0 0 12.3175 0 0 12.0791 12.3136 0 0 0 0 0 13.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1582 0 0 0 0 0 0 0 0 13.9899 0 0 14.6978 13.8744 0 0 0 0 0 0 0 0 0 0 P23677 IP3KA_HUMAN "Inositol-trisphosphate 3-kinase A, EC 2.7.1.127 (Inositol 1,4,5-trisphosphate 3-kinase A, IP3 3-kinase A, IP3K A, InsP 3-kinase A)" ITPKA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to calcium ion [GO:0071277]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cellular response to calcium ion [GO:0071277]; dendritic spine maintenance [GO:0097062]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; signal transduction [GO:0007165]" GO:0000828; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006020; GO:0007165; GO:0008440; GO:0016301; GO:0016310; GO:0030036; GO:0031267; GO:0032958; GO:0043197; GO:0046854; GO:0048167; GO:0051592; GO:0061003; GO:0071277; GO:0097062 "ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; small GTPase binding [GO:0031267]" DCLPAAGSSHLQQPRR 0.9911 -19.202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5861 0 0 0 0 0 0 0 0 0 0 0 0 P49685 GPR15_HUMAN "G-protein coupled receptor 15 (Brother of Bonzo, BoB)" GPR15 Homo sapiens (Human) angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; T cell migration [GO:0072678]; viral entry into host cell [GO:0046718] cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; T cell migration [GO:0072678]; viral entry into host cell [GO:0046718] GO:0001525; GO:0001618; GO:0004930; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0015026; GO:0046718; GO:0072678 coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; virus receptor activity [GO:0001618] ATPIKLIWSLVALIFTFFVPLLSIVTCYCCIARK 0.9911 -5.942 0 0 0 0 0 0 0 0 12.055 11.8501 0 0 0 0 0 0 13.8447 0 0 0 0 0 0 0 0 0 0 0 0 13.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8086 0 0 0 0 0 0 13.6269 0 12.4925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7609 0 0 0 0 0 0 0 0 0 12.9269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1721 0 0 0 0 0 0 0 0 0 13.0174 0 0 0 0 13.1995 0 0 0 0 0 0 0 0 0 12.8909 0 0 0 0 0 0 13.3641 12.9614 0 0 0 12.2839 0 12.6915 0 9.78908 0 0 0 0 0 0 0 13.7408 0 12.5464 0 0 Q5SZK8 FREM2_HUMAN FRAS1-related extracellular matrix protein 2 (ECM3 homolog) FREM2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009] GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0016021; GO:0042733; GO:0046872; GO:0048839; GO:0062023; GO:0070062 metal ion binding [GO:0046872] DFKGKAQK 0.9911 -4.7987 0 0 0 0 0 0 0 0 13.7949 11.8073 0 0 0 0 0 12.988 0 0 0 0 0 0 0 11.1613 0 0 0 0 0 0 16.5988 0 0 0 0 0 0 12.751 0 12.3599 11.3468 0 0 0 0 0 0 0 0 0 0 0 12.2319 12.2546 0 11.2037 11.8507 13.1296 0 0 0 0 0 0 0 0 15.1193 16.1577 16.3702 16.6271 15.5336 0 13.9222 14.2389 14.9969 13.7667 0 13.8115 0 0 0 11.9246 0 0 16.3433 0 0 0 12.7734 0 13.2681 12.8405 0 15.0503 12.5718 14.9638 0 0 12.8944 14.0324 13.5949 15.1926 0 0 12.0827 13.5778 13.5535 13.7337 14.8645 14.9589 14.0084 0 14.7071 0 13.4553 15.2349 13.6311 0 15.1251 0 13.6507 0 14.5797 13.281 13.3271 0 14.1291 14.1764 0 14.8179 11.6528 0 13.474 0 14.0437 0 16.0726 14.3982 14.5155 15.1497 13.0276 0 13.1914 14.1209 0 12.923 0 0 0 0 0 0 0 14.5948 14.5391 15.0371 18.7883 10.7926 0 12.2902 0 14.6189 0 0 0 14.7294 0 0 0 0 0 11.1373 0 0 12.7879 0 0 0 12.6377 0 Q86XP3 DDX42_HUMAN "ATP-dependent RNA helicase DDX42, EC 3.6.4.13 (DEAD box protein 42) (RNA helicase-like protein, RHELP) (RNA helicase-related protein, RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein, SF3b125)" DDX42 Homo sapiens (Human) protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008104; GO:0015030; GO:0016020; GO:0016607; GO:0016887; GO:0042981 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] FKGGKGK 0.9911 -23.357 12.9495 16.6115 13.9874 0 0 0 0 0 0 11.4189 0 0 0 13.2525 0 0 13.6306 10.8002 13.7243 10.6067 0 0 14.1658 0 14.2995 13.9169 13.4807 0 13.6979 0 0 0 0 0 0 0 0 0 0 14.0162 13.9937 0 11.4202 13.8731 14.1173 0 0 0 11.8855 0 0 11.399 10.6217 10.7546 0 0 13.7846 13.7522 13.691 13.7044 0 12.9011 13.278 0 13.1801 12.5775 16.7457 12.0478 13.1941 10.4628 0 0 0 0 0 13.0048 0 0 0 0 0 13.403 13.6246 0 0 0 0 14.2623 12.9722 12.6521 0 12.4355 0 0 12.4721 13.5475 13.1074 0 16.4781 0 0 12.0346 0 0 13.0853 12.0739 15.3161 13.6989 0 13.3922 12.1316 0 13.0766 13.0622 13.4118 0 14.3105 13.7376 12.8831 14.0326 12.3036 0 0 0 12.1428 0 13.1538 0 14.1 0 16.9147 0 13.3538 0 0 0 0 0 13.4521 0 0 0 11.7724 11.4709 13.4846 0 0 12.1956 0 12.9177 0 13.2737 0 0 12.2969 13.794 12.8188 14.9792 0 12.5058 14.4513 14.5699 12.517 12.6168 0 14.7936 14.9638 14.7681 13.4075 14.7125 14.6417 0 20.7684 0 0 14.623 0 0 0 0 Q9BZE9 ASPC1_HUMAN Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9) ASPSCR1 ASPL RCC17 TUG UBXD9 UBXN9 Homo sapiens (Human) glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0019898; GO:0031401; GO:0033116; GO:0042593; GO:0043231; GO:0046324; GO:0048471 DPQQEQER 0.9911 -21.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5162 0 0 0 0 0 0 0 0 0 12.2856 0 0 0 0 0 0 0 0 0 0 0 0 13.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1517 0 0 0 0 0 0 0 0 0 0 14.0894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C056 NKX62_HUMAN Homeobox protein Nkx-6.2 (Homeobox protein NK-6 homolog B) NKX6-2 GTX NKX6B Homo sapiens (Human) "cell differentiation [GO:0030154]; central nervous system myelination [GO:0022010]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron fate commitment [GO:0048663]; pancreatic A cell differentiation [GO:0003310]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; central nervous system myelination [GO:0022010]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuron fate commitment [GO:0048663]; pancreatic A cell differentiation [GO:0003310]; positive regulation of cell fate commitment [GO:0010455]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003310; GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0010454; GO:0010455; GO:0022010; GO:0030154; GO:0031641; GO:0045892; GO:0048663; GO:0048714; GO:0048715; GO:0050885; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ITRLLKK 0.9911 -5.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.49 12.4765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2T0 THEG_HUMAN "Testicular haploid expressed gene protein (Cancer/testis antigen 56, CT56)" THEG Homo sapiens (Human) cell differentiation [GO:0030154]; chaperone-mediated protein complex assembly [GO:0051131]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; cell differentiation [GO:0030154]; chaperone-mediated protein complex assembly [GO:0051131]; spermatogenesis [GO:0007283] GO:0005634; GO:0007283; GO:0030154; GO:0051131 GYAWISPCK 0.9911 -21.44 0 0 0 0 0 0 13.3088 0 0 0 0 0 0 0 0 0 12.2759 0 13.9817 0 0 0 0 0 0 15.0111 11.3217 0 0 0 13.3346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.51076 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2505 0 14.5585 14.5062 13.7659 0 0 0 0 14.8522 13.3096 15.2261 0 14.8643 0 0 13.8959 14.6151 0 0 0 15.142 0 15.6134 15.2209 15.1007 0 0 0 0 15.9312 13.2822 0 0 14.4775 14.6633 0 13.3177 0 0 15.6656 13.252 0 13.2812 14.2944 14.934 0 0 0 15.0626 0 12.9431 0 13.8558 15.4594 0 0 14.3861 14.9796 0 13.6214 15.4184 12.928 0 15.0003 12.2643 0 14.0321 13.3187 14.0853 0 12.9037 0 12.803 0 14.0802 12.6639 12.7449 0 0 0 0 14.1134 0 0 14.9272 13.3473 0 0 0 0 0 0 0 0 0 0 13.4248 0 0 0 12.875 0 12.9147 0 14.8579 14.8072 0 0 11.8081 12.1179 0 Q9UJM8 HAOX1_HUMAN "2-Hydroxyacid oxidase 1, HAOX1, EC 1.1.3.15 (Glycolate oxidase, GO, GOX) (Glyoxylate oxidase, EC 1.2.3.5)" HAO1 GOX1 Homo sapiens (Human) fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969]; fatty acid alpha-oxidation [GO:0001561]; glycine biosynthetic process [GO:0006545]; glycolate catabolic process [GO:0046296]; response to oxidative stress [GO:0006979] GO:0001561; GO:0003973; GO:0005777; GO:0005782; GO:0005829; GO:0006545; GO:0006979; GO:0010181; GO:0046296; GO:0047969 (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; glyoxylate oxidase activity [GO:0047969] KLVRQAEK 0.9911 -23.338 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1481 0 0 0 0 0 0 16.8912 15.8062 15.9685 0 0 0 0 0 0 0 0 0 0 0 13.3667 0 13.9045 0 0 0 0 10.883 0 0 0 0 0 0 0 14.0191 0 0 0 0 0 0 12.4561 0 0 15.0344 0 0 0 14.3446 0 0 0 14.1269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1559 0 0 0 0 0 0 0 0 0 0 15.1592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4254 0 0 0 0 0 0 14.6021 0 A0A1B0GVX0 LITAD_HUMAN LITAF domain-containing protein (LITAF-like protein) LITAFD Homo sapiens (Human) regulation of cytokine production [GO:0001817] cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; nucleus [GO:0005634] cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; regulation of cytokine production [GO:0001817] GO:0001817; GO:0005634; GO:0008270; GO:0098560; GO:0098574 zinc ion binding [GO:0008270] ELFYYHR 0.99111 -4.8171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B3KS81 SRRM5_HUMAN Serine/arginine repetitive matrix protein 5 SRRM5 ZNF576 Homo sapiens (Human) PPGGSGIGR 0.99111 -23.415 10.2758 0 0 0 0 0 9.73753 0 0 0 0 0 0 0 12.0637 0 0 0 0 0 0 0 10.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91148 0 0 0 0 0 0 11.2006 0 0 0 0 0 0 10.846 0 0 0 0 0 0 11.9303 0 13.8159 0 0 11.1732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7538 0 0 12.4253 0 0 0 0 0 11.8847 0 0 0 0 0 0 11.5419 0 0 13.8009 0 0 0 0 0 0 0 0 0 0 12.7765 0 11.627 0 0 0 0 0 0 0 12.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7713 0 0 0 0 0 12.7635 0 0 0 13.025 0 0 0 0 0 0 10.8169 0 0 0 0 0 11.2313 0 0 0 0 0 0 0 0 0 11.6107 0 14.3539 O60518 RNBP6_HUMAN "Ran-binding protein 6, RanBP6" RANBP6 Homo sapiens (Human) protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein import into nucleus [GO:0006606] GO:0005634; GO:0005737; GO:0006606; GO:0008139; GO:0061608 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] HIVELAVQKELKLLR 0.99111 -21.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.691 0 0 0 0 11.002 0 15.5509 0 0 0 0 0 0 0 0 0 0 0 0 14.0344 13.6196 15.3584 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9062 0 0 10.2203 0 0 0 0 10.3057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7522 0 0 0 10.1924 0 11.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0988 0 O15394 NCAM2_HUMAN "Neural cell adhesion molecule 2, N-CAM-2, NCAM-2" NCAM2 NCAM21 Homo sapiens (Human) axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608] GO:0005886; GO:0007158; GO:0007413; GO:0007608; GO:0016021; GO:0016604; GO:0030424; GO:0042802; GO:0043005 identical protein binding [GO:0042802] EALNPETIEIK 0.99112 -5.9627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5453 0 0 0 0 0 0 0 15.7089 14.8951 13.4911 0 0 0 13.6832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8528 13.9959 0 0 0 0 0 0 0 0 0 0 13.5416 0 0 14.2143 0 13.0669 13.3019 0 0 0 0 0 0 0 0 0 0 0 0 13.2856 0 0 0 0 0 13.2057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8171 0 0 0 0 0 0 0 Q96EL3 RM53_HUMAN "39S ribosomal protein L53, mitochondrial, L53mt, MRP-L53 (Mitochondrial large ribosomal subunit protein mL53)" MRPL53 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005762; GO:0032543 LGLRPVKQVR 0.99112 -4.8518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5734 0 13.133 13.0563 0 0 0 0 0 0 13.3362 0 0 0 13.2179 13.116 0 12.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4405 13.019 0 0 0 0 0 0 0 0 0 0 0 12.5256 13.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVX2 T106C_HUMAN Transmembrane protein 106C (Endoplasmic reticulum membrane protein overexpressed in cancer) TMEM106C EMOC Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 QDSLVILTIMATLKIR 0.99112 -5.9602 0 0 0 0 0 10.9866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28908 TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30) TNFRSF8 CD30 D1S166E Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165] GO:0004888; GO:0005737; GO:0005886; GO:0007165; GO:0008285; GO:0016021; GO:0032759; GO:0032760; GO:0043065; GO:0070062; GO:0071260 transmembrane signaling receptor activity [GO:0004888] AELPEGR 0.99113 -4.8538 0 0 0 0 0 0 0 0 14.8628 0 0 0 11.6044 0 10.7055 11.283 0 0 0 0 0 0 0 0 0 11.1504 0 0 0 0 0 0 0 0 0 10.5994 0 0 0 0 0 0 0 0 0 0 0 0 13.0717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9924 0 14.3467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5069 14.0336 0 13.0658 0 13.9992 0 0 12.7374 0 0 0 0 0 0 13.528 0 0 0 12.9669 0 11.9241 12.7875 12.1831 13.1392 0 0 0 0 0 12.8374 0 12.9701 12.9386 0 16.8162 0 0 0 0 0 0 0 0 0 0 13.2862 0 0 12.4223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0892 0 0 0 0 11.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P4I2 WDR73_HUMAN WD repeat-containing protein 73 WDR73 HSPC264 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; negative regulation of apoptotic process [GO:0043066]; nucleus organization [GO:0006997] cleavage furrow [GO:0032154]; cytosol [GO:0005829]; spindle pole [GO:0000922] cleavage furrow [GO:0032154]; cytosol [GO:0005829]; spindle pole [GO:0000922]; cytoplasmic microtubule organization [GO:0031122]; negative regulation of apoptotic process [GO:0043066]; nucleus organization [GO:0006997] GO:0000922; GO:0005829; GO:0006997; GO:0031122; GO:0032154; GO:0043066 HGGFSDR 0.99113 -4.5988 0 0 0 0 0 0 0 0 12.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8507 0 0 0 0 15.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N554 ZN276_HUMAN "Zinc finger protein 276, Zfp-276 (Zinc finger protein 477)" ZNF276 CENP-Z ZFP276 ZNF477 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; kinetochore [GO:0000776]; nucleus [GO:0005634] chromosome [GO:0005694]; kinetochore [GO:0000776]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000776; GO:0005634; GO:0005694; GO:0006357; GO:0008270; GO:0043035; GO:1990837 chromatin insulator sequence binding [GO:0043035]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] AETELDFACDQCGR 0.99113 -22.466 0 0 0 0 0 0 12.1693 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9801 0 11.8729 10.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4531 0 0 0 13.2858 0 13.6992 16.9201 0 0 0 0 0 0 0 0 0 0 0 0 14.3209 0 0 0 0 0 0 0 14.8252 15.3471 13.4741 0 14.2142 0 0 0 13.9779 0 14.0947 0 12.2983 12.9569 15.5882 0 0 11.9405 0 13.6279 0 0 0 0 0 15.3059 10.1628 0 0 0 0 0 11.0016 0 0 0 0 12.4513 0 0 0 0 0 13.818 0 0 0 0 0 0 13.4598 0 14.0879 0 0 0 0 0 0 12.0953 11.7174 0 0 0 0 14.2311 0 0 0 0 0 13.5536 0 14.4842 0 0 0 0 Q9H0S4 DDX47_HUMAN "Probable ATP-dependent RNA helicase DDX47, EC 3.6.4.13 (DEAD box protein 47)" DDX47 Homo sapiens (Human) extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016020; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] IEHLIGKK 0.99113 -5.5519 0 0 0 0 11.6678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5579 15.4661 14.8433 0 14.2044 15.1229 0 15.3667 0 0 14.2526 0 0 0 13.2139 0 0 0 13.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71603 0 0 0 0 0 13.4396 0 0 0 0 0 12.8885 0 0 0 0 0 15.047 0 0 0 0 13.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14972 VP26C_HUMAN Vacuolar protein sorting-associated protein 26C (Down syndrome critical region protein 3) (Down syndrome critical region protein A) VPS26C DCRA DSCR3 DSCRA Homo sapiens (Human) endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886] endosome [GO:0005768]; nucleus [GO:0005634] endosome [GO:0005768]; nucleus [GO:0005634]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886] GO:0005634; GO:0005768; GO:0006886; GO:0032456 ALLPKFLLR 0.99114 -5.5595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2887 0 0 0 0 0 0 0 12.5035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.484 13.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.42 0 0 0 0 0 O60303 KATIP_HUMAN Katanin-interacting protein KATNIP KIAA0556 Homo sapiens (Human) cerebrospinal fluid circulation [GO:0090660] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; cerebrospinal fluid circulation [GO:0090660] GO:0005615; GO:0005737; GO:0005856; GO:0042995; GO:0090660 EAEEALRRSSR 0.99114 -5.5574 0 0 0 0 0 0 0 0 0 0 0 16.0763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.818 0 0 0 0 0 0 12.6871 12.4541 16.0221 12.5206 0 0 15.6557 0 0 0 0 14.1976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2003 0 0 0 0 0 0 0 0 0 0 P01178 NEU1_HUMAN "Oxytocin-neurophysin 1, OT-NPI [Cleaved into: Oxytocin (Ocytocin); Neurophysin 1 ]" OXT OT Homo sapiens (Human) drinking behavior [GO:0042756]; eating behavior [GO:0042755]; female pregnancy [GO:0007565]; grooming behavior [GO:0007625]; heart development [GO:0007507]; hyperosmotic salinity response [GO:0042538]; male mating behavior [GO:0060179]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; memory [GO:0007613]; negative regulation of blood pressure [GO:0045776]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of urine volume [GO:0035811]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of female receptivity [GO:0045925]; positive regulation of hindgut contraction [GO:0060450]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of ossification [GO:0045778]; positive regulation of penile erection [GO:0060406]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of heart rate [GO:0002027]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to amphetamine [GO:0001975]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ether [GO:0045472]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to prostaglandin E [GO:0034695]; response to retinoic acid [GO:0032526]; response to sucrose [GO:0009744]; signal transduction [GO:0007165]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; terminal bouton [GO:0043195] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; terminal bouton [GO:0043195]; neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; oxytocin receptor binding [GO:0031855]; drinking behavior [GO:0042756]; eating behavior [GO:0042755]; female pregnancy [GO:0007565]; grooming behavior [GO:0007625]; heart development [GO:0007507]; hyperosmotic salinity response [GO:0042538]; male mating behavior [GO:0060179]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; memory [GO:0007613]; negative regulation of blood pressure [GO:0045776]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of urine volume [GO:0035811]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of female receptivity [GO:0045925]; positive regulation of hindgut contraction [GO:0060450]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of ossification [GO:0045778]; positive regulation of penile erection [GO:0060406]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of heart rate [GO:0002027]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to amphetamine [GO:0001975]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ether [GO:0045472]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to prostaglandin E [GO:0034695]; response to retinoic acid [GO:0032526]; response to sucrose [GO:0009744]; signal transduction [GO:0007165]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713] GO:0001975; GO:0002027; GO:0002125; GO:0005184; GO:0005185; GO:0005576; GO:0005615; GO:0007165; GO:0007204; GO:0007507; GO:0007565; GO:0007613; GO:0007625; GO:0009744; GO:0010701; GO:0014823; GO:0030141; GO:0030431; GO:0031855; GO:0032094; GO:0032308; GO:0032355; GO:0032526; GO:0032570; GO:0034695; GO:0035176; GO:0035811; GO:0035815; GO:0042220; GO:0042538; GO:0042711; GO:0042713; GO:0042755; GO:0042756; GO:0043195; GO:0043434; GO:0045472; GO:0045776; GO:0045777; GO:0045778; GO:0045925; GO:0050806; GO:0051384; GO:0051591; GO:0051602; GO:0051930; GO:0051965; GO:0060179; GO:0060406; GO:0060450; GO:0060455; GO:0070474; GO:0120162 neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; oxytocin receptor binding [GO:0031855] ACGSGGRCAVLGLCCSPDGCHADPACDAEATFSQR 0.99114 -4.6027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3264 0 0 0 11.4799 0 0 0 15.8644 0 0 0 17.0473 0 0 0 0 0 0 0 0 0 16.8863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3669 0 0 0 0 0 16.262 0 0 0 0 0 0 12.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P38159 RBMX_HUMAN "RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G, hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed ]" RBMX HNRPG RBMXP1 Homo sapiens (Human) "cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]" catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530] "catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded RNA binding [GO:0003727]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]" GO:0000381; GO:0000398; GO:0000791; GO:0000978; GO:0001649; GO:0003682; GO:0003723; GO:0003727; GO:0003729; GO:0005615; GO:0005634; GO:0005654; GO:0005681; GO:0006366; GO:0006376; GO:0006509; GO:0016020; GO:0019904; GO:0032991; GO:0042802; GO:0044530; GO:0045944; GO:0048025; GO:0048026; GO:0051260; GO:0070062; GO:0071013; GO:0071347; GO:1990904 chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded RNA binding [GO:0003727] DDGYSTKDSYSSRDYPSSR 0.99114 -19.113 0 0 0 0 0 0 10.8833 0 0 0 0 0 11.7909 0 0 0 0 0 13.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5525 13.2488 0 0 0 12.1338 0 14.1421 0 0 0 0 0 0 0 0 14.1794 0 0 0 0 0 0 0 0 13.1891 0 13.3222 13.3857 0 14.7214 14.4211 10.7882 0 0 0 0 0 0 0 0 14.1131 13.998 15.1245 13.0625 13.9448 0 0 0 0 14.007 0 13.8712 0 0 0 13.3137 13.3613 0 13.3299 0 0 0 13.7797 0 0 13.0843 0 14.0355 0 13.2118 0 0 12.8019 12.9019 0 0 14.5218 0 0 0 13.3737 13.6385 13.3606 12.8309 0 0 0 0 0 0 0 0 0 12.4564 0 0 0 13.7031 0 13.4991 12.2908 0 0 14.6292 0 0 Q5VVS0 CA140_HUMAN Putative uncharacterized protein C1orf140 C1orf140 Homo sapiens (Human) IITPYTPPR 0.99114 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3V4 UBE3B_HUMAN "Ubiquitin-protein ligase E3B, EC 2.3.2.26 (HECT-type ubiquitin transferase E3B)" UBE3B Homo sapiens (Human) protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0006511; GO:0061630 ubiquitin protein ligase activity [GO:0061630] AQLILQYIPHVIPHK 0.99114 -21.932 0 0 0 0 0 0 0 0 11.0544 10.2783 0 11.2147 0 10.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2862 11.1113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1072 0 13.1241 0 13.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 11.523 0 0 0 10.2615 0 0 0 0 0 0 0 0 0 0 0 0 12.675 0 0 0 13.0508 0 12.9371 0 0 0 12.9689 12.7028 0 0 12.5025 0 11.8444 0 12.8819 0 12.4797 12.6514 11.3028 0 13.2086 13.2826 0 0 0 0 0 0 12.316 0 0 0 13.1613 12.7396 0 0 13.0215 0 0 0 14.7792 16.1246 16.0643 0 0 12.8492 0 0 0 14.3665 0 0 0 0 0 0 0 0 0 11.905 0 0 0 0 0 0 0 0 0 0 0 12.157 0 11.5057 0 0 0 0 0 0 0 11.9388 0 0 0 14.3714 Q86WX3 AROS_HUMAN "Active regulator of SIRT1 (40S ribosomal protein S19-binding protein 1, RPS19-binding protein 1, S19BP)" RPS19BP1 AROS Homo sapiens (Human) cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; enzyme binding [GO:0019899]; RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0019899 enzyme binding [GO:0019899]; RNA binding [GO:0003723] AIQAQKLRNSAK 0.99114 -21.909 0 0 0 0 0 11.3776 0 0 0 0 0 0 0 12.6686 0 0 0 0 0 0 0 13.5106 0 13.3082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7174 0 0 0 0 13.8943 0 0 0 16.7904 16.1328 15.3113 14.85 15.7272 13.8862 16.0479 14.7321 0 0 0 0 0 14.4919 0 0 16.9613 0 14.1837 13.0119 0 0 14.5467 0 0 14.4085 14.3829 14.1815 0 14.6175 0 0 12.6881 0 0 0 0 14.2344 11.8334 14.4152 14.3913 0 0 0 14.2658 0 13.3404 0 0 0 14.7166 0 0 0 0 13.941 0 0 0 0 0 0 0 0 0 0 0 12.9858 0 14.1796 0 0 0 13.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0691 0 0 0 0 0 0 0 Q9NRJ4 TULP4_HUMAN Tubby-related protein 4 (Tubby superfamily protein) (Tubby-like protein 4) TULP4 KIAA1397 TUBL4 TUSP Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein ubiquitination [GO:0016567] GO:0005737; GO:0005829; GO:0016567 FYNVRGEHIFTLDTLVQR 0.99114 -21.341 0 0 0 0 0 0 0 0 0 0 11.7203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1165 0 0 0 9.65229 0 0 11.7331 11.5427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3087 0 0 0 0 0 0 0 0 13.9817 14.2724 0 0 12.4718 0 0 0 0 0 13.9855 14.1141 13.8486 0 13.6558 0 0 0 0 0 0 13.8739 13.5882 0 0 0 0 0 0 0 13.3547 0 0 0 Q9P0U3 SENP1_HUMAN "Sentrin-specific protease 1, EC 3.4.22.- (Sentrin/SUMO-specific protease SENP1)" SENP1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deSUMOylase activity [GO:0016929]; endopeptidase activity [GO:0004175]; SUMO-specific endopeptidase activity [GO:0070139]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508] GO:0004175; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006508; GO:0006919; GO:0016926; GO:0016929; GO:0031965; GO:0045944; GO:0070139; GO:0097190 deSUMOylase activity [GO:0016929]; endopeptidase activity [GO:0004175]; SUMO-specific endopeptidase activity [GO:0070139] ALALQLQNQRLQER 0.99114 -21.928 0 0 0 0 0 0 0 0 0 0 0 12.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P127 LUZP4_HUMAN "Leucine zipper protein 4 (Cancer/testis antigen 28, CT-28, CT28) (Tumor antigen HOM-TES-85)" LUZP4 Homo sapiens (Human) mRNA transport [GO:0051028] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA transport [GO:0051028] GO:0003723; GO:0005634; GO:0005737; GO:0051028 RNA binding [GO:0003723] AHRHRHR 0.99114 -19.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL59 ZN214_HUMAN "Zinc finger protein 214 (BWSCR2-associated zinc finger protein 1, BAZ-1)" ZNF214 BAZ1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CDDCGKDFSHSSDLR 0.99114 -21.943 0 0 0 0 0 0 0 0 0 13.5978 0 0 0 0 0 0 0 13.7302 0 0 0 12.0998 0 0 0 0 0 0 11.8067 0 0 0 0 0 0 0 0 0 0 0 10.0388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4672 0 0 0 0 0 0 0 0 14.341 0 0 14.3289 13.4298 0 0 0 13.7403 0 0 12.5305 0 0 0 10.9856 0 0 0 12.6184 0 0 12.0154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3792 0 0 0 0 11.993 0 0 0 0 0 0 0 0 0 0 0 0 11.9215 0 0 0 0 0 0 0 0 0 0 0 12.5933 0 0 11.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1761 0 0 0 0 0 12.5217 11.694 0 11.1341 0 15.16 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NCL1 GEMC1_HUMAN Geminin coiled-coil domain-containing protein 1 GMNC GEMC1 Homo sapiens (Human) cell cycle [GO:0007049]; cilium assembly [GO:0060271]; DNA replication initiation [GO:0006270]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell cycle [GO:0007049]; cilium assembly [GO:0060271]; DNA replication initiation [GO:0006270]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156] GO:0003682; GO:0005634; GO:0006270; GO:0007049; GO:0008156; GO:0045786; GO:0060271 chromatin binding [GO:0003682] AYGKFRK 0.99115 -22.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7166 0 0 10.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3821 0 14.1898 0 13.9478 0 0 14.319 12.194 0 0 0 0 14.3043 14.0684 0 13.889 0 0 0 0 14.0875 14.0224 0 0 0 0 0 0 0 0 0 13.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2942 12.6886 0 12.8247 0 0 0 0 0 0 0 12.7027 0 0 0 0 0 0 0 0 0 0 A6NKN8 PC4L1_HUMAN "Purkinje cell protein 4-like protein 1, PCP4-like protein 1" PCP4L1 IQM1 Homo sapiens (Human) GKAGNVK 0.99115 -4.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1023 0 0 0 12.465 12.2889 13.0818 13.3228 12.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6645 0 0 0 0 14.2755 13.9001 14.2869 13.0175 0 12.4893 0 0 0 0 0 0 0 14.8395 0 0 P02749 APOH_HUMAN "Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H, Apo-H) (Beta-2-glycoprotein I, B2GPI, Beta(2)GPI)" APOH B2G1 Homo sapiens (Human) "blood coagulation, intrinsic pathway [GO:0007597]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; plasminogen activation [GO:0031639]; positive regulation of blood coagulation [GO:0030194]; positive regulation of lipoprotein lipase activity [GO:0051006]; regulation of fibrinolysis [GO:0051917]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]" cell surface [GO:0009986]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; platelet dense granule lumen [GO:0031089]; very-low-density lipoprotein particle [GO:0034361] "cell surface [GO:0009986]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; platelet dense granule lumen [GO:0031089]; very-low-density lipoprotein particle [GO:0034361]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipid binding [GO:0005543]; blood coagulation, intrinsic pathway [GO:0007597]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; plasminogen activation [GO:0031639]; positive regulation of blood coagulation [GO:0030194]; positive regulation of lipoprotein lipase activity [GO:0051006]; regulation of fibrinolysis [GO:0051917]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]" GO:0001937; GO:0005543; GO:0005576; GO:0005615; GO:0006641; GO:0007597; GO:0008201; GO:0008289; GO:0009986; GO:0010596; GO:0016525; GO:0030194; GO:0030195; GO:0031089; GO:0031639; GO:0033033; GO:0034197; GO:0034361; GO:0034364; GO:0034392; GO:0042627; GO:0042802; GO:0051006; GO:0051917; GO:0051918; GO:0060230; GO:0062023; GO:0070062 heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipid binding [GO:0005543] PSAGNNSLYR 0.99115 -5.5746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8976 0 0 0 0 0 0 0 0 0 0 0 0 12.3499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0532 0 0 0 0 0 0 0 0 11.0989 0 0 0 0 0 0 0 0 0 15.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0676 0 0 0 P20594 ANPRB_HUMAN "Atrial natriuretic peptide receptor 2, EC 4.6.1.2 (Atrial natriuretic peptide receptor type B, ANP-B, ANPR-B, NPR-B) (Guanylate cyclase B, GC-B)" NPR2 ANPRB Homo sapiens (Human) bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; meiotic cell cycle [GO:0051321]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; bone development [GO:0060348]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; meiotic cell cycle [GO:0051321]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] GO:0001503; GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0008217; GO:0010753; GO:0016941; GO:0017046; GO:0019934; GO:0042562; GO:0042802; GO:0051321; GO:0051447; GO:0060348; GO:0097011; GO:1900194 ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; identical protein binding [GO:0042802]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] ALPSLLLLVAALAGGVRPPGAR 0.99115 -21.363 0 0 10.7645 11.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2958 0 0 0 10.7609 10.6689 0 0 0 0 0 0 10.6263 0 0 0 13.7555 0 0 14.3628 0 0 0 0 0 0 0 0 12.0198 0 0 0 0 0 0 12.5991 12.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8978 0 13.8949 11.7294 0 13.058 0 0 0 0 0 0 0 0 0 13.971 13.5125 0 0 11.9728 0 0 0 0 0 0 13.7943 0 0 0 0 12.3624 0 0 0 0 0 0 12.9104 0 13.4826 12.0784 0 0 0 12.1685 0 0 0 0 0 0 0 0 0 0 12.7711 0 0 13.8617 13.5874 0 0 0 0 12.4421 0 0 0 0 0 12.8886 0 0 0 0 0 14.212 P35869 AHR_HUMAN "Aryl hydrocarbon receptor, Ah receptor, AhR (Class E basic helix-loop-helix protein 76, bHLHe76)" AHR BHLHE76 Homo sapiens (Human) "apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]" aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cAMP-mediated signaling [GO:0019933]; cell cycle [GO:0007049]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; circadian regulation of gene expression [GO:0032922]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]" GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0007049; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0019933; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0051879; GO:0061629; GO:0070888; GO:0071320; GO:1904322; GO:1904613; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]" CFICRLR 0.99115 -23.333 0 0 0 0 0 0 0 0 0 12.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5052 0 0 0 0 12.2073 0 0 0 0 0 0 11.8279 0 13.8954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.97 0 0 0 0 0 0 11.3348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3203 0 0 0 0 13.9184 0 0 0 0 15.2622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12873 CHD3_HUMAN "Chromodomain-helicase-DNA-binding protein 3, CHD-3, EC 3.6.4.12 (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase, hZFH)" CHD3 Homo sapiens (Human) "centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; spindle organization [GO:0007051]" centriolar satellite [GO:0034451]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605] "centriolar satellite [GO:0034451]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]; spindle organization [GO:0007051]" GO:0000122; GO:0000785; GO:0000976; GO:0003677; GO:0003678; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006338; GO:0006355; GO:0007051; GO:0007098; GO:0008270; GO:0016575; GO:0016581; GO:0016605; GO:0016887; GO:0034451; GO:0042393; GO:0042659; GO:0045892; GO:0045893; GO:0140658; GO:2000736 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] AAISSGK 0.99115 -19.126 0 0 0 11.2465 0 0 0 0 0 0 0 0 0 10.6668 0 0 13.1823 0 0 0 0 0 13.5723 0 0 0 0 13.2043 0 0 0 0 0 0 0 0 0 12.9582 0 12.9181 0 0 14.3294 0 0 0 0 0 0 13.2677 0 0 0 13.1748 0 0 13.2292 13.828 0 16.2947 0 0 0 0 0 0 0 0 11.5623 0 0 0 0 0 0 0 0 0 0 0 14.186 0 13.4066 19.3785 0 14.5193 0 12.6807 0 12.1136 0 0 0 14.6213 0 12.9887 0 0 13.4281 14.294 0 0 14.5861 0 0 0 14.1892 0 15.615 14.3076 16.2213 0 0 0 10.8898 0 0 14.7108 0 0 14.5816 12.9867 0 0 0 0 0 0 0 14.0667 14.1086 0 0 0 0 14.6812 15.007 0 0 12.3866 13.0505 0 0 14.5723 0 0 0 13.0015 0 0 0 14.0844 0 13.8187 11.1126 13.9051 13.3849 0 15.5313 15.0546 0 14.2461 13.5738 13.5712 13.0325 0 14.8707 12.0193 14.3798 15.1161 12.8188 14.1798 0 0 13.9749 12.8827 0 15.1733 0 11.7857 Q8N5S1 S2541_HUMAN "Mitochondrial carrier protein SCaMC-3L (Mitochondrial ATP-Mg/Pi carrier protein SLC25A41) (Small calcium-binding mitochondrial carrier protein 3-like, SCaMC-3-like, SCaMC-3L) (Solute carrier family 25 member 41)" SLC25A41 Homo sapiens (Human) ADP transport [GO:0015866]; ATP transport [GO:0015867]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544] GO:0005347; GO:0005739; GO:0005743; GO:0015217; GO:0015866; GO:0015867; GO:0016021; GO:0140021; GO:1990544 ADP transmembrane transporter activity [GO:0015217]; ATP transmembrane transporter activity [GO:0005347] IQTLFRR 0.99115 -21.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5743 0 0 11.2295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4415 0 0 0 0 0 0 0 0 0 0 0 13.8543 0 0 0 0 13.7545 0 14.4328 0 0 0 0 13.6963 0 0 0 0 13.2922 13.4286 0 0 0 0 0 13.565 13.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0013 0 0 0 0 0 0 0 0 0 0 Q96EK5 KBP_HUMAN KIF-binding protein (KIF1-binding protein) (Kinesin family binding protein) KIFBP KBP KIAA1279 KIF1BP Homo sapiens (Human) central nervous system projection neuron axonogenesis [GO:0021952]; in utero embryonic development [GO:0001701]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; neuron projection maintenance [GO:1990535] cytoskeleton [GO:0005856]; mitochondrion [GO:0005739] cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; kinesin binding [GO:0019894]; central nervous system projection neuron axonogenesis [GO:0021952]; in utero embryonic development [GO:0001701]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial transport [GO:0006839]; neuron projection maintenance [GO:1990535] GO:0000226; GO:0001701; GO:0005739; GO:0005856; GO:0006839; GO:0019894; GO:0021952; GO:1990535 kinesin binding [GO:0019894] DPDSHIVKKINNLNK 0.99115 -21.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4042 0 0 0 0 0 0 0 0 0 12.16 0 11.5194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8373 0 0 0 0 0 0 0 0 0 0 0 12.7155 0 0 0 0 0 0 0 0 0 0 12.2526 0 0 0 0 0 0 0 0 12.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5874 0 0 0 0 0 0 0 0 0 0 13.0014 0 0 0 12.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXW4 MLP3C_HUMAN "Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C, MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma)" MAP1LC3C Homo sapiens (Human) aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; protein exit from endoplasmic reticulum [GO:0032527] GO:0000045; GO:0000421; GO:0000422; GO:0005776; GO:0005829; GO:0005874; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0032527; GO:0035973; GO:0036464; GO:0097352 microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625] IPSVRPFK 0.99115 -1.8185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ72 PITM2_HUMAN "Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2, PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3, NIR-3)" PITPNM2 KIAA1457 NIR3 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol-mediated signaling [GO:0048015] GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091; GO:0048015 calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971] DSDESSDDEFFDAHEDLSDTEEMFPK 0.99115 -21.344 0 0 0 0 0 0 0 0 0 12.7922 13.0637 0 0 12.4756 0 0 0 11.4036 0 0 0 0 0 0 0 0 0 0 0 12.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6601 0 0 0 0 0 0 0 0 0 0 12.9522 0 0 0 0 0 13.1451 0 0 0 0 0 0 0 0 0 0 0 0 17.0306 0 0 0 0 0 15.7944 0 0 0 0 15.7929 0 0 0 0 0 11.7302 0 0 0 0 0 15.8507 10.1924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.468 0 15.3022 0 0 0 13.2314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9834 0 0 0 0 0 0 12.685 0 0 0 0 0 15.0047 0 0 0 Q9H330 TM245_HUMAN Transmembrane protein 245 (Protein CG-2) TMEM245 C9orf5 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ADGGGPK 0.99115 -23.357 0 0 0 0 0 0 0 0 13.933 0 0 11.2469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9526 0 0 0 0 11.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3139 15.0719 14.5427 14.4088 15.3803 0 14.2995 0 11.0933 0 0 13.8089 13.5978 0 14.8505 0 15.0741 0 13.9543 13.7455 11.8008 13.9386 14.9326 0 0 0 11.8868 14.9891 0 15.1993 15.3004 14.1222 13.764 15.8022 12.8508 14.9932 0 15.3362 0 0 0 14.1831 0 0 0 0 13.9615 13.8898 0 0 13.5108 11.9829 15.6593 0 0 14.2198 13.0324 0 15.3389 15.361 14.5857 15.0047 0 0 0 14.2104 0 0 0 0 12.2195 0 0 12.8201 14.0029 0 0 12.8948 12.9124 0 0 12.6316 0 11.8214 15.4188 10.1798 0 0 0 14.1532 0 0 0 0 0 12.6997 0 0 0 0 0 0 0 0 0 0 0 0 14.0555 0 0 12.2249 0 0 Q9NS56 TOPRS_HUMAN "E3 ubiquitin-protein ligase Topors, EC 2.3.2.27 (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3, p53-binding protein 3, p53BP3)" TOPORS LUN TP53BPL Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]" centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151] "centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; transcription, DNA-templated [GO:0006351]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006351; GO:0006511; GO:0006513; GO:0006974; GO:0008630; GO:0010842; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0030496; GO:0032391; GO:0034504; GO:0035845; GO:0036064; GO:0042127; GO:0042771; GO:0043066; GO:0043161; GO:0044547; GO:0045893; GO:0046548; GO:0046549; GO:0046872; GO:0051443; GO:0051457; GO:0061630; GO:0070936 antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GDRVYSPYNHR 0.99115 -22.046 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64097 0 0 0 0 0 10.4177 0 11.4033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4454 0 11.9915 0 0 0 15.4993 15.3805 14.4892 0 0 0 16.5598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1834 0 0 0 0 0 0 0 10.9049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSI2 SLX9_HUMAN Ribosome biogenesis protein SLX9 homolog SLX9 C21orf70 FAM207A PRED56 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]" "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0005730; GO:0030686; GO:0030688 LAEQKHR 0.99115 -21.358 0 0 0 0 0 0 0 0 0 0 0 0 0 12.378 0 0 0 14.1074 0 0 0 0 13.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8267 0 0 12.8456 13.2524 13.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWZ8 SUGP1_HUMAN SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4) SUGP1 SF4 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380 RNA binding [GO:0003723] EPDYSEYK 0.99116 -4.3659 0 0 0 0 0 0 0 0 0 0 0 0 11.4902 0 11.7766 12.2171 0 0 0 0 0 0 0 0 0 0 0 0 12.0728 0 0 0 0 11.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5095 0 0 0 0 12.795 0 0 13.8218 0 0 0 13.5462 0 0 0 0 14.2389 12.0188 0 0 10.2456 0 0 0 0 0 0 0 12.2722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8035 13.4272 0 0 0 0 0 0 0 9.82404 0 0 0 12.5102 0 0 0 0 0 0 15.2086 0 0 0 0 0 0 14.4004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2197 0 0 0 0 0 Q8WY36 BBX_HUMAN HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2) BBX HBP2 Homo sapiens (Human) bone development [GO:0060348]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; bone development [GO:0060348]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0060348; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ATETDCNDK 0.99116 -23.397 0 0 0 9.97814 0 0 0 11.8242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3985 0 13.2049 0 13.1457 0 0 0 0 0 0 0 0 0 0 0 0 13.5513 11.2895 0 0 0 0 0 0 11.1506 15.0161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7465 0 14.5628 0 0 0 13.4215 12.5582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.837 12.8307 0 0 0 0 0 0 0 12.6359 0 0 0 0 0 13.1525 13.3325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5032 12.9864 0 0 0 12.9702 0 0 13.8415 16.867 0 0 0 0 0 0 0 0 0 0 0 19.6345 15.9049 0 15.8013 16.6983 15.6672 15.6708 16.0007 0 0 0 16.2829 0 0 0 0 16.7599 0 15.716 0 0 Q9BZA0 TTY10_HUMAN Putative transcript Y 10 protein TTTY10 TTY10 Homo sapiens (Human) KNCPSHKK 0.99116 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3417 0 0 0 13.7603 11.8413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5055 0 0 0 0 0 0 Q9H3S1 SEM4A_HUMAN "Semaphorin-4A (Semaphorin-B, Sema B)" SEMA4A SEMAB SEMB UNQ783/PRO1317 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of inhibitory synapse assembly [GO:1905704]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; semaphorin-plexin signaling pathway [GO:0071526]; T-helper 1 cell differentiation [GO:0045063] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of inhibitory synapse assembly [GO:1905704]; regulation of cell shape [GO:0008360]; regulation of endothelial cell migration [GO:0010594]; semaphorin-plexin signaling pathway [GO:0071526]; T-helper 1 cell differentiation [GO:0045063] GO:0001525; GO:0001755; GO:0005615; GO:0005886; GO:0005887; GO:0007411; GO:0008360; GO:0010594; GO:0016525; GO:0030215; GO:0030335; GO:0045063; GO:0045499; GO:0048843; GO:0050919; GO:0071526; GO:1904891; GO:1905704 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] ALRARGK 0.99116 -23.407 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2855 0 12.449 0 0 0 0 0 11.5324 0 0 0 0 0 0 0 0 0 12.4173 0 0 0 12.0732 0 11.4228 14.7949 0 15.243 0 17.8978 16.8215 0 0 0 0 0 13.0153 0 0 0 13.1274 0 0 0 12.6529 13.139 0 0 0 0 12.7802 0 0 0 0 0 0 0 0 13.3225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4004 0 0 0 0 0 0 13.0768 12.9218 13.3559 15.1802 14.8474 14.8667 0 13.367 15.1192 14.2366 15.2525 15.0957 14.9396 14.8464 0 0 0 0 0 0 0 14.123 0 15.5736 0 0 Q9H8X9 ZDH11_HUMAN "Palmitoyltransferase ZDHHC11, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 11, DHHC-11) (Zinc finger protein 399)" ZDHHC11 ZNF399 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling adaptor activity [GO:0035591]; antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein targeting to membrane [GO:0006612] GO:0002230; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010008; GO:0016021; GO:0018230; GO:0019706; GO:0035591; GO:0140374 protein-cysteine S-palmitoyltransferase activity [GO:0019706]; signaling adaptor activity [GO:0035591] HAHVIQNQFCHLCK 0.99116 -4.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1V8 SAM15_HUMAN "Sterile alpha motif domain-containing protein 15, SAM domain-containing protein 15" SAMD15 C14orf174 FAM15A Homo sapiens (Human) EDRPEPIKSK 0.99116 -21.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2853 0 0 0 0 0 0 0 13.7175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4693 18.3656 17.9542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBT2 SAE2_HUMAN "SUMO-activating enzyme subunit 2, EC 2.3.2.- (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2)" UBA2 SAE2 UBLE1B HRIHFB2115 Homo sapiens (Human) positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; SUMO activating enzyme complex [GO:0031510]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; positive regulation of protein sumoylation [GO:0033235]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925] GO:0000287; GO:0005524; GO:0005654; GO:0005737; GO:0016740; GO:0016925; GO:0019948; GO:0031510; GO:0032183; GO:0032446; GO:0033235; GO:0044388; GO:0044390; GO:0046982 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; SUMO activating enzyme activity [GO:0019948]; SUMO binding [GO:0032183]; transferase activity [GO:0016740]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] ALSRGLPR 0.99116 -19.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6563 10.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7419 0 0 12.465 0 0 0 0 15.4075 14.2763 18.8205 14.5836 12.757 14.3694 14.4123 19.4318 0 0 15.8333 13.9057 14.1499 0 12.5307 0 15.1864 13.8606 14.0139 0 0 0 14.1622 14.6033 14.3428 15.7624 0 12.8588 0 0 13.1115 14.5778 0 13.0642 14.325 0 17.0371 0 0 0 14.4559 0 0 15.0432 14.7091 14.5875 0 12.8864 0 19.3573 14.7126 13.5797 0 0 0 0 0 14.31 14.2385 15.1143 0 0 14.6276 14.3961 0 14.4699 14.3955 14.5659 0 14.6811 0 10.5757 14.9442 11.2939 13.6986 0 14.3076 14.6063 0 0 13.4684 14.484 0 0 0 0 0 0 0 0 13.8391 0 0 0 0 0 0 0 14.5037 0 14.5807 0 0 0 0 0 Q9ULC6 PADI1_HUMAN "Protein-arginine deiminase type-1, EC 3.5.3.15 (Peptidylarginine deiminase I) (Protein-arginine deiminase type I)" PADI1 PAD1 PDI1 Homo sapiens (Human) histone citrullination [GO:0036414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668]; histone citrullination [GO:0036414] GO:0004668; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0036414 calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668] DNLHAQK 0.99116 -21.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9834 0 0 0 0 0 14.3259 0 0 0 0 0 0 0 0 12.3298 12.3992 12.9191 12.4664 12.7053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2044 0 0 0 13.1877 0 13.533 13.0511 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7029 P02461 CO3A1_HUMAN Collagen alpha-1(III) chain COL3A1 Homo sapiens (Human) aorta smooth muscle tissue morphogenesis [GO:0060414]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; cellular response to amino acid stimulus [GO:0071230]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; digestive tract development [GO:0048565]; elastic fiber assembly [GO:0048251]; endochondral bone morphogenesis [GO:0060350]; extracellular matrix organization [GO:0030198]; fibroblast proliferation [GO:0048144]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; layer formation in cerebral cortex [GO:0021819]; limb joint morphogenesis [GO:0036022]; lung development [GO:0030324]; multicellular organism growth [GO:0035264]; negative regulation of immune response [GO:0050777]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; peptide cross-linking [GO:0018149]; platelet activation [GO:0030168]; positive regulation of Rho protein signal transduction [GO:0035025]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to radiation [GO:0009314]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tissue homeostasis [GO:0001894]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 production [GO:0032905]; wound healing [GO:0042060] collagen type III trimer [GO:0005586]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type III trimer [GO:0005586]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; SMAD binding [GO:0046332]; aorta smooth muscle tissue morphogenesis [GO:0060414]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; cellular response to amino acid stimulus [GO:0071230]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; digestive tract development [GO:0048565]; elastic fiber assembly [GO:0048251]; endochondral bone morphogenesis [GO:0060350]; extracellular matrix organization [GO:0030198]; fibroblast proliferation [GO:0048144]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; layer formation in cerebral cortex [GO:0021819]; limb joint morphogenesis [GO:0036022]; lung development [GO:0030324]; multicellular organism growth [GO:0035264]; negative regulation of immune response [GO:0050777]; negative regulation of neuron migration [GO:2001223]; neuron migration [GO:0001764]; peptide cross-linking [GO:0018149]; platelet activation [GO:0030168]; positive regulation of Rho protein signal transduction [GO:0035025]; response to angiotensin [GO:1990776]; response to cytokine [GO:0034097]; response to radiation [GO:0009314]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tissue homeostasis [GO:0001894]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 production [GO:0032905]; wound healing [GO:0042060] GO:0001701; GO:0001764; GO:0001894; GO:0002020; GO:0002062; GO:0005178; GO:0005201; GO:0005576; GO:0005586; GO:0005615; GO:0005788; GO:0007160; GO:0007179; GO:0007229; GO:0007507; GO:0009314; GO:0018149; GO:0021819; GO:0021987; GO:0030020; GO:0030168; GO:0030198; GO:0030199; GO:0030324; GO:0031012; GO:0032905; GO:0034097; GO:0035025; GO:0035264; GO:0036022; GO:0042060; GO:0043588; GO:0046332; GO:0046872; GO:0048144; GO:0048251; GO:0048407; GO:0048565; GO:0050777; GO:0060350; GO:0060414; GO:0062023; GO:0071230; GO:0071711; GO:0097435; GO:1990776; GO:2001223 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; SMAD binding [GO:0046332] DGSPGGK 0.99117 -22.974 0 0 0 0 0 0 0 11.2599 0 0 0 0 10.9911 0 11.1935 0 11.2663 0 0 10.8941 0 0 0 0 10.9813 0 0 0 0 11.0827 0 0 11.1253 0 0 12.5553 0 0 0 0 11.4769 0 0 0 0 0 0 11.1465 0 0 0 13.0013 0 0 0 13.6431 0 12.7154 0 0 13.4507 0 0 12.6648 10.8941 0 0 0 0 0 0 0 0 0 0 0 13.3582 0 13.0231 0 12.8079 13.0499 11.5302 0 0 0 0 0 0 0 13.5848 12.7306 15.0981 0 0 0 0 0 15.2403 0 0 0 0 0 0 0 0 13.8807 0 0 11.9152 0 0 0 13.0602 0 0 0 14.049 11.1113 0 0 0 0 0 0 12.9334 0 0 13.3782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1543 0 12.2578 12.2427 12.0648 12.0351 0 0 0 12.3518 0 0 0 0 0 0 13.9346 0 13.904 0 0 0 0 Q12983 BNIP3_HUMAN BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 BNIP3 NIP3 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy of mitochondrion [GO:0000422]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cell death [GO:0008219]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of programmed cell death [GO:0043067]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; autophagy of mitochondrion [GO:0000422]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cell death [GO:0008219]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of programmed cell death [GO:0043067]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; toxin transport [GO:1901998] GO:0000422; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0006915; GO:0008219; GO:0009617; GO:0010508; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0010940; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031307; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043067; GO:0043068; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0060548; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097345; GO:0140507; GO:1901998; GO:1902109; GO:1903599; GO:1903715; GO:1990144; GO:2000378 GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] GGIFSAEFLKVFLPSLLLSHLLAIGLGIYIGR 0.99117 -4.7684 11.0288 0 0 0 0 0 0 0 0 12.1815 14.1785 11.5754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7568 12.315 0 0 11.0463 0 0 0 0 10.6217 0 10.6974 0 0 15.4487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.415 0 0 0 0 0 12.6756 0 0 0 0 12.5614 13.5216 12.8555 16.9945 15.5329 17.0246 16.79 16.9843 16.9559 17.356 14.329 16.7341 16.5228 15.586 16.2112 16.6064 16.203 14.9188 13.8781 0 15.1536 13.9318 14.6192 14.4421 0 15.5725 14.2704 13.8851 0 15.1039 0 0 0 16.2801 14.5946 15.3956 15.7607 14.6914 13.65 0 13.4213 0 14.8896 13.7303 14.7047 15.0734 0 0 14.513 13.5259 13.0903 12.848 12.7647 13.2379 13.0823 0 13.383 14.1316 12.8351 11.5541 13.1815 0 13.0343 0 0 0 0 0 12.7697 0 0 13.5424 0 12.848 0 0 12.3537 13.2278 12.7067 11.5692 13.0787 0 11.8981 12.2295 0 11.9711 0 0 12.7904 13.0576 13.4685 0 13.2741 0 0 12.3004 0 10.5196 0 0 0 Q5SQ64 LY66F_HUMAN Lymphocyte antigen 6 complex locus protein G6f LY6G6F C6orf21 G6F LY6G6D NG32 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] GO:0005886; GO:0016021; GO:0031092 PAPDPGK 0.99117 -4.7795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXQ4 CB066_HUMAN Uncharacterized protein C2orf66 C2orf66 UNQ6411/PRO21186 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 APLLLLCVALVLLGHVNGATVR 0.99117 -4.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6824 11.6589 0 0 0 10.9948 0 0 10.8752 0 0 0 0 0 12.4392 0 0 0 0 0 0 0 0 0 0 0 13.8881 0 0 0 0 12.2963 0 0 0 0 0 0 14.1384 13.1633 0 13.4833 13.4244 0 12.7277 12.836 0 11.4022 12.2511 0 0 0 10.8361 0 0 0 0 0 11.0042 14.4963 13.8403 13.6355 0 13.2329 0 14.4476 0 13.454 13.5106 12.9984 0 0 0 0 0 13.2753 13.3801 0 0 0 0 0 0 0 0 0 11.9909 0 0 0 0 0 0 0 0 0 0 0 13.518 0 0 0 0 0 0 Q8N271 PROM2_HUMAN "Prominin-2, PROM-2 (Prominin-like protein 2, hPROML2)" PROM2 PROML2 UNQ2521/PRO6014 Homo sapiens (Human) negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; prominosome [GO:0071914] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microspike [GO:0044393]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; prominosome [GO:0071914]; cholesterol binding [GO:0015485]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of pinocytosis [GO:0048550]; positive regulation of cell projection organization [GO:0031346]; positive regulation of protein phosphorylation [GO:0001934]; regulation of GTPase activity [GO:0043087] GO:0001934; GO:0005887; GO:0005902; GO:0005929; GO:0009986; GO:0015485; GO:0016323; GO:0016324; GO:0031346; GO:0031410; GO:0031528; GO:0042995; GO:0043087; GO:0044393; GO:0048550; GO:0060170; GO:0070062; GO:0071914; GO:2001287 cholesterol binding [GO:0015485] ARWLAPR 0.99117 -23.574 0 0 0 0 0 0 0 12.3615 11.6314 0 0 0 13.0465 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2189 12.3349 0 0 0 0 0 0 12.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0791 0 0 0 13.6026 0 14.2251 0 0 0 13.8457 0 14.1938 0 0 0 0 0 14.3197 0 0 0 0 Q96G42 KLD7B_HUMAN Kelch domain-containing protein 7B KLHDC7B Homo sapiens (Human) ALEPATAAALR 0.99117 -4.7804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1186 0 0 0 0 12.9498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9988 15.4796 0 0 0 0 0 0 0 0 Q9H208 O10A2_HUMAN Olfactory receptor 10A2 (HP4) (Olfactory receptor OR11-86) OR10A2 OR10A2P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALALRNCIP 0.99117 -4.7845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7079 0 0 0 0 0 0 0 0 0 0 0 12.776 0 0 0 0 0 12.5551 0 0 0 0 0 12.7078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWM3 CUED1_HUMAN CUE domain-containing protein 1 CUEDC1 Homo sapiens (Human) ubiquitin binding [GO:0043130] GO:0043130 ubiquitin binding [GO:0043130] DFLLALERDRLK 0.99117 -4.7721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9962 0 0 0 0 0 0 0 0 0 0 0 0 11.8925 0 0 0 0 0 12.6493 0 0 14.774 0 0 0 0 0 14.8789 0 11.1906 0 0 P37275 ZEB1_HUMAN "Zinc finger E-box-binding homeobox 1 (NIL-2-A zinc finger protein) (Negative regulator of IL2) (Transcription factor 8, TCF-8)" ZEB1 AREB6 TCF8 Homo sapiens (Human) "anatomical structure development [GO:0048856]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cochlea morphogenesis [GO:0090103]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; keratinocyte proliferation [GO:0043616]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to activity [GO:0014823]; response to nutrient levels [GO:0031667]; semicircular canal morphogenesis [GO:0048752]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cochlea morphogenesis [GO:0090103]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; keratinocyte proliferation [GO:0043616]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mesenchymal cell proliferation [GO:0010464]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to activity [GO:0014823]; response to nutrient levels [GO:0031667]; semicircular canal morphogenesis [GO:0048752]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007389; GO:0008270; GO:0010464; GO:0010839; GO:0014823; GO:0017015; GO:0030154; GO:0030900; GO:0031667; GO:0033081; GO:0043616; GO:0045602; GO:0045666; GO:0045892; GO:0045944; GO:0048596; GO:0048704; GO:0048752; GO:0048856; GO:0051150; GO:0051216; GO:0070888; GO:0071230; GO:0071560; GO:0090103 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" ADGPRCKR 0.99118 -22.484 0 0 0 0 0 0 15.9848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.20376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2579 0 0 0 0 0 0 14.3856 0 0 0 0 0 0 0 0 0 0 0 12.1516 0 0 0 13.1075 0 0 0 0 0 0 0 12.8623 0 0 0 0 13.4089 0 0 0 0 11.0238 12.7874 0 0 0 0 0 0 0 13.8234 0 0 0 0 0 0 0 0 0 0 0 0 10.1302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1113 0 0 0 0 13.6399 0 0 12.1369 14.7141 0 0 11.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.62 0 0 0 13.7953 0 0 0 Q14012 KCC1A_HUMAN "Calcium/calmodulin-dependent protein kinase type 1, EC 2.7.11.17 (CaM kinase I, CaM-KI) (CaM kinase I alpha, CaMKI-alpha)" CAMK1 Homo sapiens (Human) cell cycle [GO:0007049]; cell differentiation [GO:0030154]; negative regulation of protein binding [GO:0032091]; nervous system development [GO:0007399]; nucleocytoplasmic transport [GO:0006913]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of muscle cell differentiation [GO:0051147]; regulation of protein binding [GO:0043393]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; negative regulation of protein binding [GO:0032091]; nervous system development [GO:0007399]; nucleocytoplasmic transport [GO:0006913]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of muscle cell differentiation [GO:0051147]; regulation of protein binding [GO:0043393]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0006913; GO:0007049; GO:0007165; GO:0007399; GO:0010976; GO:0014069; GO:0018105; GO:0030154; GO:0032091; GO:0032880; GO:0033138; GO:0043393; GO:0045944; GO:0046827; GO:0051147; GO:0051149; GO:0051835; GO:0060143; GO:0060999; GO:0071902; GO:0098978; GO:0106310; GO:1901985 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310] LGAVEGPRWK 0.99118 -4.6615 0 0 0 11.7126 0 0 0 11.1306 0 9.79216 10.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6677 0 0 0 0 12.8322 0 17.7225 0 0 0 0 0 0 0 0 0 0 0 15.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5884 0 0 0 0 0 0 11.6263 0 0 0 0 0 11.9871 0 0 0 0 0 0 Q5TCH4 CP4AM_HUMAN "Cytochrome P450 4A22 (CYPIVA22) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase, EC 1.14.14.80)" CYP4A22 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; linoleic acid metabolic process [GO:0043651]; lipid hydroxylation [GO:0002933] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; 16-hydroxypalmitate dehydrogenase activity [GO:0103002]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; laurate hydroxylase activity [GO:0102116]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; arachidonic acid metabolic process [GO:0019369]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; linoleic acid metabolic process [GO:0043651]; lipid hydroxylation [GO:0002933] GO:0001822; GO:0002933; GO:0005506; GO:0005615; GO:0005789; GO:0008391; GO:0018685; GO:0019369; GO:0020037; GO:0043231; GO:0043651; GO:0046456; GO:0048252; GO:0102033; GO:0102116; GO:0103002 16-hydroxypalmitate dehydrogenase activity [GO:0103002]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; laurate hydroxylase activity [GO:0102116]; long-chain fatty acid omega-hydroxylase activity [GO:0102033] AAQLYLHRQWLLK 0.99118 -5.9397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3309 0 10.3235 0 0 12.555 0 12.9503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8904 10.4479 0 0 11.5393 14.5307 13.6037 14.4995 13.372 14.4772 0 13.3622 0 0 0 13.7404 0 0 12.867 0 0 0 14.1074 0 13.4991 13.7581 12.9736 0 0 0 12.7994 0 0 0 0 0 12.5598 12.885 12.3635 12.6956 13.4049 0 0 0 0 0 0 0 0 13.3593 0 0 0 13.7279 13.7357 0 0 0 0 12.9601 0 12.7585 0 0 0 0 0 0 0 0 0 0 13.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5509 0 11.0401 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7898 0 0 0 0 15.1653 Q8N3Z0 PRS35_HUMAN Inactive serine protease 35 PRSS35 C6orf158 UNQ522/PRO1057 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 FSILDKRFLTNFPFSTAVK 0.99118 -4.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6522 0 0 13.78 0 0 0 0 0 0 0 0 13.3674 0 0 Q8N442 GUF1_HUMAN "Translation factor GUF1, mitochondrial, EC 3.6.5.- (Elongation factor 4 homolog, EF-4) (GTPase GUF1) (Ribosomal back-translocase)" GUF1 Homo sapiens (Human) positive regulation of translation [GO:0045727]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial ribosome binding [GO:0097177]; ribosome binding [GO:0043022]; positive regulation of translation [GO:0045727]; translation [GO:0006412] GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0043022; GO:0045727; GO:0097177 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial ribosome binding [GO:0097177]; ribosome binding [GO:0043022] ALAPRATGAALLVAPGPR 0.99118 -22.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6553 0 0 0 0 0 12.2391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7936 0 0 0 0 0 0 0 0 0 0 0 17.2488 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2135 0 0 0 0 0 0 0 0 0 0 13.3478 13.9511 0 0 19.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0932 13.0306 12.5711 0 0 0 0 13.9485 0 13.2311 16.5851 0 0 0 0 0 14.9212 0 15.0863 14.7161 11.6698 0 12.9891 0 0 14.9804 15.379 0 13.9034 0 13.7875 13.2441 0 0 0 13.148 14.2256 12.8388 15.0172 12.6466 0 12.6425 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4627 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4688 0 13.1221 0 12.8167 0 0 0 0 0 0 Q8NGK2 O52B4_HUMAN Olfactory receptor 52B4 (Olfactory receptor OR11-3) OR52B4 Homo sapiens (Human) cognition [GO:0050890] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; cognition [GO:0050890] GO:0004930; GO:0004984; GO:0005886; GO:0016021; GO:0050890 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] HIPPCIHIPLANVCILAPPMLNPIIYGIK 0.99118 -4.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6629 0 0 0 12.3821 11.3957 0 0 0 0 0 0 0 0 0 0 0 0 12.149 0 0 0 0 0 0 12.5553 11.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1154 0 0 0 12.9069 0 0 12.1462 13.4165 0 0 0 11.3183 0 0 0 11.4596 12.3767 Q9Y458 TBX22_HUMAN "T-box transcription factor TBX22, T-box protein 22" TBX22 TBOX22 Homo sapiens (Human) "cell fate specification [GO:0001708]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001708; GO:0003677; GO:0005634; GO:0006357; GO:0045892; GO:0045893 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ETEFTTVTAYQNQQITKLKIER 0.99118 -4.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5259 0 0 0 0 0 0 0 0 0 0 0 11.9058 0 0 15.0527 13.8447 13.2344 0 13.1896 0 14.0911 14.2962 14.3316 13.8617 14.2132 14.815 14.4566 0 14.2168 14.2283 15.2232 0 13.127 0 0 14.8528 0 0 13.231 13.1566 13.0941 13.3841 0 0 0 0 0 0 13.8416 0 0 0 0 13.9664 13.4188 0 0 13.3578 13.9605 0 0 0 0 0 13.2369 0 13.9308 0 12.0619 0 0 0 0 0 0 0 12.7159 0 0 0 0 0 0 0 0 0 0 0 13.3693 14.8565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15522 NKX28_HUMAN Homeobox protein Nkx-2.8 (Homeobox protein NK-2 homolog H) NKX2-8 NKX-2.8 NKX2G NKX2H Homo sapiens (Human) "axonogenesis [GO:0007409]; cell differentiation [GO:0030154]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; lung development [GO:0030324]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; axonogenesis [GO:0007409]; cell differentiation [GO:0030154]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; lung development [GO:0030324]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003690; GO:0003700; GO:0005634; GO:0006351; GO:0006357; GO:0006366; GO:0007409; GO:0030154; GO:0030324; GO:0043565; GO:0045944; GO:0050673; GO:0050680; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AQTLELERRFR 0.99119 -4.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9292 Q5M9N0 CD158_HUMAN Coiled-coil domain-containing protein 158 CCDC158 Homo sapiens (Human) DSQSPPIETTGKTCRK 0.99119 -4.6747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6531 14.153 11.0974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3299 0 0 0 0 0 0 0 0 0 0 9.99619 0 0 0 0 0 0 11.0486 0 0 0 0 0 0 0 0 0 0 0 11.8959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8869 0 0 0 0 13.8692 17.1421 13.0858 13.5588 13.2832 0 12.4429 13.028 0 0 0 17.5246 0 13.2778 13.2549 0 0 0 14.394 12.7868 13.5302 12.3452 0 0 0 0 16.1811 12.1 0 15.5156 0 0 0 0 0 14.708 0 0 0 14.8681 0 14.0037 0 0 14.3824 0 0 0 0 14.6128 0 0 12.5549 0 0 0 0 0 0 15.385 0 0 0 0 14.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3089 0 14.7135 14.001 0 0 14.1839 14.0446 0 15.9679 0 0 Q5VVY1 NTM1B_HUMAN "N-terminal Xaa-Pro-Lys N-methyltransferase 2, EC 2.1.1.299 (Alpha N-terminal protein methyltransferase 1B) (Methyltransferase-like protein 11B) (X-Pro-Lys N-terminal protein methyltransferase 1B, NTM1B)" NTMT2 C1orf184 METTL11B NRMT2 Homo sapiens (Human) N-terminal protein amino acid methylation [GO:0006480] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885]; N-terminal protein amino acid methylation [GO:0006480] GO:0005634; GO:0005737; GO:0006480; GO:0008168; GO:0071885 methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885] AGTDCALDCGSGIGR 0.99119 -4.5409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.538 16.3582 0 0 0 0 0 0 15.6013 15.6745 0 14.6752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PHW0 IYD1_HUMAN "Iodotyrosine deiodinase 1, IYD-1, EC 1.21.1.1 (Iodotyrosine dehalogenase 1)" IYD C6orf71 DEHAL1 Homo sapiens (Human) thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570] cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491]; thyroid hormone metabolic process [GO:0042403]; tyrosine metabolic process [GO:0006570] GO:0005654; GO:0005886; GO:0005887; GO:0006570; GO:0010181; GO:0016491; GO:0030659; GO:0042403; GO:0140616 FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491] AEARPWVDEDLK 0.99119 -19.107 12.4351 0 0 0 0 0 0 0 0 0 14.796 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1327 10.7255 0 0 0 0 14.3224 0 14.1829 0 0 0 0 0 0 0 0 0 0 0 13.4788 0 0 10.8979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6212 15.307 0 0 0 0 0 9.45668 0 13.5694 0 16.6244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1216 0 13.7289 0 0 0 0 0 0 0 13.5639 0 0 0 12.7561 0 0 13.2733 0 0 0 0 0 0 12.7536 0 0 0 12.6377 0 0 0 0 0 0 0 12.851 0 0 0 0 0 11.272 0 0 0 0 0 15.1826 0 0 12.1098 0 0 0 0 14.1914 0 11.1792 0 0 0 0 12.2284 0 14.3871 14.2876 0 0 0 14.3126 0 0 0 0 0 0 0 0 Q969K4 ABTB1_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein 1 (Elongation factor 1A-binding protein) ABTB1 BPOZ PP2259 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; translation elongation factor activity [GO:0003746] GO:0000151; GO:0003746; GO:0005730; GO:0005737; GO:0005829; GO:0005886 translation elongation factor activity [GO:0003746] AFFCGRSDYFRALLDDHFR 0.99119 -5.9459 0 0 0 0 0 0 10.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2364 0 0 0 13.6904 0 0 0 0 0 13.4693 0 13.7049 0 0 13.5266 13.8501 0 14.6918 0 13.3476 0 13.6554 13.9499 0 0 15.167 14.8709 12.7505 14.0351 11.951 0 0 14.1581 13.6516 13.2351 0 0 0 0 0 0 0 0 14.6843 13.8721 0 0 14.2359 13.5303 0 15.8162 13.8354 0 13.6399 13.7711 0 0 0 0 13.8693 0 14.1767 12.6679 0 0 15.5009 0 0 0 0 0 14.5345 0 14.6539 0 0 0 0 0 0 0 13.0562 0 0 0 12.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5833 0 0 0 0 14.0774 0 Q96BY2 MOAP1_HUMAN "Modulator of apoptosis 1, MAP-1, MAP1 (Paraneoplastic antigen Ma4)" MOAP1 PNMA4 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of apoptotic process [GO:0042981] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ubiquitin protein ligase binding [GO:0031625]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of apoptotic process [GO:0042981] GO:0001844; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006914; GO:0008625; GO:0008630; GO:0031625; GO:0042981; GO:0043065; GO:0090200; GO:0097190; GO:0097192; GO:2000786 ubiquitin protein ligase binding [GO:0031625] DAVNQAR 0.99119 -19.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3757 0 14.2544 0 0 0 0 0 0 0 15.8732 0 0 16.6997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGP4 LIMD1_HUMAN LIM domain-containing protein 1 LIMD1 Homo sapiens (Human) "cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; P-body assembly [GO:0033962]; phosphorylation [GO:0016310]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of cell shape [GO:0008360]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RISC complex [GO:0016442]; transcription regulator complex [GO:0005667] "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RISC complex [GO:0016442]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast development [GO:0002076]; P-body assembly [GO:0033962]; phosphorylation [GO:0016310]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of cell shape [GO:0008360]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]" GO:0000932; GO:0001666; GO:0002076; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006355; GO:0007010; GO:0008360; GO:0016310; GO:0016442; GO:0016477; GO:0033962; GO:0035195; GO:0035331; GO:0045668; GO:0045892; GO:0046872; GO:0090090; GO:2000637 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] FIEDLNMYEASK 0.99119 -21.941 0 0 0 0 0 0 0 0 13.9561 0 0 12.9376 0 12.4946 12.627 0 0 0 13.7146 0 0 0 13.1395 0 0 0 0 0 13.7548 0 0 0 0 13.1006 0 0 0 13.1865 0 0 13.1989 0 0 0 0 0 0 13.7113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2857 0 0 12.3642 0 0 0 0 0 0 0 0 16.372 0 0 0 0 0 0 0 11.7637 0 0 0 12.2068 0 0 0 0 15.1526 0 0 0 12.1566 0 0 0 0 0 12.8078 0 0 0 0 0 0 14.9087 0 0 0 0 0 0 12.9528 0 0 0 Q9Y5Y2 NUBP2_HUMAN "Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2, NBP 2)" NUBP2 Homo sapiens (Human) cell projection organization [GO:0030030]; iron-sulfur cluster assembly [GO:0016226] centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616] "centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cell projection organization [GO:0030030]; iron-sulfur cluster assembly [GO:0016226]" GO:0000166; GO:0005524; GO:0005634; GO:0005814; GO:0005829; GO:0005929; GO:0016226; GO:0030030; GO:0031616; GO:0046872; GO:0051536; GO:0051539; GO:0140663 "4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]" GPKKNALIK 0.99119 -4.5443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.946 0 0 0 0 0 0 0 0 0 0 0 0 14.7647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01213 PDYN_HUMAN "Proenkephalin-B (Beta-neoendorphin-dynorphin) (Preprodynorphin) [Cleaved into: Alpha-neoendorphin; Beta-neoendorphin; Big dynorphin, Big Dyn; Dynorphin A(1-17), Dyn-A17, Dynorphin A; Dynorphin A(1-13); Dynorphin A(1-8); Leu-enkephalin; Rimorphin (Dynorphin B, Dyn-B) (Dynorphin B(1-13)); Leumorphin (Dynorphin B-29) ]" PDYN Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neuropeptide signaling pathway [GO:0007218]; sensory perception [GO:0007600] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]; chemical synaptic transmission [GO:0007268]; neuropeptide signaling pathway [GO:0007218]; sensory perception [GO:0007600] GO:0001515; GO:0005576; GO:0005886; GO:0007218; GO:0007268; GO:0007600; GO:0030425; GO:0031628; GO:0043025; GO:0043679 opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628] FLPSISTK 0.9912 -23.323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1196 0 0 12.5158 0 12.0793 0 0 0 0 0 0 0 0 0 0 0 12.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3528 0 0 0 0 0 0 0 13.4177 0 0 0 0 0 0 0 0 0 0 0 12.7017 0 0 0 0 0 11.7703 0 0 0 0 0 11.0276 Q6NT76 HMBX1_HUMAN Homeobox-containing protein 1 (Homeobox telomere-binding protein 1) (Telomere-associated homeobox-containing protein 1) HMBOX1 HOT1 TAH1 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of telomerase activity [GO:0051972]" "Cajal body [GO:0015030]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "Cajal body [GO:0015030]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; telomeric DNA binding [GO:0042162]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of telomerase activity [GO:0051972]" GO:0000122; GO:0000781; GO:0000785; GO:0003691; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0015030; GO:0016604; GO:0016605; GO:0032212; GO:0035563; GO:0042162; GO:0042802; GO:0043565; GO:0044877; GO:0045892; GO:0045893; GO:0051972; GO:0051973; GO:1990837 double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; telomeric DNA binding [GO:0042162] EEIANACNAVIQK 0.9912 -5.96 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3182 0 0 0 0 0 0 0 0 12.3611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3643 0 0 0 0 0 13.6421 0 0 13.0201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7586 0 0 0 0 0 0 0 0 0 0 13.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N806 UBR7_HUMAN "Putative E3 ubiquitin-protein ligase UBR7, EC 2.3.2.27 (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7)" UBR7 C14orf130 Homo sapiens (Human) ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0008270; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CDCGNSK 0.9912 -21.977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5625 17.3482 0 0 13.6374 0 0 0 14.229 0 14.3861 0 0 0 0 11.1829 17.8068 0 0 0 13.9669 0 0 0 0 0 0 17.1945 0 12.6167 0 13.459 0 0 0 0 0 0 0 0 17.7944 0 0 17.094 17.1829 0 0 0 0 0 0 17.5174 0 0 0 17.0243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99961 SH3G1_HUMAN "Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein, EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1)" SH3GL1 CNSA1 SH3D2B Homo sapiens (Human) central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191] GO:0002102; GO:0005737; GO:0005829; GO:0007165; GO:0007417; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0042995; GO:0045296; GO:0070161; GO:0098793; GO:0098978 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289] AKLTMLNTVSKIR 0.9912 -5.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4797 0 12.0803 0 11.6279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3133 0 0 0 0 0 0 0 0 0 16.4137 0 0 0 0 0 0 0 0 13.3137 0 12.3519 0 0 0 0 0 0 16.6993 0 13.0419 0 0 0 0 0 0 0 0 13.1454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2325 0 0 0 0 0 0 0 0 0 12.609 0 0 0 0 Q9UIF3 TEKT2_HUMAN "Tektin-2 (Tektin-t) (Testicular tektin) (Testicular tektin B1-like protein, TEKTB1, Tektin-B1)" TEKT2 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159] axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; nucleus [GO:0005634] axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159] GO:0005634; GO:0005815; GO:0005879; GO:0015630; GO:0030317; GO:0031514; GO:0036159; GO:0060271; GO:0060294 ATLSVKPSRR 0.9912 -23.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2109 0 0 0 0 0 0 0 0 0 0 14.0613 0 0 0 12.9727 0 0 0 0 0 0 13.6886 0 0 0 0 0 0 14.1111 0 0 0 0 0 0 0 0 0 0 0 0 14.0254 0 0 0 0 13.9937 0 0 0 0 0 0 12.8455 12.8537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8522 0 0 0 14.3538 0 12.8592 0 0 12.7905 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0241 0 0 0 0 0 Q9ULE0 WWC3_HUMAN Protein WWC3 WWC3 KIAA1280 Homo sapiens (Human) "cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0035330; GO:0035331; GO:0046621; GO:0060090 kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090] ASKEIYQLRGQSHK 0.9912 -21.962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.448 0 0 0 0 0 10.9416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8736 14.0117 0 0 0 0 0 0 13.2299 0 13.2952 0 12.7076 13.8607 0 0 0 0 0 0 13.2833 0 13.2985 0 0 0 13.729 13.5316 0 0 12.7017 11.9721 12.7487 0 13.2214 13.3886 13.568 0 0 0 0 0 0 0 0 0 0 13.6265 0 12.6058 14.5888 12.8816 0 13.1259 0 0 14.0709 0 0 0 0 0 0 14.1921 13.3526 0 0 11.4644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2638 0 0 0 0 0 0 0 13.805 11.375 0 0 O00429 DNM1L_HUMAN "Dynamin-1-like protein, EC 3.6.5.5 (Dnm1p/Vps1p-like protein, DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less, Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV, HdynIV) (Dynamin-related protein 1)" DNM1L DLP1 DRP1 Homo sapiens (Human) calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511] anchoring junction [GO:0070161]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; calcium ion transport [GO:0006816]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; necroptotic process [GO:0070266]; peroxisome fission [GO:0016559]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; protein-containing complex assembly [GO:0065003]; regulation of ATP metabolic process [GO:1903578]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; regulation of ubiquitin protein ligase activity [GO:1904666]; release of cytochrome c from mitochondria [GO:0001836]; rhythmic process [GO:0048511] GO:0000266; GO:0001836; GO:0003374; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0010821; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0061025; GO:0065003; GO:0070161; GO:0070266; GO:0070584; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0090200; GO:1900063; GO:1903146; GO:1903578; GO:1904666; GO:2001244 GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] CVELVHEEMQRIIQHCSNYSTQELLRFPK 0.99121 -19.2 0 0 0 0 0 0 11.6715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3279 13.3078 0 14.2932 0 0 0 11.5481 0 0 12.4257 0 0 0 0 12.4594 0 0 14.7438 0 0 0 12.2145 0 13.0631 0 0 0 0 0 0 0 11.5535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8767 0 14.4644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2206 13.9857 0 0 0 0 13.7335 0 0 0 0 0 0 0 0 0 14.2341 0 0 0 0 13.3752 13.4722 0 12.9688 0 14.0835 13.5315 0 14.3546 0 13.3716 13.7242 13.3633 0 0 0 0 12.8261 0 14.5376 12.8682 0 0 14.8831 0 0 0 0 14.7607 14.0322 0 0 0 0 0 13.4914 13.6452 0 0 0 0 0 16.0667 0 0 0 0 0 0 0 0 0 12.9276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG32 ZCC18_HUMAN Zinc finger CCHC domain-containing protein 18 ZCCHC18 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] GO:0005634; GO:0046872 metal ion binding [GO:0046872] CSYCGEEGHSKETCDNESNK 0.99121 -4.8499 0 0 0 10.9332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7469 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13621 S12A1_HUMAN Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (Kidney-specific Na-K-Cl symporter) SLC12A1 NKCC2 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725] GO:0005886; GO:0006811; GO:0006884; GO:0008511; GO:0015379; GO:0016020; GO:0016021; GO:0016324; GO:0034220; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:1902476; GO:1990573 potassium:chloride symporter activity [GO:0015379]; sodium:potassium:chloride symporter activity [GO:0008511] AANLIVLSLPVARK 0.99121 -4.8477 0 0 14.7076 11.1353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5318 0 0 0 9.11027 0 11.3401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1912 13.1022 11.3256 0 0 14.4137 0 0 0 11.1879 0 0 0 0 0 13.9926 0 14.9821 0 0 0 0 10.7107 0 12.7561 0 0 0 0 0 0 0 13.3073 13.5749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0733 0 0 0 12.1913 0 0 0 0 0 0 12.7109 0 0 0 0 0 13.1171 0 0 0 0 0 0 0 0 12.6244 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3513 0 0 0 0 0 0 0 0 12.9947 11.9155 0 0 Q5T7M9 DIK1A_HUMAN Divergent protein kinase domain 1A (Protein FAM69A) DIPK1A FAM69A Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 DCKKIICDK 0.99121 -4.851 0 0 0 0 0 0 0 0 0 13.5758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5153 0 0 0 11.2156 0 0 0 0 0 0 0 0 0 13.5272 12.2795 13.4234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5209 0 0 0 0 0 0 0 0 0 12.0528 0 0 0 0 0 0 13.2412 0 0 0 0 0 0 0 11.9237 0 0 0 0 0 0 0 0 0 11.9465 0 0 0 0 12.395 0 0 0 0 0 0 0 0 13.5201 0 12.2646 0 0 12.5908 0 0 13.5904 0 13.4331 0 0 10.0534 0 0 0 0 0 0 0 0 0 14.6241 0 0 0 0 0 0 0 Q9H1I8 ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100) ASCC2 ASC1P100 RQT3 Homo sapiens (Human) "DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]" activating signal cointegrator 1 complex [GO:0099053]; DNA repair complex [GO:1990391]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "activating signal cointegrator 1 complex [GO:0099053]; DNA repair complex [GO:1990391]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin binding [GO:0043130]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]" GO:0005634; GO:0005654; GO:0006307; GO:0006355; GO:0016607; GO:0032508; GO:0032790; GO:0043130; GO:0072344; GO:0099053; GO:1990116; GO:1990391 ubiquitin binding [GO:0043130] AVAAQRQR 0.99121 -4.8518 0 0 0 0 0 0 0 0 12.8943 12.7722 0 12.6644 12.3631 0 12.9363 0 12.9532 13.0831 0 0 14.0901 0 0 0 0 12.8626 0 0 13.1162 0 0 12.8341 12.8004 12.6361 12.9566 12.5583 0 12.9867 0 12.7901 0 0 0 0 0 12.6777 0 12.5356 12.5893 12.7853 0 0 0 0 0 12.4089 12.768 0 0 0 11.3624 0 0 0 0 0 0 14.5116 0 0 0 0 0 0 13.9575 0 12.1099 12.9437 0 0 0 13.8154 0 12.3802 0 0 14.9459 0 0 0 0 0 0 0 0 14.8168 14.3716 0 0 19.6745 0 0 0 0 0 0 14.02 0 14.2413 13.1452 0 0 0 0 0 14.2726 13.3267 0 14.4947 0 11.1717 0 0 0 0 0 13.0595 14.1015 0 0 13.0083 0 0 0 0 0 15.5516 0 18.9446 0 0 14.1988 14.1407 15.6083 0 14.3562 0 14.7668 0 0 0 0 0 0 13.1862 0 0 14.9027 14.7774 0 0 18.9932 14.7661 0 15.0114 0 0 0 0 14.5007 14.554 12.795 0 0 0 0 0 14.6528 0 0 Q9Y5A6 ZSC21_HUMAN "Zinc finger and SCAN domain-containing protein 21 (Renal carcinoma antigen NY-REN-21) (Zinc finger protein 38 homolog, Zfp-38)" ZSCAN21 ZFP38 ZNF38 Homo sapiens (Human) "cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006355; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSNSSNLTKHRR 0.99121 -4.8466 0 0 0 0 0 0 0 0 11.2229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5283 0 0 11.8371 0 0 0 0 0 0 0 0 0 0 13.5921 0 13.2693 0 13.0632 12.7244 0 0 12.3159 0 0 12.7119 12.0363 0 15.0504 0 0 13.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8392 0 0 0 0 0 0 0 0 0 0 11.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6259 0 12.5313 0 0 0 0 0 0 0 0 0 13.6096 0 0 O14981 BTAF1_HUMAN "TATA-binding protein-associated factor 172, EC 3.6.4.- (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172, TAF-172)" BTAF1 TAF172 Homo sapiens (Human) "negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]" intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] "intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]; transcription coregulator activity [GO:0003712]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003677; GO:0003712; GO:0004386; GO:0005524; GO:0005654; GO:0008094; GO:0016887; GO:0017025; GO:0035562; GO:0043231; GO:0045892; GO:0140658 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TBP-class protein binding [GO:0017025]; transcription coregulator activity [GO:0003712]" AAAQQLGEVVKLHPHELNNLLSK 0.99122 -48.63 11.8152 0 0 0 0 0 0 0 0 9.48033 0 0 0 13.3433 0 0 10.1371 0 10.6854 0 0 0 0 0 10.9183 0 0 0 0 0 0 0 0 0 0 0 12.3478 0 0 0 0 0 0 12.392 0 0 0 0 13.2247 11.038 12.3436 0 0 12.1178 0 0 0 0 0 13.8372 0 0 0 9.51627 0 0 10.7996 0 0 0 0 0 12.2216 0 0 12.6683 11.6768 0 14.5819 12.9654 0 0 0 0 0 0 12.9137 0 13.5686 12.9719 17.6684 0 0 0 0 12.7412 0 0 13.332 13.8378 0 0 16.217 14.4124 0 0 0 0 0 0 15.6619 15.2755 13.8165 0 0 15.2443 0 0 11.377 13.0174 0 0 13.1576 14.0657 12.1834 13.7864 13.8919 12.7039 11.7503 15.8499 11.9984 0 0 11.9165 11.7112 12.7886 12.7125 0 0 13.5669 0 11.1132 0 0 0 0 0 0 10.5856 13.6108 0 11.1452 0 0 0 12.3142 10.7936 14.49 0 0 0 11.1061 0 11.4851 0 0 0 0 0 11.3209 11.5854 0 0 12.9185 0 0 0 14.7211 0 0 O60512 B4GT3_HUMAN "Beta-1,4-galactosyltransferase 3, Beta-1,4-GalTase 3, Beta4Gal-T3, b4Gal-T3, EC 2.4.1.- (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase, EC 2.4.1.38) (N-acetyllactosamine synthase, EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3)" B4GALT3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; galactosylceramide biosynthetic process [GO:0006682]; glycosylation [GO:0070085]; protein glycosylation [GO:0006486] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; galactosylceramide biosynthetic process [GO:0006682]; glycosylation [GO:0070085]; protein glycosylation [GO:0006486]" GO:0000139; GO:0003831; GO:0003945; GO:0005794; GO:0005829; GO:0005975; GO:0006486; GO:0006682; GO:0008378; GO:0016021; GO:0032580; GO:0046872; GO:0070062; GO:0070085 "beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]" AKLLNVGVR 0.99122 -22.972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9837 0 0 0 0 0 11.9609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0184 13.5863 13.6796 0 13.6565 13.7736 14.282 13.6663 14.2978 0 0 0 0 0 12.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2915 0 0 0 0 0 0 0 0 0 0 15.1369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40121 CAPG_HUMAN Macrophage-capping protein (Actin regulatory protein CAP-G) CAPG AFCP MCP Homo sapiens (Human) actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; protein-containing complex assembly [GO:0065003] actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; F-actin capping protein complex [GO:0008290]; Flemming body [GO:0090543]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726] "actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; F-actin capping protein complex [GO:0008290]; Flemming body [GO:0090543]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; protein-containing complex assembly [GO:0065003]" GO:0001726; GO:0005546; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0007417; GO:0008154; GO:0008290; GO:0015629; GO:0019904; GO:0030027; GO:0030031; GO:0042470; GO:0044877; GO:0045296; GO:0051014; GO:0051015; GO:0051016; GO:0065003; GO:0070062; GO:0072686; GO:0090543 "actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]" IYIWKGR 0.99122 -4.5931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2521 0 0 0 0 14.1395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8434 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JTH9 RRP12_HUMAN RRP12-like protein RRP12 KIAA0690 Homo sapiens (Human) rRNA processing [GO:0006364] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003723; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0016021; GO:0031965; GO:0043231 RNA binding [GO:0003723] AHGVQKK 0.99122 -48.866 0 0 0 10.1017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7771 0 12.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5932 0 0 15.8336 0 14.9781 15.1581 14.8475 0 14.2278 13.8208 0 0 18.3766 0 12.9731 12.4176 18.9366 12.927 13.6425 13.1242 16.3502 0 0 0 0 0 0 15.7782 0 11.0601 12.0572 0 0 13.695 0 0 0 0 0 16.4548 0 0 0 0 15.6005 18.6832 12.4408 0 0 0 0 15.5246 17.5942 15.6381 0 13.9996 0 12.7044 0 15.0239 14.951 0 0 15.3297 15.1944 12.8987 0 14.8696 14.7184 14.8451 0 0 0 18.3938 0 12.1984 0 14.3369 14.7191 0 12.7334 13.2942 16.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.19 11.4029 0 14.3187 0 0 0 14.3698 11.9362 Q5TKA1 LIN9_HUMAN "Protein lin-9 homolog, HuLin-9, hLin-9 (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein)" LIN9 BARA TGS Homo sapiens (Human) "cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]" nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053] "nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; reproduction [GO:0000003]; transcription, DNA-templated [GO:0006351]" GO:0000003; GO:0003677; GO:0005654; GO:0006351; GO:0006357; GO:0007049; GO:0017053; GO:0051726; GO:0071897 DNA binding [GO:0003677] DLPDEIPLPLVIGTKVTAR 0.99122 -23.573 0 0 0 0 12.9575 12.9613 0 0 0 14.8383 0 13.4427 13.2631 0 13.1699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7723 0 12.7122 0 13.0394 12.6138 0 12.8903 13.0986 13.204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2658 0 14.1519 0 0 0 0 0 0 13.7935 0 15.1759 14.6393 0 0 0 0 0 13.6631 11.7166 0 12.2505 0 0 0 0 0 0 0 0 13.3782 13.4365 0 10.4363 0 0 0 13.2264 13.3221 14.2559 0 0 0 12.0924 0 0 13.1084 0 0 14.2396 12.2488 13.373 0 0 0 0 0 0 13.8271 0 0 0 0 0 0 0 0 0 14.7232 0 0 13.0818 0 12.768 0 0 13.3677 13.8299 0 0 0 13.4944 0 0 0 0 16.4207 0 0 0 0 0 0 13.1576 13.2826 0 0 0 12.2915 12.4836 0 0 0 0 12.5024 0 0 14.7618 0 Q6P387 CP046_HUMAN Uncharacterized protein C16orf46 C16orf46 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 ALLVLPPLK 0.99122 -7.132 0 0 11.9192 12.7509 0 11.8249 0 0 0 0 0 0 0 0 0 0 13.092 0 11.6326 0 0 0 0 14.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5553 0 0 0 0 0 0 0 11.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.313 0 0 0 12.8274 0 0 0 0 0 0 12.6685 0 0 0 0 0 0 0 0 0 0 12.8053 13.6102 0 0 0 0 0 0 0 0 12.6397 0 0 0 0 0 0 0 0 0 0 0 14.5205 0 13.1512 0 0 0 0 0 0 0 0 12.7582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z478 DHX29_HUMAN "ATP-dependent RNA helicase DHX29, EC 3.6.4.13 (DEAH box protein 29) (Nucleic acid helicase DDXx)" DHX29 DDX29 Homo sapiens (Human) formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255] cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282] cytosolic small ribosomal subunit [GO:0022627]; eukaryotic 43S preinitiation complex [GO:0016282]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; nucleoside-triphosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; ribosome assembly [GO:0042255] GO:0001731; GO:0003723; GO:0003724; GO:0003743; GO:0005524; GO:0008494; GO:0016282; GO:0016887; GO:0017111; GO:0022627; GO:0042255; GO:0043024; GO:0045296; GO:0045948 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; nucleoside-triphosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation activator activity [GO:0008494]; translation initiation factor activity [GO:0003743] AAVSASR 0.99122 -48.782 10.1457 14.3508 0 0 0 0 0 0 0 0 0 0 9.88745 0 0 11.3655 0 0 0 0 0 0 0 0 0 17.0891 0 0 0 11.4967 0 0 0 0 0 0 11.2129 0 0 0 0 0 11.614 0 0 0 0 0 0 0 0 14.767 13.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.489 0 0 0 0 12.2503 11.0583 13.7368 0 12.825 0 0 11.9272 0 0 0 11.9449 0 12.6185 0 14.078 12.7335 0 13.726 0 0 0 14.1307 0 12.0144 0 13.8203 0 0 0 0 11.9898 0 12.302 14.0768 0 12.5042 0 0 0 0 0 0 0 0 15.0464 13.7961 0 0 0 14.8915 13.0833 0 0 0 13.4054 0 12.6249 14.5183 0 0 0 0 0 0 0 14.8481 0 0 12.025 0 0 10.3265 0 13.447 0 11.9833 12.0859 0 11.7208 0 0 13.3735 0 0 12.2929 0 0 13.649 13.8495 0 0 0 0 0 0 0 0 0 0 0 11.5371 0 18.4822 0 14.6375 0 0 Q9BVK2 ALG8_HUMAN "Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, EC 2.4.1.265 (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)" ALG8 HUSSY-02 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]" GO:0000033; GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016021; GO:0018279; GO:0042283 "alpha-1,3-mannosyltransferase activity [GO:0000033]; dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]" ECCKCIDGKK 0.99122 -5.5566 0 0 0 0 0 0 0 0 0 0 11.1867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4119 0 12.3846 0 0 0 0 0 0 0 0 0 13.9377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6869 0 0 0 0 0 0 0 12.1255 0 0 0 0 0 0 0 0 0 0 0 12.0379 0 0 0 0 0 0 0 0 0 0 0 0 13.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7868 0 0 0 10.3328 13.2939 0 0 0 Q9NYF8 BCLF1_HUMAN "Bcl-2-associated transcription factor 1, Btf (BCLAF1 and THRAP3 family member 1)" BCLAF1 BTF KIAA0164 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]" cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]" GO:0003677; GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0016592; GO:0016607; GO:0043065; GO:0043620; GO:0045892; GO:0045944; GO:1990830; GO:2000144; GO:2001022; GO:2001244 DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] AEGEPQEESPLK 0.99122 -48.859 0 0 0 0 0 0 0 0 0 10.657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95767 0 0 0 0 0 0 0 0 11.4499 0 13.97 0 12.1196 0 0 12.2991 0 0 0 0 15.571 0 0 0 0 0 0 12.4729 0 0 0 0 0 0 12.6165 0 0 0 0 0 0 0 13.9285 13.5248 12.8766 15.1634 0 13.7659 13.4513 15.0335 13.6222 12.9202 0 0 0 0 0 0 10.7464 0 0 0 0 14.2296 12.7718 0 0 0 13.5328 15.3473 13.4389 14.4229 13.9658 13.829 0 0 0 0 0 14.1667 0 16.1159 0 0 10.1917 0 0 0 12.0345 0 11.4907 0 0 13.3082 13.4903 0 0 0 0 0 0 13.6987 0 0 0 0 11.1101 12.7505 0 0 0 0 0 0 0 0 14.1121 0 0 0 0 0 0 0 0 11.7837 0 11.7373 0 0 0 0 0 0 0 Q9ULU4 PKCB1_HUMAN "Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3, CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8)" ZMYND8 KIAA1125 PRKCBP1 RACK7 Homo sapiens (Human) negative regulation of cell migration [GO:0030336] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; negative regulation of cell migration [GO:0030336] GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0008270; GO:0019904; GO:0030336; GO:0035064; GO:0070577; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] AKPSPHPIK 0.99122 -48.558 10.9198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7024 0 0 0 0 0 12.8309 12.7801 0 0 12.8671 11.4907 12.7266 0 0 11.2908 0 0 12.3844 0 0 0 0 0 11.6269 0 0 12.4879 12.8401 0 0 0 0 0 0 0 0 0 0 0 12.3192 0 0 0 0 0 0 0 0 0 0 11.9609 0 0 0 0 12.423 0 0 0 0 0 0 0 0 0 13.8325 0 17.527 0 18.0953 10.4648 17.7358 17.0077 17.8987 19.0608 17.7516 17.4384 16.7237 17.6516 16.7666 18.0661 17.9548 16.693 0 0 15.1635 0 0 0 15.5608 0 0 17.4266 16.4358 0 14.6527 14.8833 16.4608 0 15.4296 0 12.0651 0 0 0 0 0 0 0 11.6495 13.8092 0 0 14.4421 13.7343 0 0 0 0 17.5283 15.943 15.9476 0 14.8409 15.6739 0 0 0 0 0 0 0 15.261 0 14.9532 13.345 0 14.8938 15.6809 0 0 0 0 0 0 0 11.8794 0 0 0 0 0 0 0 0 0 0 13.6448 0 0 0 0 0 0 Q9Y3D6 FIS1_HUMAN "Mitochondrial fission 1 protein (FIS1 homolog, hFis1) (Tetratricopeptide repeat protein 11, TPR repeat protein 11)" FIS1 TTC11 CGI-135 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fatty acid transport [GO:2000192]; peroxisome fission [GO:0016559]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; release of cytochrome c from mitochondria [GO:0001836] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; autophagy of mitochondrion [GO:0000422]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fatty acid transport [GO:2000192]; peroxisome fission [GO:0016559]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; release of cytochrome c from mitochondria [GO:0001836] GO:0000266; GO:0000422; GO:0001836; GO:0005739; GO:0005777; GO:0005778; GO:0005779; GO:0005783; GO:0005829; GO:0006626; GO:0007204; GO:0008053; GO:0010821; GO:0016020; GO:0016559; GO:0031307; GO:0032471; GO:0032991; GO:0035584; GO:0042802; GO:0043280; GO:0043653; GO:0051561; GO:0070584; GO:0090141; GO:0090314; GO:1903579; GO:2000192; GO:2001244 identical protein binding [GO:0042802] MEAVLNELVSVEDLLKFEK 0.99122 -5.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15444 CCL25_HUMAN C-C motif chemokine 25 (Chemokine TECK) (Small-inducible cytokine A25) (Thymus-expressed chemokine) CCL25 SCYA25 TECK Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR10 chemokine receptor binding [GO:0031735]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; hormone activity [GO:0005179]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] GO:0001954; GO:0002548; GO:0005179; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0006955; GO:0007166; GO:0007186; GO:0008009; GO:0030593; GO:0031640; GO:0031735; GO:0042379; GO:0043547; GO:0048020; GO:0048247; GO:0060326; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:1903237 CCR chemokine receptor binding [GO:0048020]; CCR10 chemokine receptor binding [GO:0031735]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; hormone activity [GO:0005179] LLDARNK 0.99123 -4.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43683 BUB1_HUMAN "Mitotic checkpoint serine/threonine-protein kinase BUB1, hBUB1, EC 2.7.11.1 (BUB1A)" BUB1 BUB1L Homo sapiens (Human) "apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]" GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0006915; GO:0007063; GO:0007094; GO:0008283; GO:0016020; GO:0043231; GO:0051301; GO:0051754; GO:0051983; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EFLQQQYR 0.99123 -49.134 0 0 0 10.896 0 0 0 0 0 0 0 0 0 0 12.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3067 12.3753 0 9.50357 0 0 0 0 0 0 0 0 0 0 0 0 11.2741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5763 0 13.6079 0 0 0 0 0 14.2725 0 0 11.6123 13.6194 0 0 0 10.546 0 0 0 0 0 0 0 0 0 0 0 12.1924 0 0 0 0 12.2584 0 0 0 0 0 0 0 0 13.9463 0 0 0 0 0 0 12.2522 12.3485 0 0 14.5636 0 0 0 0 0 10.015 11.2062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8268 0 10.1941 11.7481 0 0 0 0 0 9.87633 0 0 0 0 0 O75822 EIF3J_HUMAN "Eukaryotic translation initiation factor 3 subunit J, eIF3j (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35)" EIF3J EIF3S1 PRO0391 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] GO:0001732; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0042802 identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743] DDLADYGGYDGGYVQDYEDFM 0.99123 -5.5746 0 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5935 11.8052 13.7693 0 0 0 0 0 12.4422 0 0 0 0 0 0 12.7023 0 0 0 0 10.7281 0 0 0 0 13.3526 13.4916 12.2478 0 0 0 0 0 12.3686 0 0 11.515 0 0 0 0 0 0 0 11.69 12.9232 0 0 0 0 12.2783 0 0 0 0 0 0 0 0 0 0 0 0 11.0522 0 0 0 0 0 14.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52701 MSH6_HUMAN "DNA mismatch repair protein Msh6, hMSH6 (G/T mismatch-binding protein, GTBP, GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit, p160)" MSH6 GTBP Homo sapiens (Human) determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; spermatogenesis [GO:0007283]" GO:0000710; GO:0000785; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006298; GO:0007283; GO:0008094; GO:0008340; GO:0008630; GO:0009411; GO:0016446; GO:0016447; GO:0019899; GO:0030983; GO:0032137; GO:0032301; GO:0035064; GO:0043231; GO:0045190; GO:0045910; GO:0051096; GO:0097193; GO:0140664 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]" GNLSKETKTILK 0.99123 -22.45 0 0 0 0 0 0 0 0 0 0 0 12.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5331 0 0 11.6484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2486 0 13.637 0 0 0 0 12.5675 0 0 0 0 0 0 0 0 0 12.7219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9561 0 13.9595 0 0 0 0 0 P58107 EPIPL_HUMAN Epiplakin (450 kDa epidermal antigen) EPPK1 EPIPL Homo sapiens (Human) intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; regulation of epithelium regeneration [GO:1905041]; wound healing [GO:0042060] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; membrane [GO:0016020]; perinucleolar compartment [GO:0097356] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; membrane [GO:0016020]; perinucleolar compartment [GO:0097356]; intermediate filament binding [GO:0019215]; keratin filament binding [GO:1990254]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; intermediate filament bundle assembly [GO:0045110]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; negative regulation of cell migration [GO:0030336]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; regulation of epithelium regeneration [GO:1905041]; wound healing [GO:0042060] GO:0003723; GO:0005198; GO:0005737; GO:0005856; GO:0005923; GO:0010839; GO:0016020; GO:0016323; GO:0016327; GO:0019215; GO:0030054; GO:0030056; GO:0030336; GO:0042060; GO:0042995; GO:0045095; GO:0045104; GO:0045109; GO:0045110; GO:0045111; GO:0050680; GO:0051548; GO:0061045; GO:0071944; GO:0097356; GO:1905041; GO:1990254 intermediate filament binding [GO:0019215]; keratin filament binding [GO:1990254]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] AEAEAEAGSPR 0.99123 -22.483 0 0 0 0 0 0 0 0 12.9268 11.5052 0 0 0 12.4213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9734 0 0 0 0 0 13.2683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4601 0 0 0 0 0 11.7829 11.9801 0 0 10.148 0 0 0 0 0 0 0 0 12.7004 0 12.183 0 0 0 11.5295 0 0 0 0 0 12.8545 0 14.4662 13.8692 0 15.7212 0 15.4352 16.8644 16.4903 15.5955 14.9555 15.9517 15.728 14.8171 15.3769 17.7756 15.7063 15.3959 0 0 14.2435 0 0 14.4225 12.6962 0 0 0 0 12.2278 0 10.0629 0 12.5523 12.4213 0 13.7708 0 0 13.7949 13.0863 12.9157 0 13.0232 0 0 0 0 0 15.067 0 0 0 0 0 13.4445 13.5188 0 13.4155 0 11.2943 0 0 0 0 13.2996 0 15.9645 12.3435 13.0173 12.9927 0 13.5962 0 0 13.3933 14.3006 13.6321 14.5082 0 13.3301 0 13.4855 0 0 10.8667 0 14.7099 14.8371 14.5435 0 0 0 12.6476 9.46722 0 0 0 0 Q05682 CALD1_HUMAN "Caldesmon, CDM" CALD1 CAD CDM Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; angiogenesis [GO:0001525]; muscle contraction [GO:0006936] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myofibril [GO:0030016]; plasma membrane [GO:0005886] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523]; actin filament bundle assembly [GO:0051017]; angiogenesis [GO:0001525]; muscle contraction [GO:0006936] GO:0001525; GO:0003779; GO:0005516; GO:0005523; GO:0005829; GO:0005856; GO:0005886; GO:0006936; GO:0015629; GO:0017022; GO:0030016; GO:0030478; GO:0045296; GO:0051017 actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523] ERREAEER 0.99123 -49.206 0 0 0 0 0 0 11.9808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6683 0 0 0 0 11.8413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7579 0 0 0 0 0 0 0 0 0 0 0 11.0032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2245 12.614 0 0 0 0 0 0 0 0 11.7066 0 13.1213 0 0 0 0 0 0 0 0 0 11.8615 0 12.7736 0 0 13.0003 0 0 0 0 0 0 10.7231 0 0 0 14.1882 13.4413 13.7383 0 10.6577 0 0 0 0 0 0 13.5005 0 0 0 0 14.1601 0 0 0 0 0 0 0 0 14.0972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07687 DLX2_HUMAN Homeobox protein DLX-2 DLX2 Homo sapiens (Human) brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cerebral cortex GABAergic interneuron fate commitment [GO:0021893]; embryonic cranial skeleton morphogenesis [GO:0048701]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb development [GO:0021772]; oligodendrocyte differentiation [GO:0048709]; positive regulation of amacrine cell differentiation [GO:1902871]; positive regulation of cell differentiation [GO:0045597]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; subpallium development [GO:0021544] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cerebral cortex GABAergic interneuron fate commitment [GO:0021893]; embryonic cranial skeleton morphogenesis [GO:0048701]; forebrain neuron differentiation [GO:0021879]; hippocampus development [GO:0021766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb development [GO:0021772]; oligodendrocyte differentiation [GO:0048709]; positive regulation of amacrine cell differentiation [GO:1902871]; positive regulation of cell differentiation [GO:0045597]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; subpallium development [GO:0021544]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0003727; GO:0005634; GO:0006357; GO:0007219; GO:0007420; GO:0009954; GO:0014016; GO:0021544; GO:0021766; GO:0021772; GO:0021879; GO:0021893; GO:0030154; GO:0042475; GO:0045597; GO:0045746; GO:0046533; GO:0048701; GO:0048709; GO:0048715; GO:0048755; GO:0051216; GO:1902871; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]" IVNGKPKK 0.99123 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6N2 TTC9B_HUMAN "Tetratricopeptide repeat protein 9B, TPR repeat protein 9B" TTC9B Homo sapiens (Human) AEGQRCYREK 0.99123 -22.464 12.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5746 0 0 12.9704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4839 11.9419 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8884 0 14.3366 0 0 13.4319 0 0 0 13.4323 0 0 0 11.2681 0 0 0 0 0 0 0 0 0 14.1817 13.0151 12.822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUI1 DECR2_HUMAN "Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], pDCR, EC 1.3.1.124 (2,4-dienoyl-CoA reductase 2) (Short chain dehydrogenase/reductase family 17C member 1)" DECR2 PDCR SDR17C1 Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; unsaturated fatty acid biosynthetic process [GO:0006636] cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] "cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; unsaturated fatty acid biosynthetic process [GO:0006636]" GO:0005777; GO:0005778; GO:0005829; GO:0006631; GO:0006636; GO:0008670; GO:0016628; GO:0019166; GO:0033540 "2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]" IAEIFMR 0.99123 -5.5635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5R6 DMRT1_HUMAN Doublesex- and mab-3-related transcription factor 1 (DM domain expressed in testis protein 1) DMRT1 DMT1 Homo sapiens (Human) cell morphogenesis [GO:0000902]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; meiosis I [GO:0007127]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of male gonad development [GO:2000020]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nodal signaling pathway [GO:1900107]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283] chromatin [GO:0000785]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell morphogenesis [GO:0000902]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; male germ cell proliferation [GO:0002176]; male sex determination [GO:0030238]; male sex differentiation [GO:0046661]; meiosis I [GO:0007127]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of male gonad development [GO:2000020]; positive regulation of meiosis I [GO:0060903]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of nodal signaling pathway [GO:1900107]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; sex differentiation [GO:0007548]; spermatogenesis [GO:0007283]" GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001674; GO:0002176; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0007127; GO:0007281; GO:0007283; GO:0007548; GO:0008354; GO:0030238; GO:0035556; GO:0042802; GO:0045835; GO:0045840; GO:0045944; GO:0046661; GO:0046872; GO:0048599; GO:0060008; GO:0060009; GO:0060903; GO:1900107; GO:1990837; GO:2000020 "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LPKCARCR 0.99123 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0269 13.1892 0 0 0 10.9495 0 0 0 0 0 0 0 0 0 0 0 0 10.6389 12.0148 0 12.3834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4662 0 0 0 0 0 0 11.0237 0 0 0 0 0 0 0 0 0 0 11.6231 0 12.0575 0 0 0 0 0 0 0 0 0 0 0 0 Q68DQ2 CRBG3_HUMAN "Very large A-kinase anchor protein, vlAKAP (Beta/gamma crystallin domain-containing protein 3)" CRYBG3 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] GO:0002088; GO:0005212; GO:0007601; GO:0030246; GO:0032991; GO:0051018 carbohydrate binding [GO:0030246]; protein kinase A binding [GO:0051018]; structural constituent of eye lens [GO:0005212] AEVMPVR 0.99124 -50.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9676 0 0 0 13.2147 0 0 0 0 0 0 0 0 11.716 0 12.2631 12.7543 0 0 0 0 10.7394 0 0 0 0 0 0 11.5664 0 0 0 0 12.4608 0 0 15.0728 14.3254 0 14.991 0 13.907 0 0 0 0 0 0 0 0 0 11.9488 0 12.8291 0 11.3381 0 0 13.5215 0 0 13.9476 0 0 0 0 0 0 0 0 12.1834 0 0 14.6787 0 13.9107 0 0 0 0 0 0 0 14.2197 13.637 0 17.0518 13.6319 0 0 14.4356 12.3283 12.8525 0 0 12.8897 13.3437 0 0 13.5655 11.7981 14.6055 0 0 0 0 14.611 0 0 13.3154 0 0 0 14.2362 13.3369 0 0 0 15.2156 0 0 0 11.0174 0 0 12.7 13.3914 13.8184 13.2384 13.6208 13.527 12.867 0 13.8399 13.4937 13.1127 0 14.5826 0 0 0 0 Q8N2S1 LTBP4_HUMAN "Latent-transforming growth factor beta-binding protein 4, LTBP-4" LTBP4 Homo sapiens (Human) elastic fiber assembly [GO:0048251]; hormone secretion [GO:0046879]; protein folding [GO:0006457]; regulation of cell growth [GO:0001558]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; elastic fiber assembly [GO:0048251]; hormone secretion [GO:0046879]; protein folding [GO:0006457]; regulation of cell growth [GO:0001558]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001527; GO:0001558; GO:0005024; GO:0005178; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0006457; GO:0007179; GO:0017015; GO:0031012; GO:0046879; GO:0048251; GO:0050431; GO:0062023 calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024] CDNTAGSFHCACPAGFR 0.99124 -19.089 0 0 0 0 0 0 0 0 0 0 14.8833 0 0 0 11.3193 0 0 0 14.5514 0 0 13.272 0 0 0 0 0 0 0 0 16.8216 0 0 0 11.39 0 0 14.9374 0 13.6599 0 16.2178 11.0268 16.5804 16.6626 0 0 0 12.6504 0 0 0 17.9206 18.6644 17.4414 17.0199 18.19 17.9937 17.7389 0 15.9663 9.15896 16.036 14.6542 0 16.8008 0 11.2934 11.505 0 0 0 0 0 14.8834 0 14.113 0 0 0 0 12.1848 0 15.1167 11.6202 11.5839 13.4026 14.0471 0 0 20.0899 0 0 0 13.8546 0 15.5172 14.8198 0 0 13.363 0 0 14.3397 13.96 0 0 0 0 0 13.5933 15.3133 0 0 12.6354 14.9878 13.7661 13.697 0 14.7185 0 0 13.0042 0 13.5372 13.227 0 0 0 13.435 0 0 0 0 13.8455 12.8801 20.2782 0 14.7573 0 0 0 0 15.2097 13.9763 0 15.7043 12.0904 16.1906 18.3274 0 13.0938 0 0 0 0 12.5071 19.4182 18.7557 17.7528 17.4592 17.1667 10.2465 0 0 0 12.8709 0 17.975 13.8375 14.838 20.5692 13.0572 0 14.263 0 0 18.1578 0 10.2434 Q969T4 UB2E3_HUMAN "Ubiquitin-conjugating enzyme E2 E3, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme E3) (UbcH9) (Ubiquitin carrier protein E3) (Ubiquitin-conjugating enzyme E2-23 kDa) (Ubiquitin-protein ligase E3)" UBE2E3 UBCE4 UBCH9 Homo sapiens (Human) protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of growth [GO:0040008] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of growth [GO:0040008] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0040008; GO:0061631; GO:0070534; GO:0070936; GO:0070979 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] IARQWTK 0.99124 -4.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95185 UNC5C_HUMAN Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C) UNC5C UNC5H3 Homo sapiens (Human) anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; regulation of neuron migration [GO:2001222] anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; brain development [GO:0007420]; chemorepulsion of axon [GO:0061643]; dorsal root ganglion development [GO:1990791]; ectopic germ cell programmed cell death [GO:0035234]; positive regulation of apoptotic process [GO:0043065]; positive regulation of developmental process [GO:0051094]; positive regulation of reproductive process [GO:2000243]; regulation of neuron migration [GO:2001222] GO:0005042; GO:0005043; GO:0005886; GO:0006915; GO:0007411; GO:0007420; GO:0009986; GO:0015631; GO:0016021; GO:0019901; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0033564; GO:0035234; GO:0043025; GO:0043065; GO:0045202; GO:0051094; GO:0061643; GO:0070161; GO:1990791; GO:2000243; GO:2001222 netrin receptor activity [GO:0005042]; netrin receptor activity involved in chemorepulsion [GO:0005043]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631] CGRGYQKR 0.99125 -4.7661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4127 0 0 0 0 11.4489 0 0 0 0 0 0 0 0 0 0 0 0 10.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0369 0 0 0 0 0 0 0 0 0 0 14.3569 0 0 0 0 0 0 0 0 0 0 0 12.1401 13.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6118 0 0 0 0 0 0 0 12.3025 0 0 0 0 0 0 0 0 0 0 0 0 0 12.907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6736 0 0 0 12.1859 0 0 0 0 0 0 0 0 0 P36269 GGT5_HUMAN "Glutathione hydrolase 5 proenzyme, EC 3.4.19.13 (Gamma-glutamyl transpeptidase-related enzyme, GGT-rel) (Gamma-glutamyltransferase 5, GGT 5, EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase, EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain ]" GGT5 GGTLA1 Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; cellular amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508] GO:0000048; GO:0002951; GO:0005886; GO:0006508; GO:0006520; GO:0006631; GO:0006750; GO:0006751; GO:0006954; GO:0016021; GO:0031226; GO:0036374; GO:0102953; GO:0103068; GO:1901750 glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048] ARGYGATVSLVLLGLGLALAVIVLAVVLSR 0.99125 -4.7665 0 13.3393 13.7554 11.6937 0 0 0 12.2916 0 0 0 0 0 0 0 0 0 0 0 10.8524 0 14.8379 12.419 12.0321 11.9593 0 0 0 10.1149 10.8546 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6152 0 0 0 0 0 9.25397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0011 0 0 0 0 11.2696 15.0598 15.8585 16.2277 0 15.4269 15.6372 15.63 16.1585 16.6104 15.8609 18.0897 17.1841 16.9029 15.8833 16.0279 16.2979 16.0261 16.3426 16.4437 15.7526 16.2237 16.7704 15.8862 16.1832 16.3801 16.2572 13.2959 16.1478 15.7908 16.3668 16.7394 15.8077 15.3509 16.1201 16.8664 16.7236 16.1993 15.4726 15.6747 16.0043 16.4265 14.4049 16.2956 0 15.6868 15.6746 15.6731 15.8946 15.7005 16.0854 16.156 16.3073 16.1095 15.9633 15.5868 0 0 14.0816 13.8898 15.2343 0 15.6757 15.7312 15.7105 16.1168 16.2823 13.463 13.5693 0 15.4185 0 13.9843 0 0 0 14.7847 16.2273 0 0 12.3774 15.0218 16.0544 15.3483 0 0 0 0 0 0 0 0 10.8797 0 0 0 0 0 0 14.7436 0 0 0 0 0 0 12.5512 Q12899 TRI26_HUMAN "Tripartite motif-containing protein 26, EC 2.3.2.27 (Acid finger protein, AFP) (RING finger protein 95) (Zinc finger protein 173)" TRIM26 RNF95 ZNF173 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; suppression of viral release by host [GO:0044790] GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0016567; GO:0044790; GO:0045087; GO:0046597; GO:0046872; GO:0051091; GO:0061630 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DPVTIDCGHVFCR 0.99125 -21.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6392 0 0 0 0 0 0 0 0 0 0 0 0 12.4421 11.938 0 0 0 0 0 0 0 0 0 0 0 12.0537 0 0 0 0 0 0 13.8673 0 12.5283 0 14.8358 0 0 12.9 0 15.7186 0 0 0 0 13.1459 12.3276 0 0 12.8944 0 0 0 0 0 0 0 0 0 0 0 0 12.8112 0 0 0 0 0 0 0 0 0 0 14.2575 0 0 0 0 0 0 0 0 12.5768 11.9776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15154 PCM1_HUMAN "Pericentriolar material 1 protein, PCM-1, hPCM-1" PCM1 Homo sapiens (Human) centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring [GO:0034453]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176] apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991] apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring [GO:0034453]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176] GO:0000242; GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007098; GO:0016020; GO:0022027; GO:0031122; GO:0031965; GO:0032991; GO:0034451; GO:0034453; GO:0034454; GO:0035176; GO:0035735; GO:0035869; GO:0036064; GO:0042802; GO:0045177; GO:0050768; GO:0060271; GO:0071539; GO:0090316; GO:0097150; GO:1905515 identical protein binding [GO:0042802] DETETVKQTQTSEVYDGPK 0.99125 -1.81 0 0 0 0 0 0 0 0 0 0 0 11.6008 0 10.9776 0 0 0 0 12.9825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1215 0 0 0 0 10.8921 0 13.7715 0 0 0 0 10.3696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7714 0 11.0054 0 0 0 0 0 0 0 0 0 15.4365 0 0 0 0 12.2529 0 0 0 0 0 0 0 12.2054 0 12.6092 0 13.3685 12.6016 0 0 0 0 12.1187 0 0 0 0 0 0 11.9396 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7456 0 13.0831 0 0 0 0 0 0 0 0 0 0 0 0 12.0512 0 0 0 11.477 0 11.0426 11.0832 0 12.3251 0 12.0305 0 0 0 0 0 0 15.24 0 0 13.9447 0 0 0 0 11.1523 0 0 0 10.5515 0 0 12.7374 0 0 0 12.3927 11.7302 0 0 0 0 Q16517 NNAT_HUMAN Neuronatin NNAT Homo sapiens (Human) brain development [GO:0007420]; positive regulation of insulin secretion [GO:0032024]; protein lipoylation [GO:0009249] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; brain development [GO:0007420]; positive regulation of insulin secretion [GO:0032024]; protein lipoylation [GO:0009249] GO:0005737; GO:0007420; GO:0009249; GO:0032024 LAYTVSR 0.99125 -19.105 0 0 0 17.0153 0 13.8945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6N021 TET2_HUMAN "Methylcytosine dioxygenase TET2, EC 1.14.11.n2" TET2 KIAA1546 Nbla00191 Homo sapiens (Human) 5-methylcytosine catabolic process [GO:0006211]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; histone H3-K4 trimethylation [GO:0080182]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; response to organic cyclic compound [GO:0014070] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; histone H3-K4 trimethylation [GO:0080182]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; response to organic cyclic compound [GO:0014070] GO:0002521; GO:0003677; GO:0005634; GO:0006211; GO:0006325; GO:0006493; GO:0007049; GO:0008198; GO:0008270; GO:0014070; GO:0030099; GO:0035511; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0080182 DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270] EIMEERFGQK 0.99125 -7.5104 0 0 0 13.2362 12.7382 0 0 0 0 0 0 0 0 0 0 13.6169 0 13.5375 14.1479 14.8148 14.6392 0 13.7197 12.5568 0 14.6078 15.1959 0 13.3529 13.7162 14.4116 0 0 0 0 0 15.0291 0 0 16.773 0 16.6644 13.6121 17.0523 0 15.2291 0 0 0 0 0 0 0 0 0 0 13.8576 0 17.5352 0 0 0 0 0 17.2512 0 0 0 0 0 0 0 12.8242 12.97 0 0 0 0 0 0 0 0 0 12.9169 13.6353 0 0 0 13.5167 13.3341 13.2473 0 0 12.3518 0 13.5118 14.3499 0 13.9087 0 13.4398 13.2269 0 14.2964 15.2746 0 13.2056 0 0 0 0 0 0 14.3989 0 0 0 13.3351 0 0 0 12.0063 0 11.637 0 0 0 12.8462 12.5022 0 12.4118 0 0 0 0 0 0 0 0 0 11.1268 0 0 0 0 0 0 0 0 0 0 0 0 13.1373 0 13.114 0 0 0 0 0 0 15.4182 0 0 0 0 0 0 0 0 0 0 0 10.8448 0 0 0 0 0 Q92817 EVPL_HUMAN Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210) EVPL Homo sapiens (Human) epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198]; epidermis development [GO:0008544]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; wound healing [GO:0042060] GO:0001533; GO:0005198; GO:0005737; GO:0005829; GO:0008544; GO:0016020; GO:0018149; GO:0019215; GO:0030057; GO:0030216; GO:0031424; GO:0042060; GO:0045104; GO:0045111; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; structural molecule activity [GO:0005198] AQVEEEGKR 0.99125 -22.032 0 0 0 0 0 0 0 0 15.0814 16.0134 0 13.3482 11.9305 11.6188 0 0 0 14.5315 0 0 0 0 0 13.4439 0 0 0 0 0 13.6601 0 0 0 10.5209 11.5937 15.4232 13.8195 0 12.1194 15.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9563 0 0 0 11.4408 0 12.4832 0 0 0 0 16.974 15.5235 0 0 13.9229 0 0 0 14.3425 13.771 0 0 13.4107 13.9182 0 0 0 11.5771 0 14.6141 14.1479 15.1384 0 0 0 0 0 14.4375 0 0 0 0 0 0 12.7852 14.8751 0 13.7399 0 14.4325 0 0 0 0 13.6482 0 0 0 0 0 0 0 0 0 0 14.7551 14.7294 14.2389 13.3464 0 0 0 0 0 0 0 0 0 0 0 0 10.8282 18.7974 14.8264 14.5699 0 17.8986 0 18.0312 0 0 14.4351 0 0 0 0 0 13.0391 0 14.7208 0 12.0836 0 13.545 Q969X0 RIPL2_HUMAN RILP-like protein 2 (Rab-interacting lysosomal protein-like 2) (p40phox-binding protein) RILPL2 RLP2 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445] GO:0003382; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0016020; GO:0036064; GO:0042802; GO:0046983; GO:0060271; GO:1903445 identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983] EEEEEEGEEDEER 0.99125 -23.272 0 0 0 0 0 0 0 0 13.3278 0 0 0 0 0 0 0 0 0 0 0 0 0 11.469 10.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.754 0 0 0 0 0 0 0 0 14.3655 0 0 0 0 0 11.5185 0 0 0 0 0 0 0 11.7474 0 14.2011 13.0008 14.7487 15.0327 13.7869 0 0 0 0 13.8824 0 0 0 0 0 13.6164 0 0 0 10.8939 0 0 0 0 0 9.96838 13.1313 0 12.0713 0 0 10.7717 0 0 11.0994 12.636 0 0 0 0 0 0 0 0 12.2584 0 0 0 0 0 0 13.6034 0 0 0 0 14.5203 10.1011 0 0 0 0 0 0 0 12.6151 0 0 0 12.4735 0 0 13.786 14.484 0 0 0 14.4529 0 0 0 0 14.0615 0 0 0 14.3045 0 0 13.7521 0 0 14.5773 0 0 11.1831 0 Q99698 LYST_HUMAN Lysosomal-trafficking regulator (Beige homolog) LYST CHS CHS1 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031] cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630] cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; protein kinase binding [GO:0019901]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; leukocyte chemotaxis [GO:0030595]; lysosome organization [GO:0007040]; mast cell secretory granule organization [GO:0033364]; melanosome organization [GO:0032438]; natural killer cell mediated cytotoxicity [GO:0042267]; phagocytosis [GO:0006909]; pigmentation [GO:0043473]; protein localization [GO:0008104]; protein transport [GO:0015031] GO:0005829; GO:0006909; GO:0007040; GO:0008104; GO:0015031; GO:0015630; GO:0016020; GO:0019901; GO:0030595; GO:0032438; GO:0032510; GO:0033364; GO:0042267; GO:0042742; GO:0042832; GO:0043473; GO:0051607 protein kinase binding [GO:0019901] EAYPKRR 0.99125 -52.885 0 11.1162 0 0 10.4215 0 0 0 13.0833 0 0 0 13.4881 0 13.9332 0 0 12.4889 0 0 14.6953 0 14.2107 11.489 0 13.8977 14.0194 13.9989 0 15.0446 10.1594 0 12.0495 13.8596 13.5022 10.1923 0 10.3225 0 0 0 0 0 13.7912 0 11.0895 14.4289 12.9167 0 15.329 0 12.422 11.7241 0 0 11.9205 0 0 0 0 0 0 0 0 0 0 0 0 11.796 16.0571 16.0272 13.5585 12.9382 9.07537 13.5158 14.9648 13.2919 12.626 17.3698 14.3624 14.3461 0 16.002 15.5793 14.1601 14.0216 15.7915 14.6151 0 0 0 15.6596 16.4815 11.1314 16.6963 13.6846 14.67 15.2673 14.6864 14.5497 0 0 13.9755 0 14.5153 12.7555 13.8474 0 0 10.2709 11.3252 14.7416 13.8857 0 0 16.0157 13.2109 15.6555 13.5873 16.4569 15.4606 15.3706 13.5852 0 11.831 14.1597 0 0 15.4581 14.072 18.0467 0 14.1907 10.3063 0 15.7686 14.3126 0 0 15.3138 13.7084 15.471 0 16.6719 15.8268 12.4822 11.5925 0 14.1177 12.7569 0 0 0 0 0 12.4972 15.5923 0 14.2538 14.7028 0 13.4528 12.1698 14.0594 11.917 12.1616 0 13.5008 12.7005 13.5361 0 12.9126 15.1825 14.7563 14.8727 0 13.6103 0 0 0 Q9NWK9 BCD1_HUMAN Box C/D snoRNA protein 1 (Serologically defined breast cancer antigen NY-BR-75) (Zinc finger HIT domain-containing protein 6) ZNHIT6 BCD1 C1orf181 Homo sapiens (Human) "box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein complex oligomerization [GO:0051259]; snoRNA localization [GO:0048254]" extracellular exosome [GO:0070062]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761] "extracellular exosome [GO:0070062]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; TFIID-class transcription factor complex binding [GO:0001094]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein complex oligomerization [GO:0051259]; snoRNA localization [GO:0048254]" GO:0000463; GO:0000492; GO:0001094; GO:0005634; GO:0019899; GO:0042802; GO:0046872; GO:0048254; GO:0051117; GO:0051259; GO:0070062; GO:0070761 ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; TFIID-class transcription factor complex binding [GO:0001094] CETCGTEEAKYRCPR 0.99125 -23.316 0 0 0 0 0 10.3863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9761 0 0 0 13.5557 0 10.4083 0 0 0 0 0 10.6579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9512 0 10.385 0 0 0 0 0 0 0 13.2318 14.0002 10.6346 0 15.6565 0 0 0 0 15.5938 0 0 0 0 0 0 13.0615 0 0 15.3773 0 0 0 0 0 0 0 0 10.662 0 12.3091 0 0 0 0 0 0 0 0 0 0 12.4765 0 0 18.0927 0 0 0 0 12.4384 13.7344 0 0 0 14.1831 0 0 0 0 0 14.804 14.3348 12.9929 0 14.6468 0 12.9826 0 0 0 0 11.1014 0 0 0 0 0 0 12.8818 0 O00212 RHOD_HUMAN "Rho-related GTP-binding protein RhoD (Rho-related protein HP1, RhoHP1)" RHOD ARHD Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; focal adhesion assembly [GO:0048041]; lamellipodium assembly [GO:0030032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; focal adhesion assembly [GO:0048041]; lamellipodium assembly [GO:0030032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0000139; GO:0003924; GO:0005085; GO:0005525; GO:0005741; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007266; GO:0008360; GO:0010008; GO:0016477; GO:0019901; GO:0030032; GO:0030335; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0045785; GO:0048041; GO:0051017; GO:0051056 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901] GRNFWRR 0.99126 -4.7794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2975 0 12.9019 0 0 0 10.9596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7282 0 0 0 0 0 12.5099 0 0 0 12.569 0 0 0 0 0 0 0 0 0 0 0 0 12.0333 0 12.9448 13.165 0 0 0 12.9739 13.3355 0 13.7248 12.948 0 11.6628 0 0 0 0 0 0 0 0 0 0 0 11.2957 0 0 12.8021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00292 LFTY2_HUMAN "Left-right determination factor 2 (Endometrial bleeding-associated factor) (Left-right determination factor A) (Protein lefty-2) (Protein lefty-A) (Transforming growth factor beta-4, TGF-beta-4)" LEFTY2 EBAF LEFTA LEFTYA TGFB4 PSEC0024 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]; BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] GO:0005125; GO:0005160; GO:0005576; GO:0005615; GO:0008083; GO:0010862; GO:0030509; GO:0031093; GO:0060395; GO:0062023 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160] AQYVVLLR 0.99126 -22.07 0 0 13.2581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1498 0 0 0 0 0 0 0 0 0 0 0 11.9319 0 0 12.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5132 0 0 0 0 0 0 0 13.3979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.64 0 0 O14960 LECT2_HUMAN "Leukocyte cell-derived chemotaxin-2, LECT-2, hLECT2" LECT2 Homo sapiens (Human) chemotaxis [GO:0006935]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; chemotaxis [GO:0006935]; skeletal system development [GO:0001501] GO:0001501; GO:0005615; GO:0005737; GO:0005829; GO:0006935; GO:0042802; GO:0043231; GO:0046872 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] GPIKKGEK 0.99126 -4.7708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8465 0 0 0 0 0 0 0 0 10.8602 0 0 0 0 0 0 0 0 0 0 14.3076 10.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7152 0 0 0 0 0 0 P04183 KITH_HUMAN "Thymidine kinase, cytosolic, EC 2.7.1.21" TK1 Homo sapiens (Human) DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; phosphorylation [GO:0016310]; protein homotetramerization [GO:0051289]; thymidine metabolic process [GO:0046104] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270]; DNA biosynthetic process [GO:0071897]; nucleobase-containing compound metabolic process [GO:0006139]; phosphorylation [GO:0016310]; protein homotetramerization [GO:0051289]; thymidine metabolic process [GO:0046104] GO:0004797; GO:0005524; GO:0005829; GO:0006139; GO:0008270; GO:0016310; GO:0042802; GO:0046104; GO:0051289; GO:0071897 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270] CLVIKYAK 0.99126 -1.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13073 COX41_HUMAN "Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1, COX IV-1)" COX4I1 COX4 Homo sapiens (Human) "cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cytochrome-c oxidase activity [GO:0004129]; cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" GO:0004129; GO:0005654; GO:0005739; GO:0005743; GO:0005751; GO:0005829; GO:0006091; GO:0006123; GO:0016020; GO:0016021; GO:0031966; GO:0045333 cytochrome-c oxidase activity [GO:0004129] AHESVVK 0.99126 -22.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2248 11.0317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0509 0 0 0 14.8761 0 0 15.3681 0 0 0 0 0 0 0 0 0 13.6064 13.0966 13.5167 13.6468 13.5075 0 0 13.2017 13.467 0 12.1897 0 13.1401 0 0 0 0 0 0 13.4265 0 13.3714 0 0 12.1401 0 0 0 0 0 0 0 12.996 0 13.6385 13.5479 0 0 0 0 0 11.769 0 0 0 0 0 0 0 0 0 13.2538 12.8142 13.2232 0 0 11.8388 0 0 12.2107 0 0 0 0 13.6413 0 0 0 0 0 0 0 0 11.3884 12.5929 0 0 0 0 0 11.3006 0 0 13.6068 0 0 0 14.9496 0 Q6WN34 CRDL2_HUMAN "Chordin-like protein 2 (Breast tumor novel factor 1, BNF-1) (Chordin-related protein 2)" CHRDL2 BNF1 CHL2 UNQ765/PRO1557 Homo sapiens (Human) cartilage development [GO:0051216]; cell differentiation [GO:0030154]; negative regulation of BMP signaling pathway [GO:0030514]; ossification [GO:0001503] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; negative regulation of BMP signaling pathway [GO:0030514]; ossification [GO:0001503] GO:0001503; GO:0005615; GO:0005737; GO:0030154; GO:0030514; GO:0036122; GO:0051216 BMP binding [GO:0036122] CPKAPGR 0.99126 -4.7703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2426 0 0 13.8685 13.1569 16.7128 13.9726 13.7699 13.9779 0 14.187 13.6245 0 0 13.94 0 13.5063 0 0 0 0 13.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7299 0 0 12.9806 0 0 14.9148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7837 0 0 0 0 0 0 0 0 0 Q7Z4G4 TRM11_HUMAN "tRNA (guanine(10)-N2)-methyltransferase homolog, EC 2.1.1.- (tRNA guanosine-2'-O-methyltransferase TRM11 homolog)" TRMT11 C6orf75 MDS024 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049] GO:0000049; GO:0004809; GO:0005737; GO:0008168 methyltransferase activity [GO:0008168]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049] GIEKWEK 0.99126 -22.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6826 0 0 0 0 0 11.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7953 0 13.9238 0 0 0 14.0438 12.6653 0 14.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3185 0 0 0 0 0 0 0 0 Q86VV4 RNB3L_HUMAN Ran-binding protein 3-like RANBP3L Homo sapiens (Human) mesenchymal cell differentiation involved in bone development [GO:1901706]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of myoblast differentiation [GO:0045663]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; SMAD binding [GO:0046332]; mesenchymal cell differentiation involved in bone development [GO:1901706]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of myoblast differentiation [GO:0045663]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006611; GO:0045663; GO:0045668; GO:0046332; GO:0050790; GO:1901706 SMAD binding [GO:0046332] EKPFKSIPK 0.99126 -4.7772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7013 0 0 0 0 0 0 0 0 13.5313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2609 0 0 0 12.9537 0 0 12.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7063 0 0 0 0 12.9259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2363 0 0 0 0 0 0 0 0 0 0 0 12.0072 Q9P2I0 CPSF2_HUMAN "Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit, CPSF 100 kDa subunit)" CPSF2 CPSF100 KIAA1367 Homo sapiens (Human) mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] GO:0003723; GO:0005654; GO:0005847; GO:0006378; GO:0006398; GO:0016020; GO:0098789 RNA binding [GO:0003723] FSQIVNLK 0.99126 -4.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1146 0 17.1891 0 0 12.3309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7717 10.7601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UP79 ATS8_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 8, ADAM-TS 8, ADAM-TS8, ADAMTS-8, EC 3.4.24.- (METH-2) (METH-8)" ADAMTS8 METH2 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; low-affinity phosphate transmembrane transporter activity [GO:0009673]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; negative regulation of cell population proliferation [GO:0008285]; proteolysis [GO:0006508] GO:0004222; GO:0005178; GO:0005576; GO:0006508; GO:0008201; GO:0008237; GO:0008270; GO:0008285; GO:0009673; GO:0030198; GO:0031012; GO:0062023 heparin binding [GO:0008201]; integrin binding [GO:0005178]; low-affinity phosphate transmembrane transporter activity [GO:0009673]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] CGVCGGK 0.99126 -4.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0181 0 0 0 0 0 0 0 0 10.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3599 12.4583 0 10.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8031 9.68636 11.7208 0 0 0 14.9107 14.9979 13.025 0 10.3476 12.5229 0 12.899 0 14.3914 0 0 14.6659 11.396 13.7092 0 13.017 14.4069 0 0 0 0 9.77896 13.0435 0 0 0 14.0314 0 0 0 0 0 15.7802 0 0 0 11.5425 0 11.9352 0 13.5597 0 0 0 12.8969 0 10.6679 0 12.6792 0 14.0531 0 0 13.7476 0 12.6815 0 10.2902 0 13.1534 0 0 13.907 11.3062 0 0 13.5888 0 0 0 11.8767 0 0 11.6495 16.0031 0 0 0 12.7305 0 0 0 0 0 16.8428 18.4515 17.6873 17.3481 17.093 17.2706 18.0109 18.2437 17.2016 16.7 12.8799 17.0986 17.5004 17.0633 0 0 10.8287 17.8815 17.0214 17.1674 16.8441 0 0 O75165 DJC13_HUMAN "DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8, RME-8)" DNAJC13 KIAA0678 RME8 Homo sapiens (Human) endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954] GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641 AAKEVEKFAK 0.99127 -48.518 0 0 0 0 0 12.2118 0 0 14.843 14.8684 0 14.9486 0 13.5223 10.2752 0 0 0 0 13.6086 13.716 0 0 0 0 0 0 0 0 0 0 0 13.4555 14.4585 14.5516 0 10.4274 0 14.4267 14.754 0 0 0 0 0 0 0 0 12.5767 0 0 13.6369 14.0387 13.7874 0 0 12.6176 16.8881 0 0 0 0 0 0 0 0 0 20.7829 0 0 0 0 0 14.6402 0 13.5826 13.1348 12.7842 14.6258 0 0 14.5856 11.4273 14.8774 16.4497 14.4592 13.3555 14.2462 13.3715 14.737 0 12.3403 13.5127 14.6638 15.0342 0 0 0 16.0731 14.7186 12.6956 12.4275 0 11.2339 13.4693 0 0 14.3805 13.8891 0 0 12.862 12.2285 0 0 15.4247 0 0 13.9508 0 0 14.0217 13.799 0 0 12.5728 0 13.0913 0 12.0299 0 13.4422 14.4483 13.4383 0 0 0 14.837 14.2205 0 0 12.8395 12.6376 14.2202 13.4001 0 13.5392 0 0 14.5848 12.0783 13.3394 13.8676 12.8207 0 0 14.9239 0 0 12.4358 9.71905 12.2333 0 0 0 12.5539 0 0 13.7324 0 0 13.6069 13.501 0 0 0 0 15.4746 0 0 O95503 CBX6_HUMAN Chromobox protein homolog 6 CBX6 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519] heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; single-stranded RNA binding [GO:0003727]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0000792; GO:0003727; GO:0005634; GO:0005654; GO:0006325; GO:0031519 single-stranded RNA binding [GO:0003727] IEYLVKWK 0.99127 -22.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4935 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7601 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1747 0 0 0 0 0 0 0 0 0 11.6428 12.1479 0 0 0 0 0 0 16.8512 16.963 0 0 0 15.8753 0 0 0 0 0 0 11.5377 0 0 0 0 0 0 0 0 14.247 0 0 14.018 0 13.7334 0 0 0 0 11.8192 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2788 0 0 0 10.2341 0 0 0 0 0 15.5204 0 0 15.693 15.6886 0 0 0 0 0 15.5633 0 0 0 0 0 0 15.1133 0 15.321 0 15.2083 15.2103 14.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3438 14.4836 0 0 0 0 0 0 0 P05156 CFAI_HUMAN "Complement factor I, EC 3.4.21.45 (C3B/C4B inactivator) [Cleaved into: Complement factor I heavy chain; Complement factor I light chain ]" CFI IF Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; regulation of complement activation, alternative pathway [GO:0030451]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; serine-type endopeptidase complex [GO:1905370] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; serine-type endopeptidase complex [GO:1905370]; metal ion binding [GO:0046872]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]; regulation of complement activation, alternative pathway [GO:0030451]" GO:0004252; GO:0005044; GO:0005576; GO:0005615; GO:0006508; GO:0006958; GO:0016020; GO:0030451; GO:0045087; GO:0046872; GO:0070062; GO:1905370 metal ion binding [GO:0046872]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252] ACDGINDCGDQSDELCCK 0.99127 -5.9479 0 0 0 0 0 0 0 0 0 0 0 11.4633 0 0 0 0 0 0 0 0 0 0 0 14.5182 0 0 0 0 0 0 0 0 12.9964 0 11.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.498 0 0 0 0 0 12.847 0 10.2192 0 0 0 0 0 0 0 0 0 0 11.2016 0 0 0 0 0 14.2338 0 0 0 0 0 0 0 12.5523 0 13.5591 0 0 0 0 0 0 0 0 0 12.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7438 0 0 0 0 0 0 0 0 0 0 0 12.1869 0 0 0 0 0 0 0 0 0 12.9166 0 0 0 0 0 0 0 0 0 0 13.329 0 0 0 0 0 13.1013 0 0 14.0463 0 0 13.4105 11.3418 0 0 0 13.7165 0 12.4919 0 0 P16871 IL7RA_HUMAN "Interleukin-7 receptor subunit alpha, IL-7 receptor subunit alpha, IL-7R subunit alpha, IL-7R-alpha, IL-7RA (CDw127) (CD antigen CD127)" IL7R Homo sapiens (Human) B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; immune response [GO:0006955]; lymph node development [GO:0048535]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of T cell differentiation in thymus [GO:0033089]; regulation of cell size [GO:0008361]; regulation of DNA recombination [GO:0000018]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; T cell mediated cytotoxicity [GO:0001913] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; cytokine receptor activity [GO:0004896]; interleukin-7 receptor activity [GO:0004917]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; immune response [GO:0006955]; lymph node development [GO:0048535]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of T cell differentiation in thymus [GO:0033089]; regulation of cell size [GO:0008361]; regulation of DNA recombination [GO:0000018]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; T cell mediated cytotoxicity [GO:0001913] GO:0000018; GO:0000902; GO:0001782; GO:0001913; GO:0001915; GO:0003823; GO:0004896; GO:0004917; GO:0005576; GO:0005654; GO:0005829; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0008284; GO:0008361; GO:0009897; GO:0010467; GO:0010628; GO:0016021; GO:0019221; GO:0030097; GO:0030669; GO:0033077; GO:0033089; GO:0042100; GO:0043029; GO:0046427; GO:0048535; GO:0050830; GO:0070233; GO:1904894 antigen binding [GO:0003823]; cytokine receptor activity [GO:0004896]; interleukin-7 receptor activity [GO:0004917] GFWSEWSPSYYFR 0.99127 -22.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5022 0 0 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 12.0954 0 11.8138 0 0 0 0 0 0 0 0 0 0 14.9052 0 12.7225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1518 0 0 14.5303 0 0 0 0 0 0 0 14.3749 0 0 0 12.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62861 RS30_HUMAN FAU ubiquitin-like and ribosomal protein S30 [Cleaved into: Ubiquitin-like protein FUBI; 40S ribosomal protein S30 (Small ribosomal subunit protein eS30) ] FAU Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small ribosomal subunit [GO:0015935] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] GO:0000028; GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0019731; GO:0022626; GO:0022627; GO:0050830; GO:0061844 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] KGPNANS 0.99127 -22.265 0 0 0 0 0 0 0 0 9.95321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7886 0 0 12.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3267 0 0 10.9301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q09013 DMPK_HUMAN "Myotonin-protein kinase, MT-PK, EC 2.7.11.1 (DM-kinase, DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase)" DMPK DM1PK MDPK Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; muscle cell apoptotic process [GO:0010657]; nuclear envelope organization [GO:0006998]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction [GO:0014853]; regulation of heart contraction [GO:0008016]; regulation of myotube differentiation [GO:0010830]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of mitochondrial outer membrane [GO:0031307]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of mitochondrial outer membrane [GO:0031307]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin phosphatase regulator activity [GO:0017020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; muscle cell apoptotic process [GO:0010657]; nuclear envelope organization [GO:0006998]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction [GO:0014853]; regulation of heart contraction [GO:0008016]; regulation of myotube differentiation [GO:0010830]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; regulation of sodium ion transport [GO:0002028]; regulation of synapse structural plasticity [GO:0051823] GO:0002028; GO:0004674; GO:0005524; GO:0005640; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006874; GO:0006998; GO:0008016; GO:0010657; GO:0010830; GO:0014722; GO:0014853; GO:0017020; GO:0018105; GO:0031307; GO:0031965; GO:0033017; GO:0035556; GO:0046872; GO:0051823; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; myosin phosphatase regulator activity [GO:0017020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DIKPDNILLDR 0.99127 -22.321 0 0 0 0 0 0 0 0 0 0 0 14.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9728 0 11.7865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5876 0 0 0 0 0 0 0 0 0 0 0 13.7582 0 0 0 0 0 0 0 0 0 14.3053 0 0 13.4665 11.3194 13.6349 0 0 0 0 0 0 0 0 0 13.0914 0 0 0 0 0 0 0 0 0 0 12.9087 0 0 0 0 0 15.2608 0 0 0 0 0 0 0 0 14.2722 15.0111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5501 12.0848 0 0 0 0 11.3345 0 0 0 17.0375 0 10.77 0 0 12.574 14.6175 0 0 12.5943 0 Q2WGJ6 KLH38_HUMAN Kelch-like protein 38 KLHL38 C8orfK36 Homo sapiens (Human) AMFCSSFR 0.99127 -22.291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7735 11.9281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4065 0 0 0 0 0 12.8816 0 0 0 0 0 11.2696 0 0 12.1112 0 0 0 0 0 0 0 0 0 0 0 0 12.9897 0 0 0 0 0 0 0 0 11.9586 0 11.8515 0 0 0 10.9299 0 0 0 0 13.9985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2039 0 0 0 0 0 0 0 0 14.1522 0 0 0 12.5631 0 0 0 0 0 0 Q4G0U5 PCDP1_HUMAN Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1) CFAP221 PCDP1 Homo sapiens (Human) cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; manchette [GO:0002177]; sperm flagellum [GO:0036126] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; manchette [GO:0002177]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316] GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0044458; GO:0051649; GO:0060271; GO:0090660; GO:0097729; GO:0120197; GO:0120316 calmodulin binding [GO:0005516] AMMHINFHR 0.99127 -22.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4907 0 0 13.2078 0 0 0 0 0 0 0 0 0 0 0 0 14.1556 0 0 0 0 0 0 0 0 14.1727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7497 0 0 0 0 0 11.3934 0 14.068 0 13.3933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0987 0 0 0 0 0 0 0 0 0 0 0 14.5866 0 0 0 0 0 0 0 0 Q5BN46 PIRC1_HUMAN "Piercer of microtubule wall 1 protein, Pierce1 (UPF0691 protein C9orf116) (p53-induced expression in RB-null cells protein 1)" PIERCE1 Homo sapiens (Human) axoneme assembly [GO:0035082]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV-C [GO:0071494]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; establishment of left/right asymmetry [GO:0061966]; regulation of gene expression [GO:0010468] axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; nucleus [GO:0005634] axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; axoneme assembly [GO:0035082]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV-C [GO:0071494]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; establishment of left/right asymmetry [GO:0061966]; regulation of gene expression [GO:0010468] GO:0003341; GO:0005634; GO:0005737; GO:0005879; GO:0006974; GO:0007368; GO:0010468; GO:0035082; GO:0061966; GO:0071494 MAEECPRACAEPVAPK 0.99127 -4.6523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7201 0 0 0 0 0 0 0 11.925 12.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6966 0 13.5191 0 0 0 0 12.9262 0 0 0 0 0 0 0 0 0 0 12.8851 0 0 0 12.2174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.862 0 0 12.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0656 0 0 0 12.6123 0 0 0 0 0 0 12.2418 0 12.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2909 0 0 0 0 11.9356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7N2 LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 (ES cell-associated protein 11) L1TD1 ECAT11 Homo sapiens (Human) "transposition, RNA-mediated [GO:0032197]" intracellular membrane-bounded organelle [GO:0043231]; ribonucleoprotein complex [GO:1990904] "intracellular membrane-bounded organelle [GO:0043231]; ribonucleoprotein complex [GO:1990904]; single-stranded RNA binding [GO:0003727]; transposition, RNA-mediated [GO:0032197]" GO:0003727; GO:0032197; GO:0043231; GO:1990904 single-stranded RNA binding [GO:0003727] AVLGGKATIPEVK 0.99127 -49.058 0 0 0 0 13.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3618 0 0 11.1268 0 13.7657 15.0759 0 0 0 0 14.6039 12.5009 0 0 0 0 0 12.1483 15.8387 0 13.4198 17.2378 16.9323 12.9085 13.4842 15.4544 13.3058 0 0 0 11.6122 0 13.8154 0 14.1553 0 0 13.6213 13.0932 0 0 0 13.3588 0 0 10.5465 14.3811 12.8478 14.6162 10.8711 0 0 0 13.064 0 0 13.5847 0 0 10.4775 0 0 0 0 0 0 0 0 10.0163 12.9451 14.8955 0 0 0 0 0 0 0 0 0 13.2192 0 0 13.9673 14.2521 0 0 0 0 0 0 13.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5613 0 0 12.9335 0 Q6P3X8 PGBD2_HUMAN PiggyBac transposable element-derived protein 2 PGBD2 Homo sapiens (Human) sequence-specific DNA binding [GO:0043565] GO:0043565 sequence-specific DNA binding [GO:0043565] AVVKPQR 0.99127 -22.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4879 0 0 0 0 13.3479 13.1063 0 0 0 0 0 0 0 0 0 12.7936 13.2871 0 0 0 0 13.2557 0 0 0 0 13.166 0 0 13.3245 11.7906 0 14.5101 0 0 0 0 0 0 0 14.401 0 0 0 0 0 0 0 0 0 12.0306 0 0 0 13.248 0 0 13.6388 0 13.3669 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 0 0 0 13.5712 0 12.7349 0 13.3228 0 0 0 0 0 13.6574 0 0 0 13.9376 0 13.9436 0 0 0 13.8408 0 0 0 Q6UXB2 CXL17_HUMAN "C-X-C motif chemokine 17, 6-Cys CXCL17 (Dendritic cell and monocyte chemokine-like protein, DMC) (VEGF coregulated chemokine 1) [Cleaved into: 4-Cys CXCL17 ]" CXCL17 VCC1 UNQ473/PRO842 Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; macrophage chemotaxis [GO:0048246]; negative regulation of inflammatory response [GO:0050728]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of vascular endothelial growth factor production [GO:0010575] extracellular space [GO:0005615] extracellular space [GO:0005615]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; macrophage chemotaxis [GO:0048246]; negative regulation of inflammatory response [GO:0050728]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of vascular endothelial growth factor production [GO:0010575] GO:0001525; GO:0005615; GO:0010575; GO:0010759; GO:0030154; GO:0048246; GO:0050728; GO:0070374; GO:0090026 DWFLRAPR 0.99127 -7.3768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6WCQ1 MPRIP_HUMAN "Myosin phosphatase Rho-interacting protein, M-RIP (Rho-interacting protein 3, RIP3) (p116Rip)" MPRIP KIAA0864 MRIP RHOIP3 Homo sapiens (Human) actin filament organization [GO:0007015] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; actin filament organization [GO:0007015] GO:0005829; GO:0005925; GO:0007015; GO:0015629; GO:0045296; GO:0051015 actin filament binding [GO:0051015]; cadherin binding [GO:0045296] EEESAMSSDR 0.99127 -22.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5068 0 14.0712 0 13.4863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6905 0 0 0 0 0 0 0 0 0 12.1899 0 0 0 0 0 15.8448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8123 0 0 0 0 0 12.312 12.956 0 13.7642 0 13.0719 12.821 0 0 0 0 0 0 0 0 0 Q7Z6E9 RBBP6_HUMAN "E3 ubiquitin-protein ligase RBBP6, EC 2.3.2.27 (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1, RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis)" RBBP6 P2PR PACT RBQ1 My038 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001701; GO:0003723; GO:0004842; GO:0005634; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016567; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630 protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AHSKSAK 0.99127 -49.106 0 0 0 0 0 14.2293 11.2355 0 0 0 0 0 0 0 16.4783 0 12.7542 11.2369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5771 0 0 0 0 0 0 0 0 0 0 0 11.6075 0 0 0 0 0 0 0 0 0 0 0 0 11.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1951 0 0 0 15.4003 15.8944 16.4367 17.0141 17.5621 16.5874 17.5065 0 14.6233 15.3653 16.1784 16.5303 15.4633 15.0951 15.5133 0 0 14.1343 0 14.0155 0 0 15.369 14.3135 13.8722 12.5589 0 0 0 0 16.8646 16.4076 16.3618 15.0327 0 0 12.5134 0 0 13.4423 15.4206 14.6299 14.6946 14.3923 15.2458 15.8017 0 14.9913 0 12.2612 0 13.6794 0 12.1095 13.5419 0 0 0 0 13.1754 12.19 14.0543 0 0 0 0 0 0 0 13.0582 0 13.2956 0 0 0 0 13.7808 14.1524 13.7945 13.9794 0 0 11.9913 0 14.1229 0 0 0 13.8178 0 14.6294 14.8854 13.354 14.2232 0 13.6688 0 0 Q8NFW9 MYRIP_HUMAN "Rab effector MyRIP (Exophilin-8) (Myosin-VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C, SlaC2-c, Slp homolog lacking C2 domains c)" MYRIP SLAC2C Homo sapiens (Human) intracellular protein transport [GO:0006886]; positive regulation of insulin secretion [GO:0032024] cortical actin cytoskeleton [GO:0030864]; dense core granule [GO:0031045]; exocyst [GO:0000145]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; transport vesicle [GO:0030133] cortical actin cytoskeleton [GO:0030864]; dense core granule [GO:0031045]; exocyst [GO:0000145]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; synapse [GO:0045202]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; myosin binding [GO:0017022]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; intracellular protein transport [GO:0006886]; positive regulation of insulin secretion [GO:0032024] GO:0000145; GO:0001750; GO:0003779; GO:0006886; GO:0008270; GO:0017022; GO:0030133; GO:0030864; GO:0031045; GO:0031267; GO:0032024; GO:0042470; GO:0045202; GO:0048471; GO:0051018 actin binding [GO:0003779]; myosin binding [GO:0017022]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] CCSPFTFLVNTK 0.99127 -48.988 0 0 11.8229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2677 0 0 0 11.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3643 0 0 11.5745 12.0038 0 0 0 0 0 0 0 0 0 0 0 0 10.7218 0 13.3214 10.7272 0 0 11.3623 0 15.0782 14.5373 14.6184 14.7369 15.892 14.9401 12.6089 0 0 21.5446 0 13.1004 0 0 14.0682 15.0641 14.8883 14.0891 0 0 14.5259 13.5699 0 0 0 0 0 0 0 15.2554 12.8498 13.6246 15.0569 13.8636 15.0442 15.026 15.7464 14.281 14.6017 13.1291 14.8517 0 0 15.6299 0 14.0478 14.6882 14.3523 15.5965 13.2396 0 0 15.8206 13.6213 14.9376 14.7633 14.9 19.0754 14.7853 0 12.9536 0 14.6081 0 15.461 14.8106 0 12.8751 14.5585 14.6061 14.5042 0 0 0 12.2409 0 14.6585 14.6137 14.0533 14.1197 14.0704 13.8329 0 0 12.3387 0 12.4025 0 0 0 0 0 0 0 0 9.97284 0 0 16.4114 0 0 15.4231 12.2543 13.5855 14.9128 0 Q96G21 IMP4_HUMAN "U3 small nucleolar ribonucleoprotein protein IMP4, U3 snoRNP protein IMP4 (Brix domain-containing protein 4)" IMP4 BXDC4 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364] fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040] fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364] GO:0001650; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042134 rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515] LIPTELR 0.99127 -23.572 0 0 0 0 0 0 16.5327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9657 0 0 0 0 0 Q96GP6 SREC2_HUMAN "Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein, SREC-II)" SCARF2 SREC2 SREPCR Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] GO:0005044; GO:0005925; GO:0007157; GO:0016021 scavenger receptor activity [GO:0005044] CDRYCQCFR 0.99127 -49.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3789 13.1413 0 0 0 0 13.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5878 0 0 10.1917 0 0 0 0 0 0 9.77395 0 0 0 0 0 0 12.5023 0 11.9096 0 0 0 0 0 0 13.1615 0 13.3711 13.3619 13.4167 0 0 0 0 12.2121 0 0 16.8439 16.6738 15.1315 0 14.5696 0 0 0 12.0072 0 0 0 17.584 17.807 14.6714 16.9911 17.5489 17.3805 12.4274 0 0 14.3449 14.0002 0 18.2649 17.5188 15.5865 13.8196 16.1405 0 15.9731 16.8938 15.376 14.6491 17.0911 18.1111 14.8633 14.3502 0 15.8442 16.4047 0 13.8198 16.3038 13.8613 16.7404 16.178 17.6895 0 0 0 16.6549 13.7017 13.0922 14.6307 16.052 13.119 14.0664 15.2261 13.135 0 15.9467 0 14.5214 11.5284 14.0777 0 14.4743 0 0 0 0 15.8181 13.0064 0 17.5661 13.2215 17.1089 0 0 0 0 0 0 0 0 0 0 0 11.5448 11.6895 0 0 0 0 15.1077 15.2208 0 0 0 0 0 Q96PQ7 KLHL5_HUMAN Kelch-like protein 5 KLHL5 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0005829; GO:0005856 actin binding [GO:0003779] DDIECQK 0.99127 -48.776 0 0 0 0 0 0 0 0 11.5793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.367 13.0804 13.7738 0 0 0 13.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP58 ABCB6_HUMAN "ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6, EC 7.6.2.5) (Mitochondrial ABC transporter 3, Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter)" ABCB6 MTABC3 PRP UMAT Homo sapiens (Human) brain development [GO:0007420]; cellular copper ion homeostasis [GO:0006878]; cellular detoxification of cadmium ion [GO:0098849]; cellular iron ion homeostasis [GO:0006879]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; heme transport [GO:0015886]; melanosome assembly [GO:1903232]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; skin development [GO:0043588]; tetrapyrrole metabolic process [GO:0033013]; transmembrane transport [GO:0055085] ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of mitochondrial outer membrane [GO:0031307]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; heme binding [GO:0020037]; tetrapyrrole binding [GO:0046906]; brain development [GO:0007420]; cellular copper ion homeostasis [GO:0006878]; cellular detoxification of cadmium ion [GO:0098849]; cellular iron ion homeostasis [GO:0006879]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; heme transport [GO:0015886]; melanosome assembly [GO:1903232]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; skin development [GO:0043588]; tetrapyrrole metabolic process [GO:0033013]; transmembrane transport [GO:0055085] GO:0000139; GO:0005524; GO:0005654; GO:0005739; GO:0005740; GO:0005741; GO:0005765; GO:0005768; GO:0005774; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006778; GO:0006779; GO:0006878; GO:0006879; GO:0007420; GO:0015439; GO:0015562; GO:0015886; GO:0016021; GO:0016887; GO:0020037; GO:0031307; GO:0031901; GO:0032585; GO:0033013; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0042626; GO:0043190; GO:0043588; GO:0046906; GO:0055085; GO:0070062; GO:0098849; GO:0140359; GO:1903232 ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; heme binding [GO:0020037]; tetrapyrrole binding [GO:0046906] ALNVLVPIFYRNIVNLLTEK 0.99127 -4.6592 0 13.9023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3526 0 0 10.5285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4205 0 0 0 0 0 0 0 0 0 12.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0687 0 0 0 0 0 0 0 0 0 0 13.9473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8416 0 0 0 14.5884 14.256 0 0 0 0 0 0 13.7471 0 0 0 0 0 0 0 0 0 0 Q9UBU7 DBF4A_HUMAN Protein DBF4 homolog A (Activator of S phase kinase) (Chiffon homolog A) (DBF4-type zinc finger-containing protein 1) DBF4 ASK DBF4A ZDBF1 Homo sapiens (Human) DNA replication [GO:0006260]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987] Dbf4-dependent protein kinase complex [GO:0031431]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Dbf4-dependent protein kinase complex [GO:0031431]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; nucleic acid binding [GO:0003676]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270]; DNA replication [GO:0006260]; G1/S transition of mitotic cell cycle [GO:0000082]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987] GO:0000082; GO:0003676; GO:0005634; GO:0005654; GO:0006260; GO:0008047; GO:0008270; GO:0010571; GO:0016604; GO:0031431; GO:0043539; GO:1901987 enzyme activator activity [GO:0008047]; nucleic acid binding [GO:0003676]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270] IHSKGHFQGGIQVKNEK 0.99127 -22.312 0 13.2077 13.806 0 12.3794 0 13.4058 12.1119 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3153 11.6701 0 11.4627 0 0 0 0 0 0 0 0 0 0 0 0 10.6289 0 0 0 0 0 0 0 13.6246 0 0 0 0 0 0 0 0 11.3884 0 0 0 0 0 0 0 0 0 0 0 12.1798 0 0 0 0 0 0 0 0 11.3749 0 11.7792 0 0 0 0 0 0 0 0 17.6109 15.1409 0 0 0 15.3214 0 0 0 15.6057 11.572 11.7399 0 0 0 0 0 13.8518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0139 0 12.6671 0 0 11.676 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1645 12.4615 13.9001 10.7291 0 0 0 0 12.7097 10.0749 0 0 0 9.76358 0 0 0 9.9297 0 0 0 0 10.5177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19113 DCHS_HUMAN "Histidine decarboxylase, HDC, EC 4.1.1.22" HDC Homo sapiens (Human) catecholamine biosynthetic process [GO:0042423]; histamine biosynthetic process [GO:0001694]; histidine catabolic process [GO:0006548]; histidine metabolic process [GO:0006547] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxy-lyase activity [GO:0016831]; histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170]; catecholamine biosynthetic process [GO:0042423]; histamine biosynthetic process [GO:0001694]; histidine catabolic process [GO:0006548]; histidine metabolic process [GO:0006547] GO:0001694; GO:0004398; GO:0005737; GO:0005829; GO:0006547; GO:0006548; GO:0016831; GO:0030170; GO:0042423 carboxy-lyase activity [GO:0016831]; histidine decarboxylase activity [GO:0004398]; pyridoxal phosphate binding [GO:0030170] AGRLFLIPATIQDKLIIR 0.99128 -22.506 0 0 0 0 0 0 9.39436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.095 0 0 0 0 0 0 0 14.5203 14.3322 0 0 0 0 0 0 0 0 13.0187 14.9793 0 0 0 0 0 12.5271 0 0 0 0 0 13.3658 0 13.9604 0 0 0 0 0 0 0 0 0 13.2292 0 0 0 0 0 0 0 0 13.2365 13.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1445 0 0 13.1993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6EMB2 TTLL5_HUMAN "Tubulin polyglutamylase TTLL5, EC 6.3.2.- (SRC1 and TIF2-associated modulatory protein, STAMP protein) (Tubulin--tyrosine ligase-like protein 5)" TTLL5 KIAA0998 STAMP Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095]; retina development in camera-type eye [GO:0060041] GO:0000226; GO:0005524; GO:0005634; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0060041; GO:0070740 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] GPWIVKPVASSR 0.99128 -22.449 0 0 0 0 10.4517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9044 0 0 0 0 0 0 0 10.8588 0 0 0 11.6116 0 0 13.2004 0 0 0 10.8576 0 0 0 0 0 0 0 0 0 0 16.1643 0 0 0 0 0 0 14.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9245 0 0 0 0 12.8637 0 0 0 0 0 0 0 11.6734 0 0 0 12.3824 0 13.3895 14.0076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7984 0 0 0 0 0 11.849 14.2266 0 14.5527 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY37 DHX37_HUMAN "Probable ATP-dependent RNA helicase DHX37, EC 3.6.4.13 (DEAH box protein 37)" DHX37 DDX37 KIAA1517 Homo sapiens (Human) "brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]" cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511]; brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]" GO:0000462; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0007420; GO:0016887; GO:0031965; GO:0034511; GO:0042254; GO:0042255; GO:2000020 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511] ADCHEALLAAWK 0.99128 -50.788 0 0 13.2912 0 0 0 11.5444 0 0 0 0 0 0 0 0 0 11.6097 0 0 0 11.8431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.185 0 0 0 0 0 0 0 0 0 0 0 14.0286 13.3807 0 0 0 0 0 0 0 0 0 0 11.5157 0 0 0 0 0 0 0 13.2146 14.1324 14.2477 13.6769 0 14.1321 15.4524 16.6754 0 12.4476 0 0 14.561 0 0 14.2296 16.3422 15.837 14.7503 0 14.9896 0 16.3779 15.3091 0 0 0 0 14.8979 0 0 12.5642 0 0 0 12.2007 15.9962 13.9028 16.2828 0 16.5177 15.1284 14.0394 14.2357 15.5476 16.3407 15.3429 16.1061 17.257 14.0425 15.573 12.4572 15.4669 14.1652 13.2938 12.8168 11.5445 15.9624 14.8369 15.3184 16.7322 13.898 0 14.6752 0 12.988 0 13.659 0 14.7751 0 0 0 0 12.0438 16.2348 15.8807 16.0392 14.0355 0 13.9816 0 13.349 0 0 0 13.6589 15.0596 14.9334 0 15.0437 0 14.0917 12.8899 15.7006 16.9618 0 0 0 0 0 0 Q8TDE3 RNAS8_HUMAN "Ribonuclease 8, RNase 8, EC 3.1.27.-" RNASE8 Homo sapiens (Human) antifungal innate immune response [GO:0061760]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540]; antifungal innate immune response [GO:0061760]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087] GO:0003676; GO:0004522; GO:0004540; GO:0005615; GO:0045087; GO:0050829; GO:0050830; GO:0050832; GO:0061760 nucleic acid binding [GO:0003676]; ribonuclease A activity [GO:0004522]; ribonuclease activity [GO:0004540] NCHQSHGPMSLTMGELTSGKYPNCRYK 0.99128 -4.5371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2097 12.8126 0 0 0 0 0 0 0 0 0 13.9339 0 0 0 0 0 0 0 0 0 13.0741 0 0 0 12.4376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP90 RAB9B_HUMAN "Ras-related protein Rab-9B (Rab-9-like protein, Rab-9L)" RAB9B RAB9L Homo sapiens (Human) "protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "cytosol [GO:0005829]; late endosome [GO:0005770]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0003924; GO:0005525; GO:0005764; GO:0005770; GO:0005829; GO:0005886; GO:0015031; GO:0019003; GO:0030667; GO:0030670; GO:0032482; GO:0042147; GO:0042802; GO:0045335 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] SGKSLLLK 0.99128 -5.96 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4836 13.5223 0 0 0 0 0 14.0815 13.7534 14.072 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3491 0 0 0 13.2029 13.2268 0 0 0 0 0 0 0 0 0 0 13.1453 0 0 0 13.2477 0 0 13.3472 0 13.1281 13.411 0 13.4807 0 0 0 13.188 0 0 0 0 0 12.9692 0 0 0 13.6486 0 0 0 13.1061 13.3386 0 13.2227 0 12.8965 13.4696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK61 TASOR_HUMAN Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein) TASOR C3orf63 FAM208A KIAA1105 Homo sapiens (Human) "anterior/posterior axis specification, embryo [GO:0008595]; in utero embryonic development [GO:0001701]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; mitotic spindle assembly [GO:0090307]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" heterochromatin [GO:0000792]; nucleoplasm [GO:0005654] "heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; anterior/posterior axis specification, embryo [GO:0008595]; in utero embryonic development [GO:0001701]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; mitotic spindle assembly [GO:0090307]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" GO:0000792; GO:0001701; GO:0003682; GO:0003723; GO:0005654; GO:0008595; GO:0045814; GO:0045869; GO:0060809; GO:0090307; GO:0090309; GO:0097355 chromatin binding [GO:0003682]; RNA binding [GO:0003723] AFLPIKLPEK 0.99129 -52.78 0 0 0 0 0 0 0 0 12.8215 0 12.8729 0 13.0759 14.1361 12.5689 0 0 13.1952 12.4797 13.3171 12.5671 0 0 13.2843 15.0516 13.7124 0 13.1904 14.5314 13.2679 0 0 13.8354 14.7582 13.4538 13.2408 11.6489 14.6294 12.953 10.8542 14.8716 14.1435 0 0 0 0 0 14.0197 12.4019 12.9968 0 12.9732 12.4467 0 13.7396 0 0 0 0 0 0 0 0 0 0 0 9.44145 11.7559 19.3109 0 0 13.0318 14.2152 0 9.47007 19.4022 15.4096 15.5197 19.4264 15.019 15.6248 12.6539 15.2401 15.3998 15.3241 15.2246 15.9238 15.8307 0 14.0003 0 0 14.6314 15.5789 16.2837 0 15.3056 14.0462 14.8871 15.15 14.2937 15.1443 0 14.5468 13.1924 14.8455 14.7864 14.9328 0 0 15.0247 0 13.5767 0 15.186 14.7771 14.8844 14.7696 15.1846 15.5365 16.6089 14.9552 15.4752 15.2134 14.8666 14.8381 15.2544 14.7201 0 15.543 12.9786 15.192 0 14.6849 14.9512 14.9009 17.2853 0 14.8796 14.7408 14.609 0 11.4791 0 0 14.8431 15.9462 0 0 0 14.6519 13.3021 13.9924 15.8971 14.7069 17.2418 0 12.9057 15.4364 13.9074 15.6413 13.2961 15.0586 13.868 13.4277 14.7013 0 0 15.2576 12.4848 0 16.3782 15.137 15.2778 0 14.4738 0 10.9905 16.809 11.036 A0A5B0 TVB14_HUMAN T cell receptor beta variable 14 TRBV14 TCRBV14S1 TCRBV16S1A1N1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 EIKFLLHFVKESK 0.99129 -4.8291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2462 0 12.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0313 0 0 0 14.7819 0 0 0 0 0 0 13.8142 0 0 0 0 0 0 0 13.3825 13.0238 13.6948 0 0 0 0 0 0 12.5379 0 0 0 0 0 0 13.8311 0 0 0 15.7393 0 0 0 0 0 0 14.9279 0 0 13.467 0 12.6057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13371 PHLP_HUMAN "Phosducin-like protein, PHLP" PDCL PHLOP1 PhLP1 Homo sapiens (Human) cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0005737; GO:0005829; GO:0005929; GO:0007165; GO:0007601; GO:0008277; GO:0030030; GO:0045880; GO:1902605 EEQCREMER 0.99129 -4.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0642 0 0 0 13.6434 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3143 0 14.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5765 0 13.9004 0 0 0 Q5T6V5 QSPP_HUMAN Queuosine salvage protein C9orf64 Homo sapiens (Human) tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] GO:0006400; GO:0101030 ESENSAQKLMHLVVESFPSYR 0.99129 -4.8381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5769 0 0 11.7452 0 0 0 0 0 0 0 0 0 10.5632 0 0 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JM3 CHAP1_HUMAN Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828) CHAMP1 C13orf8 CAMP CHAMP KIAA1802 ZNF828 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134] GO:0000776; GO:0000793; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0016604; GO:0031134; GO:0034501; GO:0035372; GO:0046872; GO:0051315; GO:0090543 metal ion binding [GO:0046872] ATLSNPK 0.99129 -19.072 0 0 0 0 0 0 0 0 11.1134 11.5635 0 13.1903 12.3448 0 10.3427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7255 0 0 0 0 0 0 0 0 0 0 0 0 17.382 0 0 0 14.0325 14.4548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2136 12.8902 13.3204 0 0 0 0 0 0 13.7339 13.8204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7614 0 0 13.0892 0 0 0 0 13.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4538 0 0 0 0 0 0 0 14.5894 0 0 13.7645 13.4398 12.6987 13.154 0 0 12.7299 13.3058 11.9415 12.0422 0 0 0 0 0 12.5456 0 12.57 0 0 Q99829 CPNE1_HUMAN Copine-1 (Chromobindin 17) (Copine I) CPNE1 CPN1 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; vesicle-mediated transport [GO:0016192] aggresome [GO:0016235]; azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] aggresome [GO:0016235]; azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786]; cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629]; negative regulation of DNA binding [GO:0043392]; negative regulation of gene expression [GO:0010629]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteolysis [GO:0006508]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; vesicle-mediated transport [GO:0016192] GO:0001786; GO:0004175; GO:0005509; GO:0005544; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006629; GO:0010629; GO:0016020; GO:0016192; GO:0016235; GO:0031965; GO:0035577; GO:0042802; GO:0043122; GO:0043392; GO:0045666; GO:0051059; GO:0051897; GO:0070062; GO:0071277; GO:1901223; GO:1903265; GO:1990138 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; phosphatidylserine binding [GO:0001786] FETVQKLRFGIYDIDNK 0.99129 -52.7 0 0 12.1447 0 0 13.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6028 0 0 0 0 0 0 0 0 0 0 0 11.744 0 0 0 0 0 0 0 0 12.6013 0 0 0 9.55317 0 0 13.6417 0 0 0 10.853 0 0 0 0 0 0 0 0 0 15.7747 0 0 0 0 0 0 14.4585 0 0 0 0 14.7178 13.64 14.9308 13.6198 0 0 0 0 0 0 12.6748 0 0 0 0 0 0 0 12.698 0 13.6208 0 0 14.6496 14.3577 0 0 12.2673 0 12.448 0 15.2785 0 13.8431 0 0 0 0 0 0 0 0 0 0 13.1998 0 13.4179 0 14.6276 0 0 0 13.9609 0 13.6164 0 15.1941 0 11.3149 0 0 0 10.5218 0 0 0 10.836 0 13.1398 0 0 0 14.0769 14.0417 0 12.8629 0 0 0 0 0 12.1163 0 12.1446 0 0 0 0 11.393 0 0 0 0 0 11.227 0 0 O14595 CTDS2_HUMAN "Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2, EC 3.1.3.16 (Nuclear LIM interactor-interacting factor 2, NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2, SCP2)" CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933]; protein dephosphorylation [GO:0006470] GO:0001933; GO:0004721; GO:0005654; GO:0006470; GO:0008420; GO:0017018; GO:0046872; GO:2000134 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] ALFCCFR 0.9913 -19.098 0 0 0 0 0 0 0 0 0 0 0 11.8447 0 11.6935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4177 12.6892 0 0 0 0 13.2434 0 0 0 0 0 0 0 0 0 12.6546 12.9196 0 0 0 0 12.8414 12.8886 12.8075 0 12.858 0 12.7525 0 0 16.0408 13.7322 0 0 13.581 0 12.8802 0 0 0 0 14.8127 11.3902 13.1139 13.1818 13.239 13.2482 0 0 12.5246 13.4578 0 0 0 0 0 0 0 0 12.8286 0 12.7269 0 0 0 0 13.1627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1864 0 0 10.5871 0 0 0 O43252 PAPS1_HUMAN "Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1, PAPS synthase 1, PAPSS 1 (Sulfurylase kinase 1, SK 1, SK1) [Includes: Sulfate adenylyltransferase, EC 2.7.7.4 (ATP-sulfurylase) (Sulfate adenylate transferase, SAT); Adenylyl-sulfate kinase, EC 2.7.1.25 (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase) ]" PAPSS1 ATPSK1 PAPSS Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; phosphorylation [GO:0016310]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103] cytosol [GO:0005829] cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; phosphorylation [GO:0016310]; skeletal system development [GO:0001501]; sulfate assimilation [GO:0000103] GO:0000103; GO:0001501; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0016310; GO:0016779; GO:0042803; GO:0050428 adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; sulfate adenylyltransferase (ATP) activity [GO:0004781] GYRRPVLLLHPLGGWTK 0.9913 -19.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1103 0 13.543 13.2441 13.6546 0 12.7209 0 12.6996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6522 0 0 0 0 0 0 12.8701 0 0 12.1109 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4987 0 0 0 0 0 0 0 0 0 0 13.0396 0 0 0 0 0 0 16.8297 0 0 0 0 0 0 0 0 13.1402 0 0 0 0 0 0 0 0 0 0 13.6999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60336 MABP1_HUMAN "Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1, JNKBP-1)" MAPKBP1 JNKBP1 KIAA0596 Homo sapiens (Human) negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; positive regulation of JNK cascade [GO:0046330] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; negative regulation of defense response to bacterium [GO:1900425]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; positive regulation of JNK cascade [GO:0046330] GO:0005654; GO:0005730; GO:0005737; GO:0032717; GO:0043124; GO:0046330; GO:0097431; GO:1900425 DPKKVGK 0.9913 -21.968 0 10.1042 10.2512 0 0 12.531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2706 0 0 0 0 0 13.9615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9109 0 10.7394 0 0 0 11.6312 0 0 0 15.8074 0 0 0 0 0 0 11.5712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9741 0 0 0 0 14.1328 0 0 0 15.0658 0 0 14.5244 0 12.935 15.6787 12.9903 0 13.6654 0 0 0 14.3615 0 0 0 0 0 14.2532 0 0 0 0 13.3012 12.6547 0 0 0 12.7708 0 14.3536 0 0 12.7423 14.165 0 0 0 16.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7042 0 0 0 0 15.3451 O75971 SNPC5_HUMAN "snRNA-activating protein complex subunit 5, SNAPc subunit 5 (Small nuclear RNA-activating complex polypeptide 5) (snRNA-activating protein complex 19 kDa subunit, SNAPc 19 kDa subunit)" SNAPC5 SNAP19 Homo sapiens (Human) snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription initiation from RNA polymerase III promoter [GO:0006384] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription initiation from RNA polymerase III promoter [GO:0006384] GO:0000995; GO:0005634; GO:0005654; GO:0005730; GO:0006384; GO:0016251; GO:0016604; GO:0042795; GO:0042796 RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995] LSRLQELRK 0.9913 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76099 OR7C1_HUMAN Olfactory receptor 7C1 (Olfactory receptor 7C4) (Olfactory receptor OR19-16) (Olfactory receptor TPCR86) OR7C1 OR7C4 Homo sapiens (Human) signal transduction [GO:0007165]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0007283; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] RALGRLLSR 0.9913 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02452 CO1A1_HUMAN Collagen alpha-1(I) chain (Alpha-1 type I collagen) COL1A1 Homo sapiens (Human) "blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]" collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141] "collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; secretory granule [GO:0030141]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; blood vessel development [GO:0001568]; bone trabecula formation [GO:0060346]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to amino acid stimulus [GO:0071230]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to fluoride [GO:1902618]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; intramembranous ossification [GO:0001957]; negative regulation of cell-substrate adhesion [GO:0010812]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein transport [GO:0015031]; response to cAMP [GO:0051591]; response to corticosteroid [GO:0031960]; response to estradiol [GO:0032355]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skin development [GO:0043588]; skin morphogenesis [GO:0043589]; tooth eruption [GO:0044691]; tooth mineralization [GO:0034505]; visual perception [GO:0007601]; wound healing [GO:0042060]" GO:0001501; GO:0001503; GO:0001568; GO:0001649; GO:0001957; GO:0001958; GO:0002020; GO:0005201; GO:0005576; GO:0005584; GO:0005615; GO:0005737; GO:0005788; GO:0005794; GO:0007601; GO:0007605; GO:0009410; GO:0009612; GO:0010718; GO:0010812; GO:0015031; GO:0030020; GO:0030141; GO:0030198; GO:0030199; GO:0030335; GO:0031012; GO:0031960; GO:0032355; GO:0032964; GO:0034504; GO:0034505; GO:0038063; GO:0042060; GO:0042542; GO:0042802; GO:0043434; GO:0043588; GO:0043589; GO:0044344; GO:0044691; GO:0045893; GO:0046872; GO:0048407; GO:0048706; GO:0051591; GO:0055093; GO:0060325; GO:0060346; GO:0060351; GO:0062023; GO:0071230; GO:0071260; GO:0071300; GO:0071306; GO:0071356; GO:0071364; GO:0071560; GO:0090263; GO:1902618 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020] DLKMCHSDWK 0.9913 -23.27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4235 10.9031 0 0 0 0 0 0 13.7035 0 0 0 0 0 0 0 0 0 13.6159 0 0 0 0 0 0 0 11.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0053 0 0 0 0 P28329 CLAT_HUMAN "Choline O-acetyltransferase, CHOACTase, ChAT, Choline acetylase, EC 2.3.1.6" CHAT Homo sapiens (Human) acetylcholine biosynthetic process [GO:0008292]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; phosphatidylcholine biosynthetic process [GO:0006656] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; choline O-acetyltransferase activity [GO:0004102]; acetylcholine biosynthetic process [GO:0008292]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter transport [GO:0006836]; phosphatidylcholine biosynthetic process [GO:0006656] GO:0004102; GO:0005634; GO:0005737; GO:0005829; GO:0006656; GO:0006836; GO:0007274; GO:0008292; GO:0043005; GO:0045202 choline O-acetyltransferase activity [GO:0004102] ADSVSELPAPRRLR 0.9913 -7.1339 13.7449 0 0 0 0 0 11.35 12.6101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1227 0 0 0 0 0 0 0 0 0 10.356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1633 0 0 0 0 0 13.9028 12.3528 0 16.9247 16.6314 0 0 0 0 16.4689 10.4329 0 0 0 14.615 0 0 0 16.4841 15.0523 11.4635 0 0 0 0 0 16.1693 0 0 14.396 0 15.0596 0 0 0 0 0 0 14.0536 0 0 0 0 12.6177 0 14.0373 0 0 0 0 0 0 0 14.4491 15.3614 0 0 15.1695 14.6786 0 0 14.5077 0 0 0 14.7359 14.563 0 0 0 0 14.6091 13.454 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9268 0 0 0 0 0 13.5376 12.5041 14.2029 13.5841 0 0 0 0 0 P53667 LIMK1_HUMAN "LIM domain kinase 1, LIMK-1, EC 2.7.11.1" LIMK1 LIMK Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149] GO:0001673; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007165; GO:0007266; GO:0007399; GO:0016020; GO:0016607; GO:0030027; GO:0030036; GO:0031072; GO:0032233; GO:0038096; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051444; GO:0051496; GO:0106310 ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CCDCSASLSHQYYEK 0.9913 -7.1319 0 0 10.9449 0 0 0 0 0 9.644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7444 0 0 0 0 0 0 0 0 0 0 0 10.5001 0 0 0 0 0 0 0 0 0 0 13.1243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1012 11.6138 16.1396 0 0 0 13.2783 11.9945 12.6644 15.0366 11.8876 0 0 13.0261 11.8476 0 0 0 0 0 0 0 13.6673 13.0444 13.5379 13.1235 0 13.1269 13.9627 0 0 15.4647 0 0 0 0 0 12.7137 0 0 0 0 0 13.1078 0 0 0 0 0 13.5111 0 0 0 0 0 0 0 14.4229 0 0 0 0 0 0 0 0 0 0 0 12.9137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9906 11.3219 11.2827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4479 0 Q02487 DSC2_HUMAN Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) DSC2 CDHF2 DSC3 Homo sapiens (Human) bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell-cardiac muscle cell adhesion [GO:0086042]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cellular response to starvation [GO:0009267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell-cardiac muscle cell adhesion [GO:0086042]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cellular response to starvation [GO:0009267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] GO:0001533; GO:0005509; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007155; GO:0007156; GO:0009267; GO:0014704; GO:0016021; GO:0030057; GO:0031410; GO:0070062; GO:0086042; GO:0086073; GO:0086083; GO:0086091; GO:0098609; GO:0098911 calcium ion binding [GO:0005509]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083] AYDPETRSSSGIRYK 0.9913 -4.8491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6923 0 14.1553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9708 0 0 10.8194 0 0 0 0 0 0 11.4208 0 0 0 0 0 0 0 0 0 0 0 0 12.6693 0 0 12.1488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.01 13.2948 0 0 0 0 0 14.4206 0 0 0 0 0 11.0595 0 0 0 0 0 0 0 0 13.1377 0 13.4097 0 0 0 0 0 11.2566 0 0 11.1013 0 0 0 0 0 0 0 17.4237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4074 0 0 0 12.7922 0 Q13769 THOC5_HUMAN "THO complex subunit 5 homolog (Functional spliceosome-associated protein 79, fSAP79) (NF2/meningioma region protein pK1.3) (Placental protein 39.2, PP39.2) (hTREX90)" THOC5 C22orf19 KIAA0983 Homo sapiens (Human) "monocyte differentiation [GO:0030224]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; primitive hemopoiesis [GO:0060215]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; monocyte differentiation [GO:0030224]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; primitive hemopoiesis [GO:0060215]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]" GO:0000346; GO:0000347; GO:0000445; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006406; GO:0008380; GO:0030224; GO:0032786; GO:0046784; GO:0060215; GO:2000002 mRNA binding [GO:0003729] EITKCLEFKSK 0.9913 -22.031 0 11.7768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0272 12.3778 0 0 15.9976 0 10.7149 0 14.5498 14.7437 0 0 0 0 0 0 0 0 0 0 12.3187 0 0 0 0 0 0 0 0 12.4977 0 13.8793 0 0 11.1513 0 11.6666 0 0 0 0 0 11.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9023 0 0 0 0 0 0 0 0 0 0 11.9694 0 12.0763 0 0 0 0 0 0 0 12.9385 0 0 0 0 0 0 0 12.2995 0 0 0 0 0 0 11.5124 0 0 0 0 0 Q14C86 GAPD1_HUMAN GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6) GAPVD1 GAPEX5 KIAA1521 RAP6 Homo sapiens (Human) endocytosis [GO:0006897]; regulation of GTPase activity [GO:0043087]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; regulation of GTPase activity [GO:0043087]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165] GO:0005085; GO:0005096; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007165; GO:0030139; GO:0031267; GO:0032794; GO:0043087; GO:0045296; GO:0051223 cadherin binding [GO:0045296]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] APIPFRK 0.9913 -19.081 0 0 0 0 0 0 0 0 0 16.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4042 16.2069 0 16.0714 0 0 0 0 0 0 0 0 0 0 0 16.0337 0 0 0 0 15.9788 0 0 0 0 12.1764 0 15.8134 16.0669 0 0 15.7897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7133 0 18.921 0 0 0 0 0 18.6503 19.0389 0 0 18.5182 0 0 0 0 0 0 19.288 0 0 0 0 0 0 0 0 0 12.5907 0 17.1948 0 18.7885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3281 0 0 0 11.8819 0 0 14.4153 0 0 14.2915 17.1584 0 0 0 14.5026 0 0 0 17.0212 0 18.2636 0 0 15.4024 0 0 0 16.5566 Q6ZNF0 ACP7_HUMAN "Acid phosphatase type 7, EC 3.1.3.2 (Purple acid phosphatase long form)" ACP7 PAPL PAPL1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] GO:0003993; GO:0005576; GO:0046872 acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872] AARPWIITMGHRPMYCSNADLDDCTR 0.9913 -7.1458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7619 14.0472 0 0 14.9099 0 0 11.0849 0 0 0 0 0 0 0 0 11.9228 0 0 0 0 0 12.7752 0 0 12.0712 12.8286 11.8567 11.4731 0 0 0 0 0 0 0 12.521 0 0 0 12.2292 12.2246 0 12.604 0 0 0 0 12.3994 0 12.4871 12.4322 0 0 0 13.5042 12.5558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9062 12.1073 0 0 14.1666 0 0 0 Q8IVG5 SAM9L_HUMAN "Sterile alpha motif domain-containing protein 9-like, SAM domain-containing protein 9-like" SAMD9L C7orf6 DRIF2 KIAA2005 UEF Homo sapiens (Human) cytoplasm [GO:0005737]; early endosome [GO:0005769] cytoplasm [GO:0005737]; early endosome [GO:0005769] GO:0005737; GO:0005769 CFRKYTELFCHLDPCLLQSK 0.9913 -23.268 0 0 0 0 0 0 10.6856 0 12.2006 0 0 12.5208 0 0 0 0 0 12.1112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5738 0 13.4196 0 0 0 0 0 0 0 14.1815 0 13.9085 0 0 0 0 0 0 0 0 13.0315 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3633 14.2325 0 0 0 0 0 0 0 14.2817 0 0 0 14.8426 0 0 14.7511 0 0 0 14.2202 11.1941 0 0 14.1834 0 0 15.0189 13.4985 0 0 0 0 0 13.2817 0 0 0 0 0 13.0677 12.4366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.319 0 0 10.2913 0 0 0 11.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4442 0 0 0 14.2308 12.2948 9.34512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.49341 0 0 Q8N1G2 CMTR1_HUMAN "Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1, EC 2.1.1.57 (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1, MTr1, hMTr1) (FtsJ methyltransferase domain-containing protein 2) (Interferon-stimulated gene 95 kDa protein, ISG95)" CMTR1 FTSJD2 KIAA0082 MTR1 Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009] GO:0003676; GO:0004483; GO:0005634; GO:0005654; GO:0005737; GO:0006370; GO:0043231; GO:0080009; GO:0097309 mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676] AAMKMANMDFVFDRMFTNPR 0.9913 -23.309 0 0 0 0 0 0 0 0 0 11.9618 0 12.31 0 12.8061 0 0 0 0 0 0 0 0 13.2043 0 0 0 11.9139 0 0 12.4923 0 0 0 10.8347 0 0 0 0 0 0 0 12.1995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4021 0 12.9272 0 0 0 0 0 0 0 0 0 13.3486 0 0 0 0 11.7093 0 0 0 0 14.389 0 0 0 13.0271 13.6278 0 14.4247 0 0 14.6217 0 0 0 0 0 0 13.6972 0 0 0 0 0 0 0 0 13.4823 14.0602 0 0 0 0 0 13.4795 0 0 0 0 13.0315 13.3065 0 0 13.8689 0 14.1396 0 0 0 0 0 0 13.4511 0 0 14.1766 13.8857 0 0 0 13.1191 0 0 0 0 0 10.8026 0 0 13.3514 0 0 0 0 0 0 0 0 13.2117 0 0 0 0 0 11.4995 0 0 0 0 13.0616 0 0 0 0 0 Q9BZQ6 EDEM3_HUMAN "ER degradation-enhancing alpha-mannosidase-like protein 3, EC 3.2.1.113 (Alpha-1,2-mannosidase EDEM3)" EDEM3 C1orf22 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; alpha-mannosidase activity [GO:0004559]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986]" GO:0004559; GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006486; GO:0006986; GO:0016020; GO:0044322; GO:1904380; GO:1904382 "alpha-mannosidase activity [GO:0004559]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" EQQLPPR 0.9913 -22.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3913 11.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0952 0 0 0 0 0 0 0 13.0903 0 0 0 0 0 0 12.9052 12.4964 0 13.2998 0 0 0 12.7498 13.2623 0 0 13.763 13.5686 12.8241 0 13.7945 0 0 0 14.3098 13.6786 14.4092 0 13.3198 13.9093 0 15.2857 0 13.5881 13.98 0 0 0 0 0 0 0 0 0 0 14.6417 0 0 0 0 0 13.772 13.1087 13.4418 12.8227 0 0 0 13.0633 0 0 0 0 0 0 12.6701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1589 14.1512 0 0 0 0 0 0 0 0 0 0 0 13.0452 0 0 12.1099 0 0 0 0 0 0 0 0 0 0 Q9P2N2 RHG28_HUMAN Rho GTPase-activating protein 28 (Rho-type GTPase-activating protein 28) ARHGAP28 KIAA1314 Homo sapiens (Human) negative regulation of GTP binding [GO:1904425]; negative regulation of stress fiber assembly [GO:0051497]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of GTP binding [GO:1904425]; negative regulation of stress fiber assembly [GO:0051497]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030833; GO:0051056; GO:0051497; GO:1904425 GTPase activator activity [GO:0005096] AFFRELPTSLFPVEYIPAFISLMER 0.9913 -22.057 0 0 11.2337 0 0 0 0 0 12.3618 0 12.3215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9965 0 0 0 0 0 0 0 0 13.4268 0 12.0467 0 0 12.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2409 0 0 0 0 0 0 0 0 0 10.919 0 0 0 0 0 0 0 0 13.5923 0 10.1561 11.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1528 13.0255 0 0 14.0502 0 13.8631 0 0 13.1871 13.6209 13.5733 0 0 0 0 0 0 0 0 0 0 0 13.2612 0 12.2993 13.1935 12.3766 11.8162 0 11.2404 0 0 0 12.7573 0 0 0 0 0 0 0 0 12.7296 14.3126 12.3042 0 0 0 0 13.2694 0 0 14.1585 13.5378 13.8652 0 12.9893 0 0 11.2486 0 13.3865 0 0 0 0 0 13.1492 0 0 Q9UKY1 ZHX1_HUMAN Zinc fingers and homeoboxes protein 1 ZHX1 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0045892; GO:0046872; GO:0046982 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]" AQTKLTRR 0.9913 -21.999 0 13.5818 0 0 0 0 0 0 0 0 0 11.7024 0 0 0 0 0 11.3793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3539 0 0 16.6774 11.5475 0 13.3641 0 0 0 0 0 0 0 0 14.1433 10.4663 0 0 0 0 0 0 0 0 0 14.009 15.2534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3887 0 0 0 0 0 0 0 16.0297 14.9111 0 14.5259 15.6702 15.602 0 0 0 0 11.0934 0 0 0 0 0 0 0 0 0 0 0 0 12.6741 0 0 0 0 0 0 14.1004 0 13.3536 14.3688 0 14.5124 0 0 0 0 0 0 0 0 0 0 11.789 0 0 0 0 0 0 0 0 0 0 0 0 0 O75038 PLCH2_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4, PLC-L4, Phospholipase C-like protein 4) (Phospholipase C-eta-2, PLC-eta2)" PLCH2 KIAA0450 PLCL4 Homo sapiens (Human) lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015] GO:0004435; GO:0005509; GO:0005737; GO:0005886; GO:0016042; GO:0046488; GO:0048015 calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435] AEEDVESGEDAGASR 0.99131 -22.091 0 0 0 0 0 0 0 0 14.5889 0 0 0 0 12.7002 14.7252 11.2237 11.728 0 0 10.3549 0 0 0 0 0 15.2196 14.3189 0 0 14.8744 0 0 0 0 0 13.7587 14.2795 0 0 0 16.0967 16.68 14.553 0 14.2889 0 12.6933 13.202 12.1847 13.3981 13.2061 13.4798 13.5904 0 0 0 0 0 0 0 10.4669 0 0 0 0 0 11.7767 12.3672 0 0 0 0 12.1893 15.1747 0 0 0 0 0 0 0 0 0 0 14.5992 0 0 16.2236 0 0 16.8051 0 0 12.8144 0 0 12.748 12.9203 0 0 13.8844 0 0 0 11.9532 0 12.1503 13.4269 0 0 14.495 0 14.0235 11.7033 13.2079 13.2143 13.2275 16.9816 0 0 13.6131 12.2738 0 13.2001 12.6992 14.9742 13.0602 0 12.5563 12.8039 13.5033 12.4461 15.2682 0 0 0 15.0465 0 0 0 0 15.6527 15.6864 0 0 0 0 14.811 0 0 17.4879 0 0 13.8595 12.7658 12.5789 0 0 0 13.8005 0 0 15.4009 0 15.7041 17.0473 0 17.1578 17.0458 0 0 0 12.9275 0 0 16.9615 13.1599 0 0 0 P19961 AMY2B_HUMAN "Alpha-amylase 2B, EC 3.2.1.1 (1,4-alpha-D-glucan glucanohydrolase 2B) (Carcinoid alpha-amylase)" AMY2B Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975] GO:0004556; GO:0005975; GO:0046872; GO:0070062 alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872] KFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWR 0.99131 -5.5629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7304 0 0 13.317 0 0 0 0 0 14.4036 0 0 0 0 0 0 0 12.8257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51114 FXR1_HUMAN RNA-binding protein FXR1 (FMR1 autosomal homolog 1) (hFXR1p) FXR1 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; skeletal muscle organ development [GO:0060538]" axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] "axon [GO:0030424]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; skeletal muscle organ development [GO:0060538]" GO:0000381; GO:0001934; GO:0003723; GO:0003730; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005844; GO:0006915; GO:0007517; GO:0014069; GO:0016020; GO:0017148; GO:0030154; GO:0030424; GO:0030426; GO:0033592; GO:0036464; GO:0042803; GO:0043025; GO:0043034; GO:0043197; GO:0043488; GO:0044326; GO:0045182; GO:0045727; GO:0046982; GO:0048471; GO:0051489; GO:0060538; GO:0098793; GO:0098978; GO:1902737; GO:2000637; GO:2001022 mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182] DVHEDSLTVVFENNWQPER 0.99131 -22.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0284 0 0 0 0 0 12.6897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3376 0 0 15.9395 0 0 0 0 0 0 0 0 0 0 0 13.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8822 13.7559 0 0 0 0 0 0 0 0 0 0 13.6547 0 0 0 0 13.7291 0 0 0 0 13.5525 0 0 0 0 0 0 0 0 13.6864 16.132 0 Q5VVQ6 OTU1_HUMAN "Ubiquitin thioesterase OTU1, EC 3.4.19.12 (DUBA-8) (HIV-1-induced protease 7, HIN-7, HsHIN7) (OTU domain-containing protein 2)" YOD1 DUBA8 HIN7 OTUD2 PRO0907 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0004843; GO:0005737; GO:0005829; GO:0016236; GO:0016579; GO:0030433; GO:0030968; GO:0031625; GO:0035523; GO:0035871; GO:0046872; GO:0061578; GO:0070536; GO:0071108; GO:0101005; GO:1904153; GO:1990167; GO:1990168; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625] SSPAFTK 0.99131 -4.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PIS1 S23A3_HUMAN Solute carrier family 23 member 3 (HPC E2-binding protein 3) (Na(+)/L-ascorbic acid transporter 3) (Sodium-dependent vitamin C transporter 3) SLC23A3 E2BP3 SVCT3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane region [GO:0098590] integral component of membrane [GO:0016021]; plasma membrane region [GO:0098590]; L-ascorbic acid transmembrane transporter activity [GO:0015229] GO:0015229; GO:0016021; GO:0098590 L-ascorbic acid transmembrane transporter activity [GO:0015229] LPLVQAPSLEFLIPALVLTSQKLPR 0.99131 -4.5927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7991 0 0 0 0 0 0 0 0 0 0 0 0 13.8446 0 0 0 0 0 0 0 12.7235 0 0 0 0 0 0 0 0 0 0 12.7233 0 0 0 0 0 0 0 0 0 0 12.4531 0 0 0 13.5035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZQ1 WDFY3_HUMAN "WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein, Alfy)" WDFY3 KIAA0993 Homo sapiens (Human) aggrephagy [GO:0035973] autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605] autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of membrane [GO:0019898]; inclusion body [GO:0016234]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; aggrephagy [GO:0035973] GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0016234; GO:0016605; GO:0019898; GO:0030424; GO:0031965; GO:0035973; GO:0043204; GO:0046872; GO:0097635 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872] AHLQGPLSHPHPNPIEVRNYSR 0.99131 -48.763 0 0 0 0 0 0 0 0 11.3595 12.0567 13.4415 10.5871 0 0 0 0 0 14.0619 0 14.9427 0 13.0833 0 0 0 13.1914 0 0 0 0 14.2691 0 10.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2128 12.6585 10.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.572 13.8194 13.9123 0 13.4357 11.2339 13.5105 15.3433 13.9386 11.3737 14.1078 0 14.4861 13.7381 13.8932 17.6198 11.4633 13.3042 0 0 13.4607 13.908 0 13.5806 13.5886 14.9959 13.9485 13.1536 11.8939 13.1254 13.814 13.8745 13.1111 11.9638 11.046 16.2682 13.8755 12.4454 14.0983 0 12.5843 12.9248 12.5646 0 14.3173 0 12.3208 19.4085 17.3606 0 13.4682 18.5049 12.0284 14.3269 15.244 12.9337 13.2509 14.1995 13.1603 14.3392 10.9487 12.8377 12.3575 13.2005 13.6175 12.3803 11.7198 14.7011 13.1054 0 15.5183 11.795 15.468 0 10.8444 15.4345 11.3471 14.4955 16.4228 12.3062 11.6721 13.4726 14.7536 0 0 0 13.979 0 12.8883 13.9092 0 0 0 14.4086 17.0118 0 0 11.2862 0 14.1273 0 0 0 13.6899 14.1028 14.181 0 10.0013 0 0 0 12.5614 Q8NAF0 ZN579_HUMAN Zinc finger protein 579 ZNF579 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000976; GO:0000981; GO:0003723; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]" AFRRPAHLSR 0.99131 -22.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6425 0 0 12.8097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4524 0 13.3699 12.9973 12.9582 0 0 12.8196 15.5147 0 17.1272 0 0 15.7638 0 14.1994 0 16.5869 0 0 15.5003 0 0 14.9441 15.5824 0 15.4619 0 14.8594 14.7936 0 14.042 0 0 0 0 15.0922 0 14.1838 0 0 0 14.4204 16.8823 0 0 0 0 13.9574 0 0 0 0 11.2398 0 13.8201 0 0 0 14.5028 0 0 0 0 0 14.3984 0 0 15.1127 0 0 0 0 0 0 0 0 16.6482 14.6251 14.6082 0 14.2902 0 14.0318 13.7832 14.172 0 13.6855 12.1019 14.5248 15.1632 14.7171 15.7092 14.479 14.6235 0 13.8957 0 13.8251 0 0 Q8NEW7 TMIE_HUMAN Transmembrane inner ear expressed protein TMIE Homo sapiens (Human) inner ear morphogenesis [GO:0042472]; sensory perception of sound [GO:0007605] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; inner ear morphogenesis [GO:0042472]; sensory perception of sound [GO:0007605] GO:0007605; GO:0016021; GO:0042472 YLQRKAAK 0.99131 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.724 0 0 0 0 10.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5512 0 0 0 0 Q8TAA3 PSMA8_HUMAN "Proteasome subunit alpha-type 8 (Proteasome alpha 4 subunit, Alpha4s) (Proteasome subunit alpha-type 7-like)" PSMA8 PSMA7L Homo sapiens (Human) cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; proteasomal protein catabolic process [GO:0010498]; regulation of meiosis I [GO:0060631]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; spermatoproteasome complex [GO:1990111]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; spermatoproteasome complex [GO:1990111]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; proteasomal protein catabolic process [GO:0010498]; regulation of meiosis I [GO:0060631]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0005634; GO:0005829; GO:0005839; GO:0006511; GO:0007283; GO:0010498; GO:0019773; GO:0030154; GO:0051321; GO:0060631; GO:0070062; GO:1990111 ALLEVVQSGGKNIELAIIRR 0.99131 -5.5651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0187 0 0 0 0 0 0 0 0 0 0 0 13.0719 0 0 0 0 0 0 0 0 13.0829 0 0 0 0 0 14.1819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9466 0 0 0 0 0 0 12.5846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1442 0 12.4644 0 0 0 0 12.2644 13.6883 12.4644 0 0 0 0 0 0 0 0 12.5664 0 0 14.2441 0 0 0 0 0 0 0 13.7124 0 Q8TBE0 BAHD1_HUMAN "Bromo adjacent homology domain-containing 1 protein, BAH domain-containing protein 1" BAHD1 KIAA0945 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]" chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654] "chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; transcription cis-regulatory region binding [GO:0000976]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0000976; GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0006338; GO:0031507; GO:0045892 chromatin binding [GO:0003682]; transcription cis-regulatory region binding [GO:0000976] AARRPSHPK 0.99131 -48.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8757 0 0 0 0 0 0 11.9073 12.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2167 0 0 13.6902 0 0 0 0 12.7338 14.3999 0 0 0 0 0 0 0 0 14.2572 0 0 0 0 0 0 0 13.8641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3404 0 0 0 0 0 0 0 0 0 15.3572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEA1 NSUN6_HUMAN "tRNA (cytosine(72)-C(5))-methyltransferase NSUN6, EC 2.1.1.- (NOL1/NOP2/Sun and PUA domain-containing protein 1) (NOL1/NOP2/Sun domain family member 6)" NSUN6 NOPD1 Homo sapiens (Human) RNA methylation [GO:0001510]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; RNA methylation [GO:0001510]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400] GO:0000049; GO:0001510; GO:0002946; GO:0005737; GO:0005829; GO:0006400; GO:0016428; GO:0030488 tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049] AFCFDGTKAVK 0.99131 -5.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4281 0 0 0 13.8794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1749 0 0 0 0 0 0 0 0 13.6024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PZ7 CSMD1_HUMAN CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1) CSMD1 KIAA1890 UNQ5952/PRO19863 Homo sapiens (Human) conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; conditioned place preference [GO:1990708]; female gonad development [GO:0008585]; glucose homeostasis [GO:0042593]; male gonad development [GO:0008584]; mammary gland branching involved in pregnancy [GO:0060745]; memory [GO:0007613]; oviduct epithelium development [GO:0035846]; startle response [GO:0001964] GO:0001964; GO:0007613; GO:0008584; GO:0008585; GO:0016021; GO:0035846; GO:0042593; GO:0060745; GO:1990708 EEAHLLLK 0.99131 -22.068 0 0 0 0 0 0 0 0 11.1249 0 0 0 0 0 0 0 0 0 12.2602 0 0 0 0 0 12.4686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5689 0 0 0 0 0 9.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1249 11.5068 0 14.2123 0 0 0 0 0 12.8193 0 0 13.2906 0 0 0 0 0 0 13.8504 0 0 0 0 14.7855 13.7156 0 0 0 0 13.2381 0 0 14.551 0 13.243 0 0 0 0 0 0 0 0 0 13.4538 0 0 0 0 0 0 0 0 0 13.1003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.818 0 0 0 0 0 0 0 0 0 0 0 0 14.19 0 0 0 0 Q9NS84 CHST7_HUMAN "Carbohydrate sulfotransferase 7, EC 2.8.2.-, EC 2.8.2.17 (Chondroitin 6-sulfotransferase 2, C6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5, GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4, GlcNAc6ST-4, Gn6st-4)" CHST7 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006044; GO:0006790; GO:0008459; GO:0016021; GO:0030206 chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517] ADFFLTGALEVICEAWLRDLLFARGAPAWLR 0.99131 -7.1473 0 11.8918 0 0 0 0 0 0 11.0404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9094 0 0 0 0 0 0 0 0 0 0 0 0 13.9274 0 13.7561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0847 12.0199 0 0 12.0079 11.0427 0 0 15.9175 0 0 0 0 0 0 0 0 0 0 0 13.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7829 0 0 0 0 0 0 11.1732 0 0 0 0 12.3745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5136 0 0 0 0 0 0 0 0 0 12.4894 0 0 0 0 0 0 0 0 0 0 10.8567 11.9599 0 0 Q9UK85 DKKL1_HUMAN "Dickkopf-like protein 1 (Cancer/testis antigen 34, CT34) (Protein soggy-1, SGY-1)" DKKL1 SGY1 UNQ735/PRO1429 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of testosterone biosynthetic process [GO:2000225]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615] acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]; anatomical structure morphogenesis [GO:0009653]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of testosterone biosynthetic process [GO:2000225]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600] GO:0001669; GO:0005615; GO:0007341; GO:0009653; GO:0039706; GO:0043065; GO:0045600; GO:0048019; GO:0090090; GO:2000225 co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019] RHRLQAIR 0.99131 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3D5 RT18C_HUMAN "28S ribosomal protein S18c, mitochondrial, MRP-S18-c, Mrps18-c, S18mt-c (28S ribosomal protein S18-1, mitochondrial, MRP-S18-1) (Mitochondrial small ribosomal subunit protein bS18c) (Mitochondrial small ribosomal subunit protein bS18m)" MRPS18C CGI-134 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543; GO:0070181 small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735] HITGLCGK 0.99131 -5.5675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0922 0 0 0 0 0 13.1709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4257 0 0 0 0 0 0 0 0 0 0 0 0 14.9142 0 0 0 0 0 0 0 0 0 13.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.88762 0 0 0 A6NDX5 ZN840_HUMAN Putative zinc finger protein 840 (Zinc finger protein 840 pseudogene) ZNF840P C20orf157 ZNF840 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDVCQKAFR 0.99132 -22.966 0 0 0 0 0 0 0 0 0 0 0 11.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2646 10.9101 0 0 0 0 0 13.568 0 13.367 0 0 13.5328 0 0 0 0 0 0 0 0 0 11.2934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2552 0 0 0 0 0 0 11.2543 12.4196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9949 0 0 0 0 13.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14802 RPC1_HUMAN "DNA-directed RNA polymerase III subunit RPC1, RNA polymerase III subunit C1, EC 2.7.7.6 (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit, RPC155) (RNA polymerase III subunit C160)" POLR3A Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0016020; GO:0032728; GO:0045087; GO:0046872; GO:0051607 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872] AVIGILQMICK 0.99132 -49.248 0 0 0 0 0 0 0 0 12.0853 10.9056 13.1172 12.6146 0 12.2606 12.4909 11.5646 0 12.7788 13.5678 11.7917 12.8447 12.5619 0 0 12.0332 12.1218 12.5657 12.6752 0 12.4964 0 11.7712 0 0 0 0 0 13.1942 0 12.2133 11.356 12.3632 0 12.36 11.9214 12.4155 0 13.6069 9.90946 0 0 13.1187 0 10.5937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1642 0 0 0 0 0 0 0 0 13.2536 10.6732 0 0 0 14.2275 13.162 13.7675 13.3458 0 0 17.3789 13.0333 12.295 17.7272 12.3289 17.0973 15.254 12.2722 0 0 0 12.5009 12.8321 0 0 12.413 0 0 13.2952 15.4974 13.3573 0 12.5065 0 0 14.1998 0 14.4309 0 12.945 15.4249 0 0 11.078 0 13.9435 0 13.6282 0 0 0 0 12.5464 14.5163 0 0 0 15.2069 0 0 0 0 14.2754 0 0 0 0 15.0224 0 0 12.6781 0 13.8412 0 0 0 16.067 0 10.1248 0 0 14.5378 12.4845 10.2587 11.3059 13.1784 14.7179 0 0 0 14.9388 13.6108 0 12.8269 0 0 0 0 17.0711 0 0 O15204 ADEC1_HUMAN "ADAM DEC1, EC 3.4.24.- (A disintegrin and metalloproteinase domain-like protein decysin-1, ADAM-like protein decysin-1)" ADAMDEC1 Homo sapiens (Human) immune response [GO:0006955]; negative regulation of cell adhesion [GO:0007162]; proteolysis [GO:0006508] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; immune response [GO:0006955]; negative regulation of cell adhesion [GO:0007162]; proteolysis [GO:0006508] GO:0004222; GO:0005576; GO:0006508; GO:0006955; GO:0007162; GO:0008270; GO:0062023 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] AHFERYLLSQKPK 0.99132 -23.624 0 0 0 0 0 13.9247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.668 0 0 0 0 13.4795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5065 0 0 0 0 0 0 13.2731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9711 0 0 0 0 11.4826 0 0 0 0 0 0 O43525 KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3) KCNQ3 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; membrane hyperpolarization [GO:0060081]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] axon initial segment [GO:0043194]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] axon initial segment [GO:0043194]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; membrane hyperpolarization [GO:0060081]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0008076; GO:0009986; GO:0016021; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0051649; GO:0060081; GO:0071805 calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] ELITAWYIGFLTLILSSFLVYLVEKDVPEVDAQGEEMK 0.99132 -22.279 0 0 0 0 0 0 0 11.1355 0 0 15.4031 13.2619 14.3044 13.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2049 0 13.1938 14.2257 13.1259 12.4909 0 13.421 0 13.2184 13.349 16.3625 13.3323 0 12.936 0 16.8127 0 0 12.3387 0 13.6427 0 0 0 0 16.1924 0 15.8764 0 14.8305 0 0 13.7804 0 0 14.7993 0 0 0 0 0 0 0 11.8197 0 15.7056 0 15.1952 0 0 0 0 0 15.4523 0 0 0 0 0 0 0 0 0 14.8086 0 14.3992 0 13.8875 0 0 13.5637 13.2946 0 0 0 0 14.2391 16.3505 0 0 11.8873 0 12.5186 13.5535 14.1308 0 13.2656 0 12.4616 0 12.516 11.6812 0 0 13.4086 0 0 12.7366 0 0 0 0 0 0 16.1207 12.7732 19.0668 15.8154 0 0 0 0 0 12.0747 12.4077 0 0 14.8036 0 11.9637 0 0 0 0 0 13.4085 0 14.4865 15.5808 14.5946 14.6099 15.6022 14.6634 14.5546 14.5345 0 0 14.4617 0 14.51 14.4681 0 0 12.8801 0 0 0 0 18.2161 0 O43827 ANGL7_HUMAN Angiopoietin-related protein 7 (Angiopoietin-like factor) (Angiopoietin-like protein 7) (Cornea-derived transcript 6 protein) ANGPTL7 CDT6 UNQ313/PRO356 Homo sapiens (Human) negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053]; response to oxidative stress [GO:0006979] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053]; response to oxidative stress [GO:0006979] GO:0005102; GO:0005576; GO:0005615; GO:0006979; GO:0042802; GO:0062023; GO:1901346; GO:1903053 identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] DNDNCLDK 0.99132 -22.259 0 0 0 0 0 10.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4221 0 0 0 0 0 0 0 0 0 0 13.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9383 0 O60287 NPA1P_HUMAN Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog) URB1 C21orf108 KIAA0539 NOP254 NPA1 Homo sapiens (Human) "maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" fibrillar center [GO:0001650]; nucleolus [GO:0005730] "fibrillar center [GO:0001650]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" GO:0000463; GO:0000466; GO:0001650; GO:0003723; GO:0005730 RNA binding [GO:0003723] ACLSLMTAMVTQGPEAAR 0.99132 -23.584 0 0 0 0 0 0 0 13.0269 12.5544 13.8935 11.6185 12.9123 13.4466 12.8062 13.0728 14.3559 12.5615 0 0 14.1373 0 13.7745 0 0 0 0 9.91199 0 0 11.4201 13.7469 13.0083 13.8216 0 12.5831 12.1081 13.6795 0 14.8491 0 13.9675 0 14.0297 0 9.65651 13.4073 0 13.9199 0 0 0 0 0 0 0 0 0 0 0 0 10.3188 0 0 0 0 10.8848 0 11.9108 11.3456 14.6738 11.3785 0 16.3379 14.1637 0 14.9601 0 11.1513 16.1138 0 0 15.4809 0 15.3112 12.9601 0 13.431 0 12.6258 11.9924 0 14.6995 0 14.3571 14.8839 14.6945 0 0 0 14.6152 15.8213 14.0235 0 12.9301 0 16.0538 15.7846 0 12.4522 12.5215 12.227 14.6721 17.3845 15.4114 16.5664 12.0616 13.7496 17.1197 13.6186 14.8473 11.5317 11.5686 0 0 0 14.3887 17.3604 13.7829 15.5143 15.3296 0 14.6171 0 0 0 12.9753 14.5402 0 15.6877 11.4247 12.2852 14.0091 15.4736 15.8916 13.0849 11.3006 0 14.8824 14.9911 0 0 14.7205 12.1482 13.769 17.3844 12.95 12.9708 13.499 0 0 0 14.2503 0 0 14.0103 13.8583 13.4171 13.4528 13.992 0 12.2643 16.4134 0 0 14.2505 0 17.182 13.3185 12.4607 13.7298 P48444 COPD_HUMAN "Coatomer subunit delta (Archain) (Delta-coat protein, Delta-COP)" ARCN1 COPD Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intracellular protein transport [GO:0006886]; pigmentation [GO:0043473]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intracellular protein transport [GO:0006886]; pigmentation [GO:0043473]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0003723; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0008344; GO:0016020; GO:0021691; GO:0030126; GO:0030133; GO:0043473; GO:0051645 RNA binding [GO:0003723] ETQEREAKAEMR 0.99132 -5.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6933 16.5864 13.7381 0 16.7598 16.4872 0 17.1381 0 16.6572 16.9238 16.8742 0 17.0697 16.58 15.7427 14.2969 15.6844 0 0 16.197 16.8071 14.8298 0 14.8588 17.0741 15.5968 0 15.6745 14.9654 15.9869 14.2997 14.7814 16.3133 16.4667 0 0 16.1688 0 15.1 0 14.5461 15.8363 16.5984 16.0039 15.4339 0 15.5272 14.7983 16.1701 14.5227 0 13.7087 14.5355 14.0891 0 12.5255 14.9319 0 0 0 0 0 0 14.4415 12.9052 0 0 12.9145 0 12.6134 0 0 0 0 0 0 15.4748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5585 0 13.7262 0 0 0 11.8057 0 0 0 Q07912 ACK1_HUMAN "Activated CDC42 kinase 1, ACK-1, EC 2.7.10.2, EC 2.7.11.1 (Tyrosine kinase non-receptor protein 2)" TNK2 ACK1 Homo sapiens (Human) cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase mediated signal transduction [GO:0007264]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; innate immune response [GO:0045087]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase mediated signal transduction [GO:0007264]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005095; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007166; GO:0007169; GO:0007264; GO:0016020; GO:0016310; GO:0030136; GO:0030154; GO:0030659; GO:0031234; GO:0031625; GO:0042802; GO:0043231; GO:0045087; GO:0046872; GO:0048471; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:0106310; GO:2000369 ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699] AAQYLKVEQLFGLGLRPR 0.99132 -22.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.213 0 0 0 0 0 0 0 0 11.0571 11.7089 13.8293 0 0 0 0 0 0 13.547 0 0 0 0 0 0 0 0 0 11.4572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13936 CAC1C_HUMAN "Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2)" CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; embryonic forelimb morphogenesis [GO:0035115]; heart development [GO:0007507]; immune system development [GO:0002520]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; L-type voltage-gated calcium channel complex [GO:1990454]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; camera-type eye development [GO:0043010]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; embryonic forelimb morphogenesis [GO:0035115]; heart development [GO:0007507]; immune system development [GO:0002520]; membrane depolarization during atrial cardiac muscle cell action potential [GO:0098912]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] GO:0002520; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005887; GO:0005891; GO:0007204; GO:0007507; GO:0008331; GO:0010881; GO:0014069; GO:0016021; GO:0030018; GO:0030425; GO:0035115; GO:0035585; GO:0043010; GO:0043204; GO:0045762; GO:0046872; GO:0051393; GO:0060402; GO:0061337; GO:0061577; GO:0070161; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086045; GO:0086056; GO:0086064; GO:0086091; GO:0098703; GO:0098839; GO:0098911; GO:0098912; GO:1990454 alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in AV node cell action potential [GO:0086056]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007] AFRVLRPLR 0.99132 -49.321 0 0 0 0 0 0 0 0 0 0 0 0 14.0109 12.1053 0 0 15.3961 15.0061 13.9881 15.1373 0 13.4106 14.0005 12.9834 15.3383 0 0 19.2649 14.7931 11.0763 0 11.1668 19.4014 0 0 0 0 19.4538 0 0 0 0 0 19.6714 15.6228 19.5661 19.5504 0 19.5174 0 19.5388 0 0 18.9821 0 0 0 19.6269 0 0 0 18.3625 0 0 0 0 0 0 14.9137 0 0 9.70567 13.6125 12.1106 14.695 0 0 0 0 13.5596 11.1182 13.0612 15.1826 14.1264 15.6712 0 14.1819 14.7691 15.2274 0 15.1164 14.7884 14.1951 14.3789 13.4446 15.402 0 0 0 12.1949 12.5054 0 0 14.6752 15.4174 15.3047 12.0486 0 0 0 0 12.3131 13.2922 0 0 0 15.147 12.0628 11.6704 15.3509 11.8924 0 0 12.5696 0 0 14.9546 14.7059 14.0083 11.0067 13.6792 0 14.9501 13.5158 14.9789 14.1181 12.1449 14.8162 16.3044 0 13.4217 0 14.8595 14.7074 0 0 0 0 0 0 0 0 0 0 0 12.421 0 0 0 0 0 18.4802 0 12.0713 11.6583 0 0 0 0 0 0 0 13.8005 11.0474 0 11.0248 11.0036 0 0 19.4217 Q86TD4 SRCA_HUMAN Sarcalumenin SRL Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197] intracellular membrane-bounded organelle [GO:0043231]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017] intracellular membrane-bounded organelle [GO:0043231]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; GTP binding [GO:0005525]; endocytosis [GO:0006897]; endosomal transport [GO:0016197] GO:0005525; GO:0006897; GO:0016197; GO:0033017; GO:0033018; GO:0043231 GTP binding [GO:0005525] FGQNFLEK 0.99132 -23.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2438 0 12.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.041 0 0 15.8169 12.4214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0515 12.7291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.157 0 0 0 0 13.4472 12.4902 0 0 0 0 0 0 0 13.2295 0 0 Q86V15 CASZ1_HUMAN Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693) CASZ1 CST SRG ZNF693 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]" chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neuron differentiation [GO:0045664]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0043231; GO:0045664; GO:0045893; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ATEDCGTADCQFYGQKTTHFHCRR 0.99132 -23.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9568 0 0 9.90112 0 0 0 0 0 0 0 12.9979 13.3574 0 0 0 0 0 0 0 0 0 0 12.885 0 13.862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0138 0 9.96636 0 10.6282 0 0 10.7977 0 10.2952 0 11.1432 11.3725 0 12.3137 0 0 0 0 15.4238 0 0 0 10.7955 0 0 12.6735 13.102 0 0 10.4948 0 0 0 0 0 0 13.7512 0 0 0 0 11.9535 0 0 0 0 0 0 0 0 13.7298 0 0 0 0 13.1577 0 0 0 0 0 0 0 0 13.2453 0 12.6891 14.8816 0 0 0 0 0 0 0 0 0 15.502 0 0 0 0 0 0 0 0 15.5382 0 0 0 14.6473 0 13.4185 0 0 13.7456 0 0 0 0 0 0 14.3534 0 0 11.5489 12.988 0 0 0 0 0 Q92519 TRIB2_HUMAN "Tribbles homolog 2, TRB-2" TRIB2 TRB2 Homo sapiens (Human) negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405] GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0006469; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629 mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106] LRKFIFK 0.99132 -22.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8809 0 0 0 0 0 0 0 0 14.6079 12.7027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9567 0 0 0 0 0 0 12.7422 0 0 0 0 0 0 0 0 0 0 12.0637 11.9604 0 0 0 0 0 0 0 0 0 Q96SW2 CRBN_HUMAN Protein cereblon CRBN AD-006 Homo sapiens (Human) locomotory exploration behavior [GO:0035641]; negative regulation of large conductance calcium-activated potassium channel activity [GO:1902607]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; locomotory exploration behavior [GO:0035641]; negative regulation of large conductance calcium-activated potassium channel activity [GO:1902607]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0016567; GO:0031333; GO:0031334; GO:0031464; GO:0035641; GO:0043161; GO:0044325; GO:0046872; GO:0048471; GO:1902607 metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325] CELDIMNK 0.99132 -23.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0504 0 0 0 0 10.4075 0 0 0 0 0 0 0 0 0 0 0 0 10.5285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0642 14.2569 0 0 12.6316 0 12.1065 0 0 0 0 0 0 0 14.0724 0 0 0 0 0 0 0 0 0 12.0794 0 18.9982 0 0 0 0 0 0 0 12.9984 12.0198 0 0 14.5575 0 12.3464 0 0 15.1342 13.5993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQT8 KI13B_HUMAN Kinesin-like protein KIF13B (Kinesin-like protein GAKIN) KIF13B GAKIN KIAA0639 Homo sapiens (Human) microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110] axon [GO:0030424]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] axon [GO:0030424]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0006605; GO:0007018; GO:0007165; GO:0008017; GO:0016887; GO:0019901; GO:0030424; GO:0042110; GO:0050770; GO:0071889 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901] AEREDEDQDPSMK 0.99132 -49.038 0 0 12.1112 0 15.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1514 0 0 0 0 0 0 0 0 0 0 12.5117 0 0 0 13.0168 0 14.194 13.4964 0 0 0 0 0 0 0 12.6113 0 0 13.0259 13.9265 0 0 0 0 13.0443 0 0 13.4416 11.5908 0 0 0 0 18.2934 0 15.2019 15.5144 0 0 0 0 0 0 0 0 15.9038 11.4859 14.109 15.9122 0 11.7086 0 15.7425 0 14.1974 13.8099 10.1833 0 0 0 0 0 0 0 0 0 16.0481 0 15.5954 11.4601 0 0 15.1571 14.1528 9.40359 0 0 0 0 14.898 0 14.5577 0 13.1707 0 0 0 0 14.9484 0 0 0 0 0 0 0 17.4248 12.4652 0 0 0 0 13.3271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6322 0 0 0 0 0 13.93 Q9UIM3 FKBPL_HUMAN "FK506-binding protein-like (WAF-1/CIP1 stabilizing protein 39, WISp39)" FKBPL DIR1 NG7 Homo sapiens (Human) regulation of blood vessel branching [GO:1905553]; response to radiation [GO:0009314] cytosol [GO:0005829]; extracellular region [GO:0005576] cytosol [GO:0005829]; extracellular region [GO:0005576]; regulation of blood vessel branching [GO:1905553]; response to radiation [GO:0009314] GO:0005576; GO:0005829; GO:0009314; GO:1905553 AAQEELGK 0.99132 -7.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5144 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5575 0 0 0 0 12.6182 0 0 0 0 0 12.6709 0 0 12.1307 0 0 0 0 0 0 0 0 0 0 0 11.3411 0 0 0 0 12.2765 0 0 0 0 0 12.0336 0 12.4507 0 11.6511 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4216 0 0 0 0 11.8653 0 0 0 0 0 0 0 0 0 11.7497 0 0 11.5956 0 0 0 0 0 0 0 0 0 0 0 0 O60504 VINEX_HUMAN "Vinexin (SH3-containing adapter molecule 1, SCAM-1) (Sorbin and SH3 domain-containing protein 3)" SORBS3 SCAM1 Homo sapiens (Human) actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; MAPK cascade [GO:0000165]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496] cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634] cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; MAPK cascade [GO:0000165]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496] GO:0000122; GO:0000165; GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0007015; GO:0007155; GO:0017166; GO:0030055; GO:0031589; GO:0043410; GO:0051495; GO:0051496 structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] ELTLQKGDIVYIHKEVDK 0.99133 -7.5099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3665 0 0 0 0 0 0 0 0 13.3891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VFX4 YL016_HUMAN Putative uncharacterized protein LOC100128554 Homo sapiens (Human) MVLPHPK 0.99133 -4.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4LE39 ARI4B_HUMAN "AT-rich interactive domain-containing protein 4B, ARID domain-containing protein 4B (180 kDa Sin3-associated polypeptide, Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1)" ARID4B BRCAA1 RBBP1L1 RBP1L1 SAP180 Homo sapiens (Human) establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription cis-regulatory region binding [GO:0000976]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] GO:0000122; GO:0000976; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006349; GO:0006357; GO:0006366; GO:0007283; GO:0016580; GO:0030336; GO:0030512; GO:0034773; GO:0036124; GO:0045944; GO:0097368; GO:1902455; GO:1902459 transcription cis-regulatory region binding [GO:0000976] ATVVNNK 0.99133 -50.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5458 0 12.0502 15.6076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4051 0 0 0 0 0 0 13.0655 0 0 0 10.1585 0 0 0 0 0 0 0 0 0 0 0 0 14.5277 0 0 0 0 0 13.5143 14.435 14.0903 14.1118 13.2341 0 13.5215 0 14.4769 0 13.6785 12.1342 15.4953 14.7724 0 13.5011 13.8379 13.5805 11.4856 12.5333 0 13.4676 0 13.7853 0 15.7569 0 0 14.8842 0 14.6093 13.5812 15.9924 13.4014 13.3476 0 12.9682 0 0 0 14.603 0 14.1003 0 0 14.1351 0 0 13.8118 0 14.6639 14.42 13.724 12.7724 14.1303 0 13.8572 12.7858 13.2936 0 0 0 13.8294 12.6011 0 14.7972 0 12.4204 0 14.534 0 14.1809 13.8204 0 13.9889 0 14.151 13.6455 0 0 14.6146 0 11.8729 0 13.3514 0 0 12.1453 0 0 0 0 0 0 0 0 13.1217 14.6915 14.645 0 0 11.5583 0 12.6143 0 12.9974 Q5MIZ7 P4R3B_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2) PPP4R3B KIAA1387 PP4R3B SMEK2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; gluconeogenesis [GO:0006094]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase activator activity [GO:0072542]; cellular response to DNA damage stimulus [GO:0006974]; gluconeogenesis [GO:0006094]; negative regulation of histone phosphorylation [GO:0033128]; positive regulation of gluconeogenesis [GO:0045722]; protein dephosphorylation [GO:0006470]; regulation of double-strand break repair [GO:2000779] GO:0000785; GO:0005654; GO:0005737; GO:0005813; GO:0006094; GO:0006470; GO:0006974; GO:0016607; GO:0030289; GO:0033128; GO:0045722; GO:0072542; GO:2000779 protein phosphatase activator activity [GO:0072542] AVVAPVEK 0.99133 -22.434 0 0 0 0 0 0 0 0 14.0926 0 0 0 0 0 0 0 0 0 11.011 0 12.0337 0 0 0 0 12.9172 0 0 12.6707 0 0 0 0 12.0885 14.4878 0 12.2207 0 14.0768 14.8377 0 14.0899 0 0 11.9192 12.1678 0 14.0918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 0 0 0 0 0 0 13.4693 0 0 0 0 12.2852 0 0 0 0 11.3711 0 0 0 13.7888 0 0 0 0 0 0 0 0 15.0611 0 0 0 0 0 0 0 0 0 0 12.8267 0 14.4244 0 0 0 0 0 13.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9732 0 0 0 0 0 0 0 0 0 13.4485 0 0 13.3983 14.2331 13.6813 13.8551 13.6776 14.8037 0 14.1569 14.174 13.7163 0 0 0 0 0 13.8796 0 14.5616 0 0 Q7L8L6 FAKD5_HUMAN "FAST kinase domain-containing protein 5, mitochondrial" FASTKD5 KIAA1792 Homo sapiens (Human) mitochondrial RNA processing [GO:0000963]; mRNA processing [GO:0006397]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial RNA processing [GO:0000963]; mRNA processing [GO:0006397]; regulation of mitochondrial mRNA stability [GO:0044528] GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0006397; GO:0019843; GO:0035770; GO:0042645; GO:0044528 RNA binding [GO:0003723]; rRNA binding [GO:0019843] ARGHFQGK 0.99133 -7.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7165 0 14.7811 14.2701 13.8099 0 0 15.0173 0 0 0 0 0 14.2394 0 0 0 0 12.1442 0 0 0 14.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7422 0 0 0 0 0 0 12.0484 0 0 0 0 0 0 0 0 0 14.2935 0 0 0 0 14.4576 0 0 0 0 0 0 14.1219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6636 11.2274 0 Q9BUJ2 HNRL1_HUMAN "Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5, E1B-AP5)" HNRNPUL1 E1BAP5 HNRPUL1 Homo sapiens (Human) response to virus [GO:0009615]; RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396] GO:0003723; GO:0005634; GO:0005654; GO:0006396; GO:0009615; GO:0019899 enzyme binding [GO:0019899]; RNA binding [GO:0003723] DNNNSNNR 0.99133 -22.444 0 0 0 0 0 0 0 10.2583 0 0 0 0 0 10.3559 0 0 0 0 12.5437 0 13.1802 0 0 0 0 0 12.6002 12.916 0 0 11.5032 0 0 0 10.2064 0 11.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.56444 0 0 0 0 15.1876 0 16.352 0 13.4078 0 0 0 0 0 0 0 0 0 14.8126 0 0 0 0 13.8657 13.8379 0 12.7848 0 14.2162 11.514 14.332 16.9549 0 0 13.2803 14.0212 0 0 0 0 14.7021 0 0 15.844 0 0 0 0 0 0 0 0 12.1968 0 13.9764 0 0 0 0 0 14.138 0 14.1049 13.4409 0 0 13.6338 0 0 13.8801 0 13.2503 0 0 11.928 0 0 10.5088 0 0 0 0 11.8341 11.5908 0 13.7971 0 12.8191 11.3006 0 0 0 0 14.5732 0 0 0 0 0 0 12.1016 0 0 0 0 0 0 0 0 13.5905 14.5711 0 0 0 0 0 0 10.8643 Q9HCS5 E41LA_HUMAN Band 4.1-like protein 4A (Erythrocyte membrane protein band 4.1-like 4A) (Protein NBL4) EPB41L4A EPB41L4 Homo sapiens (Human) actomyosin structure organization [GO:0031032] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032] GO:0005737; GO:0005856; GO:0008092; GO:0031032 cytoskeletal protein binding [GO:0008092] AKNENSPDTQR 0.99133 -22.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2009 13.824 13.6965 13.1867 10.7096 11.6683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6462 0 0 0 0 0 0 0 0 0 0 0 14.0234 0 0 0 12.4922 10.9845 0 0 16.9685 0 0 0 0 0 0 0 0 13.4962 0 0 0 0 0 0 0 0 0 0 14.4445 0 0 0 18.5959 0 0 0 12.7753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.658 0 13.5338 0 A2A2Y4 FRMD3_HUMAN "FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1, 4.1O)" FRMD3 EPB41L4O Homo sapiens (Human) actomyosin structure organization [GO:0031032] cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021] cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; actomyosin structure organization [GO:0031032] GO:0005856; GO:0008092; GO:0016021; GO:0031032 cytoskeletal protein binding [GO:0008092] DYFGIRYVDPEKQR 0.99134 -4.7653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8251 0 0 0 14.0972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4137 0 0 0 0 0 0 12.014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.115 0 13.1101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7335 0 0 Q6ZU65 UBN2_HUMAN Ubinuclein-2 UBN2 KIAA2030 Homo sapiens (Human) DNA replication-independent chromatin assembly [GO:0006336] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA replication-independent chromatin assembly [GO:0006336] GO:0005615; GO:0005634; GO:0005654; GO:0006336 DPTDESCVEFSYPELLLCGEQR 0.99134 -52.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6724 0 0 0 0 0 14.8594 0 10.2288 0 0 0 0 0 0 15.2198 14.0925 13.6154 13.0202 0 11.8733 0 0 0 0 0 15.8108 0 0 0 0 15.0089 0 0 0 0 0 11.5377 0 13.5036 0 0 10.026 0 0 0 0 0 13.7979 0 0 13.1367 0 0 0 13.1623 13.2358 0 0 0 0 0 0 0 0 13.0474 0 0 11.1203 0 0 0 0 12.9812 0 0 12.8391 12.5615 0 0 11.7862 0 0 15.3477 0 12.9456 0 0 0 0 0 0 0 0 0 0 0 0 10.5825 14.5555 0 0 0 0 0 0 0 12.4738 0 0 13.4354 0 0 0 Q7Z7M9 GALT5_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 5, EC 2.4.1.41 (Polypeptide GalNAc transferase 5, GalNAc-T5, pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5)" GALNT5 Homo sapiens (Human) glycosaminoglycan biosynthetic process [GO:0006024]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; glycosaminoglycan biosynthetic process [GO:0006024]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006024; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] APIVRASGVLINVALGK 0.99134 -51.997 0 0 0 0 0 0 0 0 14.0835 14.1839 0 0 13.2978 0 0 0 0 0 13.647 0 0 0 0 0 0 0 0 11.534 0 0 0 0 0 0 0 0 12.4973 0 0 0 11.4727 0 0 0 0 0 0 0 0 12.9678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9479 13.1155 0 0 0 12.9128 13.2357 13.5194 13.1171 13.1158 0 0 0 13.5129 0 0 12.2248 0 0 0 0 11.5203 0 13.6461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2101 0 13.7307 0 0 0 0 0 0 0 15.5254 13.611 0 0 0 0 0 0 0 15.5006 0 12.8673 0 0 12.7177 0 0 0 0 14.0015 0 0 11.9652 0 0 15.0601 0 0 0 14.8337 13.5261 0 13.1077 12.8807 0 0 0 13.7501 0 0 0 0 12.9071 0 14.4964 0 0 11.9109 0 Q9HAW4 CLSPN_HUMAN "Claspin, hClaspin" CLSPN Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217]; activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105] GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0018105; GO:0032147; GO:0033314 anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217] ADVVPVTLAPKK 0.99134 -52.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5479 14.0694 11.4055 0 0 0 0 0 12.0814 0 0 0 0 0 0 0 0 0 0 0 11.6778 0 0 0 0 0 0 0 0 0 0 0 11.7445 0 0 12.8317 0 11.9211 0 0 0 0 0 0 0 0 0 14.4781 14.2705 0 0 0 0 0 0 0 0 0 12.3036 0 13.5201 12.8185 12.765 0 13.429 14.8074 11.6907 0 0 15.5251 0 0 0 15.017 13.803 10.3188 14.4408 0 0 13.6466 14.1368 14.8698 15.21 14.3159 14.9664 0 14.2962 15.2662 14.1339 15.8113 14.0363 0 13.5185 14.4594 0 0 0 15.0251 15.4001 14.3248 13.8646 14.1492 16.0293 15.5271 15.0596 12.7452 15.4692 15.2718 14.7329 14.5487 14.2677 0 14.1604 0 0 12.607 14.8433 12.4343 0 14.4984 14.1215 0 14.0995 14.0527 12.1147 14.586 13.5831 13.8 0 0 0 12.5294 12.1501 14.4893 0 0 12.6424 13.4946 12.5004 10.601 0 11.3602 0 0 11.7853 0 0 12.8337 0 0 0 0 15.7501 0 15.2543 0 12.7187 0 13.4006 0 0 Q9ULL5 PRR12_HUMAN Proline-rich protein 12 PRR12 KIAA1205 Homo sapiens (Human) anchoring junction [GO:0070161]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] GO:0005634; GO:0014069; GO:0043005; GO:0070161 AEPPPKKR 0.99134 -52.075 0 0 0 0 0 0 0 0 0 10.9856 13.5775 11.442 0 0 0 12.5038 12.103 0 12.6325 11.7837 12.7118 0 12.5414 0 0 0 13.6108 0 12.9902 12.5404 0 12.8412 12.616 0 0 0 0 0 0 0 0 0 13.9407 12.6613 0 0 0 13.4784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5206 0 0 0 0 0 0 0 0 0 0 0 0 12.8109 0 12.2206 0 0 15.7167 0 0 0 0 0 0 0 13.2175 14.9857 0 12.7085 0 0 0 14.9459 0 15.5653 0 0 14.6162 0 15.1282 0 13.9817 13.648 0 0 12.8735 0 0 0 0 0 0 0 0 0 0 0 0 12.7843 0 13.0204 13.4202 0 12.3911 12.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0442 0 0 0 0 0 0 0 0 12.8084 14.0885 12.9234 12.6999 12.4776 0 14.7363 12.2484 12.551 0 0 11.8394 0 0 0 11.8146 0 0 13.3773 0 0 10.4486 0 Q96MU8 KREM1_HUMAN Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose) KREMEN1 KREMEN KRM1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell communication [GO:0007154]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; cell communication [GO:0007154]; limb development [GO:0060173]; negative regulation of axon regeneration [GO:0048681]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] GO:0005886; GO:0006915; GO:0007154; GO:0016020; GO:0016021; GO:0016055; GO:0030279; GO:0043025; GO:0048681; GO:0060173; GO:0060828; GO:0090090 ILLHVTFK 0.99135 -5.9493 0 16.8875 0 10.248 16.9511 16.2442 17.4526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3999 0 13.6963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1516 15.4013 17.8219 0 17.8662 0 15.3397 18.2338 18.1593 18.2242 16.2756 18.2666 16.5119 18.4473 18.4324 19.819 20.4005 20.5351 19.467 18.5433 0 0 0 16.8955 0 17.0962 0 0 16.4156 16.483 12.6995 19.329 0 16.7295 0 16.7482 0 18.3416 0 18.3044 16.4982 14.385 0 0 18.209 0 16.5942 0 16.4746 0 16.506 0 18.3423 0 0 16.6614 0 0 0 0 18.4137 16.7486 18.7576 18.3173 18.8042 18.3099 18.7773 18.4061 11.6083 0 0 0 12.4999 0 0 0 16.7766 0 0 0 0 0 11.9848 0 18.8044 18.8458 16.8233 16.7816 17.1277 16.8917 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2654 0 0 0 0 0 0 0 0 0 0 O00463 TRAF5_HUMAN TNF receptor-associated factor 5 (RING finger protein 84) TRAF5 RNF84 Homo sapiens (Human) apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829] CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0046330; GO:0048255; GO:0051091; GO:0051092; GO:0070534; GO:0097400 identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] AYSEEHK 0.99135 -19.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3174 0 0 0 0 0 0 0 0 0 11.211 0 11.7314 0 11.4245 0 0 11.5059 0 0 0 0 0 0 11.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2924 0 0 0 0 0 0 0 0 0 0 0 0 13.1942 0 0 13.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1887 12.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9799 0 0 0 0 12.242 0 0 0 0 11.8487 0 12.4692 0 0 0 0 0 0 12.5676 0 0 0 0 0 0 0 0 0 0 0 P27216 ANX13_HUMAN "Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin, ISA)" ANXA13 ANX13 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylglycerol binding [GO:1901611]; phosphatidylserine binding [GO:0001786]; cell differentiation [GO:0030154]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998] GO:0001786; GO:0005509; GO:0005544; GO:0005615; GO:0005654; GO:0005886; GO:0016323; GO:0016324; GO:0019898; GO:0030154; GO:0031410; GO:0042997; GO:0042998; GO:0045121; GO:0070062; GO:0070382; GO:1901611 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylglycerol binding [GO:1901611]; phosphatidylserine binding [GO:0001786] CAQDCEDYFAER 0.99135 -22.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7529 0 0 0 0 0 0 13.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6103 0 0 0 0 0 14.1433 0 0 0 0 0 0 0 0 0 Q02952 AKA12_HUMAN "A-kinase anchor protein 12, AKAP-12 (A-kinase anchor protein 250 kDa, AKAP 250) (Gravin) (Myasthenia gravis autoantigen)" AKAP12 AKAP250 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatic stellate cell activation [GO:0035733]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of vascular permeability [GO:0043116]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hepatic stellate cell migration [GO:0061870]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase binding [GO:0008179]; calmodulin binding [GO:0005516]; protein kinase A binding [GO:0051018]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatic stellate cell activation [GO:0035733]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of vascular permeability [GO:0043116]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hepatic stellate cell migration [GO:0061870]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165] GO:0005516; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007186; GO:0007193; GO:0008179; GO:0010738; GO:0010739; GO:0032496; GO:0032760; GO:0035733; GO:0043025; GO:0043116; GO:0050804; GO:0051018; GO:0051602; GO:0051770; GO:0061870; GO:0070374; GO:0071347; GO:0071356; GO:0090036; GO:0098685; GO:1900143 adenylate cyclase binding [GO:0008179]; calmodulin binding [GO:0005516]; protein kinase A binding [GO:0051018] DDALELQSHAK 0.99135 -23.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9013 15.188 13.3278 0 14.4186 0 0 12.384 0 0 0 0 0 14.5584 0 0 0 0 0 0 13.9388 0 10.614 0 13.8666 0 17.7663 0 0 14.1294 0 0 0 0 0 0 14.3592 0 0 0 0 10.8099 0 0 0 14.0801 0 0 0 17.647 13.5941 0 12.0436 0 0 0 0 0 0 0 0 0 0 13.366 0 13.4193 0 0 0 13.0543 0 13.285 0 0 14.1836 0 0 0 0 0 0 0 0 0 15.2869 10.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1225 0 0 0 0 0 14.2922 Q06187 BTK_HUMAN "Tyrosine-protein kinase BTK, EC 2.7.10.2 (Agammaglobulinemia tyrosine kinase, ATK) (B-cell progenitor kinase, BPK) (Bruton tyrosine kinase)" BTK AGMX1 ATK BPK Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; eosinophil homeostasis [GO:1990959]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; monocyte proliferation [GO:0061516]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; neutrophil homeostasis [GO:0001780]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17A production [GO:0150153]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phagocytosis [GO:0050766]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; protein phosphorylation [GO:0006468]; proteoglycan catabolic process [GO:0030167]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; eosinophil homeostasis [GO:1990959]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; monocyte proliferation [GO:0061516]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; neutrophil homeostasis [GO:0001780]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17A production [GO:0150153]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phagocytosis [GO:0050766]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; protein phosphorylation [GO:0006468]; proteoglycan catabolic process [GO:0030167]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]; response to lipopolysaccharide [GO:0032496]" GO:0001780; GO:0001805; GO:0001812; GO:0002250; GO:0002344; GO:0002553; GO:0002639; GO:0002721; GO:0002755; GO:0002902; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007249; GO:0007498; GO:0016004; GO:0018108; GO:0019722; GO:0030167; GO:0030889; GO:0030890; GO:0031410; GO:0032496; GO:0032693; GO:0032755; GO:0032760; GO:0034614; GO:0035556; GO:0038083; GO:0038095; GO:0042113; GO:0042802; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0046872; GO:0048469; GO:0048471; GO:0050766; GO:0050853; GO:0051092; GO:0061516; GO:0071226; GO:0097190; GO:0098761; GO:0150153; GO:1901647; GO:1990959 "ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]" AAVILESIFLK 0.99135 -22.056 0 0 0 0 0 0 0 0 0 12.6057 0 0 12.5908 0 0 0 0 0 9.82434 0 0 0 11.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8777 0 0 0 0 0 0 0 0 0 10.4446 0 0 0 0 0 0 0 13.2925 0 0 0 0 0 0 19.146 12.9158 12.4134 0 0 0 0 0 0 0 0 12.7543 11.9488 0 0 0 0 0 12.2321 0 0 0 0 0 0 0 0 14.2234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9804 0 0 0 0 0 13.2439 0 0 12.6557 0 0 0 12.6774 0 0 0 0 0 0 0 12.46 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13825 AUHM_HUMAN "Methylglutaconyl-CoA hydratase, mitochondrial, 3-MG-CoA hydratase, EC 4.2.1.18 (AU-specific RNA-binding enoyl-CoA hydratase, AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase, EC 4.2.1.56)" AUH Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552] GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0005759; GO:0006552; GO:0006635; GO:0050011 enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730] NLIKMLSK 0.99135 -7.3768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17R98 ZN827_HUMAN Zinc finger protein 827 ZNF827 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; establishment of protein localization to telomere [GO:0070200]; negative regulation of shelterin complex assembly [GO:1904791]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; telomere maintenance [GO:0000723]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325]; chromatin remodeling [GO:0006338]; establishment of protein localization to telomere [GO:0070200]; negative regulation of shelterin complex assembly [GO:1904791]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; telomere maintenance [GO:0000723]" GO:0000723; GO:0000781; GO:0000785; GO:0003677; GO:0005634; GO:0006338; GO:0010468; GO:0045892; GO:0045944; GO:0046872; GO:0070200; GO:0120325; GO:1904791; GO:1990904 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; NuRD complex binding [GO:0120325] DPSEYVANSASALFSQDISVK 0.99135 -23.293 0 0 0 0 0 0 0 0 12.0437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7698 0 0 0 0 0 0 0 0 10.1517 0 0 0 0 0 0 0 0 0 0 0 0 0 9.67664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2815 0 0 0 0 12.7485 0 0 0 0 0 0 11.6632 14.7099 0 0 0 11.9261 0 12.6328 0 14.2421 11.7186 0 0 0 11.6095 0 0 13.4073 0 12.6165 0 0 0 0 0 0 0 11.3796 0 0 0 14.0398 0 0 0 0 0 0 0 0 0 0 0 0 11.7463 0 0 0 0 0 0 12.0566 0 0 0 10.9806 0 11.7752 0 0 0 0 0 0 11.7723 0 12.4333 12.012 13.4038 0 0 13.3635 11.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3332 13.0457 0 0 0 12.4562 0 0 0 0 11.3601 0 0 Q96MK3 FA20A_HUMAN Pseudokinase FAM20A FAM20A UNQ9388/PRO34279 Homo sapiens (Human) biomineral tissue development [GO:0031214]; calcium ion homeostasis [GO:0055074]; enamel mineralization [GO:0070166]; positive regulation of protein phosphorylation [GO:0001934]; response to bacterium [GO:0009617]; tooth eruption [GO:0044691] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; protein serine/threonine kinase activator activity [GO:0043539]; biomineral tissue development [GO:0031214]; calcium ion homeostasis [GO:0055074]; enamel mineralization [GO:0070166]; positive regulation of protein phosphorylation [GO:0001934]; response to bacterium [GO:0009617]; tooth eruption [GO:0044691] GO:0001934; GO:0005615; GO:0005737; GO:0005783; GO:0005794; GO:0009617; GO:0031214; GO:0043539; GO:0044691; GO:0055074; GO:0070062; GO:0070166 protein serine/threonine kinase activator activity [GO:0043539] KTLLHLQLLAQADYRLSDVMR 0.99135 -21.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3514 0 0 0 0 0 0 0 0 0 0 0 0 13.9707 0 10.2158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7722 0 0 0 0 0 0 0 12.3511 0 0 10.8482 13.5969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3335 0 0 0 12.203 0 0 0 12.3632 13.5694 0 0 0 0 0 0 0 11.4384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6053 0 0 0 0 0 0 0 12.4953 13.8204 0 0 0 0 0 0 0 Q96T21 SEBP2_HUMAN "Selenocysteine insertion sequence-binding protein 2, SECIS-binding protein 2" SECISBP2 SBP2 Homo sapiens (Human) "forebrain neuron development [GO:0021884]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; selenocysteine incorporation [GO:0001514]; striatum development [GO:0021756]" mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] "mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; forebrain neuron development [GO:0021884]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; selenocysteine incorporation [GO:0001514]; striatum development [GO:0021756]" GO:0001514; GO:0003723; GO:0003730; GO:0005654; GO:0005739; GO:0021756; GO:0021884; GO:0035368; GO:0043021; GO:1990904; GO:2000623 mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368] AKKPTSLK 0.99135 -22.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9154 0 0 15.0686 11.9131 0 0 0 0 0 0 13.9795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0674 0 0 12.3584 14.4051 0 15.4448 0 0 12.907 0 0 0 0 0 0 0 0 0 13.8075 0 0 0 0 12.443 0 0 0 0 0 13.5986 0 13.6626 0 0 0 0 0 14.0133 0 0 0 0 0 0 12.7887 0 0 0 0 0 0 0 0 0 0 0 10.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C030 TRIM6_HUMAN "Tripartite motif-containing protein 6, EC 2.3.2.27 (RING finger protein 89) (RING-type E3 ubiquitin transferase TRIM6)" TRIM6 RNF89 Homo sapiens (Human) "cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; free ubiquitin chain polymerization [GO:0010994]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of autophagy [GO:0010508]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; response to lipopolysaccharide [GO:0032496]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; free ubiquitin chain polymerization [GO:0010994]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of autophagy [GO:0010508]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; response to lipopolysaccharide [GO:0032496]" GO:0000209; GO:0002230; GO:0002720; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0010629; GO:0010800; GO:0010994; GO:0016567; GO:0019901; GO:0030674; GO:0032496; GO:0032880; GO:0033138; GO:0035458; GO:0042802; GO:0042803; GO:0043123; GO:0045071; GO:0045087; GO:0045892; GO:0046596; GO:0051092; GO:0060340; GO:0061630; GO:0098586; GO:0140297; GO:1990782; GO:2000679; GO:2000737 DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GHHTFLVEEVAQEYQEKFQESLKK 0.99135 -19.068 0 0 0 0 0 0 0 0 12.5095 0 13.9204 13.1005 13.2792 0 12.488 0 0 0 0 0 0 0 0 0 11.4772 0 0 0 0 0 0 11.9553 12.3601 0 11.9482 0 0 0 0 13.3718 0 11.9102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3155 0 13.2555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6539 0 0 0 0 13.512 0 0 0 0 0 0 0 0 12.5653 0 0 0 0 13.2289 15.5798 12.5083 0 0 0 0 0 0 12.9423 0 0 0 0 12.9202 0 0 0 0 13.5669 0 0 13.2917 0 0 0 0 0 13.0695 14.1076 14.9044 13.1099 13.5468 14.7504 13.8988 14.3359 0 13.9647 13.9549 13.167 12.8227 13.4491 0 13.1378 0 13.2942 13.1046 13.0377 0 0 0 Q9ULP9 TBC24_HUMAN TBC1 domain family member 24 TBC1D24 KIAA1171 Homo sapiens (Human) axon development [GO:0061564]; dendrite development [GO:0016358]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron death in response to oxidative stress [GO:0036475]; neuron projection development [GO:0031175]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron migration [GO:2001224]; synaptic vesicle endocytosis [GO:0048488] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; axon development [GO:0061564]; dendrite development [GO:0016358]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron death in response to oxidative stress [GO:0036475]; neuron projection development [GO:0031175]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron migration [GO:2001224]; synaptic vesicle endocytosis [GO:0048488] GO:0005096; GO:0005737; GO:0005886; GO:0016358; GO:0030054; GO:0030659; GO:0031175; GO:0031594; GO:0036475; GO:0043195; GO:0048488; GO:0050775; GO:0061564; GO:0070161; GO:1902083; GO:1903204; GO:2000463; GO:2001224 GTPase activator activity [GO:0005096] ALKQKGITVK 0.99135 -23.268 0 0 0 0 0 0 10.5658 0 0 0 10.9511 0 0 11.0938 0 0 0 0 0 0 0 0 0 0 0 0 10.7522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2343 0 0 0 0 0 0 0 0 0 0 0 10.559 0 0 0 0 0 0 0 0 0 0 0 11.9995 0 0 0 13.2297 0 12.2768 12.5772 14.2193 0 13.5399 0 0 0 13.576 15.9098 0 0 0 0 15.9343 13.5087 0 0 0 0 0 0 13.8722 12.2705 0 0 0 0 0 0 0 0 0 0 0 12.949 0 0 0 0 0 0 12.5425 0 0 0 0 13.2457 0 15.2738 13.1071 0 0 0 0 0 0 12.9126 0 14.7266 0 14.4358 12.5755 0 0 0 0 0 0 12.6736 0 0 0 11.6442 0 0 12.7065 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6839 0 0 0 0 0 0 0 0 0 0 12.4314 0 O14681 EI24_HUMAN Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein) EI24 PIG8 Homo sapiens (Human) apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; importin-alpha family protein binding [GO:0061676]; apoptotic process [GO:0006915]; macroautophagy [GO:0016236]; negative regulation of cell growth [GO:0030308] GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0016236; GO:0030308; GO:0031965; GO:0061676 importin-alpha family protein binding [GO:0061676] AQSIERK 0.99136 -22.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6575 0 0 0 0 13.0103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2143 0 0 0 0 0 0 0 0 0 12.2501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9035 0 0 0 0 0 0 0 0 0 0 14.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1102 0 0 0 O95749 GGPPS_HUMAN "Geranylgeranyl pyrophosphate synthase, GGPP synthase, GGPPSase, EC 2.5.1.- ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase, EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase, EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase, EC 2.5.1.10)" GGPS1 Homo sapiens (Human) farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid biosynthetic process [GO:0008299]; isoprenoid metabolic process [GO:0006720] GO:0004161; GO:0004311; GO:0004337; GO:0004659; GO:0005654; GO:0005737; GO:0005829; GO:0006720; GO:0008299; GO:0030018; GO:0033384; GO:0033386; GO:0042802; GO:0045337; GO:0046872; GO:0048471 dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659] DDYANLHSKEYSENK 0.99136 -5.9592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.242 0 0 0 0 0 0 14.8435 0 0 0 0 0 0 0 0 0 0 0 0 11.9523 0 0 0 0 0 0 0 0 13.3299 12.4451 0 0 0 0 0 0 13.7132 0 0 12.9473 0 0 0 0 14.833 15.9684 0 0 0 0 0 0 13.4797 13.059 0 0 13.0212 0 0 0 0 0 0 0 0 13.8273 0 0 0 0 0 0 0 0 13.8002 0 0 13.8475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9209 0 0 0 13.9145 0 0 0 P51878 CASP5_HUMAN "Caspase-5, CASP-5, EC 3.4.22.58 (ICE(rel)-III) (Protease ICH-3) (Protease TY) [Cleaved into: Caspase-5 subunit p20; Caspase-5 subunit p10 ]" CASP5 ICH3 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NLRP1 inflammasome complex [GO:0072558] cytoplasm [GO:0005737]; cytosol [GO:0005829]; NLRP1 inflammasome complex [GO:0072558]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; substantia nigra development [GO:0021762] GO:0004197; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0021762; GO:0042981; GO:0050727; GO:0071260; GO:0072558; GO:0097199 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234] FDHLPAR 0.99136 -4.6591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0055 0 0 12.9873 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2596 0 0 0 0 0 0 0 0 0 0 0 16.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2992 0 0 0 0 0 0 0 13.4733 0 0 0 0 0 0 0 0 14.5843 0 Q6DN12 MCTP2_HUMAN Multiple C2 and transmembrane domain-containing protein 2 MCTP2 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; regulation of neurotransmitter secretion [GO:0046928] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; regulation of neurotransmitter secretion [GO:0046928] GO:0005509; GO:0005654; GO:0005829; GO:0016020; GO:0016021; GO:0019722; GO:0030672; GO:0046928 calcium ion binding [GO:0005509] DGQPNCYVLK 0.99136 -48.5 0 0 0 0 0 0 0 0 13.426 14.7077 13.0757 12.2549 0 12.5654 13.4658 0 0 0 0 0 0 0 11.7468 0 0 0 0 0 0 0 13.8602 0 0 12.2503 0 0 12.3436 12.8246 12.8893 13.9422 12.3608 0 13.2688 0 12.3337 0 0 0 11.8419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7228 0 0 0 0 12.514 0 0 0 0 12.24 0 13.7112 12.2528 0 0 12.4735 0 0 0 0 0 0 0 0 0 0 0 13.0937 0 0 14.9651 0 0 11.3641 10.78 12.1822 11.9455 11.1847 12.3311 0 11.81 11.8789 0 0 0 0 12.4311 13.4815 0 0 10.9609 0 0 0 0 0 13.6971 0 0 0 0 0 0 0 17.4515 0 0 0 0 0 0 0 0 0 0 0 0 12.1335 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5813 0 0 0 0 15.5032 0 0 0 0 0 15.4348 0 14.2271 0 0 0 0 0 0 0 0 0 Q6IPT2 GAR5A_HUMAN Golgi associated RAB2 interactor protein 5A GARIN5A FAM71E1 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of type I interferon production [GO:0032481] Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of type I interferon production [GO:0032481] GO:0005794; GO:0032481; GO:0045087; GO:0051607 FLPLLLRPLPSDGDIAMRR 0.99136 -4.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.757 0 0 0 0 12.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0103 0 0 0 0 0 0 0 0 14.352 0 0 0 0 14.2759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3766 0 0 0 0 0 0 0 0 0 0 0 13.2323 0 0 0 0 0 12.7215 0 0 12.0689 0 0 0 0 13.7425 12.2454 0 0 14.013 0 0 0 13.7535 0 0 0 0 0 0 0 0 0 Q86UA1 PRP39_HUMAN Pre-mRNA-processing factor 39 (PRP39 homolog) PRPF39 Homo sapiens (Human) mRNA 5'-splice site recognition [GO:0000395] commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395] GO:0000243; GO:0000395; GO:0005685; GO:0071004 ACTIHLPKK 0.99136 -22.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1685 0 12.1605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4561 13.2323 0 0 0 0 13.6416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8659 0 0 0 0 0 P07451 CAH3_HUMAN "Carbonic anhydrase 3, EC 4.2.1.1 (Carbonate dehydratase III) (Carbonic anhydrase III, CA-III)" CA3 Homo sapiens (Human) one-carbon metabolic process [GO:0006730]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979] cytosol [GO:0005829] cytosol [GO:0005829]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; nickel cation binding [GO:0016151]; phosphatase activity [GO:0016791]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979] GO:0004089; GO:0005829; GO:0006730; GO:0006979; GO:0008270; GO:0009617; GO:0016151; GO:0016791; GO:0016836; GO:0045471 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; nickel cation binding [GO:0016151]; phosphatase activity [GO:0016791]; zinc ion binding [GO:0008270] FDPSCLFPACR 0.99137 -4.5357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.167 0 0 0 0 0 12.5031 0 0 0 0 0 0 0 0 0 11.6444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3182 15.6298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46776 RL27A_HUMAN 60S ribosomal protein L27a (Large ribosomal subunit protein uL15) RPL27A Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] INFDKYHPGYFGK 0.99137 -23.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8195 11.4521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6663 9.95805 0 0 0 0 0 0 12.3911 12.307 0 0 0 0 0 0 0 13.0563 0 12.7137 0 0 0 16.2347 0 0 0 12.679 0 0 0 0 0 0 0 0 0 12.8705 0 13.3691 0 12.9398 13.1563 0 0 14.4181 0 0 13.953 13.7492 0 0 12.687 0 0 14.2866 17.1862 0 12.6537 0 0 0 0 12.8057 12.4863 0 0 12.9067 0 13.672 0 12.3235 0 12.6435 12.8835 13.4985 0 13.8797 0 12.1799 0 0 0 0 14.5675 12.541 0 0 0 0 0 0 0 0 0 0 11.7817 0 12.4322 0 11.9713 11.7465 0 0 0 13.5736 0 0 0 0 0 0 P48378 RFX2_HUMAN DNA-binding protein RFX2 (Regulatory factor X 2) RFX2 Homo sapiens (Human) acrosome assembly [GO:0001675]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; acrosome assembly [GO:0001675]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001675; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007286; GO:0060271; GO:1990830; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AARQFLLK 0.99137 -23.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6684 0 0 0 0 0 0 15.0986 0 0 0 0 0 0 0 0 0 0 0 0 12.182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.692 0 0 0 0 0 0 0 0 0 0 14.5198 0 0 0 11.555 0 12.0206 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8285 0 0 0 0 0 Q06330 SUH_HUMAN "Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa, RBP-J, RBP-JK) (Renal carcinoma antigen NY-REN-30)" RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH Homo sapiens (Human) "angiogenesis [GO:0001525]; aortic valve development [GO:0003176]; arterial endothelial cell fate commitment [GO:0060844]; atrioventricular canal development [GO:0036302]; auditory receptor cell fate commitment [GO:0009912]; B cell differentiation [GO:0030183]; blood vessel endothelial cell fate specification [GO:0097101]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; club cell differentiation [GO:0060486]; defense response to bacterium [GO:0042742]; dorsal aorta morphogenesis [GO:0035912]; endocardium morphogenesis [GO:0003160]; epidermal cell fate specification [GO:0009957]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle maturation [GO:0048820]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; keratinocyte differentiation [GO:0030216]; labyrinthine layer blood vessel development [GO:0060716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ossification [GO:0030279]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901297]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERBB signaling pathway [GO:1901186]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; pulmonary valve development [GO:0003177]; regulation of reproductive process [GO:2000241]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; sebaceous gland development [GO:0048733]; secondary heart field specification [GO:0003139]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; angiogenesis [GO:0001525]; aortic valve development [GO:0003176]; arterial endothelial cell fate commitment [GO:0060844]; atrioventricular canal development [GO:0036302]; auditory receptor cell fate commitment [GO:0009912]; B cell differentiation [GO:0030183]; blood vessel endothelial cell fate specification [GO:0097101]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; club cell differentiation [GO:0060486]; defense response to bacterium [GO:0042742]; dorsal aorta morphogenesis [GO:0035912]; endocardium morphogenesis [GO:0003160]; epidermal cell fate specification [GO:0009957]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle maturation [GO:0048820]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; keratinocyte differentiation [GO:0030216]; labyrinthine layer blood vessel development [GO:0060716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of ossification [GO:0030279]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901297]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERBB signaling pathway [GO:1901186]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; pulmonary valve development [GO:0003177]; regulation of reproductive process [GO:2000241]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; sebaceous gland development [GO:0048733]; secondary heart field specification [GO:0003139]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001756; GO:0001837; GO:0001974; GO:0002193; GO:0002437; GO:0003139; GO:0003151; GO:0003160; GO:0003176; GO:0003177; GO:0003198; GO:0003214; GO:0003222; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0006959; GO:0007219; GO:0007221; GO:0009912; GO:0009957; GO:0010628; GO:0017053; GO:0021983; GO:0030183; GO:0030216; GO:0030279; GO:0030513; GO:0035019; GO:0035912; GO:0036302; GO:0042742; GO:0043011; GO:0043565; GO:0045596; GO:0045892; GO:0045944; GO:0047485; GO:0048505; GO:0048733; GO:0048820; GO:0050673; GO:0050679; GO:0060045; GO:0060379; GO:0060412; GO:0060486; GO:0060716; GO:0060844; GO:0061314; GO:0061419; GO:0061629; GO:0072089; GO:0072554; GO:0097101; GO:0120163; GO:0140297; GO:1901186; GO:1901189; GO:1901297; GO:2000138; GO:2000241; GO:2000647 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]" CGESMLCVVPDISAFREGWR 0.99137 -49.483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3902 0 0 0 0 0 0 0 0 0 14.2747 0 0 0 0 13.3838 0 0 0 14.0932 14.0022 0 0 0 14.1985 14.4574 0 14.1091 0 0 0 0 14.441 14.6133 15.2064 0 0 13.274 0 0 0 13.6879 14.154 15.2835 0 0 0 0 12.7298 0 0 0 0 0 0 0 0 13.7989 0 0 0 13.7443 0 0 12.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1878 0 10.5382 0 0 0 0 0 0 0 0 13.9886 13.5597 0 0 0 0 0 0 0 Q09MP3 R51A2_HUMAN RAD51-associated protein 2 RAD51AP2 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297] protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297] GO:0000724; GO:0003690; GO:0003697; GO:0032991; GO:0036297 double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] AGWRLPLVPR 0.99137 -49.807 0 0 0 14.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5233 0 0 0 0 0 0 0 0 0 0 0 11.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.3018 0 0 0 0 0 0 0 0 13.5272 0 0 0 0 0 12.9076 14.2936 13.8196 0 0 0 0 0 0 14.6438 0 0 0 0 0 0 0 0 0 0 12.2895 0 0 0 16.1525 0 0 12.7764 0 0 0 0 0 0 0 0 0 14.1525 0 13.9162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13418 ILK_HUMAN "Integrin-linked protein kinase, EC 2.7.11.1 (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK)" ILK ILK1 ILK2 Homo sapiens (Human) "branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; neural precursor cell proliferation [GO:0061351]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; neural precursor cell proliferation [GO:0061351]; outflow tract morphogenesis [GO:0003151]; peptidyl-serine phosphorylation [GO:0018105]; platelet aggregation [GO:0070527]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of signal transduction [GO:0009967]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0000902; GO:0001658; GO:0001934; GO:0003151; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0007160; GO:0007229; GO:0008284; GO:0009967; GO:0010761; GO:0016020; GO:0018105; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0042327; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0061351; GO:0070527; GO:0090263; GO:1900026; GO:1901224; GO:2000178 ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674] APLRELLR 0.99137 -22.403 0 0 0 0 10.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9877 0 0 0 0 0 0 0 0 0 0 12.496 13.502 0 0 11.2309 0 0 0 0 0 0 11.7658 0 0 13.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8028 0 0 0 0 0 0 11.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0S7 CC152_HUMAN Coiled-coil domain-containing protein 152 CCDC152 Chr5_400 Homo sapiens (Human) DQSSEGCMK 0.99137 -23.621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2776 0 0 0 0 0 0 0 0 0 0 13.1243 0 0 0 0 12.2332 14.049 0 0 0 0 11.8081 0 12.8197 13.5179 12.8968 13.1397 14.042 0 14.5877 0 0 12.9165 0 0 0 0 12.9094 0 0 0 0 13.7574 0 0 0 0 0 12.1632 0 0 12.5831 0 0 0 13.2933 12.5202 13.3949 12.2561 0 0 13.4844 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3973 0 14.3512 0 0 0 13.0011 0 0 13.9142 14.3305 0 0 0 0 0 0 0 0 0 0 0 0 13.4182 0 0 0 0 0 0 0 0 0 0 0 Q53TQ3 IN80D_HUMAN INO80 complex subunit D INO80D Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" GO:0000723; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 APTVDPPR 0.99137 -23.629 0 11.7563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3109 0 0 0 0 13.1382 0 0 12.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2367 0 15.6914 0 0 0 0 0 0 0 0 0 0 15.6237 0 0 0 0 0 0 0 0 0 0 0 0 0 16.393 0 0 14.7638 0 15.5505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7084 0 16.2612 0 0 15.0256 0 0 0 Q7Z449 CP2U1_HUMAN "Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase, EC 1.14.14.80)" CYP2U1 Homo sapiens (Human) omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006805; GO:0008395; GO:0016021; GO:0016712; GO:0020037; GO:0043231; GO:0052869; GO:0097267; GO:0102033 "arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" ARGIPPGPTPWPLVGNFGHVLLPPFLRR 0.99137 -7.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9655 0 0 0 0 0 0 0 12.4393 0 0 0 0 0 0 10.8115 12.602 0 14.1781 0 0 0 0 13.8565 14.8024 0 15.7508 0 13.8848 13.0037 0 0 0 13.6378 0 15.5843 0 0 0 0 0 0 0 0 12.8481 0 11.3894 0 12.5965 0 0 0 0 0 0 0 0 0 0 0 13.0522 12.5099 0 0 0 0 0 0 0 0 0 11.5718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0527 0 11.2725 0 0 0 0 12.2134 0 0 0 0 0 0 10.4106 0 0 0 0 0 0 0 0 0 Q8NDX2 VGLU3_HUMAN "Vesicular glutamate transporter 3, VGluT3 (Solute carrier family 17 member 8)" SLC17A8 VGLUT3 Homo sapiens (Human) "anion transport [GO:0006820]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; regulation of acetylcholine uptake [GO:0051631]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; excitatory synapse [GO:0060076]; glial limiting end-foot [GO:0097451]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; multivesicular body [GO:0005771]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; synaptic vesicle membrane [GO:0030672]; chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; brain development [GO:0007420]; cochlea development [GO:0090102]; ion transport [GO:0006811]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; regulation of acetylcholine uptake [GO:0051631]; regulation of synapse structure or activity [GO:0050803]; sensory perception of sound [GO:0007605]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]" GO:0003407; GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005771; GO:0006811; GO:0006820; GO:0007420; GO:0007605; GO:0015813; GO:0016021; GO:0022857; GO:0030285; GO:0030672; GO:0035249; GO:0043204; GO:0043679; GO:0044341; GO:0050803; GO:0051631; GO:0051938; GO:0051951; GO:0055062; GO:0060076; GO:0070161; GO:0090102; GO:0097440; GO:0097441; GO:0097451; GO:0098700; GO:1990030 chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; neurotransmitter transmembrane transporter activity [GO:0005326]; sodium:phosphate symporter activity [GO:0005436]; transmembrane transporter activity [GO:0022857] ILKPGKEGVK 0.99137 -1.8131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NI51 CTCFL_HUMAN "Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer/testis antigen 27, CT27) (Zinc finger protein CTCF-T)" CTCFL BORIS Homo sapiens (Human) "cell cycle [GO:0007049]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription by RNA polymerase II [GO:0006357]" chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; cell cycle [GO:0007049]; DNA methylation involved in gamete generation [GO:0043046]; histone methylation [GO:0016571]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006349; GO:0006357; GO:0007049; GO:0010628; GO:0016571; GO:0016604; GO:0042393; GO:0043035; GO:0043046; GO:0043565; GO:0045893; GO:0045944; GO:0046872; GO:0051569 "chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" CGKGFSRWINLHR 0.99137 -22.959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2831 0 0 0 0 0 0 0 0 Q8TDI0 CHD5_HUMAN "Chromodomain-helicase-DNA-binding protein 5, CHD-5, EC 3.6.4.12 (ATP-dependent helicase CHD5)" CHD5 KIAA0444 Homo sapiens (Human) "cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] "chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0008285; GO:0016020; GO:0016581; GO:0016607; GO:0016887; GO:0021895; GO:0035093; GO:0042393; GO:0043967; GO:0046872; GO:0061628; GO:0098532; GO:0140658; GO:1901798 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; H3K27me3 modified histone binding [GO:0061628]; histone binding [GO:0042393]; metal ion binding [GO:0046872] AFSQFLRPLIAKK 0.99137 -50.77 0 11.7559 12.4482 0 0 0 0 0 11.6796 0 0 0 10.4554 0 0 12.862 0 12.9184 0 11.8274 0 14.0466 0 0 14.1052 0 0 0 12.7364 10.4152 0 0 0 12.039 0 0 0 0 13.688 10.4535 0 0 14.575 10.715 0 0 0 0 14.0807 0 0 0 14.0369 0 0 16.2683 12.249 0 11.6685 0 0 0 11.9565 0 0 0 0 0 0 0 0 0 10.1674 0 13.8864 0 12.8233 14.4883 0 0 14.3727 0 16.0095 0 15.4101 0 15.8095 13.8762 0 0 0 14.9321 14.8152 13.2664 0 11.7419 14.8812 0 15.1727 0 14.4474 0 0 0 0 0 13.593 0 14.9647 0 14.6318 0 12.3757 14.1431 0 0 14.581 0 13.2995 0 12.4658 15.2728 13.1072 14.8625 0 11.8285 0 0 0 12.0773 13.4477 0 14.0219 0 12.8072 0 0 14.4572 13.142 13.9591 14.2436 13.2109 0 14.0908 14.1763 11.8563 0 0 0 0 0 14.9549 0 0 0 0 0 11.8638 14.1658 0 0 0 0 0 0 0 12.4714 0 0 0 0 0 0 0 11.6242 0 0 14.0594 0 10.4367 Q969R5 LMBL2_HUMAN "Lethal(3)malignant brain tumor-like protein 2, H-l(3)mbt-like protein 2, L(3)mbt-like protein 2" L3MBTL2 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0008270; GO:0035064; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] FCSVSCSRSYSSNSK 0.99137 -23.609 0 0 0 0 0 0 0 0 0 0 0 0 9.86068 0 13.1693 0 0 0 0 12.2396 0 0 0 0 0 0 0 0 11.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9546 14.3195 0 13.3153 0 12.3638 0 0 0 0 0 0 0 10.7189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0517 0 0 14.1723 14.3985 0 0 0 0 0 12.7387 0 0 0 0 0 0 0 0 0 0 13.0953 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8116 0 13.2154 0 0 13.9365 0 0 11.7936 0 13.8958 0 14.0102 0 0 0 0 0 0 13.8522 0 0 13.0964 0 0 0 0 0 0 0 0 0 13.3903 12.7129 0 0 0 0 0 0 0 0 0 0 12.3957 0 0 0 0 0 0 0 0 0 0 0 12.403 Q96BW9 TAM41_HUMAN "Phosphatidate cytidylyltransferase, mitochondrial, EC 2.7.7.41 (CDP-diacylglycerol synthase, CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog, TAM41)" TAMM41 C3orf31 Homo sapiens (Human) cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024] extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] extrinsic component of membrane [GO:0019898]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; phosphatidate cytidylyltransferase activity [GO:0004605]; cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024] GO:0004605; GO:0005739; GO:0005743; GO:0016024; GO:0019898; GO:0031314; GO:0032049 phosphatidate cytidylyltransferase activity [GO:0004605] LYCPSEFSETLPVCRVFPSYCFIYQSYRCIGLQK 0.99137 -1.8155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0492 0 0 0 0 0 0 0 0 0 13.4861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0322 0 0 0 0 13.3096 0 13.2546 0 0 0 0 0 13.4215 12.9055 0 0 0 0 0 0 0 0 0 0 13.7417 0 0 0 0 0 0 0 0 14.0152 0 15.297 0 13.0547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DX4 RSPRY_HUMAN RING finger and SPRY domain-containing protein 1 RSPRY1 KIAA1972 UNQ328/PRO444 Homo sapiens (Human) proteolysis involved in protein catabolic process [GO:0051603] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in protein catabolic process [GO:0051603] GO:0004842; GO:0005576; GO:0005737; GO:0046872; GO:0051603 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] EGDTVGFLLDLNEK 0.99137 -22.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7526 16.7936 16.9276 16.9048 16.5383 15.8261 16.3993 0 0 0 0 0 15.0829 16.722 0 0 13.6399 12.8685 0 0 12.8136 13.9775 14.5037 0 0 0 0 0 0 0 0 12.7314 0 0 0 0 0 0 0 0 0 12.6146 0 11.5898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8541 0 12.2389 0 0 0 12.3547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6919 0 0 0 0 0 0 0 0 0 0 0 0 Q99594 TEAD3_HUMAN "Transcriptional enhancer factor TEF-5 (DTEF-1) (TEA domain family member 3, TEAD-3)" TEAD3 TEAD5 TEF5 Homo sapiens (Human) asymmetric neuroblast division [GO:0055059]; embryonic organ development [GO:0048568]; female pregnancy [GO:0007565]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; asymmetric neuroblast division [GO:0055059]; embryonic organ development [GO:0048568]; female pregnancy [GO:0007565]; hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0005667; GO:0006357; GO:0007565; GO:0035329; GO:0045944; GO:0048568; GO:0055059; GO:0061629 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" IILSDEGK 0.99137 -23.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2095 0 0 0 0 0 0 0 0 0 0 12.0128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3923 0 0 0 12.3864 0 0 0 0 0 0 0 0 0 0 0 11.866 0 0 13.4219 0 0 0 0 0 0 0 0 0 10.9779 0 0 0 0 13.6502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9661 0 0 0 13.4453 0 0 0 0 0 0 0 0 0 0 13.4285 12.8057 0 0 0 0 0 0 0 13.2189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ09 UBAP1_HUMAN "Ubiquitin-associated protein 1, UBAP-1 (Nasopharyngeal carcinoma-associated gene 20 protein)" UBAP1 NAG20 Homo sapiens (Human) membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin binding [GO:0043130]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] GO:0000813; GO:0005737; GO:0005829; GO:0005886; GO:0010008; GO:0036258; GO:0043130; GO:0043162; GO:0043231; GO:0043328; GO:0090148 ubiquitin binding [GO:0043130] KTIEWAEEIK 0.99137 -1.8142 11.0254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4359 0 0 10.7353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0381 0 12.0151 0 0 14.102 0 0 0 0 0 0 0 0 0 0 12.7511 13.4916 0 0 15.2169 0 10.6336 0 0 0 11.9092 0 0 13.0258 0 0 0 0 12.502 0 0 0 0 14.6084 12.3434 0 0 0 0 0 0 13.4931 0 0 0 11.216 0 12.465 0 0 0 0 0 0 0 11.0678 0 11.8884 0 0 0 0 0 12.7944 0 13.1427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25090 FPR2_HUMAN "N-formyl peptide receptor 2 (FMLP-related receptor I, FMLP-R-I) (Formyl peptide receptor-like 1) (HM63) (Lipoxin A4 receptor, LXA4 receptor) (RFP)" FPR2 FPRH1 FPRL1 LXA4R Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of inflammatory response [GO:0050728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; scavenger receptor binding [GO:0005124]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of inflammatory response [GO:0050728]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of innate immune response [GO:0045089]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of superoxide anion generation [GO:0032930]; receptor-mediated endocytosis [GO:0006898] GO:0001540; GO:0001774; GO:0001934; GO:0002430; GO:0002768; GO:0004875; GO:0004930; GO:0004982; GO:0005124; GO:0005737; GO:0005886; GO:0006898; GO:0006935; GO:0006954; GO:0007155; GO:0007166; GO:0007186; GO:0007193; GO:0007200; GO:0007204; GO:0016021; GO:0019722; GO:0032930; GO:0035579; GO:0038023; GO:0038024; GO:0042742; GO:0045089; GO:0048143; GO:0050728; GO:0050766; GO:0050918; GO:0061903; GO:0070374; GO:0070821; GO:0090026; GO:0101003; GO:1904646 amyloid-beta binding [GO:0001540]; cargo receptor activity [GO:0038024]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; N-formyl peptide receptor activity [GO:0004982]; scavenger receptor binding [GO:0005124]; signaling receptor activity [GO:0038023] CICVLHPVWAQNHR 0.99138 -4.5486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2123 0 0 0 0 0 0 15.1126 0 15.5488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42785 PCP_HUMAN "Lysosomal Pro-X carboxypeptidase, EC 3.4.16.2 (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase, PRCP)" PRCP PCP Homo sapiens (Human) angiogenesis involved in wound healing [GO:0060055]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155] azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185]; angiogenesis involved in wound healing [GO:0060055]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone mediated signaling pathway [GO:0002155] GO:0002155; GO:0002353; GO:0003085; GO:0004185; GO:0005886; GO:0006508; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377 dipeptidyl-peptidase activity [GO:0008239]; serine-type carboxypeptidase activity [GO:0004185] ALLLLLLSFLAPWATIALRPALR 0.99138 -4.5495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6088 0 0 0 0 0 13.3278 12.5229 0 0 0 12.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2195 0 0 0 11.5293 11.5286 0 0 13.7142 0 0 0 0 0 0 11.2124 14.2513 13.7936 13.7382 13.861 0 13.3467 0 0 14.5062 13.7418 14.3287 0 15.438 15.1324 0 14.3026 0 15.194 11.2978 14.4103 0 0 14.559 14.5378 13.7593 14.9913 0 14.0823 0 0 13.0543 0 11.373 0 14.0004 0 0 13.2619 0 12.8571 12.1008 0 13.451 14.358 11.1628 0 0 0 0 0 13.4087 11.2055 11.1894 14.0441 13.5914 0 0 13.4301 12.5718 12.7464 0 0 0 0 0 11.8334 0 0 12.3163 13.7288 0 0 0 0 0 0 10.9701 0 0 0 0 0 0 11.2038 0 11.3786 12.6014 0 12.7519 0 0 12.6387 13.062 12.3785 0 0 0 0 P52948 NUP98_HUMAN "Nuclear pore complex protein Nup98-Nup96, EC 3.4.21.- [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98, Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96, Nup96) ]" NUP98 ADAR2 Homo sapiens (Human) "mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]" cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] "cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]" GO:0003713; GO:0003729; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006508; GO:0006606; GO:0006913; GO:0006999; GO:0008139; GO:0008236; GO:0016604; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0042405; GO:0044615; GO:0048026; GO:0051028; GO:0051292; GO:1990841; GO:1990904 mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713] ADTSQEICSPR 0.99138 -50.996 0 0 11.2455 12.3057 0 0 0 12.5595 0 0 0 10.4189 0 0 11.0163 0 0 0 0 0 0 14.6607 11.6415 14.8121 0 0 0 10.212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.46459 0 0 0 0 10.7384 0 11.788 0 9.73938 12.1927 0 0 13.0042 0 11.9526 0 0 0 0 14.3019 0 12.0467 11.6747 0 0 0 15.0453 15.057 13.2988 15.4666 15.872 14.7683 16.4589 13.9298 14.9312 0 14.6258 14.0831 0 14.581 13.3134 13.6163 13.2436 0 14.3834 14.86 0 13.7239 0 14.4316 13.8659 15.4386 15.3584 15.7202 15.1127 13.7402 14.0689 0 15.4093 15.6075 15.7913 15.3276 13.8079 12.3466 0 14.0888 14.0501 0 12.4671 14.5462 12.8601 13.4507 14.0771 0 13.7849 0 0 0 15.4279 15.9542 14.8273 0 12.7894 15.0666 13.924 0 0 0 0 0 14.3329 12.2063 12.8717 0 15.6682 12.2609 15.145 0 0 0 0 13.8994 15.613 0 0 15.3408 15.2615 10.5754 14.3729 0 11.6678 0 0 0 0 11.6515 10.809 0 0 0 0 0 13.2705 0 0 15.3881 0 0 11.8878 0 14.7481 0 P78424 PO6F2_HUMAN "POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1, RPF-1)" POU6F2 RPF1 Homo sapiens (Human) "central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; central nervous system development [GO:0007417]; ganglion mother cell fate determination [GO:0007402]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007402; GO:0007417; GO:0007601 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EFAKAFKIR 0.99138 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T3F8 CSCL2_HUMAN CSC1-like protein 2 (Transmembrane protein 63B) TMEM63B C6orf110 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760] GO:0005227; GO:0005886; GO:0008381; GO:0015629; GO:0016021; GO:1990760 calcium activated cation channel activity [GO:0005227]; mechanosensitive ion channel activity [GO:0008381]; osmolarity-sensing cation channel activity [GO:1990760] CYTFLIFMVLLLPSLGLSSLDLFFRWLFDKK 0.99138 -4.8448 11.0551 0 0 0 0 11.3321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7255 0 12.2626 14.9301 9.85081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8897 0 0 0 0 0 0 0 0 0 0 13.8499 11.3838 0 0 0 0 0 0 0 0 0 0 0 13.3281 0 0 0 0 0 0 0 14.388 0 11.3628 0 0 0 0 15.6148 0 0 0 0 0 0 12.2105 13.2274 0 0 0 15.3993 0 14.2652 0 0 15.3415 0 0 0 0 0 15.5874 0 15.0105 0 0 0 12.7381 0 0 10.9923 0 0 Q7Z7J9 CK2N1_HUMAN "Calcium/calmodulin-dependent protein kinase II inhibitor 1 (CaMKII inhibitory protein alpha, CaMKIIN-alpha)" CAMK2N1 Homo sapiens (Human) long-term memory [GO:0007616]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of inflammatory response [GO:0050729] anchoring junction [GO:0070161]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; synapse [GO:0045202] anchoring junction [GO:0070161]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; protein kinase binding [GO:0019901]; long-term memory [GO:0007616]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of inflammatory response [GO:0050729] GO:0006469; GO:0007616; GO:0008427; GO:0014069; GO:0019901; GO:0030425; GO:0045202; GO:0050729; GO:0070161 calcium-dependent protein kinase inhibitor activity [GO:0008427]; protein kinase binding [GO:0019901] LGQIGRSKR 0.99138 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4719 12.7037 0 0 0 0 0 0 0 0 11.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1F7 NUP93_HUMAN Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93) NUP93 KIAA0095 Homo sapiens (Human) nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; SMAD protein signal transduction [GO:0060395] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606]; SMAD protein signal transduction [GO:0060395] GO:0005635; GO:0005643; GO:0005813; GO:0005829; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0016973; GO:0017056; GO:0031965; GO:0034399; GO:0051292; GO:0060391; GO:0060395 structural constituent of nuclear pore [GO:0017056] ALRNNTDPYK 0.99138 -22.442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7838 0 0 0 0 0 0 0 0 0 12.7468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7537 0 0 0 0 0 0 0 0 0 0 13.2344 0 14.2108 0 0 0 0 0 0 0 13.5054 0 0 12.7687 0 0 0 13.6152 12.8207 0 0 0 0 12.2517 0 12.4213 0 0 13.02 0 13.1872 0 0 0 0 0 0 0 0 12.1653 0 0 0 12.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4674 11.2244 0 0 0 0 0 0 12.957 0 0 0 0 0 0 0 0 13.9029 0 13.219 0 0 0 0 0 0 0 0 0 0 13.535 0 0 0 13.08 0 13.9944 0 0 12.2926 0 0 13.4956 0 0 0 0 13.366 0 0 0 0 Q8N3R9 PALS1_HUMAN "Protein PALS1 (MAGUK p55 subfamily member 5) (Membrane protein, palmitoylated 5) (Protein associated with Lin-7 1)" PALS1 MPP5 Homo sapiens (Human) central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lateral loop [GO:0043219]; myelin sheath adaxonal region [GO:0035749]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; morphogenesis of an epithelial sheet [GO:0002011]; myelin assembly [GO:0032288]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization to myelin sheath abaxonal region [GO:0035750]; protein localization to plasma membrane [GO:0072659]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] GO:0002011; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0010467; GO:0016324; GO:0016332; GO:0017015; GO:0019904; GO:0021954; GO:0021987; GO:0030424; GO:0032287; GO:0032288; GO:0032991; GO:0035749; GO:0035750; GO:0042802; GO:0043204; GO:0043219; GO:0043220; GO:0043296; GO:0045197; GO:0048699; GO:0070062; GO:0072659 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] ETVIHVK 0.99138 -22.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3602 0 0 0 0 0 11.8898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8074 14.4866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7665 13.2011 0 0 0 0 0 0 0 0 0 0 0 13.5523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.95 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6762 0 0 11.9907 Q8N5B7 CERS5_HUMAN "Ceramide synthase 5, CerS5 (LAG1 longevity assurance homolog 5) (Sphingoid base N-palmitoyltransferase CERS5, EC 2.3.1.291) (Sphingosine N-acyltransferase CERS5, EC 2.3.1.24)" CERS5 LASS5 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148] GO:0003677; GO:0005783; GO:0005789; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291 DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] HILSVFPLAAGIFFVRLLFER 0.99138 -4.8347 0 0 0 12.6023 0 0 0 11.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8577 0 15.5248 0 0 0 0 0 0 14.2688 0 0 0 0 0 0 0 0 0 15.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBZ2 MYBPP_HUMAN "MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1, AMAP-1)" MYCBPAP AMAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202] cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; spermatogenesis [GO:0007283] GO:0005737; GO:0007268; GO:0007283; GO:0016020; GO:0030154; GO:0045202 APKEEKR 0.99138 -51.987 0 0 0 0 0 0 0 0 13.5895 12.1682 0 0 0 0 0 0 0 0 0 0 13.5151 0 0 0 0 0 0 14.8625 0 0 0 0 0 0 0 13.0876 0 0 13.14 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4778 14.1097 0 13.2841 12.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7338 0 0 0 0 0 0 0 0 13.5017 0 0 0 0 13.4047 0 0 0 0 0 0 0 0 0 0 11.6402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99973 TEP1_HUMAN "Telomerase protein component 1 (Telomerase-associated protein 1, Telomerase protein 1) (p240) (p80 telomerase homolog)" TEP1 TLP1 TP1 Homo sapiens (Human) telomere maintenance via recombination [GO:0000722] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722]" GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] AHQYQITGCCLSPDCR 0.99138 -22.428 0 13.0877 0 0 0 0 0 0 0 11.9748 0 0 13.5944 0 0 0 0 0 11.0486 0 0 13.4435 0 0 0 0 0 0 0 0 0 0 0 0 13.8694 0 0 0 0 14.1019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0039 13.5173 0 13.4095 0 13.3587 13.2488 13.4353 0 0 0 0 0 0 12.9696 0 0 0 0 12.6416 13.6761 12.8809 13.1837 0 0 0 15.4149 0 0 13.4922 12.8185 15.4748 0 14.709 13.9553 0 0 0 0 13.859 15.4491 15.3989 0 0 12.9851 13.5159 14.8362 14.6833 13.4013 0 0 15.7212 0 12.6116 0 11.8907 14.878 14.7467 14.7533 0 0 0 0 0 14.0508 13.9586 0 13.2033 0 0 14.2486 12.9858 13.6086 0 0 0 0 0 0 0 14.0046 13.4144 0 0 15.7524 0 0 0 0 0 12.2689 0 0 0 0 0 0 0 0 13.8261 0 0 0 0 0 0 Q9UKT4 FBX5_HUMAN F-box only protein 5 (Early mitotic inhibitor 1) FBXO5 EMI1 FBX5 Homo sapiens (Human) cell division [GO:0051301]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of response to DNA damage stimulus [GO:2001021]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; anaphase-promoting complex binding [GO:0010997]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; ubiquitin ligase inhibitor activity [GO:1990948]; cell division [GO:0051301]; microtubule polymerization [GO:0046785]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA endoreduplication [GO:0032876]; negative regulation of meiotic nuclear division [GO:0045835]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of response to DNA damage stimulus [GO:2001021]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; oocyte maturation [GO:0001556]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of osteoblast differentiation [GO:0045669]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly involved in female meiosis I [GO:0007057]; vesicle organization [GO:0016050] GO:0001556; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006275; GO:0007057; GO:0007088; GO:0007346; GO:0008284; GO:0010971; GO:0010997; GO:0016050; GO:0016567; GO:0019901; GO:0032876; GO:0045669; GO:0045835; GO:0045841; GO:0046785; GO:0046872; GO:0051301; GO:0051444; GO:0070169; GO:0072687; GO:1904667; GO:1905322; GO:1990948; GO:2000773; GO:2001021 anaphase-promoting complex binding [GO:0010997]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; ubiquitin ligase inhibitor activity [GO:1990948] ATCKREGCGFDYCTK 0.99138 -22.431 0 0 0 0 0 0 11.6203 0 12.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9373 0 0 0 0 12.325 0 0 13.5746 0 0 0 0 0 0 12.7709 0 0 0 0 13.7723 0 0 0 0 0 0 0 0 0 0 0 0 14.157 0 0 14.3138 0 0 0 13.9683 14.4021 14.0489 12.692 13.2614 14.8073 0 0 0 0 0 0 0 0 0 0 13.0123 0 14.3105 0 0 0 14.74 12.3646 0 0 0 14.4048 0 0 11.8053 0 0 12.5331 0 13.5554 0 12.9504 14.5331 0 0 0 0 0 0 0 0 0 0 0 12.5808 0 0 0 0 0 0 0 0 0 0 12.217 0 0 O94778 AQP8_HUMAN "Aquaporin-8, AQP-8" AQP8 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; water transport [GO:0006833] apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; water channel activity [GO:0015250]; cellular response to cAMP [GO:0071320]; water transport [GO:0006833] GO:0005886; GO:0005887; GO:0006833; GO:0015250; GO:0016020; GO:0031966; GO:0045177; GO:0071320 water channel activity [GO:0015250] TRLILKAR 0.99139 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10768 ESTD_HUMAN "S-formylglutathione hydrolase, FGH, EC 3.1.2.12 (Esterase D) (Methylumbelliferyl-acetate deacetylase, EC 3.1.1.56)" ESD Homo sapiens (Human) formaldehyde catabolic process [GO:0046294] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294]" GO:0005788; GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0047374; GO:0052689; GO:0070062 "carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; S-formylglutathione hydrolase activity [GO:0018738]" AFSGYLGTDQSK 0.99139 -5.5616 0 11.5409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1785 14.479 0 0 0 0 0 0 0 0 0 0 11.5857 0 0 0 0 15.8338 0 0 11.5704 0 0 0 0 0 0 0 0 11.0016 0 0 P31152 MK04_HUMAN "Mitogen-activated protein kinase 4, MAP kinase 4, MAPK 4, EC 2.7.11.24 (Extracellular signal-regulated kinase 4, ERK-4) (MAP kinase isoform p63, p63-MAPK)" MAPK4 ERK4 PRKM4 Homo sapiens (Human) cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007049; GO:0019901; GO:0035556; GO:0042803; GO:0046982; GO:0106310 ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] LILDLSHWK 0.99139 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48547 KCNC1_HUMAN Potassium voltage-gated channel subfamily C member 1 (NGK2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4) KCNC1 Homo sapiens (Human) cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; globus pallidus development [GO:0021759]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] anchoring junction [GO:0070161]; axolemma [GO:0030673]; axon [GO:0030424]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; axolemma [GO:0030673]; axon [GO:0030424]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; globus pallidus development [GO:0021759]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636] GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0016021; GO:0019894; GO:0021549; GO:0021759; GO:0030424; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0044305; GO:0044325; GO:0051260; GO:0051262; GO:0070161; GO:0071466; GO:0071774; GO:0071805; GO:0099055; GO:0099056; GO:0099508; GO:1903818; GO:1990089 delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249] AAKDVLGFLRVVR 0.99139 -4.8581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1539 0 0 0 0 0 0 0 0 0 0 0 0 11.6412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3279 11.382 0 0 0 0 0 11.9147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8117 0 0 0 0 0 0 0 13.9284 0 14.3558 0 0 0 0 14.6214 12.2514 0 0 0 0 0 0 0 0 0 12.3033 0 0 0 0 0 0 0 0 0 0 0 0 14.4778 0 0 0 0 0 0 13.9162 13.9735 0 0 0 0 0 0 0 14.5971 14.1398 0 0 0 0 0 0 0 11.8525 14.0311 0 13.8895 0 12.0828 13.4631 0 0 0 13.7316 0 0 0 0 0 Q15619 OR1C1_HUMAN Olfactory receptor 1C1 (Olfactory receptor OR1-42) (Olfactory receptor TPCR27) OR1C1 Homo sapiens (Human) sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] RGLQKMLLK 0.99139 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MR6 CFA57_HUMAN Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65) CFAP57 WDR65 Homo sapiens (Human) IIEMQRLEIQRLR 0.99139 -4.707 0 0 11.3076 0 0 0 0 0 11.7171 0 12.1034 0 0 0 0 0 0 0 0 12.9495 0 0 0 0 0 10.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.477 11.0133 0 0 0 0 0 0 0 11.0588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.01 12.7926 0 0 0 14.5691 0 0 0 0 12.7078 14.48 12.2265 11.8185 0 0 0 0 14.6495 12.5056 15.0581 12.6667 0 0 0 12.322 0 0 0 0 0 0 0 0 0 12.4087 0 0 12.2102 0 0 0 0 0 14.4493 0 11.8692 13.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7815 0 0 12.3814 0 0 0 0 0 12.9 0 0 0 0 13.4389 0 0 0 0 11.2345 0 0 0 0 0 0 0 0 0 10.4525 0 0 0 0 10.538 0 0 11.7559 0 0 0 0 0 13.028 Q9Y6F7 CDY2_HUMAN "Testis-specific chromodomain protein Y 2, EC 2.3.1.48" CDY2A CDY2; CDY2B Homo sapiens (Human) spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; transcription corepressor activity [GO:0003714]; spermatogenesis [GO:0007283] GO:0003714; GO:0004402; GO:0005634; GO:0007283 histone acetyltransferase activity [GO:0004402]; transcription corepressor activity [GO:0003714] AASTLSDTK 0.99139 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94874 UFL1_HUMAN "E3 UFM1-protein ligase 1, EC 2.3.2.- (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1)" UFL1 KIAA0776 MAXER NLBP RCAD Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709] GO:0001649; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006281; GO:0006974; GO:0008284; GO:0010508; GO:0016020; GO:0016570; GO:0019901; GO:0030218; GO:0031397; GO:0032088; GO:0032434; GO:0032880; GO:0032991; GO:0033146; GO:0034976; GO:0035861; GO:0043005; GO:0043066; GO:0043122; GO:0050727; GO:0060218; GO:0060252; GO:0061666; GO:0061709; GO:0071568; GO:0071569; GO:1902065; GO:1903895; GO:1990592 protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568] DDDSDDESQSSHTGKKK 0.9914 -23.267 0 0 0 0 0 0 10.7432 9.47235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.421 0 0 0 0 0 10.8288 13.3799 0 0 0 10.2021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.936 0 0 0 0 0 0 0 0 0 0 15.9147 11.9099 13.7908 0 0 0 0 0 0 0 0 14.752 11.0825 0 13.8397 0 12.7287 0 0 0 0 0 0 12.8307 0 0 0 0 14.2078 0 0 0 0 10.703 0 11.8231 0 0 0 0 0 13.5889 12.8432 0 0 0 0 0 0 0 0 0 0 12.6452 0 0 0 12.7502 0 0 0 0 0 12.2495 0 0 0 13.1959 0 0 0 0 0 0 0 13.8502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7243 P17081 RHOQ_HUMAN Rho-related GTP-binding protein RhoQ (Ras-like protein TC10) (Ras-like protein family member 7A) RHOQ ARHQ RASL7A TC10 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; GTP metabolic process [GO:0046039]; insulin receptor signaling pathway [GO:0008286]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] actin filament [GO:0005884]; extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] actin filament [GO:0005884]; extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; profilin binding [GO:0005522]; actin cytoskeleton organization [GO:0030036]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytosis [GO:0006897]; establishment or maintenance of cell polarity [GO:0007163]; GTP metabolic process [GO:0046039]; insulin receptor signaling pathway [GO:0008286]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005522; GO:0005525; GO:0005884; GO:0005886; GO:0006897; GO:0007163; GO:0007264; GO:0008286; GO:0008360; GO:0030036; GO:0030660; GO:0030866; GO:0032427; GO:0032869; GO:0032956; GO:0045121; GO:0045944; GO:0046039; GO:0046326; GO:0051491; GO:0070062; GO:1903077 GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; profilin binding [GO:0005522] CINCCLIT 0.9914 -5.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8647 0 0 0 0 13.1033 0 0 0 0 15.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22626 ROA2_HUMAN "Heterogeneous nuclear ribonucleoproteins A2/B1, hnRNP A2/B1" HNRNPA2B1 HNRPA2B1 Homo sapiens (Human) "G-quadruplex DNA unwinding [GO:0044806]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; primary miRNA processing [GO:0031053]; RNA transport [GO:0050658]" "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]" "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded telomeric DNA binding [GO:0043047]; G-quadruplex DNA unwinding [GO:0044806]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; primary miRNA processing [GO:0031053]; RNA transport [GO:0050658]" GO:0000122; GO:0000398; GO:0000781; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0006406; GO:0015030; GO:0016020; GO:0016363; GO:0031053; GO:0035198; GO:0042802; GO:0043047; GO:0044806; GO:0048025; GO:0050658; GO:0051028; GO:0070062; GO:0071013; GO:0097157; GO:0098505; GO:1904358; GO:1905663; GO:1990247; GO:1990428; GO:1990904 G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded telomeric DNA binding [GO:0043047] MEKTLETVPLERK 0.9914 -7.5095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26842 CD27_HUMAN CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27) CD27 TNFRSF7 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; extrinsic apoptotic signaling pathway [GO:0097191]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of apoptotic process [GO:0043066]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell differentiation [GO:0045582] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; extrinsic apoptotic signaling pathway [GO:0097191]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of apoptotic process [GO:0043066]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell differentiation [GO:0045582] GO:0004888; GO:0005576; GO:0005886; GO:0005887; GO:0007166; GO:0009897; GO:0016064; GO:0043027; GO:0043066; GO:0045579; GO:0045582; GO:0046330; GO:0070233; GO:0097191; GO:1901224 cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; transmembrane signaling receptor activity [GO:0004888] GESPVEPAEPCHYSCPR 0.9914 -7.1667 0 0 0 0 0 0 0 0 0 11.7756 10.4477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4481 12.0421 0 10.7521 0 0 11.517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2867 12.6542 12.7269 0 13.2538 0 0 0 0 0 0 0 0 0 12.6867 0 0 0 0 0 0 0 0 11.8381 12.2918 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0337 13.0738 12.1548 0 12.7698 0 0 0 0 0 0 0 11.7059 0 0 0 0 10.4505 0 0 0 0 0 11.7986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3434 0 0 0 Q15788 NCOA1_HUMAN "Nuclear receptor coactivator 1, NCoA-1, EC 2.3.1.48 (Class E basic helix-loop-helix protein 74, bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1, SRC-1)" NCOA1 BHLHE74 SRC1 Homo sapiens (Human) "cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; histone H4 acetylation [GO:0043967]; labyrinthine layer morphogenesis [GO:0060713]; mRNA transcription by RNA polymerase II [GO:0042789]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; histone H4 acetylation [GO:0043967]; labyrinthine layer morphogenesis [GO:0060713]; mRNA transcription by RNA polymerase II [GO:0042789]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]" GO:0000435; GO:0000785; GO:0002155; GO:0003677; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005886; GO:0016922; GO:0017162; GO:0019899; GO:0030331; GO:0030374; GO:0032870; GO:0032991; GO:0035357; GO:0042789; GO:0043065; GO:0043967; GO:0045666; GO:0045893; GO:0045944; GO:0046983; GO:0047485; GO:0060713; GO:0090575; GO:1900076; GO:1904017; GO:1904179 aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713] GTASSPSYR 0.9914 -22.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7018 0 0 0 0 0 11.8066 11.7955 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0445 0 0 0 0 0 13.9399 0 0 0 0 0 0 14.1054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0754 0 0 0 12.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5287 0 14.7754 0 0 0 0 Q6IA86 ELP2_HUMAN "Elongator complex protein 2, ELP2 (SHINC-2) (STAT3-interacting protein 1, StIP1)" ELP2 STATIP1 Homo sapiens (Human) regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein kinase binding [GO:0019901]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006368; GO:0006417; GO:0008023; GO:0019901; GO:0033588; GO:0046425 protein kinase binding [GO:0019901] FLLAVSRDRTWSLWK 0.9914 -19.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6237 0 0 0 0 13.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9867 12.7165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KG9 SCYL1_HUMAN N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase) SCYL1 CVAK90 GKLP NTKL TAPK TEIF TRAP HT019 Homo sapiens (Human) "inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]" cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634] "cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713]; inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]" GO:0003677; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005815; GO:0005829; GO:0006890; GO:0006954; GO:0008104; GO:0016020; GO:0021522; GO:0030126; GO:0045296; GO:0048666 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; protein tyrosine kinase activity [GO:0004713] AAFKRFK 0.9914 -48.473 0 0 0 0 14.3394 0 13.9361 0 0 0 0 0 0 11.4781 0 13.7202 12.7198 0 11.1548 0 0 0 0 0 0 0 11.9828 0 0 0 0 0 0 0 12.6973 0 0 0 0 12.5557 11.2375 0 0 11.7949 0 0 0 12.8231 0 0 0 13.6215 13.6693 0 11.8961 13.1538 14.6545 14.9176 14.8276 13.7036 0 13.519 12.5516 0 11.8716 12.1391 0 0 0 12.5643 0 0 0 9.4672 0 14.582 14.5105 14.4819 0 13.5336 12.4808 17.2167 18.7197 17.2776 13.998 15.428 0 14.2511 15.3318 0 14.6702 14.8213 14.7446 14.1159 14.5185 13.9825 16.434 16.4947 0 0 0 0 0 0 11.8057 14.5034 0 0 0 0 14.5088 13.728 0 15.388 9.91736 0 0 0 0 0 0 0 13.0526 0 0 0 0 0 0 0 0 0 0 0 0 13.1654 0 0 0 0 0 13.8719 0 0 0 15.1434 0 0 0 0 0 0 0 0 13.0777 13.716 0 0 0 0 11.6775 0 12.6903 0 14.5231 13.1837 13.6813 13.5333 15.0282 13.0157 12.6143 12.797 0 15.6089 0 0 0 0 0 0 Q9BXM7 PINK1_HUMAN "Serine/threonine-protein kinase PINK1, mitochondrial, EC 2.7.11.1 (BRPK) (PTEN-induced putative kinase protein 1)" PINK1 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; dopamine secretion [GO:0014046]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]" astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "astrocyte projection [GO:0097449]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of mitochondrial outer membrane [GO:0031307]; Lewy body [GO:0097413]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase B activity [GO:0032148]; autophagy of mitochondrion [GO:0000422]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cellular response to toxic substance [GO:0097237]; dopamine secretion [GO:0014046]; establishment of protein localization to mitochondrion [GO:0072655]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; maintenance of protein location in mitochondrion [GO:0072656]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of JNK cascade [GO:0046329]; negative regulation of macroautophagy [GO:0016242]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cristae formation [GO:1903852]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of peptidase activity [GO:0010952]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of oxidative phosphorylation [GO:0002082]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; respiratory electron transport chain [GO:0022904]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; TORC2 signaling [GO:0038203]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000287; GO:0000422; GO:0000423; GO:0000785; GO:0001934; GO:0002020; GO:0002082; GO:0002931; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0006979; GO:0007005; GO:0010310; GO:0010629; GO:0010821; GO:0010857; GO:0010952; GO:0014046; GO:0016020; GO:0016239; GO:0016242; GO:0016301; GO:0016504; GO:0016567; GO:0018105; GO:0022904; GO:0030097; GO:0030424; GO:0030426; GO:0031307; GO:0031396; GO:0031398; GO:0031625; GO:0032148; GO:0032226; GO:0033138; GO:0033603; GO:0034599; GO:0035307; GO:0035556; GO:0036289; GO:0038203; GO:0042981; GO:0043123; GO:0043254; GO:0043422; GO:0043524; GO:0044297; GO:0044877; GO:0045727; GO:0046329; GO:0048471; GO:0050821; GO:0051091; GO:0051443; GO:0051881; GO:0051897; GO:0055131; GO:0061136; GO:0071456; GO:0072655; GO:0072656; GO:0090141; GO:0090200; GO:0090258; GO:0097237; GO:0097413; GO:0097449; GO:0098779; GO:0099074; GO:0106310; GO:1900407; GO:1901525; GO:1901727; GO:1902803; GO:1902902; GO:1902958; GO:1903146; GO:1903202; GO:1903204; GO:1903214; GO:1903298; GO:1903384; GO:1903751; GO:1903852; GO:1903955; GO:1904544; GO:1904783; GO:1904841; GO:1904881; GO:2000377; GO:2000378; GO:2001171; GO:2001243 ATP binding [GO:0005524]; C3HC4-type RING finger domain binding [GO:0055131]; calcium-dependent protein kinase activity [GO:0010857]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein kinase B binding [GO:0043422]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; ubiquitin protein ligase binding [GO:0031625] ALLLRFTGK 0.9914 -7.5057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.016 0 0 0 0 0 0 0 0 0 0 0 0 17.5456 0 0 0 0 0 0 14.9921 0 0 0 0 15.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9624 0 0 0 0 0 0 13.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.3684 0 0 0 0 0 0 0 11.0121 0 0 0 18.5645 0 0 0 0 0 14.9448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYE7 PCGF6_HUMAN Polycomb group RING finger protein 6 (Mel18 and Bmi1-like RING finger) (RING finger protein 134) PCGF6 MBLR RNF134 Homo sapiens (Human) "histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0005634; GO:0005654; GO:0006357; GO:0031519; GO:0035102; GO:0036353; GO:0045892; GO:0046872 metal ion binding [GO:0046872] EGVAVVTAGSVGAAK 0.9914 -7.1733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3951 13.3973 0 0 0 0 0 0 12.4684 0 0 0 0 0 0 0 0 0 0 0 0 13.4798 0 0 0 0 0 0 0 0 0 0 0 13.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0827 0 0 0 0 0 0 Q9ULW6 NP1L2_HUMAN "Nucleosome assembly protein 1-like 2 (Brain-specific protein, X-linked)" NAP1L2 BPX Homo sapiens (Human) histone H3-K14 acetylation [GO:0044154]; histone H3-K9 acetylation [GO:0043970]; neuron differentiation [GO:0030182]; nucleosome assembly [GO:0006334]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell differentiation [GO:2000738]; regulation of stem cell division [GO:2000035]; stem cell differentiation [GO:0048863] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H3-K14 acetylation [GO:0044154]; histone H3-K9 acetylation [GO:0043970]; neuron differentiation [GO:0030182]; nucleosome assembly [GO:0006334]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell differentiation [GO:2000738]; regulation of stem cell division [GO:2000035]; stem cell differentiation [GO:0048863] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0030182; GO:0042393; GO:0043970; GO:0044154; GO:0045666; GO:0048863; GO:0071442; GO:2000035; GO:2000617; GO:2000738 chromatin binding [GO:0003682]; histone binding [GO:0042393] DGNDDFLLGHNLR 0.9914 -19.071 0 0 0 0 0 0 0 0 13.5242 0 0 12.0629 0 11.6586 0 11.8382 11.8035 12.1864 0 10.9367 0 12.6244 0 0 12.0589 11.5832 11.8232 0 11.1431 0 11.7272 14.1179 0 0 0 12.3572 0 0 0 0 0 0 0 11.1729 0 0 0 11.9496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8778 12.3155 0 0 0 0 0 0 0 11.3116 0 0 0 0 0 13.2894 0 0 12.4014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7466 12.866 0 11.997 0 0 0 0 0 12.5641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8103 12.8279 0 0 0 0 0 0 0 12.2863 12.9371 0 0 12.6856 0 0 0 0 0 0 0 0 0 0 0 A6NMZ7 CO6A6_HUMAN Collagen alpha-6(VI) chain COL6A6 Homo sapiens (Human) cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] GO:0005576; GO:0005581; GO:0007155; GO:0030198; GO:0031012; GO:0062023 AINKYPPINLKIK 0.99141 -49.404 0 0 0 0 11.2104 12.4398 0 0 11.8994 0 0 0 0 0 0 0 0 0 0 12.472 0 0 0 0 0 12.1843 0 0 0 0 0 0 0 0 0 0 0 0 12.0357 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3258 0 0 0 0 0 0 12.7797 0 0 14.6287 13.2976 0 0 0 16.7807 0 0 0 0 0 0 0 0 12.9867 0 16.6705 0 0 0 0 12.0119 13.9934 13.8752 0 12.2894 0 0 12.6694 11.8129 0 14.1863 0 0 16.5339 0 19.2651 13.2082 0 12.1885 14.0835 11.4527 16.1753 17.4344 13.9044 14.7821 11.1401 12.1278 12.4499 11.9498 13.4265 0 0 0 12.4791 12.6293 0 14.7028 0 0 13.7579 0 0 0 12.5201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3959 0 0 0 0 0 0 0 0 12.0083 13.1059 0 0 0 16.1845 14.0266 P01023 A2MG_HUMAN "Alpha-2-macroglobulin, Alpha-2-M (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)" A2M CPAMD5 FWP007 Homo sapiens (Human) "acute inflammatory response to antigenic stimulus [GO:0002438]; acute-phase response [GO:0006953]; embryonic liver development [GO:1990402]; luteinization [GO:0001553]; negative regulation of complement activation, lectin pathway [GO:0001869]; response to carbon dioxide [GO:0010037]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to prostaglandin E [GO:0034695]; stem cell differentiation [GO:0048863]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; brain-derived neurotrophic factor binding [GO:0048403]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120]; acute inflammatory response to antigenic stimulus [GO:0002438]; acute-phase response [GO:0006953]; embryonic liver development [GO:1990402]; luteinization [GO:0001553]; negative regulation of complement activation, lectin pathway [GO:0001869]; response to carbon dioxide [GO:0010037]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to prostaglandin E [GO:0034695]; stem cell differentiation [GO:0048863]" GO:0001553; GO:0001869; GO:0002020; GO:0002438; GO:0004866; GO:0004867; GO:0005102; GO:0005576; GO:0005615; GO:0006953; GO:0007584; GO:0010037; GO:0019838; GO:0019899; GO:0019959; GO:0019966; GO:0031093; GO:0034695; GO:0042802; GO:0043120; GO:0048306; GO:0048403; GO:0048406; GO:0048863; GO:0051384; GO:0062023; GO:0070062; GO:0072562; GO:1990402 brain-derived neurotrophic factor binding [GO:0048403]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120] GEAFTLK 0.99141 -22.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9615 0 0 0 0 0 0 0 0 0 0 0 0 12.8535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4961 0 0 0 12.3124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17301 ITA2_HUMAN "Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia, GPIa) (VLA-2 subunit alpha) (CD antigen CD49b)" ITGA2 CD49B Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; collagen-activated signaling pathway [GO:0038065]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; hepatocyte differentiation [GO:0070365]; hypotonic response [GO:0006971]; integrin-mediated signaling pathway [GO:0007229]; mammary gland development [GO:0030879]; mesodermal cell differentiation [GO:0048333]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell projection organization [GO:0031346]; positive regulation of collagen binding [GO:0033343]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of translation [GO:0045727]; positive regulation of transmission of nerve impulse [GO:0051971]; response to amine [GO:0014075]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to muscle activity [GO:0014850]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; skin morphogenesis [GO:0043589]; substrate-dependent cell migration [GO:0006929]" axon terminus [GO:0043679]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha2-beta1 complex [GO:0034666]; integrin complex [GO:0008305]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "axon terminus [GO:0043679]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha2-beta1 complex [GO:0034666]; integrin complex [GO:0008305]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; heparan sulfate proteoglycan binding [GO:0043395]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; animal organ morphogenesis [GO:0009887]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; collagen-activated signaling pathway [GO:0038065]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; establishment of protein localization [GO:0045184]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; hepatocyte differentiation [GO:0070365]; hypotonic response [GO:0006971]; integrin-mediated signaling pathway [GO:0007229]; mammary gland development [GO:0030879]; mesodermal cell differentiation [GO:0048333]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell projection organization [GO:0031346]; positive regulation of collagen binding [GO:0033343]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of translation [GO:0045727]; positive regulation of transmission of nerve impulse [GO:0051971]; response to amine [GO:0014075]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to muscle activity [GO:0014850]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; skin morphogenesis [GO:0043589]; substrate-dependent cell migration [GO:0006929]" GO:0001540; GO:0001618; GO:0001666; GO:0002687; GO:0005178; GO:0005518; GO:0005634; GO:0005886; GO:0005925; GO:0006929; GO:0006971; GO:0007155; GO:0007160; GO:0007229; GO:0007565; GO:0007596; GO:0008283; GO:0008305; GO:0009410; GO:0009887; GO:0009897; GO:0009986; GO:0010634; GO:0010694; GO:0014075; GO:0014850; GO:0014911; GO:0030879; GO:0031346; GO:0031589; GO:0032967; GO:0033343; GO:0033591; GO:0033627; GO:0034666; GO:0038064; GO:0038065; GO:0043236; GO:0043388; GO:0043395; GO:0043589; GO:0043679; GO:0044877; GO:0045178; GO:0045184; GO:0045727; GO:0045785; GO:0045987; GO:0046872; GO:0048041; GO:0048333; GO:0048471; GO:0048661; GO:0050729; GO:0050927; GO:0050966; GO:0051971; GO:0060100; GO:0070365; GO:0071107; GO:0071260; GO:0071392; GO:0098609; GO:0098639 amyloid-beta binding [GO:0001540]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; heparan sulfate proteoglycan binding [GO:0043395]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618] AEVPTGVIIGSIIAGILLLLALVAILWK 0.99141 -7.5317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4629 0 0 0 0 0 0 0 0 0 11.9913 12.4637 0 0 0 0 0 0 12.1771 0 0 0 0 12.8987 0 0 0 0 0 0 0 12.4372 0 0 0 0 0 12.3178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7263 0 0 13.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9548 0 12.1674 0 0 0 0 0 0 0 13.581 0 0 0 0 0 0 0 0 13.4981 0 0 0 0 0 0 0 12.8537 0 0 0 0 0 0 0 12.5977 0 0 0 0 0 0 12.9577 0 0 0 0 0 0 0 13.1793 0 0 0 0 0 0 0 0 0 13.3464 0 0 13.5936 0 0 12.2758 12.1118 0 0 0 0 0 0 0 0 0 0 12.2146 0 0 0 0 13.0012 0 0 0 0 0 P43007 SATT_HUMAN "Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1, ASCT-1) (Solute carrier family 1 member 4)" SLC1A4 ASCT1 SATT Homo sapiens (Human) "amino acid transport [GO:0006865]; cognition [GO:0050890]; glutamine transport [GO:0006868]; hydroxyproline transport [GO:0034589]; L-alanine import across plasma membrane [GO:1904273]; L-alanine transport [GO:0015808]; L-aspartate import across plasma membrane [GO:0140009]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813]; L-serine import across plasma membrane [GO:1903812]; L-serine transport [GO:0015825]; proline transport [GO:0015824]; synaptic transmission, glutamatergic [GO:0035249]; threonine transport [GO:0015826]; transport across blood-brain barrier [GO:0150104]" cell surface [GO:0009986]; centrosome [GO:0005813]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cell surface [GO:0009986]; centrosome [GO:0005813]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; amino acid transmembrane transporter activity [GO:0015171]; chloride channel activity [GO:0005254]; L-alanine transmembrane transporter activity [GO:0015180]; L-aspartate transmembrane transporter activity [GO:0015183]; L-cystine transmembrane transporter activity [GO:0015184]; L-glutamine transmembrane transporter activity [GO:0015186]; L-hydroxyproline transmembrane transporter activity [GO:0034590]; L-proline transmembrane transporter activity [GO:0015193]; L-serine transmembrane transporter activity [GO:0015194]; L-threonine transmembrane transporter activity [GO:0015195]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293]; amino acid transport [GO:0006865]; cognition [GO:0050890]; glutamine transport [GO:0006868]; hydroxyproline transport [GO:0034589]; L-alanine import across plasma membrane [GO:1904273]; L-alanine transport [GO:0015808]; L-aspartate import across plasma membrane [GO:0140009]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813]; L-serine import across plasma membrane [GO:1903812]; L-serine transport [GO:0015825]; proline transport [GO:0015824]; synaptic transmission, glutamatergic [GO:0035249]; threonine transport [GO:0015826]; transport across blood-brain barrier [GO:0150104]" GO:0005254; GO:0005813; GO:0005882; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0009986; GO:0015171; GO:0015175; GO:0015180; GO:0015183; GO:0015184; GO:0015186; GO:0015193; GO:0015194; GO:0015195; GO:0015293; GO:0015808; GO:0015811; GO:0015813; GO:0015824; GO:0015825; GO:0015826; GO:0016020; GO:0016021; GO:0030425; GO:0034589; GO:0034590; GO:0035249; GO:0042470; GO:0043025; GO:0045202; GO:0050890; GO:0070062; GO:0140009; GO:0150104; GO:1903812; GO:1904273 amino acid transmembrane transporter activity [GO:0015171]; chloride channel activity [GO:0005254]; L-alanine transmembrane transporter activity [GO:0015180]; L-aspartate transmembrane transporter activity [GO:0015183]; L-cystine transmembrane transporter activity [GO:0015184]; L-glutamine transmembrane transporter activity [GO:0015186]; L-hydroxyproline transmembrane transporter activity [GO:0034590]; L-proline transmembrane transporter activity [GO:0015193]; L-serine transmembrane transporter activity [GO:0015194]; L-threonine transmembrane transporter activity [GO:0015195]; neutral amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293] CAGFLRR 0.99141 -7.5302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0118 0 0 0 0 11.8807 0 0 11.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2946 0 0 0 0 0 14.2599 0 P54646 AAPK2_HUMAN "5'-AMP-activated protein kinase catalytic subunit alpha-2, AMPK subunit alpha-2, EC 2.7.11.1 (Acetyl-CoA carboxylase kinase, ACACA kinase, EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase, HMGCR kinase, EC 2.7.11.31)" PRKAA2 AMPK AMPK2 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0003682; GO:0004672; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006325; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0007165; GO:0008610; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016239; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0035174; GO:0035556; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0050405; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:1903829; GO:1904428; GO:1905691; GO:1990044; GO:2000758 [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] ATIKDIR 0.99141 -22.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7545 14.4805 0 16.5935 0 0 0 12.8455 0 0 0 0 17.2286 13.9564 12.8037 0 0 0 0 14.414 0 0 14.8201 0 0 11.4378 0 0 0 13.9497 0 0 0 11.8382 0 0 0 0 0 0 0 0 0 0 0 0 14.2494 0 0 0 0 0 0 13.2388 0 0 0 0 0 0 0 0 0 13.2461 0 0 0 0 11.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0351 0 0 0 0 0 0 0 Q5QJ38 TCHL1_HUMAN Trichohyalin-like protein 1 (Basalin) (Protein S100-A17) (S100 calcium-binding protein A17) TCHHL1 S100A17 THHL1 Homo sapiens (Human) transition metal ion binding [GO:0046914] GO:0046914 transition metal ion binding [GO:0046914] DLPVQYGSR 0.99141 -22.167 0 11.7733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7711 0 0 0 0 0 0 0 0 0 0 0 0 13.9411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6446 0 0 0 0 10.5897 0 0 0 0 0 0 0 0 0 0 0 14.2909 15.7137 0 0 14.1817 15.9788 0 0 0 0 0 0 0 0 0 14.1451 13.7931 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6555 13.9883 0 13.7991 12.7852 12.7984 12.7759 0 0 0 14.9588 12.8381 0 0 0 0 0 0 0 0 0 14.9151 0 13.1168 0 0 0 0 0 0 13.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86U42 PABP2_HUMAN "Polyadenylate-binding protein 2, PABP-2, Poly(A)-binding protein 2 (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II, PABII) (Polyadenylate-binding nuclear protein 1)" PABPN1 PAB2 PABP2 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; muscle contraction [GO:0006936]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; muscle contraction [GO:0006936]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; RNA processing [GO:0006396] GO:0000165; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006936; GO:0016607; GO:0016973; GO:0042405; GO:0070063; GO:0071222; GO:1904247; GO:1990904 RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063] GRQIKVIPK 0.99141 -22.84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6728 0 0 10.7128 0 0 11.4748 11.135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8D7 NKAI3_HUMAN "Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3, Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 3 (Protein FAM77D)" NKAIN3 FAM77D Homo sapiens (Human) regulation of sodium ion transport [GO:0002028] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of sodium ion transport [GO:0002028] GO:0002028; GO:0005886; GO:0016021 MGCCTGR 0.99141 -4.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9896 0 0 0 0 0 12.2268 0 0 0 0 11.4894 0 0 0 0 0 0 Q8TEQ6 GEMI5_HUMAN "Gem-associated protein 5, Gemin5" GEMIN5 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]" GO:0000340; GO:0000387; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006417; GO:0016020; GO:0016604; GO:0017069; GO:0030619; GO:0030621; GO:0030622; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0065003; GO:0097504 mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] AASHLLSIHKVYEAVELLK 0.99141 -49.893 0 0 0 0 0 0 0 0 13.2178 13.3299 0 15.42 0 12.8552 13.1728 13.5194 13.1962 0 0 12.8118 0 0 0 0 0 0 0 0 0 0 0 12.4521 15.5333 13.4883 13.2022 12.6829 0 12.9497 0 13.5249 12.8359 15.5979 13.7754 0 0 0 0 0 11.6808 0 0 0 0 0 14.8329 14.724 0 15.4443 0 0 13.1089 13.2938 13.3613 12.3349 0 0 0 0 14.7569 0 0 0 0 0 0 0 12.7781 0 13.8381 14.9595 13.35 0 13.2459 13.3263 0 12.619 12.5059 0 0 0 0 0 0 12.7371 13.6942 13.6788 0 0 0 0 0 0 15.5867 14.6352 15.1032 0 13.1128 0 0 0 0 12.3484 13.823 0 0 0 10.7502 14.2533 14.2953 14.1377 14.5182 0 14.5994 13.4878 0 14.1167 0 0 0 0 11.4766 0 0 0 0 0 0 12.2089 0 0 14.9266 0 0 0 0 0 0 11.7228 0 0 0 14.8901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0718 0 0 13.9501 0 0 12.5334 0 0 0 0 Q9BQ24 ZFY21_HUMAN "Zinc finger FYVE domain-containing protein 21, ZF21" ZFYVE21 Homo sapiens (Human) endosome [GO:0005768]; focal adhesion [GO:0005925] endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872] GO:0005768; GO:0005925; GO:0046872 metal ion binding [GO:0046872] AFGSPFGLEEPQWVPDK 0.99141 -22.88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1699 0 0 11.24 0 13.6069 0 0 0 0 12.2937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86431 0 0 0 0 0 0 11.395 0 0 0 0 11.183 0 11.9675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3117 12.3372 11.462 0 0 0 0 11.3434 0 0 0 0 0 0 0 0 0 0 0 12.0457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9274 0 0 0 A4UGR9 XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Xeplin) XIRP2 CMYA3 Homo sapiens (Human) actin filament organization [GO:0007015]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281] anchoring junction [GO:0070161]; Z disc [GO:0030018] anchoring junction [GO:0070161]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393]; actin filament organization [GO:0007015]; cardiac muscle tissue morphogenesis [GO:0055008]; cell-cell junction organization [GO:0045216]; ventricular septum development [GO:0003281] GO:0003281; GO:0007015; GO:0030018; GO:0045216; GO:0051015; GO:0051393; GO:0055008; GO:0070161 actin filament binding [GO:0051015]; alpha-actinin binding [GO:0051393] DAKAVMAGSSGEQK 0.99142 -50.713 0 0 0 0 0 0 0 0 13.7681 0 0 0 0 14.9128 0 0 0 0 12.6315 13.574 0 12.1438 0 12.1938 0 0 0 0 0 0 0 0 13.093 0 0 12.3943 13.4596 0 0 0 0 0 0 0 0 0 12.3168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0554 0 10.1416 0 0 14.2985 0 12.6068 14.0901 0 15.8002 0 14.6866 15.1122 15.578 15.4801 16.4465 14.9233 15.937 15.0195 0 16.4705 15.7649 16.3789 15.7371 16.2722 16.9749 16.0219 16.8234 16.1397 0 14.5819 16.9947 14.7726 16.2346 15.6347 13.6255 15.2328 15.5669 16.3404 15.8222 11.9526 11.8761 15.313 0 0 15.007 17.9583 14.1931 18.7466 0 13.5964 10.518 14.2428 14.6379 13.0992 13.8818 15.9398 15.1009 0 16.0147 15.2172 0 14.5122 12.38 0 13.8694 0 11.9729 15.2999 14.1121 0 14.2788 14.5993 11.5891 11.1191 0 14.3491 0 0 13.2113 10.7855 0 0 0 14.1368 0 13.8825 13.5851 0 0 0 0 13.3055 13.876 0 0 15.3368 0 0 0 0 0 11.9913 0 0 13.9042 14.6035 0 0 10.1144 13.4119 0 13.3147 O60292 SI1L3_HUMAN "Signal-induced proliferation-associated 1-like protein 3, SIPA1-like protein 3 (SPA-1-like protein 3)" SIPA1L3 KIAA0545 SPAL3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cytoskeleton organization [GO:0007010]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell polarity [GO:0090162]; eye development [GO:0001654]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of small GTPase mediated signal transduction [GO:0051056] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; tricellular tight junction [GO:0061689] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; tricellular tight junction [GO:0061689]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cytoskeleton organization [GO:0007010]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell polarity [GO:0090162]; eye development [GO:0001654]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0001654; GO:0001725; GO:0002244; GO:0003382; GO:0005096; GO:0005615; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0007010; GO:0016324; GO:0045177; GO:0051056; GO:0061689; GO:0090162; GO:0090630 GTPase activator activity [GO:0005096] AFHRLSRR 0.99142 -22.388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3708 0 0 13.2398 0 12.8593 0 0 0 0 0 0 13.4975 15.9439 13.695 0 0 11.1336 0 12.1901 0 0 0 16.2655 0 0 0 0 14.9245 0 0 15.4042 11.2512 0 0 0 0 0 13.238 13.0152 11.5761 12.7396 0 12.5276 11.834 0 0 0 13.5684 0 0 0 0 0 13.5113 0 0 0 0 0 11.2881 0 13.3498 11.8883 0 12.8743 12.5768 0 0 0 12.409 0 0 0 0 0 0 13.2427 0 0 0 0 0 0 11.9492 0 0 0 0 0 0 0 0 0 0 0 13.3353 0 12.3504 0 12.8268 0 0 12.0059 0 P23942 PRPH2_HUMAN "Peripherin-2 (Retinal degeneration slow protein) (Tetraspanin-22, Tspan-22)" PRPH2 PRPH RDS TSPAN22 Homo sapiens (Human) cell adhesion [GO:0007155]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell outer segment organization [GO:0035845]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to low light intensity stimulus [GO:0009645]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; detection of light stimulus involved in visual perception [GO:0050908]; photoreceptor cell outer segment organization [GO:0035845]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to low light intensity stimulus [GO:0009645]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0005887; GO:0007155; GO:0007601; GO:0009645; GO:0016021; GO:0035845; GO:0042803; GO:0050908; GO:0051260; GO:0051291; GO:0060041 protein homodimerization activity [GO:0042803] AFLESVKK 0.99142 -23.736 0 0 0 9.34018 0 0 0 0 0 0 0 0 0 0 0 14.1721 0 0 0 0 0 0 0 0 0 0 11.9189 0 10.9715 0 13.9645 0 0 0 0 0 0 0 0 0 14.3189 0 0 0 0 14.4995 0 0 0 10.7883 0 0 0 0 0 0 0 13.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2833 0 0 0 0 0 0 0 0 10.8041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7378 0 0 0 0 0 0 0 0 0 0 0 0 11.336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6628 0 0 0 0 0 0 0 0 0 0 0 13.0133 0 0 0 12.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8935 14.7683 14.5816 14.8352 0 0 0 0 0 0 0 12.6503 12.1354 P55010 IF5_HUMAN "Eukaryotic translation initiation factor 5, eIF-5" EIF5 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; eukaryotic initiation factor eIF2 binding [GO:0071074]; GDP-dissociation inhibitor activity [GO:0005092]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] GO:0001731; GO:0001732; GO:0003723; GO:0003743; GO:0005092; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0006446; GO:0045296; GO:0071074 cadherin binding [GO:0045296]; eukaryotic initiation factor eIF2 binding [GO:0071074]; GDP-dissociation inhibitor activity [GO:0005092]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] MPRLIAK 0.99142 -22.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13547 HDAC1_HUMAN "Histone deacetylase 1, HD1, EC 3.5.1.98 (Protein deacetylase HDAC1, EC 3.5.1.-) (Protein decrotonylase HDAC1, EC 3.5.1.-)" HDAC1 RPD3L1 Homo sapiens (Human) "cellular response to platelet-derived growth factor stimulus [GO:0036120]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of amyloid-beta clearance [GO:1900221]; regulation of cell fate specification [GO:0042659]; regulation of endopeptidase activity [GO:0052548]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; core promoter sequence-specific DNA binding [GO:0001046]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; Krueppel-associated box domain binding [GO:0035851]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein lysine deacetylase activity [GO:0033558]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of amyloid-beta clearance [GO:1900221]; regulation of cell fate specification [GO:0042659]; regulation of endopeptidase activity [GO:0052548]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000118; GO:0000122; GO:0000785; GO:0000792; GO:0000978; GO:0000979; GO:0001046; GO:0001222; GO:0002039; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006338; GO:0006346; GO:0006357; GO:0006476; GO:0007492; GO:0008284; GO:0009913; GO:0010628; GO:0010629; GO:0016575; GO:0016580; GO:0016581; GO:0017053; GO:0019213; GO:0019899; GO:0021766; GO:0030182; GO:0030336; GO:0030512; GO:0032922; GO:0032991; GO:0033558; GO:0035851; GO:0036120; GO:0042475; GO:0042659; GO:0042733; GO:0042826; GO:0043025; GO:0043066; GO:0043124; GO:0043922; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0048661; GO:0048709; GO:0048714; GO:0051059; GO:0052548; GO:0060766; GO:0060789; GO:0061029; GO:0061198; GO:0061629; GO:0070888; GO:0070932; GO:0070933; GO:0090090; GO:0140297; GO:0160009; GO:1900221; GO:1902455; GO:1902459; GO:1990841; GO:2000273; GO:2000736; GO:2001243 core promoter sequence-specific DNA binding [GO:0001046]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; Krueppel-associated box domain binding [GO:0035851]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein lysine deacetylase activity [GO:0033558]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] DIGAGKGK 0.99142 -23.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6779 0 0 0 0 0 0 0 12.4293 16.0411 0 0 0 0 0 0 0 12.1403 0 0 0 0 12.0165 0 0 0 0 0 0 0 0 0 0 12.8946 0 0 0 0 12.6701 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9358 0 0 0 0 0 0 0 0 0 0 12.179 0 0 0 0 12.4489 12.2168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2502 12.9201 12.896 0 0 0 0 0 0 Q14152 EIF3A_HUMAN "Eukaryotic translation initiation factor 3 subunit A, eIF3a (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185)" EIF3A EIF3S10 KIAA0139 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]" GO:0001732; GO:0002188; GO:0003723; GO:0003729; GO:0003743; GO:0005198; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005852; GO:0006413; GO:0014069; GO:0016020; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541; GO:0075522; GO:0075525 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743] AFKDIDIEDLEELDPDFIMAKQVEQLEK 0.99142 -50.968 0 0 0 0 0 0 0 0 0 0 0 14.0435 0 0 0 0 0 0 0 11.051 0 0 0 0 13.3222 0 0 0 0 0 14.171 0 0 0 0 0 0 0 0 0 0 0 0 13.3287 10.8903 0 0 0 0 0 0 0 0 0 9.56942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7197 13.6028 0 0 0 13.1275 0 0 17.5196 0 0 12.7073 13.016 12.4246 0 12.4538 13.3136 0 13.1323 14.4163 0 11.9772 12.937 13.401 13.0713 14.0754 0 0 0 14.0445 0 0 0 0 14.9929 0 16.634 13.8675 0 0 0 13.6 0 0 12.8868 14.6424 12.9932 0 0 15.1198 0 13.1992 11.3538 0 12.8415 0 0 0 12.4775 0 0 0 12.8177 0 0 0 13.5171 0 0 0 0 12.0994 0 13.2679 0 0 12.5969 0 0 0 0 0 0 0 0 0 0 0 13.501 0 0 0 0 0 11.615 12.9729 0 0 0 0 10.4947 0 Q16348 S15A2_HUMAN "Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)" SLC15A2 PEPT2 Homo sapiens (Human) dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; renal absorption [GO:0070293]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spanning component of plasma membrane [GO:0044214]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; dipeptide import across plasma membrane [GO:0140206]; dipeptide transport [GO:0042938]; innate immune response [GO:0045087]; ion transport [GO:0006811]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; renal absorption [GO:0070293]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport [GO:0042908] GO:0005886; GO:0005887; GO:0006811; GO:0015031; GO:0015333; GO:0015835; GO:0016324; GO:0042908; GO:0042938; GO:0044214; GO:0045087; GO:0070062; GO:0070293; GO:0070424; GO:0071916; GO:0140206; GO:0150104; GO:1990961 dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333] HAEERTR 0.99142 -22.248 0 0 0 10.873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1708 12.1345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5056 0 0 0 0 0 13.5901 0 12.7311 0 0 11.004 0 0 0 0 0 0 0 0 0 0 0 0 12.3856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3644 0 0 0 11.5434 0 0 0 0 12.8167 0 0 0 0 0 11.1912 0 0 11.4901 0 0 0 0 0 0 12.4309 0 0 0 0 0 12.9951 0 0 0 0 0 0 0 0 0 11.7899 Q8NH49 OR4X1_HUMAN Olfactory receptor 4X1 (Olfactory receptor OR11-104) OR4X1 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] PCVTLPADK 0.99142 -7.3761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8902 0 11.8704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9188 0 0 0 0 0 0 0 0 14.1974 0 0 13.4041 0 0 0 0 0 0 0 0 0 0 14.138 0 0 0 0 14.6435 0 0 0 0 13.5765 0 0 0 13.4957 14.8466 0 13.5136 13.3052 0 0 0 0 12.5919 0 13.4481 0 0 0 0 0 0 14.5497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9731 13.3168 0 0 0 0 0 0 0 Q8TAU3 ZN417_HUMAN Zinc finger protein 417 ZNF417 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AYHCGECGK 0.99142 -23.031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2583 0 0 0 0 0 0 14.0195 14.4624 14.3655 0 14.1204 0 0 0 0 0 0 0 0 0 0 17.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7954 0 0 0 0 0 0 0 0 0 0 13.4515 13.0934 0 0 0 0 0 0 11.8808 0 0 13.6026 0 0 13.6262 0 0 13.1859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96ME7 ZN512_HUMAN Zinc finger protein 512 ZNF512 KIAA1805 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] DQRRNNEELVVSASCK 0.99142 -22.958 0 0 0 0 0 0 0 0 0 0 0 11.6382 0 11.6563 0 0 0 0 12.4517 0 0 0 12.1798 0 0 0 12.7235 0 0 12.864 12.4777 0 12.1206 0 0 0 12.5604 0 0 0 0 11.629 0 0 12.29 12.6906 0 12.6852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.969 0 0 0 0 0 0 0 0 0 0 0 12.7416 0 0 0 0 0 11.2575 13.2706 0 0 0 0 0 0 0 0 0 0 12.0151 0 0 0 11.3808 0 0 0 0 0 0 0 0 0 10.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0372 0 0 12.5279 0 0 13.0715 0 12.7047 13.3323 0 0 0 0 12.4471 0 0 0 0 0 12.839 0 0 12.2752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6666 0 0 12.9741 0 13.0176 0 10.8248 0 0 0 0 0 0 0 Q9C0J8 WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa) WDR33 WDC146 Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283] collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283] GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0006378; GO:0007283 RNA binding [GO:0003723] DGFPGPEDFGPEENFDASEEAAR 0.99142 -23.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.937 0 0 12.3896 0 10.9997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94122 0 0 0 0 0 0 0 12.8978 0 11.4516 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9401 0 0 0 0 0 0 0 11.5466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0879 0 13.8197 0 0 0 0 0 0 0 0 14.9867 0 0 0 0 0 0 0 0 11.0773 0 0 0 14.14 0 12.8034 0 0 0 0 0 15.5354 0 0 0 0 0 14.8741 11.0557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9469 0 0 0 0 13.1352 0 13.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5128 0 0 0 0 Q9NP74 PALMD_HUMAN Palmdelphin (Paralemmin-like protein) PALMD C1orf11 PALML Homo sapiens (Human) regulation of cell shape [GO:0008360] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; membrane [GO:0016020] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; membrane [GO:0016020]; regulation of cell shape [GO:0008360] GO:0005737; GO:0008360; GO:0016020; GO:0043197; GO:0070161 ALREKWLLDGISSGK 0.99142 -23.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5065 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8006 0 0 13.9278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2013 0 0 0 14.5175 0 0 0 0 0 0 0 0 13.7047 0 14.4762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9482 0 0 0 0 0 0 0 0 0 0 14.4497 0 Q9NYA4 MTMR4_HUMAN "Myotubularin-related protein 4, EC 3.1.3.48 (FYVE domain-containing dual specificity protein phosphatase 2, FYVE-DSP2) (Zinc finger FYVE domain-containing protein 11)" MTMR4 KIAA0647 ZFYVE11 Homo sapiens (Human) negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615] "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0004438; GO:0004722; GO:0004725; GO:0005615; GO:0005768; GO:0005829; GO:0006470; GO:0006661; GO:0007179; GO:0010506; GO:0019903; GO:0030512; GO:0031901; GO:0046856; GO:0046872; GO:0052629; GO:0060304 "metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]" AADALIAISNYRLHIK 0.99142 -22.361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.667 0 0 0 11.0705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7042 11.2706 0 0 0 0 0 0 0 0 0 14.6956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5719 0 0 0 0 0 0 15.3729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0078 0 0 0 0 0 Q9P281 BAHC1_HUMAN "BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2, BAH domain-containing protein 2)" BAHCC1 BAHD2 KIAA1447 Homo sapiens (Human) chromatin binding [GO:0003682] GO:0003682 chromatin binding [GO:0003682] AAPAFKGGGGPR 0.99142 -50.741 0 0 0 0 0 0 0 0 0 0 0 14.6956 10.4965 0 0 0 0 12.4266 0 0 0 0 0 12.6994 0 0 0 0 0 0 15.1187 0 0 0 0 0 0 0 0 0 9.46275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7813 11.7925 0 0 0 13.3346 0 0 0 0 0 0 0 0 0 0 0 0 10.3984 0 14.5865 0 10.5681 14.0338 0 0 0 0 0 0 0 0 0 11.5162 12.2296 0 11.3596 0 0 0 0 0 0 0 13.4712 0 0 0 0 0 0 9.82918 0 0 14.4622 0 0 12.245 0 0 16.3124 15.9471 0 0 0 0 0 0 0 0 14.1497 0 0 0 0 0 13.6822 0 15.3412 11.5882 0 11.4755 15.3238 0 0 10.8474 11.4557 0 0 0 0 0 0 0 14.9127 11.9965 0 0 0 0 0 0 0 0 0 12.7204 13.6508 15.0149 14.2551 0 Q9UK53 ING1_HUMAN Inhibitor of growth protein 1 ING1 Homo sapiens (Human) "cell cycle [GO:0007049]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634]; Sin3 complex [GO:0016580] "nucleus [GO:0005634]; Sin3 complex [GO:0016580]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0005634; GO:0006355; GO:0006606; GO:0007049; GO:0008285; GO:0010941; GO:0016580; GO:0030308; GO:0030336; GO:0030512; GO:0035064; GO:0045893; GO:0046872; GO:1902455; GO:1902459 metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] GRGCSSDRLPR 0.99142 -23.011 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8798 0 0 0 0 0 0 0 0 10.9462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4035 0 0 0 0 0 0 0 0 0 0 0 0 13.2367 0 0 0 13.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16610 ECM1_HUMAN Extracellular matrix protein 1 (Secretory component p85) ECM1 Homo sapiens (Human) angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; chondrocyte development [GO:0002063]; endochondral bone growth [GO:0003416]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidase activity [GO:0010466]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of bone mineralization [GO:0030500]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type 2 immune response [GO:0002828]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]; enzyme binding [GO:0019899]; interleukin-2 receptor binding [GO:0005134]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; chondrocyte development [GO:0002063]; endochondral bone growth [GO:0003416]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidase activity [GO:0010466]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of bone mineralization [GO:0030500]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type 2 immune response [GO:0002828]; signal transduction [GO:0007165] GO:0001503; GO:0001525; GO:0001938; GO:0001960; GO:0002020; GO:0002063; GO:0002828; GO:0003416; GO:0005134; GO:0005576; GO:0005615; GO:0006357; GO:0006954; GO:0007165; GO:0008022; GO:0010466; GO:0019899; GO:0030500; GO:0030502; GO:0031012; GO:0031089; GO:0031214; GO:0043123; GO:0043236; GO:0045766; GO:0062023; GO:0070062; GO:2000404 enzyme binding [GO:0019899]; interleukin-2 receptor binding [GO:0005134]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022] CCDLPFPEQACCAEEEKLTFINDLCGPRR 0.99143 -22.427 0 0 0 0 0 0 0 0 0 13.352 12.7715 14.3512 13.7583 13.1201 13.113 13.224 13.284 0 13.0049 0 13.3305 0 0 0 0 14.3652 0 14.1784 13.9254 12.8193 0 0 0 0 12.7608 0 0 13.1844 13.5975 0 13.2883 13.446 14.1296 0 0 0 0 13.6502 13.6972 12.2842 0 0 0 13.3304 0 0 0 0 0 0 0 0 0 0 0 0 12.9035 11.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4993 13.739 0 0 0 0 0 0 0 0 0 0 0 13.2081 12.9565 0 0 0 0 12.4723 0 0 0 12.7853 0 0 0 0 0 0 0 0 0 0 0 12.0997 0 0 0 0 0 0 12.8262 0 0 0 0 0 13.1861 0 0 0 0 0 0 0 0 14.096 0 0 0 0 0 0 0 0 0 14.5851 14.0623 14.3673 14.1406 14.5111 15.24 14.5401 13.9012 0 14.6188 14.1386 15.3347 15.3959 13.7676 0 0 0 0 14.0767 0 14.2052 0 0 Q3KNS1 PTHD3_HUMAN Patched domain-containing protein 3 (Patched-related protein) PTCHD3 PTR Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0016021; GO:0097225 AKAMRLLYYLK 0.99143 -4.7643 0 0 13.0188 0 0 0 0 0 0 0 0 0 0 11.1156 0 0 0 0 0 0 0 0 0 0 0 0 11.6741 0 0 0 0 0 0 0 0 0 0 0 0 11.4959 10.8357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0059 0 0 0 0 0 0 0 0 0 0 13.4684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6172 0 12.4653 0 0 Q5T4F7 SFRP5_HUMAN "Secreted frizzled-related protein 5, sFRP-5 (Frizzled-related protein 1b, FRP-1b) (Secreted apoptosis-related protein 3, SARP-3)" SFRP5 FRP1B SARP3 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; regulation of BMP signaling pathway [GO:0030510]; signal transduction [GO:0007165]; visual perception [GO:0007601] extracellular space [GO:0005615] extracellular space [GO:0005615]; Wnt-protein binding [GO:0017147]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; regulation of BMP signaling pathway [GO:0030510]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0005615; GO:0006915; GO:0007163; GO:0007165; GO:0007601; GO:0008285; GO:0009653; GO:0017147; GO:0030154; GO:0030178; GO:0030510; GO:0043433; GO:0051898; GO:0060070; GO:0090090; GO:2000057 Wnt-protein binding [GO:0017147] KLIGAQK 0.99143 -23.743 0 0 0 0 0 0 0 11.3312 0 12.1759 0 0 0 0 0 12.7933 0 0 0 0 0 0 0 0 0 0 0 0 13.0317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0572 0 0 0 0 0 0 0 0 0 0 14.9856 0 0 0 0 14.5083 0 0 14.2036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6244 0 0 0 14.5661 0 14.3632 0 0 0 14.2777 0 0 0 0 0 0 0 0 0 0 14.098 0 0 0 0 0 0 0 15.1243 14.3163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5346 0 0 0 0 0 12.8649 13.8969 0 0 0 0 0 0 0 0 0 0 0 Q6ZTW0 TPGS1_HUMAN "Tubulin polyglutamylase complex subunit 1, PGs1" TPGS1 C19orf20 Homo sapiens (Human) adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; synapse [GO:0045202] axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; motile cilium [GO:0031514]; synapse [GO:0045202]; microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; protein polyglutamylation [GO:0018095]; sperm axoneme assembly [GO:0007288]; vesicle localization [GO:0051648] GO:0005737; GO:0005813; GO:0005874; GO:0007268; GO:0007288; GO:0008017; GO:0018095; GO:0030424; GO:0030425; GO:0030534; GO:0031514; GO:0045202; GO:0051648; GO:0070740 microtubule binding [GO:0008017]; tubulin-glutamic acid ligase activity [GO:0070740] FLEAGSR 0.99143 -4.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.868 0 0 0 13.8866 0 0 0 0 12.785 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY85 EFC13_HUMAN EF-hand calcium-binding domain-containing protein 13 EFCAB13 C17orf57 Homo sapiens (Human) ACKIFSKIR 0.99143 -52.446 0 0 0 0 0 0 0 11.1105 0 0 12.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.04 10.6991 0 0 0 0 0 0 0 13.7518 13.7487 0 13.2212 13.6441 0 0 14.2349 14.0846 0 13.759 0 0 0 0 17.8815 0 0 13.696 0 0 0 0 0 0 0 0 0 0 13.272 0 0 12.3966 0 0 13.7699 0 0 0 0 0 14.503 14.9713 14.073 14.1171 0 13.2154 0 14.3904 0 0 0 0 0 14.3523 13.277 13.4446 13.2154 13.7034 13.3963 0 13.6297 12.9229 0 14.1847 14.2001 13.8411 13.6638 13.2651 13.7334 0 14.0577 13.5643 0 0 0 13.6116 0 0 13.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4162 0 0 0 0 0 0 0 0 Q8ND30 LIPB2_HUMAN "Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2, PTPRF-interacting protein-binding protein 2)" PPFIBP2 Homo sapiens (Human) neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] cytosol [GO:0005829]; extracellular space [GO:0005615]; presynaptic active zone [GO:0048786] cytosol [GO:0005829]; extracellular space [GO:0005615]; presynaptic active zone [GO:0048786]; identical protein binding [GO:0042802]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] GO:0005615; GO:0005829; GO:0007528; GO:0042802; GO:0048786; GO:0050808 identical protein binding [GO:0042802] DRRIEELTGLLNQYR 0.99143 -52.422 0 0 0 0 0 0 0 0 11.5621 0 0 12.2446 0 0 12.8242 0 10.8905 12.4369 11.628 0 0 0 0 0 12.6945 13.4746 12.2926 0 11.1577 0 0 0 0 13.0602 10.2042 0 0 12.1645 0 11.3716 11.1592 0 11.8265 12.0098 9.44406 0 0 12.8098 0 0 12.7805 0 0 0 0 0 0 0 13.511 0 0 0 0 0 10.5583 0 0 0 0 0 11.3635 0 0 0 0 0 0 0 14.2907 14.4586 0 0 0 13.7122 0 0 0 0 0 12.4928 0 13.5591 14.3699 0 0 12.9532 13.859 15.0646 0 15.0803 0 0 14.4548 0 11.9968 0 13.6986 0 13.6333 0 13.2236 15.6988 0 11.4703 11.8821 15.1596 14.3603 11.5104 13.3589 0 0 0 14.4599 0 0 0 0 13.2077 12.575 14.7592 0 0 13.2064 0 0 12.8039 0 0 13.13 0 15.1128 13.3387 14.2947 0 0 0 0 14.1842 14.5579 0 13.7877 0 14.4584 0 13.1318 14.1535 0 15.0234 13.4485 15.3201 0 15.3321 14.3168 16.0875 14.8399 0 15.0513 0 15.3913 15.8043 15.5843 14.2535 0 0 0 14.2552 0 14.5755 0 0 Q8WYB5 KAT6B_HUMAN "Histone acetyltransferase KAT6B, EC 2.3.1.48 (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4, MYST-4) (Monocytic leukemia zinc finger protein-related factor)" KAT6B KIAA0383 MORF MOZ2 MYST4 Homo sapiens (Human) "histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] "MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000786; GO:0003677; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0006334; GO:0006355; GO:0016407; GO:0016573; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050793; GO:0061629; GO:0070776; GO:1903706 acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator activity [GO:0003712] AIAHFKR 0.99143 -51.944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9651 11.942 0 0 12.7461 0 0 0 0 11.751 0 0 0 0 0 0 0 0 0 0 0 12.1868 0 0 10.1084 0 0 11.2766 0 0 0 0 11.7628 0 0 0 0 0 0 0 0 11.3851 0 0 0 14.6911 13.4027 14.1499 0 0 0 0 13.1272 11.9696 0 0 13.3387 0 0 0 0 0 0 0 12.4541 14.1706 13.3414 13.0295 0 0 0 13.8825 17.0655 15.7474 0 15.1176 14.5705 13.1974 0 0 0 16.9704 14.1763 14.3425 11.7557 11.5772 0 14.7604 0 0 0 17.1438 0 0 0 12.238 0 12.9304 0 13.4362 0 13.329 12.1512 12.5383 0 12.7024 0 14.9248 0 13.2955 14.6772 0 0 0 12.4248 12.9777 0 0 12.5839 14.6129 13.3752 0 0 11.3419 14.1765 12.8329 0 0 0 0 0 11.9932 0 0 0 0 0 0 0 0 0 0 0 15.3783 0 0 0 0 0 0 0 0 0 0 0 11.4904 11.2055 0 12.2377 0 0 0 0 0 0 Q96N46 TTC14_HUMAN "Tetratricopeptide repeat protein 14, TPR repeat protein 14" TTC14 KIAA1980 UNQ5813/PRO19630 Homo sapiens (Human) nucleic acid binding [GO:0003676] GO:0003676 nucleic acid binding [GO:0003676] AGIKDIDRYHEK 0.99143 -22.408 0 0 0 0 0 0 11.1372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7068 13.5196 13.2897 0 0 14.2489 13.1692 13.5859 14.2996 14.0562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2942 0 15.1613 0 0 11.1578 12.953 0 0 0 0 0 11.6746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5372 0 0 0 0 0 13.4374 0 0 0 0 0 Q96NB2 SFXN2_HUMAN Sideroflexin-2 SFXN2 Homo sapiens (Human) mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857]; mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300] GO:0005739; GO:0005741; GO:0022857; GO:0022889; GO:0031305; GO:0140300; GO:1990542 serine transmembrane transporter activity [GO:0022889]; transmembrane transporter activity [GO:0022857] APPLVGR 0.99143 -22.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.641 0 13.4238 0 0 0 14.0641 0 0 14.3266 0 0 15.6647 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8295 0 0 13.6424 0 13.0722 0 0 13.1023 0 0 0 0 0 0 13.271 0 0 0 0 0 0 0 0 0 0 0 0 14.5181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2934 0 0 13.7257 0 13.1386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4747 0 Q96QB1 RHG07_HUMAN "Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein, DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12, StARD12) (StAR-related lipid transfer protein 12)" DLC1 ARHGAP7 KIAA1723 STARD12 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587] caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169]; actin cytoskeleton organization [GO:0030036]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; heart morphogenesis [GO:0003007]; hindbrain morphogenesis [GO:0021575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0001843; GO:0003007; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005901; GO:0005925; GO:0006915; GO:0006919; GO:0007165; GO:0008285; GO:0008289; GO:0008360; GO:0021575; GO:0030036; GO:0030336; GO:0030864; GO:0030900; GO:0032587; GO:0032956; GO:0035023; GO:0035024; GO:0035307; GO:0042169; GO:0045121; GO:0048041; GO:0051056; GO:0051497; GO:0051895; GO:1900119 GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; SH2 domain binding [GO:0042169] CVSLPDCCHGSELR 0.99143 -51.508 0 0 0 0 0 11.9984 0 0 0 0 0 0 0 12.2192 0 0 0 0 0 0 14.3054 0 0 0 0 0 0 0 0 0 0 13.0276 0 0 13.8621 0 0 0 0 0 0 0 14.1349 0 0 0 11.8366 0 13.3025 11.4557 0 14.0986 0 0 10.8249 0 0 0 0 0 0 11.8622 12.1761 0 0 0 0 0 0 0 14.1921 0 0 0 0 10.9681 0 13.7955 12.8915 13.0202 13.702 0 0 13.06 15.3627 13.2315 0 0 0 0 0 0 0 15.7961 0 0 0 14.4407 0 15.2427 0 0 0 14.6379 0 13.0888 15.9795 0 13.6757 12.8448 14.3123 12.5038 15.2658 14.1536 0 13.0348 12.873 12.805 0 13.6934 11.3698 13.4754 13.47 0 13.1844 14.7888 13.7654 13.7832 0 13.4587 0 13.9155 0 0 0 0 0 14.5021 11.7067 0 0 0 0 0 0 0 0 14.3772 0 0 0 0 0 0 14.0583 0 0 0 0 14.2886 0 0 13.2856 0 12.5516 13.4857 0 13.2702 12.8142 13.5099 0 13.5636 0 0 0 0 12.5563 17.0938 0 0 Q9HB65 ELL3_HUMAN RNA polymerase II elongation factor ELL3 ELL3 Homo sapiens (Human) "DNA-templated transcription, elongation [GO:0006354]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; neural precursor cell proliferation [GO:0061351]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of epithelial to mesenchymal transition [GO:0010717]; snRNA transcription by RNA polymerase II [GO:0042795]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" cell junction [GO:0030054]; chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023] "cell junction [GO:0030054]; chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-templated transcription, elongation [GO:0006354]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; neural precursor cell proliferation [GO:0061351]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of epithelial to mesenchymal transition [GO:0010717]; snRNA transcription by RNA polymerase II [GO:0042795]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000987; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006354; GO:0006366; GO:0006368; GO:0007283; GO:0008023; GO:0010717; GO:0016607; GO:0030054; GO:0032786; GO:0032968; GO:0042771; GO:0042795; GO:0045944; GO:0048863; GO:0050769; GO:0061351; GO:0072089; GO:1902166; GO:2000179; GO:2000648 cis-regulatory region sequence-specific DNA binding [GO:0000987] ALQECQR 0.99143 -23.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8863 0 12.368 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6172 0 0 0 0 0 0 0 13.4439 0 12.9879 0 0 0 0 0 0 0 12.9145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7347 0 0 0 0 0 0 0 0 0 0 13.1406 0 0 0 0 0 0 0 0 0 12.5339 0 13.4952 0 12.4415 0 12.6498 0 0 0 0 0 0 0 0 0 0 0 0 12.4126 0 0 14.0845 13.8185 14.2728 12.6264 0 0 12.4426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7887 12.213 0 0 Q5T8R8 DOAS1_HUMAN Uncharacterized protein DOCK8-AS1 (DOCK8 antisense RNA 1) DOCK8-AS1 C9orf66 Homo sapiens (Human) HSVARPTR 0.99144 -23.257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0967 0 0 12.9542 0 0 0 0 0 0 0 0 14.0776 0 13.4853 0 0 0 0 13.2949 0 13.4119 13.5694 0 0 0 10.6544 0 0 0 0 13.7252 14.4449 0 14.7092 13.9512 14.7985 0 0 0 0 12.7157 13.8303 0 13.5827 0 0 0 0 0 0 0 13.6926 0 13.8174 0 0 0 0 0 0 0 0 0 13.4034 0 0 13.8537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3148 0 Q68EN5 K895L_HUMAN Uncharacterized protein KIAA0895-like KIAA0895L Homo sapiens (Human) DQVYLDGIVRILRHR 0.99144 -5.9574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YN4 VIR_HUMAN Protein virilizer homolog VIRMA KIAA1429 MSTP054 Homo sapiens (Human) mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396; GO:0080009; GO:0110104 RNA binding [GO:0003723] AHVVPPPR 0.99144 -23.266 10.8323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2369 0 13.8839 0 0 0 10.9885 13.2946 0 0 12.7563 0 0 0 13.0366 0 0 0 0 13.4006 0 0 0 10.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9568 11.3289 10.7272 0 0 0 0 0 0 0 0 0 0 12.389 13.3959 13.9285 14.3613 15.0286 13.0197 16.0453 14.6413 14.1567 15.4918 0 14.2188 0 10.7674 13.7556 14.4273 14.0323 14.5155 15.6889 15.9443 15.5793 16.4721 0 0 0 15.4181 15.0307 15.3413 11.8432 14.0326 0 14.714 12.3778 0 14.2973 14.1447 11.8313 0 13.7011 13.7949 0 0 15.0618 15.0249 13.4882 12.8072 14.7699 14.16 0 0 12.6701 15.2083 12.2232 15.0234 13.4172 0 0 13.7007 15.425 12.9532 13.1671 0 0 15.7183 0 0 11.9599 12.6354 14.5606 0 12.3684 11.8236 11.0784 0 0 0 0 14.7278 0 15.9067 0 13.1851 0 15.5095 0 12.4052 0 15.6776 12.4209 15.8475 0 0 15.6126 0 0 0 0 15.6735 0 0 0 0 15.836 0 0 15.9666 Q8IUC8 GLT13_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 13, EC 2.4.1.41 (Polypeptide GalNAc transferase 13, GalNAc-T13, pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13)" GALNT13 KIAA1918 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] CKPFSWYLENIYPDSQIPRR 0.99144 -4.3703 0 0 0 0 0 0 11.1521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4009 0 0 0 0 0 0 11.8328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULX3 NOB1_HUMAN "RNA-binding protein NOB1, EC 3.1.-.- (Phosphorylation regulatory protein HP-10) (Protein ART-4)" NOB1 ART4 NOB1P PSMD8BP1 MSTP158 Homo sapiens (Human) cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]; visual perception [GO:0007601] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490]; rRNA processing [GO:0006364]; visual perception [GO:0007601]" GO:0000469; GO:0004521; GO:0005654; GO:0005829; GO:0006364; GO:0007601; GO:0030490; GO:0030688; GO:0046872 endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872] LAVLPYELR 0.99144 -22.557 0 0 0 0 0 0 0 0 0 15.0302 0 0 0 0 0 0 0 0 0 0 13.4165 0 0 0 0 0 0 0 13.5079 0 0 0 0 0 0 12.8833 0 0 0 0 13.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0711 0 0 0 0 0 0 0 0 0 0 0 0 14.1887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7017 13.6357 0 0 0 0 0 0 0 0 0 0 0 13.4289 0 11.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6455 0 0 0 0 0 0 A5D8W1 CFA69_HUMAN Cilia- and flagella-associated protein 69 CFAP69 C7orf63 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288] cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225] cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288] GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834 AKSLQEK 0.99145 -7.1352 0 0 0 0 0 11.0094 0 0 0 0 0 0 0 0 12.4257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5596 0 0 0 0 0 10.5314 0 0 0 0 0 0 0 0 11.9365 0 0 10.8042 0 0 0 0 0 0 0 0 0 0 0 11.7598 0 0 0 0 0 0 0 0 0 0 0 0 12.2642 0 14.9876 18.4627 0 15.0597 0 16.0819 0 16.2083 15.7238 14.6299 14.4074 0 0 14.5069 15.2057 0 13.8723 11.846 0 12.686 13.3483 13.7154 0 0 0 0 0 0 13.7987 0 14.501 0 13.5643 0 16.2309 0 0 11.7531 12.0191 0 0 0 14.7879 0 12.4237 0 0 0 0 0 0 0 13.2897 0 12.304 0 0 0 0 11.4918 12.4121 0 0 11.5528 12.985 0 0 11.4661 0 0 0 0 0 0 0 0 12.3582 0 0 0 0 0 0 0 0 0 0 0 16.9225 0 0 0 0 0 0 0 0 A6QL63 BTBDB_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein BTBD11 (BTB/POZ domain-containing protein 11) BTBD11 Homo sapiens (Human) SMAD protein signal transduction [GO:0060395] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein heterodimerization activity [GO:0046982]; SMAD protein signal transduction [GO:0060395] GO:0016021; GO:0046982; GO:0060395 protein heterodimerization activity [GO:0046982] ADDCFCASRK 0.99145 -21.994 0 0 11.9926 13.1617 12.0505 0 0 10.5945 0 0 0 11.8514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7294 11.1653 0 0 0 0 0 0 0 0 0 14.2245 0 12.2857 0 0 0 0 0 15.3982 13.1418 0 0 15.9144 0 0 14.992 15.3306 0 0 15.5456 15.2903 13.7228 15.0827 14.9618 0 0 0 15.3734 0 0 0 0 15.0204 12.2507 12.1575 15.0176 12.9159 14.9993 15.1482 0 0 15.2099 14.8526 14.8333 0 11.6425 15.054 15.2035 14.8232 0 0 0 0 14.6546 0 0 0 14.6255 0 0 0 0 14.0072 14.4428 0 0 0 11.3078 0 17.3938 0 0 0 0 14.4227 0 0 0 12.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6582 0 0 0 0 0 0 P12109 CO6A1_HUMAN Collagen alpha-1(VI) chain COL6A1 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; endodermal cell differentiation [GO:0035987]; osteoblast differentiation [GO:0001649] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]; cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; endodermal cell differentiation [GO:0035987]; osteoblast differentiation [GO:0001649] GO:0001649; GO:0005518; GO:0005576; GO:0005589; GO:0005615; GO:0005765; GO:0005788; GO:0007155; GO:0016020; GO:0030020; GO:0032991; GO:0035987; GO:0042383; GO:0048407; GO:0062023; GO:0070062; GO:0071230 collagen binding [GO:0005518]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407] AGIEIFVVVVGR 0.99145 -7.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 10.775 0 0 0 0 0 12.248 0 12.6959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1942 0 0 0 0 11.0776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1411 0 0 0 0 0 14.3637 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7569 0 0 0 0 0 0 0 12.0227 0 0 0 11.3591 0 0 0 0 0 0 11.1232 14.3542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.816 0 0 13.4291 0 0 11.3888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2488 0 0 0 0 0 0 13.2827 0 0 0 0 0 Q5VIR6 VPS53_HUMAN Vacuolar protein sorting-associated protein 53 homolog VPS53 PP13624 Homo sapiens (Human) "endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000938; GO:0005794; GO:0005829; GO:0007041; GO:0010008; GO:0015031; GO:0016020; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048471; GO:0055037; GO:1990745 AEKSEQMVKEITR 0.99145 -22.007 0 0 0 0 0 0 0 0 0 0 15.2688 0 0 0 0 0 0 0 0 0 13.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1444 0 0 0 0 0 0 0 0 0 0 0 0 10.7888 0 0 0 14.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0262 0 15.1986 0 0 0 0 0 0 0 0 0 0 17.2033 0 13.8971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.451 0 0 0 0 0 13.1171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8451 8.85403 0 0 0 0 0 0 0 0 Q7L4S7 ARMX6_HUMAN Protein ARMCX6 ARMCX6 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] GO:0005739; GO:0005741; GO:0016021 AHPIKQR 0.99145 -7.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4363 13.6651 13.2337 13.0329 0 0 0 0 0 13.5075 0 0 0 0 9.26479 0 0 0 0 0 0 0 0 0 0 0 12.6 14.1427 0 0 0 0 0 14.9626 0 13.3626 12.695 12.0769 0 13.2479 0 0 0 0 0 15.688 0 0 0 0 0 0 14.108 0 12.1867 0 0 13.8168 0 0 0 14.7087 13.1165 0 0 0 0 0 0 0 0 0 0 12.3712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYW4 ENTD1_HUMAN ENTH domain-containing protein 1 (Epsin-2B) ENTHD1 Homo sapiens (Human) endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897] GO:0005543; GO:0005768; GO:0005886; GO:0006897; GO:0030125; GO:0030276 clathrin binding [GO:0030276]; phospholipid binding [GO:0005543] FGRLHNKR 0.99145 -4.5244 0 0 0 0 0 10.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3809 0 13.7491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N865 CG031_HUMAN Uncharacterized protein C7orf31 C7orf31 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 IARLIQNR 0.99145 -19.065 0 0 0 0 11.6938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.982 0 0 0 0 15.9411 0 0 0 0 0 0 0 0 15.7518 0 0 0 0 0 0 0 0 0 0 0 15.2213 0 13.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6584 0 16.0085 15.8593 15.6469 0 0 16.5632 0 16.521 15.9963 0 0 0 0 0 0 0 0 0 16.3479 0 15.7857 15.8472 0 0 0 0 0 0 0 0 0 0 0 0 13.7244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1905 0 0 0 0 0 15.1946 0 Q8N9Z9 LMTD1_HUMAN Lamin tail domain-containing protein 1 (Intermediate filament tail domain-containing protein 1) LMNTD1 IFLTD1 Homo sapiens (Human) cell population proliferation [GO:0008283] cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635] cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; cell population proliferation [GO:0008283] GO:0005635; GO:0005737; GO:0005882; GO:0008283 ASPDCITILCKPNGQAIAWYTPIHWKQAWEK 0.99145 -7.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8537 0 0 0 0 0 0 10.9822 12.759 0 0 13.2455 12.8229 0 0 11.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92698 RAD54_HUMAN "DNA repair and recombination protein RAD54-like, EC 3.6.4.12 (RAD54 homolog, hHR54, hRAD54)" RAD54L RAD54A Homo sapiens (Human) determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic cell cycle [GO:0051321]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; metal ion binding [GO:0046872]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; meiotic cell cycle [GO:0051321]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410] GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0007131; GO:0008340; GO:0009410; GO:0010212; GO:0015616; GO:0016887; GO:0032991; GO:0036310; GO:0045003; GO:0046872; GO:0051321; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; metal ion binding [GO:0046872] ALSSCVVDEEQDVER 0.99145 -4.526 0 0 0 0 12.0938 0 0 0 13.4738 0 0 10.9694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0108 0 0 0 0 11.3561 0 0 0 0 0 0 12.4055 0 0 0 0 0 14.7439 14.0792 15.1727 0 0 14.0124 12.6496 0 0 15.5513 11.2188 0 0 0 0 0 0 0 15.6732 13.0002 14.6544 0 0 0 11.9786 0 0 0 0 0 14.7033 13.3355 0 14.7599 0 0 0 0 0 0 0 0 0 0 0 0 13.9054 0 13.7894 0 0 0 12.0795 0 0 0 0 0 0 0 0 0 0 12.5595 0 0 0 12.503 0 11.8971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99250 SCN2A_HUMAN Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2) SCN2A NAC2 SCN2A1 SCN2A2 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; membrane depolarization during action potential [GO:0086010]; memory [GO:0007613]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; T-tubule [GO:0030315]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cellular response to hypoxia [GO:0071456]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; membrane depolarization during action potential [GO:0086010]; memory [GO:0007613]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0005886; GO:0005887; GO:0006814; GO:0007399; GO:0007613; GO:0008627; GO:0014704; GO:0016020; GO:0019228; GO:0030315; GO:0030424; GO:0031226; GO:0033268; GO:0033270; GO:0034706; GO:0034765; GO:0035725; GO:0042552; GO:0051402; GO:0071456; GO:0086010; GO:0098978; GO:0099056 voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] AKDIGSENDFADDEHSTFEDNDSRR 0.99145 -48.467 0 0 0 0 0 12.2598 0 10.4436 0 12.3431 0 15.339 10.0665 0 11.9842 0 0 13.7683 0 13.8941 14.7445 0 13.3955 10.1886 0 0 0 0 0 0 13.1086 0 0 0 11.038 0 0 0 13.5839 13.4955 0 12.4461 16.8656 0 0 12.0701 17.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2189 0 11.3173 0 11.4375 0 12.6839 12.6389 15.9883 0 14.129 0 0 15.7784 0 0 13.749 16.1266 0 13.6305 0 16.5167 0 14.2148 0 15.3581 14.8251 0 16.5717 0 13.2812 14.8646 0 0 0 0 0 12.7536 0 14.5528 0 0 15.2837 0 16.9192 0 14.5246 0 0 15.0981 17.451 14.7209 0 0 12.8095 13.5359 0 0 0 0 14.637 13.994 0 13.5944 0 13.7969 12.0605 0 13.0457 15.6439 0 0 14.1943 16.4892 14.9722 0 12.4197 0 14.8241 0 13.1952 0 13.0375 0 0 13.261 11.7444 0 16.3136 18.338 12.5126 0 0 0 14.7687 10.276 10.8605 14.2374 13.1186 0 0 0 0 0 13.3834 15.13 15.4522 14.9081 0 15.7328 0 11.8881 0 Q9H6F5 CCD86_HUMAN Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain) CCDC86 CYCLON Homo sapiens (Human) chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730 RNA binding [GO:0003723] DFARHLEEEKER 0.99145 -7.1296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9299 0 0 0 0 12.3511 12.4886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3418 13.4119 13.0926 12.4448 13.1992 12.9178 0 0 0 0 0 0 12.5916 0 0 0 0 0 0 0 12.4941 12.6782 13.3635 0 10.9696 0 0 0 0 0 0 0 0 12.4389 0 0 0 0 0 0 0 10.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUW6 SPEM3_HUMAN Uncharacterized protein SPEM3 SPEM3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CEALSPR 0.99146 -22.802 0 0 0 0 0 0 0 0 0 0 0 0 11.9485 12.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3387 12.2311 12.2911 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1112 0 0 0 0 0 12.0415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3343 0 0 0 0 13.7916 0 0 14.3328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NLP5 TTC36_HUMAN "Tetratricopeptide repeat protein 36, TPR repeat protein 36 (HSP70-binding protein 21)" TTC36 HBP21 Homo sapiens (Human) central nervous system neuron development [GO:0021954]; cilium assembly [GO:0060271]; memory [GO:0007613]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein binding [GO:0032091]; negative regulation of protein polyubiquitination [GO:1902915]; tyrosine metabolic process [GO:0006570]; visual learning [GO:0008542] central nervous system neuron development [GO:0021954]; cilium assembly [GO:0060271]; memory [GO:0007613]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein binding [GO:0032091]; negative regulation of protein polyubiquitination [GO:1902915]; tyrosine metabolic process [GO:0006570]; visual learning [GO:0008542] GO:0006570; GO:0007613; GO:0008542; GO:0010801; GO:0021954; GO:0032091; GO:0032435; GO:0060271; GO:1902915 GLLARLQGR 0.99146 -4.5304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14492 SH2B2_HUMAN SH2B adapter protein 2 (Adapter protein with pleckstrin homology and Src homology 2 domains) (SH2 and PH domain-containing adapter protein APS) SH2B2 APS Homo sapiens (Human) antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556] GO:0005068; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0035556; GO:0035591; GO:0042169; GO:0050851; GO:0050853 SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] FRLEFFVPPK 0.99146 -4.5341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3293 0 0 0 0 0 0 0 0 0 0 0 0 0 14.689 0 13.082 0 O14904 WNT9A_HUMAN Protein Wnt-9a (Protein Wnt-14) WNT9A WNT14 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; embryonic skeletal joint development [GO:0072498]; iris morphogenesis [GO:0061072]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; neuron differentiation [GO:0030182] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; embryonic skeletal joint development [GO:0072498]; iris morphogenesis [GO:0061072]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; neuron differentiation [GO:0030182] GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0008285; GO:0030182; GO:0032331; GO:0045165; GO:0048018; GO:0060070; GO:0061072; GO:0061303; GO:0071300; GO:0072498 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] CHREKNCESICCGR 0.99146 -18.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.821 0 0 0 13.1519 0 0 0 14.1382 12.7206 0 0 0 0 11.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.503 0 10.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2983 0 0 0 0 0 0 0 0 0 0 0 P20908 CO5A1_HUMAN Collagen alpha-1(V) chain COL5A1 Homo sapiens (Human) "blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]" basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "basement membrane [GO:0005604]; collagen type V trimer [GO:0005588]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; collagen biosynthetic process [GO:0032964]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye morphogenesis [GO:0048592]; heart morphogenesis [GO:0003007]; integrin biosynthetic process [GO:0045112]; negative regulation of endodermal cell differentiation [GO:1903225]; regulation of cellular component organization [GO:0051128]; skin development [GO:0043588]; supramolecular fiber organization [GO:0097435]; tendon development [GO:0035989]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0001568; GO:0003007; GO:0005178; GO:0005201; GO:0005576; GO:0005588; GO:0005592; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0008201; GO:0016477; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0032964; GO:0035313; GO:0035989; GO:0043394; GO:0043588; GO:0045112; GO:0046872; GO:0048407; GO:0048592; GO:0051128; GO:0062023; GO:0097435; GO:1903225 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394] AAQPADLLKVLDFHNLPDGITK 0.99146 -22.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9392 0 0 0 0 0 0 0 12.6706 15.1343 0 0 0 0 0 0 0 0 0 0 0 14.2205 0 0 14.2832 0 0 11.9432 0 0 0 0 0 0 0 10.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9261 0 0 0 15.027 0 11.3316 13.7725 14.2001 0 13.8465 14.4687 13.7456 0 17.4625 0 0 0 12.9727 13.79 0 0 0 0 11.5868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0607 0 0 0 0 0 0 11.1715 0 0 0 0 0 0 0 12.7521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9453 0 P49795 RGS19_HUMAN "Regulator of G-protein signaling 19, RGS19 (G-alpha-interacting protein, GAIP)" RGS19 GAIP GNAI3IP Homo sapiens (Human) autophagy [GO:0006914]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to ethanol [GO:0045471]; small GTPase mediated signal transduction [GO:0007264] brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to ethanol [GO:0045471]; small GTPase mediated signal transduction [GO:0007264] GO:0001965; GO:0003924; GO:0005794; GO:0005886; GO:0005903; GO:0006914; GO:0007186; GO:0007264; GO:0009968; GO:0016020; GO:0030136; GO:0045121; GO:0045471 G-protein alpha-subunit binding [GO:0001965]; GTPase activity [GO:0003924] LIYEDYVSILSPKEVSLDSR 0.99146 -4.6797 0 0 0 0 0 0 0 0 12.6238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7708 0 0 0 0 12.1638 0 0 0 0 0 0 0 0 0 0 11.3282 0 0 0 0 11.2737 0 0 0 13.3538 0 0 0 0 0 0 14.1146 0 12.9698 0 0 0 0 0 0 0 0 0 0 13.5468 12.2598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9752 0 0 11.8342 0 0 0 0 0 0 12.3796 0 0 0 0 0 0 0 0 0 13.48 0 0 0 0 0 0 0 13.4049 0 10.4029 0 0 0 0 0 0 0 0 0 0 13.6321 0 0 0 0 0 0 0 0 0 0 11.2604 0 0 0 0 0 0 0 0 0 0 13.0755 0 Q68DC2 ANKS6_HUMAN "Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6, SAM domain-containing protein 6)" ANKS6 ANKRD14 PKDR1 SAMD6 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822] ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737] ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822] GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0097543 APGNSPCA 0.99146 -22.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4793 0 0 0 0 15.4275 0 0 11.8977 0 17.0963 0 0 10.7801 0 0 0 0 0 0 0 0 0 0 0 0 15.3001 0 14.7616 11.6985 0 0 0 0 0 0 12.5572 0 13.6385 13.2245 12.7014 0 0 0 0 0 0 11.2138 16.6301 11.3344 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9205 0 0 14.6222 0 0 0 0 0 0 0 11.1633 12.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4076 0 0 0 0 0 0 0 Q6P9F7 LRC8B_HUMAN "Volume-regulated anion channel subunit LRRC8B (Leucine-rich repeat-containing protein 8B) (T-cell activation leucine repeat-rich protein, TA-LRRP)" LRRC8B KIAA0231 UNQ6413/PRO21207 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; inorganic anion transport [GO:0015698] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; plasma membrane [GO:0005886]; anion transmembrane transport [GO:0098656]; inorganic anion transport [GO:0015698] GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015698; GO:0034702; GO:0098656 ILRLKFTEMGK 0.99146 -4.5335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.897 13.332 0 0 0 0 0 12.3419 0 0 0 0 0 0 0 0 11.2845 0 0 0 0 0 11.6556 0 0 11.8352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7LBC6 KDM3B_HUMAN "Lysine-specific demethylase 3B, EC 1.14.11.65 (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B)" KDM3B C5orf7 JHDM2B JMJD1B KIAA1082 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006325; GO:0006357; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0140683 chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] AGSSVDRKVPAESMPTLTPAFPR 0.99146 -4.6829 0 0 0 0 0 0 0 0 12.3059 0 0 0 0 0 12.4533 0 0 0 11.7604 13.0689 0 0 0 0 0 0 0 0 0 0 11.9336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7349 0 11.1428 0 12.4851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.438 14.1965 0 0 0 0 0 0 15.0949 14.8616 14.729 0 14.6274 0 0 14.9813 16.7185 14.161 11.0408 13.5902 14.6038 12.629 0 0 0 12.4831 11.6673 0 0 0 0 0 0 0 0 0 17.4042 13.9362 12.3714 12.3748 13.0676 0 15.0316 0 0 15.1205 13.9821 14.2465 0 0 0 14.0806 0 13.5691 14.3118 0 13.8578 0 0 0 0 11.9381 14.6542 0 12.372 0 0 13.8479 0 13.6448 0 13.73 0 0 0 0 13.9209 14.0179 16.3501 0 0 14.5364 13.013 0 12.6749 14.6796 0 0 14.5751 0 12.5429 0 0 14.14 0 14.1283 14.6942 0 0 0 0 0 0 15.5808 0 13.7496 13.9232 0 14.7722 0 0 0 0 0 Q8IUX8 EGFL6_HUMAN "Epidermal growth factor-like protein 6, EGF-like protein 6 (MAM and EGF domains-containing gene protein)" EGFL6 MAEG PP648 UNQ281/PRO320 Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020] basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005178; GO:0005509; GO:0005604; GO:0005615; GO:0007155; GO:0010811; GO:0016020; GO:0030154; GO:0030198 calcium ion binding [GO:0005509]; integrin binding [GO:0005178] CFPGYTGKTCSQDVNECGMK 0.99146 -22.159 0 0 0 0 0 0 0 0 0 11.0649 12.6958 0 0 0 0 0 0 0 0 0 0 0 0 0 10.795 0 0 0 11.1665 0 0 0 0 0 0 0 11.4121 11.0735 0 12.2383 0 0 11.0755 0 0 11.0378 0 10.8721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93264 0 0 10.2923 0 0 0 0 0 0 0 0 0 13.8548 0 14.16 0 0 0 14.3845 14.333 12.1574 11.5232 0 0 0 14.9956 13.9246 13.6962 12.7625 12.3638 0 0 0 0 0 0 0 0 0 0 0 0 12.7298 0 0 12.8653 0 0 12.3367 0 11.8032 11.989 13.07 0 0 0 12.6367 12.6044 0 0 0 0 10.8493 11.9915 0 0 12.0927 12.0414 0 0 12.2393 0 0 0 11.7443 0 0 0 11.3034 0 0 0 12.611 0 0 0 0 0 0 0 0 0 12.5488 0 0 0 0 14.3002 11.6725 0 0 11.7023 0 12.1342 0 11.6869 0 0 0 0 0 14.263 12.0621 Q8TAA1 RNS11_HUMAN "Probable ribonuclease 11, RNase 11, EC 3.1.27.-" RNASE11 C14orf6 UNQ5832/PRO19669 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830] extracellular region [GO:0005576] extracellular region [GO:0005576]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; defense response to Gram-positive bacterium [GO:0050830] GO:0003676; GO:0004519; GO:0005576; GO:0050830 endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676] EEFTDEEMQYDMAKSGQEK 0.99146 -4.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6132 0 15.4659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWY3 PRP31_HUMAN "U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein, Protein 61K, hPrp31)" PRPF31 PRP31 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]" Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690] "Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000244; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005684; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030621; GO:0030622; GO:0042802; GO:0043021; GO:0046540; GO:0070990; GO:0071005; GO:0071011; GO:0071166; GO:0071339; GO:0097526 identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622] ARISKTLQR 0.99146 -4.6758 0 0 0 0 0 0 0 0 0 0 0 0 12.7682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9489 0 0 0 0 13.6348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96F15 GIMA5_HUMAN "GTPase IMAP family member 5 (Immune-associated nucleotide-binding protein 5) (Immunity-associated nucleotide 4-like 1 protein) (Immunity-associated nucleotide 5 protein, IAN-5, hIAN5) (Immunity-associated protein 3)" GIMAP5 IAN4L1 IAN5 IMAP3 Homo sapiens (Human) integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; GTP binding [GO:0005525] GO:0005525; GO:0005765; GO:0016021; GO:0032585 GTP binding [GO:0005525] DLVRECER 0.99146 -7.1441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5418 0 0 0 0 10.7453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1082 0 0 0 0 0 0 0 0 0 0 0 0 10.6094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5667 0 0 14.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4742 0 0 12.2962 12.6907 13.1076 0 0 0 0 0 0 0 12.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8555 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTV5 FSD1_HUMAN Fibronectin type III and SPRY domain-containing protein 1 (MID1-related protein 1) (Microtubule-associated protein GLFND) FSD1 GLFND MIR1 VLP27 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of mitotic spindle organization [GO:0060236] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of mitotic spindle organization [GO:0060236] GO:0005634; GO:0005737; GO:0005813; GO:0005874; GO:0007049; GO:0008017; GO:0031122; GO:0032154; GO:0032465; GO:0042802; GO:0051301; GO:0051302; GO:0060236 identical protein binding [GO:0042802]; microtubule binding [GO:0008017] KIIKTLAVK 0.99146 -4.53 0 0 0 10.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1885 14.8105 0 0 0 0 0 0 0 0 0 0 13.4658 0 0 11.498 0 0 11.451 0 13.3614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.758 0 0 8.82544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9337 0 0 0 0 0 0 0 0 0 0 0 0 14.4041 0 0 0 0 0 13.5482 0 13.5393 0 0 Q9C037 TRIM4_HUMAN "E3 ubiquitin-protein ligase TRIM4, EC 2.3.2.27 (RING finger protein 87) (RING-type E3 ubiquitin transferase TRIM4) (Tripartite motif-containing protein 4)" TRIM4 RNF87 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0004842; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0010468; GO:0016567; GO:0042802; GO:0045087; GO:0061630 identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] EEEETKKK 0.99146 -50.611 0 0 0 0 0 0 12.6475 0 13.4842 0 0 0 0 0 0 0 0 0 0 0 12.1173 0 0 13.5458 0 0 0 0 0 0 12.5496 0 12.1761 0 0 0 0 0 0 0 0 0 0 0 0 0 13.744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4979 17.0027 0 0 0 0 0 15.4877 0 15.7551 15.619 15.6353 15.7119 14.314 13.9972 15.4931 15.7902 14.8767 14.9755 16.9833 15.5363 14.5214 16.416 16.3299 15.6463 14.2948 15.7813 0 0 0 14.9794 14.4793 0 14.3764 16.3952 15.5414 0 14.784 0 14.435 15.566 16.1419 15.7336 15.26 0 15.4931 15.2327 16.1667 0 14.2318 16.5793 15.455 16.1511 14.2761 14.446 15.0581 14.6 15.1161 14.4112 0 14.8528 16.1131 0 15.4143 15.9093 15.745 15.1146 14.1695 14.7073 0 15.4228 14.9473 15.1588 14.9457 0 15.9734 13.7625 14.1124 14.2628 15.9042 0 0 0 15.9575 0 14.2114 0 14.9426 14.2297 17.0508 0 14.0004 13.8318 0 0 14.6395 15.4375 0 13.895 0 0 0 0 0 16.1793 15.3333 14.202 14.3204 0 0 0 15.4691 15.6552 Q9HAJ7 SP30L_HUMAN Histone deacetylase complex subunit SAP30L (HCV non-structural protein 4A-transactivated protein 2) (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like) SAP30L NS4ATP2 Homo sapiens (Human) "negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription, DNA-templated [GO:0006355]" fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580] "fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000118; GO:0000122; GO:0001650; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0016580; GO:0030336; GO:0030512; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273; GO:1902455; GO:1902459 "DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]" SISQKKLK 0.99146 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P021 CRIPT_HUMAN "Cysteine-rich PDZ-binding protein (Cysteine-rich interactor of PDZ three, Cysteine-rich interactor of PDZ3)" CRIPT HSPC139 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; establishment of protein localization [GO:0045184]; protein localization to microtubule [GO:0035372]; regulation of postsynaptic density protein 95 clustering [GO:1902897] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; cytoplasmic microtubule organization [GO:0031122]; establishment of protein localization [GO:0045184]; protein localization to microtubule [GO:0035372]; regulation of postsynaptic density protein 95 clustering [GO:1902897] GO:0005737; GO:0008017; GO:0014069; GO:0030165; GO:0030425; GO:0031122; GO:0035372; GO:0043025; GO:0043197; GO:0043198; GO:0044877; GO:0045184; GO:0070161; GO:0097110; GO:1902897 microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110] ALTSKKAR 0.99146 -7.1493 13.6893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6764 0 0 0 0 0 14.5755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9256 0 0 0 0 0 0 0 0 0 0 13.675 13.8256 0 13.9976 0 0 0 0 14.2017 0 0 0 0 14.2525 0 0 14.4516 15.2836 14.0439 0 0 14.3704 0 0 14.3697 13.9919 0 0 0 0 16.1701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JM4 LRIQ1_HUMAN Leucine-rich repeat and IQ domain-containing protein 1 LRRIQ1 KIAA1801 Homo sapiens (Human) microtubule cytoskeleton [GO:0015630] microtubule cytoskeleton [GO:0015630] GO:0015630 ASSIPTIRIPFK 0.99147 -51.423 11.6249 0 0 15.5153 0 0 0 12.9206 13.922 0 0 0 0 12.5867 0 13.0783 13.5067 13.3127 13.5554 13.0294 0 10.8257 13.1801 0 0 13.1935 13.5497 13.1828 13.5877 13.5852 12.8602 0 13.0782 0 0 0 0 14.5865 0 0 0 13.8416 13.6881 12.8243 0 13.3867 14.1677 0 16.6774 11.9986 16.4117 0 0 0 0 0 0 14.8428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1927 14.8105 0 13.3333 12.1906 11.7083 12.8885 13.8446 11.6893 14.0678 13.9294 14.928 0 17.8457 15.8425 0 14.9516 14.9778 0 0 0 0 13.7119 0 0 0 13.1161 13.2022 0 13.2161 13.1258 13.4161 0 0 0 0 0 15.4459 0 15.013 18.0457 0 0 0 13.9416 0 0 14.5731 0 12.4868 14.2942 13.6862 14.8384 15.8965 0 13.1783 0 0 13.2788 13.2091 14.3171 14.4707 0 0 0 0 0 14.4573 0 0 15.1984 0 0 0 0 0 16.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6549 0 0 13.962 13.0237 15.8317 15.4612 0 0 0 0 14.8186 A0A1B0GUI7 BRDOS_HUMAN Putative uncharacterized protein BRD3OS (BRD3 opposite strand protein) (Long intergenic non-protein coding RNA 94) (Non-protein coding RNA 94) BRD3OS LINC00094 NCRNA00094 Homo sapiens (Human) ALSEGYAR 0.99147 -7.1508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14730 RIOK3_HUMAN "Serine/threonine-protein kinase RIO3, EC 2.7.11.1 (RIO kinase 3) (sudD homolog)" RIOK3 SUDD Homo sapiens (Human) cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; protein phosphorylation [GO:0006468] "cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; protein phosphorylation [GO:0006468]" GO:0004674; GO:0005524; GO:0005829; GO:0006468; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786 ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AGIPCPTVVLLK 0.99147 -22.245 0 0 0 0 0 0 0 0 12.5505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8033 11.377 0 0 0 0 0 0 0 0 0 0 0 0 11.5212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1818 0 13.2347 0 0 0 12.892 13.2915 12.9747 0 13.0909 0 0 0 13.4862 0 13.2122 0 0 0 13.7792 13.4552 0 0 0 13.4147 0 0 0 13.6001 0 0 0 13.0512 0 0 0 0 0 0 0 0 0 12.6049 0 0 12.5795 12.362 0 0 0 0 0 0 0 0 0 0 11.5311 0 0 0 0 0 0 0 0 0 0 0 O43148 MCES_HUMAN "mRNA cap guanine-N7 methyltransferase, EC 2.1.1.56 (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase, hCMT1, hMet, hcm1p)" RNMT KIAA0398 Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830] fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235] fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830] GO:0001650; GO:0003723; GO:0004482; GO:0005634; GO:0005654; GO:0005845; GO:0006370; GO:0031533; GO:0043235; GO:1990830 mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723] DCGDAEGNSK 0.99147 -23.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5481 0 0 0 0 11.177 0 0 0 0 13.5814 0 0 13.7627 0 0 0 0 15.5027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2472 0 0 0 0 13.9525 0 0 0 0 0 0 0 0 0 0 0 0 12.506 0 0 0 0 12.2684 0 0 12.4604 0 0 0 0 0 15.978 0 0 0 0 12.424 10.8517 0 0 0 0 14.443 0 0 0 0 0 0 10.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75121 MFA3L_HUMAN Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9) MFAP3L KIAA0626 HSD-39 HSD39 Homo sapiens (Human) cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0016021; GO:0030054 AFEIAKRIPIITSAK 0.99147 -22.949 0 0 0 0 0 0 0 0 0 0 11.3657 0 0 0 0 0 0 0 9.91329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0175 0 0 0 0 0 0 0 13.4374 0 0 0 0 0 0 0 0 0 0 14.4235 0 0 0 0 0 0 0 0 0 0 11.2722 0 0 0 0 0 0 0 0 0 0 0 0 12.1867 0 11.8901 0 0 0 0 12.9021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3039 0 0 0 P23470 PTPRG_HUMAN "Receptor-type tyrosine-protein phosphatase gamma, Protein-tyrosine phosphatase gamma, R-PTP-gamma, EC 3.1.3.48" PTPRG PTPG Homo sapiens (Human) brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; brain development [GO:0007420]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; protein dephosphorylation [GO:0006470]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004725; GO:0005001; GO:0005887; GO:0006470; GO:0007169; GO:0007420; GO:0010633; GO:0010977; GO:0042802; GO:0070062 identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] CDQYWPTENSEEYGNIIVTLKSTK 0.99147 -22.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7114 0 0 13.1945 13.3442 12.9731 0 0 13.1105 0 12.909 0 0 13.197 0 12.9129 0 0 0 17.2006 17.0293 0 0 0 0 13.0527 0 0 0 0 0 0 13.39 0 0 0 0 0 0 0 0 0 0 0 0 17.302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4965 14.0121 13.6959 13.4246 13.8265 0 0 0 11.7662 0 0 0 0 0 0 13.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1168 0 0 0 0 0 0 0 0 0 0 14.5941 0 14.0604 0 0 0 0 14.5986 13.4015 0 13.1274 13.7181 13.5555 0 0 0 13.1181 13.5773 0 13.2302 0 13.4807 0 0 13.7484 0 0 0 0 0 0 14.5662 0 0 0 12.338 0 0 0 17.1959 13.747 0 0 0 0 0 13.5529 0 13.3167 0 0 0 0 0 0 P40763 STAT3_HUMAN Signal transducer and activator of transcription 3 (Acute-phase response factor) STAT3 APRF Homo sapiens (Human) "astrocyte differentiation [GO:0048708]; cell population proliferation [GO:0008283]; cellular response to hormone stimulus [GO:0032870]; cellular response to interleukin-17 [GO:0097398]; cellular response to leptin stimulus [GO:0044320]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; eye photoreceptor cell differentiation [GO:0001754]; glucose homeostasis [GO:0042593]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular receptor signaling pathway [GO:0030522]; leptin-mediated signaling pathway [GO:0033210]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of glycolytic process [GO:0045820]; negative regulation of neuron migration [GO:2001223]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of metalloendopeptidase activity [GO:1904685]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein import into nucleus [GO:0006606]; radial glial cell differentiation [GO:0060019]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of feeding behavior [GO:0060259]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to leptin [GO:0044321]; response to peptide hormone [GO:0043434]; retinal rod cell differentiation [GO:0060221]; sexual reproduction [GO:0019953]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 17 type immune response [GO:0072538]; temperature homeostasis [GO:0001659]; transforming growth factor beta receptor signaling pathway [GO:0007179]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; primary miRNA binding [GO:0070878]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; astrocyte differentiation [GO:0048708]; cell population proliferation [GO:0008283]; cellular response to hormone stimulus [GO:0032870]; cellular response to interleukin-17 [GO:0097398]; cellular response to leptin stimulus [GO:0044320]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; eye photoreceptor cell differentiation [GO:0001754]; glucose homeostasis [GO:0042593]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular receptor signaling pathway [GO:0030522]; leptin-mediated signaling pathway [GO:0033210]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of glycolytic process [GO:0045820]; negative regulation of neuron migration [GO:2001223]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of metalloendopeptidase activity [GO:1904685]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein import into nucleus [GO:0006606]; radial glial cell differentiation [GO:0060019]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of feeding behavior [GO:0060259]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to leptin [GO:0044321]; response to peptide hormone [GO:0043434]; retinal rod cell differentiation [GO:0060221]; sexual reproduction [GO:0019953]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 17 type immune response [GO:0072538]; temperature homeostasis [GO:0001659]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001659; GO:0001754; GO:0003677; GO:0003700; GO:0004879; GO:0005102; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006355; GO:0006357; GO:0006606; GO:0006952; GO:0006954; GO:0007165; GO:0007179; GO:0007259; GO:0007399; GO:0008283; GO:0008285; GO:0010507; GO:0010628; GO:0010629; GO:0016310; GO:0019221; GO:0019901; GO:0019903; GO:0019953; GO:0030335; GO:0030522; GO:0031490; GO:0032355; GO:0032731; GO:0032733; GO:0032755; GO:0032757; GO:0032760; GO:0032870; GO:0033210; GO:0035019; GO:0035591; GO:0040014; GO:0042127; GO:0042593; GO:0042755; GO:0042789; GO:0042802; GO:0042803; GO:0043434; GO:0044320; GO:0044321; GO:0045648; GO:0045747; GO:0045766; GO:0045820; GO:0045893; GO:0045944; GO:0046983; GO:0048708; GO:0051092; GO:0051726; GO:0060019; GO:0060221; GO:0060259; GO:0060396; GO:0060397; GO:0061629; GO:0070102; GO:0070878; GO:0072538; GO:0072540; GO:0090575; GO:0097009; GO:0097398; GO:0140297; GO:1900017; GO:1902895; GO:1904685; GO:1905564; GO:2000635; GO:2000637; GO:2000737; GO:2001223 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; primary miRNA binding [GO:0070878]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]" EQRCGNGGR 0.99147 -4.5586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8558 0 0 0 12.4296 9.68477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2897 19.3062 0 20.1222 0 0 0 0 12.4305 0 11.5447 0 15.9423 0 18.6587 0 16.734 12.2523 0 0 0 14.2736 0 0 12.6254 0 0 14.813 0 12.1427 0 0 0 17.0619 0 0 13.115 0 0 0 0 13.1455 0 0 0 11.8032 15.3526 0 0 0 11.8814 0 0 0 0 0 0 10.8123 0 12.8962 0 0 0 13.5299 0 0 0 0 13.89 0 0 0 0 13.8757 0 13.6008 13.5615 0 0 0 11.3249 0 0 0 0 0 0 0 0 0 P68106 FKB1B_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP1B, PPIase FKBP1B, EC 5.2.1.8 (12.6 kDa FK506-binding protein, 12.6 kDa FKBP, FKBP-12.6) (FK506-binding protein 1B, FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12)" FKBP1B FKBP12.6 FKBP1L FKBP9 OTK4 Homo sapiens (Human) 'de novo' protein folding [GO:0006458]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; chaperone-mediated protein folding [GO:0061077]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of sequestering of calcium ion [GO:0051284]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098] calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; 'de novo' protein folding [GO:0006458]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; chaperone-mediated protein folding [GO:0061077]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of sequestering of calcium ion [GO:0051284]; protein maturation by protein folding [GO:0022417]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098] GO:0000413; GO:0003755; GO:0005102; GO:0005528; GO:0005737; GO:0005829; GO:0006458; GO:0006939; GO:0007204; GO:0010459; GO:0010880; GO:0010881; GO:0016020; GO:0019227; GO:0019855; GO:0022417; GO:0030018; GO:0030551; GO:0032515; GO:0033017; GO:0033197; GO:0034704; GO:0035584; GO:0035773; GO:0042026; GO:0042098; GO:0042542; GO:0044325; GO:0048680; GO:0051209; GO:0051280; GO:0051284; GO:0051480; GO:0051775; GO:0060314; GO:0060315; GO:0061077; GO:0061179; GO:0086064 calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] PFKFRIGK 0.99147 -7.1493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78316 NOP14_HUMAN Nucleolar protein 14 (Nucleolar complex protein 14) NOP14 C4orf9 NOL14 RES4-25 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]" 90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]" GO:0000447; GO:0000462; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0019899; GO:0030490; GO:0030515; GO:0030686; GO:0030692; GO:0032040; GO:0042274 enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515] ALGKNSELLVVSAR 0.99147 -22.954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5256 0 0 16.6651 0 17.048 0 0 0 0 16.8301 0 13.3813 16.5282 0 0 0 0 0 0 0 0 0 0 0 14.952 0 14.0016 0 0 0 15.05 0 15.0017 13.9209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.184 12.8177 0 0 0 0 0 Q15904 VAS1_HUMAN "V-type proton ATPase subunit S1, V-ATPase subunit S1 (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1)" ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; endosome to plasma membrane protein transport [GO:0099638]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; osteoclast development [GO:0036035]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar acidification [GO:0007035] anchoring junction [GO:0070161]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672]; small GTPase binding [GO:0031267]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; endosome to plasma membrane protein transport [GO:0099638]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; osteoclast development [GO:0036035]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; vacuolar acidification [GO:0007035] GO:0000139; GO:0005765; GO:0005789; GO:0005886; GO:0006879; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016021; GO:0016469; GO:0030641; GO:0030665; GO:0030672; GO:0031267; GO:0033116; GO:0033176; GO:0036035; GO:0036295; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:0070161; GO:0099638; GO:1902600 small GTPase binding [GO:0031267] NVLLFLQDK 0.99147 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JXB2 UE2NL_HUMAN Putative ubiquitin-conjugating enzyme E2 N-like (Epididymis tissue protein Li 174) UBE2NL Homo sapiens (Human) protein polyubiquitination [GO:0000209] extracellular exosome [GO:0070062]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005634; GO:0061631; GO:0070062 ubiquitin conjugating enzyme activity [GO:0061631] AELPHRIIKETQR 0.99147 -4.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2789 0 0 0 0 0 0 0 0 0 11.5308 0 0 0 0 0 15.6898 0 0 0 0 0 0 0 10.7343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66K64 DCA15_HUMAN DDB1- and CUL4-associated factor 15 DCAF15 C19orf72 Homo sapiens (Human) immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; metal ion binding [GO:0046872]; small molecule binding [GO:0036094]; immune system process [GO:0002376]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of natural killer cell activation [GO:0032814] GO:0000209; GO:0002376; GO:0016567; GO:0032814; GO:0036094; GO:0046872; GO:0080008 metal ion binding [GO:0046872]; small molecule binding [GO:0036094] GRNLRPMR 0.99147 -22.238 0 0 0 0 0 0 0 0 0 0 0 0 14.8673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6WRI0 IGS10_HUMAN "Immunoglobulin superfamily member 10, IgSF10 (Calvaria mechanical force protein 608, CMF608)" IGSF10 CMF608 Homo sapiens (Human) cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222] extracellular region [GO:0005576] extracellular region [GO:0005576]; cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222] GO:0001503; GO:0005576; GO:0030154; GO:2001222 IDHKQYFRK 0.99147 -51.898 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9003 11.0729 0 0 0 0 10.3968 0 13.5501 0 13.488 0 11.4422 0 0 0 0 0 0 0 0 12.0511 0 0 0 0 0 0 10.7522 10.4282 0 0 0 11.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8414 0 0 0 15.1282 0 15.1345 0 14.8808 14.4339 16.0022 13.148 0 0 14.92 0 13.3444 0 12.9396 13.4371 0 0 0 0 0 0 0 14.7279 14.7844 15.1408 0 0 15.1858 15.5129 15.7035 14.8699 14.9044 0 12.5615 12.7137 0 0 13.2705 0 13.3697 14.0549 12.8296 0 0 0 15.0456 0 13.9178 0 0 13.2388 0 0 13.5498 14.5845 0 0 0 13.9454 13.9676 0 12.8084 0 0 13.0241 0 0 14.1105 0 0 12.7981 0 0 15.1079 0 0 0 0 0 0 13.5341 13.5001 13.6715 14.0626 0 13.8689 13.5103 0 0 0 13.4726 12.9159 13.0504 13.7762 15.9364 0 0 13.4157 0 0 14.1538 0 12.7022 Q71F56 MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like) MED13L KIAA1025 PROSIT240 THRAP2 TRAP240L Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] mediator complex [GO:0016592] mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003712; GO:0006357; GO:0016592 transcription coregulator activity [GO:0003712] ASLHHHISVAQTDELLPARNSQRVPHPLDSK 0.99147 -51.694 0 0 0 0 11.1527 0 10.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94945 0 0 0 14.5752 0 12.7727 0 0 0 0 10.7265 15.0713 0 13.2014 15.9175 12.8876 0 14.5277 0 0 0 0 12.2251 13.6026 0 0 0 12.4293 0 0 0 0 0 0 15.5369 0 0 0 14.0182 0 0 15.2159 0 0 12.9475 0 0 0 10.7686 0 0 0 0 14.1865 0 0 13.8026 13.6329 0 0 0 9.86936 0 13.2361 0 0 0 0 13.1042 0 0 14.4854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5601 0 0 0 0 0 0 0 0 0 0 13.2796 0 Q86UY5 FA83A_HUMAN Protein FAM83A (Tumor antigen BJ-TSA-9) (Tumor-specific gene expressed in prostate protein) FAM83A TSGP Homo sapiens (Human) cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; cell population proliferation [GO:0008283]; epidermal growth factor receptor signaling pathway [GO:0007173]; signal transduction [GO:0007165] GO:0005737; GO:0007165; GO:0007173; GO:0008283; GO:0019901; GO:0036312; GO:0042802 identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901] HNNIRDLVR 0.99147 -7.5056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2978 0 0 Q8NGE7 OR9K2_HUMAN Olfactory receptor 9K2 (Olfactory receptor OR12-2) OR9K2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] FLEKKNIIL 0.99147 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAX9 GSDMB_HUMAN "Gasdermin-B (Gasdermin-like protein) [Cleaved into: Gasdermin-B, N-terminal, GSDMB-NT, p30; Gasdermin-B, C-terminal, GSDMB-CT, p16 ]" GSDMB GSDML PP4052 PRO2521 Homo sapiens (Human) cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; defense response to bacterium [GO:0042742]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; pyroptosis [GO:0070269] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; defense response to bacterium [GO:0042742]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; pyroptosis [GO:0070269]" GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0016021; GO:0019835; GO:0022829; GO:0042742; GO:0070269; GO:0070273; GO:0140507; GO:1902483 "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; wide pore channel activity [GO:0022829]" DQVKSVMEQNWDELASSPPDMDYDPEAR 0.99147 -7.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5727 0 0 0 10.9835 0 0 0 0 9.98342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4455 0 0 0 0 0 0 0 0 11.5366 0 0 0 0 0 0 0 0 0 15.6336 13.4295 0 0 0 0 12.8103 11.0938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2285 0 0 12.2351 0 0 0 0 0 0 0 0 0 0 10.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1587 0 0 13.1331 0 0 0 12.6006 0 0 0 0 0 0 0 0 0 Q8WVN6 SCTM1_HUMAN Secreted and transmembrane protein 1 (Protein K-12) SECTM1 K12 Homo sapiens (Human) immune response [GO:0006955]; mesoderm development [GO:0007498]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; immune response [GO:0006955]; mesoderm development [GO:0007498]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005125; GO:0005615; GO:0005794; GO:0005886; GO:0006955; GO:0007498; GO:0016021; GO:0043123; GO:0070062 cytokine activity [GO:0005125] CRCSQQR 0.99147 -4.6987 0 10.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0141 0 0 0 0 0 0 0 0 11.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92805 GOGA1_HUMAN Golgin subfamily A member 1 (Golgin-97) GOLGA1 Homo sapiens (Human) acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802] GO:0000139; GO:0001669; GO:0005794; GO:0005802; GO:0005829; GO:0048471 AVSVLLNFSQEEENMLKETLEYK 0.99147 -23.712 0 0 0 0 0 0 0 0 0 0 0 0 13.7021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0665 0 0 0 0 14.9423 0 0 0 0 12.7952 12.7578 0 0 0 12.1341 0 0 0 0 0 0 0 0 0 0 0 0 12.8416 0 14.0021 0 13.4015 14.3509 13.4675 13.5204 0 0 0 0 13.2738 0 0 0 0 0 0 0 0 12.3845 12.9065 0 0 0 0 0 0 0 0 12.7378 12.5589 0 0 13.3228 0 0 13.5156 0 0 0 0 0 0 0 0 13.1726 11.8103 0 13.2317 0 0 13.4327 13.0058 0 0 0 0 0 0 13.3696 0 0 13.3712 0 0 0 0 0 11.3349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92993 KAT5_HUMAN "Histone acetyltransferase KAT5, EC 2.3.1.48 (60 kDa Tat-interactive protein, Tip60) (Histone acetyltransferase HTATIP, HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5, EC 2.3.1.-) (Protein acetyltransferase KAT5, EC 2.3.1.-) (Protein crotonyltransferase KAT5, EC 2.3.1.-) (cPLA(2)-interacting protein)" KAT5 HTATIP TIP60 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular senescence [GO:0090398]; chromatin organization [GO:0006325]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone exchange [GO:1900051]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of protein acetylation [GO:1901985]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of triglyceride biosynthetic process [GO:0010867]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H2A histone acetyltransferase activity [GO:0043998]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H2A-K5 specific) [GO:0043999]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular senescence [GO:0090398]; chromatin organization [GO:0006325]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone exchange [GO:1900051]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of protein acetylation [GO:1901985]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of triglyceride biosynthetic process [GO:0010867]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to ionizing radiation [GO:0010212]; spermatid development [GO:0007286]" GO:0000122; GO:0000132; GO:0000724; GO:0000776; GO:0000786; GO:0000812; GO:0003682; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005829; GO:0006289; GO:0006302; GO:0006325; GO:0006915; GO:0006974; GO:0006978; GO:0007286; GO:0010212; GO:0010508; GO:0010867; GO:0016407; GO:0016573; GO:0018394; GO:0021915; GO:0022008; GO:0032703; GO:0032777; GO:0035267; GO:0040008; GO:0042149; GO:0042393; GO:0042753; GO:0042981; GO:0043161; GO:0043231; GO:0043967; GO:0043968; GO:0043998; GO:0043999; GO:0045087; GO:0045591; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046972; GO:0048471; GO:0051726; GO:0061733; GO:0062033; GO:0071333; GO:0071392; GO:0090398; GO:0097431; GO:0106226; GO:0140064; GO:0140065; GO:0140297; GO:1900051; GO:1901985; GO:1902036; GO:1902425; GO:1905168; GO:1905691; GO:2000779 acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H2A histone acetyltransferase activity [GO:0043998]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H2A-K5 specific) [GO:0043999]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] AVAAQPGRK 0.99147 -23.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.44 0 0 0 0 0 0 0 13.1529 0 0 0 11.772 11.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.04 0 0 0 0 12.8683 13.2135 12.3492 0 13.8333 0 0 0 0 0 0 0 0 0 12.8932 0 13.043 13.4495 0 0 14.2519 0 0 13.185 0 0 0 0 0 0 12.7841 0 13.2445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9536 0 0 0 12.8132 13.354 13.0905 0 0 0 0 0 19.0313 0 0 0 0 0 0 0 0 12.4721 0 0 12.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9127 0 0 0 0 0 0 0 0 Q96A08 H2B1A_HUMAN "Histone H2B type 1-A (Histone H2B, testis, TSH2B.1, hTSH2B) (Testis-specific histone H2B)" H2BC1 HIST1H2BA TSH2B Homo sapiens (Human) "inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; positive regulation of binding [GO:0051099]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" "chromosome, telomeric region [GO:0000781]; extrinsic component of plasma membrane [GO:0019897]; female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; extrinsic component of plasma membrane [GO:0019897]; female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; inflammatory response [GO:0006954]; mononuclear cell migration [GO:0071674]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; plasminogen activation [GO:0031639]; positive regulation of binding [GO:0051099]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" GO:0000781; GO:0000786; GO:0001674; GO:0003677; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0006954; GO:0019897; GO:0030527; GO:0031639; GO:0035093; GO:0042393; GO:0046982; GO:0051099; GO:0071674 DNA binding [GO:0003677]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] EIQTAVRLLLPGELAK 0.99147 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MN2 NALP4_HUMAN "NACHT, LRR and PYD domains-containing protein 4 (Cancer/testis antigen 58, CT58) (PAAD and NACHT-containing protein 2, PAN2) (PYRIN and NACHT-containing protein 2) (PYRIN-containing APAF1-like protein 4, PYPAF4) (Ribonuclease inhibitor 2)" NLRP4 NALP4 PAN2 PYPAF4 RNH2 Homo sapiens (Human) inflammatory response [GO:0006954]; regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; inflammatory response [GO:0006954]; regulation of inflammatory response [GO:0050727] GO:0005524; GO:0005737; GO:0005829; GO:0006954; GO:0050727 ATP binding [GO:0005524] ALTHTDCR 0.99147 -22.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1835 0 0 0 0 0 0 0 0 12.1565 0 10.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0059 0 11.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3281 12.7295 0 0 13.7092 0 0 0 0 0 14.7373 0 13.8563 0 12.9467 13.019 13.1676 13.2734 14.0478 14.2303 0 0 0 0 13.99 0 0 14.0937 0 13.833 0 0 0 12.8453 16.057 14.7614 14.8883 0 14.4067 0 0 0 12.3763 15.3654 0 14.3086 13.6353 12.7841 14.2168 0 13.0555 0 0 0 0 0 0 0 0 12.8427 12.5084 12.0135 0 0 0 12.5811 0 0 11.0955 0 0 0 0 0 0 0 10.9856 0 0 0 0 0 15.5075 0 0 14.6324 0 0 0 12.9153 0 12.7694 0 0 0 0 0 0 0 13.855 0 0 Q9BXX2 AN30B_HUMAN Ankyrin repeat domain-containing protein 30B (Serologically defined breast cancer antigen NY-BR-1.1) ANKRD30B Homo sapiens (Human) ASLTPLLLAIQK 0.99147 -22.218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7677 0 0 0 13.5595 13.1097 0 0 0 0 0 0 14.0533 12.8392 14.088 0 0 0 0 0 0 0 0 0 0 12.7499 0 12.5867 0 0 0 0 0 0 0 0 0 0 0 13.4761 0 0 0 0 12.713 0 0 0 0 0 0 0 0 13.2614 0 0 0 0 0 0 13.0775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H295 DCSTP_HUMAN "Dendritic cell-specific transmembrane protein, DC-STAMP, hDC-STAMP (Dendrocyte-expressed seven transmembrane protein) (IL-four-induced protein, FIND) (Transmembrane 7 superfamily member 4)" DCSTAMP TM7SF4 Homo sapiens (Human) cellular response to interleukin-4 [GO:0071353]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to tumor necrosis factor [GO:0071356]; membrane fusion [GO:0061025]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell growth [GO:0030308]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of bone resorption [GO:0045780]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of monocyte differentiation [GO:0045657] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellular response to interleukin-4 [GO:0071353]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to tumor necrosis factor [GO:0071356]; membrane fusion [GO:0061025]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell growth [GO:0030308]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of bone resorption [GO:0045780]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of monocyte differentiation [GO:0045657] GO:0005789; GO:0005886; GO:0009986; GO:0010008; GO:0016021; GO:0030176; GO:0030308; GO:0030316; GO:0033116; GO:0034241; GO:0036006; GO:0043011; GO:0045657; GO:0045780; GO:0061025; GO:0071353; GO:0071356; GO:0072675 FLLSETWVPLSVILLILVMLGLLSSILMQLK 0.99147 -23.73 0 0 0 14.5305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8189 0 0 0 0 12.6854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9414 0 0 0 0 0 0 0 0 0 0 0 0 12.9171 0 0 0 13.916 0 0 0 0 14.5092 13.8338 0 16.6015 0 0 0 0 12.8902 0 0 0 0 0 0 0 13.3238 13.4074 0 13.1647 0 0 0 0 0 0 0 0 0 0 0 14.7868 0 13.6175 11.8443 12.4566 0 0 12.595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5619 0 0 0 0 0 13.0001 0 Q9UBL0 ARP21_HUMAN "cAMP-regulated phosphoprotein 21, ARPP-21 (Thymocyte cAMP-regulated phosphoprotein)" ARPP21 TARPP Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; nucleic acid binding [GO:0003676] GO:0003676; GO:0005516; GO:0005737 calmodulin binding [GO:0005516]; nucleic acid binding [GO:0003676] FPQMSSYQR 0.99147 -7.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7422 0 0 0 0 0 0 11.6583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2906 0 0 0 0 0 0 0 Q9UBY5 LPAR3_HUMAN "Lysophosphatidic acid receptor 3, LPA receptor 3, LPA-3 (Lysophosphatidic acid receptor Edg-7)" LPAR3 EDG7 LPA3 Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bleb assembly [GO:0032060]; chemical synaptic transmission [GO:0007268]; collateral sprouting [GO:0048668]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gene expression [GO:0010467]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; regulation of metabolic process [GO:0019222]" axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; lysophosphatidic acid receptor activity [GO:0070915]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bleb assembly [GO:0032060]; chemical synaptic transmission [GO:0007268]; collateral sprouting [GO:0048668]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gene expression [GO:0010467]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; regulation of metabolic process [GO:0019222]" GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0007187; GO:0007189; GO:0007204; GO:0007268; GO:0008289; GO:0010467; GO:0019222; GO:0030424; GO:0032060; GO:0043410; GO:0045202; GO:0048668; GO:0048672; GO:0070915 G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; lysophosphatidic acid receptor activity [GO:0070915] HMDFFYNR 0.99147 -7.5089 0 0 0 0 11.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9957 0 11.0379 0 0 0 0 0 0 0 0 0 10.5623 0 0 0 0 10.6876 0 0 10.6369 0 0 0 0 0 12.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.118 0 0 0 0 0 0 10.7586 0 12.8018 0 0 0 0 0 11.8642 0 0 13.7085 0 0 0 0 0 0 12.925 11.6412 0 0 0 11.1144 0 0 0 14.296 0 0 0 0 0 0 0 14.28 13.5631 13.4722 0 12.5558 0 0 0 0 0 0 0 0 0 0 0 0 11.224 11.7416 0 0 0 0 0 11.046 0 0 0 0 12.7414 13.1255 0 0 0 0 0 13.3995 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2Y9 KLF13_HUMAN "Krueppel-like factor 13 (Basic transcription element-binding protein 3, BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1, RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1)" KLF13 BTEB3 NSLP1 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of erythrocyte differentiation [GO:0045647]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0045647; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AVVHGPR 0.99147 -23.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0552 0 0 0 0 0 0 12.7379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6994 0 0 0 11.4471 0 0 0 0 0 14.2381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0579 Q9Y620 RA54B_HUMAN "DNA repair and recombination protein RAD54B, EC 3.6.4.- (RAD54 homolog B)" RAD54B Homo sapiens (Human) determination of adult lifespan [GO:0008340]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; hydrolase activity [GO:0016787]; RNA helicase activity [GO:0003724]; determination of adult lifespan [GO:0008340]; double-strand break repair via homologous recombination [GO:0000724]; mitotic recombination [GO:0006312]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410] GO:0000724; GO:0003677; GO:0003678; GO:0003724; GO:0005524; GO:0005634; GO:0006312; GO:0007131; GO:0008340; GO:0009410; GO:0010212; GO:0015616; GO:0016787; GO:0140658 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; hydrolase activity [GO:0016787]; RNA helicase activity [GO:0003724] CFSNPFK 0.99147 -22.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8438 0 0 13.5865 0 0 0 0 0 0 0 0 13.7305 0 0 0 0 13.4709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2478 13.2226 0 14.2931 0 0 0 0 0 0 0 0 0 0 0 0 11.9977 14.8713 0 0 0 13.9632 0 0 15.673 0 0 0 0 0 0 0 0 0 0 12.9566 0 14.3037 0 0 0 0 13.4693 0 15.2722 12.5582 0 13.9699 0 14.1407 13.5153 0 14.3859 14.2435 14.3509 0 16.0074 11.2008 12.5298 0 0 0 13.687 0 15.0416 0 0 0 0 14.8504 13.9198 0 0 12.262 0 0 14.6723 0 0 14.5831 0 13.4282 0 0 0 0 0 14.3083 0 0 0 0 0 0 14.6835 0 0 0 0 0 0 0 0 0 0 15.192 12.9434 0 0 0 0 0 0 0 Q8IVE3 PKHH2_HUMAN Pleckstrin homology domain-containing family H member 2 PLEKHH2 KIAA2028 Homo sapiens (Human) negative regulation of actin filament depolymerization [GO:0030835] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; negative regulation of actin filament depolymerization [GO:0030835] GO:0003779; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016604; GO:0030027; GO:0030835; GO:0030864 actin binding [GO:0003779] AELSEPEGPVDWKER 0.99148 -53.6 0 0 0 0 0 10.9212 0 0 0 0 0 0 0 0 9.96824 0 0 14.3831 0 0 0 11.8863 12.9465 11.9164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.283 0 0 0 0 0 0 13.0903 12.3059 0 0 0 0 0 0 0 0 10.5244 0 0 0 0 0 14.3401 14.1505 13.4533 13.5934 13.8784 13.4898 15.3301 17.2364 12.432 16.2544 15.6838 12.9766 0 16.1991 0 16.3544 0 16.146 16.1741 0 0 0 14.4259 13.6457 16.6615 0 16.4334 15.9297 16.4569 0 17.7094 0 15.1991 13.592 14.5912 0 14.7394 0 14.7363 13.4197 13.6799 10.7781 12.4749 15.0249 13.8608 14.5379 14.6617 16.102 14.5581 15.7911 12.5858 17.6047 16.0173 16.4176 15.4886 15.3624 14.1916 14.6382 0 14.3073 15.1345 0 14.0248 0 0 16.3853 15.127 0 13.4718 17.2347 15.3194 13.18 14.4526 15.7253 14.6163 0 16.3703 0 0 0 13.4551 0 0 14.8411 14.9803 12.3765 15.0069 15.7039 14.2315 14.5115 0 0 0 0 13.1752 13.4118 11.1744 0 0 0 11.6124 0 14.954 0 0 0 16.752 0 0 16.8193 0 0 0 P16234 PGFRA_HUMAN "Platelet-derived growth factor receptor alpha, PDGF-R-alpha, PDGFR-alpha, EC 2.7.10.1 (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2, PDGFR-2) (CD antigen CD140a)" PDGFRA PDGFR2 RHEPDGFRA Homo sapiens (Human) adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060] cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] cell junction [GO:0030054]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BBSome binding [GO:0062063]; growth factor binding [GO:0019838]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021]; adrenal gland development [GO:0030325]; cardiac myofibril assembly [GO:0055003]; cell activation [GO:0001775]; cell chemotaxis [GO:0060326]; cellular response to amino acid stimulus [GO:0071230]; cellular response to reactive oxygen species [GO:0034614]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; estrogen metabolic process [GO:0008210]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; hematopoietic progenitor cell differentiation [GO:0002244]; in utero embryonic development [GO:0001701]; Leydig cell differentiation [GO:0033327]; lung development [GO:0030324]; luteinization [GO:0001553]; male genitalia development [GO:0030539]; metanephric glomerular capillary formation [GO:0072277]; negative regulation of platelet activation [GO:0010544]; odontogenesis of dentin-containing tooth [GO:0042475]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; protein autophosphorylation [GO:0046777]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of chemotaxis [GO:0050920]; regulation of mesenchymal stem cell differentiation [GO:2000739]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060] GO:0001553; GO:0001701; GO:0001775; GO:0002244; GO:0004672; GO:0004714; GO:0005018; GO:0005021; GO:0005161; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0005929; GO:0007169; GO:0007204; GO:0008210; GO:0008284; GO:0009897; GO:0010544; GO:0010863; GO:0014068; GO:0016020; GO:0018108; GO:0019838; GO:0023019; GO:0030054; GO:0030198; GO:0030324; GO:0030325; GO:0030335; GO:0030539; GO:0031226; GO:0032991; GO:0033327; GO:0033674; GO:0034614; GO:0035790; GO:0038085; GO:0038091; GO:0042060; GO:0042475; GO:0042803; GO:0043235; GO:0043552; GO:0046777; GO:0048008; GO:0048015; GO:0048146; GO:0048407; GO:0048557; GO:0048701; GO:0048704; GO:0050872; GO:0050920; GO:0055003; GO:0060021; GO:0060325; GO:0060326; GO:0061298; GO:0062063; GO:0070374; GO:0070527; GO:0071230; GO:0072277; GO:2000249; GO:2000739 ATP binding [GO:0005524]; BBSome binding [GO:0062063]; growth factor binding [GO:0019838]; platelet-derived growth factor alpha-receptor activity [GO:0005018]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021] AYPPPRISWLK 0.99148 -22.42 0 0 0 0 0 0 0 0 0 0 11.0868 0 0 0 10.8685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8475 0 0 0 0 0 10.5499 10.9511 0 12.5934 11.483 0 0 0 11.2383 0 15.6415 12.1052 0 0 0 0 0 11.2395 0 11.5563 0 0 12.4298 16.1125 0 0 15.0853 14.3406 0 18.9448 0 0 12.6113 13.4265 0 0 0 11.0199 0 0 0 11.8637 0 0 0 0 0 0 0 11.8997 0 0 10.5563 0 0 0 0 10.2417 0 0 0 0 0 0 11.5506 0 0 13.0442 11.0844 0 0 11.2114 12.0458 0 0 0 0 0 0 11.429 13.6569 0 0 0 0 0 0 12.9903 0 0 0 0 0 0 0 11.5379 0 0 0 0 0 0 12.3323 0 11.1246 0 0 0 0 0 10.9247 0 0 13.1474 0 0 0 10.6501 0 0 0 13.3336 9.7904 0 P24557 THAS_HUMAN "Thromboxane-A synthase, TXA synthase, TXS, EC 5.3.99.5 (Cytochrome P450 5A1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)" TBXAS1 CYP5 CYP5A1 TXAS Homo sapiens (Human) cellular chloride ion homeostasis [GO:0030644]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; thromboxane-A synthase activity [GO:0004796]; cellular chloride ion homeostasis [GO:0030644]; cyclooxygenase pathway [GO:0019371]; icosanoid metabolic process [GO:0006690]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]" GO:0001516; GO:0004497; GO:0004796; GO:0005506; GO:0005783; GO:0005789; GO:0005829; GO:0006690; GO:0016021; GO:0016705; GO:0019371; GO:0020037; GO:0030644; GO:0036134; GO:0045471; GO:0045907; GO:0070542; GO:0106256 "12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; thromboxane-A synthase activity [GO:0004796]" CYCNYTTDVVASVAFGTPVDSWQAPEDPFVK 0.99148 -7.1682 0 13.7514 0 0 0 0 0 10.6931 0 0 0 0 0 0 0 0 0 0 12.218 0 11.4286 0 0 13.2686 0 11.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9322 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4467 0 0 0 0 0 0 0 0 0 0 12.5586 0 12.9698 0 0 0 0 0 0 0 0 0 0 11.8782 0 11.0037 0 0 13.3606 0 11.5925 0 0 0 0 0 0 0 0 13.2962 13.7585 12.7926 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3219 0 0 0 13.2488 0 13.3681 10.6036 0 0 0 0 0 0 0 0 0 13.3699 0 0 0 0 0 0 0 0 0 0 0 0 11.7522 0 0 0 0 0 0 0 0 0 0 0 P49788 TIG1_HUMAN "Retinoic acid receptor responder protein 1 (Phorbol ester-induced gene 1 protein, PERG-1) (RAR-responsive protein TIG1) (Tazarotene-induced gene 1 protein)" RARRES1 PEIG1 TIG1 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; metalloendopeptidase inhibitor activity [GO:0008191]; negative regulation of cell population proliferation [GO:0008285] GO:0005615; GO:0008191; GO:0008285; GO:0016021; GO:0070062 metalloendopeptidase inhibitor activity [GO:0008191] IHLVWYPGKPLKVK 0.99148 -4.5754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57682 KLF3_HUMAN Krueppel-like factor 3 (Basic krueppel-like factor) (CACCC-box-binding protein BKLF) (TEF-2) KLF3 BKLF Homo sapiens (Human) cellular response to peptide [GO:1901653]; hemopoiesis [GO:0030097]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to peptide [GO:1901653]; hemopoiesis [GO:0030097]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0006357; GO:0030097; GO:0046872; GO:1901653; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CDYDGCNK 0.99148 -1.8129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1904 0 0 0 13.7841 0 0 0 0 0 0 0 P78325 ADAM8_HUMAN "Disintegrin and metalloproteinase domain-containing protein 8, ADAM 8, EC 3.4.24.- (Cell surface antigen MS2) (CD antigen CD156a)" ADAM8 MS2 Homo sapiens (Human) angiogenesis [GO:0001525]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cellular response to hypoxia [GO:0071456]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein processing [GO:0010954]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; proteolysis [GO:0006508]; regulation of cell-cell adhesion [GO:0022407] alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dense core granule membrane [GO:0032127]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; podosome [GO:0002102]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule [GO:0070820]; tertiary granule membrane [GO:0070821] alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dense core granule membrane [GO:0032127]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; phagolysosome [GO:0032010]; plasma membrane [GO:0005886]; podosome [GO:0002102]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule [GO:0070820]; tertiary granule membrane [GO:0070821]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cellular response to hypoxia [GO:0071456]; extracellular matrix disassembly [GO:0022617]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of fibronectin-dependent thymocyte migration [GO:2000415]; positive regulation of innate immune response [GO:0045089]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein processing [GO:0010954]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; proteolysis [GO:0006508]; regulation of cell-cell adhesion [GO:0022407] GO:0000902; GO:0001525; GO:0002102; GO:0002523; GO:0002675; GO:0002693; GO:0004222; GO:0004252; GO:0005509; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0006954; GO:0008237; GO:0008270; GO:0009986; GO:0010954; GO:0022407; GO:0022617; GO:0032010; GO:0032127; GO:0033089; GO:0035579; GO:0042581; GO:0043406; GO:0043524; GO:0043621; GO:0045089; GO:0045780; GO:0045785; GO:0048247; GO:0050714; GO:0050839; GO:0051044; GO:0051092; GO:0051897; GO:0070245; GO:0070820; GO:0070821; GO:0071133; GO:0071456; GO:0098609; GO:0101003; GO:2000309; GO:2000391; GO:2000415; GO:2000418 calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] CCNSTTCQLAEGAQCAHGTCCQECK 0.99148 -4.7063 0 0 0 0 0 0 0 0 0 0 0 12.5129 12.445 0 0 0 10.6669 9.44104 0 0 11.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90047 0 12.7614 0 11.9646 0 0 0 0 0 12.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4506 0 0 0 12.8214 12.925 0 10.7541 0 0 14.1996 0 15.0563 0 12.5301 0 0 0 0 0 12.1411 0 14.2976 0 0 12.8431 12.5604 0 10.4443 0 10.7635 0 0 0 0 0 0 13.8995 16.3143 0 0 0 0 0 0 10.0604 0 12.9663 0 13.5032 12.3237 0 0 0 13.89 10.7757 0 13.0934 0 0 11.8509 0 11.0109 0 0 0 10.8107 0 0 0 0 0 0 9.42162 0 15.429 0 0 0 0 13.0841 0 12.9488 0 12.996 0 0 0 13.0692 0 14.4066 14.3263 15.0899 0 0 0 0 0 0 0 0 11.2017 0 0 0 13.1221 Q13099 IFT88_HUMAN "Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737 homolog) (Tetratricopeptide repeat protein 10, TPR repeat protein 10)" IFT88 TG737 TTC10 Homo sapiens (Human) cilium assembly [GO:0060271]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; sperm flagellum [GO:0036126] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; sperm flagellum [GO:0036126]; kinesin binding [GO:0019894]; cilium assembly [GO:0060271]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017] GO:0001822; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0019894; GO:0030992; GO:0031514; GO:0035720; GO:0036064; GO:0036126; GO:0042073; GO:0045724; GO:0060122; GO:0060271; GO:0097542; GO:0097546; GO:0097730; GO:1902017; GO:1905515; GO:2000785 kinesin binding [GO:0019894] EQRIKSGR 0.99148 -5.5706 0 0 0 0 0 0 0 0 0 0 11.3828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5172 12.3472 0 0 0 0 0 0 0 0 0 0 12.2729 0 0 0 12.1437 12.1553 0 12.7202 0 0 0 0 14.5516 0 0 0 0 0 0 0 0 12.8529 0 0 0 12.4371 0 0 0 10.9759 0 0 0 0 0 0 0 11.9589 0 0 0 0 0 0 11.1297 0 0 0 0 0 0 0 0 0 0 0 12.0425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4119 0 0 0 14.2633 14.0642 0 0 0 0 0 0 0 0 0 0 0 13.1981 0 13.4915 0 0 Q13434 MKRN4_HUMAN "Putative E3 ubiquitin-protein ligase makorin-4, EC 2.3.2.27 (Makorin RING finger protein pseudogene 4) (Makorin RING finger protein pseudogene 5) (RING finger protein 64) (RING-type E3 ubiquitin transferase makorin-4) (Zinc finger protein 127-Xp, ZNF127-Xp) (Zinc finger protein 127-like 1)" MKRN4P MKRN4 MKRNP5 RNF64 ZNF127L1 Homo sapiens (Human) protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567] GO:0016567; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] CEHSKPLK 0.99148 -7.1719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8103 10.5683 0 12.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5477 0 0 0 0 0 0 0 0 0 0 0 12.4477 0 13.9157 14.6583 0 15.4251 0 0 0 0 0 12.2749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1775 0 11.0429 0 0 0 0 12.1648 0 0 0 0 0 0 0 16.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3449 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1168 0 0 0 0 0 0 0 0 0 0 0 0 11.367 0 0 0 0 0 0 0 0 0 0 0 Q58WW2 DCAF6_HUMAN "DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein, ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein, NRIP)" DCAF6 IQWD1 MSTP055 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0016567; GO:0030374; GO:0045944; GO:0080008 nuclear receptor coactivator activity [GO:0030374] DDILINCR 0.99148 -23.763 0 0 0 0 17.7287 0 17.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8136 13.0075 0 14.1793 13.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3902 0 0 0 15.5314 18.8252 0 0 0 0 14.7068 0 16.2219 0 0 12.8477 0 12.4034 12.3406 0 10.9781 0 0 0 15.2264 0 0 0 0 18.7408 0 0 14.5953 12.3075 0 0 0 15.3194 16.6537 12.5922 14.3826 10.7394 14.4954 11.4019 0 0 0 0 0 0 0 14.7277 0 11.4005 0 0 0 14.5255 14.2632 15.6988 15.0251 15.5461 0 0 0 0 0 0 0 12.0419 0 14.4942 16.6514 16.0445 15.3781 0 0 0 14.5564 0 0 0 0 11.8127 0 0 16.6731 15.1125 15.0924 0 11.5539 0 0 0 11.96 0 0 11.1936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68CL5 TPGS2_HUMAN "Tubulin polyglutamylase complex subunit 2, PGs2" TPGS2 C18orf10 HMFN0601 L17 Homo sapiens (Human) protein polyglutamylation [GO:0018095] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; protein polyglutamylation [GO:0018095] GO:0005737; GO:0005815; GO:0005874; GO:0018095 HMISSWEQKNNCVMPEDVKNFYLMTNGFHMTWSVK 0.99148 -4.5768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7808 0 0 0 0 0 0 10.2588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1385 0 0 0 0 0 0 0 0 0 0 13.9608 0 0 0 0 11.1988 0 Q8N0S2 SYCE1_HUMAN "Synaptonemal complex central element protein 1 (Cancer/testis antigen 76, CT76)" SYCE1 C10orf94 Homo sapiens (Human) cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694]; synaptonemal complex [GO:0000795] central element [GO:0000801]; chromosome [GO:0005694]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; synaptonemal complex assembly [GO:0007130] GO:0000795; GO:0000801; GO:0005694; GO:0007130; GO:0051301 DLWDFHMPER 0.99148 -7.5292 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7147 11.9966 0 0 0 0 0 0 0 14.1075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3482 0 12.8547 12.855 0 0 0 13.113 0 0 11.3708 0 0 0 0 12.9243 0 0 0 14.0008 0 0 15.668 16.8291 16.8143 0 0 15.2817 15.0894 14.7024 14.1914 0 14.0637 0 14.3376 13.9565 0 0 14.9178 14.0205 13.8506 13.8359 0 16.5931 0 0 0 0 0 15.2581 0 15.336 14.5276 0 0 14.9038 15.258 18.6206 0 0 0 0 14.449 13.852 0 0 14.706 0 0 0 0 14.2798 0 0 0 0 0 16.2657 0 15.4807 15.2467 15.1086 16.2893 15.7498 14.7346 15.8795 14.8597 0 15.944 13.7546 15.8874 14.6896 14.7374 0 0 0 0 0 14.4001 15.2242 0 0 0 0 0 0 0 0 14.5154 0 0 0 0 0 0 0 0 0 0 15.0412 14.0493 0 15.0384 0 0 0 13.9187 0 Q8N4F4 S22AO_HUMAN Steroid transmembrane transporter SLC22A24 (Solute carrier family 22 member 24) SLC22A24 Homo sapiens (Human) organic anion transport [GO:0015711]; steroid metabolic process [GO:0008202]; sterol transmembrane transport [GO:0035382] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; organic anion transport [GO:0015711]; steroid metabolic process [GO:0008202]; sterol transmembrane transport [GO:0035382] GO:0008202; GO:0015711; GO:0016021; GO:0022857; GO:0035382 transmembrane transporter activity [GO:0022857] IKTSIFSLFRAPK 0.99148 -7.5277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N998 CCD89_HUMAN Coiled-coil domain-containing protein 89 (Bc8 orange-interacting protein) CCDC89 BOIP Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 AQGEYSR 0.99148 -7.1695 11.3811 0 0 0 0 0 0 0 0 0 0 0 0 9.76842 0 0 0 0 0 0 0 0 0 0 12.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.77 10.838 0 12.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4137 0 0 0 0 0 14.5117 0 0 0 0 0 0 0 14.2843 0 0 12.7036 0 0 0 0 12.9691 0 0 0 0 0 0 0 0 14.9559 0 0 12.9413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9938 14.1948 10.9259 0 0 0 0 0 0 0 0 0 0 12.9202 0 13.2194 11.4049 0 0 0 0 0 0 10.5833 10.9377 0 0 0 0 0 0 0 11.3068 0 0 0 0 11.4468 0 0 0 0 0 0 0 0 0 0 0 Q8WY21 SORC1_HUMAN "VPS10 domain-containing receptor SorCS1, hSorCS" SORCS1 SORCS Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuropeptide receptor activity [GO:0008188]; neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892] GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020; GO:0016021 neuropeptide receptor activity [GO:0008188] AERGEGASRSPR 0.99148 -4.8592 0 0 0 0 0 0 0 0 0 13.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0564 0 0 0 0 10.8465 11.0993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4671 13.644 0 0 0 0 0 0 0 0 12.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.545 0 0 0 12.4156 13.1666 0 0 0 0 0 0 0 0 0 12.8598 0 0 0 15.1425 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7104 0 0 0 12.6033 0 0 13.095 0 0 0 0 0 0 0 0 10.2616 0 0 0 0 0 0 0 0 0 0 12.3456 0 0 0 11.5356 0 0 0 0 0 0 0 0 0 0 0 12.2361 0 0 0 11.5786 Q9P258 RCC2_HUMAN Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa) RCC2 KIAA1470 TD60 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027] "chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]" "chromosome, centromeric core domain [GO:0034506]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]" GO:0003723; GO:0005085; GO:0005730; GO:0005829; GO:0005874; GO:0005886; GO:0007049; GO:0007229; GO:0008017; GO:0010762; GO:0010971; GO:0019901; GO:0019904; GO:0030334; GO:0030496; GO:0031267; GO:0031901; GO:0034260; GO:0034506; GO:0045184; GO:0048041; GO:0051301; GO:0051895; GO:0051987; GO:0072356; GO:0090630; GO:1900025; GO:1900027; GO:1990023 guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] CSSSSGGGSSGDEDGLELDGAPGGGKR 0.99148 -7.5259 0 0 0 0 0 0 0 0 17.0713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4007 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.062 16.5544 0 16.6623 0 0 0 0 0 0 16.2375 0 0 0 0 0 0 0 0 11.9108 0 0 0 0 13.6505 0 0 0 0 12.0719 0 0 0 0 0 0 0 0 13.2926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5294 0 13.5261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3226 0 0 0 0 0 O75962 TRIO_HUMAN "Triple functional domain protein, EC 2.7.11.1 (PTPRF-interacting protein)" TRIO Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007185; GO:0007411; GO:0007417; GO:0019898; GO:0042995; GO:0045599; GO:0048812; GO:0051056; GO:0106310 ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EEDWCGGADK 0.99149 -7.3747 0 0 0 0 0 0 0 0 13.3117 0 0 12.8097 13.4081 0 12.3503 10.4746 10.0329 0 10.2277 0 0 0 0 11.6622 0 0 0 0 0 0 10.3539 0 0 0 10.2423 0 11.8155 0 12.2217 10.6988 0 9.475 0 0 13.2185 0 0 0 0 0 0 0 0 0 11.1467 11.3173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4349 0 0 0 0 0 0 0 0 0 0 15.6235 0 16.1479 19.3498 12.613 0 0 0 0 0 11.6489 10.789 0 13.993 14.0624 0 0 10.552 10.6231 0 15.3168 0 14.4219 0 0 0 0 0 11.1709 0 14.5887 13.6602 0 11.7218 0 0 0 16.9858 13.1459 11.124 0 15.7545 0 15.6603 14.7897 0 12.6016 0 0 0 11.6615 14.6808 0 0 0 0 14.3452 0 14.6762 0 0 12.0042 0 15.3265 0 0 12.4961 15.0838 11.8019 0 0 0 0 0 0 0 12.2206 0 0 0 0 11.234 0 0 0 0 0 0 0 0 0 0 13.902 0 13.0355 11.4468 12.0908 11.5248 O94810 RGS11_HUMAN "Regulator of G-protein signaling 11, RGS11" RGS11 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0003924; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0008277; GO:0009968; GO:0031681; GO:0032991; GO:0035556; GO:0043005; GO:0043547 G-protein beta-subunit binding [GO:0031681]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] DPRSLMLRPDETPYR 0.99149 -4.5923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25098 ARBK1_HUMAN "Beta-adrenergic receptor kinase 1, Beta-ARK-1, EC 2.7.11.15 (G-protein coupled receptor kinase 2)" GRK2 ADRBK1 BARK BARK1 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; regulation of the force of heart contraction [GO:0002026]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079] anchoring junction [GO:0070161]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] anchoring junction [GO:0070161]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of catecholamine secretion [GO:0033605]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; regulation of the force of heart contraction [GO:0002026]; tachykinin receptor signaling pathway [GO:0007217]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079] GO:0001664; GO:0002026; GO:0002029; GO:0003108; GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007186; GO:0007213; GO:0007217; GO:0007507; GO:0009966; GO:0016020; GO:0018105; GO:0018107; GO:0019079; GO:0031623; GO:0031694; GO:0031755; GO:0033605; GO:0045988; GO:0046718; GO:0047696; GO:0060048; GO:0070161; GO:0098793; GO:0098794; GO:1901081 alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672] CLLLKIRGGK 0.99149 -4.8773 0 0 0 0 0 0 0 0 14.4321 0 0 0 13.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6333 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2681 0 0 15.1862 14.9618 0 14.3026 0 14.3477 0 0 0 0 0 0 0 0 0 0 0 14.9926 0 15.2229 0 0 0 0 0 0 14.5084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6582 14.3855 0 13.7822 14.1485 0 0 0 0 0 0 14.2506 14.3389 0 0 0 14.2829 0 0 14.3973 0 14.0611 15.3197 0 0 0 0 14.2362 0 0 0 0 13.8582 0 0 13.5819 0 0 0 0 0 0 0 0 0 15.2524 12.6095 0 0 11.3044 0 0 13.6264 0 0 13.8274 0 0 0 0 0 Q03701 CEBPZ_HUMAN "CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor, CBF, CCAAT-binding factor)" CEBPZ CBF2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634] CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003713; GO:0003723; GO:0005634; GO:0016602; GO:0045944 RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] ADIVLRR 0.99149 -48.305 0 0 0 0 11.5971 0 0 0 0 0 0 10.9313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1606 0 14.0473 0 0 0 10.9588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7008 0 0 13.1124 0 0 0 0 13.6659 0 11.4979 13.9809 0 0 0 0 15.4726 0 13.8574 0 0 0 0 0 0 0 0 0 0 0 0 14.7681 0 0 0 0 0 0 0 11.2878 15.314 0 0 0 0 12.1567 0 0 10.8946 0 0 0 0 0 0 0 0 0 10.717 0 14.1561 0 0 0 0 0 0 0 0 15.3572 0 0 0 0 0 13.3556 0 0 0 0 0 0 0 0 0 12.1263 13.9382 0 Q08629 TICN1_HUMAN Testican-1 (Protein SPOCK) SPOCK1 SPOCK TIC1 TICN1 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system neuron differentiation [GO:0021953]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; regulation of cell growth [GO:0001558] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; central nervous system neuron differentiation [GO:0021953]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; regulation of cell growth [GO:0001558] GO:0001558; GO:0001764; GO:0004867; GO:0004869; GO:0005509; GO:0005615; GO:0005737; GO:0007155; GO:0007399; GO:0008191; GO:0010812; GO:0010951; GO:0010977; GO:0014069; GO:0016528; GO:0021953; GO:0022008; GO:0031594; GO:0033268 calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867] DKYWNRFR 0.99149 -22.553 14.0582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4104 0 0 11.4031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4104 0 0 0 10.8831 0 0 11.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2202 0 11.0753 0 0 0 12.2062 11.9716 0 0 0 0 0 0 0 0 0 0 0 13.8246 0 0 11.8625 0 0 0 0 0 0 12.4637 0 0 12.7718 12.5654 0 12.0131 10.615 12.0571 0 0 0 12.0608 0 0 0 0 0 0 0 0 0 12.806 0 12.2875 0 0 0 0 14.0153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.499 0 12.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1105 0 0 0 0 0 0 Q15024 EXOS7_HUMAN Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8) EXOSC7 KIAA0116 RRP42 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042; GO:0101019 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723] AALFNTRIPRVR 0.99149 -4.8786 0 0 0 14.1581 0 0 0 12.9011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2946 11.4278 0 15.1288 0 14.1659 0 14.1302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5105 14.8857 0 0 0 0 0 12.9 15.3124 0 0 0 0 0 0 0 12.7626 0 0 0 12.1825 0 12.232 0 12.6479 13.3749 17.7274 12.0281 17.4819 12.1767 0 12.6282 0 0 0 12.7936 0 17.8522 13.5521 13.527 0 0 10.2015 0 0 0 0 0 0 0 13.3249 0 0 0 11.2509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5FBB7 SGO1_HUMAN Shugoshin 1 (Serologically defined breast cancer antigen NY-BR-85) (Shugoshin-like 1) SGO1 SGOL1 Homo sapiens (Human) "attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiotic chromosome segregation [GO:0045132]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; mitotic sister chromatid segregation [GO:0000070]" "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]" "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; chromosome segregation [GO:0007059]; homologous chromosome segregation [GO:0045143]; meiotic chromosome segregation [GO:0045132]; meiotic sister chromatid cohesion [GO:0051177]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; mitotic sister chromatid segregation [GO:0000070]" GO:0000070; GO:0000775; GO:0000776; GO:0000779; GO:0000922; GO:0005654; GO:0005813; GO:0005829; GO:0007059; GO:0008608; GO:0010457; GO:0019900; GO:0045132; GO:0045143; GO:0051177; GO:0051301; GO:0071962 kinase binding [GO:0019900] ASPAVALPKR 0.99149 -23.229 0 0 0 11.1607 10.9189 0 0 0 0 0 0 0 0 0 0 11.8285 11.9621 0 0 11.9446 0 0 0 0 0 0 12.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.25 0 12.2339 0 14.3088 10.999 0 11.3673 0 0 12.9706 0 0 0 12.1515 0 0 11.396 0 0 0 0 0 0 0 0 0 13.5457 11.4963 0 0 0 0 0 0 16.0765 0 0 0 0 0 15.4084 13.6589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2671 0 0 18.3575 0 0 13.4969 0 0 14.4343 0 14.2737 0 0 0 0 0 0 0 14.0895 0 0 0 0 Q68DK7 MSL1_HUMAN "Male-specific lethal 1 homolog, MSL-1 (Male-specific lethal 1-like 1, MSL1-like 1) (Male-specific lethal-1 homolog 1)" MSL1 MSL1L1 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0016607; GO:0043984; GO:0045893; GO:0072487; GO:1900095 chromatin binding [GO:0003682] CRLEIQK 0.99149 -48.455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6688 0 0 15.6087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1236 0 0 0 0 0 0 0 0 13.4936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6789 0 0 0 Q6NXT1 ANR54_HUMAN Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein) ANKRD54 LIAR Homo sapiens (Human) nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877]; nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531]; regulation of protein kinase activity [GO:0045859] GO:0005634; GO:0005737; GO:0006913; GO:0019887; GO:0030496; GO:0044877; GO:0045648; GO:0045859; GO:1902531 protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877] MAAAAGDADDEPR 0.99149 -18.991 0 10.4199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5109 0 0 0 13.1924 0 0 13.1062 0 13.6487 0 0 12.7367 0 0 0 0 0 0 0 0 0 0 0 0 12.916 0 0 0 0 0 0 0 12.6544 0 0 0 0 0 0 0 0 0 0 0 0 11.4714 0 0 0 0 0 0 0 12.8772 0 13.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8797 0 0 0 0 0 0 0 0 14.3053 0 14.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8593 Q6ZWB6 KCTD8_HUMAN BTB/POZ domain-containing protein KCTD8 KCTD8 Homo sapiens (Human) protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] anchoring junction [GO:0070161]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235] anchoring junction [GO:0070161]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260; GO:0070161 KHDKVTDK 0.99149 -7.3741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4859 0 0 0 0 0 12.9073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76N32 CEP68_HUMAN "Centrosomal protein of 68 kDa, Cep68" CEP68 KIAA0582 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; protein localization to organelle [GO:0033365] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; protein localization to organelle [GO:0033365] GO:0005654; GO:0005813; GO:0005829; GO:0007098; GO:0010457; GO:0019901; GO:0019904; GO:0030054; GO:0033365; GO:0034451 protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901] KDIDEHQSLTESVLQKGEILLQCLLENTPVLEDVLGR 0.99149 -23.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5197 0 0 0 0 0 0 0 16.4034 0 0 0 0 0 0 11.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0916 0 0 0 0 0 Q8IUL8 CILP2_HUMAN "Cartilage intermediate layer protein 2, CILP-2 [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2 ]" CILP2 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] GO:0005615; GO:0070062 CFDGSSDGFSR 0.99149 -23.244 0 0 16.4266 0 0 0 0 0 14.5849 13.6284 0 13.7207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7557 13.7168 0 0 0 0 0 0 0 0 0 12.8204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0736 0 0 0 0 0 0 0 0 0 13.2865 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVV7 GID4_HUMAN Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog) GID4 C17orf39 VID24 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] ubiquitin ligase complex [GO:0000151] ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0000151; GO:0043161; GO:0061630 ubiquitin protein ligase activity [GO:0061630] AGGRPSR 0.99149 -23.263 0 0 0 0 0 0 0 0 0 0 0 0 11.3971 0 11.5078 0 0 0 0 0 0 0 11.8161 0 0 0 0 11.325 10.5833 0 0 0 11.5215 0 0 11.7016 0 11.7258 0 0 0 0 0 0 11.4792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5502 0 0 0 0 0 0 0 0 18.2067 0 0 0 0 12.1007 0 0 0 0 0 0 0 12.1577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8688 0 0 0 0 0 0 10.7534 0 0 0 11.9225 0 0 0 0 0 0 0 0 0 12.1536 0 0 0 0 0 0 12.3187 0 0 0 0 0 0 12.6714 0 12.7164 12.6477 0 0 0 11.7887 0 11.9021 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYE1 CCD13_HUMAN Coiled-coil domain-containing protein 13 CCDC13 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515] cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515] GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515 AALGSALRGK 0.99149 -7.3755 0 0 0 0 0 0 0 0 14.7764 15.8088 16.055 15.0306 15.4261 14.3764 14.9598 0 0 0 0 0 0 0 11.8911 0 0 0 0 13.5209 0 0 0 14.8848 0 0 13.3898 0 0 0 0 0 13.4365 0 0 0 13.7013 0 0 0 0 0 0 11.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0529 13.6457 0 13.9789 0 0 0 0 0 0 13.1823 14.5017 14.5406 14.3366 14.3166 0 13.409 13.8308 13.8198 0 0 14.1841 15.2668 0 0 13.4503 13.5265 13.5689 13.6826 14.6794 13.3144 14.633 0 14.3311 0 0 0 0 14.3325 13.2061 13.2621 0 0 0 12.5366 14.2976 0 13.4436 0 13.1208 13.7021 12.4131 12.8096 13.412 12.7563 0 0 0 0 14.3985 13.5898 13.3844 0 0 0 13.3863 0 0 14.2375 13.8729 0 0 0 13.5084 0 13.8019 0 0 0 0 0 0 11.889 0 13.4409 0 0 13.6566 13.6361 0 0 13.6218 13.1132 0 13.5761 0 17.7965 0 12.7864 13.9726 13.7521 17.8073 0 0 0 13.4391 0 14.3778 0 0 0 12.7134 0 0 Q8N456 LRC18_HUMAN Leucine-rich repeat-containing protein 18 LRRC18 UNQ9338/PRO34010 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 CQNARDNLNRIK 0.99149 -23.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7925 12.7105 0 0 0 0 0 0 0 0 12.9428 0 0 12.5982 0 0 0 13.0473 10.9352 0 14.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6951 12.1214 0 0 13.5625 0 0 13.1442 13.6203 0 0 0 13.0703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1735 13.1943 0 0 0 0 14.6522 15.1882 0 0 0 0 0 12.9904 0 13.2393 0 0 0 0 0 0 0 0 0 14.0367 14.3706 0 14.5402 13.7536 13.0107 0 13.2903 13.4065 13.7587 12.8816 13.6101 0 0 0 0 13.4234 0 0 0 13.9135 0 13.0255 13.2049 0 0 0 0 0 13.27 13.7263 0 0 0 0 0 13.201 0 0 0 0 11.2442 12.6718 0 0 13.2233 0 0 0 0 0 13.9197 14.4108 0 12.8018 0 0 0 0 Q8NFW1 COMA1_HUMAN Collagen alpha-1(XXII) chain COL22A1 Homo sapiens (Human) angiogenesis [GO:0001525]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198] GO:0001525; GO:0001886; GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030198; GO:0031012 extracellular matrix structural constituent [GO:0005201] DGEPGLR 0.99149 -23.249 0 0 0 0 0 0 9.61899 0 0 0 0 0 13.3407 0 0 0 0 0 0 14.6357 0 0 0 0 0 0 0 0 0 12.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7585 0 0 0 0 0 0 0 0 0 0 13.2218 0 0 0 0 0 0 13.8546 0 0 0 0 0 0 0 0 13.8555 0 0 0 0 0 0 0 0 0 0 0 0 13.7521 0 0 0 0 0 14.2024 0 13.9036 0 0 0 15.1216 0 0 0 0 0 0 0 0 14.8443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7782 0 0 0 0 0 13.5783 0 0 13.0819 0 0 14.0266 0 0 Q9BZJ4 S2539_HUMAN Probable mitochondrial glutathione transporter SLC25A39 (Solute carrier family 25 member 39) SLC25A39 CGI-69 PRO2163 Homo sapiens (Human) glutathione import into mitochondrion [GO:0160007]; heme biosynthetic process [GO:0006783] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; glutathione import into mitochondrion [GO:0160007]; heme biosynthetic process [GO:0006783] GO:0005739; GO:0005743; GO:0006783; GO:0016021; GO:0160007 LNQDRLLGG 0.99149 -7.5382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8681 0 0 0 Q9UG22 GIMA2_HUMAN "GTPase IMAP family member 2 (Immunity-associated protein 2, hIMAP2)" GIMAP2 IMAP2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; identical protein binding [GO:0042802] GO:0005525; GO:0005654; GO:0005783; GO:0005811; GO:0042802 GTP binding [GO:0005525]; identical protein binding [GO:0042802] ELMDCIEDLLMEKNGDHYTNGLYSLIQR 0.99149 -7.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8073 0 0 0 12.4765 0 0 0 0 0 0 0 0 0 0 0 13.1282 14.7928 18.9589 0 0 0 0 0 0 0 14.514 0 0 0 0 0 0 0 0 0 12.8362 0 0 14.9757 0 0 0 0 0 0 0 0 0 12.3342 0 0 0 13.329 0 0 0 0 0 11.2901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75356 ENTP5_HUMAN "Nucleoside diphosphate phosphatase ENTPD5, EC 3.6.1.6 (CD39 antigen-like 4) (ER-UDPase) (Ectonucleoside triphosphate diphosphohydrolase 5, NTPDase 5) (Guanosine-diphosphatase ENTPD5, GDPase ENTPD5) (Inosine diphosphate phosphatase ENTPD5) (Nucleoside diphosphatase) (Uridine-diphosphatase ENTPD5, UDPase ENTPD5)" ENTPD5 CD39L4 PCPH Homo sapiens (Human) 'de novo' post-translational protein folding [GO:0051084]; nucleoside diphosphate catabolic process [GO:0009134]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-glucose metabolic process [GO:0006011] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; adenosine-diphosphatase activity [GO:0043262]; cytidine-diphosphatase activity [GO:0036384]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; uridine-diphosphatase activity [GO:0045134]; 'de novo' post-translational protein folding [GO:0051084]; nucleoside diphosphate catabolic process [GO:0009134]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-glucose metabolic process [GO:0006011] GO:0004382; GO:0005576; GO:0005615; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0009134; GO:0016020; GO:0017110; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003 adenosine-diphosphatase activity [GO:0043262]; cytidine-diphosphatase activity [GO:0036384]; guanosine-diphosphatase activity [GO:0004382]; inosine-diphosphatase activity [GO:1990003]; nucleoside-diphosphatase activity [GO:0017110]; uridine-diphosphatase activity [GO:0045134] AKALLFEVK 0.9915 -4.6053 0 0 0 0 0 0 0 0 0 0 13.1138 0 0 0 0 0 0 0 0 12.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6892 0 13.884 0 13.9911 0 0 14.3514 0 0 14.5072 0 14.3591 14.3482 14.3468 0 0 0 14.017 0 14.1037 0 0 0 0 13.8609 0 0 14.4573 0 14.3245 13.6639 0 0 13.1246 14.1185 14.4977 0 12.0883 0 14.0145 0 0 0 0 0 0 0 13.8733 14.4047 0 14.2173 14.3108 14.5881 0 13.6257 0 13.4198 0 0 0 0 0 0 14.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DMU9 CT45A_HUMAN Cancer/testis antigen family 45 member A10 (Cancer/testis antigen 45A10) CT45A10 Homo sapiens (Human) snRNA 3'-end processing [GO:0034472] integrator complex [GO:0032039] integrator complex [GO:0032039]; identical protein binding [GO:0042802]; snRNA 3'-end processing [GO:0034472] GO:0032039; GO:0034472; GO:0042802 identical protein binding [GO:0042802] ECDSPSYQK 0.9915 -7.3761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFN8 GP156_HUMAN Probable G-protein coupled receptor 156 (G-protein coupled receptor PGR28) (GABAB-related G-protein coupled receptor) GPR156 GABABL PGR28 Homo sapiens (Human) gamma-aminobutyric acid signaling pathway [GO:0007214] G protein-coupled receptor heterodimeric complex [GO:0038039]; plasma membrane [GO:0005886] G protein-coupled receptor heterodimeric complex [GO:0038039]; plasma membrane [GO:0005886]; G protein-coupled GABA receptor activity [GO:0004965]; transmembrane signaling receptor activity [GO:0004888]; gamma-aminobutyric acid signaling pathway [GO:0007214] GO:0004888; GO:0004965; GO:0005886; GO:0007214; GO:0038039 G protein-coupled GABA receptor activity [GO:0004965]; transmembrane signaling receptor activity [GO:0004888] DSSFSPGK 0.9915 -7.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6531 0 0 0 0 0 0 11.9291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8422 0 13.7513 12.6109 13.414 0 0 12.6326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7466 0 0 0 0 12.5019 0 0 0 0 0 12.2247 0 0 0 13.3682 12.5323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.042 0 0 0 0 0 0 Q9BY66 KDM5D_HUMAN "Lysine-specific demethylase 5D, EC 1.14.11.67 (Histocompatibility Y antigen, H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D)" KDM5D HY HYA JARID1D KIAA0234 SMCY Homo sapiens (Human) chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; regulation of androgen receptor signaling pathway [GO:0060765]; T cell antigen processing and presentation [GO:0002457] GO:0001650; GO:0002457; GO:0003677; GO:0005634; GO:0005654; GO:0006338; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0046872; GO:0050681; GO:0060765 DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681] AHFCLEARQK 0.9915 -19.063 0 0 12.0168 0 0 0 9.55524 0 0 0 15.4503 14.0868 0 0 0 16.6736 0 0 0 0 0 14.1994 10.4518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1217 0 0 0 0 0 0 0 17.0346 0 0 0 0 0 0 12.7756 0 0 0 0 0 0 0 0 0 14.0335 12.4244 0 14.675 0 11.5371 0 0 0 0 0 0 16.2438 0 15.37 14.8168 0 12.4511 12.015 18.3286 14.6339 12.5233 13.6531 13.923 0 12.8279 0 0 0 15.0652 13.2681 0 0 0 14.0933 0 0 0 0 0 0 0 0 14.3846 14.9873 0 0 0 0 11.9073 12.1226 11.8689 15.0087 0 0 0 0 0 15.6402 11.1193 15.2462 12.7303 14.3945 0 0 12.823 14.3977 14.0313 10.9497 13.6155 11.5312 12.3587 15.2213 11.7198 10.7353 0 0 11.7046 16.5663 13.4914 12.4495 0 0 0 14.4754 10.8757 0 14.6174 0 14.2592 19.5448 0 0 0 0 0 0 0 0 11.8825 0 11.1924 0 12.7622 0 15.1095 0 0 0 0 0 0 15.037 0 O00370 LORF2_HUMAN "LINE-1 retrotransposable element ORF2 protein, ORF2p [Includes: Reverse transcriptase, EC 2.7.7.49; Endonuclease, EC 3.1.21.- ]" Homo sapiens (Human) "DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]" "metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition, RNA-mediated [GO:0032197]" GO:0003964; GO:0006310; GO:0009036; GO:0032197; GO:0032199; GO:0046872; GO:0090305 metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036] ARIAKSILSQK 0.99151 -50.605 11.1549 0 13.4204 15.812 0 0 0 0 12.3861 0 12.248 0 12.4886 0 12.1361 0 0 0 0 11.142 14.2059 13.9874 0 12.9174 15.065 13.9963 0 13.5207 0 13.2621 0 0 11.9352 0 0 12.0229 0 11.4662 0 0 11.3343 0 12.6669 0 12.9109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3113 15.8237 15.9529 13.8615 15.1979 14.157 0 0 14.5488 14.2461 0 14.8164 13.1353 14.7566 14.4948 15.617 15.2133 0 13.8929 14.383 13.0577 0 16.1557 0 17.0017 14.5543 11.9199 14.3263 13.8141 13.2048 16.1955 14.2829 12.8619 14.7646 14.8419 14.1038 14.2966 18.2211 0 15.5009 13.7226 13.03 12.9119 15.4124 15.349 0 14.5406 16.1804 12.9957 13.1858 14.1027 17.0531 13.0285 15.5077 12.9065 0 14.3617 15.8628 14.5658 15.9433 15.7685 14.2038 14.2899 0 16.1136 0 14.5399 0 15.8308 16.3071 16.315 15.2857 15.3085 14.3166 0 15.5709 16.2095 15.5328 15.3894 0 15.1471 0 0 17.0298 13.8866 12.1193 14.1121 16.8835 16.0299 13.5932 0 13.7217 13.7034 15.4368 0 0 15.9717 0 0 0 13.8402 0 0 13.2764 0 15.8422 15.1894 0 14.7704 0 0 13.6419 14.3635 0 Q12852 M3K12_HUMAN "Mitogen-activated protein kinase kinase kinase 12, EC 2.7.11.25 (Dual leucine zipper bearing kinase, DLK) (Leucine-zipper protein kinase, ZPK) (MAPK-upstream kinase, MUK) (Mixed lineage kinase)" MAP3K12 ZPK Homo sapiens (Human) "intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of motor neuron apoptotic process [GO:2000672]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]" GO:0004672; GO:0004674; GO:0004706; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007254; GO:0016020; GO:0018105; GO:0018107; GO:0019901; GO:0030426; GO:0035556; GO:0042803; GO:0043507; GO:0043539; GO:0043687; GO:0045860; GO:0045893; GO:0046777; GO:0070374; GO:0106310; GO:2000672 ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674] FHGEEVAVK 0.99151 -22.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9356 10.2908 0 0 0 12.1274 0 13.2444 15.1819 15.9946 0 0 13.0609 0 0 0 0 12.7211 0 0 13.3123 0 0 0 0 0 13.5948 14.244 14.3923 13.1545 14.4021 0 14.5919 16.1222 13.1145 13.6193 13.9887 13.4273 14.962 13.2157 0 0 0 0 0 14.8968 13.755 13.8582 14.1227 0 14.1908 14.2438 13.7415 0 0 14.4488 0 13.916 15.5132 13.5072 14.8233 14.8537 14.9625 13.8232 13.3405 11.7556 15.5534 14.9014 15.3746 13.3322 0 16.0233 0 0 0 0 0 0 0 13.3489 0 0 15.3285 14.7907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4339 17.9699 14.0215 0 13.8733 0 0 0 0 0 A6NCJ1 TKTI1_HUMAN Tektin bundle interacting protein 1 TEKTIP1 C19orf71 Homo sapiens (Human) axonemal microtubule [GO:0005879] axonemal microtubule [GO:0005879] GO:0005879 DRPIRGK 0.99151 -18.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.399 0 0 0 0 0 0 11.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIJ9 O6C70_HUMAN Olfactory receptor 6C70 OR6C70 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FLITIVTREK 0.99151 -22.801 0 0 0 11.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5354 0 0 0 0 0 0 0 13.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MW92 P20L1_HUMAN PHD finger protein 20-like protein 1 PHF20L1 CGI-72 Homo sapiens (Human) histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357] NSL complex [GO:0044545] NSL complex [GO:0044545]; metal ion binding [GO:0046872]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0006357; GO:0016573; GO:0044545; GO:0046872 metal ion binding [GO:0046872] AAAAAAAK 0.99151 -22.813 0 0 10.8839 0 0 0 0 0 12.1801 0 0 13.7289 0 0 0 0 0 0 0 0 11.3791 0 0 0 0 0 0 13.9477 0 0 10.2768 0 0 0 0 0 11.2065 0 0 0 0 0 0 13.5753 13.9481 11.147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9484 0 0 0 0 0 0 0 0 0 12.509 0 0 11.0902 0 10.8392 0 0 0 0 0 0 0 11.8377 0 0 0 13.5228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4184 0 0 0 11.478 0 0 0 0 0 0 13.0562 0 0 10.9646 0 0 0 0 14.2264 0 0 0 0 0 0 11.9685 0 0 0 0 0 0 0 0 0 12.2163 0 0 0 0 0 11.5728 0 11.4614 0 0 0 12.576 0 0 0 12.5987 0 0 14.5137 12.9538 12.3886 14.7828 0 0 12.7138 0 0 14.8476 10.2939 13.7116 14.1972 0 E9PIF3 NPIA2_HUMAN Nuclear pore complex-interacting protein family member A2 NPIPA2 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 AEDYYRCKITPSAR 0.99151 -22.158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4493 12.4821 0 0 0 0 13.4396 0 0 0 0 0 0 0 16.2411 0 0 0 0 0 0 0 0 0 0 0 0 11.3213 0 0 0 0 0 0 0 0 0 0 0 12.7768 0 0 0 0 13.1731 10.9103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8999 0 0 0 19.099 0 18.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18405 S5A1_HUMAN "3-oxo-5-alpha-steroid 4-dehydrogenase 1, EC 1.3.1.22 (SR type 1) (Steroid 5-alpha-reductase 1, S5AR 1)" SRD5A1 Homo sapiens (Human) "androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; bone development [GO:0060348]; cell differentiation [GO:0030154]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cellular response to testosterone stimulus [GO:0071394]; cerebral cortex development [GO:0021987]; circadian sleep/wake cycle, REM sleep [GO:0042747]; diterpenoid metabolic process [GO:0016101]; female genitalia development [GO:0030540]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; liver development [GO:0001889]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; pituitary gland development [GO:0021983]; progesterone metabolic process [GO:0042448]; response to estrogen [GO:0043627]; response to follicle-stimulating hormone [GO:0032354]; response to fungicide [GO:0060992]; response to growth hormone [GO:0060416]; response to muscle activity [GO:0014850]; response to xenobiotic stimulus [GO:0009410]; serotonin metabolic process [GO:0042428]; sex determination [GO:0007530]; spinal cord development [GO:0021510]; steroid biosynthetic process [GO:0006694]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]" cell body fiber [GO:0070852]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471] "cell body fiber [GO:0070852]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; electron transfer activity [GO:0009055]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491]; progesterone 5-alpha-reductase activity [GO:0050213]; androgen biosynthetic process [GO:0006702]; androgen catabolic process [GO:0006710]; bone development [GO:0060348]; cell differentiation [GO:0030154]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cellular response to testosterone stimulus [GO:0071394]; cerebral cortex development [GO:0021987]; circadian sleep/wake cycle, REM sleep [GO:0042747]; diterpenoid metabolic process [GO:0016101]; female genitalia development [GO:0030540]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; liver development [GO:0001889]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; pituitary gland development [GO:0021983]; progesterone metabolic process [GO:0042448]; response to estrogen [GO:0043627]; response to follicle-stimulating hormone [GO:0032354]; response to fungicide [GO:0060992]; response to growth hormone [GO:0060416]; response to muscle activity [GO:0014850]; response to xenobiotic stimulus [GO:0009410]; serotonin metabolic process [GO:0042428]; sex determination [GO:0007530]; spinal cord development [GO:0021510]; steroid biosynthetic process [GO:0006694]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]" GO:0001655; GO:0001889; GO:0003865; GO:0005789; GO:0006694; GO:0006702; GO:0006710; GO:0007530; GO:0008584; GO:0009055; GO:0009267; GO:0009410; GO:0014850; GO:0016021; GO:0016101; GO:0016491; GO:0021510; GO:0021766; GO:0021794; GO:0021854; GO:0021983; GO:0021987; GO:0030154; GO:0030539; GO:0030540; GO:0032354; GO:0032869; GO:0033218; GO:0042428; GO:0042448; GO:0042747; GO:0043025; GO:0043209; GO:0043627; GO:0047751; GO:0048471; GO:0050213; GO:0060348; GO:0060416; GO:0060992; GO:0070402; GO:0070852; GO:0071320; GO:0071363; GO:0071392; GO:0071394; GO:0071549; GO:0071872 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; amide binding [GO:0033218]; cholestenone 5-alpha-reductase activity [GO:0047751]; electron transfer activity [GO:0009055]; NADPH binding [GO:0070402]; oxidoreductase activity [GO:0016491]; progesterone 5-alpha-reductase activity [GO:0050213] FEEYPKFR 0.99151 -22.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4156 0 0 13.4873 0 0 0 0 0 0 0 0 0 0 15.1913 0 0 0 0 0 14.7051 15.1025 0 0 0 0 0 14.8083 0 0 0 13.723 0 0 0 0 0 13.4393 0 14.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2903 11.1279 0 0 0 11.8268 12.2669 0 0 0 0 0 0 0 0 0 0 0 12.8303 0 0 14.23 13.3295 0 0 0 0 0 0 13.7048 0 0 0 0 12.5621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2QGD7 ZXDC_HUMAN Zinc finger protein ZXDC (ZXD-like zinc finger protein) ZXDC ZXDL Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; LRR domain binding [GO:0030275]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0030275; GO:0045893; GO:0046872; GO:0070742 C2H2 zinc finger domain binding [GO:0070742]; LRR domain binding [GO:0030275]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] ACRLKIHLR 0.99151 -22.822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4619 0 0 0 0 0 0 0 0 0 0 14.4882 13.6262 0 13.7516 14.1924 0 17.1585 0 0 0 0 14.1633 0 0 0 0 0 0 0 0 14.1957 0 0 0 0 0 12.7763 0 0 13.5754 13.8321 0 0 0 17.5403 0 15.075 0 14.9162 0 0 0 0 14.6198 0 13.4767 0 0 13.4828 0 0 0 0 0 0 0 12.5449 0 0 0 0 15.6443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2511 0 0 0 0 0 0 0 0 0 0 0 0 14.208 0 0 0 0 0 Q5VW00 DC122_HUMAN DDB1- and CUL4-associated factor 12-like protein 2 (WD repeat-containing protein 40C) DCAF12L2 WDR40C Homo sapiens (Human) Cul4-RING E3 ubiquitin ligase complex [GO:0080008] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] GO:0080008 ALAFSGK 0.99151 -22.148 0 0 0 0 0 10.9294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7586 0 12.1645 0 0 0 0 13.0038 0 0 0 11.0831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1154 0 0 12.8562 0 0 0 0 0 0 0 0 0 0 13.8146 0 0 0 0 0 0 0 0 0 13.7247 0 0 0 0 0 0 13.3983 0 0 0 13.4449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8802 0 0 0 0 0 0 0 12.9899 0 0 0 0 13.7948 0 14.2381 0 0 0 0 0 0 0 0 0 0 0 0 Q6DN14 MCTP1_HUMAN Multiple C2 and transmembrane domain-containing protein 1 MCTP1 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928] anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; recycling endosome [GO:0055037]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; negative regulation of cell migration [GO:0030336]; negative regulation of endocytosis [GO:0045806]; negative regulation of response to oxidative stress [GO:1902883]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928] GO:0005509; GO:0005789; GO:0016021; GO:0019722; GO:0030336; GO:0030672; GO:0045806; GO:0046928; GO:0048168; GO:0055037; GO:0070161; GO:1902883 calcium ion binding [GO:0005509] APETGEEHGSSQK 0.99151 -18.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5781 0 14.7759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0451 0 0 12.3409 0 0 0 0 0 0 0 0 14.8508 14.3998 0 0 0 0 15.8137 14.9984 0 0 0 0 14.4853 0 0 0 0 0 0 0 0 0 13.5704 0 0 12.9071 12.4209 0 12.7151 0 14.0413 0 0 0 11.2161 0 0 0 0 0 0 12.8399 0 11.5023 0 0 13.0742 0 0 12.1884 13.3571 0 0 0 0 0 0 0 13.8039 13.4611 14.193 0 0 0 0 0 0 0 0 0 11.5129 0 14.1867 0 0 0 0 0 0 0 0 0 0 0 0 13.0125 0 12.3913 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0315 Q6IEE7 T132E_HUMAN Transmembrane protein 132E TMEM132E Homo sapiens (Human) posterior lateral line neuromast hair cell development [GO:0035677] cell body [GO:0044297]; integral component of membrane [GO:0016021] cell body [GO:0044297]; integral component of membrane [GO:0016021]; posterior lateral line neuromast hair cell development [GO:0035677] GO:0016021; GO:0035677; GO:0044297 ESEDEDEEEEER 0.99151 -22.217 0 0 0 0 0 0 0 0 0 0 0 0 8.97639 0 0 0 0 0 0 0 0 12.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5394 0 0 0 0 0 0 0 0 0 0 0 0 9.75492 0 0 0 0 0 0 0 0 12.4206 0 0 13.5653 0 0 0 12.9237 0 0 10.0353 0 0 0 0 0 0 0 0 0 0 0 0 9.44642 0 0 0 0 0 0 0 0 0 12.2773 0 0 12.1107 0 0 0 0 0 0 0 14.0156 0 0 0 0 0 0 0 0 12.6242 0 0 0 0 14.9537 0 0 0 0 0 0 0 0 14.0869 0 0 0 0 0 0 0 0 0 0 13.3588 0 0 0 0 0 0 13.2828 13.0662 0 0 0 0 0 Q86XF7 ZN575_HUMAN Zinc finger protein 575 ZNF575 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSYPSKLATHR 0.99151 -22.887 0 15.6887 0 0 0 0 0 0 0 13.4727 0 0 0 0 0 0 0 0 0 0 14.8711 0 14.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7988 11.6435 0 12.7232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6071 0 0 14.7414 0 0 15.1169 12.5329 16.0632 16.0207 0 13.4273 14.0812 13.8381 0 0 0 0 0 0 0 14.3796 13.1094 0 0 0 12.6439 0 13.3918 0 13.9382 0 0 0 12.4342 0 14.0809 16.2327 0 12.5528 13.213 13.2394 0 13.857 0 13.3551 0 14.7225 13.2333 14.4892 13.8697 12.7406 15.1473 13.2799 13.7543 0 14.8891 12.8932 15.1894 14.3691 13.0802 0 15.407 0 14.6054 14.7549 13.1243 15.0863 13.581 12.8651 14.0562 13.9021 0 13.2196 15.02 14.0722 15.4653 14.2589 0 0 0 14.6932 0 0 14.4553 13.6811 14.4188 13.518 14.3137 0 14.6754 0 0 0 13.5094 14.0403 14.7215 13.1381 13.8205 0 0 0 0 0 14.5501 14.4015 14.7412 13.2723 14.2148 0 0 0 0 Q8IYM0 F186B_HUMAN Protein FAM186B FAM186B C12orf25 Homo sapiens (Human) protein-containing complex [GO:0032991] protein-containing complex [GO:0032991] GO:0032991 AIRYMATVVENLNKALILQHK 0.99151 -22.901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9182 10.2883 0 0 0 0 0 11.2198 0 0 11.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8227 0 0 0 0 0 0 0 9.30092 0 0 0 0 0 0 11.9081 0 0 0 0 0 12.0998 11.6728 0 0 0 13.54 13.4871 12.8239 0 0 0 0 0 14.4339 0 13.4312 13.7992 13.2595 12.9533 14.6062 13.4079 14.0971 0 0 14.4213 16.1822 0 0 13.0335 12.7714 0 0 0 12.4686 0 0 0 0 0 0 0 0 13.4868 0 0 0 0 0 0 0 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9415 0 0 0 0 0 13.57 0 13.7088 0 0 0 0 0 0 0 0 0 0 0 0 0 13.628 0 0 0 13.5237 0 Q8N1G1 REXO1_HUMAN "RNA exonuclease 1 homolog, EC 3.1.-.- (Elongin-A-binding protein 1, EloA-BP1) (Transcription elongation factor B polypeptide 3-binding protein 1)" REXO1 ELOABP1 KIAA1138 TCEB3BP1 Homo sapiens (Human) nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] GO:0003676; GO:0004527; GO:0005634; GO:0005654; GO:0016604 exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] ATGQPPSKEGLEAEGGGLRETK 0.99151 -49.968 0 12.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1782 0 10.3302 0 0 0 9.77706 0 0 0 0 0 11.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9431 0 12.6966 0 0 0 0 12.8878 0 13.4934 0 0 0 0 12.5433 0 0 15.1285 0 0 0 0 0 0 15.9462 14.3278 11.0549 13.5125 0 14.9306 0 0 0 0 0 11.0423 10.4758 12.7388 0 0 0 0 0 0 0 0 0 12.5846 0 15.721 0 0 0 0 0 14 0 0 0 11.0688 12.9615 0 0 0 0 12.7657 12.9566 0 0 0 0 0 16.5518 14.5329 0 0 0 0 0 0 0 0 0 0 0 0 12.2869 0 0 0 0 12.383 0 0 0 0 0 12.4422 0 0 13.1595 0 0 0 0 0 0 0 Q9UJ96 KCNG2_HUMAN Potassium voltage-gated channel subfamily G member 2 (Cardiac potassium channel subunit) (Voltage-gated potassium channel subunit Kv6.2) KCNG2 KCNF2 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008016; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0070062; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] ACRGHDDLLRVCDDYDVSR 0.99151 -22.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3568 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7426 11.118 0 15.7939 0 0 0 0 0 0 0 0 0 14.7937 15.0224 0 0 0 0 11.5223 0 0 0 0 0 12.6781 0 0 0 0 13.4699 0 0 12.8072 0 0 0 0 0 0 0 0 9.00593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6193 10.2097 0 10.0631 13.1535 0 0 0 0 0 0 0 12.432 0 0 0 0 9.81086 0 9.70686 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7716 0 0 0 13.0434 0 0 0 0 0 0 0 12.2517 Q8NE18 NSUN7_HUMAN "Putative methyltransferase NSUN7, EC 2.1.1.- (NOL1/NOP2/Sun domain family member 7)" NSUN7 Homo sapiens (Human) methylation [GO:0032259] methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; methylation [GO:0032259] GO:0003723; GO:0008168; GO:0032259 methyltransferase activity [GO:0008168]; RNA binding [GO:0003723] DHRLQKVK 0.99152 -23.05 0 0 0 16.6154 10.6321 15.6911 15.1767 13.9266 14.3557 15.6194 15.8946 15.0825 15.3277 15.9105 16.1978 15.6658 15.7143 15.4104 14.5488 15.8163 15.5385 0 14.0103 12.6587 15.6491 15.8962 14.2852 16.1306 14.9867 16.2377 16.4506 15.0381 13.8829 13.3435 15.4609 14.0152 14.2848 15.9701 15.836 15.3814 14.7534 15.6457 15.7867 15.8139 15.4062 15.9718 14.8187 15.4016 15.0556 15.4282 15.2121 15.5001 14.8954 14.9914 14.9972 14.3842 14.3432 14.0765 14.4858 0 14.4114 14.1102 11.8532 13.9764 12.5947 13.2798 12.0191 13.4736 13.027 14.1855 13.7474 0 16.0799 0 13.6051 11.2175 12.5546 15.6635 12.6431 14.6842 0 14.2226 15.014 14.3129 14.487 14.8424 16.1466 0 13.3071 0 12.3725 12.4723 13.6284 13.6089 14.0042 0 13.5367 0 0 16.3449 14.782 15.3515 15.3053 12.4208 0 14.0435 14.3207 15.6095 16.5037 15.5056 15.5245 16.1041 13.4365 14.4261 15.8616 13.5657 14.9147 16.7706 16.9905 15.3327 16.8133 15.7593 17.4229 16.4168 15.7376 14.7973 15.24 15.8203 15.0038 14.8307 14.1475 13.6676 16.2952 15.7722 12.0452 15.5665 16.9149 15.6572 16.8069 16.9161 16.3852 17.0457 16.6047 16.4626 17.8356 15.7374 15.8795 12.6464 0 0 15.5096 0 0 12.5948 0 14.9406 15.5409 11.5674 10.3238 14.087 10.6925 14.8308 0 0 13.8669 15.7907 11.9114 15.439 15.36 15.333 16.4978 16.6677 11.2727 14.1773 16.9737 15.6223 12.1526 0 16.2931 11.547 A1Z1Q3 MACD2_HUMAN "ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2, EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2, EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2, EC 3.2.2.-)" MACROD2 C20orf133 Homo sapiens (Human) brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617]" GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0007420; GO:0009617; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293 "ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]" DQDHPDGQENDSTK 0.99152 -7.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8944 10.0733 0 0 0 0 0 0 0 0 14.2171 0 0 14.6255 0 0 0 14.4047 0 0 0 0 0 0 0 0 0 0 16.2641 0 11.8964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8595 0 0 0 14.5794 13.5738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15230 LAMA5_HUMAN Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha) LAMA5 KIAA0533 KIAA1907 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of epithelial cell proliferation [GO:0050678]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; trunk neural crest cell migration [GO:0036484] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of epithelial cell proliferation [GO:0050678]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; trunk neural crest cell migration [GO:0036484] GO:0001658; GO:0001738; GO:0001942; GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005610; GO:0005615; GO:0005634; GO:0007229; GO:0007411; GO:0007517; GO:0009887; GO:0009888; GO:0016331; GO:0016477; GO:0030155; GO:0030324; GO:0030334; GO:0031594; GO:0034446; GO:0036484; GO:0042475; GO:0043083; GO:0043259; GO:0043260; GO:0045995; GO:0050678; GO:0060271; GO:0060445; GO:0062023; GO:0070062; GO:0072659; GO:0098609 extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178] AIQVFLLGGSRKR 0.99152 -51.677 0 0 0 10.7357 0 0 0 0 11.315 13.3562 0 12.048 0 13.1504 11.177 0 0 0 0 11.5216 13.1686 0 10.4578 0 0 0 0 0 0 10.0137 0 0 11.7438 10.6131 12.4207 0 0 0 0 12.3679 0 0 0 0 0 0 0 10.0845 0 0 0 11.4296 11.161 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3505 11.6767 11.077 14.9385 14.1198 0 15.8781 15.0269 0 15.1539 13.5771 15.0989 13.4365 14.7727 15.466 13.5046 14.7685 15.0241 14.4499 12.7125 14.8585 15.0953 0 16.514 0 14.4002 14.1066 14.2639 14.7888 13.8634 0 15.9816 0 16.903 12.8919 16.5903 15.7278 12.4694 0 13.8334 15.7279 13.5693 12.8095 16.4127 14.1492 12.63 15.2375 13.7416 11.6878 12.9483 17.0278 12.0037 13.4173 16.2396 16.0947 14.4366 16.7797 11.8001 13.6083 13.6668 13.9411 13.317 16.3217 16.2704 0 0 14.6152 15.2134 13.7654 14.4205 14.4331 13.8954 16.8671 0 0 15.3695 15.3967 15.317 13.9974 13.0355 14.26 0 16.0515 0 14.9732 13.1497 15.6233 12.6984 0 12.5193 13.0408 0 14.2798 13.1775 11.7786 12.9747 0 0 12.0014 0 0 0 13.016 12.8211 12.1585 0 15.3795 0 10.9188 12.1354 0 0 13.428 13.2225 O43924 PDE6D_HUMAN "Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta, GMP-PDE delta (Protein p17)" PDE6D PDED Homo sapiens (Human) response to stimulus [GO:0050896]; visual perception [GO:0007601] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005095; GO:0005737; GO:0005829; GO:0005856; GO:0005929; GO:0007601; GO:0030659; GO:0031267; GO:0031410; GO:0050896 GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267] VPKKILK 0.99152 -4.764 0 12.7963 11.8949 12.4534 0 12.6345 12.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2869 0 0 0 0 0 12.3462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2381 0 0 0 0 0 0 11.4681 13.9934 0 0 0 0 0 13.7918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3143 0 0 0 0 0 14.1618 0 0 0 0 13.1433 13.3404 0 12.3115 15.1846 14.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9441 0 0 0 0 0 0 0 0 14.0977 15.3047 0 0 11.7181 0 0 P05114 HMGN1_HUMAN Non-histone chromosomal protein HMG-14 (High mobility group nucleosome-binding domain-containing protein 1) HMGN1 HMG14 Homo sapiens (Human) "chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; post-embryonic camera-type eye morphogenesis [GO:0048597]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of development, heterochronic [GO:0040034]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV-B [GO:0010224]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nucleosomal DNA binding [GO:0031492]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; post-embryonic camera-type eye morphogenesis [GO:0048597]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of development, heterochronic [GO:0040034]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357]; response to UV-B [GO:0010224]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]" GO:0000720; GO:0000785; GO:0001674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006283; GO:0006325; GO:0006357; GO:0010224; GO:0010225; GO:0031492; GO:0032786; GO:0040034; GO:0048597; GO:0050678; GO:1901666 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nucleosomal DNA binding [GO:0031492] LSAKPPAK 0.99152 -23.055 12.9604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1681 0 12.7623 0 13.6508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2619 0 0 0 P40818 UBP8_HUMAN "Ubiquitin carboxyl-terminal hydrolase 8, EC 3.4.19.12 (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y, hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8)" USP8 KIAA0055 UBPY Homo sapiens (Human) "cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000281; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0006511; GO:0007032; GO:0007265; GO:0014069; GO:0016579; GO:0017124; GO:0019897; GO:0030496; GO:0031313; GO:0031647; GO:0032880; GO:0043197; GO:0045296; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1990090 cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; SH3 domain binding [GO:0017124] AAEHAWQKHKQLNESIIVALFQGQFK 0.99152 -22.942 0 0 0 0 0 0 12.6628 0 11.5538 0 11.5284 0 0 0 0 0 0 11.2946 0 12.8368 0 0 0 11.6785 0 0 0 0 0 0 0 0 11.0073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2875 0 0 10.3737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4165 11.8111 0 0 11.5156 0 0 0 0 0 12.6 15.2334 12.4681 0 0 0 15.1973 12.2253 0 13.3656 13.4976 0 0 0 13.0202 0 0 0 0 0 0 12.0216 0 13.8946 0 0 0 0 0 0 0 0 0 0 0 13.3647 0 0 0 0 0 0 12.6761 0 13.3109 0 0 0 0 13.5911 0 0 0 0 0 0 10.7351 0 0 13.183 0 14.4602 0 0 12.0429 0 0 0 0 15.3875 0 0 0 14.2762 0 0 11.2087 0 0 0 0 0 0 0 14.0661 14.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9992 0 Q14005 IL16_HUMAN "Pro-interleukin-16 [Cleaved into: Interleukin-16, IL-16 (Lymphocyte chemoattractant factor, LCF) ]" IL16 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924] GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0005925; GO:0006955; GO:0016607; GO:0019221; GO:0030595; GO:0032730; GO:0032735; GO:0032755; GO:0042609; GO:0050729; GO:0050930; GO:0051924; GO:0090543; GO:1902565 CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125] ALPDGPVTIVIRRK 0.99152 -51.38 0 0 0 0 0 0 0 0 0 0 0 0 10.6662 0 0 0 0 0 0 0 0 11.9179 0 0 0 0 0 0 0 0 0 0 0 0 11.0354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9082 0 0 13.521 0 13.5524 0 0 0 0 0 0 0 0 0 0 0 13.7256 13.658 0 13.7999 0 0 15.5485 16.0461 15.7244 16.0807 15.352 14.9055 0 0 14.8082 0 0 14.9896 13.8867 14.796 13.032 0 15.3687 13.2932 0 0 0 13.1354 12.9736 0 13.7321 14.9269 12.6535 12.2656 0 0 0 15.5037 14.8115 14.6402 13.4696 13.5723 13.9034 0 12.2096 15.469 13.8632 13.6522 14.1931 15.2314 0 13.5271 0 0 13.5078 13.6355 14.5746 13.3383 13.2737 0 15.2634 13.4738 15.4919 13.5488 15.3321 13.5451 14.802 15.0519 13.5572 14.3753 13.4427 15.966 0 13.4302 13.548 13.7788 14.5467 15.1114 13.8228 13.6488 14.6744 0 13.2315 14.498 14.7024 0 13.5626 0 0 0 0 13.6704 13.4616 14.7291 14.7102 11.6414 0 13.4538 12.9869 15.3766 14.3346 12.8986 13.284 13.6203 0 13.317 12.3098 15.2417 0 15.7192 14.6251 0 Q6N043 Z280D_HUMAN Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CIECCSEIK 0.99152 -23.68 8.9474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0038 0 11.0429 0 15.0218 0 0 0 0 0 12.3771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6106 0 0 0 0 0 0 16.993 0 14.3395 0 10.4412 0 0 0 0 12.5499 0 0 0 0 0 0 0 13.3896 0 0 0 0 0 0 0 0 11.7922 0 0 0 0 15.7326 0 15.8158 0 0 15.7844 0 0 14.0225 0 0 0 0 0 13.3849 10.4726 13.039 0 14.0079 0 0 0 0 0 13.0543 0 0 0 0 0 0 0 0 0 12.1573 0 0 0 0 0 0 0 0 0 0 0 10.3289 0 0 0 0 0 0 12.9384 12.8837 0 0 0 0 0 0 0 11.6706 Q8NFD4 YI018_HUMAN Uncharacterized protein FLJ76381 Homo sapiens (Human) MGGFGSR 0.99152 -4.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3845 0 0 0 0 0 0 0 13.5088 0 0 0 13.2824 13.2449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUI4 HDAC7_HUMAN "Histone deacetylase 7, HD7, EC 3.5.1.98 (Histone deacetylase 7A, HD7a)" HDAC7 HDAC7A Homo sapiens (Human) cell-cell junction assembly [GO:0007043]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; protein deacetylation [GO:0006476]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein lysine deacetylase activity [GO:0033558]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; cell-cell junction assembly [GO:0007043]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; protein deacetylation [GO:0006476]; vasculogenesis [GO:0001570] GO:0000118; GO:0000122; GO:0001570; GO:0003682; GO:0003714; GO:0004407; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0006476; GO:0007043; GO:0016575; GO:0019789; GO:0019901; GO:0032703; GO:0033558; GO:0045668; GO:0046872; GO:0071889; GO:0090050; GO:0140297; GO:1901223 14-3-3 protein binding [GO:0071889]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein lysine deacetylase activity [GO:0033558]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714] HQCSCGDNSRHPEHAGRIQSIWSR 0.99152 -23.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0697 0 0 0 0 0 0 10.7237 0 0 0 0 0 0 0 0 0 0 12.0557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2971 0 0 0 0 0 0 0 12.6182 0 0 0 14.6478 0 0 0 0 13.5436 0 0 0 0 12.3441 0 11.9954 12.5756 0 0 0 0 0 13.7113 0 12.8932 14.2018 14.5182 0 0 0 0 0 0 0 0 13.4303 0 12.9442 0 0 0 0 0 13.5925 0 0 0 0 0 0 0 13.3366 0 0 0 0 0 0 12.8135 0 0 0 0 13.9938 0 0 0 0 0 0 0 0 0 0 0 13.6201 0 0 0 0 0 13.3042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWA0 ITLN1_HUMAN "Intelectin-1, ITLN-1 (Endothelial lectin HL-1) (Galactofuranose-binding lectin) (Intestinal lactoferrin receptor) (Omentin)" ITLN1 INTL ITLN LFR UNQ640/PRO1270 Homo sapiens (Human) positive regulation of glucose import [GO:0046326]; positive regulation of protein phosphorylation [GO:0001934]; protein homotrimerization [GO:0070207]; response to nematode [GO:0009624] anchored component of membrane [GO:0031225]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; receptor complex [GO:0043235] anchored component of membrane [GO:0031225]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; oligosaccharide binding [GO:0070492]; positive regulation of glucose import [GO:0046326]; positive regulation of protein phosphorylation [GO:0001934]; protein homotrimerization [GO:0070207]; response to nematode [GO:0009624] GO:0001934; GO:0005509; GO:0005576; GO:0005615; GO:0009624; GO:0031225; GO:0031526; GO:0042802; GO:0043235; GO:0045121; GO:0046326; GO:0070062; GO:0070207; GO:0070492 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; oligosaccharide binding [GO:0070492] NSSLLRYR 0.99152 -7.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4427 0 0 0 0 0 0 0 0 12.4658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1286 0 0 0 0 0 0 0 0 0 12.7474 0 0 0 0 0 0 0 0 0 0 0 12.3727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3796 0 0 0 0 0 0 0 0 0 0 0 Q92828 COR2A_HUMAN Coronin-2A (IR10) (WD repeat-containing protein 2) CORO2A IR10 WDR2 Homo sapiens (Human) intracellular signal transduction [GO:0035556] transcription repressor complex [GO:0017053] transcription repressor complex [GO:0017053]; actin filament binding [GO:0051015]; intracellular signal transduction [GO:0035556] GO:0017053; GO:0035556; GO:0051015 actin filament binding [GO:0051015] ASKVLFLGNLKK 0.99152 -23.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2321 12.8517 14.0665 13.1457 13.1286 0 0 0 0 0 0 12.9078 0 0 0 0 12.8088 0 0 0 0 13.6036 0 0 0 0 0 0 0 0 0 0 0 13.1075 0 0 0 0 0 0 0 0 0 18.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2E3 ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 ZNFX1 KIAA1404 Homo sapiens (Human) activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; heterochromatin assembly by small RNA [GO:0031048]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380] cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; heterochromatin assembly by small RNA [GO:0031048]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071] GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607 helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] ACHPYDSSHKEFQCMKPCQK 0.99152 -51.867 0 0 0 0 0 0 0 0 0 0 0 10.4452 0 13.5274 0 13.842 14.5453 0 0 0 0 0 0 13.6134 0 14.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7618 12.8952 0 0 11.5794 0 0 0 0 0 0 0 0 0 0 11.3714 12.0336 0 0 14.4964 0 14.4402 0 0 0 13.2859 11.2178 0 0 12.3211 0 0 0 0 0 12.8212 0 0 14.4949 13.8207 0 0 0 0 0 18.2605 0 14.2033 0 0 13.6947 0 0 0 13.1671 0 0 13.4333 0 0 0 0 16.3881 14.9971 0 0 0 12.9631 14.0634 0 0 0 13.0526 0 0 12.7881 0 11.7422 0 12.4845 12.9879 0 13.8361 15.1309 0 12.9413 0 0 0 0 0 14.3939 0 13.7666 0 0 0 0 0 14.2769 0 0 13.5833 12.6802 12.6575 0 0 0 0 0 0 0 0 0 13.9727 0 0 0 0 0 0 0 0 0 0 13.6272 0 0 Q9UC07 ZNF69_HUMAN Zinc finger protein 69 (hZNF3) ZNF69 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CKQCGKAFR 0.99152 -23.024 0 0 0 0 0 0 11.4154 0 0 0 10.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9831 11.3115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8678 0 12.9075 0 0 0 0 0 0 0 0 11.1683 0 0 0 0 0 0 0 12.3793 0 0 0 0 0 0 0 0 0 0 0 0 12.6698 12.1369 12.2957 0 10.9856 0 0 0 0 0 0 16.8179 0 0 0 12.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2711 0 0 0 0 0 0 0 0 0 10.7384 0 0 0 0 0 13.7437 0 0 0 12.4468 0 0 0 0 0 0 0 0 11.3654 0 0 0 0 0 0 0 O15050 TRNK1_HUMAN TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog) TRANK1 KIAA0342 LBA1 Homo sapiens (Human) ACLVVSLCISWRRR 0.99153 -53.89 11.5539 0 0 0 0 0 11.6961 0 0 10.5719 12.4461 0 0 11.8894 14.3186 12.9119 0 0 13.154 0 0 0 0 0 0 0 0 0 0 14.0585 0 0 0 0 0 0 0 0 13.4455 0 0 13.6824 10.0053 0 12.5981 0 11.2069 0 12.6947 13.4484 0 0 0 0 0 0 0 0 11.2913 0 0 0 0 0 0 0 10.2827 0 0 0 11.0976 12.1403 0 0 14.1826 0 0 14.6945 12.0515 14.1486 11.9307 0 13.8712 0 12.7174 13.8256 14.512 13.6631 12.9706 12.9601 0 14.6656 14.1149 14.2312 0 12.6922 15.269 0 13.599 0 0 15.2077 0 11.7625 0 13.7377 13.7111 0 12.7158 12.596 0 0 0 0 14.4453 0 11.9632 13.7212 15.254 0 14.9792 11.7546 15.0323 12.245 13.0436 14.1176 14.6072 0 14.9667 0 12.4049 0 0 11.9526 0 13.3595 12.425 0 14.412 0 0 0 0 14.7446 0 0 13.1033 14.876 0 12.9825 10.7863 11.8108 0 0 0 13.9676 0 11.2209 0 11.9417 11.0268 11.3481 12.0391 0 0 0 0 0 0 0 13.7495 0 0 11.5405 0 14.2241 14.9372 0 0 12.0783 P32246 CCR1_HUMAN "C-C chemokine receptor type 1, C-C CKR-1, CC-CKR-1, CCR-1, CCR1 (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor, MIP-1alpha-R) (RANTES-R) (CD antigen CD191)" CCR1 CMKBR1 CMKR1 SCYAR1 Homo sapiens (Human) "calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of osteoclast differentiation [GO:0045672]; response to wounding [GO:0009611]" cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine (C-C motif) ligand 7 binding [GO:0035717]; chemokine receptor activity [GO:0004950]; phosphatidylinositol phospholipase C activity [GO:0004435]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell chemotaxis [GO:0002407]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of osteoclast differentiation [GO:0045672]; response to wounding [GO:0009611]" GO:0002407; GO:0004435; GO:0004950; GO:0005737; GO:0005886; GO:0005887; GO:0006816; GO:0006874; GO:0006887; GO:0006935; GO:0006954; GO:0006955; GO:0007155; GO:0007166; GO:0007187; GO:0007204; GO:0007267; GO:0009611; GO:0009897; GO:0010629; GO:0016493; GO:0019221; GO:0019722; GO:0019957; GO:0030335; GO:0030502; GO:0035717; GO:0045672; GO:0051928; GO:0060326; GO:0070098; GO:0070374; GO:0071791; GO:0090026 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine (C-C motif) ligand 5 binding [GO:0071791]; chemokine (C-C motif) ligand 7 binding [GO:0035717]; chemokine receptor activity [GO:0004950]; phosphatidylinositol phospholipase C activity [GO:0004435] AFGAQLLPPLYSLVFVIGLVGNILVVLVLVQYKR 0.99153 -23.77 0 0 0 0 0 0 11.1407 0 0 0 0 0 0 0 10.8523 0 0 0 0 0 0 0 0 0 11.4071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.109 0 0 14.5229 12.3074 14.0668 0 0 0 0 11.6489 0 12.2474 0 0 12.5767 0 0 0 0 0 0 11.9223 12.3441 12.2678 0 0 11.4392 0 0 0 0 0 13.7252 0 13.1523 0 0 0 0 0 13.4547 0 11.8706 0 11.7586 0 13.0447 0 0 0 0 11.3418 11.6313 14.7322 12.4276 0 14.9847 11.4646 0 12.5888 0 13.344 0 0 0 0 0 0 0 0 0 0 11.1957 0 0 0 11.8669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5244 0 0 P39086 GRIK1_HUMAN "Glutamate receptor ionotropic, kainate 1, GluK1 (Excitatory amino acid receptor 3, EAA3) (Glutamate receptor 5, GluR-5, GluR5)" GRIK1 GLUR5 Homo sapiens (Human) "central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; nervous system development [GO:0007399]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] "anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; nervous system development [GO:0007399]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic transmission, glutamatergic [GO:0035249]" GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007399; GO:0007417; GO:0008066; GO:0015276; GO:0015277; GO:0035249; GO:0038023; GO:0043231; GO:0045211; GO:0050804; GO:0051966; GO:0070161; GO:1904315 glutamate receptor activity [GO:0008066]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] DGSTMTFFK 0.99153 -53.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6696 0 0 0 13.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4891 0 0 0 0 0 0 0 0 0 0 0 12.552 0 0 13.2109 13.3369 14.3033 14.0214 0 0 0 0 0 13.6988 13.3066 0 13.445 0 13.6526 0 0 0 0 13.5052 0 0 0 0 0 0 0 0 0 14.5723 0 0 0 0 14.5077 0 0 0 0 0 0 0 0 0 0 13.9337 0 0 0 0 0 0 0 0 16.9738 12.9836 0 0 0 0 Q6ISU1 PTCRA_HUMAN "Pre T-cell antigen receptor alpha, pT-alpha, pTa (pT-alpha-TCR)" PTCRA Homo sapiens (Human) negative regulation of thymocyte apoptotic process [GO:0070244] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; negative regulation of thymocyte apoptotic process [GO:0070244] GO:0016021; GO:0070244 GTPGGALWLGVLRLLLFK 0.99153 -7.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.988 0 0 0 0 0 0 0 11.9757 0 0 0 0 0 0 0 0 0 0 11.5599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5704 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9537 0 0 0 0 0 0 0 0 0 12.6555 11.6515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86US8 EST1A_HUMAN "Telomerase-binding protein EST1A, EC 3.1.-.- (Ever shorter telomeres 1A, hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a)" SMG6 C17orf31 EST1A KIAA0732 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomerase activity [GO:0051972]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomerase activity [GO:0051972]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0042162; GO:0043021; GO:0046872; GO:0051972; GO:0070034; GO:0070182; GO:1904354 DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162] DFMPASK 0.99153 -54.387 0 0 0 0 12.3753 0 0 0 11.4427 0 12.7997 0 0 0 0 0 12.8793 0 0 0 0 0 0 0 0 0 0 0 12.0088 11.9879 0 0 13.5021 12.3575 0 0 0 0 13.7331 0 0 0 12.3692 0 0 0 10.7736 0 0 0 13.3548 0 13.418 12.831 14.551 14.4914 0 13.5715 13.2969 13.3929 13.9815 14.2253 14.1357 13.3108 13.2274 0 0 0 0 0 0 0 0 11.9342 13.8842 13.1279 13.9475 14.1458 0 0 0 14.7523 14.4209 16.2845 13.5355 13.941 0 0 13.3188 0 14.8194 0 0 13.4295 0 0 0 14.0669 0 0 0 0 14.4389 0 0 0 0 13.2038 0 14.359 14.2894 12.0505 0 0 0 12.6129 14.2083 15.1504 0 0 14.2152 0 0 0 14.2829 13.9384 0 0 13.9063 13.8757 13.7153 0 14.2331 14.1687 0 12.7215 0 14.6313 0 14.3033 0 14.5427 0 14.2013 14.219 13.761 14.4351 0 0 0 13.7895 0 0 0 0 12.5261 11.5875 0 0 0 0 0 0 0 0 0 0 0 0 14.0705 0 14.3604 13.8278 0 14.067 13.2166 0 0 0 0 Q9NPB8 GPCP1_HUMAN "Glycerophosphocholine phosphodiesterase GPCPD1, EC 3.1.4.2 (Glycerophosphodiester phosphodiesterase 5)" GPCPD1 GDE5 KIAA1434 Homo sapiens (Human) glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519] cytosol [GO:0005829] cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519] GO:0005829; GO:0007519; GO:0046475; GO:0047389; GO:2001070 glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070] AKGLVIFCWGDDTNDPENRR 0.99153 -23.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5934 0 0 0 0 0 0 0 0 0 0 0 14.456 0 0 0 0 14.1982 0 0 11.7307 0 0 0 0 11.8627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9992 0 10.3337 0 0 12.4447 10.3696 0 0 0 12.0542 15.0472 0 13.3772 0 11.6195 13.9075 13.5733 0 0 13.5266 0 11.3425 0 0 0 0 0 0 0 0 14.1012 12.2022 0 11.8135 0 0 0 0 14.0404 0 0 0 0 0 0 0 0 13.6756 14.4352 14.2913 15.243 0 14.0955 14.115 15.2501 0 0 0 14.7527 0 0 0 0 0 0 0 0 0 0 14.4573 12.765 0 0 13.0515 0 0 0 0 10.8574 14.5921 0 14.0409 13.9824 14.4941 14.7803 0 0 0 0 0 0 0 0 0 10.8581 0 0 0 0 0 0 0 0 0 0 11.5203 0 0 0 Q9NXZ1 SAGE1_HUMAN "Sarcoma antigen 1 (Cancer/testis antigen 14, CT14)" SAGE1 SAGE Homo sapiens (Human) snRNA 3'-end processing [GO:0034472] integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] integrator complex [GO:0032039]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; snRNA 3'-end processing [GO:0034472] GO:0005654; GO:0016604; GO:0032039; GO:0034472 FGQNYER 0.99153 -7.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7214 0 0 0 0 0 0 0 0 0 11.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5226 0 0 13.4238 0 0 0 0 0 13.2064 12.7246 11.703 0 0 13.9168 0 13.6694 13.9027 0 0 0 0 15.97 14.0355 0 15.9915 14.1361 15.7719 16.1538 13.9921 18.2441 15.8809 0 0 0 0 0 0 0 0 13.2779 12.9928 13.2835 0 0 11.9678 0 0 0 12.7987 13.366 14.2864 0 0 0 0 13.028 13.085 0 0 0 0 0 0 13.1163 13.4219 0 0 12.8971 0 0 0 12.6465 12.9805 0 0 0 0 0 0 0 12.9144 0 0 12.1217 0 0 0 0 13.288 0 0 0 12.8875 0 0 0 0 0 0 0 13.1424 13.203 0 13.6807 0 14.2572 0 0 0 0 14.0725 0 0 P49796 RGS3_HUMAN "Regulator of G-protein signaling 3, RGP3, RGS3" RGS3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165] GO:0003924; GO:0005096; GO:0005634; GO:0005829; GO:0005886; GO:0007165; GO:0007186; GO:0008277; GO:0009968 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] DGFGFTICCDSPVR 0.99154 -48.267 0 0 0 14.2319 0 0 14.2681 0 0 0 0 12.4986 0 0 0 13.0862 0 0 0 0 0 0 0 0 14.6559 0 14.541 11.3314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6472 0 0 0 10.1692 0 0 0 0 0 12.5532 0 0 0 13.4622 0 0 0 0 0 0 11.7174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8157 0 0 0 12.8431 0 0 13.9493 0 11.2789 0 12.505 0 0 0 0 0 0 12.7694 0 0 0 0 12.1717 0 0 0 0 12.9181 13.1197 0 0 0 10.3648 0 0 0 0 12.8346 0 0 0 0 0 12.699 0 0 13.8726 0 0 0 12.929 12.133 12.663 0 0 0 0 0 0 13.3214 0 0 0 0 0 0 0 12.6474 0 0 0 0 0 0 0 11.3176 P51787 KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1) KCNQ1 KCNA8 KCNA9 KVLQT1 Homo sapiens (Human) adrenergic receptor signaling pathway [GO:0071875]; atrial cardiac muscle cell action potential [GO:0086014]; auditory receptor cell development [GO:0060117]; cardiac muscle contraction [GO:0060048]; cellular chloride ion homeostasis [GO:0030644]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to xenobiotic stimulus [GO:0071466]; cochlea development [GO:0090102]; corticosterone secretion [GO:0035934]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; erythrocyte differentiation [GO:0030218]; gastrin-induced gastric acid secretion [GO:0001698]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; intestinal absorption [GO:0050892]; iodide transport [GO:0015705]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of gene expression [GO:0010629]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; neuromuscular process [GO:0050905]; non-motile cilium assembly [GO:1905515]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of gastric acid secretion [GO:0060453]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; regulation of voltage-gated sodium channel activity [GO:1905150]; renal absorption [GO:0070293]; renal sodium ion absorption [GO:0070294]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; rhythmic behavior [GO:0007622]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; stomach development [GO:0062094]; ventricular cardiac muscle cell action potential [GO:0086005] apical plasma membrane [GO:0016324]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; voltage-gated potassium channel complex [GO:0008076] "apical plasma membrane [GO:0016324]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; ion channel complex [GO:0034702]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; adrenergic receptor signaling pathway [GO:0071875]; atrial cardiac muscle cell action potential [GO:0086014]; auditory receptor cell development [GO:0060117]; cardiac muscle contraction [GO:0060048]; cellular chloride ion homeostasis [GO:0030644]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to xenobiotic stimulus [GO:0071466]; cochlea development [GO:0090102]; corticosterone secretion [GO:0035934]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; erythrocyte differentiation [GO:0030218]; gastrin-induced gastric acid secretion [GO:0001698]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; intestinal absorption [GO:0050892]; iodide transport [GO:0015705]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of gene expression [GO:0010629]; negative regulation of voltage-gated potassium channel activity [GO:1903817]; neuromuscular process [GO:0050905]; non-motile cilium assembly [GO:1905515]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of gastric acid secretion [GO:0060453]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; regulation of voltage-gated sodium channel activity [GO:1905150]; renal absorption [GO:0070293]; renal sodium ion absorption [GO:0070294]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; rhythmic behavior [GO:0007622]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; stomach development [GO:0062094]; ventricular cardiac muscle cell action potential [GO:0086005]" GO:0001698; GO:0005249; GO:0005251; GO:0005516; GO:0005546; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005886; GO:0006006; GO:0006349; GO:0007507; GO:0007605; GO:0007622; GO:0008016; GO:0008076; GO:0008157; GO:0008217; GO:0009986; GO:0010460; GO:0010467; GO:0010629; GO:0015271; GO:0015705; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0030133; GO:0030218; GO:0030644; GO:0030659; GO:0032868; GO:0034236; GO:0034237; GO:0034702; GO:0035094; GO:0035176; GO:0035934; GO:0042472; GO:0043005; GO:0043025; GO:0044325; GO:0045121; GO:0048839; GO:0050892; GO:0050905; GO:0050910; GO:0055075; GO:0060048; GO:0060117; GO:0060306; GO:0060307; GO:0060372; GO:0060452; GO:0060453; GO:0062094; GO:0070293; GO:0070294; GO:0071320; GO:0071466; GO:0071805; GO:0071872; GO:0071875; GO:0086005; GO:0086008; GO:0086011; GO:0086013; GO:0086014; GO:0086089; GO:0086091; GO:0090102; GO:0097110; GO:0097546; GO:0097623; GO:0098914; GO:0098915; GO:1901381; GO:1902260; GO:1902282; GO:1903817; GO:1905150; GO:1905515; GO:1990573; GO:1990794 "calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein phosphatase 1 binding [GO:0008157]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]" CYAAENPDSSTWK 0.99154 -22.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7294 0 0 0 0 0 0 0 0 0 0 13.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7512 0 0 0 0 13.601 0 0 0 0 0 12.0116 0 0 0 0 0 13.6623 0 0 0 0 0 Q13111 CAF1A_HUMAN "Chromatin assembly factor 1 subunit A, CAF-1 subunit A (Chromatin assembly factor I p150 subunit, CAF-I 150 kDa subunit, CAF-I p150, hp150)" CHAF1A CAF CAF1P150 Homo sapiens (Human) cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334] CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0005634; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042802; GO:0051082; GO:0070087 chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082] AEKQRLK 0.99154 -18.998 0 0 0 0 0 0 0 0 0 0 12.4888 0 0 0 11.2493 10.9438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5779 0 0 14.3056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4365 0 0 0 16.1713 0 0 0 0 0 0 0 0 0 19.2683 0 13.91 13.2393 0 0 0 0 0 13.4566 0 12.6066 13.2216 0 13.611 0 13.2446 0 0 0 0 13.4617 0 0 0 0 15.8851 0 14.8754 0 0 0 11.9576 0 13.314 14.0756 0 13.4813 13.442 0 0 0 13.4035 0 0 13.8245 0 0 0 16.7126 0 0 0 0 16.5569 16.6659 16.7623 0 0 13.8242 0 0 0 0 0 0 0 0 0 0 0 12.5717 13.0596 0 0 0 0 12.5959 0 0 12.8427 12.5015 0 12.9047 0 0 0 0 0 12.2115 0 15.2809 0 Q5T890 ER6L2_HUMAN "DNA excision repair protein ERCC-6-like 2, EC 3.6.4.- (DNA repair and recombination protein RAD26-like)" ERCC6L2 C9orf102 RAD26L Homo sapiens (Human) cellular response to reactive oxygen species [GO:0034614]; interstrand cross-link repair [GO:0036297] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901]; cellular response to reactive oxygen species [GO:0034614]; interstrand cross-link repair [GO:0036297] GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005815; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0140658 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901] AENHMSR 0.99154 -48.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1846 0 13.2315 0 14.2192 0 0 0 0 15.228 13.3578 0 15.7635 0 13.6891 14.2573 0 0 13.0864 0 13.78 13.0735 0 0 12.7839 0 0 0 15.1004 15.4387 0 14.9392 0 0 0 12.5405 0 12.794 0 15.1257 14.1575 0 0 0 13.1384 0 0 0 0 0 17.0473 13.3455 0 12.768 11.1444 11.6484 14.6903 0 0 12.7673 14.0425 0 0 0 12.6399 15.1827 0 0 10.5875 0 0 0 0 0 12.479 13.7318 0 0 0 0 0 0 11.2102 0 0 0 0 0 11.907 0 0 0 0 0 0 0 0 0 0 14.0763 12.1692 11.8394 12.1347 0 0 0 0 Q6AWC2 WWC2_HUMAN Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2) WWC2 BOMB Homo sapiens (Human) "cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; cell migration [GO:0016477]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hippo signaling [GO:0035330]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0035330; GO:0035331; GO:0046621; GO:0060090 kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090] AILTELKSIRK 0.99154 -22.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5558 0 0 0 0 0 0 16.1099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3845 0 0 0 17.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z745 MRO2B_HUMAN "Maestro heat-like repeat-containing protein family member 2B (HEAT repeat-containing protein 7B2) (Sperm PKA-interacting factor, SPIF)" MROH2B HEATR7B2 Homo sapiens (Human) cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; protein kinase A signaling [GO:0010737]; spermatogenesis [GO:0007283] GO:0001669; GO:0005737; GO:0007283; GO:0010737; GO:0030154; GO:0036126; GO:0097225 AAEAALQTLLRRCK 0.99154 -23.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9273 0 0 0 0 12.5701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1787 0 0 0 0 0 0 0 14.8053 12.2224 0 0 0 0 0 0 0 0 0 0 0 0 11.2897 0 0 12.7958 0 15.8565 15.8759 0 0 0 0 0 11.2529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3682 0 0 0 0 0 0 0 0 0 0 0 0 14.9109 0 0 0 0 13.2242 0 0 0 0 0 0 0 0 0 13.6752 14.4136 12.7903 0 12.7504 0 0 0 0 0 0 0 0 0 0 0 0 12.7019 14.2769 12.7651 0 0 0 0 0 0 0 11.5237 0 0 0 0 Q8N1W1 ARG28_HUMAN "Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor, p190-RhoGEF, p190RhoGEF) (Rho guanine nucleotide exchange factor)" ARHGEF28 KIAA1998 RGNEF Homo sapiens (Human) cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; ephrin receptor signaling pathway [GO:0048013]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; ephrin receptor signaling pathway [GO:0048013]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0000902; GO:0003723; GO:0005085; GO:0005829; GO:0005886; GO:0030154; GO:0035023; GO:0046872; GO:0048013; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] DILALLLTDVLLFLQEK 0.99154 -48.358 0 0 0 12.4359 0 10.5225 0 0 0 0 0 10.9961 0 0 0 0 0 0 0 0 0 11.6587 0 0 0 0 0 0 0 0 0 0 0 0 0 10.839 0 0 0 0 15.6371 0 0 0 10.7307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4902 0 13.6565 13.8757 13.7379 0 0 0 0 0 0 10.4001 10.9625 13.7606 0 17.0178 0 0 0 0 0 0 0 16.4795 0 17.4838 0 0 0 0 0 0 13.7327 0 0 0 0 0 0 10.4473 0 0 0 0 0 0 0 0 0 0 0 19.117 0 0 0 0 0 0 0 0 0 13.1824 0 17.3432 0 0 0 13.1903 0 0 0 13.3844 14.1427 0 13.6064 0 0 0 0 0 0 12.754 0 0 0 0 0 0 0 0 0 0 0 13.0906 0 0 0 0 12.5496 12.6339 0 0 0 13.6073 0 18.2207 0 14.1021 0 0 0 0 0 0 Q92547 TOPB1_HUMAN "DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1, TopBP1) (DNA topoisomerase II-binding protein 1)" TOPBP1 KIAA0259 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; response to ionizing radiation [GO:0010212] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922] actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; response to ionizing radiation [GO:0010212] GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005815; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0008022; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0042802; GO:0043231; GO:0070532 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022] ENAGKIMSLLSR 0.99154 -19 0 0 0 0 0 0 0 0 14.0797 0 0 0 0 0 0 0 0 0 10.1445 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0623 13.4705 0 0 0 0 13.6533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1356 15.4483 0 0 0 0 13.8346 14.8074 13.6595 0 0 12.5736 0 0 0 0 0 0 11.1877 14.8993 0 13.1531 0 0 0 11.3664 0 16.6101 0 0 0 0 0 11.7283 0 0 0 0 0 0 0 13.9739 0 0 0 0 0 15.555 0 0 12.6716 0 11.5361 12.8447 0 15.1368 0 0 0 0 13.1203 13.8202 0 14.192 13.5518 14.6814 15.1058 0 13.8914 14.1215 0 12.1216 0 14.3896 12.1329 14.193 0 0 0 0 0 0 0 0 10.8284 0 0 13.6822 0 0 0 0 0 0 0 0 0 14.1347 0 0 0 13.9344 13.7856 0 0 0 0 12.6058 0 Q9BVA0 KTNB1_HUMAN "Katanin p80 WD40 repeat-containing subunit B1, Katanin p80 subunit B1 (p80 katanin)" KATNB1 Homo sapiens (Human) cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of cell death [GO:0010942]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; protein targeting [GO:0006605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; katanin complex [GO:0008352]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; katanin complex [GO:0008352]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013]; mitotic chromosome movement towards spindle pole [GO:0007079]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of cell death [GO:0010942]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; protein targeting [GO:0006605] GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006605; GO:0007019; GO:0007026; GO:0007079; GO:0008017; GO:0008352; GO:0010942; GO:0010976; GO:0015630; GO:0016020; GO:0030426; GO:0030496; GO:0031117; GO:0031122; GO:0043025; GO:0046982; GO:0051013; GO:0051301; GO:0060590; GO:0070840 ATPase regulator activity [GO:0060590]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982] AEIQNAEDYNEIFQPKNSISRTPPR 0.99154 -23.234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2851 0 0 0 0 0 0 11.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3018 0 0 0 0 0 0 0 0 14.8555 0 14.6374 13.4932 15.0468 12.9078 13.0653 13.2979 0 0 0 0 0 0 13.8683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6651 0 11.2211 0 0 0 0 0 0 13.0763 0 0 0 0 0 12.5197 11.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5243 13.2143 11.9078 13.0149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0642 0 0 0 0 0 0 0 Q9H1A7 RPB1C_HUMAN "DNA-directed RNA polymerase II subunit RPB11-b2, RNA polymerase II subunit B11-b2, RPB11b2 (DNA-directed RNA polymerase II subunit J3)" POLR2J3 Homo sapiens (Human) "RNA polymerase II, core complex [GO:0005665]" "RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]" GO:0001055; GO:0003677; GO:0005665; GO:0046983 DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055] FRTCLLPLR 0.99154 -4.5222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4812 0 0 0 0 0 0 0 0 11.0303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.838 0 0 0 0 0 0 0 0 0 0 0 13.7055 0 0 0 0 0 0 0 0 0 0 12.879 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5E8 PCDBF_HUMAN "Protocadherin beta-15, PCDH-beta-15" PCDHB15 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391] integral component of plasma membrane [GO:0005887]; photoreceptor connecting cilium [GO:0032391]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0032391 calcium ion binding [GO:0005509] DSGENGKMICSIQDDVPFKLK 0.99154 -7.1507 0 0 0 0 0 0 0 0 0 9.72146 10.7311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.382 0 0 10.0877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8241 14.1131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8257 0 0 0 0 0 12.2821 0 0 0 0 0 0 0 0 0 15.8452 0 0 12.1593 11.893 0 0 12.9078 0 0 0 0 0 0 0 14.3878 0 0 0 0 0 0 11.021 0 0 0 0 0 0 0 0 0 0 0 0 12.7967 0 0 14.8793 0 0 0 0 0 0 0 0 0 0 12.5145 0 0 10.6746 0 0 0 0 0 0 0 0 0 11.4163 0 0 0 0 0 0 0 0 0 0 0 0 12.5743 11.8674 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2186 0 0 0 0 P69905 HBA_HUMAN Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) [Cleaved into: Hemopressin ] HBA1; HBA2 Homo sapiens (Human) carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542] blood microparticle [GO:0072562]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; membrane [GO:0016020] blood microparticle [GO:0072562]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; hemoglobin complex [GO:0005833]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; carbon dioxide transport [GO:0015670]; cellular oxidant detoxification [GO:0098869]; hydrogen peroxide catabolic process [GO:0042744]; nitric oxide transport [GO:0030185]; oxygen transport [GO:0015671]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542] GO:0001664; GO:0005344; GO:0005506; GO:0005576; GO:0005615; GO:0005829; GO:0005833; GO:0010942; GO:0015670; GO:0015671; GO:0016020; GO:0019825; GO:0020037; GO:0022627; GO:0030185; GO:0031838; GO:0042542; GO:0042744; GO:0043177; GO:0070062; GO:0071682; GO:0072562; GO:0098869 G protein-coupled receptor binding [GO:0001664]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid binding [GO:0043177]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344] MFLSFPTTK 0.99155 -7.5019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5988 16.4197 17.2344 0 0 0 0 0 0 0 0 0 15.1659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.531 0 0 0 0 0 0 0 0 0 0 12.2385 0 0 0 0 0 0 12.0594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P0Q8 MAST2_HUMAN "Microtubule-associated serine/threonine-protein kinase 2, EC 2.7.11.1" MAST2 KIAA0807 MAST205 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0018105; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AISDLAVRR 0.99155 -50.039 0 0 0 0 10.9369 0 0 0 13.909 13.3937 10.918 12.7196 0 12.5225 13.0116 11.9815 0 11.3865 0 0 0 12.6566 12.4627 12.9692 13.2064 0 11.4488 12.249 0 0 0 14.1942 0 0 14.2374 13.403 0 13.1422 0 13.1825 0 0 0 0 0 0 0 12.2442 0 0 13.1024 0 0 0 11.1723 11.2023 0 11.9614 10.2291 0 0 0 10.7453 0 0 0 13.4715 13.7111 0 0 0 13.8452 0 13.9828 13.3218 13.1024 14.9894 13.4569 15.2688 0 14.5164 0 0 14.4815 12.889 0 0 12.5058 0 0 13.4246 0 14.9216 0 11.2847 0 0 0 0 0 0 11.7015 0 0 15.3653 13.8021 16.353 14.5603 14.4768 0 14.0455 0 13.4107 13.7206 0 13.0822 15.394 0 0 16.7132 16.3624 0 14.2697 13.4059 13.4726 0 15.9557 14.039 15.1636 0 13.4251 14.2355 0 0 0 0 0 0 0 0 14.7529 14.645 0 0 12.138 0 0 14.0782 0 11.8022 13.0454 15.0332 0 0 13.2164 0 0 0 0 0 13.7701 0 0 0 0 0 0 16.107 0 14.2263 14.1987 14.9323 15.7651 14.6768 0 14.2524 0 0 11.9514 0 A0A1B0GW54 SIM39_HUMAN Small integral membrane protein 39 SMIM39 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALLRCNLPPGAQRVVVSAVLALLVLINVVLIFLLAFR 0.99155 -7.507 0 0 0 0 0 0 0 0 0 12.0409 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7378 0 0 0 0 0 0 0 13.1229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1286 0 0 0 0 0 0 0 0 0 0 10.0855 0 0 0 0 0 0 0 0 14.3913 0 0 0 0 0 0 0 13.989 0 0 0 0 13.2436 0 0 0 0 0 0 12.7954 0 0 0 0 13.5771 0 0 0 0 0 0 0 0 0 0 0 0 13.5088 12.1196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7224 0 13.3143 0 0 0 13.6861 0 11.7845 11.8495 0 0 0 0 0 0 13.1429 0 0 0 0 0 0 0 0 0 0 11.9404 0 11.4302 0 0 0 12.2567 0 0 0 11.8229 0 A6NFY4 NEMP2_HUMAN Nuclear envelope integral membrane protein 2 NEMP2 TMEM194B Homo sapiens (Human) integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637] GO:0005635; GO:0005637; GO:0016021 HNCQYPENILSFIK 0.99155 -7.5249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0392 0 0 0 0 0 0 0 0 12.0145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0829 0 0 0 0 0 0 0 11.9854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2375 10.9355 12.1145 10.8209 0 0 13.5321 12.6786 0 0 0 0 0 0 0 0 0 10.1325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3839 0 0 11.4916 0 0 0 0 0 0 12.8478 0 0 0 0 0 0 0 0 0 O15169 AXIN1_HUMAN "Axin-1 (Axis inhibition protein 1, hAxin)" AXIN1 AXIN Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; genomic imprinting [GO:0071514]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605]" beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] "beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; genomic imprinting [GO:0071514]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605]" GO:0000209; GO:0001701; GO:0001934; GO:0002039; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0008022; GO:0009950; GO:0010800; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030159; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032147; GO:0032436; GO:0033138; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043507; GO:0043621; GO:0045599; GO:0045732; GO:0045860; GO:0045893; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0051443; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071514; GO:0071944; GO:0090090; GO:1990909; GO:2000060 armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625] ACVRPACAPVLHVVPAVSDMELSETETR 0.99155 -4.6849 11.2493 0 0 0 0 0 0 0 0 12.2213 0 0 0 0 0 0 0 11.5675 0 0 10.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1228 0 0 0 0 0 0 0 0 0 0 0 0 13.7133 10.0926 0 13.6673 14.256 0 0 0 0 13.9954 13.6892 0 14.2437 14.4242 14.2075 13.7568 0 11.7064 13.7102 13.7385 0 14.2243 0 0 0 13.8803 13.8597 18.0732 0 13.9595 14.3055 0 0 0 0 15.5855 0 13.9985 14.1547 0 13.6773 13.8119 0 14.2308 16.3283 0 0 0 0 0 0 0 0 14.0313 14.2476 12.1987 0 0 0 10.6188 0 0 11.8024 0 13.6624 0 0 13.8801 14.1669 0 12.6835 0 0 0 0 O15355 PPM1G_HUMAN "Protein phosphatase 1G, EC 3.1.3.16 (Protein phosphatase 1C) (Protein phosphatase 2C isoform gamma, PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma)" PPM1G PPM1C Homo sapiens (Human) peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726] GO:0004722; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0016020; GO:0017018; GO:0035970; GO:0046872; GO:0051726 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] ALEDAFLAIDAKLTTEEVIKELAQIAGR 0.99155 -7.1644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5678 12.6761 0 0 0 0 0 0 0 0 0 0 0 12.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7707 0 0 0 0 O15554 KCNN4_HUMAN "Intermediate conductance calcium-activated potassium channel protein 4, SK4, SKCa 4, SKCa4 (IKCa1, IK1) (KCa3.1) (KCa4) (Putative Gardos channel)" KCNN4 IK1 IKCA1 KCA4 SK4 Homo sapiens (Human) calcium ion transport [GO:0006816]; cell volume homeostasis [GO:0006884]; defense response [GO:0006952]; establishment of localization in cell [GO:0051649]; immune system process [GO:0002376]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell receptor signaling pathway [GO:0050862]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; saliva secretion [GO:0046541]; stabilization of membrane potential [GO:0030322] cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] cytosol [GO:0005829]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; Intermediate conductance calcium-activated potassium channel activity [GO:0022894]; potassium channel activity [GO:0005267]; protein phosphatase binding [GO:0019903]; small conductance calcium-activated potassium channel activity [GO:0016286]; calcium ion transport [GO:0006816]; cell volume homeostasis [GO:0006884]; defense response [GO:0006952]; establishment of localization in cell [GO:0051649]; immune system process [GO:0002376]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell receptor signaling pathway [GO:0050862]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; saliva secretion [GO:0046541]; stabilization of membrane potential [GO:0030322] GO:0002376; GO:0005267; GO:0005516; GO:0005829; GO:0005886; GO:0006811; GO:0006813; GO:0006816; GO:0006884; GO:0006952; GO:0008076; GO:0015269; GO:0016286; GO:0019903; GO:0022894; GO:0030322; GO:0031982; GO:0043005; GO:0043025; GO:0045332; GO:0046541; GO:0050714; GO:0050862; GO:0051649; GO:0071805; GO:1901381 calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; Intermediate conductance calcium-activated potassium channel activity [GO:0022894]; potassium channel activity [GO:0005267]; protein phosphatase binding [GO:0019903]; small conductance calcium-activated potassium channel activity [GO:0016286] EMKESAAR 0.99155 -7.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95905 ECD_HUMAN "Protein ecdysoneless homolog (Human suppressor of GCR two, hSGT1)" ECD Homo sapiens (Human) fibroblast proliferation [GO:0048144]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; fibroblast proliferation [GO:0048144]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0035035; GO:0045944; GO:0048144; GO:2000045 histone acetyltransferase binding [GO:0035035] AHCFLPAGIVAVLKQRPR 0.99155 -4.6791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2742 0 0 0 12.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8664 0 0 0 0 0 0 0 0 0 0 12.1217 0 0 13.7476 0 0 0 0 0 13.0381 13.5405 0 12.9871 0 0 0 0 0 0 0 15.0591 0 12.2288 0 0 0 0 P41219 PERI_HUMAN Peripherin (Neurofilament 4) PRPH NEF4 PRPH1 Homo sapiens (Human) intermediate filament organization [GO:0045109] axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; type III intermediate filament [GO:0045098] axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; type III intermediate filament [GO:0045098]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005200; GO:0005737; GO:0005882; GO:0005886; GO:0016020; GO:0030424; GO:0043204; GO:0045098; GO:0045109; GO:0070062 structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] AGFSSTSYR 0.99155 -4.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2109 0 0 0 0 0 11.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0267 0 0 0 0 12.92 0 0 0 0 0 0 0 0 0 0 0 12.2927 0 11.8632 0 0 0 0 0 0 0 0 0 0 0 0 0 13.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51965 UB2E1_HUMAN "Ubiquitin-conjugating enzyme E2 E1, EC 2.3.2.23 ((E3-independent) E2 ubiquitin-conjugating enzyme E1, EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme E1) (UbcH6) (Ubiquitin carrier protein E1) (Ubiquitin-protein ligase E1)" UBE2E1 UBCH6 Homo sapiens (Human) histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; ISG15-protein conjugation [GO:0032020]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; ISG15-protein conjugation [GO:0032020]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0010390; GO:0016567; GO:0032020; GO:0033523; GO:0042296; GO:0061631; GO:0070936 ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] AEHDRMAR 0.99155 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6T310 RSLBA_HUMAN "Ras-like protein family member 11A, EC 3.6.5.2" RASL11A Homo sapiens (Human) positive regulation of transcription by RNA polymerase I [GO:0045943] nucleolus [GO:0005730] nucleolus [GO:0005730]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; positive regulation of transcription by RNA polymerase I [GO:0045943] GO:0003925; GO:0005525; GO:0005730; GO:0045943 G protein activity [GO:0003925]; GTP binding [GO:0005525] RASIIPRPR 0.99155 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3X6 LCORL_HUMAN "Ligand-dependent nuclear receptor corepressor-like protein, LCoR-like protein" LCORL Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0005634; GO:0006357; GO:1990226 DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226] AGILYGIPQKTLLLHLEALPAGK 0.99155 -7.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3343 0 13.0611 0 0 0 0 12.708 0 0 12.9311 12.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4247 13.5832 0 0 0 0 0 0 0 0 0 0 0 13.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUM4 PDC6I_HUMAN "Programmed cell death 6-interacting protein, PDCD6-interacting protein (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95)" PDCD6IP AIP1 ALIX KIAA1375 Homo sapiens (Human) actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702] actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815] actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702] GO:0000281; GO:0000915; GO:0001772; GO:0005768; GO:0005815; GO:0005829; GO:0005923; GO:0005925; GO:0006915; GO:0010824; GO:0015031; GO:0016020; GO:0031871; GO:0036258; GO:0039702; GO:0042470; GO:0042641; GO:0042803; GO:0045199; GO:0046755; GO:0048306; GO:0051260; GO:0061952; GO:0070062; GO:0070830; GO:0070971; GO:0071985; GO:0090543; GO:0090559; GO:0090611; GO:1903543; GO:1903551; GO:1903553; GO:1903561 calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871] ATFISVQLK 0.99155 -4.5325 0 0 0 0 0 10.8035 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5082 0 0 0 0 0 0 0 13.4411 12.4889 0 0 13.4206 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0227 0 13.6657 0 0 0 14.8405 13.8425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0692 13.5682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3073 14.8532 14.2187 13.6025 0 0 13.3066 0 0 0 0 0 12.6658 0 0 0 0 12.7212 0 0 0 13.1883 0 0 Q9BZM6 ULBP1_HUMAN "UL16-binding protein 1 (ALCAN-beta) (NKG2D ligand 1, N2DL-1, NKG2DL1) (Retinoic acid early transcript 1I)" ULBP1 N2DL1 RAET1I Homo sapiens (Human) natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267] anchored component of plasma membrane [GO:0046658]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267] GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0009897; GO:0030101; GO:0042267; GO:0046658; GO:0046703 natural killer cell lectin-like receptor binding [GO:0046703] AFASLGKK 0.99155 -19.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3753 0 0 0 0 0 10.2889 0 0 0 0 10.5673 0 0 0 0 0 0 0 0 0 0 10.0403 0 0 0 0 11.2963 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6 11.9246 0 0 0 0 0 0 0 0 0 10.7737 12.0508 13.7166 0 0 0 14.8229 12.8157 12.8468 0 0 0 13.3122 10.3712 0 0 0 0 0 0 0 0 11.8498 0 11.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5856 0 0 0 0 0 0 0 0 0 11.9823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.30289 0 Q13315 ATM_HUMAN "Serine-protein kinase ATM, EC 2.7.11.1 (Ataxia telangiectasia mutated, A-T mutated)" ATM Homo sapiens (Human) "brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; spindle [GO:0005819] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; spindle [GO:0005819]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; reciprocal meiotic recombination [GO:0007131]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of cellular response to heat [GO:1900034]; regulation of microglial cell activation [GO:1903978]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]" GO:0000077; GO:0000723; GO:0000724; GO:0001541; GO:0001666; GO:0001756; GO:0002331; GO:0003677; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0005829; GO:0006302; GO:0006303; GO:0006468; GO:0006974; GO:0006975; GO:0006977; GO:0007094; GO:0007095; GO:0007131; GO:0007140; GO:0007143; GO:0007165; GO:0007420; GO:0007507; GO:0008340; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0016572; GO:0018105; GO:0030335; GO:0030889; GO:0031410; GO:0032210; GO:0032212; GO:0033129; GO:0033151; GO:0035264; GO:0036289; GO:0042159; GO:0042802; GO:0042981; GO:0043065; GO:0043231; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0047485; GO:0048538; GO:0048599; GO:0051402; GO:0051726; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0090398; GO:0090399; GO:0097694; GO:0097695; GO:0106310; GO:1900034; GO:1901796; GO:1903626; GO:1903978; GO:1904262; GO:1904354; GO:1904358; GO:1904884; GO:1905843; GO:1990391 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] CANRRAPR 0.99156 -51.378 0 0 0 0 0 14.0292 0 0 0 0 0 0 0 0 0 0 14.2781 0 14.8889 0 12.6693 0 15.5097 0 0 14.3831 13.8825 0 12.2691 0 12.0327 0 13.2614 14.3702 0 0 0 12.9284 14.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7889 13.979 14.3809 0 0 0 0 0 0 0 0 11.3889 12.7918 14.0519 12.5943 0 0 0 14.6101 15.6739 9.46548 0 15.3031 0 14.9367 14.5254 16.2047 13.9764 12.6715 15.3149 15.2074 12.0227 0 11.634 0 13.1972 0 13.5946 14.3173 13.8211 10.8057 0 12.4352 0 0 15.9682 13.8635 0 0 11.5647 13.6872 15.0868 12.6005 12.4055 12.8595 0 15.5071 13.7918 0 0 0 15.0579 13.4454 16.0398 16.6584 0 0 0 0 0 0 12.1752 14.6007 0 12.833 0 0 0 11.5078 14.8097 14.8338 14.2362 0 15.0155 15.6569 15.0244 13.7449 0 13.1246 13.8268 14.0005 14.3571 14.31 15.0338 0 13.7813 14.1 0 0 0 0 12.5287 17.0319 0 0 0 0 0 0 0 0 15.32 0 0 0 0 12.1554 0 16.4856 10.8742 14.8749 0 14.1758 0 12.7524 14.002 0 A2A368 MAGBG_HUMAN Melanoma-associated antigen B16 (MAGE-B16 antigen) MAGEB16 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 GVPKTGLLIIVLGVIFMK 0.99156 -7.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1301 0 0 0 0 0 0 0 0 0 0 0 0 12.9447 0 0 0 0 0 0 0 13.6272 0 0 0 0 13.9754 15.1824 0 0 0 0 0 0 0 O94761 RECQ4_HUMAN "ATP-dependent DNA helicase Q4, EC 3.6.4.12 (DNA helicase, RecQ-like type 4, RecQ4) (RTS) (RecQ protein-like 4)" RECQL4 RECQ4 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820] "chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]" GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0032508; GO:0061820; GO:0061821; GO:1990814 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821] ALCQLQWDHEPR 0.99156 -22.813 0 0 0 0 0 0 0 0 0 0 9.03166 0 0 0 0 12.9723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4888 12.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5546 0 0 0 0 0 0 0 0 0 0 0 12.9574 0 0 0 0 0 0 0 0 0 0 10.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9244 0 0 0 0 0 0 14.4317 0 0 0 13.4856 0 14.4403 0 0 0 14.836 13.3012 0 0 13.2555 0 0 0 0 0 0 0 0 0 0 11.8402 14.1108 P26572 MGAT1_HUMAN "Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, EC 2.4.1.101 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I, GNT-I, GlcNAc-T I)" MGAT1 GGNT1 GLCT1 GLYT1 MGAT Homo sapiens (Human) in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]; viral protein processing [GO:0019082] endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] "endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]; in utero embryonic development [GO:0001701]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]; viral protein processing [GO:0019082]" GO:0000139; GO:0001701; GO:0003827; GO:0005794; GO:0006049; GO:0006486; GO:0006487; GO:0008375; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030145; GO:0033116; GO:0048471; GO:0070062; GO:1903561 "acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]" PEISRTMTFGRK 0.99156 -7.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49770 EI2BB_HUMAN Translation initiation factor eIF-2B subunit beta (S20I15) (S20III15) (eIF-2B GDP-GTP exchange factor subunit beta) EIF2B2 EIF2BB Homo sapiens (Human) central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; regulation of catalytic activity [GO:0050790]; regulation of translational initiation [GO:0006446]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; regulation of catalytic activity [GO:0050790]; regulation of translational initiation [GO:0006446]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] GO:0001541; GO:0003743; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0006446; GO:0007417; GO:0009408; GO:0009749; GO:0014003; GO:0042552; GO:0043434; GO:0050790; GO:0050852 ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743] ETLGLLRQIITDHR 0.99156 -22.806 0 0 0 0 0 0 0 0 0 0 13.216 0 0 0 9.97169 0 12.9681 0 0 0 0 0 0 0 12.5855 0 12.9971 13.7535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9248 0 0 0 12.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9717 0 0 0 0 0 0 0 0 11.1317 0 0 0 0 0 15.2098 13.6229 0 0 0 0 0 12.7212 0 0 0 0 0 0 0 0 0 13.4316 0 0 0 0 0 0 0 0 0 14.4282 0 0 0 0 0 0 14.1789 14.8748 13.4528 0 0 15.3639 14.3518 16.4524 14.2494 0 15.9582 0 13.312 13.5827 0 0 14.4927 0 14.7031 0 0 0 0 0 14.2733 0 17.8338 0 0 0 0 0 0 0 0 0 0 0 16.0617 0 0 0 0 0 13.6041 0 0 0 0 12.6938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58557 YBEY_HUMAN "Endoribonuclease YbeY, EC 3.1.-.-" YBEY C21orf57 Homo sapiens (Human) rRNA processing [GO:0006364] nucleus [GO:0005634] nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; rRNA processing [GO:0006364] GO:0004222; GO:0004521; GO:0005634; GO:0006364; GO:0046872 endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] FDLGIICVDNKNIQHINR 0.99156 -22.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 9.38375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5059 0 0 0 14.5621 0 0 13.4497 0 0 0 0 0 13.2632 0 0 0 0 0 0 13.5754 13.3962 0 0 0 0 11.7205 0 0 0 0 0 0 0 0 0 13.1946 0 0 0 0 0 13.3038 12.041 0 0 0 0 0 0 10.6316 13.1789 0 0 0 0 0 0 0 0 0 0 0 13.8124 0 0 0 0 0 14.3809 0 0 0 13.312 0 12.3402 0 13.4883 0 0 0 0 0 0 0 12.6112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14094 CCNI_HUMAN Cyclin-I CCNI Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; spermatogenesis [GO:0007283] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0007283; GO:0016538; GO:0031965; GO:0044772 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] DEVIQWLAKLK 0.99156 -22.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T5J6 SWT1_HUMAN Transcriptional protein SWT1 SWT1 C1orf26 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 DIHKCVDFK 0.99156 -22.18 0 0 0 16.5658 0 0 0 0 0 13.685 14.2786 13.3092 14.1499 0 12.1724 12.2888 15.0241 13.2958 13.7985 0 14.0241 0 12.6002 0 0 0 13.769 13.4621 13.2283 13.3207 13.9923 13.646 0 12.1826 12.66 12.2549 0 0 13.2168 0 0 12.8959 14.8915 0 14.5467 0 13.0381 13.1244 14.081 0 0 13.8028 0 14.2238 15.2168 15.5344 15.5912 16.2878 15.0611 15.3972 14.633 14.2591 12.7654 14.1669 13.7094 13.6996 0 0 0 0 0 0 0 16.1562 0 0 0 0 0 0 13.3693 0 0 0 14.8297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1856 0 11.2778 0 0 0 0 0 11.8823 14.3648 0 0 0 0 12.5521 0 0 13.6398 14.1813 0 0 0 0 0 14.0172 15.135 14.1532 16.3508 0 14.5324 14.5072 13.7899 0 0 0 0 12.8655 14.4257 0 14.2679 0 0 Q5VIY5 ZN468_HUMAN Zinc finger protein 468 ZNF468 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IHSGEKPYKCEECCK 0.99156 -7.1773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.792 0 0 12.8975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P6C2 ALKB5_HUMAN "RNA demethylase ALKBH5, EC 1.14.11.53 (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5)" ALKBH5 ABH5 OFOXD1 Homo sapiens (Human) cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; oxidative single-stranded RNA demethylation [GO:0035553]; regulation of mRNA stability [GO:0043488]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; oxidative single-stranded RNA demethylation [GO:0035553]; regulation of mRNA stability [GO:0043488]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283] GO:0001666; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006406; GO:0007283; GO:0016607; GO:0016706; GO:0030154; GO:0035515; GO:0035553; GO:0043488; GO:0046872; GO:1990931 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515]; RNA binding [GO:0003723] LYPPGDVDEIPEWVHQLVIQKLVEHR 0.99156 -4.6955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8143 0 0 0 0 14.9513 0 0 10.503 0 0 10.1293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4365 0 9.2009 10.3085 0 0 10.6283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.42 12.6005 0 10.106 0 0 0 0 10.4311 0 0 0 0 0 0 0 0 15.4789 0 0 0 0 0 18.1384 0 0 11.0441 11.3368 0 0 17.3016 0 0 0 0 0 0 0 14.2359 0 0 0 0 0 0 11.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7298 0 0 0 0 0 0 0 0 0 0 Q7L2R6 ZN765_HUMAN Zinc finger protein 765 ZNF765 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEDCDEAFSFK 0.99156 -4.687 0 0 0 0 11.1435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0879 0 0 0 0 0 0 0 13.0458 0 12.9688 0 0 0 0 10.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.931 13.68 0 0 0 0 0 0 0 13.0323 0 0 0 0 0 0 0 0 0 14.2277 0 0 0 11.9861 0 0 0 0 0 12.3947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVW1 ARL17_HUMAN ADP-ribosylation factor-like protein 17 (ADP-ribosylation factor 7 variant) ARL17A ARL17P1; ARL17B ARF1P2 ARL17A PRO2667 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005794; GO:0005886; GO:0006886; GO:0016192 GTP binding [GO:0005525]; GTPase activity [GO:0003924] LFKSLLGK 0.99156 -4.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N531 FBXL6_HUMAN F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A) FBXL6 FBL6 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0019005; GO:0031146; GO:0043153; GO:0051726 ubiquitin-protein transferase activity [GO:0004842] ASRRTPR 0.99156 -22.214 0 0 0 0 0 0 0 10.0711 0 0 0 0 11.5521 0 0 0 0 0 13.6188 0 0 0 0 0 0 0 0 0 13.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3011 0 0 0 13.2164 0 0 0 0 16.2704 0 0 16.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8506 0 0 0 12.9095 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6928 0 0 0 0 0 0 14.5974 0 0 0 0 13.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUZ0 BCL7C_HUMAN B-cell CLL/lymphoma 7 protein family member C BCL7C Homo sapiens (Human) apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; GBAF complex [GO:0140288]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; GBAF complex [GO:0140288]; SWI/SNF complex [GO:0016514]; apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000785; GO:0006338; GO:0006357; GO:0006915; GO:0008284; GO:0016514; GO:0030071; GO:0045596; GO:0070316; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 AGGGAER 0.99156 -4.6987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3238 0 14.6059 0 0 14.692 0 0 0 0 0 0 0 14.759 14.9985 0 0 14.8492 14.9805 15.1893 0 14.809 0 14.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.697 15.2712 15.5281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96C12 ARMC5_HUMAN Armadillo repeat-containing protein 5 ARMC5 Homo sapiens (Human) "adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cell development [GO:0048468]; defense response to virus [GO:0051607]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cell development [GO:0048468]; defense response to virus [GO:0051607]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]" GO:0001701; GO:0001707; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0009653; GO:0016020; GO:0035801; GO:0042098; GO:0043367; GO:0048468; GO:0050810; GO:0051607 ALLELSRGCSR 0.99156 -4.7019 0 0 0 0 0 0 0 0 0 13.3348 0 0 0 0 0 0 0 0 0 0 0 11.7335 0 12.8101 0 0 12.4717 0 0 0 0 13.1335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3584 15.6947 15.3886 15.9847 0 15.7535 15.9443 15.8906 15.0018 0 15.8561 15.7335 13.5702 13.5638 0 0 0 0 0 0 0 0 0 0 0 9.33702 0 12.5713 0 0 0 0 0 14.6623 14.9976 15.1275 0 13.9361 0 0 14.4784 0 15.7386 9.86841 14.5346 0 0 0 13.2199 14.2421 0 14.9608 14.2784 13.2006 14.3168 13.2734 0 13.7523 0 0 13.6275 14.8188 0 13.8259 13.7096 14.8875 0 14.3056 0 0 0 0 13.6819 13.6648 13.2989 0 0 13.3102 0 0 13.4102 0 0 0 0 0 0 14.5404 0 12.7922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9405 0 0 12.3957 0 0 13.6656 0 Q96C24 SYTL4_HUMAN Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin) SYTL4 Homo sapiens (Human) exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684] endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; transport vesicle membrane [GO:0030658] endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684] GO:0001778; GO:0005543; GO:0005768; GO:0005886; GO:0006886; GO:0006887; GO:0019898; GO:0030073; GO:0030658; GO:0031092; GO:0031267; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0046872; GO:0050714; GO:0070382; GO:0071985; GO:1905684 metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267] EAKNLTAAK 0.99156 -22.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.896 0 0 0 0 13.2191 0 0 0 0 0 0 0 0 0 0 0 0 13.9975 0 13.2339 13.3222 0 0 0 0 13.2814 0 13.6272 0 15.4324 0 13.3081 0 13.6905 0 0 13.4743 13.7372 0 13.6729 14.097 13.8549 0 0 0 0 0 13.4093 0 14.2616 13.5098 0 0 0 15.358 0 0 0 14.9275 0 0 0 0 0 0 0 0 0 0 0 13.432 0 0 0 13.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DX8 RTP4_HUMAN Receptor-transporting protein 4 (28 kDa interferon-responsive protein) (3CxxC-type zinc finger protein 4) RTP4 IFRG28 Z3CXXC4 Homo sapiens (Human) defense response to virus [GO:0051607]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; olfactory receptor binding [GO:0031849]; defense response to virus [GO:0051607]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] GO:0001580; GO:0005737; GO:0006612; GO:0016021; GO:0031849; GO:0051205; GO:0051607 olfactory receptor binding [GO:0031849] CQKCSWSQYEMPEFSSDSTMR 0.99156 -22.917 0 0 0 0 0 0 11.9438 0 13.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2939 0 0 0 0 12.3609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0067 0 11.1549 13.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4151 0 0 0 0 0 0 13.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3091 0 0 0 0 0 0 Q96MC4 C295L_HUMAN CEP295 N-terminal-like protein (KIAA1731 N-terminal like protein) CEP295NL KIAA1731NL Homo sapiens (Human) regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule binding [GO:0008017]; regulation of centriole replication [GO:0046599] GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0008017; GO:0046599 microtubule binding [GO:0008017] ADAKLWKNYQLQR 0.99156 -50.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4308 0 0 0 13.3419 0 0 0 0 0 0 0 0 12.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7432 0 13.7163 14.5796 0 0 0 0 14.144 13.7008 13.3794 0 0 0 11.3907 14.4029 0 0 14.1223 0 0 0 0 0 13.2214 0 0 0 0 0 15.2767 0 0 0 0 0 0 0 12.2211 0 13.1829 0 0 0 0 15.1498 14.9703 14.8924 0 0 0 0 0 0 0 14.6963 14.5552 0 14.5709 0 0 13.5575 0 12.9942 0 0 13.8234 0 0 0 0 12.3837 14.748 0 13.4746 0 0 0 0 0 13.3772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5L6 THAP9_HUMAN "DNA transposase THAP9, EC 2.7.7.- (THAP domain-containing protein 9, hTh9)" THAP9 Homo sapiens (Human) "DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, DNA-mediated [GO:0006313]" "DNA binding [GO:0003677]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transferase activity [GO:0016740]; transposase activity [GO:0004803]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition, DNA-mediated [GO:0006313]" GO:0003677; GO:0004803; GO:0006310; GO:0006313; GO:0015074; GO:0016740; GO:0043565; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transferase activity [GO:0016740]; transposase activity [GO:0004803] ASKIGSLLFVKK 0.99156 -18.644 12.5549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4906 0 0 0 0 0 10.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5795 0 0 0 12.0835 0 0 0 0 12.1582 13.0102 13.1731 14.8475 13.5454 16.6987 0 0 14.6067 12.8343 0 0 0 0 0 0 12.3051 0 11.6696 0 10.5446 0 0 0 0 13.5166 0 14.7385 0 0 10.8604 0 0 11.3557 0 0 0 0 12.2905 0 0 0 0 0 0 14.1951 0 0 0 0 12.9626 0 11.8491 0 10.8402 0 0 11.4325 0 0 0 0 0 0 0 12.4071 0 0 0 0 0 0 0 0 0 0 10.8688 0 0 0 0 0 0 0 0 0 0 0 0 12.4435 Q9H6L5 RETR1_HUMAN Reticulophagy regulator 1 (Reticulophagy receptor 1) RETREG1 FAM134B JK1 Homo sapiens (Human) collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; mitophagy [GO:0000423]; negative regulation of neuron apoptotic process [GO:0043524]; reticulophagy [GO:0061709]; sensory perception of pain [GO:0019233]; white fat cell differentiation [GO:0050872] cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear body [GO:0016604]; nucleolus [GO:0005730] cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; mitophagy [GO:0000423]; negative regulation of neuron apoptotic process [GO:0043524]; reticulophagy [GO:0061709]; sensory perception of pain [GO:0019233]; white fat cell differentiation [GO:0050872] GO:0000423; GO:0005730; GO:0005783; GO:0005801; GO:0007029; GO:0016604; GO:0019233; GO:0030176; GO:0030574; GO:0043524; GO:0050872; GO:0061709; GO:0140506 endoplasmic reticulum-autophagosome adaptor activity [GO:0140506] ERSEADKEK 0.99156 -4.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3855 0 0 0 0 0 0 0 0 0 0 0 12.2543 0 12.8902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ76 MEPE_HUMAN "Matrix extracellular phosphoglycoprotein (Osteoblast/osteocyte factor 45, OF45) (Osteoregulin)" MEPE Homo sapiens (Human) biomineral tissue development [GO:0031214]; skeletal system development [GO:0001501] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix protein binding [GO:1990430]; extracellular matrix structural constituent [GO:0005201]; biomineral tissue development [GO:0031214]; skeletal system development [GO:0001501] GO:0001501; GO:0005201; GO:0005576; GO:0005788; GO:0031012; GO:0031214; GO:1990430 extracellular matrix protein binding [GO:1990430]; extracellular matrix structural constituent [GO:0005201] AHSKDKK 0.99156 -7.5273 0 0 0 0 0 0 0 9.81369 0 0 0 0 0 0 0 0 0 12.3818 0 0 0 0 0 11.7005 0 0 10.802 13.1311 0 0 0 0 12.1082 0 0 0 0 0 0 0 0 0 0 0 11.6317 0 0 0 0 0 0 0 0 0 11.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6878 0 0 0 0 0 0 0 12.214 12.7618 0 12.9272 14.79 0 0 0 0 0 0 0 13.5342 0 0 0 12.8444 20.4682 0 12.5595 0 0 0 0 0 0 12.0196 0 0 11.1635 12.5277 12.2872 0 0 0 0 0 0 0 0 0 12.9482 0 0 0 0 13.9185 0 0 0 10.3085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8441 0 0 0 0 0 0 0 12.4996 12.5382 0 0 0 12.9598 0 0 0 0 12.9985 0 12.6265 0 0 0 12.8012 12.3502 0 12.8661 13.2662 0 0 0 0 Q9NRG9 AAAS_HUMAN Aladin (Adracalin) AAAS ADRACALA GL003 Homo sapiens (Human) fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822] GO:0000922; GO:0001578; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006913; GO:0007612; GO:0009566; GO:0015031; GO:0016020; GO:0031965; GO:0046822; GO:0051028; GO:0072686; GO:0090307 CQTGCWSPDGSR 0.99156 -22.148 0 0 0 0 0 0 11.9282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4329 0 0 0 10.3599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6471 0 0 0 0 0 0 0 0 0 0 0 15.0854 0 0 0 0 0 14.1099 9.48422 0 0 0 14.2328 0 14.8246 13.6216 13.6102 0 0 0 12.9769 0 0 0 0 13.8215 0 0 13.4939 0 14.1475 0 0 0 0 12.8005 0 0 0 0 0 0 13.1824 0 13.9044 14.003 0 13.7529 0 0 0 12.7092 0 0 0 0 0 0 13.3439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2023 12.9388 0 0 12.6401 0 0 0 0 0 13.2955 0 12.4869 0 Q9NZ08 ERAP1_HUMAN "Endoplasmic reticulum aminopeptidase 1, EC 3.4.11.- (ARTS-1) (Adipocyte-derived leucine aminopeptidase, A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase, PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator)" ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154 Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; fat cell differentiation [GO:0045444]; membrane protein ectodomain proteolysis [GO:0006509]; peptide catabolic process [GO:0043171]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]" GO:0001525; GO:0002250; GO:0002474; GO:0004175; GO:0004177; GO:0005138; GO:0005151; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007165; GO:0008217; GO:0008235; GO:0008270; GO:0009617; GO:0016020; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0045088; GO:0045444; GO:0045766; GO:0070006; GO:0070062 "aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-6 receptor binding [GO:0005138]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]" AFLIRLLR 0.99156 -18.641 0 0 0 0 0 0 0 0 0 12.6833 0 0 0 0 0 0 0 0 12.0706 0 0 0 12.4555 0 0 0 0 0 0 0 0 0 0 12.3073 0 0 0 0 0 0 0 12.3544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5187 0 12.8637 0 0 0 0 0 0 0 0 0 0 0 0 13.1726 13.3933 0 0 0 0 0 0 0 13.3184 0 0 0 0 0 14.0901 0 13.7917 0 0 0 0 0 0 0 0 0 12.5619 0 0 12.5133 0 0 14.6171 0 0 12.1527 12.7087 0 0 13.1734 0 0 0 0 0 0 0 0 0 0 13.029 0 13.7703 0 0 0 0 0 0 13.3625 13.7121 0 0 0 0 Q9P2B7 CFA97_HUMAN Cilia- and flagella-associated protein 97 CFAP97 KIAA1430 Homo sapiens (Human) spermatogenesis [GO:0007283] spermatogenesis [GO:0007283] GO:0007283 EGEDDYYTDGEESSDDGK 0.99156 -18.656 11.9576 0 0 0 0 0 0 0 10.103 12.6385 0 0 12.2945 0 0 0 13.4906 0 0 13.4955 0 0 0 0 12.5962 13.6204 0 0 0 0 12.6278 0 0 12.0061 0 0 13.1336 0 0 0 0 0 14.2808 0 0 14.001 0 11.0185 12.9883 0 0 0 15.8828 15.285 13.0184 12.9957 13.3551 0 12.4842 0 12.424 0 12.8872 11.8168 0 11.1215 0 0 0 0 0 12.6742 0 0 0 0 0 12.0966 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6245 0 0 0 0 13.1392 0 0 13.2648 0 0 0 0 0 0 0 0 0 0 0 0 14.0314 0 0 0 0 0 0 0 0 11.911 0 0 0 12.7833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5071 0 0 0 12.962 0 0 0 0 0 0 0 0 0 0 Q9Y251 HPSE_HUMAN "Heparanase, EC 3.2.1.166 (Endo-glucoronidase) (Heparanase-1, Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit ]" HPSE HEP HPA HPA1 HPR1 HPSE1 HSE1 Homo sapiens (Human) angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; Factor XII activation [GO:0002542]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin metabolic process [GO:0030202]; inflammatory response [GO:0006954]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to organic substance [GO:0010033]; vascular wound healing [GO:0061042] autophagosome [GO:0005776]; endosome [GO:0005768]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; heparanase complex [GO:1904974]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] autophagosome [GO:0005776]; endosome [GO:0005768]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; heparanase complex [GO:1904974]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545]; angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; Factor XII activation [GO:0002542]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin metabolic process [GO:0030202]; inflammatory response [GO:0006954]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to organic substance [GO:0010033]; vascular wound healing [GO:0061042] GO:0001954; GO:0002542; GO:0004566; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0005768; GO:0005776; GO:0006029; GO:0006954; GO:0007160; GO:0008284; GO:0010033; GO:0010508; GO:0010575; GO:0030194; GO:0030200; GO:0030202; GO:0030305; GO:0030335; GO:0031012; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0045121; GO:0045545; GO:0045766; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061028; GO:0061042; GO:0071806; GO:0090091; GO:1900026; GO:1904974 beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545] ESTFEER 0.99156 -4.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0345 12.4409 0 15.6763 0 0 0 0 0 0 15.9044 0 0 13.4528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y468 LMBL1_HUMAN "Lethal(3)malignant brain tumor-like protein 1, H-l(3)mbt, H-l(3)mbt protein, L(3)mbt-like (L(3)mbt protein homolog) (L3MBTL1)" L3MBTL1 KIAA0681 L3MBT L3MBTL Homo sapiens (Human) "chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitotic nuclear division [GO:0007088]" chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; condensed chromosome [GO:0000793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; condensed chromosome [GO:0000793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; nucleosome binding [GO:0031491]; SAM domain binding [GO:0032093]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; hemopoiesis [GO:0030097]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cell cycle [GO:0051726]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of mitotic nuclear division [GO:0007088]" GO:0000785; GO:0000793; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0007088; GO:0008270; GO:0030097; GO:0031491; GO:0031507; GO:0032093; GO:0035064; GO:0042393; GO:0042802; GO:0045652; GO:0045892; GO:0051726; GO:0061793 chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; nucleosome binding [GO:0031491]; SAM domain binding [GO:0032093]; zinc ion binding [GO:0008270] GYKEEEFSWSQYLR 0.99156 -4.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8695 0 0 0 0 0 0 0 12.2926 0 0 11.594 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8436 0 0 0 0 0 0 0 0 0 0 11.9977 0 0 0 0 0 0 0 12.1561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7418 0 0 0 0 0 0 0 0 0 0 0 0 12.1885 0 0 0 0 0 0 0 0 0 0 0 0 12.1648 0 0 0 13.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2742 0 13.3267 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5B6 PAXB1_HUMAN PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1) PAXBP1 C21orf66 GCFC GCFC1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; transcription by RNA polymerase II [GO:0006366]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; transcription by RNA polymerase II [GO:0006366]" GO:0000398; GO:0003677; GO:0005634; GO:0005829; GO:0006366; GO:0007517; GO:0014842; GO:0031062; GO:0045944; GO:2000288 DNA binding [GO:0003677] ALLLRMR 0.99156 -22.8 0 0 0 0 0 11.9449 11.8688 0 13.3453 0 0 12.7159 0 0 0 0 0 0 13.4564 12.5186 12.1166 0 14.138 0 11.6335 0 0 0 0 0 0 12.878 11.1745 0 12.4418 12.8892 0 12.6704 0 12.8951 0 0 10.5267 0 10.7145 12.2237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9765 0 0 0 10.0485 12.096 0 0 12.5143 10.7223 0 11.2827 15.3336 0 12.2468 12.8619 0 0 13.3136 12.8592 0 11.3108 0 0 12.7847 12.5416 0 13.6177 11.29 12.8375 14.6022 11.0645 0 12.8873 0 11.1943 0 13.1148 0 0 13.7891 12.8795 0 12.0094 12.9066 0 11.9571 16.4599 13.3062 0 0 12.4953 0 0 0 0 0 15.6631 0 0 0 0 0 20.0566 0 0 20.5944 12.4894 0 13.687 12.969 12.157 12.5117 0 0 12.2611 19.8415 0 0 0 0 0 0 0 0 0 14.1266 0 12.5131 12.7278 0 12.0231 0 0 0 0 13.1481 12.5202 14.8607 11.5803 0 14.5577 13.7079 12.396 0 12.7082 11.775 0 12.0268 0 14.3691 15.6237 0 0 13.8595 0 0 0 12.0515 Q9Y618 NCOR2_HUMAN "Nuclear receptor corepressor 2, N-CoR2 (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor, SMRT) (T3 receptor-associating factor, TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)" NCOR2 CTG26 Homo sapiens (Human) "estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243]" chromatin [GO:0000785]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear retinoid X receptor binding [GO:0046965]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243]" GO:0000122; GO:0000785; GO:0003677; GO:0003682; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0010243; GO:0010565; GO:0016020; GO:0016363; GO:0016604; GO:0017053; GO:0032355; GO:0035259; GO:0042826; GO:0044849; GO:0044877; GO:0045892; GO:0046965; GO:0047485; GO:0060766; GO:1903799 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear retinoid X receptor binding [GO:0046965]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714] ACYEESLK 0.99157 -54.115 0 0 14.0826 13.4993 13.5727 0 12.1675 12.6895 0 0 0 12.2789 10.3972 0 12.476 0 0 0 0 0 0 12.3054 0 12.2017 0 0 0 0 12.6525 12.6313 0 0 0 0 0 0 0 0 0 0 0 0 11.6659 0 0 0 0 0 0 0 0 0 0 12.6066 12.4167 12.977 12.9003 12.924 0 0 0 0 11.3132 12.0259 0 0 0 0 0 0 0 0 0 13.8031 0 14.9515 12.9686 15.3562 14.449 15.1163 13.9837 14.8975 0 0 16.0593 15.189 15.0423 15.8926 15.4802 15.4178 15.8249 15.1374 14.4135 19.8525 14.4471 15.3832 0 15.0309 14.1215 14.3935 14.5946 15.4744 19.5418 19.5359 11.2504 16.0202 15.0569 14.1003 0 15.2399 19.8287 12.6717 15.8503 14.9504 13.2089 13.5505 15.4761 14.3786 14.4832 16.7209 15.6296 16.467 19.5521 0 0 14.7656 16.2608 0 14.8397 14.6381 15.7433 15.2299 14.8037 0 16.0151 15.4965 0 16.1326 14.4885 15.3873 0 15.5455 0 14.3589 15.7131 13.0513 15.9361 0 15.1044 13.8737 16.2812 0 14.4404 0 14.9745 14.9478 0 0 0 0 13.8411 0 0 0 0 0 0 0 13.126 0 13.0249 0 0 15.6449 13.4607 0 13.956 0 14.6706 13.7563 A6NMN3 F170B_HUMAN Protein FAM170B (Acrosome-related protein) FAM170B C10orf73 Homo sapiens (Human) fertilization [GO:0009566]; positive regulation of acrosome reaction [GO:2000344]; regulation of fertilization [GO:0080154] acrosomal vesicle [GO:0001669]; outer acrosomal membrane [GO:0002081] acrosomal vesicle [GO:0001669]; outer acrosomal membrane [GO:0002081]; fertilization [GO:0009566]; positive regulation of acrosome reaction [GO:2000344]; regulation of fertilization [GO:0080154] GO:0001669; GO:0002081; GO:0009566; GO:0080154; GO:2000344 AQGQAHDQQLEEEQSPSDNSECSR 0.99157 -4.5722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MWY0 ELAP2_HUMAN "Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein, hEIG121L)" ELAPOR2 EIG121L KIAA1324L Homo sapiens (Human) negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; BMP receptor binding [GO:0070700]; negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684] GO:0005886; GO:0016021; GO:0030513; GO:0045684; GO:0051961; GO:0070700 BMP receptor binding [GO:0070700] ARGPVRGR 0.99157 -23.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1683 11.0632 0 12.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7224 0 14.1854 14.8839 12.6094 0 0 0 0 0 0 0 0 12.2489 0 0 0 13.2973 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0681 0 0 0 0 12.6235 0 0 13.8593 0 0 10.6847 0 12.4127 12.4687 0 0 0 0 0 0 13.7501 0 12.4683 0 13.9881 10.4392 0 13.5831 0 0 0 10.3211 0 0 12.8578 0 0 0 11.1704 0 14.8073 0 12.8063 14.4047 0 0 13.2197 12.1999 0 0 0 0 0 0 0 0 12.8355 13.8339 0 0 0 0 0 0 0 0 0 0 10.6771 0 0 0 14.8207 15.1076 0 0 0 0 0 12.2283 0 0 O15027 SC16A_HUMAN "Protein transport protein Sec16A (SEC16 homolog A, p250)" SEC16A KIAA0310 SEC16 SEC16L Homo sapiens (Human) autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762] cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976]; substantia nigra development [GO:0021762] GO:0000139; GO:0005789; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0012507; GO:0021762; GO:0031090; GO:0032527; GO:0034976; GO:0043000; GO:0048208; GO:0048471; GO:0050821; GO:0070971; GO:0070973; GO:0072659 AAGTRAR 0.99157 -53.099 0 0 0 0 0 0 0 0 13.6426 0 13.1553 0 0 0 0 0 0 0 0 0 10.7272 0 0 0 9.77294 0 0 0 13.5803 0 13.3065 13.0974 13.7818 0 0 0 0 13.5193 0 0 0 0 13.6479 0 0 0 11.9452 12.4698 0 0 13.3122 11.8302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3985 0 11.9673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4624 0 0 0 0 0 0 0 12.6969 0 0 0 14.3577 0 0 12.3858 0 0 0 13.1336 0 0 0 0 13.3643 0 0 13.6119 0 0 0 0 0 0 0 12.8413 0 0 0 15.004 0 0 0 0 0 0 0 13.6657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2006 14.79 13.984 0 12.0958 0 0 13.7618 0 0 0 0 0 13.4462 12.3003 0 Q15058 KIF14_HUMAN Kinesin-like protein KIF14 KIF14 KIAA0042 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446] cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233] cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0001558; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0008284; GO:0008574; GO:0010389; GO:0015631; GO:0016020; GO:0016887; GO:0019901; GO:0021685; GO:0021693; GO:0021695; GO:0021766; GO:0021772; GO:0021846; GO:0021987; GO:0030155; GO:0030165; GO:0030334; GO:0030496; GO:0031146; GO:0031641; GO:0032147; GO:0032467; GO:0032487; GO:0033624; GO:0034446; GO:0043066; GO:0043161; GO:0043523; GO:0043524; GO:0045184; GO:0051233; GO:0051301; GO:0090543; GO:1903429; GO:2000045 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631] AKTDSAEK 0.99157 -53.456 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9375 0 0 0 0 0 0 0 12.9083 0 0 12.0687 9.25397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2854 12.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4025 15.7777 15.4951 0 14.9017 12.5949 0 0 13.5699 0 0 0 0 0 0 16.0355 14.0533 14.1031 14.2019 14.1618 13.6691 11.2052 15.0432 12.5934 0 12.4023 14.2037 14.3856 13.5083 13.2516 13.7821 13.6912 12.2662 0 12.5235 0 0 13.3249 0 14.8905 0 0 0 14.04 0 0 13.7087 12.6671 0 14.8379 0 12.7355 0 0 13.285 13.7389 13.3613 12.1679 14.2317 0 0 0 0 13.9228 0 0 13.4281 0 14.7463 13.4215 0 0 12.6406 0 0 0 13.4542 0 0 0 0 14.9 0 0 0 0 0 0 0 0 11.6054 0 0 0 0 0 14.0602 0 0 0 0 12.9873 0 10.8262 0 Q96KQ4 ASPP1_HUMAN Apoptosis-stimulating of p53 protein 1 (Protein phosphatase 1 regulatory subunit 13B) PPP1R13B ASPP1 KIAA0771 Homo sapiens (Human) intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; p53 binding [GO:0002039]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786] GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0045786; GO:0072332 p53 binding [GO:0002039] EPGEGSCHLAEVWRGNER 0.99157 -23.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7356 10.728 0 0 0 0 13.8018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2725 0 0 0 0 0 0 0 0 0 0 0 10.3599 0 12.0744 12.5454 0 0 13.5358 0 0 0 12.6342 0 12.2364 14.8751 13.3159 0 12.3584 0 0 0 0 0 16.354 0 0 0 0 0 0 0 0 13.6516 0 0 0 14.635 14.091 13.2897 14.355 14.366 0 13.5339 0 12.8436 12.7097 14.3371 0 0 0 0 13.1829 13.3205 0 0 0 0 0 13.2788 0 0 0 14.2988 14.8348 13.9296 15.1958 14.0715 0 13.986 13.9243 0 13.0066 13.2104 12.9612 0 14.3481 13.2027 0 12.7654 13.104 0 0 13.7691 0 12.5127 17.317 0 12.9959 12.9145 0 0 0 0 12.6978 0 0 0 0 0 0 0 13.1948 12.595 0 0 0 0 12.2868 14.4437 13.9913 0 0 0 0 0 0 0 Q96KQ7 EHMT2_HUMAN "Histone-lysine N-methyltransferase EHMT2, EC 2.1.1.-, EC 2.1.1.367 (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3, H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a)" EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130] GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006306; GO:0006325; GO:0007130; GO:0007286; GO:0007616; GO:0008270; GO:0009267; GO:0009566; GO:0010424; GO:0016279; GO:0016571; GO:0016607; GO:0018024; GO:0018027; GO:0034968; GO:0035265; GO:0036166; GO:0044030; GO:0045471; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0051567; GO:0051569; GO:0051570; GO:0060992; GO:0070734; GO:0070742; GO:0071314; GO:0071466; GO:1902902; GO:1990841 C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270] DGEVYCIDAR 0.99157 -53.543 0 0 0 0 0 0 12.3842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5121 10.8746 0 0 0 0 0 0 0 14.0836 0 0 0 13.8772 0 15.1822 12.8278 12.788 0 0 0 12.5687 15.2335 13.733 0 15.2789 0 0 0 0 0 13.4112 0 0 0 0 14.8283 0 13.0062 0 12.5497 0 13.2058 0 0 0 0 14.5335 0 13.0687 13.3308 15.1441 0 14.3679 0 13.7013 0 0 0 0 12.7742 0 0 0 0 0 0 14.4927 15.2323 13.9564 13.5209 0 0 0 0 0 0 0 0 14.2216 0 0 0 0 0 0 0 0 14.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8491 0 0 14.8125 14.1175 0 0 0 0 0 0 0 Q9GZT3 SLIRP_HUMAN "SRA stem-loop-interacting RNA-binding protein, mitochondrial" SLIRP C14orf156 DC23 DC50 PD04872 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; mitochondrion morphogenesis [GO:0070584]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; single fertilization [GO:0007338]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; sperm flagellum [GO:0036126]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; flagellated sperm motility [GO:0030317]; mitochondrion morphogenesis [GO:0070584]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; single fertilization [GO:0007338]; spermatid development [GO:0007286] GO:0000961; GO:0001669; GO:0003723; GO:0003729; GO:0005634; GO:0005739; GO:0007286; GO:0007338; GO:0030317; GO:0036126; GO:0048471; GO:0070584; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723] MAASAAR 0.99157 -4.5809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1603 0 0 0 0 0 13.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBG6 IF122_HUMAN Intraflagellar transport protein 122 homolog (WD repeat-containing protein 10) (WD repeat-containing protein 140) IFT122 SPG WDR10 WDR140 Homo sapiens (Human) camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic heart tube development [GO:0035050]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic heart tube development [GO:0035050]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb development [GO:0060173]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512] GO:0001843; GO:0005737; GO:0005929; GO:0010172; GO:0016020; GO:0030991; GO:0032391; GO:0035050; GO:0035721; GO:0036064; GO:0042073; GO:0045879; GO:0048593; GO:0060173; GO:0060271; GO:0061512; GO:0097542; GO:0097730; GO:1905515 AFHKAGRQR 0.99157 -23.725 0 10.9781 11.2687 0 11.2033 0 0 0 0 0 0 0 0 0 0 0 10.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1277 0 0 12.2607 0 0 0 0 0 11.1611 0 0 0 0 0 16.0366 0 16.3678 14.4621 14.882 0 0 15.2359 0 0 0 12.1208 11.4809 0 0 11.4842 12.2821 0 12.2288 11.8918 11.6054 0 0 0 0 13.5264 0 10.9986 0 0 0 0 14.3962 0 0 11.3547 11.1911 0 0 11.2357 0 0 0 0 0 0 0 0 0 0 15.6229 0 0 0 0 0 0 11.5631 0 13.0555 0 0 0 0 0 0 0 0 0 0 0 14.7857 13.697 0 0 13.3288 0 0 0 0 0 12.8865 0 15.1376 0 14.0185 0 13.4784 0 0 0 0 0 0 0 0 12.4852 13.1423 0 0 0 0 13.5054 0 0 0 12.4222 13.1657 0 0 0 0 0 0 Q9NQ36 SCUB2_HUMAN "Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)" SCUBE2 CEGP1 Homo sapiens (Human) signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; signal transduction [GO:0007165] GO:0005509; GO:0005576; GO:0005615; GO:0007165; GO:0008289; GO:0009986 calcium ion binding [GO:0005509]; lipid binding [GO:0008289] CGGELGDFTGYIESPNYPGNYPANTECTWTINPPPK 0.99157 -7.3731 0 0 0 0 0 0 0 0 0 12.9323 13.9227 12.7113 0 0 0 0 0 0 0 11.7017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0466 10.2197 0 14.1571 9.98428 15.9452 11.7471 12.2097 0 15.9801 13.0021 13.454 0 0 11.8203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7463 0 0 0 13.2145 0 0 0 12.0514 0 0 0 12.1144 0 0 0 0 0 0 0 0 0 0 11.9605 0 13.1561 13.7533 0 0 0 12.1896 0 0 0 0 0 0 0 0 14.0962 0 11.5853 0 0 0 13.676 0 12.8509 0 0 0 0 12.5709 0 0 0 0 0 0 12.826 0 0 0 0 12.7141 0 0 0 13.3167 13.2193 0 0 0 0 0 0 0 0 0 0 0 0 11.7156 0 0 0 0 0 0 0 0 0 0 0 12.9085 12.368 0 12.7882 0 0 11.9765 0 13.7498 0 0 0 Q9NZV1 CRIM1_HUMAN "Cysteine-rich motor neuron 1 protein, CRIM-1 (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein ]" CRIM1 S52 UNQ1886/PRO4330 Homo sapiens (Human) negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin-like growth factor receptor activity [GO:0005010]; PDZ domain binding [GO:0030165]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399] GO:0004867; GO:0005010; GO:0005576; GO:0005886; GO:0007399; GO:0016021; GO:0030165; GO:0030514; GO:0045668 insulin-like growth factor receptor activity [GO:0005010]; PDZ domain binding [GO:0030165]; serine-type endopeptidase inhibitor activity [GO:0004867] ALVCLPCDESKCEEPR 0.99157 -5.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8075 0 0 0 11.8146 0 11.0454 0 0 15.1046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1184 0 10.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5643 0 0 0 12.6178 0 0 11.9152 0 0 0 0 0 0 0 0 0 0 0 0 12.7656 10.9662 0 11.8853 0 0 14.6806 0 0 0 0 0 0 0 0 0 11.6271 0 14.9353 11.2238 0 0 11.3021 0 12.0979 0 0 0 0 0 10.7855 0 0 11.0043 0 13.4086 0 0 0 0 0 0 0 14.1151 0 0 0 0 0 0 11.1602 0 0 0 0 11.8487 0 0 10.9141 0 10.7936 0 13.5703 0 0 0 12.8408 10.5469 13.8209 0 0 0 0 12.2886 0 12.3101 Q9Y235 ABEC2_HUMAN "C->U-editing enzyme APOBEC-2, EC 3.5.4.36 (mRNA(cytosine(6666)) deaminase 2)" APOBEC2 Homo sapiens (Human) cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397] GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0006397; GO:0016554; GO:0016556; GO:0042802; GO:0046872; GO:0080111 cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] IIKTLSK 0.99157 -4.5752 0 0 0 17.958 0 0 0 0 0 10.1476 0 0 0 0 0 0 13.0151 12.5117 13.9837 14.9478 14.0742 0 0 0 0 0 0 0 0 0 13.5344 0 0 13.6756 0 0 0 0 13.7144 0 0 0 14.0917 13.7269 13.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3 0 0 14.2729 13.5204 0 13.6769 0 0 10.75 0 0 0 0 0 0 0 11.0346 0 0 0 0 0 13.6167 0 0 13.1872 0 0 0 0 0 0 14.9475 0 0 0 0 0 0 0 0 0 0 0 13.9918 0 0 14.7845 0 0 14.9288 15.0007 0 14.973 0 0 0 13.7084 14.3293 14.5748 14.6704 0 0 0 0 14.6088 0 0 0 0 0 0 0 0 10.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.438 14.2279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 M0R2J8 DCDC1_HUMAN Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein) DCDC1 DCDC5 KIAA1493 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412] GO:0005737; GO:0005874; GO:0007049; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412 carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017] AAEGTSLEGYK 0.99158 -54.359 0 0 0 0 0 0 0 0 0 17.2165 0 0 12.5275 0 12.0276 0 13.7279 0 12.0241 0 0 0 0 0 0 12.0636 0 13.5878 0 0 0 16.4387 10.475 0 13.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4587 0 0 0 11.7777 0 0 0 0 0 10.1732 0 0 0 0 0 12.8274 12.7037 0 0 0 0 0 0 0 0 0 0 0 13.5106 0 13.9181 18.8255 18.718 0 0 12.4337 0 0 14.7361 13.5068 0 0 0 12.5836 14.4674 0 14.3024 0 0 12.4432 0 13.411 10.559 0 10.2921 0 12.4635 0 0 12.7439 0 0 0 0 0 11.2924 0 0 0 0 0 0 13.1601 9.67354 0 0 12.6123 14.3248 14.0433 8.84743 12.7632 0 13.1097 0 12.0064 0 0 0 0 0 0 0 12.8628 14.2954 12.9326 0 0 13.843 0 0 0 0 0 0 16.0754 0 18.7258 0 0 0 0 9.25673 12.8682 12.7158 12.2803 13.4844 13.3554 14.0545 12.6198 0 0 10.6855 12.6473 0 0 0 13.3861 P08670 VIME_HUMAN Vimentin VIM Homo sapiens (Human) astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]; SMAD protein signal transduction [GO:0060395] axon [GO:0030424]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904] axon [GO:0030424]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; protein domain specific binding [GO:0019904]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]; SMAD protein signal transduction [GO:0060395] GO:0003725; GO:0005200; GO:0005212; GO:0005737; GO:0005777; GO:0005815; GO:0005829; GO:0005844; GO:0005856; GO:0005882; GO:0005886; GO:0005925; GO:0010977; GO:0014002; GO:0016363; GO:0019904; GO:0030424; GO:0031175; GO:0031252; GO:0032967; GO:0042802; GO:0043488; GO:0045109; GO:0045111; GO:0045335; GO:0045727; GO:0060020; GO:0060395; GO:0070062; GO:0070307; GO:0071222; GO:0071225; GO:0071346; GO:0097110; GO:1990254; GO:1990904 double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; protein domain specific binding [GO:0019904]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212] DNLAEDIMRLR 0.99158 -7.5826 0 0 0 0 0 0 0 0 0 10.1221 12.2475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3883 0 0 0 0 0 0 0 0 0 0 12.0392 0 0 0 0 0 0 0 0 0 10.5067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0191 0 0 0 0 0 0 0 15.2313 0 0 0 0 0 0 0 10.2575 0 0 11.5068 0 11.9309 0 0 0 0 12.7138 0 0 0 12.7773 0 0 0 14.8262 0 0 0 0 0 0 0 12.7869 0 0 15.3996 12.1745 0 0 0 0 0 0 11.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9593 Q5JQF8 PAP1M_HUMAN Polyadenylate-binding protein 1-like 2 (RNA-binding motif protein 32) (RNA-binding protein 32) PABPC1L2A PABPC1L2 RBM32A; PABPC1L2B PABPC1L2 RBM32B Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; RNA binding [GO:0003723] GO:0003723; GO:0070062 RNA binding [GO:0003723] DFEEDTDEEATLR 0.99158 -4.5921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7332 0 0 0 0 0 12.9989 12.7332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z570 Z804A_HUMAN Zinc finger protein 804A ZNF804A C2orf10 Homo sapiens (Human) positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; regulation of neuron projection development [GO:0010975] cytoplasm [GO:0005737]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] cytoplasm [GO:0005737]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; metal ion binding [GO:0046872]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; regulation of neuron projection development [GO:0010975] GO:0005634; GO:0005737; GO:0005886; GO:0010628; GO:0010975; GO:0010976; GO:0030426; GO:0043025; GO:0043197; GO:0043198; GO:0046872; GO:0098793; GO:0098794; GO:1901588; GO:1902952 metal ion binding [GO:0046872] CKMEAENSYTENAGK 0.99158 -48.23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7973 0 0 0 0 0 0 0 0 0 0 12.1841 0 0 0 0 0 0 11.1805 0 0 0 0 9.9402 0 12.2453 13.527 0 12.0613 0 13.6857 13.0531 0 0 0 0 0 0 15.6914 15.5046 13.4197 12.5703 0 0 16.3547 0 0 0 0 0 0 0 0 0 13.4691 0 0 0 0 0 0 0 14.8986 13.2325 0 0 0 0 0 0 15.0497 0 0 0 0 0 0 0 0 0 13.4388 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1629 0 0 14.414 0 0 0 0 0 0 0 0 0 13.468 13.6184 0 0 13.7524 0 13.7659 0 12.7774 0 0 13.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92904 DAZL_HUMAN Deleted in azoospermia-like (DAZ homolog) (DAZ-like autosomal) (Deleted in azoospermia-like 1) (SPGY-like-autosomal) DAZL DAZH DAZL1 DAZLA SPGYLA Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; germ cell development [GO:0007281]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; germ cell development [GO:0007281]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283] GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0007281; GO:0007283; GO:0008494; GO:0032991; GO:0045948; GO:0070935 mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; translation activator activity [GO:0008494] IVESQINFHGK 0.99158 -7.4033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6823 0 0 0 0 0 0 0 0 0 0 10.9304 0 0 12.4208 11.0559 0 0 10.7708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJA9 ENPP5_HUMAN "Ectonucleotide pyrophosphatase/phosphodiesterase family member 5, E-NPP 5, NPP-5, EC 3.1.-.-" ENPP5 UNQ550/PRO1107 Homo sapiens (Human) cell communication [GO:0007154] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270]; cell communication [GO:0007154] GO:0000210; GO:0005576; GO:0005886; GO:0007154; GO:0008270; GO:0016021 NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270] IIEWFTSK 0.99158 -7.4063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKB1 FBW1B_HUMAN "F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein, HOS)" FBXW11 BTRCP2 FBW1B FBXW1B KIAA0696 Homo sapiens (Human) "brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear migration [GO:0007097]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; vesicle transport along microtubule [GO:0047496]; Wnt signaling pathway [GO:0016055]" axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] "axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842]; brain morphogenesis [GO:0048854]; establishment of mitotic spindle orientation [GO:0000132]; germ cell development [GO:0007281]; microtubule organizing center organization [GO:0031023]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear migration [GO:0007097]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; retrograde axonal transport [GO:0008090]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; vesicle transport along microtubule [GO:0047496]; Wnt signaling pathway [GO:0016055]" GO:0000132; GO:0000151; GO:0000209; GO:0000776; GO:0004842; GO:0005634; GO:0005635; GO:0005813; GO:0005829; GO:0005875; GO:0005881; GO:0006470; GO:0007097; GO:0007281; GO:0008090; GO:0016055; GO:0016567; GO:0019005; GO:0031023; GO:0031146; GO:0031648; GO:0042753; GO:0043005; GO:0043025; GO:0043161; GO:0045862; GO:0045892; GO:0045893; GO:0046983; GO:0047496; GO:0048511; GO:0048854; GO:0051010; GO:0070840; GO:1904115 dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; protein dimerization activity [GO:0046983]; ubiquitin-protein transferase activity [GO:0004842] EKDLCIKYFDQWSESDQVEFVEHLISR 0.99158 -4.5818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y548 YIPF1_HUMAN Protein YIPF1 (YIP1 family member 1) YIPF1 Homo sapiens (Human) vesicle-mediated transport [GO:0016192] Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; small GTPase binding [GO:0031267]; vesicle-mediated transport [GO:0016192] GO:0000138; GO:0005654; GO:0005794; GO:0005797; GO:0005802; GO:0005886; GO:0016021; GO:0016192; GO:0030133; GO:0031267; GO:0031902 small GTPase binding [GO:0031267] GSLLPIPGK 0.99158 -4.8771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52736 ZN133_HUMAN Zinc finger protein 133 (Zinc finger protein 150) ZNF133 ZNF150 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GVELEASPAQSGNPEETDK 0.99159 -7.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2865 0 12.3549 0 0 0 0 13.8712 0 0 0 0 10.6023 0 0 0 12.5345 0 0 0 0 0 0 0 0 0 12.4152 0 0 0 0 13.3779 12.1724 13.5196 0 0 0 12.3594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3967 0 14.6274 0 0 0 0 0 0 0 0 0 0 12.838 14.9057 13.4847 13.8995 13.9755 12.6104 14.1715 0 15.4326 16.5879 14.3635 14.1145 14.9094 16.0608 14.7589 14.0242 12.406 15.1393 14.7206 0 0 15.334 13.9348 16.1011 13.2723 0 15.6198 14.6861 0 14.6798 15.7264 15.144 15.5019 15.3679 0 0 11.6876 0 15.9807 0 15.0959 14.4603 15.4211 14.2523 13.9281 0 0 14.6035 14.5627 14.9645 12.5068 11.3035 0 0 0 0 0 0 0 15.7643 0 0 15.5893 14.8525 16.0402 0 0 0 0 0 0 0 0 0 12.6563 0 0 0 0 15.9871 0 12.0691 11.8141 13.9707 0 0 0 0 0 O15264 MK13_HUMAN "Mitogen-activated protein kinase 13, MAP kinase 13, MAPK 13, EC 2.7.11.24 (Mitogen-activated protein kinase p38 delta, MAP kinase p38 delta) (Stress-activated protein kinase 4)" MAPK13 PRKM13 SAPK4 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to anisomycin [GO:0072740]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to sodium arsenite [GO:1903936]; cellular response to sorbitol [GO:0072709]; cellular response to UV [GO:0034644]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; response to osmotic stress [GO:0006970]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to anisomycin [GO:0072740]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to sodium arsenite [GO:1903936]; cellular response to sorbitol [GO:0072709]; cellular response to UV [GO:0034644]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; response to osmotic stress [GO:0006970]; stress-activated MAPK cascade [GO:0051403] GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006970; GO:0007049; GO:0018105; GO:0032755; GO:0034644; GO:0035556; GO:0050729; GO:0051403; GO:0070301; GO:0071347; GO:0072709; GO:0072740; GO:0106310; GO:1903936 ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] LNDKAAK 0.99159 -18.982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8652 0 0 0 0 12.4042 0 0 0 0 0 0 0 0 12.5933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7093 O95972 BMP15_HUMAN "Bone morphogenetic protein 15, BMP-15 (Growth/differentiation factor 9B, GDF-9B)" BMP15 GDF9B Homo sapiens (Human) BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]; BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] GO:0001541; GO:0005125; GO:0005615; GO:0005788; GO:0007292; GO:0008083; GO:0010862; GO:0030509; GO:0060016; GO:0060395; GO:0070698 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698] EYEGMIAESCTCR 0.99159 -23.218 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0025 0 0 0 0 11.4239 0 12.029 0 0 0 0 0 0 0 0 0 0 12.1725 0 0 0 0 0 0 0 0 0 0 0 0 12.2962 0 0 0 0 0 0 0 0 0 0 0 0 11.7395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9377 0 0 0 0 14.7433 13.583 13.1113 0 0 0 13.258 0 0 13.1935 0 0 0 13.1668 13.0514 0 0 0 0 0 0 0 0 12.4535 12.1398 0 0 0 0 0 0 13.8819 0 0 0 0 12.7393 0 0 12.9464 12.9081 0 13.5492 13.2469 0 0 0 0 12.947 0 0 0 0 0 13.5528 0 0 0 11.5828 13.4163 0 0 13.4323 0 12.5167 12.4148 12.3431 0 0 0 0 0 12.599 0 0 0 12.6738 0 0 0 0 0 0 0 0 0 0 0 13.2394 0 0 10.8436 0 13.2939 0 0 12.7282 0 0 0 0 0 P04083 ANXA1_HUMAN Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26 ] ANXA1 ANX1 LPC1 Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gliogenesis [GO:0042063]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil activation [GO:0042119]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]" adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle [GO:0031982] "adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]; actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gliogenesis [GO:0042063]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil activation [GO:0042119]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]" GO:0001533; GO:0001780; GO:0001891; GO:0002250; GO:0002548; GO:0002685; GO:0005102; GO:0005509; GO:0005543; GO:0005544; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006909; GO:0006954; GO:0007165; GO:0007166; GO:0007187; GO:0008360; GO:0009986; GO:0010165; GO:0014839; GO:0016323; GO:0016324; GO:0016328; GO:0018149; GO:0019834; GO:0019898; GO:0030073; GO:0030216; GO:0030850; GO:0031018; GO:0031232; GO:0031313; GO:0031340; GO:0031394; GO:0031514; GO:0031532; GO:0031901; GO:0031982; GO:0032355; GO:0032508; GO:0032652; GO:0032717; GO:0032743; GO:0033031; GO:0035924; GO:0042063; GO:0042102; GO:0042119; GO:0042383; GO:0043066; GO:0043434; GO:0045087; GO:0045627; GO:0045629; GO:0045920; GO:0046632; GO:0046883; GO:0048306; GO:0050482; GO:0050727; GO:0062023; GO:0070062; GO:0070301; GO:0070365; GO:0070459; GO:0070555; GO:0071385; GO:0071621; GO:0090050; GO:0090303; GO:0097350; GO:0098641; GO:1900087; GO:1900138 cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102] GVGTRHKALIR 0.99159 -18.955 0 0 0 0 11.9483 0 0 0 12.0708 12.1434 11.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8962 0 0 12.0157 12.0514 0 11.7394 11.2879 0 0 0 0 0 0 0 0 0 0 12.1838 11.373 11.7006 11.6072 0 0 0 12.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7719 0 0 0 12.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0668 0 0 0 0 0 0 0 0 0 0 0 13.2521 12.9518 0 14.0647 0 0 0 13.9918 0 0 0 0 0 0 0 0 0 0 12.9899 12.9796 0 0 0 0 0 0 0 0 13.6915 0 13.8895 13.4333 13.7416 12.89 13.2949 0 14.0308 13.9696 14.5381 0 0 0 0 0 0 0 13.4942 13.7264 13.9277 0 0 13.9312 14.9925 15.8981 18.112 14.2739 12.4636 13.933 0 13.1376 13.5241 0 0 0 0 14.6831 0 14.892 0 0 Q13191 CBLB_HUMAN "E3 ubiquitin-protein ligase CBL-B, EC 2.3.2.27 (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B)" CBLB RNF56 Nbla00127 Homo sapiens (Human) "CD4-positive, alpha-beta T cell proliferation [GO:0035739]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of T cell receptor signaling pathway [GO:0050860]; NLS-bearing protein import into nucleus [GO:0006607]; peptidyl-amino acid modification [GO:0018193]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell anergy [GO:0002669]; protein catabolic process [GO:0030163]; regulation of GTPase activity [GO:0043087]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of protein binding [GO:0043393]; signal transduction [GO:0007165]; T cell anergy [GO:0002870]; T cell receptor signaling pathway [GO:0050852]" cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of T cell receptor signaling pathway [GO:0050860]; NLS-bearing protein import into nucleus [GO:0006607]; peptidyl-amino acid modification [GO:0018193]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell anergy [GO:0002669]; protein catabolic process [GO:0030163]; regulation of GTPase activity [GO:0043087]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of protein binding [GO:0043393]; signal transduction [GO:0007165]; T cell anergy [GO:0002870]; T cell receptor signaling pathway [GO:0050852]" GO:0001784; GO:0002669; GO:0002870; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0006607; GO:0006955; GO:0007165; GO:0007175; GO:0008270; GO:0017124; GO:0018193; GO:0030163; GO:0030971; GO:0031398; GO:0035556; GO:0035739; GO:0043087; GO:0043393; GO:0045121; GO:0045732; GO:0050852; GO:0050860; GO:0061630; GO:2000562; GO:2000583 calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AIRLFKEGK 0.99159 -18.949 0 13.5843 0 0 0 0 10.1623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6617 0 0 0 0 0 0 0 0 0 0 0 0 12.0563 0 0 0 0 0 0 0 0 0 14.9105 0 0 0 0 12.891 0 0 0 0 0 11.7055 0 0 0 0 0 0 0 14.3187 0 0 0 0 0 0 0 10.5396 0 0 0 13.9112 0 0 0 0 0 0 0 0 0 12.6185 0 13.0397 0 0 0 12.8109 0 0 0 11.0227 0 13.6103 0 0 0 15.4337 0 10.2977 0 13.2554 0 12.3428 0 0 13.2265 0 0 0 0 0 0 0 0 13.6842 13.1626 9.98769 0 0 0 0 11.675 0 0 0 12.5274 12.0654 0 0 0 0 0 12.2445 0 0 0 11.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4542 0 0 0 0 11.4633 0 Q5T036 F120S_HUMAN Uncharacterized protein FAM120AOS (FAM120A opposite strand protein) FAM120AOS C9orf10OS Homo sapiens (Human) AFSSAPLKKTK 0.99159 -22.55 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4199 14.8559 14.6991 0 0 0 13.9618 13.9421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7543 13.6577 0 0 0 0 0 0 0 0 0 13.084 0 0 0 0 0 11.6444 0 0 0 9.65866 0 0 0 0 0 0 0 0 0 11.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5J4 SPIC_HUMAN Transcription factor Spi-C SPIC Homo sapiens (Human) blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001824; GO:0005634; GO:0006357; GO:0030154 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GIFQFVSK 0.99159 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9054 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHP6 MSPD2_HUMAN Motile sperm domain-containing protein 2 MOSPD2 Homo sapiens (Human) chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; chemotaxis [GO:0006935]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023] GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006935; GO:0012505; GO:0016020; GO:0035579; GO:0044232; GO:0090023; GO:0090026; GO:0140284 AKLISETRR 0.99159 -18.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6827 0 12.9347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.127 0 13.2531 13.0442 12.9621 0 0 12.6109 0 0 0 0 0 0 13.4379 0 0 12.0066 12.4033 0 12.9788 0 0 0 0 0 13.3302 0 0 0 0 0 0 12.8798 0 13.3991 13.5083 0 15.6429 13.0239 0 0 13.7229 13.0826 14.0152 0 13.1642 0 12.8781 0 0 0 0 13.7795 0 0 0 13.1772 0 0 0 0 0 0 0 0 14.46 0 0 0 0 0 0 15.1294 0 0 0 12.6967 15.9672 0 0 12.7872 0 0 0 0 0 0 0 0 0 12.6948 0 0 0 0 0 0 0 0 14.5647 0 0 0 13.6899 11.7451 Q9BQA5 HINFP_HUMAN "Histone H4 transcription factor (Histone nuclear factor P, HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein)" HINFP MIZF ZNF743 Homo sapiens (Human) "anatomical structure development [GO:0048856]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure development [GO:0048856]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" GO:0000077; GO:0000082; GO:0000083; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0006357; GO:0010468; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0045184; GO:0045445; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0048856 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" CDCCDYSCK 0.99159 -18.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4804 0 0 0 0 0 10.8528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1356 0 0 0 0 0 0 0 12.1778 0 0 0 0 0 0 0 12.875 0 0 0 0 0 0 0 0 9.84743 0 0 0 0 0 0 0 0 13.9818 10.589 0 0 0 0 0 0 0 12.5783 0 11.4819 0 0 0 0 0 0 0 0 12.3368 0 0 0 0 0 0 0 12.3039 0 11.5752 0 0 11.6526 0 0 0 0 0 0 0 0 10.6344 0 0 0 12.37 12.129 11.5188 0 0 0 0 0 13.5205 0 0 0 12.6403 12.8529 0 0 0 0 0 0 0 11.7049 0 0 11.0482 0 Q9H6P5 TASP1_HUMAN "Threonine aspartase 1, Taspase-1, EC 3.4.25.- [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta ]" TASP1 C20orf13 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of transcription, DNA-templated [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]" GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604 identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298] FSLAAFKR 0.99159 -6.045 0 0 0 0 0 0 12.6879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.68006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0284 0 0 0 0 0 12.0434 0 13.8001 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8815 12.6243 0 0 0 0 0 0 0 0 0 12.0726 0 12.7498 0 0 0 0 0 0 0 0 0 13.0362 0 0 0 0 0 0 0 0 0 0 12.1522 0 0 0 0 0 0 0 0 0 13.9371 0 12.3984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZI5 GRHL1_HUMAN Grainyhead-like protein 1 homolog (Mammalian grainyhead) (NH32) (Transcription factor CP2-like 2) (Transcription factor LBP-32) GRHL1 LBP32 MGR TFCP2L2 Homo sapiens (Human) desmosome organization [GO:0002934]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of keratinocyte differentiation [GO:0045616]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of keratinocyte differentiation [GO:0045616]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002934; GO:0005634; GO:0005654; GO:0006357; GO:0008544; GO:0031490; GO:0042803; GO:0043231; GO:0043565; GO:0045616; GO:0045944; GO:0061436; GO:1990837 "chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" CIDIADYK 0.99159 -22.655 9.53253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4115 0 11.0126 0 0 0 0 0 13.8015 0 13.1518 13.4905 0 0 0 0 0 0 0 13.3117 14.9868 0 0 0 0 0 0 0 0 0 15.3256 0 0 0 0 12.1752 0 0 0 0 13.1184 12.1988 13.2428 12.8403 12.641 12.7139 0 0 0 0 0 13.8102 0 0 0 0 0 14.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0696 0 0 0 0 0 0 0 0 10.9093 0 0 0 12.5625 0 0 0 0 0 0 0 Q9UH77 KLHL3_HUMAN Kelch-like protein 3 KLHL3 KIAA1129 Homo sapiens (Human) distal tubule morphogenesis [GO:0072156]; gene expression [GO:0010467]; ion homeostasis [GO:0050801]; potassium ion homeostasis [GO:0055075]; protein K48-linked ubiquitination [GO:0070936]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; selective autophagy [GO:0061912]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; cullin family protein binding [GO:0097602]; structural molecule activity [GO:0005198]; distal tubule morphogenesis [GO:0072156]; gene expression [GO:0010467]; ion homeostasis [GO:0050801]; potassium ion homeostasis [GO:0055075]; protein K48-linked ubiquitination [GO:0070936]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; selective autophagy [GO:0061912]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0003779; GO:0005198; GO:0005829; GO:0005856; GO:0006468; GO:0006511; GO:0010467; GO:0016567; GO:0031463; GO:0050801; GO:0055075; GO:0061912; GO:0070294; GO:0070936; GO:0072156; GO:0097602 actin binding [GO:0003779]; cullin family protein binding [GO:0097602]; structural molecule activity [GO:0005198] CRAGVVFMAGHVYAVGGFNGSLRVR 0.99159 -18.985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0501 0 0 11.1591 0 11.3199 0 0 0 0 0 0 0 0 0 9.56533 9.09207 12.7562 13.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1749 0 10.3708 0 0 13.0181 0 0 0 0 0 0 12.6941 13.3154 12.8866 0 12.8858 0 16.1554 0 0 0 13.1928 0 16.3946 11.737 15.2301 0 0 0 13.0706 0 0 0 0 0 13.9963 0 0 13.318 0 0 0 0 15.4574 0 0 0 0 13.1142 13.5085 0 0 13.6026 14.3898 0 0 0 14.1146 0 13.2945 14.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULU8 CAPS1_HUMAN "Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1, CAPS-1)" CADPS CAPS CAPS1 KIAA1121 Homo sapiens (Human) dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] anchoring junction [GO:0070161]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle membrane [GO:0099012]; presynapse [GO:0098793] anchoring junction [GO:0070161]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; neuronal dense core vesicle membrane [GO:0099012]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] GO:0005829; GO:0006887; GO:0008289; GO:0015031; GO:0016079; GO:0019901; GO:0045921; GO:0046872; GO:0070161; GO:0098793; GO:0098978; GO:0099012; GO:1990504 lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901] ATLSLLER 0.99159 -7.5952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6453 10.8891 0 14.2335 0 0 0 0 0 0 0 0 11.1437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8144 0 0 0 0 0 0 0 0 0 14.5013 0 13.8911 11.9014 0 0 0 12.653 0 0 0 13.072 12.8717 12.8624 0 0 12.5923 0 0 13.7455 16.6902 0 14.6872 0 13.5779 13.6582 0 13.3332 14.3742 0 0 0 14.1446 14.4601 0 0 0 0 0 0 13.367 0 0 0 0 0 0 0 0 12.8443 0 0 0 18.3071 0 0 10.509 0 0 0 0 11.829 12.9042 0 0 0 0 0 0 0 0 0 0 0 0 12.6902 0 0 0 0 12.0198 0 0 14.9944 0 0 0 12.2759 0 0 0 0 13.6915 0 0 0 0 0 0 12.7907 16.7547 0 0 0 11.9511 15.9612 15.9534 9.57397 0 12.7964 12.4319 0 0 0 0 0 A5YKK6 CNOT1_HUMAN "CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog, NOT1H, hNOT1)" CNOT1 CDC39 KIAA1007 NOT1 AD-005 Homo sapiens (Human) "miRNA-mediated gene silencing [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]" CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778] "CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778]; armadillo repeat domain binding [GO:0070016]; molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; miRNA-mediated gene silencing [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829]" GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:0090503; GO:1900153; GO:2000036 armadillo repeat domain binding [GO:0070016]; molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] AFSAFVGQMHQQGILKTDDLITR 0.9916 -50.255 0 0 13.4108 0 0 0 0 0 11.007 0 0 0 0 0 0 13.1178 0 0 13.6234 0 13.3764 0 13.8502 0 0 0 14.753 0 0 0 0 0 12.5884 0 0 12.6691 0 12.2483 0 0 0 0 0 0 0 0 14.1142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6554 12.6396 0 0 0 0 0 0 0 0 0 0 0 0 14.9576 0 13.8708 13.9109 13.689 0 0 14.1365 0 0 0 12.4078 19.3695 13.7454 14.2386 13.4069 14.322 14.2633 14.1823 13.9966 0 0 0 13.6849 0 0 0 12.2789 12.9514 15.249 11.3214 0 0 0 13.4437 0 0 15.0831 0 14.4388 14.5839 12.9375 0 0 0 0 0 14.4922 12.8665 14.4605 15.417 0 0 0 0 0 0 0 14.4477 0 0 0 0 0 0 10.9564 0 14.5963 0 0 13.7687 0 0 11.3918 0 15.0795 0 0 0 0 12.3861 10.4681 14.1892 0 12.5103 0 0 13.7461 0 0 0 0 0 0 12.4324 0 0 0 0 0 0 0 11.2969 0 0 P05198 IF2A_HUMAN "Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha, eIF-2-alpha, eIF-2A, eIF-2alpha)" EIF2S1 EIF2A Homo sapiens (Human) aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; polysome [GO:0005844]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; regulation of translational initiation in response to stress [GO:0043558]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063] GO:0003723; GO:0003743; GO:0005634; GO:0005829; GO:0005844; GO:0005850; GO:0005851; GO:0007568; GO:0010494; GO:0016020; GO:0032057; GO:0033290; GO:0034063; GO:0034198; GO:0034599; GO:0034605; GO:0034644; GO:0034976; GO:0036499; GO:0043022; GO:0043558; GO:0043614; GO:0044207; GO:0045202; GO:0046777; GO:0070062; GO:0097451; GO:1901216; GO:1905098; GO:1990737; GO:2000676 ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] ADIEVACYGYEGIDAVK 0.9916 -7.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9207 0 0 0 11.2811 0 0 10.8581 0 0 0 0 0 0 10.4451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4027 0 0 0 0 0 0 0 0 0 0 0 0 10.6033 0 0 0 0 0 0 12.845 12.2171 13.8577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0322 10.2705 0 0 0 0 0 10.0736 0 0 0 0 0 0 0 11.4374 0 0 P13804 ETFA_HUMAN "Electron transfer flavoprotein subunit alpha, mitochondrial, Alpha-ETF" ETFA Homo sapiens (Human) cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; cellular amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904] GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0016491; GO:0022904; GO:0033539; GO:0045251; GO:0050660 electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491] AAAPGQLRRAASLLR 0.9916 -19.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1622 0 0 0 13.3252 13.7874 0 0 0 0 0 0 0 0 0 0 0 0 11.6781 0 0 0 0 0 0 0 0 0 0 0 12.3417 0 0 0 0 0 0 0 0 14.0873 14.9209 13.9336 14.5143 14.9705 0 14.5426 0 0 0 0 12.3288 0 0 14.4942 0 14.8093 0 0 0 13.0567 0 0 11.4023 0 15.3142 12.8271 0 0 0 0 0 0 10.1594 0 0 0 0 0 0 0 0 0 12.7407 0 0 0 0 0 0 15.0295 12.6356 0 0 0 0 0 0 0 0 0 13.5907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8229 14.6303 13.8456 13.6579 0 0 0 0 0 0 0 14.9309 0 11.6911 0 0 P42684 ABL2_HUMAN "Tyrosine-protein kinase ABL2, EC 2.7.10.2 (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG)" ABL2 ABLL ARG Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of T cell migration [GO:2000406]; protein modification process [GO:0036211]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell adhesion [GO:0007155]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of T cell migration [GO:2000406]; protein modification process [GO:0036211]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165] GO:0000287; GO:0001784; GO:0003785; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0007155; GO:0007165; GO:0007204; GO:0010506; GO:0010863; GO:0010976; GO:0015629; GO:0018108; GO:0030100; GO:0030145; GO:0030155; GO:0035024; GO:0035640; GO:0036211; GO:0051015; GO:0051353; GO:0071300; GO:1903905; GO:2000145; GO:2000249; GO:2000406 actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713] AASSSSVVPYLPRLPILPSK 0.9916 -22.783 0 9.74015 0 0 0 0 0 0 13.3677 12.5969 11.6344 0 12.308 0 0 0 13.9116 0 0 0 0 0 0 0 0 12.1215 0 0 0 11.7031 0 0 0 0 0 13.3147 0 0 0 0 0 0 0 0 0 11.7523 0 0 0 0 0 0 12.4197 12.1584 0 0 0 0 0 0 0 0 10.9583 0 0 10.2444 0 0 0 0 0 0 0 11.0322 0 10.3859 0 0 0 0 12.3932 0 15.2578 17.4829 15.5432 0 12.0148 13.9929 14.1695 11.5231 14.4865 15.2325 14.3328 0 15.5611 0 0 15.5469 0 0 0 0 0 10.9234 0 0 0 0 14.1005 0 0 0 12.7559 15.1557 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7515 11.7497 0 15.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8954 0 11.3475 0 0 12.3873 10.2958 0 0 15.4231 13.5468 15.8803 14.1765 0 0 0 14.3476 0 0 0 10.3252 11.9304 0 0 12.3744 0 0 0 0 12.3006 0 11.7138 12.9405 P50548 ERF_HUMAN ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2) ERF Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0030154; GO:0043565 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]" AVAGADK 0.9916 -19.03 0 0 0 0 0 0 0 13.1423 0 0 0 10.2366 0 14.1186 0 0 14.3537 14.5132 13.618 13.467 0 12.1963 14.3832 0 13.7563 0 0 13.7221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0982 0 0 0 0 0 0 12.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4463 0 11.9851 0 0 0 10.6421 0 0 0 0 0 13.8229 0 0 0 0 0 0 0 0 0 0 13.6025 0 0 11.6009 0 0 0 0 0 0 14.9803 0 0 0 0 0 0 12.2876 0 0 0 0 0 0 0 0 0 11.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 0 0 13.4102 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5537 11.0899 0 0 11.8005 0 0 0 0 13.1663 P55196 AFAD_HUMAN "Afadin (ALL1-fused gene from chromosome 6 protein, Protein AF-6) (Afadin adherens junction formation factor)" AFDN AF6 MLLT4 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; pore complex assembly [GO:0046931]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165] GO:0005654; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0007155; GO:0007165; GO:0007267; GO:0008022; GO:0010628; GO:0016607; GO:0022409; GO:0030054; GO:0030336; GO:0031267; GO:0032880; GO:0043547; GO:0044291; GO:0044331; GO:0045296; GO:0046930; GO:0046931; GO:0050839; GO:0051015; GO:0061951; GO:0070160; GO:0070830; GO:0090557; GO:2000049 actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; small GTPase binding [GO:0031267] ARLEEERER 0.9916 -50.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3755 11.6128 11.8257 11.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8903 0 0 0 0 0 0 0 0 0 0 0 16.5299 0 0 0 0 0 0 0 14.1506 0 14.1791 0 0 17.2939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1205 0 0 0 14.296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6664 0 0 0 0 0 10.988 0 0 15.2668 0 0 16.5486 10.757 0 0 0 0 0 0 0 0 0 0 0 Q12851 M4K2_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 2, EC 2.7.11.1 (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase, GC kinase) (MAPK/ERK kinase kinase kinase 2, MEK kinase kinase 2, MEKKK 2) (Rab8-interacting protein)" MAP4K2 GCK RAB8IP Homo sapiens (Human) immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903] GO:0000139; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006903; GO:0006955; GO:0007254; GO:0008349; GO:0016323; GO:0031435; GO:0035556; GO:0043507; GO:0045087; GO:0046330; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] IIPRRFALSTK 0.9916 -19.028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7411 0 0 0 0 0 0 0 0 0 0 0 0 16.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7321 0 0 0 Q1XH10 SKDA1_HUMAN SKI/DACH domain-containing protein 1 (Protein DLN-1) SKIDA1 C10orf140 DLN1 Homo sapiens (Human) GLSGAAR 0.9916 -22.797 0 0 10.7651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1398 0 12.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.719 12.0719 11.2163 0 0 0 0 0 0 13.134 0 0 13.7062 0 0 0 0 15.3368 0 13.6886 14.2275 0 14.5534 14.8148 0 0 12.7357 13.8237 0 0 16.3128 14.3771 14.8196 14.2229 0 14.2988 14.16 13.7446 12.3365 13.6584 16.7782 14.1311 14.3363 14.3613 15.1232 0 0 0 13.3613 13.0389 13.2487 15.4366 14.1782 14.4499 14.4997 15.1127 0 0 13.0041 14.3082 13.345 14.801 14.0177 15.2292 13.1169 13.5248 13.3028 0 13.2496 12.6531 15.2835 16.3514 12.8952 12.6323 15.3507 15.3005 13.1636 13.2844 12.9468 14.6345 13.4738 14.6464 0 14.4115 14.542 13.967 17.0492 16.6454 0 13.9011 12.9596 0 9.21084 12.5223 16.1483 0 15.2909 0 13.5314 14.7256 0 0 0 0 0 0 0 0 0 0 13.1378 0 0 0 16.742 13.2062 0 13.8049 0 0 0 12.3938 14.3347 Q8IV42 PSTK_HUMAN "L-seryl-tRNA(Sec) kinase, EC 2.7.1.164 (O-phosphoseryl-tRNA(Sec) kinase)" PSTK C10orf89 Homo sapiens (Human) phosphorylation [GO:0016310]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; translation [GO:0006412] ATP binding [GO:0005524]; kinase activity [GO:0016301]; L-seryl-tRNA(Sec) kinase activity [GO:0043915]; tRNA binding [GO:0000049]; phosphorylation [GO:0016310]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; translation [GO:0006412] GO:0000049; GO:0005524; GO:0006412; GO:0016301; GO:0016310; GO:0043915; GO:0097056 ATP binding [GO:0005524]; kinase activity [GO:0016301]; L-seryl-tRNA(Sec) kinase activity [GO:0043915]; tRNA binding [GO:0000049] IILGNEHIKCR 0.9916 -5.9554 0 0 0 0 0 0 0 13.1725 0 12.0532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAM6 ZSCA4_HUMAN Zinc finger and SCAN domain-containing protein 4 (Zinc finger protein 494) ZSCAN4 ZNF494 Homo sapiens (Human) negative regulation of mitotic recombination [GO:0045950]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833] "chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of mitotic recombination [GO:0045950]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833]" GO:0000781; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0010833; GO:0045950; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" QELQRLYR 0.9916 -7.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7F0 AT133_HUMAN "Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase, EC 7.6.2.16)" ATP13A3 AFURS1 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; polyamine transmembrane transport [GO:1902047]; transmembrane transport [GO:0055085] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ABC-type polyamine transporter activity [GO:0015417]; ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type transmembrane transporter activity [GO:0140358]; cellular calcium ion homeostasis [GO:0006874]; polyamine transmembrane transport [GO:1902047]; transmembrane transport [GO:0055085] GO:0005524; GO:0006874; GO:0015417; GO:0015594; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0055085; GO:0140358; GO:1902047 ABC-type polyamine transporter activity [GO:0015417]; ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type transmembrane transporter activity [GO:0140358] CCLPWALGCR 0.9916 -19.061 0 0 0 9.9976 0 0 0 0 0 0 0 11.8715 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1023 0 0 0 0 0 0 0 0 0 0 0 0 11.7582 0 0 0 13.0225 11.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9021 0 0 0 0 0 0 0 0 0 0 0 0 13.3788 13.7034 0 0 0 0 0 13.8618 13.0609 0 0 12.6472 0 14.0861 0 0 0 0 12.504 0 0 0 12.9854 0 0 10.4477 14.5635 15.3141 0 0 12.346 0 0 13.6077 0 13.4919 13.1955 10.5536 0 14.3399 0 0 0 12.8894 0 0 0 0 0 11.7461 0 0 0 0 0 13.1701 0 0 12.4787 0 12.6092 0 0 10.6067 13.6468 12.6474 0 0 0 0 13.5296 0 0 0 0 0 0 12.8127 11.891 0 0 0 0 0 0 0 0 0 0 11.3679 0 0 0 0 0 0 0 13.2464 0 0 0 0 0 0 Q9NSK7 CS012_HUMAN Protein C19orf12 C19orf12 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitochondrial calcium ion homeostasis [GO:0051560]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitochondrial calcium ion homeostasis [GO:0051560]; response to oxidative stress [GO:0006979] GO:0005739; GO:0005783; GO:0005829; GO:0006914; GO:0006915; GO:0006979; GO:0016021; GO:0031966; GO:0051560 KMKAAVK 0.9916 -4.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8296 0 0 0 0 0 13.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.579 0 0 13.7268 0 0 14.1648 0 0 13.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL63 MKLN1_HUMAN Muskelin MKLN1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; actin cytoskeleton reorganization [GO:0031532]; cell-matrix adhesion [GO:0007160]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; signal transduction [GO:0007165] GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005737; GO:0005829; GO:0005938; GO:0007160; GO:0007165; GO:0008360; GO:0031532; GO:0042802; GO:0042803; GO:0070161; GO:0098794 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] GDGEDNR 0.9916 -22.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6336 0 0 0 0 0 0 0 11.4478 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7181 0 0 0 0 0 0 0 0 12.5948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.864 12.914 0 0 0 0 12.0984 0 0 0 0 0 0 12.4909 0 0 0 0 0 0 0 0 0 0 0 12.8907 0 0 0 0 0 0 0 0 10.7219 11.6582 0 0 0 0 0 12.8572 0 0 0 0 0 20.5674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1185 11.5548 13.9592 0 0 0 0 0 0 0 14.5124 0 0 0 0 0 0 0 0 0 14.3216 0 P16112 PGCA_HUMAN "Aggrecan core protein (Cartilage-specific proteoglycan core protein, CSPCP) (Chondroitin sulfate proteoglycan core protein 1, Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2 ]" ACAN AGC1 CSPG1 MSK16 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] GO:0001501; GO:0005201; GO:0005540; GO:0005576; GO:0005796; GO:0006508; GO:0007155; GO:0007417; GO:0030246; GO:0031012; GO:0043202; GO:0046872; GO:0062023 carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; metal ion binding [GO:0046872] CQPSGHWEEPQITCTDPTTYK 0.99161 -18.626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5717 0 0 0 0 0 0 0 0 0 12.773 0 0 11.8478 0 0 0 0 0 0 0 0 12.3821 12.2352 0 0 0 0 0 0 11.2003 12.2506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3626 13.7226 0 0 0 0 0 0 0 0 0 0 0 0 12.9379 0 14.4095 0 0 0 14.4666 0 15.4374 0 14.4915 10.848 0 13.7265 12.8303 14.0694 0 0 14.3005 0 0 0 0 0 0 0 0 0 14.2319 12.8935 0 0 0 15.0655 0 0 0 0 0 0 14.4829 0 0 0 0 0 0 0 0 0 0 0 9.26479 0 0 0 0 0 0 0 0 0 0 0 0 12.4114 0 0 0 0 0 0 14.4012 0 0 0 0 0 0 0 Q14896 MYPC3_HUMAN "Myosin-binding protein C, cardiac-type, Cardiac MyBP-C (C-protein, cardiac muscle isoform)" MYBPC3 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; heart morphogenesis [GO:0003007]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of muscle filament sliding [GO:0032971]; regulation of striated muscle contraction [GO:0006942]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] A band [GO:0031672]; C zone [GO:0014705]; cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863] A band [GO:0031672]; C zone [GO:0014705]; cardiac myofibril [GO:0097512]; cytosol [GO:0005829]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; actin binding [GO:0003779]; ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; heart morphogenesis [GO:0003007]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of muscle filament sliding [GO:0032971]; regulation of striated muscle contraction [GO:0006942]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0001671; GO:0003007; GO:0003779; GO:0005829; GO:0005863; GO:0006942; GO:0007155; GO:0008307; GO:0014705; GO:0017022; GO:0030017; GO:0031432; GO:0031672; GO:0032036; GO:0032781; GO:0032971; GO:0042802; GO:0046872; GO:0055010; GO:0060048; GO:0097512 actin binding [GO:0003779]; ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432] AGVKVRWQR 0.99161 -22.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1656 0 0 10.1881 0 0 0 0 0 0 0 0 0 12.5132 0 12.3693 0 0 0 0 0 0 0 0 0 0 0 12.216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7526 0 0 0 14.1132 0 12.5709 0 0 0 14.0201 12.295 0 0 0 0 0 12.374 0 15.2719 14.3083 0 0 14.855 15.3446 0 0 15.031 0 0 0 0 0 13.6211 0 0 0 12.2126 0 14.1974 0 0 14.5838 12.9267 15.1145 0 14.6502 0 0 0 0 0 0 14.0771 13.8548 14.9181 0 0 11.9803 14.1938 14.489 13.5167 12.9316 0 0 0 0 0 0 0 0 13.3437 13.9143 0 0 15.5239 0 0 0 14.4025 14.9296 0 0 0 0 0 0 0 0 0 0 14.3639 0 0 0 0 0 Q5H9F3 BCORL_HUMAN "BCL-6 corepressor-like protein 1, BCoR-L1, BCoR-like protein 1" BCORL1 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005886; GO:0006325 transcription corepressor activity [GO:0003714] AKAGQAR 0.99161 -51.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.601 0 0 0 0 12.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0269 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4873 13.1343 14.5079 11.9023 0 0 0 13.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2947 0 0 0 15.2655 11.6994 0 0 0 13.3898 0 0 0 0 0 0 0 0 0 0 0 0 13.1282 13.8064 0 0 0 0 0 14.0918 0 11.1232 0 0 0 0 0 0 0 0 0 0 12.6961 0 0 0 0 0 0 13.2783 15.8819 14.5787 14.8833 0 0 0 0 0 0 14.344 11.5644 14.6382 0 0 0 0 0 0 0 0 0 0 0 Q5T8I9 HENMT_HUMAN "Small RNA 2'-O-methyltransferase, EC 2.1.1.n8 (HEN1 methyltransferase homolog 1)" HENMT1 C1orf59 Homo sapiens (Human) piRNA metabolic process [GO:0034587]; RNA methylation [GO:0001510]; siRNA processing [GO:0030422] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486]; piRNA metabolic process [GO:0034587]; RNA methylation [GO:0001510]; siRNA processing [GO:0030422] GO:0001510; GO:0003723; GO:0005634; GO:0005737; GO:0008171; GO:0008173; GO:0030422; GO:0034587; GO:0043186; GO:0046872; GO:0090486 metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486] FFVPLQR 0.99161 -18.639 0 0 0 0 0 0 0 0 11.6888 12.6998 14.0079 12.7286 14.1404 0 0 0 0 0 0 11.187 0 0 0 0 11.4691 0 0 0 0 12.9859 14.8991 0 0 11.7524 0 11.5949 0 11.4435 0 12.7848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8749 12.4865 0 13.0172 0 12.1724 0 0 11.3497 12.6673 0 0 0 0 12.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1021 0 11.0549 0 0 0 0 11.2426 0 0 0 0 0 0 0 11.7926 0 0 0 0 11.47 0 0 0 0 0 0 13.7422 0 16.2918 0 0 0 14.4605 0 16.6595 0 13.9903 12.9082 0 0 0 0 0 0 0 0 0 0 Q6NY19 KANK3_HUMAN KN motif and ankyrin repeat domain-containing protein 3 (Ankyrin repeat domain-containing protein 47) KANK3 ANKRD47 Homo sapiens (Human) negative regulation of actin filament polymerization [GO:0030837] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; negative regulation of actin filament polymerization [GO:0030837] GO:0005737; GO:0005856; GO:0030837 AEKARLLAGR 0.99161 -18.679 0 0 0 0 0 0 0 0 0 0 0 11.6945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2863 0 0 0 0 0 0 0 0 0 0 12.7354 13.1266 13.1631 0 0 12.3797 11.8789 0 0 0 0 0 0 0 0 0 12.5074 0 0 12.4812 0 13.0229 11.615 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4191 0 12.7815 13.1483 0 0 0 0 0 12.8842 0 11.9871 0 0 0 0 0 0 0 0 0 0 0 14.5731 0 0 0 0 14.9969 13.2916 0 0 0 13.9772 0 10.1952 0 0 0 0 0 15.6215 0 0 13.8156 12.5201 0 11.2344 0 0 14.3477 0 0 0 0 13.8014 0 0 14.1825 0 0 0 0 15.129 13.8316 12.8884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1812 0 16.3933 11.2063 0 0 0 14.4241 0 0 14.0072 0 0 15.3406 Q8IVU3 HERC6_HUMAN "Probable E3 ubiquitin-protein ligase HERC6, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 6) (HECT-type E3 ubiquitin transferase HERC6)" HERC6 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; protein ubiquitination [GO:0016567]; response to bacterium [GO:0009617]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; hematopoietic progenitor cell differentiation [GO:0002244]; protein ubiquitination [GO:0016567]; response to bacterium [GO:0009617]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0002244; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0009617; GO:0016567; GO:0061630 ubiquitin protein ligase activity [GO:0061630] ELSPRLGK 0.99161 -22.798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0858 0 0 0 0 0 0 10.1461 0 0 13.7441 0 0 0 0 0 0 0 0 14.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95761 0 0 12.4048 0 0 12.9063 11.7237 0 0 14.0715 0 15.1448 0 0 0 0 13.015 0 12.8359 0 0 0 0 0 0 0 0 0 0 0 13.8509 0 0 0 0 12.4425 0 0 0 0 0 0 12.3812 12.3571 0 0 0 12.5222 12.3398 0 0 0 12.5745 12.2052 0 0 0 12.2226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7122 0 0 0 0 0 0 0 0 0 0 0 12.3041 13.4931 11.9389 13.8876 13.1579 13.9262 13.177 0 14.2781 14.1374 0 0 0 0 0 0 0 0 0 12.2941 0 0 Q96FG2 ELMD3_HUMAN ELMO domain-containing protein 3 (RNA-binding motif and ELMO domain-containing protein 1) (RNA-binding motif protein 29) (RNA-binding protein 29) ELMOD3 RBED1 RBM29 PP4068 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] GO:0005737; GO:0005856; GO:0005886; GO:0032420; GO:0060091 DKSVLAFRGIPISELK 0.99161 -18.686 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2855 0 0 0 0 0 0 0 0 11.6934 0 0 0 0 11.6289 0 0 0 0 0 12.1755 0 0 0 0 12.0783 0 0 0 0 11.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3949 0 0 0 0 0 0 0 0 0 0 0 13.6148 0 0 0 0 0 0 13.2341 0 0 0 0 0 13.4633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4947 13.4184 0 0 0 Q96PM9 Z385A_HUMAN Zinc finger protein 385A (Hematopoietic zinc finger protein) (Retinal zinc finger protein) ZNF385A HZF RZF ZNF385 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; hemostasis [GO:0007599]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; platelet alpha granule organization [GO:0070889]; platelet formation [GO:0030220]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of fat cell differentiation [GO:0045600]; regulation of cytoplasmic translation [GO:2000765]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; hemostasis [GO:0007599]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; platelet alpha granule organization [GO:0070889]; platelet formation [GO:0030220]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of fat cell differentiation [GO:0045600]; regulation of cytoplasmic translation [GO:2000765]" GO:0002039; GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006915; GO:0006974; GO:0007599; GO:0007611; GO:0007626; GO:0008270; GO:0010609; GO:0030220; GO:0030425; GO:0035855; GO:0043025; GO:0045600; GO:0070889; GO:1902164; GO:1902166; GO:2000765 DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] AVLSHTFGGPLLKTK 0.99161 -18.683 0 0 0 0 0 0 0 0 13.3647 0 0 12.8027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8573 0 0 0 0 0 0 0 0 0 0 0 0 12.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60923 0 0 0 0 0 13.6864 0 12.4368 13.2229 0 0 13.44 0 0 0 0 0 0 0 11.0342 13.2182 0 0 0 0 0 0 0 0 0 0 12.7459 11.8831 11.7618 0 0 0 12.7358 0 13.027 0 13.6109 0 13.5488 0 12.1473 12.2867 14.9831 13.216 12.4531 0 0 9.60188 0 0 12.9428 13.2004 12.3397 0 0 0 0 0 0 0 10.2606 0 0 0 0 11.1223 13.2038 0 12.8756 10.7454 0 0 0 14.3504 0 13.1086 13.4014 0 0 0 0 0 0 0 13.2016 0 0 0 0 0 0 0 13.9894 0 0 0 0 0 0 0 0 0 10.8998 0 0 0 Q9C093 SPEF2_HUMAN Sperm flagellar protein 2 (Protein KPL2) SPEF2 KIAA1770 KPL2 Homo sapiens (Human) brain morphogenesis [GO:0048854]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; brain morphogenesis [GO:0048854]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; respiratory system development [GO:0060541]; skeletal system morphogenesis [GO:0048705]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] GO:0002177; GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0007283; GO:0007288; GO:0036126; GO:0048705; GO:0048854; GO:0060541; GO:0097225 AQLGAKSEQLLK 0.99161 -22.143 0 0 0 0 0 0 0 0 0 12.5621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0733 0 0 9.35506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.369 0 10.6762 0 12.3264 0 12.9114 0 0 0 15.3729 0 0 0 0 0 0 0 13.1466 0 0 0 0 0 0 13.357 13.9674 0 10.2115 11.3555 0 0 0 13.4402 13.3677 13.2505 0 13.7102 0 13.0376 13.353 0 0 13.7967 0 0 0 11.7173 14.6863 0 12.1201 0 0 12.5844 0 0 0 0 13.1392 0 12.254 14.0644 13.0452 13.1646 0 12.4321 0 0 0 0 14.1331 14.0251 0 0 0 0 0 0 0 14.4892 13.9285 14.4396 0 13.3316 13.4927 12.7636 13.2526 0 0 11.2867 0 0 11.9329 13.2652 0 12.1026 0 0 12.9964 13.9286 0 0 0 0 0 0 Q9UBR1 BUP1_HUMAN "Beta-ureidopropionase, EC 3.5.1.6 (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase)" UPB1 BUP1 Homo sapiens (Human) beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]; UMP catabolic process [GO:0046050] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; beta-ureidopropionase activity [GO:0003837]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; protein homodimerization activity [GO:0042803]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]; UMP catabolic process [GO:0046050]" GO:0001701; GO:0001889; GO:0003837; GO:0005829; GO:0006248; GO:0006249; GO:0016811; GO:0033396; GO:0042803; GO:0046050; GO:0046079; GO:0046135; GO:0051260; GO:0051289; GO:0070062 "beta-ureidopropionase activity [GO:0003837]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; protein homodimerization activity [GO:0042803]" ELRKLDLPR 0.99161 -7.1381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5364 15.1507 0 0 14.6539 0 0 16.3004 0 14.34 0 16.2719 0 0 0 0 0 16.4714 0 0 15.633 15.6132 0 0 0 0 15.8623 0 16.2361 0 0 0 0 15.8677 0 0 0 14.6991 16.0157 0 0 0 0 0 0 16.5592 15.6271 0 0 0 15.763 0 0 0 0 0 15.269 0 0 0 0 15.4535 15.7252 15.4679 0 0 0 15.5911 15.2183 0 0 0 0 0 14.7118 14.5726 0 0 14.4696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9277 15.116 0 14.5803 0 0 0 14.6058 0 Q149N8 SHPRH_HUMAN "E3 ubiquitin-protein ligase SHPRH, EC 2.3.2.27, EC 3.6.4.- (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)" SHPRH KIAA2023 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] nucleoplasm [GO:0005654]; nucleosome [GO:0000786] nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; nucleosome assembly [GO:0006334]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] GO:0000209; GO:0000786; GO:0003677; GO:0004386; GO:0004842; GO:0005524; GO:0005654; GO:0006281; GO:0006334; GO:0006974; GO:0016567; GO:0016787; GO:0031625; GO:0046872; GO:0061630; GO:0140658 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] CGTECEEAHR 0.99162 -54.051 0 0 0 0 0 0 0 0 10.3453 0 0 0 0 11.2301 0 0 0 0 0 11.8427 0 0 0 0 11.2544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6792 0 12.8163 0 12.6254 13.6056 0 0 0 0 0 11.0325 13.3603 0 0 0 0 0 12.5338 0 0 0 0 13.083 0 13.1535 0 12.0743 12.9915 0 0 0 0 0 0 0 13.1911 0 0 0 0 0 12.6145 0 0 0 0 0 0 0 0 0 0 0 0 12.2063 0 13.0335 15.5295 13.0616 0 0 11.7246 0 0 0 0 0 13.0189 0 13.1054 0 12.1351 11.9115 0 0 0 11.6457 0 0 0 12.6797 0 11.6397 0 0 14.1238 0 12.4506 0 0 0 0 0 0 0 0 0 12.9776 12.587 0 0 12.5928 11.6535 14.3865 0 11.4266 10.8431 Q15678 PTN14_HUMAN "Tyrosine-protein phosphatase non-receptor type 14, EC 3.1.3.48 (Protein-tyrosine phosphatase pez)" PTPN14 PEZ PTPD2 Homo sapiens (Human) lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712]; lymphangiogenesis [GO:0001946]; negative regulation of cell population proliferation [GO:0008285]; protein dephosphorylation [GO:0006470]; regulation of protein export from nucleus [GO:0046825] GO:0001946; GO:0003712; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005856; GO:0006470; GO:0008285; GO:0030971; GO:0046825 protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; transcription coregulator activity [GO:0003712] FKVTTKFR 0.99162 -53.399 0 0 0 17.7792 0 0 0 0 16.3426 14.7087 13.0385 12.7446 12.9316 12.5545 0 0 0 13.7601 0 0 0 0 0 0 0 0 0 0 12.8251 12.7195 0 12.4896 13.2802 0 12.5335 0 0 12.6146 12.8127 0 11.9923 0 0 12.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2535 0 0 0 0 0 14.6169 14.6606 0 0 12.0213 11.7892 12.6239 0 0 0 0 0 0 11.4712 0 13.5263 11.724 0 0 13.3838 13.4601 0 12.1548 0 0 12.4505 12.4645 13.217 15.748 12.5175 13.1334 0 0 0 0 0 14.2094 0 0 0 14.0129 0 0 12.8796 14.7992 0 0 0 12.334 0 13.5732 0 13.3892 13.7352 13.4255 0 12.4662 0 0 0 13.3472 12.6858 13.6101 0 0 13.3832 0 0 0 13.5452 0 0 14.0845 13.1552 14.5753 0 13.7891 13.1739 0 0 12.8325 12.4368 12.5402 18.7847 16.3546 0 12.7481 14.8451 0 14.1621 14.8916 0 0 19.2763 0 19.056 14.5951 0 0 0 11.6597 0 0 16.6333 0 0 Q15942 ZYX_HUMAN Zyxin (Zyxin-2) ZYX Homo sapiens (Human) cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to interferon-gamma [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001725; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0007160; GO:0007165; GO:0007179; GO:0007229; GO:0007267; GO:0015629; GO:0043149; GO:0045335; GO:0046872; GO:0050727; GO:0071346 metal ion binding [GO:0046872]; RNA binding [GO:0003723] AAPRPSPAISVSVSAPAFYAPQKK 0.99162 -18.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4449 0 0 0 0 0 0 0 12.4068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3SY69 AL1L2_HUMAN "Mitochondrial 10-formyltetrahydrofolate dehydrogenase, Mitochondrial 10-FTHFDH, mtFDH, EC 1.5.1.6 (Aldehyde dehydrogenase family 1 member L2)" ALDH1L2 Homo sapiens (Human) 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730]" GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155; GO:0016742; GO:0046655; GO:0070062 "aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]" IQGSTIPINQARPNRNLTFTK 0.99162 -7.5013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9527 0 0 0 0 0 0 0 0 0 0 0 Q7Z7G0 TARSH_HUMAN "Target of Nesh-SH3, Tarsh (ABI gene family member 3-binding protein) (Nesh-binding protein, NeshBP)" ABI3BP NESHBP TARSH Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005576; GO:0005615; GO:0010811; GO:0030198; GO:0062023 DAIWTER 0.99162 -53.185 0 0 0 0 0 12.1574 12.4996 0 13.4822 13.7476 13.6413 14.8379 12.4879 14.9188 0 13.2124 10.0214 14.215 14.1888 13.2729 13.5806 0 13.2077 0 10.3716 0 13.8733 0 13.4061 11.5202 13.3723 14.3974 15.1812 15.1323 14.932 14.4444 13.7846 12.4541 14.5004 0 14.0378 11.0511 13.4201 13.3796 0 0 12.8151 0 0 14.7996 0 0 0 9.73829 0 0 0 0 0 0 10.0972 0 13.0243 13.9139 0 0 12.4626 11.4669 0 13.4819 0 13.7803 0 0 15.167 0 13.0626 11.7738 14.2721 0 15.0371 0 13.6582 0 13.9168 0 13.2556 14.6395 13.2732 12.9891 14.8513 0 0 15.4759 0 14.4241 0 15.5692 13.0595 0 14.8871 13.8482 13.5413 0 0 14.0106 12.7343 0 0 12.9699 0 14.5798 0 0 14.2079 13.7334 0 14.8786 14.1462 13.576 0 12.7625 0 13.9038 0 11.4095 13.6013 13.4535 13.12 0 0 12.8438 0 0 13.4057 10.5435 0 11.7645 0 14.152 15.2828 0 12.4492 0 0 13.1959 13.4409 14.374 0 0 13.2685 13.456 0 13.1766 13.2456 13.9037 0 14.1394 16.4964 15.3245 15.2252 14.5881 15.5386 0 0 0 15.9141 14.1261 15.0322 14.2731 15.3633 0 0 0 12.4474 0 0 15.1175 0 10.3563 Q9UGF5 O14J1_HUMAN Olfactory receptor 14J1 (Hs6M1-28) (Olfactory receptor 5U1) (Olfactory receptor OR6-25) OR14J1 OR5U1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IPSAEGR 0.99162 -7.1501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0052 0 0 0 0 11.6505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.503 0 0 0 0 0 12.4641 0 0 0 0 0 0 0 0 P08263 GSTA1_HUMAN "Glutathione S-transferase A1, EC 2.5.1.18 (13-hydroperoxyoctadecadienoate peroxidase, EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase, EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Cleaved into: Glutathione S-transferase A1, N-terminally processed ]" GSTA1 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805] GO:0004364; GO:0004602; GO:0004769; GO:0005504; GO:0005829; GO:0006693; GO:0006749; GO:0006805; GO:0030855; GO:0043651; GO:0070062; GO:1901687 fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769] AILNYIASKYNLYGKDIK 0.99163 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20810 ICAL_HUMAN Calpastatin (Calpain inhibitor) (Sperm BS-17 component) CAST Homo sapiens (Human) inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; presynaptic active zone organization [GO:1990709] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; cadherin binding [GO:0045296]; calcium-dependent cysteine-type endopeptidase inhibitor activity [GO:0010859]; endopeptidase inhibitor activity [GO:0004866]; RNA binding [GO:0003723]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; presynaptic active zone organization [GO:1990709] GO:0003723; GO:0004866; GO:0005737; GO:0005783; GO:0005829; GO:0010859; GO:0016020; GO:0045296; GO:0097340; GO:1990709; GO:2000675 cadherin binding [GO:0045296]; calcium-dependent cysteine-type endopeptidase inhibitor activity [GO:0010859]; endopeptidase inhibitor activity [GO:0004866]; RNA binding [GO:0003723] AEHRDKLGER 0.99163 -48.212 0 0 0 0 0 0 9.46422 0 16.091 13.1612 13.3478 12.9666 13.1793 12.7637 14.5046 0 0 0 12.0715 0 0 0 0 0 0 0 0 0 12.868 0 13.0004 11.2667 12.6715 12.4602 12.7598 12.6662 12.5052 12.7397 12.3523 12.6062 0 0 0 12.5959 0 13.2012 17.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9773 0 0 0 0 0 0 0 18.2627 0 0 0 0 17.7273 0 14.9015 17.3784 0 0 0 0 0 0 12.1368 0 0 0 0 0 0 0 0 0 11.4703 10.282 0 0 0 10.8825 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2496 0 0 0 14.0842 0 0 0 0 0 12.9511 0 0 0 0 0 0 10.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4964 0 0 0 0 0 12.8279 12.4682 0 0 0 0 12.3774 14.5798 0 12.9278 0 0 0 0 0 0 0 12.1866 0 0 0 9.91133 0 0 0 0 12.236 13.74 P36957 ODO2_HUMAN "Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial, EC 2.3.1.61 (2-oxoglutarate dehydrogenase complex component E2, OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)" DLST DLTS Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; acyltransferase activity [GO:0016746]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099] GO:0004149; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006091; GO:0006099; GO:0006103; GO:0006104; GO:0016020; GO:0016746; GO:0033512; GO:0045252; GO:0106077 acyltransferase activity [GO:0016746]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149] EKMNRMR 0.99163 -7.1748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1829 0 0 0 0 0 0 0 0 0 13.7084 0 13.2788 0 0 0 0 0 0 13.6418 0 0 0 0 11.9213 0 0 0 0 12.2578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4501 12.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13639 5HT4R_HUMAN "5-hydroxytryptamine receptor 4, 5-HT-4, 5-HT4 (Serotonin receptor 4)" HTR4 Homo sapiens (Human) "adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; regulation of appetite [GO:0032098]" GO:0004993; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007198; GO:0007268; GO:0016020; GO:0030425; GO:0030594; GO:0032098; GO:0045202; GO:0051378 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] MRTETKAAK 0.99163 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8904 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8796 0 0 0 0 0 0 0 0 0 0 12.3897 0 0 0 13.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA31 RN187_HUMAN "E3 ubiquitin-protein ligase RNF187, EC 2.3.2.27 (RING domain AP1 coactivator 1, RACO-1) (RING finger protein 187) (RING-type E3 ubiquitin transferase RNF187)" RNF187 Homo sapiens (Human) "innate immune response [GO:0045087]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; innate immune response [GO:0045087]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]" GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008284; GO:0010468; GO:0016567; GO:0043161; GO:0045087; GO:0045893; GO:0046872; GO:0051865; GO:0061630; GO:0070936 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] APREPVR 0.99163 -7.1778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7994 0 0 0 0 0 10.6972 0 0 10.708 0 0 0 0 0 0 0 16.8647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5219 0 0 0 0 0 0 0 0 0 0 0 0 11.8103 0 0 0 0 0 0 0 0 10.8876 0 0 0 0 15.4685 0 13.5479 14.1987 14.4739 0 0 0 0 0 0 13.4381 0 12.8281 0 0 0 10.2907 12.5788 0 0 11.4478 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6182 0 0 0 11.3509 0 0 0 12.0556 0 0 0 11.5204 0 0 0 0 0 0 0 0 0 0 11.9659 0 0 0 0 0 0 0 0 11.9222 0 0 0 0 0 0 0 0 0 Q68DH5 LMBD2_HUMAN G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2) LMBRD2 Homo sapiens (Human) adrenergic receptor signaling pathway [GO:0071875] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adrenergic receptor signaling pathway [GO:0071875] GO:0005886; GO:0016020; GO:0016021; GO:0071875 CPTEYQEKMGRNMDDYEDFDEK 0.99163 -7.1802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0283 0 0 0 0 0 0 11.0256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7397 0 0 0 0 0 0 0 0 0 11.445 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9478 0 0 Q6NSI8 SANBR_HUMAN "SANT and BTB domain regulator of class switch recombination, SANT and BTB domain regulator of CSR" SANBR KIAA1841 Homo sapiens (Human) isotype switching [GO:0045190] identical protein binding [GO:0042802]; isotype switching [GO:0045190] GO:0042802; GO:0045190 identical protein binding [GO:0042802] DKTWDVHEYLNSLFEELKSWR 0.99163 -4.522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N300 SVBP_HUMAN Small vasohibin-binding protein (Coiled coil domain-containing protein 23) SVBP CCDC23 Homo sapiens (Human) axon development [GO:0061564]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein ubiquitination [GO:0031397]; protein secretion [GO:0009306]; proteolysis [GO:0006508]; regulation of metallopeptidase activity [GO:1905048] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; microtubule binding [GO:0008017]; axon development [GO:0061564]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein ubiquitination [GO:0031397]; protein secretion [GO:0009306]; proteolysis [GO:0006508]; regulation of metallopeptidase activity [GO:1905048] GO:0005576; GO:0005737; GO:0005856; GO:0006508; GO:0008017; GO:0009306; GO:0010596; GO:0031397; GO:0045177; GO:0061564; GO:1905048 microtubule binding [GO:0008017] AEIYALNR 0.99163 -7.5212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4192 14.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PC2 IP6K3_HUMAN "Inositol hexakisphosphate kinase 3, InsP6 kinase 3, EC 2.7.4.21 (Inositol hexaphosphate kinase 3)" IP6K3 IHPK3 Homo sapiens (Human) inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; locomotion [GO:0040011]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol diphosphate tetrakisphosphate kinase activity [GO:0052839]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate 6-kinase activity [GO:0000831]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; kinase activity [GO:0016301]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; locomotion [GO:0040011]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein phosphorylation [GO:0006468]" GO:0000827; GO:0000828; GO:0000829; GO:0000831; GO:0000832; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0016301; GO:0032958; GO:0040011; GO:0043647; GO:0046488; GO:0046854; GO:0052723; GO:0052724; GO:0052836; GO:0052839 "ATP binding [GO:0005524]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol diphosphate tetrakisphosphate kinase activity [GO:0052839]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate 6-kinase activity [GO:0000831]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; kinase activity [GO:0016301]" ELLEPILHQLR 0.99163 -7.175 0 0 0 0 0 0 9.29524 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2633 0 0 0 0 0 0 0 0 0 11.7005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2452 0 0 0 0 0 0 0 0 0 0 14.2394 13.8116 0 0 0 0 0 0 0 0 0 13.0529 0 0 0 0 0 0 0 0 13.7985 0 13.8626 0 0 0 0 0 0 0 0 12.4118 0 0 0 0 0 0 11.2746 0 0 0 0 15.0477 0 12.6865 0 0 0 0 0 0 0 10.6799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1797 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H930 SP14L_HUMAN Nuclear body protein SP140-like protein SP140L Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0016604; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" CGGWPLR 0.99163 -55.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7404 12.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2716 0 0 0 0 0 0 0 0 0 0 0 10.7902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1514 0 0 0 11.416 0 0 12.9498 0 12.2792 0 0 0 0 14.8287 13.9526 13.0074 11.8131 12.8291 13.1856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2819 0 16.8428 0 12.814 0 0 0 12.8928 14.8377 13.9185 0 0 0 0 0 0 0 0 0 0 12.3896 11.3039 0 0 0 13.7805 17.6928 0 0 0 0 0 12.6926 0 0 0 0 0 0 13.0473 0 12.3424 13.8282 0 0 0 0 0 13.9933 12.5443 0 13.2644 0 0 0 13.288 0 11.4415 0 0 0 0 0 0 0 0 0 0 0 14.4336 0 13.4138 0 13.6151 12.0374 0 0 A6PVS8 LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 (Leucine-rich repeat-containing protein 44) LRRIQ3 LRRC44 Homo sapiens (Human) DIRLERSMK 0.99164 -7.3705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7073 17.5666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2985 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7571 0 11.6368 0 0 0 0 0 0 0 0 0 0 0 0 14.9027 13.3019 13.1274 16.2767 13.0589 18.4478 18.1674 18.1254 18.0837 18.327 13.9818 18.7322 12.7115 0 18.4986 0 0 13.6287 0 18.9132 0 13.9657 14.0007 18.9017 14.3703 13.6987 15.8499 13.3205 18.521 13.8525 19.7638 13.9518 0 13.9735 13.3083 11.9031 15.1456 17.6859 0 13.3026 12.0337 14.9248 0 15.2423 12.0147 12.4229 0 13.2434 0 12.8736 13.5352 12.9402 0 0 11.9409 18.8792 13.9537 11.4426 15.0746 13.7944 12.1899 0 0 18.4805 14.4571 11.6294 0 0 0 14.5459 14.9783 12.1012 0 13.5793 13.4919 11.1014 0 0 13.7865 18.5225 0 0 14.079 0 12.7498 0 0 0 0 13.7777 0 0 0 0 11.8779 0 13.8107 0 0 0 0 0 0 0 0 11.8182 15.2819 18.5428 12.6505 0 0 14.2003 0 0 A6NL88 SHSA7_HUMAN "Protein shisa-7 (Cystine-knot AMPAR modulating protein of 59 kDa, CKAMP59) (GABA(A) receptor auxiliary subunit Shisa7) (Protein shisa-6-like)" SHISA7 Homo sapiens (Human) gamma-aminobutyric acid receptor clustering [GO:0097112]; gamma-aminobutyric acid signaling pathway [GO:0007214]; memory [GO:0007613]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of AMPA receptor activity [GO:2000311]; regulation of GABA-A receptor activity [GO:0106040]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of short-term neuronal synaptic plasticity [GO:0048172] "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; dendritic spine membrane [GO:0032591]; integral component of postsynaptic specialization membrane [GO:0099060]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]" "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; dendritic spine membrane [GO:0032591]; integral component of postsynaptic specialization membrane [GO:0099060]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; GABA receptor binding [GO:0050811]; ionotropic glutamate receptor binding [GO:0035255]; gamma-aminobutyric acid receptor clustering [GO:0097112]; gamma-aminobutyric acid signaling pathway [GO:0007214]; memory [GO:0007613]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of AMPA receptor activity [GO:2000311]; regulation of GABA-A receptor activity [GO:0106040]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of short-term neuronal synaptic plasticity [GO:0048172]" GO:0007214; GO:0007613; GO:0014069; GO:0032281; GO:0032591; GO:0035255; GO:0045211; GO:0048172; GO:0050811; GO:0070161; GO:0097112; GO:0098839; GO:0098962; GO:0098985; GO:0099060; GO:0106040; GO:1900273; GO:1904717; GO:2000311 GABA receptor binding [GO:0050811]; ionotropic glutamate receptor binding [GO:0035255] AHRDINVPR 0.99164 -18.966 16.1795 15.0761 11.6751 15.695 19.5132 18.9319 19.7798 14.8135 0 0 0 0 0 0 11.9176 13.233 13.6917 14.4027 19.3447 14.801 15.3747 19.3356 15.5607 19.4718 13.1895 13.8354 13.356 14.5967 0 0 12.3334 0 0 0 13.7451 0 0 0 12.3845 12.7817 0 12.0122 0 0 14.0351 12.7996 12.0137 13.9974 0 13.368 0 16.2071 13.7148 0 13.4219 11.754 12.2668 0 0 0 11.2987 10.8439 0 0 0 11.2644 19.8449 19.7194 19.8132 15.4648 19.5509 19.6233 14.4407 19.5336 19.8661 17.6869 17.314 19.9805 20.0085 20.1968 20.3282 17.0282 20.2407 20.3282 20.1887 20.19 16.9027 17.1498 18.1678 16.9412 17.2877 18.1564 17.5022 17.7291 17.2962 17.3278 17.9908 20.1852 16.2842 18.1694 18.3716 20.1723 20.4998 18.4693 18.3825 20.2968 18.0026 17.5347 20.1538 17.7322 20.1235 15.0023 20.2404 17.5432 18.0155 18.1256 17.9723 17.4366 20.2614 17.9163 20.1778 17.2903 20.2658 20.1732 20.3101 18.1418 20.3427 20.1587 18.3203 20.1636 17.1532 20.307 18.1361 17.8175 18.2696 17.5812 17.5926 17.9974 17.8158 17.6894 16.728 18.4795 18.2513 20.2034 20.215 17.4461 16.8708 19.8527 19.899 19.9274 19.996 20.249 20.0997 20.2107 17.7218 17.813 13.8792 0 0 0 0 0 0 0 0 14.8681 0 0 13.3779 13.7926 0 18.4541 17.9588 17.3435 17.6133 0 0 0 14.5609 0 O60237 MYPT2_HUMAN "Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2, Myosin phosphatase target subunit 2)" PPP1R12B MYPT2 Homo sapiens (Human) regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165] A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018] A band [GO:0031672]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Z disc [GO:0030018]; enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; regulation of muscle contraction [GO:0006937]; signal transduction [GO:0007165] GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006937; GO:0007165; GO:0008047; GO:0019208; GO:0019901; GO:0030018; GO:0031672 enzyme activator activity [GO:0008047]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901] ALERKMSEMEEEMK 0.99164 -23.218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9939 0 0 11.8077 0 0 12.9148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9276 0 15.9673 12.0396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5269 0 0 12.3604 0 14.4211 0 13.7693 0 14.2493 13.3035 13.3746 13.6371 14.2306 12.1046 0 0 18.8279 0 11.662 0 13.5058 13.1832 14.3343 0 0 0 14.6484 0 13.2836 0 0 12.5701 13.9593 14.2082 0 0 0 11.703 0 0 0 12.1078 13.6584 12.9729 13.318 11.4765 14.5998 18.1161 0 13.4284 12.6255 13.9295 0 0 0 0 0 0 0 0 0 0 0 12.6963 0 13.7444 0 10.9158 0 0 0 18.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4649 0 0 12.9758 12.5542 0 0 13.1248 0 0 11.4604 0 0 13.0099 0 0 Q01740 FMO1_HUMAN "Dimethylaniline monooxygenase [N-oxide-forming] 1, EC 1.14.13.8 (Dimethylaniline oxidase 1) (Fetal hepatic flavin-containing monooxygenase 1, FMO 1)" FMO1 Homo sapiens (Human) energy homeostasis [GO:0097009]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; response to osmotic stress [GO:0006970]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; energy homeostasis [GO:0097009]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; response to osmotic stress [GO:0006970]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0004499; GO:0005788; GO:0005789; GO:0006082; GO:0006805; GO:0006970; GO:0009404; GO:0016021; GO:0032496; GO:0046322; GO:0050660; GO:0050661; GO:0070995; GO:0097009 "flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]" GQYFHSR 0.99164 -18.89 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9374 14.144 0 0 13.059 0 0 0 0 12.7036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.22 0 0 0 0 0 0 0 14.8773 14.0995 14.6877 14.7027 14.2091 14.796 0 0 15.5763 0 0 14.5895 0 14.8589 0 0 0 0 0 14.2567 0 0 0 14.2492 0 14.236 14.2041 0 0 14.5783 0 0 15.0678 0 0 0 14.1905 14.2991 0 14.2341 0 0 14.9706 14.1729 14.0318 14.1532 0 0 0 0 0 0 0 0 0 0 0 0 15.3385 0 0 12.4002 0 0 0 0 0 0 0 0 14.6956 12.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0291 0 0 0 0 13.7536 14.0486 0 0 0 0 Q02094 RHAG_HUMAN "Ammonium transporter Rh type A (Erythrocyte membrane glycoprotein Rh50) (Erythrocyte plasma membrane 50 kDa glycoprotein, Rh50A) (Rhesus blood group family type A glycoprotein, Rh family type A glycoprotein, Rh type A glycoprotein) (Rhesus blood group-associated ammonia channel) (Rhesus blood group-associated glycoprotein) (CD antigen CD241)" RHAG RH50 Homo sapiens (Human) ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular ion homeostasis [GO:0006873]; erythrocyte development [GO:0048821]; inorganic cation transmembrane transport [GO:0098662]; multicellular organismal iron ion homeostasis [GO:0060586] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; ankyrin binding [GO:0030506]; carbon dioxide transmembrane transporter activity [GO:0035379]; leak channel activity [GO:0022840]; ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488]; bicarbonate transport [GO:0015701]; carbon dioxide transport [GO:0015670]; cellular ion homeostasis [GO:0006873]; erythrocyte development [GO:0048821]; inorganic cation transmembrane transport [GO:0098662]; multicellular organismal iron ion homeostasis [GO:0060586] GO:0005886; GO:0005887; GO:0006873; GO:0008519; GO:0015670; GO:0015701; GO:0016020; GO:0022840; GO:0030506; GO:0035379; GO:0048821; GO:0060586; GO:0072488; GO:0097272; GO:0098662 ammonium transmembrane transporter activity [GO:0008519]; ankyrin binding [GO:0030506]; carbon dioxide transmembrane transporter activity [GO:0035379]; leak channel activity [GO:0022840] FLTPLFTTK 0.99164 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8527 15.2828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13574 DGKZ_HUMAN "Diacylglycerol kinase zeta, DAG kinase zeta, EC 2.7.1.107 (Diglyceride kinase zeta, DGK-zeta)" DGKZ DAGK6 Homo sapiens (Human) "cell migration [GO:0016477]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid kinase activity [GO:0001727]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein C-terminus binding [GO:0008022]; cell migration [GO:0016477]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of synaptic transmission, glutamatergic [GO:0051966]" GO:0001727; GO:0003951; GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008022; GO:0016301; GO:0016477; GO:0016607; GO:0030027; GO:0030168; GO:0031571; GO:0035556; GO:0045930; GO:0046339; GO:0046486; GO:0046834; GO:0046872; GO:0050860; GO:0051966; GO:0090216 ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid kinase activity [GO:0001727]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein C-terminus binding [GO:0008022] CAACKIVVHTPCIEQLEKINFR 0.99164 -22.653 0 0 0 0 0 0 0 0 0 0 0 11.8362 0 0 12.2376 0 0 0 12.5083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.333 0 0 0 0 0 0 0 0 12.343 0 0 0 0 0 0 0 12.5502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5369 0 12.4438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0934 0 0 14.5521 0 0 0 0 0 13.9684 0 0 0 0 0 0 0 0 13.8456 0 0 13.9802 14.2357 13.7982 0 0 0 0 0 0 0 0 0 Q14894 CRYM_HUMAN "Ketimine reductase mu-crystallin, EC 1.5.1.25 (NADP-regulated thyroid-hormone-binding protein)" CRYM THBP Homo sapiens (Human) lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; lysine catabolic process [GO:0006554]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327] GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0006554; GO:0007605; GO:0042403; GO:0042562; GO:0042803; GO:0047127; GO:0050661; GO:0070062; GO:0070324; GO:0070327 hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714] LVTFYEDR 0.99164 -18.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3209 0 0 0 14.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76G19 PDZD4_HUMAN PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein) PDZD4 KIAA1444 PDZK4 PDZRN4L Homo sapiens (Human) cell cortex [GO:0005938] cell cortex [GO:0005938] GO:0005938 DSTSAYNTGESCR 0.99164 -22.65 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6896 0 0 0 0 0 0 0 12.3493 12.3067 12.5083 13.3142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8111 16.358 0 0 0 0 0 0 0 0 12.5779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8806 0 10.974 0 0 0 10.8641 0 0 0 0 0 0 10.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7299 0 13.5507 0 0 12.7944 0 13.2358 0 11.3099 0 12.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.601 0 0 Q8IVF4 DYH10_HUMAN Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10) DNAH10 KIAA2017 Homo sapiens (Human) microtubule-based movement [GO:0007018] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; microtubule-based movement [GO:0007018] GO:0005524; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0097729 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] AIDSFDRR 0.99164 -101.54 0 11.9505 0 10.8987 0 0 0 0 0 13.8895 0 0 0 14.1894 11.9646 13.7782 11.5952 0 0 9.34105 0 0 12.957 12.383 13.1052 0 0 0 11.7468 0 0 0 0 0 0 0 12.4306 12.2662 0 0 0 0 11.4416 0 0 11.6055 0 0 12.4311 16.4984 0 0 0 0 0 10.7231 11.0845 0 0 0 0 0 0 0 0 0 15.5185 14.8707 17.2989 0 11.8964 12.3888 0 0 0 14.9386 13.6624 10.9944 0 0 14.3797 16.0967 13.4354 14.8519 0 13.747 12.0638 12.1226 14.3457 14.9859 14.4876 14.5912 14.8808 15.3199 15.4445 14.0832 14.4088 0 15.0671 14.8444 0 0 15.0414 0 14.2209 15.1209 15.4164 15.1641 12.7895 15.6269 0 15.0772 0 0 13.8016 0 13.3126 0 13.6806 0 0 0 14.3436 15.1736 14.444 15.026 0 0 14.2572 0 13.8581 0 0 14.3184 14.8795 0 15.38 12.3859 0 12.2291 11.1911 14.6487 0 13.0576 12.4528 0 0 19.075 0 14.9677 0 14.953 10.9852 13.5596 13.205 0 13.4398 10.9303 0 13.5226 13.2148 12.6898 0 12.6982 0 0 15.7195 12.4313 13.1892 0 0 12.6171 12.7032 13.5457 15.2023 14.1 13.011 13.8637 15.3397 16.3274 Q8NF37 PCAT1_HUMAN "Lysophosphatidylcholine acyltransferase 1, LPC acyltransferase 1, LPCAT-1, LysoPC acyltransferase 1, EC 2.3.1.23 (1-acylglycerol-3-phosphate O-acyltransferase, EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase, EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase, EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase, Acetyl-CoA:lyso-PAF acetyltransferase, Lyso-PAF acetyltransferase, LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3)" LPCAT1 AYTL2 PFAAP3 Homo sapiens (Human) negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200]; negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129] GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0006654; GO:0006656; GO:0008654; GO:0016020; GO:0016021; GO:0030163; GO:0035577; GO:0036148; GO:0036151; GO:0043129; GO:0045732; GO:0047144; GO:0047159; GO:0047184; GO:0047191; GO:0047192; GO:0050200; GO:0060041; GO:2001246 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0050200] GLGLKPEKLEK 0.99164 -22.588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6933 0 0 0 0 0 11.9709 0 0 0 0 0 0 0 0 0 0 13.1153 12.6753 0 0 0 0 0 0 0 11.2318 11.0235 0 0 0 0 0 0 0 10.9039 0 0 0 0 0 0 0 0 0 0 13.07 0 0 0 12.5678 12.5898 0 0 0 15.0928 0 0 15.2799 0 0 0 0 14.6658 0 0 14.7876 0 13.7671 0 14.4099 12.2999 13.6245 0 0 12.4227 0 14.0472 0 13.699 0 16.1416 0 0 13.8467 15.8054 13.5887 0 13.0079 0 10.5072 12.8767 0 13.2643 0 0 0 0 0 16.0936 0 13.2812 0 0 0 0 0 0 0 15.8384 0 0 15.8764 0 0 0 16.3372 0 0 0 14.8454 15.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9923 0 0 Q8NFM7 I17RD_HUMAN "Interleukin-17 receptor D, IL-17 receptor D, IL-17RD (IL17Rhom) (Interleukin-17 receptor-like protein) (Sef homolog, hSef)" IL17RD IL17RLM SEF UNQ6115/PRO20026 Homo sapiens (Human) negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; interleukin-17 receptor activity [GO:0030368]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] GO:0000139; GO:0005654; GO:0005794; GO:0005886; GO:0010719; GO:0016021; GO:0030368; GO:0030512 interleukin-17 receptor activity [GO:0030368] ARGADTCGWR 0.99164 -18.883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8925 0 0 0 0 0 0 0 0 0 0 0 12.3716 0 0 0 0 0 0 14.618 0 0 0 14.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.477 0 0 0 0 0 11.778 0 0 0 0 0 0 0 Q96AP4 ZUP1_HUMAN "Zinc finger-containing ubiquitin peptidase 1, EC 3.4.19.12 (Lys-63-specific deubiquitinase ZUFSP, DUB) (Zinc finger with UFM1-specific peptidase domain protein)" ZUP1 C6orf113 ZUFSP Homo sapiens (Human) regulation of gene expression [GO:0010468] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; metal ion binding [GO:0046872]; regulation of gene expression [GO:0010468] GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0010468; GO:0046872 cysteine-type deubiquitinase activity [GO:0004843]; metal ion binding [GO:0046872] GMLIPCIPK 0.99164 -22.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4798 0 0 0 0 0 0 0 0 11.6739 0 0 0 0 0 0 0 0 0 0 13.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCI6 K1586_HUMAN "E3 SUMO-protein ligase KIAA1586, EC 2.3.2.- (E3 SUMO-protein transferase KIAA1586)" KIAA1586 Homo sapiens (Human) protein sumoylation [GO:0016925] SUMO ligase activity [GO:0061665]; protein sumoylation [GO:0016925] GO:0016925; GO:0061665 SUMO ligase activity [GO:0061665] EFVNNNIK 0.99164 -18.974 0 0 0 0 0 0 0 0 0 13.6774 0 0 14.149 13.0358 11.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9415 0 13.6143 0 12.668 13.4054 13.0622 0 0 0 0 13.3122 0 0 0 12.9191 0 0 13.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7017 0 0 0 0 0 0 0 0 0 0 14.5812 0 0 0 0 0 0 12.1818 0 0 0 0 0 15.0823 0 0 0 15.2764 0 0 14.452 14.8032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9956 0 0 0 13.0122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRZ9 HELLS_HUMAN "Lymphoid-specific helicase, EC 3.6.4.- (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6)" HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; kidney development [GO:0001822]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508] "chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]" "chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; kidney development [GO:0001822]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]" GO:0000775; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006306; GO:0006346; GO:0006915; GO:0007049; GO:0010216; GO:0016787; GO:0031508; GO:0046651; GO:0051301; GO:0140658; GO:1990830; GO:2001243 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787] CRLIRELK 0.99164 -22.663 14.617 14.9908 0 0 14.6809 0 0 0 11.3507 12.2977 0 12.5422 0 12.1729 10.8401 0 11.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0085 0 0 11.6698 0 0 0 0 0 0 11.8728 0 0 0 0 0 0 0 12.7149 0 13.5401 0 13.835 14.2185 13.5007 0 13.2409 12.2175 12.6155 13.5097 0 12.6315 0 0 0 0 0 11.9369 0 17.4995 17.4362 0 0 0 0 0 0 0 0 0 0 13.0756 14.7502 0 0 0 0 0 0 0 0 18.4477 18.3242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3984 0 0 0 0 0 14.5861 0 0 0 0 0 0 0 0 0 0 0 16.625 0 0 0 0 15.2096 0 0 0 0 0 0 14.775 0 0 0 0 0 11.9953 14.9163 0 0 14.1482 0 13.9171 0 0 0 0 0 0 0 14.9163 13.798 0 Q9P2D1 CHD7_HUMAN "Chromodomain-helicase-DNA-binding protein 7, CHD-7, EC 3.6.4.12 (ATP-dependent helicase CHD7)" CHD7 KIAA1416 Homo sapiens (Human) "adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; ventricular trabecula myocardium morphogenesis [GO:0003222]" chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta morphogenesis [GO:0035909]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chordate embryonic development [GO:0043009]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; limb development [GO:0060173]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; ventricular trabecula myocardium morphogenesis [GO:0003222]" GO:0000785; GO:0000978; GO:0001501; GO:0001701; GO:0001974; GO:0003007; GO:0003222; GO:0003226; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006355; GO:0006364; GO:0006366; GO:0007417; GO:0007512; GO:0007605; GO:0007628; GO:0008015; GO:0009617; GO:0010468; GO:0010880; GO:0016887; GO:0021545; GO:0021553; GO:0021772; GO:0030217; GO:0030540; GO:0035116; GO:0035909; GO:0036302; GO:0040018; GO:0042048; GO:0042393; GO:0042472; GO:0043009; GO:0043584; GO:0045944; GO:0048752; GO:0048806; GO:0050767; GO:0050890; GO:0060041; GO:0060123; GO:0060173; GO:0060324; GO:0060384; GO:0060411; GO:0060429; GO:0062009; GO:0140658; GO:1990841 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AKTATPKPK 0.99164 -22.548 0 0 0 0 12.6247 13.368 13.4101 0 12.9831 12.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5745 0 0 0 0 9.99067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4451 11.9721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0416 12.0091 0 14.1555 0 0 13.6462 0 0 13.2864 13.7932 14.9227 15.4799 14.4233 0 14.6893 15.8596 12.9366 0 14.1171 13.9428 0 10.7531 0 0 0 0 15.3391 0 13.6595 13.8055 0 13.5354 9.48265 0 0 12.0241 0 13.4436 14.673 0 12.9771 13.8762 10.0329 0 0 14.758 14.4959 12.8141 12.2222 0 0 0 14.3617 11.0908 0 0 14.2005 0 0 13.2866 0 0 0 0 0 0 0 0 11.819 14.1962 15.2002 12.0647 13.6505 0 0 11.5108 12.2626 0 12.5606 0 0 0 14.7703 10.1128 0 0 0 13.8198 0 0 12.7585 0 0 0 0 0 12.4212 0 0 0 0 14.755 11.1663 0 0 0 0 0 Q9UKY4 POMT2_HUMAN "Protein O-mannosyl-transferase 2, EC 2.4.1.109 (Dolichyl-phosphate-mannose--protein mannosyltransferase 2)" POMT2 Homo sapiens (Human) positive regulation of protein O-linked glycosylation [GO:1904100]; protein O-linked mannosylation [GO:0035269] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; metal ion binding [GO:0046872]; positive regulation of protein O-linked glycosylation [GO:1904100]; protein O-linked mannosylation [GO:0035269] GO:0000030; GO:0004169; GO:0005654; GO:0005730; GO:0005783; GO:0005789; GO:0005829; GO:0016021; GO:0035269; GO:0046872; GO:1904100 dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; metal ion binding [GO:0046872] CGPQAARAAGR 0.99164 -18.944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8647 Q9UKL0 RCOR1_HUMAN REST corepressor 1 (Protein CoREST) RCOR1 KIAA0071 RCOR Homo sapiens (Human) "chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; histone deacetylation [GO:0016575]; histone H4 deacetylation [GO:0070933]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]" DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; histone deacetylation [GO:0016575]; histone H4 deacetylation [GO:0070933]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000118; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0006357; GO:0010629; GO:0016575; GO:0017053; GO:0019899; GO:0030218; GO:0045654; GO:0045892; GO:0070933; GO:1990391 chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714] FNIDEVLQEWEAEHGK 0.99165 -19.034 10.774 0 0 0 0 17.5457 17.9934 13.0758 9.54189 0 13.7624 0 13.4376 0 0 18.3473 15.0047 14.3943 16.5458 15.6271 16.8809 18.8752 17.3346 15.908 16.2073 16.6756 16.837 16.2604 14.6904 14.6938 13.8917 0 0 0 0 0 0 14.2359 0 13.5221 15.0982 14.7051 13.4041 14.2419 0 14.4904 0 14.0457 0 14.7997 13.8857 19.1581 16.0002 14.7012 14.6752 13.7181 13.6579 15.3091 12.0628 0 0 0 12.5437 0 13.031 0 15.9656 16.2923 16.5301 15.7545 16.9047 13.716 19.0131 18.8747 14.2308 15.723 15.8649 16.0903 15.9875 15.9276 16.2992 14.5432 15.7254 16.8248 15.1474 13.7169 0 19.0676 16.4157 15.9274 16.9876 0 17.0848 16.5807 0 16.0722 15.5645 15.7197 0 16.4429 14.8321 15.2307 14.9915 0 0 15.6137 15.148 16.2335 14.887 15.6735 16.2579 0 16.8071 16.1254 14.5585 16.3751 18.7903 16.7998 16.3451 14.9491 15.8125 14.8352 16.4214 14.5647 15.2005 15.5291 14.8914 16.1183 15.0235 0 0 15.0869 15.8137 15.7871 14.5092 16.3381 15.699 19.5495 15.6185 16.2552 15.2946 16.6914 15.4633 15.834 16.4013 16.5344 16.8178 15.7336 16.7507 19.2611 15.9528 15.9831 0 16.2358 16.4268 14.0829 15.6644 14.7887 15.1821 15.9656 0 0 14.8681 15.8032 15.035 15.2871 14.3266 13.5859 0 13.6686 16.4982 15.8211 15.2035 15.6881 17.1793 19.4208 0 16.9485 15.9661 0 O75838 CIB2_HUMAN "Calcium and integrin-binding family member 2 (Kinase-interacting protein 2, KIP 2)" CIB2 KIP2 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; cellular response to ATP [GO:0071318]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cytosolic calcium ion concentration [GO:0007204] blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420] blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; calcium ion homeostasis [GO:0055074]; cellular response to ATP [GO:0071318]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0000287; GO:0001750; GO:0001917; GO:0005178; GO:0005509; GO:0005737; GO:0005927; GO:0007204; GO:0031594; GO:0032420; GO:0032437; GO:0042383; GO:0042803; GO:0045494; GO:0055074; GO:0071318; GO:0071944; GO:0072562 calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] EDLELTLARLTKSELDEEEVVLVCDK 0.99165 -4.6889 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6003 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3319 0 0 14.0273 0 0 0 0 0 0 0 0 0 0 12.9786 0 0 13.079 0 0 0 0 0 12.9419 0 0 0 0 0 0 0 0 0 P10911 MCF2_HUMAN Proto-oncogene DBL (Proto-oncogene MCF-2) [Cleaved into: MCF2-transforming protein; DBL-transforming protein ] MCF2 DBL Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to leukemia inhibitory factor [GO:1990830]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; negative regulation of axonogenesis [GO:0050771]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005737; GO:0005829; GO:0005856; GO:0016020; GO:0016358; GO:0035556; GO:0050771; GO:0051056; GO:1990830 guanyl-nucleotide exchange factor activity [GO:0005085] AEMDNPEMFDLMPPLLR 0.99165 -19.032 0 0 9.97341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.26 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1795 12.7196 0 0 0 0 0 0 0 0 0 12.3346 0 0 0 0 0 15.8122 11.0875 0 12.8626 0 0 0 0 0 0 15.0922 15.519 13.1232 13.3072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.666 0 0 0 0 0 0 0 0 0 0 0 11.1476 0 0 0 14.4536 16.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3708 10.64 0 13.4119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50897 PPT1_HUMAN "Palmitoyl-protein thioesterase 1, PPT-1, EC 3.1.2.22 (Palmitoyl-protein hydrolase 1)" PPT1 CLN1 PPT Homo sapiens (Human) adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular macromolecule catabolic process [GO:0044265]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; cellular macromolecule catabolic process [GO:0044265]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of phospholipase A2 activity [GO:0032429]; regulation of synapse structure or activity [GO:0050803]; response to stimulus [GO:0050896]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601] GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005794; GO:0005829; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0016290; GO:0016790; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0031579; GO:0032429; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0044265; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0050896; GO:0070062; GO:0120146 lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; sulfatide binding [GO:0120146]; thiolester hydrolase activity [GO:0016790] CPGESSHICDFIR 0.99165 -7.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7684 0 0 0 0 0 0 14.8532 0 0 0 0 15.4128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7555 13.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9867 0 12.8449 0 0 0 0 12.9394 0 0 0 0 0 14.0142 0 0 0 0 0 0 0 0 0 12.5196 0 0 0 P52179 MYOM1_HUMAN Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1) MYOM1 Homo sapiens (Human) muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737] M band [GO:0031430]; striated muscle myosin thick filament [GO:0005863] M band [GO:0031430]; striated muscle myosin thick filament [GO:0005863]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737] GO:0005863; GO:0006936; GO:0008307; GO:0010628; GO:0010737; GO:0019900; GO:0031430; GO:0042802; GO:0042803; GO:0050714; GO:0051015 actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307] ATNHSTVVLVGDVFKKLQK 0.99165 -22.793 0 0 0 0 0 0 0 0 0 14.1326 0 13.4346 0 13.4486 13.2516 14.9287 13.1529 13.3979 13.1325 13.0561 0 12.589 0 0 13.193 13.2579 13.1243 0 13.0041 12.8829 13.0692 13.1433 0 0 0 0 0 0 16.4121 0 0 0 0 12.9038 0 13.1448 13.2703 0 16.3213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8491 0 0 12.163 11.2124 0 0 11.6379 0 0 12.6852 0 0 0 12.8781 13.2147 0 14.6683 13.8758 0 12.0766 14.4555 0 0 10.9551 14.3188 0 15.5411 0 0 11.7246 0 0 0 0 10.9279 0 13.2544 15.5747 0 0 0 0 0 0 0 0 14.0651 0 14.8507 0 0 0 0 0 0 13.5256 0 13.9051 0 0 0 12.4041 13.6988 0 0 0 0 8.86378 0 0 0 0 0 14.1921 0 0 14.6563 0 0 0 14.5969 0 0 13.764 13.776 0 12.3862 0 0 13.9349 0 0 0 0 15.5195 0 15.4256 0 13.4103 15.1665 0 0 0 15.8166 15.5964 0 0 13.3842 0 Q12789 TF3C1_HUMAN "General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit, TFIIIC 220 kDa subunit, TFIIIC220) (Transcription factor IIIC subunit alpha)" GTF3C1 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797] GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904 DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] ALVGDFMNRR 0.99165 -51.305 0 0 0 0 0 0 0 0 0 0 12.7575 0 0 0 15.0238 0 0 13.748 12.4409 12.3266 0 0 13.734 0 0 0 13.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2465 0 0 0 0 0 0 0 11.1521 0 0 0 0 0 13.7632 0 9.47007 0 0 0 0 0 0 0 0 0 12.4727 0 0 13.6667 0 0 0 0 14.7189 14.11 14.2299 13.8823 14.1245 13.6969 14.331 13.6865 12.6426 13.5975 13.59 13.5955 13.5027 15.2037 14.1185 14.6852 13.1988 14.9926 15.5241 14.992 14.4581 15.5018 0 13.6477 11.0604 13.3368 0 15.2878 0 0 13.8018 13.4437 13.332 12.9054 0 0 13.7328 0 0 0 0 13.4355 17.0212 13.7877 0 13.9348 13.365 13.7799 14.6174 12.8145 13.8264 9.93345 13.4315 0 14.0663 0 13.2986 13.6108 0 0 13.4773 0 14.7566 0 0 13.63 0 12.8878 16.6092 0 0 12.1059 0 0 0 0 0 12.9146 0 0 14.3943 12.675 0 0 0 0 10.5511 12.4525 0 0 0 12.3277 0 13.1274 0 12.8572 0 16.2984 0 0 16.228 0 0 0 12.1376 11.2441 Q12860 CNTN1_HUMAN Contactin-1 (Glycoprotein gp135) (Neural cell surface protein F3) CNTN1 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system myelin formation [GO:0032289]; cerebellum development [GO:0021549]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sodium ion transport [GO:0010765] anchored component of postsynaptic membrane [GO:0099025]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] anchored component of postsynaptic membrane [GO:0099025]; anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; central nervous system myelin formation [GO:0032289]; cerebellum development [GO:0021549]; gene expression [GO:0010467]; locomotory behavior [GO:0007626]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sodium ion transport [GO:0010765] GO:0005886; GO:0007155; GO:0007219; GO:0007411; GO:0007420; GO:0007626; GO:0010467; GO:0010628; GO:0010765; GO:0010976; GO:0016020; GO:0021549; GO:0030246; GO:0030424; GO:0032289; GO:0045121; GO:0050731; GO:0070062; GO:0098609; GO:0098632; GO:0099025; GO:0099026 carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632] ASPFPVYK 0.99165 -19.05 0 0 10.9983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.982 0 11.5493 0 11.7852 11.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3468 0 0 0 0 0 0 0 0 0 10.7807 0 0 10.3503 10.3137 0 0 0 0 12.3878 0 0 0 12.4186 0 0 0 0 0 13.6713 12.1339 12.2927 0 11.66 0 13.6214 12.1048 14.8417 0 11.879 0 0 11.4559 0 0 12.2698 0 0 10.2504 0 12.3923 0 12.7246 0 0 0 0 0 0 0 11.909 12.2322 0 12.3801 0 0 0 13.3676 0 0 0 0 0 0 12.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7907 0 0 0 0 0 0 0 0 0 12.1229 0 0 0 0 0 0 0 11.9264 0 0 Q13127 REST_HUMAN RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor) REST NRSF XBR Homo sapiens (Human) "auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to xenobiotic stimulus [GO:0071466]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]" GO:0000122; GO:0000381; GO:0000976; GO:0000978; GO:0000979; GO:0001227; GO:0001666; GO:0002244; GO:0002931; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0010468; GO:0010628; GO:0010629; GO:0017053; GO:0032348; GO:0035019; GO:0042802; GO:0043065; GO:0043280; GO:0043922; GO:0045665; GO:0045666; GO:0045667; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046676; GO:0046872; GO:0050768; GO:0050885; GO:0050910; GO:0060088; GO:0060379; GO:0061629; GO:0070933; GO:0071257; GO:0071385; GO:0071466; GO:0097150; GO:0099563; GO:1902459; GO:1902894; GO:1903203; GO:1903204; GO:1903223; GO:2000065; GO:2000678; GO:2000706; GO:2000740; GO:2000798 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]" ARESGSSTAEEGDFSK 0.99165 -51.328 0 0 0 12.3354 0 0 12.082 12.2637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9253 13.5727 11.5413 12.7094 0 13.3958 14.7395 12.7471 0 17.5218 14.7863 14.2484 13.4126 13.5462 15.3287 15.0486 15.1169 13.9415 0 0 0 0 0 0 15.0158 14.0692 0 13.6234 14.7307 14.1919 13.0289 14.0786 13.9555 14.6098 13.3414 13.6863 0 14.7239 13.58 14.274 15.2723 0 14.0477 0 13.3174 14.0694 13.9503 15.9287 0 13.586 15.19 15.1731 14.2668 14.4838 15.7665 0 0 0 0 15.0532 14.4978 15.775 0 0 12.0148 15.5868 13.1042 0 14.1081 0 15.5726 0 13.1243 13.6299 0 0 14.3243 0 0 0 0 0 0 0 0 11.6549 13.4714 0 0 0 0 0 0 0 14.6448 13.1047 13.4567 0 0 11.6472 0 0 Q53TS8 CTSRT_HUMAN "Cation channel sperm-associated targeting subunit tau, CatSper-tau (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein) (C2 calcium-dependent domain-containing protein 6)" C2CD6 ALS2CR11 CATSPERT Homo sapiens (Human) AEQKGPNSFQGKYSETVK 0.99165 -50.541 0 0 0 0 0 0 0 0 11.851 0 15.377 0 0 0 0 0 0 0 0 0 0 12.4665 0 12.7777 0 0 0 0 0 0 14.6196 0 0 0 0 0 0 0 13.2579 0 0 0 0 0 0 14.4502 0 12.4245 0 0 13.0261 0 0 0 0 0 0 9.47555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4039 10.4807 15.5007 0 0 15.0701 0 0 0 0 13.4051 13.2639 0 0 10.7967 0 0 0 13.3183 14.146 14.0319 13.7813 0 13.7441 0 0 0 0 0 0 0 0 0 11.9294 0 0 0 0 0 0 11.3053 13.3473 0 0 14.2791 0 0 14.0752 0 12.0204 0 13.9279 0 14.1407 0 0 13.7038 0 0 0 0 0 15.0004 0 14.9138 0 0 0 0 13.5468 0 0 14.4728 0 10.8649 0 0 15.8485 14.3674 0 0 0 0 0 0 0 0 14.9114 0 11.2939 0 0 0 0 12.1732 0 0 0 0 0 15.2995 0 0 0 0 0 0 0 Q6L9W6 B4GN3_HUMAN "Beta-1,4-N-acetylgalactosaminyltransferase 3, B4GalNAcT3, Beta4GalNAc-T3, Beta4GalNAcT3, EC 2.4.1.244 (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2, NGalNAc-T2)" B4GALNT3 Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842] GO:0005794; GO:0008376; GO:0016021; GO:0032580; GO:0033842; GO:0043231 acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842] AQEPKLCWPQGFSWSHRAVVHFVVPVK 0.99165 -19.058 0 0 0 0 0 0 0 0 10.825 13.6573 0 0 0 0 0 12.6627 0 0 0 0 0 0 13.2114 0 0 14.2427 0 0 0 0 0 0 14.5106 0 0 14.1075 0 0 0 11.7633 0 0 10.9604 13.4982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7149 0 0 0 0 0 11.7541 0 0 13.6024 0 0 0 10.4216 14.9187 11.3637 14.6578 13.8768 15.3588 0 13.5758 0 12.6737 0 0 15.87 0 12.5572 12.7791 0 15.4565 0 0 0 12.3857 0 14.9966 0 0 12.5938 13.732 0 0 13.1771 0 13.4603 0 14.3509 14.3641 0 0 14.0913 12.877 13.1282 12.6634 11.8604 0 12.5619 0 12.2874 0 13.4525 0 10.748 0 15.6239 14.439 13.9127 0 0 0 13.0418 14.6643 0 14.3183 14.5365 13.4389 0 0 10.931 0 0 0 0 15.6488 0 0 0 12.0463 11.6245 0 0 0 0 0 13.6532 14.267 0 0 0 15.7692 0 0 13.3308 14.0095 13.0409 0 12.2687 0 13.1443 14.1821 0 0 Q8NDH3 PEPL1_HUMAN "Probable aminopeptidase NPEPL1, EC 3.4.11.- (Aminopeptidase-like 1)" NPEPL1 KIAA1974 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; proteolysis [GO:0006508] GO:0005634; GO:0005737; GO:0006508; GO:0008233; GO:0030145; GO:0070006 manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233] TTMPGMK 0.99165 -4.5557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4573 0 0 0 0 0 0 0 0 0 0 11.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1503 0 0 0 0 0 0 0 0 0 14.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4735 0 0 0 0 0 10.4382 0 0 Q8NHC7 O14CZ_HUMAN Olfactory receptor 14C36 (Olfactory receptor 5BF1) (Olfactory receptor OR1-59) OR14C36 OR5BF1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IMKRIFYSENV 0.99165 -7.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8207 13.7335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.762 0 0 0 0 0 0 0 0 0 14.6079 0 0 0 0 14.1215 0 0 0 0 0 0 0 0 0 0 0 13.946 0 0 0 0 14.0382 0 0 0 0 0 14.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE23 TS1R2_HUMAN Taste receptor type 1 member 2 (G-protein coupled receptor 71) (Sweet taste receptor T1R2) TAS1R2 GPR71 T1R2 TR2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytokinesis [GO:0032467]; sensory perception of sweet taste [GO:0050916] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sweet taste receptor complex [GO:1903767] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sweet taste receptor complex [GO:1903767]; G protein-coupled receptor activity [GO:0004930]; sweet taste receptor activity [GO:0033041]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of sweet taste [GO:0001582]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytokinesis [GO:0032467]; sensory perception of sweet taste [GO:0050916] GO:0001582; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008527; GO:0016021; GO:0032467; GO:0033041; GO:0043235; GO:0050916; GO:1903767 G protein-coupled receptor activity [GO:0004930]; sweet taste receptor activity [GO:0033041]; taste receptor activity [GO:0008527] LVTIVDK 0.99165 -22.782 0 0 0 0 0 0 12.0949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5441 0 11.6818 0 0 0 0 0 0 0 0 0 0 0 11.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8886 0 0 0 0 0 0 0 0 0 0 11.1406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7764 0 0 0 0 0 0 0 Q96QA5 GSDMA_HUMAN "Gasdermin-A (Gasdermin-1) [Cleaved into: Gasdermin-A, N-terminal, GSDMA-NT; Gasdermin-A, C-terminal, GSDMA-CT ]" GSDMA GSDM GSDM1 FKSG9 Homo sapiens (Human) apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]" GO:0001786; GO:0005546; GO:0005829; GO:0005886; GO:0006915; GO:0016021; GO:0042742; GO:0048471; GO:0070269; GO:0070273 "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]" LLVKSMEKK 0.99165 -19.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.337 0 0 0 0 0 0 0 0 0 0 0 15.7092 0 0 0 15.1249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0313 0 0 0 0 13.4872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6789 0 14.4834 0 0 0 0 0 0 Q9BS31 ZN649_HUMAN Zinc finger protein 649 ZNF649 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005615; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] HQQTHNIEKAHECTDCGK 0.99165 -4.6941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7408 0 0 0 0 0 0 0 0 10.3947 0 0 0 0 0 12.6261 0 0 12.4152 0 0 13.6798 13.4911 0 0 0 0 0 0 0 0 12.6394 0 0 13.0271 13.2268 0 0 0 0 13.0195 0 0 0 12.1328 0 0 0 0 0 0 0 0 0 0 13.2588 13.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVL2 NUP58_HUMAN Nucleoporin p58/p45 (58 kDa nucleoporin) (Nucleoporin-like protein 1) NUP58 KIAA0410 NUPL1 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643] nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306] GO:0005635; GO:0005643; GO:0006913; GO:0008139; GO:0015031; GO:0017056; GO:0031965; GO:0042306; GO:0042802; GO:0044877; GO:0051028 identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056] ALKQLLSLAANGIQR 0.99165 -4.6981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXT4 TDRD1_HUMAN "Tudor domain-containing protein 1 (Cancer/testis antigen 41.1, CT41.1)" TDRD1 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546] cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0005737; GO:0007281; GO:0007283; GO:0030719; GO:0031047; GO:0034587; GO:0043046; GO:0043186; GO:0046872; GO:0051321; GO:0071546 metal ion binding [GO:0046872] AIIQNVDVQQKK 0.99165 -4.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5394 0 0 11.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2258 0 17.5068 0 0 0 0 0 0 0 0 0 0 14.7137 0 0 0 12.2722 0 0 0 13.7738 0 13.9622 0 0 0 0 0 0 11.9461 0 0 0 0 0 0 0 14.9761 0 0 0 0 15.587 0 0 0 0 0 0 0 0 0 11.7918 0 0 0 0 0 16.3164 0 0 0 0 0 0 0 0 0 0 0 14.0998 0 0 0 0 0 0 0 0 0 0 14.0157 0 0 0 0 0 0 0 0 0 0 Q9BYG0 B3GN5_HUMAN "Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase, EC 2.4.1.206 (Lactotriaosylceramide synthase, Lc(3)Cer synthase, Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5, BGnT-5, Beta-1,3-Gn-T5, Beta-1,3-N-acetylglucosaminyltransferase 5, Beta3Gn-T5)" B3GNT5 Homo sapiens (Human) brain development [GO:0007420]; central nervous system development [GO:0007417]; glycolipid biosynthetic process [GO:0009247]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; brain development [GO:0007420]; central nervous system development [GO:0007417]; glycolipid biosynthetic process [GO:0009247]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]" GO:0000139; GO:0006486; GO:0007417; GO:0007420; GO:0008457; GO:0008499; GO:0009247; GO:0016021; GO:0016266; GO:0016757; GO:0047256 "beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]" GAPPIRDK 0.99165 -18.98 0 0 0 0 0 0 0 0 0 0 0 11.5717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4827 0 0 0 10.0049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7182 14.6177 0 0 13.4771 0 13.6162 0 0 0 0 13.0998 12.9735 0 0 0 0 0 0 0 0 0 0 Q9UII5 ZN107_HUMAN Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25) ZNF107 ZFD25 ZNF588 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNQHSNLINHR 0.99165 -4.6955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8876 0 12.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2315 0 0 0 0 0 0 0 0 0 11.0274 0 14.8206 0 0 0 0 0 0 0 0 0 0 14.7189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7483 0 10.9313 12.8257 0 0 0 0 0 0 14.322 0 0 0 0 0 0 0 16.0477 0 0 0 0 0 0 Q9Y6U3 SCIN_HUMAN Scinderin (Adseverin) SCIN KIAA1905 Homo sapiens (Human) actin filament capping [GO:0051693]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; calcium-ion regulated exocytosis [GO:0017156]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of actin nucleation [GO:0051127]; positive regulation of apoptotic process [GO:0043065]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of secretion [GO:0051047]; regulation of chondrocyte differentiation [GO:0032330]; sequestering of actin monomers [GO:0042989] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; podosome [GO:0002102] "actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; podosome [GO:0002102]; 1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; actin filament capping [GO:0051693]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; calcium-ion regulated exocytosis [GO:0017156]; cell projection assembly [GO:0030031]; central nervous system development [GO:0007417]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of actin nucleation [GO:0051127]; positive regulation of apoptotic process [GO:0043065]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of secretion [GO:0051047]; regulation of chondrocyte differentiation [GO:0032330]; sequestering of actin monomers [GO:0042989]" GO:0001786; GO:0002102; GO:0003779; GO:0005509; GO:0005545; GO:0005546; GO:0005737; GO:0005903; GO:0005938; GO:0007417; GO:0008154; GO:0008285; GO:0015629; GO:0017156; GO:0030031; GO:0032330; GO:0042989; GO:0042995; GO:0043065; GO:0045010; GO:0045654; GO:0051014; GO:0051015; GO:0051016; GO:0051047; GO:0051127; GO:0051693; GO:0070062; GO:0070161 "1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]" DANEVEKKESLK 0.99165 -19.021 0 0 0 10.9038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2223 13.0739 13.0948 13.5259 0 0 0 0 0 0 0 0 0 0 10.3594 0 0 0 12.3001 0 0 0 0 0 0 0 0 12.4508 0 0 11.061 0 0 0 0 0 0 0 0 0 15.2085 12.9069 14.7738 14.2104 0 0 12.8486 13.9731 0 13.3379 0 13.8239 0 0 0 0 0 0 12.5395 0 15.0523 0 0 0 0 0 0 0 0 13.2812 0 0 13.8746 0 0 0 0 0 0 15.6021 12.3764 0 0 0 0 0 0 0 12.9988 15.5857 0 0 12.9929 0 0 0 0 0 12.6526 0 0 16.5966 13.0764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00303 EIF3F_HUMAN "Eukaryotic translation initiation factor 3 subunit F, eIF3f (Deubiquitinating enzyme eIF3f, EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47)" EIF3F EIF3S5 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413]" GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0016020; GO:0016282; GO:0016579; GO:0031369; GO:0033290; GO:0042802; GO:0070122; GO:0071541; GO:0075522; GO:0140492 cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; isopeptidase activity [GO:0070122]; metal-dependent deubiquitinase activity [GO:0140492]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] IGVDLIMK 0.99166 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14544 SOCS6_HUMAN "Suppressor of cytokine signaling 6, SOCS-6 (Cytokine-inducible SH2 protein 4, CIS-4) (Suppressor of cytokine signaling 4, SOCS-4)" SOCS6 CIS4 SOCS4 Homo sapiens (Human) defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008] cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; phosphatidylinositol 3-kinase complex [GO:0005942] cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008] GO:0001772; GO:0005737; GO:0005829; GO:0005942; GO:0006952; GO:0007259; GO:0009968; GO:0010498; GO:0016567; GO:0035556; GO:0040008; GO:0046854; GO:0046935; GO:0050868 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935] DSENGAFCYSRSR 0.99166 -7.5948 0 0 0 0 0 0 0 0 0 0 0 9.85667 0 0 14.5259 0 0 0 0 0 0 0 12.5171 0 0 0 0 0 10.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6153 0 0 0 0 0 0 0 0 13.5944 0 16.2374 0 12.8024 0 0 0 0 0 0 11.4966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9426 12.8757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1198 0 0 0 13.9139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12111 CO6A3_HUMAN Collagen alpha-3(VI) chain COL6A3 Homo sapiens (Human) cell adhesion [GO:0007155]; muscle organ development [GO:0007517] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383] collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; muscle organ development [GO:0007517] GO:0004867; GO:0005576; GO:0005589; GO:0005615; GO:0005788; GO:0007155; GO:0007517; GO:0030020; GO:0031012; GO:0042383; GO:0062023; GO:0070062; GO:1903561 extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867] AAEGIPKLLVLITGGK 0.99166 -53.38 0 0 0 0 0 0 0 0 0 12.5203 0 0 0 0 0 0 0 10.7651 0 0 11.6531 0 0 0 12.7292 11.3937 11.3168 11.9151 13.2441 15.9187 13.0431 0 10.1369 10.1161 11.0583 0 0 0 0 13.1617 0 13.2308 12.6603 0 13.0009 11.5285 12.1164 11.2329 11.7547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2498 13.9444 0 0 0 0 0 16.7436 0 0 13.6756 12.9512 13.946 12.3783 12.2913 13.63 17.8943 16.1454 15.5624 16.3176 0 13.0054 13.4916 13.8017 0 12.6748 13.2483 0 14.7491 0 0 13.7616 17.3859 0 13.2137 0 0 13.869 14.0575 10.4102 0 0 13.7653 0 13.8339 14.8567 14.5365 0 0 15.6543 13.0164 0 0 0 12.5816 10.8755 0 0 0 13.2456 0 0 0 0 12.2618 0 0 0 13.5143 0 14.2749 14.4108 14.8492 12.8833 17.6386 12.5662 14.4741 0 0 14.3117 14.1863 14.9719 0 13.4338 0 0 16.0304 14.7827 0 13.6077 14.1351 18.1054 15.2942 0 13.3529 14.5028 18.1142 0 12.6851 14.4063 14.169 13.2109 14.8057 13.282 0 0 13.1228 11.8132 14.5848 0 13.9819 13.7265 0 Q13356 PPIL2_HUMAN "RING-type E3 ubiquitin-protein ligase PPIL2, EC 2.3.2.27 (CYC4) (Cyclophilin-60, Cyclophilin-like protein Cyp-60, Cyp60, hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2, PPIase) (Rotamase PPIL2)" PPIL2 Homo sapiens (Human) protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0000413; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006457; GO:0034450; GO:0061630; GO:0071013; GO:0072659 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] GILSMANSGPNSNR 0.99166 -4.7251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4422 0 12.3785 12.3473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8311 12.8384 0 0 0 0 0 0 12.437 0 0 0 0 0 0 0 0 0 0 Q52LA3 LIN52_HUMAN Protein lin-52 homolog LIN52 C14orf46 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" DRM complex [GO:0070176]; nucleoplasm [GO:0005654] "DRM complex [GO:0070176]; nucleoplasm [GO:0005654]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005654; GO:0006355; GO:0070176 FLNILEKPKK 0.99166 -4.7234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2452 0 0 0 0 0 0 0 0 0 0 14.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JRX3 PREP_HUMAN "Presequence protease, mitochondrial, hPreP, EC 3.4.24.- (Pitrilysin metalloproteinase 1, Metalloprotease 1, hMP1)" PITRM1 KIAA1104 MP1 PREP Homo sapiens (Human) protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; protein targeting to mitochondrion [GO:0006626]; proteolysis [GO:0006508] GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006626; GO:0008047; GO:0008237; GO:0008270; GO:0016485 enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] EDTNNLFSVQFR 0.99166 -7.5863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4783 0 0 0 11.7816 0 11.866 0 0 0 0 0 0 0 0 12.3735 0 0 0 12.7117 13.6039 11.8434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2075 0 0 0 0 0 0 0 0 0 15.1476 12.0341 13.2534 0 0 12.1936 12.281 0 17.0515 0 0 0 0 0 12.0172 11.9227 0 12.5389 0 0 11.6595 12.1222 12.2427 14.1126 13.403 11.6782 11.443 0 0 0 14.1573 13.6276 13.8295 0 0 0 0 13.5881 0 0 11.6257 0 12.2114 12.2687 0 0 12.6895 13.4909 14.2658 0 0 13.9619 12.8449 12.9323 13.2507 0 0 0 0 11.4638 0 0 0 13.6422 13.6869 13.0438 0 0 12.847 0 14.1149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1734 14.0329 0 0 0 13.6011 14.2521 0 Q6TGC4 PADI6_HUMAN "Protein-arginine deiminase type-6, EC 3.5.3.15 (Peptidyl arginine deiminase-like protein) (Peptidylarginine deiminase VI, hPADVI) (Protein-arginine deiminase type VI)" PADI6 PAD6 Homo sapiens (Human) cytoplasm organization [GO:0007028]; cytoskeleton organization [GO:0007010]; embryonic cleavage [GO:0040016]; histone citrullination [GO:0036414]; regulation of translation by machinery localization [GO:0043143] cortical granule [GO:0060473]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634] cortical granule [GO:0060473]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668]; cytoplasm organization [GO:0007028]; cytoskeleton organization [GO:0007010]; embryonic cleavage [GO:0040016]; histone citrullination [GO:0036414]; regulation of translation by machinery localization [GO:0043143] GO:0004668; GO:0005509; GO:0005634; GO:0005737; GO:0007010; GO:0007028; GO:0036414; GO:0040016; GO:0043143; GO:0045111; GO:0060473 calcium ion binding [GO:0005509]; protein-arginine deiminase activity [GO:0004668] ELQLQGFVDTVTK 0.99166 -7.5876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.208 0 0 0 13.6459 0 0 0 0 0 0 0 0 0 0 0 13.2134 0 0 0 0 0 0 0 13.256 13.4982 0 0 0 0 0 0 0 13.3937 13.896 0 0 0 0 0 0 13.7067 0 13.2667 0 0 0 14.3671 0 14.1113 13.2683 14.8179 0 0 0 0 0 13.3271 0 13.4122 0 0 0 0 0 0 13.9336 0 0 0 0 0 0 0 14.1618 0 0 0 13.5196 14.6391 0 13.3939 0 0 0 0 0 0 0 0 13.5801 0 0 0 0 0 0 0 13.8349 11.4527 0 0 0 0 0 0 Q8NDV3 SMC1B_HUMAN "Structural maintenance of chromosomes protein 1B, SMC protein 1B, SMC-1-beta, SMC-1B" SMC1B SMC1L2 Homo sapiens (Human) meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062] "chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; meiotic cell cycle [GO:0051321]; sister chromatid cohesion [GO:0007062]" GO:0000775; GO:0000800; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007062; GO:0008278; GO:0016887; GO:0030893; GO:0034991; GO:0051321 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677] DSEKQCSKQEDDIK 0.99166 -7.5879 0 0 0 12.5022 0 0 0 0 0 0 13.2879 13.4829 0 11.3945 0 13.0914 13.4705 13.2881 13.3171 0 13.3117 12.2599 13.1101 0 14.1163 13.4006 0 13.3378 13.3281 13.1873 0 0 0 0 12.4002 0 0 0 0 0 0 10.0289 0 12.998 0 14.7604 0 0 0 0 0 12.2376 12.3821 0 0 12.247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2953 0 0 0 0 0 11.9554 0 0 0 0 0 0 0 0 0 0 12.8286 0 14.5342 13.1468 12.0039 0 13.4099 0 0 13.9515 0 0 0 0 0 0 0 11.5554 0 0 13.4061 14.1451 14.0135 14.304 0 0 0 14.7393 0 0 11.9286 14.1732 0 0 0 0 0 0 11.8537 0 0 0 0 0 15.3556 14.1948 0 0 0 0 14.1432 0 11.009 14.0793 0 0 13.4429 0 13.5588 0 0 0 0 11.9792 0 11.9644 0 0 14.4831 0 14.2734 0 0 0 15.2592 0 14.8568 14.5536 13.7839 11.376 0 10.6652 0 18.863 0 0 14.2523 14.201 0 14.0281 0 0 Q92922 SMRC1_HUMAN "SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155, BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1)" SMARCC1 BAF155 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell differentiation [GO:0045596]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; male germ cell nucleus [GO:0001673]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741] "brahma complex [GO:0035060]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; male germ cell nucleus [GO:0001673]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; chromatin remodeling [GO:0006338]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell differentiation [GO:0045596]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000776; GO:0000785; GO:0001673; GO:0001741; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0008286; GO:0009887; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032435; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045893; GO:0045944; GO:0047485; GO:0070316; GO:0071564; GO:0071565; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription coactivator activity [GO:0003713] ASHHIYPYSSSQDDEEWLRPVMRK 0.99166 -18.639 0 0 0 0 0 0 0 0 0 0 11.4318 0 12.4328 12.6548 0 12.9743 13.0569 13.2897 13.9985 0 0 0 13.1077 0 13.8688 0 14.7904 0 12.7448 13.5383 0 0 0 0 0 12.8554 13.0569 0 0 0 12.7241 13.9571 0 0 0 0 13.8824 13.731 14.3754 13.7315 13.9658 13.5691 13.9056 13.9975 12.3179 0 13.6462 0 12.9309 0 0 0 0 0 12.758 12.592 0 0 0 0 0 0 0 0 0 12.4524 14.1545 0 0 0 0 0 0 0 0 0 15.5371 0 13.6349 0 0 0 0 0 14.6411 0 0 0 0 0 10.6804 0 15.1262 0 0 0 0 0 13.0613 0 13.9943 0 0 0 0 0 0 13.5941 0 0 0 0 0 0 0 13.6155 0 0 0 0 0 0 0 13.8901 13.6036 0 0 0 13.5865 0 0 12.2672 0 0 0 0 0 14.7109 0 0 0 0 0 0 0 13.4428 0 15.5174 14.7105 15.4082 15.8169 16.2496 13.0337 14.5244 0 14.3495 16.1349 14.5449 15.405 14.0168 13.0827 0 0 0 14.5485 15.2568 0 14.5834 0 0 Q96GE6 CALL4_HUMAN Calmodulin-like protein 4 (Serologically defined breast cancer antigen NY-BR-20) CALML4 Homo sapiens (Human) calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234] GO:0005509; GO:0030234 calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234] EILLAMLMVDK 0.99166 -18.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.463 0 0 0 0 12.6164 0 0 13.0337 13.9927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QE4 LR37B_HUMAN Leucine-rich repeat-containing protein 37B (C66 SLIT-like testicular protein) LRRC37B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DSFEGLLYLQYLDLSCNKIR 0.99166 -7.4031 0 0 0 0 0 0 0 0 0 0 0 0 12.9078 0 0 15.9794 0 0 12.8908 0 0 0 0 0 0 0 12.7185 0 0 0 0 0 0 0 0 0 0 0 0 12.9445 0 0 0 11.4287 0 0 0 0 0 0 0 0 0 0 0 15.9365 0 0 0 0 0 0 0 0 0 14.9332 0 0 11.3297 0 0 0 13.4479 0 0 13.275 12.8586 0 12.8275 14.32 0 14.345 0 14.6049 15.3464 15.3192 13.7262 14.13 14.5413 0 13.7593 13.8686 14.712 16.006 0 0 12.7434 0 10.2364 0 13.7912 14.2674 0 0 11.93 14.3883 0 13.8326 0 0 0 10.9219 14.7813 12.6401 0 0 0 0 0 0 0 0 0 14.0736 13.5221 0 0 0 0 9.74937 0 12.4433 0 0 0 0 13.4776 10.3013 0 0 0 0 0 0 13.3479 0 0 0 0 0 0 0 0 12.6894 0 0 0 0 0 9.99492 0 0 11.1734 0 0 14.5186 0 0 0 0 0 10.07 0 14.5378 0 0 0 0 0 0 Q9BWN1 PRR14_HUMAN Proline-rich protein 14 PRR14 Homo sapiens (Human) muscle organ development [GO:0007517] chromosome [GO:0005694]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; muscle organ development [GO:0007517] GO:0005652; GO:0005654; GO:0005694; GO:0007517 ALWGARSPK 0.99166 -4.5602 0 0 0 0 0 0 0 0 0 11.6829 13.0773 0 11.8379 12.3399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3786 0 0 11.3038 0 0 0 0 0 0 0 0 0 0 0 0 14.2365 0 0 0 12.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3691 14.4084 13.9524 13.3911 14.7021 0 0 0 0 0 0 0 0 12.7546 0 13.0343 0 0 0 0 0 0 14.3298 0 0 0 0 0 0 0 0 0 0 13.4159 13.2626 13.5099 0 0 0 14.7166 15.3688 14.691 14.8608 14.3158 0 0 0 0 0 14.5798 14.0493 14.9294 0 13.8089 0 0 15.4743 14.6988 0 0 0 13.5744 13.6631 0 0 0 0 0 0 13.4227 0 14.8998 13.0021 13.7818 0 14.0215 14.6383 15.8345 13.3068 0 13.0589 0 13.2175 12.8491 12.9547 0 16.1486 13.1215 14.2325 0 12.8031 13.0843 14.0101 0 13.684 0 0 12.8597 0 0 0 0 Q9NYP8 CU062_HUMAN Uncharacterized protein C21orf62 (B37) C21orf62 C21orf120 Homo sapiens (Human) TFPMPSNK 0.99166 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2324 0 0 0 0 0 0 0 0 0 13.5132 0 0 0 0 0 0 13.788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6973 0 Q9UBP9 GULP1_HUMAN PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP) GULP1 CED6 GULP Homo sapiens (Human) "apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; lipid transport [GO:0006869]; phagocytosis, engulfment [GO:0006911]" GO:0005737; GO:0006869; GO:0006911; GO:0006915 FARHIKK 0.99166 -4.7272 13.2038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1934 0 15.1516 0 0 0 0 0 0 0 0 12.1295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6021 0 0 0 13.1347 0 0 14.5989 0 0 0 0 0 0 14.3724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2908 0 0 0 13.5811 Q9UI12 VATH_HUMAN "V-type proton ATPase subunit H, V-ATPase subunit H (Nef-binding protein 1, NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD)" ATP6V1H CGI-11 Homo sapiens (Human) endocytosis [GO:0006897]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; endocytosis [GO:0006897]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" GO:0000139; GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0006897; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0030234; GO:0030665; GO:0033176; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:1902600 "enzyme regulator activity [GO:0030234]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" IILAAFRNFLEK 0.99166 -7.5937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y619 ORNT1_HUMAN Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15) SLC25A15 ORC1 ORNT1 SP1855 Homo sapiens (Human) L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; transmembrane transporter activity [GO:0022857]; L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050] GO:0000050; GO:0000064; GO:0005739; GO:0005743; GO:0015189; GO:0015297; GO:0016021; GO:0022857; GO:0061459; GO:1903401; GO:1903826; GO:1990575 antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; transmembrane transporter activity [GO:0022857] SFFASGR 0.99166 -7.5977 0 0 0 0 0 0 0 0 0 13.2853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4606 13.2274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3052 0 13.1387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NMB9 FIGL2_HUMAN Fidgetin-like protein 2 FIGNL2 Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule severing ATPase activity [GO:0008568] GO:0005524; GO:0008568; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule severing ATPase activity [GO:0008568] TVLLFGPR 0.99167 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.971 0 0 0 0 0 0 0 13.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.201 0 0 0 0 0 P05543 THBG_HUMAN Thyroxine-binding globulin (Serpin A7) (T4-binding globulin) SERPINA7 TBG Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; thyroid hormone transport [GO:0070327] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; thyroid hormone transport [GO:0070327] GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0070062; GO:0070327 serine-type endopeptidase inhibitor activity [GO:0004867] ELELQIGNALFIGKHLK 0.99167 -18.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7736 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8999 0 0 0 0 0 0 0 0 Q05066 SRY_HUMAN Sex-determining region Y protein (Testis-determining factor) SRY TDF Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; male sex determination [GO:0030238]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; male sex determination [GO:0030238]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; sex differentiation [GO:0007548]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0007548; GO:0009653; GO:0010628; GO:0016607; GO:0030154; GO:0030238; GO:0045893; GO:0045944; GO:0140297; GO:2000020 "calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GNVQDRVK 0.99167 -7.1233 0 0 0 0 0 0 0 0 0 0 9.31116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15493 RGN_HUMAN "Regucalcin, RC (Gluconolactonase, GNL, EC 3.1.1.17) (Senescence marker protein 30, SMP-30)" RGN SMP30 Homo sapiens (Human) aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; aging [GO:0007568]; cellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of calcium-dependent ATPase activity [GO:1903611]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of GTPase activity [GO:0034260]; negative regulation of leucine-tRNA ligase activity [GO:1903634]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of dUTP diphosphatase activity [GO:1903629]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283] GO:0001822; GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0006469; GO:0006874; GO:0007283; GO:0007568; GO:0008270; GO:0010867; GO:0010907; GO:0010922; GO:0019853; GO:0030234; GO:0032515; GO:0032781; GO:0034260; GO:0043066; GO:0043547; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0051344; GO:0097421; GO:1901318; GO:1901671; GO:1901896; GO:1902679; GO:1903011; GO:1903052; GO:1903611; GO:1903625; GO:1903629; GO:1903634; GO:2000279 calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270] FNDGKVDPAGR 0.99167 -4.8717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4513 0 0 0 0 0 0 0 0 0 12.4969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5GAN3 RNS13_HUMAN Probable inactive ribonuclease-like protein 13 RNASE13 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830] extracellular region [GO:0005576] extracellular region [GO:0005576]; nucleic acid binding [GO:0003676]; defense response to Gram-positive bacterium [GO:0050830] GO:0003676; GO:0005576; GO:0050830 nucleic acid binding [GO:0003676] GFRGYCNGLMSYMRGK 0.99167 -6.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7X0 ADGB_HUMAN Androglobin (Calpain-7-like protein) ADGB C6orf103 CAPN7L Homo sapiens (Human) proteolysis [GO:0006508] calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825]; proteolysis [GO:0006508] GO:0004198; GO:0006508; GO:0019825; GO:0020037 calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825] AIIKLANIDIHVADR 0.99167 -55.34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2372 0 0 0 0 0 0 0 0 0 0 11.1319 0 0 10.5554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.878 0 0 0 0 0 0 0 0 0 0 0 0 10.0347 0 0 0 0 0 13.3355 0 0 0 0 0 0 0 0 0 0 0 13.1104 0 11.9387 0 0 0 0 16.8579 0 0 0 15.0538 0 13.1054 0 13.5103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.179 0 0 0 0 0 0 0 0 0 13.5852 0 13.901 0 10.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2211 0 0 0 0 0 0 0 10.0922 0 13.1637 11.667 0 0 13.5665 0 11.5227 0 0 0 0 0 Q969T7 5NT3B_HUMAN "7-methylguanosine phosphate-specific 5'-nucleotidase, 7-methylguanosine nucleotidase, EC 3.1.3.91 (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein, cN-III-like protein, EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase)" NT5C3B NT5C3L Homo sapiens (Human) exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nucleotide metabolic process [GO:0009117] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nucleotide metabolic process [GO:0009117] GO:0000166; GO:0000287; GO:0005737; GO:0005829; GO:0008253; GO:0009117; GO:0043928 5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166] ELTALLHHYYPIEIDPHRTVK 0.99167 -6.0445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3701 0 0 0 0 0 0 0 0 0 12.2764 12.6879 13.4774 11.653 11.574 0 0 12.5428 12.5842 0 0 0 0 0 12.6587 0 0 12.4642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0868 0 11.9065 0 0 0 0 0 0 Q96N23 CFA54_HUMAN Cilia- and flagella-associated protein 54 CFAP54 C12orf55 C12orf63 Homo sapiens (Human) cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; extracellular region [GO:0005576] axoneme [GO:0005930]; extracellular region [GO:0005576]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] GO:0005576; GO:0005930; GO:0007283; GO:0051649; GO:0060271; GO:0060294; GO:0090660; GO:0120197; GO:0120316 ADIMTNLQDIIHLLEGNEFISPQSRLTLAR 0.99167 -4.8759 0 0 10.9282 0 0 0 0 14.9763 0 0 0 0 13.1723 13.5075 0 0 0 0 12.6149 13.7931 0 0 14.0983 0 0 0 0 0 0 0 0 0 13.1094 13.5173 12.9889 10.7293 0 14.0235 13.8752 0 0 0 0 0 13.6747 0 0 0 0 0 0 11.6906 0 0 11.8607 0 0 0 11.9862 0 0 0 0 0 0 0 0 0 0 11.6947 0 0 0 0 0 13.9462 13.9386 13.9709 10.6847 15.9892 13.8628 15.2759 13.6347 14.1108 0 12.4042 13.153 0 12.6847 11.6204 0 15.4251 13.8629 15.144 15.9607 14.9821 14.3165 0 11.113 15.5394 12.1873 14.592 12.4052 0 14.5281 15.0483 0 0 0 0 13.3588 0 15.7144 0 15.3365 12.2122 12.0351 12.9868 0 14.6534 13.6156 13.9575 12.7215 15.3879 13.8887 0 0 0 0 0 11.5332 0 13.8653 0 11.4749 12.2844 14.8015 0 14.0552 12.8233 14.6715 12.6349 15.1633 12.9162 0 0 15.142 13.7879 12.8304 0 12.9128 0 14.766 14.5908 13.2687 14.2647 13.9936 13.5101 12.5924 0 0 12.5384 0 12.9863 12.2267 10.2063 13.2121 11.9062 12.3237 14.4795 0 0 0 13.974 14.869 14.2066 15.5726 0 13.4239 14.5021 Q9NUJ7 PLCX1_HUMAN PI-PLC X domain-containing protein 1 PLCXD1 Homo sapiens (Human) lipid metabolic process [GO:0006629] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; phosphoric diester hydrolase activity [GO:0008081]; lipid metabolic process [GO:0006629] GO:0005737; GO:0006629; GO:0008081 phosphoric diester hydrolase activity [GO:0008081] LLQLLNKALPCITRPVVLK 0.99167 -4.5813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0373 0 0 0 0 12.4024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.227 0 0 11.5119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2203 0 0 0 15.6669 0 0 0 0 0 0 0 0 0 0 12.6815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7707 0 0 0 12.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5441 0 0 0 0 0 0 0 0 0 11.0156 0 0 0 O95259 KCNH1_HUMAN "Potassium voltage-gated channel subfamily H member 1 (Ether-a-go-go potassium channel 1, EAG channel 1, h-eag, hEAG1) (Voltage-gated potassium channel subunit Kv10.1)" KCNH1 EAG EAG1 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; myoblast fusion [GO:0007520]; phosphatidylinositol-mediated signaling [GO:0048015]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of cell population proliferation [GO:0042127]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; startle response [GO:0001964] anchoring junction [GO:0070161]; axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; axolemma [GO:0030673]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; voltage-gated potassium channel complex [GO:0008076]; 14-3-3 protein binding [GO:0071889]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; cellular response to calcium ion [GO:0071277]; myoblast fusion [GO:0007520]; phosphatidylinositol-mediated signaling [GO:0048015]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of cell population proliferation [GO:0042127]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; startle response [GO:0001964] GO:0001964; GO:0005249; GO:0005251; GO:0005516; GO:0005637; GO:0005886; GO:0005887; GO:0006813; GO:0007520; GO:0008076; GO:0009986; GO:0019901; GO:0030425; GO:0030673; GO:0031901; GO:0034765; GO:0042127; GO:0042391; GO:0042802; GO:0043204; GO:0043231; GO:0044325; GO:0044877; GO:0048015; GO:0048471; GO:0070161; GO:0071277; GO:0071805; GO:0071889; GO:0098839; GO:0099056; GO:1902936 14-3-3 protein binding [GO:0071889]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] ADICVHLNR 0.99168 -89.346 0 0 0 0 0 0 0 0 11.6229 11.5521 0 0 0 11.4148 0 0 0 0 0 0 0 0 11.4459 0 0 0 0 0 12.07 0 0 0 11.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5683 0 0 0 0 11.3523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0832 0 0 0 11.7363 0 0 0 0 0 13.0681 0 0 0 0 11.6037 0 0 11.4001 0 0 11.7287 0 0 12.7543 12.691 11.9445 0 0 10.9599 0 0 12.3777 0 0 0 0 0 0 0 0 0 0 0 14.994 12.4623 0 0 0 15.1719 0 14.8271 0 12.019 0 0 0 0 13.2501 0 0 0 0 0 0 0 0 0 10.8553 0 12.3628 14.5149 14.3076 14.1057 14.6059 12.5006 0 14.6163 14.1863 0 14.424 14.0165 14.4947 0 14.4041 14.8792 0 14.8719 12.0473 0 10.5108 12.521 13.5448 0 P04275 VWF_HUMAN "von Willebrand factor, vWF [Cleaved into: von Willebrand antigen 2 (von Willebrand antigen II) ]" VWF F8VWF Homo sapiens (Human) blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to wounding [GO:0009611] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; Weibel-Palade body [GO:0033093] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; Weibel-Palade body [GO:0033093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to wounding [GO:0009611] GO:0002020; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0007596; GO:0007599; GO:0009611; GO:0019865; GO:0030168; GO:0031012; GO:0031091; GO:0031093; GO:0031589; GO:0033093; GO:0042802; GO:0047485; GO:0051087; GO:0062023; GO:0070062; GO:1902533 chaperone binding [GO:0051087]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485] ALSVVWDR 0.99168 -23.889 0 0 0 0 0 0 0 0 0 0 13.5302 11.674 0 13.9077 0 0 0 0 0 0 10.8852 11.1798 0 12.0959 0 0 0 0 0 0 11.7153 0 0 0 0 14.0031 13.285 11.3961 0 0 14.1357 0 0 0 0 0 0 0 0 11.5276 0 11.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6739 0 13.5561 0 0 0 14.3947 15.2853 11.8333 0 14.1808 12.6998 0 0 13.7309 0 0 11.2606 0 0 11.8153 11.6246 0 0 12.6377 0 16.3452 11.0595 0 11.5089 12.0175 0 14.0104 0 13.7569 15.0982 0 0 13.5688 0 12.0037 0 0 0 0 12.2637 13.804 0 0 0 11.1699 0 0 0 12.7302 12.7998 12.7867 11.5505 0 0 14.3595 11.8833 0 12.7299 0 0 11.8214 13.6565 0 0 0 11.2494 0 0 12.1674 11.5318 0 13.6028 0 12.7764 12.6931 0 0 0 0 0 0 0 15.1348 11.9517 0 12.5679 0 0 0 0 13.5327 13.9248 0 0 0 12.9127 12.6276 0 0 0 0 0 11.8943 0 0 Q03001 DYST_HUMAN "Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1, BPA, Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein)" DST BP230 BP240 BPAG1 DMH DT KIAA0728 Homo sapiens (Human) cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; maintenance of cell polarity [GO:0030011]; microtubule cytoskeleton organization [GO:0000226]; response to wounding [GO:0009611]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060] GO:0000226; GO:0003779; GO:0005178; GO:0005198; GO:0005509; GO:0005604; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005882; GO:0005925; GO:0005938; GO:0007010; GO:0007155; GO:0007229; GO:0008017; GO:0008022; GO:0008090; GO:0009611; GO:0009925; GO:0015629; GO:0015630; GO:0016020; GO:0016021; GO:0030011; GO:0030018; GO:0030056; GO:0030424; GO:0031122; GO:0031252; GO:0031410; GO:0031581; GO:0031673; GO:0035371; GO:0042060; GO:0042803; GO:0045104; GO:0045111; GO:0048870; GO:0051010; GO:1904115 actin binding [GO:0003779]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198] ACSTSEMMEEK 0.99168 -100.33 0 0 0 0 0 0 0 10.9009 14.592 14.0085 10.3151 13.7934 13.9975 12.6763 0 14.3901 0 14.2622 14.2013 11.335 0 0 0 13.3407 12.1719 0 12.6898 12.908 0 0 17.187 13.0524 0 12.7474 0 13.6194 0 0 0 0 10.7178 0 13.0539 12.536 0 0 0 0 0 0 0 0 0 0 0 11.8829 0 0 0 0 0 12.0823 0 0 0 0 11.0777 0 0 0 0 16.4758 13.0668 15.6347 14.4824 12.1821 14.9841 15.0416 15.2472 14.5099 14.1123 15.6455 15.6543 14.1108 12.5286 14.5656 14.1766 12.4149 0 13.688 16.035 15.3629 16.6143 11.0137 13.5888 13.9362 15.608 15.3554 14.881 14.7555 13.1478 14.5767 13.9311 15.9621 13.2915 14.8964 15.3974 15.1186 16.1703 15.5829 0 14.642 14.7184 15.5379 12.9077 15.7972 14.1137 15.984 14.5518 15.3552 14.407 14.7103 10.0444 16.0723 0 15.7832 13.5505 10.8392 13.1732 14.6893 14.0276 10.7872 16.202 13.9365 15.1865 16.353 15.8971 15.7228 16.2414 15.2209 15.8047 15.8304 16.5002 15.5079 14.1293 16.1394 14.454 16.5721 0 0 15.4422 17.0766 15.1019 15.0115 16.2688 15.1515 15.4647 0 14.8709 0 0 14.0357 0 12.8602 14.5403 13.4719 14.4407 14.9577 0 13.1318 0 16.4948 14.8621 0 0 0 0 13.4401 14.6636 10.9908 Q09666 AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK (Desmoyokin) AHNAK PM227 Homo sapiens (Human) positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; cell-cell contact zone [GO:0044291]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493]; positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385] GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1901385; GO:1905686 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; structural molecule activity conferring elasticity [GO:0097493] ADLDVSGPK 0.99168 -96.922 0 0 0 0 0 0 0 11.4388 0 0 11.3425 0 12.3233 0 12.6585 12.3856 0 0 0 0 0 0 12.2477 0 12.9529 13.6178 0 13.5747 0 0 11.0492 12.9827 11.6357 0 11.8257 0 0 13.0462 13.0592 0 0 10.4236 0 13.2848 0 11.5539 0 0 0 0 0 0 11.7684 0 12.0141 0 11.4795 13.5326 0 0 12.1883 0 0 0 13.1159 13.1148 11.2467 0 0 11.7837 14.7423 0 0 11.75 13.348 9.77706 0 0 0 0 0 12.8033 0 13.5489 16.7834 18.6242 17.0333 16.7623 15.3855 0 12.2637 0 0 15.1474 16.9517 15.3791 13.7475 15.5665 13.6171 13.8164 12.9189 0 11.7832 11.5468 0 14.6324 13.8919 0 13.0029 13.9114 0 13.6687 0 12.3548 0 0 0 11.7979 0 0 13.9011 0 13.4865 0 0 14.8629 12.4935 12.0871 12.7346 11.5039 0 0 0 0 13.5645 0 11.833 13.1355 13.6069 12.7526 0 14.0448 0 12.9363 12.6039 0 0 14.5214 11.92 0 0 0 0 0 13.0002 0 14.8523 10.8667 0 13.2368 0 0 14.1771 14.515 0 0 14.7682 14.545 14.7556 13.4486 14.9527 11.3576 0 14.5201 0 13.8284 0 0 12.2045 0 Q6ZNE5 BAKOR_HUMAN "Beclin 1-associated autophagy-related key regulator, Barkor (Autophagy-related protein 14-like protein, Atg14L)" ATG14 ATG14L KIAA0831 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein phosphorylation [GO:0001933]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; post-transcriptional regulation of gene expression [GO:0010608]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; regulation of macroautophagy [GO:0016241]; regulation of protein complex stability [GO:0061635]; regulation of protein phosphorylation [GO:0001932]; regulation of triglyceride metabolic process [GO:0090207]; response to mitochondrial depolarisation [GO:0098780] "autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle [GO:0045335]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]" "autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagocytic vesicle [GO:0045335]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; GTPase binding [GO:0051020]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cellular response to glucose starvation [GO:0042149]; cellular response to starvation [GO:0009267]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein phosphorylation [GO:0001933]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; post-transcriptional regulation of gene expression [GO:0010608]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; regulation of macroautophagy [GO:0016241]; regulation of protein complex stability [GO:0061635]; regulation of protein phosphorylation [GO:0001932]; regulation of triglyceride metabolic process [GO:0090207]; response to mitochondrial depolarisation [GO:0098780]" GO:0000045; GO:0000421; GO:0000423; GO:0001932; GO:0001933; GO:0001934; GO:0005776; GO:0005789; GO:0005829; GO:0005930; GO:0006468; GO:0006622; GO:0008333; GO:0009267; GO:0010608; GO:0016236; GO:0016240; GO:0016241; GO:0034045; GO:0035032; GO:0036092; GO:0042149; GO:0043552; GO:0044233; GO:0045022; GO:0045335; GO:0051020; GO:0061635; GO:0090207; GO:0097352; GO:0097629; GO:0097632; GO:0098780 GTPase binding [GO:0051020] AMEGKWITDQLR 0.99168 -23.903 0 0 0 0 0 0 0 0 0 0 0 10.8532 0 0 0 0 0 0 0 11.0898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.199 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9218 0 0 0 0 0 0 0 0 0 0 0 13.4431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1712 0 0 0 0 0 Q8NEV4 MYO3A_HUMAN "Myosin-IIIa, EC 2.7.11.1" MYO3A Homo sapiens (Human) cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0018105; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0050896; GO:0051491; GO:0060002; GO:0090103; GO:0106310 actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALFKIPR 0.99168 -48.212 0 0 0 0 0 0 0 0 11.9822 15.0096 11.9906 0 11.0341 11.8216 0 14.2644 14.0923 0 0 0 0 14.3648 0 0 13.647 0 11.2627 0 14.4285 0 11.558 14.3083 11.5614 14.3161 14.2311 14.7452 0 0 0 13.912 0 11.183 13.2194 10.0325 0 11.7726 0 10.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0009 10.9076 0 0 0 11.7984 15.8919 0 0 13.0541 18.8767 0 12.8068 0 0 0 0 16.5161 14.0283 16.4352 13.6972 17.9428 15.5207 16.4434 0 15.9555 0 0 15.2092 15.6081 0 14.9273 12.2883 15.819 13.4226 18.5843 0 0 0 15.5096 15.868 14.8411 14.8737 0 15.5497 0 16.1157 0 14.9277 15.8238 12.0206 0 15.1551 14.0604 14.5612 14.0236 0 14.1002 14.0784 15.5022 0 14.6673 14.062 0 0 0 0 0 0 15.0051 0 0 14.3465 0 0 0 14.7206 0 0 0 14.5264 0 12.5893 0 0 12.6174 0 11.7501 14.3161 0 0 0 0 0 14.7126 12.3775 0 11.0598 0 0 0 0 0 0 0 14.748 13.6461 0 14.2115 12.0234 14.8553 0 0 0 O60229 KALRN_HUMAN "Kalirin, EC 2.7.11.1 (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain)" KALRN DUET DUO HAPIP TRAD Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; central nervous system development [GO:0007417]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] GO:0004674; GO:0005085; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007165; GO:0007399; GO:0007411; GO:0007417; GO:0014069; GO:0015629; GO:0016192; GO:0019898; GO:0035556; GO:0046872; GO:0048013; GO:0051056; GO:0070062; GO:0106310 ATP binding [GO:0005524]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AGLECSDIEKAVELMCLVPK 0.99169 -50.373 0 0 14.2607 0 0 0 12.7106 0 0 0 0 13.8645 13.6588 0 0 12.5819 0 0 12.5246 0 0 0 13.2111 0 13.3727 0 14.08 0 0 11.2886 14.1319 11.0881 0 11.5297 0 0 14.1625 0 10.8819 13.9243 0 11.8941 16.8562 0 10.5532 11.9802 17.442 11.4434 0 0 0 0 0 13.4736 11.7228 11.926 11.406 0 0 0 0 0 12.6945 0 15.5772 0 12.149 0 14.187 0 0 13.0915 0 0 13.8879 0 14.0686 14.2074 14.2761 15.3009 14.7168 15.0917 17.7228 0 18.2018 14.9017 15.2589 13.7377 0 14.0773 13.6877 12.8095 14.2591 13.7089 14.9176 14.2682 0 12.42 13.2571 12.8349 13.5303 14.4274 14.5748 15.6374 11.4076 12.4565 12.1844 15.0657 14.1302 13.3195 12.4043 13.272 15.4613 14.2907 14.617 14.987 14.7669 15.5884 17.5629 17.112 14.6446 15.3349 15.4508 13.6164 15.4667 0 16.1326 13.249 13.3222 13.1526 16.3378 13.0726 0 16.0886 15.62 16.181 18.5467 16.0699 14.1376 14.2947 0 13.2989 14.1962 15.5301 15.7272 0 11.2062 13.3024 0 13.8617 0 14.7455 15.6435 14.5542 15.1484 13.7021 14.3292 14.2769 11.0381 11.4004 12.4212 14.967 15.3692 14.5818 0 0 0 13.9026 0 13.3914 0 14.1867 18.0996 15.0199 14.5896 14.048 12.9203 0 12.8732 12.0066 A0A1B0GTU1 ZC11B_HUMAN Zinc finger CCCH domain-containing protein 11B ZC3H11B ZC3HDC11B Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973] GO:0003729; GO:0016973; GO:0046872 metal ion binding [GO:0046872]; mRNA binding [GO:0003729] AVEMHPAVTAAVKPLSSSSVLQEPPAK 0.99169 -50.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1101 0 15.6085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9775 0 0 0 0 0 0 0 12.7422 0 0 15.5059 13.5875 0 0 12.0305 0 12.6862 0 0 0 0 0 0 11.7589 0 0 0 0 0 0 0 0 0 0 11.882 0 14.6449 0 0 0 0 0 0 15.1939 13.8851 13.7503 13.6681 0 13.8878 0 15.2454 0 0 0 0 0 13.1104 0 0 12.2961 0 0 0 0 0 0 0 0 0 0 14.0958 0 0 15.7188 12.8767 12.0168 13.8228 12.6085 0 13.1215 0 12.2055 12.3391 0 0 0 0 0 0 0 0 0 0 0 13.134 0 0 0 13.6168 0 0 0 0 0 0 0 0 12.3053 0 13.711 15.6139 15.6767 0 0 0 0 0 0 0 0 12.3702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00491 PNPH_HUMAN "Purine nucleoside phosphorylase, PNP, EC 2.4.2.1 (Inosine phosphorylase) (Inosine-guanosine phosphorylase)" PNP NP Homo sapiens (Human) allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418] GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813 guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731] GPNDERFGDR 0.99169 -5.9553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12757 SKIL_HUMAN Ski-like protein (Ski-related oncogene) (Ski-related protein) SKIL SNO Homo sapiens (Human) blastocyst formation [GO:0001825]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to antibiotic [GO:0046677]; response to cytokine [GO:0034097]; response to growth factor [GO:0070848]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] "acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; blastocyst formation [GO:0001825]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lens fiber cell differentiation [GO:0070306]; lymphocyte homeostasis [GO:0002260]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of axonogenesis [GO:0050772]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; regulation of cell cycle [GO:0051726]; response to antibiotic [GO:0046677]; response to cytokine [GO:0034097]; response to growth factor [GO:0070848]; skeletal muscle tissue development [GO:0007519]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001669; GO:0001825; GO:0002260; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0007179; GO:0007283; GO:0007519; GO:0008625; GO:0008630; GO:0016605; GO:0019904; GO:0030512; GO:0030514; GO:0032991; GO:0034097; GO:0042802; GO:0044877; GO:0045596; GO:0046332; GO:0046677; GO:0050772; GO:0051726; GO:0070306; GO:0070848; GO:1902043; GO:1902231 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]" CTSDQLHILK 0.99169 -18.883 0 0 0 0 0 0 0 0 0 0 0 0 10.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6384 0 0 0 0 0 0 0 0 0 0 12.3952 0 0 12.9991 11.5354 12.6787 0 12.7224 12.8415 12.917 0 0 13.9433 13.8404 15.76 10.9582 0 13.0318 0 0 0 0 13.4204 0 0 0 0 15.4791 0 0 12.7284 11.2261 0 0 13.7405 0 0 0 0 0 0 0 0 0 0 0 0 0 11.348 0 11.0198 12.3569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6463 0 0 0 0 0 11.7798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20809 IL11_HUMAN "Interleukin-11, IL-11 (Adipogenesis inhibitory factor, AGIF) (Oprelvekin)" IL11 Homo sapiens (Human) B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; fat cell differentiation [GO:0045444]; megakaryocyte differentiation [GO:0030219]; negative regulation of hormone secretion [GO:0046888]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-11 receptor binding [GO:0005142]; B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; fat cell differentiation [GO:0045444]; megakaryocyte differentiation [GO:0030219]; negative regulation of hormone secretion [GO:0046888]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005125; GO:0005142; GO:0005576; GO:0005615; GO:0005737; GO:0008083; GO:0008283; GO:0008284; GO:0030183; GO:0030219; GO:0033138; GO:0043410; GO:0045444; GO:0045944; GO:0046888; GO:0050731 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-11 receptor binding [GO:0005142] AAHAILGGLHLTLDWAVRGLLLLK 0.99169 -24.755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9806 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5799 14.4693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4906 0 0 0 0 0 0 0 13.8752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2973 14.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36894 BMR1A_HUMAN "Bone morphogenetic protein receptor type-1A, BMP type-1A receptor, BMPR-1A, EC 2.7.11.30 (Activin receptor-like kinase 3, ALK-3) (Serine/threonine-protein kinase receptor R5, SKR5) (CD antigen CD292)" BMPR1A ACVRLK3 ALK3 Homo sapiens (Human) atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222] dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein phosphorylation [GO:0006468]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]" GO:0001649; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003148; GO:0003151; GO:0003161; GO:0003171; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0004675; GO:0005025; GO:0005524; GO:0005886; GO:0006468; GO:0006955; GO:0007179; GO:0007398; GO:0009897; GO:0009950; GO:0009953; GO:0010629; GO:0010862; GO:0014032; GO:0014912; GO:0016021; GO:0019211; GO:0021953; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0032915; GO:0035019; GO:0035137; GO:0035912; GO:0036122; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043235; GO:0043539; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0050673; GO:0050679; GO:0050768; GO:0051148; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060412; GO:0060914; GO:0060928; GO:0061312; GO:0061626; GO:0071363; GO:0071773; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:1990712; GO:2000772 "ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]" AVLKLMSECWAHNPASRLTALR 0.99169 -22.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1121 0 0 0 0 0 0 0 0 0 0 13.5361 Q86UU1 PHLB1_HUMAN Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha) PHLDB1 KIAA0638 LL5A DLNB07 Homo sapiens (Human) positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507] basal cortex [GO:0045180]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] basal cortex [GO:0045180]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0005829; GO:0005886; GO:0010470; GO:0010717; GO:0043231; GO:0045171; GO:0045180; GO:0070507; GO:1904261 ELAGQGLLRSKAELLR 0.99169 -23.215 0 0 0 0 0 0 0 0 16.8408 12.6188 0 15.726 12.9659 0 0 11.1935 0 0 0 0 0 0 0 0 11.8174 14.4862 0 0 11.9243 0 0 12.6357 0 15.7858 15.86 15.8505 16.6203 16.619 16.6594 0 0 0 0 0 0 0 0 0 11.952 0 0 13.1921 0 13.5237 14.6982 15.3414 17.0452 13.5442 16.0517 15.3752 14.475 14.3839 13.7667 13.8977 15.2645 14.8736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2783 0 0 0 0 0 0 13.9307 16.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3491 13.102 0 0 0 0 0 11.732 0 0 0 11.6378 0 12.9739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1518 0 0 0 14.26 0 18.2923 14.8005 18.187 14.4116 14.1617 0 15.9493 0 18.7645 0 0 0 13.3828 0 0 0 15.0682 0 0 0 0 Q8N4C8 MINK1_HUMAN "Misshapen-like kinase 1, EC 2.7.11.1 (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6, MEK kinase kinase 6, MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6)" MINK1 B55 MAP4K6 MINK YSK2 ZC3 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of MAPK cascade [GO:0043408] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; brain development [GO:0007420]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; regulation of MAPK cascade [GO:0043408] GO:0000165; GO:0001952; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007254; GO:0007268; GO:0007420; GO:0014069; GO:0022407; GO:0030334; GO:0030424; GO:0030425; GO:0031532; GO:0035556; GO:0043408; GO:0046330; GO:0046777; GO:0048812; GO:0048813; GO:0070062; GO:0070161; GO:0106310; GO:1900745; GO:2000311 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AMDYSSSSEEVESSEDDEEEGEGGPAEGSR 0.99169 -18.942 0 0 0 0 0 0 0 0 12.9018 12.787 12.1245 12.5764 12.4894 12.9618 12.5488 0 0 0 0 0 0 0 0 11.6191 0 0 0 0 0 0 12.2092 12.5483 12.3675 12.076 11.0943 12.2911 12.9828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.885 0 0 0 0 0 0 0 0 13.0222 0 0 0 0 12.6675 0 0 0 0 14.54 0 12.7929 12.7799 0 0 13.691 0 0 0 12.9016 13.0019 0 0 0 0 0 13.1708 0 0 13.2491 0 0 12.2299 12.7808 13.0809 14.6782 14.2152 14.871 10.8134 0 0 13.0903 12.8967 12.4358 0 13.1164 0 0 0 0 0 0 0 12.7593 0 13.025 0 0 0 0 12.261 0 0 0 0 0 11.5721 0 0 13.3686 0 0 0 0 0 0 11.5338 0 0 0 0 0 0 0 0 0 12.3814 0 0 0 13.6305 13.8428 13.4508 0 13.5436 13.9963 13.215 0 14.3255 13.3428 13.5413 13.8091 12.2979 0 12.3651 12.5095 0 0 0 0 14.2731 0 14.5567 Q8WVV4 POF1B_HUMAN Protein POF1B (Premature ovarian failure protein 1B) POF1B Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; epithelial cell morphogenesis [GO:0003382] actin filament [GO:0005884]; adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; desmosome [GO:0030057] actin filament [GO:0005884]; adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; desmosome [GO:0030057]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bicellular tight junction assembly [GO:0070830]; epithelial cell morphogenesis [GO:0003382] GO:0003382; GO:0005884; GO:0005912; GO:0005923; GO:0007015; GO:0030036; GO:0030057; GO:0051015; GO:0070830 actin filament binding [GO:0051015] EICRLRSQLNQYHK 0.99169 -22.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0134 0 14.6676 11.0227 0 0 0 0 0 0 0 0 14.9169 0 0 14.0771 14.4065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0301 0 0 0 0 0 Q96IW2 SHD_HUMAN SH2 domain-containing adapter protein D SHD Homo sapiens (Human) phosphotyrosine residue binding [GO:0001784] GO:0001784 phosphotyrosine residue binding [GO:0001784] ELRRPPPR 0.99169 -5.9545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1967 0 0 0 0 0 0 0 11.8693 0 0 0 0 0 12.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N64 PWP2A_HUMAN PWWP domain-containing protein 2A PWWP2A KIAA1935 MST101 Homo sapiens (Human) "negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription, initiation [GO:2000142]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NuRD complex binding [GO:0120325]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of histone H3-K9 acetylation [GO:2000616]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of DNA-templated transcription, initiation [GO:2000142]" GO:0003682; GO:0005634; GO:0032968; GO:0035064; GO:0035067; GO:0042393; GO:0120325; GO:1901675; GO:2000142; GO:2000616 chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NuRD complex binding [GO:0120325] AITEAAKAAK 0.99169 -18.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5848 15.3941 0 0 0 0 0 0 0 0 0 12.7556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9817 0 0 0 0 0 15.4135 0 0 15.4288 0 16.5422 0 0 0 0 0 0 0 0 0 13.0032 0 0 0 0 15.5176 0 13.4446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8526 0 0 0 0 Q9HCS2 CP4FC_HUMAN "Cytochrome P450 4F12, EC 1.14.14.1 (CYPIVF12)" CYP4F12 UNQ568/PRO1129 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; phylloquinone catabolic process [GO:0042376]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; xenobiotic metabolic process [GO:0006805] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; phylloquinone catabolic process [GO:0042376]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; xenobiotic metabolic process [GO:0006805] GO:0000038; GO:0001676; GO:0003091; GO:0003095; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006631; GO:0006805; GO:0008391; GO:0008392; GO:0016021; GO:0016324; GO:0018685; GO:0019369; GO:0019373; GO:0020037; GO:0036101; GO:0042360; GO:0042361; GO:0042376; GO:0043231; GO:0050051; GO:0055078; GO:0070330 alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497] DNLFIRFLKPWLGEGILLSGGDK 0.99169 -18.937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7618 0 10.9725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3735 0 0 0 11.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9508 14.2436 0 11.0699 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9766 0 0 14.6703 0 13.8447 14.487 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9912 0 11.9036 0 13.7851 0 0 0 0 0 0 0 0 0 0 12.8234 0 0 0 0 12.4554 0 0 0 0 12.6674 0 0 0 13.4701 12.5594 0 0 12.0386 0 0 0 0 0 11.8727 0 0 0 0 0 0 0 0 0 0 0 11.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9635 0 Q9UI10 EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta) EIF2B4 EIF2BD Homo sapiens (Human) myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; regulation of catalytic activity [GO:0050790]; regulation of translation [GO:0006417]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; regulation of catalytic activity [GO:0050790]; regulation of translation [GO:0006417]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] GO:0001541; GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0006417; GO:0009408; GO:0009749; GO:0014003; GO:0031369; GO:0042552; GO:0043434; GO:0050790; GO:0050852 translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] EDSGSGMK 0.99169 -22.636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9151 0 0 12.5551 0 0 0 0 16.1094 0 0 15.6577 0 12.8867 0 0 0 13.9973 0 0 0 0 0 0 0 13.2224 0 14.4413 0 0 0 12.9222 13.2521 0 0 0 0 0 0 0 0 13.4037 0 0 0 0 0 0 0 0 14.7169 13.4696 0 0 13.4171 0 0 0 0 0 0 0 0 0 0 0 0 14.3183 14.2107 0 0 0 0 0 15.182 0 0 13.2965 0 0 0 10.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4189 0 0 0 13.4219 0 Q9UIV8 SPB13_HUMAN "Serpin B13 (HaCaT UV-repressible serpin, Hurpin) (Headpin) (Peptidase inhibitor 13, PI-13) (Proteinase inhibitor 13)" SERPINB13 PI13 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; negative regulation of keratinocyte apoptotic process [GO:1902173]; regulation of proteolysis [GO:0030162]; response to UV [GO:0009411] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of keratinocyte apoptotic process [GO:1902173]; regulation of proteolysis [GO:0030162]; response to UV [GO:0009411] GO:0002020; GO:0004867; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0009411; GO:0010951; GO:0016607; GO:0030162; GO:0043202; GO:0070062; GO:1902173 cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] ADYSGMSSGSGLYAQK 0.99169 -18.933 0 0 0 0 0 0 0 12.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3265 0 12.4968 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0419 0 0 0 0 0 0 0 0 0 0 0 0 12.4487 0 12.4563 0 0 0 0 0 0 0 0 0 0 0 0 12.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3867 0 0 0 0 0 0 0 14.5803 0 0 0 12.7019 11.6052 0 0 13.4051 0 12.0506 0 0 0 0 0 13.1669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12756 KIF1A_HUMAN "Kinesin-like protein KIF1A (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein, hUnc-104)" KIF1A ATSV C2orf20 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; dense core granule cytoskeletal transport [GO:0099519]; microtubule-based movement [GO:0007018]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal transport [GO:0008089]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; dense core granule cytoskeletal transport [GO:0099519]; microtubule-based movement [GO:0007018]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; retrograde neuronal dense core vesicle transport [GO:1990049]; vesicle-mediated transport [GO:0016192] GO:0003774; GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:0042802; GO:0045202; GO:0048471; GO:0060998; GO:0061001; GO:0070161; GO:0098674; GO:0098992; GO:0099519; GO:1904115; GO:1990048; GO:1990049 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] AFVYLSNLLYPVPLVHRVAIVSEK 0.9917 -22.79 0 0 0 0 0 0 0 11.1913 12.887 0 0 0 0 14.553 0 13.6513 14.2046 0 15.9872 13.1519 11.5976 0 14.1323 0 9.84163 10.2523 10.4142 14.082 12.2631 14.034 13.2558 14.9773 0 0 0 0 0 0 0 0 0 0 14.1294 0 14.0956 0 0 0 0 0 0 18.2571 18.0029 17.6455 0 0 0 18.9759 19.1188 17.9815 19.1424 18.8616 0 0 0 0 13.7745 11.1551 13.8914 13.7425 13.7295 0 18.1151 0 0 0 0 12.8523 0 0 0 0 0 14.6804 0 13.6331 12.8094 0 16.42 0 0 0 0 13.2287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1008 0 0 0 18.8394 0 0 16.4125 0 0 0 13.7088 0 12.1438 0 9.3478 0 0 0 0 0 0 0 0 0 0 0 18.1119 18.0496 0 0 0 0 0 13.6681 0 0 0 0 0 11.0151 0 0 0 0 0 0 0 14.7582 0 0 0 0 0 0 11.912 0 0 0 0 0 0 0 0 14.7115 0 11.1769 11.4985 13.1463 0 11.1608 0 Q2M389 WASC4_HUMAN "WASH complex subunit 4 (Strumpellin and WASH-interacting protein, SWIP) (WASH complex subunit SWIP)" WASHC4 KIAA1033 Homo sapiens (Human) endosomal transport [GO:0016197]; endosome organization [GO:0007032]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315] early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203] early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315] GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0071203; GO:0140591 ALCRLVELLKAIEHMFYR 0.9917 -22.772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9192 0 0 11.2951 0 0 13.4799 13.5542 0 11.4478 0 0 10.1653 11.4713 0 10.0731 0 0 0 0 0 11.473 0 0 0 0 11.4507 0 11.4926 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7781 0 0 0 10.8666 0 0 0 0 0 0 0 0 0 0 10.8688 0 0 0 0 0 12.7361 15.5321 15.2056 13.5536 15.8864 0 0 13.8827 14.6868 16.4755 14.7001 13.8282 13.068 15.2958 0 11.668 13.3376 13.1058 12.1776 12.4815 0 11.9824 0 0 13.883 0 15.4566 0 0 0 0 0 0 14.7849 12.5252 12.3479 0 13.1929 0 0 0 13.4167 0 0 12.1258 12.827 15.4541 0 0 12.3364 0 13.2969 14.1167 0 0 14.1057 0 16.5603 0 0 0 0 12.3397 0 0 14.1256 11.7022 13.7362 14.2256 0 0 0 0 0 11.8019 13.5742 0 12.4425 0 0 12.3184 0 0 0 0 0 0 12.8641 0 0 13.8126 0 12.5556 0 15.1753 0 0 0 0 14.7679 0 10.892 0 Q53F19 NCBP3_HUMAN Nuclear cap-binding protein subunit 3 (Protein ELG) NCBP3 C17orf85 Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; snRNA export from nucleus [GO:0006408] cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518] cytoplasm [GO:0005737]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; snRNA export from nucleus [GO:0006408] GO:0000339; GO:0000340; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005845; GO:0005846; GO:0006370; GO:0006406; GO:0006408; GO:0016607; GO:0034518; GO:0042789; GO:0051607 mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339] AAVRGLR 0.9917 -51.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1012 0 0 0 0 0 0 0 0 0 14.6964 0 0 13.2653 0 0 12.6729 0 0 0 0 0 0 0 0 0 0 12.0552 0 0 9.29283 0 0 9.89963 0 0 0 0 0 0 0 0 0 17.1203 0 0 0 0 0 0 0 0 13.4059 14.0582 0 0 13.2204 0 14.1653 0 13.822 0 0 0 0 0 13.889 13.9171 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8058 0 0 0 0 13.3405 10.7385 0 0 0 13.8908 0 0 0 0 13.8302 12.5665 12.9108 0 0 0 0 14.3343 0 0 0 0 0 0 0 0 0 13.8318 0 0 0 0 13.8974 0 0 13.5017 0 0 0 0 12.6565 0 0 0 0 0 13.0027 0 0 0 0 12.1089 0 11.861 0 0 0 0 0 0 0 0 13.4828 0 0 0 0 0 0 0 Q7L2J0 MEPCE_HUMAN "7SK snRNA methylphosphate capping enzyme, MePCE, EC 2.1.1.- (Bicoid-interacting protein 3 homolog, Bin3 homolog)" MEPCE BCDIN3 Homo sapiens (Human) negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031] 7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] 7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031] GO:0000122; GO:0001510; GO:0003723; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0035562; GO:0040031; GO:0097322; GO:0120259; GO:1900087; GO:1904871; GO:1905382; GO:1990276; GO:1990904 7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069] FQYGNYCKYYGYRNPSCEDGR 0.9917 -7.52 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6566 0 0 0 0 0 0 0 0 0 14.8811 0 0 0 0 0 0 0 0 0 0 13.5052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2843 0 0 0 0 0 0 15.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.392 0 14.3378 0 0 0 14.9486 0 0 0 0 0 0 0 0 Q7Z4N2 TRPM1_HUMAN "Transient receptor potential cation channel subfamily M member 1 (Long transient receptor potential channel 1, LTrpC1) (Melastatin-1)" TRPM1 LTRPC1 MLSN MLSN1 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cation transmembrane transport [GO:0098655]; cellular response to light stimulus [GO:0071482]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; protein tetramerization [GO:0051262]; visual perception [GO:0007601] axon [GO:0030424]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon [GO:0030424]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cation transmembrane transport [GO:0098655]; cellular response to light stimulus [GO:0071482]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; protein tetramerization [GO:0051262]; visual perception [GO:0007601] GO:0005261; GO:0005262; GO:0005789; GO:0005886; GO:0005887; GO:0007216; GO:0007601; GO:0030424; GO:0051262; GO:0060402; GO:0070588; GO:0071482; GO:0098655; GO:0098703 calcium channel activity [GO:0005262]; cation channel activity [GO:0005261] ASTETEC 0.9917 -19.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9206 12.5584 0 0 17.0124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9879 0 13.4022 0 0 0 13.0131 0 0 0 0 0 0 0 0 0 0 0 13.5554 0 13.5212 0 0 0 0 0 13.4507 13.3471 0 0 0 0 0 0 10.9299 0 11.8299 0 0 12.9779 0 0 0 0 12.65 11.8362 0 0 0 0 0 0 0 0 0 0 0 0 11.5114 12.241 0 0 0 0 0 0 0 0 0 0 12.5151 0 0 0 0 0 0 0 0 14.203 0 0 0 0 0 0 0 0 12.3275 0 0 0 0 0 0 0 0 0 Q92565 RPGF5_HUMAN "Rap guanine nucleotide exchange factor 5 (Guanine nucleotide exchange factor for Rap1) (M-Ras-regulated Rap GEF, MR-GEF) (Related to Epac, Repac)" RAPGEF5 GFR KIAA0277 MRGEF Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005634; GO:0005654; GO:0005886; GO:0007264; GO:0007265; GO:0007399; GO:0016604; GO:0030742; GO:0043547 GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085] ELKEFQK 0.9917 -18.973 0 0 0 0 11.9237 0 0 0 0 0 0 12.8267 0 0 12.1882 0 0 0 0 0 0 0 12.8851 0 0 0 0 0 13.1999 0 11.7731 13.4003 11.9256 0 0 0 11.3016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5825 0 0 0 0 0 0 0 0 0 0 0 0 13.6517 0 0 0 0 13.6225 11.3073 0 10.4404 0 0 0 0 11.0081 0 0 0 14.0255 0 0 0 10.6799 12.9737 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5897 0 0 0 0 0 13.5044 0 11.5297 0 0 0 0 12.8608 0 0 0 0 0 0 0 12.8051 0 11.4755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4765 0 0 0 14.6293 13.3475 0 0 0 0 0 0 0 0 0 0 15.427 0 0 0 0 Q92629 SGCD_HUMAN "Delta-sarcoglycan, Delta-SG (35 kDa dystrophin-associated glycoprotein, 35DAG)" SGCD Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell development [GO:0055013]; cardiac muscle tissue development [GO:0048738]; coronary vasculature morphogenesis [GO:0060977]; heart contraction [GO:0060047]; muscle organ development [GO:0007517]; protein-containing complex localization [GO:0031503] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529] cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell development [GO:0055013]; cardiac muscle tissue development [GO:0048738]; coronary vasculature morphogenesis [GO:0060977]; heart contraction [GO:0060047]; muscle organ development [GO:0007517]; protein-containing complex localization [GO:0031503] GO:0005856; GO:0005886; GO:0007517; GO:0016010; GO:0016012; GO:0016021; GO:0016529; GO:0019722; GO:0031503; GO:0042383; GO:0048738; GO:0055013; GO:0055074; GO:0060047; GO:0060977; GO:0086003 PGNALYFK 0.9917 -22.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7766 12.2306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6546 0 0 0 13.5823 13.0472 0 0 0 0 0 0 12.9339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5738 0 0 13.4387 0 0 0 0 0 0 0 0 0 0 0 0 13.2051 12.4426 0 12.8866 0 0 0 0 0 0 13.2634 0 13.2447 0 13.3242 0 0 Q9H501 ESF1_HUMAN ESF1 homolog (ABT1-associated protein) ESF1 ABTAP C20orf6 HDCMC28P Homo sapiens (Human) rRNA processing [GO:0006364] extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0006364 RNA binding [GO:0003723] DGTSPEEEIEIER 0.9917 -22.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2921 0 0 0 0 0 11.667 0 11.7038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4916 0 0 11.8832 0 0 0 0 0 0 13.6106 0 0 0 0 0 10.2934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5607 0 0 12.351 12.8704 0 0 13.986 0 15.2968 0 16.5569 12.2376 0 0 12.9949 0 0 0 0 11.866 0 0 13.804 0 13.3122 0 0 0 0 0 0 0 0 0 11.8908 0 0 0 0 0 0 14.9431 0 0 0 12.8319 0 0 0 0 11.4842 0 0 0 0 0 0 13.73 0 13.3923 13.4791 0 0 13.8905 0 13.3953 13.8349 13.8451 16.1879 0 0 12.9646 0 0 0 0 0 0 11.7095 0 0 0 14.6621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2285 0 0 0 0 0 Q9UM11 FZR1_HUMAN "Fizzy-related protein homolog, Fzr (CDC20-like protein 1) (Cdh1/Hct1 homolog, hCDH1)" FZR1 CDH1 FYR FZR KIAA1242 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346] GO:0005654; GO:0005680; GO:0005829; GO:0006281; GO:0007095; GO:0007346; GO:0008284; GO:0010997; GO:0031145; GO:0031965; GO:0040020; GO:0051301; GO:0051445; GO:0070306; GO:0070979; GO:1904668; GO:1905786; GO:1990757; GO:2000773 anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757] DRMILQR 0.9917 -19.047 0 0 0 0 0 0 0 0 0 0 0 0 13.3202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8176 0 0 0 0 0 0 0 0 0 0 13.9723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9787 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIF8 BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) BAZ2B KIAA1476 Homo sapiens (Human) chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0005634; GO:0006338; GO:0006357; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] ALLKVLHLR 0.99171 -53.339 0 0 0 14.4922 15.7354 0 0 0 14.009 0 11.9836 16.7532 0 12.2299 15.0393 0 0 14.736 0 15.2148 17.361 0 13.0579 0 16.4091 12.9067 11.7235 15.1182 0 0 0 17.2945 15.6258 15.3655 0 16.1276 14.2374 0 0 16.9251 0 17.8294 0 0 0 13.0866 0 0 0 15.7199 0 17.0538 16.6519 15.9228 17.5498 17.5465 17.9995 16.7511 16.7956 17.3745 13.5303 15.5838 16.9541 16.2204 17.3645 17.0701 0 0 0 0 0 0 12.1495 12.7933 0 13.0932 11.2499 0 0 11.9657 0 0 13.919 0 0 0 11.0304 0 11.1996 0 14.0892 0 0 0 0 0 14.3759 13.6221 0 16.9242 0 0 0 0 14.4588 0 10.9307 15.9346 13.0885 10.1211 13.8432 17.5499 11.8548 0 14.1215 18.3752 12.679 13.6835 13.0771 0 13.9287 11.4491 0 12.5216 10.9523 14.6703 0 0 0 0 14.58 14.9505 0 0 0 0 12.8969 12.284 14.1758 15.4491 0 14.5497 12.3693 0 0 0 13.6159 0 18.2749 11.3734 13.7512 0 15.8891 12.7319 0 0 19.0206 19.0699 11.1307 0 17.2375 16.7528 17.773 0 16.7547 0 17.8448 0 0 14.0638 12.4089 10.8061 0 12.3463 18.089 17.9307 11.4725 18.1286 18.0171 18.0607 O75444 MAF_HUMAN Transcription factor Maf (Proto-oncogene c-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog) MAF Homo sapiens (Human) cell development [GO:0048468]; inner ear development [GO:0048839]; integrated stress response signaling [GO:0140467]; lens fiber cell differentiation [GO:0070306]; megakaryocyte differentiation [GO:0030219]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; inner ear development [GO:0048839]; integrated stress response signaling [GO:0140467]; lens fiber cell differentiation [GO:0070306]; megakaryocyte differentiation [GO:0030219]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005737; GO:0006357; GO:0006366; GO:0010628; GO:0030219; GO:0032330; GO:0042802; GO:0048468; GO:0048839; GO:0070306; GO:0090575; GO:0140467; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DAYKEKYEK 0.99171 -19.058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1783 0 0 0 0 0 0 13.572 0 0 0 0 0 0 0 0 17.6195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.518 0 0 11.4817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6326 0 0 0 0 0 0 0 Q3V6T2 GRDN_HUMAN "Girdin (Akt phosphorylation enhancer, APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein, GIV) (Girders of actin filament) (Hook-related protein 1, HkRP1)" CCDC88A APE GRDN KIAA1212 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; maintenance of protein location in plasma membrane [GO:0072660]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cilium assembly [GO:0045724]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; TOR signaling [GO:0031929] GO:0001932; GO:0001965; GO:0003779; GO:0005080; GO:0005085; GO:0005092; GO:0005154; GO:0005158; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0006260; GO:0006275; GO:0007264; GO:0007399; GO:0008017; GO:0010975; GO:0016020; GO:0016477; GO:0030027; GO:0030032; GO:0030705; GO:0031122; GO:0031410; GO:0031929; GO:0032147; GO:0032148; GO:0032956; GO:0035091; GO:0036064; GO:0042127; GO:0042169; GO:0042803; GO:0043184; GO:0043422; GO:0045724; GO:0045742; GO:0051496; GO:0051959; GO:0061024; GO:0072660; GO:1903566 actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; epidermal growth factor receptor binding [GO:0005154]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; guanyl-nucleotide exchange factor activity [GO:0005085]; insulin receptor binding [GO:0005158]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; vascular endothelial growth factor receptor 2 binding [GO:0043184] ATIDIKTLVTLR 0.99171 -19.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0134 0 0 0 0 0 0 0 11.54 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1177 0 0 16.1562 0 0 0 0 0 0 0 0 0 0 14.4415 0 19.4736 0 0 13.0086 0 14.5884 13.4102 11.9256 13.0144 0 0 0 0 0 13.1873 0 13.2086 0 13.2561 0 0 0 0 0 0 12.0179 0 0 0 13.2096 0 0 0 13.2831 12.3881 18.4031 0 14.2466 0 11.993 13.0745 0 0 13.2608 17.6157 14.2787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1895 0 0 0 0 0 0 13.2281 0 13.3782 0 0 0 0 0 0 13.5947 0 13.9363 0 15.968 0 15.0996 0 0 0 0 0 0 0 0 0 0 0 Q6PHR2 ULK3_HUMAN "Serine/threonine-protein kinase ULK3, EC 2.7.11.1 (Unc-51-like kinase 3)" ULK3 Homo sapiens (Human) autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular senescence [GO:0090398]; fibroblast activation [GO:0072537]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; smoothened signaling pathway [GO:0007224] autophagosome [GO:0005776]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407] autophagosome [GO:0005776]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; cellular senescence [GO:0090398]; fibroblast activation [GO:0072537]; negative regulation of smoothened signaling pathway [GO:0045879]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; smoothened signaling pathway [GO:0007224] GO:0000407; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0006914; GO:0007224; GO:0018105; GO:0045879; GO:0045880; GO:0046777; GO:0072537; GO:0090398; GO:0097542; GO:0106310; GO:1905037 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DLLREMAR 0.99171 -18.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.334 13.3967 0 13.6242 13.8978 13.9447 0 12.1073 0 0 11.67 0 0 13.5296 11.3106 0 0 12.7674 12.6817 0 0 0 0 0 0 0 0 0 12.8488 0 0 0 0 0 11.7739 10.0236 0 14.374 0 13.4698 0 0 12.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7443 0 0 0 0 0 0 0 0 11.3164 0 0 0 0 0 0 0 0 0 0 0 14.4515 11.1915 12.5586 0 0 0 0 0 0 0 13.7964 0 0 0 0 0 0 0 0 0 0 0 Q8IXL7 MSRB3_HUMAN "Methionine-R-sulfoxide reductase B3, MsrB3, EC 1.8.4.12, EC 1.8.4.14" MSRB3 UNQ1965/PRO4487 Homo sapiens (Human) protein repair [GO:0030091]; response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979] GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745 L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270] MSPRRTLPR 0.99171 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7512 0 0 0 0 11.4795 0 0 0 0 11.6672 0 0 0 0 0 0 0 11.3057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2183 12.7038 0 0 0 0 0 0 0 0 0 0 0 0 Q8NI27 THOC2_HUMAN "THO complex subunit 2, Tho2 (hTREX120)" THOC2 CXorf3 Homo sapiens (Human) blastocyst development [GO:0001824]; cell morphogenesis [GO:0000902]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380]; stem cell division [GO:0017145]; viral mRNA export from host cell nucleus [GO:0046784] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; mRNA binding [GO:0003729]; blastocyst development [GO:0001824]; cell morphogenesis [GO:0000902]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380]; stem cell division [GO:0017145]; viral mRNA export from host cell nucleus [GO:0046784] GO:0000346; GO:0000347; GO:0000445; GO:0000902; GO:0001824; GO:0003729; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0010468; GO:0010793; GO:0010977; GO:0016607; GO:0016973; GO:0017145; GO:0046784; GO:0048666; GO:0048699 mRNA binding [GO:0003729] AAAAVVVPAEWIKNWEK 0.99171 -18.622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2063 12.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1293 0 0 0 0 0 0 10.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6094 0 13.9814 11.6312 0 14.0583 0 0 0 0 0 13.9558 15.2511 0 0 0 13.0485 0 0 0 0 0 14.2296 0 0 14.8797 15.0514 14.0657 14.3824 13.7007 12.7718 0 0 14.7249 0 15.1483 0 0 13.4055 0 12.6742 0 13.9133 0 14.0591 0 12.5427 14.1609 0 0 0 15.0947 13.7161 0 0 14.5586 14.8244 14.5214 0 0 0 14.3228 0 0 14.2183 0 0 0 0 0 0 0 0 12.3645 14.0984 0 0 0 10.6809 0 13.0821 0 0 0 0 0 0 15.04 15.8365 14.0505 0 0 0 0 13.4493 12.9108 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0076 0 0 0 13.7491 Q9NVN8 GNL3L_HUMAN Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) "negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; negative regulation of protein binding [GO:0032091]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of protein stability [GO:0031647]; ribosome biogenesis [GO:0042254]" GO:0003723; GO:0005525; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0016020; GO:0031334; GO:0031397; GO:0031647; GO:0032091; GO:0032211; GO:0033234; GO:0042254; GO:1904816 GTP binding [GO:0005525]; RNA binding [GO:0003723] EAELKKK 0.99171 -7.5432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.129 15.3495 0 14.855 14.5543 0 0 0 9.72108 0 0 0 13.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3211 0 15.0024 0 14.044 0 0 13.275 0 0 0 0 0 13.1957 0 13.9327 14.0445 0 0 0 10.6571 11.1629 0 0 0 0 0 10.3834 14.5476 0 0 0 0 9.4215 0 0 0 0 0 0 0 0 0 0 0 15.0637 0 0 0 0 11.2161 0 0 0 14.0849 0 0 0 0 0 0 0 0 0 0 0 0 13.1238 0 12.7231 12.6549 13.0221 0 0 13.3549 13.7574 0 0 0 13.8626 0 0 0 0 0 13.0803 0 0 Q8WXX0 DYH7_HUMAN Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2) DNAH7 KIAA0944 Homo sapiens (Human) cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874] axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005829; GO:0005858; GO:0005874; GO:0005929; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] ADIPKRPSYVAPLYK 0.99172 -48.197 11.3627 0 0 14.5415 13.904 11.2888 15.2612 0 0 0 13.375 13.3556 12.1075 12.041 0 13.156 12.5761 13.6312 12.4239 13.2577 12.6885 0 13.685 0 14.4732 0 11.8678 14.0205 12.878 14.1695 0 13.3544 14.1693 10.457 10.7581 12.4853 13.5156 12.941 13.3429 14.3794 13.1282 12.9931 14.3875 0 14.3216 11.5509 13.7356 13.9792 0 13.4872 14.0586 14.0492 12.2575 14.0729 14.4001 12.8101 13.1519 0 16.4391 0 9.98712 13.045 12.2936 11.0821 0 10.4119 12.8001 9.9197 12.2303 13.5836 13.5175 12.5676 11.332 11.9892 0 12.0988 13.8649 11.4144 14.8225 16.9957 15.2497 0 15.0054 16.4763 14.8506 14.486 15.2342 12.8401 14.9484 16.4939 16.1646 14.87 15.1208 15.4154 16.3548 15.952 15.8937 15.1739 15.5733 13.727 13.1821 13.5584 12.754 14.5697 15.4851 0 14.9087 14.8067 15.568 15.005 15.7072 16.7632 16.5607 14.6758 11.9426 0 14.4514 14.3567 12.3427 14.6384 0 14.49 12.6529 13.8916 13.9211 13.3025 15.948 14.7794 14.6869 15.4723 15.2437 13.4378 15.1447 15.4226 13.9397 14.985 13.3845 14.6402 14.8497 15.1678 12.0498 12.7767 13.5601 12.1125 0 13.178 14.316 14.3713 16.5203 15.5738 15.2994 15.1007 0 0 14.3871 15.1749 14.4536 15.8177 14.7907 13.8971 14.3284 14.391 0 15.5526 15.836 14.4335 15.2417 15.5939 13.1466 15.2066 13.8089 15.1863 14.6871 15.8958 16.4737 15.1232 12.2634 14.4413 15.3272 0 O00264 PGRC1_HUMAN "Membrane-associated progesterone receptor component 1, mPR (Dap1) (IZA)" PGRMC1 HPR6.6 PGRMC Homo sapiens (Human) heme biosynthetic process [GO:0006783] cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202] cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496]; heme biosynthetic process [GO:0006783] GO:0001540; GO:0005496; GO:0005741; GO:0005783; GO:0005886; GO:0005887; GO:0006783; GO:0012505; GO:0016020; GO:0020037; GO:0030868; GO:0035579; GO:0042803; GO:0043005; GO:0043025; GO:0044297; GO:0045202; GO:0046872 amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496] VFDVTKGRK 0.99172 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14782 KIF3C_HUMAN Kinesin-like protein KIF3C KIF3C Homo sapiens (Human) microtubule-based movement [GO:0007018] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] GO:0003774; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0097542 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ASEALKVVAR 0.99172 -17.796 0 0 0 0 0 0 0 0 0 0 14.7596 14.1946 0 0 0 0 0 13.8686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0645 0 0 0 0 14.8216 0 0 0 0 0 0 0 0 0 0 0 12.4968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1602 0 13.857 0 0 14.0689 0 0 0 15.3572 13.9485 15.1948 15.0576 14.2152 14.7116 16.7717 16.871 16.19 12.3674 0 0 0 13.4079 0 15.7316 15.3777 14.2052 0 0 0 16.2952 11.429 0 15.3869 14.5052 17.2919 0 0 0 0 14.8407 15.2056 14.5632 14.7442 14.2041 14.8998 14.5191 13.6376 0 0 14.3264 15.1023 0 0 0 12.1646 0 13.9005 0 0 14.8979 15.5332 15.0125 0 0 0 0 0 0 0 0 0 13.7769 0 14.9105 16.518 15.4376 0 0 0 0 0 13.2753 13.0039 11.4386 14.028 0 0 0 0 0 0 0 0 14.172 0 13.6996 0 0 13.5788 0 0 P0C7M8 CLC2L_HUMAN C-type lectin domain family 2 member L CLEC2L Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246] GO:0016021; GO:0030246 carbohydrate binding [GO:0030246] CEAPCPEDWLLYGR 0.99172 -4.5186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1413 0 0 11.0355 0 0 0 12.5117 0 0 0 0 0 0 0 0 0 13.0673 0 0 0 0 13.2812 13.5352 0 14.3132 13.3871 0 0 0 0 0 0 13.4728 0 0 0 0 0 13.2705 13.3079 0 0 0 13.4291 13.4319 0 0 0 0 0 0 0 13.0706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0131 0 0 0 0 0 12.8441 0 0 0 0 0 0 0 0 12.9476 0 0 0 12.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62304 RUXE_HUMAN "Small nuclear ribonucleoprotein E, snRNP-E (Sm protein E, Sm-E, SmE)" SNRPE Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005829; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:1903241 RNA binding [GO:0003723] IQVWLYEQVNMR 0.99172 -4.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15772 SPEG_HUMAN "Striated muscle preferentially expressed protein kinase, EC 2.7.11.1 (Aortic preferentially expressed protein 1, APEG-1)" SPEG APEG1 KIAA1297 Homo sapiens (Human) muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; protein phosphorylation [GO:0006468] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0007517; GO:0008285; GO:0042692; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALSIHVSVPQSGLR 0.99172 -87.188 11.2867 14.8338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1357 10.2109 0 12.6264 0 0 0 13.0662 0 12.7804 0 0 13.5796 13.2179 0 0 0 12.9519 13.4264 0 0 0 10.7972 0 0 12.1633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6105 0 15.2832 0 10.5326 0 0 14.8363 15.1852 11.0896 0 0 0 0 0 10.7133 14.1346 0 13.2876 13.8361 14.1294 14.2186 0 0 14.4529 14.4767 17.2774 13.4372 14.3567 12.7857 12.7671 14.8523 0 13.0454 0 14.5492 14.2658 13.8002 13.176 12.5575 13.0188 0 12.926 0 13.5311 14.4458 14.6835 0 13.1364 0 0 14.7172 14.9227 14.3371 0 14.232 11.1542 0 11.6939 0 0 10.6885 14.5881 0 12.9771 12.6324 0 0 0 13.6475 14.2093 13.4445 0 12.3335 0 13.4394 12.4223 12.0984 0 0 13.62 0 14.1968 0 15.3058 0 0 0 0 0 10.9981 0 13.0779 0 0 0 0 0 16.103 12.3299 0 0 0 0 0 0 0 12.0771 12.8442 0 12.5687 0 12.4002 Q495M9 USH1G_HUMAN pre-mRNA splicing regulator USH1G (Scaffold protein containing ankyrin repeats and SAM domain) (Usher syndrome type-1G protein) USH1G SANS Homo sapiens (Human) equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; regulation of clathrin-dependent endocytosis [GO:2000369]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; Cajal body [GO:0015030]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; Cajal body [GO:0015030]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; spectrin binding [GO:0030507]; equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; regulation of clathrin-dependent endocytosis [GO:2000369]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] GO:0001917; GO:0005829; GO:0005886; GO:0007605; GO:0015030; GO:0015629; GO:0016607; GO:0030507; GO:0032391; GO:0036064; GO:0042472; GO:0042802; GO:0045494; GO:0050953; GO:0050957; GO:0060122; GO:0097546; GO:0097733; GO:2000369 identical protein binding [GO:0042802]; spectrin binding [GO:0030507] ATLAAEPAHSEVSTDSGHDSLFTR 0.99172 -4.381 13.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6895 0 0 0 0 0 0 0 0 13.1403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0441 0 0 0 0 0 0 13.343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2242 0 0 0 0 12.3089 0 Q53QW1 TEX44_HUMAN Testis-expressed protein 44 TEX44 C2orf57 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 QAQADPNYD 0.99172 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1255 0 0 0 0 0 0 12.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VR7 VS10L_HUMAN "V-set and immunoglobulin domain-containing protein 10-like, VSIG10-like protein" VSIG10L Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021 DNPQALPLFLLLASLVGILTLR 0.99172 -4.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0746 Q8IWI9 MGAP_HUMAN MAX gene-associated protein (MAX dimerization protein 5) MGA KIAA0518 MAD5 Homo sapiens (Human) "cell fate specification [GO:0001708]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell fate specification [GO:0001708]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0005654; GO:0006357; GO:0045893; GO:0046983; GO:0071339 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AGPRLLLIPVQQGSPTLR 0.99172 -87.399 0 0 0 0 0 0 0 11.5286 0 0 0 14.5172 9.97728 0 0 0 0 10.9062 14.0998 13.1778 0 10.6612 0 0 13.9856 0 0 14.8643 10.4189 14.6395 0 0 13.4795 11.5958 0 0 0 0 0 0 0 12.2576 0 14.1669 12.0469 0 0 0 0 0 0 0 0 12.0903 0 0 0 0 0 0 10.6772 0 0 0 0 10.1563 0 0 11.87 0 13.6898 13.2579 12.6953 17.4318 17.7017 14.8496 17.4467 17.4896 16.6851 0 13.8709 0 13.9263 17.9214 15.815 18.5834 15.5452 0 12.9927 13.3689 12.6929 15.6851 12.5947 15.8114 0 12.9462 15.6783 16.2018 17.6183 14.198 15.3896 17.2039 16.6741 15.6461 12.2642 12.9585 13.6774 14.974 14.4755 15.6839 17.3546 13.5701 15.6476 14.5996 14.4226 13.1384 13.8385 15.4659 14.5631 0 15.8696 0 14.6817 13.4761 15.6365 15.52 14.498 14.8137 17.518 13.1857 14.2403 0 14.6235 17.7072 16.04 11.5083 16.3987 17.2274 14.4149 0 16.3699 14.6657 13.0743 13.3105 16.0981 0 0 0 0 0 0 13.8249 0 14.7513 16.7414 15.954 12.6039 0 0 0 0 0 13.9962 0 12.6446 16.9979 0 0 0 12.4348 0 16.2663 16.6893 15.9624 13.4189 0 0 0 0 0 Q8N122 RPTOR_HUMAN "Regulatory-associated protein of mTOR, Raptor (p150 target of rapamycin (TOR)-scaffold protein)" RPTOR KIAA1303 RAPTOR Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; TORC1 complex [GO:0031931]; 14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; phosphorylation [GO:0016310]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TOR signaling [GO:0032008]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of autophagy [GO:0010506]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202] GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0001938; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006974; GO:0008361; GO:0009267; GO:0009410; GO:0010494; GO:0010506; GO:0010507; GO:0010800; GO:0016310; GO:0019901; GO:0030291; GO:0030295; GO:0030307; GO:0030425; GO:0030674; GO:0031669; GO:0031929; GO:0031931; GO:0032008; GO:0033138; GO:0035176; GO:0038202; GO:0043025; GO:0044877; GO:0045821; GO:0045945; GO:0046889; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0071889; GO:0071902; GO:1900087; GO:1905857 14-3-3 protein binding [GO:0071889]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156] ALETIGANLQKQYENWQPRAR 0.99172 -23.074 0 0 0 0 0 0 0 0 15.3903 0 14.3298 0 0 15.73 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1836 0 0 0 0 0 0 12.7316 0 0 13.9711 0 0 0 0 0 0 0 0 0 11.2014 10.249 11.1335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1979 12.0142 14.5758 0 0 0 0 0 12.1309 12.2641 0 0 0 13.5651 0 0 12.6002 0 17.0749 0 0 0 12.7969 12.3796 0 0 0 0 0 0 0 0 14.1282 0 14.223 0 0 0 0 0 12.4859 12.3048 0 12.5039 0 12.5848 12.3876 0 14.2536 0 0 11.6876 14.0125 11.6126 12.3035 13.198 0 0 0 0 11.7847 0 13.5293 0 0 0 0 0 0 0 10.9098 11.7365 0 0 12.1022 14.9054 11.6521 0 12.0095 0 0 0 0 13.5929 0 10.946 0 14.4602 11.7487 0 0 13.7498 0 0 13.0008 0 10.8838 0 0 0 0 Q8TAL5 CI043_HUMAN Uncharacterized protein C9orf43 C9orf43 Homo sapiens (Human) IKLAMMKK 0.99172 -55.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4373 15.5934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9449 0 0 0 0 0 0 0 0 0 12.8349 0 0 0 0 0 0 16.1691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZX7 AICDA_HUMAN "Single-stranded DNA cytosine deaminase, EC 3.5.4.38 (Activation-induced cytidine deaminase, AID) (Cytidine aminohydrolase)" AICDA AID Homo sapiens (Human) B cell differentiation [GO:0030183]; cellular response to lipopolysaccharide [GO:0071222]; cytidine to uridine editing [GO:0016554]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; isotype switching [GO:0045190]; mRNA processing [GO:0006397]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; regulation of nuclear cell cycle DNA replication [GO:0033262]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; B cell differentiation [GO:0030183]; cellular response to lipopolysaccharide [GO:0071222]; cytidine to uridine editing [GO:0016554]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; isotype switching [GO:0045190]; mRNA processing [GO:0006397]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; regulation of nuclear cell cycle DNA replication [GO:0033262]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446] GO:0000932; GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0006397; GO:0008270; GO:0010529; GO:0016445; GO:0016446; GO:0016554; GO:0030183; GO:0031625; GO:0032991; GO:0033262; GO:0042742; GO:0042802; GO:0045190; GO:0045869; GO:0047844; GO:0051607; GO:0070383; GO:0071222; GO:0080111; GO:0090310 cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] AEPEGLRR 0.99172 -7.3687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5954 0 0 0 0 0 Q9H8H0 NOL11_HUMAN Nucleolar protein 11 NOL11 L14 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; t-UTP complex [GO:0034455] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838] GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0034455; GO:1901838 RNA binding [GO:0003723] CKAEPSFYPR 0.99172 -7.3721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6557 0 0 0 14.9018 14.3751 0 0 0 0 0 0 0 0 0 0 0 9.69007 14.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0289 0 13.6847 0 0 15.8436 0 0 0 0 0 12.2618 0 12.3123 0 0 0 9.45191 12.7459 0 0 0 0 0 13.1195 13.1882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7281 15.835 0 0 0 0 0 12.9663 0 0 0 0 15.4207 0 0 9.94458 0 0 15.7951 0 0 0 0 0 0 0 0 0 0 0 0 15.5026 0 0 13.9142 0 11.9437 0 11.2331 0 0 0 0 0 0 0 0 0 12.7066 0 0 0 0 0 0 0 0 0 0 0 Q9UH65 SWP70_HUMAN "Switch-associated protein 70, SWAP-70" SWAP70 KIAA0640 HSPC321 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880]; regulation of small GTPase mediated signal transduction [GO:0051056] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0003677; GO:0005085; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007204; GO:0015629; GO:0030027; GO:0030835; GO:0032233; GO:0032880; GO:0033633; GO:0045190; GO:0045296; GO:0051017; GO:0051056; GO:0060754; GO:1902309 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085] DKKGDILLDENCCVESLPDK 0.99172 -4.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6997 0 0 0 0 11.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.487 0 0 0 0 0 0 0 0 14.6856 0 0 0 0 12.0958 12.5186 0 0 0 14.9347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5171 14.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN71 PCDGG_HUMAN "Protocadherin gamma-B4, PCDH-gamma-B4 (Cadherin-20) (Fibroblast cadherin-2)" PCDHGB4 CDH20 FIB2 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0016020; GO:0016339 calcium ion binding [GO:0005509] LVTDAVLDR 0.99172 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2K1 ZBTB1_HUMAN Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) B cell differentiation [GO:0030183]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pro-T cell differentiation [GO:2000176]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated immunity [GO:0002711]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; translesion synthesis [GO:0019985] centrosome [GO:0005813]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; B cell differentiation [GO:0030183]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pro-T cell differentiation [GO:2000176]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell mediated immunity [GO:0002711]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; translesion synthesis [GO:0019985]" GO:0000122; GO:0000978; GO:0001227; GO:0002711; GO:0005634; GO:0005654; GO:0005813; GO:0006281; GO:0006338; GO:0006357; GO:0006974; GO:0016604; GO:0019985; GO:0030183; GO:0031965; GO:0032825; GO:0033077; GO:0034644; GO:0042789; GO:0042803; GO:0045087; GO:0045582; GO:0046872; GO:0046982; GO:0048538; GO:0051260; GO:0070530; GO:2000176 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHLREHYTVHTK 0.99172 -17.798 0 0 0 0 0 10.3048 0 0 13.2075 0 12.034 0 0 0 0 0 0 0 0 0 0 9.38465 0 0 0 0 0 0 0 0 0 0 0 12.1273 12.2923 11.2459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.233 0 0 9.13983 0 0 0 0 0 0 0 0 0 0 10.5971 0 0 0 0 0 0 0 0 0 0 14.1956 0 0 0 13.1911 14.3929 10.3594 0 0 0 0 0 0 13.1465 0 0 0 12.9941 0 0 0 0 0 0 0 0 12.4219 0 11.9279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7645 0 0 0 0 0 0 0 10.1805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6094 0 0 0 0 0 9.78459 0 0 0 0 0 0 0 0 0 11.6749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2X0 MED16_HUMAN "Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16) (Thyroid hormone receptor-associated protein 5) (Thyroid hormone receptor-associated protein complex 95 kDa component, Trap95) (Vitamin D3 receptor-interacting protein complex 92 kDa component, DRIP92)" MED16 DRIP92 THRAP5 Homo sapiens (Human) "positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]" GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0016020; GO:0016592; GO:0032968; GO:0042809; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0070847 nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713] CRIDTEILPSLFMR 0.99172 -4.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1579 0 0 0 0 0 0 0 0 0 0 0 0 10.2497 12.3509 0 13.196 0 0 0 0 0 0 0 0 0 0 0 0 10.8507 0 0 0 0 0 0 0 0 10.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3003 0 0 13.7748 0 0 0 0 0 15.5101 12.945 13.2377 13.3892 0 0 0 12.3614 0 0 13.2145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5768 0 0 0 0 9.97154 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9835 0 0 0 0 0 0 0 0 Q9Y3T6 R3HC1_HUMAN R3H and coiled-coil domain-containing protein 1 R3HCC1 Homo sapiens (Human) nucleic acid binding [GO:0003676] GO:0003676 nucleic acid binding [GO:0003676] EFSVLKIRPLTQGTK 0.99172 -4.3806 0 0 0 11.7163 15.6329 16.0004 15.9169 12.6139 0 0 0 0 0 0 0 0 0 0 0 0 12.5271 0 10.8547 0 10.723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4244 0 11.5882 12.6806 0 0 0 0 0 0 0 0 0 0 0 0 14.4158 0 12.6615 0 0 0 0 0 0 0 0 0 0 10.2149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6067 11.1381 0 0 0 0 14.1261 0 0 0 0 0 0 0 15.7714 13.2065 0 13.4173 0 0 0 0 0 13.3044 0 0 14.0145 0 0 0 0 12.9377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8146 0 0 0 12.4499 0 0 0 0 0 0 0 Q9Y6F9 WNT6_HUMAN Protein Wnt-6 WNT6 Homo sapiens (Human) "axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]" cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0001658; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0009798; GO:0009986; GO:0010628; GO:0030182; GO:0030666; GO:0031012; GO:0042475; GO:0045165; GO:0045893; GO:0060070; GO:0060684; GO:0061303; GO:0070062; GO:0070172; GO:0071300; GO:0072079 cytokine activity [GO:0005125]; frizzled binding [GO:0005109] ACNSSAPDLSGCDLLCCGR 0.99172 -4.389 0 0 0 0 0 0 0 0 0 12.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.896 0 0 0 0 0 0 0 11.3262 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.997 0 0 11.517 0 0 0 0 0 0 0 0 0 0 0 13.494 0 0 0 0 0 O14686 KMT2D_HUMAN "Histone-lysine N-methyltransferase 2D, Lysine N-methyltransferase 2D, EC 2.1.1.364 (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)" KMT2D ALR MLL2 MLL4 Homo sapiens (Human) "beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin assembly [GO:0031507]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to estrogen [GO:0043627]" histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; beta-catenin-TCF complex assembly [GO:1904837]; heterochromatin assembly [GO:0031507]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to estrogen [GO:0043627]" GO:0000976; GO:0001555; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006355; GO:0008284; GO:0031507; GO:0033148; GO:0035097; GO:0042393; GO:0042800; GO:0043627; GO:0044648; GO:0044666; GO:0045944; GO:0046872; GO:0048477; GO:0051568; GO:0080182; GO:0097692; GO:1904837 DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] ACGAGSAELNPNSEWFENYSLCHRCHKAQGGQTIR 0.99173 -96.765 0 16.0192 14.9363 0 0 0 0 0 0 0 12.5959 0 0 0 10.9307 0 0 0 0 11.0398 0 13.7816 0 0 0 12.5116 0 0 12.9453 12.6674 12.577 0 0 11.3009 0 0 0 0 11.3006 0 0 9.40487 12.2417 11.7294 0 0 0 14.5768 0 0 0 0 10.5507 12.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1185 0 0 16.8534 11.1219 12.9919 0 11.782 14.1163 16.9043 14.0052 13.0309 12.6474 14.6688 16.0788 0 13.9243 18.3095 12.5682 14.8711 0 17.1928 14.967 0 0 0 0 0 12.0592 0 17.9678 0 17.0556 16.3081 0 0 14.6765 16.5375 0 14.4055 16.6968 14.9662 15.7613 17.6281 13.8073 12.6904 14.496 13.3319 15.644 0 0 17.5634 0 14.3983 16.1608 14.2731 17.0751 13.8623 15.1746 14.3861 17.458 12.9979 13.1139 15.0875 0 13.1157 15.4674 0 0 13.934 15.2125 15.9846 13.7756 13.6768 17.6643 13.6771 12.1139 13.9353 12.4608 15.0547 0 13.9496 14.1559 15.4587 14.087 14.5364 13.8585 0 0 11.3931 0 14.9795 13.2681 14.0874 15.9846 13.3817 12.5356 0 0 14.5838 0 0 0 13.4424 13.5436 11.9568 17.481 13.4962 0 14.7408 13.9434 14.1319 0 A6H8Y1 BDP1_HUMAN "Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150, TFIIIB150) (Transcription factor-like nuclear regulator)" BDP1 KIAA1241 KIAA1689 TFNR Homo sapiens (Human) RNA polymerase III preinitiation complex assembly [GO:0070898] nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126] nucleoplasm [GO:0005654]; transcription factor TFIIIB complex [GO:0000126]; TFIIIC-class transcription factor complex binding [GO:0001156]; RNA polymerase III preinitiation complex assembly [GO:0070898] GO:0000126; GO:0001156; GO:0005654; GO:0070898 TFIIIC-class transcription factor complex binding [GO:0001156] ALRPVQVR 0.99173 -141.24 0 0 0 0 0 0 0 0 0 0 0 0 11.0643 0 0 0 0 0 0 12.1349 0 0 0 12.1103 0 0 0 12.1267 0 0 13.6676 13.6776 0 0 0 0 0 0 0 0 0 0 0 0 14.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.399 0 14.5153 0 0 0 14.3898 14.8304 0 13.7476 13.0153 0 0 13.2679 0 0 0 0 0 0 0 0 16.3495 13.4868 0 0 0 12.7541 0 13.1337 12.7488 12.8282 13.119 0 0 0 0 0 0 14.9507 0 12.1089 0 13.1293 13.6562 0 11.2744 13.4601 0 13.14 12.8418 0 13.8566 13.4218 0 12.638 14.1547 14.8353 17.8567 0 0 0 0 0 12.7163 0 11.4307 0 0 13.7074 0 0 0 14.9147 0 14.4153 0 13.386 0 0 11.8562 12.5722 0 0 14.9401 0 0 0 15.8333 14.8855 13.3351 0 12.6057 0 0 0 0 0 0 0 12.2807 0 11.6023 0 0 0 0 13.6448 0 0 0 12.8886 0 A6NIU2 CU037_HUMAN Putative uncharacterized protein encoded by LINC01549 LINC01549 C21orf37 Homo sapiens (Human) ERAQCLRK 0.99173 -7.593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00220 TR10A_HUMAN "Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1, TRAIL receptor 1, TRAIL-R1) (CD antigen CD261)" TNFRSF10A APO2 DR4 TRAILR1 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]; TRAIL-activated apoptotic signaling pathway [GO:0036462] cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165]; TRAIL-activated apoptotic signaling pathway [GO:0036462] GO:0002020; GO:0005035; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0007250; GO:0008625; GO:0009986; GO:0016021; GO:0036462; GO:0038023; GO:0042802; GO:0043065; GO:0045121; GO:0045569; GO:0071260; GO:0097191 death receptor activity [GO:0005035]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569] GCPRGMVK 0.99173 -24.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7526 0 0 0 0 0 13.0815 13.3339 0 10.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5784 12.7365 12.6289 0 0 0 0 0 13.1563 0 13.8632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60641 AP180_HUMAN Clathrin coat assembly protein AP180 (91 kDa synaptosomal-associated protein) (Clathrin coat-associated protein AP180) (Phosphoprotein F1-20) SNAP91 KIAA0656 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; protein transport [GO:0015031]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; vesicle budding from membrane [GO:0006900] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; synaptic vesicle [GO:0008021] "clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; synaptic vesicle [GO:0008021]; 1-phosphatidylinositol binding [GO:0005545]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; protein transport [GO:0015031]; regulation of clathrin-dependent endocytosis [GO:2000369]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; vesicle budding from membrane [GO:0006900]" GO:0000149; GO:0005545; GO:0005546; GO:0005905; GO:0006900; GO:0008021; GO:0015031; GO:0016185; GO:0019901; GO:0030136; GO:0032050; GO:0048268; GO:0072583; GO:0098894; GO:2000369 "1-phosphatidylinositol binding [GO:0005545]; clathrin heavy chain binding [GO:0032050]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; SNARE binding [GO:0000149]" QMAFDFAR 0.99173 -7.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54277 PMS1_HUMAN PMS1 protein homolog 1 (DNA mismatch repair protein PMS1) PMS1 PMSL1 Homo sapiens (Human) mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410] mismatch repair complex [GO:0032300]; nucleus [GO:0005634] mismatch repair complex [GO:0032300]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410] GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032300; GO:0140664 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] AVIWQKSR 0.99173 -23.081 0 0 0 0 0 0 0 0 0 11.853 0 13.7332 13.7363 12.9215 0 0 12.7412 13.1397 0 12.7346 12.8238 0 12.8927 0 0 12.8082 0 0 0 0 13.0285 13.2099 15.4255 0 0 0 0 0 0 0 13.5214 0 0 0 13.4001 13.5017 0 0 11.9799 12.2041 0 14.0818 13.3215 0 0 0 0 14.2706 13.6258 13.6573 0 0 14.4619 0 13.5407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4568 0 0 11.2382 0 11.7194 0 13.0155 0 14.5307 13.5899 14.4716 0 12.9983 13.9182 13.4157 0 0 0 13.0776 13.2643 0 0 0 12.6285 0 0 0 0 0 14.906 0 0 13.7546 0 13.7637 10.528 13.8814 0 0 0 0 0 0 13.3688 0 0 0 0 0 0 16.6267 0 0 0 0 0 0 11.6185 0 0 18.5823 0 14.2359 0 0 14.8844 17.7828 0 0 0 0 0 0 0 13.1433 12.8427 0 13.2709 13.9794 0 13.0992 14.0767 15.9273 0 13.0887 15.2249 14.3951 14.2446 13.9398 0 0 0 0 0 0 0 0 0 Q02643 GHRHR_HUMAN "Growth hormone-releasing hormone receptor, GHRH receptor (Growth hormone-releasing factor receptor, GRF receptor, GRFR)" GHRHR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; determination of adult lifespan [GO:0008340]; establishment of localization in cell [GO:0051649]; growth hormone secretion [GO:0030252]; hormone metabolic process [GO:0042445]; lactation [GO:0007595]; multicellular organismal reproductive process [GO:0048609]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of intracellular steroid hormone receptor signaling pathway [GO:0033143]; regulation of protein metabolic process [GO:0051246]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; somatotropin secreting cell development [GO:0060133]; water homeostasis [GO:0030104]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; secretory granule [GO:0030141]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; growth factor binding [GO:0019838]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP-mediated signaling [GO:0019933]; cell maturation [GO:0048469]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; determination of adult lifespan [GO:0008340]; establishment of localization in cell [GO:0051649]; growth hormone secretion [GO:0030252]; hormone metabolic process [GO:0042445]; lactation [GO:0007595]; multicellular organismal reproductive process [GO:0048609]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of intracellular steroid hormone receptor signaling pathway [GO:0033143]; regulation of protein metabolic process [GO:0051246]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; somatotropin secreting cell development [GO:0060133]; water homeostasis [GO:0030104]" GO:0004930; GO:0005637; GO:0005640; GO:0005737; GO:0005886; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007595; GO:0008284; GO:0008340; GO:0008528; GO:0009986; GO:0016021; GO:0016363; GO:0016520; GO:0017046; GO:0019838; GO:0019933; GO:0030104; GO:0030141; GO:0030252; GO:0032868; GO:0032869; GO:0033143; GO:0040018; GO:0042383; GO:0042445; GO:0043568; GO:0043627; GO:0046010; GO:0048469; GO:0048609; GO:0051246; GO:0051384; GO:0051649; GO:0060124; GO:0060133; GO:0071333 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; growth factor binding [GO:0019838]; growth hormone-releasing hormone receptor activity [GO:0016520]; peptide hormone binding [GO:0017046] AGAVFLK 0.99173 -7.5841 0 0 0 0 0 0 0 0 0 13.74 0 13.8172 0 0 0 14.0778 0 0 0 0 13.9035 0 0 0 0 0 0 0 14.3346 0 13.4547 0 0 11.5921 0 0 0 0 12.8218 0 0 0 0 14.3264 13.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8222 13.03 0 0 0 0 0 12.4869 0 12.3047 0 0 0 0 0 0 0 0 0 13.8164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1263 0 0 0 0 0 0 0 13.6338 13.6932 0 0 13.0332 12.6691 12.6005 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 0 0 14.7608 0 13.3773 12.7489 0 0 13.0356 0 0 0 0 12.1135 0 0 0 0 0 12.0655 0 0 0 0 0 12.0815 0 0 0 0 0 0 0 14.0493 0 0 12.327 0 0 0 0 0 Q05397 FAK1_HUMAN "Focal adhesion kinase 1, FADK 1, EC 2.7.10.2 (Focal adhesion kinase-related nonkinase, FRNK) (Protein phosphatase 1 regulatory subunit 71, PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)" PTK2 FAK FAK1 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell motility [GO:0048870]; detection of muscle stretch [GO:0035995]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of cell polarity [GO:0030010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway [GO:0060396]; heart morphogenesis [GO:0003007]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-cell adhesion [GO:0022408]; netrin-activated signaling pathway [GO:0038007]; peptidyl-tyrosine phosphorylation [GO:0018108]; placenta development [GO:0001890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of endothelial cell migration [GO:0010594]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0001525; GO:0001725; GO:0001890; GO:0001932; GO:0001934; GO:0003007; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0006468; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007411; GO:0008284; GO:0008360; GO:0008432; GO:0010594; GO:0010632; GO:0010759; GO:0010763; GO:0014068; GO:0016477; GO:0018108; GO:0019901; GO:0019903; GO:0022408; GO:0030010; GO:0030154; GO:0030155; GO:0030335; GO:0031234; GO:0033628; GO:0035995; GO:0036064; GO:0038007; GO:0038096; GO:0042127; GO:0042169; GO:0043066; GO:0043087; GO:0043197; GO:0043231; GO:0043552; GO:0045087; GO:0045667; GO:0045860; GO:0046777; GO:0048010; GO:0048013; GO:0048870; GO:0051493; GO:0051893; GO:0051897; GO:0060396; GO:0090303; GO:0120041; GO:1900024; GO:2000060; GO:2000811 actin binding [GO:0003779]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; JUN kinase binding [GO:0008432]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102] AVIEMSSKIQPAPPEEYVPMVK 0.99173 -24.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8974 14.4785 13.4479 13.9582 0 0 0 14.2758 0 0 0 13.1073 18.2392 0 0 0 0 13.0563 0 0 0 0 0 14.0754 0 15.2708 13.5139 0 0 12.9524 0 0 0 0 0 0 10.1835 12.7747 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9509 15.1488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1426 0 0 0 13.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0004 0 0 0 0 0 0 0 0 0 14.9133 Q13023 AKAP6_HUMAN "A-kinase anchor protein 6, AKAP-6 (A-kinase anchor protein 100 kDa, AKAP 100) (Protein kinase A-anchoring protein 6, PRKA6) (mAKAP)" AKAP6 AKAP100 KIAA0311 Homo sapiens (Human) action potential [GO:0001508]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; protein targeting [GO:0006605]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315] calcium channel complex [GO:0034704]; caveola [GO:0005901]; cytoplasm [GO:0005737]; intercalated disc [GO:0014704]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; adenylate cyclase binding [GO:0008179]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325]; action potential [GO:0001508]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell growth [GO:0030307]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; protein targeting [GO:0006605]; regulation of membrane repolarization [GO:0060306]; regulation of protein kinase A signaling [GO:0010738]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] GO:0001508; GO:0005635; GO:0005737; GO:0005901; GO:0006605; GO:0008179; GO:0010738; GO:0010880; GO:0014701; GO:0014704; GO:0016529; GO:0019933; GO:0030307; GO:0030315; GO:0031965; GO:0034237; GO:0034704; GO:0043495; GO:0044325; GO:0048471; GO:0051018; GO:0051281; GO:0060090; GO:0060306; GO:0060316; GO:0061051; GO:0070886; GO:0071320; GO:0071345; GO:1901381; GO:1902261 adenylate cyclase binding [GO:0008179]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter binding [GO:0044325] DMLRMIASQWK 0.99173 -23.091 0 0 0 0 11.6937 0 0 11.4737 0 0 0 0 0 0 0 0 0 13.9614 0 0 0 0 0 0 0 0 0 0 0 0 12.9672 0 0 12.1307 0 0 0 12.1071 0 9.7362 0 0 9.646 11.6227 0 0 0 0 0 0 0 0 11.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 14.645 13.6952 0 13.6131 0 16.9312 0 0 13.1445 13.3833 13.4988 14.3794 12.5461 14.804 0 0 16.2606 0 0 0 13.6503 0 12.3541 0 13.6516 14.4323 0 13.0318 0 13.675 0 15.9452 0 13.5353 0 0 13.6313 0 13.561 0 12.9853 13.1658 14.2897 0 0 0 0 13.2133 0 0 13.9148 0 16.0356 13.6607 14.5665 13.8228 15.8852 14.7327 0 0 13.2869 0 0 0 15.1128 13.6804 0 0 0 0 13.0036 13.0953 13.4114 13.6251 0 15.4447 14.7778 0 0 12.8555 0 0 0 0 12.6138 12.7625 15.2557 0 12.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2678 13.3139 14.3509 0 0 17.5883 0 0 0 Q13505 MTX1_HUMAN Metaxin-1 (Mitochondrial outer membrane import complex protein 1) MTX1 MTX MTXN Homo sapiens (Human) inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; SAM complex [GO:0001401] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; SAM complex [GO:0001401]; inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040] GO:0001401; GO:0005737; GO:0005741; GO:0007005; GO:0007007; GO:0007595; GO:0016021; GO:0045040; GO:0140275 ATPARAPGTR 0.99173 -7.4051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.172 0 0 0 0 0 0 0 0 15.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3096 15.1688 0 0 0 0 0 0 0 15.2229 0 0 11.1424 0 0 0 0 0 0 0 0 13.3584 0 0 0 Q13761 RUNX3_HUMAN "Runt-related transcription factor 3 (Acute myeloid leukemia 2 protein) (Core-binding factor subunit alpha-3, CBF-alpha-3) (Oncogene AML-2) (Polyomavirus enhancer-binding protein 2 alpha C subunit, PEA2-alpha C, PEBP2-alpha C) (SL3-3 enhancer factor 1 alpha C subunit) (SL3/AKV core-binding factor alpha C subunit)" RUNX3 AML2 CBFA3 PEBP2A3 Homo sapiens (Human) "chondrocyte differentiation [GO:0002062]; hemopoiesis [GO:0030097]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of cell cycle [GO:0045786]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]" chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]; chondrocyte differentiation [GO:0002062]; hemopoiesis [GO:0030097]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of cell cycle [GO:0045786]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001503; GO:0002062; GO:0003700; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006468; GO:0016513; GO:0030097; GO:0030182; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045786; GO:0045893; GO:0048935; GO:0050680; GO:0071559; GO:1990837 "ATP binding [GO:0005524]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]" FGDLERLR 0.99173 -7.4014 0 0 0 0 0 0 0 0 0 0 0 0 11.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0232 0 0 0 12.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8561 13.7245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8828 0 0 0 0 Q49A17 GLTL6_HUMAN "Polypeptide N-acetylgalactosaminyltransferase-like 6, EC 2.4.1.41 (Polypeptide GalNAc transferase 17, GalNAc-T17, pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17)" GALNTL6 GALNT17 Homo sapiens (Human) protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0018243; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] DWHDYESIQK 0.99173 -5.9978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T6J7 GNTK_HUMAN "Probable gluconokinase, EC 2.7.1.12 (Gluconate kinase)" IDNK C9orf103 Homo sapiens (Human) D-gluconate catabolic process [GO:0046177]; phosphorylation [GO:0016310] ATP binding [GO:0005524]; gluconokinase activity [GO:0046316]; D-gluconate catabolic process [GO:0046177]; phosphorylation [GO:0016310] GO:0005524; GO:0016310; GO:0046177; GO:0046316 ATP binding [GO:0005524]; gluconokinase activity [GO:0046316] CEESGKEAK 0.99173 -6.0098 0 0 0 0 0 0 0 0 11.968 0 11.8021 11.7791 11.7143 11.766 11.793 0 0 0 0 0 0 0 0 0 0 0 0 11.8366 11.8141 11.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4171 12.9963 0 12.9057 0 0 0 0 0 13.4737 12.8979 0 0 13.089 0 0 0 0 0 0 0 0 0 Q6AI08 HEAT6_HUMAN HEAT repeat-containing protein 6 (Amplified in breast cancer protein 1) HEATR6 ABC1 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] DGVSSSFSSSSWK 0.99173 -7.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6992 13.8756 0 0 0 0 0 0 0 12.6576 12.5468 0 0 0 0 15.3928 15.4196 0 15.4162 0 15.3412 0 15.248 0 15.0518 0 12.9852 14.392 0 0 0 15.6971 0 0 15.2375 0 0 0 0 0 0 0 14.4032 0 0 14.5274 15.0076 0 0 14.8113 0 0 0 0 0 0 0 14.822 0 16.0122 0 0 0 14.3405 0 0 0 0 0 0 0 0 14.0461 0 0 13.8858 13.987 0 0 0 0 0 0 0 0 12.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6B0I6 KDM4D_HUMAN "Lysine-specific demethylase 4D, EC 1.14.11.66 (JmjC domain-containing histone demethylation protein 3D) (Jumonji domain-containing protein 2D) ([histone H3]-trimethyl-L-lysine(9) demethylase 4D)" KDM4D JHDM3D JMJD2D Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932] blood microparticle [GO:0072562]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861] blood microparticle [GO:0072562]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]; cellular response to ionizing radiation [GO:0071479]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of protein phosphorylation [GO:0001932] GO:0000724; GO:0001932; GO:0003684; GO:0005634; GO:0005654; GO:0005721; GO:0006338; GO:0031490; GO:0032452; GO:0032454; GO:0033169; GO:0035563; GO:0035861; GO:0046872; GO:0071479; GO:0072562; GO:0140684; GO:1900113; GO:2001034 chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872] EEFNDFDK 0.99173 -7.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1315 0 0 0 0 0 0 0 0 10.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0291 12.9495 0 0 10.7497 0 0 0 12.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1061 0 0 0 0 0 14.2542 0 0 0 14.2078 0 10.0318 0 0 0 0 11.6247 0 13.3486 14.493 12.6891 0 12.956 0 9.68233 0 0 0 0 14.5098 13.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3597 0 13.5272 11.7543 0 0 0 0 0 16.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZRR7 LRRC9_HUMAN Leucine-rich repeat-containing protein 9 LRRC9 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ELWIAECCIEK 0.99173 -23.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.712 13.224 0 12.7312 0 0 14.9545 0 0 0 0 0 13.7487 17.0346 0 15.7179 15.5759 11.6722 0 0 13.9118 0 15.5573 0 0 0 10.5595 0 0 12.013 0 0 0 10.7463 0 0 0 0 14.7575 14.9584 0 0 14.3192 0 12.8495 0 12.7608 0 0 15.6771 0 14.6742 0 0 14.4696 13.6742 12.7554 0 0 0 0 0 14.6048 15.8731 11.742 12.1463 0 0 13.8595 0 13.7538 0 0 14.3387 12.6567 14.0722 0 0 0 15.1268 13.7519 15.0531 14.5598 14.7889 11.7032 0 0 0 12.4854 16.7722 0 0 0 14.1962 15.2249 0 13.9346 14.7027 17.9342 0 13.9142 0 0 0 0 0 0 0 0 0 0 0 12.3981 0 0 0 12.8065 0 0 0 0 0 0 0 0 14.0904 0 0 0 0 0 0 0 11.7297 13.329 13.31 13.3038 0 13.5608 0 12.8269 Q70J99 UN13D_HUMAN Protein unc-13 homolog D (Munc13-4) UNC13D Homo sapiens (Human) defense response to virus [GO:0051607]; germinal center formation [GO:0002467]; granuloma formation [GO:0002432]; natural killer cell degranulation [GO:0043320]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of mast cell degranulation [GO:0043304]; secretion [GO:0046903] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; recycling endosome [GO:0055037]; secretory vesicle [GO:0099503]; Weibel-Palade body [GO:0033093] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; recycling endosome [GO:0055037]; secretory vesicle [GO:0099503]; Weibel-Palade body [GO:0033093]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; defense response to virus [GO:0051607]; germinal center formation [GO:0002467]; granuloma formation [GO:0002432]; natural killer cell degranulation [GO:0043320]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of mast cell degranulation [GO:0043304]; secretion [GO:0046903] GO:0002432; GO:0002467; GO:0005576; GO:0005764; GO:0005770; GO:0005829; GO:0006909; GO:0016020; GO:0031267; GO:0033093; GO:0035578; GO:0043231; GO:0043304; GO:0043320; GO:0045921; GO:0046872; GO:0046903; GO:0051607; GO:0055037; GO:0070382; GO:0099503; GO:1900026; GO:1903307 metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] HIQKLVGVR 0.99173 -23.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.141 0 0 0 0 0 0 0 13.6419 0 0 11.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2451 0 0 0 0 0 0 0 0 13.6883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3G6 PRIC2_HUMAN Prickle-like protein 2 PRICKLE2 Homo sapiens (Human) "Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytoplasm [GO:0005737]; nuclear membrane [GO:0031965] "cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; zinc ion binding [GO:0008270]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0005737; GO:0008270; GO:0031965; GO:0060071 zinc ion binding [GO:0008270] DSGMNVSEK 0.99173 -23.096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84552 10.5318 0 0 0 9.50222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8222 0 14.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5392 0 0 0 0 0 0 0 0 0 0 14.3226 0 0 0 0 0 0 0 0 11.6244 15.2426 0 0 0 0 11.2095 14.1765 0 0 0 0 0 13.9936 0 0 0 0 0 0 0 10.8965 0 0 0 0 10.5341 0 0 0 11.3632 0 0 0 0 0 0 0 0 0 0 13.003 0 0 0 0 0 13.8781 0 0 0 10.5149 0 0 0 0 Q86UX6 ST32C_HUMAN "Serine/threonine-protein kinase 32C, EC 2.7.11.1 (PKE) (Yet another novel kinase 3)" STK32C YANK3 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] GO:0004674; GO:0005524; GO:0018105; GO:0035556; GO:0046872; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ATALAGTK 0.99173 -23.087 12.2882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1468 0 0 0 0 12.6666 0 12.4342 13.9868 0 0 0 0 15.8677 0 13.5494 12.8211 0 0 0 0 0 0 0 0 0 0 13.9509 0 0 0 0 0 0 0 13.0262 0 0 0 0 0 0 0 13.197 0 0 0 0 0 0 0 0 0 0 13.3906 0 0 13.7172 0 0 0 0 0 0 0 0 13.5121 13.0649 15.7532 13.4585 12.0098 0 0 0 0 0 0 13.393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4585 0 0 0 0 0 Q9BPX6 MICU1_HUMAN "Calcium uptake protein 1, mitochondrial (Atopy-related autoantigen CALC, ara CALC) (Calcium-binding atopy-related autoantigen 1) (allergen Hom s 4)" MICU1 CALC CBARA1 Homo sapiens (Human) calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; defense response [GO:0006952]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069] calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246] calcium channel complex [GO:0034704]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; defense response [GO:0006952]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069] GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0006851; GO:0006952; GO:0032592; GO:0034704; GO:0036444; GO:0042802; GO:0046982; GO:0051260; GO:0051560; GO:0051561; GO:0070509; GO:1900069; GO:1990246 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982] DMGFTRLMQAMWKCAQETAWDFALPK 0.99173 -23.085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.802 0 0 17.0018 0 0 0 0 0 0 12.5081 0 0 13.2381 0 0 13.8674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9609 0 13.0606 0 11.1267 0 0 0 0 Q9UPQ0 LIMC1_HUMAN LIM and calponin homology domains-containing protein 1 LIMCH1 KIAA1102 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893] cytoplasm [GO:0005737]; stress fiber [GO:0001725] cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]; actomyosin structure organization [GO:0031032]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893] GO:0001725; GO:0001934; GO:0003779; GO:0005737; GO:0030336; GO:0031032; GO:0032034; GO:0046872; GO:0051496; GO:0051893; GO:0060327 actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034] AVPMLTPK 0.99173 -24.731 0 0 0 0 0 0 0 0 0 13.6209 0 0 12.5486 14.0861 0 0 0 0 0 0 13.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0825 0 0 0 0 0 0 15.5948 16.1987 15.3052 0 0 14.7836 0 0 14.258 0 17.333 14.3329 13.6663 13.6782 13.5137 13.1334 0 0 0 11.9236 0 13.7438 0 0 16.7399 13.6678 0 17.4079 16.7607 13.1766 0 15.0677 12.0497 12.8433 0 0 0 0 0 12.773 0 13.8002 14.0674 0 14.7773 11.5603 0 0 14.5784 12.9962 0 13.9431 0 0 0 0 0 12.099 15.231 15.5749 12.8614 0 0 0 12.7477 12.7463 13.3231 0 0 13.0165 0 0 0 0 0 0 16.0098 15.1921 12.0145 14.2319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7684 0 0 0 0 14.9939 0 12.1223 0 0 14.4057 0 Q9Y572 RIPK3_HUMAN "Receptor-interacting serine/threonine-protein kinase 3, EC 2.7.11.1 (RIP-like protein kinase 3) (Receptor-interacting protein 3, RIP-3)" RIPK3 RIP3 Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; amyloid fibril formation [GO:1990000]; apoptotic signaling pathway [GO:0097190]; cellular response to hydrogen peroxide [GO:0070301]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lymph node development [GO:0048535]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ligase activity [GO:0051351]; positive regulation of necroptotic process [GO:0060545]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein modification process [GO:0036211]; reactive oxygen species metabolic process [GO:0072593]; regulation of activated T cell proliferation [GO:0046006]; regulation of activation-induced cell death of T cells [GO:0070235]; regulation of adaptive immune response [GO:0002819]; regulation of apoptotic process [GO:0042981]; regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000452]; regulation of interferon-gamma production [GO:0032649]; regulation of T cell mediated cytotoxicity [GO:0001914]; signal transduction [GO:0007165]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; activation of protein kinase activity [GO:0032147]; amyloid fibril formation [GO:1990000]; apoptotic signaling pathway [GO:0097190]; cellular response to hydrogen peroxide [GO:0070301]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; lymph node development [GO:0048535]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of ligase activity [GO:0051351]; positive regulation of necroptotic process [GO:0060545]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein modification process [GO:0036211]; reactive oxygen species metabolic process [GO:0072593]; regulation of activated T cell proliferation [GO:0046006]; regulation of activation-induced cell death of T cells [GO:0070235]; regulation of adaptive immune response [GO:0002819]; regulation of apoptotic process [GO:0042981]; regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation [GO:2000452]; regulation of interferon-gamma production [GO:0032649]; regulation of T cell mediated cytotoxicity [GO:0001914]; signal transduction [GO:0007165]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]" GO:0001914; GO:0002819; GO:0003713; GO:0004672; GO:0004674; GO:0004704; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007249; GO:0010922; GO:0032147; GO:0032649; GO:0032991; GO:0033077; GO:0036211; GO:0042802; GO:0042981; GO:0043029; GO:0044877; GO:0046006; GO:0046777; GO:0048535; GO:0048536; GO:0048538; GO:0051092; GO:0051351; GO:0051353; GO:0051607; GO:0060545; GO:0070235; GO:0070266; GO:0070301; GO:0072593; GO:0097190; GO:0097300; GO:0097527; GO:0097528; GO:0106310; GO:1990000; GO:2000379; GO:2000452; GO:2001244 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713] DFLSQLRSSNRR 0.99173 -7.4054 0 0 0 0 0 0 0 0 0 0 12.05 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1193 0 0 0 13.0956 0 0 0 0 12.1676 0 0 0 13.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4579 13.6761 13.712 13.2351 0 0 0 0 0 0 0 11.8991 12.6951 0 0 0 0 12.7704 0 0 0 0 0 0 14.3308 12.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60313 OPA1_HUMAN "Dynamin-like 120 kDa protein, mitochondrial, EC 3.6.5.5 (Optic atrophy protein 1) [Cleaved into: Dynamin-like 120 kDa protein, form S1 ]" OPA1 KIAA0567 Homo sapiens (Human) apoptotic process [GO:0006915]; axonal transport of mitochondrion [GO:0019896]; cellular senescence [GO:0090398]; GTP metabolic process [GO:0046039]; inner mitochondrial membrane organization [GO:0007007]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neural tube closure [GO:0001843]; protein complex oligomerization [GO:0051259]; visual perception [GO:0007601] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; axonal transport of mitochondrion [GO:0019896]; cellular senescence [GO:0090398]; GTP metabolic process [GO:0046039]; inner mitochondrial membrane organization [GO:0007007]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neural tube closure [GO:0001843]; protein complex oligomerization [GO:0051259]; visual perception [GO:0007601] GO:0000002; GO:0000266; GO:0000287; GO:0001843; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005758; GO:0005829; GO:0005874; GO:0006915; GO:0007005; GO:0007007; GO:0007601; GO:0008017; GO:0008053; GO:0016020; GO:0016021; GO:0019896; GO:0030061; GO:0030425; GO:0031966; GO:0043066; GO:0046039; GO:0051259; GO:0070300; GO:0090201; GO:0090398; GO:0097749; GO:1901612; GO:1902236; GO:1904115 cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300] EAVKEESIKR 0.99174 -50.357 0 0 0 0 0 10.3218 0 0 0 17.2644 0 0 14.9388 0 14.8998 0 0 0 0 0 0 0 14.3394 0 0 0 0 0 15.6312 16.394 0 0 14.797 14.1775 17.3977 14.9828 0 11.4177 0 13.9928 10.5671 17.5676 16.7656 0 0 0 0 0 0 0 0 0 0 0 0 10.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6721 13.7506 16.9976 0 0 0 12.9248 0 0 0 0 0 0 0 12.3102 14.4338 12.3591 0 0 12.825 0 0 0 0 0 0 0 0 0 0 13.1452 0 0 0 0 0 0 0 11.2035 0 0 0 0 12.4875 12.1695 0 11.6606 0 0 0 0 0 0 12.2405 21.5236 0 0 0 0 10.0662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6575 0 0 11.995 12.8523 12.6296 21.8028 15.5984 21.1762 19.6215 20.2697 14.4264 0 13.9872 12.2148 0 0 0 0 10.6367 0 0 0 0 O43405 COCH_HUMAN Cochlin (COCH-5B2) COCH COCH5B2 UNQ257/PRO294 Homo sapiens (Human) defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; collagen binding [GO:0005518]; defense response to bacterium [GO:0042742]; positive regulation of innate immune response [GO:0045089]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605] GO:0005518; GO:0005576; GO:0007605; GO:0008360; GO:0042742; GO:0045089; GO:0062023 collagen binding [GO:0005518] ENVLAVIR 0.99174 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6518 13.6777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75116 ROCK2_HUMAN "Rho-associated protein kinase 2, EC 2.7.11.1 (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II, ROCK-II) (p164 ROCK-2)" ROCK2 KIAA0619 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of protein metabolic process [GO:0051246]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939] GO:0000281; GO:0001837; GO:0001934; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007249; GO:0007266; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0018105; GO:0018107; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0035509; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0046872; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051246; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902961; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] ADHEADK 0.99174 -50.43 0 0 0 0 0 0 0 0 0 0 11.0133 0 0 14.1972 0 0 0 0 12.6945 0 12.4604 0 0 0 0 0 0 0 0 0 11.8275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9474 0 0 0 0 0 0 0 0 0 0 12.6054 12.6269 16.6691 0 15.4629 0 18.3502 14.9337 16.8722 0 0 0 12.7438 17.8843 17.6579 13.7457 17.5985 13.3125 0 13.7928 15.1138 13.1812 0 0 0 16.5399 12.9894 0 16.0596 15.6292 0 0 14.0763 15.1807 0 18.4505 18.5536 0 13.623 14.423 0 14.1961 13.269 0 17.9382 0 0 12.1057 17.6226 0 0 0 15.231 0 13.9936 0 18.1108 0 0 12.3106 0 0 18.4956 12.6841 14.5549 0 0 0 13.4528 0 13.0729 0 0 13.63 0 0 13.2233 13.3436 12.3066 12.4833 12.5687 0 10.7501 14.6579 13.3877 0 0 0 14.3409 0 0 0 0 17.8551 17.9394 13.4255 0 13.1576 12.5456 12.3881 11.4688 P10242 MYB_HUMAN Transcriptional activator Myb (Proto-oncogene c-Myb) MYB Homo sapiens (Human) "chromatin remodeling [GO:0006338]; erythrocyte differentiation [GO:0030218]; mitotic cell cycle [GO:0000278]; myeloid cell development [GO:0061515]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin remodeling [GO:0006338]; erythrocyte differentiation [GO:0030218]; mitotic cell cycle [GO:0000278]; myeloid cell development [GO:0061515]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006355; GO:0016363; GO:0030218; GO:0045624; GO:0045653; GO:0045892; GO:0045893; GO:0045944; GO:0051571; GO:0051574; GO:0061515; GO:0090575; GO:1901533; GO:1902895 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HALAAQEIKYGPLK 0.99174 -22.622 0 0 14.342 0 0 0 0 0 0 10.8384 11.1501 0 0 10.5295 10.9369 0 0 10.7796 0 0 0 0 0 0 0 0 0 0 0 0 11.2848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2518 0 0 0 0 0 0 0 0 0 0 0 13.8266 0 0 13.1381 0 0 0 14.1753 0 0 0 0 0 0 0 0 0 0 0 0 12.9784 0 0 13.7033 0 0 0 0 0 0 0 14.2597 13.5454 0 0 0 0 0 0 0 0 0 0 13.012 0 0 0 0 0 14.0679 0 0 0 0 12.9871 0 0 0 0 0 0 0 0 0 0 0 0 13.139 14.1018 14.2399 0 0 0 0 14.4614 14.3829 0 0 0 0 0 0 0 15.8272 12.8284 12.647 0 0 0 0 0 0 14.8032 0 P11498 PYC_HUMAN "Pyruvate carboxylase, mitochondrial, EC 6.4.1.1 (Pyruvic carboxylase, PCB)" PC Homo sapiens (Human) gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074] GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0006629; GO:0006734; GO:0006739; GO:0009374; GO:0010629; GO:0019074; GO:0019076; GO:0042802; GO:0044794; GO:0046872 ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736] ACTELGIR 0.99174 -22.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9205 0 0 11.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9029 13.0954 0 0 0 14.7357 0 0 0 0 13.9686 14.2594 0 0 0 0 0 11.2893 0 0 0 0 0 0 0 0 0 0 0 13.9221 0 13.9053 0 0 0 11.9731 0 0 0 0 11.4628 13.4101 0 0 0 0 0 12.4113 0 0 0 0 14.5023 13.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4351 0 0 0 0 0 0 0 10.9474 0 0 0 0 0 15.072 0 0 0 Q13794 APR_HUMAN "Phorbol-12-myristate-13-acetate-induced protein 1, PMA-induced protein 1 (Immediate-early-response protein APR) (Protein Noxa)" PMAIP1 NOXA Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; proteasomal protein catabolic process [GO:0010498]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; release of cytochrome c from mitochondria [GO:0001836]; response to dsRNA [GO:0043331]; T cell homeostasis [GO:0043029]" Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; proteasomal protein catabolic process [GO:0010498]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; release of cytochrome c from mitochondria [GO:0001836]; response to dsRNA [GO:0043331]; T cell homeostasis [GO:0043029]" GO:0001836; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0010498; GO:0010907; GO:0010917; GO:0042149; GO:0043029; GO:0043065; GO:0043280; GO:0043331; GO:0043517; GO:0046902; GO:0051607; GO:0071456; GO:0072332; GO:0072593; GO:0090200; GO:0097136; GO:0097193; GO:1902043; GO:1902237; GO:2001244 LNFRQKLLNLISK 0.99174 -4.6972 0 0 0 0 0 0 0 0 0 11.4499 0 0 12.138 12.9516 10.7066 0 0 0 0 0 0 0 0 0 0 0 11.9694 0 0 0 11.7381 0 0 10.7476 0 0 0 0 0 0 0 0 12.5778 0 0 12.5568 12.0024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9134 0 0 0 0 0 13.2358 12.7522 13.1254 13.0337 13.1931 12.6975 0 11.5952 12.7036 0 0 0 0 0 0 0 0 0 Q8NA19 LMBL4_HUMAN "Lethal(3)malignant brain tumor-like protein 4, H-l(3)mbt-like protein 4, L(3)mbt-like protein 4, L3mbt-like 4" L3MBTL4 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0006325; GO:0008270; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] AFLLLTQTDIVK 0.99174 -23.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.923 0 0 0 0 0 0 0 12.2891 0 0 0 0 0 0 14.2654 0 0 0 13.9794 0 0 0 0 0 0 12.9165 0 0 0 0 0 13.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2881 0 15.4323 0 0 0 0 0 0 0 0 11.9157 0 0 0 14.4429 0 12.7532 0 0 0 0 0 0 0 0 0 Q8NEK5 ZN548_HUMAN Zinc finger protein 548 ZNF548 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CSECGKSFRYHCR 0.99174 -18.876 0 14.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4328 0 13.9368 13.4832 13.5991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7346 0 0 0 0 13.1899 13.5023 0 13.4337 0 0 0 15.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92841 DDX17_HUMAN "Probable ATP-dependent RNA helicase DDX17, EC 3.6.4.13 (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)" DDX17 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; immune system process [GO:0002376]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]" cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]; alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; defense response to virus [GO:0051607]; epithelial to mesenchymal transition [GO:0001837]; gene silencing by RNA [GO:0031047]; immune system process [GO:0002376]; intracellular estrogen receptor signaling pathway [GO:0030520]; miRNA metabolic process [GO:0010586]; myoblast differentiation [GO:0045445]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]" GO:0000380; GO:0000381; GO:0001837; GO:0002376; GO:0003713; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0006364; GO:0006396; GO:0008186; GO:0010586; GO:0016020; GO:0016607; GO:0016887; GO:0030520; GO:0030521; GO:0031047; GO:0045445; GO:0045944; GO:0051607; GO:1990904; GO:2001014 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coactivator activity [GO:0003713]" CTYLVLDEADR 0.99174 -18.932 0 10.4988 0 0 0 0 0 0 0 15.2965 0 11.3544 0 0 0 0 0 0 0 12.0514 10.4408 0 13.1785 0 0 0 0 0 12.0609 0 0 0 0 0 14.6085 13.4366 0 13.9283 0 0 0 0 0 0 10.3805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3414 13.0886 0 13.7693 0 0 0 0 15.0541 13.2583 13.2261 13.628 14.824 0 0 0 14.3149 0 15.5797 13.8096 14.6469 0 0 13.8508 0 13.3309 12.8193 0 13.991 14.2729 12.9969 13.3375 13.6037 0 13.5382 0 0 0 13.5291 0 0 13.568 13.8236 0 0 13.1978 14.1235 0 0 0 14.4462 0 12.5912 0 0 0 0 0 0 0 13.3132 0 0 0 0 0 0 11.8283 13.3615 0 0 0 13.0095 0 0 0 13.2899 0 0 0 0 14.4985 0 0 14.7121 0 0 0 0 0 0 0 0 13.7987 0 0 0 12.4829 0 0 0 0 0 0 0 Q9Y6N7 ROBO1_HUMAN Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1) ROBO1 DUTT1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] GO:0002042; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005886; GO:0005887; GO:0006919; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035481; GO:0035904; GO:0042802; GO:0043406; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748 axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275] CEARGDPVPTVRWR 0.99174 -22.645 0 0 0 0 0 0 0 0 0 10.2269 0 0 0 0 0 0 0 11.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1017 0 0 0 0 0 0 0 0 0 0 12.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3245 0 0 0 0 0 0 0 0 0 12.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5601 0 0 0 13.5022 0 14.2421 0 0 0 0 0 12.4881 0 0 0 12.6305 0 13.5834 15.0171 14.2835 0 0 0 0 0 0 0 0 0 12.691 0 0 0 0 0 0 0 0 0 0 0 18.6996 0 0 0 0 0 0 0 0 14.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A096LP49 CC187_HUMAN Coiled-coil domain-containing protein 187 CCDC187 Homo sapiens (Human) microtubule anchoring [GO:0034453] centrosome [GO:0005813] centrosome [GO:0005813]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453] GO:0005813; GO:0008017; GO:0034453 microtubule binding [GO:0008017] ASHGQGR 0.99175 -22.766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.578 0 0 0 11.4792 0 12.6543 11.5933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7247 0 0 12.2245 12.8607 0 16.7774 0 0 0 0 16.337 0 15.4169 11.4292 13.586 0 0 13.1972 0 14.878 0 16.2686 0 0 0 0 0 0 0 0 0 0 0 0 13.2081 0 0 0 12.9418 0 15.2753 0 0 16.3324 0 0 17.5462 17.0586 0 12.3234 0 0 0 13.7049 0 11.893 0 0 0 0 0 12.4014 0 0 13.4103 0 10.3694 0 0 0 0 0 0 0 0 13.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9056 0 0 0 0 11.4493 0 0 0 13.1694 O75409 HYPM_HUMAN Huntingtin-interacting protein M (Histone H2A.P) (Huntingtin yeast partner M) H2AP CXorf27 HYPM Homo sapiens (Human) nucleosome [GO:0000786] nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GO:0000786; GO:0003677; GO:0030527; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] EREVDNNR 0.99175 -7.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7558 11.9621 0 0 0 0 0 0 0 0 0 11.0972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48380 RFX3_HUMAN Transcription factor RFX3 (Regulatory factor X 3) RFX3 Homo sapiens (Human) "cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; type B pancreatic cell maturation [GO:0072560]" chromatin [GO:0000785]; extracellular region [GO:0005576]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; extracellular region [GO:0005576]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type B pancreatic cell development [GO:2000078]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; type B pancreatic cell maturation [GO:0072560]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005576; GO:0005634; GO:0005667; GO:0006351; GO:0006355; GO:0006357; GO:0031018; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0050796; GO:0060271; GO:0060285; GO:0060287; GO:0072560; GO:1990837; GO:2000078 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" AARQFLLK 0.99175 -4.7266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4632 0 12.5037 0 0 0 0 0 0 0 11.7736 0 0 0 0 0 0 12.3123 12.9265 12.6973 12.7406 11.8649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8833 12.9924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48549 KCNJ3_HUMAN "G protein-activated inward rectifier potassium channel 1, GIRK-1 (Inward rectifier K(+) channel Kir3.1) (Potassium channel, inwardly rectifying subfamily J member 3)" KCNJ3 GIRK1 Homo sapiens (Human) membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; response to electrical stimulus [GO:0051602]; ventricular cardiac muscle cell membrane repolarization [GO:0099625] external side of plasma membrane [GO:0009897]; integral component of presynaptic membrane [GO:0099056]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076] external side of plasma membrane [GO:0009897]; integral component of presynaptic membrane [GO:0099056]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; response to electrical stimulus [GO:0051602]; ventricular cardiac muscle cell membrane repolarization [GO:0099625] GO:0005886; GO:0006813; GO:0008076; GO:0009897; GO:0015467; GO:0030315; GO:0034765; GO:0051602; GO:0086089; GO:0086091; GO:0098688; GO:0098914; GO:0099056; GO:0099625; GO:1902282; GO:1990573 G-protein activated inward rectifier potassium channel activity [GO:0015467]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282] ITGREDFPK 0.99175 -19.017 0 0 0 0 0 0 0 0 11.0595 0 0 0 0 0 11.6323 0 0 0 10.8323 0 0 0 0 0 0 0 13.105 0 0 0 0 0 0 0 12.377 0 0 0 0 0 0 0 12.9793 0 12.7573 0 0 12.2353 10.0633 0 0 0 0 0 12.9957 0 11.9957 0 14.1602 0 12.6832 0 0 10.743 10.7839 12.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8879 14.3149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5365 0 0 0 0 0 13.3946 0 0 0 0 0 0 0 0 0 0 0 0 10.8278 0 0 0 0 0 0 0 11.1575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2132 0 0 12.8678 12.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8474 0 0 13.0286 0 0 0 0 0 0 0 0 0 0 Q2YD98 UVSSA_HUMAN UV-stimulated scaffold protein A UVSSA KIAA1530 Homo sapiens (Human) protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283] chromosome [GO:0005694]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; RNA polymerase II complex binding [GO:0000993]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; transcription-coupled nucleotide-excision repair [GO:0006283] GO:0000993; GO:0005654; GO:0005694; GO:0006283; GO:0009411; GO:0016567 RNA polymerase II complex binding [GO:0000993] AELELVLRKYK 0.99175 -4.8694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7279 0 0 0 0 0 0 0 0 10.6909 0 0 0 0 11.7946 0 0 0 0 0 0 0 0 0 0 0 0 15.1885 0 0 0 0 0 0 0 0 0 0 0 11.6248 0 0 0 0 0 0 10.6852 0 0 0 0 0 0 0 0 11.5216 12.5524 0 0 0 0 0 0 0 0 0 10.9963 0 0 12.8463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3218 0 0 0 0 0 0 0 10.7131 0 0 0 0 0 0 0 0 0 0 11.1992 0 0 0 0 0 0 Q86YD5 LRAD3_HUMAN "Low-density lipoprotein receptor class A domain-containing protein 3, LDLR class A domain-containing protein 3" LDLRAD3 LRAD3 Homo sapiens (Human) receptor-mediated endocytosis [GO:0006898]; regulation of protein processing [GO:0070613] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; receptor-mediated endocytosis [GO:0006898]; regulation of protein processing [GO:0070613] GO:0001540; GO:0005886; GO:0006898; GO:0016021; GO:0070613 amyloid-beta binding [GO:0001540] CNGFEDCPDGSDEENCTANPLLCSTARYHCK 0.99175 -4.8726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6096 14.4917 0 0 0 0 0 0 0 0 14.3974 0 0 13.9106 0 0 0 0 14.9819 0 0 0 0 0 0 14.6685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6084 0 0 0 0 0 13.632 0 Q8N7A1 KLDC1_HUMAN Kelch domain-containing protein 1 KLHDC1 MSTP025 Homo sapiens (Human) protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; cytosol [GO:0005829] Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0005737; GO:0005829; GO:0016567; GO:0031466; GO:0140627; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] GGVPPQPR 0.99175 -4.8615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4264 13.6241 0 0 0 0 0 0 0 0 0 0 0 0 13.1398 0 0 0 13.6371 13.5969 0 0 13.4584 13.1806 0 0 0 0 0 13.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0259 0 0 0 15.3839 15.0331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6004 0 0 0 0 0 0 0 0 0 12.7739 0 0 0 0 0 0 0 0 0 0 0 15.2999 0 0 0 15.2291 14.6084 0 0 0 0 14.4453 15.029 13.9274 0 0 0 0 0 0 0 0 13.8983 13.6376 0 13.979 13.6806 14.9983 14.4358 14.2547 13.7719 0 14.1472 13.6858 13.8566 0 0 0 0 0 14.8769 0 0 0 0 0 Q8NET6 CHSTD_HUMAN "Carbohydrate sulfotransferase 13, EC 2.8.2.5 (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3, C4ST-3, C4ST3)" CHST13 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; proteoglycan biosynthetic process [GO:0030166] GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0030206; GO:0047756 chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] EEPFNEHWER 0.99175 -4.5666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0402 0 0 0 12.8314 0 0 12.0126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1188 0 0 11.8922 0 0 10.8409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.193 0 0 0 10.1944 0 10.9461 15.5419 14.6934 0 12.3893 13.6254 12.5218 0 0 0 0 0 0 13.3285 0 0 0 14.0604 0 0 0 0 0 0 0 0 0 0 0 13.8144 0 0 11.7173 0 0 13.4592 0 0 0 13.3226 0 0 0 0 11.9568 0 12.1411 12.1395 12.7364 0 10.7797 0 0 0 0 12.8299 0 13.8442 0 0 0 10.5674 12.4727 0 0 0 0 0 0 0 0 0 0 11.4069 0 0 0 0 0 12.6485 0 0 13.2379 0 13.6147 13.0467 13.0463 12.5514 0 13.9186 0 0 0 0 0 13.6167 0 0 0 0 Q8NH19 O10AG_HUMAN Olfactory receptor 10AG1 (Olfactory receptor OR11-160) OR10AG1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KLLAKLLT 0.99175 -6.0433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3277 0 0 0 0 0 0 0 15.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4242 0 0 15.0793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2806 0 0 0 0 0 0 0 0 13.2089 0 Q8WU66 TSEAR_HUMAN "Thrombospondin-type laminin G domain and EAR repeat-containing protein, TSP-EAR" TSPEAR C21orf29 Homo sapiens (Human) hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; extracellular region [GO:0005576]; stereocilium [GO:0032420]; hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505] GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170 GLQLSVAAPRTMSFPASR 0.99175 -4.7212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7215 0 14.7972 0 0 0 11.026 0 0 0 0 13.4192 0 0 0 14.5884 0 12.9995 14.9716 0 0 0 0 13.5407 0 0 0 14.7954 0 13.2187 12.6986 0 0 0 0 0 13.2618 12.2481 0 0 0 0 0 13.9377 0 13.4196 0 0 0 0 13.1251 0 13.0362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2192 0 0 0 0 0 0 0 13.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.829 0 Q96T60 PNKP_HUMAN "Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase, EC 3.1.3.32 (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase, EC 2.7.1.78 ]" PNKP Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair, DNA damage removal [GO:0000718]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]" membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; base-excision repair, gap-filling [GO:0006287]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair, DNA damage removal [GO:0000718]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]" GO:0000718; GO:0003684; GO:0003690; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006261; GO:0006281; GO:0006287; GO:0006303; GO:0006979; GO:0009314; GO:0010836; GO:0016020; GO:0017076; GO:0032212; GO:0035861; GO:0046403; GO:0046404; GO:0046939; GO:0051103; GO:0051973; GO:1904355; GO:2001034 ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076] ARYVQCAR 0.99175 -18.964 0 0 0 0 10.2444 0 0 0 14.3452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7734 0 0 0 0 0 14.2804 10.541 11.4496 0 0 0 0 0 0 0 0 13.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.073 0 0 0 0 12.65 0 0 0 0 12.4352 12.7017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3372 0 0 0 0 0 0 0 0 0 0 0 0 12.6121 0 0 0 12.0858 0 0 0 0 0 0 0 0 11.6972 11.022 0 0 16.3888 12.8788 0 0 0 0 0 0 0 0 0 11.6443 0 0 0 0 0 0 0 0 0 12.1174 16.1534 0 0 0 0 0 0 0 0 0 0 Q9NUL3 STAU2_HUMAN Double-stranded RNA-binding protein Staufen homolog 2 STAU2 Homo sapiens (Human) anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; eye morphogenesis [GO:0048592]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; kinesin binding [GO:0019894]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; eye morphogenesis [GO:0048592]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489]; regulation of gene expression [GO:0010468] GO:0003723; GO:0003725; GO:0003729; GO:0005730; GO:0005783; GO:0005874; GO:0005886; GO:0007281; GO:0008298; GO:0010468; GO:0010494; GO:0016020; GO:0019894; GO:0030424; GO:0030544; GO:0031965; GO:0032839; GO:0032956; GO:0034599; GO:0035418; GO:0043005; GO:0043022; GO:0043025; GO:0043198; GO:0048592; GO:0051019; GO:0051489; GO:0051965; GO:0061003; GO:0098964; GO:1900454; GO:1990124 double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; kinesin binding [GO:0019894]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] AATTVLQELKKLPPLPVVEK 0.99175 -4.7251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0855 0 0 0 14.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60673 REV3L_HUMAN "DNA polymerase zeta catalytic subunit, EC 2.7.7.7 (Protein reversionless 3-like, REV3-like, hREV3)" REV3L POLZ REV3 Homo sapiens (Human) DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-prone translesion synthesis [GO:0042276]" GO:0000166; GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005730; GO:0006261; GO:0016035; GO:0042276; GO:0046872; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]" AAALSIDLCRMISRVPDDK 0.99176 -54.672 0 0 0 12.0746 0 0 0 0 11.3089 13.8166 13.637 0 0 12.8907 0 0 0 0 0 0 0 0 13.6739 12.9969 11.6892 0 9.58639 13.2136 12.4437 12.4603 14.0496 0 0 0 12.041 14.5389 11.4131 12.1082 11.518 0 0 0 13.1473 0 0 0 0 13.9481 11.3658 11.328 13.8075 0 11.43 0 0 12.8914 0 0 0 0 0 0 0 0 0 0 11.3348 13.0175 11.0727 0 0 13.2922 0 9.85557 0 0 0 0 0 11.8159 15.2461 14.4714 17.5114 0 11.813 12.9295 0 0 12.819 0 12.9766 11.2407 0 18.006 15.1138 0 17.7029 16.3248 16.6949 13.7723 0 0 0 0 12.611 15.9386 0 12.6177 13.624 13.7527 14.4169 13.0255 0 12.5258 19.0345 12.2638 13.8816 14.6667 11.4087 0 14.8212 15.8247 12.0411 15.9805 15.9892 17.954 0 15.1846 18.2577 16.9587 14.5339 17.2006 0 0 14.0712 14.9494 15.0229 17.5165 18.0296 15.8316 13.8184 12.1206 13.3202 0 0 13.0216 14.4437 0 12.708 0 16.3171 14.4338 16.397 14.9299 0 14.9436 13.9204 14.0424 0 14.4514 13.0007 13.5066 14.7757 0 12.4901 13.1949 11.4933 0 0 12.3029 14.4623 12.9568 13.7697 12.7258 0 0 0 13.6385 0 0 P31930 QCR1_HUMAN "Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)" UQCRC1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; response to activity [GO:0014823]; response to alkaloid [GO:0043279]" mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; ubiquitin protein ligase binding [GO:0031625]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; response to activity [GO:0014823]; response to alkaloid [GO:0043279]" GO:0005739; GO:0005743; GO:0005746; GO:0005750; GO:0006119; GO:0006122; GO:0008121; GO:0009060; GO:0014823; GO:0031625; GO:0043279; GO:0044877; GO:0045333; GO:0046872 metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; ubiquitin protein ligase binding [GO:0031625] ALSKDLPK 0.99176 -18.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5646 0 14.4533 0 16.4138 16.7914 15.8377 13.3181 14.6547 15.6168 14.9664 13.6703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2176 0 0 14.0115 0 0 0 0 0 0 0 0 14.143 14.4952 12.9454 0 0 P32780 TF2H1_HUMAN "General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit, BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit)" GTF2H1 BTF2 Homo sapiens (Human) "DNA repair [GO:0006281]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]" nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] "nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966]; DNA repair [GO:0006281]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]" GO:0000079; GO:0000439; GO:0003682; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0009755; GO:0045893; GO:0046966; GO:0070816 chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966] DAVKDLLQQLLPKFK 0.99176 -4.7358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5664 0 0 12.3818 0 0 0 0 10.7923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6619 0 0 0 0 0 0 12.3685 0 12.9014 0 0 0 0 0 0 11.227 0 0 0 11.1716 0 0 0 0 0 0 0 0 0 P59074 CHM4P_HUMAN Putative charged multivesicular body protein 4B-like protein CHMP4BP1 (Charged multivesicular body protein 4B pseudogene 1) CHMP4BP1 CGI-301 Homo sapiens (Human) autophagosome maturation [GO:0097352]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; cytoplasmic side of plasma membrane [GO:0009898]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643] amphisome membrane [GO:1904930]; cytoplasmic side of plasma membrane [GO:0009898]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; autophagosome maturation [GO:0097352]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; plasma membrane repair [GO:0001778]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0006900; GO:0007080; GO:0009898; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0039702; GO:0043162; GO:0046761; GO:0060548; GO:0061952; GO:0097352; GO:1901673; GO:1902774; GO:1904930 NKPAALQALKR 0.99176 -4.7344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5378 0 12.4923 13.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1683 0 0 0 0 14.089 0 Q86UR5 RIMS1_HUMAN "Regulating synaptic membrane exocytosis protein 1 (Rab-3-interacting molecule 1, RIM 1) (Rab-3-interacting protein 2)" RIMS1 KIAA0340 RAB3IP2 RIM1 Nbla00761 Homo sapiens (Human) acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic plasticity [GO:0048167]; response to stimulus [GO:0050896]; secretion [GO:0046903]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; GTPase regulator activity [GO:0030695]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; acrosomal vesicle exocytosis [GO:0060478]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; protein-containing complex assembly [GO:0065003]; regulated exocytosis [GO:0045055]; regulation of membrane potential [GO:0042391]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic plasticity [GO:0048167]; response to stimulus [GO:0050896]; secretion [GO:0046903]; synaptic vesicle exocytosis [GO:0016079]; visual perception [GO:0007601] GO:0003723; GO:0005829; GO:0005886; GO:0006886; GO:0007601; GO:0010628; GO:0016079; GO:0017156; GO:0030154; GO:0030695; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0045055; GO:0046872; GO:0046903; GO:0046928; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0050896; GO:0060478; GO:0061025; GO:0065003; GO:0070161; GO:0097151; GO:1903861; GO:2000463 GTPase regulator activity [GO:0030695]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] AQEPLRK 0.99176 -54.743 0 0 0 11.3458 0 0 0 0 12.4051 0 0 15.4936 0 0 0 13.5 12.2457 0 0 0 0 0 0 0 0 13.4221 13.2972 12.0858 13.2925 0 12.9262 13.0933 12.9299 12.7236 0 0 0 0 0 0 12.4572 13.1348 13.4922 13.2656 0 0 0 13.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.582 0 0 0 0 0 13.8473 14.0831 0 0 12.4069 12.2041 0 11.6719 0 0 14.0032 17.6767 0 12.4798 0 0 13.1463 13.2994 16.6799 0 13.1955 15.4984 17.8625 0 0 0 0 0 0 0 0 0 0 0 0 14.6011 0 0 12.8582 0 0 14.1619 0 11.0195 0 0 0 0 11.3373 0 12.1348 0 13.101 0 13.3981 0 0 0 0 10.8173 0 0 0 0 15.8697 0 0 0 0 14.1691 14.9317 12.8415 0 12.6801 0 0 0 0 15.7626 0 14.6575 15.5914 0 14.029 0 12.0042 0 15.2274 15.1786 14.3942 0 16.0336 15.3158 14.931 15.0617 15.692 0 14.1755 14.1189 14.1556 14.7043 0 14.9544 0 14.6463 0 14.9444 0 0 Q8IY33 MILK2_HUMAN "MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2, MICAL-L2)" MICALL2 JRAB Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0001725; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0031532; GO:0032456; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:1903955 actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] ALQQWCR 0.99176 -55.21 13.6846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6053 0 0 0 0 0 0 15.4993 0 0 0 0 0 0 0 0 0 14.1059 0 0 0 0 12.0756 0 0 0 14.4286 14.3337 0 11.9108 0 0 14.6225 0 0 0 13.3119 0 0 0 14.6333 0 0 14.1874 14.2807 0 0 0 14.6007 0 14.174 0 13.0041 13.054 0 0 12.583 0 0 0 0 0 0 0 0 14.437 0 0 13.348 0 0 13.5804 0 0 0 0 0 0 0 0 0 0 11.2453 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3722 12.8238 0 0 0 13.1075 Q8N475 FSTL5_HUMAN Follistatin-related protein 5 (Follistatin-like protein 5) FSTL5 KIAA1263 Homo sapiens (Human) cell differentiation [GO:0030154] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154] GO:0005509; GO:0005576; GO:0030154 calcium ion binding [GO:0005509] AEEWPWNR 0.99176 -18.621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.29 0 0 0 11.0855 0 0 0 14.3906 0 0 13.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1004 0 0 0 0 0 0 0 0 0 12.6774 13.2361 0 0 0 0 12.1126 12.1897 16.5848 12.5089 12.6376 0 0 0 13.6535 0 0 0 0 0 0 0 0 0 0 0 14.3763 0 0 0 0 0 0 0 0 10.764 0 0 0 0 0 0 0 11.0974 0 0 14.5147 0 0 0 0 0 0 0 0 0 0 0 13.3573 0 0 14.5673 0 0 14.3713 0 0 0 0 0 0 0 0 14.0792 0 0 0 0 0 0 0 0 0 0 0 15.5739 0 0 0 0 0 11.0821 0 0 0 12.2268 0 0 0 0 0 0 12.9923 13.01 0 0 13.0481 12.745 0 0 0 0 0 0 12.8581 0 0 0 0 0 0 13.7696 0 0 0 0 Q99805 TM9S2_HUMAN Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908] cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] cytoskeleton [GO:0005856]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908] GO:0005768; GO:0005794; GO:0005856; GO:0005887; GO:0006672; GO:0006688; GO:0010008; GO:0010908; GO:0016020; GO:0070062; GO:0072657 FCNPGFPIGCYITDK 0.99176 -4.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8283 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1028 0 13.6017 0 0 0 0 0 0 11.3355 0 13.7204 0 13.6539 13.0013 13.9479 0 0 0 0 13.6891 15.6774 15.3074 15.1119 14.7075 0 13.5817 0 0 0 0 0 0 15.6637 12.572 13.2182 13.3801 0 12.276 0 14.5707 0 0 13.0272 12.5757 0 14.02 0 13.3799 0 11.7607 0 12.8543 0 0 13.7096 0 12.1975 0 0 12.6511 0 10.9927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1549 13.9031 14.4678 11.8686 0 0 0 0 0 12.0732 0 Q9UFN0 NPS3A_HUMAN "Protein NipSnap homolog 3A, NipSnap3A (Protein NipSnap homolog 4, NipSnap4) (Target for Salmonella secreted protein C, TassC)" NIPSNAP3A NIPSNAP4 HSPC299 Homo sapiens (Human) cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] GO:0005634; GO:0005739; GO:0005829 LVLRSALTRALASR 0.99176 -4.5884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2529 0 0 0 0 0 0 0 0 0 0 13.6564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0473 0 15.5335 0 0 0 0 0 0 0 15.9911 0 13.407 0 0 0 0 0 0 16.0011 0 0 0 0 0 13.2979 0 15.2089 0 0 14.8681 0 0 0 0 0 0 0 0 0 0 11.947 11.8366 0 0 0 0 0 0 15.5212 0 0 11.3311 0 0 14.7111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.078 0 0 0 0 12.5112 16.1309 0 0 15.9441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0015 0 0 0 0 14.6957 0 0 0 0 0 Q99715 COCA1_HUMAN Collagen alpha-1(XII) chain COL12A1 COL12A1L Homo sapiens (Human) cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561] collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987] GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0035987; GO:0062023; GO:0070062; GO:1903561 extracellular matrix structural constituent conferring tensile strength [GO:0030020] AFLEVLVK 0.99177 -48.184 0 0 9.94604 0 0 0 0 0 0 0 0 0 0 0 0 12.7657 0 0 10.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2113 10.4324 0 0 0 0 10.9321 0 0 0 0 0 0 12.3022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1576 15.7635 15.6914 14.4003 15.6933 17.9612 0 14.2354 0 14.4824 15.569 14.5398 15.6449 0 14.8059 15.4266 15.3384 0 17.5993 0 0 14.7393 13.3115 15.1825 14.7329 13.9442 14.5608 14.7894 13.1665 15.2513 0 0 0 0 14.6369 15.3147 14.3325 12.5433 12.8566 0 14.9627 0 14.379 13.5825 0 13.4078 14.5083 14.6398 0 0 14.8249 15.1592 0 0 0 0 0 13.4659 15.1468 0 15.1524 13.4097 0 14.3113 13.389 13.8028 0 13.2953 0 0 12.8088 10.895 15.7556 11.7118 0 13.5715 13.9686 14.7205 13.1157 0 11.6255 0 0 0 0 0 0 15.0405 0 0 0 14.5625 10.2219 0 0 0 0 12.025 0 12.575 0 14.5515 0 0 0 0 10.9021 10.4888 0 13.2707 0 12.926 13.5674 0 O00555 CAC1A_HUMAN "Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I, BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)" CACNA1A CACH4 CACN3 CACNL1A4 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell death [GO:0008219]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] cell projection [GO:0042995]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] cell projection [GO:0042995]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell death [GO:0008219]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] GO:0001540; GO:0005245; GO:0005634; GO:0005737; GO:0005886; GO:0005891; GO:0007204; GO:0007268; GO:0008219; GO:0008331; GO:0016021; GO:0019905; GO:0034765; GO:0042995; GO:0043025; GO:0045202; GO:0046872; GO:0050804; GO:0070588; GO:0098703; GO:1904645; GO:1904646 amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245] AARLIKLLR 0.99177 -48.16 0 13.4105 0 0 0 0 10.1092 0 0 14.0254 13.8897 14.497 14.9588 13.8367 12.9838 0 11.9873 9.32017 0 0 0 15.1863 13.2851 0 0 13.4253 0 13.4807 0 13.44 13.7294 0 0 15.3384 13.8266 0 13.7342 13.2737 0 13.3547 12.4709 0 0 12.4798 13.4934 9.7608 0 0 0 0 0 11.7375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9561 0 0 0 14.0831 13.972 0 15.3103 12.9554 12.4979 0 12.5205 0 14.1927 0 15.3787 0 0 13.8227 17.323 13.0468 13.1555 0 14.1648 0 12.8508 0 15.0728 14.773 13.2298 14.6675 16.8154 14.3325 0 12.3992 12.0689 0 13.226 12.5293 0 15.2816 14.1549 12.2239 0 11.0015 14.613 13.4764 0 14.6108 0 13.0173 14.2209 14.6257 14.7691 11.4531 13.2999 13.5891 24.059 15.4958 12.2007 12.8276 0 14.8722 11.8486 11.3728 13.0931 0 15.2951 0 12.0835 14.9527 14.1785 15.4794 0 0 0 13.0843 14.374 14.0229 11.0402 0 0 12.8494 0 0 0 14.3893 0 13.3733 14.8779 14.0444 14.593 0 11.4368 11.9204 14.0738 14.4048 0 0 14.3332 0 11.7502 0 14.5072 0 13.7368 16.4069 0 0 16.4027 14.8485 15.6866 0 P06733 ENOA_HUMAN "Alpha-enolase, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase, NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)" ENO1 ENO1L1 MBPB1 MPB1 Homo sapiens (Human) "canonical glycolysis [GO:0061621]; glycolytic process [GO:0006096]; negative regulation of cell growth [GO:0030308]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; response to virus [GO:0009615]" cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886] "cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; canonical glycolysis [GO:0061621]; glycolytic process [GO:0006096]; negative regulation of cell growth [GO:0030308]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; response to virus [GO:0009615]" GO:0000015; GO:0000122; GO:0000287; GO:0000977; GO:0001222; GO:0001227; GO:0003714; GO:0003723; GO:0004634; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006096; GO:0009615; GO:0009986; GO:0010756; GO:0016020; GO:0030308; GO:0031430; GO:0042803; GO:0045296; GO:0045892; GO:0045933; GO:0051020; GO:0061621; GO:0070062; GO:1903298; GO:2001171 "cadherin binding [GO:0045296]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]" AVEHINKTIAPALVSKK 0.99177 -7.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7214 0 0 0 0 0 0 12.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5146 P29074 PTN4_HUMAN "Tyrosine-protein phosphatase non-receptor type 4, EC 3.1.3.48 (Protein-tyrosine phosphatase MEG1, MEG, PTPase-MEG1)" PTPN4 Homo sapiens (Human) peptidyl-tyrosine phosphorylation [GO:0018108]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0018108; GO:0035254 cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] EKANKDR 0.99177 -23.796 0 0 0 0 0 0 0 0 14.694 13.0355 0 15.047 14.7738 0 14.99 12.4699 0 0 12.8749 13.5206 0 0 0 0 12.9397 13.6116 11.9751 12.4655 11.9021 13.0328 11.8462 0 12.0344 0 0 11.8005 14.5889 14.8627 0 0 14.6606 0 0 0 13.7942 12.1549 14.1803 0 14.6026 12.87 14.9401 0 0 0 0 11.1619 16.3914 0 11.694 0 0 14.6494 0 14.915 14.7343 0 11.6962 11.8471 0 0 15.3014 15.2192 0 0 12.5178 0 0 0 0 13.2688 0 0 13.0109 0 0 0 0 0 0 0 0 0 0 11.8563 0 0 16.9413 0 16.9973 0 0 0 11.8594 0 0 14.6303 0 11.9539 15.2733 11.295 13.5309 15.0338 0 16.0763 0 0 18.4611 14.1709 13.611 0 13.3533 0 0 0 0 0 14.0433 0 0 15.506 15.0195 16.4063 0 0 0 0 0 0 0 13.7324 15.1154 12.7319 0 0 0 0 0 14.4215 0 0 15.6771 15.5826 0 0 0 13.352 13.352 13.7639 13.9633 13.4164 14.325 13.7586 14.8353 14.8478 13.4803 0 13.9644 13.6907 13.6636 13.3311 13.4413 13.3404 0 14.3159 14.6808 16.4891 0 14.3694 0 0 P29374 ARI4A_HUMAN "AT-rich interactive domain-containing protein 4A, ARID domain-containing protein 4A (Retinoblastoma-binding protein 1, RBBP-1)" ARID4A RBBP1 RBP1 Homo sapiens (Human) "erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; erythrocyte development [GO:0048821]; establishment of Sertoli cell barrier [GO:0097368]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000976; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006349; GO:0006357; GO:0006366; GO:0007283; GO:0016580; GO:0017053; GO:0030336; GO:0030512; GO:0034773; GO:0036124; GO:0045892; GO:0045944; GO:0048821; GO:0080182; GO:0097368; GO:1902455; GO:1902459 DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976] DNDTENK 0.99177 -86.675 0 0 0 0 0 0 0 0 12.174 14.1179 15.5948 12.4502 0 12.6164 14.586 12.5612 14.3285 13.6103 14.3169 13.1753 13.7096 0 14.1683 0 14.6929 12.9992 14.9055 15.7393 13.0551 15.6164 14.9068 14.8792 14.925 13.3436 13.6253 12.6521 12.7339 12.8685 12.1963 14.8441 15.1343 15.2074 14.6243 0 13.9046 14.5867 13.2421 12.8247 13.6146 13.8495 14.2371 0 13.0528 14.7753 12.9998 13.3946 12.1057 13.6872 11.9375 12.85 0 0 11.5745 11.7393 0 11.6847 11.796 10.3088 0 12.5717 0 13.9163 0 14.1515 14.514 12.4591 11.5157 0 13.1995 12.8635 14.125 11.3154 12.6986 0 0 0 13.4684 13.7224 13.0918 12.6151 15.5955 0 0 14.7331 13.9897 14.6561 0 0 14.1711 0 14.1563 13.9304 13.6098 13.5727 13.3529 11.881 13.5827 12.0051 13.9126 13.602 13.0005 14.9306 13.4037 15.2854 13.4346 13.4236 14.6937 10.9555 13.0356 14.3237 13.7159 14.8129 14.8897 0 13.1476 14.1949 13.2686 0 0 0 0 13.1309 0 14.7237 0 13.8195 14.3346 13.7544 0 12.6474 14.5901 13.3146 13.2519 14.0179 13.2718 13.4747 13.2524 13.8612 0 12.8911 13.4171 0 13.6372 0 12.9725 0 12.0727 16.1189 16.1539 13.1381 15.2727 11.0778 17.015 15.2859 13.6497 16.9686 15.5584 17.1221 0 14.4015 13.227 14.0439 15.6308 12.7832 13.2932 16.4535 13.2815 13.7097 11.9377 0 Q14204 DYHC1_HUMAN "Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)" DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 Homo sapiens (Human) cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874] axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063] GO:0000278; GO:0003723; GO:0005524; GO:0005576; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005881; GO:0005938; GO:0007018; GO:0007052; GO:0007097; GO:0008090; GO:0008569; GO:0016020; GO:0030175; GO:0030286; GO:0031122; GO:0032388; GO:0033962; GO:0034063; GO:0035578; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0070062; GO:0072382; GO:0090235; GO:0120162; GO:1904115; GO:1905832 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723] AATSPALFNR 0.99177 -96.748 0 0 0 0 0 0 0 14.967 0 12.0112 12.9328 12.4405 12.9158 11.159 11.8453 0 0 0 12.6889 0 0 0 0 11.3329 11.1381 0 12.54 12.0644 12.3572 12.7977 12.8145 14.749 0 15.7489 0 12.3792 0 0 0 0 14.6542 12.8697 11.7902 13.5907 0 13.0833 11.8077 12.3429 11.5307 0 14.2295 0 11.7837 10.3272 10.483 13.0897 11.4059 0 0 0 0 0 0 0 0 0 15.2198 10.8919 0 12.7865 13.5848 14.0928 12.9659 13.4433 14.0907 11.1534 0 13.5811 0 0 14.2404 0 13.8051 14.8344 17.0446 14.4248 14.8417 12.2863 12.4401 13.5317 12.8089 15.5553 14.0946 13.5504 15.0549 15.1975 14.9274 11.6462 17.6686 13.9079 15.0421 12.8858 12.9225 0 13.4704 15.766 15.8672 14.2835 0 15.7554 12.4993 0 0 12.9375 15.2899 13.4795 13.6217 16.0072 13.6481 17.3549 0 13.4079 16.0303 13.7744 14.8668 0 15.2208 14.2755 13.7484 14.817 0 14.5837 14.3281 11.9337 0 11.793 15.7534 14.1953 13.6195 0 0 14.0542 0 14.8526 16.8317 0 16.5386 14.6087 0 14.2872 14.1497 14.4278 13.6003 13.5098 14.7114 15.0807 17.187 0 11.4233 0 15.2785 0 17.7951 13.0436 0 14.359 13.4168 14.9661 13.2074 14.6074 0 12.2881 13.446 16.4451 13.6858 14.0872 13.2979 16.0404 12.0562 16.3771 Q7Z602 GP141_HUMAN Probable G-protein coupled receptor 141 (G-protein coupled receptor PGR13) GPR141 PGR13 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930] ELAYTYVKIINYMIVIFVIAVAVILLVFQVFIIMLMVQK 0.99177 -5.9515 0 0 0 0 0 0 0 0 0 0 0 0 13.2807 13.0787 12.49 0 0 0 0 0 0 0 0 11.1569 0 0 0 0 0 0 0 0 0 0 0 0 12.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3212 14.0306 0 0 0 0 14.3933 0 0 0 0 0 0 16.051 0 0 0 0 12.3166 0 0 0 0 11.4394 13.4512 0 0 0 0 12.7189 12.3645 0 0 0 0 0 0 0 0 12.8242 0 0 0 0 0 0 0 0 0 0 0 11.9872 0 12.8267 0 0 0 11.1035 12.0833 0 0 0 0 12.8704 12.108 0 0 0 0 0 0 0 0 0 12.136 0 0 0 0 0 0 0 11.7859 0 0 0 0 0 0 0 0 10.9801 0 0 0 0 Q9Y4I1 MYO5A_HUMAN "Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)" MYO5A MYH12 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; melanosome transport [GO:0032402]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192] GO:0000146; GO:0001726; GO:0003723; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006892; GO:0007015; GO:0015031; GO:0015629; GO:0016020; GO:0016192; GO:0016459; GO:0030048; GO:0030050; GO:0030426; GO:0031267; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0042470; GO:0043005; GO:0051015; GO:0070062; GO:0072659 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] AVIIQKRVR 0.99177 -87.057 11.1887 0 0 0 0 0 11.5105 0 0 14.7018 9.77849 0 13.1349 12.582 13.4493 11.6197 11.627 0 11.7016 12.5253 12.5217 13.2118 0 13.0796 0 12.4099 0 13.7692 11.7602 0 0 11.3681 10.0518 0 0 0 0 0 0 0 12.5662 0 11.5351 0 10.0756 0 10.2896 0 11.2531 0 12.6471 0 0 0 14.3563 14.3731 0 0 16.6661 0 0 13.6072 0 10.5848 0 0 12.4947 10.099 0 0 0 0 0 0 10.7707 13.6279 11.8009 0 10.2531 0 13.0631 13.8714 15.964 14.8604 16.374 15.7004 13.4534 13.6703 13.3455 13.1671 13.7973 15.1138 13.6924 0 0 0 0 0 16.0188 0 0 16.2944 15.4682 0 17.3878 0 0 17.2352 17.6161 17.2874 17.0972 0 10.3016 14.1274 14.9029 14.441 15.8126 13.4333 16.4373 16.4053 0 10.5467 14.4599 15.8723 15.8572 15.7609 0 0 0 13.703 9.35544 0 0 0 0 14.178 10.7585 15.2469 16.9305 13.3759 12.1847 15.2157 14.9349 15.4124 12.6343 0 15.441 12.9439 14.0934 0 13.7178 14.6382 10.7405 0 13.1075 11.4072 0 0 0 13.3082 13.3361 0 0 0 11.6447 13.9915 0 0 0 0 0 13.9577 14.4293 0 14.2314 13.9614 0 0 15.6716 0 Q8WZ42 TITIN_HUMAN "Titin, EC 2.7.11.1 (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)" TTN Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018] condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941] GO:0000794; GO:0002020; GO:0003300; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019899; GO:0019901; GO:0030018; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042805; GO:0043621; GO:0045214; GO:0045859; GO:0048769; GO:0050714; GO:0050790; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733 actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433] AAAHLTVIEKLRIVVPLK 0.99178 NaN 14.31 13.6229 17.5066 16.663 20.3793 15.7309 18.8397 16.3971 16.3319 16.6968 16.1333 16.1052 16.998 17.158 18.6148 20.9126 21.2923 21.5571 22.2634 22.3546 22.3092 17.0135 20.8707 15.6985 21.202 21.4249 20.1664 15.807 17.5745 17.1493 17.2402 16.9878 17.5857 16.044 15.6309 16.7694 17.1753 19.7272 17.3814 16.5903 16.1621 17.2153 16.9794 17.0299 16.992 19.3435 16.3969 17.0471 16.3942 17.2335 15.3298 16.5211 14.5585 16.4501 16.4789 16.8517 13.235 14.0826 15.0638 14.7642 0 14.7468 15.2134 13.9611 15.0036 15.1607 23.134 18.2314 17.6251 17.7849 21.1868 21.4986 19.7996 23.1584 23.1495 19.9405 20.1846 20.4203 19.9603 24.9849 19.145 25.0256 24.1565 24.0914 24.1496 23.9311 23.941 20.7309 21.8954 23.9045 20.5207 21.508 20.6788 23.634 20.9426 20.909 21.1088 24.2768 23.897 22.0796 23.8298 21.6909 24.0828 21.3996 23.8411 21.2548 23.6054 21.5884 23.8994 23.8923 23.6733 21.5985 20.4925 23.8322 23.6434 23.7385 24.0717 21.4528 24.1739 24.2379 24.3962 21.721 19.2815 21.3389 23.6678 21.0965 21.8393 20.989 23.2611 24.4391 21.2427 23.9245 24.2536 23.9648 22.476 21.48 21.1742 23.3892 24.4897 24.4255 24.4685 23.3281 21.2736 23.8877 21.2942 23.6169 23.7222 20.8274 20.4908 20.4614 21.0998 23.8474 23.6765 20.799 21.3923 24.3892 19.2282 16.6056 17.777 17.232 17.4227 17.5976 17.912 17.5113 17.3091 18.3623 17.9204 18.3726 17.1115 17.4429 17.8897 19.2326 21.1645 20.9998 21.8889 18.3886 20.7087 16.8432 23.6366 16.553 Q68E01 INT3_HUMAN "Integrator complex subunit 3, Int3 (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A, SOSS-A, Sensor of ssDNA subunit A)" INTS3 C1orf193 C1orf60 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180] GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0010212; GO:0016180; GO:0032039; GO:0034243; GO:0035861; GO:0044818; GO:0070876 DESCYDNAEAAFSDDEEDLNSK 0.99178 -24.739 0 0 0 0 0 0 0 9.35107 0 0 12.6336 0 0 0 0 10.3437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3234 0 0 0 0 0 0 0 0 0 0 13.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1044 13.9538 0 12.7354 0 0 0 14.617 14.6053 14.3602 0 13.7744 0 13.7309 14.4238 14.7118 13.7095 15.6082 15.1488 17.5914 15.2736 0 17.0651 0 14.5487 0 0 14.0915 13.6681 14.4333 11.4685 0 0 0 11.3648 0 13.2962 0 0 16.3621 0 11.9588 0 0 0 14.8109 0 14.0712 0 13.2608 13.8146 13.8463 12.9433 15.0444 0 0 0 13.9667 0 12.8727 0 0 14.5812 13.7471 0 13.4485 0 14.5947 0 15.7215 0 0 0 0 0 0 0 0 0 0 13.1018 15.1919 15.0785 0 12.0245 0 0 0 12.7605 0 11.7263 0 0 0 13.5445 0 11.8529 0 0 13.8701 0 0 0 0 0 14.4638 13.3292 Q8IZT6 ASPM_HUMAN "Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog, Asp homolog)" ASPM MCPH5 Homo sapiens (Human) asymmetric cell division [GO:0008356]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634] apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; asymmetric cell division [GO:0008356]; cerebral cortex development [GO:0021987]; developmental growth [GO:0048589]; forebrain neuroblast division [GO:0021873]; maintenance of centrosome location [GO:0051661]; male gonad development [GO:0008584]; meiotic spindle assembly [GO:0090306]; negative regulation of asymmetric cell division [GO:0045769]; negative regulation of neuron differentiation [GO:0045665]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; oogenesis [GO:0048477]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuroblast proliferation [GO:0002052]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653]; spindle organization [GO:0007051] GO:0001764; GO:0002052; GO:0005516; GO:0005634; GO:0005737; GO:0005813; GO:0007051; GO:0007283; GO:0008356; GO:0008584; GO:0016324; GO:0021873; GO:0021987; GO:0030496; GO:0036449; GO:0045665; GO:0045769; GO:0048477; GO:0048589; GO:0051445; GO:0051653; GO:0051661; GO:0072687; GO:0090263; GO:0090306; GO:0097150; GO:0097431 calmodulin binding [GO:0005516] AAAIQLQAAFRRLK 0.99178 -139.83 10.3062 12.4405 0 0 0 0 0 0 0 12.3753 12.3201 11.9883 14.0126 0 0 0 14.5976 14.4757 13.1111 16.1894 0 0 14.4724 12.506 15.4769 0 11.9815 14.8518 14.1664 0 15.2395 11.7761 0 0 14.2059 13.6944 0 0 0 0 13.8514 13.5771 14.3027 0 16.3122 0 0 12.2336 0 15.2912 0 0 0 0 0 0 0 0 0 9.64225 0 0 0 0 0 0 0 14.1393 14.1969 0 0 11.3832 17.3398 14.6735 15.6593 15.4157 15.2724 15.1983 15.8376 15.4836 16.6734 13.9639 16.2484 15.5085 15.6247 16.7848 15.1545 14.497 15.2102 15.37 13.1208 16.1492 13.8023 15.4309 15.3153 15.8215 0 0 0 0 13.4112 12.4982 15.2741 17.4298 15.5444 16.9835 15.3406 16.1146 14.6028 14.8 14.5387 14.4413 15.3493 13.8078 17.1311 16.9331 15.0453 18.3957 14.4864 12.7459 13.5719 14.1475 15.7606 14.5853 13.2991 14.6979 0 0 15.5854 16.7997 15.2446 14.3939 12.8456 13.3081 0 13.815 14.4031 14.4286 14.0477 0 0 0 0 0 14.5319 11.2706 13.3947 15.3335 12.695 15.3361 13.4397 14.5842 13.3824 0 15.3243 11.7996 13.9277 15.4407 16.3656 13.6846 14.5546 13.689 16.6948 16.4793 14.3553 15.9363 0 15.0642 15.7509 12.7395 14.5769 15.5934 18.2355 14.8189 15.0901 15.2762 0 14.4321 0 12.0074 Q9C0H5 RHG39_HUMAN Rho GTPase-activating protein 39 ARHGAP39 KIAA1688 Homo sapiens (Human) postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007165; GO:0051056; GO:0098978; GO:0099173 GTPase activator activity [GO:0005096] ADPLHVALEVATKGWSVQGLRDELYIQLCR 0.99178 -23.878 14.4741 0 0 0 0 0 0 0 13.9353 0 0 12.7335 0 0 0 0 0 0 12.3542 0 12.0583 0 0 0 0 0 13.2905 0 0 0 0 0 0 0 12.8998 0 0 0 0 0 0 0 0 12.0965 0 0 0 0 14.7726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9185 0 0 0 13.7268 0 0 12.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6261 0 0 0 0 0 0 0 0 10.7691 0 0 0 14.04 0 0 14.3882 0 0 14.7477 0 0 0 0 12.5746 0 0 0 0 0 16.2932 0 0 0 0 0 0 0 16.403 0 13.353 0 0 14.8978 0 0 0 0 0 0 0 0 0 14.7144 0 0 0 0 0 0 0 0 0 11.7897 0 0 0 0 0 0 0 0 13.6767 14.7315 0 12.3195 14.3884 14.7071 0 15.4226 0 14.2871 0 0 0 0 0 0 A6NI03 TR64B_HUMAN Putative tripartite motif-containing protein 64B TRIM64B Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ELWETCHMPDVVLLQDVRNVSARTDLAQMQK 0.99178 -23.841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4351 0 0 0 12.0636 0 0 13.6036 0 0 0 0 11.4639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9026 0 0 0 0 0 0 0 0 0 0 10.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7597 0 15.3307 0 0 0 0 0 0 0 0 0 13.9173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42696 RBM34_HUMAN RNA-binding protein 34 (RNA-binding motif protein 34) RBM34 KIAA0117 Homo sapiens (Human) chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005694; GO:0005730 RNA binding [GO:0003723] IQINQEEERLK 0.99178 -18.755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6185 0 0 0 0 0 0 0 13.8899 0 0 0 0 0 0 0 0 0 0 14.2181 0 0 0 13.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7245 0 Q03164 KMT2A_HUMAN "Histone-lysine N-methyltransferase 2A, Lysine N-methyltransferase 2A, EC 2.1.1.364 (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A, EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa, p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa, p180) ]" KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; DNA methylation [GO:0006306]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; negative regulation of DNA methylation [GO:1905642]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; visual learning [GO:0008542]" cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; DNA methylation [GO:0006306]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; negative regulation of DNA methylation [GO:1905642]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; post-embryonic development [GO:0009791]; protein-containing complex assembly [GO:0065003]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K27 acetylation [GO:1901674]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; visual learning [GO:0008542]" GO:0003680; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006306; GO:0006325; GO:0006915; GO:0008270; GO:0008542; GO:0009791; GO:0009952; GO:0018026; GO:0032411; GO:0032922; GO:0035097; GO:0035162; GO:0035640; GO:0035864; GO:0042800; GO:0042802; GO:0042803; GO:0043984; GO:0044648; GO:0045322; GO:0045893; GO:0045944; GO:0048144; GO:0048147; GO:0048172; GO:0048536; GO:0048873; GO:0051568; GO:0051571; GO:0051899; GO:0060216; GO:0065003; GO:0070577; GO:0071339; GO:0071440; GO:0080182; GO:0097692; GO:0106363; GO:1901674; GO:1905642; GO:2000615 chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] AEVHLRKSAFDMFNFLASK 0.99178 -125.87 0 0 0 0 0 0 0 0 14.4056 11.8444 12.7424 11.0571 15.3287 13.2858 13.3537 11.2399 14.0192 0 0 0 12.5306 14.3526 0 0 0 0 0 0 11.5434 0 12.3141 11.4327 13.8282 12.7733 13.2752 10.8704 14.2333 15.6372 13.0598 12.9178 0 13.9562 13.9501 0 0 14.153 12.2921 12.6435 14.4498 13.7953 12.976 14.7755 0 0 0 0 0 0 0 11.825 0 0 11.9303 0 0 0 0 0 12.4524 12.3882 0 0 0 10.5775 14.0559 0 12.0283 0 11.8994 0 0 12.6166 13.9217 14.0476 13.0667 15.7702 0 0 14.8648 13.937 15.6666 13.7095 12.7914 15.0408 13.8984 13.4387 12.9355 13.4152 14.9423 14.7948 13.6962 0 0 0 13.0833 0 0 13.2168 12.3538 14.562 0 15.0012 12.9168 14.5068 0 12.2801 10.1594 13.1353 14.8302 13.8776 0 0 14.4776 12.9502 15.4023 0 13.8529 0 13.249 14.3254 14.1381 13.5833 13.7313 0 0 12.5473 14.0713 0 15.3045 0 0 16.7406 14.2989 0 12.7094 13.5552 14.9974 16.6085 16.8261 12.7265 15.2727 0 0 18.2715 13.2687 13.0336 16.7724 0 12.9765 13.1661 0 0 12.8482 14.2301 0 0 13.2969 14.7813 0 13.4359 0 12.9801 14.4846 0 12.9185 16.7717 14.2794 15.1568 11.9168 0 Q15413 RYR3_HUMAN "Ryanodine receptor 3, RYR-3, RyR3 (Brain ryanodine receptor-calcium release channel) (Brain-type ryanodine receptor) (Type 3 ryanodine receptor)" RYR3 HBRR Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ATP [GO:0071318]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; cellular response to magnesium ion [GO:0071286]; protein homotetramerization [GO:0051289] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ATP [GO:0071318]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; cellular response to magnesium ion [GO:0071286]; protein homotetramerization [GO:0051289] GO:0005219; GO:0005509; GO:0005516; GO:0005790; GO:0006816; GO:0006874; GO:0015278; GO:0016021; GO:0016529; GO:0030018; GO:0030659; GO:0033017; GO:0042383; GO:0048763; GO:0051289; GO:0070588; GO:0071277; GO:0071286; GO:0071313; GO:0071318 calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219] ADMEDGEK 0.99178 -23.084 0 11.667 0 11.5894 14.6714 10.736 15.0992 0 0 0 0 0 0 0 0 11.3038 11.4624 13.0621 12.8622 0 14.8687 13.5808 13.9715 0 0 0 0 0 14.1602 0 13.2725 14.3957 10.099 11.3088 0 12.6068 0 0 0 9.68641 0 0 13.5658 13.2404 0 0 0 0 0 0 0 13.0357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3726 0 12.6077 0 0 0 0 0 0 13.5689 15.4008 0 12.3088 0 13.3749 15.0448 12.2271 0 15.9321 0 16.3323 15.7557 15.4501 11.3089 12.6203 14.3471 14.8622 0 14.6892 0 13.3745 0 13.4886 0 15.7647 15.2307 13.9033 12.5761 15.0612 13.3396 0 0 13.4207 12.695 14.0615 0 15.3565 0 13.9531 13.0195 15.7887 13.4087 13.9248 14.405 0 11.5903 13.5214 12.0985 13.7247 14.2063 15.1146 14.4931 0 14.6475 0 13.5288 12.9098 11.1191 0 13.4159 0 0 12.6682 13.2655 13.78 0 14.9019 0 0 0 12.8151 13.8769 0 15.0906 0 12.814 14.299 0 12.5512 0 0 0 10.6344 0 0 0 13.9351 0 14.5317 0 13.1864 0 0 0 12.9956 0 15.2813 13.8813 0 0 0 10.9941 14.1731 15.1083 Q15642 CIP4_HUMAN "Cdc42-interacting protein 4 (Protein Felic) (Salt tolerant protein, hSTP) (Thyroid receptor-interacting protein 10, TR-interacting protein 10, TRIP-10)" TRIP10 CIP4 STOT STP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell communication [GO:0007154]; endocytosis [GO:0006897]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; cell communication [GO:0007154]; endocytosis [GO:0006897]; signal transduction [GO:0007165] GO:0001891; GO:0005654; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0005856; GO:0005938; GO:0006897; GO:0007154; GO:0007165; GO:0008289; GO:0030036; GO:0042802; GO:0042995; GO:0043231; GO:0048471; GO:0070062 identical protein binding [GO:0042802]; lipid binding [GO:0008289] DCREAEK 0.99178 -23.864 0 0 0 0 0 0 0 0 0 0 14.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6022 15.1839 0 0 0 0 0 0 0 14.1331 0 14.2923 0 0 17.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9502 0 0 0 0 0 0 0 0 0 0 0 15.4002 0 0 0 0 0 0 0 13.9649 0 0 0 0 0 0 0 0 12.9837 0 0 0 0 14.291 0 0 0 0 0 0 Q2M218 ZN630_HUMAN Zinc finger protein 630 ZNF630 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFIKKSQLIIHQR 0.99178 -23.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4641 0 0 10.0922 13.4379 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3003 0 0 0 15.0689 0 0 0 0 0 0 0 0 0 0 0 0 13.6282 0 9.60663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7053 0 0 17.0893 0 0 0 12.1196 0 0 0 0 0 0 11.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2226 10.0389 0 0 0 0 0 13.1407 9.92159 0 0 0 0 11.6422 0 14.0058 0 0 0 0 0 13.7938 0 0 15.8191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76296 0 0 0 0 0 10.3939 0 0 0 0 14.966 0 Q8IZJ3 CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 CPAMD8 KIAA1283 Homo sapiens (Human) eye development [GO:0001654] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654] GO:0001654; GO:0004867; GO:0005615; GO:0005886 serine-type endopeptidase inhibitor activity [GO:0004867] AAPALEK 0.99178 -24.731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4016 0 0 0 0 0 0 0 0 0 0 0 0 13.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 11.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0165 0 12.7159 0 0 0 0 0 15.9969 0 0 0 0 0 0 0 10.9506 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4965 13.2056 0 0 0 0 0 13.0685 0 0 0 0 0 10.6296 0 0 0 0 0 0 0 0 0 0 0 0 19.2602 0 0 0 19.1214 0 0 0 0 0 0 0 Q8N1P7 CRBG2_HUMAN Beta/gamma crystallin domain-containing protein 2 (Absent in melanoma 1-like protein) CRYBG2 AIM1L Homo sapiens (Human) carbohydrate binding [GO:0030246] GO:0030246 carbohydrate binding [GO:0030246] ARVVSATLTWRQR 0.99178 -23.85 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3851 0 0 12.2757 0 0 0 10.2907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6244 0 0 0 0 0 0 0 11.7422 0 0 0 0 15.1135 0 14.7877 0 0 13.726 0 0 0 0 0 0 0 14.6093 0 0 11.646 0 0 0 0 0 12.1416 0 0 0 0 0 0 0 0 0 0 13.2516 0 15.7983 0 0 0 0 0 13.6184 13.3403 13.5715 0 0 0 0 0 0 0 0 13.3225 0 0 0 0 0 9.82047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3477 0 0 0 20.0329 0 0 0 0 0 0 0 0 0 0 0 0 12.7412 0 0 0 0 0 0 9.84015 0 0 19.9607 Q8N3Z6 ZCHC7_HUMAN Zinc finger CCHC domain-containing protein 7 (TRAMP-like complex RNA-binding factor ZCCHC7) ZCCHC7 HSPC086 Homo sapiens (Human) ncRNA polyadenylation [GO:0043629]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038] cytosol [GO:0005829]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499] cytosol [GO:0005829]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; ncRNA polyadenylation [GO:0043629]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038] GO:0003723; GO:0005730; GO:0005829; GO:0008270; GO:0031499; GO:0043629; GO:0071031; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DDDILLNLVGCENSVTEGEDGINWSISDKDIEAQIANNR 0.99178 -18.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8528 0 13.4529 0 0 12.1445 0 0 0 0 12.438 0 0 0 0 13.0994 14.1394 0 13.1632 13.2585 12.9406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3216 0 0 0 0 0 0 0 0 0 0 0 0 Q8N587 ZN561_HUMAN Zinc finger protein 561 ZNF561 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAIYLSR 0.99178 -24.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6166 0 0 13.2018 0 0 0 0 0 0 0 0 0 10.3682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9743 14.8292 0 0 12.7056 0 0 14.1092 0 0 0 0 0 0 0 0 0 0 0 15.0047 14.693 0 0 0 0 0 0 0 0 16.0338 0 0 13.664 13.364 0 0 0 0 13.2217 0 0 0 0 0 0 13.42 0 12.973 0 0 0 0 0 12.9833 0 0 12.7748 0 0 0 0 0 0 0 0 0 0 0 0 14.5801 0 12.7129 0 0 0 12.6341 0 0 0 0 0 0 0 13.3581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5819 0 0 0 0 Q8NDH2 CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 (Coiled-coil domain-containing protein 168) CCDC168 C13orf40 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AEKSPLSHILKTK 0.99178 -253.64 9.86347 0 12.5748 12.2098 14.6897 0 13.4707 0 13.24 13.214 14.0067 13.62 0 13.5657 13.5495 13.2541 13.5898 13.2419 14.4247 13.4069 14.1186 0 14.5244 13.4414 13.4533 14.0176 14.7583 0 0 14.513 0 13.1635 16.8381 0 0 0 13.183 13.3682 0 14.2303 14.6616 14.4791 13.9244 14.5072 14.7775 14.0429 14.516 13.9464 14.3129 11.8939 0 0 12.1127 0 11.4841 0 0 16.8149 0 0 0 0 0 0 0 0 14.5189 15.064 13.1341 14.2884 15.1263 13.9859 0 0 14.9332 13.3699 15.6188 16.0288 16.5983 17.2875 17.3912 13.9444 12.976 12.1255 12.773 13.1638 15.981 14.4742 15.6471 15.8268 14.6576 17.9456 17.6776 18.32 16.4821 16.5169 14.4192 12.911 0 13.4741 15.1192 11.7 17.2402 17.1864 16.5465 14.5041 14.7609 14.9509 13.2383 16.1371 16.0945 15.2592 19.4171 17.0886 17.1886 14.5886 15.2243 16.9506 16.9503 16.839 16.5052 16.3743 15.7765 15.5719 17.1773 18.3997 15.4873 13.9859 13.951 17.1661 15.9293 16.2968 13.608 15.1771 14.0957 14.2223 15.2374 19.0031 17.2159 16.5406 16.6359 17.5501 14.1706 14.486 16.6181 16.681 10.4048 12.8787 13.7485 13.6703 17.1019 15.3451 0 17.7862 16.9495 17.4418 16.5718 0 0 0 11.7931 0 13.0621 14.8185 12.4334 15.4274 14.1196 12.0506 0 16.2113 15.8996 16.1367 16.3148 16.6758 17.4031 14.2948 15.3391 15.3898 15.452 14.6539 Q8NFG4 FLCN_HUMAN Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein) FLCN BHD Homo sapiens (Human) cell proliferation involved in kidney development [GO:0072111]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein kinase B signaling [GO:0043491]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]; transforming growth factor beta receptor signaling pathway [GO:0007179] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cell proliferation involved in kidney development [GO:0072111]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome localization [GO:0032418]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cellular respiration [GO:1901856]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of gene expression [GO:0010629]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial DNA metabolic process [GO:1901859]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of muscle tissue development [GO:1901862]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein kinase B signaling [GO:0043491]; regulation of cytokinesis [GO:0032465]; regulation of histone acetylation [GO:0035065]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0000122; GO:0001701; GO:0001932; GO:0001934; GO:0004857; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0007179; GO:0009267; GO:0010508; GO:0010629; GO:0010823; GO:0019899; GO:0030097; GO:0030308; GO:0030336; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0032465; GO:0034198; GO:0035024; GO:0035065; GO:0043065; GO:0043491; GO:0043547; GO:0044877; GO:0045785; GO:0045820; GO:0045944; GO:0046578; GO:0050673; GO:0050680; GO:0051898; GO:0070371; GO:0070373; GO:0072111; GO:0072686; GO:0097009; GO:0097193; GO:0120163; GO:1900181; GO:1901723; GO:1901856; GO:1901859; GO:1901862; GO:1901874; GO:1903444; GO:1904263; GO:2000973; GO:2001170; GO:2001244 enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877] EDTQKLLSILGASEEDNVK 0.99178 -18.761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6754 12.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0672 0 0 0 0 14.5272 0 0 0 0 0 17.4638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1512 0 0 0 0 0 12.5374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43865 SAHH2_HUMAN "S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3), IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2, AdoHcyase 2)" AHCYL1 DCAL IRBIT XPVKONA Homo sapiens (Human) angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353] GO:0003723; GO:0005737; GO:0005789; GO:0005829; GO:0006378; GO:0006611; GO:0006730; GO:0006915; GO:0010765; GO:0016324; GO:0031440; GO:0032412; GO:0033353; GO:0038166; GO:0042045; GO:0042802; GO:0044070; GO:0044233; GO:0051592; GO:0070062; GO:1990456 identical protein binding [GO:0042802]; RNA binding [GO:0003723] FDNLYCCR 0.99179 -7.5442 0 0 0 0 0 0 0 0 12.6048 0 0 0 0 0 0 0 0 0 0 12.3352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4969 12.5421 0 0 0 0 0 0 0 0 13.0214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0369 0 0 0 0 0 0 0 0 12.5191 0 0 0 0 0 14.2677 0 0 0 0 0 0 0 0 12.7711 0 0 0 0 0 0 0 0 0 0 0 0 13.8162 0 0 0 0 P06307 CCKN_HUMAN "Cholecystokinin, CCK [Cleaved into: Cholecystokinin-58, CCK58; Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39, CCK39; Cholecystokinin-33, CCK33; Cholecystokinin-25, CCK25; Cholecystokinin-18, CCK18; Cholecystokinin-12, CCK12; Cholecystokinin-8, CCK8; Cholecystokinin-7, CCK7; Cholecystokinin-5, CCK5 ]" CCK Homo sapiens (Human) axonogenesis [GO:0007409]; digestion [GO:0007586]; eating behavior [GO:0042755]; neuron migration [GO:0001764]; signal transduction [GO:0007165] axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615] axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]; axonogenesis [GO:0007409]; digestion [GO:0007586]; eating behavior [GO:0042755]; neuron migration [GO:0001764]; signal transduction [GO:0007165] GO:0001764; GO:0005179; GO:0005184; GO:0005576; GO:0005615; GO:0007165; GO:0007409; GO:0007586; GO:0030424; GO:0042755; GO:0051428 hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428] AHLGALLARYIQQARK 0.99179 -7.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1733 0 0 0 0 0 0 0 0 0 0 0 13.9345 0 0 0 0 0 10.9506 0 12.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4187 0 0 12.0803 0 0 0 0 0 0 10.5914 0 0 0 0 0 0 0 0 0 0 11.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30793 GCH1_HUMAN "GTP cyclohydrolase 1, EC 3.5.4.16 (GTP cyclohydrolase I, GTP-CH-I)" GCH1 DYT5 GCH Homo sapiens (Human) "7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]" cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]" GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0006809; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032496; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042802; GO:0042803; GO:0044306; GO:0044877; GO:0045776; GO:0046654; GO:0048265; GO:0050884; GO:0051000; GO:0051019; GO:0065003; GO:2000121 calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270] IVEIYSRR 0.99179 -5.5406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2883 0 0 0 0 0 0 0 0 0 0 11.4849 0 0 0 0 13.3875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4693 0 0 0 0 0 0 0 12.8011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9273 0 0 14.2383 0 0 0 0 0 0 0 13.0949 13.3882 12.9812 0 12.9064 0 0 0 0 0 0 0 0 0 Q86TU6 CN070_HUMAN Putative uncharacterized protein encoded by LINC00523 LINC00523 C14orf70 Homo sapiens (Human) LKSKQNLK 0.99179 -7.1823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVY7 UBCP1_HUMAN "Ubiquitin-like domain-containing CTD phosphatase 1, EC 3.1.3.16 (Nuclear proteasome inhibitor UBLCP1)" UBLCP1 Homo sapiens (Human) protein dephosphorylation [GO:0006470] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470] GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0006470; GO:0017018 myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] ALPIIVK 0.99179 -18.87 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0188 0 0 0 12.2834 0 12.9415 12.0403 11.6955 12.4403 0 12.8339 12.1856 12.8448 0 0 0 0 0 0 0 0 0 0 0 12.8798 0 15.3872 14.2167 13.8306 0 12.5013 0 13.2892 0 13.4552 13.5799 13.9589 0 15.9652 12.354 0 0 0 12.972 0 0 0 12.1432 0 0 0 15.1141 14.9117 0 0 0 0 12.6015 12.692 0 0 0 13.5998 12.8734 14.3498 0 0 12.0712 13.963 0 0 0 0 0 0 0 13.7499 0 0 0 0 0 0 0 0 14.7273 0 0 0 0 0 0 12.1568 0 0 0 0 0 14.6327 12.0763 0 0 0 0 14.8499 0 0 0 0 0 0 0 0 0 0 12.2203 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVR0 KLH11_HUMAN Kelch-like protein 11 KLHL11 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 DVTVYNPELDKWHNLESAPK 0.99179 -23.205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9132 0 0 0 0 0 0 0 0 0 0 12.5246 0 0 0 10.4466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0798 0 0 0 0 13.291 0 0 0 0 13.0568 11.8873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8661 0 0 0 11.5566 11.1973 11.9058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.999 0 0 12.8126 0 12.7791 0 0 0 0 0 0 0 12.2677 0 0 0 14.218 11.9446 0 0 13.0017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1322 0 0 0 0 0 0 0 0 12.7033 0 0 12.5871 0 0 0 Q9UJY4 GGA2_HUMAN "ADP-ribosylation factor-binding protein GGA2 (Gamma-adaptin-related protein 2) (Golgi-localized, gamma ear-containing, ARF-binding protein 2) (VHS domain and ear domain of gamma-adaptin, Vear)" GGA2 KIAA1080 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394] clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802] clathrin-coated vesicle [GO:0030136]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; protein localization to cell surface [GO:0034394] GO:0005794; GO:0005802; GO:0006886; GO:0006893; GO:0010008; GO:0030136; GO:0031267; GO:0031901; GO:0034394; GO:0035091; GO:0043001; GO:0043130 phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130] FHSEVAK 0.99179 -7.3677 0 0 0 0 0 0 0 13.6344 0 0 0 12.9065 10.9924 0 13.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4621 0 0 0 0 0 0 0 0 0 13.0855 0 0 0 0 0 12.9855 0 0 0 12.8866 0 0 0 0 12.7647 12.5505 0 0 12.0394 0 0 0 12.8878 13.0685 0 0 0 12.1493 12.6383 0 13.1179 0 0 0 0 0 0 12.5373 0 0 0 13.4661 0 12.2223 0 13.457 13.228 0 0 0 0 0 0 0 0 0 0 0 12.6577 0 0 0 12.8281 0 0 0 0 0 0 13.7766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5332 0 Q9UQ07 MOK_HUMAN "MAPK/MAK/MRK overlapping kinase, EC 2.7.11.22 (MOK protein kinase) (Renal tumor antigen 1, RAGE-1)" MOK RAGE RAGE1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007165; GO:0035556; GO:0046872; GO:0097546; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FESIEQVNNLREIQALR 0.99179 -23.214 0 0 0 0 0 11.6448 0 0 0 0 0 0 0 0 0 0 13.7274 0 0 0 0 0 0 0 0 13.4429 0 14.2464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.397 15.2311 0 0 0 13.4467 12.2479 0 0 0 0 0 0 12.5526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6387 0 0 14.5736 14.0782 0 0 0 0 15.8069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1812 0 13.692 0 0 0 0 0 0 0 13.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3009 0 0 0 0 12.3656 12.7701 0 0 0 0 0 0 0 0 13.0602 0 0 0 0 14.7525 0 0 0 0 0 0 0 0 0 0 Q9Y2L9 LRCH1_HUMAN "Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81, NP81)" LRCH1 CHDC1 KIAA1016 Homo sapiens (Human) cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cellular response to chemokine [GO:1990869]; negative regulation of GTPase activity [GO:0034260]; negative regulation of T cell migration [GO:2000405] GO:0005737; GO:0034260; GO:1990869; GO:2000405 DSDSGVGSDNGDKR 0.99179 -7.5423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0081 0 0 0 0 14.3991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4A0 JERKL_HUMAN "Jerky protein homolog-like (Human homolog of mouse jerky gene protein, HHMJG)" JRKL Homo sapiens (Human) central nervous system development [GO:0007417] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; central nervous system development [GO:0007417] GO:0003677; GO:0005634; GO:0007417 DNA binding [GO:0003677] EINIRNER 0.99179 -22.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4139 0 0 12.0052 0 0 0 0 0 0 0 13.2085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0253 13.2491 0 0 0 0 0 0 0 0 0 0 15.5296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1689 0 0 0 13.593 0 O75204 TM127_HUMAN Transmembrane protein 127 TMEM127 Homo sapiens (Human) endosome organization [GO:0007032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of TOR signaling [GO:0032007]; regulation of TOR signaling [GO:0032006] cytoplasm [GO:0005737]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; small GTPase binding [GO:0031267]; endosome organization [GO:0007032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of TOR signaling [GO:0032007]; regulation of TOR signaling [GO:0032006] GO:0005737; GO:0005769; GO:0005886; GO:0007032; GO:0008285; GO:0016020; GO:0016021; GO:0031267; GO:0032006; GO:0032007 small GTPase binding [GO:0031267] HPALKITRR 0.9918 -5.5476 0 0 10.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.16822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2344 0 0 0 0 0 0 0 13.4314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2657 0 0 0 0 0 0 0 0 0 0 0 12.1858 0 0 0 0 0 0 0 0 0 12.1938 0 0 0 0 0 0 0 0 0 0 12.5275 0 0 0 0 0 0 0 0 0 0 0 13.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.177 0 0 0 P48443 RXRG_HUMAN Retinoic acid receptor RXR-gamma (Nuclear receptor subfamily 2 group B member 3) (Retinoid X receptor gamma) RXRG NR2B3 Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle tissue development [GO:0007519] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; peripheral nervous system development [GO:0007422]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myelination [GO:0031641]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle tissue development [GO:0007519]" GO:0000785; GO:0000978; GO:0000981; GO:0003707; GO:0004879; GO:0005654; GO:0005737; GO:0006357; GO:0007422; GO:0007507; GO:0007519; GO:0008270; GO:0030154; GO:0030182; GO:0031641; GO:0032526; GO:0044323; GO:0045944; GO:0048384; GO:0048856; GO:0090575; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" FAKLLLRLPALR 0.9918 -7.3883 0 0 0 14.1931 0 0 0 13.3633 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9398 0 12.7916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0883 0 0 0 0 0 0 P78545 ELF3_HUMAN "ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1, ESE-1)" ELF3 ERT ESX JEN Homo sapiens (Human) "blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001824; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006357; GO:0006366; GO:0006954; GO:0030154; GO:0030198; GO:0030855; GO:0045892; GO:0045944; GO:0060056; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ASWLGEQPQFWSK 0.9918 -7.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4585 16.3141 0 14.6084 0 0 12.782 0 15.2861 0 0 14.3884 14.4214 14.0876 14.3307 14.7885 14.8302 0 0 0 0 0 15.2747 16.8132 14.6287 0 12.3934 13.2966 12.2702 0 0 0 16.1675 0 15.0026 0 14.0522 12.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2879 0 13.3198 0 0 0 0 0 12.2145 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2698 0 0 0 13.2896 13.6962 0 12.7224 0 12.473 12.7304 13.4476 0 11.79 0 13.5404 0 0 0 13.2753 0 13.7794 0 0 Q12999 TSN31_HUMAN "Tetraspanin-31, Tspan-31 (Sarcoma-amplified sequence)" TSPAN31 SAS Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; positive regulation of cell population proliferation [GO:0008284] GO:0005887; GO:0008284; GO:0016020 FRNQKDPR 0.9918 -7.3971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13470 TNK1_HUMAN "Non-receptor tyrosine-protein kinase TNK1, EC 2.7.10.2 (CD38 negative kinase 1)" TNK1 Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020] cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0006468; GO:0007169; GO:0016020; GO:0030154; GO:0031234; GO:0045087; GO:0046777 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] ERLPWPK 0.9918 -18.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5657 0 0 12.8974 15.1775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7906 0 0 0 0 0 0 0 14.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q567U6 CCD93_HUMAN Coiled-coil domain-containing protein 93 CCDC93 Homo sapiens (Human) endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231] early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031] GO:0005769; GO:0006893; GO:0015031; GO:0032456; GO:0043231 DQLNDQYLELLEKQRLYFK 0.9918 -7.5791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1493 0 0 0 15.4798 0 0 0 0 0 0 14.6598 0 0 16.8266 16.5191 17.0926 16.4806 16.5951 0 16.2386 16.3055 0 0 16.2785 16.7358 17.505 16.4085 0 16.7675 0 15.0714 0 0 0 0 0 13.0088 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9372 0 13.9539 13.0906 13.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5U649 CL060_HUMAN Uncharacterized protein C12orf60 C12orf60 Homo sapiens (Human) EQSDVTTSER 0.9918 -7.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNQ3 LRC69_HUMAN Leucine-rich repeat-containing protein 69 LRRC69 Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 ALSGGKNTK 0.9918 -22.766 0 0 0 0 0 0 0 0 0 13.7638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6646 13.9909 13.8576 13.4642 13.5337 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7838 0 0 0 0 0 0 0 0 0 0 15.4588 0 0 0 0 0 0 11.5193 0 0 12.7974 0 0 13.3233 0 0 0 13.3925 0 0 13.4298 0 15.5554 0 13.1897 13.2945 13.4719 14.1978 0 16.1746 0 0 13.8555 0 0 0 14.7713 0 0 0 0 0 0 0 0 0 0 14.7017 0 0 0 0 0 0 13.8608 0 13.4931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.266 0 12.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4083 0 0 0 0 0 0 Q92665 RT31_HUMAN "28S ribosomal protein S31, mitochondrial, MRP-S31, S31mt (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)" MRPS31 IMOGN38 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0019904; GO:0032543 protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ISFSNIISDMKVARSATAR 0.9918 -7.3874 0 0 0 0 0 10.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.809 12.3589 0 0 0 0 0 0 0 9.882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9414 0 0 12.6348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.066 0 0 0 0 0 0 0 0 11.7675 0 0 0 0 0 0 0 10.3879 0 0 0 12.8043 0 0 0 0 0 0 0 0 0 0 10.3292 0 9.7364 Q96KT0 FAAS1_HUMAN Uncharacterized protein FAM167A-AS1 (FAM167A antisense RNA 1) (FAM167A antisense gene protein 1) FAM167A-AS1 C8orf12 Homo sapiens (Human) MGRSPCFFKSFK 0.9918 -7.3964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0752 0 0 0 0 0 0 0 0 15.074 0 0 0 0 0 0 0 14.7902 0 0 0 0 0 0 Q96LT9 RNPC3_HUMAN "RNA-binding region-containing protein 3 (RNA-binding motif protein 40, RNA-binding protein 40) (U11/U12 small nuclear ribonucleoprotein 65 kDa protein, U11/U12 snRNP 65 kDa protein, U11/U12-65K)" RNPC3 KIAA1839 RBM40 RNP SNRNP65 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0008380; GO:0030626; GO:0097157 pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626] ALTRLHQLK 0.9918 -7.3948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9023 0 0 0 0 13.2603 0 0 0 0 0 0 0 0 0 0 0 0 11.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6098 13.6355 12.1117 0 0 0 0 0 0 0 0 0 0 0 0 14.0125 0 0 0 0 13.7324 0 0 0 14.0155 0 13.2363 13.4392 0 0 0 14.1046 13.9475 13.7198 0 13.6597 13.2681 0 0 0 0 0 0 0 0 0 14.5203 14.6341 13.5413 13.9697 0 0 0 15.0065 13.2488 0 0 0 0 0 0 0 0 13.1489 0 0 0 13.24 13.0665 0 13.0318 13.2946 0 0 0 0 12.2431 0 0 0 0 14.1652 11.1615 14.7415 0 0 10.6456 14.3829 0 12.1314 0 0 0 12.4186 0 15.9052 0 0 12.8726 0 0 0 0 0 11.7866 0 Q9HAF1 EAF6_HUMAN "Chromatin modification-related protein MEAF6, MYST/Esa1-associated factor 6 (Esa1-associated factor 6 homolog, Protein EAF6 homolog, hEAF6) (Sarcoma antigen NY-SAR-91)" MEAF6 C1orf149 CENP-28 EAF6 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of double-strand break repair [GO:2000779]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] "histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of double-strand break repair [GO:2000779]; regulation of hemopoiesis [GO:1903706]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000123; GO:0000776; GO:0000786; GO:0001558; GO:0005634; GO:0005654; GO:0005730; GO:0006275; GO:0006325; GO:0006355; GO:0016570; GO:0016573; GO:0035267; GO:0042981; GO:0043967; GO:0043968; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045893; GO:0050793; GO:0051726; GO:0070776; GO:1903706; GO:1905168; GO:2000278; GO:2000779 HRIDLKLNK 0.9918 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y279 VSIG4_HUMAN V-set and immunoglobulin domain-containing protein 4 (Protein Z39Ig) VSIG4 CRIg Z39IG UNQ317/PRO362 Homo sapiens (Human) "complement activation, alternative pathway [GO:0006957]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage activation [GO:0043031]; negative regulation of T cell proliferation [GO:0042130]" integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991] "integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; complement component C3b binding [GO:0001851]; complement activation, alternative pathway [GO:0006957]; negative regulation of complement activation, alternative pathway [GO:0045957]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage activation [GO:0043031]; negative regulation of T cell proliferation [GO:0042130]" GO:0001851; GO:0006957; GO:0016021; GO:0032703; GO:0032991; GO:0042130; GO:0043031; GO:0045957 complement component C3b binding [GO:0001851] DSSKLLKTK 0.9918 -5.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NLW8 DUXA_HUMAN Double homeobox protein A DUXA Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ARHGFQK 0.99181 -18.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15042 SR140_HUMAN U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140) U2SURP KIAA0332 SR140 Homo sapiens (Human) RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396] GO:0003723; GO:0005634; GO:0005654; GO:0006396 RNA binding [GO:0003723] AKLREIELK 0.99181 -54.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9499 0 10.7147 14.0279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.40829 12.3198 0 12.8178 0 0 0 12.604 12.6769 10.08 0 0 0 0 0 0 0 0 0 0 13.44 0 0 0 0 0 15.398 14.7605 14.3717 13.894 14.5552 12.3343 13.7822 15.809 0 13.152 13.3748 14.2082 13.3799 15.4934 15.6598 16.1618 13.9524 16.0719 16.1179 14.8733 12.6773 14.528 0 15.7331 13.2288 13.7062 13.2865 0 15.2754 15.2296 15.8733 14.1247 11.6822 13.7457 14.4789 13.0991 14.4157 11.5708 0 14.6919 16.3304 15.2335 13.9752 13.4668 0 0 14.57 15.3581 15.1736 15.2886 14.4528 13.8467 14.9729 14.9457 14.4633 14.9571 13.8969 12.5954 0 14.5857 15.0282 15.2549 15.6257 14.9536 15.3566 15.4647 14.8446 15.444 15.5207 16.5301 13.751 15.0783 13.3085 0 0 0 0 14.4496 14.1426 15.9052 16.1138 15.5494 0 0 0 0 14.6141 14.5858 0 0 0 12.5036 0 0 0 17.0462 0 0 15.1903 0 13.2972 0 0 0 0 0 P07585 PGS2_HUMAN Decorin (Bone proteoglycan II) (PG-S2) (PG40) DCN SLRR1B Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of transcription by RNA polymerase II [GO:0045944] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; RNA binding [GO:0003723]; animal organ morphogenesis [GO:0009887]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003723; GO:0005518; GO:0005539; GO:0005576; GO:0005615; GO:0005796; GO:0009887; GO:0010508; GO:0010596; GO:0014068; GO:0016239; GO:0016525; GO:0019800; GO:0030021; GO:0043202; GO:0045944; GO:0050840; GO:0051901; GO:0062023; GO:0090141; GO:1900747 collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; RNA binding [GO:0003723] ELPEKMPK 0.99181 -4.5211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5868 0 0 0 0 0 10.985 0 0 0 0 0 0 0 0 13.2907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9739 0 13.256 0 0 0 0 0 12.807 12.5354 0 12.0652 0 0 0 12.4422 0 0 14.6461 0 0 0 0 15.5099 14.7689 14.4937 0 14.6816 14.9937 0 14.2936 14.4945 0 0 0 0 13.7667 0 0 0 0 14.348 13.435 0 0 0 0 0 14.6174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5752 11.4435 0 0 0 0 11.5459 0 0 0 0 0 0 0 0 0 0 14.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2712 0 0 0 0 0 0 0 0 0 P80370 DLK1_HUMAN "Protein delta homolog 1, DLK-1 (pG2) [Cleaved into: Fetal antigen 1, FA1 ]" DLK1 DLK Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746] GO:0005509; GO:0005615; GO:0005737; GO:0016020; GO:0016021; GO:0030154; GO:0045746 calcium ion binding [GO:0005509] CETWVSNLR 0.99181 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16881 TRXR1_HUMAN "Thioredoxin reductase 1, cytoplasmic, TR, EC 1.8.1.9 (Gene associated with retinoic and interferon-induced mortality 12 protein, GRIM-12, Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Peroxidase TXNRD1, EC 1.11.1.2) (Thioredoxin reductase TR1)" TXNRD1 GRIM12 KDRF Homo sapiens (Human) cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; mesoderm formation [GO:0001707]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; FAD binding [GO:0071949]; glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; NADPH peroxidase activity [GO:0050137]; thioredoxin-disulfide reductase activity [GO:0004791]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; mesoderm formation [GO:0001707]; signal transduction [GO:0007165] GO:0001650; GO:0001707; GO:0004791; GO:0005654; GO:0005739; GO:0005829; GO:0007165; GO:0008283; GO:0042802; GO:0045454; GO:0050137; GO:0070062; GO:0071949; GO:0097573 FAD binding [GO:0071949]; glutathione oxidoreductase activity [GO:0097573]; identical protein binding [GO:0042802]; NADPH peroxidase activity [GO:0050137]; thioredoxin-disulfide reductase activity [GO:0004791] IGGHGPTLK 0.99181 -5.9968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.747 0 0 0 0 0 0 0 0 0 0 11.86 0 13.5482 0 0 0 13.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2739 13.3066 12.4777 0 12.5512 0 0 0 Q68DA7 FMN1_HUMAN Formin-1 (Limb deformity protein homolog) FMN1 FMN LD Homo sapiens (Human) actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092] actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin filament [GO:0005884]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124]; actin nucleation [GO:0045010]; forelimb morphogenesis [GO:0035136]; gene expression [GO:0010467]; hindlimb morphogenesis [GO:0035137]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of actin nucleation [GO:0051127]; positive regulation of focal adhesion assembly [GO:0051894]; skeletal system morphogenesis [GO:0048705]; ureteric bud invasion [GO:0072092] GO:0003779; GO:0005634; GO:0005737; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0010467; GO:0017124; GO:0030838; GO:0035136; GO:0035137; GO:0045010; GO:0048705; GO:0051127; GO:0051894; GO:0072092 actin binding [GO:0003779]; microtubule binding [GO:0008017]; SH3 domain binding [GO:0017124] DPSEFEYLFSKDTTQQKK 0.99181 -48.122 0 0 0 0 10.4759 0 0 0 0 0 11.3473 10.5614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1771 0 0 12.1592 0 0 0 0 0 0 0 0 0 0 0 13.0941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.198 0 12.7697 12.1597 11.8665 0 0 0 0 0 0 12.0157 13.4719 0 0 0 0 12.8782 0 14.5651 0 11.5878 0 0 0 0 0 0 0 0 0 13.8576 0 0 0 0 14.9584 0 13.6932 0 0 14.3853 14.9169 11.0307 0 0 0 0 0 0 0 9.77872 0 13.8236 0 0 0 0 0 14.613 0 0 0 14.8457 12.8647 0 0 13.2735 0 13.9373 0 17.4031 0 0 0 12.9113 0 14.0899 0 0 0 13.2448 0 12.4657 0 0 0 0 0 0 17.0756 0 12.8733 11.7375 12.9254 0 0 0 0 0 12.7984 0 0 10.3485 0 12.0254 0 12.511 0 9.70127 0 0 0 13.3947 0 Q6ZSS7 MFSD6_HUMAN Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog) MFSD6 MMR2 Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590] GO:0005886; GO:0016020; GO:0016021; GO:0042590 GKIVLLFSLLCWVLFNLGIGFVKPATLR 0.99181 -18.602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0339 0 0 0 11.951 0 0 0 0 14.4055 0 12.3488 0 11.266 0 0 0 0 0 12.0715 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5411 0 12.0413 12.2608 Q8N2C7 UNC80_HUMAN Protein unc-80 homolog UNC80 C2orf21 KIAA1843 Homo sapiens (Human) cation homeostasis [GO:0055080] axon [GO:0030424]; cation channel complex [GO:0034703]; plasma membrane [GO:0005886] axon [GO:0030424]; cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080] GO:0005261; GO:0005886; GO:0030424; GO:0034703; GO:0055080 cation channel activity [GO:0005261] CNRGNWPEWMK 0.99181 -86.499 12.5018 0 0 0 0 0 12.8989 12.5445 13.5362 16.4527 16.7917 16.3949 17.0666 13.0811 16.4258 15.4517 14.0733 15.4558 0 14.2543 0 14.1465 13.9781 14.3251 13.6991 15.5461 14.6596 0 14.1592 0 13.1622 16.9282 17.3837 16.0007 12.5355 15.3829 0 0 0 16.4957 16.5178 17.0696 16.0269 16.8925 16.6626 17.6229 17.5211 17.4896 0 0 13.7972 0 0 0 0 17.0199 18.19 18.365 18.0925 16.8113 18.0069 17.8307 18.8366 16.8441 15.2451 16.256 15.6753 0 12.9757 14.0304 17.0921 11.6241 0 0 0 15.3161 15.8808 14.8995 16.8081 0 15.7471 17.1908 14.6833 13.8619 15.7917 0 0 0 0 14.8282 16.8271 12.9295 14.2207 15.3757 13.07 15.474 15.7542 15.8726 15.3133 14.5982 0 11.6515 14.2388 14.2222 0 12.6075 0 0 15.1348 15.7359 16.7136 14.0069 0 0 16.8002 0 15.2957 15.0673 15.8533 15.2075 0 0 14.0244 14.2258 0 0 14.5271 15.1509 0 15.0503 0 0 15.6146 17.3228 16.1796 15.1536 0 15.9769 14.9152 15.7109 15.9948 14.5582 11.3899 14.748 0 0 15.0139 0 15.2708 0 0 15.2649 15.6346 14.4001 13.986 0 14.8378 19.5213 19.1135 18.7486 14.9472 13.6973 17.8727 18.2838 15.6308 14.4439 0 0 18.2775 14.6159 18.2716 14.5005 0 14.9092 13.5794 16.9498 0 13.6602 14.4947 0 Q8TD31 CCHCR_HUMAN "Coiled-coil alpha-helical rod protein 1 (Alpha-helical coiled-coil rod protein) (Putative gene 8 protein, Pg8)" CCHCR1 C6orf18 HCR Homo sapiens (Human) cell differentiation [GO:0030154]; protein export from nucleus [GO:0006611] centriole [GO:0005814]; cytosol [GO:0005829]; nucleus [GO:0005634] centriole [GO:0005814]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; protein export from nucleus [GO:0006611] GO:0005634; GO:0005814; GO:0005829; GO:0006611; GO:0030154; GO:0042802 identical protein binding [GO:0042802] DSLHATAELLQVRVQSLTHILALQEEELTR 0.99181 -4.3804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2401 0 15.2447 0 12.4395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5948 11.4465 13.326 0 0 0 0 0 0 0 12.5531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0495 0 0 0 12.2053 0 0 0 0 0 0 0 0 13.8354 0 0 0 0 0 0 14.3694 0 13.0624 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7516 0 0 0 0 0 0 0 0 0 9.26012 0 0 0 0 0 0 Q8TDR4 TCP1L_HUMAN "T-complex protein 10A homolog 1, T-complex protein 10A-1, TCP10A-1 (TCP10-like)" TCP10L PRED77 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] centriole [GO:0005814]; nucleus [GO:0005634] centriole [GO:0005814]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003714; GO:0005634; GO:0005814; GO:0042802; GO:0043621; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; transcription corepressor activity [GO:0003714] ALQLQRWKAR 0.99181 -4.384 0 0 0 0 0 0 15.1278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8424 16.6702 0 0 0 0 0 0 0 0 0 18.1407 18.1633 0 0 0 0 0 0 0 0 0 0 0 16.746 0 0 0 0 0 0 0 0 0 9.76497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5494 17.4536 0 17.2222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5394 0 0 0 0 0 0 0 Q8WZA1 PMGT1_HUMAN "Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1, POMGnT1, EC 2.4.1.- (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2, GnT I.2)" POMGNT1 MGAT1.2 UNQ746/PRO1475 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]" GO:0000139; GO:0006493; GO:0008375; GO:0016021; GO:0016266; GO:0030145; GO:0030173; GO:0047223 "acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]" GLWRLFRK 0.99181 -4.387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5879 13.1671 13.1416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.532 0 0 0 13.3341 0 0 0 15.4285 0 0 0 15.7273 0 0 0 0 0 0 0 0 11.8157 0 0 0 0 10.6576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8254 0 0 0 0 0 0 0 13.7369 Q96L91 EP400_HUMAN "E1A-binding protein p400, EC 3.6.4.- (CAG repeat protein 32) (Domino homolog, hDomino) (Trinucleotide repeat-containing gene 12 protein) (p400 kDa SWI2/SNF2-related protein)" EP400 CAGH32 KIAA1498 KIAA1818 TNRC12 Homo sapiens (Human) "DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812] "NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein antigen binding [GO:1990405]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]" GO:0000786; GO:0000812; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005654; GO:0006281; GO:0016573; GO:0016607; GO:0016787; GO:0035267; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:0140658; GO:1905168; GO:1990405; GO:2000779 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein antigen binding [GO:1990405] AQEWCDR 0.99181 -55.19 0 0 0 0 0 0 0 0 0 0 12.7144 0 0 0 0 13.2316 10.7134 10.5701 0 0 0 0 0 0 10.3394 0 0 0 12.3004 0 0 0 0 0 0 11.2027 13.8269 12.8118 0 11.6225 0 0 0 0 0 0 0 0 0 0 10.4422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3945 0 10.3082 0 0 0 0 0 0 0 13.8668 0 14.7494 15.0965 13.5001 13.9828 14.7866 12.5673 13.8336 0 14.3565 13.4638 14.689 13.9304 13.8387 0 0 0 13.8085 14.4326 15.5587 12.1581 14.9817 0 12.3877 13.3628 13.6155 0 12.1786 0 0 12.5562 13.2275 0 0 0 0 13.9624 0 13.0072 0 13.5606 14.1357 13.2593 0 13.356 12.6702 15.4892 14.6417 0 0 0 13.7846 13.2289 0 13.1855 0 0 0 0 12.3848 13.8517 0 13.5234 0 0 13.7791 0 0 0 13.2005 0 0 13.6496 0 13.3372 0 13.491 0 0 12.2188 13.12 12.7273 11.1997 0 0 0 0 0 11.9235 0 14.8643 0 0 0 0 0 14.0854 0 14.4804 0 0 0 14.2245 Q9NPC8 SIX2_HUMAN Homeobox protein SIX2 (Sine oculis homeobox homolog 2) SIX2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; condensed mesenchymal cell proliferation [GO:0072137]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; kidney development [GO:0001822]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; mesenchymal stem cell maintenance involved in nephron morphogenesis [GO:0072038]; mesenchymal stem cell proliferation [GO:0097168]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; middle ear morphogenesis [GO:0042474]; negative regulation of epithelial cell differentiation [GO:0030857]; nephron development [GO:0072006]; nephron morphogenesis [GO:0072028]; positive regulation of chondrocyte proliferation [GO:1902732]; protein import into nucleus [GO:0006606]; regulation of branching involved in ureteric bud morphogenesis [GO:0090189]; regulation of chondrocyte differentiation [GO:0032330]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; condensed mesenchymal cell proliferation [GO:0072137]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; kidney development [GO:0001822]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; mesenchymal stem cell maintenance involved in nephron morphogenesis [GO:0072038]; mesenchymal stem cell proliferation [GO:0097168]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; middle ear morphogenesis [GO:0042474]; negative regulation of epithelial cell differentiation [GO:0030857]; nephron development [GO:0072006]; nephron morphogenesis [GO:0072028]; positive regulation of chondrocyte proliferation [GO:1902732]; protein import into nucleus [GO:0006606]; regulation of branching involved in ureteric bud morphogenesis [GO:0090189]; regulation of chondrocyte differentiation [GO:0032330]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0002062; GO:0003337; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0006606; GO:0007501; GO:0008283; GO:0009653; GO:0009948; GO:0016477; GO:0030278; GO:0030857; GO:0032330; GO:0042474; GO:0044877; GO:0048557; GO:0048701; GO:0072006; GO:0072028; GO:0072038; GO:0072137; GO:0072161; GO:0090189; GO:0097168; GO:1902732; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AHYIEAEKLR 0.99181 -4.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7663 0 0 0 0 0 0 11.7041 12.0397 0 12.9474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6449 0 0 0 0 0 12.7268 11.9769 0 0 0 0 0 12.6032 0 12.5482 0 0 13.3595 12.4567 0 0 0 0 0 0 0 12.1671 0 13.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5235 0 0 0 0 0 0 0 0 12.7287 0 0 0 0 0 0 0 Q9P126 CLC1B_HUMAN "C-type lectin domain family 1 member B (C-type lectin-like receptor 2, CLEC-2)" CLEC1B CLEC2 UNQ721/PRO1384 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952]; platelet formation [GO:0030220]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; defense response [GO:0006952]; platelet formation [GO:0030220]; signal transduction [GO:0007165] GO:0004888; GO:0005886; GO:0005887; GO:0006952; GO:0007165; GO:0007166; GO:0030220; GO:0030246 carbohydrate binding [GO:0030246]; transmembrane signaling receptor activity [GO:0004888] CSPCDTNWRYYGDSCYGFFRHNLTWEESK 0.99181 -6.0086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.593 0 0 0 0 0 0 0 0 0 0 0 10.7658 0 0 11.5481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9701 0 0 0 0 0 0 0 0 13.6907 12.2804 0 0 13.0425 0 0 0 0 0 0 0 0 0 10.4227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6659 0 0 0 0 13.5647 0 0 0 0 0 0 0 0 0 0 0 18.141 0 0 0 0 10.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXH0 SYNE2_HUMAN "Nesprin-2 (KASH domain-containing protein 2, KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein, Protein NUANCE) (Synaptic nuclear envelope protein 2, Syne-2)" SYNE2 KIAA1011 NUA Homo sapiens (Human) centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017] GO:0003779; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005737; GO:0005739; GO:0005925; GO:0007097; GO:0016021; GO:0016529; GO:0021817; GO:0030018; GO:0030335; GO:0031022; GO:0031258; GO:0031527; GO:0031965; GO:0031981; GO:0033017; GO:0034993; GO:0045111; GO:0051015; GO:0051642; GO:0070062; GO:0140444; GO:1902017 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444] APDSSPESRRLNAQILSQR 0.99182 -93.107 0 0 14.2769 14.0674 0 0 0 14.9206 13.7388 12.0067 0 0 11.3747 0 13.1373 0 0 13.3696 0 0 0 16.2766 0 11.8427 0 12.5944 0 13.2013 0 0 0 0 14.5509 0 0 0 11.7016 14.3348 0 0 13.5683 0 0 12.985 10.8423 0 12.7472 14.2309 0 15.412 0 13.1045 13.0562 0 0 0 0 0 0 0 0 0 0 0 0 0 19.822 17.4192 14.4556 15.1429 15.5842 18.7616 15.9178 18.9895 14.5794 18.9812 10.4965 0 15.1328 12.5272 18.9362 15.3792 19.8068 18.4888 16.8985 15.9679 14.6325 11.1327 13.2517 15.951 15.4087 14.5717 15.477 14.2007 15.729 12.8584 13.9611 16.6906 14.2266 14.2962 14.1906 18.297 18.6987 13.5459 18.544 13.0049 13.8286 13.5143 16.5093 16.2107 11.0989 19.359 16.6609 14.8261 0 15.363 16.0569 13.8295 14.7692 13.4951 15.5937 14.9751 18.1058 18.8236 15.3545 0 18.4097 18.1116 16.4592 14.677 18.3222 18.1322 16.1436 18.034 12.2461 13.9106 13.0825 16.0594 18.4988 0 0 0 15.7032 15.8113 13.9541 0 13.3871 11.9994 10.7576 14.119 17.9249 12.997 12.9828 17.8913 15.3807 16.3749 0 0 14.7985 11.0903 14.1003 0 0 13.8285 0 0 0 12.6168 15.2458 11.4892 0 14.9721 13.9048 15.4483 14.3056 13.9334 10.0309 14.3618 16.0399 0 Q8NF91 SYNE1_HUMAN "Nesprin-1 (Enaptin) (KASH domain-containing protein 1, KASH1) (Myocyte nuclear envelope protein 1, Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1, Syne-1)" SYNE1 C6orf98 KIAA0796 KIAA1262 KIAA1756 MYNE1 Homo sapiens (Human) Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283] GO:0000932; GO:0003723; GO:0003779; GO:0005521; GO:0005634; GO:0005635; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005856; GO:0006997; GO:0007030; GO:0007283; GO:0016021; GO:0019899; GO:0030017; GO:0031965; GO:0034993; GO:0042692; GO:0042802; GO:0042803; GO:0045211; GO:0051015; GO:0090292; GO:0140444 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] AEAIKQVKHFR 0.99182 -139.33 0 12.5297 12.0406 12.0018 12.3454 0 11.5905 13.1054 0 0 0 0 13.903 0 15.0402 13.7634 0 18.4206 13.0794 14.5605 14.4752 12.6058 14.0166 0 13.1502 17.7899 12.4034 12.6912 12.5707 14.6861 14.8219 0 10.0997 0 0 0 14.2348 0 13.4875 13.5723 17.7368 0 12.9164 13.6868 13.5207 14.1142 14.5306 11.4046 0 11.3796 0 13.3156 13.7304 13.6066 13.3995 0 11.5299 0 0 0 12.6297 0 0 0 0 0 13.9807 16.0976 0 18.4978 16.3745 16.4275 14.7498 12.1559 9.61879 13.6618 15.8078 14.788 13.6997 13.9853 14.6117 11.0259 17.7367 18.0167 13.5 15.829 17.6924 0 18.8749 14.5127 16.1951 13.8641 15.6149 14.9947 14.8794 18.5467 15.8527 15.9898 13.3726 18.6762 18.4535 14.5473 19.1214 15.8485 14.2721 15.5539 14.1394 14.7203 16.1997 15.0921 13.3838 15.6714 18.1871 14.9934 13.5108 11.7224 14.7232 18.5121 18.398 13.5309 15.1228 14.813 0 15.6135 14.4129 18.6939 14.9594 12.6849 0 15.4318 16.1165 12.7731 18.4291 13.6058 18.6049 14.6331 16.1725 12.2948 16.0266 14.0824 15.9414 13.6597 15.6849 13.7433 15.3081 18.5225 0 15.8001 14.6128 14.7113 14.3591 16.2427 14.7142 15.723 14.3442 15.2263 13.3848 13.4235 14.232 0 11.7639 13.7724 12.5919 11.6373 14.1509 15.5761 15.5071 0 11.219 12.9514 13.0858 12.4233 8.84602 14.7961 19.5343 13.9833 13.3493 0 0 0 O43543 XRCC2_HUMAN DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2) XRCC2 Homo sapiens (Human) centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756]; strand invasion [GO:0042148] centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657] centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756]; strand invasion [GO:0042148] GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269 ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677] LVNDYRLVLFATTQTIMQK 0.99182 -7.7358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9911 0 0 0 13.908 0 0 0 0 0 0 0 0 0 0 0 12.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8205 0 0 0 0 0 0 13.5887 0 13.5259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.633 0 0 0 0 0 0 0 O94812 BAIP3_HUMAN "BAI1-associated protein 3, BAP3 (Brain-specific angiogenesis inhibitor I-associated protein 3)" BAIAP3 KIAA0734 Homo sapiens (Human) "dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; secretory vesicle [GO:0099503]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; secretory vesicle [GO:0099503]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:0099503; GO:1905413; GO:1990502 calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] CHYEAAEQR 0.99182 -17.791 0 0 0 0 0 10.3137 0 0 0 0 0 13.0329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7015 0 0 0 0 0 0 0 0 0 0 0 0 12.2853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7002 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7113 0 10.6719 0 13.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1842 0 0 0 0 0 0 0 0 14.1616 0 0 0 0 0 0 0 0 0 0 0 12.1487 0 14.883 0 13.8884 0 0 0 12.9126 0 0 0 0 0 0 0 0 0 0 0 15.7145 0 0 14.6879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.382 0 12.6833 0 0 0 0 0 11.0806 O94823 AT10B_HUMAN "Phospholipid-transporting ATPase VB, EC 7.6.2.1 (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B)" ATP10B ATPVB KIAA0715 Homo sapiens (Human) lysosomal membrane organization [GO:0097212]; phospholipid translocation [GO:0045332] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of lysosomal membrane [GO:1905103]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of lysosomal membrane [GO:1905103]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; lysosomal membrane organization [GO:0097212]; phospholipid translocation [GO:0045332] GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0016887; GO:0031902; GO:0045332; GO:0097212; GO:0140326; GO:0140345; GO:0140351; GO:1905103; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345] AMLNNSGPRYK 0.99182 -6.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.106 0 14.1602 0 0 0 13.2608 0 14.5111 0 0 0 0 0 0 0 0 0 0 13.4896 0 0 0 0 0 0 13.7247 14.1848 14.9909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6375 14.0592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0217 0 13.5062 0 0 0 0 0 0 0 P20929 NEBU_HUMAN Nebulin NEB Homo sapiens (Human) cardiac muscle thin filament assembly [GO:0071691]; muscle organ development [GO:0007517]; regulation of actin filament length [GO:0030832]; somatic muscle development [GO:0007525] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; structural constituent of muscle [GO:0008307]; cardiac muscle thin filament assembly [GO:0071691]; muscle organ development [GO:0007517]; regulation of actin filament length [GO:0030832]; somatic muscle development [GO:0007525] GO:0005829; GO:0007517; GO:0007525; GO:0008307; GO:0015629; GO:0030018; GO:0030832; GO:0051015; GO:0070062; GO:0071691 actin filament binding [GO:0051015]; structural constituent of muscle [GO:0008307] AAYVLDTPEMR 0.99182 -178.26 0 0 0 0 0 0 0 0 11.0664 11.4152 0 0 0 0 0 0 0 0 12.5314 12.7642 13.0376 0 0 0 0 0 0 0 10.5968 0 0 13.6776 0 0 11.6905 0 0 0 11.9948 0 0 0 0 0 0 0 0 13.5371 0 0 0 13.5889 13.3752 13.1607 0 0 15.423 15.0027 0 0 14.0098 14.013 14.0746 0 14.667 0 13.3629 0 11.4672 12.8894 0 15.4499 0 10.8057 0 0 10.9871 13.8726 12.7058 13.6072 12.6018 13.3426 13.1794 14.2743 0 0 16.1657 12.8628 0 0 15.4256 14.8179 12.6984 14.7467 0 12.8246 0 14.3011 15.687 13.2229 0 12.2223 12.028 10.0681 14.0173 0 14.3373 12.2688 0 12.8698 0 13.6643 12.2242 0 0 15.1288 0 11.3916 0 14.1534 0 0 9.38567 13.1237 14.7192 13.7597 0 13.2367 14.3154 0 16.2936 0 0 14.5604 0 13.5715 0 0 12.5635 14.9067 13.3354 13.0003 13.1728 12.7042 13.4488 13.4833 13.2077 12.9295 10.9165 14.2568 0 0 14.168 0 13.8598 11.6437 14.038 16.036 17.185 15.1939 14.6444 14.709 14.5145 15.5667 13.5821 14.1754 0 13.4458 15.0091 15.7801 15.9798 13.7633 0 13.1144 12.272 15.2671 12.9218 12.9947 0 0 Q13402 MYO7A_HUMAN Unconventional myosin-VIIa MYO7A USH1B Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; equilibrioception [GO:0050957]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagolysosome assembly [GO:0001845]; pigment granule transport [GO:0051904]; post-embryonic animal organ morphogenesis [GO:0048563]; protein localization [GO:0008104]; sensory organ development [GO:0007423]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; myosin complex [GO:0016459]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; myosin complex [GO:0016459]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420]; stereocilium base [GO:0120044]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; auditory receptor cell stereocilium organization [GO:0060088]; equilibrioception [GO:0050957]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mechanoreceptor differentiation [GO:0042490]; phagolysosome assembly [GO:0001845]; pigment granule transport [GO:0051904]; post-embryonic animal organ morphogenesis [GO:0048563]; protein localization [GO:0008104]; sensory organ development [GO:0007423]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]; visual perception [GO:0007601] GO:0000146; GO:0001750; GO:0001845; GO:0001917; GO:0005516; GO:0005524; GO:0005737; GO:0005765; GO:0005829; GO:0005902; GO:0005938; GO:0006886; GO:0007015; GO:0007040; GO:0007423; GO:0007601; GO:0007605; GO:0008104; GO:0015629; GO:0016324; GO:0016459; GO:0019904; GO:0030048; GO:0030050; GO:0030507; GO:0032391; GO:0032420; GO:0042462; GO:0042470; GO:0042490; GO:0045202; GO:0048563; GO:0050953; GO:0050957; GO:0051015; GO:0051904; GO:0060088; GO:0070161; GO:0120044 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; spectrin binding [GO:0030507] AEYLWRLEAEKMR 0.99182 -95.838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7692 0 0 0 0 0 0 0 0 12.0416 0 0 12.2902 12.9105 11.684 0 0 12.3055 0 0 0 0 0 10.2927 0 0 0 0 0 11.9487 10.6075 13.1626 11.082 0 0 11.0645 0 0 0 0 0 0 0 0 0 10.679 0 0 0 11.3735 0 14.587 0 0 0 0 13.7253 0 15.714 15.7931 14.7434 0 13.4061 13.3464 15.2239 15.3694 14.7274 15.3143 17.8553 13.2498 14.0406 0 13.5425 15.8758 14.5231 14.7162 14.9698 14.5767 18.0859 15.9252 0 14.5658 14.5326 13.3791 15.2605 14.6468 14.8652 14.4813 14.9671 13.0755 14.8174 15.4522 15.4729 15.4018 14.7881 12.3857 0 0 15.7073 15.2046 12.6383 0 15.604 14.8182 0 13.022 0 15.8907 0 0 0 13.5734 12.7073 0 0 13.7148 15.6608 0 0 13.3191 0 15.8734 13.4992 14.9675 0 14.3959 17.2742 12.8428 14.8193 14.9481 0 0 0 0 11.8728 0 13.8052 15.6947 15.1869 14.1381 13.7673 14.7851 0 14.3498 15.6346 15.4442 15.3392 14.9142 15.9315 14.6077 13.1585 0 14.0006 14.9618 0 13.1539 0 16.1183 12.1267 14.2129 0 0 Q504Y2 PKDCC_HUMAN "Extracellular tyrosine-protein kinase PKDCC, EC 2.7.10.2 (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)" PKDCC SGK493 VLK Homo sapiens (Human) bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501] GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] LLKEMVLLER 0.99182 -7.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.008 0 0 0 0 0 0 0 13.6145 0 0 0 0 0 0 14.8873 14.2598 0 0 0 14.8543 0 0 0 0 0 14.3134 0 0 0 0 0 15.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W92 LIPB1_HUMAN "Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1, PTPRF-interacting protein-binding protein 1) (hSGT2)" PPFIBP1 KIAA1230 Homo sapiens (Human) cell adhesion [GO:0007155]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; neuromuscular junction development [GO:0007528]; synapse organization [GO:0050808] GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007528; GO:0045296; GO:0048786; GO:0050808 cadherin binding [GO:0045296] ETIQKTSEDR 0.99182 -18.62 0 0 0 10.5433 0 0 0 0 14.8067 14.3147 0 0 0 0 0 0 0 0 0 13.7111 0 13.2451 0 13.1422 0 0 0 0 0 0 0 0 13.6396 0 14.0937 13.5067 0 0 0 0 13.4111 0 0 13.5785 13.2436 0 0 12.1985 0 0 0 0 11.1134 0 0 13.7227 14.0285 0 0 0 12.6524 0 0 12.0498 0 0 15.5538 16.2055 16.0347 0 0 15.241 16.1314 15.9036 17.0431 16.13 17.7819 15.9152 16.5981 16.1642 15.941 15.174 13.9322 15.2687 0 12.0919 0 15.1544 15.4818 13.0049 14.4645 14.6908 13.6821 15.5266 14.6554 13.2991 14.0624 13.5174 14.9183 14.0369 17.83 16.2589 14.7246 0 14.7322 14.2972 15.1069 0 15.5516 16.0674 16.0111 0 15.8891 16.0315 15.5585 15.4915 15.3911 15.7164 15.6981 15.9693 15.375 13.4385 15.0518 15.7494 15.0779 15.5244 15.9316 13.6508 14.118 16.8449 16.3269 15.98 15.7215 0 14.7896 0 14.8743 17.1123 16.1013 15.5272 16.7418 15.5289 15.8582 15.2963 12.289 13.4157 16.4319 0 0 13.492 16.435 14.9248 0 14.3639 13.4611 11.3482 0 0 13.832 0 15.9395 0 0 0 0 12.7221 0 13.2246 0 0 0 0 15.9034 13.0775 15.0744 0 0 0 15.9481 0 Q8IX21 SLF2_HUMAN SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1) SLF2 C10orf6 FAM178A Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" GO:0000724; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0006974; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0043231; GO:0044877; GO:1990166; GO:2000781 protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] DKERSSSK 0.99182 -23.83 0 0 0 12.8998 0 0 0 0 0 0 0 0 0 13.8392 0 0 0 12.9602 0 0 13.7241 0 0 0 0 0 0 0 0 0 11.9391 0 0 0 0 9.9678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8045 0 0 0 0 0 0 0 0 0 14.6616 0 13.4946 14.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8195 0 0 0 0 0 14.0592 0 0 0 0 13.6731 0 0 0 0 0 0 15.2649 0 15.0553 0 0 0 14.3131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.082 0 0 12.3602 13.5578 0 0 15.6421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3008 0 0 13.5597 14.2865 0 0 0 0 0 Q9H4B6 SAV1_HUMAN "Protein salvador homolog 1 (45 kDa WW domain protein, hWW45)" SAV1 WW45 Homo sapiens (Human) cardiac muscle cell proliferation [GO:0060038]; epithelial cell proliferation [GO:0050673]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte apoptotic process [GO:0097283]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of keratinocyte apoptotic process [GO:1902174]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; beta-1 adrenergic receptor binding [GO:0031697]; identical protein binding [GO:0042802]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; cardiac muscle cell proliferation [GO:0060038]; epithelial cell proliferation [GO:0050673]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte apoptotic process [GO:0097283]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of keratinocyte apoptotic process [GO:1902174]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of stem cell population maintenance [GO:2000036]; signal transduction [GO:0007165]; ventricular septum morphogenesis [GO:0060412] GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007165; GO:0030159; GO:0030216; GO:0030425; GO:0031697; GO:0035329; GO:0042802; GO:0043113; GO:0045600; GO:0046332; GO:0050673; GO:0050680; GO:0050821; GO:0051091; GO:0060038; GO:0060044; GO:0060412; GO:0060487; GO:0060575; GO:0070699; GO:0097283; GO:1902174; GO:2000036 beta-1 adrenergic receptor binding [GO:0031697]; identical protein binding [GO:0042802]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699] HASGIGR 0.99182 -4.3879 0 0 0 0 0 0 0 0 0 12.924 13.2468 0 0 12.5507 12.3174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9516 0 13.2943 0 12.2028 0 0 0 0 0 12.332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.45422 0 0 0 0 0 0 0 0 13.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2992 0 0 0 0 A6NJW4 LRR3C_HUMAN Leucine-rich repeat-containing protein 3C LRRC3C Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] GO:0005615; GO:0016021; GO:0031012 APVLPVR 0.99183 -6.0402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7961 14.7513 15.4494 14.4209 0 0 0 0 0 15.9817 16.1971 0 0 0 0 0 0 0 0 0 20.1881 0 0 O14771 ZN213_HUMAN Zinc finger protein 213 (Putative transcription factor CR53) (Zinc finger protein with KRAB and SCAN domains 21) ZNF213 ZKSCAN21 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AALGPVVGARRGR 0.99183 -18.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.914 0 0 0 0 0 0 13.7272 0 0 0 0 0 13.4992 14.9213 0 0 0 0 0 0 0 15.2963 0 0 0 0 13.6239 0 0 0 0 0 0 0 0 13.3711 0 0 0 0 0 0 0 0 0 11.6978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9326 0 0 0 0 0 0 16.2264 O43295 SRGP3_HUMAN "SLIT-ROBO Rho GTPase-activating protein 3, srGAP3 (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein, WRP)" SRGAP3 ARHGAP14 KIAA0411 KIAA1156 MEGAP SRGAP2 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336; GO:0051056 GTPase activator activity [GO:0005096] ASEDWWEGR 0.99183 -7.4664 0 0 0 0 0 0 0 0 13.5787 0 0 0 0 0 0 12.0857 11.895 0 0 0 0 13.1524 0 0 10.4709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9613 12.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9747 12.3366 13.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3019 0 0 0 12.5966 0 13.2249 0 13.7172 0 0 0 0 0 0 0 0 0 0 13.0668 15.5137 12.5797 0 0 12.6665 12.0158 0 12.942 0 0 0 0 0 13.0633 0 13.3291 0 0 0 0 0 0 0 0 0 0 0 13.7475 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3642 0 12.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1386 0 12.7859 0 0 0 0 0 0 O75339 CILP1_HUMAN "Cartilage intermediate layer protein 1, CILP-1 (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2 ]" CILP UNQ602/PRO1188 Homo sapiens (Human) cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of SMAD protein signal transduction [GO:0060392] GO:0005615; GO:0010629; GO:0043569; GO:0060392; GO:0062023; GO:0070062; GO:0071560 ACYIKVK 0.99183 -23.197 0 11.0341 0 0 0 0 0 0 0 13.8555 0 12.9347 0 0 0 13.3617 0 8.79585 0 0 0 0 0 0 12.354 0 0 0 0 13.0512 0 13.7503 0 13.1949 0 10.1221 0 12.3382 0 13.6566 0 13.3863 0 0 13.2771 0 0 12.4792 0 0 12.5947 0 0 0 0 11.5869 0 0 0 0 0 0 0 0 0 0 11.4 0 0 0 0 0 0 0 12.4961 0 0 0 0 0 0 13.4751 0 0 0 14.3665 0 0 0 0 14.3912 0 0 0 0 0 13.3421 0 0 0 13.2385 0 0 0 14.4087 14.9661 14.3728 0 11.9209 0 0 0 13.1952 0 0 13.9159 0 14.3673 11.6515 0 13.5983 14.0982 0 0 11.5127 14.6244 0 13.7674 0 0 12.0437 13.6843 0 0 13.0581 0 13.5602 15.4179 0 15.0216 0 0 0 0 0 13.0567 0 14.0918 0 0 0 0 0 0 0 0 13.7012 0 0 0 0 0 13.47 0 13.9595 0 0 0 0 0 16.1643 0 0 0 0 0 0 0 0 10.7392 P29965 CD40L_HUMAN "CD40 ligand, CD40-L (T-cell antigen Gp39) (TNF-related activation protein, TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form, sCD40L ]" CD40LG CD40L TNFSF5 TRAP Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; isotype switching [GO:0045190]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of apoptotic process [GO:0043066]; platelet activation [GO:0030168]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell proliferation [GO:0042102]; regulation of immunoglobulin production [GO:0002637]; T cell costimulation [GO:0031295] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; CD40 receptor binding [GO:0005174]; cytokine activity [GO:0005125]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; tumor necrosis factor receptor binding [GO:0005164]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; isotype switching [GO:0045190]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of apoptotic process [GO:0043066]; platelet activation [GO:0030168]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell proliferation [GO:0042102]; regulation of immunoglobulin production [GO:0002637]; T cell costimulation [GO:0031295] GO:0002637; GO:0005125; GO:0005164; GO:0005174; GO:0005178; GO:0005615; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0007159; GO:0007229; GO:0009897; GO:0009986; GO:0016021; GO:0023035; GO:0030168; GO:0030183; GO:0031295; GO:0032733; GO:0032735; GO:0032753; GO:0042100; GO:0042102; GO:0043066; GO:0043539; GO:0045190; GO:0051092; GO:2000353 CD40 receptor binding [GO:0005174]; cytokine activity [GO:0005125]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; tumor necrosis factor receptor binding [GO:0005164] DIMLNKEETK 0.99183 -4.5549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55786 PSA_HUMAN "Puromycin-sensitive aminopeptidase, PSA, EC 3.4.11.14 (Cytosol alanyl aminopeptidase, AAP-S)" NPEPPS PSA Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] GO:0000209; GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955 aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] DHVEGKQILSADLR 0.99183 -23.109 0 0 0 0 12.9548 12.6952 0 0 0 0 0 13.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5684 13.32 0 0 13.2952 11.3695 13.1747 0 0 0 0 0 0 0 11.9195 0 0 0 0 0 0 0 10.7594 0 0 0 0 0 0 0 0 0 0 0 0 12.3148 0 0 0 0 0 0 0 0 15.2502 12.8988 0 0 0 13.7126 15.7137 0 14.5049 0 15.3537 14.4248 0 14.3977 0 0 13.961 0 14.489 0 0 0 0 15.0954 0 0 0 0 0 0 0 0 14.2604 0 0 0 0 0 13.6476 0 0 11.4502 0 0 12.6615 0 0 0 0 0 0 12.4758 12.2916 0 0 0 0 0 0 14.6792 0 13.8696 0 12.6271 0 0 14.0191 0 0 0 0 0 0 0 0 0 0 13.2583 0 0 0 0 0 0 0 12.958 0 0 13.7782 0 0 14.2519 0 0 0 0 0 0 0 0 0 0 15.7073 0 0 Q49AN0 CRY2_HUMAN Cryptochrome-2 CRY2 KIAA0658 Homo sapiens (Human) "blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein import into nucleus [GO:0006606]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; nuclear receptor binding [GO:0016922]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription cis-regulatory region binding [GO:0000976]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein import into nucleus [GO:0006606]; regulation of circadian rhythm [GO:0042752]; regulation of sodium-dependent phosphate transport [GO:2000118]; response to activity [GO:0014823]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]" GO:0000122; GO:0000976; GO:0003677; GO:0003684; GO:0003697; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006606; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0016607; GO:0016922; GO:0019901; GO:0019902; GO:0019915; GO:0032515; GO:0032868; GO:0032922; GO:0042593; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0071949; GO:2000118; GO:2000323; GO:2000850 blue light photoreceptor activity [GO:0009882]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; nuclear receptor binding [GO:0016922]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; transcription cis-regulatory region binding [GO:0000976] EFFYTAATNNPR 0.99183 -23.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7955 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2031 0 12.6407 12.8978 0 0 0 12.9428 0 0 0 0 0 0 0 0 0 0 0 0 0 13.637 0 0 Q5T2Q4 CCYL2_HUMAN Cyclin-Y-like protein 2 CCNYL2 C10orf21 Homo sapiens (Human) regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859] cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; plasma membrane [GO:0005886] cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859] GO:0000308; GO:0005886; GO:0019901; GO:0045859; GO:0060828; GO:0061575 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901] KSQTDVQEK 0.99183 -7.4669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8177 0 0 0 0 0 0 0 0 0 13.5003 0 0 0 0 0 0 0 14.7369 0 0 0 13.578 0 0 0 13.7544 14.3489 14.4981 13.4385 0 0 14.7019 0 0 14.7827 13.5505 0 0 0 14.6374 0 0 0 0 0 13.8904 0 0 0 0 0 0 0 0 13.164 0 0 0 0 0 0 0 13.5239 0 13.4546 0 0 0 0 0 11.0792 0 0 0 14.0734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VWQ8 DAB2P_HUMAN "Disabled homolog 2-interacting protein, DAB2 interaction protein, DAB2-interacting protein (ASK-interacting protein 1, AIP-1) (DOC-2/DAB-2 interactive protein)" DAB2IP AF9Q34 AIP1 KIAA1743 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell cycle [GO:0051726]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]" AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886] "AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of dendrite development [GO:1900006]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell cycle [GO:0051726]; regulation of growth [GO:0040008]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]" GO:0000122; GO:0001525; GO:0001933; GO:0005096; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007049; GO:0007252; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0014067; GO:0016525; GO:0017124; GO:0019900; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030163; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032088; GO:0032266; GO:0032809; GO:0034144; GO:0034260; GO:0034620; GO:0035148; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0038026; GO:0040008; GO:0042059; GO:0042177; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043124; GO:0043184; GO:0043254; GO:0043407; GO:0043410; GO:0043507; GO:0043539; GO:0043548; GO:0043553; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045296; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0046580; GO:0048147; GO:0048812; GO:0050680; GO:0051721; GO:0051726; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071364; GO:0071889; GO:0071901; GO:0071902; GO:0072577; GO:0090090; GO:0090129; GO:1900006; GO:1900744; GO:1900747; GO:1901800; GO:1903896; GO:1990032; GO:1990597; GO:2001224; GO:2001235 14-3-3 protein binding [GO:0071889]; cadherin binding [GO:0045296]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184] CFSCRSAAER 0.99183 -23.114 0 0 0 0 0 0 0 0 0 11.3087 0 0 0 0 0 0 0 0 0 11.9933 12.6495 0 0 0 0 0 0 12.8021 0 12.1934 0 0 0 11.0825 0 0 0 0 0 13.2076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8047 0 0 0 0 0 0 0 10.0971 12.5637 13.0469 0 0 0 12.1699 0 0 0 13.3639 0 12.3633 0 0 11.6642 12.1502 14.1582 0 12.2197 12.3727 0 16.0331 0 0 0 14.1037 0 0 14.138 13.7169 0 0 0 0 13.0511 13.5297 12.6672 0 13.4914 0 14.1202 16.059 0 0 0 0 13.4367 0 0 0 14.0098 0 12.9949 0 0 0 0 0 11.4907 14.1964 0 0 0 0 0 0 0 13.2899 12.4126 0 13.445 13.0147 12.6798 0 0 0 12.7411 13.7025 11.7071 0 0 0 0 0 0 13.2527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULB1 NRX1A_HUMAN Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha) NRXN1 KIAA0578 Homo sapiens (Human) "adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" anchoring junction [GO:0070161]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982] "anchoring junction [GO:0070161]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0005887; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0070161; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463 acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023] AYGILMATTSR 0.99183 -18.747 0 0 0 0 0 0 0 0 0 11.8814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3674 0 0 0 16.1978 16.3519 0 0 0 0 0 0 11.8201 0 0 0 11.6893 0 10.2528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1695 0 0 0 0 0 0 0 0 12.7205 0 11.7974 0 0 0 0 0 0 0 12.6561 12.8047 0 0 0 0 0 0 0 0 0 0 0 13.9213 0 0 0 0 13.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.532 0 0 0 12.3599 0 0 0 0 12.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.672 0 0 0 0 0 0 0 13.3278 14.0913 0 0 14.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN81 LORF1_HUMAN "LINE-1 retrotransposable element ORF1 protein, L1ORF1p (LINE retrotransposable element 1) (LINE1 retrotransposable element 1)" L1RE1 LRE1 Homo sapiens (Human) "transposition, RNA-mediated [GO:0032197]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transposition, RNA-mediated [GO:0032197]" GO:0000166; GO:0003697; GO:0003727; GO:0005730; GO:0005737; GO:0010494; GO:0032197; GO:0036464; GO:0042802; GO:1990904 identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727] AAREKGR 0.99183 -23.875 10.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9826 0 0 0 0 0 0 0 11.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.35 0 0 0 0 0 11.2014 9.95015 11.5416 0 0 0 0 0 0 0 0 0 13.4625 10.8446 0 0 0 0 15.839 0 0 0 13.0623 0 0 0 0 12.0523 0 0 14.3164 0 12.2973 0 14.9506 0 0 10.5734 0 13.3502 0 0 0 13.0956 0 0 0 0 0 12.9319 0 0 0 0 0 0 0 0 0 0 0 0 13.2945 0 0 13.0074 0 12.727 0 12.5473 0 0 0 13.3401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0781 0 0 0 0 0 Q9UQ03 COR2B_HUMAN "Coronin-2B (Coronin-like protein C, Clipin-C) (Protein FC96)" CORO2B KIAA0925 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of establishment of protein localization [GO:1904950]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of establishment of protein localization [GO:1904951]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cellular response to stress [GO:0080135]; regulation of glomerular filtration [GO:0003093] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; talin binding [GO:1990147]; vinculin binding [GO:0017166]; actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of establishment of protein localization [GO:1904950]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of establishment of protein localization [GO:1904951]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cellular response to stress [GO:0080135]; regulation of glomerular filtration [GO:0003093] GO:0003093; GO:0003779; GO:0005737; GO:0005925; GO:0010812; GO:0015629; GO:0016020; GO:0017166; GO:0030036; GO:0032956; GO:0048041; GO:0051015; GO:0051497; GO:0080135; GO:1904950; GO:1904951; GO:1990147 actin binding [GO:0003779]; actin filament binding [GO:0051015]; talin binding [GO:1990147]; vinculin binding [GO:0017166] DIRIRQLQLELK 0.99183 -23.928 0 0 0 0 0 0 0 0 11.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1499 0 0 12.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5496 12.9867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6533 12.7085 0 0 14.0559 0 0 13.2204 0 13.04 0 0 0 0 0 0 0 0 13.6163 13.68 11.8876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0764 0 0 0 0 0 0 0 0 11.963 0 0 0 0 0 0 0 0 0 0 Q9Y6H5 SNCAP_HUMAN "Synphilin-1, Sph1 (Alpha-synuclein-interacting protein)" SNCAIP Homo sapiens (Human) cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928] GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083 identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625] ACSTGSSESSSSNMAPFCVLSPVK 0.99183 -18.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3212 0 12.451 0 0 0 0 0 0 0 0 0 0 12.7796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5407 0 0 0 11.9679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0426 0 11.2709 0 0 0 0 0 0 16.3213 0 0 0 0 0 0 0 0 0 0 13.2789 0 0 0 14.6122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.481 A8MYA2 CX049_HUMAN Uncharacterized protein CXorf49 CXorf49; CXorf49B Homo sapiens (Human) AQLPTHRPGLPR 0.99184 -6.0532 0 0 0 0 0 0 0 0 0 0 14.2263 0 0 14.7659 13.6232 10.7668 12.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2058 13.8461 13.6855 0 0 0 0 13.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5651 12.3745 0 0 0 0 0 13.9958 0 0 0 14.2064 0 0 13.9543 0 13.7994 13.6533 0 10.9279 13.6771 0 0 0 13.7316 0 0 13.2167 0 0 0 13.0438 0 0 0 0 0 0 0 0 0 0 11.0563 0 0 0 0 0 0 0 0 12.9945 0 0 0 0 0 0 0 0 13.3285 0 0 0 0 0 0 0 0 0 0 0 16.2885 10.6694 0 0 0 0 0 0 0 0 15.288 0 16.1599 15.8171 16.2032 15.7297 16.2247 15.8499 14.435 0 16.3413 15.7155 15.8245 15.426 0 0 0 0 0 0 16.795 0 15.4761 Q5VTR2 BRE1A_HUMAN "E3 ubiquitin-protein ligase BRE1A, BRE1-A, hBRE1, EC 2.3.2.27 (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A)" RNF20 BRE1A Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; negative regulation of cell migration [GO:0030336]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000151; GO:0000209; GO:0002039; GO:0003682; GO:0003713; GO:0003730; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006511; GO:0010390; GO:0030336; GO:0031062; GO:0031625; GO:0033503; GO:0033523; GO:0042393; GO:0042802; GO:0045893; GO:0046872; GO:0061630; GO:0071894 chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] AQEDISR 0.99184 -23.213 0 0 0 14.3814 0 0 0 0 11.867 0 0 0 0 0 12.1716 0 0 0 0 0 11.7922 0 0 12.6101 0 0 0 10.4177 0 0 12.3744 0 0 0 0 0 0 9.85045 0 0 11.7287 0 0 14.8056 0 13.3875 0 0 11.723 0 0 0 0 0 0 0 0 13.1212 0 0 0 0 0 0 0 0 12.7585 10.5825 13.0549 14.2919 13.3181 12.7028 0 0 15.1251 13.6756 14.5827 0 13.92 0 14.9858 13.1968 14.7521 15.8504 0 16.5153 0 14.293 15.8441 16.3795 16.0765 16.8611 15.1062 15.6241 16.3076 16.4019 15.7751 15.4402 13.4161 14.8179 15.8866 16.0531 13.8149 15.371 16.9508 12.1756 14.8159 15.1423 15.2944 15.7685 16.0127 14.1961 16.1455 14.1256 0 15.9421 15.5628 13.5865 13.7076 14.857 13.379 13.4797 13.7139 13.9341 13.8424 14.109 14.6793 14.7149 13.8273 13.3737 14.3028 14.8847 14.8332 14.9247 0 14.9491 0 14.1844 13.1951 0 0 0 14.5925 14.6409 0 0 13.8921 13.5697 0 0 13.3947 13.249 0 14.4573 14.8134 14.161 14.8855 0 0 11.926 0 13.1223 13.6654 0 12.9726 14.24 0 12.4731 0 0 0 0 0 13.13 0 14.0723 12.6088 0 0 0 O75503 CLN5_HUMAN "Ceroid-lipofuscinosis neuronal protein 5, Protein CLN5 [Cleaved into: Ceroid-lipofuscinosis neuronal protein 5, secreted form ]" CLN5 Homo sapiens (Human) "brain development [GO:0007420]; glycosylation [GO:0070085]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; neurogenesis [GO:0022008]; neuron maturation [GO:0042551]; positive regulation of GTP binding [GO:1904426]; protein catabolic process [GO:0030163]; retrograde transport, endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465]; visual perception [GO:0007601]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuolar lumen [GO:0005775] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuolar lumen [GO:0005775]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; mannose binding [GO:0005537]; brain development [GO:0007420]; glycosylation [GO:0070085]; lysosomal lumen acidification [GO:0007042]; lysosome organization [GO:0007040]; neurogenesis [GO:0022008]; neuron maturation [GO:0042551]; positive regulation of GTP binding [GO:1904426]; protein catabolic process [GO:0030163]; retrograde transport, endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465]; visual perception [GO:0007601]" GO:0005537; GO:0005764; GO:0005765; GO:0005775; GO:0005783; GO:0005794; GO:0005829; GO:0006465; GO:0007040; GO:0007042; GO:0007420; GO:0007601; GO:0016021; GO:0016798; GO:0022008; GO:0030163; GO:0042147; GO:0042551; GO:0048471; GO:0070062; GO:0070085; GO:1904426 "hydrolase activity, acting on glycosyl bonds [GO:0016798]; mannose binding [GO:0005537]" ASPEKGAETWFDSYDCSKFVLR 0.99184 -7.5001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6311 0 0 0 0 0 0 0 0 0 0 0 13.0064 0 0 0 0 0 0 0 10.9524 0 0 13.0466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3488 0 0 0 0 0 10.7021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3896 0 0 0 0 0 0 0 0 0 0 0 0 13.7221 0 0 0 0 0 0 0 0 0 0 0 0 P0DN37 PAL4G_HUMAN "Peptidyl-prolyl cis-trans isomerase A-like 4G, PPIase A-like 4G, EC 5.2.1.8 (Peptidylprolyl cis-trans isomerase A-like 4)" PPIAL4G Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] GO:0000413; GO:0003755; GO:0005737; GO:0006457; GO:0016018; GO:0043231 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] FDDENLIR 0.99184 -4.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12107 COBA1_HUMAN Collagen alpha-1(XI) chain COL11A1 COLL6 Homo sapiens (Human) cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601] collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; ossification [GO:0001503]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601] GO:0001502; GO:0001503; GO:0002063; GO:0005201; GO:0005576; GO:0005592; GO:0005615; GO:0005788; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0050840; GO:0050910; GO:0055010; GO:0062023; GO:1904399 extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674] DSDLLVDGDLGEYDFYEYKEYEDK 0.99184 -23.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.11 0 11.9897 0 0 0 0 0 12.0444 0 0 0 0 0 0 0 0 0 0 0 0 11.879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9574 0 13.9169 0 0 0 0 0 0 0 0 12.7745 0 0 0 0 0 0 0 10.5551 0 0 12.7158 0 0 0 0 0 0 0 0 0 0 13.4871 0 0 0 0 0 14.7008 0 14.0534 0 13.5826 0 0 0 0 0 0 0 0 0 0 0 12.9676 12.8082 0 0 0 0 0 0 0 0 14.1358 0 0 0 0 0 0 0 0 0 0 0 0 12.5076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.566 0 0 10.1595 0 0 0 0 0 P18440 ARY1_HUMAN "Arylamine N-acetyltransferase 1, EC 2.3.1.5 (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase, MNAT) (N-acetyltransferase type 1, NAT-1)" NAT1 AAC1 Homo sapiens (Human) xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829] cytosol [GO:0005829]; arylamine N-acetyltransferase activity [GO:0004060]; xenobiotic metabolic process [GO:0006805] GO:0004060; GO:0005829; GO:0006805 arylamine N-acetyltransferase activity [GO:0004060] KLVPKHGDR 0.99184 -4.8646 0 0 0 0 0 0 0 0 12.4455 0 11.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3066 0 0 0 0 0 0 0 14.0556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3115 0 0 0 0 0 0 0 0 0 0 0 0 12.0688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0871 0 0 0 0 13.7285 0 P56975 NRG3_HUMAN "Pro-neuregulin-3, membrane-bound isoform, Pro-NRG3 [Cleaved into: Neuregulin-3, NRG-3 ]" NRG3 Homo sapiens (Human) animal organ development [GO:0048513]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; intracellular signal transduction [GO:0035556]; mammary placode formation [GO:0060596]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron migration [GO:2001223]; pattern specification process [GO:0007389]; regulation of cell growth [GO:0001558] extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887] extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; animal organ development [GO:0048513]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; ERBB4 signaling pathway [GO:0038130]; ERBB4-ERBB4 signaling pathway [GO:0038138]; intracellular signal transduction [GO:0035556]; mammary placode formation [GO:0060596]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron migration [GO:2001223]; pattern specification process [GO:0007389]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005102; GO:0005576; GO:0005615; GO:0005887; GO:0007389; GO:0008083; GO:0021842; GO:0030297; GO:0030971; GO:0035556; GO:0038130; GO:0038138; GO:0045499; GO:0048018; GO:0048513; GO:0050804; GO:0060596; GO:0098978; GO:2001223 chemorepellent activity [GO:0045499]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] ASSTMAK 0.99184 -4.7139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2972 13.0149 0 0 0 0 0 0 0 0 0 0 0 0 0 12.91 0 0 0 0 0 13.2133 0 0 0 0 0 0 0 0 13.1636 0 0 0 0 0 13.3504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13200 PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2) PSMD2 TRAP2 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]" GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008540; GO:0016020; GO:0022624; GO:0030234; GO:0034515; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813 enzyme regulator activity [GO:0030234] AVPLALALISVSNPR 0.99184 -18.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.66 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4583 0 0 12.7679 0 0 0 10.6663 0 0 0 0 0 0 0 0 0 13.8173 0 0 13.8212 0 15.4009 14.9934 13.4736 0 0 12.9015 0 13.0456 0 0 0 13.1743 0 0 12.6103 0 0 0 0 14.2926 0 0 0 0 0 0 0 0 0 0 14.6044 12.4793 0 0 0 0 0 0 13.9952 0 0 0 12.6002 0 0 0 0 0 12.159 0 0 0 0 0 0 0 0 0 0 12.3083 0 0 12.4705 0 11.7359 0 0 0 0 0 0 0 0 0 0 12.5302 12.6234 0 12.0323 0 0 0 0 0 0 0 0 0 11.3235 0 0 0 Q13501 SQSTM_HUMAN "Sequestosome-1 (EBI3-associated protein of 60 kDa, EBIAP, p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62)" SQSTM1 ORCA OSIL Homo sapiens (Human) aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511] aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225] aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000122; GO:0000407; GO:0000422; GO:0000423; GO:0000932; GO:0001659; GO:0001934; GO:0002376; GO:0002931; GO:0004674; GO:0005080; GO:0005654; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006468; GO:0006511; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008104; GO:0008270; GO:0010821; GO:0016197; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030971; GO:0031397; GO:0031625; GO:0035255; GO:0035556; GO:0035973; GO:0042169; GO:0042802; GO:0043065; GO:0043122; GO:0043130; GO:0043231; GO:0044753; GO:0044754; GO:0044877; GO:0045944; GO:0046578; GO:0061635; GO:0061912; GO:0070062; GO:0070342; GO:0070530; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:1900273; GO:1903078; GO:1905719 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] CSVCPDYDLCSVCEGK 0.99184 -4.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5513 0 0 0 0 0 12.6483 12.0583 0 0 0 12.9641 0 0 0 0 11.2748 0 0 0 0 0 13.7035 0 0 0 0 13.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3576 0 0 0 0 0 0 0 0 11.9643 0 0 0 13.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2295 0 0 11.9442 0 0 0 Q14681 KCTD2_HUMAN BTB/POZ domain-containing protein KCTD2 (Potassium channel tetramerization domain-containing protein 2) KCTD2 KIAA0176 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cullin family protein binding [GO:0097602]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260] GO:0005737; GO:0031463; GO:0043161; GO:0044877; GO:0051260; GO:0097602 cullin family protein binding [GO:0097602]; protein-containing complex binding [GO:0044877] AGGGGAAR 0.99184 -6.0541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9537 0 0 0 14.328 0 15.1507 0 0 0 0 0 0 0 0 0 0 0 Q2VIQ3 KIF4B_HUMAN Chromosome-associated kinesin KIF4B (Chromokinesin-B) KIF4B Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; spindle elongation [GO:0051231] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; spindle elongation [GO:0051231] GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005654; GO:0005829; GO:0005874; GO:0005875; GO:0007018; GO:0007052; GO:0008017; GO:0016363; GO:0046872; GO:0051231; GO:0051256; GO:0051536 ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] IILTEQVNEK 0.99184 -22.617 0 0 0 0 0 10.2021 0 0 11.8731 12.8834 13.7356 0 0 0 11.0291 10.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8251 0 0 0 0 0 0 0 0 0 0 13.4186 0 13.0692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.762 0 0 0 11.1225 13.5269 0 0 13.5209 0 0 0 0 0 12.5636 11.9366 14.2406 14.3824 0 15.0396 0 0 14.0882 14.4286 0 14.0707 14.442 15.0281 0 0 13.9845 0 13.9781 13.4501 12.1495 11.1225 14.4528 16.0386 0 12.5114 0 0 12.975 12.7682 0 14.728 13.6728 0 0 12.4637 13.2946 12.442 11.5041 0 13.3261 13.5021 0 12.7696 13.8407 0 0 0 0 16.5374 0 0 0 0 0 14.44 12.4919 0 0 0 13.6847 0 0 0 0 0 0 0 0 13.2008 0 0 0 0 10.9082 12.2874 0 0 0 0 0 0 0 11.6986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXS9 CASPC_HUMAN "Inactive caspase-12, CASP-12" CASP12 UNQ9415/PRO34398 Homo sapiens (Human) proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727] AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; IPAF inflammasome complex [GO:0072557]; NLRP3 inflammasome complex [GO:0072559] AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; IPAF inflammasome complex [GO:0072557]; NLRP3 inflammasome complex [GO:0072559]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727] GO:0005737; GO:0005783; GO:0006508; GO:0042981; GO:0050727; GO:0072557; GO:0072559; GO:0097169; GO:0097199 cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199] ADEKPSNGVLVHMVKLLIK 0.99184 -6.0473 0 0 0 0 0 0 0 0 0 0 0 9.4095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NC24 RELL2_HUMAN RELT-like protein 2 RELL2 C5orf16 UNQ9423/PRO34565 Homo sapiens (Human) positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of p38MAPK cascade [GO:1900745] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of p38MAPK cascade [GO:1900745] GO:0005518; GO:0005604; GO:0005886; GO:0010811; GO:0016021; GO:1900745 collagen binding [GO:0005518] DSSLTPRALEGNPR 0.99184 -4.7182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4768 0 11.5229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.463 0 0 0 0 0 0 0 0 12.8459 0 11.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2257 0 0 0 0 12.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1412 0 0 0 0 0 0 0 12.0617 0 0 0 11.2518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1048 0 0 13.0562 13.8293 0 0 0 0 0 0 0 0 13.2067 0 0 0 0 0 0 13.2627 0 0 Q8WU58 F222B_HUMAN Protein FAM222B FAM222B C17orf63 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 AGLLAIVKVPAKSILK 0.99184 -6.0544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2954 12.7918 13.2562 0 0 0 0 0 0 0 12.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2102 0 0 12.243 0 0 0 0 0 0 11.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MT8 CEP63_HUMAN "Centrosomal protein of 63 kDa, Cep63" CEP63 Homo sapiens (Human) cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint signaling [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; spindle pole [GO:0000922] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; spindle pole [GO:0000922]; cell division [GO:0051301]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; DNA damage checkpoint signaling [GO:0000077]; signal transduction in response to DNA damage [GO:0042770]; spindle assembly [GO:0051225] GO:0000077; GO:0000922; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0042770; GO:0051225; GO:0051301; GO:0098535 AVEHKEILDQLESLK 0.99184 -22.608 0 0 0 0 0 0 0 0 0 0 11.2464 0 11.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3912 0 12.5538 0 0 12.5359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4154 0 0 0 12.7411 13.0206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9145 0 0 0 0 0 10.7569 0 0 0 14.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3184 0 0 0 0 0 0 0 Q9UJW8 ZN180_HUMAN Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DDPWLSSCEEVDDCK 0.99184 -4.8691 0 0 0 0 0 0 0 10.6393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.75 0 0 0 0 0 0 0 0 0 0 11.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.428 0 0 0 0 0 0 0 0 12.6108 0 0 0 0 0 0 0 0 0 0 0 0 9.19921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2A3K4 PTPC1_HUMAN "Protein tyrosine phosphatase domain-containing protein 1, EC 3.1.3.-" PTPDC1 PTP9Q22 Homo sapiens (Human) cilium assembly [GO:0060271]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cilium assembly [GO:0060271]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005654; GO:0005737; GO:0006470; GO:0008138; GO:0060271 protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] DGPKPGL 0.99185 -18.927 12.6259 0 0 0 0 10.0598 0 0 0 0 0 0 0 0 13.2499 0 12.9869 12.6999 0 0 13.3036 0 0 0 0 0 12.9363 0 0 0 12.292 12.4178 0 0 0 0 0 0 0 0 0 0 13.1131 0 0 12.7914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6512 0 0 0 0 0 12.5673 0 0 0 0 0 0 0 0 0 0 0 0 0 12.972 14.1 0 0 0 14.0718 0 0 0 0 13.2534 0 0 13.7886 0 0 14.4351 14.4957 0 0 12.6966 0 0 0 0 0 13.4737 0 0 0 0 0 0 0 0 13.819 0 0 0 0 14.0954 0 0 0 13.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8665 0 0 0 15.5303 0 0 0 0 0 0 0 0 0 0 14.192 0 0 0 0 12.7388 0 0 13.532 12.6961 0 0 12.6 0 0 0 14.7809 0 0 0 P02647 APOA1_HUMAN "Apolipoprotein A-I, Apo-AI, ApoA-I (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I, ProapoA-I; Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242)) ]" APOA1 Homo sapiens (Human) adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of triglyceride catabolic process [GO:0010898]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]; vitamin transport [GO:0051180] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361] blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]; amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; apolipoprotein receptor binding [GO:0034190]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; glucocorticoid metabolic process [GO:0008211]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of triglyceride catabolic process [GO:0010898]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]; vitamin transport [GO:0051180] GO:0001540; GO:0001932; GO:0001935; GO:0002719; GO:0005102; GO:0005543; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005829; GO:0005886; GO:0006656; GO:0006695; GO:0007186; GO:0007229; GO:0008035; GO:0008203; GO:0008211; GO:0010804; GO:0010873; GO:0010875; GO:0010898; GO:0010903; GO:0015485; GO:0018158; GO:0018206; GO:0019899; GO:0019915; GO:0030139; GO:0030300; GO:0030301; GO:0030325; GO:0031072; GO:0031210; GO:0031410; GO:0032489; GO:0032691; GO:0033344; GO:0033700; GO:0034115; GO:0034190; GO:0034191; GO:0034361; GO:0034364; GO:0034366; GO:0034372; GO:0034375; GO:0034380; GO:0034384; GO:0034774; GO:0035025; GO:0042157; GO:0042158; GO:0042627; GO:0042632; GO:0042802; GO:0042803; GO:0043534; GO:0043691; GO:0045499; GO:0045723; GO:0046470; GO:0046889; GO:0050728; GO:0050766; GO:0050821; GO:0050919; GO:0051006; GO:0051180; GO:0051345; GO:0051346; GO:0051496; GO:0055091; GO:0060228; GO:0060354; GO:0060761; GO:0062023; GO:0070062; GO:0070328; GO:0070508; GO:0070653; GO:0071682; GO:0072562; GO:0090205; GO:0120020; GO:1900026; GO:1902995; GO:1903561; GO:1905920 amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; apolipoprotein receptor binding [GO:0034190]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] PALEDLR 0.99185 -4.7344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6113 0 14.4293 14.1926 16.3939 0 0 0 0 13.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.653 0 0 0 0 0 0 0 0 0 0 0 P62266 RS23_HUMAN 40S ribosomal protein S23 (Small ribosomal subunit protein uS12) RPS23 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; maintenance of translational fidelity [GO:1990145]; stress granule assembly [GO:0034063]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ribosome [GO:0005840]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maintenance of translational fidelity [GO:1990145]; stress granule assembly [GO:0034063]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005783; GO:0005791; GO:0005829; GO:0005840; GO:0006412; GO:0016020; GO:0022626; GO:0022627; GO:0034063; GO:0042788; GO:0045202; GO:1990145 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] FKVVKVANVSLLALYK 0.99185 -4.7393 0 0 0 0 0 0 0 0 13.5575 0 14.1603 15.2422 0 0 0 0 0 0 12.7364 0 0 0 0 0 0 0 0 0 0 14.2056 0 0 0 0 0 0 0 0 0 0 13.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1665 0 0 0 0 0 0 0 0 0 13.4584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.115 0 12.9515 0 16.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7083 0 0 0 13.8225 0 0 0 0 0 12.2809 0 0 0 0 15.6377 0 0 0 0 14.1441 0 12.8712 0 14.6516 0 0 0 0 0 12.7267 0 Q86TJ2 TAD2B_HUMAN "Transcriptional adapter 2-beta (ADA2-like protein beta, ADA2-beta)" TADA2B ADA2B Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000124; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006338; GO:0006357; GO:0008270; GO:0035066; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0070461 chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] EFDDLFENMHKEK 0.99185 -4.7309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3721 0 11.2684 0 0 0 0 0 0 10.6919 12.6617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWT1 CDCA7_HUMAN Cell division cycle-associated protein 7 (Protein JPO1) CDCA7 JPO1 Homo sapiens (Human) "apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; regulation of cell population proliferation [GO:0042127]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006915; GO:0042127 LISMETSSSSDDSCDSFASDNFANTR 0.99185 -22.765 0 0 0 0 0 0 0 0 13.9051 13.9123 13.808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4765 12.5946 12.3235 12.9147 11.8718 11.366 12.6045 10.8518 14.0605 12.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1938 0 0 0 0 0 13.0018 0 13.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9998 0 0 0 0 0 0 13.6589 0 0 0 13.1389 0 0 0 0 12.6555 0 0 13.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2217 0 0 0 0 0 0 0 13.2455 13.7711 0 0 0 0 0 14.9525 0 0 0 0 Q9BXT5 TEX15_HUMAN "Testis-expressed protein 15 (Cancer/testis antigen 42, CT42)" TEX15 Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; regulation of double-strand break repair via homologous recombination [GO:0010569]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; regulation of double-strand break repair via homologous recombination [GO:0010569]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] GO:0005634; GO:0005737; GO:0006281; GO:0006306; GO:0007130; GO:0007140; GO:0007283; GO:0010529; GO:0010569; GO:0030154; GO:0031047 CEDSQEQQQDTTVSSCK 0.99185 -55.141 10.9829 0 0 12.5241 0 0 0 12.8846 0 0 14.5479 0 13.6193 0 0 13.1167 0 11.8842 0 12.2908 13.3772 0 0 0 0 12.8352 12.3899 11.7655 0 0 0 12.397 0 0 0 0 0 0 0 0 0 12.7026 0 0 0 13.2943 13.3239 0 12.9493 12.8263 0 12.6236 12.9427 13.3927 13.6513 14.168 12.601 0 0 0 0 11.3775 0 11.4923 0 0 0 0 0 11.539 0 0 0 0 0 15.168 0 0 0 9.49035 13.1507 0 14.076 13.1619 13.5319 0 12.947 13.5275 0 0 0 0 0 14.3476 0 0 14.0986 0 14.5713 0 12.8357 12.215 0 0 0 0 12.6553 14.2499 14.1033 0 0 0 0 0 0 11.3285 0 11.5926 0 0 12.7598 0 0 14.6089 13.9092 0 0 13.0272 0 0 13.3759 10.8612 0 14.2546 15.1144 0 12.7099 0 0 14.8237 0 0 0 0 0 0 12.4396 16.5729 0 0 0 14.4817 0 0 0 0 14.0821 0 10.6369 0 0 0 14.1056 0 0 13.9511 0 16.4123 16.0322 0 0 0 0 0 11.4065 14.191 13.1307 0 13.9984 0 Q9HCE7 SMUF1_HUMAN "E3 ubiquitin-protein ligase SMURF1, hSMURF1, EC 2.3.2.26 (HECT-type E3 ubiquitin transferase SMURF1) (SMAD ubiquitination regulatory factor 1) (SMAD-specific E3 ubiquitin-protein ligase 1)" SMURF1 KIAA1625 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of dendrite extension [GO:1903861]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; ectoderm development [GO:0007398]; engulfment of target by autophagosome [GO:0061736]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of dendrite extension [GO:1903861]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein export from nucleus [GO:0006611]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; protein targeting to vacuole involved in autophagy [GO:0071211]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; substrate localization to autophagosome [GO:0061753]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0000209; GO:0004842; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0006611; GO:0007398; GO:0016567; GO:0030154; GO:0030424; GO:0030509; GO:0030512; GO:0030514; GO:0030579; GO:0032801; GO:0034394; GO:0043025; GO:0043161; GO:0048185; GO:0060071; GO:0061630; GO:0061736; GO:0061753; GO:0070062; GO:0070411; GO:0070412; GO:0071211; GO:0072659; GO:1903861; GO:2000060 activin binding [GO:0048185]; I-SMAD binding [GO:0070411]; phospholipid binding [GO:0005543]; R-SMAD binding [GO:0070412]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ARLLQFVTGSTR 0.99185 -4.8807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1552 0 0 0 0 0 0 0 0 0 0 0 0 12.3609 0 0 0 0 13.1085 0 13.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4509 0 Q9P2F6 RHG20_HUMAN Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20) ARHGAP20 KIAA1391 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0007165; GO:0051056 GTPase activator activity [GO:0005096] CSEPNIEDQNR 0.99185 -22.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3425 12.7006 13.4015 0 0 0 13.8726 0 0 0 0 0 0 0 0 0 0 0 0 10.2569 0 0 0 0 0 0 0 0 0 0 0 13.1357 0 0 9.89483 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2229 0 0 0 0 0 0 0 0 12.9013 0 0 16.6204 0 0 0 0 0 0 0 0 0 13.7524 0 0 0 0 13.8914 0 0 0 0 0 14.9919 0 0 0 0 0 0 13.9527 0 0 0 0 O43909 EXTL3_HUMAN "Exostosin-like 3, EC 2.4.1.223 (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3)" EXTL3 EXTL1L EXTR1 KIAA0519 Homo sapiens (Human) heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of cell growth [GO:0030307]; protein glycosylation [GO:0006486] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of cell growth [GO:0030307]; protein glycosylation [GO:0006486] GO:0001888; GO:0005783; GO:0005789; GO:0005794; GO:0006486; GO:0015012; GO:0016021; GO:0016757; GO:0030307; GO:0046872 glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872] CINFFVK 0.99186 -55.645 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5899 0 11.3007 0 0 0 0 11.9749 12.0742 0 0 0 0 0 12.5373 0 0 0 0 0 0 0 11.193 0 0 0 0 0 11.5048 0 0 0 11.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1918 10.8209 0 0 0 0 13.765 0 0 0 0 0 0 0 16.92 0 16.2903 16.9103 16.8433 18.1815 17.3056 17.3926 17.259 14.3561 13.0108 0 16.1514 16.4574 16.4563 0 16.2363 15.294 0 15.0513 0 13.9592 15.5285 0 15.0838 16.0036 0 14.4523 14.6379 0 0 0 16.1542 14.9682 15.0658 13.971 13.9536 15.3803 13.8507 14.6979 14.6864 14.719 14.4232 15.7335 15.4704 15.0047 15.3855 15.4338 0 0 0 13.7544 0 15.0603 14.1331 15.9461 13.8193 0 14.1102 13.5517 15.3509 0 0 13.8858 0 0 0 12.2051 0 0 12.174 0 0 0 12.6057 0 12.5596 0 0 0 0 0 13.2434 0 0 0 0 0 0 14.0309 14.1915 12.0885 0 0 12.372 13.0008 0 0 P06729 CD2_HUMAN T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2) CD2 SRBC Homo sapiens (Human) apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; heterotypic cell-cell adhesion [GO:0034113]; membrane raft polarization [GO:0001766]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell activation [GO:0030887]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of T cell differentiation [GO:0045580]; T cell activation [GO:0042110] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic side of plasma membrane [GO:0009898]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; heterotypic cell-cell adhesion [GO:0034113]; membrane raft polarization [GO:0001766]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell activation [GO:0030887]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of T cell differentiation [GO:0045580]; T cell activation [GO:0042110] GO:0001766; GO:0005102; GO:0005576; GO:0005654; GO:0005794; GO:0005886; GO:0005887; GO:0005911; GO:0006915; GO:0007166; GO:0009897; GO:0009898; GO:0009986; GO:0030101; GO:0030887; GO:0030971; GO:0032729; GO:0032757; GO:0032760; GO:0032991; GO:0034113; GO:0038023; GO:0042110; GO:0042267; GO:0042802; GO:0043621; GO:0045121; GO:0045580; GO:0046658; GO:0098609 identical protein binding [GO:0042802]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102] IAQFRKEK 0.99186 -18.529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4621 0 0 0 0 0 0 0 0 0 0 0 12.584 0 0 0 0 0 0 14.3142 0 13.2712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18621 RL17_HUMAN 60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1) RPL17 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0022625; GO:0022626 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] KQKLMAR 0.99186 -18.53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46821 MAP1B_HUMAN "Microtubule-associated protein 1B, MAP-1B [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1 ]" MAP1B Homo sapiens (Human) axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; axon [GO:0030424]; basal dendrite [GO:0097441]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; hippocampal mossy fiber [GO:0097457]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; varicosity [GO:0043196]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to peptide hormone stimulus [GO:0071375]; dendrite development [GO:0016358]; developmental maturation [GO:0021700]; establishment of monopolar cell polarity [GO:0061162]; induction of synaptic plasticity by chemical substance [GO:0051915]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; negative regulation of intracellular transport [GO:0032387]; negative regulation of microtubule depolymerization [GO:0007026]; neuron migration [GO:0001764]; odontoblast differentiation [GO:0071895]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of axon extension [GO:0045773]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron differentiation [GO:0045666]; regulation of microtubule depolymerization [GO:0031114]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to inorganic substance [GO:0010035]; response to insecticide [GO:0017085]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] GO:0000226; GO:0001578; GO:0001750; GO:0001764; GO:0003779; GO:0005198; GO:0005543; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0007026; GO:0007409; GO:0007416; GO:0008017; GO:0009410; GO:0009612; GO:0009743; GO:0010035; GO:0014012; GO:0014069; GO:0016358; GO:0017085; GO:0021700; GO:0030424; GO:0030425; GO:0030426; GO:0031114; GO:0031116; GO:0032355; GO:0032387; GO:0033189; GO:0036477; GO:0043025; GO:0043196; GO:0043197; GO:0043204; GO:0044877; GO:0045202; GO:0045666; GO:0045773; GO:0047497; GO:0048471; GO:0048675; GO:0051915; GO:0061162; GO:0070161; GO:0071363; GO:0071375; GO:0071895; GO:0097440; GO:0097441; GO:0097457 actin binding [GO:0003779]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] AETEEAEEPEEDGEEHVCVSASKHSPTEDEESAK 0.99186 -86.436 0 0 0 0 14.3097 0 0 0 10.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6667 14.0509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6417 12.8489 15.3162 0 13.3281 13.6929 0 13.4416 0 0 13.6826 0 0 12.2478 10.7911 12.6824 0 0 0 13.4327 0 0 0 0 14.5269 0 0 0 0 0 0 0 12.4814 11.995 0 0 13.1734 0 15.6319 12.2989 0 0 12.6369 0 14.6004 0 0 0 12.2909 0 0 0 0 10.2773 0 0 0 0 12.6415 13.4103 0 13.3496 14.2627 13.6362 0 12.3054 12.8175 0 13.1066 17.1218 14.2641 0 12.3962 14.3145 11.7239 0 0 0 15.2986 12.6805 11.8335 0 13.9112 12.9669 14.9868 12.6009 0 0 14.1759 14.1566 16.5215 0 0 0 0 12.546 0 14.5433 12.4069 14.1798 0 14.0252 12.0506 0 0 0 12.0973 0 13.5092 0 0 0 0 0 12.0244 0 12.766 0 0 0 0 0 0 0 0 Q12792 TWF1_HUMAN Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9) TWF1 PTK9 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of neuron projection development [GO:0010976]; regulation of actin phosphorylation [GO:0043538]; regulation of lamellipodium assembly [GO:0010591]; sequestering of actin monomers [GO:0042989] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587] "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of neuron projection development [GO:0010976]; regulation of actin phosphorylation [GO:0043538]; regulation of lamellipodium assembly [GO:0010591]; sequestering of actin monomers [GO:0042989]" GO:0003779; GO:0003785; GO:0005524; GO:0005546; GO:0005737; GO:0005829; GO:0005884; GO:0005911; GO:0005925; GO:0010591; GO:0010613; GO:0010976; GO:0015629; GO:0030016; GO:0030042; GO:0030175; GO:0030837; GO:0032587; GO:0042989; GO:0043538; GO:0045296; GO:0048471; GO:0051015; GO:0051016 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" LNNRQLNYVQLEIDIK 0.99186 -7.5489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9538 0 0 0 0 0 0 13.0551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4209 14.3268 0 0 0 0 13.3166 0 0 14.9512 0 13.6607 0 0 0 0 0 0 14.5078 0 13.7057 0 0 13.3129 0 14.6267 0 12.8031 0 0 0 0 0 0 12.2138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9163 14.2994 0 0 0 0 0 0 Q15696 U2AFM_HUMAN "U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein, URP)" ZRSR2 U2AF1-RS2 U2AF1L2 U2AF1RS2 URP Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701] "nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008380; GO:0030628; GO:0042802; GO:0046872; GO:0089701 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628] AAPEKMTFPEKPSHK 0.99186 -48.114 0 0 0 0 0 0 0 0 12.2971 0 11.66 0 0 0 0 12.7068 0 0 0 0 0 0 0 0 9.42259 0 0 0 12.8088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7543 11.7327 11.7977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0208 0 0 0 0 0 15.478 0 0 0 0 0 0 0 0 0 11.8056 0 0 14.0361 0 0 0 0 0 0 12.9881 0 0 11.751 0 13.1206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4028 14.6548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5491 0 0 0 0 0 12.9157 0 0 0 0 Q6UWX4 HIPL2_HUMAN HHIP-like protein 2 HHIPL2 HHIP3 KIAA1822L UNQ841/PRO1779 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 APPGKCK 0.99186 -86.063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3465 0 12.9438 13.6165 15.5003 14.9077 14.4207 13.9006 14.6247 0 0 0 14.2699 0 14.9884 13.9139 13.767 14.1278 13.5106 12.6951 0 13.2589 13.5031 0 0 0 0 0 12.8011 0 12.3191 0 13.4175 0 0 12.5084 12.7102 12.861 0 0 0 0 14.296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7164 0 0 0 0 0 0 13.1064 13.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZV73 FGD6_HUMAN "FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)" FGD6 KIAA1362 ZFYVE24 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087] GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] AMCNETTSFEK 0.99186 -92.711 0 0 12.9093 0 0 11.9578 0 0 15.2664 13.5765 14.5527 0 13.8703 14.8614 15.1926 14.7918 14.4535 14.3534 17.6722 14.7143 14.7392 0 13.1054 17.2211 14.557 14.783 14.3466 14.0147 14.6678 15.3287 15.004 13.0965 15.5424 14.6327 0 14.285 14.3875 13.9727 10.2125 14.5676 15.4467 15.3758 15.2561 13.4429 0 13.5353 0 10.6517 13.6997 12.989 12.516 17.5549 14.1266 14.0843 13.5364 12.6249 12.2109 0 0 0 13.2282 12.7365 0 0 0 13.9493 12.6738 0 14.8022 12.3761 13.4047 18.837 0 0 13.6442 12.4427 0 14.6402 13.4226 19.3645 13.2348 15.9114 16.4272 0 15.1524 13.3191 0 19.5298 15.0771 0 14.5174 0 0 14.1742 10.6721 14.6436 13.9448 13.8033 14.4494 19.6819 0 0 13.9187 0 14.0474 0 15.3487 15.0525 13.2304 10.856 12.9176 15.1701 0 15.2354 15.3887 0 14.5012 16.1483 0 15.0489 10.5118 0 15.7073 19.928 14.4023 19.7686 15.7463 19.5404 14.5998 0 13.3708 14.6965 0 14.7805 0 0 0 0 15.4436 11.1469 0 19.5522 19.5784 19.5039 0 0 0 15.7882 15.4518 14.168 11.5412 0 0 17.112 13.3122 13.1664 15.2548 13.0362 15.0758 15.2077 0 13.6745 14.8224 14.3896 16.324 16.5436 14.8896 14.7187 13.5824 12.5188 13.8797 0 14.8795 19.5973 14.8494 14.1848 0 14.9149 13.5683 13.7675 Q86TC9 MYPN_HUMAN Myopalladin (145 kDa sarcomeric protein) MYPN MYOP Homo sapiens (Human) axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; sarcomere organization [GO:0045214] axon [GO:0030424]; I band [GO:0031674]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018] axon [GO:0030424]; I band [GO:0031674]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; cytoskeletal protein binding [GO:0008092]; muscle alpha-actinin binding [GO:0051371]; SH3 domain binding [GO:0017124]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; sarcomere organization [GO:0045214] GO:0003779; GO:0005634; GO:0005886; GO:0007156; GO:0007411; GO:0008092; GO:0017124; GO:0030018; GO:0030424; GO:0031674; GO:0045214; GO:0051371; GO:0070593; GO:0098632 actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; cytoskeletal protein binding [GO:0008092]; muscle alpha-actinin binding [GO:0051371]; SH3 domain binding [GO:0017124] CIATNKTGQNSFSLELSVVAKEVK 0.99186 -48.087 0 0 0 0 0 0 0 0 14.488 0 0 13.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6959 13.7851 0 13.9105 0 0 0 14.0968 15.9241 15.1885 14.8802 15.7571 14.9479 0 12.3265 10.5679 0 12.103 13.9063 0 0 0 0 0 0 0 0 0 0 0 12.09 13.9375 0 13.8046 13.628 0 0 11.7631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9298 0 0 13.6795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2104 0 0 0 0 0 0 0 13.0458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7184 0 0 0 16.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9079 0 16.6334 0 0 0 12.9503 0 0 0 12.3805 0 0 11.7855 0 0 0 0 0 0 0 0 0 Q8IXL6 FA20C_HUMAN "Extracellular serine/threonine protein kinase FAM20C, EC 2.7.11.1 (Dentin matrix protein 4, DMP-4) (Golgi casein kinase) (Golgi-enriched fraction casein kinase, GEF-CK)" FAM20C DMP4 Homo sapiens (Human) biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173] "endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; enamel mineralization [GO:0070166]; odontoblast differentiation [GO:0071895]; osteoclast maturation [GO:0036179]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of phosphorus metabolic process [GO:0051174]" GO:0002020; GO:0004672; GO:0004674; GO:0005509; GO:0005524; GO:0005615; GO:0005788; GO:0005794; GO:0006468; GO:0016773; GO:0030145; GO:0030173; GO:0030501; GO:0031214; GO:0036179; GO:0040036; GO:0043621; GO:0043687; GO:0045669; GO:0046777; GO:0051174; GO:0070062; GO:0070166; GO:0071895; GO:0097187; GO:0106310 "ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protease binding [GO:0002020]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]" AEWEVDPDYCEEVK 0.99186 -7.5507 0 0 0 0 0 0 0 0 0 0 10.8802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2997 0 0 0 0 0 0 0 13.2116 0 11.7624 0 0 0 11.5997 0 0 0 0 0 0 0 0 0 0 0 11.9908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4603 0 0 0 0 11.1908 0 0 0 0 0 12.2883 0 0 0 0 0 0 0 0 0 0 Q8NEZ4 KMT2C_HUMAN "Histone-lysine N-methyltransferase 2C, Lysine N-methyltransferase 2C, EC 2.1.1.364 (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3)" KMT2C HALR KIAA1506 MLL3 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0016746; GO:0035097; GO:0042054; GO:0042393; GO:0042800; GO:0044666; GO:0045944; GO:0046872; GO:0051568; GO:0097692 acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] AAPRSKK 0.99186 -95.48 0 0 0 0 0 0 0 0 0 0 0 12.6819 0 13.1671 0 10.4606 0 0 0 0 0 0 0 0 0 0 0 13.918 0 0 0 0 0 0 0 0 0 0 0 14.2907 14.9419 0 0 0 0 0 0 0 0 0 0 11.6715 0 0 9.52054 0 14.8001 0 14.929 0 15.0303 15.0267 0 0 0 14.9653 0 0 0 0 0 10.9871 0 11.0681 13.5109 13.8855 14.3597 14.2875 0 0 0 12.8496 10.5926 0 13.1575 0 11.3222 13.903 12.8193 0 0 11.4163 0 13.8724 0 13.364 0 0 14.9707 0 11.5207 14.2325 15.8627 15.9431 0 0 0 0 0 0 11.7786 15.3185 0 0 16.2451 14.1203 13.6607 13.9254 0 0 0 15.0852 14.226 14.2839 14.8661 0 0 0 12.8096 0 0 14.3334 12.5622 0 0 14.87 14.2583 11.6225 0 13.2726 13.1998 0 0 11.9016 13.774 0 11.288 13.5212 0 13.0845 13.6898 0 15.2616 13.8941 0 16.3938 0 0 0 0 13.3219 0 0 14.5752 12.9963 11.3388 0 14.3858 14.1037 18.6703 0 0 0 0 13.6507 10.8138 13.1849 0 0 0 Q8TAG5 VTM2A_HUMAN V-set and transmembrane domain-containing protein 2A VSTM2A VSTM2 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of white fat cell proliferation [GO:0070352] extracellular region [GO:0005576]; integral component of membrane [GO:0016021] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; cellular response to BMP stimulus [GO:0071773]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of white fat cell proliferation [GO:0070352] GO:0005576; GO:0010628; GO:0010884; GO:0016021; GO:0030154; GO:0042802; GO:0070352; GO:0071773; GO:0090336 identical protein binding [GO:0042802] LQISKVRK 0.99186 -7.1823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WY54 PPM1E_HUMAN "Protein phosphatase 1E, EC 3.1.3.16 (Ca(2+)/calmodulin-dependent protein kinase phosphatase N, CaMKP-N) (CaMKP-nucleus, CaMKN) (Partner of PIX 1) (Partner of PIX-alpha, Partner of PIXA)" PPM1E CAMKN KIAA1072 POPX1 Homo sapiens (Human) cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; protein dephosphorylation [GO:0006470] GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006469; GO:0006470; GO:0017018; GO:0032991; GO:0035970; GO:0046872; GO:0051496; GO:0071466 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] AGCIPEEK 0.99186 -18.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6622 0 0 0 0 0 0 12.8524 0 0 0 0 0 0 9.40013 0 0 0 0 12.131 0 0 0 0 0 0 0 0 0 0 13.4676 0 0 0 0 13.8948 12.4392 0 0 0 0 0 0 0 0 0 10.6624 0 0 0 0 0 0 16.4359 0 0 0 0 0 0 0 0 0 0 0 0 13.6353 0 15.4163 0 13.4824 0 0 0 0 0 0 13.4619 0 0 12.274 0 0 0 0 0 0 0 0 0 0 0 13.5533 13.5159 0 12.2429 0 0 0 0 0 0 14.0922 0 0 0 0 0 0 0 0 0 0 13.4873 14.4209 14.2331 0 13.2317 13.8402 13.9922 14.1072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYA3 GOG6A_HUMAN Golgin subfamily A member 6A (Golgin linked to PML) (Golgin-like protein) GOLGA6A GLP GOLGA6 Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 ALCAVSTQQQEEDR 0.99186 -18.525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4789 13.53 0 0 12.0173 13.9283 0 14.1081 0 13.6693 13.6838 0 0 13.54 13.3365 0 0 13.7435 0 0 0 0 0 0 0 13.8869 0 0 13.4499 0 0 0 13.7058 0 0 0 0 0 0 14.2267 0 0 0 0 0 0 14.3831 14.3871 0 13.1291 0 0 0 13.8077 0 13.0298 0 0 0 0 14.1497 0 0 0 0 0 0 0 0 0 0 0 12.4714 0 0 0 0 0 12.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2386 0 0 0 0 0 0 0 Q96DT5 DYH11_HUMAN Dynein axonemal heavy chain 11 (Axonemal beta dynein heavy chain 11) (Ciliary dynein heavy chain 11) DNAH11 Homo sapiens (Human) cardiac septum morphogenesis [GO:0060411]; cilium movement [GO:0003341]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; learning or memory [GO:0007611]; microtubule-based movement [GO:0007018]; protein localization to motile cilium [GO:0120229]; regulation of cilium beat frequency [GO:0003356] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; proximal portion of axoneme [GO:0120134] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; proximal portion of axoneme [GO:0120134]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cardiac septum morphogenesis [GO:0060411]; cilium movement [GO:0003341]; determination of left/right asymmetry in nervous system [GO:0035545]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; learning or memory [GO:0007611]; microtubule-based movement [GO:0007018]; protein localization to motile cilium [GO:0120229]; regulation of cilium beat frequency [GO:0003356] GO:0003341; GO:0003356; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007611; GO:0008569; GO:0030286; GO:0030317; GO:0031514; GO:0035545; GO:0045505; GO:0051959; GO:0060287; GO:0060411; GO:0097728; GO:0097729; GO:0120134; GO:0120229 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] AAKVFMGK 0.99187 -110.21 17.6787 16.5786 17.0552 0 15.9574 12.1982 12.7208 0 0 0 0 14.2204 14.9374 13.7312 13.9589 10.2176 14.8438 12.2807 12.3655 15.4361 0 12.7315 12.8787 19.7078 12.6474 13.5061 13.2191 0 13.684 11.9666 0 0 0 0 0 0 0 13.8662 0 12.6579 0 11.1587 0 0 14.6719 13.7151 0 0 12.242 12.1373 13.7354 12.9112 11.8721 12.4236 0 13.5549 0 13.7139 11.897 13.7581 0 0 0 0 14.6533 8.94945 15.397 14.107 13.8627 17.9814 13.7194 13.8942 12.3728 16.2731 16.0108 16.992 15.2451 15.6597 14.3695 9.78426 10.9148 14.7384 12.4209 15.7908 15.747 15.2492 16.2689 16.9018 15.3778 15.6999 17.6556 16.0638 15.5353 14.9435 15.1248 15.6087 15.61 13.2727 15.0879 13.7508 14.8006 15.3178 16.707 15.7452 16.4489 16.1665 13.5868 15.8784 14.0268 15.7161 15.9721 15.0668 15.0991 14.8645 15.4839 14.1183 16.2829 15.2732 15.4736 13.221 15.4063 18.687 14.0186 16.2139 15.2197 13.367 15.4177 15.8368 15.6755 15.4876 15.935 13.6988 13.6612 15.8541 14.2784 15.76 15.1763 13.7465 16.7201 17.8381 18.267 14.3509 15.0582 14.0136 14.0446 11.0176 12.2644 16.7273 15.6943 0 14.8908 15.5831 13.1437 0 16.283 12.6624 14.0961 14.9256 15.9197 11.5759 11.916 0 11.965 13.1208 13.3062 14.4354 16.7253 16.0079 0 13.2557 13.8786 14.3617 0 12.5825 15.2884 16.1397 12.3769 16.0535 13.8264 12.01 O43278 SPIT1_HUMAN "Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1, HAI-1)" SPINT1 HAI1 UNQ223/PRO256 Homo sapiens (Human) branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to BMP stimulus [GO:0071773]; epidermis development [GO:0008544]; epithelium development [GO:0060429]; extracellular matrix organization [GO:0030198]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural tube closure [GO:0001843]; placenta blood vessel development [GO:0060674]; positive regulation of glial cell differentiation [GO:0045687] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to BMP stimulus [GO:0071773]; epidermis development [GO:0008544]; epithelium development [GO:0060429]; extracellular matrix organization [GO:0030198]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural tube closure [GO:0001843]; placenta blood vessel development [GO:0060674]; positive regulation of glial cell differentiation [GO:0045687] GO:0001843; GO:0004867; GO:0005576; GO:0005615; GO:0005886; GO:0008544; GO:0016020; GO:0030198; GO:0045687; GO:0060429; GO:0060670; GO:0060674; GO:0070062; GO:0071773; GO:2000178 serine-type endopeptidase inhibitor activity [GO:0004867] CSNGCCIDSFLECDDTPNCPDASDEAACEK 0.99187 -7.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0711 0 0 14.0648 0 0 11.6216 0 0 0 0 0 0 0 0 12.8604 11.0682 0 0 10.5486 0 0 13.5463 0 0 13.1968 0 0 0 0 15.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5236 0 0 0 0 0 0 0 10.3516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0426 0 0 0 0 0 0 0 11.561 0 0 0 0 0 0 0 O75027 ABCB7_HUMAN "Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7, ABC transporter 7 protein)" ABCB7 ABC7 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; protein homodimerization activity [GO:0042803]; cellular iron ion homeostasis [GO:0006879]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085] GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0015232; GO:0016021; GO:0016226; GO:0034755; GO:0042626; GO:0042803; GO:0055072; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903331; GO:1903427 ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; protein homodimerization activity [GO:0042803] CGAQFALVTLGTLGTYTAFTVAVTR 0.99187 -24.608 0 0 0 0 0 0 0 11.6554 0 12.4445 11.9276 12.2747 0 12.0631 0 0 0 0 0 0 12.0298 0 0 0 12.3282 0 0 0 0 11.9976 0 0 11.8582 0 0 0 0 11.05 0 0 0 0 12.1456 12.2909 0 11.8204 0 0 13.1285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87557 0 0 0 0 12.5968 0 0 0 12.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0714 0 0 0 16.0145 0 0 14.5069 0 0 14.7805 0 0 0 14.6343 0 12.122 14.2384 14.0505 0 0 0 12.447 0 14.914 12.6226 0 0 0 0 0 0 15.091 0 13.3478 0 0 0 0 0 11.9236 13.7932 0 15.496 0 0 0 15.2636 0 0 0 15.4685 0 0 0 0 0 0 0 0 0 0 0 14.2143 0 14.6861 14.3483 14.548 0 0 14.5043 14.378 14.4815 14.576 0 14.0477 14.5807 0 0 15.1801 13.2402 0 12.8441 14.1856 0 0 O75362 ZN217_HUMAN Zinc finger protein 217 ZNF217 ZABC1 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000118; GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0016607; GO:0045892; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" AFRTYHQLVLHSR 0.99187 -24.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2026 0 11.9058 0 0 0 0 0 0 0 0 15.926 0 0 0 0 0 11.0976 0 0 0 0 0 0 11.5064 0 0 0 0 0 0 0 0 0 0 0 11.7726 0 0 0 0 0 0 0 14.7376 0 0 0 0 0 0 11.8143 0 0 0 0 0 0 0 0 0 14.7138 0 0 0 14.096 0 0 0 0 0 0 0 0 12.3542 0 0 0 0 0 0 0 0 13.5747 0 0 0 13.1718 12.5907 11.9317 0 0 0 0 0 0 0 0 0 0 10.5253 0 0 0 11.5222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.462 0 0 12.5143 0 0 0 0 0 0 0 13.8626 15.0456 0 0 11.0374 0 0 0 0 0 0 0 0 P09913 IFIT2_HUMAN "Interferon-induced protein with tetratricopeptide repeats 2, IFIT-2 (ISG-54 K) (Interferon-induced 54 kDa protein, IFI-54K, P54)" IFIT2 CIG-42 G10P2 IFI54 ISG54 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; RNA binding [GO:0003723]; apoptotic mitochondrial changes [GO:0008637]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; response to virus [GO:0009615] GO:0003723; GO:0005737; GO:0005783; GO:0005829; GO:0008637; GO:0009615; GO:0032091; GO:0035457; GO:0043065; GO:0045087; GO:0051607 RNA binding [GO:0003723] AKVCFEK 0.99187 -7.5533 0 0 12.986 0 0 0 0 0 0 0 0 0 0 13.9885 13.8173 0 0 13.3051 11.7009 0 0 0 0 0 0 0 13.4841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9669 13.0207 0 0 0 0 0 0 0 0 0 0 12.3685 0 0 11.8613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3122 0 0 0 0 0 0 0 11.4341 0 0 0 0 14.7492 0 0 0 0 0 0 0 0 0 0 0 0 12.2603 0 0 0 0 0 10.1205 0 0 0 0 0 0 0 0 0 0 0 13.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.159 0 0 10.2482 0 11.5265 0 0 0 0 10.5344 0 11.0356 0 0 0 0 0 0 0 0 0 0 0 P20062 TCO2_HUMAN "Transcobalamin-2, TC-2 (Transcobalamin II, TC II, TCII)" TCN2 TC2 Homo sapiens (Human) cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202] endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; cargo receptor ligand activity [GO:0140355]; cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824] GO:0005576; GO:0005615; GO:0005768; GO:0006824; GO:0009235; GO:0009897; GO:0015889; GO:0031419; GO:0043202; GO:0046872; GO:0140355 cargo receptor ligand activity [GO:0140355]; cobalamin binding [GO:0031419]; metal ion binding [GO:0046872] ANCEFVR 0.99187 -18.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42694 HELZ_HUMAN "Probable helicase with zinc finger domain, EC 3.6.4.- (Down-regulated in human cancers protein)" HELZ DRHC KIAA0054 Homo sapiens (Human) post-transcriptional gene silencing by RNA [GO:0035194] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; post-transcriptional gene silencing by RNA [GO:0035194] GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005829; GO:0016020; GO:0016787; GO:0035194; GO:0043186; GO:0046872 ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] AEKSCEQACESLKR 0.99187 -17.794 12.0938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.426 0 0 0 15.1951 0 11.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2551 0 11.1325 0 11.8204 0 12.981 0 0 0 0 0 0 0 0 0 0 12.5236 0 10.9556 11.6107 13.8646 0 15.3225 0 14.2669 0 0 13.5115 14.0885 18.3417 12.7831 14.6283 0 0 13.9572 0 0 0 13.0321 0 13.2288 13.9903 15.8581 0 0 0 16.115 0 0 0 0 15.6586 0 0 0 0 0 0 16.8245 13.9291 0 12.7211 0 0 9.84171 0 0 0 13.9583 0 0 13.4569 0 0 16.6945 0 15.7382 0 12.7839 0 13.3883 13.5716 0 0 0 14.755 11.6121 15.7862 16.3567 0 0 0 0 0 12.4884 0 12.1401 0 0 13.4106 0 0 0 13.477 16.0414 11.8575 0 0 0 0 0 0 0 0 0 11.1972 0 12.6949 13.3942 0 0 0 0 0 0 0 0 12.1093 11.6695 P60520 GBRL2_HUMAN "Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2, GEF-2) (General protein transport factor p16) (Golgi-associated ATPase enhancer of 16 kDa, GATE-16) (MAP1 light chain 3-related protein)" GABARAPL2 FLC3A GEF2 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; ATPase binding [GO:0051117]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; SNARE binding [GO:0000149]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; macroautophagy [GO:0016236]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031] GO:0000045; GO:0000139; GO:0000149; GO:0000421; GO:0000422; GO:0005737; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006891; GO:0006914; GO:0006995; GO:0008017; GO:0015031; GO:0016236; GO:0031410; GO:0031625; GO:0032781; GO:0048487; GO:0050811; GO:0051117; GO:0070972; GO:1901799 ATPase binding [GO:0051117]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; SNARE binding [GO:0000149]; ubiquitin protein ligase binding [GO:0031625] AKYPDRVPVIVEK 0.99187 -7.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1164 0 0 0 0 0 0 0 0 12.6291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2195 0 0 0 0 0 0 0 0 0 0 0 Q13478 IL18R_HUMAN "Interleukin-18 receptor 1, IL-18R-1, IL-18R1, EC 3.2.2.6 (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein, IL-1Rrp, IL1R-rp) (Interleukin-18 receptor alpha, IL-18R-alpha, IL-18Ralpha) (CD antigen CD218a)" IL18R1 IL1RRP Homo sapiens (Human) immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; natural killer cell activation [GO:0030101]; negative regulation of cold-induced thermogenesis [GO:0120163]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; signal transduction [GO:0007165]; T-helper 1 cell differentiation [GO:0045063] interleukin-18 receptor complex [GO:0045092]; plasma membrane [GO:0005886] "interleukin-18 receptor complex [GO:0045092]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-18 binding [GO:0042007]; interleukin-18 receptor activity [GO:0042008]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; natural killer cell activation [GO:0030101]; negative regulation of cold-induced thermogenesis [GO:0120163]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; signal transduction [GO:0007165]; T-helper 1 cell differentiation [GO:0045063]" GO:0004908; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0030101; GO:0032729; GO:0035655; GO:0038023; GO:0038061; GO:0042007; GO:0042008; GO:0045063; GO:0045092; GO:0050135; GO:0051092; GO:0061809; GO:0120163; GO:1901224; GO:2000556 "interleukin-1 receptor activity [GO:0004908]; interleukin-18 binding [GO:0042007]; interleukin-18 receptor activity [GO:0042008]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]" FFQITCENSYYQTLVNSTSLYKNCK 0.99187 -23.829 0 0 0 0 10.8409 0 0 0 12.6081 0 0 0 0 0 0 0 12.9123 0 0 0 0 0 0 0 12.9987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9073 0 0 0 0 0 0 16.2183 0 0 0 0 13.1955 11.9709 0 12.1021 12.4872 0 0 15.7852 0 14.2308 0 0 0 0 0 12.1999 0 0 0 13.7638 18.4925 0 0 11.509 0 0 0 0 14.518 0 0 0 0 13.8349 0 13.5615 13.0819 0 14.8542 0 15.6769 0 0 13.2447 0 0 14.6963 0 14.0561 12.5189 0 0 13.5942 0 12.2193 0 14.2247 0 13.567 0 0 0 0 12.7627 16.954 0 0 0 0 0 0 0 0 0 0 13.7402 11.9398 13.7529 0 0 0 0 14.0606 0 14.0642 14.6521 0 15.4363 0 13.6062 0 0 0 0 0 0 13.1184 0 0 0 16.6843 Q13491 GPM6B_HUMAN "Neuronal membrane glycoprotein M6-b, M6b" GPM6B M6B Homo sapiens (Human) extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893] GO:0001503; GO:0005886; GO:0007399; GO:0015031; GO:0016021; GO:0030501; GO:0031175; GO:0032956; GO:0045121; GO:0051612; GO:0051893; GO:0085029; GO:2000009 GCFECCIK 0.99187 -7.3671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8149 0 0 0 0 0 0 0 0 0 0 0 0 12.9531 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VU97 CAHD1_HUMAN "VWFA and cache domain-containing protein 1, Cache domain-containing protein 1" CACHD1 KIAA1573 VWCD1 Homo sapiens (Human) voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245] GO:0005245; GO:0005891 voltage-gated calcium channel activity [GO:0005245] CKGSYEHR 0.99187 -7.5624 0 0 0 0 0 0 0 0 0 11.7751 0 0 0 0 0 11.1328 0 13.3315 13.9465 0 0 0 10.3503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2174 0 13.2452 0 13.4957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3316 0 0 13.8032 0 0 0 0 0 0 0 0 0 15.1806 13.5603 12.3071 13.9248 11.1492 14.3412 12.6873 13.269 0 0 14.1086 0 0 11.8397 13.2161 12.4505 12.7216 0 11.7103 0 0 0 13.3315 0 0 0 0 0 0 10.8865 12.8548 13.1332 13.4397 11.8965 12.8372 13.7286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6881 13.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4974 0 12.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2349 0 0 14.8918 0 14.1501 0 Q63HN8 RN213_HUMAN "E3 ubiquitin-protein ligase RNF213, EC 2.3.2.27, EC 3.6.4.- (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213, EC 2.3.2.-) (Mysterin) (RING finger protein 213)" RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR Homo sapiens (Human) angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792] GO:0001525; GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005737; GO:0005811; GO:0005829; GO:0006511; GO:0016020; GO:0016567; GO:0016887; GO:0019216; GO:0042742; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ASVGCGSEAARYRMR 0.99187 -125.53 14.411 0 0 0 13.2086 12.6702 13.1887 13.7423 14.0297 14.7392 15.4849 15.038 15.1541 14.7733 12.1713 14.8322 12.1714 11.5762 12.4742 12.7758 0 13.1349 0 12.7543 0 14.9352 11.6214 14.2064 14.1505 15.1631 15.397 15.0829 15.4361 12.6196 13.9874 13.9443 13.5134 15.2699 13.9017 14.3955 11.9966 15.0649 15.0811 15.5229 0 14.937 13.6333 15.302 11.4839 13.021 12.8226 0 0 0 0 0 0 9.87781 14.2827 13.9105 0 0 10.9599 0 0 10.2197 0 0 0 0 12.9703 13.9325 16.2908 13.5708 11.9862 0 0 11.5105 14.4797 16.106 12.8869 0 15.47 0 13.8419 14.0348 11.9477 13.7922 15.3964 14.4119 12.645 12.4462 13.3149 14.8292 15.5786 15.2977 17.1847 0 0 15.6594 0 11.783 14.7554 13.0192 14.7813 15.1976 12.2292 13.3432 0 13.6324 0 12.8031 14.8037 13.3464 0 0 14.2106 0 0 10.7306 11.7344 11.7066 14.2755 14.6739 11.1115 13.4015 11.2034 13.4975 13.1802 14.5582 0 14.7413 0 12.4769 13.283 16.5258 15.5103 13.2143 14.8561 14.9516 14.4848 13.8004 0 0 14.4271 15.3415 15.9377 16.2488 14.6994 10.5807 14.6622 15.0986 13.5286 13.7119 14.4175 13.4503 0 16.1795 16.6437 16.3029 13.5637 13.1687 16.333 16.3439 16.1866 16.3456 16.7393 14.9134 12.1494 13.9643 12.7919 0 14.8563 0 0 14.9313 12.8885 14.5625 12.608 0 Q6UB99 ANR11_HUMAN Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1) ANKRD11 ANCO1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; anatomical structure morphogenesis [GO:0009653]; face morphogenesis [GO:0060325]; odontogenesis of dentin-containing tooth [GO:0042475]; skeletal system morphogenesis [GO:0048705] GO:0005634; GO:0005654; GO:0005829; GO:0009653; GO:0042475; GO:0048705; GO:0060325 ADIEDELDKTIELFSTEKK 0.99187 -107.54 0 15.4246 0 0 0 0 0 0 0 0 12.9007 12.9061 10.7307 0 0 0 0 0 0 0 0 11.4554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6993 12.4465 16.0663 0 14.1921 0 0 0 0 0 0 12.9098 0 10.219 17.9731 0 13.6921 12.761 0 13.7557 0 0 0 0 12.673 0 12.3087 13.4905 13.8248 11.4562 0 13.269 0 14.0492 0 0 13.3202 0 13.464 0 12.7138 0 14.8112 0 12.9086 0 12.0097 14.2101 0 0 0 12.9009 0 13.8923 13.9022 0 0 13.8349 0 0 0 16.1242 13.841 0 13.9687 12.8185 0 0 0 15.3066 0 0 0 14.4755 0 13.0764 0 0 0 0 13.8641 0 0 0 0 0 0 0 14.1665 13.5658 0 0 11.7662 0 0 0 10.8802 0 0 15.0363 0 0 0 14.1682 0 15.2929 0 0 0 0 0 14.2632 11.3689 0 Q6ZQQ6 WDR87_HUMAN WD repeat-containing protein 87 (Testis development protein NYD-SP11) WDR87 Homo sapiens (Human) AIRLGVLKSPLK 0.99187 -106.72 13.3068 0 0 12.0879 12.9201 0 0 13.0101 13.7628 16.3138 16.7105 16.3721 16.2687 0 12.3329 16.9078 16.7357 17.356 14.6265 13.8824 0 0 14.9605 0 16.5455 17.5641 17.4506 0 13.1282 13.0784 16.684 17.1317 15.4523 15.1515 17.1958 17.0927 17.2178 17.0948 15.5798 17.1271 15.0304 17.1435 11.7908 15.2794 17.2365 16.7055 14.2465 16.8488 0 13.4747 12.5149 0 16.4377 16.4032 16.3934 16.3696 16.646 16.3202 0 15.7704 15.383 0 15.4761 0 0 0 11.3964 13.4959 0 13.3405 13.341 13.7017 0 0 13.815 0 15.3748 13.8655 15.0408 16.0775 13.9348 15.5958 14.1517 13.8797 14.4952 15.5657 0 17.2896 16.9524 16.019 15.4886 14.5248 15.8335 15.0697 17.641 15.9663 15.747 14.9754 15.7057 15.2222 0 12.1173 16.2236 15.8699 17.3878 17.4425 14.5306 0 14.2625 13.4217 15.9157 13.3404 0 15.036 12.8052 17.1665 16.0997 13.8555 13.8972 17.0662 14.0555 16.4045 12.2063 0 16.3029 15.7609 15.9483 0 15.7761 15.6101 15.2208 15.4041 14.0583 14.4837 0 16.0985 15.7358 14.4719 15.6468 15.5417 0 12.5954 12.8231 13.929 0 0 13.6091 0 13.3167 0 13.7294 13.6126 0 12.0852 13.9613 0 10.8684 12.5785 17.9298 13.7925 18.2111 14.3012 17.43 17.4993 17.7816 17.4735 17.5657 17.5691 14.2724 0 0 0 13.4776 15.7675 14.7552 17.4536 0 17.6527 0 0 Q99880 H2B1L_HUMAN "Histone H2B type 1-L (Histone H2B.c, H2B/c)" H2BC13 H2BFC HIST1H2BL Homo sapiens (Human) nucleosome assembly [GO:0006334] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; nucleosome assembly [GO:0006334] GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AVTKAQKK 0.99187 -18.609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C099 LRCC1_HUMAN Leucine-rich repeat and coiled-coil domain-containing protein 1 (Centrosomal leucine-rich repeat and coiled-coil domain-containing protein) LRRCC1 CLERC KIAA1764 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005737; GO:0005813; GO:0005814; GO:0007049; GO:0051301 AEQAENKLMDYIDELHK 0.99187 -24.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.24 0 0 0 0 0 0 0 10.928 0 9.37461 0 0 0 0 11.904 0 10.3508 0 0 0 0 0 0 0 10.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3593 0 0 0 0 0 0 0 0 0 0 11.9283 0 0 0 0 11.7486 18.243 0 0 0 18.159 18.0728 17.9298 0 0 11.298 0 13.4067 0 10.1864 0 14.2197 0 0 12.41 16.3753 15.7606 0 10.5836 11.8754 13.292 17.5406 11.2482 0 16.438 0 17.0486 0 0 0 0 0 0 0 0 0 12.016 15.4112 0 14.2901 0 0 0 0 0 0 13.8838 0 0 11.4133 14.4878 13.8473 0 0 0 0 0 12.2291 0 0 10.2295 0 0 0 0 15.417 0 0 11.5724 16.1971 0 15.0856 11.0986 11.7688 13.0103 15.4255 10.8959 0 0 12.6545 0 13.2372 0 0 0 0 13.0151 0 0 Q9UD71 PPR1B_HUMAN Protein phosphatase 1 regulatory subunit 1B (DARPP-32) (Dopamine- and cAMP-regulated neuronal phosphoprotein) PPP1R1B DARPP32 Homo sapiens (Human) "behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; negative regulation of female receptivity [GO:0007621]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; response to amphetamine [GO:0001975]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]; visual learning [GO:0008542]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; negative regulation of female receptivity [GO:0007621]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; response to amphetamine [GO:0001975]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; transcription, DNA-templated [GO:0006351]; visual learning [GO:0008542]" GO:0001975; GO:0004860; GO:0004862; GO:0004864; GO:0005634; GO:0005737; GO:0005829; GO:0006351; GO:0007165; GO:0007621; GO:0007626; GO:0008542; GO:0019888; GO:0032515; GO:0035556; GO:0043025; GO:0043278; GO:0048148; GO:0071314 cAMP-dependent protein kinase inhibitor activity [GO:0004862]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888] PSPSEPGT 0.99187 -7.3658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1348 0 0 0 0 0 Q9UPV9 TRAK1_HUMAN Trafficking kinesin-binding protein 1 (106 kDa O-GlcNAc transferase-interacting protein) (Protein Milton) TRAK1 KIAA1042 OIP106 Homo sapiens (Human) anterograde axonal transport of mitochondrion [GO:0098957]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein O-linked glycosylation [GO:0006493]; protein targeting [GO:0006605]; regulation of transcription by RNA polymerase II [GO:0006357]; vesicle transport along microtubule [GO:0047496] axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634] axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102]; anterograde axonal transport of mitochondrion [GO:0098957]; endosome to lysosome transport [GO:0008333]; mitochondrion distribution [GO:0048311]; neurogenesis [GO:0022008]; protein O-linked glycosylation [GO:0006493]; protein targeting [GO:0006605]; regulation of transcription by RNA polymerase II [GO:0006357]; vesicle transport along microtubule [GO:0047496] GO:0005102; GO:0005634; GO:0005737; GO:0005739; GO:0005769; GO:0005829; GO:0005938; GO:0006357; GO:0006493; GO:0006605; GO:0008333; GO:0017022; GO:0022008; GO:0030425; GO:0031410; GO:0031966; GO:0047496; GO:0048311; GO:0050811; GO:0098957; GO:1904115 GABA receptor binding [GO:0050811]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102] CMSQTNSTFTFTTCRILHPSDELTR 0.99187 -17.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.564 12.9754 0 0 13.2117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8572 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1822 0 0 0 0 0 0 0 0 13.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9894 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ35 SRRM2_HUMAN "Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa, SR-related nuclear matrix protein of 300 kDa, Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803, TaxREB803)" SRRM2 KIAA0324 SRL300 SRM300 HSPC075 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0015030; GO:0016607; GO:0047485; GO:0070742; GO:0071005; GO:0071007; GO:0071013 C2H2 zinc finger domain binding [GO:0070742]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723] APSPSSR 0.99187 -166.33 0 0 0 0 0 0 0 0 0 0 12.5792 10.8645 0 0 0 12.576 13.3259 0 12.4977 12.8195 0 0 0 0 0 0 0 0 13.442 0 0 0 13.5075 0 0 14.3679 16.5793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9117 14.0979 0 14.4377 0 0 0 0 0 0 0 0 13.7172 0 0 0 0 9.94562 13.258 12.8438 13.226 0 0 0 12.7935 0 14.3208 0 0 0 0 0 14.0668 13.0599 0 0 13.2488 0 0 0 14.1016 0 13.0889 0 11.5891 12.7477 12.645 0 17.0142 13.5304 13.2681 0 0 0 0 0 0 14.1327 14.2951 12.3332 15.1765 0 16.1261 0 15.8658 0 14.8697 0 0 0 13.1955 0 13.2212 0 14.3377 13.3792 14.4202 13.0801 14.7229 0 0 0 14.4448 13.4481 0 14.4017 0 14.6115 0 0 13.1097 15.2651 0 0 0 0 12.6364 0 13.3685 0 19.0008 12.0164 0 0 0 0 15.1398 15.2481 0 0 0 11.0682 13.6726 13.2816 0 14.4219 0 0 15.3477 0 0 0 17.0823 13.4895 0 12.4668 0 13.9623 0 A0A2R8Y7D0 TINCR_HUMAN Ubiquitin domain-containing protein TINCR (Placenta-specific protein 2) (Terminal differentiation-induced cornification regulator) TINCR LINC00036 NCRNA00036 PLAC2 Homo sapiens (Human) AFYYNAR 0.99188 -7.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.15 0 14.2832 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04003 C4BPA_HUMAN "C4b-binding protein alpha chain, C4bp (Proline-rich protein, PRP)" C4BPA C4BP Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]" blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of protein catabolic process [GO:0045732]; regulation of opsonization [GO:1903027]; response to symbiotic bacterium [GO:0009609]" GO:0003723; GO:0005576; GO:0005615; GO:0005886; GO:0006958; GO:0009609; GO:0045087; GO:0045732; GO:0045959; GO:0072562; GO:1903027 RNA binding [GO:0003723] CQKGFVLR 0.99188 -17.844 0 0 0 0 0 0 0 0 0 0 0 13.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7584 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8877 14.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7842 0 0 0 12.5176 0 0 0 0 0 0 0 0 13.6442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05060 SCG1_HUMAN "Secretogranin-1 (Chromogranin-B, CgB) (Secretogranin I, SgI) [Cleaved into: PE-11; GAWK peptide; CCB peptide ]" CHGB SCG1 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; hormone activity [GO:0005179] GO:0005179; GO:0005615; GO:0005788; GO:0030141 hormone activity [GO:0005179] ASEEEPEYGEEIK 0.99188 -24.707 0 0 0 0 16.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4501 0 0 0 0 0 0 0 0 0 0 0 10.8206 0 0 0 0 0 11.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6394 0 0 10.4145 12.3939 0 0 0 0 13.138 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3566 0 0 10.5867 0 11.5053 0 0 0 0 12.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0881 0 0 0 0 0 0 11.3187 0 11.7307 13.4574 0 0 0 0 0 12.3468 0 0 0 12.7701 0 0 0 0 0 0 11.9482 0 0 0 0 0 0 0 0 0 12.2305 0 0 13.4404 0 0 0 0 0 0 0 12.0313 0 13.0558 0 0 0 0 0 0 0 0 0 11.5242 0 P0DTE4 UD2A1_HUMAN "UDP-glucuronosyltransferase 2A1, UDPGT 2A1, UGT2A1, EC 2.4.1.17" UGT2A1 Homo sapiens (Human) bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695]; response to stimulus [GO:0050896]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; bile acid metabolic process [GO:0008206]; cellular glucuronidation [GO:0052695]; response to stimulus [GO:0050896]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608] GO:0005789; GO:0007606; GO:0007608; GO:0008206; GO:0015020; GO:0016021; GO:0050896; GO:0052695 glucuronosyltransferase activity [GO:0015020] AEIWLIR 0.99188 -23.099 0 0 0 0 0 0 0 0 0 14.8788 15.2835 13.7579 15.8611 15.8519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.261 15.4079 13.2046 14.4396 15.1269 15.264 12.8363 0 12.207 13.3386 12.5507 0 15.517 0 15.2822 0 0 12.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9522 13.3626 0 0 0 11.3162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4592 0 0 0 0 0 12.6167 0 0 0 0 0 0 0 0 0 0 14.1111 0 0 0 0 0 0 0 0 13.4561 0 0 16.1476 0 0 0 0 0 0 0 0 0 13.5296 15.8717 16.9734 15.3687 14.0495 16.4718 0 15.7357 15.6166 0 13.4764 15.3631 12.6177 0 0 0 0 0 0 0 0 0 16.3163 P13612 ITA4_HUMAN Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d) ITGA4 CD49D Homo sapiens (Human) axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; cellular response to cytokine stimulus [GO:0071345]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; import into cell [GO:0098657]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integrin alpha4-beta1 complex [GO:0034668]; integrin alpha4-beta7 complex [GO:0034669]; integrin complex [GO:0008305]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integrin alpha4-beta1 complex [GO:0034668]; integrin alpha4-beta7 complex [GO:0034669]; integrin complex [GO:0008305]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-matrix adhesion involved in ameboidal cell migration [GO:0003366]; cellular response to amyloid-beta [GO:1904646]; cellular response to cytokine stimulus [GO:0071345]; clathrin-dependent extracellular exosome endocytosis [GO:1990771]; diapedesis [GO:0050904]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; import into cell [GO:0098657]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; negative regulation of protein homodimerization activity [GO:0090074]; neuron projection extension [GO:1990138]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of T cell migration [GO:2000406]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; receptor clustering [GO:0043113]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0001968; GO:0003366; GO:0005178; GO:0005886; GO:0005925; GO:0007159; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0015026; GO:0016020; GO:0030183; GO:0030426; GO:0033627; GO:0033631; GO:0034113; GO:0034446; GO:0034668; GO:0034669; GO:0035987; GO:0043025; GO:0043113; GO:0046872; GO:0050839; GO:0050900; GO:0050901; GO:0050904; GO:0060385; GO:0070062; GO:0071345; GO:0090074; GO:0098609; GO:0098657; GO:0140039; GO:1903238; GO:1904646; GO:1905564; GO:1990138; GO:1990405; GO:1990771; GO:2000353; GO:2000406 cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405] ADGISSTFSQR 0.99188 -18.74 0 0 0 0 10.1273 0 0 0 0 11.6876 11.7019 10.3454 12.2068 0 10.716 0 9.70472 0 0 0 0 0 0 0 0 0 11.6896 0 10.8035 0 11.6033 0 11.6933 0 0 11.3066 10.7185 10.6722 0 0 0 0 0 0 0 0 0 11.7719 0 0 0 0 0 0 0 0 0 12.6019 0 0 11.73 12.7094 0 0 13.6603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6726 0 0 0 0 13.4826 16.6147 16.5702 14.3254 16.5444 0 0 14.4531 0 0 0 0 0 0 0 0 0 13.7776 13.7807 0 0 0 0 0 14.0772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7356 0 0 0 0 0 0 0 0 0 0 0 0 12.3504 0 0 0 0 0 0 0 12.5115 0 0 0 12.5853 15.2445 12.938 11.7892 0 0 12.4405 0 0 0 0 0 0 0 0 11.406 13.0873 0 0 0 0 P29373 RABP2_HUMAN "Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II, CRABP-II)" CRABP2 Homo sapiens (Human) "embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; positive regulation of collateral sprouting [GO:0048672]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; positive regulation of collateral sprouting [GO:0048672]; regulation of transcription, DNA-templated [GO:0006355]; retinoic acid biosynthetic process [GO:0002138]; signal transduction [GO:0007165]" GO:0001972; GO:0002138; GO:0005501; GO:0005504; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006355; GO:0007165; GO:0008544; GO:0015908; GO:0016918; GO:0019841; GO:0030332; GO:0035115; GO:0048672; GO:0070062 cyclin binding [GO:0030332]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841] LLKGEGPK 0.99188 -5.5466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2444 0 16.1315 0 0 0 P29622 KAIN_HUMAN "Kallistatin (Kallikrein inhibitor) (Peptidase inhibitor 4, PI-4) (Serpin A4)" SERPINA4 KST PI4 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005576; GO:0005615; GO:0010951; GO:0031089; GO:0070062 serine-type endopeptidase inhibitor activity [GO:0004867] EIEEVLTPEMLMRWNNLLRK 0.99188 -23.939 0 0 0 0 9.69106 0 0 0 0 0 0 16.0763 16.2782 0 0 12.9786 12.8214 0 12.6212 0 0 0 12.3346 0 0 13.1203 13.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60268 0 0 0 0 0 11.5418 0 0 0 0 0 0 0 0 0 13.0454 14.1181 13.727 0 0 0 0 0 0 0 0 0 0 14.5328 0 17.0259 13.5563 0 0 0 0 0 0 0 11.0045 0 17.1088 0 0 12.8458 0 0 0 0 0 0 0 0 0 13.9926 0 0 0 0 0 0 14.1629 0 0 12.2444 0 0 0 0 0 14.1136 0 0 15.5486 0 0 0 0 0 0 0 0 0 0 13.3615 13.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3592 0 0 10.5921 0 0 13.1805 0 0 0 13.7569 0 0 0 13.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4769 0 0 0 13.2639 0 Q13144 EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] GO:0001541; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0007568; GO:0009408; GO:0009749; GO:0010226; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045948; GO:0048708; GO:0050852 guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] AAQIKEHLLK 0.99188 -17.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2697 0 10.4511 0 0 0 0 10.9819 0 0 0 0 0 11.3029 0 0 11.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3091 0 0 0 0 0 0 0 0 0 11.3397 11.6076 0 0 0 0 12.9213 0 0 12.6353 0 0 14.1552 0 0 0 0 0 0 11.3691 0 0 14.9007 11.7857 0 0 0 11.3564 0 9.95061 11.8531 0 0 0 0 12.5041 0 0 11.5857 0 11.9254 0 12.2038 0 0 0 0 0 0 0 0 11.7911 11.3724 0 0 0 0 0 13.7973 0 0 0 0 11.7265 0 0 0 0 9.66876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9244 0 0 0 0 0 0 0 0 0 Q14203 DCTN1_HUMAN "Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150, DP-150) (p135) (p150-glued)" DCTN1 Homo sapiens (Human) "cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of synapse structure [GO:0099558]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]" axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] "axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of synapse structure [GO:0099558]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]" GO:0000132; GO:0000278; GO:0000776; GO:0000922; GO:0005634; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0007399; GO:0007528; GO:0008017; GO:0010457; GO:0015630; GO:0015631; GO:0016020; GO:0019901; GO:0021517; GO:0030286; GO:0030424; GO:0031116; GO:0031122; GO:0031252; GO:0032402; GO:0034454; GO:0035371; GO:0036064; GO:0042147; GO:0043005; GO:0043025; GO:0045171; GO:0048156; GO:0050905; GO:0051010; GO:0051081; GO:0051301; GO:0060236; GO:0061744; GO:0070050; GO:0072686; GO:0090063; GO:0099558; GO:0099738; GO:0120103; GO:1904398; GO:1905515; GO:1990535 microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631] DSPLLLQQISAMRLHISQLQHENSILK 0.99188 -23.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8918 12.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14687 GSE1_HUMAN Genetic suppressor element 1 GSE1 KIAA0182 Homo sapiens (Human) DSEEEEEEDDEDGEDEEEVPKR 0.99188 -18.727 0 11.4667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1921 0 0 0 0 13.3716 0 0 0 0 12.9906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0243 0 0 0 0 0 0 0 0 0 0 0 0 11.4488 0 12.2308 0 0 0 0 0 0 0 0 0 0 12.0015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0559 0 0 0 0 0 0 0 0 0 0 0 12.3996 0 0 0 0 0 0 0 0 0 0 0 0 14.0244 0 0 0 0 0 0 0 0 12.7945 14.1014 0 0 11.5886 0 Q6ZW31 SYDE1_HUMAN "Rho GTPase-activating protein SYDE1 (Synapse defective protein 1 homolog 1, Protein syd-1 homolog 1)" SYDE1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of cytoskeleton organization [GO:0051493]; regulation of Ras protein signal transduction [GO:0046578]; signal transduction [GO:0007165] synaptic membrane [GO:0097060] synaptic membrane [GO:0097060]; GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of cytoskeleton organization [GO:0051493]; regulation of Ras protein signal transduction [GO:0046578]; signal transduction [GO:0007165] GO:0005096; GO:0007165; GO:0016477; GO:0030695; GO:0031532; GO:0046578; GO:0051493; GO:0090630; GO:0097060; GO:1901165 GTPase activator activity [GO:0005096]; GTPase regulator activity [GO:0030695] AEPLLRK 0.99188 -23.171 0 0 0 0 0 0 0 0 14.8626 0 12.6067 0 0 0 0 0 12.3397 0 0 0 0 0 0 10.9393 11.6568 0 0 0 0 14.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7898 13.8378 0 0 0 0 0 13.8081 0 14.032 0 0 0 0 12.7006 0 14.7916 0 0 0 0 19.5011 0 13.8726 0 0 12.8486 0 0 0 0 0 0 0 13.6666 14.4228 16.9597 13.8202 15.2166 0 0 0 0 13.9355 0 0 11.7917 11.939 13.7238 0 0 11.7721 14.1427 14.0524 12.8167 0 0 0 0 15.0797 11.4349 11.9535 13.9071 0 0 0 0 0 13.2274 0 0 13.447 11.4846 12.6144 0 0 0 12.7158 13.142 0 0 0 0 0 0 0 0 0 14.6856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6342 0 13.6079 0 0 0 0 0 0 Q86X27 RGPS2_HUMAN Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2) RALGPS2 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of Ral protein signal transduction [GO:0032485] GO:0005085; GO:0005737; GO:0005886; GO:0007265; GO:0032485; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] EILHAQTLKIR 0.99188 -5.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4279 0 0 0 0 0 0 0 0 0 0 0 14.1073 0 0 0 0 0 0 0 0 0 0 0 0 12.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAV4 STML3_HUMAN "Stomatin-like protein 3, SLP-3" STOML3 Homo sapiens (Human) signal transduction [GO:0007165] cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; signal transduction [GO:0007165] GO:0005886; GO:0005929; GO:0007165; GO:0016021; GO:0043005; GO:0045121 IIKEYERAVVFR 0.99188 -7.3868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7974 9.12771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92608 DOCK2_HUMAN Dedicator of cytokinesis protein 2 DOCK2 KIAA0209 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; myoblast fusion [GO:0007520]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; T cell receptor binding [GO:0042608]; actin cytoskeleton organization [GO:0030036]; alpha-beta T cell proliferation [GO:0046633]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; establishment of T cell polarity [GO:0001768]; immunological synapse formation [GO:0001771]; macropinocytosis [GO:0044351]; membrane raft polarization [GO:0001766]; myeloid dendritic cell activation involved in immune response [GO:0002277]; myoblast fusion [GO:0007520]; negative thymic T cell selection [GO:0045060]; positive regulation of phagocytosis [GO:0050766]; positive thymic T cell selection [GO:0045059]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0001766; GO:0001768; GO:0001771; GO:0002277; GO:0005085; GO:0005096; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006935; GO:0007264; GO:0007520; GO:0016020; GO:0016477; GO:0030036; GO:0031267; GO:0035580; GO:0042608; GO:0044351; GO:0045059; GO:0045060; GO:0046633; GO:0050766; GO:0051056; GO:0070062 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; T cell receptor binding [GO:0042608] ATIPIFFDMMLCEYQR 0.99188 -7.7183 0 0 0 0 0 0 0 11.2195 0 11.507 11.3417 11.6896 0 0 0 9.87411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4045 12.6244 0 14.9661 0 0 0 0 13.2551 11.4774 0 0 0 0 0 0 0 13.0087 14.8907 12.786 13.7149 0 0 0 0 11.3445 0 0 0 0 10.5514 0 15.5423 0 14.5631 0 0 11.7655 13.4617 12.9743 12.2242 0 0 0 0 11.8986 0 0 0 0 13.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.704 11.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0454 0 0 0 0 0 0 15.3756 10.0598 12.835 0 0 0 0 0 0 14.2955 0 13.5199 0 0 14.9732 0 11.2258 0 0 12.51 11.935 11.0435 0 0 Q92674 CENPI_HUMAN "Centromere protein I, CENP-I (FSH primary response protein 1) (Follicle-stimulating hormone primary response protein) (Interphase centromere complex protein 19) (Leucine-rich primary response protein 1)" CENPI FSHPRH1 ICEN19 LRPR1 Homo sapiens (Human) centromere complex assembly [GO:0034508]; sex differentiation [GO:0007548] cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; centromere complex assembly [GO:0034508]; sex differentiation [GO:0007548] GO:0000776; GO:0005654; GO:0005829; GO:0007548; GO:0016604; GO:0034508 ASQNKDKTLEK 0.99188 -23.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.544 0 0 0 0 0 0 0 0 0 10.6554 0 11.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6492 0 0 0 11.0222 0 0 0 0 12.4211 0 0 12.0862 0 0 0 0 0 0 0 0 0 0 15.3051 0 0 11.3602 0 0 11.406 0 0 0 0 0 0 0 0 0 14.6408 13.8516 14.0683 0 0 14.4684 0 0 0 14.4049 0 0 0 0 12.1527 0 0 0 0 0 0 0 0 14.3672 0 14.3912 0 0 0 0 15.2714 0 0 0 0 0 0 13.099 0 0 0 0 0 0 0 14.1895 0 14.0752 0 0 0 12.3013 0 0 0 11.0301 0 0 0 0 0 12.909 0 0 0 10.6174 0 0 0 0 0 0 0 14.0082 0 Q96QZ0 PANX3_HUMAN Pannexin-3 PANX3 Homo sapiens (Human) cation transport [GO:0006812]; cell-cell signaling [GO:0007267]; positive regulation of interleukin-1 production [GO:0032732] gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; wide pore channel activity [GO:0022829]; cation transport [GO:0006812]; cell-cell signaling [GO:0007267]; positive regulation of interleukin-1 production [GO:0032732] GO:0005198; GO:0005886; GO:0005921; GO:0006812; GO:0007267; GO:0016021; GO:0022829; GO:0032732 structural molecule activity [GO:0005198]; wide pore channel activity [GO:0022829] GLRLELPLDR 0.99188 -18.769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0512 12.6336 0 0 12.1016 0 12.3686 0 0 12.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8636 0 0 0 0 0 0 14.5846 0 0 0 14.3643 0 0 13.4534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7153 13.8408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ61 TRIR_HUMAN "Telomerase RNA component interacting RNase, EC 3.1.13.- (Exoribonuclease TRIR)" TRIR C19orf43 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" "3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" GO:0003723; GO:0008408; GO:0008409; GO:0016075; GO:0090503 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; RNA binding [GO:0003723] LALKTGIVAKK 0.99188 -7.717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2599 11.4007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1537 0 13.2791 0 0 0 0 0 0 0 13.749 0 0 0 0 0 13.7686 0 0 0 0 0 0 0 0 0 0 0 0 13.9793 0 0 0 0 11.8225 0 0 0 0 0 0 0 0 12.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.775 0 0 0 0 11.5232 0 0 Q9BTF0 THUM2_HUMAN THUMP domain-containing protein 2 THUMPD2 C2orf8 Homo sapiens (Human) tRNA methylation [GO:0030488] RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488] GO:0003723; GO:0016423; GO:0030488 RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423] CLNPEEK 0.99188 -24.674 0 12.2149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3807 14.5515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5923 0 0 0 0 0 0 0 0 0 12.8691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8731 0 0 0 0 0 0 0 13.1993 0 0 0 0 13.7063 13.9553 0 0 0 14.0098 14.6268 0 0 14.0837 0 0 14.4017 0 0 0 0 0 0 14.1006 0 0 0 15.0834 0 14.2781 13.9421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5672 0 0 14.7112 Q9P265 DIP2B_HUMAN "Disco-interacting protein 2 homolog B, DIP2 homolog B" DIP2B KIAA1463 Homo sapiens (Human) negative regulation of axon extension [GO:0030517]; nervous system development [GO:0007399]; positive regulation of peptidyl-lysine acetylation [GO:2000758] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204] axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204]; alpha-tubulin binding [GO:0043014]; negative regulation of axon extension [GO:0030517]; nervous system development [GO:0007399]; positive regulation of peptidyl-lysine acetylation [GO:2000758] GO:0005634; GO:0005737; GO:0007399; GO:0016020; GO:0030424; GO:0030425; GO:0030517; GO:0043014; GO:0043204; GO:0070062; GO:2000758 alpha-tubulin binding [GO:0043014] CRDLHWAMMAHR 0.99188 -23.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7613 0 0 0 0 0 0 0 0 0 0 0 16.8831 13.3425 0 12.3523 0 0 13.7585 0 0 14.2496 0 14.6213 0 0 0 13.3351 15.5314 0 0 0 14.7805 14.4947 0 0 0 0 0 0 0 0 11.5898 0 0 0 0 0 13.4179 0 0 0 0 13.5465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0449 Q9UII4 HERC5_HUMAN "E3 ISG15--protein ligase HERC5, EC 2.3.2.- (Cyclin-E-binding protein 1) (HECT domain and RCC1-like domain-containing protein 5)" HERC5 CEB1 CEBP1 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; protein ubiquitination [GO:0016567]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of defense response to virus [GO:0050688]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cyclin binding [GO:0030332]; ISG15 transferase activity [GO:0042296]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; protein ubiquitination [GO:0016567]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of defense response to virus [GO:0050688]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000079; GO:0003723; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0030332; GO:0032020; GO:0042296; GO:0045087; GO:0048471; GO:0050688; GO:0051607; GO:0061630 cyclin binding [GO:0030332]; ISG15 transferase activity [GO:0042296]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AAATQPAK 0.99188 -17.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9172 0 14.479 0 13.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2682 0 0 0 13.1984 0 0 0 0 0 0 0 0 0 0 0 12.8137 0 0 0 0 0 0 15.4748 0 12.5675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3983 0 0 0 13.7483 12.2007 0 0 0 0 0 0 14.7118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4667 0 0 0 0 13.6671 0 0 0 0 Q9ULD8 KCNH3_HUMAN "Potassium voltage-gated channel subfamily H member 3 (Brain-specific eag-like channel 1, BEC1) (Ether-a-go-go-like potassium channel 2, ELK channel 2, ELK2) (Voltage-gated potassium channel subunit Kv12.2)" KCNH3 KIAA1282 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] GO:0005249; GO:0005886; GO:0005887; GO:0006813; GO:0016021; GO:0034765; GO:0042391; GO:0071805 voltage-gated potassium channel activity [GO:0005249] EFKAELILYR 0.99188 -23.196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0185 0 12.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57981 9.44506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4297 0 10.4578 0 15.9176 0 0 0 0 0 0 0 0 0 0 14.4006 9.95761 0 10.4482 0 12.9452 12.7281 0 14.1075 18.4688 0 12.6022 0 0 12.7446 12.3647 10.5798 13.5939 0 0 0 0 0 0 0 0 0 11.288 0 0 14.757 9.80088 11.358 0 0 13.9261 0 14.0385 0 0 11.2464 0 0 0 16.8482 0 0 11.1861 0 0 11.4192 0 0 0 0 0 0 0 11.483 0 0 0 0 0 0 0 17.9756 0 14.0658 0 0 0 12.3187 0 14.6733 Q9Y388 RBMX2_HUMAN "RNA-binding motif protein, X-linked 2" RBMX2 CGI-79 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005] "nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0005686; GO:0071005; GO:0071011; GO:1903241 RNA binding [GO:0003723] EGQKLPK 0.99188 -18.766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0787 0 0 0 12.5783 0 0 0 12.8589 0 0 0 0 0 0 0 0 12.9437 0 13.8165 0 13.3212 0 0 13.7645 0 0 0 0 0 0 13.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1531 13.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75683 SURF6_HUMAN Surfeit locus protein 6 SURF6 SURF-6 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274] chromosome [GO:0005694]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274] GO:0001652; GO:0003677; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0042273; GO:0042274 DNA binding [GO:0003677]; RNA binding [GO:0003723] ILPQDLER 0.99189 -22.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8662 0 0 0 0 0 0 0 0 0 0 0 13.8939 0 0 0 12.9036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7198 0 0 0 0 0 0 0 0 0 0 0 0 18.4175 16.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09884 DPOLA_HUMAN "DNA polymerase alpha catalytic subunit, EC 2.7.7.7 (DNA polymerase alpha catalytic subunit p180)" POLA1 POLA Homo sapiens (Human) "DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479]" alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479]" GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006281; GO:0006303; GO:0008270; GO:0016363; GO:0017076; GO:0019103; GO:0019901; GO:0032479; GO:1902975 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270] DPQDYPDK 0.99189 -18.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8436 0 0 0 0 0 0 0 0 0 0 0 12.9867 0 0 0 0 0 0 0 0 0 0 0 10.7302 0 0 0 0 11.194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5289 0 0 0 0 0 11.8323 11.1828 0 15.3585 14.7001 16.2178 0 0 0 0 0 13.9018 13.6608 13.5196 12.7465 18.2457 13.496 13.6058 0 13.9586 13.7466 14.8758 0 0 0 0 0 15.5397 15.4478 15.9779 10.9165 0 0 14.0559 15.4107 14.905 0 17.4786 15.0464 0 0 16.1293 0 15.2056 13.872 0 0 12.3432 0 0 0 14.1897 12.7597 0 0 0 0 14.2564 0 13.3887 0 0 0 15.7135 0 12.5062 12.8363 0 0 0 0 0 0 0 0 0 0 13.6891 15.5813 15.1909 0 0 0 0 0 0 0 17.0263 0 14.8864 0 15.4294 0 0 0 0 0 0 11.9143 0 0 0 15.153 15.8788 0 P31276 HXC13_HUMAN Homeobox protein Hox-C13 (Homeobox protein Hox-3G) HOXC13 HOX3G Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; hair follicle development [GO:0001942]; nail development [GO:0035878]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; tongue morphogenesis [GO:0043587]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; hair follicle development [GO:0001942]; nail development [GO:0035878]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; tongue morphogenesis [GO:0043587]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001942; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0009653; GO:0009952; GO:0035878; GO:0043587; GO:0045893; GO:0140297; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" KRVPYTK 0.99189 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2426 0 0 0 0 12.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55263 ADK_HUMAN "Adenosine kinase, AK, EC 2.7.1.20 (Adenosine 5'-phosphotransferase)" ADK Homo sapiens (Human) AMP salvage [GO:0044209]; dAMP salvage [GO:0106383]; dATP biosynthetic process [GO:0006175]; GMP salvage [GO:0032263]; phosphorylation [GO:0016310]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleoside salvage [GO:0006166]; ribonucleoside monophosphate biosynthetic process [GO:0009156] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; deoxyadenosine kinase activity [GO:0004136]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; AMP salvage [GO:0044209]; dAMP salvage [GO:0106383]; dATP biosynthetic process [GO:0006175]; GMP salvage [GO:0032263]; phosphorylation [GO:0016310]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleoside salvage [GO:0006166]; ribonucleoside monophosphate biosynthetic process [GO:0009156] GO:0003723; GO:0004001; GO:0004136; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006144; GO:0006166; GO:0006175; GO:0009156; GO:0016310; GO:0032263; GO:0044209; GO:0046872; GO:0106383 adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; deoxyadenosine kinase activity [GO:0004136]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] EKHLDLEK 0.99189 -7.7348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4287 0 16.3462 15.1347 0 0 0 0 0 0 12.2506 0 11.7873 0 0 0 0 0 0 0 12.3737 0 0 0 0 13.4103 0 0 0 0 0 0 0 0 0 0 0 14.3668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2069 0 0 0 0 0 16.8988 0 0 0 0 0 0 0 0 0 13.0078 13.9795 0 0 0 0 0 0 0 0 0 0 11.8432 0 12.7699 0 P57723 PCBP4_HUMAN Poly(rC)-binding protein 4 (Alpha-CP4) PCBP4 Homo sapiens (Human) "negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of RNA metabolic process [GO:0051252]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of RNA metabolic process [GO:0051252]" GO:0003677; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0010468; GO:0043488; GO:0048025; GO:0051252 DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] MAAANGSK 0.99189 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16623 STX1A_HUMAN Syntaxin-1A (Neuron-specific antigen HPC-1) STX1A STX1 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of norepinephrine secretion [GO:0010701]; protein localization to membrane [GO:0072657]; protein sumoylation [GO:0016925]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle priming [GO:0010807]; response to gravity [GO:0009629]; secretion by cell [GO:0032940]; SNARE complex assembly [GO:0035493]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] actomyosin [GO:0042641]; anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone membrane [GO:0048787]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; voltage-gated potassium channel complex [GO:0008076] actomyosin [GO:0042641]; anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone membrane [GO:0048787]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex [GO:0070033]; voltage-gated potassium channel complex [GO:0008076]; ATP-dependent protein binding [GO:0043008]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; chloride channel inhibitor activity [GO:0019869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; myosin head/neck binding [GO:0032028]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325]; calcium-ion regulated exocytosis [GO:0017156]; exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of catecholamine secretion [GO:0033605]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of norepinephrine secretion [GO:0010701]; protein localization to membrane [GO:0072657]; protein sumoylation [GO:0016925]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle priming [GO:0010807]; response to gravity [GO:0009629]; secretion by cell [GO:0032940]; SNARE complex assembly [GO:0035493]; synaptic vesicle docking [GO:0016081]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0001956; GO:0005484; GO:0005576; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006906; GO:0008021; GO:0008076; GO:0009629; GO:0010701; GO:0010807; GO:0012505; GO:0014069; GO:0016021; GO:0016079; GO:0016081; GO:0016925; GO:0017156; GO:0019855; GO:0019869; GO:0019900; GO:0019904; GO:0030073; GO:0030141; GO:0030285; GO:0030424; GO:0031201; GO:0031629; GO:0031965; GO:0032028; GO:0032940; GO:0033605; GO:0035493; GO:0042641; GO:0042802; GO:0043005; GO:0043008; GO:0044325; GO:0044877; GO:0045956; GO:0047485; GO:0048278; GO:0048306; GO:0048488; GO:0048787; GO:0050796; GO:0070032; GO:0070033; GO:0070044; GO:0070161; GO:0072657; GO:0098978; GO:0099056; GO:2000463 ATP-dependent protein binding [GO:0043008]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; chloride channel inhibitor activity [GO:0019869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; myosin head/neck binding [GO:0032028]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; transmembrane transporter binding [GO:0044325] FVEVMSEYNATQSDYR 0.99189 -6.0084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8734 13.3439 0 0 13.9825 14.5653 0 0 0 0 13.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8332 0 0 0 0 13.4201 0 0 0 0 0 0 0 0 0 14.5241 0 0 0 0 0 13.0484 0 0 0 0 0 13.5188 0 0 0 0 12.9314 0 0 0 0 0 0 0 0 13.7165 0 0 0 0 0 0 0 0 0 0 0 12.9059 0 0 Q5VWN6 TASO2_HUMAN Protein TASOR 2 TASOR2 C10orf18 FAM208B KIAA2006 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 ETPLPVSLPSDKTMVMEALSLAK 0.99189 -18.822 0 0 0 0 0 0 0 0 12.258 0 0 0 0 0 0 11.594 0 0 0 0 0 0 15.002 13.4853 0 0 11.6523 0 10.9173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6827 13.3757 0 0 0 0 0 9.6957 0 0 0 0 0 0 0 0 12.3785 13.3418 14.1935 15.9094 12.9296 0 0 0 0 15.1863 0 12.2392 17.2465 0 16.1945 14.5829 0 0 0 0 0 11.1144 0 0 0 0 0 0 14.0744 0 16.6361 0 0 13.1303 0 16.1847 16.0381 11.8635 13.205 14.1656 0 14.473 0 0 0 0 16.1764 0 15.4934 0 0 15.0099 0 0 0 14.5187 13.8078 0 0 13.1027 0 15.3848 12.8705 0 0 0 0 0 0 0 0 16.1905 0 0 16.2646 0 15.399 11.4736 0 16.2119 0 0 15.2923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2333 0 16.3607 0 0 0 0 0 0 Q8IU80 TMPS6_HUMAN "Transmembrane protease serine 6, EC 3.4.21.- (Matriptase-2)" TMPRSS6 UNQ354/PRO618 Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]" extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; BMP signaling pathway [GO:0030509]; cellular iron ion homeostasis [GO:0006879]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; iron ion homeostasis [GO:0055072]; membrane protein proteolysis [GO:0033619]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; self proteolysis [GO:0097264]" GO:0000122; GO:0004222; GO:0004252; GO:0005615; GO:0005886; GO:0006879; GO:0016021; GO:0022617; GO:0030509; GO:0030514; GO:0030574; GO:0033619; GO:0045892; GO:0045944; GO:0055072; GO:0097264 metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252] DCPNGLDERNCVCR 0.99189 -7.428 18.3577 18.5937 18.1576 13.8327 17.1938 17.0483 17.0651 15.3061 0 11.9675 0 0 0 0 0 0 0 10.2286 0 0 0 0 0 17.4861 0 12.119 0 0 0 0 0 0 0 0 9.95957 0 0 0 0 0 0 0 0 0 12.3547 0 0 0 0 0 0 13.7676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.043 19.1475 18.9998 13.8169 18.9564 12.2825 0 19.0418 14.6486 19.0878 19.1057 19.0859 13.3849 19.1772 19.1906 20.6587 20.6125 20.695 18.8959 12.6596 12.4843 14.2098 13.8546 0 13.2707 0 13.0282 13.8433 0 13.533 11.5698 14.2769 14.2994 13.5366 19.3293 19.4549 19.512 0 14.8472 19.4603 14.1562 0 13.1786 14.5012 15.4094 0 14.8282 15.3353 13.1097 15.0339 15.5451 0 13.4503 15.7287 14.974 13.6879 19.5363 14.763 13.8021 14.227 15.8168 19.4884 19.5338 19.56 19.5094 19.5521 19.4492 14.9718 15.1511 0 0 13.4992 14.6861 14.6357 0 14.3761 13.0866 13.7093 0 13.3015 0 0 14.6885 0 19.6731 19.6589 19.5818 19.7155 13.1938 15.0535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7422 15.6566 14.4934 14.5483 0 0 0 13.5446 12.1105 Q8NA77 TEX19_HUMAN Testis-expressed protein 19 TEX19 Homo sapiens (Human) cell differentiation [GO:0030154]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; placenta development [GO:0001890]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; piRNA binding [GO:0034584]; cell differentiation [GO:0030154]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; negative regulation of transposition [GO:0010529]; placenta development [GO:0001890]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283] GO:0001890; GO:0005634; GO:0005737; GO:0007131; GO:0007140; GO:0007283; GO:0008584; GO:0010529; GO:0030154; GO:0034584 piRNA binding [GO:0034584] MCPPVSMR 0.99189 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92731 ESR2_HUMAN "Estrogen receptor beta, ER-beta (Nuclear receptor subfamily 3 group A member 2)" ESR2 ESTRB NR3A2 Homo sapiens (Human) "cell-cell signaling [GO:0007267]; cellular response to estradiol stimulus [GO:0071392]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; nuclear estrogen receptor activity [GO:0030284]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; receptor antagonist activity [GO:0048019]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; cellular response to estradiol stimulus [GO:0071392]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0006357; GO:0007165; GO:0007267; GO:0008270; GO:0019899; GO:0030284; GO:0030308; GO:0030518; GO:0030520; GO:0034056; GO:0043231; GO:0045893; GO:0045944; GO:0048019; GO:0051091; GO:0071392 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; nuclear estrogen receptor activity [GO:0030284]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; receptor antagonist activity [GO:0048019]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]" CGSRRER 0.99189 -7.431 0 0 0 0 0 0 0 0 0 0 13.2478 13.4274 0 0 0 0 0 0 0 0 0 0 13.8299 0 0 0 0 0 11.9571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8651 0 0 0 0 0 0 0 0 0 0 14.4939 0 0 14.8755 14.8369 0 14.618 0 0 14.8936 14.309 0 0 0 14.5612 0 0 0 14.827 0 14.5352 0 0 0 0 13.6422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y312 AAR2_HUMAN Protein AAR2 homolog (AAR2 splicing factor homolog) AAR2 C20orf4 CGI-23 PRO0225 Homo sapiens (Human) spliceosomal tri-snRNP complex assembly [GO:0000244] spliceosomal complex [GO:0005681]; U5 snRNP [GO:0005682] spliceosomal complex [GO:0005681]; U5 snRNP [GO:0005682]; spliceosomal tri-snRNP complex assembly [GO:0000244] GO:0000244; GO:0005681; GO:0005682 LLNLLCR 0.99189 -6.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2109 13.9114 13.8115 13.9317 0 0 0 0 0 0 15.9742 0 15.6351 0 0 14.5915 0 13.7472 0 16.0007 15.2979 0 13.9621 14.9846 14.5516 14.3819 0 0 0 14.2619 13.2586 13.2569 15.2959 0 0 13.5352 14.5595 0 0 14.7166 14.8278 14.2338 0 0 14.5413 0 13.9182 14.8529 14.6181 0 0 0 0 0 0 0 13.7754 0 0 14.6227 0 0 0 0 0 14.372 0 0 0 0 0 0 0 0 13.8908 0 0 0 0 15.4335 0 13.2871 15.2976 12.9811 0 0 0 0 0 0 0 0 0 13.107 0 0 0 0 0 0 14.7378 0 14.2605 0 0 0 0 11.1989 Q9Y5W3 KLF2_HUMAN Krueppel-like factor 2 (Lung krueppel-like factor) KLF2 LKLF Homo sapiens (Human) "cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]; vasodilation [GO:0042311]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]; vasodilation [GO:0042311]" GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0001701; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0032715; GO:0035264; GO:0036003; GO:0040029; GO:0042311; GO:0043249; GO:0045429; GO:0045893; GO:0045944; GO:0046872; GO:0048386; GO:0051247; GO:0060509; GO:0070301; GO:0071347; GO:0071356; GO:0071409; GO:0071498; GO:0071499; GO:0097533; GO:1901653; GO:1903671; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EGAPGPAASCMRGPGGR 0.99189 -18.835 0 0 0 0 0 0 0 0 0 0 0 15.137 14.5747 0 0 0 0 0 16.9607 0 0 0 0 0 0 0 0 13.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2832 0 0 0 0 0 0 0 17.9937 0 17.0748 0 0 15.4744 16.3127 15.2461 15.2131 0 0 0 13.8072 0 0 0 0 0 0 0 0 0 0 0 0 13.1476 0 0 0 0 12.4715 0 0 0 0 0 0 12.5472 0 10.3274 11.0005 0 0 0 0 0 0 13.4862 0 0 0 0 13.1213 0 0 0 12.4352 0 0 12.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A5B6 TVB28_HUMAN T cell receptor beta variable 28 TRBV28 TCRBV3S1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; peptide antigen binding [GO:0042605]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101; GO:0042605 peptide antigen binding [GO:0042605] LIYFSYDVK 0.9919 -6.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10915 HPLN1_HUMAN "Hyaluronan and proteoglycan link protein 1 (Cartilage-linking protein 1, Cartilage-link protein) (Proteoglycan link protein)" HAPLN1 CRTL1 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; synapse [GO:0045202] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; synapse [GO:0045202]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501] GO:0001501; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0031012; GO:0045202; GO:0062023 hyaluronic acid binding [GO:0005540] FVGFPDKK 0.9919 -22.699 0 0 0 0 0 10.3808 0 0 0 0 0 0 0 10.0473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9114 0 11.6636 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8146 0 0 0 0 0 0 0 0 0 10.0631 0 0 0 0 0 0 10.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9243 0 0 11.0027 0 0 0 0 0 0 0 0 0 0 0 0 11.6627 0 0 11.0659 0 0 0 0 10.3573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9498 0 0 11.3952 0 0 0 0 0 0 0 0 P60896 SEM1_HUMAN 26S proteasome complex subunit SEM1 (26S proteasome complex subunit DSS1) (Deleted in split hand/split foot protein 1) (Split hand/foot deleted protein 1) (Split hand/foot malformation type 1 protein) SEM1 C7orf76 DSS1 SHFDG1 SHFM1 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; protein-containing complex [GO:0032991]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; protein-containing complex [GO:0032991]; double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0000724; GO:0005654; GO:0005829; GO:0006406; GO:0008541; GO:0032991; GO:0043161; GO:0043248 HGYKMETS 0.9919 -7.1233 10.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00526 CDK3_HUMAN "Cyclin-dependent kinase 3, EC 2.7.11.22 (Cell division protein kinase 3)" CDK3 CDKN3 Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; G0 to G1 transition [GO:0045023]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of Notch signaling pathway [GO:0045746]; protein phosphorylation [GO:0006468] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; G0 to G1 transition [GO:0045023]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of Notch signaling pathway [GO:0045746]; protein phosphorylation [GO:0006468] GO:0000082; GO:0000307; GO:0004693; GO:0005524; GO:0005634; GO:0006468; GO:0006974; GO:0008283; GO:0045023; GO:0045746; GO:0051301; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] AFGVPLR 0.9919 -4.378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8972 0 0 0 0 0 0 0 14.5703 0 0 0 0 0 0 15.3423 14.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2S7 TTC41_HUMAN "Putative tetratricopeptide repeat protein 41, TPR repeat protein 41 (Grp94-neighboring nucleotidase)" TTC41P GNN Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ADQCHTMR 0.9919 -48.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3353 11.7596 0 0 0 0 12.5398 10.833 0 0 0 0 0 0 0 0 0 0 0 0 11.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1978 0 0 0 0 0 0 0 14.7579 13.8371 0 15.1516 0 13.7704 11.8262 0 14.2246 14.5612 15.4303 0 14.0239 12.3666 0 13.4476 12.4886 0 0 0 0 14.522 0 13.1793 14.2902 15.0201 14.2037 15.5736 0 0 15.807 12.7298 13.5853 15.316 0 0 0 13.3722 9.51086 0 12.0222 0 0 14.68 0 14.2301 0 13.3522 15.3852 0 13.0913 0 15.0764 13.0919 0 0 0 0 0 0 0 0 0 14.4519 0 0 0 0 0 0 0 0 12.506 14.6971 15.2543 0 0 12.5205 0 12.9696 0 0 0 0 0 0 0 0 0 0 0 0 10.3743 0 0 0 0 0 Q8NCM8 DYHC2_HUMAN "Cytoplasmic dynein 2 heavy chain 1 (Cytoplasmic dynein 2 heavy chain) (Dynein cytoplasmic heavy chain 2) (Dynein heavy chain 11, hDHC11) (Dynein heavy chain isotype 1B)" DYNC2H1 DHC1B DHC2 DNCH2 DYH1B KIAA1997 Homo sapiens (Human) cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; forebrain development [GO:0030900]; Golgi organization [GO:0007030]; intraciliary retrograde transport [GO:0035721]; kidney development [GO:0001822]; microtubule-based movement [GO:0007018]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein processing [GO:0016485]; spinal cord motor neuron differentiation [GO:0021522] apical part of cell [GO:0045177]; axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; axoneme [GO:0005930]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; forebrain development [GO:0030900]; Golgi organization [GO:0007030]; intraciliary retrograde transport [GO:0035721]; kidney development [GO:0001822]; microtubule-based movement [GO:0007018]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to cilium [GO:0061512]; protein processing [GO:0016485]; spinal cord motor neuron differentiation [GO:0021522] GO:0001822; GO:0003774; GO:0005524; GO:0005794; GO:0005868; GO:0005874; GO:0005886; GO:0005929; GO:0005930; GO:0007018; GO:0007030; GO:0007368; GO:0008569; GO:0009953; GO:0016485; GO:0021522; GO:0030286; GO:0030326; GO:0030900; GO:0031514; GO:0035721; GO:0045177; GO:0045505; GO:0045880; GO:0051959; GO:0060271; GO:0060976; GO:0061512; GO:0070062; GO:0097542; GO:1905515 ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] ALQWVLK 0.9919 -86.06 0 0 0 0 13.9552 0 0 0 0 0 0 0 0 0 0 0 14.5087 0 0 0 0 0 0 0 11.9938 0 0 11.128 0 0 0 0 14.7332 12.0938 0 0 0 11.5999 0 0 0 0 0 0 14.5046 0 12.9174 0 0 10.9725 0 0 13.5425 0 14.4797 0 0 10.7109 11.6207 0 0 0 0 0 0 0 14.6058 0 13.5962 0 0 0 15.764 15.6615 13.2607 0 13.1859 0 16.2724 12.2878 15.1091 0 14.8684 17.1292 14.0983 14.5374 16.2662 14.4027 17.6183 13.5427 14.7187 0 14.7419 0 12.6808 14.0928 16.4754 0 16.7328 12.4905 14.5811 14.2371 14.5929 15.8557 15.5238 0 17.0223 0 15.8563 13.5269 12.6197 14.894 13.758 16.3041 14.3782 13.4099 14.2636 15.4132 0 0 0 12.3937 0 13.7261 13.9432 12.6129 0 13.3617 14.6079 14.557 16.1807 10.8662 15.4874 13.5658 14.7435 14.2796 0 12.9945 14.789 11.3814 14.4378 0 14.5046 0 0 0 0 12.3231 13.5767 0 15.3224 0 14.5152 0 15.1787 15.2109 0 0 0 0 0 11.767 13.9188 12.6538 14.0317 0 0 0 12.0987 0 12.6171 14.3857 14.8496 13.8841 13.5553 0 0 0 0 0 Q969V1 MCHR2_HUMAN "Melanin-concentrating hormone receptor 2, MCH receptor 2, MCH-R2, MCHR-2 (G-protein coupled receptor 145) (GPRv17) (MCH-2R, MCH2, MCH2R)" MCHR2 GPR145 SLT Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide signaling pathway [GO:0007218] GO:0005886; GO:0005887; GO:0007218; GO:0008528 G protein-coupled peptide receptor activity [GO:0008528] CCNPSVPK 0.9919 -22.746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2883 0 0 0 0 14.6816 13.8115 0 12.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8105 0 0 0 10.4711 0 0 0 0 0 0 11.2996 0 0 0 0 0 0 11.5946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9389 0 0 0 0 0 0 0 0 0 10.0689 0 0 Q96A47 ISL2_HUMAN "Insulin gene enhancer protein ISL-2, Islet-2" ISL2 Homo sapiens (Human) axonogenesis [GO:0007409]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; peripheral nervous system neuron development [GO:0048935]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord motor neuron cell fate specification [GO:0021520]; visceral motor neuron differentiation [GO:0021524] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]; axonogenesis [GO:0007409]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; peripheral nervous system neuron development [GO:0048935]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord motor neuron cell fate specification [GO:0021520]; visceral motor neuron differentiation [GO:0021524]" GO:0000785; GO:0000981; GO:0000987; GO:0003677; GO:0005634; GO:0006357; GO:0007409; GO:0021520; GO:0021524; GO:0031290; GO:0045665; GO:0046872; GO:0048665; GO:0048666; GO:0048935; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific double-stranded DNA binding [GO:1990837]" ARDSVYHIECFR 0.9919 -6.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4715 0 0 0 0 0 14.2456 0 0 0 0 0 0 0 0 11.6276 14.9965 Q96JG9 ZN469_HUMAN Zinc finger protein 469 ZNF469 KIAA1858 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of extracellular matrix organization [GO:1903053] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of extracellular matrix organization [GO:1903053] GO:0000122; GO:0003677; GO:0005634; GO:0046872; GO:1903053 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AKDGHQR 0.9919 -48.069 0 12.6626 0 0 0 0 0 0 0 0 0 14.1874 0 0 0 0 0 0 0 0 0 0 0 0 13.2512 0 0 0 0 0 0 0 0 11.0996 0 0 0 0 0 0 0 14.3963 0 0 0 0 0 0 0 0 0 0 9.60489 0 12.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8636 14.1285 0 0 15.1404 12.6698 0 13.2022 12.35 12.6279 0 0 0 12.4741 13.3016 15.7348 16.0678 14.4599 0 0 13.3577 11.4298 16.9133 16.8028 13.4861 16.9717 17.2887 16.439 0 16.8527 16.8802 0 0 12.8672 17.1496 15.9818 0 14.4021 0 13.0442 14.5955 14.2847 0 16.5215 0 15.1713 0 14.3184 0 0 0 13.1526 17.1759 13.0719 14.2679 0 14.2963 14.7735 13.6332 0 0 0 0 0 0 13.6915 12.6391 0 0 13.2729 14.2762 0 0 14.3598 14.4081 0 12.0151 0 0 0 0 15.2687 0 11.7782 0 0 14.2867 14.1617 0 0 0 14.2545 0 13.7822 0 14.9079 0 0 0 0 0 0 13.3392 0 0 0 0 0 11.1589 0 14.5249 Q96L34 MARK4_HUMAN "MAP/microtubule affinity-regulating kinase 4, EC 2.7.11.1 (MAP/microtubule affinity-regulating kinase-like 1)" MARK4 KIAA1860 MARKL1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cilium organization [GO:0044782]; intracellular signal transduction [GO:0035556]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; positive regulation of cell cycle [GO:0045787]; positive regulation of cilium assembly [GO:0045724]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein localization to centrosome [GO:1904781]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; gamma-tubulin complex [GO:0000930]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; neuron projection [GO:0043005] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; gamma-tubulin complex [GO:0000930]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium organization [GO:0044782]; intracellular signal transduction [GO:0035556]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; nervous system development [GO:0007399]; positive regulation of cell cycle [GO:0045787]; positive regulation of cilium assembly [GO:0045724]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein localization to centrosome [GO:1904781]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605] GO:0000226; GO:0000930; GO:0001578; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0007049; GO:0007399; GO:0008017; GO:0015630; GO:0030425; GO:0030496; GO:0035556; GO:0036064; GO:0043005; GO:0043015; GO:0043068; GO:0043130; GO:0044782; GO:0045724; GO:0045787; GO:0046605; GO:0048156; GO:0050321; GO:0051301; GO:0106310; GO:1904781 ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin binding [GO:0043130] CTLEQIMKDK 0.9919 -55.139 0 0 0 0 10.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4571 0 0 0 0 0 0 0 0 0 0 13.6776 0 11.8915 0 0 0 0 0 0 0 0 12.4666 0 0 0 0 0 0 11.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9879 0 0 0 0 0 0 0 12.4809 14.2362 13.7039 0 0 13.8866 0 14.0075 0 0 15.9769 0 14.8263 13.8768 13.4494 13.7174 13.5567 14.2075 15.4312 0 0 0 0 13.5712 15.5611 0 0 0 15.3609 12.4272 0 12.9526 0 0 0 13.1397 13.8253 0 13.8067 0 13.9295 12.7744 12.6991 13.3418 0 14.953 13.6861 14.4987 0 0 13.6073 13.4567 13.3704 15.2877 0 12.5317 0 0 0 0 14.1794 14.423 0 0 0 11.7459 0 13.2204 12.343 0 0 0 0 14.5155 0 0 14.9522 0 14.4069 0 0 0 0 0 0 14.1087 11.9067 12.8164 0 0 0 0 0 0 0 0 14.8407 0 0 0 0 9.17615 Q96M93 ADAD1_HUMAN Adenosine deaminase domain-containing protein 1 (Testis nuclear RNA-binding protein) ADAD1 TENR Homo sapiens (Human) adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286] GO:0001673; GO:0003725; GO:0003726; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0007286; GO:0008251 double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251] DGVNRISSMSSSDK 0.9919 -18.857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6609 0 0 0 12.8313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP87 DPOLM_HUMAN "DNA-directed DNA/RNA polymerase mu, Pol Mu, EC 2.7.7.7 (Terminal transferase)" POLM polmu Homo sapiens (Human) DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303] GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006303; GO:0006310; GO:0046872 DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] TADRWYR 0.9919 -4.3832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYR9 KBRS2_HUMAN "NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2, Kappa B-Ras protein 2, KappaB-Ras2)" NKIRAS2 KBRAS2 Homo sapiens (Human) I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; lung alveolus development [GO:0048286]; Ral protein signal transduction [GO:0032484]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129] GO:0003924; GO:0005525; GO:0005737; GO:0006954; GO:0007249; GO:0010803; GO:0032484; GO:0032794; GO:0043122; GO:0043129; GO:0048286 GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924] DGAELPR 0.9919 -18.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8658 0 0 0 0 0 0 0 11.5376 0 0 0 0 0 0 0 0 0 11.905 0 0 0 0 10.5803 0 0 0 0 0 11.8644 0 0 0 12.5603 13.1369 0 0 0 0 0 0 0 0 0 0 0 0 11.7557 0 13.4381 0 0 12.3952 0 12.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7012 0 13.7035 0 0 0 0 0 0 0 14.4648 0 13.5706 13.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2559 0 0 0 Q5VST9 OBSCN_HUMAN "Obscurin, EC 2.7.11.1 (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase, Obscurin-MLCK)" OBSCN KIAA1556 KIAA1639 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]; myofibril [GO:0030016]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018] "cell-cell junction [GO:0005911]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; M band [GO:0031430]; myofibril [GO:0030016]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cell-cell adhesion [GO:0098609]; protein localization to M-band [GO:0036309]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056]; sarcomere organization [GO:0045214]" GO:0004674; GO:0005085; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0006468; GO:0008307; GO:0010314; GO:0016604; GO:0030016; GO:0030018; GO:0030506; GO:0031430; GO:0031432; GO:0032266; GO:0036309; GO:0042383; GO:0043325; GO:0045214; GO:0046872; GO:0050839; GO:0051056; GO:0070273; GO:0098609; GO:0106310 "ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]" AIRKSQK 0.99191 -125.16 0 0 0 0 0 14.2027 0 0 15.3478 14.4604 13.4132 15.058 12.7525 14.3315 14.8128 12.5674 0 13.5684 0 12.6416 0 11.1521 13.5132 0 0 0 18.2392 17.867 17.8798 14.7823 13.3358 14.1166 18.6096 13.6385 13.4031 14.6218 12.4528 12.8075 18.0949 0 13.9269 11.991 18.1731 18.0456 18.0034 15.0219 13.8093 13.2064 12.9931 13.8305 18.1236 14.7642 0 17.6117 0 0 13.5943 0 0 0 16.8888 0 0 0 0 0 0 0 13.0279 0 13.4677 0 0 13.857 14.9452 14.8052 13.2868 12.6062 13.0639 0 0 16.567 14.3523 13.5286 15.2887 14.7217 0 0 0 12.9296 14.28 0 0 11.1082 0 14.6306 12.6728 14.1052 15.5561 15.0832 13.7179 15.1687 0 14.6387 14.9745 0 19.0656 14.5563 15.0702 14.4348 15.0799 11.9338 12.9133 0 14.8458 14.604 16.6003 16.1136 13.9956 14.5036 13.8496 12.6316 12.6254 0 14.7476 14.293 13.9732 20.6008 12.6575 14.6473 0 14.3126 0 15.0622 12.7851 14.1944 14.2614 14.2949 13.447 15.9118 14.5885 11.1951 0 13.0458 14.231 13.4581 13.6641 15.0819 0 0 14.5943 16.6068 0 10.2675 0 13.2302 0 15.0458 12.3683 15.2251 14.5837 14.5862 19.181 19.2037 14.3235 19.159 17.5473 19.0811 17.0236 0 0 15.7891 0 13.8431 14.6103 15.5144 0 14.7255 0 0 P46013 KI67_HUMAN "Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67, Antigen KI-67, Antigen Ki67)" MKI67 Homo sapiens (Human) cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] chromosome [GO:0005694]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell population proliferation [GO:0008283]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0007049; GO:0007088; GO:0008022; GO:0008283; GO:0016020; GO:0016604; GO:0051983; GO:1902275 ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723] AEALEDLVGFKELFQTPGHTEESMTDDK 0.99191 -114 10.9211 0 0 0 13.2742 0 0 0 13.858 15.1686 18.9693 19.1218 19.0095 19.0664 19.0766 14.8948 13.9605 13.845 14.4829 12.1221 12.1278 0 13.9416 11.2305 14.9165 14.0277 14.9662 13.8282 12.7662 12.9984 19.4241 19.0793 16.6128 19.0936 13.7349 13.6294 15.1391 14.2959 14.0149 19.3119 0 19.1765 11.1385 0 13.5713 17.5392 17.1953 13.6781 0 14.9412 12.6264 15.3337 14.9984 14.98 16.2814 14.8273 17.4163 18.445 16.9158 17.383 16.2635 16.8408 18.6062 16.8945 16.5918 16.2788 15.3911 15.6444 15.6055 0 12.8259 13.248 10.9511 12.2693 12.7041 18.1312 18.1189 0 15.1332 0 0 13.7963 18.1613 14.3131 0 12.3494 0 14.6402 0 12.2821 14.1699 0 0 0 0 13.2553 13.8056 15.9367 14.3066 13.9933 18.3879 0 15.9692 16.3445 0 13.3339 14.1125 13.685 13.0649 13.3536 16.4812 15.0522 0 15.6572 0 11.1936 16.5867 0 0 0 13.3805 0 13.6663 12.0131 13.2737 13.3149 0 13.1381 14.7759 13.763 13.9898 14.3041 0 13.2437 13.4767 15.1999 13.1086 13.4039 12.4012 14.5252 13.0438 12.7456 13.7846 0 13.5666 0 0 16.3716 13.3628 13.3852 0 0 0 13.6098 17.9114 15.3622 15.7043 15.5441 20.0832 15.219 14.8459 15.1014 14.8192 15.1454 15.4132 15.5616 19.2887 15.4712 14.4296 13.241 14.9725 15.0052 13.4171 14.8959 11.6273 16.4419 0 15.4786 12.0592 0 Q8TE73 DYH5_HUMAN Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5) DNAH5 DNAHC5 HL1 KIAA1603 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0097728; GO:0097729 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] AQAAEKVKAEVQK 0.99191 -94.755 0 13.1695 0 17.1709 0 0 0 0 13.1441 0 12.5101 13.0506 13.0066 13.1103 0 11.9233 11.4308 12.6212 12.795 14.0506 11.5859 12.3676 11.5294 0 0 0 13.5683 13.5344 12.8366 11.9176 0 12.8908 12.9121 13.6966 14.3731 14.4421 13.548 0 14.6868 15.0421 0 13.4074 12.2486 0 13.6109 0 0 10.8333 13.4619 0 0 0 14.8132 13.0892 14.2898 0 13.3306 0 0 0 14.6352 0 14.0776 14.4429 13.309 12.8731 0 0 12.553 13.9782 0 0 14.9442 0 0 14.4099 0 15.0816 14.5999 12.418 14.8345 13.1758 0 15.438 16.9623 15.8059 13.1372 15.4735 16.1713 13.4698 16.2709 15.0035 15.2309 15.2456 15.7025 15.8763 15.1222 17.1405 0 14.4089 15.6363 16.5676 12.7615 0 15.4101 16.325 13.0802 14.5439 13.8366 9.92827 0 14.4087 12.7214 12.0104 16.3754 16.6393 15.6327 14.2353 16.2876 0 0 16.3759 13.9488 0 15.6941 16.1617 0 14.957 17.5987 15.6085 12.7263 15.8086 16.1411 15.7459 13.0655 14.8959 16.3566 16.2813 16.5894 15.1086 16.4888 16.1037 0 14.8485 0 14.7898 14.6425 16.0826 11.211 13.7357 11.9597 11.9327 0 12.6381 14.814 14.5467 13.9553 10.6828 14.0536 13.7414 14.0495 13.6937 0 0 0 13.6606 14.2208 0 14.2897 0 16.7378 16.1902 15.0149 15.4537 13.7015 12.5455 15.0872 0 13.6279 11.9123 A6NLU5 VTM2B_HUMAN V-set and transmembrane domain-containing protein 2B VSTM2B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DVTVREGDDIEMPCAFRASGATSYSLEIQWWYLK 0.99191 -7.4662 0 0 0 0 0 0 0 0 10.3559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55877 0 0 0 0 10.6937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7981 0 0 0 0 0 0 0 0 0 11.0505 0 15.2914 14.7637 0 0 0 14.9289 0 0 0 0 0 0 15.0555 0 0 0 0 0 14.832 14.3871 0 14.6555 14.9336 0 10.4883 0 0 0 0 11.4256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5827 0 0 0 0 0 0 0 14.4654 0 13.4201 0 0 0 0 0 0 12.0025 0 0 0 0 0 13.7798 0 0 0 0 0 0 13.2446 0 0 0 0 0 0 0 0 0 0 0 0 O15417 TNC18_HUMAN Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein) TNRC18 CAGL79 KIAA1856 Homo sapiens (Human) cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682] GO:0003682; GO:0005654; GO:0005739; GO:0005829; GO:0031965 chromatin binding [GO:0003682] ADEDCVDDR 0.99191 -114.97 0 0 0 0 0 0 0 0 0 0 0 10.116 0 10.965 12.6476 0 0 0 0 0 0 0 0 0 0 0 11.5741 14.4716 12.4218 0 0 12.7496 0 0 0 0 0 0 14.5507 11.9996 0 12.658 0 0 0 0 0 16.1773 0 12.2475 0 10.9812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8142 14.1331 14.0348 0 0 13.171 0 11.8617 14.4024 14.9748 15.9595 14.7332 15.0119 12.968 13.5371 11.6683 19.0365 15.5114 0 14.7343 14.0493 12.9258 0 0 14.1127 14.5148 14.6939 14.0148 12.561 14.6689 13.5338 0 15.1662 13.7876 0 15.141 0 0 15.3853 14.6202 13.7696 13.4745 13.6292 19.7012 15.0757 0 0 13.1887 16.4663 14.9582 16.0496 14.0579 0 0 15.2147 12.9477 13.5774 15.219 15.792 15.1137 13.2969 14.8848 14.184 15.0887 0 0 14.3289 13.8893 13.2194 0 16.0074 14.5357 15.5352 15.6153 12.914 14.0734 15.4497 13.4855 14.8766 16.1392 14.3055 0 14.1592 0 14.6866 14.1167 15.1427 14.7949 15.9893 15.8443 15.309 12.6373 0 0 0 0 13.2117 13.6815 13.0053 14.7126 0 15.7139 0 15.2063 15.873 14.3577 14.6683 18.2437 15.1917 0 0 0 14.6396 0 O60231 DHX16_HUMAN "Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16, EC 3.6.4.13 (ATP-dependent RNA helicase #3) (DEAH-box protein 16)" DHX16 DBP2 DDX16 KIAA0577 PRP2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0008380; GO:0016887; GO:0071005 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AMVPELRK 0.99191 -18.552 0 0 0 0 0 0 0 0 0 0 0 0 11.8729 0 0 0 0 0 0 0 0 0 0 0 0 12.3503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9425 0 15.7295 13.6986 0 11.0546 0 0 12.8456 0 0 0 0 0 0 13.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6316 0 0 0 0 0 0 0 12.4895 0 0 0 0 12.7338 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2442 14.3346 0 0 0 0 0 12.342 0 0 0 0 0 0 0 11.9884 13.3283 0 11.751 0 0 12.0995 0 0 0 0 0 0 14.6601 13.6095 14.746 0 13.1126 0 0 0 12.7544 12.7868 12.6164 12.4374 13.4251 0 12.5366 0 0 0 0 0 0 0 0 0 0 0 0 O75140 DEPD5_HUMAN GATOR complex protein DEPDC5 (DEP domain-containing protein 5) DEPDC5 KIAA0645 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508] GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0032007; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130 GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877] AQCLTTCR 0.99191 -18.556 0 0 0 0 10.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7181 0 0 0 0 0 0 0 0 0 0 0 0 11.6394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.516 0 11.6576 0 0 0 12.0706 11.058 0 0 0 0 0 0 0 13.2852 14.3359 14.5851 0 0 0 0 0 0 0 0 0 0 0 0 14.9142 0 0 0 0 11.2196 0 0 0 0 0 12.1833 0 0 0 0 0 0 0 0 12.1592 0 0 0 0 11.3271 0 0 14.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7007 0 0 0 0 0 0 0 0 O75751 S22A3_HUMAN "Solute carrier family 22 member 3 (Extraneuronal monoamine transporter, EMT) (Organic cation transporter 3)" SLC22A3 EMTH OCT3 Homo sapiens (Human) dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic anion transport [GO:0015711]; organic cation transport [GO:0015695]; purine-containing compound transmembrane transport [GO:0072530]; quaternary ammonium group transport [GO:0015697]; regulation of appetite [GO:0032098]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] GO:0001692; GO:0005326; GO:0005886; GO:0005887; GO:0006836; GO:0008504; GO:0008514; GO:0015101; GO:0015651; GO:0015695; GO:0015697; GO:0015711; GO:0015718; GO:0015844; GO:0016020; GO:0019534; GO:0032098; GO:0042908; GO:0043025; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0072530; GO:0090494; GO:0098793; GO:0150104; GO:1901998 monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic anion transmembrane transporter activity [GO:0008514]; organic cation transmembrane transporter activity [GO:0015101]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; toxin transmembrane transporter activity [GO:0019534] ALQILRRIAK 0.99191 -7.482 0 0 12.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4811 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6457 0 0 0 0 0 0 0 0 12.0045 0 0 0 0 0 0 0 12.3069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1101 0 0 0 0 0 0 0 13.5356 11.4333 0 0 0 0 0 0 0 0 12.8447 0 0 0 0 0 0 0 16.1519 0 0 0 0 0 0 13.775 0 0 0 13.2812 0 0 0 0 0 12.3156 0 0 0 0 0 13.3882 0 0 0 0 11.3965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C6C1 AN34C_HUMAN Ankyrin repeat domain-containing protein 34C ANKRD34C Homo sapiens (Human) ARLPQLK 0.99191 -18.528 0 0 0 0 0 10.7746 10.3616 0 0 0 0 0 0 10.8126 10.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0684 0 12.4546 0 0 0 0 0 0 0 14.351 0 17.3597 0 0 10.9973 0 0 0 0 14.6134 10.6615 0 0 0 12.1298 0 0 0 0 0 0 11.5193 0 0 0 0 0 14.006 0 0 0 0 13.0304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7711 0 0 0 0 13.2635 0 0 0 0 0 0 0 0 0 0 17.2593 0 14.9005 0 0 0 0 0 13.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8632 0 P13671 CO6_HUMAN Complement component C6 C6 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]" GO:0001701; GO:0005576; GO:0005579; GO:0005615; GO:0005886; GO:0006956; GO:0006958; GO:0019835; GO:0045087; GO:0050778; GO:0070062 CDSGRCIAR 0.99191 -7.472 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0384 0 0 0 0 0 0 10.1361 11.697 0 0 0 0 0 0 0 12.1445 0 0 0 0 12.0768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.623 0 13.2014 13.0326 0 0 0 0 0 0 0 0 0 0 11.1486 0 11.8552 10.4011 0 0 0 11.8597 13.2323 0 10.0206 0 0 12.3469 0 13.0497 12.2106 13.1083 0 0 12.0794 0 0 0 0 12.4025 11.3902 0 9.4606 0 0 0 12.9494 0 12.4783 0 0 0 0 0 0 0 0 0 0 0 13.4331 12.5084 0 0 11.8752 0 0 0 0 0 0 0 12.3632 0 0 10.9637 12.3479 0 0 0 0 11.9734 0 0 11.5085 0 0 13.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6856 12.7189 0 13.0627 P49675 STAR_HUMAN "Steroidogenic acute regulatory protein, mitochondrial, StAR (START domain-containing protein 1, StARD1)" STAR STARD1 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; glucocorticoid metabolic process [GO:0008211]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694] mitochondrial intermembrane space [GO:0005758] mitochondrial intermembrane space [GO:0005758]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cellular lipid metabolic process [GO:0044255]; cholesterol metabolic process [GO:0008203]; glucocorticoid metabolic process [GO:0008211]; intracellular cholesterol transport [GO:0032367]; positive regulation of bile acid biosynthetic process [GO:0070859]; regulation of steroid biosynthetic process [GO:0050810]; steroid biosynthetic process [GO:0006694] GO:0005758; GO:0006694; GO:0008203; GO:0008211; GO:0015485; GO:0032367; GO:0044255; GO:0050810; GO:0070859; GO:0120020 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020] ALGGPTPSTWINQVR 0.99191 -7.474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9003 0 13.0678 0 0 0 0 14.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5246 0 0 0 0 0 0 0 0 14.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5837 15.5108 0 0 14.77 14.7672 0 0 0 0 0 0 0 0 0 Q0VDD8 DYH14_HUMAN Dynein axonemal heavy chain 14 (Axonemal beta dynein heavy chain 14) (Ciliary dynein heavy chain 14) DNAH14 C1orf67 Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] ADVAELRVYTRPPFLVLTVMNAVCILLQK 0.99191 -95.123 0 0 0 0 0 0 0 0 10.9283 0 0 11.1639 0 0 13.8582 10.3259 11.8287 0 10.0556 10.5919 11.6608 0 0 0 0 12.0618 0 13.852 13.258 0 0 12.3179 0 9.56765 0 0 12.4939 0 0 13.1413 13.8657 0 0 0 0 12.8062 12.8883 11.414 10.9848 13.0418 11.5675 12.705 13.5152 0 0 13.1345 0 11.6081 0 0 0 0 11.0325 0 0 0 0 0 0 13.3908 13.3117 13.391 0 0 0 9.7528 0 13.3794 13.8237 0 12.5794 0 13.7644 0 16.456 12.9105 16.5642 0 14.5354 14.5604 13.3278 16.9524 13.3916 12.5273 16.1641 0 13.9204 13.9033 15.9249 0 15.9217 15.4435 0 15.0419 0 15.9029 13.5232 0 14.6685 14.7352 14.6977 0 12.6727 0 14.3468 0 12.5011 10.925 14.6084 0 14.4244 15.2929 12.9483 0 15.228 0 15.7821 0 0 14.8647 11.7317 14.6533 0 13.1686 14.6957 14.3168 12.5361 0 13.5347 14.6632 12.3959 11.4049 0 15.0311 14.5907 13.6992 0 0 0 14.3594 13.2442 11.6672 14.3744 11.9897 12.1331 13.5089 0 0 12.3375 0 12.0373 13.5275 13.045 0 13.871 13.2523 10.5307 0 0 12.5321 0 14.7258 0 0 0 13.8986 0 0 0 0 Q8IWT1 SCN4B_HUMAN Sodium channel subunit beta-4 SCN4B Homo sapiens (Human) AV node cell action potential [GO:0086016]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; establishment of localization in cell [GO:0051649]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of sodium ion transport [GO:0010765]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518] intercalated disc [GO:0014704]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; AV node cell action potential [GO:0086016]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; establishment of localization in cell [GO:0051649]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; positive regulation of sodium ion transport [GO:0010765]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0005886; GO:0006814; GO:0010765; GO:0014704; GO:0017080; GO:0031226; GO:0035725; GO:0044325; GO:0051649; GO:0060048; GO:0060307; GO:0086002; GO:0086006; GO:0086012; GO:0086016; GO:0086091; GO:2000649 sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006] ITLVGSTKEK 0.99191 -18.555 11.3994 12.3363 0 0 0 0 11.0973 0 0 0 10.0129 0 0 15.1211 14.3813 15.2611 12.2292 13.8405 15.0673 14.1583 12.7942 14.8996 9.43702 14.2321 13.5486 0 14.1707 12.2139 0 0 14.9557 14.4376 0 0 0 0 0 0 12.5769 13.0583 14.4633 0 14.7304 0 14.9513 0 0 14.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.52695 9.6196 0 11.3881 13.6588 10.8166 0 13.9747 13.7951 14.0185 14.6286 13.344 0 13.8426 0 0 13.3512 11.0736 0 10.6599 14.1123 0 12.5789 0 13.8206 14.6393 16.463 14.5142 14.2336 0 11.3557 11.92 0 0 0 12.8459 0 0 13.4033 13.4078 13.5677 13.7275 13.1723 14.6735 14.3803 11.5179 14.9744 14.7136 15.2314 0 13.9713 8.87544 14.9854 14.0989 0 13.7597 13.2295 0 13.984 12.1704 12.8335 0 13.3315 10.9764 11.3506 12.8533 13.2077 10.2977 13.3978 0 0 0 13.1174 0 0 0 0 15.7719 0 0 12.1741 0 0 14.3494 12.1199 0 0 12.9713 0 0 13.1875 0 0 0 14.652 0 0 11.3349 0 0 0 0 13.9867 0 13.7177 0 0 0 0 0 10.4037 13.4925 0 16.144 Q96JK4 HIPL1_HUMAN HHIP-like protein 1 HHIPL1 HHIP2 KIAA1822 UNQ9245/PRO34761 Homo sapiens (Human) extracellular region [GO:0005576]; membrane [GO:0016020] extracellular region [GO:0005576]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044] GO:0005044; GO:0005576; GO:0016020 scavenger receptor activity [GO:0005044] DAELTRR 0.99191 -4.3865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9481 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0628 0 14.3822 0 0 0 0 0 0 14.896 0 15.6457 15.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9679 0 0 0 0 0 0 0 0 0 0 0 0 14.4519 14.085 0 0 14.2376 14.3076 0 0 0 0 0 14.0339 0 13.5043 0 0 11.4994 14.0414 0 0 0 15.1251 0 0 0 0 0 0 0 0 11.8558 0 0 0 0 0 0 0 0 11.1638 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0559 0 0 11.4119 0 0 13.8886 0 0 Q99748 NRTN_HUMAN Neurturin NRTN Homo sapiens (Human) MAPK cascade [GO:0000165]; nerve development [GO:0021675]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; extracellular region [GO:0005576] axon [GO:0030424]; extracellular region [GO:0005576]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; MAPK cascade [GO:0000165]; nerve development [GO:0021675]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0000165; GO:0001755; GO:0005102; GO:0005576; GO:0007169; GO:0007399; GO:0008083; GO:0021675; GO:0030116; GO:0030424; GO:0030971; GO:0031175 glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] ARARLGAR 0.99191 -7.4614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.761 0 0 0 0 0 0 0 0 0 0 0 0 13.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5574 20.0566 0 0 0 0 0 0 0 0 19.6407 0 0 0 0 0 0 0 12.8264 19.4991 0 0 0 0 15.792 0 0 0 0 0 0 0 0 0 16.0319 15.9667 15.9405 16.0235 15.6906 15.8939 15.8372 15.9053 15.8642 0 15.9699 0 12.7176 0 0 0 0 0 15.9056 0 15.942 0 0 Q9NRR4 RNC_HUMAN "Ribonuclease 3, EC 3.1.26.3 (Protein Drosha) (Ribonuclease III, RNase III) (p241)" DROSHA RN3 RNASE3L RNASEN Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] GO:0001530; GO:0003723; GO:0003725; GO:0004525; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0010468; GO:0010586; GO:0010628; GO:0014069; GO:0017151; GO:0031053; GO:0031054; GO:0042803; GO:0045589; GO:0046332; GO:0046872; GO:0050727; GO:0050829; GO:0050830; GO:0070412; GO:0070877; GO:0070878; GO:2000628 DEAD/H-box RNA helicase binding [GO:0017151]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332] CLLQLAMTHPSHHLNFGMNPDHARNSLSNCGIR 0.99191 -18.547 0 0 0 0 0 0 0 0 13.2246 0 0 12.26 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3293 0 0 0 0 0 13.5467 0 0 0 0 0 0 0 0 0 12.5439 11.3048 11.249 0 0 0 0 0 12.1434 0 12.2228 12.0118 0 0 13.4315 0 0 0 0 0 0 0 0 0 0 0 0 11.6974 12.0814 0 0 0 0 0 0 0 0 0 0 14.8383 13.1183 0 0 0 17.1597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8351 0 0 0 0 0 0 0 0 0 0 13.8645 0 0 13.7962 13.6475 0 14.336 0 0 15.3323 0 0 0 0 0 0 0 0 0 13.7511 0 0 A7MBM2 DISP2_HUMAN Protein dispatched homolog 2 DISP2 C15orf36 DISPB KIAA1742 LINC00594 Homo sapiens (Human) smoothened signaling pathway [GO:0007224]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; smoothened signaling pathway [GO:0007224]; transmembrane transport [GO:0055085] GO:0005886; GO:0007224; GO:0016021; GO:0022857; GO:0055085 transmembrane transporter activity [GO:0022857] DGTWKPPAVQHHVVSVR 0.99192 -17.783 0 0 0 0 0 0 0 11.5992 0 0 0 0 0 0 0 0 0 13.8649 0 0 0 0 0 0 0 12.6647 0 0 0 12.4531 0 11.5372 0 0 0 0 0 12.9474 11.362 9.86115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6657 14.1277 0 0 0 16.9268 12.9488 12.8178 12.032 13.1922 13.5998 0 0 16.3229 12.9208 12.4963 13.196 13.1645 0 10.4922 0 12.3545 13.9643 0 0 0 0 0 0 0 0 0 0 0 12.8149 0 0 0 0 12.1665 0 0 0 0 13.344 0 0 0 11.9339 0 12.3201 0 0 0 12.1157 0 12.5043 0 12.6703 0 0 0 0 12.8497 0 0 11.0395 0 11.9747 0 11.0936 0 0 0 0 0 13.2523 0 0 0 0 14.5335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7448 0 0 16.6484 A8MQ27 NEU1B_HUMAN "E3 ubiquitin-protein ligase NEURL1B, EC 2.3.2.27 (Neuralized-2, NEUR2) (Neuralized-like protein 1B) (Neuralized-like protein 3) (RING-type E3 ubiquitin transferase NEURL1B)" NEURL1B NEURL3 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; ubiquitin-dependent endocytosis [GO:0070086] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; early endosome [GO:0005769] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; Notch signaling pathway [GO:0007219]; ubiquitin-dependent endocytosis [GO:0070086] GO:0005769; GO:0005829; GO:0007219; GO:0015629; GO:0046872; GO:0061630; GO:0070086 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LLATRPCCGPGPER 0.99192 -6.0527 0 0 0 0 0 0 0 0 0 0 0 10.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8323 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9955 0 0 0 0 0 0 11.2521 0 0 0 0 0 0 0 0 0 0 0 0 12.2908 0 13.6043 0 0 10.8162 0 0 0 0 0 0 0 15.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2207 0 0 11.8846 0 O14776 TCRG1_HUMAN Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) TCERG1 CA150 TAF2S Homo sapiens (Human) mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; RNA splicing [GO:0008380] GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation regulator activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] AARERAIVPLEAR 0.99192 -18.581 0 0 11.4091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4997 0 0 0 0 10.8711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4862 10.6832 0 12.6646 12.7792 10.5945 0 0 11.9647 12.1625 12.3083 0 10.9781 0 0 12.4589 12.8904 0 13.3681 0 12.4806 12.8502 11.5055 0 0 14.4801 0 14.6493 13.9983 11.772 12.7286 0 0 0 0 13.8362 12.7446 13.3667 13.0135 0 0 0 13.8572 0 0 0 0 0 0 0 0 0 0 0 12.4995 12.8309 0 0 0 0 0 0 0 10.2614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1744 0 0 0 0 0 0 0 0 12.6855 0 0 0 0 O15013 ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 ARHGEF10 KIAA0294 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] centrosome [GO:0005813]; cytosol [GO:0005829] centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005813; GO:0005829; GO:0019894; GO:0022011; GO:0030036; GO:0035023; GO:0051056; GO:0051298; GO:0051496; GO:0090307; GO:0090630 guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894] AAVKRGR 0.99192 -18.577 0 0 0 0 0 0 0 0 0 0 12.7281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3565 0 0 0 13.0098 12.7948 0 0 11.2475 0 0 0 11.9033 0 0 0 14.2128 0 0 0 0 0 0 0 0 0 0 0 0 11.4934 0 12.4214 0 0 0 0 0 0 0 0 11.9984 0 11.5405 0 0 13.107 13.3072 0 0 0 12.6898 0 0 0 0 0 0 0 0 14.1141 14.4674 14.3773 0 0 0 0 0 0 0 0 0 15.2353 0 12.7518 0 0 0 0 0 0 14.0887 12.2417 0 0 0 0 0 0 0 0 0 0 0 13.8773 0 0 0 0 14.2631 0 0 12.2497 0 0 0 0 0 12.7728 0 0 11.8107 12.7531 11.6711 0 0 0 0 0 0 0 12.5637 0 0 0 13.2704 0 0 0 0 0 0 0 12.8602 14.0348 0 0 14.3897 0 11.0885 13.7529 14.126 13.6458 14.4349 0 13.5109 12.8835 0 0 0 0 0 0 0 0 12.9094 O60308 CE104_HUMAN "Centrosomal protein of 104 kDa, Cep104" CEP104 KIAA0562 Homo sapiens (Human) centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596] GO:0000922; GO:0005737; GO:0005814; GO:0005929; GO:0016594; GO:0016595; GO:0016596 glutamate binding [GO:0016595]; glycine binding [GO:0016594]; thienylcyclohexylpiperidine binding [GO:0016596] AIKDIVTSVFQASLKLLK 0.99192 -24.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1807 0 0 0 0 0 0 0 12.5762 0 0 0 0 0 15.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7261 12.6249 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0276 13.6346 0 0 0 0 0 12.7327 12.8437 0 0 12.7438 0 0 0 13.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5529 13.1106 0 0 0 0 0 12.1146 0 0 0 0 0 0 0 0 O75051 PLXA2_HUMAN Plexin-A2 (Semaphorin receptor OCT) PLXNA2 KIAA0463 OCT PLXN2 UNQ209/PRO235 Homo sapiens (Human) centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154]; centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; somitogenesis [GO:0001756] GO:0001756; GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021915; GO:0021935; GO:0030334; GO:0042802; GO:0043087; GO:0050772; GO:0051642; GO:0060037; GO:0060174; GO:0071526; GO:1902287 identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154] ALKLFAQLINNKVFLLTFIR 0.99192 -18.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2568 0 10.9375 0 0 0 10.7525 0 13.1703 0 0 14.4374 0 14.5274 0 0 0 0 0 0 0 13.3673 0 0 13.9781 0 0 0 16.3327 0 17.3684 0 15.5397 16.003 16.1638 15.6988 16.7483 0 15.6476 12.8357 14.734 0 15.3098 0 0 16.4644 0 15.4407 16.8659 0 16.1571 0 0 17.315 0 17.1798 0 0 0 0 10.6441 15.6908 0 15.5209 0 0 0 0 16.7724 17.1786 16.0056 0 0 15.0266 15.1154 0 0 16.416 15.1494 14.9404 0 0 0 14.8792 13.4516 0 0 14.7598 0 15.3507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.092 15.8012 16.2132 0 0 0 0 0 0 Q05586 NMDZ1_HUMAN "Glutamate receptor ionotropic, NMDA 1, GluN1 (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1, NMD-R1)" GRIN1 NMDAR1 Homo sapiens (Human) "brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of membrane potential [GO:0042391]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to glycine [GO:1905429]; visual learning [GO:0008542]" anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; brain development [GO:0007420]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; ionotropic glutamate receptor signaling pathway [GO:0035235]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; propylene metabolic process [GO:0018964]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of membrane potential [GO:0042391]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; response to glycine [GO:1905429]; visual learning [GO:0008542]" GO:0001540; GO:0004972; GO:0005509; GO:0005516; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0006812; GO:0007268; GO:0007420; GO:0008021; GO:0008542; GO:0009986; GO:0010524; GO:0014069; GO:0015276; GO:0016594; GO:0016595; GO:0017146; GO:0018964; GO:0022849; GO:0030425; GO:0035235; GO:0038023; GO:0042165; GO:0042391; GO:0043005; GO:0043083; GO:0043195; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0045471; GO:0045944; GO:0048167; GO:0048168; GO:0051290; GO:0051968; GO:0055074; GO:0060076; GO:0060079; GO:0070161; GO:0097060; GO:0097553; GO:0098655; GO:0098976; GO:1903428; GO:1904062; GO:1905429; GO:2000463; GO:2001056 amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; NMDA glutamate receptor activity [GO:0004972]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] DTVLPRR 0.99192 -18.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3724 0 12.4805 13.4267 13.1223 12.9984 10.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1263 13.5839 0 0 0 0 13.7207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3533 12.7836 0 0 0 0 0 0 0 0 0 0 0 13.0262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4524 0 0 0 14.0906 0 0 12.3906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0125 0 0 0 0 0 0 12.873 13.416 0 0 13.7488 0 0 0 0 0 0 Q14680 MELK_HUMAN "Maternal embryonic leucine zipper kinase, hMELK, EC 2.7.11.1 (Protein kinase Eg3, pEg3 kinase) (Protein kinase PK38, hPK38) (Tyrosine-protein kinase MELK, EC 2.7.10.2)" MELK KIAA0175 Homo sapiens (Human) apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] cell cortex [GO:0005938]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; hemopoiesis [GO:0030097]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] GO:0000086; GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006468; GO:0006915; GO:0008283; GO:0008289; GO:0008631; GO:0016020; GO:0030097; GO:0035556; GO:0043065; GO:0046777; GO:0061351; GO:0106310 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ARGKPVR 0.99192 -24.538 9.63383 0 0 0 0 0 0 0 0 13.3911 0 0 11.6205 0 0 0 0 0 0 0 0 12.3122 0 0 0 0 12.0898 0 11.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6636 13.4974 0 0 14.2849 0 14.1178 0 0 13.1334 12.7495 0 0 11.4743 0 14.0501 0 0 0 13.6828 0 11.589 0 0 0 12.0435 12.9339 0 14.1457 0 0 0 14.2017 13.6241 13.945 13.2791 15.1686 13.8891 0 13.6245 0 0 13.9468 0 0 0 13.6714 14.1012 10.4917 0 0 0 0 0 15.3495 0 13.9748 0 0 13.7831 13.8978 0 0 0 11.085 13.7451 0 0 0 0 0 13.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4043 0 0 0 14.0725 0 0 0 12.6072 0 0 Q8N323 NXPE1_HUMAN NXPE family member 1 (Protein FAM55A) NXPE1 FAM55A Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AIERLFLRSPATK 0.99192 -7.4953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9044 12.6049 0 0 0 0 0 0 0 0 12.8765 0 0 0 13.4876 0 0 0 0 11.4375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1368 0 0 0 11.833 0 0 0 0 0 0 0 0 0 0 0 0 13.061 0 0 13.7144 0 0 0 0 0 0 0 0 Q8NGH7 O52L1_HUMAN Olfactory receptor 52L1 (Olfactory receptor OR11-50) OR52L1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GLLLLIPFPILLGK 0.99192 -6.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3263 0 0 0 0 0 0 0 0 0 0 14.4275 0 0 0 0 0 0 14.0961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6172 0 0 0 0 0 0 0 0 0 0 0 0 10.789 0 10.5764 13.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1108 0 0 0 0 0 0 0 12.9336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92989 CLP1_HUMAN "Polyribonucleotide 5'-hydroxyl-kinase Clp1, EC 2.7.1.78 (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1)" CLP1 HEAB Homo sapiens (Human) "cerebellar cortex development [GO:0021695]; global gene silencing by mRNA cleavage [GO:0098795]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; phosphorylation [GO:0016310]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214] "cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polydeoxyribonucleotide kinase activity [GO:0051733]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; cerebellar cortex development [GO:0021695]; global gene silencing by mRNA cleavage [GO:0098795]; mRNA 3'-end processing [GO:0031124]; mRNA polyadenylation [GO:0006378]; phosphorylation [GO:0016310]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0000214; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005849; GO:0006378; GO:0006388; GO:0006396; GO:0016310; GO:0021695; GO:0031124; GO:0046404; GO:0051731; GO:0051733; GO:0051736; GO:0070922; GO:0098795 ATP binding [GO:0005524]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; polydeoxyribonucleotide kinase activity [GO:0051733]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736] DFRRECR 0.99192 -24.602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5328 0 0 0 0 0 0 0 0 0 0 11.663 0 0 0 0 13.6057 0 15.283 0 0 0 0 0 0 0 0 0 0 0 14.0498 0 0 0 10.702 0 0 0 0 0 0 10.7456 0 0 0 0 13.6874 0 0 0 0 0 0 0 0 0 0 0 15.1545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2224 0 0 0 0 0 14.8188 0 0 0 11.7398 0 0 0 0 0 0 0 0 0 0 10.4506 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969F8 KISSR_HUMAN "KiSS-1 receptor, KiSS-1R (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175, hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor)" KISS1R AXOR12 GPR54 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] cell surface [GO:0009986]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218] GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0007218; GO:0008188; GO:0008528; GO:0009986; GO:0016021; GO:0043231 G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188] ALERAFALYNLLALYLLPLLATCACYAAMLRHLGR 0.99192 -17.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4048 0 0 0 0 0 13.5429 0 0 0 0 0 0 0 0 0 13.2658 0 0 0 0 13.0563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1296 0 0 0 0 0 13.2002 0 0 0 0 14.5615 0 13.0091 0 0 0 0 14.272 0 0 0 0 0 0 0 0 0 0 14.2249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.899 0 0 0 0 0 0 Q9BXY4 RSPO3_HUMAN "R-spondin-3 (Protein with TSP type-1 repeat, hPWTSR) (Roof plate-specific spondin-3, hRspo3) (Thrombospondin type-1 domain-containing protein 2)" RSPO3 PWTSR THSD2 Homo sapiens (Human) "blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]" extracellular region [GO:0005576] "extracellular region [GO:0005576]; frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; canonical Wnt signaling pathway [GO:0060070]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]" GO:0001974; GO:0002040; GO:0005102; GO:0005109; GO:0005576; GO:0008201; GO:0030177; GO:0060070; GO:0060670; GO:0090263; GO:2000052; GO:2000096 frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] ADCDTCFNKNFCTK 0.99192 -7.4995 0 0 0 0 0 0 0 0 0 12.6152 0 0 0 0 0 0 0 0 0 0 12.5418 0 0 0 0 0 0 0 12.2377 0 0 12.6637 12.1765 0 12.3449 12.3651 0 0 12.6833 0 0 0 11.4532 0 0 0 0 0 12.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7924 0 0 0 0 0 0 0 0 11.2206 0 15.8678 0 0 0 0 0 0 0 14.823 0 11.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.803 0 0 0 14.3606 0 0 0 0 13.797 0 14.0689 13.7015 14.0054 0 0 0 0 0 0 14.142 0 0 Q9NX58 LYAR_HUMAN Cell growth-regulating nucleolar protein LYAR PNAS-5 Homo sapiens (Human) erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416]; erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] GO:0000122; GO:0001750; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0046872; GO:0048821; GO:0050766; GO:0140297; GO:0140416 DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416] GYEGKTHK 0.99192 -24.583 0 0 0 0 0 0 0 0 0 0 12.8837 0 0 0 0 0 12.0686 0 0 0 0 11.9082 0 0 0 0 0 0 0 0 14.8934 0 0 0 0 0 14.347 0 0 0 0 0 0 0 0 0 0 13.6694 0 14.3023 15.4265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7271 0 13.1218 12.2019 13.3009 13.432 14.6823 0 14.0092 0 0 0 0 0 0 0 0 0 0 14.5029 0 0 13.0264 12.9327 12.1618 12.4423 0 12.2719 12.9605 0 0 0 0 12.936 0 0 0 0 0 0 13.6229 0 11.8901 13.0994 0 0 0 13.5807 12.9574 12.9171 12.2822 0 13.0683 0 0 0 0 0 0 0 0 13.5163 0 0 12.9238 15.053 0 0 0 0 0 0 13.325 13.059 0 0 0 0 0 0 0 0 0 13.5036 17.3806 0 0 0 0 0 0 14.0559 0 0 14.7623 0 0 0 0 0 17.6023 0 0 0 0 0 0 0 Q9UJ98 STAG3_HUMAN Cohesin subunit SA-3 (SCC3 homolog 3) (Stromal antigen 3) (Stromalin-3) STAG3 Homo sapiens (Human) establishment of meiotic sister chromatid cohesion [GO:0034089]; sister chromatid cohesion [GO:0007062]; synaptonemal complex assembly [GO:0007130] "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; extracellular space [GO:0005615]; meiotic cohesin complex [GO:0030893]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; extracellular space [GO:0005615]; meiotic cohesin complex [GO:0030893]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; chromatin binding [GO:0003682]; establishment of meiotic sister chromatid cohesion [GO:0034089]; sister chromatid cohesion [GO:0007062]; synaptonemal complex assembly [GO:0007130]" GO:0000775; GO:0000785; GO:0000795; GO:0003682; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0007062; GO:0007130; GO:0008278; GO:0030893; GO:0034089 chromatin binding [GO:0003682] AAKRPPK 0.99192 -18.592 0 0 0 0 0 0 0 0 0 0 0 0 11.0943 0 0 0 0 0 0 0 0 0 0 11.7328 0 0 0 0 0 0 10.7859 0 0 0 0 0 0 0 0 11.4002 15.1494 10.7713 0 0 0 10.4829 0 0 16.9447 0 16.9436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4283 0 0 11.2438 0 0 13.6194 0 0 0 0 13.0047 13.7202 0 12.3869 0 20.6945 19.0596 20.2778 20.057 21.2468 19.5289 0 13.4946 18.1566 14.8525 0 18.2842 18.2123 18.1684 15.4278 18.9337 0 16.8985 0 14.8362 14.2031 0 16.383 15.5656 15.6218 15.1804 0 12.206 0 13.0029 13.3065 15.6972 16.7269 16.4452 0 14.1153 11.6182 0 11.7106 12.5101 15.0687 12.7986 12.8254 14.1854 12.7561 0 12.9485 12.4559 0 0 0 0 11.002 12.9652 11.1785 14.2013 0 0 0 12.67 13.5229 0 0 0 0 0 12.9948 12.8305 10.2113 0 0 0 13.0578 0 0 0 0 0 10.3401 0 0 0 0 0 11.8741 0 14.0077 0 13.842 0 13.106 0 0 11.4052 15.1948 0 0 0 Q5SSJ5 HP1B3_HUMAN Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74) HP1BP3 Homo sapiens (Human) "cellular response to hypoxia [GO:0071456]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of cell population proliferation [GO:0042127]; regulation of nucleus size [GO:0097298]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleosome [GO:0000786]; nucleus [GO:0005634] "chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome binding [GO:0031491]; cellular response to hypoxia [GO:0071456]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of cell population proliferation [GO:0042127]; regulation of nucleus size [GO:0097298]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000786; GO:0003677; GO:0005634; GO:0005694; GO:0006334; GO:0006355; GO:0016607; GO:0031491; GO:0042127; GO:0070828; GO:0071456; GO:0097298 DNA binding [GO:0003677]; nucleosome binding [GO:0031491] DEDEDEDESSEEDSEDEEPPPK 0.99193 -18.706 0 11.2328 0 0 0 0 0 0 14.8822 0 12.6006 12.0623 12.6994 0 0 0 12.1642 0 12.0909 0 0 0 11.0097 0 0 0 12.118 12.237 0 0 11.9655 0 0 12.5876 0 12.704 12.497 0 0 12.2164 12.0223 12.3004 0 0 0 0 12.0663 0 19.3062 0 19.4035 0 0 0 0 0 0 14.82 0 0 13.5537 0 13.5125 13.5637 13.4231 0 16.2385 16.0846 0 10.394 0 0 0 0 17.4886 0 17.5805 13.24 20.0803 0 20.5037 19.9109 22.2905 22.166 0 0 0 13.7527 0 15.0311 0 13.5588 15.803 0 14.289 15.2236 15.16 0 13.7326 0 13.3025 0 18.3517 0 0 13.2144 0 0 14.5158 0 0 0 14.9602 14.1612 0 0 17.3504 17.3838 17.6577 0 17.3258 10.5903 0 0 0 17.1634 0 20.138 14.509 0 0 19.3618 0 17.8258 13.1134 11.1684 0 16.9716 16.9379 0 0 0 16.5633 16.5648 13.681 14.5979 0 14.3132 0 0 18.8947 18.3465 0 0 13.357 0 0 0 13.9177 0 14.7863 13.7696 13.8517 0 13.9164 14.808 14.0026 13.7136 13.9925 10.7901 14.7925 0 18.5691 0 0 14.8194 0 13.9211 10.4477 0 A0JLT2 MED19_HUMAN Mediator of RNA polymerase II transcription subunit 19 (Lung cancer metastasis-related protein 1) (Mediator complex subunit 19) MED19 LCMR1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0003712; GO:0005634; GO:0016592; GO:0032968; GO:0045944; GO:0051123; GO:0060261; GO:0070847 transcription coregulator activity [GO:0003712] EEDPDRK 0.99193 -17.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9079 13.2102 13.1003 0 0 0 0 13.9138 0 0 0 0 13.3396 0 0 0 0 0 0 0 0 0 0 0 0 12.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4366 13.587 13.9126 0 0 0 0 14.1849 0 0 0 0 0 12.6644 0 14.332 0 0 0 0 0 0 13.3708 0 0 O60318 GANP_HUMAN "Germinal-center associated nuclear protein, GANP, EC 2.3.1.48 (80 kDa MCM3-associated protein) (MCM3 acetylating protein, MCM3AP, EC 2.3.1.-) (MCM3 acetyltransferase)" MCM3AP GANP KIAA0572 MAP80 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446] GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390 chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676] CLQSLKEMYQDLR 0.99193 -24.686 0 0 0 0 11.2388 0 0 0 12.7916 0 0 0 0 0 13.9305 13.0572 0 0 13.7017 0 0 0 12.9197 0 0 0 0 0 0 0 0 0 0 13.8529 12.5972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4078 0 12.0291 0 0 14.6627 0 0 0 0 0 0 0 0 0 0 0 11.965 18.9888 0 0 0 0 0 17.0264 16.7719 0 12.8427 0 0 0 19.2177 20.6424 0 0 12.2748 0 0 0 0 0 14.4738 13.7699 13.1076 0 0 0 0 16.0238 0 0 0 13.5143 12.0056 0 0 0 0 12.653 0 0 0 0 0 13.918 14.647 0 15.7957 13.8711 14.7033 0 0 0 0 12.7056 13.3551 14.1563 0 0 13.0454 12.3451 13.8288 14.1499 0 0 12.7429 11.1446 0 0 0 13.8855 12.968 12.9952 13.9133 0 12.5661 0 0 0 15.9459 0 0 0 15.3656 0 0 0 0 0 0 14.7775 0 0 0 0 0 0 0 12.4661 13.9964 0 0 14.7288 0 13.5041 13.6978 0 0 11.302 14.6618 0 O95405 ZFYV9_HUMAN "Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein, Madh-interacting protein) (Novel serine protease, NSP) (Receptor activation anchor, hSARA) (Smad anchor for receptor activation)" ZFYVE9 MADHIP SARA SMADIP Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0005545; GO:0005769; GO:0005829; GO:0006897; GO:0007179; GO:0016197; GO:0019904; GO:0031901; GO:0032991; GO:0043231; GO:0046872 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904] ACGKVFCASCCSLKCK 0.99193 -23.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2674 0 13.5155 0 0 0 0 11.9465 0 0 0 0 0 0 0 12.9225 0 0 0 0 0 0 0 0 13.3942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5686 0 0 0 0 0 0 0 0 11.5432 0 0 0 0 0 P06280 AGAL_HUMAN "Alpha-galactosidase A, EC 3.2.1.22 (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (Melibiase) (Agalsidase)" GLA Homo sapiens (Human) glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; oligosaccharide metabolic process [GO:0009311] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; galactosylgalactosylglucosylceramidase activity [GO:0017041]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; oligosaccharide metabolic process [GO:0009311] GO:0003824; GO:0004557; GO:0005102; GO:0005576; GO:0005737; GO:0005764; GO:0005794; GO:0009311; GO:0016139; GO:0016787; GO:0016936; GO:0017041; GO:0035578; GO:0042803; GO:0043202; GO:0045019; GO:0046477; GO:0046479; GO:0051001; GO:0052692; GO:0070062 alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; galactosylgalactosylglucosylceramidase activity [GO:0017041]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102] DAGYEYLCIDDCWMAPQR 0.99193 -17.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8347 0 11.497 10.9597 0 0 0 0 0 0 11.2268 0 0 11.1171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7184 0 0 14.5153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5338 12.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5425 0 0 11.7821 0 0 0 11.568 0 0 0 0 12.4511 0 0 12.1878 0 0 0 0 0 0 0 P13584 CP4B1_HUMAN "Cytochrome P450 4B1, EC 1.14.14.1 (CYPIVB1) (Cytochrome P450-HP)" CYP4B1 Homo sapiens (Human) biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631] GO:0004497; GO:0005506; GO:0005789; GO:0006631; GO:0018879; GO:0019825; GO:0020037; GO:0070330 aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825] AEVDTFMFEGHDTTTSGISWFLYCMALYPEHQHR 0.99193 -7.6509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4 0 10.1684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8817 0 13.8475 11.5444 0 0 11.678 0 13.2865 0 12.5857 0 0 13.7623 13.8591 0 0 0 0 0 0 0 11.8419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7918 0 0 0 0 0 11.4349 0 0 0 0 0 0 0 10.7942 14.4684 0 0 0 0 0 0 14.3168 0 0 0 0 0 0 14.7155 0 0 0 0 0 0 11.5511 0 0 0 0 0 0 0 12.4715 0 0 0 12.4712 10.8521 0 0 0 0 10.5492 0 0 0 0 0 15.3721 0 0 0 11.9835 0 0 0 13.5922 P32298 GRK4_HUMAN "G protein-coupled receptor kinase 4, EC 2.7.11.16 (G protein-coupled receptor kinase GRK4) (ITI1)" GRK4 GPRK2L GPRK4 Homo sapiens (Human) protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006468; GO:0007165; GO:0008277; GO:0009966; GO:0022400; GO:0031623; GO:0050254; GO:0097381 ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254] DYSSLCDK 0.99193 -7.6613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9911 0 0 0 0 0 0 0 0 0 13.9825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43694 GATA4_HUMAN Transcription factor GATA-4 (GATA-binding factor 4) GATA4 Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle morphogenesis [GO:0003208]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion development [GO:0003197]; endoderm development [GO:0007492]; heart looping [GO:0001947]; intestinal epithelial cell differentiation [GO:0060575]; male gonad development [GO:0008584]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein kinase B signaling [GO:0051896]; regulation of transcription, DNA-templated [GO:0006355]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; transdifferentiation [GO:0060290]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]" chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue regeneration [GO:0061026]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac ventricle morphogenesis [GO:0003208]; cell fate commitment [GO:0045165]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell-cell signaling [GO:0007267]; cellular response to glucose stimulus [GO:0071333]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion development [GO:0003197]; endoderm development [GO:0007492]; heart looping [GO:0001947]; intestinal epithelial cell differentiation [GO:0060575]; male gonad development [GO:0008584]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of autophagy [GO:0010507]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein kinase B signaling [GO:0051896]; regulation of transcription, DNA-templated [GO:0006355]; response to mechanical stimulus [GO:0009612]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; transdifferentiation [GO:0060290]; ventricular septum development [GO:0003281]; wound healing [GO:0042060]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0001947; GO:0003162; GO:0003180; GO:0003190; GO:0003197; GO:0003208; GO:0003215; GO:0003281; GO:0003289; GO:0003290; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007267; GO:0007492; GO:0008270; GO:0008584; GO:0009410; GO:0009612; GO:0010507; GO:0010575; GO:0010667; GO:0016604; GO:0019901; GO:0030513; GO:0033189; GO:0035054; GO:0036302; GO:0042060; GO:0043565; GO:0045165; GO:0045766; GO:0045893; GO:0045944; GO:0048617; GO:0051525; GO:0051891; GO:0051896; GO:0060290; GO:0060413; GO:0060575; GO:0061026; GO:0061049; GO:0061629; GO:0070374; GO:0070410; GO:0071333; GO:0086004; GO:0090575; GO:1903202; GO:1990837; GO:2001234 "co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" ECVNCGAMSTPLWR 0.99193 -18.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2052 0 0 0 0 0 0 0 10.4296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8808 0 0 0 0 14.9043 14.4814 0 0 10.3237 0 0 0 0 15.3557 0 0 0 0 0 0 0 0 0 12.8996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0582 0 0 0 16.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7729 11.9539 0 12.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03167 TGBR3_HUMAN "Transforming growth factor beta receptor type 3, TGF-beta receptor type 3, TGFR-3 (Betaglycan) (Transforming growth factor beta receptor III, TGF-beta receptor type III)" TGFBR3 Homo sapiens (Human) animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412] cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]; animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]" GO:0001666; GO:0001837; GO:0001889; GO:0003007; GO:0003150; GO:0003151; GO:0003223; GO:0005024; GO:0005114; GO:0005160; GO:0005539; GO:0005615; GO:0005737; GO:0005887; GO:0006955; GO:0007179; GO:0007181; GO:0008201; GO:0009897; GO:0009986; GO:0015026; GO:0016477; GO:0017015; GO:0017134; GO:0030165; GO:0030509; GO:0030511; GO:0030512; GO:0031012; GO:0031100; GO:0032354; GO:0034673; GO:0034695; GO:0034699; GO:0035556; GO:0043235; GO:0043393; GO:0046332; GO:0048185; GO:0050431; GO:0050680; GO:0055010; GO:0060038; GO:0060045; GO:0060216; GO:0060317; GO:0060318; GO:0060347; GO:0060389; GO:0060412; GO:0060939; GO:0060979; GO:0061384; GO:0062009; GO:0070062; GO:0070123 "activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]" EPEEVQGSVDIALSVK 0.99193 -23.15 0 0 0 0 0 0 0 0 0 0 11.4609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5655 0 0 0 0 0 12.1875 0 0 11.7673 0 0 12.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4792 0 0 13.6786 0 0 14.4138 0 0 0 0 0 0 15.0866 0 13.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9832 0 0 10.9312 0 0 0 0 0 0 12.7484 0 0 0 0 12.545 0 0 0 0 0 0 0 0 0 11.2907 0 0 0 12.0174 13.7377 0 0 0 0 0 0 0 12.3477 0 0 0 12.5177 12.0763 0 Q14184 DOC2B_HUMAN "Double C2-like domain-containing protein beta, Doc2-beta" DOC2B DOC2BL Homo sapiens (Human) calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; syntaxin binding [GO:0019905]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669] GO:0005509; GO:0005544; GO:0005737; GO:0005886; GO:0006887; GO:0008104; GO:0017158; GO:0019905; GO:0031340; GO:0032024; GO:0045202; GO:0045956; GO:0048791; GO:0061669; GO:0098793 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; syntaxin binding [GO:0019905] GERLKHWFDCLK 0.99193 -24.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9829 0 13.3489 0 0 12.6602 0 0 0 13.7001 0 0 0 0 13.5589 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3092 0 12.098 13.646 0 0 0 0 0 0 0 0 0 0 0 0 11.3748 0 0 11.9819 14.8341 0 0 0 0 0 0 0 0 0 0 0 0 14.977 0 11.5985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9795 0 0 13.3147 12.468 0 12.3426 Q14249 NUCG_HUMAN "Endonuclease G, mitochondrial, Endo G, EC 3.1.30.-" ENDOG Homo sapiens (Human) aging [GO:0007568]; apoptotic DNA fragmentation [GO:0006309]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; DNA recombination [GO:0006310]; in utero embryonic development [GO:0001701]; mitochondrial DNA catabolic process [GO:0032043]; negative regulation of TOR signaling [GO:0032007]; neuron death in response to oxidative stress [GO:0036475]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of response to DNA damage stimulus [GO:2001022]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; aging [GO:0007568]; apoptotic DNA fragmentation [GO:0006309]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; DNA recombination [GO:0006310]; in utero embryonic development [GO:0001701]; mitochondrial DNA catabolic process [GO:0032043]; negative regulation of TOR signaling [GO:0032007]; neuron death in response to oxidative stress [GO:0036475]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of response to DNA damage stimulus [GO:2001022]; response to antibiotic [GO:0046677]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612] GO:0000014; GO:0000287; GO:0001701; GO:0003676; GO:0004519; GO:0004520; GO:0004521; GO:0005634; GO:0005739; GO:0005743; GO:0005829; GO:0006309; GO:0006310; GO:0007568; GO:0009612; GO:0010508; GO:0032007; GO:0032043; GO:0032355; GO:0034612; GO:0036475; GO:0042803; GO:0043065; GO:0043204; GO:0046677; GO:0071277; GO:0071333; GO:0071456; GO:0090297; GO:1901300; GO:1902512; GO:2001022 endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] AAPGLLGRLPVLPVAAAAELPPVPGGPR 0.99193 -17.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3159 0 0 0 12.3849 0 13.0363 0 0 0 0 0 0 0 0 0 11.407 0 0 12.95 0 0 12.1451 0 0 0 0 0 0 0 0 13.2837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9799 0 0 0 0 13.3005 11.6392 0 0 12.2369 0 0 0 0 0 0 0 0 0 12.2218 0 0 0 0 0 0 0 0 0 0 14.091 0 0 0 0 0 0 0 0 0 0 14.1385 0 0 0 0 0 0 0 0 17.376 0 0 11.8405 0 0 0 13.9334 0 12.7363 0 0 0 0 0 0 0 0 14.6194 14.2501 0 0 0 0 0 0 0 0 0 0 0 11.9009 0 14.4211 0 0 0 14.3777 0 0 0 0 0 0 0 0 14.3979 0 0 0 15.3525 14.8085 0 0 0 0 0 Q49A88 CCD14_HUMAN Coiled-coil domain-containing protein 14 CCDC14 Homo sapiens (Human) protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762] GO:0005737; GO:0005813; GO:0021762; GO:0034451; GO:0071539 ATYLRKIPR 0.99193 -6.7296 0 0 0 9.53786 0 0 0 0 0 0 0 0 0 0 13.7455 0 11.3296 0 0 0 11.1054 0 0 0 0 12.725 0 0 11.1331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.378 0 0 0 0 0 14.5315 0 0 0 0 0 0 0 0 0 0 0 12.993 0 0 0 0 15.1128 14.6065 0 14.5753 0 12.6524 11.1619 0 16.5914 0 0 0 0 0 0 12.5736 0 14.1683 0 0 13.8881 0 0 0 0 0 0 0 13.5016 0 0 13.657 13.9287 0 0 0 0 0 0 12.2115 0 0 0 0 0 0 0 0 0 0 12.0525 0 0 0 13.7302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.776 0 11.9389 0 0 0 0 0 0 0 0 0 0 0 14.2924 0 0 0 0 0 Q52LD8 RFTN2_HUMAN Raftlin-2 (Raft-linking protein 2) RFTN2 C2orf11 Homo sapiens (Human) dsRNA transport [GO:0033227]; response to exogenous dsRNA [GO:0043330] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; dsRNA transport [GO:0033227]; response to exogenous dsRNA [GO:0043330] GO:0005886; GO:0033227; GO:0043330 GEASDNK 0.99193 -23.153 0 0 0 0 0 0 0 0 11.9385 0 0 11.3129 13.3306 0 0 0 13.4935 0 0 0 0 0 0 0 0 0 0 0 13.0735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9303 0 0 0 0 11.2435 0 0 0 0 0 0 14.0856 0 10.7136 0 10.8287 14.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0042 0 0 0 0 0 0 0 0 0 13.7083 0 0 0 0 0 0 0 14.9751 0 0 0 12.3523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VWJ9 SNX30_HUMAN Sorting nexin-30 SNX30 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]; reticulophagy [GO:0061709] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phagophore assembly site [GO:0000407] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phagophore assembly site [GO:0000407]; phosphatidylinositol binding [GO:0035091]; autophagy of mitochondrion [GO:0000422]; endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]; reticulophagy [GO:0061709] GO:0000407; GO:0000422; GO:0005769; GO:0015031; GO:0031901; GO:0032456; GO:0035091; GO:0061709; GO:2000786 phosphatidylinositol binding [GO:0035091] CQDRMECFNADLKADMER 0.99193 -24.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6047 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4471 0 15.4507 0 0 15.3067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0517 15.166 0 0 13.136 0 12.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9733 0 0 0 11.6137 0 14.3403 13.4375 13.6317 13.9448 0 0 0 13.8124 10.9981 13.9285 13.4872 0 0 0 0 0 0 0 0 14.3154 0 0 Q86T24 KAISO_HUMAN Transcriptional regulator Kaiso (Zinc finger and BTB domain-containing protein 33) ZBTB33 KAISO ZNF348 Homo sapiens (Human) "intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006357; GO:0008327; GO:0016055; GO:0035556; GO:0043565; GO:0045892; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" HFNIHSWEKK 0.99193 -4.5652 0 0 0 0 0 0 0 12.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3896 0 0 0 0 0 0 0 0 0 0 12.164 0 13.274 0 0 0 0 0 14.4843 0 0 13.0592 12.3553 0 0 0 0 0 11.6151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0142 0 0 0 0 0 0 0 0 0 0 0 0 13.3593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0574 12.3722 0 0 0 0 0 0 12.5482 0 0 0 0 0 0 0 0 0 0 13.3487 0 0 0 0 13.9601 0 0 0 0 0 0 13.8359 0 0 0 0 Q86UW6 N4BP2_HUMAN "NEDD4-binding protein 2, N4BP2, EC 3.-.-.- (BCL-3-binding protein)" N4BP2 B3BP KIAA1413 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ubiquitin binding [GO:0043130] GO:0004519; GO:0005524; GO:0005829; GO:0043130; GO:0046404 ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ubiquitin binding [GO:0043130] EKQLFKIFPAINQNFLVDIFK 0.99193 -17.841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5626 0 0 13.7832 0 0 0 0 0 0 0 0 0 0 15.071 15.0426 0 0 0 0 0 0 0 0 0 0 0 13.1419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2516 0 12.5197 0 0 0 0 0 0 0 11.152 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8699 0 0 0 0 0 0 0 0 0 0 0 0 11.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6642 0 11.041 0 0 0 0 0 0 0 0 0 0 Q8NI35 INADL_HUMAN "InaD-like protein, Inadl protein, hINADL (Channel-interacting PDZ domain-containing protein) (Pals1-associated tight junction protein) (Protein associated to tight junctions)" PATJ CIPP INADL Homo sapiens (Human) establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; tight junction assembly [GO:0120192] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; tight junction assembly [GO:0120192] GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0016324; GO:0030054; GO:0034451; GO:0035089; GO:0035556; GO:0043296; GO:0045197; GO:0048471; GO:0070062; GO:0120192 EVPPPFTLVCCRR 0.99193 -23.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8675 0 0 0 0 0 0 0 0 0 0 0 0 12.1434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6387 0 0 0 0 0 0 13.5355 0 0 13.3911 11.8282 13.4106 0 13.5215 0 0 11.8326 0 10.8401 13.6924 0 0 0 0 10.7654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0069 12.6653 0 12.2727 0 0 0 12.0707 0 0 0 0 11.5662 0 0 0 11.5107 0 0 12.17 0 0 0 0 12.1005 12.1289 0 12.3619 12.5357 0 0 0 0 16.724 0 0 0 0 0 0 0 9.67985 0 16.8396 0 0 0 0 0 0 16.7771 16.7542 0 0 0 0 0 0 0 0 0 0 12.8427 16.4707 Q8TE49 OTU7A_HUMAN "OTU domain-containing protein 7A, EC 3.4.19.12 (Zinc finger protein Cezanne 2)" OTUD7A C15orf16 CEZANNE2 OTUD7 Homo sapiens (Human) negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536] GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0016579; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:0071947 cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270] AETEHYCSYCYREELRR 0.99193 -17.83 0 0 0 0 11.6779 0 0 0 0 14.8279 14.6244 0 0 0 0 0 0 14.4563 0 0 0 0 0 0 0 0 0 0 0 0 11.4312 0 0 0 0 0 0 0 0 0 0 0 0 14.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9704 0 11.6224 14.021 11.1964 0 0 0 0 12.5741 12.4811 0 0 0 0 0 0 0 0 0 0 0 11.5864 0 12.6571 12.7762 12.9013 12.854 0 0 14.43 0 0 12.6168 0 0 0 0 0 0 0 14.4393 0 0 0 14.6204 0 0 14.582 0 13.2253 0 11.3096 0 0 0 0 0 0 0 0 0 0 13.0713 0 0 12.3277 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5318 0 0 0 13.8394 0 0 0 0 0 Q96MM7 H6ST2_HUMAN "Heparan-sulfate 6-O-sulfotransferase 2, HS6ST-2, EC 2.8.2.-" HS6ST2 PSEC0092 Homo sapiens (Human) "glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]" GO:0000139; GO:0006024; GO:0015015; GO:0016021; GO:0017095 heparan sulfate 6-O-sulfotransferase activity [GO:0017095] ALLTRGLAALGHSLKHVLGAIFSK 0.99193 -17.806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0315 0 0 0 0 0 0 0 0 0 0 0 12.476 0 0 0 0 0 16.1917 0 12.6402 0 0 0 0 0 0 0 0 0 0 0 0 13.8214 0 0 0 0 14.9892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8345 0 0 0 11.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5132 12.4554 12.4569 0 0 0 12.5803 0 0 0 0 13.7815 0 0 0 0 0 16.2141 0 0 0 0 0 0 Q96PF1 TGM7_HUMAN "Protein-glutamine gamma-glutamyltransferase Z (Transglutaminase Z, TG(Z), TGZ, TGase Z, EC 2.3.2.13) (Transglutaminase-7, TGase-7)" TGM7 Homo sapiens (Human) peptide cross-linking [GO:0018149] metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149] GO:0003810; GO:0018149; GO:0046872 metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] DYGFVYK 0.99193 -23.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2722 0 0 0 0 0 0 0 12.4358 0 0 12.2573 0 0 0 0 0 0 0 0 12.8413 0 0 12.8519 0 0 12.3789 0 0 0 12.7257 0 12.6505 0 12.6338 0 0 0 0 0 12.3926 0 12.5692 0 0 12.8245 0 0 0 0 0 0 14.294 12.8066 12.8377 12.8038 0 13.3425 0 0 0 0 12.5026 0 12.5806 13.1801 0 0 13.1873 13.014 13.3692 0 0 0 12.6328 12.5225 12.3808 0 0 0 0 0 14.7725 0 0 0 0 12.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8282 12.9831 0 0 0 0 0 0 A8MVW5 HECA2_HUMAN HEPACAM family member 2 (Mitotic kinetics regulator) HEPACAM2 MIKI UNQ305/PRO346 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle [GO:0005819] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome cycle [GO:0007098] GO:0000139; GO:0005654; GO:0005794; GO:0005813; GO:0005819; GO:0007098; GO:0016021; GO:0030496; GO:0043231; GO:0051301; GO:0072686 KYQPYKVIK 0.99194 -7.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9388 0 0 13.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5421 0 12.8815 12.3222 0 0 0 0 0 0 0 0 13.6782 0 0 0 0 0 0 0 0 0 0 0 0 12.5854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75173 ATS4_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 4, ADAM-TS 4, ADAM-TS4, ADAMTS-4, EC 3.4.24.82 (ADMP-1) (Aggrecanase-1)" ADAMTS4 KIAA0688 UNQ769/PRO1563 Homo sapiens (Human) extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] GO:0001501; GO:0002020; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0016607; GO:0022617; GO:0030198; GO:0031012; GO:0046872; GO:0062023 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protease binding [GO:0002020] AKRFASLSR 0.99194 -7.3652 0 0 0 0 0 0 10.1326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6017 0 0 14.7031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0221 0 0 0 0 10.499 0 0 0 0 0 0 0 0 0 13.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3885 12.3111 0 0 0 0 12.0097 0 0 0 0 0 14.2077 0 0 0 0 0 0 0 0 0 0 10.8664 0 0 0 0 12.8202 0 0 12.6081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6996 0 13.975 0 0 0 0 0 0 0 0 13.3433 0 0 13.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21980 TGM2_HUMAN "Protein-glutamine gamma-glutamyltransferase 2, EC 2.3.2.13 (Erythrocyte transglutaminase) (Heart G alpha(h), hhG alpha(h)) (Isopeptidase TGM2, EC 3.4.-.-) (Protein G alpha(h), G(h)) (Protein-glutamine deamidase TGM2, EC 3.5.1.44) (Protein-glutamine dopaminyltransferase TGM2, EC 2.3.1.-) (Protein-glutamine histaminyltransferase TGM2, EC 2.3.1.-) (Protein-glutamine noradrenalinyltransferase TGM2, EC 2.3.1.-) (Protein-glutamine serotonyltransferase TGM2, EC 2.3.1.-) (Tissue transglutaminase, tTG, tTgase) (Transglutaminase C, TG(C), TGC, TGase C) (Transglutaminase H, TGase H) (Transglutaminase II, TGase II) (Transglutaminase-2, TG2, TGase-2, hTG2)" TGM2 Homo sapiens (Human) apoptotic cell clearance [GO:0043277]; bone development [GO:0060348]; branching involved in salivary gland morphogenesis [GO:0060445]; cellular response to cocaine [GO:0071314]; cellular response to dopamine [GO:1903351]; cellular response to serotonin [GO:1904015]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peptide cross-linking [GO:0018149]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of neurogenesis [GO:0050769]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; protein deamination [GO:0018277]; protein homooligomerization [GO:0051260]; proteolysis [GO:0006508]; regulation of apoptotic cell clearance [GO:2000425]; regulation of apoptotic process [GO:0042981]; salivary gland cavitation [GO:0060662] chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; histone dopaminyltransferase activity [GO:0120297]; histone serotonyltransferase activity [GO:0120295]; peptidase activity [GO:0008233]; peptide histaminyltransferase activity [GO:0120299]; peptide noradrenalinyltransferase activity [GO:0120298]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; protein-glutamine glutaminase activity [GO:0050568]; apoptotic cell clearance [GO:0043277]; bone development [GO:0060348]; branching involved in salivary gland morphogenesis [GO:0060445]; cellular response to cocaine [GO:0071314]; cellular response to dopamine [GO:1903351]; cellular response to serotonin [GO:1904015]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peptide cross-linking [GO:0018149]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of neurogenesis [GO:0050769]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; protein deamination [GO:0018277]; protein homooligomerization [GO:0051260]; proteolysis [GO:0006508]; regulation of apoptotic cell clearance [GO:2000425]; regulation of apoptotic process [GO:0042981]; salivary gland cavitation [GO:0060662] GO:0000785; GO:0003810; GO:0005509; GO:0005525; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007200; GO:0008233; GO:0018149; GO:0018277; GO:0031012; GO:0031226; GO:0032471; GO:0042981; GO:0043065; GO:0043277; GO:0043547; GO:0045785; GO:0048471; GO:0050568; GO:0050769; GO:0051057; GO:0051260; GO:0051561; GO:0060348; GO:0060445; GO:0060662; GO:0062023; GO:0070062; GO:0071314; GO:0120295; GO:0120297; GO:0120298; GO:0120299; GO:1903351; GO:1904015; GO:2000425 calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; histone dopaminyltransferase activity [GO:0120297]; histone serotonyltransferase activity [GO:0120295]; peptidase activity [GO:0008233]; peptide histaminyltransferase activity [GO:0120299]; peptide noradrenalinyltransferase activity [GO:0120298]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; protein-glutamine glutaminase activity [GO:0050568] EDITHTYKYPEGSSEER 0.99194 -18.792 0 0 0 0 0 0 0 0 0 0 0 10.9704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7124 0 0 0 0 0 0 0 13.9416 0 0 0 13.0868 0 13.9069 0 0 0 0 12.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8868 0 0 0 0 0 0 0 0 0 0 0 13.7948 0 0 0 0 0 0 0 0 0 0 0 Q5BJF6 ODFP2_HUMAN Outer dense fiber protein 2 (Cenexin) (Outer dense fiber of sperm tails protein 2) ODF2 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatid development [GO:0007286] GO:0000922; GO:0001520; GO:0005198; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0005929; GO:0007286; GO:0008104; GO:0010457; GO:0031267; GO:0036064; GO:0036126; GO:0043231; GO:0044782; GO:0097539; GO:0120103; GO:1902017 small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198] ASVKNYEGMIDNYK 0.99194 -7.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.582 12.8156 0 12.3359 0 14.8001 0 12.5786 0 12.9038 13.669 0 0 0 0 0 0 14.1614 0 0 0 0 0 0 0 12.0639 0 0 0 14.7144 0 12.476 12.7349 13.559 0 0 0 0 10.5314 13.7446 0 0 0 0 14.4798 0 0 0 0 0 0 0 0 0 0 0 0 15.0285 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0857 11.6498 0 0 11.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44603 0 0 0 Q8N1Y9 YI025_HUMAN Putative uncharacterized protein FLJ37218 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AAGPQPR 0.99194 -7.5615 0 12.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7748 0 0 15.025 0 0 0 14.0901 0 0 0 0 0 14.177 0 0 0 0 0 14.4648 0 0 13.4357 0 0 12.3618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1741 0 0 0 0 0 0 0 0 0 Q8N5U0 CK042_HUMAN Uncharacterized protein C11orf42 C11orf42 Homo sapiens (Human) GVLGPQK 0.99194 -18.775 0 0 0 0 0 0 0 0 11.6971 0 0 0 0 0 0 11.9429 0 0 0 0 0 0 0 0 0 0 0 0 11.659 0 0 11.8368 0 0 12.8729 0 0 13.2592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4418 0 0 0 12.7534 0 0 0 0 0 0 0 0 0 0 12.8291 16.6915 14.471 0 0 0 0 13.8459 0 0 0 0 13.4242 0 0 13.0763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9281 0 0 0 0 0 0 14.7933 13.6454 11.5114 0 0 0 0 0 0 0 13.5841 14.1021 0 14.0575 0 0 12.6167 0 0 0 0 0 0 0 0 0 0 0 0 12.4885 0 0 0 Q8NEF3 CC112_HUMAN Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1) CCDC112 MBC1 Homo sapiens (Human) AKIQQQLAKIHNNVK 0.99194 -18.834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5097 0 0 0 0 13.6633 0 0 0 0 0 0 0 0 0 0 16.3173 0 12.4284 0 0 0 0 0 0 0 0 0 0 14.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8929 0 0 0 0 10.1331 16.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0051 0 0 12.1179 0 0 0 0 11.5657 0 0 0 0 0 0 0 0 0 0 Q8WV93 AFG1L_HUMAN "AFG1-like ATPase (Lactation elevated protein 1, EC 3.6.-.-) (Protein AFG1 homolog)" AFG1L AFG1 LACE1 Homo sapiens (Human) "mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]" cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]" GO:0005524; GO:0005737; GO:0005739; GO:0006123; GO:0007005; GO:0016887; GO:0031966; GO:0035694 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ELPAAGK 0.99194 -17.867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8814 0 0 0 0 0 0 0 0 0 0 0 12.2202 0 0 11.6099 0 0 0 12.2568 0 12.0514 0 11.7586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8588 0 0 Q9HC58 NCKX3_HUMAN Sodium/potassium/calcium exchanger 3 (Na(+)/K(+)/Ca(2+)-exchange protein 3) (Solute carrier family 24 member 3) SLC24A3 NCKX3 Homo sapiens (Human) bone mineralization [GO:0030282]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transport [GO:0006811]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104] cell periphery [GO:0071944]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell periphery [GO:0071944]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; bone mineralization [GO:0030282]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transport [GO:0006811]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]" GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0008273; GO:0010628; GO:0010629; GO:0015293; GO:0030282; GO:0035725; GO:0070588; GO:0071805; GO:0071944; GO:0150104 "calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]" DSIYYTLSVIALIVFIYDEK 0.99194 -4.8818 0 0 0 0 0 0 0 0 0 0 14.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6086 0 14.9156 0 0 0 0 0 0 0 0 0 0 0 13.4976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9572 0 0 0 0 0 0 0 0 Q9P2D8 UNC79_HUMAN Protein unc-79 homolog UNC79 KIAA1409 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 DGTFLRTLASSLMDFNELSSIAALSQLLEGLNNK 0.99194 -18.818 15.5242 0 0 15.0888 0 0 13.9697 0 0 0 0 0 0 0 0 0 14.108 0 0 0 0 0 0 0 10.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9893 0 0 0 0 0 13.7566 0 0 13.4712 0 0 0 0 13.6908 13.3969 12.3778 0 0 0 13.7529 11.5171 13.9075 0 0 0 0 0 0 0 13.4689 13.3857 16.1402 0 0 0 0 13.8646 0 0 0 0 0 13.4159 0 0 0 0 0 14.3655 0 0 0 14.2457 0 14.4289 0 0 14.9494 0 0 0 0 0 0 12.5886 0 0 0 12.2046 0 16.9842 0 0 12.0985 17.2951 13.278 12.8349 0 0 0 0 13.886 14.8781 14.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.895 0 0 0 0 0 0 0 P12034 FGF5_HUMAN "Fibroblast growth factor 5, FGF-5 (Heparin-binding growth factor 5, HBGF-5) (Smag-82)" FGF5 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019] GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010001; GO:0010628; GO:0023019; GO:0030154; GO:0030334; GO:0051781 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] FRERFQENSYNTYASAIHR 0.99195 -18.864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44966 12.8091 0 0 0 0 0 0 0 0 0 0 0 13.0324 0 0 0 12.9162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2447 17.6853 0 0 0 0 0 0 0 0 13.1319 0 0 0 0 0 0 0 0 0 0 0 0 12.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3573 0 0 0 15.7586 0 0 11.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4834 0 13.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0703 0 0 0 0 P17031 ZNF26_HUMAN Zinc finger protein 26 (Zinc finger protein KOX20) ZNF26 KOX20 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IHRKTHK 0.99195 -22.692 0 0 0 0 12.8693 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0817 11.7809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4178 12.1863 12.5026 12.4966 12.3899 0 0 13.6887 12.5824 0 0 0 0 0 0 0 0 12.3599 0 0 0 0 12.4466 0 0 0 0 12.2295 0 0 0 0 12.5174 0 0 0 0 0 0 0 12.6215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9924 0 0 0 0 0 0 12.2515 0 0 0 0 12.9968 0 0 12.806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8968 0 12.6919 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13049 TRI32_HUMAN "E3 ubiquitin-protein ligase TRIM32, EC 2.3.2.27 (72 kDa Tat-interacting protein) (RING-type E3 ubiquitin transferase TRIM32) (Tripartite motif-containing protein 32) (Zinc finger protein HT2A)" TRIM32 HT2A Homo sapiens (Human) actin ubiquitination [GO:0007014]; axon development [GO:0061564]; fat cell differentiation [GO:0045444]; free ubiquitin chain polymerization [GO:0010994]; innate immune response [GO:0045087]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of chemokine (C-C motif) ligand 20 production [GO:1903886]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17-mediated signaling pathway [GO:1903883]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of proteolysis [GO:0045862]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; suppression of viral release by host [GO:0044790]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; striated muscle myosin thick filament [GO:0005863] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; striated muscle myosin thick filament [GO:0005863]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; translation initiation factor binding [GO:0031369]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin ubiquitination [GO:0007014]; axon development [GO:0061564]; fat cell differentiation [GO:0045444]; free ubiquitin chain polymerization [GO:0010994]; innate immune response [GO:0045087]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of chemokine (C-C motif) ligand 20 production [GO:1903886]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17-mediated signaling pathway [GO:1903883]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of proteolysis [GO:0045862]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; suppression of viral release by host [GO:0044790]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0001894; GO:0003713; GO:0003723; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0005863; GO:0006511; GO:0007014; GO:0008270; GO:0009411; GO:0010508; GO:0010994; GO:0016567; GO:0017022; GO:0030307; GO:0030335; GO:0030957; GO:0031369; GO:0032897; GO:0034612; GO:0042802; GO:0043123; GO:0043130; GO:0043621; GO:0044790; GO:0045087; GO:0045444; GO:0045666; GO:0045732; GO:0045787; GO:0045862; GO:0046716; GO:0048147; GO:0050769; GO:0051091; GO:0051092; GO:0051155; GO:0061564; GO:0061630; GO:0070936; GO:1902230; GO:1903265; GO:1903883; GO:1903886; GO:2000147 identical protein binding [GO:0042802]; myosin binding [GO:0017022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; translation initiation factor binding [GO:0031369]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AALEGVSK 0.99195 -18.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2859 0 0 0 0 0 0 0 0 13.6851 13.8135 13.9204 14.3395 14.3209 14.2735 14.3743 0 14.2229 0 0 0 0 0 0 0 0 13.7543 0 0 0 13.6455 13.8872 14.1072 0 0 0 0 0 0 0 0 0 0 0 11.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8911 0 13.848 0 0 0 0 0 Q13129 RLF_HUMAN Zinc finger protein Rlf (Rearranged L-myc fusion gene protein) (Zn-15-related protein) RLF Homo sapiens (Human) "histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0044030; GO:0045893; GO:0045944; GO:0046872; GO:0097692 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" APISFKTR 0.99195 -55.815 0 0 0 0 0 0 0 0 0 0 12.2878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0582 0 0 11.853 10.9376 0 0 0 0 0 0 0 0 0 0 12.716 0 12.138 0 12.8671 0 0 11.5425 12.1184 14.1281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1261 15.2071 12.3157 0 13.2535 0 14.132 0 12.4708 11.1984 0 0 0 13.8471 0 14.5107 15.857 16.0457 13.2624 16.4949 13.6174 0 0 16.4702 16.3763 17.1488 16.4934 12.1984 0 12.893 0 15.4581 0 13.3764 0 0 0 0 0 0 0 0 13.8849 13.813 12.6889 0 0 0 0 11.9763 16.0866 9.91518 16.1704 16.4852 16.403 16.5975 0 0 0 0 0 11.1958 0 0 0 0 0 0 0 0 12.892 0 0 0 0 0 0 0 11.8497 15.7395 0 12.4217 13.6439 0 15.9816 0 0 13.3676 0 15.2388 12.7198 13.0431 12.0948 13.5007 14.013 0 13.4738 0 0 12.2597 0 0 0 0 0 14.7956 12.8131 0 0 0 Q15393 SF3B3_HUMAN "Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit, SF3b130) (STAF130) (Spliceosome-associated protein 130, SAP 130)" SF3B3 KIAA0017 SAP130 Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; protein-containing complex binding [GO:0044877]; U2 snRNA binding [GO:0030620]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]" GO:0000124; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006282; GO:0008380; GO:0030620; GO:0035521; GO:0035522; GO:0042177; GO:0043484; GO:0043966; GO:0044877; GO:0045893; GO:0071005; GO:0071013; GO:1903241 protein-containing complex binding [GO:0044877]; U2 snRNA binding [GO:0030620] DLILNPR 0.99195 -22.74 0 0 0 0 0 0 0 12.4841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7963 0 0 0 0 0 0 0 0 0 0 15.0644 0 14.9517 0 0 0 0 0 0 0 0 14.7678 0 0 0 0 13.2504 13.6798 13.2872 13.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.845 0 0 0 0 0 0 0 11.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.485 0 10.8191 0 0 0 0 0 0 14.3419 12.2264 0 0 0 0 0 12.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4947 0 0 0 Q9NTI5 PDS5B_HUMAN Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3) PDS5B APRIN AS3 KIAA0979 Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127]" GO:0000775; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0007064; GO:0008283; GO:0008285; GO:0042127; GO:0051301 DNA binding [GO:0003677] AIFSKVMVITR 0.99195 -85.691 11.0738 0 12.1535 0 11.5477 11.9507 0 0 0 0 0 0 11.7486 0 14.3778 0 12.0693 0 0 12.0933 11.9691 0 11.8302 12.5413 11.7503 12.4253 11.846 0 10.8424 9.97154 0 12.8868 0 0 11.4739 0 0 0 0 11.5141 0 0 13.2208 11.0232 0 11.7688 11.6445 11.5066 0 0 10.5856 0 0 0 0 0 0 0 0 0 0 11.0978 0 0 0 0 0 0 0 0 11.6064 0 14.4846 14.9548 0 0 10.3014 0 0 13.7021 12.6917 13.7442 13.3691 14.4255 14.0551 13.919 0 0 13.189 14.7646 0 14.2098 13.597 13.4988 11.6349 18.8701 14.1153 16.1885 0 0 14.8283 13.3665 12.399 16.2115 14.2998 13.5781 0 12.7927 9.4851 0 13.1043 13.3989 0 0 0 13.5248 13.2932 14.5097 14.0984 12.2471 14.3009 12.9731 14.8481 13.4588 14.6385 15.5652 0 13.8899 0 0 0 13.7402 13.4393 12.8359 14.5841 14.4951 15.4443 14.1921 0 13.3565 14.4542 13.1346 0 0 10.9499 14.24 11.9627 12.933 0 0 12.4655 0 16.283 14.3627 14.1771 0 11.8131 14.9799 14.3613 0 13.954 13.9801 13.8211 13.6425 0 0 13.8285 0 0 14.3183 0 13.4808 12.0305 14.2456 13.6513 14.1856 0 11.423 0 0 Q9NZQ9 TMOD4_HUMAN "Tropomodulin-4 (Skeletal muscle tropomodulin, Sk-Tmod)" TMOD4 Homo sapiens (Human) actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694] cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865] cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694] GO:0005523; GO:0005856; GO:0005865; GO:0006936; GO:0007015; GO:0030016; GO:0030239; GO:0051015; GO:0051694 actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523] QRDQTKK 0.99195 -4.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0781 0 0 0 0 13.2306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1363 0 0 Q9Y6E0 STK24_HUMAN "Serine/threonine-protein kinase 24, EC 2.7.11.1 (Mammalian STE20-like protein kinase 3, MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal, MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal, MST3/C) ]" STK24 MST3 STK3 Homo sapiens (Human) cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165] GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0008631; GO:0009267; GO:0030336; GO:0042542; GO:0045296; GO:0046777; GO:0046872; GO:0048679; GO:0048680; GO:0070062; GO:0097194; GO:0106310 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GIDNRTQK 0.99195 -7.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6X6 MYO16_HUMAN Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16) MYO16 KIAA0865 MYO16B NYAP3 Homo sapiens (Human) cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903]; cerebellum development [GO:0021549]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] GO:0003774; GO:0005524; GO:0005654; GO:0005737; GO:0005886; GO:0008285; GO:0014065; GO:0016459; GO:0019903; GO:0021549; GO:0048471; GO:0048812; GO:0051015; GO:2000134 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; protein phosphatase binding [GO:0019903] AGPSAEAPK 0.99195 -47.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6116 0 12.6059 11.4277 12.6573 0 0 11.4883 0 12.0933 12.1269 11.9021 18.8959 0 0 0 0 0 0 0 0 0 0 0 12.3821 18.8564 13.525 14.2024 13.9378 13.0397 0 0 0 0 0 0 0 0 0 0 0 18.7489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.635 0 0 0 12.6037 0 0 0 0 0 0 0 0 0 0 0 0 14.2152 0 0 12.917 0 15.2272 10.4136 14.1447 13.5948 12.9409 13.3787 13.7556 0 0 0 13.5429 0 0 0 15.168 0 0 12.1653 0 0 13.8105 0 0 0 11.8995 0 0 0 0 0 0 0 0 0 0 13.7763 0 14.142 0 12.6611 0 0 0 0 0 0 14.0549 14.3495 14.3853 0 0 0 12.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8625 14.3786 0 13.4148 0 0 0 0 0 0 19.5516 Q9Y6V0 PCLO_HUMAN Protein piccolo (Aczonin) PCLO ACZ KIAA0559 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of exocytosis [GO:0017157]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoskeleton [GO:0005856]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoskeleton [GO:0005856]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882]; cytoskeleton organization [GO:0007010]; insulin secretion [GO:0030073]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of exocytosis [GO:0017157]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle exocytosis [GO:0016079] GO:0005509; GO:0005522; GO:0005544; GO:0005856; GO:0007010; GO:0014069; GO:0016079; GO:0017157; GO:0030073; GO:0030424; GO:0035418; GO:0045202; GO:0048788; GO:0070062; GO:0070161; GO:0097091; GO:0098882; GO:0098978; GO:0098982; GO:0099526; GO:1904071 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; profilin binding [GO:0005522]; structural constituent of presynaptic active zone [GO:0098882] AEQAPTVKR 0.99196 -121.48 12.3234 10.3494 0 11.9014 11.3265 0 0 0 14.8652 14.8444 0 14.5026 0 11.5193 13.0097 12.5192 0 11.6556 10.958 10.3938 0 0 11.8077 0 11.8669 0 0 0 10.8384 0 12.0157 14.3554 13.9917 13.8 0 0 15.4919 15.1645 0 13.8693 13.853 0 0 0 14.3322 13.7924 0 13.5438 0 10.7318 0 10.9049 13.2357 11.7585 13.0944 0 14.0441 0 9.16659 12.6093 12.8022 12.8569 11.5426 0 0 12.5966 0 15.452 15.7684 14.887 13.4955 0 0 0 16.0111 11.3519 15.8571 14.6016 15.0233 12.5642 15.4458 14.9119 18.6034 13.1361 12.6328 14.1379 14.029 11.8596 0 0 19.1687 14.2217 16.6689 15.3028 16.1421 14.2125 0 12.6383 14.38 13.1241 15.4955 16.4459 16.8953 16.7281 16.6549 15.4497 13.3365 15.0792 15.2876 15.4443 15.0298 16.3948 15.2869 14.9323 16.7911 15.565 14.8918 0 12.5289 16.5964 13.8952 15.1004 17.7552 13.2839 14.8626 13.045 15.8117 0 14.4798 15.2444 12.7237 15.6718 14.9363 13.2075 14.3383 16.2373 15.4562 15.0639 13.6184 13.7403 0 0 15.3507 15.9606 0 15.4312 14.6931 14.3527 0 16.2452 0 0 0 15.6531 15.7864 16.6782 15.0393 15.7014 13.1595 11.9044 12.4927 13.8608 13.7784 0 14.6465 12.6486 15.2531 14.0018 14.2848 0 14.6124 13.8767 14.9068 14.5989 13.4374 15.4884 0 0 0 0 P0CAP2 GRL1A_HUMAN DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A) POLR2M GRINL1A Homo sapiens (Human) intracellular signal transduction [GO:0035556]; maintenance of ER location [GO:0051685] "neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase II, holoenzyme [GO:0016591]" "neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase II, holoenzyme [GO:0016591]; intracellular signal transduction [GO:0035556]; maintenance of ER location [GO:0051685]" GO:0005635; GO:0005665; GO:0016591; GO:0035556; GO:0043025; GO:0051685 DEDDDWSSDEF 0.99196 -18.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7421 0 0 0 12.2933 0 0 11.7865 0 0 0 0 0 12.5986 0 0 13.442 0 0 0 0 0 0 0 13.6502 13.6555 0 0 0 0 0 13.8224 0 0 0 0 10.4017 0 0 0 0 0 0 12.5852 15.563 0 0 11.7931 0 0 0 0 0 0 0 0 0 0 0 0 11.8504 0 0 0 0 0 0 0 0 0 0 11.6277 0 0 0 0 0 0 0 0 0 0 11.3568 0 0 11.957 0 0 0 P52744 ZN138_HUMAN Zinc finger protein 138 ZNF138 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HTENKHFRCK 0.99196 -7.7161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0887 0 0 0 P54577 SYYC_HUMAN "Tyrosine--tRNA ligase, cytoplasmic, EC 6.1.1.1 (Tyrosyl-tRNA synthetase, TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed ]" YARS1 YARS Homo sapiens (Human) apoptotic process [GO:0006915]; tyrosyl-tRNA aminoacylation [GO:0006437] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; apoptotic process [GO:0006915]; tyrosyl-tRNA aminoacylation [GO:0006437] GO:0000049; GO:0003723; GO:0004831; GO:0005153; GO:0005524; GO:0005615; GO:0005737; GO:0005829; GO:0006437; GO:0006915; GO:0016604 ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831] HVLFPLKSEFVILRDEK 0.99196 -7.7129 0 0 0 10.9781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1605 0 0 0 14.7096 0 0 0 0 0 10.0497 0 0 0 0 12.9118 0 0 0 0 13.8616 14.1788 13.5423 0 0 12.3658 14.5482 13.0612 13.2506 0 0 0 0 0 0 0 0 13.4638 0 9.42775 0 0 0 0 0 0 12.508 0 0 12.5579 0 0 0 0 0 0 0 0 0 0 11.9076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9316 0 0 0 0 0 13.3112 0 0 0 13.6223 0 0 10.2421 0 0 0 0 0 0 0 12.6133 0 0 Q0P651 ABD18_HUMAN "Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18, Abhydrolase domain-containing protein 18)" ABHD18 C4orf29 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 EWNSKYR 0.99196 -7.7332 0 0 0 0 0 0 0 0 0 0 0 15.137 0 0 0 17.8312 0 0 0 12.6754 0 0 0 0 0 0 0 0 0 0 0 0 16.6128 0 0 14.5029 14.6083 0 0 0 0 0 0 0 0 11.3261 0 13.187 0 0 13.2717 0 12.7703 0 0 0 0 0 0 16.8113 0 0 0 0 0 0 0 12.6677 0 0 0 0 12.0147 0 0 0 0 0 0 0 0 0 0 13.8932 12.8063 0 15.1889 12.7338 0 0 0 0 0 0 0 0 13.8244 12.8522 0 13.1635 0 0 0 11.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1677 0 0 9.65397 0 0 0 0 0 13.3418 0 0 0 0 0 0 0 0 0 0 0 0 13.4617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2392 0 0 0 0 0 0 0 0 0 13.4054 0 0 0 0 0 0 0 Q5HY98 ZN766_HUMAN Zinc finger protein 766 ZNF766 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0005634; GO:0006355; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] HKFSLTVHQR 0.99196 -5.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8381 0 11.0375 0 0 0 13.0494 0 0 0 0 0 0 0 13.1758 0 14.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NSI3 FA53A_HUMAN Protein FAM53A (Dorsal neural-tube nuclear protein) FAM53A Homo sapiens (Human) protein import into nucleus [GO:0006606] nucleus [GO:0005634] nucleus [GO:0005634]; protein import into nucleus [GO:0006606] GO:0005634; GO:0006606 CDSGGSATR 0.99196 -7.7154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5205 14.6655 0 0 15.8562 15.7586 14.2739 0 14.2751 0 0 0 13.8081 0 0 0 0 14.7001 0 14.6994 0 14.3965 0 0 0 0 0 0 10.8651 0 0 0 0 0 0 0 0 0 13.8593 0 0 0 0 0 0 0 0 0 10.2227 9.86508 0 0 0 0 10.3074 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZQN5 FOXI2_HUMAN Forkhead box protein I2 FOXI2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" MFDNGNFRR 0.99196 -5.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.602 0 0 0 0 0 11.1863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6U2 CL033_HUMAN Putative uncharacterized protein encoded by LINC00612 LINC00612 C12orf33 Homo sapiens (Human) CARWPHR 0.99196 -18.52 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4061 14.0585 14.318 0 0 0 14.1702 0 0 0 0 0 0 0 13.9516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGI4 OR4DB_HUMAN Olfactory receptor 4D11 OR4D11 OR4D11P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AISVTFTVISPLLNPLIYTLR 0.99196 -24.511 0 0 0 0 0 12.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3818 0 0 0 0 0 0 0 0 0 15.1553 0 0 0 0 0 0 10.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.072 0 0 0 0 0 0 11.2789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7703 0 0 0 0 0 0 0 0 0 0 0 0 10.9179 0 0 0 0 0 0 0 10.2021 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8581 0 0 0 0 12.0594 0 0 0 0 0 Q9H0H3 KLH25_HUMAN "Kelch-like protein 25 (Ectoderm-neural cortex protein 2, ENC-2)" KLHL25 ENC2 Homo sapiens (Human) protein ubiquitination [GO:0016567]; regulation of translational initiation [GO:0006446]; ubiquitin-dependent protein catabolic process [GO:0006511] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein ubiquitination [GO:0016567]; regulation of translational initiation [GO:0006446]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005737; GO:0005829; GO:0006446; GO:0006511; GO:0016567; GO:0031463 DTLLDLISSDELETEDER 0.99196 -7.7259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75906 0 0 9.87544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3966 0 0 0 0 0 0 13.1821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8588 0 0 9.90402 0 0 0 0 0 0 10.9349 0 0 0 0 0 0 0 0 0 12.6615 14.152 0 0 13.9453 0 0 10.327 0 Q9NSI5 IGSF5_HUMAN "Immunoglobulin superfamily member 5, IgSF5 (Junctional adhesion molecule 4, JAM-4)" IGSF5 JAM4 Homo sapiens (Human) cell-cell adhesion [GO:0098609] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; cell-cell adhesion [GO:0098609] GO:0005923; GO:0009986; GO:0016021; GO:0016324; GO:0098609 ARKSATVNLTVIR 0.99196 -7.413 0 0 0 0 0 0 0 0 12.9303 0 0 0 12.4399 15.2876 0 0 12.2924 0 0 0 13.3329 11.4213 0 0 13.1187 0 10.8598 12.7559 13.2413 13.5922 12.2566 0 0 0 9.59139 0 12.1533 0 0 0 13.1662 13.1369 14.0696 0 0 0 0 0 0 0 11.2599 0 0 0 0 0 0 0 0 0 0 0 0 13.4127 0 0 13.4533 11.1136 13.7618 13.719 0 0 0 0 13.1524 0 0 0 11.1324 13.9957 0 0 0 10.6278 0 12.7258 0 0 0 0 0 0 0 0 0 0 14.5841 0 12.1809 0 0 0 0 0 0 0 0 0 12.4166 11.2171 0 0 0 0 0 0 0 0 0 13.9261 13.0991 0 0 0 0 10.3623 13.7586 0 16.2635 0 15.3015 14.7756 0 14.7503 12.2075 0 0 0 11.4798 0 0 10.702 12.0886 0 9.73196 0 10.8291 12.4185 11.3987 11.431 15.6361 10.1727 11.3835 16.2824 12.0994 15.6733 9.618 0 0 0 0 0 13.3644 0 0 15.033 0 14.7807 0 0 14.9354 14.991 11.5931 0 13.6862 0 15.4273 0 0 0 Q9Y243 AKT3_HUMAN "RAC-gamma serine/threonine-protein kinase, EC 2.7.11.1 (Protein kinase Akt-3) (Protein kinase B gamma, PKB gamma) (RAC-PK-gamma) (STK-2)" AKT3 PKBG Homo sapiens (Human) brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; mitochondrial genome maintenance [GO:0000002]; negative regulation of cellular senescence [GO:2000773]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain morphogenesis [GO:0048854]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; mitochondrial genome maintenance [GO:0000002]; negative regulation of cellular senescence [GO:2000773]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell size [GO:0045793]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of TOR signaling [GO:0032008]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0000002; GO:0001938; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007165; GO:0016020; GO:0018105; GO:0032008; GO:0035556; GO:0043536; GO:0045766; GO:0045793; GO:0048854; GO:0048873; GO:0090050; GO:0106310; GO:1905564; GO:1905653; GO:2000773 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CQLMKTER 0.99196 -5.5457 0 0 0 0 0 0 0 0 0 0 10.1911 0 0 0 0 11.8573 0 0 0 10.3679 0 0 0 0 0 13.7101 0 0 0 0 0 0 0 11.8407 0 0 0 0 0 0 0 0 0 0 0 0 12.0156 0 12.6408 0 0 10.6497 0 0 13.7738 12.4476 10.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4012 12.4768 12.5688 0 0 9.36783 0 0 0 12.2215 13.2899 0 0 0 14.4949 0 13.4455 0 10.5689 12.3874 0 0 11.4546 12.9948 13.1583 13.6562 13.7808 13.6259 0 0 0 13.4411 0 0 0 0 0 0 0 0 0 0 0 0 13.1431 0 12.7964 15.1635 0 12.169 0 0 0 0 0 0 11.9284 0 0 0 0 0 12.2354 0 0 0 12.8752 12.0862 0 0 11.9124 0 15.2378 0 12.991 0 0 0 0 0 0 0 0 0 0 0 12.6271 0 12.2935 12.9952 0 0 9.40384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7863 Q9Y6X5 ENPP4_HUMAN "Bis(5'-adenosyl)-triphosphatase ENPP4, EC 3.6.1.29 (AP3A hydrolase, AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4, E-NPP 4, NPP-4)" ENPP4 KIAA0879 NPP4 Homo sapiens (Human) blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]; purine ribonucleoside catabolic process [GO:0046130] extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; positive regulation of blood coagulation [GO:0030194]; purine ribonucleoside catabolic process [GO:0046130] GO:0005886; GO:0007596; GO:0016020; GO:0016021; GO:0030194; GO:0046130; GO:0046872; GO:0047710; GO:0070062; GO:0101003 bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872] FYYQHNDR 0.99196 -7.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6267 0 0 0 0 0 0 0 0 0 0 13.4736 13.2671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8133 0 0 9.60546 0 0 0 0 12.5464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1879 0 0 0 10.6933 0 O00570 SOX1_HUMAN Transcription factor SOX-1 SOX1 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; forebrain neuron development [GO:0021884]; interneuron migration [GO:1904936]; lens morphogenesis in camera-type eye [GO:0002089]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of transcription, DNA-templated [GO:0006355]; ventral spinal cord interneuron specification [GO:0021521]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; forebrain neuron development [GO:0021884]; interneuron migration [GO:1904936]; lens morphogenesis in camera-type eye [GO:0002089]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of transcription, DNA-templated [GO:0006355]; ventral spinal cord interneuron specification [GO:0021521]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002089; GO:0003677; GO:0003700; GO:0005634; GO:0006325; GO:0006355; GO:0009653; GO:0021521; GO:0021884; GO:0030154; GO:0045944; GO:0048713; GO:1904936; GO:1990830 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" APCPGDLR 0.99197 -18.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2089 0 0 0 0 0 0 0 0 0 0 13.4765 0 13.6658 13.8095 0 0 0 16.8995 0 0 0 13.3408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7701 0 0 0 0 0 0 0 0 0 0 0 13.0632 13.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43614 OX2R_HUMAN "Orexin receptor type 2, Ox-2-R, Ox2-R, Ox2R (Hypocretin receptor type 2)" HCRTR2 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]" GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0040011; GO:0045202; GO:0051480 G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046] KWKPLQPVSQPR 0.99197 -4.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0266 0 13.2034 13.9727 0 0 0 0 0 14.3873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2034 0 0 0 11.481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6122 0 0 0 0 0 0 0 14.8522 0 0 0 0 0 0 0 0 0 0 0 14.3201 0 0 0 16.0742 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6344 13.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0361 0 14.2753 0 0 0 12.1545 0 0 0 0 0 0 0 0 0 0 0 0 15.7207 11.8597 0 11.7609 0 0 0 0 0 13.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76070 SYUG_HUMAN "Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin, SR)" SNCG BCSG1 PERSYN PRSN Homo sapiens (Human) adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neuron death [GO:1901214]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] axon terminus [GO:0043679]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cuprous ion binding [GO:1903136]; adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; protein secretion [GO:0009306]; regulation of dopamine secretion [GO:0014059]; regulation of neuron death [GO:1901214]; regulation of neurotransmitter secretion [GO:0046928]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488] GO:0005737; GO:0005815; GO:0005819; GO:0007268; GO:0008344; GO:0009306; GO:0014059; GO:0043025; GO:0043679; GO:0046928; GO:0048471; GO:0048488; GO:0050808; GO:0070062; GO:1901214; GO:1903136 cuprous ion binding [GO:1903136] EGVVGAVEK 0.99197 -5.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8712 13.711 0 0 0 13.807 12.9998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0926 0 0 0 0 0 0 0 0 13.6519 0 13.52 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32121 ARRB2_HUMAN Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3) ARRB2 ARB2 ARR2 Homo sapiens (Human) "adult walking behavior [GO:0007628]; brain development [GO:0007420]; cell chemotaxis [GO:0060326]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] "basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; 14-3-3 protein binding [GO:0071889]; alpha-1A adrenergic receptor binding [GO:0031691]; alpha-1B adrenergic receptor binding [GO:0031692]; angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; D1 dopamine receptor binding [GO:0031748]; enzyme binding [GO:0019899]; follicle-stimulating hormone receptor binding [GO:0031762]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; platelet activating factor receptor binding [GO:0031859]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]; type 2A serotonin receptor binding [GO:0031826]; ubiquitin protein ligase binding [GO:0031625]; adult walking behavior [GO:0007628]; brain development [GO:0007420]; cell chemotaxis [GO:0060326]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of GTPase activity [GO:0034260]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0001664; GO:0001933; GO:0002031; GO:0002032; GO:0002092; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0006366; GO:0007179; GO:0007212; GO:0007420; GO:0007628; GO:0010628; GO:0014069; GO:0015031; GO:0016323; GO:0016567; GO:0019899; GO:0019904; GO:0030139; GO:0031397; GO:0031410; GO:0031623; GO:0031625; GO:0031691; GO:0031692; GO:0031701; GO:0031702; GO:0031748; GO:0031762; GO:0031826; GO:0031859; GO:0032088; GO:0032226; GO:0032691; GO:0032695; GO:0032715; GO:0032720; GO:0032967; GO:0033138; GO:0034122; GO:0034260; GO:0034392; GO:0042699; GO:0042802; GO:0043154; GO:0043161; GO:0043197; GO:0043422; GO:0043524; GO:0044877; GO:0045211; GO:0045953; GO:0050731; GO:0050965; GO:0051019; GO:0051897; GO:0051898; GO:0051928; GO:0060079; GO:0060326; GO:0070374; GO:0071889; GO:0090201; GO:1904037; GO:1990763; GO:2000573; GO:2000727 14-3-3 protein binding [GO:0071889]; alpha-1A adrenergic receptor binding [GO:0031691]; alpha-1B adrenergic receptor binding [GO:0031692]; angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; D1 dopamine receptor binding [GO:0031748]; enzyme binding [GO:0019899]; follicle-stimulating hormone receptor binding [GO:0031762]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019]; platelet activating factor receptor binding [GO:0031859]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702]; type 2A serotonin receptor binding [GO:0031826]; ubiquitin protein ligase binding [GO:0031625] DRKVFVTLTCAFR 0.99197 -24.558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9885 0 0 11.7855 0 0 0 0 12.3747 0 13.7612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7654 0 0 0 0 0 0 0 0 0 0 0 0 16.4013 0 0 0 11.0317 0 12.8274 0 13.1837 13.2633 12.9215 0 0 13.2276 0 13.0364 0 0 0 0 0 0 0 0 0 0 14.3052 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7547 0 0 0 0 16.1904 0 0 0 0 0 0 0 14.4332 0 0 0 0 0 0 0 0 0 13.2247 0 14.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9338 0 0 0 0 13.4134 0 0 0 0 0 0 13.5278 0 P35716 SOX11_HUMAN Transcription factor SOX-11 SOX11 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; closure of optic fissure [GO:0061386]; cornea development in camera-type eye [GO:0061303]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic skeletal system morphogenesis [GO:0048704]; eyelid development in camera-type eye [GO:0061029]; glial cell development [GO:0021782]; glial cell proliferation [GO:0014009]; hard palate development [GO:0060022]; kidney development [GO:0001822]; lens morphogenesis in camera-type eye [GO:0002089]; limb bud formation [GO:0060174]; lung morphogenesis [GO:0060425]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neural crest cell development [GO:0014032]; neural tube formation [GO:0001841]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; noradrenergic neuron differentiation [GO:0003357]; oligodendrocyte development [GO:0014003]; outflow tract morphogenesis [GO:0003151]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of hippo signaling [GO:0035332]; positive regulation of hormone secretion [GO:0046887]; positive regulation of lens epithelial cell proliferation [GO:2001111]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; skeletal muscle cell differentiation [GO:0035914]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]; somite development [GO:0061053]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; ventricular septum morphogenesis [GO:0060412]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0001822; GO:0001841; GO:0002089; GO:0003151; GO:0003211; GO:0003357; GO:0003700; GO:0005634; GO:0005654; GO:0005886; GO:0006355; GO:0008284; GO:0009653; GO:0010628; GO:0010629; GO:0014003; GO:0014009; GO:0014032; GO:0017015; GO:0021510; GO:0021782; GO:0030154; GO:0030182; GO:0030513; GO:0035332; GO:0035914; GO:0045666; GO:0045669; GO:0045778; GO:0045893; GO:0045944; GO:0046887; GO:0048485; GO:0048557; GO:0048704; GO:0050672; GO:0050769; GO:0060022; GO:0060023; GO:0060174; GO:0060253; GO:0060412; GO:0060425; GO:0060548; GO:0060563; GO:0061029; GO:0061053; GO:0061303; GO:0061386; GO:2000648; GO:2000678; GO:2001111 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" HMADYPDYKYR 0.99197 -6.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5127 0 0 0 0 0 0 0 0 0 0 0 0 11.0631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9352 0 0 0 0 13.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9269 0 0 0 0 0 13.9577 0 0 0 12.9547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.508 0 0 Q13670 PM2PB_HUMAN Putative postmeiotic segregation increased 2-like protein 11 (PMS2-related protein 6) (Putative postmeiotic segregation increased 2 pseudogene 11) PMS2P11 PMS2L11 PMSR6 Homo sapiens (Human) mismatch repair [GO:0006298]; phosphorylation [GO:0016310] mismatch repair complex [GO:0032300] mismatch repair complex [GO:0032300]; ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301]; mismatch repair [GO:0006298]; phosphorylation [GO:0016310] GO:0006298; GO:0016301; GO:0016310; GO:0016887; GO:0032300 ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301] AIKPIDR 0.99197 -7.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14767 LTBP2_HUMAN "Latent-transforming growth factor beta-binding protein 2, LTBP-2" LTBP2 C14orf141 LTBP3 Homo sapiens (Human) protein secretion [GO:0009306]; protein targeting [GO:0006605]; supramolecular fiber organization [GO:0097435]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436]; protein secretion [GO:0009306]; protein targeting [GO:0006605]; supramolecular fiber organization [GO:0097435]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0005509; GO:0005576; GO:0005615; GO:0006605; GO:0007179; GO:0008201; GO:0009306; GO:0019838; GO:0031012; GO:0050436; GO:0062023; GO:0070062; GO:0097435 calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; microfibril binding [GO:0050436] AEEEELARPPR 0.99197 -18.581 0 0 0 0 0 0 0 0 0 0 9.82777 0 0 0 10.9302 0 0 0 0 11.5049 0 0 0 0 9.78467 0 0 0 0 0 10.8593 0 0 0 0 0 0 0 0 0 11.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4721 0 0 0 0 0 0 0 0 12.4553 11.4563 0 0 13.2688 0 11.5709 0 0 0 0 0 0 0 0 0 11.4727 0 12.5353 0 13.2923 0 0 0 0 0 12.4112 0 0 0 14.2827 0 14.2119 16.3354 0 0 0 0 12.9832 0 0 0 0 12.8273 0 0 0 0 0 0 13.7559 0 0 13.7097 13.5183 14.127 0 0 0 12.4955 13.7209 0 0 11.4635 12.6103 0 0 13.671 0 0 0 0 0 0 0 0 0 12.8305 0 13.913 0 11.281 0 0 0 0 0 0 0 0 0 13.2752 0 0 13.0908 0 0 14.3546 0 0 12.7493 0 0 13.6402 0 Q15735 PI5PA_HUMAN "Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A, EC 3.1.3.56 (Inositol polyphosphate 5-phosphatase J)" INPP5J PIB5PA PIPP Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extrinsic component of membrane [GO:0019898]; growth cone [GO:0030426]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]" GO:0001726; GO:0004439; GO:0004445; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0010977; GO:0017124; GO:0019898; GO:0030426; GO:0031115; GO:0033137; GO:0034485; GO:0043198; GO:0043647; GO:0046855; GO:0046856; GO:0052658; GO:0052659 "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]" GLEEGGLGP 0.99197 -24.52 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2037 12.7472 0 0 0 12.1272 0 0 0 0 0 0 0 0 0 0 0 0 11.2286 0 0 0 0 0 0 0 0 0 11.2367 12.1777 0 0 0 11.7867 0 12.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1307 0 0 0 0 13.7308 12.6211 13.8358 0 0 0 0 0 0 0 14.4053 14.007 11.0441 0 14.9585 14.0715 13.853 0 0 0 0 14.6342 0 0 13.1407 0 0 0 11.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6666 0 0 0 0 0 0 13.0876 0 0 0 0 10.3755 0 0 13.0691 0 0 11.9566 0 0 0 0 0 13.1693 0 0 0 0 0 0 0 0 11.6582 0 0 0 0 0 0 0 0 0 0 0 0 14.3791 0 12.79 0 0 0 12.5788 0 0 0 0 0 0 13.11 12.1371 11.9836 0 0 0 Q6RFH5 WDR74_HUMAN WD repeat-containing protein 74 (NOP seven-associated protein 1) WDR74 NSA1 Homo sapiens (Human) blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364]" GO:0001825; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016070; GO:0030687; GO:0042273 GVNLQRKQAANFTAGGQPR 0.99197 -6.0035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5456 0 0 0 0 0 0 0 0 0 0 0 0 13.5985 0 0 0 0 0 0 0 13.4779 0 0 0 0 0 0 0 13.5519 0 0 0 0 0 13.0706 0 0 0 0 13.1791 0 0 0 0 11.7649 0 0 0 0 0 0 13.3876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9317 0 0 0 0 0 0 0 0 Q86VP1 TAXB1_HUMAN Tax1-binding protein 1 (TRAF6-binding protein) TAX1BP1 T6BP PRO0105 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088] GO:0005829; GO:0006915; GO:0019900; GO:0032088; GO:0043066; GO:0046872; GO:0070062 kinase binding [GO:0019900]; metal ion binding [GO:0046872] AGLLELKIEK 0.99197 -24.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5359 0 0 14.55 0 12.7559 0 0 13.0847 0 0 13.9741 0 0 0 14.1691 13.5843 0 0 0 0 0 0 12.8799 17.6054 12.0811 0 12.9308 0 0 0 0 0 13.8338 0 14.9742 0 0 14.3227 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7905 0 0 17.5603 0 12.5684 0 0 0 0 0 0 0 12.0908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.18 0 0 0 12.739 0 0 0 0 0 0 0 Q8N4G2 ARL14_HUMAN ADP-ribosylation factor-like protein 14 (ADP-ribosylation factor 7) ARL14 ARF7 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0016192; GO:0031410 GTP binding [GO:0005525]; GTPase activity [GO:0003924] QFEHILKNEHIK 0.99197 -7.4297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0325 0 0 0 0 0 0 0 0 0 0 12.5748 0 0 12.8373 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8145 0 0 0 0 0 13.1986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3346 13.2001 0 0 0 0 0 0 0 12.7356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHC4 O10J5_HUMAN Olfactory receptor 10J5 (Olfactory receptor OR1-28) OR10J5 Homo sapiens (Human) "angiogenesis [GO:0001525]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; lipid homeostasis [GO:0055088]; muscle organ development [GO:0007517]; regulation of angiogenesis [GO:0045765]; regulation of muscle cell differentiation [GO:0051147]; sensory perception of smell [GO:0007608]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984]; angiogenesis [GO:0001525]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; lipid homeostasis [GO:0055088]; muscle organ development [GO:0007517]; regulation of angiogenesis [GO:0045765]; regulation of muscle cell differentiation [GO:0051147]; sensory perception of smell [GO:0007608]" GO:0001525; GO:0004984; GO:0004993; GO:0005886; GO:0005887; GO:0006935; GO:0007187; GO:0007268; GO:0007517; GO:0007608; GO:0030425; GO:0030594; GO:0045202; GO:0045765; GO:0051147; GO:0055088 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984] SESSIEK 0.99197 -24.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2452 0 0 0 0 13.7955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZV1 UBXN6_HUMAN UBX domain-containing protein 6 (UBX domain-containing protein 1) UBXN6 UBXD1 UBXDC2 Homo sapiens (Human) endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236] GO:0005634; GO:0005737; GO:0005765; GO:0005768; GO:0005815; GO:0005829; GO:0016236; GO:0019898; GO:0031901; GO:0031902; GO:0032510; GO:0032991; GO:0036503; GO:0070062 FKSAGPGQKLK 0.99197 -24.672 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8525 0 0 0 0 0 0 0 14.3946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7402 0 0 0 0 0 0 12.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ53 PDXL2_HUMAN Podocalyxin-like protein 2 (Endoglycan) PODXL2 UNQ1861/PRO3742 Homo sapiens (Human) leukocyte tethering or rolling [GO:0050901] Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887] Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; glycosaminoglycan binding [GO:0005539]; leukocyte tethering or rolling [GO:0050901] GO:0005539; GO:0005796; GO:0005887; GO:0050901 glycosaminoglycan binding [GO:0005539] EEEEEEEEEEER 0.99197 -4.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6079 0 0 0 0 11.9663 12.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6666 0 0 0 0 0 0 12.6405 12.6177 0 11.9846 12.1141 0 0 0 0 0 0 0 12.7382 0 0 0 11.4553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9394 0 0 0 13.8646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9411 0 0 0 0 0 0 Q9UHV7 MED13_HUMAN "Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component, ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component, Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250, DRIP250)" MED13 ARC250 KIAA0593 THRAP1 TRAP240 Homo sapiens (Human) "cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328]" mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cholesterol homeostasis [GO:0042632]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; triglyceride homeostasis [GO:0070328]" GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0030374; GO:0042632; GO:0042809; GO:0043433; GO:0045893; GO:0045944; GO:0046966; GO:0060261; GO:0070328 nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] CFLEMVQTLPPHIK 0.99197 -24.624 0 0 0 0 0 0 0 0 0 11.496 0 0 11.594 0 0 0 0 0 0 0 0 10.5603 0 0 0 0 11.2873 10.5137 0 0 10.719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3775 0 0 0 0 0 0 0 0 0 0 0 10.5161 0 0 0 0 0 0 0 0 0 12.5903 13.8583 0 15.6105 0 13.0432 13.6531 0 0 0 14.8604 12.3739 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9031 0 0 0 14.3987 0 13.2267 0 15.4348 11.9852 0 0 0 0 0 0 0 13.4405 13.4507 0 0 0 0 0 11.0673 13.2781 12.7158 0 0 0 0 0 0 12.5547 13.7091 0 0 13.3541 14.1148 16.6942 15.0996 0 13.6611 13.3639 14.7731 0 14.6026 13.0539 0 0 11.9702 0 0 0 13.8558 0 0 0 0 0 0 0 0 0 12.9153 0 0 0 0 12.477 0 0 0 0 0 0 0 0 15.198 0 0 0 0 13.5715 Q9H0K6 PUS7L_HUMAN "Pseudouridylate synthase PUS7L, EC 5.4.99.- (Pseudouridylate synthase 7 homolog-like protein)" PUS7L Homo sapiens (Human) mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522] nucleus [GO:0005634] nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; pseudouridine synthesis [GO:0001522] GO:0001522; GO:0003723; GO:0005634; GO:0006397; GO:0009982; GO:1990481 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] ASLHSAIR 0.99198 -17.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9696 16.8906 0 13.5571 16.6587 16.7743 16.0581 15.7509 15.7523 19.5912 0 0 18.387 19.24 18.9812 13.8767 0 13.4165 16.8085 14.0507 15.174 15.2437 15.4862 0 0 0 0 18.3618 20.3381 17.218 0 14.7914 0 20.0676 13.3584 13.2298 20.0254 18.4316 18.9821 13.5634 16.0188 18.9307 0 18.8255 18.5281 19.5531 18.6436 19.8333 14.3168 0 13.6683 12.9921 19.4826 18.1154 0 0 20.0546 0 13.9503 0 0 20.7925 0 18.4086 0 19.7139 13.8183 0 14.6282 15.1897 0 0 19.3544 14.9869 14.8406 20.4622 13.1657 19.8386 0 16.7428 0 18.9138 0 19.0285 0 18.9997 16.6986 20.0576 19.1836 20.5491 0 0 0 0 0 0 0 0 0 0 0 0 10.6947 0 0 15.9903 15.1226 15.8182 19.3871 0 0 0 0 0 O15054 KDM6B_HUMAN "Lysine-specific demethylase 6B, EC 1.14.11.68 (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B) ([histone H3]-trimethyl-L-lysine(27) demethylase 6B)" KDM6B JMJD3 KIAA0346 Homo sapiens (Human) cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; inflammatory response [GO:0006954]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; inflammatory response [GO:0006954]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0006954; GO:0007507; GO:0008013; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0045165; GO:0045446; GO:0045944; GO:0046872; GO:0048333; GO:0055007; GO:0070301; GO:0071557; GO:0071558; GO:0120162 beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ESEDEESEEPDSTTGTPPSSAPDPKNHHIIK 0.99198 -17.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4278 0 0 0 0 0 0 11.9953 11.8344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6901 13.061 0 0 11.3546 0 12.9931 12.5749 0 0 0 0 0 14.0409 0 0 0 0 0 0 14.5412 0 0 0 0 0 0 0 13.8006 0 0 0 0 0 0 0 0 0 0 0 12.5919 14.5401 0 0 0 0 0 0 0 0 0 0 0 12.0348 0 0 12.0501 0 0 0 0 13.2675 12.7332 0 0 0 10.5568 O60330 PCDGC_HUMAN "Protocadherin gamma-A12, PCDH-gamma-A12 (Cadherin-21) (Fibroblast cadherin-3)" PCDHGA12 CDH21 FIB3 KIAA0588 UNQ371/PRO707 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887] cell-cell junction [GO:0005911]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0005911; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DLGLEPRELAER 0.99198 -23.161 0 0 0 0 0 0 0 0 0 0 0 0 12.8865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3454 0 0 0 0 0 12.7534 14.4925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.607 0 0 0 0 0 0 0 0 13.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95718 ERR2_HUMAN "Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta, ERR-beta) (Nuclear receptor subfamily 3 group B member 2)" ESRRB ERRB2 ESRL2 NR3B2 Homo sapiens (Human) "cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; photoreceptor cell maintenance [GO:0045494]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]" chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]; cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; inner ear development [GO:0048839]; negative regulation of stem cell differentiation [GO:2000737]; photoreceptor cell maintenance [GO:0045494]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]" GO:0000785; GO:0000793; GO:0000978; GO:0000981; GO:0000987; GO:0000993; GO:0001228; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008270; GO:0008283; GO:0017145; GO:0019827; GO:0043565; GO:0043697; GO:0045494; GO:0045893; GO:0045944; GO:0048839; GO:0061629; GO:0071931; GO:0090282; GO:1902459; GO:1990837; GO:2000035; GO:2000737 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]" AVQHFYSVKLQGK 0.99198 -17.821 0 0 0 15.2682 0 0 0 0 11.1718 13.5512 12.2936 0 0 0 11.5557 0 12.7922 0 13.1663 11.4205 0 0 0 0 0 13.0864 11.5151 0 0 11.3716 14.2808 0 14.0636 12.8581 13.681 0 12.9944 12.6554 13.4789 12.9274 14.7489 0 13.4098 0 13.3666 13.3134 13.9433 0 12.3504 13.0747 13.5415 0 0 0 0 0 0 0 10.2176 0 0 0 0 0 0 0 0 13.8299 14.8197 0 14.6577 0 12.4774 0 0 0 0 0 12.4747 12.4844 0 13.4817 0 15.351 13.6207 14.2882 0 0 0 0 0 0 11.7469 0 0 0 11.752 13.1202 0 0 0 0 0 14.709 12.1328 0 0 0 0 0 13.3058 14.3052 0 0 0 0 0 12.5653 0 0 11.9526 12.5282 0 12.9874 13.0212 12.7489 0 0 0 0 0 11.5006 0 12.8327 11.6823 13.925 0 12.3358 0 0 0 0 0 13.3174 0 0 0 12.8938 0 0 0 9.75002 0 15.2209 0 0 0 14.7991 11.5093 0 13.0174 0 14.203 14.4299 14.2221 12.005 0 14.3625 14.8071 10.5919 0 0 0 0 0 14.1954 0 0 0 12.7528 P08294 SODE_HUMAN "Extracellular superoxide dismutase [Cu-Zn], EC-SOD, EC 1.15.1.1" SOD3 Homo sapiens (Human) blood vessel diameter maintenance [GO:0097746]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; heparin binding [GO:0008201]; superoxide dismutase activity [GO:0004784]; blood vessel diameter maintenance [GO:0097746]; removal of superoxide radicals [GO:0019430]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666] GO:0001666; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005796; GO:0008201; GO:0019430; GO:0046688; GO:0062023; GO:0070062; GO:0097746 copper ion binding [GO:0005507]; heparin binding [GO:0008201]; superoxide dismutase activity [GO:0004784] ESECKAA 0.99198 -23.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8844 11.9361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1901 0 0 0 12.9783 0 0 0 0 0 0 0 0 12.7946 0 0 0 0 0 0 0 0 12.9014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1977 0 0 0 0 0 0 0 0 0 0 13.0903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5975 0 0 0 0 0 0 0 12.6847 0 11.9737 0 0 0 0 11.7145 0 0 P53621 COPA_HUMAN "Coatomer subunit alpha (Alpha-coat protein, Alpha-COP) (HEP-COP, HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin ]" COPA Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062 hormone activity [GO:0005179]; structural molecule activity [GO:0005198] AWEVDTCRGHYNNVSCAVFHPR 0.99198 -17.784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7265 0 0 0 0 0 0 0 0 0 0 0 0 15.0921 0 0 0 13.1089 0 0 12.6682 0 0 0 0 15.3359 0 0 0 0 0 0 0 14.0331 0 0 0 0 0 0 0 0 0 13.0888 0 0 0 0 0 0 0 12.1943 0 0 11.4235 0 0 0 12.7149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4147 0 0 0 0 0 12.6668 0 0 0 0 11.5472 11.8696 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7038 P61968 LMO4_HUMAN "LIM domain transcription factor LMO4 (Breast tumor autoantigen) (LIM domain only protein 4, LMO-4)" LMO4 Homo sapiens (Human) negative regulation of protein-containing complex assembly [GO:0031333]; neural tube closure [GO:0001843]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell activation [GO:0050865]; regulation of cell fate specification [GO:0042659]; regulation of cell migration [GO:0030334]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron differentiation [GO:0021522]; thymus development [GO:0048538]; ventral spinal cord interneuron differentiation [GO:0021514]; ventricular septum development [GO:0003281] cell leading edge [GO:0031252]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] cell leading edge [GO:0031252]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; negative regulation of protein-containing complex assembly [GO:0031333]; neural tube closure [GO:0001843]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell activation [GO:0050865]; regulation of cell fate specification [GO:0042659]; regulation of cell migration [GO:0030334]; spinal cord association neuron differentiation [GO:0021527]; spinal cord motor neuron differentiation [GO:0021522]; thymus development [GO:0048538]; ventral spinal cord interneuron differentiation [GO:0021514]; ventricular septum development [GO:0003281] GO:0001843; GO:0003281; GO:0003713; GO:0005634; GO:0005667; GO:0021514; GO:0021522; GO:0021527; GO:0030334; GO:0031252; GO:0031333; GO:0033674; GO:0042659; GO:0045944; GO:0046872; GO:0048538; GO:0050865; GO:0090575; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713] CFTCSTCR 0.99198 -7.4611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16666 IF16_HUMAN "Gamma-interferon-inducible protein 16, Ifi-16 (Interferon-inducible myeloid differentiation transcriptional activator)" IFI16 IFNGIP1 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to interferon-beta [GO:0035458]; cellular response to ionizing radiation [GO:0071479]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of DNA binding [GO:0043392]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression, epigenetic [GO:0040029]" cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; cellular response to glucose starvation [GO:0042149]; cellular response to interferon-beta [GO:0035458]; cellular response to ionizing radiation [GO:0071479]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of DNA binding [GO:0043392]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy [GO:0010506]; regulation of gene expression, epigenetic [GO:0040029]" GO:0000122; GO:0001819; GO:0002218; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006914; GO:0006954; GO:0008134; GO:0010506; GO:0016020; GO:0016607; GO:0030099; GO:0030224; GO:0032731; GO:0035458; GO:0040029; GO:0042149; GO:0042771; GO:0042802; GO:0043392; GO:0045071; GO:0045087; GO:0045824; GO:0045892; GO:0045944; GO:0051607; GO:0071479; GO:0072332; GO:0097202; GO:2000117 double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134] EVMVLNATESFVYEPKEQKK 0.99198 -7.4713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2754 0 0 0 0 0 0 0 10.1083 0 0 0 0 0 0 0 0 0 0 0 0 11.8477 0 0 0 13.6552 13.8835 13.2905 0 0 0 0 0 0 0 0 0 13.0784 0 0 13.7648 13.2205 0 0 0 0 0 0 0 15.6045 0 0 12.7125 12.8263 16.2089 14.4153 0 13.6542 0 0 13.1209 0 0 0 16.9762 13.8236 0 15.8435 0 0 0 0 0 0 0 15.8119 0 0 0 0 0 14.9567 0 12.8109 13.1099 14.1114 0 14.6129 0 0 0 0 0 0 0 0 0 0 12.3337 0 13.735 12.8094 0 0 0 17.7012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RQ9 NKPD1_HUMAN NTPase KAP family P-loop domain-containing protein 1 NKPD1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ARLWDVFRDNSR 0.99198 -7.4602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.38498 0 0 0 12.0147 0 0 0 0 0 0 0 13.0761 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86638 0 0 15.6715 0 0 12.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7924 0 13.3619 0 0 0 0 13.4058 13.0595 0 0 12.856 0 0 0 0 0 0 12.6482 11.9477 0 13.4303 0 0 0 19.1516 14.6081 0 12.0828 19.7517 12.2682 12.3904 11.3075 0 0 0 0 0 0 14.6106 0 0 19.2209 0 0 0 0 0 19.0604 0 12.6462 18.1134 18.0235 0 0 0 18.5471 0 0 17.5641 11.4975 11.2115 16.8532 16.7121 0 12.108 12.2356 13.1257 16.066 0 16.5338 0 0 0 16.8465 0 17.6804 0 0 13.581 0 0 0 0 10.4322 0 13.261 14.1062 0 0 12.7008 14.1561 0 0 0 0 16.0439 0 10.9638 0 0 11.6803 0 0 Q2TB10 ZN800_HUMAN Zinc finger protein 800 ZNF800 PP902 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] DVIRHITVVHKK 0.99198 -23.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8422 0 0 0 0 0 15.5227 0 0 13.8846 0 0 0 0 0 0 0 0 0 0 16.3519 0 0 16.5804 16.6626 11.1372 0 17.1535 0 0 0 17.1976 17.7099 0 17.4414 17.0199 18.19 17.9937 0 0 16.3312 16.8647 18.1337 0 0 16.2736 14.4309 0 14.7756 0 0 0 0 0 14.0538 14.611 12.615 14.6732 12.6296 13.0654 13.001 13.1324 11.6194 14.283 12.8986 0 0 0 0 0 12.6051 14.9969 0 12.989 0 12.563 0 0 12.8366 13.0449 0 14.109 0 0 0 14.3624 13.7395 18.1122 14.4035 13.8619 15.3796 0 0 0 19.6057 13.761 0 15.5934 13.2547 14.4081 13.2994 14.0799 12.6285 14.1909 12.8996 0 14.2693 13.2744 14.3514 15.0067 14.1715 12.8127 12.7791 0 19.4352 13.4147 12.7518 0 13.9196 14.8092 0 0 0 14.2072 12.7269 13.0466 18.5628 18.5645 18.4113 18.3274 13.0473 0 0 12.9743 0 13.1718 0 0 0 0 0 0 0 0 13.7707 0 18.0998 0 0 0 0 20.5646 0 0 0 0 0 0 0 0 Q6NTF9 RHBD2_HUMAN Rhomboid domain-containing protein 2 RHBDD2 RHBDL7 Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000139; GO:0000839; GO:0004252; GO:0005654; GO:0005794; GO:0030176; GO:0030433; GO:0030968; GO:0048471; GO:0051787 misfolded protein binding [GO:0051787]; serine-type endopeptidase activity [GO:0004252] AASGPGCR 0.99198 -7.4659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6281 0 0 0 Q6PKC3 TXD11_HUMAN Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1) TXNDC11 EFP1 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 FVRRVMK 0.99198 -23.132 0 0 0 0 0 0 0 0 0 0 0 12.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6427 0 0 0 0 0 0 0 0 0 0 0 0 13.6787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9443 0 0 0 0 0 0 0 0 0 0 0 13.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9793 0 0 0 0 0 0 0 0 Q7Z7M8 B3GN8_HUMAN "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8, BGnT-8, Beta-1,3-Gn-T8, Beta-1,3-N-acetylglucosaminyltransferase 8, Beta3Gn-T8, EC 2.4.1.-" B3GNT8 B3GALT7 BGALT15 Homo sapiens (Human) O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" GO:0000139; GO:0008194; GO:0008499; GO:0016021; GO:0016262; GO:0016266; GO:0016757; GO:0030311; GO:0070062 "glycosyltransferase activity [GO:0016757]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" CLLCLSALLTLLGLKVYIEWTSESRLSK 0.99198 -17.787 0 0 0 0 0 0 0 0 0 0 0 13.124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9045 0 12.6717 0 0 11.1048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5096 12.4337 0 11.6717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V81 THOC4_HUMAN "THO complex subunit 4, Tho4 (Ally of AML-1 and LEF-1) (Aly/REF export factor) (Transcriptional coactivator Aly/REF) (bZIP-enhancing factor BEF)" ALYREF ALY BEF THOC4 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; replication fork processing [GO:0031297]; RNA export from nucleus [GO:0006405]; viral mRNA export from host cell nucleus [GO:0046784]" GO:0000018; GO:0000346; GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016020; GO:0016607; GO:0031297; GO:0032786; GO:0046784; GO:0062153; GO:0070062; GO:0071013 C5-methylcytidine-containing RNA binding [GO:0062153]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GAGRNSK 0.99198 -24.679 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0849 0 12.1655 11.7695 0 12.0418 0 0 0 0 0 0 0 0 0 0 0 12.8498 12.3546 12.2034 0 0 0 0 0 0 11.2147 12.1161 0 0 0 11.3356 0 12.1266 12.432 0 0 0 0 14.1543 0 12.9295 16.4057 16.2449 16.4497 17.2847 15.2836 16.1638 15.4059 16.5955 16.0441 15.3011 14.5217 0 0 0 0 0 12.4838 0 0 0 0 0 0 0 12.6163 12.951 0 0 0 0 0 0 0 13.0432 0 13.3963 13.4197 13.6404 0 0 0 0 0 13.2216 14.0529 15.5367 13.4247 0 0 0 0 12.239 0 13.7633 12.1031 0 13.6526 0 0 0 0 13.9634 0 0 0 0 0 0 0 0 0 12.5422 0 0 12.881 0 12.6469 12.7431 0 0 0 0 0 0 14.9705 14.425 0 0 0 0 0 0 13.5976 0 0 13.161 0 12.8136 0 0 0 0 13.9522 12.6991 0 12.7816 0 13.4898 15.4774 13.448 15.4194 15.0001 16.2386 0 0 0 0 0 0 0 12.7859 0 0 0 0 Q96F83 CLBA1_HUMAN Uncharacterized protein CLBA1 (Clathrin-binding box of aftiphilin-containing protein 1) CLBA1 C14orf79 Homo sapiens (Human) intracellular transport [GO:0046907] AP-1 adaptor complex [GO:0030121]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; intracellular transport [GO:0046907] GO:0030121; GO:0030276; GO:0032588; GO:0046907 clathrin binding [GO:0030276] LTLFNSDVC 0.99198 -6.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0858 0 0 0 0 0 0 12.0411 0 0 0 0 12.4778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3742 12.6562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9428 0 0 11.6938 0 13.5078 0 12.1452 0 12.6623 0 0 0 11.5599 0 0 0 0 12.6958 0 0 0 0 14.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HA1 P121A_HUMAN Nuclear envelope pore membrane protein POM 121 (Nuclear envelope pore membrane protein POM 121A) (Nucleoporin Nup121) (Pore membrane protein of 121 kDa) POM121 KIAA0618 NUP121 POM121A Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] GO:0005635; GO:0005643; GO:0005654; GO:0005789; GO:0006405; GO:0006606; GO:0006913; GO:0008139; GO:0016021; GO:0017056; GO:0031965; GO:0051028 nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] GCGGPAR 0.99198 -23.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4325 0 0 0 13.3401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6774 0 0 0 0 13.4689 0 0 0 0 0 0 0 0 0 0 0 0 15.5457 0 0 0 0 0 0 12.7231 15.3493 0 0 0 0 0 13.0572 0 0 0 0 0 0 0 0 15.219 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7181 0 0 0 0 0 0 0 0 14.7618 0 0 0 16.8656 Q9BYT9 ANO3_HUMAN Anoctamin-3 (Transmembrane protein 16C) ANO3 C11orf25 TMEM16C GENX-3947 Homo sapiens (Human) calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005229; GO:0005254; GO:0005886; GO:0016021; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0051649; GO:0055085; GO:0061590; GO:0061591; GO:1902476 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] ARIHHFIINNK 0.99198 -24.796 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9845 0 0 0 0 0 0 0 0 10.3372 9.78183 0 10.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6738 0 0 0 0 0 0 0 0 0 0 10.512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3563 0 0 0 0 0 0 0 0 0 11.5354 0 0 0 0 0 0 0 0 0 0 0 0 13.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9131 0 0 0 0 Q9HBL0 TENS1_HUMAN Tensin-1 TNS1 TNS Homo sapiens (Human) fibroblast migration [GO:0010761] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; fibroblast migration [GO:0010761] GO:0003723; GO:0003779; GO:0005737; GO:0005856; GO:0005925; GO:0009986; GO:0010761 actin binding [GO:0003779]; RNA binding [GO:0003723] FYEDKIVPIGQPSQRR 0.99198 -24.014 0 0 0 0 0 0 0 0 0 11.9505 11.585 12.3418 11.7893 0 12.1544 0 0 0 0 0 0 0 0 0 0 0 11.5318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8069 15.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0119 14.4506 0 15.6001 0 0 0 14.7567 0 14.9367 0 0 0 16.0125 0 0 0 15.5194 0 15.263 0 0 0 15.5589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1496 0 12.9308 0 0 0 0 0 0 15.0997 12.7231 0 0 13.0804 13.4583 13.4065 0 0 0 13.3312 0 0 0 12.9748 13.2123 0 13.2562 0 0 0 0 0 0 13.1456 0 0 Q9NPH9 IL26_HUMAN "Interleukin-26, IL-26 (Protein AK155)" IL26 AK155 Homo sapiens (Human) cell-cell signaling [GO:0007267]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cell-cell signaling [GO:0007267]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001819; GO:0005125; GO:0005576; GO:0005615; GO:0005829; GO:0007267; GO:0032874; GO:0045944; GO:0046427; GO:0050680; GO:0051897; GO:0070374 cytokine activity [GO:0005125] CGLLLVTLSLAIAK 0.99198 -18.725 0 0 0 0 0 0 0 0 0 9.65048 0 0 0 0 0 0 0 0 11.6696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5188 0 0 0 0 0 14.0032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6068 12.0867 0 0 0 0 0 0 0 0 13.2988 0 0 0 13.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5L3 ENTP2_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 2, NTPDase 2, EC 3.6.1.- (CD39 antigen-like 1) (Ecto-ATP diphosphohydrolase 2, Ecto-ATPDase 2, Ecto-ATPase 2)" ENTPD2 CD39L1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; nucleoside diphosphate catabolic process [GO:0009134]; platelet activation [GO:0030168]; purine ribonucleoside diphosphate catabolic process [GO:0009181] basement membrane [GO:0005604]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; G protein-coupled receptor signaling pathway [GO:0007186]; nucleoside diphosphate catabolic process [GO:0009134]; platelet activation [GO:0030168]; purine ribonucleoside diphosphate catabolic process [GO:0009181] GO:0004382; GO:0005524; GO:0005604; GO:0005789; GO:0005886; GO:0007186; GO:0009134; GO:0009181; GO:0016020; GO:0016021; GO:0017110; GO:0017111; GO:0030168; GO:0045134; GO:0070062 ATP binding [GO:0005524]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134] AFGGVIFQKK 0.99198 -6.0083 0 0 12.0647 10.8988 0 0 0 0 0 0 0 0 0 11.5557 0 0 0 0 0 8.1264 0 0 12.8597 0 0 0 0 0 0 11.7657 12.8492 11.2352 0 14.0469 0 0 0 0 0 0 11.8739 0 0 0 0 0 0 11.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8221 0 0 0 14.1894 0 0 12.5547 0 0 0 0 14.8022 14.9384 14.2072 0 0 0 0 0 0 0 0 0 0 14.3045 0 0 0 0 11.8578 0 12.6593 12.0844 0 9.65785 0 13.1191 11.3466 0 11.594 0 13.6152 0 0 0 11.3817 0 11.9378 0 12.8274 0 0 0 0 0 13.9078 10.7912 0 0 0 0 0 0 10.561 0 13.5135 13.5113 0 12.9977 0 0 13.9233 11.4946 13.1184 0 13.074 0 0 13.4367 11.3083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8579 Q9P2D7 DYH1_HUMAN "Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1, HSRF-1) (hDHC7)" DNAH1 DHC7 DNAHC1 KIAA1410 Homo sapiens (Human) cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288] GO:0003341; GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007288; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] AGAITSDTNKK 0.99199 -56.004 0 13.7159 0 0 0 0 11.6444 0 15.3956 15.8502 15.3451 16.1019 16.5569 15.9698 16.0584 17.9322 14.8319 14.616 14.8609 12.6042 11.3951 0 0 0 15.1604 15.4993 14.0243 14.7379 14.947 15.0437 16.9854 16.7394 16.826 15.1477 15.8261 15.4062 15.4629 15.6241 14.9152 16.793 16.596 16.4347 16.8548 17.0071 17.2094 17.5793 17.3491 17.2263 14.5004 11.6174 14.299 13.3602 0 11.9483 13.2506 17.4994 18.6564 18.4158 18.2911 17.3485 19.2668 19.4299 19.7784 18.1556 18.3318 18.5664 11.6064 0 10.0156 12.4998 12.0594 0 0 0 11.336 13.8619 13.1351 15.0247 10.8598 12.3847 0 0 0 13.8206 14.8692 0 0 16.0516 0 0 0 0 0 0 11.3512 14.1151 16.3122 0 12.102 0 11.838 11.1624 0 0 0 0 0 0 10.6042 11.4138 0 14.4338 0 14.1172 0 0 0 14.6061 0 14.3551 0 11.5437 12.9577 0 0 14.9502 0 0 0 0 11.5644 0 0 12.7655 0 0 0 0 0 0 0 0 0 0 13.6563 13.7977 0 16.058 0 11.6231 11.0492 0 0 0 0 0 19.7177 19.4404 18.7763 17.9705 18.5397 17.7108 0 15.6224 18.5241 14.3751 18.7321 18.3497 18.0572 18.1321 18.0259 13.367 0 13.6842 0 15.3581 18.5919 14.7466 13.4886 0 O00401 WASL_HUMAN "Actin nucleation-promoting factor WASL (Neural Wiskott-Aldrich syndrome protein, N-WASP)" WASL Homo sapiens (Human) actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; cell division [GO:0051301]; dendritic spine morphogenesis [GO:0060997]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; cell division [GO:0051301]; dendritic spine morphogenesis [GO:0060997]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of membrane tubulation [GO:1903526]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of protein localization [GO:0032880]; response to bacterium [GO:0009617]; spindle localization [GO:0051653]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0006900; GO:0008154; GO:0009617; GO:0015629; GO:0016050; GO:0030027; GO:0030041; GO:0030048; GO:0030050; GO:0030478; GO:0030666; GO:0030695; GO:0031410; GO:0031503; GO:0032880; GO:0045944; GO:0051301; GO:0051491; GO:0051653; GO:0060997; GO:0065003; GO:0070062; GO:1903526; GO:2000370; GO:2000402; GO:2000601 actin binding [GO:0003779]; GTPase regulator activity [GO:0030695] AIHSSDEDEDEDDEEDFEDDDEWED 0.99199 -7.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6687 0 0 0 0 10.6045 0 0 0 0 0 0 0 0 13.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5006 13.685 14.9568 0 0 0 0 0 0 0 0 0 0 0 0 16.4267 0 0 13.4567 0 0 0 16.4546 12.7114 16.4351 0 0 0 0 12.7176 0 0 13.9417 0 12.1217 0 0 0 0 13.6084 11.4977 0 0 0 0 12.1893 11.0272 0 0 13.3512 0 0 0 0 0 0 0 0 14.1841 0 0 0 11.5673 13.332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.962 0 0 0 0 0 0 0 0 12.672 0 0 0 12.8497 0 0 0 0 13.6712 0 O00567 NOP56_HUMAN Nucleolar protein 56 (Nucleolar protein 5A) NOP56 NOL5A Homo sapiens (Human) rRNA processing [GO:0006364] box C/D RNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] box C/D RNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364] GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0045296; GO:0070761; GO:1990226 cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515] DINTFSMRVREWYGYHFPELVK 0.99199 -17.839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6331 0 0 0 0 13.501 0 0 0 0 0 0 0 0 13.3911 11.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8218 0 0 0 0 14.0721 13.8816 0 0 0 14.3039 14.2101 0 0 14.2075 0 0 13.8237 0 0 0 0 0 0 0 0 0 14.4398 0 0 13.2458 12.5558 0 0 0 0 14.5597 0 14.0994 0 0 0 0 0 0 0 0 0 13.4124 0 0 0 0 13.4464 0 0 0 0 0 0 14.2347 0 0 0 0 0 0 0 14.1221 0 0 11.2241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09848 LPH_HUMAN "Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase, EC 3.2.1.108; Glycosylceramidase, EC 3.2.1.62 (Phlorizin hydrolase) ]" LCT LPH Homo sapiens (Human) cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] external side of apical plasma membrane [GO:0098591]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of apical plasma membrane [GO:0098591]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803]; cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733] GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005887; GO:0005990; GO:0008422; GO:0017042; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892 beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803] AAPWGTR 0.99199 -47.901 0 0 0 0 14.0147 0 0 0 0 14.6811 13.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5986 12.946 13.1505 12.9296 12.849 0 12.9262 0 13.0237 13.3411 0 0 0 0 12.3607 0 0 0 13.0941 0 0 0 0 0 0 0 0 0 13.0063 0 12.5787 12.3445 0 12.4002 12.7775 0 0 12.132 13.6156 0 0 0 12.3313 0 0 0 10.514 0 0 0 0 0 0 0 0 0 11.7633 0 0 0 0 0 0 0 0 0 11.6932 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3087 0 13.7384 0 12.5061 0 0 0 0 0 0 12.2796 0 0 0 0 0 0 0 0 0 13.1501 0 0 0 0 0 0 0 0 0 14.8105 10.6587 0 0 0 0 0 13.8125 0 0 0 13.6363 0 12.8569 0 0 0 0 0 0 14.6463 14.9464 0 0 0 0 0 11.0482 0 0 0 0 15.9449 0 11.9188 0 0 11.9616 11.582 12.1323 0 Q13395 TARB1_HUMAN "Probable methyltransferase TARBP1, EC 2.1.1.- (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa, TRP-185)" TARBP1 TRM3 TRP185 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488] nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488] GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488 RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423] AFVQFVFDNKVLTIAAKIK 0.99199 -18.818 0 0 0 0 0 0 0 0 0 0 0 14.2267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1426 11.2455 0 12.5153 0 0 0 0 16.0284 0 0 0 10.7613 0 0 0 0 0 0 11.248 0 12.1361 0 0 11.0328 0 0 0 0 11.3768 0 0 0 0 12.8798 0 0 13.1559 0 16.623 0 11.1722 0 11.3842 0 0 0 0 0 0 0 0 0 11.7414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0724 0 0 0 12.2102 0 18.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9612 0 0 0 Q7Z2Z1 TICRR_HUMAN "Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)" TICRR C15orf42 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212] GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0007095; GO:0010212; GO:0030174; GO:0033314; GO:0043231 chromatin binding [GO:0003682] DFKTEEELLSYIR 0.99199 -55.806 0 0 0 0 0 0 0 0 15.0614 0 0 0 0 0 0 0 0 0 0 0 0 13.0123 0 13.3554 0 0 0 0 0 0 0 0 0 0 0 0 10.3096 0 0 0 0 0 0 0 0 14.2868 0 0 0 0 0 0 10.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5195 0 0 18.6065 14.0594 0 0 15.5871 18.9908 0 0 14.8147 14.8552 0 11.0086 0 0 0 0 0 15.8708 0 0 15.3033 14.9781 0 0 0 18.8101 0 14.532 0 18.1283 15.4272 0 14.4457 0 0 0 0 15.5783 13.9858 16.0487 19.1882 15.6195 0 12.564 15.2936 0 13.0043 14.3085 0 0 16.157 15.5077 15.6653 15.5915 14.3512 15.8681 0 14.9003 0 0 15.8052 13.9542 15.1133 16.368 0 12.7143 13.8149 13.8932 15.5458 0 15.2873 14.2205 13.5918 13.3727 0 18.4784 13.5313 0 0 15.4428 0 13.3815 0 0 15.2257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3718 0 18.3762 0 11.0358 14.2044 15.6153 0 0 Q8IV48 ERI1_HUMAN "3'-5' exoribonuclease 1, EC 3.1.-.- (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-end-specific exoribonuclease) (Histone mRNA 3'-exonuclease 1) (Protein 3'hExo, HEXO)" ERI1 3'EXO THEX1 Homo sapiens (Human) "exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; gene silencing by RNA [GO:0031047]; rRNA 3'-end processing [GO:0031125]" cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; gene silencing by RNA [GO:0031047]; rRNA 3'-end processing [GO:0031125]" GO:0000175; GO:0000467; GO:0005634; GO:0005730; GO:0005737; GO:0008408; GO:0019843; GO:0031047; GO:0031125; GO:0043022; GO:0046872; GO:0071204; GO:0071207 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exoribonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843] LKELGTKYK 0.99199 -7.4846 0 0 0 0 0 0 0 0 0 0 0 10.5587 0 0 0 0 0 0 0 0 0 0 0 10.9418 0 0 0 0 0 0 0 0 11.2509 0 0 0 0 0 0 0 0 10.6798 0 0 0 0 0 10.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.897 0 0 0 0 0 0 0 0 13.367 0 0 0 0 0 0 0 0 0 13.7094 0 0 0 0 14.839 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9894 0 14.0717 0 0 14.5191 0 0 0 14.3047 0 0 0 13.253 14.0159 0 0 13.757 14.9217 0 0 0 0 13.6261 0 0 12.3703 0 0 0 0 13.0594 0 0 0 14.6265 0 14.5139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1934 15.6923 0 14.2073 0 0 14.3083 0 Q8NFI4 F10A5_HUMAN Putative protein FAM10A5 (Suppression of tumorigenicity 13 pseudogene 5) ST13P5 FAM10A5 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983] GO:0005737; GO:0046983 protein dimerization activity [GO:0046983] AFVKMCK 0.99199 -7.4844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE68 ES8L1_HUMAN "Epidermal growth factor receptor kinase substrate 8-like protein 1, EPS8-like protein 1 (Epidermal growth factor receptor pathway substrate 8-related protein 1, EPS8-related protein 1)" EPS8L1 DRC3 EPS8R1 PP10566 Homo sapiens (Human) positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608]; positive regulation of ruffle assembly [GO:1900029]; regulation of catalytic activity [GO:0050790]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266] GO:0003779; GO:0005829; GO:0005886; GO:0007266; GO:0032587; GO:0032991; GO:0035023; GO:0042608; GO:0045296; GO:0050790; GO:0070062; GO:1900029 actin binding [GO:0003779]; cadherin binding [GO:0045296]; T cell receptor binding [GO:0042608] AVISTVER 0.99199 -18.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3395 0 0 0 0 0 0 0 0 0 9.85403 0 0 0 0 0 0 13.2971 0 0 0 0 0 0 15.7572 13.3302 15.6811 14.2175 0 0 0 0 0 0 0 0 0 0 11.9303 0 0 12.3316 12.09 0 0 0 0 0 0 14.6542 15.3173 14.4253 0 0 15.1117 14.2058 16.3377 14.8099 0 13.6846 0 15.4236 0 15.054 16.0593 14.9523 15.2749 13.9856 13.7859 13.7808 16.1909 0 0 16.5761 16.1903 16.1143 13.3869 14.4926 0 0 0 15.5179 0 0 0 0 0 0 16.2399 15.8725 15.5966 15.9872 0 15.2748 0 0 0 13.811 0 0 14.7584 14.2555 15.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9668 0 17.1163 0 0 0 0 14.2602 10.0014 Q96KN4 LRAT1_HUMAN "Protein LRATD1 (LRAT domain-containing 1) (Neurologic sensory protein 1, NSE1) (Protein FAM84A)" LRATD1 FAM84A NSE1 Homo sapiens (Human) cell morphogenesis [GO:0000902]; cell motility [GO:0048870] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870] GO:0000902; GO:0005737; GO:0048870 IDASGRLR 0.99199 -6.037 0 0 0 0 0 0 0 0 0 0 0 10.5241 0 0 0 0 0 0 0 11.8185 0 0 0 0 0 0 0 13.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9609 12.8687 0 0 0 0 0 12.4073 0 0 12.7562 12.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8299 0 0 0 0 0 0 0 13.4676 13.8667 12.8872 0 0 0 0 0 12.9803 0 0 0 12.9686 13.52 0 12.891 0 0 13.5163 0 12.9042 0 13.1818 0 0 0 0 0 0 13.7092 0 13.7863 0 0 0 13.8914 13.1413 0 0 0 12.8617 0 0 0 14.3049 0 0 0 12.7557 0 0 13.17 13.5315 13.0947 13.3348 13.3829 0 13.4415 13.8108 13.3882 0 0 0 13.3871 13.6475 0 0 0 15.1562 0 13.0299 0 0 Q9H3U7 SMOC2_HUMAN "SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2, SMOC-2) (Smooth muscle-associated protein 2, SMAP-2)" SMOC2 SMAP2 MSTP117 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of vascular wound healing [GO:0035470] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular space [GO:0005615] basement membrane [GO:0005604]; cell periphery [GO:0071944]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; extracellular matrix organization [GO:0030198]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of vascular wound healing [GO:0035470] GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0010595; GO:0030198; GO:0035470; GO:0045743; GO:0045766; GO:0045931; GO:0050840; GO:0071944; GO:1900748; GO:2000573; GO:2001028 calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] EDGKADTK 0.99199 -18.804 0 0 0 0 0 12.1721 0 0 0 0 0 0 0 0 15.2026 0 0 0 0 0 0 12.5964 0 13.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2112 15.2781 15.2451 15.3852 0 0 14.7689 0 15.3956 0 0 0 0 0 0 0 0 0 0 14.7291 0 0 0 0 14.1636 0 12.2748 0 0 0 0 14.8259 0 0 0 14.8954 0 0 0 14.8264 0 0 0 0 15.4376 0 12.4778 0 12.5003 0 14.8859 0 14.7275 0 0 0 0 13.5581 0 15.2325 0 0 0 0 0 0 15.5177 0 0 15.1036 15.0079 14.5122 0 0 0 0 12.1885 0 0 0 0 0 0 14.352 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9196 0 0 0 0 0 0 14.5141 0 Q9NR09 BIRC6_HUMAN "Baculoviral IAP repeat-containing protein 6, EC 2.3.2.27 (BIR repeat-containing ubiquitin-conjugating enzyme, BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon, APOLLON)" BIRC6 KIAA1289 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cellular protein metabolic process [GO:0032268]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712] cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cellular protein metabolic process [GO:0032268]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712] GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0007049; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032268; GO:0032465; GO:0042127; GO:0043066; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237 cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] AKIPLGFYYGHTYILPWESELK 0.99199 -85.69 0 0 0 0 0 0 0 12.452 13.2778 0 0 12.1652 0 0 0 10.6609 0 14.101 13.5099 0 13.4078 0 0 0 0 15.4687 12.4928 0 0 0 0 0 0 0 0 0 0 0 0 13.147 0 0 0 0 0 0 0 0 0 0 0 0 12.5207 0 12.9816 0 0 0 0 0 0 0 0 0 0 14.1486 15.0209 0 0 12.8774 12.3205 11.4209 0 12.2199 16.8947 17.3667 16.6505 16.2153 14.0564 13.4812 13.7726 11.4799 14.2928 15.5151 0 0 14.1254 0 0 0 0 0 0 14.1971 14.1957 14.2896 12.01 0 0 0 14.092 16.5551 14.4741 16.1307 15.3722 13.0245 14.4784 13.3483 14.759 15.3658 15.5723 12.7306 14.7456 0 0 0 14.7241 13.1031 14.0831 15.7845 15.0609 12.7434 0 14.8125 11.5286 13.1119 10.5559 12.1894 15.0082 14.5111 15.3924 15.2994 15.1858 12.6386 14.755 13.5068 0 0 13.9316 14.466 14.6972 13.457 0 15.3339 0 12.9351 15.0777 12.5942 0 0 13.6349 15.1831 13.9112 14.8803 0 0 12.2034 0 13.2607 0 0 11.5485 10.3743 0 9.74519 0 0 0 0 0 12.7629 13.0065 13.0592 13.3092 13.9991 14.4264 0 0 0 12.2978 Q9UHR4 BI2L1_HUMAN "Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1, BAI1-associated protein 2-like protein 1 (Insulin receptor tyrosine kinase substrate)" BAIAP2L1 IRTKS Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; regulation of insulin receptor signaling pathway [GO:0046626]; response to bacterium [GO:0009617] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; proline-rich region binding [GO:0070064]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; regulation of insulin receptor signaling pathway [GO:0046626]; response to bacterium [GO:0009617] GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0007009; GO:0009617; GO:0030838; GO:0046626; GO:0051017; GO:0051764; GO:0070062; GO:0070064; GO:0098641; GO:2000251 actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; proline-rich region binding [GO:0070064] EALLEEK 0.99199 -17.827 0 0 0 0 0 0 0 0 11.349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9898 0 0 11.9247 0 0 0 0 0 0 0 0 0 0 11.6169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.729 12.4518 0 0 12.896 0 12.7762 0 0 0 0 0 13.5582 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3167 0 0 0 11.9531 0 12.8387 0 11.2726 0 0 0 12.0042 0 0 11.3312 11.8417 11.468 11.9409 0 0 11.7636 0 0 0 0 0 0 0 0 10.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8943 0 10.6177 0 0 0 10.7746 0 0 0 11.198 0 0 0 Q9ULK2 AT7L1_HUMAN Ataxin-7-like protein 1 (Ataxin-7-like protein 4) ATXN7L1 ATXN7L4 KIAA1218 Homo sapiens (Human) DKEHLLTSTR 0.99199 -18.797 0 0 0 0 0 0 0 0 10.9237 0 0 13.4365 0 0 0 0 11.8578 0 0 0 0 0 0 0 0 12.6055 0 0 0 11.6919 0 0 0 13.3044 0 9.84175 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0673 14.2581 12.1094 0 13.9288 13.1427 0 15.4855 0 0 0 0 0 0 0 14.3925 0 0 0 0 0 0 0 0 14.0504 0 13.5712 13.1737 0 13.3129 11.5087 0 13.6341 13.8486 12.6768 0 0 0 0 0 0 0 0 11.9615 14.0234 14.0523 13.1286 0 0 0 14.3153 0 0 0 12.7498 0 0 0 0 14.3804 13.4907 0 0 11.7875 0 0 0 13.8121 14.0798 15.1144 0 12.9877 0 14.843 0 0 12.197 12.5621 0 0 0 12.7057 0 0 0 0 13.3714 0 0 13.9915 0 0 0 0 0 0 0 0 15.0756 13.776 0 0 0 0 0 A0A0J9YXQ4 PMA6E_HUMAN Paraneoplastic antigen Ma6E PNMA6E Homo sapiens (Human) AALSPLGRYRVLTK 0.992 -18.853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6494 0 0 0 0 0 0 0 0 0 0 0 11.1375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7348 0 0 0 0 0 15.0729 0 0 0 0 0 13.2109 0 0 0 0 0 0 0 0 0 0 0 13.9297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43896 KIF1C_HUMAN Kinesin-like protein KIF1C KIF1C KIAA0706 Homo sapiens (Human) "anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874] "axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; RNA binding [GO:0003723]; anterograde neuronal dense core vesicle transport [GO:1990048]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192]" GO:0003723; GO:0003774; GO:0003777; GO:0005524; GO:0005783; GO:0005794; GO:0005871; GO:0005874; GO:0006890; GO:0007018; GO:0008017; GO:0008574; GO:0016192; GO:0016887; GO:0030424; GO:0030425; GO:0030705; GO:1904115; GO:1990048; GO:1990049 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; RNA binding [GO:0003723] CGLPSSGKR 0.992 -18.839 0 0 0 0 0 0 0 0 0 0 15.6372 0 0 13.9052 0 0 0 0 0 0 12.717 0 0 0 13.4576 0 11.7455 0 0 0 14.0868 13.3998 15.4359 0 0 0 0 0 15.3099 0 0 15.0288 0 0 14.7123 13.5344 0 0 0 0 0 0 0 0 0 15.3919 0 0 15.6914 15.5029 0 0 0 14.8938 15.2651 0 0 14.1236 0 0 0 0 15.0234 0 13.6998 14.7733 15.1277 0 0 15.4877 0 0 0 0 0 0 0 0 0 0 0 0 13.0755 0 0 0 0 15.4621 0 0 0 0 0 0 0 19.4822 0 0 0 13.3599 13.5046 0 12.8904 0 16.7686 12.7371 14.034 0 13.3749 0 0 0 0 14.3527 16.4854 0 0 12.8357 0 16.6012 13.3455 0 15.063 14.9223 0 0 19.4063 13.2334 14.5637 0 13.8383 0 15.3805 15.1808 15.8055 0 15.9428 0 0 0 0 15.2679 0 14.4444 0 0 0 15.4906 0 0 13.4612 15.4132 0 0 15.4863 0 0 13.5838 0 0 14.2014 0 15.6048 16.5897 13.6829 15.0774 0 0 0 11.354 P08590 MYL3_HUMAN "Myosin light chain 3 (Cardiac myosin light chain 1, CMLC1) (Myosin light chain 1, slow-twitch muscle B/ventricular isoform, MLC1SB) (Ventricular myosin alkali light chain) (Ventricular myosin light chain 1, VLCl) (Ventricular/slow twitch myosin alkali light chain, MLC-lV/sb)" MYL3 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of striated muscle contraction [GO:0006942]; regulation of the force of heart contraction [GO:0002026]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] A band [GO:0031672]; cytosol [GO:0005829]; I band [GO:0031674]; muscle myosin complex [GO:0005859]; myosin II complex [GO:0016460]; sarcomere [GO:0030017] A band [GO:0031672]; cytosol [GO:0005829]; I band [GO:0031674]; muscle myosin complex [GO:0005859]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; actin monomer binding [GO:0003785]; calcium ion binding [GO:0005509]; myosin II heavy chain binding [GO:0032038]; structural constituent of muscle [GO:0008307]; cardiac muscle contraction [GO:0060048]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of striated muscle contraction [GO:0006942]; regulation of the force of heart contraction [GO:0002026]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0002026; GO:0003785; GO:0005509; GO:0005829; GO:0005859; GO:0006942; GO:0008307; GO:0016460; GO:0030017; GO:0031672; GO:0031674; GO:0032038; GO:0032781; GO:0055010; GO:0060048 actin monomer binding [GO:0003785]; calcium ion binding [GO:0005509]; myosin II heavy chain binding [GO:0032038]; structural constituent of muscle [GO:0008307] KDDAKAAPK 0.992 -6.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01581 HMCS1_HUMAN "Hydroxymethylglutaryl-CoA synthase, cytoplasmic, HMG-CoA synthase, EC 2.3.3.10 (3-hydroxy-3-methylglutaryl coenzyme A synthase)" HMGCS1 HMGCS Homo sapiens (Human) "acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803]; acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]" GO:0004421; GO:0005737; GO:0005829; GO:0006084; GO:0006629; GO:0006695; GO:0010142; GO:0042803 hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803] CYSVYCK 0.992 -7.6486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2691 14.1795 14.2029 15.2685 14.7901 14.7536 13.7592 12.797 13.6439 15.2036 14.1751 0 0 0 0 18.8084 0 0 10.7237 0 0 12.5721 11.7357 0 0 12.4713 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2536 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5059 0 11.1305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1141 14.4865 0 13.0204 12.9217 0 0 0 0 0 13.7313 0 0 0 0 0 0 0 0 0 0 0 0 Q8IU89 CERS3_HUMAN "Ceramide synthase 3, CerS3 (Dihydroceramide synthase 3) (LAG1 longevity assurance homolog 3) (Sphingosine N-acyltransferase CERS3, EC 2.3.1.24) (Ultra-long-chain ceramide synthase CERS3, EC 2.3.1.298) (Very-long-chain ceramide synthase CERS3, EC 2.3.1.297)" CERS3 LASS3 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; cornification [GO:0070268]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; cornification [GO:0070268]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; sphingolipid biosynthetic process [GO:0030148] GO:0003677; GO:0005783; GO:0005789; GO:0008544; GO:0016021; GO:0016410; GO:0030148; GO:0030216; GO:0046513; GO:0050291; GO:0070268 DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] EMDCLKNGLR 0.992 -6.0555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3031 0 0 0 0 0 14.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5089 0 0 15.9737 0 0 14.5391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9228 0 0 15.0261 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9115 0 0 11.5348 0 0 0 14.7413 0 15.5959 0 15.7024 0 15.4191 0 16.0232 0 0 15.3609 0 0 0 0 0 0 0 0 14.7622 10.3086 0 0 14.6223 0 0 0 0 14.8004 0 0 0 0 0 0 0 0 14.2726 0 0 13.157 15.0076 0 Q8TF62 AT8B4_HUMAN "Probable phospholipid-transporting ATPase IM, EC 7.6.2.1 (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4)" ATP8B4 KIAA1939 Homo sapiens (Human) Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; Golgi organization [GO:0007030]; phospholipid translocation [GO:0045332] GO:0000287; GO:0005524; GO:0005794; GO:0005802; GO:0005886; GO:0007030; GO:0016021; GO:0016887; GO:0035579; GO:0045332; GO:0070821; GO:0140326; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287] AQVVELVKK 0.992 -7.6536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8455 0 0 0 0 0 0 0 0 0 0 0 12.8093 0 12.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7352 0 13.4679 0 0 0 0 0 0 0 0 0 12.6224 0 0 0 0 0 0 13.0691 0 0 0 0 0 0 0 14.9554 0 0 0 0 0 0 0 0 0 11.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.972 0 0 0 Q92478 CLC2B_HUMAN C-type lectin domain family 2 member B (Activation-induced C-type lectin) (C-type lectin superfamily member 2) (IFN-alpha-2b-inducing-related protein 1) CLEC2B AICL CLECSF2 IFNRG1 Homo sapiens (Human) external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802] GO:0005886; GO:0005887; GO:0009897; GO:0030246; GO:0042802 carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802] CFIIVGVLITTNIITLIVKLTR 0.992 -7.6501 0 0 0 13.8314 0 13.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 12.864 0 0 11.6858 14.0011 0 0 0 0 0 0 0 0 0 10.9471 10.4486 0 0 0 0 0 0 12.5109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4709 0 0 0 0 0 0 0 0 10.9022 0 0 0 0 0 0 0 0 0 11.6176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0635 0 0 12.9819 0 0 0 0 12.3533 11.9587 0 0 11.1675 0 0 11.7584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0K0 BC11B_HUMAN "B-cell lymphoma/leukemia 11B, BCL-11B (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein, hRit1)" BCL11B CTIP2 RIT1 Homo sapiens (Human) alpha-beta T cell differentiation [GO:0046632]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of thymocyte apoptotic process [GO:0070244]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymocyte apoptotic process [GO:0070242]; thymus development [GO:0048538]; transcription by RNA polymerase II [GO:0006366] neuron projection [GO:0043005]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "neuron projection [GO:0043005]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; alpha-beta T cell differentiation [GO:0046632]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; epithelial cell morphogenesis [GO:0003382]; hematopoietic stem cell migration [GO:0035701]; keratinocyte development [GO:0003334]; lymphoid lineage cell migration into thymus [GO:0097535]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of thymocyte apoptotic process [GO:0070244]; odontogenesis of dentin-containing tooth [GO:0042475]; olfactory bulb axon guidance [GO:0071678]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive T cell selection [GO:0043368]; post-embryonic camera-type eye development [GO:0031077]; regulation of keratinocyte proliferation [GO:0010837]; regulation of lipid metabolic process [GO:0019216]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; striatal medium spiny neuron differentiation [GO:0021773]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; thymocyte apoptotic process [GO:0070242]; thymus development [GO:0048538]; transcription by RNA polymerase II [GO:0006366]" GO:0000978; GO:0001228; GO:0003334; GO:0003382; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0008285; GO:0010837; GO:0016514; GO:0019216; GO:0021773; GO:0021902; GO:0031077; GO:0033077; GO:0033153; GO:0035701; GO:0042475; GO:0043005; GO:0043368; GO:0045664; GO:0045944; GO:0046632; GO:0046872; GO:0048538; GO:0070242; GO:0070244; GO:0071678; GO:0097535; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CELCNYACAQSSK 0.992 -7.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRC8 SIR7_HUMAN "NAD-dependent protein deacetylase sirtuin-7, EC 2.3.1.286 (NAD-dependent protein deacylase sirtuin-7, EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7)" SIRT7 SIR2L7 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone glutamine methylation [GO:1990258]; histone H3 deacetylation [GO:0070932]; histone modification [GO:0016570]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transposition [GO:0010529]; osteoblast differentiation [GO:0001649]; peptidyl-lysine desuccinylation [GO:0036049]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop disassembly [GO:0062176]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of gluconeogenesis [GO:0006111]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-propionyllysine depropionylase activity [GO:0106231]; protein-succinyllysine desuccinylase activity [GO:0036055]; transcription corepressor activity [GO:0003714]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone glutamine methylation [GO:1990258]; histone H3 deacetylation [GO:0070932]; histone modification [GO:0016570]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transposition [GO:0010529]; osteoblast differentiation [GO:0001649]; peptidyl-lysine desuccinylation [GO:0036049]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in exit from mitosis [GO:0007072]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop disassembly [GO:0062176]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of gluconeogenesis [GO:0006111]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303] GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006111; GO:0006281; GO:0006282; GO:0006325; GO:0006476; GO:0006974; GO:0007072; GO:0007129; GO:0009303; GO:0010529; GO:0010821; GO:0016570; GO:0016607; GO:0019213; GO:0031397; GO:0034979; GO:0035861; GO:0036049; GO:0036055; GO:0045944; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0070932; GO:0097372; GO:0106230; GO:0106231; GO:1901836; GO:1990258; GO:2000234; GO:2001032 chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; histone deacetylase activity [GO:0004407]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity (H3-K18 specific) [GO:0097372]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-propionyllysine depropionylase activity [GO:0106231]; protein-succinyllysine desuccinylase activity [GO:0036055]; transcription corepressor activity [GO:0003714] ADTILCLGSSLKVLKK 0.992 -7.6479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTW7 ZF64B_HUMAN "Zinc finger protein 64, Zfp-64 (Zinc finger protein 338)" ZFP64 ZNF338 Homo sapiens (Human) mesenchymal cell differentiation [GO:0048762]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076]; nucleus [GO:0005634] cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mesenchymal cell differentiation [GO:0048762]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] GO:0003677; GO:0005634; GO:0005737; GO:0010468; GO:0043076; GO:0045944; GO:0046872; GO:0048762 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AFRCETCGASFVRDDSLR 0.992 -18.85 0 0 0 0 0 0 0 0 10.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3085 0 0 0 0 0 0 11.2067 0 10.3733 0 0 0 0 14.279 0 0 0 0 0 0 13.1821 0 0 0 0 13.7313 0 0 0 0 0 0 0 0 0 0 0 13.4531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0585 0 0 9.98485 0 0 0 0 0 0 0 0 0 0 Q9UDT6 CLIP2_HUMAN "CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115, CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein)" CLIP2 CYLN2 KIAA0291 WBSCR3 WBSCR4 WSCR4 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122] cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634] cytoplasm [GO:0005737]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122] GO:0005634; GO:0005737; GO:0005875; GO:0008017; GO:0031122; GO:0035371; GO:0051010 microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010] AQAERLLR 0.992 -22.739 0 0 0 0 0 0 0 0 0 11.0867 0 13.9037 0 0 12.5867 14.2784 0 14.1862 0 0 0 0 13.4556 0 14.5761 14.7244 14.7153 0 0 0 0 13.7023 13.4775 0 0 0 0 10.84 0 13.7646 12.8427 12.565 0 13.5936 13.8591 0 12.5756 0 0 0 0 0 0 0 9.6926 0 0 0 0 0 0 0 0 0 0 0 14.7461 14.4776 0 0 0 0 0 0 0 0 0 12.2796 0 0 0 0 0 0 0 0 0 0 0 0 13.2326 13.5906 0 0 0 0 0 0 14.9656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2279 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6176 0 0 0 0 0 0 0 12.9574 0 0 0 0 0 13.0815 12.8002 0 0 14.6428 0 0 0 0 14.547 0 0 0 0 0 15.4864 0 0 0 A6NMK8 INY2B_HUMAN Protein INSYN2B (Inhibitory synaptic factor family member 2B) INSYN2B C5orf57 FAM196B Homo sapiens (Human) IKVLLNVIQDLEK 0.99201 -18.516 0 0 0 0 0 0 0 0 0 11.7 0 0 16.1204 0 0 16.3777 16.0035 16.447 13.8858 13.5619 16.0716 0 14.9374 12.8198 16.2302 16.1033 14.6417 16.1017 16.0265 11.798 0 0 11.0851 0 11.412 0 0 0 15.9937 0 0 15.8778 15.8727 0 13.2672 0 16.1033 11.1494 15.8365 15.8598 15.8302 0 15.965 0 0 0 0 14.7327 14.9741 0 0 0 0 0 0 0 0 0 0 0 0 14.3556 15.4919 15.4465 0 0 0 0 13.5778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8701 0 14.5919 0 11.268 0 0 17.6002 0 0 0 0 0 17.0082 0 11.4538 17.0594 17.781 0 17.075 12.9506 0 0 0 0 0 0 12.5537 0 16.5311 12.7457 0 17.0411 0 0 16.9448 17.0799 0 10.3348 0 14.7036 0 17.859 17.0995 0 0 18.4771 0 17.6009 0 0 0 0 13.0246 0 12.8623 15.3413 0 0 0 0 0 13.8942 13.5366 13.4134 13.7493 0 0 0 0 13.3271 13.477 13.4927 0 17.5962 0 17.6314 0 17.624 0 O95847 UCP4_HUMAN "Mitochondrial uncoupling protein 4, UCP 4 (Solute carrier family 25 member 27)" SLC25A27 UCP4 UNQ772/PRO1566 Homo sapiens (Human) response to cold [GO:0009409] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; transmembrane transporter activity [GO:0022857]; response to cold [GO:0009409] GO:0005739; GO:0005743; GO:0009409; GO:0016021; GO:0022857; GO:0031966 transmembrane transporter activity [GO:0022857] LEGKPLR 0.99201 -7.3645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.867 14.4772 0 0 0 0 0 0 0 0 0 0 0 0 14.5881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2874 0 0 0 0 0 0 P17480 UBF1_HUMAN "Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1, UBF-1)" UBTF UBF UBF1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360]; transcription initiation from RNA polymerase I promoter [GO:0006361] GO:0001164; GO:0001165; GO:0001181; GO:0001650; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006360; GO:0006361; GO:0045943; GO:0097110 chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase I cis-regulatory region sequence-specific DNA binding [GO:0001165]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; scaffold protein binding [GO:0097110] AMEMTWNNMEK 0.99201 -24.511 0 0 0 0 10.9786 0 0 16.9639 12.2983 0 13.0527 0 0 12.3996 12.5875 13.4857 12.6958 12.8928 12.1556 12.7502 0 0 0 0 0 11.8789 0 0 13.7039 13.0581 0 0 0 12.6001 13.7924 0 0 0 0 0 12.8555 0 13.8647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2464 0 0 0 13.9493 0 11.2551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0753 0 0 0 0 0 0 0 0 10.4525 0 0 0 0 14.8051 14.2967 10.8342 0 0 0 0 0 0 0 0 0 0 0 12.6473 0 0 0 0 13.3844 0 0 0 0 11.6405 0 0 0 0 0 0 0 0 0 0 0 16.2821 0 0 0 0 0 0 0 0 13.9313 8.71973 13.5867 14.5413 0 0 0 13.1963 14.4526 14.3777 0 13.3654 0 13.7371 14.0307 0 0 0 0 13.2569 0 14.6408 0 0 P48788 TNNI2_HUMAN "Troponin I, fast skeletal muscle (Troponin I, fast-twitch isoform)" TNNI2 Homo sapiens (Human) "cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]" cytosol [GO:0005829]; nucleus [GO:0005634]; troponin complex [GO:0005861] "cytosol [GO:0005829]; nucleus [GO:0005634]; troponin complex [GO:0005861]; actin binding [GO:0003779]; troponin T binding [GO:0031014]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of muscle contraction [GO:0006937]; skeletal muscle contraction [GO:0003009]" GO:0003009; GO:0003779; GO:0005634; GO:0005829; GO:0005861; GO:0006936; GO:0006937; GO:0031014; GO:0045893; GO:0060048 actin binding [GO:0003779]; troponin T binding [GO:0031014] AITARRQHLK 0.99201 -18.519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0002 0 13.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55160 NCKPL_HUMAN Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1) NCKAP1L HEM1 Homo sapiens (Human) "actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of TORC2 signaling [GO:1904515]; protein-containing complex assembly [GO:0065003]; response to xenobiotic stimulus [GO:0009410]; T cell homeostasis [GO:0043029]" cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SCAR complex [GO:0031209]; secretory granule membrane [GO:0030667]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841]; actin polymerization-dependent cell motility [GO:0070358]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; cortical actin cytoskeleton organization [GO:0030866]; erythrocyte development [GO:0048821]; erythrocyte homeostasis [GO:0034101]; maintenance of cell polarity [GO:0030011]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphorylation [GO:0042327]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of TORC2 signaling [GO:1904515]; protein-containing complex assembly [GO:0065003]; response to xenobiotic stimulus [GO:0009410]; T cell homeostasis [GO:0043029]" GO:0000902; GO:0001782; GO:0002262; GO:0002687; GO:0005096; GO:0005829; GO:0005886; GO:0005887; GO:0006935; GO:0009410; GO:0016020; GO:0016477; GO:0030011; GO:0030031; GO:0030295; GO:0030593; GO:0030667; GO:0030838; GO:0030866; GO:0030890; GO:0031209; GO:0032700; GO:0032715; GO:0033630; GO:0034101; GO:0035509; GO:0042102; GO:0042327; GO:0043029; GO:0043066; GO:0043318; GO:0043372; GO:0043378; GO:0044877; GO:0045579; GO:0045588; GO:0045621; GO:0045648; GO:0048812; GO:0048821; GO:0050853; GO:0060100; GO:0065003; GO:0070062; GO:0070358; GO:0090023; GO:0101003; GO:1902624; GO:1904515; GO:1904841 GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; protein-containing complex binding [GO:0044877]; TORC2 complex binding [GO:1904841] AVSGALLSLHFLFVRR 0.99201 -18.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9458 0 0 12.346 0 0 0 0 0 0 13.0669 14.3852 0 0 0 0 0 0 0 0 12.2135 12.6917 0 0 0 0 12.9102 0 0 0 0 0 0 0 0 0 14.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1031 13.2839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4788 0 0 Q08AD1 CAMP2_HUMAN Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1) CAMSAP2 CAMSAP1L1 KIAA1078 Homo sapiens (Human) axon development [GO:0061564]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of dendrite development [GO:0050773]; regulation of Golgi organization [GO:1903358]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule end [GO:1990752] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule end [GO:1990752]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; axon development [GO:0061564]; cytoplasmic microtubule organization [GO:0031122]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of dendrite development [GO:0050773]; regulation of Golgi organization [GO:1903358]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043] GO:0000226; GO:0005516; GO:0005794; GO:0005829; GO:0007026; GO:0030507; GO:0031113; GO:0031122; GO:0033043; GO:0036064; GO:0050773; GO:0051011; GO:0061564; GO:1903358; GO:1990752 calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507] AALLEKRLR 0.99201 -24.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3626 0 12.3356 0 0 12.8193 9.90486 0 0 0 13.3593 0 0 12.6628 0 0 11.3235 0 12.9003 0 13.1332 0 11.9362 13.0681 12.9072 12.8454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.58 0 13.3106 0 0 14.5275 14.7247 0 0 0 13.0945 0 0 0 15.5723 0 14.4988 0 14.0812 12.9177 12.4225 0 13.2355 14.0052 0 0 0 0 0 13.6773 0 15.4855 0 0 0 0 0 15.6588 13.7788 0 14.8814 14.838 0 0 0 0 12.5981 13.9155 12.5528 13.3143 0 0 0 0 13.7849 0 13.1536 0 0 12.9234 15.7241 14.8325 0 12.5746 0 14.6669 14.8549 0 12.9031 15.5098 13.7933 0 12.4672 0 14.547 14.5883 0 14.5621 0 0 0 0 13.5949 0 15.1429 14.7807 14.5184 0 15.05 0 0 12.6214 0 0 0 0 12.8652 13.3187 0 12.3249 13.6413 0 0 15.586 14.3777 0 12.6416 0 0 0 0 Q14031 CO4A6_HUMAN Collagen alpha-6(IV) chain COL4A6 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198] collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198] GO:0005201; GO:0005576; GO:0005587; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030198; GO:0031012; GO:0038063; GO:0062023; GO:0071230 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] ATPFIECSGAR 0.99201 -6.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9008 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2811 0 0 0 0 0 0 11.7307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9177 0 0 0 11.2567 0 0 0 0 0 0 0 0 12.7124 0 14.3961 14.3329 0 14.7402 14.6722 0 0 15.2906 14.2212 15.0207 14.5495 0 14.8278 0 0 0 0 0 0 14.7225 0 0 0 0 0 0 0 13.3218 0 13.3987 0 0 0 0 0 0 0 0 0 0 0 0 12.2197 0 0 0 0 0 0 11.8125 0 0 10.8488 0 12.049 0 0 0 0 0 0 12.594 0 0 0 0 0 11.8162 0 0 0 12.2973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PIL6 KCIP4_HUMAN "Kv channel-interacting protein 4, KChIP4 (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4)" KCNIP4 CALP KCHIP4 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379] GO:0005244; GO:0005267; GO:0005509; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0008076; GO:0015459; GO:0030425; GO:0043025; GO:0072659; GO:1901379 calcium ion binding [GO:0005509]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; voltage-gated ion channel activity [GO:0005244] CTYPVLK 0.99201 -6.7349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.059 0 16.1699 0 0 14.8151 0 0 0 0 0 0 15.6507 0 0 0 0 0 0 0 0 0 0 10.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9684 0 0 0 0 0 0 0 0 0 0 0 0 0 13.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHJ3 SMBT1_HUMAN "Scm-like with four MBT domains protein 1, hSFMBT (Renal ubiquitous protein 1)" SFMBT1 RU1 Homo sapiens (Human) "cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription, DNA-templated [GO:0045892]; spermatogenesis [GO:0007283]" GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635 chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714] KNVFVHK 0.99201 -24.518 0 0 0 0 0 0 0 0 0 0 12.6154 0 0 12.4431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9563 0 0 0 11.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1878 0 0 0 0 0 14.4724 13.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4752 0 0 0 0 0 0 0 0 0 0 12.2954 0 0 0 0 0 0 0 0 0 0 0 13.3648 0 0 0 0 0 0 0 0 0 0 0 13.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15170 ERF3A_HUMAN "Eukaryotic peptide chain release factor GTP-binding subunit ERF3A, Eukaryotic peptide chain release factor subunit 3a, eRF3a (G1 to S phase transition protein 1 homolog)" GSPT1 ERF3A Homo sapiens (Human) "G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747]; G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]" GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747] AYFETEKK 0.99202 -24.553 0 0 0 0 11.3381 0 0 0 14.9497 15.2865 0 0 16.3874 0 13.9583 0 0 0 0 0 0 0 0 0 0 0 11.4918 0 0 0 0 0 0 0 0 0 12.634 12.9912 0 0 0 0 0 0 0 13.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2562 0 0 0 13.55 0 13.832 13.8692 14.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2733 0 0 0 12.5289 0 0 0 13.2744 0 0 13.9133 13.3035 0 0 0 0 12.6232 0 0 0 0 0 0 0 0 12.8403 0 0 0 0 0 0 0 0 0 0 12.8573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6873 0 0 0 0 0 0 13.1433 0 0 0 12.5513 0 0 0 0 0 P21127 CD11B_HUMAN "Cyclin-dependent kinase 11B, EC 2.7.11.22 (Cell division cycle 2-like protein kinase 1, CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1)" CDK11B CDC2L1 CDK11 PITSLREA PK58 Homo sapiens (Human) "apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of mitotic cell cycle [GO:0007346]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of mitotic cell cycle [GO:0007346]; regulation of mRNA processing [GO:0050684]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000278; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0007346; GO:0042981; GO:0046605; GO:0050684; GO:0051726; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] EEKMEERDLLSDLQDISDSER 0.99202 -18.569 0 0 0 0 0 0 0 0 0 0 12.4514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0612 0 0 0 17.8066 0 0 0 0 0 17.0114 0 0 0 0 0 0 0 0 0 15.5648 15.306 0 0 0 0 0 0 0 0 0 0 11.6887 0 0 0 0 13.2645 0 16.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7056 0 12.4032 13.2685 0 0 0 10.9045 0 0 0 0 12.9622 0 0 0 0 16.4187 0 0 0 0 0 0 0 0 0 0 0 0 11.7465 11.9386 0 0 0 0 0 0 0 0 0 0 12.7533 0 P38570 ITAE_HUMAN Integrin alpha-E (HML-1 antigen) (Integrin alpha-IEL) (Mucosal lymphocyte 1 antigen) (CD antigen CD103) [Cleaved into: Integrin alpha-E light chain; Integrin alpha-E heavy chain ] ITGAE Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] GO:0005178; GO:0005886; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0033627; GO:0046872; GO:0098609 integrin binding [GO:0005178]; metal ion binding [GO:0046872] DEKYHSLPIIIKGSVGGLLVLIVILVILFK 0.99202 -7.5767 0 0 0 0 0 0 0 11.2595 0 0 0 10.8679 0 0 0 0 0 0 0 0 0 0 0 11.1848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6835 13.7584 13.341 13.3264 13.344 13.0129 12.4041 13.9223 0 0 12.5077 0 13.6196 13.4964 0 0 0 13.578 0 10.0876 0 0 0 0 0 10.5157 0 0 0 0 0 0 16.3963 12.509 0 13.3608 0 14.9024 0 13.371 14.1437 0 13.9935 0 0 14.8687 0 0 0 13.4042 0 0 0 0 0 13.4488 12.276 0 0 10.9383 0 0 15.4043 0 0 0 0 0 11.1529 12.4989 14.434 0 0 0 0 0 0 0 11.4534 0 0 11.5285 0 11.4093 12.8908 13.7522 0 0 0 12.3231 0 13.2246 0 0 13.2956 0 11.8962 10.9302 13.2915 12.5637 0 0 0 0 0 0 0 0 13.8467 0 0 0 0 0 0 14.458 0 0 0 0 0 13.3813 0 14.3578 0 0 0 13.5672 12.297 0 Q13231 CHIT1_HUMAN "Chitotriosidase-1, EC 3.2.1.14 (Chitinase-1)" CHIT1 Homo sapiens (Human) chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617]" GO:0000272; GO:0004553; GO:0004568; GO:0005576; GO:0005615; GO:0005764; GO:0006032; GO:0006955; GO:0008061; GO:0008843; GO:0009617; GO:0035580; GO:0044245; GO:1904724 "chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" DNQWVGFDDVESFKTKVSYLK 0.99202 -7.5615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3307 0 0 0 0 0 0 0 13.9921 0 0 0 0 0 13.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.297 0 0 0 0 0 0 0 0 14.6965 0 0 0 0 14.4126 0 0 0 0 0 0 0 0 0 13.2722 0 0 0 0 0 13.9589 0 11.8065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4869 0 0 0 0 Q86XK3 SFR1_HUMAN Swi5-dependent recombination DNA repair protein 1 homolog (Meiosis protein 5 homolog) SFR1 C10orf78 MEI5 MEIR5 Homo sapiens (Human) "cellular response to estrogen stimulus [GO:0071391]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of transcription, DNA-templated [GO:0045893]" nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798] "nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798]; nuclear receptor coactivator activity [GO:0030374]; cellular response to estrogen stimulus [GO:0071391]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000724; GO:0005634; GO:0030374; GO:0032798; GO:0045893; GO:0071391 nuclear receptor coactivator activity [GO:0030374] LVKMYRSK 0.99202 -7.1823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92523 CPT1B_HUMAN "Carnitine O-palmitoyltransferase 1, muscle isoform, CPT1-M, EC 2.3.1.21 (Carnitine O-palmitoyltransferase I, muscle isoform, CPT I, CPTI-M) (Carnitine palmitoyltransferase 1B) (Carnitine palmitoyltransferase I-like protein)" CPT1B KIAA1670 Homo sapiens (Human) carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; response to blue light [GO:0009637] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid transport [GO:0015909]; response to blue light [GO:0009637] GO:0004095; GO:0005739; GO:0005741; GO:0006631; GO:0006635; GO:0006853; GO:0009437; GO:0009637; GO:0015909; GO:0016021 carnitine O-palmitoyltransferase activity [GO:0004095] FCLTYEASMTRMFR 0.99202 -24.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4965 0 0 14.5416 0 0 0 0 0 0 0 0 0 0 0 12.6032 13.7465 0 0 0 16.6718 0 17.1449 0 0 12.612 0 13.2232 15.8802 0 0 0 0 0 15.8011 0 14.9312 0 0 0 0 0 0 0 0 0 14.8121 14.3647 0 0 0 0 0 0 0 0 14.9939 0 13.8085 12.9054 0 0 0 0 17.9932 0 0 14.1212 0 14.2691 0 0 10.7061 13.7001 0 0 0 13.2441 0 0 13.6776 0 13.2311 0 0 0 0 0 11.5007 13.3068 0 0 0 0 0 0 0 0 0 0 0 13.791 0 0 0 0 0 Q9H2E6 SEM6A_HUMAN "Semaphorin-6A (Semaphorin VIA, Sema VIA) (Semaphorin-6A-1, SEMA6A-1)" SEMA6A KIAA1368 SEMAQ Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526] axon [GO:0030424]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] axon [GO:0030424]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytoskeleton organization [GO:0007010]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion involved in sprouting angiogenesis [GO:0106089]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron migration [GO:2001224]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005887; GO:0006915; GO:0007010; GO:0007166; GO:0007399; GO:0007411; GO:0009887; GO:0016021; GO:0016525; GO:0030215; GO:0030335; GO:0030424; GO:0035924; GO:0045499; GO:0048843; GO:0050919; GO:0070373; GO:0071526; GO:0106089; GO:1900747; GO:1903671; GO:2001224 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] CSYDGVEDK 0.99202 -24.63 0 0 0 0 0 0 0 0 0 0 0 0 11.531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4499 0 0 0 0 10.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1336 0 0 0 0 0 0 0 0 0 0 0 0 13.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0225 0 0 0 0 0 0 0 0 0 0 0 0 14.4793 0 0 0 0 0 11.9489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4325 0 14.888 0 0 0 0 0 Q9NVP1 DDX18_HUMAN "ATP-dependent RNA helicase DDX18, EC 3.6.4.13 (DEAD box protein 18) (Myc-regulated DEAD box protein, MrDb)" DDX18 cPERP-D Homo sapiens (Human) "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730] "chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]" GO:0000463; GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0016020; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AKTENKGK 0.99202 -24.556 11.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.537 0 0 0 0 0 0 10.7856 0 0 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8042 0 0 0 0 0 0 0 12.805 0 0 12.4866 0 10.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66889 0 0 0 0 0 0 0 0 14.1114 0 0 0 0 0 0 14.8208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0262 0 0 0 0 12.4954 0 0 0 0 0 0 12.0386 0 0 0 11.4955 0 0 11.4201 0 0 0 0 0 0 0 9.55198 0 0 0 Q9UKW4 VAV3_HUMAN "Guanine nucleotide exchange factor VAV3, VAV-3" VAV3 Homo sapiens (Human) angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906] cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to xenobiotic stimulus [GO:0009410]; small GTPase mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906] GO:0001525; GO:0001772; GO:0005085; GO:0005096; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0006906; GO:0006974; GO:0007229; GO:0007264; GO:0008361; GO:0009410; GO:0016477; GO:0030032; GO:0030168; GO:0030593; GO:0030890; GO:0038095; GO:0038096; GO:0043087; GO:0043552; GO:0045785; GO:0046872; GO:0050853; GO:0051056 epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872] AGNSLLSPK 0.99202 -18.574 0 11.6405 0 0 0 0 0 0 0 0 12.4352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2976 0 11.8726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3922 11.086 12.7682 0 11.9376 13.2835 0 0 0 13.8775 0 12.4409 13.4689 0 0 0 12.2283 14.0986 14.0641 0 0 0 12.2729 0 0 0 0 0 0 0 13.65 0 0 0 12.5539 0 12.8221 12.7289 13.6208 12.6271 0 0 0 0 0 12.6027 11.9927 0 14.0684 0 0 0 0 0 0 0 0 0 12.6443 0 0 12.7547 0 0 0 11.5243 0 13.0511 0 0 0 0 0 14.4137 12.2563 0 0 0 0 0 0 0 0 0 13.0066 0 0 13.474 0 0 0 11.564 11.8621 0 12.394 0 0 0 0 0 11.4167 0 11.9294 0 0 P02549 SPTA1_HUMAN "Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)" SPTA1 SPTA Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; actin filament organization [GO:0007015]; hemopoiesis [GO:0030097]; lymphocyte homeostasis [GO:0002260]; plasma membrane organization [GO:0007009]; porphyrin-containing compound biosynthetic process [GO:0006779]; positive regulation of protein binding [GO:0032092]; positive regulation of T cell proliferation [GO:0042102]; regulation of cell shape [GO:0008360] GO:0002260; GO:0005200; GO:0005509; GO:0005829; GO:0005886; GO:0006779; GO:0007009; GO:0007015; GO:0008091; GO:0008360; GO:0014731; GO:0015629; GO:0030036; GO:0030054; GO:0030097; GO:0030424; GO:0030864; GO:0031235; GO:0032092; GO:0032437; GO:0042102; GO:0042995; GO:0051015; GO:0051693 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200] AIEERYAALLKR 0.99203 -23.997 0 0 11.0803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2525 0 0 0 0 12.543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.922 0 0 0 11.4417 0 0 0 13.1633 0 13.2976 13.2037 0 0 13.9776 12.3157 0 0 0 12.0603 0 13.4875 0 0 0 0 0 0 0 0 0 0 0 11.644 0 0 0 12.7363 0 0 10.3882 0 0 0 0 0 0 0 0 14.4031 0 11.5265 0 0 0 0 0 0 14.9568 19.1463 12.6497 14.4416 12.0783 13.2881 0 0 14.1657 0 15.1581 14.4531 0 13.7596 0 14.2922 15.1485 0 15.2212 13.9194 15.8773 0 0 0 0 0 13.086 0 0 0 0 12.7251 0 0 0 12.9373 0 13.7837 0 0 10.9994 0 0 0 0 0 0 0 12.1399 0 0 0 0 0 0 12.8493 P21333 FLNA_HUMAN "Filamin-A, FLN-A (Actin-binding protein 280, ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin)" FLNA FLN FLN1 Homo sapiens (Human) "actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]" actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018] "actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of axon regeneration [GO:0048680]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]" GO:0001525; GO:0001664; GO:0001837; GO:0001974; GO:0003007; GO:0003723; GO:0005080; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005925; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0030018; GO:0030334; GO:0031267; GO:0031523; GO:0031532; GO:0032231; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0044325; GO:0045022; GO:0045184; GO:0045216; GO:0045296; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051220; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0140297; GO:1900026; GO:1901381; GO:1905000; GO:1905031; GO:1990779; GO:2001046 actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] GDGSCDVR 0.99203 -17.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.601 0 0 0 0 11.4366 10.3741 0 0 0 0 0 0 0 0 0 13.0145 0 0 0 12.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0889 0 0 12.033 0 11.6493 0 0 11.7853 0 0 0 0 0 12.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4145 0 0 12.3032 0 0 12.0656 12.4265 13.141 0 0 0 0 0 0 0 0 0 0 13.1935 0 0 0 0 0 0 0 0 0 0 11.9693 0 0 0 0 0 0 12.425 11.7729 12.7008 0 0 0 0 0 0 0 0 11.5787 11.9785 0 0 0 0 0 12.7273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52945 PDX1_HUMAN "Pancreas/duodenum homeobox protein 1, PDX-1 (Glucose-sensitive factor, GSF) (Insulin promoter factor 1, IPF-1) (Insulin upstream factor 1, IUF-1) (Islet/duodenum homeobox-1, IDX-1) (Somatostatin-transactivating factor 1, STF-1)" PDX1 IPF1 STF1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; central nervous system development [GO:0007417]; detection of glucose [GO:0051594]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver development [GO:0001889]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell death [GO:0010942]; positive regulation of DNA binding [GO:0043388]; positive regulation of insulin secretion [GO:0032024]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; response to chlorate [GO:0010157]; response to cytokine [GO:0034097]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to iron(II) ion [GO:0010040]; response to leucine [GO:0043201]; response to nicotine [GO:0035094]; response to vitamin [GO:0033273]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transdifferentiation [GO:0060290]; type B pancreatic cell apoptotic process [GO:0097050]; type B pancreatic cell differentiation [GO:0003309]; type B pancreatic cell proliferation [GO:0044342] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; central nervous system development [GO:0007417]; detection of glucose [GO:0051594]; digestive tract development [GO:0048565]; exocrine pancreas development [GO:0031017]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin secretion [GO:0030073]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver development [GO:0001889]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of cell death [GO:0010942]; positive regulation of DNA binding [GO:0043388]; positive regulation of insulin secretion [GO:0032024]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; response to chlorate [GO:0010157]; response to cytokine [GO:0034097]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to iron(II) ion [GO:0010040]; response to leucine [GO:0043201]; response to nicotine [GO:0035094]; response to vitamin [GO:0033273]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transdifferentiation [GO:0060290]; type B pancreatic cell apoptotic process [GO:0097050]; type B pancreatic cell differentiation [GO:0003309]; type B pancreatic cell proliferation [GO:0044342]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001889; GO:0003309; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006006; GO:0006091; GO:0006357; GO:0006366; GO:0007224; GO:0007263; GO:0007417; GO:0009410; GO:0009611; GO:0009887; GO:0010040; GO:0010157; GO:0010942; GO:0016331; GO:0016607; GO:0030073; GO:0031017; GO:0031100; GO:0032024; GO:0033273; GO:0034097; GO:0035094; GO:0035774; GO:0042593; GO:0043201; GO:0043279; GO:0043388; GO:0044342; GO:0044877; GO:0045944; GO:0048565; GO:0048863; GO:0050680; GO:0051384; GO:0051594; GO:0060290; GO:0070059; GO:0070542; GO:0097050; GO:1902236; GO:1904692; GO:1990837; GO:1990841; GO:2000675 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AQLLELEK 0.99203 -4.7461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4001 14.2386 0 13.0237 0 0 0 0 0 0 0 0 0 12.1571 0 0 0 0 0 0 0 0 0 0 0 0 13.6779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02218 ODO1_HUMAN "2-oxoglutarate dehydrogenase complex component E1, E1o, OGDC-E1, OGDH-E1, EC 1.2.4.2 (2-oxoglutarate dehydrogenase, mitochondrial) (Alpha-ketoglutarate dehydrogenase, Alpha-KGDH-E1) (Thiamine diphosphate (ThDP)-dependent 2-oxoglutarate dehydrogenase)" OGDH Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252] mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; cerebellar cortex development [GO:0021695]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; hippocampus development [GO:0021766]; histone succinylation [GO:0106077]; NADH metabolic process [GO:0006734]; olfactory bulb mitral cell layer development [GO:0061034]; pyramidal neuron development [GO:0021860]; striatum development [GO:0021756]; succinyl-CoA metabolic process [GO:0006104]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thalamus development [GO:0021794]; tricarboxylic acid cycle [GO:0006099] GO:0004591; GO:0005634; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0006099; GO:0006103; GO:0006104; GO:0006734; GO:0021695; GO:0021756; GO:0021766; GO:0021794; GO:0021860; GO:0022028; GO:0030976; GO:0031072; GO:0031966; GO:0034602; GO:0045252; GO:0046872; GO:0051087; GO:0061034; GO:0106077 chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (NAD+) activity [GO:0034602]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976] DVVVDLVCYR 0.99203 -24.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2028 0 0 0 0 0 0 13.3455 0 13.069 0 0 0 0 13.5613 14.4827 0 0 0 0 0 0 0 0 0 0 13.288 0 0 13.0907 0 0 0 0 12.5887 0 0 0 0 0 0 11.0639 0 0 0 0 12.206 0 0 0 0 0 0 0 0 0 0 0 0 13.2881 0 0 0 0 0 0 0 0 12.492 0 0 0 0 0 0 0 0 0 0 13.0799 0 0 0 0 12.9141 0 0 0 0 0 12.9499 0 Q5VTH2 FLTOP_HUMAN Protein Flattop (Cilia- and flagella-associated protein 126) CFAP126 C1orf192 FLTP Homo sapiens (Human) cilium organization [GO:0044782] apical plasma membrane [GO:0016324]; axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929] apical plasma membrane [GO:0016324]; axonemal microtubule [GO:0005879]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cilium organization [GO:0044782] GO:0005879; GO:0005929; GO:0016324; GO:0036064; GO:0044782 ESISSHEGYTQIIANDR 0.99203 -7.7094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGT0 O13C9_HUMAN Olfactory receptor 13C9 (Olfactory receptor OR9-13) OR13C9 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005654; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EAVKHLPNR 0.99203 -4.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTV1 THAP3_HUMAN THAP domain-containing protein 3 THAP3 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003677; GO:0045944; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] GHQGLQAR 0.99203 -4.7454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5675 0 0 0 0 0 0 0 0 0 11.8581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2L1 RRP44_HUMAN "Exosome complex exonuclease RRP44, EC 3.1.13.-, EC 3.1.26.- (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44)" DIS3 KIAA1008 RRP44 Homo sapiens (Human) CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364] GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0043928; GO:0071034 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] ESRRHLFTPADK 0.99203 -23.976 0 0 0 0 0 0 12.697 0 0 0 0 12.7373 0 0 12.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2495 0 0 0 0 0 0 0 0 0 12.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.787 14.0196 0 0 11.1897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.27 11.7304 0 13.6959 0 0 0 0 13.341 0 0 0 0 0 0 0 14.2782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9398 0 0 12.6715 0 0 0 0 0 12.8022 0 0 0 13.0851 0 0 0 0 0 0 0 0 0 0 0 0 12.6325 0 0 0 0 0 0 0 0 0 0 0 12.5167 0 0 0 0 0 0 0 0 0 11.9937 Q9UIF9 BAZ2A_HUMAN "Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5, TTF-I-interacting protein 5, Tip5) (hWALp3)" BAZ2A KIAA0314 TIP5 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; rDNA heterochromatin [GO:0033553] "chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; rDNA heterochromatin [GO:0033553]; DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" GO:0000183; GO:0001188; GO:0003677; GO:0003723; GO:0005677; GO:0005730; GO:0005829; GO:0006306; GO:0006338; GO:0006351; GO:0006355; GO:0016575; GO:0016607; GO:0016922; GO:0033553; GO:0042393; GO:0046872; GO:0070577 DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723] ALHKHLNK 0.99204 -47.546 0 0 0 0 0 13.595 13.992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3565 0 13.9632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.864 0 0 0 0 0 0 0 0 0 0 13.0502 13.4726 13.0856 13.0854 12.7996 12.4163 0 0 11.8357 0 12.3512 15.2378 15.4763 0 12.0572 0 0 0 0 15.8145 14.3892 15.7198 15.5105 15.7786 14.5077 15.1163 13.7662 15.4163 16.714 16.7889 17.8862 14.5843 16.4513 16.5734 16.194 14.8254 17.3039 17.6411 0 16.9994 13.6681 0 13.3715 16.1993 15.1097 14.3442 15.2376 0 0 14.3249 14.6587 14.6282 13.4115 14.5616 17.4028 15.197 0 14.9725 0 11.6429 13.7467 15.8928 14.8849 0 15.3525 13.8523 14.8732 14.84 16.3829 15.6024 14.4817 14.6005 14.5403 0 14.4932 14.3778 15.5542 14.1625 15.5871 15.5228 0 14.9923 0 15.7926 15.8362 0 14.9424 14.9766 13.4108 13.4426 16.1601 14.1611 0 16.0331 0 14.4318 0 0 14.7871 15.0917 16.7767 13.6426 12.9206 0 0 0 12.7237 0 12.3852 12.2478 0 17.2285 0 0 0 0 0 0 15.1544 0 14.6562 0 0 0 0 O43715 TRIA1_HUMAN "TP53-regulated inhibitor of apoptosis 1 (Protein 15E1.1) (WF-1) (p53-inducible cell-survival factor, p53CSV)" TRIAP1 15E1.1 HSPC132 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intermembrane lipid transfer [GO:0120009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of membrane lipid distribution [GO:0097035]" mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; p53 binding [GO:0002039]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intermembrane lipid transfer [GO:0120009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of membrane lipid distribution [GO:0097035]" GO:0002039; GO:0005634; GO:0005654; GO:0005739; GO:0005758; GO:0006915; GO:0006977; GO:0015914; GO:0030330; GO:0032991; GO:0034644; GO:0043066; GO:0043154; GO:0045332; GO:0045944; GO:0090201; GO:0097035; GO:0120009; GO:1902166; GO:2001140 p53 binding [GO:0002039] EYDQCFNR 0.99204 -18.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3137 0 0 0 10.7318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95373 IPO7_HUMAN "Importin-7, Imp7 (Ran-binding protein 7, RanBP7)" IPO7 RANBP7 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; protein import into nucleus [GO:0006606] GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0016020; GO:0030695; GO:0031267; GO:0042393; GO:0045087; GO:0045736; GO:0046332 GTPase regulator activity [GO:0030695]; histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267] AFAVGVQQVLLKVLYQYK 0.99204 -7.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3469 0 0 0 0 0 11.4086 0 0 0 0 0 0 0 0 0 0 0 0 11.7407 0 0 0 12.6254 0 12.7847 0 0 0 0 0 0 0 0 13.6786 0 0 0 0 13.0534 0 0 0 0 0 12.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95398 RPGF3_HUMAN "Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1, EPAC 1) (Rap1 guanine-nucleotide-exchange factor directly activated by cAMP) (cAMP-regulated guanine nucleotide exchange factor I, cAMP-GEFI)" RAPGEF3 CGEF1 EPAC EPAC1 Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; associative learning [GO:0008306]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of syncytium formation by plasma membrane fusion [GO:0034242]; positive regulation of angiogenesis [GO:0045766]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton reorganization [GO:2000249]; signal transduction [GO:0007165] endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; associative learning [GO:0008306]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of syncytium formation by plasma membrane fusion [GO:0034242]; positive regulation of angiogenesis [GO:0045766]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton reorganization [GO:2000249]; signal transduction [GO:0007165] GO:0001525; GO:0002250; GO:0005085; GO:0005886; GO:0005902; GO:0007165; GO:0007265; GO:0008306; GO:0012505; GO:0016020; GO:0019904; GO:0019933; GO:0030027; GO:0030175; GO:0030552; GO:0032486; GO:0033138; GO:0034242; GO:0043547; GO:0045766; GO:0046827; GO:0051496; GO:0060143; GO:0061028; GO:0070062; GO:0071320; GO:1901985; GO:2000249 cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904] AATIILR 0.99204 -47.66 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7506 11.5038 0 0 0 0 0 0 0 0 0 0 0 0 11.9472 0 0 0 12.7604 0 0 0 0 0 0 10.1549 0 0 0 11.0625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6673 0 0 0 0 0 0 12.1278 0 0 12.1379 0 0 0 0 0 0 0 11.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2997 13.4844 0 11.0539 0 0 0 14.1912 0 0 0 12.2094 0 0 12.7819 0 0 0 0 13.0383 11.8544 15.3119 0 0 0 14.5402 0 0 12.4513 0 0 0 11.0274 14.2291 0 0 0 0 P06737 PYGL_HUMAN "Glycogen phosphorylase, liver form, EC 2.4.1.1" PYGL Homo sapiens (Human) 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; response to bacterium [GO:0009617] GO:0002060; GO:0005524; GO:0005536; GO:0005576; GO:0005737; GO:0005829; GO:0005977; GO:0005980; GO:0006015; GO:0008184; GO:0009617; GO:0016208; GO:0019842; GO:0030170; GO:0032052; GO:0034774; GO:0042593; GO:0042802; GO:0070062; GO:0070266; GO:0102250; GO:0102499; GO:1904813 AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842] DYYFALAHTVR 0.99204 -7.4277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2554 0 0 0 11.138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3836 0 13.5201 0 0 0 0 0 0 0 12.1999 14.9892 0 0 0 0 0 14.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4897 0 0 12.5305 0 0 0 0 11.9283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.278 0 0 0 0 0 15.3892 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4769 0 0 0 0 0 0 P39880 CUX1_HUMAN "Homeobox protein cut-like 1 (CCAAT displacement protein, CDP) (CDP/Cux p200) (Homeobox protein cux-1) [Cleaved into: CDP/Cux p110 ]" CUX1 CUTL1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006357; GO:0043565; GO:0050775; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" DNPLRKK 0.99204 -18.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4485 0 0 0 0 0 0 0 0 0 0 0 0 11.676 0 0 12.9505 0 13.9989 0 0 0 11.8522 12.3867 0 15.1605 15.4432 13.5183 13.4061 13.7708 13.4707 13.6831 12.6685 14.2742 0 0 14.9576 0 17.8789 0 0 0 0 0 0 0 11.7675 13.8321 0 0 13.8412 13.0595 14.8124 14.2366 0 13.8588 14.6633 0 0 0 0 0 13.2972 12.1342 0 12.4264 0 0 0 0 0 12.0116 0 11.9299 0 0 13.0166 0 13.3549 0 12.3445 0 0 0 0 0 0 0 13.1243 0 0 11.7012 0 0 0 0 0 11.6566 0 10.7114 0 0 0 0 0 0 0 0 0 0 12.5094 11.0696 0 0 0 12.7725 0 0 P59044 NLRP6_HUMAN "NACHT, LRR and PYD domains-containing protein 6 (Angiotensin II/vasopressin receptor) (PYRIN-containing APAF1-like protein 5)" NLRP6 NALP6 PYPAF5 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; acute inflammatory response [GO:0002526]; acute inflammatory response to antigenic stimulus [GO:0002438]; antiviral innate immune response [GO:0140374]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; necroptotic process [GO:0070266]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; NLRP6 inflammasome complex assembly [GO:0140739]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-18-mediated signaling pathway [GO:2000494]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of mucus secretion [GO:0070255]; response to bacterium [GO:0009617]; wound healing [GO:0042060] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP6 inflammasome complex [GO:0140738]; non-membrane-bounded organelle [GO:0043228]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP6 inflammasome complex [GO:0140738]; non-membrane-bounded organelle [GO:0043228]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; molecular condensate scaffold activity [GO:0140693]; pattern recognition receptor activity [GO:0038187]; peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000]; activation of cysteine-type endopeptidase activity [GO:0097202]; acute inflammatory response [GO:0002526]; acute inflammatory response to antigenic stimulus [GO:0002438]; antiviral innate immune response [GO:0140374]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; necroptotic process [GO:0070266]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; NLRP6 inflammasome complex assembly [GO:0140739]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-18-mediated signaling pathway [GO:2000494]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of mucus secretion [GO:0070255]; response to bacterium [GO:0009617]; wound healing [GO:0042060] GO:0001530; GO:0002438; GO:0002526; GO:0002862; GO:0003725; GO:0005000; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0009617; GO:0010506; GO:0031965; GO:0032689; GO:0034122; GO:0038187; GO:0042060; GO:0042277; GO:0043124; GO:0043228; GO:0048874; GO:0050727; GO:0050729; GO:0050830; GO:0051260; GO:0051607; GO:0061702; GO:0070255; GO:0070266; GO:0070269; GO:0070373; GO:0070891; GO:0070946; GO:0097202; GO:0140374; GO:0140693; GO:0140738; GO:0140739; GO:2000494 ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; molecular condensate scaffold activity [GO:0140693]; pattern recognition receptor activity [GO:0038187]; peptide binding [GO:0042277]; vasopressin receptor activity [GO:0005000] ALLPTALLLVTTRAAAPGRLQGR 0.99204 -47.41 13.7523 0 0 0 0 13.3767 0 0 0 16.1084 0 0 0 0 0 0 0 12.3907 0 13.3029 15.0437 0 12.0559 0 0 14.0342 11.987 12.2838 0 12.7272 0 13.0127 0 0 0 0 0 0 0 0 0 12.8164 0 0 12.8964 0 0 0 0 11.763 11.9999 0 0 12.7245 0 14.1304 12.3732 0 13.5087 0 0 0 0 0 0 0 0 0 0 0 0 12.9792 0 0 0 0 0 12.9364 14.4058 12.8857 0 0 15.0456 0 12.5019 0 14.1685 14.4501 0 14.4892 0 0 14.2949 0 12.1079 0 0 0 0 0 0 0 0 0 0 13.1568 0 0 0 0 12.177 0 0 0 0 0 0 0 0 0 11.5045 0 0 0 0 0 0 0 11.309 0 0 0 12.6504 0 14.3777 0 0 0 0 15.5143 0 0 0 0 14.0772 0 0 0 0 0 0 0 0 0 0 0 15.0021 13.6177 15.4669 0 18.3048 0 0 0 0 18.3905 0 0 0 0 0 0 0 12.5391 0 0 12.9699 0 16.6157 0 Q16280 CNGA2_HUMAN "Cyclic nucleotide-gated olfactory channel (Cyclic nucleotide-gated cation channel 2) (Cyclic nucleotide-gated channel alpha-2, CNG channel alpha-2, CNG-2, CNG2)" CNGA2 CNCA CNCA1 CNCG2 Homo sapiens (Human) cation transmembrane transport [GO:0098655]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877]; cation transmembrane transport [GO:0098655]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] GO:0005222; GO:0005223; GO:0005516; GO:0005886; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0030660; GO:0044877; GO:0050896; GO:0060170; GO:0098655 calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877] AEIAINVHLSTLKKVR 0.99204 -5.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2812 0 0 0 0 0 0 9.71615 0 0 0 12.3993 13.6826 13.6264 0 0 0 0 0 0 0 12.8888 0 13.4498 0 13.0856 0 0 0 0 0 0 14.4467 12.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 13.156 13.876 0 0 13.1913 0 0 0 0 0 0 0 0 0 13.1117 0 0 0 0 0 0 0 0 12.6755 0 0 0 0 0 0 0 0 0 12.9692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5XPI4 RN123_HUMAN "E3 ubiquitin-protein ligase RNF123, EC 2.3.2.27 (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123)" RNF123 KPC1 FP1477 Homo sapiens (Human) proteolysis involved in protein catabolic process [GO:0051603] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis involved in protein catabolic process [GO:0051603] GO:0004842; GO:0005737; GO:0005829; GO:0031965; GO:0046872; GO:0051603 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] FLLSNVLFDVLRSVVFFYIK 0.99204 -18.346 0 0 0 0 0 0 0 0 0 0 0 0 16.0563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2981 0 0 0 10.9551 16.2188 0 0 11.9618 0 0 16.3965 16.4626 0 16.2431 16.4681 0 0 0 16.2012 16.3213 16.5735 0 0 12.2805 0 0 15.8831 0 16.0072 15.6408 0 0 0 0 0 0 0 0 0 15.391 0 0 0 0 0 11.8423 11.6892 0 12.6166 0 0 17.1033 0 12.6601 0 0 0 14.61 16.4229 0 0 12.1622 0 0 0 13.0829 0 12.0851 0 0 0 0 0 0 0 0 11.718 11.5428 12.7802 12.6783 12.7696 0 0 10.642 12.5827 0 12.3994 0 13.5195 17.1592 0 0 0 0 0 13.8539 0 0 0 13.5475 12.5274 0 0 11.7166 0 0 0 17.5563 0 0 0 12.0269 14.4204 0 0 13.8948 0 12.0761 12.5402 0 0 0 0 0 13.9323 0 0 0 12.6683 0 16.6722 0 0 0 0 0 0 0 0 0 16.774 16.6704 0 0 0 0 0 0 0 12.5133 0 Q7L273 KCTD9_HUMAN BTB/POZ domain-containing protein KCTD9 KCTD9 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567] cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567] GO:0016567; GO:0035556; GO:0042802; GO:0043621; GO:0051260; GO:0097602 cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein self-association [GO:0043621] KEFVRFLLATPTK 0.99204 -7.4249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7642 0 0 0 0 0 0 0 0 0 12.2661 0 0 0 14.107 14.3045 14.456 0 0 12.0966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0834 13.4236 0 0 13.5127 0 0 0 0 0 0 12.6749 0 0 0 0 0 0 0 0 13.832 0 0 0 0 0 0 0 0 0 0 0 11.8471 0 0 0 0 0 11.2784 0 0 0 0 11.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4236 0 Q86Y26 NUTM1_HUMAN NUT family member 1 (Nuclear protein in testis) NUTM1 C15orf55 NUT Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 DDCGLQLR 0.99204 -17.82 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3149 11.725 13.7829 0 10.7371 0 0 13.4435 0 0 0 11.1541 0 0 0 0 0 0 0 0 13.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9894 0 0 12.8459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1409 0 0 0 0 12.2936 0 0 0 0 0 0 0 0 14.8001 0 0 0 Q8IYA6 CKP2L_HUMAN "Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein, Radmis)" CKAP2L Homo sapiens (Human) centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922] GO:0000922; GO:0005813; GO:0005829; GO:0015630; GO:0072686 EMNISFWKSIEK 0.99204 -18.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8687 11.192 0 0 12.733 0 0 0 0 0 0 0 0 0 19.0082 16.5509 0 0 0 0 14.1662 0 0 0 0 15.1792 0 0 0 0 0 14.7616 0 0 0 0 0 0 0 11.5182 0 0 12.6995 0 0 13.0625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9017 0 12.0597 14.6991 0 0 0 0 13.8827 0 12.5 0 0 0 0 0 0 0 0 0 0 12.3148 0 0 0 14.2855 0 0 0 0 0 12.5562 0 0 0 0 0 0 0 0 0 0 0 0 12.2023 14.2912 0 0 Q8N7U6 EFHB_HUMAN EF-hand domain-containing family member B (Cilia- and flagella-associated protein 21) EFHB CFAP21 Homo sapiens (Human) calcium ion transport [GO:0006816]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256] axonemal microtubule [GO:0005879] axonemal microtubule [GO:0005879]; calcium ion sensor activity [GO:0061891]; calcium ion transport [GO:0006816]; negative regulation of protein binding [GO:0032091]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of store-operated calcium entry [GO:2001256] GO:0005879; GO:0006816; GO:0032091; GO:0061891; GO:0070884; GO:2001256 calcium ion sensor activity [GO:0061891] DVVNPPK 0.99204 -47.897 0 0 10.6586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0291 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3544 0 0 0 0 0 13.9987 15.1023 0 0 0 17.8322 0 0 0 0 0 0 0 0 0 0 16.3773 0 0 0 0 0 0 0 13.2373 0 17.5569 0 0 0 17.527 0 12.6754 0 0 0 0 0 0 12.3897 0 13.3965 13.2827 0 0 12.8131 15.4413 0 0 0 0 0 17.4747 0 0 13.0293 0 0 0 17.383 0 12.5961 0 17.3852 17.4824 0 13.6467 13.3757 0 0 13.9013 17.8242 0 0 0 0 17.2485 11.7751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1186 0 0 0 0 0 0 0 Q9H6T0 ESRP2_HUMAN Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) ESRP2 RBM35B PP7059 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial cell proliferation [GO:0050673]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of RNA splicing [GO:0043484]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; branching involved in salivary gland morphogenesis [GO:0060445]; epithelial cell proliferation [GO:0050673]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of RNA splicing [GO:0043484]" GO:0000380; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0043484; GO:0050673; GO:0050679; GO:0060441; GO:0060445; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723] ARGLPWQSSDQDVAR 0.99204 -18.315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4416 0 0 0 0 0 11.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.21 0 0 0 0 0 0 0 0 0 0 0 0 12.4688 0 0 0 13.5954 18.1316 0 0 0 0 0 0 0 0 0 12.4099 0 15.4392 0 0 0 13.0876 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2612 0 0 0 0 0 0 0 0 14.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRB3 CHSTC_HUMAN "Carbohydrate sulfotransferase 12, EC 2.8.2.5 (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2, C4ST-2, C4ST2) (Sulfotransferase Hlo)" CHST12 UNQ500/PRO1017 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166] Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166] GO:0000139; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030173; GO:0030206; GO:0030208; GO:0047756; GO:0050656 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146] DPFVRLISAFR 0.99204 -18.784 0 0 0 0 0 0 0 0 12.3136 0 0 12.1038 0 12.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3674 12.6684 13.0396 0 0 0 10.8842 0 0 0 0 0 11.1441 0 12.3418 0 0 13.5199 13.3846 0 0 0 0 0 0 0 0 0 9.90486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5047 14.2126 0 0 0 11.7668 0 15.6759 0 14.0648 14.5504 13.729 0 0 0 0 12.9654 14.8865 0 0 0 0 0 0 12.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2655 0 12.5817 14.9514 0 0 0 11.7018 0 0 14.2275 13.7462 14.3243 0 13.6245 14.3414 0 0 0 0 0 15.8787 0 14.0316 0 0 0 0 0 0 0 0 0 12.7272 0 0 0 0 0 0 0 0 0 13.6756 13.8322 0 0 0 14.6021 0 0 12.7437 14.5369 0 0 0 13.7715 13.4856 13.6159 11.9021 0 0 0 Q9UQ13 SHOC2_HUMAN Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog) SHOC2 KIAA0862 Homo sapiens (Human) fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] GO:0000164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007265; GO:0008157; GO:0008543; GO:0019888; GO:0019903; GO:0046579 protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888] ASGGFGK 0.99204 -7.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69378 0 0 0 0 0 0 0 0 0 10.6652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.49937 0 0 0 0 0 0 0 0 10.0444 0 13.7896 14.1978 0 0 10.6086 0 0 0 0 0 13.5179 13.461 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0131 0 0 0 0 14.2192 0 0 0 10.2366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4061 13.365 0 0 0 10.7998 0 11.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1934 14.2048 Q9Y6I9 TX264_HUMAN Testis-expressed protein 264 (Putative secreted protein Zsig11) TEX264 ZSIG11 UNQ337/PRO536 Homo sapiens (Human) protein-DNA covalent cross-linking repair [GO:0106300]; reticulophagy [GO:0061709] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; replication fork [GO:0005657] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; replication fork [GO:0005657]; signaling receptor activity [GO:0038023]; protein-DNA covalent cross-linking repair [GO:0106300]; reticulophagy [GO:0061709] GO:0000421; GO:0005576; GO:0005634; GO:0005657; GO:0005789; GO:0005829; GO:0016021; GO:0031093; GO:0038023; GO:0061709; GO:0106300 signaling receptor activity [GO:0038023] GWDDGDTR 0.99204 -7.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C0HM02 PKHUO_HUMAN "PRKCH upstream open reading frame 2, uORF2 (Protein uPEP2)" PRKCH Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of translation [GO:0017148]; positive regulation of translation in response to stress [GO:0032056] protein serine/threonine kinase binding [GO:0120283]; protein serine/threonine kinase inhibitor activity [GO:0030291]; translation regulator activity [GO:0045182]; cellular response to amino acid starvation [GO:0034198]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of translation [GO:0017148]; positive regulation of translation in response to stress [GO:0032056] GO:0017148; GO:0030291; GO:0032056; GO:0034198; GO:0045182; GO:0071901; GO:0120283 protein serine/threonine kinase binding [GO:0120283]; protein serine/threonine kinase inhibitor activity [GO:0030291]; translation regulator activity [GO:0045182] MASRGALR 0.99205 -6.1383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2352 0 0 0 13.0177 0 14.6535 0 0 0 0 0 0 0 0 12.8251 0 0 0 0 0 0 0 0 0 0 0 0 0 P14091 CATE_HUMAN "Cathepsin E, EC 3.4.23.34 [Cleaved into: Cathepsin E form I; Cathepsin E form II ]" CTSE Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231] endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508] GO:0004190; GO:0005768; GO:0006508; GO:0008233; GO:0016540; GO:0019886; GO:0042802; GO:0043231 aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233] KTLLLLLLVLLELGEAQGSLHR 0.99205 -7.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0164 13.9314 0 12.1087 0 0 12.7161 0 0 0 12.0537 0 10.5262 0 0 12.2936 0 0 0 0 11.3706 0 12.9363 11.8325 0 0 12.8201 0 0 0 0 11.6729 0 0 0 11.8588 0 0 0 0 0 0 0 10.7353 0 0 16.1892 17.5852 17.9491 17.4521 16.3317 16.3045 13.9674 18.296 18.4386 19.2769 19.2319 19.2683 18.7695 18.6422 18.5053 19.588 19.4413 19.3511 16.3923 20.0637 15.631 19.0113 0 19.0595 17.6138 13.9128 13.9186 15.0951 19.1191 16.1393 14.9773 19.0017 0 13.413 19.5087 19.3491 18.982 19.0266 0 18.6053 18.731 14.157 16.1481 15.5969 16.5272 0 14.7128 17.51 16.2899 16.518 18.576 16.3647 19.1989 19.1715 16.291 15.7819 14.2955 16.4995 15.7432 15.9306 15.2604 15.7865 15.4612 18.8761 18.9341 14.7384 18.6698 18.3452 17.253 17.3011 17.9075 19.4631 19.6807 18.215 18.1525 17.0877 17.5938 15.555 17.0697 14.8297 16.7419 10.4765 14.1598 0 19.5539 16.2532 19.9053 13.9497 13.4769 19.591 14.286 0 0 0 0 0 0 0 0 11.9968 0 0 0 0 0 17.1952 18.7939 17.8483 15.6123 0 0 0 13.9153 0 P40261 NNMT_HUMAN "Nicotinamide N-methyltransferase, EC 2.1.1.1" NNMT Homo sapiens (Human) animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinamide metabolic process [GO:0006769]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein deacetylation [GO:0090312]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone methylation [GO:0031060]; regulation of polyamine biosynthetic process [GO:0010967]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829] cytosol [GO:0005829]; N-methyltransferase activity [GO:0008170]; nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760]; animal organ regeneration [GO:0031100]; methylation [GO:0032259]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; nicotinamide metabolic process [GO:0006769]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein deacetylation [GO:0090312]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone methylation [GO:0031060]; regulation of polyamine biosynthetic process [GO:0010967]; response to organonitrogen compound [GO:0010243]; response to xenobiotic stimulus [GO:0009410] GO:0005829; GO:0006769; GO:0008112; GO:0008170; GO:0009410; GO:0010243; GO:0010967; GO:0030760; GO:0031060; GO:0031100; GO:0032259; GO:0034356; GO:0045722; GO:0051569; GO:0090312 N-methyltransferase activity [GO:0008170]; nicotinamide N-methyltransferase activity [GO:0008112]; pyridine N-methyltransferase activity [GO:0030760] NLFKIFCLDGVK 0.99205 -5.5436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9418 0 0 0 0 13.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5984 0 P49959 MRE11_HUMAN "Double-strand break repair protein MRE11, EC 3.1.-.- (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1, MRE11 homolog 1) (Meiotic recombination 11 homolog A, MRE11 homolog A)" MRE11 HNGS1 MRE11A Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860] "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 5'-3' exonuclease activity [GO:0008409]; cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]" GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008022; GO:0008283; GO:0008296; GO:0008408; GO:0008409; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0070533; GO:0097552; GO:0098687; GO:0110025 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 5'-3' exonuclease activity [GO:0008409]; cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] ERHIDALEDK 0.99205 -18.815 0 0 0 0 0 0 0 0 0 0 0 0 11.0059 0 0 10.1135 0 11.549 0 0 0 10.648 12.7442 0 0 0 0 0 0 0 0 0 0 0 0 10.7807 0 0 0 0 0 0 0 12.6562 0 11.6483 0 0 14.6312 0 0 0 0 0 13.9917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4151 0 0 12.0597 0 0 0 0 0 0 0 0 0 0 0 13.6188 0 0 0 0 15.2677 0 0 0 0 0 0 0 0 0 0 15.8033 0 0 0 0 0 0 14.5361 0 0 0 0 0 0 0 0 13.5728 0 0 0 0 0 0 0 0 12.0843 0 0 0 0 0 0 13.5313 12.2482 0 0 13.3733 0 0 11.7032 0 0 0 13.7947 0 0 0 0 0 0 0 0 0 0 0 11.1931 0 0 0 0 0 0 0 0 0 0 0 11.9443 0 0 0 0 0 0 0 0 Q02386 ZNF45_HUMAN Zinc finger protein 45 (BRC1744) (Zinc finger protein 13) (Zinc finger protein KOX5) ZNF45 KOX5 ZNF13 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKSFSWRSR 0.99205 -7.1231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8375 0 0 0 10.9012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15113 PCOC1_HUMAN "Procollagen C-endopeptidase enhancer 1 (Procollagen COOH-terminal proteinase enhancer 1, PCPE-1, Procollagen C-proteinase enhancer 1) (Type 1 procollagen C-proteinase enhancer protein) (Type I procollagen COOH-terminal proteinase enhancer)" PCOLCE PCPE1 Homo sapiens (Human) collagen biosynthetic process [GO:0032964]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; collagen biosynthetic process [GO:0032964]; proteolysis [GO:0006508] GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0016504; GO:0032964; GO:0070062 collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504] FDLEPDTYCRYDSVSVFNGAVSDDSR 0.99205 -7.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0645 0 0 0 0 0 12.2414 0 0 0 0 0 0 13.9639 0 0 0 0 0 0 0 0 0 0 0 0 10.4267 0 0 0 0 0 12.6399 0 14.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15397 PUM3_HUMAN "Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8, HLA-HA8)" PUM3 cPERP-C KIAA0020 PUF-A XTP5 Homo sapiens (Human) regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417] chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417] GO:0003677; GO:0003723; GO:0003729; GO:0005654; GO:0005694; GO:0005730; GO:0005783; GO:0006417; GO:0010835 DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] AALKSLIPTLEKTK 0.99205 -18.845 0 0 0 0 0 0 0 0 0 0 14.1308 0 0 12.6188 0 0 0 0 0 12.2784 0 0 0 0 0 0 0 0 0 0 13.0577 9.29508 13.4588 12.6337 0 0 0 0 0 14.0014 0 0 0 0 0 0 0 0 0 0 0 0 12.0947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1243 0 0 0 0 0 14.9501 0 12.635 12.9688 0 0 12.1674 0 0 11.938 0 0 11.6761 11.6177 0 0 0 0 0 13.3837 0 12.4026 13.1938 0 0 0 10.8753 0 0 13.5008 13.0883 0 0 0 11.9721 0 0 13.6237 0 0 0 0 12.2693 0 0 13.2694 0 0 0 0 0 0 12.0499 0 0 0 0 0 0 0 0 0 0 12.1998 0 0 0 0 0 0 0 15.1441 0 0 0 0 0 0 14.7828 0 0 0 0 0 0 12.4749 0 0 0 Q6XD76 ASCL4_HUMAN "Achaete-scute homolog 4, ASH-4, hASH4 (Achaete-scute-like protein 4) (Class A basic helix-loop-helix protein 44, bHLHa44)" ASCL4 BHLHA44 HASH4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588] chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]; skin development [GO:0043588]" GO:0000785; GO:0000977; GO:0000981; GO:0006357; GO:0043588; GO:0046983; GO:0090575 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AAIDYIKHLQELLERQAWGLEGAAGAVPQR 0.99205 -7.4584 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0022 0 0 0 0 13.1321 0 0 0 0 0 0 0 0 0 0 15.0125 0 0 0 0 0 0 0 0 0 0 14.9242 0 13.6658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1212 12.7406 11.9732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7646 0 11.7613 0 11.4241 0 11.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6872 0 0 0 0 0 0 0 Q8NEF9 SRFB1_HUMAN Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP) SRFBP1 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490] 90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] 90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490] GO:0003723; GO:0005634; GO:0030490; GO:0030686; GO:0048471 RNA binding [GO:0003723] AIARLAVHPLLKK 0.99205 -22.732 0 0 0 0 11.4604 0 0 12.7604 14.0293 13.5817 13.3105 14.44 13.742 0 13.4402 13.8945 14.0522 14.2932 0 0 13.6726 0 13.5593 0 0 0 13.2499 13.2522 13.7498 0 13.3782 0 0 12.7224 14.4239 0 0 13.2242 13.6404 12.2031 12.3839 0 14.1669 11.6927 0 0 13.8696 14.2541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6389 0 15.3615 15.6319 15.3674 15.6118 15.9927 16.3698 12.7266 12.0033 0 11.0704 13.604 11.6636 0 12.0655 12.8352 14.6298 11.4532 13.3161 12.755 13.4186 0 0 15.2167 0 0 0 0 11.6721 12.9401 0 0 13.1947 0 0 0 12.2887 12.82 14.3943 0 0 12.3103 0 0 0 12.7043 13.0456 13.0082 0 0 0 0 13.4914 0 0 12.9185 0 0 0 14.0559 0 0 0 12.5562 13.5046 0 0 12.962 0 0 0 0 0 0 0 0 0 0 0 0 13.7082 14.3972 0 0 13.7877 0 0 12.9835 14.149 0 13.3674 0 0 0 0 0 0 14.4544 0 0 Q9UL46 PSME2_HUMAN "Proteasome activator complex subunit 2 (11S regulator complex subunit beta, REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta, PA28b, PA28beta)" PSME2 Homo sapiens (Human) positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136] GO:0000502; GO:0005654; GO:0005737; GO:0005829; GO:0008537; GO:0010950; GO:0016020; GO:0042802; GO:0061133; GO:0061136; GO:0070062; GO:2000045 endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802] DEAAYGELRAMVLDLR 0.99205 -7.4377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.602 16.8437 0 0 0 0 0 12.459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9717 0 0 0 0 0 0 0 0 0 0 0 0 O15151 MDM4_HUMAN Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4) MDM4 MDMX Homo sapiens (Human) "atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular septum development [GO:0003281]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]; atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ventricular septum development [GO:0003281]" GO:0000122; GO:0002039; GO:0003170; GO:0003181; GO:0003203; GO:0003281; GO:0003283; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0008285; GO:0017053; GO:0019899; GO:0030330; GO:0042177; GO:0043066; GO:0045892; GO:0050821; GO:0051726; GO:0065003; GO:0071456 enzyme binding [GO:0019899]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270] ENEGNDVPDCR 0.99206 -7.4936 0 0 0 0 0 0 0 0 12.2104 13.2983 13.6506 0 0 12.5643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.442 0 0 0 13.1346 0 12.438 12.5701 12.1113 12.6097 12.495 11.8556 12.4129 0 0 0 0 0 0 0 0 0 0 0 0 10.0893 13.625 13.6798 0 13.3073 12.2442 0 12.3504 11.9846 11.7855 11.4166 0 0 0 0 0 14.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5223 0 0 14.9724 0 0 0 0 15.8659 13.7707 12.3768 0 11.925 0 0 0 0 12.2409 12.1835 0 0 0 0 0 0 0 0 0 0 14.5681 0 0 0 0 0 10.4229 0 0 0 0 0 0 14.1566 0 0 13.9059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N814 YG045_HUMAN Putative uncharacterized protein FLJ40140 Homo sapiens (Human) QSYLVGCFR 0.99206 -6.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHQ8 RASF8_HUMAN Ras association domain-containing protein 8 (Carcinoma-associated protein HOJ-1) RASSF8 C12orf2 Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 AVERSLGQATKR 0.99206 -24.493 0 0 10.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.719 13.601 0 13.9442 0 0 0 0 0 15.0276 13.9658 0 15.1504 13.9452 14.9784 14.8739 0 12.7769 13.6717 0 0 13.368 14.6024 14.8032 0 0 0 0 14.5278 0 0 0 0 0 0 0 15.5416 15.2601 0 0 0 0 0 0 0 0 0 13.4402 0 13.9007 0 13.4139 0 0 0 13.282 13.544 0 0 0 0 0 13.1396 0 0 0 13.8479 0 0 13.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2304 13.2569 13.9163 0 0 0 0 0 15.2119 0 0 0 0 0 0 0 Q9BX74 TM2D1_HUMAN "TM2 domain-containing protein 1 (Amyloid-beta-binding protein, hBBP)" TM2D1 BBP Homo sapiens (Human) apoptotic signaling pathway [GO:0097190] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930]; apoptotic signaling pathway [GO:0097190] GO:0001540; GO:0004930; GO:0005887; GO:0097190 amyloid-beta binding [GO:0001540]; G protein-coupled receptor activity [GO:0004930] LSITNETFR 0.99206 -6.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8W5 TRI45_HUMAN Tripartite motif-containing protein 45 (RING finger protein 99) TRIM45 RNF99 Homo sapiens (Human) "bone development [GO:0060348]; positive regulation of transcription, DNA-templated [GO:0045893]" chromatin [GO:0000785]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000785; GO:0004842; GO:0005654; GO:0005829; GO:0008270; GO:0045171; GO:0045893; GO:0060348 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] FCPQEKAGQCR 0.99206 -4.9389 16.1673 14.7156 14.2195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6381 0 10.4303 0 0 10.8115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3138 13.4204 16.3966 16.3662 16.461 15.1596 14.992 0 18.6755 18.7645 18.6623 0 0 0 0 0 0 14.8279 0 0 0 0 14.3609 0 0 0 0 12.6139 0 12.3207 0 0 0 0 0 15.1506 14.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2063 14.6699 14.6288 0 14.6706 0 0 0 0 0 14.7163 0 0 0 0 0 0 0 0 0 14.7544 0 0 0 0 0 0 14.5205 0 0 0 14.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6359 0 13.3707 0 0 0 0 0 Q9NYH9 UTP6_HUMAN U3 small nucleolar RNA-associated protein 6 homolog (Hepatocellular carcinoma-associated antigen 66) (Multiple hat domains protein) UTP6 C17orf40 HCA66 MHAT Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0005654; GO:0005694; GO:0005730; GO:0030515; GO:0032040; GO:0034388 snoRNA binding [GO:0030515] ALLAVIGADSVTLK 0.99206 -18.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3435 0 0 0 0 0 0 11.1374 0 0 0 0 0 15.2343 0 15.75 15.3045 0 0 0 0 0 0 11.9807 11.7118 0 10.7987 0 0 11.1508 12.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0734 14.4617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4761 Q9Y2H9 MAST1_HUMAN "Microtubule-associated serine/threonine-protein kinase 1, EC 2.7.11.1 (Syntrophin-associated serine/threonine-protein kinase)" MAST1 KIAA0973 SAST Homo sapiens (Human) brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ARHQQMSGDVAVEKR 0.99206 -24.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.777 0 0 0 0 0 0 0 0 0 11.7295 0 0 0 0 0 0 11.6101 0 0 12.0323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6828 0 0 0 0 0 0 0 0 13.3404 12.1959 0 0 0 0 0 0 14.3226 0 13.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1645 12.2802 0 0 0 0 0 0 12.8727 0 12.0251 0 0 0 0 0 0 0 0 0 0 0 0 12.2952 0 0 0 0 0 0 0 0 0 0 11.552 0 12.9585 0 0 0 0 0 0 0 0 0 0 0 13.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5552 13.4055 Q9Y5Y7 LYVE1_HUMAN "Lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE-1 (Cell surface retention sequence-binding protein 1, CRSBP-1) (Extracellular link domain-containing protein 1) (Hyaluronic acid receptor)" LYVE1 CRSBP1 HAR XLKD1 UNQ230/PRO263 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cellular extravasation [GO:0002693]; response to wounding [GO:0009611] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; hyaluronic acid binding [GO:0005540]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; anatomical structure morphogenesis [GO:0009653]; cell-matrix adhesion [GO:0007160]; glycosaminoglycan catabolic process [GO:0006027]; positive regulation of cellular extravasation [GO:0002693]; response to wounding [GO:0009611] GO:0002693; GO:0004888; GO:0005540; GO:0005886; GO:0005887; GO:0006027; GO:0007160; GO:0009611; GO:0009653; GO:0016020; GO:0038023; GO:0070062 hyaluronic acid binding [GO:0005540]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] ANDSNPNEESK 0.99206 -7.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3597 0 0 0 0 0 0 0 0 0 0 0 P0DKL9 A14EL_HUMAN ARL14 effector protein-like ARL14EPL Homo sapiens (Human) MNEQSEK 0.99207 -18.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1672 0 0 0 0 0 0 P49279 NRAM1_HUMAN "Natural resistance-associated macrophage protein 1, NRAMP 1 (Solute carrier family 11 member 1)" SLC11A1 LSH NRAMP NRAMP1 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; antigen processing and presentation of peptide antigen [GO:0048002]; antimicrobial humoral response [GO:0019730]; cadmium ion transmembrane transport [GO:0070574]; cell redox homeostasis [GO:0045454]; cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; establishment of localization in cell [GO:0051649]; inflammatory response [GO:0006954]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; L-arginine transmembrane transport [GO:1903826]; macrophage activation [GO:0042116]; manganese ion transport [GO:0006828]; metal ion transport [GO:0030001]; MHC class II biosynthetic process [GO:0045342]; mRNA stabilization [GO:0048255]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cytokine production [GO:0001818]; nitrite transport [GO:0015707]; phagocytosis [GO:0006909]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; respiratory burst [GO:0045730]; response to bacterium [GO:0009617]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; T cell proliferation involved in immune response [GO:0002309]; vacuolar acidification [GO:0007035]; wound healing [GO:0042060] ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion:proton antiporter activity [GO:0051139]; protein homodimerization activity [GO:0042803]; transition metal ion transmembrane transporter activity [GO:0046915]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of peptide antigen [GO:0048002]; antimicrobial humoral response [GO:0019730]; cadmium ion transmembrane transport [GO:0070574]; cell redox homeostasis [GO:0045454]; cellular cadmium ion homeostasis [GO:0006876]; cellular iron ion homeostasis [GO:0006879]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; establishment of localization in cell [GO:0051649]; inflammatory response [GO:0006954]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; L-arginine transmembrane transport [GO:1903826]; macrophage activation [GO:0042116]; manganese ion transport [GO:0006828]; metal ion transport [GO:0030001]; MHC class II biosynthetic process [GO:0045342]; mRNA stabilization [GO:0048255]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of cytokine production [GO:0001818]; nitrite transport [GO:0015707]; phagocytosis [GO:0006909]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of phagocytosis [GO:0050766]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; respiratory burst [GO:0045730]; response to bacterium [GO:0009617]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; T cell proliferation involved in immune response [GO:0002309]; vacuolar acidification [GO:0007035]; wound healing [GO:0042060] GO:0001818; GO:0001819; GO:0002309; GO:0002606; GO:0002827; GO:0005381; GO:0005384; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0006826; GO:0006828; GO:0006876; GO:0006879; GO:0006909; GO:0006954; GO:0007035; GO:0009617; GO:0010628; GO:0015086; GO:0015707; GO:0019730; GO:0030001; GO:0030670; GO:0031902; GO:0032147; GO:0032496; GO:0032729; GO:0034341; GO:0042060; GO:0042116; GO:0042742; GO:0042803; GO:0042832; GO:0045342; GO:0045454; GO:0045730; GO:0045944; GO:0046915; GO:0048002; GO:0048255; GO:0050766; GO:0050829; GO:0051139; GO:0051649; GO:0055072; GO:0060586; GO:0070574; GO:0070821; GO:0101003; GO:1903826 cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; metal ion:proton antiporter activity [GO:0051139]; protein homodimerization activity [GO:0042803]; transition metal ion transmembrane transporter activity [GO:0046915] LLWVLLWATVLGLLCQR 0.99207 -6.0294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3909 0 0 0 0 15.753 0 0 0 0 0 15.9807 11.2174 15.3632 0 0 16.2838 0 16.3606 16.2576 15.9238 15.4778 15.2654 15.1445 0 0 0 0 0 0 0 15.7622 0 0 0 0 0 0 0 0 0 0 15.0288 15.4203 0 0 14.6034 0 14.6504 0 0 0 0 0 0 0 0 13.3318 0 14.2082 15.1046 0 0 0 0 0 0 0 0 0 15.0579 0 0 0 0 0 0 0 14.0149 0 0 0 0 0 Q13472 TOP3A_HUMAN "DNA topoisomerase 3-alpha, EC 5.6.2.1 (DNA topoisomerase III alpha)" TOP3A TOP3 Homo sapiens (Human) chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; resolution of recombination intermediates [GO:0071139] mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RecQ family helicase-topoisomerase III complex [GO:0031422] "mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RecQ family helicase-topoisomerase III complex [GO:0031422]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]; chromosome separation [GO:0051304]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mitochondrial DNA metabolic process [GO:0032042]; resolution of recombination intermediates [GO:0071139]" GO:0000724; GO:0003677; GO:0003697; GO:0003916; GO:0003917; GO:0005634; GO:0005654; GO:0005759; GO:0006265; GO:0008270; GO:0016605; GO:0031422; GO:0032042; GO:0051304; GO:0051321; GO:0071139 "DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270]" AVKPNLQVLR 0.99207 -24.667 10.9761 0 0 0 0 0 0 0 0 0 10.9282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1541 0 0 0 0 12.6378 0 0 0 0 0 0 0 0 12.1123 0 0 0 0 0 0 0 0 11.12 0 0 0 0 0 0 0 0 0 0 0 0 13.088 14.1301 13.1352 11.9204 0 0 12.9467 0 12.9756 0 0 16.8411 0 0 0 14.2544 18.2053 0 0 18.0873 12.7598 0 0 14.5841 0 14.8857 14.9483 0 0 0 0 0 0 0 0 0 14.2449 17.662 0 18.8901 0 0 0 0 0 0 0 14.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0937 0 0 0 0 0 12.526 0 13.5203 0 0 17.8305 0 14.5258 13.9319 0 0 13.8365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1497 0 0 0 0 15.4996 0 0 0 0 Q7Z4U5 CF201_HUMAN Uncharacterized protein C6orf201 C6orf201 Homo sapiens (Human) ILARHQLPK 0.99207 -6.0302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2956 13.4455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1269 0 0 Q8WWZ3 EDAD_HUMAN Ectodysplasin-A receptor-associated adapter protein (EDAR-associated death domain protein) (Protein crinkled homolog) EDARADD Homo sapiens (Human) cell differentiation [GO:0030154]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; cell differentiation [GO:0030154]; signal transduction [GO:0007165] GO:0005829; GO:0007165; GO:0030154 AEECDTITLNCPR 0.99207 -4.5098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.619 0 0 0 0 0 0 0 14.1596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8599 0 0 0 14.6639 0 0 0 0 0 0 0 0 0 0 14.5233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4735 0 0 0 14.1411 14.5236 11.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SN8 CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215) CDK5RAP2 CEP215 KIAA1633 Homo sapiens (Human) "brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]" cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922] "cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664]" GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0015631; GO:0019901; GO:0022008; GO:0030054; GO:0031023; GO:0031116; GO:0035371; GO:0043015; GO:0044877; GO:0045664; GO:0045665; GO:0045736; GO:0045893; GO:0046600; GO:0048471; GO:0070062; GO:0090266; GO:0097431 calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631] AEVTKLHK 0.99207 -24.655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0539 0 0 0 0 0 0 0 0 0 0 0 11.3787 0 0 0 0 0 0 0 0 0 10.5382 0 0 0 0 0 0 0 0 0 0 0 0 11.6172 0 0 0 0 11.0798 0 0 0 0 0 0 0 0 0 0 0 0 13.373 0 0 0 0 0 0 17.1853 10.3591 0 0 0 0 0 0 0 0 11.8936 0 0 0 20.727 0 0 0 0 0 11.9308 11.1213 13.0117 13.1456 0 0 0 0 0 0 0 13.2413 10.765 10.4168 13.5379 0 0 0 0 0 0 0 0 13.1865 12.1283 13.3467 0 14.8735 13.9369 12.0155 0 0 0 11.2069 0 0 0 17.4613 12.9982 0 14.0603 0 0 14.1656 0 0 0 0 0 0 10.6251 11.6941 0 0 0 13.5761 0 0 0 0 11.7516 13.3908 0 0 0 0 0 0 0 0 0 0 0 10.5068 0 0 0 14.6373 0 13.9424 0 0 10.201 0 0 12.9788 Q96T83 SL9A7_HUMAN "Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7, NHE-7) (Solute carrier family 9 member 7)" SLC9A7 NHE7 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719] GO:0000139; GO:0005802; GO:0005886; GO:0006811; GO:0006885; GO:0015385; GO:0015386; GO:0016021; GO:0043231; GO:0051453; GO:0055037; GO:0055038; GO:0071805; GO:0098719; GO:1905526 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] ATGAPPPRLLLLPLLLGWGLR 0.99207 -6.0199 0 0 0 0 0 0 0 0 0 0 13.0726 0 0 0 0 0 0 0 0 12.609 0 0 0 0 0 0 0 0 0 0 0 10.4147 11.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2082 0 0 11.8424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6217 0 0 0 11.2128 0 0 0 0 0 13.1624 0 0 0 0 0 14.0766 0 0 0 0 0 0 13.9129 12.0734 0 0 0 0 0 0 12.3836 0 0 0 0 0 0 11.4039 0 0 0 0 0 12.765 0 0 0 0 0 0 0 0 0 0 0 12.4986 0 0 0 0 0 12.0238 0 0 0 0 10.0942 0 11.8858 0 0 10.9221 0 0 0 10.107 0 0 0 12.242 0 0 0 0 13.317 15.3798 12.4504 0 0 0 0 0 0 0 12.8392 0 0 0 0 0 0 0 0 0 0 13.5457 0 14.3765 0 0 Q99525 H4G_HUMAN Histone H4-like protein type G (H4-clustered histone 7) H4C7 H4/L H4FL HIST1H4G Homo sapiens (Human) nucleosome assembly [GO:0006334] nucleosome [GO:0000786]; nucleus [GO:0005634] nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; nucleosome assembly [GO:0006334] GO:0000786; GO:0003677; GO:0005634; GO:0006334; GO:0030527; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AGKGLGKGGAK 0.99207 -7.6467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4235 0 0 0 0 0 0 Q9Y473 ZN175_HUMAN Zinc finger protein 175 (Zinc finger protein OTK18) ZNF175 Homo sapiens (Human) defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; defense response to virus [GO:0051607]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005730; GO:0005829; GO:0006357; GO:0045944; GO:0046872; GO:0051607 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFFQMLSLFRHQR 0.99207 -15.172 0 0 0 0 9.77032 0 0 0 10.1834 0 0 0 0 0 0 0 14.0402 0 0 0 0 0 0 0 0 0 0 0 0 14.4233 0 0 12.1053 0 0 0 0 0 0 0 13.7911 0 11.6927 14.9365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9457 12.8077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0799 12.9009 0 0 0 10.6246 13.6201 0 0 0 0 0 0 0 0 0 12.5749 0 0 0 0 14.3597 0 14.2845 0 0 12.7187 0 15.9457 0 0 0 0 0 13.1196 0 0 0 16.9618 0 0 9.35878 0 12.4912 0 0 0 0 0 12.4399 12.1975 0 13.4681 11.2628 0 0 0 13.0605 0 0 14.1566 0 0 0 0 0 12.2965 0 0 0 0 0 0 0 0 0 10.4367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P37023 ACVL1_HUMAN "Serine/threonine-protein kinase receptor R3, SKR3, EC 2.7.11.30 (Activin receptor-like kinase 1, ALK-1) (TGF-B superfamily receptor type I, TSR-I)" ACVRL1 ACVRLK1 ALK1 Homo sapiens (Human) "angiogenesis [GO:0001525]; artery development [GO:0060840]; blood circulation [GO:0008015]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; blood vessel maturation [GO:0001955]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of DNA replication [GO:0006275]; regulation of endothelial cell proliferation [GO:0001936]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]" BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; angiogenesis [GO:0001525]; artery development [GO:0060840]; blood circulation [GO:0008015]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; blood vessel maturation [GO:0001955]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral pattern formation [GO:0009953]; endocardial cushion morphogenesis [GO:0003203]; endothelial tube morphogenesis [GO:0061154]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of DNA replication [GO:0006275]; regulation of endothelial cell proliferation [GO:0001936]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]; venous blood vessel development [GO:0060841]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0001525; GO:0001666; GO:0001701; GO:0001936; GO:0001937; GO:0001938; GO:0001946; GO:0001955; GO:0001974; GO:0002043; GO:0003203; GO:0004674; GO:0004675; GO:0005024; GO:0005025; GO:0005524; GO:0005886; GO:0005887; GO:0006275; GO:0006355; GO:0006468; GO:0007162; GO:0007165; GO:0007179; GO:0007507; GO:0008015; GO:0008217; GO:0008285; GO:0009953; GO:0009986; GO:0010596; GO:0010629; GO:0010862; GO:0016361; GO:0019901; GO:0030308; GO:0030336; GO:0030425; GO:0030509; GO:0030513; GO:0032332; GO:0035313; GO:0035912; GO:0043025; GO:0043235; GO:0043535; GO:0043537; GO:0045602; GO:0045603; GO:0045766; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048185; GO:0050431; GO:0051895; GO:0060836; GO:0060840; GO:0060841; GO:0061154; GO:0061298; GO:0070724; GO:0071363; GO:0071560; GO:0071773; GO:0098821; GO:2000279 "activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]" DEQSWFR 0.99208 -7.6675 0 0 0 0 0 0 0 0 0 10.6927 0 0 0 0 0 0 9.66196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9282 0 0 0 0 10.2807 14.9964 15.1388 15.0166 0 11.7729 13.5708 14.7974 15.3113 15.902 16.2363 0 0 13.8663 0 0 0 14.033 13.7993 0 14.2144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4136 0 15.0109 0 0 15.8443 0 0 0 15.3695 0 15.5115 0 12.1272 0 0 0 15.0601 15.3671 0 0 0 0 0 0 0 15.1921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1373 0 0 0 0 0 0 0 0 0 0 0 0 A2RUH7 MBPHL_HUMAN Myosin-binding protein H-like MYBPHL Homo sapiens (Human) in utero embryonic development [GO:0001701] myofilament [GO:0036379]; sarcomere [GO:0030017] myofilament [GO:0036379]; sarcomere [GO:0030017]; in utero embryonic development [GO:0001701] GO:0001701; GO:0030017; GO:0036379 ALRQTYIR 0.99208 -7.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14526 FCHO1_HUMAN F-BAR domain only protein 1 FCHO1 KIAA0290 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; AP-2 adaptor complex binding [GO:0035612]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; positive regulation of T cell activation [GO:0050870]; T cell receptor signaling pathway [GO:0050852] GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0035612; GO:0048268; GO:0050852; GO:0050870; GO:0072583 AP-2 adaptor complex binding [GO:0035612] ATAGSLILPPGPGGTMKR 0.99208 -6.7265 0 0 0 0 0 0 0 0 13.4648 14.0572 0 12.921 13.6738 13.2926 12.927 0 11.9454 0 0 12.8452 0 0 0 0 0 0 12.4403 0 11.5026 0 0 0 12.8574 0 0 0 0 0 12.1002 0 0 0 13.8104 0 0 0 13.6146 10.5625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0107 12.1204 0 0 0 0 0 0 0 13.1572 0 0 0 0 0 0 12.7897 0 0 0 0 0 0 11.0025 0 0 0 0 0 0 0 0 0 13.2501 0 0 0 13.5744 0 0 12.2032 0 0 12.7639 0 0 13.9891 0 0 0 0 0 13.0357 13.1747 0 12.4859 13.132 12.6928 12.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4093 12.5755 13.4691 0 0 0 0 0 0 0 0 0 0 0 0 11.0769 0 0 13.8289 13.6361 13.0831 13.4887 12.9605 14.3261 12.9021 0 14.4179 13.5308 0 0 13.4774 14.4069 12.9723 11.6427 0 0 0 0 0 14.8169 0 0 O43934 MFS11_HUMAN UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET) MFSD11 ET Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GSDYRSI 0.99208 -4.5102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75078 ADA11_HUMAN "Disintegrin and metalloproteinase domain-containing protein 11, ADAM 11 (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein, MDC)" ADAM11 MDC Homo sapiens (Human) integrin-mediated signaling pathway [GO:0007229]; proteolysis [GO:0006508] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; integrin-mediated signaling pathway [GO:0007229]; proteolysis [GO:0006508] GO:0004222; GO:0005178; GO:0005886; GO:0006508; GO:0007229; GO:0008237; GO:0016021 integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] CTLTHDAMCSDGLCCR 0.99208 -6.7173 0 0 0 0 0 0 0 0 13.5979 0 0 0 13.6687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5486 0 12.0503 11.8051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8544 10.5102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6314 0 0 0 0 0 0 12.2589 11.8827 0 0 0 0 0 0 0 0 13.6286 0 0 0 0 0 0 0 0 12.5554 12.4888 0 13.6294 0 0 0 0 0 12.7663 0 0 12.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5716 0 12.2283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9219 0 0 0 0 P05129 KPCG_HUMAN "Protein kinase C gamma type, PKC-gamma, EC 2.7.11.13" PRKCG PKCG Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511] calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060] calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; chemosensory behavior [GO:0007635]; innervation [GO:0060384]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of mismatch repair [GO:0032425]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of phagocytosis [GO:0050764]; regulation of response to food [GO:0032095]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to morphine [GO:0043278]; response to pain [GO:0048265]; response to psychosocial stress [GO:1990911]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511] GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004712; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007268; GO:0007611; GO:0007635; GO:0008270; GO:0009636; GO:0014069; GO:0016310; GO:0018105; GO:0030425; GO:0031397; GO:0032095; GO:0032425; GO:0035556; GO:0042177; GO:0042752; GO:0043278; GO:0043524; GO:0044305; GO:0046777; GO:0048265; GO:0048471; GO:0048511; GO:0050764; GO:0060291; GO:0060384; GO:0097060; GO:0099171; GO:0099523; GO:0099524; GO:0106310; GO:1901799; GO:1990911; GO:2000300 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; zinc ion binding [GO:0008270] CSCCEMNVHR 0.99208 -6.7164 0 10.6512 0 0 12.9735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6146 0 0 0 0 0 0 0 0 0 0 11.2497 0 15.4764 0 15.2824 15.3951 12.3965 0 15.505 13.8172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8605 14.1434 12.7378 13.4596 0 0 0 0 0 11.4572 0 0 0 0 0 0 0 0 0 0 0 0 13.2391 13.2083 0 14.2322 14.5296 0 0 0 0 13.2472 0 15.2696 13.7243 12.758 0 13.666 14.4122 0 0 0 0 13.1546 13.6319 0 0 0 13.6014 14.5476 13.8861 0 13.4398 14.2368 0 0 14.0947 0 0 0 0 0 14.3843 14.921 14.7762 13.9643 0 14.1422 14.5912 0 14.1399 13.2751 14.2267 0 0 0 14.3703 0 0 15.759 0 0 0 0 0 0 13.4026 14.4922 13.3066 0 0 0 0 0 0 13.4666 0 0 0 14.1713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8442 0 0 0 0 0 0 P16401 H15_HUMAN Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3) H1-5 H1F5 HIST1H1B Homo sapiens (Human) chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; establishment of protein localization to chromatin [GO:0071169]; muscle organ development [GO:0007517]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; positive regulation of cell growth [GO:0030307]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein stabilization [GO:0050821] chromatin [GO:0000785]; chromosome [GO:0005694]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin [GO:0000785]; chromosome [GO:0005694]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; establishment of protein localization to chromatin [GO:0071169]; muscle organ development [GO:0007517]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; positive regulation of cell growth [GO:0030307]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein stabilization [GO:0050821] GO:0000122; GO:0000785; GO:0000786; GO:0000792; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006334; GO:0007517; GO:0030261; GO:0030307; GO:0030527; GO:0031490; GO:0031492; GO:0042826; GO:0045910; GO:0050821; GO:0051574; GO:0071169 chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] AAGAGAAK 0.99208 -23.997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3974 0 0 0 P39023 RL3_HUMAN "60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B, TARBP-B) (Large ribosomal subunit protein uL3)" RPL3 OK/SW-cl.32 Homo sapiens (Human) cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0008097; GO:0022625; GO:0022626; GO:0032991; GO:0045202; GO:0070062; GO:0071353 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AFMGPLK 0.99208 -47.517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4561 0 0 0 0 16.6422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5389 0 0 0 0 0 14.6873 14.5392 15.7262 16.3234 0 0 13.4491 15.1944 16.0321 12.5087 13.0993 14.3092 0 0 0 15.0243 0 0 0 0 18.9155 0 0 0 0 16.6584 0 0 0 16.8518 0 11.2116 17.117 17.0343 0 0 16.7152 17.6832 0 17.1074 17.2669 17.065 14.3985 16.9092 0 0 18.0115 0 0 0 0 17.5606 17.42 0 17.6102 0 13.7524 0 16.9084 0 0 0 0 0 15.1005 0 13.5325 17.0732 0 0 17.0998 17.1733 17.4066 17.3078 0 0 0 17.2578 0 15.8272 16.674 13.8334 0 0 0 0 16.4464 16.2881 16.2799 13.0784 16.2638 14.3228 0 0 0 0 15.8685 16.0783 0 16.2401 16.1131 0 15.9509 0 13.897 0 14.6593 13.2973 13.5761 13.2326 0 0 0 12.7884 0 0 0 15.7196 15.7974 15.6922 0 0 0 0 0 0 P49753 ACOT2_HUMAN "Acyl-coenzyme A thioesterase 2, mitochondrial, Acyl-CoA thioesterase 2, EC 3.1.2.2 (Acyl-coenzyme A thioester hydrolase 2a) (CTE-Ia) (Long-chain acyl-CoA thioesterase 2) (ZAP128)" ACOT2 PTE2 PTE2A Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0001676; GO:0005739; GO:0005759; GO:0005782; GO:0005829; GO:0006631; GO:0006637; GO:0016290; GO:0047617; GO:0052689; GO:0102991 acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] EPVRVGR 0.99208 -17.742 0 11.7611 0 0 13.4248 0 12.603 0 0 0 0 0 11.2959 0 0 0 0 0 0 0 0 0 0 0 0 16.0205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.439 0 0 0 0 0 0 0 12.381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0152 0 0 0 0 13.2526 0 0 0 0 0 0 0 0 13.7994 0 0 0 0 0 13.6312 0 0 0 13.1103 0 0 0 0 P54278 PMS2_HUMAN "Mismatch repair endonuclease PMS2, EC 3.1.-.- (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2)" PMS2 PMSL2 Homo sapiens (Human) mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410]; somatic hypermutation of immunoglobulin genes [GO:0016446] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410]; somatic hypermutation of immunoglobulin genes [GO:0016446] GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006298; GO:0009410; GO:0016446; GO:0016887; GO:0032138; GO:0032300; GO:0032389; GO:0036464; GO:0140664 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138] AESSSTEPAK 0.99208 -47.657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3735 13.2053 0 0 0 12.6725 0 0 0 0 0 0 0 0 0 0 0 18.9988 19.3043 0 0 0 0 0 0 0 0 0 0 12.2619 0 0 0 0 0 0 0 0 11.3506 14.3633 11.4265 0 12.3815 0 0 0 13.1181 0 0 0 12.8894 11.2419 12.9012 0 12.641 13.8913 14.2046 0 0 0 0 0 0 0 0 13.6849 0 0 13.6534 0 13.6801 0 0 0 14.4255 0 0 0 12.8434 11.6974 11.2096 0 13.5947 0 13.0125 0 12.5342 0 0 0 0 13.0856 0 11.6263 0 0 0 0 0 13.2314 0 0 0 0 0 13.5499 0 0 0 0 0 0 0 0 0 14.6493 0 13.4138 15.1725 0 0 0 0 0 0 16.2193 0 12.5673 0 0 0 0 0 0 0 0 0 0 10.5581 0 0 0 P61353 RL27_HUMAN 60S ribosomal protein L27 (Large ribosomal subunit protein eL27) RPL27 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:0098556; GO:1904044; GO:1990904 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] PYSHALVAGIDRYPR 0.99208 -17.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6098 0 0 0 12.5847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7647 0 0 0 0 14.3939 0 0 0 0 0 0 0 0 12.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4839 0 0 0 0 0 0 0 14.0674 0 0 0 0 0 0 12.6049 0 Q07157 ZO1_HUMAN Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1) TJP1 ZO1 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of actin cytoskeleton reorganization [GO:2000250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of actin cytoskeleton reorganization [GO:2000250]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493] GO:0002102; GO:0005516; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005921; GO:0005923; GO:0007043; GO:0008284; GO:0016323; GO:0030054; GO:0030335; GO:0031032; GO:0032991; GO:0034334; GO:0035633; GO:0042995; GO:0043066; GO:0043296; GO:0045177; GO:0045216; GO:0045296; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000250; GO:2000810 cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cell adhesion molecule binding [GO:0050839] APGFGFGIAISGGRDNPHFQSGETSIVISDVLK 0.99208 -47.392 0 0 0 0 0 0 0 0 13.5933 13.675 13.247 13.2163 17.5471 13.5047 13.3994 0 0 0 0 0 0 0 0 0 0 0 12.2781 0 13.1517 0 13.6017 13.1969 13.2778 17.1846 13.2298 0 13.3472 13.2659 0 0 0 0 0 0 13.4597 12.6046 0 0 0 0 0 0 0 0 0 17.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5078 0 12.1307 0 0 13.6066 12.951 0 0 0 0 0 16.9017 15.111 14.3437 0 0 0 0 0 0 0 17.1129 12.7058 0 13.9203 0 12.5877 14.5421 14.2855 0 0 14.8286 0 0 12.8998 16.5723 13.6788 11.3391 0 0 0 0 14.0693 0 12.9763 0 14.8637 0 11.3194 0 15.0034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0298 13.4573 0 0 0 0 0 0 0 0 0 0 0 11.1444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.143 0 0 0 0 12.5543 14.4447 0 11.5077 0 0 0 Q11203 SIAT6_HUMAN "CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase, EC 2.4.99.6 (Beta-galactoside alpha-2,3-sialyltransferase 3, Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III, ST3GalIII) (ST3N) (Sialyltransferase 6)" ST3GAL3 SIAT6 Homo sapiens (Human) ganglioside biosynthetic process via lactosylceramide [GO:0010706]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; viral protein processing [GO:0019082] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; viral protein processing [GO:0019082]" GO:0000139; GO:0003836; GO:0005576; GO:0006486; GO:0008118; GO:0008373; GO:0009312; GO:0010706; GO:0016021; GO:0016266; GO:0018146; GO:0019082; GO:0032580 "beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; sialyltransferase activity [GO:0008373]" CIIVGNGGVLANK 0.99208 -7.3537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9616 0 0 0 0 11.4776 0 0 0 0 0 0 0 0 12.063 0 0 0 16.6928 0 0 0 0 12.3448 20.65 12.2048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5085 0 15.0146 0 0 15.4174 0 15.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6242 0 0 0 0 0 0 0 0 17.6387 12.3468 0 0 0 0 0 0 0 0 0 0 0 12.2764 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53GG5 PDLI3_HUMAN PDZ and LIM domain protein 3 (Actinin-associated LIM protein) (Alpha-actinin-2-associated LIM protein) PDLIM3 ALP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; stress fiber [GO:0001725]; Z disc [GO:0030018] adherens junction [GO:0005912]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061] GO:0001725; GO:0003779; GO:0005829; GO:0005912; GO:0007507; GO:0030018; GO:0030036; GO:0031941; GO:0046872; GO:0051371; GO:0061061 actin binding [GO:0003779]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371] SVRAPVTK 0.99208 -6.0364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4832 0 0 0 0 0 0 0 0 11.9159 0 0 0 0 0 13.5494 0 13.8831 0 0 14.2204 13.6353 0 0 11.4047 0 0 0 0 0 0 0 0 0 13.3711 0 0 0 14.0083 0 13.7438 0 13.6287 0 0 13.7841 0 0 13.6668 0 13.7627 0 0 0 13.8015 11.2546 13.7071 0 0 11.106 11.3417 0 0 0 0 13.4774 13.9304 0 0 0 0 0 0 0 0 0 0 0 14.0435 0 13.8642 0 0 0 0 0 0 0 0 0 0 11.1482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JS54 PSMG4_HUMAN "Proteasome assembly chaperone 4, PAC-4, hPAC4" PSMG4 C6orf86 PAC4 Homo sapiens (Human) proteasome assembly [GO:0043248] protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; proteasome assembly [GO:0043248] GO:0032991; GO:0043248; GO:0044877 protein-containing complex binding [GO:0044877] EEMEAFPEK 0.99208 -6.7235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0863 0 0 15.3439 0 0 14.2129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0F9 C2D1B_HUMAN "Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2, FRE under dual repression-binding protein 2, Freud-2)" CC2D1B KIAA1836 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005635; GO:0005654; GO:0006357; GO:0043231 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EAAASAK 0.99208 -47.606 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2147 0 0 0 14.6365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7158 0 0 0 14.9656 12.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9205 10.5042 0 0 0 0 0 0 10.3963 0 0 0 0 0 0 0 13.7579 13.532 13.5908 13.625 13.6333 0 0 0 13.7484 0 15.9484 13.785 0 14.4331 0 13.9964 0 0 0 0 13.4219 13.3813 0 0 0 13.2503 0 0 10.5911 0 0 14.1745 14.0939 0 0 0 0 13.8816 0 13.8049 12.2244 0 0 13.1283 0 0 14.9082 14.4849 12.2194 14.1947 0 0 0 0 0 0 0 0 0 0 0 0 13.6187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.655 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1021 0 Q7Z443 PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 (PC1-like 3 protein) (Polycystin-1L3) PKD1L3 Homo sapiens (Human) cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of mechanical stimulus [GO:0050982]; kidney development [GO:0001822]; sensory perception of sour taste [GO:0050915] cation channel complex [GO:0034703]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cation channel complex [GO:0034703]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; cation transport [GO:0006812]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of mechanical stimulus [GO:0050982]; kidney development [GO:0001822]; sensory perception of sour taste [GO:0050915] GO:0001581; GO:0001822; GO:0005262; GO:0005886; GO:0006812; GO:0016020; GO:0030246; GO:0034703; GO:0043235; GO:0050915; GO:0050982; GO:0070062; GO:0071468 calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246] AGEGSWLESKR 0.99208 -6.7182 0 0 0 0 0 0 0 0 14.8539 0 0 0 0 0 0 0 0 0 0 0 13.9709 0 0 0 0 0 0 0 0 0 0 15.6505 0 14.9886 0 0 14.1298 15.2479 14.8924 0 14.0367 0 0 0 15.4921 0 11.7272 13.7357 15.1124 0 0 11.666 0 0 0 0 0 0 0 0 10.8568 0 0 0 0 0 0 0 0 0 10.9443 10.7839 0 0 0 0 0 0 0 0 0 12.8155 0 0 0 0 0 14.4956 14.9943 15.0059 0 14.3665 0 0 0 0 0 0 11.5616 0 0 0 0 0 0 0 13.6984 13.1931 0 0 0 11.3554 0 0 11.0306 11.4975 0 11.9648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6132 0 0 0 0 0 11.6613 0 0 0 0 0 0 12.0089 0 0 0 0 0 0 0 0 0 0 0 0 14.5828 14.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXT5 RB12B_HUMAN RNA-binding protein 12B (RNA-binding motif protein 12B) RBM12B Homo sapiens (Human) regulation of RNA splicing [GO:0043484] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; regulation of RNA splicing [GO:0043484] GO:0003723; GO:0005654; GO:0043484; GO:1990904 RNA binding [GO:0003723] AEMQKTIEMKR 0.99208 -47.788 0 0 0 0 19.3016 0 19.6639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1002 0 10.518 0 0 0 0 0 0 0 0 14.008 0 0 0 0 0 0 0 0 0 12.8036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1269 0 0 0 0 0 17.6865 17.8748 17.702 15.3314 15.1318 0 0 0 16.8504 0 14.9163 12.8087 0 14.5818 13.7873 13.7104 14.2136 13.6754 14.6467 0 14.3351 13.7588 0 14.1829 12.3161 0 12.6167 14.9278 12.8237 14.9979 0 14.5842 12.2436 13.8645 15.1882 14.279 0 0 13.8755 16.2365 15.0228 14.1128 0 0 14.4189 13.2201 12.1051 13.8702 10.5667 0 0 11.1249 0 14.5204 0 0 0 14.5533 14.3591 13.5749 14.0052 17.3882 0 16.86 0 0 0 0 11.7816 0 0 0 13.7878 0 0 0 14.1761 0 0 12.5863 13.8085 14.9175 0 0 11.5303 0 12.7244 0 0 0 0 0 0 0 0 0 11.3169 0 0 0 0 0 0 0 0 0 Q8NCH0 CHSTE_HUMAN "Carbohydrate sulfotransferase 14, EC 2.8.2.35 (Dermatan 4-sulfotransferase 1, D4ST-1, hD4ST1)" CHST14 D4ST1 UNQ1925/PRO4400 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655] GO:0000139; GO:0001537; GO:0008146; GO:0016021; GO:0016051; GO:0030208; GO:0042301; GO:0050655; GO:0070062 N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146] AGLGGPPLLLPSMLMFAVIVASSGLLLMIERGILAEMK 0.99208 -7.6622 0 0 0 0 0 0 0 0 11.9452 0 11.1515 13.5451 13.0948 13.3006 13.1257 13.2981 13.9733 13.0256 0 0 0 0 0 0 13.6253 15.7056 0 0 13.8882 0 0 13.9808 0 12.3379 0 0 0 0 0 12.9227 13.3597 0 0 13.413 0 14.1859 14.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.938 0 0 0 0 0 13.7945 0 18.912 0 17.8754 0 18.116 0 13.6638 17.9877 0 0 0 0 0 0 10.3555 12.4235 0 0 0 14.353 0 0 0 14.3902 0 0 0 0 0 18.4625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7502 0 0 0 0 0 0 0 12.1185 0 17.1824 0 0 0 0 0 0 0 0 17.1994 0 0 0 0 0 0 0 0 14.4921 14.4022 13.9222 0 13.3584 13.4649 0 0 0 17.7791 10.6807 0 0 0 0 Q8WTR7 ZN473_HUMAN "Zinc finger protein 473 (Zinc finger protein 100 homolog, Zfp-100)" ZNF473 KIAA1141 ZFP100 Homo sapiens (Human) mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; regulation of transcription by RNA polymerase II [GO:0006357] Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0006398; GO:0015030; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFTRIFHLTR 0.99208 -17.748 0 0 0 0 0 0 0 0 0 0 11.8365 0 0 11.5484 0 0 0 0 0 0 0 12.1295 0 13.1898 0 0 0 0 11.5523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.887 0 0 0 0 0 10.864 0 10.8423 0 10.8081 0 0 0 10.2454 13.2598 14.4034 0 0 0 0 10.9758 0 0 0 0 13.5984 11.823 13.2596 11.7754 14.7033 13.9028 14.4982 13.2203 0 15.1808 0 0 0 0 14.0535 0 14.3212 0 0 14.3208 13.361 13.206 13.8002 12.9781 13.2522 0 15.6023 0 0 0 15.6342 15.3333 0 0 13.3382 13.0367 0 11.0092 10.8114 0 0 0 0 15.3777 15.8307 0 0 0 12.0059 15.2912 0 0 0 0 0 0 0 13.1774 14.8613 12.523 14.0397 0 0 0 0 0 0 15.3113 0 0 11.1725 0 0 0 0 0 0 12.0885 15.7929 12.7949 0 0 0 0 0 12.0466 0 0 13.2872 0 0 12.2383 0 0 14.6706 0 14.6111 0 0 0 0 0 12.3146 Q8WXQ3 CN183_HUMAN Putative uncharacterized protein encoded by LINC01599 LINC01599 C14orf183 Homo sapiens (Human) GKCCCCR 0.99208 -4.513 0 0 0 0 0 0 0 0 11.6432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8472 0 12.3446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92802 N42L2_HUMAN NEDD4-binding protein 2-like 2 (Phosphonoformate immuno-associated protein 5) N4BP2L2 CG005 PFAAP5 Homo sapiens (Human) blastocyst development [GO:0001824]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035] extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]; blastocyst development [GO:0001824]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035] GO:0000122; GO:0001824; GO:0003714; GO:0005634; GO:0017053; GO:0019899; GO:0070062; GO:1902035; GO:1902037 enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714] AMPSHCDYQQNLGNEPDK 0.99208 -17.737 0 0 0 13.824 0 12.4447 13.2657 0 0 0 13.8179 12.9205 9.93924 0 0 0 13.0525 0 0 0 13.1337 12.4019 0 13.644 0 0 0 0 13.1291 0 12.9544 0 12.9856 0 0 0 13.3187 0 0 13.8745 14.0799 0 0 0 0 0 0 0 0 14.388 14.4202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2227 13.5671 14.4374 14.169 15.6573 0 15.4255 14.8201 15.4437 0 13.7471 14.0604 0 15.5241 14.2555 14.3461 0 0 13.4962 11.0842 0 0 14.1603 13.9431 13.9885 14.3385 15.024 0 14.9411 14.8675 11.8733 15.3582 14.1713 11.3483 0 15.2616 14.8769 14.8427 14.4645 14.1148 14.423 14.1412 14.6249 14.4035 14.5093 14.5659 16.3979 13.1061 14.3991 13.946 15.1537 14.4153 15.4873 15.4162 15.3968 14.6668 14.9543 14.3333 15.4458 14.2392 12.2325 0 15.4423 14.4224 14.3288 15.3625 14.9308 14.251 15.7514 0 15.8616 12.67 0 0 14.3392 12.9546 0 18.8781 15.6277 12.9887 0 0 15.0305 0 13.5976 15.2945 14.4248 14.6695 13.0077 15.0396 14.3656 12.2133 0 0 10.2815 0 0 13.6639 12.5726 0 0 0 0 0 0 0 14.9936 15.8719 15.5183 13.6738 0 0 14.4608 0 Q96PM5 ZN363_HUMAN "RING finger and CHY zinc finger domain-containing protein 1, EC 2.3.2.27 (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein, hPirh2)" RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363 Homo sapiens (Human) error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0002039; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0043231; GO:0051865; GO:0061630; GO:0070987 p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CKICESYNTAQAGGR 0.99208 -7.6637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3616 0 11.0975 0 0 0 0 0 0 0 12.5926 0 10.8572 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6244 13.3085 10.4719 0 0 0 11.0437 0 0 0 0 0 0 0 0 0 0 0 0 14.8639 13.2887 0 0 0 0 0 0 0 0 0 12.596 0 13.7054 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3256 0 0 0 0 0 0 0 0 0 0 0 0 13.2258 0 0 0 12.0013 0 10.3709 0 0 0 0 0 0 0 11.2288 0 0 12.7478 0 11.1163 0 0 0 0 0 0 0 0 0 0 11.3382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1679 0 0 0 0 0 Q99500 S1PR3_HUMAN "Sphingosine 1-phosphate receptor 3, S1P receptor 3, S1P3 (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3, S1P receptor Edg-3)" S1PR3 C9orf108 C9orf47 EDG3 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of establishment of endothelial barrier [GO:1903141]; Notch signaling pathway [GO:0007219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of interleukin-1 beta production [GO:0032651]; regulation of metabolic process [GO:0019222] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of establishment of endothelial barrier [GO:1903141]; Notch signaling pathway [GO:0007219]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of interleukin-1 beta production [GO:0032651]; regulation of metabolic process [GO:0019222] GO:0004930; GO:0005178; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007189; GO:0007193; GO:0007204; GO:0007219; GO:0008284; GO:0008289; GO:0009653; GO:0019222; GO:0032651; GO:0038036; GO:1903141 G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036] AFFRLVCNCLVRGR 0.99208 -17.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.845 0 0 0 0 0 0 14.5569 0 0 0 0 0 0 0 13.2787 0 0 0 12.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.525 0 0 0 0 0 0 0 0 0 13.7868 0 0 0 0 12.5637 0 0 0 14.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6526 0 0 0 0 0 13.3658 0 0 0 0 0 0 0 0 0 0 0 Q9H0E3 SP130_HUMAN Histone deacetylase complex subunit SAP130 (130 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p130) SAP130 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459] nuclear speck [GO:0016607]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822] nuclear speck [GO:0016607]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459] GO:0000122; GO:0005634; GO:0016580; GO:0016607; GO:0030336; GO:0030512; GO:0070822; GO:1902455; GO:1902459 HYRNPWK 0.99208 -17.73 0 0 0 0 0 0 0 0 0 11.8974 0 12.4798 0 11.8214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7733 0 0 0 0 10.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8361 0 14.2993 0 0 0 0 0 0 12.9078 0 0 0 0 13.2831 0 0 12.3961 0 0 0 0 12.4904 13.1112 0 0 0 0 0 0 0 11.6534 0 0 0 0 0 12.4861 0 0 0 0 0 0 0 0 12.153 13.0959 0 0 0 0 0 12.6139 0 0 0 14.1421 0 0 0 0 0 0 0 0 0 0 0 12.1686 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1805 0 0 0 0 0 0 0 0 0 0 0 13.0146 0 0 0 0 0 0 15.0715 11.9308 0 0 Q9H7D0 DOCK5_HUMAN Dedicator of cytokinesis protein 5 DOCK5 Homo sapiens (Human) cell migration [GO:0016477]; myoblast fusion [GO:0007520]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; myoblast fusion [GO:0007520]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0007520; GO:0010634; GO:0016477; GO:0031267; GO:1900026; GO:1904694; GO:1904754 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] AIHPGAGYEGISEYK 0.99208 -47.29 0 0 0 10.5137 0 0 0 0 0 0 0 0 0 0 0 15.0048 11.8348 0 13.6467 0 0 0 0 0 13.4871 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4545 0 0 12.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.595 13.2935 0 13.6692 13.2433 0 10.7801 0 0 0 14.3675 10.7133 12.3331 0 0 0 0 14.2948 0 0 0 16.4031 13.688 0 0 0 15.3824 0 0 11.8072 0 0 0 13.9198 0 0 0 0 0 11.7205 0 0 0 0 0 0 0 0 0 17.3149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0292 0 0 0 0 0 13.6829 0 0 0 0 13.7174 12.3297 0 0 0 0 0 0 14.8621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1161 12.9013 0 0 12.5839 17.0775 0 0 13.5522 0 0 12.1105 0 16.3798 12.7784 16.6214 Q9HCN6 GPVI_HUMAN "Platelet glycoprotein VI, GPVI (Glycoprotein 6)" GP6 Homo sapiens (Human) collagen-activated signaling pathway [GO:0038065]; enzyme-linked receptor protein signaling pathway [GO:0007167]; platelet activation [GO:0030168]; positive regulation of platelet aggregation [GO:1901731] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; collagen binding [GO:0005518]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; collagen-activated signaling pathway [GO:0038065]; enzyme-linked receptor protein signaling pathway [GO:0007167]; platelet activation [GO:0030168]; positive regulation of platelet aggregation [GO:1901731] GO:0004888; GO:0005518; GO:0005886; GO:0005887; GO:0007167; GO:0009986; GO:0030168; GO:0038023; GO:0038065; GO:0045121; GO:0070062; GO:0097197; GO:1901731; GO:1990782 collagen binding [GO:0005518]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] AVQRPLPPLPPLPLTR 0.99208 -17.773 0 0 0 0 0 0 0 0 0 0 10.1223 0 0 0 0 0 0 9.92107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7057 0 0 0 0 0 0 0 0 0 11.5644 13.3857 0 0 0 0 0 0 0 0 0 0 0 13.9916 0 0 0 0 0 0 0 0 0 0 10.2322 0 0 0 14.0089 0 0 0 0 0 0 0 0 0 0 0 0 12.7274 0 0 0 0 0 0 0 13.1241 10.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2961 0 10.1342 0 10.3194 0 0 12.5356 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4213 13.2688 0 0 0 0 0 0 0 0 0 12.4338 0 0 0 0 0 0 9.82909 0 Q9NT68 TEN2_HUMAN "Teneurin-2, Ten-2 (Protein Odd Oz/ten-m homolog 2) (Tenascin-M2, Ten-m2) (Teneurin transmembrane protein 2) [Cleaved into: Ten-2, soluble form; Ten-2 intracellular domain, Ten-2 ICD ]" TENM2 KIAA1127 ODZ2 TNM2 Homo sapiens (Human) axon guidance [GO:0007411]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell-cell adhesion [GO:0098609]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; positive regulation of filopodium assembly [GO:0051491]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell-cell adhesion [GO:0098609]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; positive regulation of filopodium assembly [GO:0051491]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; signal transduction [GO:0007165] GO:0000122; GO:0005102; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005911; GO:0007157; GO:0007165; GO:0007411; GO:0016605; GO:0030054; GO:0030175; GO:0030425; GO:0030426; GO:0035584; GO:0042803; GO:0043005; GO:0043197; GO:0045202; GO:0045211; GO:0046982; GO:0048666; GO:0050839; GO:0051491; GO:0070161; GO:0098609; GO:0098942 calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] CEEGWTGAACDQR 0.99208 -47.401 0 0 0 0 12.7853 0 0 0 10.7244 0 0 0 0 0 0 0 0 11.126 11.5031 0 0 14.1115 0 0 11.9902 0 0 13.0354 0 10.1472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5067 12.5094 0 11.0267 0 13.6036 0 0 0 11.5492 0 0 0 0 0 0 0 10.141 0 0 0 0 0 10.4837 0 0 0 0 0 0 0 0 0 13.5753 11.8964 0 0 0 15.6626 15.6558 0 0 0 15.6849 0 14.0753 0 12.9562 12.8493 11.8088 14.2573 0 0 17.2072 0 13.9496 0 12.7119 0 0 0 11.4801 11.4537 14.1483 14.0811 13.559 12.6106 0 15.0317 0 14.227 15.0194 0 14.8055 0 0 0 13.5335 13.9281 0 0 15.5729 14.4682 13.9556 13.1046 0 0 12.1845 10.2824 13.3899 0 0 13.4598 13.5018 0 13.0275 0 14.2027 0 16.2706 0 10.9312 0 12.4477 11.4077 0 0 13.5964 0 13.8202 0 14.8022 12.6804 13.1389 14.1041 0 0 12.7466 12.8841 0 0 0 0 0 12.1393 0 13.1553 0 0 0 0 0 0 0 0 0 Q9UMY1 NOL7_HUMAN Nucleolar protein 7 (Nucleolar protein of 27 kDa) NOL7 C6orf90 NOP27 Homo sapiens (Human) chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; RNA binding [GO:0003723] GO:0003723; GO:0005694; GO:0005730; GO:0005739 RNA binding [GO:0003723] MVQLRPR 0.99208 -17.765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7922 0 0 0 16.996 0 0 13.724 0 0 12.0976 0 14.428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7921 0 0 0 0 0 0 0 17.1466 0 0 0 0 0 0 0 0 0 0 0 12.8976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1582 0 13.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3S1 WNK2_HUMAN "Serine/threonine-protein kinase WNK2, EC 2.7.11.1 (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43)" WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0008285; GO:0010766; GO:0019869; GO:0019870; GO:0035556; GO:0046777; GO:0050801; GO:0070373; GO:0090263; GO:0106310; GO:1903288; GO:2000651 ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AKAARPGPQR 0.99208 -47.836 0 0 0 0 0 0 0 13.2077 12.2749 0 13.0268 0 0 0 0 0 11.8028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6716 0 13.9182 0 0 11.5653 12.7163 0 0 0 0 0 0 0 0 13.0522 0 0 0 12.051 0 0 0 0 0 0 0 0 0 0 11.3504 0 0 0 13.216 0 0 0 0 0 0 14.1967 0 0 0 0 15.955 0 0 0 0 0 0 0 0 11.8767 12.9913 13.6237 0 14.3884 0 13.1596 14.2968 14.9832 0 12.2819 0 14.441 14.0359 0 0 0 0 11.9908 13.9153 14.5273 13.9597 15.2164 0 0 14.8253 14.9804 13.2883 0 0 0 14.8201 0 14.1706 0 13.4253 0 0 10.338 12.6465 13.7606 0 0 16.7052 13.3224 0 12.8049 13.5314 0 0 13.493 10.9798 15.2322 17.0559 0 15.032 14.3766 0 12.5304 0 18.8193 13.6325 0 12.8335 0 0 0 12.6678 0 0 0 13.7951 0 0 13.3313 0 0 13.863 10.8507 18.7066 14.3695 0 13.7492 13.7489 0 Q9Y3Z3 SAMH1_HUMAN "Deoxynucleoside triphosphate triphosphohydrolase SAMHD1, dNTPase, EC 3.1.5.- (Dendritic cell-derived IFNG-induced protein, DCIP) (Monocyte protein 5, MOP-5) (SAM domain and HD domain-containing protein 1, hSAMHD1)" SAMHD1 MOP5 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; tetraspanin-enriched microdomain [GO:0097197]; deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446] GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0004540; GO:0005525; GO:0005634; GO:0005654; GO:0005886; GO:0006203; GO:0006955; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0042802; GO:0045087; GO:0045088; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0097197; GO:0106375; GO:0110025 deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270] ADDYIEITGAGGK 0.99208 -23.973 0 0 0 0 0 0 0 0 0 10.8741 0 0 0 0 0 9.85538 9.25368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7461 0 0 0 0 10.8986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.511 0 0 0 0 13.0489 0 0 0 0 0 0 0 0 15.4453 0 0 0 0 0 15.7586 0 0 0 0 0 0 0 0 12.7176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2479 0 0 0 0 0 0 0 0 0 0 15.6143 0 0 0 0 0 0 0 0 0 0 0 0 10.009 0 0 0 0 0 0 0 0 Q9Y608 LRRF2_HUMAN "Leucine-rich repeat flightless-interacting protein 2, LRR FLII-interacting protein 2" LRRFIP2 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" "LRR domain binding [GO:0030275]; regulation of transcription, DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055]" GO:0006355; GO:0016055; GO:0030275 LRR domain binding [GO:0030275] EELLSQIR 0.99208 -24.81 0 0 0 0 12.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1931 0 10.8901 0 0 14.0557 0 0 0 0 0 13.2838 0 0 11.2306 0 0 0 0 0 0 0 13.4838 13.6796 0 0 0 0 12.4799 12.9566 12.9021 11.8173 12.0025 0 0 0 0 0 0 0 0 0 11.2617 0 0 0 12.2689 0 15.9465 12.8019 15.5886 0 0 0 0 16.7619 0 0 0 17.1041 0 0 0 0 0 0 0 13.1804 0 13.5637 0 12.726 0 0 0 0 17.1995 0 11.7094 13.2473 0 0 0 19.2478 0 0 11.8124 0 0 11.9127 0 0 0 0 14.325 12.3689 0 0 0 12.769 0 13.5761 11.4947 0 0 0 10.7622 0 0 12.333 12.1964 0 0 0 0 13.8357 0 0 13.3092 0 0 12.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3158 11.8844 0 12.3457 0 13.1588 0 0 12.9745 0 13.2432 0 0 O00562 PITM1_HUMAN "Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1, PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2, NIR-2)" PITPNM1 DRES9 NIR2 PITPNM Homo sapiens (Human) brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031] cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496] cell body [GO:0044297]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971]; brain development [GO:0007420]; lipid metabolic process [GO:0006629]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipid transport [GO:0015914]; phototransduction [GO:0007602]; protein transport [GO:0015031] GO:0005509; GO:0005737; GO:0005789; GO:0005811; GO:0005829; GO:0006629; GO:0006661; GO:0007420; GO:0007602; GO:0008525; GO:0008526; GO:0015031; GO:0015914; GO:0016020; GO:0030496; GO:0030971; GO:0031210; GO:0032154; GO:0032580; GO:0035091; GO:0043231; GO:0044297; GO:0070300 calcium ion binding [GO:0005509]; phosphatidic acid binding [GO:0070300]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971] DSENSSEEEFFDAHEGFSDSEEVFPKEMTK 0.99209 -7.6723 0 0 0 0 0 0 0 0 0 12.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8549 13.9933 0 12.0104 0 14.1613 0 12.9076 0 0 0 0 0 0 0 13.8394 13.8153 0 0 0 0 12.1975 0 0 0 0 0 14.4693 0 0 0 0 0 0 0 0 0 0 12.327 0 0 0 0 0 0 0 0 0 0 0 14.0202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1832 0 0 0 15.0291 15.98 0 0 0 0 0 19.179 0 0 0 0 0 0 13.928 0 0 0 0 14.3326 0 14.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7626 13.955 0 0 0 0 0 0 0 0 0 0 0 0 O60683 PEX10_HUMAN Peroxisome biogenesis factor 10 (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10) (RING finger protein 69) PEX10 RNF69 Homo sapiens (Human) peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558] integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558] GO:0005777; GO:0005778; GO:0005779; GO:0007031; GO:0008022; GO:0008270; GO:0016558; GO:0046872 metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; zinc ion binding [GO:0008270] AECPLCR 0.99209 -7.5681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5012 0 13.0687 0 0 14.6598 0 0 0 0 12.984 0 14.7416 0 13.9612 0 0 13.9966 0 0 14.6857 0 11.9664 0 0 10.9752 0 14.6039 0 14.2279 0 10.6301 0 11.6343 0 0 0 15.5283 0 0 15.4234 0 14.7601 0 0 14.6395 14.0678 0 13.9762 0 14.376 0 0 0 13.8238 12.2516 0 0 0 13.4534 0 13.695 12.1958 0 0 0 0 0 0 0 11.8815 0 0 0 14.3469 0 14.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7155 0 0 0 0 0 0 0 O95947 TBX6_HUMAN "T-box transcription factor TBX6, T-box protein 6" TBX6 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cardiac chamber development [GO:0003205]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; heart looping [GO:0001947]; mesoderm development [GO:0007498]; mesodermal cell fate specification [GO:0007501]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in regulation of gene expression [GO:0023019]; somite rostral/caudal axis specification [GO:0032525] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cardiac chamber development [GO:0003205]; cell fate specification [GO:0001708]; central nervous system development [GO:0007417]; heart looping [GO:0001947]; mesoderm development [GO:0007498]; mesodermal cell fate specification [GO:0007501]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in regulation of gene expression [GO:0023019]; somite rostral/caudal axis specification [GO:0032525]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001947; GO:0003205; GO:0003677; GO:0005634; GO:0006357; GO:0007417; GO:0007498; GO:0007501; GO:0008284; GO:0009653; GO:0010977; GO:0014043; GO:0023019; GO:0032525; GO:0043433; GO:0045944; GO:0061629; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" AAQLCSQHWGGMASFR 0.99209 -18.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5001 0 0 0 0 0 0 0 0 0 0 14.8073 0 0 0 0 0 0 0 0 0 0 0 12.3773 0 0 0 0 0 0 14.8293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14651 PLSI_HUMAN "Plastin-1 (Intestine-specific plastin, I-plastin)" PLS1 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; auditory receptor cell stereocilium organization [GO:0060088]; intestinal D-glucose absorption [GO:0001951]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of microvillus length [GO:0032532]; terminal web assembly [GO:1902896]; vestibular receptor cell stereocilium organization [GO:0060121] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; stereocilium [GO:0032420]; terminal web [GO:1990357] actin filament [GO:0005884]; actin filament bundle [GO:0032432]; brush border [GO:0005903]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; stereocilium [GO:0032420]; terminal web [GO:1990357]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; auditory receptor cell stereocilium organization [GO:0060088]; intestinal D-glucose absorption [GO:0001951]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of microvillus length [GO:0032532]; terminal web assembly [GO:1902896]; vestibular receptor cell stereocilium organization [GO:0060121] GO:0001951; GO:0005200; GO:0005509; GO:0005737; GO:0005884; GO:0005903; GO:0032420; GO:0032432; GO:0032532; GO:0040018; GO:0051015; GO:0051017; GO:0051639; GO:0060088; GO:0060121; GO:0070062; GO:1902896; GO:1903078; GO:1990357 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; structural constituent of cytoskeleton [GO:0005200] DISKTFR 0.99209 -7.1902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1447 0 0 0 0 0 11.3365 0 12.0606 0 0 0 12.8636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15544 TAF11_HUMAN "Transcription initiation factor TFIID subunit 11 (TFIID subunit p30-beta) (Transcription initiation factor TFIID 28 kDa subunit, TAF(II)28, TAFII-28, TAFII28)" TAF11 TAF2I PRO2134 Homo sapiens (Human) mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669] Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein phosphorylation [GO:0006468]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005794; GO:0006366; GO:0006367; GO:0006468; GO:0016251; GO:0017025; GO:0042789; GO:0042809; GO:0043923; GO:0046966; GO:0046982; GO:0047485; GO:0051123; GO:0060261 nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713] DDAHESPSDK 0.99209 -18.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1012 12.8602 0 0 0 0 0 0 12.345 0 0 0 0 0 14.5411 14.3335 14.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5473 0 0 0 0 0 0 0 13.9433 12.216 0 0 0 0 0 13.3056 0 0 0 13.2253 12.9364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TB80 CE162_HUMAN "Centrosomal protein of 162 kDa, Cep162 (Protein QN1 homolog)" CEP162 C6orf84 KIAA1009 QN1 Homo sapiens (Human) cilium assembly [GO:0060271] axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819] axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cilium assembly [GO:0060271] GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0060271 ARSAPPLLK 0.99209 -47.893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2916 0 11.9764 0 0 0 0 0 0 0 11.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.008 0 0 0 0 0 0 0 0 0 0 10.1339 0 0 0 0 0 0 11.4837 0 0 0 0 0 13.6231 13.6431 9.68335 12.6547 12.8156 16.6417 14.1242 16.9508 12.7431 16.9936 16.8674 0 14.0407 14.1873 14.1604 14.0266 0 0 0 17.8101 15.4883 13.4751 0 0 13.1127 0 0 0 11.3106 14.0055 12.372 13.6413 0 0 0 0 12.003 0 13.6015 13.8867 0 0 13.0145 0 0 0 0 10.5208 14.0896 0 0 0 14.4528 0 0 0 13.0284 0 0 11.4263 0 0 0 0 12.126 0 13.4459 12.4786 12.6165 0 0 0 0 0 13.8778 15.0864 14.0407 0 0 0 0 12.692 0 0 0 0 0 0 0 0 12.1616 13.0977 12.3712 0 0 0 10.7864 14.2128 0 0 14.2863 Q70YC5 ZN365_HUMAN Protein ZNF365 (DISC1-binding zinc-finger protein) (Protein su48) ZNF365 DBZ KIAA0844 Homo sapiens (Human) cerebellar molecular layer morphogenesis [GO:0021687]; dendrite arborization [GO:0140059]; dendritic spine morphogenesis [GO:0060997]; negative regulation of neuron projection development [GO:0010977]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA strand resection involved in replication fork processing [GO:0110026]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neuron projection development [GO:0010975]; telomere maintenance [GO:0000723] centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cerebellar molecular layer morphogenesis [GO:0021687]; dendrite arborization [GO:0140059]; dendritic spine morphogenesis [GO:0060997]; negative regulation of neuron projection development [GO:0010977]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA strand resection involved in replication fork processing [GO:0110026]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neuron projection development [GO:0010975]; telomere maintenance [GO:0000723] GO:0000723; GO:0005737; GO:0005813; GO:0010569; GO:0010975; GO:0010977; GO:0021687; GO:0042802; GO:0046872; GO:0048714; GO:0060997; GO:0110026; GO:0140059 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] ALNRQVDVAVEMIAVLR 0.99209 -18.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2886 0 12.8381 0 12.1241 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9181 0 0 13.2776 Q86VY9 T200A_HUMAN Transmembrane protein 200A TMEM200A KIAA1913 HBE61 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DIYSTVIDIHTLR 0.99209 -18.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2452 0 0 13.6926 0 0 0 0 0 17.8694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8016 13.0039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7141 16.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7434 0 Q92963 RIT1_HUMAN "GTP-binding protein Rit1, EC 3.6.5.2 (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1)" RIT1 RIBB RIT ROC1 Homo sapiens (Human) Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003 calmodulin binding [GO:0005516]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] DSGTRPVGSCCSSPAGLSREYK 0.99209 -7.5692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9489 0 13.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8568 0 0 0 0 0 0 0 0 0 0 0 0 12.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7074 0 0 0 0 0 0 Q9BQE5 APOL2_HUMAN "Apolipoprotein L2 (Apolipoprotein L-II, ApoL-II)" APOL2 Homo sapiens (Human) acute-phase response [GO:0006953]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; maternal process involved in female pregnancy [GO:0060135] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; membrane [GO:0016020]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; maternal process involved in female pregnancy [GO:0060135] GO:0005102; GO:0005576; GO:0005789; GO:0006629; GO:0006869; GO:0006953; GO:0008035; GO:0008203; GO:0008289; GO:0016020; GO:0042157; GO:0060135 high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; signaling receptor binding [GO:0005102] ARAQARNLDQSGTNVAK 0.99209 -7.3587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2767 0 0 0 0 11.7423 0 11.2638 0 0 0 0 0 0 0 0 0 0 0 0 11.2135 0 0 0 0 11.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5137 0 0 0 0 0 0 0 0 0 0 10.7345 0 0 0 0 0 0 0 0 0 0 0 0 11.0032 0 0 0 0 0 0 0 0 Q9BY15 AGRE3_HUMAN Adhesion G protein-coupled receptor E3 (EGF-like module receptor 3) (EGF-like module-containing mucin-like hormone receptor-like 3) ADGRE3 EMR3 UNQ683/PRO1562 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005509; GO:0005576; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0030667; GO:0101003 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] KELQKIVDK 0.99209 -7.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.245 0 0 0 0 0 0 0 0 0 16.1742 0 0 0 0 0 0 0 11.867 0 12.4951 0 0 0 0 0 0 0 0 12.9552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8106 0 0 0 0 0 0 0 0 16.6489 0 0 0 0 0 0 0 16.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPL8 TIDC1_HUMAN "Complex I assembly factor TIMMDC1, mitochondrial (Protein M5-14) (Translocase of inner mitochondrial membrane domain-containing protein 1, TIMM domain containing-protein 1)" TIMMDC1 C3orf1 UNQ247/PRO284 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] GO:0005654; GO:0005739; GO:0005743; GO:0016021 GFIRYGWR 0.99209 -7.685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3803 15.5657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UH03 SEPT3_HUMAN Neuronal-specific septin-3 SEPTIN3 SEP3 SEPT3 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104] anchoring junction [GO:0070161]; cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940] anchoring junction [GO:0070161]; cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104] GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0042802; GO:0043005; GO:0060090; GO:0061640; GO:0070161; GO:0098793; GO:0099569 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090] EVTHNIHYETYR 0.99209 -6.7347 0 0 0 0 0 0 11.0393 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98142 0 0 0 0 0 0 0 0 14.2637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4468 0 0 13.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7874 0 13.6442 0 0 0 14.0909 0 0 12.0847 0 0 0 0 0 12.1914 12.731 12.052 11.7151 0 0 11.7846 0 0 12.5848 0 0 0 0 14.5666 12.3189 13.403 14.7181 14.0899 13.5089 14.5875 12.9678 12.6069 14.6903 12.8305 0 0 0 0 12.7607 0 0 0 0 0 0 0 0 14.4142 12.9189 14.79 0 0 0 0 0 0 13.9663 0 16.9875 0 0 11.8723 0 14.2164 0 0 0 17.006 13.0088 12.6738 0 0 0 0 0 16.8628 0 0 0 0 0 0 0 14.3185 0 0 13.0039 0 0 Q9Y4Z0 LSM4_HUMAN "U6 snRNA-associated Sm-like protein LSm4 (Glycine-rich protein, GRP)" LSM4 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]" cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688] "cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0000398; GO:0000932; GO:0000956; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005829; GO:0008380; GO:0016020; GO:0017070; GO:0032991; GO:0033962; GO:0042731; GO:0046540; GO:0071005; GO:0097526; GO:0120115 PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] GMGGAGR 0.99209 -7.6833 0 0 0 13.0175 13.1925 0 0 0 0 0 0 13.75 0 13.0769 0 13.1979 0 0 12.6966 13.2887 0 0 17.0508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3491 0 0 0 0 12.9346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0123 0 0 12.2112 0 0 0 15.1336 14.5939 0 0 0 11.9944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2098 0 0 0 0 14.1297 0 0 0 0 0 0 0 0 0 0 0 11.8768 15.601 0 0 13.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4951 0 13.6267 0 0 0 11.7163 0 14.2461 0 0 0 0 0 0 0 0 0 12.3359 0 0 0 0 0 0 0 0 13.0495 0 0 0 0 0 0 0 11.01 0 0 0 Q9Y6A1 POMT1_HUMAN "Protein O-mannosyl-transferase 1, EC 2.4.1.109 (Dolichyl-phosphate-mannose--protein mannosyltransferase 1)" POMT1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of protein O-linked glycosylation [GO:1904100]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] acrosomal vesicle [GO:0001669]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529] acrosomal vesicle [GO:0001669]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum [GO:0016529]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; positive regulation of protein O-linked glycosylation [GO:1904100]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269] GO:0000030; GO:0001669; GO:0004169; GO:0005783; GO:0005789; GO:0006493; GO:0016021; GO:0016529; GO:0030198; GO:0035269; GO:0046872; GO:1904100 dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; metal ion binding [GO:0046872] HQLVVSSPPRPVR 0.99209 -7.3622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0927 0 0 0 0 0 0 10.1585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5322 0 0 0 0 0 0 0 0 0 0 0 12.4311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9605 0 0 0 0 0 0 0 0 0 0 12.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0875 0 0 0 0 0 0 0 0 0 11.7715 0 12.1197 0 11.6052 0 0 0 12.5343 0 0 0 0 0 O14523 C2C2L_HUMAN "Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like, C2CD2-like) (Transmembrane protein 24)" C2CD2L KIAA0285 TMEM24 DLNB23 Homo sapiens (Human) positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774] GO:0005789; GO:0005886; GO:0008526; GO:0016021; GO:0032541; GO:0035091; GO:0035774; GO:0043559; GO:0140268 insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526] GEEQVELSTIEELIKDAIVSTQPAMMVNLR 0.9921 -6.7578 0 0 11.2385 0 0 0 0 0 10.4603 0 10.9961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8669 0 13.5515 13.5858 13.7995 0 0 13.9506 13.5042 0 15.6223 0 0 0 14.1495 0 0 0 0 0 0 12.5585 0 12.5869 15.5201 15.7507 16.6861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0184 0 0 0 0 0 0 0 0 13.1995 13.8664 0 13.1547 13.3742 0 0 0 13.5536 0 0 12.9305 0 0 0 14.7452 0 11.5657 11.4721 0 0 0 0 0 0 0 0 0 12.3074 0 0 0 0 11.8731 0 0 0 0 11.7324 0 0 0 0 15.3452 0 0 12.3239 O95715 CXL14_HUMAN C-X-C motif chemokine 14 (Chemokine BRAK) (MIP-2G) (Small-inducible cytokine B14) CXCL14 MIP2G NJAC SCYB14 PSEC0212 UNQ240/PRO273 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of another organism [GO:0031640]; signal transduction [GO:0007165] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemokine activity [GO:0008009]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of another organism [GO:0031640]; signal transduction [GO:0007165] GO:0005615; GO:0005794; GO:0006935; GO:0007165; GO:0007267; GO:0008009; GO:0031640; GO:0061844 chemokine activity [GO:0008009] APPVSMRLLAAALLLLLLALYTARVDGSK 0.9921 -18.815 0 0 0 0 0 0 0 0 0 10.0341 0 14.4344 0 14.3485 0 14.5672 0 0 0 0 0 0 14.0818 0 0 14.7757 0 0 0 13.3947 0 0 0 0 0 0 0 13.0807 0 11.0239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1403 0 0 0 0 0 0 0 15.0075 14.4229 15.0452 14.8024 14.7224 14.5332 10.9803 14.6085 0 0 14.947 0 0 0 0 0 11.8288 0 0 0 0 0 13.4648 0 0 0 13.4873 0 11.6267 0 13.7291 0 13.9552 14.1025 0 0 0 14.4026 0 0 0 0 13.975 13.732 0 0 0 0 0 0 0 17.9572 0 0 0 0 13.6015 11.7989 12.3805 13.8683 0 0 0 0 0 0 0 0 11.9882 14.0187 0 0 11.8839 0 14.8981 0 0 12.7811 11.0898 12.0644 0 0 13.4311 0 0 14.0846 0 0 12.9987 12.8947 13.8763 0 12.2363 14.0217 0 0 0 0 P14543 NID1_HUMAN "Nidogen-1, NID-1 (Entactin)" NID1 NID Homo sapiens (Human) basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; glomerular basement membrane development [GO:0032836]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011] GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0005886; GO:0007160; GO:0010811; GO:0032836; GO:0043236; GO:0043237; GO:0043394; GO:0045785; GO:0051149; GO:0062023; GO:0070062; GO:0071711; GO:0098637; GO:0110011; GO:2001046 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394] CECVEGYQFSDEGTCVAVVDQR 0.9921 -7.5763 0 0 0 0 11.46 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5051 11.7843 0 0 0 0 14.4259 0 0 14.1093 14.9506 0 0 0 0 0 0 0 0 0 0 0 0 13.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16435 NCPR_HUMAN "NADPH--cytochrome P450 reductase, CPR, P450R, EC 1.6.2.4" POR CYPOR Homo sapiens (Human) carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; electron transport chain [GO:0022900]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to dexamethasone [GO:0071548]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; electron transport chain [GO:0022900]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to dexamethasone [GO:0071548]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805]" GO:0003420; GO:0003958; GO:0004128; GO:0005739; GO:0005789; GO:0005829; GO:0006805; GO:0007584; GO:0008941; GO:0009055; GO:0009437; GO:0009725; GO:0009812; GO:0010181; GO:0016020; GO:0016021; GO:0016491; GO:0016787; GO:0018393; GO:0019395; GO:0019899; GO:0022900; GO:0032332; GO:0032770; GO:0043154; GO:0043231; GO:0043602; GO:0045542; GO:0045880; GO:0046210; GO:0047726; GO:0050660; GO:0050661; GO:0060192; GO:0070988; GO:0071372; GO:0071375; GO:0071548; GO:0090031; GO:0090346 "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]" ALVPMFVR 0.9921 -18.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7108 0 0 0 0 0 0 0 0 0 13.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20807 CAN3_HUMAN "Calpain-3, EC 3.4.22.54 (Calcium-activated neutral proteinase 3, CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1, nCL-1)" CAPN3 CANP3 CANPL3 NCL1 Homo sapiens (Human) "apoptotic process [GO:0006915]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; G1 to G0 transition involved in cell differentiation [GO:0070315]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of myoblast differentiation [GO:0045661]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; myofibril [GO:0030016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; apoptotic process [GO:0006915]; calcium-dependent self proteolysis [GO:1990092]; cellular response to calcium ion [GO:0071277]; cellular response to salt stress [GO:0071472]; G1 to G0 transition involved in cell differentiation [GO:0070315]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription, DNA-templated [GO:0045893]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to membrane [GO:0072657]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of catalytic activity [GO:0050790]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of myoblast differentiation [GO:0045661]; response to calcium ion [GO:0051592]; response to muscle activity [GO:0014850]; sarcomere organization [GO:0045214]; self proteolysis [GO:0097264]" GO:0003824; GO:0004198; GO:0005509; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0007517; GO:0008233; GO:0008234; GO:0008307; GO:0014718; GO:0014850; GO:0030016; GO:0030018; GO:0030163; GO:0030239; GO:0030315; GO:0031402; GO:0031432; GO:0031648; GO:0032991; GO:0033234; GO:0042802; GO:0043066; GO:0043122; GO:0045214; GO:0045661; GO:0045862; GO:0045892; GO:0045893; GO:0046716; GO:0050790; GO:0051092; GO:0051281; GO:0051592; GO:0055103; GO:0060090; GO:0061061; GO:0065003; GO:0070315; GO:0071277; GO:0071472; GO:0072657; GO:0097264; GO:1990092 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; catalytic activity [GO:0003824]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; ligase regulator activity [GO:0055103]; molecular adaptor activity [GO:0060090]; peptidase activity [GO:0008233]; sodium ion binding [GO:0031402]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432] GCSAGGCR 0.9921 -18.343 0 0 0 11.3168 0 0 0 14.5158 0 0 0 0 0 0 0 10.9113 0 0 0 0 0 9.19923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6516 0 0 0 0 0 0 11.3301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7871 0 0 0 0 0 13.3399 0 12.4907 0 13.6855 0 0 0 0 0 17.9894 0 0 0 0 12.5567 14.5182 11.3132 0 0 11.1186 0 0 0 0 0 0 0 0 0 16.3433 0 0 0 0 14.0159 0 0 12.0953 0 0 15.4167 0 14.9894 12.9098 12.9974 11.8541 0 0 12.8642 0 0 13.1771 0 0 0 0 0 0 0 0 12.9114 13.8517 0 0 0 0 0 0 0 12.1007 0 0 0 0 12.0764 10.7019 12.3512 0 0 0 11.9498 0 0 0 0 0 0 0 0 0 10.8576 12.0372 0 0 0 12.2164 0 12.9 0 13.985 12.6397 0 0 0 0 P39748 FEN1_HUMAN "Flap endonuclease 1, FEN-1, EC 3.1.-.- (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1, MF1, hFEN-1)" FEN1 RAD2 Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]; telomere maintenance via semi-conservative replication [GO:0032201]; UV protection [GO:0009650]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; base-excision repair, gap-filling [GO:0006287]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]; telomere maintenance via semi-conservative replication [GO:0032201]; UV protection [GO:0009650]" GO:0000287; GO:0000724; GO:0000781; GO:0003677; GO:0003684; GO:0003690; GO:0004519; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006260; GO:0006281; GO:0006287; GO:0006302; GO:0007613; GO:0008309; GO:0008409; GO:0009650; GO:0016020; GO:0017108; GO:0030145; GO:0032201; GO:0032991; GO:0043137; GO:0045876; GO:0048256; GO:0090305 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523] FTKRLVK 0.9921 -7.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3113 0 0 0 0 0 0 0 15.8579 0 0 0 0 0 15.0055 0 0 16.3402 0 0 0 15.1771 0 0 0 0 0 0 0 0 0 0 0 0 16.2014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1921 12.2268 0 0 0 0 0 0 P49327 FAS_HUMAN "Fatty acid synthase, EC 2.3.1.85 (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase, EC 2.3.1.38; [Acyl-carrier-protein] S-malonyltransferase, EC 2.3.1.39; 3-oxoacyl-[acyl-carrier-protein] synthase, EC 2.3.1.41; 3-oxoacyl-[acyl-carrier-protein] reductase, EC 1.1.1.100; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase, EC 4.2.1.59; Enoyl-[acyl-carrier-protein] reductase, EC 1.3.1.39; Acyl-[acyl-carrier-protein] hydrolase, EC 3.1.2.14 ]" FASN FAS Homo sapiens (Human) cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; osteoblast differentiation [GO:0001649] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]; cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; osteoblast differentiation [GO:0001649]" GO:0001649; GO:0002068; GO:0003723; GO:0004312; GO:0004313; GO:0004314; GO:0004315; GO:0004316; GO:0004317; GO:0004320; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006631; GO:0006633; GO:0006954; GO:0008611; GO:0008659; GO:0008693; GO:0016020; GO:0016295; GO:0016296; GO:0030223; GO:0030224; GO:0030879; GO:0031177; GO:0042470; GO:0042587; GO:0045296; GO:0047117; GO:0047451; GO:0070062; GO:0071353; GO:0090557 "(3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity [GO:0008693]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [GO:0004317]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723]" DSQRDLVEAVAHILGIR 0.9921 -7.7082 0 12.2512 0 0 0 0 0 0 0 0 0 0 0 10.6697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7055 0 0 11.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5519 0 0 0 15.2813 0 0 0 0 0 0 0 0 0 0 0 0 12.1515 13.0911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.56773 12.6796 0 12.6209 0 12.6045 0 0 0 13.7757 13.6004 14.312 12.1359 0 0 0 0 12.5068 0 11.1735 0 0 0 0 0 10.3701 0 0 0 0 0 0 0 0 0 0 0 12.2233 0 0 0 0 0 0 0 0 0 0 0 12.4313 0 0 0 0 0 0 0 0 0 13.7983 13.2354 0 0 0 13.7101 0 0 0 0 11.5132 12.4757 0 0 0 0 12.3717 0 0 11.5894 0 0 0 0 0 0 0 0 0 0 0 0 P52848 NDST1_HUMAN "Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1, NDST-1) (N-heparan sulfate sulfotransferase 1, N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1, HSNST 1) [Includes: Heparan sulfate N-deacetylase 1, EC 3.5.1.-; Heparan sulfate N-sulfotransferase 1, EC 2.8.2.8 ]" NDST1 HSST HSST1 Homo sapiens (Human) "aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange by respiratory system [GO:0007585]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network membrane [GO:0032588]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; protein sulfation [GO:0006477]; respiratory gaseous exchange by respiratory system [GO:0007585]" GO:0000139; GO:0003279; GO:0005794; GO:0006024; GO:0006477; GO:0006954; GO:0007585; GO:0008283; GO:0008543; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0030900; GO:0030901; GO:0032588; GO:0035904; GO:0043410; GO:0045880; GO:0048702; GO:0048703; GO:0050119; GO:0060976; GO:0102140 [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119] AKVLTILINPADR 0.9921 -18.809 0 0 0 0 0 0 0 0 0 12.7943 0 0 0 12.833 11.6576 0 0 0 0 0 0 0 16.2522 0 0 0 15.5227 0 12.4814 0 12.8227 14.5468 12.5279 0 0 0 0 12.3992 0 12.4483 0 12.8181 0 0 0 0 0 0 0 0 0 11.2687 0 0 0 11.5059 11.4455 0 0 0 0 0 0 0 0 0 0 0 0 11.1116 0 12.7205 0 0 0 0 0 0 0 0 0 0 0 12.7559 0 0 14.0841 0 0 0 0 0 0 0 0 14.6466 0 0 0 0 0 0 0 0 0 0 0 0 12.7904 0 13.21 0 0 0 0 0 0 0 13.2995 0 0 0 0 0 13.4754 0 0 0 0 0 0 0 0 0 13.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7192 15.9764 0 0 0 0 0 0 0 0 0 14.9816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVI1 FANCI_HUMAN "Fanconi anemia group I protein, Protein FACI" FANCI KIAA1794 Homo sapiens (Human) cell cycle [GO:0007049]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; cell cycle [GO:0007049]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398] GO:0000785; GO:0003677; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0016020; GO:0031398; GO:0036297; GO:0070182; GO:1990391 DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182] EGSLVNGKSLELLPIILTALATK 0.9921 -22.729 0 0 12.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5338 0 0 0 0 0 0 0 10.6356 0 0 0 0 0 0 0 0 0 16.1873 0 0 0 0 0 0 0 0 0 10.2531 0 0 0 0 0 18.4411 0 0 10.468 12.2061 0 0 0 14.7684 0 0 0 0 0 0 0 0 0 0 0 15.8107 15.5276 0 0 15.2884 0 0 0 0 0 17.1315 0 0 0 0 0 0 0 0 10.9685 0 15.3729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.35107 10.6683 0 0 13.31 13.0424 0 0 0 0 13.6155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9178 0 0 0 0 0 0 0 0 Q9NW13 RBM28_HUMAN RNA-binding protein 28 (RNA-binding motif protein 28) RBM28 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleolus [GO:0005730]; spliceosomal complex [GO:0005681] nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0005681; GO:0005730; GO:0006397; GO:0008380 RNA binding [GO:0003723] AAQHHTEEQSKVPPEQKR 0.9921 -25.111 0 0 0 0 0 12.4739 0 0 0 0 0 0 0 0 0 0 0 11.4342 0 12.243 0 0 0 0 0 0 0 11.0982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0899 0 0 0 0 0 13.1387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7368 0 0 0 12.2216 13.4153 14.5537 15.3065 15.7193 14.6903 13.7907 0 0 0 0 0 0 0 19.2517 14.3107 14.2557 13.3361 0 0 17.8497 0 0 13.496 0 13.3478 14.0446 0 13.4817 12.9819 14.7423 14.5028 14.9237 15.6317 15.0712 0 0 0 0 11.2841 14.285 14.9988 13.6336 13.0956 14.384 15.0184 14.6312 0 0 13.4468 15.0248 14.8319 15.239 0 14.5171 15.1941 13.8601 14.2356 14.913 0 14.7581 14.5719 0 14.2232 0 0 14.0807 0 15.583 13.3817 14.5288 13.7386 0 13.1059 0 0 13.8202 13.8989 13.1503 0 0 0 0 0 0 0 0 0 0 0 0 12.534 0 0 0 0 14.0052 15.4213 13.6381 13.3266 14.0857 0 0 16.2252 0 0 Q9UNA4 POLI_HUMAN "DNA polymerase iota, EC 2.7.7.7 (Eta2) (RAD30 homolog B)" POLI RAD30B Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; translesion synthesis [GO:0019985] GO:0003684; GO:0003887; GO:0005654; GO:0006260; GO:0006281; GO:0016607; GO:0019985; GO:0036464; GO:0042276; GO:0046872 damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] DHLSSSK 0.9921 -18.349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4298 0 0 0 0 0 0 0 0 0 0 0 0 11.1626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7744 0 0 0 0 0 0 13.123 0 13.7717 0 0 13.5101 13.9056 14.6229 0 13.1527 14.8001 13.3573 13.3134 14.5832 13.7884 13.8914 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7969 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4071 12.2445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17661 DESM_HUMAN Desmin DES Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intermediate filament organization [GO:0045109]; muscle contraction [GO:0006936]; regulation of heart contraction [GO:0008016]; skeletal muscle organ development [GO:0060538] cardiac myofibril [GO:0097512]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; Z disc [GO:0030018] cardiac myofibril [GO:0097512]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; cytoskeleton organization [GO:0007010]; intermediate filament organization [GO:0045109]; muscle contraction [GO:0006936]; regulation of heart contraction [GO:0008016]; skeletal muscle organ development [GO:0060538] GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0005911; GO:0005916; GO:0006936; GO:0007010; GO:0008016; GO:0008092; GO:0014704; GO:0030018; GO:0031594; GO:0042383; GO:0042802; GO:0045109; GO:0045111; GO:0060538; GO:0070062; GO:0097512 cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200] EPTRVAELYEEELR 0.99211 -7.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8223 0 0 0 0 0 0 0 0 0 10.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3034 14.0847 13.6551 10.9934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1928 0 0 0 12.9804 0 0 0 11.8908 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6797 0 0 0 0 0 0 0 0 0 0 0 0 9.78503 0 0 10.996 13.1174 0 0 0 0 0 0 0 0 0 0 13.076 0 0 12.7107 13.3394 0 0 0 0 0 13.0673 13.1178 0 8.94339 0 0 0 0 9.55198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1812 0 0 0 0 0 P41594 GRM5_HUMAN "Metabotropic glutamate receptor 5, mGluR5" GRM5 GPRC1E MGLUR5 Homo sapiens (Human) "calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]" astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] "astrocyte projection [GO:0097449]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to amyloid-beta [GO:1904646]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; negative regulation of locomotion [GO:0040013]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein tyrosine kinase activity [GO:0061098]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of intracellular calcium activated chloride channel activity [GO:1902938]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; regulation of translational elongation [GO:0006448]; synapse organization [GO:0050808]; trans-synaptic signaling by endocannabinoid, modulating synaptic transmission [GO:0099553]" GO:0001640; GO:0001932; GO:0002029; GO:0004930; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006417; GO:0006448; GO:0006468; GO:0007205; GO:0007206; GO:0007216; GO:0007268; GO:0007611; GO:0007612; GO:0007626; GO:0008066; GO:0030296; GO:0031687; GO:0035584; GO:0040013; GO:0042802; GO:0043197; GO:0043198; GO:0043410; GO:0048170; GO:0050808; GO:0050890; GO:0051966; GO:0061098; GO:0097449; GO:0098685; GO:0098839; GO:0098978; GO:0099055; GO:0099170; GO:0099530; GO:0099553; GO:0099583; GO:1902938; GO:1904646; GO:1990782 A2A adenosine receptor binding [GO:0031687]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase binding [GO:1990782] EAVGGITIK 0.99211 -18.486 11.4932 9.84152 0 18.4432 0 0 0 0 17.9609 17.5506 0 0 12.4352 17.9325 17.16 14.7827 0 0 0 0 0 0 9.95476 0 0 0 18.1841 14.3168 12.4207 17.7298 18.3497 12.9222 0 14.7634 13.3069 12.7758 0 0 13.6656 0 12.7924 0 0 12.9812 0 0 12.3597 0 17.7229 0 0 0 0 0 0 0 0 11.3732 0 0 16.9455 0 0 0 0 0 0 14.9484 12.6853 12.4023 0 11.2109 0 0 0 0 14.522 13.2649 0 12.1823 0 13.5666 12.7444 0 0 0 0 13.0105 0 0 11.6183 13.37 13.3429 11.5256 12.8565 14.3786 10.736 0 14.6429 0 12.6706 0 13.1505 15.9659 13.762 12.588 0 0 0 13.08 13.8452 13.4622 12.3342 0 0 0 13.4878 0 0 0 0 0 14.6656 0 14.6937 0 14.5835 12.6897 0 0 14.0806 0 11.6091 14.7642 0 13.9138 0 0 0 0 15.2781 13.7342 0 0 14.032 12.7888 12.5452 14.1176 14.5715 0 0 14.2496 0 14.7587 12.2902 12.9277 18.7511 12.1755 18.7329 13.1714 11.5788 18.6197 18.6264 14.034 0 18.6252 18.6367 0 18.5931 18.5405 18.5129 0 13.9737 12.9462 18.3342 0 0 11.6289 18.6834 18.4679 P51659 DHB4_HUMAN "Peroxisomal multifunctional enzyme type 2, MFE-2 (17-beta-hydroxysteroid dehydrogenase 4, 17-beta-HSD 4) (D-bifunctional protein, DBP) (Multifunctional protein 2, MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.n12; Enoyl-CoA hydratase 2, EC 4.2.1.107, EC 4.2.1.119 (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase) ]" HSD17B4 EDH17B4 SDR8C1 Homo sapiens (Human) androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] "cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; (3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]" GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386 "(3R)-hydroxyacyl-CoA dehydrogenase (NAD) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]" AIKARFAK 0.99211 -24.508 10.8427 0 0 0 0 0 0 12.2857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.039 0 0 0 0 0 15.7361 15.0148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7865 0 0 0 0 0 0 13.8387 14.5281 14.7198 0 15.4406 15.3337 15.007 0 15.3294 0 0 0 0 12.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7305 14.2196 0 0 0 0 0 0 0 Q3B820 F161A_HUMAN Protein FAM161A FAM161A Homo sapiens (Human) cilium assembly [GO:0060271]; cilium organization [GO:0044782]; positive regulation of protein acetylation [GO:1901985]; response to stimulus [GO:0050896]; visual perception [GO:0007601] astral microtubule [GO:0000235]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; spindle microtubule [GO:0005876] astral microtubule [GO:0000235]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; spindle microtubule [GO:0005876]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; positive regulation of protein acetylation [GO:1901985]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0000235; GO:0001917; GO:0005813; GO:0005876; GO:0007601; GO:0008017; GO:0032391; GO:0036064; GO:0042802; GO:0044782; GO:0050896; GO:0060271; GO:0072686; GO:0097431; GO:1901985 identical protein binding [GO:0042802]; microtubule binding [GO:0008017] CKDTGFHAAEKR 0.99211 -24.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9141 0 0 0 0 12.1917 13.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9179 0 0 0 0 0 0 0 0 0 12.0437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5614 0 0 14.2828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5MJ08 SPXN4_HUMAN "Sperm protein associated with the nucleus on the X chromosome N4 (Nuclear-associated protein SPAN-Xn4, SPANX-N4) (SPANX family member N4)" SPANXN4 Homo sapiens (Human) AKYPTLVFYCR 0.99211 -7.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3353 0 0 0 0 12.8483 0 0 0 0 0 0 13.1274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.395 11.5405 0 0 0 0 0 0 0 11.4756 0 0 0 0 0 0 0 0 0 12.0958 0 0 0 14.1236 13.0742 13.2158 12.3806 12.7343 0 0 14.6291 0 12.8412 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4583 0 0 0 0 0 0 0 0 0 0 0 12.559 0 0 0 0 0 0 13.9076 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1384 0 0 0 12.9529 0 13.7931 0 0 0 0 0 13.3344 Q8N9V6 ANR53_HUMAN Ankyrin repeat domain-containing protein 53 ANKRD53 Homo sapiens (Human) cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle organization [GO:0060236] cytoplasm [GO:0005737]; spindle [GO:0005819]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; spindle [GO:0005819]; spindle pole [GO:0000922]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; positive regulation of microtubule polymerization [GO:0031116]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle organization [GO:0060236] GO:0000922; GO:0005737; GO:0005819; GO:0007080; GO:0031116; GO:0051301; GO:0060236; GO:1902412 ADPSPSK 0.99211 -24.503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3782 0 0 0 0 12.5835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8007 14.9098 0 0 0 0 13.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3256 0 0 0 11.2447 13.5626 0 0 0 0 0 13.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2394 Q96GY0 ZC21A_HUMAN Zinc finger C2HC domain-containing protein 1A ZC2HC1A C8orf70 FAM164A CGI-62 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] EQAARISNKGK 0.99211 -7.7401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3425 0 0 0 0 0 0 0 0 0 11.692 0 0 12.4577 13.3508 0 0 0 0 0 0 0 0 0 0 12.6261 0 0 0 0 0 0 12.426 0 13.0276 0 0 0 13.1996 0 0 0 0 0 12.8549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H222 ABCG5_HUMAN "ATP-binding cassette sub-family G member 5, EC 7.6.2.- (Sterolin-1)" ABCG5 Homo sapiens (Human) bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]; triglyceride homeostasis [GO:0070328] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; bile acid signaling pathway [GO:0038183]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to ionizing radiation [GO:0010212]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sterol transport [GO:0015918]; transmembrane transport [GO:0055085]; triglyceride homeostasis [GO:0070328] GO:0005524; GO:0005886; GO:0005887; GO:0007584; GO:0009410; GO:0010212; GO:0010949; GO:0014850; GO:0015918; GO:0016020; GO:0016324; GO:0030299; GO:0033344; GO:0038183; GO:0042626; GO:0042632; GO:0043190; GO:0043235; GO:0045796; GO:0046872; GO:0046982; GO:0055085; GO:0070328; GO:0120020; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol transfer activity [GO:0120020]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982] FTMNFLILYSFIPALVILGIVVFKIR 0.99211 -7.7322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.26 0 0 0 0 11.2862 13.008 0 12.7718 0 0 0 0 0 0 12.6191 0 0 12.9011 0 0 0 0 0 0 0 0 0 0 13.3864 0 0 0 0 0 0 0 0 0 0 0 14.3272 0 0 0 0 0 0 11.6771 0 0 0 0 13.3041 0 0 0 0 0 16.0681 0 0 0 0 0 0 12.0752 0 0 0 0 0 12.9879 0 0 0 0 0 0 0 Q9NVE5 UBP40_HUMAN "Ubiquitin carboxyl-terminal hydrolase 40, EC 3.4.19.12 (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40)" USP40 Homo sapiens (Human) protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0031647 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] AWTVERKR 0.99211 -24.51 0 0 0 0 0 0 0 0 0 13.7041 0 0 0 14.7694 14.6931 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3038 0 0 0 0 0 0 0 0 12.9211 0 0 0 0 12.1412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6556 0 0 0 0 0 0 0 0 0 0 0 12.104 0 15.0512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1405 13.9277 12.2717 0 10.9973 0 0 14.0172 0 12.8368 0 0 0 0 13.1052 0 0 0 0 0 11.5226 0 0 0 0 0 0 0 0 0 13.2495 13.1142 14.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1982 0 15.9181 0 0 0 0 0 0 0 0 0 0 13.697 0 0 16.0168 0 0 14.836 14.5648 0 16.6648 0 16.4478 16.6206 0 12.8136 0 16.2994 0 0 0 0 0 A0A1B0GVQ3 CC200_HUMAN Coiled-coil domain-containing protein 200 CCDC200 Homo sapiens (Human) EQELKNHQEEEQQSEEKLQPHK 0.99212 -4.7482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75899 GABR2_HUMAN "Gamma-aminobutyric acid type B receptor subunit 2, GABA-B receptor 2, GABA-B-R2, GABA-BR2, GABABR2, Gb2 (G-protein coupled receptor 51) (HG20)" GABBR2 GPR51 GPRC3B Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]" GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0070161; GO:0150099; GO:1902710; GO:1902712 G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] LLLLLLLPLLLPLAPGAWGWAR 0.99212 -15.169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2984 14.7715 0 0 14.544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3924 14.8831 0 0 15.4712 0 15.6386 15.3794 15.6945 15.5937 0 0 16.5411 14.96 13.9235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.132 0 13.8019 0 0 0 0 0 0 0 0 0 0 0 10.7052 14.0454 0 13.8659 11.7703 0 0 14.9039 0 15.0363 10.8771 0 0 0 0 15.7543 0 0 0 0 0 0 11.3278 0 14.3568 15.1103 0 0 0 13.2009 0 0 0 13.4906 0 0 0 0 0 0 0 14.6203 0 0 0 11.7887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8077 0 0 0 0 0 0 10.9383 0 P29350 PTN6_HUMAN "Tyrosine-protein phosphatase non-receptor type 6, EC 3.1.3.48 (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C, PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)" PTPN6 HCP PTP1C Homo sapiens (Human) abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; megakaryocyte development [GO:0035855]; mitotic cell cycle [GO:0000278]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852] alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; megakaryocyte development [GO:0035855]; mitotic cell cycle [GO:0000278]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852] GO:0000165; GO:0000278; GO:0001784; GO:0002244; GO:0002924; GO:0004725; GO:0004726; GO:0005001; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005911; GO:0006470; GO:0007186; GO:0008284; GO:0008285; GO:0014068; GO:0016020; GO:0017124; GO:0018108; GO:0019221; GO:0019901; GO:0030154; GO:0030220; GO:0031295; GO:0032715; GO:0032720; GO:0032991; GO:0033007; GO:0033277; GO:0033630; GO:0035335; GO:0035556; GO:0035580; GO:0035855; GO:0042098; GO:0042105; GO:0042130; GO:0042169; GO:0042267; GO:0042981; GO:0043407; GO:0045577; GO:0050732; GO:0050839; GO:0050852; GO:0050853; GO:0050860; GO:0051279; GO:0060338; GO:0070062; GO:0070372; GO:0070527; GO:0140031; GO:1904724; GO:1905867; GO:2000045 cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] FIYVAIAQFIETTKKK 0.99212 -4.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3304 13.0712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6677 0 0 0 0 12.8164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA45 INT11_HUMAN "Integrator complex subunit 11, Int11, EC 3.1.27.- (Cleavage and polyadenylation-specific factor 3-like protein, CPSF3-like protein) (Protein related to CPSF subunits of 68 kDa, RC-68)" INTS11 CPSF3L RC68 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016180; GO:0032039; GO:0034243; GO:0072562 endoribonuclease activity [GO:0004521] GLPQAPS 0.99212 -18.512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6976 0 12.3381 12.4081 12.614 13.6314 0 14.0748 13.13 0 15.2827 15.3236 14.6482 0 0 13.5328 13.0745 15.0317 14.1969 13.9486 14.8956 13.5518 0 0 15.128 14.4381 0 0 13.8287 13.7509 12.7954 0 0 0 12.6501 12.87 0 0 14.5122 0 0 0 13.5355 0 0 0 0 0 0 14.1856 13.8405 0 13.39 13.5328 12.8104 0 0 13.5017 0 0 0 12.9211 12.2029 0 13.5161 0 13.0345 13.5236 12.2428 12.2639 0 10.8705 0 0 0 0 0 0 0 0 0 0 0 0 14.9108 0 11.4954 0 0 0 0 14.4519 0 0 0 12.5039 14.4444 13.5242 0 0 0 0 0 0 0 Q658N2 WSCD1_HUMAN WSC domain-containing protein 1 WSCD1 KIAA0523 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146] GO:0008146; GO:0016021 sulfotransferase activity [GO:0008146] DHNWTGLPREYVPR 0.99212 -24.667 0 0 0 0 0 0 0 0 0 0 0 11.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2433 0 0 0 0 0 0 9.9147 0 0 0 0 0 11.3512 0 0 0 0 0 0 0 0 0 0 0 11.8746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5126 0 13.4182 0 0 0 0 0 13.6932 13.9547 0 12.4878 0 14.8497 13.1882 0 0 15.554 0 0 0 14.7254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2109 15.5855 0 0 0 0 0 0 0 0 13.179 15.0442 0 11.0332 0 13.3034 0 11.8851 0 0 0 0 10.9596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2631 0 Q6PIF6 MYO7B_HUMAN Unconventional myosin-VIIb MYO7B Homo sapiens (Human) actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; microvillus [GO:0005902]; myosin complex [GO:0016459] actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; microvillus [GO:0005902]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0005524; GO:0005902; GO:0005903; GO:0007015; GO:0007423; GO:0007605; GO:0015629; GO:0016459; GO:0030050; GO:0030154; GO:0051015; GO:0090651; GO:1904970 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146] AALSIQKVLRGYR 0.99212 -47.284 0 0 0 0 0 0 0 0 10.2738 0 0 10.9543 0 0 12.2915 0 0 0 12.3399 0 10.8771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6896 0 0 0 0 0 0 13.6232 0 0 0 11.4142 0 0 0 0 10.4716 0 0 0 0 0 11.3588 0 0 0 0 0 0 0 0 0 0 10.3176 0 13.7137 0 0 0 0 0 11.2153 15.7484 0 0 11.8382 0 0 13.9951 0 0 13.9961 0 0 11.9023 0 0 0 14.2894 15.5543 13.6509 13.4691 0 0 0 12.5172 0 0 0 0 0 12.8497 0 15.0982 0 11.2624 13.5579 0 0 12.9144 0 0 12.8855 0 11.6411 0 13.1907 0 0 13.2058 0 14.043 13.8096 0 12.4344 13.6427 0 0 12.412 0 13.7357 0 13.8102 13.7401 12.8917 0 12.6223 0 12.4737 12.2126 14.3505 13.9164 14.1377 0 0 0 0 0 10.2562 14.6629 14.0011 14.9893 0 0 0 0 0 0 13.2103 12.6286 13.6416 0 0 12.9072 0 0 0 13.7688 0 0 0 12.9369 Q6UX01 LMBRL_HUMAN "Protein LMBR1L (Limb region 1 protein homolog-like) (Lipocalin-1-interacting membrane receptor, LIMR)" LMBR1L KIAA1174 LIMR UNQ458/PRO783 Homo sapiens (Human) hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]; T cell differentiation [GO:0030217]; T cell proliferation [GO:0042098]; Wnt signaling pathway [GO:0016055] GO:0004888; GO:0005789; GO:0005886; GO:0005887; GO:0006898; GO:0007165; GO:0016055; GO:0030217; GO:0042098; GO:0060218; GO:0070231; GO:0090090 transmembrane signaling receptor activity [GO:0004888] QVLALQTQRVLLEK 0.99212 -4.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7M0 MEGF8_HUMAN "Multiple epidermal growth factor-like domains protein 8, Multiple EGF-like domains protein 8 (Epidermal growth factor-like protein 4, EGF-like protein 4)" MEGF8 C19orf49 EGFL4 KIAA0817 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888] GO:0003143; GO:0005509; GO:0005634; GO:0009887; GO:0009888; GO:0010468; GO:0016021; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0070062; GO:0071907; GO:0097094; GO:0097155 calcium ion binding [GO:0005509] ALGKVLAMALVLALAVLGSLSPGAR 0.99212 -4.7452 0 0 0 10.4303 0 0 0 0 0 12.5925 11.365 0 0 13.3954 0 0 0 13.4186 0 10.4064 0 11.4219 0 0 0 0 0 9.84053 0 10.6937 0 0 10.606 0 12.2459 0 0 10.5211 12.1485 12.6339 0 0 0 10.6077 12.5305 0 0 13.6162 10.389 0 0 0 10.2537 0 12.3299 0 14.1462 0 0 11.1552 0 0 0 0 11.4446 0 0 0 10.585 10.2637 14.0807 14.9171 15.9493 0 0 13.3369 12.0938 0 10.8289 12.2061 13.363 14.3517 14.7724 0 13.7434 14.284 13.5025 14.0363 0 0 13.0395 14.8547 13.2889 0 13.0953 10.057 14.9542 14.9138 12.5199 14.2753 0 0 13.3898 13.8343 14.3086 10.7971 14.2416 12.6563 13.9767 0 0 0 12.6995 11.2986 0 13.2414 14.186 11.2065 0 0 0 13.4031 0 14.7194 0 10.9331 0 13.7499 0 13.8854 0 0 13.7364 14.1091 11.7663 13.5559 14.0051 14.5224 0 12.5849 15.2333 13.4163 11.9057 12.5704 13.0909 0 0 0 0 0 0 0 10.9311 0 0 0 0 0 12.3262 0 0 0 0 13.3103 12.5096 0 0 10.4387 0 12.1989 12.9886 12.0744 0 13.354 12.6231 0 0 14.0283 0 0 Q8NEY1 NAV1_HUMAN "Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1, unc53H1)" NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; nervous system development [GO:0007399]; neuron migration [GO:0001764] axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule bundle formation [GO:0001578]; nervous system development [GO:0007399]; neuron migration [GO:0001764] GO:0001578; GO:0001764; GO:0005737; GO:0005874; GO:0007399; GO:0015630; GO:0043194 AAAADGRGMLPK 0.99212 -47.26 0 0 10.9437 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5087 0 0 0 0 0 0 0 0 10.0897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1632 0 0 0 0 0 0 0 0 0 0 0 14.7618 0 15.2859 0 12.304 0 12.3808 0 0 0 14.5388 15.2529 14.3266 14.2385 13.8476 14.5298 0 14.1426 14.177 0 12.9471 0 0 0 17.2552 0 14.0914 0 14.6171 15.1985 0 0 0 0 14.8421 15.5184 0 15.0996 0 0 16.0037 16.4384 15.0863 15.396 15.3837 0 14.0196 0 13.8117 0 13.2916 14.05 15.2595 16.1612 12.5905 16.0394 0 14.4368 14.7712 0 0 0 14.2094 15.2981 0 0 0 0 14.5827 0 0 16.4912 15.0121 16.2653 16.1071 14.8244 14.7742 0 15.4862 13.896 0 0 0 0 13.8224 0 0 13.4324 14.1345 0 0 0 0 0 0 0 0 14.0642 0 0 0 0 0 0 0 15.7636 15.0084 13.1568 14.0861 0 13.2831 0 14.5668 0 Q96CN9 GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1) GCC1 Homo sapiens (Human) cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; small GTPase binding [GO:0031267] GO:0000138; GO:0000139; GO:0005794; GO:0005829; GO:0031267 small GTPase binding [GO:0031267] AKQKDQLAIQK 0.99212 -24.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3368 0 0 0 0 0 0 0 0 0 0 0 12.4064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9413 0 0 0 0 0 0 0 0 0 0 10.9823 0 0 0 11.4359 0 0 0 0 12.3669 0 12.9742 0 12.7218 12.9343 13.1326 13.5964 0 0 0 0 0 0 0 0 0 0 0 16.152 14.39 0 0 0 14.0069 0 0 13.3243 0 12.8688 0 0 9.23836 13.9566 0 14.0543 0 12.875 12.4737 0 0 0 0 14.3073 14.4505 13.1732 0 13.6808 12.6373 0 0 13.3082 0 0 11.7957 0 0 13.5062 0 0 0 0 0 14.0244 0 11.6684 13.7822 0 12.1529 13.0625 0 0 0 10.5151 12.4917 0 0 0 0 0 0 0 0 0 0 15.0371 0 0 0 0 0 0 0 0 0 0 0 0 13.4477 14.0329 0 0 11.6526 0 0 0 9.81567 11.632 Q9H0J4 QRIC2_HUMAN Glutamine-rich protein 2 QRICH2 Homo sapiens (Human) cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126]; cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059] GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059 DEAGVPR 0.99212 -47.193 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9338 0 0 0 13.4735 0 0 0 0 12.356 0 10.8364 0 9.59921 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4589 0 0 12.7293 12.9699 0 0 13.744 0 0 0 14.1862 0 14.8714 10.42 0 0 11.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0925 0 0 14.5122 0 0 0 0 15.007 0 15.439 0 0 15.4021 0 13.788 0 0 0 15.0455 0 0 0 0 0 14.7065 0 13.5603 0 0 14.2522 0 12.7291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4178 0 0 0 0 0 0 0 0 0 16.8913 0 0 0 15.9872 0 0 0 0 0 0 0 10.2453 0 0 0 16.5765 0 0 13.3926 0 0 13.4482 14.7344 14.4351 15.0297 15.0456 15.7491 0 0 0 0 0 12.6566 14.2608 12.2122 0 0 0 0 Q9HC77 CENPJ_HUMAN "Centromere protein J, CENP-J (Centrosomal P4.1-associated protein) (LAG-3-associated protein) (LYST-interacting protein 1)" CENPJ CPAP LAP LIP1 Homo sapiens (Human) astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centriole replication [GO:0046601]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of spindle assembly [GO:1905832]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleus [GO:0005634]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleus [GO:0005634]; procentriole replication complex [GO:0120099]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; microtubule nucleation [GO:0007020]; microtubule polymerization [GO:0046785]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centriole replication [GO:0046601]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of spindle assembly [GO:1905832]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007020; GO:0007099; GO:0007224; GO:0008275; GO:0015631; GO:0019901; GO:0019904; GO:0030954; GO:0036064; GO:0042802; GO:0043015; GO:0044458; GO:0046427; GO:0046599; GO:0046601; GO:0046785; GO:0051301; GO:0060236; GO:0060271; GO:0061511; GO:0120099; GO:1900087; GO:1902857; GO:1903724; GO:1904951; GO:1905515; GO:1905832 gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631] DKEGNVLMDTEL 0.99212 -46.982 0 0 0 0 0 0 0 9.73052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2966 0 0 0 0 0 0 15.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1264 0 0 11.0502 0 10.8184 0 0 13.0458 0 0 0 0 10.8389 0 10.5602 0 0 0 0 0 0 0 0 0 12.6213 0 0 11.8919 0 0 0 0 0 0 13.5632 0 0 0 0 14.2291 14.1501 0 0 0 13.0072 0 12.3575 0 11.9486 0 13.1625 0 0 0 0 0 0 0 0 13.7593 0 0 0 13.9682 0 0 0 0 0 0 0 14.0937 0 0 15.247 0 0 0 14.7045 12.2854 0 11.7878 0 0 0 14.2192 14.3355 14.8158 12.5121 12.8748 0 14.0163 0 0 0 0 0 12.32 0 0 0 0 0 13.4002 12.984 13.0112 13.712 0 11.9549 0 15.09 0 0 0 0 0 0 0 0 12.0181 0 13.1027 0 12.2654 0 0 0 0 0 0 Q9NP78 ABCB9_HUMAN "ABC-type oligopeptide transporter ABCB9, EC 7.4.2.6 (ATP-binding cassette sub-family B member 9) (ATP-binding cassette transporter 9, ABC transporter 9 protein, hABCB9) (TAP-like protein, TAPL)" ABCB9 KIAA1520 Homo sapiens (Human) antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; peptide metabolic process [GO:0006518]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class I peptide loading complex [GO:0042824] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; MHC class I peptide loading complex [GO:0042824]; ABC-type oligopeptide transporter activity [GO:0015421]; ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; transmembrane transporter activity [GO:0022857]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; peptide metabolic process [GO:0006518]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085] GO:0005524; GO:0005764; GO:0005765; GO:0005789; GO:0006518; GO:0015031; GO:0015421; GO:0015433; GO:0015440; GO:0015833; GO:0016021; GO:0019885; GO:0022857; GO:0030176; GO:0042626; GO:0042803; GO:0042824; GO:0043231; GO:0046978; GO:0055085 ABC-type oligopeptide transporter activity [GO:0015421]; ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; transmembrane transporter activity [GO:0022857] LLLFSEVRR 0.99212 -7.44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.554 0 0 0 0 0 13.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0938 0 0 0 0 0 0 0 0 14.0937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7455 13.902 0 0 0 13.4311 0 0 0 0 0 0 0 0 0 0 0 0 A6NN92 CXE1_HUMAN "Putative gap junction epsilon-1 protein (Connexin-23, Cx23)" GJE1 Homo sapiens (Human) cell morphogenesis [GO:0000902]; cell-cell signaling [GO:0007267]; lens development in camera-type eye [GO:0002088]; organ growth [GO:0035265] connexin complex [GO:0005922]; integral component of membrane [GO:0016021] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell morphogenesis [GO:0000902]; cell-cell signaling [GO:0007267]; lens development in camera-type eye [GO:0002088]; organ growth [GO:0035265] GO:0000902; GO:0002088; GO:0005243; GO:0005922; GO:0007267; GO:0016021; GO:0035265 gap junction channel activity [GO:0005243] NFYEGCVK 0.99213 -7.6206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MUZ8 Z705G_HUMAN Putative zinc finger protein 705G ZNF705G Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CHQYGKVFIQSFNLQR 0.99213 -5.5368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3503 0 0 0 0 0 O15440 MRP5_HUMAN "ATP-binding cassette sub-family C member 5, EC 7.6.2.-, EC 7.6.2.2 (Multi-specific organic anion transporter C, MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11)" ABCC5 MRP5 Homo sapiens (Human) cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910]; cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] GO:0005524; GO:0005796; GO:0005886; GO:0005887; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0010008; GO:0015216; GO:0015232; GO:0015562; GO:0015865; GO:0016020; GO:0016323; GO:0016324; GO:0030213; GO:0034634; GO:0034775; GO:0035351; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0070730; GO:0070731; GO:0098838; GO:0140115; GO:0150104 ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910] EAFADCTMLTIAHR 0.99213 -47.783 0 0 0 0 0 0 0 0 9.62965 11.6928 0 0 0 0 0 0 0 0 0 0 0 14.3809 0 0 0 11.3282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0645 0 12.3063 0 0 0 12.088 11.6976 0 0 10.3639 0 10.7685 11.4996 11.5378 0 0 10.7588 0 0 0 0 0 0 0 0 0 13.6931 0 11.5619 11.4901 0 0 0 12.4071 0 0 0 0 0 12.2531 0 0 15.0694 12.2233 0 14.2567 0 0 0 15.5927 11.6066 0 0 0 0 15.1331 11.8662 0 0 0 14.7249 0 0 14.9156 0 12.2193 12.4334 0 0 11.9605 0 0 0 15.293 0 14.5749 0 11.3812 13.0058 14.6408 13.4567 0 13.643 0 9.92952 0 11.5907 0 13.4922 0 0 0 0 0 0 0 0 0 0 13.2579 13.9266 12.3599 0 0 0 0 0 0 12.8886 0 0 0 0 0 0 0 0 0 0 12.4069 0 13.442 0 12.1024 0 0 0 0 0 0 0 12.1101 0 0 0 0 0 0 0 P0DPD8 EFCE2_HUMAN "EEF1AKMT4-ECE2 readthrough transcript protein, EC 3.4.24.71 [Includes: Methyltransferase-like region, EC 2.1.1.-; Endothelin-converting enzyme 2 region, EC 3.4.24.71 ]" EEF1AKMT4-ECE2 Homo sapiens (Human) brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; heart development [GO:0007507]; methylation [GO:0032259]; protein processing [GO:0016485] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; heart development [GO:0007507]; methylation [GO:0032259]; protein processing [GO:0016485] GO:0000139; GO:0004222; GO:0005886; GO:0007420; GO:0007507; GO:0008757; GO:0010002; GO:0016021; GO:0016485; GO:0030658; GO:0032259; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] APPELPERNCGYR 0.99213 -7.1231 0 0 0 0 10.3255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3611 13.6111 0 0 10.8296 0 0 14.1131 13.8164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3489 0 0 0 0 0 13.8392 0 12.3714 0 0 0 0 0 0 0 11.8666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9328 0 0 0 0 0 0 0 12.3457 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7237 0 13.6624 0 Q03923 ZNF85_HUMAN Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1) ZNF85 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFNWSSTLTK 0.99213 -47.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.306 0 0 11.6109 0 12.8573 11.4571 0 0 0 0 0 0 0 0 0 0 13.4645 0 0 12.5581 0 0 0 0 0 11.8481 0 0 0 0 0 0 12.8965 0 14.5927 0 13.6361 0 0 0 0 0 0 0 0 0 0 0 0 15.0124 15.1768 0 0 0 0 11.9432 0 0 0 0 0 0 13.0332 0 0 0 0 0 15.2316 0 0 14.5317 0 0 0 13.0345 0 0 0 0 0 0 14.6506 14.8256 0 0 0 0 0 11.9396 0 0 0 0 12.0023 0 0 0 0 0 13.0946 0 0 10.0922 0 12.0226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1992 13.0927 0 0 0 Q14571 ITPR2_HUMAN "Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2, IP3R 2, InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor, Type 2 InsP3 receptor)" ITPR2 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667] "cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]; cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]" GO:0001666; GO:0005220; GO:0005509; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0005938; GO:0007165; GO:0015085; GO:0016020; GO:0016021; GO:0016529; GO:0030659; GO:0030667; GO:0031095; GO:0033017; GO:0035091; GO:0043235; GO:0044325; GO:0051209; GO:0070679; GO:0071320; GO:0071361; GO:0097110 "calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]" AAMGWRLSARSGPR 0.99213 -23.989 0 12.8109 0 0 0 0 13.4177 0 0 12.3941 0 14.5606 12.5039 0 12.6847 0 0 0 0 0 0 0 0 0 12.2444 0 0 13.3674 0 0 14.2416 0 12.2881 0 0 0 12.3054 0 13.0176 0 0 0 12.5904 0 0 0 0 0 0 0 11.9495 0 0 10.258 0 0 0 12.4606 12.7631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1632 0 14.9634 0 0 14.784 0 14.1894 0 0 0 0 13.1774 12.8982 12.5636 0 13.3082 0 14.6482 14.2098 13.712 13.0217 13.151 14.0895 0 16.6284 0 0 13.7474 12.2146 0 0 0 14.426 14.0948 13.696 15.3186 13.6065 13.4612 0 0 12.4201 14.5801 13.6829 13.4924 13.5482 0 0 15.7061 13.5317 0 12.1849 14.1122 15.5294 14.9212 11.7114 13.0948 0 12.8179 0 0 0 15.3228 0 14.1536 0 15.1673 12.916 14.0726 12.3697 0 0 0 0 0 0 0 12.6628 0 15.0434 0 0 0 0 14.0275 13.6426 0 15.272 14.4524 0 14.2949 0 12.7302 14.7016 0 0 11.9566 0 0 0 0 13.2414 0 0 15.3006 15.9338 0 Q2M296 MTHSD_HUMAN Methenyltetrahydrofolate synthase domain-containing protein MTHFSD Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723] GO:0003723; GO:0005737 RNA binding [GO:0003723] ALRELGSVPLR 0.99213 -18.208 0 0 0 0 0 0 0 0 0 13.0163 0 0 0 0 0 13.1618 0 0 0 0 0 14.604 0 12.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2688 0 14.3031 0 0 0 0 0 0 0 0 0 0 14.0817 0 0 15.1675 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1749 0 0 0 0 0 0 0 14.6658 0 0 12.2225 0 0 12.564 12.4281 12.1021 12.5811 0 0 0 0 13.7567 12.3884 13.2308 0 0 0 0 0 0 0 0 0 0 0 12.8507 0 0 0 0 0 0 0 12.7026 12.6011 0 0 0 0 13.0718 0 0 0 12.1506 0 0 0 0 0 0 12.3355 0 0 0 0 12.4113 0 0 0 0 0 0 0 14.6503 0 0 0 0 0 0 0 Q3SY17 S2552_HUMAN Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A52 (Mitochondrial NAD(+) transporter SLC25A52) (Mitochondrial carrier triple repeat protein 2) (Solute carrier family 25 member 52) SLC25A52 MCART2 Homo sapiens (Human) mitochondrial NAD transmembrane transport [GO:1990549]; mitochondrial transmembrane transport [GO:1990542] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD transmembrane transporter activity [GO:0051724]; mitochondrial NAD transmembrane transport [GO:1990549]; mitochondrial transmembrane transport [GO:1990542] GO:0005739; GO:0005743; GO:0016021; GO:0051724; GO:1990542; GO:1990549 NAD transmembrane transporter activity [GO:0051724] DGFRNLYR 0.99213 -17.728 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4103 0 0 0 11.84 0 0 11.9214 0 0 0 0 0 0 0 0 0 0 11.7598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.891 0 0 0 0 14.8506 0 0 0 0 0 0 0 13.4987 0 11.859 0 0 0 0 0 0 0 12.6774 0 0 14.3995 0 0 0 0 0 0 0 12.4674 0 0 0 0 0 0 0 0 12.7618 0 0 0 0 0 0 0 0 0 0 13.0218 0 0 0 14.3741 12.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5591 0 0 0 0 14.2066 0 0 0 0 12.0573 0 0 0 0 0 0 12.2969 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3T906 GNPTA_HUMAN "N-acetylglucosamine-1-phosphotransferase subunits alpha/beta, EC 2.7.8.17 (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta ]" GNPTAB GNPTA KIAA1208 Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex [GO:0070622] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase complex [GO:0070622]; calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976]; carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299] GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016021; GO:0016256; GO:0033299; GO:0046835; GO:0070622 calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976] ACNNSACDWDGGDCSGNSGGSR 0.99213 -24.816 0 10.4776 0 0 0 0 0 0 15.1555 0 0 0 0 11.9195 14.9221 0 0 0 0 0 0 12.1511 0 0 0 0 0 0 12.3598 0 0 0 0 0 14.9823 12.4602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2119 0 13.2329 0 0 0 0 0 12.9497 12.9052 14.2059 13.0216 0 0 13.7237 0 13.5119 14.6396 13.9285 14.3281 16.7697 0 0 0 0 0 0 14.0487 13.4663 14.3671 13.1656 14.0737 0 14.311 15.0317 13.9687 0 0 0 14.2122 0 13.1045 0 0 0 0 15.6074 14.1234 14.0466 0 0 0 0 0 0 0 14.0212 0 0 0 13.7545 0 0 14.1874 0 14.144 13.447 0 13.9844 14.3501 16.6276 0 0 12.2895 0 0 14.3606 14.1232 14.0369 0 10.4954 0 0 0 13.6262 0 0 0 0 0 12.6188 13.8471 13.3269 11.3302 0 0 14.8661 14.683 14.632 14.0555 0 0 13.1924 0 11.5871 0 0 0 0 14.6411 0 12.8882 0 0 Q5T4S7 UBR4_HUMAN "E3 ubiquitin-protein ligase UBR4, EC 2.3.2.27 (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa, RBAF600, p600) (Zinc finger UBR1-type protein 1)" UBR4 KIAA0462 KIAA1307 RBAF600 ZUBR1 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005516; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0008270; GO:0016020; GO:0016021; GO:0035579; GO:0061630; GO:0070821; GO:0101003 calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ACVLQRQR 0.99213 -85.075 0 0 0 0 0 0 12.3858 0 15.6423 12.6651 12.6204 15.1334 14.4398 15.5158 15.2374 12.9089 14.8529 14.8312 15.1649 12.1232 13.6003 0 15.5155 0 15.137 12.0621 15.8403 14.6073 0 14.5366 14.326 14.9335 13.7048 14.8672 0 13.9741 13.3814 12.6356 13.6284 0 14.861 14.4145 0 14.0433 15.6952 12.8027 11.6071 14.3661 15.0394 12.9351 0 12.7867 11.7886 12.6703 11.6723 0 12.1192 0 14.1429 0 0 0 0 0 0 0 14.6508 11.4349 15.0672 0 0 0 0 14.654 0 12.5983 0 13.3295 13.9686 12.2978 13.0324 0 12.4002 0 14.8359 14.4862 15.139 0 0 15.3174 0 14.1844 0 0 16.5287 14.5296 13.0102 0 14.2063 0 0 17.2935 16.7653 0 0 13.313 0 12.6104 0 0 15.0239 13.6533 11.6374 14.5224 13.4122 17.7703 0 17.3023 0 10.8478 14.2655 15.0229 0 16.177 15.0206 0 12.5355 0 0 0 0 11.7655 0 15.0719 0 16.3464 16.9521 15.4252 0 0 12.9418 12.7321 0 13.9032 0 0 0 17.3266 0 15.535 13.8782 15.5666 11.3474 12.3642 0 0 15.2282 12.9822 15.8072 16.2485 15.4153 15.055 14.1295 15.9892 16.159 14.1687 14.8521 13.8857 17.293 13.645 16.6944 13.2218 14.7456 0 16.0823 12.6247 0 16.6698 11.7724 12.3839 Q86UP3 ZFHX4_HUMAN "Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4, ZFH-4)" ZFHX4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AVGPAQSHKR 0.99213 -17.747 0 11.2051 11.6793 0 0 0 0 0 0 10.9545 0 0 0 0 0 0 13.3476 16.4832 13.4398 14.0209 16.9347 0 0 0 12.5129 0 0 10.6408 0 0 0 0 0 0 0 13.0013 0 0 0 0 0 0 0 0 11.1555 0 0 0 12.377 12.3571 0 12.276 12.3644 0 9.95466 0 0 0 0 0 0 0 0 0 0 0 0 11.5802 0 11.2859 12.8597 0 13.6531 0 0 14.439 13.8118 0 0 0 0 0 15.3709 15.6163 15.3487 15.6938 0 14.9052 0 0 0 14.4836 0 16.8233 0 14.9122 15.0026 16.3372 0 0 0 0 14.8976 13.015 13.2851 0 13.9164 11.6424 14.1855 0 0 14.5228 0 0 0 17.8525 12.7537 0 10.4682 12.0405 0 0 0 0 0 0 10.4074 0 0 0 0 0 13.1972 0 0 0 0 13.4327 0 11.5602 0 0 0 0 0 12.9063 14.5739 0 13.3126 0 0 0 0 0 0 0 0 12.9334 0 13.8966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4319 0 0 0 0 Q8N999 CL029_HUMAN Uncharacterized protein C12orf29 C12orf29 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244 HHLGLCWPIPDTYMNSR 0.99213 -6.133 0 0 0 0 0 0 0 0 0 15.0298 14.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8216 16.3399 16.6128 0 0 0 14.6083 14.794 0 0 0 0 0 0 0 17.4138 0 0 0 0 0 0 0 0 0 17.0199 18.19 18.2444 14.9668 17.3485 18.1288 15.5309 16.6792 17.4881 16.8272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5955 0 0 0 0 0 0 0 0 0 0 0 14.5336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1667 0 0 14.229 0 0 14.8998 17.9448 0 0 0 0 0 0 13.2976 0 0 0 0 Q8TAD2 IL17D_HUMAN "Interleukin-17D, IL-17D (Interleukin-27, IL-27)" IL17D UNQ3096/PRO21175 Homo sapiens (Human) inflammatory response [GO:0006954]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; inflammatory response [GO:0006954]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757] GO:0005125; GO:0005615; GO:0006954; GO:0032725; GO:0032755; GO:0032757; GO:0042803; GO:0048018; GO:1900017; GO:1903707 cytokine activity [GO:0005125]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018] ISYDPARYPR 0.99213 -17.762 0 0 0 0 0 0 0 0 0 0 0 0 12.4916 0 12.9704 12.4966 12.2444 0 11.9507 0 0 0 0 0 11.5667 0 12.1285 0 0 0 0 12.6002 0 0 12.5521 0 0 0 0 0 0 0 12.2513 12.4718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0284 0 0 Q8WV16 DCAF4_HUMAN DDB1- and CUL4-associated factor 4 (WD repeat-containing protein 21A) DCAF4 WDR21 WDR21A Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; protein ubiquitination [GO:0016567] GO:0005654; GO:0016567; GO:0080008 DSEDRSDSR 0.99213 -24.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0478 0 0 17.9412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0189 0 0 0 10.2232 0 Q96IR7 HPDL_HUMAN "4-hydroxyphenylpyruvate dioxygenase-like protein, HPD-like protein, EC 1.13.-.- (Glyoxalase domain-containing protein 1)" HPDL GLOXD1 Homo sapiens (Human) aromatic amino acid family metabolic process [GO:0009072] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; aromatic amino acid family metabolic process [GO:0009072] GO:0003868; GO:0005739; GO:0009072; GO:0046872 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872] FLLQVFTK 0.99213 -7.6204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5163 0 0 0 0 0 0 0 0 0 0 0 0 13.0518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LI9 CX058_HUMAN Uncharacterized protein CXorf58 CXorf58 Homo sapiens (Human) FLLQRPVTQEIHKHQLR 0.99213 -18.199 12.3955 11.9051 11.7242 0 0 0 0 0 0 0 0 0 0 15.5417 15.1403 0 14.9074 0 15.9176 14.4298 0 10.8094 16.1959 11.038 0 15.3068 14.9784 0 0 0 0 0 0 0 0 14.059 13.1177 0 13.8924 0 0 0 13.9484 14.9922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6626 0 0 0 0 0 0 0 0 12.2016 12.5854 0 0 0 0 0 0 12.3589 0 0 13.9979 0 0 14.2085 0 13.3024 13.1597 13.4218 13.3105 13.5694 0 0 0 0 0 0 15.7375 14.1383 13.9248 0 0 0 0 0 0 0 0 13.8895 12.3589 13.7186 13.3544 14.687 0 0 0 10.9981 0 12.8744 0 13.3164 0 13.8588 13.6054 0 0 0 0 0 0 12.8761 0 0 0 0 0 0 0 0 0 12.6055 0 0 0 0 0 0 0 0 0 13.7052 0 0 0 0 12.525 0 0 10.6916 0 0 0 0 0 0 0 11.9668 0 0 0 0 14.9269 0 0 0 Q9BZR9 TRIM8_HUMAN "E3 ubiquitin-protein ligase TRIM8, EC 2.3.2.27 (Glioblastoma-expressed RING finger protein) (RING finger protein 27) (RING-type E3 ubiquitin transferase TRIM8) (Tripartite motif-containing protein 8)" TRIM8 GERP RNF27 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to nucleus [GO:1900182]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; suppression of viral release by host [GO:0044790] cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605] cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to nucleus [GO:1900182]; protein ubiquitination [GO:0016567]; stem cell population maintenance [GO:0019827]; suppression of viral release by host [GO:0044790] GO:0003713; GO:0005634; GO:0005829; GO:0008270; GO:0010508; GO:0016567; GO:0016605; GO:0016740; GO:0019827; GO:0032897; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0046597; GO:0051091; GO:0051092; GO:1900182 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270] ILMDRTQTCTSSSLSPTKIGHLNSK 0.99213 -18.197 11.6784 0 0 0 0 0 0 0 0 0 0 10.2427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.389 0 0 0 0 0 0 12.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2283 0 11.5062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8809 0 0 0 0 0 0 0 13.0589 0 14.1423 0 0 13.6071 0 0 0 0 0 0 0 0 13.9334 0 16.6893 0 0 0 0 0 0 0 0 0 11.2016 0 0 0 14.1411 0 0 0 12.8499 13.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3791 0 0 0 0 0 0 0 0 0 0 0 0 12.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2641 0 0 12.2561 0 0 0 0 0 0 0 0 0 Q9H0A9 SPC1L_HUMAN Speriolin-like protein (Spermatogenesis and centriole-associated protein 1-like protein) SPATC1L C21orf56 Homo sapiens (Human) actin polymerization or depolymerization [GO:0008154]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of protein kinase A signaling [GO:0010739]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; sperm connecting piece [GO:0097224] centrosome [GO:0005813]; sperm connecting piece [GO:0097224]; identical protein binding [GO:0042802]; protein kinase A regulatory subunit binding [GO:0034237]; actin polymerization or depolymerization [GO:0008154]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of protein kinase A signaling [GO:0010739]; spermatogenesis [GO:0007283] GO:0005813; GO:0007283; GO:0008154; GO:0010739; GO:0034237; GO:0042802; GO:0097224; GO:2000481 identical protein binding [GO:0042802]; protein kinase A regulatory subunit binding [GO:0034237] EMVRPKK 0.99213 -17.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4305 0 0 0 15.052 15.07 14.9139 0 0 0 15.812 0 0 15.5477 0 15.4759 0 15.094 14.938 14.6692 0 0 0 15.1615 14.982 0 0 14.4239 14.0756 0 0 13.8854 14.7377 14.4253 0 0 0 0 0 14.5478 0 0 14.4657 0 15.1182 14.659 14.346 0 0 0 0 0 0 0 14.0222 0 13.9262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQX3 GEPH_HUMAN "Gephyrin [Includes: Molybdopterin adenylyltransferase, MPT adenylyltransferase, EC 2.7.7.75 (Domain G); Molybdopterin molybdenumtransferase, MPT Mo-transferase, EC 2.10.1.1 (Domain E) ]" GPHN GPH KIAA1385 Homo sapiens (Human) establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038] anchored component of synaptic membrane [GO:0099144]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; synaptic membrane [GO:0097060] anchored component of synaptic membrane [GO:0099144]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038] GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007529; GO:0008940; GO:0010038; GO:0014069; GO:0018315; GO:0030425; GO:0032324; GO:0042802; GO:0043546; GO:0045211; GO:0046872; GO:0061598; GO:0061599; GO:0070161; GO:0072579; GO:0097060; GO:0097112; GO:0098970; GO:0099144; GO:0099572; GO:0099634 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940] GVQVLPR 0.99213 -7.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4392 0 0 0 0 11.7095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8453 0 0 14.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9662 0 0 0 0 0 0 0 0 0 0 0 0 11.7286 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWS8 RMND1_HUMAN Required for meiotic nuclear division protein 1 homolog RMND1 C6orf96 Homo sapiens (Human) positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412] GO:0005739; GO:0006412; GO:0070131 ALRLEWMIVILITIEVMFELGRVFF 0.99213 -18.212 0 0 0 0 0 0 0 0 0 12.9904 0 0 0 0 0 0 0 12.4675 12.3734 12.5199 12.6622 0 0 0 12.5542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2369 0 0 0 0 11.9073 16.632 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4547 14.1343 16.1521 14.2529 14.2529 14.2502 0 0 0 0 0 0 16.8679 0 0 19.4502 0 0 0 0 0 13.929 0 0 0 0 0 13.6431 0 17.2887 15.8737 19.2173 0 14.1045 0 0 0 14.4771 0 14.1973 0 0 0 19.7943 0 14.4882 0 0 0 0 0 17.6788 0 19.2622 14.3624 0 18.9804 0 14.5222 0 0 0 0 0 0 0 14.5101 0 0 0 0 0 0 0 0 12.1374 0 0 0 14.5372 0 0 0 0 0 0 0 0 0 0 14.2353 0 0 0 0 0 0 0 0 14.1763 0 0 0 0 0 14.1214 0 0 0 0 0 0 0 0 Q9P1Z0 ZBTB4_HUMAN "Zinc finger and BTB domain-containing protein 4 (KAISO-like zinc finger protein 1, KAISO-L1)" ZBTB4 KIAA1538 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; methyl-CpNpG binding [GO:0010428]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0006974; GO:0008327; GO:0010428; GO:0016604; GO:0019901; GO:0042803; GO:0043565; GO:0045892; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; methyl-CpNpG binding [GO:0010428]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]" AGGEDQLWRPYYSYK 0.99213 -7.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3019 0 0 0 0 0 0 0 0 0 0 0 15.6264 0 0 0 11.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMN6 KMT2B_HUMAN "Histone-lysine N-methyltransferase 2B, Lysine N-methyltransferase 2B, EC 2.1.1.364 (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7, WBP-7)" KMT2B HRX2 KIAA0304 MLL2 MLL4 TRX2 WBP7 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription, DNA-templated [GO:0045893]" histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0005634; GO:0005654; GO:0006325; GO:0008270; GO:0035097; GO:0042800; GO:0044648; GO:0044665; GO:0045322; GO:0045893; GO:0051568; GO:0097692 histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] CKEGPGPGPGTPR 0.99213 -56.308 0 0 10.7313 0 0 0 0 0 13.1717 0 0 0 0 0 0 0 0 0 11.4607 0 0 12.7766 0 0 0 0 0 11.5607 0 12.7888 13.3457 0 0 0 11.4128 11.2706 0 0 0 0 11.7685 0 0 0 0 14.2724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0606 0 0 13.2445 12.5309 13.5948 0 0 0 0 0 11.0668 0 0 13.683 0 0 0 0 12.5635 12.3872 0 0 0 17.1367 0 11.3565 0 0 0 13.054 12.0852 14.1232 0 15.9677 13.9445 0 12.5978 0 13.2313 12.2842 0 13.3614 14.9897 0 0 13.6389 0 0 0 14.4225 12.8698 0 0 12.3474 0 12.5017 0 0 0 14.657 0 14.0931 0 0 0 12.1186 0 14.0908 14.0076 0 11.4553 0 0 0 12.3312 0 0 12.3727 15.4501 14.6985 14.1715 0 0 14.4379 12.0496 12.6999 13.3842 0 0 0 14.7719 0 18.0488 12.4815 0 0 0 15.2225 0 0 0 13.8576 12.3535 0 15.6584 0 0 0 0 0 0 0 0 A6NHN0 OTOL1_HUMAN Otolin-1 OTOL1 Homo sapiens (Human) collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; otolith mineralization [GO:0045299]; protein homooligomerization [GO:0051260] collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; otolith mineralization [GO:0045299]; protein homooligomerization [GO:0051260] GO:0005201; GO:0005509; GO:0005576; GO:0005587; GO:0005615; GO:0030198; GO:0031012; GO:0038063; GO:0045299; GO:0051260 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] GCCGDSGER 0.99214 -18.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7618 0 12.7187 0 0 9.50259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.851 0 0 11.7339 0 0 10.123 0 0 0 0 0 0 14.4466 0 14.6866 15.5488 0 0 0 10.83 13.8773 14.1355 14.2798 0 14.1302 0 0 14.3034 15.7901 16.1895 15.5987 0 14.1525 14.6393 15.3879 16.5715 14.452 16.2252 15.672 0 0 0 14.3789 0 0 0 10.324 14.2347 11.0347 0 0 12.7586 14.0994 14.0779 0 14.3616 14.2289 0 0 0 0 14.0889 0 0 0 0 14.6612 0 14.3315 14.5728 0 0 9.94822 14.3041 14.3204 14.2994 0 14.2296 14.7892 14.4457 0 0 0 0 14.2343 0 0 0 14.7813 0 10.846 14.638 14.2678 0 0 0 0 14.2859 12.844 14.3831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4587 0 9.85803 0 0 0 0 0 0 A6NDD5 SYN1L_HUMAN "Synapse differentiation-inducing gene protein 1-like (Capucin) (Dispanin subfamily C member 1, DSPC1) (Transmembrane protein 90A)" SYNDIG1L TMEM90A Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] GO:0005794; GO:0016020; GO:0016021; GO:0043231 DQEDDQEEEESDATSTESESEDNFLTLPPR 0.99214 -7.4926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2379 0 0 0 0 0 0 0 15.8144 0 0 16.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2483 0 13.0953 0 0 17.773 0 0 0 0 0 0 0 0 0 0 0 0 13.8789 0 0 0 0 O43157 PLXB1_HUMAN Plexin-B1 (Semaphorin receptor SEP) PLXNB1 KIAA0407 PLXN5 SEP Homo sapiens (Human) cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888]; cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220] GO:0002116; GO:0004888; GO:0005096; GO:0005576; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0014068; GO:0016477; GO:0017154; GO:0030215; GO:0030334; GO:0032794; GO:0033689; GO:0035556; GO:0043087; GO:0043547; GO:0043931; GO:0048812; GO:0050772; GO:0051493; GO:0071526; GO:1900220; GO:1902287; GO:1904862 GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888] CQTAMPQYGCVWCEGERPR 0.99214 -6.0158 0 0 0 0 0 11.4683 11.8385 0 0 13.8491 0 0 0 0 0 0 0 0 0 0 0 13.0141 0 13.1522 0 13.3779 12.9334 0 0 0 0 0 0 0 0 0 0 0 0 9.4783 0 0 0 0 0 0 0 0 0 0 0 0 14.1007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6803 0 0 0 10.692 0 0 17.8643 17.9375 18.1361 18.1853 0 16.7193 15.4137 17.732 0 14.2761 15.2393 14.2475 0 13.9899 0 0 10.9085 0 0 13.1095 11.4812 16.1818 0 16.8341 15.8608 11.7891 11.6923 0 0 0 0 0 11.099 0 0 0 0 0 11.1121 18.2389 0 0 0 14.5066 10.9408 0 0 0 0 0 13.0627 0 0 0 0 0 0 0 0 17.7718 10.1862 0 0 17.8001 0 0 14.4108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6491 0 13.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0656 0 0 0 Q13105 ZBT17_HUMAN "Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1, Miz-1) (Zinc finger protein 151) (Zinc finger protein 60)" ZBTB17 MIZ1 ZNF151 ZNF60 Homo sapiens (Human) ectoderm development [GO:0007398]; G1 to G0 transition [GO:0070314]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993] "nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]; ectoderm development [GO:0007398]; G1 to G0 transition [GO:0070314]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001046; GO:0001223; GO:0001227; GO:0001228; GO:0001702; GO:0003700; GO:0005654; GO:0006357; GO:0007398; GO:0008285; GO:0032991; GO:0032993; GO:0045786; GO:0045944; GO:0046872; GO:0070314; GO:0140297 "core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]" CSVCSKAFVNVGDLSK 0.99214 -18.301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.611 0 0 0 0 11.9404 0 0 13.8652 0 0 0 0 0 12.693 0 0 0 0 0 0 0 0 0 12.7364 12.9647 0 0 0 14.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8198 0 0 0 0 0 0 0 0 0 13.4617 0 0 13.454 0 13.3095 13.1444 13.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6038 0 0 0 0 0 0 0 0 13.3655 0 13.3715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0293 0 12.57 0 0 0 0 0 0 0 0 0 14.0939 0 13.6705 0 0 0 0 0 0 0 13.876 12.5182 0 0 0 14.0335 0 0 13.0567 13.5923 0 0 13.7413 0 0 12.8432 0 0 0 0 0 0 13.6032 0 0 15.0108 0 13.1081 0 0 Q5VTT2 CFA95_HUMAN Cilia- and flagella-associated protein 95 CFAP95 C9orf135 Homo sapiens (Human) axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005737; GO:0005879; GO:0005886; GO:0016021 CRSQFTDLNGSKR 0.99214 -7.4896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1804 0 0 0 0 0 11.3888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8402 0 0 0 0 0 0 0 0 0 0 11.4341 0 0 0 0 0 0 0 14.0468 0 0 0 0 13.2704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8466 0 12.7015 0 0 0 0 0 0 Q8NAP3 ZBT38_HUMAN Zinc finger and BTB domain-containing protein 38 ZBTB38 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of transcription, DNA-templated [GO:0006355]" blood microparticle [GO:0072562]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "blood microparticle [GO:0072562]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0006355; GO:0006974; GO:0008327; GO:0042803; GO:0045892; GO:0045944; GO:0046872; GO:0072562 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DDFHSDTVLSILNEQR 0.99214 -25.109 0 0 0 0 0 0 0 0 0 12.6767 0 0 12.6215 0 0 0 0 0 12.04 10.8697 12.9031 0 0 0 0 0 11.8658 0 0 0 0 0 0 10.1085 0 11.5036 0 12.4762 0 0 0 0 0 0 0 12.9638 0 0 0 0 0 11.0336 0 0 0 0 0 12.0149 11.2416 0 0 0 0 11.4001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6368 0 14.7781 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7736 12.8999 0 0 0 15.113 0 0 0 15.5888 12.8425 0 11.3816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7326 0 0 10.5552 0 0 0 0 0 0 11.5366 0 0 0 0 0 0 0 0 13.3079 0 12.7195 0 0 0 0 12.6848 12.4988 11.9899 0 0 0 0 0 13.3238 0 0 0 0 0 0 0 0 0 0 0 12.209 0 0 0 0 0 0 Q96CE8 T4S18_HUMAN Transmembrane 4 L6 family member 18 TM4SF18 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CCQSENCSK 0.99214 -6.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR63 CP26B_HUMAN "Cytochrome P450 26B1, EC 1.14.13.- (Cytochrome P450 26A2) (Cytochrome P450 retinoic acid-inactivating 2, Cytochrome P450RAI-2) (Retinoic acid-metabolizing cytochrome)" CYP26B1 CYP26A2 P450RAI2 Homo sapiens (Human) bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]" GO:0001709; GO:0001768; GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006766; GO:0006805; GO:0006954; GO:0007140; GO:0007283; GO:0008401; GO:0009954; GO:0010628; GO:0016125; GO:0016491; GO:0016709; GO:0020037; GO:0030326; GO:0033189; GO:0034653; GO:0042573; GO:0043587; GO:0045580; GO:0048384; GO:0048387; GO:0060349; GO:0061436; GO:0070268; GO:0071300; GO:2001037 "heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]" EMTMQELK 0.99214 -4.9368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8614 0 0 0 0 0 0 0 0 14.0566 0 0 0 0 0 0 0 0 0 12.2175 0 0 0 13.6932 0 0 14.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3735 0 15.9338 0 0 0 0 0 0 0 0 0 0 11.6387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8908 0 13.3117 0 0 0 0 0 0 0 0 0 0 0 11.7925 0 0 0 0 0 0 0 14.4628 10.5536 O60663 LMX1B_HUMAN "LIM homeobox transcription factor 1-beta (LIM/homeobox protein 1.2, LMX-1.2) (LIM/homeobox protein LMX1B)" LMX1B Homo sapiens (Human) "dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0009953; GO:0030182; GO:0045944; GO:0046872; GO:0071542; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ALECVYHLGCFCCCVCER 0.99215 -18.338 0 0 0 0 0 0 0 0 0 13.6592 0 0 0 0 0 13.6222 0 12.8288 0 0 0 0 10.3633 0 0 13.1046 0 0 0 0 0 10.7329 0 0 0 0 0 0 0 10.8418 0 0 0 0 12.9188 10.4727 0 10.4952 0 0 10.5932 11.5746 0 0 0 11.713 10.5026 0 0 0 0 0 0 0 0 0 0 0 10.6043 0 0 0 0 0 13.475 12.4104 11.7012 12.681 13.6607 13.9256 0 0 0 13.1136 12.5635 0 15.7145 15.4558 15.9195 15.5965 0 15.4198 0 15.6646 0 14.4376 12.4078 14.099 0 14.0076 15.5296 15.2282 0 15.521 15.4943 13.5434 14.5095 0 14.6739 11.8163 12.5293 0 0 15.313 0 0 0 0 0 0 13.1242 15.4341 0 13.5228 14.7268 13.4176 17.1605 16.7046 0 13.5482 12.8589 0 10.7996 0 0 17.5486 17.8828 18.718 13.852 10.4864 0 0 0 0 14.1342 13.6496 0 0 0 0 10.5788 12.8871 0 17.4868 0 15.6378 0 0 0 12.5418 0 0 0 0 0 0 0 11.9569 0 0 0 13.3692 0 13.7604 14.6311 0 0 0 0 0 P28472 GBRB3_HUMAN Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) GABRB3 Homo sapiens (Human) "cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0030659; GO:0034220; GO:0034707; GO:0042391; GO:0042802; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060021; GO:0070161; GO:0071420; GO:1902476; GO:1902711; GO:1904315; GO:1904862 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] EGHGRFLGDR 0.99215 -4.9444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0786 0 0 0 0 0 0 0 0 12.5681 12.9022 12.3774 0 12.0136 0 0 0 0 0 0 0 0 0 0 12.6628 10.8374 0 0 0 0 0 0 14.9586 0 0 0 0 0 0 0 0 0 15.8486 0 0 0 12.7108 0 0 14.7124 14.6161 0 0 12.7989 14.4638 0 12.0388 0 13.4213 0 13.1408 0 0 0 12.1551 0 13.9913 12.5175 0 0 0 0 14.131 0 12.6096 0 13.0169 12.5217 12.0012 0 0 0 0 0 0 0 12.3869 0 0 13.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5523 0 14.0822 0 0 0 0 0 Q68DE3 USF3_HUMAN Basic helix-loop-helix domain-containing protein USF3 (Upstream transcription factor 3) USF3 KIAA2018 Homo sapiens (Human) negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000977; GO:0001228; GO:0005634; GO:0010719; GO:0045944; GO:0046983 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" HPLQDSSGSKIR 0.99215 -7.6576 0 0 0 10.8858 0 0 0 0 0 0 10.5517 0 0 0 0 0 0 0 0 0 10.9106 9.89408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8618 0 0 0 0 0 0 12.3986 0 0 0 0 0 0 0 0 0 0 0 10.2958 0 0 11.8576 12.1235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6154 0 0 12.651 0 0 0 0 12.832 13.7625 0 12.8641 13.1311 0 0 13.5085 0 12.1419 15.3636 14.5929 14.7912 0 0 0 0 11.0389 0 0 0 13.9487 0 0 0 0 12.6177 12.2069 14.014 14.6481 0 13.5511 0 0 0 0 0 11.2973 0 11.1665 14.3741 0 15.2622 0 0 10.9856 14.4015 0 0 14.9369 0 0 0 0 0 11.0973 0 0 0 14.1819 0 0 14.8633 14.2025 0 10.8858 0 0 0 0 0 0 0 0 0 12.3117 0 0 12.6982 0 15.2201 0 0 0 0 0 0 0 Q6AZZ1 TRI68_HUMAN "E3 ubiquitin-protein ligase TRIM68, EC 2.3.2.27 (RING finger protein 137) (RING-type E3 ubiquitin transferase TRIM68) (SSA protein SS-56, SS-56) (Tripartite motif-containing protein 68)" TRIM68 GC109 RNF137 SS56 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0035035; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0048471; GO:0050681; GO:0051092; GO:0051865; GO:0060765; GO:0061630 histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] LELNHSELIQQSQVLWR 0.99215 -7.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9776 0 0 0 0 9.33387 0 0 0 0 0 10.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3385 0 0 0 0 0 0 0 10.5614 0 0 0 0 0 0 0 0 0 9.49917 0 0 0 0 0 0 0 0 0 0 11.909 0 0 0 13.8828 0 0 0 0 0 0 0 0 0 0 0 11.775 0 0 0 10.7235 0 0 11.8584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9105 0 10.47 0 0 13.1351 0 0 0 0 0 12.0846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1267 0 0 0 15.164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4124 0 0 14.0269 0 0 Q6ZU35 CRACD_HUMAN Capping protein-inhibiting regulator of actin dynamics (Cancer-related regulator of actin dynamics) CRACD CRAD KIAA1211 Homo sapiens (Human) epithelial structure maintenance [GO:0010669]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838] cytosol [GO:0005829] cytosol [GO:0005829]; epithelial structure maintenance [GO:0010669]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838] GO:0005829; GO:0010669; GO:0030277; GO:0030838; GO:2000813 EDQESSDR 0.99215 -17.889 0 0 0 0 0 0 0 0 0 0 12.7225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8791 0 13.5893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VD7 S2542_HUMAN Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42) SLC25A42 Homo sapiens (Human) ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228]; ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349] GO:0005347; GO:0005634; GO:0005739; GO:0005743; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0016021; GO:0035349; GO:0043262; GO:0080121; GO:0080122 adenosine-diphosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228] ISREEGLK 0.99215 -6.6868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83278 0 0 0 0 0 13.1626 0 0 13.2909 0 0 0 0 0 0 0 0 0 0 0 0 11.2472 0 0 0 0 12.539 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8145 0 0 12.0913 0 0 0 0 0 0 0 0 0 0 0 11.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5C8 TAB3_HUMAN "TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 3) (NF-kappa-B-activating protein 1) (TAK1-binding protein 3, TAB-3) (TGF-beta-activated kinase 1-binding protein 3)" TAB3 MAP3K7IP3 Homo sapiens (Human) negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; negative regulation of autophagy [GO:0010507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005829; GO:0005886; GO:0008270; GO:0010008; GO:0010507; GO:0043123; GO:0043130; GO:0070062; GO:0070530 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] ALSQESSK 0.99215 -18.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7555 0 0 0 0 0 0 16.6517 0 0 0 13.5882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0428 0 0 0 0 0 0 15.808 0 15.9228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1608 0 0 12.3179 12.6206 0 0 0 0 18.366 0 0 12.4657 13.3723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7793 13.1912 0 0 0 0 0 0 Q8NGH8 O56A4_HUMAN Olfactory receptor 56A4 (Olfactory receptor OR11-49) OR56A4 Homo sapiens (Human) integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AEGAVAK 0.99215 -4.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1839 0 0 0 0 0 0 11.0439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8289 0 0 0 0 0 0 0 12.9659 0 0 0 0 12.5234 0 0 0 0 0 0 0 12.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCT6 SPPL3_HUMAN "Signal peptide peptidase-like 3, SPP-like 3, EC 3.4.23.- (Intramembrane protease 2, IMP-2) (Presenilin homologous protein 1, PSH1) (Presenilin-like protein 4)" SPPL3 IMP2 PSL4 Homo sapiens (Human) membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852] endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] "endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852]" GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0032092; GO:0033116; GO:0033619; GO:0035307; GO:0042500; GO:0042803; GO:0043231; GO:0050852; GO:0070886; GO:0071458; GO:0071556 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]" MWSEPFHSK 0.99215 -6.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC36 MRM3_HUMAN "rRNA methyltransferase 3, mitochondrial, EC 2.1.1.- (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)" MRM3 RNMTL1 HC90 Homo sapiens (Human) rRNA 2'-O-methylation [GO:0000451] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451] GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0042802; GO:0070039 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] AEDLSRDR 0.99215 -17.88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78565 0 0 0 0 0 0 0 0 0 15.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3038 0 13.4705 0 Q9ULQ0 STRP2_HUMAN Striatin-interacting protein 2 (Protein FAM40B) STRIP2 FAM40B KIAA1170 Homo sapiens (Human) cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360] GO:0005737; GO:0005829; GO:0007010; GO:0008360; GO:0016477 ALKVKQAMLQLYVLK 0.99215 -17.92 0 11.326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0689 0 0 0 0 0 0 0 0 0 0 0 12.9626 11.8161 0 0 0 0 0 0 0 0 0 0 12.8928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.087 0 14.632 14.4361 14.4248 0 0 0 13.3558 10.5333 0 0 13.6831 0 11.483 11.1112 13.2583 0 13.0874 11.8339 0 0 0 13.4902 13.3659 0 0 0 0 0 0 0 12.0013 0 0 0 11.2989 0 0 0 0 0 0 0 0 11.1016 0 0 0 0 12.1419 0 0 0 14.5862 0 0 0 0 0 0 12.8884 15.2976 0 11.1608 0 0 13.2615 0 13.7722 0 15.3942 0 0 0 0 11.3252 0 10.1615 0 0 0 0 11.5093 0 14.4995 0 0 0 0 0 0 0 12.6929 0 0 0 0 14.7345 0 12.6552 0 0 0 0 0 11.3964 0 0 0 0 0 0 10.9442 O00422 SAP18_HUMAN Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (2HOR0202) (Cell growth-inhibiting gene 38 protein) (Sin3-associated polypeptide p18) SAP18 GIG38 Homo sapiens (Human) "mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]" ASAP complex [GO:0061574]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ASAP complex [GO:0061574]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]" GO:0000118; GO:0000381; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0043065; GO:0045892; GO:0048025; GO:0061574 RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] APPPSGR 0.99216 -7.6661 0 0 0 10.9875 0 0 0 0 13.2037 0 11.8751 0 0 11.8815 0 13.166 0 0 0 0 0 0 0 14.2195 0 11.0572 0 0 0 0 0 0 0 0 12.0595 13.4553 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2316 0 0 0 0 0 0 0 0 0 0 0 10.7687 10.5857 0 0 0 0 0 0 0 12.7506 0 0 0 0 0 12.0719 0 0 12.8453 0 12.9147 15.7698 0 0 0 0 0 0 16.0956 14.0548 0 0 0 0 0 0 0 0 0 16.2173 16.1286 0 0 0 14.8843 0 0 0 12.3963 0 0 0 0 0 0 0 13.7728 0 0 0 0 0 0 0 0 13.5036 0 0 12.8913 0 0 15.1585 0 0 0 0 0 12.6465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94806 KPCD3_HUMAN "Serine/threonine-protein kinase D3, EC 2.7.11.13 (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu)" PRKD3 EPK2 PRKCN Homo sapiens (Human) protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148] GO:0004697; GO:0004698; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0007205; GO:0016020; GO:0016301; GO:0030148; GO:0046872; GO:0089700; GO:0106310 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310] APTFCDYCGEMLWGLVR 0.99216 -17.984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.79 0 0 0 0 0 0 0 11.7251 0 0 12.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2554 0 0 0 0 0 0 0 0 0 0 14.633 0 0 0 0 0 0 0 0 0 0 0 14.1543 0 0 12.9946 0 0 0 14.4644 14.2056 0 17.4238 0 0 0 12.8068 0 0 0 0 15.1041 0 10.741 0 13.0244 0 0 19.0909 0 0 0 0 0 0 12.1325 0 0 11.3647 11.5102 0 0 0 0 0 19.7605 12.2459 19.7506 0 0 0 0 0 0 0 0 12.3618 0 11.9675 0 0 12.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1638 11.274 0 0 0 0 0 0 0 O94929 ABLM3_HUMAN "Actin-binding LIM protein 3, abLIM-3 (Actin-binding LIM protein family member 3)" ABLIM3 KIAA0843 HMFN1661 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; cilium assembly [GO:0060271]; lamellipodium assembly [GO:0030032]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366] GO:0001725; GO:0005737; GO:0006366; GO:0015629; GO:0030027; GO:0030032; GO:0030036; GO:0045944; GO:0046872; GO:0051015; GO:0060271; GO:0098978; GO:1903955 actin filament binding [GO:0051015]; metal ion binding [GO:0046872] CETCDRYISGR 0.99216 -25.456 0 0 0 0 0 0 0 10.5149 0 0 0 0 0 0 0 0 0 0 0 10.1718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8991 0 0 0 0 0 12.1952 0 0 0 0 13.6712 13.1504 0 13.2436 0 0 0 12.4463 0 0 9.93213 0 0 0 0 0 12.7611 0 0 0 0 0 0 12.6042 0 0 0 0 0 12.9038 12.6767 0 13.3042 0 0 0 13.708 14.1357 0 0 11.8954 14.0951 0 0 11.1421 12.8952 0 0 14.9893 0 15.6164 0 0 0 0 0 0 0 12.9202 13.4022 0 0 0 0 0 0 13.2181 0 0 0 0 0 0 12.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2231 0 14.7245 0 0 0 11.3728 0 0 0 12.693 0 14.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08240 SRPRA_HUMAN "Signal recognition particle receptor subunit alpha, SR-alpha (Docking protein alpha, DP-alpha)" SRPRA SRPR Homo sapiens (Human) "cotranslational protein targeting to membrane [GO:0006613]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785] "endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; cotranslational protein targeting to membrane [GO:0006613]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" GO:0003723; GO:0003924; GO:0005047; GO:0005525; GO:0005785; GO:0005789; GO:0006605; GO:0006613; GO:0006617; GO:0016020; GO:0045047; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047] DIMDAQRRQR 0.99216 -7.3506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8511 P0CH99 Z705D_HUMAN Zinc finger protein 705D ZNF705D Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AYTNCFYLR 0.99216 -7.355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42568 AF9_HUMAN Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3) MLLT3 AF9 YEATS3 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; histone acetylation [GO:0016573]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]" chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] "chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; histone acetylation [GO:0016573]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379]" GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006338; GO:0006357; GO:0007379; GO:0008023; GO:0009952; GO:0010467; GO:0016573; GO:0032783; GO:0035267; GO:0042393; GO:0045893; GO:0060218; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:1902275; GO:2000035; GO:2000096 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030] AGGDPNR 0.99216 -25.454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9463 0 14.1144 14.2604 10.9032 0 0 0 12.6576 13.6316 0 12.3047 0 0 12.509 12.9287 0 12.8108 13.1807 13.0258 0 0 0 0 0 0 12.5068 0 0 0 14.7207 0 14.5613 0 13.3744 0 0 12.1721 13.7147 13.1792 0 0 0 12.2488 0 0 12.6964 14.2666 13.839 12.7602 13.9739 0 0 12.9921 13.1898 0 0 13.2628 0 0 0 0 0 13.7329 15.2216 0 0 0 0 0 0 14.4174 11.9864 0 0 0 14.458 0 0 13.3471 0 0 0 0 0 0 0 0 0 11.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48728 GCST_HUMAN "Aminomethyltransferase, mitochondrial, EC 2.1.2.10 (Glycine cleavage system T protein, GCVT)" AMT GCST Homo sapiens (Human) glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464] GO:0004047; GO:0005654; GO:0005739; GO:0005759; GO:0006546; GO:0008483; GO:0019464 aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483] ILGSDRVK 0.99216 -6.7264 0 0 0 0 12.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0434 0 0 0 0 0 0 10.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1506 0 13.288 0 0 0 0 14.623 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4944 0 13.741 0 0 0 0 11.5947 0 0 0 0 12.879 0 0 0 0 0 13.759 0 0 0 0 0 0 0 13.0775 13.2744 0 0 0 12.9071 0 12.9974 0 13.2593 0 13.2861 13.5101 0 0 0 0 13.4896 0 0 13.8371 0 0 13.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8474 0 0 0 0 12.096 0 0 0 P50876 R144A_HUMAN "E3 ubiquitin-protein ligase RNF144A, EC 2.3.2.31 (RING finger protein 144A) (UbcM4-interacting protein 4) (Ubiquitin-conjugating enzyme 7-interacting protein 4)" RNF144A KIAA0161 RNF144 UBCE7IP4 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0005737; GO:0005794; GO:0005886; GO:0006511; GO:0010008; GO:0016021; GO:0016567; GO:0031624; GO:0032436; GO:0043231; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] CKVYIER 0.99216 -15.058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7983 0 0 0 0 0 0 0 0 0 0 0 0 12.1551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78356 PI42B_HUMAN "Phosphatidylinositol 5-phosphate 4-kinase type-2 beta, EC 2.7.1.149 (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta, PI(5)P 4-kinase type II beta, PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta)" PIP4K2B PIP5K2B Homo sapiens (Human) "1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; autophagosome-lysosome fusion [GO:0061909]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]" autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803]; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; autophagosome-lysosome fusion [GO:0061909]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]" GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0007166; GO:0010506; GO:0016308; GO:0016309; GO:0016310; GO:0042803; GO:0046627; GO:0046854; GO:0061909; GO:0090217; GO:1902635; GO:2000786 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803] FLTTYDRRFVIK 0.99216 -24.482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.866 0 0 0 0 14.2701 0 0 0 12.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14584 ZN266_HUMAN Zinc finger protein 266 (Zinc finger protein HZF1) ZNF266 KIAA2007 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ECGIAFTR 0.99216 -4.5063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8568 0 0 0 14.8561 0 0 0 0 0 12.9514 0 0 0 0 0 0 0 0 10.0844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7995 0 0 0 0 0 0 0 0 0 0 Q6T423 S22AP_HUMAN Solute carrier family 22 member 25 (Organic anion transporter UST6) SLC22A25 UST6 Homo sapiens (Human) organic anion transport [GO:0015711] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; organic anion transport [GO:0015711] GO:0015711; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] FGRKFVLR 0.99216 -17.991 0 0 0 0 0 0 0 0 0 0 0 14.1651 0 14.7607 12.6967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6643 0 0 0 0 0 14.9176 0 0 0 13.5006 0 0 0 13.6856 0 0 0 0 0 12.9367 0 0 0 0 0 0 14.7573 0 0 0 0 0 0 0 0 0 0 12.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3737 0 0 0 0 0 0 0 0 11.3955 0 0 0 0 0 0 0 0 11.5264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9437 0 0 Q6ZRF8 RN207_HUMAN RING finger protein 207 RNF207 C1orf188 Homo sapiens (Human) cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207] GO:0008270; GO:0010628; GO:0030544; GO:0044325; GO:0048471; GO:0051087; GO:0055117; GO:0086019; GO:1901018; GO:1901207; GO:1902261; GO:1903762; GO:1903954 chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; transmembrane transporter binding [GO:0044325]; zinc ion binding [GO:0008270] CANCDLECSEQDVETTYFCNTCGQPLCAR 0.99216 -7.6833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2992 0 0 0 0 0 0 13.2762 0 0 0 0 0 0 13.9988 0 0 0 13.5245 13.496 13.724 12.5154 0 12.3106 12.6598 0 0 0 0 14.7752 13.9636 0 0 0 0 0 0 0 0 0 0 0 13.6847 0 0 0 0 0 13.3615 12.852 0 0 0 0 0 0 0 13.9595 0 14.1603 0 0 0 0 0 12.9697 0 0 12.8103 0 13.8095 0 0 0 0 0 0 0 0 0 0 0 12.5071 0 0 0 0 0 0 0 0 0 13.3034 13.0123 0 0 0 0 0 0 0 0 11.6181 0 0 0 0 Q7Z7B1 PIGW_HUMAN "Phosphatidylinositol-glycan biosynthesis class W protein, PIG-W, EC 2.3.-.-" PIGW Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; preassembly of GPI anchor in ER membrane [GO:0016254]; protein localization to plasma membrane [GO:0072659] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]; O-acyltransferase activity [GO:0008374]; GPI anchor biosynthetic process [GO:0006506]; GPI anchor metabolic process [GO:0006505]; preassembly of GPI anchor in ER membrane [GO:0016254]; protein localization to plasma membrane [GO:0072659] GO:0005789; GO:0006505; GO:0006506; GO:0008374; GO:0016021; GO:0016254; GO:0032216; GO:0072659 glucosaminyl-phosphatidylinositol O-acyltransferase activity [GO:0032216]; O-acyltransferase activity [GO:0008374] LHYFTNSLYSVWPLVFLGIGRLAIIK 0.99216 -7.3566 0 0 0 0 0 0 0 0 11.4437 0 0 0 0 0 0 0 0 0 0 0 13.1878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7264 0 0 0 0 0 0 0 12.452 0 0 0 0 0 0 0 0 0 0 0 0 12.253 0 0 0 0 0 0 0 0 10.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6319 0 0 0 10.3509 0 0 0 0 0 13.0251 0 0 0 0 11.6545 0 0 0 0 0 0 0 0 0 0 13.1785 12.8422 0 0 0 0 0 0 0 0 12.2844 12.1303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9133 0 0 0 0 0 Q8IWK6 AGRA3_HUMAN Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125) ADGRA3 GPR125 UNQ556/PRO1113 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0009897; GO:0016021 G protein-coupled receptor activity [GO:0004930] CPNSSAESSCTNK 0.99216 -25.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1013 0 0 0 0 14.368 14.1012 0 0 0 0 12.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.085 0 0 11.9332 0 11.7314 0 10.9534 0 0 10.809 0 12.6992 0 0 0 0 0 0 0 0 0 0 0 0 0 13.816 15.9028 0 0 13.061 15.625 0 16.3021 16.4057 15.0561 0 0 14.17 15.5287 16.2582 16.4749 0 12.696 14.8721 0 0 0 15.3029 12.4597 0 0 13.8997 0 14.6069 0 0 0 0 13.8348 0 14.188 13.3654 0 13.7656 14.1555 0 14.3483 0 0 0 0 14.2124 13.9293 12.8058 0 10.505 13.0835 14.1236 0 13.9419 15.1673 0 0 0 0 0 14.0153 15.112 13.2323 14.6649 0 12.7412 0 0 0 0 0 13.7247 0 0 0 13.0819 0 0 0 14.7051 13.1395 0 13.6091 13.8306 0 0 11.9283 13.7292 13.3606 0 13.8093 0 0 13.8582 0 14.058 Q8N2F6 ARM10_HUMAN Armadillo repeat-containing protein 10 (Splicing variant involved in hepatocarcinogenesis protein) ARMC10 SVH PSEC0198 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of growth rate [GO:0040010]; regulation of growth [GO:0040008] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; DNA binding domain binding [GO:0050692]; p53 binding [GO:0002039]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of growth rate [GO:0040010]; regulation of growth [GO:0040008] GO:0002039; GO:0005739; GO:0005783; GO:0005789; GO:0016021; GO:0040008; GO:0040010; GO:0043066; GO:0050692; GO:1902254 DNA binding domain binding [GO:0050692]; p53 binding [GO:0002039] EILLRVLTLFQNIK 0.99216 -4.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4562 13.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0499 0 0 0 0 0 0 0 0 0 16.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBR6 MINY2_HUMAN "Ubiquitin carboxyl-terminal hydrolase MINDY-2, EC 3.4.19.12 (Deubiquitinating enzyme MINDY-2) (Protein FAM63B)" MINDY2 FAM63B KIAA1164 Homo sapiens (Human) protein K48-linked deubiquitination [GO:0071108] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; protein K48-linked deubiquitination [GO:0071108] GO:0004843; GO:0005654; GO:0016807; GO:0036435; GO:0070530; GO:0071108; GO:0071795; GO:0071796; GO:1990380 cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380] LQEEEDRR 0.99216 -7.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0381 0 0 0 0 0 0 0 12.3279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1141 0 11.9299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0384 Q8TD16 BICD2_HUMAN "Protein bicaudal D homolog 2, Bic-D 2" BICD2 KIAA0699 Homo sapiens (Human) "centrosome localization [GO:0051642]; microtubule anchoring at microtubule organizing center [GO:0072393]; microtubule-based movement [GO:0007018]; minus-end-directed organelle transport along microtubule [GO:0072385]; mRNA transport [GO:0051028]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] "annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein light intermediate chain binding [GO:0051959]; small GTPase binding [GO:0031267]; centrosome localization [GO:0051642]; microtubule anchoring at microtubule organizing center [GO:0072393]; microtubule-based movement [GO:0007018]; minus-end-directed organelle transport along microtubule [GO:0072385]; mRNA transport [GO:0051028]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0005635; GO:0005642; GO:0005643; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006890; GO:0007018; GO:0008093; GO:0015031; GO:0031267; GO:0031410; GO:0033365; GO:0034067; GO:0034452; GO:0051028; GO:0051642; GO:0051959; GO:0070507; GO:0070840; GO:0072385; GO:0072393 cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein light intermediate chain binding [GO:0051959]; small GTPase binding [GO:0031267] CDEYITQLDEMQR 0.99216 -4.5048 0 0 0 0 0 0 13.8871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5195 0 13.1194 0 0 0 0 0 0 0 0 14.0782 0 14.3321 0 0 0 14.8789 0 0 14.401 0 0 0 12.7937 0 13.2248 0 0 12.66 0 0 0 0 0 13.8469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1677 0 0 0 12.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0196 0 0 0 Q96P16 RPR1A_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein) RPRD1A P15RS Homo sapiens (Human) dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]" "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]" GO:0000993; GO:0005634; GO:0005654; GO:0016591; GO:0031124; GO:0042802; GO:0070940 identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993] CQKEALAEKEHK 0.99216 -17.986 0 0 0 0 12.2714 0 0 0 0 10.6699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2822 0 0 0 0 0 0 0 12.3435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3593 0 12.6688 13.2554 0 0 0 0 0 0 0 0 11.4303 0 12.0185 0 0 0 0 0 0 0 0 0 0 11.3934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2233 0 15.443 14.2403 0 0 0 0 0 0 0 0 0 0 0 13.2879 0 15.1426 14.5078 0 13.1507 13.3058 13.6225 0 0 0 0 0 0 0 0 0 0 0 0 13.4708 0 0 12.1088 0 0 12.9371 0 0 0 0 0 0 0 0 0 0 13.6239 0 14.0885 0 0 0 0 12.6483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.776 0 12.5389 0 0 0 0 0 0 0 0 0 0 0 0 Q9HA77 SYCM_HUMAN "Probable cysteine--tRNA ligase, mitochondrial, EC 6.1.1.16 (Cysteinyl-tRNA synthetase, CysRS)" CARS2 OK/SW-cl.10 Homo sapiens (Human) cysteinyl-tRNA aminoacylation [GO:0006423] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423] GO:0004817; GO:0005524; GO:0005737; GO:0005759; GO:0006423; GO:0046872 ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872] GNAYSTAK 0.99216 -6.0355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1022 0 0 0 0 0 0 0 0 14.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4011 0 0 0 0 0 0 0 13.6917 0 0 15.7261 13.7599 0 0 0 0 0 13.6731 0 0 0 0 13.9315 13.114 0 13.2583 0 0 0 13.951 15.2069 0 0 0 0 13.7867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8984 0 Q9NTK5 OLA1_HUMAN "Obg-like ATPase 1 (DNA damage-regulated overexpressed in cancer 45, DOC45) (GTP-binding protein 9)" OLA1 GTPBP9 PRO2455 PTD004 Homo sapiens (Human) ATP metabolic process [GO:0046034] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; ATP metabolic process [GO:0046034] GO:0005524; GO:0005525; GO:0005576; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0016020; GO:0016887; GO:0031093; GO:0043022; GO:0043023; GO:0045296; GO:0046034; GO:0046872; GO:0070062 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022] FGTSLKIGIVGLPNVGK 0.99216 -7.6809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.07 13.7864 0 0 0 0 0 9.97126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.838 12.3463 0 0 0 0 0 12.1889 13.9135 14.1867 0 0 0 0 0 13.9754 0 12.9255 0 0 0 14.1176 0 0 0 0 0 0 0 0 14.1589 14.1985 0 0 0 0 0 0 0 0 0 0 11.3512 0 0 0 0 0 12.6429 0 0 12.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY33 DPP3_HUMAN "Dipeptidyl peptidase 3, EC 3.4.14.4 (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III, DPP III) (Enkephalinase B)" DPP3 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; dipeptidyl-peptidase activity [GO:0008239]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0005737; GO:0005829; GO:0006508; GO:0008239; GO:0008270; GO:0070006; GO:0070062 dipeptidyl-peptidase activity [GO:0008239]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] DLYILWKGPSFDVQVGLHELLGHGSGK 0.99216 -24.424 12.6981 0 14.4103 0 0 0 0 0 12.7309 13.2613 0 0 0 0 0 0 0 0 0 12.7751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2399 15.9763 15.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9978 0 0 0 0 0 0 12.5566 0 0 0 0 0 13.3778 0 0 0 0 0 0 0 11.7127 0 14.4637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7831 0 0 0 0 0 0 13.5552 0 0 0 0 0 0 0 0 0 0 0 Q9UBC3 DNM3B_HUMAN "DNA (cytosine-5)-methyltransferase 3B, Dnmt3b, EC 2.1.1.37 (DNA methyltransferase HsaIIIB, DNA MTase HsaIIIB, M.HsaIIIB)" DNMT3B Homo sapiens (Human) C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571] catalytic complex [GO:1902494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "catalytic complex [GO:1902494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [GO:0051718]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; C-5 methylation of cytosine [GO:0090116]; DNA methylation [GO:0006306]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]" GO:0000122; GO:0003677; GO:0003714; GO:0003886; GO:0005634; GO:0005654; GO:0006306; GO:0009008; GO:0010628; GO:0046872; GO:0051571; GO:0051573; GO:0051718; GO:0090116; GO:1902494 "DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [GO:0051718]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]" EGDDRPFFWMFENVVAMK 0.99216 -7.682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8505 12.7282 0 0 0 13.5531 14.9817 0 0 0 0 12.4512 14.9475 15.023 13.475 0 14.1646 0 13.2087 0 0 0 0 0 0 0 0 0 12.7456 0 0 0 12.2822 10.9809 0 0 12.3042 13.0248 0 0 12.907 13.7313 0 0 0 0 14.0843 14.0201 13.5645 12.8937 0 0 0 0 12.5989 0 13.3266 0 0 0 0 13.0697 0 13.5839 0 12.8418 13.5757 0 13.8191 0 13.3146 0 14.1769 0 0 0 9.94787 0 0 0 12.6704 0 12.8052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2L5 TPPC8_HUMAN Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) TRAPPC8 KIAA1012 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization to phagophore assembly site [GO:0034497]; vesicle tethering [GO:0099022] GO:0000407; GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0031410; GO:0034497; GO:0048208; GO:0099022; GO:1990072 ACFVHTGVYNLGTPR 0.99216 -7.3586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9431 0 0 0 0 0 0 0 0 11.8685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.098 0 0 0 0 0 0 0 12.8015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0066 0 0 13.0128 0 0 12.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.296 0 0 0 0 0 0 0 13.1686 0 0 0 0 0 14.3496 0 0 0 0 Q9Y6C5 PTC2_HUMAN "Protein patched homolog 2, PTC2" PTCH2 UNQ560/PRO1121/PRO57079 Homo sapiens (Human) cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119]; cell fate determination [GO:0001709]; epidermal cell fate specification [GO:0009957]; hair cycle [GO:0042633]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of cell growth [GO:0001558]; skin development [GO:0043588]; smoothened signaling pathway [GO:0007224] GO:0001558; GO:0001709; GO:0005119; GO:0005886; GO:0007224; GO:0008158; GO:0009957; GO:0016021; GO:0042633; GO:0043588; GO:0045606; GO:0045879; GO:0097108 hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; smoothened binding [GO:0005119] AACKSLPCARWNLAHFAR 0.99216 -24.432 0 11.7155 11.6325 0 11.4741 0 0 0 13.9323 14.7795 12.6258 16.4304 15.0648 13.2165 15.0083 12.9122 12.7128 13.8317 12.4819 13.1905 13.7116 0 0 0 0 12.3566 12.7246 11.0939 0 13.4031 0 0 10.6776 12.6393 0 12.9207 14.0761 0 13.0825 0 0 0 13.3571 0 0 0 0 0 12.7946 10.3616 0 0 0 0 11.6788 0 11.4456 0 0 0 10.9552 0 0 10.8539 0 0 0 10.6238 0 10.5308 0 0 12.2211 0 11.9589 12.6339 12.3096 12.667 13.1771 13.8733 0 0 15.8794 0 13.4127 15.5015 0 0 0 13.6719 0 12.0377 0 10.6216 0 13.1654 14.0819 0 12.0387 14.8005 13.367 14.7845 14.8568 13.7076 0 0 13.8467 0 13.2942 0 0 14.2938 0 0 0 14.4604 11.8041 0 0 14.8291 0 0 0 0 0 11.9339 0 0 11.9481 0 0 0 0 0 0 0 0 0 0 14.2383 0 11.8171 0 0 0 0 14.7613 11.5375 0 0 12.7149 0 0 12.0762 14.9438 12.7509 10.9878 10.4816 0 12.7085 0 0 0 0 0 0 0 14.0181 0 0 0 10.8394 0 0 0 0 0 0 11.9611 15.3746 Q9ULT8 HECD1_HUMAN "E3 ubiquitin-protein ligase HECTD1, EC 2.3.2.26 (E3 ligase for inhibin receptor, EULIR) (HECT domain-containing protein 1)" HECTD1 KIAA1131 Homo sapiens (Human) anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] nuclear speck [GO:0016607] nuclear speck [GO:0016607]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; anatomical structure development [GO:0048856]; aorta development [GO:0035904]; heart valve development [GO:0003170]; natural killer cell differentiation [GO:0001779]; negative regulation of protein localization to plasma membrane [GO:1903077]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; spongiotrophoblast differentiation [GO:0060708]; trophoblast giant cell differentiation [GO:0060707]; ventricular septum development [GO:0003281] GO:0000209; GO:0001779; GO:0001843; GO:0003170; GO:0003281; GO:0016607; GO:0032436; GO:0035904; GO:0043161; GO:0046872; GO:0048856; GO:0051865; GO:0060707; GO:0060708; GO:0061630; GO:0070534; GO:0072659; GO:1903077 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AIVWLQNR 0.99217 -85.036 0 0 0 0 0 0 0 0 0 12.8432 0 0 0 0 13.6346 0 14.4903 11.4484 0 0 0 0 13.1267 0 0 0 12.2136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.36955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4535 0 0 13.933 0 0 0 0 0 0 15.6424 15.6897 15.1571 15.3326 15.0639 16.7725 0 0 17.1115 15.6785 0 15.9329 13.4672 15.8626 15.12 0 17.376 17.2808 17.5325 0 16.3274 15.6163 17.245 15.8214 17.3002 16.2084 10.8355 0 0 16.2018 0 0 0 0 0 16.641 0 15.4614 16.2493 15.1793 16.284 15.6024 14.96 16.8193 16.9399 15.853 14.3228 16.0144 14.678 0 0 10.5049 0 10.2706 0 0 13.8084 17.5256 11.8887 10.8349 13.8529 13.2968 0 12.814 0 0 13.053 0 13.24 0 0 0 14.5152 0 0 0 0 0 0 0 0 0 13.61 0 0 0 0 0 13.255 0 10.8848 14.8054 0 16.6068 12.457 14.3294 0 A1L168 CT202_HUMAN Uncharacterized protein C20orf202 C20orf202 Homo sapiens (Human) AQNQVSVK 0.99217 -7.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00192 ARVC_HUMAN Splicing regulator ARVCF (Armadillo repeat protein deleted in velo-cardio-facial syndrome) ARVCF Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; RNA splicing [GO:0008380] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; RNA splicing [GO:0008380] GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0008380; GO:0016339; GO:0045296; GO:0098609; GO:1990124 cadherin binding [GO:0045296] ATVRKER 0.99217 -25.482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0893 0 0 0 0 13.2728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.065 13.6466 0 11.8194 14.616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0844 0 0 0 0 0 0 0 0 0 0 0 O60260 PRKN_HUMAN "E3 ubiquitin-protein ligase parkin, Parkin, EC 2.3.2.31 (Parkin RBR E3 ubiquitin-protein ligase) (Parkinson juvenile disease protein 2, Parkinson disease protein 2)" PRKN PARK2 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; amyloid fibril formation [GO:1990000]; autophagy of mitochondrion [GO:0000422]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]" aggresome [GO:0016235]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151] "aggresome [GO:0016235]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Lewy body [GO:0097413]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; amyloid fibril formation [GO:1990000]; autophagy of mitochondrion [GO:0000422]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; cellular response to unfolded protein [GO:0034620]; central nervous system development [GO:0007417]; dopamine metabolic process [GO:0042417]; dopamine uptake involved in synaptic transmission [GO:0051583]; ERAD pathway [GO:0036503]; free ubiquitin chain polymerization [GO:0010994]; learning [GO:0007612]; macroautophagy [GO:0016236]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; mitochondrion to lysosome transport [GO:0099074]; mitophagy [GO:0000423]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of gene expression [GO:0010629]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intralumenal vesicle formation [GO:1905366]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of primary amine oxidase activity [GO:1902283]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron cellular homeostasis [GO:0070050]; norepinephrine metabolic process [GO:0042415]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of dendrite extension [GO:1903861]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of neurotransmitter uptake [GO:0051582]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of retrograde transport, endosome to Golgi [GO:1905281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein deubiquitination [GO:0016579]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid transport [GO:0032368]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of protein ubiquitination [GO:0031396]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synaptic vesicle transport [GO:1902803]; response to endoplasmic reticulum stress [GO:0034976]; response to oxidative stress [GO:0006979]; startle response [GO:0001964]; synaptic transmission, glutamatergic [GO:0035249]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069]" GO:0000122; GO:0000151; GO:0000209; GO:0000266; GO:0000422; GO:0000423; GO:0001664; GO:0001933; GO:0001964; GO:0003714; GO:0003779; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005794; GO:0005829; GO:0006511; GO:0006513; GO:0006979; GO:0007005; GO:0007417; GO:0007612; GO:0008013; GO:0008270; GO:0008344; GO:0010498; GO:0010506; GO:0010628; GO:0010629; GO:0010636; GO:0010637; GO:0010821; GO:0010906; GO:0010994; GO:0014059; GO:0014069; GO:0015631; GO:0016235; GO:0016236; GO:0016567; GO:0016579; GO:0016607; GO:0017124; GO:0019899; GO:0019900; GO:0019901; GO:0030163; GO:0030165; GO:0030544; GO:0031072; GO:0031396; GO:0031624; GO:0031625; GO:0031647; GO:0031648; GO:0032092; GO:0032232; GO:0032368; GO:0032436; GO:0033132; GO:0034620; GO:0034976; GO:0035249; GO:0035519; GO:0036503; GO:0042053; GO:0042415; GO:0042417; GO:0042802; GO:0042826; GO:0042981; GO:0043005; GO:0043123; GO:0043130; GO:0043161; GO:0043274; GO:0043388; GO:0043524; GO:0044314; GO:0044828; GO:0044877; GO:0045732; GO:0045944; GO:0046329; GO:0046676; GO:0048471; GO:0050821; GO:0051087; GO:0051582; GO:0051583; GO:0051865; GO:0051881; GO:0055069; GO:0060548; GO:0060828; GO:0061630; GO:0061734; GO:0070050; GO:0070161; GO:0070534; GO:0070585; GO:0070842; GO:0070936; GO:0070979; GO:0071287; GO:0085020; GO:0090090; GO:0090141; GO:0090201; GO:0097237; GO:0097413; GO:0097602; GO:0098779; GO:0098793; GO:0099074; GO:1900407; GO:1901215; GO:1901800; GO:1902236; GO:1902254; GO:1902283; GO:1902530; GO:1902803; GO:1903202; GO:1903214; GO:1903265; GO:1903351; GO:1903377; GO:1903382; GO:1903542; GO:1903599; GO:1903861; GO:1904049; GO:1905281; GO:1905366; GO:1905477; GO:1990000; GO:1990381; GO:1990444; GO:1990452; GO:2000377; GO:2000378 actin binding [GO:0003779]; beta-catenin binding [GO:0008013]; chaperone binding [GO:0051087]; cullin family protein binding [GO:0097602]; enzyme binding [GO:0019899]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; PDZ domain binding [GO:0030165]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270] CHVPVEK 0.99217 -18.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3957 0 0 0 0 0 0 10.9526 0 0 0 12.6044 0 0 0 0 0 0 0 0 0 0 0 0 10.2175 0 0 0 0 0 0 0 0 12.4577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9052 0 0 0 0 0 0 0 0 0 0 13.1615 0 12.3178 0 0 14.9604 0 0 0 0 0 0 0 12.8385 13.3677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2618 0 0 0 0 0 12.4496 0 0 0 0 0 0 0 13.5116 11.1709 10.4777 0 0 0 0 0 0 0 0 0 0 13.2577 0 0 0 0 0 0 0 0 13.9499 0 0 0 0 0 0 0 0 P06702 S10A9_HUMAN "Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14, MRP-14, p14) (S100 calcium-binding protein A9)" S100A9 CAGB CFAG MRP14 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of process of another organism [GO:0035821]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptidyl-cysteine S-nitrosylation [GO:0018119]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of cytoskeleton organization [GO:0051493]; regulation of integrin biosynthetic process [GO:0045113]; response to lipopolysaccharide [GO:0032496]; sequestering of zinc ion [GO:0032119] cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; antioxidant activity [GO:0016209]; arachidonic acid binding [GO:0050544]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of process of another organism [GO:0035821]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptidyl-cysteine S-nitrosylation [GO:0018119]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of cytoskeleton organization [GO:0051493]; regulation of integrin biosynthetic process [GO:0045113]; response to lipopolysaccharide [GO:0032496]; sequestering of zinc ion [GO:0032119] GO:0002523; GO:0002544; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0006915; GO:0006919; GO:0006954; GO:0007267; GO:0008017; GO:0008270; GO:0010976; GO:0014002; GO:0016209; GO:0018119; GO:0030054; GO:0030307; GO:0030593; GO:0032119; GO:0032496; GO:0034774; GO:0035425; GO:0035606; GO:0035662; GO:0035821; GO:0042742; GO:0045087; GO:0045113; GO:0048306; GO:0050544; GO:0050729; GO:0050786; GO:0050832; GO:0051092; GO:0051493; GO:0061844; GO:0062023; GO:0070062; GO:0070488; GO:2001244 antioxidant activity [GO:0016209]; arachidonic acid binding [GO:0050544]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270] DLQNFLK 0.99217 -18.038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4102 0 0 0 0 0 P08572 CO4A2_HUMAN Collagen alpha-2(IV) chain [Cleaved into: Canstatin ] COL4A2 Homo sapiens (Human) "aging [GO:0007568]; angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of angiogenesis [GO:0016525]; response to activity [GO:0014823]; transcription, DNA-templated [GO:0006351]" collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; aging [GO:0007568]; angiogenesis [GO:0001525]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; negative regulation of angiogenesis [GO:0016525]; response to activity [GO:0014823]; transcription, DNA-templated [GO:0006351]" GO:0001525; GO:0005201; GO:0005576; GO:0005587; GO:0005615; GO:0005788; GO:0006351; GO:0007568; GO:0014823; GO:0016525; GO:0030020; GO:0030198; GO:0031012; GO:0035987; GO:0038063; GO:0062023; GO:0070062; GO:0071560 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] DCSGGCQCYPEKGGR 0.99217 -7.7081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9503 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8191 10.9202 0 0 0 0 11.7335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2789 0 0 0 11.6971 0 0 0 17.3023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.977 0 11.2002 0 0 0 0 0 13.7187 0 0 0 0 0 0 0 0 0 0 0 0 11.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0368 0 0 P30414 NKTR_HUMAN "NK-tumor recognition protein, NK-TR protein (Natural-killer cells cyclophilin-related protein) (Peptidyl-prolyl cis-trans isomerase NKTR, PPIase, EC 5.2.1.8) (Rotamase)" NKTR Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413] GO:0000413; GO:0003755; GO:0005634; GO:0005737; GO:0005886; GO:0006457; GO:0016018; GO:0043231 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] DENFILKHDRAFLLSMANR 0.99217 -47.364 0 0 10.5503 0 0 0 0 0 11.8416 12.1909 0 13.2316 0 12.8603 0 0 10.6566 0 12.2955 0 0 0 12.876 12.3673 0 0 0 12.9989 0 0 12.1004 0 0 0 0 0 0 12.6926 0 0 0 0 0 0 12.3008 0 0 0 0 0 0 10.4606 12.573 13.3421 11.9239 0 0 13.6213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6478 0 12.9111 0 0 0 14.6332 0 0 14.0668 13.3975 14.1799 10.9192 14.3002 14.5807 14.1303 13.3015 15.0349 0 13.9186 0 14.3553 15.5704 12.2593 15.3983 0 0 13.3379 11.1239 14.3608 13.1514 14.0214 13.5492 0 0 0 11.1743 0 13.7529 13.7393 0 0 0 15.3323 13.5831 0 13.4914 13.7212 13.1011 13.1687 13.1571 0 0 0 0 0 0 0 0 12.2385 0 0 13.0836 0 0 0 0 12.006 13.141 0 0 0 0 0 0 13.3147 0 13.8905 0 0 11.1636 0 11.5652 0 0 0 11.9228 0 0 0 13.4588 13.1711 0 13.2437 13.6577 14.3728 0 0 13.0987 0 0 0 14.3215 13.0689 0 13.0002 0 0 P52746 ZN142_HUMAN Zinc finger protein 142 ZNF142 KIAA0236 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CELCDFTCR 0.99217 -46.975 14.1853 0 0 0 0 0 12.712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1521 0 0 14.7192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7967 0 0 12.938 0 11.272 0 11.8626 10.637 0 0 11.5756 0 0 13.2825 0 0 0 0 11.7432 0 0 13.9317 12.4147 0 0 0 0 12.9535 12.4502 11.5351 0 11.8356 0 12.6376 12.7124 0 0 0 0 13.3529 13.0616 0 0 0 12.8423 0 0 14.7736 0 13.8398 0 0 0 0 0 0 0 16.7394 0 0 0 0 13.2142 10.93 13.5736 12.7151 14.3562 14.1668 12.7102 12.1704 0 13.3549 14.708 13.9247 11.0767 0 12.1696 0 0 12.9037 0 0 0 16.7108 0 0 0 14.3236 14.3977 0 0 0 14.32 0 0 0 0 0 0 0 0 10.3709 12.2967 0 0 15.9031 0 12.4302 0 0 0 0 0 P57086 SCND1_HUMAN SCAN domain-containing protein 1 SCAND1 SDP1 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" nucleus [GO:0005634] "nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0005634; GO:0045893 ELSRQWLRPDIR 0.99217 -6.0583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08828 ADCY1_HUMAN "Adenylate cyclase type 1, EC 4.6.1.1 (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase)" ADCY1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226]; response to xenobiotic stimulus [GO:0009410] GO:0004016; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0007409; GO:0007420; GO:0007616; GO:0007623; GO:0008294; GO:0009410; GO:0010226; GO:0019933; GO:0032793; GO:0042752; GO:0045121; GO:0046872; GO:0070062; GO:0071277; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0150076; GO:1900273; GO:1904322; GO:2000300 adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872] GKVSVKGK 0.99217 -18.502 0 0 0 0 0 0 0 0 12.2543 11.8925 11.5865 13.3735 11.4662 12.7196 0 0 0 0 0 11.9688 0 0 11.8729 0 10.8103 0 0 0 13.739 0 0 12.9959 0 13.6017 13.0782 13.1835 13.2812 14.2079 0 13.0754 0 0 0 13.1161 0 11.0632 12.9247 13.0512 0 0 0 0 12.9445 0 0 13.9324 13.8093 0 0 0 0 0 0 0 0 0 18.3649 0 0 18.3318 0 0 0 0 0 0 0 13.5425 0 14.1963 0 0 0 0 0 0 0 0 0 0 12.7515 0 0 0 0 0 0 13.1776 0 0 11.2935 0 14.9183 0 14.7797 0 0 0 0 0 0 0 0 0 12.5585 0 14.8844 0 12.6123 13.1823 0 0 0 13.0716 0 0 0 11.1359 14.5728 0 0 0 12.9613 0 0 0 13.9127 0 12.4776 0 0 0 0 0 0 0 0 12.5258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7255 13.994 0 0 0 0 0 12.7717 0 19.0036 0 0 0 0 0 16.3392 0 0 Q2TAZ0 ATG2A_HUMAN Autophagy-related protein 2 homolog A ATG2A KIAA0404 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; reticulophagy [GO:0061709] endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; organelle membrane contact site [GO:0044232]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; organelle membrane contact site [GO:0044232]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; reticulophagy [GO:0061709] GO:0000045; GO:0000407; GO:0000422; GO:0005789; GO:0005811; GO:0019898; GO:0032266; GO:0034045; GO:0034727; GO:0044232; GO:0044805; GO:0061709; GO:0120013; GO:2000786 lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266] ACPCSHVR 0.99217 -47.248 10.4316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7786 0 0 0 0 0 0 0 0 0 11.7756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.599 0 0 0 0 0 13.3597 0 0 0 0 0 0 0 16.673 14.0109 10.7399 0 13.9708 0 12.2235 0 14.941 0 0 0 14.1269 14.6904 14.3766 13.4844 0 0 0 0 0 0 13.5886 0 0 0 0 13.5379 12.4853 14.6178 11.8493 0 13.1597 0 0 0 13.8318 13.6422 0 0 0 14.5649 0 0 14.4436 0 0 0 0 0 0 0 0 13.3873 0 12.0873 0 0 13.3935 0 0 0 0 0 14.2027 13.0761 0 0 0 0 0 0 0 0 0 0 0 0 15.3717 12.9346 0 12.7509 0 13.2742 12.1107 13.4513 0 0 0 0 0 Q6ZS11 RINL_HUMAN Ras and Rab interactor-like protein RINL Homo sapiens (Human) endocytosis [GO:0006897]; protein transport [GO:0015031] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; protein transport [GO:0015031] GO:0001726; GO:0005085; GO:0005096; GO:0005829; GO:0006897; GO:0015031; GO:0015629; GO:0030139; GO:0031267 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] DVLPRTLLLPPPTLGPR 0.99217 -18.473 0 0 0 12.4515 12.6318 12.141 12.3015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2533 18.1668 11.4229 0 0 13.2205 12.5732 0 14.0825 14.2604 14.1777 14.8763 12.4522 0 12.8066 0 14.0188 16.7128 17.4691 17.5612 17.6348 16.6884 0 0 0 0 14.5595 0 15.2187 16.489 0 16.0285 0 12.836 0 12.7628 0 0 0 15.8577 0 13.2799 12.7904 17.4778 17.0291 12.3135 13.4159 12.5181 17.0204 0 0 0 0 15.1502 16.2857 12.6139 16.2738 16.5175 16.7812 16.5283 16.3071 16.2697 0 15.8833 0 12.3149 0 0 0 14.1189 13.3085 13.709 0 0 0 0 13.2154 12.0884 0 0 0 0 11.8223 0 0 0 0 0 17.3491 15.2429 14.4178 0 12.6572 0 0 0 0 0 14.2204 0 0 0 0 13.0209 0 0 12.5211 13.2026 0 0 0 0 0 0 Q86W25 NAL13_HUMAN "NACHT, LRR and PYD domains-containing protein 13 (Nucleotide-binding oligomerization domain protein 14)" NLRP13 NALP13 NOD14 Homo sapiens (Human) regulation of inflammatory response [GO:0050727] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; regulation of inflammatory response [GO:0050727] GO:0005524; GO:0005737; GO:0050727 ATP binding [GO:0005524] CNLTTACCQHLFSVLSSSK 0.99217 -47.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0168 0 0 0 0 0 0 12.2222 0 0 0 12.5623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.015 0 11.2175 0 0 12.8083 0 14.4162 0 0 0 13.2906 0 0 0 0 0 15.7427 0 0 0 0 13.0712 0 0 0 0 0 13.6295 13.1054 13.125 0 0 14.9738 0 13.0949 0 0 0 13.6945 13.0344 0 0 0 0 0 13.0059 13.2979 0 13.8711 13.4709 14.5755 13.9397 14.9102 12.2133 12.9071 0 12.7097 15.2703 0 12.1402 13.899 12.9005 12.9053 0 0 0 14.205 14.9953 13.8273 0 0 0 16.7183 0 0 0 0 0 0 12.4404 12.483 0 0 0 13.1248 12.4904 12.0297 0 0 0 0 0 12.5871 9.90584 0 0 0 12.5233 0 0 0 0 0 12.614 0 13.3093 0 15.6115 Q8NBN7 RDH13_HUMAN "Retinol dehydrogenase 13, EC 1.1.1.300 (Short chain dehydrogenase/reductase family 7C member 3)" RDH13 SDR7C3 PSEC0082 UNQ736/PRO1430 Homo sapiens (Human) eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] mitochondrial inner membrane [GO:0005743] mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574] GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650 NADP-retinol dehydrogenase activity [GO:0052650] HLDLASLKSIR 0.99217 -7.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.302 0 0 0 0 0 0 0 0 0 0 0 0 12.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW43 APH1B_HUMAN "Gamma-secretase subunit APH-1B, APH-1b (Aph-1beta) (Presenilin-stabilization factor-like)" APH1B PSFL UNQ688/PRO1328 Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; gamma-secretase complex [GO:0070765]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; gamma-secretase complex [GO:0070765]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; endopeptidase activator activity [GO:0061133]; protein-macromolecule adaptor activity [GO:0030674]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485] GO:0000139; GO:0005783; GO:0005789; GO:0005886; GO:0007219; GO:0007220; GO:0010008; GO:0010950; GO:0016021; GO:0016485; GO:0030133; GO:0030674; GO:0034205; GO:0042987; GO:0061133; GO:0070765 endopeptidase activator activity [GO:0061133]; protein-macromolecule adaptor activity [GO:0030674] FAYYKLLK 0.99217 -6.7408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RK0 CIC_HUMAN Protein capicua homolog CIC KIAA0306 Homo sapiens (Human) "brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0007420; GO:0007612; GO:0007613; GO:0035176; GO:0043231; GO:0045892 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AILGSYRKK 0.99217 -14.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7839 0 0 0 0 0 13.2673 13.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.725 0 0 11.6079 12.3267 12.2739 0 0 0 14.4043 13.7128 14.303 0 0 0 14.5023 0 14.4081 0 0 0 11.2851 0 0 14.2924 0 0 0 13.8903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7548 13.3472 0 0 0 0 0 0 0 0 0 15.6389 0 11.7032 14.5214 0 0 0 0 0 0 0 0 10.6174 0 0 Q96SB8 SMC6_HUMAN "Structural maintenance of chromosomes protein 6, SMC protein 6, SMC-6, hSMC6" SMC6 SMC6L1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722] "chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]" GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003684; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006974; GO:0016605; GO:0016607; GO:0016925; GO:0030915; GO:0031625; GO:0032204; GO:0035061; GO:0035861; GO:0051984; GO:0090398; GO:0097431 ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] DGDEDECK 0.99217 -47.152 0 0 0 0 0 0 0 0 0 0 13.638 0 0 12.9495 0 0 0 13.1939 0 0 0 0 0 13.3242 13.4853 0 0 0 0 0 12.3883 0 0 0 0 0 0 0 0 0 16.3479 13.4087 0 0 0 0 0 0 0 11.8554 0 0 11.3908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6735 0 14.0005 11.0347 13.0059 0 0 0 0 14.2413 13.7395 18.1853 0 0 0 18.821 17.4787 14.4424 14.0404 0 17.9016 13.9911 16.4812 13.384 0 0 0 0 15.0571 15.4269 14.7169 0 0 0 0 14.672 14.7451 15.2731 15.7393 0 0 17.3057 17.4892 16.1151 15.3871 0 15.6052 0 11.1235 15.8055 15.2047 14.6199 0 14.2556 15.3225 14.7361 14.7637 15.4589 0 0 14.6979 14.6323 15.492 14.6561 0 0 14.713 15.7581 0 14.8537 12.8343 14.6463 0 0 12.6055 15.5371 0 0 0 14.3051 14.7162 0 13.6346 14.872 12.8247 14.7378 0 0 0 0 13.5775 15.5045 0 13.1388 0 15.4306 0 0 0 14.3511 0 14.5534 0 0 13.1268 0 15.2458 0 0 Q9C0D6 FHDC1_HUMAN FH2 domain-containing protein 1 (Inverted formin-1) FHDC1 INF1 KIAA1727 Homo sapiens (Human) actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] actin filament [GO:0005884]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874] actin filament [GO:0005884]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149] GO:0003779; GO:0005794; GO:0005874; GO:0005881; GO:0005884; GO:0005929; GO:0008017; GO:0030041; GO:0043149; GO:0060271; GO:0090161 actin binding [GO:0003779]; microtubule binding [GO:0008017] DPRPLFCISDTTDCSLTLDCSEGTDSRPR 0.99217 -7.5677 0 0 11.4451 0 0 0 10.2834 0 0 0 0 0 12.8013 0 0 0 0 0 10.7287 12.5391 10.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1951 0 0 0 0 0 11.0604 0 0 0 0 0 0 0 0 14.5644 12.6801 0 0 0 0 0 0 0 13.7208 12.3167 0 0 0 12.5025 0 13.4584 12.7004 0 0 14.2815 12.8228 12.3075 12.6054 14.881 13.9142 0 0 11.5413 0 0 13.5928 0 15.2932 14.4056 14.1351 14.7845 14.7219 14.1419 13.175 14.5619 13.1663 0 13.2551 0 12.9205 0 14.342 13.8035 0 0 14.9816 14.2454 15.6685 0 0 0 0 13.2002 0 0 0 0 0 0 0 0 0 0 0 12.2683 0 0 0 18.1657 0 0 0 0 0 0 0 18.1427 0 0 0 0 12.5372 0 0 0 11.8666 0 0 0 Q9P2D6 F135A_HUMAN Protein FAM135A FAM135A KIAA1411 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255] cellular lipid metabolic process [GO:0044255] GO:0044255 AAHIAVLDSEIFLEKFFLVAALK 0.99217 -6.0564 0 0 0 0 13.4094 0 14.3509 0 11.6555 0 0 0 0 0 0 0 0 0 0 0 0 16.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9409 0 0 0 0 0 0 0 14.2209 0 0 0 0 17.3323 0 0 11.673 0 14.8163 0 0 0 14.2118 0 0 0 15.4439 0 0 0 0 11.9809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6664 0 0 0 0 0 0 0 0 0 13.3923 0 13.5784 0 0 0 0 0 0 12.3694 0 13.4306 0 0 0 0 0 11.9933 0 0 0 0 0 0 0 0 0 0 13.8704 0 0 0 0 12.4497 0 0 0 0 0 0 0 0 12.4151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2496 0 0 Q9ULG6 CCPG1_HUMAN Cell cycle progression protein 1 (Cell cycle progression restoration protein 8) CCPG1 CCP8 CPR8 KIAA1254 Homo sapiens (Human) cell cycle [GO:0007049]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001106] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell cycle [GO:0007049]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001106] GO:0007049; GO:0008284; GO:0016020; GO:0016021; GO:0045787; GO:0045944; GO:2001106 ALSSLQEELNK 0.99217 -25.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5165 0 0 0 14.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.778 0 0 0 0 0 0 12.0373 0 0 0 0 0 0 10.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9055 0 0 0 0 0 Q9ULK0 GRID1_HUMAN "Glutamate receptor ionotropic, delta-1, GluD1, GluR delta-1 subunit" GRID1 KIAA1220 Homo sapiens (Human) "modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] "anchoring junction [GO:0070161]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; modulation of chemical synaptic transmission [GO:0050804]; social behavior [GO:0035176]; synaptic transmission, glutamatergic [GO:0035249]" GO:0004970; GO:0005886; GO:0008066; GO:0015276; GO:0035176; GO:0035249; GO:0038023; GO:0042802; GO:0045211; GO:0050804; GO:0070062; GO:0070161; GO:0098978; GO:0099061; GO:1904315 glutamate receptor activity [GO:0008066]; identical protein binding [GO:0042802]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] FVMFYDSEYDIR 0.99217 -7.1995 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2536 0 0 0 0 0 0 0 11.4134 0 0 10.2663 0 0 0 0 0 0 0 0 11.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.774 0 0 0 11.559 0 0 14.827 13.7822 14.0643 15.6309 13.7679 14.0518 14.5522 13.4728 13.9579 14.5436 14.7194 14.726 14.9136 15.7189 13.187 13.5126 13.0308 0 14.2017 16.4444 0 14.8228 14.5628 0 0 14.7415 13.0048 0 0 12.5106 12.7807 0 0 0 0 0 0 14.82 14.6508 0 14.2503 0 0 0 13.0167 14.6178 0 14.4401 11.7567 0 13.9002 0 13.5577 0 14.8101 0 0 14.6081 0 12.3628 14.4472 14.0725 13.8988 13.981 0 14.0395 0 0 14.217 13.2351 0 0 0 13.7927 0 0 13.6901 15.4052 14.664 0 13.5618 0 0 0 0 11.5403 0 0 0 0 0 0 0 14.0883 14.1506 13.3425 0 12.9356 0 0 11.2833 0 Q14964 RB39A_HUMAN "Ras-related protein Rab-39A, Rab-39" RAB39A RAB39 Homo sapiens (Human) autophagy [GO:0006914]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0006914; GO:0015031; GO:0016192; GO:0030670; GO:0032482; GO:0045335; GO:0090383; GO:0090385 GTP binding [GO:0005525]; GTPase activity [GO:0003924] ETIWIYQFR 0.99218 -6.7574 0 0 0 0 0 0 0 0 14.009 0 15.7303 0 14.2717 14.8943 15.0767 0 15.3588 16.3194 0 0 0 0 0 0 15.3897 15.7242 0 0 0 0 16.7361 16.8851 0 0 0 0 13.8195 0 0 17.5905 18.8722 0 17.7817 0 0 17.7029 0 0 15.5389 0 0 15.673 15.8423 0 16.2075 13.2626 16.5824 16.3234 15.8287 17.0909 11.1931 0 15.949 15.3971 16.2635 15.5938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8816 22.0562 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3881 0 0 0 18.3752 0 0 0 12.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0313 0 11.5073 0 0 0 0 0 0 0 0 18.2634 18.2749 18.2288 0 0 0 0 0 0 0 19.0699 18.8338 17.1591 17.0581 16.7528 17.773 18.3999 18.5587 18.5482 18.9346 18.0184 16.6863 16.6019 16.388 0 0 0 18.0457 17.8826 18.946 18.1286 17.893 18.0607 A0MZ66 SHOT1_HUMAN Shootin-1 (Shootin1) SHTN1 KIAA1598 Homo sapiens (Human) "actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]" axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] "axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]" GO:0005737; GO:0005874; GO:0005875; GO:0006930; GO:0007265; GO:0007409; GO:0015630; GO:0019894; GO:0030027; GO:0030175; GO:0030424; GO:0030426; GO:0031252; GO:0032488; GO:0038007; GO:0042802; GO:0043204; GO:0044295; GO:0045296; GO:0045773; GO:0048471; GO:0048812; GO:0051015; GO:0060327; GO:0061163; GO:0061573; GO:2000114; GO:2001224 actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894] EQAIGEYEDLRAENQK 0.99218 -6.762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.94246 10.7855 0 0 13.6027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4477 0 0 0 0 0 0 14.5772 0 0 0 13.7169 0 0 0 0 0 0 0 13.9975 13.223 0 0 0 10.1799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5166 0 0 0 0 0 0 0 0 0 0 0 12.4706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1935 0 0 0 0 0 0 0 0 0 Q8NC74 RB8NL_HUMAN RBBP8 N-terminal-like protein RBBP8NL C20orf151 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 APDMSPQR 0.99218 -15.169 0 0 0 0 0 0 0 0 0 0 0 13.5174 0 0 0 0 0 0 0 0 0 0 10.1596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9721 0 0 0 0 0 0 0 0 0 10.782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9107 0 0 0 0 0 0 0 13.5619 0 0 15.2643 0 0 0 0 0 0 18.3097 19.2439 0 0 0 0 14.4198 0 0 0 14.9 0 0 17.2466 15.9123 14.9271 0 13.9901 0 0 0 0 0 0 0 14.6951 0 0 0 0 15.7987 16.083 0 0 0 0 0 0 0 12.6572 11.904 0 0 0 0 13.8418 0 0 0 0 0 14.0982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0256 0 0 0 0 Q9H9T3 ELP3_HUMAN "Elongator complex protein 3, hELP3, EC 2.3.1.- (tRNA uridine(34) acetyltransferase)" ELP3 Homo sapiens (Human) central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]; central nervous system development [GO:0007417]; neuron migration [GO:0001764]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098]" GO:0000049; GO:0001764; GO:0002098; GO:0002926; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0006417; GO:0007417; GO:0008080; GO:0008607; GO:0016407; GO:0030335; GO:0033588; GO:0046872; GO:0051539; GO:0106261 "4 iron, 4 sulfur cluster binding [GO:0051539]; acetyltransferase activity [GO:0016407]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]" AVCESFHLAK 0.99218 -18.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3073 0 12.8105 0 0 12.3931 0 0 12.0058 0 0 12.4146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1382 12.6322 0 0 0 0 0 0 0 0 0 0 0 0 12.4199 0 0 0 0 0 0 0 0 0 0 12.7693 13.3599 12.8653 10.488 0 0 0 0 0 0 0 0 0 0 0 12.8399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.161 14.2584 0 0 0 0 0 0 0 14.0328 0 0 14.6365 0 0 0 0 0 0 0 0 0 14.0166 0 0 0 0 0 13.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGM5 FETUB_HUMAN Fetuin-B (16G2) (Fetuin-like protein IRL685) (Gugu) FETUB Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; negative regulation of endopeptidase activity [GO:0010951]; single fertilization [GO:0007338] extracellular exosome [GO:0070062]; extracellular region [GO:0005576] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of endopeptidase activity [GO:0010951]; single fertilization [GO:0007338] GO:0004866; GO:0004869; GO:0005576; GO:0007338; GO:0007339; GO:0008191; GO:0010951; GO:0070062 cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191] AWQDCGMR 0.99218 -7.2179 0 0 0 0 0 0 10.6571 0 0 14.1284 0 14.1131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK39 NOCT_HUMAN "Nocturnin, EC 3.1.3.108 (Carbon catabolite repression 4-like protein)" NOCT CCR4 CCRN4L NOC Homo sapiens (Human) circadian regulation of gene expression [GO:0032922]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; P-body assembly [GO:0033962]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA stabilization [GO:0048255]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; P-body assembly [GO:0033962]; positive regulation of fat cell differentiation [GO:0045600]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; response to extracellular stimulus [GO:0009991]; response to lipopolysaccharide [GO:0032496]; transcription by RNA polymerase II [GO:0006366] GO:0000175; GO:0000290; GO:0000932; GO:0003729; GO:0004535; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006366; GO:0006739; GO:0009991; GO:0010629; GO:0019178; GO:0032496; GO:0032922; GO:0033962; GO:0042752; GO:0045600; GO:0045668; GO:0045995; GO:0046872; GO:0048255; GO:0048471; GO:0102757 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; NADP phosphatase activity [GO:0019178]; NADPH phosphatase activity [GO:0102757]; poly(A)-specific ribonuclease activity [GO:0004535] AVLHTRPPR 0.99218 -17.727 11.2632 0 0 0 0 0 0 0 14.0573 0 14.7542 0 0 0 0 14.692 14.954 13.8672 13.5069 0 0 0 14.4027 0 0 0 0 0 0 14.4748 0 14.458 0 13.9527 0 0 13.9557 14.3463 14.1036 14.1855 0 0 0 0 0 0 0 13.9382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMS6 SYNP2_HUMAN Synaptopodin-2 (Genethonin-2) (Myopodin) SYNPO2 Homo sapiens (Human) autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725]; vesicle tethering complex [GO:0099023]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein-macromolecule adaptor activity [GO:0030674]; autophagosome assembly [GO:0000045]; chaperone-mediated autophagy [GO:0061684]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298] GO:0000045; GO:0001725; GO:0003779; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0015629; GO:0030018; GO:0030335; GO:0030674; GO:0031005; GO:0032233; GO:0043231; GO:0051371; GO:0051393; GO:0061684; GO:0071889; GO:0099023; GO:2000298 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; protein-macromolecule adaptor activity [GO:0030674] FSAKKSGVTIQVWK 0.99218 -18.177 0 0 0 0 0 0 0 0 0 0 0 11.5383 0 0 11.4628 0 0 0 0 10.3099 0 0 0 0 9.70216 0 0 0 0 0 14.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7682 0 0 0 0 0 0 0 0 0 12.8545 12.7275 14.3784 13.6419 13.2114 0 15.4368 0 13.0354 0 0 0 11.5031 0 0 0 0 0 0 0 0 0 0 0 11.6108 12.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9001 0 0 0 0 0 0 13.8661 0 0 0 0 0 0 0 0 0 0 0 13.7918 11.6284 0 0 13.6942 0 13.9951 13.9014 0 0 13.9257 0 0 0 11.4864 0 0 0 0 0 0 O95229 ZWINT_HUMAN "ZW10 interactor (ZW10-interacting protein 1, Zwint-1)" ZWINT Homo sapiens (Human) cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; NMS complex [GO:0031617]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein N-terminus binding [GO:0047485]; cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094] GO:0000070; GO:0000776; GO:0005654; GO:0005737; GO:0005829; GO:0007094; GO:0016604; GO:0030425; GO:0031617; GO:0047485; GO:0051301; GO:0051649 protein N-terminus binding [GO:0047485] DKLLCSQLQVADFLQNILAQEDTAK 0.99219 -18.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.201 0 0 13.5073 0 0 0 0 0 0 0 0 0 0 0 13.1736 0 13.1165 0 0 0 13.1023 0 0 0 0 0 0 0 0 0 0 13.8571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0204 0 0 13.0292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3516 0 0 0 12.173 0 0 0 0 0 0 0 0 0 P10586 PTPRF_HUMAN "Receptor-type tyrosine-protein phosphatase F, EC 3.1.3.48 (Leukocyte common antigen related, LAR)" PTPRF LAR Homo sapiens (Human) cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] GO:0004725; GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0007155; GO:0007185; GO:0008201; GO:0016477; GO:0031102; GO:0035335; GO:0035373; GO:0043005; GO:0043025; GO:0044877; GO:0048679; GO:0050839; GO:0070062; GO:0099560; GO:1900121 cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] CHQYWPAERSAR 0.99219 -17.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6372 0 0 0 13.0977 0 11.4473 0 0 0 12.8248 0 0 11.3701 0 11.8508 0 0 16.909 12.8118 0 0 0 0 0 0 0 11.8726 0 0 0 0 0 0 0 0 0 13.432 15.4319 0 0 0 11.5028 0 0 0 0 0 0 0 0 12.5621 0 12.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1108 0 0 0 0 P30533 AMRP_HUMAN "Alpha-2-macroglobulin receptor-associated protein, Alpha-2-MRAP (Low density lipoprotein receptor-related protein-associated protein 1, RAP)" LRPAP1 A2MRAP Homo sapiens (Human) amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165] cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237] cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165] GO:0001540; GO:0002091; GO:0005102; GO:0005576; GO:0005768; GO:0005783; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0007165; GO:0008201; GO:0009986; GO:0010916; GO:0012505; GO:0031904; GO:0032091; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0060548; GO:0070326; GO:0150093; GO:1900116; GO:1900222; GO:1900223 amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326] GLPALLLLLLFLGPWPAASHGGK 0.99219 -25.1 0 0 0 0 0 0 0 0 0 0 11.8434 0 11.1609 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6595 0 0 0 0 0 11.5546 15.3759 0 15.9313 0 0 0 11.3507 0 0 0 15.9561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6547 0 0 0 0 0 15.1949 0 13.0538 0 0 13.0761 0 0 0 0 0 12.4974 0 0 0 12.8259 12.6074 0 13.3102 0 0 13.0835 0 0 0 0 0 0 12.4204 0 13.3547 12.5759 13.3038 0 11.9853 15.4396 0 0 0 0 0 12.7221 0 0 0 0 0 0 0 0 12.778 0 0 0 0 0 12.6321 0 0 14.4099 0 0 13.3596 0 0 0 12.7908 0 14.5023 13.974 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6481 0 0 0 0 0 0 0 0 12.0315 0 0 0 13.3323 13.0691 0 0 0 12.922 0 Q07617 SPAG1_HUMAN Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1) SPAG1 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]; single fertilization [GO:0007338] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821]; single fertilization [GO:0007338] GO:0005525; GO:0005737; GO:0005829; GO:0007338; GO:0016787; GO:0050821; GO:0070286; GO:0101031; GO:0120293 GTP binding [GO:0005525]; hydrolase activity [GO:0016787] AACYLKEGNCSGCIQDCNR 0.99219 -7.2271 11.2628 0 11.1368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3351 0 0 0 0 0 0 0 0 11.6632 0 0 0 9.96217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1911 0 0 0 0 0 10.9266 0 13.0678 0 10.1257 12.2944 0 13.5676 0 12.0358 14.6941 10.0992 13.6345 13.6664 12.4971 0 11.6761 10.839 13.4067 0 12.529 13.3215 0 0 0 0 0 10.5392 0 11.1873 0 0 0 0 0 0 0 12.9894 0 0 12.4004 14.1206 13.0664 10.9839 15.1744 12.2474 0 13.3191 0 0 0 0 11.9776 0 0 0 0 0 0 0 0 0 14.2079 0 0 12.4256 0 0 0 0 0 0 0 0 12.6014 0 0 0 0 0 0 0 0 11.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14011 CIRBP_HUMAN Cold-inducible RNA-binding protein (A18 hnRNP) (Glycine-rich RNA-binding protein CIRP) CIRBP A18HNRNP CIRP Homo sapiens (Human) "mRNA stabilization [GO:0048255]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to UV [GO:0009411]; stress granule assembly [GO:0034063]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; translation repressor activity [GO:0030371]; mRNA stabilization [GO:0048255]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to UV [GO:0009411]; stress granule assembly [GO:0034063]" GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0009409; GO:0009411; GO:0010494; GO:0030371; GO:0034063; GO:0045727; GO:0048026; GO:0048255; GO:0070181 mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; translation repressor activity [GO:0030371] DAMMAMNGKSVDGRQIR 0.99219 -18.301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.305 10.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9224 12.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0463 0 0 Q15431 SYCP1_HUMAN "Synaptonemal complex protein 1, SCP-1 (Cancer/testis antigen 8, CT8)" SYCP1 SCP1 Homo sapiens (Human) cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] "central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]" "central element [GO:0000801]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; male germ cell nucleus [GO:0001673]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; cell division [GO:0051301]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; lateral element assembly [GO:0051878]; meiotic DNA repair synthesis [GO:0000711]; protein homotetramerization [GO:0051289]; reciprocal meiotic recombination [GO:0007131]; regulation of protein localization [GO:0032880]; sperm DNA condensation [GO:0035092]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]" GO:0000711; GO:0000775; GO:0000795; GO:0000801; GO:0000802; GO:0001673; GO:0003677; GO:0003690; GO:0005694; GO:0007129; GO:0007130; GO:0007131; GO:0007283; GO:0032880; GO:0035092; GO:0051026; GO:0051289; GO:0051301; GO:0051878 DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690] EDYEKIQHLEQEYKK 0.99219 -7.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6081 0 0 0 0 0 0 0 0 0 0 0 0 13.334 12.8938 0 0 0 12.9279 0 12.2642 11.6216 0 10.7205 0 12.0011 0 0 0 0 0 0 0 11.7159 0 0 0 12.1477 0 0 0 0 0 0 0 0 0 0 10.9459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUS5 CC121_HUMAN Coiled-coil domain-containing protein 121 CCDC121 Homo sapiens (Human) AQALKLAAK 0.99219 -7.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9492 0 0 10.5313 0 0 0 11.623 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2251 0 0 0 0 0 0 0 0 0 0 0 0 13.5626 0 0 9.62302 0 0 0 0 0 0 0 0 0 0 13.4656 14.0918 0 0 0 0 0 0 0 0 0 12.6204 0 0 0 0 0 0 0 12.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6968 0 13.1105 0 0 14.3397 0 0 0 13.3745 0 0 0 12.9997 0 0 12.3248 14.1488 0 0 0 0 0 13.0989 12.5308 0 13.0005 0 0 0 0 0 0 0 0 0 0 12.5447 0 0 0 0 0 12.2723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5563 0 0 0 0 0 11.6694 0 Q86X59 CQ082_HUMAN Putative uncharacterized protein LINC02875 LINC02875 C17orf82 Homo sapiens (Human) ARPGLGPRQLLTGPR 0.99219 -4.3916 0 0 0 0 0 0 0 0 0 0 14.3301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3684 0 0 0 0 0 14.2716 15.5108 15.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N264 RHG24_HUMAN "Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP, FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa, RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP)" ARHGAP24 FILGAP Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]" adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] "adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:0090630; GO:1900028 GTPase activator activity [GO:0005096] ELQDAFDCGEKPSFDSNTDVHTVASLLKLYLR 0.99219 -18.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5322 11.8183 11.6545 12.3098 12.4591 0 0 11.0356 0 12.8573 14.1629 11.0805 0 0 0 0 0 11.7901 0 0 0 0 0 0 0 0 0 13.5722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2177 14.5925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9113 0 0 0 0 13.1429 0 0 0 0 11.778 11.606 0 0 0 0 14.1944 14.2889 0 0 0 14.2943 12.4451 14.137 0 0 14.2966 0 14.5191 0 0 0 0 0 14.7094 0 19.0476 0 0 0 0 0 0 0 0 0 0 0 0 13.6276 0 0 13.9742 14.0484 0 0 0 14.074 14.1308 0 0 13.0727 0 0 14.3267 0 Q8WU03 GLYL2_HUMAN "Glycine N-acyltransferase-like protein 2, EC 2.3.1.13 (Acyl-CoA:glycine N-acyltransferase-like protein 2)" GLYATL2 Homo sapiens (Human) long-chain fatty acid catabolic process [GO:0042758]; medium-chain fatty acid catabolic process [GO:0051793]; monounsaturated fatty acid catabolic process [GO:1903965] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410]; long-chain fatty acid catabolic process [GO:0042758]; medium-chain fatty acid catabolic process [GO:0051793]; monounsaturated fatty acid catabolic process [GO:1903965] GO:0005739; GO:0005783; GO:0016410; GO:0042758; GO:0047961; GO:0051793; GO:1903965 glycine N-acyltransferase activity [GO:0047961]; N-acyltransferase activity [GO:0016410] LVLHNSQK 0.99219 -18.206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H611 PIF1_HUMAN "ATP-dependent DNA helicase PIF1, EC 3.6.4.12 (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein)" PIF1 C15orf20 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004] "chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]" "chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; replication fork [GO:0005657]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004]" GO:0000002; GO:0000287; GO:0000781; GO:0005524; GO:0005654; GO:0005657; GO:0005739; GO:0006260; GO:0006281; GO:0006310; GO:0007004; GO:0010521; GO:0016887; GO:0017116; GO:0032204; GO:0032211; GO:0032508; GO:0033678; GO:0042162; GO:0043139; GO:0051880; GO:0051974 5'-3' DNA helicase activity [GO:0043139]; 5'-3' DNA/RNA helicase activity [GO:0033678]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; single-stranded DNA helicase activity [GO:0017116]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162] ELMLRLQAPGPAGRPR 0.99219 -18.296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2175 0 0 0 0 0 0 0 0 0 12.8781 0 14.4452 14.7843 0 0 0 0 0 0 0 0 12.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2731 0 14.7839 13.857 0 0 0 0 11.8492 0 0 0 0 0 0 12.1899 0 0 0 0 12.7005 0 12.2816 Q9H972 CN093_HUMAN Uncharacterized protein C14orf93 C14orf93 Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of gene expression [GO:0010628] extracellular region [GO:0005576] extracellular region [GO:0005576]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of gene expression [GO:0010628] GO:0003723; GO:0005576; GO:0010628; GO:0030154; GO:0048856 RNA binding [GO:0003723] CCCCACK 0.99219 -17.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4831 0 0 0 0 0 0 12.55 0 0 0 13.9349 10.8099 0 11.9165 0 0 0 13.9124 0 0 12.7204 0 10.6317 0 0 0 0 0 15.0285 15.603 0 0 0 12.3569 11.3171 0 10.4631 0 0 0 0 0 0 0 0 0 0 0 11.3798 0 0 0 11.3446 0 0 0 0 0 0 12.4069 12.2678 12.6687 12.8414 0 13.2886 0 12.2985 0 0 0 0 0 12.9732 13.2772 12.6276 0 14.4166 0 0 13.045 0 0 12.9666 13.4511 12.6321 12.7338 0 14.3703 12.672 11.7344 13.5504 13.2612 0 11.9592 12.0212 0 0 0 0 0 0 12.9863 12.6515 10.7503 12.9068 11.5188 11.5839 12.7008 0 0 12.3219 12.1561 0 0 0 13.0741 11.8493 0 0 0 0 0 0 11.6415 0 0 11.498 0 12.7898 0 0 0 0 0 12.5455 0 0 13.5726 0 0 0 0 14.5854 0 11.8436 0 0 0 11.5719 0 12.1864 0 0 0 0 0 0 0 0 12.0652 0 0 0 0 Q9NS62 THSD1_HUMAN Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module) THSD1 TMTSP UNQ3010/PRO9769 Homo sapiens (Human) focal adhesion assembly [GO:0048041] cell periphery [GO:0071944]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021] cell periphery [GO:0071944]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; extracellular matrix binding [GO:0050840]; focal adhesion assembly [GO:0048041] GO:0005576; GO:0005768; GO:0005829; GO:0005925; GO:0010008; GO:0016021; GO:0048041; GO:0050840; GO:0071944 extracellular matrix binding [GO:0050840] IIPPLFSYR 0.99219 -7.2208 0 0 0 0 0 0 0 10.2537 0 0 0 0 0 0 0 11.4342 0 11.3395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4843 0 0 11.5932 0 0 0 0 0 0 0 0 13.1666 0 11.7561 13.0358 12.4165 0 0 0 0 0 16.1114 14.2594 14.3021 0 0 0 0 0 11.6359 0 11.8705 0 0 0 0 13.7787 14.4337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2596 0 0 13.2814 14.5705 0 0 0 0 0 0 0 12.242 13.5905 0 0 0 0 0 13.5735 11.7438 0 0 0 0 0 0 0 12.9978 0 0 0 13.2928 0 0 0 0 0 0 0 0 0 0 12.4498 0 0 0 13.0537 0 14.6411 0 0 13.2112 0 0 0 16.5515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7093 0 0 0 Q9Y2G9 SBNO2_HUMAN Protein strawberry notch homolog 2 SBNO2 KIAA0963 Homo sapiens (Human) "bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; bone mineralization [GO:0030282]; bone trabecula morphogenesis [GO:0061430]; cellular response to interleukin-11 [GO:0071348]; cellular response to interleukin-6 [GO:0071354]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; macrophage activation involved in immune response [GO:0002281]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoclast differentiation [GO:0030316]; osteoclast fusion [GO:0072675]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727]; regulation of transcription, DNA-templated [GO:0006355]" GO:0002281; GO:0005634; GO:0006355; GO:0030282; GO:0030316; GO:0031490; GO:0042393; GO:0045892; GO:0045944; GO:0050727; GO:0061430; GO:0071222; GO:0071348; GO:0071354; GO:0072675; GO:1990830 chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] DCSITKFLNRILGLEVHK 0.99219 -18.243 0 0 0 0 0 0 0 0 14.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.62403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5903 0 0 0 0 0 0 0 14.5184 0 0 0 0 0 0 0 14.5488 0 0 0 0 0 0 0 0 0 0 14.0609 12.8564 0 14.0773 0 0 0 14.1893 0 0 0 0 0 13.9263 0 0 10.4789 0 0 14.4123 0 0 0 0 16.4793 14.3836 0 0 0 0 14.2146 0 0 13.9278 0 0 14.0806 14.2674 0 0 0 0 0 0 0 0 13.7957 0 0 13.9357 0 0 0 0 0 0 0 14.2842 0 0 0 12.7296 0 0 0 0 0 0 0 0 0 0 0 13.1004 14.0346 0 0 0 15.3002 0 0 0 0 0 O14649 KCNK3_HUMAN "Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1, Two pore K(+) channel KT3.1)" KCNK3 TASK TASK1 Homo sapiens (Human) brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410]; stabilization of membrane potential [GO:0030322] GO:0005216; GO:0005252; GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0007268; GO:0007420; GO:0008022; GO:0009410; GO:0015271; GO:0022841; GO:0030322; GO:0034220; GO:0044548; GO:0045202; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071805; GO:0090102; GO:1903818 ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein C-terminus binding [GO:0008022]; S100 protein binding [GO:0044548] DLSTSDTCVEQSHSSPGGGGRYSDTPSR 0.9922 -24.403 0 0 0 0 0 0 0 0 0 11.8435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.572 0 12.3379 0 0 0 0 0 0 13.1024 14.2784 12.6531 0 0 13.3959 0 0 0 15.1012 13.3802 0 0 0 0 14.2595 14.6501 14.8047 0 0 0 12.5558 12.8763 10.5583 0 0 0 0 13.1752 0 12.7625 0 0 14.2732 12.7038 0 11.0831 11.3238 0 0 13.0179 0 12.2494 0 0 0 13.7831 0 0 0 0 0 13.0389 0 0 9.68641 13.6494 0 0 0 0 10.2245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5308 0 11.0215 0 0 0 0 12.3259 0 0 0 0 0 0 0 O60542 PSPN_HUMAN "Persephin, PSP" PSPN Homo sapiens (Human) central nervous system development [GO:0007417]; nervous system development [GO:0007399] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; central nervous system development [GO:0007417]; nervous system development [GO:0007399] GO:0005102; GO:0005576; GO:0005615; GO:0007399; GO:0007417; GO:0008083; GO:0030116; GO:0030971 glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] PLARLRR 0.9922 -6.1237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6698 0 0 0 0 0 0 12.1323 13.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8278 0 0 0 0 12.2898 0 0 12.7316 0 0 0 0 0 11.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7414 0 0 0 0 0 0 0 12.2112 12.0545 0 12.5655 0 0 0 0 0 0 0 0 P49715 CEBPA_HUMAN "CCAAT/enhancer-binding protein alpha, C/EBP alpha" CEBPA CEBP Homo sapiens (Human) "brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; embryonic placenta development [GO:0001892]; epithelial cell maturation [GO:0002070]; fat cell differentiation [GO:0045444]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; granulocyte differentiation [GO:0030851]; hematopoietic stem cell proliferation [GO:0071425]; inner ear development [GO:0048839]; integrated stress response signaling [GO:0140467]; interleukin-6-mediated signaling pathway [GO:0070102]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; lung development [GO:0030324]; macrophage differentiation [GO:0030225]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of hematopoietic stem cell proliferation [GO:1902034]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage activation [GO:0043032]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase I [GO:0006360]; urea cycle [GO:0000050]; white fat cell differentiation [GO:0050872]" C/EBP complex [GO:1990647]; CHOP-C/EBP complex [GO:0036488]; chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "C/EBP complex [GO:1990647]; CHOP-C/EBP complex [GO:0036488]; chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; RNA polymerase I transcription regulatory region sequence-specific DNA binding [GO:0001163]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; brown fat cell differentiation [GO:0050873]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; embryonic placenta development [GO:0001892]; epithelial cell maturation [GO:0002070]; fat cell differentiation [GO:0045444]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; granulocyte differentiation [GO:0030851]; hematopoietic stem cell proliferation [GO:0071425]; inner ear development [GO:0048839]; integrated stress response signaling [GO:0140467]; interleukin-6-mediated signaling pathway [GO:0070102]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; lung development [GO:0030324]; macrophage differentiation [GO:0030225]; mitochondrion organization [GO:0007005]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of hematopoietic stem cell proliferation [GO:1902034]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage activation [GO:0043032]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase I [GO:0006360]; urea cycle [GO:0000050]; white fat cell differentiation [GO:0050872]" GO:0000050; GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001163; GO:0001228; GO:0001889; GO:0001892; GO:0002070; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006091; GO:0006355; GO:0006357; GO:0006360; GO:0007005; GO:0007219; GO:0008203; GO:0008285; GO:0010628; GO:0019221; GO:0019900; GO:0030099; GO:0030225; GO:0030324; GO:0030851; GO:0031490; GO:0032436; GO:0036488; GO:0042593; GO:0042802; GO:0042803; GO:0043032; GO:0043231; GO:0045444; GO:0045600; GO:0045669; GO:0045736; GO:0045892; GO:0045944; GO:0045945; GO:0048839; GO:0050729; GO:0050872; GO:0050873; GO:0055088; GO:0061629; GO:0070102; GO:0071285; GO:0071356; GO:0071407; GO:0071425; GO:0090575; GO:0097677; GO:0140467; GO:1902034; GO:1990647; GO:2000144 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; RNA polymerase I transcription regulatory region sequence-specific DNA binding [GO:0001163]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]" PLVIKQEPR 0.9922 -24.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8806 0 0 0 0 0 0 11.2369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1328 14.0268 0 0 14.2091 14.9822 0 0 0 0 0 11.5692 0 0 0 0 0 12.3001 0 0 0 0 0 0 12.3261 0 0 0 11.9034 12.5481 0 0 0 0 12.672 0 0 0 0 0 0 17.2108 0 0 15.8701 12.4945 0 0 0 0 0 0 12.3511 0 16.8876 0 0 16.7756 12.6778 0 0 0 0 16.7215 11.4448 0 0 0 0 0 0 0 0 0 0 0 0 16.2771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57076 CF298_HUMAN Cilia- and flagella-associated protein 298 (Protein kurly homolog) CFAP298 C21orf48 C21orf59 Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of cilium movement [GO:0003352] cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634] cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; regulation of cilium movement [GO:0003352] GO:0003352; GO:0005634; GO:0005829; GO:0005856; GO:0005929; GO:0060271 IIAKIQQR 0.9922 -24.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5259 0 0 0 0 0 0 0 0 11.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.782 0 0 0 0 0 0 0 0 0 0 0 11.9801 0 0 0 0 0 0 0 0 0 0 0 14.4383 0 0 0 0 0 15.3882 13.8814 13.989 0 0 0 0 0 15.5442 13.7849 14.0208 0 13.957 0 0 13.9042 0 0 0 0 0 0 0 13.5304 13.0541 15.0033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15399 TLR1_HUMAN "Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein, TIL) (CD antigen CD281)" TLR1 KIAA0012 Homo sapiens (Human) cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354] "Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; detection of triacyl bacterial lipopeptide [GO:0042495]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage activation [GO:0042116]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; signal transduction [GO:0007165]; toll-like receptor 1 signaling pathway [GO:0034130]; toll-like receptor signaling pathway [GO:0002224]" GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0016020; GO:0030670; GO:0032755; GO:0032757; GO:0032760; GO:0034130; GO:0034137; GO:0035354; GO:0035663; GO:0038023; GO:0042116; GO:0042495; GO:0042802; GO:0043235; GO:0045087; GO:0045121; GO:0050135; GO:0061809; GO:0071221; GO:0071723; GO:0071727 "identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]" CDYPESYR 0.9922 -7.1231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3134 0 11.2033 0 11.2714 0 0 0 0 11.3574 0 0 0 0 0 11.4821 0 0 0 0 0 0 0 11.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3721 0 0 0 0 0 0 0 12.4419 0 0 0 0 0 0 0 0 0 14.0631 12.7746 13.0467 0 12.829 14.3751 0 12.5105 0 0 0 0 0 12.3593 12.0606 0 0 0 0 0 0 0 14.2465 0 0 12.2096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0646 0 0 0 0 11.8564 14.3762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8288 0 0 0 0 Q5TEJ8 THMS2_HUMAN "Protein THEMIS2 (Induced by contact to basement membrane 1 protein, Protein ICB-1) (Thymocyte-expressed molecule involved in selection protein 2)" THEMIS2 C1orf38 ICB1 Homo sapiens (Human) cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; regulation of B cell activation [GO:0050864]; T cell receptor signaling pathway [GO:0050852] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; regulation of B cell activation [GO:0050864]; T cell receptor signaling pathway [GO:0050852] GO:0005634; GO:0005737; GO:0006954; GO:0007155; GO:0050852; GO:0050864 KGHRPAK 0.9922 -7.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.62158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9653 0 0 0 0 0 0 0 13.4218 0 0 0 0 0 0 0 12.572 0 0 0 0 0 0 0 0 0 0 0 13.3204 0 0 12.7275 0 0 0 0 12.4138 0 0 13.448 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1697 0 0 12.1886 0 0 0 12.0108 0 0 0 0 0 0 0 0 14.0438 0 0 0 0 0 0 0 0 0 11.3192 0 0 0 0 0 0 0 0 13.084 11.4362 0 0 0 13.3056 0 0 Q68DV7 RNF43_HUMAN "E3 ubiquitin-protein ligase RNF43, EC 2.3.2.27 (RING finger protein 43) (RING-type E3 ubiquitin transferase RNF43)" RNF43 Homo sapiens (Human) negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055] GO:0004842; GO:0005109; GO:0005635; GO:0005789; GO:0005886; GO:0005887; GO:0006511; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0046872; GO:0061630; GO:0072089 frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AIIRVIPLK 0.9922 -18.338 0 0 0 12.202 0 0 0 0 0 0 0 0 0 0 11.4007 11.4385 11.8355 11.8762 11.5377 12.2278 0 0 11.6691 0 11.9616 0 0 11.9986 0 0 0 12.4448 0 0 0 0 0 0 11.4374 0 11.6659 0 0 0 11.6531 0 0 0 0 0 10.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.926 0 0 0 11.9452 12.4934 0 0 12.7724 0 13.7749 0 0 0 0 0 0 0 0 0 0 0 0 14.2054 0 0 0 0 0 0 0 0 0 0 0 0 12.485 12.8454 12.2418 0 0 0 0 0 0 0 0 0 0 0 11.4024 13.682 0 0 12.9962 14.4707 14.0165 13.0817 13.0921 0 0 10.8988 0 13.6209 11.9038 0 0 11.3631 0 11.4658 0 13.0789 12.7709 12.5876 0 0 0 0 0 0 0 10.6334 0 0 0 0 11.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6MZM0 HPHL1_HUMAN "Ferroxidase HEPHL1, EC 1.16.3.1 (Hephaestin-like protein 1)" HEPHL1 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]; cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826] GO:0004322; GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0006879; GO:0016021; GO:0016491; GO:0055072 copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491] AALVILFIIGLLLLITTVILSLR 0.9922 -7.4516 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9991 0 0 0 0 0 0 0 0 0 0 11.8669 0 0 0 10.201 0 11.7272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.783 0 0 0 0 13.7302 0 0 0 0 12.34 0 0 0 0 14.4353 13.9964 13.8204 11.4678 0 0 0 13.4153 0 0 17.4128 14.7081 11.2739 0 0 0 0 0 13.3224 0 0 0 13.3277 0 14.0645 0 12.4605 15.5942 10.8262 0 0 0 0 0 0 0 0 0 0 0 0 15.066 0 0 0 0 0 14.0387 0 14.5128 0 13.4975 0 0 0 0 0 0 0 0 0 14.5062 0 0 12.6874 12.1656 0 0 0 10.6123 11.926 0 14.2107 12.9096 0 0 0 0 0 0 0 0 12.3497 12.5023 0 0 0 0 0 14.1025 0 0 0 Q8N6Y2 LRC17_HUMAN Leucine-rich repeat-containing protein 17 (p37NB) LRRC17 P37NB UNQ3076/PRO9909 Homo sapiens (Human) bone marrow development [GO:0048539]; negative regulation of osteoclast differentiation [GO:0045671]; ossification [GO:0001503] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bone marrow development [GO:0048539]; negative regulation of osteoclast differentiation [GO:0045671]; ossification [GO:0001503] GO:0001503; GO:0005615; GO:0031012; GO:0045671; GO:0048539 AAELRKASPGSVR 0.9922 -7.4462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5249 0 0 0 0 0 11.975 12.8597 0 0 15.4894 0 0 0 15.0751 0 0 14.5345 14.7448 14.8835 0 0 0 0 14.3309 0 15.7522 15.8161 0 15.2994 0 0 0 0 15.9987 15.9634 0 15.4292 0 0 13.8558 0 15.866 15.3883 15.7937 0 0 0 0 0 0 16.0652 0 0 0 15.527 0 0 11.1441 12.612 12.2929 0 15.3967 15.3094 14.7094 15.4015 15.1648 0 0 0 14.9622 0 0 0 0 0 0 0 0 0 14.447 11.5557 0 0 0 0 0 12.0437 0 0 0 0 0 0 0 0 0 0 0 15.2104 0 0 14.21 0 0 0 0 Q8WX92 NELFB_HUMAN "Negative elongation factor B, NELF-B (Cofactor of BRCA1)" NELFB COBRA1 KIAA1182 Homo sapiens (Human) cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; stem cell differentiation [GO:0048863] cytoplasm [GO:0005737]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; NELF complex [GO:0032021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; stem cell differentiation [GO:0048863] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737 RNA binding [GO:0003723] ENVHRHALR 0.9922 -24.424 0 11.7673 0 9.00571 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6154 13.5013 13.4464 0 0 13.5038 0 0 0 13.2041 13.2116 0 0 0 0 0 12.5119 0 0 0 0 0 0 0 0 0 0 0 0 13.877 0 0 0 10.2932 0 0 9.67839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8963 0 0 0 13.6533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9057 13.0532 0 0 0 0 0 0 10.8563 10.8328 0 0 0 0 0 13.3508 0 0 11.8927 0 0 0 0 0 0 0 0 13.3738 0 0 0 0 0 0 14.7426 0 14.1497 14.5049 13.8085 0 0 0 0 0 0 0 14.5159 14.2243 0 0 0 0 12.3889 0 0 0 13.2865 Q9UK10 ZN225_HUMAN Zinc finger protein 225 ZNF225 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEDCGKRYK 0.9922 -18.321 0 0 0 0 0 0 0 0 0 0 0 0 13.1481 0 0 0 12.2731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8884 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9 0 0 0 10.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5806 0 0 0 0 0 0 0 14.0329 0 11.8457 0 0 0 0 0 0 0 0 0 0 0 0 10.5419 0 0 0 0 0 13.9021 0 0 0 0 0 0 0 0 0 12.729 12.9459 13.6178 0 0 0 0 0 0 11.2433 0 0 9.9193 0 0 0 0 0 0 0 0 0 13.0315 12.0657 14.2544 0 0 0 11.0079 0 0 14.5135 0 0 0 0 0 0 0 0 0 0 13.9071 0 10.3189 12.4858 0 13.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDD1 DDX54_HUMAN "ATP-dependent RNA helicase DDX54, EC 3.6.4.13 (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54)" DDX54 Homo sapiens (Human) intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; intracellular estrogen receptor signaling pathway [GO:0030520]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] GO:0003714; GO:0003723; GO:0003724; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006364; GO:0006396; GO:0016020; GO:0016070; GO:0016887; GO:0030331; GO:0030520 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714] AAVLLHLLHNVVR 0.99221 -17.915 0 0 0 0 10.6598 11.7579 11.026 0 0 0 13.1843 0 11.5689 0 0 10.6019 0 17.3926 16.9607 16.9476 0 15.8761 0 0 0 11.3032 0 0 0 0 11.1607 0 0 0 0 0 0 0 12.2076 0 0 0 0 0 0 0 0 9.35189 14.4216 0 14.299 0 0 18.6644 17.4414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.462 0 10.8554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5347 0 0 0 13.0396 0 13.4407 0 0 0 18.8033 0 17.4493 0 11.7629 0 0 0 0 11.6918 0 0 12.2533 0 0 0 0 0 20.0566 17.9269 0 0 13.8727 0 0 0 0 0 13.3329 0 0 0 0 0 12.965 0 10.9013 19.099 12.8433 0 18.5628 18.5645 0 0 0 0 12.2007 0 0 0 19.6905 13.087 0 0 12.8509 12.6249 0 12.854 13.3276 0 13.4935 13.1572 0 12.0037 13.3243 0 20.496 20.5686 13.3643 12.0561 0 12.1897 0 0 P35579 MYH9_HUMAN "Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A, NMMHC-A) (Non-muscle myosin heavy chain IIa, NMMHC II-a, NMMHC-IIA)" MYH9 Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]" actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931] "actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; actomyosin contractile ring [GO:0005826]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cleavage furrow [GO:0032154]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; spindle [GO:0005819]; stress fiber [GO:0001725]; uropod [GO:0001931]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723]; actin cytoskeleton reorganization [GO:0031532]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; angiogenesis [GO:0001525]; blood vessel endothelial cell migration [GO:0043534]; cortical granule exocytosis [GO:0060471]; cytokinetic process [GO:0032506]; establishment of meiotic spindle localization [GO:0051295]; establishment of T cell polarity [GO:0001768]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lysosome localization [GO:0032418]; meiotic spindle organization [GO:0000212]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte differentiation [GO:0030224]; myoblast fusion [GO:0007520]; negative regulation of actin filament severing [GO:1903919]; phagocytosis, engulfment [GO:0006911]; plasma membrane repair [GO:0001778]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; regulation of cell shape [GO:0008360]; regulation of plasma membrane repair [GO:1905684]; uropod organization [GO:0032796]" GO:0000146; GO:0000212; GO:0001525; GO:0001701; GO:0001725; GO:0001726; GO:0001768; GO:0001772; GO:0001778; GO:0001931; GO:0003723; GO:0003774; GO:0003779; GO:0005178; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005826; GO:0005829; GO:0005886; GO:0005903; GO:0005912; GO:0005925; GO:0006509; GO:0006911; GO:0007229; GO:0007520; GO:0008360; GO:0009898; GO:0015031; GO:0015629; GO:0016020; GO:0016460; GO:0016604; GO:0019904; GO:0030048; GO:0030220; GO:0030224; GO:0031032; GO:0031252; GO:0031532; GO:0031594; GO:0032154; GO:0032418; GO:0032506; GO:0032796; GO:0032982; GO:0032991; GO:0042641; GO:0042802; GO:0042803; GO:0043495; GO:0043531; GO:0043534; GO:0045055; GO:0045296; GO:0050900; GO:0051015; GO:0051295; GO:0060471; GO:0060473; GO:0070062; GO:0070527; GO:0097513; GO:1903919; GO:1903923; GO:1905684 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; RNA binding [GO:0003723] AGKLDPHLVLDQLRCNGVLEGIR 0.99221 -47.117 12.6655 0 0 0 0 0 0 0 0 0 0 0 0 11.7386 0 0 11.6625 11.9868 0 0 12.6335 12.9446 0 12.8305 0 14.8987 12.2838 0 0 0 0 0 0 0 14.7941 0 12.1601 0 0 0 0 0 12.7321 0 0 0 10.8315 0 0 12.5763 0 0 13.7399 15.0468 14.4498 0 11.1206 0 0 0 13.3849 0 0 0 13.3055 0 15.6574 15.6769 15.2141 16.0571 0 0 0 0 15.7522 14.5872 14.5153 14.7901 16.8064 14.9718 17.3767 14.3576 11.5806 0 14.0448 13.9774 15.8739 15.5305 16.3066 14.2347 14.2675 14.7756 13.616 14.5114 15.649 15.4568 13.3718 14.6978 14.7546 13.8045 14.7949 14.3775 0 0 15.4802 16.1333 0 15.5726 15.2223 15.5815 14.9347 13.5718 15.7268 14.8929 14.5433 14.8581 13.2946 16.2545 15.7982 14.9381 17.2219 16.3498 16.6928 15.3875 0 16.2993 15.4392 13.7618 17.3906 11.5539 15.2578 18.4949 16.975 18.6333 14.6872 14.3584 16.2112 17.4388 14.2177 13.755 0 15.3176 15.278 14.0765 15.1135 15.5518 0 0 0 0 0 15.091 0 14.2004 0 13.9614 0 12.6484 12.3986 0 12.8387 0 14.4098 14.2663 0 15.4989 0 13.4093 14.1006 11.8344 0 13.8027 0 14.7362 0 0 0 0 0 0 P12931 SRC_HUMAN "Proto-oncogene tyrosine-protein kinase Src, EC 2.7.10.2 (Proto-oncogene c-Src) (pp60c-src, p60-Src)" SRC SRC1 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; cellular response to prolactin [GO:1990646]; DNA biosynthetic process [GO:0071897]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of hippo signaling [GO:0035332]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein transport [GO:0051222]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]" "actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]" "actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; nuclear estrogen receptor binding [GO:0030331]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; activation of protein kinase B activity [GO:0032148]; adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; cellular response to prolactin [GO:1990646]; DNA biosynthetic process [GO:0071897]; entry of bacterium into host cell [GO:0035635]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of hippo signaling [GO:0035332]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein transport [GO:0051222]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of protein binding [GO:0043393]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]" GO:0001545; GO:0001819; GO:0002102; GO:0002223; GO:0002862; GO:0004672; GO:0004713; GO:0004715; GO:0005080; GO:0005102; GO:0005158; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005764; GO:0005770; GO:0005829; GO:0005884; GO:0005886; GO:0005901; GO:0005925; GO:0007049; GO:0007155; GO:0007165; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007283; GO:0007611; GO:0008022; GO:0008283; GO:0009410; GO:0009612; GO:0009615; GO:0010447; GO:0010632; GO:0010634; GO:0010907; GO:0010954; GO:0014068; GO:0014069; GO:0014911; GO:0016004; GO:0016236; GO:0018105; GO:0018108; GO:0019899; GO:0020037; GO:0022407; GO:0030054; GO:0030154; GO:0030168; GO:0030331; GO:0030900; GO:0031234; GO:0031295; GO:0031333; GO:0031648; GO:0031667; GO:0031954; GO:0032148; GO:0032211; GO:0032587; GO:0032869; GO:0033146; GO:0033625; GO:0034332; GO:0034446; GO:0035306; GO:0035332; GO:0035556; GO:0035635; GO:0036035; GO:0036120; GO:0038083; GO:0038096; GO:0038128; GO:0042169; GO:0042476; GO:0043025; GO:0043065; GO:0043066; GO:0043114; GO:0043149; GO:0043154; GO:0043274; GO:0043393; GO:0043406; GO:0043552; GO:0044294; GO:0044325; GO:0045056; GO:0045087; GO:0045121; GO:0045124; GO:0045296; GO:0045453; GO:0045737; GO:0045747; GO:0045780; GO:0045892; GO:0045893; GO:0046579; GO:0046628; GO:0046777; GO:0046875; GO:0048010; GO:0048011; GO:0048013; GO:0048041; GO:0048471; GO:0048477; GO:0050731; GO:0050847; GO:0050900; GO:0051057; GO:0051117; GO:0051219; GO:0051222; GO:0051385; GO:0051602; GO:0051895; GO:0051897; GO:0051902; GO:0051974; GO:0060065; GO:0060444; GO:0060491; GO:0060576; GO:0070062; GO:0070102; GO:0070301; GO:0070374; GO:0070555; GO:0070700; GO:0070851; GO:0071222; GO:0071253; GO:0071375; GO:0071393; GO:0071398; GO:0071456; GO:0071498; GO:0071803; GO:0071897; GO:0071902; GO:0086098; GO:0090263; GO:0097060; GO:0097110; GO:0098609; GO:0098962; GO:0098978; GO:0099091; GO:1900182; GO:1902737; GO:1903997; GO:1904707; GO:1990646; GO:2000256; GO:2000386; GO:2000394; GO:2000573; GO:2000588; GO:2000641; GO:2000811; GO:2001237; GO:2001243; GO:2001286 ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; nuclear estrogen receptor binding [GO:0030331]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] ESLRLEVK 0.99221 -4.8879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4329 0 0 0 0 0 0 0 0 0 0 0 0 16.2708 0 0 0 0 0 11.7715 0 0 0 0 0 0 10.2525 14.6238 0 0 14.6531 14.6911 0 0 0 0 0 13.3912 12.4473 0 0 0 0 0 11.9812 0 0 0 0 0 Q53S33 BOLA3_HUMAN BolA-like protein 3 BOLA3 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; cell redox homeostasis [GO:0045454]; iron ion homeostasis [GO:0055072]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035] GO:0005739; GO:0005759; GO:0005829; GO:0016226; GO:0016604; GO:0045454; GO:0055072; GO:0106035; GO:1990229 FPRATAIK 0.99221 -17.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2272 0 0 0 12.2136 0 0 0 0 0 0 0 0 0 0 0 0 14.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T9C9 PI5L1_HUMAN "Phosphatidylinositol 4-phosphate 5-kinase-like protein 1, PI(4)P 5-kinase-like protein 1, PtdIns(4)P-5-kinase-like protein 1, EC 2.7.1.68" PIP5KL1 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein phosphorylation [GO:0001933]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065] cell projection [GO:0042995]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cell projection [GO:0042995]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; negative regulation of cell migration [GO:0030336]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein phosphorylation [GO:0001933]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065] GO:0001933; GO:0005524; GO:0005829; GO:0005886; GO:0010917; GO:0016308; GO:0016310; GO:0030336; GO:0042995; GO:0043065; GO:0046854 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524] ASFFLSHDQR 0.99221 -24.471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9065 0 0 0 0 0 12.1813 0 0 0 0 0 0 0 0 0 0 0 13.53 13.6183 13.7691 12.943 0 13.568 0 0 13.5525 13.2397 12.5824 0 0 11.9425 0 0 0 0 0 12.2965 0 0 0 13.7364 0 0 0 0 12.4271 11.7549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4488 12.0781 0 0 11.9362 0 0 0 0 0 0 0 0 0 0 0 11.7529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VVP1 S31A6_HUMAN Spermatogenesis-associated protein 31A6 (Protein FAM75A6) SPATA31A6 FAM75A6 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 AGETREAVPQCR 0.99221 -7.6206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6MZZ7 CAN13_HUMAN "Calpain-13, EC 3.4.22.- (Calcium-activated neutral proteinase 13, CANP 13)" CAPN13 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; negative regulation of apoptotic process [GO:0043066]; proteolysis [GO:0006508] GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0043066 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] AVKTATK 0.99221 -24.46 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3518 0 0 0 0 0 0 0 12.43 0 15.9086 0 13.1028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4235 0 0 0 0 0 0 0 0 11.5621 0 0 12.3765 0 0 0 0 0 0 0 0 0 0 12.7991 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.141 0 15.4136 14.8642 14.3766 15.3467 0 0 0 0 0 0 0 0 0 Q6P5Q4 LMOD2_HUMAN "Leiomodin-2 (Cardiac leiomodin, C-LMOD) (Leiomodin)" LMOD2 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838]; sarcomere organization [GO:0045214] actin filament [GO:0005884]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865] actin filament [GO:0005884]; cytoskeleton [GO:0005856]; M band [GO:0031430]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838]; sarcomere organization [GO:0045214] GO:0003779; GO:0003785; GO:0005523; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0030016; GO:0030017; GO:0030041; GO:0030239; GO:0030838; GO:0031430; GO:0045010; GO:0045214; GO:0051694 actin binding [GO:0003779]; actin monomer binding [GO:0003785]; tropomyosin binding [GO:0005523] GTPSSSPYVSPR 0.99221 -6.1325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9356 0 0 13.3845 0 0 0 0 0 0 0 13.9189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3315 0 0 0 0 0 0 0 0 0 0 Q6PCB5 RSBNL_HUMAN "Lysine-specific demethylase RSBN1L, EC 1.14.11.- (Round spermatid basic protein 1-like protein)" RSBN1L Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872] GO:0005634; GO:0046872; GO:0051213 dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872] EAGGASR 0.99221 -25.445 0 0 0 0 0 0 0 0 0 0 0 0 14.1058 13.794 0 0 13.3845 13.1348 0 0 14.0756 0 0 0 0 14.1419 13.459 0 0 0 0 0 0 0 0 0 13.8111 0 0 0 13.7912 0 0 13.9986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2809 12.5724 0 0 0 0 0 0 13.2066 0 0 0 0 0 12.8819 0 14.2207 0 0 0 0 13.2985 14.0789 12.8173 14.4561 0 0 0 0 14.002 15.3628 0 15.4372 15.0253 14.7734 14.3806 0 0 0 0 14.0821 13.3723 0 13.9577 0 14.8389 0 0 18.3011 0 0 0 13.1297 13.8411 14.6884 0 14.2162 0 0 12.6337 12.7741 0 0 12.6277 0 0 0 0 13.5108 0 0 0 0 0 13.2708 12.7211 14.3406 0 12.5802 0 16.9608 0 0 0 0 0 0 0 12.3 14.4526 0 0 0 0 14.4453 0 0 0 0 0 0 0 0 14.0305 0 13.9924 0 0 0 0 12.5691 0 0 Q8N8U2 CDYL2_HUMAN "Chromodomain Y-like protein 2, CDY-like 2" CDYL2 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; catalytic activity [GO:0003824]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714] GO:0003714; GO:0003824; GO:0005634; GO:0035064 catalytic activity [GO:0003824]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714] ESTRIAEAIRDFVK 0.99221 -17.968 0 0 10.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1324 0 11.6515 0 0 0 0 0 0 14.0814 0 0 0 14.0718 0 0 0 0 0 0 0 0 10.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2762 0 0 0 0 0 0 0 0 0 0 0 0 12.3897 0 13.3708 0 0 0 0 0 10.3016 0 13.9658 0 0 0 16.4704 11.5814 12.4911 12.6872 0 0 0 0 0 0 0 0 0 12.7685 0 0 0 11.7223 0 0 0 14.1655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6051 12.51 0 0 11.3832 0 0 12.9933 12.8638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7647 0 0 0 0 11.4017 13.0949 0 0 0 0 12.2994 0 0 0 0 0 0 0 0 14.7058 0 12.9914 14.2024 0 15.141 0 0 0 0 0 0 12.6026 0 11.3256 Q8WUB8 PHF10_HUMAN "PHD finger protein 10 (BRG1-associated factor 45a, BAF45a) (XAP135)" PHF10 BAF45A Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] "chromatin [GO:0000785]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000776; GO:0000785; GO:0003712; GO:0005654; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045944; GO:0046872; GO:0070316; GO:0071564; GO:1902459; GO:2000045; GO:2000781; GO:2000819 histone binding [GO:0042393]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] APPTPRKVGR 0.99221 -5.531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9845 0 0 0 0 0 0 16.2159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EK7 F120B_HUMAN "Constitutive coactivator of peroxisome proliferator-activated receptor gamma, Constitutive coactivator of PPAR-gamma, Constitutive coactivator of PPARG (PPARG constitutive coactivator 1, PGCC1) (Protein FAM120B)" FAM120B CCPG KIAA1838 Homo sapiens (Human) fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357] nucleus [GO:0005634] nucleus [GO:0005634]; fat cell differentiation [GO:0045444]; peroxisome proliferator activated receptor signaling pathway [GO:0035357] GO:0005634; GO:0035357; GO:0045444 KLEEILPLGPNKALFYK 0.99221 -5.5357 0 0 0 0 0 0 15.1314 0 11.6237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4421 0 0 0 0 13.2268 0 0 0 0 0 0 16.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1388 0 0 0 13.7543 0 0 0 0 0 0 12.7238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.923 13.2292 0 0 0 0 0 0 0 0 14.3116 13.7511 0 0 0 13.1976 0 0 0 0 0 0 0 0 12.8355 0 0 0 12.2891 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0B2 CFA74_HUMAN Cilia- and flagella-associated protein 74 CFAP74 C1orf222 KIAA1751 Homo sapiens (Human) axoneme assembly [GO:0035082] axoneme [GO:0005930] axoneme [GO:0005930]; axoneme assembly [GO:0035082] GO:0005930; GO:0035082 AELAEQRVQAEKK 0.99221 -46.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1299 10.4081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6929 0 0 0 0 0 0 0 0 10.6159 0 0 0 0 0 0 0 0 0 11.9294 0 0 0 0 0 14.5573 13.3309 13.1548 11.5958 0 0 0 0 0 0 0 11.4481 0 10.7484 0 0 0 0 0 0 11.2105 11.4394 0 0 0 0 0 0 0 0 0 12.0188 11.2466 0 0 10.7586 0 11.727 0 0 0 0 0 0 0 0 0 0 0 13.6282 11 0 0 0 0 0 0 0 0 13.3153 0 0 0 10.5059 0 0 0 0 0 0 0 0 16.3314 0 0 10.7501 0 0 0 0 0 0 0 0 0 0 0 10.9115 0 0 0 0 0 0 10.4186 0 0 11.5355 Q9UDV7 ZN282_HUMAN "Zinc finger protein 282 (HTLV-I U5RE-binding protein 1, HUB-1)" ZNF282 HUB1 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0006357; GO:0008270; GO:0045892; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" APVFPDRMMR 0.99221 -25.482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5528 0 0 0 0 0 0 0 0 0 0 12.8421 0 0 0 0 11.4693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3853 12.907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0496 0 0 13.7885 0 0 0 0 0 0 15.3695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4443 0 0 0 0 0 0 0 Q9UJA3 MCM8_HUMAN "DNA helicase MCM8, EC 3.6.4.12 (Minichromosome maintenance 8)" MCM8 C20orf154 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; male gamete generation [GO:0048232]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; protein stabilization [GO:0050821]; recombinational interstrand cross-link repair [GO:0036298] GO:0000724; GO:0003678; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0006974; GO:0007049; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0032508; GO:0036298; GO:0042555; GO:0048232; GO:0050821; GO:0070716; GO:0071168; GO:0097362 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; single-stranded DNA binding [GO:0003697] EDAEDIVEIMKYSMLGTYSDEFGNLDFER 0.99221 -6.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1839 14.0936 0 0 0 0 0 0 0 0 0 0 0 0 10.5944 0 0 0 0 0 0 0 0 13.1313 0 0 0 0 0 0 0 0 13.4231 0 0 0 0 0 0 13.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77569 11.0155 0 0 0 0 0 11.4477 0 0 0 0 0 0 13.3178 0 0 12.0631 0 0 Q9ULI1 NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239) NWD2 KIAA1239 Homo sapiens (Human) AGHINPLIIYGGPCTGKTLLLAEVAK 0.99221 -25.437 0 9.63183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5561 11.2538 0 0 0 0 11.8051 13.8629 12.8961 14.36 10.9185 11.6033 12.3172 0 14.306 0 14.3172 12.6812 14.1904 11.6404 0 13.6536 13.633 14.3413 0 0 0 13.3063 14.6862 15.0455 12.7247 0 13.7445 14.0861 13.399 0 12.8062 12.9851 0 0 13.1443 13.5335 14.9075 14.5124 0 12.6574 13.1469 15.4334 14.0715 14.4424 13.8517 0 14.5247 14.8762 0 13.865 13.141 0 0 13.0296 0 0 0 0 13.5015 13.6033 0 16.1334 0 0 12.8199 0 0 10.8665 0 11.9082 0 16.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5494 13.2739 0 0 0 0 0 0 0 Q9Y285 SYFA_HUMAN "Phenylalanine--tRNA ligase alpha subunit, EC 6.1.1.20 (CML33) (Phenylalanyl-tRNA synthetase alpha subunit, PheRS)" FARSA FARS FARSL FARSLA Homo sapiens (Human) phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290] GO:0000049; GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006432; GO:0009328; GO:0016020; GO:0051290 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049] DQHDTFFLRDPAEALQLPMDYVQR 0.99221 -24.446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4B4 ARIP4_HUMAN "Helicase ARIP4, EC 3.6.4.12 (Androgen receptor-interacting protein 4) (RAD54-like protein 2)" RAD54L2 ARIP4 KIAA0809 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0016887; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] AAQQEELERR 0.99221 -24.473 0 0 0 0 0 0 0 10.671 0 10.1556 0 0 0 0 0 0 0 12.215 14.0182 14.7361 0 0 0 0 0 13.1865 14.1484 0 0 13.4329 13.7778 0 10.2177 0 0 0 0 0 0 13.1314 0 0 0 11.0294 0 0 0 12.4156 0 0 0 0 0 0 0 0 0 13.2971 0 11.907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.421 0 0 0 0 0 0 0 0 0 0 0 14.3635 14.8853 13.1051 12.1133 0 15.1918 0 0 13.3729 0 0 0 0 0 0 0 13.1464 0 0 0 12.0763 0 0 0 14.0114 0 0 0 14.1058 13.9113 14.9929 0 14.3803 0 0 0 13.2251 0 14.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4437 0 10.0958 0 0 0 0 14.5584 0 0 0 0 14.2053 13.8937 14.5072 0 14.3221 0 13.8509 0 13.7625 0 14.1258 9.90928 0 13.4671 10.0515 0 13.4041 0 13.7414 0 0 P16383 GCFC2_HUMAN "Intron Large complex component GCFC2 (GC-rich sequence DNA-binding factor) (GC-rich sequence DNA-binding factor 2) (Transcription factor 9, TCF-9)" GCFC2 C2orf3 GCF TCF9 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal complex assembly [GO:0000245]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type post-mRNA release spliceosomal complex [GO:0071008] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; DNA binding [GO:0003677]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000398; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0045892; GO:0071008 DNA binding [GO:0003677] ESEDDPESEPDDHEKR 0.99222 -17.994 0 0 0 10.3548 0 0 0 10.4042 0 0 11.2318 0 0 0 0 0 0 0 0 0 0 0 0 11.7365 0 0 0 0 0 0 0 0 0 0 13.2127 0 0 0 0 0 0 0 0 0 10.6989 12.025 0 13.2432 0 13.0396 0 10.9708 0 0 0 17.0199 0 0 0 0 0 0 0 0 0 0 12.2418 0 0 0 0 0 0 0 13.7067 0 13.6804 0 0 0 13.7932 14.0073 0 0 14.4565 14.7649 0 0 13.0031 14.5759 0 10.1621 19.8292 0 0 0 0 0 20.2763 0 0 14.0911 0 0 0 0 12.6768 11.3232 11.2038 0 13.1151 19.6529 19.5784 0 19.6266 13.7639 0 0 12.1568 14.3268 0 11.099 0 0 0 20.0697 13.2962 16.0202 10.903 0 11.6842 12.3203 0 0 19.4206 0 0 12.7827 0 0 0 0 19.4991 0 0 0 18.5628 18.5645 18.4113 18.372 11.6551 0 0 14.7803 0 0 0 0 11.2747 0 0 0 15.2009 0 0 0 0 0 11.7431 0 0 20.5714 0 20.5686 0 0 0 11.1609 10.8675 10.2363 Q96L73 NSD1_HUMAN "Histone-lysine N-methyltransferase, H3 lysine-36 specific, EC 2.1.1.357 (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1, NR-binding SET domain-containing protein)" NSD1 ARA267 KMT3B Homo sapiens (Human) "chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000414; GO:0000785; GO:0000978; GO:0003682; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0008270; GO:0016571; GO:0018024; GO:0030331; GO:0033135; GO:0042799; GO:0042974; GO:0045893; GO:0046965; GO:0046966; GO:0046975; GO:0050681; GO:1903025 chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] AALVMDLIDLTPR 0.99222 -85.034 0 12.3315 0 0 0 0 0 12.8033 0 0 0 0 14.5865 0 0 0 0 0 12.0598 0 0 0 0 13.8397 14.5302 0 0 0 12.3469 10.4116 0 0 0 0 0 0 0 0 0 0 0 10.4049 0 0 13.0711 13.0454 0 0 0 0 10.8796 0 0 0 0 0 11.0305 0 0 0 0 0 0 0 0 0 11.4894 12.967 10.6292 0 13.8787 0 16.4522 16.1558 0 10.9893 0 0 16.1849 15.0737 15.2194 14.5933 14.8836 16.2961 0 12.5802 0 0 11.5728 13.5028 0 14.5199 12.4558 12.4664 13.8666 12.5967 0 12.9933 16.3298 15.6284 14.0732 12.7819 0 13.2114 0 12.8009 15.292 14.1802 12.5874 15.1885 15.2673 0 0 14.6254 13.249 0 16.5579 13.0949 14.4617 16.6602 12.6674 15.5637 12.2705 15.6981 13.6604 0 13.3712 11.57 13.29 12.2652 0 16.2205 15.4307 15.1337 14.9864 16.1031 15.9935 0 13.2049 0 16.7603 14.1797 12.5064 15.2723 0 0 14.8946 0 12.8641 14.1655 15.5181 13.4793 0 13.6628 15.6824 16.0999 10.254 15.4889 12.459 0 0 0 0 11.6241 14.8073 0 0 13.7412 0 0 0 0 15.1621 0 0 0 0 13.4642 12.0033 0 C9JL84 HHLA1_HUMAN HERV-H LTR-associating protein 1 HHLA1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GTARTSKPTTK 0.99222 -7.6463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00471 EXOC5_HUMAN "Exocyst complex component 5 (Exocyst complex component Sec10, hSec10)" EXOC5 SEC10 SEC10L1 Homo sapiens (Human) epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496] cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0001736; GO:0005737; GO:0005829; GO:0006887; GO:0006892; GO:0006893; GO:0006904; GO:0015031; GO:0030496; GO:0031267; GO:0047485; GO:0072659; GO:0090148; GO:0090522; GO:1904019; GO:1905515 protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267] AVEAQKLMK 0.99222 -18.027 12.7722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4452 0 0 0 12.8289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.704 0 0 0 0 0 0 0 0 0 13.252 0 12.6283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4327 0 0 0 0 0 0 0 0 12.0822 0 0 0 0 0 0 0 0 0 0 0 0 11.1166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1607 0 0 14.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14672 ADA10_HUMAN "Disintegrin and metalloproteinase domain-containing protein 10, ADAM 10, EC 3.4.24.81 (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c)" ADAM10 KUZ MADM Homo sapiens (Human) adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998] adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197] adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; toxin transport [GO:1901998] GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005102; GO:0005178; GO:0005634; GO:0005737; GO:0005788; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0005925; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0007229; GO:0007267; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016020; GO:0016021; GO:0016485; GO:0017124; GO:0019901; GO:0022617; GO:0030136; GO:0030307; GO:0030335; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0035579; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0043231; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070062; GO:0070573; GO:0070821; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:1901342; GO:1901998; GO:1902945 endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102] AVSHEDQFLRLDFHAHGR 0.99222 -18.471 0 0 0 0 0 0 0 0 0 0 0 0 12.0937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5259 0 0 13.3712 0 0 11.7593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5432 0 13.8704 13.6608 0 0 0 0 13.179 13.6041 0 0 0 11.9724 0 14.1316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.822 0 11.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4528 0 0 0 0 0 0 0 0 0 0 0 14.088 0 O76100 OR7AA_HUMAN Olfactory receptor 7A10 (OST027) (Olfactory receptor OR19-18) OR7A10 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] TFFRGKQ 0.99222 -4.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95602 RPA1_HUMAN "DNA-directed RNA polymerase I subunit RPA1, RNA polymerase I subunit A1, EC 2.7.7.6 (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit, RPA194)" POLR1A Homo sapiens (Human) negative regulation of protein localization to nucleolus [GO:1904750] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; negative regulation of protein localization to nucleolus [GO:1904750] GO:0001054; GO:0003677; GO:0003682; GO:0005654; GO:0005694; GO:0005736; GO:0008270; GO:1904750 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270] DSEPLGIEEAQIGKR 0.99222 -18.036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7502 0 0 0 0 0 14.9571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0294 0 0 0 0 12.5338 0 0 0 0 0 0 0 0 0 0 0 14.1069 0 0 0 0 12.518 13.0975 14.4508 0 0 0 13.1709 0 0 0 0 12.986 0 0 0 0 0 0 0 0 0 0 0 0 13.8038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4542 0 0 0 0 0 0 0 9.88313 0 0 0 0 12.0503 0 0 0 0 0 0 0 0 0 0 0 15.6083 0 0 0 0 0 0 0 0 12.4616 0 0 0 0 0 P38432 COIL_HUMAN Coilin (p80-coilin) COIL CLN80 Homo sapiens (Human) spliceosomal snRNP assembly [GO:0000387] Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cajal body [GO:0015030]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; spliceosomal snRNP assembly [GO:0000387] GO:0000387; GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0008022; GO:0015030; GO:0016020; GO:0016604; GO:0030619; GO:0030620; GO:0042802 identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620] CRVVTDLISLIRQR 0.99222 -6.6868 0 0 0 0 0 0 0 0 0 0 10.6254 0 0 11.2254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6068 0 0 0 0 0 10.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3656 13.531 13.9004 14.0549 0 0 0 0 14.6855 15.0064 0 0 0 14.0574 14.2578 0 0 0 0 12.9663 9.85432 0 0 0 0 0 12.424 0 14.6203 14.5841 13.9749 0 14.0506 14.1784 14.8939 0 0 12.7831 13.2178 12.7056 0 0 0 0 0 0 13.7317 12.9012 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0622 13.7046 0 12.8865 0 12.9498 0 13.246 12.6919 0 0 0 0 0 0 0 0 12.6011 0 0 0 0 0 0 13.2124 0 0 Q2TBE0 C19L2_HUMAN CWF19-like protein 2 CWF19L2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" post-mRNA release spliceosomal complex [GO:0071014] "post-mRNA release spliceosomal complex [GO:0071014]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0071014 AIMESDEEWSMNK 0.99222 -18.035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.333 0 10.9945 0 11.6668 0 12.5237 0 16.3003 12.0085 0 0 16.1586 0 0 16.2529 0 0 11.9658 12.1268 0 12.0133 0 0 0 12.4897 0 0 0 0 0 11.4023 0 0 0 0 0 0 0 0 0 14.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.108 0 0 0 0 14.2676 0 0 0 0 0 0 11.8125 0 0 0 0 14.0339 0 0 0 0 0 0 0 0 0 0 0 13.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8525 0 0 0 0 0 12.1193 0 0 0 13.0678 0 0 0 0 15.0967 0 0 0 0 0 0 0 0 0 0 0 13.1149 0 0 0 0 0 0 0 0 0 16.3682 0 12.9539 0 16.9125 Q6NUI6 CHADL_HUMAN Chondroadherin-like protein CHADL SLRR4B Homo sapiens (Human) negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of collagen fibril organization [GO:1904027] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of collagen fibril organization [GO:1904027] GO:0005518; GO:0005615; GO:0030021; GO:0031012; GO:0032331; GO:0062023; GO:0098633; GO:1904027 collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent conferring compression resistance [GO:0030021] AFAHCPRLHTLDLR 0.99222 -4.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5631 0 0 0 0 0 0 0 10.6481 0 0 0 0 0 0 0 0 11.8024 0 0 0 0 0 13.2222 0 10.9891 0 12.4829 0 0 0 0 12.3885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7792 13.2965 13.8572 14.6449 14.735 0 14.9066 13.6385 0 0 0 0 0 0 9.90001 0 0 0 0 0 0 0 0 0 0 0 0 12.6669 0 0 0 14.6514 0 0 13.7627 13.8801 0 12.4839 0 14.6175 0 0 0 0 13.5913 0 12.4731 14.0603 0 0 0 0 12.5055 14.2396 14.6168 0 0 0 14.199 12.666 13.9425 14.874 14.0382 0 12.9631 0 11.5171 12.276 14.5508 14.4855 15.0135 0 11.5454 13.7555 0 0 14.2059 0 0 11.2834 0 0 0 13.3063 0 0 10.6264 13.3205 0 0 0 0 0 14.2319 0 0 0 0 13.2707 0 0 0 0 0 0 0 Q6ZV70 LANC3_HUMAN LanC-like protein 3 LANCL3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; carbohydrate metabolic process [GO:0005975] GO:0005886; GO:0005975 DTKRCFANR 0.99222 -25.491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.685 0 12.8796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUD2 RB6I2_HUMAN "ELKS/Rab6-interacting/CAST family member 1, ERC-1 (Rab6-interacting protein 2)" ERC1 ELKS KIAA1081 RAB6IP2 Homo sapiens (Human) "I-kappaB phosphorylation [GO:0007252]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; retrograde transport, endosome to Golgi [GO:0042147]" anchoring junction [GO:0070161]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton of presynaptic active zone [GO:0048788]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic membrane [GO:0042734]; synapse [GO:0045202] "anchoring junction [GO:0070161]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton of presynaptic active zone [GO:0048788]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882]; I-kappaB phosphorylation [GO:0007252]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0005737; GO:0005813; GO:0006355; GO:0007252; GO:0007274; GO:0008385; GO:0015031; GO:0030165; GO:0031267; GO:0036064; GO:0042147; GO:0042734; GO:0045202; GO:0045296; GO:0048167; GO:0048788; GO:0048790; GO:0051092; GO:0070161; GO:0098882 cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882] ALRKDEASK 0.99222 -25.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7815 0 0 0 0 0 0 0 0 0 0 12.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6019 13.0562 0 12.8602 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6801 0 0 0 14.7722 0 15.5803 0 0 0 0 0 0 0 0 0 0 0 13.3722 13.3603 0 0 0 0 0 14.0866 0 0 12.8193 12.9829 0 13.4111 14.5448 0 0 0 13.7343 13.4418 13.6484 13.0235 0 0 0 11.4222 0 0 0 0 14.0042 0 0 13.2928 0 0 0 0 0 0 0 14.3065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9741 0 0 0 0 12.8434 12.6032 12.3191 0 0 0 0 0 Q8TCG5 CPT1C_HUMAN "Carnitine O-palmitoyltransferase 1, brain isoform, CPT1-B, EC 2.3.1.21 (CPT IC) (Carnitine O-palmitoyltransferase I, brain isoform, CPTI-B) (Carnitine palmitoyltransferase 1C)" CPT1C CATL1 Homo sapiens (Human) carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; postsynapse [GO:0098794] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; postsynapse [GO:0098794]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine metabolic process [GO:0009437]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] GO:0004095; GO:0005739; GO:0005741; GO:0005783; GO:0006631; GO:0006635; GO:0009437; GO:0030176; GO:0030424; GO:0030425; GO:0032281; GO:0070161; GO:0098794; GO:0098978; GO:0099072 carnitine O-palmitoyltransferase activity [GO:0004095] DYIRHLHDSQHVAVFHR 0.99222 -18.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7297 0 0 0 0 0 0 0 0 0 0 13.3818 0 0 0 0 0 0 0 0 0 0 0 0 12.9349 0 0 0 0 0 0 0 0 0 0 11.6991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96E29 MTEF3_HUMAN "Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3, mTERF3) (mTERF domain-containing protein 1, mitochondrial)" MTERF3 MTERFD1 CGI-12 Homo sapiens (Human) "mitochondrial ribosome assembly [GO:0061668]; negative regulation of transcription, DNA-templated [GO:0045892]" cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transcription cis-regulatory region binding [GO:0000976]; mitochondrial ribosome assembly [GO:0061668]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0000976; GO:0005739; GO:0005741; GO:0005829; GO:0045892; GO:0061668 transcription cis-regulatory region binding [GO:0000976] AQYDPAKPNYISLDK 0.99222 -18.058 11.6087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2802 0 14.0897 0 11.9228 12.209 0 0 15.5106 12.4114 15.2042 12.7333 0 13.6041 0 0 0 0 13.1473 0 0 0 14.1878 0 0 0 0 0 0 0 0 0 0 0 13.6426 0 0 0 13.0004 0 0 0 0 0 0 0 0 0 0 15.331 13.8166 0 0 0 13.1691 0 0 0 0 0 0 0 14.0285 0 0 13.7444 0 0 12.8793 14.132 15.4791 15.0063 0 0 12.7332 12.9139 0 0 12.5854 0 0 12.9605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5636 0 14.42 0 0 0 0 0 0 Q96S79 RSLAB_HUMAN "Ras-like protein family member 10B, EC 3.6.5.2 (Ras-like protein VTS58635) (Ras-related protein 17, RRP17)" RASL10B Homo sapiens (Human) positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; positive regulation of peptide hormone secretion [GO:0090277]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050] GO:0003050; GO:0003925; GO:0005525; GO:0005886; GO:0090277 G protein activity [GO:0003925]; GTP binding [GO:0005525] CGYVECSAK 0.99222 -18.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7947 0 0 0 11.9876 0 0 0 0 0 0 0 0 11.9157 0 0 0 0 0 0 0 0 0 0 0 0 12.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5302 0 0 12.767 0 13.1973 0 0 0 13.2367 12.9642 0 0 0 0 13.034 12.8685 0 13.0459 0 0 12.8946 0 12.6905 0 0 0 0 0 0 13.5817 0 0 13.3075 0 0 12.8622 0 12.5012 0 0 13.6348 0 0 0 13.1861 0 0 0 0 13.2028 13.7075 0 0 0 13.108 0 0 0 13.49 12.318 0 0 0 0 0 12.6335 12.2911 0 0 12.7786 0 0 0 13.6076 0 0 11.8543 0 0 0 0 0 0 0 0 0 0 0 0 12.7065 0 12.7047 13.2271 0 13.0789 12.4219 0 0 0 0 13.995 0 0 0 0 Q9H267 VP33B_HUMAN "Vacuolar protein sorting-associated protein 33B, hVPS33B" VPS33B Homo sapiens (Human) collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; megakaryocyte development [GO:0035855]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; regulation of platelet aggregation [GO:0090330]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; vacuole [GO:0005773]; vesicle tethering complex [GO:0099023] clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; vacuole [GO:0005773]; vesicle tethering complex [GO:0099023]; protein-containing complex binding [GO:0044877]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; megakaryocyte development [GO:0035855]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; regulation of platelet aggregation [GO:0090330]; vesicle-mediated transport [GO:0016192] GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005770; GO:0005773; GO:0005794; GO:0005829; GO:0006886; GO:0007032; GO:0015031; GO:0016192; GO:0017185; GO:0030136; GO:0030199; GO:0030897; GO:0031091; GO:0031901; GO:0031902; GO:0032400; GO:0032418; GO:0032963; GO:0033263; GO:0035855; GO:0044877; GO:0046907; GO:0048471; GO:0055037; GO:0061025; GO:0070889; GO:0090330; GO:0090385; GO:0099023 protein-containing complex binding [GO:0044877] DYFLEGDQR 0.99222 -4.9296 0 0 0 0 0 0 0 0 14.0865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1233 13.727 0 13.826 14.6686 0 0 0 0 12.1224 13.4291 0 0 0 0 13.3318 0 0 0 0 13.1476 0 0 0 0 0 12.9961 0 0 0 0 12.855 0 13.2909 13.5871 13.3953 12.3433 0 14.5229 0 12.5197 19.0707 0 14.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.784 0 0 0 14.6126 0 13.2633 0 0 13.2105 0 0 0 15.1885 0 0 0 14.3613 14.6372 0 0 0 0 0 16.5103 0 0 16.385 0 0 0 0 0 0 0 0 0 0 0 13.583 14.3678 0 0 0 0 0 16.2868 Q9H6Q4 CIAO3_HUMAN "Cytosolic iron-sulfur assembly component 3 (Cytosolic Fe-S cluster assembly factor NARFL) (Iron-only hydrogenase-like protein 1, IOP1) (Nuclear prelamin A recognition factor-like protein) (Protein related to Narf)" CIAO3 NARFL PRN Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; iron-sulfur cluster assembly [GO:0016226]; oxygen homeostasis [GO:0032364]; regulation of gene expression [GO:0010468]; response to hypoxia [GO:0001666] CIA complex [GO:0097361] "CIA complex [GO:0097361]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; hematopoietic progenitor cell differentiation [GO:0002244]; iron-sulfur cluster assembly [GO:0016226]; oxygen homeostasis [GO:0032364]; regulation of gene expression [GO:0010468]; response to hypoxia [GO:0001666]" GO:0001666; GO:0002244; GO:0010468; GO:0016226; GO:0032364; GO:0046872; GO:0051539; GO:0097361 "4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]" EFVRRFR 0.99222 -4.4483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6128 0 0 0 14.6083 0 0 0 0 0 0 0 10.3819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9784 0 0 0 0 0 0 0 0 13.0734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7593 0 0 0 0 0 0 0 12.2969 0 0 0 0 10.0471 0 0 0 0 0 0 0 0 0 0 0 13.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9923 0 0 0 0 17.7528 0 0 0 0 0 0 0 0 0 10.152 0 0 13.7088 0 0 0 0 0 0 0 Q9HC84 MUC5B_HUMAN "Mucin-5B, MUC-5B (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)" MUC5B MUC5 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0043231; GO:0070062 AAQLPDMPLEELGQQVDCDR 0.99222 -15.057 0 0 0 0 0 0 0 0 0 0 11.2685 0 11.8963 0 14.4132 0 0 13.8121 11.4692 0 0 0 0 0 0 0 0 0 0 12.2287 13.1658 0 0 0 13.1433 12.0093 0 0 0 0 12.4157 13.1002 0 0 12.5071 11.0916 13.3871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1368 11.5002 13.6749 0 15.7115 0 12.0082 13.584 0 0 14.464 14.7478 16.6813 0 0 0 0 13.2354 13.6945 12.3186 0 0 12.9737 15.613 14.7305 0 11.7618 0 13.3619 0 12.9564 13.8442 0 14.3582 0 12.9353 0 0 13.5525 0 15.6962 13.0505 14.0138 0 12.6123 0 0 0 11.0616 0 0 14.3079 0 14.3979 0 12.8699 0 0 14.3193 0 0 0 0 15.6226 0 0 0 0 11.5994 15.3217 11.151 0 0 0 0 12.4425 0 0 0 0 0 0 0 0 11.641 14.9467 0 13.9992 0 0 0 0 0 0 13.3596 0 12.5054 0 10.7711 0 0 14.4558 13.9805 0 0 0 0 12.4941 Q9NPD3 EXOS4_HUMAN Exosome complex component RRP41 (Exosome component 4) (Ribosomal RNA-processing protein 41) (p12A) EXOSC4 RRP41 SKI6 Homo sapiens (Human) "defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000460; GO:0000791; GO:0000956; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0030307; GO:0034427; GO:0034475; GO:0035925; GO:0043231; GO:0045006; GO:0051607; GO:0071028; GO:0071044; GO:0071051; GO:0101019 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925] ALAVVYGPHEIRGSR 0.99222 -7.6446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9477 0 0 0 0 0 13.2412 0 0 14.5836 0 0 0 0 0 0 0 0 0 0 13.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4127 0 0 0 P20815 CP3A5_HUMAN "Cytochrome P450 3A5, EC 1.14.14.1 (CYPIIIA5) (Cytochrome P450-PCN3)" CYP3A5 Homo sapiens (Human) aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006805; GO:0008202; GO:0008210; GO:0008401; GO:0009822; GO:0016491; GO:0019825; GO:0020037; GO:0042178; GO:0042572; GO:0042573; GO:0043231; GO:0046222; GO:0070330; GO:0070989; GO:0101020 aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401] APPTYDAVVQMEYLDMVVNETLRLFPVAIRLER 0.99223 -7.6696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2459 0 0 0 0 12.2565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9429 0 14.4539 16.2666 0 0 0 11.8226 0 0 0 0 0 0 0 0 0 0 0 13.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0634 0 0 0 0 0 0 0 0 11.2597 0 0 0 0 0 0 0 0 13.1788 0 0 0 0 0 11.529 0 0 0 0 0 10.9125 0 0 12.1549 0 0 P23468 PTPRD_HUMAN "Receptor-type tyrosine-protein phosphatase delta, Protein-tyrosine phosphatase delta, R-PTP-delta, EC 3.1.3.48" PTPRD Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0005887; GO:0006470; GO:0006796; GO:0007157; GO:0007185; GO:0030182; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0099151; GO:0099545; GO:0099560; GO:1905606 cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] CHQYWPAERSAR 0.99223 -18.156 0 0 0 0 0 0 0 0 0 0 0 13.5126 0 12.0268 13.442 0 11.8499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0735 0 0 14.1259 0 0 0 0 12.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4621 0 0 0 0 0 0 13.3542 0 13.3117 0 0 12.4543 11.2497 0 0 0 0 0 13.4886 15.1294 14.5978 0 0 0 12.1467 0 0 12.9533 0 14.9922 0 0 0 11.6786 13.5465 0 0 13.6017 0 0 0 0 0 0 13.623 12.3923 14.1047 10.5259 0 0 0 0 0 0 0 0 13.2334 0 0 0 0 0 0 0 0 0 14.8489 0 13.1973 0 13.8954 0 0 0 0 0 0 0 0 0 12.1916 0 0 0 14.304 0 0 13.6149 0 0 0 0 11.9367 0 14.88 0 15.5544 0 0 0 13.2191 0 0 0 13.0338 13.5052 0 0 0 0 Q08AE8 SPIR1_HUMAN "Protein spire homolog 1, Spir-1" SPIRE1 KIAA1135 SPIR1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0003779; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0015031; GO:0016192; GO:0030036; GO:0030041; GO:0030659; GO:0031307; GO:0036089; GO:0040038; GO:0045010; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781 actin binding [GO:0003779] CKRYTLR 0.99223 -7.3502 0 0 0 0 0 0 9.65987 0 0 0 0 0 0 0 0 0 0 10.7458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0952 0 11.5112 0 0 0 0 0 0 0 0 0 0 0 13.1739 0 17.526 0 0 0 10.391 0 0 0 11.6782 10.3895 0 0 0 0 0 0 0 0 0 12.9536 0 0 0 0 0 0 0 14.3207 13.2077 0 14.7768 0 0 0 0 0 0 0 0 0 0 0 0 13.1406 0 11.007 0 0 0 0 0 11.9921 15.0134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.541 0 12.9528 13.6733 0 0 12.7287 0 0 0 10.162 Q14588 ZN234_HUMAN Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4) ZNF234 ZNF269 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDVCGKEFSQSSHLQTHQR 0.99223 -15.168 0 0 0 0 0 0 0 0 0 0 0 13.0682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7882 0 0 0 10.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0133 0 0 0 0 0 0 0 0 0 9.6855 0 0 Q15021 CND1_HUMAN "Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2, hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog)" NCAPD2 CAPD2 CNAP1 KIAA0159 Homo sapiens (Human) cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821] "condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]" GO:0000779; GO:0000793; GO:0000796; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0016020; GO:0042393; GO:0051301; GO:1905821 histone binding [GO:0042393] FCMISATFCDSQLRLLFTMLEKSPLPIVR 0.99223 -6.0334 0 12.6844 0 0 0 0 0 0 0 0 0 0 0 12.9217 0 0 0 12.6312 0 0 0 0 0 0 0 0 0 12.2366 0 0 0 0 0 0 0 0 0 0 0 0 0 12.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6121 0 0 0 12.1036 0 0 0 0 0 0 0 0 0 11.3737 0 0 0 14.7196 0 0 0 0 14.3755 0 0 0 0 0 0 0 0 13.5071 13.357 0 0 0 0 0 0 0 13.8105 0 0 0 0 13.0675 14.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8447 0 12.2694 0 0 0 0 0 0 0 0 0 0 12.4519 0 0 0 0 13.8449 13.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9606 0 0 0 18.2335 0 0 14.5627 0 Q684P5 RPGP2_HUMAN "Rap1 GTPase-activating protein 2, Rap1GAP2 (GTPase-activating Rap/Ran-GAP domain-like protein 4)" RAP1GAP2 GARNL4 KIAA1039 RAP1GA2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0002250; GO:0005096; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0008361; GO:0031965; GO:0048471; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096] AYRRHFLGK 0.99223 -14.799 0 0 0 0 0 0 0 0 0 12.7107 11.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7982 0 0 0 0 0 0 0 0 0 0 0 0 12.8781 0 0 0 0 0 11.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3307 14.8066 0 13.6777 0 0 0 0 0 0 0 0 0 0 0 0 11.2985 0 0 0 0 0 11.2779 0 0 0 0 11.5803 0 0 0 14.3508 0 13.3691 0 13.9742 0 0 0 0 0 0 0 0 11.4538 0 0 0 0 0 0 0 0 0 13.3746 14.9403 0 12.0889 0 0 0 0 0 0 0 0 0 11.2467 0 0 0 0 0 0 13.8992 14.0792 13.1824 0 0 0 0 0 0 0 0 0 0 0 0 12.34 0 11.8912 0 0 0 0 0 0 0 0 15.172 0 12.8505 0 14.3202 Q7Z6L1 TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 TECPR1 KIAA1358 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; regulation of autophagosome maturation [GO:1901096] GO:0000421; GO:0005654; GO:0005765; GO:0006914; GO:0016021; GO:0016236; GO:0031410; GO:0032266; GO:0032991; GO:0043231; GO:0097352; GO:1901096 phosphatidylinositol-3-phosphate binding [GO:0032266] DIWAKIPSKDDPK 0.99223 -17.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4278 0 0 13.2551 12.2976 12.877 0 0 0 0 0 0 0 0 13.994 13.476 0 0 0 0 0 0 0 0 0 0 13.2498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.504 0 0 0 0 0 0 13.6957 0 0 13.9081 14.1637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IU57 INLR1_HUMAN "Interferon lambda receptor 1, IFN-lambda receptor 1, IFN-lambda-R1 (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12, CRF2-12) (Interleukin-28 receptor subunit alpha, IL-28 receptor subunit alpha, IL-28R-alpha, IL-28RA) (Likely interleukin or cytokine receptor 2, LICR2)" IFNLR1 IL28RA LICR2 Homo sapiens (Human) cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; mucosal immune response [GO:0002385]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cellular respiration [GO:1901857]; regulation of defense response to virus by host [GO:0050691]; response to type III interferon [GO:0034342]; type III interferon signaling pathway [GO:0038196] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; interleukin-28 receptor complex [GO:0032002]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; interleukin-28 receptor complex [GO:0032002]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; mucosal immune response [GO:0002385]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cellular respiration [GO:1901857]; regulation of defense response to virus by host [GO:0050691]; response to type III interferon [GO:0034342]; type III interferon signaling pathway [GO:0038196] GO:0002385; GO:0004896; GO:0005886; GO:0005887; GO:0008285; GO:0016021; GO:0019221; GO:0032002; GO:0034342; GO:0038196; GO:0050691; GO:0051607; GO:0098586; GO:1901857 cytokine receptor activity [GO:0004896] TIYTFSVPK 0.99223 -4.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7505 0 0 0 0 0 0 0 12.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N119 MMP21_HUMAN "Matrix metalloproteinase-21, MMP-21, EC 3.4.24.-" MMP21 Homo sapiens (Human) collagen catabolic process [GO:0030574]; coronary vasculature development [GO:0060976]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; coronary vasculature development [GO:0060976]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244]; proteolysis [GO:0006508] GO:0002244; GO:0004222; GO:0005615; GO:0006508; GO:0007368; GO:0008270; GO:0030198; GO:0030574; GO:0031012; GO:0060976; GO:0061371 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] DERYFFQGNQYWR 0.99223 -14.799 11.5918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.898 12.3405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9376 0 0 14.1415 0 0 0 0 0 14.4939 0 12.0449 13.8051 0 13.8981 14.07 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0982 10.442 14.2864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9308 0 0 0 Q8NEN0 ARMC2_HUMAN Armadillo repeat-containing protein 2 ARMC2 Homo sapiens (Human) cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288] cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288] GO:0007288; GO:0044782 DCCTALASYSRCYALFLNLINK 0.99223 -14.797 0 0 0 0 0 0 0 0 0 11.2885 0 0 0 12.1162 0 0 0 0 13.3821 0 0 0 13.7447 12.8263 0 0 0 12.8431 0 0 0 0 0 0 0 0 13.2034 0 0 0 13.5718 12.3577 0 0 13.5969 13.6554 0 0 0 0 10.6107 0 0 0 0 0 11.4815 0 0 0 0 0 10.4067 0 0 0 14.5909 0 0 0 0 0 0 10.988 11.3161 0 0 0 0 15.756 0 15.5521 0 15.9205 0 0 15.1095 0 0 0 0 12.3235 0 0 0 0 0 12.3983 0 0 0 0 0 0 12.9353 0 0 0 0 0 12.9403 0 0 0 0 0 0 0 0 0 15.0552 12.5319 0 0 12.2148 13.6681 0 0 0 0 0 0 0 0 0 0 14.0191 11.0202 0 0 14.5731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2334 12.5058 0 0 0 13.9174 12.0275 0 0 0 11.7573 0 0 0 0 0 0 0 0 0 0 0 Q9H4A4 AMPB_HUMAN "Aminopeptidase B, AP-B, EC 3.4.11.6 (Arginine aminopeptidase) (Arginyl aminopeptidase)" RNPEP APB Homo sapiens (Human) proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0004177; GO:0004301; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008235; GO:0008270; GO:0070006; GO:0070062 aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; zinc ion binding [GO:0008270] FRSILADDFLDFYLEYFPELK 0.99223 -7.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB89 NMUR1_HUMAN "Neuromedin-U receptor 1, NMU-R1 (G-protein coupled receptor 66) (G-protein coupled receptor FM-3)" NMUR1 GPR66 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; chloride transport [GO:0006821]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; smooth muscle contraction [GO:0006939] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188]; activation of phospholipase C activity [GO:0007202]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; chloride transport [GO:0006821]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate-mediated signaling [GO:0048016]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; smooth muscle contraction [GO:0006939] GO:0001607; GO:0004930; GO:0005886; GO:0005887; GO:0006816; GO:0006821; GO:0006939; GO:0007186; GO:0007200; GO:0007202; GO:0007218; GO:0008188; GO:0016021; GO:0019722; GO:0042924; GO:0048016 G protein-coupled receptor activity [GO:0004930]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188] LLLMQEAK 0.99223 -7.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXK6 PAQR5_HUMAN "Membrane progestin receptor gamma, mPR gamma (Membrane progesterone P4 receptor gamma) (Membrane progesterone receptor gamma) (Progesterone and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member V)" PAQR5 MPRG Homo sapiens (Human) oogenesis [GO:0048477] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; steroid binding [GO:0005496]; oogenesis [GO:0048477] GO:0005496; GO:0005886; GO:0016021; GO:0038023; GO:0048477 signaling receptor activity [GO:0038023]; steroid binding [GO:0005496] IPKPELHK 0.99223 -6.7088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0504 0 0 0 0 0 0 0 12.3292 13.1631 12.6622 12.6991 13.0625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1325 0 12.8949 13.0376 12.5263 0 0 0 0 0 0 0 0 0 12.9297 0 0 0 12.6082 12.8464 0 0 0 13.4703 0 0 0 0 12.9646 0 0 0 0 12.8036 0 0 0 0 0 0 0 12.7303 0 0 0 13.5454 14.2922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PEZ8 PONL1_HUMAN Podocan-like protein 1 PODNL1 SLRR5B Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 ACPLRCSCPR 0.99224 -6.7154 10.7691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8992 0 0 18.8831 0 0 0 0 14.2645 12.3342 13.4836 13.7806 0 14.9623 13.3178 13.294 13.7042 12.1285 0 19.9686 14.5011 0 0 12.0055 13.5125 13.2889 13.6868 11.1374 14.1695 13.5071 0 0 16.3118 19.8955 16.4413 0 12.4953 0 0 0 0 19.972 12.4092 13.2592 10.825 12.9395 13.2569 14.3686 15.0821 14.3779 15.762 14.4299 0 12.8149 0 0 12.8292 0 0 13.6648 13.9513 14.6736 12.621 15.0697 15.2358 19.4599 0 0 0 10.3042 0 12.4721 13.8294 0 0 13.7399 0 0 0 11.8166 12.9289 0 0 0 15.0929 0 0 0 0 0 0 0 9.60515 10.1594 0 0 0 0 0 0 0 0 12.7396 0 12.6027 0 13.3277 0 0 15.2945 0 0 0 A6NGB9 WIPF3_HUMAN WAS/WASL-interacting protein family member 3 (Corticosteroids and regional expression protein 16 homolog) WIPF3 CR16 Homo sapiens (Human) actin filament-based movement [GO:0030048]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] actin filament [GO:0005884]; cytosol [GO:0005829] actin filament [GO:0005884]; cytosol [GO:0005829]; actin binding [GO:0003779]; SH3 domain binding [GO:0017124]; actin filament-based movement [GO:0030048]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0003779; GO:0005829; GO:0005884; GO:0007283; GO:0017124; GO:0030048; GO:0030154 actin binding [GO:0003779]; SH3 domain binding [GO:0017124] APSPRLPNK 0.99224 -18.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7446 0 0 0 0 0 0 0 0 0 0 0 11.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6087 0 0 0 0 14.8238 0 0 0 0 0 0 0 0 0 0 0 0 10.1293 0 0 0 0 14.0631 0 12.1109 0 0 12.9969 0 0 0 0 0 0 13.0304 0 12.4 0 0 0 0 0 10.5678 0 0 0 10.384 0 0 0 0 0 0 0 12.1478 0 12.9611 11.8898 0 12.4731 0 0 0 0 0 0 10.9559 13.1625 0 13.2009 0 0 0 11.2216 0 0 0 0 0 0 0 0 11.4849 0 0 0 0 0 0 0 0 12.781 0 0 0 0 0 O15015 ZN646_HUMAN Zinc finger protein 646 ZNF646 KIAA0296 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGDCGRTYR 0.99224 -15.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9576 0 12.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3647 0 0 0 0 0 0 14.5489 14.5655 0 0 0 0 0 0 16.2208 16.143 0 0 0 0 0 0 14.6843 0 13.093 0 13.8874 0 0 0 16.2307 17.1867 0 0 0 0 14.764 0 0 0 0 0 0 14.9467 0 14.2456 14.1964 0 14.0284 13.7655 0 0 14.0246 14.9522 13.8067 0 15.9524 0 0 0 14.0867 14.3643 13.785 0 0 0 0 0 0 0 0 13.6508 13.9595 0 0 0 13.935 0 0 0 0 0 0 13.8402 0 13.9464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1523 0 0 0 0 14.8766 0 O15127 SCAM2_HUMAN "Secretory carrier-associated membrane protein 2, Secretory carrier membrane protein 2" SCAMP2 Homo sapiens (Human) post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031] GO:0005794; GO:0006892; GO:0015031; GO:0016021; GO:0032588; GO:0043231; GO:0055038; GO:0070062 ERELQNTVANLHVRQNNWPPLPSWCPVK 0.99224 -7.6803 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3245 13.0993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3396 0 0 0 0 14.5519 0 0 0 13.7586 0 0 0 0 0 0 0 0 0 0 0 0 11.2573 0 0 0 0 0 0 0 13.3926 0 0 13.9394 0 0 0 13.7419 0 0 13.8524 0 0 0 13.1363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1673 0 0 13.9955 0 0 0 0 0 0 0 0 O60882 MMP20_HUMAN "Matrix metalloproteinase-20, MMP-20, EC 3.4.24.- (Enamel metalloproteinase) (Enamelysin)" MMP20 Homo sapiens (Human) amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of enamel mineralization [GO:0070173] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; amelogenesis [GO:0097186]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of enamel mineralization [GO:0070173] GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0022617; GO:0030163; GO:0030198; GO:0030574; GO:0031012; GO:0070173; GO:0097186 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] IKELQAFFGLQVTGK 0.99224 -4.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94952 FBX21_HUMAN F-box only protein 21 FBXO21 FBX21 KIAA0875 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0003677; GO:0004842; GO:0005829; GO:0006511 DNA binding [GO:0003677]; ubiquitin-protein transferase activity [GO:0004842] ALTWKYYAK 0.99224 -25.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3197 0 0 0 0 14.2707 0 0 12.6566 13.6004 14.0697 14.0516 13.918 0 13.8491 0 13.7457 0 13.9052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4516 13.5375 13.1536 0 0 0 0 0 0 0 0 13.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5432 12.2535 13.1366 11.645 0 0 0 0 0 P17275 JUNB_HUMAN Transcription factor JunB (Transcription factor AP-1 subunit JunB) JUNB Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; integrated stress response signaling [GO:0140467]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to calcium ion [GO:0071277]; decidualization [GO:0046697]; embryonic process involved in female pregnancy [GO:0060136]; integrated stress response signaling [GO:0140467]; labyrinthine layer blood vessel development [GO:0060716]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of T-helper 17 cell differentiation [GO:2000319]; regulation of transcription by RNA polymerase II [GO:0006357]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001649; GO:0001829; GO:0002158; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030316; GO:0033687; GO:0035976; GO:0042127; GO:0045597; GO:0045944; GO:0046697; GO:0051726; GO:0060136; GO:0060716; GO:0071277; GO:0090575; GO:0140467; GO:1990837; GO:2000319 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LEDKVKTLK 0.99224 -18.239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5132 0 0 0 0 0 0 0 0 0 0 0 14.8642 0 0 0 0 0 0 13.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22314 UBA1_HUMAN "Ubiquitin-like modifier-activating enzyme 1, EC 6.2.1.45 (Protein A1S9) (Ubiquitin-activating enzyme E1)" UBA1 A1S9T UBE1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0003723; GO:0004839; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006511; GO:0006974; GO:0016567; GO:0032446; GO:0070062 ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839] IIPAIATTTAAVVGLVCLELYK 0.99224 -15.185 0 0 0 0 0 0 0 0 0 0 0 13.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9008 0 0 0 0 0 0 0 0 0 0 0 13.7412 0 0 0 0 0 0 12.7174 0 0 0 0 0 0 0 0 13.0305 12.8913 0 13.5594 0 0 0 0 16.3717 0 0 0 12.4928 0 0 11.7111 0 0 11.8632 0 13.074 0 0 0 0 0 0 12.8803 0 13.0367 0 0 0 0 0 0 0 0 0 10.6079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7471 0 0 13.0516 0 12.0856 0 0 0 0 0 0 0 0 10.8243 0 0 0 0 0 13.0403 0 12.8994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41161 ETV5_HUMAN ETS translocation variant 5 (Ets-related protein ERM) ETV5 ERM Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0034599; GO:0045944; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" CLYNYCAYDR 0.99224 -18.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3831 0 0 0 13.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2648 0 0 0 0 0 0 15.3141 0 0 0 0 12.9373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5956 0 0 0 0 0 0 0 0 13.6193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3669 0 Q02156 KPCE_HUMAN "Protein kinase C epsilon type, EC 2.7.11.13 (nPKC-epsilon)" PRKCE PKCE Homo sapiens (Human) "apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]" cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell-substrate adhesion [GO:0031589]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to prostaglandin E stimulus [GO:0071380]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; locomotory exploration behavior [GO:0035641]; macrophage activation involved in immune response [GO:0002281]; MAPK cascade [GO:0000165]; mucus secretion [GO:0070254]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cellular glucuronidation [GO:2001031]; positive regulation of cytokinesis [GO:0032467]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to morphine [GO:0043278]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]; TRAM-dependent toll-like receptor 4 signaling pathway [GO:0035669]" GO:0000165; GO:0002281; GO:0003785; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007165; GO:0008047; GO:0010634; GO:0010763; GO:0010811; GO:0018105; GO:0019899; GO:0030073; GO:0030546; GO:0030838; GO:0031397; GO:0031589; GO:0031663; GO:0032024; GO:0032230; GO:0032467; GO:0035276; GO:0035556; GO:0035641; GO:0035669; GO:0038096; GO:0043123; GO:0043231; GO:0043278; GO:0043410; GO:0045111; GO:0045202; GO:0046872; GO:0048471; GO:0050730; GO:0050996; GO:0051279; GO:0051301; GO:0051649; GO:0051932; GO:0061178; GO:0070254; GO:0070257; GO:0071361; GO:0071380; GO:0071456; GO:0071889; GO:0071944; GO:0090303; GO:0106310; GO:1903078; GO:2000650; GO:2001031 14-3-3 protein binding [GO:0071889]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; ethanol binding [GO:0035276]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor activator activity [GO:0030546] DRLFFVMEYVNGGDLMFQIQR 0.99224 -4.9513 0 11.4076 10.3868 0 0 0 0 0 0 0 0 0 0 0 0 11.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0669 0 0 0 0 0 0 0 0 0 0 0 0 13.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5062 0 0 0 0 0 0 13.3637 0 0 0 0 0 12.0595 0 0 13.486 12.1678 0 0 15.0148 0 0 13.2949 0 0 0 0 0 13.0961 0 0 12.5918 0 0 13.03 12.5389 15.4552 12.865 14.5038 0 15.4592 14.4361 0 11.0131 16.4164 12.9279 0 0 12.8056 0 0 0 0 0 0 0 0 14.2897 0 0 12.1408 0 0 0 0 13.2473 0 0 0 0 0 0 0 10.576 0 0 0 13.0451 0 0 0 0 0 0 0 Q13625 ASPP2_HUMAN "Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein, Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2, 53BP2, p53-binding protein 2, p53BP2)" TP53BP2 ASPP2 BBP Homo sapiens (Human) cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124]; cell cycle [GO:0007049]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of cell cycle [GO:0045786]; positive regulation of execution phase of apoptosis [GO:1900119]; signal transduction [GO:0007165] GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0017124; GO:0030054; GO:0042802; GO:0045786; GO:0048471; GO:0051059; GO:0072332; GO:1900119 identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; SH3 domain binding [GO:0017124] ECLNKRNSEVAVMDK 0.99224 -25.098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0682 0 0 0 0 0 11.975 0 12.3087 13.1151 0 0 0 0 0 0 0 0 0 11.3826 12.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 12.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5858 0 13.4797 0 0 0 0 0 0 0 12.8835 0 0 0 0 0 0 0 0 0 0 12.2391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0846 0 14.2069 0 0 0 0 0 0 0 13.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6855 0 0 0 0 0 0 0 0 0 Q14157 UBP2L_HUMAN Ubiquitin-associated protein 2-like (Protein NICE-4) UBAP2L KIAA0144 NICE4 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; RNA binding [GO:0003723]; binding of sperm to zona pellucida [GO:0007339]; hematopoietic stem cell homeostasis [GO:0061484]; stress granule assembly [GO:0034063] GO:0003723; GO:0005634; GO:0005737; GO:0007339; GO:0010494; GO:0031519; GO:0034063; GO:0061484 RNA binding [GO:0003723] DRDYSRR 0.99224 -25.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4644 14.7417 15.3511 15.0356 0 0 14.1582 14.259 0 0 0 0 0 0 0 0 0 0 14.777 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0277 0 0 0 0 13.6059 0 0 0 0 0 15.378 13.8769 0 0 0 14.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.52 0 0 12.4959 0 0 0 0 0 0 0 0 12.3493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L5Y6 DET1_HUMAN DET1 homolog (De-etiolated-1 homolog) DET1 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003] GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756 protein-containing complex binding [GO:0044877]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625] FFQYFDQLR 0.99224 -25.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4174 0 0 0 0 0 0 0 0 0 0 10.9238 0 0 11.491 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.968 0 11.1214 12.7693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1772 12.3108 0 0 0 0 0 11.5907 0 0 11.0594 0 0 0 0 13.4512 0 0 0 0 0 0 0 0 0 0 10.2475 0 0 0 0 0 0 0 0 13.1887 0 0 13.5158 0 0 0 10.2881 0 12.7897 0 0 0 13.4898 0 13.2202 0 0 0 0 0 0 0 0 11.7471 0 0 0 12.207 0 0 0 0 0 0 0 0 0 13.6143 0 11.7116 0 0 0 0 0 0 Q7Z3Z2 RD3_HUMAN Protein RD3 (Retinal degeneration protein 3) RD3 C1orf36 Homo sapiens (Human) negative regulation of guanylate cyclase activity [GO:0031283]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; rod photoreceptor outer segment [GO:0120200] cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; rod photoreceptor outer segment [GO:0120200]; negative regulation of guanylate cyclase activity [GO:0031283]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] GO:0001750; GO:0001917; GO:0005634; GO:0005737; GO:0005768; GO:0007601; GO:0015031; GO:0031283; GO:0048471; GO:0050896; GO:0060041; GO:0120199; GO:0120200 EAERQQRER 0.99224 -4.4855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5672 0 0 0 0 0 0 0 0 0 0 0 13.1549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0255 0 0 0 0 0 0 12.3582 0 0 0 0 0 0 0 0 0 0 Q86X52 CHSS1_HUMAN "Chondroitin sulfate synthase 1, EC 2.4.1.175, EC 2.4.1.226 (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1, ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1)" CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923] GO:0000139; GO:0002063; GO:0005576; GO:0008376; GO:0009954; GO:0016020; GO:0016021; GO:0030206; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0051923; GO:0060349 acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] AWLSVLLGLVLGFVLASRLVLPR 0.99224 -4.4903 0 0 12.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9399 0 15.5811 11.7124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5513 13.6126 0 0 0 0 0 0 14.0679 13.8799 13.2428 15.02 0 0 0 0 0 0 15.6801 13.9536 0 13.4453 14.0761 0 0 0 0 13.5077 12.8094 12.9134 0 0 0 13.2782 0 0 0 0 0 0 11.7135 13.3134 14.0967 0 0 0 13.5878 0 0 0 13.83 12.5012 0 0 14.8922 0 0 0 0 0 0 0 14.1899 0 13.5591 0 0 0 12.4288 0 0 0 0 0 0 15.0863 13.8321 13.0023 0 0 0 0 0 0 0 11.7041 0 0 0 0 0 0 0 14.873 0 0 0 0 0 14.2184 0 Q8N239 KLH34_HUMAN Kelch-like protein 34 KLHL34 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 ALFKSHTQESR 0.99224 -18.189 0 0 0 0 0 0 0 0 11.9796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3266 0 0 0 0 12.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5186 0 0 0 0 14.644 0 0 0 0 0 0 0 0 0 0 14.2848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8771 0 11.5877 0 11.9537 0 0 0 0 0 13.1913 0 13.205 14.3001 0 0 0 12.7224 0 0 0 0 0 0 0 0 13.2193 0 0 13.6733 13.1513 0 0 0 13.5965 0 10.4923 0 0 0 11.4205 13.8512 0 10.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1274 0 0 0 0 12.2245 Q8NE09 RGS22_HUMAN "Regulator of G-protein signaling 22, RGS22" RGS22 Homo sapiens (Human) negative regulation of signal transduction [GO:0009968] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; G-protein alpha-subunit binding [GO:0001965]; negative regulation of signal transduction [GO:0009968] GO:0001650; GO:0001965; GO:0005634; GO:0005737; GO:0005829; GO:0009968; GO:0015629 G-protein alpha-subunit binding [GO:0001965] ALLNPVTSRQFQRFVALK 0.99224 -4.4878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5294 9.82402 0 0 0 0 0 0 0 0 0 0 0 13.1316 12.6696 0 0 0 0 0 0 0 0 11.6615 0 10.0752 12.2945 0 0 0 0 0 0 15.3644 13.2022 14.9081 15.1317 0 0 10.9912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3348 0 0 0 0 0 0 12.604 0 10.7689 11.5155 13.2072 0 0 0 0 0 0 13.6938 0 0 0 0 0 0 12.503 0 0 0 0 0 0 0 0 0 0 10.3365 0 0 0 15.9375 0 13.8794 13.1958 0 0 15.7971 16.5101 0 0 0 0 12.8349 0 12.8424 0 13.3849 0 0 12.5486 10.58 15.7472 0 16.0621 0 0 0 0 0 16.1292 0 0 0 16.1499 0 0 0 0 17.3938 0 0 0 0 14.7674 0 0 0 0 0 16.7558 0 0 0 0 0 0 0 11.0274 0 0 0 0 14.3589 0 0 0 0 0 0 Q8NI32 LPD6B_HUMAN Ly6/PLAUR domain-containing protein 6B LYPD6B Homo sapiens (Human) anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acetylcholine receptor regulator activity [GO:0030548] GO:0005576; GO:0005886; GO:0030548; GO:0031225 acetylcholine receptor regulator activity [GO:0030548] CASRSECHFVGCHHSR 0.99224 -4.4822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8715 0 0 0 0 0 11.2509 0 0 0 0 0 11.3127 0 0 0 0 0 12.2543 0 11.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUA2 PPIL4_HUMAN "Peptidyl-prolyl cis-trans isomerase-like 4, PPIase, EC 5.2.1.8 (Cyclophilin-like protein PPIL4) (Rotamase PPIL4)" PPIL4 Homo sapiens (Human) protein peptidyl-prolyl isomerization [GO:0000413]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407] GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005829; GO:1901407 peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723] ACLNFLK 0.99224 -15.188 0 0 0 0 0 0 0 0 0 0 0 13.928 0 0 14.8828 0 0 0 13.381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0636 0 0 0 0 0 0 0 0 16.0449 0 0 0 0 15.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7314 0 0 0 0 0 0 0 0 0 0 0 0 13.3832 0 0 15.0932 0 0 0 16.0335 0 0 14.2037 14.2326 14.0744 0 13.9427 0 0 0 15.1896 0 0 0 0 0 0 15.3634 13.1003 0 0 0 0 18.4892 0 14.0112 14.4444 0 0 0 0 0 0 0 13.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.079 0 0 0 0 0 0 0 0 0 0 0 0 14.7595 15.4835 13.761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RY5 CRML_HUMAN Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein) CRAMP1 C16orf34 CRAMP1L HN1L KIAA1426 Homo sapiens (Human) pattern specification process [GO:0007389] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; pattern specification process [GO:0007389] GO:0003677; GO:0003682; GO:0005634; GO:0007389 chromatin binding [GO:0003682]; DNA binding [GO:0003677] DPPSAVGSGNAGGSGPRGK 0.99224 -15.2 0 0 0 0 0 0 0 0 0 0 15.0859 0 0 0 0 0 14.9425 0 0 0 0 0 0 0 0 0 0 0 0 14.9075 14.9223 0 0 14.8587 0 0 12.2314 0 0 0 0 0 0 0 0 0 0 11.7493 0 0 15.161 0 0 14.8471 0 14.4308 0 0 0 0 0 0 0 13.411 0 0 0 10.2715 0 0 0 0 0 0 0 0 0 0 0 0 12.3211 0 0 0 15.1623 0 0 13.9122 0 12.7964 0 0 0 0 0 0 13.1417 0 0 0 0 0 0 13.7078 0 0 12.7137 0 14.7013 0 0 0 0 0 10.537 0 0 0 0 0 0 0 12.3747 12.7611 0 0 0 0 12.517 0 0 13.791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4917 0 14.5317 0 12.0418 0 0 0 0 0 0 0 0 0 16.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4508 Q9BSW2 EFC4B_HUMAN "EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A, CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46)" CRACR2A EFCAB4B RAB46 Homo sapiens (Human) activation of store-operated calcium channel activity [GO:0032237]; endosomal transport [GO:0016197]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; activation of store-operated calcium channel activity [GO:0032237]; endosomal transport [GO:0016197]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063] GO:0000139; GO:0001772; GO:0002115; GO:0003924; GO:0005509; GO:0005525; GO:0005576; GO:0005737; GO:0005815; GO:0005886; GO:0016020; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0035580; GO:0045063; GO:0046330; GO:0051928 calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] DMQRLHK 0.99224 -25.049 0 0 0 0 0 0 0 10.6133 0 0 0 11.0558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2043 0 0 0 0 0 0 0 0 0 10.1037 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4174 0 0 0 0 0 12.3266 0 0 0 0 0 0 0 0 0 0 0 12.0236 0 0 15.2075 0 0 0 10.8055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3203 0 0 0 0 0 0 10.3161 0 0 0 0 0 0 0 0 0 0 0 10.7659 0 0 0 0 0 0 0 0 13.7402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1804 0 0 0 0 0 0 0 13.2772 0 0 12.5285 13.4186 0 15.4052 Q9BV94 EDEM2_HUMAN ER degradation-enhancing alpha-mannosidase-like protein 2 EDEM2 C20orf31 C20orf49 UNQ573/PRO1135 Homo sapiens (Human) "carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]; viral protein processing [GO:0019082]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of first mannose on A branch [GO:0036511]; trimming of second mannose on A branch [GO:0036512]; trimming of terminal mannose on B branch [GO:0036509]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466]; viral protein processing [GO:0019082]" GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006986; GO:0016020; GO:0019082; GO:0036509; GO:0036510; GO:0036511; GO:0036512; GO:0044322; GO:0097466; GO:1904154; GO:1904380; GO:1904382 "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" AIRNYTRFDDWYLWVQMYK 0.99224 -4.4809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6835 0 13.5548 0 0 0 11.6816 12.112 0 0 0 0 0 0 0 0 0 0 0 0 12.8162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9944 13.8552 0 0 0 0 0 0 0 0 0 0 13.9008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZZ6 ACH10_HUMAN "Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10, NACHR alpha-10)" CHRNA10 NACHRA10 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; axon [GO:0030424]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; axon [GO:0030424]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" GO:0004888; GO:0005102; GO:0005231; GO:0005262; GO:0005887; GO:0005892; GO:0007165; GO:0007204; GO:0007268; GO:0007271; GO:0010996; GO:0016020; GO:0022848; GO:0030424; GO:0030594; GO:0034220; GO:0042127; GO:0042391; GO:0042472; GO:0043005; GO:0043204; GO:0045202; GO:0050877; GO:0050910; GO:0051899; GO:0070161; GO:0070373; GO:0098981; GO:0099060; GO:1904315 acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GLRSHHLSLGLLLLFLLPAECLGAEGRLALK 0.99224 -4.4836 0 0 0 0 0 0 0 0 11.387 0 0 12.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7578 0 0 0 0 0 0 0 0 0 0 0 0 11.1302 0 0 0 0 14.0264 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2715 0 12.2541 0 0 0 0 0 0 0 11.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6161 0 0 0 0 0 0 0 0 0 0 12.3223 0 0 0 0 12.6161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD90 NDF4_HUMAN "Neurogenic differentiation factor 4, NeuroD4 (Class A basic helix-loop-helix protein 4, bHLHa4) (Protein atonal homolog 3, ATH-3, Atoh3)" NEUROD4 ATH3 ATOH3 BHLHA4 Homo sapiens (Human) amacrine cell differentiation [GO:0035881]; cell fate commitment [GO:0045165]; motor neuron migration [GO:0097475]; neuroblast proliferation [GO:0007405]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell differentiation [GO:0045597]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; amacrine cell differentiation [GO:0035881]; cell fate commitment [GO:0045165]; motor neuron migration [GO:0097475]; neuroblast proliferation [GO:0007405]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; Notch signaling pathway [GO:0007219]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell differentiation [GO:0045597]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007219; GO:0007405; GO:0030182; GO:0035881; GO:0045165; GO:0045597; GO:0046983; GO:0048666; GO:0048709; GO:0097475 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IETLRLAR 0.99224 -6.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UI36 DACH1_HUMAN "Dachshund homolog 1, Dach1" DACH1 DACH Homo sapiens (Human) "development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342]" GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" HLVGGLHTVYTKLKR 0.99224 -7.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8188 0 0 0 0 0 0 0 0 0 0 13.132 0 0 0 0 0 0 0 11.7154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1407 0 0 11.737 12.9396 13.0862 0 0 0 0 14.4674 0 0 0 12.6218 0 11.7967 0 0 0 0 12.5571 11.9377 0 0 0 0 0 0 12.1268 0 0 12.5858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7317 0 0 Q9Y5T4 DJC15_HUMAN "DnaJ homolog subfamily C member 15 (Cell growth-inhibiting gene 22 protein) (Methylation-controlled J protein, MCJ)" DNAJC15 DNAJD1 GIG22 HSD18 Homo sapiens (Human) "cellular response to starvation [GO:0009267]; intracellular protein transport [GO:0006886]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import into mitochondrial matrix [GO:0030150]; protein-containing complex assembly [GO:0065003]; regulation of lipid metabolic process [GO:0019216]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATPase activator activity [GO:0001671]; cellular response to starvation [GO:0009267]; intracellular protein transport [GO:0006886]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import into mitochondrial matrix [GO:0030150]; protein-containing complex assembly [GO:0065003]; regulation of lipid metabolic process [GO:0019216]" GO:0001405; GO:0001671; GO:0005743; GO:0005744; GO:0006120; GO:0006886; GO:0009267; GO:0016021; GO:0019216; GO:0030150; GO:0031333; GO:0065003; GO:1902957 ATPase activator activity [GO:0001671] AKIRTAHR 0.99224 -6.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4625 0 0 0 0 0 0 0 0 0 0 0 0 13.9171 0 0 0 0 0 0 0 14.5049 14.3513 0 0 0 0 0 0 0 0 14.2932 0 12.7432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1W2PR19 GSTT4_HUMAN "Glutathione S-transferase theta-4, EC 2.5.1.18 (GST class-theta-4) (Glutathione S-transferase theta pseudogene 1)" GSTT4 GSTTP1 Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749] GO:0004364; GO:0005737; GO:0005829; GO:0006749 glutathione transferase activity [GO:0004364] ENISELLKK 0.99225 -4.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3543 0 0 0 0 0 0 0 11.7083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8871 13.3475 0 0 0 0 0 0 12.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 O00444 PLK4_HUMAN "Serine/threonine-protein kinase PLK4, EC 2.7.11.21 (Polo-like kinase 4, PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak)" PLK4 SAK STK18 Homo sapiens (Human) centriole replication [GO:0007099]; cilium assembly [GO:0060271]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; trophoblast giant cell differentiation [GO:0060707] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; spindle pole [GO:0000922]; XY body [GO:0001741] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleolus [GO:0005730]; nucleus [GO:0005634]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; spindle pole [GO:0000922]; XY body [GO:0001741]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; mitotic cell cycle [GO:0000278]; positive regulation of centriole replication [GO:0046601]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; trophoblast giant cell differentiation [GO:0060707] GO:0000278; GO:0000922; GO:0001741; GO:0004674; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0007099; GO:0032154; GO:0032465; GO:0042802; GO:0046601; GO:0060271; GO:0060707; GO:0098535; GO:0098536; GO:0106310; GO:0120098; GO:0120099 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DFQGHPDLQK 0.99225 -24.46 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6216 14.4662 0 0 0 15.1596 14.992 0 0 0 13.1995 11.9532 13.6804 14.6231 0 0 0 0 0 0 0 13.4014 0 0 0 0 14.9876 14.7901 15.0895 14.0716 0 0 12.8258 11.4858 12.0236 0 0 0 12.9694 0 12.1968 0 0 0 0 0 0 12.5211 0 16.4356 0 0 16.0981 0 0 0 0 0 0 0 0 13.3194 13.2377 13.477 0 14.5442 0 0 16.1931 0 0 14.8701 0 0 0 0 0 10.6255 0 13.6827 11.0062 0 12.1878 0 0 0 0 0 13.1969 0 0 0 13.4634 0 0 0 0 0 10.8409 0 0 0 0 0 0 14.2699 0 0 0 14.245 0 0 0 O95551 TYDP2_HUMAN "Tyrosyl-DNA phosphodiesterase 2, Tyr-DNA phosphodiesterase 2, hTDP2, EC 3.1.4.- (5'-tyrosyl-DNA phosphodiesterase, 5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II, EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase)" TDP2 EAP2 TTRAP AD-022 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666] aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; 5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317]; cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666] GO:0000287; GO:0003697; GO:0003714; GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0007166; GO:0016235; GO:0016604; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260 5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317] FDRIFFR 0.99225 -4.497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55285 CADH6_HUMAN "Cadherin-6 (Kidney cadherin, K-cadherin)" CDH6 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219] GO:0000902; GO:0005509; GO:0005654; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007156; GO:0007219; GO:0016021; GO:0016339; GO:0016342; GO:0030054; GO:0034332; GO:0045296; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] FLYLGPFK 0.99225 -18.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3087 0 0 0 0 0 17.7271 0 0 14.6223 0 0 0 0 0 0 11.66 15.5313 0 0 17.938 13.7913 0 0 15.3942 0 16.0315 11.3402 0 15.148 0 15.192 0 0 12.0358 0 0 0 15.3724 0 0 0 0 0 18.0316 0 11.694 0 11.7232 0 0 12.4512 0 0 0 0 0 0 0 0 11.6676 0 0 0 15.0007 17.9748 0 0 0 0 0 0 12.6488 0 13.7193 0 0 14.1941 0 12.2362 0 14.0025 14.0244 0 14.0613 0 0 0 0 0 17.9701 0 0 0 0 0 0 0 0 0 0 13.8738 0 0 11.5836 0 0 0 0 0 0 13.2028 0 0 0 11.8972 0 0 0 0 P56199 ITA1_HUMAN Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a) ITGA1 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; vasodilation [GO:0042311] acrosomal vesicle [GO:0001669]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha1-beta1 complex [GO:0034665]; integrin complex [GO:0008305]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha1-beta1 complex [GO:0034665]; integrin complex [GO:0008305]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein phosphatase binding [GO:0019903]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; vasodilation [GO:0042311] GO:0001669; GO:0005178; GO:0005518; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008285; GO:0008305; GO:0009897; GO:0009986; GO:0016020; GO:0019903; GO:0030593; GO:0032516; GO:0033627; GO:0034665; GO:0042059; GO:0042311; GO:0043005; GO:0043204; GO:0043410; GO:0043525; GO:0045121; GO:0045123; GO:0045178; GO:0046872; GO:0048812; GO:0070062; GO:0098609; GO:0098639 collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein phosphatase binding [GO:0019903] ASQIIIPRNTTFNVESTKK 0.99225 -24.384 0 0 0 0 0 0 0 0 14.7261 14.4227 0 14.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6822 13.0696 0 0 0 0 0 12.6539 0 0 12.3491 13.8292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9986 0 0 0 0 11.33 0 0 12.551 0 12.2164 0 13.3372 0 11.5077 0 0 0 0 0 0 0 0 13.3848 0 0 0 0 0 0 10.4506 13.0222 0 0 0 0 0 0 0 0 12.4127 0 0 0 0 0 0 0 12.544 0 0 13.1317 0 0 0 0 0 0 0 12.5365 0 0 0 0 0 0 12.1719 10.9994 13.353 0 0 0 13.141 14.9641 12.8504 0 0 0 0 0 0 0 12.0172 0 0 0 13.1363 0 0 14.7994 0 12.6173 13.7054 0 0 0 0 13.4861 0 12.0316 0 0 0 0 0 11.9762 Q08945 SSRP1_HUMAN "FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit, FACT 80 kDa subunit, FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1, hSSRP1) (T160)" SSRP1 FACT80 Homo sapiens (Human) DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of chromatin organization [GO:1902275] FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of chromatin organization [GO:1902275] GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0006334; GO:0006337; GO:0031491; GO:0035101; GO:0042393; GO:1902275 DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723] AKMAKDR 0.99225 -18.32 11.9954 0 0 0 0 0 0 0 0 0 13.6776 0 0 0 0 0 0 0 12.6753 0 0 0 0 0 0 0 0 0 12.3217 0 0 11.4461 0 0 0 12.3622 0 0 0 0 0 0 0 0 0 0 13.2497 0 13.8406 0 13.6436 12.5411 0 0 0 0 12.5966 11.8324 11.9875 0 12.0796 0 11.714 11.952 0 11.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5298 11.9718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2982 13.448 0 0 0 11.6104 0 0 0 0 0 0 0 0 0 13.1593 0 0 0 0 0 0 12.4082 0 11.8871 0 0 0 0 0 13.0919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2493 13.9915 0 12.4412 0 0 16.8849 0 12.9877 0 0 0 0 0 0 0 16.9326 0 0 0 0 0 12.4887 0 0 12.4982 0 0 0 0 0 0 12.7783 0 12.8525 0 0 Q13868 EXOS2_HUMAN Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) EXOSC2 RRP4 Homo sapiens (Human) "CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0008312; GO:0030307; GO:0034427; GO:0034475; GO:0043928; GO:0071034; GO:0071035; GO:0071038; GO:0071051; GO:0101019 3'-5'-exoribonuclease activity [GO:0000175]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723] SAEDELAMR 0.99225 -7.7079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8762 0 12.4962 12.5354 13.0065 0 0 0 0 0 0 0 0 0 0 13.8174 0 0 0 0 0 0 0 11.8723 0 0 0 0 0 12.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9406 0 13.8176 0 0 0 12.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3B7J2 GFOD2_HUMAN "Glucose-fructose oxidoreductase domain-containing protein 2, EC 1.-.-.-" GFOD2 UNQ9430/PRO34691 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491]; extracellular matrix organization [GO:0030198] GO:0000166; GO:0005576; GO:0016491; GO:0030198; GO:0031012 nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491] AATSVDAFRMVTASR 0.99225 -6.7435 0 0 0 0 0 0 0 0 0 10.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3132 12.1538 0 0 0 0 14.7356 0 0 0 0 0 0 0 0 13.2384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1913 0 12.7039 12.9416 0 0 10.1221 0 0 0 0 0 13.2592 13.3625 0 0 0 0 0 0 10.6798 13.3446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4207 0 0 0 0 0 0 0 11.2007 12.8626 0 0 0 0 0 0 Q52LJ0 FA98B_HUMAN Protein FAM98B FAM98B Homo sapiens (Human) "positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein methylation [GO:0006479]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein methylation [GO:0006479]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006388; GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0042802; GO:0043231; GO:0072669 identical protein binding [GO:0042802]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723] EDLSKIIR 0.99225 -6.7547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6051 0 0 0 0 0 0 17.8735 0 0 0 0 0 0 13.9985 0 0 0 0 0 0 0 13.5485 0 14.3699 0 0 12.8291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PEV8 F199X_HUMAN Protein FAM199X FAM199X CXorf39 Homo sapiens (Human) KERLSGLFLNEEVLSLK 0.99225 -6.0564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8ND24 RN214_HUMAN RING finger protein 214 RNF214 Homo sapiens (Human) metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] AEILSLESRKELLVLK 0.99225 -4.5041 0 0 0 0 0 0 0 0 0 0 12.3696 13.6434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2621 0 0 0 0 0 0 0 0 0 17.1927 0 0 0 0 15.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5222 0 12.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7699 0 0 0 0 0 0 0 Q8WXD0 RXFP2_HUMAN Relaxin receptor 2 (G-protein coupled receptor 106) (G-protein coupled receptor affecting testicular descent) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2) RXFP2 GPR106 GREAT LGR8 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584] GO:0005886; GO:0005887; GO:0007189; GO:0007190; GO:0008528; GO:0008584; GO:0009755; GO:0016500 G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500] DDCGNGADEENCGDTSGWATIFGTVHGNANSVALTQECFLK 0.99225 -4.4984 0 0 0 0 0 0 0 0 0 0 14.116 0 0 0 0 0 0 0 14.7472 14.7836 0 0 0 0 14.3573 0 0 0 0 13.4037 0 0 0 0 0 0 0 0 0 0 0 0 13.2446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3369 0 0 0 0 0 0 0 0 14.9255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8677 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3275 0 0 0 0 0 0 0 0 0 11.2083 0 0 0 0 0 10.3753 13.9728 13.9088 0 0 0 0 12.0578 0 0 0 0 0 11.9437 0 0 0 0 13.9765 0 0 0 0 0 10.7469 0 0 0 0 0 0 0 0 0 0 10.8999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1011 0 0 0 Q8WXD5 GEMI6_HUMAN "Gem-associated protein 6, Gemin-6 (SIP2)" GEMIN6 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" GO:0000245; GO:0000387; GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504 MSEWMKKGPLEWQDYIYK 0.99225 -4.4919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9105 0 0 0 0 0 0 Q92558 WASF1_HUMAN "Actin-binding protein WASF1 (Protein WAVE-1) (Verprolin homology domain-containing protein 1) (Wiskott-Aldrich syndrome protein family member 1, WASP family protein member 1)" WASF1 KIAA0269 SCAR1 WAVE1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; dendritic transport of mitochondrion [GO:0098939]; lamellipodium morphogenesis [GO:0072673]; mitochondrion morphogenesis [GO:0070584]; modification of postsynaptic actin cytoskeleton [GO:0098885]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; SCAR complex [GO:0031209] actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitochondrial outer membrane [GO:0005741]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; SCAR complex [GO:0031209]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; dendritic transport of mitochondrion [GO:0098939]; lamellipodium morphogenesis [GO:0072673]; mitochondrion morphogenesis [GO:0070584]; modification of postsynaptic actin cytoskeleton [GO:0098885]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898] GO:0003779; GO:0005741; GO:0005829; GO:0005856; GO:0005925; GO:0006898; GO:0015629; GO:0016601; GO:0030027; GO:0030036; GO:0030041; GO:0031209; GO:0032839; GO:0032991; GO:0034237; GO:0051018; GO:0051388; GO:0065003; GO:0070584; GO:0071933; GO:0072673; GO:0097484; GO:0098794; GO:0098885; GO:0098939; GO:1990416; GO:2000601 actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237] APHDRRR 0.99225 -6.7538 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4819 13.6503 14.3974 0 0 0 0 0 0 0 0 11.6728 0 0 12.9649 0 12.7602 0 11.836 9.42811 0 0 0 0 15.3994 0 0 14.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0697 0 0 0 0 0 0 0 14.2526 0 Q96BD8 SKA1_HUMAN Spindle and kinetochore-associated protein 1 SKA1 C18orf24 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0000278; GO:0000776; GO:0000940; GO:0005829; GO:0005876; GO:0007059; GO:0008017; GO:0015630; GO:0031110; GO:0034451; GO:0045171; GO:0051301; GO:0072686 microtubule binding [GO:0008017] AVISKYKILHQPK 0.99225 -6.7421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6414 14.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2211 13.5345 0 0 0 0 0 13.3127 0 0 0 16.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78527 PRKDC_HUMAN "DNA-dependent protein kinase catalytic subunit, DNA-PK catalytic subunit, DNA-PKcs, EC 2.7.11.1 (DNPK1) (p460)" PRKDC HYRC HYRC1 Homo sapiens (Human) activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immature B cell differentiation [GO:0002327]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maturation of 5.8S rRNA [GO:0000460]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of platelet formation [GO:1905221]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of smooth muscle cell proliferation [GO:0048660]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; small-subunit processome assembly [GO:0034462]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723] "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; small-subunit processome [GO:0032040]; transcription regulator complex [GO:0005667]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; small-subunit processome [GO:0032040]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; U3 snoRNA binding [GO:0034511]; activation of innate immune response [GO:0002218]; B cell lineage commitment [GO:0002326]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; ectopic germ cell programmed cell death [GO:0035234]; heart development [GO:0007507]; immature B cell differentiation [GO:0002327]; immunoglobulin V(D)J recombination [GO:0033152]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; maturation of 5.8S rRNA [GO:0000460]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of platelet formation [GO:1905221]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; pro-B cell differentiation [GO:0002328]; protein destabilization [GO:0031648]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of epithelial cell proliferation [GO:0050678]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of smooth muscle cell proliferation [GO:0048660]; response to gamma radiation [GO:0010332]; rhythmic process [GO:0048511]; small-subunit processome assembly [GO:0034462]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell receptor V(D)J recombination [GO:0033153]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]" GO:0000460; GO:0000723; GO:0000781; GO:0001756; GO:0001933; GO:0002218; GO:0002326; GO:0002327; GO:0002328; GO:0002360; GO:0003690; GO:0003723; GO:0004672; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0005958; GO:0006302; GO:0006303; GO:0006468; GO:0006974; GO:0007420; GO:0007507; GO:0008630; GO:0010332; GO:0016020; GO:0016233; GO:0018105; GO:0018107; GO:0019899; GO:0019904; GO:0031571; GO:0031648; GO:0032040; GO:0032869; GO:0032991; GO:0032993; GO:0033077; GO:0033152; GO:0033153; GO:0034462; GO:0034511; GO:0035234; GO:0036211; GO:0042752; GO:0043065; GO:0043066; GO:0045087; GO:0045621; GO:0045648; GO:0045727; GO:0045944; GO:0048511; GO:0048660; GO:0050678; GO:0061629; GO:0070418; GO:0070419; GO:0097681; GO:0106310; GO:1902036; GO:1905221; GO:2001034 ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; U3 snoRNA binding [GO:0034511] AILELHYSQELSLLYLLQDDVDR 0.99226 -47.115 0 0 10.3674 0 0 0 0 0 15.4222 0 13.6086 0 13.958 0 13.4151 0 11.5016 0 15.6045 0 0 0 0 0 11.7767 0 0 0 14.6473 14.8915 0 15.3456 0 11.5693 15.2716 0 14.5204 15.1334 14.9684 14.4974 0 0 13.7497 0 0 0 12.7519 0 0 0 0 0 0 0 11.5348 0 0 0 0 0 0 0 10.4326 0 0 0 12.638 16.1243 11.577 15.321 0 0 0 10.2473 0 0 18.4529 15.1998 14.3483 0 0 0 14.3728 12.7373 19.0419 12.9105 0 13.5575 13.772 0 12.0788 0 14.8554 14.6079 0 12.4872 15.1028 18.1159 0 12.8928 14.0248 15.8953 15.5701 12.5891 0 0 17.0458 17.0505 0 11.7536 0 17.0684 0 0 11.6389 8.87869 0 0 0 0 13.0733 13.5687 0 0 13.5094 15.4924 13.4265 0 0 0 14.5826 12.4706 11.203 14.8981 0 14.0594 0 13.8942 0 14.2618 0 11.6523 0 0 0 0 16.4361 15.2356 14.6695 15.1991 13.568 12.7516 0 13.7401 0 0 0 15.055 14.5553 13.8562 16.6573 14.1644 15.0451 14.6489 14.6684 0 12.6305 0 10.2879 13.7781 13.9333 0 0 0 0 0 13.898 15.4287 0 18.2494 O43150 ASAP2_HUMAN "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3, PAG3) (Pyk2 C-terminus-associated protein, PAP)" ASAP2 DDEF2 KIAA0400 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547] Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886] Golgi cisterna membrane [GO:0032580]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of GTPase activity [GO:0043547] GO:0005096; GO:0005886; GO:0032580; GO:0043547; GO:0046872 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] EIISEVQR 0.99226 -24.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5043 0 0 0 0 0 0 11.3343 12.5586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0231 0 0 0 0 13.3912 0 0 14.3952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6688 0 0 0 0 0 0 0 0 0 0 13.896 13.1856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.801 0 0 0 15.7555 0 0 0 14.195 15.387 15.7864 0 15.7007 0 0 15.2478 13.992 0 0 13.9814 0 0 0 14.1994 0 0 0 0 0 14.7619 14.1882 0 0 0 0 0 11.8228 0 0 15.9241 0 0 0 0 0 0 0 0 0 0 0 12.9257 13.8236 12.0529 12.6396 0 13.8002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0183 13.6044 0 0 15.6109 13.5103 15.1329 0 O14647 CHD2_HUMAN "Chromodomain-helicase-DNA-binding protein 2, CHD-2, EC 3.6.4.12 (ATP-dependent helicase CHD2)" CHD2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000785; GO:0000978; GO:0003677; GO:0003678; GO:0003682; GO:0003723; GO:0005524; GO:0005634; GO:0006338; GO:0006357; GO:0006974; GO:0007517; GO:0010467; GO:0016887; GO:0034728; GO:0042393; GO:0060218; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ARRPVPR 0.99226 -84.91 0 0 0 0 0 0 0 0 0 15.0298 0 11.3304 14.5747 0 0 17.8312 0 0 13.6994 0 0 0 0 0 0 9.42662 0 0 0 0 0 16.3399 16.6128 0 0 0 0 0 0 16.1978 0 0 16.5601 16.5804 0 0 17.1953 17.1535 0 0 14.5836 0 0 0 0 17.0199 18.19 0 15.3318 17.3485 17.3136 17.0444 15.9388 16.3509 15.1499 0 11.0347 0 0 0 12.0683 0 0 0 0 14.5942 0 0 14.515 14.8697 0 16.0103 10.1182 0 0 0 0 13.3508 0 0 13.9132 15.2718 0 13.9333 13.6849 0 0 0 0 0 0 14.5534 11.5077 0 15.247 0 0 0 13.0093 0 14.272 0 0 13.6461 0 14.6398 13.3556 0 12.32 0 13.4919 14.0664 13.4432 0 0 0 0 0 0 0 0 0 0 0 13.2211 0 0 14.9451 0 13.6526 13.4186 0 0 12.3817 0 14.2774 0 15.2657 0 0 15.9173 0 13.9889 0 0 0 19.6789 19.3904 18.8108 0 18.4606 17.1667 12.2245 13.7183 0 12.0849 0 14.8456 17.9448 17.7195 17.5764 13.237 13.1833 0 14.3382 14.2892 0 14.226 0 0 O95661 DIRA3_HUMAN GTP-binding protein Di-Ras3 (Distinct subgroup of the Ras family member 3) (Rho-related GTP-binding protein RhoI) DIRAS3 ARHI NOEY2 RHOI Homo sapiens (Human) regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of gene expression by genomic imprinting [GO:0006349]; small GTPase mediated signal transduction [GO:0007264] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of gene expression by genomic imprinting [GO:0006349]; small GTPase mediated signal transduction [GO:0007264] GO:0000079; GO:0003924; GO:0005525; GO:0005886; GO:0006349; GO:0007264; GO:0019003 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] AFKPHRK 0.99226 -7.2201 0 0 0 0 12.8943 0 0 0 0 0 15.3204 14.1601 0 0 0 0 13.7538 13.5001 13.4144 0 0 0 0 13.8413 0 12.0315 11.8968 15.6887 13.4027 0 0 0 0 0 13.9637 0 0 0 0 0 14.2278 0 0 14.7717 0 15.3285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44228 0 0 15.4028 15.8817 15.1348 13.4752 12.264 0 14.8034 13.3129 0 0 0 0 14.3048 0 0 0 13.804 13.5013 14.435 0 0 0 11.3599 0 15.2094 0 14.6835 14.3157 15.3809 0 0 12.1867 15.4289 14.9814 14.6269 15.5286 10.6742 16.0457 14.5319 14.2288 13.8965 0 15.6202 0 14.4717 14.1633 13.8251 14.2492 13.9853 0 14.3183 14.1734 0 0 0 0 15.3462 16.0029 16.3708 13.976 13.595 12.1283 14.8811 0 14.6748 15.3637 0 14.5858 14.0998 11.8509 10.6059 0 13.7555 13.5344 0 0 0 0 0 0 0 14.286 10.7864 0 14.11 10.8417 11.6229 13.7507 0 0 0 0 0 14.4053 0 0 14.5554 13.2395 14.9945 14.6433 15.0793 12.1502 0 11.6968 13.2651 15.4791 P08123 CO1A2_HUMAN Collagen alpha-2(I) chain (Alpha-2 type I collagen) COL1A2 Homo sapiens (Human) blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; odontogenesis [GO:0042476]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type I trimer [GO:0005584]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; blood vessel development [GO:0001568]; bone mineralization [GO:0030282]; cellular response to amino acid stimulus [GO:0071230]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; extracellular matrix assembly [GO:0085029]; extracellular matrix organization [GO:0030198]; odontogenesis [GO:0042476]; protein heterotrimerization [GO:0070208]; regulation of blood pressure [GO:0008217]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001501; GO:0001568; GO:0002020; GO:0005201; GO:0005576; GO:0005584; GO:0005615; GO:0005783; GO:0005788; GO:0007179; GO:0007266; GO:0008217; GO:0030020; GO:0030198; GO:0030199; GO:0030282; GO:0030674; GO:0031012; GO:0032963; GO:0042476; GO:0042802; GO:0043589; GO:0046332; GO:0046872; GO:0048407; GO:0062023; GO:0070062; GO:0070208; GO:0071230; GO:0085029 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; platelet-derived growth factor binding [GO:0048407]; protease binding [GO:0002020]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332] GPAGPPGK 0.99226 -7.2251 12.1693 19.5295 13.7982 12.3371 19.6549 0 14.2538 14.1123 0 0 0 14.8138 0 0 12.2751 0 0 0 0 0 12.1563 13.0969 13.2093 14.6725 12.4821 11.8101 12.4965 12.2751 0 0 0 0 0 0 0 0 0 11.8512 0 0 0 0 11.8792 0 14.0267 0 0 12.0543 15.282 13.7806 0 13.022 0 11.99 0 0 0 0 0 0 0 11.0209 0 0 0 0 20.9341 13.6743 20.9589 13.9983 0 13.8157 0 0 17.4106 16.9662 17.1344 15.5203 14.9832 14.136 14.0464 14.0193 13.6059 15.6581 0 15.6741 0 0 16.0303 15.841 14.0795 14.0936 14.9092 16.0878 0 13.8624 14.7777 15.5406 14.2857 13.8893 15.8666 15.7226 0 14.0359 15.754 17.0272 16.6038 15.6972 16.2612 16.0905 16.2169 0 14.9053 15.3686 15.6096 14.7651 15.432 13.8786 15.8017 14.8986 16.5403 15.7254 20.399 14.6637 15.3952 14.617 14.7386 14.5658 20.3386 14.5202 15.6116 20.3892 20.4028 13.6083 14.9938 0 14.7026 13.4186 15.8085 19.907 14.6505 15.8332 15.8979 15.3138 13.3308 15.2436 15.5214 0 0 0 16.189 15.7001 13.8051 15.5521 16.462 13.9963 0 15.0655 14.9452 0 0 15.0468 0 0 15.4231 15.4236 0 15.3868 0 0 13.8895 15.4806 0 15.2375 15.8149 0 0 15.4269 14.2998 0 P28838 AMPL_HUMAN "Cytosol aminopeptidase, EC 3.4.11.1 (Cysteinylglycine-S-conjugate dipeptidase, EC 3.4.13.23) (Leucine aminopeptidase 3, LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase, EC 3.4.11.5) (Prolyl aminopeptidase)" LAP3 LAPEP PEPS Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; proteolysis [GO:0006508] GO:0004177; GO:0004180; GO:0005634; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005925; GO:0006508; GO:0008233; GO:0008235; GO:0030145; GO:0030496; GO:0070006; GO:0070062 aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233] FLLPLPAAGRVVVRR 0.99226 -14.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6125 0 0 0 0 0 0 0 0 0 0 14.5723 0 0 0 0 0 14.6414 0 0 0 0 0 14.1905 0 0 0 0 0 0 0 0 12.5486 0 0 0 0 14.7705 14.0483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0098 0 0 0 0 0 0 0 0 0 0 14.0644 0 0 0 0 0 0 0 0 15.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7701 0 0 0 14.1436 0 0 0 0 0 0 0 0 18.1035 0 0 0 0 0 0 0 15.5913 0 0 0 0 0 0 0 13.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9737 0 0 0 0 14.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40925 MDHC_HUMAN "Malate dehydrogenase, cytoplasmic, EC 1.1.1.37 (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase, EC 1.1.1.96)" MDH1 MDHA Homo sapiens (Human) malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; diiodophenylpyruvate reductase activity [GO:0047860]; L-malate dehydrogenase activity [GO:0030060]; malic enzyme activity [GO:0004470]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099] GO:0004470; GO:0005615; GO:0005737; GO:0005813; GO:0005829; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0006739; GO:0030060; GO:0047860; GO:0070062 diiodophenylpyruvate reductase activity [GO:0047860]; L-malate dehydrogenase activity [GO:0030060]; malic enzyme activity [GO:0004470] AKAQIALKLGVTANDVK 0.99226 -25.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4119 0 0 0 0 0 14.466 0 0 0 0 0 0 0 0 0 12.8321 0 0 0 0 0 0 0 0 0 0 0 12.585 0 0 0 0 0 0 0 0 0 0 0 12.833 0 0 0 0 0 0 0 0 0 0 14.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2411 0 P98174 FGD1_HUMAN "FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1, Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3)" FGD1 FGDY ZFYVE3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; animal organ morphogenesis [GO:0009887]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; animal organ morphogenesis [GO:0009887]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0007165; GO:0008360; GO:0009887; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] AQRSLPLIGFEVGPPEAGER 0.99226 -24.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7097 0 0 11.0305 0 0 0 0 0 0 0 0 0 11.6813 12.0594 0 0 0 11.9671 0 0 10.7781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1849 0 0 0 0 0 0 0 12.9367 11.783 0 0 0 0 0 14.4316 14.1568 0 0 0 0 0 13.3927 0 14.0623 13.9039 0 0 0 0 0 14.1217 0 0 0 12.7603 0 13.3235 0 15.629 0 0 12.8774 0 13.941 0 15.7768 12.8171 14.8751 0 0 0 0 14.2994 13.4168 12.3641 0 0 0 12.926 14.3894 0 0 11.8337 0 0 0 15.2431 14.2964 14.5854 0 14.9979 14.9135 14.9098 0 0 0 12.4653 0 0 0 0 0 12.7541 0 14.3742 0 12.4619 0 12.2419 0 0 12.4391 11.6959 0 10.8052 0 0 0 15.7064 12.2405 15.1874 13.1283 0 0 0 0 12.2736 0 0 Q13618 CUL3_HUMAN "Cullin-3, CUL-3" CUL3 KIAA0617 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922] centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell projection organization [GO:0030030]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway [GO:0097193]; liver morphogenesis [GO:0072576]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] GO:0000082; GO:0000122; GO:0000209; GO:0000922; GO:0001831; GO:0005112; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005829; GO:0005886; GO:0006511; GO:0006513; GO:0006888; GO:0006954; GO:0007080; GO:0007229; GO:0007369; GO:0008284; GO:0010467; GO:0016020; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031461; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070062; GO:0070936; GO:0071630; GO:0072576; GO:0072686; GO:0097193; GO:1901992 cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] ARFLPSPVVIKK 0.99226 -7.2218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1753 0 15.2651 0 0 0 0 0 14.9084 0 0 14.7323 11.745 11.3512 14.8434 15.0691 15.0459 14.4489 11.3697 0 0 0 0 0 0 14.6975 0 0 10.9456 0 0 0 14.4728 0 13.2766 0 0 13.7497 0 15.2713 0 0 0 0 0 0 0 14.0519 0 0 13.4625 0 0 0 13.8067 0 0 0 0 0 0 0 13.6014 0 0 13.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5439 0 0 0 0 0 13.3036 0 13.1607 0 0 0 0 0 0 Q15437 SC23B_HUMAN "Protein transport protein Sec23B, hSec23B (SEC23-related protein B)" SEC23B Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886] GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012505; GO:0030127; GO:0048471; GO:0070971; GO:0090110 GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270] ATYLEFIQQNEERDGVRFSWNVWPSSR 0.99226 -7.4213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9923 0 0 0 0 0 0 0 0 0 0 0 14.9237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5683 0 0 0 0 0 0 11.6856 Q5TCY1 TTBK1_HUMAN "Tau-tubulin kinase 1, EC 2.7.11.1 (Brain-derived tau kinase)" TTBK1 BDTK KIAA1855 Homo sapiens (Human) learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762] GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0006468; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032091; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0061890; GO:0106310; GO:1903980; GO:1904031; GO:2001056 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] AQAGARPPAPRSPR 0.99226 -25.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8033 0 10.6785 0 0 0 0 0 0 10.9814 0 0 0 0 0 0 0 0 14.0398 13.5893 0 0 0 0 0 0 0 0 0 0 0 0 18.3828 0 14.0325 0 0 0 14.265 0 0 13.8629 0 0 0 0 13.6468 13.4569 0 0 0 13.3006 13.1791 13.5328 0 0 13.4982 0 0 0 13.3741 0 0 0 11.4623 0 14.521 13.5442 12.9466 0 14.4538 0 0 0 0 13.3763 0 13.277 0 0 0 0 0 13.7027 13.3911 0 0 13.6868 0 0 0 13.335 13.1146 0 13.0147 0 13.1516 0 13.3439 0 0 0 0 0 13.0104 12.4286 13.2626 12.7895 0 0 0 0 14.0367 0 0 0 0 0 0 12.8491 0 0 0 0 13.572 0 12.8176 0 14.4912 0 13.6741 0 Q8IUS5 EPHX4_HUMAN "Epoxide hydrolase 4, EC 3.3.-.- (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein)" EPHX4 ABHD7 EH4 EPHXRP Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787] GO:0016021; GO:0016787 hydrolase activity [GO:0016787] GPAQTFRR 0.99226 -7.2162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8838 0 0 0 0 0 0 0 0 0 0 0 0 13.9246 0 0 0 0 0 0 13.5016 12.2507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2989 0 0 0 0 0 0 0 0 0 0 0 0 16.8115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QZ7 MAGI1_HUMAN "Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (Atrophin-1-interacting protein 3, AIP-3) (BAI1-associated protein 1, BAP-1) (Membrane-associated guanylate kinase inverted 1, MAGI-1) (Trinucleotide repeat-containing gene 19 protein) (WW domain-containing protein 3, WWP3)" MAGI1 AIP3 BAIAP1 BAP1 TNRC19 Homo sapiens (Human) cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell-cell adhesion [GO:0022409]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of cell-cell adhesion [GO:0022409]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165] GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007155; GO:0007165; GO:0007166; GO:0008022; GO:0022409; GO:0030054; GO:0042995; GO:0051393; GO:0060090; GO:0065003; GO:0071944 alpha-actinin binding [GO:0051393]; ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; protein C-terminus binding [GO:0008022] ETGFGFR 0.99226 -46.905 0 0 0 0 0 0 0 0 0 0 0 13.1822 0 0 0 0 0 0 0 0 12.4042 0 0 10.5539 0 12.718 0 0 0 0 12.2779 0 11.1549 0 0 14.1767 0 0 0 12.0966 12.4643 13.7395 15.0674 10.8556 0 12.7856 13.4107 12.6503 0 11.1145 0 0 0 12.9325 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7867 0 0 0 0 0 0 0 0 0 0 0 0 11.3897 0 0 18.6219 0 13.9615 0 0 0 0 13.1857 0 0 12.5833 12.2357 0 0 0 0 0 0 0 14.7153 0 0 0 12.8121 14.3408 13.7198 13.6984 13.4335 0 0 0 11.4835 14.1622 0 13.1965 13.6337 0 0 0 0 0 14.3165 14.0417 0 0 13.3109 13.4485 0 0 12.4714 0 12.3617 0 13.4519 0 14.4501 13.0796 0 0 0 0 13.0257 0 13.1345 0 15.7127 0 10.904 0 0 13.5879 0 0 0 0 14.0746 0 0 0 0 0 0 15.4853 0 0 0 0 0 0 13.5658 13.6063 0 0 0 14.8054 12.0466 0 Q9H2M9 RBGPR_HUMAN "Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150, Rab3-GAP150) (Rab3-GAP regulatory subunit)" RAB3GAP2 KIAA0839 Homo sapiens (Human) establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087] GO:0005096; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0030234; GO:0031267; GO:0032991; GO:0043087; GO:0097051; GO:1903061; GO:1903373; GO:2000786 enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] ACRNQVAK 0.99226 -25.481 12.3628 0 0 0 12.1545 0 0 0 14.5273 0 0 14.7091 0 14.1756 14.9681 0 0 12.617 0 12.4946 0 0 12.9757 0 13.4842 0 13.7183 14.48 0 0 0 13.4962 10.3489 0 0 0 0 0 0 0 0 0 0 13.6184 11.7385 0 10.0404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1899 11.3115 0 0 0 0 0 12.1311 0 0 0 0 0 0 0 0 14.0218 0 13.7239 0 0 0 0 0 0 0 0 14.086 0 13.5315 0 0 0 14.837 14.1128 14.7294 0 0 0 0 0 0 12.5418 0 14.3525 0 0 0 13.3569 0 0 15.0381 0 0 12.2613 13.3143 15.5793 0 0 15.6573 0 0 0 0 0 0 0 13.11 0 14.9432 0 11.7667 0 0 13.559 0 0 0 13.5401 0 15.306 0 10.9186 14.7729 0 0 14.1185 0 0 14.4057 11.9904 0 0 0 0 13.5166 14.936 14.6832 14.9204 14.0853 15.7552 13.6602 0 0 12.8184 13.811 0 0 15.0817 0 14.2437 0 0 Q9H4I8 SEHL2_HUMAN "Serine hydrolase-like protein 2, EC 3.1.-.-" SERHL2 SERHL Homo sapiens (Human) perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777] perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787] GO:0005777; GO:0016787; GO:0048471 hydrolase activity [GO:0016787] AIEHVLQVEASQEPSHVFSLKQLLQRLLK 0.99226 -7.7457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5199 0 0 0 0 0 0 0 0 0 10.833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9261 0 0 0 0 0 0 0 0 0 Q9NR46 SHLB2_HUMAN Endophilin-B2 (SH3 domain-containing GRB2-like protein B2) SH3GLB2 KIAA1848 PP578 Homo sapiens (Human) membrane organization [GO:0061024] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; membrane organization [GO:0061024] GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0042802; GO:0045296; GO:0061024 cadherin binding [GO:0045296]; identical protein binding [GO:0042802] AAEAKATTVPDFQETRPR 0.99226 -7.2178 0 0 0 0 0 0 0 0 0 0 14.6066 0 0 14.0496 0 0 0 0 0 0 0 0 0 0 0 0 12.3676 0 0 0 0 13.6086 0 13.4002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6372 0 0 0 Q9UIG0 BAZ1B_HUMAN "Tyrosine-protein kinase BAZ1B, EC 2.7.10.2 (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2)" BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; post-translational protein modification [GO:0043687]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357] B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535] B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; post-translational protein modification [GO:0043687]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000793; GO:0004713; GO:0004715; GO:0005524; GO:0005654; GO:0005721; GO:0005730; GO:0006338; GO:0006357; GO:0006974; GO:0008270; GO:0035066; GO:0035173; GO:0042393; GO:0043687; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0110016; GO:1905213; GO:1990164; GO:2001020 ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270] AFQEGIAKAKLVMR 0.99226 -83.75 0 12.9053 0 0 0 0 11.4188 0 11.4193 0 0 17.1505 0 10.8386 17.0581 0 0 0 0 0 0 12.7514 0 12.8795 0 13.3424 10.6051 0 16.6137 0 13.5042 0 0 0 11.5552 12.3116 11.6358 0 16.4317 12.4376 14.1846 12.6339 16.3349 0 10.4341 0 0 16.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3025 9.98982 0 0 0 15.1739 15.2888 0 12.7669 0 15.398 10.8844 15.4598 10.3215 0 10.5533 12.842 0 0 14.2628 0 0 0 11.9311 0 13.8509 0 0 0 10.7129 0 15.4046 13.877 0 13.8733 0 14.5656 0 13.8085 0 13.8089 0 12.5007 0 0 0 0 11.3661 11.1671 13.211 0 14.257 0 13.0781 0 11.9527 0 13.6873 13.7343 13.0527 14.2745 11.5456 0 14.2408 10.2939 13.332 13.4328 12.2245 12.2196 13.3695 0 0 0 12.3231 12.4257 12.0936 13.0366 0 0 13.8517 16.146 0 0 0 0 15.5543 0 0 0 13.066 0 0 0 0 0 16.05 0 0 0 0 0 18.0683 0 18.0663 13.3071 13.4836 0 0 0 12.3424 0 13.3607 0 Q9UNA1 RHG26_HUMAN Rho GTPase-activating protein 26 (GTPase regulator associated with focal adhesion kinase) (Oligophrenin-1-like protein) (Rho-type GTPase-activating protein 26) ARHGAP26 GRAF KIAA0621 OPHN1L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; nervous system development [GO:0007399]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005543; GO:0005829; GO:0005856; GO:0005925; GO:0007165; GO:0007399; GO:0030036; GO:0051056 GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543] HLNLSSKKK 0.99226 -17.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7585 0 0 0 0 0 0 0 A6NL46 YF016_HUMAN Putative UPF0607 protein ENSP00000332738 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] KNVRVLSR 0.99227 -7.4442 10.5603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0209 0 0 0 0 0 0 0 0 12.2576 0 13.7741 0 0 0 0 0 0 10.8675 0 0 13.6093 0 0 0 0 12.2513 0 0 12.4527 13.9812 13.1353 0 14.5451 14.1782 13.9889 0 0 0 0 11.7431 0 0 14.1806 0 0 0 12.946 13.9408 14.6188 15.1521 0 0 15.138 13.9377 13.985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.066 0 0 0 0 0 0 0 0 0 0 13.5168 13.4294 13.5659 0 0 0 0 0 0 0 0 0 0 0 0 12.1409 0 0 0 0 0 0 0 0 0 0 0 A8MUI8 YA034_HUMAN Putative UPF0607 protein ENSP00000383783 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] IPHLRGK 0.99227 -15.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6976 13.8349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8469 0 0 0 0 0 0 0 0 0 0 0 0 E2RYF7 PBMU2_HUMAN Protein PBMUCL2 (HLA complex group 22) (Panbronchiolitis-related mucin-like protein 2) HCG22 G2 PBMUCL2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 DSITADPR 0.99227 -4.9975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0224 0 14.0004 0 0 0 11.4617 0 0 0 0 0 0 0 0 0 0 0 14.0942 0 0 11.7568 0 12.0552 0 0 0 0 0 12.4259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1107 0 0 0 14.6303 0 0 0 14.2133 0 0 0 0 0 0 0 13.7463 0 14.8321 13.0197 13.9639 16.1093 0 0 0 0 0 13.6817 0 0 10.8612 0 0 0 0 0 0 0 0 0 0 0 0 15.6651 0 13.8851 0 0 13.5534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1651 14.5531 14.6357 0 0 0 0 12.2141 O43379 WDR62_HUMAN WD repeat-containing protein 62 WDR62 C19orf14 Homo sapiens (Human) centriole replication [GO:0007099]; cerebral cortex development [GO:0021987]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; regulation of centrosome cycle [GO:0046605]; regulation of neuron differentiation [GO:0045664] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922]; centriole replication [GO:0007099]; cerebral cortex development [GO:0021987]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron migration [GO:2001224]; regulation of centrosome cycle [GO:0046605]; regulation of neuron differentiation [GO:0045664] GO:0000922; GO:0002052; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007099; GO:0021987; GO:0022008; GO:0034451; GO:0045664; GO:0046605; GO:0072686; GO:2001224 AGQEPLK 0.99227 -25.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9737 0 0 0 0 0 14.5 0 0 0 13.6782 0 0 0 0 16.2712 14.6921 0 0 0 0 0 0 0 0 13.2812 0 0 0 0 0 0 0 0 0 0 0 12.1677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95985 TOP3B_HUMAN "DNA topoisomerase 3-beta-1, EC 5.6.2.1 (DNA topoisomerase III beta-1)" TOP3B TOP3B1 Homo sapiens (Human) chromosome segregation [GO:0007059]; DNA topological change [GO:0006265] condensed chromosome [GO:0000793]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; nucleus [GO:0005634] "condensed chromosome [GO:0000793]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]" GO:0000793; GO:0003677; GO:0003723; GO:0003916; GO:0003917; GO:0005634; GO:0006265; GO:0007059; GO:0140225 "DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; RNA binding [GO:0003723]" AKQRPLALNTVEMLR 0.99227 -18.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2877 0 13.4855 0 0 0 14.128 0 0 0 0 0 11.0327 0 0 0 0 0 0 0 0 0 14.5573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06746 DPOLB_HUMAN "DNA polymerase beta, EC 2.7.7.7, EC 4.2.99.-" POLB Homo sapiens (Human) "aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]" cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876] "cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]" GO:0001701; GO:0003684; GO:0003887; GO:0003906; GO:0005634; GO:0005654; GO:0005737; GO:0005874; GO:0005876; GO:0006261; GO:0006281; GO:0006284; GO:0006287; GO:0006290; GO:0006303; GO:0006954; GO:0006974; GO:0007435; GO:0007568; GO:0008017; GO:0008630; GO:0010332; GO:0016446; GO:0016829; GO:0019899; GO:0032991; GO:0045471; GO:0046872; GO:0048535; GO:0048536; GO:0048872; GO:0051402; GO:0055093; GO:0071707 damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017] LNHHQRIGLKYFGDFEK 0.99227 -18.045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.831 0 0 0 0 11.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4046 13.0288 0 0 0 0 0 12.56 13.1831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1228 0 0 0 0 0 0 0 0 0 14.1294 0 0 0 0 0 0 0 0 13.5522 0 0 0 0 12.577 13.0212 0 0 0 0 0 13.4029 0 0 0 0 0 0 0 0 0 0 0 0 12.3563 0 0 0 0 0 P26045 PTN3_HUMAN "Tyrosine-protein phosphatase non-receptor type 3, EC 3.1.3.48 (Protein-tyrosine phosphatase H1, PTP-H1)" PTPN3 PTPH1 Homo sapiens (Human) liver regeneration [GO:0097421]; MAPK cascade [GO:0000165]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; protein dephosphorylation [GO:0006470]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of sodium ion transmembrane transporter activity [GO:2000649] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; sodium channel regulator activity [GO:0017080]; liver regeneration [GO:0097421]; MAPK cascade [GO:0000165]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of mitotic cell cycle [GO:0045930]; protein dephosphorylation [GO:0006470]; regulation of membrane depolarization during action potential [GO:0098902]; regulation of sodium ion transmembrane transporter activity [GO:2000649] GO:0000165; GO:0001784; GO:0004725; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0008092; GO:0009898; GO:0017080; GO:0042059; GO:0045930; GO:0051045; GO:0051117; GO:0097421; GO:0098902; GO:2000649 ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; sodium channel regulator activity [GO:0017080] ELALVIRR 0.99227 -18.459 12.5741 13.0636 14.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7616 14.3449 15.2248 0 0 0 0 15.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.062 0 0 0 13.7892 0 0 0 13.6469 0 12.9536 0 12.6511 0 0 0 0 0 0 14.2218 0 0 0 0 0 0 0 0 0 0 13.5266 14.2154 0 0 14.5211 0 0 0 0 0 0 0 15.5232 14.5242 15.0188 0 0 0 0 0 0 0 0 0 0 0 0 13.9101 0 14.2606 0 0 14.5906 0 0 0 14.3831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0706 12.9782 0 P31391 SSR4_HUMAN "Somatostatin receptor type 4, SS-4-R, SS4-R, SS4R, SST4" SSTR4 Homo sapiens (Human) "cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]" cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]" GO:0004930; GO:0004994; GO:0005737; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007218; GO:0008285; GO:0016477; GO:0030900; GO:0042277; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994] IPLTRTTTF 0.99227 -6.1002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5143 0 0 14.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4747 0 0 13.2239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0778 0 0 0 0 12.6854 0 0 0 0 0 0 0 0 13.0889 0 0 13.6718 0 0 0 13.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48741 HSP77_HUMAN Putative heat shock 70 kDa protein 7 (Heat shock 70 kDa protein B) HSPA7 HSP70B Homo sapiens (Human) cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; vesicle-mediated transport [GO:0016192] GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0072562; GO:0140662 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] KFADTTVQSDMKHWPFQVVSEGGK 0.99227 -4.9944 0 0 0 0 0 0 10.2604 0 0 0 0 0 10.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5511 0 10.9424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56180 TPTE_HUMAN "Putative tyrosine-protein phosphatase TPTE, EC 3.1.3.48 (Cancer/testis antigen 44, CT44) (Transmembrane phosphatase with tensin homology) (Tumor antigen BJ-HCC-5)" TPTE Homo sapiens (Human) cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896]; signal transduction [GO:0007165] cell projection [GO:0042995]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cell projection [GO:0042995]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]; cell motility [GO:0048870]; dephosphorylation [GO:0016311]; negative regulation of cell population proliferation [GO:0008285]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of protein kinase B signaling [GO:0051896]; signal transduction [GO:0007165]" GO:0004725; GO:0005634; GO:0005829; GO:0005886; GO:0006470; GO:0007165; GO:0008285; GO:0014065; GO:0016021; GO:0016311; GO:0016314; GO:0042995; GO:0046856; GO:0048870; GO:0051896 "phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; protein tyrosine phosphatase activity [GO:0004725]" FLDKKHR 0.99227 -18.467 0 0 0 0 0 0 0 0 0 0 0 0 12.3025 0 0 0 0 0 0 0 0 0 0 0 0 12.7837 0 0 0 0 0 0 0 12.3939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5663 0 0 0 14.0589 13.9581 0 0 10.1511 0 0 0 0 0 0 0 0 0 0 0 13.9395 0 12.7139 0 0 0 13.6812 13.9484 13.8321 14.5561 12.7931 0 0 13.3093 0 0 13.5983 0 14.0571 0 0 0 13.2205 13.2503 15.0181 0 0 0 0 0 0 0 12.3619 0 0 0 0 0 12.025 0 0 13.1459 0 0 0 0 13.8135 0 0 0 12.4622 13.7881 0 14.2066 12.6052 12.2533 13.1549 0 0 11.9145 0 0 0 0 0 0 11.3123 0 0 0 0 0 0 0 13.3005 0 0 0 12.0299 0 0 0 0 0 0 0 0 0 0 0 0 13.1746 0 0 0 0 0 0 P98073 ENTK_HUMAN "Enteropeptidase, EC 3.4.21.9 (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain ]" TMPRSS15 ENTK PRSS7 Homo sapiens (Human) proteolysis [GO:0006508] brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020] brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005044; GO:0005903; GO:0006508; GO:0016020; GO:0016021 scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252] ITSGVTYNPNLQDK 0.99227 -7.2266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.273 0 0 13.3075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.218 0 Q15418 KS6A1_HUMAN "Ribosomal protein S6 kinase alpha-1, S6K-alpha-1, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 1, p90-RSK 1, p90RSK1, p90S6K) (MAP kinase-activated protein kinase 1a, MAPK-activated protein kinase 1a, MAPKAP kinase 1a, MAPKAPK-1a) (Ribosomal S6 kinase 1, RSK-1)" RPS6KA1 MAPKAPK1A RSK1 Homo sapiens (Human) "cell cycle [GO:0007049]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165]" GO:0000287; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007268; GO:0018105; GO:0030307; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045202; GO:0045597; GO:0045893; GO:0045944; GO:0072574; GO:0106310; GO:2000491 ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] GFSFVATGLMEDDGK 0.99227 -7.4508 0 0 0 0 0 0 0 0 12.0825 12.2257 12.0402 0 0 11.5788 11.2354 0 10.8831 0 0 0 0 0 0 0 11.6353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7495 0 12.6434 13.0232 0 0 0 0 0 0 12.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3883 0 0 0 12.1378 12.428 12.6186 12.9875 0 12.5365 12.5121 0 0 0 0 0 11.0993 0 0 0 0 0 0 Q15833 STXB2_HUMAN "Syntaxin-binding protein 2 (Protein unc-18 homolog 2, Unc18-2) (Protein unc-18 homolog B, Unc-18B)" STXBP2 UNC18B Homo sapiens (Human) intracellular protein transport [GO:0006886]; leukocyte mediated cytotoxicity [GO:0001909]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; regulation of mast cell degranulation [GO:0043304]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] azurophil granule [GO:0042582]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820] azurophil granule [GO:0042582]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348]; intracellular protein transport [GO:0006886]; leukocyte mediated cytotoxicity [GO:0001909]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; regulation of mast cell degranulation [GO:0043304]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] GO:0001909; GO:0005576; GO:0005829; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0016192; GO:0017075; GO:0019905; GO:0030141; GO:0030348; GO:0042581; GO:0042582; GO:0043304; GO:0043312; GO:0044194; GO:0070062; GO:0070820; GO:0098793 syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; syntaxin-3 binding [GO:0030348] AADPVSPLLHELTFQAMAYDLLDIEQDTYR 0.99227 -25.68 12.6137 0 0 0 0 0 0 0 0 0 12.8198 0 0 0 0 0 0 0 0 0 11.1094 9.99237 0 0 0 13.1058 0 11.6989 12.6853 12.6938 0 0 0 0 0 0 0 0 0 11.8919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3508 0 0 12.5749 0 0 0 0 0 0 0 0 0 11.9873 0 0 15.1044 14.6082 0 11.9773 0 0 0 0 0 0 0 13.4957 0 0 0 0 13.8791 0 0 0 0 0 0 0 0 0 13.9125 14.3955 0 0 0 0 0 0 0 0 0 12.5718 0 0 0 11.7955 0 0 0 0 0 0 0 0 0 0 0 11.7287 0 0 0 0 11.1449 0 0 14.2144 0 13.6574 0 0 0 0 0 13.6011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.023 0 0 0 0 0 Q17RC7 EX3L4_HUMAN Exocyst complex component 3-like protein 4 EXOC3L4 C14orf73 Homo sapiens (Human) exocyst localization [GO:0051601]; exocytosis [GO:0006887] exocyst [GO:0000145] exocyst [GO:0000145]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887] GO:0000145; GO:0000149; GO:0006887; GO:0051601 SNARE binding [GO:0000149] ALGLFVPR 0.99227 -25.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.84 0 0 0 0 0 14.1734 0 0 0 0 0 0 12.4884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3488 0 0 0 0 0 0 14.7684 0 0 0 0 0 13.9703 0 0 0 0 0 0 0 0 0 0 0 11.6792 0 0 0 0 0 0 0 0 11.3489 0 0 0 12.1155 14.5905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3B7T3 BEAN1_HUMAN "Protein BEAN1 (Brain-expressed protein associating with Nedd4 homolog, BEAN)" BEAN1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EYEHGYVSDEHTYSR 0.99227 -6.097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7531 0 0 0 12.2414 13.1512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7841 11.7156 0 0 0 0 0 0 11.8672 0 0 0 0 11.5098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EBL4 RIPL1_HUMAN RILP-like protein 1 (Rab-interacting lysosomal-like protein 1) RILPL1 RLP1 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of neuron death [GO:1901214] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein dimerization activity [GO:0046983]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of neuron death [GO:1901214] GO:0003382; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0036064; GO:0046983; GO:0060271; GO:1901214; GO:1903445 protein dimerization activity [GO:0046983] DVLHERNELK 0.99227 -18.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.567 0 0 0 0 0 15.4246 0 0 0 0 0 0 0 0 11.4095 0 0 0 0 0 0 15.8576 0 0 0 0 0 15.6815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q75V66 ANO5_HUMAN Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) ANO5 GDD1 TMEM16E Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0006821; GO:0016021; GO:0031982; GO:0034220; GO:0046983; GO:0055085; GO:1902476 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983] ARTNSEK 0.99227 -18.01 0 0 0 0 0 0 0 0 0 12.2672 0 0 0 0 0 0 12.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7587 0 0 11.1146 0 0 0 0 0 0 0 0 0 0 10.3992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7646 0 0 0 0 0 0 0 0 11.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2239 0 0 14.4173 0 12.9814 0 0 0 13.8343 0 0 0 0 0 0 0 0 0 0 0 0 11.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9113 0 0 14.8019 0 0 15.3864 0 0 0 0 0 0 14.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0253 0 0 0 0 0 0 0 0 0 0 0 0 14.048 13.6524 0 0 0 0 0 14.4807 0 Q7Z304 MAMC2_HUMAN "MAM domain-containing protein 2 (MAM domain-containing proteoglycan, Mamcan)" MAMDC2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020] GO:0005576; GO:0005783; GO:0016020 ARLLSRPLR 0.99227 -6.0955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5478 0 0 0 0 0 0 0 0 12.6382 0 0 0 0 0 0 0 0 0 0 0 0 14.9472 0 14.195 0 0 0 0 0 0 0 12.5422 0 0 0 13.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1X5 YF001_HUMAN Uncharacterized protein FLJ37310 Homo sapiens (Human) CGSDSTPPPPLPRRR 0.99227 -6.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6535 0 0 0 0 13.8864 0 0 0 0 14.0495 0 0 0 0 0 0 0 0 0 0 11.7282 0 0 13.9666 0 0 14.1446 0 10.7402 0 13.1391 0 0 11.7606 0 0 0 13.6666 0 0 0 0 12.7402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCC3 RM30_HUMAN "39S ribosomal protein L30, mitochondrial, L30mt, MRP-L30 (39S ribosomal protein L28, mitochondrial, L28mt, MRP-L28) (Mitochondrial large ribosomal subunit protein uL30m)" MRPL30 MRPL28 RPML28 HSPC249 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0032543 structural constituent of ribosome [GO:0003735] AGILRLVVQWPPGR 0.99227 -15.055 0 0 0 0 0 0 0 0 14.1783 14.332 14.3586 15.3845 13.8107 15.4069 14.08 13.5396 13.2217 0 13.2695 13.3711 0 0 0 0 13.8795 0 13.5554 0 0 13.4685 0 0 10.0692 0 0 0 11.5657 0 0 0 13.717 0 0 0 13.2153 0 13.7959 0 0 0 0 0 0 0 0 12.9445 13.4837 12.8957 0 0 12.5842 12.6097 0 12.8935 12.4113 12.4908 0 0 0 0 0 10.8518 0 0 0 0 0 0 0 0 0 14.246 13.8967 13.9431 0 13.3899 14.9799 13.5841 0 0 13.5845 14.5736 0 0 13.8517 0 13.944 0 0 0 0 0 0 14.5155 0 0 13.6101 0 0 0 0 0 0 0 0 0 0 0 14.8999 14.8655 0 0 0 0 0 14.0404 0 0 0 0 0 0 0 14.088 0 0 14.1161 0 0 14.5412 0 0 0 13.3316 0 14.1345 0 0 0 0 0 0 0 14.998 0 0 0 0 0 0 0 0 0 0 0 0 13.6976 0 0 0 13.7903 13.5126 0 0 0 0 0 0 12.2414 0 Q8TE57 ATS16_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 16, ADAM-TS 16, ADAM-TS16, ADAMTS-16, EC 3.4.24.-" ADAMTS16 KIAA2029 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073] GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AAQCAEHNSRRFR 0.99227 -17.968 0 0 0 0 0 0 0 14.2951 11.6659 0 0 0 0 0 0 0 0 0 0 12.1346 0 0 0 0 13.7666 0 0 0 0 0 0 0 0 11.2921 0 0 0 11.3327 0 0 0 0 0 0 0 0 0 13.3536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1225 0 0 0 0 0 0 0 0 0 0 13.0572 0 0 0 0 0 0 0 0 0 0 14.4939 0 0 0 0 0 0 0 0 0 0 0 0 14.0057 0 0 0 0 0 0 0 0 0 0 14.4328 0 0 0 0 12.9383 0 0 0 0 0 12.9363 12.7314 0 12.8364 12.7685 12.9133 0 0 0 14.7501 0 0 0 12.5432 13.857 0 0 0 12.8454 0 0 0 0 Q99424 ACOX2_HUMAN "Peroxisomal acyl-coenzyme A oxidase 2, EC 1.17.99.3 (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA 24-hydroxylase) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA oxidase) (Trihydroxycoprostanoyl-CoA oxidase, THCA-CoA oxidase, THCCox)" ACOX2 Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; positive regulation of cell death [GO:0010942]; positive regulation of response to oxidative stress [GO:1902884]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity [GO:0033791]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; positive regulation of cell death [GO:0010942]; positive regulation of response to oxidative stress [GO:1902884]; very long-chain fatty acid metabolic process [GO:0000038]" GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0010942; GO:0016401; GO:0033540; GO:0033791; GO:0042803; GO:0043231; GO:0050660; GO:0055088; GO:0071949; GO:1902884 "3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity [GO:0033791]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; protein homodimerization activity [GO:0042803]" AFHIRLIARR 0.99227 -7.4434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8608 0 0 0 0 0 0 0 0 0 11.8813 0 0 0 0 0 13.5801 0 12.7042 0 0 12.0295 0 0 0 0 0 0 0 11.6679 0 0 0 0 13.1555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1472 0 0 0 0 0 0 0 13.238 0 0 12.2679 13.5691 0 11.5107 0 0 0 0 12.8342 11.1462 0 0 11.9076 0 0 0 0 0 0 0 Q99750 MDFI_HUMAN MyoD family inhibitor (Myogenic repressor I-mf) MDFI Homo sapiens (Human) cytoplasmic sequestering of transcription factor [GO:0042994]; dorsal/ventral axis specification [GO:0009950]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; trophoblast giant cell differentiation [GO:0060707] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; cytoplasmic sequestering of transcription factor [GO:0042994]; dorsal/ventral axis specification [GO:0009950]; embryonic skeletal system morphogenesis [GO:0048704]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; trophoblast giant cell differentiation [GO:0060707] GO:0000122; GO:0005634; GO:0005737; GO:0009950; GO:0030178; GO:0042802; GO:0042994; GO:0043392; GO:0048704; GO:0060707; GO:0140416 identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416] MYQVSGQR 0.99227 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3028 0 0 0 0 0 0 Q9BYE0 HES7_HUMAN "Transcription factor HES-7, hHes7 (Class B basic helix-loop-helix protein 37, bHLHb37) (Hairy and enhancer of split 7) (bHLH factor Hes7)" HES7 BHLHB37 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; post-anal tail morphogenesis [GO:0036342]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; mesoderm development [GO:0007498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; post-anal tail morphogenesis [GO:0036342]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; skeletal system development [GO:0001501]; somitogenesis [GO:0001756]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001501; GO:0001756; GO:0003677; GO:0005634; GO:0006357; GO:0007219; GO:0007498; GO:0009952; GO:0036342; GO:0046983; GO:0048511; GO:0050767; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DRAENRDGPK 0.99227 -7.2332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4798 0 0 10.4748 10.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4772 0 0 0 0 0 0 12.3208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7984 12.7466 0 0 0 0 12.1909 14.1437 0 0 0 0 0 0 0 0 0 11.4466 13.8861 0 0 0 0 Q9C0I4 THS7B_HUMAN Thrombospondin type-1 domain-containing protein 7B THSD7B KIAA1679 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532] GO:0005886; GO:0016021; GO:0031532 CIQKLNR 0.99227 -7.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5887 0 10.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1972 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1337 0 0 0 11.8729 0 0 0 13.6811 0 0 0 0 0 13.1805 0 0 0 0 0 0 0 0 0 13.673 0 0 13.3252 13.8861 0 0 0 0 0 0 0 0 13.7076 0 0 0 14.1019 13.6216 0 12.2494 0 0 0 0 12.4234 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9198 0 0 0 0 0 0 0 0 0 0 0 12.8489 0 0 0 0 0 0 0 O43196 MSH5_HUMAN "MutS protein homolog 5, hMSH5" MSH5 Homo sapiens (Human) chiasma assembly [GO:0051026]; mismatch repair [GO:0006298] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983]; chiasma assembly [GO:0051026]; mismatch repair [GO:0006298] GO:0003690; GO:0005524; GO:0005634; GO:0006298; GO:0030983; GO:0051026; GO:0140664 ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983] AAVLTRVLDLASRLDVLLALASAAR 0.99228 -6.1197 0 10.6682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8662 0 0 0 0 0 0 0 0 13.0895 0 11.1137 0 0 0 12.6785 0 0 0 11.183 0 0 0 0 0 0 0 0 11.2675 0 0 13.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4015 0 0 0 0 11.0086 0 0 14.7971 0 0 0 0 0 0 12.6255 13.7741 0 0 10.2834 0 0 10.0638 0 0 0 0 0 13.6217 0 11.1043 0 0 0 12.6444 0 0 0 0 0 0 0 12.7341 0 0 13.6578 14.7756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4478 0 13.4477 0 0 0 0 0 11.4633 0 0 0 0 11.8191 0 0 0 0 0 10.9069 0 0 0 13.7476 0 0 0 0 0 0 0 0 0 0 0 13.2321 11.3716 0 15.8891 0 16.0218 0 P26232 CTNA2_HUMAN Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein) CTNNA2 CAPR Homo sapiens (Human) axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823] GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0016477; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222 actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200] AVADQCPDSACK 0.99228 -7.1208 0 0 0 0 0 0 13.333 0 0 0 0 0 0 0 0 0 0 10.6497 0 0 0 11.1351 0 13.044 0 0 12.1509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7446 0 0 0 0 0 0 0 15.5171 0 0 15.139 16.9498 0 14.8278 0 0 0 0 0 0 0 0 0 0 13.5766 15.6666 13.5285 14.3071 12.7668 0 15.7445 13.7901 13.6426 0 0 0 13.8331 16.4198 13.4977 13.4592 0 0 0 18.7107 0 0 13.5732 13.7576 13.4486 0 0 0 12.0372 0 0 0 0 13.6922 0 12.7543 0 0 0 18.9892 15.2561 13.5585 0 0 15.9202 13.5775 0 0 14.6588 0 13.8893 0 13.5369 0 14.4107 13.6922 11.6957 0 13.5022 15.1166 0 0 15.5046 0 15.1261 0 13.3011 14.1995 14.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3589 0 13.6287 0 15.0574 0 15.2136 0 P59901 LIRA4_HUMAN "Leukocyte immunoglobulin-like receptor subfamily A member 4 (CD85 antigen-like family member G) (Immunoglobulin-like transcript 7, ILT-7) (CD antigen CD85g)" LILRA4 ILT7 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of toll-like receptor 7 signaling pathway [GO:0034156]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; negative regulation of tumor necrosis factor production [GO:0032720] Fc-epsilon receptor I complex [GO:0032998]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] Fc-epsilon receptor I complex [GO:0032998]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; coreceptor activity [GO:0015026]; inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor binding [GO:0005102]; cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of toll-like receptor 7 signaling pathway [GO:0034156]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; negative regulation of tumor necrosis factor production [GO:0032720] GO:0005102; GO:0005886; GO:0005887; GO:0015026; GO:0019221; GO:0032396; GO:0032687; GO:0032720; GO:0032998; GO:0034156; GO:0034164; GO:0038095; GO:0045087 coreceptor activity [GO:0015026]; inhibitory MHC class I receptor activity [GO:0032396]; signaling receptor binding [GO:0005102] DNAPFRVVEPWEQI 0.99228 -7.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0485 16.5069 0 14.642 14.9252 0 0 0 0 0 0 14.2406 13.995 0 0 0 0 0 0 15.6073 0 0 0 0 0 13.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2178 0 0 0 0 0 0 0 0 0 0 0 0 0 11.535 0 0 0 13.8166 0 0 0 0 13.0155 12.8525 0 0 14.0951 12.9319 0 0 0 0 0 14.4105 0 0 0 0 0 0 0 0 0 0 0 0 Q13614 MTMR2_HUMAN "Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTMR2 KIAA1073 Homo sapiens (Human) dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]; identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; dendritic spine maintenance [GO:0097062]; inositol phosphate dephosphorylation [GO:0046855]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]" GO:0002091; GO:0004438; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0006470; GO:0006661; GO:0008021; GO:0008138; GO:0014069; GO:0030424; GO:0030425; GO:0031642; GO:0031901; GO:0032288; GO:0042802; GO:0043197; GO:0043231; GO:0045806; GO:0046855; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0060304; GO:0070062; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645 "identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]" DIRNLRFAHK 0.99228 -17.682 13.7542 0 0 0 0 0 0 0 13.8825 14.1336 14.5927 13.9172 0 13.9306 12.9918 0 0 0 0 12.3719 0 0 0 0 0 0 0 13.2203 16.1711 0 0 13.5775 0 13.0563 0 13.5458 0 0 0 13.1986 0 13.4549 0 0 12.7935 0 0 13.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0829 13.5266 0 0 0 0 0 0 0 13.5339 0 14.8604 0 0 0 14.2429 0 0 0 0 0 0 0 13.1945 11.7901 0 14.939 15.9062 0 0 0 0 13.8629 0 0 0 0 0 0 0 0 0 0 0 13.6767 0 15.2948 0 0 13.5757 0 0 12.8857 0 0 0 0 0 0 0 0 15.2338 0 0 0 0 13.8169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4479 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMJ4 IL34_HUMAN "Interleukin-34, IL-34" IL34 C16orf77 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098] GO:0001934; GO:0005125; GO:0005157; GO:0005576; GO:0005615; GO:0006954; GO:0008083; GO:0008284; GO:0010628; GO:0010759; GO:0042802; GO:0043406; GO:0045087; GO:0045651; GO:0045657; GO:0048714; GO:0061098; GO:0061514; GO:0061518; GO:0120041 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157] HYFPINYK 0.99228 -7.6206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZQ8 MYCD_HUMAN Myocardin MYOCD MYCD Homo sapiens (Human) "cardiac muscle cell apoptotic process [GO:0010659]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cardiac ventricle development [GO:0003231]; cardiocyte differentiation [GO:0035051]; cellular component maintenance [GO:0043954]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; lung alveolus development [GO:0048286]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of skeletal muscle cell differentiation [GO:2001015]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of histone acetylation [GO:0035065]; regulation of myoblast differentiation [GO:0045661]; regulation of phenotypic switching [GO:1900239]; regulation of smooth muscle cell differentiation [GO:0051150]; response to hypoxia [GO:0001666]; smooth muscle cell differentiation [GO:0051145]; transcription by RNA polymerase II [GO:0006366]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell differentiation [GO:0055012]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; cardiac muscle cell apoptotic process [GO:0010659]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cardiac ventricle development [GO:0003231]; cardiocyte differentiation [GO:0035051]; cellular component maintenance [GO:0043954]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; lung alveolus development [GO:0048286]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of skeletal muscle cell differentiation [GO:2001015]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of histone acetylation [GO:0035065]; regulation of myoblast differentiation [GO:0045661]; regulation of phenotypic switching [GO:1900239]; regulation of smooth muscle cell differentiation [GO:0051150]; response to hypoxia [GO:0001666]; smooth muscle cell differentiation [GO:0051145]; transcription by RNA polymerase II [GO:0006366]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vasculogenesis [GO:0001570]; ventricular cardiac muscle cell differentiation [GO:0055012]" GO:0000122; GO:0000785; GO:0001560; GO:0001570; GO:0001666; GO:0003231; GO:0003713; GO:0005634; GO:0006366; GO:0008284; GO:0008285; GO:0010628; GO:0010659; GO:0010667; GO:0010832; GO:0030511; GO:0035035; GO:0035051; GO:0035065; GO:0042826; GO:0043388; GO:0043954; GO:0045661; GO:0045736; GO:0045893; GO:0045944; GO:0045987; GO:0048286; GO:0048565; GO:0051091; GO:0051145; GO:0051150; GO:0051152; GO:0055007; GO:0055012; GO:0060065; GO:0060157; GO:0060354; GO:0060379; GO:0060947; GO:0061629; GO:0070412; GO:0097070; GO:0140297; GO:1900222; GO:1900239; GO:1902895; GO:1904706; GO:1904753; GO:2000587; GO:2000727; GO:2001015 DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; R-SMAD binding [GO:0070412]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] ARLADDLNEKIALR 0.99228 -14.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCL4 GALT6_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 6, EC 2.4.1.41 (Polypeptide GalNAc transferase 6, GalNAc-T6, pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6)" GALNT6 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872; GO:0048471 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] NSGSGTCLTSQDK 0.99228 -24.054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6386 0 0 0 13.6632 0 0 16.3675 0 14.5419 0 0 16.325 0 14.0488 11.8686 0 0 0 0 13.1061 0 0 12.294 0 0 0 0 0 12.8272 0 0 10.6131 0 0 0 11.5089 0 12.5002 12.3131 12.6343 0 0 0 11.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AK3 ABC3D_HUMAN "DNA dC->dU-editing enzyme APOBEC-3D, A3D, A3DE, EC 3.5.4.38" APOBEC3D APOBEC3DE Homo sapiens (Human) cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529] GO:0000932; GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0008270; GO:0010529; GO:0016554; GO:0045087; GO:0045869; GO:0047844; GO:0051607; GO:0070383; GO:0080111 cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DWRWVLLR 0.99228 -6.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0435 0 0 0 0 0 0 0 0 14.5663 16.5854 14.085 0 13.332 14.8534 13.7885 13.9882 0 0 0 13.4895 13.9882 0 0 0 0 0 13.8522 0 0 0 13.3465 13.2864 0 0 13.9445 0 0 0 0 0 11.6741 0 0 13.9744 0 0 0 0 0 13.9569 12.7841 0 0 10.6857 0 0 0 13.155 13.152 0 0 0 0 0 0 0 0 11.3053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96K83 ZN521_HUMAN Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3) ZNF521 EHZF LIP3 Homo sapiens (Human) neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0019904; GO:0046872; GO:0048663 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CSHGFANPAAK 0.99228 -7.6183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1923 0 13.9809 0 0 0 0 0 0 0 0 0 0 16.8408 0 0 0 0 0 0 15.1571 0 0 0 13.2953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.332 0 0 0 0 Q9BUL9 RPP25_HUMAN "Ribonuclease P protein subunit p25, RNase P protein subunit p25" RPP25 Homo sapiens (Human) rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682] centriolar satellite [GO:0034451]; multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172] centriolar satellite [GO:0034451]; multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682] GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005654; GO:0005730; GO:0006364; GO:0030681; GO:0033204; GO:0034451 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] RLAGLHQVTR 0.99228 -4.3915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5437 0 0 0 0 0 0 0 0 13.168 0 0 0 13.6732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14638 ENPP3_HUMAN "Ectonucleotide pyrophosphatase/phosphodiesterase family member 3, E-NPP 3, NPP3 (Phosphodiesterase I beta, PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) [Includes: Alkaline phosphodiesterase I, EC 3.1.4.1; Nucleotide pyrophosphatase, NPPase, EC 3.6.1.9 (Nucleotide diphosphatase) ]" ENPP3 PDNP3 Homo sapiens (Human) ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; pyrimidine nucleotide metabolic process [GO:0006220] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270]; ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; pyrimidine nucleotide metabolic process [GO:0006220] GO:0002276; GO:0003676; GO:0004528; GO:0005509; GO:0006220; GO:0006796; GO:0008270; GO:0009143; GO:0009897; GO:0016021; GO:0016324; GO:0033007; GO:0035529; GO:0036218; GO:0046034; GO:0047429; GO:0048471; GO:0050728; GO:0055062; GO:0070062; GO:0070667 calcium ion binding [GO:0005509]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; zinc ion binding [GO:0008270] ALQVVDHAFGMLMEGLKQR 0.99229 -18.232 0 0 0 0 0 0 0 0 0 0 0 0 11.3605 0 0 0 0 12.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0828 0 0 0 0 0 11.9444 0 0 0 9.77068 0 0 0 0 0 0 0 0 10.5513 10.553 0 9.96636 0 11.2696 0 0 0 13.2776 0 0 0 0 0 0 0 0 0 0 13.1322 15.7101 0 0 13.9045 15.7231 13.7624 0 0 0 0 0 12.8526 14.4355 13.8825 0 11.5274 12.1487 14.9901 0 13.649 13.0798 14.3567 0 13.9177 0 0 13.6984 0 0 13.0336 13.3229 0 0 0 13.2866 13.412 0 0 0 0 0 0 0 13.6376 13.0458 11.4798 0 11.8822 0 0 0 0 0 0 0 0 0 0 0 12.9028 0 14.1203 12.2467 0 0 0 0 0 0 0 0 0 0 0 0 12.8836 13.3464 11.5956 0 0 13.4108 0 12.709 13.6099 0 0 0 10.6083 0 0 0 0 0 O95925 EPPI_HUMAN "Eppin (Cancer/testis antigen 71, CT71) (Epididymal protease inhibitor) (Protease inhibitor WAP7) (Serine protease inhibitor-like with Kunitz and WAP domains 1) (WAP four-disulfide core domain protein 7)" EPPIN SPINLW1 WAP7 WFDC7 Homo sapiens (Human) defense response to bacterium [GO:0042742]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of peptidase activity [GO:0010466] acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; sperm plasma membrane [GO:0097524] acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; sperm plasma membrane [GO:0097524]; serine-type endopeptidase inhibitor activity [GO:0004867]; defense response to bacterium [GO:0042742]; negative regulation of calcium ion import [GO:0090281]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of peptidase activity [GO:0010466] GO:0001669; GO:0004867; GO:0005615; GO:0009986; GO:0010466; GO:0032991; GO:0042742; GO:0090281; GO:0097524; GO:1901318 serine-type endopeptidase inhibitor activity [GO:0004867] CCVFSCGK 0.99229 -15.185 0 10.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9306 0 14.7711 0 0 0 0 0 13.4852 0 0 0 0 0 0 0 0 0 0 0 0 12.4764 0 0 0 0 0 0 0 0 0 0 11.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6707 0 0 0 0 11.4116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7095 0 0 0 0 0 10.9088 0 0 0 0 0 0 0 0 0 0 10.2354 0 11.4098 P08708 RS17_HUMAN 40S ribosomal protein S17 (Small ribosomal subunit protein eS17) RPS17 RPS17L Homo sapiens (Human) cytoplasmic translation [GO:0002181]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; erythrocyte homeostasis [GO:0034101]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412]; translational initiation [GO:0006413] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006364; GO:0006412; GO:0006413; GO:0016020; GO:0022626; GO:0022627; GO:0034101; GO:0042274; GO:0045202 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] IQRGPVR 0.99229 -25.036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1706 14.3317 14.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1236 0 0 13.9726 14.3655 0 0 0 13.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8609 0 0 0 0 0 0 11.894 0 0 0 0 0 0 0 0 0 17.7802 0 0 0 13.2807 0 0 0 0 0 0 0 0 0 15.2499 0 14.0072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20073 ANXA7_HUMAN Annexin A7 (Annexin VII) (Annexin-7) (Synexin) ANXA7 ANX7 SNX OK/SW-cl.95 Homo sapiens (Human) autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; negative regulation of gene expression [GO:0010629] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; epithelial cell differentiation [GO:0030855]; negative regulation of gene expression [GO:0010629] GO:0003723; GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005789; GO:0006914; GO:0010629; GO:0016020; GO:0030855; GO:0048306; GO:0062023; GO:0070062 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; RNA binding [GO:0003723] GFGTDEQAIVDVVANR 0.99229 -6.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8095 0 0 0 0 0 13.1062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8678 0 0 0 0 0 0 16.4912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32455 GBP1_HUMAN "Guanylate-binding protein 1, EC 3.6.5.- (GTP-binding protein 1, GBP-1, HuGBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1)" GBP1 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein localization to vacuole [GO:0072665]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein localization to plasma membrane [GO:1903076] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of T cell receptor signaling pathway [GO:0050860]; protein localization to vacuole [GO:0072665]; regulation of calcium-mediated signaling [GO:0050848]; regulation of protein localization to plasma membrane [GO:1903076] GO:0000139; GO:0003779; GO:0003924; GO:0005525; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0012506; GO:0015629; GO:0019003; GO:0019899; GO:0019955; GO:0030507; GO:0031410; GO:0032703; GO:0042802; GO:0042803; GO:0050848; GO:0050860; GO:0051607; GO:0051879; GO:0070373; GO:0071346; GO:0071347; GO:0071356; GO:0072665; GO:1900025; GO:1903076; GO:1903077 actin binding [GO:0003779]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spectrin binding [GO:0030507] ELAAQLEKK 0.99229 -15.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5321 13.4941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.06 0 14.3529 0 0 0 0 0 13.7469 12.3342 13.0923 0 14.2085 13.1771 0 14.2284 0 0 0 13.1384 12.7299 0 15.5344 0 0 0 0 0 0 0 0 0 0 12.5712 0 12.8798 12.4009 0 12.6012 0 13.679 0 0 0 0 0 0 0 0 13.2695 0 0 0 0 0 12.5364 0 0 0 0 0 0 0 0 0 13.1321 0 0 0 0 12.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1946 13.1423 0 0 0 0 0 0 0 0 P51797 CLCN6_HUMAN "H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6, ClC-6) (Chloride transport protein 6)" CLCN6 KIAA0046 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765] endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165] GO:0005247; GO:0005524; GO:0005765; GO:0006821; GO:0006884; GO:0007165; GO:0009612; GO:0010008; GO:0015108; GO:0015297; GO:0016021; GO:0031902; GO:0034220; GO:0043231 antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247] AGCRGSLCCCCRWCCCCGER 0.99229 -17.724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3753 0 0 0 0 0 0 0 0 0 11.5551 0 0 0 0 14.3182 12.0058 0 0 0 0 0 0 0 0 0 0 14.059 0 0 0 0 0 0 0 0 0 0 9.8724 0 0 0 0 0 0 0 0 0 11.67 0 0 0 0 0 14.7098 0 12.3881 9.53666 0 0 11.6991 11.8647 0 11.4983 0 11.3104 0 0 0 0 0 0 0 11.5375 0 0 0 0 13.7613 0 0 0 0 0 0 0 0 0 12.7639 16.5564 0 0 12.9493 12.6452 13.3693 14.3699 13.6312 0 0 10.7667 13.768 0 0 0 0 0 11.2808 0 0 0 0 0 0 0 0 12.984 0 0 0 0 0 0 0 0 13.0982 11.3859 0 0 0 13.0529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.044 0 0 0 0 12.7256 Q01968 OCRL_HUMAN "Inositol polyphosphate 5-phosphatase OCRL, EC 3.1.3.36, EC 3.1.3.56 (Inositol polyphosphate 5-phosphatase OCRL-1, OCRL-1) (Lowe oculocerebrorenal syndrome protein) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase, EC 3.1.3.86)" OCRL OCRL1 Homo sapiens (Human) cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; lipid metabolic process [GO:0006629]; membrane organization [GO:0061024]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; Golgi-associated vesicle [GO:0005798]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] "clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi stack [GO:0005795]; Golgi-associated vesicle [GO:0005798]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; small GTPase binding [GO:0031267]; cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; lipid metabolic process [GO:0006629]; membrane organization [GO:0061024]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]" GO:0001701; GO:0001750; GO:0004439; GO:0004445; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005769; GO:0005795; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005905; GO:0006629; GO:0006661; GO:0007165; GO:0016020; GO:0030136; GO:0030670; GO:0031267; GO:0031901; GO:0034485; GO:0034596; GO:0043087; GO:0043647; GO:0043813; GO:0046855; GO:0046856; GO:0052658; GO:0052659; GO:0052745; GO:0060271; GO:0061024 "GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; small GTPase binding [GO:0031267]" ILWRGTNVNQLNYRSHMELK 0.99229 -7.6443 0 0 0 0 0 0 0 13.2318 0 14.0757 0 12.3853 0 13.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4165 0 13.1 0 0 0 0 0 0 0 0 0 10.1518 0 0 0 0 0 0 0 0 0 0 10.8176 0 0 0 0 12.4739 13.9151 0 0 0 0 0 0 0 0 0 13.0709 13.5417 14.4106 0 0 0 13.7991 12.6043 12.3425 0 0 0 14.4357 0 13.4006 13.6582 12.7441 14.6063 13.0135 0 0 0 0 12.7025 0 0 0 12.2621 11.7791 12.507 13.4616 0 13.8245 12.1148 0 0 0 0 0 13.0178 0 0 0 0 0 0 0 0 0 0 0 0 13.7278 11.9406 0 0 0 14.1248 0 0 0 0 0 0 12.467 0 13.6266 13.5134 0 0 0 0 0 12.5971 12.9676 0 0 0 0 0 0 0 0 0 15.2361 0 0 0 0 0 0 0 0 Q13247 SRSF6_HUMAN "Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)" SRSF6 SFRS6 SRP55 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell death [GO:0060548]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell death [GO:0060548]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]" GO:0000380; GO:0000381; GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0006376; GO:0010837; GO:0016607; GO:0032868; GO:0036002; GO:0045617; GO:0048025; GO:0060501; GO:0060548; GO:0061041; GO:2000675 mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] ARSVSPPPKR 0.99229 -40.597 0 0 0 0 0 0 0 0 0 14.1025 0 0 12.3081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3547 0 0 0 0 0 12.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6464 17.0185 0 0 0 14.4077 0 0 14.4433 0 0 0 15.4994 0 0 0 0 13.6281 0 0 0 0 0 0 0 0 0 12.0685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9547 0 0 13.0736 0 0 12.1244 0 0 0 12.574 0 0 0 0 0 0 0 0 12.3151 0 0 0 0 0 0 0 0 0 13.4605 0 12.776 0 12.4748 0 0 13.4837 0 0 0 0 0 0 Q53FD0 ZC21C_HUMAN Zinc finger C2HC domain-containing protein 1C ZC2HC1C C14orf140 FAM164C Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] AEPPQKSNWR 0.99229 -18.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4839 0 0 0 10.3413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4635 0 0 0 0 12.3084 0 14.83 0 0 0 10.8899 0 0 0 0 0 0 0 12.3082 0 0 0 0 0 0 0 0 11.6274 0 12.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9951 0 0 0 0 0 0 0 13.1169 0 13.6404 0 0 0 0 0 13.026 0 12.3323 0 14.4886 0 0 0 13.5555 0 0 0 0 0 0 0 0 0 0 15.6952 12.8808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68CQ4 UTP25_HUMAN U3 small nucleolar RNA-associated protein 25 homolog (Digestive organ expansion factor homolog) (UTP25 small subunit processor component) UTP25 C1orf107 DEF DIEXF Homo sapiens (Human) "embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511]; embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]" GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019; GO:0048568; GO:1902570 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511] DIDLKSLHLQK 0.99229 -5.5292 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4925 0 0 0 12.5934 11.255 0 0 0 0 11.5415 11.1455 0 11.6373 0 0 0 13.3903 0 0 11.9695 0 0 0 0 11.471 0 0 0 0 0 0 0 0 11.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8957 15.7832 0 0 0 0 13.0084 11.5092 0 0 0 0 0 0 12.6178 12.464 0 0 0 0 0 12.7358 0 0 0 0 0 0 0 0 0 0 0 12.578 11.3805 0 0 0 0 12.8872 0 0 0 0 0 0 15.0081 0 0 0 0 0 0 0 0 0 0 12.9935 12.8232 0 0 0 0 0 0 12.4087 0 0 0 11.9202 0 0 14.3083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9087 0 13.3468 0 0 11.6396 0 0 0 12.5896 0 Q6ZP82 CC141_HUMAN Coiled-coil domain-containing protein 141 (Coiled-coil protein associated with myosin II and DISC1) CCDC141 CAMDI Homo sapiens (Human) centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799] centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuron projection [GO:0043005] centrosome [GO:0005813]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799] GO:0005737; GO:0005813; GO:0021799; GO:0043005; GO:0051642 EKMHADNNFTKTQDR 0.99229 -18.168 12.4644 0 0 0 0 0 12.1015 0 0 10.2732 0 0 0 9.19182 0 12.1261 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64758 0 0 0 13.9134 0 0 11.8939 0 11.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6548 0 0 0 0 0 0 14.2008 0 0 11.2667 13.3741 0 11.0128 10.8967 0 13.0091 11.1508 16.8011 11.052 0 0 0 0 0 16.0335 0 12.9862 0 0 0 13.7563 15.2672 0 0 14.9885 15.2679 13.5425 0 0 16.8381 0 0 0 11.3028 13.6559 12.4853 11.399 0 13.2847 11.6201 0 9.55959 0 0 0 0 0 0 0 13.2939 0 0 0 17.6507 0 0 0 11.5366 0 0 0 0 0 0 0 0 11.8076 0 0 0 11.9936 11.8829 11.1803 0 0 13.0616 0 0 15.8474 14.1558 0 12.0544 0 0 0 0 0 0 0 11.8181 0 0 18.1613 0 0 0 10.5281 12.428 10.5275 0 0 0 0 0 0 13.683 13.0378 0 0 0 0 Q86YE8 ZN573_HUMAN Zinc finger protein 573 ZNF573 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FHTGEKPYECTECGK 0.99229 -18.156 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3585 0 14.0298 0 0 0 11.6844 0 11.5754 0 0 0 0 0 12.4398 0 0 0 14.2253 0 0 0 14.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8132 0 0 0 0 0 0 0 0 0 0 0 12.0969 0 0 0 0 0 0 0 0 15.7887 0 0 0 0 0 0 0 0 0 12.107 0 14.7223 0 11.9207 0 0 0 0 14.7713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2915 0 0 13.3472 0 0 0 0 0 0 0 0 0 0 13.6525 0 10.8207 0 0 0 0 0 0 0 0 13.6012 0 0 0 13.5427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2659 0 0 0 0 0 0 0 0 0 0 Q8N567 ZCHC9_HUMAN Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0005654; GO:0005730; GO:0008270 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DCPESQNSERMVTVGR 0.99229 -14.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7559 13.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXS4 CCGL_HUMAN Voltage-dependent calcium channel gamma-like subunit (Neuronal voltage-gated calcium channel gamma-like subunit) (Transmembrane protein 37) TMEM37 PR Homo sapiens (Human) regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium channel activity [GO:0005262]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765] GO:0005244; GO:0005262; GO:0016021; GO:0034765 calcium channel activity [GO:0005262]; voltage-gated ion channel activity [GO:0005244] PLGQRQPRR 0.99229 -4.8858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6899 0 0 0 0 0 0 0 0 11.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1703 0 0 11.4613 0 0 0 0 0 0 0 0 13.1923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92797 SYMPK_HUMAN Symplekin SYMPK SPK Homo sapiens (Human) cell adhesion [GO:0007155]; mRNA polyadenylation [GO:0006378]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA polyadenylation [GO:0006378]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307] GO:0005654; GO:0005737; GO:0005829; GO:0005847; GO:0005856; GO:0005886; GO:0005923; GO:0006378; GO:0007155; GO:0016604; GO:0032091; GO:0035307; GO:0097165 CPELREPLLAHVR 0.99229 -25.026 0 0 12.37 0 11.2254 0 0 11.8251 0 0 0 0 0 0 0 0 0 13.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5503 0 0 0 0 0 0 11.4256 0 0 12.7613 0 0 0 0 11.538 0 0 11.7382 0 11.7757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3489 0 0 0 0 0 0 0 12.6426 0 0 12.2761 15.6284 15.3717 14.8766 14.8278 14.0291 13.9756 14.4146 0 0 14.0005 13.8979 0 14.0336 13.1429 15.7835 0 15.4858 0 0 0 14.1045 0 12.3485 0 13.6939 0 13.1882 14.1973 11.7266 0 14.9419 16.0221 15.105 12.6737 15.8089 15.1389 0 0 0 0 13.4729 13.2747 14.1338 12.5576 14.0579 15.7553 15.2225 0 15.0841 13.1669 14.4385 0 13.6994 14.6477 0 11.2087 0 14.4585 0 14.2594 13.9964 12.6306 14.2917 13.7069 14.1757 0 13.7164 12.632 10.1152 0 0 0 0 0 14.8966 13.5778 0 0 0 0 0 0 0 0 0 12.2317 0 0 0 0 0 0 0 13.4413 0 0 13.7916 0 0 0 0 0 Q96DB5 RMD1_HUMAN "Regulator of microtubule dynamics protein 1, RMD-1, hRMD-1 (Protein FAM82B)" RMDN1 FAM82B CGI-90 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; mitotic spindle organization [GO:0007052] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; mitotic spindle organization [GO:0007052] GO:0005737; GO:0005876; GO:0007052; GO:0008017; GO:0051315; GO:0097431 microtubule binding [GO:0008017] ESEDAELLWRLAR 0.99229 -7.6396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7356 0 0 0 0 0 0 12.5036 0 0 0 12.8758 0 13.3704 0 10.3635 12.8846 0 0 0 0 0 0 10.5678 13.4827 0 0 0 0 0 0 0 0 13.6533 0 0 0 0 0 0 0 12.6909 0 0 12.9578 12.5671 0 13.3485 13.2591 0 0 0 13.1354 13.6345 13.4014 0 0 0 0 12.0205 0 0 12.724 0 9.81804 0 0 0 0 0 0 0 15.7261 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3839 0 0 0 0 0 0 12.1488 12.6014 0 10.09 13.6503 0 0 0 0 0 0 0 Q96KK4 O10C1_HUMAN Olfactory receptor 10C1 (Hs6M1-17) (Olfactory receptor 10C2) OR10C1 OR10C2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ILVTIFRIPSVAGRR 0.99229 -6.1324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYQ3 HAOX2_HUMAN "2-Hydroxyacid oxidase 2, HAOX2, EC 1.1.3.15 ((S)-2-hydroxy-acid oxidase, peroxisomal) (Cell growth-inhibiting gene 16 protein) (Long chain alpha-hydroxy acid oxidase) (Long-chain L-2-hydroxy acid oxidase)" HAO2 HAOX2 GIG16 Homo sapiens (Human) fatty acid oxidation [GO:0019395] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181]; fatty acid oxidation [GO:0019395] GO:0003973; GO:0005782; GO:0005829; GO:0010181; GO:0019395 (S)-2-hydroxy-acid oxidase activity [GO:0003973]; FMN binding [GO:0010181] LPIILKGILTKEDAELAVK 0.99229 -6.1303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJW7 ZN229_HUMAN Zinc finger protein 229 ZNF229 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CTSSLHK 0.99229 -25.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4278 0 0 0 0 0 0 0 0 12.6232 0 0 0 0 0 0 0 0 0 12.2756 0 0 11.0288 0 11.3531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2958 13.7147 12.0909 0 0 0 0 0 0 0 0 0 12.6462 13.4439 12.8073 0 12.9723 0 13.0336 0 0 11.9821 0 0 0 0 0 0 0 0 0 0 0 0 16.728 0 13.7202 0 14.1427 0 0 0 0 0 0 0 0 0 0 0 0 14.8469 14.6559 0 0 15.2185 12.2241 13.7516 0 0 0 12.623 0 12.8095 0 0 11.4267 0 13.3073 0 0 0 14.0628 14.1895 0 0 0 0 0 0 0 0 0 12.8091 12.3441 13.8509 14.1626 0 12.4278 0 0 11.8033 0 0 13.0752 0 0 0 15.5015 12.5514 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3951 Q9UL42 PNMA2_HUMAN Paraneoplastic antigen Ma2 (40 kDa neuronal protein) (Onconeuronal antigen Ma2) (Paraneoplastic neuronal antigen MM2) PNMA2 KIAA0883 MA2 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] nucleolus [GO:0005730] nucleolus [GO:0005730]; positive regulation of apoptotic process [GO:0043065] GO:0005730; GO:0043065 KRWLAESLR 0.99229 -25.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9316 0 0 0 0 0 11.637 0 0 0 0 0 0 0 0 0 11.4371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5477 0 0 0 0 0 0 0 0 0 13.0376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6106 0 0 0 12.3263 0 0 0 0 0 0 0 0 A0A087WXS9 TBC3I_HUMAN TBC1 domain family member 3I TBC1D3I Homo sapiens (Human) activation of GTPase activity [GO:0090630] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0005886; GO:0090630 GTPase activator activity [GO:0005096] EAKQIRR 0.9923 -18.333 0 0 0 0 0 0 0 0 0 0 0 11.6804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1116 12.7659 11.822 0 0 0 0 0 0 13.2715 0 0 13.4765 0 0 10.9286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1763 0 0 0 0 0 14.9374 0 0 0 0 13.8988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14967 CLGN_HUMAN Calmegin CLGN Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; protein folding [GO:0006457]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; protein folding [GO:0006457]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005509; GO:0005783; GO:0005789; GO:0006457; GO:0007338; GO:0007339; GO:0016021; GO:0030433; GO:0044183; GO:0051082; GO:0065003 calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] CGEDYKLHFIFR 0.9923 -18.276 0 0 0 9.56815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6926 0 0 0 14.5037 0 0 0 12.0899 0 0 0 0 0 13.3278 0 0 0 O75351 VPS4B_HUMAN "Vacuolar protein sorting-associated protein 4B, EC 3.6.4.6 (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1, Protein SKD1)" VPS4B SKD1 VPS42 MIG1 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000922; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006813; GO:0006914; GO:0006997; GO:0007080; GO:0008022; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0030301; GO:0030496; GO:0031468; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0046761; GO:0051261; GO:0060548; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1903542; GO:1903543; GO:1903724; GO:1904903; GO:1904949 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] AEKLKEYLK 0.9923 -6.6835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00587 BORG5_HUMAN Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55) CDC42EP1 BORG5 CEP1 MSE55 Homo sapiens (Human) positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; cadherin binding involved in cell-cell adhesion [GO:0098641]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007266; GO:0008360; GO:0012505; GO:0030838; GO:0031274; GO:0098641 cadherin binding involved in cell-cell adhesion [GO:0098641] LQLVRRVGAPPR 0.9923 -15.211 13.5126 13.3626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2487 12.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.751 Q32NB8 PGPS1_HUMAN "CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial, EC 2.7.8.5 (Phosphatidylglycerophosphate synthase 1, PGP synthase 1)" PGS1 Homo sapiens (Human) cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655] endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655] GO:0005509; GO:0005524; GO:0005739; GO:0005743; GO:0005783; GO:0006655; GO:0008444; GO:0032049; GO:0046339 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444] AVAAAAAAGPVFWRRLLGLLPGR 0.9923 -6.1654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5052 0 0 0 0 0 0 0 0 0 9.84391 0 0 0 0 0 12.1636 0 0 0 0 0 0 0 0 0 0 12.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.38498 0 0 0 0 14.0037 0 14.3119 0 13.1702 14.5057 14.3633 13.1326 0 0 0 16.6153 16.8667 15.3612 15.551 15.7286 15.2093 15.2227 16.3059 16.133 16.9813 0 15.3138 11.9449 14.9144 15.0508 0 0 15.9022 15.622 16.4046 15.1801 16.5182 16.3483 15.7554 0 15.5775 15.0981 15.7428 14.786 0 14.967 0 14.559 16.5432 16.1902 16.015 15.1135 0 0 14.2826 11.948 16.2944 16.437 15.1849 15.1803 16.2472 14.0711 15.9875 0 14.752 13.831 15.2639 0 15.8502 15.6299 15.5742 0 14.6996 13.901 14.1111 0 15.2569 13.6985 0 13.4122 14.2552 0 0 0 0 0 0 0 0 0 0 15.0137 0 0 0 0 0 13.3103 0 0 0 13.3902 0 0 0 12.3232 0 13.6749 0 0 0 0 0 Q8N2M8 CLASR_HUMAN "CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)" CLASRP SFRS16 SWAP2 UNQ2428/PRO4988 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0005654; GO:0006397; GO:0008380 ALEEEKAMYSGR 0.9923 -24.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4759 0 10.8299 11.7363 0 0 11.6692 13.6223 11.5353 0 0 12.1747 0 0 11.7076 0 0 10.5501 0 0 0 0 0 0 0 11.7785 0 13.0677 13.5732 0 10.5747 13.7236 14.2195 13.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0607 0 14.096 13.135 13.8076 0 14.9894 0 0 0 0 0 12.8619 0 0 0 15.4032 0 0 0 0 14.8769 13.6214 0 14.449 0 0 0 0 14.3197 14.35 12.2686 14.2822 14.413 15.1009 0 0 13.6821 0 11.9139 0 11.9797 0 0 0 0 13.2828 0 0 0 0 0 12.0011 0 13.2983 16.3838 0 13.3187 0 0 0 0 0 0 0 0 0 0 0 12.822 0 13.8108 0 0 0 14.9563 15.0361 15.414 0 0 0 0 0 11.4944 0 0 0 0 0 0 0 0 0 12.2901 14.8309 14.2063 0 11.5136 0 0 0 0 Q8NGJ7 O51A2_HUMAN Olfactory receptor 51A2 OR51A2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FAGHVSPLINVLMANVLLLVPPLMK 0.9923 -6.6858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.229 0 15.9186 0 0 0 0 0 0 0 0 0 14.7224 13.3576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8914 0 0 0 0 0 0 0 0 Q8NH54 O56A3_HUMAN Olfactory receptor 56A3 (Olfactory receptor 56A6) OR56A3 OR56A3P OR56A6 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAMFILTR 0.9923 -4.7485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2552 0 0 0 0 0 0 13.5191 0 0 0 13.6504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8144 0 0 0 15.7172 0 14.8197 14.5188 14.2561 0 0 0 13.8219 14.3705 11.3329 0 0 0 0 0 0 0 0 13.1177 0 0 0 13.6838 0 0 0 0 0 0 0 0 0 13.2208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWY7 WFD12_HUMAN WAP four-disulfide core domain protein 12 (Putative protease inhibitor WAP12) (Whey acidic protein 2) WFDC12 C20orf122 WAP2 UNQ544/PRO844 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0004867; GO:0005615; GO:0019731; GO:0042742; GO:0045087 serine-type endopeptidase inhibitor activity [GO:0004867] AGVCPADNVRCFKSDPPQCHTDQDCLGER 0.9923 -4.7527 0 0 9.66541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.378 0 0 11.1242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RL7 VP13A_HUMAN Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein) (Chorein) (Vacuolar protein sorting-associated protein 13A) VPS13A CHAC KIAA0986 Homo sapiens (Human) autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225]; autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382] GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0006914; GO:0007399; GO:0007626; GO:0008104; GO:0010008; GO:0019898; GO:0030317; GO:0030382; GO:0031966; GO:0035176; GO:0044233; GO:0045053; GO:0097225; GO:0099013; GO:1905146 ACPFLPVK 0.9923 -18.27 0 0 0 0 0 13.68 0 0 0 10.7972 0 0 10.1805 0 0 12.3778 0 0 0 12.1944 0 11.321 0 11.1212 11.933 0 0 0 11.4846 0 0 11.1844 10.7837 0 0 10.2423 0 10.6866 0 0 0 0 12.2613 0 10.6638 0 13.4939 0 0 0 0 13.122 12.7746 12.398 0 13.7658 0 0 11.5551 0 0 0 0 0 0 10.5496 12.0127 15.6025 0 0 0 0 14.2057 0 14.4788 13.1395 12.6947 11.6372 14.642 13.1882 12.0657 13.7079 12.4672 0 17.2041 0 0 16.4421 13.4506 0 14.7726 17.6151 16.382 15.4105 14.5021 17.7202 0 0 0 15.3299 12.5252 13.8218 0 0 15.7028 13.1548 13.4359 14.4944 12.6744 15.0552 14.6845 13.7512 13.7995 15.6596 13.9471 11.825 0 0 0 14.3908 12.6614 14.628 14.9762 13.951 0 12.92 0 0 0 0 0 12.3735 15.0348 13.8171 15.1913 15.8636 0 0 14.576 0 0 0 12.4834 14.5691 12.9057 0 12.7418 0 0 0 15.1633 0 12.3947 16.813 0 17.044 0 12.4188 12.5371 12.7531 0 12.7577 0 13.0932 0 0 0 12.7855 12.6603 0 0 13.4992 15.8812 13.1466 0 12.4228 11.4963 11.8972 0 0 Q99929 ASCL2_HUMAN "Achaete-scute homolog 2, ASH-2, hASH2 (Class A basic helix-loop-helix protein 45, bHLHa45) (Mash2)" ASCL2 BHLHA45 HASH2 Homo sapiens (Human) negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; spongiotrophoblast layer development [GO:0060712] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; placenta development [GO:0001890]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sensory organ development [GO:0007423]; somatic stem cell population maintenance [GO:0035019]; spongiotrophoblast differentiation [GO:0060708]; spongiotrophoblast layer development [GO:0060712]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001666; GO:0001890; GO:0005634; GO:0005737; GO:0006357; GO:0007423; GO:0010626; GO:0030182; GO:0035019; GO:0045944; GO:0046983; GO:0050767; GO:0060708; GO:0060712; GO:0070888; GO:0090575; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" LLAEHDAVR 0.9923 -4.9119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3757 0 0 0 13.18 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8403 14.3693 13.7099 0 0 0 13.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3135 0 0 0 13.1534 0 0 0 0 0 0 0 0 0 14.1001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5339 0 0 0 0 0 Q9H0K4 RSH6A_HUMAN Radial spoke head protein 6 homolog A (Radial spoke head-like protein 1) RSPH6A RSHL1 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; manchette disassembly [GO:1905199]; motile cilium assembly [GO:0044458] axoneme [GO:0005930]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; manchette disassembly [GO:1905199]; motile cilium assembly [GO:0044458] GO:0001534; GO:0003341; GO:0005930; GO:0035082; GO:0036126; GO:0044458; GO:0060294; GO:1905199 AYLLQTSINCDLSLYEHLVNLLTKILNQR 0.9923 -18.293 0 0 0 0 0 0 0 0 0 0 0 0 0 10.794 0 0 0 0 0 0 10.0444 0 15.5022 0 0 0 12.9839 0 16.2439 0 0 11.5087 0 0 0 11.1306 11.1093 0 0 0 12.7549 0 10.0539 0 9.58976 0 0 0 0 0 0 0 13.3807 11.979 0 11.7796 13.0054 13.7263 12.0437 14.1327 13.4198 12.3562 0 11.611 11.6985 11.4327 0 0 0 0 0 0 0 0 0 0 0 11.3337 0 0 0 0 12.3517 12.3062 10.8467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2962 0 0 14.7947 0 0 0 0 10.6577 13.1213 0 0 13.8777 14.2494 0 0 0 0 0 0 0 0 0 0 0 0 12.2855 0 0 0 0 11.8395 11.8969 14.8215 11.8755 0 0 0 0 0 0 0 11.7731 13.0702 10.4144 0 0 0 0 0 0 0 0 0 0 12.6462 0 11.8774 15.6953 0 12.5059 0 0 15.6705 16.0341 13.9278 13.6962 15.4659 13.9408 0 0 0 0 0 12.7071 0 0 0 15.1677 0 0 Q9NTI2 AT8A2_HUMAN "Phospholipid-transporting ATPase IB, EC 7.6.2.1 (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2)" ATP8A2 ATPIB Homo sapiens (Human) aging [GO:0007568]; aminophospholipid translocation [GO:0140331]; axonogenesis [GO:0007409]; detection of light stimulus involved in visual perception [GO:0050908]; eating behavior [GO:0042755]; inner ear morphogenesis [GO:0042472]; involuntary skeletal muscle contraction [GO:0003011]; negative regulation of cell population proliferation [GO:0008285]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular process controlling posture [GO:0050884]; neuron development [GO:0048666]; phospholipid translocation [GO:0045332]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipid translocation [GO:0061092]; response to auditory stimulus [GO:0010996]; retina layer formation [GO:0010842]; skin development [GO:0043588] cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] cell projection [GO:0042995]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; aging [GO:0007568]; aminophospholipid translocation [GO:0140331]; axonogenesis [GO:0007409]; detection of light stimulus involved in visual perception [GO:0050908]; eating behavior [GO:0042755]; inner ear morphogenesis [GO:0042472]; involuntary skeletal muscle contraction [GO:0003011]; negative regulation of cell population proliferation [GO:0008285]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular process controlling posture [GO:0050884]; neuron development [GO:0048666]; phospholipid translocation [GO:0045332]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipid translocation [GO:0061092]; response to auditory stimulus [GO:0010996]; retina layer formation [GO:0010842]; skin development [GO:0043588] GO:0000139; GO:0000287; GO:0003011; GO:0005524; GO:0005654; GO:0005794; GO:0005886; GO:0007409; GO:0007568; GO:0008285; GO:0010008; GO:0010842; GO:0010976; GO:0010996; GO:0016021; GO:0016887; GO:0040018; GO:0042472; GO:0042755; GO:0042995; GO:0043588; GO:0045332; GO:0048666; GO:0050884; GO:0050908; GO:0060052; GO:0061092; GO:0090555; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] AAKHTCK 0.9923 -18.268 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3889 0 0 0 0 0 0 0 0 11.1087 0 0 0 0 0 0 0 0 0 0 0 11.5573 0 0 0 9.84773 0 0 0 0 0 0 0 0 0 10.1399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.689 0 0 15.449 0 15.0136 0 0 0 12.7985 11.8696 0 11.1112 17.7328 0 0 11.23 0 0 0 0 0 0 0 0 0 0 15.57 12.2206 0 15.6227 0 12.7798 0 11.582 11.6693 11.611 12.1317 14.8386 0 0 12.1608 0 0 0 10.9991 0 0 0 0 14.2261 0 0 0 14.9143 0 16.5729 16.3795 0 0 0 14.1848 0 0 0 0 0 0 0 13.367 0 0 15.3201 0 0 0 0 0 0 0 0 0 0 16.8823 0 0 0 0 0 13.5124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1896 0 0 Q9UQB3 CTND2_HUMAN "Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein, NPRAP) (Neurojungin)" CTNND2 NPRAP Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055] GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609 beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] CKLGSETGSMSSMSSAEEQFQWQSQDGQK 0.9923 -5.5345 0 0 0 0 0 0 0 11.3204 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5108 12.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5806 0 12.5102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2025 13.1903 0 0 0 0 0 0 0 0 13.975 0 0 0 0 11.9787 0 0 0 16.3567 0 14.611 0 0 0 0 13.3393 0 12.6171 0 0 0 0 0 16.2695 0 12.4248 12.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9742 0 0 14.3246 0 0 0 0 15.5637 0 0 0 0 0 12.1211 0 Q9P2P6 STAR9_HUMAN "StAR-related lipid transfer protein 9 (START domain-containing protein 9, StARD9)" STARD9 KIAA1300 Homo sapiens (Human) microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225] centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634] centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; spindle assembly [GO:0051225] GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0007018; GO:0008017; GO:0008289; GO:0051225 ATP binding [GO:0005524]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ADPSYCKDR 0.99231 -83.736 0 0 0 12.9858 0 0 0 0 0 0 0 0 12.1656 0 13.718 12.7815 0 0 13.6923 0 0 13.8453 0 0 0 13.6524 10.9523 0 0 12.6152 0 0 0 11.7644 12.9327 0 0 12.346 0 13.6728 0 0 0 0 0 0 0 0 0 0 0 15.0054 14.716 14.5964 13.495 13.2823 0 11.5881 0 0 0 12.904 0 11.7099 0 0 13.8717 14.7507 13.7825 13.9219 0 10.4731 15.3462 15.7864 17.6865 18.1934 17.9706 17.7683 16.6615 18.0128 16.077 15.5412 19.4778 15.6872 18.5701 18.9335 17.663 16.4641 16.1623 15.255 17.8403 16.4557 16.7304 16.0899 18.1015 17.5885 16.9507 17.0626 17.2151 13.8985 17.818 18.5474 0 13.8126 17.3352 18.6287 14.8866 14.7721 14.7946 17.0829 16.7188 16.5886 15.9148 16.154 17.1165 17.3698 17.1168 14.3063 17.1393 16.3596 16.6004 0 16.8122 17.2199 17.2804 16.8692 17.1368 14.341 17.305 17.6932 15.6421 16.6544 16.2358 16.6384 16.243 17.8302 15.6368 16.0238 17.8718 14.3389 16.4969 17.0789 16.4097 16.5414 13.7713 12.5516 14.4396 0 16.2936 0 15.732 15.8027 15.2906 15.8337 15.8041 16.6224 0 12.9619 0 0 0 0 0 0 0 12.8833 0 14.378 0 0 0 0 0 16.0836 16.4765 0 11.7633 0 16.3373 0 Q14160 SCRIB_HUMAN "Protein scribble homolog, Scribble, hScrib (Protein LAP4)" SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of receptor recycling [GO:0001921]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]" adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750] "adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750]; cadherin binding [GO:0045296]; activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of receptor recycling [GO:0001921]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]" GO:0001768; GO:0001772; GO:0001843; GO:0001921; GO:0005654; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016080; GO:0016323; GO:0016477; GO:0021747; GO:0030027; GO:0030054; GO:0030859; GO:0032729; GO:0034750; GO:0035089; GO:0035748; GO:0036342; GO:0042060; GO:0043065; GO:0043113; GO:0043615; GO:0044291; GO:0045197; GO:0045296; GO:0045930; GO:0046007; GO:0048488; GO:0050918; GO:0060088; GO:0060561; GO:0060603; GO:0070062; GO:0071896; GO:0090630; GO:0097120; GO:0098609; GO:0098793; GO:0098887; GO:0098968; GO:0098978; GO:0099147; GO:0099149 cadherin binding [GO:0045296] ALSPAELR 0.99231 -18.37 0 13.6962 0 13.2829 16.1424 14.4038 16.2821 13.6398 16.1172 16.2917 0 16.4111 16.9799 17.0952 16.5564 17.9034 17.7172 16.8012 17.5302 17.0161 17.4782 16.5101 17.1957 16.6227 17.0611 16.491 16.3679 16.1749 15.1345 15.1798 15.8391 15.0809 14.6448 0 0 10.5529 0 14.4768 16.1697 11.2481 0 14.7391 0 15.6068 16.4168 15.0395 0 15.1317 15.1352 0 14.1226 14.4495 13.9606 14.4192 12.9931 0 12.3417 0 0 0 0 10.2582 0 0 11.1841 0 0 0 0 10.6711 0 0 12.4705 0 17.0401 17.635 18.141 17.7595 17.8598 16.8832 16.5988 17.0764 0 16.11 14.2614 0 13.6755 15.5362 14.7427 14.3886 15.3212 14.243 14.2683 15.2925 14.0116 14.1913 0 14.9013 12.822 14.2158 15.6373 15.012 15.8354 0 16.8455 16.2677 14.829 14.1053 16.6944 15.53 16.8074 16.5012 15.5635 15.0584 14.1895 15.7769 15.4944 14.4376 0 17.8967 14.3684 14.9256 16.4295 14.1668 15.6432 16.3516 14.5156 13.3273 0 14.4772 13.9027 15.5644 15.9352 16.7412 16.672 16.0068 15.0749 0 15.1075 16.7642 14.2064 14.5606 17.3214 0 15.1964 0 16.7066 10.3799 15.8783 13.7754 16.2267 16.5019 0 15.7424 16.5414 15.6856 14.7339 13.3132 13.8453 13.1001 15.3623 10.9131 0 12.3852 0 15.4278 0 15.6651 0 0 0 0 13.8971 16.6306 14.9664 14.3438 17.2755 14.4563 0 0 A4D263 SPT48_HUMAN Spermatogenesis-associated protein 48 SPATA48 C7orf72 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0030154 ILSEELQQNRR 0.99231 -4.9292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26439 3BHS2_HUMAN "3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II, 3-beta-HSD II) (3-beta-HSD adrenal and gonadal type) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase, EC 1.1.1.145 (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase, EC 5.3.3.1 (Delta-5-3-ketosteroid isomerase) ]" HSD3B2 HSDB3B Homo sapiens (Human) androgen biosynthetic process [GO:0006702]; C21-steroid hormone metabolic process [GO:0008207]; hippocampus development [GO:0021766]; response to corticosterone [GO:0051412]; steroid biosynthetic process [GO:0006694] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleolus [GO:0005730]; smooth endoplasmic reticulum membrane [GO:0030868] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; nucleolus [GO:0005730]; smooth endoplasmic reticulum membrane [GO:0030868]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; cholesterol dehydrogenase activity [GO:0102294]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid delta-isomerase activity [GO:0004769]; androgen biosynthetic process [GO:0006702]; C21-steroid hormone metabolic process [GO:0008207]; hippocampus development [GO:0021766]; response to corticosterone [GO:0051412]; steroid biosynthetic process [GO:0006694]" GO:0003854; GO:0004769; GO:0005730; GO:0005737; GO:0005743; GO:0005758; GO:0005783; GO:0005789; GO:0006694; GO:0006702; GO:0008207; GO:0016021; GO:0016616; GO:0021766; GO:0030868; GO:0031966; GO:0043231; GO:0045171; GO:0051412; GO:0102294 "3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; cholesterol dehydrogenase activity [GO:0102294]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid delta-isomerase activity [GO:0004769]" AFRPELR 0.99231 -4.9154 10.7908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9742 0 0 0 0 0 0 0 0 0 0 11.4119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26885 FKBP2_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP2, PPIase FKBP2, EC 5.2.1.8 (13 kDa FK506-binding protein, 13 kDa FKBP, FKBP-13) (FK506-binding protein 2, FKBP-2) (Immunophilin FKBP13) (Rotamase)" FKBP2 FKBP13 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein peptidyl-prolyl isomerization [GO:0000413] GO:0000413; GO:0003755; GO:0005528; GO:0005783; GO:0005789; GO:0061077 FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] GWDQGLLGMCEGEK 0.99231 -4.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4838 0 0 0 0 0 0 10.3895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6896 0 0 0 0 0 14.3865 0 0 0 0 11.7996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8836 0 0 0 0 0 0 P47736 RPGP1_HUMAN "Rap1 GTPase-activating protein 1, Rap1GAP, Rap1GAP1" RAP1GAP KIAA0474 RAP1GA1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0007165; GO:0016020; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0051056; GO:0090630; GO:1903697; GO:1904425; GO:1904442; GO:1990792 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] CRTYHDVIPISCLTEFPNVVQMAK 0.99231 -17.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8356 0 0 11.8689 0 0 0 12.2979 0 0 12.5229 13.5296 15.4095 12.9408 14.3665 0 14.0093 0 0 0 0 0 0 0 0 0 12.9897 0 0 0 0 0 10.7934 15.0596 0 0 0 0 0 0 12.9665 0 0 0 0 0 0 0 0 11.0781 0 0 0 10.9701 12.4964 0 11.8661 0 0 0 13.2244 0 0 0 0 0 11.3699 0 0 0 0 0 0 0 0 11.5146 0 0 0 11.4548 0 0 0 0 0 12.2591 0 0 0 0 0 0 0 12.3211 12.4841 0 12.7109 0 0 0 0 0 0 0 11.9131 0 0 0 0 0 P49005 DPOD2_HUMAN DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50) POLD2 Homo sapiens (Human) DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035] delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035]; DNA binding [GO:0003677]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276] GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0042575; GO:0043625; GO:0071897 DNA binding [GO:0003677] AKYLTKK 0.99231 -6.7087 0 0 0 0 0 0 0 10.2512 0 0 0 0 13.6494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.038 0 0 0 0 0 0 13.0818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4266 0 0 0 0 13.1814 0 0 13.098 12.2747 0 13.2571 0 0 0 13.7398 13.391 14.8453 0 0 13.2196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7303 0 14.4907 0 0 15.2917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5796 0 0 0 0 15.1518 0 14.5559 0 0 0 0 0 0 0 15.5015 15.4123 15.5337 0 0 0 15.2414 0 15.1592 14.8986 14.8608 0 0 0 0 0 0 0 15.0035 0 15.1432 14.6763 0 P49207 RL34_HUMAN 60S ribosomal protein L34 (Large ribosomal subunit protein eL34) RPL34 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0022625; GO:0022626; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AQAQSQKAK 0.99231 -7.6888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1492 0 0 13.8001 0 0 0 0 0 0 0 11.3796 0 11.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9023 0 0 15.0455 0 0 0 0 0 0 14.3063 0 0 0 0 0 0 0 0 0 0 0 16.2698 0 0 0 0 0 0 0 0 0 11.6116 0 0 0 0 14.7601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78559 MAP1A_HUMAN "Microtubule-associated protein 1A, MAP-1A (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2 ]" MAP1A MAP1L Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein localization to microtubule [GO:1902817]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]; voluntary musculoskeletal movement [GO:0050882] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic branch [GO:0044307]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; synapse [GO:0045202] axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic branch [GO:0044307]; dendritic microtubule [GO:1901588]; dendritic shaft [GO:0043198]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; synapse [GO:0045202]; actin binding [GO:0003779]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; anterograde axonal protein transport [GO:0099641]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; memory [GO:0007613]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein localization to microtubule [GO:1902817]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to cell surface [GO:2000010]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic plasticity [GO:0048167]; retrograde axonal protein transport [GO:0099642]; voluntary musculoskeletal movement [GO:0050882] GO:0000226; GO:0003779; GO:0005198; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0007409; GO:0007613; GO:0008017; GO:0008093; GO:0008306; GO:0015631; GO:0016358; GO:0030424; GO:0030425; GO:0031114; GO:0032435; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0044307; GO:0045202; GO:0048156; GO:0048167; GO:0050882; GO:0070050; GO:0099641; GO:0099642; GO:0150001; GO:1901588; GO:1902817; GO:1903829; GO:1904115; GO:1990535; GO:2000010 actin binding [GO:0003779]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631] AKVPGRVK 0.99231 -83.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3171 11.5389 0 0 11.4487 0 0 0 0 0 0 10.2569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3346 0 0 0 0 0 0 0 0 0 0 0 14.7265 0 0 0 0 0 0 0 0 13.1529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5394 14.2742 13.8953 17.1731 0 0 13.7879 0 0 0 14.2445 0 0 0 14.3669 16.0653 13.8469 17.3862 0 19.2938 13.1967 14.1097 13.9431 0 0 0 0 10.5762 0 11.1148 0 0 0 0 0 0 14.4221 13.3071 0 0 0 0 0 13.2402 0 20.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7919 0 13.392 0 0 0 0 0 0 0 12.7032 0 0 0 16.7984 0 13.0331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4154 0 0 0 Q7Z460 CLAP1_HUMAN "CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1, hOrbit1)" CLASP1 KIAA0622 MAST1 Homo sapiens (Human) "astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]" basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] "basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903]" GO:0000226; GO:0000776; GO:0001578; GO:0002162; GO:0005794; GO:0005813; GO:0005815; GO:0005828; GO:0005829; GO:0005876; GO:0005881; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030953; GO:0030981; GO:0031023; GO:0031111; GO:0031116; GO:0031592; GO:0034453; GO:0035371; GO:0040001; GO:0043515; GO:0045180; GO:0045921; GO:0051010; GO:0051294; GO:0051301; GO:0051497; GO:0051893; GO:0070507; GO:0072686; GO:0090091; GO:0090162; GO:0090307; GO:1903690; GO:1904261 dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010] DHSIRALALRVLR 0.99231 -25.431 12.4747 0 0 0 11.0736 10.2863 0 0 0 11.4776 0 13.8431 0 0 0 13.241 0 0 13.343 14.2463 11.0847 0 12.0492 12.1555 0 0 0 0 13.5984 0 0 0 0 0 0 0 0 13.4472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2203 0 0 14.4267 0 13.8005 13.6673 0 0 0 11.9671 0 0 10.9497 0 0 14.049 0 12.708 12.3461 0 0 0 0 0 0 0 0 12.2979 14.4427 0 18.7941 14.9784 15.2557 0 0 14.3667 0 0 0 0 13.0646 0 14.1257 12.2392 0 0 0 14.4868 0 14.5639 14.8162 12.0131 14.3665 12.3319 10.7276 0 13.4307 14.5601 0 0 11.8681 0 0 0 0 0 13.5338 12.1386 10.1367 14.2879 14.6393 12.2837 13.7658 12.4255 13.5313 15.789 0 0 0 12.979 12.3678 14.5731 0 0 0 0 0 0 0 0 0 11.8517 0 0 0 0 0 0 12.397 0 0 9.73259 0 0 0 0 0 0 12.3248 0 0 0 Q7Z5J4 RAI1_HUMAN Retinoic acid-induced protein 1 RAI1 KIAA1820 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" GO:0001501; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0032922; GO:0040015; GO:0045893; GO:0046872 metal ion binding [GO:0046872] EDGGEEAAPADKGR 0.99231 -25.51 0 0 0 0 0 0 0 0 0 0 0 10.5714 0 10.6664 0 13.9209 0 0 0 13.7484 0 0 0 12.2897 15.432 0 0 12.707 0 0 0 0 0 0 0 0 0 0 0 13.1391 0 0 0 14.2909 0 0 0 0 13.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5043 0 0 14.8508 15.2477 15.3753 0 13.0295 0 0 0 13.1978 11.7669 16.6213 14.6056 0 0 15.7122 16.1667 0 14.8783 0 12.9673 15.6737 16.5105 0 0 0 12.5841 13.2645 0 14.8849 14.9851 0 0 14.5004 0 12.8023 0 14.747 0 0 0 13.9598 14.9767 0 0 14.3813 16.883 15.7767 14.9477 14.8612 15.3153 0 15.2402 12.8008 13.5614 15.2276 0 0 13.4932 12.6751 0 11.7567 0 0 0 0 11.8374 0 0 0 0 0 0 0 13.9601 0 13.6774 12.4831 15.0196 0 0 0 0 11.7862 0 0 0 0 12.9089 0 0 0 0 0 14.419 13.3525 0 0 15.2814 0 0 0 0 Q7Z5N4 SDK1_HUMAN Protein sidekick-1 SDK1 Homo sapiens (Human) behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0042802; GO:0045202; GO:0048148; GO:0060998; GO:0070161 identical protein binding [GO:0042802] AAKLGPGR 0.99231 -17.083 0 0 0 0 0 0 0 0 12.3123 0 10.136 0 0 0 12.2317 0 0 0 0 0 0 14.842 0 0 0 0 11.0221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8283 0 0 0 0 11.8722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5827 0 0 0 0 0 0 0 0 15.4755 0 0 0 0 0 0 17.0098 13.1903 0 0 0 0 0 0 0 0 0 13.2251 15.2823 0 0 0 0 13.1231 17.2977 0 0 0 0 15.6494 0 0 0 0 0 12.8712 0 0 0 14.7367 0 0 13.287 0 14.7449 0 0 0 0 0 0 0 0 0 0 0 13.366 15.046 16.1775 13.0882 0 0 0 0 0 0 0 13.7281 0 0 0 0 0 0 0 0 0 13.2465 0 12.5888 0 0 0 12.7757 13.5962 13.0321 0 0 0 12.9643 0 0 0 0 0 0 13.159 14.449 0 0 0 0 0 Q86X51 EZHIP_HUMAN EZH inhibitory protein EZHIP CXorf67 Homo sapiens (Human) negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K27 trimethylation [GO:1902465] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K27 trimethylation [GO:1902465] GO:0005634; GO:0005654; GO:0005829; GO:0061086; GO:1902465 ASSPSPPGR 0.99231 -4.4433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2397 0 0 0 0 0 Q8IUB2 WFDC3_HUMAN WAP four-disulfide core domain protein 3 (Putative protease inhibitor WAP14) WFDC3 WAP14 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] GO:0004867; GO:0005615; GO:0019731; GO:0045087 serine-type endopeptidase inhibitor activity [GO:0004867] CCSTGCGR 0.99231 -17.896 0 0 12.5665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3839 0 0 11.7649 0 0 0 0 0 14.3844 0 0 0 0 0 0 0 0 0 0 0 0 11.4205 11.4961 0 0 13.1317 0 0 0 0 0 0 0 0 0 0 0 11.1112 0 0 0 12.411 0 0 12.7048 0 0 0 0 0 0 0 0 0 0 10.8297 0 0 0 0 0 0 11.7006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9M1 CS047_HUMAN Uncharacterized protein C19orf47 C19orf47 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654 ASPQPALTVKAK 0.99231 -7.6802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7025 0 18.0155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD23 ZN675_HUMAN Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein) ZNF675 TIZ Homo sapiens (Human) "bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; bone resorption [GO:0045453]; cytokine-mediated signaling pathway [GO:0019221]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006355; GO:0007249; GO:0008270; GO:0010804; GO:0019221; GO:0031625; GO:0032088; GO:0043508; GO:0045453; GO:0045671; GO:0046329; GO:0048471; GO:2000660; GO:2000678 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]" CKECGKAFK 0.99231 -7.6758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4061 0 0 0 0 13.2045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.483 0 0 0 0 0 0 0 0 15.2795 0 0 Q8WXA2 PATE1_HUMAN Prostate and testis expressed protein 1 PATE1 PATE Homo sapiens (Human) regulation of neurotransmitter receptor activity [GO:0099601] extracellular region [GO:0005576] extracellular region [GO:0005576]; acetylcholine receptor regulator activity [GO:0030548]; regulation of neurotransmitter receptor activity [GO:0099601] GO:0005576; GO:0030548; GO:0099601 acetylcholine receptor regulator activity [GO:0030548] ALSGSLSMR 0.99231 -4.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1553 0 0 0 0 0 0 0 0 12.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92736 RYR2_HUMAN "Ryanodine receptor 2, RYR-2, RyR2, hRYR-2 (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor)" RYR2 Homo sapiens (Human) calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to epinephrine stimulus [GO:0071872]; detection of calcium ion [GO:0005513]; embryonic heart tube morphogenesis [GO:0003143]; establishment of localization in cell [GO:0051649]; establishment of protein localization to endoplasmic reticulum [GO:0072599]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of heart rate [GO:0010460]; positive regulation of sequestering of calcium ion [GO:0051284]; positive regulation of the force of heart contraction [GO:0098735]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to muscle stretch [GO:0035994]; response to redox state [GO:0051775]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; type B pancreatic cell apoptotic process [GO:0097050]; ventricular cardiac muscle cell action potential [GO:0086005] calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018] calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein self-association [GO:0043621]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; suramin binding [GO:0043924]; transmembrane transporter binding [GO:0044325]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; calcium-mediated signaling [GO:0019722]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to epinephrine stimulus [GO:0071872]; detection of calcium ion [GO:0005513]; embryonic heart tube morphogenesis [GO:0003143]; establishment of localization in cell [GO:0051649]; establishment of protein localization to endoplasmic reticulum [GO:0072599]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of heart rate [GO:0010460]; positive regulation of sequestering of calcium ion [GO:0051284]; positive regulation of the force of heart contraction [GO:0098735]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of AV node cell action potential [GO:0098904]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to muscle stretch [GO:0035994]; response to redox state [GO:0051775]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; type B pancreatic cell apoptotic process [GO:0097050]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0001666; GO:0002027; GO:0003143; GO:0003220; GO:0003300; GO:0005219; GO:0005262; GO:0005509; GO:0005513; GO:0005516; GO:0005790; GO:0005886; GO:0006816; GO:0006874; GO:0010460; GO:0010881; GO:0010882; GO:0014701; GO:0014808; GO:0014850; GO:0015278; GO:0016020; GO:0016529; GO:0019722; GO:0019899; GO:0030018; GO:0030659; GO:0031000; GO:0032991; GO:0033017; GO:0034236; GO:0034237; GO:0034704; GO:0035584; GO:0035994; GO:0042383; GO:0042802; GO:0043621; GO:0043924; GO:0044325; GO:0048763; GO:0051209; GO:0051284; GO:0051480; GO:0051649; GO:0051775; GO:0055117; GO:0060048; GO:0060402; GO:0070296; GO:0071313; GO:0071872; GO:0072599; GO:0086005; GO:0086029; GO:0086064; GO:0097050; GO:0098735; GO:0098904; GO:0098907; GO:0098910; GO:0098911; GO:1901896 calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; protein self-association [GO:0043621]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; suramin binding [GO:0043924]; transmembrane transporter binding [GO:0044325] AMFDHLSYLLENSSVGLASPAMR 0.99231 -84.859 0 0 0 0 12.9114 0 0 11.062 11.1544 16.9688 16.9665 11.2702 0 17.0062 0 0 0 13.2833 0 0 11.0688 0 0 0 0 0 0 0 0 11.6426 0 0 0 0 0 0 0 0 0 16.9984 0 0 0 10.5718 0 12.6703 18.0619 0 13.0101 0 0 15.8382 0 0 10.3997 0 14.5344 16.3234 0 16.378 0 0 0 0 0 0 14.5934 0 13.907 13.2592 14.7407 15.785 15.503 16.2201 0 15.0837 13.0355 14.9634 11.6774 15.2934 0 15.8374 12.8635 0 18.9294 11.7162 0 0 12.6095 0 0 0 0 14.0489 15.1963 14.1478 15.2957 12.1387 16.2205 11.9897 0 13.1186 13.2903 0 14.6836 0 10.4539 12.5015 11.9785 14.5146 0 15.3819 13.9712 0 12.7638 13.7645 0 12.0722 0 15.2004 13.7306 12.8557 0 15.094 14.663 13.6314 0 0 13.4539 0 0 13.783 0 11.6593 13.7322 14.4188 16.4362 13.8205 12.2682 12.1332 14.241 12.4482 0 12.4482 14.4841 13.8423 13.8506 0 0 10.3546 0 15.7715 13.9018 13.7291 11.7487 13.2458 19.0342 0 12.1374 18.034 13.275 18.1026 18.1981 0 16.7547 11.0482 18.0623 0 11.294 0 0 13.2637 12.4138 0 14.8593 0 0 12.0969 12.7649 10.828 Q92915 FGF14_HUMAN "Fibroblast growth factor 14, FGF-14 (Fibroblast growth factor homologous factor 4, FHF-4)" FGF14 FHF4 Homo sapiens (Human) cell-cell signaling [GO:0007267]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; cell-cell signaling [GO:0007267]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165] GO:0005576; GO:0005634; GO:0005737; GO:0007165; GO:0007254; GO:0007267; GO:0007399; GO:0008083; GO:0008201; GO:0017080; GO:1905150 growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080] KTKPAAHFLPK 0.99231 -18.369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4091 0 0 0 0 17.1949 15.354 0 15.4433 15.4064 15.2438 0 15.469 15.0647 0 0 0 14.7527 15.8057 16.3327 0 16.2955 16.5619 0 0 14.5311 0 0 0 0 0 0 0 0 0 0 0 0 14.9656 0 0 13.0549 12.589 0 0 0 0 0 0 0 0 15.9735 0 0 0 0 0 0 0 13.5848 0 0 0 0 0 0 0 0 0 13.9531 0 0 0 0 13.1456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8698 0 0 0 13.182 0 0 0 Q969V5 MUL1_HUMAN "Mitochondrial ubiquitin ligase activator of NFKB 1, EC 2.3.2.27 (E3 SUMO-protein ligase MUL1) (E3 ubiquitin-protein ligase MUL1) (Growth inhibition and death E3 ligase) (Mitochondrial-anchored protein ligase) (Protein Hades) (Putative NF-kappa-B-activating protein 266) (RING finger protein 218) (RING-type E3 ubiquitin transferase NFKB 1)" MUL1 C1orf166 GIDE MAPL MULAN RNF218 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of cell growth [GO:0030308]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of dendrite extension [GO:1903861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein sumoylation [GO:0033235]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of mitochondrion organization [GO:0010821] axon [GO:0030424]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777] axon [GO:0030424]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of cell growth [GO:0030308]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of dendrite extension [GO:1903861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein sumoylation [GO:0033235]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of mitochondrion organization [GO:0010821] GO:0000209; GO:0000266; GO:0002039; GO:0004842; GO:0005739; GO:0005777; GO:0006915; GO:0006919; GO:0010637; GO:0010821; GO:0016020; GO:0016567; GO:0019789; GO:0030308; GO:0030424; GO:0031307; GO:0031625; GO:0031648; GO:0033235; GO:0042802; GO:0043025; GO:0043123; GO:0045824; GO:0046872; GO:0050689; GO:0050821; GO:0051646; GO:0051881; GO:0051898; GO:0060339; GO:0061630; GO:0071360; GO:0071650; GO:0090141; GO:1901028; GO:1903861; GO:1904925 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] PEDRESLK 0.99231 -7.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J87 CELF6_HUMAN "CUGBP Elav-like family member 6, CELF-6 (Bruno-like protein 6) (CUG-BP- and ETR-3-like factor 6) (RNA-binding protein BRUNOL-6)" CELF6 BRUNOL6 Homo sapiens (Human) "mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723] PAASEGR 0.99231 -4.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1679 0 0 0 0 0 0 0 12.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LL4 CH048_HUMAN Uncharacterized protein C8orf48 C8orf48 Homo sapiens (Human) DAFSCTVPDELLNRIYFKNMR 0.99231 -6.7127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6943 0 12.8086 12.5468 0 0 0 0 0 0 12.4102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.325 0 0 0 0 0 0 0 0 0 0 0 0 14.2603 0 0 0 0 14.2122 0 0 0 0 0 0 0 Q96SQ7 ATOH8_HUMAN "Transcription factor ATOH8 (Class A basic helix-loop-helix protein 21, bHLHa21) (Helix-loop-helix protein hATH-6, hATH6) (Protein atonal homolog 8)" ATOH8 ATH6 BHLHA21 Homo sapiens (Human) "formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; tube formation [GO:0035148]" GO:0000785; GO:0000978; GO:0000981; GO:0001704; GO:0001937; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010595; GO:0010629; GO:0016607; GO:0030182; GO:0035148; GO:0045603; GO:0045892; GO:0045893; GO:0046983; GO:0051450; GO:0060395; GO:0070888; GO:0140297; GO:1902895 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ALQQTRRLLANAR 0.99231 -25.479 0 0 0 0 0 0 0 0 0 11.8705 0 0 0 0 0 0 0 0 0 0 0 10.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3411 0 0 0 0 0 10.547 0 0 0 0 0 0 0 0 0 14.8842 0 14.5857 14.8406 13.5863 14.3977 0 14.7501 0 15.3994 0 0 0 13.627 0 13.1139 0 0 13.0835 14.3192 15.0395 0 0 0 0 12.9908 12.0521 14.3648 10.1594 13.2955 13.6306 0 13.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1124 13.7868 0 0 0 0 14.9543 0 0 0 0 0 0 0 0 0 0 0 0 11.2715 0 0 0 0 0 0 12.8448 0 0 13.193 0 0 0 0 0 0 0 0 0 0 0 0 10.6872 0 0 0 Q9H307 PININ_HUMAN "Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein, DRS protein, DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein)" PNN DRS MEMA Homo sapiens (Human) "cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] "catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003677; GO:0003723; GO:0005198; GO:0005882; GO:0005886; GO:0005911; GO:0007155; GO:0016020; GO:0016607; GO:0030057; GO:0071013 DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] DSSSSTSSSSESR 0.99231 -18.365 0 0 0 0 0 0 0 0 0 0 0 12.282 0 0 0 0 0 0 0 13.5558 0 0 0 0 0 0 0 0 11.0158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3692 0 0 0 0 0 12.6833 12.6147 12.0867 0 0 0 11.3424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0279 0 0 0 0 0 0 13.1172 18.3686 18.4176 19.0501 18.574 19.4846 15.818 15.8079 15.3088 16.6519 18.4925 17.0564 15.3566 16.2156 0 15.8101 16.0691 19.9252 13.7551 0 0 0 0 0 13.9042 14.9667 0 0 0 0 0 13.1731 0 15.9246 15.1072 14.0019 14.213 0 0 13.169 12.3809 0 13.8936 14.9983 13.8319 0 0 14.8431 12.7392 0 13.4086 11.5806 0 0 12.4109 0 12.0568 12.2996 0 0 0 0 0 10.7216 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8299 0 0 0 0 0 0 0 0 0 13.6591 13.3523 0 0 0 0 0 0 0 0 0 0 Q9UEU5 GGE2D_HUMAN "G antigen 2D, GAGE-2D (Cancer/testis antigen 4.8, CT4.8) (G antigen 8, GAGE-8)" GAGE2D; GAGE8 Homo sapiens (Human) MSWRGRSTYR 0.99231 -18.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76898 0 0 0 0 0 0 0 12.8531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4676 0 13.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3614 0 0 0 0 0 12.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0333 0 0 0 13.1974 13.9421 0 0 0 0 0 0 0 0 0 13.616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2208 0 0 0 0 0 0 12.6117 Q8TEJ3 SH3R3_HUMAN "E3 ubiquitin-protein ligase SH3RF3, EC 2.3.2.27 (Plenty of SH3s 2) (SH3 domain-containing RING finger protein 3) (SH3 multiple domains protein 4)" SH3RF3 POSH2 SH3MD4 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] GO:0006915; GO:0016567; GO:0032436; GO:0046330; GO:0046872; GO:0051865; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AGSLDLNFTSPSRQAPLSMAAIRPEPK 0.99232 -7.1961 0 0 0 0 0 0 0 0 16.0138 16.071 16.0754 16.1481 0 0 0 0 0 0 0 0 12.3205 0 0 0 0 11.6898 0 0 0 0 0 0 16.2996 16.3663 0 16.4287 16.4062 16.3804 0 16.3748 0 16.4074 11.2016 0 0 0 13.3693 0 0 0 0 0 0 0 0 16.6684 0 16.7241 16.5642 16.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.973 10.994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7342 0 0 14.7616 12.9545 0 0 0 0 0 0 13.5895 0 0 0 0 11.1749 14.6763 12.1777 0 0 0 0 0 0 12.4743 0 0 13.0637 12.6623 12.5752 12.8698 14.2221 0 13.3973 14.8372 13.8369 0 12.7423 12.868 0 0 0 0 0 0 0 15.1256 0 0 0 0 10.9219 0 0 0 13.2628 14.7304 0 16.5547 0 0 18.3725 18.3945 18.3753 18.8516 18.4155 0 12.5963 0 0 13.8498 12.0903 15.5111 0 0 18.414 13.0519 18.4207 18.4149 O15123 ANGP2_HUMAN "Angiopoietin-2, ANG-2" ANGPT2 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014] GO:0001525; GO:0001666; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0007165; GO:0007281; GO:0009314; GO:0009612; GO:0009749; GO:0010467; GO:0010812; GO:0014070; GO:0014823; GO:0016525; GO:0030971; GO:0031100; GO:0042995; GO:0043537; GO:0045766; GO:0046872; GO:0048014; GO:0050928; GO:0060135; GO:0062023; GO:0071363; GO:0072012 metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] EEQISFRDCAEVFK 0.99232 -4.9349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5379 12.4935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9491 0 0 0 11.4865 0 12.6927 0 0 12.7232 0 0 0 0 11.5196 0 0 13.4537 0 0 0 0 0 0 13.6308 0 0 0 0 0 13.1368 0 14.5359 0 0 14.3231 0 0 0 0 0 0 11.9133 0 0 0 12.8686 0 0 0 0 0 0 0 0 14.7628 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2629 0 0 0 0 0 0 14.3088 0 O15335 CHAD_HUMAN Chondroadherin (Cartilage leucine-rich protein) CHAD SLRR4A Homo sapiens (Human) bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155] GO:0005615; GO:0031012; GO:0060348; GO:1900155 DTDAFRSCK 0.99232 -7.6968 0 14.5844 0 0 0 0 0 0 0 0 10.7746 0 0 0 0 0 0 0 0 0 10.7753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0807 0 0 12.4237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0348 0 0 11.8969 11.1282 0 0 0 11.6526 0 0 0 0 0 0 0 0 0 10.9058 0 0 11.4299 0 0 0 0 0 0 0 13.6051 12.4198 0 0 0 0 0 0 14.1257 0 0 0 11.4937 0 0 0 0 0 0 12.7575 0 0 0 0 0 13.6071 11.0156 0 12.4911 0 0 0 0 0 0 0 12.8076 0 0 12.5969 0 0 0 0 0 0 14.2907 0 0 0 0 0 0 0 0 0 0 0 0 12.6836 0 0 0 0 0 12.0723 0 0 0 O75469 NR1I2_HUMAN "Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor, SXR)" NR1I2 PXR Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]" chromatin [GO:0000785]; intermediate filament cytoskeleton [GO:0045111]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; intermediate filament cytoskeleton [GO:0045111]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0004879; GO:0005654; GO:0005667; GO:0006355; GO:0006805; GO:0007165; GO:0008202; GO:0008270; GO:0010628; GO:0016604; GO:0016922; GO:0030154; GO:0042178; GO:0042908; GO:0045111; GO:0045892; GO:0045893; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" ESWNHADFVHCEDTESVPGK 0.99232 -25.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3868 0 0 0 0 0 0 0 14.4211 0 0 0 0 12.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95365 ZBT7A_HUMAN "Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1, FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor, POK erythroid myeloid ontogenic factor, Pokemon, Pokemon 1) (TTF-I-interacting peptide 21, TIP21) (Zinc finger protein 857A)" ZBTB7A FBI1 LRF ZBTB7 ZNF857A Homo sapiens (Human) "B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "cytoplasm [GO:0005737]; DNA-dependent protein kinase complex [GO:0070418]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; erythrocyte maturation [GO:0043249]; fat cell differentiation [GO:0045444]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to nucleus [GO:0034504]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of glycolytic process [GO:0006110]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription regulatory region DNA binding [GO:2000677]; transcription, DNA-templated [GO:0006351]" GO:0000122; GO:0000381; GO:0000978; GO:0000981; GO:0001222; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006110; GO:0006325; GO:0006338; GO:0006351; GO:0006357; GO:0030183; GO:0030512; GO:0034504; GO:0035035; GO:0035861; GO:0042981; GO:0043249; GO:0045444; GO:0045746; GO:0045892; GO:0046332; GO:0046872; GO:0050681; GO:0051090; GO:0051092; GO:0060766; GO:0070418; GO:0097680; GO:0140297; GO:1990837; GO:2000677 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription corepressor binding [GO:0001222]" GVMDYYLK 0.99232 -15.036 0 0 0 14.3701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5325 14.7131 13.8303 0 13.7134 0 13.8474 19.6401 13.7073 0 0 0 0 13.3099 0 13.8236 12.3781 13.4691 14.0856 0 0 0 15.5521 19.5704 0 13.44 13.2598 13.2718 0 0 0 0 13.5628 13.0061 0 14.6772 13.4637 0 0 14.2897 0 0 0 0 0 0 0 0 13.3509 0 0 0 0 0 13.9347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7742 0 0 13.9256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95755 RAB36_HUMAN Ras-related protein Rab-36 RAB36 Homo sapiens (Human) protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0015031; GO:0016192 GTP binding [GO:0005525]; GTPase activity [GO:0003924] TGENVKAFFSR 0.99232 -4.9321 0 0 0 0 0 0 0 0 0 0 0 12.1031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96766 0 0 0 P17342 ANPRC_HUMAN "Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C, ANP-C, ANPR-C, NPR-C)" NPR3 ANPRC C5orf23 NPRC Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; vasodilation [GO:0042311] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; protein-containing complex [GO:0032991]; chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoclast proliferation [GO:0002158]; pancreatic juice secretion [GO:0030157]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of urine volume [GO:0035810]; regulation of blood pressure [GO:0008217]; regulation of osteoblast proliferation [GO:0033688]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; vasodilation [GO:0042311] GO:0001501; GO:0002158; GO:0005887; GO:0007165; GO:0007193; GO:0007194; GO:0007200; GO:0008217; GO:0008528; GO:0016941; GO:0017046; GO:0030157; GO:0031404; GO:0032991; GO:0033688; GO:0035810; GO:0038023; GO:0042277; GO:0042311; GO:0042562; GO:0042803; GO:0048015; GO:0048662; GO:0051000; GO:0070062; GO:0120163 chloride ion binding [GO:0031404]; G protein-coupled peptide receptor activity [GO:0008528]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] FEMRPNVK 0.99232 -17.975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2802 0 0 0 0 0 0 0 0 0 0 0 14.5267 0 0 0 0 0 0 0 0 0 0 0 13.7828 0 0 14.9388 0 0 0 0 0 12.7463 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6764 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2515 0 12.9566 0 0 0 12.7107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3408 0 0 0 0 0 0 0 0 0 12.9715 0 0 0 0 0 0 0 P33992 MCM5_HUMAN "DNA replication licensing factor MCM5, EC 3.6.4.12 (CDC46 homolog) (P1-CDC46)" MCM5 CDC46 Homo sapiens (Human) cell cycle [GO:0007049]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174] "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697]; cell cycle [GO:0007049]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174]" GO:0000727; GO:0000781; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006268; GO:0006270; GO:0007049; GO:0016020; GO:0016887; GO:0030174; GO:0042555; GO:0071162 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; single-stranded DNA binding [GO:0003697] DEHNEER 0.99232 -18.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9454 0 0 0 0 0 0 14.5927 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 0 0 0 0 0 0 14.1883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0608 0 0 14.0393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5702 0 0 0 0 0 0 P53582 MAP11_HUMAN "Methionine aminopeptidase 1, MAP 1, MetAP 1, EC 3.4.11.18 (Peptidase M 1)" METAP1 KIAA0094 Homo sapiens (Human) N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; platelet aggregation [GO:0070527]; protein initiator methionine removal involved in protein maturation [GO:0035551]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; platelet aggregation [GO:0070527]; protein initiator methionine removal involved in protein maturation [GO:0035551]; regulation of translation [GO:0006417] GO:0004177; GO:0005737; GO:0005829; GO:0006417; GO:0008235; GO:0018206; GO:0031365; GO:0035551; GO:0046872; GO:0070006; GO:0070527 aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235] GSWATHKLLHKK 0.99232 -15.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7321 13.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0244 0 12.8256 0 0 0 0 0 14.2593 0 0 0 0 0 0 13.2897 0 0 12.7654 0 0 0 0 0 0 0 0 0 0 0 0 12.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13671 RIN1_HUMAN Ras and Rab interactor 1 (Ras inhibitor JC99) (Ras interaction/interference protein 1) RIN1 Homo sapiens (Human) endocytosis [GO:0006897]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; endocytosis [GO:0006897]; signal transduction [GO:0007165] GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030139; GO:0031267 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] DILLLPLQLPRAIHHAATHK 0.99232 -7.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3753 0 0 12.2798 0 0 0 0 0 10.6537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2635 0 0 13.8697 0 0 12.6511 0 0 0 13.1552 0 0 0 0 0 0 11.7902 0 0 0 0 0 0 14.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZST2 COLDT_HUMAN Putative uncharacterized protein COL25A1-DT (COL25A1 divergent transcript) (Zinc finger CCHC domain-containing protein 23) COL25A1-DT ZCCHC23 Homo sapiens (Human) nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0008270 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] FVDELCISYSAKKGR 0.99232 -7.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6799 0 0 11.8959 0 0 12.9347 0 0 13.5785 0 13.088 0 0 0 13.6453 13.5558 0 0 14.4392 12.8199 0 0 0 0 13.3887 0 0 14.1342 0 0 0 0 0 0 13.7855 0 0 0 0 0 0 0 0 0 14.2531 0 0 13.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2408 12.6918 0 0 0 0 0 0 0 0 12.8385 0 0 0 0 0 0 0 0 0 12.0775 0 0 0 0 0 14.0718 0 0 0 0 0 0 0 14.4982 0 0 0 0 0 0 Q7L2E3 DHX30_HUMAN "ATP-dependent RNA helicase DHX30, EC 3.6.4.13 (DEAH box protein 30)" DHX30 DDX30 KIAA0890 Homo sapiens (Human) central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775] GO:0003682; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0007417; GO:0016887; GO:0035770; GO:0042645; GO:1902775 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AAALACK 0.99232 -17.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9682 0 0 0 10.9216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3911 18.2869 0 0 0 13.3845 0 0 0 14.9227 0 15.6813 0 0 0 0 13.356 0 13.416 0 0 0 0 0 0 0 0 13.388 0 16.0546 0 0 0 0 0 0 0 0 0 0 14.0234 0 0 0 0 0 0 13.184 0 0 0 0 11.8781 0 0 0 0 0 0 0 0 0 12.9237 15.5697 0 0 14.0471 0 0 0 0 0 0 0 0 0 0 0 0 14.1836 0 0 0 0 0 0 0 Q8IV38 ANKY2_HUMAN Ankyrin repeat and MYND domain-containing protein 2 ANKMY2 Homo sapiens (Human) cilium [GO:0005929] cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872] GO:0005929; GO:0019899; GO:0046872 enzyme binding [GO:0019899]; metal ion binding [GO:0046872] DGENKLDTLIKSLLK 0.99232 -17.965 0 0 0 0 0 0 0 0 0 12.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5621 12.4929 12.1062 0 0 0 0 0 0 0 0 0 0 12.1534 0 0 0 12.975 13.4009 14.0748 13.7663 14.2116 0 14.869 0 0 14.2461 0 0 0 0 15.8323 0 0 13.3505 15.2745 14.8836 15.0437 16.8338 13.8598 0 0 0 0 0 13.1117 0 0 14.3414 14.2208 15.413 15.374 0 0 15.7981 0 0 0 15.9246 15.8665 16.2175 0 0 14.6185 12.9449 0 0 0 0 0 0 12.4024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0029 0 15.1943 0 0 15.5291 0 0 0 Q8NB16 MLKL_HUMAN "Mixed lineage kinase domain-like protein, hMLKL" MLKL Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207]; protein phosphorylation [GO:0006468] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207]; protein phosphorylation [GO:0006468] GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007166; GO:0019901; GO:0030054; GO:0042802; GO:0044877; GO:0051607; GO:0070207; GO:0070266; GO:0097527; GO:0097528 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877] CEEMKYCK 0.99232 -18.456 0 0 0 0 9.92825 0 0 0 0 11.6515 0 0 12.2742 0 0 0 0 0 0 10.8024 0 0 0 0 0 0 0 0 0 13.2227 0 0 0 0 10.4105 12.8057 0 0 11.2674 0 0 10.86 0 0 0 0 0 0 12.6498 13.2983 12.918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8388 0 0 0 10.0828 0 0 0 0 0 13.6815 0 0 0 0 11.3421 0 0 0 0 0 0 0 0 0 0 11.0897 12.1594 0 0 13.1448 12.5853 0 0 0 12.4046 14.3749 14.7233 0 12.6422 0 0 0 0 0 12.9541 0 12.9214 0 0 12.5796 12.5019 0 12.3517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1622 0 0 0 0 0 11.6877 0 0 0 0 0 0 0 15.6973 0 0 11.7772 13.0151 0 0 0 0 0 14.4891 Q96H20 SNF8_HUMAN "Vacuolar-sorting protein SNF8 (ELL-associated protein of 30 kDa) (ESCRT-II complex subunit VPS22, hVps22)" SNF8 EAP30 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral budding via host ESCRT complex [GO:1903772] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; transcription regulator complex [GO:0005667]; channel regulator activity [GO:0016247]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of protein catabolic process [GO:0042176]; regulation of protein complex stability [GO:0061635]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral budding via host ESCRT complex [GO:1903772] GO:0000814; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0008022; GO:0010008; GO:0010628; GO:0016020; GO:0016236; GO:0016247; GO:0031902; GO:0032456; GO:0036258; GO:0042176; GO:0042803; GO:0043328; GO:0045022; GO:0045732; GO:0047485; GO:0048471; GO:0055037; GO:0061635; GO:0070062; GO:0071985; GO:0090148; GO:1903543; GO:1903772 channel regulator activity [GO:0016247]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485] QVLEHLLK 0.99232 -6.0351 0 0 0 12.716 0 0 12.347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HA7 TONSL_HUMAN "Tonsoku-like protein (Inhibitor of kappa B-related protein, I-kappa-B-related protein, IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2)" TONSL IKBR NFKBIL2 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; histone binding [GO:0042393]; histone reader activity [GO:0140566]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297] GO:0000724; GO:0005654; GO:0005737; GO:0016604; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566 histone binding [GO:0042393]; histone reader activity [GO:0140566] AGQHSQAMRCLEGARECAHTMR 0.99232 -7.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4854 0 13.6964 0 0 0 0 0 13.2745 10.0638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4961 0 0 0 15.085 13.4419 0 0 0 0 0 0 0 0 0 0 0 11.823 0 0 0 0 12.4925 0 0 0 0 0 0 0 11.028 0 0 0 0 0 0 0 0 12.2938 0 0 14.2433 0 0 0 0 0 15.4651 0 0 0 0 0 0 0 12.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KN3 PKNX2_HUMAN Homeobox protein PKNOX2 (Homeobox protein PREP-2) (PBX/knotted homeobox 2) PKNOX2 PREP2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003785; GO:0005654; GO:0005737; GO:0006357; GO:0015629; GO:0015630; GO:0045171; GO:0051015; GO:1990837 "actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DFCNRYITCLK 0.99232 -6.0349 0 11.7645 0 0 12.0681 0 0 0 0 0 0 0 0 13.9539 0 0 13.5621 0 0 0 0 0 0 0 0 0 0 0 0 14.1232 0 0 0 0 14.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.777 0 0 0 13.8142 0 0 0 0 0 12.936 0 0 14.4434 0 0 0 0 0 0 0 17.5986 0 0 0 0 0 0 0 0 0 0 0 0 14.38 0 12.7632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.177 0 0 0 0 0 0 0 0 0 0 Q99501 GA2L1_HUMAN GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1) GAS2L1 GAR22 Homo sapiens (Human) actin crosslink formation [GO:0051764]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; protein localization to microtubule plus-end [GO:1904825]; regulation of cell cycle [GO:0051726]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; nuclear thyroid hormone receptor binding [GO:0046966]; actin crosslink formation [GO:0051764]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; protein localization to microtubule plus-end [GO:1904825]; regulation of cell cycle [GO:0051726]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0001578; GO:0005737; GO:0005856; GO:0007026; GO:0008017; GO:0008093; GO:0009267; GO:0010629; GO:0030308; GO:0031110; GO:0045647; GO:0046966; GO:0051015; GO:0051726; GO:0051764; GO:0097067; GO:1904825 actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; microtubule binding [GO:0008017]; nuclear thyroid hormone receptor binding [GO:0046966] ARSPAAPR 0.99232 -18.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4731 12.0673 0 0 0 0 0 0 0 11.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6636 0 0 0 0 0 0 0 0 13.449 13.2723 0 0 0 12.9332 0 0 13.1805 0 0 0 13.0642 13.2341 0 0 0 12.0438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0146 0 0 0 13.3966 0 0 0 0 0 13.7704 13.6827 0 0 0 13.5908 0 0 0 12.5377 13.1857 0 0 13.3112 0 0 13.3946 0 0 0 0 0 12.5167 0 13.3168 14.2152 0 0 12.9316 0 13.4213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.213 0 0 0 0 13.2963 0 0 0 0 12.8771 Q9BRT2 UQCC2_HUMAN Ubiquinol-cytochrome-c reductase complex assembly factor 2 (Breast cancer-associated protein SGA-81M) (Mitochondrial nucleoid factor 1) (Mitochondrial protein M19) UQCC2 C6orf125 MNF1 Homo sapiens (Human) mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]; regulation of insulin secretion [GO:0050796]; regulation of oxidative phosphorylation [GO:0002082]; regulation of skeletal muscle cell differentiation [GO:2001014] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]; regulation of insulin secretion [GO:0050796]; regulation of oxidative phosphorylation [GO:0002082]; regulation of skeletal muscle cell differentiation [GO:2001014] GO:0002082; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0016604; GO:0034551; GO:0042645; GO:0050796; GO:0070131; GO:2001014 GMWKKLQEK 0.99232 -4.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7946 0 0 0 0 0 0 0 12.2743 0 0 14.0585 0 0 0 0 0 0 0 0 12.519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8108 0 0 0 10.9085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0J9 PAR12_HUMAN "Protein mono-ADP-ribosyltransferase PARP12, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 12, ARTD12) (Poly [ADP-ribose] polymerase 12, PARP-12) (Zinc finger CCCH domain-containing protein 1)" PARP12 ZC3HDC1 Homo sapiens (Human) protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; RNA binding [GO:0003723]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] GO:0003723; GO:0003950; GO:0005634; GO:0046872; GO:0070213; GO:0140289; GO:1990404 metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; RNA binding [GO:0003723] AFVQKNLVYGTTKK 0.99232 -7.7079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8766 0 0 0 0 12.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5758 16.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8402 0 0 0 0 Q9UDX4 S14L3_HUMAN SEC14-like protein 3 (Tocopherol-associated protein 2) SEC14L3 TAP2 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; lipid binding [GO:0008289] GO:0005737; GO:0008289; GO:0016607; GO:0070062 lipid binding [GO:0008289] DQVKTQYEHSVQINRGSSHQVEYEILFPGCVLR 0.99232 -7.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8446 12.4043 0 0 0 0 0 12.4227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7205 11.3713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5564 0 0 0 0 12.1592 11.0083 10.8279 11.2093 12.0876 0 13.8137 0 0 0 0 13.5168 0 0 15.4959 11.3683 0 13.3411 0 0 11.4565 12.9612 0 0 11.1132 0 12.0255 0 12.9696 12.4119 0 0 0 0 13.0392 0 0 11.726 0 0 0 0 0 0 0 0 11.6164 0 0 0 0 0 0 0 0 11.3648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1091 0 0 11.626 0 0 0 0 0 0 0 Q9UHL0 DDX25_HUMAN "ATP-dependent RNA helicase DDX25, EC 3.6.4.13 (DEAD box protein 25) (Gonadotropin-regulated testicular RNA helicase)" DDX25 GRTH Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]; spermatid development [GO:0007286] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0006406; GO:0006417; GO:0007286; GO:0010494; GO:0016887; GO:0016973; GO:0033391 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] FRDGKEK 0.99232 -18.461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3935 0 11.6653 15.9063 0 0 0 0 14.6809 0 0 0 0 0 0 0 0 13.4281 13.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3173 0 0 0 0 0 0 0 0 0 0 0 0 13.0892 0 0 0 0 0 0 0 0 13.8887 0 0 15.0755 12.5568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5J1 UTP18_HUMAN U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50) UTP18 WDR50 CDABP0061 CGI-48 Homo sapiens (Human) rRNA processing [GO:0006364] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0031965; GO:0032040; GO:0034388 RNA binding [GO:0003723] GNFPPQK 0.99232 -18.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.567 0 0 0 0 0 0 13.1628 0 0 0 0 14.3233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.342 0 0 0 12.764 0 0 0 0 0 0 0 0 0 13.6849 0 0 0 0 0 12.5093 0 12.2435 0 0 0 0 0 0 0 0 0 0 0 0 0 13.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7959 0 0 0 0 0 0 0 0 10.7817 0 O15528 CP27B_HUMAN "25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, EC 1.14.15.18 (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase, VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1)" CYP27B1 CYP1ALPHA CYP27B Homo sapiens (Human) bone mineralization [GO:0030282]; calcitriol biosynthetic process from calciol [GO:0036378]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; decidualization [GO:0046697]; G1 to G0 transition [GO:0070314]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of bone mineralization [GO:0030500]; response to estrogen [GO:0043627]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcidiol 1-monooxygenase activity [GO:0004498]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; secalciferol 1-monooxygenase activity [GO:0062185]; bone mineralization [GO:0030282]; calcitriol biosynthetic process from calciol [GO:0036378]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; decidualization [GO:0046697]; G1 to G0 transition [GO:0070314]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of bone mineralization [GO:0030500]; response to estrogen [GO:0043627]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766] GO:0004498; GO:0005506; GO:0005737; GO:0005739; GO:0005741; GO:0006766; GO:0006816; GO:0008285; GO:0010956; GO:0010980; GO:0020037; GO:0030282; GO:0030308; GO:0030500; GO:0032496; GO:0033280; GO:0034341; GO:0036378; GO:0042359; GO:0042369; GO:0043627; GO:0045618; GO:0046697; GO:0055074; GO:0062185; GO:0070314; GO:0070564 calcidiol 1-monooxygenase activity [GO:0004498]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; secalciferol 1-monooxygenase activity [GO:0062185] DIHVGDYIIPK 0.99233 -4.9508 0 0 0 11.4676 0 0 0 0 0 0 0 0 0 0 0 12.323 0 11.866 0 0 12.4124 0 11.3493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3445 0 0 0 0 0 0 0 0 0 13.1834 0 0 0 0 0 12.0409 0 0 0 0 0 12.9867 12.9419 0 0 0 0 0 0 0 0 0 0 0 0 14.4608 0 14.3851 14.5498 0 13.8776 0 0 0 0 0 0 0 13.4371 0 0 13.7778 0 0 0 0 13.0494 13.0623 0 0 0 0 0 0 0 0 0 0 0 0 13.2845 0 0 0 0 12.6829 0 0 0 13.4837 14.2989 0 13.6604 12.8137 11.7999 0 0 0 0 0 0 0 11.9262 0 13.2041 15.0813 13.3174 13.3115 14.9114 0 0 15.4236 13.5955 0 0 0 0 14.9573 0 0 0 13.9979 0 0 0 0 13.2651 0 0 0 0 0 0 13.1207 0 0 13.2686 0 0 0 12.6284 0 14.6734 0 13.0098 0 0 0 0 0 0 P04062 GLCM_HUMAN "Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC 3.2.1.45 (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase, Beta-GC) (Cholesterol glucosyltransferase, SGTase, EC 2.4.1.-) (Cholesteryl-beta-glucosidase, EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase, EC 3.2.1.46) (Lysosomal glycosylceramidase)" GBA GC GLUC Homo sapiens (Human) antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295]; antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of cellular protein metabolic process [GO:0032268]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of water loss via skin [GO:0033561]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021] GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006680; GO:0006914; GO:0007040; GO:0008203; GO:0008340; GO:0009267; GO:0009268; GO:0014004; GO:0016241; GO:0019882; GO:0019898; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032268; GO:0032436; GO:0032715; GO:0033077; GO:0033561; GO:0033574; GO:0035307; GO:0043161; GO:0043202; GO:0043243; GO:0043407; GO:0043524; GO:0043589; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050905; GO:0051247; GO:0051402; GO:0061518; GO:0061744; GO:0070062; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901215; GO:1901805; GO:1903052; GO:1903061; GO:1904457; GO:1904925; GO:1905037; GO:1905165 galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295] DVPLTIK 0.99233 -24.051 0 0 0 0 0 0 11.8667 0 0 0 0 0 0 0 0 0 0 10.6064 0 0 0 0 0 0 0 0 0 0 0 11.1139 13.2519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4784 0 0 12.1215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3001 12.4506 13.3597 12.8289 13.5145 12.8866 13.5503 13.8578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4743 0 0 0 0 0 14.8769 0 0 0 0 13.1047 0 0 13.9569 0 0 11.7404 13.348 0 13.906 14.2421 14.7099 0 0 0 0 0 0 0 0 0 13.9381 13.3611 0 0 0 0 0 0 0 0 0 0 0 0 14.2185 14.0475 0 0 0 0 0 0 0 0 0 11.7099 0 0 15.3723 0 15.0306 15.1996 0 0 15.1033 0 15.0471 0 14.9603 0 0 14.7848 0 0 0 11.0463 15.5222 0 15.0097 0 0 P15248 IL9_HUMAN "Interleukin-9, IL-9 (Cytokine P40) (T-cell growth factor P40)" IL9 Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-9 receptor binding [GO:0005140]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] GO:0005125; GO:0005140; GO:0005576; GO:0005615; GO:0006954; GO:0008083; GO:0008284; GO:0016064; GO:0030183; GO:0030307; GO:0032754; GO:0042100; GO:0046425; GO:0050730; GO:2001268 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-9 receptor binding [GO:0005140] SLLEIFQKEK 0.99233 -18.114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52799 EFNB2_HUMAN "Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5, LERK-5) (HTK ligand, HTK-L)" EFNB2 EPLG5 HTKL LERK5 Homo sapiens (Human) adherens junction organization [GO:0034332]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; keratinocyte proliferation [GO:0043616]; lymph vessel development [GO:0001945]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron projection development [GO:0010977]; nephric duct morphogenesis [GO:0072178]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron death [GO:1901216]; presynapse assembly [GO:0099054]; regulation of chemotaxis [GO:0050920]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; T cell costimulation [GO:0031295]; venous blood vessel morphogenesis [GO:0048845] adherens junction [GO:0005912]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] adherens junction [GO:0005912]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; ephrin receptor binding [GO:0046875]; virus receptor activity [GO:0001618]; adherens junction organization [GO:0034332]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; ephrin receptor signaling pathway [GO:0048013]; keratinocyte proliferation [GO:0043616]; lymph vessel development [GO:0001945]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron projection development [GO:0010977]; nephric duct morphogenesis [GO:0072178]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron death [GO:1901216]; presynapse assembly [GO:0099054]; regulation of chemotaxis [GO:0050920]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; T cell costimulation [GO:0031295]; venous blood vessel morphogenesis [GO:0048845] GO:0001618; GO:0001945; GO:0002042; GO:0005886; GO:0005887; GO:0005912; GO:0005925; GO:0007155; GO:0007267; GO:0007411; GO:0008284; GO:0009653; GO:0009887; GO:0010839; GO:0010977; GO:0031295; GO:0034332; GO:0043616; GO:0046875; GO:0048013; GO:0048514; GO:0048845; GO:0050920; GO:0071222; GO:0072178; GO:0098685; GO:0098978; GO:0099054; GO:0099056; GO:0099061; GO:0099072; GO:0099149; GO:1901216; GO:1903849; GO:2000727 ephrin receptor binding [GO:0046875]; virus receptor activity [GO:0001618] ENTPLLNCAK 0.99233 -4.4789 0 0 0 12.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3554 0 0 0 0 0 0 0 0 0 0 0 0 Q08AN1 ZN616_HUMAN Zinc finger protein 616 ZNF616 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFGRLFSLSK 0.99233 -6.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1551 0 0 0 0 0 0 11.2623 0 0 0 0 13.7757 13.4196 0 0 0 0 12.7751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9966 0 14.3035 0 0 0 0 0 0 12.8022 0 0 0 0 0 0 0 13.8924 0 0 0 14.0428 0 0 0 12.0707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13607 OR2F1_HUMAN Olfactory receptor 2F1 (Olfactory receptor 2F3) (Olfactory receptor 2F4) (Olfactory receptor 2F5) (Olfactory receptor-like protein OLF3) OR2F1 OLF3 OR2F3 OR2F3P OR2F4 OR2F5 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EVKGAWQKLLWK 0.99233 -7.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5FWF4 ZRAB3_HUMAN "DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2, AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3, EC 3.6.4.-; Endonuclease ZRANB3, EC 3.1.-.- ]" ZRANB3 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; endodeoxyribonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411] GO:0004386; GO:0004520; GO:0005524; GO:0005654; GO:0006281; GO:0006974; GO:0009411; GO:0031297; GO:0036292; GO:0036310; GO:0043596; GO:0045910; GO:0046872; GO:0048478; GO:0070530; GO:0140658 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; endodeoxyribonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872] DTSKKVQTISDCEK 0.99233 -18.122 11.8702 0 0 0 0 0 0 0 0 11.8925 11.4603 0 0 0 0 0 0 0 0 17.1007 0 0 17.2822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0368 17.1274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.68 0 13.2216 0 13.2204 19.8937 12.5631 12.007 14.715 14.6311 14.3096 12.977 0 0 14.8282 0 14.5112 13.9833 18.3547 0 13.2003 0 0 13.5992 14.0366 13.4964 0 0 18.2907 13.0968 0 0 0 0 12.3955 12.5545 0 13.8758 15.0606 13.1001 19.4205 18.2951 12.8418 12.501 12.723 12.6657 0 15.549 14.3044 13.4705 14.4796 14.6346 16.9789 0 0 12.4509 0 11.5792 0 12.6725 13.3125 13.168 0 0 0 12.9273 13.1967 0 0 12.3506 12.7602 0 0 10.0873 0 0 0 14.4238 0 0 18.0778 0 0 0 0 0 12.7275 0 0 0 0 0 11.4476 0 13.2651 0 0 13.1761 0 0 0 12.1069 0 0 Q5U623 MCAF2_HUMAN "Activating transcription factor 7-interacting protein 2, ATF7-interacting protein 2 (MBD1-containing chromatin-associated factor 2)" ATF7IP2 MCAF2 Homo sapiens (Human) "positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription coregulator activity [GO:0003712]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003712; GO:0005634; GO:0005667; GO:0006355; GO:0090309 transcription coregulator activity [GO:0003712] ELNQRIGK 0.99233 -4.4831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NSI4 RADX_HUMAN "RPA-related protein RADX (RPA-related and RAD51-antagonist, X-chromosome)" RADX CXorf57 Homo sapiens (Human) negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA repair [GO:0006282] nuclear speck [GO:0016607]; replication fork [GO:0005657] nuclear speck [GO:0016607]; replication fork [GO:0005657]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA repair [GO:0006282] GO:0003697; GO:0003723; GO:0005657; GO:0006282; GO:0016607; GO:2000042 RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] DPPTNIIIIPEKQVK 0.99233 -24.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1447 13.7711 13.2966 13.3212 13.4424 13.6275 14.0017 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2287 0 0 13.5976 0 11.7548 0 11.8546 0 11.9281 0 0 13.0649 0 0 0 13.1897 0 0 0 0 0 0 0 0 13.1034 0 0 0 0 0 0 0 0 10.9232 0 15.0395 0 0 0 0 0 0 0 0 0 12.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN06 ZN813_HUMAN Zinc finger protein 813 ZNF813 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNYSSLLRKHQIIHLGEK 0.99233 -24.068 0 0 0 12.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9013 0 0 0 Q86U90 YRDC_HUMAN "Threonylcarbamoyl-AMP synthase, EC 2.7.7.87 (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog, hIRIP)" YRDC DRIP3 IRIP Homo sapiens (Human) negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949] GO:0000049; GO:0002949; GO:0003725; GO:0005737; GO:0005739; GO:0005886; GO:0006450; GO:0016779; GO:0051051; GO:0061710 double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049] DLLPGPVTLVMERSEELNK 0.99233 -6.7553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWF6 DEN6A_HUMAN Protein DENND6A (DENN domain-containing protein 6A) DENND6A FAM116A Homo sapiens (Human) positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome [GO:0055037] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome [GO:0055037]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049] GO:0005085; GO:0005737; GO:0005829; GO:0043231; GO:0055037; GO:2000049 guanyl-nucleotide exchange factor activity [GO:0005085] ALRGPAGLGPGSR 0.99233 -7.7447 0 0 0 0 0 0 0 0 0 14.103 0 0 0 10.5844 0 0 13.4445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0831 0 12.9626 0 0 0 0 0 0 12.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3265 0 0 0 0 0 0 13.6523 0 0 13.9975 0 0 11.5797 0 12.2991 12.9078 12.1801 0 0 0 0 0 0 0 12.7172 0 0 0 0 0 0 0 0 0 17.8664 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6284 10.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFR9 I17RE_HUMAN "Interleukin-17 receptor E, IL-17 receptor E, IL-17RE" IL17RE UNQ3056/PRO9877 Homo sapiens (Human) inflammatory response [GO:0006954] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; interleukin-17 receptor activity [GO:0030368]; inflammatory response [GO:0006954] GO:0005576; GO:0005737; GO:0005886; GO:0006954; GO:0016021; GO:0030368 interleukin-17 receptor activity [GO:0030368] AAPLLALLHAAPRPLLLLAYFSRLCAK 0.99233 -6.7658 0 0 0 0 0 0 0 0 0 0 15.2389 0 0 0 0 0 0 0 0 0 0 0 13.3421 0 12.4168 13.5798 0 0 13.4939 0 15.0948 14.4249 13.4925 0 0 14.0314 0 11.623 11.7336 0 14.8469 12.8722 0 14.4719 0 15.4136 0 0 0 0 0 11.0381 0 0 0 0 10.6598 9.87727 0 0 0 0 0 0 0 0 13.1503 0 0 0 0 0 11.0088 0 0 13.8882 0 0 12.2246 14.4501 16.0625 0 0 15.0668 16.6214 0 16.2801 15.5167 14.9877 0 14.3137 13.3621 13.5786 15.0402 0 15.7159 0 14.2235 16.3481 0 0 0 15.2683 15.4092 0 0 17.4317 13.7252 0 15.9985 9.9424 0 14.8232 0 0 10.1233 0 0 12.9175 15.4295 0 12.3359 11.2962 0 0 14.9709 11.456 12.8947 13.3327 0 10.1546 0 0 0 0 0 0 0 0 0 0 0 14.0879 0 0 0 0 0 0 0 0 0 0 16.3835 0 0 14.8358 15.7034 9.58474 0 0 0 0 12.9693 0 0 0 0 0 0 0 14.0797 0 0 0 0 11.697 0 10.8625 0 Q92985 IRF7_HUMAN "Interferon regulatory factor 7, IRF-7" IRF7 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; establishment of viral latency [GO:0019043]; immune system process [GO:0002376]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of adaptive immune response [GO:0002819]; regulation of immune response [GO:0050776]; regulation of monocyte differentiation [GO:0045655]; regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034124]; regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; establishment of viral latency [GO:0019043]; immune system process [GO:0002376]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of adaptive immune response [GO:0002819]; regulation of immune response [GO:0050776]; regulation of monocyte differentiation [GO:0045655]; regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034124]; regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0002376; GO:0002819; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006974; GO:0009615; GO:0010008; GO:0016064; GO:0019043; GO:0032479; GO:0032727; GO:0032728; GO:0034124; GO:0034127; GO:0039530; GO:0045087; GO:0045655; GO:0045893; GO:0045944; GO:0050776; GO:0051607; GO:0060337; GO:0060340; GO:1990837; GO:2000110 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ALAPERAAPR 0.99233 -18.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8901 0 0 14.2097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KK3 KCNS1_HUMAN Potassium voltage-gated channel subfamily S member 1 (Delayed-rectifier K(+) channel alpha subunit 1) (Voltage-gated potassium channel subunit Kv9.1) KCNS1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259] integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259] GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0016021; GO:0048471; GO:0051260; GO:0071805; GO:1902259 delayed rectifier potassium channel activity [GO:0005251]; potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249] ALARFPGTRLGR 0.99233 -24.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5379 13.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8112 13.9133 0 0 0 0 13.8578 0 0 14.3373 0 0 0 12.033 0 0 0 0 0 0 0 0 0 0 0 14.1367 0 14.127 0 0 0 0 14.0828 14.2852 0 0 14.5159 0 0 0 0 0 14.7484 0 14.712 14.6729 14.447 14.2792 14.5343 0 0 0 14.2372 14.4107 14.4126 14.1153 0 0 0 14.2366 14.549 0 14.2301 0 14.2617 0 0 0 0 0 14.5891 0 0 0 14.8392 0 0 0 0 14.5112 14.7417 14.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.863 14.4564 0 0 0 0 0 14.4058 0 Q9HAK2 COE2_HUMAN "Transcription factor COE2 (Early B-cell factor 2, EBF-2)" EBF2 COE2 Homo sapiens (Human) adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cell fate determination [GO:0001709]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cell fate determination [GO:0001709]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001709; GO:0003682; GO:0005634; GO:0006357; GO:0035563; GO:0046872; GO:0050873; GO:0060612; GO:0120162 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FIYTALNEPTIDYGFQR 0.99233 -6.7537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5285 0 0 0 0 12.9789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1785 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4089 12.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRL3 STRN4_HUMAN Striatin-4 (Zinedin) STRN4 ZIN Homo sapiens (Human) anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; FAR/SIN/STRIPAK complex [GO:0090443]; membrane [GO:0016020]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877] GO:0005516; GO:0005737; GO:0016020; GO:0030425; GO:0043197; GO:0044877; GO:0051721; GO:0070016; GO:0070161; GO:0090443 armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877] ALIASAGADALAK 0.99233 -4.4782 0 0 0 0 0 0 0 0 0 0 0 0 12.0066 0 0 11.3057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9215 0 0 0 0 13.0775 0 0 0 0 0 0 0 0 0 0 12.5341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9862 0 11.3205 0 Q9UBH6 XPR1_HUMAN "Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3, X-receptor)" XPR1 SYG1 XR Homo sapiens (Human) cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to phosphate starvation [GO:0016036]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615] GO:0000822; GO:0001618; GO:0004888; GO:0004930; GO:0005737; GO:0005794; GO:0005886; GO:0006817; GO:0007186; GO:0009615; GO:0015114; GO:0015562; GO:0016021; GO:0016036; GO:0030643; GO:0031226; GO:0035435; GO:0038023 efflux transmembrane transporter activity [GO:0015562]; G protein-coupled receptor activity [GO:0004930]; inositol hexakisphosphate binding [GO:0000822]; phosphate ion transmembrane transporter activity [GO:0015114]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] FIQCLRRYR 0.99233 -18.054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8674 0 0 0 0 0 0 11.5663 0 0 0 0 11.7715 0 0 0 0 0 0 0 0 0 0 0 0 12.6919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4323 13.9869 0 14.2447 13.8471 0 0 14.3918 0 0 0 0 0 0 12.6126 0 0 0 0 0 0 0 0 0 14.6272 0 0 0 10.2174 0 0 0 0 0 0 0 12.5066 0 0 14.515 0 12.9805 0 0 0 12.7679 0 0 13.026 0 0 0 0 0 12.8707 0 0 0 13.4026 0 14.082 13.2515 0 14.1232 12.6159 0 14.3927 0 14.4889 13.2362 14.4102 0 13.89 0 0 0 14.1554 12.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4105 0 0 0 0 0 0 0 13.4372 Q9UPX0 TUTLB_HUMAN "Protein turtle homolog B (Immunoglobulin superfamily member 9B, IgSF9B)" IGSF9B KIAA1030 Homo sapiens (Human) cell adhesion [GO:0007155]; nervous system development [GO:0007399] anchoring junction [GO:0070161]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629] anchoring junction [GO:0070161]; GABA-ergic synapse [GO:0098982]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization of symmetric synapse [GO:0099629]; cell adhesion [GO:0007155]; nervous system development [GO:0007399] GO:0007155; GO:0007399; GO:0014069; GO:0016021; GO:0043005; GO:0045211; GO:0070161; GO:0098982; GO:0099629 DLSQDTWYEFR 0.99233 -17.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.699 0 12.914 0 0 0 0 0 0 0 0 0 0 10.4659 0 0 10.7136 0 0 0 11.1035 0 0 0 0 0 0 0 0 0 10.6278 0 0 0 0 0 10.6031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.906 0 0 0 10.695 0 13.8216 15.1921 0 0 0 14.0317 0 0 0 16.1268 0 15.913 16.3404 14.4793 15.2839 15.4751 12.3144 15.3378 0 13.6423 0 0 0 0 14.4645 14.079 13.581 0 0 0 0 0 16.2341 0 15.1549 13.4348 12.9236 15.5963 0 0 0 13.674 14.4335 13.7595 13.5292 13.7917 13.474 13.5854 14.4215 0 0 0 0 13.4625 0 0 12.253 0 0 0 0 0 0 0 0 0 0 12.8838 0 12.9652 0 0 0 0 0 12.1559 13.6307 0 0 0 0 0 0 0 0 0 0 0 13.0207 13.8746 0 0 0 0 0 0 0 0 0 0 Q9Y2Q0 AT8A1_HUMAN "Phospholipid-transporting ATPase IA, EC 7.6.2.1 (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1)" ATP8A1 ATPIA Homo sapiens (Human) aminophospholipid translocation [GO:0140331]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transport across blood-brain barrier [GO:0150104] azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802] azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; aminophospholipid translocation [GO:0140331]; ion transmembrane transport [GO:0034220]; learning [GO:0007612]; phospholipid translocation [GO:0045332]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; transport across blood-brain barrier [GO:0150104] GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007612; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0030335; GO:0031090; GO:0031410; GO:0034220; GO:0035577; GO:0035579; GO:0042584; GO:0043231; GO:0045332; GO:0061092; GO:0070062; GO:0090556; GO:0140326; GO:0140331; GO:0140346; GO:0150104; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] AQLLKNVFK 0.99233 -18.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3E1 HDGR3_HUMAN "Hepatoma-derived growth factor-related protein 3, HRP-3 (Hepatoma-derived growth factor 2, HDGF-2)" HDGFL3 HDGF2 HDGFRP3 CGI-142 Homo sapiens (Human) microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; tubulin binding [GO:0015631]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003690; GO:0003712; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007026; GO:0008017; GO:0008083; GO:0015631; GO:0031175; GO:0046785 double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; tubulin binding [GO:0015631] MKGYPHWPAR 0.99233 -15.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54296 MYOM2_HUMAN Myomesin-2 (165 kDa connectin-associated protein) (165 kDa titin-associated protein) (M-protein) (Myomesin family member 2) MYOM2 Homo sapiens (Human) muscle contraction [GO:0006936]; sarcomere organization [GO:0045214] M band [GO:0031430]; mitochondrion [GO:0005739]; myosin filament [GO:0032982] M band [GO:0031430]; mitochondrion [GO:0005739]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; kinase binding [GO:0019900]; structural constituent of muscle [GO:0008307]; muscle contraction [GO:0006936]; sarcomere organization [GO:0045214] GO:0005739; GO:0006936; GO:0008307; GO:0019900; GO:0031430; GO:0032982; GO:0045214; GO:0051015 actin filament binding [GO:0051015]; kinase binding [GO:0019900]; structural constituent of muscle [GO:0008307] AAAFAEK 0.99234 -18.167 0 0 0 0 12.0715 0 0 11.3865 0 0 0 0 10.2206 0 0 0 0 0 0 11.3247 0 0 0 0 0 0 0 0 0 0 0 10.9718 0 0 0 12.1611 0 0 0 0 0 12.37 0 0 0 0 0 0 12.0611 0 0 0 0 0 0 0 0 0 0 0 14.3761 14.0991 14.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0249 0 0 13.6763 13.9254 0 0 0 13.8839 10.3962 14.3385 11.9897 12.0215 0 0 0 0 0 0 0 12.1006 0 17.9242 13.2245 0 0 0 0 12.8497 0 0 0 0 13.418 0 13.9022 0 0 0 0 14.488 0 13.544 0 12.7777 0 14.689 15.0827 0 0 0 0 0 12.4999 18.0018 14.3702 14.2724 14.5536 0 0 14.0313 0 14.8981 0 14.3058 0 13.2806 0 11.0524 0 0 0 14.0944 0 0 17.9654 0 0 14.615 0 0 0 0 0 0 0 0 11.3315 0 0 0 0 0 0 13.5495 12.3339 0 12.817 11.579 0 0 0 O15530 PDPK1_HUMAN "3-phosphoinositide-dependent protein kinase 1, hPDK1, EC 2.7.11.1" PDPK1 PDK1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323] GO:0003323; GO:0004674; GO:0004676; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006469; GO:0006972; GO:0007173; GO:0010518; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0018105; GO:0018107; GO:0019722; GO:0030036; GO:0030512; GO:0031410; GO:0032148; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043274; GO:0043304; GO:0043536; GO:0045766; GO:0046777; GO:0051281; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:2000352 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DLVEKLLVLDATKR 0.99234 -25.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2214 0 0 0 0 0 11.5716 0 0 0 0 11.3518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7764 0 0 0 0 0 15.3595 0 14.9459 0 0 13.3662 0 0 0 0 19.3179 0 0 0 0 13.4081 0 13.4272 0 0 13.6496 0 12.8218 0 0 0 0 0 0 0 13.3801 0 0 11.2062 0 0 15.1137 0 0 0 0 0 0 19.3349 0 0 0 0 14.7892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3192 0 0 0 16.6318 0 16.5073 10.679 0 14.594 0 0 0 0 14.6265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6589 O94911 ABCA8_HUMAN "ABC-type organic anion transporter ABCA8, EC 7.6.2.- (ATP-binding cassette sub-family A member 8)" ABCA8 KIAA0822 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol transport [GO:0030301]; lipid transport [GO:0006869]; positive regulation of cholesterol efflux [GO:0010875]; regulation of cholesterol efflux [GO:0010874]; sphingomyelin biosynthetic process [GO:0006686]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; cholesterol transport [GO:0030301]; lipid transport [GO:0006869]; positive regulation of cholesterol efflux [GO:0010875]; regulation of cholesterol efflux [GO:0010874]; sphingomyelin biosynthetic process [GO:0006686]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] GO:0005319; GO:0005524; GO:0005783; GO:0005886; GO:0006686; GO:0006869; GO:0008559; GO:0010874; GO:0010875; GO:0016021; GO:0016323; GO:0030301; GO:0033344; GO:0042626; GO:0042908; GO:0043231; GO:0055085; GO:0140359 ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] EAIRIRNVTK 0.99234 -18.144 0 0 0 0 0 13.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4689 0 11.984 14.9359 14.24 0 0 0 15.0333 14.1117 13.0115 13.0597 11.5299 14.6286 13.3749 0 0 0 0 12.9419 0 0 14.7276 0 13.9007 0 0 0 12.6125 11.6966 0 13.7495 0 0 0 14.5742 0 0 12.3506 13.4723 0 13.2478 13.3886 0 0 0 0 0 11.6442 0 14.5064 12.1173 0 0 0 0 12.0642 0 13.0631 0 0 14.3854 12.9994 14.8509 0 0 12.7217 0 0 0 0 0 14.8182 0 14.2232 0 0 0 0 0 0 0 0 11.3842 0 12.0429 14.525 0 0 0 11.7194 0 0 11.3158 0 0 0 0 0 0 0 13.0165 14.2219 O95832 CLD1_HUMAN Claudin-1 (Senescence-associated epithelial membrane protein) CLDN1 CLD1 SEMP1 UNQ481/PRO944 Homo sapiens (Human) aging [GO:0007568]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell junction maintenance [GO:0034331]; cell-cell junction organization [GO:0045216]; cellular response to butyrate [GO:1903545]; cellular response to interferon-gamma [GO:0071346]; cellular response to lead ion [GO:0071284]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; establishment of blood-nerve barrier [GO:0008065]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of skin barrier [GO:0061436]; hyperosmotic salinity response [GO:0042538]; liver regeneration [GO:0097421]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of wound healing [GO:0090303]; protein complex oligomerization [GO:0051259]; response to dexamethasone [GO:0071548]; response to ethanol [GO:0045471]; response to interleukin-18 [GO:0070673]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; xenobiotic transport across blood-nerve barrier [GO:0061772] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618]; aging [GO:0007568]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cell junction maintenance [GO:0034331]; cell-cell junction organization [GO:0045216]; cellular response to butyrate [GO:1903545]; cellular response to interferon-gamma [GO:0071346]; cellular response to lead ion [GO:0071284]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; establishment of blood-nerve barrier [GO:0008065]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of skin barrier [GO:0061436]; hyperosmotic salinity response [GO:0042538]; liver regeneration [GO:0097421]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of wound healing [GO:0090303]; protein complex oligomerization [GO:0051259]; response to dexamethasone [GO:0071548]; response to ethanol [GO:0045471]; response to interleukin-18 [GO:0070673]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; xenobiotic transport across blood-nerve barrier [GO:0061772] GO:0001618; GO:0005198; GO:0005737; GO:0005886; GO:0005887; GO:0005923; GO:0007155; GO:0007568; GO:0008065; GO:0009636; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0016338; GO:0030335; GO:0032496; GO:0032991; GO:0034331; GO:0035633; GO:0042538; GO:0042802; GO:0045216; GO:0045471; GO:0051259; GO:0060054; GO:0061436; GO:0061772; GO:0070160; GO:0070673; GO:0070830; GO:0071284; GO:0071346; GO:0071356; GO:0071548; GO:0071560; GO:0090303; GO:0090557; GO:0097421; GO:1903348; GO:1903545 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; virus receptor activity [GO:0001618] ALMVVGILLGVIAIFVATVGMK 0.99234 -14.772 0 0 0 14.2199 0 0 0 12.8462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7244 0 0 0 0 0 0 0 9.35489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.693 0 0 0 0 0 0 0 0 0 0 0 0 13.9503 0 13.5188 0 12.929 12.8164 13.314 0 0 14.0292 0 12.1231 0 0 13.8016 14.2276 0 0 0 0 0 0 12.0547 0 0 11.5298 12.4343 0 0 0 0 0 0 0 0 0 0 0 0 14.1022 0 0 0 0 0 0 12.0696 0 0 0 0 0 0 0 0 0 0 13.5195 0 0 0 11.4452 0 0 0 14.3544 0 0 0 0 0 12.9135 0 0 0 0 0 0 0 0 0 0 11.6009 0 0 0 0 0 0 0 0 P30872 SSR1_HUMAN "Somatostatin receptor type 1, SS-1-R, SS1-R, SS1R, SST1 (SRIF-2)" SSTR1 Homo sapiens (Human) "cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994]; cellular response to estradiol stimulus [GO:0071392]; cellular response to leukemia inhibitory factor [GO:1990830]; cerebellum development [GO:0021549]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; response to starvation [GO:0042594]; spermatogenesis [GO:0007283]" GO:0004930; GO:0004994; GO:0005737; GO:0005886; GO:0005887; GO:0007187; GO:0007215; GO:0007218; GO:0007283; GO:0008285; GO:0021549; GO:0030900; GO:0042277; GO:0042594; GO:0042923; GO:0043005; GO:0071392; GO:1990830 G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; peptide binding [GO:0042277]; somatostatin receptor activity [GO:0004994] LVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAAR 0.99234 -7.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1931 0 0 11.4925 0 0 0 0 12.4641 0 0 13.2562 13.055 0 12.8036 13.9506 0 0 0 0 0 0 0 0 13.2099 0 0 0 0 0 0 0 0 0 0 12.3523 11.6882 0 0 0 0 0 0 0 12.9973 0 0 11.8254 0 0 12.6157 0 0 0 0 0 12.361 0 0 0 0 0 0 0 0 12.7209 0 0 13.7736 0 0 0 0 0 0 0 0 0 10.0107 0 0 0 0 0 0 0 13.4865 0 0 0 0 11.6562 0 12.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9782 11.4768 0 0 0 0 0 P54136 SYRC_HUMAN "Arginine--tRNA ligase, cytoplasmic, EC 6.1.1.19 (Arginyl-tRNA synthetase, ArgRS)" RARS1 RARS Homo sapiens (Human) arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA aminoacylation for protein translation [GO:0006418] GO:0000049; GO:0004814; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006418; GO:0006420; GO:0016020; GO:0017101; GO:0034618; GO:0045296; GO:0070062 arginine binding [GO:0034618]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; tRNA binding [GO:0000049] FGDYQCNSAMGISQMLK 0.99234 -40.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7153 0 0 0 0 0 0 0 0 0 0 0 16.9484 0 0 12.2078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56962 STX17_HUMAN Syntaxin-17 STX17 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0000421; GO:0005484; GO:0005739; GO:0005776; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007030; GO:0012505; GO:0012507; GO:0016021; GO:0016240; GO:0019901; GO:0019903; GO:0030134; GO:0030868; GO:0031201; GO:0033116; GO:0034497; GO:0044233; GO:0048278; GO:0097111; GO:0097352 protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] EIEKLCLKVR 0.99234 -7.2251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4937 0 13.5109 13.4248 13.5908 0 0 13.6116 0 0 0 0 0 0 14.1467 12.0251 0 0 0 0 0 13.6437 0 14.0744 14.3505 0 0 0 13.5573 0 14.4783 14.284 14.0979 13.797 14.2238 0 0 0 0 13.9606 14.1874 0 0 0 13.877 14.2225 0 0 0 0 0 14.3389 14.2196 13.9353 14.0372 0 13.8874 14.031 14.0847 0 0 0 0 0 11.7469 0 15.1546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2083 0 14.1964 0 0 0 13.4502 0 Q14149 MORC3_HUMAN MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3) MORC3 KIAA0136 NXP2 ZCWCC3 Homo sapiens (Human) innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821] chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821] GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006468; GO:0008270; GO:0009791; GO:0016363; GO:0016605; GO:0016887; GO:0018105; GO:0035064; GO:0045087; GO:0048147; GO:0050821; GO:0051457; GO:2000774 ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DVYRPKFLSK 0.99234 -25.016 0 0 10.1624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.083 11.8072 13.1326 0 0 0 0 0 0 0 14.9373 11.8987 0 0 12.966 0 0 0 0 0 0 0 0 0 13.2176 0 0 0 0 12.671 0 0 0 0 0 12.1411 0 0 0 11.7957 0 0 0 0 0 0 0 0 0 0 0 12.888 13.6026 0 0 0 0 0 0 0 0 11.2218 0 0 15.1518 0 0 0 12.4974 0 15.1433 0 0 0 0 0 0 11.3093 13.7746 0 0 12.6134 0 0 0 0 0 0 0 0 0 0 11.1338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7313 Q14781 CBX2_HUMAN Chromobox protein homolog 2 CBX2 Homo sapiens (Human) cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122] euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0000791; GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0030154; GO:0031519; GO:0035064; GO:0035102; GO:0045137 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064] AQILVAKPELKDPIR 0.99234 -15.153 0 0 14.1024 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0639 0 0 0 10.8709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7214 0 0 13.8313 12.2673 13.3046 14.0345 0 11.7106 0 12.0355 0 0 0 0 0 14.0702 11.3587 0 0 0 0 14.1072 10.8158 13.5932 0 0 12.6538 13.1437 0 0 0 16.6451 0 0 0 12.8969 0 0 14.843 0 0 12.2879 12.8626 12.6471 0 14.3627 13.9727 0 0 13.146 0 13.7959 0 0 12.8101 0 0 0 13.5317 0 12.1795 12.4183 0 0 0 0 0 14.0923 0 0 11.5576 13.1308 0 0 12.1606 0 13.6956 0 12.3984 0 0 0 0 10.9118 0 0 0 0 0 0 0 0 13.0363 16.2257 0 14.1771 0 14.2644 0 0 0 0 11.6858 Q14966 ZN638_HUMAN "Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1, CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein)" ZNF638 NP220 ZFML Homo sapiens (Human) RNA splicing [GO:0008380] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; RNA splicing [GO:0008380] GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0043231 double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] ASVAKVNK 0.99234 -64.676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6182 13.3712 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.52 0 0 0 0 0 0 0 0 13.3247 0 15.6477 0 0 0 16.5951 0 0 0 13.184 0 0 10.64 0 0 14.7519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.788 0 0 12.6664 0 0 0 0 0 0 13.7169 0 0 0 0 0 0 0 0 0 0 0 13.0081 12.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6333 0 0 0 0 0 0 0 0 Q2M3G4 SHRM1_HUMAN Protein Shroom1 (Apical protein 2) SHROOM1 APXL2 KIAA1960 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; microtubule [GO:0005874] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902] GO:0000902; GO:0005874; GO:0005912; GO:0007015; GO:0016324; GO:0030864; GO:0043296; GO:0045159; GO:0051015; GO:0051017 actin filament binding [GO:0051015]; myosin II binding [GO:0045159] AAVLAQQR 0.99234 -18.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1571 0 0 0 0 13.6497 0 14.502 14.279 0 0 0 0 0 0 0 13.5434 13.4485 0 0 0 0 0 0 0 0 14.0943 13.696 0 0 0 0 0 0 0 0 0 0 0 0 0 9.0922 13.3825 0 0 10.725 0 0 0 0 0 14.6227 0 0 0 12.6619 0 0 12.4737 0 0 0 0 0 0 0 0 0 13.4691 0 0 0 13.5572 0 0 0 0 0 0 0 0 13.7201 0 0 9.68317 0 0 11.6701 0 0 0 0 0 13.4075 12.2922 0 0 13.8705 0 14.5514 0 0 12.3428 13.2544 0 0 0 0 0 0 0 0 0 15.189 0 10.0676 0 0 0 0 0 0 11.202 0 0 0 0 0 0 12.9985 13.9912 12.8669 0 0 0 0 0 0 0 13.5746 0 0 0 0 0 0 0 0 0 10.3404 0 0 0 13.9542 0 10.5806 0 15.2452 0 11.0183 0 0 0 Q3B8N2 LEG9B_HUMAN "Galectin-9B, Gal-9B (Galectin-9-like protein A)" LGALS9B Homo sapiens (Human) "negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of interferon-gamma production [GO:0032689]; positive regulation of gene expression [GO:0010628]" GO:0005634; GO:0005829; GO:0010628; GO:0016936; GO:0030246; GO:0032689; GO:2000562 carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936] QKPPSVR 0.99234 -4.5039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2739 0 0 0 0 0 0 16.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7791 19.1966 14.0464 0 0 14.9496 0 0 0 0 13.9005 0 19.1821 0 0 0 0 16.1195 0 13.9692 0 17.6364 0 0 0 0 0 0 0 13.8639 0 19.2263 0 15.0788 0 13.7398 0 0 0 0 0 0 13.4524 0 0 0 14.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KQZ1 S2535_HUMAN Solute carrier family 25 member 35 SLC25A35 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] GO:0005743; GO:0016021 HGLVGLWR 0.99234 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0P3 HYDIN_HUMAN Hydrocephalus-inducing protein homolog HYDIN HYDIN1 KIAA1864 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930] axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591] GO:0002064; GO:0003341; GO:0005930; GO:0021591; GO:0060438; GO:1904158; GO:1990716; GO:1990718 ARFKISNVGK 0.99234 -65.193 0 0 0 0 0 11.5701 11.4493 0 0 0 0 0 14.4003 12.7906 0 9.75589 16.6919 0 12.2853 0 0 13.6204 13.3239 0 0 0 0 13.7525 0 0 13.617 0 12.7128 0 11.0406 0 0 9.49368 0 14.4425 12.4006 12.8306 0 17.1599 13.8517 0 0 0 0 14.3693 0 0 0 0 0 11.6852 0 0 10.8087 0 0 0 0 0 0 10.57 16.2386 0 11.8076 0 0 0 0 13.0854 14.4168 0 11.9281 0 0 11.3934 14.3467 13.1425 14.1137 14.0842 0 0 13.0652 14.8807 13.7263 11.3704 0 13.1033 0 15.392 0 11.4841 17.6386 0 12.3288 0 11.8425 13.9776 0 0 0 0 13.7159 14.6833 0 13.2563 0 14.2852 13.7921 12.8619 0 0 11.9181 15.7429 14.6192 0 13.1734 12.5384 12.9658 13.3075 0 13.9592 15.2952 0 10.9601 13.6664 0 13.7406 0 0 0 0 12.732 14.6856 14.913 0 13.5981 0 14.0981 13.6353 9.86205 0 13.4437 13.0978 13.9139 0 14.613 14.2894 0 0 13.6015 15.0738 0 0 12.0496 13.8168 0 12.2767 10.6755 0 0 0 11.1053 0 10.6945 12.8968 15.2646 13.8702 0 16.1586 13.1733 14.3695 0 0 9.47476 13.8925 Q5T6S3 PHF19_HUMAN "PHD finger protein 19 (Polycomb-like protein 3, hPCL3)" PHF19 PCL3 Homo sapiens (Human) "chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0019827; GO:0035064; GO:0035098; GO:0046872; GO:0048863; GO:0061087 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] AYMPLRAKR 0.99234 -17.724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60663 0 11.0836 0 0 0 0 0 0 11.6704 0 0 0 0 0 0 0 0 0 0 0 16.7023 0 13.0202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8674 0 0 0 0 0 0 15.2754 0 0 0 0 10.4264 0 0 0 12.3779 0 10.9458 0 0 0 0 0 0 0 0 0 13.3355 0 0 0 13.3435 0 0 0 0 0 0 0 0 14.3073 13.88 0 0 0 15.7465 0 0 0 0 0 0 0 0 0 0 0 14.2715 0 0 0 0 0 13.3465 0 0 0 0 0 11.4824 15.5752 15.7397 15.7267 0 13.6877 13.7192 0 15.3144 14.7025 14.7991 14.0037 14.9311 14.4863 14.0041 13.9576 0 14.4155 14.7227 12.5748 0 0 13.1493 0 0 0 14.4571 12.5087 0 0 0 0 0 0 0 0 0 0 0 0 14.9043 0 0 15.2389 14.1008 0 14.0942 17.7379 15.4596 0 12.8209 0 Q5VTT5 MYOM3_HUMAN Myomesin-3 (Myomesin family member 3) MYOM3 Homo sapiens (Human) muscle contraction [GO:0006936] M band [GO:0031430] M band [GO:0031430]; actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]; muscle contraction [GO:0006936] GO:0006936; GO:0031430; GO:0042803; GO:0051015 actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803] FQWFFQR 0.99234 -40.458 0 0 11.469 0 0 14.0032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8068 10.5516 14.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5085 0 0 0 0 0 12.0828 0 14.0652 0 0 0 0 11.3669 0 0 0 0 13.5891 0 0 0 0 0 0 0 0 0 0 0 13.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.903 0 Q6EMK4 VASN_HUMAN Vasorin (Protein slit-like 2) VASN SLITL2 UNQ314/PRO357/PRO1282 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cellular response to redox state [GO:0071461]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; transforming growth factor beta binding [GO:0050431]; cellular response to hypoxia [GO:0071456]; cellular response to redox state [GO:0071461]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] GO:0005615; GO:0005739; GO:0005765; GO:0005886; GO:0009986; GO:0010719; GO:0016021; GO:0030512; GO:0031012; GO:0045296; GO:0050431; GO:0070062; GO:0071456; GO:0071461 cadherin binding [GO:0045296]; transforming growth factor beta binding [GO:0050431] ALPPLRLPR 0.99234 -25.201 0 0 0 0 0 0 0 0 0 0 11.6422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3953 0 0 0 0 0 0 0 0 0 0 0 10.6221 0 0 0 0 0 11.6392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9356 0 0 0 0 0 0 0 0 0 13.1546 12.3061 0 13.1486 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4574 0 0 0 0 0 0 0 0 14.9297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.213 14.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7873 0 14.5646 Q765P7 MTSS2_HUMAN "Protein MTSS 2 (Actin-bundling with BAIAP2 homology protein 1, ABBA-1) (MTSS1-like protein)" MTSS2 MTSS1L Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell projection assembly [GO:0030031]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178] actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587] "actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; lamellipodium [GO:0030027]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell projection assembly [GO:0030031]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; ruffle assembly [GO:0097178]" GO:0003779; GO:0003785; GO:0005096; GO:0005543; GO:0005546; GO:0007009; GO:0015629; GO:0030027; GO:0030031; GO:0030864; GO:0031235; GO:0031267; GO:0032587; GO:0036120; GO:0061024; GO:0090630; GO:0097178; GO:0097581 "actin binding [GO:0003779]; actin monomer binding [GO:0003785]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]" DHAKEYKR 0.99234 -14.77 0 0 0 12.0591 0 0 0 11.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7475 0 0 0 0 0 0 10.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9678 0 0 0 0 12.1257 0 0 0 0 0 0 0 0 0 0 0 13.7048 0 12.475 0 12.8772 12.9734 0 0 0 14.0889 12.8757 0 0 0 11.8678 0 14.6851 0 0 0 13.9921 0 0 0 13.8235 0 14.4841 0 13.9949 16.0191 15.5925 14.4445 0 0 16.1058 15.982 0 0 0 14.0041 0 0 0 0 0 14.5453 14.229 0 15.7475 15.9894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6497 11.1628 0 0 0 0 0 0 0 0 10.0929 0 0 0 12.1058 0 0 0 0 13.8229 0 0 0 0 0 0 Q8IZV5 RDH10_HUMAN "Retinol dehydrogenase 10, EC 1.1.1.300 (Short chain dehydrogenase/reductase family 16C member 4)" RDH10 SDR16C4 UNQ9375/PRO34191 Homo sapiens (Human) bud elongation involved in lung branching [GO:0060449]; ear development [GO:0043583]; embryonic camera-type eye development [GO:0031076]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; metanephros development [GO:0001656]; neural crest cell development [GO:0014032]; nose development [GO:0043584]; positive regulation of retinoic acid biosynthetic process [GO:1900054]; primary lung bud formation [GO:0060431]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; bud elongation involved in lung branching [GO:0060449]; ear development [GO:0043583]; embryonic camera-type eye development [GO:0031076]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; metanephros development [GO:0001656]; neural crest cell development [GO:0014032]; nose development [GO:0043584]; positive regulation of retinoic acid biosynthetic process [GO:1900054]; primary lung bud formation [GO:0060431]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601]" GO:0001523; GO:0001656; GO:0001701; GO:0002138; GO:0004745; GO:0005737; GO:0005789; GO:0005811; GO:0007601; GO:0008406; GO:0014032; GO:0016021; GO:0016616; GO:0031076; GO:0035115; GO:0042572; GO:0042574; GO:0043583; GO:0043584; GO:0048703; GO:0052650; GO:0060431; GO:0060449; GO:1900054 "NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" IRKEIEPFLPPLK 0.99234 -4.4886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.477 0 13.1391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1331 0 0 0 0 0 0 0 0 0 0 13.6592 0 0 12.5597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8935 0 0 0 0 0 0 0 11.145 0 0 0 0 0 0 0 13.2302 0 0 13.7728 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BR84 ZN559_HUMAN Zinc finger protein 559 ZNF559 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFAFSPDLAKHIR 0.99234 -14.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8644 0 0 10.8208 0 0 0 11.4025 0 0 0 0 0 12.864 0 0 0 0 0 13.1934 12.3158 11.9557 0 11.0197 0 0 0 15.0372 0 0 0 0 0 0 11.9999 14.4389 0 0 0 14.1742 13.8768 0 14.5754 12.5649 0 0 0 0 0 12.3075 12.3923 12.743 0 0 14.5591 0 0 0 0 0 0 0 14.0899 0 0 0 0 13.2897 0 0 0 0 0 0 0 0 11.8546 0 0 0 0 13.1187 0 0 0 17.7922 0 0 0 0 12.4324 0 0 0 0 12.9133 0 0 0 0 0 11.8738 0 0 0 0 0 0 0 Q9C0D2 CE295_HUMAN Centrosomal protein of 295 kDa CEP295 KIAA1731 Homo sapiens (Human) centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599] GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0007099; GO:0008017; GO:0010825; GO:0046599; GO:1901985; GO:1903724; GO:1904951; GO:1990498 microtubule binding [GO:0008017] ADLRHKEALK 0.99234 -40.498 0 0 0 0 11.9523 11.898 0 0 15.1355 14.7512 15.6761 14.7218 0 16.0291 0 0 0 0 0 13.1619 0 0 0 0 0 0 12.5042 0 12.9197 0 0 14.3979 13.3086 11.6828 11.6742 13.4891 0 0 12.1655 0 0 14.2336 0 13.5315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2198 14.3652 13.8746 0 0 12.6515 0 0 13.9197 0 0 13.1449 0 0 11.2385 15.0623 0 12.5846 12.0341 14.1915 0 0 0 0 13.5218 12.3059 0 0 0 0 0 0 14.4163 0 0 13.003 13.3991 0 0 12.8687 0 0 0 0 0 14.1112 12.8123 0 0 0 0 11.5873 11.2195 10.8763 0 0 0 0 0 0 15.388 0 0 12.9635 0 10.7193 14.1872 0 13.3115 0 0 14.1362 0 12.1053 0 0 13.7183 13.6415 0 0 14.127 0 0 0 0 14.7275 0 0 0 0 0 12.0731 0 12.2449 13.2876 13.3369 13.1548 0 0 13.2607 14.8855 0 0 Q9H2I8 LRMDA_HUMAN Leucine-rich melanocyte differentiation-associated protein LRMDA C10orf11 CDA017 Homo sapiens (Human) melanocyte differentiation [GO:0030318] melanocyte differentiation [GO:0030318] GO:0030318 CRYVYYGKNSEGNR 0.99234 -25.083 0 0 0 0 0 0 0 0 0 0 12.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2793 0 0 0 0 0 15.5607 15.2053 0 0 0 0 0 0 0 13.3884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCJ6 VAT1L_HUMAN "Synaptic vesicle membrane protein VAT-1 homolog-like, EC 1.-.-.-" VAT1L KIAA1576 Homo sapiens (Human) oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] GO:0008270; GO:0016491 oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] AEETEQMIEKEAGK 0.99234 -6.7931 0 0 13.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6362 0 15.976 0 0 0 0 0 0 0 0 0 0 16.1249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYF0 DACT1_HUMAN "Dapper homolog 1, hDPR1 (Dapper antagonist of catenin 1) (Hepatocellular carcinoma novel gene 3 protein)" DACT1 DPR1 HNG3 Homo sapiens (Human) "embryonic hindgut morphogenesis [GO:0048619]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube development [GO:0021915]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein stability [GO:0031647]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]" anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; histone deacetylase binding [GO:0042826]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; embryonic hindgut morphogenesis [GO:0048619]; negative regulation of beta-catenin-TCF complex assembly [GO:1904864]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube development [GO:0021915]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein stability [GO:0031647]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008013; GO:0016055; GO:0021915; GO:0030177; GO:0030178; GO:0031647; GO:0032091; GO:0032092; GO:0042826; GO:0045202; GO:0045732; GO:0046329; GO:0048619; GO:0051018; GO:0060828; GO:0061629; GO:0070097; GO:0070161; GO:0090090; GO:0090263; GO:1904864; GO:2000095; GO:2000134 beta-catenin binding [GO:0008013]; delta-catenin binding [GO:0070097]; histone deacetylase binding [GO:0042826]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] AQFIPGQQPSVRLHR 0.99234 -14.782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5534 0 0 0 0 0 0 15.2039 0 0 0 0 0 15.3629 12.9858 13.2697 0 0 13.8521 15.2886 0 13.9006 0 0 14.6939 0 0 0 0 0 10.6101 0 12.3872 0 0 12.9585 13.1384 13.4573 0 0 13.696 0 13.3636 0 0 0 12.4069 14.1278 0 12.8818 13.4603 0 0 0 13.1274 12.6385 0 13.3192 0 12.4137 0 0 0 0 12.7213 0 0 0 0 0 0 0 14.4986 0 0 0 0 12.7594 0 0 13.7732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.105 0 0 0 12.8408 0 0 0 0 Q9NZM1 MYOF_HUMAN Myoferlin (Fer-1-like protein 3) MYOF FER1L3 KIAA1207 Homo sapiens (Human) blood circulation [GO:0008015]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292] caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; blood circulation [GO:0008015]; membrane fusion [GO:0061025]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292] GO:0001778; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0006936; GO:0007009; GO:0007520; GO:0008015; GO:0016021; GO:0030659; GO:0031410; GO:0031965; GO:0033292; GO:0043231; GO:0046872; GO:0061025; GO:0070062 metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] AEDIPQMDDAFSQTVK 0.99234 -64.536 0 0 0 0 0 0 0 0 0 18.3179 0 0 0 0 0 0 0 0 0 0 0 0 11.9874 0 0 0 0 0 0 0 0 0 11.3177 0 0 0 10.3092 0 0 0 0 0 12.1029 13.3394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3749 0 0 12.6937 0 0 0 0 15.8551 14.7824 0 14.247 14.3703 13.438 14.0482 13.0434 0 0 13.3643 13.2591 14.6614 0 0 13.1623 14.0362 0 13.2847 0 15.5608 0 0 13.1739 0 0 13.3852 0 0 0 0 0 12.3514 13.9269 0 0 0 14.2876 0 0 0 0 0 0 0 13.3794 0 0 0 0 13.4625 0 0 0 0 0 0 0 14.3582 0 12.6045 12.798 0 0 0 0 0 0 0 0 0 0 0 10.8962 0 0 0 0 13.7782 0 0 13.8468 0 13.5292 0 0 0 0 0 14.8011 14.6779 0 0 0 0 0 0 0 0 0 0 0 0 Q9UID3 VPS51_HUMAN Vacuolar protein sorting-associated protein 51 homolog (Another new gene 2 protein) (Protein fat-free homolog) VPS51 ANG2 C11orf2 C11orf3 FFR PP5382 Homo sapiens (Human) "autophagy [GO:0006914]; brain morphogenesis [GO:0048854]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; autophagy [GO:0006914]; brain morphogenesis [GO:0048854]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000938; GO:0005730; GO:0005794; GO:0005829; GO:0006869; GO:0006914; GO:0007030; GO:0007041; GO:0015031; GO:0016020; GO:0016021; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048193; GO:0048854; GO:0055037; GO:1990745 ISLKTLLECVRLR 0.99234 -40.542 0 0 0 0 0 0 0 0 0 0 0 0 12.5624 13.4769 12.6488 0 0 14.6438 0 13.4533 12.7188 0 12.4299 0 13.868 0 12.4771 13.4654 0 0 0 13.8269 0 0 11.6049 0 0 0 11.9942 0 12.2982 0 0 0 12.9623 0 0 13.4101 0 0 0 0 0 0 14.4095 0 14.03 13.857 13.5992 13.001 12.7324 0 0 11.5601 0 11.716 0 0 0 0 0 11.2501 10.6597 0 13.1237 0 0 0 0 14.3679 0 0 0 13.5833 13.3443 0 13.624 0 0 0 0 0 14.8431 0 0 0 13.7434 14.0593 0 13.907 0 0 0 13.7026 0 12.7309 0 0 0 0 0 0 0 0 0 14.7202 0 0 0 0 0 13.0731 0 14.6476 14.1357 14.3477 13.2244 0 0 14.8747 11.2531 0 0 0 0 0 15.6479 0 0 0 0 0 0 0 0 12.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.835 0 0 12.6093 12.1563 0 0 0 0 0 13.963 0 0 0 0 Q9Y2J4 AMOL2_HUMAN "Angiomotin-like protein 2 (Leman coiled-coil protein, LCCP)" AMOTL2 KIAA0989 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055] bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055] GO:0001525; GO:0003365; GO:0005829; GO:0005886; GO:0005923; GO:0016055; GO:0030036; GO:0030334; GO:0031410; GO:0055037 ALRAQQR 0.99234 -18.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5139 10.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9998 0 11.5343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6147 0 0 0 0 0 0 12.7835 0 13.0236 0 0 0 0 14.1993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2262 14.8668 0 0 0 0 11.9757 0 0 0 0 11.4476 0 0 0 0 0 0 0 0 0 0 10.8479 0 13.8347 0 0 0 13.4815 13.61 0 0 0 0 14.7456 0 0 0 11.7118 0 15.4435 0 0 0 0 0 0 0 11.8073 0 0 0 0 Q9Y3Q4 HCN4_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 HCN4 Homo sapiens (Human) blood circulation [GO:0008015]; cation transport [GO:0006812]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; sinoatrial node development [GO:0003163]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; intrinsic component of plasma membrane [GO:0031226]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] axon [GO:0030424]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; intrinsic component of plasma membrane [GO:0031226]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248]; blood circulation [GO:0008015]; cation transport [GO:0006812]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; muscle contraction [GO:0006936]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cation channel activity [GO:2001257]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; SA node cell action potential [GO:0086015]; sinoatrial node development [GO:0003163]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725] GO:0002027; GO:0003163; GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0006812; GO:0006936; GO:0008015; GO:0030424; GO:0030425; GO:0030552; GO:0031226; GO:0035725; GO:0042391; GO:0042802; GO:0048471; GO:0055117; GO:0071320; GO:0071321; GO:0071805; GO:0086012; GO:0086015; GO:0086041; GO:0086046; GO:0086091; GO:0098719; GO:0098855; GO:0098907; GO:0098909; GO:1990573; GO:2001257 cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellular cAMP-activated cation channel activity [GO:0005222]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in SA node cell action potential depolarization [GO:0086041]; voltage-gated sodium channel activity [GO:0005248] EEIINFNCR 0.99234 -14.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3149 0 0 0 10.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6866 0 0 0 0 12.6099 0 0 0 0 0 13.5435 15.8258 13.2978 15.6941 13.9317 0 13.8604 0 0 12.4443 0 0 0 0 16.2421 12.1559 13.869 12.5994 13.3343 0 0 13.9964 0 12.7379 14.1015 13.2038 0 13.9744 0 0 11.7923 12.5374 14.5783 0 0 0 0 13.7738 0 0 0 13.2512 0 0 14.907 0 13.3981 13.2739 0 0 14.2254 14.6448 0 0 12.5143 0 0 0 12.2916 0 0 12.9255 0 13.6674 0 0 14.8003 13.9816 0 0 15.1193 0 12.0753 0 0 0 13.5083 0 0 10.8446 0 0 12.0901 0 13.8947 12.9032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4664 13.4635 Q9Y462 ZN711_HUMAN Zinc finger protein 711 (Zinc finger protein 6) ZNF711 CMPX1 ZNF6 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0010468; GO:0043565; GO:0045893; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" CEHCPQAFGDER 0.99234 -14.775 0 0 0 0 10.431 0 0 0 0 0 10.3722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4601 0 0 13.332 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5931 0 0 0 0 0 0 12.5938 0 0 11.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6665 0 0 0 0 0 10.5686 0 0 0 13.6139 0 0 0 0 0 0 0 0 11.9971 0 0 0 0 0 0 0 16.5169 0 0 0 0 0 14.2888 0 0 15.1175 0 14.8807 0 0 0 13.6229 0 12.3949 0 15.3855 0 0 13.939 14.1067 0 0 0 14.6614 0 14.5821 14.555 14.5646 14.1394 0 14.1515 0 0 0 10.3172 0 0 0 0 13.7238 0 0 0 0 0 0 0 10.782 0 0 0 0 13.4047 0 0 0 9.12322 0 0 11.0783 0 0 0 0 0 0 0 0 18.016 0 0 0 0 0 0 0 0 0 0 0 0 E9PB15 PTG3L_HUMAN Putative protein PTGES3L (Prostaglandin E synthase 3-like) PTGES3L Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457] GO:0005634; GO:0005829; GO:0006457; GO:0051087; GO:0051131; GO:0051879 chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879] GSCWGRPQDLK 0.99235 -6.0975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4101 0 0 0 0 0 11.6142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15090 ZN536_HUMAN Zinc finger protein 536 ZNF536 KIAA0390 Homo sapiens (Human) "negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0044323; GO:0045665; GO:0046872; GO:0048387 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CPYCDHRAAQKGNLK 0.99235 -4.9936 0 0 0 0 0 0 0 0 12.8294 0 14.5895 11.192 12.4671 12.5122 12.4339 12.1553 11.9247 11.8682 0 0 12.5105 0 13.6151 0 12.9033 13.6531 10.7903 0 0 13.9522 0 12.6833 0 10.0852 0 13.0854 0 0 0 13.6195 0 13.0636 13.6486 0 0 0 13.2319 0 0 10.4627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0423 0 0 0 0 13.3939 14.6959 0 0 0 0 0 0 16.2765 0 0 0 13.6215 12.9267 0 0 0 13.9842 0 0 0 0 0 0 0 0 13.5062 0 0 0 0 0 0 13.0392 0 0 0 13.0303 0 0 0 0 0 0 0 0 0 0 0 13.7698 0 13.1027 0 0 0 0 0 0 0 0 0 0 0 0 15.903 14.6242 15.1661 0 14.619 0 0 0 14.5578 13.3266 0 0 0 0 0 13.1 0 0 0 0 O60256 KPRB_HUMAN "Phosphoribosyl pyrophosphate synthase-associated protein 2, PRPP synthase-associated protein 2 (41 kDa phosphoribosypyrophosphate synthetase-associated protein, PAP41)" PRPSAP2 Homo sapiens (Human) 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189] cytoplasm [GO:0005737]; ribose phosphate diphosphokinase complex [GO:0002189]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleobase-containing compound metabolic process [GO:0006139]; purine nucleotide biosynthetic process [GO:0006164] GO:0000287; GO:0002189; GO:0004749; GO:0004857; GO:0005737; GO:0006015; GO:0006139; GO:0006164; GO:0042802; GO:0060348 enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749] KRGSIVSK 0.99235 -6.0942 0 0 0 0 0 0 0 0 0 13.8036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2772 0 0 0 0 14.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02750 A2GL_HUMAN "Leucine-rich alpha-2-glycoprotein, LRG" LRG1 LRG Homo sapiens (Human) "brown fat cell differentiation [GO:0050873]; keratinocyte migration [GO:0051546]; leukocyte adhesion to vascular endothelial cell [GO:0061756]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to bacterium [GO:0009617]; wound healing, spreading of epidermal cells [GO:0035313]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; brown fat cell differentiation [GO:0050873]; keratinocyte migration [GO:0051546]; leukocyte adhesion to vascular endothelial cell [GO:0061756]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to bacterium [GO:0009617]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0001938; GO:0005114; GO:0005576; GO:0005615; GO:0009617; GO:0010718; GO:0010838; GO:0016020; GO:0030511; GO:0034713; GO:0035313; GO:0035580; GO:0043231; GO:0045766; GO:0050873; GO:0051546; GO:0060054; GO:0061756; GO:0070062; GO:1904724; GO:1904813 type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114] CAGPEAVK 0.99235 -4.9969 13.5877 0 0 0 0 0 0 0 0 0 14.7118 0 0 0 0 13.4071 0 0 14.3954 0 0 0 0 0 14.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5619 0 0 0 0 0 0 0 15.1763 0 0 0 0 0 0 0 14.5143 13.3548 0 0 0 13.4462 0 0 0 0 0 0 0 13.7052 14.8248 13.8379 0 0 14.522 0 0 0 0 0 0 0 0 0 11.1378 0 0 14.9548 0 14.5223 0 0 0 13.6119 13.8687 0 0 14.163 0 0 15.0544 0 0 13.9537 13.3401 0 0 13.8513 0 0 13.8452 0 0 0 15.0667 0 0 0 0 0 0 0 0 14.0035 12.9776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6445 0 0 0 0 0 0 0 P24723 KPCL_HUMAN "Protein kinase C eta type, EC 2.7.11.13 (PKC-L) (nPKC-eta)" PRKCH PKCL PRKCL Homo sapiens (Human) cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; regulation of bicellular tight junction assembly [GO:2000810]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007165; GO:0010744; GO:0018105; GO:0019899; GO:0030154; GO:0031267; GO:0034351; GO:0035556; GO:0045618; GO:0046872; GO:0050861; GO:0051092; GO:0060252; GO:0070062; GO:0070528; GO:0106310; GO:1903078; GO:2000810 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] GHQLLDPYLTVSVDQVRVGQTSTK 0.99235 -7.2505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4136 0 0 13.093 13.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9832 0 0 0 0 0 0 0 0 0 11.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2004 0 0 0 0 0 0 0 0 0 13.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1778 0 0 0 0 0 0 0 0 0 0 12.3173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52739 ZN131_HUMAN Zinc finger protein 131 ZNF131 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654] "intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0001228; GO:0005654; GO:0006357; GO:0045111; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ALEVRNK 0.99235 -15.21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3095 0 0 0 Q02252 MMSA_HUMAN "Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, MMSDH, Malonate-semialdehyde dehydrogenase [acylating], EC 1.2.1.18, EC 1.2.1.27 (Aldehyde dehydrogenase family 6 member A1)" ALDH6A1 MMSDH Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity [GO:0102662]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]; branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]" GO:0000062; GO:0003723; GO:0004491; GO:0005654; GO:0005739; GO:0005759; GO:0006210; GO:0006573; GO:0006574; GO:0009083; GO:0018478; GO:0019859; GO:0050873; GO:0102662 "fatty-acyl-CoA binding [GO:0000062]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; malonate-semialdehyde dehydrogenase (acetylating, NAD+) activity [GO:0102662]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; RNA binding [GO:0003723]" AISFVGSNK 0.99235 -7.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3603 0 0 0 0 0 0 0 0 0 0 0 13.3301 13.4175 14.8242 0 0 14.6875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4823 0 0 0 0 0 0 0 0 0 0 0 0 12.4039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0ZGT2 NEXN_HUMAN Nexilin (F-actin-binding protein) (Nelin) NEXN Homo sapiens (Human) axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cell-cell adhesion mediator activity [GO:0098632]; structural constituent of muscle [GO:0008307]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of cell migration [GO:0030334]; regulation of cytoskeleton organization [GO:0051493] GO:0005886; GO:0005912; GO:0005925; GO:0007156; GO:0007411; GO:0008307; GO:0015629; GO:0030018; GO:0030334; GO:0030424; GO:0051015; GO:0051493; GO:0070593; GO:0098632 actin filament binding [GO:0051015]; cell-cell adhesion mediator activity [GO:0098632]; structural constituent of muscle [GO:0008307] CLSLVMDDEIESEAK 0.99235 -24.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4707 0 0 0 13.7488 13.3962 0 12.8876 13.234 13.9031 0 16.1778 14.0808 13.0071 0 0 0 0 0 0 0 0 0 14.2315 0 0 0 0 0 0 0 13.5618 0 13.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2033 0 0 0 13.4562 0 0 0 0 0 0 0 0 0 0 11.7683 0 0 0 0 0 0 0 0 0 0 12.7432 0 0 Q13103 SPP24_HUMAN "Secreted phosphoprotein 24, Spp-24 (Secreted phosphoprotein 2)" SPP2 SPP24 Homo sapiens (Human) bone remodeling [GO:0046849]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; bone remodeling [GO:0046849]; skeletal system development [GO:0001501] GO:0001501; GO:0004866; GO:0005576; GO:0005788; GO:0031089; GO:0046849; GO:0062023 endopeptidase inhibitor activity [GO:0004866] DYYVSTAVCRSTVKVSAQQVQGVHAR 0.99235 -7.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.515 0 0 0 0 0 0 0 0 0 11.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6543 0 0 0 0 0 0 0 12.5531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13107 UBP4_HUMAN "Ubiquitin carboxyl-terminal hydrolase 4, EC 3.4.19.12 (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein homolog)" USP4 UNP UNPH Homo sapiens (Human) negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine receptor binding [GO:0031685]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; negative regulation of protein ubiquitination [GO:0031397]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000244; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0006511; GO:0016579; GO:0031397; GO:0031647; GO:0031685; GO:0034394; GO:0042802; GO:0046872 adenosine receptor binding [GO:0031685]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] DEYEAEINRDNPLGMK 0.99235 -15.197 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2127 0 0 0 12.5719 0 0 0 0 11.6304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1293 0 0 0 0 0 0 0 0 0 13.6435 0 0 0 0 0 12.743 11.9153 0 13.7965 13.6144 0 11.5711 13.8708 0 0 11.447 0 0 0 0 13.2444 0 0 0 13.1731 12.8097 11.8583 0 10.927 0 11.5651 0 0 0 0 0 11.29 0 0 13.0315 0 0 0 0 0 0 0 15.1482 0 0 0 0 0 14.9555 0 0 0 0 0 0 0 0 0 0 0 11.1497 10.968 0 0 0 0 12.6291 14.0645 0 0 0 12.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6154 0 11.9441 0 Q13415 ORC1_HUMAN Origin recognition complex subunit 1 (Replication control protein 1) ORC1 ORC1L PARC1 Homo sapiens (Human) DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314] "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]" GO:0000781; GO:0000808; GO:0003677; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005829; GO:0006270; GO:0016887; GO:0033314; GO:0046872 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872] AHYPTRLK 0.99235 -46.859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9327 0 0 10.4069 0 0 0 10.3647 0 0 0 0 0 0 0 0 0 0 12.5164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1801 0 10.6251 0 0 11.1744 0 15.2262 0 0 0 0 0 0 0 0 0 9.3388 0 10.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2687 0 0 0 0 0 0 0 0 0 0 0 13.2112 0 15.1005 13.8565 0 13.679 15.4069 15.3629 12.6386 0 0 0 0 0 0 15.3836 0 0 0 10.2569 Q14517 FAT1_HUMAN "Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form ]" FAT1 CDHF7 FAT Homo sapiens (Human) actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088] apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088] GO:0002088; GO:0003382; GO:0003412; GO:0005509; GO:0005634; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007015; GO:0007155; GO:0007156; GO:0007163; GO:0007267; GO:0009653; GO:0016324; GO:0016477; GO:0030027; GO:0030175; GO:0048471; GO:0070062; GO:0098609 calcium ion binding [GO:0005509] ALRNILGVRR 0.99235 -18.286 0 11.4569 0 0 0 0 0 10.8134 0 0 0 0 14.5843 11.7628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0166 0 0 0 0 0 9.85727 0 0 0 0 9.79743 0 0 13.0759 0 0 0 12.8898 0 0 10.731 0 0 0 0 0 0 0 0 12.0667 0 11.9361 0 0 0 0 13.0577 0 0 0 0 11.7654 0 11.6835 0 0 0 0 0 15.1072 10.2909 0 0 0 10.6285 12.2272 12.436 0 13.9336 0 0 0 13.4696 13.6353 0 0 13.6159 0 10.9525 14.992 0 13.167 0 13.8269 0 0 0 0 13.7451 0 12.3641 16.5974 0 15.2972 0 0 0 0 0 0 14.4973 0 0 11.1716 0 12.3165 0 0 13.03 0 10.1232 0 12.5658 0 11.2766 0 0 0 11.7905 0 0 0 0 0 13.5153 0 0 0 0 0 0 0 0 0 0 11.4423 9.31816 0 11.3637 0 0 0 13.6295 0 0 0 0 0 0 0 11.4561 0 Q15415 RBY1F_HUMAN "RNA-binding motif protein, Y chromosome, family 1 member F/J (Y chromosome RNA recognition motif 2)" RBMY1F YRRM2; RBMY1J Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]" nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000380; GO:0000398; GO:0003723; GO:0005654; GO:0005730; GO:0016607; GO:0042802 identical protein binding [GO:0042802]; RNA binding [GO:0003723] AVFGKHGPISEVLLIK 0.99235 -7.6138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5964 12.4742 0 0 0 0 0 0 0 0 0 10.8421 0 13.7732 0 11.6543 0 0 12.0786 12.6203 0 0 13.5825 0 0 14.3202 0 13.9048 14.2652 0 0 0 0 0 0 0 14.3142 12.596 10.8911 0 0 0 10.9766 0 0 0 12.422 0 11.0188 0 0 11.2055 0 0 11.9605 11.1873 0 13.5427 0 10.6963 0 0 11.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.164 12.655 0 0 0 0 0 0 0 15.4674 0 0 0 0 11.6397 0 0 0 0 0 11.8851 0 0 0 0 0 0 0 Q5VT06 CE350_HUMAN "Centrosome-associated protein 350, Cep350 (Centrosome-associated protein of 350 kDa)" CEP350 CAP350 KIAA0480 GM133 Homo sapiens (Human) microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539] cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819] cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539] GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0008017; GO:0016020; GO:0034453; GO:0042995; GO:0071539; GO:1905515 microtubule binding [GO:0008017] AEQEALESQR 0.99235 -83.316 0 0 0 0 13.4357 0 0 13.8008 0 0 0 0 0 13.8831 0 0 13.7541 13.1292 0 13.6028 12.0233 0 0 0 11.8431 11.9976 12.2767 13.7575 13.087 12.4019 12.7242 0 13.0904 0 12.6229 12.3971 0 13.1618 14.8023 12.0284 0 13.551 0 0 0 13.4419 0 13.4861 0 0 0 0 0 0 11.6226 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2078 0 0 0 13.3895 13.6021 14.4508 15.5452 14.0185 0 14.6122 14.7352 15.7973 14.7066 17.6959 0 0 17.6573 18.6823 0 0 13.9716 14.6661 0 18.1736 14.4135 0 0 17.1359 12.5007 16.8265 14.643 0 16.1888 16.0666 15.4884 17.5224 14.3366 15.7537 0 10.8822 16.4602 15.0851 0 13.2335 0 16.4513 15.5477 11.2321 14.7209 15.6789 14.6672 16.1864 16.3105 15.1837 13.2403 15.8792 13.8406 12.9474 16.3573 0 14.39 0 14.0678 13.669 15.8412 15.0757 15.6006 14.985 15.7494 16.2612 14.8755 16.1496 0 13.4441 15.3145 15.6815 13.8045 15.2576 11.9652 11.9442 0 13.724 13.6699 0 11.695 16.3346 12.9552 11.8702 0 0 0 11.9314 12.8118 0 0 15.2859 14.1861 11.2015 14.2275 0 0 13.9435 13.4219 15.8712 13.9361 14.1205 0 12.3174 14.1982 0 12.9297 Q6UX04 CWC27_HUMAN "Spliceosome-associated protein CWC27 homolog (Antigen NY-CO-10) (Probable inactive peptidyl-prolyl cis-trans isomerase CWC27 homolog, PPIase CWC27) (Serologically defined colon cancer antigen 10)" CWC27 SDCCAG10 UNQ438/PRO871 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; U2-type precatalytic spliceosome [GO:0071005] "catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]" GO:0000398; GO:0000413; GO:0005654; GO:0006457; GO:0071005; GO:0071013 EAPKACR 0.99235 -15.198 0 0 0 0 0 0 0 0 0 0 13.1524 0 13.2084 13.7123 13.3547 12.8154 0 13.3422 0 0 13.0744 0 0 0 0 0 0 13.2234 0 0 13.3187 13.6489 0 0 0 0 0 13.4257 13.416 12.5751 0 12.3722 12.3481 0 0 0 0 12.2986 0 0 12.2069 0 0 0 0 0 0 0 0 0 0 0 9.51045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.117 19.179 0 0 12.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1221 0 0 0 0 0 0 0 0 0 14.6414 0 0 0 0 0 0 12.7273 0 0 14.4877 0 0 0 14.5777 14.5198 0 14.5603 14.8067 0 0 14.5563 14.4846 14.4148 0 0 0 0 14.4935 0 0 0 0 Q86T29 ZN605_HUMAN Zinc finger protein 605 ZNF605 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AQLIIHQR 0.99235 -15.163 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7608 0 0 0 0 0 0 0 0 0 11.5329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5881 0 0 13.4741 0 0 0 0 17.3198 0 0 13.3888 0 0 0 0 0 0 0 0 0 0 0 12.5308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7212 14.387 11.9207 0 0 10.1567 0 0 0 0 0 0 0 0 0 0 0 0 13.6831 13.3318 0 0 0 0 0 0 0 13.8896 0 0 0 0 14.0593 0 0 0 0 0 Q8N142 PURA1_HUMAN "Adenylosuccinate synthetase isozyme 1, AMPSase 1, AdSS 1, EC 6.3.4.4 (Adenylosuccinate synthetase, basic isozyme) (Adenylosuccinate synthetase, muscle isozyme, M-type adenylosuccinate synthetase) (Adenylosuccinate synthetase-like 1, AdSSL1) (IMP--aspartate ligase 1)" ADSS1 ADSSL1 Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; AMP biosynthetic process [GO:0006167]; immune system process [GO:0002376]; IMP metabolic process [GO:0046040] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; 'de novo' AMP biosynthetic process [GO:0044208]; AMP biosynthetic process [GO:0006167]; immune system process [GO:0002376]; IMP metabolic process [GO:0046040] GO:0000287; GO:0002376; GO:0004019; GO:0005525; GO:0005737; GO:0005829; GO:0006167; GO:0042301; GO:0044208; GO:0046040 adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301] ADTTGAR 0.99235 -7.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4645 13.0618 13.264 0 13.8776 13.3526 13.388 13.3187 0 13.2802 0 0 0 13.0539 14.2786 13.0249 12.7728 0 0 0 0 0 0 0 0 0 0 13.5846 0 0 0 0 12.5077 0 0 0 0 0 0 12.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6134 0 0 0 0 0 0 0 12.3743 0 0 0 0 0 0 0 0 12.7847 0 12.9173 0 0 0 0 13.2516 13.0819 0 0 0 0 0 0 0 13.993 13.9828 0 0 0 0 0 13.4179 0 0 0 0 0 0 0 0 0 0 0 0 11.9571 13.0552 0 12.0238 0 0 0 0 0 0 0 13.2019 0 0 0 0 0 0 0 0 0 0 0 13.537 14.5578 0 0 13.3355 12.5095 0 12.3057 0 0 14.8575 0 12.6345 0 14.4329 0 0 13.316 0 0 12.6008 0 0 0 0 Q8NER1 TRPV1_HUMAN "Transient receptor potential cation channel subfamily V member 1, TrpV1 (Capsaicin receptor) (Osm-9-like TRP channel 1, OTRPC1) (Vanilloid receptor 1)" TRPV1 VR1 Homo sapiens (Human) behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to temperature stimulus [GO:0071502]; cellular response to tumor necrosis factor [GO:0071356]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; glutamate secretion [GO:0014047]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; negative regulation of establishment of blood-brain barrier [GO:0090212]; negative regulation of heart rate [GO:0010459]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; response to peptide hormone [GO:0043434]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]; thermoception [GO:0050955] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendritic spine membrane [GO:0032591]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendritic spine membrane [GO:0032591]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; chloride channel regulator activity [GO:0017081]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; voltage-gated calcium channel activity [GO:0005245]; behavioral response to pain [GO:0048266]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to acidic pH [GO:0071468]; cellular response to alkaloid [GO:0071312]; cellular response to ATP [GO:0071318]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to temperature stimulus [GO:0071502]; cellular response to tumor necrosis factor [GO:0071356]; chemosensory behavior [GO:0007635]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; detection of temperature stimulus involved in thermoception [GO:0050960]; diet induced thermogenesis [GO:0002024]; fever generation [GO:0001660]; glutamate secretion [GO:0014047]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; negative regulation of establishment of blood-brain barrier [GO:0090212]; negative regulation of heart rate [GO:0010459]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptide secretion [GO:0002790]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gastric acid secretion [GO:0060454]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein homotetramerization [GO:0051289]; response to capsazepine [GO:1901594]; response to peptide hormone [GO:0043434]; sensory perception of mechanical stimulus [GO:0050954]; smooth muscle contraction involved in micturition [GO:0060083]; thermoception [GO:0050955] GO:0000122; GO:0001660; GO:0001774; GO:0002024; GO:0002790; GO:0003085; GO:0004888; GO:0005216; GO:0005230; GO:0005231; GO:0005245; GO:0005262; GO:0005516; GO:0005524; GO:0005739; GO:0005829; GO:0005886; GO:0005887; GO:0006629; GO:0007166; GO:0007204; GO:0007635; GO:0009897; GO:0010459; GO:0010917; GO:0014047; GO:0015278; GO:0016021; GO:0017081; GO:0031226; GO:0032591; GO:0034605; GO:0035091; GO:0042802; GO:0043025; GO:0043065; GO:0043434; GO:0045211; GO:0045429; GO:0046872; GO:0048266; GO:0050954; GO:0050955; GO:0050960; GO:0050965; GO:0050968; GO:0051219; GO:0051289; GO:0060083; GO:0060454; GO:0070161; GO:0070588; GO:0071312; GO:0071318; GO:0071356; GO:0071468; GO:0071502; GO:0090212; GO:0097603; GO:0098703; GO:1901594; GO:1990090 ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; chloride channel regulator activity [GO:0017081]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellular ligand-gated ion channel activity [GO:0005230]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphoprotein binding [GO:0051219]; temperature-gated ion channel activity [GO:0097603]; transmembrane signaling receptor activity [GO:0004888]; voltage-gated calcium channel activity [GO:0005245] FVKRIFYFNFLVYCLYMIIFTMAAYYR 0.99235 -7.1118 0 0 0 0 0 0 0 0 13.2835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1081 0 0 0 0 11.4403 0 0 0 0 0 0 0 0 0 15.1254 10.8853 0 0 0 0 0 0 13.5298 0 0 0 12.7699 0 0 0 0 0 0 0 0 0 0 0 0 0 13.854 0 0 0 0 0 0 0 0 0 0 0 15.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96D09 GASP2_HUMAN "G-protein coupled receptor-associated sorting protein 2, GASP-2" GPRASP2 Homo sapiens (Human) hematopoietic stem cell homeostasis [GO:0061484] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; G protein-coupled receptor binding [GO:0001664]; hematopoietic stem cell homeostasis [GO:0061484] GO:0001540; GO:0001664; GO:0005634; GO:0005737; GO:0005829; GO:0061484 amyloid-beta binding [GO:0001540]; G protein-coupled receptor binding [GO:0001664] AQKDVDSDR 0.99235 -18.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5513 0 0 16.7922 0 0 0 0 0 0 0 0 0 13.0523 0 13.8269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7284 0 16.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6327 0 0 0 0 0 12.549 14.2223 0 0 0 14.1855 14.1797 0 0 14.2928 13.816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7346 0 0 0 0 0 0 0 0 12.8739 0 0 0 0 0 0 0 0 16.0407 16.0399 0 0 0 0 0 0 0 13.3105 0 0 0 0 0 13.2458 0 0 0 14.0187 0 0 0 0 0 0 0 Q96QU8 XPO6_HUMAN "Exportin-6, Exp6 (Ran-binding protein 20)" XPO6 KIAA0370 RANBP20 Homo sapiens (Human) protein export from nucleus [GO:0006611] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611] GO:0005049; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006611; GO:0031267; GO:0032991 nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267] ALESLMTEFFHDCTTNERKR 0.99235 -7.4502 0 0 0 0 0 0 0 0 0 0 13.3757 12.6556 13.1177 0 12.9368 0 0 0 0 0 0 15.0883 0 0 0 12.0072 0 0 0 0 0 13.8134 0 13.1866 13.8092 13.1199 13.6195 13.2361 13.0552 13.4449 0 14.2048 13.0363 11.351 0 11.6798 11.9805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6582 0 13.7855 0 0 0 0 0 11.1115 0 0 0 0 0 0 0 0 0 14.548 0 0 0 0 0 0 0 0 0 0 0 0 15.1953 13.7074 15.768 12.5194 14.7269 0 0 13.3361 0 12.1051 0 14.0297 13.334 0 0 0 0 0 0 0 0 0 0 0 14.3166 0 0 0 13.0324 0 0 13.4907 0 0 0 10.9942 0 0 0 0 0 0 0 9.63952 13.5999 0 0 16.7832 0 10.8515 0 0 0 0 0 0 0 15.4186 13.6526 16.7457 0 0 0 16.8898 13.853 13.3414 15.2743 18.4498 14.6271 14.8527 0 0 0 0 0 13.7022 0 13.6408 0 0 Q9BUN1 MENT_HUMAN Protein MENT (Methylated in normal thymocytes protein) MENT C1orf56 UNQ547/PRO1104 Homo sapiens (Human) regulation of cell population proliferation [GO:0042127] extracellular region [GO:0005576] extracellular region [GO:0005576]; regulation of cell population proliferation [GO:0042127] GO:0005576; GO:0042127 FGGPMTR 0.99235 -7.6112 0 0 0 0 0 0 0 0 0 0 0 13.5844 13.5383 0 0 0 0 0 0 0 0 0 0 13.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3817 0 0 0 0 15.6519 0 0 0 0 0 0 0 0 13.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5206 0 0 0 12.9812 0 0 13.6755 0 0 0 0 0 0 11.44 0 0 0 0 0 0 0 0 0 0 12.8456 0 0 0 0 0 0 0 0 0 0 0 13.3467 0 13.357 0 0 0 0 0 0 0 12.7739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4054 0 0 0 0 12.9206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVH7 SIA7E_HUMAN "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5, EC 2.4.99.- (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V, ST6GalNAcV) (Sialyltransferase 7E, SIAT7-E)" ST6GALNAC5 SIAT7E Homo sapiens (Human) ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]" GO:0000139; GO:0001574; GO:0001665; GO:0006486; GO:0006688; GO:0008373; GO:0009311; GO:0009312; GO:0016021 "alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]" GRKGSHHR 0.99235 -15.196 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1558 10.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3662 0 11.3895 0 0 0 0 0 0 0 0 0 0 0 14.8113 0 0 0 0 0 0 0 0 11.646 0 0 10.9916 0 0 0 0 0 0 0 0 0 0 12.2306 0 0 0 0 0 0 0 0 0 0 0 0 12.2386 0 0 0 0 0 0 0 0 0 0 0 11.4142 0 0 0 0 0 0 0 0 0 14.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.764 0 0 0 0 0 0 0 0 0 12.4295 0 0 0 0 0 0 0 0 Q9GZS0 DNAI2_HUMAN Dynein axonemal intermediate chain 2 (Axonemal dynein intermediate chain 2) DNAI2 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein axonemal particle [GO:0120293]; external side of plasma membrane [GO:0009897]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0003777; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0009897; GO:0036126; GO:0036157; GO:0036158; GO:0045503; GO:0045504; GO:0060271; GO:0120293 dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777] AEEEFFDIIFAELK 0.99235 -6.1009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1301 0 0 0 0 0 0 0 0 0 0 0 0 12.66 11.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1035 0 12.7411 0 11.6425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9J4 UBP42_HUMAN "Ubiquitin carboxyl-terminal hydrolase 42, EC 3.4.19.12 (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42)" USP42 Homo sapiens (Human) cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0007283; GO:0016579; GO:0030154; GO:0042981 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] AAQSVNK 0.99235 -15.206 0 0 0 0 0 0 13.3183 0 0 0 0 0 0 0 0 0 0 0 0 11.4351 15.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2401 0 14.8255 12.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8521 9.76505 0 14.5067 0 0 0 0 0 14.3199 19.7398 19.6647 19.6019 19.5727 19.5242 19.6097 14.0917 19.5935 11.989 19.5248 19.5214 0 0 14.3584 0 16.9222 16.9751 0 13.1652 15.7665 13.174 13.7441 13.917 0 19.2826 0 14.0012 11.716 14.1232 14.8579 19.3325 0 0 0 0 13.7828 12.9809 12.9759 0 0 0 0 0 9.58474 0 14.35 0 14.7864 0 14.6114 0 14.4631 14.8126 19.055 0 0 19.1496 19.1073 19.2065 19.0995 19.0972 0 0 12.83 0 0 0 0 13.1679 0 0 13.6672 0 0 0 0 0 0 19.0057 0 13.9111 0 18.9992 0 0 0 0 14.5329 0 0 0 0 0 0 0 0 0 0 0 0 13.8785 0 0 0 0 14.4242 0 Q9NNZ6 PRM3_HUMAN Protamine-3 (Sperm protamine P3) PRM3 Homo sapiens (Human) cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleosome [GO:0000786]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] GO:0000786; GO:0003677; GO:0005634; GO:0005737; GO:0007283; GO:0030154; GO:0030261; GO:0030317 DNA binding [GO:0003677] GHESSMK 0.99235 -6.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2956 0 13.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR23 GDF3_HUMAN "Growth/differentiation factor 3, GDF-3" GDF3 UNQ222/PRO248 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; endoderm development [GO:0007492]; eye development [GO:0001654]; formation of anatomical boundary [GO:0048859]; in utero embryonic development [GO:0001701]; mesoderm development [GO:0007498]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of myoblast differentiation [GO:0045662]; notochord development [GO:0030903]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; primitive streak formation [GO:0090009]; regulation of cell fate commitment [GO:0010453]; response to dietary excess [GO:0002021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein kinase binding [GO:0019901]; BMP signaling pathway [GO:0030509]; endoderm development [GO:0007492]; eye development [GO:0001654]; formation of anatomical boundary [GO:0048859]; in utero embryonic development [GO:0001701]; mesoderm development [GO:0007498]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of myoblast differentiation [GO:0045662]; notochord development [GO:0030903]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; primitive streak formation [GO:0090009]; regulation of cell fate commitment [GO:0010453]; response to dietary excess [GO:0002021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525] GO:0001501; GO:0001654; GO:0001701; GO:0002021; GO:0005125; GO:0005615; GO:0005737; GO:0007492; GO:0007498; GO:0008083; GO:0010453; GO:0010862; GO:0019901; GO:0030509; GO:0030514; GO:0030903; GO:0032525; GO:0045600; GO:0045605; GO:0045662; GO:0048859; GO:0060395; GO:0090009 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein kinase binding [GO:0019901] AAIPVPK 0.99235 -18.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3557 0 0 0 0 0 0 0 0 0 0 12.4485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7701 13.8898 0 0 0 0 0 0 0 13.9376 0 0 15.6488 0 13.9395 12.9776 14.7964 12.5448 0 15.3012 0 14.4196 14.1988 0 0 0 13.5906 14.8222 0 0 0 11.434 0 0 14.0739 13.4677 0 0 0 0 0 0 12.6033 11.4708 0 14.3473 0 0 14.241 0 0 0 13.4699 0 0 0 0 0 13.0555 0 0 12.005 15.1865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9893 0 0 0 11.3283 13.013 0 0 0 11.5538 0 0 0 10.3122 10.8738 0 0 0 14.7111 0 0 10.8927 0 0 0 0 0 13.0537 14.4955 Q9NVA4 T184C_HUMAN Transmembrane protein 184C (Transmembrane protein 34) TMEM184C TMEM34 PRO1355 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FLCVKLVVFVSFWQAVVIALLVK 0.99235 -7.6103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.109 0 0 0 12.686 0 0 0 0 0 0 0 0 0 16.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5214 0 0 0 0 10.6337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8458 0 0 0 0 10.9487 0 13.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2018 0 0 0 0 0 0 0 0 0 0 0 13.2043 10.3686 0 0 13.1108 0 0 0 13.1506 0 0 13.6795 0 0 0 0 0 0 0 0 0 0 0 10.4337 0 14.2149 0 0 11.4151 0 13.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYG8 KCNK4_HUMAN "Potassium channel subfamily K member 4 (TWIK-related arachidonic acid-stimulated potassium channel protein, TRAAK) (Two pore potassium channel KT4.1, Two pore K(+) channel KT4.1)" KCNK4 TRAAK Homo sapiens (Human) cellular response to alkaline pH [GO:0071469]; cellular response to fatty acid [GO:0071398]; cellular response to mechanical stimulus [GO:0071260]; cellular response to temperature stimulus [GO:0071502]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; identical protein binding [GO:0042802]; mechanosensitived potassium channel activity [GO:0098782]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; temperature-gated cation channel activity [GO:0097604]; cellular response to alkaline pH [GO:0071469]; cellular response to fatty acid [GO:0071398]; cellular response to mechanical stimulus [GO:0071260]; cellular response to temperature stimulus [GO:0071502]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; memory [GO:0007613]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of pain [GO:0019233]; sensory perception of temperature stimulus [GO:0050951]; stabilization of membrane potential [GO:0030322] GO:0005267; GO:0005886; GO:0005887; GO:0006813; GO:0007613; GO:0015271; GO:0019233; GO:0022841; GO:0030322; GO:0034705; GO:0034765; GO:0042802; GO:0050951; GO:0050976; GO:0071260; GO:0071398; GO:0071469; GO:0071502; GO:0071805; GO:0097604; GO:0098782 identical protein binding [GO:0042802]; mechanosensitived potassium channel activity [GO:0098782]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; temperature-gated cation channel activity [GO:0097604] HGIGHIEAIFLKWHVPPELVR 0.99235 -15.196 0 0 0 0 0 0 0 0 0 0 0 14.9715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9604 13.5785 0 12.8207 0 16.6032 12.6877 0 12.8955 0 0 0 0 0 12.0196 0 0 0 0 0 0 0 0 12.9021 0 13.3574 0 0 12.1871 0 0 14.1958 0 0 0 0 15.8481 0 0 16.149 14.2024 0 0 0 13.0395 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5441 0 0 0 0 0 0 0 12.6353 0 0 0 0 0 13.2195 0 13.1324 0 0 0 0 0 0 0 0 0 12.9786 0 0 0 0 0 0 0 0 12.9499 0 0 0 0 0 Q9UQF0 SYCY1_HUMAN "Syncytin-1 (Endogenous retrovirus group W member 1) (Env-W) (Envelope polyprotein gPr73) (Enverin) (HERV-7q Envelope protein) (HERV-W envelope protein) (HERV-W_7q21.2 provirus ancestral Env polyprotein) (Syncytin) [Cleaved into: Surface protein, SU (gp50); Transmembrane protein, TM (gp24) ]" ERVW-1 ERVWE1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anatomical structure morphogenesis [GO:0009653]; myoblast fusion [GO:0007520]; syncytium formation [GO:0006949]; syncytium formation by plasma membrane fusion [GO:0000768] GO:0000768; GO:0005886; GO:0006949; GO:0007520; GO:0009653; GO:0016021 PGNIDAPSYR 0.99235 -4.9957 0 0 0 0 12.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7366 0 12.3436 11.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3733 0 0 0 0 0 0 0 0 0 12.7481 13.5435 12.1626 0 12.9466 0 0 0 0 13.376 0 0 12.592 12.7326 0 0 0 0 0 0 14.6132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8156 0 0 0 0 0 0 Q96ST8 CEP89_HUMAN "Centrosomal protein of 89 kDa, Cep89 (Centrosomal protein 123, Cep123) (Coiled-coil domain-containing protein 123)" CEP89 CCDC123 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; synapse [GO:0045202] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; synapse [GO:0045202]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515] GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007005; GO:0007268; GO:0031514; GO:0045202; GO:0060271; GO:0097539; GO:0097730; GO:1905515 AAVPRTPPPR 0.99236 -17.076 0 0 0 0 0 0 0 0 13.0424 0 0 0 0 0 0 0 11.0637 0 0 13.8644 0 0 0 0 0 0 10.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3291 0 0 0 0 0 0 0 13.6948 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1928 0 0 0 11.6611 0 0 0 0 0 0 0 0 0 0 0 0 11.6171 0 0 0 0 0 0 0 0 13.479 0 0 12.4481 0 13.6098 0 12.3185 0 0 0 0 0 0 12.2203 11.6177 0 14.8338 0 0 0 0 13.2486 0 0 0 13.5225 13.5619 0 0 0 12.6214 14.9797 0 14.401 0 0 0 13.1161 12.517 14.0286 12.6039 12.3582 13.3117 0 0 0 0 14.9774 0 0 13.5285 0 13.2942 0 0 12.8696 11.7412 0 0 0 0 0 0 0 0 11.7588 0 0 0 0 0 12.3586 11.2242 0 0 0 0 13.6821 16.0067 13.0046 0 0 11.4647 0 11.7894 P49750 YLPM1_HUMAN YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113) YLPM1 C14orf170 ZAP3 Homo sapiens (Human) regulation of telomere maintenance [GO:0032204] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; regulation of telomere maintenance [GO:0032204] GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016607; GO:0032204 RNA binding [GO:0003723] ATQSYLQEK 0.99236 -57.11 0 12.16 0 0 0 0 13.271 0 0 0 14.5883 0 0 0 0 0 0 0 9.19921 0 13.0253 14.6217 13.8652 14.7614 0 0 0 11.9892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7103 13.5017 15.0682 12.5578 16.2455 15.8295 0 0 15.0494 13.9611 15.2783 13.9081 15.9184 14.2787 14.2993 14.9181 16.3087 16.3287 13.5784 0 15.2374 0 16.5657 16.9464 14.1112 13.6175 12.9182 0 0 0 14.8596 14.355 0 15.0556 0 15.132 15.4371 15.4452 0 14.1637 14.6677 13.4883 15.044 14.6027 0 0 0 15.7523 0 0 13.6912 14.8084 0 15.3388 15.353 0 0 12.7988 13.6198 13.5581 14.3375 15.565 13.9557 14.9154 16.0728 14.0713 14.8547 15.9267 15.5233 14.2308 15.9394 15.2004 0 13.3659 0 15.4976 15.9288 14.6306 0 14.6972 15.6357 0 14.879 0 13.0559 13.1373 14.6522 13.1327 0 14.8357 14.6337 0 0 0 0 0 0 0 13.3362 12.4499 17.8636 0 12.4696 11.5487 0 15.4546 14.1929 13.5269 15.2501 14.5509 15.1019 0 0 0 A8MTZ0 BBIP1_HUMAN BBSome-interacting protein 1 (BBSome-interacting protein of 10 kDa) BBIP1 BBIP10 NCRNA00081 Homo sapiens (Human) cilium assembly [GO:0060271]; eating behavior [GO:0042755]; protein transport [GO:0015031]; receptor localization to non-motile cilium [GO:0097500] BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829] BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cilium assembly [GO:0060271]; eating behavior [GO:0042755]; protein transport [GO:0015031]; receptor localization to non-motile cilium [GO:0097500] GO:0005737; GO:0005829; GO:0015031; GO:0034464; GO:0042755; GO:0060170; GO:0060271; GO:0097500 LEKMHQAAQNTIR 0.99236 -6.1181 0 0 0 0 0 0 0 0 12.329 12.2331 0 0 12.3505 11.9354 0 0 12.4717 12.2638 0 0 0 0 0 0 0 12.363 0 0 12.5877 11.8052 12.955 12.1935 0 0 12.3787 0 12.2718 12.4611 11.9048 12.1615 0 12.3972 12.3943 12.8747 0 0 0 12.4717 0 0 0 11.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5166 0 14.5688 0 0 0 0 0 0 14.541 0 0 0 0 0 0 0 0 0 0 0 0 0 O43291 SPIT2_HUMAN "Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2, HAI-2) (Placental bikunin)" SPINT2 HAI2 KOP Homo sapiens (Human) basement membrane organization [GO:0071711]; cellular response to BMP stimulus [GO:0071773]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of cell motility [GO:2000146]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural tube closure [GO:0001843] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; basement membrane organization [GO:0071711]; cellular response to BMP stimulus [GO:0071773]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of cell motility [GO:2000146]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural tube closure [GO:0001843] GO:0001843; GO:0004866; GO:0004867; GO:0005576; GO:0005737; GO:0005886; GO:0007163; GO:0016021; GO:0022408; GO:0060672; GO:0071711; GO:0071773; GO:2000146; GO:2000178 endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] AFLALLGSLLLSGVLAADRER 0.99236 -6.1079 0 12.4174 0 0 0 0 0 0 0 14.0418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.092 13.0081 13.36 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0895 12.57 0 0 0 0 0 0 0 0 0 0 0 13.8517 14.2607 0 0 0 0 13.5476 13.3727 0 0 0 14.0437 13.8595 0 0 0 0 15.2446 0 0 0 14.5018 0 0 0 0 0 0 0 0 0 0 14.5568 0 0 0 0 0 0 13.9449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TU7 SETD3_HUMAN "Actin-histidine N-methyltransferase, EC 2.1.1.85 (Protein-L-histidine N-tele-methyltransferase) (SET domain-containing protein 3, hSETD3)" SETD3 C14orf154 Homo sapiens (Human) "actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; actin modification [GO:0030047]; histone H3-K36 methylation [GO:0010452]; peptidyl-histidine methylation [GO:0018021]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of uterine smooth muscle contraction [GO:0070472]" GO:0000785; GO:0003713; GO:0003779; GO:0005654; GO:0005737; GO:0010452; GO:0018021; GO:0018023; GO:0018026; GO:0018027; GO:0018064; GO:0030047; GO:0042800; GO:0045893; GO:0045944; GO:0046975; GO:0051149; GO:0061629; GO:0070472 actin binding [GO:0003779]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] ASLLLKTYK 0.99236 -6.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7143 13.1577 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7213 13.9716 14.277 0 14.0502 14.3766 15.8745 14.6508 14.1802 14.1383 0 0 0 0 0 11.7768 0 0 10.942 0 0 13.5036 0 0 0 0 0 0 12.5888 0 0 0 0 10.8321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9279 0 0 0 0 0 0 0 0 11.8203 0 0 0 0 0 Q8N3E9 PLCD3_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3, EC 3.1.4.11 (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3, PLC-delta-3)" PLCD3 KIAA1964 Homo sapiens (Human) angiogenesis [GO:0001525]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cell population proliferation [GO:0042127] cleavage furrow [GO:0032154]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cleavage furrow [GO:0032154]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435]; angiogenesis [GO:0001525]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cell population proliferation [GO:0042127] GO:0001525; GO:0004435; GO:0005829; GO:0005886; GO:0016042; GO:0032154; GO:0042127; GO:0046872; GO:0048015; GO:0060716 metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435] ECDHSNNDR 0.99236 -25.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3061 0 0 0 14.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0067 11.3695 0 0 0 0 0 0 0 11.6076 10.3657 0 0 0 0 0 0 0 0 0 0 0 0 10.6349 11.2537 0 0 0 0 0 0 0 0 0 11.9493 11.1246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4937 0 0 0 0 0 0 0 12.4152 0 0 0 0 0 0 11.9086 0 15.0418 0 0 0 0 0 0 0 0 10.7449 0 Q8TAF3 WDR48_HUMAN WD repeat-containing protein 48 (USP1-associated factor 1) (WD repeat endosomal protein) (p80) WDR48 KIAA1449 UAF1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; protein deubiquitination [GO:0016579]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; protein deubiquitination [GO:0016579]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283] GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005654; GO:0005764; GO:0005770; GO:0005829; GO:0006974; GO:0007283; GO:0007338; GO:0016579; GO:0035264; GO:0035800; GO:0043130; GO:0043231; GO:0043588; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168 deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130] IELLCQDQVLDPNMDLRTVKHFIWK 0.99236 -7.6227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3209 16.1269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6166 0 12.1826 0 0 0 0 12.7688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96D71 REPS1_HUMAN RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1) REPS1 Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197]; receptor-mediated endocytosis [GO:0006898] clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886] clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; receptor-mediated endocytosis [GO:0006898] GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006897; GO:0006898; GO:0016197; GO:0017124 calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124] KVVVNGR 0.99236 -7.6237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4975 0 12.5216 12.5918 10.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1513 0 0 0 0 9.60659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.199 0 12.486 0 0 0 0 0 0 0 0 10.7104 0 0 0 11.7491 0 0 13.1756 13.8196 13.3562 0 0 0 0 0 13.1957 0 0 0 11.9183 0 0 0 0 0 14.5591 0 0 0 0 0 0 12.9622 0 0 0 0 0 0 0 0 0 0 12.9099 0 12.9039 0 0 0 0 0 0 Q96IZ2 ADTRP_HUMAN "Androgen-dependent TFPI-regulating protein (Fatty acid esters of hydroxy fatty acids hydrolase ADTRP, FAHFA hydrolase ADTRP, EC 3.1.-.-)" ADTRP C6orf105 Homo sapiens (Human) cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to steroid hormone stimulus [GO:0071383]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of blood coagulation [GO:0030195]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491] caveola [GO:0005901]; cell surface [GO:0009986]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020] caveola [GO:0005901]; cell surface [GO:0009986]; endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; hydrolase activity [GO:0016787]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to steroid hormone stimulus [GO:0071383]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of blood coagulation [GO:0030195]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491] GO:0001934; GO:0002042; GO:0002686; GO:0003332; GO:0005901; GO:0009986; GO:0010628; GO:0012505; GO:0016020; GO:0016021; GO:0016787; GO:0030195; GO:0042758; GO:0043491; GO:0050709; GO:0071383; GO:0140052; GO:1903038; GO:2000402 hydrolase activity [GO:0016787] DEVKPKILANGAR 0.99236 -6.1031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2523 0 0 0 0 12.3712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2634 13.2593 0 13.7304 13.8298 14.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.29 0 0 0 0 13.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6745 0 Q99543 DNJC2_HUMAN "DnaJ homolog subfamily C member 2 (M-phase phosphoprotein 11) (Zuotin-related factor 1) [Cleaved into: DnaJ homolog subfamily C member 2, N-terminally processed ]" DNAJC2 MPHOSPH11 MPP11 ZRF1 Homo sapiens (Human) "'de novo' cotranslational protein folding [GO:0051083]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to heat [GO:1900034]; regulation of translational fidelity [GO:0006450]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin modification-dependent histone binding [GO:0061649]; 'de novo' cotranslational protein folding [GO:0051083]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular response to heat [GO:1900034]; regulation of translational fidelity [GO:0006450]" GO:0001671; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006325; GO:0006450; GO:0030544; GO:0031965; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649; GO:1900034; GO:2000279 ATPase activator activity [GO:0001671]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin modification-dependent histone binding [GO:0061649] ATQRQIKAAHK 0.99236 -56.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65353 0 0 0 0 0 0 0 0 11.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4662 0 11.882 0 0 0 0 0 12.3901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9798 0 0 0 14.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4676 0 0 11.6636 0 0 0 0 0 12.197 0 13.016 0 0 0 0 10.178 0 0 14.2471 0 0 0 0 14.0069 14.3733 12.2882 0 12.8679 14.0014 0 0 0 0 0 0 0 0 12.4737 0 0 12.8933 0 0 11.5466 0 14.0283 0 13.8348 0 0 0 0 0 0 Q9NS23 RASF1_HUMAN Ras association domain-containing protein 1 RASSF1 RDA32 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction [GO:0007165] GO:0000922; GO:0005634; GO:0005737; GO:0005815; GO:0005874; GO:0006974; GO:0007049; GO:0007165; GO:0007265; GO:0008270; GO:0015630; GO:0031398; GO:0042802; GO:0047485; GO:0050821; GO:0051726; GO:0070507; GO:1902806 identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; zinc ion binding [GO:0008270] ANALRIARGTACNPTR 0.99236 -7.6375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.204 0 0 0 0 0 0 Q9UG01 IF172_HUMAN Intraflagellar transport protein 172 homolog IFT172 KIAA1179 Homo sapiens (Human) bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular vesicle [GO:1903561]; intraciliary transport particle B [GO:0030992]; sperm cytoplasmic droplet [GO:0097598]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; bone development [GO:0060348]; brain development [GO:0007420]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral pattern formation [GO:0009953]; embryonic camera-type eye morphogenesis [GO:0048596]; epidermis development [GO:0008544]; heart looping [GO:0001947]; hindgut development [GO:0061525]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; left/right axis specification [GO:0070986]; limb development [GO:0060173]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of smoothened signaling pathway [GO:0045880]; protein processing [GO:0016485]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; spinal cord motor neuron differentiation [GO:0021522] GO:0001843; GO:0001947; GO:0005929; GO:0005930; GO:0007219; GO:0007224; GO:0007420; GO:0008544; GO:0009953; GO:0010839; GO:0016485; GO:0021522; GO:0030992; GO:0031122; GO:0035720; GO:0036064; GO:0042073; GO:0043616; GO:0045879; GO:0045880; GO:0048596; GO:0060021; GO:0060173; GO:0060271; GO:0060348; GO:0061525; GO:0070986; GO:0097225; GO:0097228; GO:0097542; GO:0097598; GO:1903561; GO:1905515 AEGLLLRAQR 0.99236 -57.019 0 0 0 0 0 0 0 0 14.3692 14.044 0 0 12.9283 0 0 0 0 0 12.9922 0 11.2977 0 0 0 0 0 0 0 0 0 0 0 11.27 10.6251 13.2488 0 0 0 0 0 13.5695 0 0 0 0 0 0 11.1917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9855 0 13.3105 0 0 12.5933 13.2288 17.4059 0 13.6873 0 11.0658 0 13.9348 0 0 0 13.1153 0 0 0 0 0 0 13.6683 0 11.0631 0 0 0 14.3742 0 13.1934 0 0 13.8243 13.282 0 14.7445 0 0 0 0 0 12.9647 12.3737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7304 0 0 0 0 0 0 0 0 13.5264 0 0 0 0 0 0 0 0 13.8141 0 0 0 0 12.4194 0 0 0 0 0 0 0 0 0 0 0 12.0903 0 0 0 Q9UNZ5 L10K_HUMAN Leydig cell tumor 10 kDa protein homolog C19orf53 HSPC023 Homo sapiens (Human) ARVVQQQK 0.99236 -17.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4859 0 0 12.6851 0 0 13.737 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9494 0 0 0 13.721 0 0 0 0 0 13.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPW5 CBPC1_HUMAN "Cytosolic carboxypeptidase 1, EC 3.4.17.-, EC 3.4.17.24 (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1)" AGTPBP1 CCP1 KIAA1035 NNA1 Homo sapiens (Human) adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; neurotransmitter metabolic process [GO:0042133]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958] GO:0001754; GO:0004181; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0042133; GO:0043231; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060 metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] DKKFGVK 0.99236 -25.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5223 0 0 0 0 0 13.2509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9072 0 14.1974 0 0 0 0 14.0329 0 0 0 0 0 0 13.4684 0 0 0 0 13.0196 0 13.8759 13.0067 0 14.9113 0 0 11.7679 14.0812 0 0 0 15.0025 0 14.3891 13.1666 0 0 0 0 0 0 13.5975 0 0 11.1447 0 0 0 0 0 0 14.9128 0 16.2686 0 0 0 12.7131 0 0 14.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3419 10.6384 0 14.192 0 0 0 0 0 0 0 0 0 13.1737 0 0 0 0 0 0 0 0 0 12.6787 0 12.175 15.3515 0 0 0 0 0 0 0 0 0 15.7984 0 0 O95466 FMNL1_HUMAN Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin) FMNL1 C17orf1 C17orf1B FMNL FRL1 Homo sapiens (Human) actin filament severing [GO:0051014]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360] bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267]; actin filament severing [GO:0051014]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell shape [GO:0008360] GO:0005829; GO:0005886; GO:0005938; GO:0008360; GO:0016020; GO:0016477; GO:0030866; GO:0031267; GO:0032059; GO:0032794; GO:0045335; GO:0051014; GO:0051015; GO:0070062 actin filament binding [GO:0051015]; GTPase activating protein binding [GO:0032794]; small GTPase binding [GO:0031267] EFVRQDDCMVLK 0.99237 -17.929 0 0 10.6228 14.5137 14.2938 15.1556 13.0695 14.7556 0 0 0 0 0 10.4032 0 9.95404 0 0 0 0 0 14.6497 0 15.0251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9359 14.6928 13.8325 0 18.2244 0 12.703 15.2188 17.978 13.7866 16.0307 17.1663 0 17.08 0 14.7955 0 13.4484 15.9994 14.7777 17.0437 15.3293 15.645 14.0756 13.843 0 13.7552 15.865 15.3 12.7516 14.7929 16.404 15.9608 16.9956 16.6774 16.6492 0 12.2979 15.5118 17.4679 15.6634 15.0411 0 16.9319 17.507 15.5325 0 15.7679 14.5111 0 0 14.7305 14.4035 16.7221 0 0 14.6841 0 15.2804 16.1447 14.4061 15.4969 0 14.3604 14.0374 17.9664 15.7116 16.6648 15.4674 0 18.623 17.5013 15.5716 19.7231 16.1605 15.4187 14.3091 14.1323 14.2279 16.3809 0 0 0 15.3337 17.2636 19.3328 15.6444 0 15.7958 0 11.1697 0 0 12.428 11.5282 0 0 0 0 0 0 0 0 0 14.4942 14.3143 0 14.4433 0 0 0 16.2087 0 Q9NYC9 DYH9_HUMAN Dynein axonemal heavy chain 9 (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9) DNAH9 DNAH17L DNEL1 KIAA0357 Homo sapiens (Human) cell projection organization [GO:0030030]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; mucociliary clearance [GO:0120197] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; distal portion of axoneme [GO:0120135]; dynein complex [GO:0030286]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cell projection organization [GO:0030030]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; mucociliary clearance [GO:0120197] GO:0003341; GO:0005524; GO:0005576; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030030; GO:0030286; GO:0031514; GO:0036157; GO:0045505; GO:0051649; GO:0051959; GO:0090660; GO:0097729; GO:0120135; GO:0120197 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] AIKSVLVVAGSLK 0.99237 -18.427 10.9298 11.5156 0 11.0369 0 0 11.8333 11.894 12.6696 0 13.98 13.3841 0 11.7799 0 0 0 11.7876 0 0 11.3117 17.476 9.33885 15.9937 0 0 0 0 0 0 0 0 0 11.201 13.9467 0 0 0 0 0 10.5331 0 11.2553 0 0 0 11.7068 14.1575 11.1037 0 0 0 0 0 14.0315 13.9092 14.0496 0 12.4482 13.3551 13.2529 13.3556 13.0455 13.5362 0 0 0 12.5957 11.2751 0 0 0 11.4119 14.88 15.6254 14.9545 13.1373 0 15.4088 11.6844 13.015 14.9826 0 0 16.1438 16.0805 21.645 15.5935 16.3539 16.5613 15.4535 19.4194 18.5224 18.486 18.0798 18.8074 13.5554 0 14.6145 0 0 18.1409 0 16.8984 17.5075 11.1247 16.9268 12.2438 18.5151 19.0137 13.012 18.4207 18.9211 18.1062 18.863 14.9298 13.1703 12.1544 17.7371 18.2588 0 0 0 18.65 18.6189 0 19.436 19.163 18.9302 0 0 18.2593 18.7272 13.2577 15.4149 0 12.847 0 18.2516 0 17.481 0 0 18.7957 12.8574 18.3557 0 0 0 0 17.7729 12.6697 9.87764 0 17.2697 16.7828 12.5736 0 0 0 0 0 0 0 12.3016 10.3903 0 0 0 0 0 19.6619 17.7793 15.3034 13.5851 0 0 0 12.0453 12.3396 A6NK53 ZN233_HUMAN Zinc finger protein 233 ZNF233 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSHNNCGKDCVK 0.99237 -18.437 0 0 0 0 0 0 0 0 0 11.8418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0855 11.514 0 0 0 0 0 0 0 0 12.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8966 0 15.5179 0 0 0 0 0 14.0953 0 0 0 0 12.304 0 14.3875 0 0 0 0 12.7313 0 0 0 11.9176 0 0 0 0 0 0 11.7541 12.5046 0 0 0 0 13.7002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6744 0 0 0 0 0 0 0 0 0 0 0 0 15.1757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8477 0 0 0 O95067 CCNB2_HUMAN G2/mitotic-specific cyclin-B2 CCNB2 Homo sapiens (Human) cell division [GO:0051301]; G2/MI transition of meiotic cell cycle [GO:0008315]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; G2/MI transition of meiotic cell cycle [GO:0008315]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of growth [GO:0040008]; spindle assembly involved in female meiosis I [GO:0007057]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538] GO:0000079; GO:0000307; GO:0001701; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0007057; GO:0008315; GO:0015630; GO:0016020; GO:0016538; GO:0040008; GO:0043029; GO:0044772; GO:0045296; GO:0048538; GO:0051301 cadherin binding [GO:0045296]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] DIYQYLR 0.99237 -25.664 0 0 0 0 0 0 0 0 0 0 0 0 15.5193 0 0 0 0 0 0 0 0 0 0 13.18 0 0 0 0 0 0 0 0 9.81578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2815 11.6324 0 0 9.35865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3571 13.8717 14.7678 0 0 13.85 13.9985 14.0211 14.194 14.3613 14.2606 13.7541 14.2694 14.2406 0 14.1275 14.0104 0 11.101 0 14.3273 14.1614 0 0 10.3931 0 0 0 0 13.3741 0 0 0 0 0 0 0 0 0 0 13.8596 11.1551 0 0 0 0 0 0 0 12.7085 0 0 0 0 9.96456 0 0 0 10.4676 0 14.4863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9735 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5926 0 0 10.7808 0 0 0 0 11.1996 12.809 0 0 0 0 Q13454 TUSC3_HUMAN "Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3, Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33)" TUSC3 N33 Homo sapiens (Human) cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085] GO:0005739; GO:0005789; GO:0005886; GO:0005887; GO:0006487; GO:0008250; GO:0015095; GO:0015693; GO:0018279; GO:0050890; GO:0055085 magnesium ion transmembrane transporter activity [GO:0015095] FIKAPPR 0.99237 -17.974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8633 12.5715 0 0 0 0 0 11.813 0 12.9382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9504 0 0 0 0 0 0 0 0 0 0 0 0 18.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8661 0 12.2762 0 0 0 0 0 0 0 0 0 0 13.0503 0 0 0 0 0 0 0 0 13.1399 0 0 0 0 0 Q13480 GAB1_HUMAN GRB2-associated-binding protein 1 (GRB2-associated binder 1) (Growth factor receptor bound protein 2-associated protein 1) GAB1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; endothelial cell chemotaxis to vascular endothelial growth factor [GO:0090668]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; response to hepatocyte growth factor [GO:0035728]; signal transduction [GO:0007165]; vascular endothelial growth factor signaling pathway [GO:0038084] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; signaling adaptor activity [GO:0035591]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; endothelial cell chemotaxis to vascular endothelial growth factor [GO:0090668]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; response to hepatocyte growth factor [GO:0035728]; signal transduction [GO:0007165]; vascular endothelial growth factor signaling pathway [GO:0038084] GO:0001525; GO:0005737; GO:0005829; GO:0005911; GO:0007165; GO:0007173; GO:0008286; GO:0031532; GO:0035591; GO:0035728; GO:0038084; GO:0038089; GO:0045766; GO:0090668 signaling adaptor activity [GO:0035591] DASSQDCYDIPR 0.99237 -14.994 0 0 0 0 0 0 0 0 13.5708 15.0298 0 0 14.5153 13.8154 0 0 0 0 0 0 0 11.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5029 0 0 0 0 12.2162 0 0 0 16.6626 0 17.1953 0 0 0 0 0 0 0 0 0 0 17.9937 0 0 15.8507 0 0 0 15.3462 0 14.2935 13.1449 13.1362 14.6369 14.3448 0 13.6642 13.9678 0 13.3015 14.4496 0 15.4083 0 13.2825 0 0 15.2317 0 0 13.8082 0 0 0 0 0 0 13.7579 0 12.986 0 13.3304 13.4552 13.426 12.9848 13.5853 13.9819 14.2257 0 0 0 13.5203 14.5647 13.4912 14.8645 0 13.1682 16.5864 14.3261 14.1304 0 14.6497 14.7426 15.5519 0 15.4998 15.9966 15.7228 0 14.193 0 13.7221 0 14.7407 0 14.9941 13.705 14.9093 14.5308 0 14.232 14.0548 13.4585 0 0 0 0 13.773 0 0 0 0 0 0 0 15.9032 0 14.9611 0 13.4712 0 0 18.7557 12.8837 0 0 0 0 0 0 0 0 12.1878 0 0 14.051 13.9021 0 14.238 0 11.7359 0 0 0 Q6ZSB9 ZBT49_HUMAN Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509) ZBTB49 ZNF509 Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001223; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007049; GO:0008285; GO:0015630; GO:0043565; GO:0045944; GO:0046872; GO:0051726; GO:0140297 "DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]" KAIHLKK 0.99237 -25.654 0 0 9.72398 0 0 0 11.2178 0 13.4645 0 0 0 0 14.2646 9.55275 0 0 0 0 0 0 0 0 0 0 0 0 13.8227 0 0 12.9019 0 0 0 14.0072 13.9349 13.9681 14.3781 14.0097 10.2159 14.0975 13.446 8.75181 13.3467 0 0 10.7261 0 0 0 0 0 0 11.3337 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6724 0 0 0 0 0 0 0 0 0 10.0735 11.8788 0 0 10.7909 0 11.0356 0 0 0 0 11.2553 12.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1048 0 0 0 11.0348 0 0 0 0 0 0 0 0 11.9625 0 0 0 0 0 0 0 0 11.719 0 11.2936 0 0 9.65769 0 0 0 0 11.1096 0 0 0 0 0 11.5298 0 0 0 11.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7556 0 0 13.8177 13.1657 0 13.5794 0 0 12.7941 0 12.9397 0 13.9245 12.2603 14.2549 Q8IYL3 CA174_HUMAN UPF0688 protein C1orf174 C1orf174 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 AKDDDDDDDDDAEM 0.99237 -4.3961 0 0 0 0 0 0 0 0 0 0 0 10.94 0 0 0 11.6651 0 0 0 10.0788 0 0 0 0 0 0 0 0 0 0 0 0 14.3175 0 0 0 0 0 0 0 0 12.25 0 0 0 0 0 0 0 0 0 0 13.5119 10.9134 10.7359 0 9.76134 0 0 0 0 0 0 0 0 0 11.0334 0 13.4194 0 11.5126 0 0 11.5886 13.6614 12.8198 0 12.4414 0 0 0 0 10.2376 0 10.9028 13.5406 0 11.447 0 0 0 13.8742 11.5036 0 12.4489 0 15.5008 0 0 0 13.1207 0 0 10.6271 0 0 0 12.1181 0 0 14.7019 12.7571 0 0 15.0165 0 0 13.8327 0 14.2333 0 0 12.7063 0 14.6424 0 9.17615 9.39566 13.4967 0 0 0 0 9.95434 0 0 0 13.0992 10.4685 10.0411 0 9.87255 0 0 0 12.3351 12.1373 11.4699 13.1409 0 12.6787 11.8798 0 0 0 0 12.2056 9.85336 0 0 0 0 0 11.4115 0 10.8111 12.6507 0 0 12.1024 9.87928 0 0 0 0 0 13.7264 0 0 0 Q8N187 CARTF_HUMAN "Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor, CaRF) (Testis development protein NYD-SP24)" CARF ALS2CR8 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; positive regulation of transcription from RNA polymerase II promoter in response to calcium ion [GO:0061400]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357] granular component [GO:0001652]; nucleus [GO:0005634] "granular component [GO:0001652]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; positive regulation of transcription from RNA polymerase II promoter in response to calcium ion [GO:0061400]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001228; GO:0001652; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0035865; GO:0051090; GO:0061400; GO:0071277 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KFVERELFK 0.99237 -4.3933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9112 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC57 M1AP_HUMAN Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37) M1AP C2orf65 SPATA37 Homo sapiens (Human) cell differentiation [GO:0030154]; chromatin assembly [GO:0031497]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; chromatin assembly [GO:0031497]; female gamete generation [GO:0007292]; male meiosis chromosome separation [GO:0051308]; meiosis I [GO:0007127]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283] GO:0005737; GO:0006396; GO:0007127; GO:0007283; GO:0007292; GO:0016021; GO:0030154; GO:0031497; GO:0042802; GO:0051308 identical protein binding [GO:0042802] DNPMCLKCDLQER 0.99237 -17.963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF76 HASP_HUMAN "Serine/threonine-protein kinase haspin, EC 2.7.11.1 (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase)" HASPIN GSG2 Homo sapiens (Human) "chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]" centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] "centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]" GO:0000278; GO:0004672; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005819; GO:0006325; GO:0006468; GO:0007064; GO:0007094; GO:0035556; GO:0071459; GO:0072354; GO:0106310 ATP binding [GO:0005524]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] ARPSLTVTPRR 0.99237 -7.6442 0 0 0 0 0 0 0 0 11.8413 0 0 0 0 0 0 0 11.6496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9195 0 0 13.6582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.545 0 0 0 0 0 0 0 0 0 0 0 11.5921 0 0 0 0 0 0 0 0 0 11.9864 0 0 Q96CS2 HAUS1_HUMAN "HAUS augmin-like complex subunit 1 (Coiled-coil domain-containing protein 5) (Enhancer of invasion-cluster, HEI-C)" HAUS1 CCDC5 HEIC Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; spindle pole [GO:0000922]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0000922; GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:1990498 LARLKQQTIPLK 0.99237 -17.945 0 8.97189 0 0 0 0 0 0 0 0 0 0 0 13.7244 0 0 14.223 0 0 0 0 0 0 0 0 0 0 0 0 13.4679 0 0 0 0 0 0 0 0 0 0 13.0629 0 0 0 13.4611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99705 MCHR1_HUMAN "Melanin-concentrating hormone receptor 1, MCH receptor 1, MCH-R1, MCHR-1 (G-protein coupled receptor 24) (MCH-1R, MCH1R, MCHR) (SLC-1) (Somatostatin receptor-like protein)" MCHR1 GPR24 SLC1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204] ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanin-concentrating hormone receptor activity [GO:0030273]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell surface receptor signaling pathway [GO:0007166]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; generation of precursor metabolites and energy [GO:0006091]; neuropeptide signaling pathway [GO:0007218]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204] GO:0004930; GO:0005102; GO:0005886; GO:0005887; GO:0005929; GO:0006091; GO:0007166; GO:0007186; GO:0007193; GO:0007204; GO:0007218; GO:0007631; GO:0008022; GO:0008188; GO:0030273; GO:0042277; GO:0042562; GO:0042923; GO:0043005; GO:0051928; GO:0060170; GO:0097730 G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanin-concentrating hormone receptor activity [GO:0030273]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; peptide binding [GO:0042277]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102] FRKPSVATLVICLLWALSFISITPVWLYAR 0.99237 -14.973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1579 0 0 13.37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9543 0 0 0 0 0 0 0 14.4596 0 0 0 0 0 13.3001 0 0 0 0 0 10.1285 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6616 0 0 12.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2887 0 0 0 0 0 0 0 0 0 0 14.0402 0 0 0 Q9UGI8 TES_HUMAN Testin (TESS) TES Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285] cell junction [GO:0030054]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cell junction [GO:0030054]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; negative regulation of cell population proliferation [GO:0008285] GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0005925; GO:0008270; GO:0008285; GO:0030054; GO:0032991; GO:0045296 cadherin binding [GO:0045296]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] CKEKCEGFELHFWR 0.99237 -6.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5525 0 Q9UH90 FBX40_HUMAN F-box only protein 40 (Muscle disease-related protein) FBXO40 FBX40 KIAA1195 Homo sapiens (Human) muscle cell differentiation [GO:0042692] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; muscle cell differentiation [GO:0042692] GO:0005737; GO:0005829; GO:0008270; GO:0042692; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DFVYGKLEAQEVK 0.99237 -18.43 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7334 0 0 0 0 0 0 0 11.0329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8261 0 0 0 11.8071 0 14.4238 15.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.047 0 0 0 0 0 0 0 0 0 0 13.468 12.7046 0 0 0 0 0 0 12.883 0 13.3527 0 0 0 13.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9118 0 0 12.9921 0 Q9UMR3 TBX20_HUMAN "T-box transcription factor TBX20, T-box protein 20" TBX20 Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrioventricular canal development [GO:0036302]; atrioventricular valve development [GO:0003171]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum development [GO:0003279]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endoderm formation [GO:0001706]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; lateral mesoderm formation [GO:0048370]; mesenchymal cell development [GO:0014031]; motor neuron migration [GO:0097475]; muscle contraction [GO:0006936]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of transcription by RNA polymerase II [GO:0006357]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrioventricular canal development [GO:0036302]; atrioventricular valve development [GO:0003171]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum development [GO:0003279]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endoderm formation [GO:0001706]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; lateral mesoderm formation [GO:0048370]; mesenchymal cell development [GO:0014031]; motor neuron migration [GO:0097475]; muscle contraction [GO:0006936]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of transcription by RNA polymerase II [GO:0006357]; tricuspid valve development [GO:0003175]; vasculogenesis [GO:0001570]; visceral motor neuron differentiation [GO:0021524]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001569; GO:0001570; GO:0001706; GO:0001708; GO:0001947; GO:0003143; GO:0003148; GO:0003171; GO:0003175; GO:0003180; GO:0003193; GO:0003203; GO:0003207; GO:0003215; GO:0003272; GO:0003279; GO:0003344; GO:0005634; GO:0005737; GO:0006357; GO:0006936; GO:0008015; GO:0008283; GO:0009953; GO:0010718; GO:0010991; GO:0014031; GO:0021524; GO:0030513; GO:0035922; GO:0036302; GO:0036306; GO:0045892; GO:0048370; GO:0055008; GO:0060045; GO:0060413; GO:0060577; GO:0061629; GO:0097475; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" RYRYAYHR 0.99237 -17.08 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPN6 SCAF8_HUMAN SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) SCAF8 CCAP7 KIAA1116 RBM16 Homo sapiens (Human) "mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]" cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]" GO:0000993; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005849; GO:0006369; GO:0006378; GO:0016363; GO:0032786; GO:0043175; GO:1990269; GO:2000805 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993] HVVQSVEK 0.99237 -18.455 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.171 0 0 0 0 16.3633 0 0 0 0 0 0 13.4558 13.7499 13.9829 0 0 15.482 0 0 0 0 14.28 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8119 13.2653 0 0 0 14.6896 0 0 12.5919 13.3505 12.8221 0 0 13.9506 0 0 0 12.7988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7236 12.6603 13.1553 12.7941 14.0577 0 0 0 0 0 0 0 0 12.5058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZJ4 SACS_HUMAN "Sacsin (DnaJ homolog subfamily C member 29, DNAJC29)" SACS KIAA0730 Homo sapiens (Human) negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457] axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634] axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457] GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0051087; GO:0070628; GO:0070852; GO:0090084 chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628] ADADTVLLFLKSVQDVSLYVR 0.99238 -65.059 0 13.1906 11.6585 13.129 0 0 0 11.1319 0 10.7808 0 0 0 0 0 0 0 0 0 13.501 12.9078 10.6022 0 12.5365 12.9409 0 0 0 0 0 10.365 0 0 13.3315 0 0 0 11.5094 0 0 0 12.9833 14.0808 0 9.28589 0 10.189 13.2266 0 0 12.7056 0 0 0 0 0 0 15.2859 12.8956 13.6528 11.1048 13.3422 0 0 10.1441 0 14.8498 14.9177 0 0 0 0 13.9858 14.3288 15.5976 15.2314 16.0555 15.275 15.9993 13.7485 12.322 13.683 17.7414 14.4075 14.7812 13.6041 16.6233 16.8083 17.0519 0 16.8753 14.1721 14.0238 15.5695 16.9672 13.2922 16.1599 14.6111 13.701 15.9082 15.0785 15.7268 15.3942 12.1577 15.4453 13.7746 16.233 14.8349 18.2701 16.783 16.034 0 14.0017 14.8005 15.3385 13.7663 14.7043 14.2869 14.3415 15.7889 15.2432 15.5171 14.6576 13.8658 14.863 15.1315 16.173 13.5855 14.6446 15.6061 0 15.1484 14.6951 14.5594 14.6897 14.2774 15.1452 0 13.8765 16.0077 12.6745 13.9178 13.9165 15.4208 15.7574 16.1436 13.8563 0 0 15.0084 15.4215 12.7529 0 13.4622 15.6325 16.4678 13.2633 12.3971 14.6032 14.2697 14.5975 16.7487 15.4801 14.1862 12.4944 14.515 0 0 0 14.3445 0 0 15.9115 15.9852 0 0 0 14.2932 11.4619 0 A1A5C7 S22AN_HUMAN Solute carrier family 22 member 23 SLC22A23 C6orf85 Homo sapiens (Human) ion transport [GO:0006811] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811] GO:0005886; GO:0006811; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] ELSRRPK 0.99238 -15.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4106 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1877 0 0 17.9103 13.9176 13.6453 15.419 15.0982 14.2344 13.4378 0 13.1307 0 0 0 0 0 0 11.9965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7055 13.4236 0 0 0 13.798 0 0 0 0 13.3759 0 0 0 0 0 0 0 0 0 0 0 15.2014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9212 0 0 0 0 0 0 0 P00374 DYR_HUMAN "Dihydrofolate reductase, EC 1.5.1.3" DHFR Homo sapiens (Human) axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653] GO:0000900; GO:0003729; GO:0004146; GO:0005542; GO:0005739; GO:0005829; GO:0006545; GO:0006729; GO:0006730; GO:0017148; GO:0031103; GO:0031427; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661; GO:0051000; GO:0070402; GO:1990825; GO:2000121 dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825] FEVYEKND 0.99238 -7.3493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4633 P02786 TFR1_HUMAN "Transferrin receptor protein 1, TR, TfR, TfR1, Trfr (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form, sTfR ]" TFRC Homo sapiens (Human) acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618]; acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104] GO:0001618; GO:0001666; GO:0001934; GO:0003723; GO:0003725; GO:0004998; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005768; GO:0005769; GO:0005886; GO:0005887; GO:0005905; GO:0006826; GO:0006879; GO:0006953; GO:0007568; GO:0007584; GO:0009897; GO:0009986; GO:0010008; GO:0010039; GO:0010042; GO:0010628; GO:0010637; GO:0016020; GO:0016323; GO:0019901; GO:0030316; GO:0030544; GO:0030669; GO:0030890; GO:0031334; GO:0031410; GO:0031623; GO:0032526; GO:0033138; GO:0033572; GO:0035556; GO:0042102; GO:0042470; GO:0042802; GO:0042803; GO:0043066; GO:0043123; GO:0043231; GO:0044877; GO:0045780; GO:0045830; GO:0046688; GO:0048471; GO:0051087; GO:0051092; GO:0055037; GO:0055038; GO:0070062; GO:0071466; GO:0072562; GO:0150104; GO:1900182; GO:1903561; GO:1990712; GO:1990830 chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618] EAGSQKDENLALYVENQFR 0.99238 -24.924 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7399 0 11.105 0 0 0 12.1747 12.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6624 0 0 0 0 0 13.1745 12.9642 0 0 0 0 0 0 0 0 0 0 17.9815 0 0 0 0 0 0 0 0 0 0 0 0 10.6425 11.9752 0 0 0 0 0 11.8232 0 0 13.3401 13.0349 0 12.7273 12.7714 14.0062 0 0 0 0 11.9399 13.3421 0 0 14.007 0 0 0 0 0 14.6233 0 0 0 13.2223 0 0 0 14.6458 0 0 0 0 0 12.9082 0 15.5173 0 0 0 0 0 14.3967 0 0 14.2535 12.4363 0 0 12.7378 0 0 0 12.6628 0 13.0399 0 0 0 0 0 0 14.8398 0 14.4585 0 0 0 14.6854 0 0 14.3641 0 0 0 12.7411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5701 15.1373 0 0 0 0 0 0 P07550 ADRB2_HUMAN "Beta-2 adrenergic receptor (Beta-2 adrenoreceptor, Beta-2 adrenoceptor)" ADRB2 ADRB2R B2AR Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenergic receptor signaling pathway [GO:0071875]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; endosome to lysosome transport [GO:0008333]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; response to psychosocial stress [GO:1990911]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366] apical plasma membrane [GO:0016324]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; activation of adenylate cyclase activity [GO:0007190]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenergic receptor signaling pathway [GO:0071875]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; desensitization of G protein-coupled receptor signaling pathway by arrestin [GO:0002032]; diet induced thermogenesis [GO:0002024]; endosome to lysosome transport [GO:0008333]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; response to psychosocial stress [GO:1990911]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366] GO:0001540; GO:0002024; GO:0002025; GO:0002028; GO:0002032; GO:0004930; GO:0004941; GO:0005634; GO:0005764; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005887; GO:0006366; GO:0006898; GO:0006939; GO:0007166; GO:0007171; GO:0007188; GO:0007190; GO:0008179; GO:0008333; GO:0009409; GO:0010008; GO:0010739; GO:0015459; GO:0016020; GO:0016324; GO:0030501; GO:0030669; GO:0031649; GO:0040015; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0044877; GO:0045453; GO:0045944; GO:0045986; GO:0050873; GO:0051380; GO:0061885; GO:0071875; GO:0071880; GO:0071902; GO:0120162; GO:1901098; GO:1904504; GO:1904646; GO:1990911; GO:2000481; GO:2000969 adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] NCSTNDSLL 0.99238 -17.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6987 0 18.6212 18.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DJD0 RGPD1_HUMAN "RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6, RanBP2-like 6, RanBP2L6)" RGPD1 RANBP2L6 RGP1 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006607; GO:0050790 AAKLFPGSPAIYKLK 0.99238 -24.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4471 0 0 0 0 0 0 0 0 14.2861 0 0 0 13.4831 13.7443 13.6054 13.4755 0 12.9553 0 15.0931 0 14.2739 0 14.9145 0 0 0 0 0 0 14.9866 0 0 0 0 0 0 0 0 0 0 0 14.0301 0 0 13.9784 0 0 13.2295 12.4338 13.7691 0 14.3255 0 0 0 0 14.0357 0 12.0315 0 0 0 0 0 0 0 0 0 0 0 14.2702 0 0 0 0 0 0 0 0 0 0 0 12.7425 0 0 0 0 0 0 0 0 0 0 0 0 11.5947 11.6822 0 11.7618 15.1075 0 0 0 0 0 0 0 P51857 AK1D1_HUMAN "Aldo-keto reductase family 1 member D1, EC 1.3.1.3 (3-oxo-5-beta-steroid 4-dehydrogenase) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase)" AKR1D1 SRD5B1 Homo sapiens (Human) androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; steroid metabolic process [GO:0008202] cytosol [GO:0005829] cytosol [GO:0005829]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586]; steroid metabolic process [GO:0008202] GO:0004032; GO:0004033; GO:0005496; GO:0005829; GO:0006699; GO:0006707; GO:0007586; GO:0008202; GO:0008207; GO:0008209; GO:0016229; GO:0030573; GO:0047086; GO:0047787 alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229] EDIFYCGK 0.99238 -24.962 0 0 0 0 0 0 15.1356 0 0 14.1711 0 0 0 12.8264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4649 0 0 0 0 0 0 12.0478 0 15.2468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.531 0 0 0 0 0 13.5317 15.3029 0 0 0 0 0 0 0 12.8373 11.2117 0 0 0 0 0 0 0 0 0 0 11.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6384 0 0 0 0 12.2222 0 0 0 0 0 0 0 P53990 IST1_HUMAN "IST1 homolog, hIST1 (Charged multivesicular body protein 8, CHMP8) (Putative MAPK-activating protein PM28)" IST1 KIAA0174 Homo sapiens (Human) abscission [GO:0009838]; cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076] GO:0005576; GO:0005635; GO:0005793; GO:0005813; GO:0005829; GO:0008104; GO:0009838; GO:0015031; GO:0019076; GO:0019904; GO:0030496; GO:0035578; GO:0036258; GO:0042802; GO:0043231; GO:0044877; GO:0045184; GO:0045296; GO:0045862; GO:0046745; GO:0048668; GO:0048672; GO:0051301; GO:0061640; GO:0070062; GO:0090541; GO:0090543; GO:1904903 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877] LRVNLRLVINR 0.99238 -5.5288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2868 0 0 12.0609 0 0 11.2404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1319 13.2409 0 0 0 10.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2094 13.7957 13.8324 11.2623 0 14.0782 0 0 0 0 0 0 0 17.567 12.5013 0 0 15.0121 0 0 0 17.7169 18.5903 17.7349 0 14.5125 14.4986 0 0 16.2931 16.3555 17.8564 14.5927 0 0 16.5092 16.8467 0 14.4351 0 17.6347 0 0 0 16.8021 16.4614 14.5347 0 17.4682 17.2732 17.2171 17.2431 17.1349 15.4628 17.1506 16.8234 13.2821 0 16.4009 16.2126 0 0 13.9675 0 16.7213 16.5692 0 0 0 16.8083 0 0 0 0 0 13.1124 0 11.3506 0 13.4637 0 0 0 0 0 0 0 0 0 0 0 14.8093 0 0 0 0 0 0 16.92 0 0 0 0 0 0 0 P55081 MFAP1_HUMAN Microfibrillar-associated protein 1 (Spliceosome B complex protein MFAP1) MFAP1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" centrosome [GO:0005813]; extracellular region [GO:0005576]; microfibril [GO:0001527]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "centrosome [GO:0005813]; extracellular region [GO:0005576]; microfibril [GO:0001527]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0001527; GO:0003723; GO:0005576; GO:0005634; GO:0005654; GO:0005684; GO:0005813; GO:0071005 RNA binding [GO:0003723] AELRANGKVITNK 0.99238 -24.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2492 0 0 0 0 0 11.3191 0 0 0 0 0 0 0 0 0 10.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3112 0 0 10.7762 0 0 0 11.5691 0 0 0 0 0 12.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5106 0 0 0 0 0 0 0 0 0 13.3963 0 0 0 13.2775 0 13.4131 11.7464 0 0 0 14.1065 0 10.9154 0 0 0 0 0 0 0 0 0 0 12.9149 0 11.6547 12.5059 0 0 11.6527 0 0 0 11.1178 0 0 0 0 0 0 0 0 0 0 0 0 13.1926 0 12.8677 0 0 0 16.2005 11.7365 Q13009 TIAM1_HUMAN "Rho guanine nucleotide exchange factor TIAM1 (T-lymphoma invasion and metastasis-inducing protein 1, TIAM-1)" TIAM1 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; lipid binding [GO:0008289]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of protein binding [GO:0032092]; protein-containing complex assembly [GO:0065003]; Rac protein signal transduction [GO:0016601]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0005085; GO:0005829; GO:0005886; GO:0005911; GO:0007160; GO:0007264; GO:0008284; GO:0008289; GO:0010717; GO:0010718; GO:0016020; GO:0016477; GO:0016601; GO:0019900; GO:0030335; GO:0031234; GO:0032092; GO:0044291; GO:0045202; GO:0048013; GO:0050772; GO:0051056; GO:0060071; GO:0065003; GO:0090630; GO:1904338; GO:2000050 guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; lipid binding [GO:0008289] ANSLGDLYAQK 0.99238 -6.6828 0 0 9.44276 0 0 0 0 0 10.2642 0 12.5235 0 0 0 0 12.9902 0 11.8036 0 0 0 0 0 0 15.353 13.695 0 0 0 0 0 13.8741 13.2959 0 0 14.3089 13.6203 13.5212 0 0 0 0 0 0 0 13.0542 0 0 0 0 0 0 12.5441 15.3052 14.7107 13.0863 0 0 0 0 0 0 10.7489 0 0 0 0 15.8059 15.4696 0 0 0 15.4795 0 0 0 0 15.2691 16.4615 15.1488 16.5486 16.894 13.8437 0 0 13.3322 0 13.329 0 0 0 0 12.9957 0 0 0 0 0 0 0 11.4996 0 0 0 0 12.4304 0 0 0 11.6618 12.8468 0 0 0 0 0 0 0 10.3047 0 0 0 0 0 0 0 0 15.5659 12.2981 0 0 0 11.5279 0 0 14.0876 0 0 11.7152 0 0 0 0 0 12.3776 13.9305 0 0 0 0 0 0 0 12.4334 14.6646 0 0 0 0 0 12.657 0 0 10.8357 0 0 0 0 12.6568 12.8301 0 0 0 12.4545 0 0 0 12.4828 12.46 12.1789 Q495Y7 SPDE7_HUMAN Putative speedy protein E7 (Speedy protein E7 pseudogene) SPDYE7P Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0019901; GO:0045737 protein kinase binding [GO:0019901] FLAWDKGLR 0.99238 -6.1651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0308 0 11.6249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VVM6 CCD30_HUMAN Coiled-coil domain-containing protein 30 (Prefoldin subunit 6-like protein) CCDC30 PFDN6L Homo sapiens (Human) ENLLEMTCSQQQSR 0.99238 -15.034 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5882 0 0 0 12.3157 0 0 13.2685 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9598 0 0 0 12.7509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9372 0 0 0 14.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9699 14.4989 14.713 0 0 0 0 0 12.5048 0 14.743 15.6649 0 0 0 0 0 0 0 0 15.5297 0 0 0 0 0 0 14.4661 0 0 12.7123 0 0 0 0 0 0 13.8136 13.1264 0 14.3453 0 12.7815 0 0 0 0 0 0 0 0 14.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P995 F171B_HUMAN Protein FAM171B FAM171B KIAA1946 NPD019 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AELSRSDLSLIQQQQQQQQQQQQQQK 0.99238 -18.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1274 0 0 0 0 0 0 13.2704 0 0 12.208 0 0 0 0 0 11.0419 0 0 0 11.1814 0 13.407 13.8029 0 10.3661 0 0 0 0 0 0 0 10.9741 0 0 0 0 0 0 13.9287 0 0 15.0971 13.3151 0 0 0 14.1972 14.7394 0 0 0 0 0 0 0 0 0 0 0 14.131 13.7417 0 0 15.3861 0 13.978 11.4114 0 0 13.5293 0 0 14.1384 0 13.373 0 0 13.4599 0 0 0 13.3365 12.1533 0 13.8341 0 0 0 0 0 0 12.5406 0 0 0 12.4054 9.78865 0 0 0 0 0 0 0 0 12.1651 0 0 0 0 0 0 13.056 0 0 13.2198 12.6536 0 0 0 0 0 0 0 0 16.4554 0 0 0 0 13.3884 15.4904 13.7867 Q7Z340 ZN551_HUMAN Zinc finger protein 551 (Zinc finger protein KOX23) ZNF551 KOX23 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFIHKSEFIHHQRR 0.99238 -25.009 0 11.7271 0 0 0 0 0 0 0 0 0 13.9776 0 0 0 0 0 0 0 0 0 0 11.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5902 0 0 0 0 0 0 9.23726 0 0 0 0 0 0 0 10.4389 11.7103 0 0 0 0 0 0 0 0 0 0 0 10.2623 0 0 0 12.1595 10.0798 12.6117 0 0 11.5696 12.0092 0 14.7452 12.177 0 0 0 0 11.4156 12.485 12.479 0 15.148 11.2706 13.6148 13.7843 14.0247 14.4625 13.4416 0 0 0 0 11.8725 0 0 0 0 0 0 0 12.2258 0 12.6041 0 0 0 0 0 12.3542 0 12.1145 0 0 0 0 0 0 0 0 0 12.2296 0 0 0 0 0 0 10.3808 0 0 0 0 0 0 0 0 0 0 13.311 11.9888 12.5247 0 13.0739 0 0 0 13.147 12.3567 0 11.5844 0 0 0 13.2514 12.2499 13.5344 0 0 0 14.9497 0 11.5892 0 0 0 0 0 0 0 0 0 0 0 0 12.8595 Q86UQ4 ABCAD_HUMAN "ATP-binding cassette sub-family A member 13, EC 7.6.2.-" ABCA13 Homo sapiens (Human) ceramide transport [GO:0035627]; lipid transport [GO:0006869]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of synaptic vesicle endocytosis [GO:1900244] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] azurophil granule membrane [GO:0035577]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; ceramide transport [GO:0035627]; lipid transport [GO:0006869]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of synaptic vesicle endocytosis [GO:1900244] GO:0005319; GO:0005524; GO:0005886; GO:0006869; GO:0016021; GO:0030667; GO:0032376; GO:0035577; GO:0035627; GO:0042626; GO:0043231; GO:0097708; GO:0140359; GO:1900244 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] AFKKFIR 0.99238 -64.535 0 0 0 0 0 0 0 0 13.2316 0 0 11.9385 0 11.948 0 0 12.0227 12.449 0 13.5349 0 12.0239 0 11.5274 13.2991 0 11.7539 0 0 0 0 0 0 11.8461 19.4167 0 12.6785 0 10.8573 0 0 0 9.99251 0 12.5704 12.9205 0 12.101 0 0 0 0 0 0 0 11.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9882 0 0 0 0 11.1587 9.97799 0 0 13.4759 0 12.8241 0 0 13.6204 12.4375 0 13.26 10.5243 14.4481 14.3495 14.8233 15.5685 14.6577 15.5813 14.7588 14.9325 14.7909 14.93 0 13.7307 14.5167 0 0 0 11.8968 12.8539 13.8614 0 0 0 0 13.8842 0 13.5708 13.367 13.3771 0 13.4231 13.0778 15.6275 13.1776 12.7998 0 0 11.5778 0 12.4751 0 12.6352 13.7279 0 0 0 0 0 14.5889 0 12.166 13.9377 11.8729 0 15.4737 14.1697 0 0 14.0355 10.753 0 14.4374 0 0 0 14.388 11.9238 0 12.4389 12.8077 16.5838 15.2007 13.7122 13.2822 14.5977 18.5806 15.2891 14.8323 14.2726 0 14.2606 13.3851 13.3877 14.1691 0 12.8255 0 0 14.8694 0 12.2418 13.963 12.9048 Q8TCG2 P4K2B_HUMAN "Phosphatidylinositol 4-kinase type 2-beta, EC 2.7.1.67 (Phosphatidylinositol 4-kinase type II-beta, PI4KII-BETA)" PI4K2B Homo sapiens (Human) endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310] GO:0000139; GO:0004430; GO:0005524; GO:0005768; GO:0005789; GO:0005802; GO:0005829; GO:0005886; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0016310; GO:0031901; GO:0046854 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524] EDPSEPDRLASADGGSPEEEEDGER 0.99238 -40.437 0 0 0 0 0 0 0 0 15.1572 11.4499 0 0 0 12.7975 13.5857 12.962 12.7632 13.1119 13.0492 12.804 12.8661 10.6604 13.0515 0 12.894 13.0696 12.921 0 11.6336 12.1551 0 15.4161 0 0 15.2925 0 0 0 0 12.8057 0 0 13.0869 0 12.6969 12.9605 0 0 12.246 12.4918 0 12.0216 12.5807 13.2573 13.5249 0 12.2979 0 14.504 0 0 0 0 0 0 0 9.93427 0 0 0 0 0 0 0 0 0 13.3993 0 0 0 0 0 0 13.557 0 0 0 0 0 16.2899 0 0 16.2721 0 16.3125 0 16.9908 0 0 15.8984 0 0 0 14.4638 14.8929 16.1979 0 16.7627 0 15.7049 12.7133 16.0848 0 0 16.1096 0 15.7903 15.5156 0 15.3671 0 15.7384 0 0 0 0 0 0 0 15.5463 0 0 0 14.7006 14.6322 0 0 0 15.3555 16.1848 15.1847 0 0 14.9574 16.0185 16.3078 14.8461 0 9.32885 0 0 19.0008 0 0 0 12.7158 15.0911 0 0 0 0 0 11.8767 12.4078 0 0 12.9035 0 14.0707 14.468 0 0 15.0657 14.5825 14.4519 13.5656 0 0 0 13.2632 Q8TCS8 PNPT1_HUMAN "Polyribonucleotide nucleotidyltransferase 1, mitochondrial, EC 2.7.7.8 (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1, PNPase 1) (Polynucleotide phosphorylase-like protein)" PNPT1 PNPASE Homo sapiens (Human) cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion morphogenesis [GO:0070584]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cell cycle [GO:0051726]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion morphogenesis [GO:0070584]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cell cycle [GO:0051726]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; RNA polyadenylation [GO:0043631]; rRNA import into mitochondrion [GO:0035928] GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005634; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0006401; GO:0006402; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042788; GO:0043457; GO:0043631; GO:0045025; GO:0045926; GO:0051260; GO:0051591; GO:0051726; GO:0060416; GO:0061014; GO:0070207; GO:0070584; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772 3'-5'-exoribonuclease activity [GO:0000175]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723] GEIEDYR 0.99238 -18.077 0 0 0 0 0 0 0 0 14.6184 0 0 14.0811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2564 14.4012 0 0 13.1263 0 0 0 0 0 13.5404 13.5848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3119 0 0 0 0 0 0 0 16.4649 0 0 14.5463 14.467 0 13.4324 15.1366 12.7685 16.913 11.8803 14.7815 13.7834 0 0 0 13.4398 0 13.292 0 0 14.5869 0 11.0633 0 0 0 13.6435 0 0 0 0 0 0 0 0 0 0 0 16.5904 15.4205 11.2313 0 0 16.8138 16.6451 0 0 16.7245 0 0 15.3577 0 0 0 0 17.6822 0 0 0 0 0 0 0 0 0 9.26948 0 0 17.3779 0 0 18.2696 0 0 0 14.2677 0 0 0 0 14.9044 0 14.8379 0 0 0 0 15.5669 0 0 0 0 0 0 0 0 16.2507 0 0 Q96ES7 SGF29_HUMAN SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29) SGF29 CCDC101 Homo sapiens (Human) "chromatin organization [GO:0006325]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461] "ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" GO:0000124; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0016573; GO:0031063; GO:0035064; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0044154; GO:0045893; GO:0045995; GO:0051302; GO:0051726; GO:0070461; GO:0071169; GO:0072686; GO:0090043; GO:0140672 methylated histone binding [GO:0035064] HTLSRRR 0.99238 -7.6798 12.1751 15.2986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2024 0 14.3794 13.5098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3403 15.0532 0 0 0 15.2545 0 12.3696 13.2686 0 0 0 0 0 0 12.9634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0D4 Z518B_HUMAN Zinc finger protein 518B ZNF518B KIAA1729 Homo sapiens (Human) chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006325; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AVAKLEPK 0.99238 -40.482 0 0 0 12.1853 0 0 0 0 0 13.5697 0 0 0 0 0 0 10.7508 10.4616 0 0 0 13.2084 0 0 0 0 0 0 0 0 0 14.7496 14.0953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6712 0 0 0 0 0 0 0 0 0 15.0648 14.5376 14.6484 14.8842 0 14.6657 0 0 14.5471 0 14.5075 0 0 15.6257 14.4537 14.4457 13.4535 0 14.6238 0 0 0 14.2461 14.2665 13.231 0 13.4128 0 0 0 0 14.9592 12.6289 0 0 14.7651 0 0 0 0 0 0 0 0 11.7628 12.3057 14.2397 12.8602 15.1971 14.9638 13.5278 13.5411 14.6335 13.6663 13.8565 13.9517 0 0 0 13.452 13.4428 0 0 0 13.6591 15.0011 13.9425 0 14.8603 13.8528 0 14.7151 15.7512 0 15.6723 0 14.2808 0 0 0 14.9429 0 0 0 0 13.8543 0 13.6408 15.2175 14.4984 0 0 11.7087 0 0 0 0 0 0 0 0 14.0343 0 0 0 13.9256 13.9226 0 14.0517 0 0 10.8816 15.3768 0 Q9P0K1 ADA22_HUMAN "Disintegrin and metalloproteinase domain-containing protein 22, ADAM 22 (Metalloproteinase-disintegrin ADAM22-3) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2)" ADAM22 MDC2 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; negative regulation of cell adhesion [GO:0007162]; proteolysis [GO:0006508] axon [GO:0030424]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886] axon [GO:0030424]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; negative regulation of cell adhesion [GO:0007162]; proteolysis [GO:0006508] GO:0004222; GO:0005178; GO:0005886; GO:0006508; GO:0007155; GO:0007162; GO:0007417; GO:0016021; GO:0030424; GO:0099061 integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222] DKDTWIQCNKR 0.99238 -17.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3887 0 0 0 0 0 12.3736 12.5697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9611 0 12.1496 0 0 13.2157 0 0 0 9.99817 0 12.5509 0 0 0 0 0 12.7161 0 12.9532 0 0 0 0 12.5531 0 12.9424 0 14.6697 11.2042 0 0 0 0 0 0 0 14.3475 0 0 0 11.6974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4812 0 0 14.4765 0 0 0 0 0 0 0 10.3194 0 12.2915 0 0 0 15.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4345 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2E4 DIP2C_HUMAN "Disco-interacting protein 2 homolog C, DIP2 homolog C" DIP2C KIAA0934 Homo sapiens (Human) AEKIAVMLMER 0.99238 -5.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0383 0 0 0 0 0 0 0 0 0 0 0 0 13.9527 13.3058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9183 10.8471 0 0 0 13.4303 11.4614 11.5686 11.6428 0 10.4244 0 0 0 0 0 0 11.2883 0 0 0 0 0 0 0 0 14.1737 0 0 0 0 14.3487 14.4447 14.3583 0 15.2216 15.3603 14.3754 13.7445 15.2203 13.8718 15.9085 0 11.5592 14.6559 13.8978 14.0777 14.1433 0 10.7736 10.6573 13.5157 14.1185 13.5775 0 0 0 0 13.7413 15.5371 0 0 0 0 0 0 0 0 12.2488 14.2411 10.312 0 0 0 0 10.4233 0 0 14.0829 0 12.9002 0 13.5353 0 11.3585 0 0 0 0 12.7821 0 0 0 0 0 0 12.3862 0 10.5556 14.6816 0 0 14.8462 0 0 0 0 0 0 0 16.4727 0 0 0 0 0 0 0 0 14.0245 10.8059 0 0 0 11.5378 13.3865 Q9Y3T9 NOC2L_HUMAN "Nucleolar complex protein 2 homolog, Protein NOC2 homolog (NOC2-like protein) (Novel INHAT repressor)" NOC2L NIR Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273] chromosome [GO:0005694]; cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273] GO:0000122; GO:0002903; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006915; GO:0030690; GO:0030691; GO:0031491; GO:0031497; GO:0034644; GO:0035067; GO:0042273; GO:0042393; GO:0140297; GO:2001243 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] ECKVANYCR 0.99238 -17.642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3749 0 0 0 0 0 0 0 0 0 13.1771 12.4523 0 0 0 14.7372 0 0 0 12.9212 0 0 13.278 0 0 0 0 0 13.7035 0 0 13.364 0 0 0 0 0 0 0 13.4051 0 0 0 0 0 0 0 0 11.6087 0 0 13.3435 0 11.4112 0 0 0 0 0 0 0 0 0 0 0 13.0116 0 0 0 0 0 13.9757 0 0 0 0 0 0 0 0 0 0 0 11.5395 0 0 0 0 0 0 0 0 Q9Y4B5 MTCL1_HUMAN Microtubule cross-linking factor 1 (Coiled-coil domain-containing protein 165) (PAR-1-interacting protein) (SOGA family member 2) MTCL1 CCDC165 KIAA0802 SOGA2 Homo sapiens (Human) establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506] GO:0000922; GO:0001578; GO:0003723; GO:0005615; GO:0005737; GO:0005856; GO:0008017; GO:0010506; GO:0016324; GO:0016327; GO:0016328; GO:0030496; GO:0042803; GO:0045197; GO:0090314; GO:0097427 microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] ADQPNNR 0.99238 -65.113 0 0 0 0 0 0 12.4581 0 0 0 0 0 0 0 0 12.504 0 0 0 0 0 0 0 0 0 9.93279 0 10.3693 0 0 0 0 0 11.8574 11.918 0 0 0 0 0 0 0 0 0 0 0 11.6022 0 0 0 0 0 0 0 0 11.3632 0 0 0 0 0 0 0 0 0 0 12.7711 0 0 0 10.9344 0 0 0 0 0 0 14.0971 0 0 9.95174 0 13.1952 14.5512 0 0 0 13.4123 0 14.9079 14.5608 14.1873 13.4952 13.751 0 0 0 13.3224 13.9037 0 13.0037 0 13.6962 0 0 0 13.0114 0 0 0 0 11.0476 0 16.4441 0 0 0 0 13.2279 0 0 9.94898 0 0 13.6441 0 13.1494 13.393 0 11.7637 0 0 12.0538 15.1445 14.0909 0 13.5735 14.3292 14.765 15.3582 0 0 0 13.5566 13.5533 0 0 12.7289 0 0 0 0 0 0 0 0 12.6523 0 0 13.5407 12.5592 0 0 0 13.6876 0 0 0 0 0 13.2383 14.1336 12.8368 0 0 0 0 13.1565 0 0 Q9Y4F9 RIPR2_HUMAN Rho family-interacting cell polarization regulator 2 RIPOR2 C6orf32 DIFF48 FAM65B KIAA0386 PL48 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to chemokine [GO:1990869]; chemotaxis [GO:0006935]; negative regulation of cell adhesion [GO:0007162]; negative regulation of establishment of T cell polarity [GO:1903904]; negative regulation of protein localization to cell leading edge [GO:1905872]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T cell migration [GO:2000405]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic spindle assembly [GO:1901673]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; 14-3-3 protein binding [GO:0071889]; cell adhesion [GO:0007155]; cellular response to chemokine [GO:1990869]; chemotaxis [GO:0006935]; negative regulation of cell adhesion [GO:0007162]; negative regulation of establishment of T cell polarity [GO:1903904]; negative regulation of protein localization to cell leading edge [GO:1905872]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T cell migration [GO:2000405]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic spindle assembly [GO:1901673]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741] GO:0005737; GO:0005856; GO:0006935; GO:0007155; GO:0007162; GO:0007605; GO:0016324; GO:0030175; GO:0032420; GO:0035024; GO:0042130; GO:0045663; GO:0048741; GO:0051491; GO:0051726; GO:0060171; GO:0071889; GO:0090023; GO:1901673; GO:1901741; GO:1903904; GO:1905872; GO:1990869; GO:2000114; GO:2000391; GO:2000405; GO:2001107 14-3-3 protein binding [GO:0071889] CKPAVSR 0.99238 -24.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3061 0 0 0 0 0 0 0 0 0 0 13.8893 0 0 0 0 0 0 10.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8584 0 0 12.7913 12.5828 0 0 0 0 0 0 0 0 0 0 0 0 12.6357 0 0 12.4552 0 0 0 0 0 0 0 0 0 12.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4061 0 0 13.2839 0 0 15.037 0 0 0 0 0 0 0 12.8042 0 0 13.2548 0 0 12.5987 0 0 0 0 0 0 12.0787 0 10.5977 0 0 0 0 13.1964 0 0 A1L0T0 HACL2_HUMAN "2-hydroxyacyl-CoA lyase 2, EC 4.1.2.- (Acetolactate synthase-like protein) (IlvB-like protein)" ILVBL AHAS HACL2 Homo sapiens (Human) fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099] acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099] GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016020; GO:0016021; GO:0016829; GO:0030976; GO:0050660 acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976] AAVETLGVPCFLGGMARGLLGRNHPLHIR 0.99239 -4.9126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7604 0 0 0 12.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6235 0 0 0 0 14.3501 0 0 0 0 0 0 0 0 13.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3211 0 0 0 0 13.1889 0 0 0 14.0456 0 0 0 0 0 0 0 0 13.797 0 0 0 0 0 0 0 0 0 0 13.8436 0 13.083 0 0 0 0 13.4539 0 0 0 0 0 0 0 0 0 12.6004 O43147 SGSM2_HUMAN Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1) SGSM2 KIAA0397 RUTBC1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547] cytoplasm [GO:0005737]; melanosome [GO:0042470] cytoplasm [GO:0005737]; melanosome [GO:0042470]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; late endosome to Golgi transport [GO:0034499]; positive regulation of GTPase activity [GO:0043547] GO:0005096; GO:0005737; GO:0031267; GO:0034499; GO:0042470; GO:0043547; GO:0090630 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] ELELLRQVYYGGIEHEIR 0.99239 -25.213 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.801 0 0 0 0 0 0 0 0 0 0 0 13.4455 0 0 13.5636 0 11.4264 0 0 0 0 0 0 0 13.1031 0 0 0 13.2116 0 0 0 0 0 0 0 0 0 0 0 12.8198 0 0 0 0 0 0 14.1307 17.6792 13.3918 13.7785 16.6191 0 17.2493 0 0 0 0 0 0 0 0 13.332 0 0 0 0 0 0 0 0 16.3861 0 0 0 0 0 0 0 0 10.8768 0 0 0 0 0 0 0 0 0 0 0 11.9945 0 0 0 0 0 11.6573 0 0 0 0 12.7945 12.9421 0 0 0 0 0 0 0 0 O60566 BUB1B_HUMAN "Mitotic checkpoint serine/threonine-protein kinase BUB1 beta, EC 2.7.11.1 (MAD3/BUB1-related protein kinase, hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1)" BUB1B BUBR1 MAD3L SSK1 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; phosphorylation [GO:0016310]; protein localization to chromosome, centromeric region [GO:0071459]" anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic checkpoint complex [GO:0033597]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] "anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic checkpoint complex [GO:0033597]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; phosphorylation [GO:0016310]; protein localization to chromosome, centromeric region [GO:0071459]" GO:0000776; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005680; GO:0005737; GO:0005815; GO:0005819; GO:0005829; GO:0006915; GO:0007091; GO:0007094; GO:0016310; GO:0033597; GO:0048471; GO:0051301; GO:0051444; GO:0051754; GO:0071459; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALWKVGK 0.99239 -40.667 0 0 0 0 0 0 0 0 13.9892 13.6128 14.4314 13.7187 14.4177 0 13.4805 0 0 0 0 0 11.7532 0 0 0 0 12.4299 0 0 12.8063 14.3986 13.608 12.4806 13.18 13.8664 13.5907 12.8888 0 14.3325 14.136 14.051 14.1335 14.4937 13.8093 0 13.2167 0 0 0 0 0 0 0 13.3556 13.1228 12.8716 12.7377 0 12.7523 0 0 0 12.3418 0 11.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9542 15.7403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5754 0 0 0 0 0 0 0 14.2526 12.9967 0 14.0442 0 0 12.98 0 12.764 0 0 13.8598 0 0 0 12.9251 14.5425 12.6614 14.324 0 14.8643 14.7105 0 12.7522 14.0511 14.5044 0 14.3272 13.7754 13.9753 13.4858 12.4204 14.0856 14.2593 0 0 0 14.0661 0 0 13.681 0 14.4547 0 0 12.8199 0 0 10.8094 0 0 14.716 12.8412 0 14.0598 0 13.7047 12.8916 0 0 12.4272 0 0 0 0 13.1074 0 0 0 0 0 0 0 0 0 P01893 HLAH_HUMAN "Putative HLA class I histocompatibility antigen, alpha chain H (HLA-12.4) (HLA-AR) (MHC class I antigen H)" HLA-H HLAH Homo sapiens (Human) antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; immune response [GO:0006955] azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; beta-2-microglobulin binding [GO:0030881]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; immune response [GO:0006955] GO:0000139; GO:0002474; GO:0002476; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0009897; GO:0009986; GO:0012507; GO:0030670; GO:0030881; GO:0031901; GO:0035577; GO:0042612; GO:0055038; GO:0071556 beta-2-microglobulin binding [GO:0030881] EEPRAPWMER 0.99239 -17.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04179 SODM_HUMAN "Superoxide dismutase [Mn], mitochondrial, EC 1.15.1.1" SOD2 Homo sapiens (Human) acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to reactive oxygen species [GO:0001315]; cellular response to ethanol [GO:0071361]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]; acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; age-dependent response to reactive oxygen species [GO:0001315]; cellular response to ethanol [GO:0071361]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; iron ion homeostasis [GO:0055072]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; oxygen homeostasis [GO:0032364]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to cold [GO:0009409]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] GO:0000303; GO:0001315; GO:0001666; GO:0001836; GO:0001889; GO:0003032; GO:0003069; GO:0003677; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006749; GO:0006801; GO:0007507; GO:0007626; GO:0008217; GO:0008285; GO:0008630; GO:0008631; GO:0009409; GO:0009410; GO:0009791; GO:0010042; GO:0010043; GO:0010269; GO:0010332; GO:0010729; GO:0014823; GO:0019430; GO:0019825; GO:0019899; GO:0022904; GO:0030097; GO:0030145; GO:0030335; GO:0032364; GO:0032496; GO:0033591; GO:0034021; GO:0035900; GO:0035902; GO:0042542; GO:0042554; GO:0042645; GO:0042802; GO:0043524; GO:0045429; GO:0045599; GO:0046686; GO:0048147; GO:0048666; GO:0048678; GO:0048773; GO:0050665; GO:0050790; GO:0051289; GO:0051602; GO:0051881; GO:0055072; GO:0055093; GO:0070062; GO:0071000; GO:0071361; GO:1902176; GO:1902631; GO:1904706; GO:1905461; GO:1905932 DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784] DFGSFDK 0.99239 -4.7517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22735 TGM1_HUMAN "Protein-glutamine gamma-glutamyltransferase K, EC 2.3.2.13 (Epidermal TGase) (Transglutaminase K, TG(K), TGK, TGase K) (Transglutaminase-1, TGase-1)" TGM1 KTG Homo sapiens (Human) cell envelope organization [GO:0043163]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein modification process [GO:0036211] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; plasma membrane [GO:0005886] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; cell envelope organization [GO:0043163]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein modification process [GO:0036211] GO:0001533; GO:0003810; GO:0005829; GO:0005886; GO:0010838; GO:0016020; GO:0018149; GO:0030216; GO:0031224; GO:0031424; GO:0036211; GO:0042802; GO:0043163; GO:0045787; GO:0046872; GO:0070062 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] CCGCCSCR 0.99239 -18.167 0 0 0 0 0 0 0 0 0 0 10.2705 0 12.2661 0 0 0 0 0 0 0 0 11.4806 0 0 11.4747 0 0 0 0 13.4138 0 10.3915 0 0 0 0 0 0 0 0 0 11.2063 0 0 0 0 0 0 10.7108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9338 12.3614 13.4416 0 0 11.2708 14.2538 0 0 0 14.4498 12.2543 0 0 0 13.6905 14.3047 12.8919 11.6887 11.6395 0 17.1396 12.7245 11.1594 14.5349 0 0 13.738 15.8997 0 0 0 0 0 0 0 0 13.5961 0 0 0 0 11.9345 13.2919 16.829 16.1613 16.1765 0 14.2079 14.6269 0 14.0718 14.0609 0 0 14.693 13.7621 0 0 13.0875 12.625 0 0 12.8678 0 12.2982 15.9504 0 14.7239 13.6419 13.1717 16.0499 0 0 16.1443 0 0 0 0 0 0 0 0 0 14.1555 12.0855 0 0 0 0 0 12.9897 0 11.5652 0 14.0668 13.9128 0 0 0 0 0 16.5977 14.55 0 0 12.0341 0 0 0 0 P47900 P2RY1_HUMAN "P2Y purinoceptor 1, P2Y1 (ADP receptor) (Purinergic receptor)" P2RY1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aging [GO:0007568]; blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ATP [GO:0071318]; cellular response to purine-containing compound [GO:0071415]; eating behavior [GO:0042755]; establishment of localization in cell [GO:0051649]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell migration [GO:0008347]; ion transport [GO:0006811]; negative regulation of binding [GO:0051100]; negative regulation of norepinephrine secretion [GO:0010700]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hormone secretion [GO:0046887]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of ion transport [GO:0043270]; positive regulation of penile erection [GO:0060406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of signaling receptor activity [GO:0010469]; regulation of synaptic vesicle exocytosis [GO:2000300]; relaxation of muscle [GO:0090075]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]; signal transduction involved in regulation of gene expression [GO:0023019] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell surface [GO:0009986]; cilium [GO:0005929]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell surface [GO:0009986]; cilium [GO:0005929]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; A1 adenosine receptor binding [GO:0031686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G protein-coupled ADP receptor activity [GO:0001621]; G protein-coupled ATP receptor activity [GO:0045031]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; protein heterodimerization activity [GO:0046982]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aging [GO:0007568]; blood vessel diameter maintenance [GO:0097746]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ATP [GO:0071318]; cellular response to purine-containing compound [GO:0071415]; eating behavior [GO:0042755]; establishment of localization in cell [GO:0051649]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell migration [GO:0008347]; ion transport [GO:0006811]; negative regulation of binding [GO:0051100]; negative regulation of norepinephrine secretion [GO:0010700]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hormone secretion [GO:0046887]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of ion transport [GO:0043270]; positive regulation of penile erection [GO:0060406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of signaling receptor activity [GO:0010469]; regulation of synaptic vesicle exocytosis [GO:2000300]; relaxation of muscle [GO:0090075]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233]; signal transduction involved in regulation of gene expression [GO:0023019] GO:0001621; GO:0001934; GO:0001973; GO:0005524; GO:0005739; GO:0005886; GO:0005887; GO:0005929; GO:0006811; GO:0007166; GO:0007186; GO:0007193; GO:0007200; GO:0007204; GO:0007568; GO:0008347; GO:0008360; GO:0009612; GO:0009986; GO:0010469; GO:0010700; GO:0014069; GO:0016323; GO:0016324; GO:0019233; GO:0023019; GO:0030168; GO:0030425; GO:0031686; GO:0032962; GO:0038023; GO:0042755; GO:0043270; GO:0043531; GO:0044297; GO:0045028; GO:0045031; GO:0045211; GO:0045944; GO:0046887; GO:0046982; GO:0051100; GO:0051649; GO:0060406; GO:0070374; GO:0070848; GO:0071318; GO:0071415; GO:0072659; GO:0090075; GO:0097110; GO:0097746; GO:0098978; GO:0099059; GO:0099509; GO:2000300 A1 adenosine receptor binding [GO:0031686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G protein-coupled ADP receptor activity [GO:0001621]; G protein-coupled ATP receptor activity [GO:0045031]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; protein heterodimerization activity [GO:0046982]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] KKNAICISVLVWLIVVVAISPILFYSGTGVR 0.99239 -18.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.348 0 0 0 0 0 0 0 0 10.7613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5794 0 0 0 0 0 0 0 0 11.6956 12.2432 0 0 0 0 0 0 0 11.6426 0 0 0 0 0 0 13.7985 0 0 12.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9506 12.3969 0 0 0 0 0 0 0 0 0 12.2247 0 0 0 0 0 11.6636 0 0 0 0 0 0 0 0 0 0 0 11.3591 0 0 0 0 0 0 0 0 14.804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4095 0 0 0 0 0 0 0 0 0 P51788 CLCN2_HUMAN "Chloride channel protein 2, ClC-2" CLCN2 Homo sapiens (Human) acinar cell differentiation [GO:0090425]; cell differentiation involved in salivary gland development [GO:0060689]; chloride transport [GO:0006821]; lung development [GO:0030324]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of ion transmembrane transport [GO:0034765]; retina development in camera-type eye [GO:0060041] chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated chloride channel activity [GO:0005247]; acinar cell differentiation [GO:0090425]; cell differentiation involved in salivary gland development [GO:0060689]; chloride transport [GO:0006821]; lung development [GO:0030324]; regulation of aldosterone biosynthetic process [GO:0032347]; regulation of ion transmembrane transport [GO:0034765]; retina development in camera-type eye [GO:0060041] GO:0005247; GO:0005886; GO:0005887; GO:0006821; GO:0030324; GO:0030425; GO:0032347; GO:0034707; GO:0034765; GO:0043204; GO:0060041; GO:0060689; GO:0090425 voltage-gated chloride channel activity [GO:0005247] AIEGSVTAQGVK 0.99239 -14.776 0 0 0 0 0 0 0 0 0 0 12.2622 12.2795 12.964 0 0 0 12.6408 12.3343 12.8285 0 12.249 0 12.5686 0 0 0 0 12.6244 12.0803 0 12.5678 0 12.4799 0 0 0 0 0 0 0 0 0 11.6438 12.3066 0 11.6349 11.1772 0 12.9576 0 0 0 0 0 0 11.671 0 0 0 0 0 0 0 0 0 0 0 0 14.5203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3322 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2523 0 0 0 0 0 0 0 0 0 0 13.6813 0 0 0 12.3602 13.0771 0 0 0 12.2723 0 0 0 14.0911 0 0 0 0 0 0 0 0 13.7145 14.2487 0 0 0 0 0 0 0 0 0 14.228 0 0 0 0 0 0 0 0 14.1877 0 13.0274 0 0 0 0 0 12.218 0 14.023 0 0 14.0345 13.5579 0 0 0 0 0 13.8612 0 0 0 Q03135 CAV1_HUMAN Caveolin-1 CAV1 CAV Homo sapiens (Human) angiogenesis [GO:0001525]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; apoptotic signaling pathway [GO:0097190]; basement membrane organization [GO:0071711]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol homeostasis [GO:0042632]; cholesterol transport [GO:0030301]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell proliferation [GO:0001935]; establishment of localization in cell [GO:0051649]; fibroblast proliferation [GO:0048144]; glandular epithelial cell differentiation [GO:0002067]; insulin receptor internalization [GO:0038016]; lactation [GO:0007595]; lipid storage [GO:0019915]; maintenance of protein location in cell [GO:0032507]; mammary gland development [GO:0030879]; mammary gland involution [GO:0060056]; MAPK cascade [GO:0000165]; membrane depolarization [GO:0051899]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of anoikis [GO:2000811]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of necroptotic process [GO:0060546]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein binding [GO:0032091]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide homeostasis [GO:0033484]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane raft [GO:0044860]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of peptidase activity [GO:0052547]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; tyrosine phosphorylation of STAT protein [GO:0007260]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]; vesicle organization [GO:0016050] acrosomal membrane [GO:0002080]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cell cortex [GO:0005938]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] acrosomal membrane [GO:0002080]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cell cortex [GO:0005938]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; patched binding [GO:0005113]; peptidase activator activity [GO:0016504]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; angiogenesis [GO:0001525]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; apoptotic signaling pathway [GO:0097190]; basement membrane organization [GO:0071711]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell differentiation [GO:0030154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol homeostasis [GO:0042632]; cholesterol transport [GO:0030301]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell proliferation [GO:0001935]; establishment of localization in cell [GO:0051649]; fibroblast proliferation [GO:0048144]; glandular epithelial cell differentiation [GO:0002067]; insulin receptor internalization [GO:0038016]; lactation [GO:0007595]; lipid storage [GO:0019915]; maintenance of protein location in cell [GO:0032507]; mammary gland development [GO:0030879]; mammary gland involution [GO:0060056]; MAPK cascade [GO:0000165]; membrane depolarization [GO:0051899]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of anoikis [GO:2000811]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of necroptotic process [GO:0060546]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein binding [GO:0032091]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide homeostasis [GO:0033484]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane raft [GO:0044860]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; receptor internalization involved in canonical Wnt signaling pathway [GO:2000286]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of peptidase activity [GO:0052547]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; tyrosine phosphorylation of STAT protein [GO:0007260]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]; vesicle organization [GO:0016050] GO:0000122; GO:0000139; GO:0000165; GO:0001525; GO:0001570; GO:0001666; GO:0001935; GO:0001937; GO:0001960; GO:0002067; GO:0002080; GO:0002095; GO:0002931; GO:0003057; GO:0005102; GO:0005113; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0005886; GO:0005887; GO:0005901; GO:0005925; GO:0005929; GO:0005938; GO:0006641; GO:0006809; GO:0006816; GO:0006874; GO:0006940; GO:0007260; GO:0007519; GO:0007595; GO:0008104; GO:0009267; GO:0009617; GO:0010524; GO:0010608; GO:0010628; GO:0010875; GO:0015031; GO:0015485; GO:0016020; GO:0016050; GO:0016323; GO:0016324; GO:0016504; GO:0019065; GO:0019217; GO:0019221; GO:0019899; GO:0019901; GO:0019915; GO:0030154; GO:0030193; GO:0030301; GO:0030335; GO:0030512; GO:0030514; GO:0030666; GO:0030674; GO:0030857; GO:0030879; GO:0031267; GO:0031295; GO:0031397; GO:0031398; GO:0031410; GO:0031623; GO:0031901; GO:0032091; GO:0032092; GO:0032507; GO:0032570; GO:0032991; GO:0033137; GO:0033138; GO:0033484; GO:0034141; GO:0038016; GO:0042310; GO:0042532; GO:0042632; GO:0042802; GO:0043085; GO:0043407; GO:0043409; GO:0043627; GO:0044325; GO:0044860; GO:0044877; GO:0045019; GO:0045121; GO:0045907; GO:0046426; GO:0046716; GO:0046982; GO:0048144; GO:0048147; GO:0048471; GO:0048550; GO:0050998; GO:0051001; GO:0051092; GO:0051117; GO:0051480; GO:0051592; GO:0051649; GO:0051899; GO:0052547; GO:0055074; GO:0060056; GO:0060090; GO:0060355; GO:0060546; GO:0061099; GO:0070320; GO:0070836; GO:0071360; GO:0071375; GO:0071455; GO:0071560; GO:0071711; GO:0072584; GO:0086091; GO:0086098; GO:0090090; GO:0090263; GO:0097190; GO:0098903; GO:0098909; GO:0098911; GO:0120162; GO:1900027; GO:1900085; GO:1901380; GO:1901844; GO:1903071; GO:1903361; GO:1903598; GO:1903609; GO:2000286; GO:2000535; GO:2000811; GO:2001238; GO:2001244 ATPase binding [GO:0051117]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; patched binding [GO:0005113]; peptidase activator activity [GO:0016504]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] IFSNVRINLQK 0.99239 -7.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13017 RHG05_HUMAN Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B) ARHGAP5 RHOGAP5 Homo sapiens (Human) cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169]; cell adhesion [GO:0007155]; mammary gland development [GO:0030879]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007266; GO:0008361; GO:0030879; GO:0042169; GO:0051056 GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169] ADFQLCFVVLEKTPWDETDHIDK 0.99239 -17.692 0 0 0 0 12.9964 0 0 0 11.8557 12.5796 0 0 0 0 0 0 0 0 0 0 0 0 10.454 0 9.95292 10.375 0 0 0 11.6 0 0 0 0 0 0 0 0 0 0 9.81791 0 0 0 0 0 0 0 0 0 11.5652 10.6612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4364 0 0 0 0 11.2911 0 0 12.2894 0 0 0 0 0 0 11.7548 14.2105 13.0062 0 13.9187 13.6995 12.0869 0 0 0 12.8636 14.235 13.5164 14.2702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3176 11.8953 12.649 0 0 0 0 0 0 0 12.9456 14.0993 0 0 17.0166 15.5366 0 13.5887 0 12.0913 13.2308 12.4754 0 11.5084 12.7292 0 13.7732 14.2992 13.7966 0 13.3339 11.4214 0 0 0 0 0 0 0 16.3353 0 0 13.4476 0 0 0 12.2844 0 12.8987 0 0 0 12.6404 0 0 0 11.0812 0 0 11.2562 0 0 0 11.2637 0 0 11.7264 0 0 0 0 Q13635 PTC1_HUMAN "Protein patched homolog 1, PTC, PTC1" PTCH1 PTCH Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spermatid development [GO:0007286]; spinal cord motor neuron differentiation [GO:0021522]; stem cell proliferation [GO:0072089]" apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; caveola [GO:0005901]; ciliary membrane [GO:0060170]; dendritic growth cone [GO:0044294]; endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation involved in kidney development [GO:0061005]; cell fate determination [GO:0001709]; cell proliferation involved in metanephros development [GO:0072203]; cellular response to cholesterol [GO:0071397]; commissural neuron axon guidance [GO:0071679]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; epidermal cell fate specification [GO:0009957]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; in utero embryonic development [GO:0001701]; keratinocyte proliferation [GO:0043616]; limb morphogenesis [GO:0035108]; liver regeneration [GO:0097421]; mammary gland duct morphogenesis [GO:0060603]; mammary gland epithelial cell differentiation [GO:0060644]; metanephric collecting duct development [GO:0072205]; negative regulation of cell division [GO:0051782]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate axis specification [GO:0021997]; neural tube closure [GO:0001843]; neural tube patterning [GO:0021532]; pharyngeal system development [GO:0060037]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization [GO:0032880]; regulation of smoothened signaling pathway [GO:0008589]; response to chlorate [GO:0010157]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]; somite development [GO:0061053]; spermatid development [GO:0007286]; spinal cord motor neuron differentiation [GO:0021522]; stem cell proliferation [GO:0072089]" GO:0000122; GO:0001658; GO:0001701; GO:0001709; GO:0001843; GO:0003007; GO:0005113; GO:0005119; GO:0005634; GO:0005886; GO:0005901; GO:0007224; GO:0007286; GO:0007346; GO:0007420; GO:0008158; GO:0008201; GO:0008589; GO:0009410; GO:0009612; GO:0009887; GO:0009953; GO:0009957; GO:0010157; GO:0010839; GO:0010875; GO:0014069; GO:0015485; GO:0016021; GO:0016485; GO:0021522; GO:0021532; GO:0021997; GO:0030326; GO:0030332; GO:0030496; GO:0030666; GO:0030850; GO:0032355; GO:0032526; GO:0032880; GO:0035108; GO:0035137; GO:0040015; GO:0042593; GO:0043231; GO:0043433; GO:0043616; GO:0044294; GO:0044295; GO:0044877; GO:0045177; GO:0045606; GO:0045668; GO:0045879; GO:0045893; GO:0048471; GO:0048568; GO:0048745; GO:0051782; GO:0060037; GO:0060170; GO:0060603; GO:0060644; GO:0060831; GO:0061005; GO:0061053; GO:0071397; GO:0071679; GO:0072089; GO:0072203; GO:0072205; GO:0072659; GO:0097108; GO:0097421; GO:2000647 cholesterol binding [GO:0015485]; cyclin binding [GO:0030332]; hedgehog family protein binding [GO:0097108]; hedgehog receptor activity [GO:0008158]; heparin binding [GO:0008201]; patched binding [GO:0005113]; protein-containing complex binding [GO:0044877]; smoothened binding [GO:0005119] ADYPNIQHLLYDLHRSFSNVKYVMLEENK 0.99239 -14.77 0 0 12.5908 14.6854 14.3876 13.3385 13.9874 13.7453 0 14.7186 0 0 0 0 0 13.74 13.5254 14.3093 13.7218 13.5373 0 0 13.854 0 13.6902 13.5767 0 13.7798 0 0 13.8917 0 0 0 0 0 0 13.3805 0 0 13.7357 13.5641 13.5302 13.521 0 13.695 13.8235 13.8217 13.8284 14.7423 0 13.9634 13.7961 13.9089 0 13.7966 13.9667 0 13.3922 0 12.9611 13.1494 13.1878 13.3585 0 13.3412 0 10.098 0 10.7497 0 0 0 10.4753 0 0 0 0 0 0 12.3404 0 0 0 12.1198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2285 0 11.9598 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97728 0 13.0164 0 0 11.6585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7437 0 15.1864 13.0845 0 0 0 0 10.4636 0 15.9581 0 0 12.6109 0 0 0 0 0 0 0 0 15.0439 15.0517 0 0 15.0582 14.7795 0 0 0 14.1146 15.0009 0 15.0041 0 0 Q2UY09 COSA1_HUMAN Collagen alpha-1(XXVIII) chain COL28A1 COL28 Homo sapiens (Human) cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] GO:0004867; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0030198; GO:0031012; GO:0062023 extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] FNSEKECQETCIQG 0.99239 -18.106 0 0 13.4771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8551 0 0 14.2362 0 0 0 0 0 0 0 0 0 0 0 14.6639 0 0 0 0 12.3182 0 12.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7211 0 0 0 0 0 0 0 0 0 0 0 0 14.3782 0 0 13.5535 0 0 13.1825 0 11.5841 0 15.176 0 0 0 0 0 15.6694 0 0 0 15.1783 0 15.999 0 0 0 0 0 0 0 0 12.2304 13.3127 15.4549 0 0 0 15.9307 12.06 0 0 15.6136 15.7747 13.6307 16.7024 0 0 0 0 0 16.1214 0 0 0 0 0 12.2926 0 0 0 14.0003 13.6887 0 0 0 0 0 0 13.0953 0 0 0 13.3202 0 15.311 15.1425 0 0 0 0 0 0 0 0 0 0 0 0 12.8601 0 13.6156 14.4629 0 0 14.1517 0 0 0 0 0 0 Q5TGP6 MROH9_HUMAN Maestro heat-like repeat-containing protein family member 9 MROH9 C1orf129 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 CQNDIGTNK 0.99239 -25.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.254 0 0 0 0 11.6018 0 0 0 0 0 0 13.3387 0 0 0 0 0 0 0 0 12.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5264 12.3815 14.2126 0 0 0 0 0 0 13.0422 0 0 0 0 0 0 11.3531 0 0 11.2095 0 0 0 0 12.7278 0 0 0 12.1045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1412 0 0 0 0 12.4481 0 0 0 0 0 0 0 0 0 Q6GTS8 P20D1_HUMAN "N-fatty-acyl-amino acid synthase/hydrolase PM20D1, EC 3.5.1.114, EC 3.5.1.14 (Peptidase M20 domain-containing protein 1)" PM20D1 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; negative regulation of neuron death [GO:1901215]; nitrogen compound metabolic process [GO:0006807]; proteolysis [GO:0006508]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275] extracellular exosome [GO:0070062]; extracellular region [GO:0005576] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; cellular amide catabolic process [GO:0043605]; cellular amino acid metabolic process [GO:0006520]; cellular lipid metabolic process [GO:0044255]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; negative regulation of neuron death [GO:1901215]; nitrogen compound metabolic process [GO:0006807]; proteolysis [GO:0006508]; regulation of oxidative phosphorylation uncoupler activity [GO:2000275]" GO:0004046; GO:0005576; GO:0006508; GO:0006520; GO:0006631; GO:0006807; GO:0008233; GO:0016811; GO:0016829; GO:0043604; GO:0043605; GO:0044255; GO:0046872; GO:0070062; GO:0097009; GO:1901215; GO:1990845; GO:2000275 "aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]" AQRCVCVLALVAMLLLVFPTVSR 0.99239 -6.7078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2151 0 0 0 12.074 0 0 0 0 0 0 0 0 0 11.5559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5801 0 0 0 0 0 12.0474 0 0 0 0 11.2293 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9965 0 0 0 0 0 11.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0107 0 0 0 0 0 0 0 0 0 0 0 14.1816 13.992 0 14.3963 0 0 0 0 0 0 14.6964 14.3197 0 12.2399 0 0 0 0 13.9794 0 0 Q86SQ9 DHDDS_HUMAN "Dehydrodolichyl diphosphate synthase complex subunit DHDDS, EC 2.5.1.87 (Cis-isoprenyltransferase, CIT, Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m)" DHDDS HDS Homo sapiens (Human) dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094] dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; metal ion binding [GO:0046872]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094] GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0045547; GO:0046872; GO:1904423 dehydrodolichyl diphosphate synthase activity [GO:0045547]; metal ion binding [GO:0046872] ARDMYAEERK 0.99239 -14.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8491 0 0 0 0 0 0 0 0 12.3222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZ57 NRSN1_HUMAN "Neurensin-1 (Neuro-p24) (Vesicular membrane protein of 24 kDa, Vesicular membrane protein p24)" NRSN1 VMP Homo sapiens (Human) nervous system development [GO:0007399] cytoplasmic vesicle [GO:0031410]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133] cytoplasmic vesicle [GO:0031410]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; nervous system development [GO:0007399] GO:0007399; GO:0016021; GO:0030133; GO:0030426; GO:0031410; GO:0043005; GO:0043025 APGPGETK 0.99239 -6.7082 0 0 0 0 0 0 0 0 0 10.178 0 0 0 0 0 11.2021 0 0 0 9.66979 0 0 0 9.68131 0 0 0 10.2031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4598 0 12.64 12.3705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3263 0 0 0 0 0 0 0 0 0 0 10.7097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N123 CPXCR_HUMAN "CPX chromosomal region candidate gene 1 protein (Cancer/testis antigen 77, CT77)" CPXCR1 Homo sapiens (Human) CRFRAIVR 0.99239 -6.7033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7449 0 0 0 0 0 0 0 0 0 0 14.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8722 0 0 0 0 0 0 0 0 12.0896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4655 0 0 Q8NGX5 O10K1_HUMAN Olfactory receptor 10K1 (Olfactory receptor OR1-6) OR10K1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IISAILKIPSSVGRYK 0.99239 -4.9008 0 0 0 0 0 0 0 0 14.0455 0 0 0 0 0 0 0 0 0 12.5108 15.01 0 0 13.4512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7928 0 0 12.4416 0 0 0 0 0 0 0 0 0 14.56 0 0 0 0 0 0 0 15.6837 0 0 0 0 0 0 14.5464 15.6057 0 15.4837 0 0 15.16 0 15.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1434 0 15.2699 0 0 0 0 0 0 0 0 15.8446 0 0 17.0475 0 16.5561 0 15.8231 15.9821 14.9776 0 0 0 14.7582 0 14.8414 15.4473 0 0 0 0 15.6881 15.5894 0 16.539 15.3872 15.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.264 0 0 0 0 0 0 0 Q96HR8 NAF1_HUMAN "H/ACA ribonucleoprotein complex non-core subunit NAF1, hNAF1" NAF1 Homo sapiens (Human) box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNP assembly [GO:0000493]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; ribosome biogenesis [GO:0042254]; RNA stabilization [GO:0043489]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomerase holoenzyme complex assembly [GO:1905323]; telomerase RNA stabilization [GO:0090669] GO:0000454; GO:0000493; GO:0003723; GO:0005654; GO:0005732; GO:0005737; GO:0032212; GO:0042254; GO:0042802; GO:0043489; GO:0051973; GO:0070034; GO:0090669; GO:1904358; GO:1904874; GO:1905323 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] GFSRARYPR 0.99239 -18.129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.936 0 0 11.1142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2651 0 12.9364 0 0 0 12.5301 13.6198 0 13.0918 0 13.1444 14.064 0 13.6199 0 0 13.3305 0 0 13.7153 0 0 0 0 0 0 13.5481 0 0 0 0 13.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1079 0 13.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9446 0 11.2441 0 0 0 0 0 0 0 0 0 0 0 0 0 13.036 0 0 0 0 0 12.227 0 0 Q96HW7 INT4_HUMAN "Integrator complex subunit 4, Int4" INTS4 MSTP093 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] integrator complex [GO:0032039]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0005730; GO:0016180; GO:0032039; GO:0034243 AAHLKKR 0.99239 -18.111 0 0 0 14.5437 0 0 0 12.6799 0 13.5189 0 0 0 0 0 0 0 0 13.1958 14.6045 13.1218 0 0 0 0 0 0 0 0 13.3624 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7177 0 0 0 0 13.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0068 0 0 15.0966 15.357 0 0 0 0 0 0 0 0 0 11.3568 0 0 11.1805 0 0 0 14.3676 0 0 14.5461 0 0 0 12.8426 0 0 14.9633 15.0682 0 0 0 0 0 0 0 13.664 14.905 11.4279 0 0 13.3073 0 0 13.9486 0 0 0 13.164 0 0 14.5062 0 14.3972 0 11.1734 0 0 0 13.9733 0 14.5463 14.2596 0 14.0185 0 0 0 0 14.7523 14.0527 0 0 0 0 13.0002 14.7852 0 0 13.9649 15.3786 0 14.6849 0 0 14.14 0 14.527 13.4393 0 0 0 0 0 14.7663 0 0 10.4841 0 Q96IC2 REXO5_HUMAN "RNA exonuclease 5, EC 3.1.-.- (Exonuclease NEF-sp)" REXO5 44M2.3 Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723] GO:0003723; GO:0004527; GO:0005634; GO:0005730; GO:0070062 exonuclease activity [GO:0004527]; RNA binding [GO:0003723] EGTERHPRK 0.99239 -17.719 0 0 14.1496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.121 0 0 0 0 0 0 0 0 0 0 0 14.2527 0 0 0 0 0 0 0 0 12.8079 0 0 12.9876 13.2749 13.3551 0 0 17.6499 0 0 0 0 0 16.5756 0 0 16.2209 0 0 15.4291 0 0 0 15.3305 0 13.0641 15.5555 0 0 14.0913 0 0 0 0 0 0 14.2782 0 0 0 0 0 13.702 0 0 0 0 13.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7793 0 0 0 0 0 0 0 Q99700 ATX2_HUMAN Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) ATXN2 ATX2 SCA2 TNRC13 Homo sapiens (Human) negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; negative regulation of receptor internalization [GO:0002091]; P-body assembly [GO:0033962]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063] GO:0002091; GO:0003723; GO:0005154; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005844; GO:0006417; GO:0008022; GO:0010494; GO:0016020; GO:0016070; GO:0033962; GO:0034063; GO:0048471; GO:0050658; GO:1990904 epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723] ARVALENDDRSEEEK 0.99239 -25.194 0 12.0814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3893 12.7118 0 0 11.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4537 0 0 0 0 0 0 0 0 15.1356 0 0 0 0 0 11.8203 0 0 0 0 0 0 0 14.4813 0 12.8337 0 0 0 0 0 0 0 0 0 14.0202 0 0 0 0 13.0873 0 13.2129 12.5138 12.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1385 12.3344 0 12.6497 0 12.8683 0 0 0 0 9.8405 12.3057 0 0 0 0 0 0 0 11.9409 0 0 0 0 12.6456 0 12.8242 11.1033 13.1002 0 0 10.8681 0 0 0 13.1405 0 0 0 0 0 0 0 0 Q9GZM7 TINAL_HUMAN "Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein, OLRG-2) (Tubulointerstitial nephritis antigen-related protein, TIN Ag-related protein, TIN-Ag-RP)" TINAGL1 GIS5 LCN7 OLRG2 TINAGL PP6614 PSEC0088 UNQ204/PRO230 Homo sapiens (Human) endosomal transport [GO:0016197] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; endosomal transport [GO:0016197] GO:0005201; GO:0005576; GO:0005615; GO:0005764; GO:0016197; GO:0043236; GO:0062023; GO:0070062 extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236] AMGRGKR 0.99239 -7.6968 0 0 0 14.6778 0 0 0 0 0 0 0 0 0 11.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0491 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0165 0 11.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.49181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8245 0 0 0 0 0 0 12.5687 0 13.292 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9323 14.1114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8049 14.2144 0 13.5058 0 13.1106 0 0 0 0 0 11.4473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8165 12.2579 0 0 0 0 0 0 Q9H857 NT5D2_HUMAN "5'-nucleotidase domain-containing protein 2, EC 3.1.3.-" NT5DC2 Homo sapiens (Human) 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] GO:0008253; GO:0046872 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] ALFNAQFGSIFRTFHNPTYFSR 0.99239 -4.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAS0 NJMU_HUMAN Protein Njmu-R1 C17orf75 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] GO:0005802; GO:0006886; GO:0031410; GO:0099041 EALDQSF 0.99239 -6.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.156 0 0 0 0 0 0 0 0 13.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 0 0 0 0 14.0372 0 0 0 0 0 0 0 12.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0884 0 0 0 0 0 0 13.1889 0 0 0 0 15.981 0 0 Q9NZ20 PA2G3_HUMAN "Group 3 secretory phospholipase A2, EC 3.1.1.4 (Group III secretory phospholipase A2, GIII sPLA2, sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3)" PLA2G3 Homo sapiens (Human) acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288] centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] centriole [GO:0005814]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; arachidonic acid secretion [GO:0050482]; cell maturation [GO:0048469]; cilium assembly [GO:0060271]; high-density lipoprotein particle remodeling [GO:0034375]; lipoxygenase pathway [GO:0019372]; low-density lipoprotein particle remodeling [GO:0034374]; macrophage activation [GO:0042116]; mast cell degranulation [GO:0043303]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylserine metabolic process [GO:0006658]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of histamine secretion by mast cell [GO:1903595]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of mast cell differentiation [GO:0060376]; positive regulation of neuron projection development [GO:0010976]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of endocytic recycling [GO:2001135]; sperm axoneme assembly [GO:0007288] GO:0001675; GO:0002532; GO:0005576; GO:0005615; GO:0005814; GO:0005886; GO:0006644; GO:0006658; GO:0007288; GO:0010629; GO:0010744; GO:0010976; GO:0019372; GO:0031394; GO:0032308; GO:0034374; GO:0034375; GO:0042116; GO:0043303; GO:0043524; GO:0046337; GO:0046470; GO:0046471; GO:0046473; GO:0046488; GO:0046872; GO:0047498; GO:0048469; GO:0050482; GO:0055037; GO:0060271; GO:0060376; GO:1900017; GO:1900222; GO:1903595; GO:2001135 calcium-dependent phospholipase A2 activity [GO:0047498]; metal ion binding [GO:0046872] HLRRLQQR 0.99239 -40.524 0 0 0 0 0 0 0 0 0 12.3923 11.698 0 0 0 0 14.3815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.386 0 0 0 0 10.6051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1481 0 0 0 0 0 0 0 0 0 0 12.1813 0 0 12.927 0 0 0 10.5291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7344 0 0 13.8392 0 0 12.0737 0 0 13.508 13.6435 12.6345 14.0276 13.3617 13.4821 0 0 0 0 14.0927 0 13.4897 9.74771 0 Q9UP38 FZD1_HUMAN "Frizzled-1, Fz-1, hFz1 (FzE1)" FZD1 Homo sapiens (Human) "astrocyte-dopaminergic neuron signaling [GO:0036520]; autocrine signaling [GO:0035425]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; cell-cell signaling [GO:0007267]; endothelial cell differentiation [GO:0045446]; hard palate development [GO:0060022]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; presynapse assembly [GO:0099054]; regulation of presynapse assembly [GO:1905606]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] "cell surface [GO:0009986]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; astrocyte-dopaminergic neuron signaling [GO:0036520]; autocrine signaling [GO:0035425]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; cell-cell signaling [GO:0007267]; endothelial cell differentiation [GO:0045446]; hard palate development [GO:0060022]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; presynapse assembly [GO:0099054]; regulation of presynapse assembly [GO:1905606]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" GO:0001934; GO:0003149; GO:0003150; GO:0003151; GO:0004930; GO:0005102; GO:0005109; GO:0005886; GO:0005925; GO:0007267; GO:0009410; GO:0009986; GO:0010976; GO:0016021; GO:0017147; GO:0030165; GO:0030182; GO:0030514; GO:0035425; GO:0036520; GO:0042813; GO:0044338; GO:0044339; GO:0045446; GO:0045892; GO:0045893; GO:0051091; GO:0060022; GO:0060070; GO:0090090; GO:0090179; GO:0099054; GO:1903204; GO:1904953; GO:1905606; GO:1990909 frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] AEEEAPKK 0.99239 -7.7077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1764 0 0 0 0 0 0 0 13.0262 0 0 0 0 0 10.6193 11.8684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7218 15.6617 13.9954 0 15.3303 10.8434 0 11.9792 10.3648 13.9825 13.7748 13.7074 0 0 0 0 0 0 0 0 12.8746 14.992 15.3777 14.4558 15.2191 15.0854 0 14.7448 14.8901 0 0 0 0 13.5419 11.3654 11.1187 0 13.594 0 0 12.7853 11.2274 0 0 0 0 0 13.8025 0 0 13.1345 0 13.3372 13.5548 13.3102 0 0 0 12.261 14.2486 0 0 0 13.1459 0 13.1713 12.9324 13.4579 0 13.3899 0 12.9524 13.4891 0 0 0 0 0 0 0 0 13.2729 0 0 12.7123 0 0 0 0 0 0 0 0 0 0 0 0 12.4751 0 0 0 0 0 12.7551 0 13.1421 12.1459 12.3936 0 0 0 0 11.953 0 Q9Y225 RNF24_HUMAN RING finger protein 24 RNF24 Homo sapiens (Human) endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0000139; GO:0005794; GO:0008270; GO:0012505; GO:0016021; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] HAFHRKCLIK 0.99239 -4.9041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6069 0 0 0 12.4979 0 0 0 0 0 0 0 0 0 12.7002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2J8 PADI2_HUMAN "Protein-arginine deiminase type-2, EC 3.5.3.15 (PAD-H19) (Peptidylarginine deiminase II) (Protein-arginine deiminase type II)" PADI2 KIAA0994 PAD2 PDI2 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of lymphocyte chemotaxis [GO:1901624]; substantia nigra development [GO:0021762] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; nuclear estrogen receptor binding [GO:0030331]; protein homodimerization activity [GO:0042803]; protein-arginine deiminase activity [GO:0004668]; cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone citrullination [GO:0036414]; histone H3-R26 citrullination [GO:0036413]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of lymphocyte chemotaxis [GO:1901624]; substantia nigra development [GO:0021762] GO:0000791; GO:0004668; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0021762; GO:0030331; GO:0030520; GO:0035578; GO:0036413; GO:0036414; GO:0042803; GO:0045815; GO:0070062; GO:0070100; GO:1901624; GO:1990830 calcium ion binding [GO:0005509]; nuclear estrogen receptor binding [GO:0030331]; protein homodimerization activity [GO:0042803]; protein-arginine deiminase activity [GO:0004668] DFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKK 0.99239 -17.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H6 FND3A_HUMAN Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts) FNDC3A FNDC3 HUGO KIAA0970 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; vesicle membrane [GO:0012506] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; vesicle membrane [GO:0012506]; RNA binding [GO:0003723]; cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286] GO:0000139; GO:0001669; GO:0003723; GO:0005737; GO:0005794; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0016020; GO:0016021; GO:0043231; GO:0060009; GO:0098609 RNA binding [GO:0003723] APSDNGSK 0.9924 -24.363 0 0 0 0 0 0 13.1828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.453 12.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6567 0 0 0 0 15.8117 15.5516 14.4778 15.5704 14.4781 14.6558 15.7 0 13.6815 0 0 0 0 15.2487 14.7246 15.8558 14.3807 14.9989 0 0 0 0 0 15.2799 0 15.4808 16.2207 15.1992 0 0 0 0 14.1669 14.8948 15.3315 16.054 0 0 15.1244 0 15.3274 14.1253 14.8443 14.6086 16.1233 14.4083 0 14.6471 0 15.2183 0 15.0276 14.7434 15.3257 15.0705 14.1326 0 0 16.0098 15.1548 15.2644 16.0288 16.5272 15.7376 0 14.4689 14.9938 14.7696 14.9453 0 15.4865 16.6308 14.7178 0 0 0 15.077 0 0 0 15.1896 15.9214 0 0 0 0 0 0 0 0 12.0384 0 0 0 0 0 0 0 13.9471 15.4698 15.6455 0 0 11.0526 14.8822 0 O00139 KIF2A_HUMAN "Kinesin-like protein KIF2A (Kinesin-2, hK2)" KIF2A KIF2 KNS2 Homo sapiens (Human) cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334] GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0051301; GO:0090307; GO:0120103 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ATANFGK 0.9924 -18.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1567 0 0 12.6677 13.1258 13.1903 0 11.8498 0 0 0 14.1449 12.9215 13.3468 0 0 0 13.2541 0 0 14.9138 0 0 0 13.5071 13.5778 14.4289 0 0 0 0 0 0 14.6777 13.0123 13.8797 0 0 0 13.7778 0 0 0 0 14.584 12.6134 0 0 14.3214 14.3098 12.4614 14.4506 0 0 12.7055 13.4238 0 0 0 0 0 16.7757 0 0 13.1628 0 0 0 0 0 0 0 0 0 0 12.1786 0 11.3416 0 12.788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2498 0 0 0 0 0 0 0 O14607 UTY_HUMAN "Histone demethylase UTY, EC 1.14.11.68 (Ubiquitously-transcribed TPR protein on the Y chromosome) (Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase UTY)" UTY KDM6C Homo sapiens (Human) chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; regulation of gene expression [GO:0010468] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654] MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone H3-K27 demethylation [GO:0071557]; regulation of gene expression [GO:0010468] GO:0000978; GO:0005654; GO:0006325; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0044666; GO:0046872; GO:0071557; GO:0071558 chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] CYLNAAR 0.9924 -18.228 0 0 0 0 0 12.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5018 0 0 0 0 0 0 13.5764 0 0 0 0 0 13.8189 0 0 0 0 0 0 12.4618 12.4731 11.4849 0 0 0 0 11.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6057 14.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5575 12.7961 13.4397 13.3302 0 0 0 0 13.6102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6465 0 0 0 0 0 0 0 0 0 0 0 14.0205 0 15.1492 14.7057 14.4569 0 0 0 0 0 0 13.702 13.968 0 0 0 0 0 0 0 0 0 O75112 LDB3_HUMAN LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein) LDB3 KIAA0613 ZASP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; heart development [GO:0007507]; muscle structure development [GO:0061061]; sarcomere organization [GO:0045214] GO:0001725; GO:0003779; GO:0005080; GO:0005856; GO:0005912; GO:0007507; GO:0008092; GO:0030018; GO:0030036; GO:0031143; GO:0031941; GO:0045214; GO:0046872; GO:0048471; GO:0051371; GO:0061061 actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080] HAHTINL 0.9924 -18.225 0 0 0 0 12.0014 0 0 12.0637 0 0 0 0 0 0 10.6075 0 0 0 0 0 0 0 0 0 11.5436 0 10.6078 0 0 0 0 0 0 0 10.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7833 13.8136 0 0 0 0 0 0 0 0 0 0 0 0 12.7138 18.2808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8019 0 0 0 12.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5205 0 0 12.0118 0 0 0 0 0 0 0 0 0 14.1633 P35658 NU214_HUMAN Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN) NUP214 CAIN CAN KIAA0023 Homo sapiens (Human) mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405] GO:0000278; GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876 nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] ITPPAAK 0.9924 -15.155 0 0 0 0 0 0 0 0 13.5976 0 0 11.0344 0 0 0 0 0 13.6804 0 0 0 0 0 0 0 10.3784 0 0 0 0 0 0 0 13.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5228 15.4225 15.5884 0 11.871 18.258 0 0 11.3351 15.4283 0 0 0 0 0 14.7484 0 0 9.88583 0 0 0 0 0 0 0 13.3476 9.23491 0 0 0 0 0 15.2734 0 0 0 0 0 0 0 10.664 0 12.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8721 0 0 15.0313 0 0 0 0 0 0 0 0 0 15.3611 18.329 0 0 0 0 0 0 11.2623 0 P43403 ZAP70_HUMAN "Tyrosine-protein kinase ZAP-70, EC 2.7.10.2 (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase)" ZAP70 SRK Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; calcium-mediated signaling [GO:0019722]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; beta selection [GO:0043366]; calcium-mediated signaling [GO:0019722]; cell differentiation [GO:0030154]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative thymic T cell selection [GO:0045060]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of T cell differentiation [GO:0045582]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; T cell activation [GO:0042110]; T cell aggregation [GO:0070489]; T cell differentiation [GO:0030217]; T cell migration [GO:0072678]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001772; GO:0001784; GO:0002250; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006955; GO:0007169; GO:0018108; GO:0019722; GO:0030154; GO:0030217; GO:0031234; GO:0035556; GO:0042101; GO:0042110; GO:0042113; GO:0043366; GO:0045059; GO:0045060; GO:0045087; GO:0045582; GO:0046638; GO:0046641; GO:0046777; GO:0050850; GO:0050852; GO:0070489; GO:0072678 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] AHCGPAELCEFYSR 0.9924 -14.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0404 0 0 0 0 0 0 0 0 0 0 0 0 12.1515 0 0 0 0 0 0 0 0 0 11.3304 0 0 0 11.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8465 0 0 0 12.5166 0 0 13.6298 13.4182 0 12.0657 0 0 0 0 0 0 13.6231 0 0 0 0 14.4556 13.5359 15.2334 0 0 0 14.1335 0 14.682 16.5472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1514 0 0 0 0 0 0 0 0 0 13.3725 0 0 13.2533 0 0 0 0 0 13.5072 0 0 13.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8461 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3523 0 0 0 0 0 0 0 0 Q12870 TCF15_HUMAN "Transcription factor 15, TCF-15 (Class A basic helix-loop-helix protein 40, bHLHa40) (Paraxis) (Protein bHLH-EC2)" TCF15 BHLHA40 BHLHEC2 Homo sapiens (Human) developmental process [GO:0032502]; ear development [GO:0043583]; establishment of epithelial cell apical/basal polarity [GO:0045198]; mesenchymal to epithelial transition [GO:0060231]; mesoderm development [GO:0007498]; muscle organ morphogenesis [GO:0048644]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular process controlling posture [GO:0050884]; paraxial mesoderm development [GO:0048339]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; regulation of extracellular matrix organization [GO:1903053]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell population maintenance [GO:0019827] chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; developmental process [GO:0032502]; ear development [GO:0043583]; establishment of epithelial cell apical/basal polarity [GO:0045198]; mesenchymal to epithelial transition [GO:0060231]; mesoderm development [GO:0007498]; muscle organ morphogenesis [GO:0048644]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; neuromuscular process controlling posture [GO:0050884]; paraxial mesoderm development [GO:0048339]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; regulation of extracellular matrix organization [GO:1903053]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell population maintenance [GO:0019827]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001756; GO:0003016; GO:0003700; GO:0005634; GO:0006357; GO:0007498; GO:0019827; GO:0032502; GO:0036342; GO:0043425; GO:0043583; GO:0045198; GO:0045944; GO:0046983; GO:0048339; GO:0048644; GO:0048705; GO:0050884; GO:0060231; GO:0070888; GO:0090575; GO:1902037; GO:1903053; GO:2000738 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GPGPGGGR 0.9924 -7.1946 0 0 0 0 0 0 0 0 0 15.3744 15.3828 13.5244 0 11.5445 15.1419 11.1002 12.1612 13.0156 0 13.713 13.7346 0 0 0 0 0 12.3705 12.9874 0 14.2696 0 14.5078 0 0 0 13.5348 14.6707 0 15.3225 0 0 14.1867 13.776 14.4462 13.7762 14.0399 0 0 14.2338 0 0 0 0 0 0 11.1508 11.2845 0 0 0 0 0 0 0 0 0 0 11.4738 0 0 0 0 0 0 14.5994 0 11.3967 0 14.1898 0 15.3607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7844 13.4198 0 0 0 0 0 15.1021 14.7159 13.4657 0 14.512 0 0 0 0 0 0 0 11.1529 0 15.3937 14.8978 14.7244 0 0 0 0 14.8325 0 0 0 0 0 0 0 15.9277 14.1315 14.0202 0 0 0 13.9535 0 0 0 15.8507 14.3605 14.4442 0 0 0 13.5837 0 0 0 14.4965 0 0 14.0048 0 13.4562 0 0 13.5974 14.2696 0 0 0 13.6269 14.1629 14.0274 0 0 15.2309 0 13.6462 0 13.6259 0 0 Q13485 SMAD4_HUMAN "Mothers against decapentaplegic homolog 4, MAD homolog 4, Mothers against DPP homolog 4 (Deletion target in pancreatic carcinoma 4) (SMAD family member 4, SMAD 4, Smad4, hSMAD4)" SMAD4 DPC4 MADH4 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; aging [GO:0007568]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]" activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] "activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; aging [GO:0007568]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate commitment [GO:0048663]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of binding [GO:0051098]; regulation of hair follicle development [GO:0051797]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006366; GO:0006879; GO:0007179; GO:0007183; GO:0007283; GO:0007338; GO:0007411; GO:0007568; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010666; GO:0010718; GO:0010862; GO:0014033; GO:0017015; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0030513; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036302; GO:0042060; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048663; GO:0048733; GO:0048859; GO:0051098; GO:0051571; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060548; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:1901522; GO:1902895; GO:1905305; GO:2000617 "chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]" ARLHIGKGVQLECK 0.9924 -6.0349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14692 BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog) BMS1 BMS1L KIAA0187 Homo sapiens (Human) "endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" 90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0030686; GO:0034511 ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] AAGEGSK 0.9924 -46.846 11.9479 0 0 0 0 0 0 0 0 12.4693 0 0 0 0 12.5274 0 16.4344 0 0 0 0 12.2536 0 0 11.6008 11.2293 0 0 0 0 0 0 0 0 0 0 0 12.2964 0 11.7968 0 0 0 0 12.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6242 11.4463 13.7513 13.5884 0 0 12.3496 0 0 0 0 0 0 13.8909 15.4227 0 13.9839 0 0 0 0 12.6887 14.1925 0 0 14.5846 0 0 11.8773 0 0 0 0 15.5351 15.3943 13.2192 0 0 0 13.1363 0 14.7305 13.7017 0 0 12.2931 0 0 13.2087 13.1454 11.7534 0 0 0 0 10.3508 0 0 0 0 0 13.3654 0 13.7466 13.0052 12.386 0 0 0 16.2602 0 0 0 13.3313 0 11.984 0 0 0 0 0 0 0 0 0 11.7395 13.7805 0 0 0 0 0 0 0 0 12.1256 0 0 0 0 0 0 0 0 0 0 12.8392 0 0 0 0 0 13.5668 0 Q53EV4 LRC23_HUMAN Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7) LRRC23 LRPB7 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829] GO:0005737; GO:0005829 AEADVIR 0.9924 -15.143 0 0 0 11.1653 0 0 0 11.6989 0 0 0 0 0 0 0 0 0 12.0075 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5704 0 0 0 0 0 0 11.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7874 0 12.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0195 10.9098 12.571 13.8903 0 12.9633 0 13.5957 0 0 14.0611 0 0 0 11.7611 0 0 0 0 0 0 0 12.5309 0 0 0 0 0 0 0 12.8842 0 12.9465 14.0221 14.0341 0 0 0 0 0 0 0 13.764 0 0 13.7286 0 0 14.0746 0 13.803 0 0 0 0 0 13.8018 0 14.1566 0 0 0 0 13.3902 0 0 0 0 0 0 0 0 0 10.0986 12.4727 0 0 0 0 0 12.6454 0 15.5494 0 14.6981 14.9038 0 12.1009 12.8782 12.3975 0 0 0 0 0 0 0 0 0 0 0 0 12.9633 0 0 0 0 0 0 Q6PJF5 RHDF2_HUMAN "Inactive rhomboid protein 2, iRhom2 (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6)" RHBDF2 IRHOM2 RHBDL5 RHBDL6 Homo sapiens (Human) negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of protein secretion [GO:0050709]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of metalloendopeptidase activity [GO:1904683]; regulation of protein secretion [GO:0050708] endoplasmic reticulum membrane [GO:0005789]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; protein transporter activity [GO:0140318]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of protein secretion [GO:0050709]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of metalloendopeptidase activity [GO:1904683]; regulation of protein secretion [GO:0050708] GO:0002862; GO:0005789; GO:0005796; GO:0005886; GO:0015031; GO:0016021; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0072659; GO:0140318; GO:1904683 growth factor binding [GO:0019838]; protein transporter activity [GO:0140318] APVPGPRR 0.9924 -15.152 0 0 0 12.6389 11.2413 0 13.9251 11.423 0 0 12.4198 0 11.9494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0034 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0119 0 0 0 0 0 0 0 12.9928 0 14.3662 13.9388 13.8034 0 0 0 0 0 14.1447 14.3951 0 0 0 0 0 0 0 0 0 0 0 13.3884 13.3593 0 13.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5339 17.6648 13.6179 0 0 0 0 13.4333 0 14.7068 0 14.862 0 14.4963 14.1739 0 13.8269 0 0 0 0 11.7881 0 0 0 0 0 0 0 0 0 0 0 13.1916 0 0 0 0 0 0 0 0 0 0 0 14.168 0 0 0 0 0 Q7Z412 PEX26_HUMAN Peroxisome assembly protein 26 (Peroxin-26) PEX26 Homo sapiens (Human) protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATPase binding [GO:0051117]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046] GO:0005777; GO:0005778; GO:0005779; GO:0005829; GO:0008022; GO:0016558; GO:0044877; GO:0045046; GO:0051117 ATPase binding [GO:0051117]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] KSLLAALILCLLVVR 0.9924 -15.162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.628 0 0 15.1711 13.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2747 0 13.2532 13.2096 0 0 0 0 11.8088 0 0 0 0 0 0 0 0 15.6744 0 0 0 14.545 0 0 0 0 15.0722 0 16.4538 0 14.1829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.821 0 0 14.4365 15.3102 0 0 0 0 14.1324 0 0 14.5382 13.5878 13.9267 0 0 0 0 0 0 0 0 0 13.4472 0 0 0 0 0 0 0 0 13.8299 0 0 0 0 0 0 0 0 0 0 0 0 13.4071 0 0 0 0 0 13.3527 0 0 0 14.3556 0 0 0 0 Q86YW9 MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like) MED12L KIAA1635 TNRC11L TRALP TRALPUSH PRO0314 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] mediator complex [GO:0016592] mediator complex [GO:0016592]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003713; GO:0008013; GO:0016592; GO:0045944 beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] AYMNLVKKLK 0.9924 -46.841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.315 0 13.3075 0 0 0 0 12.0898 0 0 0 0 0 0 10.8877 13.5703 0 0 0 0 0 0 0 11.9911 0 13.0054 0 0 13.5671 0 0 0 13.993 0 0 13.1968 0 0 0 0 0 11.5162 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4551 0 14.6054 0 0 16.0106 0 0 0 0 14.1218 14.3262 15.6076 0 16.0236 14.856 16.2174 15.5679 14.2851 0 14.6196 14.0812 14.1016 13.7477 11.329 15.9907 0 13.5897 11.9076 0 0 13.7423 0 0 10.3363 0 0 15.239 13.9859 14.5556 0 0 11.1791 13.8368 0 0 0 0 0 12.3782 0 0 14.6458 0 0 0 13.8332 15.535 14.3938 14.6074 14.0887 13.9927 14.1043 0 0 0 12.1126 0 0 15.637 14.0973 0 0 0 0 11.6407 14.9438 0 13.7076 16.5916 16.0253 0 0 0 16.2014 13.9186 0 12.2781 0 0 14.9821 0 0 15.0109 0 14.4698 0 0 13.9646 14.0901 0 0 0 0 0 10.7977 0 0 13.9081 0 13.4229 Q8N136 DAW1_HUMAN Dynein assembly factor with WDR repeat domains 1 (Outer row dynein assembly protein 16 homolog) (WD repeat-containing protein 69) DAW1 WDR69 Homo sapiens (Human) cerebrospinal fluid circulation [GO:0090660]; determination of left/right symmetry [GO:0007368]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; protein polyubiquitination [GO:0000209] cilium [GO:0005929]; extracellular region [GO:0005576]; SCF ubiquitin ligase complex [GO:0019005] cilium [GO:0005929]; extracellular region [GO:0005576]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; cerebrospinal fluid circulation [GO:0090660]; determination of left/right symmetry [GO:0007368]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005576; GO:0005929; GO:0007368; GO:0007507; GO:0019005; GO:0036158; GO:0051649; GO:0090660; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] MKLKSLLLR 0.9924 -4.9195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4805 0 0 13.4055 0 0 0 0 0 0 0 14.5044 0 0 0 13.0976 0 0 0 0 0 11.9198 12.3239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2715 0 Q96IY1 NSL1_HUMAN Kinetochore-associated protein NSL1 homolog NSL1 C1orf48 DC31 DC8 MIS14 Homo sapiens (Human) cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear speck [GO:0016607] cytosol [GO:0005829]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear speck [GO:0016607]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070] GO:0000070; GO:0000444; GO:0000776; GO:0005829; GO:0016607; GO:0031617; GO:0051301 ILECVIKTIK 0.9924 -4.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2724 11.8061 0 0 0 13.1133 0 12.8904 13.07 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9655 0 0 0 0 0 0 0 0 12.7711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96K78 AGRG7_HUMAN Adhesion G-protein coupled receptor G7 (G-protein coupled receptor 128) ADGRG7 GPR128 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] AWNLRVLVAVVCGLLTGIILGLGIWRIVIR 0.9924 -4.4424 0 0 0 0 0 0 15.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8065 0 0 13.7462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7778 0 14.8002 0 0 13.6238 0 14.3578 13.6175 0 15.9055 15.9086 0 0 0 0 13.3117 0 0 0 0 14.7446 13.4248 0 0 0 0 0 0 14.7421 0 0 13.8969 0 0 0 0 0 0 0 0 0 0 12.7131 13.2776 14.3728 0 16.3669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6419 0 12.9547 0 0 0 13.3056 0 0 0 0 20.2439 20.0076 19.5974 18.1063 17.9216 0 19.3456 19.2545 20.5773 20.1259 0 20.2071 0 0 0 16.2339 0 14.9609 0 0 0 19.1816 0 18.9144 Q96MN5 TEAN2_HUMAN Transcription elongation factor A N-terminal and central domain-containing protein 2 TCEANC2 C1orf83 Homo sapiens (Human) "transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0006351 LINGPYRR 0.9924 -14.813 0 0 0 0 0 0 0 0 0 0 0 0 12.5228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1899 0 0 12.026 12.8678 0 0 0 0 0 13.8653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.083 0 0 0 0 15.2159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.821 0 14.9533 0 0 0 0 0 14.4084 0 0 0 0 0 0 0 15.1715 0 0 15.1003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0134 0 0 14.8874 15.1978 0 0 0 15.1181 0 0 0 0 0 0 0 0 0 0 0 15.2835 0 0 Q9C0G0 ZN407_HUMAN Zinc finger protein 407 ZNF407 KIAA1703 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] GO:0003677; GO:0005634; GO:0008270; GO:0010468; GO:0045944 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] AQVAFKK 0.9924 -83.124 0 0 0 0 0 0 0 0 10.9482 13.3922 0 13.9617 0 0 0 13.1753 0 0 0 0 11.0993 0 0 0 0 13.5858 0 0 0 0 12.8453 0 0 0 10.9085 0 0 13.6303 12.273 0 0 0 0 13.229 0 0 0 0 11.8427 13.97 0 12.2051 0 13.72 0 0 15.1747 15.2779 14.8214 14.5809 0 0 0 13.8948 14.2529 0 14.7398 16.6009 16.2307 14.4803 17.548 17.6438 0 11.3324 13.6757 14.5501 13.4411 14.0447 14.3813 14.6007 15.091 0 0 15.4727 0 17.3632 14.052 13.1692 0 12.8153 13.3008 13.1524 11.6869 13.6365 0 13.3534 0 0 0 14.4674 14.0209 0 14.2008 0 0 13.2175 12.7639 11.8283 13.3711 13.6146 14.5186 0 15.2708 14.2859 14.3556 14.4981 14.5735 0 13.2905 14.6987 14.6703 13.5747 12.704 0 12.8901 12.1272 11.9965 14.4037 15.5877 13.286 14.3513 12.5381 14.9662 11.5523 0 13.6375 14.9518 0 13.4621 0 13.1677 13.2226 13.1019 13.2004 14.0399 13.4612 0 12.092 0 16.8172 13.5401 13.1953 13.0308 0 13.9164 14.348 0 16.5804 16.522 16.7465 16.7156 16.6639 16.1602 16.1656 16.3211 15.9002 15.9367 15.9544 0 13.4932 0 0 13.9092 14.2135 13.5445 0 0 16.9588 13.5875 16.9449 Q9HAU6 TCTP8_HUMAN Putative translationally-controlled tumor protein-like protein TPT1P8 (Putative apoptosis inhibitor FKSG2) TPT1P8 FKSG2 Homo sapiens (Human) apoptotic process [GO:0006915] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; apoptotic process [GO:0006915] GO:0005509; GO:0005737; GO:0006915 calcium ion binding [GO:0005509] LEEQRPER 0.9924 -14.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4189 0 0 12.0942 0 14.3474 0 0 0 12.1579 0 13.5733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5283 14.4833 0 0 12.8636 0 0 0 0 0 0 0 0 0 13.3922 0 0 0 0 0 14.7241 0 0 12.6406 0 0 0 0 0 0 0 0 0 0 13.6249 0 0 13.4486 0 0 14.5577 0 0 0 0 14.1691 0 15.7225 0 0 0 0 0 0 0 12.5838 0 0 13.8763 13.9059 0 0 0 0 0 0 14.8846 13.3934 0 14.7178 0 0 0 0 0 0 0 0 13.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3052 13.5412 13.4917 0 0 0 14.3137 0 0 Q9P032 NDUF4_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa) NDUFAF4 C6orf66 HRPAP20 HSPC125 My013 Homo sapiens (Human) defense response to virus [GO:0051607]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; defense response to virus [GO:0051607]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284] GO:0005516; GO:0005739; GO:0005743; GO:0008284; GO:0031966; GO:0032981; GO:0043066; GO:0051607 calmodulin binding [GO:0005516] AAETCQEPK 0.9924 -4.9289 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5177 0 0 0 0 0 0 0 9.76762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7858 13.6464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPP1 PHF8_HUMAN "Histone lysine demethylase PHF8, EC 1.14.11.27, EC 1.14.11.65 (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8)" PHF8 KIAA1111 ZNF422 Homo sapiens (Human) "brain development [GO:0007420]; chromatin organization [GO:0006325]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; chromatin organization [GO:0006325]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000082; GO:0003682; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0007420; GO:0008270; GO:0016706; GO:0031965; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0045943; GO:0051864; GO:0061188; GO:0070544; GO:0071557; GO:0071558; GO:0140680; GO:0140683 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] ALNLAFRAWTRK 0.9924 -25.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1873 0 13.6027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9897 0 0 14.2661 0 0 0 0 14.4468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8235 0 0 14.729 0 0 0 0 0 12.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7714 0 0 0 0 0 0 0 0 0 0 Q96BN8 OTUL_HUMAN "Ubiquitin thioesterase otulin, EC 3.4.19.12 (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby)" OTULIN FAM105B Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797] cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] GO:0002040; GO:0004843; GO:0005737; GO:0005829; GO:0008234; GO:0010803; GO:0016055; GO:0016567; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:0071797; GO:1990108 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234] ESLTLLRK 0.99241 -15.217 0 0 0 0 0 0 0 0 11.0316 0 0 13.0751 13.6656 12.8122 0 14.2868 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8058 0 13.0312 0 0 0 0 0 0 0 0 0 13.1685 0 0 12.2725 0 0 0 0 0 13.0631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5819 0 0 14.7306 12.3902 19.3236 11.4473 11.2061 0 0 0 0 0 0 0 0 0 0 15.8936 0 15.9712 14.8548 0 15.9537 16.0926 14.4689 15.0435 0 0 0 13.1608 0 0 16.136 0 0 0 0 16.4187 0 0 19.0536 14.7846 15.4694 16.1192 0 0 15.5226 0 16.0481 19.0731 15.5272 16.6376 15.8585 0 19.1543 15.3993 15.8102 0 0 15.675 18.9689 0 16.1806 0 19.0519 0 0 16.4988 0 16.0907 19.4528 0 0 0 0 14.866 19.0003 15.0248 0 16.0086 0 0 0 15.5979 0 0 0 0 15.0667 0 0 0 0 0 0 0 0 0 0 13.7595 0 0 0 0 0 13.3868 14.4093 19.0913 0 0 0 15.343 0 Q9UPN3 MACF1_HUMAN "Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein, ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)" MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] GO:0003723; GO:0003779; GO:0005198; GO:0005509; GO:0005737; GO:0005794; GO:0005856; GO:0005874; GO:0005886; GO:0010632; GO:0015629; GO:0016020; GO:0016055; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0045296; GO:0045773; GO:0051011; GO:0051015; GO:0051893; GO:0150011 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] AELVAISSSEDEGNLR 0.99241 -57.185 0 0 0 0 0 12.9763 0 13.6115 0 0 11.0165 0 13.7117 11.9835 0 13.4925 13.8484 12.8207 12.4664 13.4831 10.697 13.0536 0 13.3339 0 0 11.7777 12.4524 12.6872 14.9119 0 0 0 0 13.1529 0 14.4918 13.0804 12.849 0 0 11.5922 0 0 0 0 14.1438 13.1007 0 0 14.7161 17.2469 18.7757 18.6644 17.4699 0 12.0375 0 0 0 0 17.9344 0 0 0 0 16.0768 12.9797 12.811 14.1548 0 13.0124 15.5466 16.0006 11.4069 14.4721 16.0372 15.1085 13.2589 15.6575 13.0855 16.4096 16.2205 14.0389 14.9907 16.654 16.4009 15.7132 13.9051 14.4327 14.1323 16.1549 17.0112 13.6959 15.7092 15.9402 0 22.1791 15.8326 11.3296 16.2906 12.4667 14.4378 0 12.201 13.4857 0 13.8288 18.5908 13.2701 0 14.5653 0 12.8212 13.7263 15.8065 18.2895 15.3256 18.1076 12.1534 14.9085 13.024 15.4596 14.2911 14.8329 0 12.4917 14.5797 16.3289 15.306 13.6108 0 0 13.3744 15.5522 13.7897 13.7391 16.1139 0 14.7665 13.4882 14.1892 13.4576 0 0 0 11.757 12.7795 16.0459 18.3274 15.2871 16.0312 17.9516 14.4248 14.4695 14.344 15.5248 0 0 0 13.7922 11.2279 12.9448 0 14.5236 17.1506 13.8987 12.7145 13.0116 13.9318 11.692 20.5692 13.8508 20.5958 13.662 15.6815 0 13.6089 14.6327 13.0618 O15091 MRPP3_HUMAN "Mitochondrial ribonuclease P catalytic subunit, EC 3.1.26.5 (Mitochondrial ribonuclease P protein 3, Mitochondrial RNase P protein 3) (Protein only RNase P catalytic subunit)" PRORP KIAA0391 MRPP3 Homo sapiens (Human) mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526]; mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682] GO:0001682; GO:0004526; GO:0005654; GO:0005739; GO:0005759; GO:0030678; GO:0042645; GO:0046872; GO:0097745 metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526] ATNLIAKAR 0.99241 -5.1087 0 0 0 0 0 0 0 0 0 15.2414 15.9059 15.5962 0 0 0 0 14.0603 0 15.2253 0 0 0 0 0 0 0 0 0 0 15.8145 0 14.2404 15.5827 15.364 0 14.9487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1951 0 0 0 0 0 0 0 0 0 0 0 15.6703 0 0 0 14.6474 0 15.4027 0 0 0 0 0 0 0 0 0 0 0 0 13.7656 0 0 O15360 FANCA_HUMAN "Fanconi anemia group A protein, Protein FACA" FANCA FAA FACA FANCH Homo sapiens (Human) DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein monoubiquitination [GO:0006513]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of germ cell proliferation [GO:1905936]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein monoubiquitination [GO:0006513]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of germ cell proliferation [GO:1905936]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589] GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0007140; GO:0008584; GO:0008585; GO:0036297; GO:0043240; GO:0045589; GO:0050727; GO:0051090; GO:0065003; GO:1905936; GO:2000348 AFHVCAAILECLEK 0.99241 -6.7504 0 0 0 0 0 0 15.1356 0 0 0 0 0 10.9348 0 0 0 0 15.2957 0 15.0056 11.1767 14.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7227 0 0 0 11.7158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4861 0 0 0 0 13.4546 13.1383 15.7035 13.5303 13.8025 0 15.1236 15.1467 12.7563 11.2095 14.2055 13.5647 17.4707 0 14.1351 13.3907 13.7841 0 14.7208 0 14.647 14.9096 14.253 0 12.1222 13.5379 15.1884 13.3606 12.7591 16.268 11.304 0 0 0 12.3352 0 0 13.5757 0 0 11.7331 0 0 14.1617 0 17.2336 13.2351 14.8694 12.6236 0 13.2723 14.8071 13.6811 13.8082 14.2229 11.7839 0 0 0 0 0 0 14.5691 15.7344 0 0 15.1943 14.8184 0 12.2106 0 12.4983 0 12.5632 0 0 0 0 10.614 11.215 0 0 0 15.7992 14.2805 0 0 0 0 13.0044 0 11.5331 11.9648 0 0 0 0 0 0 0 11.1522 10.4265 11.1061 0 0 0 0 12.1825 O60343 TBCD4_HUMAN "TBC1 domain family member 4 (Akt substrate of 160 kDa, AS160)" TBC1D4 AS160 KIAA0603 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; vesicle [GO:0031982] cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192] GO:0005096; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869; GO:0090630 GTPase activator activity [GO:0005096] AIHQQILLLR 0.99241 -56.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8403 0 0 0 0 0 0 0 0 0 0 0 11.1265 0 15.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6056 0 13.8987 0 0 0 14.9779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.131 0 0 17.3314 14.7849 11.6421 10.9998 0 0 0 13.4915 0 0 0 0 0 0 12.3198 13.0377 0 13.9979 0 0 0 14.7357 0 14.5934 11.5536 0 0 0 0 0 0 13.5536 0 0 0 0 0 0 0 0 0 14.5477 0 0 0 13.6426 0 12.2005 0 0 0 12.3963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2223 13.4046 0 0 10.7389 13.1948 0 0 0 0 0 0 0 13.479 0 14.8395 0 0 0 0 13.2437 0 P07093 GDN_HUMAN "Glia-derived nexin, GDN (Peptidase inhibitor 7, PI-7) (Protease nexin 1, PN-1) (Protease nexin I) (Serpin E2)" SERPINE2 PI7 PN1 Homo sapiens (Human) "cell differentiation [GO:0030154]; cerebellar granular layer morphogenesis [GO:0021683]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; mating plug formation [GO:0042628]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of proteolysis [GO:0045861]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transport [GO:0010766]; platelet activation [GO:0030168]; positive regulation of astrocyte differentiation [GO:0048711]; protein catabolic process [GO:0030163]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of timing of cell differentiation [GO:0048505]; secretion by cell [GO:0032940]; secretory granule organization [GO:0033363]; seminal vesicle epithelium development [GO:0061108]" collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of external side of plasma membrane [GO:0031232]; neuromuscular junction [GO:0031594]; platelet alpha granule [GO:0031091] "collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of external side of plasma membrane [GO:0031232]; neuromuscular junction [GO:0031594]; platelet alpha granule [GO:0031091]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cerebellar granular layer morphogenesis [GO:0021683]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; innervation [GO:0060384]; long-term synaptic potentiation [GO:0060291]; mating plug formation [GO:0042628]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of proteolysis [GO:0045861]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of sodium ion transport [GO:0010766]; platelet activation [GO:0030168]; positive regulation of astrocyte differentiation [GO:0048711]; protein catabolic process [GO:0030163]; regulation of cell migration [GO:0030334]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of timing of cell differentiation [GO:0048505]; secretion by cell [GO:0032940]; secretory granule organization [GO:0033363]; seminal vesicle epithelium development [GO:0061108]" GO:0004867; GO:0005102; GO:0005539; GO:0005576; GO:0005615; GO:0005829; GO:0008201; GO:0008285; GO:0010757; GO:0010766; GO:0010951; GO:0010955; GO:0014067; GO:0021683; GO:0030154; GO:0030163; GO:0030168; GO:0030195; GO:0030308; GO:0030334; GO:0031091; GO:0031232; GO:0031594; GO:0032940; GO:0033363; GO:0042177; GO:0042628; GO:0045861; GO:0045879; GO:0048505; GO:0048711; GO:0050974; GO:0051966; GO:0060291; GO:0060384; GO:0061108; GO:0062023; GO:0090331; GO:1903561 glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102] DVFQCEVR 0.99241 -6.7679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13094 LCP2_HUMAN "Lymphocyte cytosolic protein 2 (SH2 domain-containing leukocyte protein of 76 kDa) (SLP-76 tyrosine phosphoprotein, SLP76)" LCP2 Homo sapiens (Human) immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005829; GO:0005911; GO:0006955; GO:0007169; GO:0035556; GO:0036398; GO:0044853; GO:0045576; GO:0045860; GO:0050852 EDFLSVSDIIDYFRK 0.99241 -15.216 0 0 0 0 0 0 0 0 13.3873 0 11.9836 0 0 0 11.6435 0 0 0 0 0 12.1391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8722 0 0 0 11.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5733 0 14.7216 12.742 0 0 12.7744 0 0 0 0 0 14.6924 0 0 0 14.2005 15.1104 0 0 0 14.827 0 14.1669 12.8954 0 0 0 0 0 0 9.92136 0 0 14.6533 0 14.6383 15.1916 0 0 0 0 0 0 0 12.7773 0 13.3542 0 0 13.9663 14.2339 0 0 0 14.4017 14.284 12.7153 0 0 13.5905 0 0 12.785 0 0 11.7722 13.4631 0 0 0 0 14.0738 0 0 10.489 12.9514 0 0 0 13.1453 0 0 0 0 14.5735 14.7037 0 0 0 13.8402 0 13.7057 14.1644 0 0 13.6682 12.8833 0 0 0 12.991 13.0227 0 14.4493 0 0 0 0 Q15465 SHH_HUMAN "Sonic hedgehog protein, SHH, EC 3.1.-.- (HHG-1) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains, ShhNC) [Cleaved into: Sonic hedgehog protein N-product, ShhN (Shh N-terminal processed signaling domains, ShhNp) ]" SHH Homo sapiens (Human) "alpha-beta T cell differentiation [GO:0046632]; androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of epithelial cell polarity [GO:0090162]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein import into nucleus [GO:0006606]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of glial cell proliferation [GO:0060251]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; regulation of stem cell proliferation [GO:0072091]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; skeletal muscle cell proliferation [GO:0014856]; skeletal muscle fiber differentiation [GO:0098528]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; T cell proliferation [GO:0042098]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; trunk neural crest cell migration [GO:0036484]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270]; alpha-beta T cell differentiation [GO:0046632]; androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of epithelial cell polarity [GO:0090162]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lung-associated mesenchyme development [GO:0060484]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein import into nucleus [GO:0006606]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of glial cell proliferation [GO:0060251]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; regulation of stem cell proliferation [GO:0072091]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; skeletal muscle cell proliferation [GO:0014856]; skeletal muscle fiber differentiation [GO:0098528]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; T cell proliferation [GO:0042098]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; trunk neural crest cell migration [GO:0036484]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]" GO:0000122; GO:0000139; GO:0001569; GO:0001570; GO:0001656; GO:0001658; GO:0001708; GO:0001755; GO:0001947; GO:0002052; GO:0002076; GO:0002320; GO:0003140; GO:0004175; GO:0005113; GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0006606; GO:0006897; GO:0007224; GO:0007228; GO:0007267; GO:0007389; GO:0007398; GO:0007405; GO:0007411; GO:0007417; GO:0007418; GO:0007442; GO:0007507; GO:0007596; GO:0008209; GO:0008270; GO:0008284; GO:0009880; GO:0009949; GO:0009953; GO:0009986; GO:0010468; GO:0010628; GO:0010629; GO:0014003; GO:0014706; GO:0014856; GO:0014858; GO:0016015; GO:0016539; GO:0016540; GO:0021513; GO:0021522; GO:0021794; GO:0021904; GO:0021930; GO:0021938; GO:0021978; GO:0030162; GO:0030177; GO:0030324; GO:0030326; GO:0030336; GO:0030539; GO:0030850; GO:0030878; GO:0030900; GO:0030901; GO:0030902; GO:0031016; GO:0031069; GO:0032435; GO:0033077; GO:0033085; GO:0033089; GO:0033092; GO:0034244; GO:0035115; GO:0035116; GO:0036484; GO:0042098; GO:0042127; GO:0042130; GO:0042307; GO:0042475; GO:0042481; GO:0042733; GO:0043010; GO:0043066; GO:0043237; GO:0043369; GO:0045059; GO:0045060; GO:0045109; GO:0045121; GO:0045445; GO:0045596; GO:0045880; GO:0045893; GO:0045944; GO:0046632; GO:0046638; GO:0046639; GO:0048468; GO:0048538; GO:0048557; GO:0048617; GO:0048643; GO:0048645; GO:0048663; GO:0048706; GO:0048709; GO:0048711; GO:0048714; GO:0048745; GO:0048754; GO:0048839; GO:0048859; GO:0048864; GO:0051155; GO:0051781; GO:0060020; GO:0060021; GO:0060070; GO:0060174; GO:0060251; GO:0060428; GO:0060439; GO:0060445; GO:0060447; GO:0060458; GO:0060459; GO:0060463; GO:0060484; GO:0060516; GO:0060523; GO:0060662; GO:0060664; GO:0060685; GO:0060738; GO:0060767; GO:0060769; GO:0060782; GO:0060783; GO:0060840; GO:0060916; GO:0061053; GO:0061189; GO:0062023; GO:0071285; GO:0071542; GO:0072089; GO:0072091; GO:0072136; GO:0072205; GO:0090090; GO:0090162; GO:0090370; GO:0097152; GO:0097190; GO:0098528; GO:1900175; GO:1900180; GO:1904339; GO:1905327; GO:2000062; GO:2000063; GO:2000357; GO:2000358; GO:2000729; GO:2001054 calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270] DRSKYGMLAR 0.99241 -6.7486 0 0 11.4518 0 0 0 0 0 0 0 0 0 12.1304 0 0 0 0 0 0 0 12.1226 0 0 11.0889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0077 0 0 0 0 0 0 0 0 0 0 0 10.9376 0 0 0 0 0 0 0 0 11.8882 12.27 12.3049 0 0 0 13.328 13.025 12.7672 13.9251 0 0 0 12.6578 14.2202 0 0 11.4433 0 0 0 13.3615 0 12.2441 0 0 0 0 0 12.4792 0 11.9493 0 0 12.3694 0 0 0 0 0 0 13.5738 14.0727 0 0 0 0 13.9542 0 12.5361 12.3091 13.1887 13.8177 0 14.1398 13.0386 12.8803 13.4645 14.9538 15.3093 0 0 13.2639 13.5416 0 13.8678 14.4417 12.5284 0 12.7133 0 16.3315 0 0 12.6445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8071 0 0 0 0 0 0 0 Q1W4C9 ISK13_HUMAN Serine protease inhibitor Kazal-type 13 (Hepatitis B virus DNA polymerase transactivated serine protease inhibitor) (Hespintor) (Serine protease inhibitor Kazal-type 5-like 3) SPINK13 HBVDNAPTP1 SPINK5L3 Homo sapiens (Human) negative regulation of acrosome reaction [GO:1902225] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of acrosome reaction [GO:1902225] GO:0004867; GO:0005576; GO:1902225 serine-type endopeptidase inhibitor activity [GO:0004867] FEKYGKCD 0.99241 -6.0632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TA78 LCE4A_HUMAN Late cornified envelope protein 4A (Late envelope protein 8) (Small proline-rich-like epidermal differentiation complex protein 4A) LCE4A LEP8 SPRL4A Homo sapiens (Human) keratinization [GO:0031424] identical protein binding [GO:0042802]; keratinization [GO:0031424] GO:0031424; GO:0042802 identical protein binding [GO:0042802] CASSCPPPISSCCGSSSGGCGCCSSEGGGCCLSHHR 0.99241 -5.1061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5849 12.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3875 0 0 0 0 0 0 0 0 0 0 0 0 12.6439 13.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.138 0 0 Q86UQ8 NFE4_HUMAN Transcription factor NF-E4 NFE4 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor binding [GO:0140297]; protein homodimerization activity [GO:0042803]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003712; GO:0005634; GO:0006355; GO:0006357; GO:0032991; GO:0042803; GO:0045944; GO:0065003; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; protein homodimerization activity [GO:0042803]; transcription coregulator activity [GO:0003712] ISSALPLK 0.99241 -15.195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9399 0 0 0 0 14.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7979 0 0 0 0 0 0 Q8N3D4 EH1L1_HUMAN EH domain-binding protein 1-like protein 1 EHBP1L1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036] endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815] endosome [GO:0005768]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; actin cytoskeleton organization [GO:0030036] GO:0005768; GO:0005815; GO:0016020; GO:0030036; GO:0031941 AAKFQFVACYHELVLECTKK 0.99241 -25.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6439 0 0 0 0 0 11.2451 13.904 0 12.6554 0 0 0 0 0 0 0 0 0 0 0 0 14.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.958 12.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3534 0 0 13.3851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0462 0 0 0 0 14.977 0 0 0 13.0392 0 0 12.2072 0 0 0 17.879 0 0 0 17.089 0 0 15.8571 13.4642 0 0 0 0 0 0 13.0694 0 0 0 0 0 0 0 0 0 0 15.0493 13.6396 13.2078 0 0 0 0 0 0 0 13.9625 0 0 0 0 0 0 12.3957 0 0 14.4689 0 0 0 0 0 12.5307 13.0717 11.279 0 0 0 0 14.8195 13.3902 0 0 0 0 Q8NB42 ZN527_HUMAN Zinc finger protein 527 ZNF527 KIAA1829 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGKFFRTDSQLNR 0.99241 -7.2144 0 0 0 0 0 0 0 11.5727 0 0 0 0 0 0 0 0 0 0 0 0 12.1081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3004 0 11.1263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6935 0 13.8975 0 0 0 0 0 0 0 0 0 0 13.228 0 0 12.2354 13.4651 0 0 0 12.2687 0 0 0 0 0 0 13.4276 14.5212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7169 0 0 0 0 0 0 0 0 0 0 0 11.8251 0 0 0 0 0 0 0 0 0 0 0 0 10.2674 0 0 13.4493 0 0 11.1329 0 0 10.7387 Q8WTX9 ZDHC1_HUMAN "Palmitoyltransferase ZDHHC1, EC 2.3.1.225 (DHHC domain-containing cysteine-rich protein 1) (Zinc finger DHHC domain-containing protein 1, DHHC-1) (Zinc finger protein 377)" ZDHHC1 C16orf1 ZNF377 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] GO:0002230; GO:0003677; GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0010008; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0070062; GO:0140374 DNA binding [GO:0003677]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] CVCGFDHHCK 0.99241 -6.7689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3459 12.4496 10.7921 0 0 0 12.1733 0 0 0 0 0 0 0 11.7637 0 0 0 0 0 0 0 0 0 0 0 11.8716 0 12.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.37352 0 0 0 0 0 12.242 0 0 0 0 0 14.5303 0 0 0 0 0 0 0 0 0 0 14.556 0 0 0 0 0 12.4582 0 14.3771 0 13.7357 0 0 0 0 0 0 0 13.401 14.6874 0 0 0 0 12.5384 0 0 13.8754 0 12.0673 0 0 0 0 0 0 0 0 0 0 0 0 12.63 0 0 0 13.284 13.2018 0 0 0 0 10.7756 14.6488 0 0 14.1189 0 0 0 0 0 0 11.9325 14.5325 0 0 0 0 13.4449 0 0 0 0 0 0 0 11.1561 0 0 0 0 0 0 Q96QF7 GCNA_HUMAN Germ cell nuclear acidic protein (Acidic repeat-containing protein) (Germ cell nuclear acidic peptidase) (Germ cell nuclear antigen) GCNA ACRC Homo sapiens (Human) protein-DNA covalent cross-linking repair [GO:0106300] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; SUMO polymer binding [GO:0032184]; protein-DNA covalent cross-linking repair [GO:0106300] GO:0005634; GO:0005654; GO:0005694; GO:0016605; GO:0032184; GO:0106300 SUMO polymer binding [GO:0032184] GSLVMVPLTQK 0.99241 -57.686 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8536 0 0 0 12.5425 0 0 0 0 0 0 0 0 0 13.512 0 0 14.6124 13.7466 0 0 13.3807 0 15.1423 0 12.4454 0 0 12.7425 0 0 13.4671 0 0 0 0 0 11.1579 0 0 0 0 0 13.6522 0 12.371 0 0 0 0 13.4342 0 0 0 0 0 0 0 0 0 13.9072 0 0 13.2737 0 0 0 0 14.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9584 0 0 0 14.7732 0 0 0 0 0 0 0 0 0 10.6367 13.5658 0 0 0 0 0 0 Q96RG2 PASK_HUMAN "PAS domain-containing serine/threonine-protein kinase, PAS-kinase, PASKIN, hPASK, EC 2.7.11.1" PASK KIAA0135 Homo sapiens (Human) energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0035091; GO:0035556; GO:0043576; GO:0045719; GO:0045727; GO:0046777; GO:0070092; GO:0097009; GO:0106310 ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AIFTVDAK 0.99241 -6.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1843 0 0 0 0 0 0 11.309 0 0 0 0 0 0 11.9828 0 0 0 0 0 0 0 13.7159 0 0 0 11.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.244 0 0 0 0 0 0 0 13.3019 0 14.3217 0 0 0 11.1282 0 0 0 0 14.6066 0 14.1506 0 13.839 0 0 14.032 0 13.666 0 0 0 0 0 13.5791 0 0 13.3938 0 0 0 0 13.6854 0 13.463 0 0 0 0 13.1683 0 0 13.3167 0 14.6785 11.2082 14.2237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6708 13.2153 13.6752 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3W5 LRRN3_HUMAN "Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3, NLRR-3)" LRRN3 Nbla10363 UNQ194/PRO220 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965] GO:0005615; GO:0016021; GO:0031012; GO:0051965 DMNFKPLINLR 0.99241 -5.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1026 0 0 10.9102 0 0 0 14.1961 0 0 0 0 13.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7978 13.3987 0 0 0 0 0 0 0 0 0 13.0432 0 13.4231 0 0 0 0 0 0 0 0 0 12.456 0 0 0 0 0 0 0 0 0 0 13.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.019 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0269 0 11.1642 11.6499 Q9NRL2 BAZ1A_HUMAN "Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1, hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180, WCRF180) (hWALp1)" BAZ1A ACF1 WCRF180 HSPC317 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of heterochromatin assembly [GO:0031445]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] "ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of heterochromatin assembly [GO:0031445]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000228; GO:0003677; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0008623; GO:0016590; GO:0031445; GO:0045740; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] ADALEAKKK 0.99241 -56.725 0 0 0 0 10.9012 0 0 0 0 0 12.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.152 11.8457 0 0 0 12.2304 0 0 0 12.2516 0 13.4886 0 0 0 0 12.497 13.0546 0 0 0 0 0 0 0 11.7904 0 11.9454 0 11.744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8579 14.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5519 0 0 0 17.8897 0 0 0 0 12.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5477 0 0 0 13.8738 0 0 0 0 0 0 0 0 14.643 13.5976 15.0402 0 0 0 0 0 0 13.9148 0 0 14.4217 14.3831 0 0 14.4836 0 0 0 10.9113 12.4777 0 0 13.1999 12.8544 0 0 0 0 0 0 0 Q9NVR2 INT10_HUMAN "Integrator complex subunit 10, Int10" INTS10 C8orf35 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243 CEWQMDKGR 0.99241 -4.9493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2247 0 11.9268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5875 0 0 0 0 13.4805 0 0 0 0 11.5102 0 0 0 0 0 0 0 0 0 0 0 0 11.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIG8 SO3A1_HUMAN "Solute carrier organic anion transporter family member 3A1, OATP3A1 (Organic anion transporter polypeptide-related protein 3, OATP-RP3, OATPRP3) (Organic anion-transporting polypeptide D, OATP-D) (PGE1 transporter) (Sodium-independent organic anion transporter D) (Solute carrier family 21 member 11)" SLCO3A1 OATP3A1 OATPD SLC21A11 Homo sapiens (Human) positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]; transport across blood-brain barrier [GO:0150104] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; prostaglandin transport [GO:0015732]; sodium-independent organic anion transport [GO:0043252]; transport across blood-brain barrier [GO:0150104] GO:0001934; GO:0005886; GO:0005887; GO:0015347; GO:0015732; GO:0043252; GO:0051092; GO:0150104 sodium-independent organic anion transmembrane transporter activity [GO:0015347] TVSPELK 0.99241 -4.9343 0 0 0 0 0 0 0 0 0 0 12.0032 14.7911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5212 0 15.7424 0 0 0 0 0 0 15.1696 13.3597 0 0 0 13.1199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKN5 PRDM4_HUMAN "PR domain zinc finger protein 4, EC 2.1.1.- (PR domain-containing protein 4)" PRDM4 PFM1 Homo sapiens (Human) histone H4-R3 methylation [GO:0043985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; transcription by RNA polymerase II [GO:0006366] cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; histone H4-R3 methylation [GO:0043985]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; transcription by RNA polymerase II [GO:0006366]" GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005737; GO:0006366; GO:0008168; GO:0010468; GO:0035097; GO:0043985; GO:0045944; GO:0046872; GO:1990226; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ARLSLPK 0.99241 -15.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7428 0 0 0 0 0 0 0 13.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6394 0 0 0 0 0 0 0 0 0 0 0 0 13.5573 0 0 0 0 13.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3177 0 0 0 0 0 Q9XRX5 HHLA3_HUMAN HERV-H LTR-associating protein 3 (Human endogenous retrovirus-H long terminal repeat-associating protein 3) HHLA3 Homo sapiens (Human) GVPIQTPR 0.99241 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VV8 RTTN_HUMAN Rotatin RTTN Homo sapiens (Human) centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368] GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0032053; GO:0036064 CSELLYVFQTQLALK 0.99242 -7.2437 15.8359 15.194 0 0 0 0 0 11.5447 0 14.158 15.0271 14.8611 0 0 0 0 0 0 12.682 13.9152 10.7328 0 0 10.9287 0 0 0 11.2977 0 0 0 13.7436 0 13.0931 0 0 0 10.673 0 0 0 0 0 11.5164 0 12.7472 0 12.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8023 15.4507 11.3964 17.5245 0 15.0695 19.4524 0 15.1392 12.9275 17.6114 17.7833 14.9302 0 15.6088 14.6226 14.4608 0 0 0 14.1082 12.7913 12.6944 0 0 0 14.2601 0 0 12.5488 13.0442 0 0 13.7058 14.4005 13.6162 0 12.933 14.272 12.4476 14.1991 12.4617 14.32 13.6387 0 12.4971 13.5074 16.1442 12.8025 12.5654 14.915 13.2439 13.8244 17.0295 14.4871 0 15.5107 13.9897 0 15.2279 0 12.3665 14.8495 15.1604 14.761 16.0282 0 17.897 14.2951 0 14.3412 11.0322 11.7342 0 13.4822 14.6707 12.2963 0 0 0 13.5871 12.1393 0 11.6765 15.7866 14.2214 17.9576 0 13.3691 18.0965 12.6594 13.3066 14.5884 0 0 13.3788 13.2456 13.9279 0 12.3267 13.4368 13.3292 0 0 0 0 0 14.9128 12.7564 14.9836 0 13.2936 12.1253 0 O14786 NRP1_HUMAN Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304) NRP1 NRP VEGF165R Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; artery morphogenesis [GO:0048844]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; basal dendrite development [GO:0150018]; branching involved in blood vessel morphogenesis [GO:0001569]; branchiomotor neuron axon guidance [GO:0021785]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell signaling [GO:0007267]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; dorsal root ganglion morphogenesis [GO:1904835]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; endothelial tip cell fate specification [GO:0097102]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; integrin-mediated signaling pathway [GO:0007229]; motor neuron migration [GO:0097475]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; neuropilin signaling pathway [GO:0038189]; otic placode development [GO:1905040]; outflow tract septum morphogenesis [GO:0003148]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytokine activity [GO:0060301]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynapse organization [GO:0099173]; protein localization to early endosome [GO:1902946]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vesicle-mediated transport [GO:0060627]; renal artery morphogenesis [GO:0061441]; response to wounding [GO:0009611]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal ganglion cell axon guidance [GO:0031290]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; toxin transport [GO:1901998]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190]; VEGF-activated neuropilin signaling pathway involved in axon guidance [GO:1902378]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]; viral entry into host cell [GO:0046718]" axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; mitochondrial membrane [GO:0031966]; neurofilament [GO:0005883]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; semaphorin receptor complex [GO:0002116]; sorting endosome [GO:0097443] "axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; mitochondrial membrane [GO:0031966]; neurofilament [GO:0005883]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; semaphorin receptor complex [GO:0002116]; sorting endosome [GO:0097443]; coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; GTPase activator activity [GO:0005096]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; artery morphogenesis [GO:0048844]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; basal dendrite development [GO:0150018]; branching involved in blood vessel morphogenesis [GO:0001569]; branchiomotor neuron axon guidance [GO:0021785]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell signaling [GO:0007267]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; dorsal root ganglion morphogenesis [GO:1904835]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; endothelial tip cell fate specification [GO:0097102]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; integrin-mediated signaling pathway [GO:0007229]; motor neuron migration [GO:0097475]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; neuropilin signaling pathway [GO:0038189]; otic placode development [GO:1905040]; outflow tract septum morphogenesis [GO:0003148]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytokine activity [GO:0060301]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynapse organization [GO:0099173]; protein localization to early endosome [GO:1902946]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vesicle-mediated transport [GO:0060627]; renal artery morphogenesis [GO:0061441]; response to wounding [GO:0009611]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal ganglion cell axon guidance [GO:0031290]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; toxin transport [GO:1901998]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190]; VEGF-activated neuropilin signaling pathway involved in axon guidance [GO:1902378]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]; viral entry into host cell [GO:0046718]" GO:0001525; GO:0001569; GO:0001570; GO:0001755; GO:0001764; GO:0001938; GO:0002040; GO:0002042; GO:0002116; GO:0003148; GO:0005021; GO:0005096; GO:0005615; GO:0005769; GO:0005829; GO:0005883; GO:0005886; GO:0005887; GO:0005925; GO:0006930; GO:0007165; GO:0007229; GO:0007267; GO:0007411; GO:0007413; GO:0008201; GO:0009611; GO:0009887; GO:0010595; GO:0014911; GO:0015026; GO:0017154; GO:0019838; GO:0019901; GO:0019955; GO:0021612; GO:0021637; GO:0021649; GO:0021675; GO:0021785; GO:0021828; GO:0030424; GO:0030947; GO:0031290; GO:0031410; GO:0031532; GO:0031966; GO:0032489; GO:0034446; GO:0035729; GO:0035767; GO:0035924; GO:0036486; GO:0038023; GO:0038085; GO:0038189; GO:0038190; GO:0042327; GO:0043005; GO:0043235; GO:0043524; GO:0043542; GO:0045766; GO:0046718; GO:0046872; GO:0048008; GO:0048010; GO:0048012; GO:0048842; GO:0048843; GO:0048844; GO:0048846; GO:0050731; GO:0050918; GO:0051491; GO:0051496; GO:0051894; GO:0060301; GO:0060385; GO:0060627; GO:0060666; GO:0060978; GO:0060982; GO:0061299; GO:0061441; GO:0061549; GO:0061551; GO:0070374; GO:0071526; GO:0071679; GO:0090050; GO:0090259; GO:0097102; GO:0097374; GO:0097443; GO:0097475; GO:0097490; GO:0097491; GO:0098978; GO:0099055; GO:0099173; GO:0150018; GO:0150020; GO:1900026; GO:1901166; GO:1901998; GO:1902285; GO:1902287; GO:1902336; GO:1902378; GO:1902946; GO:1903375; GO:1904835; GO:1905040; GO:2000251; GO:2001237 coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; GTPase activator activity [GO:0005096]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021] DCKYDYVEVFDGENENGHFR 0.99242 -17.951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2761 0 11.5806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6308 0 0 0 0 0 0 0 0 P09001 RM03_HUMAN "39S ribosomal protein L3, mitochondrial, L3mt, MRP-L3 (Mitochondrial large ribosomal subunit protein uL3m)" MRPL3 MRL3 RPML3 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ATSILEFYRELGLPPKQTVK 0.99242 -25.706 0 9.93859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1235 0 0 0 0 0 11.5479 0 0 0 0 0 0 11.4798 0 0 0 0 0 0 0 0 0 0 0 10.2869 0 0 0 0 0 13.0768 13.545 0 0 0 0 14.0411 0 0 0 0 0 14.2205 14.1945 0 0 0 0 0 0 0 0 14.3538 0 0 0 0 0 0 0 14.2649 0 0 0 0 0 0 0 0 0 0 0 0 13.1662 0 0 14.1092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2945 0 0 0 0 13.904 0 13.1042 0 0 0 12.7225 0 0 0 0 0 0 0 0 0 12.4263 0 12.2081 12.4627 12.9441 13.0744 0 0 0 12.4814 12.6872 12.7933 12.2745 13.7135 12.1359 0 0 0 0 0 0 0 0 0 P0DMR3 AT8OS_HUMAN Putative protein ATXN8OS (ATXN8 opposite strand) (Spinocerebellar ataxia 8) (kelch-like 1 antisense) ATXN8OS KLHL1AS SCA8 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 EEEEEDGEDDEEEEEEGFFQK 0.99242 -6.7928 0 0 0 0 0 0 0 0 0 0 12.0736 0 0 0 0 0 0 0 11.7077 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2564 0 0 0 0 0 0 12.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8635 0 0 0 0 10.9152 0 0 0 0 0 0 0 12.2398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4351 0 12.636 0 0 0 0 0 12.4978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1209 0 12.374 0 0 10.4789 0 0 11.9339 0 0 0 0 0 9.79123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52429 DGKE_HUMAN "Diacylglycerol kinase epsilon, DAG kinase epsilon, EC 2.7.1.107 (Diglyceride kinase epsilon, DGK-epsilon)" DGKE DAGK5 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] GO:0003951; GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0006661; GO:0007205; GO:0016020; GO:0016021; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046834; GO:0046872; GO:0050804; GO:0098978 ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951] GNVPLCSYCMVCKQQCGCQPK 0.99242 -7.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9005 0 0 0 0 0 0 0 0 0 0 11.676 0 0 0 0 0 P56377 AP1S2_HUMAN AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin) AP1S2 DC22 Homo sapiens (Human) intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin adaptor activity [GO:0035615]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0016192; GO:0030119; GO:0030121; GO:0030659; GO:0032588; GO:0035615; GO:0043231; GO:0060155; GO:1903232 clathrin adaptor activity [GO:0035615] QFMLLFSR 0.99242 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02750 MP2K1_HUMAN "Dual specificity mitogen-activated protein kinase kinase 1, MAP kinase kinase 1, MAPKK 1, MKK1, EC 2.7.12.2 (ERK activator kinase 1) (MAPK/ERK kinase 1, MEK 1)" MAP2K1 MEK1 PRKMK1 Homo sapiens (Human) "Bergmann glial cell differentiation [GO:0060020]; cell motility [GO:0048870]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; chemotaxis [GO:0006935]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; placenta blood vessel development [GO:0060674]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]" cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; protein C-terminus binding [GO:0008022]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; Bergmann glial cell differentiation [GO:0060020]; cell motility [GO:0048870]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; chemotaxis [GO:0006935]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; placenta blood vessel development [GO:0060674]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]" GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004712; GO:0004713; GO:0005078; GO:0005524; GO:0005634; GO:0005739; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005925; GO:0006468; GO:0006935; GO:0007165; GO:0007507; GO:0008022; GO:0008285; GO:0010628; GO:0021697; GO:0030182; GO:0030216; GO:0030295; GO:0030878; GO:0032872; GO:0035987; GO:0043539; GO:0045893; GO:0047485; GO:0048538; GO:0048679; GO:0048870; GO:0050772; GO:0060020; GO:0060324; GO:0060440; GO:0060502; GO:0060674; GO:0060711; GO:0070371; GO:0070374; GO:0071902; GO:0090170; GO:0090398; GO:0097110; GO:0106310; GO:1903226; GO:1903800; GO:2000641 ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; protein C-terminus binding [GO:0008022]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110] GLTYLREK 0.99242 -7.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13057 COASY_HUMAN "Bifunctional coenzyme A synthase, CoA synthase (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase, EC 2.7.7.3 (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase, PPAT); Dephospho-CoA kinase, DPCK, EC 2.7.1.24 (Dephosphocoenzyme A kinase, DPCOAK) ]" COASY PSEC0106 Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310] GO:0004140; GO:0004595; GO:0005524; GO:0005741; GO:0005759; GO:0015937; GO:0016310; GO:0070062 ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595] AWALLQK 0.99242 -17.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4483 12.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5116 0 0 0 0 0 10.8776 0 0 0 13.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2184 0 0 0 0 0 0 0 0 0 0 0 0 12.7624 0 0 0 0 0 0 0 0 0 10.4735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14201 BTG3_HUMAN Protein BTG3 (Abundant in neuroepithelium area protein) (BTG family member 3) (Protein Tob5) BTG3 ANA TOB5 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic cell cycle [GO:0045930] GO:0005634; GO:0005737; GO:0008285; GO:0045930 DEISRKVTR 0.99242 -4.4778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q30KQ6 DB114_HUMAN "Beta-defensin 114 (Beta-defensin 14, DEFB-14) (Defensin, beta 114)" DEFB114 DEFB14 Homo sapiens (Human) antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of inflammatory response [GO:0050729] extracellular region [GO:0005576] extracellular region [GO:0005576]; lipopolysaccharide binding [GO:0001530]; antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of inflammatory response [GO:0050729] GO:0001530; GO:0005576; GO:0031665; GO:0032720; GO:0043407; GO:0045087; GO:0050729; GO:0050829; GO:0050830; GO:0061760 lipopolysaccharide binding [GO:0001530] ICCTEKLYEEDDMF 0.99242 -7.6094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6912 0 0 13.3146 0 0 12.5542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HY92 FIGN_HUMAN Fidgetin FIGN Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005524; GO:0005737; GO:0005815; GO:0005874; GO:0007049; GO:0008022; GO:0008568; GO:0016363; GO:0016887; GO:0051301 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule severing ATPase activity [GO:0008568]; protein C-terminus binding [GO:0008022] AFYMAGQGDMDSSYGNYSYGQQR 0.99242 -7.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4082 0 13.0051 0 12.6505 0 0 0 0 0 0 13.1038 12.7082 0 0 0 0 0 0 0 0 13.771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9512 0 0 0 0 0 0 14.8338 0 0 12.6416 0 0 0 0 0 0 13.1578 12.5554 14.8765 13.4344 0 0 0 0 0 12.793 0 0 14.7404 14.4998 0 14.3493 0 0 0 0 0 0 Q6IN84 MRM1_HUMAN "rRNA methyltransferase 1, mitochondrial, EC 2.1.1.- (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase)" MRM1 Homo sapiens (Human) rRNA 2'-O-methylation [GO:0000451]; rRNA modification [GO:0000154] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; rRNA 2'-O-methylation [GO:0000451]; rRNA modification [GO:0000154] GO:0000154; GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0016435; GO:0070039 RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039] DIPVLRPRR 0.99242 -17.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6579 0 0 0 0 0 13.8686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6KF10 GDF6_HUMAN "Growth/differentiation factor 6, GDF-6 (Bone morphogenetic protein 13, BMP-13) (Growth/differentiation factor 16)" GDF6 BMP13 GDF16 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]" extracellular space [GO:0005615] "extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]" GO:0001656; GO:0005125; GO:0005615; GO:0006915; GO:0008083; GO:0010862; GO:0030509; GO:0032332; GO:0032924; GO:0035788; GO:0042802; GO:0045444; GO:0045666; GO:0045893; GO:0060389; GO:0060395; GO:1900745; GO:1990009 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802] ALLVVFTR 0.99242 -17.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6389 0 0 0 Q7L0J3 SV2A_HUMAN Synaptic vesicle glycoprotein 2A SV2A KIAA0736 PSEC0174 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; regulation of gamma-aminobutyric acid secretion [GO:0014052]; synaptic vesicle priming [GO:0016082] cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; protein kinase binding [GO:0019901]; transmembrane transporter activity [GO:0022857]; cellular calcium ion homeostasis [GO:0006874]; regulation of gamma-aminobutyric acid secretion [GO:0014052]; synaptic vesicle priming [GO:0016082] GO:0005783; GO:0005886; GO:0005911; GO:0006874; GO:0008021; GO:0014052; GO:0016021; GO:0016082; GO:0019901; GO:0022857; GO:0030285; GO:0030425; GO:0030672; GO:0031594; GO:0043005; GO:0043025; GO:0048786; GO:0098978; GO:0098982 protein kinase binding [GO:0019901]; transmembrane transporter activity [GO:0022857] FEEEDDDDDFPAPSDGYYR 0.99242 -4.4722 11.9916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7991 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VQ6 TRXR3_HUMAN "Thioredoxin reductase 3, EC 1.8.1.9 (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2)" TXNRD3 TGR TRXR3 Homo sapiens (Human) cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; glutathione oxidoreductase activity [GO:0097573]; thioredoxin-disulfide reductase activity [GO:0004791]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; spermatogenesis [GO:0007283] GO:0004791; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0007283; GO:0030154; GO:0045454; GO:0050660; GO:0097573 flavin adenine dinucleotide binding [GO:0050660]; glutathione oxidoreductase activity [GO:0097573]; thioredoxin-disulfide reductase activity [GO:0004791] ARLSSPGPSR 0.99242 -17.948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2188 0 0 0 0 0 0 0 13.7892 13.7442 13.428 0 0 0 0 0 0 11.1679 0 14.4565 14.6215 14.1972 0 0 0 0 0 0 0 0 13.5371 0 0 0 0 13.2786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3404 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8616 0 13.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2929 0 0 0 0 0 0 0 Q8IWW6 RHG12_HUMAN Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12) ARHGAP12 Homo sapiens (Human) "actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; phagocytic cup [GO:0001891] "cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]" GO:0001891; GO:0002011; GO:0005096; GO:0005737; GO:0006911; GO:0007015; GO:0007165; GO:0043087; GO:0051058 GTPase activator activity [GO:0005096] EIIKSRSLDR 0.99242 -17.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9174 0 0 0 0 0 0 0 11.6547 0 0 0 0 0 11.5501 0 10.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8569 12.7545 0 12.7444 0 0 0 12.7442 0 10.7399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7466 0 0 0 0 0 0 0 0 0 15.6321 0 0 0 0 0 13.1691 13.5479 16.248 0 0 0 0 0 0 0 0 0 14.2295 0 14.3171 0 0 0 0 18.4476 0 0 0 0 11.9109 0 0 0 0 0 0 0 0 13.1285 0 0 11.9285 0 0 0 0 0 0 0 11.6175 0 0 12.1762 0 0 12.5024 0 0 0 0 12.8602 13.2232 0 0 0 0 0 0 Q8N228 SCML4_HUMAN Sex comb on midleg-like protein 4 SCML4 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393] FLAKLCR 0.99242 -18.436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0015 12.4961 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4423 0 0 0 0 0 0 13.8392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0895 0 0 0 0 0 15.0707 0 Q8NEY3 SPAT4_HUMAN Spermatogenesis-associated protein 4 (Testis and spermatogenesis cell-related protein 2) (Testis spermatocyte apoptosis-related gene 2 protein) SPATA4 TSARG2 Homo sapiens (Human) regulation of cytoskeleton organization [GO:0051493] axoneme [GO:0005930]; nucleus [GO:0005634] axoneme [GO:0005930]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; regulation of cytoskeleton organization [GO:0051493] GO:0005634; GO:0005930; GO:0008017; GO:0051493 microtubule binding [GO:0008017] CLVYPHAPK 0.99242 -7.2466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG35 D105A_HUMAN "Beta-defensin 105 (Beta-defensin 5, BD-5, DEFB-5) (Defensin, beta 105)" DEFB105A BD5 DEFB105 DEFB5; DEFB105B Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 LNFLCCR 0.99242 -4.4781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHY0 B4GN2_HUMAN "Beta-1,4 N-acetylgalactosaminyltransferase 2, EC 2.4.1.- (Sd(a) beta-1,4-GalNAc transferase) (UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase)" B4GALNT2 GALGT2 Homo sapiens (Human) lipid glycosylation [GO:0030259]; negative regulation of cell-cell adhesion [GO:0022408]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]; UDP-N-acetylglucosamine metabolic process [GO:0006047] Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; lipid glycosylation [GO:0030259]; negative regulation of cell-cell adhesion [GO:0022408]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]; UDP-N-acetylglucosamine metabolic process [GO:0006047] GO:0000139; GO:0006047; GO:0008376; GO:0009312; GO:0016021; GO:0018279; GO:0019276; GO:0022408; GO:0030173; GO:0030259 acetylgalactosaminyltransferase activity [GO:0008376] FPVTIRHPVIPK 0.99242 -17.076 0 0 0 0 0 0 0 0 0 0 12.9813 10.1897 12.3933 0 13.7863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2164 0 0 0 0 0 0 0 0 0 0 9.68235 0 0 0 0 13.9686 0 12.9966 0 0 0 0 9.85336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4513 0 0 0 13.4286 0 0 0 0 15.8307 16.5748 0 12.7849 0 13.8119 12.5849 0 0 0 0 0 0 0 0 0 12.6572 0 0 0 0 0 0 12.6342 12.8906 0 10.0272 0 0 12.5533 0 0 0 0 0 13.0407 13.3444 0 12.8995 0 12.9033 13.1191 13.9712 13.8519 0 14.9027 0 14.836 14.3556 0 0 0 14.8922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8679 15.7267 14.8612 15.5339 15.3695 15.056 15.3819 0 15.1771 0 0 15.6544 0 15.6693 0 0 0 0 0 0 12.3242 14.3053 0 Q9BSJ8 ESYT1_HUMAN "Extended synaptotagmin-1, E-Syt1 (Membrane-bound C2 domain-containing protein)" ESYT1 FAM62A KIAA0747 MBC2 Homo sapiens (Human) endoplasmic reticulum-plasma membrane tethering [GO:0061817]; intermembrane lipid transfer [GO:0120009] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of endoplasmic reticulum membrane [GO:0030176]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; phospholipid transfer activity [GO:0120014]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; intermembrane lipid transfer [GO:0120009] GO:0005509; GO:0005544; GO:0005783; GO:0005789; GO:0008429; GO:0016020; GO:0030176; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0061817; GO:0120009; GO:0120014 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; phospholipid transfer activity [GO:0120014] GLIEGKSDPYALVRLGTQTFCSR 0.99242 -25.652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3093 0 0 0 0 13.9672 0 0 0 12.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0757 0 0 13.5454 0 0 0 0 0 0 0 0 0 15.3588 0 0 11.3774 0 0 15.0637 0 13.3216 0 0 13.3015 0 0 13.8828 0 0 0 0 0 0 0 0 0 0 13.1928 0 0 0 0 15.8526 15.971 0 0 0 0 0 0 10.0803 0 15.0716 0 12.3214 0 14.2831 13.0756 0 0 0 0 0 15.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1397 0 0 11.0256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1893 0 0 0 0 0 0 0 0 Q9H7P9 PKHG2_HUMAN "Pleckstrin homology domain-containing family G member 2, PH domain-containing family G member 2" PLEKHG2 Homo sapiens (Human) regulation of actin filament polymerization [GO:0030833] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of actin filament polymerization [GO:0030833] GO:0005085; GO:0005829; GO:0030833 guanyl-nucleotide exchange factor activity [GO:0005085] DSSEEEEEEEEGLEMDER 0.99242 -17.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2869 0 0 0 0 0 0 18.3392 0 0 0 10.2456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1249 0 0 0 0 0 0 19.566 19.5814 0 19.6983 0 0 0 19.3132 15.6008 0 0 17.703 18.3179 17.3687 19.6827 18.8705 11.6096 0 0 13.2188 0 12.4613 0 0 13.7418 14.951 13.856 0 0 0 17.2846 0 15.4568 15.4332 0 0 0 14.0256 13.8653 14.0203 13.6907 0 0 0 0 0 13.0015 0 0 14.8991 0 0 0 13.0526 0 0 13.7124 0 13.8939 0 0 0 0 0 0 0 0 0 0 0 0 14.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8019 0 0 0 0 12.6001 0 0 Q9HCM3 K1549_HUMAN UPF0606 protein KIAA1549 KIAA1549 Homo sapiens (Human) integral component of membrane [GO:0016021]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] GO:0005886; GO:0016021; GO:0032391 AVQEYIITAIKEVLRIHFNR 0.99242 -17.059 0 11.8661 0 0 10.6452 0 0 0 0 0 0 0 0 0 0 11.4534 0 0 0 13.2244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9786 0 0 11.6134 17.4212 0 0 0 0 0 0 0 0 0 0 12.3742 0 12.631 17.4078 0 13.6237 11.9016 0 0 0 0 11.805 0 0 0 0 13.7713 13.8819 14.7151 0 0 0 0 0 0 13.6917 0 0 0 0 14.0403 0 14.4065 0 14.0344 14.7516 0 0 0 0 14.0712 0 13.7558 0 17.4154 13.8653 0 0 0 17.1064 0 0 14.7398 0 0 12.2177 0 0 0 0 0 0 0 0 14.5288 15.6481 0 0 13.5772 0 14.9694 0 12.5064 0 0 0 0 13.6555 0 11.6854 0 0 0 0 0 13.0588 0 0 13.3803 12.4668 0 0 0 0 13.345 0 Q9NRF9 DPOE3_HUMAN "DNA polymerase epsilon subunit 3 (Arsenic-transactivated protein, AsTP) (Chromatin accessibility complex 17 kDa protein, CHRAC-17, HuCHRAC17) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17)" POLE3 CHRAC17 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; heterochromatin assembly [GO:0031507]; histone H3 acetylation [GO:0043966]; leading strand elongation [GO:0006272]; nucleosome assembly [GO:0006334]; regulation of DNA replication [GO:0006275] ATAC complex [GO:0140672]; CHRAC [GO:0008623]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATAC complex [GO:0140672]; CHRAC [GO:0008623]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; heterochromatin assembly [GO:0031507]; histone H3 acetylation [GO:0043966]; leading strand elongation [GO:0006272]; nucleosome assembly [GO:0006334]; regulation of DNA replication [GO:0006275] GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006272; GO:0006275; GO:0006334; GO:0006338; GO:0006974; GO:0008622; GO:0008623; GO:0031490; GO:0031507; GO:0043966; GO:0046982; GO:0140672 chromatin DNA binding [GO:0031490]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982] DEDNDEDEER 0.99242 -4.9569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5162 0 0 13.2545 0 0 0 0 0 14.2022 0 13.6365 16.1723 0 0 0 0 0 0 0 0 0 0 0 13.9386 0 0 0 0 0 13.9049 12.6851 0 14.5593 0 0 13.4405 11.8964 0 0 0 0 0 0 0 11.8516 13.7322 0 0 0 0 13.8757 14.9746 12.0981 0 0 0 0 0 0 0 0 13.2915 14.535 0 14.1163 12.3921 0 0 0 0 15.9384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1666 0 0 0 0 0 0 Q9NV39 PRR34_HUMAN Proline-rich protein 34 PRR34 C22orf26 Homo sapiens (Human) APRLPHPAARAR 0.99242 -18.375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7475 0 14.1266 14.2752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3853 0 0 14.7737 0 0 0 0 0 0 0 0 14.0214 0 0 0 14.2731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8028 0 0 0 0 0 0 0 14.9615 0 0 14.1158 0 0 0 0 0 0 0 0 0 0 0 0 13.618 0 0 0 0 0 0 0 0 0 0 13.1816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ52 GGA3_HUMAN "ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3)" GGA3 KIAA0154 Homo sapiens (Human) endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647] GO:0005764; GO:0005794; GO:0005802; GO:0006622; GO:0006886; GO:0006893; GO:0010008; GO:0030163; GO:0031267; GO:0031647; GO:0031648; GO:0031901; GO:0032456; GO:0032991; GO:0034394; GO:0035091; GO:0043001; GO:0043130; GO:0044877; GO:0045732; GO:0055038; GO:1902430 phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130] FHNEVGKFRFLNELIK 0.99242 -7.6057 0 0 0 0 0 0 0 0 0 0 0 0 11.0751 0 0 0 12.4327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 12.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.435 0 0 0 11.1741 10.8972 0 0 0 0 0 0 0 0 0 0 0 0 16.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1016 0 0 0 0 0 10.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3139 0 9.45605 0 0 0 0 0 0 0 0 0 0 13.672 0 14.2087 0 0 14.2604 0 0 0 0 0 0 0 0 15.4844 13.6119 0 0 0 0 Q9ULX5 RN112_HUMAN "RING finger protein 112, EC 2.3.2.27 (Brain finger protein) (Zinc finger protein 179)" RNF112 BFP ZNF179 Homo sapiens (Human) cell death in response to hydrogen peroxide [GO:0036474]; cell death in response to oxidative stress [GO:0036473]; embryonic brain development [GO:1990403]; endoplasmic reticulum organization [GO:0007029]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neuron differentiation [GO:0030182]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of neuron differentiation [GO:0045666]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; regulation of cell cycle [GO:0051726]; response to hydroperoxide [GO:0033194] anchoring junction [GO:0070161]; cell body [GO:0044297]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; cell body [GO:0044297]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell death in response to hydrogen peroxide [GO:0036474]; cell death in response to oxidative stress [GO:0036473]; embryonic brain development [GO:1990403]; endoplasmic reticulum organization [GO:0007029]; G1 to G0 transition involved in cell differentiation [GO:0070315]; neuron differentiation [GO:0030182]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of neuron differentiation [GO:0045666]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; regulation of cell cycle [GO:0051726]; response to hydroperoxide [GO:0033194] GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0007029; GO:0008021; GO:0008270; GO:0014069; GO:0016021; GO:0016604; GO:0019898; GO:0030182; GO:0033194; GO:0036473; GO:0036474; GO:0043005; GO:0043204; GO:0043621; GO:0044297; GO:0045666; GO:0045687; GO:0051260; GO:0051726; GO:0051865; GO:0061630; GO:0070161; GO:0070315; GO:1990403 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CQGYWNEGRAVAR 0.99242 -17.103 0 0 0 0 0 0 0 0 12.114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0131 0 0 0 0 0 12.6299 0 0 0 0 0 0 0 0 0 0 0 10.1134 0 0 0 0 0 0 0 9.90112 0 0 0 0 0 0 0 0 11.7055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6896 13.8634 14.7715 0 0 13.5116 13.8711 13.9855 0 0 13.6025 0 0 0 0 0 13.3053 13.5933 0 0 0 12.8414 0 13.3607 0 0 12.8936 0 0 0 14.1455 14.8069 0 0 0 0 0 13.0559 0 0 0 0 0 0 0 0 15.0579 13.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H5 PKHA6_HUMAN "Pleckstrin homology domain-containing family A member 6, PH domain-containing family A member 6 (Phosphoinositol 3-phosphate-binding protein 3, PEPP-3)" PLEKHA6 KIAA0969 PEPP3 Homo sapiens (Human) EQDRLVQQLR 0.99242 -24.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.344 11.2146 12.333 0 0 12.1422 0 0 0 0 12.3705 12.5735 0 0 10.2705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5563 0 13.0136 0 13.858 0 0 0 12.2896 13.5523 13.2717 14.358 0 16.4888 0 0 0 0 0 0 0 0 0 0 13.7521 0 0 0 0 0 0 0 0 0 0 0 14.5349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5816 12.1748 0 0 12.6099 0 13.4512 12.7922 0 0 13.6066 0 0 0 0 0 0 0 14.363 0 0 14.0014 0 0 0 0 14.7541 0 0 0 0 0 0 0 0 12.4343 0 0 0 12.0672 0 0 0 0 0 0 14.4251 0 0 0 Q9Y592 CEP83_HUMAN "Centrosomal protein of 83 kDa, Cep83 (Coiled-coil domain-containing protein 41) (Renal carcinoma antigen NY-REN-58)" CEP83 CCDC41 Homo sapiens (Human) cilium assembly [GO:0060271]; establishment of centrosome localization [GO:0051660]; protein localization to centrosome [GO:0071539]; vesicle docking [GO:0048278] centriole [GO:0005814]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] centriole [GO:0005814]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; establishment of centrosome localization [GO:0051660]; protein localization to centrosome [GO:0071539]; vesicle docking [GO:0048278] GO:0005794; GO:0005814; GO:0005829; GO:0042802; GO:0048278; GO:0051660; GO:0060271; GO:0071539; GO:0097539 identical protein binding [GO:0042802] AAIAQKKR 0.99242 -17.106 0 0 0 0 0 0 0 0 0 0 0 0 0 9.51757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.351 0 0 0 0 0 0 11.9539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3796 0 0 0 0 0 0 0 13.962 0 0 0 0 0 13.8587 0 0 0 0 13.035 0 0 15.5898 0 15.6547 0 0 13.5833 14.7457 0 0 0 0 0 0 0 0 13.6321 0 13.0429 0 0 0 0 10.562 0 0 13.0421 0 0 0 0 0 0 0 15.8176 0 14.7381 0 0 0 0 0 0 0 0 0 0 13.8553 0 0 13.2897 0 0 0 0 0 0 0 0 0 0 11.1747 0 0 0 0 14.5345 0 0 14.1842 0 0 13.5043 0 13.8122 0 13.2293 0 0 0 0 0 0 14.6661 0 0 Q14674 ESPL1_HUMAN "Separin, EC 3.4.22.49 (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)" ESPL1 ESP1 KIAA0165 Homo sapiens (Human) apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; catalytic activity [GO:0003824]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508] GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051307; GO:0072686 catalytic activity [GO:0003824]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] ALESGHFPQPEK 0.99243 -64.399 0 0 12.7293 0 0 0 0 0 14.3494 0 0 0 14.6111 0 0 0 0 0 0 0 0 10.6636 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3201 0 0 0 0 0 0 0 0 13.4314 11.2026 0 0 0 0 0 0 0 0 0 0 0 0 14.6099 12.3712 0 0 0 0 0 0 0 0 12.3339 0 0 0 13.0433 13.7477 12.9903 11.8965 0 0 0 0 14.0322 0 16.2338 0 13.1678 0 0 0 12.9367 12.5362 13.9341 14.2755 12.6887 14.1293 0 0 0 0 15.4379 0 15.0782 12.9212 13.5919 13.9272 0 0 14.0375 14.8992 0 0 13.8837 13.923 14.3676 0 0 14.089 0 0 14.3586 13.2571 12.9172 15.1257 14.0291 13.3803 14.3371 0 0 0 0 14.1592 0 0 0 0 13.0208 0 0 14.7706 0 15.0599 14.5191 14.7983 16.4743 14.8612 0 14.5471 13.3918 0 0 0 0 13.8797 12.0325 15.6293 15.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3032 0 11.5434 0 0 13.0839 0 0 0 0 0 0 O43491 E41L2_HUMAN "Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1, 4.1G)" EPB41L2 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091] cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actomyosin structure organization [GO:0031032]; cell cycle [GO:0007049]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778] GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007049; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778 actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198] AAKRLWK 0.99243 -25.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5695 0 12.0685 0 0 0 0 0 0 0 0 0 0 0 0 12.0533 11.7471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1216 0 0 0 0 0 0 11.3306 0 15.239 0 15.093 0 0 15.0653 14.7415 0 0 15.4222 0 13.3464 12.9431 13.5366 0 0 0 12.374 12.1992 13.0939 12.9371 14.0263 0 0 14.6313 14.0124 0 12.2364 0 0 0 0 14.2473 0 12.3414 0 12.0506 0 12.1473 15.2832 0 0 12.583 0 0 0 0 0 0 0 0 14.182 0 14.17 0 0 0 0 0 0 0 0 0 0 0 11.5419 0 0 0 0 0 0 0 0 0 0 11.3479 13.9917 0 0 0 0 0 0 0 14.0551 0 0 0 12.5053 0 P08236 BGLR_HUMAN "Beta-glucuronidase, EC 3.2.1.31 (Beta-G1)" GUSB Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]; glycosaminoglycan catabolic process [GO:0006027] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; membrane [GO:0016020] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; carbohydrate metabolic process [GO:0005975]; glucuronoside catabolic process [GO:0019391]; glycosaminoglycan catabolic process [GO:0006027] GO:0004566; GO:0005102; GO:0005576; GO:0005615; GO:0005975; GO:0006027; GO:0016020; GO:0019391; GO:0019904; GO:0030246; GO:0035578; GO:0043202; GO:0043231; GO:0070062; GO:1904813 beta-glucuronidase activity [GO:0004566]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102] ADFSDNR 0.99243 -24.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4051 0 0 0 0 P17029 ZKSC1_HUMAN Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18) ZKSCAN1 KOX18 ZNF139 ZNF36 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AETSEDSASRGETTGR 0.99243 -18.066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9423 0 0 0 0 0 0 0 0 0 0 0 0 14.138 0 14.0025 0 14.8568 14.1159 0 14.797 0 0 13.7535 13.6084 14.8756 14.9291 14.3493 14.058 0 0 13.2112 13.5435 14.4905 0 15.1974 13.9671 0 13.4851 0 0 0 13.3742 0 14.8133 13.4289 0 0 15.2289 0 0 14.2148 14.199 0 0 0 0 0 12.9868 0 0 13.7328 0 14.0545 13.6606 0 0 0 0 0 13.4836 14.2468 0 0 0 13.9261 0 12.5046 0 0 0 0 0 0 0 14.4263 13.5812 13.3327 0 12.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35499 SCN4A_HUMAN Sodium channel protein type 4 subunit alpha (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4) SCN4A Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of skeletal muscle contraction by action potential [GO:0100001]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0006814; GO:0006936; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0086010; GO:0100001 voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] AFLLGLLHGKILSPK 0.99243 -24.863 0 14.8458 0 0 0 0 0 13.6431 0 0 14.4452 0 14.709 0 0 0 0 12.4719 0 0 0 0 0 0 0 0 0 0 13.4661 0 0 0 0 12.377 0 0 0 0 0 0 14.7443 0 0 0 0 0 0 0 13.1611 0 11.6006 0 0 0 0 11.0717 0 0 0 0 0 0 0 0 10.1101 0 0 0 14.5877 9.98982 0 0 14.1077 11.0404 12.2484 13.1714 0 0 13.5125 13.9551 14.0657 13.7276 13.7624 10.9559 13.9032 0 11.463 12.9518 13.3305 0 15.0097 0 0 13.1372 13.312 15.4909 0 12.0221 0 12.8486 0 15.7585 12.4369 12.569 12.2882 0 0 0 0 11.7556 13.0197 0 12.7803 0 14.6413 0 0 0 13.5073 13.1809 12.4368 0 15.2665 0 0 0 0 0 0 0 11.3303 0 0 0 0 0 0 0 12.6608 11.7842 0 0 0 11.3954 0 0 0 0 12.1816 11.2671 0 0 0 0 12.3382 0 0 0 0 0 0 0 0 0 0 12.8078 0 13.2263 13.2981 0 0 0 13.912 13.3845 0 0 0 0 0 0 P42658 DPP6_HUMAN "Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI, DPP VI)" DPP6 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; regulation of potassium ion transmembrane transport [GO:1901379] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; regulation of potassium ion transmembrane transport [GO:1901379] GO:0005886; GO:0006508; GO:0008076; GO:0008236; GO:0015459; GO:0016021; GO:0072659; GO:1901379 potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236] AIPQGGR 0.99243 -25.005 0 0 0 0 12.8723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9513 12.8314 0 0 0 0 0 0 0 0 10.435 0 0 0 10.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.214 0 0 0 0 0 0 10.9875 10.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9919 0 0 0 0 11.897 0 0 0 12.9644 0 0 0 0 0 16.6817 0 0 0 13.8185 0 0 12.6813 0 11.951 0 0 16.762 12.2847 13.7917 13.6085 11.412 13.5533 13.3696 0 0 0 11.0434 14.5322 0 0 0 0 16.9498 13.6324 0 16.5031 0 0 13.4457 0 0 0 12.9526 13.0288 17.1783 0 13.5528 12.3845 0 0 0 10.3057 0 0 0 0 0 0 0 0 14.6445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6382 0 0 0 0 0 0 0 P49863 GRAK_HUMAN "Granzyme K, EC 3.4.21.- (Fragmentin-3) (Granzyme-3) (NK-tryptase-2, NK-Tryp-2)" GZMK TRYP2 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0006508; GO:0008236 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] MLHIRSK 0.99243 -7.1131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4525 0 0 0 0 0 0 0 0 0 0 11.699 12.2589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8845 0 0 0 0 0 0 0 0 0 16.5045 16.3571 0 16.1917 15.7318 15.7556 15.5542 15.3903 0 0 15.2639 0 0 0 0 0 0 0 15.5226 0 15.33 0 0 P62256 UBE2H_HUMAN "Ubiquitin-conjugating enzyme E2 H, EC 2.3.2.23 ((E3-independent) E2 ubiquitin-conjugating enzyme H, EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H)" UBE2H Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842] EQEEGTGDSSSESSMSDFSEDEAQDMEL 0.99243 -7.2615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13368 MPP3_HUMAN MAGUK p55 subfamily member 3 (Discs large homolog 3) (Protein MPP3) MPP3 DLG3 Homo sapiens (Human) cell-cell junction [GO:0005911]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165] GO:0005886; GO:0005911; GO:0030165 PDZ domain binding [GO:0030165] ALFHYNPR 0.99243 -17.637 0 0 0 0 0 0 0 0 11.1421 13.2982 12.5142 11.5434 0 0 0 11.2741 0 0 0 0 12.7346 13.5494 0 0 0 0 0 0 0 0 0 0 0 10.2426 0 0 0 0 0 0 11.4486 0 0 0 0 0 0 11.7841 0 0 0 12.4817 0 0 0 0 0 0 0 0 0 0 10.6418 0 0 0 0 0 0 12.6304 0 0 0 0 0 15.4927 0 0 0 0 0 13.0103 0 0 0 0 15.2136 0 0 14.2155 0 13.1252 0 0 0 0 0 13.0811 0 0 0 0 0 0 14.9303 13.2457 0 13.4959 0 13.1592 12.5481 0 0 0 0 0 0 0 14.1934 0 0 0 0 13.4085 0 13.0259 13.3622 0 0 0 0 0 0 0 0 0 13.357 0 0 0 0 0 0 0 12.3985 0 0 14.6667 0 0 0 0 0 13.5223 13.985 13.4201 0 12.8008 0 13.5136 12.693 0 14.563 13.3219 17.3188 12.8774 13.0064 12.9086 13.1392 0 0 0 0 0 0 12.8863 12.2539 12.7113 0 0 Q16363 LAMA4_HUMAN Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha) LAMA4 Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995] GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0030155; GO:0030334; GO:0045995; GO:0062023; GO:0070062; GO:0120163 extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102] AFTSLSLYMKPPVKR 0.99243 -15.001 13.2912 0 0 0 0 0 0 0 0 0 0 10.7995 0 0 0 0 10.8562 0 0 0 0 0 0 0 0 12.1456 0 0 11.7625 0 0 0 0 0 0 11.3586 0 11.7167 10.9518 0 0 0 0 0 0 12.5294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5535 0 0 0 15.0083 0 0 0 13.3711 0 15.6468 15.242 0 0 13.5613 15.1588 0 14.7938 16.3237 14.7806 14.8767 12.1901 0 13.8056 14.2604 15.2762 0 0 0 12.7489 0 0 0 0 0 13.1907 0 12.9964 16.0313 13.0881 0 14.9081 0 0 0 0 0 0 0 0 0 14.425 0 14.8357 0 0 12.6843 0 14.4969 0 0 0 0 12.7936 0 0 0 0 0 0 0 0 0 0 0 13.5612 10.207 0 13.8817 0 0 10.6325 0 0 0 14.4333 13.4799 14.4929 13.6247 12.7046 13.6174 0 13.9795 0 13.7293 0 0 13.073 0 0 0 0 0 13.8209 10.6792 13.2316 0 0 Q32MH5 F214A_HUMAN Protein FAM214A FAM214A KIAA1370 Homo sapiens (Human) DCLSTCEQPK 0.99243 -6.093 0 0 0 0 0 0 0 12.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9836 0 0 0 0 0 0 0 0 0 0 0 12.8109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1419 0 0 0 0 0 0 0 0 0 0 13.9044 0 12.1025 0 14.6761 0 0 0 12.7978 12.7101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6808 0 0 0 0 0 0 Q5SW79 CE170_HUMAN "Centrosomal protein of 170 kDa, Cep170 (KARP-1-binding protein, KARP1-binding protein)" CEP170 FAM68A KAB KIAA0470 Homo sapiens (Human) centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; spindle [GO:0005819] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; spindle [GO:0005819] GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0120103 AFKTNGK 0.99243 -40.428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6697 0 0 0 10.8603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2802 0 0 13.7872 0 0 13.0059 0 0 0 0 0 13.2021 0 0 0 0 0 0 0 12.9196 0 11.1055 0 0 0 14.0169 0 0 0 0 14.6265 0 13.1311 13.5468 12.5666 0 0 0 11.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5878 0 0 0 16.2872 0 0 0 0 0 0 0 0 11.3556 0 0 0 0 11.0425 0 0 0 0 0 0 0 Q6AHZ1 Z518A_HUMAN Zinc finger protein 518A ZNF518A KIAA0335 ZNF518 Homo sapiens (Human) chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006325; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AKFNCWFCGR 0.99243 -24.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1943 0 0 0 0 11.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3715 0 13.9603 0 0 11.6477 0 14.2698 11.9432 14.1055 0 0 10.8077 12.6922 0 0 10.8598 0 0 0 12.381 0 0 0 11.0524 0 0 12.1185 14.7475 14.2627 0 0 0 0 0 0 0 10.8833 0 12.2534 0 0 0 0 0 0 13.3236 13.9112 0 0 11.0798 12.3691 0 13.9902 12.3055 0 0 0 0 0 0 0 0 0 13.1682 0 0 10.3755 12.343 0 10.8216 13.7979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7538 13.6503 0 11.4566 0 0 13.8391 0 0 0 0 0 11.2959 0 0 0 0 0 0 14.4787 14.2379 0 11.1675 0 0 0 0 0 0 0 13.5254 0 0 0 0 11.8211 0 12.1179 11.9952 0 0 0 0 0 12.1407 0 0 13.123 10.8702 0 0 Q86U86 PB1_HUMAN "Protein polybromo-1, hPB1 (BRG1-associated factor 180, BAF180) (Polybromo-1D)" PBRM1 BAF180 PB1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000228; GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005654; GO:0006338; GO:0006357; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:2000045; GO:2000781; GO:2000819 chromatin binding [GO:0003682]; DNA binding [GO:0003677] AEYEERAAK 0.99243 -45.967 0 15.3387 0 0 0 0 0 11.1115 14.3793 0 0 0 0 0 0 0 15.1481 12.4961 0 11.7507 11.5826 14.9655 0 14.6087 12.1151 13.1646 12.1025 0 0 0 0 0 0 0 12.502 0 12.4645 0 12.9758 0 0 0 0 0 0 0 0 0 13.8541 11.8221 12.6715 12.663 12.3022 11.8251 0 9.83093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7282 13.4235 0 13.5662 0 15.18 15.0702 0 0 0 0 14.1607 0 0 0 0 13.9137 0 0 17.1634 17.309 16.253 15.9424 12.4086 16.3925 14.4383 0 0 14.9078 13.148 13.6628 13.9576 15.5508 0 0 0 0 14.7528 14.3708 0 13.6552 15.2159 13.4583 14.5058 0 15.9597 13.6291 0 16.665 16.3659 16.378 0 13.7156 0 14.0948 15.3675 15.8388 14.5139 0 0 11.051 13.9387 0 12.2603 12.9537 14.5563 0 0 0 0 0 14.1899 0 12.0968 0 14.1885 12.7243 0 0 14.145 14.7811 0 0 13.4077 0 13.0012 0 13.4005 11.8794 0 12.7097 0 0 0 0 0 0 12.0891 12.5763 12.8617 11.8507 12.6211 12.112 0 11.7837 Q8IVH8 M4K3_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 3, EC 2.7.11.1 (Germinal center kinase-related protein kinase, GLK) (MAPK/ERK kinase kinase kinase 3, MEK kinase kinase 3, MEKKK 3)" MAP4K3 RAB8IPL1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411] GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0007254; GO:0008349; GO:0009411; GO:0034612; GO:0035556; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AKIPPPLPPKPK 0.99243 -24.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4037 0 14.7265 0 14.9533 0 0 0 0 0 0 10.5608 0 14.495 0 0 0 0 0 0 0 14.3912 14.6753 0 10.2671 0 0 12.103 0 0 0 18.0631 18.5476 12.9328 17.8994 17.7658 0 0 16.838 0 16.5435 15.9694 16.0935 0 17.9297 17.9544 13.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5754 12.0469 0 0 0 0 0 0 13.2467 0 0 0 13.5436 13.1179 14.4546 0 11.5684 11.0538 0 14.3542 0 0 0 0 14.5884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9668 0 0 0 0 14.9715 0 0 0 0 0 0 0 0 14.8387 0 13.2471 13.8799 0 0 0 0 10.3613 14.1429 0 Q8N684 CPSF7_HUMAN "Cleavage and polyadenylation specificity factor subunit 7 (Cleavage and polyadenylation specificity factor 59 kDa subunit, CPSF 59 kDa subunit) (Cleavage factor Im complex 59 kDa subunit, CFIm59) (Pre-mRNA cleavage factor Im 59 kDa subunit)" CPSF7 Homo sapiens (Human) messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] cytoplasm [GO:0005737]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005847; GO:0005849; GO:0016020; GO:0031124; GO:0051262; GO:0051290; GO:0098789; GO:0110104; GO:1990120 mRNA binding [GO:0003729]; RNA binding [GO:0003723] DCLHGIEAK 0.99243 -24.858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N907 DAND5_HUMAN "DAN domain family member 5 (Cerberus-like protein 2, Cerl-2) (Cysteine knot superfamily 1, BMP antagonist 3) (Gremlin-3)" DAND5 CER2 CKTSF1B3 GREM3 SP1 Homo sapiens (Human) atrial septum development [GO:0003283]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of nodal from receptor via nodal binding [GO:0038101]; signal transduction involved in regulation of gene expression [GO:0023019]; ventricular septum development [GO:0003281] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; morphogen activity [GO:0016015]; atrial septum development [GO:0003283]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of nodal from receptor via nodal binding [GO:0038101]; signal transduction involved in regulation of gene expression [GO:0023019]; ventricular septum development [GO:0003281] GO:0003140; GO:0003281; GO:0003283; GO:0005576; GO:0005615; GO:0016015; GO:0023019; GO:0030512; GO:0030514; GO:0035582; GO:0038101; GO:0061371; GO:1900108; GO:1900176 morphogen activity [GO:0016015] AFLGLQKAR 0.99243 -4.5036 0 0 0 0 0 0 0 0 0 0 0 0 10.8934 0 0 11.456 0 11.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.972 13.738 0 0 0 0 0 0 0 0 0 0 0 0 13.2354 0 0 0 0 13.1448 13.4271 0 0 0 0 0 13.8157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1315 13.8254 13.3139 0 13.5218 0 0 0 0 0 0 0 0 0 0 0 0 13.1796 0 0 0 0 0 0 0 0 0 0 13.6259 12.8121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2681 0 0 0 0 0 0 0 Q8N9U9 SPOT1_HUMAN Putative uncharacterized protein SPANXA2-OT1 SPANXA2-OT1 CXorf18 Homo sapiens (Human) MASPFGR 0.99243 -14.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.384 0 0 0 0 0 0 0 0 0 12.9912 0 0 0 0 0 0 12.8537 0 0 0 12.8457 0 0 12.9123 0 0 13.2527 13.4529 0 0 13.19 0 0 0 13.3383 0 12.8537 0 0 13.1283 0 0 0 0 0 0 0 0 0 0 0 12.9306 0 0 0 0 0 0 0 12.9647 0 0 13.2166 12.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NET8 TRPV3_HUMAN "Transient receptor potential cation channel subfamily V member 3, TrpV3 (Vanilloid receptor-like 3, VRL-3)" TRPV3 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; negative regulation of hair cycle [GO:0042636]; positive regulation of calcium ion import [GO:0090280]; response to heat [GO:0009408] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; negative regulation of hair cycle [GO:0042636]; positive regulation of calcium ion import [GO:0090280]; response to heat [GO:0009408] GO:0005216; GO:0005262; GO:0005886; GO:0005887; GO:0009408; GO:0042636; GO:0042802; GO:0043235; GO:0070588; GO:0090280; GO:0098703 calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216] ALLNINPNTKEIVRILLAFAEENDILGR 0.99243 -4.9739 0 0 0 0 0 0 0 0 0 0 13.5572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7572 0 0 12.9669 0 0 0 0 0 14.0948 0 0 0 14.102 0 0 0 0 0 0 0 0 14.6771 0 0 0 0 12.8277 12.9308 0 0 15.204 0 0 0 0 0 12.8355 0 0 0 0 11.5911 0 0 0 0 0 0 15.2271 0 0 0 0 13.6477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7306 0 0 0 0 14.4601 0 0 14.0523 14.3444 0 0 12.0303 0 0 14.6765 0 0 0 0 0 0 0 12.634 0 0 0 0 0 14.4499 0 0 0 0 0 0 0 0 0 Q8NFP0 PXT1_HUMAN Peroxisomal testis-specific protein 1 (Small testis-specific peroxisomal protein) PXT1 STEPP Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] nucleus [GO:0005634]; peroxisome [GO:0005777] nucleus [GO:0005634]; peroxisome [GO:0005777]; positive regulation of apoptotic process [GO:0043065] GO:0005634; GO:0005777; GO:0043065 EVLNPSPK 0.99243 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXF3 REL3_HUMAN "Relaxin-3 (Insulin-like peptide INSL7, Insulin-like peptide 7) (Prorelaxin H3) [Cleaved into: Relaxin-3 B chain; Relaxin-3 A chain ]" RLN3 INSL7 RXN3 ZINS4 UNQ6188/PRO20213 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179] GO:0001664; GO:0005179; GO:0005576 G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179] AAPYGVR 0.99243 -14.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RV3 PCX1_HUMAN Pecanex-like protein 1 (Pecanex homolog protein 1) PCNX1 KIAA0805 KIAA0995 PCNX PCNXL1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DEWIFADMELLRKVVVPGIR 0.99243 -25.919 0 0 0 0 0 0 0 0 0 0 0 14.5798 0 0 0 0 0 0 0 12.5904 0 0 0 0 0 0 10.9457 15.8806 0 0 0 0 0 0 0 0 13.0866 0 15.5898 0 14.7518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3408 11.0023 13.5248 0 0 9.76368 0 12.3914 0 0 0 0 0 13.5555 13.7029 13.6873 0 14.2773 0 13.761 16.6672 0 0 15.3606 0 0 0 13.5265 15.187 15.0756 0 0 0 14.2317 15.0355 14.4064 0 0 0 0 0 0 0 13.4106 13.1573 0 0 0 0 0 13.2192 13.3673 0 0 14.2251 13.3985 18.3468 12.6064 0 12.7436 10.6108 13.1573 12.4664 0 0 13.2886 0 0 0 0 13.9158 0 0 0 0 0 0 14.4033 0 0 0 13.4247 0 0 0 11.0128 0 0 0 12.7303 0 12.9514 0 0 0 0 0 0 0 0 0 13.389 0 0 0 0 0 11.5371 0 0 0 0 0 0 Q99814 EPAS1_HUMAN "Endothelial PAS domain-containing protein 1, EPAS-1 (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73, bHLHe73) (HIF-1-alpha-like factor, HLF) (Hypoxia-inducible factor 2-alpha, HIF-2-alpha, HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2)" EPAS1 BHLHE73 HIF2A MOP2 PASD2 Homo sapiens (Human) angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; epithelial cell maturation [GO:0002070]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; mRNA transcription by RNA polymerase II [GO:0042789]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; cellular response to hypoxia [GO:0071456]; embryonic placenta development [GO:0001892]; epithelial cell maturation [GO:0002070]; erythrocyte differentiation [GO:0030218]; iron ion homeostasis [GO:0055072]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; mRNA transcription by RNA polymerase II [GO:0042789]; myoblast fate commitment [GO:0048625]; norepinephrine metabolic process [GO:0042415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart rate [GO:0002027]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; surfactant homeostasis [GO:0043129]; visual perception [GO:0007601]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001228; GO:0001525; GO:0001666; GO:0001892; GO:0001974; GO:0002027; GO:0002070; GO:0003677; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0007005; GO:0007165; GO:0007601; GO:0016607; GO:0030218; GO:0030324; GO:0042415; GO:0042789; GO:0043129; GO:0043619; GO:0045944; GO:0046982; GO:0048625; GO:0055072; GO:0061629; GO:0071456; GO:0120162; GO:2000434 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]" DFFMRMKCTVTNR 0.99243 -17.646 0 0 0 0 0 0 0 0 0 13.4277 0 0 13.4519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1608 16.8595 16.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8313 0 0 0 15.0837 0 0 0 0 0 0 14.6104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.825 0 0 0 0 0 0 0 0 0 0 0 0 13.0784 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0422 0 0 0 0 0 0 0 0 11.1331 11.1857 0 12.4323 0 0 0 0 0 0 13.224 13.24 0 0 0 0 0 0 0 12.8188 0 10.916 0 0 0 0 0 0 13.4361 0 0 0 0 0 0 12.7718 Q9BR76 COR1B_HUMAN Coronin-1B (Coronin-2) CORO1B Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060] actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein localization to cell leading edge [GO:1902463]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; wound healing [GO:0042060] GO:0001725; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007015; GO:0016477; GO:0030027; GO:0030036; GO:0031252; GO:0031529; GO:0034315; GO:0034316; GO:0035767; GO:0036120; GO:0042060; GO:0042802; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071672; GO:0071933; GO:0071944; GO:0090135; GO:1902463; GO:2000394 actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802] ALRALVKEQGDR 0.99243 -4.9674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5552 0 0 0 0 0 10.3662 0 0 0 0 0 0 0 0 0 0 0 10.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8285 0 0 0 11.6092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.02 0 0 0 0 0 0 0 11.7581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.278 0 0 0 Q9BZF1 OSBL8_HUMAN "Oxysterol-binding protein-related protein 8, ORP-8, OSBP-related protein 8" OSBPL8 KIAA1451 ORP8 OSBP10 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204] cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965] cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204] GO:0001786; GO:0005548; GO:0005783; GO:0005789; GO:0005829; GO:0010891; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0016021; GO:0030336; GO:0031965; GO:0032148; GO:0032541; GO:0032934; GO:0036150; GO:0043231; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0090204; GO:0140343 cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] CWMDALELALK 0.99243 -24.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.532 0 0 12.7017 0 0 13.28 12.5711 0 12.3949 0 11.7983 12.094 15.0466 12.8854 0 0 0 0 0 14.8107 11.0574 12.6279 0 0 0 0 0 14.9592 0 0 0 0 0 0 11.8499 0 0 0 10.8568 0 0 11.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9761 0 0 11.538 0 0 0 15.6512 0 0 0 0 0 0 0 15.1794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7231 0 0 0 0 10.3879 0 13.7125 0 0 0 0 0 0 0 0 0 Q9H269 VPS16_HUMAN "Vacuolar protein sorting-associated protein 16 homolog, hVPS16" VPS16 Homo sapiens (Human) "autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]" autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037] "autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]" GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352 actin binding [GO:0003779]; actin filament binding [GO:0051015] ARAQAQKK 0.99243 -24.947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8398 0 0 0 0 11.9029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8866 0 0 16.8836 0 0 0 0 0 14.3554 0 15.1486 0 0 0 0 0 0 10.4473 0 12.8702 14.9269 14.8208 15.0008 13.3414 14.753 0 0 14.4405 0 0 0 14.5438 0 13.1628 15.0377 0 14.5018 0 0 0 14.5916 0 0 0 0 0 14.9076 0 13.0924 11.874 14.7076 14.1923 14.7945 14.7552 0 0 0 0 0 14.5066 0 0 11.6636 0 14.0083 0 0 0 0 0 0 0 0 0 0 14.5563 0 0 0 0 0 13.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1546 0 0 14.8218 Q9NYL9 TMOD3_HUMAN "Tropomodulin-3 (Ubiquitous tropomodulin, U-Tmod)" TMOD3 Homo sapiens (Human) actin filament organization [GO:0007015]; erythrocyte development [GO:0048821]; mitotic cell cycle phase transition [GO:0044772]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of mitotic cell cycle phase transition [GO:1901992] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; erythrocyte development [GO:0048821]; mitotic cell cycle phase transition [GO:0044772]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of mitotic cell cycle phase transition [GO:1901992] GO:0003779; GO:0005523; GO:0005856; GO:0005865; GO:0005912; GO:0006936; GO:0007015; GO:0030016; GO:0030239; GO:0044772; GO:0048821; GO:0051694; GO:0098641; GO:1901992 actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; tropomyosin binding [GO:0005523] AANAITKNNDLVR 0.99243 -18.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P215 POGK_HUMAN Pogo transposable element with KRAB domain POGK KIAA1513 LST003 SLTP003 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0005634; GO:0005654; GO:0006355 DNA binding [GO:0003677] CHRYGWMTEDLMQDWLEVVWRR 0.99243 -18.454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0234 0 0 14.3686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1019 0 0 0 0 0 0 0 0 0 Q9P2D3 HTR5B_HUMAN HEAT repeat-containing protein 5B HEATR5B KIAA1414 p200 p200a Homo sapiens (Human) "endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471] "clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005829; GO:0006897; GO:0008104; GO:0015031; GO:0016020; GO:0016607; GO:0030136; GO:0030139; GO:0042147; GO:0043231; GO:0048471 AHGAHLK 0.99243 -14.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0264 0 0 0 0 0 0 0 0 13.1001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0868 0 13.8333 0 13.0571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60218 0 0 0 0 0 0 0 12.7675 0 12.9771 11.193 13.6793 13.7432 9.90829 11.0362 0 0 0 15.0555 0 0 0 0 13.1851 0 0 0 0 0 14.2758 0 0 0 0 0 0 0 0 10.014 13.4367 0 0 0 14.7932 11.4448 0 0 0 14.1551 0 0 14.6179 15.3893 0 0 14.9706 18.4357 0 0 0 9.77569 13.2067 0 0 0 0 0 0 0 13.7035 0 0 0 0 14.2162 0 0 0 13.3082 0 0 13.2361 0 0 0 12.964 0 0 0 0 0 0 0 0 0 12.2247 0 0 14.1195 0 0 0 0 0 0 0 11.7454 13.65 0 0 0 14.4962 0 Q9UG63 ABCF2_HUMAN ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2) ABCF2 HUSSY-18 Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020]; ATP binding [GO:0005524] GO:0005524; GO:0016020 ATP binding [GO:0005524] AMLEKEAER 0.99243 -7.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3977 11.8815 0 12.8248 0 0 18.0703 0 0 0 0 14.7014 0 0 0 0 0 0 0 0 0 17.3576 0 0 0 14.255 0 0 14.7588 0 0 0 0 11.2944 0 0 0 0 0 0 0 0 0 15.4445 0 14.0803 0 13.7508 0 12.24 0 0 0 0 0 14.5442 14.3194 14.7801 0 0 0 0 0 0 0 14.9026 12.3525 0 14.9333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9606 0 0 0 0 0 0 14.1075 Q9Y3A5 SBDS_HUMAN Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein) SBDS CGI-97 Homo sapiens (Human) bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364] GO:0000922; GO:0001833; GO:0002244; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539 microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] DIHYSVK 0.99243 -15.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5217 0 0 0 0 15.5877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6013 0 0 0 0 0 0 0 0 0 0 Q9Y566 SHAN1_HUMAN "SH3 and multiple ankyrin repeat domains protein 1, Shank1 (Somatostatin receptor-interacting protein, SSTR-interacting protein, SSTRIP)" SHANK1 Homo sapiens (Human) adult behavior [GO:0030534]; associative learning [GO:0008306]; dendritic spine morphogenesis [GO:0060997]; determination of affect [GO:0050894]; habituation [GO:0046959]; long-term memory [GO:0007616]; negative regulation of actin filament bundle assembly [GO:0032232]; neuromuscular process controlling balance [GO:0050885]; olfactory behavior [GO:0042048]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; regulation of AMPA receptor activity [GO:2000311]; righting reflex [GO:0060013]; social behavior [GO:0035176]; synapse maturation [GO:0060074]; vocalization behavior [GO:0071625] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; ankyrin repeat binding [GO:0071532]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; somatostatin receptor binding [GO:0031877]; synaptic receptor adaptor activity [GO:0030160]; adult behavior [GO:0030534]; associative learning [GO:0008306]; dendritic spine morphogenesis [GO:0060997]; determination of affect [GO:0050894]; habituation [GO:0046959]; long-term memory [GO:0007616]; negative regulation of actin filament bundle assembly [GO:0032232]; neuromuscular process controlling balance [GO:0050885]; olfactory behavior [GO:0042048]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; regulation of AMPA receptor activity [GO:2000311]; righting reflex [GO:0060013]; social behavior [GO:0035176]; synapse maturation [GO:0060074]; vocalization behavior [GO:0071625] GO:0005829; GO:0005886; GO:0007616; GO:0008022; GO:0008306; GO:0014069; GO:0016020; GO:0017124; GO:0030160; GO:0030425; GO:0030534; GO:0031877; GO:0032232; GO:0035176; GO:0035255; GO:0035418; GO:0042048; GO:0042802; GO:0043005; GO:0043197; GO:0044877; GO:0045211; GO:0046959; GO:0050885; GO:0050894; GO:0060013; GO:0060074; GO:0060076; GO:0060997; GO:0060999; GO:0065003; GO:0070161; GO:0071532; GO:0071625; GO:0097110; GO:0098685; GO:0098978; GO:2000311; GO:2000463 ankyrin repeat binding [GO:0071532]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; somatostatin receptor binding [GO:0031877]; synaptic receptor adaptor activity [GO:0030160] ALDPASPLGLALAAR 0.99243 -7.618 0 10.3147 0 9.79818 15.2539 15.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8761 0 0 0 0 0 0 0 0 0 0 13.8655 0 0 0 0 0 11.4451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4328 0 0 0 0 0 0 0 0 0 0 0 0 14.6361 0 14.6838 0 14.3578 0 14.4874 0 13.0462 0 0 0 0 0 0 0 0 0 0 0 0 12.2034 0 19.761 0 0 0 0 0 0 0 0 0 0 0 0 15.6243 15.2891 0 0 0 0 0 0 0 0 0 13.1228 0 0 0 0 14.4664 0 0 0 0 0 0 0 17.7274 0 15.5226 0 0 0 12.682 14.8226 0 14.4585 15.5057 0 0 0 14.2108 0 0 14.2577 14.4006 0 0 0 0 0 0 0 0 15.0657 14.3025 0 0 0 12.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2271 0 0 17.5238 0 Q9H7N4 SFR19_HUMAN "Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1, SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor, SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1, SR-A1)" SCAF1 SFRS19 SRA1 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366] GO:0003723; GO:0005634; GO:0006366; GO:0006397; GO:0008380; GO:0019904; GO:0099122 protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122] AAPGSTK 0.99244 -46.831 0 0 0 0 11.4651 0 0 0 0 13.2072 0 13.2535 12.5917 0 14.6596 0 14.5007 14.5525 0 13.7451 14.8612 13.4585 13.9922 0 0 15.1064 14.92 14.2912 11.6356 0 12.0631 0 0 9.9088 13.6841 0 0 11.8781 0 0 0 0 12.0941 12.3513 12.0521 13.6224 12.367 15.0391 12.5239 12.5867 13.7256 12.8694 13.6973 12.1214 0 14.3752 13.3892 14.1124 13.7239 0 12.939 13.5813 0 0 0 12.6218 0 0 0 0 13.2064 13.6466 0 0 0 0 14.5616 15.0975 15.202 15.7642 14.7995 0 0 0 13.9415 0 0 0 0 0 13.2022 0 13.0018 0 15.0071 13.5151 0 13.0349 0 14.2441 0 14.9069 15.6629 0 0 12.4454 15.2438 15.4219 14.4853 14.8042 12.8141 0 13.6101 17.1511 13.0272 14.4914 13.3641 14.5275 0 15.8373 14.4484 0 14.166 17.6152 14.7164 14.4462 0 0 14.4703 14.9189 14.0771 15.2225 16.16 14.7216 14.6117 15.5313 15.1246 14.7405 14.5594 14.9238 0 14.6421 14.3527 0 14.3621 0 14.6976 12.6871 15.3432 13.1882 16.2628 14.464 0 14.4519 14.6241 14.5812 14.756 0 0 0 0 0 0 0 13.772 14.6744 0 0 14.5468 0 14.5983 14.9472 12.5224 17.4854 15.7145 14.6501 0 0 15.535 0 O75569 PRKRA_HUMAN "Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)" PRKRA PACT RAX HSD-14 HSD14 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; immune response [GO:0006955]; middle ear morphogenesis [GO:0042474]; miRNA processing [GO:0035196]; negative regulation of cell population proliferation [GO:0008285]; outer ear morphogenesis [GO:0042473]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; pre-miRNA processing [GO:0031054]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of production of small RNA involved in gene silencing by RNA [GO:0070920]; response to virus [GO:0009615]; siRNA processing [GO:0030422]; skeletal system morphogenesis [GO:0048705] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; cellular response to oxidative stress [GO:0034599]; immune response [GO:0006955]; middle ear morphogenesis [GO:0042474]; miRNA processing [GO:0035196]; negative regulation of cell population proliferation [GO:0008285]; outer ear morphogenesis [GO:0042473]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; pre-miRNA processing [GO:0031054]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of production of small RNA involved in gene silencing by RNA [GO:0070920]; response to virus [GO:0009615]; siRNA processing [GO:0030422]; skeletal system morphogenesis [GO:0048705] GO:0003723; GO:0003725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008047; GO:0008285; GO:0009615; GO:0016020; GO:0016442; GO:0019899; GO:0030422; GO:0031054; GO:0034599; GO:0035196; GO:0035197; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0048471; GO:0048705; GO:0050821; GO:0070578; GO:0070883; GO:0070920; GO:2001244 double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; siRNA binding [GO:0035197] AEAPPLER 0.99244 -4.9932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2248 0 0 0 0 0 0 0 0 0 0 12.1465 0 0 0 0 0 0 0 0 0 10.1299 0 0 0 0 0 18.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5561 14.4659 0 14.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7M7 ACSM4_HUMAN "Acyl-coenzyme A synthetase ACSM4, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 4)" ACSM4 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633] GO:0004321; GO:0005524; GO:0005759; GO:0006633; GO:0006637; GO:0015645; GO:0046872; GO:0047760; GO:0102391 ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872] AFVVLAAPFK 0.99244 -18.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6538 13.5063 0 0 0 0 0 0 0 0 14.1459 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1243 0 14.4511 0 12.8487 0 0 0 0 0 0 0 0 0 18.1891 13.1521 0 0 0 17.1901 0 0 0 13.4067 0 0 0 0 12.5236 13.5406 0 0 0 0 0 0 0 0 0 0 0 14.3405 0 0 13.1103 0 0 0 13.4426 0 0 0 0 0 0 13.961 0 13.8071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14653 HXB1_HUMAN Homeobox protein Hox-B1 (Homeobox protein Hox-2I) HOXB1 HOX2I Homo sapiens (Human) "anatomical structure formation involved in morphogenesis [GO:0048646]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; facial nerve structural organization [GO:0021612]; facial nucleus development [GO:0021754]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhombomere 4 development [GO:0021570]; rhombomere 5 development [GO:0021571]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure formation involved in morphogenesis [GO:0048646]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; facial nerve structural organization [GO:0021612]; facial nucleus development [GO:0021754]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhombomere 4 development [GO:0021570]; rhombomere 5 development [GO:0021571]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007389; GO:0009952; GO:0019904; GO:0021570; GO:0021571; GO:0021612; GO:0021754; GO:0045944; GO:0048646; GO:0048704; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ARRVEIAATLELNETQVK 0.99244 -4.9916 0 0 0 0 0 0 0 0 0 0 13.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2177 0 13.9515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4828 0 0 0 0 0 12.6823 0 0 0 12.5191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6913 0 12.8414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24386 RAE1_HUMAN "Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein) (Rab escort protein 1, REP-1) (TCD protein)" CHM REP1 TCD Homo sapiens (Human) protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601] GO:0004663; GO:0005092; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005968; GO:0006612; GO:0007264; GO:0007601; GO:0016192; GO:0018344; GO:0031267 GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267] ENHCDDK 0.99244 -15.032 0 0 0 0 0 0 0 0 0 0 10.7995 0 0 0 11.5869 0 0 0 0 0 0 0 0 11.5292 0 0 0 0 0 0 0 0 11.9528 0 0 0 10.2698 0 0 0 0 0 11.1438 0 0 0 0 0 0 0 0 0 0 0 10.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0307 0 0 0 0 0 0 0 0 0 12.8299 0 0 0 0 0 0 0 0 12.9425 0 0 0 0 0 0 0 0 12.4109 0 0 0 0 0 11.7775 0 0 0 0 11.6093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4404 0 12.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2809 0 0 0 0 0 0 0 11.1537 0 0 12.8948 0 0 P48167 GLRB_HUMAN Glycine receptor subunit beta (Glycine receptor 58 kDa subunit) GLRB Homo sapiens (Human) "acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]" anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acrosome reaction [GO:0007340]; adult walking behavior [GO:0007628]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid receptor clustering [GO:0097112]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; righting reflex [GO:0060013]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic transmission, glycinergic [GO:0060012]; visual perception [GO:0007601]" GO:0001964; GO:0004888; GO:0005231; GO:0005737; GO:0005886; GO:0005887; GO:0006811; GO:0007165; GO:0007218; GO:0007268; GO:0007340; GO:0007399; GO:0007601; GO:0007628; GO:0016594; GO:0016933; GO:0016934; GO:0016935; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0044877; GO:0045202; GO:0045211; GO:0050877; GO:0060012; GO:0060013; GO:0070161; GO:0097112; GO:0098690; GO:0098982; GO:1902476; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ALDVWLIACLLFGFASLVEYAVVQVMLNNPKR 0.99244 -17.673 0 0 0 0 0 0 0 0 12.0117 0 11.624 0 12.0893 0 0 0 0 0 0 0 0 0 0 0 0 11.3878 11.8309 0 11.673 11.3546 0 0 0 0 0 0 0 0 0 0 0 11.2982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.765 0 0 0 0 0 0 0 12.8307 0 0 0 0 0 13.2132 0 0 13.4666 0 0 0 0 0 0 0 0 0 0 0 0 13.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0708 0 0 0 0 0 11.5107 0 0 0 12.9867 0 0 12.8491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5117 0 0 0 0 0 0 0 0 0 0 12.676 0 0 0 0 0 0 14.1713 0 0 P53779 MK10_HUMAN "Mitogen-activated protein kinase 10, MAP kinase 10, MAPK 10, EC 2.7.11.24 (MAP kinase p49 3F12) (Stress-activated protein kinase 1b, SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3)" MAPK10 JNK3 JNK3A PRKM10 SAPK1B Homo sapiens (Human) cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; response to light stimulus [GO:0009416]; rhythmic process [GO:0048511]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; response to light stimulus [GO:0009416]; rhythmic process [GO:0048511]; signal transduction [GO:0007165] GO:0004674; GO:0004705; GO:0004707; GO:0004708; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007254; GO:0009416; GO:0035556; GO:0038095; GO:0042752; GO:0048511; GO:0051090; GO:0090398; GO:0106310 ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AYRELVLMK 0.99244 -17.712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8843 0 0 0 13.4592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0826 0 0 0 0 0 12.3712 0 0 0 0 0 0 0 12.8669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8248 13.8988 0 0 12.8069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0758 0 0 0 0 13.0648 0 0 0 0 0 Q01543 FLI1_HUMAN Friend leukemia integration 1 transcription factor (Proto-oncogene Fli-1) (Transcription factor ERGB) FLI1 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; hemostasis [GO:0007599]; megakaryocyte development [GO:0035855]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; animal organ morphogenesis [GO:0009887]; blood circulation [GO:0008015]; cell differentiation [GO:0030154]; hemostasis [GO:0007599]; megakaryocyte development [GO:0035855]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007599; GO:0008015; GO:0009887; GO:0016604; GO:0030154; GO:0035855; GO:0045893; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ADMTASGSPDYGQPHK 0.99244 -4.9881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0831 0 0 11.6667 0 0 0 0 0 0 12.7202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1133 0 0 0 0 0 0 0 0 0 0 0 15.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3498 0 0 0 0 0 0 0 0 0 0 13.3198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2536 0 0 0 0 0 0 0 0 0 13.1733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2859 12.4959 0 0 0 0 0 0 0 Q02224 CENPE_HUMAN "Centromere-associated protein E (Centromere protein E, CENP-E) (Kinesin-7) (Kinesin-related protein CENPE)" CENPE Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071] "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase plate congression [GO:0051310]; microtubule plus-end directed mitotic chromosome migration [GO:0099606]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of protein kinase activity [GO:0045860]; regulation of mitotic metaphase/anaphase transition [GO:0030071]" GO:0000278; GO:0000775; GO:0000776; GO:0000779; GO:0003777; GO:0005524; GO:0005634; GO:0005694; GO:0005828; GO:0005829; GO:0005874; GO:0007018; GO:0007052; GO:0007059; GO:0007079; GO:0007080; GO:0008017; GO:0008574; GO:0015630; GO:0016020; GO:0030071; GO:0030496; GO:0043231; GO:0043515; GO:0045171; GO:0045860; GO:0051233; GO:0051301; GO:0051310; GO:0051315; GO:0051382; GO:0072686; GO:0099606; GO:0099607; GO:1990023 ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] ALILKSEHIRLEK 0.99244 -82.717 14.18 0 0 0 0 0 0 0 0 12.7872 0 14.8032 0 15.9639 14.5188 0 11.5872 0 0 0 16.8188 0 0 13.553 0 0 0 0 11.5179 0 0 0 0 0 14.2412 14.0412 0 0 0 0 13.5854 0 0 0 0 0 0 0 0 0 0 10.4781 0 0 0 0 0 0 11.3839 0 0 0 0 0 0 0 13.2791 11.0019 12.3086 0 0 0 12.9582 16.2961 0 12.1019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9345 0 15.452 16.1362 0 18.8721 0 0 0 0 0 15.53 15.8538 0 0 0 0 10.63 0 0 0 0 0 12.9638 11.5162 0 0 0 13.6633 0 0 0 13.9441 13.0806 0 0 12.4737 13.4504 0 0 0 0 0 0 0 0 14.8915 0 11.9246 13.1789 11.1465 12.795 0 0 0 0 12.9432 0 0 0 0 15.9705 16.1987 0 15.4808 0 13.9735 14.2756 0 15.8733 18.4736 20.1094 14.9564 0 0 0 0 15.7569 0 0 0 0 0 0 13.6989 16.1146 0 0 Q12774 ARHG5_HUMAN Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM) ARHGEF5 TIM Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular signal transduction [GO:0035556]; myeloid dendritic cell chemotaxis [GO:0002408]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein import [GO:1904591]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] anchoring junction [GO:0070161]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102] anchoring junction [GO:0070161]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; hematopoietic stem cell homeostasis [GO:0061484]; intracellular signal transduction [GO:0035556]; myeloid dendritic cell chemotaxis [GO:0002408]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein import [GO:1904591]; positive regulation of stress fiber assembly [GO:0051496]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0002102; GO:0002408; GO:0005085; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008289; GO:0030036; GO:0032956; GO:0035556; GO:0042995; GO:0043087; GO:0043507; GO:0051056; GO:0051091; GO:0051493; GO:0051496; GO:0061484; GO:0070161; GO:0071803; GO:0071944; GO:0090630; GO:1904591 GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289] DCNNNVQSMR 0.99244 -17.653 0 10.2732 0 0 0 0 0 11.6594 13.6924 11.8477 0 0 12.8319 13.3549 0 0 11.7432 0 0 11.9589 0 0 0 0 12.6059 0 0 0 0 0 0 0 0 0 0 0 13.0663 0 12.3767 13.7474 12.8871 0 13.3295 0 0 0 0 0 11.0781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0255 0 13.2229 13.5231 0 0 0 0 0 13.9375 12.167 13.9434 11.1579 0 0 0 0 16.1236 0 0 0 16.3849 0 13.5327 13.8693 0 0 13.3009 14.3397 17.2898 0 17.7263 17.9424 17.2154 13.8438 16.6051 12.6573 0 0 0 0 0 16.6587 0 16.1731 0 0 11.5968 0 0 0 13.7389 0 0 0 0 0 11.687 14.6689 14.6762 0 0 13.8322 0 0 0 0 13.8781 0 0 0 0 0 13.5465 0 0 0 0 11.0792 14.7825 14.4602 0 0 12.4718 0 14.6145 14.5986 13.4659 0 12.2038 12.1959 0 16.0212 12.9427 0 0 0 0 12.659 13.7232 0 13.8296 0 13.7116 12.311 0 13.5434 12.7314 0 13.4027 0 0 0 0 0 Q16719 KYNU_HUMAN "Kynureninase, EC 3.7.1.3 (L-kynurenine hydrolase)" KYNU Homo sapiens (Human) 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; NAD biosynthetic process [GO:0009435]; quinolinate biosynthetic process [GO:0019805]; response to interferon-gamma [GO:0034341]; response to vitamin B6 [GO:0034516]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441] GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006569; GO:0009435; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034341; GO:0034354; GO:0034516; GO:0042803; GO:0043420; GO:0061981; GO:0097053 3-hydroxykynureninase activity [GO:0061981]; kynureninase activity [GO:0030429]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] GVVCDKR 0.99244 -18.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3197 0 0 13.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.936 0 13.2469 12.5752 0 0 0 0 0 0 0 0 0 12.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.867 0 0 0 0 0 0 13.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8392 12.4376 0 0 0 0 0 12.8479 12.3565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9385 0 0 0 0 0 0 0 12.5773 0 0 0 0 0 0 Q58FF6 H90B4_HUMAN Putative heat shock protein HSP 90-beta 4 HSP90AB4P Homo sapiens (Human) cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0005524; GO:0005829; GO:0005886; GO:0006457; GO:0016887; GO:0019899; GO:0032991; GO:0034605; GO:0048471; GO:0050821; GO:0051082; GO:0097718 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; unfolded protein binding [GO:0051082] EISDDEEEK 0.99244 -17.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0122 0 0 0 0 12.2508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P656 CF161_HUMAN Cilia- and flagella-associated protein 161 CFAP161 C15orf26 Homo sapiens (Human) cilium assembly [GO:0060271] axonemal microtubule [GO:0005879]; motile cilium [GO:0031514] axonemal microtubule [GO:0005879]; motile cilium [GO:0031514]; cilium assembly [GO:0060271] GO:0005879; GO:0031514; GO:0060271 ILINHCHTNR 0.99244 -6.1171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4677 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P9A1 ZN530_HUMAN Zinc finger protein 530 ZNF530 KIAA1508 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HLRVPTGR 0.99244 -18.076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6712 16.7849 0 0 0 0 0 0 0 0 16.8574 17.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1983 16.8127 0 0 0 17.0118 0 17.0804 10.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6271 0 0 13.9935 0 15.2273 0 0 0 0 0 0 0 0 13.2817 0 0 0 0 0 0 0 0 0 0 17.3563 0 0 0 0 0 0 0 0 0 0 11.422 0 0 14.0988 0 11.0593 0 0 0 17.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3848 0 0 0 0 0 0 12.6353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5807 0 13.8201 0 0 11.7888 0 Q6TFL4 KLH24_HUMAN "Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6, KRIP6) (Protein DRE1)" KLHL24 DRE1 Homo sapiens (Human) intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204] adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312] GO:0005737; GO:0005912; GO:0016567; GO:0030057; GO:0030424; GO:0031463; GO:0043204; GO:0045109; GO:0051865; GO:2000312 FADTHSLKTLFTK 0.99244 -17.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.943 0 0 0 0 9.31309 0 0 0 0 0 0 10.5884 0 0 0 0 0 0 0 11.5291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6689 0 14.9789 0 0 0 0 0 0 0 12.8376 0 13.0992 0 0 10.7546 12.0189 0 0 0 0 0 0 13.8686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6489 0 0 0 0 0 0 0 13.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8768 0 14.8629 0 0 0 0 0 0 0 0 0 0 11.3613 0 0 0 0 0 0 14.5379 0 0 0 0 0 0 Q6YHU6 THADA_HUMAN Thyroid adenoma-associated protein (Gene inducing thyroid adenomas protein) THADA GITA KIAA1767 Homo sapiens (Human) adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554] cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488] GO:0030488; GO:0032471; GO:0055088; GO:0098554; GO:1901895; GO:1990845 CGHSPVYHSR 0.99244 -18.093 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5432 0 0 0 0 0 0 0 0 0 0 0 11.2433 0 0 0 11.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4142 0 0 0 0 0 0 0 0 0 0 0 13.2107 12.8695 0 0 0 0 0 0 13.3012 0 14.5889 13.6399 14.4668 14.8681 0 13.6274 13.94 12.7719 14.4411 14.7601 13.0373 0 14.3091 13.5441 13.4204 0 13.2754 14.7811 15.3469 13.9481 13.2545 15.074 0 11.887 12.9718 0 0 15.0615 0 0 12.6317 14.5048 13.9974 13.7276 14.2804 0 14.6049 14.272 13.5631 0 0 14.1167 0 13.9262 12.7168 10.918 0 13.2095 0 0 0 0 13.6442 15.1053 15.0856 0 12.6915 13.0075 0 12.9838 13.282 0 0 0 12.0384 14.8197 12.4891 14.1618 0 14.5736 14.7057 0 0 13.5943 0 0 0 0 14.5471 0 0 11.9037 0 0 0 0 0 0 13.6818 0 0 12.6891 12.7215 0 16.9399 0 13.6656 0 13.319 0 0 0 0 0 Q86YC3 LRC33_HUMAN Transforming growth factor beta activator LRRC33 (Leucine-rich repeat-containing protein 33) (Negative regulator of reactive oxygen species) NRROS LRRC33 UNQ3030/PRO9833 Homo sapiens (Human) immune response [GO:0006955]; inflammatory response [GO:0006954]; microglia development [GO:0014005]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; superoxide metabolic process [GO:0006801]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 activation [GO:0036364] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transforming growth factor beta binding [GO:0050431]; immune response [GO:0006955]; inflammatory response [GO:0006954]; microglia development [GO:0014005]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; superoxide metabolic process [GO:0006801]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta1 activation [GO:0036364] GO:0005576; GO:0005783; GO:0005789; GO:0005886; GO:0006801; GO:0006954; GO:0006955; GO:0007179; GO:0009986; GO:0014005; GO:0016021; GO:0035583; GO:0036364; GO:0050431 transforming growth factor beta binding [GO:0050431] KPLLQVIK 0.99244 -4.9896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5389 0 0 0 0 0 0 0 12.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1429 13.0945 13.0026 13.0282 0 0 0 11.7547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7875 0 0 0 0 0 0 11.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW35 CEP97_HUMAN "Centrosomal protein of 97 kDa, Cep97 (Leucine-rich repeat and IQ domain-containing protein 2)" CEP97 LRRIQ2 Homo sapiens (Human) cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; calmodulin binding [GO:0005516]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673] GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0030030; GO:0032991; GO:1901673; GO:1902018 calmodulin binding [GO:0005516] DVRYEIRLR 0.99244 -15.051 0 0 0 0 0 13.8328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8386 0 0 0 0 0 0 0 0 0 0 0 0 14.1045 0 13.8885 0 14.5072 0 0 13.7927 0 0 0 0 13.7008 0 0 13.5632 0 0 0 0 0 0 0 0 0 0 0 12.9134 0 0 0 0 0 0 15.0075 15.0463 13.8252 14.568 0 0 14.0697 13.9012 14.2495 0 0 11.3863 0 0 0 13.5341 14.3895 0 0 0 0 15.0813 0 0 0 14.8907 0 0 0 0 15.7702 0 0 0 13.5111 0 13.141 0 0 0 0 0 14.3029 12.0469 0 Q8N2E2 VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein VWDE Homo sapiens (Human) anatomical structure development [GO:0048856] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856] GO:0005102; GO:0005576; GO:0009986; GO:0048856 signaling receptor binding [GO:0005102] CETMVCNR 0.99244 -25.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.18 0 0 0 0 13.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3513 10.271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4949 0 0 0 0 0 0 0 0 0 0 0 16.4521 0 0 0 0 0 0 0 0 0 15.1766 15.0054 0 0 10.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5858 0 0 0 0 0 0 15.2074 0 0 0 12.2945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91453 0 0 0 11.9007 0 0 0 0 0 0 0 0 13.4751 0 0 0 0 0 0 0 0 0 13.6574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDM7 CFA43_HUMAN Cilia- and flagella-associated protein 43 (WD repeat-containing protein 96) CFAP43 C10orf79 WDR96 Homo sapiens (Human) brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576] 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; mucociliary clearance [GO:0120197]; regulation of cilium beat frequency [GO:0003356]; sperm axoneme assembly [GO:0007288] GO:0003356; GO:0005576; GO:0005930; GO:0007288; GO:0007420; GO:0051649; GO:0060271; GO:0090660; GO:0097729; GO:0120197 ARTVEELK 0.99244 -25.186 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0767 14.2481 0 0 13.6769 13.5833 13.0198 10.6013 13.6058 0 0 0 15.8092 11.9814 10.4932 0 0 0 0 0 0 0 12.309 0 0 0 12.77 0 0 0 0 0 0 17.9087 12.8048 12.2952 12.8254 0 0 0 12.5404 0 0 11.4126 0 17.2563 0 0 13.2897 12.671 0 0 0 16.8286 13.2443 13.7767 16.437 13.4114 0 0 0 0 0 0 0 0 16.0933 17.4925 0 0 0 0 16.0491 17.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.071 12.6097 0 0 0 13.4103 0 0 0 Q9BX40 LS14B_HUMAN "Protein LSM14 homolog B (RNA-associated protein 55B, hRAP55B)" LSM14B C20orf40 FAM61B RAP55B Homo sapiens (Human) regulation of translation [GO:0006417] mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of translation [GO:0006417] GO:0003723; GO:0003729; GO:0006417 mRNA binding [GO:0003729]; RNA binding [GO:0003723] EEIYEYIIFR 0.99244 -18.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4778 0 0 0 0 0 0 0 0 0 0 0 11.2448 0 0 0 0 12.5139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5356 13.0013 12.0656 0 0 0 0 12.6602 11.8282 0 0 0 0 0 0 0 0 0 11.2525 0 0 0 13.1798 0 14.3455 0 0 0 0 0 0 0 0 14.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4704 0 0 0 0 0 0 0 0 0 0 13.763 0 0 0 Q9BYG8 GSDMC_HUMAN "Gasdermin-C (Melanoma-derived leucine zipper-containing extranuclear factor) [Cleaved into: Gasdermin-C, N-terminal, GSDMC-NT; Gasdermin-C, C-terminal, GSDMC-CT ]" GSDMC MLZE Homo sapiens (Human) defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; defense response to bacterium [GO:0042742]; pyroptosis [GO:0070269]" GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0016021; GO:0042742; GO:0070269; GO:0070273 "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]" DPILYLLEAIMVLSDFQHDLLACSMEK 0.99244 -6.1068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1468 0 12.2679 0 0 0 0 0 12.1931 0 0 0 0 0 0 0 0 0 0 0 0 12.4367 0 0 0 0 0 0 0 11.5836 0 0 0 0 0 13.6421 0 13.2475 0 0 0 0 0 0 0 0 0 0 0 0 10.7119 0 0 0 0 0 0 0 0 11.435 0 13.8002 11.6408 0 12.3963 0 0 0 14.5443 0 17.5603 0 0 0 0 0 0 0 0 0 0 0 0 0 14.349 0 0 0 0 0 0 0 0 0 0 12.8461 0 0 13.3497 0 0 0 0 0 0 0 0 0 0 0 Q9NRZ5 PLCD_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase delta, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 4, 1-AGP acyltransferase 4, 1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta, LPAAT-delta)" AGPAT4 UNQ499/PRO1016 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006654; GO:0008654; GO:0012505; GO:0016021; GO:0016024; GO:0016746 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] FGLLGGSKVLAKK 0.99244 -6.1029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2B4 T53G5_HUMAN TP53-target gene 5 protein (TP53-inducible gene 5 protein) TP53TG5 C20orf10 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308] GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0030308; GO:0035556 CWHSLLSVPKILR 0.99244 -17.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9028 9.90584 16.3602 14.8569 15.5974 0 15.1248 0 15.0317 0 14.0498 0 0 0 0 0 0 0 0 0 0 0 0 14.4615 16.1853 0 0 12.7104 0 0 0 0 14.2974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6454 0 0 0 0 0 14.9921 15.076 0 0 15.7651 0 0 0 0 11.9663 0 0 14.6287 0 0 0 0 0 14.93 0 0 12.7544 14.8528 0 14.648 0 0 0 15.4242 12.3733 0 0 15.4641 0 0 0 0 13.6526 0 13.8384 17.3796 0 0 0 0 0 0 14.6687 0 0 0 0 13.5847 13.7026 0 12.2653 0 14.2696 0 0 0 12.9709 0 0 0 13.5242 15.3599 14.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1172 0 15.6827 0 0 0 0 0 0 0 0 0 0 0 15.8566 13.8203 0 A2A2Z9 AN18B_HUMAN Ankyrin repeat domain-containing protein 18B ANKRD18B Homo sapiens (Human) AEREVIVREFQEELVDHLK 0.99245 -24.362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.933 0 0 0 0 0 0 0 0 0 12.3283 0 11.3228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.796 0 0 0 0 0 11.9791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0061 0 0 0 0 0 0 0 0 0 0 0 0 10.5326 0 0 0 0 0 10.894 13.0152 0 0 11.8905 0 0 0 0 O94813 SLIT2_HUMAN "Slit homolog 2 protein, Slit-2 [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product ]" SLIT2 SLIL3 Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] GO:0001657; GO:0001933; GO:0002042; GO:0002689; GO:0003180; GO:0003184; GO:0005095; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0007411; GO:0008045; GO:0008201; GO:0009986; GO:0010593; GO:0010596; GO:0014912; GO:0016020; GO:0021836; GO:0021972; GO:0030308; GO:0030336; GO:0030837; GO:0031290; GO:0032870; GO:0035385; GO:0042802; GO:0042803; GO:0043065; GO:0043116; GO:0043237; GO:0043394; GO:0048495; GO:0048754; GO:0048846; GO:0050772; GO:0050919; GO:0050929; GO:0051058; GO:0051414; GO:0060412; GO:0061364; GO:0070062; GO:0070100; GO:0071504; GO:0071672; GO:0071676; GO:0090024; GO:0090027; GO:0090260; GO:0090288 calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495] CDCTPGYVGEHCDIDFDDCQDNK 0.99245 -6.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6513 0 0 0 0 0 0 0 0 12.6384 0 0 0 12.3158 0 0 0 0 0 0 0 0 0 11.6344 10.4811 11.9209 0 0 0 0 0 0 0 0 0 14.969 0 0 12.1381 0 15.2753 0 0 0 10.9591 0 0 13.5823 0 14.5218 0 0 0 17.161 12.2723 0 0 0 0 11.1882 0 0 0 12.9169 0 11.0165 0 13.2368 11.7619 14.2938 14.5834 0 13.094 0 0 0 10.8965 0 0 0 0 0 0 11.6226 0 0 12.1849 0 11.3756 0 0 11.3466 12.4742 13.1959 0 0 0 0 0 12.4019 0 0 0 0 0 11.5098 14.1713 11.2779 0 13.5662 0 0 0 13.5898 0 14.5423 12.3914 11.5348 0 0 14.5335 0 14.9106 0 0 0 10.6755 0 12.4058 0 0 0 15.7372 10.7777 12.5281 0 12.8392 0 0 0 0 12.9738 0 0 0 13.1243 0 14.6219 P17066 HSP76_HUMAN Heat shock 70 kDa protein 6 (Heat shock 70 kDa protein B') HSPA6 HSP70B' Homo sapiens (Human) cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192] blood microparticle [GO:0072562]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] blood microparticle [GO:0072562]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192] GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006986; GO:0016192; GO:0016887; GO:0019899; GO:0031072; GO:0031625; GO:0034605; GO:0034620; GO:0034774; GO:0042026; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0072562; GO:0140662; GO:1904813 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] CREVLAWLEHNQLAEKEEYEHQK 0.99245 -14.768 0 0 0 0 0 0 0 10.5493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8399 12.1059 0 0 0 0 0 0 0 0 0 0 12.0052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3607 0 0 0 0 0 0 11.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9861 0 0 0 0 0 0 0 0 13.479 0 0 0 0 0 0 0 P35749 MYH11_HUMAN "Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC)" MYH11 KIAA0866 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cardiac muscle cell development [GO:0055013]; elastic fiber assembly [GO:0048251]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; structural constituent of muscle [GO:0008307]; actomyosin structure organization [GO:0031032]; cardiac muscle cell development [GO:0055013]; elastic fiber assembly [GO:0048251]; skeletal muscle myosin thick filament assembly [GO:0030241]; smooth muscle contraction [GO:0006939] GO:0000146; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006939; GO:0008307; GO:0016460; GO:0030241; GO:0031032; GO:0032982; GO:0042470; GO:0048251; GO:0051015; GO:0055013; GO:0070062 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; structural constituent of muscle [GO:0008307] AARNKAEK 0.99245 -25.403 0 0 14.7578 0 0 0 0 0 13.6175 12.8905 0 0 13.0655 0 0 0 0 10.4011 0 0 17.1161 15.8125 0 15.9937 0 0 11.9153 0 0 0 11.5462 13.2272 0 0 0 0 0 0 0 0 0 0 0 11.8115 0 0 11.8209 0 0 0 0 0 11.4136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8129 0 0 0 15.8328 16.8911 0 14.0357 14.8063 13.2707 14.0356 0 13.9028 0 14.3759 14.8097 14.6817 15.3214 0 0 0 0 18.2587 15.3861 0 0 0 0 0 0 0 13.327 0 0 0 0 0 0 0 0 0 12.4624 0 0 12.7158 0 13.5887 0 0 0 0 12.3409 0 0 0 0 0 18.2398 0 12.7518 0 0 15.7346 0 18.2237 0 13.3849 0 12.2931 13.4658 0 0 0 0 0 0 17.2334 0 0 14.5895 17.2668 16.7336 0 0 0 0 0 0 0 0 0 11.9053 0 0 0 0 12.3426 0 13.3838 0 0 0 0 0 12.0896 0 P35914 HMGCL_HUMAN "Hydroxymethylglutaryl-CoA lyase, mitochondrial, HL, HMG-CoA lyase, EC 4.1.3.4 (3-hydroxy-3-methylglutarate-CoA lyase)" HMGCL Homo sapiens (Human) ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005] GO:0000287; GO:0004419; GO:0005198; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006552; GO:0006629; GO:0007005; GO:0030145; GO:0032991; GO:0046872; GO:0046951 hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198] ALPRRLVGLASLR 0.99245 -6.1298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4279 0 0 0 0 0 0 0 0 11.7396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3852 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5055 0 10.6108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41595 5HT2B_HUMAN "5-hydroxytryptamine receptor 2B, 5-HT-2B, 5-HT2B (Serotonin receptor 2B)" HTR2B Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular calcium ion homeostasis [GO:0006874]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]" anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; Gq/11-coupled serotonin receptor activity [GO:0001587]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular calcium ion homeostasis [GO:0006874]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]" GO:0001587; GO:0001755; GO:0001819; GO:0001938; GO:0001965; GO:0002031; GO:0003007; GO:0003300; GO:0004993; GO:0005096; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0007186; GO:0007187; GO:0007200; GO:0007202; GO:0007205; GO:0007208; GO:0007268; GO:0007610; GO:0008284; GO:0009410; GO:0010507; GO:0010513; GO:0014033; GO:0014065; GO:0014827; GO:0016310; GO:0019722; GO:0019934; GO:0030425; GO:0030594; GO:0042310; GO:0043066; GO:0043123; GO:0043406; GO:0045202; GO:0048598; GO:0050795; GO:0051000; GO:0051209; GO:0051378; GO:0051781; GO:0060548; GO:0070161; GO:0070371; GO:0070374; GO:0070528; GO:0071502; GO:0098664; GO:0098666 G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; Gq/11-coupled serotonin receptor activity [GO:0001587]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] ATKSVKTLR 0.99245 -6.6755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3628 0 14.0816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2267 0 0 0 0 0 0 0 0 12.2926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWY0 ARSK_HUMAN "Arylsulfatase K, ASK, EC 3.1.6.1 (Glucuronate-2-sulfatase, EC 3.1.6.18) (Telethon sulfatase)" ARSK TSULF UNQ630/PRO1246 Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; lysosome [GO:0005764] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; glucuronate-2-sulfatase activity [GO:0015024]; metal ion binding [GO:0046872] GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0015024; GO:0046872 arylsulfatase activity [GO:0004065]; glucuronate-2-sulfatase activity [GO:0015024]; metal ion binding [GO:0046872] FTKKEIK 0.99245 -25.287 0 0 0 0 0 11.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6168 0 0 0 0 12.4357 12.3029 0 12.3733 11.1608 0 0 0 11.881 0 0 0 14.1723 0 11.118 0 0 12.3248 0 0 0 13.9757 0 0 0 0 0 14.3815 0 12.4699 0 12.9999 0 0 0 0 0 13.928 0 0 0 0 0 0 12.3814 0 11.6057 0 0 0 0 0 0 12.3994 0 0 0 0 0 0 0 0 0 0 0 15.6781 0 0 0 0 0 0 0 0 0 13.0442 0 0 0 0 10.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNA4 RN111_HUMAN "E3 ubiquitin-protein ligase Arkadia, EC 2.3.2.27 (RING finger protein 111, hRNF111) (RING-type E3 ubiquitin transferase Arkadia)" RNF111 Homo sapiens (Human) "global genome nucleotide-excision repair [GO:0070911]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630]; global genome nucleotide-excision repair [GO:0070911]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]" GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0007389; GO:0016567; GO:0016605; GO:0030511; GO:0030579; GO:0031398; GO:0032184; GO:0032991; GO:0045893; GO:0046332; GO:0046872; GO:0061630; GO:0070911 metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630] ILMQRKK 0.99245 -15.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6381 0 0 0 0 0 0 0 0 0 0 0 11.0367 0 17.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6526 0 0 0 0 0 0 0 10.8781 0 0 0 13.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86Y33 CD20B_HUMAN Cell division cycle protein 20 homolog B CDC20B G6VTS76519 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786] anaphase-promoting complex [GO:0005680] anaphase-promoting complex [GO:0005680]; anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786] GO:0005680; GO:0010997; GO:0031145; GO:1905786; GO:1990757 anaphase-promoting complex binding [GO:0010997]; ubiquitin ligase activator activity [GO:1990757] APHAMDR 0.99245 -25.289 13.1089 11.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1719 0 0 16.3824 0 0 0 0 0 0 0 13.5848 0 0 0 0 0 0 0 0 0 0 0 12.4311 15.8148 0 0 0 0 0 0 0 0 13.5918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7664 16.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1601 0 0 15.4467 0 0 0 14.93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFD5 ARI1B_HUMAN "AT-rich interactive domain-containing protein 1B, ARID domain-containing protein 1B (BRG1-associated factor 250b, BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2, hOsa2) (p250R)" ARID1B BAF250B DAN15 KIAA1235 OSA2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0003677; GO:0003713; GO:0005654; GO:0005829; GO:0005886; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819 DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] DPFGGMR 0.99245 -24.359 0 0 0 17.1677 0 0 0 0 18.848 18.9893 18.9693 19.0277 0 19.0664 19.0573 0 0 0 0 0 0 10.3008 11.9212 0 0 0 13.9742 0 12.0935 11.891 19.1332 19.0445 19.2156 19.0866 19.1194 19.1549 19.0785 0 19.0934 19.1349 19.1462 19.1765 0 0 0 0 0 0 0 0 10.9393 0 0 11.3622 0 17.6594 17.792 18.2806 17.5345 16.3841 0 0 0 15.8653 16.257 15.8601 0 12.5461 0 0 0 12.1874 0 14.8436 10.5689 13.4751 0 0 12.625 0 0 13.4721 0 0 0 14.5933 13.1858 12.9473 14.423 13.9634 12.9141 0 0 0 0 0 0 13.8567 0 13.0962 0 0 0 15.434 0 0 0 0 14.7631 0 0 0 0 0 13.5961 0 13.3563 0 0 13.537 13.769 0 12.9295 0 0 0 13.7074 0 0 0 0 12.0051 0 0 0 14.8755 0 0 0 15.5368 0 0 0 0 0 0 12.623 0 12.8319 0 0 14.272 0 15.6525 0 0 20.1655 0 20.0714 19.9436 0 12.0463 19.1013 0 19.0233 19.0939 0 19.0366 0 0 0 14.532 0 0 12.1931 0 0 19.4729 13.4294 19.5827 Q9NYV4 CDK12_HUMAN "Cyclin-dependent kinase 12, EC 2.7.11.22, EC 2.7.11.23 (Cdc2-related kinase, arginine/serine-rich, CrkRS) (Cell division cycle 2-related protein kinase 7, CDC2-related protein kinase 7) (Cell division protein kinase 12, hCDK12)" CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368] GO:0000307; GO:0002944; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006368; GO:0006397; GO:0006468; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0046777; GO:0070816; GO:0106310; GO:2000737 ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] AAAAAAAK 0.99245 -57.59 0 0 0 0 0 0 12.5899 0 0 0 0 0 0 0 11.0251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.421 0 11.6451 12.7783 0 0 0 0 0 0 0 0 0 0 0 10.8808 0 0 0 13.7794 14.2957 15.3628 0 0 0 0 0 15.814 0 0 0 0 0 13.4633 0 0 0 0 0 0 0 0 0 0 15.7239 12.9327 9.10347 13.5163 0 15.3729 0 0 14.1473 0 14.4329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5713 0 0 0 0 0 13.478 0 14.0822 0 0 0 0 0 0 0 0 12.1985 0 0 0 0 0 0 0 0 0 0 0 0 0 13.468 0 0 0 0 0 11.2722 13.5229 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9792 0 0 0 0 0 12.8658 0 0 Q9P0X4 CAC1I_HUMAN "Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3, Ca(v)3.3)" CACNA1I KIAA1120 Homo sapiens (Human) calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431] neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248]; calcium ion import [GO:0070509]; flagellated sperm motility [GO:0030317]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of ion transmembrane transport [GO:0034765]; signal transduction [GO:0007165]; sleep [GO:0030431] GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0007165; GO:0008332; GO:0019228; GO:0030317; GO:0030431; GO:0034765; GO:0043005; GO:0045956; GO:0070509; GO:0086010 low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248] AAGPAPGHEDCNGR 0.99245 -17.719 0 0 0 0 0 19.2013 0 0 12.0501 0 11.5912 0 12.4692 11.3331 16.786 10.9601 0 0 0 0 0 0 0 12.3867 13.2069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1957 0 12.257 0 0 0 0 11.1611 12.9299 15.8973 14.9277 15.2534 13.0908 0 0 0 13.5682 13.0746 0 12.786 13.7993 13.5442 13.8996 12.2498 13.0543 15.5834 14.4983 15.1991 16.9952 0 15.0564 0 12.529 0 0 0 13.794 11.7989 13.6129 15.4373 12.0704 0 13.6526 15.3588 0 14.9987 15.2315 15.3151 14.5539 11.904 0 16.1205 13.5826 0 0 12.2331 11.7873 15.5334 13.662 0 14.2005 12.4852 13.3892 12.0542 0 0 0 13.5657 0 10.2226 0 0 14.4286 12.1312 0 13.7806 11.468 11.5414 0 0 0 0 0 10.6589 14.5115 11.9378 11.4356 12.6113 14.0165 0 12.0824 0 0 0 0 0 0 0 13.0362 0 0 0 0 0 13.7509 13.3113 0 0 0 16.0851 0 14.3329 0 Q9Y4D7 PLXD1_HUMAN Plexin-D1 PLXND1 KIAA0620 Homo sapiens (Human) angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; synapse assembly [GO:0007416] axon [GO:0030424]; cell body [GO:0044297]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] axon [GO:0030424]; cell body [GO:0044297]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; synapse assembly [GO:0007416] GO:0001525; GO:0001569; GO:0001822; GO:0002116; GO:0003151; GO:0003279; GO:0005886; GO:0005887; GO:0007162; GO:0007416; GO:0008360; GO:0017154; GO:0019904; GO:0030027; GO:0030334; GO:0030424; GO:0031258; GO:0032092; GO:0035904; GO:0043087; GO:0043524; GO:0043542; GO:0044297; GO:0045765; GO:0050772; GO:0060666; GO:0060976; GO:0071526; GO:1902287 protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154] AAAASPPPFQTPPR 0.99245 -25.282 0 0 0 0 0 0 0 0 0 11.4242 0 13.8746 14.156 0 13.5433 0 0 12.2205 11.8357 12.0693 0 16.4519 0 0 0 0 0 14.0717 10.5258 0 12.0271 0 15.654 12.6411 0 0 14.8943 0 0 0 0 0 10.0522 14.2945 0 0 0 0 14.0768 0 0 0 0 0 0 0 0 0 10.4496 0 0 0 0 0 0 0 0 0 12.4291 14.3176 0 0 0 0 18.516 0 0 13.5501 14.5018 0 13.7367 0 0 13.426 13.0989 13.1295 12.9143 0 0 12.8503 15.6979 15.1313 15.284 0 0 0 0 13.7588 0 15.0262 0 15.1303 0 13.2623 0 0 12.3133 0 14.2776 10.4566 13.2612 14.0778 0 0 14.4118 12.6761 0 13.4914 13.5459 15.3137 11.9555 0 0 0 0 0 14.2041 14.9387 0 0 0 0 0 12.9505 12.9572 0 13.0644 0 14.7136 0 12.8931 13.1336 0 0 0 15.4328 12.1242 15.0753 0 0 0 0 12.8457 12.5487 0 0 0 0 11.6712 12.2807 0 0 0 0 12.0417 0 0 0 11.7576 15.121 0 0 13.0941 12.1309 0 0 0 0 14.6948 0 A0A075B6L2 TVG11_HUMAN Probable non-functional T cell receptor gamma variable 11 TRGV11 Homo sapiens (Human) adaptive immune response [GO:0002250] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101] external side of plasma membrane [GO:0009897]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0009897; GO:0042101 IIHWYWQK 0.99246 -6.6798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.15959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0049 0 0 0 13.1282 0 0 0 0 0 0 O60522 TDRD6_HUMAN "Tudor domain-containing protein 6 (Antigen NY-CO-45) (Cancer/testis antigen 41.2, CT41.2)" TDRD6 Homo sapiens (Human) P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0005737; GO:0007283; GO:0030719; GO:0033391; GO:0034587; GO:0043186 AFTVGSKCVVWSSLR 0.99246 -60.434 0 0 0 0 0 0 0 0 10.1991 10.8324 0 0 0 0 13.2588 0 0 0 0 11.3392 0 11.6052 0 0 12.0792 0 14.0725 0 12.034 0 0 0 10.3274 0 0 0 0 11.0049 0 0 0 0 0 0 11.9247 12.2861 12.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1144 11.9705 0 10.7539 0 0 0 0 0 14.1784 12.693 0 13.4462 12.8586 13.9516 0 0 0 14.9052 13.3938 0 13.8167 0 0 0 14.0391 13.4628 13.44 13.4981 0 14.4761 0 11.9467 0 11.8042 0 0 11.038 13.2562 12.8011 14.037 0 0 12.2015 0 0 15.0652 13.0803 13.7707 0 13.8881 13.2194 0 0 0 12.7884 11.8604 13.0338 14.1329 14.7122 0 12.8202 13.8755 0 0 13.0274 0 12.7553 0 0 12.6701 12.187 0 0 13.3578 13.2159 12.436 0 0 13.7618 14.8266 15.0097 0 0 11.2494 0 0 0 12.8291 11.8474 0 11.9283 0 0 13.7562 0 0 0 0 0 0 0 0 0 0 0 12.9562 0 0 0 13.0765 0 O95396 MOCS3_HUMAN "Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) (Molybdopterin synthase sulfurylase, MPT synthase sulfurylase) [Includes: Molybdopterin-synthase adenylyltransferase, EC 2.7.7.80 (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase, EC 2.8.1.11 (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3) ]" MOCS3 UBA4 Homo sapiens (Human) Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292] CRSLQLLSPEERVSVTDYK 0.99246 -5.5231 0 0 0 0 0 0 0 0 0 0 0 0 11.3381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5927 0 12.7796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0559 0 0 0 11.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3838 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5675 0 0 0 0 0 0 0 10.8536 0 0 0 0 0 0 0 0 0 0 P12830 CADH1_HUMAN "Cadherin-1 (CAM 120/80) (Epithelial cadherin, E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3 ]" CDH1 CDHE UVO Homo sapiens (Human) "adherens junction organization [GO:0034332]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to indole-3-methanol [GO:0071681]; cellular response to lithium ion [GO:0071285]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; neuron projection development [GO:0031175]; pituitary gland development [GO:0021983]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; regulation of gene expression [GO:0010468]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; response to Gram-positive bacterium [GO:0140459]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]" actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; flotillin complex [GO:0016600]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802] "actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; flotillin complex [GO:0016600]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; ankyrin binding [GO:0030506]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; gamma-catenin binding [GO:0045295]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; protein tyrosine kinase binding [GO:1990782]; adherens junction organization [GO:0034332]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cellular response to indole-3-methanol [GO:0071681]; cellular response to lithium ion [GO:0071285]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; neuron projection development [GO:0031175]; pituitary gland development [GO:0021983]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to plasma membrane [GO:0072659]; regulation of gene expression [GO:0010468]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; response to Gram-positive bacterium [GO:0140459]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]" GO:0005509; GO:0005576; GO:0005737; GO:0005768; GO:0005802; GO:0005886; GO:0005912; GO:0007156; GO:0007416; GO:0008013; GO:0009410; GO:0009636; GO:0009898; GO:0010468; GO:0015629; GO:0016021; GO:0016328; GO:0016342; GO:0016600; GO:0021983; GO:0022408; GO:0030027; GO:0030054; GO:0030336; GO:0030506; GO:0031175; GO:0032794; GO:0034332; GO:0042307; GO:0042802; GO:0043296; GO:0045295; GO:0045296; GO:0045893; GO:0048471; GO:0050839; GO:0070062; GO:0071285; GO:0071681; GO:0072659; GO:0098609; GO:0098742; GO:0098794; GO:0098978; GO:0099576; GO:0140459; GO:1990782 ankyrin binding [GO:0030506]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; gamma-catenin binding [GO:0045295]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; protein tyrosine kinase binding [GO:1990782] AQPVEAGLQIPAILGILGGILALLILILLLLLFLRR 0.99246 -6.1632 0 0 0 13.3376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6475 13.232 0 0 0 0 0 10.9283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3775 0 0 0 13.9315 0 0 0 0 0 12.7015 0 0 0 0 0 0 0 14.5366 0 0 0 0 11.526 0 0 0 0 0 15.284 0 0 0 13.5957 0 0 0 0 0 0 0 12.969 12.665 0 0 14.8849 0 0 0 13.5482 0 0 0 0 0 12.5308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9802 0 0 0 0 0 0 0 0 0 11.9813 0 0 0 0 0 0 0 0 11.9629 0 0 12.2067 0 0 0 0 0 0 0 0 0 12.4111 0 0 0 P15822 ZEP1_HUMAN "Zinc finger protein 40 (Cirhin interaction protein, CIRIP) (Gate keeper of apoptosis-activating protein, GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1, HIV-EP1) (Major histocompatibility complex-binding protein 1, MBP-1) (Positive regulatory domain II-binding factor 1, PRDII-BF1)" HIVEP1 ZNF40 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006357; GO:0016604; GO:0030509; GO:0045944; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CTDNNQER 0.99246 -14.818 0 0 0 10.2005 0 0 0 0 11.6833 0 0 0 0 10.3555 10.668 0 0 0 0 0 13.2788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9206 0 0 0 0 0 0 0 15.3204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2648 0 0 0 0 0 0 12.7402 0 0 0 13.5688 0 13.079 10.8357 0 12.4372 0 0 0 0 0 0 0 0 0 0 10.6501 0 0 0 0 0 0 13.9269 0 11.8624 0 0 0 0 0 0 0 0 0 0 0 0 13.7726 0 0 0 0 0 11.1963 0 10.6201 0 0 12.865 0 0 0 0 0 0 0 0 0 0 0 17.1778 0 0 0 0 0 13.5417 0 0 0 14.4467 0 14.9257 0 0 14.3168 14.3161 11.4625 0 0 0 0 0 0 0 0 0 17.0444 0 14.4877 0 12.0594 P25940 CO5A3_HUMAN Collagen alpha-3(V) chain COL5A3 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; skin development [GO:0043588] collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type V trimer [GO:0005588]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; skin development [GO:0043588] GO:0005201; GO:0005518; GO:0005576; GO:0005588; GO:0005615; GO:0005788; GO:0007160; GO:0008201; GO:0030020; GO:0030198; GO:0030199; GO:0031012; GO:0043394; GO:0043588; GO:0062023 collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394] AAREDEEGDDSTMGPDFR 0.99246 -6.6811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6546 10.8549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4338 0 0 0 0 0 0 0 0 0 0 0 11.5652 0 0 10.9381 0 0 0 0 0 0 0 0 9.93161 0 0 0 10.6079 0 0 0 0 0 0 0 0 12.003 0 14.2078 0 11.9599 0 0 0 0 0 12.7886 0 0 14.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7429 0 0 0 0 0 0 0 0 0 12.759 0 0 0 0 0 0 0 0 0 0 0 0 13.6478 0 0 14.655 0 13.9086 0 0 14.7537 10.9864 0 14.2169 0 12.85 0 13.9077 14.7538 0 14.2939 0 0 0 0 0 0 0 13.9659 0 0 0 9.89688 0 0 0 0 0 0 0 12.9066 0 0 0 0 0 0 0 0 13.3257 14.7412 0 11.3968 0 0 0 0 0 P46663 BKRB1_HUMAN "B1 bradykinin receptor, B1R, BK-1 receptor" BDKRB1 BRADYB1 Homo sapiens (Human) cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell growth [GO:0030308]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233] endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; bradykinin receptor activity [GO:0004947]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; cell migration [GO:0016477]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell growth [GO:0030308]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; sensory perception of pain [GO:0019233] GO:0001933; GO:0002687; GO:0004930; GO:0004947; GO:0005783; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007204; GO:0007205; GO:0009612; GO:0016477; GO:0019233; GO:0030308; GO:0032496; GO:0042277; GO:0043005; GO:0045776; GO:0051281 bradykinin receptor activity [GO:0004947]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277] EIFQLFWRN 0.99246 -4.3938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5562 0 12.7462 0 0 0 15.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4532 0 13.4115 0 0 0 0 0 0 12.2682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1299 0 0 0 0 0 Q5HYK7 SH319_HUMAN "SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein, EBP)" SH3D19 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604] GO:0005654; GO:0005829; GO:0005886; GO:0007010; GO:0022604; GO:0051044; GO:0070064 proline-rich region binding [GO:0070064] EYVNEEWAR 0.99246 -25.541 0 0 0 0 0 0 0 0 15.0285 0 0 14.4759 0 0 0 0 0 0 0 0 13.6288 13.291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1268 0 0 14.8697 10.337 0 0 0 14.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8616 11.9691 12.2683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0216 13.1304 14.2244 18.6377 0 13.8533 13.4515 12.567 0 13.7895 13.7775 14.3909 0 13.6314 13.4853 0 0 0 15.3168 0 0 13.5545 13.8708 12.863 0 0 13.8128 0 13.1817 13.3643 14.1154 12.3552 13.6569 13.3852 12.5176 0 0 13.8746 0 0 12.9096 0 0 0 0 12.4177 0 15.0779 0 0 13.1211 13.0071 13.5079 0 12.1949 0 0 13.8112 13.4651 13.2068 0 13.3093 0 13.5847 14.9629 12.6962 11.6333 0 0 0 0 13.3813 0 12.2576 10.4544 12.7198 0 0 0 13.8008 0 14.0634 0 0 13.1548 0 0 0 0 13.7511 0 0 0 0 12.6778 0 0 Q8IXS6 PALM2_HUMAN Paralemmin-2 PALM2 Homo sapiens (Human) regulation of cell shape [GO:0008360] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; regulation of cell shape [GO:0008360] GO:0005654; GO:0005886; GO:0008360 EAKLEMVHKSR 0.99246 -15.15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7904 0 0 0 0 0 0 0 0 0 0 0 13.8888 13.1179 0 0 0 13.9062 0 17.2093 0 0 0 0 0 0 0 0 0 13.4039 0 0 0 0 0 0 0 0 14.1232 0 0 0 0 13.1678 0 0 13.1128 0 0 0 0 0 12.9508 13.7677 0 0 0 0 0 0 0 13.05 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MH6 TMM68_HUMAN Transmembrane protein 68 TMEM68 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; acyltransferase activity [GO:0016746] GO:0016021; GO:0016746 acyltransferase activity [GO:0016746] IFIHKGR 0.99246 -6.1507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6969 0 0 0 0 0 0 15.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5003 14.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99459 CDC5L_HUMAN "Cell division cycle 5-like protein, Cdc5-like protein (Pombe cdc5-related protein)" CDC5L KIAA0432 PCDC5RP Homo sapiens (Human) "cell cycle [GO:0007049]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]; cell cycle [GO:0007049]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000077; GO:0000398; GO:0000974; GO:0000977; GO:0000981; GO:0001228; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006281; GO:0006357; GO:0007049; GO:0016020; GO:0016607; GO:0042802; GO:0045944; GO:0071007; GO:0071013; GO:0071987 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]" AAGIEIQKKR 0.99246 -6.1645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1484 0 0 12.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5833 0 0 13.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3817 0 0 0 0 14.9554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7777 0 10.1687 0 0 0 0 0 0 0 0 0 0 Q9BZG2 PPAT_HUMAN "Testicular acid phosphatase, EC 3.1.3.2 (Acid phosphatase 4)" ACP4 ACPT Homo sapiens (Human) dephosphorylation [GO:0016311]; lysosome organization [GO:0007040]; negative regulation of ERBB4 signaling pathway [GO:0120154]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein processing [GO:0010955]; odontogenesis [GO:0042476]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of neuronal synaptic plasticity [GO:0048168] integral component of membrane [GO:0016021]; lysosome [GO:0005764]; postsynaptic membrane [GO:0045211] integral component of membrane [GO:0016021]; lysosome [GO:0005764]; postsynaptic membrane [GO:0045211]; acid phosphatase activity [GO:0003993]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; dephosphorylation [GO:0016311]; lysosome organization [GO:0007040]; negative regulation of ERBB4 signaling pathway [GO:0120154]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein processing [GO:0010955]; odontogenesis [GO:0042476]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of neuronal synaptic plasticity [GO:0048168] GO:0003993; GO:0004725; GO:0005764; GO:0007040; GO:0010955; GO:0010977; GO:0016021; GO:0016311; GO:0016791; GO:0030971; GO:0042476; GO:0045211; GO:0048168; GO:0120154; GO:1990264 acid phosphatase activity [GO:0003993]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971] AGLGFWGHPAGPLLLLLLLVLPPR 0.99246 -7.3468 0 0 0 0 0 0 0 0 0 0 0 0 11.7772 11.8383 0 0 0 0 0 0 11.4245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3943 15.58 0 14.7201 14.236 0 0 0 0 0 0 12.8569 14.0243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.417 0 0 0 0 12.655 0 0 0 0 12.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6319 0 0 0 0 12.4126 0 12.2159 0 12.025 0 0 0 0 0 13.0808 0 0 0 12.3363 0 0 0 0 12.4291 0 0 12.1274 12.6235 0 0 0 0 0 0 0 0 11.207 0 Q9P218 COKA1_HUMAN Collagen alpha-1(XX) chain COL20A1 KIAA1510 Homo sapiens (Human) collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0062023 DGETCPAFVSACSCSSETPGPPGPQGPPGLPGR 0.99246 -25.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6812 0 15.3144 0 0 12.2527 0 0 0 0 0 0 0 15.1252 0 0 0 0 0 14.7056 14.0955 0 14.5545 12.5174 0 0 0 12.2958 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6707 0 0 0 11.2727 0 0 0 14.8951 15.0632 0 0 0 0 0 0 0 0 0 13.0991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2K6 KLH42_HUMAN "Kelch-like protein 42 (Cullin-3-binding protein 9, Ctb9) (Kelch domain-containing protein 5)" KLHL42 KIAA1340 KLHDC5 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of microtubule-based process [GO:0032886] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; spindle [GO:0005819] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; spindle [GO:0005819]; cell cycle [GO:0007049]; cell division [GO:0051301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of microtubule-based process [GO:0032886] GO:0000209; GO:0005819; GO:0005829; GO:0007049; GO:0031463; GO:0032886; GO:0043161; GO:0051301 LNNCLEMYR 0.99246 -5.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9948 0 11.1448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4237 0 0 0 11.7955 0 0 0 0 0 0 0 13.2099 15.1612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5303 0 0 0 0 0 0 0 11.049 13.1716 0 14.7585 0 0 0 0 0 0 0 0 15.2427 0 0 0 0 0 0 0 0 0 13.3491 12.95 0 0 0 0 0 0 0 0 12.162 0 0 0 0 0 0 0 0 0 0 0 14.6598 15.2611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3453 14.5079 0 0 0 0 0 0 15.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNH6 SNX7_HUMAN Sorting nexin-7 SNX7 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]; reticulophagy [GO:0061709] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phagophore assembly site [GO:0000407] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phagophore assembly site [GO:0000407]; phosphatidylinositol binding [GO:0035091]; autophagy of mitochondrion [GO:0000422]; endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]; reticulophagy [GO:0061709] GO:0000407; GO:0000422; GO:0005769; GO:0015031; GO:0031901; GO:0032456; GO:0035091; GO:0061709; GO:2000786 phosphatidylinositol binding [GO:0035091] DVASCIDRCCKATEK 0.99246 -14.828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.419 0 0 0 0 0 0 0 12.6207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02388 CO7A1_HUMAN "Collagen alpha-1(VII) chain (Long-chain collagen, LC collagen)" COL7A1 Homo sapiens (Human) cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544] basement membrane [GO:0005604]; collagen type VII trimer [GO:0005590]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type VII trimer [GO:0005590]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544] GO:0004867; GO:0005576; GO:0005590; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0008544; GO:0030020; GO:0030134; GO:0033116; GO:0035987; GO:0062023 extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867] AEATRRVLER 0.99247 -63.881 0 0 0 0 0 0 0 0 16.712 15.9301 11.4627 12.1426 11.9201 10.5085 10.6744 11.4348 11.6049 11.561 0 0 0 0 0 13.8304 0 0 0 0 0 0 15.7499 0 0 16.9015 16.9671 16.8501 18.0531 18.0283 18.0374 0 15.3789 15.3537 0 0 0 0 0 0 0 11.3841 0 11.1522 11.7111 10.9968 12.0306 0 0 0 0 0 0 0 0 13.4748 0 13.4724 0 12.6342 0 0 0 13.2255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7248 0 14.8795 11.9819 0 0 13.0517 0 0 0 0 0 0 0 0 0 12.2159 0 0 0 0 0 13.9316 0 0 0 0 0 0 12.6717 0 0 12.5502 0 0 0 0 0 0 0 0 0 0 0 0 12.9546 0 12.1594 0 0 0 0 0 0 0 0 0 0 11.2612 0 0 0 0 0 0 13.2643 0 12.6777 14.5634 18.2292 14.458 18.7968 18.7993 0 17.4045 17.6412 18.3135 18.3507 18.4379 12.7531 12.8814 13.7995 0 0 13.0156 0 18.8463 0 17.7821 0 0 O14646 CHD1_HUMAN "Chromodomain-helicase-DNA-binding protein 1, CHD-1, EC 3.6.4.12 (ATP-dependent helicase CHD1)" CHD1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; nucleosome organization [GO:0034728]; positive regulation by host of viral transcription [GO:0043923]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; chromatin remodeling [GO:0006338]; nucleosome organization [GO:0034728]; positive regulation by host of viral transcription [GO:0043923]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000228; GO:0000785; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006357; GO:0016887; GO:0034728; GO:0035064; GO:0042393; GO:0043923; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064] CCNHCYLIK 0.99247 -66.212 13.9232 11.343 0 0 0 0 0 0 11.6445 0 12.9273 0 10.5224 0 0 0 0 0 0 10.3372 0 0 0 11.0349 0 13.6793 13.3938 0 0 0 0 0 0 0 12.3381 0 0 10.829 0 0 13.4345 0 10.2384 10.1697 10.393 0 13.4165 12.3663 0 0 0 0 12.6065 12.2344 17.0013 10.8499 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9472 11.8205 18.9659 0 12.3406 15.5072 11.547 15.857 0 0 14.5631 0 11.2713 0 0 0 18.6198 0 0 0 0 0 12.8964 0 0 12.5947 14.3997 0 0 15.4133 14.3688 14.6726 13.6258 16.758 13.2424 0 0 12.653 15.1397 12.8125 13.5616 13.0069 0 14.0216 0 14.6353 14.0895 0 11.5511 14.0179 0 13.3231 0 15.6797 0 0 0 0 11.1323 10.9929 0 0 16.5678 10.8922 0 11.9207 0 0 0 12.7931 19.3184 12.8946 0 0 13.0776 13.7266 13.255 15.216 13.4344 13.3366 0 11.3929 11.7943 0 0 0 13.1821 11.9461 12.2276 0 0 0 10.7827 10.8498 0 13.4338 0 12.325 0 12.5072 0 12.6065 0 0 11.5678 14.0803 0 0 0 0 0 P09544 WNT2_HUMAN "Protein Wnt-2 (Int-1-like protein 1) (Int-1-related protein, IRP)" WNT2 INT1L1 IRP Homo sapiens (Human) atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; mesenchymal cell proliferation [GO:0010463]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; mesenchymal cell proliferation [GO:0010463]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001938; GO:0002053; GO:0002088; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0007267; GO:0008284; GO:0010463; GO:0022008; GO:0030182; GO:0031232; GO:0033278; GO:0045165; GO:0045944; GO:0048018; GO:0048146; GO:0050769; GO:0051091; GO:0055009; GO:0060038; GO:0060045; GO:0060070; GO:0060317; GO:0060492; GO:0060501; GO:0060502; GO:0060716; GO:0061072; GO:0061180; GO:0062023; GO:0071300; GO:0071560; GO:1904948; GO:1904954; GO:1990909 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] AVKRFLK 0.99247 -17.523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4925 0 0 0 10.8219 0 0 11.8285 0 0 0 11.5971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6771 0 0 0 0 0 0 0 12.461 0 0 0 0 10.5313 0 0 14.8639 0 14.2459 0 0 14.6466 13.6506 0 0 0 10.9497 0 0 0 12.0014 0 0 0 0 0 0 0 0 0 14.611 0 0 11.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1278 11.7242 0 0 0 0 0 0 0 0 11.4883 11.7995 0 0 0 0 0 9.53997 0 0 0 0 0 9.74123 0 0 0 10.283 P0C7U9 FA87A_HUMAN Protein FAM87A FAM87A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IPRPALIYGR 0.99247 -7.7031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9236 0 0 0 0 12.198 0 0 14.4165 0 0 14.4699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7446 0 0 0 0 0 0 14.7036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48742 LHX1_HUMAN "LIM/homeobox protein Lhx1, LIM homeobox protein 1 (Homeobox protein Lim-1, hLim-1)" LHX1 LIM-1 LIM1 Homo sapiens (Human) "anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; cervix development [GO:0060067]; comma-shaped body morphogenesis [GO:0072049]; dorsal spinal cord interneuron posterior axon guidance [GO:0097379]; dorsal/ventral pattern formation [GO:0009953]; ectoderm formation [GO:0001705]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; endoderm formation [GO:0001706]; epithelium development [GO:0060429]; forebrain regionalization [GO:0021871]; gastrulation with mouth forming second [GO:0001702]; head development [GO:0060322]; kidney development [GO:0001822]; lateral motor column neuron migration [GO:0097477]; mesendoderm development [GO:0048382]; mesonephric duct development [GO:0072177]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerulus development [GO:0072224]; metanephric part of ureteric bud development [GO:0035502]; metanephric renal vesicle morphogenesis [GO:0072283]; metanephric S-shaped body morphogenesis [GO:0072284]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct elongation [GO:0035849]; nephric duct morphogenesis [GO:0072178]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; oviduct development [GO:0060066]; oviduct epithelium development [GO:0035846]; paramesonephric duct development [GO:0061205]; pattern specification process [GO:0007389]; positive regulation of anterior head development [GO:2000744]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primitive streak formation [GO:0090009]; pronephros development [GO:0048793]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle morphogenesis [GO:0072077]; retina layer formation [GO:0010842]; S-shaped body morphogenesis [GO:0072050]; somite rostral/caudal axis specification [GO:0032525]; spinal cord association neuron differentiation [GO:0021527]; telencephalon development [GO:0021537]; transcription by RNA polymerase II [GO:0006366]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; uterine epithelium development [GO:0035847]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventral spinal cord development [GO:0021517]" chromatin [GO:0000785]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cerebellar Purkinje cell differentiation [GO:0021702]; cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation [GO:0021937]; cerebellum development [GO:0021549]; cervix development [GO:0060067]; comma-shaped body morphogenesis [GO:0072049]; dorsal spinal cord interneuron posterior axon guidance [GO:0097379]; dorsal/ventral pattern formation [GO:0009953]; ectoderm formation [GO:0001705]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; endoderm formation [GO:0001706]; epithelium development [GO:0060429]; forebrain regionalization [GO:0021871]; gastrulation with mouth forming second [GO:0001702]; head development [GO:0060322]; kidney development [GO:0001822]; lateral motor column neuron migration [GO:0097477]; mesendoderm development [GO:0048382]; mesonephric duct development [GO:0072177]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric glomerulus development [GO:0072224]; metanephric part of ureteric bud development [GO:0035502]; metanephric renal vesicle morphogenesis [GO:0072283]; metanephric S-shaped body morphogenesis [GO:0072284]; motor neuron axon guidance [GO:0008045]; negative regulation of transcription, DNA-templated [GO:0045892]; nephric duct elongation [GO:0035849]; nephric duct morphogenesis [GO:0072178]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; oviduct development [GO:0060066]; oviduct epithelium development [GO:0035846]; paramesonephric duct development [GO:0061205]; pattern specification process [GO:0007389]; positive regulation of anterior head development [GO:2000744]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primitive streak formation [GO:0090009]; pronephros development [GO:0048793]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle morphogenesis [GO:0072077]; retina layer formation [GO:0010842]; S-shaped body morphogenesis [GO:0072050]; somite rostral/caudal axis specification [GO:0032525]; spinal cord association neuron differentiation [GO:0021527]; telencephalon development [GO:0021537]; transcription by RNA polymerase II [GO:0006366]; ureter morphogenesis [GO:0072197]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; uterine epithelium development [GO:0035847]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventral spinal cord development [GO:0021517]" GO:0000785; GO:0000977; GO:0000981; GO:0000987; GO:0001655; GO:0001657; GO:0001658; GO:0001702; GO:0001705; GO:0001706; GO:0001822; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0006366; GO:0007267; GO:0007389; GO:0007399; GO:0008045; GO:0009653; GO:0009791; GO:0009880; GO:0009887; GO:0009948; GO:0009952; GO:0009953; GO:0010468; GO:0010842; GO:0021517; GO:0021527; GO:0021537; GO:0021549; GO:0021702; GO:0021871; GO:0021937; GO:0030182; GO:0032525; GO:0032991; GO:0035502; GO:0035846; GO:0035847; GO:0035849; GO:0040019; GO:0044344; GO:0045892; GO:0045893; GO:0046872; GO:0048382; GO:0048646; GO:0048703; GO:0048793; GO:0060059; GO:0060065; GO:0060066; GO:0060067; GO:0060068; GO:0060322; GO:0060429; GO:0061205; GO:0072049; GO:0072050; GO:0072077; GO:0072177; GO:0072178; GO:0072197; GO:0072224; GO:0072278; GO:0072283; GO:0072284; GO:0090009; GO:0090190; GO:0097379; GO:0097477; GO:1990837; GO:2000543; GO:2000744; GO:2000768 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AAFAATPK 0.99247 -17.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8135 0 0 0 0 0 0 0 0 0 0 14.1319 0 12.1979 0 0 0 0 0 0 0 0 0 0 0 0 14.1628 13.5889 0 0 0 0 12.2075 14.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0834 14.4413 0 0 0 0 0 14.0039 0 13.9497 0 0 0 11.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52747 ZN143_HUMAN "Zinc finger protein 143 (SPH-binding factor) (Selenocysteine tRNA gene transcription-activating factor, hStaf)" ZNF143 SBF STAF Homo sapiens (Human) "positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0005654; GO:0006355; GO:0006357; GO:0006359; GO:0045944; GO:0045945; GO:0046872; GO:0048661; GO:1905382 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRCEYDGCGKLYTTAHHLK 0.99247 -25.648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7132 0 0 0 0 0 0 0 0 0 0 0 0 13.051 0 12.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.623 0 12.4412 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1233 0 0 0 0 0 0 0 0 0 0 13.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62955 CCG7_HUMAN "Voltage-dependent calcium channel gamma-7 subunit (Neuronal voltage-gated calcium channel gamma-7 subunit) (Transmembrane AMPAR regulatory protein gamma-7, TARP gamma-7)" CACNG7 Homo sapiens (Human) "calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of dendrite extension [GO:1903861]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; regulation of mRNA stability [GO:0043488]; transmission of nerve impulse [GO:0019226]" AMPA glutamate receptor complex [GO:0032281]; cerebellar mossy fiber [GO:0044300]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; L-type voltage-gated calcium channel complex [GO:1990454]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891] "AMPA glutamate receptor complex [GO:0032281]; cerebellar mossy fiber [GO:0044300]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; L-type voltage-gated calcium channel complex [GO:1990454]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of dendrite extension [GO:1903861]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; regulation of mRNA stability [GO:0043488]; transmission of nerve impulse [GO:0019226]" GO:0005245; GO:0005246; GO:0005769; GO:0005886; GO:0005891; GO:0006816; GO:0016247; GO:0019226; GO:0032281; GO:0043025; GO:0043488; GO:0044300; GO:0051968; GO:0098839; GO:0098943; GO:0098970; GO:0098978; GO:0099061; GO:0099590; GO:0099645; GO:1903861; GO:1990454; GO:2000311 calcium channel regulator activity [GO:0005246]; channel regulator activity [GO:0016247]; voltage-gated calcium channel activity [GO:0005245] PQRTILAFVSGIFFILSGLSLVVGLVLYISSINDEVMNR 0.99247 -17.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5657 0 12.7322 0 0 0 11.708 0 0 0 11.038 12.9244 0 0 0 0 0 0 0 0 0 0 12.774 0 0 0 0 0 0 0 0 0 13.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3959 0 Q14498 RBM39_HUMAN "RNA-binding protein 39 (CAPER alpha, CAPERalpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1)" RBM39 HCC1 RNPC2 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] "centriolar satellite [GO:0034451]; microtubule cytoskeleton [GO:0015630]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" GO:0003723; GO:0005654; GO:0006396; GO:0006397; GO:0008380; GO:0015630; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733 RNA binding [GO:0003723]; RS domain binding [GO:0050733] DARTVFCMQLAAR 0.99247 -4.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4488 0 0 0 0 0 0 0 0 13.0013 13.3745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7541 0 0 0 0 0 0 0 0 0 0 0 0 Q16186 ADRM1_HUMAN "Proteasomal ubiquitin receptor ADRM1 (110 kDa cell membrane glycoprotein, Gp110) (Adhesion-regulating molecule 1, ARM-1) (Proteasome regulatory particle non-ATPase 13, hRpn13) (Rpn13 homolog)" ADRM1 GP110 Homo sapiens (Human) proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; transcription elongation from RNA polymerase II promoter [GO:0006368]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000502; GO:0002020; GO:0005654; GO:0005829; GO:0005886; GO:0006368; GO:0006511; GO:0008541; GO:0043130; GO:0043161; GO:0043248; GO:0061133; GO:0070628 endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130] DEEEDMSLD 0.99247 -17.507 0 0 0 0 0 0 0 0 0 0 9.96316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4591 0 0 0 0 10.6475 0 0 12.6086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.739 0 0 0 0 0 0 0 0 0 0 11.4277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74604 0 0 0 0 0 0 0 0 12.7035 0 0 11.4115 0 0 0 10.9579 0 0 0 0 0 0 0 0 0 12.1532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3813 0 0 0 0 0 0 0 Q16653 MOG_HUMAN Myelin-oligodendrocyte glycoprotein MOG Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001618; GO:0001817; GO:0005102; GO:0005886; GO:0007155; GO:0007417; GO:0009897; GO:0016021; GO:0050852 signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618] ALVGDEVELPCR 0.99247 -7.7037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.578 0 0 0 11.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4002 0 11.2404 0 0 0 0 0 0 0 0 13.4093 0 0 0 15.2772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2D8 XRRA1_HUMAN X-ray radiation resistance-associated protein 1 XRRA1 Homo sapiens (Human) response to X-ray [GO:0010165] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165] GO:0005634; GO:0005654; GO:0005737; GO:0010165; GO:0016604 AFSGIYK 0.99247 -64.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3904 0 0 0 0 0 0 0 0 11.3462 13.5793 0 0 0 0 0 0 13.7171 0 13.878 13.9088 13.7095 14.034 0 15.6426 0 13.7559 0 12.6457 0 0 13.9267 0 12.3563 0 0 0 0 0 0 0 0 0 14.5123 0 0 13.3993 0 0 15.2438 0 0 0 0 0 13.2932 0 0 12.3064 0 13.4993 13.7718 14.3276 0 0 14.3011 13.4291 0 12.4832 0 0 0 12.7335 0 0 0 0 0 0 0 0 14.7812 0 Q6PCB0 VWA1_HUMAN von Willebrand factor A domain-containing protein 1 VWA1 Homo sapiens (Human) behavioral response to pain [GO:0048266]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; identical protein binding [GO:0042802]; behavioral response to pain [GO:0048266]; extracellular matrix organization [GO:0030198] GO:0005604; GO:0005614; GO:0005615; GO:0005788; GO:0030198; GO:0042802; GO:0048266; GO:0062023; GO:0070062 identical protein binding [GO:0042802] LLRPQILR 0.99247 -4.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9219 12.4159 0 0 12.0051 0 0 14.1411 13.9634 0 13.8854 0 14.3047 0 0 0 0 0 13.5901 0 13.4656 0 13.5651 0 13.2023 0 0 0 12.8168 0 0 12.3392 0 0 0 0 0 13.47 0 0 0 0 0 0 0 0 0 0 0 11.9898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZM8 ZN654_HUMAN Zinc finger protein 654 (Melanoma-associated antigen) ZNF654 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" ARYLIACER 0.99247 -66.037 0 0 0 0 0 0 0 0 13.7752 0 0 0 0 0 0 0 0 0 0 0 0 10.8489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6929 0 0 0 12.0431 0 0 0 12.3374 12.2474 0 10.7337 11.2148 0 10.5763 10.9279 0 0 0 0 0 0 0 0 0 0 0 12.5447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4521 0 0 0 11.9238 0 0 0 0 0 13.1539 0 0 0 0 12.7125 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1496 0 0 12.9945 13.9087 0 13.62 0 0 0 12.6587 0 0 0 0 0 0 0 0 0 12.5149 0 0 0 0 0 0 0 0 0 0 0 13.1242 0 0 0 0 0 0 0 Q8N1E6 FXL14_HUMAN F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14) FBXL14 FBL14 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0019005; GO:0031146 ubiquitin-protein transferase activity [GO:0004842] GIRRVQILSLR 0.99247 -17.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4392 13.2066 0 0 0 0 0 0 0 0 0 0 0 15.3593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0142 0 0 0 0 0 0 0 0 0 0 0 0 15.0042 14.3406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8855 11.5445 11.8771 11.9772 11.0878 0 11.4788 0 0 11.6677 0 11.7181 0 0 0 16.406 16.2006 16.1028 0 0 0 0 0 0 Q8N465 D2HDH_HUMAN "D-2-hydroxyglutarate dehydrogenase, mitochondrial, EC 1.1.99.39" D2HGDH D2HGD Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; malate metabolic process [GO:0006108]; protein metabolic process [GO:0019538]; response to cobalt ion [GO:0032025]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; FAD binding [GO:0071949]; zinc ion binding [GO:0008270]; 2-oxoglutarate metabolic process [GO:0006103]; malate metabolic process [GO:0006108]; protein metabolic process [GO:0019538]; response to cobalt ion [GO:0032025]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043] GO:0005739; GO:0005759; GO:0006103; GO:0006108; GO:0008270; GO:0010042; GO:0010043; GO:0019538; GO:0032025; GO:0051990; GO:0071949 (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; FAD binding [GO:0071949]; zinc ion binding [GO:0008270] ARLGPHAK 0.99247 -6.1722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8835 0 0 0 0 0 0 0 0 0 13.0088 0 0 0 0 0 0 0 12.1887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4617 0 12.8441 12.9628 0 0 0 12.6775 0 13.8647 14.6226 13.8883 14.129 13.7629 0 0 0 0 0 0 0 14.0837 0 0 0 0 13.9781 0 0 0 0 0 0 0 13.0984 0 0 13.6143 0 0 0 0 12.3465 0 0 0 0 13.8916 0 12.8778 13.5383 0 0 0 13.4265 13.0725 13.6994 0 0 13.6064 0 0 0 0 0 12.9643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGP4 OR5M3_HUMAN Olfactory receptor 5M3 (Olfactory receptor OR11-191) OR5M3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] MLENLLSDK 0.99247 -4.8999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUM9 S20A1_HUMAN "Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1, GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1, PiT-1) (Solute carrier family 20 member 1)" SLC20A1 GLVR1 PIT1 Homo sapiens (Human) biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]; biomineral tissue development [GO:0031214]; ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005315; GO:0005316; GO:0005436; GO:0005886; GO:0005887; GO:0006796; GO:0006811; GO:0016020; GO:0031214; GO:0035435; GO:0038023; GO:0043123 high-affinity inorganic phosphate:sodium symporter activity [GO:0005316]; inorganic phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436] DSGLYKELLHKLHLAK 0.99247 -17.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1274 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8073 0 0 0 0 0 0 13.3198 0 0 14.3427 0 14.8746 0 0 0 0 0 0 13.3529 0 17.0207 0 0 0 0 0 0 0 0 15.1251 0 0 0 0 0 0 0 13.5974 0 0 0 0 0 0 0 13.3407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0097 0 0 0 0 0 0 0 0 0 Q96GX5 GWL_HUMAN "Serine/threonine-protein kinase greatwall, GW, GWL, hGWL, EC 2.7.11.1 (Microtubule-associated serine/threonine-protein kinase-like, MAST-L)" MASTL GW GWL THC2 Homo sapiens (Human) cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; female meiosis II [GO:0007147]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; regulation of cell cycle [GO:0051726] GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0007147; GO:0016301; GO:0018105; GO:0032154; GO:0032515; GO:0035556; GO:0051301; GO:0051721; GO:0051726; GO:0106310; GO:1904668 ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ESSFEESNIEDPLIVTPDCQEK 0.99247 -17.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0591 0 0 0 0 0 0 0 0 14.311 0 0 0 14.3086 0 0 0 0 0 0 0 0 0 0 0 0 14.8912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JE7 SC16B_HUMAN "Protein transport protein Sec16B (Leucine zipper transcription regulator 2) (Regucalcin gene promoter region-related protein p117, RGPR-p117) (SEC16 homolog B)" SEC16B KIAA1928 LZTR2 RGPR SEC16S Homo sapiens (Human) autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031] cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; positive regulation of gene expression [GO:0010628]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein transport [GO:0015031] GO:0000139; GO:0005789; GO:0005829; GO:0006888; GO:0006914; GO:0007029; GO:0007030; GO:0007031; GO:0010628; GO:0012507; GO:0015031; GO:0016559; GO:0043231; GO:0048208; GO:0070863; GO:0070971; GO:0070973 AAQSCKSETLGSR 0.99247 -17.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9306 0 13.7693 14.9056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4157 13.6518 13.6319 13.1763 0 0 0 0 0 12.2402 0 0 0 0 0 0 0 0 0 0 0 0 13.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1731 0 0 0 0 11.2172 0 Q96NL8 CF418_HUMAN Cilia- and flagella-associated protein 418 CFAP418 C8orf37 smalltalk Homo sapiens (Human) photoreceptor cell morphogenesis [GO:0008594] cell junction [GO:0030054]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886] cell junction [GO:0030054]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; photoreceptor cell morphogenesis [GO:0008594] GO:0001917; GO:0005737; GO:0005829; GO:0005886; GO:0008594; GO:0030054; GO:0097546 GCGGGTHSSDR 0.99247 -6.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7846 0 0 0 0 0 0 0 0 0 0 12.7022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RU3 FNBP1_HUMAN "Formin-binding protein 1 (Formin-binding protein 17, hFBP17)" FNBP1 FBP17 KIAA0554 Homo sapiens (Human) endocytosis [GO:0006897]; signal transduction [GO:0007165] cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; signal transduction [GO:0007165] GO:0005764; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005938; GO:0006897; GO:0007165; GO:0008289; GO:0031410; GO:0042802; GO:0043231 identical protein binding [GO:0042802]; lipid binding [GO:0008289] AQQHIETCWKQLESSKR 0.99247 -17.947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8522 0 0 0 0 0 0 0 12.0301 0 0 0 0 0 0 0 0 0 11.4863 10.6688 0 0 0 0 0 0 0 0 0 0 0 15.9016 0 15.2906 0 14.7796 12.691 0 11.952 12.8524 0 13.1605 0 12.5121 12.6983 0 0 0 0 0 0 11.6958 0 0 0 13.5981 13.0326 0 10.889 0 0 0 0 12.0646 0 0 0 0 0 0 0 12.4726 0 0 0 12.8679 0 0 0 0 0 0 0 0 0 0 0 14.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5789 0 13.3415 0 0 0 0 0 13.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8162 0 0 0 12.6455 0 0 0 0 0 0 12.4229 0 0 0 0 0 0 0 12.4781 0 0 0 0 0 0 0 12.4451 0 17.7379 0 0 0 0 Q99550 MPP9_HUMAN M-phase phosphoprotein 9 MPHOSPH9 MPP9 Homo sapiens (Human) negative regulation of cilium assembly [GO:1902018] centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; negative regulation of cilium assembly [GO:1902018] GO:0000139; GO:0005794; GO:0005813; GO:0005814; GO:0016020; GO:1902018 DIYYKKQR 0.99247 -17.547 0 0 0 0 0 15.0811 0 0 0 13.8349 14.18 0 0 14.2543 0 13.6092 13.6081 14.5092 0 12.8216 12.4543 0 12.7682 0 13.6352 13.2228 13.8167 12.8774 14.2672 13.7121 0 0 0 0 0 0 0 0 13.1938 13.6393 13.4362 0 0 0 13.3567 14.0559 14.4785 0 17.1074 0 13.4543 13.2223 0 13.4847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9865 0 0 14.9594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8607 0 0 0 16.3969 0 0 13.0279 0 0 0 18.8115 0 0 19.9052 0 14.6876 14.3847 0 0 15.4834 0 14.9143 0 12.199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8889 0 0 0 11.1751 0 0 0 0 0 0 0 0 14.354 0 0 0 19.652 18.9443 0 0 0 14.8983 15.0671 0 0 13.6722 13.6295 16.3307 0 14.5775 12.1012 14.6254 14.6953 13.7377 13.5231 13.5163 0 0 0 0 0 0 14.4386 0 0 Q9HB09 B2L12_HUMAN "Bcl-2-like protein 12, Bcl2-L-12 (Bcl-2-related proline-rich protein)" BCL2L12 BPR Homo sapiens (Human) apoptotic process [GO:0006915]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] membrane [GO:0016020]; nucleus [GO:0005634] membrane [GO:0016020]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] GO:0005634; GO:0006915; GO:0016020; GO:0045944; GO:1990001; GO:2001236 ACPGPPPPSPEPLARLALAMELSR 0.99247 -17.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5935 0 0 0 10.8022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5682 Q9NR96 TLR9_HUMAN Toll-like receptor 9 (CD antigen CD289) TLR9 UNQ5798/PRO19605 Homo sapiens (Human) activation of innate immune response [GO:0002218]; cellular response to chloroquine [GO:1902350]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to metal ion [GO:0071248]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; maintenance of gastrointestinal epithelium [GO:0030277]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell activation [GO:0050871]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of B cell differentiation [GO:0045577]; regulation of dendritic cell cytokine production [GO:0002730]; regulation of toll-like receptor 9 signaling pathway [GO:0034163]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome [GO:0036019]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome [GO:0036019]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; interleukin-1 receptor binding [GO:0005149]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; unmethylated CpG binding [GO:0045322]; activation of innate immune response [GO:0002218]; cellular response to chloroquine [GO:1902350]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to metal ion [GO:0071248]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; innate immune response [GO:0045087]; maintenance of gastrointestinal epithelium [GO:0030277]; male gonad development [GO:0008584]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901895]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of autophagy [GO:0010508]; positive regulation of B cell activation [GO:0050871]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of B cell differentiation [GO:0045577]; regulation of dendritic cell cytokine production [GO:0002730]; regulation of toll-like receptor 9 signaling pathway [GO:0034163]; response to molecule of bacterial origin [GO:0002237]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224] GO:0000139; GO:0001774; GO:0002218; GO:0002224; GO:0002237; GO:0002639; GO:0002730; GO:0002755; GO:0004888; GO:0005149; GO:0005576; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005886; GO:0007249; GO:0007252; GO:0008584; GO:0010008; GO:0010508; GO:0010628; GO:0016021; GO:0016323; GO:0016324; GO:0030277; GO:0030890; GO:0032009; GO:0032088; GO:0032715; GO:0032717; GO:0032722; GO:0032725; GO:0032727; GO:0032728; GO:0032729; GO:0032733; GO:0032735; GO:0032741; GO:0032755; GO:0032757; GO:0032760; GO:0034122; GO:0034123; GO:0034162; GO:0034163; GO:0034165; GO:0035197; GO:0036019; GO:0036020; GO:0038187; GO:0042742; GO:0042803; GO:0043123; GO:0043410; GO:0043507; GO:0045087; GO:0045322; GO:0045577; GO:0045944; GO:0046330; GO:0050729; GO:0050829; GO:0050871; GO:0051092; GO:0051607; GO:0051770; GO:0070373; GO:0071222; GO:0071248; GO:1901224; GO:1901895; GO:1902350 interleukin-1 receptor binding [GO:0005149]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; unmethylated CpG binding [GO:0045322] AFQGLTQLR 0.99247 -18.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9649 0 0 0 0 17.1697 0 0 0 0 0 0 0 0 13.773 0 0 0 0 0 11.1653 0 0 0 0 0 0 0 0 0 0 0 12.2519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.933 0 0 0 13.3404 0 0 0 0 11.198 0 0 0 0 0 0 0 0 0 0 11.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RUC4 TYW5_HUMAN "tRNA wybutosine-synthesizing protein 5, hTYW5, EC 1.14.11.42 (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase)" TYW5 C2orf60 Homo sapiens (Human) wybutosine biosynthetic process [GO:0031591] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524]; wybutosine biosynthetic process [GO:0031591] GO:0000049; GO:0005506; GO:0005737; GO:0016706; GO:0031591; GO:0042803; GO:0102524 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524] DPTAASR 0.99248 -24.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1847 0 0 0 0 0 0 15.4284 0 0 0 14.3127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7619 0 0 0 0 0 0 0 0 13.3796 0 0 0 0 0 0 14.2281 0 0 A6NI56 CC154_HUMAN Coiled-coil domain-containing protein 154 CCDC154 C16orf29 Homo sapiens (Human) bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691] early endosome [GO:0005769] early endosome [GO:0005769]; bone mineralization involved in bone maturation [GO:0035630]; bone resorption [GO:0045453]; odontogenesis of dentin-containing tooth [GO:0042475]; tooth eruption [GO:0044691] GO:0005769; GO:0035630; GO:0042475; GO:0044691; GO:0045453 ALPSLVRPRVFIK 0.99248 -45.904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.513 0 13.3174 13.3669 13.0571 13.6028 0 0 0 13.2849 16.1443 13.4705 13.071 0 13.1908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0744 12.9323 12.9539 14.8599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7765 0 0 0 0 0 0 0 16.2807 16.1024 16.1469 16.3064 16.1157 15.9715 15.7286 14.9924 18.2044 12.6501 0 0 12.6886 0 0 0 0 0 0 0 0 0 16.3818 17.6912 17.3309 0 0 16.9931 0 0 0 17.4461 0 0 0 16.6695 16.2341 0 0 0 0 0 0 0 0 0 16.6759 0 12.5739 0 0 16.8651 0 0 11.8308 16.446 0 13.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2469 0 0 15.4011 0 0 0 0 0 15.1675 0 0 0 0 0 0 15.0904 0 0 0 11.4394 0 0 0 0 0 16.163 0 12.9681 0 0 0 0 0 14.3154 A6NKQ9 CGB1_HUMAN Choriogonadotropin subunit beta variant 1 CGB1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0005179; GO:0005615; GO:0005737; GO:0007186 hormone activity [GO:0005179] EPLRPRCR 0.99248 -4.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8479 0 0 10.3637 0 0 0 0 10.2396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3683 12.7587 0 12.1192 12.0326 0 0 0 0 0 0 0 0 0 13.0514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5191 0 12.9648 13.1001 12.3183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3329 0 0 0 0 0 12.2026 0 0 12.5403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B2CW77 KILIN_HUMAN Killin KLLN Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; cell cycle [GO:0007049] GO:0003677; GO:0005654; GO:0005730; GO:0006915; GO:0007049 DNA binding [GO:0003677] GDLGGFK 0.99248 -17.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8082 0 0 O60547 GMDS_HUMAN "GDP-mannose 4,6 dehydratase, EC 4.2.1.47 (GDP-D-mannose dehydratase, GMD)" GMDS Homo sapiens (Human) 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219]" GO:0005737; GO:0005829; GO:0007219; GO:0008446; GO:0019673; GO:0042351; GO:0042802; GO:0070062; GO:0070401 "GDP-mannose 4,6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]" MAHAPAR 0.99248 -14.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DKX0 ZN728_HUMAN Zinc finger protein 728 ZNF728 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSWVSVLNKHKK 0.99248 -6.7485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7842 0 0 0 0 0 0 0 0 0 0 11.5798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10515 ODP2_HUMAN "Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial, EC 2.3.1.12 (70 kDa mitochondrial autoantigen of primary biliary cirrhosis, PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2, PDC-E2, PDCE2)" DLAT DLTA Homo sapiens (Human) acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099] GO:0004742; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0042802; GO:0043231; GO:0045254 dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802] GFDVASMMSVTLSCDHR 0.99248 -4.9083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2024 0 0 0 0 0 0 0 0 0 0 0 0 14.7569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12956 XRCC6_HUMAN "X-ray repair cross-complementing protein 6, EC 3.6.4.-, EC 4.2.99.- (5'-deoxyribose-5-phosphate lyase Ku70, 5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit, CTC75, CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70, Ku70) (Thyroid-lupus autoantigen, TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6)" XRCC6 G22P1 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA ligation [GO:0006266]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; innate immune response [GO:0045087]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; telomere maintenance [GO:0000723]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; secretory granule lumen [GO:0034774]; transcription regulator complex [GO:0005667]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; secretory granule lumen [GO:0034774]; transcription regulator complex [GO:0005667]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin binding [GO:0030332]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; activation of innate immune response [GO:0002218]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA ligation [GO:0006266]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; innate immune response [GO:0045087]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; telomere maintenance [GO:0000723]" GO:0000723; GO:0000725; GO:0000781; GO:0000783; GO:0000976; GO:0002218; GO:0003677; GO:0003678; GO:0003684; GO:0003690; GO:0003723; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005829; GO:0006266; GO:0006303; GO:0008022; GO:0008094; GO:0016020; GO:0016787; GO:0030332; GO:0032991; GO:0032993; GO:0034774; GO:0042162; GO:0043564; GO:0044877; GO:0045087; GO:0045621; GO:0045860; GO:0045892; GO:0045893; GO:0045944; GO:0048660; GO:0051575; GO:0070418; GO:0070419; GO:0071480; GO:0071481; GO:0097110; GO:0097680; GO:1904813 "5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin binding [GO:0030332]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; hydrolase activity [GO:0016787]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]" ALKPPPIK 0.99248 -25.005 0 0 0 0 0 0 0 0 15.515 11.2959 0 0 0 0 0 0 0 14.1931 0 0 0 14.61 0 14.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0595 0 0 15.2637 0 0 0 0 15.3342 0 0 14.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7489 0 0 14.7275 13.6416 0 15.2017 0 0 0 0 0 0 15.8446 0 16.4388 0 0 0 0 0 0 0 0 14.6128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18077 RL35A_HUMAN 60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33) RPL35A GIG33 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0000049; GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042273; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049] AIFAGYK 0.99248 -24.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5641 0 0 0 0 0 0 0 0 0 10.9399 0 0 0 0 0 0 0 0 0 16.7752 0 11.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.735 0 0 0 13.9974 0 0 0 0 14.9909 0 0 13.495 0 0 0 0 0 0 0 0 0 13.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5074 0 0 0 0 0 0 0 0 0 0 0 15.6927 0 0 0 13.2991 0 0 0 14.3945 0 0 0 0 0 0 0 0 12.0764 0 0 0 12.2986 0 0 0 0 P82933 RT09_HUMAN "28S ribosomal protein S9, mitochondrial, MRP-S9, S9mt (Mitochondrial small ribosomal subunit protein uS9m)" MRPS9 RPMS9 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005730; GO:0005739; GO:0005743; GO:0005763; GO:0015935; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ALCSFVTEDEVEWMR 0.99248 -25.919 0 0 0 0 11.9852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2016 0 0 0 0 0 0 0 0 0 0 0 0 15.4468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5297 0 0 0 0 0 14.1745 0 0 0 0 0 0 0 0 0 0 14.1746 13.541 0 0 0 0 0 0 0 0 11.9437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1082 0 11.6016 0 0 0 0 0 0 0 14.6932 0 13.2026 0 Q16819 MEP1A_HUMAN "Meprin A subunit alpha, EC 3.4.24.18 (Endopeptidase-2) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit alpha) (PABA peptide hydrolase) (PPH alpha)" MEP1A Homo sapiens (Human) epidermal growth factor receptor ligand maturation [GO:0038004]; signaling receptor ligand precursor processing [GO:0140448] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; plasma membrane [GO:0005886]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; epidermal growth factor receptor ligand maturation [GO:0038004]; signaling receptor ligand precursor processing [GO:0140448] GO:0004222; GO:0005615; GO:0005886; GO:0005887; GO:0008237; GO:0008270; GO:0017090; GO:0038004; GO:0070062; GO:0070573; GO:0140448 metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] NGLRDPNTR 0.99248 -4.9119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3098 0 0 0 0 0 0 0 11.8916 0 0 0 0 0 0 0 12.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9652 0 0 0 0 0 0 Q6UY09 CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 CEACAM20 UNQ9366/PRO34155 Homo sapiens (Human) immune system process [GO:0002376]; positive regulation of cytokine production [GO:0001819]; regulation of immune system process [GO:0002682]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; protein tyrosine kinase binding [GO:1990782]; immune system process [GO:0002376]; positive regulation of cytokine production [GO:0001819]; regulation of immune system process [GO:0002682]; response to bacterium [GO:0009617]; signal transduction [GO:0007165] GO:0001819; GO:0002376; GO:0002682; GO:0005886; GO:0007165; GO:0009617; GO:0009986; GO:0016021; GO:0016324; GO:0031528; GO:1990782 protein tyrosine kinase binding [GO:1990782] DALLSQR 0.99248 -24.135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2374 0 0 0 0 0 0 0 0 0 16.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEA4 FBX36_HUMAN F-box only protein 36 FBXO36 FBX36 Homo sapiens (Human) FAKLCMSDK 0.99248 -7.2139 0 0 0 0 0 0 0 0 0 0 12.2557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6027 0 0 13.2109 13.2426 0 0 0 0 13.6551 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEA8 DTD1_HUMAN "D-aminoacyl-tRNA deacylase 1, DTD, EC 3.1.1.96 (DNA-unwinding element-binding protein B, DUE-B) (Gly-tRNA(Ala) deacylase) (Histidyl-tRNA synthase-related)" DTD1 C20orf88 DUEB HARS2 Homo sapiens (Human) DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399] GO:0000049; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0006399; GO:0046872; GO:0051500 D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049] ELEHMVRK 0.99248 -7.7485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2733 0 0 0 0 0 12.4775 0 0 0 0 0 0 0 0 13.0147 0 0 0 0 0 Q96PN8 TSSK3_HUMAN "Testis-specific serine/threonine-protein kinase 3, TSK-3, TSSK-3, Testis-specific kinase 3, EC 2.7.11.1 (Serine/threonine-protein kinase 22C)" TSSK3 SPOGA3 STK22C Homo sapiens (Human) cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0030154; GO:0035556; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FLPRELQIVRTLDHK 0.99248 -4.7579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYK8 HELZ2_HUMAN "Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1, PDIP1, PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein, EC 3.6.4.-)" HELZ2 KIAA1769 PRIC285 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]" cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000184; GO:0003677; GO:0003723; GO:0003724; GO:0004540; GO:0005524; GO:0005654; GO:0005737; GO:0016020; GO:0030374; GO:0045944; GO:0046872 ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ALERSAFGRCAR 0.99248 -40.416 16.2812 15.6276 0 0 0 0 13.6561 13.4146 0 0 0 0 0 0 0 0 0 11.0578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3421 0 0 0 0 0 0 0 0 14.8787 0 0 14.6807 0 0 0 0 15.3187 15.3353 0 12.9293 14.373 0 0 14.564 0 0 0 0 15.8028 15.6584 0 14.4615 14.5886 0 0 0 0 14.2778 12.3398 0 12.3351 14.0604 0 0 15.075 0 0 15.2006 0 0 0 14.8028 15.2313 0 12.6058 14.7192 0 14.6111 14.5155 0 14.2229 14.2583 12.5001 15.2534 14.108 0 14.2934 0 0 0 14.8834 10.844 0 11.8536 0 0 0 10.8472 14.2272 14.7369 13.1317 0 0 11.524 15.0369 14.8036 13.4205 0 14.1419 0 0 0 11.7492 0 0 15.6241 0 0 0 10.7875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6009 Q9H098 F107B_HUMAN Protein FAM107B FAM107B C10orf45 Homo sapiens (Human) NHQDLHR 0.99248 -4.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7275 0 0 0 0 0 0 0 0 12.2741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVM9 INT13_HUMAN Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95) INTS13 ASUN C12orf11 GCT1 Homo sapiens (Human) cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016180; GO:0016604; GO:0030317; GO:0032039; GO:0034243; GO:0043231; GO:0051301; GO:0051642; GO:0080154; GO:0090435 EGSFKETITLK 0.99248 -18.436 0 0 0 0 0 0 0 0 0 0 0 13.9465 0 13.0034 0 12.1678 0 0 0 13.6125 0 0 0 0 0 0 0 0 0 13.4151 0 13.3072 0 0 0 0 0 0 13.2059 11.3033 0 12.4436 0 0 0 11.9271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.508 0 0 0 14.5341 0 0 0 0 13.746 0 14.4858 0 0 0 0 0 0 0 0 0 0 0 0 14.5685 0 14.6611 0 0 14.3021 0 14.7641 16.0441 13.7356 13.4866 13.7306 0 0 13.6588 0 0 14.6563 13.7942 0 14.0932 0 0 14.4524 13.7433 13.6651 13.9485 13.358 0 0 0 0 14.5032 0 0 0 14.5911 0 13.4097 0 0 0 13.2329 0 13.4985 0 0 0 0 13.3325 0 0 0 0 13.2045 0 12.8471 0 0 0 13.8301 12.7653 0 13.1645 0 12.6751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8085 0 0 0 0 Q8NA47 CCD63_HUMAN Coiled-coil domain-containing protein 63 CCDC63 Homo sapiens (Human) cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286] axoneme [GO:0005930] axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286] GO:0003341; GO:0005930; GO:0007286; GO:0036158 EEALKAKK 0.99249 -4.4415 0 0 0 0 0 0 0 0 17.7196 0 13.375 13.5774 13.0931 0 0 0 12.3355 0 13.1818 13.3461 13.0802 0 13.4365 0 14.3219 13.3581 0 14.0562 0 11.4511 12.9197 0 13.6323 13.0764 0 0 0 0 0 12.9705 0 0 0 12.9879 13.6298 13.7141 14.1532 13.8693 0 0 0 0 12.6562 13.0728 0 12.1384 14.6436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5819 0 12.5282 11.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7771 0 0 15.0103 0 13.7104 0 0 0 14.2363 0 11.2321 0 0 0 0 0 0 0 0 0 0 13.266 0 12.4071 0 0 0 12.9577 0 12.1806 0 0 0 0 12.0169 0 12.6741 0 13.7439 0 11.9942 0 0 0 0 0 0 0 0 0 0 15.5471 11.9663 0 0 0 0 0 0 0 11.9691 0 14.376 15.1383 18.4597 14.8279 12.9772 12.614 13.5841 11.7026 13.6904 14.0621 15.238 15.118 13.9285 12.3798 0 0 0 15.084 0 14.4396 11.951 0 O00308 WWP2_HUMAN "NEDD4-like E3 ubiquitin-protein ligase WWP2, EC 2.3.2.26 (Atrophin-1-interacting protein 2, AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2)" WWP2 Homo sapiens (Human) "extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transporter activity [GO:0032410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; transcription by RNA polymerase II [GO:0006366]; viral entry into host cell [GO:0046718]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transporter activity [GO:0032410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; transcription by RNA polymerase II [GO:0006366]; viral entry into host cell [GO:0046718]" GO:0000122; GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006366; GO:0006858; GO:0008134; GO:0010629; GO:0016020; GO:0016567; GO:0032410; GO:0034765; GO:0036211; GO:0042391; GO:0043161; GO:0043433; GO:0045746; GO:0045892; GO:0045944; GO:0046718; GO:0051224; GO:0051865; GO:0061629; GO:0061630; GO:0070062; GO:0070534; GO:1901016 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AGVALPFEK 0.99249 -15.046 0 0 0 0 0 0 0 0 0 0 0 0 12.4212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9915 13.3461 0 0 0 0 0 0 0 0 0 13.8682 0 0 0 0 0 0 0 0 0 12.3139 0 0 0 0 0 0 15.3544 0 0 0 0 12.2398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1229 0 0 12.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3507 0 O43316 PAX4_HUMAN Paired box protein Pax-4 PAX4 Homo sapiens (Human) anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; pancreas development [GO:0031016]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0005654; GO:0006357; GO:0009887; GO:0030154; GO:0031016; GO:0048856; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ILGRYYR 0.99249 -15.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43520 AT8B1_HUMAN "Phospholipid-transporting ATPase IC, EC 7.6.2.1 (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1)" ATP8B1 ATPIC FIC1 PFIC Homo sapiens (Human) "apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; regulation of microvillus assembly [GO:0032534]; regulation of plasma membrane organization [GO:1903729]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]; xenobiotic transmembrane transport [GO:0006855]" apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; trans-Golgi network [GO:0005802] "apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; regulation of microvillus assembly [GO:0032534]; regulation of plasma membrane organization [GO:1903729]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]; xenobiotic transmembrane transport [GO:0006855]" GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006855; GO:0007030; GO:0007605; GO:0008206; GO:0015721; GO:0016324; GO:0016604; GO:0016887; GO:0021650; GO:0032420; GO:0032534; GO:0034220; GO:0045176; GO:0045332; GO:0045892; GO:0060119; GO:0090554; GO:0090556; GO:0140326; GO:0140345; GO:0140346; GO:1901612; GO:1903729; GO:1990531; GO:2001225 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] ALIITGSWLNEILLEKKTK 0.99249 -46.824 13.7119 13.1897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9084 12.4423 0 0 0 12.4969 0 0 0 0 12.9486 0 0 13.3882 0 0 0 0 0 12.6032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8659 0 0 0 0 0 0 0 15.523 0 0 16.9819 0 0 15.7998 0 14.8381 0 12.4118 0 13.965 0 12.2282 0 0 14.792 13.9474 0 0 0 0 0 0 0 15.8163 0 0 12.8911 0 0 0 0 0 0 13.4493 0 13.8422 12.6327 0 0 0 0 0 0 12.7413 13.2583 0 0 15.0636 0 0 12.2602 0 0 0 0 0 12.9249 14.0979 0 0 0 0 15.3866 0 12.382 0 0 0 0 0 0 0 0 0 0 0 13.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 O95841 ANGL1_HUMAN "Angiopoietin-related protein 1 (Angiopoietin-3, ANG-3) (Angiopoietin-like protein 1)" ANGPTL1 ANG3 ANGPT3 ARP1 PSEC0154 UNQ162/PRO188 Homo sapiens (Human) transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005102; GO:0005615; GO:0007169; GO:0062023; GO:0070062 signaling receptor binding [GO:0005102] DLMPPPDLATSPTKSPFKIPPVTFINEGPFK 0.99249 -15.021 0 12.8102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1029 0 0 0 0 0 0 0 0 0 15.4682 0 15.8933 15.6473 13.5337 14.9827 15.8257 14.8526 16.7128 14.7222 15.9895 16.6716 16.7867 16.0331 15.0649 14.0175 14.4079 0 0 12.2223 0 0 13.9355 13.9558 16.344 14.4855 15.719 13.1358 17.4694 15.7995 15.6114 0 0 14.6121 0 0 0 0 0 15.0786 14.7035 14.1031 15.746 14.2831 0 0 13.8663 16.2131 16.6707 14.6757 0 14.714 13.6311 14.2936 0 14.6748 13.8554 0 0 15.4163 0 0 14.6774 17.0765 14.8333 13.4124 15.3428 14.8522 13.629 15.8717 14.5364 14.1839 16.3917 15.476 0 0 15.3886 14.7998 14.3308 15.2176 15.0445 0 13.9847 0 15.7081 15.5092 14.3058 15.7512 13.2227 15.1679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5041 0 0 0 0 15.5774 0 O96033 MOC2A_HUMAN "Molybdopterin synthase sulfur carrier subunit (MOCO1-A) (Molybdenum cofactor synthesis protein 2 small subunit) (Molybdenum cofactor synthesis protein 2A, MOCS2A) (Molybdopterin-synthase small subunit) (Sulfur carrier protein MOCS2A)" MOCS2 MOCO1 Homo sapiens (Human) Mo-molybdopterin cofactor biosynthetic process [GO:0006777] cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008] cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; molybdopterin synthase activity [GO:0030366]; nucleotide binding [GO:0000166]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777] GO:0000166; GO:0005829; GO:0006777; GO:0019008; GO:0030366 molybdopterin synthase activity [GO:0030366]; nucleotide binding [GO:0000166] NQIIFAVR 0.99249 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01715 LV301_HUMAN Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X) IGLV3-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814 antigen binding [GO:0003823] YACWYQQK 0.99249 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14621 ACYP2_HUMAN "Acylphosphatase-2, EC 3.6.1.7 (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2)" ACYP2 ACYP Homo sapiens (Human) phosphate-containing compound metabolic process [GO:0006796] acylphosphatase activity [GO:0003998]; identical protein binding [GO:0042802]; phosphate-containing compound metabolic process [GO:0006796] GO:0003998; GO:0006796; GO:0042802 acylphosphatase activity [GO:0003998]; identical protein binding [GO:0042802] IGVVGWVK 0.99249 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13084 RM28_HUMAN "39S ribosomal protein L28, mitochondrial, L28mt, MRP-L28 (Melanoma antigen p15) (Melanoma-associated antigen recognized by T-lymphocytes) (Mitochondrial large ribosomal subunit protein bL28m)" MRPL28 MAAT1 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005829; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] FGMDLKR 0.99249 -25.178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0989 0 0 12.7792 0 0 0 0 0 0 0 0 0 0 0 12.4267 0 0 12.2347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6855 0 0 0 0 0 0 0 0 11.5269 0 0 0 0 0 0 0 0 Q15155 NOMO1_HUMAN Nodal modulator 1 (pM5 protein) NOMO1 PM5 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; ribosome binding [GO:0043022] GO:0005789; GO:0016020; GO:0016021; GO:0030246; GO:0043022 carbohydrate binding [GO:0030246]; ribosome binding [GO:0043022] AYALAGVSFEIK 0.99249 -17.665 0 12.0734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0199 0 0 0 0 0 11.6484 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.677 0 0 0 0 0 0 0 0 11.8035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1229 0 0 13.5106 0 10.4272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6803 0 0 10.7518 0 0 0 0 0 0 11.6159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66GS9 CP135_HUMAN "Centrosomal protein of 135 kDa, Cep135 (Centrosomal protein 4)" CEP135 CEP4 KIAA0635 Homo sapiens (Human) centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857] GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008022; GO:0010457; GO:1902857; GO:1904951 protein C-terminus binding [GO:0008022] AEDWEVK 0.99249 -81.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0745 0 0 0 0 0 12.465 0 0 0 13.0029 0 0 12.971 0 13.2788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4656 0 0 0 0 0 0 0 0 0 0 0 15.4021 0 0 0 0 0 0 14.6858 0 0 10.8199 0 0 0 12.2434 0 0 0 0 0 0 0 0 0 0 14.0267 0 0 0 0 0 0 0 0 13.5229 0 0 0 0 13.1945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8873 0 0 14.8067 0 0 0 0 13.0022 Q6N075 MFSD5_HUMAN "Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog, hsMOT2)" MFSD5 UNQ832/PRO1759 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098] GO:0005886; GO:0015098; GO:0016020; GO:0016021 molybdate ion transmembrane transporter activity [GO:0015098] NWGENYDR 0.99249 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.613 13.5178 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3685 0 0 0 0 0 0 0 12.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N612 FHI1B_HUMAN "FHF complex subunit HOOK interacting protein 1B, FHIP1B (FTS and Hook-interacting protein, FHIP)" FHIP1B C11orf56 FAM160A2 KIAA1759 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] cytosol [GO:0005829]; FHF complex [GO:0070695] cytosol [GO:0005829]; FHF complex [GO:0070695]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031] GO:0005829; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0045022; GO:0070695; GO:1905719 FLSLIPR 0.99249 -18.091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5461 11.0463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9466 0 0 0 0 0 0 0 0 0 0 0 14.9092 0 0 0 0 11.1061 0 0 13.1835 0 0 0 0 0 0 0 0 10.1787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0599 0 0 0 0 0 12.851 16.7699 16.8394 0 0 0 14.4628 0 0 0 0 0 0 0 11.7438 0 0 0 0 0 14.5042 0 0 0 0 0 0 13.5324 0 0 0 0 13.9929 0 14.1019 0 0 0 0 14.0168 0 0 0 0 0 0 0 0 13.8066 0 0 15.1673 12.3913 0 0 0 0 0 0 0 0 0 0 0 0 12.8353 0 Q8TD08 MK15_HUMAN "Mitogen-activated protein kinase 15, MAP kinase 15, MAPK 15, EC 2.7.11.24 (Extracellular signal-regulated kinase 7, ERK-7) (Extracellular signal-regulated kinase 8, ERK-8)" MAPK15 ERK7 ERK8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; dopamine uptake [GO:0090494]; endoplasmic reticulum organization [GO:0007029]; intracellular signal transduction [GO:0035556]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of spindle assembly [GO:1905832]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to ciliary transition zone [GO:1904491]; regulation of autophagy [GO:0010506]; regulation of cilium assembly [GO:1902017]; regulation of COPII vesicle coating [GO:0003400] autophagosome [GO:0005776]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; nucleus [GO:0005634] autophagosome [GO:0005776]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; cellular response to DNA damage stimulus [GO:0006974]; dopamine uptake [GO:0090494]; endoplasmic reticulum organization [GO:0007029]; intracellular signal transduction [GO:0035556]; negative regulation of cell migration [GO:0030336]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of metaphase/anaphase transition of meiosis I [GO:1905188]; positive regulation of spindle assembly [GO:1905832]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to ciliary transition zone [GO:1904491]; regulation of autophagy [GO:0010506]; regulation of cilium assembly [GO:1902017]; regulation of COPII vesicle coating [GO:0003400] GO:0003400; GO:0003682; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005776; GO:0005794; GO:0005814; GO:0005911; GO:0005923; GO:0006974; GO:0007029; GO:0008284; GO:0010506; GO:0016301; GO:0017124; GO:0030336; GO:0031410; GO:0032212; GO:0035556; GO:0036064; GO:0046777; GO:0051973; GO:0072687; GO:0090494; GO:0106310; GO:1902017; GO:1904355; GO:1904491; GO:1905188; GO:1905832 ATP binding [GO:0005524]; chromatin binding [GO:0003682]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124] AAKNVPR 0.99249 -18.132 0 0 0 0 0 0 0 12.4795 0 0 11.7933 0 0 0 0 0 0 0 0 0 13.7315 0 0 0 0 0 0 0 0 0 12.6117 0 0 0 0 0 0 0 0 0 12.9709 0 10.3703 0 0 12.9604 12.9781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.197 0 0 0 0 0 0 0 0 0 0 0 0 11.4746 0 12.6357 12.5366 0 0 18.013 0 18.3929 11.3446 0 0 0 0 16.7673 0 0 0 0 0 0 0 0 12.6103 12.6774 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8324 0 0 0 13.6612 0 0 0 0 0 12.4615 0 0 11.9713 0 12.295 11.7463 0 12.6077 12.9169 13.0164 0 12.3654 13.4517 13.0147 13.6296 12.7144 11.9388 0 0 0 0 13.7903 0 0 0 10.3972 0 0 0 0 0 0 13.4991 0 0 14.2374 13.2982 0 0 0 14.9792 0 0 0 12.4302 13.2486 14.3708 0 0 14.7791 0 13.6617 0 0 Q96F81 DISP1_HUMAN Protein dispatched homolog 1 DISP1 DISPA Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708]; smoothened signaling pathway [GO:0007224]; transmembrane transport [GO:0055085] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; peptide transmembrane transporter activity [GO:1904680]; transmembrane transporter activity [GO:0022857]; determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708]; smoothened signaling pathway [GO:0007224]; transmembrane transport [GO:0055085] GO:0007224; GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016021; GO:0016323; GO:0022857; GO:0050708; GO:0055085; GO:0060539; GO:0070207; GO:1904680 peptide transmembrane transporter activity [GO:1904680]; transmembrane transporter activity [GO:0022857] IVERDVSHTLKLLR 0.99249 -17.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1995 0 0 0 14.5684 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4517 0 0 0 0 0 0 13.6509 11.9599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7101 11.0401 11.1522 10.8337 11.8137 12.5671 0 0 0 0 0 0 0 0 0 11.7071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IT1 ZN496_HUMAN Zinc finger protein 496 (Zinc finger protein with KRAB and SCAN domains 17) ZNF496 ZKSCAN17 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0045893; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EQILELLVLEQFLAILPR 0.99249 -25.282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0438 0 10.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6057 0 0 0 9.95591 11.0612 0 0 0 11.1488 0 0 0 0 0 13.2512 12.2993 0 0 12.5011 0 0 0 0 0 12.1126 13.3925 12.3297 0 0 15.4585 11.9728 0 11.8765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7537 0 0 0 0 13.6717 0 13.0333 11.0395 0 0 10.7432 0 0 0 0 0 11.9056 0 0 0 0 10.1826 0 13.284 0 0 15.4689 0 11.4266 0 0 0 0 0 12.2711 0 0 0 0 0 0 0 0 0 0 0 11.2138 0 0 0 0 0 0 0 0 0 9.88257 0 0 0 0 0 11.1005 Q96T53 MBOA4_HUMAN "Ghrelin O-acyltransferase, EC 2.3.1.- (Membrane-bound O-acyltransferase domain-containing protein 4, O-acyltransferase domain-containing protein 4)" MBOAT4 GOAT OACT4 FKSG89 Homo sapiens (Human) lipid modification [GO:0030258]; peptide hormone processing [GO:0016486]; peptidyl-serine octanoylation [GO:0018191]; protein decanoylation [GO:0051366] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; acyltransferase activity [GO:0016746]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; O-acyltransferase activity [GO:0008374]; serine O-acyltransferase activity [GO:0016412]; lipid modification [GO:0030258]; peptide hormone processing [GO:0016486]; peptidyl-serine octanoylation [GO:0018191]; protein decanoylation [GO:0051366]" GO:0005783; GO:0005789; GO:0008374; GO:0016020; GO:0016412; GO:0016486; GO:0016746; GO:0016747; GO:0018191; GO:0030176; GO:0030258; GO:0051366 "acyltransferase activity [GO:0016746]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; O-acyltransferase activity [GO:0008374]; serine O-acyltransferase activity [GO:0016412]" AASGGFR 0.99249 -15.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZY4 COA1_HUMAN Cytochrome c oxidase assembly factor 1 homolog (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa) COA1 C7orf44 MITRAC15 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981] cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981] GO:0005739; GO:0005743; GO:0005829; GO:0031305; GO:0032981; GO:0033617 IPVSGSK 0.99249 -4.9343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3S3 TMPS5_HUMAN "Transmembrane protease serine 5, EC 3.4.21.- (Spinesin)" TMPRSS5 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005044; GO:0005886; GO:0006508; GO:0008233; GO:0016021; GO:0043025 peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252] CSECGAR 0.99249 -18.074 12.6296 0 0 0 0 0 0 0 0 0 0 0 11.0817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4382 0 0 14.2993 0 0 0 11.9136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4509 0 0 14.9313 0 0 13.4423 0 0 0 0 0 13.0723 0 0 0 0 0 0 0 0 0 0 0 0 12.9769 0 0 0 0 0 0 0 12.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8M9 EVA1A_HUMAN Protein eva-1 homolog A (Protein FAM176A) (Transmembrane protein 166) EVA1A FAM176A TMEM166 SP24 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagy [GO:0006914] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; autophagy [GO:0006914] GO:0005765; GO:0005788; GO:0005789; GO:0005886; GO:0006914; GO:0006915; GO:0016021; GO:0043231 ISCHTDCR 0.99249 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRD5 PICK1_HUMAN PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein) PICK1 PRKCABP Homo sapiens (Human) "cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005543; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006886; GO:0006890; GO:0007205; GO:0008021; GO:0008022; GO:0014069; GO:0015844; GO:0019899; GO:0019904; GO:0021782; GO:0030666; GO:0032588; GO:0034315; GO:0034316; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043045; GO:0043046; GO:0043113; GO:0045161; GO:0045202; GO:0046872; GO:0048471; GO:0050796; GO:0051015; GO:0060292; GO:0070161; GO:0071933; GO:0097061; GO:0097062; GO:0098842; GO:0140090 actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102] FGIRLLKTIK 0.99249 -17.663 0 0 0 0 0 0 0 0 0 0 12.8932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.917 0 0 0 0 0 0 0 12.7857 0 0 0 13.4127 0 0 0 14.5436 0 0 0 0 0 0 13.0862 0 13.6463 0 0 0 0 13.7521 0 0 0 0 0 0 0 0 14.4773 14.2466 0 13.7205 0 0 0 0 0 13.49 0 14.0008 0 13.5199 0 0 13.3368 0 0 0 0 0 0 0 13.1217 0 13.2575 0 13.6546 13.1831 13.4867 0 12.7314 0 13.9315 0 0 0 0 13.5167 13.1922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVW2 RNF12_HUMAN "E3 ubiquitin-protein ligase RLIM, EC 2.3.2.27 (LIM domain-interacting RING finger protein) (RING finger LIM domain-binding protein, R-LIM) (RING finger protein 12) (RING-type E3 ubiquitin transferase RLIM) (Renal carcinoma antigen NY-REN-43)" RLIM RNF12 Homo sapiens (Human) "negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; random inactivation of X chromosome [GO:0060816]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; random inactivation of X chromosome [GO:0060816]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000122; GO:0003714; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0017053; GO:0043433; GO:0045892; GO:0046872; GO:0060816; GO:0061630; GO:1900095 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AGVRTYVSTIRIPIR 0.99249 -15.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8536 0 0 0 0 0 0 0 0 0 0 0 0 12.2664 12.9759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4103 0 0 0 0 0 0 0 0 0 12.5958 13.7299 0 0 14.3525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.102 0 13.4385 13.4786 0 0 0 0 0 0 0 0 0 13.7665 0 0 0 0 0 0 0 12.1491 0 0 0 0 0 0 0 0 0 13.0182 0 0 0 0 11.7104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKM9 RALY_HUMAN "RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2, hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog)" RALY HNRPCL2 P542 Homo sapiens (Human) "cholesterol homeostasis [GO:0042632]; mRNA splicing, via spliceosome [GO:0000398]; regulation of nucleic acid-templated transcription [GO:1903506]" catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; cholesterol homeostasis [GO:0042632]; mRNA splicing, via spliceosome [GO:0000398]; regulation of nucleic acid-templated transcription [GO:1903506]" GO:0000398; GO:0003712; GO:0003723; GO:0005634; GO:0042632; GO:0071013; GO:1903506 RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] AAVLGENGRVLAGQTLDINMAGEPK 0.99249 -15.031 0 0 0 11.7849 10.6382 0 0 0 11.8913 13.7179 0 0 14.2818 0 0 0 10.6452 0 0 0 0 0 0 11.5488 11.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.38003 0 0 0 11.0605 0 0 0 0 12.0297 0 0 0 0 16.2414 16.3629 14.941 15.0975 15.3206 15.5034 16.7485 15.4638 15.4083 16.404 15.502 15.5964 16.0563 16.0504 15.7579 15.5961 15.5871 0 0 14.5588 15.7029 14.5209 0 15.1012 14.5663 16.0022 0 0 14.1997 0 11.702 15.8123 15.9191 14.8126 14.3851 14.1113 0 12.9295 15.7653 14.7316 14.3558 13.0753 0 14.5057 0 14.3159 0 14.1089 0 14.458 0 0 13.5741 14.1889 0 0 14.7662 14.0969 12.4577 14.9262 13.8991 0 0 0 13.9017 13.8414 0 0 14.1911 0 12.3346 0 0 0 0 0 0 0 13.665 0 0 0 0 0 0 0 0 0 0 14.0689 13.7986 0 13.4365 0 0 0 0 0 Q9ULJ6 ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17) ZMIZ1 KIAA1224 RAI17 ZIMP10 Homo sapiens (Human) androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cellular senescence [GO:0090398]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of nucleic acid-templated transcription [GO:1903508]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of protein sumoylation [GO:0033233]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; androgen receptor signaling pathway [GO:0030521]; artery morphogenesis [GO:0048844]; cellular senescence [GO:0090398]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of nucleic acid-templated transcription [GO:1903508]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of protein sumoylation [GO:0033233]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296] GO:0001570; GO:0001701; GO:0003007; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007179; GO:0007296; GO:0008270; GO:0021852; GO:0030374; GO:0030521; GO:0033233; GO:0045582; GO:0045747; GO:0045944; GO:0046332; GO:0048146; GO:0048589; GO:0048844; GO:0060395; GO:0090398; GO:1903508 nuclear receptor coactivator activity [GO:0030374]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] GHDCKHVQCFDLESYLQLNCER 0.99249 -6.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7688 0 10.7172 10.3393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6245 0 0 0 0 0 0 13.648 0 0 0 13.5936 0 0 0 0 0 13.5418 0 14.162 13.6119 14.5392 13.5157 13.6005 0 0 0 0 0 0 0 0 0 0 0 0 13.6359 13.3987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0816 0 0 A0A0A0MS06 TVB23_HUMAN Probable non-functional T cell receptor beta variable 23-1 TRBV23-1 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 GKGQKTK 0.9925 -14.756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0671 0 0 0 13.0903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2679 0 0 0 0 0 A6NJ78 MET15_HUMAN "12S rRNA N4-methylcytidine (m4C) methyltransferase, 12S rRNA m4C methyltransferase, EC 2.1.1.- (Methyltransferase 5 domain-containing protein 1) (Methyltransferase-like protein 15)" METTL15 METT5D1 Homo sapiens (Human) rRNA base methylation [GO:0070475] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; rRNA base methylation [GO:0070475] GO:0005739; GO:0005759; GO:0070475; GO:0071424 rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424] DFETMAK 0.9925 -14.765 0 0 0 0 0 0 0 0 12.5434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1243 0 0 0 0 0 0 12.65 12.2276 0 0 0 0 0 0 0 12.3548 0 0 0 0 0 0 0 0 0 0 0 0 11.5911 0 0 0 0 0 12.0691 0 0 0 11.839 11.9418 0 0 0 0 0 0 0 0 12.1423 0 0 0 0 12.7413 0 0 0 0 12.5022 0 0 11.8256 0 0 0 0 12.0275 0 0 12.1862 0 0 0 0 0 0 0 0 0 0 11.8724 0 0 0 0 0 0 0 0 0 0 0 12.4646 12.0535 0 0 0 0 0 0 0 0 0 0 12.343 11.9501 13.7584 0 11.1216 0 0 0 0 0 O60281 ZN292_HUMAN Zinc finger protein 292 ZNF292 KIAA0530 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" AKWPAIIR 0.9925 -57.869 0 0 0 0 0 11.3 0 0 0 0 0 0 11.827 0 0 10.7687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3769 0 10.4851 0 0 10.6739 0 0 12.711 0 0 0 0 0 12.3172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8425 0 13.4302 0 11.3607 0 11.2371 0 13.6704 12.9779 12.879 0 13.318 14.6444 13.6406 13.5729 14.4079 18.0086 0 0 0 15.4868 13.5867 14.7282 0 0 12.9947 13.4301 14.3632 16.0067 0 0 0 15.9122 0 15.3442 16.7524 11.9916 14.8224 13.8107 15.018 0 0 0 0 0 0 0 13.3359 0 15.9401 0 0 12.155 0 15.6055 14.3949 13.7166 14.9071 15.4471 0 0 0 0 0 0 15.3507 0 0 0 0 17.5257 0 12.1269 14.9845 13.383 0 0 14.0092 0 12.6154 14.2201 0 0 0 0 0 14.6234 0 14.1958 0 0 0 0 0 13.9028 0 13.6602 0 0 12.2376 0 0 0 0 0 16.9175 0 0 12.3756 0 0 O60729 CC14B_HUMAN "Dual specificity protein phosphatase CDC14B, EC 3.1.3.16, EC 3.1.3.48 (CDC14 cell division cycle 14 homolog B)" CDC14B Homo sapiens (Human) cilium assembly [GO:0060271]; DNA repair [GO:0006281]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of cytokinesis [GO:0032467]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein dephosphorylation [GO:0006470]; regulation of exit from mitosis [GO:0007096] centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of cytokinesis [GO:0032467]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein dephosphorylation [GO:0006470]; regulation of exit from mitosis [GO:0007096] GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006281; GO:0006470; GO:0007095; GO:0007096; GO:0008138; GO:0017018; GO:0032467; GO:0060271; GO:0072686; GO:1904668 myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GQENGQHR 0.9925 -6.0609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9421 0 0 0 0 0 0 0 0 0 0 0 0 14.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4775 0 0 0 0 0 0 0 12.9642 0 0 O76015 KRT38_HUMAN "Keratin, type I cuticular Ha8 (Hair keratin, type I Ha8) (Keratin-38, K38)" KRT38 HHA8 HKA8 KRTHA8 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109; GO:0070062 structural molecule activity [GO:0005198] LAADDFR 0.9925 -7.6053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.632 0 0 14.4558 0 0 0 0 0 0 0 0 13.0247 13.0919 0 0 0 0 0 12.8984 0 0 0 0 0 0 0 0 0 13.0656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9333 0 0 0 0 17.7006 0 0 0 0 0 O95831 AIFM1_HUMAN "Apoptosis-inducing factor 1, mitochondrial, EC 1.6.99.- (Programmed cell death protein 8)" AIFM1 AIF PDCD8 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; programmed cell death [GO:0012501]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]" GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0006919; GO:0009636; GO:0012501; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045 "DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]" DKVVVGIVLWNIFNR 0.9925 -24.357 0 0 0 0 0 0 0 0 14.963 0 0 15.319 0 0 0 0 13.6491 0 0 13.6914 0 0 0 0 13.997 0 0 12.8816 0 0 0 0 13.6371 0 0 0 0 0 0 0 0 0 13.847 0 13.8674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.36 0 0 0 0 0 14.8058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5928 0 0 10.7953 0 0 0 14.4505 0 0 12.7309 0 16.252 11.6176 0 0 0 0 0 0 0 0 0 0 0 0 13.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0746 0 0 0 P0C860 MS3L2_HUMAN "Putative male-specific lethal-3 protein-like 2, MSL3-like 2 (Male-specific lethal-3 homolog 2) (Male-specific lethal-3 homolog pseudogene 1)" MSL3P1 MSL3L2 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]" histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267] "histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000123; GO:0006325; GO:0006355; GO:0016573; GO:0016575; GO:0035267; GO:0043967; GO:0043968; GO:0043984; GO:0072487 DEKISEECDIEEK 0.9925 -5.1034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9985 0 0 0 0 0 11.3657 0 0 0 0 0 0 0 0 13.6469 0 0 0 12.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6493 0 0 0 0 0 11.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13985 HRES1_HUMAN Putative HTLV-1-related endogenous sequence (p25) HRES1 Homo sapiens (Human) APSGPRPPSR 0.9925 -24.35 0 0 0 0 12.0216 0 0 11.1433 0 0 0 0 0 0 14.8712 11.242 0 17.3926 0 16.9476 16.8677 0 0 0 15.223 0 15.5227 13.9204 0 13.8846 0 0 0 0 0 0 0 0 0 0 0 16.2178 0 16.5804 0 0 0 17.1535 0 0 14.299 0 18.7757 17.5456 17.4414 0 17.3099 16.2778 17.4375 0 16.8345 17.4817 16.4394 0 0 17.181 12.6494 12.4507 0 0 12.8295 0 0 0 0 12.2127 12.6709 12.69 0 12.5488 13.0422 0 0 0 0 0 13.6014 15.0464 12.4214 0 0 15.1753 0 19.6997 0 0 0 22.1765 0 0 0 0 15.8699 0 0 14.9415 0 18.0668 0 0 0 14.8118 12.4748 0 15.5595 19.0356 15.4017 14.4555 0 12.5413 0 14.9605 15.0864 0 13.1988 0 0 13.3617 12.5897 15.1401 0 0 12.4732 0 12.5271 0 11.1132 12.5181 13.7919 0 0 0 19.4991 0 0 0 0 0 13.4324 16.0213 0 0 0 13.5314 0 0 19.6929 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4782 20.5646 20.496 0 0 0 0 0 0 11.8077 P46527 CDN1B_HUMAN Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase inhibitor p27) (p27Kip1) CDKN1B KIP1 p27 Homo sapiens (Human) "autophagic cell death [GO:0048102]; cellular response to antibiotic [GO:0071236]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell apoptotic process [GO:1904019]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; inner ear development [GO:0048839]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; Notch signaling pathway [GO:0007219]; placenta development [GO:0001890]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; potassium ion transport [GO:0006813]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of exit from mitosis [GO:0007096]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lens fiber cell differentiation [GO:1902746]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]" Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; Hsp70 protein binding [GO:0030544]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cellular response to antibiotic [GO:0071236]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell apoptotic process [GO:1904019]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; inner ear development [GO:0048839]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; Notch signaling pathway [GO:0007219]; placenta development [GO:0001890]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; potassium ion transport [GO:0006813]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of exit from mitosis [GO:0007096]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lens fiber cell differentiation [GO:1902746]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]" GO:0000079; GO:0000082; GO:0001666; GO:0001890; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0006813; GO:0006977; GO:0007096; GO:0007219; GO:0007507; GO:0007605; GO:0008284; GO:0008285; GO:0009410; GO:0009749; GO:0010942; GO:0019901; GO:0019903; GO:0030308; GO:0030332; GO:0030544; GO:0031116; GO:0031464; GO:0032355; GO:0033673; GO:0042326; GO:0043200; GO:0043231; GO:0043434; GO:0044877; GO:0045732; GO:0045736; GO:0045737; GO:0045892; GO:0045930; GO:0046686; GO:0048102; GO:0048839; GO:0051087; GO:0051726; GO:0060767; GO:0060770; GO:0071236; GO:0071285; GO:0071407; GO:0090398; GO:1902746; GO:1902806; GO:1902807; GO:1904019; GO:1904030; GO:1904036; GO:1904706; GO:1905179; GO:2000045 chaperone binding [GO:0051087]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; Hsp70 protein binding [GO:0030544]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877] DLEKHCR 0.9925 -14.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0373 0 0 0 11.3649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9173 0 0 0 0 0 0 0 0 11.9383 0 0 0 0 0 0 0 12.6832 0 12.6307 0 0 0 12.769 0 0 13.107 0 0 0 0 0 0 0 0 12.4213 0 0 0 0 0 0 0 0 0 0 0 12.6708 0 0 0 0 0 0 0 12.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3908 0 0 12.8526 0 0 0 0 12.6681 12.8406 0 0 11.8677 0 0 0 0 0 0 0 0 0 P55039 DRG2_HUMAN "Developmentally-regulated GTP-binding protein 2, DRG-2 (Translation factor GTPase DRG2, TRAFAC GTPase DRG2, EC 3.6.5.-)" DRG2 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165] GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] IFNAEVLFR 0.9925 -4.9483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.504 0 0 0 0 0 0 0 0 0 0 0 0 0 P61289 PSME3_HUMAN "Proteasome activator complex subunit 3 (11S regulator complex subunit gamma, REG-gamma) (Activator of multicatalytic protease subunit 3) (Ki nuclear autoantigen) (Proteasome activator 28 subunit gamma, PA28g, PA28gamma)" PSME3 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome activator complex [GO:0008537]; proteasome complex [GO:0000502]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136] GO:0000502; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007049; GO:0008537; GO:0010950; GO:0016020; GO:0042802; GO:0061133; GO:0061136; GO:0097371; GO:2000045; GO:2001237 endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039] KLLELDSFLK 0.9925 -5.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P84550 SKOR1_HUMAN "SKI family transcriptional corepressor 1 (Functional Smad-suppressing element on chromosome 15, Fussel-15) (LBX1 corepressor 1) (Ladybird homeobox corepressor 1)" SKOR1 CORL1 FUSSEL15 LBXCOR1 Homo sapiens (Human) "negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0005667; GO:0006355; GO:0030425; GO:0030514; GO:0043025; GO:0046332; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]" CGYCSMYFSPNK 0.9925 -18.141 0 0 0 0 0 0 0 0 0 0 0 0 14.8439 0 12.8374 0 0 0 0 0 0 0 0 17.0454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1137 0 0 0 0 0 0 0 13.9828 0 0 0 0 0 15.72 0 0 0 0 0 13.4034 0 0 0 0 14.356 0 0 0 0 0 0 12.4762 13.0975 0 0 0 0 0 0 0 0 0 0 0 0 18.0685 0 0 15.4385 13.6417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.805 0 0 0 0 0 0 0 0 12.9539 0 0 0 0 0 0 0 0 0 12.9692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07020 RL18_HUMAN 60S ribosomal protein L18 (Large ribosomal subunit protein eL18) RPL18 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EPKSQDIYLRLLVK 0.9925 -7.2583 0 0 0 0 0 0 0 11.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4733 0 13.316 0 0 0 0 0 10.7768 0 0 0 0 0 0 0 0 0 10.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15149 PLEC_HUMAN "Plectin, PCN, PLTN (Hemidesmosomal protein 1, HD1) (Plectin-1)" PLEC PLEC1 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin contractile ring assembly actin filament organization [GO:2000689]; adherens junction organization [GO:0034332]; cardiac muscle cell development [GO:0055013]; cell morphogenesis [GO:0000902]; cellular response to extracellular stimulus [GO:0031668]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to mechanical stimulus [GO:0071260]; establishment of skin barrier [GO:0061436]; fibroblast migration [GO:0010761]; gene expression [GO:0010467]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte development [GO:0003334]; leukocyte migration involved in immune response [GO:0002522]; mitochondrion morphogenesis [GO:0070584]; multicellular organism growth [GO:0035264]; myoblast differentiation [GO:0045445]; negative regulation of protein kinase activity [GO:0006469]; nucleus organization [GO:0006997]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization [GO:0008104]; protein-containing complex organization [GO:0043933]; regulation of ATP citrate synthase activity [GO:2000983]; regulation of vascular permeability [GO:0043114]; respiratory electron transport chain [GO:0022904]; response to food [GO:0032094]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]; skeletal myofibril assembly [GO:0014866]; T cell chemotaxis [GO:0010818]; tight junction organization [GO:0120193]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060] axon [GO:0030424]; brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018] axon [GO:0030424]; brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; actin cytoskeleton reorganization [GO:0031532]; actomyosin contractile ring assembly actin filament organization [GO:2000689]; adherens junction organization [GO:0034332]; cardiac muscle cell development [GO:0055013]; cell morphogenesis [GO:0000902]; cellular response to extracellular stimulus [GO:0031668]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to mechanical stimulus [GO:0071260]; establishment of skin barrier [GO:0061436]; fibroblast migration [GO:0010761]; gene expression [GO:0010467]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte development [GO:0003334]; leukocyte migration involved in immune response [GO:0002522]; mitochondrion morphogenesis [GO:0070584]; multicellular organism growth [GO:0035264]; myoblast differentiation [GO:0045445]; negative regulation of protein kinase activity [GO:0006469]; nucleus organization [GO:0006997]; peripheral nervous system myelin maintenance [GO:0032287]; protein localization [GO:0008104]; protein-containing complex organization [GO:0043933]; regulation of ATP citrate synthase activity [GO:2000983]; regulation of vascular permeability [GO:0043114]; respiratory electron transport chain [GO:0022904]; response to food [GO:0032094]; sarcomere organization [GO:0045214]; skeletal muscle fiber development [GO:0048741]; skeletal myofibril assembly [GO:0014866]; T cell chemotaxis [GO:0010818]; tight junction organization [GO:0120193]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060] GO:0000902; GO:0002162; GO:0002522; GO:0003334; GO:0003723; GO:0003779; GO:0005198; GO:0005200; GO:0005737; GO:0005741; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0006469; GO:0006997; GO:0008104; GO:0008307; GO:0010467; GO:0010761; GO:0010818; GO:0014866; GO:0016020; GO:0016528; GO:0019226; GO:0022904; GO:0030018; GO:0030056; GO:0030424; GO:0030425; GO:0030506; GO:0031532; GO:0031581; GO:0031668; GO:0032094; GO:0032287; GO:0034332; GO:0035264; GO:0042060; GO:0042383; GO:0043034; GO:0043114; GO:0043209; GO:0043621; GO:0043933; GO:0045104; GO:0045109; GO:0045111; GO:0045214; GO:0045296; GO:0045445; GO:0048471; GO:0048741; GO:0055013; GO:0061436; GO:0070062; GO:0070584; GO:0071260; GO:0071464; GO:0071498; GO:0120193; GO:2000689; GO:2000983 actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198] AFCGFEDPRTK 0.9925 -58.036 0 0 0 0 0 0 0 0 0 15.2976 12.905 15.3242 13.5944 0 0 12.7623 0 13.3021 13.9164 0 11.1623 0 13.3608 10.8718 13.2041 11.4727 11.7336 0 0 0 16.0856 0 12.5721 0 15.8045 15.8649 15.8206 12.7735 15.7207 16.9522 0 12.7459 0 16.153 15.9645 0 15.7894 16.0003 13.1758 14.1153 11.436 0 0 0 13.5234 13.5729 11.9287 16.3954 8.91516 0 0 0 14.5765 14.7586 11.517 14.3438 10.9479 0 11.7503 0 0 12.7526 0 12.8646 0 0 15.2301 0 0 13.7076 14.3709 14.6565 14.0452 13.1068 14.9872 18.1636 14.3166 19.6064 11.9597 12.4847 13.518 15.8154 19.2548 0 11.5347 0 15.1796 18.4382 0 0 13.5245 14.136 14.619 12.8738 0 0 0 13.8313 13.9752 15.3984 0 13.2416 14.1888 0 19.4629 0 12.9624 14.5877 0 17.8037 0 0 13.6288 0 10.5082 0 0 14.5376 0 13.3009 0 0 12.1265 12.4326 13.6911 13.0177 0 19.0919 14.4055 12.5926 0 11.9506 14.8164 14.0097 0 0 13.9147 14.2309 13.1941 16.621 19.0804 14.6631 13.4992 0 14.1889 15.1357 12.9728 14.3558 13.1744 0 12.2932 14.9639 12.7775 12.1339 16.2626 14.5212 0 0 14.2905 14.2136 13.9001 0 0 14.3683 13.6383 14.5498 0 0 13.7671 12.7139 Q15569 TESK1_HUMAN "Dual specificity testis-specific protein kinase 1, EC 2.7.12.1 (Testicular protein kinase 1)" TESK1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; establishment of vesicle localization [GO:0051650]; negative regulation of cilium assembly [GO:1902018]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; podocyte cell migration [GO:0090521]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; establishment of vesicle localization [GO:0051650]; negative regulation of cilium assembly [GO:1902018]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; podocyte cell migration [GO:0090521]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; spermatogenesis [GO:0007283] GO:0001934; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0007283; GO:0008022; GO:0019901; GO:0030027; GO:0030036; GO:0031410; GO:0031953; GO:0032880; GO:0032956; GO:0042326; GO:0046872; GO:0048471; GO:0051496; GO:0051650; GO:0071901; GO:0090521; GO:0106310; GO:1900026; GO:1900182; GO:1902018 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] EDLRGGK 0.9925 -17.718 0 0 0 0 0 0 0 0 0 0 0 13.8403 0 0 0 0 0 0 10.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0276 12.7398 0 12.7439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6109 0 0 0 0 0 0 0 0 12.9721 0 0 19.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1119 0 0 12.4672 0 0 0 0 0 0 0 13.0791 0 0 0 16.9868 Q15631 TSN_HUMAN "Translin, EC 3.1.-.- (Component 3 of promoter of RISC, C3PO)" TSN Homo sapiens (Human) DNA recombination [GO:0006310]; siRNA processing [GO:0030422] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoribonuclease complex [GO:1902555]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoribonuclease complex [GO:1902555]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; DNA recombination [GO:0006310]; siRNA processing [GO:0030422] GO:0001673; GO:0003677; GO:0003697; GO:0003723; GO:0003729; GO:0004519; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006310; GO:0030422; GO:0042802; GO:0043565; GO:1902555 DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697] AREHFGTVK 0.9925 -5.1061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q58FG1 HS904_HUMAN "Putative heat shock protein HSP 90-alpha A4 (Heat shock 90 kDa protein 1 alpha-like 2) (Heat shock protein 90-alpha D, Heat shock protein 90Ad)" HSP90AA4P HSP90AD HSPCAL2 Homo sapiens (Human) cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] cytosol [GO:0005829]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016887; GO:0032991; GO:0034605; GO:0043025; GO:0043209; GO:0048471; GO:0050821; GO:0051082; GO:0097718 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; disordered domain specific binding [GO:0097718]; unfolded protein binding [GO:0051082] EFYKSLTINWEDYLAVK 0.9925 -6.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1511 0 0 0 0 12.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8835 0 0 0 0 0 0 0 Q658T7 F90A2_HUMAN Putative protein FAM90A2P FAM90A2P Homo sapiens (Human) AALVPPTLGK 0.9925 -17.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UU5 GGN_HUMAN Gametogenetin GGN Homo sapiens (Human) cell differentiation [GO:0030154]; double-strand break repair [GO:0006302]; gamete generation [GO:0007276]; spermatogenesis [GO:0007283] ubiquitin protein ligase binding [GO:0031625]; cell differentiation [GO:0030154]; double-strand break repair [GO:0006302]; gamete generation [GO:0007276]; spermatogenesis [GO:0007283] GO:0006302; GO:0007276; GO:0007283; GO:0030154; GO:0031625 ubiquitin protein ligase binding [GO:0031625] AARGATR 0.9925 -6.7957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6975 0 0 12.9823 13.5033 0 0 0 12.8868 0 0 13.4108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.787 13.7261 0 0 0 0 0 12.7306 0 0 0 0 0 0 0 12.7029 0 0 0 0 0 0 0 0 13.3567 0 0 0 0 11.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9333 0 Q86WZ0 HEAT4_HUMAN HEAT repeat-containing protein 4 HEATR4 Homo sapiens (Human) oxidoreductase activity [GO:0016491] GO:0016491 oxidoreductase activity [GO:0016491] AAAQALGQMSLGKEVHDIIR 0.9925 -14.756 0 0 0 0 0 0 0 0 0 0 12.2516 0 0 0 0 0 0 0 0 0 0 10.5904 0 0 11.0151 0 11.5309 0 12.065 0 0 0 11.6847 0 0 0 0 0 11.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2234 13.1941 0 0 0 15.8667 0 10.5087 14.5873 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6619 0 0 9.95299 0 0 0 12.5994 0 0 14.7358 14.2011 13.3737 0 12.8573 13.5114 0 14.6136 14.0885 11.7007 0 0 0 0 0 0 0 0 16.1273 0 0 0 0 14.1176 0 0 0 13.9343 0 0 0 14.7199 0 0 0 0 0 13.2565 0 0 0 13.3895 0 0 0 0 0 0 0 0 0 16.6937 0 0 0 0 0 0 10.0625 0 0 0 0 0 0 0 0 0 0 12.27 0 Q8IWZ4 TRI48_HUMAN "E3 ubiquitin-protein ligase TRIM48, EC 2.3.2.27 (RING finger protein 101) (Tripartite motif-containing protein 48)" TRIM48 RNF101 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] HCPAEWAAEEHWEK 0.9925 -5.1079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4688 0 0 0 0 0 13.2953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYA7 MKX_HUMAN Homeobox protein Mohawk MKX C10orf48 IRXL1 Homo sapiens (Human) cell development [GO:0048468]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; muscle organ development [GO:0007517]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007517; GO:0048468 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" NTIVFNK 0.9925 -17.71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7B9 EFCB3_HUMAN EF-hand calcium-binding domain-containing protein 3 EFCAB3 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] ETCLDLAGNPGILLFEILSRLLETSALPRK 0.9925 -7.2673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7668 0 0 0 11.2366 0 0 0 0 0 0 13.3573 0 0 0 12.4738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3289 0 0 0 0 0 0 0 0 0 0 0 0 13.3226 0 0 0 0 0 0 0 0 0 13.3428 0 0 0 14.5573 0 0 0 0 0 13.0863 0 0 0 0 0 13.2968 0 0 0 13.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92766 RREB1_HUMAN "Ras-responsive element-binding protein 1, RREB-1 (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1, Zep-1)" RREB1 FINB Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0001650; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0010634; GO:0016604; GO:0016607; GO:0033601; GO:0045893; GO:0045944; GO:0046872; GO:0070062; GO:0090336; GO:1900026; GO:1903691; GO:2000394 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AALIRHLR 0.9925 -25.403 0 0 0 0 0 0 0 0 0 16.4419 0 0 0 0 0 0 0 12.3436 0 0 0 0 0 0 0 0 0 10.5274 0 13.4351 0 0 0 0 0 0 13.5626 0 0 0 0 0 0 12.7438 0 0 0 0 0 0 13.5315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.613 0 0 14.2467 0 0 0 10.4859 0 0 0 0 0 0 0 14.481 14.3877 0 15.835 13.5289 13.714 14.4385 14.0212 0 0 17.9247 13.2543 0 0 0 0 0 0 12.1403 0 0 0 12.5098 0 12.2108 0 12.5373 0 0 0 0 14.4358 0 0 12.3499 0 0 0 14.3875 14.0704 0 0 0 0 0 0 12.0013 13.3045 12.4438 0 0 11.6188 13.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2056 0 0 0 0 0 12.7739 0 0 0 0 0 0 0 0 14.0011 0 0 0 0 11.8334 0 0 0 0 0 10.3452 0 0 0 13.6284 Q96RT8 GCP5_HUMAN "Gamma-tubulin complex component 5, GCP-5" TUBGCP5 GCP5 KIAA1899 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0031122; GO:0043015; GO:0051225; GO:0051321 gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017] EELAEIEKCIINNDTTITLAIVVDKLAPR 0.9925 -7.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71086 0 0 0 0 0 0 12.4242 0 0 11.7684 0 0 0 0 0 0 0 0 0 0 10.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3535 0 9.54676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.012 0 0 0 12.9366 0 11.6151 11.1777 0 0 0 0 0 14.7778 0 0 0 0 11.1852 0 0 0 0 0 0 0 15.1327 0 0 0 12.337 13.9203 0 0 0 0 0 0 0 11.9055 0 0 0 13.8094 0 0 0 0 0 0 11.0539 10.6037 0 0 0 0 0 0 0 0 0 0 14.5118 15.2965 0 0 0 0 0 11.4974 0 0 12.8794 0 0 0 0 0 0 0 0 0 0 13.3742 14.7975 0 0 0 0 0 0 13.3188 0 0 0 0 0 0 0 0 0 0 0 Q99592 ZBT18_HUMAN "Zinc finger and BTB domain-containing protein 18 (58 kDa repressor protein) (Transcriptional repressor RP58) (Translin-associated zinc finger protein 1, TAZ-1) (Zinc finger protein 238) (Zinc finger protein C2H2-171)" ZBTB18 RP58 TAZ1 ZNF238 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]" heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "heterochromatin [GO:0000792]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]" GO:0000122; GO:0000792; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007519; GO:0016607; GO:0043565; GO:0045892; GO:0045944; GO:0046872; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ATTEADSTK 0.9925 -15.05 0 0 0 0 0 0 0 0 11.4576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2609 0 0 0 0 0 0 9.98214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6094 0 0 0 0 0 0 0 0 0 12.5626 0 0 12.2958 0 0 0 0 0 0 0 0 0 0 0 0 11.724 0 0 0 0 0 13.1248 0 0 0 0 0 0 10.9327 0 0 0 0 0 0 0 0 0 0 0 11.1022 0 0 0 0 0 0 0 0 0 0 11.9189 0 0 0 0 0 0 13.7025 0 0 0 0 0 0 0 0 12.107 0 0 0 0 0 0 0 0 0 0 0 0 11.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6815 0 0 0 Q9BTC0 DIDO1_HUMAN "Death-inducer obliterator 1, DIO-1, hDido1 (Death-associated transcription factor 1, DATF-1)" DIDO1 C20orf158 DATF1 KIAA0333 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]" GO:0003723; GO:0005634; GO:0005737; GO:0005819; GO:0006351; GO:0046872; GO:0097190 metal ion binding [GO:0046872]; RNA binding [GO:0003723] AFDTQLVERGRR 0.9925 -58.402 0 0 0 0 0 0 0 13.3046 0 0 0 0 0 0 12.9151 0 9.9332 0 0 0 0 0 0 11.3883 0 0 0 14.5909 0 0 13.5962 13.313 0 0 14.1307 0 14.8782 0 0 0 0 12.2374 12.1906 0 13.1962 0 0 0 10.2983 0 13.9187 0 0 0 0 0 11.1191 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1575 10.699 0 0 0 0 0 0 0 0 0 0 0 13.2137 0 0 0 0 14.9308 12.3087 14.2398 0 8.79999 14.3918 13.0503 0 0 0 12.4531 0 0 12.2361 0 12.5713 11.9772 13.768 0 14.1372 0 12.5178 16.6045 0 0 13.853 13.3295 13.5239 15.1911 16.1801 0 14.9104 0 0 14.4406 12.5522 0 0 0 0 0 0 12.976 11.4643 0 13.2444 13.3493 14.5593 13.6247 13.9149 13.329 0 0 0 12.3728 0 0 0 13.2564 0 0 0 0 12.9228 11.8863 0 0 0 0 13.5016 0 12.4933 11.6952 13.5416 0 0 0 0 0 0 11.669 0 12.099 13.9931 0 13.3507 0 11.8042 0 0 0 0 Q9BUB4 ADAT1_HUMAN "tRNA-specific adenosine deaminase 1, hADAT1, EC 3.5.4.34 (tRNA-specific adenosine-37 deaminase)" ADAT1 Homo sapiens (Human) tRNA processing [GO:0008033] metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; tRNA processing [GO:0008033] GO:0003723; GO:0008033; GO:0008251; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251] EVVSMGTGTKCIGQSKMR 0.9925 -14.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6828 11.8902 0 0 12.4001 0 0 0 0 0 11.8149 12.4937 0 12.4059 11.7036 0 0 0 0 0 0 11.951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.372 12.6776 0 0 0 12.481 0 0 0 11.498 0 0 11.6257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.757 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1532 0 0 0 13.6855 13.421 14.7109 0 0 0 0 0 12.8163 14.4905 0 13.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5874 0 0 0 0 0 0 0 0 0 17.6734 0 0 0 0 0 0 0 15.5752 0 0 0 0 0 0 0 15.9027 0 16.0152 0 0 0 0 12.8285 12.4909 13.2447 0 0 0 0 0 0 11.9785 0 0 0 0 0 12.9757 0 13.1809 0 12.5058 Q9H944 MED20_HUMAN "Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog, hTRFP)" MED20 TRFP Homo sapiens (Human) "positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription coactivator activity [GO:0003713]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" GO:0003713; GO:0003899; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0006366; GO:0016592; GO:0032968; GO:0035914; GO:0051123; GO:0060261; GO:0070847 DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription coactivator activity [GO:0003713] LEMLGAEK 0.9925 -7.1096 0 0 0 0 0 0 0 0 0 12.5258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2279 0 0 0 0 0 0 0 0 0 0 0 0 13.1251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWF4 S52A1_HUMAN "Solute carrier family 52, riboflavin transporter, member 1 (Porcine endogenous retrovirus A receptor 2, PERV-A receptor 2, huPAR-2) (Protein GPR172B) (Riboflavin transporter 1, hRFT1)" SLC52A1 GPR172B PAR2 RFT1 Homo sapiens (Human) riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218] GO:0001618; GO:0005886; GO:0005887; GO:0006771; GO:0032217; GO:0032218 riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618] DCVDPCGP 0.9925 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYB0 TE2IP_HUMAN "Telomeric repeat-binding factor 2-interacting protein 1, TERF2-interacting telomeric protein 1, TRF2-interacting telomeric protein 1 (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog, RAP1 homolog, hRap1)" TERF2IP DRIP5 RAP1 PP8000 Homo sapiens (Human) "negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomere maintenance via telomere lengthening [GO:0010833]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomere maintenance via telomere lengthening [GO:0010833]" GO:0000228; GO:0000723; GO:0000781; GO:0000783; GO:0001673; GO:0001933; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007004; GO:0010569; GO:0010833; GO:0016233; GO:0016604; GO:0019902; GO:0031848; GO:0032204; GO:0032205; GO:0032206; GO:0033138; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187; GO:0070198; GO:0098505; GO:1901224; GO:1901985 G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162] DRYLKHLR 0.9925 -7.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7784 0 0 0 15.6167 0 0 0 0 0 0 0 0 0 0 15.8737 0 0 0 0 0 0 0 0 17.6283 0 0 0 0 0 0 0 0 0 0 0 0 15.1353 0 0 0 14.4551 14.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0897 0 0 0 0 14.6255 0 P40967 PMEL_HUMAN "Melanocyte protein PMEL (ME20-M, ME20M) (Melanocyte protein Pmel 17) (Melanocytes lineage-specific antigen GP100) (Melanoma-associated ME20 antigen) (P1) (P100) (Premelanosome protein) (Silver locus protein homolog) [Cleaved into: M-alpha (95 kDa melanocyte-specific secreted glycoprotein) (P26) (Secreted melanoma-associated ME20 antigen, ME20-S, ME20S); M-beta ]" PMEL D12S53E PMEL17 SILV Homo sapiens (Human) melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; melanin biosynthetic process [GO:0042438]; melanosome organization [GO:0032438] GO:0005576; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0032438; GO:0032585; GO:0042438; GO:0042470; GO:0042802 identical protein binding [GO:0042802] CLLHLAVIGALLAVGATKVPR 0.99251 -7.6356 0 10.6828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9435 0 0 0 0 0 0 0 0 0 0 0 11.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4354 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4097 0 0 0 0 0 0 0 0 0 0 0 14.2214 0 0 0 0 0 0 0 12.4873 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0734 0 0 0 0 0 0 0 0 0 12.5571 0 0 0 0 12.347 0 0 12.5728 0 0 12.5933 0 12.1477 0 12.4223 12.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6719 0 0 0 0 0 0 16.3708 0 0 0 0 0 P43251 BTD_HUMAN "Biotinidase, Biotinase, EC 3.5.1.12" BTD Homo sapiens (Human) biotin metabolic process [GO:0006768]; central nervous system development [GO:0007417] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; biotinidase activity [GO:0047708]; biotin metabolic process [GO:0006768]; central nervous system development [GO:0007417] GO:0005576; GO:0005615; GO:0005759; GO:0006768; GO:0007417; GO:0047708; GO:0070062 biotinidase activity [GO:0047708] ILSGDPYCEKDAQEVHCDEATK 0.99251 -6.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1134 12.1724 11.93 11.1445 11.8336 0 0 0 0 10.8987 0 10.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0031 0 0 0 13.8424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.193 0 0 0 0 0 12.7639 0 0 0 0 0 0 0 0 16.1992 0 0 0 0 0 0 0 0 12.9072 0 0 0 0 13.4261 0 0 0 0 10.4241 12.0723 11.3863 11.7712 0 0 0 0 11.5971 0 0 13.0848 0 0 0 0 0 0 13.0469 0 0 0 0 0 12.0024 0 0 0 11.7571 0 0 0 0 0 12.5083 0 11.7522 0 0 0 0 0 0 0 0 0 0 11.2398 0 11.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9609 0 10.9011 0 11.6904 14.2047 0 0 0 0 0 0 0 0 Q10471 GALT2_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 2, EC 2.4.1.41 (Polypeptide GalNAc transferase 2, GalNAc-T2, pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form ]" GALNT2 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243] GO:0000139; GO:0004653; GO:0005576; GO:0005789; GO:0005794; GO:0005795; GO:0006493; GO:0016020; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030173; GO:0030246; GO:0032580; GO:0048471; GO:0051604 carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] EDWNEIDPIK 0.99251 -15.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6812 14.4247 13.6431 0 12.2561 0 0 0 12.1707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3025 0 13.4522 14.1581 14.2698 14.5021 0 14.7503 14.8999 0 0 0 0 10.4502 0 0 0 0 0 13.0343 0 0 0 12.5497 0 14.7701 0 11.6751 0 0 0 0 0 0 0 13.259 0 0 0 0 0 0 0 0 14.2596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.227 0 0 0 14.1658 0 0 0 14.3044 0 0 0 0 13.4607 0 0 0 0 0 0 0 0 0 0 0 12.8265 0 0 12.2166 0 0 0 Q6NSJ2 PHLB3_HUMAN Pleckstrin homology-like domain family B member 3 PHLDB3 Homo sapiens (Human) enzyme binding [GO:0019899] GO:0019899 enzyme binding [GO:0019899] EETKLKGVIYFQAIEEVYYDHLR 0.99251 -7.1129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4691 0 13.501 12.2289 0 0 0 0 0 0 0 0 0 15.3667 11.6383 11.6429 12.8767 0 11.844 0 0 0 0 0 0 12.764 11.4335 11.5545 0 0 0 0 0 0 0 12.6118 0 0 13.623 13.4617 0 0 12.597 12.4644 12.4911 12.9966 0 12.8545 0 0 0 0 12.819 0 0 0 0 11.9976 12.2684 13.4769 0 11.7973 0 0 0 0 0 0 0 0 0 0 0 0 0 13.381 0 0 12.4722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3958 0 Q8NFC6 BD1L1_HUMAN Biorientation of chromosomes in cell division protein 1-like 1 BOD1L1 BOD1L FAM44A KIAA1327 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; replication fork processing [GO:0031297] centrosome [GO:0005813]; nucleoplasm [GO:0005654]; outer kinetochore [GO:0000940]; Set1C/COMPASS complex [GO:0048188]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922] centrosome [GO:0005813]; nucleoplasm [GO:0005654]; outer kinetochore [GO:0000940]; Set1C/COMPASS complex [GO:0048188]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; histone H3-K4 methylation [GO:0051568]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; replication fork processing [GO:0031297] GO:0000922; GO:0000940; GO:0004864; GO:0005654; GO:0005813; GO:0005876; GO:0006281; GO:0006974; GO:0031297; GO:0032515; GO:0048188; GO:0051568; GO:0051721 protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864] AADLLAVHAVK 0.99251 -60.697 0 0 0 11.6483 0 0 0 0 13.0407 0 10.8323 0 0 0 0 0 0 0 0 0 11.6903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3439 12.1444 0 0 0 0 0 0 0 0 0 0 11.0784 0 0 0 0 0 0 13.1924 0 0 0 0 0 0 0 0 0 13.9106 0 11.4885 13.972 0 0 0 0 0 0 0 0 11.8352 12.8527 13.1652 0 13.3454 0 0 0 0 0 0 0 0 12.4891 13.1541 0 0 0 13.7403 16.1409 12.0851 0 13.1495 0 0 0 0 0 0 0 0 0 0 13.2854 11.8524 0 0 0 0 0 0 0 0 0 0 0 0 14.0338 0 12.3269 0 0 13.4043 12.9917 0 0 0 0 0 0 12.3979 0 0 0 0 0 0 0 11.8879 14.1313 0 0 0 0 0 0 13.4169 13.6034 12.544 0 0 12.6405 0 0 0 11.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2706 0 0 Q8TEV9 SMCR8_HUMAN Guanine nucleotide exchange protein SMCR8 (Smith-Magenis syndrome chromosomal region candidate gene 8 protein) SMCR8 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432] anchoring junction [GO:0070161]; Atg1/ULK1 kinase complex [GO:1990316]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793] anchoring junction [GO:0070161]; Atg1/ULK1 kinase complex [GO:1990316]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor complex [GO:0032045]; nucleoplasm [GO:0005654]; postsynapse [GO:0098794]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of exocytosis [GO:0045920]; negative regulation of gene expression [GO:0010629]; negative regulation of immune response [GO:0050777]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432] GO:0000785; GO:0004860; GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0006469; GO:0006914; GO:0010506; GO:0010629; GO:0016242; GO:0019901; GO:0032008; GO:0032045; GO:0042995; GO:0043547; GO:0045920; GO:0050777; GO:0070161; GO:0098793; GO:0098794; GO:1901098; GO:1902902; GO:1903432; GO:1990316 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] AGQNALK 0.99251 -4.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7393 0 0 13.4094 0 0 0 0 0 0 0 0 0 0 12.6551 0 12.7115 0 0 0 0 0 0 0 0 13.2068 0 0 0 12.1322 0 0 0 0 0 0 0 0 19.0464 0 0 0 0 0 0 0 0 13.8815 0 0 13.5866 0 0 0 0 12.8801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5325 0 13.3772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3654 0 0 0 0 0 0 Q9HCK8 CHD8_HUMAN "Chromodomain-helicase-DNA-binding protein 8, CHD-8, EC 3.6.4.12 (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1)" CHD8 HELSNF1 KIAA1564 Homo sapiens (Human) "brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; regulation of gene expression [GO:0010468]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription, DNA-templated [GO:0045893]; prepulse inhibition [GO:0060134]; regulation of gene expression [GO:0010468]; social behavior [GO:0035176]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0000785; GO:0001701; GO:0002039; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0007420; GO:0008013; GO:0010468; GO:0016055; GO:0016887; GO:0032991; GO:0035064; GO:0035176; GO:0042393; GO:0045892; GO:0045893; GO:0045944; GO:0045945; GO:0048565; GO:0060134; GO:0070016; GO:0071339; GO:0090090; GO:0140658; GO:2000270 armadillo repeat domain binding [GO:0070016]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039] ADWIRKYNPDTLFQDESYK 0.99251 -60.431 0 0 0 0 0 0 0 9.60227 13.3599 0 0 11.3772 12.5625 0 11.577 12.0623 0 0 0 0 0 0 11.7636 0 12.5274 0 12.1031 0 0 0 0 0 0 13.4643 0 0 0 13.5326 10.4826 0 11.0878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1454 0 0 0 0 0 14.3457 0 12.5374 14.2394 11.6311 0 13.2425 15.7316 14.7513 13.6797 15.5679 15.051 16.1397 0 15.1112 14.3071 0 16.0327 13.1803 16.3808 14.5612 14.493 15.9529 0 15.7994 14.641 15.5992 0 15.1372 14.7901 14.9132 14.7411 15.964 14.16 13.3916 15.9998 0 15.0182 15.81 11.7979 15.6183 12.9713 16.5604 0 14.7488 16.4165 16.4898 12.5462 0 15.2133 15.235 0 14.7399 0 14.3861 0 15.3224 15.1077 15.2609 13.3092 15.9991 0 0 15.5963 0 0 14.9681 14.9133 13.2672 13.4119 0 13.9959 12.7074 13.7986 15.8792 0 0 12.6535 15.9994 12.55 13.5771 15.1187 13.6397 15.7242 0 0 0 12.8757 13.0083 13.7573 0 0 14.1321 0 0 0 14.5116 11.576 0 14.872 14.8706 14.9325 12.4455 13.4525 12.9138 0 14.9338 0 Q9NR81 ARHG3_HUMAN "Rho guanine nucleotide exchange factor 3 (Exchange factor found in platelets and leukemic and neuronal tissues, XPLN)" ARHGEF3 Homo sapiens (Human) positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0005085; GO:0005829; GO:0007266; GO:0035025; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] ALLDHKK 0.99251 -7.2811 0 0 0 0 0 0 14.2148 0 0 0 0 12.2158 0 0 12.4137 0 13.3545 0 0 11.5274 13.3341 12.1395 12.5954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8525 12.0556 0 13.6399 0 9.11317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6651 0 0 0 0 12.92 13.9017 15.4762 14.3722 15.5858 0 0 0 0 12.7664 0 13.0523 14.7064 13.0334 14.8521 14.2538 13.4146 15.6793 0 15.7082 11.5222 0 0 18.9656 15.3597 14.4324 15.1317 0 16.6815 0 12.9368 13.5399 0 13.8587 13.2902 16.4766 17.8918 15.7004 0 0 0 0 13.7233 17.41 0 17.935 18.0305 18.2758 13.2172 0 13.9739 13.3848 0 0 0 13.5214 13.3308 0 13.8851 14.0869 13.2782 0 0 13.8726 0 12.6469 0 13.3426 0 0 0 0 0 0 0 0 0 13.7594 17.9522 0 13.7021 0 0 0 0 0 0 0 0 0 0 0 0 12.8291 0 14.8619 15.4608 0 0 0 0 12.9009 0 12.8712 Q9Y305 ACOT9_HUMAN "Acyl-coenzyme A thioesterase 9, mitochondrial, Acyl-CoA thioesterase 9, EC 3.1.2.- (Acyl-CoA thioester hydrolase 9)" ACOT9 CGI-16 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637] GO:0003986; GO:0005739; GO:0005759; GO:0006637; GO:0016290; GO:0047617; GO:0052689 acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-CoA hydrolase activity [GO:0016290] DHVKAMEER 0.99251 -14.828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.302 16.6521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYW2 CFA46_HUMAN Cilia- and flagella-associated protein 46 (Tetratricopeptide repeat protein 40) CFAP46 C10orf123 C10orf124 C10orf92 C10orf93 TTC40 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294] axoneme [GO:0005930] axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294] GO:0005930; GO:0035082; GO:0060294 AAGHLRR 0.99252 -45.546 0 0 10.4338 14.9769 14.5569 13.9509 0 0 0 12.0383 14.243 12.7008 0 15.5003 15.3807 17.9236 17.7906 17.4545 17.2 17.3993 16.8825 0 16.2435 0 15.8874 15.6861 15.648 15.3861 12.7462 13.7464 16.8216 11.6274 0 0 13.3518 12.2159 12.9359 11.7482 0 13.6608 16.601 16.5338 16.9471 16.7642 16.7519 17.7183 17.4318 17.1767 13.6991 14.8478 14.6566 17.2396 18.8987 18.8995 17.4655 17.058 18.6653 18.7095 17.4582 0 19.1358 19.2304 18.9175 16.2789 16.1984 17.8264 12.6705 0 0 15.0202 13.7542 14.3862 0 12.8527 0 0 0 0 14.4906 15.4189 13.3428 15.1794 11.7154 0 0 12.8748 22.2066 14.4202 19.6093 19.9028 20.8693 13.3611 20.894 20.7366 19.767 19.8613 21.0654 22.1786 22.4364 14.5063 15.154 13.5942 0 0 13.6107 12.9346 13.0442 18.0652 14.3275 14.1449 0 19.6529 19.5914 15.2946 19.6129 19.018 18.5604 19.6766 0 14.6794 14.6554 13.3071 15.7399 19.0736 14.5737 21.3456 20.8328 13.6902 0 14.9313 13.4819 15.668 14.3636 15.3593 20.5245 20.3832 20.1745 19.8944 15.2902 14.5802 13.9317 19.9309 19.4991 13.4188 19.4181 10.2459 18.5628 18.7073 18.4451 18.418 0 14.8549 0 0 20.0777 19.7667 20.0738 13.4789 13.2684 13.2725 12.9542 14.1524 13.9319 13.6056 13.9357 15.2198 18.3254 18.8049 18.0596 17.8368 17.6296 20.592 20.5123 20.6054 18.8942 13.1015 0 14.7827 17.9565 0 P11532 DMD_HUMAN Dystrophin DMD Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519] cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cortical actin cytoskeleton [GO:0030864]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018] cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cortical actin cytoskeleton [GO:0030864]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; cardiac muscle cell action potential [GO:0086001]; cardiac muscle contraction [GO:0060048]; maintenance of blood-brain barrier [GO:0035633]; motile cilium assembly [GO:0044458]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; muscle organ development [GO:0007517]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; neuron development [GO:0048666]; peptide biosynthetic process [GO:0043043]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cellular response to growth factor stimulus [GO:0090287]; regulation of heart rate [GO:0002027]; regulation of muscle system process [GO:0090257]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of skeletal muscle contraction [GO:0014819]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; regulation of voltage-gated calcium channel activity [GO:1901385]; response to muscle stretch [GO:0035994]; skeletal muscle tissue development [GO:0007519] GO:0002027; GO:0002162; GO:0003779; GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007517; GO:0007519; GO:0008104; GO:0008270; GO:0008307; GO:0009986; GO:0010880; GO:0010881; GO:0010976; GO:0014809; GO:0014819; GO:0016010; GO:0016013; GO:0017022; GO:0017166; GO:0030018; GO:0030036; GO:0030054; GO:0030055; GO:0030175; GO:0030864; GO:0031527; GO:0032991; GO:0033137; GO:0035633; GO:0035994; GO:0042383; GO:0042995; GO:0043034; GO:0043043; GO:0044306; GO:0044458; GO:0045121; GO:0045202; GO:0045211; GO:0045666; GO:0046716; GO:0048666; GO:0050998; GO:0051015; GO:0055001; GO:0060048; GO:0060314; GO:0065003; GO:0086001; GO:0090257; GO:0090287; GO:1901385; GO:1902083; GO:2000651 actin binding [GO:0003779]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; myosin binding [GO:0017022]; nitric-oxide synthase binding [GO:0050998]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] AFKRELK 0.99252 -65.806 0 0 0 0 12.1949 0 11.4947 12.4995 0 0 14.3606 0 0 0 0 0 0 0 0 0 0 16.2784 17.9992 0 11.5798 0 13.7659 16.0622 0 0 0 0 13.2348 0 0 0 13.669 0 12.4224 0 0 0 12.8554 13.263 10.4301 11.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6791 0 0 0 0 18.0055 12.8012 10.2662 13.0051 13.5739 17.9656 17.7597 0 0 12.6129 12.3398 11.3472 13.5378 0 0 14.6778 13.577 14.9 15.5909 0 20.076 0 16.4418 14.7507 12.7507 15.0907 14.0945 14.8203 14.1709 13.8063 15.6327 0 13.9302 0 13.9981 12.8098 14.7743 0 14.1103 0 13.1606 0 0 14.5765 0 12.9888 15.9525 16.2807 13.6929 15.4971 12.5878 14.0291 12.0459 16.1065 18.3594 13.5104 14.4682 15.8446 18.5577 14.6788 13.3161 16.1304 14.5899 13.7665 0 12.6101 0 0 12.6362 13.8431 13.7043 14.4821 15.2198 14.7094 13.7743 12.234 10.5486 13.5881 13.4663 18.3422 9.80653 0 13.0424 0 0 14.8908 18.3668 12.923 0 16.7394 0 0 0 13.4793 0 0 0 0 0 11.5898 0 0 14.8588 0 0 14.9289 13.8404 13.4751 0 0 0 0 0 0 P42263 GRIA3_HUMAN "Glutamate receptor 3, GluR-3 (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3, GluA3)" GRIA3 GLUR3 GLURC Homo sapiens (Human) glutamate receptor signaling pathway [GO:0007215] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; glutamate receptor signaling pathway [GO:0007215] GO:0001540; GO:0004971; GO:0005886; GO:0007215; GO:0015276; GO:0030666; GO:0032281; GO:0038023; GO:0043197; GO:0045211; GO:0070161; GO:0098688; GO:1904315 AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] DVQEFRR 0.99252 -17.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4735 0 14.4372 0 0 0 12.833 13.6734 13.1336 0 13.6491 0 11.7874 0 13.5681 0 0 0 0 0 13.7021 14.1524 0 0 0 13.5529 0 13.4485 0 0 12.854 0 13.743 13.3009 0 0 0 0 13.5999 0 13.28 0 0 0 13.8686 0 13.6683 13.1463 13.563 0 0 13.5439 0 0 0 10.75 0 0 0 11.6864 13.9254 0 14.0423 11.9961 0 12.4052 13.8712 13.3437 0 0 0 13.4895 0 0 0 0 0 0 13.5335 13.2233 0 0 13.4988 0 0 0 11.465 13.8493 0 0 0 0 0 0 11.1977 12.9484 0 11.8359 0 0 0 0 0 0 13.4035 0 0 0 0 0 0 0 P56715 RP1_HUMAN Oxygen-regulated protein 1 (Retinitis pigmentosa 1 protein) (Retinitis pigmentosa RP1 protein) RP1 ORP1 Homo sapiens (Human) "axoneme assembly [GO:0035082]; cellular response to light stimulus [GO:0071482]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction, visible light [GO:0007603]; positive regulation of non-motile cilium assembly [GO:1902857]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]" axoneme [GO:0005930]; ciliary tip [GO:0097542]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] "axoneme [GO:0005930]; ciliary tip [GO:0097542]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; microtubule binding [GO:0008017]; axoneme assembly [GO:0035082]; cellular response to light stimulus [GO:0071482]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction, visible light [GO:0007603]; positive regulation of non-motile cilium assembly [GO:1902857]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]" GO:0001750; GO:0001917; GO:0005874; GO:0005875; GO:0005930; GO:0007601; GO:0007603; GO:0008017; GO:0032391; GO:0035082; GO:0035556; GO:0035845; GO:0042461; GO:0045494; GO:0046548; GO:0046549; GO:0060041; GO:0071482; GO:0097542; GO:1902857 microtubule binding [GO:0008017] DLNILTDPEYK 0.99252 -17.507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2734 0 0 0 0 0 0 10.7256 0 0 0 0 0 11.7861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6539 0 0 0 0 0 0 0 13.4445 13.9244 12.1806 15.0421 0 15.1318 12.8816 0 0 0 0 0 0 0 0 0 0 14.2797 0 0 0 12.933 0 0 14.7972 0 13.7706 14.1688 0 0 14.6642 0 0 14.9359 0 14.8495 0 0 13.0461 0 0 0 0 0 0 14.6263 0 0 0 0 0 0 19.004 0 14.0848 13.93 16.9896 0 13.994 0 15.8168 12.6761 0 15.8605 0 13.9808 0 18.0466 0 12.5374 0 15.1467 0 10.897 15.5142 14.3796 0 15.4956 0 14.0181 0 0 0 0 0 0 0 0 0 12.654 0 0 0 11.6931 0 0 0 0 0 0 13.6725 0 0 13.6954 0 P78524 DEN2B_HUMAN DENN domain-containing protein 2B (HeLa tumor suppression 1) (Suppression of tumorigenicity 5 protein) DENND2B HTS1 ST5 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374] cell cortex [GO:0005938]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] cell cortex [GO:0005938]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] GO:0005085; GO:0005886; GO:0005938; GO:0055037; GO:0070374 guanyl-nucleotide exchange factor activity [GO:0005085] AHSLGIR 0.99252 -66.811 0 0 0 0 0 0 0 0 12.1086 0 0 0 0 0 0 0 0 12.2327 0 0 0 10.4546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2392 0 0 0 0 13.8454 12.2393 0 0 0 0 0 12.7065 11.625 0 14.4327 0 0 0 0 0 0 0 0 0 13.8202 0 0 0 14.4991 0 12.3534 11.0347 11.9328 0 13.9229 15.4631 0 0 0 12.0756 0 0 0 0 10.7531 0 0 0 15.5218 0 0 12.0023 0 13.2917 0 0 0 0 14.784 14.1842 0 0 0 11.3883 0 0 0 13.8128 0 0 0 0 12.3113 0 0 0 0 0 0 13.3096 0 0 0 0 0 0 0 0 13.893 12.7762 12.4462 12.6946 12.3192 0 13.333 0 0 0 0 13.8902 0 0 0 0 0 0 0 14.3151 0 0 12.8022 0 Q0JRZ9 FCHO2_HUMAN F-BAR domain only protein 2 FCHO2 Homo sapiens (Human) clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488] clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835] "clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488]" GO:0001786; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098835 "identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]" ADFEQKMTETAQK 0.99252 -4.9673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1934 13.8478 0 0 0 0 0 0 0 0 0 12.5986 0 0 0 0 0 0 0 0 10.2556 0 0 0 13.9224 0 0 0 12.8466 0 0 12.8312 0 11.427 0 0 0 15.7397 10.1258 0 0 0 0 0 0 0 0 0 0 0 13.0704 0 0 0 0 0 0 0 0 0 0 0 0 0 14.141 10.4043 11.8488 12.5174 0 14.1749 0 0 15.4854 13.1542 0 0 0 12.613 0 12.4049 0 14.1464 11.1008 13.7324 12.1339 0 0 0 0 0 0 0 0 16.7181 0 0 0 0 0 17.2817 10.5999 0 0 0 14.4569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5258 11.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7665 0 0 0 0 13.7216 0 0 0 10.9502 0 0 0 0 0 Q5TG30 RHG40_HUMAN Rho GTPase-activating protein 40 (Rho-type GTPase-activating protein 40) ARHGAP40 C20orf95 Homo sapiens (Human) regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of actin filament polymerization [GO:0030833]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030833; GO:0051056 GTPase activator activity [GO:0005096] AGDGLEATPKVAKIQVVWPIK 0.99252 -17.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4988 0 0 0 0 0 0 0 0 0 14.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8294 14.2782 0 12.5953 13.0957 0 0 0 0 0 0 0 0 0 0 0 13.7289 0 10.2294 0 0 14.3064 0 0 12.8122 0 12.3335 0 0 0 0 19.9153 0 0 0 0 0 0 0 14.1887 0 0 0 0 0 0 13.6553 13.6025 11.6871 0 0 0 13.644 0 13.1348 0 0 0 0 0 0 12.99 0 0 0 0 0 0 0 0 12.9166 12.8571 15.4998 0 0 0 0 0 0 0 13.2303 12.3288 0 0 0 0 0 0 0 0 12.6137 0 0 0 0 12.7423 0 0 0 Q71RC2 LARP4_HUMAN La-related protein 4 (La ribonucleoprotein domain family member 4) LARP4 PP13296 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell morphogenesis [GO:0022604]; translation [GO:0006412] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; cytoskeleton organization [GO:0007010]; positive regulation of translation [GO:0045727]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell morphogenesis [GO:0022604]; translation [GO:0006412] GO:0003723; GO:0003730; GO:0005829; GO:0006412; GO:0007010; GO:0008143; GO:0010494; GO:0010608; GO:0016020; GO:0022604; GO:0045727 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723] IKAINTFFAK 0.99252 -4.5018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4464 0 0 0 0 0 0 0 0 0 13.2217 0 12.7828 0 12.9332 18.511 18.5832 0 0 13.4993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0342 0 0 0 0 0 0 0 0 0 0 Q7Z333 SETX_HUMAN "Probable helicase senataxin, EC 3.6.4.- (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin)" SETX ALS4 KIAA0625 SCAR1 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; RNA processing [GO:0006396]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]" GO:0000165; GO:0000228; GO:0000781; GO:0001147; GO:0003677; GO:0003678; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006396; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0008543; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0043066; GO:0043491; GO:0044344; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:0071300; GO:2000144; GO:2000806 ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147] AQEYGYDQSMMARFCR 0.99252 -45.705 0 0 10.3199 0 0 0 0 0 0 0 0 0 0 14.317 11.8135 13.6087 0 13.8111 14.0507 0 13.7064 0 14.7002 12.5232 0 13.8182 0 0 13.1823 0 0 10.2919 13.9294 0 11.8346 0 13.2737 0 0 13.9688 0 0 13.3277 0 0 12.9577 11.0953 0 12.5567 0 0 0 0 13.1798 12.6736 0 0 12.0849 0 0 0 0 0 0 10.3359 11.8767 12.6805 0 0 0 0 14.5053 11.6717 13.4351 0 11.7184 15.9318 0 15.0579 15.1441 14.688 0 0 0 13.3753 14.184 16.9244 14.9499 13.3187 0 12.0115 0 0 0 12.9629 12.0567 0 12.947 12.8568 0 14.5557 13.7616 14.7644 13.8041 0 12.8146 0 13.7972 15.341 15.747 11.6176 0 14.1077 13.6281 0 15.4263 0 14.1619 15.7568 16.1454 0 14.9231 0 14.9092 12.5326 0 14.0288 0 15.0836 12.0874 13.739 11.7954 12.5664 14.5087 13.854 14.2891 0 15.5055 14.3799 0 0 0 0 13.2397 0 0 0 14.0809 0 18.6099 9.96252 14.9237 0 15.7377 13.9743 14.9243 0 0 13.4424 0 13.5392 0 0 15.0155 11.3091 13.2157 0 11.0706 11.638 0 13.9317 0 13.2388 13.5754 0 0 0 0 12.4525 13.4842 Q8IU54 IFNL1_HUMAN "Interferon lambda-1, IFN-lambda-1 (Cytokine Zcyto21) (Interleukin-29, IL-29)" IFNL1 IL29 ZCYTO21 Homo sapiens (Human) "cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of memory T cell differentiation [GO:0043381]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of immune response [GO:0050778]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]; type III interferon signaling pathway [GO:0038196]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-28 receptor complex [GO:0032002] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-28 receptor complex [GO:0032002]; cytokine activity [GO:0005125]; interleukin-28 receptor binding [GO:0032003]; signaling receptor binding [GO:0005102]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of memory T cell differentiation [GO:0043381]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of immune response [GO:0050778]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]; type III interferon signaling pathway [GO:0038196]" GO:0002829; GO:0005102; GO:0005125; GO:0005576; GO:0005615; GO:0007259; GO:0008285; GO:0032002; GO:0032003; GO:0032696; GO:0032714; GO:0032729; GO:0038196; GO:0042531; GO:0043381; GO:0045087; GO:0045345; GO:0045581; GO:0045892; GO:0045893; GO:0046427; GO:0050778; GO:0051607; GO:0098586 cytokine activity [GO:0005125]; interleukin-28 receptor binding [GO:0032003]; signaling receptor binding [GO:0005102] LLQVRERPVALEAELALTLK 0.99252 -6.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWZ3 ANKH1_HUMAN "Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain, hMASK)" ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) innate immune response [GO:0045087] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087] GO:0003723; GO:0005737; GO:0045087 RNA binding [GO:0003723] AENSHNAGQVDTRSLAEACSDGDVNAVRK 0.99252 -17.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0201 0 0 0 0 12.9603 0 13.2346 14.1196 0 0 13.3009 0 14.1591 0 0 0 0 0 0 13.177 0 14.0798 11.7483 0 0 14.3301 0 0 0 0 14.1478 14.2365 0 12.4674 0 0 14.1648 0 0 0 0 0 0 0 0 0 15.4986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ04 TOMT_HUMAN "Transmembrane O-methyltransferase, EC 2.1.1.6 (Catechol O-methyltransferase 2) (Protein LRTOMT2)" TOMT COMT2 LRTOMT PP7517 Homo sapiens (Human) auditory receptor cell development [GO:0060117]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259]; neurotransmitter catabolic process [GO:0042135]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; catechol O-methyltransferase activity [GO:0016206]; L-dopa O-methyltransferase activity [GO:0102084]; O-methyltransferase activity [GO:0008171]; orcinol O-methyltransferase activity [GO:0102938]; auditory receptor cell development [GO:0060117]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259]; neurotransmitter catabolic process [GO:0042135]; sensory perception of sound [GO:0007605] GO:0005783; GO:0005886; GO:0007605; GO:0008171; GO:0016021; GO:0016206; GO:0032259; GO:0032502; GO:0042135; GO:0042417; GO:0042420; GO:0042424; GO:0060117; GO:0102084; GO:0102938 catechol O-methyltransferase activity [GO:0016206]; L-dopa O-methyltransferase activity [GO:0102084]; O-methyltransferase activity [GO:0008171]; orcinol O-methyltransferase activity [GO:0102938] ALPPGGR 0.99252 -17.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7082 0 12.0553 0 12.0562 0 0 0 0 0 0 0 10.7205 0 12.2545 0 0 0 0 12.0297 0 0 0 13.5664 0 0 0 0 0 12.9856 0 0 0 12.6877 0 0 0 12.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5536 0 0 0 0 0 0 0 0 0 13.5384 0 0 0 0 0 12.2805 0 0 0 0 0 0 0 0 0 13.9867 0 0 10.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.302 0 0 0 12.0336 0 0 13.2132 0 0 0 0 0 13.663 0 12.5417 0 12.7445 0 0 0 0 12.0954 0 0 0 0 12.1287 0 13.2458 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3431 0 Q93086 P2RX5_HUMAN "P2X purinoceptor 5, P2X5 (ATP receptor) (Purinergic receptor)" P2RX5 P2X5 Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; response to ATP [GO:0033198]; signal transduction [GO:0007165] cytosol [GO:0005829]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] cytosol [GO:0005829]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; ion channel activity [GO:0005216]; purinergic nucleotide receptor activity [GO:0001614]; transmembrane signaling receptor activity [GO:0004888]; nervous system development [GO:0007399]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; response to ATP [GO:0033198]; signal transduction [GO:0007165] GO:0001614; GO:0004888; GO:0004931; GO:0005216; GO:0005524; GO:0005639; GO:0005829; GO:0005886; GO:0005887; GO:0007165; GO:0007399; GO:0010524; GO:0033198; GO:0050850; GO:0098794 ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; ion channel activity [GO:0005216]; purinergic nucleotide receptor activity [GO:0001614]; transmembrane signaling receptor activity [GO:0004888] AASECHPHYSFSR 0.99252 -6.1019 0 0 0 0 11.9443 0 0 0 0 10.6872 0 0 0 0 0 12.3029 0 0 0 0 0 0 11.8083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2213 0 13.4945 11.5969 0 11.1202 12.8243 14.973 0 0 0 0 14.9107 16.2374 17.3522 0 0 0 13.7 13.3454 13.5381 0 0 14.2715 12.6768 13.801 11.534 0 0 0 0 0 0 0 0 0 13.4808 12.6142 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9426 0 13.353 0 12.522 0 13.5947 0 0 12.0531 0 0 14.9812 0 0 14.3873 14.0946 0 12.6054 0 0 0 12.5869 0 0 12.9835 0 0 0 0 0 14.053 0 0 0 0 0 0 0 13.3918 0 0 0 0 0 0 0 0 14.5502 12.4873 15.041 12.8159 0 0 0 0 0 Q99879 H2B1M_HUMAN "Histone H2B type 1-M (Histone H2B.e, H2B/e)" H2BC14 H2BFE HIST1H2BM Homo sapiens (Human) nucleosome assembly [GO:0006334] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; nucleosome assembly [GO:0006334] GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] EIQTAVRLLLPGELAK 0.99252 -25.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5571 0 0 0 0 11.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5252 0 0 14.4945 14.8008 0 15.3695 0 0 0 0 0 13.0508 13.6591 0 13.5943 14.3787 14.6963 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.681 0 0 0 0 0 13.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0221 13.3836 0 0 0 13.0579 12.8744 12.7524 0 0 0 13.3541 0 0 0 0 12.7534 12.7456 0 0 0 0 0 0 12.8708 0 0 Q9BTE3 MCMBP_HUMAN "Mini-chromosome maintenance complex-binding protein, MCM-BP, MCM-binding protein" MCMBP C10orf119 Homo sapiens (Human) cell division [GO:0051301]; DNA-templated DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062] cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-templated DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062] GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006261; GO:0007062; GO:0030054; GO:0051301 chromatin binding [GO:0003682] DQHAGAR 0.99252 -40.371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4032 11.8601 0 12.8576 0 0 0 0 9.99633 0 0 0 0 0 0 0 13.2545 0 13.6129 13.7335 13.6761 9.89216 13.5928 13.8626 13.6521 13.6566 0 0 0 13.8159 0 0 0 0 0 13.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1925 0 0 14.4301 0 13.6295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75916 9.37378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYW2 SETD2_HUMAN "Histone-lysine N-methyltransferase SETD2, EC 2.1.1.359 (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1, HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2, EC 2.1.1.-) (SET domain-containing protein 2, hSET2) (p231HBP)" SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription, DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0001525; GO:0001763; GO:0001843; GO:0005634; GO:0005654; GO:0005694; GO:0006298; GO:0006355; GO:0006368; GO:0010468; GO:0010569; GO:0010793; GO:0016279; GO:0018023; GO:0018024; GO:0018026; GO:0030900; GO:0032465; GO:0032727; GO:0034340; GO:0034728; GO:0035441; GO:0035987; GO:0043014; GO:0046872; GO:0046975; GO:0048332; GO:0048701; GO:0048863; GO:0048864; GO:0051607; GO:0060039; GO:0060669; GO:0060977; GO:0097198; GO:0097676; GO:1902850; GO:1905634 alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279] AAGGKMK 0.99252 -63.86 11.0161 9.79354 0 0 0 0 11.5183 0 0 10.2635 11.7262 10.8391 11.3829 11.3845 0 12.8231 13.5099 0 13.6898 10.6768 0 0 13.6978 0 13.7786 13.6879 0 12.5049 0 10.2746 0 0 10.6009 13.4946 14.5214 0 0 0 0 0 11.3698 0 0 13.3851 13.9784 0 11.2815 0 0 11.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6726 0 14.1794 10.3623 11.7619 0 0 0 9.95841 14.8339 13.9273 0 10.2342 0 12.6145 0 0 0 18.846 13.6676 0 13.9769 16.562 14.3795 16.8811 13.4477 11.1122 0 13.8742 13.6623 12.3955 14.248 18.8524 14.118 13.0994 10.5511 12.2982 11.0748 13.0258 12.9569 0 13.9594 0 0 12.5763 0 13.0444 13.3112 12.8057 13.6758 10.9073 13.8098 0 0 13.4497 13.2151 13.7107 0 14.0516 13.2853 0 0 14.7286 0 0 0 0 14.1606 0 12.529 12.168 0 12.1737 12.5329 0 0 11.687 11.5972 0 0 0 12.3381 11.9339 11.958 14.7937 0 10.4401 0 12.2795 0 0 0 0 0 12.412 0 14.1185 0 0 0 11.5208 0 0 0 0 14.6346 13.7243 0 0 0 12.9045 0 13.5404 13.5784 Q9GZY0 NXF2_HUMAN "Nuclear RNA export factor 2 (Cancer/testis antigen 39, CT39) (TAP-like protein 2, TAPL-2)" NXF2 TAPL2; NXF2B Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA transport [GO:0050658] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA transport [GO:0050658] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0016973; GO:0042272; GO:0050658 RNA binding [GO:0003723] AGQAFTMLQTEGK 0.99252 -17.054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6172 0 0 13.8826 0 0 13.0187 12.9655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7425 0 0 0 0 0 0 0 0 0 0 11.4252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4568 0 0 0 Q9H875 PKRI1_HUMAN PRKR-interacting protein 1 PRKRIP1 Homo sapiens (Human) mRNA processing [GO:0006397]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein kinase activity [GO:0006469]; renal system process [GO:0003014]; RNA splicing [GO:0008380] extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681] extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; spliceosomal complex [GO:0005681]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; mRNA processing [GO:0006397]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein kinase activity [GO:0006469]; renal system process [GO:0003014]; RNA splicing [GO:0008380] GO:0003014; GO:0003725; GO:0004860; GO:0005681; GO:0005730; GO:0006397; GO:0006469; GO:0008380; GO:0019901; GO:0042326; GO:0070062 double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] LMKNPDK 0.99252 -18.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1Z3 HCN3_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 HCN3 KIAA1535 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to dopamine [GO:1903351]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; response to cisplatin [GO:0072718]; sodium ion transmembrane transport [GO:0035725] axon [GO:0030424]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; HCN channel complex [GO:0098855]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; cellular response to cAMP [GO:0071320]; cellular response to dopamine [GO:1903351]; potassium ion transmembrane transport [GO:0071805]; regulation of cation channel activity [GO:2001257]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of SA node cell action potential [GO:0098907]; response to cisplatin [GO:0072718]; sodium ion transmembrane transport [GO:0035725] GO:0003254; GO:0005248; GO:0005249; GO:0005886; GO:0030424; GO:0030425; GO:0030552; GO:0035725; GO:0042391; GO:0043025; GO:0044316; GO:0071320; GO:0071805; GO:0072718; GO:0086091; GO:0098855; GO:0098907; GO:1903351; GO:2001257 cAMP binding [GO:0030552]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] DTRLTDGSYFGEICLLTR 0.99252 -25.645 0 0 0 0 0 0 0 0 12.9532 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4858 0 12.4263 0 0 0 0 0 0 10.5683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5184 0 0 0 0 0 13.5206 13.2852 0 13.1189 13.2507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4625 0 0 0 0 13.932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9386 14.0279 0 13.6466 0 0 0 0 10.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2883 0 14.7085 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4455 0 0 0 0 0 0 0 0 0 14.3137 0 Q9UFD9 RIM3A_HUMAN "RIMS-binding protein 3A, RIM-BP3.A (RIMS-binding protein 3.1, RIM-BP3.1)" RIMBP3 KIAA1666 RIMBP3A Homo sapiens (Human) fertilization [GO:0009566]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; benzodiazepine receptor binding [GO:0030156]; fertilization [GO:0009566]; spermatid development [GO:0007286] GO:0005634; GO:0005737; GO:0005856; GO:0007286; GO:0009566; GO:0030156 benzodiazepine receptor binding [GO:0030156] AELTGLARRLADR 0.99252 -45.075 0 9.88419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.008 0 0 0 0 0 0 0 0 0 0 11.5621 0 0 0 13.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2897 0 0 0 0 0 0 0 0 0 0 0 14.2581 0 14.3264 13.2128 0 14.1141 14.2633 0 0 0 0 14.1412 14.0821 0 13.6731 0 13.7722 15.0887 14.2737 0 13.3209 0 0 0 0 0 0 0 0 0 0 12.1842 0 13.5579 0 14.4892 13.6606 12.2609 16.5111 12.7625 0 0 12.8035 0 14.8916 0 0 0 0 0 13.8336 0 0 0 14.2888 0 0 0 0 0 12.5705 15.0348 0 12.3268 0 0 0 0 0 0 12.854 0 0 14.3245 0 13.8458 0 0 0 0 0 0 0 13.2353 0 0 13.5831 0 0 0 0 12.4285 0 0 0 14.9823 0 0 0 12.7622 0 Q9ULD9 ZN608_HUMAN Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36) ZNF608 KIAA1281 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0005634; GO:0006357; GO:0046872 metal ion binding [GO:0046872] AGKNSGK 0.99252 -45.654 11.4048 0 0 0 0 0 0 0 12.6211 0 12.267 0 12.1289 0 0 0 0 0 0 0 0 10.249 0 0 0 0 0 0 0 0 0 12.5204 12.1303 12.1351 12.8176 12.5614 12.8593 12.8599 0 11.9115 0 0 0 0 0 0 0 0 0 0 12.0226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.41 13.9516 0 0 14.0736 0 0 14.1238 0 11.5231 18.1747 0 13.4941 14.1758 14.5882 14.6218 0 0 13.3682 13.4856 0 0 17.7558 13.2099 12.9652 0 0 0 0 0 11.4305 0 0 0 0 0 0 14.495 13.213 14.2499 0 13.8768 0 13.4677 0 0 0 0 0 0 0 0 0 12.3535 12.5575 12.1338 0 12.2483 0 0 0 13.6905 13.0084 0 13.5578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5201 0 0 12.8078 0 0 0 14.6161 0 0 0 12.3447 0 0 0 0 0 0 13.1837 0 P12036 NFH_HUMAN "Neurofilament heavy polypeptide, NF-H (200 kDa neurofilament protein) (Neurofilament triplet H protein)" NEFH KIAA0845 NFH Homo sapiens (Human) axon development [GO:0061564]; axonogenesis [GO:0007409]; cell projection assembly [GO:0030031]; cellular response to leukemia inhibitory factor [GO:1990830]; intermediate filament bundle assembly [GO:0045110]; microtubule cytoskeleton organization [GO:0000226]; neurofilament bundle assembly [GO:0033693]; neurofilament cytoskeleton organization [GO:0060052]; peripheral nervous system neuron axonogenesis [GO:0048936]; regulation of organelle transport along microtubule [GO:1902513] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]; postsynaptic density [GO:0014069]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; Schaffer collateral - CA1 synapse [GO:0098685] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]; postsynaptic density [GO:0014069]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; Schaffer collateral - CA1 synapse [GO:0098685]; dynein complex binding [GO:0070840]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic intermediate filament cytoskeleton [GO:0099184]; axon development [GO:0061564]; axonogenesis [GO:0007409]; cell projection assembly [GO:0030031]; cellular response to leukemia inhibitory factor [GO:1990830]; intermediate filament bundle assembly [GO:0045110]; microtubule cytoskeleton organization [GO:0000226]; neurofilament bundle assembly [GO:0033693]; neurofilament cytoskeleton organization [GO:0060052]; peripheral nervous system neuron axonogenesis [GO:0048936]; regulation of organelle transport along microtubule [GO:1902513] GO:0000226; GO:0005200; GO:0005737; GO:0005856; GO:0005883; GO:0007409; GO:0008017; GO:0014069; GO:0019894; GO:0019901; GO:0030031; GO:0030424; GO:0030674; GO:0033693; GO:0045110; GO:0048936; GO:0060052; GO:0061564; GO:0070840; GO:0097418; GO:0098685; GO:0099160; GO:0099184; GO:1902513; GO:1990830 dynein complex binding [GO:0070840]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic intermediate filament cytoskeleton [GO:0099184] APEKEIPK 0.99253 -25.84 13.339 0 0 0 0 0 18.989 0 0 0 0 0 0 0 0 0 0 0 11.7345 0 0 0 13.2099 12.3373 0 0 15.6085 12.3095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0064 12.6447 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5392 19.6034 13.6354 13.6095 0 0 19.8241 14.6859 14.7249 0 14.9893 13.5979 0 14.3517 0 14.8809 14.09 14.0097 14.0226 14.9819 14.4446 15.6032 13.8473 0 14.5237 13.9207 10.0681 13.9578 13.9075 14.3354 15.4711 0 14.8719 14.1946 16.8591 0 13.5382 13.6489 13.6726 0 14.7977 15.0298 14.4228 0 0 13.9962 11.8719 19.4243 14.4551 13.9691 15.0859 14.3584 14.1443 14.8966 0 0 14.2586 15.1148 13.7903 15.6522 14.7964 14.0031 13.7441 14.8014 13.6714 14.0857 0 15.1059 0 14.8113 13.8424 15.4384 13.7736 0 0 0 14.6237 14.9349 13.7432 0 13.9306 0 15.0332 0 0 0 10.9669 17.0697 0 0 0 0 14.0354 0 0 0 0 0 13.9005 13.7974 15.0152 13.9127 0 0 11.4061 14.8695 13.9252 Q8IWU6 SULF1_HUMAN "Extracellular sulfatase Sulf-1, hSulf-1, EC 3.1.6.-" SULF1 KIAA1077 Homo sapiens (Human) apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0001822; GO:0001937; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005794; GO:0005795; GO:0005886; GO:0006915; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0032836; GO:0035860; GO:0040036; GO:0040037; GO:0045121; GO:0048010; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686 arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] AYIDKEIEALQDK 0.99253 -6.6798 0 0 0 0 11.8684 0 0 0 0 0 0 0 12.0112 0 0 0 0 0 0 12.3801 0 0 0 0 0 0 0 0 0 0 0 0 12.2007 0 0 0 0 0 0 0 0 0 0 0 11.202 0 0 0 0 0 11.2661 0 0 0 0 0 0 0 0 0 0 0 10.4561 0 0 0 0 0 10.1795 0 0 0 0 0 11.5465 11.7549 0 0 0 13.231 13.041 0 14.4009 0 16.9969 15.5814 14.477 17.0155 0 14.3353 16.9049 17.1756 0 13.7802 0 13.4346 0 11.5254 0 0 13.9375 13.0368 0 13.3504 0 0 0 13.1131 12.4853 0 12.1299 0 12.8754 14.164 14.352 13.4445 13.623 13.1525 13.604 0 0 0 0 12.7494 0 0 0 14.5553 0 0 0 0 0 0 0 12.4115 0 0 13.8774 13.8282 13.4097 0 12.9227 12.5388 0 0 0 12.8072 0 0 13.0216 12.2015 0 0 0 15.6716 0 0 0 0 0 13.4029 11.4501 0 0 0 0 0 0 0 0 0 0 13.3472 0 0 0 13.2237 0 13.7179 Q8WWZ4 ABCAA_HUMAN "ATP-binding cassette sub-family A member 10, EC 7.6.2.-" ABCA10 Homo sapiens (Human) lipid transport [GO:0006869] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869] GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] ALLCLLLVLGIAFIPIILEKIMYKVTR 0.99253 -45.837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0603 11.2388 11.4011 0 10.4714 0 0 0 0 0 0 10.3136 0 0 0 0 0 0 0 12.4581 0 0 0 12.202 13.214 13.1035 0 0 14.6461 14.8749 13.7875 0 9.97327 0 12.7178 13.5921 13.0551 0 13.239 13.3846 0 0 0 12.6033 11.3971 0 12.4243 15.0412 13.9434 0 0 13.1366 0 0 0 0 0 0 16.4989 0 0 13.7599 0 14.7822 0 0 16.6792 0 13.9649 0 11.5647 0 0 0 11.9605 12.2207 13.1147 12.5795 12.0614 0 0 0 0 0 0 0 0 0 13.543 0 0 0 12.3807 0 0 0 0 0 0 0 0 0 0 0 14.3426 0 12.0213 0 11.9811 0 0 0 13.4143 0 10.5591 13.4201 12.8287 10.9644 12.8438 11.482 0 0 0 0 0 0 0 12.0723 12.8409 0 0 12.3661 0 0 0 0 0 0 11.0005 0 0 0 0 0 13.0337 0 0 0 0 0 12.3401 B9A014 F243A_HUMAN Uncharacterized protein C21orf140 (Protein FAM243A) C21orf140 FAM243A Homo sapiens (Human) FASPLLR 0.99253 -25.937 0 0 0 0 0 0 0 12.4323 0 0 0 0 0 0 0 0 0 12.7644 11.9277 0 12.1164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6537 17.6032 0 0 14.3931 13.8698 0 0 13.4915 15.3693 0 15.1841 14.2594 14.3604 14.0834 0 14.3054 0 0 0 13.9816 0 0 0 12.7582 0 14.0864 0 0 12.7423 14.3634 14.1869 0 0 0 0 0 0 0 0 0 13.9885 13.9201 14.0756 0 0 13.0318 12.8689 0 0 14.4807 15.0452 13.6577 14.721 0 0 14.6385 13.5838 14.0616 0 0 0 14.9761 0 0 0 12.84 13.7944 0 13.4926 0 14.3775 0 0 0 12.9798 0 14.9205 0 15.5413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2744 0 0 0 0 0 0 P10809 CH60_HUMAN "60 kDa heat shock protein, mitochondrial, EC 5.6.1.7 (60 kDa chaperonin) (Chaperonin 60, CPN60) (Heat shock protein 60, HSP-60, Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)" HSPD1 HSP60 Homo sapiens (Human) 'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225] cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110] GO:0001530; GO:0002039; GO:0002755; GO:0002842; GO:0003688; GO:0003697; GO:0003723; GO:0003725; GO:0005524; GO:0005615; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005769; GO:0005829; GO:0005886; GO:0005905; GO:0006457; GO:0006458; GO:0006919; GO:0006986; GO:0008035; GO:0008637; GO:0009409; GO:0009986; GO:0016020; GO:0016853; GO:0016887; GO:0019899; GO:0030135; GO:0030141; GO:0031625; GO:0032727; GO:0032729; GO:0032733; GO:0032735; GO:0032755; GO:0032991; GO:0034185; GO:0034186; GO:0034514; GO:0042026; GO:0042100; GO:0042110; GO:0042113; GO:0043032; GO:0043065; GO:0043066; GO:0045041; GO:0046696; GO:0048291; GO:0050821; GO:0050870; GO:0051082; GO:0051087; GO:0051131; GO:0051604; GO:0051702; GO:0070062; GO:0097225; GO:0140662 apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] DPGMGAMGGMGGGMGGGMF 0.99253 -18.419 0 0 0 0 0 0 11.3795 0 0 0 0 11.3409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9161 0 0 17.5815 0 0 0 0 0 0 0 0 0 0 17.7673 0 0 0 0 0 0 0 11.4141 0 0 0 0 0 0 0 0 0 0 16.9833 0 0 0 0 0 10.4313 0 0 0 0 13.6571 14.1336 14.5865 0 14.6617 14.2372 0 16.2399 14.2644 0 0 0 12.6205 12.1734 12.389 0 15.7206 14.0083 13.9784 15.3737 14.4523 13.3281 13.9365 0 0 15.13 0 0 12.0156 10.8071 0 0 0 0 0 11.8572 14.9888 15.1671 13.8835 12.3382 0 0 0 0 13.3157 15.1297 0 14.2641 14.8046 11.989 13.9757 13.7527 12.5143 13.6271 0 14.8489 13.911 0 0 15.5811 11.5158 14.2046 13.9252 13.123 14.6997 0 14.3242 17.6521 0 12.7649 13.2815 12.8259 0 0 13.3327 0 0 0 12.5368 0 0 0 0 0 0 0 0 0 0 10.556 0 11.3368 0 0 0 0 0 0 0 0 0 16.7263 13.4728 0 12.9174 0 0 0 Q06250 WIT1_HUMAN "Putative Wilms tumor upstream neighbor 1 gene protein, WIT-1 (Wilms tumor-associated antisense RNA)" WT1-AS WIT1 Homo sapiens (Human) RCPLHLTER 0.99253 -14.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1111 13.0664 0 0 0 0 0 0 0 0 0 0 0 9.49949 0 0 0 0 0 0 0 0 0 12.3561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.832 0 0 0 13.3778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6593 0 12.4861 0 0 14.187 0 0 0 0 Q13683 ITA7_HUMAN Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form ] ITGA7 UNQ406/PRO768 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519] GO:0005178; GO:0005886; GO:0007160; GO:0007229; GO:0007517; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0033627; GO:0034113; GO:0035987; GO:0043236; GO:0046872; GO:0050900; GO:0098609 integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872] AIVVTLSYSLQTPR 0.99253 -16.306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6534 0 0 0 0 12.8068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8261 13.7717 0 0 12.5629 0 13.3264 0 0 14.2412 0 0 0 0 0 0 13.0469 0 12.8677 0 0 13.243 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9935 0 0 11.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2987 0 0 0 0 12.1881 11.4733 0 0 Q2NKX8 ERC6L_HUMAN "DNA excision repair protein ERCC-6-like, EC 3.6.4.12 (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15)" ERCC6L PICH Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020] cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0000776; GO:0003677; GO:0003678; GO:0005524; GO:0005829; GO:0007049; GO:0015616; GO:0016020; GO:0016887; GO:0051301; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616] AGFVHSK 0.99253 -45.892 0 0 0 0 0 0 11.4625 0 0 0 0 0 0 0 0 0 0 12.2191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2136 11.8003 0 0 0 0 0 0 0 0 0 11.8059 0 0 0 0 0 0 0 13.2225 0 13.366 0 13.0131 12.4422 12.9816 13.0232 12.9764 12.4515 0 0 0 0 0 0 0 0 0 0 12.5804 0 0 13.1039 0 12.9972 12.0966 10.9755 0 0 0 0 0 0 0 0 13.3962 0 0 0 0 0 0 0 0 17.8585 12.5535 12.805 0 0 0 0 0 0 0 13.1216 0 0 0 0 0 0 0 13.085 0 13.1535 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6799 0 0 13.0452 12.9602 0 13.5652 0 0 0 0 12.9885 0 12.9807 14.8294 0 0 0 14.2041 0 0 0 0 0 14.5237 0 0 13.8196 0 0 0 0 12.1289 0 0 0 0 0 0 0 0 0 0 0 0 12.6886 13.3813 Q5W0A0 ERI6B_HUMAN Glutamate-rich protein 6B (Protein FAM194B) ERICH6B FAM194B Homo sapiens (Human) EDTEVELDEESLQDESPFSPEGESLEDK 0.99253 -24.133 14.6061 0 14.7233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2543 0 0 0 11.3699 10.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5015 0 0 0 0 0 0 0 0 0 10.2476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1611 11.0464 0 0 16.6902 0 0 0 0 12.7462 13.7105 0 0 12.9244 0 11.6833 16.5029 14.1918 0 0 0 0 0 0 0 13.3982 0 12.9554 0 0 14.6158 0 0 0 12.1744 14.5788 15.2147 0 0 0 12.9462 12.92 13.2743 14.0364 0 13.9408 0 12.8227 0 0 0 0 14.0137 0 0 0 0 0 0 11.8675 0 0 13.7666 0 0 0 10.668 0 0 0 0 0 13.0844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5762 0 0 0 0 0 0 0 0 Q6PRD1 GP179_HUMAN "Probable G-protein coupled receptor 179 (Probable G-protein coupled receptor 158-like 1, GPR158-like)" GPR179 GPR158L GPR158L1 Homo sapiens (Human) visual perception [GO:0007601] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; visual perception [GO:0007601] GO:0004930; GO:0005886; GO:0007601; GO:0016021 G protein-coupled receptor activity [GO:0004930] AEICPWEAGGGAAEEGEQER 0.99253 -24.999 0 0 11.8812 0 0 0 0 0 13.3264 10.0169 0 0 0 0 0 0 0 13.7255 0 11.3035 0 0 0 16.3439 0 0 0 0 0 0 13.4422 0 11.8188 0 0 0 11.1522 0 0 0 12.9592 0 18.3479 0 0 0 0 0 0 0 0 11.2413 0 0 0 0 17.0804 16.3234 0 0 0 0 15.4732 16.3697 0 0 11.7798 0 0 0 0 0 0 0 0 0 0 12.5361 13.82 0 0 13.1624 14.642 0 0 12.6347 15.3329 16.0307 12.0089 12.6357 11.823 0 0 12.0024 14.8787 14.2924 0 16.629 0 14.0749 10.5792 13.2375 0 0 16.8046 0 0 14.6619 11.678 0 0 14.027 16.1456 14.9671 0 11.9968 11.5663 0 16.1978 14.4654 0 0 15.4439 0 17.0904 0 16.7885 15.2644 15.095 10.0814 11.2024 18.2935 0 0 0 12.1146 0 0 14.4769 13.1392 0 15.9976 0 0 0 12.2021 0 0 0 0 0 0 0 18.4159 0 0 0 0 0 12.1149 0 16.7528 0 10.8242 0 13.7935 0 0 0 15.1236 0 0 13.5501 0 0 0 0 0 0 18.0999 Q6U841 S4A10_HUMAN Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10) SLC4A10 NBCN2 NCBE Homo sapiens (Human) bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; chloride transport [GO:0006821]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basal dendrite [GO:0097441]; basolateral plasma membrane [GO:0016323]; CA3 pyramidal cell dendrite [GO:0097442]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; brain morphogenesis [GO:0048854]; chloride transport [GO:0006821]; ion homeostasis [GO:0050801]; locomotory exploration behavior [GO:0035641]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; proton transmembrane transport [GO:1902600]; pyramidal neuron development [GO:0021860]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to light stimulus [GO:0009416]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] GO:0005452; GO:0005886; GO:0006821; GO:0007601; GO:0008510; GO:0009416; GO:0009791; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0016324; GO:0021860; GO:0022857; GO:0030425; GO:0035264; GO:0035641; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0048854; GO:0050801; GO:0051453; GO:0055085; GO:0070161; GO:0097440; GO:0097441; GO:0097442; GO:0098794; GO:1902600 anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857] DQGAQMEPLLPTRNDEEAVVDR 0.99253 -17.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3755 0 0 0 0 0 0 11.3281 0 0 0 0 0 0 0 0 0 0 0 12.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5882 0 0 0 0 0 0 0 0 0 0 11.7417 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0012 0 15.6434 0 0 0 13.198 0 0 0 0 14.3803 0 0 13.8216 0 10.824 10.9251 0 0 0 0 11.1303 0 10.631 0 0 11.7885 0 0 13.2777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6945 12.5246 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5196 16.9506 0 0 0 0 Q76B58 BRNP3_HUMAN BMP/retinoic acid-inducible neural-specific protein 3 (DBCCR1-like protein 1) BRINP3 DBCCR1L DBCCR1L1 FAM5C Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to retinoic acid [GO:0071300]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of neuron differentiation [GO:0045666] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; cell cycle [GO:0007049]; cellular response to retinoic acid [GO:0071300]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of neuron differentiation [GO:0045666] GO:0005576; GO:0005739; GO:0005783; GO:0007049; GO:0030425; GO:0043025; GO:0045666; GO:0045930; GO:0071300 AYNSDFEESDEFK 0.99253 -6.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0298 0 13.4912 14.0504 0 0 0 0 13.4225 0 11.0647 0 0 0 0 0 14.0614 0 13.9062 0 0 0 0 0 0 0 0 0 13.8607 0 0 13.5285 13.9328 0 0 0 13.2404 0 0 0 0 0 0 12.1049 0 0 0 12.2463 0 0 0 0 0 0 0 0 0 13.0602 13.0056 0 0 0 0 12.1484 0 0 10.8094 0 0 0 13.2551 0 10.9654 0 0 0 0 0 12.7034 0 0 0 0 0 13.0609 0 0 0 0 0 0 12.6792 0 0 0 0 0 12.7601 0 0 0 0 0 0 13.2063 13.7306 0 0 Q8IY81 SPB1_HUMAN "pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3, EC 2.1.1.- (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)" FTSJ3 SB92 Homo sapiens (Human) "enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]" "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]" "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA 2'-O-methyltransferase activity [GO:0062105]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]" GO:0000453; GO:0000463; GO:0000466; GO:0001510; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0008173; GO:0008650; GO:0016435; GO:0030687; GO:0030688; GO:0031167; GO:0062105 RNA 2'-O-methyltransferase activity [GO:0062105]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650] CRQALRK 0.99253 -25.917 0 13.5992 0 0 0 0 0 0 13.1221 0 0 0 0 0 0 11.3517 10.6368 0 0 11.9705 0 0 11.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3058 0 0 0 12.4036 12.0276 0 14.2724 14.1847 0 0 0 0 14.4932 0 0 0 18.4938 0 0 12.705 12.3286 0 0 0 0 0 13.2556 0 0 0 19.0592 12.5813 0 0 0 0 0 0 12.7939 0 0 0 0 0 0 0 0 0 0 13.3597 0 0 0 0 0 0 13.0307 0 0 0 0 0 0 0 0 12.7735 0 0 0 0 0 0 0 0 0 11.2898 0 0 0 0 0 0 12.1965 0 0 11.9803 0 12.7187 0 0 0 0 0 0 12.343 0 12.0321 0 0 0 0 0 0 0 Q8IYT8 ULK2_HUMAN "Serine/threonine-protein kinase ULK2, EC 2.7.11.1 (Unc-51-like kinase 2)" ULK2 KIAA0623 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; collateral sprouting [GO:0048668]; late nucleophagy [GO:0044805]; negative regulation of collateral sprouting [GO:0048671]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; phagophore assembly site membrane [GO:0034045] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; phagophore assembly site membrane [GO:0034045]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; collateral sprouting [GO:0048668]; late nucleophagy [GO:0044805]; negative regulation of collateral sprouting [GO:0048671]; peptidyl-serine phosphorylation [GO:0018105]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] GO:0000045; GO:0000422; GO:0004674; GO:0005524; GO:0005737; GO:0006914; GO:0007165; GO:0010508; GO:0018105; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0044805; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FCITMCKKLTEK 0.99253 -18.448 0 0 0 0 0 0 0 0 0 0 14.7788 14.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1733 0 13.1775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.829 0 18.1753 0 0 0 0 0 0 0 0 0 15.4169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3976 0 0 0 0 0 0 0 0 0 0 0 0 12.9656 0 0 0 0 0 0 11.5656 0 0 0 0 0 0 0 0 0 0 13.1559 0 0 0 0 0 0 0 13.1332 0 14.3751 13.8502 11.1714 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4723 0 0 0 0 0 10.5659 Q8N143 BCL6B_HUMAN B-cell CLL/lymphoma 6 member B protein (Bcl6-associated zinc finger protein) (Zinc finger protein 62) BCL6B BAZF ZNF62 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; type 2 immune response [GO:0042092] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; type 2 immune response [GO:0042092]" GO:0000122; GO:0000978; GO:0001227; GO:0001817; GO:0002682; GO:0005654; GO:0006357; GO:0042092; GO:0042127; GO:0045595; GO:0046872; GO:0050727; GO:1990837 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CETCGSR 0.99253 -6.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7X4 MAGB6_HUMAN "Melanoma-associated antigen B6 (Cancer/testis antigen 3.4, CT3.4) (MAGE-B6 antigen)" MAGEB6 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 AYAETTKMR 0.99253 -14.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1775 0 0 0 0 11.8341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6168 0 0 0 0 0 0 0 0 0 0 12.4971 0 0 0 0 0 0 0 13.7878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8I6 CQ055_HUMAN Putative uncharacterized protein encoded by LINC00482 LINC00482 C17orf55 Homo sapiens (Human) AQLRSLLPR 0.99253 -6.1293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4282 0 0 0 0 0 0 0 14.0277 0 0 0 0 0 0 0 14.3651 0 12.6158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0178 0 0 0 0 0 0 0 0 0 0 0 0 12.3902 0 0 0 0 0 0 0 13.8262 Q8NBP7 PCSK9_HUMAN "Proprotein convertase subtilisin/kexin type 9, EC 3.4.21.- (Neural apoptosis-regulated convertase 1, NARC-1) (Proprotein convertase 9, PC9) (Subtilisin/kexin-like protease PC9)" PCSK9 NARC1 PSEC0052 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; kidney development [GO:0001822]; lipoprotein metabolic process [GO:0042157]; liver development [GO:0001889]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; lysosomal transport [GO:0007041]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of low-density lipoprotein particle receptor binding [GO:1905596]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of receptor internalization [GO:0002091]; negative regulation of receptor recycling [GO:0001920]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; phospholipid metabolic process [GO:0006644]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of receptor internalization [GO:0002092]; protein autoprocessing [GO:0016540]; regulation of neuron apoptotic process [GO:0043523]; regulation of signaling receptor activity [GO:0010469]; triglyceride metabolic process [GO:0006641] cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; PCSK9-AnxA2 complex [GO:1990667]; PCSK9-LDLR complex [GO:1990666]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; PCSK9-AnxA2 complex [GO:1990667]; PCSK9-LDLR complex [GO:1990666]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor binding [GO:0034190]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; signaling receptor inhibitor activity [GO:0030547]; sodium channel inhibitor activity [GO:0019871]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor binding [GO:0070326]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; kidney development [GO:0001822]; lipoprotein metabolic process [GO:0042157]; liver development [GO:0001889]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; lysosomal transport [GO:0007041]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of low-density lipoprotein particle receptor binding [GO:1905596]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of receptor internalization [GO:0002091]; negative regulation of receptor recycling [GO:0001920]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; phospholipid metabolic process [GO:0006644]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of receptor internalization [GO:0002092]; protein autoprocessing [GO:0016540]; regulation of neuron apoptotic process [GO:0043523]; regulation of signaling receptor activity [GO:0010469]; triglyceride metabolic process [GO:0006641] GO:0001822; GO:0001889; GO:0001920; GO:0002091; GO:0002092; GO:0003723; GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005788; GO:0005791; GO:0005794; GO:0005886; GO:0006641; GO:0006644; GO:0006915; GO:0007041; GO:0008203; GO:0009267; GO:0009986; GO:0010469; GO:0010989; GO:0016540; GO:0019871; GO:0022008; GO:0030134; GO:0030169; GO:0030182; GO:0030547; GO:0031232; GO:0032802; GO:0032805; GO:0032869; GO:0034185; GO:0034189; GO:0034190; GO:0036020; GO:0042157; GO:0042632; GO:0043523; GO:0043525; GO:0043621; GO:0048471; GO:0050750; GO:0070326; GO:1905596; GO:1905598; GO:1905601; GO:1990666; GO:1990667; GO:2000650 apolipoprotein binding [GO:0034185]; apolipoprotein receptor binding [GO:0034190]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; signaling receptor inhibitor activity [GO:0030547]; sodium channel inhibitor activity [GO:0019871]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor binding [GO:0070326] ILHVFHGLLPGFLVK 0.99253 -25.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2013 0 11.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6261 0 0 12.9356 0 0 0 0 11.6497 13.5085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0676 0 0 0 12.157 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1065 0 0 0 0 0 15.0443 0 0 0 0 0 13.4473 0 0 0 0 0 0 0 0 0 12.7718 0 0 0 0 0 10.1355 0 0 0 0 0 0 10.8005 10.6644 0 0 0 0 0 0 0 0 0 10.7561 0 0 13.0576 0 0 11.7891 0 0 14.6794 14.8041 0 13.1059 0 0 0 0 0 0 0 14.1852 0 0 Q8NCE0 SEN2_HUMAN "tRNA-splicing endonuclease subunit Sen2, EC 4.6.1.16 (tRNA-intron endonuclease Sen2, HsSen2)" TSEN2 SEN2 Homo sapiens (Human) "mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" centrosome [GO:0005813]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214] "centrosome [GO:0005813]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; tRNA-intron endonuclease complex [GO:0000214]; lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213]; mRNA processing [GO:0006397]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]" GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0006388; GO:0006397; GO:0016829 lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213] ILKDYTKPLEHPPVK 0.99253 -14.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66135 0 0 0 0 0 0 0 0 0 16.004 0 0 0 0 0 0 0 0 0 0 9.55013 Q8ND76 CCNY_HUMAN "Cyclin-Y, Cyc-Y (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X)" CCNY C10orf9 CBCP1 CFP1 Homo sapiens (Human) cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of autophagy [GO:0010508]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of autophagy [GO:0010508]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055] GO:0000086; GO:0000307; GO:0000308; GO:0005634; GO:0005886; GO:0007283; GO:0010508; GO:0016055; GO:0016538; GO:0019901; GO:0045737; GO:0045859; GO:0051301; GO:0060828; GO:0061575 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] ERAHKLEAISR 0.99253 -4.9916 0 0 0 0 0 0 8.9978 0 0 0 0 0 0 12.5708 0 0 12.0266 0 0 0 0 0 0 12.8427 0 0 0 0 0 0 11.6812 0 11.5287 0 0 0 0 11.3607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7585 12.5659 0 12.0075 0 12.1749 12.4489 0 0 0 0 0 0 Q8TD26 CHD6_HUMAN "Chromodomain-helicase-DNA-binding protein 6, CHD-6, EC 3.6.4.12 (ATP-dependent helicase CHD6) (Radiation-induced gene B protein)" CHD6 CHD5 KIAA1335 RIGB Homo sapiens (Human) chromatin remodeling [GO:0006338]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coregulator binding [GO:0001221]; chromatin remodeling [GO:0006338]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; regulation of gene expression [GO:0010468]" GO:0000785; GO:0001221; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0008094; GO:0010468; GO:0016887; GO:0036091; GO:0042393; GO:0140658 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; transcription coregulator binding [GO:0001221]" AARTLYRIELLR 0.99253 -46.733 0 12.5473 0 0 0 0 0 0 0 0 0 13.2246 0 0 0 0 12.7285 0 0 0 0 0 12.4147 0 0 0 0 0 12.3132 12.4121 13.3267 0 14.218 0 0 0 0 0 0 0 0 0 0 0 13.0435 0 0 0 13.6736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0986 0 0 0 0 0 14.1553 16.7568 0 14.4059 0 13.432 14.0011 0 0 16.0429 14.3652 13.4221 14.1539 0 14.1023 0 13.4794 13.728 15.8059 12.7658 14.7864 0 12.8157 15.0873 0 0 0 0 0 12.2062 0 0 13.389 12.1434 12.4072 0 0 13.9838 11.2597 0 0 13.5223 0 0 13.4359 13.7084 14.7648 0 14.492 0 0 16.1785 0 0 0 0 13.5774 0 0 0 12.7338 14.3473 13.8227 14.6169 0 0 0 13.9785 0 0 0 0 0 13.5402 0 0 12.3029 15.3249 12.9345 0 14.0843 14.9812 14.8323 16.4153 15.0606 0 0 0 0 13.5665 15.008 13.851 14.4693 0 13.7944 0 0 15.0114 0 0 14.5012 12.5474 0 Q92537 SUSD6_HUMAN Sushi domain-containing protein 6 (Drug-activated gene overexpressed protein) SUSD6 DRAGO KIAA0247 Homo sapiens (Human) cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974] GO:0006974; GO:0008219; GO:0016021 DTHTSLGVPTLSIVASTASSVALILLLVVLFVLLQPK 0.99253 -4.5031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0852 0 10.9266 0 0 0 0 0 14.5263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M53 TBATA_HUMAN "Protein TBATA (Protein SPATIAL) (Stromal protein associated with thymii and lymph node homolog) (Thymus, brain and testes-associated protein)" TBATA C10orf27 SPATIAL Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] ciliary basal body [GO:0036064]; cytosol [GO:0005829] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005829; GO:0007283; GO:0030154; GO:0036064 ELVIPGIVDFERIRR 0.99253 -6.6744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99731 CCL19_HUMAN "C-C motif chemokine 19 (Beta-chemokine exodus-3) (CK beta-11) (Epstein-Barr virus-induced molecule 1 ligand chemokine, EBI1 ligand chemokine, ELC) (Macrophage inflammatory protein 3 beta, MIP-3-beta) (Small-inducible cytokine A19)" CCL19 ELC MIP3B SCYA19 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell maturation [GO:0048469]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mature conventional dendritic cell differentiation [GO:0097029]; monocyte chemotaxis [GO:0002548]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell motility [GO:2000147]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell dendrite assembly [GO:2000549]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell projection assembly [GO:0060491]; release of sequestered calcium ion into cytosol [GO:0051209]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; response to virus [GO:0009615]; T cell costimulation [GO:0031295] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR10 chemokine receptor binding [GO:0031735]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell maturation [GO:0048469]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mature conventional dendritic cell differentiation [GO:0097029]; monocyte chemotaxis [GO:0002548]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell motility [GO:2000147]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell dendrite assembly [GO:2000549]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell projection assembly [GO:0060491]; release of sequestered calcium ion into cytosol [GO:0051209]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; response to virus [GO:0009615]; T cell costimulation [GO:0031295] GO:0001768; GO:0001771; GO:0002407; GO:0002408; GO:0002548; GO:0002606; GO:0005576; GO:0005615; GO:0006874; GO:0006954; GO:0006955; GO:0007154; GO:0007186; GO:0008009; GO:0009615; GO:0010560; GO:0030593; GO:0031295; GO:0031640; GO:0031732; GO:0031735; GO:0032731; GO:0032735; GO:0032760; GO:0034695; GO:0042102; GO:0042379; GO:0043123; GO:0043507; GO:0043547; GO:0043552; GO:0045627; GO:0045807; GO:0045860; GO:0046330; GO:0048020; GO:0048247; GO:0048260; GO:0048469; GO:0050921; GO:0051209; GO:0051897; GO:0060491; GO:0061844; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0071731; GO:0090023; GO:0097029; GO:0098586; GO:1901224; GO:2000147; GO:2000549; GO:2000669 CCR chemokine receptor binding [GO:0048020]; CCR10 chemokine receptor binding [GO:0031735]; CCR7 chemokine receptor binding [GO:0031732]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379] IIQRLQRTSAK 0.99253 -5.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99969 RARR2_HUMAN Retinoic acid receptor responder protein 2 (Chemerin) (RAR-responsive protein TIG2) (Tazarotene-induced gene 2 protein) RARRES2 TIG2 Homo sapiens (Human) antifungal humoral response [GO:0019732]; antifungal innate immune response [GO:0061760]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; embryonic digestive tract development [GO:0048566]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin receptor signaling pathway [GO:0008286]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of protein phosphorylation [GO:0001934]; regulation of lipid catabolic process [GO:0050994]; retinoid metabolic process [GO:0001523] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]; signaling receptor binding [GO:0005102]; antifungal humoral response [GO:0019732]; antifungal innate immune response [GO:0061760]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; embryonic digestive tract development [GO:0048566]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin receptor signaling pathway [GO:0008286]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of protein phosphorylation [GO:0001934]; regulation of lipid catabolic process [GO:0050994]; retinoid metabolic process [GO:0001523] GO:0001523; GO:0001934; GO:0005102; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0008286; GO:0010759; GO:0019732; GO:0030154; GO:0031012; GO:0031089; GO:0045087; GO:0045600; GO:0048566; GO:0050829; GO:0050830; GO:0050921; GO:0050994; GO:0061760; GO:0062023 signaling receptor binding [GO:0005102] KCLACIK 0.99253 -18.423 0 0 11.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2166 0 0 0 0 0 0 0 0 0 0 0 0 13.3965 12.8987 0 0 0 0 0 0 13.9872 0 12.6258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5V7 IKZF5_HUMAN Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) IKZF5 ZNFN1A5 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0019904; GO:0032991 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" CELCSFRCSDRSNLSHHR 0.99253 -24.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2373 0 0 10.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6297 0 0 13.5954 0 0 0 0 0 11.8996 0 10.8008 0 0 0 0 0 0 0 0 0 12.8782 0 0 0 0 11.77 11.541 0 0 0 0 0 0 0 13.6928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9614 0 13.6109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8858 0 0 0 0 0 13.1305 0 0 0 0 0 0 0 Q9NQU5 PAK6_HUMAN "Serine/threonine-protein kinase PAK 6, EC 2.7.11.1 (PAK-5) (p21-activated kinase 6, PAK-6)" PAK6 PAK5 Homo sapiens (Human) "apoptotic process [GO:0006915]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; neuron projection arborization [GO:0140058]; neuron projection extension [GO:1990138]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408]; regulation of transcription, DNA-templated [GO:0006355]" cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] "cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; neuron projection arborization [GO:0140058]; neuron projection extension [GO:1990138]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001650; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0006915; GO:0007010; GO:0007612; GO:0007613; GO:0007626; GO:0030054; GO:0035556; GO:0043408; GO:0045296; GO:0106310; GO:0140058; GO:1990138 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AQSLGPAEFQGASQR 0.99253 -24.91 0 0 0 12.0581 0 0 11.9957 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9498 0 0 0 0 0 0 0 0 0 0 14.28 0 0 0 0 0 0 15.1055 0 0 0 14.56 14.8608 0 0 13.9981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1Z9 CC180_HUMAN Coiled-coil domain-containing protein 180 CCDC180 C9orf174 KIAA1529 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 CQPENSGK 0.99253 -17.521 0 0 0 0 0 0 9.51288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0275 0 0 0 0 0 0 13.8573 0 0 11.9042 0 0 0 0 0 12.2932 0 9.84546 0 0 0 0 0 12.9826 12.3423 0 12.7962 13.3665 12.4274 12.2829 0 0 9.33599 0 0 0 0 12.466 15.0178 12.1888 0 0 0 12.0742 0 0 14.2376 0 0 0 13.5707 0 0 0 14.238 0 0 0 0 0 0 11.4434 11.5085 0 12.3716 0 0 11.8308 0 12.8882 0 12.1934 0 16.221 15.3822 0 0 0 0 0 0 13.5419 13.7959 0 11.5726 0 0 0 0 12.1224 0 0 0 0 0 12.2061 0 17.8908 0 13.3846 14.7646 0 0 0 11.6406 14.3832 0 13.6059 0 0 0 0 0 13.0929 13.3435 0 0 0 0 0 13.5008 0 0 0 12.9088 0 0 13.0359 0 0 0 13.3397 0 11.805 0 12.787 0 12.7978 0 10.3896 0 0 0 14.2524 0 0 0 0 14.2432 0 0 Q9UBY9 HSPB7_HUMAN "Heat shock protein beta-7, HspB7 (Cardiovascular heat shock protein, cvHsp)" HSPB7 CVHSP Homo sapiens (Human) heart development [GO:0007507]; regulation of heart contraction [GO:0008016]; response to unfolded protein [GO:0006986] actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; filamin binding [GO:0031005]; protein C-terminus binding [GO:0008022]; heart development [GO:0007507]; regulation of heart contraction [GO:0008016]; response to unfolded protein [GO:0006986] GO:0005634; GO:0005654; GO:0005737; GO:0006986; GO:0007507; GO:0008016; GO:0008022; GO:0015030; GO:0015629; GO:0016235; GO:0031005 filamin binding [GO:0031005]; protein C-terminus binding [GO:0008022] ALSMFSDDFGSFMR 0.99253 -7.3466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1984 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULL8 SHRM4_HUMAN Protein Shroom4 (Second homolog of apical protein) SHROOM4 KIAA1202 SHAP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890] actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725] actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; brain development [GO:0007420]; cognition [GO:0050890] GO:0001725; GO:0005654; GO:0005737; GO:0005884; GO:0005912; GO:0005925; GO:0007015; GO:0007420; GO:0009898; GO:0009925; GO:0016324; GO:0030036; GO:0030864; GO:0043231; GO:0043296; GO:0045159; GO:0050890; GO:0051015 actin filament binding [GO:0051015]; myosin II binding [GO:0045159] AASGTEAGEEGDSEPKECSR 0.99253 -24.098 0 0 0 0 0 11.9827 0 0 14.1882 0 0 0 15.303 13.4829 13.1238 12.0228 12.4684 0 0 0 0 0 0 0 0 12.3057 0 12.7994 0 0 0 0 0 0 0 0 0 13.3918 0 0 0 0 12.5855 12.6549 0 0 13.6332 0 13.6817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6462 0 0 13.4165 0 0 0 13.6202 0 0 0 0 0 13.4599 0 0 14.9402 0 13.1104 14.0624 13.7311 14.0069 12.8245 0 13.1949 0 0 0 13.0635 0 0 0 0 16.5129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2299 0 0 0 0 0 0 0 12.4007 0 0 13.4107 0 13.2136 0 0 0 0 10.1717 0 0 0 0 13.7914 14.6922 0 0 0 0 0 0 12.3126 0 0 13.1932 11.9998 0 0 0 13.0664 14.4082 0 13.5349 0 13.0296 0 0 0 0 10.8472 13.0263 0 0 0 0 0 12.3995 0 0 11.4356 0 15.0025 0 11.5525 11.6877 15.3366 10.4265 Q9UQ88 CD11A_HUMAN "Cyclin-dependent kinase 11A, EC 2.7.11.22 (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2)" CDK11A CDC2L2 CDC2L3 PITSLREB Homo sapiens (Human) "apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of mitotic cell cycle [GO:0007346]; regulation of mRNA processing [GO:0050684]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]" cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of mitotic cell cycle [GO:0007346]; regulation of mRNA processing [GO:0050684]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000278; GO:0000307; GO:0001558; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0007346; GO:0042981; GO:0043484; GO:0046605; GO:0050684; GO:0051726; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EEKMEERDLLSDLQDISDSER 0.99253 -6.1442 12.2226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F2Z3F1 CE067_HUMAN Uncharacterized protein C5orf67 C5orf67 Homo sapiens (Human) IFYKHRK 0.99254 -25.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5687 0 0 0 0 0 0 0 0 12.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75794 CD123_HUMAN "Cell division cycle protein 123 homolog, Protein D123 (HT-1080) (PZ32)" CDC123 C10orf7 D123 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; eukaryotic translation initiation factor 2 complex assembly [GO:1905143]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational initiation [GO:0045948]; regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]; eukaryotic translation initiation factor 2 complex assembly [GO:1905143]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translational initiation [GO:0045948]; regulation of cell cycle [GO:0051726] GO:0005737; GO:0007049; GO:0008284; GO:0045948; GO:0051301; GO:0051726; GO:1905143 GVTIKSVILPLPQNVK 0.99254 -6.7025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2335 0 0 0 0 0 11.8268 0 0 0 0 0 0 0 0 0 0 0 12.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0349 0 0 0 0 O95453 PARN_HUMAN "Poly(A)-specific ribonuclease PARN, EC 3.1.13.4 (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease)" PARN DAN Homo sapiens (Human) "box H/ACA RNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; miRNA catabolic process [GO:0010587]; ncRNA deadenylation [GO:0110008]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; telomerase RNA stabilization [GO:0090669]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nuclease activity [GO:0004518]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA RNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; miRNA catabolic process [GO:0010587]; ncRNA deadenylation [GO:0110008]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; telomerase RNA stabilization [GO:0090669]" GO:0000175; GO:0000184; GO:0000289; GO:0000495; GO:0003723; GO:0003730; GO:0004518; GO:0004535; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0007292; GO:0009451; GO:0010587; GO:0016607; GO:0019901; GO:0032212; GO:0043169; GO:0046872; GO:0051973; GO:0070034; GO:0071051; GO:0090503; GO:0090669; GO:0110008; GO:1904872 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nuclease activity [GO:0004518]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] HSMDFLLFQFGLCTFKYDYTDSK 0.99254 -24.349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1858 0 0 0 0 0 0 12.4217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1672 0 0 0 0 0 0 0 0 12.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95876 FRITZ_HUMAN "WD repeat-containing and planar cell polarity effector protein fritz homolog, hFRTZ (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein)" WDPCP BBS15 C2orf86 FRITZ Homo sapiens (Human) auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; podocyte cell migration [GO:0090521]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587] axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886] axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886]; auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; podocyte cell migration [GO:0090521]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587] GO:0001736; GO:0001822; GO:0002093; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0021915; GO:0032185; GO:0032880; GO:0042073; GO:0042733; GO:0043010; GO:0043587; GO:0044782; GO:0045184; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072359; GO:0090521; GO:0097541; GO:1900027; GO:1902017; GO:2000114 EPMADSCIYECIRNK 0.99254 -18.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4099 13.9857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1682 0 0 13.3955 13.5471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.164 13.3348 0 0 0 0 0 0 0 0 0 0 0 0 13.5184 13.3608 13.7211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19532 TFE3_HUMAN "Transcription factor E3 (Class E basic helix-loop-helix protein 33, bHLHe33)" TFE3 BHLHE33 Homo sapiens (Human) "adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; adaptive immune response [GO:0002250]; humoral immune response [GO:0006959]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell adhesion [GO:0045785]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002250; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006959; GO:0045670; GO:0045785; GO:0045893; GO:0045944; GO:0046983; GO:0090336; GO:0120163; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" AQAQEQERR 0.99254 -6.1504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5228 0 0 0 0 0 0 0 12.5265 0 11.3686 0 0 0 0 0 0 0 0 10.319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.42402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9701 13.0281 0 12.9235 0 0 0 0 0 0 13.1152 0 0 0 0 0 0 0 0 0 0 0 0 P29475 NOS1_HUMAN "Nitric oxide synthase, brain, EC 1.14.13.39 (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS, N-NOS, nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS)" NOS1 Homo sapiens (Human) "arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter biosynthetic process [GO:0042136]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]" anchoring junction [GO:0070161]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synapse [GO:0045202]; vesicle membrane [GO:0012506] "anchoring junction [GO:0070161]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; synapse [GO:0045202]; vesicle membrane [GO:0012506]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325]; arginine catabolic process [GO:0006527]; cell redox homeostasis [GO:0045454]; cellular response to growth factor stimulus [GO:0071363]; multicellular organismal response to stress [GO:0033555]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; neurotransmitter biosynthetic process [GO:0042136]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle contraction [GO:0055117]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of sodium ion transport [GO:0002028]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; vasodilation [GO:0042311]; xenobiotic catabolic process [GO:0042178]" GO:0001666; GO:0001917; GO:0002028; GO:0004517; GO:0005516; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006527; GO:0006809; GO:0006936; GO:0006941; GO:0007263; GO:0007520; GO:0009408; GO:0009725; GO:0010181; GO:0010523; GO:0012506; GO:0014069; GO:0016491; GO:0016529; GO:0017080; GO:0018119; GO:0020037; GO:0031284; GO:0032496; GO:0032991; GO:0033138; GO:0033555; GO:0034617; GO:0034618; GO:0035066; GO:0042136; GO:0042178; GO:0042311; GO:0042383; GO:0043197; GO:0043267; GO:0044325; GO:0045121; GO:0045202; GO:0045454; GO:0045776; GO:0045893; GO:0045944; GO:0046870; GO:0048306; GO:0048471; GO:0050660; GO:0050661; GO:0051346; GO:0051612; GO:0051926; GO:0055117; GO:0060314; GO:0070161; GO:0071363; GO:0071944; GO:0097110; GO:0098735; GO:0098924; GO:1902307; GO:1902514 arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; tetrahydrobiopterin binding [GO:0034617]; transmembrane transporter binding [GO:0044325] DCTTAHGMFNYICNHVK 0.99254 -6.7005 0 0 0 0 0 11.5403 0 0 0 0 14.3301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0241 0 0 0 0 0 12.0682 12.7609 11.1218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2959 0 0 0 0 0 0 0 0 0 10.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6439 12.0965 0 11.7624 0 0 0 0 0 0 14.8985 0 15.1857 16.1845 0 15.6908 0 0 0 15.4887 14.9414 15.2235 0 0 0 0 0 0 13.6607 0 15.4856 0 0 14.8137 0 0 0 14.6172 0 0 0 0 0 0 0 0 0 0 15.1799 0 0 0 0 15.7115 0 0 13.9541 0 13.4621 0 0 0 0 0 0 0 0 0 14.3836 0 0 0 0 0 0 0 0 0 11.9815 13.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2011 0 0 P30550 GRPR_HUMAN "Gastrin-releasing peptide receptor, GRP-R (GRP-preferring bombesin receptor)" GRPR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of respiratory gaseous exchange [GO:1903942]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; learning or memory [GO:0007611]; motor behavior [GO:0061744]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of respiratory gaseous exchange [GO:1903942]; psychomotor behavior [GO:0036343]; regulation of cell population proliferation [GO:0042127]; response to external biotic stimulus [GO:0043207]; social behavior [GO:0035176] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007611; GO:0008188; GO:0008528; GO:0035176; GO:0036343; GO:0042127; GO:0042923; GO:0043207; GO:0061744; GO:1903942; GO:2000987 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188] IFCTVKSMR 0.99254 -5.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4191 11.0411 0 0 0 11.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56134 ATPK_HUMAN "ATP synthase subunit f, mitochondrial (ATP synthase membrane subunit f)" ATP5MF ATP5J2 ATP5JL Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]" "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600]" GO:0005739; GO:0005743; GO:0005753; GO:0015986; GO:0016021; GO:0031965; GO:0042776; GO:0045263; GO:1902600 DKKLLEVK 0.99254 -15.003 0 0 0 0 0 13.762 0 13.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13546 RIPK1_HUMAN "Receptor-interacting serine/threonine-protein kinase 1, EC 2.7.11.1 (Cell death protein RIP) (Receptor-interacting protein 1, RIP-1)" RIPK1 RIP RIP1 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; inflammatory response [GO:0006954]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of necroptotic process [GO:0060545]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; regulation of ATP:ADP antiporter activity [GO:0070926]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; endosome membrane [GO:0010008]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ripoptosome [GO:0097342] cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; endosome membrane [GO:0010008]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ripoptosome [GO:0097342]; ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; extrinsic apoptotic signaling pathway [GO:0097191]; inflammatory response [GO:0006954]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of necroptotic process [GO:0060545]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; regulation of ATP:ADP antiporter activity [GO:0070926]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0001934; GO:0004672; GO:0004674; GO:0004706; GO:0005123; GO:0005524; GO:0005739; GO:0005829; GO:0005886; GO:0006915; GO:0006954; GO:0008219; GO:0010008; GO:0010940; GO:0030163; GO:0031264; GO:0031625; GO:0032757; GO:0032760; GO:0032991; GO:0033209; GO:0034612; GO:0036289; GO:0042802; GO:0042803; GO:0043065; GO:0043066; GO:0043068; GO:0043123; GO:0043124; GO:0043235; GO:0044877; GO:0045121; GO:0045651; GO:0045944; GO:0046330; GO:0046777; GO:0050729; GO:0051092; GO:0060545; GO:0060546; GO:0070105; GO:0070231; GO:0070266; GO:0070301; GO:0070513; GO:0070926; GO:0071356; GO:0071363; GO:0097191; GO:0097300; GO:0097342; GO:0097343; GO:0097527; GO:0106310; GO:1901026; GO:1903265; GO:1903800; GO:1905206; GO:1990000; GO:2000379; GO:2001237; GO:2001238; GO:2001240 ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] AEMSTPLSVKGR 0.99254 -6.1499 11.9964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2221 0 13.6405 0 0 0 0 0 0 0 0 0 12.9105 11.9997 12.4578 13.1304 0 0 0 0 14.2394 0 0 0 0 0 0 0 11.9605 14.3258 0 0 0 0 0 11.5673 0 0 0 0 0 0 13.4756 0 13.2413 0 0 0 0 0 0 0 13.3615 0 0 10.7437 0 0 0 0 0 13.2142 0 0 0 0 13.2361 0 0 0 0 0 0 0 0 13.9764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5707 0 14.0866 0 0 0 0 0 0 Q6PI48 SYDM_HUMAN "Aspartate--tRNA ligase, mitochondrial, EC 6.1.1.12 (Aspartyl-tRNA synthetase, AspRS)" DARS2 Homo sapiens (Human) aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; aspartyl-tRNA aminoacylation [GO:0006422]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145]; tRNA aminoacylation [GO:0043039] GO:0000049; GO:0004815; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006422; GO:0042803; GO:0043039; GO:0050560; GO:0070145 aspartate-tRNA ligase activity [GO:0004815]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049] LECADLLETR 0.99254 -6.1626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5678 13.8491 14.0196 0 0 0 0 0 0 0 0 0 13.4033 0 0 0 0 0 0 0 0 0 12.5954 0 0 0 11.9212 17.5305 0 0 0 0 0 0 0 0 0 13.1628 0 13.2915 12.7944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2872 13.0672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHG8 ZNRF2_HUMAN "E3 ubiquitin-protein ligase ZNRF2, EC 2.3.2.27 (Protein Ells2) (RING finger protein 202) (RING-type E3 ubiquitin transferase ZNRF2) (Zinc/RING finger protein 2)" ZNRF2 RNF202 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936] GO:0001650; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0010008; GO:0016020; GO:0030659; GO:0032991; GO:0042734; GO:0042995; GO:0043161; GO:0043231; GO:0046872; GO:0061630; GO:0070161; GO:0070936 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LPCLCIYHK 0.99254 -5.5229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.035 0 0 0 12.8423 13.1812 0 0 12.7581 0 0 0 0 0 0 0 0 0 0 0 11.6887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8521 0 0 0 0 0 0 12.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF68 ZN384_HUMAN "Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4, Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein)" ZNF384 CAGH1 CIZ NMP4 TNRC1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFTQLSNLQSHRRQHNK 0.99254 -6.1566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2703 14.3623 0 0 0 0 0 0 0 0 0 0 0 11.9396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3341 0 0 0 11.2197 0 12.6555 0 0 0 0 Q92782 DPF1_HUMAN "Zinc finger protein neuro-d4 (BRG1-associated factor 45B, BAF45B) (D4, zinc and double PHD fingers family 1)" DPF1 BAF45B NEUD4 Homo sapiens (Human) "apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0003712; GO:0005737; GO:0006338; GO:0006357; GO:0006915; GO:0007399; GO:0008270; GO:0030071; GO:0042393; GO:0045597; GO:0045892; GO:0045944; GO:0070316; GO:0071565; GO:1990837; GO:2000045; GO:2000781; GO:2000819 histone binding [GO:0042393]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] ASAYITLT 0.99254 -17.661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1572 0 0 0 0 0 0 0 0 14.8124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5069 0 0 0 0 0 0 0 12.0398 0 0 0 0 0 0 0 0 0 11.4859 0 0 0 0 0 0 0 12.5642 0 0 0 0 11.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GY3 LIN37_HUMAN Protein lin-37 homolog (Antolefinin) LIN37 MSTP064 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053] Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; transcription repressor complex [GO:0017053]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005654; GO:0017053; GO:0031523 FPVKVKVEK 0.99254 -17.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6289 11.4455 13.0468 13.1399 0 0 0 0 0 0 0 14.2895 14.6649 0 0 0 0 11.1747 0 0 12.9924 0 0 0 13.4721 0 0 0 0 0 0 0 0 13.2142 0 0 0 0 0 0 0 0 0 13.267 0 0 0 0 0 11.6019 0 0 0 0 12.279 0 0 10.718 0 11.3061 0 11.4768 0 0 0 0 12.2962 0 0 0 0 0 12.1848 0 0 12.7231 0 12.8272 0 0 0 0 0 0 0 0 0 0 0 0 10.6537 0 0 0 0 0 12.187 13.4561 0 0 0 0 0 0 0 Q99665 I12R2_HUMAN "Interleukin-12 receptor subunit beta-2, IL-12 receptor subunit beta-2, IL-12R subunit beta-2, IL-12R-beta-2, IL-12RB2" IL12RB2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; response to lipopolysaccharide [GO:0032496] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-12 receptor complex [GO:0042022]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; interleukin-12 receptor complex [GO:0042022]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; response to lipopolysaccharide [GO:0032496] GO:0004896; GO:0005886; GO:0005887; GO:0006955; GO:0007166; GO:0008284; GO:0009897; GO:0018108; GO:0019221; GO:0019901; GO:0019955; GO:0032496; GO:0032729; GO:0032819; GO:0042022; GO:0042102; GO:0043235; GO:0046427; GO:0051142 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901] DEGLVLLNRLR 0.99254 -17.601 0 0 0 0 0 0 0 0 0 0 0 13.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1072 0 0 0 0 0 0 10.8757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7376 0 12.5475 0 0 0 0 0 0 0 0 0 0 10.4827 0 0 0 0 0 0 13.723 0 0 0 0 0 0 14.1939 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2186 0 0 0 13.09 0 13.0482 0 0 0 0 13.5396 0 0 0 0 0 0 0 0 0 0 0 0 A6NFQ2 TCAF2_HUMAN TRPM8 channel-associated factor 2 (TRP channel-associated factor 2) TCAF2 FAM115C FAM139A Homo sapiens (Human) negative regulation of anion channel activity [GO:0010360]; positive regulation of cell migration [GO:0030335]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of anion channel activity [GO:0010359] cell junction [GO:0030054]; plasma membrane [GO:0005886] cell junction [GO:0030054]; plasma membrane [GO:0005886]; transmembrane transporter binding [GO:0044325]; negative regulation of anion channel activity [GO:0010360]; positive regulation of cell migration [GO:0030335]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of anion channel activity [GO:0010359] GO:0005886; GO:0010359; GO:0010360; GO:0030054; GO:0030335; GO:0044325; GO:0090314 transmembrane transporter binding [GO:0044325] DPEPVLR 0.99255 -14.718 0 0 0 0 0 0 0 0 14.7728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9102 0 0 0 0 0 0 0 0 0 0 10.1438 0 0 0 0 0 0 0 13.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1521 0 0 0 0 0 12.8036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8495 0 13.9381 0 0 0 0 0 0 0 0 0 0 0 13.3075 0 0 0 0 0 O94964 SOGA1_HUMAN "Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form; C-terminal 80 kDa form, 80-kDa SOGA fragment ]" SOGA1 C20orf117 KIAA0889 SOGA Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; insulin receptor signaling pathway [GO:0008286]; negative regulation of gluconeogenesis [GO:0045721]; regulation of autophagy [GO:0010506] GO:0005615; GO:0008286; GO:0010506; GO:0045721; GO:0070062 AAQTGQVDGELIR 0.99255 -60.088 12.6715 0 0 0 0 0 0 0 14.829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0161 0 0 0 0 0 0 0 0 0 0 0 10.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4539 0 0 13.577 0 0 0 0 0 0 0 0 0 0 0 0 11.7495 11.9374 0 14.9992 0 0 0 0 0 0 0 0 0 0 12.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4141 12.3935 15.5322 0 0 0 0 0 0 13.6199 0 0 0 0 0 0 13.6963 0 0 0 0 0 0 0 13.1093 0 0 0 0 0 12.7188 0 0 0 0 0 0 0 0 0 12.7024 0 0 0 0 0 0 0 0 12.5326 0 0 0 0 0 0 0 0 0 0 13.0628 0 0 0 0 0 0 P10620 MGST1_HUMAN "Microsomal glutathione S-transferase 1, Microsomal GST-1, EC 2.5.1.18 (Microsomal GST-I)" MGST1 GST12 MGST Homo sapiens (Human) cellular response to lipid hydroperoxide [GO:0071449]; glutathione transport [GO:0034635] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular response to lipid hydroperoxide [GO:0071449]; glutathione transport [GO:0034635] GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0016021; GO:0034635; GO:0035577; GO:0071449 glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364] ALSFFVGYGVTLSMAYRLLKSK 0.99255 -6.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4643 0 0 0 0 0 P35354 PGH2_HUMAN "Prostaglandin G/H synthase 2, EC 1.14.99.1 (Cyclooxygenase-2, COX-2) (PHS II) (Prostaglandin H2 synthase 2, PGH synthase 2, PGHS-2) (Prostaglandin-endoperoxide synthase 2)" PTGS2 COX2 Homo sapiens (Human) "aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to nematode [GO:0009624]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]" caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991] "caveola [GO:0005901]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]; aging [GO:0007568]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; brown fat cell differentiation [GO:0050873]; cellular response to ATP [GO:0071318]; cellular response to fluid shear stress [GO:0071498]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lead ion [GO:0071284]; cellular response to mechanical stimulus [GO:0071260]; cellular response to non-ionic osmotic stress [GO:0071471]; cellular response to UV [GO:0034644]; cyclooxygenase pathway [GO:0019371]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; hair cycle [GO:0042633]; inflammatory response [GO:0006954]; learning [GO:0007612]; maintenance of blood-brain barrier [GO:0035633]; memory [GO:0007613]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of synaptic transmission, dopaminergic [GO:0032227]; ovulation [GO:0030728]; positive regulation of apoptotic process [GO:0043065]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fever generation [GO:0031622]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vasoconstriction [GO:0045907]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin secretion [GO:0032310]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; regulation of neuroinflammatory response [GO:0150077]; response to angiotensin [GO:1990776]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to fructose [GO:0009750]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to lithium ion [GO:0010226]; response to manganese ion [GO:0010042]; response to nematode [GO:0009624]; response to oxidative stress [GO:0006979]; response to tumor necrosis factor [GO:0034612]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]" GO:0001516; GO:0001525; GO:0004601; GO:0004666; GO:0005637; GO:0005640; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005901; GO:0006954; GO:0006979; GO:0007566; GO:0007568; GO:0007612; GO:0007613; GO:0008217; GO:0008285; GO:0009410; GO:0009624; GO:0009750; GO:0010042; GO:0010226; GO:0010575; GO:0016702; GO:0019233; GO:0019371; GO:0019899; GO:0020037; GO:0030282; GO:0030728; GO:0031394; GO:0031622; GO:0031915; GO:0032227; GO:0032310; GO:0032355; GO:0032496; GO:0032991; GO:0033138; GO:0033280; GO:0034605; GO:0034612; GO:0034644; GO:0035633; GO:0042307; GO:0042633; GO:0042803; GO:0043005; GO:0043065; GO:0043154; GO:0043231; GO:0045429; GO:0045786; GO:0045907; GO:0045986; GO:0045987; GO:0046697; GO:0046872; GO:0048661; GO:0050727; GO:0050873; GO:0051384; GO:0051926; GO:0051968; GO:0070542; GO:0071260; GO:0071284; GO:0071318; GO:0071456; GO:0071471; GO:0071498; GO:0071636; GO:0090050; GO:0090271; GO:0090336; GO:0090362; GO:0150077; GO:1902219; GO:1990776 "enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]; protein homodimerization activity [GO:0042803]" IKLFLKPTPNTVHYILTHFK 0.99255 -7.2042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8555 0 0 0 0 0 0 0 0 12.9843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5124 0 0 13.0895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50748 KNTC1_HUMAN "Kinetochore-associated protein 1 (Rough deal homolog, HsROD, Rod, hRod)" KNTC1 KIAA0166 Homo sapiens (Human) cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; small GTPase binding [GO:0031267]; cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096] GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0065003; GO:1903394; GO:1990423 small GTPase binding [GO:0031267] DVFENLWK 0.99255 -25.399 0 0 0 0 0 0 0 0 10.454 0 0 0 0 0 0 0 0 0 11.7743 0 0 0 0 0 0 0 0 14.8144 0 0 0 0 0 0 0 0 0 0 11.3298 0 0 0 0 0 0 0 0 11.3518 0 10.8086 0 17.7791 0 10.8996 12.6805 0 11.9635 0 11.5257 0 0 0 0 0 0 0 0 0 0 13.6193 0 0 0 0 0 0 0 0 13.0218 14.6322 0 0 0 13.9624 0 0 0 0 14.1717 0 0 0 13.1993 0 0 0 0 0 14.834 0 0 14.1706 0 0 10.5675 0 0 0 0 10.5856 0 0 0 0 12.6905 14.1719 0 13.0305 13.0248 0 0 13.3129 0 0 0 0 0 0 15.5729 15.9062 0 15.7729 13.1134 0 0 10.1932 0 13.0264 0 15.5634 0 15.2066 0 0 15.3716 0 0 0 14.9175 15.9332 15.0406 14.6132 0 14.0444 0 13.0127 14.9231 0 0 0 0 13.4351 0 0 14.1024 0 0 0 0 0 0 14.2598 11.7151 14.8953 16.3202 16.1726 0 0 14.9943 0 P58397 ATS12_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 12, ADAM-TS 12, ADAM-TS12, ADAMTS-12, EC 3.4.24.-" ADAMTS12 UNQ1918/PRO4389 Homo sapiens (Human) cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727] GO:0002062; GO:0004222; GO:0005576; GO:0007160; GO:0016477; GO:0030167; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AECCFSCPQTHITHTQRQRR 0.99255 -60.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.749 0 13.6312 13.1602 14.6917 0 0 0 0 0 12.2456 0 0 0 15.7402 0 0 0 0 0 13.1497 0 0 14.6525 14.0615 0 13.2493 0 0 0 0 13.7844 13.6436 13.7625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.162 13.3957 0 0 0 0 0 0 0 14.191 13.9007 13.0309 14.0644 15.3617 13.6875 13.978 13.6231 14.3514 0 14.4428 0 0 0 11.3847 12.7366 12.4577 0 0 0 13.5609 0 0 0 0 0 0 0 0 0 0 13.5774 0 11.9991 0 0 0 0 13.7428 0 0 0 0 0 13.8042 0 Q15349 KS6A2_HUMAN "Ribosomal protein S6 kinase alpha-2, S6K-alpha-2, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 2, p90-RSK 2, p90RSK2) (MAP kinase-activated protein kinase 1c, MAPK-activated protein kinase 1c, MAPKAP kinase 1c, MAPKAPK-1c) (Ribosomal S6 kinase 3, RSK-3) (pp90RSK3)" RPS6KA2 MAPKAPK1C RSK3 Homo sapiens (Human) brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; brain renin-angiotensin system [GO:0002035]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to carbohydrate stimulus [GO:0071322]; chemical synaptic transmission [GO:0007268]; heart contraction [GO:0060047]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of meiotic nuclear division [GO:0045835]; oocyte maturation [GO:0001556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165] GO:0000287; GO:0001556; GO:0002035; GO:0004674; GO:0004711; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0007268; GO:0007507; GO:0008285; GO:0010628; GO:0010659; GO:0018105; GO:0035556; GO:0043065; GO:0045202; GO:0045786; GO:0045835; GO:0060047; GO:0070613; GO:0071322; GO:0072687; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711] EYLSPNQLSR 0.99255 -15.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2437 0 10.6428 0 0 0 0 0 0 14.5196 14.9635 0 0 12.3978 15.6032 0 0 0 0 0 0 0 0 13.2897 0 0 18.1212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.949 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9779 0 Q8IVI9 NOSTN_HUMAN Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer) NOSTRIN Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]" cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; DNA binding [GO:0003677]; negative regulation of transcription, DNA-templated [GO:0045892]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]" GO:0003677; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0007165; GO:0016191; GO:0030666; GO:0045892; GO:0098793; GO:0098978 DNA binding [GO:0003677] GDIVIIHEK 0.99255 -14.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0349 0 0 0 0 0 10.752 15.323 13.6556 15.0767 12.187 12.4455 11.8898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2776 12.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5902 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1194 0 0 0 11.4083 13.4418 0 0 0 0 14.3356 0 0 0 0 0 0 0 0 0 0 0 12.1222 0 0 0 0 0 0 Q8IWP9 CC28A_HUMAN Coiled-coil domain-containing protein 28A (CCRL1AP) CCDC28A C6orf80 Homo sapiens (Human) AGLPLGAWRLYLLRHFR 0.99255 -15.044 0 0 15.5489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3664 0 0 0 0 0 0 14.6249 0 0 0 17.758 0 0 0 0 0 0 14.8474 0 0 0 0 14.9882 0 0 0 0 0 14.7813 0 0 0 0 0 0 0 0 14.9047 0 0 0 0 0 0 0 0 14.8516 0 0 0 0 14.8091 0 0 14.944 0 0 0 14.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96G28 CFA36_HUMAN Cilia- and flagella-associated protein 36 (Coiled-coil domain-containing protein 104) CFAP36 CCDC104 UNQ163/PRO189 Homo sapiens (Human) axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; motile cilium [GO:0031514]; nucleus [GO:0005634] axoneme [GO:0005930]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; motile cilium [GO:0031514]; nucleus [GO:0005634]; protein N-terminus binding [GO:0047485] GO:0005634; GO:0005930; GO:0031514; GO:0035869; GO:0047485; GO:0097546 protein N-terminus binding [GO:0047485] CEVFDDEEESKLTYTEIHQEYK 0.99255 -5.5235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3B8 ORN_HUMAN "Oligoribonuclease, mitochondrial, EC 3.1.15.- (RNA exonuclease 2 homolog) (Small fragment nuclease)" REXO2 SFN SMFN CGI-114 Homo sapiens (Human) nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117] GO:0000175; GO:0000287; GO:0003676; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0006139; GO:0008296; GO:0008408; GO:0009117 3'-5' exonuclease activity [GO:0008408]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676] FGARGVR 0.99255 -17.71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUY1 MRCOL_HUMAN MARCO-like protein MARCOL Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198] GO:0005201; GO:0005615; GO:0030198; GO:0031012 extracellular matrix structural constituent [GO:0005201] GNPESSNK 0.99256 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NFN9 ANKUB_HUMAN Protein ANKUB1 (Ankyrin repeat and ubiquitin domain-containing 1) ANKUB1 C3orf16 Homo sapiens (Human) EGPVLKYQKR 0.99256 -7.2139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5177 0 0 0 0 0 0 0 0 0 0 0 13.1576 12.7285 0 0 0 0 0 0 0 0 0 12.3701 13.7886 0 0 0 0 0 0 0 0 0 12.2831 0 0 0 0 0 0 0 12.1589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NN90 CB081_HUMAN Uncharacterized protein C2orf81 C2orf81 Homo sapiens (Human) AELLGELWAGRTR 0.99256 -25.606 0 0 0 0 0 0 0 0 0 0 12.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1549 0 10.3845 0 0 0 0 10.8364 0 0 0 11.8311 0 0 0 12.0489 0 0 10.7575 0 0 0 0 13.8057 0 0 0 0 0 0 0 14.2905 0 0 0 0 0 0 0 13.1358 12.8072 0 0 0 0 0 14.1115 0 0 12.782 13.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7186 0 0 0 12.3636 12.2308 11.5548 0 0 0 0 0 0 11.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0789 0 0 0 0 0 P17019 ZN708_HUMAN Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8) ZNF708 KOX8 ZNF15 ZNF15L1 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFNQSPNLTK 0.99256 -15.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1849 0 0 0 0 0 14.6395 0 13.2669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3686 0 0 P43405 KSYK_HUMAN "Tyrosine-protein kinase SYK, EC 2.7.10.2 (Spleen tyrosine kinase) (p72-Syk)" SYK Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell differentiation [GO:0030154]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; mast cell degranulation [GO:0043303]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101] B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101]; ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell differentiation [GO:0030154]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; mast cell degranulation [GO:0043303]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001525; GO:0001775; GO:0001784; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0002862; GO:0004672; GO:0004674; GO:0004713; GO:0004715; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006606; GO:0007159; GO:0007169; GO:0007229; GO:0009887; GO:0010543; GO:0010803; GO:0016170; GO:0018105; GO:0018108; GO:0019370; GO:0019722; GO:0019815; GO:0019901; GO:0019902; GO:0030154; GO:0030168; GO:0030183; GO:0030593; GO:0031234; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032725; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032765; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0035556; GO:0038063; GO:0038095; GO:0038096; GO:0038156; GO:0042101; GO:0042169; GO:0042492; GO:0042742; GO:0043274; GO:0043280; GO:0043303; GO:0043306; GO:0043313; GO:0043366; GO:0043507; GO:0045087; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0046777; GO:0048514; GO:0050731; GO:0050764; GO:0050850; GO:0050853; GO:0051090; GO:0051712; GO:0070372; GO:0071226; GO:0071396; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0097110; GO:0120162; GO:1990858 ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325] EMYDLMNLCWTYDVENRPGFAAVELR 0.99256 -14.755 0 0 0 0 0 0 0 0 15.0388 14.7261 14.7864 13.3212 0 12.4703 0 0 13.5118 0 0 12.0235 0 0 14.5582 0 0 0 0 0 12.3665 0 0 0 0 0 13.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0353 0 0 0 0 0 0 0 11.4799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0113 13.1278 0 13.419 0 0 10.7464 0 0 0 0 0 0 0 0 13.1764 13.8602 0 12.0657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5355 0 14.419 0 0 0 0 0 0 0 0 0 0 0 0 10.8939 0 0 0 0 0 0 0 12.8898 0 0 0 13.5579 0 0 0 13.1678 0 0 0 0 0 0 0 0 0 0 0 0 13.4207 0 0 0 0 0 0 0 0 0 0 0 Q07864 DPOE1_HUMAN "DNA polymerase epsilon catalytic subunit A, EC 2.7.7.7 (3'-5' exodeoxyribonuclease, EC 3.1.11.-) (DNA polymerase II subunit A)" POLE POLE1 Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]" epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]; base-excision repair, gap-filling [GO:0006287]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]" GO:0000082; GO:0000166; GO:0000278; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005634; GO:0005654; GO:0005886; GO:0006260; GO:0006261; GO:0006272; GO:0006287; GO:0006297; GO:0008270; GO:0008310; GO:0008622; GO:0045004; GO:0048568; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]" AFHELSR 0.99256 -63.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4197 14.3097 0 0 0 0 0 0 10.3122 0 10.3412 0 0 11.9856 0 0 0 0 0 0 0 13.78 0 0 0 14.7841 0 0 0 14.8074 14.9278 0 11.0532 13.8805 18.7385 0 0 0 14.7316 0 15.4916 0 0 13.8477 14.9863 16.1074 0 13.7949 0 14.5803 0 0 0 14.3712 0 0 0 0 0 11.9195 14.1592 14.3305 0 14.7191 0 0 0 14.5088 0 14.2248 0 0 10.5845 13.1765 0 12.6385 12.9151 0 0 14.4089 13.2399 0 0 0 13.8408 0 0 0 0 0 0 16.0437 13.3826 0 13.07 14.0096 0 14.2911 13.5779 0 0 0 0 10.2879 0 16.3913 12.5466 0 13.2756 0 0 13.1666 0 0 13.7578 0 0 0 11.5653 12.5472 0 0 13.6663 0 13.4101 0 0 Q5VW22 AGAP6_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6, AGAP-6 (Centaurin-gamma-like family member 3)" AGAP6 CTGLF3 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630] GO:0003924; GO:0005096; GO:0046872; GO:0090630 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872] AIPIKQGMLLK 0.99256 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q75VX8 GARE2_HUMAN GRB2-associated and regulator of MAPK protein 2 (GRB2-associated and regulator of MAPK1-like) GAREM2 FAM59B GAREML KIAA2038 HRIHFB2063 Homo sapiens (Human) AIIERVR 0.99256 -4.3991 0 0 13.9222 0 0 0 0 0 12.0201 0 0 0 0 0 13.315 0 11.5614 11.5807 0 0 0 0 0 0 0 0 11.0391 0 0 11.6779 0 11.8164 11.9308 0 0 0 0 0 0 0 0 0 11.5534 15.238 0 0 0 11.3604 13.5429 0 13.3888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.097 0 0 13.309 0 0 12.3041 0 0 0 0 10.716 0 0 0 10.7947 0 0 0 12.1313 0 0 0 0 11.228 10.6978 0 0 0 0 0 0 0 14.1468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6284 0 0 10.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6476 0 0 14.7042 0 0 0 0 0 0 Q8NCQ7 PRCA1_HUMAN Protein PROCA1 (Protein interacting with cyclin A1) PROCA1 Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; phospholipid metabolic process [GO:0006644] cyclin binding [GO:0030332]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; phospholipid metabolic process [GO:0006644] GO:0004623; GO:0006644; GO:0030332; GO:0050482 cyclin binding [GO:0030332]; phospholipase A2 activity [GO:0004623] EPDKCCWR 0.99256 -25.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0624 0 12.5067 0 0 12.1728 12.6491 0 0 12.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84364 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8497 17.8267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.273 0 0 0 0 0 0 0 0 15.2441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEA9 GMCL2_HUMAN Germ cell-less protein-like 2 (Germ cell-less protein-like 1-like) GMCL2 GCL GMCL1L GMCL1P1 Homo sapiens (Human) germ cell development [GO:0007281]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] nuclear matrix [GO:0016363]; nucleus [GO:0005634] nuclear matrix [GO:0016363]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; germ cell development [GO:0007281]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] GO:0005634; GO:0007281; GO:0007283; GO:0016363; GO:0016567; GO:0097602 cullin family protein binding [GO:0097602] QQPLLNTPARK 0.99256 -7.2091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3454 0 0 0 0 0 0 0 0 12.4019 12.4293 0 12.6133 14.144 13.8884 13.982 0 0 0 0 14.1552 0 0 14.5261 0 0 0 0 0 0 13.3318 0 14.4806 13.7259 0 0 14.1089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7723 12.3794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2615 0 0 0 19.2602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2258 0 13.0453 0 0 0 0 0 0 Q8WUY8 NAT14_HUMAN "Probable N-acetyltransferase 14, EC 2.3.1.- (K562 cell-derived leucine-zipper-like protein 1)" NAT14 KLP1 Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription, DNA-templated [GO:0045893]" integral component of membrane [GO:0016021]; nucleus [GO:0005634] "integral component of membrane [GO:0016021]; nucleus [GO:0005634]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003677; GO:0005634; GO:0006352; GO:0008080; GO:0016021; GO:0045893 DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080] FVLASFALALLLPVFLAVAAVK 0.99256 -4.8976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7978 0 0 0 0 0 12.1082 0 0 10.0812 0 0 0 0 0 10.8246 0 0 0 0 0 0 14.0577 0 0 0 15.0298 0 0 0 13.0409 15.3341 12.2984 0 0 0 0 0 15.3007 14.1093 14.3848 0 0 0 0 14.4332 0 0 0 13.9044 14.4213 0 14.2525 0 0 14.3503 0 0 0 14.3061 14.0124 14.0142 0 0 0 10.8128 14.0731 0 0 0 14.564 0 0 15.1019 0 0 0 0 0 0 13.8999 11.7587 11.9919 13.9617 0 0 13.39 0 0 0 0 0 0 11.5039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.886 0 0 0 0 0 12.0754 Q96QU6 1A1L1_HUMAN "1-aminocyclopropane-1-carboxylate synthase-like protein 1, ACC synthase-like protein 1" ACCS PHACS Homo sapiens (Human) biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520] identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520] GO:0006520; GO:0008483; GO:0009058; GO:0030170; GO:0042802 identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483] ALGIPFLSR 0.99256 -7.2054 0 11.8445 0 0 0 0 0 0 0 0 13.4848 0 0 0 0 13.0522 0 0 10.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5062 10.9383 0 0 0 13.3171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7998 13.0239 13.6273 13.1252 0 0 0 14.3049 0 0 0 0 14.7038 14.1283 0 0 13.5336 0 0 0 11.2294 0 0 0 0 0 0 0 13.3841 11.4561 14.9747 0 15.1999 0 13.4731 0 0 0 0 14.4093 0 0 0 0 13.1996 0 0 0 14.1891 17.8735 0 0 0 0 12.0303 0 0 0 0 0 0 12.4915 0 0 13.3211 11.4107 0 0 0 0 0 0 0 11.6745 0 0 0 12.2082 14.1037 0 0 0 0 0 0 10.8832 0 9.96217 0 0 0 0 0 0 0 0 0 12.7874 10.8177 0 0 0 0 13.284 0 Q9GZV9 FGF23_HUMAN "Fibroblast growth factor 23, FGF-23 (Phosphatonin) (Tumor-derived hypophosphatemia-inducing factor) [Cleaved into: Fibroblast growth factor 23 N-terminal peptide; Fibroblast growth factor 23 C-terminal peptide ]" FGF23 HYPF UNQ3027/PRO9828 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; calcium ion homeostasis [GO:0055074]; cell differentiation [GO:0030154]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to interleukin-6 [GO:0071354]; cellular response to leptin stimulus [GO:0044320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of bone mineralization [GO:0030502]; negative regulation of hormone secretion [GO:0046888]; negative regulation of osteoblast differentiation [GO:0045668]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; regulation of cell migration [GO:0030334]; regulation of phosphate transport [GO:0010966]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; vitamin D catabolic process [GO:0042369]" cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] "cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; animal organ morphogenesis [GO:0009887]; calcium ion homeostasis [GO:0055074]; cell differentiation [GO:0030154]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to interleukin-6 [GO:0071354]; cellular response to leptin stimulus [GO:0044320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of bone mineralization [GO:0030502]; negative regulation of hormone secretion [GO:0046888]; negative regulation of osteoblast differentiation [GO:0045668]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; regulation of cell migration [GO:0030334]; regulation of phosphate transport [GO:0010966]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; vitamin D catabolic process [GO:0042369]" GO:0001934; GO:0005104; GO:0005105; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0006796; GO:0008083; GO:0008284; GO:0008543; GO:0009887; GO:0010628; GO:0010966; GO:0010980; GO:0030154; GO:0030334; GO:0030502; GO:0030643; GO:0032026; GO:0042369; GO:0044320; GO:0045668; GO:0045893; GO:0046888; GO:0055062; GO:0055074; GO:0070371; GO:0070374; GO:0071305; GO:0071354; GO:0071374; GO:0090080; GO:1904383 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105] RYLCMDFR 0.99256 -7.2081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUZ1 ACOXL_HUMAN "Acyl-coenzyme A oxidase-like protein, Acyl-CoA oxidase-like protein, EC 1.3.3.-" ACOXL Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0033540; GO:0050660; GO:0055088; GO:0071949 acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660] AGQDLAEKTKNFVSR 0.99256 -15.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1325 0 13.0642 0 12.8406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9147 0 0 0 0 14.9811 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0848 0 0 0 0 12.6429 0 0 12.2318 0 11.8522 0 13.3791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3365 0 0 0 0 0 0 0 0 10.7736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P273 TEN3_HUMAN "Teneurin-3, Ten-3 (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3, Ten-m3) (Teneurin transmembrane protein 3)" TENM3 KIAA1455 ODZ3 TNM3 Homo sapiens (Human) camera-type eye morphogenesis [GO:0048593]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005] axon [GO:0030424]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; camera-type eye morphogenesis [GO:0048593]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron development [GO:0048666]; positive regulation of neuron projection development [GO:0010976]; regulation of homophilic cell adhesion [GO:1903385]; signal transduction [GO:0007165] GO:0005887; GO:0007156; GO:0007157; GO:0007165; GO:0010976; GO:0016020; GO:0030424; GO:0042803; GO:0043005; GO:0046982; GO:0048593; GO:0048666; GO:0050839; GO:1903385 cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CECSQGWNGEHCTIEGCPGLCNSNGR 0.99256 -44.716 10.7329 0 0 0 0 0 0 0 0 0 0 0 16.3451 0 0 0 0 0 0 0 11.9798 0 0 0 0 12.5099 0 0 12.4466 10.7032 0 0 0 0 0 0 16.1911 0 0 0 0 0 11.945 0 0 0 0 17.1535 0 0 0 0 0 10.6345 17.4414 0 10.1589 0 17.4375 0 0 0 0 0 0 0 0 12.2066 0 0 0 0 0 0 0 13.9602 0 0 0 0 0 11.0883 0 16.4347 0 14.5109 12.5552 0 13.7348 0 14.0464 14.3437 0 14.3619 0 12.625 16.0368 0 14.5504 10.4007 0 0 15.9191 15.6991 0 0 0 0 0 14.8058 0 13.2085 15.3629 13.709 16.4385 0 13.6985 16.0964 0 0 0 12.039 16.1042 15.2328 11.9244 0 0 11.7223 0 0 13.4265 13.3238 0 12.9039 0 15.6308 0 0 14.0328 12.3137 15.1513 17.0974 16.0048 0 0 0 0 0 0 18.3274 0 13.435 0 0 14.1975 14.4139 0 15.3899 0 0 0 0 0 14.7044 10.3162 15.4792 0 15.7465 0 0 0 0 20.496 0 0 15.3537 0 14.61 13.4115 0 A6NEE1 PLHD1_HUMAN "Pleckstrin homology domain-containing family D member 1, PH domain-containing family D member 1" PLEKHD1 Homo sapiens (Human) ELELTARCLK 0.99257 -25.629 0 0 0 0 0 0 0 0 0 12.2366 0 0 0 0 0 0 0 0 10.2288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5673 0 0 0 0 0 0 0 0 11.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7285 12.4556 0 0 0 0 0 0 0 0 0 0 0 0 11.6099 0 0 11.4662 13.1799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2773 0 0 0 11.8369 0 0 0 11.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3234 0 0 0 0 11.2622 0 0 0 0 0 0 10.7117 0 0 0 0 0 0 0 0 0 0 0 0 O75064 DEN4B_HUMAN DENN domain-containing protein 4B DENND4B KIAA0476 Homo sapiens (Human) regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of Rab protein signal transduction [GO:0032483] GO:0005085; GO:0005654; GO:0005794; GO:0005829; GO:0031410; GO:0032483 guanyl-nucleotide exchange factor activity [GO:0005085] CFGAPPEC 0.99257 -25.623 0 0 0 15.3792 15.0609 0 0 0 0 0 16.8557 14.7067 0 17.3087 16.7264 0 13.9106 0 0 0 0 12.9785 0 0 14.1155 14.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0897 0 0 0 0 0 0 0 0 0 10.3238 0 0 0 0 0 0 0 0 0 0 0 0 10.8239 0 13.1591 0 11.7415 0 0 18.2632 18.4393 0 0 13.5103 16.6154 0 0 12.5311 15.666 13.7817 20.3957 20.3115 20.55 20.5725 20.5568 0 11.4155 11.8136 15.0918 0 0 16.6117 0 0 0 0 0 14.8717 14.1407 0 13.0139 0 0 15.225 14.3052 13.7972 13.4903 13.897 0 0 0 0 15.1975 14.0541 0 0 13.8626 0 0 14.1321 13.7934 0 0 12.3779 0 15.4486 15.5021 0 13.5529 13.4384 10.0023 11.9881 15.6719 13.1284 0 0 0 0 0 13.437 13.9998 15.0027 15.1235 0 0 14.0814 11.8939 0 0 14.3962 0 0 0 13.9597 0 0 0 0 13.0992 13.4298 0 0 0 0 0 0 0 0 0 0 14.2095 13.6738 0 0 0 0 0 0 O75084 FZD7_HUMAN "Frizzled-7, Fz-7, hFz7 (FzE3)" FZD7 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; mesenchymal to epithelial transition [GO:0060231]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of ectodermal cell fate specification [GO:0042666]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; stem cell population maintenance [GO:0019827]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation in thymus [GO:0033077]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] "integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; mesenchymal to epithelial transition [GO:0060231]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of ectodermal cell fate specification [GO:0042666]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; stem cell population maintenance [GO:0019827]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation in thymus [GO:0033077]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0004930; GO:0005109; GO:0005546; GO:0005886; GO:0006355; GO:0010812; GO:0014834; GO:0016021; GO:0017147; GO:0019827; GO:0030165; GO:0030182; GO:0033077; GO:0034446; GO:0038031; GO:0042327; GO:0042666; GO:0042813; GO:0043231; GO:0045893; GO:0046330; GO:0048103; GO:0055038; GO:0060054; GO:0060070; GO:0060071; GO:0060231; GO:0060828; GO:0071300; GO:2000726 "frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]" FSDDGYR 0.99257 -7.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75161 NPHP4_HUMAN Nephrocystin-4 (Nephroretinin) NPHP4 KIAA0673 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; flagellated sperm motility [GO:0030317]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization to ciliary transition zone [GO:1904491]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual behavior [GO:0007632] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor distal connecting cilium [GO:0120206]; ribbon synapse [GO:0097470] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor distal connecting cilium [GO:0120206]; ribbon synapse [GO:0097470]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell-cell adhesion [GO:0098609]; flagellated sperm motility [GO:0030317]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of bicellular tight junction assembly [GO:1903348]; protein localization to ciliary transition zone [GO:1904491]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; visual behavior [GO:0007632] GO:0005198; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005923; GO:0007165; GO:0007632; GO:0016604; GO:0030036; GO:0030317; GO:0035845; GO:0035869; GO:0036064; GO:0043231; GO:0045494; GO:0060041; GO:0090090; GO:0097470; GO:0097546; GO:0097730; GO:0098609; GO:0120206; GO:1903348; GO:1904491 structural molecule activity [GO:0005198] DFFVIIYSDR 0.99257 -25.831 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5615 0 12.7803 17.7636 17.3926 12.8104 12.8686 16.8422 15.8761 16.1876 15.7128 0 15.2719 12.7047 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6483 12.7482 13.7839 12.7803 0 0 0 12.6866 14.4216 12.5759 14.6953 0 17.9206 12.4941 0 13.1748 13.7981 0 0 0 11.3706 0 0 11.6002 0 0 0 0 14.102 0 14.4142 0 13.5535 13.7923 0 0 0 0 0 0 15.4648 14.8201 12.7988 14.643 14.2976 12.6319 15.3195 19.8725 14.1405 19.8441 19.7297 15.587 15.5007 13.8433 0 14.6262 0 22.1836 14.2094 0 0 0 17.3888 0 15.0793 12.6376 18.8418 0 0 0 0 12.5294 17.1645 13.098 0 19.018 0 14.5029 14.11 14.5502 19.3366 15.2594 14.5003 19.6146 20.0566 20.0697 14.095 0 0 13.2312 0 13.0769 0 19.6407 13.2991 20.3949 0 0 0 0 0 0 0 19.104 19.4644 18.9398 18.6168 12.9319 18.4113 18.3274 0 12.7034 0 0 11.6361 12.9066 14.2374 0 0 0 0 0 0 0 0 14.7461 0 0 14.3589 14.5221 0 20.5646 20.496 20.5885 0 0 0 0 16.9015 0 P0C7M6 IQCF3_HUMAN IQ domain-containing protein F3 IQCF3 Homo sapiens (Human) calmodulin binding [GO:0005516] GO:0005516 calmodulin binding [GO:0005516] CCKGGPDEDAVERQR 0.99257 -4.9073 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3219 0 0 0 0 0 0 0 10.1635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9232 0 0 13.3435 0 14.64 15.3204 14.1009 13.6773 13.1895 0 0 0 0 0 0 0 0 0 0 0 12.8283 0 14.0923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6476 0 0 0 0 12.3881 11.3268 0 0 0 0 0 12.5237 0 0 0 0 0 0 0 13.6179 0 12.323 0 12.7524 P18887 XRCC1_HUMAN DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) XRCC1 Homo sapiens (Human) base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; response to xenobiotic stimulus [GO:0009410]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; response to xenobiotic stimulus [GO:0009410]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882]" GO:0000012; GO:0000781; GO:0000785; GO:0001666; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006303; GO:0009410; GO:0010033; GO:0010836; GO:0019899; GO:0021587; GO:0021766; GO:0032356; GO:0033194; GO:0050882; GO:0061819; GO:0070522; GO:1903518; GO:1904877; GO:1905765; GO:1990414; GO:1990599 3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356] EWVLDCHR 0.99257 -17.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5307 0 0 0 14.9998 0 0 0 0 13.7886 0 14.5237 0 14.4277 0 0 0 0 13.4022 0 0 13.5703 0 0 13.2322 0 0 13.4078 15.1861 14.8266 0 0 0 0 0 0 0 0 0 0 13.2741 0 13.5517 13.7303 13.6798 13.5035 0 13.8829 0 0 0 0 0 16.9038 13.8125 14.6682 0 0 0 0 0 13.1169 0 12.0205 15.3262 0 14.4508 13.4624 0 0 0 0 13.4165 0 0 0 0 0 15.6785 0 13.488 16.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3413 0 0 0 0 14.0854 0 P25025 CXCR2_HUMAN "C-X-C chemokine receptor type 2, CXC-R2, CXCR-2 (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B, IL-8R B) (IL-8 receptor type 2) (CD antigen CD182)" CXCR2 IL8RB Homo sapiens (Human) acute inflammatory response to antigenic stimulus [GO:0002438]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; metanephric tubule morphogenesis [GO:0072173]; midbrain development [GO:0030901]; negative regulation of neutrophil apoptotic process [GO:0033030]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular permeability [GO:0043117]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918]; acute inflammatory response to antigenic stimulus [GO:0002438]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; metanephric tubule morphogenesis [GO:0072173]; midbrain development [GO:0030901]; negative regulation of neutrophil apoptotic process [GO:0033030]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular permeability [GO:0043117]; receptor internalization [GO:0031623]; signal transduction [GO:0007165] GO:0002407; GO:0002438; GO:0004918; GO:0004930; GO:0005654; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007165; GO:0007166; GO:0007200; GO:0007204; GO:0008284; GO:0009897; GO:0009986; GO:0010666; GO:0015630; GO:0016020; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0019959; GO:0030593; GO:0030667; GO:0030901; GO:0031623; GO:0033030; GO:0038112; GO:0042119; GO:0042629; GO:0043117; GO:0045766; GO:0060326; GO:0072173; GO:0072686; GO:0090023 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918] AHMGQKHR 0.99257 -7.6028 0 0 0 0 0 0 0 0 13.8316 0 0 0 0 13.6355 0 0 0 0 0 0 0 0 10.6231 15.7128 0 0 0 0 0 13.4075 0 0 0 0 0 0 0 11.0719 0 0 0 12.5163 0 0 0 13.4639 0 12.514 0 12.6396 0 0 0 0 0 11.4398 0 0 0 0 0 0 0 0 0 0 14.3562 14.192 0 0 0 0 0 0 11.2442 0 0 0 14.0821 0 0 14.0843 0 0 0 0 0 13.0342 0 0 0 0 0 0 12.1586 13.8439 0 0 0 0 12.1955 12.0693 12.9817 14.1337 0 0 14.2492 0 12.867 12.6488 0 0 0 0 0 0 11.7429 0 0 12.8523 14.0359 0 0 0 20.0616 0 0 0 0 12.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.503 0 0 0 0 0 11.1385 0 0 0 0 0 0 0 0 12.6288 0 0 0 0 0 0 10.0639 0 0 0 0 0 0 0 P49755 TMEDA_HUMAN "Transmembrane emp24 domain-containing protein 10, Protein TMED10 (21 kDa transmembrane-trafficking protein) (S31I125) (S31III125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1, p24delta1) (p24delta)" TMED10 TMP21 Homo sapiens (Human) "COPI coating of Golgi vesicle [GO:0048205]; COPI-coated vesicle budding [GO:0035964]; COPII vesicle coating [GO:0048208]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle cargo loading [GO:0035459]; vesicle targeting, to, from or within Golgi [GO:0048199]" cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; zymogen granule membrane [GO:0042589] "cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; zymogen granule membrane [GO:0042589]; protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905]; COPI coating of Golgi vesicle [GO:0048205]; COPI-coated vesicle budding [GO:0035964]; COPII vesicle coating [GO:0048208]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle cargo loading [GO:0035459]; vesicle targeting, to, from or within Golgi [GO:0048199]" GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005801; GO:0005886; GO:0006886; GO:0006888; GO:0006890; GO:0007030; GO:0008320; GO:0012507; GO:0016021; GO:0019905; GO:0030133; GO:0030134; GO:0030137; GO:0030140; GO:0030667; GO:0032732; GO:0033116; GO:0035459; GO:0035964; GO:0042470; GO:0042589; GO:0045055; GO:0048199; GO:0048205; GO:0048208; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003; GO:1902960 protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905] GPFPLALLLLFLLGPR 0.99257 -7.1095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8297 12.908 0 0 0 0 0 14.371 0 16.0709 0 15.6068 0 0 15.672 15.7112 0 0 12.8844 14.96 15.4387 0 15.0154 0 14.7822 0 0 0 0 0 0 15.2283 13.4077 13.0742 0 0 0 0 0 0 14.5961 14.777 13.7793 0 0 0 0 0 0 0 0 14.6484 0 12.7511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6716 0 14.6405 0 0 0 0 0 0 0 12.6857 0 0 12.8397 0 0 0 0 0 0 0 0 12.8693 0 0 0 0 0 0 12.2631 0 0 0 0 0 0 0 0 P53805 RCAN1_HUMAN "Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1, MCIP1) (Regulator of calcineurin 1)" RCAN1 ADAPT78 CSP1 DSC1 DSCR1 Homo sapiens (Human) calcineurin-NFAT signaling cascade [GO:0033173]; calcium-mediated signaling [GO:0019722]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; skeletal muscle fiber development [GO:0048741] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-mediated signaling [GO:0019722]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979]; short-term memory [GO:0007614]; skeletal muscle fiber development [GO:0048741] GO:0002931; GO:0003676; GO:0005634; GO:0005737; GO:0006979; GO:0007614; GO:0008597; GO:0019722; GO:0031987; GO:0033173; GO:0042802; GO:0043666; GO:0048741; GO:0070885 calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676] AKFESLFR 0.99257 -25.741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7578 0 0 0 0 0 0 0 0 0 0 0 13.5612 13.7747 0 0 14.6915 0 0 13.4984 0 0 0 14.1828 0 0 0 0 0 0 11.9398 0 0 0 0 0 0 0 0 0 13.3449 13.054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.115 0 14.2975 0 0 0 0 0 10.4231 0 0 0 0 0 0 0 0 0 0 13.4909 0 0 0 0 0 0 0 Q08117 TLE5_HUMAN "TLE family member 5 (Amino-terminal enhancer of split, Amino enhancer of split) (Gp130-associated protein GAM) (Grg-5) (Groucho-related protein 5) (Protein ESP1) (Protein GRG) (TLE family member 5, transcriptional modulator)" TLE5 AES GRG GRG5 Homo sapiens (Human) "cellular response to extracellular stimulus [GO:0031668]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; regulation of growth [GO:0040008]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; Wnt signaling pathway [GO:0016055]" nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; cellular response to extracellular stimulus [GO:0031668]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; regulation of growth [GO:0040008]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0001501; GO:0003714; GO:0005634; GO:0005667; GO:0010629; GO:0016055; GO:0031668; GO:0032091; GO:0040008; GO:0042802; GO:0045892; GO:0060761; GO:0070555; GO:0090090; GO:2000210 identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714] EDKNGHDGDTHQEDDGEKSD 0.99257 -7.6003 0 0 0 0 11.8167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2845 0 0 0 0 0 0 0 13.5222 0 0 12.6314 0 0 0 0 0 0 0 0 0 0 0 9.637 0 0 0 0 0 0 13.3935 0 0 13.6899 15.5922 0 0 0 0 0 0 0 0 0 0 0 0 12.9348 0 0 0 0 0 0 0 0 0 14.0971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0858 0 0 10.2983 10.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4746 11.2755 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16787 LAMA3_HUMAN "Laminin subunit alpha-3 (Epiligrin 170 kDa subunit, E170) (Epiligrin subunit alpha) (Kalinin subunit alpha) (Laminin-5 subunit alpha) (Laminin-6 subunit alpha) (Laminin-7 subunit alpha) (Nicein subunit alpha)" LAMA3 LAMNA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; morphogenesis of a polarized epithelium [GO:0001738]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888] adherens junction [GO:0005912]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; hemidesmosome [GO:0030056]; laminin-3 complex [GO:0005608]; laminin-5 complex [GO:0005610] adherens junction [GO:0005912]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; hemidesmosome [GO:0030056]; laminin-3 complex [GO:0005608]; laminin-5 complex [GO:0005610]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; morphogenesis of a polarized epithelium [GO:0001738]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888] GO:0001738; GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005610; GO:0005783; GO:0005912; GO:0007229; GO:0007411; GO:0008544; GO:0009887; GO:0009888; GO:0016477; GO:0030056; GO:0030155; GO:0030334; GO:0031581; GO:0035987; GO:0045995; GO:0062023; GO:0070062; GO:0098609 extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] ALGPVLPPTPLLLLVLR 0.99257 -45.455 0 11.4368 11.7803 0 0 0 0 0 0 0 0 0 0 10.6376 0 0 0 0 12.6341 0 0 11.0636 11.3882 0 12.1979 0 0 10.3335 0 0 11.6424 0 0 16.9001 0 17.0033 16.9332 12.8238 0 0 0 0 0 0 12.3878 0 0 10.3858 0 0 0 0 0 0 10.516 13.8368 13.4242 0 0 0 0 0 12.8193 12.4938 15.7322 0 0 13.6332 0 11.6015 0 0 13.7112 11.8403 0 12.2834 0 0 12.2226 15.8778 0 0 0 12.9606 10.1501 13.1874 13.7131 0 13.2022 13.7551 14.9816 0 0 13.5068 0 0 0 0 13.8825 12.4405 0 0 12.8083 0 13.7016 0 13.2279 0 0 0 0 0 0 11.5176 14.0302 13.1472 15.4157 12.6633 0 0 12.4922 10.9733 0 0 0 13.4271 12.9849 0 11.9634 0 0 11.2557 14.1898 0 13.3795 11.5699 12.923 0 0 16.0335 13.0895 0 0 10.641 0 11.9361 0 0 0 12.5613 0 11.7857 14.9701 0 11.4086 0 13.734 17.3948 11.4185 13.5649 12.3899 0 10.1506 14.8344 17.599 17.6559 0 0 11.7177 10.4685 0 12.4985 14.2393 0 12.0942 12.8687 11.8678 0 0 0 Q4FZB7 KMT5B_HUMAN "Histone-lysine N-methyltransferase KMT5B (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1, Su(var)4-20 homolog 1, Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B, EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B, EC 2.1.1.361)" KMT5B SUV420H1 CGI-85 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830] "condensed chromosome, centromeric region [GO:0000779]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "condensed chromosome, centromeric region [GO:0000779]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]" GO:0000779; GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0007517; GO:0018024; GO:0034772; GO:0034773; GO:0042799; GO:0045830; GO:0046872; GO:1904047; GO:2001034 chromatin binding [GO:0003682]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047] CHKSDTGMSK 0.99257 -45.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2105 10.1899 10.6104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9499 14.5066 0 12.597 0 13.0059 0 14.1079 0 12.9289 13.6262 13.3417 0 14.5778 15.0871 16.1588 14.4721 14.4071 14.244 14.2902 0 13.5122 13.3514 13.4265 14.4108 0 14.9425 13.0366 11.4847 0 14.5948 0 10.8802 0 13.0163 0 11.0246 14.5171 12.6644 13.984 0 0 0 0 13.7767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7749 11.841 0 0 0 0 0 0 0 11.556 0 10.3526 0 0 15.0175 0 0 11.5942 12.2271 0 0 0 13.7947 0 11.965 0 12.7307 11.0291 0 0 0 0 0 0 0 0 13.4416 0 13.1495 0 12.1485 0 Q68CK6 ACS2B_HUMAN "Acyl-coenzyme A synthetase ACSM2B, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 2B) (Benzoate--CoA ligase, EC 6.2.1.25) (Butyrate--CoA ligase 2B) (Butyryl-coenzyme A synthetase 2B) (Middle-chain acyl-CoA synthetase 2B) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-A)" ACSM2B ACSM2 HYST1046 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; xenobiotic metabolic process [GO:0006805] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; xenobiotic metabolic process [GO:0006805] GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0006805; GO:0015645; GO:0016405; GO:0018858; GO:0046872; GO:0047760; GO:0102391 ATP binding [GO:0005524]; benzoate-CoA ligase activity [GO:0018858]; butyrate-CoA ligase activity [GO:0047760]; CoA-ligase activity [GO:0016405]; decanoate-CoA ligase activity [GO:0102391]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872] ADDIINSSGYR 0.99257 -14.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2683 0 0 0 0 12.5546 0 13.5961 13.0856 0 0 13.2284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7927 0 0 0 0 0 13.5084 0 12.9865 0 13.3412 0 0 0 0 12.8359 13.0612 0 0 0 0 13.3505 14.1753 0 14.6041 13.5269 0 13.8265 0 0 13.9897 0 0 0 0 0 0 13.18 14.9542 0 13.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0983 13.6873 0 0 0 0 0 Q68DN1 CB016_HUMAN Uncharacterized protein C2orf16 C2orf16 Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleus [GO:0005634] GO:0005634; GO:0070062 DRPVIRR 0.99257 -45.824 0 0 0 0 0 0 0 0 12.6049 10.4748 0 0 0 0 0 0 0 0 15.6631 0 0 0 15.7813 14.1586 0 0 10.5061 0 0 0 0 0 0 11.3373 0 0 12.5344 0 0 0 0 0 0 0 0 0 0 13.1009 0 0 12.4691 0 12.5525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1687 0 0 0 0 0 0 0 11.7181 0 0 0 0 0 14.1277 12.4765 0 11.3119 13.0026 0 12.1509 0 11.3091 0 11.6258 12.0651 12.6055 0 0 0 14.1881 0 14.8117 11.1889 0 13.1562 0 0 0 0 0 0 0 0 12.7478 13.5125 0 14.1392 0 12.2927 0 0 0 0 0 0 11.8149 15.5122 12.5591 12.1681 0 0 13.7887 0 0 13.0499 0 13.2622 0 0 0 0 11.3085 0 0 0 0 14.1085 0 14.5679 0 0 13.5964 14.635 10.9534 12.1834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8305 0 0 0 0 0 13.4353 0 Q75N90 FBN3_HUMAN Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide ] FBN3 KIAA1776 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; anatomical structure morphogenesis [GO:0009653] GO:0001527; GO:0005201; GO:0005509; GO:0005576; GO:0009653; GO:0031012; GO:0062023 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] ACADVDECEENPR 0.99257 -45.625 0 0 0 0 0 0 0 11.1372 0 0 11.6226 0 0 0 12.9316 0 0 11.8223 0 11.9231 11.8091 12.862 0 0 12.6966 0 0 0 12.6304 0 13.1096 0 11.8139 12.6603 0 0 0 0 12.1651 0 12.2348 0 0 0 0 12.3363 0 0 10.8932 0 0 0 12.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3004 0 0 0 11.8517 0 0 0 0 14.703 13.2302 0 16.6582 13.2348 0 12.8913 15.1526 0 11.5116 0 12.0482 0 11.7597 14.115 0 14.0948 13.4926 12.4152 13.6812 12.8495 13.9342 0 12.1961 12.9038 0 0 12.8287 13.9172 0 0 13.2741 12.2672 11.8628 0 12.7117 14.4076 14.3477 0 0 14.1839 0 0 13.9532 0 10.0291 14.4933 0 11.989 11.395 14.4903 0 0 0 0 0 10.9064 0 0 0 0 14.1651 0 11.7196 14.5306 0 13.8567 13.3156 0 0 0 0 0 15.8988 0 13.0706 11.3821 12.0754 12.0514 0 12.5874 12.9541 12.7027 13.0936 14.4362 0 0 12.6339 12.721 0 13.1894 0 11.8786 10.7645 13.3798 0 13.0973 0 0 12.5128 15.4663 14.6516 0 0 10.8173 Q8IU85 KCC1D_HUMAN "Calcium/calmodulin-dependent protein kinase type 1D, EC 2.7.11.17 (CaM kinase I delta, CaM kinase ID, CaM-KI delta, CaMKI delta, CaMKID) (CaMKI-like protein kinase, CKLiK)" CAMK1D CAMKID Homo sapiens (Human) inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis [GO:0050766]; positive regulation of respiratory burst [GO:0060267]; regulation of dendrite development [GO:0050773]; regulation of granulocyte chemotaxis [GO:0071622] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis [GO:0050766]; positive regulation of respiratory burst [GO:0060267]; regulation of dendrite development [GO:0050773]; regulation of granulocyte chemotaxis [GO:0071622] GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0007399; GO:0010976; GO:0018105; GO:0032793; GO:0043065; GO:0043066; GO:0050766; GO:0050773; GO:0060267; GO:0071622; GO:0090023; GO:0106310 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310] ATGKLFAVK 0.99257 -6.7764 0 0 0 0 0 0 0 0 0 0 11.7716 0 0 13.6677 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8113 0 0 0 0 0 0 0 0 0 0 0 11.543 0 0 0 13.3696 11.4334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7871 0 0 0 0 0 14.9522 15.1441 0 0 0 0 0 0 0 0 0 0 0 0 Q8N743 KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 (CD158 antigen-like family member Z) (Killer cell inhibitory receptor 1) (CD antigen CD158z) KIR3DL3 CD158Z KIR3DL7 KIRC1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 KNAVVMDQEPAGNR 0.99257 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5148 0 12.9135 0 0 0 0 0 0 0 0 0 0 0 12.5747 0 0 12.8078 0 0 0 0 0 0 0 0 0 0 13.209 0 0 0 0 0 0 Q8NCW6 GLT11_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 11, EC 2.4.1.41 (Polypeptide GalNAc transferase 11, GalNAc-T11, pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11)" GALNT11 Homo sapiens (Human) cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593] GO:0000139; GO:0004653; GO:0005112; GO:0005794; GO:0006493; GO:0007220; GO:0007368; GO:0008593; GO:0016021; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] EQYFSLRPDLKTK 0.99257 -46.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.003 0 0 0 0 0 0 0 0 0 0 0 0 0 10.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90126 0 15.6763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2641 13.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5917 15.5836 0 0 0 0 0 11.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0609 0 0 12.5155 0 0 0 0 0 11.8722 0 0 0 0 0 0 0 0 0 14.0916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUH2 TGFA1_HUMAN "Transforming growth factor-beta receptor-associated protein 1, TGF-beta receptor-associated protein 1, TRAP-1, TRAP1" TGFBRAP1 Homo sapiens (Human) "autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]" CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] "CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0005160; GO:0005737; GO:0005769; GO:0006355; GO:0006886; GO:0006914; GO:0007165; GO:0007179; GO:0008333; GO:0016020; GO:0033263; GO:0034058; GO:0035542; GO:0043231; GO:0046332 SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160] ALHILVHELQDFAAAEDYCLWCSEGR 0.99257 -6.4103 0 0 0 0 0 0 0 0 0 0 13.1052 0 0 0 12.3554 0 12.6214 11.7722 14.1825 13.0844 15.0084 0 12.3536 0 13.7983 0 17.3791 12.2745 12.9257 0 0 0 0 11.4312 0 0 12.8506 0 0 11.9665 10.2101 0 0 0 0 12.9911 0 0 13.9152 0 17.1494 0 17.1928 0 0 0 10.858 0 0 0 0 0 0 0 0 0 14.1517 14.7122 15.0165 14.0492 0 0 0 0 15.4283 0 14.3577 0 0 0 12.2293 0 0 0 0 0 0 0 0 0 0 0 14.9131 0 0 0 0 0 0 0 0 14.3476 0 0 0 0 0 0 0 12.7562 0 0 0 0 0 0 0 0 19.6422 0 0 0 0 11.3841 0 0 0 13.5948 0 0 0 0 0 0 0 0 0 12.2187 0 0 0 0 0 0 0 0 0 0 0 0 11.6606 0 0 0 0 0 0 0 0 0 11.609 0 12.0819 0 0 0 0 0 12.7556 13.895 0 0 0 0 0 12.9556 0 11.3404 0 0 Q9BQC6 RT63_HUMAN "Ribosomal protein 63, mitochondrial, hMRP63 (Mitochondrial large ribosomal subunit protein mL63) (Mitochondrial ribosomal protein 63) (Mitochondrial ribosomal protein L57)" MRPL57 MRP63 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 structural constituent of ribosome [GO:0003735] FPPHRFIADQLDHLNVTK 0.99257 -6.7823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2813 0 Q9HAB3 S52A2_HUMAN "Solute carrier family 52, riboflavin transporter, member 2 (Porcine endogenous retrovirus A receptor 1, PERV-A receptor 1) (Protein GPR172A) (Riboflavin transporter 3, hRFT3)" SLC52A2 GPR172A PAR1 RFT3 Homo sapiens (Human) riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; 4-hydroxybutyrate receptor activity [GO:0062124]; riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618]; riboflavin metabolic process [GO:0006771]; riboflavin transport [GO:0032218] GO:0001618; GO:0005886; GO:0005887; GO:0006771; GO:0032217; GO:0032218; GO:0062124 4-hydroxybutyrate receptor activity [GO:0062124]; riboflavin transmembrane transporter activity [GO:0032217]; virus receptor activity [GO:0001618] DCADPCDS 0.99257 -6.7783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.802 0 0 0 0 0 0 0 11.2333 0 0 0 0 0 0 0 0 10.8491 0 0 0 12.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR30 DDX21_HUMAN "Nucleolar RNA helicase 2, EC 3.6.4.13 (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)" DDX21 Homo sapiens (Human) chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of histone acetylation [GO:0035066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366] B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] B-WICH complex [GO:0110016]; chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]; chromatin remodeling [GO:0006338]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; osteoblast differentiation [GO:0001649]; positive regulation of histone acetylation [GO:0035066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop disassembly [GO:0062176]; response to exogenous dsRNA [GO:0043330]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366] GO:0001649; GO:0002735; GO:0003723; GO:0003724; GO:0003725; GO:0005524; GO:0005654; GO:0005694; GO:0005730; GO:0005739; GO:0005829; GO:0006338; GO:0006364; GO:0006366; GO:0016020; GO:0016887; GO:0019843; GO:0030515; GO:0035066; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045943; GO:0045944; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515] APQVLVLAPTR 0.99257 -40.327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2227 0 0 0 0 0 11.3305 0 0 0 13.5672 0 13.7082 0 0 12.9847 0 0 0 0 11.6868 0 13.1134 0 0 0 0 11.934 0 11.5373 12.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2177 0 0 0 13.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4416 13.1568 0 0 0 11.8184 0 13.8693 0 0 0 13.1065 0 0 0 0 0 13.335 0 0 0 0 0 0 0 0 12.5979 0 0 0 0 0 0 0 13.346 0 0 0 0 0 0 0 0 0 0 12.9234 0 0 0 0 0 0 0 0 0 0 13.2229 0 0 0 0 0 12.2891 0 14.0348 0 0 0 0 0 0 0 0 0 13.6494 0 0 14.2757 0 0 13.5458 14.1599 13.9828 14.1103 13.5911 0 0 0 14.0827 0 0 0 0 0 13.4211 0 Q9NZJ0 DTL_HUMAN Denticleless protein homolog (DDB1- and CUL4-associated factor 2) (Lethal(2) denticleless protein homolog) (Retinoic acid-regulated nuclear matrix-associated protein) DTL CDT2 CDW1 DCAF2 L2DTL RAMP Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; chromosome [GO:0005694]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005813; GO:0005829; GO:0006260; GO:0006511; GO:0006513; GO:0006974; GO:0007095; GO:0009411; GO:0010971; GO:0019985; GO:0030674; GO:0031464; GO:0031465; GO:0031965; GO:0043161; GO:0045732; GO:0048511; GO:0051726; GO:0080008 protein-macromolecule adaptor activity [GO:0030674] GHQCSLK 0.99257 -7.1057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4957 0 0 0 0 0 0 0 0 0 0 0 11.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8282 12.7001 12.2336 11.887 0 11.9099 0 0 11.8499 13.1885 0 12.9826 0 13.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0172 12.9278 13.5101 0 0 0 12.368 13.333 13.5325 13.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8344 0 0 0 0 0 0 0 0 0 0 13.6634 0 0 0 0 Q9UBB9 TFP11_HUMAN "Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1, STIP-1)" TFIP11 STIP HSPC006 Homo sapiens (Human) "biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]" "catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]" "catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]; nucleic acid binding [GO:0003676]; biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]" GO:0000390; GO:0000398; GO:0000781; GO:0003676; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0006396; GO:0016607; GO:0031012; GO:0031214; GO:0031333; GO:0031848; GO:0032091; GO:0071008; GO:0071013; GO:1904876; GO:2001033 nucleic acid binding [GO:0003676] DCTYGTEIISKWK 0.99257 -45.117 0 0 0 0 0 0 0 0 0 0 0 10.6051 12.3961 0 12.5854 14.2374 13.284 14.1411 13.0163 0 0 0 13.9693 0 0 0 13.2034 0 0 13.6157 0 0 12.0374 11.9934 0 12.0602 0 0 0 0 0 0 13.1824 0 0 0 0 12.8199 0 12.6634 0 12.7865 12.3875 12.9538 0 0 0 0 12.4357 0 0 10.2172 0 0 0 0 0 0 0 10.554 12.8584 12.8683 0 0 11.4192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5077 0 0 0 0 0 0 0 0 0 0 12.6652 12.6097 0 14.1178 11.7917 14.2467 13.4097 0 0 15.3307 0 0 13.7533 0 0 0 14.0364 12.6505 12.7082 0 0 0 0 0 0 0 0 0 0 0 13.1583 0 0 0 0 0 0 0 0 13.5841 0 12.0737 0 0 0 14.5773 0 0 0 12.9517 0 0 0 0 0 13.1443 0 0 13.2854 13.0775 0 0 14.4542 14.5685 14.4987 14.0404 0 14.2438 0 0 0 0 12.4974 0 0 14.6491 14.8303 0 Q9UIS9 MBD1_HUMAN Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1) MBD1 CXXC3 PCM1 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; transcription by RNA polymerase II [GO:0006366]" chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription by RNA polymerase II [GO:0006366]" GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006366; GO:0008270; GO:0008327; GO:0010385; GO:0016363; GO:0016607; GO:0045322; GO:0045892 DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] CDFCCDK 0.99257 -14.828 0 0 0 0 10.1727 0 10.7042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9645 0 0 0 0 15.4154 0 0 0 0 10.9797 10.0741 0 0 0 0 0 0 0 0 9.88883 0 0 0 0 12.6774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0425 0 0 0 0 12.0575 0 10.1047 0 0 0 0 0 11.7295 10.5621 14.2769 0 0 10.3156 0 13.5805 0 12.5287 0 9.73733 0 13.3041 11.9089 0 0 0 0 12.1221 0 12.3637 12.4016 0 10.2442 11.7384 0 0 0 0 0 0 0 0 0 11.1373 13.4274 12.2131 0 11.1229 0 0 0 0 0 10.6297 13.1698 12.2363 0 12.6842 14.1797 0 11.6425 0 11.2188 0 11.0761 0 0 0 0 0 0 0 16.3377 0 12.4934 0 0 0 12.5899 0 11.0408 0 0 0 0 0 0 11.5745 0 0 0 0 10.7062 0 0 14.903 0 0 0 0 11.97 0 0 Q9Y2K9 STB5L_HUMAN Syntaxin-binding protein 5-like (Lethal(2) giant larvae protein homolog 4) (Tomosyn-2) STXBP5L KIAA1006 LLGL4 Homo sapiens (Human) exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708] GO:0005096; GO:0005737; GO:0005886; GO:0006887; GO:0015031; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0050708 GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905] ILAIGTRTGAIR 0.99257 -24.902 0 12.4168 0 0 0 0 0 0 0 0 10.7331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.519 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1341 13.1899 0 0 0 13.3411 0 0 0 13.2077 0 0 12.183 0 0 0 12.6614 12.3 0 0 0 0 0 0 0 0 13.7784 0 11.7358 0 13.0459 0 0 0 0 13.3589 0 0 0 0 0 0 12.2036 0 0 0 0 11.6274 0 0 0 0 0 0 14.407 0 12.7944 0 0 0 0 0 0 0 0 13.314 0 0 0 0 13.6012 13.5344 0 13.0447 13.5171 0 0 0 0 13.6354 13.0032 0 0 0 13.6834 0 0 0 0 0 0 0 Q9Y5Q3 MAFB_HUMAN "Transcription factor MafB, Maf-B (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B)" MAFB KRML Homo sapiens (Human) "abducens nerve formation [GO:0021599]; brain segmentation [GO:0035284]; cornified envelope assembly [GO:1903575]; fat cell differentiation [GO:0045444]; inner ear morphogenesis [GO:0042472]; integrated stress response signaling [GO:0140467]; keratinocyte differentiation [GO:0030216]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; protein processing [GO:0016485]; regulation of myeloid cell differentiation [GO:0045637]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; rhombomere 5 development [GO:0021571]; rhombomere 6 development [GO:0021572]; segment specification [GO:0007379]; sensory organ development [GO:0007423]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]" chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; abducens nerve formation [GO:0021599]; brain segmentation [GO:0035284]; cornified envelope assembly [GO:1903575]; fat cell differentiation [GO:0045444]; inner ear morphogenesis [GO:0042472]; integrated stress response signaling [GO:0140467]; keratinocyte differentiation [GO:0030216]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; protein processing [GO:0016485]; regulation of myeloid cell differentiation [GO:0045637]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; respiratory gaseous exchange by respiratory system [GO:0007585]; rhombomere 5 development [GO:0021571]; rhombomere 6 development [GO:0021572]; segment specification [GO:0007379]; sensory organ development [GO:0007423]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006355; GO:0006357; GO:0007379; GO:0007423; GO:0007585; GO:0016485; GO:0021571; GO:0021572; GO:0021599; GO:0030216; GO:0033077; GO:0035284; GO:0042472; GO:0042802; GO:0043565; GO:0044877; GO:0045444; GO:0045637; GO:0045647; GO:0045671; GO:0045893; GO:0048538; GO:0090575; GO:0140467; GO:1903575 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" DAYKVKCEK 0.99257 -4.9102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NED2 RCCD1_HUMAN RCC1 domain-containing protein 1 RCCD1 Homo sapiens (Human) chromatin organization [GO:0006325] chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886] chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325] GO:0005694; GO:0005829; GO:0005886; GO:0006325 APFYRPLAPELR 0.99258 -17.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9084 0 0 0 0 0 0 0 13.0608 0 0 10.7615 0 0 0 0 0 0 0 0 0 0 0 12.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGE4 DC8L1_HUMAN DDB1- and CUL4-associated factor 8-like protein 1 (WD repeat-containing protein 42B) DCAF8L1 WDR42B Homo sapiens (Human) Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737] GO:0005737; GO:0080008 AHQPGWR 0.99258 -18.403 11.8456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4363 0 0 0 0 12.6984 0 0 0 0 0 0 12.7293 0 11.0819 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0041 0 0 0 0 0 0 0 0 0 0 13.621 0 0 0 0 0 0 0 0 0 0 0 11.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.763 0 0 0 0 0 13.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3464 13.3029 0 0 0 0 0 A6NLE4 SIM23_HUMAN Small integral membrane protein 23 SMIM23 C5orf50 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 GSHCDDEK 0.99258 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 I6L899 GOG8R_HUMAN Golgin subfamily A member 8R GOLGA8R Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 ADLSELLKKQELR 0.99258 -25.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5048 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4712 0 0 0 0 0 0 0 11.6595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2917 0 0 11.3155 0 9.95028 0 0 0 10.5688 0 0 0 0 0 0 0 12.61 0 0 0 0 0 0 0 0 0 0 13.1088 14.7941 0 0 0 0 0 13.8769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9848 14.9974 0 0 0 0 0 12.1699 0 0 0 0 0 0 0 0 0 15.7511 12.9613 0 14.6287 0 14.7064 0 0 0 0 0 0 0 0 0 9.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9905 0 0 0 0 O00462 MANBA_HUMAN "Beta-mannosidase, EC 3.2.1.25 (Lysosomal beta A mannosidase) (Mannanase, Mannase)" MANBA MANB1 Homo sapiens (Human) glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211] azurophil granule membrane [GO:0035577]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211] GO:0004567; GO:0005537; GO:0005886; GO:0006516; GO:0009313; GO:0035577; GO:0036211; GO:0043202 beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537] AHTRYQVPPDCPPLVQK 0.99258 -7.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6636 0 0 0 0 0 0 0 0 10.5373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0451 0 0 0 0 10.7348 0 0 11.2936 0 0 0 0 0 0 14.97 0 0 0 0 0 0 0 0 0 0 0 12.1533 11.7398 0 0 14.5551 0 0 0 0 0 0 11.1038 0 0 0 0 0 0 10.9093 0 0 0 0 0 11.5713 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2552 0 0 0 0 0 0 0 0 9.76296 0 0 0 0 0 0 10.51 0 0 11.9687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14836 TR13B_HUMAN Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267) TNFRSF13B TACI Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; cell surface receptor signaling pathway [GO:0007166]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of B cell proliferation [GO:0030889] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; cell surface receptor signaling pathway [GO:0007166]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of B cell proliferation [GO:0030889] GO:0001782; GO:0002244; GO:0002250; GO:0005886; GO:0005887; GO:0007166; GO:0030889; GO:0038023 signaling receptor activity [GO:0038023] LRSPVNLPPELRR 0.99258 -7.2808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5074 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8839 0 0 0 0 0 0 0 0 0 0 0 0 13.1848 0 0 0 0 0 0 0 0 0 0 0 13.4972 0 0 0 0 13.6787 0 0 0 0 14.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3824 0 0 0 0 0 0 0 0 O15212 PFD6_HUMAN Prefoldin subunit 6 (Protein Ke2) PFDN6 HKE2 PFD6 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0001540; GO:0005737; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0051087; GO:0051131; GO:0101031; GO:1905907; GO:1990062 amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] AGAPGKA 0.99258 -16.321 0 0 0 0 0 0 10.1387 0 0 0 0 0 0 10.3489 0 0 0 10.6917 0 0 10.3071 0 0 11.4822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0254 12.779 0 0 0 0 0 0 0 12.9672 0 0 0 0 0 0 0 0 0 12.5253 0 12.8318 0 14.8297 0 0 0 0 0 0 0 13.1507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9824 12.6391 0 12.7568 0 0 11.8776 0 0 11.7814 O75143 ATG13_HUMAN Autophagy-related protein 13 ATG13 KIAA0652 Homo sapiens (Human) autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of cell population proliferation [GO:0008285]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein autophosphorylation [GO:0046777]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; response to mitochondrial depolarisation [GO:0098780] Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407] Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; protein kinase binding [GO:0019901]; autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of cell population proliferation [GO:0008285]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein autophosphorylation [GO:0046777]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; regulation of protein lipidation [GO:1903059]; response to mitochondrial depolarisation [GO:0098780] GO:0000045; GO:0000407; GO:0000423; GO:0005739; GO:0005789; GO:0005829; GO:0006468; GO:0008285; GO:0010508; GO:0019898; GO:0019901; GO:0034497; GO:0034727; GO:0046777; GO:0098780; GO:1903059; GO:1903955; GO:1990316 protein kinase binding [GO:0019901] LSLLLKSLLAITR 0.99258 -7.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9932 0 0 13.7312 11.8119 0 0 11.4352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3215 0 0 15.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0653 12.9078 13.0684 0 13.2764 0 15.8295 11.9696 0 0 0 0 0 0 0 0 0 0 0 0 16.0041 0 16.1111 0 0 13.4967 13.6477 14.6558 0 0 0 0 0 0 12.8925 0 0 0 0 0 0 0 0 0 0 0 0 11.5197 0 0 0 0 0 11.5721 0 0 0 12.949 0 0 0 0 13.5387 10.7459 13.1696 0 0 0 0 13.5179 0 0 0 0 12.5545 0 13.9628 13.3392 0 0 14.3217 13.1442 0 0 0 13.1056 0 0 0 0 13.1431 0 0 0 0 0 0 0 0 13.1572 0 0 0 0 0 0 O75897 ST1C4_HUMAN "Sulfotransferase 1C4, ST1C4, EC 2.8.2.1 (Sulfotransferase 1C2, SULT1C#2)" SULT1C4 SULT1C2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805] GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923 aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] GAVGDWKK 0.99258 -7.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9206 12.6184 0 12.3337 0 11.9392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8153 0 0 0 0 11.0943 11.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11388 TOP2A_HUMAN "DNA topoisomerase 2-alpha, EC 5.6.2.2 (DNA topoisomerase II, alpha isozyme)" TOP2A TOP2 Homo sapiens (Human) apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819] "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]" "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]" GO:0000287; GO:0000712; GO:0000775; GO:0000793; GO:0000819; GO:0001673; GO:0002244; GO:0003677; GO:0003682; GO:0003723; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006266; GO:0006974; GO:0007059; GO:0007143; GO:0008022; GO:0008094; GO:0008301; GO:0009330; GO:0019899; GO:0030263; GO:0032991; GO:0040016; GO:0042752; GO:0042803; GO:0042826; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:1905463; GO:1990904 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]" AAPKGTK 0.99258 -40.942 0 0 0 11.872 0 16.0201 15.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4431 0 0 0 0 0 0 0 0 0 0 0 11.0567 0 0 0 0 0 0 0 0 0 0 0 0 14.8511 14.2014 0 0 14.5299 14.6512 0 0 0 0 0 0 0 16.8481 0 16.5239 0 0 0 15.6233 0 0 0 13.7252 0 12.4138 16.3894 15.823 0 13.1648 0 13.2942 0 0 0 12.3096 0 0 0 0 0 0 0 0 0 0 0 15.7709 0 14.6437 15.8463 0 14.6594 15.2698 0 0 0 0 0 16.0177 0 0 0 14.7754 0 15.5934 18.2872 0 0 16.6003 0 0 14.6415 14.6931 0 0 0 15.0996 15.1286 0 15.3353 0 0 0 0 14.2075 0 13.6428 15.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42166 LAP2A_HUMAN "Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha, TP alpha) (Thymopoietin-related peptide isoform alpha, TPRP isoform alpha) [Cleaved into: Thymopoietin, TP (Splenin); Thymopentin (TP5) ]" TMPO LAP2 Homo sapiens (Human) chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; lamin binding [GO:0005521] GO:0000785; GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0045296 cadherin binding [GO:0045296]; DNA binding [GO:0003677]; lamin binding [GO:0005521] IDASELSFPFHESILKVIEEEWQQVDR 0.99258 -6.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9308 0 0 0 0 0 0 0 0 0 0 10.5779 0 0 0 0 0 0 0 0 0 0 14.7553 0 0 0 0 0 0 0 0 0 12.9601 0 0 0 0 0 0 0 11.886 0 0 0 0 0 0 0 12.7562 0 0 0 0 0 0 13.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7583 0 11.5344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0904 0 P55083 MFAP4_HUMAN Microfibril-associated glycoprotein 4 MFAP4 Homo sapiens (Human) "cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; complement activation, lectin pathway [GO:0001867]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650]" collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] "collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; antigen binding [GO:0003823]; carbohydrate derivative binding [GO:0097367]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cellular response to UV-B [GO:0071493]; complement activation, lectin pathway [GO:0001867]; elastic fiber assembly [GO:0048251]; regulation of collagen metabolic process [GO:0010712]; supramolecular fiber organization [GO:0097435]; UV protection [GO:0009650]" GO:0001527; GO:0001867; GO:0003823; GO:0005102; GO:0005576; GO:0005615; GO:0007155; GO:0009650; GO:0010712; GO:0048251; GO:0062023; GO:0071493; GO:0071953; GO:0097367; GO:0097435 antigen binding [GO:0003823]; carbohydrate derivative binding [GO:0097367]; signaling receptor binding [GO:0005102] ALLALPLLLLLSTPPCAPQVSGIR 0.99258 -6.0731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58173 OR2B6_HUMAN "Olfactory receptor 2B6 (Hs6M1-32) (Olfactory receptor 2B1) (Olfactory receptor 2B5) (Olfactory receptor 5-40, OR5-40) (Olfactory receptor 6-31, OR6-31) (Olfactory receptor OR6-4)" OR2B6 OR2B1 OR2B1P OR2B5 OR2B6P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVLRIQSAEGR 0.99258 -7.2661 0 0 0 0 0 0 0 0 0 0 11.8414 0 0 0 0 0 0 0 0 0 0 0 10.9169 10.8349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7106 0 0 0 0 0 0 0 12.5629 0 0 0 0 10.6205 11.1291 0 10.9842 0 0 0 0 0 0 11.667 0 0 0 12.6614 0 0 0 15.6479 13.4522 10.9477 12.4258 13.9992 12.3803 0 15.4439 14.5316 0 0 0 0 14.5771 0 11.3677 13.267 13.1521 13.2637 14.3405 0 13.5125 15.3585 16.0149 13.741 11.6905 0 0 0 0 0 14.6247 0 14.3961 0 12.253 13.5927 0 11.4909 0 14.4228 12.9428 0 12.5992 0 13.1948 0 13.1594 12.6955 0 11.2632 0 11.9204 13.1911 0 14.109 13.3428 14.5768 13.8931 14.3134 14.0701 11.7587 14.2712 13.8914 0 0 0 0 16.0886 12.4032 0 0 12.171 0 14.264 0 10.8889 13.6451 13.6319 0 14.6209 12.1165 0 0 12.1284 12.5919 11.8916 0 0 0 0 14.0592 0 0 0 0 12.6534 12.4369 12.367 0 11.9308 13.0013 0 0 0 0 Q07092 COGA1_HUMAN Collagen alpha-1(XVI) chain COL16A1 FP1572 Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amino acid stimulus [GO:0071230]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of focal adhesion assembly [GO:0051894] collagen type V trimer [GO:0005588]; collagen type XVI trimer [GO:0005597]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type V trimer [GO:0005588]; collagen type XVI trimer [GO:0005597]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amino acid stimulus [GO:0071230]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of focal adhesion assembly [GO:0051894] GO:0005178; GO:0005201; GO:0005576; GO:0005588; GO:0005597; GO:0005615; GO:0005788; GO:0007155; GO:0007229; GO:0007565; GO:0030020; GO:0030198; GO:0031012; GO:0033622; GO:0033627; GO:0051894; GO:0062023; GO:0071230 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178] AGHCNPSDCFGAMPMEQQYPPMK 0.99258 -25.948 13.619 13.3366 12.6973 13.1253 13.2366 13.6867 13.7818 13.6056 0 0 0 0 13.5701 0 0 0 11.7775 0 12.839 0 0 13.5082 14.5185 15.5031 0 13.9632 0 12.9322 0 11.4782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2054 0 0 0 0 12.1245 0 13.8193 14.062 0 11.8188 0 0 0 0 0 0 0 0 0 0 0 17.0079 17.5105 17.4674 17.7219 16.4421 16.3125 16.9895 16.0661 17.275 16.8358 17.1829 16.7303 16.2553 14.961 16.73 14.3817 13.8171 11.1703 13.5866 0 20.6336 20.5524 20.5915 0 15.3198 20.5565 20.5305 20.5406 20.5291 20.521 20.6184 13.6959 20.5833 15.0839 15.1084 13.6818 15.7279 20.6045 20.4803 14.1826 20.4671 20.4387 20.4565 15.4951 15.1273 20.4292 20.5037 16.185 20.4327 15.4018 17.1935 15.435 15.484 16.6181 20.3966 20.3734 14.7065 14.6226 14.4125 0 13.9358 17.705 13.3691 13.5909 15.4613 17.7693 15.4074 15.4076 15.5345 13.5873 15.8354 20.3961 14.9556 16.1354 20.4058 15.7036 15.8281 20.3367 15.0783 16.6475 20.3214 0 16.076 0 20.3037 16.055 13.8672 20.2715 20.2175 20.2384 13.3551 0 0 0 0 0 0 0 0 14.0805 0 0 0 0 13.2564 16.0099 14.5627 16.9845 20.1957 0 20.124 0 15.2701 0 Q0VD83 APOBR_HUMAN "Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor, Apolipoprotein B48 receptor, apoB-48R)" APOBR APOB48R Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; triglyceride metabolic process [GO:0006641] chylomicron [GO:0042627]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361] chylomicron [GO:0042627]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869]; triglyceride metabolic process [GO:0006641] GO:0005886; GO:0006641; GO:0006869; GO:0008203; GO:0016020; GO:0030229; GO:0034361; GO:0034362; GO:0042627 very-low-density lipoprotein particle receptor activity [GO:0030229] AGAVGPK 0.99258 -7.6356 0 0 0 0 0 0 0 0 0 0 10.7355 0 0 0 0 0 12.1788 0 0 0 0 0 0 0 0 12.0264 11.8752 0 0 0 11.6094 0 9.92495 0 12.7692 0 11.4219 0 0 0 0 0 10.6162 0 0 0 0 0 10.6465 0 0 13.0325 0 0 0 0 0 0 0 0 0 0 0 0 10.0943 0 0 0 0 0 0 0 12.395 12.0835 0 12.3684 0 0 0 12.5164 12.6141 0 0 0 0 0 0 12.4062 0 0 0 0 0 0 0 0 14.1958 12.5526 0 0 0 0 0 0 0 0 0 12.6696 0 14.0412 0 0 0 0 0 0 0 0 0 0 0 12.6346 0 0 0 0 0 0 0 12.1899 0 0 0 0 0 0 0 0 12.5832 0 0 0 12.3775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1409 11.9214 0 0 11.7397 0 0 11.9038 0 0 13.5714 0 0 0 0 0 10.7716 14.157 0 0 0 0 Q13535 ATR_HUMAN "Serine/threonine-protein kinase ATR, EC 2.7.11.1 (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1)" ATR FRP1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; negative regulation of DNA replication [GO:0008156]; nucleobase-containing compound metabolic process [GO:0006139]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of double-strand break repair [GO:2000779]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to arsenic-containing substance [GO:0046685]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]" ATR-ATRIP complex [GO:0070310]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "ATR-ATRIP complex [GO:0070310]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; interstrand cross-link repair [GO:0036297]; negative regulation of DNA replication [GO:0008156]; nucleobase-containing compound metabolic process [GO:0006139]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of cellular response to heat [GO:1900034]; regulation of double-strand break repair [GO:2000779]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to arsenic-containing substance [GO:0046685]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]" GO:0000077; GO:0000723; GO:0003677; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0006139; GO:0006260; GO:0006281; GO:0006468; GO:0006974; GO:0008156; GO:0009410; GO:0016605; GO:0018105; GO:0031297; GO:0032212; GO:0032405; GO:0032407; GO:0034644; GO:0036297; GO:0043517; GO:0046685; GO:0046777; GO:0070198; GO:0070310; GO:0071480; GO:0090399; GO:0097694; GO:0097695; GO:0106310; GO:1900034; GO:1904884; GO:2000779 ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AALCHLLQYFLK 0.99258 -46.714 0 0 0 0 10.4048 0 0 0 0 0 13.6855 0 11.0658 0 0 0 0 0 0 13.7796 0 0 0 0 0 12.6122 0 11.7541 0 0 0 0 0 13.6006 0 0 0 0 0 0 0 10.7692 0 0 0 0 13.7607 0 0 0 0 0 0 12.9967 0 0 0 0 0 0 0 0 0 0 0 0 11.4015 11.3545 0 12.6398 0 0 0 0 0 10.3315 0 14.3502 13.5271 0 0 14.4537 16.1587 15.6635 0 0 0 0 13.317 0 13.5674 0 13.4252 0 11.977 0 0 0 0 0 0 16.2983 14.6572 15.2324 13.7824 0 0 0 0 14.3906 14.9777 13.5836 0 11.4103 12.7457 0 0 0 15.2021 14.3679 0 14.8553 14.8329 12.0892 12.5226 14.444 14.0254 0 0 0 14.6719 14.5915 14.6493 0 0 0 13.8116 14.2558 14.7044 14.1524 15.0379 0 0 0 16.5287 0 0 0 13.7787 0 12.7219 0 0 13.5155 14.0379 12.3814 10.6813 14.7214 0 14.4721 0 0 0 0 0 0 0 15.5855 0 0 0 0 14.2652 0 0 14.4304 15.8194 0 0 13.0585 Q14114 LRP8_HUMAN "Low-density lipoprotein receptor-related protein 8, LRP-8 (Apolipoprotein E receptor 2)" LRP8 APOER2 Homo sapiens (Human) ammon gyrus development [GO:0021541]; cellular response to cholesterol [GO:0071397]; cellular response to growth factor stimulus [GO:0071363]; chemical synaptic transmission [GO:0007268]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; layer formation in cerebral cortex [GO:0021819]; lipid metabolic process [GO:0006629]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine kinase activity [GO:0061098]; proteolysis [GO:0006508]; reelin-mediated signaling pathway [GO:0038026]; regulation of apoptotic process [GO:0042981]; regulation of innate immune response [GO:0045088]; response to xenobiotic stimulus [GO:0009410]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517] axon [GO:0030424]; caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235] axon [GO:0030424]; caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; high-density lipoprotein particle binding [GO:0008035]; kinesin binding [GO:0019894]; low-density lipoprotein particle receptor activity [GO:0005041]; protein N-terminus binding [GO:0047485]; reelin receptor activity [GO:0038025]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle receptor activity [GO:0030229]; ammon gyrus development [GO:0021541]; cellular response to cholesterol [GO:0071397]; cellular response to growth factor stimulus [GO:0071363]; chemical synaptic transmission [GO:0007268]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; layer formation in cerebral cortex [GO:0021819]; lipid metabolic process [GO:0006629]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein tyrosine kinase activity [GO:0061098]; proteolysis [GO:0006508]; reelin-mediated signaling pathway [GO:0038026]; regulation of apoptotic process [GO:0042981]; regulation of innate immune response [GO:0045088]; response to xenobiotic stimulus [GO:0009410]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517] GO:0001523; GO:0001540; GO:0004888; GO:0005041; GO:0005509; GO:0005615; GO:0005875; GO:0005886; GO:0005901; GO:0006508; GO:0006629; GO:0006897; GO:0007165; GO:0007268; GO:0008035; GO:0009410; GO:0009986; GO:0014069; GO:0016020; GO:0016021; GO:0019221; GO:0019894; GO:0021517; GO:0021541; GO:0021819; GO:0030229; GO:0030424; GO:0030425; GO:0032793; GO:0034185; GO:0038024; GO:0038025; GO:0038026; GO:0042981; GO:0043025; GO:0043235; GO:0045088; GO:0047485; GO:0048306; GO:0048813; GO:0050731; GO:0050804; GO:0061003; GO:0061098; GO:0071363; GO:0071397; GO:1900006 amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; high-density lipoprotein particle binding [GO:0008035]; kinesin binding [GO:0019894]; low-density lipoprotein particle receptor activity [GO:0005041]; protein N-terminus binding [GO:0047485]; reelin receptor activity [GO:0038025]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle receptor activity [GO:0030229] CDEDDDCLDHSDEDDCPK 0.99258 -6.7881 0 12.1655 0 0 0 0 0 0 0 0 0 0 10.5031 0 0 0 10.1126 0 0 0 11.7354 0 0 0 0 0 0 12.6803 0 0 11.7943 12.209 0 0 0 0 0 0 0 0 0 0 11.4113 0 0 0 0 0 13.1272 0 0 0 0 12.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8927 14.1706 14.1438 0 11.107 12.3242 12.8948 13.9089 13.4211 0 15.7333 14.4433 12.6265 13.7857 14.9564 12.9308 0 12.883 11.8942 11.1683 0 0 12.0154 0 12.8319 13.0405 13.6598 0 0 15.3711 13.8348 12.8284 13.5495 0 11.2404 17.2271 0 15.117 13.8392 16.8407 15.5352 13.9042 16.5671 12.3185 0 17.1417 12.4194 12.0234 17.24 0 14.2275 0 0 14.4613 15.8836 14.3902 0 0 15.4978 12.6214 13.7736 0 15.4408 15.8927 16.1241 0 12.4108 14.2592 15.4556 0 14.6428 0 0 12.5321 11.6627 0 11.6945 0 0 10.5208 0 10.8978 0 11.9675 0 0 0 11.7175 0 0 0 11.6 0 0 11.9477 11.734 0 15.2444 0 0 14.3389 0 0 0 12.6636 0 Q14289 FAK2_HUMAN "Protein-tyrosine kinase 2-beta, EC 2.7.10.2 (Calcium-dependent tyrosine kinase, CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta, CAK-beta, CAKB) (Focal adhesion kinase 2, FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase, RAFTK)" PTK2B FAK2 PYK2 RAFTK Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; blood vessel endothelial cell migration [GO:0043534]; bone resorption [GO:0045453]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; glial cell proliferation [GO:0014009]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of potassium ion transport [GO:0043267]; neuron projection development [GO:0031175]; oocyte maturation [GO:0001556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of establishment of cell polarity [GO:2000114]; regulation of inositol trisphosphate biosynthetic process [GO:0032960]; regulation of macrophage chemotaxis [GO:0010758]; regulation of NMDA receptor activity [GO:2000310]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to cation stress [GO:0043157]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to ischemia [GO:0002931]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; stress fiber assembly [GO:0043149]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]" apical dendrite [GO:0097440]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069] "apical dendrite [GO:0097440]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase binding [GO:0043423]; ATP binding [GO:0005524]; calmodulin-dependent protein kinase activity [GO:0004683]; NMDA glutamate receptor activity [GO:0004972]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; blood vessel endothelial cell migration [GO:0043534]; bone resorption [GO:0045453]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; focal adhesion assembly [GO:0048041]; glial cell proliferation [GO:0014009]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of potassium ion transport [GO:0043267]; neuron projection development [GO:0031175]; oocyte maturation [GO:0001556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of translation [GO:0045727]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of establishment of cell polarity [GO:2000114]; regulation of inositol trisphosphate biosynthetic process [GO:0032960]; regulation of macrophage chemotaxis [GO:0010758]; regulation of NMDA receptor activity [GO:2000310]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to cation stress [GO:0043157]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to ischemia [GO:0002931]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; stress fiber assembly [GO:0043149]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]" GO:0000165; GO:0001556; GO:0001666; GO:0001954; GO:0002040; GO:0002250; GO:0002315; GO:0002931; GO:0004683; GO:0004713; GO:0004715; GO:0004972; GO:0005102; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0005938; GO:0006468; GO:0006915; GO:0006968; GO:0007165; GO:0007166; GO:0007169; GO:0007172; GO:0007173; GO:0007204; GO:0007229; GO:0008022; GO:0008284; GO:0008285; GO:0008360; GO:0009410; GO:0009612; GO:0009725; GO:0009749; GO:0010226; GO:0010595; GO:0010656; GO:0010752; GO:0010758; GO:0010976; GO:0014009; GO:0014069; GO:0017146; GO:0018108; GO:0030027; GO:0030154; GO:0030155; GO:0030307; GO:0030335; GO:0030425; GO:0030426; GO:0030502; GO:0030838; GO:0031175; GO:0031234; GO:0031625; GO:0032960; GO:0033209; GO:0035235; GO:0035902; GO:0038083; GO:0042220; GO:0042542; GO:0042976; GO:0043025; GO:0043066; GO:0043149; GO:0043157; GO:0043197; GO:0043267; GO:0043423; GO:0043507; GO:0043524; GO:0043534; GO:0043552; GO:0043621; GO:0044297; GO:0044877; GO:0045087; GO:0045121; GO:0045429; GO:0045453; GO:0045471; GO:0045638; GO:0045727; GO:0045766; GO:0045860; GO:0046330; GO:0046777; GO:0048010; GO:0048041; GO:0048167; GO:0048471; GO:0050731; GO:0050848; GO:0051000; GO:0051279; GO:0051591; GO:0051592; GO:0051968; GO:0060291; GO:0060292; GO:0065003; GO:0070098; GO:0070374; GO:0071300; GO:0071498; GO:0086100; GO:0090630; GO:0097440; GO:0098978; GO:2000058; GO:2000060; GO:2000114; GO:2000249; GO:2000310; GO:2000379; GO:2000463; GO:2000538; GO:2000573 3-phosphoinositide-dependent protein kinase binding [GO:0043423]; ATP binding [GO:0005524]; calmodulin-dependent protein kinase activity [GO:0004683]; NMDA glutamate receptor activity [GO:0004972]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625] CWDYDPSDR 0.99258 -6.4179 0 0 0 0 0 0 0 0 13.0729 13.3989 13.6373 13.1387 0 13.1158 13.4836 13.8634 13.3824 13.2451 14.5637 13.1455 14.3953 14.424 13.1688 14.591 13.2651 13.146 13.2467 13.1935 14.0816 13.1265 0 13.1046 0 12.9569 0 12.912 0 12.2228 0 0 0 0 0 13.1228 13.8079 0 9.86378 0 13.1933 12.433 12.0769 0 0 0 0 13.1393 13.4095 0 0 12.2027 11.572 11.982 0 11.3621 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0891 0 0 0 0 13.0168 0 0 13.2409 0 0 16.895 0 16.7631 0 13.6623 0 13.9119 13.6763 0 0 0 12.7418 14.1749 12.8517 0 0 0 0 10.184 0 11.0193 0 0 0 0 0 0 15.2898 0 13.9911 13.5657 14.1215 0 0 0 0 0 0 14.3504 0 15.901 0 0 0 0 11.2068 0 15.0585 0 13.4274 15.2412 0 0 0 13.2998 12.3111 0 13.9029 0 14.6061 10.9811 0 0 0 0 0 0 0 14.4001 14.6813 0 14.8707 14.6587 14.9004 0 0 14.7749 14.5294 12.3515 0 18.6067 14.485 12.4078 13.7425 0 0 0 14.4177 0 0 0 0 Q14512 FGFP1_HUMAN "Fibroblast growth factor-binding protein 1, FGF-BP, FGF-BP1, FGF-binding protein 1, FGFBP-1 (17 kDa heparin-binding growth factor-binding protein, 17 kDa HBGF-binding protein, HBp17)" FGFBP1 FGFBP HBP17 Homo sapiens (Human) cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; myoblast proliferation [GO:0051450]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of myoblast proliferation [GO:2000288]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; myoblast proliferation [GO:0051450]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of myoblast proliferation [GO:2000288]; signal transduction [GO:0007165] GO:0005576; GO:0005615; GO:0005886; GO:0007165; GO:0007267; GO:0008201; GO:0008285; GO:0008543; GO:0009986; GO:0017134; GO:0019838; GO:0045743; GO:0051450; GO:0090050; GO:1903589; GO:2000288 fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201] APECVEDPDMANQR 0.99258 -16.304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2271 0 0 0 0 0 0 0 0 0 11.5054 0 0 0 0 0 0 0 0 0 0 13.6214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64225 0 0 0 0 0 0 0 11.6936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JPB2 ZN831_HUMAN Zinc finger protein 831 ZNF831 C20orf174 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] APEGRLR 0.99258 -24.127 0 0 0 13.6022 0 0 14.7167 0 11.0394 0 0 12.8109 0 11.9495 14.3445 0 12.2635 0 0 14.3075 12.9231 0 0 13.3487 0 15.4314 11.9132 11.9628 15.3472 0 0 0 14.9938 0 10.413 0 13.9953 0 0 0 14.4085 13.2935 0 0 0 10.3677 0 0 0 0 0 13.1271 0 0 10.3436 0 12.7685 0 0 10.9227 10.8323 11.8773 0 12.2087 12.8648 13.8793 15.1858 12.2926 0 0 11.7187 13.353 12.942 12.7042 14.1044 0 13.8586 0 0 0 12.7712 0 13.7622 14.8104 14.9397 14.0469 15.0818 13.4934 0 16.1796 14.0389 13.5716 16.3419 15.1653 11.9306 14.4974 14.3495 12.9842 15.9511 15.4723 14.0486 0 14.1758 13.9661 14.3011 15.1971 0 16.4547 14.6565 13.8862 13.6732 15.0912 11.9812 14.1922 14.324 0 0 14.6546 0 0 0 13.779 0 0 0 13.3895 16.5903 13.8603 16.1183 11.8491 0 13.7095 13.1613 15.7087 14.7745 15.0411 0 14.0558 13.0213 10.4911 0 15.3155 0 15.1226 0 0 13.2991 0 0 14.1325 0 10.5376 0 0 0 12.2783 15.1458 0 0 0 0 0 0 11.4541 0 13.7205 0 0 0 0 0 0 13.4833 0 15.0258 0 0 0 0 12.0981 Q5T655 CFA58_HUMAN Cilia- and flagella-associated protein 58 (Coiled-coil domain-containing protein 147) CFAP58 C10orf80 CCDC147 Homo sapiens (Human) cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317] GO:0005615; GO:0005737; GO:0005813; GO:0005856; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317 AEVEQHKETLK 0.99258 -41.051 0 10.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8147 0 0 12.2269 0 11.9669 0 0 15.2587 12.572 12.58 0 10.7288 0 12.5036 0 0 0 13.8791 0 12.7268 14.3997 0 0 0 0 14.3431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7748 0 0 0 0 11.4235 12.0862 12.4261 0 0 11.9617 11.3605 0 12.4153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.063 0 0 14.1053 0 0 0 13.1666 0 0 Q76MJ5 ERN2_HUMAN "Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2, hIRE2p) (Ire1-beta, IRE1b) [Includes: Serine/threonine-protein kinase, EC 2.7.11.1; Endoribonuclease, EC 3.1.26.- ]" ERN2 IRE2 Homo sapiens (Human) "apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; IRE1-TRAF2-ASK1 complex [GO:1990604]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; apoptotic chromosome condensation [GO:0030263]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA processing [GO:0006397]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; rRNA catabolic process [GO:0016075]" GO:0000287; GO:0004519; GO:0004521; GO:0004674; GO:0005524; GO:0005783; GO:0005829; GO:0006397; GO:0006468; GO:0016021; GO:0016075; GO:0030263; GO:0034976; GO:0036498; GO:0043507; GO:0044322; GO:0045892; GO:0051082; GO:0070059; GO:0106310; GO:1990604 ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082] ASAVRGSRPWPR 0.99258 -25.994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5794 0 0 0 0 13.1146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IU60 DCP2_HUMAN "m7GpppN-mRNA hydrolase, EC 3.6.1.62 (Nucleoside diphosphate-linked moiety X motif 20, Nudix motif 20) (mRNA-decapping enzyme 2, hDpc)" DCP2 NUDT20 Homo sapiens (Human) "deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]" cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442] "cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; 5'-3' exoribonuclease activity [GO:0004534]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]" GO:0000184; GO:0000290; GO:0000932; GO:0004534; GO:0005654; GO:0005737; GO:0005829; GO:0006402; GO:0016442; GO:0016896; GO:0030054; GO:0030145; GO:0032211; GO:0036464; GO:0043488; GO:0043928; GO:0050072; GO:0070034; GO:0071044; GO:1904872 "5'-3' exoribonuclease activity [GO:0004534]; exoribonuclease activity, producing 5'-phosphomonoesters [GO:0016896]; m7G(5')pppN diphosphatase activity [GO:0050072]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034]" EEAPHDCAAR 0.99258 -25.982 0 10.1881 12.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2864 0 0 14.2664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8223 15.164 14.6432 14.8634 0 0 0 12.9975 14.0085 0 0 0 0 13.2512 14.9232 11.627 14.9626 0 0 12.2719 0 14.929 0 0 0 0 0 0 0 0 13.9306 13.3746 0 0 0 0 14.6178 0 0 0 0 13.6395 15.8291 13.5671 0 15.5272 0 0 13.0227 15.2322 0 0 0 13.7995 13.4503 0 12.9453 0 15.3019 14.1424 0 15.8367 15.0807 15.6902 0 0 0 14.5058 0 14.5233 14.9982 0 14.6646 0 0 0 0 0 0 0 14.2102 11.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8036 0 0 0 0 0 0 0 Q8NGR4 OR5C1_HUMAN "Olfactory receptor 5C1 (Olfactory receptor 5C2) (Olfactory receptor 9-F, OR9-F)" OR5C1 OR5C2P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] FHCPGQGSQ 0.99258 -17.518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1197 0 0 0 0 12.4756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3902 0 11.92 0 0 0 0 0 0 0 12.2915 0 0 0 0 Q8TDM0 BCAS4_HUMAN Breast carcinoma-amplified sequence 4 BCAS4 Homo sapiens (Human) BLOC-1 complex [GO:0031083] BLOC-1 complex [GO:0031083] GO:0031083 TGGGAPR 0.99258 -6.0752 0 0 0 0 0 0 0 0 14.195 0 14.0504 13.818 14.3969 13.4525 12.7443 12.4088 12.9235 11.4912 12.1183 13.5164 13.34 0 0 0 0 11.6949 12.2632 13.657 11.1956 11.8947 0 14.3842 14.2918 14.2407 14.0898 13.0939 14.6773 13.5005 15.474 14.5818 14.7107 13.5999 13.0623 0 13.4677 14.6971 14.7852 12.7213 0 12.0734 0 0 0 0 0 0 13.5533 14.4406 14.7953 15.0569 14.7472 12.7728 14.9495 13.318 14.4661 13.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0642 0 0 0 0 0 13.5064 14.6825 0 0 0 12.5527 0 0 0 13.7076 0 0 0 14.8719 0 0 0 0 0 0 14.7082 0 0 13.8564 0 13.4833 14.4946 13.7764 0 0 0 13.9227 0 0 0 0 13.9599 13.6959 15.355 14.2766 0 0 0 0 0 0 0 0 0 0 0 12.8534 13.5178 14.4939 13.2936 0 14.8472 12.3803 13.732 0 0 0 0 12.0974 0 0 13.6517 15.2027 0 14.6236 0 12.9868 0 0 Q8TEB1 DCA11_HUMAN DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23) DCAF11 WDR23 GL014 PRO2389 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] GO:0005654; GO:0016567; GO:0043161; GO:0080008 DQTIKLWDIR 0.99258 -17.544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.128 0 0 0 0 0 0 0 0 0 0 0 13.6693 0 0 0 0 0 0 0 13.9472 0 13.8088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0192 0 0 0 0 13.704 0 0 0 0 0 0 13.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2219 0 0 0 0 0 0 0 0 0 0 0 12.8332 0 0 11.9909 12.5898 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWQ8 STAB2_HUMAN "Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2, FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis) ]" STAB2 FEEL2 FELL FEX2 HARE Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; receptor-mediated endocytosis [GO:0006898] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; receptor-mediated endocytosis [GO:0006898] GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0005887; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030666; GO:0042742; GO:0050830 calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] AKIISSDIISTNGIVHIIDK 0.99258 -25.916 0 0 0 11.2454 0 0 0 0 13.7429 15.3829 0 15.7434 15.1867 15.6117 14.9944 13.9421 0 0 13.0642 0 0 11.1999 0 0 0 0 0 0 13.3066 0 12.5841 0 0 0 0 0 0 0 0 0 13.0323 0 0 0 0 0 12.8618 10.6917 0 11.8164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5794 0 12.3673 0 0 0 0 0 11.9307 0 11.8799 0 0 13.6035 11.5186 0 13.1663 12.2444 10.3583 0 0 12.0431 14.7187 0 15.7488 13.437 0 0 13.723 0 13.9354 11.8648 0 0 0 0 0 0 0 0 0 11.6667 0 11.6825 0 11.5827 0 0 0 0 11.6977 0 0 0 0 0 0 0 0 14.0257 0 0 11.7736 14.1901 0 0 16.7576 14.7322 0 0 10.7585 0 0 10.9133 0 0 17.313 17.4713 17.6047 16.5959 16.7129 16.6297 17.2243 16.6922 0 16.6007 0 0 0 0 0 0 0 0 16.6098 0 16.5751 14.862 16.3343 Q8WYN3 CSRN3_HUMAN "Cysteine/serine-rich nuclear protein 3, CSRNP-3 (Protein FAM130A2) (TGF-beta-induced apoptosis protein 2, TAIP-2)" CSRNP3 FAM130A2 TAIP2 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0043065; GO:0043565; GO:0045944 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]" ALLRASGVKK 0.99258 -18.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0433 0 0 0 0 0 0 12.3128 0 0 11.452 0 0 0 0 0 0 11.9178 0 0 0 0 0 0 12.4408 0 0 0 0 0 12.5383 0 0 0 13.0076 0 12.5585 12.6205 0 0 0 0 12.4579 0 0 0 0 12.3562 12.9427 13.8562 10.3207 0 12.3828 12.4821 0 0 0 0 0 12.5287 0 13.1559 0 0 0 12.9862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9655 0 0 14.6026 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 13.1594 0 0 0 12.7591 0 14.7557 0 0 0 11.8398 0 0 Q96RR1 PEO1_HUMAN "Twinkle mtDNA helicase, EC 3.6.4.12 (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)" TWNK C10orf2 PEO1 Homo sapiens (Human) cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697]; cellular response to glucose stimulus [GO:0071333]; DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214] GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005759; GO:0006264; GO:0006268; GO:0006390; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139; GO:0071333 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697] IAAQDYIIGVFRK 0.99258 -18.402 0 0 13.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1055 0 0 12.0732 0 0 0 0 0 0 0 0 0 0 10.9474 0 0 0 14.7768 0 0 0 14.5552 0 18.6538 15.1129 14.6633 13.9022 0 0 0 0 14.3424 0 0 0 0 0 15.0628 0 0 0 0 12.8982 0 0 0 0 0 0 0 14.5718 0 0 13.0032 0 0 14.5854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6097 0 0 0 0 0 0 0 0 0 0 0 Q9BX66 SRBS1_HUMAN "Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein, CAP)" SORBS1 KIAA0894 KIAA1296 SH3D5 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149] adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915] adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; stress fiber assembly [GO:0043149] GO:0001725; GO:0003779; GO:0005158; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005912; GO:0005915; GO:0005925; GO:0007160; GO:0008092; GO:0008286; GO:0016363; GO:0016600; GO:0030055; GO:0030159; GO:0031589; GO:0032869; GO:0043149; GO:0045121; GO:0045725; GO:0046326; GO:0046628; GO:0046889; GO:0048041; GO:1903078 actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159] AERGAGERGPGGPK 0.99258 -25.977 0 0 0 0 0 0 9.89292 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87891 0 12.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0505 0 0 0 0 0 0 0 0 0 9.96044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8546 0 0 0 0 14.8726 0 0 0 0 0 0 14.4245 0 0 0 0 0 0 13.4762 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9234 0 11.8273 0 0 0 0 0 0 0 0 0 0 0 0 13.7708 13.7226 0 0 0 0 0 12.7761 0 0 0 0 0 13.7788 0 0 0 0 0 0 12.5321 0 0 16.3144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZC7 ABCA2_HUMAN "ATP-binding cassette sub-family A member 2, EC 7.6.2.- (ATP-binding cassette transporter 2, ATP-binding cassette 2)" ABCA2 ABC2 KIAA1062 Homo sapiens (Human) cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886] ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of cholesterol esterification [GO:0010872]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0000166; GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006357; GO:0006629; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0009410; GO:0010008; GO:0010872; GO:0016020; GO:0016021; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:0150104; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905598; GO:1905601; GO:2000008 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166] AAQVFYNNK 0.99258 -25.965 0 0 0 0 0 0 0 0 0 0 0 12.8984 0 0 0 0 0 0 0 0 0 0 0 12.5917 11.9247 0 0 12.6315 0 0 0 0 0 12.321 0 0 0 0 0 12.8513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7578 15.1665 12.1876 0 0 0 13.498 13.4705 0 11.9284 0 12.5288 0 0 0 0 0 14.236 14.3919 13.8935 0 14.4291 14.2598 14.8991 14.0478 14.0091 0 0 0 0 11.8966 11.7987 0 12.5651 0 12.3251 0 0 0 0 0 0 11.9819 0 0 12.8604 0 0 11.9267 0 0 0 0 0 0 11.9748 0 0 0 0 0 0 0 12.2617 12.3595 0 0 0 12.6168 0 0 0 0 12.8785 0 0 0 0 0 12.4514 0 0 12.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H254 SPTN4_HUMAN "Spectrin beta chain, non-erythrocytic 4 (Beta-IV spectrin) (Spectrin, non-erythroid beta chain 3)" SPTBN4 KIAA1642 SPTBN3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult walking behavior [GO:0007628]; axonogenesis [GO:0007409]; cardiac conduction [GO:0061337]; central nervous system projection neuron axonogenesis [GO:0021952]; clustering of voltage-gated sodium channels [GO:0045162]; fertilization [GO:0009566]; negative regulation of heart rate [GO:0010459]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to plasma membrane [GO:0072659]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of sodium ion transport [GO:0002028]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]; vesicle-mediated transport [GO:0016192] actin filament [GO:0005884]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; cell body fiber [GO:0070852]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear matrix [GO:0016363]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spectrin [GO:0008091] actin filament [GO:0005884]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; cell body fiber [GO:0070852]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; nuclear matrix [GO:0016363]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein-membrane anchor activity [GO:0106006]; phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; adult walking behavior [GO:0007628]; axonogenesis [GO:0007409]; cardiac conduction [GO:0061337]; central nervous system projection neuron axonogenesis [GO:0021952]; clustering of voltage-gated sodium channels [GO:0045162]; fertilization [GO:0009566]; negative regulation of heart rate [GO:0010459]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to plasma membrane [GO:0072659]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of sodium ion transport [GO:0002028]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]; vesicle-mediated transport [GO:0016192] GO:0002028; GO:0003779; GO:0005200; GO:0005543; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0007409; GO:0007605; GO:0007628; GO:0008091; GO:0009566; GO:0010459; GO:0014704; GO:0016020; GO:0016192; GO:0016363; GO:0016605; GO:0019226; GO:0019902; GO:0021952; GO:0030036; GO:0030054; GO:0030506; GO:0030507; GO:0030864; GO:0033135; GO:0033268; GO:0033270; GO:0040018; GO:0042995; GO:0043025; GO:0043194; GO:0043203; GO:0045162; GO:0051015; GO:0051693; GO:0061337; GO:0070062; GO:0070852; GO:0072659; GO:0106006 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein-membrane anchor activity [GO:0106006]; phosphatase binding [GO:0019902]; phospholipid binding [GO:0005543]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200] ATSEVASDYKK 0.99258 -81.522 0 0 0 12.4602 0 0 0 0 12.5068 13.39 10.6917 12.6045 0 0 13.1157 0 0 0 0 0 11.123 0 0 0 0 0 11.9085 0 12.3085 0 0 14.1625 0 0 0 10.879 0 12.0801 0 12.156 0 0 0 0 0 10.1731 0 0 13.1755 13.0512 0 10.7324 0 0 0 14.3346 0 0 0 0 0 13.7266 0 11.4459 13.2122 0 0 13.09 0 0 0 0 0 12.7638 0 12.8048 0 0 0 11.8362 14.2167 0 14.988 15.1752 0 0 14.04 0 0 0 0 13.6259 13.4987 0 0 12.9921 0 12.8313 13.3008 13.4067 13.5115 13.4905 0 0 0 12.2739 14.2999 0 0 15.2153 0 0 0 14.8204 0 13.3822 14.4363 0 11.6818 14.0039 12.2273 0 0 0 0 14.7897 13.2115 0 0 13.8529 14.0076 12.5624 13.805 0 0 0 0 0 14.4246 12.9347 12.0447 10.8088 0 0 0 14.0609 0 0 0 10.7074 0 13.7136 0 0 0 0 0 12.395 14.9017 11.0204 14.7412 13.8894 10.9211 14.4993 15.5568 11.4203 14.3349 14.6076 0 14.0085 0 13.0446 0 0 0 12.6864 13.0801 14.5461 0 0 Q9H329 E41LB_HUMAN Band 4.1-like protein 4B (Erythrocyte membrane protein band 4.1-like 4B) (FERM-containing protein CG1) (Protein EHM2) EPB41L4B EHM2 LULU2 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; wound healing [GO:0042060] apical part of cell [GO:0045177]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; wound healing [GO:0042060] GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0008092; GO:0010628; GO:0031032; GO:0042060; GO:0045177; GO:0045785; GO:0051549 cytoskeletal protein binding [GO:0008092]; structural constituent of cytoskeleton [GO:0005200] CAVEHHAFFR 0.99258 -14.897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4339 14.5145 0 0 12.8783 0 12.7011 0 0 14.3414 0 0 0 0 0 0 0 0 0 0 13.2907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8758 0 0 0 0 0 0 0 0 12.6872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2774 0 0 0 0 0 10.8883 0 0 0 0 0 0 0 0 0 15.0421 0 11.3307 0 0 0 12.4412 0 0 0 0 0 0 0 0 0 0 0 0 Q9H336 CRLD1_HUMAN "Cysteine-rich secretory protein LCCL domain-containing 1 (CocoaCrisp) (Cysteine-rich secretory protein 10, CRISP-10) (LCCL domain-containing cysteine-rich secretory protein 1) (Trypsin inhibitor Hl)" CRISPLD1 CRISP10 LCRISP1 UNQ342/PRO541 Homo sapiens (Human) face morphogenesis [GO:0060325]; hematopoietic stem cell homeostasis [GO:0061484] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; face morphogenesis [GO:0060325]; hematopoietic stem cell homeostasis [GO:0061484] GO:0005615; GO:0060325; GO:0061484; GO:0070062 AAIHYGIIDNDGGWVDITRQGR 0.99258 -5.1032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6715 0 0 0 0 0 0 0 11.8001 0 0 0 0 14.0391 13.9429 13.9315 0 0 0 14.1358 0 0 0 0 0 0 0 0 12.0466 0 14.4636 0 0 0 0 0 0 0 0 0 0 0 0 0 13.738 0 0 0 0 0 13.9126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0961 0 0 0 0 11.7768 0 0 0 0 0 0 0 0 0 0 Q9HCE3 ZN532_HUMAN Zinc finger protein 532 ZNF532 KIAA1629 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] EDTKVPSPK 0.99258 -40.917 0 0 0 0 0 0 0 0 0 0 13.0359 0 0 13.4061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2711 0 0 0 0 0 0 0 0 0 12.1651 0 0 0 0 0 13.1852 0 0 0 0 0 0 0 11.7462 0 0 0 0 0 0 0 0 16.2411 0 14.2639 13.6188 0 0 14.0459 14.7252 0 0 0 14.6422 0 11.5517 0 12.4281 0 0 11.9605 0 0 11.6526 0 0 14.3481 0 0 0 14.4416 0 0 0 0 0 0 0 14.6692 0 0 0 0 0 12.7751 14.3154 0 0 0 12.8633 0 12.5022 12.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7624 0 0 14.51 0 0 0 13.7041 0 0 0 0 13.7951 12.6868 12.3549 12.4978 0 0 0 0 0 12.3511 0 0 0 0 12.7156 10.6004 0 11.692 0 0 0 0 13.1176 0 0 0 0 12.6147 0 0 0 Q9NUT2 MITOS_HUMAN "Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial, ABCB8) (Mitochondrial ATP-binding cassette 1, M-ABC1) (Mitochondrial sulfonylurea-receptor, MITOSUR)" ABCB8 MABC1 MITOSUR Homo sapiens (Human) cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085] ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of membrane [GO:0016021]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085] GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0006884; GO:0016021; GO:0031966; GO:0042626; GO:0043190; GO:0055085; GO:0062157; GO:0071805; GO:0140141; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626] ASAGRTVLVIAHRLSTVR 0.99258 -18.404 11.5424 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6647 0 0 0 12.9774 14.2108 12.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4726 13.3008 0 0 0 0 0 0 0 10.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0362 12.4546 0 0 0 0 13.5377 0 14.2239 0 14.1287 0 0 0 0 0 0 15.0234 0 0 14.1146 0 14.3748 14.2209 0 14.1735 0 0 0 13.3396 0 0 0 0 0 14.9849 0 14.1784 13.9815 0 0 0 0 0 0 0 15.3368 0 0 0 0 0 0 0 13.1808 0 0 0 0 0 0 0 14.4486 0 13.5619 0 14.7978 0 0 0 0 12.5646 0 0 13.9531 0 0 0 13.6267 0 14.2748 0 0 0 0 0 0 0 0 0 0 0 15.01 14.3359 14.7209 0 0 0 0 0 13.2634 13.3187 13.6208 15.5313 12.041 0 0 0 Q9P1W3 CSC1_HUMAN Calcium permeable stress-gated cation channel 1 (Transmembrane protein 63C) TMEM63C C14orf171 CSC1 Homo sapiens (Human) cation transport [GO:0006812]; glomerular filtration [GO:0003094] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; osmolarity-sensing cation channel activity [GO:1990760]; cation transport [GO:0006812]; glomerular filtration [GO:0003094] GO:0003094; GO:0005227; GO:0005886; GO:0006812; GO:0016021; GO:1990760 calcium activated cation channel activity [GO:0005227]; osmolarity-sensing cation channel activity [GO:1990760] GFCSWFFNSITMK 0.99258 -18.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8866 0 0 0 0 0 0 0 0 0 12.8336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1265 0 0 0 0 0 0 0 0 0 12.0086 0 0 0 0 0 0 0 0 10.5486 12.2003 0 0 0 0 0 0 0 0 0 0 0 0 13.5475 0 0 0 0 0 0 14.0131 0 11.6204 0 0 0 0 0 0 0 14.3672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3768 0 0 0 0 0 0 0 0 0 0 0 14.9896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9356 0 0 0 0 13.4107 0 0 0 0 Q9UM00 TMCO1_HUMAN "Calcium load-activated calcium channel, CLAC channel (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3)" TMCO1 TMCC4 PNAS-10 PNAS-136 UNQ151/PRO177 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; ribosome binding [GO:0043022]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983] GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0006874; GO:0006983; GO:0030176; GO:0032469; GO:0043022; GO:0070588 calcium channel activity [GO:0005262]; ribosome binding [GO:0043022] IERQEEKLK 0.99258 -4.4405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3985 0 0 0 0 0 0 0 12.6968 0 0 0 0 0 0 0 13.5087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7676 0 0 0 13.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1479 0 0 0 0 0 Q9UMQ6 CAN11_HUMAN "Calpain-11, EC 3.4.22.- (Calcium-activated neutral proteinase 11, CANP 11)" CAPN11 Homo sapiens (Human) proteolysis [GO:0006508] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233]; proteolysis [GO:0006508] GO:0001669; GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0008233 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233] AGIKLNNK 0.99258 -14.901 0 0 0 0 0 0 0 0 13.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.098 0 0 0 0 11.8758 0 0 0 0 0 0 0 0 0 0 0 0 10.3826 0 0 0 0 15.4139 15.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5318 0 0 0 14.1836 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8736 0 0 0 13.6457 0 0 0 0 0 0 0 0 0 0 0 13.3376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3519 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2027 0 0 0 0 0 13.7105 0 14.0591 0 0 O95255 MRP6_HUMAN "ATP-binding cassette sub-family C member 6, EC 7.6.2.-, EC 7.6.2.3 (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E, MOAT-E) (Multidrug resistance-associated protein 6)" ABCC6 ARA MRP6 Homo sapiens (Human) ATP metabolic process [GO:0046034]; ATP transport [GO:0015867]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; cellular phosphate ion homeostasis [GO:0030643]; gene expression [GO:0010467]; inorganic diphosphate transport [GO:0030505]; leukotriene transport [GO:0071716]; phosphate ion homeostasis [GO:0055062]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ATP metabolic process [GO:0046034]; ATP transport [GO:0015867]; biomineralization [GO:0110148]; calcium ion homeostasis [GO:0055074]; cellular phosphate ion homeostasis [GO:0030643]; gene expression [GO:0010467]; inorganic diphosphate transport [GO:0030505]; leukotriene transport [GO:0071716]; phosphate ion homeostasis [GO:0055062]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; response to xenobiotic stimulus [GO:0009410]; transmembrane transport [GO:0055085]; visual perception [GO:0007601] GO:0005524; GO:0005576; GO:0005654; GO:0005789; GO:0005886; GO:0007601; GO:0009410; GO:0010467; GO:0015431; GO:0015867; GO:0016020; GO:0016021; GO:0016323; GO:0030505; GO:0030643; GO:0032026; GO:0042626; GO:0043225; GO:0046034; GO:0055062; GO:0055074; GO:0055085; GO:0071716; GO:0110148; GO:1904383 ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626] AGWPAGK 0.99259 -58.344 0 0 0 13.1206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8893 9.9368 0 0 0 0 0 0 0 0 0 0 0 0 10.7156 0 0 0 0 0 0 12.7168 0 12.5938 0 0 0 0 0 12.104 0 0 0 11.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3499 0 12.071 15.6828 0 13.2497 15.5412 12.9735 0 15.0147 0 12.7564 12.4062 0 0 0 13.6893 15.1647 12.5375 15.7212 13.4179 14.9493 0 0 0 0 0 0 11.5313 0 0 13.4214 14.8615 0 0 13.4285 0 13.4108 0 13.3733 0 12.8348 15.4369 0 0 0 13.4701 0 11.2433 13.2143 0 0 13.5761 0 0 13.4911 0 13.5342 0 12.9639 13.8429 0 0 0 0 0 0 0 0 0 0 14.854 0 15.0327 0 0 0 13.8746 0 0 0 12.8952 12.8747 0 0 0 0 0 0 0 0 0 0 0 14.4651 0 0 0 0 0 0 13.2966 14.5875 14.036 0 0 0 0 0 P0C221 CC175_HUMAN Coiled-coil domain-containing protein 175 CCDC175 C14orf38 Homo sapiens (Human) AEIQAITEKIQNAEVRR 0.99259 -25.228 0 0 0 0 0 0 0 0 0 11.157 0 10.0013 0 0 0 0 0 9.79463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2474 0 0 0 13.4051 0 0 0 11.3 0 0 0 15.0218 15.4157 15.281 0 0 14.4153 14.211 0 0 12.4898 0 0 12.4802 12.9717 17.08 14.0482 14.0701 13.4926 0 0 14.0802 0 0 12.4034 14.9831 15.721 0 13.8075 14.0231 13.4608 0 13.5549 14.1239 13.6081 14.5667 17.1051 0 13.3934 13.1894 13.6498 0 0 11.8157 0 0 14.9108 0 0 0 0 0 0 0 0 0 0 13.0697 13.1274 13.2031 14.3316 0 12.1068 13.5226 11.9457 13.8006 13.1538 13.4467 14.6734 0 0 0 0 14.8151 0 14.623 15.39 0 14.7221 14.9843 0 0 0 0 0 0 0 0 0 0 0 15.0345 14.8217 14.8408 14.1881 13.4058 13.4244 0 0 0 0 0 0 P23508 CRCM_HUMAN "Colorectal mutant cancer protein, Protein MCC" MCC Homo sapiens (Human) establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0036464; GO:0038023; GO:0045184; GO:0050680; GO:0090090 signaling receptor activity [GO:0038023] AQCEQSHLMREHEDVQERTTLR 0.99259 -24.349 13.3285 13.8362 12.2425 13.5643 0 13.2034 13.985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8114 0 0 0 0 12.6515 0 0 0 0 0 0 0 0 12.9218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8152 0 0 13.9015 0 14.7826 0 0 12.4479 0 0 0 12.9311 0 0 12.4532 0 0 0 0 0 0 0 0 0 0 11.1908 0 0 0 12.8799 0 0 0 0 0 0 0 0 13.264 0 0 0 0 14.9308 13.5689 0 0 0 13.5752 0 14.1032 13.5103 0 0 13.9944 0 0 0 14.1911 0 0 14.2723 13.2784 13.2654 16.0378 0 0 0 15.7866 0 0 0 0 0 13.3399 0 13.5068 0 0 14.7434 0 14.2885 0 14.4724 0 16.2828 15.6081 13.8687 14.8136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2362 14.5536 14.4579 0 0 0 14.707 0 P31327 CPSM_HUMAN "Carbamoyl-phosphate synthase [ammonia], mitochondrial, EC 6.3.4.16 (Carbamoyl-phosphate synthetase I, CPSase I)" CPS1 Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; nitrogen compound metabolic process [GO:0006807]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; nitrogen compound metabolic process [GO:0006807]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311] GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0006207; GO:0006541; GO:0006807; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0032094; GO:0032496; GO:0032991; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877] APMFSWPRLRDADPILR 0.99259 -14.963 0 0 0 0 10.1486 0 0 14.1007 0 11.9063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6075 0 0 0 0 0 0 12.0063 0 0 13.2314 0 0 0 0 0 0 11.3972 0 0 0 0 0 0 18.1649 0 0 0 0 14.4438 0 0 0 0 0 0 0 14.2281 0 0 0 0 0 0 0 0 0 0 0 0 13.2784 0 13.7404 13.1317 12.899 0 0 0 0 13.4422 0 0 13.6241 0 0 0 0 0 0 0 0 0 11.8068 0 0 0 0 0 0 0 0 0 0 0 14.6316 0 0 0 11.503 12.8471 13.7789 0 0 0 0 0 0 0 9.95767 13.1884 0 0 0 0 0 0 0 0 0 0 14.7485 0 11.1992 12.0321 13.0209 14.5672 0 0 11.8117 0 0 0 0 0 0 13.0698 0 0 0 11.6723 11.5519 11.6913 0 0 0 0 0 0 0 0 P41221 WNT5A_HUMAN Protein Wnt-5a WNT5A Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] "cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]; activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]" GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003283; GO:0003323; GO:0003402; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006468; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008104; GO:0008543; GO:0008584; GO:0008595; GO:0009986; GO:0010033; GO:0010463; GO:0010595; GO:0010628; GO:0010631; GO:0010800; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030509; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032092; GO:0032148; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0033138; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0038031; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043507; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048846; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051092; GO:0051216; GO:0051885; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060775; GO:0060809; GO:0060907; GO:0061036; GO:0061347; GO:0061348; GO:0061349; GO:0061350; GO:0061354; GO:0062009; GO:0070062; GO:0070242; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090037; GO:0090082; GO:0090090; GO:0090103; GO:0090179; GO:0090630; GO:0097325; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:0099566; GO:0140013; GO:0150012; GO:1900020; GO:1901216; GO:1902035; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904938; GO:1904953; GO:1904955; GO:2000049; GO:2000052 chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115] CHCKFHWCCYVK 0.99259 -4.4651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54198 HIRA_HUMAN Protein HIRA (TUP1-like enhancer of split protein 1) HIRA DGCR1 HIR TUPLE1 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; DNA replication-independent chromatin assembly [GO:0006336]; gastrulation [GO:0007369]; muscle cell differentiation [GO:0042692]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; extracellular exosome [GO:0070062]; HIR complex [GO:0000417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; extracellular exosome [GO:0070062]; HIR complex [GO:0000417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; anatomical structure morphogenesis [GO:0009653]; DNA replication-independent chromatin assembly [GO:0006336]; gastrulation [GO:0007369]; muscle cell differentiation [GO:0042692]; osteoblast differentiation [GO:0001649]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" GO:0000417; GO:0000785; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0006336; GO:0006351; GO:0006357; GO:0007369; GO:0009653; GO:0016605; GO:0032991; GO:0042393; GO:0042692; GO:0061629; GO:0070062 histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] ELLKELLPVIGQNLR 0.99259 -17.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0271 0 11.7912 0 0 10.0612 0 11.7757 0 0 0 0 0 0 0 0 0 0 0 10.5559 10.8103 0 0 0 0 10.1459 10.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1178 13.1114 0 12.3327 12.2787 0 0 0 12.1671 13.2795 10.7489 12.5558 11.7524 0 11.5158 0 12.3697 0 17.1672 0 17.0926 0 0 16.6399 12.5968 0 0 0 0 12.8005 0 0 0 9.29614 0 11.1916 12.6744 12.4644 0 0 10.4239 13.4805 0 0 0 0 0 0 0 0 13.246 0 16.8716 0 0 0 10.4556 0 12.1434 0 0 0 16.9969 0 0 0 0 0 12.3424 17.8709 0 0 0 0 11.7669 0 11.8214 0 11.1466 0 0 0 0 15.6972 0 11.6394 0 0 13.1704 0 0 11.6181 0 0 0 0 12.3942 0 0 0 13.2193 13.1011 0 0 0 13.8938 12.6792 16.7239 0 0 0 0 0 0 Q13428 TCOF_HUMAN Treacle protein (Treacher Collins syndrome protein) TCOF1 Homo sapiens (Human) neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of translation [GO:0006417]; skeletal system development [GO:0001501] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of translation [GO:0006417]; skeletal system development [GO:0001501] GO:0001501; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006417; GO:0014029; GO:0014032; GO:0030674; GO:0042790; GO:0046982; GO:0097110 protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110] AALAPAK 0.99259 -17.126 0 0 13.4665 0 0 0 0 0 13.0279 0 0 14.1232 0 0 14.0162 0 12.8454 0 0 11.9649 12.6572 0 0 0 0 13.6597 13.7864 13.234 0 14.0534 0 0 10.7714 0 0 0 16.8117 0 0 13.4059 13.2457 0 0 0 0 0 12.8414 0 0 10.9963 0 0 10.3456 0 0 0 0 0 0 0 0 0 0 0 0 10.0119 13.9022 12.2618 0 0 12.7384 0 14.1961 0 15.1598 12.9561 13.1089 13.5364 12.9882 12.9151 12.2574 14.0738 0 0 0 14.9815 10.5414 13.228 13.7209 0 13.2229 14.2761 14.7608 0 14.0989 0 0 11.8769 0 0 0 14.1702 15.8397 12.4055 14.4387 14.0831 14.011 13.4645 14.4391 14.5621 13.5042 0 0 0 0 13.5425 0 13.571 14.703 16.1754 14.3735 15.4113 13.4795 0 14.8164 14.8617 12.9652 0 14.0509 0 14.3385 13.1387 0 13.2252 15.1577 13.5349 14.6991 15.2943 0 15.1238 14.4416 14.617 12.8273 14.0432 0 0 13.1397 16.1598 0 0 14.2456 13.3394 0 12.9921 0 15.2429 16.6873 14.9215 0 0 0 0 13.9601 11.5945 0 0 13.3039 14.3288 0 0 0 14.5498 12.9968 13.098 14.8413 0 0 14.188 0 14.4898 Q13972 RGRF1_HUMAN "Ras-specific guanine nucleotide-releasing factor 1, Ras-GRF1 (Guanine nucleotide-releasing protein, GNRP) (Ras-specific nucleotide exchange factor CDC25)" RASGRF1 CDC25 GNRP GRF1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; long-term memory [GO:0007616]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; long-term memory [GO:0007616]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rac protein signal transduction [GO:0035020]; regulation of Ras protein signal transduction [GO:0046578]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342] GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035020; GO:0035023; GO:0035254; GO:0043005; GO:0043547; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168; GO:0090630; GO:2000310 glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085] FSKTMNSCKVLQIR 0.99259 -24.338 0 0 0 0 11.1715 0 10.7689 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2771 11.0935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0326 0 0 0 0 13.9309 0 0 0 0 0 0 0 0 0 0 0 0 13.9889 10.5573 0 0 0 0 14.5444 11.71 0 0 0 14.3853 0 0 0 11.5811 0 0 0 0 0 11.494 0 13.9464 14.6072 0 0 0 0 0 0 11.8455 0 0 0 0 0 0 14.2721 0 0 11.4084 0 13.1702 12.6598 0 0 14.8494 0 11.8407 0 0 0 0 0 13.7704 0 0 0 0 0 13.9941 0 0 12.4335 0 13.5016 0 0 0 0 0 0 0 0 0 0 0 0 12.2942 12.6973 11.8622 0 11.9565 0 0 12.1715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4331 11.833 0 0 0 12.9335 0 0 Q49MG5 MAP9_HUMAN Microtubule-associated protein 9 (Aster-associated protein) MAP9 ASAP Homo sapiens (Human) mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle organization [GO:0060236] astral microtubule [GO:0000235]; axon [GO:0030424]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; spindle midzone [GO:0051233] astral microtubule [GO:0000235]; axon [GO:0030424]; cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; mitotic spindle midzone [GO:1990023]; spindle midzone [GO:0051233]; microtubule binding [GO:0008017]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic cytokinesis [GO:1902412]; regulation of mitotic spindle organization [GO:0060236] GO:0000235; GO:0000281; GO:0005737; GO:0008017; GO:0030424; GO:0046602; GO:0051233; GO:0060236; GO:0072686; GO:0090307; GO:1902412; GO:1990023 microtubule binding [GO:0008017] LEEKNKK 0.99259 -6.0922 0 0 0 0 0 0 0 0 0 0 16.6605 0 0 0 16.4535 0 0 16.4832 0 0 0 0 0 0 0 0 0 0 0 0 16.3056 0 16.2835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6741 0 15.6924 0 13.2207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0129 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9783 0 0 0 0 0 0 0 0 13.3187 0 0 0 0 0 0 13.6573 0 0 13.4848 19.2337 0 0 0 0 0 0 0 0 0 12.8325 0 0 0 0 0 0 0 0 0 18.9631 0 0 0 18.8577 0 0 0 0 0 0 0 0 0 0 0 0 13.0379 14.2038 0 0 18.8898 18.8164 0 Q5THR3 EFCB6_HUMAN "EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein, DJBP)" EFCAB6 DJBP KIAA1672 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509] GO:0005509; GO:0005654 calcium ion binding [GO:0005509] DPYSAFFK 0.99259 -25.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.431 12.1555 11.7628 0 0 0 0 0 13.3783 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4199 0 0 0 0 0 0 0 0 0 0 0 0 12.0992 0 0 0 0 0 0 0 13.7294 0 0 0 0 0 12.6288 0 0 0 0 0 0 0 0 13.6141 13.23 16.2299 0 15.4387 0 0 0 0 0 0 0 13.7099 0 16.6796 12.9629 0 0 0 13.9446 0 0 0 0 0 0 13.7598 0 0 0 0 11.7167 0 0 0 0 0 0 13.6338 13.9622 0 13.2145 0 0 0 Q6ZNC4 ZN704_HUMAN Zinc finger protein 704 ZNF704 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] CLWKNCGK 0.99259 -14.922 0 0 0 0 0 0 0 0 0 0 10.6844 0 11.4545 10.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3878 0 11.6154 0 0 0 0 0 0 0 0 10.7736 11.3049 0 0 0 10.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8555 0 0 0 0 0 0 11.0786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7587 12.6788 0 0 12.3755 0 0 0 0 0 12.2376 0 0 0 11.2133 0 0 0 0 0 0 0 0 0 Q8IV61 GRP3_HUMAN Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1) RASGRP3 GRP3 KIAA0846 Homo sapiens (Human) MAPK cascade [GO:0000165]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267]; MAPK cascade [GO:0000165]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] GO:0000165; GO:0005085; GO:0005096; GO:0005509; GO:0005886; GO:0005887; GO:0007264; GO:0007265; GO:0019900; GO:0019992; GO:0031267; GO:0032045; GO:0043547; GO:0048471 calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; small GTPase binding [GO:0031267] AEVITKFINVAK 0.99259 -6.089 0 10.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9248 12.4245 13.6565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8063 0 0 14.1669 0 15.6017 13.4078 0 0 0 0 0 0 0 0 13.3295 0 0 0 15.0031 13.9028 0 0 0 12.7247 13.9784 14.0259 0 13.7972 17.0173 13.7536 0 12.1349 0 13.0823 13.3399 15.8674 0 13.3322 12.2417 0 12.4412 0 0 0 13.5196 0 0 13.8274 16.0988 14.8858 13.6853 11.3246 12.9341 10.8394 0 0 0 0 14.3851 0 0 12.079 0 0 0 0 12.5065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3069 0 0 0 0 12.7383 13.4805 0 13.448 15.8209 0 14.82 0 Q8IYS4 DAAF8_HUMAN Dynein axonemal assembly factor 8 (Dynein axonemal-associated protein 1) DNAAF8 C16orf71 DAAP1 Homo sapiens (Human) outer dynein arm assembly [GO:0036158] dynein axonemal particle [GO:0120293] dynein axonemal particle [GO:0120293]; dynein complex binding [GO:0070840]; outer dynein arm assembly [GO:0036158] GO:0036158; GO:0070840; GO:0120293 dynein complex binding [GO:0070840] ASACARK 0.99259 -14.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4175 0 0 0 0 0 0 0 14.4488 0 0 0 0 12.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.151 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A35 RM24_HUMAN "39S ribosomal protein L24, mitochondrial, L24mt, MRP-L24 (Mitochondrial large ribosomal subunit protein uL24m)" MRPL24 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] KPTEIEWR 0.99259 -14.919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9439 0 0 0 0 0 0 0 0 Q9BZ67 FRMD8_HUMAN "FERM domain-containing protein 8 (Band4.1 inhibitor LRP interactor, Bili) (iRhom tail-associated protein, iTAP)" FRMD8 FKSG44 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of tumor necrosis factor production [GO:0032760]; protein localization to plasma membrane [GO:0072659] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of tumor necrosis factor production [GO:0032760]; protein localization to plasma membrane [GO:0072659] GO:0005654; GO:0005829; GO:0005886; GO:0032760; GO:0034451; GO:0072659; GO:0090090 MDGTEGSAGQPGPAERSHR 0.99259 -14.622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9794 0 0 0 0 0 0 0 13.363 0 0 0 14.1173 0 0 12.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y696 CLIC4_HUMAN Chloride intracellular channel protein 4 (Intracellular chloride ion channel protein p64H1) CLIC4 Homo sapiens (Human) angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; chloride transport [GO:0006821]; endothelial cell morphogenesis [GO:0001886]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; fertilization [GO:0009566]; keratinocyte differentiation [GO:0030216]; multicellular organism growth [GO:0035264]; negative regulation of cell migration [GO:0030336]; regulation of cytoskeleton organization [GO:0051493]; regulation of ion transmembrane transport [GO:0034765]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuolar acidification [GO:0007035] actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microvillus [GO:0005902]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microvillus [GO:0005902]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; chloride transport [GO:0006821]; endothelial cell morphogenesis [GO:0001886]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; fertilization [GO:0009566]; keratinocyte differentiation [GO:0030216]; multicellular organism growth [GO:0035264]; negative regulation of cell migration [GO:0030336]; regulation of cytoskeleton organization [GO:0051493]; regulation of ion transmembrane transport [GO:0034765]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuolar acidification [GO:0007035] GO:0001525; GO:0001886; GO:0005244; GO:0005254; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005902; GO:0005911; GO:0006821; GO:0007035; GO:0009566; GO:0009986; GO:0015629; GO:0016020; GO:0016363; GO:0030154; GO:0030216; GO:0030336; GO:0030496; GO:0030659; GO:0034707; GO:0034765; GO:0035088; GO:0035264; GO:0045177; GO:0048471; GO:0048754; GO:0051493; GO:0061299; GO:0070062; GO:0071277 chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244] DEFTNTCPSDK 0.99259 -5.1059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K8P3 SFI1_HUMAN "Protein SFI1 homolog, hSFI1" SFI1 KIAA0542 Homo sapiens (Human) centriole [GO:0005814]; cytosol [GO:0005829] centriole [GO:0005814]; cytosol [GO:0005829]; phosphatase binding [GO:0019902] GO:0005814; GO:0005829; GO:0019902 phosphatase binding [GO:0019902] AAEFHMAQLLRWAWSQWRECLALR 0.9926 -25.352 0 11.8052 12.4855 0 0 0 0 0 11.7361 14.6309 0 11.604 0 13.3065 0 14.1911 16.025 0 0 13.3712 0 0 0 0 0 0 0 11.3421 0 0 0 0 0 0 0 13.3157 0 0 0 0 0 13.5137 0 0 13.2169 12.4496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6375 0 0 14.389 0 14.9311 14.6439 0 16.2794 13.4389 0 0 0 12.7299 0 0 0 0 13.1152 12.5881 13.2604 0 12.5865 12.8249 0 14.1102 0 12.6144 0 12.9633 0 0 14.2779 0 15.1099 15.6898 0 0 14.2193 13.7686 16.1422 0 0 0 0 0 0 15.5753 15.3238 15.9176 14.7397 0 16.1128 15.0557 14.3021 0 0 14.9381 12.9208 13.8493 14.0599 0 13.1189 0 0 0 12.2842 0 13.2116 0 0 0 14.2147 13.2906 10.5212 14.8772 0 0 0 0 0 13.4067 13.8487 0 14.9765 15.4267 0 0 14.352 0 0 0 11.5663 0 13.5537 12.6012 13.3761 0 0 0 0 14.0608 16.8027 0 16.4945 0 0 0 0 0 O75110 ATP9A_HUMAN "Probable phospholipid-transporting ATPase IIA, EC 7.6.2.1 (ATPase class II type 9A)" ATP9A ATPIIA KIAA0611 Homo sapiens (Human) "endocytosis [GO:0006897]; negative regulation of exosomal secretion [GO:1903542]; phospholipid translocation [GO:0045332]; regulation of endocytic recycling [GO:2001135]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; endocytosis [GO:0006897]; negative regulation of exosomal secretion [GO:1903542]; phospholipid translocation [GO:0045332]; regulation of endocytic recycling [GO:2001135]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000287; GO:0002020; GO:0005524; GO:0005768; GO:0005769; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0016887; GO:0031901; GO:0032588; GO:0045332; GO:0048471; GO:0055037; GO:0055038; GO:0140326; GO:1903542; GO:1905279; GO:2001135 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020] AGCCEWLRCCGGGEARPR 0.9926 -17.71 0 0 10.8508 0 0 0 0 0 0 0 0 0 0 12.527 11.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8818 12.5765 0 0 0 0 0 11.8373 13.6672 0 0 0 0 0 13.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7359 0 0 0 13.233 0 0 10.8887 0 13.0458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9352 0 0 0 0 0 0 10.5693 0 0 0 0 0 0 0 0 0 0 P27658 CO8A1_HUMAN Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin ] COL8A1 C3orf7 Homo sapiens (Human) angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] collagen type VIII trimer [GO:0005591]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type VIII trimer [GO:0005591]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0001525; GO:0005201; GO:0005576; GO:0005591; GO:0005615; GO:0005788; GO:0007155; GO:0010811; GO:0030198; GO:0031012; GO:0035987; GO:0048593; GO:0050673; GO:0062023 extracellular matrix structural constituent [GO:0005201] AVLPGPLQLLGVLLTISLSSIR 0.9926 -15.005 11.6374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8252 0 0 0 11.6834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3201 0 0 0 10.9259 0 0 0 13.1857 13.7845 0 0 0 0 0 0 0 0 0 0 0 0 13.8254 0 0 0 0 0 0 0 14.6719 0 0 0 0 0 13.531 0 13.913 13.6822 0 13.7361 0 14.1259 0 14.188 0 13.6868 0 0 0 0 0 0 13.9366 13.5433 0 0 0 0 13.9915 13.7994 12.9556 0 0 0 0 13.8772 11.0828 14.7902 14.7983 0 14.0026 14.066 14.0904 13.7228 13.6357 0 0 13.7468 0 0 12.2872 13.7631 10.7199 0 0 0 0 10.6159 0 0 0 0 0 0 11.7731 0 0 0 0 0 0 15.5966 0 13.9389 0 14.8564 0 0 0 0 0 P59090 TSAS2_HUMAN Putative uncharacterized protein TSPEAR-AS2 (TSPEAR antisense RNA 2) (TSPEAR antisense gene protein 2) TSPEAR-AS2 C21orf90 Homo sapiens (Human) GNPRLPRLLCALK 0.9926 -4.9671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13616 CUL1_HUMAN "Cullin-1, CUL-1" CUL1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000082; GO:0005654; GO:0005829; GO:0005886; GO:0006513; GO:0008283; GO:0009887; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031625; GO:0070936; GO:0097193; GO:1990452 protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] DLNEQFKK 0.9926 -60.992 0 0 0 11.5372 0 0 0 0 0 0 0 0 0 0 12.7547 0 12.3128 0 0 0 0 0 0 0 0 0 0 0 0 12.5589 0 11.6174 0 0 0 0 12.3943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1183 0 0 0 0 0 0 0 0 13.207 14.0229 10.5635 0 0 0 0 11.4224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.849 0 12.48 12.6872 0 0 0 0 0 0 0 14.8625 0 0 13.2326 0 0 0 0 0 0 0 0 0 12.9474 0 0 0 13.1395 12.9471 12.9419 12.9429 11.5339 15.4716 0 0 11.7717 0 0 0 0 0 0 0 0 11.0893 0 Q14683 SMC1A_HUMAN "Structural maintenance of chromosomes protein 1A, SMC protein 1A, SMC-1-alpha, SMC-1A (Sb1.8)" SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1 Homo sapiens (Human) cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; somatic stem cell population maintenance [GO:0035019] "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; somatic stem cell population maintenance [GO:0035019]" GO:0000070; GO:0000775; GO:0000776; GO:0000794; GO:0003677; GO:0003682; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0009314; GO:0016363; GO:0016887; GO:0030893; GO:0034089; GO:0034991; GO:0035019; GO:0036033; GO:0046982; GO:0051301; GO:0051321; GO:0072423; GO:0090307; GO:0097431 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] AFVSMVYSEEGAEDR 0.9926 -60.084 0 0 0 0 0 0 0 0 13.9145 12.8739 12.7949 13.0307 0 0 0 0 0 0 0 0 0 0 0 11.7398 0 0 13.0448 13.0681 0 13.5462 0 0 0 13.9561 0 0 0 0 0 0 0 0 0 13.3875 0 0 0 0 0 0 0 0 0 13.4538 13.2622 12.5788 0 0 0 0 0 0 0 0 17.0478 10.775 0 0 0 0 0 15.0719 0 0 11.5215 0 12.4308 11.4733 14.4622 14.8459 0 14.1348 10.6709 0 0 10.3826 15.3447 15.3077 14.2533 10.7323 14.2492 15.6017 13.238 14.2839 14.6875 0 0 0 14.061 11.6604 13.361 13.9802 14.5661 0 14.6213 15.3215 13.4051 12.5416 12.7524 12.5825 0 0 14.0157 13.7933 16.7944 14.5948 0 13.107 15.9187 13.6051 0 0 0 14.2975 12.9317 13.2262 14.1458 12.9103 13.6104 12.4578 13.2153 12.8401 0 0 13.4157 16.4161 0 0 15.4306 0 12.4251 0 0 0 0 0 0 0 0 0 0 0 13.5444 14.8682 13.6981 15.2866 12.3759 0 14.2932 14.1332 0 0 14.436 0 14.1683 0 0 14.6481 0 0 14.3028 11.0879 0 0 13.6334 0 0 13.9514 0 0 Q15835 GRK1_HUMAN "Rhodopsin kinase GRK1, RK, EC 2.7.11.14 (G protein-coupled receptor kinase 1)" GRK1 RHOK Homo sapiens (Human) protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; rhodopsin mediated signaling pathway [GO:0016056]; visual perception [GO:0007601] cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381] cytoplasm [GO:0005737]; photoreceptor disc membrane [GO:0097381]; ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; regulation of signal transduction [GO:0009966]; rhodopsin mediated signaling pathway [GO:0016056]; visual perception [GO:0007601] GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0006468; GO:0007601; GO:0008277; GO:0009966; GO:0016056; GO:0022400; GO:0046777; GO:0050254; GO:0097381 ATP binding [GO:0005524]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; rhodopsin kinase activity [GO:0050254] ALFYTAQIICGLEHLHQRRIVYR 0.9926 -25.334 0 0 10.1085 0 0 0 0 0 0 0 0 10.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4132 0 0 0 0 0 13.0574 0 0 0 15.0258 9.94696 0 0 0 0 9.81266 13.1927 0 0 13.2658 13.9113 0 12.9812 0 12.5405 0 0 0 0 0 0 0 14.5452 15.6256 0 0 0 0 0 0 0 0 0 0 0 0 13.3734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8691 0 0 0 0 0 0 0 12.5098 0 0 0 0 0 13.9575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3414 0 0 0 12.7902 0 0 14.2191 0 0 0 Q16627 CCL14_HUMAN "C-C motif chemokine 14 (Chemokine CC-1/CC-3, HCC-1/HCC-3) (HCC-1(1-74)) (NCC-2) (Small-inducible cytokine A14) [Cleaved into: HCC-1(3-74); HCC-1(4-74); HCC-1(9-74) ]" CCL14 NCC2 SCYA14 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] extracellular space [GO:0005615] extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547] GO:0002548; GO:0005615; GO:0006874; GO:0006954; GO:0007186; GO:0008009; GO:0008284; GO:0030593; GO:0043547; GO:0048020; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009] KISVAAIPFFLLITIALGTK 0.9926 -4.9578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.68506 0 0 0 10.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7454 0 0 0 0 0 0 0 14.5396 0 0 0 0 0 0 0 10.9186 0 0 0 0 12.6651 0 0 0 0 0 0 12.3453 0 0 10.4073 0 0 0 0 0 0 11.1248 0 0 0 0 0 0 0 0 0 0 0 0 14.9228 0 0 0 0 9.57924 0 0 0 0 0 0 0 0 0 10.958 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1152 0 0 0 0 0 0 0 0 10.8643 0 Q70HW3 SAMC_HUMAN S-adenosylmethionine mitochondrial carrier protein (Mitochondrial S-adenosylmethionine transporter) (Solute carrier family 25 member 26) SLC25A26 SAMC Homo sapiens (Human) ion transport [GO:0006811]; S-adenosyl-L-methionine transport [GO:0015805] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095]; ion transport [GO:0006811]; S-adenosyl-L-methionine transport [GO:0015805] GO:0000095; GO:0005739; GO:0005743; GO:0006811; GO:0015805; GO:0016021 S-adenosyl-L-methionine transmembrane transporter activity [GO:0000095] AQVSASTR 0.9926 -17.71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2557 0 13.5558 12.9441 0 13.0712 0 0 0 13.3599 0 0 0 0 13.0258 0 0 0 0 0 0 0 0 12.755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3884 13.737 13.3078 13.1374 0 0 0 0 12.6052 0 0 13.3294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2334 0 13.7875 0 0 0 0 0 0 Q8NDB2 BANK1_HUMAN B-cell scaffold protein with ankyrin repeats BANK1 Homo sapiens (Human) B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; MAPK cascade [GO:0000165]; negative regulation of B cell activation [GO:0050869]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translational initiation [GO:0045947]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase B signaling [GO:0043491]; response to bacterium [GO:0009617] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; phospholipase binding [GO:0043274]; protease binding [GO:0002020]; protein tyrosine kinase binding [GO:1990782]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; MAPK cascade [GO:0000165]; negative regulation of B cell activation [GO:0050869]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of translational initiation [GO:0045947]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase B signaling [GO:0043491]; response to bacterium [GO:0009617] GO:0000165; GO:0002020; GO:0005102; GO:0009617; GO:0032715; GO:0035591; GO:0042113; GO:0043274; GO:0043410; GO:0043491; GO:0045947; GO:0048471; GO:0050731; GO:0050853; GO:0050869; GO:0051898; GO:1990782 phospholipase binding [GO:0043274]; protease binding [GO:0002020]; protein tyrosine kinase binding [GO:1990782]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102] CKLLILSNSLLRDLTPK 0.9926 -25.338 0 12.8659 0 0 0 0 0 0 12.3435 12.1017 0 0 13.2376 12.1548 0 14.6353 13.6281 0 12.7767 0 13.0901 10.3468 13.9048 0 0 14.712 0 13.0949 12.7497 12.9612 0 15.2134 0 11.9466 0 12.007 14.641 0 12.0312 0 0 0 12.7441 11.745 13.527 12.534 0 0 0 0 0 0 0 12.8344 11.1819 0 13.3156 13.7101 11.7027 0 13.169 13.7878 0 12.9638 0 0 0 14.5895 0 14.1815 11.6545 0 0 0 0 0 0 0 14.1943 12.9472 12.0839 13.6201 14.783 13.0783 0 0 13.5341 16.3345 15.169 16.2192 14.6182 15.2221 14.5856 15.5892 16.3031 15.3249 14.5931 11.2579 12.572 0 16.4463 13.7626 14.3857 15.4517 14.958 14.0797 14.3537 0 0 0 0 15.7568 16.1393 15.8524 14.8115 13.0713 13.3701 14.4163 0 15.3492 15.4429 14.6032 15.06 15.0323 15.622 15.3039 0 14.6787 11.9332 14.6178 0 15.1564 0 0 14.6936 0 13.7071 12.6304 14.032 15.0684 0 0 0 13.6528 0 0 0 13.9011 0 0 0 0 0 12.6119 16.3011 16.0374 0 16.5468 0 0 14.801 14.0038 12.8574 14.939 12.9999 15.3983 14.3619 15.7368 14.6509 13.0119 12.6026 12.1633 12.768 0 11.4525 15.1296 0 15.4229 0 0 Q8TF72 SHRM3_HUMAN "Protein Shroom3 (Shroom-related protein, hShrmL)" SHROOM3 KIAA1481 SHRML MSTP013 Homo sapiens (Human) actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360] GO:0000902; GO:0001843; GO:0002064; GO:0005856; GO:0005874; GO:0005912; GO:0007015; GO:0007389; GO:0008360; GO:0016324; GO:0030864; GO:0043296; GO:0043482; GO:0045176; GO:0051015 actin filament binding [GO:0051015] AAWSGGVK 0.9926 -61.19 0 0 0 0 0 0 0 0 12.4074 11.2383 9.77842 0 12.7502 11.3634 0 0 0 12.6354 0 0 0 0 12.1349 0 12.2973 0 0 0 12.2352 0 0 0 0 0 0 0 0 0 0 0 0 12.6109 0 0 0 0 0 0 0 11.9677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2522 13.7788 0 0 10.4699 0 0 0 0 0 0 0 12.9089 0 0 15.6425 0 0 0 0 0 0 0 0 0 13.0548 0 0 0 14.347 0 0 12.8232 0 0 14.1867 14.0833 0 0 0 0 0 0 12.5532 13.6358 0 0 0 0 0 11.8349 0 0 0 0 0 13.6374 12.8954 0 0 0 0 0 0 0 0 0 0 0 14.0428 0 14.4349 0 13.1968 0 0 0 0 0 0 11.377 0 13.0645 0 0 13.9032 13.9276 0 0 0 0 14.9263 0 0 11.3609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5119 0 0 Q9BZE1 RM37_HUMAN "39S ribosomal protein L37, mitochondrial, L37mt, MRP-L37 (39S ribosomal protein L2, mitochondrial, L2mt, MRP-L2) (Mitochondrial large ribosomal subunit protein mL37)" MRPL37 MRPL2 RPML2 HSPC235 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] DQACYIFHHR 0.9926 -6.2689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9127 0 0 0 12.1496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1P3 OSBL2_HUMAN "Oxysterol-binding protein-related protein 2, ORP-2, OSBP-related protein 2" OSBPL2 KIAA0772 ORP2 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020] "cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]" GO:0005546; GO:0005811; GO:0005829; GO:0006699; GO:0007009; GO:0008526; GO:0015248; GO:0015485; GO:0015914; GO:0016020; GO:0030301; GO:0031234; GO:0032367; GO:0032934; GO:0043231; GO:0051289; GO:0120020 "cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]" AKEEAEWQTR 0.9926 -4.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWL6 ASND1_HUMAN Asparagine synthetase domain-containing protein 1 (HCV NS3-transactivated protein 1) ASNSD1 NS3TP1 Nbla00058 Homo sapiens (Human) asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541] asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; asparagine biosynthetic process [GO:0006529]; glutamine metabolic process [GO:0006541] GO:0004066; GO:0006529; GO:0006541 asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066] HVSVPDR 0.9926 -25.395 0 0 0 0 0 0 0 0 0 0 0 13.4984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6917 12.5436 13.5637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5168 0 0 0 0 0 10.7768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8052 0 0 0 0 0 0 0 0 13.6941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.224 0 0 0 0 0 0 0 0 0 13.5749 0 0 0 0 0 0 12.7597 0 0 0 0 0 0 17.3501 0 0 0 0 0 0 0 0 0 0 0 13.1464 13.2731 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHC3 ASIC3_HUMAN "Acid-sensing ion channel 3, ASIC3, hASIC3 (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1, hTNaC1)" ASIC3 ACCN3 SLNAC1 TNAC1 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; establishment of localization in cell [GO:0051649]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; sensory perception [GO:0007600]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725] integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; acid-sensing ion channel activity [GO:0044736]; cation channel activity [GO:0005261]; enterobactin transmembrane transporter activity [GO:0042931]; ligand-gated sodium channel activity [GO:0015280]; sodium channel activity [GO:0005272]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; establishment of localization in cell [GO:0051649]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; sensory perception [GO:0007600]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725] GO:0005261; GO:0005272; GO:0005886; GO:0005887; GO:0007165; GO:0007600; GO:0009408; GO:0010447; GO:0015280; GO:0035725; GO:0042931; GO:0044736; GO:0048471; GO:0050915; GO:0050965; GO:0050966; GO:0050968; GO:0051649 acid-sensing ion channel activity [GO:0044736]; cation channel activity [GO:0005261]; enterobactin transmembrane transporter activity [GO:0042931]; ligand-gated sodium channel activity [GO:0015280]; sodium channel activity [GO:0005272] DSCACPNPCASTR 0.9926 -17.706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0429 0 0 0 0 14.2787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8028 0 0 0 0 0 0 0 0 0 12.3499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2223 0 0 0 0 0 12.5006 0 0 0 0 0 0 0 0 Q9UMZ3 PTPRQ_HUMAN "Phosphatidylinositol phosphatase PTPRQ, EC 3.1.3.- (Receptor-type tyrosine-protein phosphatase Q, PTP-RQ, R-PTP-Q, EC 3.1.3.48)" PTPRQ Homo sapiens (Human) peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598] integral component of membrane [GO:0016021]; receptor complex [GO:0043235] integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of fat cell differentiation [GO:0045598] GO:0004725; GO:0016021; GO:0043235; GO:0045598; GO:1990264 protein tyrosine phosphatase activity [GO:0004725] AEDQTSPVVTTR 0.9926 -15.005 0 0 0 0 0 0 0 0 12.5046 0 12.9277 0 12.3242 11.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3822 0 12.5959 0 0 0 0 0 0 0 0 0 0 0 11.8869 0 0 11.7275 0 0 0 0 0 13.832 13.6979 0 0 10.3018 11.1832 0 0 0 0 0 0 0 0 0 0 12.2942 0 0 0 13.9679 0 0 0 0 0 0 0 13.8062 0 0 0 13.9345 14.7326 0 13.7932 0 0 0 0 0 14.1525 0 13.9683 0 0 0 0 0 13.2485 0 13.4881 11.2508 0 0 0 0 0 0 0 13.5612 15.423 12.026 12.6551 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0472 0 0 0 12.7427 0 0 12.4075 0 0 14.4902 0 11.2743 0 0 0 0 15.0635 15.2932 0 0 12.206 13.3009 0 0 12.0916 0 9.0219 0 0 0 0 0 0 0 0 0 0 0 12.2647 0 0 0 0 13.8595 0 11.9496 11.4814 0 9.95439 10.7783 0 0 Q9UPU9 SMAG1_HUMAN "Protein Smaug homolog 1, Smaug 1, hSmaug1 (Sterile alpha motif domain-containing protein 4A, SAM domain-containing protein 4A)" SAMD4A KIAA1053 SAMD4 SMAUG1 Homo sapiens (Human) nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of translation [GO:0045727] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; P-body [GO:0000932]; synapse [GO:0045202] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; P-body [GO:0000932]; synapse [GO:0045202]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of translation [GO:0045727] GO:0000289; GO:0000932; GO:0001650; GO:0003723; GO:0003729; GO:0005829; GO:0030054; GO:0030371; GO:0030425; GO:0045202; GO:0045727; GO:0070161 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371] DKVISLLLTHLPLLK 0.9926 -15.018 0 0 0 0 11.1913 0 0 0 14.1618 0 0 0 0 0 0 0 13.1271 0 0 0 0 0 0 0 0 15.1061 0 12.7113 0 0 13.8946 0 0 0 0 0 0 13.3511 0 13.665 0 13.0326 0 0 12.5363 13.2017 0 0 0 0 0 0 9.91601 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7013 15.1688 14.015 13.9943 0 0 0 11.6015 0 0 0 0 12.1863 0 0 14.5351 13.0387 13.6323 10.2739 0 0 0 0 0 0 0 0 14.6147 14.0051 0 0 0 17.2265 0 0 0 0 0 0 12.5276 0 0 0 0 0 0 0 12.1209 0 12.4719 0 0 11.5741 0 0 0 0 0 0 0 14.0482 16.5212 0 0 0 0 0 11.8925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9833 0 0 0 0 0 0 12.6961 0 12.8743 0 14.096 0 0 0 0 11.2068 0 0 0 12.2475 0 0 15.3658 10.9625 P49792 RBP2_HUMAN "E3 SUMO-protein ligase RanBP2, EC 2.3.2.- (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2, RanBP2) (p270)" RANBP2 NUP358 Homo sapiens (Human) centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; positive regulation of glucokinase activity [GO:0033133]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; positive regulation of glucokinase activity [GO:0033133]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111] GO:0000413; GO:0003723; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0016020; GO:0016925; GO:0019789; GO:0031267; GO:0031965; GO:0033133; GO:0042405; GO:0043231; GO:0044614; GO:0044615; GO:0046872; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789] AAKLFPGSPAIYKLK 0.99261 -40.323 14.3824 15.4934 15.8348 19.0733 0 0 13.143 15.8249 20.3413 20.2625 19.634 19.5415 20.3272 20.3339 20.3507 18.9155 14.5713 13.8267 11.5378 13.8988 18.9289 13.3005 14.8237 13.973 15.3523 18.8845 14.5304 14.8566 18.9966 18.9421 20.0514 20.3557 20.4813 19.9948 20.3506 20.3694 20.3653 19.5391 19.6859 19.5735 20.0903 20.0903 19.0724 19.0693 14.6298 19.0516 15.0005 19.0279 19.0982 19.1526 19.1169 14.7862 15.4797 15.9795 16.931 15.8412 18.8022 16.275 17.8567 17.8449 15.9599 15.9669 15.7125 16.9983 17.1717 16.274 11.8063 13.6452 14.1122 15.8704 15.2983 16.2173 0 0 11.423 0 13.5339 12.9431 15.1722 16.2738 13.4005 15.0989 16.246 16.0163 14.6575 14.6098 13.4922 15.1448 15.2542 10.8521 12.0732 14.2263 13.6535 16.4952 0 13.5626 14.1829 0 13.2519 13.4053 13.801 13.6404 13.7785 13.6063 14.3735 14.2073 14.4663 14.4476 13.4719 15.2083 14.4838 17.2968 13.7237 13.2103 14.4526 13.9063 16.2446 13.9801 12.3296 15.5609 13.964 12.8013 13.6559 13.8208 14.3877 15.1159 14.9788 14.7954 15.0336 14.5992 13.85 15.0634 12.4272 16.5434 15.6389 0 15.3317 15.2678 13.9871 15.6408 14.9625 13.8571 15.1448 13.9604 0 16.0884 15.5098 17.1391 15.5708 0 12.8232 13.54 15.7449 15.603 14.5183 12.1286 20.0088 20.9142 20.9499 20.796 20.8132 19.7477 19.251 20.3564 19.9882 19.969 18.2447 19.5338 20.4071 17.6878 20.0276 15.2767 13.9557 11.0871 13.4097 17.9041 0 19.4986 19.3877 19.2236 A0A0A0MS14 HV145_HUMAN Immunoglobulin heavy variable 1-45 IGHV1-45 Homo sapiens (Human) "B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]" "external side of plasma membrane [GO:0009897]; immunoglobulin complex, circulating [GO:0042571]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]" GO:0003823; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0034987; GO:0042571; GO:0042742; GO:0045087; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] DRSMSTAYMELSSLRSEDTAMYYCAR 0.99261 -7.3465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2023 0 0 0 0 0 13.4204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.408 0 0 0 0 0 0 10.5584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6158 0 0 0 15.7399 0 0 0 0 0 0 0 0 0 16.6227 0 0 12.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.569 0 0 0 0 0 0 0 0 0 0 0 0 10.7433 0 0 O43280 TREA_HUMAN "Trehalase, EC 3.2.1.28 (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)" TREH TREA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991] anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062] "anchored component of membrane [GO:0031225]; anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; alpha,alpha-trehalase activity [GO:0004555]; animal organ morphogenesis [GO:0009887]; trehalose catabolic process [GO:0005993]; trehalose metabolic process [GO:0005991]" GO:0004555; GO:0005991; GO:0005993; GO:0009887; GO:0031225; GO:0046658; GO:0070062 "alpha,alpha-trehalase activity [GO:0004555]" LAFLEPHCLAATLLPSLLLSLLPW 0.99261 -6.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43795 MYO1B_HUMAN "Unconventional myosin-Ib (MYH-1c) (Myosin I alpha, MMI-alpha, MMIa)" MYO1B Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; post-Golgi vesicle-mediated transport [GO:0006892]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; post-Golgi vesicle-mediated transport [GO:0006892]; vesicle transport along actin filament [GO:0030050]" GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0007015; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030050; GO:0030175; GO:0045177; GO:0045296; GO:0048471; GO:0051015; GO:0051017; GO:0070062; GO:0071944 "actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AGYAFRQAYEPCLERYK 0.99261 -45.314 0 12.443 0 0 0 0 0 0 0 0 0 0 0 12.5023 12.4099 12.219 12.146 12.5954 13.08 0 13.5234 12.1943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2769 0 10.9948 12.1137 12.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4119 0 0 18.2962 0 14.5257 13.1917 13.3299 12.3299 15.6011 0 18.051 18.9707 14.722 12.8515 13.2383 0 0 13.733 13.0124 18.0018 0 0 13.2916 0 13.5044 0 0 0 15.2071 17.4497 17.8341 13.1597 0 12.8394 0 13.1343 13.6069 0 0 14.0145 13.2714 18.5205 10.6936 0 0 0 13.4834 12.7851 12.8562 12.7622 0 13.8424 17.9715 0 12.727 0 12.8715 0 0 14.1529 0 0 14.3707 0 0 14.1751 11.2026 0 0 12.79 0 13.0033 12.679 0 0 0 0 0 12.0739 13.1857 0 0 0 13.0767 0 0 0 0 0 11.2291 0 13.3137 13.6965 0 0 0 12.6342 0 13.2384 0 0 0 0 0 0 0 13.4062 O60293 ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2) ZFC3H1 CCDC131 KIAA0546 PSRC2 Homo sapiens (Human) RNA processing [GO:0006396] exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634] exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA processing [GO:0006396] GO:0000178; GO:0005615; GO:0005634; GO:0006396; GO:0046872 metal ion binding [GO:0046872] ADSLKQLILKTTTGITEK 0.99261 -67.877 0 14.3508 0 13.9817 0 0 0 0 0 0 12.2092 0 0 13.4147 14.2366 0 12.487 12.0812 0 11.9293 0 14.6324 0 0 0 0 13.6515 9.80916 0 0 0 0 0 0 11.807 0 0 0 12.0527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.463 0 14.2524 0 0 0 12.0263 10.4525 0 0 0 0 0 0 0 0 11.5072 0 0 14.808 0 0 0 0 0 0 0 0 0 12.5901 0 0 0 0 0 0 0 0 0 0 14.9076 0 0 0 0 0 13.1826 13.4798 14.5338 13.2549 13.9177 0 0 0 0 14.5087 0 0 0 16.0508 12.6207 12.9921 15.1648 12.3091 0 0 0 0 0 12.6147 0 0 0 0 0 0 13.4857 12.1605 12.8438 0 0 0 0 11.891 13.5658 0 13.731 0 0 0 0 0 0 0 0 0 0 0 0 14.0953 0 0 0 11.8756 12.6428 0 0 14.1801 0 17.2665 0 0 12.3839 0 0 0 0 0 0 0 0 0 14.973 0 O75592 MYCB2_HUMAN "E3 ubiquitin-protein ligase MYCBP2, EC 2.3.2.33 (Myc-binding protein 2) (Protein associated with Myc)" MYCBP2 KIAA0916 PAM Homo sapiens (Human) axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] axon [GO:0030424]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] axon [GO:0030424]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582] GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007411; GO:0008270; GO:0008582; GO:0015630; GO:0016020; GO:0016567; GO:0021785; GO:0021952; GO:0030424; GO:0031267; GO:0031398; GO:0032880; GO:0032922; GO:0042177; GO:0042802; GO:0043231; GO:0050905; GO:0051493; GO:0061630; GO:1902667 guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ACARELDGQEAR 0.99261 -63.815 0 0 0 0 0 0 0 0 13.3261 0 13.2768 12.3778 12.4342 12.033 0 0 0 0 0 12.2765 0 0 0 0 10.6579 11.1321 0 12.0189 0 12.2089 0 0 13.2605 11.8997 12.4072 10.669 12.1755 12.2765 17.084 17.0539 12.0987 13.8418 0 12.5394 0 0 0 13.5565 0 0 0 0 11.9011 0 0 9.59089 16.643 0 0 0 0 0 0 0 0 0 12.8397 0 14.5821 12.4041 15.8736 13.2413 11.944 0 0 0 13.2612 12.8566 0 14.0276 0 15.4137 12.0519 13.9863 0 0 0 14.601 0 0 14.043 17.3104 11.8473 13.3685 0 15.3425 0 11.4581 13.0774 16.7632 16.794 0 0 0 15.8604 0 16.765 16.9081 14.2121 12.6534 0 0 0 14.8286 0 13.4833 0 13.0126 16.4019 12.0486 13.5185 12.4251 12.164 0 0 0 11.2931 11.6889 12.3614 11.8898 0 0 0 13.4815 11.1158 15.9378 12.7274 14.3269 0 0 12.2234 12.9745 0 0 12.8891 11.9663 12.3445 13.2718 0 10.9247 0 0 0 0 0 18.2152 15.0131 12.8891 0 11.6861 12.7321 0 13.8776 15.863 0 13.8461 0 0 0 12.6355 12.0581 13.7497 13.2312 12.8671 0 10.5906 0 0 0 12.1301 P08709 FA7_HUMAN "Coagulation factor VII, EC 3.4.21.21 (Proconvertin) (Serum prothrombin conversion accelerator, SPCA) (Eptacog alfa) [Cleaved into: Factor VII light chain; Factor VII heavy chain ]" F7 Homo sapiens (Human) "activation of blood coagulation via clotting cascade [GO:0002543]; animal organ regeneration [GO:0031100]; blood coagulation [GO:0007596]; blood coagulation, extrinsic pathway [GO:0007598]; blood coagulation, fibrin clot formation [GO:0072378]; blood coagulation, intrinsic pathway [GO:0007597]; circadian rhythm [GO:0007623]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell migration [GO:0030335]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein kinase B signaling [GO:0051897]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; response to anticoagulant [GO:0061476]; response to astaxanthin [GO:1905217]; response to carbon dioxide [GO:0010037]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to genistein [GO:0033595]; response to growth hormone [GO:0060416]; response to hypoxia [GO:0001666]; response to Thyroid stimulating hormone [GO:1904400]; response to thyrotropin-releasing hormone [GO:1905225]; response to thyroxine [GO:0097068]; response to vitamin K [GO:0032571]; response to wounding [GO:0009611]; zymogen activation [GO:0031638]" collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; serine-type peptidase complex [GO:1905286]; vesicle [GO:0031982] "collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; serine-type peptidase complex [GO:1905286]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; activation of blood coagulation via clotting cascade [GO:0002543]; animal organ regeneration [GO:0031100]; blood coagulation [GO:0007596]; blood coagulation, extrinsic pathway [GO:0007598]; blood coagulation, fibrin clot formation [GO:0072378]; blood coagulation, intrinsic pathway [GO:0007597]; circadian rhythm [GO:0007623]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell migration [GO:0030335]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of platelet-derived growth factor receptor signaling pathway [GO:0010641]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein kinase B signaling [GO:0051897]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; response to anticoagulant [GO:0061476]; response to astaxanthin [GO:1905217]; response to carbon dioxide [GO:0010037]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to genistein [GO:0033595]; response to growth hormone [GO:0060416]; response to hypoxia [GO:0001666]; response to Thyroid stimulating hormone [GO:1904400]; response to thyrotropin-releasing hormone [GO:1905225]; response to thyroxine [GO:0097068]; response to vitamin K [GO:0032571]; response to wounding [GO:0009611]; zymogen activation [GO:0031638]" GO:0001666; GO:0002543; GO:0002690; GO:0004252; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0007598; GO:0007623; GO:0008236; GO:0009611; GO:0010037; GO:0010641; GO:0016020; GO:0016485; GO:0030194; GO:0030335; GO:0031100; GO:0031638; GO:0031982; GO:0032355; GO:0032571; GO:0032991; GO:0033595; GO:0043627; GO:0050927; GO:0051897; GO:0060416; GO:0061476; GO:0062023; GO:0070723; GO:0072378; GO:0097068; GO:1904400; GO:1904612; GO:1905217; GO:1905225; GO:1905286; GO:1905370 calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102] DDQLICVNENGGCEQYCSDHTGTKRSCR 0.99261 -4.9808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4171 0 0 0 0 0 0 12.4107 12.2385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7638 0 0 0 0 0 0 0 15.012 19.7583 0 0 0 11.9473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3633 0 0 16.0922 0 0 0 0 0 14.9753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5516 14.4276 14.6852 0 0 0 0 13.001 0 0 0 0 0 0 0 0 0 0 0 13.4451 0 0 0 0 0 11.2236 0 P0DMC3 ELA_HUMAN "Apelin receptor early endogenous ligand (Protein Elabela, ELA) (Protein Toddler)" APELA ELA TDL Homo sapiens (Human) adult heart development [GO:0007512]; angiogenesis [GO:0001525]; apelin receptor signaling pathway [GO:0060183]; cell migration involved in mesendoderm migration [GO:0090134]; coronary vasculature development [GO:0060976]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart development [GO:0007507]; mesendoderm migration [GO:0090133]; mesoderm migration involved in gastrulation [GO:0007509]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of heart contraction [GO:0045823]; positive regulation of trophoblast cell migration [GO:1901165]; vasculogenesis [GO:0001570] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; apelin receptor binding [GO:0031704]; hormone activity [GO:0005179]; adult heart development [GO:0007512]; angiogenesis [GO:0001525]; apelin receptor signaling pathway [GO:0060183]; cell migration involved in mesendoderm migration [GO:0090134]; coronary vasculature development [GO:0060976]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart development [GO:0007507]; mesendoderm migration [GO:0090133]; mesoderm migration involved in gastrulation [GO:0007509]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of heart contraction [GO:0045823]; positive regulation of trophoblast cell migration [GO:1901165]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0005179; GO:0005576; GO:0005615; GO:0007492; GO:0007507; GO:0007509; GO:0007512; GO:0031704; GO:0035050; GO:0045766; GO:0045823; GO:0060183; GO:0060674; GO:0060976; GO:0070374; GO:0090133; GO:0090134; GO:1901165; GO:1903589; GO:1904022 apelin receptor binding [GO:0031704]; hormone activity [GO:0005179] PVNLTMRRK 0.99261 -4.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4964 0 0 0 0 12.0868 0 0 0 0 0 0 0 11.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40939 ECHA_HUMAN "Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase, EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase, EC 4.2.1.17; Long chain 3-hydroxyacyl-CoA dehydrogenase, EC 1.1.1.211 ]" HADHA HADH Homo sapiens (Human) cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]; protein-containing complex binding [GO:0044877]; cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410] GO:0000062; GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0009410; GO:0016507; GO:0016508; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0044877; GO:0070403 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD+ binding [GO:0070403]; protein-containing complex binding [GO:0044877] AIGILSRFSAFRILR 0.99261 -40.28 0 0 0 0 0 0 0 0 0 0 12.8867 13.2982 0 13.3982 0 13.2349 0 0 0 0 0 0 12.327 0 0 0 0 0 0 0 0 0 13.7946 13.2268 0 12.3849 13.4691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0918 13.5415 0 0 0 0 0 0 0 0 0 0 13.9951 0 0 0 0 0 16.9807 0 0 0 0 0 0 14.6114 14.6969 0 0 0 0 15.2955 0 0 0 0 0 0 13.8454 0 0 13.8574 15.1421 0 0 13.8943 0 0 13.8623 0 13.7631 0 0 0 0 13.9881 0 0 0 0 0 11.2298 0 0 0 0 0 13.1757 0 0 0 0 13.7315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0893 13.5793 0 0 0 0 14.9975 0 0 11.6017 0 0 0 12.3981 0 13.5576 12.2855 0 10.24 0 0 Q12955 ANK3_HUMAN "Ankyrin-3, ANK-3 (Ankyrin-G)" ANK3 Homo sapiens (Human) axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165] axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018] axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; costamere [GO:0043034]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165] GO:0000281; GO:0005200; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007009; GO:0007165; GO:0007409; GO:0007528; GO:0008092; GO:0008093; GO:0009925; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014704; GO:0014731; GO:0016323; GO:0016328; GO:0016529; GO:0019228; GO:0030018; GO:0030315; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0034112; GO:0042383; GO:0043001; GO:0043005; GO:0043034; GO:0043194; GO:0043266; GO:0044325; GO:0045184; GO:0045211; GO:0045296; GO:0045838; GO:0071286; GO:0071709; GO:0072659; GO:0072660; GO:0090314; GO:0099612; GO:1900827; GO:1902260; GO:2000651; GO:2001259 cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] AAPILSK 0.99261 -67.311 16.4149 17.1297 17.487 0 0 0 0 16.2495 0 12.7022 0 0 0 14.3582 13.6066 0 11.2143 0 0 0 15.1304 12.0232 0 12.0863 14.1666 0 13.0564 12.2956 0 13.7282 11.7053 13.6495 0 0 13.5535 0 10.7975 0 0 14.7254 13.6462 0 0 14.5729 14.0499 11.9474 0 0 0 0 0 9.76865 0 12.6364 0 0 0 0 0 15.9717 0 0 0 0 0 0 0 17.7343 17.7163 0 0 0 0 12.4686 0 14.3888 18.4874 0 0 13.1832 0 16.074 14.1513 13.9297 0 0 14.1854 0 14.4877 15.9864 15.5873 12.2185 11.1578 14.2306 15.4104 15.3767 0 0 13.9387 0 0 12.6166 0 14.7724 14.3859 0 0 0 0 12.2636 14.4176 13.866 14.2202 12.7618 14.4216 0 13.5157 13.7537 0 0 0 14.0989 13.7221 13.8593 12.9384 0 13.9592 15.9849 0 15.0408 18.3196 15.1655 13.2561 0 0 0 0 11.2885 13.673 15.3123 14.2608 0 14.6868 14.6128 0 10.8334 14.6831 14.7238 0 0 13.742 13.7231 0 13.3505 0 14.5427 14.3507 0 14.8636 12.9044 0 0 12.0754 15.1113 0 0 0 0 0 0 0 0 13.5773 0 13.4418 18.0612 13.8399 15.0658 0 12.7641 Q15043 S39AE_HUMAN "Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4, LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14, ZIP-14)" SLC39A14 KIAA0062 ZIP14 Homo sapiens (Human) cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular zinc ion homeostasis [GO:0006882]; chondrocyte differentiation [GO:0002062]; gluconeogenesis [GO:0006094]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; insulin receptor signaling pathway [GO:0008286]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; regulation of hormone levels [GO:0010817]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; anion:cation symporter activity [GO:0015296]; cadmium ion transmembrane transporter activity [GO:0015086]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular zinc ion homeostasis [GO:0006882]; chondrocyte differentiation [GO:0002062]; gluconeogenesis [GO:0006094]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; insulin receptor signaling pathway [GO:0008286]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; regulation of hormone levels [GO:0010817]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577] GO:0002062; GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0005887; GO:0006094; GO:0006882; GO:0008286; GO:0010817; GO:0015086; GO:0015093; GO:0015296; GO:0016021; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0032869; GO:0033212; GO:0034755; GO:0045745; GO:0051344; GO:0055071; GO:0071333; GO:0071421; GO:0071577; GO:0071578; GO:0098662; GO:0098739 anion:cation symporter activity [GO:0015296]; cadmium ion transmembrane transporter activity [GO:0015086]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; zinc ion transmembrane transporter activity [GO:0005385] ALLNHLDVGVGRGNVTQHVQGHR 0.99261 -15.101 0 0 0 0 0 10.9294 0 0 0 0 0 11.8733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0255 0 12.3743 11.3891 0 0 0 0 0 0 0 0 0 10.2277 0 0 0 0 0 0 0 0 0 0 0 0 11.0244 0 12.9916 10.0325 11.7469 10.0486 0 13.2518 11.6177 10.4207 0 0 15.277 0 0 10.5182 11.637 13.2366 0 0 0 12.5522 12.838 0 0 0 11.109 13.6101 0 0 13.293 0 12.66 0 0 0 0 0 0 0 0 0 0 12.7734 0 13.2245 0 13.2823 0 0 0 12.8605 0 0 0 0 13.7613 14.0124 12.8682 0 0 0 0 0 0 0 0 12.5411 0 0 0 0 0 0 0 0 0 0 13.8211 13.2393 12.4107 0 0 14.774 0 0 0 15.0787 Q2LD37 K1109_HUMAN Transmembrane protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; presynapse [GO:0098793]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488] GO:0001558; GO:0005634; GO:0006909; GO:0016020; GO:0016021; GO:0016197; GO:0030856; GO:0032456; GO:0048488; GO:0098793 AASLKDK 0.99261 -68.21 0 0 12.1672 0 0 0 0 13.3837 15.4332 12.1066 0 13.8243 11.7262 0 13.1601 0 0 12.8593 0 12.2457 12.8911 0 0 0 13.8276 0 12.5524 0 0 0 0 13.8954 0 0 13.2249 0 15.1934 12.9435 0 14.8559 0 14.6958 14.2095 0 11.7996 11.0874 0 0 9.92708 0 0 0 0 0 0 11.4137 0 0 10.8219 0 0 0 0 0 0 0 10.7277 0 0 0 0 0 0 0 13.4086 13.492 0 0 0 11.3954 13.3923 14.5861 0 14.602 0 0 0 14.6229 12.7207 0 14.0487 0 0 14.2288 13.2082 12.8212 16.5775 15.3258 11.5539 0 12.1795 0 15.3142 13.7021 13.7112 12.8609 0 0 0 13.7667 12.6121 0 13.1626 0 12.8333 0 0 13.8752 13.7123 14.7956 11.5518 12.8875 0 15.4625 14.4998 13.28 15.4703 0 11.3339 0 0 13.5243 0 0 14.9084 0 0 0 15.2932 0 0 0 13.0933 0 13.7106 13.513 0 0 0 0 0 14.7216 0 0 0 11.6718 0 0 0 0 18.1375 17.2543 0 0 0 0 13.9132 0 0 0 13.7577 0 0 11.8161 0 13.4281 15.6071 0 14.3658 0 Q2MJR0 SPRE3_HUMAN "Sprouty-related, EVH1 domain-containing protein 3, Spred-3" SPRED3 EVE-3 Homo sapiens (Human) negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] GO:0005886; GO:0010719; GO:0019901; GO:0030512; GO:0043409; GO:0070373; GO:1902747 protein kinase binding [GO:0019901] ACHWVAARCGCAGCGGR 0.99261 -4.9827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2957 0 0 0 12.6224 0 0 0 0 0 0 0 0 0 0 0 0 14.1137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4151 12.955 13.8837 13.9705 13.1193 0 0 13.9434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4L180 FIL1L_HUMAN "Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1, DOC-1)" FILIP1L COL4A3BPIP DOC1 GIP90 Homo sapiens (Human) cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] GO:0005634; GO:0005737; GO:0016020 DDLKNKLK 0.99261 -14.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7888 0 0 11.2315 11.2368 0 0 0 0 0 0 0 0 0 0 0 0 13.8567 0 0 0 0 12.4222 13.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8383 0 0 0 16.6406 0 0 0 0 0 0 0 0 0 0 0 0 13.7298 0 0 0 11.2755 0 0 0 12.9798 0 0 13.6187 0 0 16.0463 0 0 0 13.1701 0 0 0 13.318 0 0 0 0 0 0 12.1686 0 0 0 0 0 0 0 0 12.0822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5923 0 0 0 0 12.1947 0 0 Q5SRE5 NU188_HUMAN "Nucleoporin NUP188, hNup188" NUP188 KIAA0169 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0044611; GO:0051028 structural constituent of nuclear pore [GO:0017056] ALLLVPASVNCLRLGSMKCTLLLILLR 0.99261 -15.042 0 0 14.0358 0 0 0 13.6735 13.7186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7437 0 11.8721 0 0 0 0 0 0 0 0 0 11.7424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5609 10.4777 11.2308 10.8212 14.0772 0 0 0 13.11 0 0 0 0 0 0 14.5951 14.2755 18.5696 14.6897 0 12.0469 14.213 0 13.845 0 0 0 11.6017 0 0 18.682 0 0 0 0 16.6018 0 0 0 0 0 0 13.2247 0 9.68133 0 13.7692 13.7505 12.8817 0 15.0036 13.3346 14.2359 0 13.0764 0 13.2426 0 0 0 0 11.9564 0 0 0 11.466 0 0 0 0 0 12.4711 14.0551 14.672 13.8436 13.4824 0 12.8808 0 12.7424 0 0 13.1183 0 0 13.0407 0 0 0 0 0 0 0 0 0 12.9075 0 12.4466 0 0 0 0 0 0 0 0 15.1985 0 0 11.613 11.8033 0 0 Q5T601 AGRF1_HUMAN Adhesion G-protein coupled receptor F1 (G protein-coupled receptor 110) (G protein-coupled receptor KPG_012) (G protein-coupled receptor PGR19) ADGRF1 GPR110 PGR19 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; neuron projection development [GO:0031175]; positive regulation of CREB transcription factor activity [GO:0032793]; synapse assembly [GO:0007416] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; neuron projection development [GO:0031175]; positive regulation of CREB transcription factor activity [GO:0032793]; synapse assembly [GO:0007416] GO:0004930; GO:0004949; GO:0005576; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007613; GO:0016021; GO:0031175; GO:0032793 cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930] DLRNFLKLLK 0.99261 -14.715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4157 13.8289 0 0 0 0 0 0 0 12.2116 0 0 0 0 0 0 0 0 0 0 0 0 11.9362 0 0 0 0 0 0 0 0 11.8028 12.249 12.4465 0 0 0 0 0 12.0954 12.0336 16.2229 15.7038 14.2168 15.1686 15.244 13.7286 13.7245 0 0 0 0 0 0 0 0 0 12.4106 12.8234 13.7586 0 0 13.2907 0 0 0 13.1105 0 15.5454 0 11.5503 13.952 0 0 0 0 0 11.9401 0 0 0 11.0484 0 13.0964 12.7738 11.3779 0 0 14.8028 0 15.0336 0 11.1558 13.2374 0 0 0 0 0 12.7286 0 0 0 0 0 0 0 15.3741 12.9393 0 18.6544 15.7708 0 0 0 0 12.7272 11.4887 0 0 0 0 0 0 15.3029 12.5631 0 0 12.4247 0 0 0 0 0 0 0 0 12.6205 0 11.2012 0 0 0 12.7793 0 12.8339 0 0 0 0 12.1054 0 0 11.7076 13.3942 Q6KC79 NIPBL_HUMAN Nipped-B-like protein (Delangin) (SCC2 homolog) NIPBL IDN3 SCC2 Homo sapiens (Human) "brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic cohesin loading [GO:0061780]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038]" chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] "chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic cohesin loading [GO:0061780]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038]" GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008022; GO:0008104; GO:0031065; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045892; GO:0045944; GO:0045995; GO:0047485; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061780; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0071921; GO:0090694; GO:1990414; GO:1990841; GO:2001224 chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485] ACTQLVDNLVEHILKYEESLADSDNK 0.99261 -68.64 0 0 0 0 0 0 0 0 0 10.5574 0 0 0 0 0 13.8822 0 0 0 0 0 0 0 0 13.3432 0 0 0 0 0 0 0 0 12.5426 0 0 0 0 0 0 0 0 13.4906 0 0 12.6049 13.7791 10.6937 0 14.8857 0 12.1351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5681 0 0 0 0 0 0 0 14.7146 0 11.8881 14.8195 12.5467 0 0 0 0 16.4435 0 0 0 0 13.2794 11.1229 0 10.435 0 16.4403 0 0 15.9114 13.5548 15.658 14.1483 14.8142 15.6478 0 11.9095 0 0 12.2689 13.6959 0 0 0 14.5025 0 0 15.0427 0 0 15.6143 15.0582 12.1608 13.3083 14.9894 11.3047 15.4677 0 0 0 0 0 14.6815 16.1714 0 13.1819 0 0 0 14.9813 0 13.4663 11.5426 0 0 0 14.9108 0 0 14.5333 0 14.6545 13.0101 0 15.5267 14.9527 0 0 0 0 12.7795 0 11.9128 0 0 0 0 0 12.2957 13.6211 0 0 14.6848 0 13.7804 0 0 0 0 0 13.0592 Q7Z4L5 TT21B_HUMAN "Tetratricopeptide repeat protein 21B, TPR repeat protein 21B (Intraflagellar transport 139 homolog)" TTC21B IFT139 KIAA1992 Nbla10696 Homo sapiens (Human) Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991] ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; chromatin binding [GO:0003682]; Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591] GO:0003682; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799 chromatin binding [GO:0003682] AQCLEMR 0.99261 -25.619 0 0 0 0 0 0 0 0 0 12.6572 12.342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1203 0 0 12.1975 0 0 0 11.1869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4685 13.0958 11.365 0 0 15.6792 0 15.0051 0 0 0 11.8899 16.0325 0 0 15.853 14.8951 0 0 14.4257 15.4995 14.9926 15.4892 14.9045 0 0 0 0 0 0 12.9488 15.1526 14.8233 0 0 12.6695 0 0 0 0 15.8656 0 0 0 16.0066 0 0 0 0 0 0 0 0 0 0 13.27 0 13.657 0 0 0 0 0 0 0 0 0 0 11.1558 12.7034 13.2734 0 0 13.1854 0 11.539 12.2757 0 0 0 12.9002 0 0 0 0 14.375 14.6914 0 13.2842 0 15.5786 11.9872 14.6482 0 0 14.4126 12.4961 Q7Z6K3 PTAR1_HUMAN Protein prenyltransferase alpha subunit repeat-containing protein 1 PTAR1 Homo sapiens (Human) protein prenylation [GO:0018342] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein prenyltransferase activity [GO:0008318]; protein prenylation [GO:0018342] GO:0005737; GO:0008318; GO:0018342 protein prenyltransferase activity [GO:0008318] ELILSGTLNPIK 0.99261 -14.717 0 0 11.6077 0 11.5548 0 0 0 0 0 0 0 0 0 13.2795 0 0 0 0 0 0 0 0 0 0 0 12.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 11.575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1924 14.6582 0 0 0 13.4549 13.55 0 0 0 0 13.2058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1131 0 14.3164 14.294 0 0 0 0 0 0 0 14.3251 0 0 0 0 0 0 15.4089 0 0 0 0 13.4824 0 0 14.4861 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9681 0 0 0 15.1727 0 0 0 0 14.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0352 0 0 0 0 0 0 0 0 0 0 0 0 15.3387 Q7Z7L8 CK096_HUMAN Uncharacterized protein C11orf96 (Protein Ag2 homolog) C11orf96 AG2 Homo sapiens (Human) ARFKWHSLSSELR 0.99261 -14.754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1993 0 0 0 0 0 0 0 0 0 0 0 12.487 0 12.6522 0 0 14.9838 14.7155 12.285 0 0 11.9785 0 0 0 14.4128 0 0 0 0 0 0 0 12.4019 0 0 0 0 0 0 13.5912 0 0 13.1305 0 0 0 0 0 0 0 0 13.0181 0 0 0 0 0 0 0 0 0 0 12.8056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6856 12.2703 0 0 0 0 0 0 0 Q8IYB5 SMAP1_HUMAN Stromal membrane-associated protein 1 SMAP1 Homo sapiens (Human) positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369] GO:0005096; GO:0005737; GO:0005886; GO:0030276; GO:0045648; GO:0046872; GO:2000369 clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] ATRSCREK 0.99261 -14.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9188 14.0833 0 0 0 12.5333 0 0 0 0 14.2704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7804 0 0 13.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4051 0 0 0 0 0 0 0 0 0 0 0 15.1501 0 0 0 0 0 13.3658 0 0 0 11.7057 0 0 0 0 0 0 0 0 0 0 Q8N2H9 PELI3_HUMAN "E3 ubiquitin-protein ligase pellino homolog 3, Pellino-3, EC 2.3.2.27 (RING-type E3 ubiquitin transferase pellino homolog 3)" PELI3 Homo sapiens (Human) negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592] cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592] GO:0000209; GO:0005829; GO:0008592; GO:0010804; GO:0061630; GO:0070534; GO:2001237 ubiquitin protein ligase activity [GO:0061630] CGHVHGYHGWGCR 0.99261 -14.723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N568 DCLK2_HUMAN "Serine/threonine-protein kinase DCLK2, EC 2.7.11.1 (CaMK-like CREB regulatory kinase 2, CL2, CLICK-II, CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2)" DCLK2 DCAMKL2 DCDC3B DCK2 Homo sapiens (Human) hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; protein localization to nucleus [GO:0034504]; pyramidal neuron development [GO:0021860] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; protein localization to nucleus [GO:0034504]; pyramidal neuron development [GO:0021860] GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008017; GO:0018105; GO:0021766; GO:0021860; GO:0034504; GO:0035556; GO:0106310; GO:1900181 ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DFIKPKLVTVIR 0.99261 -40.119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0898 0 0 13.4331 0 0 0 0 0 0 0 0 0 0 12.5156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2733 0 0 0 0 0 12.1595 0 0 0 0 0 0 0 0 10.9478 0 11.4911 0 0 0 0 0 0 0 13.0878 0 0 12.5825 0 0 15.3358 0 0 0 12.9666 0 0 13.3045 0 0 0 0 0 0 0 0 0 0 0 13.2445 0 0 0 0 0 0 0 12.7529 0 0 13.5561 0 0 0 12.2055 15.1448 0 0 0 0 13.2363 0 0 0 0 0 13.7397 0 12.7929 0 12.1466 0 0 0 0 0 0 0 13.8775 14.3152 14.3509 11.9423 0 14.7279 0 0 0 0 0 0 0 14.075 0 13.632 13.3389 0 Q8NHM5 KDM2B_HUMAN "Lysine-specific demethylase 2B, EC 1.14.11.27 (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein, Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B)" KDM2B CXXC2 FBL10 FBXL10 JHDM1B NDY1 PCCX2 Homo sapiens (Human) chromatin organization [GO:0006325]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678] GO:0000122; GO:0000978; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0007283; GO:0008270; GO:0019843; GO:0021555; GO:0021592; GO:0021670; GO:0021678; GO:0021993; GO:0030307; GO:0030900; GO:0030901; GO:0030902; GO:0032452; GO:0035518; GO:0043524; GO:0045322; GO:0048596; GO:0051864; GO:0070544; GO:0140680; GO:1902459; GO:2000178 DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-36 demethylase activity [GO:0140680]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] CEACLRTECGECHFCK 0.99261 -45.002 0 0 0 0 0 0 0 0 0 0 0 11.7494 0 11.9424 0 0 0 0 10.2325 0 0 0 0 0 0 0 10.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6695 11.4927 0 0 11.0782 0 13.3676 12.9229 0 0 0 10.97 0 0 12.9981 11.0541 11.3951 0 11.1318 0 0 0 0 0 0 12.2532 0 12.7725 0 11.3215 0 0 0 0 0 0 11.0783 0 0 0 0 0 12.7594 0 13.2223 10.9851 14.066 13.9813 12.6529 14.36 0 13.4992 0 12.8676 13.1771 14.7195 12.7289 0 0 0 0 15.0187 0 11.8767 12.7879 0 10.4864 0 0 0 0 0 0 0 0 0 0 0 0 12.8576 0 11.521 0 0 10.6421 14.3708 0 12.4491 0 0 0 0 0 0 11.9365 0 0 0 0 0 0 0 0 0 0 0 0 12.0374 0 0 13.1678 0 0 0 13.3998 12.6545 0 0 0 12.6374 0 12.8102 0 0 11.8073 0 0 0 10.7972 0 0 0 0 0 12.7939 13.596 14.0199 0 Q96SB3 NEB2_HUMAN Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin) PPP1R9B PPP1R6 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to morphine [GO:0071315]; cellular response to peptide [GO:1901653]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; developmental process involved in reproduction [GO:0003006]; filopodium assembly [GO:0046847]; hippocampus development [GO:0021766]; learning [GO:0007612]; male mating behavior [GO:0060179]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; neuron projection development [GO:0031175]; positive regulation of protein localization to actin cortical patch [GO:1904372]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to actin cytoskeleton [GO:1903119]; protein localization to cell periphery [GO:1990778]; regulation of cell cycle [GO:0051726]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of protein phosphorylation [GO:0001932]; reproductive system development [GO:0061458]; response to amphetamine [GO:0001975]; response to clozapine [GO:0097338]; response to immobilization stress [GO:0035902]; response to kainic acid [GO:1904373]; response to L-phenylalanine derivative [GO:1904386]; response to nicotine [GO:0035094]; response to prostaglandin E [GO:0034695]; response to steroid hormone [GO:0048545]; RNA splicing [GO:0008380] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of dendritic spine plasma membrane [GO:1990780]; dendrite [GO:0030425]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of dendritic spine plasma membrane [GO:1990780]; dendrite [GO:0030425]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 1 complex [GO:0000164]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; D2 dopamine receptor binding [GO:0031749]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; transmembrane transporter binding [GO:0044325]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to morphine [GO:0071315]; cellular response to peptide [GO:1901653]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; developmental process involved in reproduction [GO:0003006]; filopodium assembly [GO:0046847]; hippocampus development [GO:0021766]; learning [GO:0007612]; male mating behavior [GO:0060179]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell growth [GO:0030308]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; neuron projection development [GO:0031175]; positive regulation of protein localization to actin cortical patch [GO:1904372]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to actin cytoskeleton [GO:1903119]; protein localization to cell periphery [GO:1990778]; regulation of cell cycle [GO:0051726]; regulation of cell growth by extracellular stimulus [GO:0001560]; regulation of cell population proliferation [GO:0042127]; regulation of exit from mitosis [GO:0007096]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of protein phosphorylation [GO:0001932]; reproductive system development [GO:0061458]; response to amphetamine [GO:0001975]; response to clozapine [GO:0097338]; response to immobilization stress [GO:0035902]; response to kainic acid [GO:1904373]; response to L-phenylalanine derivative [GO:1904386]; response to nicotine [GO:0035094]; response to prostaglandin E [GO:0034695]; response to steroid hormone [GO:0048545]; RNA splicing [GO:0008380] GO:0000164; GO:0001560; GO:0001932; GO:0001975; GO:0003006; GO:0004672; GO:0004864; GO:0005654; GO:0005737; GO:0005886; GO:0005912; GO:0007015; GO:0007096; GO:0007568; GO:0007612; GO:0008022; GO:0008157; GO:0008380; GO:0014069; GO:0015629; GO:0016358; GO:0016477; GO:0019722; GO:0019900; GO:0021766; GO:0021987; GO:0030027; GO:0030042; GO:0030175; GO:0030308; GO:0030425; GO:0030426; GO:0030864; GO:0031175; GO:0031749; GO:0032515; GO:0032587; GO:0034695; GO:0035094; GO:0035902; GO:0042127; GO:0043025; GO:0044325; GO:0044326; GO:0044327; GO:0046847; GO:0048545; GO:0050804; GO:0051015; GO:0051726; GO:0060179; GO:0061458; GO:0071315; GO:0071364; GO:0071392; GO:0071466; GO:0097338; GO:1901653; GO:1903078; GO:1903119; GO:1904372; GO:1904373; GO:1904386; GO:1990778; GO:1990780; GO:2000474 actin filament binding [GO:0051015]; D2 dopamine receptor binding [GO:0031749]; kinase binding [GO:0019900]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; transmembrane transporter binding [GO:0044325] ERPGEQSEVAQLIQQTLEQERWQR 0.99261 -25.591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.048 0 0 17.2431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4286 0 0 0 0 0 0 Q9BXP5 SRRT_HUMAN Serrate RNA effector molecule homolog (Arsenite-resistance protein 2) SRRT ARS2 ASR2 Homo sapiens (Human) "mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]" cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of transcription, DNA-templated [GO:0006355]; response to arsenic-containing substance [GO:0046685]" GO:0003677; GO:0003723; GO:0005654; GO:0005737; GO:0006355; GO:0006397; GO:0016604; GO:0030674; GO:0031053; GO:0032991; GO:0046685; GO:0050769; GO:0097150; GO:0140262; GO:1990904 DNA binding [GO:0003677]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] AEIISLCK 0.99261 -25.553 0 0 0 0 0 0 0 0 0 0 0 0 0 10.934 0 0 0 0 0 0 0 0 0 0 0 11.0392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1273 0 0 0 0 11.5839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4363 0 0 0 13.4991 0 0 0 0 13.2836 0 0 0 0 0 19.7098 0 0 12.9165 12.1516 0 0 0 13.4295 13.9364 13.498 0 0 0 13.6543 13.9539 0 13.9918 0 13.1314 12.0648 15.0276 0 14.2859 16.7032 0 0 10.2283 14.1293 0 13.4828 0 13.796 14.2799 12.2837 12.7477 0 13.2758 13.5263 12.3222 14.8012 0 0 0 0 13.409 0 14.5059 0 0 0 13.2965 14.7285 0 12.7927 0 0 0 14.4307 14.5699 14.896 13.5298 0 11.7831 0 0 14.3838 0 0 0 0 0 0 0 11.7413 0 0 0 12.1364 0 0 0 12.7718 12.0169 0 0 0 0 13.294 13.2777 0 0 0 12.3922 0 0 Q9BXP8 PAPP2_HUMAN "Pappalysin-2, EC 3.4.24.- (Pregnancy-associated plasma protein A2, PAPP-A2) (Pregnancy-associated plasma protein E1, PAPP-E)" PAPPA2 PLAC3 Homo sapiens (Human) bone morphogenesis [GO:0060349]; cell surface receptor signaling pathway [GO:0007166]; proteolysis [GO:0006508]; regulation of cell growth [GO:0001558]; response to salt stress [GO:0009651] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; bone morphogenesis [GO:0060349]; cell surface receptor signaling pathway [GO:0007166]; proteolysis [GO:0006508]; regulation of cell growth [GO:0001558]; response to salt stress [GO:0009651] GO:0001558; GO:0004222; GO:0005576; GO:0005615; GO:0005829; GO:0006508; GO:0007166; GO:0008237; GO:0008270; GO:0009651; GO:0016324; GO:0060349; GO:0070062 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] AEDGQGDSGISSHFQPWPKHSLK 0.99261 -44.585 0 0 0 0 0 0 0 0 14.0895 0 0 0 11.7523 13.1068 0 0 13.4961 0 12.8603 0 0 0 0 0 0 14.4501 0 0 13.5347 0 0 13.8923 0 0 0 0 0 0 0 0 11.4439 0 0 0 13.5826 14.6156 0 0 0 12.0138 0 12.076 10.1645 0 13.3752 0 0 0 0 0 0 0 0 0 0 11.0419 0 0 0 0 0 15.3538 0 0 0 0 12.015 0 0 14.827 14.6316 0 0 0 0 0 0 12.8147 0 0 12.4494 0 12.7527 0 0 13.0563 14.4039 0 0 0 12.1646 0 0 15.6066 0 0 0 0 13.3566 0 0 0 13.193 0 0 0 13.9198 15.8128 0 12.7569 0 0 0 0 11.3656 0 0 14.8825 0 0 0 0 0 0 0 0 0 12.2792 13.3079 0 0 0 0 12.8304 0 0 0 12.9172 12.7374 0 0 0 0 11.0343 13.6938 0 13.6191 0 13.2482 0 0 0 0 0 14.356 13.8767 13.9016 13.4771 14.7931 0 12.6354 0 0 0 11.6061 16.1196 0 13.8284 0 0 Q9BYP7 WNK3_HUMAN "Serine/threonine-protein kinase WNK3, EC 2.7.11.1 (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3)" WNK3 KIAA1566 PRKWNK3 Homo sapiens (Human) cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell volume homeostasis [GO:0006884]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of apoptotic process [GO:0043066]; negative regulation of sodium ion transport [GO:0010766]; osmosensory signaling pathway [GO:0007231]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein autophosphorylation [GO:0046777]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of calcium ion import [GO:0090279]; regulation of cation transmembrane transport [GO:1904062] GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005912; GO:0005923; GO:0006468; GO:0006884; GO:0007231; GO:0010765; GO:0010766; GO:0010800; GO:0018107; GO:0019869; GO:0019870; GO:0032414; GO:0035556; GO:0035633; GO:0043066; GO:0046777; GO:0050801; GO:0051928; GO:0072659; GO:0090279; GO:0106310; GO:1903078; GO:1903288; GO:1904062; GO:2000651 ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; potassium channel inhibitor activity [GO:0019870]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ATDSGDPASTEDSEK 0.99261 -44.793 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3954 0 0 0 0 0 0 0 0 0 15.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2291 0 13.0006 0 13.447 13.1672 0 0 0 0 0 0 0 0 14.0328 13.5693 0 0 0 0 0 0 0 0 0 0 0 0 13.202 0 13.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2041 10.8578 0 13.5303 0 0 0 0 12.8914 0 0 0 0 13.318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3949 14.7145 0 0 13.2458 0 0 13.335 13.4967 0 0 0 0 0 12.7799 0 Q9H3T2 SEM6C_HUMAN "Semaphorin-6C (Semaphorin-Y, Sema Y)" SEMA6C KIAA1869 SEMAY Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005737; GO:0005887; GO:0007411; GO:0009986; GO:0030215; GO:0030335; GO:0030517; GO:0045499; GO:0048843; GO:0050919; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] EPHFVQALEHGDHVYFFFR 0.99261 -14.725 0 0 0 0 11.3381 0 10.5847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6249 0 13.5113 0 0 0 0 0 0 0 0 12.8575 0 0 0 0 0 12.8868 0 11.7263 12.2618 0 12.4781 0 0 0 12.1992 0 12.7403 12.3412 13.3763 0 13.7677 0 0 0 0 13.0833 12.9735 0 0 0 11.5918 12.4991 0 0 12.7564 0 0 0 0 12.1065 14.9546 0 0 0 0 13.6234 12.0183 12.0131 13.9183 0 0 12.8318 0 0 10.9227 0 0 0 14.6841 0 0 12.0918 13.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.067 0 Q9HCE1 MOV10_HUMAN "Helicase MOV-10, EC 3.6.4.13 (Armitage homolog) (Moloney leukemia virus 10 protein)" MOV10 KIAA1631 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]" cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932] "cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of transposition, RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011]" GO:0000932; GO:0003723; GO:0005524; GO:0005615; GO:0005634; GO:0005829; GO:0010494; GO:0010526; GO:0016887; GO:0032574; GO:0035194; GO:0035195; GO:0035279; GO:0036464; GO:0043186; GO:0051607; GO:0061014; GO:0061158; GO:0150011 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] DGQLLIRLDLNRK 0.99261 -25.611 0 0 0 0 0 0 0 0 0 12.8833 0 9.83232 0 0 0 0 0 0 0 0 0 0 0 0 11.9747 0 0 0 0 0 0 0 0 0 0 12.6043 0 0 0 0 0 11.933 0 0 0 0 12.1232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1585 12.3864 0 0 0 0 0 0 0 0 0 13.063 0 0 0 0 0 15.9653 0 0 0 0 14.3786 14.914 0 0 12.8706 11.3547 0 0 0 11.7779 0 0 0 0 0 0 13.9696 0 12.044 11.6775 0 0 0 13.0618 0 12.757 0 0 12.1599 0 0 0 0 0 0 0 0 12.7234 0 0 0 0 0 0 0 0 12.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3166 0 12.2126 0 0 0 0 0 0 0 0 12.342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NU22 MDN1_HUMAN Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein) MDN1 KIAA0301 Homo sapiens (Human) regulation of ribosomal subunit export from nucleus [GO:2000200]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] "cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]" "cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; regulation of ribosomal subunit export from nucleus [GO:2000200]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]" GO:0000027; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0016020; GO:0016887; GO:0030687; GO:0045111; GO:2000200 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] AHKETENEK 0.99261 -68.922 12.5208 0 0 0 0 0 12.8277 0 14.9827 0 13.898 13.9967 0 13.2082 0 0 0 0 0 14.2964 14.0232 0 13.6738 12.9876 0 0 0 13.0244 0 0 13.8878 0 0 15.2822 0 0 0 10.256 0 0 0 0 0 12.4974 0 12.0875 0 0 0 0 12.3877 0 0 0 0 0 0 0 13.7794 0 0 0 0 0 0 0 0 0 0 14.8507 0 0 0 13.9449 12.2417 0 15.3755 0 14.9871 14.1589 15.0535 15.1571 14.9614 0 14.6773 16.4901 16.9302 14.3525 15.7827 14.1773 13.9603 12.9645 13.9094 15.4868 13.4696 13.0551 16.5495 13.5723 0 0 15.7438 9.71119 0 0 11.4808 11.6782 12.7665 14.2377 10.3569 0 14.3145 13.1674 14.7873 0 11.3898 13.7357 14.9535 13.8464 0 0 13.9042 14.8553 13.021 11.6661 14.3959 14.234 12.1472 14.6558 13.4488 0 0 15.5335 0 12.7912 15.6829 14.717 15.5668 15.0174 14.5504 14.8346 0 14.1105 13.1261 0 15.2118 13.0852 0 0 0 12.112 15.3152 14.5008 0 0 13.9889 12.7962 13.3117 12.5703 12.3534 0 0 0 10.6075 13.4925 0 0 0 0 13.0874 0 11.2103 13.4717 0 0 13.2091 13.4547 14.4113 10.5453 10.7688 0 Q9NYQ6 CELR1_HUMAN "Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2, hFmi2)" CELSR1 CDHF9 FMI2 Homo sapiens (Human) "apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016021; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] ALQLVRALR 0.99261 -45.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.926 0 0 0 0 0 11.3953 0 0 0 0 0 0 13.0878 0 0 0 13.8863 0 0 11.9791 0 0 0 0 0 15.7773 0 0 0 0 12.5653 0 0 0 0 0 0 0 0 11.3991 15.5528 10.8368 0 17.9815 0 0 0 0 11.1196 0 11.6998 0 14.6182 0 0 14.6117 0 0 0 13.51 0 0 13.2603 0 13.8022 0 14.6478 14.2252 12.9202 15.2735 9.8186 15.3203 0 0 11.9981 0 13.0482 0 13.897 0 0 13.5525 17.0977 15.8865 13.532 0 12.5856 13.6835 12.1469 10.9759 13.2524 12.5302 15.7344 0 0 0 13.7669 15.5211 0 0 14.1249 14.6494 13.9498 15.3166 0 0 13.6111 0 11.9726 14.2326 15.859 0 14.4918 15.7176 0 0 12.9848 15.6374 11.1145 0 0 0 14.0515 14.089 0 0 0 15.653 14.5045 0 16.4293 0 0 0 13.2945 13.0192 12.0592 14.5737 13.5049 0 0 0 12.4272 0 0 0 0 0 0 11.8834 0 0 0 0 0 0 0 13.7042 0 0 0 11.7716 13.1156 10.5195 Q9UPR6 ZFR2_HUMAN Zinc finger RNA-binding protein 2 ZFR2 KIAA1086 Homo sapiens (Human) intracellular membrane-bounded organelle [GO:0043231] intracellular membrane-bounded organelle [GO:0043231]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] GO:0003725; GO:0003727; GO:0008270; GO:0043231 double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] ASGLQPCVIVIRVLR 0.99261 -44.65 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.95957 12.0585 13.8956 0 0 0 0 0 0 0 12.2895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0005 0 0 0 0 13.4895 0 0 0 0 0 0 0 12.5818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.815 A1A4Y4 IRGM_HUMAN "Immunity-related GTPase family M protein, EC 3.6.5.- (Immunity-related GTPase family M protein 1) (Interferon-inducible protein 1) (LPS-stimulated RAW 264.7 macrophage protein 47 homolog, LRG-47)" IRGM IFI1 IRGM1 LRG47 Homo sapiens (Human) autophagosome assembly [GO:0000045]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein destabilization [GO:0031648]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254] autophagosome membrane [GO:0000421]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670] autophagosome membrane [GO:0000421]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; BH3 domain binding [GO:0051434]; CARD domain binding [GO:0050700]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; autophagosome assembly [GO:0000045]; CAMKK-AMPK signaling cascade [GO:0061762]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein destabilization [GO:0031648]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254] GO:0000045; GO:0000139; GO:0000421; GO:0001891; GO:0001934; GO:0003924; GO:0005525; GO:0005739; GO:0005789; GO:0005794; GO:0005829; GO:0006952; GO:0006954; GO:0010508; GO:0010800; GO:0019901; GO:0030670; GO:0031648; GO:0033138; GO:0035458; GO:0042742; GO:0042995; GO:0043254; GO:0043539; GO:0045087; GO:0050700; GO:0050821; GO:0050829; GO:0051434; GO:0060335; GO:0061635; GO:0061739; GO:0061762; GO:0070431; GO:0071222; GO:0071902; GO:0098586; GO:1901098 BH3 domain binding [GO:0051434]; CARD domain binding [GO:0050700]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539] ASPPTELVKATQR 0.99262 -6.7017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0527 0 0 0 13.8838 14.0403 0 0 0 15.0906 0 0 15.5855 0 0 0 0 0 14.4743 15.0508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MVU1 NCF1C_HUMAN "Putative neutrophil cytosol factor 1C, NCF-1C (Putative SH3 and PX domain-containing protein 1C)" NCF1C SH3PXD1C Homo sapiens (Human) respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554] cytoplasm [GO:0005737]; NADPH oxidase complex [GO:0043020] cytoplasm [GO:0005737]; NADPH oxidase complex [GO:0043020]; phosphatidylinositol binding [GO:0035091]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; respiratory burst [GO:0045730]; superoxide anion generation [GO:0042554] GO:0005737; GO:0016176; GO:0035091; GO:0042554; GO:0043020; GO:0045730 phosphatidylinositol binding [GO:0035091]; superoxide-generating NADPH oxidase activator activity [GO:0016176] KDDVTGYFPSMYLQK 0.99262 -6.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3862 0 0 14.3026 0 0 0 0 0 0 0 0 0 0 0 0 0 O60783 RT14_HUMAN "28S ribosomal protein S14, mitochondrial, MRP-S14, S14mt (Mitochondrial small ribosomal subunit protein uS14m)" MRPS14 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; small ribosomal subunit [GO:0015935] mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005763; GO:0006412; GO:0015935; GO:0031965; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] LSRIVFR 0.99262 -6.3413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1502 0 12.7652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3301 0 0 0 0 0 0 0 0 0 0 0 0 15.2417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2902 14.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75334 LIPA2_HUMAN "Liprin-alpha-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2, PTPRF-interacting protein alpha-2)" PPFIA2 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; synapse organization [GO:0050808] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; cell-matrix adhesion [GO:0007160]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001]; synapse organization [GO:0050808] GO:0005737; GO:0005829; GO:0007160; GO:0009986; GO:0030424; GO:0043197; GO:0048786; GO:0050808; GO:0060998; GO:0061001; GO:0070062; GO:0070161; GO:0099519 ALKSLFEHHK 0.99262 -40.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9413 0 12.634 14.1731 0 0 0 12.5117 0 0 0 0 0 0 0 0 14.7569 0 0 13.1735 0 0 0 13.0756 0 0 14.0165 14.5352 13.1707 0 0 0 14.1954 13.2455 0 18.4909 0 13.939 0 0 0 0 0 13.1785 0 0 0 0 0 0 12.8362 0 0 13.5222 0 0 0 0 13.1572 0 0 0 0 12.9605 0 0 12.5332 0 13.9316 13.8307 13.6353 0 0 0 0 0 0 0 0 14.2129 12.2801 11.9434 0 0 15.0268 0 13.8107 13.9172 0 0 0 0 0 0 13.8578 13.2425 0 11.8119 0 0 0 0 0 0 0 12.2694 0 0 P02794 FRIH_HUMAN "Ferritin heavy chain, Ferritin H subunit, EC 1.16.3.1 (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed ]" FTH1 FTH FTHL6 OK/SW-cl.84 PIG15 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147] autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] autolysosome [GO:0044754]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular ferritin complex [GO:0008043]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; cellular iron ion homeostasis [GO:0006879]; immune response [GO:0006955]; intracellular sequestering of iron ion [GO:0006880]; iron ion transport [GO:0006826]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147] GO:0004322; GO:0005506; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006826; GO:0006879; GO:0006880; GO:0006955; GO:0008043; GO:0008198; GO:0008199; GO:0008285; GO:0042802; GO:0044754; GO:0048147; GO:0070062; GO:1904724; GO:1904813 ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506] ELGDHVTNLR 0.99262 -4.503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4733 0 14.3134 0 0 0 0 0 0 11.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06396 GELS_HUMAN "Gelsolin (AGEL) (Actin-depolymerizing factor, ADF) (Brevin)" GSN Homo sapiens (Human) "actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]" actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774] "actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament reorganization [GO:0090527]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to interferon-gamma [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]" GO:0002102; GO:0003779; GO:0005509; GO:0005546; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0006911; GO:0007417; GO:0008154; GO:0010628; GO:0014891; GO:0015629; GO:0016528; GO:0030027; GO:0030031; GO:0030041; GO:0030042; GO:0030478; GO:0030864; GO:0031648; GO:0034774; GO:0035994; GO:0036313; GO:0042989; GO:0045010; GO:0045159; GO:0045335; GO:0046597; GO:0051014; GO:0051015; GO:0051016; GO:0051127; GO:0051693; GO:0055119; GO:0060271; GO:0070062; GO:0071346; GO:0071801; GO:0072562; GO:0086003; GO:0090527; GO:0097017; GO:0097284; GO:1902174; GO:1903903; GO:1903906; GO:1903909; GO:1903923; GO:1904813; GO:1990000; GO:2001269 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AAYRTSPR 0.99262 -25.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9441 0 0 0 0 0 0 0 14.492 14.7182 0 0 0 0 0 0 0 0 0 0 10.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9524 0 0 0 13.0807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16070 CD44_HUMAN "CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III, ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1, PGP-1) (Phagocytic glycoprotein I, PGP-I) (CD antigen CD44)" CD44 LHR MDU2 MDU3 MIC4 Homo sapiens (Human) "cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]" apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]" GO:0004888; GO:0005518; GO:0005540; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0005902; GO:0005925; GO:0006954; GO:0007155; GO:0007160; GO:0009986; GO:0016323; GO:0016324; GO:0016477; GO:0019221; GO:0030214; GO:0030667; GO:0031258; GO:0033138; GO:0034116; GO:0035692; GO:0042110; GO:0042995; GO:0043066; GO:0043154; GO:0043518; GO:0044319; GO:0044344; GO:0050731; GO:0051216; GO:0070062; GO:0070374; GO:0070487; GO:0098609; GO:1900625; GO:1902166; GO:2000392 collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888] ALSIGFETCR 0.99262 -6.1473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5255 0 0 0 12.7055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9969 0 0 0 0 0 0 P20648 ATP4A_HUMAN "Potassium-transporting ATPase alpha chain 1, EC 7.2.2.19 (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump)" ATP4A Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376] apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; magnesium ion binding [GO:0000287]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; potassium ion binding [GO:0030955]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; ion transmembrane transport [GO:0034220]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376] GO:0000287; GO:0005391; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006883; GO:0008900; GO:0016324; GO:0016887; GO:0019829; GO:0030007; GO:0030955; GO:0034220; GO:0036376; GO:1902600; GO:1990573 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; magnesium ion binding [GO:0000287]; P-type potassium:proton transporter activity [GO:0008900]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; potassium ion binding [GO:0030955] AESDIMHLRPR 0.99262 -6.342 0 0 0 0 0 0 0 0 10.1877 0 0 10.6163 0 0 0 0 0 0 0 0 0 0 11.0449 14.3832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3417 0 0 0 0 0 0 0 0 10.9927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2658 13.8885 13.5198 13.7283 0 0 10.523 10.5156 0 0 12.4156 0 0 15.9125 14.5653 12.6367 0 15.8822 15.8992 11.5974 0 0 0 14.9488 13.146 14.4523 14.3867 13.4765 13.4925 13.3761 0 16.9644 13.409 15.1652 14.4841 14.9451 13.4043 16.3015 13.6025 13.186 0 12.6802 14.5682 0 15.0426 0 13.6186 16.178 13.6762 0 13.7142 14.0543 15.2428 14.4627 14.0777 0 14.0185 0 14.0363 14.0583 13.3419 0 0 0 0 14.3452 11.5947 10.1468 0 13.5258 0 0 13.9715 13.9288 12.6376 16.446 13.234 13.3273 0 12.7214 0 0 16.276 0 14.2668 12.78 0 0 12.3297 14.1539 0 0 12.5007 0 0 0 11.6342 0 0 0 0 0 0 0 0 0 0 16.5444 0 0 14.0701 0 0 0 P98160 PGBM_HUMAN "Basement membrane-specific heparan sulfate proteoglycan core protein, HSPG (Perlecan, PLC) [Cleaved into: Endorepellin; LG3 peptide ]" HSPG2 Homo sapiens (Human) angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888] GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907 amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022] AAGALLLALLLHGR 0.99262 -46.709 10.8966 0 0 0 0 11.8501 10.9958 0 0 10.3161 0 10.5837 0 0 11.9272 13.3784 0 0 0 0 0 0 0 0 12.0895 0 0 12.5916 0 0 10.3872 0 0 12.1032 0 0 0 0 13.4198 10.8605 0 0 0 0 0 11.8586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89621 0 13.1818 0 0 0 11.8966 0 0 0 0 0 12.5005 0 0 0 0 13.6348 0 0 11.3535 0 15.0442 0 0 0 10.7247 13.2411 13.018 14.7614 13.1678 12.8439 11.3836 11.7901 14.0385 12.9046 0 0 0 14.5031 13.4059 0 12.5666 12.7792 0 0 13.7146 14.3161 13.7557 0 13.1072 12.8859 13.6137 14.4443 12.4217 13.0787 0 14.909 0 14.9316 12.8728 13.4836 13.5644 12.8419 12.4754 0 13.1043 13.0469 0 11.589 0 0 0 11.3974 10.5853 0 12.4631 12.7363 13.5813 12.6481 13.3701 14.6951 17.3705 0 0 0 0 0 0 0 0 0 0 11.8977 0 12.9962 0 0 0 0 0 12.0558 0 0 12.5383 0 12.3078 0 12.7104 13.9232 0 0 12.2357 0 0 0 Q00537 CDK17_HUMAN "Cyclin-dependent kinase 17, EC 2.7.11.22 (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2)" CDK17 PCTAIRE2 PCTK2 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083] GO:0000083; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] GLAYCHR 0.99262 -25.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5535 13.9082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0905 0 0 0 0 15.1989 0 0 0 0 0 13.3748 13.6108 0 0 0 0 14.1565 0 0 0 0 0 0 0 0 0 0 0 0 15.0135 0 0 0 0 0 14.699 0 0 0 0 0 0 0 0 0 0 15.117 0 0 0 0 0 0 0 0 14.8683 0 12.4312 0 0 11.8459 0 0 0 0 0 0 12.6048 13.0399 0 10.5229 13.6218 0 0 0 12.5763 0 0 11.6721 14.6653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2872 12.9417 0 0 0 0 0 0 Q01484 ANK2_HUMAN "Ankyrin-2, ANK-2 (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin)" ANK2 ANKB Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018] A band [GO:0031672]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; endocytosis [GO:0006897]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0002027; GO:0003283; GO:0005200; GO:0005739; GO:0005764; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0006874; GO:0006897; GO:0008093; GO:0008104; GO:0010628; GO:0010881; GO:0010882; GO:0014704; GO:0015031; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0030018; GO:0030315; GO:0030507; GO:0030674; GO:0030913; GO:0031430; GO:0031647; GO:0031672; GO:0033292; GO:0033365; GO:0034394; GO:0036309; GO:0036371; GO:0042383; GO:0043005; GO:0043034; GO:0043268; GO:0044325; GO:0045121; GO:0045211; GO:0050821; GO:0051117; GO:0051279; GO:0051597; GO:0051924; GO:0051928; GO:0055037; GO:0055117; GO:0060307; GO:0070296; GO:0070972; GO:0072659; GO:0086004; GO:0086005; GO:0086014; GO:0086015; GO:0086046; GO:0086066; GO:0086070; GO:0086091; GO:0098907; GO:0098910; GO:0140031; GO:1901018; GO:1901019; GO:1901021; GO:2001259 ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; phosphorylation-dependent protein binding [GO:0140031]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; transmembrane transporter binding [GO:0044325] ADEAKPK 0.99262 -73.77 9.54214 0 0 15.4653 0 15.5154 0 0 11.3883 0 13.392 0 0 0 11.6882 0 0 0 14.4133 12.4906 11.7837 12.7662 0 13.2963 10.2227 10.1021 0 10.1223 0 0 0 0 0 0 0 11.197 0 0 0 0 0 0 0 0 0 11.9931 12.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1461 0 14.0759 0 10.4525 0 15.159 14.1732 12.6735 11.6691 13.2298 0 15.948 0 0 16.9555 0 13.6052 0 13.1818 14.424 0 11.6972 0 15.4945 12.9746 0 12.8407 13.3319 14.7858 0 0 0 0 14.9712 12.2316 0 0 14.6299 13.444 12.9297 0 0 13.4363 13.4159 0 15.5875 0 13.2631 12.605 14.7884 0 12.6203 13.185 14.9411 0 12.0919 16.0466 15.9203 0 0 0 0 0 15.5765 14.9836 0 10.9647 12.9133 17.1364 14.2033 0 0 15.27 0 0 16.2162 16.0104 12.9044 10.6798 0 0 0 0 12.0422 0 0 14.9573 14.5053 17.4381 0 10.2476 0 0 0 0 0 12.5339 0 0 12.2756 0 0 13.3824 11.1818 0 0 0 0 12.8176 0 13.6273 15.25 0 Q07283 TRHY_HUMAN Trichohyalin TCHH THH THL TRHY Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0001533; GO:0005509; GO:0005829; GO:0005856; GO:0031424; GO:0045109; GO:0046914 calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] AQQLQEEEDGLQEDQERR 0.99262 -73.592 0 0 0 0 0 0 0 0 0 0 0 0 11.9628 0 0 0 11.8459 0 0 0 0 0 10.7809 0 0 0 0 0 13.3408 0 0 0 0 0 0 0 0 10.9724 0 11.2597 0 0 0 11.2827 0 0 0 0 0 0 0 13.0814 12.4349 11.7104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9368 14.5858 0 0 0 13.5786 0 11.8996 13.4021 0 0 13.8508 14.3012 0 0 13.0884 12.6851 0 14.4905 12.8887 12.7213 0 0 12.6177 12.9479 0 0 0 0 12.2431 0 13.3949 0 0 0 12.4575 10.3862 12.6255 11.2046 0 14.2906 0 0 0 0 14.4997 12.1955 0 12.5893 0 12.4633 0 14.2719 14.0393 12.1777 0 13.5482 0 0 0 0 12.57 13.9237 0 0 0 15.2813 11.885 0 0 0 12.3056 10.8223 11.6271 0 0 11.6637 0 0 10.8718 0 0 0 0 0 13.334 14.1133 0 13.5283 0 0 13.3853 0 14.0086 0 0 0 12.4526 0 11.1909 0 0 14.0262 13.5446 0 0 12.9206 0 0 Q14185 DOCK1_HUMAN "Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK, DOCK180)" DOCK1 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; integrin-mediated signaling pathway [GO:0007229]; myoblast fusion [GO:0007520]; phagocytosis, engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]" GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007165; GO:0007229; GO:0007264; GO:0007520; GO:0010634; GO:0016477; GO:0016607; GO:0017124; GO:0031267; GO:0032045; GO:1900026 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] ALESIFKFIVR 0.99262 -41.037 0 0 0 0 0 0 0 0 0 12.7683 11.9644 0 10.2454 0 11.1083 0 0 11.6701 0 0 12.0649 0 0 0 0 11.729 0 0 0 0 11.7262 12.8712 0 10.3985 0 0 0 0 0 10.555 0 11.958 11.8818 0 0 13.9072 13.3768 0 11.9628 12.5502 0 0 0 0 0 0 0 0 0 0 0 9.46685 0 0 0 0 0 0 12.8449 0 0 11.9947 13.9604 13.0908 10.0444 16.3906 0 13.4293 0 0 0 0 0 0 0 17.0421 15.6852 14.8947 0 0 0 12.4636 14.4363 10.7561 0 0 13.3446 0 0 0 12.8095 0 0 0 0 0 0 10.8427 0 0 0 14.7447 0 0 0 0 0 0 0 0 13.6319 14.2233 0 15.1836 13.8682 0 0 0 0 10.269 0 0 11.63 0 13.6632 0 0 13.5325 0 0 0 10.9752 0 10.7825 0 10.0631 0 0 0 9.17562 0 0 0 0 0 0 13.0257 0 0 0 0 13.7001 13.448 14.4786 13.1911 14.984 14.0043 0 0 13.141 0 0 0 0 10.7964 13.3825 0 0 0 0 Q14669 TRIPC_HUMAN "E3 ubiquitin-protein ligase TRIP12, EC 2.3.2.26 (E3 ubiquitin-protein ligase for Arf, ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12, TR-interacting protein 12, TRIP-12)" TRIP12 KIAA0045 ULF Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006511; GO:0006974; GO:0016607; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:1901315; GO:2000779; GO:2000780 nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630] CLRAILRIIYFADAELLK 0.99262 -45.796 0 0 0 0 0 0 0 0 0 0 0 13.6868 14.2449 13.6559 0 13.4506 13.3726 13.4268 13.2638 13.4264 0 11.0336 0 0 13.628 0 14.151 13.1622 0 0 11.0679 0 0 12.6904 0 0 0 0 13.5552 0 13.3791 13.8746 13.9254 14.7454 12.7415 11.0445 0 0 12.6492 12.2238 12.2207 16.6526 0 0 0 0 0 0 0 14.994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3044 0 0 12.5468 0 0 11.8974 0 0 13.1374 0 13.3791 12.2247 0 15.1657 15.2098 13.3151 0 0 14.4717 14.223 14.3639 17.6273 12.4011 12.989 12.1256 0 12.2827 0 12.8218 13.2483 0 0 11.0441 0 0 11.3557 0 0 13.8233 0 12.7846 0 13.2108 0 0 0 0 0 0 0 13.2906 12.8655 15.9168 0 12.312 0 12.1453 0 0 0 14.4992 0 0 12.021 0 0 0 0 0 15.3646 12.1256 11.9756 0 0 14.4242 0 13.1268 0 0 0 13.8563 0 0 0 11.8068 16.1324 16.1867 14.171 0 16.146 16.1879 15.5813 0 0 0 12.1226 0 13.739 0 0 0 14.5346 0 0 0 Q27J81 INF2_HUMAN Inverted formin-2 (HBEBP2-binding protein C) INF2 C14orf151 C14orf173 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of mitochondrial fission [GO:0090140]; regulation of small GTPase mediated signal transduction [GO:0051056] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; regulation of mitochondrial fission [GO:0090140]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0003779; GO:0030036; GO:0031267; GO:0048471; GO:0051056; GO:0090140 actin binding [GO:0003779]; small GTPase binding [GO:0031267] ARTQLRNEFIGLQLLDVLAR 0.99262 -25.823 0 0 0 0 0 0 0 0 0 0 10.198 0 0 0 0 0 0 0 0 0 10.5479 0 0 10.6803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0704 0 0 0 0 0 0 0 11.7945 0 0 0 0 0 11.764 0 10.9712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9024 0 12.3029 0 13.81 0 0 0 0 15.4198 0 0 0 0 10.0602 0 0 0 0 0 0 0 10.9759 0 0 0 0 0 0 13.6901 14.3483 0 0 0 12.5959 0 0 0 0 10.9005 14.3417 0 12.032 0 11.9033 0 0 0 0 0 0 12.0531 0 0 0 0 0 13.6086 14.6424 0 0 0 0 0 0 0 12.001 0 0 11.1383 0 0 0 0 0 0 0 0 10.7119 11.1978 0 0 0 0 0 11.1081 11.3126 0 0 0 0 0 0 0 0 15.9215 Q2M3G0 ABCB5_HUMAN "ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5, EC 7.6.2.2)" ABCB5 Homo sapiens (Human) cell differentiation [GO:0030154]; eye development [GO:0001654]; regulation of membrane potential [GO:0042391]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; cell differentiation [GO:0030154]; eye development [GO:0001654]; regulation of membrane potential [GO:0042391]; transmembrane transport [GO:0055085] GO:0001654; GO:0005524; GO:0005886; GO:0005887; GO:0008559; GO:0015562; GO:0016021; GO:0030154; GO:0042391; GO:0042626; GO:0055085 ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562] ADEQMESMTYSTERK 0.99262 -17 0 0 0 0 0 0 16.4023 0 0 0 0 11.6636 0 0 13.6614 0 13.2822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0359 0 0 15.9227 12.3458 0 0 0 0 0 0 0 0 15.8125 0 0 0 0 0 14.58 0 13.6496 0 15.6081 0 0 0 0 0 0 0 0 0 0 14.5759 0 0 0 0 0 0 15.8663 0 0 0 0 0 12.6042 0 12.2934 0 0 0 0 16.1903 0 0 13.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5341 0 13.4606 0 0 12.6143 0 0 14.3533 0 0 0 0 11.8304 11.6831 0 0 0 0 0 0 0 0 0 0 16.9668 0 0 0 0 0 0 0 0 Q6P0N0 M18BP_HUMAN "Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog, HsKNL-2) (P243)" MIS18BP1 C14orf106 KIAA1903 KNL2 M18BP1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301] "chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]" GO:0000775; GO:0003677; GO:0005654; GO:0007049; GO:0051301 DNA binding [GO:0003677] AEVKKTK 0.99262 -74.786 0 0 0 0 0 0 0 11.1858 11.9264 0 0 0 0 0 0 0 0 11.5998 0 11.2282 11.4252 0 0 0 0 0 0 0 0 0 11.4056 0 0 0 0 0 10.8035 0 0 0 0 10.4412 0 0 0 0 0 0 0 0 0 0 0 12.4121 0 0 0 0 0 0 10.9067 0 12.7376 0 0 0 11.5377 0 0 0 0 0 0 11.0892 0 0 0 11.0469 0 0 13.4069 0 12.7803 14.0141 14.4471 0 13.9216 14.7274 15.1546 0 13.1445 12.957 13.6877 13.6632 0 14.498 0 0 14.8084 10.1763 12.4464 15.1223 0 0 12.3167 12.5462 12.5441 11.7144 0 14.6658 0 12.6918 13.0697 15.2503 14.3969 11.0808 12.892 0 12.4691 0 0 0 11.8429 0 0 12.3158 0 0 0 0 0 11.1669 11.6133 0 12.3018 0 12.3778 12.0852 0 0 13.3547 12.0101 0 11.16 0 0 12.2922 0 0 0 0 0 0 14.1026 0 0 11.7337 0 0 11.7492 0 0 12.7572 0 0 0 0 0 12.6577 0 0 12.8841 0 12.2942 12.5183 0 11.0972 0 0 0 Q6ZMT9 DTHD1_HUMAN Death domain-containing protein 1 DTHD1 Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 ESFTVTKK 0.99262 -17.015 0 0 0 0 0 0 13.2623 0 12.9008 13.2491 0 0 0 0 12.2089 12.0227 12.5932 0 0 0 12.7443 0 0 0 0 12.5217 12.4294 12.4431 0 11.8065 12.2588 0 13.912 13.7135 0 14.9247 0 0 0 0 0 0 0 0 12.0365 0 0 0 11.7691 12.7448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5193 0 0 0 0 0 0 0 0 0 13.1309 0 0 0 0 0 0 0 0 14.0047 0 0 0 0 12.9917 0 0 0 0 0 0 0 0 0 0 13.0055 0 0 0 0 0 0 0 13.1301 0 0 0 0 0 13.0618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2688 12.5148 0 0 0 12.4549 12.6559 0 14.2987 0 0 0 0 0 0 14.6839 0 0 10.9931 11.5583 0 13.3379 0 0 0 0 0 0 0 0 0 Q7Z7A1 CNTRL_HUMAN "Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa, Cep110)" CNTRL CEP1 CEP110 Homo sapiens (Human) aorta development [GO:0035904]; cell cycle [GO:0007049]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cell cycle [GO:0007049]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281] GO:0001822; GO:0003281; GO:0005813; GO:0005815; GO:0005829; GO:0007049; GO:0008092; GO:0016020; GO:0034451; GO:0035904; GO:0048471; GO:0051301; GO:0051493; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103 cytoskeletal protein binding [GO:0008092] AEAEIELLQNLLRQKGEQFR 0.99262 -45.603 0 10.9347 0 0 0 0 0 0 13.2864 11.6148 13.2014 13.0208 13.4914 13.376 13.2104 13.4189 12.5674 0 0 0 0 0 0 0 0 13.2926 0 13.2755 0 0 13.619 13.3624 13.0774 13.822 0 0 13.3982 13.539 13.3489 12.9634 13.9614 0 10.6548 0 13.294 0 12.3547 0 12.1577 12.7732 0 0 0 11.5421 0 0 0 0 0 10.7829 0 0 0 0 0 0 0 15.1079 0 0 13.2424 15.5149 0 0 14.2858 10.9109 11.9416 0 0 0 14.9819 13.4173 14.5285 17.2225 0 0 13.8218 15.3281 14.8269 0 0 11.6969 14.0693 14.9733 14.7254 0 14.925 16.8143 15.1978 12.7977 14.6798 14.0038 16.0604 0 15.8857 0 16.3522 15.4707 13.8312 14.235 14.5735 0 14.1294 15.2793 14.3357 0 14.0565 13.9424 12.1374 14.3233 14.5361 15.4788 0 0 0 0 13.3305 0 16.5406 16.3228 0 16.3899 13.4422 0 15.2078 16.1252 14.0124 0 16.1849 16.5064 0 16.2171 13.7073 0 0 13.0126 0 14.9931 15.3172 0 0 0 0 0 16.0622 16.452 0 15.2136 14.6272 15.2883 14.7028 14.4389 14.5891 14.5631 14.4977 15.1727 14.7465 14.4686 0 0 0 14.6709 0 13.9227 0 0 13.4624 15.6414 0 0 Q86TM3 DDX53_HUMAN "Probable ATP-dependent RNA helicase DDX53, EC 3.6.4.13 (Cancer-associated gene protein) (Cancer/testis antigen 26, CT26) (DEAD box protein 53) (DEAD box protein CAGE)" DDX53 CAGE Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0016887; GO:0043231 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ILITTDIVSR 0.99262 -6.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7077 13.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVL8 CBPO_HUMAN "Carboxypeptidase O, CPO, EC 3.4.17.-" CPO Homo sapiens (Human) proteolysis [GO:0006508] anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; extracellular space [GO:0005615] anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0016324; GO:0046658 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] AVASFIESK 0.99262 -5.0029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYB3 SRRM1_HUMAN "Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa, SRm160) (Ser/Arg-related nuclear matrix protein)" SRRM1 SRM160 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0008380; GO:0016363; GO:0016607; GO:0048024; GO:0071013 DNA binding [GO:0003677]; RNA binding [GO:0003723] AASPSPQSVRRVSSSR 0.99262 -81.434 0 0 11.2663 0 0 0 0 0 13.4665 0 0 0 17.4465 0 14.1803 13.6123 14.1573 0 0 0 0 0 0 0 0 0 0 13.2496 0 0 0 0 0 0 13.7442 0 11.7016 14.5179 13.8819 12.6668 0 0 0 12.5389 13.7952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9528 0 15.5304 10.8262 16.0205 0 16.0355 11.1612 13.7237 0 0 15.3318 0 0 0 0 14.4009 14.891 0 0 0 0 11.343 14.455 0 14.8453 0 11.6534 13.4201 14.1451 0 0 16.033 16.1575 0 13.8123 16.1953 0 0 0 0 15.2981 0 15.0154 15.2006 0 0 0 0 14.0428 14.502 0 0 0 15.4639 0 0 13.2495 0 16.0597 0 15.2346 14.4395 0 0 0 0 0 0 0 0 0 0 0 0 13.01 0 0 0 0 14.4762 0 14.2011 0 12.0504 14.503 0 13.933 13.9308 0 13.9708 0 14.2453 0 13.9951 0 0 0 0 Q8NA57 CL050_HUMAN Uncharacterized protein C12orf50 C12orf50 Homo sapiens (Human) poly(A)+ mRNA export from nucleus [GO:0016973] mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973] GO:0003729; GO:0016973 mRNA binding [GO:0003729] CREDPSSMNDVQPVKK 0.99262 -6.7004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1174 0 0 0 0 0 0 0 0 0 0 10.6123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6448 0 0 0 0 0 0 13.2098 12.5614 10.5681 12.5869 0 0 13.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1989 13.012 0 12.1252 0 11.8683 0 0 0 0 10.5651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2961 0 Q8NB49 AT11C_HUMAN "Phospholipid-transporting ATPase IG, EC 7.6.2.1 (ATPase IQ) (ATPase class VI type 11C) (P4-ATPase flippase complex alpha subunit ATP11C)" ATP11C ATPIG ATPIQ Homo sapiens (Human) ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332] GO:0000287; GO:0005524; GO:0005765; GO:0005783; GO:0005789; GO:0005802; GO:0005886; GO:0005887; GO:0016887; GO:0031901; GO:0034220; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:0140346; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556] AAVCTTLKYVWQSTPYNDEPWYNQKTQK 0.99262 -17.008 0 0 0 0 0 0 11.4724 0 0 0 0 0 0 0 12.9073 12.924 0 0 0 12.2018 0 0 11.4371 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2419 0 0 0 0 0 0 0 0 14.7028 0 0 0 0 0 0 0 9.39397 0 0 0 0 0 0 0 0 0 11.534 0 0 0 0 12.4156 0 13.816 0 0 0 13.0224 15.3572 0 14.4099 0 12.0885 0 0 15.2329 15.5245 0 0 11.3513 0 0 0 12.1452 12.1566 13.3887 13.1928 0 0 0 11.7914 0 12.9149 13.1875 14.7157 0 0 0 13.0997 0 12.8889 12.4015 12.0033 0 0 0 15.0817 0 13.4192 13.1847 13.6555 0 0 15.5402 13.0987 14.4308 14.1069 0 11.6202 0 13.049 0 14.3492 14.8056 0 0 13.899 13.2174 0 0 0 10.9773 13.9003 0 0 0 0 0 0 0 0 0 12.8259 13.1359 13.0156 0 0 13.1775 0 0 0 12.8786 14.3049 13.4979 0 13.6657 0 0 0 0 0 11.3535 13.933 0 13.9209 11.6621 13.0761 0 0 0 0 0 0 Q8NHY2 COP1_HUMAN "E3 ubiquitin-protein ligase COP1, EC 2.3.2.27 (Constitutive photomorphogenesis protein 1 homolog, hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2)" COP1 RFWD2 RNF200 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to ionizing radiation [GO:0010212] GO:0004842; GO:0005654; GO:0005829; GO:0010212; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] CGHSFCYK 0.99262 -5.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1652 14.812 13.5641 0 0 0 0 0 0 0 0 0 0 14.9698 0 0 0 0 0 0 0 13.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4621 Q96G03 PGM2_HUMAN "Phosphopentomutase, EC 5.4.2.7 (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphoglucomutase-2, EC 5.4.2.2)" PGM2 MSTP006 Homo sapiens (Human) glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; purine ribonucleoside salvage [GO:0006166] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; glucose metabolic process [GO:0006006]; glycogen catabolic process [GO:0005980]; purine ribonucleoside salvage [GO:0006166] GO:0000287; GO:0004614; GO:0005576; GO:0005829; GO:0005980; GO:0006006; GO:0006166; GO:0008973; GO:0034774; GO:0070062; GO:1904813 magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973] DGVSAAVISAELASFLATKNLSLSQQLKAIYVEYGYHITK 0.99262 -6.6981 0 0 0 0 0 0 0 0 11.2867 0 0 0 0 11.4619 0 12.3857 11.9681 11.1626 0 0 0 0 0 0 0 0 12.2688 0 12.6633 0 0 0 0 0 0 0 0 12.9351 0 0 0 0 0 0 12.5001 0 0 0 13.8982 12.3725 12.8261 0 0 0 0 13.3544 11.8508 13.3941 13.1673 13.6116 12.8142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6232 0 0 0 0 19.1441 0 0 0 0 13.138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.313 19.1672 0 0 0 0 0 0 19.0837 19.0792 0 0 19.1114 0 19.1162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4521 0 0 0 13.7971 13.8959 0 0 13.7929 15.2813 13.9101 14.8972 13.6215 14.2835 14.6696 0 0 0 0 15.2026 0 13.2512 0 0 Q96PE2 ARHGH_HUMAN "Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor, p164-RhoGEF, p164RhoGEF) (Tumor endothelial marker 4)" ARHGEF17 KIAA0337 TEM4 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005829; GO:0030036; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] AIPIMKTR 0.99262 -40.887 0 11.7914 0 0 0 0 0 0 12.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2488 0 0 13.628 0 15.9482 0 13.569 0 0 0 0 0 0 0 0 14.0904 0 0 12.3246 0 14.8496 12.3412 0 0 0 0 0 0 0 0 0 0 0 0 12.893 13.6999 13.1012 13.0487 13.7007 14.4243 0 0 0 13.1233 0 13.5425 14.3579 0 0 0 12.0715 0 15.6471 0 0 0 12.8265 14.9734 0 0 13.6948 13.7782 0 0 0 0 0 0 0 0 0 16.4976 0 0 0 11.7799 0 0 12.2405 0 14.5701 0 0 0 0 0 0 14.4841 15.4127 0 0 0 0 0 0 Q99884 SC6A7_HUMAN Sodium-dependent proline transporter (Solute carrier family 6 member 7) SLC6A7 PROT Homo sapiens (Human) neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298]; neurotransmitter transport [GO:0006836]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725] GO:0005298; GO:0005886; GO:0005887; GO:0006836; GO:0015193; GO:0015824; GO:0016020; GO:0035725 L-proline transmembrane transporter activity [GO:0015193]; proline:sodium symporter activity [GO:0005298] EIAEEEESMM 0.99262 -6.1582 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5672 0 0 0 0 0 9.63176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5631 0 0 0 0 0 0 0 11.4282 0 0 0 0 0 0 0 0 11.5796 0 0 0 0 0 11.2625 0 0 0 0 0 0 12.3479 0 0 0 0 0 0 0 11.7573 12.7444 0 12.6837 0 0 0 0 0 11.0704 11.1637 0 0 0 0 0 0 0 11.5767 0 0 0 0 Q9BQ69 MACD1_HUMAN "ADP-ribose glycohydrolase MACROD1 (MACRO domain-containing protein 1) (O-acetyl-ADP-ribose deacetylase MACROD1, EC 3.1.1.106) (Protein LRP16) ([Protein ADP-ribosylaspartate] hydrolase MACROD1, EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD1, EC 3.2.2.-)" MACROD1 LRP16 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]" GO:0005634; GO:0005654; GO:0006974; GO:0016798; GO:0019213; GO:0042278; GO:0051725; GO:0140291; GO:0140293 "ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]" DFVRLKK 0.99262 -16.997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9411 0 0 0 13.5266 0 0 13.725 13.8767 0 13.3581 0 0 0 0 0 0 0 0 13.1529 0 0 0 11.7835 0 0 0 0 0 0 0 0 0 0 0 0 13.3226 0 13.7996 14.1376 0 0 0 0 0 0 13.9205 14.8672 14.3133 0 0 0 0 0 0 0 0 14.1989 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6654 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5052 0 0 0 13.5943 0 Q9H5Q4 TFB2M_HUMAN "Dimethyladenosine transferase 2, mitochondrial, EC 2.1.1.- (Hepatitis C virus NS5A-transactivated protein 5, HCV NS5A-transactivated protein 5) (Mitochondrial 12S rRNA dimethylase 2) (Mitochondrial transcription factor B2, h-mtTFB, h-mtTFB2, hTFB2M, mtTFB2) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2)" TFB2M NS5ATP5 Homo sapiens (Human) mitochondrial transcription [GO:0006390]; rRNA methylation [GO:0031167]; transcription initiation from mitochondrial promoter [GO:0006391] mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; transcription coregulator activity [GO:0003712]; mitochondrial transcription [GO:0006390]; rRNA methylation [GO:0031167]; transcription initiation from mitochondrial promoter [GO:0006391]" GO:0000179; GO:0003712; GO:0003723; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0031167; GO:0034246; GO:0042645 "mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; transcription coregulator activity [GO:0003712]" LRLSALAGAGR 0.99262 -15.135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87971 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4678 0 0 0 12.8575 12.9225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1008 0 13.1509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0251 12.624 0 0 0 0 0 0 0 13.2784 0 0 0 0 0 13.2222 12.0079 0 0 13.7252 0 0 0 0 0 0 12.9895 0 0 0 0 0 0 0 0 0 12.9127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.718 0 0 0 0 0 0 0 0 0 Q9H7B4 SMYD3_HUMAN "Histone-lysine N-methyltransferase SMYD3, EC 2.1.1.354 (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1)" SMYD3 ZMYND1 ZNFN3A1 Homo sapiens (Human) cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; histone lysine methylation [GO:0034968]; myotube cell development [GO:0014904]; negative regulation of protein kinase activity [GO:0006469]; nucleosome assembly [GO:0006334]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0006469; GO:0014904; GO:0018024; GO:0033138; GO:0034968; GO:0045184; GO:0045944; GO:0046872; GO:0071549 histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162] AVTPLRPGELLFRSDPLAYTVCK 0.99262 -6.7024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7107 0 0 0 0 0 0 0 0 0 0 9.75789 0 0 0 0 0 12.6705 11.5204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4394 0 0 14.4456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7828 0 0 0 0 0 0 0 0 13.0155 0 0 0 0 0 0 0 0 11.8004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0548 0 0 0 0 0 12.086 0 11.2161 0 11.9012 0 0 0 0 0 0 0 12.414 0 0 0 0 0 0 0 0 0 0 0 0 13.8861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHC1 MLH3_HUMAN DNA mismatch repair protein Mlh3 (MutL protein homolog 3) MLH3 Homo sapiens (Human) female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696]; female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130] GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696] ACSETEESNTCCSDWQR 0.99262 -40.79 0 0 0 0 0 0 0 0 13.0813 12.0308 11.5844 14.9388 0 11.677 10.7551 0 0 11.6422 0 0 0 0 0 0 0 0 10.4061 0 13.8563 0 10.9665 0 11.7975 0 14.3195 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1812 0 0 10.5638 0 12.1268 12.6792 0 13.2316 0 0 0 0 0 0 0 0 0 12.1929 12.307 12.82 15.232 10.2874 0 0 0 12.0722 15.4263 13.7325 15.6819 12.8355 15.7639 14.2592 0 0 14.8402 12.2382 0 14.4343 0 0 0 13.8652 0 0 0 12.4967 0 0 0 14.7393 0 0 0 12.8569 0 0 10.8645 14.665 0 0 16.5755 0 0 0 0 10.3725 11.3339 13.7878 13.9551 12.9326 0 15.284 14.5175 14.6289 13.0648 0 0 13.1296 14.6046 12.9566 13.876 0 11.6039 11.1434 0 0 0 0 0 14.4803 10.889 0 12.9245 0 0 0 0 0 13.253 0 0 0 9.80329 0 0 11.1878 13.7553 13.7118 13.3619 14.5887 13.1156 13.3436 14.1628 0 13.582 0 12.0361 0 0 0 14.6441 14.9796 15.1763 0 0 11.9647 0 0 13.2177 0 10.9183 Q9Y219 JAG2_HUMAN "Protein jagged-2, Jagged2, hJ2" JAG2 Homo sapiens (Human) auditory receptor cell fate commitment [GO:0009912]; cell differentiation [GO:0030154]; epithelial cell apoptotic process involved in palatal shelf morphogenesis [GO:1990134]; gamma-delta T cell differentiation [GO:0042492]; in utero embryonic development [GO:0001701]; morphogenesis of embryonic epithelium [GO:0016331]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; respiratory system process [GO:0003016]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]; thymic T cell selection [GO:0045061] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; auditory receptor cell fate commitment [GO:0009912]; cell differentiation [GO:0030154]; epithelial cell apoptotic process involved in palatal shelf morphogenesis [GO:1990134]; gamma-delta T cell differentiation [GO:0042492]; in utero embryonic development [GO:0001701]; morphogenesis of embryonic epithelium [GO:0016331]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of cell adhesion [GO:0030155]; regulation of cell population proliferation [GO:0042127]; respiratory system process [GO:0003016]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]; thymic T cell selection [GO:0045061] GO:0001501; GO:0001701; GO:0003016; GO:0005112; GO:0005509; GO:0005886; GO:0005887; GO:0007219; GO:0007283; GO:0008083; GO:0009912; GO:0016331; GO:0030154; GO:0030155; GO:0030217; GO:0042127; GO:0042475; GO:0042492; GO:0045061; GO:0045747; GO:1990134 calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112] ACMDGWMGK 0.99262 -15.139 0 0 10.1611 0 0 0 0 10.7576 0 12.0179 13.2963 0 0 13.3461 0 0 12.2497 0 0 0 0 13.3987 0 0 9.15175 0 13.6069 0 0 0 11.2617 0 0 12.4858 11.7032 10.7577 13.4446 0 0 12.2191 0 0 0 10.2521 0 0 0 0 0 0 10.7015 12.9577 0 0 0 0 0 0 0 0 0 0 10.8981 0 0 0 0 12.694 0 0 0 0 13.3759 0 12.8116 0 10.052 13.9136 0 12.3843 12.9933 11.7746 13.6614 14.0643 0 0 12.1422 0 12.5903 15.6539 0 12.1896 15.9298 12.9965 15.5998 0 0 0 0 15.3689 0 15.0354 14.0802 11.028 14.8025 11.923 16.0941 15.202 0 11.6637 0 14.4179 15.5379 0 11.789 15.8027 0 0 10.9721 0 12.3888 12.4706 11.2895 13.3229 14.8768 0 13.6746 0 0 0 0 0 14.1238 12.9875 12.582 11.5069 15.4816 15.0757 0 0 13.8658 12.7804 0 0 15.0904 12.391 0 12.8009 0 0 13.6869 12.1863 0 0 13.2284 12.2654 0 0 13.2327 0 15.4851 0 16.2804 11.8734 13.8901 0 0 14.5509 15.7504 14.8449 0 0 14.199 12.4874 0 11.5622 13.8062 13.4634 0 0 O75526 RMXL2_HUMAN "RNA-binding motif protein, X-linked-like-2 (Testis-specific heterogeneous nuclear ribonucleoprotein G-T, hnRNP G-T)" RBMXL2 HNRNPGT Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" U12-type spliceosomal complex [GO:0005689] "U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; snRNA binding [GO:0017069]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003729; GO:0005689; GO:0017069 mRNA binding [GO:0003729]; snRNA binding [GO:0017069] DPYLGPR 0.99263 -25.994 0 0 0 0 0 0 10.6199 0 13.9474 13.3126 0 0 0 0 0 0 0 12.1958 0 0 11.3346 13.7063 0 0 0 0 10.3396 0 0 0 0 0 0 0 0 11.3824 12.9618 0 0 13.7294 0 0 0 13.2048 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0129 0 0 0 0 0 0 0 10.1085 12.2642 12.2437 0 0 0 0 8.8489 0 0 0 0 0 15.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3957 0 0 0 0 0 0 0 0 0 0 0 0 13.3483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4129 0 0 0 0 0 0 0 13.2074 0 15.5577 0 0 0 0 0 0 12.868 14.8593 15.8318 19.2066 0 13.5291 19.2921 15.0237 13.6463 13.657 13.8295 0 13.8063 14.9164 14.0645 0 0 0 0 14.2319 11.3947 13.8091 12.2285 0 A5PLN7 F149A_HUMAN Protein FAM149A FAM149A MST119 Homo sapiens (Human) GLSEGRR 0.99263 -17.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15504 NUP42_HUMAN Nucleoporin NUP42 (NLP-1) (NUP42 homolog) (Nucleoporin hCG1) (Nucleoporin-42) (Nucleoporin-like protein 2) NUP42 CG1 NUPL2 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611] GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006611; GO:0006913; GO:0031965; GO:0046872; GO:0051028 metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723] CRFGDRCWNEHPGAR 0.99263 -6.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.662 0 0 0 10.8037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1032 0 0 13.7849 0 13.4746 12.4715 0 14.9932 0 14.262 0 0 0 0 0 0 13.6117 0 0 0 14.198 14.5223 0 0 0 0 0 13.7138 14.0276 0 0 0 0 0 0 0 0 0 0 0 14.4877 13.4995 13.7746 0 0 0 0 0 13.4905 0 0 0 11.6571 0 0 0 0 0 0 12.943 0 0 0 0 0 12.723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7804 0 0 0 0 0 0 0 O75691 UTP20_HUMAN "Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73, NNP73) (Protein Key-1A6)" UTP20 DRIM Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]" "90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]" "90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; rRNA processing [GO:0006364]" GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040 RNA binding [GO:0003723] AADRLLFSFLTLITKLIK 0.99263 -24.126 0 9.87529 0 0 13.0867 0 0 0 0 9.80731 13.5061 0 0 12.7651 11.2978 0 12.7795 13.1682 10.8152 0 15.3651 12.0677 11.6794 9.75495 0 11.4776 13.3516 0 0 12.3671 0 12.0562 18.6786 10.8081 0 0 11.2318 0 0 0 11.4894 0 0 0 11.5454 0 0 0 0 10.6145 0 0 13.8628 0 11.5872 0 0 0 0 0 0 0 0 0 0 0 0 13.1632 15.4953 0 12.231 10.7226 11.47 10.8506 13.807 14.6465 17.8856 14.7358 15.2445 14.7694 15.219 13.1044 17.6232 0 16.0879 14.2099 15.4043 12.8828 17.7592 15.3227 15.4539 14.1863 13.8756 14.7055 13.9506 14.7121 0 17.3247 14.0492 14.2343 0 15.3199 13.3632 16.2354 12.4482 14.815 13.1508 15.9584 13.5807 15.3937 18.7083 0 15.2076 13.6781 14.8909 13.489 14.1931 17.869 12.4807 13.8617 14.6709 12.9319 14.7032 17.9893 14.2718 13.9971 15.172 13.6278 16.6498 15.6114 14.097 13.1313 17.6 15.6817 13.628 14.4149 14.2784 15.2369 13.2362 14.5294 14.6938 14.0085 13.8569 14.4466 13.1452 13.2727 14.3908 0 0 13.8704 16.9978 12.9684 0 16.4883 0 14.3202 17.4325 0 12.4827 0 13.1047 0 12.2523 14.8491 0 0 13.5505 14.8742 15.0561 15.2253 13.1318 14.0987 0 13.4073 12.6342 12.3148 0 0 0 0 O95471 CLD7_HUMAN "Claudin-7, CLDN-7" CLDN7 CEPTRL2 CPETRL2 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; response to ethanol [GO:0045471] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; response to ethanol [GO:0045471] GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0007162; GO:0008284; GO:0016021; GO:0016323; GO:0016327; GO:0016328; GO:0016338; GO:0019904; GO:0031333; GO:0042802; GO:0043066; GO:0045471; GO:0050839; GO:0070830; GO:2000147 cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198] CTRCGGDDK 0.99263 -5.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0317 0 0 0 0 0 0 0 0 0 0 0 15.0794 0 0 0 0 0 12.9294 0 0 0 0 0 0 0 0 0 10.9579 13.2801 0 0 0 0 0 0 0 11.5141 0 13.6062 11.9114 11.1171 0 0 0 0 0 0 0 0 0 0 0 14.3219 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0285 0 0 0 0 0 0 0 0 0 11.3241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13942 COBA2_HUMAN Collagen alpha-2(XI) chain COL11A2 Homo sapiens (Human) cartilage development [GO:0051216]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; soft palate development [GO:0060023] collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; cartilage development [GO:0051216]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; soft palate development [GO:0060023] GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005592; GO:0005615; GO:0005788; GO:0007605; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0031012; GO:0046872; GO:0051216; GO:0060021; GO:0060023; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674] AGADGAR 0.99263 -25.959 0 0 0 0 0 0 0 12.9453 0 0 0 0 0 0 0 0 0 13.4578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0926 0 0 12.0749 0 0 0 0 0 0 9.99746 0 0 0 0 0 0 0 0 0 0 15.1456 0 0 0 0 0 0 12.861 0 0 0 14.0708 13.2253 13.5801 0 0 0 14.1286 11.9416 0 11.2655 0 13.6983 15.0261 14.8633 0 13.964 14.5209 0 0 0 17.4833 0 0 14.0071 0 0 0 0 0 0 0 13.9489 13.5686 0 0 12.9741 14.1184 0 0 0 0 0 0 0 14.6127 0 0 0 0 0 0 0 0 0 0 0 14.554 0 0 14.0512 0 0 0 0 14.6629 13.1272 0 0 0 0 13.0282 0 0 0 0 0 0 12.5308 0 14.7379 0 0 0 0 0 0 0 0 0 13.8837 0 0 0 0 12.8507 0 0 12.6556 0 15.0851 0 0 13.5063 P48357 LEPR_HUMAN "Leptin receptor, LEP-R (HuB219) (OB receptor, OB-R) (CD antigen CD295)" LEPR DB OBR Homo sapiens (Human) angiogenesis [GO:0001525]; bone growth [GO:0098868]; cell surface receptor signaling pathway [GO:0007166]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; energy homeostasis [GO:0097009]; energy reserve metabolic process [GO:0006112]; glial cell proliferation [GO:0014009]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glycogen metabolic process [GO:0005977]; leptin-mediated signaling pathway [GO:0033210]; multicellular organism development [GO:0007275]; negative regulation of autophagy [GO:0010507]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of hydrolase activity [GO:0051346]; phagocytosis [GO:0006909]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein phosphorylation [GO:0001934]; regulation of bone remodeling [GO:0046850]; regulation of feeding behavior [GO:0060259]; regulation of transport [GO:0051049]; response to leptin [GO:0044321]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235] basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; leptin receptor activity [GO:0038021]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]; angiogenesis [GO:0001525]; bone growth [GO:0098868]; cell surface receptor signaling pathway [GO:0007166]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; energy homeostasis [GO:0097009]; energy reserve metabolic process [GO:0006112]; glial cell proliferation [GO:0014009]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glycogen metabolic process [GO:0005977]; leptin-mediated signaling pathway [GO:0033210]; multicellular organism development [GO:0007275]; negative regulation of autophagy [GO:0010507]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of hydrolase activity [GO:0051346]; phagocytosis [GO:0006909]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein phosphorylation [GO:0001934]; regulation of bone remodeling [GO:0046850]; regulation of feeding behavior [GO:0060259]; regulation of transport [GO:0051049]; response to leptin [GO:0044321]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; transport across blood-brain barrier [GO:0150104] GO:0001525; GO:0001934; GO:0004888; GO:0004896; GO:0005576; GO:0005977; GO:0006094; GO:0006112; GO:0006909; GO:0007166; GO:0007275; GO:0008203; GO:0009897; GO:0010507; GO:0014009; GO:0016021; GO:0016323; GO:0017046; GO:0019221; GO:0019953; GO:0019955; GO:0030217; GO:0033210; GO:0038021; GO:0042593; GO:0042802; GO:0043235; GO:0044321; GO:0045721; GO:0046850; GO:0051049; GO:0051346; GO:0060259; GO:0097009; GO:0098868; GO:0120162; GO:0150104 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; leptin receptor activity [GO:0038021]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888] ENKIVPSK 0.99263 -18.401 0 0 0 0 0 0 0 0 0 0 0 13.6093 12.2369 0 12.2868 0 12.9681 0 0 0 0 0 0 0 0 12.4849 12.7405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5964 12.2351 0 0 0 0 12.9601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4369 0 0 0 0 0 0 0 0 0 13.3444 0 13.1374 0 0 0 0 0 0 13.0169 0 0 0 0 0 0 13.1138 12.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1803 0 18.3196 0 0 0 0 0 13.3176 0 0 12.302 0 0 0 0 0 0 0 12.2821 0 0 13.7009 13.5097 0 0 13.733 0 0 0 0 0 0 0 0 13.4867 0 0 0 0 0 0 0 0 0 13.6401 0 12.6876 14.2847 0 0 0 13.943 13.9541 0 14.2467 0 13.7447 0 0 0 0 0 11.3127 0 0 0 0 Q13201 MMRN1_HUMAN "Multimerin-1 (EMILIN-4) (Elastin microfibril interface located protein 4, Elastin microfibril interfacer 4) (Endothelial cell multimerin) [Cleaved into: Platelet glycoprotein Ia*; 155 kDa platelet multimerin, p-155, p155 ]" MMRN1 ECM EMILIN4 GPIA* MMRN Homo sapiens (Human) blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of wound healing [GO:0061045]; positive regulation of platelet aggregation [GO:1901731] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; multimerin complex [GO:1990972]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; multimerin complex [GO:1990972]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; calcium ion binding [GO:0005509]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of wound healing [GO:0061045]; positive regulation of platelet aggregation [GO:1901731] GO:0005509; GO:0005576; GO:0007155; GO:0007596; GO:0031091; GO:0031093; GO:0033627; GO:0061045; GO:0062023; GO:1901731; GO:1990972 calcium ion binding [GO:0005509] GDSSSSQR 0.99263 -18.384 0 14.9946 14.5145 13.6354 0 0 0 11.8744 0 14.0357 0 0 0 0 0 12.1103 0 0 0 0 0 0 0 0 0 11.041 0 0 0 0 0 0 0 0 0 0 0 17.2452 0 0 0 0 0 0 0 0 15.1657 0 14.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0188 0 0 0 0 0 0 0 0 11.5773 0 0 0 0 12.5515 0 13.2215 12.5564 11.995 14.0435 14.1823 0 0 0 0 0 12.9176 0 0 12.9091 0 0 13.9056 0 0 12.6103 0 0 10.0614 0 0 0 0 14.1538 12.6259 0 16.5768 0 0 12.8559 12.8354 0 0 0 0 0 0 0 0 0 0 0 11.3623 0 0 13.0443 0 0 13.8833 14.2966 0 0 0 0 0 0 0 0 0 0 0 0 14.3915 14.0406 14.7029 0 0 0 0 0 0 0 0 12.9538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1729 Q13423 NNTM_HUMAN "NAD(P) transhydrogenase, mitochondrial, EC 7.1.1.1 (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)" NNT Homo sapiens (Human) NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; tricarboxylic acid cycle [GO:0006099] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; tricarboxylic acid cycle [GO:0006099] GO:0003957; GO:0005739; GO:0005743; GO:0005746; GO:0006099; GO:0006740; GO:0008746; GO:0016020; GO:0016021; GO:0050661; GO:0051287; GO:0072593; GO:1902600 NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661] KAPVLFNK 0.99263 -14.826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8163 0 0 0 0 0 0 0 0 0 0 12.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9281 0 0 0 0 0 0 0 0 0 0 13.1502 14.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14129 DGCR6_HUMAN Protein DGCR6 (DiGeorge syndrome critical region 6) DGCR6 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155] extracellular matrix [GO:0031012]; nucleus [GO:0005634] extracellular matrix [GO:0031012]; nucleus [GO:0005634]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155] GO:0005634; GO:0007155; GO:0009887; GO:0031012 IVLELDRK 0.99263 -7.2081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14585 ZN345_HUMAN Zinc finger protein 345 (Zinc finger protein HZF10) ZNF345 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]" GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0006359; GO:0006366; GO:0006383; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFGSGSK 0.99263 -17.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14980 NUMA1_HUMAN "Nuclear mitotic apparatus protein 1 (Nuclear matrix protein-22, NMP-22) (Nuclear mitotic apparatus protein, NuMA protein) (SP-H antigen)" NUMA1 NMP22 NUMA Homo sapiens (Human) anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236] GO:0000132; GO:0000139; GO:0000922; GO:0001578; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005938; GO:0006997; GO:0007059; GO:0008017; GO:0008022; GO:0015631; GO:0016328; GO:0016363; GO:0019897; GO:0019904; GO:0030425; GO:0030513; GO:0030953; GO:0031116; GO:0031616; GO:0032388; GO:0032991; GO:0035091; GO:0035371; GO:0036449; GO:0043025; GO:0044877; GO:0045618; GO:0051010; GO:0051011; GO:0051301; GO:0051321; GO:0051798; GO:0051984; GO:0055028; GO:0055048; GO:0060236; GO:0061673; GO:0070062; GO:0070840; GO:0072686; GO:0090235; GO:0097427; GO:0097431; GO:0097575; GO:0097718; GO:0099738; GO:1902365; GO:1902846; GO:1904778; GO:1905720; GO:1905820; GO:1905832; GO:1990023 disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631] ATSCFPR 0.99263 -17.043 0 0 0 0 0 0 0 0 13.3428 10.247 17.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6714 14.2646 15.9758 16.4835 0 14.5132 0 14.7031 0 0 14.8261 16.4451 16.619 16.4325 16.8274 16.6957 14.3699 0 0 17.0089 14.5548 0 14.5886 0 0 0 0 13.6334 0 0 0 17.7098 0 0 14.9614 0 0 0 0 0 0 0 0 0 0 0 13.8553 0 13.6595 0 0 0 12.6578 0 0 0 17.3691 0 14.5042 0 0 12.255 0 0 0 0 0 0 0 0 12.3819 0 14.1455 0 0 0 0 0 0 11.3602 13.5475 0 0 12.4601 0 0 0 0 0 12.9661 15.2159 12.5681 0 0 0 0 0 0 0 0 12.7935 0 0 0 0 0 0 11.7676 0 0 0 0 16.279 13.4861 0 0 0 0 0 12.6197 0 12.8658 0 0 0 0 10.7933 13.2811 0 0 0 0 0 0 0 13.4251 0 15.7799 0 0 0 0 12.1706 0 0 0 0 0 0 0 0 15.4016 Q52LW3 RHG29_HUMAN Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29) ARHGAP29 PARG1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0030165; GO:0032991; GO:0046872; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165] AKLLCMQR 0.99263 -25.91 0 0 0 0 0 0 0 0 0 0 11.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9117 0 0 10.3796 0 0 0 0 0 0 0 0 10.7378 0 0 0 11.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.294 0 13.0228 0 12.9583 0 15.6035 0 14.5838 0 15.9733 0 0 0 0 15.2214 0 0 0 15.0841 0 0 0 13.8037 12.4696 12.4043 0 13.7248 0 0 0 0 13.0548 0 0 0 0 0 13.0501 0 0 0 0 0 11.58 13.5558 0 0 0 13.0469 0 0 12.8176 0 15.022 0 0 0 13.2563 0 0 0 13.0059 13.6122 12.735 14.6653 13.3046 0 0 0 13.5174 0 0 0 14.1105 13.5229 0 0 0 0 13.0944 0 0 0 0 0 18.9158 0 0 0 0 0 0 0 0 0 13.6527 0 13.7458 0 12.9757 0 0 10.863 0 Q68CQ1 MROH7_HUMAN Maestro heat-like repeat-containing protein family member 7 (HEAT repeat-containing protein 8) MROH7 C1orf175 HEATR8 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] GO:0005615; GO:0005737; GO:0016021 DKEETNK 0.99263 -17.499 0 0 0 14.9071 0 0 0 0 15.4584 0 0 14.1827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8462 0 0 0 0 0 14.8953 10.0576 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1908 0 0 0 0 0 0 11.9971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5971 0 0 0 0 0 0 13.5729 0 0 0 12.1198 14.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6263 0 11.1098 0 0 0 0 13.6568 0 0 0 13.6551 0 0 0 0 0 0 0 0 0 0 0 13.4737 0 14.995 0 0 13.9648 0 0 0 0 13.7826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YQ0 CYTSA_HUMAN "Cytospin-A (Renal carcinoma antigen NY-REN-22) (Sperm antigen with calponin homology and coiled-coil domains 1-like, SPECC1-like protein)" SPECC1L CYTSA KIAA0376 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; gap junction [GO:0005921]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301] GO:0005737; GO:0005815; GO:0005819; GO:0005921; GO:0007049; GO:0007155; GO:0015629; GO:0030036; GO:0031941; GO:0051301 AQLENEKQK 0.99263 -25.913 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6187 0 0 0 0 0 0 11.7538 14.5524 0 0 0 0 0 0 0 13.0772 0 0 0 0 0 0 0 0 0 0 13.8299 0 0 0 0 0 0 0 14.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3097 0 0 0 0 0 0 0 0 0 13.0233 14.152 0 14.2879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9503 12.7693 0 0 0 13.0958 0 0 0 0 12.7256 0 Q6T4P5 PLPR3_HUMAN "Phospholipid phosphatase-related protein type 3 (Inactive phospholipid phosphatase PLPPR3) (Lipid phosphate phosphatase-related protein type 3) (PAP-2-like protein 2) (Plasticity-related gene 2 protein, PRG-2)" PLPPR3 LPPR3 PHP2 PRG2 Homo sapiens (Human) phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0042577; GO:0046839 lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195] AAGGGAK 0.99263 -18.409 10.4623 0 0 0 0 0 0 14.4015 0 0 0 11.3239 0 0 0 11.6516 0 0 0 0 11.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9122 0 11.8588 0 0 0 0 0 0 0 0 0 0 0 9.61502 0 12.5546 0 0 0 0 10.0807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4944 0 0 0 0 0 11.6391 13.8228 13.7939 0 12.3913 11.4827 0 14.9357 0 0 0 0 0 0 0 0 13.1548 0 11.762 0 14.4848 0 0 13.7487 14.4278 0 13.5026 16.2444 13.2203 12.8407 13.0957 0 0 12.9729 0 0 15.0734 0 0 13.5915 13.366 13.7764 15.0493 14.2821 14.3995 12.4038 0 0 13.9454 14.1193 0 12.4507 0 14.3063 14.8573 13.6809 14.8578 0 0 13.2868 0 12.8439 0 15.661 0 12.5376 12.8543 11.5866 13.97 11.2318 0 0 0 0 15.6149 13.5772 0 0 0 0 14.4721 0 0 0 0 0 0 0 13.1831 13.3224 0 0 0 0 0 0 0 13.701 13.5467 0 15.0359 0 0 14.0964 Q6UWJ1 TMCO3_HUMAN Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein) TMCO3 C13orf11 UNQ2419/PRO4976 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386] GO:0015386; GO:0016021 potassium:proton antiporter activity [GO:0015386] AGVISREVYLLILSVTTLSLLLAPVLWRAAITR 0.99263 -14.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4963 0 13.0296 11.7984 0 0 0 12.8882 12.1826 0 0 11.6939 11.4256 0 0 0 0 0 0 0 0 12.4159 12.0361 0 0 0 0 0 0 0 0 10.4107 0 0 0 0 0 0 0 0 0 0 0 11.3636 0 11.133 0 0 13.8202 14.0906 14.5067 0 0 0 0 0 0 0 0 12.8127 0 0 0 0 0 0 0 0 0 0 14.3295 0 16.0939 0 0 0 12.6476 0 0 0 13.3696 0 0 0 14.4045 14.9414 0 14.5534 14.3127 0 0 0 0 0 0 14.5247 0 14.1867 0 13.9935 15.9868 12.7899 0 13.8282 0 13.5127 0 13.5892 0 14.7154 0 0 13.4778 13.8876 14.3259 0 0 0 15.0183 0 0 0 0 0 0 0 0 0 0 12.1249 0 0 0 0 12.0697 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5347 0 0 0 12.1635 0 0 14.0797 0 Q7L8S5 OTU6A_HUMAN "OTU domain-containing protein 6A, EC 3.4.19.12 (DUBA-2)" OTUD6A DUBA2 Homo sapiens (Human) protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168] cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168] GO:0004843; GO:0016579; GO:0035523; GO:0035871; GO:1990167; GO:1990168 cysteine-type deubiquitinase activity [GO:0004843] KPIILVYLR 0.99263 -7.2089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5083 0 0 0 0 0 0 0 0 0 11.0598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4B1 SESQ1_HUMAN "Sesquipedalian-1, Ses1 (27 kDa inositol polyphosphate phosphatase-interacting protein A, IPIP27A) (PH domain-containing endocytic trafficking adaptor 1)" PHETA1 FAM109A Homo sapiens (Human) "endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]" clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] "clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; protein homodimerization activity [GO:0042803]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037 protein homodimerization activity [GO:0042803] ENGCAVWSTEATFR 0.99263 -6.3658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0385 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MM6 HS12B_HUMAN Heat shock 70 kDa protein 12B HSPA12B C20orf60 Homo sapiens (Human) ATP binding [GO:0005524] GO:0005524 ATP binding [GO:0005524] AGALNISLPFSFIDFYRKQR 0.99263 -17.038 0 0 0 0 0 0 0 0 0 0 0 0 15.066 0 0 0 0 0 0 11.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4232 0 0 0 0 0 0 0 14.2534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2309 0 0 0 0 0 18.823 0 17.7367 0 0 0 0 11.8664 0 0 0 14.1346 0 0 0 0 0 0 0 0 0 0 0 0 13.4932 0 0 0 0 0 0 15.2625 13.5205 0 10.8826 0 0 14.3635 13.8846 0 0 12.6546 0 10.0518 0 0 13.8221 14.2334 0 0 0 0 13.8981 0 0 0 0 0 11.3927 0 0 0 0 0 0 0 0 14.8104 0 0 18.1933 0 0 12.1921 18.1059 0 0 0 0 0 0 0 0 0 0 12.295 0 0 13.1653 0 0 0 0 0 0 0 0 0 14.6077 0 0 0 0 0 0 0 0 12.5468 Q9H814 PHAX_HUMAN Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein) PHAX RNUXA Homo sapiens (Human) protein transport [GO:0015031]; RNA stabilization [GO:0043489]; snRNA export from nucleus [GO:0006408] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA cap binding complex binding [GO:0140262]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643]; protein transport [GO:0015031]; RNA stabilization [GO:0043489]; snRNA export from nucleus [GO:0006408] GO:0003723; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006408; GO:0015030; GO:0015031; GO:0015643; GO:0043025; GO:0043489; GO:0140262; GO:1990904 mRNA cap binding complex binding [GO:0140262]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643] DLIARVVR 0.99263 -17.539 14.5677 15.2044 15.1001 0 12.6924 14.0528 14.5873 0 0 0 0 0 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7542 0 16.347 0 15.8033 0 0 15.774 16.0052 15.3001 16.4191 16.1318 16.3712 0 0 12.1636 0 0 0 0 13.6259 12.4739 0 0 13.6626 13.7209 0 0 12.5664 0 15.8763 0 0 14.7177 13.7335 0 13.8363 0 14.1775 0 12.0293 14.0106 0 0 0 0 0 15.3741 0 0 0 13.79 15.5569 13.8361 13.6584 0 14.2109 14.9439 0 0 0 0 14.1484 15.6023 12.2607 15.6808 15.5084 15.1595 15.816 0 13.4964 14.0118 14.8626 16.1907 15.4537 13.8957 0 0 0 0 0 0 14.904 0 14.1704 15.3244 12.9242 0 0 0 0 0 0 0 0 12.0041 0 0 0 0 0 0 13.0079 0 14.085 0 0 13.6686 0 0 0 0 14.3934 Q9H8H3 MET7A_HUMAN "Putative methyltransferase-like protein 7A, EC 2.1.1.- (Protein AAM-B)" METTL7A PRO0066 UNQ1902/PRO4348 Homo sapiens (Human) methylation [GO:0032259] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]; methyltransferase activity [GO:0008168]; methylation [GO:0032259] GO:0005576; GO:0005783; GO:0005811; GO:0008168; GO:0016020; GO:0032259; GO:1904724 methyltransferase activity [GO:0008168] ELTIFILR 0.99263 -17.03 0 11.8705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.627 0 0 0 0 16.9088 13.2586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9S4 CB39L_HUMAN Calcium-binding protein 39-like (Antigen MLAA-34) (MO25beta) (Mo25-like protein) CAB39L Homo sapiens (Human) intracellular signal transduction [GO:0035556] cytosol [GO:0005829] cytosol [GO:0005829]; protein serine/threonine kinase activator activity [GO:0043539]; intracellular signal transduction [GO:0035556] GO:0005829; GO:0035556; GO:0043539 protein serine/threonine kinase activator activity [GO:0043539] CGIMLRECIR 0.99263 -7.2113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7875 0 0 13.7597 12.6368 0 0 0 0 0 0 0 0 0 0 13.8376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5402 0 14.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPH5 NOX4_HUMAN "NADPH oxidase 4, EC 1.6.3.- (Kidney oxidase-1, KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase)" NOX4 RENOX Homo sapiens (Human) bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell morphogenesis [GO:0000902]; cellular response to glucose stimulus [GO:0071333]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; reactive oxygen species biosynthetic process [GO:1903409]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell morphogenesis [GO:0000902]; cellular response to glucose stimulus [GO:0071333]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; reactive oxygen species biosynthetic process [GO:1903409]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] GO:0000166; GO:0000902; GO:0003015; GO:0005634; GO:0005730; GO:0005739; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0006954; GO:0008285; GO:0009055; GO:0010467; GO:0016021; GO:0016174; GO:0016175; GO:0019826; GO:0020037; GO:0042554; GO:0043020; GO:0043406; GO:0045453; GO:0048471; GO:0050660; GO:0050667; GO:0051897; GO:0055007; GO:0061098; GO:0070374; GO:0071333; GO:0072341; GO:0097038; GO:1903409; GO:1990782; GO:2000573 electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; nucleotide binding [GO:0000166]; oxygen sensor activity [GO:0019826]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] FQANFPQTWLWISGPLCLYCAERLYR 0.99263 -6.1698 10.9203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4533 0 11.6598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7801 0 12.9666 0 0 0 0 12.1472 0 0 0 0 0 14.313 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2205 0 0 13.6372 0 0 0 0 0 13.9051 0 0 15.5934 15.8467 0 13.288 0 0 0 0 0 0 14.8762 0 12.2972 0 0 0 0 0 0 0 13.9957 0 15.0481 16.5819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1968 0 0 Q9UI47 CTNA3_HUMAN Catenin alpha-3 (Alpha T-catenin) (Cadherin-associated protein) CTNNA3 Homo sapiens (Human) actin filament organization [GO:0007015]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; lamellipodium [GO:0030027] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fascia adherens [GO:0005916]; lamellipodium [GO:0030027]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; actin filament organization [GO:0007015]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] GO:0005829; GO:0005856; GO:0005912; GO:0005916; GO:0007015; GO:0008013; GO:0016477; GO:0030027; GO:0045296; GO:0051015; GO:0086073; GO:0086091; GO:0090136; GO:0098609; GO:0098911 actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] ALLAAVTRLLILADMIDVMCLLQHVSAFQR 0.99263 -6.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9177 0 0 11.1609 0 0 0 0 0 0 0 0 9.74015 0 0 0 11.7782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1133 0 0 0 0 0 0 0 0 0 0 12.4304 0 0 0 11.5438 0 0 0 0 0 10.5869 12.4583 0 0 0 0 0 0 0 0 0 0 0 0 13.765 0 0 0 11.7106 0 14.4328 0 0 0 0 0 Q9Y2R4 DDX52_HUMAN "Probable ATP-dependent RNA helicase DDX52, EC 3.6.4.13 (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52)" DDX52 ROK1 HUSSY-19 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; maturation of SSU-rRNA [GO:0030490] GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0016020; GO:0016887; GO:0030490 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] DVHDLFR 0.99263 -18.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5059 0 0 0 0 0 0 14.4807 14.2495 0 12.1847 14.8386 0 0 0 0 0 0 0 14.6066 0 14.6686 0 0 13.1747 0 14.9725 0 0 0 0 0 0 0 0 0 0 0 14.5658 0 13.0931 0 0 13.3652 0 12.0228 0 0 0 0 12.6892 0 0 0 12.8678 0 14.5389 0 12.9778 13.0023 12.5974 15.3855 0 0 12.5472 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0244 0 0 0 13.0282 0 0 0 0 0 0 0 0 12.3128 0 0 0 0 0 0 13.2822 0 0 0 0 0 A6NK59 ASB14_HUMAN "Ankyrin repeat and SOCS box protein 14, ASB-14" ASB14 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 AAVQLNRK 0.99264 -16.314 0 0 0 0 11.8888 0 0 12.6348 0 0 0 0 0 0 0 10.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0386 0 0 0 0 0 0 0 0 0 0 0 0 9.5713 0 0 0 0 0 0 9.96982 0 0 0 0 11.6282 0 10.8203 0 0 0 0 0 0 0 0 0 0 12.6104 0 0 0 0 19.4121 0 0 0 0 0 0 0 0 0 0 0 0 12.2607 0 0 0 11.5738 0 0 0 0 12.1312 0 0 0 0 11.6726 0 0 0 0 0 0 0 0 0 0 12.3632 0 0 0 0 12.7285 0 0 0 0 0 11.4023 12.6832 0 0 0 0 0 0 14.403 0 0 0 14.0205 0 0 0 0 0 0 0 0 14.7826 0 13.2838 12.9501 0 0 13.8664 12.7134 0 0 0 14.2302 13.7028 0 16.4717 0 0 0 0 14.5654 0 12.6686 0 12.2533 B1AL88 NALF1_HUMAN NALCN channel auxiliary factor 1 (Transmembrane protein FAM155A) NALF1 FAM155A NLF-1 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion import across plasma membrane [GO:0098703] GO:0005886; GO:0016021; GO:0098703 ARDKEHQQQQR 0.99264 -14.895 0 0 0 0 0 13.3865 0 0 0 0 0 0 0 0 0 0 14.3469 0 0 0 14.4834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.37708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2371 0 0 0 0 0 0 0 0 11.0741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15231 ZN185_HUMAN Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A) ZNF185 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; actin filament binding [GO:0051015]; zinc ion binding [GO:0008270] GO:0005737; GO:0005925; GO:0008270; GO:0015629; GO:0051015 actin filament binding [GO:0051015]; zinc ion binding [GO:0008270] DTIHCGK 0.99264 -16.318 0 0 0 0 0 0 0 0 0 14.0794 0 0 0 0 0 0 0 0 0 9.83223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7013 0 0 0 0 0 14.4873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4648 13.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43166 SI1L1_HUMAN "Signal-induced proliferation-associated 1-like protein 1, SIPA1-like protein 1 (High-risk human papilloma viruses E6 oncoproteins targeted protein 1, E6-targeted protein 1)" SIPA1L1 E6TP1 KIAA0440 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; ephrin receptor signaling pathway [GO:0048013]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of synaptic plasticity [GO:0048167] GO:0005096; GO:0005737; GO:0005886; GO:0014069; GO:0015629; GO:0031532; GO:0043087; GO:0043197; GO:0046875; GO:0048013; GO:0048167; GO:0048814; GO:0050770; GO:0051056; GO:0061001; GO:0070161; GO:0090630 ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096] CFAHYDVQSILFDLNEAIMNR 0.99264 -14.926 0 0 0 0 0 0 0 0 0 0 9.95699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3954 0 0 0 0 0 10.558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0428 10.5657 0 0 12.7012 16.4741 0 0 0 0 0 0 0 12.2498 0 13.7353 0 0 0 0 0 12.2533 13.8127 0 13.0826 0 0 0 13.2497 0 0 0 0 0 12.8026 11.7486 0 0 0 0 0 0 0 0 0 14.8286 13.9296 0 0 0 0 0 0 11.6114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0168 0 0 0 10.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5043 0 0 0 0 19.2076 0 0 10.4846 0 0 O94913 PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11) PCF11 KIAA0824 Homo sapiens (Human) mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369] GO:0000993; GO:0003729; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0006378; GO:0006379 mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993] ASGHYFDEK 0.99264 -14.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8034 0 0 0 0 0 13.1433 0 0 0 0 13.8963 0 0 0 0 0 0 0 0 0 11.7647 0 0 0 0 0 0 0 0 0 0 12.5606 0 0 0 0 0 0 12.8234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9513 0 0 13.9491 0 13.0033 12.622 13.8832 0 0 14.2708 14.0181 0 0 13.7002 0 0 12.8551 0 12.9025 15.4866 0 14.3063 13.2207 12.3058 12.9423 13.0986 0 13.6531 12.9986 0 13.494 0 0 0 0 0 0 0 0 12.8267 0 0 0 0 12.4766 13.0024 0 13.1342 11.4898 12.8392 13.064 0 13.3205 0 0 12.543 0 11.2197 11.2663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0953 0 13.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3677 12.9866 0 0 0 0 0 0 0 P16471 PRLR_HUMAN "Prolactin receptor, PRL-R" PRLR Homo sapiens (Human) activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694] cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901]; activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694] GO:0004896; GO:0004923; GO:0004925; GO:0005127; GO:0005576; GO:0005886; GO:0006694; GO:0007171; GO:0007259; GO:0007566; GO:0007595; GO:0008284; GO:0009617; GO:0009897; GO:0009986; GO:0016021; GO:0017046; GO:0019221; GO:0019901; GO:0019955; GO:0030155; GO:0030856; GO:0031904; GO:0038165; GO:0042976; GO:0043066; GO:0043235; GO:0046872; GO:0060644; GO:0060736; GO:0060749; GO:0120162 ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901] CRSPNKETFTCWWR 0.99264 -7.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8295 0 15.3251 0 0 0 0 0 0 0 0 11.9947 0 0 12.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1855 0 0 18.0357 0 0 0 0 0 0 0 0 0 0 13.8915 0 0 0 0 0 0 0 0 0 0 14.9589 13.4677 0 0 0 11.1422 0 14.9447 0 0 18.0965 0 0 0 0 0 0 0 0 0 11.4615 0 0 0 0 0 0 0 10.4007 13.7304 0 0 0 0 0 P41180 CASR_HUMAN "Extracellular calcium-sensing receptor, CaR, CaSR, hCasR (Parathyroid cell calcium-sensing receptor 1, PCaR1)" CASR GPRC2A PCAR1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311] apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol phospholipase C activity [GO:0004435]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311] GO:0001503; GO:0002931; GO:0004435; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0006874; GO:0006915; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0007635; GO:0008284; GO:0009653; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0032024; GO:0032781; GO:0032782; GO:0035729; GO:0042311; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:1901653; GO:1902476 amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol phospholipase C activity [GO:0004435]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325] IPTSFHRK 0.99264 -16.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1154 0 0 0 0 0 0 0 0 0 0 0 13.5388 0 0 0 0 13.6902 20.4595 0 0 0 0 0 0 0 0 0 12.3034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.529 0 15.0863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9787 0 0 0 0 14.9399 0 0 0 0 0 13.1813 0 0 0 0 0 13.4981 11.9917 0 P59282 TPPP2_HUMAN Tubulin polymerization-promoting protein family member 2 (Protein p25-beta) (TPPP/p18) TPPP2 C14orf8 Homo sapiens (Human) cell differentiation [GO:0030154]; positive regulation of protein polymerization [GO:0032273]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; sperm flagellum [GO:0036126] cytosol [GO:0005829]; sperm flagellum [GO:0036126]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; positive regulation of protein polymerization [GO:0032273]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283] GO:0005829; GO:0007283; GO:0015631; GO:0030154; GO:0032273; GO:0036126; GO:1901317 tubulin binding [GO:0015631] ASEAEKTFHR 0.99264 -16.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4325 13.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1071 0 0 0 0 0 0 0 0 0 0 0 0 0 12.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0053 0 0 0 0 0 0 0 11.5209 0 0 0 0 0 0 0 0 0 11.1932 0 0 0 0 0 0 0 0 0 13.7338 0 0 0 0 0 0 0 0 0 0 0 0 11.4447 0 12.6947 0 0 0 P84103 SRSF3_HUMAN "Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)" SRSF3 SFRS3 SRP20 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]; regulation of mRNA splicing, via spliceosome [GO:0048024]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; phospholipase binding [GO:0043274]; primary miRNA binding [GO:0070878]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]; regulation of mRNA splicing, via spliceosome [GO:0048024]" GO:0000398; GO:0003723; GO:0005654; GO:0005737; GO:0006406; GO:0016607; GO:0031053; GO:0043274; GO:0048024; GO:0070878; GO:1990830 phospholipase binding [GO:0043274]; primary miRNA binding [GO:0070878]; RNA binding [GO:0003723] PSRSFSRSR 0.99264 -6.3703 0 0 0 0 0 0 10.1355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7184 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0609 11.7561 12.9246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5383 0 10.1799 0 0 15.2064 14.6977 14.5646 0 14.3429 0 0 0 0 15.3708 15.0789 0 0 0 0 0 0 0 0 14.4042 14.0932 0 14.8034 13.9663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7194 0 0 0 12.6609 0 0 0 0 14.2024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5522 13.4939 0 0 0 0 0 0 0 Q0P6D2 DIK1C_HUMAN Divergent protein kinase domain 1C (Protein FAM69C) DIPK1C C18orf51 FAM69C Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 EILEQNCTGDEDCNFFDCFSR 0.99264 -7.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.46 0 12.0843 0 0 0 0 0 0 0 13.2531 0 0 0 0 0 0 0 0 13.4114 12.5329 0 0 0 12.2656 0 0 0 0 15.7068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2074 13.8081 0 0 0 13.0191 0 0 14.6582 0 0 0 0 0 0 0 13.1896 0 0 0 0 0 0 0 0 0 0 12.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13003 GRIK3_HUMAN "Glutamate receptor ionotropic, kainate 3, GluK3 (Excitatory amino acid receptor 5, EAA5) (Glutamate receptor 7, GluR-7, GluR7)" GRIK3 GLUR7 Homo sapiens (Human) "G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; kainate selective glutamate receptor complex [GO:0032983]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; terminal bouton [GO:0043195]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; regulation of membrane potential [GO:0042391]; synaptic transmission, glutamatergic [GO:0035249]" GO:0001640; GO:0004970; GO:0005886; GO:0005887; GO:0007215; GO:0007216; GO:0008066; GO:0015276; GO:0015277; GO:0030424; GO:0030425; GO:0032839; GO:0032983; GO:0035249; GO:0038023; GO:0042391; GO:0042734; GO:0043195; GO:0043204; GO:0045211; GO:0050804; GO:0051967; GO:0070161; GO:0098978; GO:0099507; GO:1904315 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; kainate selective glutamate receptor activity [GO:0015277]; ligand-gated ion channel activity [GO:0015276]; ligand-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ADLAVAPLTITHVREK 0.99264 -14.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2885 0 0 0 0 0 0 0 0 0 0 12.2879 12.9357 0 0 0 0 0 0 0 0 0 13.1415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5216 0 0 0 12.4189 0 0 0 0 0 10.4222 0 0 0 0 13.1025 0 0 0 0 0 0 0 0 13.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7144 0 0 0 0 0 0 0 12.3016 0 14.768 12.4156 0 0 Q13018 PLA2R_HUMAN "Secretory phospholipase A2 receptor, PLA2-R, PLA2R (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor, Soluble PLA2-R, Soluble PLA2R ]" PLA2R1 CLEC13C Homo sapiens (Human) "negative regulation of arachidonic acid secretion [GO:1900139]; negative regulation of phospholipase A2 activity [GO:1900138]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of podocyte apoptotic process [GO:1904635]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; replicative senescence [GO:0090399]" cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; carbohydrate binding [GO:0030246]; phospholipase binding [GO:0043274]; signaling receptor activity [GO:0038023]; negative regulation of arachidonic acid secretion [GO:1900139]; negative regulation of phospholipase A2 activity [GO:1900138]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of podocyte apoptotic process [GO:1904635]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; replicative senescence [GO:0090399]" GO:0001819; GO:0005576; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0016021; GO:0030246; GO:0038023; GO:0043235; GO:0043274; GO:0043517; GO:0072593; GO:0090238; GO:0090399; GO:0090403; GO:1900138; GO:1900139; GO:1904635 carbohydrate binding [GO:0030246]; phospholipase binding [GO:0043274]; signaling receptor activity [GO:0038023] ANKTLLPLHCGSKR 0.99264 -17.597 12.5102 0 11.2562 0 0 0 0 0 0 0 0 10.8772 11.3146 0 0 0 0 0 0 0 0 0 0 0 10.6446 0 0 0 0 14.4275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3629 0 0 0 13.9368 12.7829 0 0 0 0 11.9972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3214 0 15.3166 13.8924 0 0 0 0 0 0 0 0 0 0 12.7549 0 0 0 0 0 13.0347 0 0 0 15.1427 0 12.369 0 0 0 0 0 14.3926 0 12.0919 0 0 0 0 14.3429 11.911 0 13.4932 0 0 0 12.1207 11.422 0 0 0 0 0 11.2472 14.691 0 0 0 0 0 13.6774 0 0 0 11.4674 14.6751 0 0 0 0 0 0 0 0 0 12.1336 0 0 0 0 0 0 14.276 0 0 12.4672 0 0 12.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5301 0 0 Q3KQV9 UAP1L_HUMAN "UDP-N-acetylhexosamine pyrophosphorylase-like protein 1, EC 2.7.7.-" UAP1L1 Homo sapiens (Human) UDP-N-acetylglucosamine biosynthetic process [GO:0006048] UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] GO:0003977; GO:0006048 UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977] ARLQRAGQEHLLR 0.99264 -16.303 0 0 0 0 0 0 0 0 0 0 12.4997 13.0749 0 11.7172 0 0 11.9139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5806 12.2453 0 0 0 12.5907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3188 0 0 15.5958 15.5573 0 15.8637 0 15.6681 0 0 0 15.6314 0 0 15.4148 0 15.3714 15.1631 0 15.2761 14.2983 0 0 0 15.3868 12.5193 0 13.9627 0 0 14.2455 0 15.716 15.1995 15.0258 14.6184 0 0 13.6488 13.3358 0 0 0 12.0037 0 0 14.8155 13.7802 12.2021 13.6469 13.4171 14.0937 12.9057 0 0 0 0 0 13.7395 0 0 13.2317 0 0 0 0 11.6203 0 0 12.5986 0 0 0 0 0 0 14.0043 10.7967 0 0 0 0 0 0 0 0 14.356 0 14.1352 0 0 10.6595 0 0 13.9212 0 0 0 0 Q5JVG2 ZN484_HUMAN Zinc finger protein 484 ZNF484 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHTGERHYECSECGK 0.99264 -14.925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1695 0 0 0 0 0 0 0 0 0 0 0 15.2397 0 0 0 0 10.9213 12.0636 0 0 0 0 0 0 0 0 0 14.5512 0 13.3253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8523 0 0 0 12.6857 0 0 0 0 0 0 0 10.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7B8 KIF24_HUMAN Kinesin-like protein KIF24 KIF24 C9orf48 Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018] GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ALDQEHTHTPFR 0.99264 -15.984 0 0 0 0 0 0 14.0799 0 0 10.7967 0 0 0 0 0 0 13.4649 0 0 0 0 0 0 13.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5556 0 0 0 0 0 12.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.919 10.691 0 0 0 0 0 0 0 0 0 0 13.1788 0 13.5695 0 13.2205 14.3081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9165 0 11.4375 0 0 0 0 11.53 12.1002 0 13.61 14.5335 0 13.7508 0 13.1212 0 0 0 0 0 0 0 0 0 0 0 13.3302 0 14.2095 0 0 0 0 0 0 0 0 0 Q5VZF2 MBNL2_HUMAN Muscleblind-like protein 2 (Muscleblind-like protein 1) (Muscleblind-like protein-like) (Muscleblind-like protein-like 39) MBNL2 MBLL MBLL39 MLP1 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" GO:0000381; GO:0003723; GO:0005654; GO:0005737; GO:0006397; GO:0008380; GO:0043484; GO:0046872; GO:1990837 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837] ALNVAPVRDTK 0.99264 -17.129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3432 0 0 0 0 12.8721 0 0 0 0 10.2678 0 0 0 Q6ZRU5 YQ032_HUMAN Putative uncharacterized protein FLJ46089 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 CPRDSNR 0.99264 -17.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3713 12.012 14.4573 15.1353 13.7605 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8798 0 0 0 13.3115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9375 0 15.3261 13.1847 0 13.2157 0 0 14.0866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5814 0 0 0 0 0 0 13.0326 14.3867 0 Q70E73 RAPH1_HUMAN "Ras-associated and pleckstrin homology domains-containing protein 1, RAPH1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2, PREL-2) (Protein RMO1)" RAPH1 ALS2CR18 ALS2CR9 KIAA1681 LPD PREL2 RMO1 Homo sapiens (Human) axon extension [GO:0048675]; signal transduction [GO:0007165] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; axon extension [GO:0048675]; signal transduction [GO:0007165] GO:0005829; GO:0005856; GO:0005886; GO:0007165; GO:0016604; GO:0030027; GO:0030175; GO:0048675 ATQKLPVSRHTLK 0.99264 -25.332 0 0 0 0 0 0 0 0 12.2857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5158 0 0 0 0 11.5643 0 0 12.3902 14.8511 0 14.4562 0 0 0 15.3016 0 0 0 0 0 0 14.7949 0 0 13.314 14.657 0 0 0 0 14.0127 0 0 0 0 0 0 0 0 14.4644 0 0 11.3561 0 0 0 0 0 14.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.385 0 0 0 0 0 14.5837 0 0 0 14.0588 0 0 14.5969 0 0 12.4252 0 0 10.247 0 0 12.2492 0 13.0686 0 0 0 0 0 12.7326 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3E2 CC186_HUMAN Coiled-coil domain-containing protein 186 (CTCL tumor antigen HD-CL-01/L14-2) CCDC186 C10orf118 Homo sapiens (Human) insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; response to bacterium [GO:0009617]; vesicle cytoskeletal trafficking [GO:0099518] trans-Golgi network [GO:0005802] trans-Golgi network [GO:0005802]; small GTPase binding [GO:0031267]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; response to bacterium [GO:0009617]; vesicle cytoskeletal trafficking [GO:0099518] GO:0005802; GO:0009617; GO:0031267; GO:0035773; GO:0099518 small GTPase binding [GO:0031267] DLTKQLQQARR 0.99264 -58.327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6572 0 0 0 0 0 0 0 0 14.6208 0 0 0 12.3929 0 0 0 0 0 0 16.4429 0 0 14.3087 0 0 0 0 0 0 0 0 0 14.3151 0 0 0 0 0 0 0 0 0 0 0 0 16.6675 0 0 0 0 0 0 0 0 0 0 13.7967 0 0 0 0 0 0 0 13.7179 0 0 0 14.0587 0 0 0 0 0 0 0 0 0 0 0 14.5283 0 0 0 14.8582 0 13.8425 0 0 0 18.9722 0 0 0 0 14.6058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVV2 LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 LOXHD1 Homo sapiens (Human) sensory perception of sound [GO:0007605] stereocilium [GO:0032420] stereocilium [GO:0032420]; sensory perception of sound [GO:0007605] GO:0007605; GO:0032420 DKYNFNCNR 0.99264 -25.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1854 13.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3062 0 0 0 0 0 0 0 14.5027 13.0042 0 13.5267 0 0 0 0 0 0 0 0 0 14.3236 0 0 0 13.3137 0 0 13.7107 0 0 14.1608 0 0 12.4719 0 0 0 13.7987 14.692 0 0 0 0 0 0 0 14.4731 0 0 0 0 0 0 0 0 0 0 0 0 0 13.547 0 0 0 0 12.1357 12.7585 0 0 0 0 0 0 0 0 Q8IYW5 RN168_HUMAN "E3 ubiquitin-protein ligase RNF168, hRNF168, EC 2.3.2.27 (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168)" RNF168 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked ubiquitination [GO:0070535]; histone H2A monoubiquitination [GO:0035518]; histone H2A-K13 ubiquitination [GO:0036351]; histone H2A-K15 ubiquitination [GO:0036352]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0010212; GO:0016567; GO:0031491; GO:0032991; GO:0034244; GO:0035518; GO:0035861; GO:0036297; GO:0036351; GO:0036352; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0046872; GO:0070530; GO:0070534; GO:0070535 chromatin binding [GO:0003682]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842] ASEEEENKASEEYIQR 0.99264 -17.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2541 13.5036 0 0 0 0 0 0 0 0 0 0 11.3026 0 13.5693 0 0 0 0 16.325 0 0 0 0 0 13.2498 0 14.4151 0 0 0 0 0 0 0 0 13.2861 0 13.0182 11.0891 0 0 0 0 0 0 12.4781 0 0 0 0 13.2742 0 12.9219 0 0 0 0 0 0 12.7705 0 0 0 12.3595 12.6032 0 12.2686 0 0 0 0 0 11.7957 0 0 11.7837 0 0 0 0 0 0 0 0 0 0 0 13.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4686 0 0 0 12.9177 0 0 0 Q8IZM0 CNG1O_HUMAN Putative CNGA1-overlapping antisense gene protein (Anti-CNG1) Homo sapiens (Human) SSRPSFIK 0.99264 -7.1022 0 0 10.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1193 13.1057 12.9338 13.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3671 0 0 0 0 0 0 0 0 13.0987 0 0 0 0 0 0 12.4952 0 0 0 0 0 0 0 13.2516 0 0 0 0 0 13.1763 12.7904 0 0 0 0 0 0 0 0 12.9004 13.2487 0 13.1891 0 13.0449 13.9633 0 0 0 0 0 13.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2481 0 0 0 0 0 Q8NGS8 O13C5_HUMAN Olfactory receptor 13C5 (Olfactory receptor OR9-11) OR13C5 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005654; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EAVKHLLR 0.99264 -15.988 0 0 0 0 0 0 0 0 12.7828 0 0 0 0 10.8945 0 11.8201 0 0 0 11.2892 0 0 0 0 0 0 11.9927 0 0 0 0 0 11.923 0 10.8041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2211 0 14.1767 0 0 0 0 0 0 0 0 0 0 0 0 12.147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2007 0 0 0 0 0 0 0 15.1531 12.4293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1412 0 0 0 0 0 0 13.0804 12.6135 0 0 0 0 0 0 0 0 0 0 0 Q8TDB4 HUMMR_HUMAN "Protein MGARP (Corneal endothelium-specific protein 1, CESP-1) (Hypoxia up-regulated mitochondrial movement regulator protein) (Mitochondria-localized glutamic acid-rich protein) (Ovary-specific acidic protein)" MGARP C4orf49 CESP1 HUMMR OSAP GS3582 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axonal transport of mitochondrion [GO:0019896]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to hypoxia [GO:0071456]; cellular response to steroid hormone stimulus [GO:0071383]; cerebral cortex development [GO:0021987]; negative regulation of dendrite development [GO:2000171]; positive regulation of mitochondrion organization [GO:0010822]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; retrograde axonal transport [GO:0008090] axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] axon cytoplasm [GO:1904115]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; anterograde axonal transport [GO:0008089]; axon development [GO:0061564]; axonal transport of mitochondrion [GO:0019896]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to hypoxia [GO:0071456]; cellular response to steroid hormone stimulus [GO:0071383]; cerebral cortex development [GO:0021987]; negative regulation of dendrite development [GO:2000171]; positive regulation of mitochondrion organization [GO:0010822]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; retrograde axonal transport [GO:0008090] GO:0005739; GO:0005743; GO:0006626; GO:0008089; GO:0008090; GO:0010821; GO:0010822; GO:0019896; GO:0021987; GO:0031307; GO:0061564; GO:0071383; GO:0071456; GO:0097211; GO:1904115; GO:2000171 TVTSDQAK 0.99264 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LW9 ZSC31_HUMAN Zinc finger and SCAN domain-containing protein 31 (Zinc finger protein 323) ZSCAN31 ZNF310P ZNF323 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DVSLDSKYR 0.99264 -14.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6749 0 0 0 0 13.1426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7174 12.1872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVJ6 UT14A_HUMAN U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16) UTP14A SDCCAG16 Homo sapiens (Human) rRNA processing [GO:0006364] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040 RNA binding [GO:0003723] AFQKLTTPK 0.99264 -17.593 0 0 0 0 12.2581 0 12.4314 0 0 12.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7061 11.0458 0 0 10.7386 0 10.2938 0 0 0 12.9664 0 0 0 0 0 0 0 0 0 11.6571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4114 0 0 0 0 0 0 11.604 12.3762 0 11.0913 11.7118 0 0 0 0 0 13.6033 12.9327 0 0 14.6795 0 13.184 0 0 0 0 0 0 0 0 0 13.8896 0 0 0 14.4226 0 0 13.6137 0 14.2496 0 0 0 0 0 0 14.5204 0 0 15.3325 0 0 0 0 15.0216 14.9164 15.4682 11.7212 13.3055 14.6125 0 0 15.1106 0 0 14.9749 12.5398 12.1339 13.5738 13.2886 0 12.4248 0 0 15.5841 14.309 0 0 14.8785 0 0 14.5484 0 14.6509 14.6551 14.3772 0 0 0 0 0 0 0 0 0 0 14.068 13.3301 12.9825 0 0 0 0 0 0 13.3757 0 0 0 0 Q9BWT3 PAPOG_HUMAN "Poly(A) polymerase gamma, PAP-gamma, EC 2.7.7.19 (Neo-poly(A) polymerase, Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme, SRP RNA-adenylating enzyme)" PAPOLG PAP2 PAPG Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631] GO:0003723; GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006378; GO:0016020; GO:0016604; GO:0043631; GO:0046872 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723] DPRTAEER 0.99264 -14.59 0 12.7941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5646 0 0 0 11.8421 0 0 0 0 0 0 0 0 0 0 0 0 11.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6899 0 0 0 0 15.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4663 0 12.8291 0 0 0 0 0 0 0 0 0 0 0 12.6808 14.0923 0 13.1201 11.8931 13.0193 0 0 0 0 0 0 0 0 0 0 13.1242 0 0 0 0 0 0 0 0 0 0 13.2953 0 0 0 0 13.1958 0 0 0 12.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7309 0 0 0 0 13.7404 0 0 Q9P203 BTBD7_HUMAN BTB/POZ domain-containing protein 7 BTBD7 KIAA1525 Homo sapiens (Human) morphogenesis of a branching epithelium [GO:0061138]; regulation of branching involved in salivary gland morphogenesis [GO:0060693] nucleus [GO:0005634] nucleus [GO:0005634]; morphogenesis of a branching epithelium [GO:0061138]; regulation of branching involved in salivary gland morphogenesis [GO:0060693] GO:0005634; GO:0060693; GO:0061138 EPNLLSGTAHSVNKR 0.99264 -15.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4624 0 0 0 0 13.2998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0878 13.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6776 14.1408 0 0 0 12.6723 0 0 0 0 13.1528 0 0 0 0 0 0 0 0 12.2564 0 15.571 0 14.9587 13.1484 15.9919 0 0 0 14.224 0 0 0 0 0 0 0 14.6552 14.3049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2P7 ZN256_HUMAN "Zinc finger protein 256 (Bone marrow zinc finger 3, BMZF-3)" ZNF256 BMZF3 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0045892; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FDLIVHER 0.99264 -17.611 0 0 0 0 0 0 10.9555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7446 12.7198 0 0 0 0 0 0 0 0 0 12.5483 0 0 0 0 0 10.6798 0 0 0 0 0 0 0 0 0 0 0 0 11.9321 12.0043 0 0 0 0 0 11.0806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6095 10.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y330 ZBT12_HUMAN Zinc finger and BTB domain-containing protein 12 (Protein G10) ZBTB12 C6orf46 G10 NG35 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AEEEDEDEDEDVSDICIVK 0.99264 -16.321 0 0 0 0 0 0 0 0 13.6866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8644 0 0 0 0 0 0 0 0 0 13.7675 0 0 0 0 0 12.2477 12.1563 0 0 0 0 0 13.8092 0 12.8259 0 0 0 0 14.7103 0 13.1976 15.3861 0 16.2999 0 0 0 0 0 0 11.6803 0 0 0 0 12.1559 0 0 0 0 13.6232 0 0 0 0 0 0 0 13.8992 0 0 0 0 0 0 0 0 0 12.3949 14.1742 13.1342 0 0 0 0 0 0 0 0 0 0 0 0 12.3547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9543 0 0 0 0 0 0 0 Q9Y3M8 STA13_HUMAN "StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein, DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13, StARD13)" STARD13 DLC2 GT650 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966] cytosol [GO:0005829]; lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; actin cytoskeleton organization [GO:0030036]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005811; GO:0005829; GO:0007165; GO:0008289; GO:0030036; GO:0031966; GO:0035023; GO:0043542; GO:0051056; GO:0090051; GO:0097498 GTPase activator activity [GO:0005096]; lipid binding [GO:0008289] AVFGVPLIVHVQRTGQPLPQSIQQALRYLR 0.99264 -25.263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2199 0 0 0 0 0 0 0 14.2872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2603 15.7631 0 13.2323 0 0 13.2741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0519 0 0 0 0 0 0 0 0 0 0 14.7848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6N1 COX11_HUMAN "Cytochrome c oxidase assembly protein COX11, mitochondrial" COX11 Homo sapiens (Human) metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132] integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] integral component of mitochondrial inner membrane [GO:0031305]; intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; metal ion homeostasis [GO:0055065]; negative regulation of glucokinase activity [GO:0033132] GO:0005507; GO:0005739; GO:0009055; GO:0031304; GO:0031305; GO:0032991; GO:0033132; GO:0055065 copper ion binding [GO:0005507]; electron transfer activity [GO:0009055] CVPFCGWR 0.99264 -24.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.213 11.8903 0 0 0 0 0 0 0 0 0 0 10.8268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6664 0 0 0 0 0 0 0 0 0 0 0 12.6606 0 0 0 0 0 0 14.318 0 0 0 0 0 0 0 0 0 0 12.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14573 ITPR3_HUMAN "Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3, IP3R 3, InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor, Type 3 InsP3 receptor)" ITPR3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917] apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667] "apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917]" GO:0000822; GO:0005220; GO:0005509; GO:0005640; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005903; GO:0007186; GO:0007204; GO:0007613; GO:0015278; GO:0016020; GO:0016529; GO:0030659; GO:0030667; GO:0031095; GO:0035091; GO:0043025; GO:0043209; GO:0043235; GO:0043533; GO:0045177; GO:0050909; GO:0050913; GO:0050916; GO:0050917; GO:0051592; GO:0060291; GO:0070679 "calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; phosphatidylinositol binding [GO:0035091]" AFPRVTPTANQWDYKNIIEK 0.99265 -14.963 0 0 0 14.1467 12.9717 0 0 11.1053 0 0 0 0 0 0 0 0 0 0 0 0 13.1952 0 0 0 12.6603 0 0 11.6974 0 0 0 0 0 0 0 0 0 11.9937 0 0 0 0 12.1877 0 11.026 0 10.9592 0 0 0 0 12.3008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6389 0 0 0 12.4361 0 0 0 12.7923 13.7306 0 0 15.6524 0 12.4608 14.0843 13.9141 14.119 15.6068 15.5385 13.7771 0 11.7297 15.2438 0 13.3385 14.8744 12.3008 0 0 11.6216 0 12.31 15.0797 0 13.5845 0 0 13.6017 0 14.6935 12.2753 13.9145 0 14.0103 11.6484 0 13.4484 12.216 0 15.9003 13.4945 16.5974 12.8622 12.3568 11.2536 0 0 0 14.6167 0 13.0639 13.1751 13.7777 0 13.6026 0 0 0 13.0768 0 0 13.9878 16.2237 14.1691 11.9379 13.3225 0 14.5218 0 12.6054 12.2493 14.5628 0 0 0 14.7131 0 0 0 0 0 9.88988 0 12.0579 0 0 0 0 0 0 0 0 0 0 12.5113 0 0 11.9787 0 13.6169 0 15.6322 0 O14709 ZN197_HUMAN Zinc finger protein 197 (Zinc finger protein with KRAB and SCAN domains 9) (ZnF20) (pVHL-associated KRAB domain-containing protein) ZNF197 ZKSCAN9 ZNF166 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDMCCKHFNKISHLINHR 0.99265 -44.623 0 0 0 0 0 0 0 0 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2105 0 0 0 0 0 0 0 0 0 0 0 11.6722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2023 0 0 0 0 0 0 0 0 13.9457 14.0656 0 0 0 0 0 0 0 14.1567 0 0 11.7694 0 0 0 13.6059 0 13.6123 13.3006 13.6469 13.6159 0 0 0 0 0 13.833 0 0 0 11.984 19.5678 0 0 0 0 0 13.7365 0 0 19.4902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.997 0 0 19.5786 13.7569 0 0 0 0 0 0 0 0 0 0 12.1539 0 0 0 0 0 0 0 0 0 0 0 0 13.1032 0 0 0 0 12.9373 15.3465 13.2326 13.3834 0 0 0 13.58 0 0 0 0 0 13.0182 0 0 0 0 0 0 15.2647 0 0 0 O75147 OBSL1_HUMAN Obscurin-like protein 1 OBSL1 KIAA0657 Homo sapiens (Human) cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Z disc [GO:0030018] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; Z disc [GO:0030018]; cytoskeletal anchor activity [GO:0008093]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] GO:0000226; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0007010; GO:0007030; GO:0007088; GO:0007156; GO:0007416; GO:0008093; GO:0010842; GO:0014704; GO:0030018; GO:0031430; GO:0034067; GO:0045202; GO:0048471; GO:0050775; GO:0055003; GO:1990393 cytoskeletal anchor activity [GO:0008093] AGAPVVWSHNGR 0.99265 -44.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9284 0 0 0 0 0 15.7314 0 0 16.5783 13.551 14.8372 0 14.5827 13.5238 16.0212 13.4616 13.5394 13.2354 13.6119 12.2856 13.737 16.0058 0 0 0 10.5152 14.4283 0 0 0 0 11.6217 0 0 0 13.9346 13.3505 13.7289 13.3309 0 13.21 0 13.8034 0 0 0 13.4264 0 15.5525 15.727 13.4602 13.1442 14.5549 13.0771 12.7457 0 0 14.021 13.7662 13.5716 0 13.5026 0 14.9896 13.4357 13.6524 0 15.5424 12.311 14.2925 0 0 14.7518 13.554 13.7139 0 14.9067 12.2824 0 0 16.3005 13.871 0 14.3754 16.5955 14.5137 0 0 0 0 0 0 0 0 0 0 0 0 11.6676 0 0 0 15.2542 10.8246 0 0 0 0 13.9554 0 P05107 ITB2_HUMAN "Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)" ITGB2 CD18 MFI7 Homo sapiens (Human) "amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]" cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] "cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integrin alphaL-beta2 complex [GO:0034687]; integrin alphaM-beta2 complex [GO:0034688]; integrin alphaX-beta2 complex [GO:0034689]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; amyloid-beta clearance [GO:0097242]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; microglial cell activation [GO:0001774]; negative regulation of dopamine metabolic process [GO:0045963]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; phagocytosis, engulfment [GO:0006911]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of neuron death [GO:1901216]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of prostaglandin-E synthase activity [GO:2000363]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of superoxide anion generation [GO:0032930]; receptor clustering [GO:0043113]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of cell shape [GO:0008360]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]" GO:0001540; GO:0001774; GO:0001851; GO:0005178; GO:0005886; GO:0005925; GO:0006898; GO:0006911; GO:0006915; GO:0006954; GO:0007155; GO:0007159; GO:0007160; GO:0007229; GO:0007267; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016020; GO:0016477; GO:0019901; GO:0030369; GO:0030593; GO:0031072; GO:0031623; GO:0032930; GO:0033627; GO:0034113; GO:0034687; GO:0034688; GO:0034689; GO:0035579; GO:0035987; GO:0043113; GO:0043235; GO:0043315; GO:0044853; GO:0045963; GO:0046872; GO:0050730; GO:0050839; GO:0070062; GO:0070821; GO:0071404; GO:0090314; GO:0097242; GO:0098609; GO:0098742; GO:0101003; GO:1901216; GO:1903561; GO:1904996; GO:1990266; GO:2000363 amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; complement component C3b binding [GO:0001851]; heat shock protein binding [GO:0031072]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901] CDTGYIGKNCECQTQGRSSQELEGSCR 0.99265 -4.4031 0 0 0 0 0 0 0 0 0 0 14.3222 14.5902 0 0 0 14.5222 0 0 0 0 0 10.6851 0 0 13.2447 0 0 0 0 14.0439 0 0 0 11.1662 0 0 0 0 13.4087 0 0 0 12.3673 0 13.0236 0 0 0 0 0 0 0 0 0 0 0 9.79198 0 0 10.1614 0 0 0 0 0 0 0 0 11.9227 11.4538 0 0 0 11.2646 0 12.1755 0 0 0 13.3236 0 12.2238 14.7706 0 14.3676 0 0 0 14.334 15.1711 15.0293 14.9912 15.1 0 0 0 0 12.1741 0 0 0 0 14.9367 14.2331 15.3329 0 0 13.0416 12.0479 0 0 0 13.5277 15.4348 0 11.869 0 14.8679 0 0 0 0 0 0 11.6111 0 0 0 0 0 0 0 0 11.3426 0 0 0 0 0 13.2743 0 0 0 0 0 0 0 14.2682 0 0 0 0 0 15.1813 15.6441 0 0 0 11.8742 0 13.18 11.5733 0 11.4282 13.5066 0 0 0 0 11.877 0 0 0 0 0 10.5836 0 14.2566 0 0 P08311 CATG_HUMAN "Cathepsin G, CG, EC 3.4.21.20 [Cleaved into: Cathepsin G, C-terminal truncated form ]" CTSG Homo sapiens (Human) angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; biofilm matrix disassembly [GO:0098786]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; monocyte chemotaxis [GO:0002548]; negative regulation of T cell activation [GO:0050868]; neutrophil activation [GO:0042119]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; platelet activation [GO:0030168]; positive regulation of immune response [GO:0050778]; positive regulation of platelet aggregation [GO:1901731]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; proteolysis [GO:0006508]; purinergic nucleotide receptor signaling pathway [GO:0035590] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; caspase binding [GO:0089720]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiotensin maturation [GO:0002003]; antibacterial humoral response [GO:0019731]; biofilm matrix disassembly [GO:0098786]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; monocyte chemotaxis [GO:0002548]; negative regulation of T cell activation [GO:0050868]; neutrophil activation [GO:0042119]; neutrophil-mediated killing of gram-positive bacterium [GO:0070946]; platelet activation [GO:0030168]; positive regulation of immune response [GO:0050778]; positive regulation of platelet aggregation [GO:1901731]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; proteolysis [GO:0006508]; purinergic nucleotide receptor signaling pathway [GO:0035590] GO:0002003; GO:0002548; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005886; GO:0006468; GO:0006508; GO:0006955; GO:0008201; GO:0008233; GO:0008236; GO:0010494; GO:0016020; GO:0016485; GO:0019221; GO:0019731; GO:0022617; GO:0030141; GO:0030168; GO:0035578; GO:0035590; GO:0042119; GO:0043231; GO:0048018; GO:0050778; GO:0050829; GO:0050830; GO:0050832; GO:0050868; GO:0062023; GO:0070062; GO:0070946; GO:0071222; GO:0089720; GO:0098786; GO:1901731 caspase binding [GO:0089720]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] CGGFLVR 0.99265 -16.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9321 0 0 0 0 0 0 0 12.5094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2329 0 0 P13611 CSPG2_HUMAN "Versican core protein (Chondroitin sulfate proteoglycan core protein 2, Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein, GHAP) (Large fibroblast proteoglycan) (PG-M)" VCAN CSPG2 Homo sapiens (Human) cell adhesion [GO:0007155]; cell recognition [GO:0008037]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; osteoblast differentiation [GO:0001649]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell recognition [GO:0008037]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; osteoblast differentiation [GO:0001649]; skeletal system development [GO:0001501] GO:0001501; GO:0001649; GO:0001750; GO:0005509; GO:0005539; GO:0005540; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0007155; GO:0007417; GO:0008037; GO:0008347; GO:0016020; GO:0030021; GO:0030246; GO:0031012; GO:0033165; GO:0043202; GO:0062023 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540] APRVGCYGDKMGK 0.99265 -61.672 0 0 0 0 0 0 0 0 0 12.9175 0 0 0 0 0 0 0 12.1179 0 0 11.6445 0 0 0 0 0 0 0 0 0 0 12.3712 0 11.6848 0 10.3785 0 0 0 14.4253 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7425 0 0 0 0 0 12.4147 13.5168 0 13.2638 12.6977 0 0 13.1302 13.2205 0 0 13.922 0 12.9377 0 0 14.5796 0 0 0 12.6163 0 12.6679 0 0 0 0 12.505 12.4383 0 0 0 12.7539 0 0 0 13.0105 0 0 0 0 0 0 15.153 0 0 0 0 0 13.3937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2593 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9352 0 0 0 0 0 0 0 11.9904 0 0 0 0 0 0 0 13.4746 P50539 MXI1_HUMAN "Max-interacting protein 1, Max interactor 1 (Class C basic helix-loop-helix protein 11, bHLHc11)" MXI1 BHLHC11 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0046983; GO:0090575 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHIKKLEEAER 0.99265 -15.999 0 0 0 0 10.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6674 11.7829 0 0 0 0 0 0 0 0 0 0 0 14.4164 0 14.7172 11.2853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8607 11.8099 0 0 0 0 0 12.7861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2687 0 0 0 13.7296 0 0 13.3231 12.7118 0 0 13.3211 0 0 0 0 0 0 0 12.3535 13.2198 11.8262 13.8225 13.3608 0 0 0 0 0 0 16.7078 0 12.1408 0 0 0 0 0 13.6271 13.14 13.9189 0 0 0 0 0 0 P55265 DSRAD_HUMAN "Double-stranded RNA-specific adenosine deaminase, DRADA, EC 3.5.4.37 (136 kDa double-stranded RNA-binding protein, p136) (Interferon-inducible protein 4, IFI-4) (K88DSRBP)" ADAR ADAR1 DSRAD G1P1 IFI4 Homo sapiens (Human) adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by RNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by RNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566] GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0097284; GO:0098586; GO:1900369; GO:1903944 DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251] ETSVNWCLADGYDLEILDGTRGTVDGPR 0.99265 -44.464 0 11.3061 0 0 0 0 0 0 0 0 14.6023 0 14.3908 14.4575 14.0855 12.2368 12.6474 13.4294 0 0 0 0 0 0 0 0 0 0 12.1559 0 0 0 12.8684 0 12.6202 0 0 0 0 0 0 0 0 0 0 11.3259 11.6786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5459 0 0 11.6877 14.4203 11.2669 0 11.0922 0 0 14.8199 15.2532 12.424 0 0 12.7609 0 0 0 13.5477 0 12.8506 12.7467 12.8088 0 12.6025 0 0 13.5422 13.425 0 12.9159 0 0 15.208 16.0488 13.965 15.4282 0 11.1579 13.4182 14.16 0 0 14.1517 0 0 0 0 13.8696 0 16.8683 12.262 0 14.0679 0 14.0836 11.6159 0 0 15.6089 0 0 0 0 0 15.84 14.6726 0 15.4847 14.6307 0 0 13.9662 0 13.1548 0 14.8515 13.0505 0 0 16.7742 0 0 11.6064 13.5057 0 12.7724 0 0 15.4852 0 0 0 12.2711 0 0 0 0 13.6808 12.0923 13.3294 0 0 11.6417 12.1737 13.1065 13.0811 15.7997 0 0 0 13.4622 0 P57078 RIPK4_HUMAN "Receptor-interacting serine/threonine-protein kinase 4, EC 2.7.11.1 (Ankyrin repeat domain-containing protein 3) (PKC-delta-interacting protein kinase)" RIPK4 ANKRD3 DIK Homo sapiens (Human) morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; morphogenesis of an epithelium [GO:0002009]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein phosphorylation [GO:0006468] GO:0002009; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0016020; GO:0051092; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ACSHLIRLMQR 0.99265 -26.357 0 0 0 0 0 0 0 0 0 15.866 0 0 0 14.7212 0 0 0 0 0 0 0 11.6488 0 0 0 0 0 0 0 0 0 0 14.75 0 0 0 0 0 0 0 0 0 0 14.5008 0 0 0 0 0 0 0 0 0 12.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3168 0 14.8066 0 14.2088 15.3656 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8391 0 0 0 0 0 0 0 0 0 14.0649 12.8889 0 0 0 0 0 11.8407 13.054 0 0 0 12.8793 0 12.1126 0 0 0 0 0 13.8122 0 0 0 0 0 0 0 13.2122 0 0 0 0 0 0 0 0 11.0321 0 0 12.2577 0 0 0 0 11.446 0 0 0 10.3214 0 0 0 14.6052 14.1846 13.78 0 0 0 0 0 0 11.8019 12.926 0 0 0 0 0 0 0 14.1948 0 P57081 WDR4_HUMAN "tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 (Protein Wuho homolog, hWH) (WD repeat-containing protein 4)" WDR4 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; cellular response to DNA damage stimulus [GO:0006974]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400] GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006400; GO:0006974; GO:0043527; GO:0106004 FILTADRDEKIR 0.99265 -6.4096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7577 11.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13206 DDX10_HUMAN "Probable ATP-dependent RNA helicase DDX10, EC 3.6.4.13 (DEAD box protein 10)" DDX10 Homo sapiens (Human) anterior head development [GO:0097065]; rRNA processing [GO:0006364] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; anterior head development [GO:0097065]; rRNA processing [GO:0006364] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0006364; GO:0016887; GO:0097065 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AKDEEEAFLDWSDDDDDDDDGFDPSTLPDPDKYR 0.99265 -25.384 0 0 0 13.8579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3148 0 0 11.8119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1554 0 0 0 0 0 13.3058 12.7005 13.8877 13.6874 13.1558 0 0 0 0 0 11.257 15.124 0 0 12.2873 13.832 0 0 11.7867 14.2993 13.1199 0 13.7097 14.3775 14.0866 12.9848 17.3359 17.2005 17.4659 0 0 15.4103 14.2879 12.5282 0 12.6816 0 15.1327 11.9513 13.6865 14.2737 16.6781 0 16.484 15.5882 14.5562 0 0 14.0735 14.1996 13.8784 13.8045 13.3269 13.0629 15.8922 0 0 0 14.2991 14.386 14.2871 0 15.1201 14.4538 14.7031 13.0413 14.7614 13.504 13.9947 13.3273 15.2235 0 0 0 12.5475 0 0 12.9385 12.8385 13.9421 15.4802 0 0 0 0 0 0 0 0 14.2485 14.83 12.5079 0 0 0 0 15.4817 12.0955 14.4181 14.0885 0 0 0 14.0061 0 12.2007 0 12.0824 0 13.1412 0 0 0 0 13.0302 12.9961 14.1836 0 0 0 0 12.3206 0 0 0 Q15032 R3HD1_HUMAN R3H domain-containing protein 1 R3HDM1 KIAA0029 R3HDM Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] DDNQMRIR 0.99265 -15.995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.248 10.9003 0 0 0 0 15.9619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3643 0 0 0 0 15.3441 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7202 0 0 0 0 0 0 0 0 15.1138 0 11.7798 0 0 0 19.099 0 0 0 0 0 0 0 0 0 12.9421 0 12.1483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3172 10.7829 0 0 0 0 0 0 0 Q5VSL9 STRP1_HUMAN Striatin-interacting protein 1 (Protein FAM40A) STRIP1 FAM40A KIAA1761 Homo sapiens (Human) cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] GO:0005634; GO:0005829; GO:0007010; GO:0019901; GO:0022604; GO:0030866; GO:0031267; GO:0070062 protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] AEWRTMR 0.99265 -6.4148 0 0 0 0 0 0 0 0 0 10.1032 0 0 0 0 0 0 11.5265 0 0 0 0 0 0 13.5092 0 11.0891 0 0 13.3246 0 11.7463 0 0 0 12.2835 0 0 0 0 0 0 10.8454 12.6399 13.5567 0 10.6421 10.1618 12.0936 12.6752 12.6745 12.7618 0 0 12.6975 0 0 0 0 12.7884 0 0 11.5003 0 0 0 0 0 0 0 0 0 12.7728 12.6009 12.1079 14.3334 0 0 12.3335 11.5503 13.6819 12.1641 13.0661 0 0 0 0 0 0 0 0 0 14.688 0 0 14.9274 0 11.9394 11.8696 14.5151 10.891 0 11.6126 0 0 0 0 0 11.3202 0 14.0194 0 13.0291 14.3472 0 0 0 14.309 0 0 0 0 0 14.3293 0 11.4534 13.6415 12.0108 0 11.3693 0 13.9248 0 10.5091 0 0 0 0 15.3092 11.9666 0 11.3977 0 0 0 0 11.4983 0 0 15.4554 0 0 14.1532 0 0 11.8294 12.4548 0 0 0 0 0 0 0 0 11.37 0 0 11.1222 0 11.0649 0 0 0 12.4115 0 0 12.4274 0 0 0 Q68CZ1 FTM_HUMAN "Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein, RPGRIP1-like protein)" RPGRIP1L FTM KIAA1005 NPHP8 Homo sapiens (Human) cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; cerebellum development [GO:0021549]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; retinal rod cell development [GO:0046548] GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005879; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0008589; GO:0021532; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0032391; GO:0035115; GO:0035116; GO:0035253; GO:0035869; GO:0036064; GO:0043584; GO:0045744; GO:0046548; GO:0060039; GO:0090102; GO:1905515 thromboxane A2 receptor binding [GO:0031870] AILQKQEMPNR 0.99265 -26.359 11.948 0 12.7993 0 0 0 0 0 13.1051 13.291 13.47 13.3095 10.2376 13.319 0 12.6768 13.4888 13.0918 12.8798 16.219 0 0 0 0 13.1839 13.1694 0 13.1158 12.6453 12.4184 10.7819 0 0 0 12.3932 0 0 0 0 0 12.6755 12.2594 0 12.464 0 0 0 0 12.8584 0 12.4648 0 13.1915 13.6718 0 12.8176 0 0 0 0 0 0 0 0 0 12.2018 0 0 0 11.7087 19.3178 0 0 0 19.4438 13.3134 0 0 0 13.7402 0 0 0 0 13.8536 0 0 19.2343 11.0112 0 0 0 0 0 0 0 0 0 0 12.2077 12.2245 0 0 0 0 0 14.0878 12.7751 0 0 0 0 0 0 0 0 0 0 19.264 0 13.1783 13.2896 0 14.4549 13.5786 0 13.4984 13.4852 12.3886 0 0 0 13.5241 0 12.1238 13.2402 0 0 11.6961 0 0 0 0 18.2519 11.4471 0 0 0 0 15.5553 0 0 0 0 11.7816 0 0 0 14.941 0 14.625 0 11.8863 14.7346 0 14.8238 0 14.7658 14.5591 0 14.5989 0 10.7027 11.757 0 14.9811 10.9866 0 13.4103 0 Q6Q759 SPG17_HUMAN Sperm-associated antigen 17 (Projection protein PF6 homolog) SPAG17 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514] acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953 AGRYIMR 0.99265 -63.795 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2686 0 0 0 0 10.1522 0 0 0 0 0 0 11.6629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.03356 0 0 0 0 14.1301 0 13.8472 0 12.6608 10.6991 13.5643 0 11.7399 11.2781 12.3472 0 0 0 0 0 0 0 0 11.9452 11.8939 11.7796 0 0 0 0 12.1426 0 12.3059 0 0 12.2801 0 0 11.8539 0 14.9522 14.4112 0 0 0 16.5414 0 0 0 0 14.6271 0 0 0 0 0 0 0 0 0 14.6707 12.3431 15.3404 0 0 11.6921 0 14.483 13.4486 14.5557 0 0 0 13.2758 0 0 13.1428 0 13.8521 13.7262 13.0078 0 0 0 13.55 0 0 0 14.4104 0 15.0311 0 15.0803 0 14.6649 13.0612 0 0 0 10.4565 0 0 0 0 12.6583 0 0 0 16.7297 14.0967 15.0965 15.5273 0 12.6286 0 0 0 0 0 0 0 12.8845 0 0 0 12.4639 0 0 0 13.5772 0 0 14.343 0 0 0 0 0 0 Q6ZN11 ZN793_HUMAN Zinc finger protein 793 ZNF793 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GCSHCEK 0.99265 -26.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1079 0 0 0 0 0 0 0 0 10.8238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4511 0 0 0 0 0 0 0 0 0 15.9016 0 0 0 0 0 0 0 0 13.1056 0 0 0 0 0 0 0 0 0 0 0 0 15.087 0 0 0 0 17.2192 0 11.8806 0 0 0 0 0 0 0 0 0 0 0 13.6428 0 0 0 0 0 0 10.315 0 0 0 0 0 0 0 11.0936 14.0628 0 0 0 0 0 9.63436 0 0 0 0 12.0695 0 0 0 0 0 15.4772 0 0 0 0 0 0 0 0 0 0 0 0 11.2218 0 0 0 10.2849 0 0 0 Q7Z5U6 WDR53_HUMAN WD repeat-containing protein 53 WDR53 Homo sapiens (Human) VNWLLGTK 0.99265 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TEM1 PO210_HUMAN "Nuclear pore membrane glycoprotein 210, Nuclear pore protein gp210 (Nuclear envelope pore membrane protein POM 210, POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)" NUP210 KIAA0906 PSEC0245 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0016021; GO:0031965; GO:0051028 AARGRGLLLLTLSVLLAAGPSAAAAK 0.99265 -25.376 0 0 0 0 0 0 0 0 13.628 0 0 12.0475 0 0 0 0 0 13.7009 0 0 0 11.1829 14.5268 12.1897 0 0 0 0 0 9.98442 0 0 0 0 13.0826 11.9954 0 0 0 0 0 0 12.747 12.2336 0 0 0 0 0 12.1999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8573 15.1231 0 0 0 0 0 0 14.6651 11.8553 14.4299 0 15.3965 13.3004 14.194 14.6407 13.053 0 0 15.2677 14.1334 0 16.5057 15.4282 13.7956 12.9108 14.9777 0 14.7166 13.5173 14.8719 0 15.1522 12.8722 0 14.2543 13.8424 0 14.8726 0 0 14.24 14.2815 0 14.1072 11.1912 0 0 0 13.8695 15.6634 11.2259 0 0 12.7099 0 0 13.8344 0 14.3475 0 0 0 13.6764 13.103 11.6299 14.8294 13.2258 0 13.2218 12.6075 15.0881 0 14.7224 14.2413 12.9922 14.7618 14.4232 13.6929 12.7751 14.1983 14.1079 0 0 10.8774 13.8114 0 13.2366 0 0 0 0 0 0 13.098 0 0 0 0 0 0 0 0 12.8252 0 0 14.2679 12.782 16.0078 0 0 0 14.6763 0 Q8WV99 ZFN2B_HUMAN "AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein, AIRAP-like protein)" ZFAND2B AIRAPL Homo sapiens (Human) "proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502] "anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" GO:0000502; GO:0005737; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0031225; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047 K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] LDFLPLK 0.99265 -17.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6072 0 0 0 0 13.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NY7 CLIC6_HUMAN Chloride intracellular channel protein 6 (Parchorin) CLIC6 CLIC1L Homo sapiens (Human) regulation of ion transmembrane transport [GO:0034765] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; D2 dopamine receptor binding [GO:0031749]; D3 dopamine receptor binding [GO:0031750]; D4 dopamine receptor binding [GO:0031751]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765] GO:0005244; GO:0005254; GO:0005737; GO:0005886; GO:0031749; GO:0031750; GO:0031751; GO:0034707; GO:0034765; GO:0070062 chloride channel activity [GO:0005254]; D2 dopamine receptor binding [GO:0031749]; D3 dopamine receptor binding [GO:0031750]; D4 dopamine receptor binding [GO:0031751]; voltage-gated ion channel activity [GO:0005244] GAAAVKEAGGGGPDR 0.99265 -6.7758 0 0 0 11.9314 0 0 13.0705 11.7771 0 0 0 12.3926 12.7169 12.302 0 0 0 9.48026 0 0 0 0 0 0 11.2924 0 0 0 10.6239 0 10.6723 0 0 0 0 0 0 0 0 0 11.3914 0 0 0 0 0 11.241 0 0 0 0 12.1987 0 0 0 0 14.0312 0 11.8159 0 10.7376 0 0 0 0 0 14.1938 0 14.0124 0 13.0785 0 11.4143 11.4066 14.2877 14.2499 13.2024 0 0 0 0 0 0 0 0 0 15.5357 0 0 0 0 15.2926 14.5256 10.6412 0 0 13.926 0 0 0 0 13.9451 10.313 11.6032 0 0 13.8606 0 0 0 13.3137 0 0 0 0 0 0 0 16.5202 0 0 0 0 0 0 12.731 0 0 0 13.5539 13.3811 13.6766 0 0 13.7383 0 0 0 0 15.1234 0 0 0 0 0 10.1951 0 15.0188 0 0 0 0 0 0 0 0 0 16.0582 0 15.5412 15.3424 0 16.441 15.1835 14.9831 14.486 14.412 14.5719 11.3811 0 0 0 0 0 0 14.9274 0 0 0 0 Q96RW7 HMCN1_HUMAN "Hemicentin-1 (Fibulin-6, FIBL-6)" HMCN1 FIBL6 Homo sapiens (Human) actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927] adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; actin filament reorganization [GO:0090527]; basement membrane organization [GO:0071711]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601] GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007049; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711; GO:0090527 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] AEVSDTGQYVCRAINVAGR 0.99265 -44.415 0 0 0 0 16.4293 0 0 0 15.0601 14.8154 0 14.5335 14.7081 11.9468 11.5039 11.9468 12.0396 11.9023 12.1671 12.2601 0 0 16.926 0 11.6009 14.2138 0 14.1845 0 14.3485 0 14.6444 0 13.5537 13.6769 13.487 14.8229 0 12.0561 14.9 11.4023 0 14.0725 11.5279 11.3631 13.5655 13.7405 13.695 0 13.8035 14.1146 0 0 0 0 13.2285 11.0749 0 0 0 14.7367 0 0 0 0 10.3581 0 0 0 0 11.3824 0 0 0 0 0 0 13.8742 0 12.5854 0 12.909 15.3903 14.9571 17.2495 0 15.4981 14.7678 13.1019 13.7562 0 0 13.7009 14.5656 0 0 18.2046 17.9734 13.1484 0 14.6202 0 0 0 0 0 0 14.9073 0 0 0 14.3162 17.1264 0 0 14.7776 0 17.5644 0 15.8459 0 14.0445 13.679 15.1117 12.9603 14.6274 0 14.5771 14.2031 13.418 0 11.9215 0 14.1084 0 0 0 13.1219 0 0 12.7993 14.4902 12.9044 0 16.5178 0 0 0 11.5721 14.836 11.9666 0 11.5774 11.6289 0 14.1432 13.0541 0 0 0 13.8256 0 0 0 14.018 14.3716 0 0 14.5252 14.1053 0 12.6262 10.9029 14.3469 0 14.235 14.9118 0 13.9791 0 Q9BYG4 PAR6G_HUMAN "Partitioning defective 6 homolog gamma, PAR-6 gamma (PAR6D)" PARD6G PAR6G Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; protein kinase C binding [GO:0005080]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341] GO:0005080; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0016324; GO:0051301; GO:0060341; GO:0070160 protein kinase C binding [GO:0005080] AHLDIGLPRDFR 0.99265 -7.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4059 0 Q9BZF9 UACA_HUMAN Uveal autoantigen with coiled-coil domains and ankyrin repeats UACA KIAA1561 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic signaling pathway [GO:0097190]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280] GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0043280; GO:0070062; GO:0097190; GO:1901223 DLSQKYTEVKNVK 0.99265 -14.621 0 0 0 0 0 0 0 0 0 13.5657 13.5434 13.5322 13.508 13.9411 0 0 0 0 14.1801 0 0 0 0 0 0 0 0 0 0 0 0 13.2165 13.0163 13.0685 13.1582 13.3778 0 13.629 12.9927 0 0 0 13.0435 13.4232 13.6321 12.8339 0 0 0 10.6 0 0 0 0 0 0 12.5998 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2038 0 17.2783 0 15.2593 11.5761 0 0 0 0 0 17.0745 0 18.9831 12.895 15.3926 0 0 0 14.8888 12.9031 12.1263 12.3947 13.488 0 14.351 17.9842 18.7184 0 17.4922 0 0 12.0697 12.3745 0 16.9264 0 0 0 16.7676 12.7725 0 0 17.0506 0 19.3628 17.4657 0 18.4331 0 18.0685 12.9625 12.2072 18.8479 18.7312 13.5177 18.6094 18.4593 0 0 0 0 0 0 0 0 17.1854 19.0371 0 16.0052 0 0 0 16.8934 16.2631 16.1028 0 0 0 0 0 10.9331 0 15.0777 0 14.0642 0 14.4596 14.6973 12.3174 14.6294 0 13.9792 0 0 0 14.1163 14.5658 0 0 11.3306 19.109 0 19.0636 17.0718 0 0 13.9897 0 12.1567 Q9BZI7 REN3B_HUMAN "Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B, hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X, hUpf3p-X)" UPF3B RENT3B UPF3X Homo sapiens (Human) "mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" GO:0000184; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0017056; GO:0034451; GO:0035145; GO:0045727; GO:0051028 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056] EALSKVVIR 0.99265 -25.368 0 0 0 0 0 0 0 0 14.6696 0 0 0 0 0 0 0 12.9404 0 12.9437 0 0 0 0 0 0 0 0 14.0815 13.1996 0 10.5937 12.6594 10.1625 0 14.1566 0 10.0562 0 0 0 0 12.2638 0 0 0 0 13.1564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0156 0 0 0 0 0 0 0 0 0 12.0347 14.0333 12.7728 15.0152 0 0 0 0 13.3024 0 0 0 11.6512 0 0 0 0 0 0 13.0694 18.8516 0 0 0 0 15.182 11.8741 13.4176 0 0 0 15.3662 11.7136 0 0 0 14.7445 0 0 0 14.9889 13.1781 12.194 12.8343 0 12.981 12.7628 0 0 0 0 10.4986 0 15.9766 0 0 0 0 0 0 0 0 18.3554 0 0 0 11.3512 11.4536 0 0 0 0 0 0 0 15.0852 0 0 0 0 0 0 0 12.1606 0 0 0 0 0 0 0 0 0 13.9404 0 0 0 0 0 15.3876 0 0 Q9H0L4 CSTFT_HUMAN "Cleavage stimulation factor subunit 2 tau variant (CF-1 64 kDa subunit tau variant) (Cleavage stimulation factor 64 kDa subunit tau variant, CSTF 64 kDa subunit tau variant) (TauCstF-64)" CSTF2T KIAA0689 Homo sapiens (Human) pre-mRNA cleavage required for polyadenylation [GO:0098789] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; pre-mRNA cleavage required for polyadenylation [GO:0098789] GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0043231; GO:0098789 mRNA binding [GO:0003729]; RNA binding [GO:0003723] GLPMDGR 0.99265 -16.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2785 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6074 0 0 0 0 0 0 0 0 0 0 0 0 13.7505 0 0 14.6558 14.7614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8569 12.2034 0 14.3308 0 Q9H1C4 UN93B_HUMAN "Protein unc-93 homolog B1, Unc-93B1, hUNC93B1" UNC93B1 UNC93 UNC93B Homo sapiens (Human) adaptive immune response [GO:0002250]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] early phagosome [GO:0032009]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764] early phagosome [GO:0032009]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; Toll-like receptor binding [GO:0035325]; adaptive immune response [GO:0002250]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] GO:0000139; GO:0002250; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0006886; GO:0016021; GO:0032009; GO:0034138; GO:0034154; GO:0034162; GO:0035325; GO:0045087; GO:0051607 Toll-like receptor binding [GO:0035325] IPRPQHK 0.99265 -4.3991 0 0 0 0 0 0 0 10.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.516 0 10.5881 0 0 0 0 0 0 0 0 0 0 0 0 12.6312 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6904 0 0 0 12.8476 0 12.1309 0 0 0 0 0 0 0 0 0 0 0 12.5434 0 0 12.7982 0 0 0 12.1883 0 0 12.2447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0997 13.4629 0 0 0 12.3718 0 0 0 0 0 0 0 0 0 0 Q9UBT3 DKK4_HUMAN "Dickkopf-related protein 4, Dickkopf-4, Dkk-4, hDkk-4 [Cleaved into: Dickkopf-related protein 4 short form ]" DKK4 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hair follicle placode formation [GO:0061170]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615] extracellular space [GO:0005615]; co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hair follicle placode formation [GO:0061170]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055] GO:0005615; GO:0016055; GO:0030178; GO:0039706; GO:0048019; GO:0061170; GO:0090090 co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019] GSQCLSDTDCNTR 0.99265 -6.7876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4279 0 Q9UBZ9 REV1_HUMAN "DNA repair protein REV1, EC 2.7.7.- (Alpha integrin-binding protein 80, AIBP80) (Rev1-like terminal deoxycytidyl transferase)" REV1 REV1L Homo sapiens (Human) DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA replication [GO:0006260]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411] GO:0003684; GO:0003887; GO:0005654; GO:0006260; GO:0009411; GO:0017125; GO:0042276; GO:0046872; GO:0070987 damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] CAASVGIGSNILLARMATRK 0.99265 -25.389 13.9305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2801 0 0 0 0 0 0 0 11.7317 0 0 0 0 0 0 0 0 0 14.8684 0 12.064 0 16.3011 12.2315 11.1736 0 0 15.3537 0 0 0 13.2542 13.1013 0 0 0 0 0 0 0 0 0 0 13.282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6827 0 12.7166 0 13.6948 12.1279 0 0 0 0 0 0 0 0 0 12.4338 0 0 0 0 0 14.2056 0 0 13.1791 0 0 14.073 0 0 0 0 0 0 13.1966 0 0 0 0 0 0 0 12.6314 0 0 0 0 0 0 0 13.4905 0 0 0 0 0 0 0 14.0457 0 0 0 0 0 11.7516 A0A1B0GVZ9 TM269_HUMAN Transmembrane protein 269 TMEM269 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GNRFILCCMASLMILFMMDQSYYPYDK 0.99266 -6.4175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2893 0 0 0 0 0 0 0 0 0 0 14.3621 12.3901 0 0 0 0 0 0 0 13.243 0 0 0 0 10.7559 13.9332 14.3117 15.1834 13.9311 15.2781 14.9697 14.1545 15.3182 0 0 0 0 14.5087 0 0 15.3261 15.7896 0 13.3063 0 0 14.0759 0 0 0 13.7975 14.517 14.0524 14.6861 0 0 0 13.9939 0 13.8862 13.9429 0 0 0 0 12.6244 0 13.2802 0 12.9894 0 15.3433 0 13.0103 0 0 0 13.9695 0 0 0 0 0 15.5523 0 0 0 0 0 0 0 0 13.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6867 13.3194 13.9601 0 0 0 0 0 0 13.953 O75151 PHF2_HUMAN "Lysine-specific demethylase PHF2, EC 1.14.11.- (GRC5) (PHD finger protein 2)" PHF2 CENP-35 KIAA0662 Homo sapiens (Human) epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; liver development [GO:0001889]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; liver development [GO:0001889]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000776; GO:0001889; GO:0003712; GO:0003713; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0006482; GO:0008270; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045815; GO:0061188 histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] AYEVERRLK 0.99266 -45.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8147 0 14.1232 12.1656 0 0 0 0 11.4477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6455 0 0 0 0 0 10.166 0 10.719 0 13.4736 13.1528 12.7358 12.69 0 0 19.6891 12.4758 0 19.357 0 0 12.379 0 0 0 0 12.7683 0 0 0 0 0 0 13.7015 12.5191 14.717 14.3017 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8366 14.2478 13.7369 0 13.5794 0 14.2589 0 0 0 0 12.2406 0 13.6781 0 13.5405 0 0 13.6589 14.1973 12.711 0 0 0 0 14.0037 0 0 14.2336 0 0 0 0 0 11.7432 12.693 13.9236 13.0353 13.5912 0 13.6273 0 0 0 0 12.8526 0 0 0 0 0 0 0 13.5462 0 11.3755 0 13.1477 0 0 13.7772 10.933 O95886 DLGP3_HUMAN "Disks large-associated protein 3, DAP-3 (PSD-95/SAP90-binding protein 3) (SAP90/PSD-95-associated protein 3, SAPAP3)" DLGAP3 DAP3 Homo sapiens (Human) modification of synaptic structure [GO:0099563]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572] anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; glutamatergic synapse [GO:0098978]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090]; modification of synaptic structure [GO:0099563]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; signaling [GO:0023052] GO:0001540; GO:0005886; GO:0014069; GO:0023052; GO:0031594; GO:0060090; GO:0070161; GO:0098962; GO:0098978; GO:0098981; GO:0099563; GO:0099572 amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090] APTYSVFR 0.99266 -40.133 0 0 0 0 0 0 0 0 0 0 0 0 12.8424 0 0 0 14.7484 0 0 0 0 0 10.6184 0 0 0 0 0 0 0 0 0 0 8.95026 0 10.8135 0 0 0 0 0 0 10.6141 0 0 0 0 0 0 10.9748 12.3907 0 0 11.745 0 0 0 0 0 0 0 0 0 0 10.4477 0 0 0 0 0 0 0 14.0143 11.1291 0 0 0 14.1745 14.1076 0 13.2951 14.6521 0 0 0 0 0 0 15.4328 0 12.2133 0 13.8468 0 14.5033 0 15.3464 0 14.9815 13.6887 14.3314 12.6817 15.306 0 0 9.82812 13.8253 15.2367 14.8959 0 13.8481 13.4607 16.4034 14.4942 0 14.2619 15.7924 0 0 14.6531 14.6812 15.3367 14.5163 15.0736 0 0 14.5103 0 0 0 13.5992 13.9248 15.7498 13.9049 0 14.374 0 14.4759 15.2007 14.2737 15.2697 15.1104 14.2811 0 13.4244 13.4666 14.0228 0 0 0 14.9025 13.2693 0 0 14.3243 0 0 12.9786 0 0 13.388 0 13.384 14.5172 12.1913 13.7787 0 11.7876 0 12.4169 0 0 0 0 0 13.9945 0 13.1185 0 0 P09488 GSTM1_HUMAN "Glutathione S-transferase Mu 1, EC 2.5.1.18 (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4)" GSTM1 GST1 Homo sapiens (Human) cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178] GO:0004364; GO:0005737; GO:0005829; GO:0006693; GO:0006749; GO:0018916; GO:0019899; GO:0042178; GO:0042803; GO:0043295; GO:0045171; GO:0051122; GO:0070458; GO:1901687 enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803] FLPRPVFSK 0.99266 -6.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36776 LONM_HUMAN "Lon protease homolog, mitochondrial, EC 3.4.21.53 (LONHs) (Lon protease-like protein, LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)" LONP1 PRSS15 Homo sapiens (Human) aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666] GO:0000002; GO:0001018; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0007568; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0032042; GO:0034599; GO:0042645; GO:0042802; GO:0043531; GO:0043565; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407 ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727] AKLSSDVLTLLIK 0.99266 -40.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3279 12.8523 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7705 0 0 0 0 10.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 13.2675 0 0 0 0 0 0 15.8955 0 0 13.6209 15.0414 15.0496 0 0 14.5972 0 12.5031 14.6318 0 0 13.976 0 0 0 13.7288 0 11.94 0 0 0 13.4837 12.9589 0 0 0 0 0 14.5763 0 0 12.7935 0 15.4521 14.0492 15.6706 14.5446 15.3532 15.2126 13.9996 0 12.7264 0 0 0 0 0 14.0815 0 0 13.7996 12.3881 13.3136 0 0 11.3946 0 0 14.2664 0 0 0 0 0 0 0 0 0 0 14.6905 0 0 14.2359 0 0 12.6458 0 0 0 0 0 0 12.6821 0 0 0 0 0 0 0 13.032 0 0 0 0 0 P42685 FRK_HUMAN "Tyrosine-protein kinase FRK, EC 2.7.10.2 (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5)" FRK PTK5 RAK Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0000122; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0007169; GO:0030154; GO:0031234; GO:0035578; GO:0035580; GO:0045087; GO:0070062 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] HEIKLPVK 0.99266 -14.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6087 0 0 0 0 0 0 0 0 0 0 0 14.0904 0 0 0 0 0 0 13.7363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1055 0 0 0 0 0 0 0 0 0 0 0 0 13.454 13.5732 0 0 13.5834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15287 RNPS1_HUMAN RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2) RNPS1 LDC2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]" ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]" GO:0000184; GO:0000381; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0008380; GO:0016607; GO:0043065; GO:0048025; GO:0061574 mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723] DLSGVKK 0.99266 -45.782 13.371 0 13.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6469 0 13.7545 0 0 13.8728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5495 0 16.337 0 16.5361 0 0 0 13.7502 0 0 15.838 13.2634 0 0 0 13.2082 13.2305 0 0 0 13.3024 13.6506 0 14.1887 0 0 0 0 16.0936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5548 0 0 16.0399 0 15.7729 0 0 15.5187 16.312 15.9645 0 16.1767 16.1283 13.2153 0 0 0 0 0 0 0 12.7007 13.1442 0 14.0194 0 14.2555 0 0 16.4888 14.8177 0 0 0 0 0 0 0 0 12.9982 0 10.3314 0 0 0 0 0 0 0 0 0 0 0 10.9012 0 0 0 15.751 0 Q15935 ZNF77_HUMAN Zinc finger protein 77 (ZNFpT1) ZNF77 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ECGKAFR 0.99266 -7.2791 0 0 0 0 12.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0404 0 0 0 0 0 0 0 13.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2PPJ7 RGPA2_HUMAN "Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt, AS250) (p220)" RALGAPA2 C20orf74 KIAA1272 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0046982; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982] ANLCVYISR 0.99266 -40.018 0 12.4642 15.7606 0 0 0 0 0 13.5265 0 0 0 0 0 0 0 0 0 0 0 0 12.5662 0 12.4404 14.0497 0 13.3904 10.4359 0 0 13.3569 0 11.3422 0 0 0 0 0 0 12.1879 13.9098 0 0 0 0 0 0 0 0 0 0 13.4813 12.811 0 0 12.7175 0 11.6206 0 0 0 0 0 0 0 0 0 10.6582 0 10.9404 0 11.8618 0 0 0 0 10.6472 9.60598 13.7537 14.1842 15.1157 0 14.835 13.0772 16.2919 16.2401 15.1676 13.7602 0 16.299 0 14.794 13.9324 0 14.5569 15.6567 0 0 0 15.3845 13.2543 12.5191 14.1739 15.3316 14.3877 12.969 13.925 14.1981 12.197 0 14.6886 15.2858 0 0 0 0 0 14.1269 0 0 13.8175 0 0 0 12.5119 15.4087 0 14.7132 13.7066 12.0296 9.58643 14.5077 0 12.5997 14.7322 0 0 0 0 15.1564 0 0 13.6159 13.7619 0 0 15.0049 12.8261 14.9336 12.0822 0 13.6571 12.8526 0 15.7716 12.9168 0 0 0 0 0 0 0 0 0 0 0 0 17.7881 0 0 0 0 0 0 0 0 0 0 0 Q5JR59 MTUS2_HUMAN "Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150, Tracking protein of 150 kDa)" MTUS2 CAZIP KIAA0774 TIP150 Homo sapiens (Human) cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] GO:0005634; GO:0005737; GO:0005874; GO:0008017; GO:0015630; GO:0042803; GO:0045171 microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] AAGGDLK 0.99266 -67.589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5179 0 0 12.2682 13.2341 0 17.1232 0 0 0 13.1234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9691 0 0 0 0 0 12.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9253 0 0 10.8598 12.6384 0 0 15.0164 0 13.4192 14.8292 14.5183 15.3636 0 0 18.7586 14.9765 14.6508 15.8846 16.3481 0 14.9033 14.3846 0 0 0 14.689 18.0464 0 0 0 18.7107 0 13.8951 0 17.5917 18.2966 0 17.8471 0 0 15.0949 14.1268 14.5393 0 0 14.8549 0 11.4435 14.4871 15.2555 14.6788 13.5362 11.7618 18.4744 14.6111 0 13.478 14.0131 18.5036 0 13.4867 0 0 13.2538 15.2025 0 13.029 0 0 12.6143 18.3557 13.3132 15.1633 0 0 17.62 0 0 14.3351 0 14.6359 14.4288 0 0 0 14.795 0 14.2132 14.4269 0 13.2532 14.3421 13.245 0 0 0 0 13.8555 0 12.6218 14.2915 0 14.819 0 0 Q6P1M9 ARMX5_HUMAN Armadillo repeat-containing X-linked protein 5 ARMCX5 Homo sapiens (Human) IPPYHGPYYQTLAEIKKQIR 0.99266 -25.578 0 0 0 0 0 10.2674 0 0 0 10.6916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4974 0 15.6758 0 0 0 0 0 Q6P280 ZN529_HUMAN Zinc finger protein 529 ZNF529 KIAA1615 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ACGKVFR 0.99266 -25.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.39 14.6561 14.7031 15.032 0 0 0 0 0 0 0 0 0 13.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4872 0 0 0 0 0 12.724 0 0 0 0 0 0 0 0 12.0924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8492 0 0 0 0 0 0 13.3981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9046 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9703 0 0 0 0 0 0 0 Q6ZS17 RIPR1_HUMAN Rho family-interacting cell polarization regulator 1 RIPOR1 FAM65A KIAA1930 Homo sapiens (Human) cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506]; 14-3-3 protein binding [GO:0071889]; cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266] GO:0005737; GO:0005794; GO:0007266; GO:0009267; GO:0009611; GO:0012506; GO:0016020; GO:0030335; GO:0031252; GO:0034067; GO:0035024; GO:0051683; GO:0070062; GO:0071889; GO:0090316; GO:1990869; GO:2001107 14-3-3 protein binding [GO:0071889] ALSSLLVHGNNK 0.99266 -7.27 0 0 0 0 0 0 0 10.5678 0 0 0 0 0 0 14.3489 0 0 0 0 14.5117 0 0 0 0 0 0 0 0 13.8712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7621 13.0469 12.6651 12.9826 12.9176 13.1069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6692 0 0 0 0 0 12.8053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3566 0 0 13.0237 0 0 0 12.8611 0 0 12.9232 13.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4743 0 0 0 0 12.9589 0 15.4385 0 0 16.5019 0 Q7RTP6 MICA3_HUMAN "[F-actin]-monooxygenase MICAL3, EC 1.14.13.225 (Molecule interacting with CasL protein 3, MICAL-3)" MICAL3 KIAA0819 KIAA1364 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; small GTPase binding [GO:0031267]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]" GO:0003779; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005886; GO:0005938; GO:0006887; GO:0007010; GO:0007049; GO:0016709; GO:0030042; GO:0031267; GO:0042995; GO:0045171; GO:0046872; GO:0051015; GO:0051301; GO:0071949; GO:0090543 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; small GTPase binding [GO:0031267]" AELQLRR 0.99266 -40.271 0 0 9.75495 0 0 10.4344 0 0 0 0 12.1562 0 0 0 10.9514 0 0 0 11.0009 0 0 0 12.2075 0 0 0 0 13.0067 0 0 0 0 0 0 13.5056 12.4769 0 0 11.6472 0 12.6267 0 0 0 9.19518 0 0 12.088 0 0 11.4033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0267 0 0 0 15.0337 13.5505 10.4827 0 0 0 0 0 13.2219 13.7767 13.5866 14.3547 15.2233 13.9271 15.0947 15.103 18.4251 13.5671 0 14.8299 0 14.8902 13.6643 0 0 14.1512 0 0 14.3567 0 12.8764 0 0 15.0491 0 0 15.0899 12.5897 11.9085 14.204 13.0966 0 14.2231 0 0 0 14.1347 12.9246 15.0596 14.2483 13.3014 16.0693 0 13.2067 0 0 0 0 11.3454 12.5386 13.2412 15.3696 14.2661 0 12.6252 0 13.6191 13.3756 0 0 0 12.9603 0 13.1701 0 0 13.6634 0 0 0 0 0 0 0 12.7841 12.4403 0 0 0 0 0 0 10.7893 0 10.5059 0 0 12.9216 0 0 0 0 13.1948 0 0 0 0 12.0893 0 0 Q8N1F8 S11IP_HUMAN Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1) STK11IP KIAA1898 LIP1 LKB1IP STK11IP1 Homo sapiens (Human) protein localization [GO:0008104] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; protein kinase binding [GO:0019901]; protein localization [GO:0008104] GO:0005576; GO:0005737; GO:0005765; GO:0008104; GO:0019901; GO:0035578; GO:0043231 protein kinase binding [GO:0019901] EEGEMVEQGEEEAGEEEEEEQDQKEVEAELCR 0.99266 -7.2722 0 11.2735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4201 0 0 0 0 0 0 0 0 0 14.751 14.6136 0 0 0 0 0 0 0 0 14.9405 0 0 13.7522 0 0 0 14.0078 13.7137 0 0 0 0 0 14.3229 0 0 0 0 0 0 0 13.4059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4454 0 0 13.2861 0 0 14.4392 0 0 0 0 0 0 Q8TD57 DYH3_HUMAN "Dynein axonemal heavy chain 3 (Axonemal beta dynein heavy chain 3, HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)" DNAH3 DNAHC3B Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] 9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0030286; GO:0045505; GO:0051959; GO:0060285; GO:0097729 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] APMSLVMFRFAIEHISR 0.99266 -45.242 11.4027 0 0 0 0 0 0 10.6699 12.2113 0 0 16.1283 14.148 0 14.3101 14.2564 0 13.2054 0 0 14.9964 12.792 0 0 0 0 0 0 0 0 14.5524 0 0 0 0 10.8243 14.2761 0 15.008 13.967 0 14.175 0 13.9406 14.3873 11.1906 13.9448 14.3794 0 13.469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7069 12.2957 14.8768 0 0 13.2311 0 0 12.3241 0 13.2293 14.6851 14.5129 12.3021 13.8698 0 12.9753 13.4651 15.1585 0 14.744 14.1135 0 0 14.0128 13.6554 12.0466 13.9628 13.9894 14.6514 10.6578 0 0 13.7423 12.8892 13.3735 12.6868 15.691 14.5044 15.3936 12.6802 0 12.8913 16.4974 13.2493 13.4843 14.245 12.6223 0 0 0 13.1694 0 11.2843 12.8507 14.342 14.6857 15.4851 13.0469 13.7048 0 15.6014 10.8409 12.6279 14.2002 0 14.4498 0 0 0 0 0 14.2265 14.0592 0 0 0 12.9116 12.9073 13.3201 11.3617 0 0 14.3015 12.9222 13.9221 0 0 0 14.3556 11.2756 14.6201 12.8783 15.0873 0 13.1402 15.245 0 14.8776 13.0726 12.6241 13.9498 15.725 13.9946 0 12.7952 15.251 11.4136 14.3356 12.2066 0 0 0 0 Q8WXR4 MYO3B_HUMAN "Myosin-IIIb, EC 2.7.11.1" MYO3B Homo sapiens (Human) cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426] cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] GO:0000146; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0018105; GO:0030832; GO:0032426; GO:0032433; GO:0050896; GO:0051491; GO:0090103; GO:0106310 actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DQCIVISGESGSGKTESAHLIVQHLTFLGKANNQTLR 0.99266 -44.976 0 0 0 0 0 0 0 0 0 0 10.5433 0 0 0 0 12.8929 0 15.1944 10.5596 14.3817 0 0 0 14.1202 0 0 12.4002 0 0 11.886 0 0 0 0 0 0 0 0 0 9.68464 0 0 15.1646 0 15.2845 0 0 0 11.234 0 0 0 0 0 0 0 0 0 0 0 10.2787 0 0 0 0 0 0 12.6882 0 0 0 0 0 11.7012 0 0 0 0 15.6615 0 0 14.9779 0 0 13.2178 0 15.0474 0 13.7789 0 0 13.1978 0 0 0 0 0 0 0 0 0 14.4141 15.1125 0 0 0 14.1786 12.6892 15.9156 0 15.3563 0 12.7311 0 11.7279 13.1681 13.0543 14.1697 12.6987 15.1307 0 0 14.6093 13.9346 13.3093 0 0 15.1806 0 15.5243 0 15.5587 15.5358 0 0 0 0 14.9868 0 12.9103 12.0349 0 15.0914 12.3519 0 15.3842 0 0 0 0 14.6012 0 0 0 14.8017 13.2651 0 0 0 0 0 0 11.7755 0 0 15.9836 0 11.9947 0 12.3168 0 0 14.2056 14.3296 0 0 14.4724 12.7791 15.7017 11.713 Q92997 DVL3_HUMAN "Segment polarity protein dishevelled homolog DVL-3, Dishevelled-3 (DSH homolog 3)" DVL3 KIAA0208 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein localization [GO:0032880]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" chromatin [GO:0000785]; cytosol [GO:0005829] "chromatin [GO:0000785]; cytosol [GO:0005829]; beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein localization [GO:0032880]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0000785; GO:0001934; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0031267; GO:0032880; GO:0035556; GO:0035567; GO:0038031; GO:0043507; GO:0043547; GO:0045893; GO:0045944; GO:0050821; GO:0060070; GO:0060071; GO:0090179; GO:0150012 beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] IIYHLDGQETPYLVKLPLPAERVTLADFK 0.99266 -7.2805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CB8 INT12_HUMAN "Integrator complex subunit 12, Int12 (PHD finger protein 22)" INTS12 PHF22 SBBI22 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243; GO:0034472; GO:0046872 metal ion binding [GO:0046872] LSSTTQNNTGKPATSSANQK 0.99266 -15.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6677 0 0 0 0 0 0 0 0 0 0 15.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0706 0 0 0 0 0 0 0 0 0 0 0 11.6157 0 0 0 Q96KE9 BTBD6_HUMAN BTB/POZ domain-containing protein 6 (Lens BTB domain protein) BTBD6 BDPL Homo sapiens (Human) neurogenesis [GO:0022008] cytosol [GO:0005829] cytosol [GO:0005829]; neurogenesis [GO:0022008] GO:0005829; GO:0022008 CHRFQSSAYR 0.99266 -7.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71075 0 0 0 0 0 0 0 0 16.3057 0 0 0 0 0 0 0 0 11.1204 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9031 0 0 0 0 0 13.5459 0 0 0 0 0 0 0 0 0 0 16.546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6262 0 0 0 0 0 0 12.8784 0 0 0 0 0 14.1267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.243 12.5085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWV1 BOC_HUMAN "Brother of CDO, Protein BOC" BOC UNQ604/PRO1190 Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; smoothened signaling pathway [GO:0007224] axon [GO:0030424]; axonal growth cone [GO:0044295]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon [GO:0030424]; axonal growth cone [GO:0044295]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; nervous system development [GO:0007399]; positive regulation of myoblast differentiation [GO:0045663]; smoothened signaling pathway [GO:0007224] GO:0005886; GO:0005887; GO:0007224; GO:0007399; GO:0007411; GO:0030424; GO:0044295; GO:0045663; GO:0098609 DDPGASPQSSSQPDHGR 0.99266 -7.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6065 0 0 14.6056 0 0 0 0 0 0 0 0 15.4497 0 0 14.094 0 14.2042 0 0 0 12.6268 14.3144 0 15.0196 0 14.3904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5344 0 0 0 13.2037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8826 0 0 0 0 0 0 0 0 Q9H799 CPLN1_HUMAN Ciliogenesis and planar polarity effector 1 (Protein JBTS17) CPLANE1 C5orf42 JBTS17 Homo sapiens (Human) cilium assembly [GO:0060271] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021] ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cilium assembly [GO:0060271] GO:0016021; GO:0035869; GO:0060271 AFPYPEDVRVPLR 0.99266 -72.95 0 0 11.6044 0 0 0 0 0 14.7627 0 0 0 0 10.2329 10.8591 0 12.4543 12.3127 15.1325 10.9771 0 13.1162 0 12.5879 0 0 0 12.1257 0 0 12.6418 0 0 0 0 0 0 0 0 0 0 0 0 13.2444 0 0 0 13.8357 0 12.7855 11.9756 0 12.5919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.11 0 10.8076 0 0 12.5984 0 12.3187 10.5822 0 13.0093 0 13.6286 14.2697 13.7508 0 13.3259 0 0 0 11.8038 0 12.1996 0 16.2751 15.3245 12.9177 12.1406 0 12.6079 14.321 12.6147 13.9605 15.2618 0 0 0 0 14.7559 12.68 14.3695 14.5747 12.7377 15.2135 11.9061 14.6963 12.9167 12.5505 11.0447 14.5973 0 15.0262 12.8911 14.8592 0 11.9911 12.2855 0 12.9617 0 15.2329 0 15.4176 9.57283 15.2168 13.9114 0 15.2799 14.3387 13.3095 14.3273 0 12.9369 14.7485 13.7368 0 12.4104 13.3818 14.0666 0 0 11.9514 0 0 0 0 14.9376 15.3246 15.2626 14.106 14.213 12.8556 0 0 0 0 0 11.9869 12.0839 13.0664 14.7055 0 0 14.984 0 12.9985 13.1801 12.1151 0 12.3878 10.3075 0 0 Q9NPP4 NLRC4_HUMAN "NLR family CARD domain-containing protein 4 (CARD, LRR, and NACHT-containing protein, CED-4-like protein Clan) (Caspase recruitment domain-containing protein 12) (Ice protease-activating factor, Ipaf)" NLRC4 CARD12 CLAN CLAN1 IPAF UNQ6189/PRO20215 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein processing [GO:0010954]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; intracellular membrane-bounded organelle [GO:0043231]; IPAF inflammasome complex [GO:0072557] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; intracellular membrane-bounded organelle [GO:0043231]; IPAF inflammasome complex [GO:0072557]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein processing [GO:0010954]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269] GO:0000287; GO:0002218; GO:0002221; GO:0005524; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0006954; GO:0010954; GO:0016045; GO:0032731; GO:0042742; GO:0042802; GO:0042803; GO:0043065; GO:0043231; GO:0045087; GO:0046456; GO:0050729; GO:0051092; GO:0051260; GO:0061133; GO:0061702; GO:0070269; GO:0072557; GO:0089720; GO:0097202 ATP binding [GO:0005524]; caspase binding [GO:0089720]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] EEVNIICCEK 0.99266 -40.118 0 11.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7457 0 13.7879 0 14.3359 0 0 13.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0572 0 0 0 0 0 0 0 0 0 15.0522 0 15.0993 13.5633 0 0 12.7209 0 0 14.4007 12.0231 0 0 0 0 12.7547 17.2336 0 0 0 0 0 0 0 0 13.3298 0 0 0 0 0 0 0 0 0 14.9379 0 0 0 0 12.6212 12.9663 0 0 0 0 14.2479 0 13.2917 0 0 0 0 0 0 0 0 13.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5814 0 0 13.2961 0 0 0 0 0 0 0 0 0 0 0 13.0954 13.2285 13.3845 0 0 0 0 0 0 13.4525 0 0 Q8NFP9 NBEA_HUMAN Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B) NBEA BCL8B KIAA1544 LYST2 Homo sapiens (Human) protein localization [GO:0008104] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; protein kinase binding [GO:0019901]; protein localization [GO:0008104] GO:0005802; GO:0005829; GO:0005886; GO:0008104; GO:0012505; GO:0016020; GO:0019901 protein kinase binding [GO:0019901] AAIEYGTEEDVVKSK 0.99267 -74.609 0 0 0 0 16.9511 0 0 0 0 14.4177 0 0 0 0 0 0 0 0 10.0179 0 0 16.4523 11.7293 0 0 0 13.6876 14.9432 12.7181 0 0 0 0 0 0 0 0 0 11.2859 0 0 0 0 0 14.4848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0424 0 13.1396 13.6952 18.108 17.9831 11.7292 0 16.0374 18.2242 0 14.3806 0 17.9671 14.675 0 15.349 13.3295 0 18.876 13.967 17.1789 14.878 13.8833 14.3947 0 0 13.8118 0 16.483 12.6522 17.2985 0 0 16.7685 0 14.2441 13.658 0 0 0 15.0637 16.7268 0 13.5433 0 16.7584 16.8083 0 0 14.6253 13.6566 16.7265 15.4984 16.8856 16.6614 0 16.7212 18.8205 0 0 18.8133 16.6233 18.7225 18.4279 13.3689 16.7862 16.9719 0 11.6434 16.7009 18.7723 18.7355 0 13.2184 11.8593 14.7488 16.7833 15.2688 0 0 0 0 0 16.9289 0 12.9977 0 16.9544 0 0 0 0 0 0 0 0 0 0 14.328 12.7625 0 0 0 11.8062 11.3251 11.1037 16.6086 13.7476 13.0592 13.0365 12.401 0 0 Q86UW7 CAPS2_HUMAN "Calcium-dependent secretion activator 2 (Calcium-dependent activator protein for secretion 2, CAPS-2)" CADPS2 CAPS2 KIAA1591 Homo sapiens (Human) dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] anchoring junction [GO:0070161]; cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; presynapse [GO:0098793] anchoring junction [GO:0070161]; cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; presynapse [GO:0098793]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; dense core granule exocytosis [GO:1990504]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; synaptic vesicle exocytosis [GO:0016079] GO:0005654; GO:0006887; GO:0008289; GO:0015031; GO:0016079; GO:0030659; GO:0043231; GO:0045921; GO:0046872; GO:0070161; GO:0098793; GO:0098978; GO:1990504 lipid binding [GO:0008289]; metal ion binding [GO:0046872] AGGGGAAR 0.99267 -46.353 14.1651 14.967 14.711 0 15.0094 14.9455 19.3367 14.8085 0 0 0 11.0828 0 0 0 10.7762 11.4915 12.6572 10.6822 12.6544 13.5465 13.1734 12.1067 0 0 0 0 0 10.4578 0 0 0 0 0 0 0 0 0 11.2575 0 0 0 0 0 0 0 0 0 0 0 0 0 11.785 0 0 0 0 0 10.7033 12.8669 0 0 0 0 0 0 14.638 16.3363 14.3126 10.4164 0 14.8907 13.4997 13.8384 20.8366 16.3298 16.9873 17.9436 15.656 15.4333 16.122 20.6306 18.6508 17.3065 0 15.8278 15.2346 17.0339 16.7958 16.9993 16.8812 16.8169 16.9284 14.1372 16.4265 0 0 13.9897 19.6234 17.3179 17.1575 17.2817 13.4648 16.0594 15.0939 15.8306 15.606 17.1932 17.0151 14.9331 16.6454 0 17.4519 13.4424 20.3413 14.6318 17.4116 15.6676 18.6211 13.6119 16.1265 14.3327 15.895 15.335 16.1587 15.8511 15.6861 17.1805 16.2995 20.5917 13.5788 17.4789 20.6149 20.6141 17.4085 16.3372 15.2889 12.6728 16.4671 16.4531 13.7938 17.2413 16.1942 20.5672 16.1716 15.0593 15.7187 20.652 0 0 20.4684 17.7188 0 17.4012 17.4072 17.396 0 0 0 0 0 0 0 0 0 0 10.6563 0 12.4757 13.0414 11.3462 12.3839 15.4156 15.6116 14.5681 0 0 0 0 14.7329 Q9NZR2 LRP1B_HUMAN "Low-density lipoprotein receptor-related protein 1B, LRP-1B (Low-density lipoprotein receptor-related protein-deleted in tumor, LRP-DIT)" LRP1B LRPDIT Homo sapiens (Human) protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898] GO:0005041; GO:0005509; GO:0005886; GO:0006898; GO:0015031; GO:0016021; GO:0043235 calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041] AILRSNKYTGGDTK 0.99267 -41.012 11.3623 0 10.0422 0 0 12.6665 11.7931 12.8339 13.6372 11.3501 0 12.3347 12.5429 14.0104 10.4337 13.8835 12.898 11.7291 15.8757 14.1381 15.11 9.70736 0 13.2996 12.204 13.8243 0 0 0 12.3562 11.7614 0 0 13.637 12.4821 12.3522 11.9129 11.8141 12.5361 13.7111 0 14.47 12.2552 15.0038 11.4988 11.5146 0 0 0 0 13.079 10.9749 0 13.3817 0 10.2427 0 0 9.93574 0 0 10.8078 0 0 9.9409 0 16.5772 17.0295 15.5438 15.8098 14.32 10.4789 11.5316 15.4856 15.1035 15.718 16.8886 15.6761 15.8133 15.5456 14.7887 13.4616 11.7501 10.1053 13.7572 18.7565 15.1251 15.1253 15.7188 14.0666 18.1693 12.1617 15.0869 12.2919 14.3731 14.1634 13.1535 14.7024 16.2743 15.361 12.9587 15.1996 16.0232 15.5539 12.9179 0 0 14.9804 14.7065 15.5685 15.9462 15.322 13.7955 14.3235 14.5653 14.8635 15.504 14.6544 14.3536 15.8098 14.516 15.4964 13.6797 15.0438 14.4606 15.5432 15.216 14.2323 13.917 16.4199 15.3814 13.5682 16.26 15.4898 15.8778 14.869 14.3004 16.4134 14.9088 15.7178 12.2723 13.6626 12.0258 15.1378 15.1638 15.0036 17.2798 16.0591 15.0982 10.7986 14.8833 15.3412 11.6298 14.8135 11.4215 15.2978 0 11.2729 13.8838 13.7 14.2971 14.3728 14.773 13.5456 12.4412 13.7917 12.3853 13.0677 15.4858 11.4107 11.3137 13.9001 14.6106 11.8158 14.0244 14.4448 11.6663 13.152 14.2943 11.6952 Q96M86 DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 (Dynein heavy chain domain 1-like protein) (Protein CCDC35) DNHD1 C11orf47 CCDC35 DHCD1 DNHD1L UNQ5781/PRO12970 Homo sapiens (Human) cilium movement [GO:0003341]; microtubule-based movement [GO:0007018] 9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156] 9+2 motile cilium [GO:0097729]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; inner dynein arm [GO:0036156]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018] GO:0003341; GO:0005524; GO:0007018; GO:0008569; GO:0030286; GO:0036156; GO:0045505; GO:0051959; GO:0070062; GO:0097729 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] AALLTPMRAWTTQLQKLK 0.99267 -46.362 0 0 0 0 12.5445 0 15.3819 15.4595 0 0 0 0 0 0 0 0 0 0 0 10.7952 0 0 0 0 0 0 12.42 12.769 0 10.7287 0 0 12.7252 13.9741 0 0 13.9279 0 0 0 0 0 10.7912 13.1271 0 0 0 0 0 0 0 10.9967 9.73383 13.9153 0 0 14.6155 0 0 0 0 0 11.1833 0 0 0 14.6306 0 0 0 11.2355 13.6579 0 11.9118 9.98114 11.7213 0 0 13.5042 13.6255 13.8531 13.1785 16.4208 16.3903 14.2517 14.5502 11.6546 15.1869 16.0667 15.5831 15.0194 15.1519 14.3117 13.0931 13.2962 16.32 14.276 14.4899 17.6731 14.2405 13.3803 12.21 0 12.1408 14.9883 16.2176 14.5789 0 12.3896 16.0805 15.6837 0 11.7016 15.005 14.829 0 0 0 16.3035 16.3562 0 14.367 0 15.3199 14.3451 0 14.9858 0 14.9895 15.364 15.9932 13.4672 0 0 14.1075 13.2802 18.8987 14.0405 17.1297 14.814 14.6963 10.0232 0 0 15.3573 14.9357 0 19.5972 14.5344 13.7106 11.2527 14.12 0 0 16.2594 14.0072 11.3081 0 0 0 0 13.0581 0 0 0 11.907 11.4683 0 0 0 0 13.5536 12.6706 15.2337 0 0 0 10.8667 14.4072 14.3895 O14641 DVL2_HUMAN "Segment polarity protein dishevelled homolog DVL-2, Dishevelled-2 (DSH homolog 2)" DVL2 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cochlea morphogenesis [GO:0090103]; convergent extension involved in neural plate elongation [GO:0022007]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" aggresome [GO:0016235]; apical part of cell [GO:0045177]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; apical part of cell [GO:0045177]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cochlea morphogenesis [GO:0090103]; convergent extension involved in neural plate elongation [GO:0022007]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001843; GO:0001934; GO:0003151; GO:0005109; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0007379; GO:0007507; GO:0008104; GO:0016235; GO:0016328; GO:0016604; GO:0019901; GO:0019904; GO:0022007; GO:0030674; GO:0031267; GO:0031410; GO:0035556; GO:0035567; GO:0042802; GO:0043507; GO:0043547; GO:0043621; GO:0044340; GO:0045177; GO:0045334; GO:0045944; GO:0051091; GO:0060070; GO:0060071; GO:0061098; GO:0090103; GO:0090179; GO:0150012 frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] DSSEHGAGGHR 0.99267 -6.0781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5365 13.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7277 12.5455 0 0 0 0 0 0 13.7743 0 0 0 12.6218 0 0 0 0 0 0 0 0 0 0 0 0 12.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2572 0 0 0 0 0 12.4458 0 0 0 0 13.9031 0 11.2018 0 0 12.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15121 DEGS1_HUMAN "Sphingolipid delta(4)-desaturase DES1, EC 1.14.19.17 (Cell migration-inducing gene 15 protein) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1) (Membrane lipid desaturase) (Retinol isomerase, EC 5.2.1.-)" DEGS1 DES1 MLD MIG15 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; myelin maintenance [GO:0043217]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; electron transfer activity [GO:0009055]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284]; ceramide biosynthetic process [GO:0046513]; myelin maintenance [GO:0043217]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636] GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0006636; GO:0009055; GO:0016020; GO:0030148; GO:0031966; GO:0035579; GO:0042284; GO:0043217; GO:0046513; GO:0050251 electron transfer activity [GO:0009055]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284] EILAKYPEIKSLMK 0.99267 -5.1029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97298 9.50476 0 0 0 0 0 0 0 13.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02790 HEMO_HUMAN Hemopexin (Beta-1B-glycoprotein) HPX Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; heme metabolic process [GO:0042168]; heme transport [GO:0015886]; hemoglobin metabolic process [GO:0020027]; interferon-gamma-mediated signaling pathway [GO:0060333]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; tyrosine phosphorylation of STAT protein [GO:0007260] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; heme transmembrane transporter activity [GO:0015232]; metal ion binding [GO:0046872]; cellular iron ion homeostasis [GO:0006879]; heme metabolic process [GO:0042168]; heme transport [GO:0015886]; hemoglobin metabolic process [GO:0020027]; interferon-gamma-mediated signaling pathway [GO:0060333]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0002639; GO:0002925; GO:0005576; GO:0005615; GO:0006879; GO:0007260; GO:0015232; GO:0015886; GO:0020027; GO:0042168; GO:0042531; GO:0046872; GO:0060333; GO:0060335; GO:0062023; GO:0070062; GO:0071682; GO:0072562 heme transmembrane transporter activity [GO:0015232]; metal ion binding [GO:0046872] ELISERWK 0.99267 -14.722 0 0 0 0 0 0 0 0 0 12.5597 0 11.6828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2321 13.8295 0 0 12.7136 12.8992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0181 0 0 0 0 0 0 0 13.4274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0437 0 14.0791 0 0 0 0 13.7306 0 13.4578 0 0 0 0 0 0 0 0 0 P08183 MDR1_HUMAN "ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1, EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1, EC 7.6.2.1) (CD antigen CD243)" ABCB1 MDR1 PGY1 Homo sapiens (Human) carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910]; carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic transport across blood-brain barrier [GO:1990962] GO:0000086; GO:0005524; GO:0005654; GO:0005886; GO:0008559; GO:0009410; GO:0009986; GO:0015562; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0031625; GO:0042626; GO:0042910; GO:0045332; GO:0046865; GO:0046943; GO:0047484; GO:0055085; GO:0070062; GO:0070633; GO:0072089; GO:0090554; GO:0090555; GO:0098591; GO:0099038; GO:0099040; GO:0140115; GO:0140328; GO:0150104; GO:1901529; GO:1905039; GO:1990961; GO:1990962; GO:2001225 ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910] FGAYLVAHK 0.99267 -15.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28715 ERCC5_HUMAN "DNA excision repair protein ERCC-5, EC 3.1.-.- (DNA repair protein complementing XP-G cells) (Xeroderma pigmentosum group G-complementing protein)" ERCC5 ERCM2 XPG XPGC Homo sapiens (Human) "base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of catalytic activity [GO:0050790]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697]; base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of catalytic activity [GO:0050790]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" GO:0000109; GO:0000405; GO:0000724; GO:0000993; GO:0003684; GO:0003690; GO:0003697; GO:0004519; GO:0004520; GO:0005634; GO:0005654; GO:0005694; GO:0006283; GO:0006285; GO:0006289; GO:0006295; GO:0006296; GO:0008047; GO:0009411; GO:0009650; GO:0010225; GO:0032991; GO:0042803; GO:0043066; GO:0044877; GO:0046872; GO:0047485; GO:0050790 bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697] ALDDDEDVK 0.99267 -40.784 0 0 0 0 0 11.7893 16.1568 0 0 0 0 0 12.5015 12.6177 0 12.2502 11.9894 0 0 11.5069 0 0 0 0 12.6332 12.385 12.6474 11.327 12.4721 11.9816 0 0 0 0 0 14.3925 0 0 0 12.0511 0 12.1343 13.4643 12.7069 12.0455 13.5832 0 12.2435 0 0 0 12.2077 12.6575 0 11.3304 0 0 0 12.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3253 0 0 0 12.1918 18.4458 0 0 0 0 0 0 0 15.2438 0 0 0 14.3458 0 0 14.74 16.3636 15.0189 14.1151 15.5806 0 11.6566 0 0 0 0 0 12.6165 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8181 0 0 0 0 0 12.3304 0 0 0 0 17.7136 13.8078 0 11.6047 0 14.195 0 0 14.1928 0 0 0 0 13.7788 0 0 0 0 14.2662 14.2914 0 0 0 0 0 13.7508 0 0 13.4946 0 14.1566 14.3302 12.4075 0 14.9823 0 13.9199 14.6777 14.7731 14.9531 0 0 0 0 13.5434 10.3801 0 14.4207 0 0 P34931 HS71L_HUMAN "Heat shock 70 kDa protein 1-like, Heat shock 70 kDa protein 1L (Heat shock 70 kDa protein 1-Hom, HSP70-Hom)" HSPA1L Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192] blood microparticle [GO:0072562]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199] blood microparticle [GO:0072562]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; vesicle-mediated transport [GO:0016192] GO:0002199; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0005886; GO:0006986; GO:0007339; GO:0016192; GO:0016887; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0044183; GO:0044297; GO:0051082; GO:0051085; GO:0051787; GO:0072562; GO:0140662; GO:1903955 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] ALRDAKMDK 0.99267 -15.099 0 0 0 0 0 0 0 0 0 0 12.1186 12.7006 0 0 12.7231 11.6373 12.4275 0 12.5056 12.6453 12.4685 0 0 0 12.4352 12.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5816 0 0 0 0 0 0 0 0 0 0 10.6896 0 0 0 0 0 0 0 0 0 13.582 0 0 0 0 17.0119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.811 0 0 0 0 0 13.4619 0 0 0 0 0 0 0 0 13.5215 0 0 0 0 0 13.279 0 13.2284 13.2894 0 13.2047 0 13.1383 12.9945 0 0 0 0 13.0619 0 13.5067 0 0 P35520 CBS_HUMAN "Cystathionine beta-synthase, EC 4.2.1.22 (Beta-thionase) (Serine sulfhydrase)" CBS Homo sapiens (Human) blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346] GO:0001958; GO:0001974; GO:0004122; GO:0005634; GO:0005737; GO:0005829; GO:0006535; GO:0006563; GO:0006565; GO:0006801; GO:0010749; GO:0019343; GO:0019344; GO:0019346; GO:0019448; GO:0019825; GO:0019899; GO:0020037; GO:0021587; GO:0030170; GO:0031625; GO:0042262; GO:0042802; GO:0042803; GO:0043066; GO:0043418; GO:0043506; GO:0046872; GO:0050421; GO:0050667; GO:0051593; GO:0060135; GO:0060351; GO:0070025; GO:0070026; GO:0070814; GO:0071456; GO:0072341; GO:0097746; GO:1904047 carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625] ILPDILKK 0.99267 -6.2556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03169 TNAP2_HUMAN "Tumor necrosis factor alpha-induced protein 2, TNF alpha-induced protein 2 (Primary response gene B94 protein)" TNFAIP2 Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; exocyst localization [GO:0051601]; exocytosis [GO:0006887] exocyst [GO:0000145]; extracellular space [GO:0005615] exocyst [GO:0000145]; extracellular space [GO:0005615]; SNARE binding [GO:0000149]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; exocyst localization [GO:0051601]; exocytosis [GO:0006887] GO:0000145; GO:0000149; GO:0001525; GO:0005615; GO:0006887; GO:0030154; GO:0051601 SNARE binding [GO:0000149] IRSILDVSMGAQEPSRPLFSLIK 0.99267 -4.4394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4872 0 0 0 0 0 0 0 0 0 13.6873 13.4679 14.3858 0 0 14.7056 0 0 13.8623 0 0 11.8298 0 0 12.8479 0 0 0 0 0 0 0 13.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6029 0 11.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9095 0 0 0 0 0 0 0 Q06787 FMR1_HUMAN "Fragile X messenger ribonucleoprotein 1 (Fragile X messenger ribonucleoprotein, FMRP) (Protein FMR-1)" FMR1 Homo sapiens (Human) "cellular response to virus [GO:0098586]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]" "anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]" "anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; transmembrane transporter binding [GO:0044325]; cellular response to virus [GO:0098586]; DNA repair [GO:0006281]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]" GO:0000381; GO:0000775; GO:0001934; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0005844; GO:0005845; GO:0006281; GO:0006397; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0014069; GO:0015030; GO:0016020; GO:0017148; GO:0019897; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0031047; GO:0031369; GO:0032433; GO:0033592; GO:0034046; GO:0035064; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042802; GO:0042803; GO:0042995; GO:0043005; GO:0043022; GO:0043025; GO:0043197; GO:0043204; GO:0043488; GO:0043679; GO:0044325; GO:0044326; GO:0044830; GO:0045182; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060964; GO:0060998; GO:0060999; GO:0070161; GO:0070840; GO:0071598; GO:0097386; GO:0098586; GO:0098793; GO:0098794; GO:0098908; GO:1900453; GO:1901254; GO:1901386; GO:1901800; GO:1902373; GO:1902416; GO:1902737; GO:1990124; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766; GO:2001022 chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]; transmembrane transporter binding [GO:0044325] AWQGMVPFVFVGTK 0.99267 -15.101 0 0 0 0 0 0 0 0 0 9.84152 0 0 0 0 0 0 0 12.1555 0 0 0 0 11.244 0 0 10.0136 0 0 11.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0319 0 0 0 13.6991 15.0124 0 0 12.4328 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1206 15.3158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6783 0 14.4564 14.6272 0 0 0 0 11.4448 11.5098 13.4041 0 0 13.3151 0 0 11.9665 10.8846 0 0 0 0 0 0 0 0 12.9167 0 0 0 0 0 0 0 13.2243 0 0 0 0 0 0 0 0 0 0 0 12.9936 0 0 0 13.228 0 0 0 0 0 0 13.8553 0 Q0VAA5 PLCX2_HUMAN PI-PLC X domain-containing protein 2 PLCXD2 Homo sapiens (Human) lipid catabolic process [GO:0016042]; signal transduction [GO:0007165] nucleus [GO:0005634] nucleus [GO:0005634]; phosphoric diester hydrolase activity [GO:0008081]; lipid catabolic process [GO:0016042]; signal transduction [GO:0007165] GO:0005634; GO:0007165; GO:0008081; GO:0016042 phosphoric diester hydrolase activity [GO:0008081] LARISLVK 0.99267 -16.947 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8158 0 0 0 10.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2954 0 0 0 0 0 0 0 0 12.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8931 0 0 14.9252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9663 0 0 0 12.1438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15056 IF4H_HUMAN "Eukaryotic translation initiation factor 4H, eIF-4H (Williams-Beuren syndrome chromosomal region 1 protein)" EIF4H KIAA0038 WBSCR1 WSCR1 Homo sapiens (Human) developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] "cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953]" GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0008135; GO:0016020; GO:0016281; GO:0019953; GO:0033592; GO:0034057; GO:0043024; GO:0045296; GO:0048471; GO:0048589; GO:0097010 "cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" ADFDTYDDR 0.99267 -6.2576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78901 0 9.76092 11.0982 0 0 0 0 11.1521 0 12.8853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4217 0 0 0 0 0 0 0 10.3386 0 0 0 0 0 0 0 12.0176 0 0 0 0 0 0 0 0 0 11.0032 0 0 0 0 0 17.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2NKJ3 CTC1_HUMAN CST complex subunit CTC1 (Conserved telomere maintenance component 1) (HBV DNAPTP1-transactivated protein B) CTC1 C17orf68 Homo sapiens (Human) aging [GO:0007568]; bone marrow development [GO:0048539]; cellular response to DNA damage stimulus [GO:0006974]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; spleen development [GO:0048536]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; thymus development [GO:0048538] "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162]; aging [GO:0007568]; bone marrow development [GO:0048539]; cellular response to DNA damage stimulus [GO:0006974]; hematopoietic stem cell proliferation [GO:0071425]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; spleen development [GO:0048536]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; thymus development [GO:0048538]" GO:0000723; GO:0000781; GO:0003697; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0007568; GO:0010389; GO:0010833; GO:0016233; GO:0032211; GO:0035264; GO:0042162; GO:0045740; GO:0048146; GO:0048536; GO:0048538; GO:0048539; GO:0071425; GO:0090399; GO:0098505; GO:1990879 G-rich strand telomeric DNA binding [GO:0098505]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162] AERFQLIVERDVR 0.99267 -15.124 0 0 11.2355 0 0 0 0 0 0 0 0 13.3048 0 13.8474 0 0 0 0 0 0 12.5446 0 0 0 0 0 0 12.3921 0 0 0 0 10.1304 0 13.0697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.911 0 0 0 12.557 0 11.9663 0 0 0 0 0 0 0 13.865 0 13.6887 13.9866 13.2145 15.1718 14.7732 0 0 0 0 0 0 0 0 0 0 0 14.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7599 0 0 0 0 11.6112 0 0 0 0 11.5889 0 0 0 0 13.7953 0 0 0 0 0 0 12.6511 0 0 0 0 0 0 12.2017 0 0 0 0 10.3644 0 14.0979 0 0 0 0 0 0 0 0 0 0 14.0633 19.9855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8993 0 0 Q5T011 SZT2_HUMAN KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog) SZT2 C1orf84 KIAA0467 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777] KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668] GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0140007; GO:1901668; GO:1904262 FGDWSGAPSLKDLGGTGIKATK 0.99267 -46.698 0 10.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0172 13.6118 14.7574 16.4276 0 0 0 12.9248 12.6649 0 0 12.7283 12.7282 0 0 0 0 0 0 0 0 0 14.5483 14.67 12.8063 0 12.4173 0 0 0 11.3681 15.0961 0 0 0 12.0784 14.06 0 0 0 0 0 0 0 0 12.1118 0 13.313 0 0 13.2995 0 0 0 0 12.4375 0 0 0 12.1058 0 14.4949 0 11.3829 0 0 11.2486 0 0 0 11.8158 12.3028 14.7698 0 13.7354 0 12.7209 11.7181 11.5468 0 12.8165 0 15.4723 0 0 0 0 0 0 0 0 12.9248 12.9063 0 0 0 0 11.4772 14.7721 0 12.1956 14.7381 13.7035 0 0 12.0178 15.7946 15.7013 13.7522 0 14.2545 0 0 0 13.1063 0 13.7115 15.0835 0 10.9088 0 13.6534 0 0 Q6IBS0 TWF2_HUMAN "Twinfilin-2 (A6-related protein, hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein)" TWF2 PTK9L MSTP011 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; cell projection organization [GO:0030030]; cellular response to growth factor stimulus [GO:0071363]; cellular response to retinoic acid [GO:0071300]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of axon extension [GO:0045773]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of lamellipodium assembly [GO:0010591]; regulation of microvillus length [GO:0032532]; sequestering of actin monomers [GO:0042989] actin filament [GO:0005884]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420] "actin filament [GO:0005884]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; cell projection organization [GO:0030030]; cellular response to growth factor stimulus [GO:0071363]; cellular response to retinoic acid [GO:0071300]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of axon extension [GO:0045773]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of lamellipodium assembly [GO:0010591]; regulation of microvillus length [GO:0032532]; sequestering of actin monomers [GO:0042989]" GO:0003723; GO:0003785; GO:0005080; GO:0005524; GO:0005546; GO:0005737; GO:0005884; GO:0010591; GO:0010592; GO:0010976; GO:0030016; GO:0030027; GO:0030030; GO:0030042; GO:0030175; GO:0030426; GO:0030837; GO:0032420; GO:0032532; GO:0032956; GO:0042989; GO:0045296; GO:0045773; GO:0048471; GO:0051015; GO:0051016; GO:0070062; GO:0071300; GO:0071363 "actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]" ALQQLKQKMVNYIQMK 0.99267 -15.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5202 0 0 0 0 0 0 0 12.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8043 0 10.9856 0 0 0 0 0 0 13.6508 12.9939 0 0 0 0 0 0 0 0 0 0 0 10.8722 0 0 0 0 0 11.1032 13.6735 0 0 0 13.2407 13.4234 0 0 0 0 0 0 13.0755 11.2859 0 0 13.9966 0 0 0 0 10.7487 12.5279 11.8749 0 12.7806 0 0 0 0 11.2924 0 13.3626 0 12.3929 12.6199 0 0 11.5665 12.1883 0 12.4549 0 0 0 0 12.8619 12.988 0 0 0 0 12.3935 13.6172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3736 0 0 0 0 Q6NUN7 JHY_HUMAN Jhy protein homolog JHY C11orf63 Homo sapiens (Human) axoneme assembly [GO:0035082]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebrospinal fluid circulation [GO:0090660]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; regulation of establishment of planar polarity [GO:0090175] extracellular region [GO:0005576] extracellular region [GO:0005576]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cell differentiation [GO:0030154]; cerebrospinal fluid circulation [GO:0090660]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; regulation of establishment of planar polarity [GO:0090175] GO:0005576; GO:0007420; GO:0030154; GO:0035082; GO:0044458; GO:0051649; GO:0090175; GO:0090660 ALRSHNLK 0.99267 -25.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7142 0 0 0 0 12.3999 12.8994 13.0222 0 0 0 0 0 0 0 12.2211 12.6204 0 0 0 0 13.5825 0 13.5488 14.2489 13.1625 0 12.2958 0 0 12.9177 0 0 0 0 12.5177 0 0 0 13.7464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4806 0 0 0 0 0 0 Q6UX72 B3GN9_HUMAN "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9, BGnT-9, Beta-1,3-Gn-T9, Beta-1,3-N-acetylglucosaminyltransferase 9, Beta3Gn-T9, EC 2.4.1.-" B3GNT9 UNQ1922/PRO4397 Homo sapiens (Human) poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486] GO:0000139; GO:0006486; GO:0008194; GO:0016021; GO:0016757; GO:0016758; GO:0030311 glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194] CRGDGAPGGR 0.99267 -6.2543 0 0 0 0 0 0 0 0 0 0 0 11.8445 12.1319 0 0 0 0 0 0 0 0 0 13.3332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.626 0 0 0 0 0 0 0 0 0 0 0 13.3734 0 0 0 0 0 0 0 0 0 0 0 13.3953 0 0 0 0 12.3277 0 0 12.0472 12.9052 0 0 0 0 11.642 0 11.3808 0 0 0 0 11.6912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5036 12.5958 0 10.6403 14.153 12.6788 0 0 11.6255 0 0 0 0 10.804 0 12.733 0 12.6134 10.9077 0 0 0 0 0 0 11.3638 0 0 0 0 0 11.6032 0 12.5875 0 0 0 0 0 0 0 0 0 0 0 12.8465 0 0 Q7Z7G8 VP13B_HUMAN Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B) VPS13B CHS1 COH1 KIAA0532 Homo sapiens (Human) acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; lipid transport [GO:0006869]; neuron projection development [GO:0031175] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588] acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588]; acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; lipid transport [GO:0006869]; neuron projection development [GO:0031175] GO:0000139; GO:0001675; GO:0002080; GO:0006869; GO:0007030; GO:0007417; GO:0031175; GO:0032588; GO:0033106; GO:0033116; GO:0060612; GO:0090168 AILTPVLTDFSVRITGAPAVIFTK 0.99267 -40.833 0 0 0 0 10.3246 0 0 0 14.4738 0 0 0 0 0 0 0 0 10.7928 0 13.8165 0 0 0 0 0 0 0 14.0984 0 12.1466 0 0 0 0 0 13.8143 13.4533 12.8465 0 0 0 13.4807 15.3559 0 0 0 0 10.2442 16.3311 0 0 14.284 0 0 0 0 10.6314 0 0 12.812 0 0 0 0 0 0 0 12.7845 10.9159 14.3748 12.811 0 13.8491 0 0 0 18.1929 13.7383 10.6156 0 0 15.1252 0 13.9124 14.3086 16.237 13.9149 0 0 15.2888 12.7745 13.0798 12.4044 0 0 0 15.2384 15.7686 13.5788 12.6252 13.4156 14.6526 0 0 0 0 0 0 15.9456 12.5222 0 0 14.1439 0 0 0 10.6154 10.6832 13.0399 14.5066 0 12.519 0 13.2409 0 11.1555 11.86 0 0 12.909 0 0 0 12.9191 11.5792 0 0 13.3688 13.4795 0 0 0 12.5368 0 0 0 14.4399 0 14.2769 12.8653 0 12.8874 14.4995 14.6434 14.604 11.7216 12.5325 0 12.2386 0 0 12.3679 0 13.5748 0 12.8977 0 0 0 0 0 0 11.9053 0 13.4019 15.5078 14.2442 0 0 11.4548 Q86WI3 NLRC5_HUMAN "Protein NLRC5 (Caterpiller protein 16.1, CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4)" NLRC5 NOD27 NOD4 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of kinase activity [GO:0043549] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of kinase activity [GO:0043549] GO:0000978; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0032088; GO:0035556; GO:0043549; GO:0045087; GO:0045345; GO:0045944; GO:0051607; GO:0060335; GO:0060339; GO:0060340 ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ALPLCPQLKEVSFR 0.99267 -14.754 12.1051 0 0 0 0 0 0 0 11.4865 0 10.9173 12.1394 0 0 12.1325 11.6249 0 12.1904 12.3908 0 11.8411 13.0458 12.781 0 11.3866 0 11.7993 14.578 0 0 11.8647 0 0 0 0 0 12.7698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6721 0 0 0 0 0 0 0 0 0 0 14.4471 0 0 0 14.2767 17.9146 12.789 0 15.0677 0 14.4635 0 14.5988 0 14.3443 13.9776 13.3443 0 0 0 0 0 0 0 0 0 0 0 0 15.0216 16.7794 14.6172 13.6718 0 15.3706 15.6317 0 15.2898 0 0 0 13.7358 0 15.1317 0 13.3083 0 16.9171 14.1779 14.739 0 14.5115 15.1176 15.022 15.6374 0 0 0 15.5576 13.8931 13.2183 14.3816 0 0 15.4078 0 13.1956 14.871 15.1039 0 15.1763 0 0 12.118 16.3198 15.2621 14.3958 0 13.7028 14.7954 0 0 0 0 14.6893 0 0 13.9551 0 0 12.8521 0 13.1529 11.8107 12.1271 11.8687 11.9336 0 0 12.6033 11.499 0 0 12.1544 13.3096 16.0277 14.1089 14.3951 0 0 0 16.3832 0 Q8IZ21 PHAR4_HUMAN Phosphatase and actin regulator 4 PHACTR4 PRO2963 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; closure of optic fissure [GO:0061386]; enteric nervous system development [GO:0048484]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of catalytic activity [GO:0043085]; regulation of cell cycle [GO:0051726]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; lamellipodium [GO:0030027] cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542]; actin cytoskeleton organization [GO:0030036]; closure of optic fissure [GO:0061386]; enteric nervous system development [GO:0048484]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of catalytic activity [GO:0043085]; regulation of cell cycle [GO:0051726]; Rho protein signal transduction [GO:0007266] GO:0001755; GO:0001843; GO:0003779; GO:0005737; GO:0007266; GO:0008157; GO:0030027; GO:0030036; GO:0043085; GO:0048484; GO:0051726; GO:0061386; GO:0072542; GO:2001045 actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542] DATSSGGTAR 0.99267 -15.097 0 0 0 0 0 0 0 0 12.5699 13.2826 12.6184 12.4353 0 12.9169 12.2746 12.0669 13.4407 12.665 0 0 12.4052 0 0 0 0 0 12.9021 12.7536 12.1442 12.8259 12.1911 13.471 0 0 12.4933 0 0 0 0 0 12.349 12.3161 0 0 0 12.4834 13.3522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9954 0 0 0 0 12.2278 0 0 0 0 12.2895 0 12.2365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9515 0 0 0 0 0 0 0 0 0 0 15.232 0 15.2612 0 0 0 0 0 15.3985 14.6816 14.1994 13.6506 15.2656 0 0 0 0 15.2804 0 0 0 0 Q8IZD2 KMT2E_HUMAN "Inactive histone-lysine N-methyltransferase 2E, Inactive lysine N-methyltransferase 2E (Myeloid/lymphoid or mixed-lineage leukemia protein 5)" KMT2E MLL5 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone acetylation [GO:0035065]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone acetylation [GO:0035065]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000791; GO:0002446; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005886; GO:0006306; GO:0006325; GO:0006355; GO:0007049; GO:0016604; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0034967; GO:0035064; GO:0035065; GO:0042119; GO:0045893; GO:0046872; GO:0070210; GO:1900087; GO:1905437 enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] AWMDRYEEANNNQYSEGVQR 0.99267 -46.316 0 0 10.3972 11.7927 0 0 0 0 0 0 14.1081 0 0 13.9108 12.0023 0 0 0 11.8549 0 11.3301 0 0 11.8924 11.6591 0 11.1777 12.4383 0 12.5091 0 0 13.3281 0 0 0 12.6603 12.3579 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8518 0 0 0 13.3332 12.6362 0 0 0 11.6053 0 0 0 0 0 0 11.6239 0 0 0 0 0 10.7433 0 0 15.9989 15.3369 12.6537 13.5359 0 14.3721 0 14.5301 15.3703 0 15.1351 0 0 0 13.0109 13.6637 0 0 0 0 0 0 0 12.5972 14.5279 0 13.2841 0 0 11.7756 13.4271 13.375 0 0 0 0 0 0 0 14.0173 0 0 0 0 12.2484 0 13.2214 0 0 12.7651 0 12.809 12.9343 14.6602 12.3787 0 0 0 11.1353 0 0 0 0 0 0 12.6188 0 0 12.7894 14.0846 0 0 14.4125 0 0 12.0598 11.9153 0 0 16.4645 0 0 13.8371 0 0 0 10.7948 0 12.7738 12.8957 15.5592 13.4455 0 0 11.8621 14.2232 0 0 0 0 13.3366 11.8952 11.9867 0 Q8N4C6 NIN_HUMAN "Ninein, hNinein (Glycogen synthase kinase 3 beta-interacting protein, GSK3B-interacting protein)" NIN KIAA1565 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; protein localization [GO:0008104] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasmic microtubule [GO:0005881]; dendrite [GO:0030425]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasmic microtubule [GO:0005881]; dendrite [GO:0030425]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; microtubule minus-end binding [GO:0051011]; centriole-centriole cohesion [GO:0010457]; centrosome localization [GO:0051642]; centrosome-templated microtubule nucleation [GO:0090222]; collateral sprouting [GO:0048668]; corpus callosum morphogenesis [GO:0021540]; corticospinal tract morphogenesis [GO:0021957]; microtubule anchoring at centrosome [GO:0034454]; positive regulation of axonogenesis [GO:0050772]; protein localization [GO:0008104] GO:0000242; GO:0000922; GO:0005509; GO:0005525; GO:0005654; GO:0005730; GO:0005813; GO:0005814; GO:0005881; GO:0005886; GO:0008104; GO:0010457; GO:0019900; GO:0021540; GO:0021957; GO:0030425; GO:0034454; GO:0044295; GO:0045177; GO:0048668; GO:0050772; GO:0051011; GO:0051642; GO:0072686; GO:0090222; GO:0097431; GO:0097539; GO:0120103 calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; kinase binding [GO:0019900]; microtubule minus-end binding [GO:0051011] AHEIAWLHGTIQTHQERPR 0.99267 -46.293 0 0 0 0 0 0 0 0 0 0 0 11.5243 0 0 0 0 13.755 0 11.1682 0 0 0 0 12.5762 0 0 13.1724 0 13.6308 0 0 0 0 0 0 0 0 0 0 10.9358 0 12.9578 0 0 0 0 0 0 0 0 0 0 0 11.2351 0 10.5491 0 0 0 0 0 0 0 0 0 0 0 0 12.91 0 0 0 0 12.9252 14.6279 14.0547 0 0 13.6345 14.4466 13.653 0 13.8554 0 0 12.4196 0 0 13.9402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9503 0 0 0 14.5841 0 0 14.8968 15.7002 0 13.0394 13.4986 13.0213 0 13.7675 0 0 14.3437 0 13.3531 15.285 13.2183 0 0 0 13.7416 0 16.6057 0 13.2808 13.201 0 13.9962 0 10.6764 0 13.2903 10.7775 0 0 0 0 0 10.4213 0 0 0 0 0 15.1398 13.5714 14.6085 14.0274 0 0 11.377 0 0 0 0 0 12.4247 0 0 12.5867 0 0 12.9124 0 0 0 0 Q8TCU4 ALMS1_HUMAN Centrosome-associated protein ALMS1 (Alstrom syndrome protein 1) ALMS1 KIAA0328 Homo sapiens (Human) endosomal transport [GO:0016197]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of stress fiber assembly [GO:0051492] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; endosomal transport [GO:0016197]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of stress fiber assembly [GO:0051492] GO:0000922; GO:0005813; GO:0005829; GO:0005929; GO:0008017; GO:0016197; GO:0046599; GO:0051492; GO:0120162 microtubule binding [GO:0008017] AHAWNMK 0.99267 -80.88 10.4455 0 0 0 0 0 0 0 12.2796 12.5047 12.6827 12.8628 12.2157 0 12.627 0 0 0 13.946 0 0 0 0 0 0 0 0 0 0 0 0 13.7859 0 0 0 0 0 11.006 0 0 0 0 11.7968 0 0 0 0 9.63258 0 0 0 13.8367 14.0371 13.313 12.722 0 0 0 0 0 0 11.7509 0 12.1325 0 0 13.5857 0 0 0 0 0 0 0 0 0 0 0 0 12.4201 0 12.9384 0 0 0 0 0 0 0 0 0 0 0 15.2633 11.4347 14.4765 0 0 0 0 15.1779 0 0 11.1602 15.0485 0 0 0 14.6219 0 0 0 0 0 0 0 13.714 15.8502 0 0 13.2788 12.6947 12.8273 12.5656 13.2319 0 0 0 0 0 0 0 0 14.5055 13.428 0 0 12.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1004 0 13.6903 0 12.9633 14.7558 15.6196 13.8812 0 0 0 12.2808 0 0 0 13.9296 0 12.9782 0 0 Q8WUU4 ZN296_HUMAN "Zinc finger protein 296, ZFP296 (Zinc finger protein 342)" ZNF296 ZNF342 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283] GO:0000122; GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0007283; GO:0045944; GO:0046872; GO:1990837 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] AGSAPRR 0.99267 -15.104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7385 0 0 0 0 0 13.6154 0 0 0 0 0 0 0 0 Q8WYK0 ACO12_HUMAN "Acetyl-coenzyme A thioesterase, EC 3.1.2.1 (Acyl-CoA thioester hydrolase 12) (Acyl-coenzyme A thioesterase 12, Acyl-CoA thioesterase 12) (Cytoplasmic acetyl-CoA hydrolase 1, CACH-1, hCACH-1) (START domain-containing protein 15, StARD15)" ACOT12 CACH CACH1 STARD15 Homo sapiens (Human) acetyl-CoA metabolic process [GO:0006084]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; carboxylic ester hydrolase activity [GO:0052689]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA binding [GO:0036042]; acetyl-CoA metabolic process [GO:0006084]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631] GO:0003986; GO:0005524; GO:0005654; GO:0005829; GO:0006084; GO:0006631; GO:0006637; GO:0008289; GO:0036042; GO:0042802; GO:0045171; GO:0047617; GO:0052689 acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; carboxylic ester hydrolase activity [GO:0052689]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA binding [GO:0036042] DDFRRYR 0.99267 -6.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3176 0 0 0 0 0 0 0 0 0 0 0 Q96F07 CYFP2_HUMAN Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121) CYFIP2 KIAA1168 PIR121 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202]; small GTPase binding [GO:0031267]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process [GO:0006915]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833] GO:0000902; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0016020; GO:0030833; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0070062; GO:0070161; GO:0097202; GO:0097484; GO:0098609 small GTPase binding [GO:0031267] FAFVEVIAMIK 0.99267 -17.432 0 0 0 0 0 0 0 0 0 13.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9062 0 0 0 0 0 0 0 0 0 0 0 11.4639 0 0 0 0 11.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6758 0 0 0 0 0 0 0 0 0 0 0 12.6808 0 0 0 0 16.7628 0 0 0 11.2565 0 0 0 0 0 11.6879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3117 Q9BXB1 LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48) LGR4 GPR48 Homo sapiens (Human) "bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine production [GO:0001818]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription, DNA-templated [GO:0045893]; spermatogenesis [GO:0007283]" GO:0001649; GO:0001818; GO:0001942; GO:0004888; GO:0004930; GO:0005886; GO:0005887; GO:0007283; GO:0016500; GO:0030282; GO:0030539; GO:0032922; GO:0034122; GO:0036335; GO:0045087; GO:0045892; GO:0045893; GO:0046849; GO:0048565; GO:0061290; GO:0072202; GO:0072224; GO:0072282; GO:0090190; GO:0090263; GO:0120163; GO:2001013 G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888] ACFYQSR 0.99267 -15.127 0 0 0 0 0 0 0 0 14.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5137 0 0 0 0 0 0 0 0 0 0 0 13.3641 0 0 0 0 0 0 13.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5998 0 0 0 0 13.7121 13.6556 0 0 0 0 0 0 0 10.6597 0 14.0978 0 0 16.5798 13.437 0 0 0 16.1561 0 0 16.8787 13.3273 0 0 0 0 0 0 14.2708 0 14.663 0 0 0 0 0 14.1684 0 0 0 0 14.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6406 0 0 0 0 0 0 0 0 14.7012 0 0 13.7806 0 0 0 0 0 0 14.3582 0 0 0 0 14.1554 0 13.4039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H175 CSRN2_HUMAN "Cysteine/serine-rich nuclear protein 2, CSRNP-2 (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12, TAIP-12)" CSRNP2 C12orf22 FAM130A1 TAIP12 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0019902; GO:0043565; GO:0045944 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; phosphatase binding [GO:0019902]; sequence-specific DNA binding [GO:0043565]" AIRLSREECGCDCR 0.99267 -6.0858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2766 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1878 0 0 0 0 0 0 0 14.2244 11.3708 0 0 12.1592 0 0 0 12.9969 0 0 0 0 0 0 0 13.9012 0 0 11.8256 0 0 0 0 0 0 0 0 11.9934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1917 0 11.8978 0 0 0 0 0 Q9NPE2 NGRN_HUMAN Neugrin (Mesenchymal stem cell protein DSC92) (Neurite outgrowth-associated protein) (Spinal cord-derived protein FI58G) NGRN FI58G HT020 Homo sapiens (Human) mitochondrial ribosome assembly [GO:0061668]; neuron differentiation [GO:0030182]; positive regulation of mitochondrial translation [GO:0070131] intercellular bridge [GO:0045171]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] intercellular bridge [GO:0045171]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; mitochondrial ribosome assembly [GO:0061668]; neuron differentiation [GO:0030182]; positive regulation of mitochondrial translation [GO:0070131] GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016604; GO:0019843; GO:0030182; GO:0031966; GO:0045171; GO:0061668; GO:0070131; GO:0072686 RNA binding [GO:0003723]; rRNA binding [GO:0019843] EPDPDSDWEPEER 0.99267 -14.749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3269 0 0 12.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2972 Q9NQZ2 SAS10_HUMAN "Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1, CRL1) (Disrupter of silencing SAS10) (UTP3 homolog)" UTP3 CRLZ1 SAS10 Homo sapiens (Human) "brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0007420; GO:0032040 RNA binding [GO:0003723] DDAVKKELIPK 0.99267 -17.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2956 0 0 14.0907 0 0 0 0 13.6547 0 0 13.3424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3103 0 0 0 0 0 10.1635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4104 0 0 0 0 0 0 0 0 0 0 0 0 13.7791 0 0 0 0 0 0 0 Q9NSD4 ZN275_HUMAN Zinc finger protein 275 ZNF275 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRQSSSLLEHAR 0.99267 -40.734 0 0 0 0 0 0 0 0 0 0 13.0851 12.2878 0 0 0 11.7902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4689 12.6147 0 0 12.5893 0 12.8835 0 0 0 0 0 0 0 10.8199 0 14.5882 13.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2095 0 0 0 0 12.2757 0 0 0 0 0 12.4792 11.5792 0 0 0 0 13.3516 0 0 0 0 0 0 0 0 0 0 0 13.7518 0 0 0 0 0 0 13.3915 0 0 0 13.0691 11.1734 0 0 0 0 11.3089 0 0 12.3447 12.0354 12.2725 0 0 0 0 0 0 10.9755 0 0 0 13.0137 0 0 10.9153 0 0 0 0 0 0 0 0 12.4303 0 12.5317 0 14.5386 0 0 0 0 13.3542 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3244 0 0 0 11.5094 12.7503 0 0 0 0 0 0 Q9NWX6 THG1_HUMAN "Probable tRNA(His) guanylyltransferase, EC 2.7.7.79 (Induced in high glucose-1, IHG-1) (Interphase cytoplasmic foci protein 45) (tRNA-histidine guanylyltransferase)" THG1L ICF45 Homo sapiens (Human) mitochondrial fusion [GO:0008053]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; stress-induced mitochondrial fusion [GO:1990046]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transferase complex [GO:1990234] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193]; mitochondrial fusion [GO:0008053]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; stress-induced mitochondrial fusion [GO:1990046]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] GO:0000049; GO:0000287; GO:0005085; GO:0005524; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006400; GO:0006979; GO:0008033; GO:0008053; GO:0008193; GO:0016779; GO:0042802; GO:0051289; GO:1990046; GO:1990234 ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193] HNFAKPNDSRALQLMTK 0.99267 -6.2587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9464 14.3904 0 14.0694 14.8474 14.3479 0 0 0 0 13.1649 13.527 0 13.2598 0 0 0 0 0 0 13.6514 14.4564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UEF7 KLOT_HUMAN "Klotho, EC 3.2.1.31 [Cleaved into: Klotho peptide ]" KL Homo sapiens (Human) acute inflammatory response [GO:0002526]; aging [GO:0007568]; calcium ion homeostasis [GO:0055074]; carbohydrate metabolic process [GO:0005975]; energy reserve metabolic process [GO:0006112]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; negative regulation of systemic arterial blood pressure [GO:0003085]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of bone mineralization [GO:0030501]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to vitamin D [GO:0033280] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; beta-glucuronidase activity [GO:0004566]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hormone activity [GO:0005179]; vitamin D binding [GO:0005499]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; calcium ion homeostasis [GO:0055074]; carbohydrate metabolic process [GO:0005975]; energy reserve metabolic process [GO:0006112]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; negative regulation of systemic arterial blood pressure [GO:0003085]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of bone mineralization [GO:0030501]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to vitamin D [GO:0033280] GO:0002526; GO:0003085; GO:0004566; GO:0005104; GO:0005179; GO:0005499; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0005975; GO:0006112; GO:0007568; GO:0008286; GO:0008422; GO:0008543; GO:0014823; GO:0016021; GO:0016324; GO:0017134; GO:0030501; GO:0033280; GO:0042421; GO:0055074; GO:0070062; GO:0090080; GO:1990776 beta-glucosidase activity [GO:0008422]; beta-glucuronidase activity [GO:0004566]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hormone activity [GO:0005179]; vitamin D binding [GO:0005499] ALADHFR 0.99267 -25.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4169 0 0 0 0 13.8377 0 0 0 0 0 0 0 0 0 0 0 11.8308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8739 12.9532 0 0 10.8233 13.5221 0 0 0 0 0 12.174 16.5283 14.9003 0 0 12.1148 0 12.7323 0 11.6731 11.6737 0 0 0 0 0 13.8067 0 0 0 0 12.2892 0 0 0 0 0 0 0 10.3593 0 0 0 0 0 0 0 0 0 0 0 14.2599 0 0 0 0 0 0 0 12.3307 0 0 0 0 0 12.7312 0 0 11.8322 11.6285 0 13.0213 0 14.8879 0 0 12.8599 0 0 13.0273 12.1088 0 0 12.5306 0 0 0 0 11.8051 13.5369 0 0 0 0 0 0 11.3761 0 0 0 0 0 0 0 12.9377 0 0 0 0 0 0 0 Q9UKP4 ATS7_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 7, ADAM-TS 7, ADAM-TS7, ADAMTS-7, EC 3.4.24.- (COMPase)" ADAMTS7 Homo sapiens (Human) cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in protein catabolic process [GO:0051603] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in protein catabolic process [GO:0051603] GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] CERDRLSFGFCETLR 0.99267 -15.075 0 0 0 0 0 0 0 0 0 0 0 0 11.1953 12.0982 0 13.6773 0 0 0 0 0 0 0 0 0 0 0 0 11.4449 10.7594 0 0 0 0 12.4356 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8622 0 14.1202 13.77 12.8925 0 0 12.78 0 13.4442 0 0 0 12.3145 11.7203 0 0 0 16.3736 13.0775 13.4242 0 0 0 0 12.1975 0 12.1071 13.3073 13.5083 0 0 12.5249 13.608 0 14.3673 0 13.2531 0 0 0 0 0 0 13.0868 0 0 0 0 0 0 14.2848 0 13.4656 0 0 0 0 14.1328 0 0 13.2316 13.2757 12.2295 13.7454 12.4805 0 0 13.9192 13.9768 12.7562 0 0 12.3911 0 0 0 0 0 0 11.0062 0 0 0 0 0 0 0 0 0 0 12.5599 0 0 0 0 0 13.9857 12.6074 0 0 0 12.5896 0 0 0 0 0 0 0 0 0 0 0 12.5525 0 0 0 0 0 0 0 0 11.2366 0 0 0 0 0 0 0 0 Q9Y271 CLTR1_HUMAN "Cysteinyl leukotriene receptor 1, CysLTR1 (Cysteinyl leukotriene D4 receptor, LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81)" CYSLTR1 CYSLT1 Homo sapiens (Human) calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; defense response [GO:0006952]; establishment of localization in cell [GO:0051649]; inflammatory response to antigenic stimulus [GO:0002437]; neuropeptide signaling pathway [GO:0007218]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of vasoconstriction [GO:0045907]; respiratory gaseous exchange by respiratory system [GO:0007585] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene receptor activity [GO:0004974]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; defense response [GO:0006952]; establishment of localization in cell [GO:0051649]; inflammatory response to antigenic stimulus [GO:0002437]; neuropeptide signaling pathway [GO:0007218]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of vasoconstriction [GO:0045907]; respiratory gaseous exchange by respiratory system [GO:0007585] GO:0001631; GO:0002437; GO:0004974; GO:0005886; GO:0005887; GO:0006816; GO:0006935; GO:0006952; GO:0007166; GO:0007204; GO:0007218; GO:0007585; GO:0008528; GO:0016020; GO:0045766; GO:0045907; GO:0051649 cysteinyl leukotriene receptor activity [GO:0001631]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene receptor activity [GO:0004974] KNLSSHKK 0.99267 -6.0875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6067 0 13.3002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y287 ITM2B_HUMAN "Integral membrane protein 2B (Immature BRI2, imBRI2) (Protein E25B) (Transmembrane protein BRI, Bri) [Cleaved into: BRI2, membrane form (Mature BRI2, mBRI2); BRI2 intracellular domain, BRI2 ICD; BRI2C, soluble form; Bri23 peptide, Bri2-23 (ABri23) (C-terminal peptide) (P23 peptide) ]" ITM2B BRI BRI2 Homo sapiens (Human) negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; nervous system development [GO:0007399] endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of organelle membrane [GO:0031301]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of organelle membrane [GO:0031301]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; nervous system development [GO:0007399] GO:0000139; GO:0001540; GO:0005524; GO:0005576; GO:0005615; GO:0005794; GO:0005886; GO:0007399; GO:0010008; GO:0016020; GO:0030660; GO:0031301; GO:0042985; GO:0043231; GO:0070062 amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524] ETIKGIQK 0.99267 -7.3065 0 0 0 0 0 0 0 0 0 0 14.7795 14.4336 14.766 14.2216 14.3604 13.9066 14.0861 13.893 14.3294 13.4236 0 0 0 0 0 13.4921 0 0 13.7687 0 13.6957 13.7035 0 13.3386 0 13.0515 0 0 13.3987 13.5581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7986 0 0 Q7Z6B7 SRGP1_HUMAN "SLIT-ROBO Rho GTPase-activating protein 1, srGAP1 (Rho GTPase-activating protein 13)" SRGAP1 ARHGAP13 KIAA1304 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; negative regulation of cell migration [GO:0030336]; signal transduction [GO:0007165] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0030336 GTPase activator activity [GO:0005096] ALHIRKLLLTLPR 0.99268 -16.996 0 0 0 0 0 0 0 10.5468 0 12.4766 0 12.5066 12.9051 12.9385 12.1463 13.3965 13.6021 13.6649 12.7265 11.2425 11.2734 10.5126 0 0 11.6342 0 12.3648 12.7105 12.6707 11.3602 12.8446 13.5602 0 13.4259 13.7922 13.6572 12.4366 0 10.7764 13.5381 12.9823 0 11.7071 0 12.507 11.3964 0 11.1596 0 0 0 0 0 13.4018 14.0648 14.4272 14.6586 14.3637 13.9153 13.6951 13.124 12.3596 12.9386 11.5787 0 11.6824 14.1964 10.6557 12.4334 14.1695 10.4777 0 14.6718 11.8902 0 13.4242 0 0 0 0 0 11.765 0 15.7558 15.588 14.6281 11.3087 13.3971 15.6099 13.0367 0 13.7996 14.9894 0 13.2607 0 0 14.7573 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2709 11.4227 0 0 0 0 13.4337 0 0 0 0 0 0 15.0104 0 12.2488 0 0 0 0 0 0 0 0 15.4102 0 0 0 0 12.5672 12.9264 11.1951 11.0329 0 12.308 0 15.7384 0 11.572 0 12.6037 11.167 13.0755 15.4529 0 0 15.2129 13.956 12.1443 14.7478 14.0718 11.8888 13.7476 13.0794 12.8933 0 0 15.0874 12.9018 0 0 11.54 0 0 12.8536 0 12.4942 0 0 A8MQT2 GOG8B_HUMAN Golgin subfamily A member 8B (Golgin-67) GOLGA8B Homo sapiens (Human) Golgi organization [GO:0007030]; spindle assembly [GO:0051225] cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030]; spindle assembly [GO:0051225] GO:0000137; GO:0005794; GO:0005801; GO:0005829; GO:0007030; GO:0032580; GO:0051225 EYWQRNR 0.99268 -14.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4496 0 0 0 0 0 0 13.092 0 0 0 14.2734 0 0 0 0 0 0 0 0 0 13.8384 0 0 14.8279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2114 0 0 0 0 0 0 0 14.2527 14.3927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 0 0 0 0 0 0 12.7598 O60290 ZN862_HUMAN Zinc finger protein 862 ZNF862 KIAA0543 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355; GO:0046872; GO:0046983 metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983] ASCCSSSICEEGDGPRR 0.99268 -24.143 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8673 0 0 0 0 0 0 16.8188 16.817 11.5563 14.5121 0 10.8487 0 0 0 16.9159 0 0 14.8056 0 0 0 0 13.8756 0 0 0 0 0 0 12.9611 0 0 13.3738 0 0 0 13.2986 10.6093 17.0535 13.6796 13.9884 14.3659 14.4903 13.809 0 11.9936 16.5654 11.2837 0 11.0485 11.6886 0 0 0 0 0 0 0 0 0 14.5745 12.5318 0 0 0 0 0 12.5324 11.7557 0 14.5479 13.2573 0 0 13.2936 0 0 14.1058 16.9463 0 0 0 0 16.4198 12.8187 0 14.9045 12.4718 0 0 0 0 0 12.988 15.2301 0 13.5254 12.2423 16.5092 0 16.5295 0 0 0 0 0 15.1724 0 0 0 13.3404 12.7742 0 0 0 13.1577 0 0 12.8048 0 15.1251 13.5094 0 0 0 0 14.5106 0 0 0 14.8399 17.3408 14.067 0 0 0 0 0 0 0 0 13.9254 14.2541 0 0 0 0 0 0 0 14.8298 0 0 0 0 0 14.3389 0 0 0 0 0 0 13.5602 12.2612 O95450 ATS2_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 2, ADAM-TS 2, ADAM-TS2, ADAMTS-2, EC 3.4.24.14 (Procollagen I N-proteinase, PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase, pNPI)" ADAMTS2 PCINP PCPNI Homo sapiens (Human) collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283] GO:0004222; GO:0005576; GO:0007283; GO:0008237; GO:0008270; GO:0016485; GO:0030198; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588; GO:0062023 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] ACNPQECSQPVWVTGEWEPCSQTCGR 0.99268 -17.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8145 0 0 0 0 0 0 0 0 0 14.0202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3626 0 0 15.0218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0177 0 0 12.1398 20.1466 0 12.8789 0 0 0 0 0 0 0 0 0 0 0 0 14.7523 0 13.7102 0 15.3638 0 0 0 0 14.6533 13.0864 13.2606 12.4316 0 0 13.3049 0 0 0 12.8869 0 0 0 12.6196 0 0 13.3551 12.8952 0 0 0 12.3619 0 0 11.2333 11.9784 0 15.6406 0 0 0 14.6149 14.5885 11.5023 0 14.3595 0 0 13.1039 0 0 0 0 0 0 0 0 0 0 0 13.7578 12.9076 13.5836 0 0 0 0 14.0381 0 11.2831 0 0 0 0 0 0 13.4709 0 0 0 0 0 0 0 0 12.0576 0 P18859 ATP5J_HUMAN "ATP synthase-coupling factor 6, mitochondrial, ATPase subunit F6 (ATP synthase peripheral stalk subunit F6)" ATP5PF ATP5A ATP5J ATPM Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; substantia nigra development [GO:0021762] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; substantia nigra development [GO:0021762]" GO:0000276; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0021762; GO:0042776 proton transmembrane transporter activity [GO:0015078] LFRFSSVIR 0.99268 -4.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7787 0 0 0 0 0 0 12.0221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51955 NEK2_HUMAN "Serine/threonine-protein kinase Nek2, EC 2.7.11.1 (HSPK 21) (Never in mitosis A-related kinase 2, NimA-related protein kinase 2) (NimA-like protein kinase 1)" NEK2 NEK2A NLK1 Homo sapiens (Human) blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225] centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922] centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; negative regulation of DNA binding [GO:0043392]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225] GO:0000070; GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032212; GO:0032991; GO:0043392; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051973; GO:0051988; GO:0090307; GO:0106310; GO:1903126; GO:1904355 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ELKHPNIVR 0.99268 -7.3444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4813 0 0 0 0 0 0 14.3894 0 0 0 15.096 16.0418 0 11.6175 0 0 0 0 0 13.7112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3817 0 15.2569 14.1774 0 0 0 17.794 0 0 15.7666 0 0 0 0 14.7881 0 0 0 0 0 14.1509 13.5377 0 14.9037 0 0 0 0 0 0 19.0506 0 0 13.8682 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2645 0 13.4423 0 0 0 0 0 0 0 0 0 0 15.0015 0 0 0 0 0 19.0953 0 0 0 0 0 15.2691 0 Q05C16 LRC63_HUMAN Leucine-rich repeat-containing protein 63 LRRC63 Homo sapiens (Human) MQKPPLLLR 0.99268 -17.047 0 12.0228 0 0 0 12.082 0 0 0 0 0 0 0 0 0 0 0 13.9165 0 0 0 0 0 0 0 0 0 0 14.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5088 0 12.4842 12.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14244 MAP7_HUMAN "Ensconsin (Epithelial microtubule-associated protein of 115 kDa, E-MAP-115) (Microtubule-associated protein 7, MAP-7)" MAP7 Homo sapiens (Human) establishment or maintenance of cell polarity [GO:0007163]; microtubule cytoskeleton organization [GO:0000226]; protein localization to plasma membrane [GO:0072659]; response to osmotic stress [GO:0006970] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471] axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; establishment or maintenance of cell polarity [GO:0007163]; microtubule cytoskeleton organization [GO:0000226]; protein localization to plasma membrane [GO:0072659]; response to osmotic stress [GO:0006970] GO:0000226; GO:0005102; GO:0005198; GO:0005829; GO:0005874; GO:0005875; GO:0006970; GO:0007163; GO:0015630; GO:0016323; GO:0030424; GO:0048471; GO:0072659 signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] AAPAQVR 0.99268 -18.4 0 0 0 10.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8213 0 0 13.3963 0 0 0 0 14.2641 13.6639 0 0 0 0 14.6164 0 0 0 0 0 14.4648 0 13.1749 0 0 14.3869 12.4502 13.6385 14.5325 0 14.7827 0 0 14.5388 0 0 13.1256 0 0 13.2508 14.6161 14.3255 0 0 14.3865 0 14.5385 0 0 11.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7384 0 0 12.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2888 16.3192 Q16816 PHKG1_HUMAN "Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, PHK-gamma-M, EC 2.7.11.19 (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1, EC 2.7.11.1, EC 2.7.11.26)" PHKG1 PHKG Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine kinase activity [GO:0106310]; tau-protein kinase activity [GO:0050321]; carbohydrate metabolic process [GO:0005975]; glycogen biosynthetic process [GO:0005978]; protein phosphorylation [GO:0006468] GO:0004689; GO:0005516; GO:0005524; GO:0005829; GO:0005964; GO:0005975; GO:0005978; GO:0006468; GO:0019899; GO:0050321; GO:0106310 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine kinase activity [GO:0106310]; tau-protein kinase activity [GO:0050321] ALLEVICTLHKLNIVHRDLK 0.99268 -4.4642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9286 0 0 0 0 0 0 0 0 0 0 0 0 16.4496 0 14.2347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TEA6 SE1L2_HUMAN "Protein sel-1 homolog 2 (Suppressor of lin-12-like protein 2, Sel-1L2)" SEL1L2 C20orf50 Homo sapiens (Human) ERAD pathway [GO:0036503] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ERAD pathway [GO:0036503] GO:0005789; GO:0016021; GO:0036503 ALHYFLK 0.99268 -6.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8462 0 0 0 0 0 0 0 13.7141 0 0 0 13.7359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9048 0 0 12.9502 0 0 0 0 0 12.5852 0 0 0 12.7547 14.3145 0 15.4419 15.1314 0 0 0 14.0872 0 0 0 12.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7816 13.9539 0 0 0 13.7708 0 0 0 0 0 0 0 0 0 14.9392 0 12.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6537 0 0 0 14.4843 0 0 11.7894 0 0 11.0137 0 0 0 0 0 0 0 0 0 0 15.0221 Q6PJI9 WDR59_HUMAN GATOR complex protein WDR59 (WD repeat-containing protein 59) WDR59 KIAA1923 FP977 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263] GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774] GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774]; signaling adaptor activity [GO:0035591]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263] GO:0005765; GO:0005774; GO:0032008; GO:0034198; GO:0035591; GO:0035859; GO:0061700; GO:1904262; GO:1904263 signaling adaptor activity [GO:0035591] DTALQKVK 0.99268 -17.014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.109 0 0 0 0 0 12.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1698 0 0 13.7189 13.0967 0 12.6443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7374 0 0 0 0 0 0 0 0 12.2513 0 13.1567 0 18.0061 10.9419 0 10.9389 0 19.4204 0 0 0 10.5339 0 0 0 0 0 12.5876 0 0 13.5946 0 0 11.4705 0 0 0 0 0 0 0 11.9839 0 0 0 0 12.0595 0 0 0 0 0 9.51179 0 0 0 0 0 13.0382 0 0 13.0751 0 0 0 0 0 0 0 0 0 0 11.265 0 0 0 0 0 0 0 0 0 0 10.6793 0 0 12.1791 0 0 0 0 11.8243 0 0 10.8572 9.82895 13.1759 13.1384 0 13.1449 0 0 0 0 0 0 10.7925 0 0 0 12.5332 0 Q6ZN08 ZNF66_HUMAN Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene) ZNF66 ZNF66P Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGEAFK 0.99268 -14.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0228 0 0 0 0 0 0 0 0 14.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3369 0 0 0 0 0 0 10.7989 0 0 0 0 0 0 0 16.2285 0 0 16.295 0 16.0084 16.0824 0 0 0 0 0 0 0 0 0 Q8IV63 VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 (Serine/threonine-protein pseudokinase VRK3) (Vaccinia-related kinase 3) VRK3 Homo sapiens (Human) histone phosphorylation [GO:0016572]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; histone phosphorylation [GO:0016572]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519] GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0007165; GO:0007519; GO:0016572; GO:0018105; GO:0019903; GO:0032516; GO:0043231; GO:0070373 ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674] GSGSRPPTPKSSPQK 0.99268 -17.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6332 0 13.8992 12.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9312 0 0 0 12.3833 0 0 0 0 0 0 0 0 14.3856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7737 0 0 0 0 0 13.9388 13.002 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGD3 OR4K5_HUMAN Olfactory receptor 4K5 (Olfactory receptor OR14-16) OR4K5 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FLAIFYTVFTPVLNPIIYTLR 0.99268 -15.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9636 14.2211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3376 0 0 0 11.2168 0 13.8488 0 0 0 10.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8847 12.9741 12.497 0 0 0 0 10.2415 0 0 0 0 0 0 0 12.4329 0 12.5355 0 0 11.3405 0 11.5999 0 13.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4615 0 0 0 12.6943 0 0 Q8WYR1 PI3R5_HUMAN "Phosphoinositide 3-kinase regulatory subunit 5, PI3-kinase regulatory subunit 5 (PI3-kinase p101 subunit) (Phosphatidylinositol 4,5-bisphosphate 3-kinase regulatory subunit, PtdIns-3-kinase regulatory subunit) (Protein FOAP-2) (PtdIns-3-kinase p101) (p101-PI3K)" PIK3R5 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897] "centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]" "centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; G-protein beta/gamma-subunit complex binding [GO:0031683]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]" GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006955; GO:0007186; GO:0014065; GO:0016020; GO:0031683; GO:0034451; GO:0043406; GO:0046935; GO:0051897 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; G-protein beta/gamma-subunit complex binding [GO:0031683] AGFPGVLDTAKPGKLHTIPIPVAR 0.99268 -25.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.896 0 0 0 10.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3647 14.3442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5273 0 0 0 0 0 0 13.1291 14.4244 15.1309 0 0 12.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0849 0 0 12.3777 0 12.209 0 0 0 0 11.3895 0 0 0 0 0 0 0 0 0 0 0 Q969Z3 MARC2_HUMAN "Mitochondrial amidoxime reducing component 2, mARC2, EC 1.7.-.- (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2, MOSC domain-containing protein 2, Moco sulfurase C-terminal domain-containing protein 2)" MTARC2 MARC2 MOSC2 Homo sapiens (Human) cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] "mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]; cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809]" GO:0005739; GO:0005741; GO:0005777; GO:0006809; GO:0008940; GO:0016661; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0051410; GO:0070458; GO:0098809 "molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]" DRFWLVIK 0.99268 -24.126 0 0 0 0 0 0 0 0 0 11.2724 0 0 11.5657 0 0 11.6177 11.8095 0 0 0 0 0 0 0 0 0 0 0 0 11.632 0 0 0 11.4835 0 0 0 11.6927 0 11.6859 0 0 11.5684 0 0 0 0 0 0 12.5491 0 0 0 0 0 0 13.7261 0 0 0 0 0 0 0 0 0 12.7275 0 0 0 0 0 0 0 0 0 0 0 12.7628 0 12.9541 0 14.2269 0 0 0 0 14.4605 0 13.3075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2811 0 14.3453 0 14.2411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.828 0 0 0 13.4648 0 0 0 13.9321 0 0 0 0 0 0 0 10.5741 0 0 14.3778 0 0 0 0 0 13.2258 0 0 0 14.3129 14.1694 14.0638 0 13.9742 14.2063 0 14.1038 0 14.5106 0 13.9194 0 0 0 0 0 0 13.7192 0 13.9257 0 0 Q9H4M7 PKHA4_HUMAN "Pleckstrin homology domain-containing family A member 4, PH domain-containing family A member 4 (Phosphoinositol 3-phosphate-binding protein 1, PEPP-1)" PLEKHA4 PEPP1 Homo sapiens (Human) "positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" GO:0005546; GO:0005737; GO:0005886; GO:0031234; GO:0032266; GO:0042802; GO:0043325; GO:0080025; GO:0090263; GO:2000096 "identical protein binding [GO:0042802]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" ALGRASR 0.99268 -18.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.13227 0 0 0 0 0 0 0 0 0 0 0 0 17.4536 0 0 0 0 0 0 0 11.5727 0 0 0 0 11.5287 0 0 0 15.1887 0 0 0 0 15.5797 16.8381 13.2644 17.0163 0 13.4959 13.5221 0 0 0 17.1749 12.593 0 0 0 0 13.5451 0 0 0 0 0 0 0 0 0 0 0 12.0891 13.0201 0 0 0 0 0 0 0 0 10.872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3487 0 0 10.867 0 0 0 0 0 0 15.2669 0 0 14.6959 0 0 0 0 0 0 0 0 0 0 13.2147 0 0 0 0 0 12.631 0 0 Q9H9L7 AKIR1_HUMAN Akirin-1 AKIRIN1 C1orf108 Homo sapiens (Human) myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000785; GO:0003712; GO:0005634; GO:0005654; GO:0010592; GO:0010759; GO:0014839; GO:0031965; GO:0045663; GO:0045944; GO:1902723; GO:1902725 transcription coregulator activity [GO:0003712] ACGATLKR 0.99268 -6.266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9339 0 0 0 0 0 0 0 0 0 0 0 0 11.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4023 0 0 0 0 0 0 0 Q9HAC7 SUCHY_HUMAN "Succinate--hydroxymethylglutarate CoA-transferase, EC 2.8.3.13 (Dermal papilla-derived protein 13) (SuccinylCoA:glutarate-CoA transferase)" SUGCT C7orf10 DERP13 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369] GO:0005739; GO:0047369 succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369] DPKGVKIIK 0.99268 -17.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9053 13.0075 12.8714 0 0 11.5979 0 0 0 0 0 14.8031 0 0 13.93 0 0 0 0 0 0 0 0 0 0 14.9048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3255 0 0 14.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7533 0 0 0 12.2301 0 0 0 0 0 0 0 14.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6207 0 0 0 0 0 0 0 0 Q9UJ04 TSYL4_HUMAN "Testis-specific Y-encoded-like protein 4, TSPY-like protein 4" TSPYL4 KIAA0721 Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0042393 chromatin binding [GO:0003682]; histone binding [GO:0042393] AISAAVEKEGEAGAAMEEK 0.99268 -5.1147 13.3501 0 0 0 0 10.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1674 0 0 0 0 0 13.0365 13.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3025 0 0 Q9UQ84 EXO1_HUMAN "Exonuclease 1, hExo1, EC 3.1.-.- (Exonuclease I, hExoI)" EXO1 EXOI HEX1 Homo sapiens (Human) DNA recombination [GO:0006310]; DNA repair [GO:0006281]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]; t-circle formation [GO:0090656] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0051908]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; somatic hypermutation of immunoglobulin genes [GO:0016446]; t-circle formation [GO:0090656] GO:0002455; GO:0003677; GO:0003682; GO:0004523; GO:0004527; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006298; GO:0006310; GO:0008409; GO:0016446; GO:0016604; GO:0017108; GO:0035312; GO:0045145; GO:0045190; GO:0046872; GO:0048256; GO:0051321; GO:0051908; GO:0090656 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0051908]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145] EVERSRR 0.99268 -17.498 0 10.2668 0 0 0 0 0 12.7327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9805 0 0 0 0 0 0 0 13.544 15.0903 0 0 0 0 13.0886 13.5082 0 0 0 0 13.4975 0 13.6531 0 0 0 13.52 0 12.0628 0 0 0 13.4998 0 13.7811 0 0 0 0 13.807 13.4115 13.0657 0 13.9908 13.6699 14.0605 14.5386 0 14.6047 15.1856 0 12.8944 12.9144 10.5534 0 0 0 12.6832 0 14.1765 0 12.6006 12.4177 0 0 12.5939 0 0 0 0 0 0 0 13.3602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1328 0 0 0 0 0 0 0 0 12.593 0 0 Q9Y4H2 IRS2_HUMAN "Insulin receptor substrate 2, IRS-2" IRS2 Homo sapiens (Human) brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; epithelial cell migration [GO:0010631]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; mammary gland development [GO:0030879]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of kinase activity [GO:0033673]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; regulation of lipid metabolic process [GO:0019216]; response to glucose [GO:0009749]; signal transduction [GO:0007165]; stem cell proliferation [GO:0072089]; type B pancreatic cell proliferation [GO:0044342] cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; 14-3-3 protein binding [GO:0071889]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; epithelial cell migration [GO:0010631]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; mammary gland development [GO:0030879]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of kinase activity [GO:0033673]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; regulation of lipid metabolic process [GO:0019216]; response to glucose [GO:0009749]; signal transduction [GO:0007165]; stem cell proliferation [GO:0072089]; type B pancreatic cell proliferation [GO:0044342] GO:0002053; GO:0002903; GO:0005158; GO:0005829; GO:0005886; GO:0006006; GO:0007165; GO:0007420; GO:0008284; GO:0008286; GO:0009749; GO:0010631; GO:0010634; GO:0010748; GO:0010907; GO:0019216; GO:0019901; GO:0019903; GO:0019904; GO:0030879; GO:0030890; GO:0032000; GO:0032024; GO:0032869; GO:0032991; GO:0033673; GO:0043548; GO:0044342; GO:0045725; GO:0046326; GO:0055088; GO:0071333; GO:0071889; GO:0072089; GO:1904692; GO:2000648 14-3-3 protein binding [GO:0071889]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903] DEYFAVAAENEQEQEGWYR 0.99268 -4.4597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2782 0 0 0 0 0 12.1655 0 0 0 0 14.6189 0 0 0 0 0 0 0 12.5467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9314 0 12.1086 0 0 0 0 A0A0U1RRE5 NBDY_HUMAN Negative regulator of P-body association (P-body dissociating protein) (Protein NoBody) NBDY LINC01420 Homo sapiens (Human) mRNA processing [GO:0006397]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; nuclear-transcribed mRNA catabolic process [GO:0000956] P-body [GO:0000932] P-body [GO:0000932]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic mRNA processing body assembly [GO:0010607]; nuclear-transcribed mRNA catabolic process [GO:0000956] GO:0000932; GO:0000956; GO:0006397; GO:0010607 EAKPPKK 0.99269 -14.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RRD8 ZN320_HUMAN Zinc finger protein 320 ZNF320 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ATLACHHR 0.99269 -16.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1863 11.4943 0 0 0 12.1398 12.7531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6355 0 0 0 0 A8K830 COLC2_HUMAN Colorectal cancer-associated protein 2 (Cancer susceptibility candidate protein 13) COLCA2 C11orf93 CASC13 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ETNCDICYS 0.99269 -4.9668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8919 0 0 0 A9YTQ3 AHRR_HUMAN "Aryl hydrocarbon receptor repressor, AhR repressor, AhRR (Class E basic helix-loop-helix protein 77, bHLHe77)" AHRR BHLHE77 KIAA1234 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; xenobiotic metabolic process [GO:0006805] aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]; regulation of transcription by RNA polymerase II [GO:0006357]; xenobiotic metabolic process [GO:0006805]" GO:0000785; GO:0000976; GO:0000981; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006805; GO:0034751; GO:0046983 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]" AAEAAPVVK 0.99269 -17.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2545 0 0 0 0 0 0 0 0 11.102 0 0 0 0 10.3542 0 0 0 0 0 0 0 0 0 0 0 0 10.0881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4661 0 0 0 0 0 14.6788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15068 MCF2L_HUMAN Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) MCF2L KIAA0362 OST Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091]; intracellular signal transduction [GO:0035556]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0012505; GO:0019898; GO:0031234; GO:0035025; GO:0035091; GO:0035556; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091] ASVLRIAASFPANLQLVLVLR 0.99269 -24.265 0 0 0 0 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2729 0 0 0 0 0 0 0 13.3961 0 0 11.9332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8453 0 0 15.115 0 0 12.6007 0 0 0 0 0 0 0 12.6071 0 0 0 0 0 0 0 0 0 14.1658 0 0 0 0 0 0 0 0 14.3971 0 0 0 0 0 0 0 14.0605 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5545 0 0 0 0 0 0 0 0 0 13.7671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5356 0 0 0 13.9624 0 0 14.0164 13.3476 0 0 0 0 0 0 0 0 0 0 0 0 O43395 PRPF3_HUMAN "U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3, hPrp3) (U4/U6 snRNP 90 kDa protein)" PRPF3 HPRP3 PRP3 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "Cajal body [GO:0015030]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006397; GO:0008380; GO:0015030; GO:0016607; GO:0042802; GO:0046540; GO:0071005 identical protein binding [GO:0042802]; RNA binding [GO:0003723] AAELQARIQAQLALK 0.99269 -14.871 0 0 0 0 0 0 0 0 0 0 12.6146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6261 0 0 14.3149 0 0 0 0 0 0 0 0 13.9163 0 0 0 0 0 0 10.6601 12.9538 0 0 0 0 0 0 0 13.9943 0 0 0 0 0 0 0 0 0 0 0 0 10.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4342 12.7102 0 0 0 0 0 0 0 13.1607 12.8372 0 0 0 0 0 11.1764 0 0 0 0 0 0 0 0 0 0 0 0 10.5407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95084 PRS23_HUMAN "Serine protease 23, EC 3.4.21.- (Putative secreted protein Zsig13)" PRSS23 ZSIG13 UNQ270/PRO307 Homo sapiens (Human) proteolysis [GO:0006508] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005634; GO:0005788; GO:0006508; GO:0070062 serine-type endopeptidase activity [GO:0004252] DSGSSGK 0.99269 -14.893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4964 0 15.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9264 0 0 17.3304 0 13.6471 14.4549 0 0 0 0 0 0 13.4038 13.8696 0 18.5335 0 0 0 0 0 0 0 0 0 0 13.1299 0 0 0 13.3113 13.8332 12.8479 0 0 0 16.9091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3609 0 0 0 0 0 0 0 17.181 0 0 0 0 0 14.7033 0 15.9179 0 0 0 0 0 0 17.0329 0 0 0 0 0 0 14.6572 0 0 14.9829 0 0 14.6083 0 14.0554 0 0 0 14.4083 0 0 0 14.5203 P04233 HG2A_HUMAN "HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain, Ii) (CD antigen CD74) [Cleaved into: Class-II-associated invariant chain peptide, CLIP ]" CD74 DHLAG Homo sapiens (Human) "antigen processing and presentation [GO:0019882]; antigen processing and presentation of endogenous antigen [GO:0019883]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell population proliferation [GO:0008283]; chaperone cofactor-dependent protein refolding [GO:0051085]; immunoglobulin mediated immune response [GO:0016064]; intracellular protein transport [GO:0006886]; macrophage migration inhibitory factor signaling pathway [GO:0035691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of peptide secretion [GO:0002792]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of viral entry into host cell [GO:0046597]; negative thymic T cell selection [GO:0045060]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of viral entry into host cell [GO:0046598]; positive thymic T cell selection [GO:0045059]; prostaglandin biosynthetic process [GO:0001516]; protein stabilization [GO:0050821]; protein trimerization [GO:0070206]; protein-containing complex assembly [GO:0065003]; regulation of macrophage activation [GO:0043030]; response to interferon-gamma [GO:0034341]; T cell activation involved in immune response [GO:0002286]; T cell selection [GO:0045058]" cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; macrophage migration inhibitory factor receptor complex [GO:0035692]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; multivesicular body [GO:0005771]; NOS2-CD74 complex [GO:0035693]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; vacuole [GO:0005773] "cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; macrophage migration inhibitory factor receptor complex [GO:0035692]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; multivesicular body [GO:0005771]; NOS2-CD74 complex [GO:0035693]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network membrane [GO:0032588]; transport vesicle membrane [GO:0030658]; vacuole [GO:0005773]; amyloid-beta binding [GO:0001540]; CD4 receptor binding [GO:0042609]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; macrophage migration inhibitory factor binding [GO:0035718]; MHC class II protein binding [GO:0042289]; MHC class II protein binding, via antigen binding groove [GO:0042658]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase binding [GO:0050998]; protein folding chaperone [GO:0044183]; antigen processing and presentation [GO:0019882]; antigen processing and presentation of endogenous antigen [GO:0019883]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell population proliferation [GO:0008283]; chaperone cofactor-dependent protein refolding [GO:0051085]; immunoglobulin mediated immune response [GO:0016064]; intracellular protein transport [GO:0006886]; macrophage migration inhibitory factor signaling pathway [GO:0035691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of peptide secretion [GO:0002792]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of viral entry into host cell [GO:0046597]; negative thymic T cell selection [GO:0045060]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of viral entry into host cell [GO:0046598]; positive thymic T cell selection [GO:0045059]; prostaglandin biosynthetic process [GO:0001516]; protein stabilization [GO:0050821]; protein trimerization [GO:0070206]; protein-containing complex assembly [GO:0065003]; regulation of macrophage activation [GO:0043030]; response to interferon-gamma [GO:0034341]; T cell activation involved in immune response [GO:0002286]; T cell selection [GO:0045058]" GO:0000139; GO:0001516; GO:0001540; GO:0001934; GO:0001961; GO:0002286; GO:0002606; GO:0002792; GO:0002830; GO:0002906; GO:0004896; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005773; GO:0005886; GO:0006886; GO:0008283; GO:0009897; GO:0009986; GO:0010628; GO:0012507; GO:0016020; GO:0016021; GO:0016064; GO:0019882; GO:0019883; GO:0019886; GO:0019955; GO:0023026; GO:0030336; GO:0030658; GO:0030666; GO:0030669; GO:0030890; GO:0031394; GO:0032588; GO:0032722; GO:0032755; GO:0032757; GO:0032991; GO:0033674; GO:0034341; GO:0035691; GO:0035692; GO:0035693; GO:0035718; GO:0042289; GO:0042609; GO:0042613; GO:0042658; GO:0042802; GO:0043030; GO:0043066; GO:0043123; GO:0043202; GO:0043410; GO:0043518; GO:0044183; GO:0045058; GO:0045059; GO:0045060; GO:0045581; GO:0045582; GO:0045657; GO:0045893; GO:0046597; GO:0046598; GO:0048146; GO:0050731; GO:0050821; GO:0050998; GO:0051085; GO:0060907; GO:0065003; GO:0070062; GO:0070206; GO:0070374; GO:0071556; GO:0090023; GO:1902166; GO:2000343; GO:2000448 "amyloid-beta binding [GO:0001540]; CD4 receptor binding [GO:0042609]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; macrophage migration inhibitory factor binding [GO:0035718]; MHC class II protein binding [GO:0042289]; MHC class II protein binding, via antigen binding groove [GO:0042658]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase binding [GO:0050998]; protein folding chaperone [GO:0044183]" GHHNCSESLELEDPSSGLGVTK 0.99269 -17.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2349 P0C7P2 RFL3S_HUMAN Putative protein RFPL3S (RFPL3 antisense RNA 1) (RFPL3 antisense gene protein 1) (Ret finger protein-like 3 antisense gene protein) RFPL3S RFPL3-AS1 Homo sapiens (Human) RKLLAVSASK 0.99269 -4.4753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0005 0 0 0 0 0 0 14.7992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6763 0 16.2861 0 0 0 0 0 0 0 0 0 0 12.2244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57058 HUNK_HUMAN "Hormonally up-regulated neu tumor-associated kinase, EC 2.7.11.1 (B19) (Serine/threonine-protein kinase MAK-V)" HUNK MAKV Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004674; GO:0005524; GO:0006468; GO:0007165; GO:0035556; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ASKSSFPDKDSFGCR 0.99269 -25.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9588 0 14.4402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0841 0 0 0 0 0 0 0 0 0 0 0 13.026 0 0 0 13.5026 0 0 14.3875 0 0 0 0 0 0 0 0 0 14.1797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.733 0 0 0 0 0 0 0 0 0 0 12.7677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8114 13.051 0 0 0 12.8735 0 0 0 P57060 RWD2B_HUMAN RWD domain-containing protein 2B RWDD2B C21orf6 GL011 Homo sapiens (Human) KNILEWAK 0.99269 -17.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9313 0 0 0 0 0 11.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9491 0 0 0 0 0 0 0 0 0 0 0 0 14.1655 0 0 0 0 0 0 13.7663 0 0 13.6093 0 0 0 0 0 0 0 0 0 0 13.8374 12.9343 0 0 0 0 12.2258 14.5746 0 14.0444 12.0028 13.0372 12.0956 14.5865 14.486 13.9757 14.2637 12.1706 0 0 14.1778 13.8797 0 0 0 0 14.4387 0 14.5912 0 0 0 0 11.8561 0 0 0 12.7944 0 11.7703 0 0 0 0 0 0 12.3544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1812 0 0 0 14.2128 0 Q04864 REL_HUMAN Proto-oncogene c-Rel REL Homo sapiens (Human) I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097] chromatin [GO:0000785]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006954; GO:0007249; GO:0010629; GO:0032688; GO:0034097; GO:0038061; GO:0043123; GO:0045087; GO:0045944; GO:0071159 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AITEPVTVK 0.99269 -25.243 0 0 0 0 0 0 0 0 0 0 0 0 15.543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9052 0 0 0 0 0 0 0 0 0 0 0 12.2574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7889 0 0 12.0948 0 0 0 0 0 0 0 0 13.5928 13.426 13.6148 0 0 0 0 0 0 0 0 12.9792 13.4969 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6755 Q12872 SFSWA_HUMAN "Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)" SFSWAP SFRS8 SWAP Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]" nucleus [GO:0005634] "nucleus [GO:0005634]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]" GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025 RNA binding [GO:0003723] AALFLQTLK 0.99269 -26.348 0 0 0 0 0 0 0 13.1228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3415 0 0 0 11.2636 0 0 0 0 0 0 0 11.8103 0 0 0 0 0 0 0 0 0 0 0 12.0551 11.0566 0 0 0 0 11.0053 0 0 12.3959 0 0 0 0 0 0 0 0 0 0 0 0 12.5489 0 12.4048 13.4043 0 0 0 0 10 11.225 0 0 0 0 0 0 0 13.2795 16.9194 13.1038 14.0555 14.3153 13.4539 0 12.7796 15.2694 12.0172 0 0 0 0 0 0 16.3452 16.3433 0 0 0 0 0 0 12.9682 0 0 12.2454 0 0 0 0 0 12.7221 0 0 0 0 12.4161 0 11.8325 0 0 0 0 0 0 0 13.711 13.7338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6087 0 0 0 0 0 0 11.4485 0 0 13.3161 0 0 0 0 Q13291 SLAF1_HUMAN Signaling lymphocytic activation molecule (CDw150) (IPO-3) (SLAM family member 1) (CD antigen CD150) SLAMF1 SLAM Homo sapiens (Human) adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; myeloid dendritic cell activation involved in immune response [GO:0002277]; natural killer cell differentiation [GO:0001779]; natural killer cell proliferation [GO:0001787]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of tumor necrosis factor production [GO:0032720]; phagocytosis [GO:0006909]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; regulation of catalytic activity [GO:0050790]; regulation of vesicle fusion [GO:0031338] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; antigen binding [GO:0003823]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; myeloid dendritic cell activation involved in immune response [GO:0002277]; natural killer cell differentiation [GO:0001779]; natural killer cell proliferation [GO:0001787]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of tumor necrosis factor production [GO:0032720]; phagocytosis [GO:0006909]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; regulation of catalytic activity [GO:0050790]; regulation of vesicle fusion [GO:0031338] GO:0001618; GO:0001779; GO:0001787; GO:0002232; GO:0002250; GO:0002277; GO:0002725; GO:0003823; GO:0004888; GO:0006909; GO:0007155; GO:0008284; GO:0009897; GO:0010759; GO:0016021; GO:0031338; GO:0032689; GO:0032695; GO:0032715; GO:0032720; GO:0032729; GO:0038023; GO:0042104; GO:0042169; GO:0042802; GO:0045087; GO:0045335; GO:0046330; GO:0050790; GO:0070062; GO:0070374; GO:2000349; GO:2000510; GO:2000556 antigen binding [GO:0003823]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] PGPLQKK 0.99269 -16.297 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0632 0 0 0 0 10.6422 0 0 0 11.7228 0 12.5393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2173 13.083 0 0 0 0 13.3214 14.1651 12.2962 0 0 0 0 0 14.6983 13.4893 13.4211 12.2827 0 0 14.9853 0 13.8581 0 0 13.2084 0 0 0 0 13.2613 0 0 0 0 13.5991 0 0 0 0 0 0 0 0 0 12.1007 0 0 13.0745 12.7797 0 10.7003 10.1836 0 0 0 0 0 0 0 0 0 0 11.5231 0 0 0 0 14.0066 0 0 13.1814 0 0 0 13.951 12.173 0 0 0 0 12.4806 0 0 0 0 0 0 0 0 0 0 0 0 12.2192 0 0 13.1425 12.5085 0 13.6963 13.6295 0 Q14789 GOGB1_HUMAN "Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein, GCP372) (Giantin) (Macrogolgin)" GOLGB1 Homo sapiens (Human) "chondrocyte proliferation [GO:0035988]; Golgi organization [GO:0007030]; protein localization to pericentriolar material [GO:1905793]; regulation of transcription, DNA-templated [GO:0006355]" cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; chondrocyte proliferation [GO:0035988]; Golgi organization [GO:0007030]; protein localization to pericentriolar material [GO:1905793]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000139; GO:0003723; GO:0005793; GO:0005794; GO:0005795; GO:0005801; GO:0005829; GO:0006355; GO:0007030; GO:0016020; GO:0016021; GO:0035988; GO:0043565; GO:1905793 RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] AADNKIKK 0.99269 -62.694 0 0 0 0 0 0 12.5223 0 0 0 0 0 0 16.7002 0 0 0 0 0 12.7664 0 0 0 0 13.3844 0 0 11.1202 0 0 0 0 12.1295 0 0 0 0 0 0 0 0 0 0 11.8701 0 0 0 0 0 12.1955 0 0 0 14.1481 0 10.3539 12.7109 12.0495 13.4615 0 0 0 0 13.3171 13.3021 0 13.3045 0 0 12.0739 11.5287 12.63 0 10.8876 15.7546 0 0 0 13.1323 13.4015 17.4668 0 0 0 0 18.101 0 12.9496 0 0 11.1966 15.1365 0 13.5137 12.7462 15.476 15.0602 13.2561 0 13.9799 13.5957 0 15.6845 15.1532 17.5169 14.6609 15.5543 16.3496 13.5025 14.8225 15.5691 14.5962 12.2122 12.4595 12.541 0 0 0 0 13.5205 12.6744 0 12.5278 15.0625 14.4165 13.4788 11.9161 14.8418 0 17.8463 13.2563 18.2719 13.8876 13.8429 13.0414 0 0 13.2609 17.1098 14.1988 13.0398 0 12.2892 0 13.0226 0 14.0422 13.3877 0 0 0 14.9281 0 15.2052 17.2209 0 0 0 12.563 12.5551 0 11.8263 0 13.9543 12.8175 13.0215 9.25948 0 0 11.9667 0 13.7887 0 0 0 12.8796 16.2115 12.1772 0 13.0129 Q15973 ZN124_HUMAN Zinc finger protein 124 (Zinc finger protein HZF-16) ZNF124 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CSSSLRDHER 0.99269 -25.318 0 0 0 0 0 0 0 0 0 0 0 12.6723 0 0 0 0 0 0 0 0 11.8904 0 0 0 12.1419 0 0 11.6539 0 12.0465 0 0 0 0 12.5129 0 0 0 0 0 0 0 0 0 12.4837 0 0 0 0 13.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6037 0 0 14.3692 14.3429 17.2796 0 13.0861 0 14.1582 0 13.7509 0 0 0 12.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8927 0 0 0 0 0 0 11.0379 0 0 13.6469 0 0 0 14.6386 0 14.625 0 0 0 0 0 0 0 0 0 0 12.4374 Q5VUA4 ZN318_HUMAN Zinc finger protein 318 (Endocrine regulatory protein) ZNF318 HRIHFB2436 Homo sapiens (Human) "meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003676; GO:0005654; GO:0005829; GO:0008270; GO:0042803; GO:0045892; GO:0045893; GO:0051321 nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] ASPSPPRGR 0.99269 -59.589 0 0 0 0 9.98257 0 0 0 13.4583 14.5291 13.8634 13.3025 14.6176 9.98 11.5844 0 0 0 0 0 0 12.9612 0 13.3229 0 0 13.2925 0 13.1349 13.1988 13.1928 13.3065 13.2122 12.8274 12.9086 13.5201 13.7722 13.0802 12.8597 13.057 0 0 0 0 0 0 0 0 0 0 12.2275 11.7948 0 0 0 0 0 0 0 0 14.2055 0 13.6167 0 0 13.8302 0 0 0 0 12.3813 0 13.5049 10.5337 0 13.1206 0 0 0 0 12.6334 16.1914 0 17.0192 0 14.3006 16.8638 11.8796 0 13.2498 0 0 16.2817 11.5869 0 0 0 13.2357 12.2185 0 0 14.7324 17.9721 14.1188 0 12.9601 12.6201 0 13.8642 13.9228 15.4978 0 13.9352 0 13.4685 13.7405 0 0 0 0 0 0 0 0 0 0 0 0 12.2403 11.7413 13.3089 12.2977 14.5554 11.5974 0 12.9479 0 0 0 14.4519 0 0 0 0 0 0 0 14.4499 11.1831 0 0 0 11.1282 14.8717 0 14.8127 0 14.0979 16.55 0 0 19.4212 0 0 0 0 0 0 13.5241 13.9635 0 0 13.5764 0 0 14.0868 0 0 0 0 Q6PFW1 VIP1_HUMAN "Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1, EC 2.7.4.24 (Diphosphoinositol pentakisphosphate kinase 1) (Histidine acid phosphatase domain-containing protein 2A) (IP6 kinase) (Inositol pyrophosphate synthase 1) (InsP6 and PP-IP5 kinase 1) (VIP1 homolog, hsVIP1)" PPIP5K1 HISPPD2A IP6K IPS1 KIAA0377 VIP1 Homo sapiens (Human) inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; phosphorylation [GO:0016310] cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; plasma membrane [GO:0005886]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; phosphorylation [GO:0016310]" GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0005886; GO:0006020; GO:0016310; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092 "5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]" ASDEPDR 0.99269 -61.491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1672 0 0 13.2872 0 14.4341 0 0 0 0 0 0 0 13.595 0 0 0 13.6468 0 9.91782 0 0 0 0 0 0 0 0 0 0 0 16.3626 0 0 12.2971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7583 0 0 16.8802 16.4422 12.0635 0 0 15.8996 0 11.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9231 13.4301 0 0 0 0 0 0 0 14.1191 0 0 0 0 0 0 16.2158 0 0 0 0 0 0 18.9063 0 0 0 0 0 0 0 0 0 0 14.3686 0 15.4653 16.386 16.5079 0 0 0 16.5221 0 0 0 16.2391 0 0 0 11.8695 0 0 0 0 0 13.7491 0 0 0 0 0 0 0 13.4788 14.7272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2727 14.4683 15.5699 0 Q6R6M4 U17L2_HUMAN "Ubiquitin carboxyl-terminal hydrolase 17, USP17, EC 3.4.19.12 (Deubiquitinating enzyme 17-like protein 2) (Deubiquitinating protein 3, DUB-3) (Ubiquitin carboxyl-terminal hydrolase 17-like protein 2) (Ubiquitin thioesterase 17-like protein 2) (Ubiquitin-specific-processing protease 17-like protein 2)" USP17L2 DUB3 USP17 USP17H USP17I USP17J USP17K USP17L USP17M Homo sapiens (Human) apoptotic process [GO:0006915]; CAAX-box protein processing [GO:0071586]; cell cycle [GO:0007049]; MAPK cascade [GO:0000165]; negative regulation of GTPase activity [GO:0034260]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of defense response to virus by host [GO:0050691]; regulation of G2/MI transition of meiotic cell cycle [GO:0110030]; regulation of ruffle assembly [GO:1900027]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915]; CAAX-box protein processing [GO:0071586]; cell cycle [GO:0007049]; MAPK cascade [GO:0000165]; negative regulation of GTPase activity [GO:0034260]; negative regulation of histone deacetylation [GO:0031064]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to membrane [GO:0090315]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of defense response to virus by host [GO:0050691]; regulation of G2/MI transition of meiotic cell cycle [GO:0110030]; regulation of ruffle assembly [GO:1900027]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000165; GO:0004197; GO:0004843; GO:0005634; GO:0005789; GO:0005829; GO:0006511; GO:0006915; GO:0007049; GO:0010955; GO:0016579; GO:0030334; GO:0031064; GO:0034260; GO:0042127; GO:0042981; GO:0043547; GO:0050691; GO:0070536; GO:0071108; GO:0071586; GO:0090315; GO:0110030; GO:1900027; GO:1900245; GO:1900246 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] APASKTLTLHTSAKVLILVLK 0.99269 -4.9587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZR08 DYH12_HUMAN Dynein axonemal heavy chain 12 (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein axonemal heavy chain 7-like) (Dynein heavy chain domain-containing protein 2) DNAH12 DHC3 DLP12 DNAH12L DNAH7L DNAHC3 DNHD2 HDHC3 HL19 Homo sapiens (Human) microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; microtubule [GO:0005874] axonemal dynein complex [GO:0005858]; microtubule [GO:0005874]; ATP binding [GO:0005524]; minus-end-directed microtubule motor activity [GO:0008569]; microtubule-based movement [GO:0007018] GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569 ATP binding [GO:0005524]; minus-end-directed microtubule motor activity [GO:0008569] AAVHRNLEGARK 0.99269 -14.85 12.3319 13.2335 0 0 13.3925 0 0 0 0 0 0 0 12.9104 0 0 0 0 0 0 0 0 10.3252 0 0 0 0 0 0 11.5013 0 11.9073 0 0 11.0503 13.0213 0 0 0 12.7822 0 13.5889 0 0 0 0 10.0829 0 0 13.9217 0 0 0 0 0 0 0 0 0 11.3373 0 0 0 0 0 0 0 0 0 0 0 9.76994 11.0099 0 0 0 15.1609 0 0 15.3003 0 15.4676 13.3853 11.2543 14.68 17.5539 0 0 0 14.4529 0 0 0 0 16.1458 12.1933 16.98 16.3187 15.9549 0 15.8435 16.0979 15.5483 16.3409 16.5033 0 15.7588 10.9186 12.6016 0 14.8402 0 13.6028 14.7436 15.7704 12.8402 16.1174 16.3313 14.6153 15.1967 15.0354 0 0 0 14.7448 13.594 16.0956 0 15.0765 0 0 14.0582 0 0 11.4554 12.701 13.6333 13.4366 15.0282 0 0 12.9024 13.5807 15.2734 0 12.2018 14.4755 13.4173 11.9365 0 12.5218 0 0 0 0 13.887 15.172 0 15.2543 0 15.0742 0 0 0 13.5311 13.0644 0 0 0 12.1773 0 0 0 13.4363 0 14.8821 12.475 0 0 11.7958 15.2865 Q86VF7 NRAP_HUMAN "Nebulin-related-anchoring protein, N-RAP" NRAP Homo sapiens (Human) cardiac muscle thin filament assembly [GO:0071691] fascia adherens [GO:0005916]; muscle tendon junction [GO:0005927]; Z disc [GO:0030018] fascia adherens [GO:0005916]; muscle tendon junction [GO:0005927]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; vinculin binding [GO:0017166]; cardiac muscle thin filament assembly [GO:0071691] GO:0003779; GO:0005916; GO:0005927; GO:0017166; GO:0030018; GO:0046872; GO:0051015; GO:0051371; GO:0071691 actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; vinculin binding [GO:0017166] AKTNAKLFSEVK 0.99269 -17.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.604 13.0132 0 14.1258 0 13.7541 0 11.2708 0 0 0 0 0 0 12.7754 0 0 0 0 13.325 0 0 0 0 0 0 11.0549 0 0 0 0 0 0 0 0 0 0 13.1012 0 0 0 0 0 0 0 0 0 0 10.4465 0 0 0 12.8113 0 0 0 11.8522 12.5548 12.5118 11.692 13.6283 0 13.5901 13.3252 0 0 12.0484 13.0017 0 0 0 0 0 14.2743 0 0 0 0 0 14.9507 0 0 0 0 0 0 0 0 13.581 0 0 13.7505 12.5159 0 12.361 0 11.8186 0 0 0 0 14.0527 0 13.1899 0 15.6429 Q8IZ73 RUSD2_HUMAN "Pseudouridylate synthase RPUSD2, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 2)" RPUSD2 C15orf19 Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481] pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481] GO:0000455; GO:0003723; GO:0006397; GO:0009982; GO:1990481 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] CRPLTGR 0.99269 -25.322 0 0 0 0 0 0 0 0 0 11.1327 0 0 0 13.2321 0 0 0 0 0 0 14.0377 0 0 0 0 0 0 0 12.5131 0 0 0 0 0 0 0 0 0 0 0 10.9877 0 0 0 0 10.3566 0 0 12.3541 0 0 0 0 11.7579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7746 0 0 0 0 0 0 13.4132 13.6732 0 13.3588 0 13.7425 0 0 0 13.5293 0 0 0 0 0 0 0 0 0 0 0 16.1509 0 16.999 0 14.1062 0 14.9028 12.7846 0 0 0 0 0 13.6136 13.0809 0 12.0449 15.0521 0 0 0 0 0 0 0 14.9103 13.0424 13.035 13.4197 14.148 0 0 0 0 0 12.7714 13.7609 0 0 14.2829 12.7954 0 0 0 14.2225 11.958 0 0 0 0 0 0 0 0 12.2051 0 0 0 0 12.9968 0 0 0 0 12.7558 0 0 13.7749 0 0 0 0 0 0 12.9367 0 0 11.7513 0 13.5012 0 0 0 0 Q96AX1 VP33A_HUMAN "Vacuolar protein sorting-associated protein 33A, hVPS33A" VPS33A Homo sapiens (Human) autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773] autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005773; GO:0005776; GO:0006886; GO:0008333; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0034058; GO:0035542; GO:0035751; GO:0048070; GO:0048471; GO:0097352 AIVWDEYLTGPFGLIAQYSLLK 0.99269 -24.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.332 0 0 13.1038 0 0 0 0 0 0 0 0 0 0 0 0 10.431 11.179 0 13.0651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3185 12.2251 0 0 0 0 11.8711 0 0 0 13.5597 0 0 13.3015 0 0 0 0 0 13.034 0 13.5199 13.1583 0 0 0 0 12.845 12.4555 0 0 0 0 12.999 15.6488 13.8395 0 0 0 0 0 13.1195 13.3545 0 0 0 0 12.64 13.8927 0 13.5569 0 0 13.205 12.9054 0 0 0 0 12.961 0 0 0 13.9013 12.9424 0 0 12.9863 0 13.1673 0 0 12.9335 12.5456 10.6282 0 14.3542 13.5755 0 0 12.913 0 12.0998 0 0 0 11.8728 12.6909 0 0 0 0 0 0 0 0 0 0 0 0 12.7888 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVC3 DCC1_HUMAN Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) DSCC1 DCC1 UNQ9337/PRO34008 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275] "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; Ctf18 RFC-like complex [GO:0031390]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]" GO:0000775; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006275; GO:0031390; GO:0032508; GO:0034088; GO:0034421; GO:1900264 DNA binding [GO:0003677] GLALVDRHSRPEIIFLLK 0.99269 -4.9636 0 0 0 0 0 0 0 0 0 13.2706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6137 0 0 0 0 0 0 13.6514 0 0 0 0 0 13.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7273 14.8073 0 0 0 0 0 0 0 0 0 Q9BZY9 TRI31_HUMAN "E3 ubiquitin-protein ligase TRIM31, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TRIM31) (Tripartite motif-containing protein 31)" TRIM31 C6orf13 RNF Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; viral release from host cell [GO:0019076] GO:0003713; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0010468; GO:0016567; GO:0019076; GO:0032897; GO:0045087; GO:0046597; GO:0051091; GO:0061630 transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] EKETVQVKAQGVHR 0.99269 -14.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.169 10.2566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4057 0 0 13.1995 0 0 0 0 0 0 0 0 0 11.7784 0 0 0 0 0 12.9821 0 0 0 0 0 0 12.6858 0 0 0 0 0 0 0 0 0 14.2568 0 0 0 12.8768 14.2007 14.1073 0 0 0 0 0 13.9058 0 0 0 0 0 0 13.9185 0 0 0 12.3578 14.6149 14.1986 14.0302 0 0 0 0 14.0391 10.8225 0 0 12.9044 0 15.1197 0 0 0 12.3541 0 0 0 0 12.1736 0 12.3915 0 13.5624 13.3527 0 0 0 0 0 0 0 0 9.98499 0 0 0 0 0 13.1659 0 0 0 0 0 0 0 13.5215 0 Q9H0Y0 ATG10_HUMAN "Ubiquitin-like-conjugating enzyme ATG10, EC 2.3.2.- (Autophagy-related protein 10, APG10-like)" ATG10 APG10L PP12616 Homo sapiens (Human) autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031] cytosol [GO:0005829] cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; autophagy [GO:0006914]; ER overload response [GO:0006983]; macroautophagy [GO:0016236]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031] GO:0005829; GO:0006497; GO:0006914; GO:0006983; GO:0015031; GO:0016236; GO:0019777; GO:0031401; GO:0032446 Atg12 transferase activity [GO:0019777] DCSDGYMCK 0.99269 -6.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2753 0 0 0 10.1655 0 0 12.452 0 0 0 11.1788 12.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64387 0 0 11.8311 0 0 0 0 0 0 0 0 10.4682 0 0 10.0717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6Y7 RN167_HUMAN "E3 ubiquitin-protein ligase RNF167, EC 2.3.2.27 (RING finger protein 167)" RNF167 RING105 LP2254 Homo sapiens (Human) "cellular response to leucine starvation [GO:1990253]; lysosome localization [GO:0032418]; negative regulation of cell cycle [GO:0045786]; negative regulation of TORC1 signaling [GO:1904262]; organelle localization [GO:0051640]; protein polyubiquitination [GO:0000209]; regulation of synaptic transmission, glutamatergic [GO:0051966]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; lysosome [GO:0005764] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leucine starvation [GO:1990253]; lysosome localization [GO:0032418]; negative regulation of cell cycle [GO:0045786]; negative regulation of TORC1 signaling [GO:1904262]; organelle localization [GO:0051640]; protein polyubiquitination [GO:0000209]; regulation of synaptic transmission, glutamatergic [GO:0051966]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000209; GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0006511; GO:0008270; GO:0016021; GO:0032418; GO:0036020; GO:0045786; GO:0051640; GO:0051966; GO:0061630; GO:1904262; GO:1990253 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ALFVYEK 0.99269 -17.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9624 0 0 0 0 0 0 0 13.3818 0 0 0 12.4434 12.5582 0 0 0 0 0 0 0 0 0 11.7737 0 12.0366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5766 0 13.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9891 0 14.4867 0 0 0 0 0 0 0 0 0 13.1419 0 0 13.4921 13.1531 0 0 0 12.7913 0 0 0 13.3667 0 0 0 13.9022 0 0 0 0 10.2681 0 0 13.5762 0 0 0 0 12.9321 0 0 0 0 0 13.996 0 12.3675 0 0 0 0 0 0 14.168 0 0 0 12.9253 0 0 0 0 0 0 0 0 0 13.909 Q9NSI6 BRWD1_HUMAN Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007010; GO:0008360 AESISEEADSEPGR 0.99269 -59.976 0 0 0 0 0 0 0 0 0 13.2432 0 12.6065 0 0 0 0 0 0 11.3017 0 0 9.91862 0 0 0 0 0 0 0 0 10.9105 0 11.2815 0 0 0 0 15.1936 14.727 15.5922 15.3396 0 14.8569 0 14.7084 0 14.7603 14.7686 0 0 0 0 10.8702 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5167 0 15.9463 0 0 0 0 0 10.9204 11.6921 15.1203 12.619 0 14.0122 13.274 0 14.4826 0 13.1452 0 14.8191 0 16.0792 0 0 11.4213 0 0 0 0 0 18.763 0 0 0 0 0 0 0 0 10.8842 0 0 0 0 12.6996 0 11.1381 0 13.1572 13.2019 0 0 13.5035 0 0 12.4869 0 0 0 0 12.5636 0 0 0 11.9772 0 0 12.8617 0 0 9.93924 14.8692 11.0142 11.6841 11.0839 0 0 0 0 0 0 0 13.4206 0 12.787 0 0 13.9362 0 0 0 0 0 0 11.4639 0 12.5454 0 10.1004 11.842 13.1731 11.0226 14.149 0 0 0 0 12.8189 0 0 11.0525 11.4871 12.9288 Q9P2E9 RRBP1_HUMAN "Ribosome-binding protein 1 (180 kDa ribosome receptor homolog, RRp) (ES/130-related protein) (Ribosome receptor protein)" RRBP1 KIAA1398 Homo sapiens (Human) osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; translation [GO:0006412] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ribosome [GO:0005840] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ribosome [GO:0005840]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; translation [GO:0006412] GO:0001649; GO:0003723; GO:0005783; GO:0005840; GO:0006412; GO:0015031; GO:0016020; GO:0030176; GO:0038023 RNA binding [GO:0003723]; signaling receptor activity [GO:0038023] AAILETAPK 0.99269 -17.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6831 0 0 13.4719 0 0 12.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1085 0 0 0 14.509 0 13.3202 10.8086 0 0 0 0 0 11.741 11.8488 0 13.1351 0 14.0451 0 11.2233 0 0 0 0 0 0 0 14.6084 0 0 0 0 0 0 0 0 0 0 0 0 0 10.543 0 0 11.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0779 0 0 0 0 0 0 0 0 0 0 0 13.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9162 0 0 12.9225 0 0 0 0 0 0 0 Q9UK13 ZN221_HUMAN Zinc finger protein 221 ZNF221 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKGFYTNSRR 0.99269 -25.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3217 0 11.7373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9943 0 0 0 0 0 0 0 0 0 0 11.9256 0 0 0 0 0 0 0 0 O60307 MAST3_HUMAN "Microtubule-associated serine/threonine-protein kinase 3, EC 2.7.11.1" MAST3 KIAA0561 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] GO:0000287; GO:0004674; GO:0005524; GO:0007010; GO:0018105; GO:0035556; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALVGQSR 0.9927 -14.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0811 13.4234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.971 13.2812 16.7758 0 0 0 0 15.1445 0 13.6994 0 0 0 15.123 0 0 0 0 12.6872 0 0 0 0 0 0 0 0 0 15.5532 0 0 13.9093 0 0 0 0 14.9072 0 0 0 15.1704 0 14.7827 0 0 0 0 0 0 0 17.9678 0 0 0 0 0 16.5279 0 12.4166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0947 0 11.8854 0 0 0 0 0 O14746 TERT_HUMAN "Telomerase reverse transcriptase, EC 2.7.7.49 (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2, TP2)" TERT EST2 TCS1 TRT Homo sapiens (Human) "cellular response to hypoxia [GO:0071456]; DNA biosynthetic process [GO:0071897]; DNA strand elongation [GO:0022616]; double-stranded RNA biosynthetic process [GO:0062103]; establishment of protein localization to telomere [GO:0070200]; mitochondrion organization [GO:0007005]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of siRNA production [GO:1903704]; positive regulation of angiogenesis [GO:0045766]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glucose import [GO:0046326]; positive regulation of hair cycle [GO:0042635]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transdifferentiation [GO:1903620]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of protein stability [GO:0031647]; replicative senescence [GO:0090399]; response to cadmium ion [GO:0046686]; RNA-templated DNA biosynthetic process [GO:0006278]; siRNA processing [GO:0030422]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; transcription, RNA-templated [GO:0001172]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nuclear speck [GO:0016607]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; RNA-directed RNA polymerase complex [GO:0031379]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]; TERT-RMRP complex [GO:1990572]" "chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; nuclear speck [GO:0016607]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; RNA-directed RNA polymerase complex [GO:0031379]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]; TERT-RMRP complex [GO:1990572]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; RNA-directed DNA polymerase activity [GO:0003964]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomerase RNA reverse transcriptase activity [GO:0003721]; telomeric DNA binding [GO:0042162]; template-free RNA nucleotidyltransferase [GO:0098680]; transcription coactivator binding [GO:0001223]; tRNA binding [GO:0000049]; cellular response to hypoxia [GO:0071456]; DNA biosynthetic process [GO:0071897]; DNA strand elongation [GO:0022616]; double-stranded RNA biosynthetic process [GO:0062103]; establishment of protein localization to telomere [GO:0070200]; mitochondrion organization [GO:0007005]; negative regulation of cellular senescence [GO:2000773]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of siRNA production [GO:1903704]; positive regulation of angiogenesis [GO:0045766]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glucose import [GO:0046326]; positive regulation of hair cycle [GO:0042635]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transdifferentiation [GO:1903620]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of protein stability [GO:0031647]; replicative senescence [GO:0090399]; response to cadmium ion [GO:0046686]; RNA-templated DNA biosynthetic process [GO:0006278]; siRNA processing [GO:0030422]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; transcription, RNA-templated [GO:0001172]" GO:0000049; GO:0000333; GO:0000723; GO:0000781; GO:0000783; GO:0001172; GO:0001223; GO:0003677; GO:0003720; GO:0003721; GO:0003723; GO:0003964; GO:0003968; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005829; GO:0005886; GO:0006278; GO:0007004; GO:0007005; GO:0008022; GO:0010629; GO:0016605; GO:0016607; GO:0022616; GO:0030177; GO:0030422; GO:0031379; GO:0031647; GO:0032092; GO:0042162; GO:0042635; GO:0042645; GO:0042802; GO:0042803; GO:0043524; GO:0045766; GO:0046326; GO:0046686; GO:0046872; GO:0047485; GO:0051000; GO:0051087; GO:0062103; GO:0070034; GO:0070200; GO:0071456; GO:0071897; GO:0090399; GO:0098680; GO:1900087; GO:1902895; GO:1903620; GO:1903704; GO:1903799; GO:1904707; GO:1904751; GO:1904754; GO:1990572; GO:2000352; GO:2000648; GO:2000773; GO:2001240 chaperone binding [GO:0051087]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; RNA-directed DNA polymerase activity [GO:0003964]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomerase RNA reverse transcriptase activity [GO:0003721]; telomeric DNA binding [GO:0042162]; template-free RNA nucleotidyltransferase [GO:0098680]; transcription coactivator binding [GO:0001223]; tRNA binding [GO:0000049] AAVTPAAGVCAR 0.9927 -63.736 0 0 10.2939 0 0 0 0 0 0 14.6375 13.7451 14.4552 0 13.6839 14.0389 13.6606 0 0 0 0 0 13.6327 0 0 0 0 0 0 0 0 0 0 13.5941 13.8452 0 13.4427 0 0 0 0 0 0 0 0 0 0 11.9253 0 0 0 0 12.6433 13.4809 0 12.8976 13.2542 14.5361 0 0 0 0 0 0 0 0 0 0 10.112 0 0 0 0 0 0 13.1346 0 0 0 13.3708 13.5727 13.6964 13.208 13.9974 12.3902 17.1124 16.9895 16.6952 15.1442 0 14.6555 15.2314 14.5512 0 0 14.4651 15.5919 0 13.5216 15.0192 14.4866 15 0 13.3817 0 0 0 13.4767 13.2183 15.4079 13.1949 0 0 0 14.7913 0 14.6126 0 0 0 0 0 14.3032 0 0 0 11.4991 14.57 14.0235 0 0 0 0 12.7593 0 12.4857 17.4112 17.1231 0 16.1599 0 17.8334 12.3325 14.8269 13.1725 14.2329 13.3211 13.8341 14.6435 0 13.6374 12.337 0 0 0 0 0 12.0371 0 0 0 0 0 0 0 12.5304 0 13.9319 11.8708 13.4077 0 0 0 13.7909 0 0 0 0 0 16.6579 12.4717 O60422 ONEC3_HUMAN "One cut domain family member 3 (One cut homeobox 3) (Transcription factor ONECUT-3, OC-3)" ONECUT3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ETFRRMWK 0.9927 -14.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6958 0 0 0 9.65862 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6983 0 0 11.8077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1133 15.3824 0 0 0 14.4661 0 0 0 0 0 0 0 0 14.8513 0 0 0 0 0 0 13.8738 0 0 12.9018 0 0 0 0 0 13.319 0 0 0 13.6844 0 0 0 0 13.0452 0 0 0 11.8893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4145 0 0 0 0 0 0 0 0 0 13.2582 0 12.8036 0 0 0 0 0 14.3138 0 0 11.735 0 0 0 0 0 0 0 0 0 0 12.9633 0 0 0 12.8092 0 O75159 SOCS5_HUMAN "Suppressor of cytokine signaling 5, SOCS-5 (Cytokine-inducible SH2 protein 6, CIS-6) (Cytokine-inducible SH2-containing protein 5)" SOCS5 CIS6 CISH5 CISH6 KIAA0671 Homo sapiens (Human) cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of signal transduction [GO:0009968]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; vascular endothelial cell response to fluid shear stress [GO:0097699] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942] cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; epidermal growth factor receptor binding [GO:0005154]; receptor tyrosine kinase binding [GO:0030971]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of signal transduction [GO:0009968]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; vascular endothelial cell response to fluid shear stress [GO:0097699] GO:0005154; GO:0005829; GO:0005942; GO:0007173; GO:0007175; GO:0007259; GO:0009968; GO:0016567; GO:0019221; GO:0030971; GO:0032436; GO:0032715; GO:0035556; GO:0040008; GO:0045627; GO:0045629; GO:0046854; GO:0046935; GO:0050728; GO:0071404; GO:0071638; GO:0097699 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; epidermal growth factor receptor binding [GO:0005154]; receptor tyrosine kinase binding [GO:0030971] DSAQEDYLFSVSFRR 0.9927 -6.3408 0 0 0 0 0 0 0 0 11.1559 0 0 0 0 0 0 0 0 0 0 12.7768 11.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8845 0 0 0 0 0 0 0 0 0 0 0 15.026 0 0 0 0 14.0495 0 0 0 0 0 0 0 13.3626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2584 0 0 12.7773 0 12.1253 0 0 0 0 0 13.9497 0 0 0 0 0 0 0 0 14.6323 0 0 0 0 0 0 0 12.7256 13.8318 0 0 0 0 0 0 0 11.9291 0 0 17.1715 0 0 0 O94769 ECM2_HUMAN Extracellular matrix protein 2 (Matrix glycoprotein SC1/ECM2) ECM2 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; collagen V binding [GO:0070052]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005178; GO:0005576; GO:0005614; GO:0007160; GO:0008201; GO:0010811; GO:0030198; GO:0031012; GO:0070052 collagen V binding [GO:0070052]; heparin binding [GO:0008201]; integrin binding [GO:0005178] ALHFLRLNNNK 0.9927 -14.589 0 0 0 0 12.8163 0 0 0 0 0 0 0 0 0 11.9326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4649 0 0 0 0 0 0 0 0 10.3446 12.4834 15.2018 0 0 0 0 0 11.7747 0 9.76861 0 0 0 0 0 0 11.2282 13.7515 0 9.88816 0 0 0 0 0 11.3145 0 15.8382 0 0 0 0 0 0 0 11.8756 0 0 0 14.7368 0 0 0 13.7757 0 0 0 0 0 0 0 0 0 15.265 0 0 10.691 13.1076 13.4357 0 0 0 0 0 0 0 0 0 13.9894 0 12.5175 13.6802 0 10.5361 0 0 0 0 11.6527 0 0 0 0 0 0 15.9953 0 0 0 0 0 13.9034 0 0 12.5968 0 0 0 0 14.2403 0 0 0 0 P04637 P53_HUMAN Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53) TP53 P53 Homo sapiens (Human) "autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac muscle cell apoptotic process [GO:0010659]; cardiac septum morphogenesis [GO:0060411]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; cellular response to xenobiotic stimulus [GO:0071466]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; circadian behavior [GO:0048512]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; fibroblast proliferation [GO:0048144]; gastrulation [GO:0007369]; glial cell proliferation [GO:0014009]; glucose catabolic process to lactate via pyruvate [GO:0019661]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial DNA repair [GO:0043504]; mitophagy [GO:0000423]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1 to G0 transition [GO:1903451]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of helicase activity [GO:0051097]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cellular senescence [GO:2000774]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; Ras protein signal transduction [GO:0007265]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to antibiotic [GO:0046677]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to salt stress [GO:0009651]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; thymocyte apoptotic process [GO:0070242]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]" centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; germ cell nucleus [GO:0043073]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; germ cell nucleus [GO:0043073]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac muscle cell apoptotic process [GO:0010659]; cardiac septum morphogenesis [GO:0060411]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; cellular response to xenobiotic stimulus [GO:0071466]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; circadian behavior [GO:0048512]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; fibroblast proliferation [GO:0048144]; gastrulation [GO:0007369]; glial cell proliferation [GO:0014009]; glucose catabolic process to lactate via pyruvate [GO:0019661]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial DNA repair [GO:0043504]; mitophagy [GO:0000423]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1 to G0 transition [GO:1903451]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of helicase activity [GO:0051097]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cellular senescence [GO:2000774]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; Ras protein signal transduction [GO:0007265]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; regulation of transcription, DNA-templated [GO:0006355]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to antibiotic [GO:0046677]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to salt stress [GO:0009651]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; thymocyte apoptotic process [GO:0070242]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]" GO:0000122; GO:0000423; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001046; GO:0001094; GO:0001227; GO:0001228; GO:0001701; GO:0001756; GO:0001836; GO:0002020; GO:0002039; GO:0002244; GO:0002309; GO:0002326; GO:0002360; GO:0002931; GO:0003677; GO:0003682; GO:0003700; GO:0003730; GO:0005507; GO:0005634; GO:0005654; GO:0005657; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0006357; GO:0006606; GO:0006914; GO:0006974; GO:0006977; GO:0006978; GO:0006983; GO:0007179; GO:0007265; GO:0007369; GO:0007405; GO:0007406; GO:0008104; GO:0008156; GO:0008270; GO:0008285; GO:0008340; GO:0009299; GO:0009303; GO:0009651; GO:0010165; GO:0010332; GO:0010628; GO:0010659; GO:0010666; GO:0014009; GO:0016032; GO:0016363; GO:0016605; GO:0017053; GO:0019661; GO:0019899; GO:0019901; GO:0019903; GO:0021549; GO:0030308; GO:0030330; GO:0030512; GO:0030971; GO:0031065; GO:0031497; GO:0031571; GO:0031625; GO:0032991; GO:0033077; GO:0033209; GO:0034103; GO:0034644; GO:0035033; GO:0035035; GO:0035264; GO:0035794; GO:0035861; GO:0036003; GO:0036310; GO:0042149; GO:0042771; GO:0042802; GO:0042826; GO:0042981; GO:0043065; GO:0043066; GO:0043073; GO:0043153; GO:0043504; GO:0043516; GO:0043525; GO:0043621; GO:0045861; GO:0045892; GO:0045893; GO:0045899; GO:0045944; GO:0046677; GO:0046982; GO:0047485; GO:0048144; GO:0048147; GO:0048512; GO:0048539; GO:0048568; GO:0050731; GO:0050821; GO:0051087; GO:0051097; GO:0051262; GO:0051402; GO:0051721; GO:0051726; GO:0051974; GO:0060218; GO:0060253; GO:0060333; GO:0060411; GO:0061419; GO:0061629; GO:0062100; GO:0065003; GO:0070059; GO:0070242; GO:0070245; GO:0070266; GO:0071456; GO:0071466; GO:0071479; GO:0071480; GO:0071494; GO:0072089; GO:0072331; GO:0072332; GO:0072593; GO:0072717; GO:0090200; GO:0090398; GO:0090399; GO:0090403; GO:0097193; GO:0097252; GO:0097371; GO:0097718; GO:0140296; GO:1900119; GO:1901525; GO:1902108; GO:1902253; GO:1902749; GO:1902895; GO:1903451; GO:1903799; GO:1903800; GO:1904024; GO:1905856; GO:1990144; GO:1990248; GO:1990440; GO:1990841; GO:2000269; GO:2000378; GO:2000379; GO:2000647; GO:2000774; GO:2001244 "ATP-dependent DNA/DNA annealing activity [GO:0036310]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]" ALPNNTSSSPQPKKK 0.9927 -15.986 0 0 0 0 0 0 0 0 0 0 12.2056 0 0 0 0 0 0 0 0 0 0 10.3124 0 0 0 0 0 0 0 0 0 0 0 0 11.601 10.4889 0 0 0 0 0 11.0454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0884 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9885 12.8756 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1652 12.4625 0 0 0 0 0 0 0 0 0 13.7305 13.5742 12.6064 0 0 0 0 0 12.3767 0 0 12.0654 11.6609 0 0 13.5147 0 0 0 0 0 0 0 11.9703 0 0 13.6095 0 11.4768 11.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6528 0 0 0 0 0 12.4369 0 0 0 0 10.9412 0 0 0 0 0 0 11.7306 0 0 0 0 0 0 0 10.3154 0 12.1972 0 0 0 P04798 CP1A1_HUMAN "Cytochrome P450 1A1, CYPIA1, EC 1.14.14.1 (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)" CYP1A1 Homo sapiens (Human) 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; DNA methylation [GO:0006306]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743] "endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; DNA methylation [GO:0006306]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805]" GO:0001666; GO:0001676; GO:0002933; GO:0004497; GO:0005506; GO:0005743; GO:0005789; GO:0006306; GO:0006631; GO:0006694; GO:0006778; GO:0006805; GO:0007568; GO:0008202; GO:0008210; GO:0008283; GO:0008391; GO:0009308; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009692; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0017143; GO:0019341; GO:0019373; GO:0019825; GO:0019899; GO:0020037; GO:0030544; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042359; GO:0042572; GO:0042759; GO:0042904; GO:0043010; GO:0043231; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0051879; GO:0055093; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071280; GO:0071407; GO:0097267; GO:0101020; GO:0101021; GO:0102033; GO:0106256; GO:0120319; GO:1900087 "arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]" GFYIPKGR 0.9927 -6.3384 0 0 0 0 0 0 0 0 0 0 0 11.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7547 0 0 0 0 11.8528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.819 0 0 12.5296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5203 0 0 13.9476 14.5906 0 0 0 0 0 0 19.1174 0 0 0 0 0 0 0 0 0 0 0 13.9982 0 0 0 0 0 15.0685 0 0 0 0 0 0 19.0743 0 14.5591 0 0 0 0 0 0 14.5554 0 0 0 14.9541 0 0 12.78 0 0 0 0 14.2593 0 0 0 0 0 0 0 0 0 13.3951 0 0 0 13.5106 14.3043 14.5145 0 14.286 13.7881 0 14.1476 14.3284 13.3772 0 0 0 0 0 12.0453 0 0 0 P08172 ACM2_HUMAN Muscarinic acetylcholine receptor M2 CHRM2 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to virus [GO:0009615]" anchoring junction [GO:0070161]; asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; cholinergic synapse [GO:0098981]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synapse [GO:0045202] "anchoring junction [GO:0070161]; asymmetric synapse [GO:0032279]; axon terminus [GO:0043679]; cholinergic synapse [GO:0098981]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synapse [GO:0045202]; arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; chemical synaptic transmission [GO:0007268]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; regulation of heart contraction [GO:0008016]; regulation of smooth muscle contraction [GO:0006940]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to virus [GO:0009615]" GO:0004993; GO:0005886; GO:0005887; GO:0006940; GO:0007186; GO:0007187; GO:0007188; GO:0007197; GO:0007207; GO:0007213; GO:0007268; GO:0007399; GO:0008016; GO:0009615; GO:0016021; GO:0016907; GO:0030425; GO:0030594; GO:0030669; GO:0032279; GO:0032280; GO:0043025; GO:0043679; GO:0045202; GO:0070161; GO:0098978; GO:0098981; GO:0099055; GO:0099056; GO:1990763; GO:2000300 arrestin family protein binding [GO:1990763]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594] KPPPSREK 0.9927 -15.984 0 0 0 0 0 0 0 14.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0424 0 0 0 0 0 0 12.5661 0 14.537 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8739 12.2852 0 0 0 0 0 14.0776 13.6656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.813 11.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20783 NTF3_HUMAN "Neurotrophin-3, NT-3 (HDNF) (Nerve growth factor 2, NGF-2) (Neurotrophic factor)" NTF3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cell-cell signaling [GO:0007267]; induction of positive chemotaxis [GO:0050930]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor internalization [GO:0002092]; regulation of apoptotic process [GO:0042981]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021] axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102]; activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cell-cell signaling [GO:0007267]; induction of positive chemotaxis [GO:0050930]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor internalization [GO:0002092]; regulation of apoptotic process [GO:0042981]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0002092; GO:0005102; GO:0005163; GO:0005576; GO:0005615; GO:0007165; GO:0007169; GO:0007267; GO:0007399; GO:0007422; GO:0007613; GO:0008021; GO:0008083; GO:0008284; GO:0021675; GO:0030335; GO:0030424; GO:0030425; GO:0032148; GO:0033138; GO:0038180; GO:0042056; GO:0042981; GO:0043406; GO:0043524; GO:0045664; GO:0048812; GO:0050731; GO:0050732; GO:0050804; GO:0050930; GO:0090630; GO:2000251 chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102] HWNSQCK 0.9927 -16.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2992 0 0 0 0 0 0 0 15.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.423 0 0 0 0 0 0 0 0 0 0 0 11.8402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51790 CLCN3_HUMAN "H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3, ClC-3) (Chloride transporter ClC-3)" CLCN3 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; endosomal lumen acidification [GO:0048388]; negative regulation of cell volume [GO:0045794]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of pH [GO:0006885]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]" apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506] "apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; PDZ domain binding [GO:0030165]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320]; adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; endosomal lumen acidification [GO:0048388]; negative regulation of cell volume [GO:0045794]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of pH [GO:0006885]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]" GO:0000139; GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006885; GO:0006911; GO:0008021; GO:0008344; GO:0009897; GO:0009986; GO:0010008; GO:0012506; GO:0015297; GO:0015299; GO:0016020; GO:0016021; GO:0016324; GO:0030141; GO:0030165; GO:0030285; GO:0031410; GO:0031901; GO:0031902; GO:0032587; GO:0035249; GO:0042581; GO:0043231; GO:0043679; GO:0045335; GO:0045494; GO:0045794; GO:0048388; GO:0051932; GO:0055037; GO:0060077; GO:0072320; GO:0097401; GO:0098978; GO:0098982; GO:0099055; GO:1902476; GO:1903428 antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; PDZ domain binding [GO:0030165]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320] ESEQLFHR 0.9927 -14.925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0093 0 0 0 0 0 0 0 0 0 0 12.9039 0 0 0 0 0 15.2437 0 15.0337 0 0 0 0 0 12.9483 13.0285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0785 0 13.4378 13.852 12.9799 0 0 0 13.7151 0 0 0 14.6335 0 0 0 0 Q14764 MVP_HUMAN "Major vault protein, MVP (Lung resistance-related protein)" MVP LRP Homo sapiens (Human) ERBB signaling pathway [GO:0038127]; mRNA transport [GO:0051028]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein tyrosine kinase activity [GO:0061099]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; ERBB signaling pathway [GO:0038127]; mRNA transport [GO:0051028]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein tyrosine kinase activity [GO:0061099]; protein transport [GO:0015031] GO:0005576; GO:0005634; GO:0005643; GO:0005737; GO:0005829; GO:0005856; GO:0015031; GO:0016020; GO:0019901; GO:0019903; GO:0031953; GO:0034774; GO:0038127; GO:0042059; GO:0042802; GO:0048471; GO:0051028; GO:0061099; GO:0070062; GO:1904813 identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903] DPQETAK 0.9927 -40.104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7848 0 0 0 0 0 0 14.3264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3337 0 0 0 0 0 0 0 0 0 0 0 0 14.6237 0 0 0 Q5VUG0 SMBT2_HUMAN "Scm-like with four MBT domains protein 2, Scm-like with 4 MBT domains protein 2" SFMBT2 KIAA1617 Homo sapiens (Human) "negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]" aggresome [GO:0016235]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "aggresome [GO:0016235]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0010629; GO:0016235; GO:0016604; GO:0016607; GO:0042393; GO:0043231; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714] KSIFVQKK 0.9927 -25.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.452 12.671 13.0649 12.4859 11.5554 0 0 13.5135 12.8755 0 0 14.3881 12.8036 13.5493 14.1562 0 14.3604 13.6148 13.6888 16.2761 14.4674 14.6761 0 13.7513 0 13.3042 0 0 0 14.3355 14.5456 12.9085 13.4462 0 13.9033 13.2029 0 0 14.0761 14.607 0 0 0 0 0 13.7585 12.3545 13.4719 13.6806 13.1559 13.247 0 0 0 0 12.776 14.4233 0 0 0 12.9036 0 0 13.7265 0 0 0 0 14.4149 12.1734 0 0 0 0 0 12.1412 16.1652 14.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VYP0 S31A3_HUMAN Spermatogenesis-associated protein 31A3 (Protein FAM75A3) SPATA31A3 FAM75A3 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 AGETREAVPQCR 0.9927 -14.915 0 0 11.8298 0 0 0 0 0 13.6531 12.1693 0 0 12.5822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.107 0 0 0 0 12.8162 0 0 10.6792 0 0 0 0 0 0 0 0 0 0 12.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9632 15.0588 11.8935 0 0 0 0 0 0 11.859 0 13.4338 0 0 0 0 13.7371 0 0 0 0 0 0 0 0 0 15.6073 15.144 0 0 0 0 0 11.5681 13.2371 11.525 0 12.3343 0 11.3316 0 0 0 12.9556 0 0 0 12.8345 0 0 0 0 0 0 0 0 11.254 0 0 0 15.1978 0 14.4248 0 0 0 14.8742 14.418 13.6966 13.6214 14.2551 0 0 0 13.2681 0 0 0 13.0081 0 0 0 0 0 14.1961 0 0 0 0 0 14.6374 0 0 13.2453 0 13.0685 0 0 0 0 0 14.2503 14.5386 15.2029 Q6GTX8 LAIR1_HUMAN "Leukocyte-associated immunoglobulin-like receptor 1, LAIR-1, hLAIR1 (CD antigen CD305)" LAIR1 CD305 Homo sapiens (Human) adaptive immune response [GO:0002250] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; adaptive immune response [GO:0002250] GO:0002250; GO:0005886; GO:0016021; GO:0035579; GO:0070821 AVSPQSTK 0.9927 -6.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87294 0 0 0 0 11.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69803 12.2521 0 0 0 0 0 0 9.76368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9562 0 0 0 0 0 0 0 0 0 0 Q6PCB7 S27A1_HUMAN "Long-chain fatty acid transport protein 1 (Arachidonate--CoA ligase, EC 6.2.1.15) (Fatty acid transport protein 1, FATP-1) (Long-chain-fatty-acid--CoA ligase, EC 6.2.1.3) (Solute carrier family 27 member 1) (Very long-chain acyl-CoA synthetase, EC 6.2.1.-)" SLC27A1 ACSVL5 FATP1 Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]; transport across blood-brain barrier [GO:0150104] basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; response to insulin [GO:0032868]; transport across blood-brain barrier [GO:0150104] GO:0000166; GO:0001579; GO:0004467; GO:0005324; GO:0005783; GO:0005886; GO:0005887; GO:0006646; GO:0006654; GO:0006655; GO:0006656; GO:0006659; GO:0006661; GO:0009409; GO:0009925; GO:0010867; GO:0015225; GO:0015245; GO:0015562; GO:0015878; GO:0015909; GO:0015911; GO:0016020; GO:0031652; GO:0031957; GO:0032049; GO:0032868; GO:0033211; GO:0042802; GO:0044381; GO:0044539; GO:0047676; GO:0071072; GO:0071902; GO:0090434; GO:0140115; GO:0150104; GO:1901480; GO:1905135; GO:1990379 arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; very long-chain fatty acid-CoA ligase activity [GO:0031957] EAERRHR 0.9927 -15.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1491 0 0 0 0 0 10.5388 0 0 0 0 0 0 0 0 0 0 10.5338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.50532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9658 0 0 0 0 10.8814 0 0 12.8873 0 12.7936 0 0 0 0 13.2067 0 0 0 0 0 0 0 0 14.5735 0 0 0 13.4851 11.7412 0 0 12.6345 15.6627 12.5191 12.1949 0 0 12.6887 0 0 0 0 0 12.5236 0 0 12.6751 12.7063 0 0 13.4653 0 13.0516 0 0 Q6ZWL3 CP4V2_HUMAN "Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2, EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase, EC 1.14.14.80)" CYP4V2 Homo sapiens (Human) fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; fatty acid omega-oxidation [GO:0010430]; response to stimulus [GO:0050896]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601] GO:0001523; GO:0004497; GO:0005506; GO:0005789; GO:0007601; GO:0010430; GO:0016021; GO:0016125; GO:0020037; GO:0050896; GO:0102033 heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497] ANEMNANEDCRGDGR 0.9927 -14.929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7023 11.0312 11.9583 0 0 11.0496 0 0 0 0 0 0 10.7047 0 0 0 0 0 0 0 0 11.5149 11.1457 0 0 0 0 0 11.2609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5314 0 0 0 0 0 0 0 10.1107 13.2304 0 0 0 14.7801 0 0 0 0 0 14.5136 0 0 0 0 0 14.5419 0 11.4759 0 0 0 0 0 0 0 12.7778 0 12.93 0 0 0 0 0 0 0 13.164 0 0 0 0 0 0 13.2689 0 13.9108 0 0 0 0 11.8746 0 0 0 13.3828 0 0 0 0 0 10.8701 0 0 0 0 0 0 0 13.1479 Q7L590 MCM10_HUMAN "Protein MCM10 homolog, HsMCM10" MCM10 PRO2249 Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270] GO:0003688; GO:0003697; GO:0005634; GO:0005654; GO:0005730; GO:0006270; GO:0006974; GO:0008283; GO:0019899; GO:0031298; GO:0042802; GO:0046872 DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697] ALQEQLKVTTIK 0.9927 -14.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3457 0 0 0 0 0 0 0 0 0 0 14.4611 0 0 0 0 0 0 0 13.9669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.52576 0 0 0 0 0 0 0 0 0 0 0 13.5575 0 0 10.4357 13.9024 14.0264 0 11.457 0 0 11.5249 0 13.1715 0 0 0 0 0 0 0 0 0 0 11.6227 0 0 12.6844 0 0 0 0 13.0556 13.2903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4239 0 0 12.1352 0 0 12.2856 0 0 0 0 14.437 0 0 0 0 0 0 12.1928 12.2366 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7B1 HORM2_HUMAN HORMA domain-containing protein 2 HORMAD2 Homo sapiens (Human) meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177] centrosome [GO:0005813]; chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] centrosome [GO:0005813]; chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177] GO:0000795; GO:0005634; GO:0005654; GO:0005694; GO:0005813; GO:0005829; GO:0051177; GO:0051321 ILREDKK 0.9927 -17.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2515 0 0 0 12.2277 Q8TD17 ZN398_HUMAN Zinc finger protein 398 (Zinc finger DNA-binding protein p52/p71) ZNF398 KIAA1339 ZER6 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0006357; GO:0045893; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" HQMIHTGERPYPCTDCSKSFMR 0.9927 -4.98 0 0 0 0 0 0 0 0 12.0812 0 0 0 0 13.1305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.63 0 0 0 0 14.6375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8911 0 0 0 12.649 0 0 0 0 0 0 0 0 0 Q92616 GCN1_HUMAN "eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1, HsGCN1)" GCN1 GCN1L1 KIAA0219 Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; polysome [GO:0005844]; ribosome [GO:0005840]; cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417]" GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0005844; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0019901; GO:0033674; GO:0034198; GO:0036003; GO:0043022; GO:0045296; GO:1990253 "cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]" AADALGKLISIHIK 0.9927 -44.544 10.0959 11.0682 0 0 0 0 0 0 0 0 0 0 13.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7741 12.2295 0 0 0 12.1942 0 12.7269 14.3904 0 0 15.3207 12.7572 14.0166 11.5812 0 0 0 0 0 12.8285 0 0 14.2538 0 12.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.484 15.5845 14.3071 14.8198 0 0 11.8614 13.0631 14.436 12.8347 0 0 0 0 12.8372 11.3079 13.7549 12.6785 14.7783 0 12.245 14.4447 0 14.5569 14.4569 14.5035 14.2697 11.9057 12.7144 15.5898 0 0 0 13.2201 13.3828 14.2484 0 0 0 14.0481 13.6221 15.682 13.3266 13.0679 11.081 15.5205 14.476 0 14.2195 14.1409 0 14.8134 12.8385 10.763 14.8153 14.0933 0 0 13.2738 15.7544 0 0 0 13.3093 0 0 0 11.2261 10.9177 15.2481 15.709 12.44 0 0 0 0 13.9849 0 14.3927 13.945 14.2492 0 13.531 13.3819 13.7479 0 0 13.5622 12.5762 0 0 0 0 0 0 0 0 0 11.8775 11.5274 0 0 0 0 0 0 0 0 13.9158 16.4954 10.9131 0 0 11.1348 Q92765 SFRP3_HUMAN "Secreted frizzled-related protein 3, sFRP-3 (Frezzled) (Fritz) (Frizzled-related protein 1) (FrzB-1)" FRZB FIZ FRE FRP FRZB1 SFRP3 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; epithelial cell development [GO:0002064]; hepatocyte differentiation [GO:0070365]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; epithelial cell development [GO:0002064]; hepatocyte differentiation [GO:0070365]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053] GO:0001501; GO:0002064; GO:0005615; GO:0005737; GO:0008285; GO:0010721; GO:0014033; GO:0016020; GO:0017147; GO:0030178; GO:0030308; GO:0043065; GO:0045600; GO:0060029; GO:0060070; GO:0061037; GO:0061053; GO:0070365; GO:0070367; GO:0090090; GO:0090103 Wnt-protein binding [GO:0017147] LLLVEGSIAEKWK 0.9927 -17.626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6421 0 0 0 0 0 0 15.1396 15.5274 14.797 0 0 0 0 0 0 0 0 0 0 0 0 0 14.249 0 0 15.1764 0 0 0 0 0 0 0 0 0 0 0 13.3658 0 0 0 0 0 0 0 0 0 0 13.5927 13.3673 13.5335 0 0 13.6951 0 0 0 0 0 0 13.435 0 0 14.5594 13.9735 0 0 0 0 0 0 13.5488 0 0 0 13.6146 0 0 0 0 0 0 0 0 0 13.2321 0 15.1121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2054 13.3375 0 13.0181 0 0 0 0 0 Q96B01 R51A1_HUMAN "RAD51-associated protein 1, HsRAD51AP1 (RAD51-interacting protein)" RAD51AP1 PIR51 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of double-strand break repair via homologous recombination [GO:0010569] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; D-loop DNA binding [GO:0062037]; DNA binding [GO:0003677]; DNA secondary structure binding [GO:0000217]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of double-strand break repair via homologous recombination [GO:0010569]" GO:0000217; GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006974; GO:0010569; GO:0010845; GO:0032991; GO:0036297; GO:0051321; GO:0062037; GO:0071479; GO:1905168 D-loop DNA binding [GO:0062037]; DNA binding [GO:0003677]; DNA secondary structure binding [GO:0000217]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] AASKAAAQQR 0.9927 -16.751 0 0 0 0 0 0 0 0 0 0 14.2761 0 0 0 15.7301 0 0 0 0 0 0 10.4319 0 0 0 0 0 16.2139 0 0 0 0 0 0 0 0 0 0 15.043 15.0616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0201 0 0 0 12.8667 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9294 14.4318 14.6782 0 0 0 0 0 0 0 0 0 13.6123 0 0 0 0 0 0 0 0 0 0 0 12.8151 0 0 13.9439 0 0 0 0 0 15.6685 0 0 0 0 12.8202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.203 0 0 0 0 0 0 0 0 Q96RD7 PANX1_HUMAN Pannexin-1 PANX1 MRS1 UNQ2529/PRO6028 Homo sapiens (Human) calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cell-cell signaling [GO:0007267]; oogenesis [GO:0048477]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage cytokine production [GO:0060907]; response to ATP [GO:0033198]; response to ischemia [GO:0002931] bleb [GO:0032059]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] bleb [GO:0032059]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; leak channel activity [GO:0022840]; protease binding [GO:0002020]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]; wide pore channel activity [GO:0022829]; calcium ion transport [GO:0006816]; cation transport [GO:0006812]; cell-cell signaling [GO:0007267]; oogenesis [GO:0048477]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage cytokine production [GO:0060907]; response to ATP [GO:0033198]; response to ischemia [GO:0002931] GO:0002020; GO:0002931; GO:0005102; GO:0005198; GO:0005243; GO:0005262; GO:0005783; GO:0005789; GO:0005886; GO:0005921; GO:0006812; GO:0006816; GO:0007267; GO:0016020; GO:0016021; GO:0022829; GO:0022840; GO:0032059; GO:0032730; GO:0032731; GO:0032991; GO:0033198; GO:0042802; GO:0044325; GO:0048477; GO:0051015; GO:0060907; GO:0097110 actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; leak channel activity [GO:0022840]; protease binding [GO:0002020]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]; wide pore channel activity [GO:0022829] FFPYILLLFAILLYLPPLFWR 0.9927 -4.9808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1471 13.4522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8994 0 0 0 0 0 0 Q99742 NPAS1_HUMAN "Neuronal PAS domain-containing protein 1, Neuronal PAS1 (Basic-helix-loop-helix-PAS protein MOP5) (Class E basic helix-loop-helix protein 11, bHLHe11) (Member of PAS protein 5) (PAS domain-containing protein 5)" NPAS1 BHLHE11 MOP5 PASD5 Homo sapiens (Human) "central nervous system development [GO:0007417]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; startle response [GO:0001964]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; central nervous system development [GO:0007417]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; startle response [GO:0001964]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001964; GO:0003700; GO:0005634; GO:0006357; GO:0007417; GO:0042711; GO:0045892; GO:0046982 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EKSRNAAR 0.9927 -4.982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWG6 SCNM1_HUMAN Sodium channel modifier 1 SCNM1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleus [GO:0005634] "nuclear speck [GO:0016607]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; alternative mRNA splicing, via spliceosome [GO:0000380]; RNA splicing [GO:0008380]" GO:0000380; GO:0005634; GO:0008380; GO:0016607; GO:0019899; GO:0046872 enzyme binding [GO:0019899]; metal ion binding [GO:0046872] AGKKHLSSLQLFYGK 0.9927 -14.956 0 0 0 0 0 0 0 0 0 0 0 12.2938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXJ3 C1QT4_HUMAN Complement C1q tumor necrosis factor-related protein 4 (C1q/TNF-related protein 4) C1QTNF4 CTRP4 Homo sapiens (Human) positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor production [GO:0032760] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor production [GO:0032760] GO:0005125; GO:0005615; GO:0032755; GO:0032760; GO:0070105; GO:1901224 cytokine activity [GO:0005125] NRDEVQALAFDEQRR 0.9927 -6.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3857 0 0 14.4787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7056 0 0 14.2224 0 0 0 0 0 13.2476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NV70 EXOC1_HUMAN Exocyst complex component 1 (Exocyst complex component Sec3) EXOC1 SEC3 SEC3L1 BM-012 Homo sapiens (Human) defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]" GO:0000145; GO:0000281; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006887; GO:0006893; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0048015; GO:0048471; GO:0050714; GO:0051607; GO:0090148; GO:0090522; GO:0090543; GO:0098592 "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AYTKLIR 0.9927 -40.086 0 12.9364 0 0 0 0 0 11.1814 15.493 0 0 0 13.7961 0 0 0 12.8646 0 0 0 0 0 0 0 0 0 0 0 11.1011 0 0 0 12.6636 0 0 0 0 0 0 0 12.7766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.073 14.5008 0 11.7374 13.2516 0 12.9577 15.1337 0 0 11.409 13.1906 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7578 14.6599 13.8385 11.8996 0 0 0 13.2097 0 14.4369 16.5066 0 0 14.4776 0 0 0 17.8142 0 0 0 12.452 0 0 0 12.3362 15.1448 0 12.1269 14.4633 12.6934 12.7755 13.1342 0 0 0 0 10.8934 0 0 0 13.7008 0 13.5947 12.8836 0 0 0 15.3705 0 0 14.4007 0 0 0 0 0 0 13.3154 13.6167 0 0 0 0 0 0 0 9.82515 13.0735 13.2865 0 11.152 12.8564 0 0 0 13.1419 0 13.2031 0 0 Q9P225 DYH2_HUMAN Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) (Dynein heavy chain domain-containing protein 3) DNAH2 DNAHC2 DNHD3 KIAA1503 Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018] GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] AEDLRILRENLLLVAR 0.9927 -40.012 10.6865 0 0 0 0 0 0 0 13.5758 0 11.6874 14.2198 0 0 0 0 0 0 0 0 0 10.5867 11.4382 0 0 0 0 0 15.9785 0 0 0 11.9363 0 0 0 10.2153 11.4095 0 0 0 11.3412 0 0 12.1163 11.0229 0 0 0 0 0 0 0 11.5948 0 0 13.5013 0 0 0 0 0 0 0 0 10.99 15.6588 10.6666 0 0 12.7864 12.7791 0 11.8172 11.3788 12.3486 0 12.8482 0 14.5275 14.4805 13.2165 0 18.3303 11.6547 16.1486 11.8917 14.6434 13.4397 14.8413 14.4362 16.4755 0 14.8537 14.9284 12.9344 16.7756 15.3734 16.2757 0 12.2849 0 14.016 0 0 14.0542 12.9077 13.0284 13.3401 12.7074 0 16.2176 13.3731 14.7532 14.7114 13.2388 0 10.6188 13.5955 0 14.5373 14.7147 16.1485 0 12.3308 11.0275 13.3122 12.8118 13.0678 11.6644 14.4118 12.2693 13.5721 13.9651 13.6539 13.6793 0 0 0 0 13.0185 13.828 0 13.0695 0 10.4579 0 14.7526 10.2442 14.3236 13.9674 13.18 0 0 12.7074 13.7909 15.6916 14.0899 14.2604 13.3073 14.2009 14.5741 15.0798 15.1795 13.9554 0 15.1352 14.5264 14.2102 14.6947 12.4667 12.1905 11.5093 0 0 13.5511 14.181 12.1938 16.8135 15.1454 Q9P2Q2 FRM4A_HUMAN FERM domain-containing protein 4A FRMD4A FRMD4 KIAA1294 Homo sapiens (Human) establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein-macromolecule adaptor activity [GO:0030674]; establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714] GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162 protein-macromolecule adaptor activity [GO:0030674] GAGRAAVSDELR 0.9927 -14.62 0 0 0 0 0 0 11.4975 0 0 0 0 0 0 0 0 0 0 0 11.6548 0 10.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9369 0 0 0 0 13.6297 14.3389 14.8646 11.499 13.2591 15.187 0 0 0 0 0 0 15.3088 0 0 0 0 0 15.3182 0 0 0 0 0 15.7726 17.9411 14.4946 0 15.4709 0 0 0 0 14.9057 15.1965 0 0 12.1646 0 0 0 15.7979 12.549 13.6116 0 0 0 13.7358 0 15.3182 0 12.089 0 0 0 0 0 13.7398 0 0 0 12.5136 12.3821 15.5045 0 15.8732 12.6603 13.3019 0 15.8689 13.8845 0 0 0 13.5303 0 0 0 0 0 0 0 0 0 12.3981 0 0 0 0 12.0443 0 0 0 0 0 0 0 0 0 0 0 0 14.4795 0 0 0 0 13.8415 Q9UL40 ZN346_HUMAN Zinc finger protein 346 (Just another zinc finger protein) ZNF346 JAZ Homo sapiens (Human) cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GO:0003723; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008270; GO:0019899; GO:0035198 double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] IVLNSIEQYQAHVSGFKHK 0.9927 -14.589 0 11.6601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7181 12.5139 12.9045 12.6325 12.814 0 12.7778 0 0 0 0 0 0 0 12.6799 0 0 0 0 0 0 0 0 0 0 12.946 0 0 12.5259 0 12.4915 0 0 12.5938 12.7946 0 12.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7437 14.0179 14.0684 0 14.143 0 13.7661 0 0 0 0 0 0 0 0 0 0 0 14.1147 0 0 14.4982 0 0 13.0224 0 13.521 12.1044 0 0 0 0 0 0 0 0 0 13.2022 0 14.285 12.601 13.7921 0 0 12.9337 15.1899 14.8575 15.0128 0 15.56 0 13.8321 13.333 14.2071 13.6387 0 14.138 0 0 0 15.3802 14.9772 14.997 0 0 0 0 0 0 0 0 0 0 0 0 12.2567 0 0 14.2176 0 0 0 12.8236 0 0 0 0 14.3678 0 0 12.9831 14.1243 14.2193 0 0 0 13.8995 14.4163 0 14.4385 0 0 Q9Y2M2 SSUH2_HUMAN Protein SSUH2 homolog (Protein ssu-2 homolog) SSUH2 C3orf32 FLS485 Homo sapiens (Human) odontogenesis [GO:0042476] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082]; odontogenesis [GO:0042476] GO:0005634; GO:0005737; GO:0031072; GO:0042476; GO:0051082 heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082] ARVLQQR 0.9927 -44.409 0 0 0 0 0 0 0 0 0 0 0 0 11.3796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8526 11.6937 0 0 0 0 10.7683 0 0 0 11.749 10.3367 0 0 12.4455 10.4609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2251 0 12.2833 0 0 0 0 0 0 0 0 0 14.941 0 0 0 0 0 0 0 0 0 0 0 0 13.4728 13.4776 0 0 0 0 0 0 12.8424 0 0 0 0 0 0 0 0 0 0 13.5046 0 0 0 11.8073 0 0 0 0 12.4893 0 0 12.2909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6135 11.6818 0 0 0 0 0 Q9Y2X3 NOP58_HUMAN Nucleolar protein 58 (Nucleolar protein 5) NOP58 NOL5 NOP5 HSPC120 Homo sapiens (Human) rRNA processing [GO:0006364]; snoRNA localization [GO:0048254] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254] GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0048254; GO:0051117; GO:0070761 ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094] CLQKVGDRK 0.9927 -14.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.477 13.9882 0 0 0 12.1385 0 0 0 18.8584 18.1259 0 0 0 17.1417 16.7473 0 16.0282 0 0 0 12.4521 12.8018 0 16.4797 13.9705 0 0 0 0 0 15.5158 11.7102 0 0 0 0 0 0 0 0 0 0 12.3821 0 0 0 14.2082 0 0 13.8415 0 0 0 0 13.5305 0 0 0 0 0 0 0 0 0 11.9954 0 0 0 12.77 0 0 0 0 0 0 13.596 0 12.3054 0 0 0 0 0 0 0 0 0 0 0 11.881 0 0 0 0 0 0 12.2069 0 12.4285 0 0 0 O14503 BHE40_HUMAN "Class E basic helix-loop-helix protein 40, bHLHe40 (Class B basic helix-loop-helix protein 2, bHLHb2) (Differentially expressed in chondrocytes protein 1, DEC1) (Enhancer-of-split and hairy-related protein 2, SHARP-2) (Stimulated by retinoic acid gene 13 protein)" BHLHE40 BHLHB2 DEC1 SHARP2 STRA13 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; MRF binding [GO:0043426]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007623; GO:0009952; GO:0016604; GO:0019904; GO:0032922; GO:0042752; GO:0042803; GO:0043153; GO:0043425; GO:0043426; GO:0043433; GO:0045892; GO:0046982; GO:0050767; GO:0061629; GO:0070888; GO:1990837 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; MRF binding [GO:0043426]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" AVVLELTLKHVK 0.99271 -6.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5816 0 0 0 11.2241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9936 0 0 O15078 CE290_HUMAN "Centrosomal protein of 290 kDa, Cep290 (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87, CT87) (Nephrocystin-6) (Tumor antigen se2-2)" CEP290 BBS14 KIAA0373 NPHP6 Homo sapiens (Human) "camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]" centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580] "centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; camera-type eye development [GO:0043010]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]" GO:0001822; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0015031; GO:0016020; GO:0030902; GO:0030916; GO:0032391; GO:0032991; GO:0034451; GO:0035580; GO:0035869; GO:0036038; GO:0036064; GO:0042462; GO:0042802; GO:0043010; GO:0045893; GO:0048793; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:1905349; GO:1905515 identical protein binding [GO:0042802] AEHCQKMYEHLRTSLK 0.99271 -75.531 0 0 0 12.3913 0 0 0 14.2091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5611 0 11.8724 0 0 0 0 0 0 0 10.9779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5735 0 0 0 0 10.9299 13.2228 15.4534 0 0 15.0359 15.6296 0 0 0 12.4382 0 0 16.3333 0 15.3766 14.8564 14.952 0 0 0 12.3656 12.8219 13.0023 0 14.9935 0 14.0152 0 0 0 0 14.907 14.6896 14.7538 0 14.8464 0 15.0066 14.4292 12.6685 13.0297 0 13.7575 0 13.8127 14.4771 15.0894 0 16.0331 0 0 0 0 0 10.0889 14.6058 0 0 13.1747 10.9796 0 12.6446 0 9.74229 0 0 12.3644 0 0 11.72 0 0 16.4338 0 11.2271 12.9111 0 0 14.0771 0 0 0 0 9.57858 0 0 0 14.8514 12.9789 0 0 0 0 0 0 0 13.5157 0 14.7887 O15347 HMGB3_HUMAN "High mobility group protein B3 (High mobility group protein 2a, HMG-2a) (High mobility group protein 4, HMG-4)" HMGB3 HMG2A HMG4 Homo sapiens (Human) DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000400; GO:0003690; GO:0003723; GO:0005634; GO:0005694; GO:0005737; GO:0006310; GO:0006357; GO:0008301; GO:0032392; GO:0045087; GO:0045578; GO:0045638 "DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]" FDEMAKADKVR 0.99271 -46.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4347 0 0 0 0 0 14.0797 0 11.1938 0 0 0 0 0 0 0 0 13.1642 0 10.3049 0 0 0 0 0 0 0 14.1085 0 0 0 0 0 0 0 0 0 0 15.341 11.9519 14.8905 0 14.1704 12.3085 11.1652 12.0443 12.9217 0 0 10.7244 12.0065 0 0 0 0 0 0 0 0 0 0 0 10.9953 0 12.9488 0 0 13.5049 0 0 11.1051 12.2846 11.5561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8957 0 11.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8944 0 0 0 0 0 0 0 0 14.4142 0 11.6388 0 0 0 0 0 0 13.9079 11.4581 0 16.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0533 13.7297 0 0 10.8092 0 0 0 13.3767 0 0 14.3632 14.7458 0 0 0 14.8127 O43361 ZN749_HUMAN Zinc finger protein 749 ZNF749 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFLTQAHLDGHQKIQTGERR 0.99271 -46.248 0 0 0 0 0 0 0 0 0 0 10.9122 0 0 0 9.65705 0 10.0965 11.0415 0 0 0 0 0 0 0 0 0 0 0 12.948 0 0 0 0 0 11.2763 0 0 0 13.8505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0851 0 12.9235 0 0 14.1964 0 11.4733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3856 0 13.4865 0 0 0 16.2463 14.2776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6868 0 0 0 0 0 0 0 0 0 10.7693 13.8767 0 11.0529 13.8821 0 0 0 0 0 0 0 0 0 0 0 P17041 ZNF32_HUMAN Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30) ZNF32 KOX30 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" PYACTQCR 0.99271 -7.5977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7832 0 0 0 0 0 0 12.9875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35580 MYH10_HUMAN "Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B, NMMHC-B) (Non-muscle myosin heavy chain IIb, NMMHC II-b, NMMHC-IIB)" MYH10 Homo sapiens (Human) actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; cell adhesion [GO:0007155]; mitotic cytokinesis [GO:0000281]; positive regulation of protein secretion [GO:0050714]; regulation of cell shape [GO:0008360] actomyosin [GO:0042641]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; polysome [GO:0005844]; stress fiber [GO:0001725] actomyosin [GO:0042641]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; nucleus [GO:0005634]; polysome [GO:0005844]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; cell adhesion [GO:0007155]; mitotic cytokinesis [GO:0000281]; positive regulation of protein secretion [GO:0050714]; regulation of cell shape [GO:0008360] GO:0000146; GO:0000281; GO:0001725; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005938; GO:0007155; GO:0008360; GO:0016459; GO:0016460; GO:0030027; GO:0030048; GO:0030496; GO:0031032; GO:0032154; GO:0032982; GO:0035613; GO:0042641; GO:0043531; GO:0048027; GO:0050714; GO:0051015; GO:0070062; GO:0097513 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613] AGKLDPHLVLDQLRCNGVLEGIR 0.99271 -74.344 0 10.7991 0 0 11.056 13.4435 0 0 0 0 12.4996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5748 0 0 0 11.4484 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8066 0 11.6931 0 0 11.3111 0 13.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4875 0 0 14.3391 13.7388 0 13.6233 0 14.2223 11.1312 13.166 12.2305 0 15.2398 14.5161 12.0286 0 0 0 14.5487 12.2306 14.4649 0 12.9986 13.7211 13.3369 13.0674 13.6819 0 0 0 0 12.225 16.058 0 0 0 0 0 12.9496 12.965 14.1275 0 0 0 0 11.9849 0 11.9747 0 0 13.4998 14.778 12.2744 0 0 14.1514 13.2003 14.0673 12.83 12.8786 13.1513 0 0 0 0 0 0 13.2978 12.2169 0 0 14.3132 14.6161 0 0 0 11.8799 0 13.0987 12.0547 0 0 0 0 0 0 0 0 0 0 13.1871 12.4565 13.8411 13.8174 14.4629 14.0405 0 0 0 0 0 0 13.8251 0 0 0 0 0 P67809 YBOX1_HUMAN "Y-box-binding protein 1, YB-1 (CCAAT-binding transcription factor I subunit A, CBF-A) (DNA-binding protein B, DBPB) (Enhancer factor I subunit A, EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor)" YBX1 NSEP1 YB1 Homo sapiens (Human) "cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]" CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; histone pre-mRNA 3'end processing complex [GO:0071204]; intracellular membrane-bounded organelle [GO:0043231]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689] "CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; histone pre-mRNA 3'end processing complex [GO:0071204]; intracellular membrane-bounded organelle [GO:0043231]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]; C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]" GO:0000122; GO:0001701; GO:0003676; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003729; GO:0005576; GO:0005634; GO:0005654; GO:0005689; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0006397; GO:0008380; GO:0008544; GO:0010468; GO:0010494; GO:0017148; GO:0035198; GO:0043231; GO:0045944; GO:0048255; GO:0048598; GO:0050658; GO:0051020; GO:0051031; GO:0051154; GO:0051781; GO:0062153; GO:0070062; GO:0070934; GO:0070937; GO:0071204; GO:0098761; GO:1900152; GO:1903608; GO:1990124; GO:1990428; GO:1990837; GO:1990904; GO:2000767; GO:2000773 C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697] FPPYYMR 0.99271 -14.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2524 0 0 0 0 0 0 0 0 0 15.0718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98170 XIAP_HUMAN "E3 ubiquitin-protein ligase XIAP, EC 2.3.2.27 (Baculoviral IAP repeat-containing protein 4) (IAP-like protein, ILP, hILP) (Inhibitor of apoptosis protein 3, IAP-3, hIAP-3, hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein, X-linked IAP)" XIAP API3 BIRC4 IAP3 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; copper ion homeostasis [GO:0055070]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; inhibition of cysteine-type endopeptidase activity involved in apoptotic process [GO:1990001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055] GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005876; GO:0006974; GO:0010804; GO:0016055; GO:0030510; GO:0031398; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0045088; GO:0046330; GO:0046872; GO:0050727; GO:0051402; GO:0051726; GO:0055070; GO:0060785; GO:0061630; GO:0070424; GO:0090263; GO:0097340; GO:0120283; GO:1902530; GO:1990001 cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] DHFALDR 0.99271 -6.3695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8109 11.6299 0 0 0 0 0 0 0 0 16.6782 0 0 0 0 0 0 0 0 0 Q13564 ULA1_HUMAN "NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa, APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)" NAE1 APPBP1 HPP1 Homo sapiens (Human) mitotic DNA replication checkpoint signaling [GO:0033314]; neuron apoptotic process [GO:0051402]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625]; mitotic DNA replication checkpoint signaling [GO:0033314]; neuron apoptotic process [GO:0051402]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165] GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0019781; GO:0031625; GO:0032446; GO:0032991; GO:0033314; GO:0042981; GO:0043523; GO:0045116; GO:0046982; GO:0051402 NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin protein ligase binding [GO:0031625] DDYVHEFCR 0.99271 -5.0019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14CX7 NAA25_HUMAN "N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20, NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)" NAA25 C12orf30 MDM20 NAP1 Homo sapiens (Human) N-terminal peptidyl-methionine acetylation [GO:0017196] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196] GO:0005737; GO:0005794; GO:0005829; GO:0017196; GO:0031416 AIGLQRTGK 0.99271 -40.776 0 12.304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9719 0 0 0 0 0 0 0 0 0 18.0403 0 0 0 0 0 18.1815 0 15.1495 15.3853 0 0 13.6323 0 0 0 0 13.3787 0 15.831 13.7017 0 0 0 0 0 0 12.7373 12.5299 0 0 0 0 0 0 0 0 13.5063 13.7829 13.4346 0 0 0 0 14.4778 0 13.3239 0 14.4468 0 0 16.1836 0 0 0 0 0 14.5865 0 18.4685 0 13.0148 14.1951 0 13.4115 0 0 0 12.7639 0 0 0 0 0 14.2036 0 0 0 0 0 0 0 13.4236 0 0 0 0 0 0 0 0 0 0 0 13.0176 0 0 0 15.9061 0 13.4843 0 Q16822 PCKGM_HUMAN "Phosphoenolpyruvate carboxykinase [GTP], mitochondrial, PEPCK-M, EC 4.1.1.32" PCK2 PEPCK2 Homo sapiens (Human) cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594] GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006094; GO:0006107; GO:0006116; GO:0019543; GO:0030145; GO:0032024; GO:0032496; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071356; GO:0071549 GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; phosphoenolpyruvate carboxykinase activity [GO:0004611] EVLAELEALERRVHK 0.99271 -7.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0341 0 0 14.0984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6291 0 0 14.8936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4516 0 0 Q2NL82 TSR1_HUMAN Pre-rRNA-processing protein TSR1 homolog TSR1 KIAA1401 Homo sapiens (Human) "endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]" "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]" GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005829; GO:0030688; GO:0034511 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511] AHKGGRHR 0.99271 -46.157 0 0 0 0 0 0 0 9.27877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5875 0 0 13.0113 0 0 0 0 0 0 12.7542 12.715 0 0 12.4873 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9314 0 11.2275 11.7891 0 0 0 0 0 0 0 0 0 0 0 0 14.5364 0 0 0 13.1021 0 0 13.1531 0 0 0 0 14.6182 14.268 13.3433 13.7413 0 14.4821 0 0 0 0 13.8701 11.8526 14.084 14.2897 14.014 13.9798 0 0 0 12.9974 0 0 0 0 0 0 13.2512 0 0 0 14.1447 0 0 0 14.1851 0 0 0 0 0 13.5172 13.8024 13.7961 14.3941 0 0 12.8859 12.7012 0 0 0 0 0 12.5734 0 0 0 0 0 0 13.1867 12.4612 0 0 0 14.2442 0 0 13.6971 12.678 0 0 13.5142 13.3997 0 0 0 0 0 0 0 0 0 0 0 0 13.9243 0 15.9107 12.8607 0 13.5582 0 0 0 0 0 0 Q4ZIN3 MBRL_HUMAN Membralin (Transmembrane protein 259) TMEM259 C19orf6 Homo sapiens (Human) negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; negative regulation of neuron death [GO:1901215]; positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976] GO:0005783; GO:0005789; GO:0016021; GO:0034976; GO:1901215; GO:1904294 FNGQYSSLALVTSWLFIQHSMIYFFHHYELPAILQQVR 0.99271 -5.0054 0 0 0 0 0 0 0 0 0 14.5646 13.699 0 0 0 14.6241 0 13.6476 0 12.2885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1293 0 0 0 0 0 0 0 12.6431 0 12.4385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2122 0 0 0 11.6634 0 0 0 0 0 0 14.9915 0 11.7716 0 0 0 11.5656 0 0 0 0 0 0 11.6002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8182 0 0 0 0 0 0 0 0 0 0 10.9041 0 0 0 0 0 0 11.5519 0 0 13.1843 0 0 0 0 12.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2956 0 0 0 Q5K4L6 S27A3_HUMAN "Long-chain fatty acid transport protein 3, FATP-3, Fatty acid transport protein 3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase, EC 6.2.1.3) (Solute carrier family 27 member 3) (Very long-chain acyl-CoA synthetase homolog 3, VLCS-3, EC 6.2.1.-)" SLC27A3 ACSVL3 FATP3 PSEC0067 UNQ367/PRO703 Homo sapiens (Human) fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid transport [GO:0015908]; long-chain fatty acid metabolic process [GO:0001676] GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005739; GO:0005783; GO:0015908; GO:0016020; GO:0016021; GO:0031957; GO:0031966; GO:0047676 arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957] AALLLLPLLLLLPLLLLK 0.99271 -6.3528 10.6273 0 0 0 0 0 0 0 0 15.3216 0 12.537 14.462 11.4458 12.5667 0 13.6924 0 0 0 11.701 0 11.3985 0 0 14.4017 0 14.4972 0 13.9347 0 13.8232 0 12.6853 0 0 0 12.3322 13.5328 0 12.6918 14.3154 0 12.2757 0 0 0 0 0 0 12.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8831 0 0 13.7091 0 0 13.1823 0 0 0 0 0 14.5217 12.2911 0 15.0528 0 0 0 0 0 0 0 11.4813 14.0866 11.7508 14.142 13.5089 0 0 0 13.2506 0 16.491 0 0 0 11.0755 0 12.0487 0 14.3857 14.2222 10.4163 11.9545 16.7009 12.7537 0 0 15.9033 12.3309 0 15.374 0 10.7416 0 0 0 0 0 11.8119 0 15.501 12.6977 0 0 0 0 0 0 0 0 15.4603 0 11.9459 0 0 10.947 0 0 0 0 13.5871 0 0 12.3125 0 12.312 0 0 10.4927 0 0 0 11.6121 13.6928 12.625 0 0 0 0 10.8682 0 11.6071 0 16.2141 0 0 0 0 Q5T200 ZC3HD_HUMAN Zinc finger CCCH domain-containing protein 13 ZC3H13 KIAA0853 Homo sapiens (Human) mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; regulation of stem cell population maintenance [GO:2000036]; RNA splicing [GO:0008380] GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0036396; GO:0046872; GO:0080009; GO:2000036 metal ion binding [GO:0046872]; RNA binding [GO:0003723] ALCFRRDSAIR 0.99271 -75.654 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7364 0 9.75146 12.1732 0 10.965 10.0518 0 0 0 0 14.1495 0 0 0 0 0 0 0 10.0572 0 0 12.9346 0 0 0 0 0 0 14.6843 0 0 0 0 0 0 0 0 0 0 0 12.2915 0 15.7583 0 0 12.8825 0 0 17.1289 11.1035 0 0 11.441 0 0 0 14.3234 0 0 0 0 0 0 0 14.8833 0 0 13.3404 0 0 0 12.0107 0 11.276 0 0 0 15.5996 12.0777 0 0 0 0 0 0 10.2648 0 15.2302 0 0 0 0 0 0 0 17.2883 10.7495 14.7757 0 0 0 0 0 15.1659 0 0 0 0 0 14.3113 14.9566 14.8999 0 14.9207 14.9421 14.9452 0 0 0 14.9643 11.1289 13.7988 0 0 15.0436 16.2922 0 0 0 0 13.8461 0 11.8971 0 10.558 0 12.7916 0 0 0 14.029 0 0 0 0 0 12.1414 0 0 0 Q6ZMI0 PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1) PPP1R21 CCDC128 KLRAQ1 Homo sapiens (Human) early endosome [GO:0005769]; membrane [GO:0016020] early endosome [GO:0005769]; membrane [GO:0016020] GO:0005769; GO:0016020 ILPYQLK 0.99271 -25.576 0 13.4289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6611 0 0 0 0 0 0 0 0 0 0 13.8634 0 0 13.8349 13.9962 12.9889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1908 12.6875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4511 0 0 0 0 0 0 0 0 0 0 15.1398 14.4107 0 14.6959 0 0 0 10.9461 0 0 0 0 0 0 0 0 0 11.807 0 0 0 0 0 Q86XH1 DRC11_HUMAN Dynein regulatory complex protein 11 (IQ and AAA domain-containing protein 1) IQCA1 DRC11 IQCA Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005737; GO:0005856; GO:0016887; GO:0031514 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] EALVTIKNDLKLIEGVDIK 0.99271 -25.57 0 0 0 0 0 0 0 0 0 0 13.2232 11.9382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1533 11.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1179 0 13.5183 0 0 13.0733 0 0 0 0 0 0 15.3604 0 0 0 0 0 0 0 0 0 13.6577 0 0 0 13.0068 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4947 13.7561 14.3854 13.896 0 13.2074 13.5056 0 0 0 0 0 11.9355 0 0 0 0 11.3106 0 0 0 0 0 0 0 12.5171 0 12.1368 0 0 12.3464 0 0 11.8385 0 12.617 0 0 0 12.1574 0 0 0 0 13.7644 0 0 0 0 0 12.9619 12.3821 12.8016 0 0 0 0 12.2829 0 0 0 12.2276 0 0 0 12.7827 0 Q9BVI0 PHF20_HUMAN PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000123; GO:0003677; GO:0005654; GO:0005829; GO:0006325; GO:0006357; GO:0016573; GO:0031965; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0046872; GO:0051571; GO:0071339; GO:1900095 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AYYPAVEQKLVVETR 0.99271 -45.438 0 0 0 0 0 10.4783 0 0 12.6683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.009 0 0 0 0 0 0 0 9.93105 0 0 0 0 12.2337 0 0 0 0 0 12.9179 0 0 11.5725 12.668 0 11.3321 0 0 10.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6231 0 0 13.9828 0 0 0 0 13.7881 0 0 0 13.5722 0 0 12.7581 0 0 0 0 0 0 0 11.832 0 0 0 13.6077 0 0 0 0 0 0 0 0 13.5494 13.2403 0 0 0 13.2833 0 0 0 0 0 10.4849 0 0 0 0 12.7828 0 0 12.6561 0 12.6196 0 0 0 0 0 0 0 0 0 0 13.3045 0 13.5429 0 0 0 0 0 0 12.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5941 Q9BVW5 TIPIN_HUMAN TIMELESS-interacting protein TIPIN Homo sapiens (Human) cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]; response to UV [GO:0009411] GO:0000076; GO:0000785; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0008284; GO:0009411; GO:0031298; GO:0031573; GO:0033262; GO:0043111; GO:0044770; GO:0048478; GO:0051301 DNA binding [GO:0003677] GLPALRHVFDK 0.99271 -17.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4748 13.0438 0 0 0 0 0 0 0 0 0 0 0 14.018 0 0 14.62 0 0 0 0 0 13.7042 0 13.7925 0 0 0 0 0 13.2174 14.5453 0 13.6707 0 12.2017 0 0 0 0 0 0 0 0 0 14.0476 0 15.7937 15.7569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2Y7 ZN106_HUMAN "Zinc finger protein 106, Zfp-106 (Zinc finger protein 474)" ZNF106 SH3BP3 ZFP106 ZNF474 Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286] GO:0003723; GO:0005730; GO:0005829; GO:0008286; GO:0016020; GO:0016607; GO:0017124; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124] DARNGLLLR 0.99271 -40.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6694 13.2897 14.8451 12.9322 0 0 13.069 11.1898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7609 13.0118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9516 11.9283 14.1507 0 14.5559 0 0 0 0 13.3966 0 13.3753 0 14.5135 0 14.9518 15.9464 0 13.3048 0 13.1732 0 0 13.7384 13.1494 14.6085 0 13.3496 13.4155 0 0 14.6659 0 10.7248 0 0 0 0 12.9984 13.6986 13.1808 13.6616 13.3026 14.3283 0 0 0 14.1966 14.0996 12.3951 12.8484 0 0 14.5518 14.4952 12.389 0 13.783 0 0 0 0 13.6395 13.5491 14.9092 0 13.0612 0 13.4267 0 0 0 0 13.7242 0 0 13.2412 0 14.6324 14.8699 0 0 0 0 0 12.5307 0 0 13.847 13.3486 13.365 0 0 0 0 0 0 0 0 13.1014 0 0 0 14.2739 12.6956 0 0 0 0 0 0 0 0 0 Q9Y4X0 AMMR1_HUMAN Nuclear protein AMMECR1 (AMME syndrome candidate gene 1 protein) AMMECR1 Homo sapiens (Human) mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005739 APITNEFR 0.99271 -5.0043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3688 0 0 0 0 0 0 0 0 0 0 12.8464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1A4V9 CF119_HUMAN Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189) CFAP119 C16orf93 CCDC189 Homo sapiens (Human) acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] GO:0001669; GO:0005737; GO:0097228 AYIKTQVNK 0.99272 -7.1049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7627 13.2326 0 0 0 0 13.878 12.8123 0 0 0 0 0 11.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3568 0 0 0 0 0 0 0 11.8827 0 0 0 0 0 12.7505 12.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04040 CATA_HUMAN "Catalase, EC 1.11.1.6" CAT Homo sapiens (Human) aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650] catalase complex [GO:0062151]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774] "catalase complex [GO:0062151]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to growth factor stimulus [GO:0071363]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650]" GO:0000268; GO:0000302; GO:0001649; GO:0001657; GO:0001666; GO:0004046; GO:0004096; GO:0005576; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005778; GO:0005782; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006641; GO:0007568; GO:0008203; GO:0009060; GO:0009410; GO:0009642; GO:0009650; GO:0010193; GO:0010288; GO:0014068; GO:0014823; GO:0014854; GO:0016020; GO:0016209; GO:0016684; GO:0019899; GO:0020027; GO:0020037; GO:0032088; GO:0032355; GO:0032868; GO:0032991; GO:0033189; GO:0033197; GO:0033591; GO:0034774; GO:0042542; GO:0042744; GO:0042802; GO:0042803; GO:0043066; GO:0043231; GO:0045471; GO:0046686; GO:0046872; GO:0050661; GO:0051092; GO:0051781; GO:0055093; GO:0061692; GO:0062151; GO:0070062; GO:0070542; GO:0071363; GO:0080184; GO:1904813 "aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxisome targeting sequence binding [GO:0000268]; protein homodimerization activity [GO:0042803]" DLFNAIATGK 0.99272 -16.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9372 0 0 0 0 0 0 13.7157 13.7622 13.7884 0 0 0 0 0 0 0 14.0063 14.3959 0 0 0 0 0 0 0 0 14.1018 0 13.0313 0 0 0 0 0 12.7641 0 12.3234 0 13.0419 0 0 13.3212 0 12.7986 0 13.6619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20848 A1ATR_HUMAN Alpha-1-antitrypsin-related protein (Protease inhibitor 1-like) (Serpin A2) SERPINA2 ARGS ATR PIL SERPINA2P Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0005783; GO:0010951 serine-type endopeptidase inhibitor activity [GO:0004867] AWSKYQTVMFNR 0.99272 -16.947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8186 0 0 11.2475 0 0 0 0 0 13.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1339 0 0 0 0 0 0 14.3446 0 0 0 0 0 0 0 0 0 0 0 13.9883 0 0 13.6144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1501 0 0 0 0 0 0 13.145 0 0 0 0 0 0 0 11.9734 0 0 0 0 0 0 0 0 0 0 14.0939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1236 0 0 0 Q14088 RB33A_HUMAN Ras-related protein Rab-33A (Small GTP-binding protein S10) RAB33A RABS10 Homo sapiens (Human) antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; Rab protein signal transduction [GO:0032482] GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0005886; GO:0019882; GO:0032482 GTP binding [GO:0005525]; GTPase activity [GO:0003924] DAERQQGK 0.99272 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0392 0 0 12.8742 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15131 CDK10_HUMAN "Cyclin-dependent kinase 10, EC 2.7.11.22 (Cell division protein kinase 10) (Serine/threonine-protein kinase PISSLRE)" CDK10 Homo sapiens (Human) cell projection organization [GO:0030030]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of mitotic cell cycle [GO:0007346]; traversing start control point of mitotic cell cycle [GO:0007089] ciliary basal body [GO:0036064]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] ciliary basal body [GO:0036064]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell projection organization [GO:0030030]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of mitotic cell cycle [GO:0007346]; traversing start control point of mitotic cell cycle [GO:0007089] GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007089; GO:0007346; GO:0008285; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0106310; GO:1902018; GO:1902749 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AYGVPVK 0.99272 -6.3771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7001 0 0 0 0 15.5674 0 0 0 14.5174 0 0 0 0 0 0 0 0 0 0 0 13.2046 0 0 13.5591 0 0 0 0 0 0 0 13.2169 14.7902 0 0 13.5554 13.042 0 11.9237 0 0 11.8298 0 0 0 0 0 0 0 14.1535 0 13.3008 0 0 0 0 0 0 13.9878 0 0 15.5875 0 0 0 0 0 0 0 0 0 0 10.5428 0 12.9016 0 0 15.5054 0 0 0 0 0 0 17.4879 0 11.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9917 0 0 0 0 0 0 0 Q5T1M5 FKB15_HUMAN "FK506-binding protein 15, FKBP-15 (133 kDa FK506-binding protein, 133 kDa FKBP, FKBP-133) (WASP- and FKBP-like protein, WAFL)" FKBP15 KIAA0674 Homo sapiens (Human) endocytosis [GO:0006897] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020] actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; endocytosis [GO:0006897] GO:0003755; GO:0003779; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030426 actin binding [GO:0003779]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] AAVEFNKQVCIAK 0.99272 -15.088 0 12.0757 0 16.6629 0 0 0 0 0 0 0 0 0 15.2735 14.8403 0 15.3391 0 15.6917 0 0 0 11.3473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0703 0 0 0 0 0 0 0 0 0 0 0 13.2883 15.4043 14.4677 0 0 0 0 15.9896 13.1207 14.0299 0 11.8523 14.6125 0 0 0 0 0 0 0 0 10.8372 0 0 11.641 0 0 0 11.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8898 0 0 0 0 0 0 0 14.3832 0 0 0 0 12.8329 0 0 14.8943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3693 0 16.1092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3949 0 0 0 0 0 15.0058 0 0 0 14.4957 0 0 0 0 0 0 0 0 0 17.1777 Q5T4W7 ARTN_HUMAN Artemin (Enovin) (Neublastin) ARTN EVN Homo sapiens (Human) axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165] GO:0005102; GO:0005576; GO:0005615; GO:0007165; GO:0007405; GO:0007411; GO:0007422; GO:0008083; GO:0030116; GO:0030971; GO:0050930; GO:0061146; GO:0097021 glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] AGGPGSR 0.99272 -6.3721 0 11.4017 11.8921 0 11.5652 0 0 0 15.5549 13.2759 0 13.2083 0 14.7162 12.906 12.5364 0 16.059 14.2558 16.5873 0 0 0 0 15.9711 0 16.1489 12.5983 0 14.919 11.8444 0 12.641 15.03 12.5223 0 0 0 0 14.5548 14.2167 0 0 14.6047 14.2926 0 0 13.2142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7556 14.2208 14.0289 14.3989 13.4767 0 0 0 13.1574 13.6964 14.4283 14.4387 0 13.4401 0 13.7125 13.3645 13.518 14.0289 0 0 13.2729 19.0755 0 19.3036 19.3272 19.2873 0 19.0984 19.1426 18.9337 13.8581 19.0029 19.4082 13.4484 0 0 0 0 0 11.1425 13.5373 15.3961 19.871 14.2421 13.5985 18.8179 18.8607 19.7881 19.6911 19.7892 0 0 13.639 14.4355 0 0 0 0 0 13.9448 15.3984 0 0 13.4665 0 0 14.0676 14.3011 0 14.0492 0 19.5607 19.5445 0 18.363 18.3486 0 13.2772 18.2009 13.4573 18.9297 18.7784 18.7799 0 0 0 0 0 19.4086 18.7568 0 18.657 15.1988 14.4995 14.9895 17.8362 14.5767 17.7934 18.8126 18.6839 15.2638 16.857 17.1866 14.4706 14.8928 0 0 19.9136 19.3905 19.3501 0 18.0436 0 Q6ZS52 YF013_HUMAN Putative uncharacterized protein FLJ45825 Homo sapiens (Human) FQLAPIK 0.99272 -16.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6783 0 0 0 0 0 0 0 0 10.5998 0 0 0 12.2232 0 0 15.3845 16.3241 0 0 14.5281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7012 0 0 0 0 0 0 0 0 0 14.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1489 0 0 0 12.7431 13.7865 14.2601 0 0 0 0 0 0 13.7899 Q6ZUM4 RHG27_HUMAN Rho GTPase-activating protein 27 (CIN85-associated multi-domain-containing Rho GTPase-activating protein 1) (Rho-type GTPase-activating protein 27) (SH3 domain-containing protein 20) ARHGAP27 CAMGAP1 SH3D20 PP905 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; receptor-mediated endocytosis [GO:0006898]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; positive regulation of GTPase activity [GO:0043547]; receptor-mediated endocytosis [GO:0006898]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005737; GO:0005829; GO:0006898; GO:0007165; GO:0016020; GO:0017124; GO:0043087; GO:0043547; GO:0051056 GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] ERSRVPR 0.99272 -25.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9708 0 0 0 0 0 12.4949 0 0 0 0 0 12.6139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5971 0 13.5386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.734 0 0 0 0 0 0 0 0 13.4179 0 0 0 0 0 0 0 0 12.87 0 0 0 12.4985 13.6571 0 0 0 0 12.8777 0 0 0 0 Q86XF0 DYR2_HUMAN "Dihydrofolate reductase 2, mitochondrial (Dihydrofolate reductase, mitochondrial, EC 1.5.1.3) (Dihydrofolate reductase-like protein 1)" DHFR2 DHFRL1 DHFRP4 Homo sapiens (Human) dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; folate reductase activity [GO:0033560]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105] GO:0003729; GO:0004146; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006545; GO:0006730; GO:0033560; GO:0046105; GO:0046452; GO:0046653; GO:0046654; GO:0046655; GO:0050661 dihydrofolate reductase activity [GO:0004146]; folate reductase activity [GO:0033560]; mRNA binding [GO:0003729]; NADP binding [GO:0050661] FEVCEKDD 0.99272 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5I4 DHRSX_HUMAN "Dehydrogenase/reductase SDR family member on chromosome X, EC 1.1.-.- (DHRSXY) (Short chain dehydrogenase/reductase family 46C member 1) (Short chain dehydrogenase/reductase family 7C member 6)" DHRSX CXorf11 DHRS5X SDR46C1 SDR7C6 UNQ6508/PRO21433 Homo sapiens (Human) positive regulation of autophagy [GO:0010508] extracellular region [GO:0005576] extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491]; positive regulation of autophagy [GO:0010508] GO:0005576; GO:0010508; GO:0016491 oxidoreductase activity [GO:0016491] AALRVYAVGAAVILAQLLR 0.99272 -15.096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0001 0 0 0 0 0 0 13.7093 11.6948 11.7864 12.7131 13.0018 0 0 11.6879 0 15.4416 14.7142 0 0 0 0 0 0 0 0 0 0 0 0 10.2954 0 0 0 0 0 0 0 0 10.4375 0 0 15.698 13.3125 0 0 0 0 0 13.8653 13.2145 12.988 0 0 0 13.3994 0 0 10.7859 0 0 0 0 0 0 0 0 0 12.1636 0 0 14.1611 14.6491 0 0 13.1655 0 0 0 0 0 0 0 0 0 0 0 11.4865 0 0 0 0 0 0 0 11.8898 0 0 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 13.5576 0 Q8WW35 DYT2B_HUMAN Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2) DYNLT2B TCTEX1D2 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799] GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799 dynein intermediate chain binding [GO:0045505] EMGFDRYK 0.99272 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92576 PHF3_HUMAN PHD finger protein 3 PHF3 KIAA0244 Homo sapiens (Human) "transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0006351; GO:0046872 metal ion binding [GO:0046872] CCAEEDK 0.99272 -25.818 0 0 0 0 0 15.6908 0 0 0 13.238 13.5316 9.99619 0 0 0 0 0 0 13.062 0 0 12.4405 0 0 0 13.9806 0 0 0 12.2275 0 0 0 0 0 0 12.3779 0 0 0 0 0 0 0 0 0 11.7747 13.8672 13.7999 0 13.7773 0 0 0 0 0 12.1542 0 0 9.64218 12.2542 11.1345 0 0 0 0 0 0 0 0 0 0 0 0 0 12.707 0 0 0 0 0 0 0 20.4799 20.6855 17.093 17.0491 0 9.79588 0 12.1227 10.2745 0 0 0 0 10.2973 0 14.1877 0 0 0 0 0 0 0 0 0 12.5908 0 0 0 0 0 15.4288 11.1924 0 12.6096 13.6627 0 10.0925 0 0 0 13.7934 0 0 0 13.1449 0 15.85 0 0 0 0 0 13.8815 13.206 14.1065 13.3383 0 10.4113 0 13.0241 13.0727 0 0 0 0 14.3103 14.1632 0 13.1289 12.1964 14.4376 14.1248 0 0 0 0 0 0 10.3884 0 0 12.936 0 12.2305 9.97327 0 0 15.0881 0 15.0521 0 12.858 14.9343 0 15.0936 13.1739 Q96NS5 ASB16_HUMAN "Ankyrin repeat and SOCS box protein 16, ASB-16" ASB16 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 AAAQQCR 0.99272 -25.814 0 0 0 10.6219 0 0 0 0 0 0 0 0 0 0 0 12.658 0 0 0 0 0 0 0 13.2308 0 0 0 10.807 0 0 0 0 0 10.7618 0 0 10.0721 0 0 0 0 0 0 0 0 0 10.7956 0 0 0 0 0 10.5376 0 10.3038 0 0 0 0 9.99336 0 0 0 0 0 0 0 12.1341 12.1799 0 0 11.425 10.7819 0 0 13.5655 0 0 0 0 0 12.2236 0 0 11.8977 0 0 0 0 14.0871 0 12.7853 0 0 0 12.5144 0 0 0 11.763 13.7868 13.2355 0 0 0 11.7255 0 0 0 0 0 0 0 12.8193 0 11.4463 0 0 0 0 12.122 12.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3689 12.4952 13.5727 0 0 0 0 12.8964 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7376 0 13.9163 0 0 13.8814 0 12.2809 12.1799 0 0 0 13.5845 15.2346 0 0 11.5073 12.1722 0 0 17.37 0 12.5334 Q96PN6 ADCYA_HUMAN "Adenylate cyclase type 10, EC 4.6.1.1 (AH-related protein) (Adenylate cyclase homolog) (Germ cell soluble adenylyl cyclase, hsAC, sAC) (Testicular soluble adenylyl cyclase)" ADCY10 SAC Homo sapiens (Human) cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; cAMP biosynthetic process [GO:0006171]; cellular response to inorganic substance [GO:0071241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; spermatogenesis [GO:0007283] GO:0000287; GO:0003351; GO:0004016; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005929; GO:0006171; GO:0007283; GO:0016324; GO:0030145; GO:0030425; GO:0030426; GO:0035556; GO:0043025; GO:0043065; GO:0045178; GO:0048471; GO:0051117; GO:0071241; GO:0071890 adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; bicarbonate binding [GO:0071890]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] ALQMWALLQNPNRHYQSLCR 0.99272 -40.983 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9161 0 0 0 0 0 0 0 12.273 0 0 11.6888 12.0072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5851 0 0 0 0 0 0 0 0 0 0 0 14.9473 0 0 0 13.2527 13.0025 12.4883 0 12.1371 12.2119 13.9533 0 0 0 13.3176 0 13.2465 0 0 0 0 0 13.0209 0 0 0 12.2723 12.0852 0 0 0 12.0503 0 0 0 0 10.9963 0 13.116 12.5146 0 0 0 0 0 0 0 0 0 12.5566 0 12.3521 0 12.5417 13.4946 0 0 11.6063 0 0 0 0 0 0 0 0 13.4078 0 0 12.5088 0 11.0101 0 11.5039 12.8226 12.7846 0 13.2283 0 0 0 0 0 10.8831 0 10.2457 0 0 0 10.9499 0 0 0 0 0 0 0 0 0 12.2627 0 0 0 0 13.1295 0 0 0 0 13.434 0 Q9P2J8 ZN624_HUMAN Zinc finger protein 624 ZNF624 KIAA1349 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNDCGKAFSQMVHVTEHQK 0.99272 -14.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.146 0 0 0 0 11.6847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1247 0 16.664 16.3328 16.4447 0 10.8969 0 0 0 0 12.5874 0 17.9258 0 0 14.5977 0 11.2096 14.2704 0 0 16.0291 0 16.3167 0 16.2906 0 0 0 13.0314 0 0 10.456 10.1277 0 13.9659 0 0 13.5898 14.3436 16.7994 0 15.0676 14.0877 0 0 0 0 0 0 0 0 12.9303 0 12.6735 0 12.5734 0 0 0 0 0 12.7371 0 12.0042 0 0 0 12.614 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7974 12.8929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8544 0 0 0 0 0 0 0 0 Q9UKZ9 PCOC2_HUMAN "Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2, PCPE-2, Procollagen C-proteinase enhancer 2)" PCOLCE2 PCPE2 UNQ250/PRO287 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830] extracellular region [GO:0005576] extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830] GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830 collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504] FEKFDVER 0.99272 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4G6 TLN2_HUMAN Talin-2 TLN2 KIAA0320 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043] GO:0001726; GO:0003779; GO:0005178; GO:0005198; GO:0005200; GO:0005737; GO:0005886; GO:0005925; GO:0007043; GO:0007155; GO:0015629; GO:0045202; GO:0051015; GO:0098609 actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] ALEATIECIK 0.99272 -46.686 10.0246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3584 0 0 0 0 0 0 0 13.3806 0 13.6193 0 0 0 0 0 0 15.2107 0 0 12.1883 0 0 13.5614 0 0 0 14.7144 14.8222 0 0 13.9377 14.0455 0 0 11.3477 0 14.368 0 0 0 0 12.9544 0 0 14.7703 15.5299 15.0453 14.1971 17.3754 13.8553 12.7334 0 0 0 0 0 16.7848 0 0 14.0446 0 0 0 0 14.2364 13.7004 13.5511 11.7695 0 0 0 13.9248 13.728 0 0 0 13.5523 0 0 17.9819 0 0 12.7272 0 0 0 17.3231 0 0 0 0 0 0 0 0 12.9523 13.5991 15.9138 0 0 0 0 0 12.9669 15.0769 0 0 0 0 0 0 0 A6NF36 CC182_HUMAN Coiled-coil domain-containing protein 182 CCDC182 Homo sapiens (Human) female gonad development [GO:0008585] female gonad development [GO:0008585] GO:0008585 DALRATKK 0.99273 -6.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8854 0 A6NKX1 F223B_HUMAN Protein FAM223B FAM223B CXorf52B LINC00204B Homo sapiens (Human) AGGVGGK 0.99273 -14.752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.562 0 0 14.4941 13.8942 0 0 0 0 0 0 0 13.7163 0 0 0 11.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3548 11.9277 0 12.2029 10.0293 0 0 0 0 0 13.7307 0 0 O75311 GLRA3_HUMAN Glycine receptor subunit alpha-3 GLRA3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]" anchoring junction [GO:0070161]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]" GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0043200; GO:0043204; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0051260; GO:0060012; GO:0070161; GO:1902476; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] AHVRHFR 0.99273 -16.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9238 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3917 0 13.1054 0 0 0 0 0 0 0 11.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7874 0 0 0 0 0 0 0 0 0 0 0 13.9068 0 0 0 0 0 0 14.3502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2392 0 0 0 0 0 0 0 0 0 0 0 0 12.5236 0 0 12.599 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5072 0 0 0 0 0 0 0 0 0 0 12.5408 0 0 0 0 0 0 0 0 0 0 0 14.2349 14.1336 0 14.2575 13.7419 0 0 14.3611 14.0757 0 0 0 0 12.2654 0 0 0 0 0 0 0 P30405 PPIF_HUMAN "Peptidyl-prolyl cis-trans isomerase F, mitochondrial, PPIase F, EC 5.2.1.8 (Cyclophilin D, CyP-D, CypD) (Cyclophilin F) (Mitochondrial cyclophilin, CyP-M) (Rotamase F)" PPIF CYP3 Homo sapiens (Human) "apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic mitochondrial changes [GO:0008637]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of oxidative phosphorylation uncoupler activity [GO:2000276]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of necrotic cell death [GO:0010939]; regulation of proton-transporting ATPase activity, rotational mechanism [GO:0010849]; response to ischemia [GO:0002931]" GO:0000413; GO:0002931; GO:0003755; GO:0005737; GO:0005739; GO:0005743; GO:0005757; GO:0005759; GO:0006457; GO:0008637; GO:0010849; GO:0010939; GO:0016018; GO:0016020; GO:0032780; GO:0043066; GO:0043231; GO:0046902; GO:0070266; GO:0070301; GO:0071243; GO:0071277; GO:0090200; GO:0090201; GO:0090324; GO:1902445; GO:1902686; GO:2000276; GO:2001243 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] HVVFGHVK 0.99273 -7.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7001 13.3514 0 13.7683 0 0 0 0 0 0 0 14.8748 0 0 0 0 13.7404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58743 S26A5_HUMAN Prestin (Solute carrier family 26 member 5) SLC26A5 PRES Homo sapiens (Human) cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; lateral wall of outer hair cell [GO:0120249] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; lateral wall of outer hair cell [GO:0120249]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605] GO:0002931; GO:0005737; GO:0005887; GO:0007605; GO:0008271; GO:0008360; GO:0009410; GO:0009751; GO:0010996; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015755; GO:0016323; GO:0016328; GO:0019531; GO:0030507; GO:0034766; GO:0035864; GO:0042391; GO:0042802; GO:0045793; GO:0090102; GO:0097066; GO:0120249; GO:1902074; GO:2000147 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116] MDHAEENEILAATQRYYVER 0.99273 -6.4085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3547 0 0 0 0 0 0 12.6317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P82932 RT06_HUMAN "28S ribosomal protein S6, mitochondrial, MRP-S6, S6mt (Mitochondrial small ribosomal subunit protein bS6m)" MRPS6 C21orf101 RPMS6 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit [GO:0015935] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit [GO:0015935]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0006412; GO:0015935; GO:0032543; GO:0070181 small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735] PRYELALILK 0.99273 -7.6317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12772 SRBP2_HUMAN "Sterol regulatory element-binding protein 2, SREBP-2 (Class D basic helix-loop-helix protein 2, bHLHd2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2) ]" SREBF2 BHLHD2 SREBP2 Homo sapiens (Human) cellular response to laminar fluid shear stress [GO:0071499]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription by RNA polymerase II [GO:0006357]; SREBP signaling pathway [GO:0032933] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription by RNA polymerase II [GO:0006357]; SREBP signaling pathway [GO:0032933]" GO:0000122; GO:0000139; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0008022; GO:0008203; GO:0008593; GO:0009267; GO:0010886; GO:0012507; GO:0032933; GO:0032937; GO:0042632; GO:0043231; GO:0045542; GO:0045944; GO:0046983; GO:0070888; GO:0071404; GO:0071499; GO:0090370; GO:1902895; GO:1903146; GO:1903955; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein C-terminus binding [GO:0008022]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ADGQQSSFCHCER 0.99273 -17.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1543 14.1374 11.8053 0 0 0 0 0 0 0 14.2863 0 0 0 13.5686 0 0 0 13.8568 0 0 12.5773 0 0 0 14.7917 0 0 12.7984 0 0 13.6131 0 12.8222 13.2625 12.5922 0 0 0 0 0 0 0 0 0 14.1017 0 0 15.1396 0 0 0 14.3497 0 0 0 10.7775 0 0 0 0 0 0 0 12.9211 0 0 0 0 0 0 13.471 0 0 0 0 0 0 12.8651 0 0 13.3123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1853 12.48 14.0235 14.6508 0 0 0 0 0 Q16625 OCLN_HUMAN Occludin OCLN Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of wound healing [GO:0090303]; protein localization to cell leading edge [GO:1902463]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; protein domain specific binding [GO:0019904]; bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of wound healing [GO:0090303]; protein localization to cell leading edge [GO:1902463]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827] GO:0001933; GO:0005765; GO:0005886; GO:0005911; GO:0005923; GO:0010592; GO:0010628; GO:0010629; GO:0010827; GO:0016021; GO:0016324; GO:0016327; GO:0019904; GO:0030054; GO:0030139; GO:0031116; GO:0031252; GO:0031410; GO:0032991; GO:0035633; GO:0045216; GO:0046326; GO:0065003; GO:0070160; GO:0070830; GO:0090303; GO:1902463; GO:1905605 protein domain specific binding [GO:0019904] EESEEYMAAADEYNR 0.99273 -17.46 0 0 0 0 0 0 0 0 0 0 0 0 11.9527 15.1906 15.1798 0 0 0 0 0 0 13.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3392 0 0 0 0 0 12.355 0 0 0 0 0 0 0 0 0 0 0 0 12.1234 0 0 0 0 0 0 0 0 0 0 0 0 14.7302 0 13.7226 14.7283 0 0 0 0 14.6448 0 13.9783 0 0 0 0 0 0 0 0 13.2906 0 0 0 0 0 0 0 0 0 14.4875 0 0 0 0 0 0 0 0 0 14.1123 0 0 0 0 0 0 0 0 0 0 11.1073 0 0 0 0 0 0 0 0 11.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5546 0 Q5JVG8 ZN506_HUMAN Zinc finger protein 506 ZNF506 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleolus [GO:0005730] "nucleolus [GO:0005730]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005730; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CRHDNLQLK 0.99273 -16.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8224 0 12.4304 12.5846 12.8866 0 12.5346 0 12.3069 0 12.4675 0 12.5587 0 0 13.2999 0 0 0 0 0 0 13.4172 0 11.7792 0 0 0 13.4802 0 0 0 0 0 11.6665 13.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7357 14.8389 14.8042 0 12.2855 0 0 0 0 0 0 13.2886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3873 0 0 0 12.1784 0 14.7457 0 0 0 0 0 12.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.372 0 13.5875 0 14.5376 0 0 0 0 14.6267 14.7405 11.583 0 15.2883 0 0 0 0 0 Q6DHV7 ADAL_HUMAN "Adenosine deaminase-like protein, EC 3.5.4.- (Adenosine deaminase-like protein isoform 1) (N6-mAMP deaminase, HsMAPDA) (N6-methyl-AMP aminohydrolase)" ADAL ADAL1 Homo sapiens (Human) adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] cytosol [GO:0005829]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-mAMP deaminase activity [GO:0062154]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117] GO:0004000; GO:0005829; GO:0006154; GO:0009117; GO:0046103; GO:0046872; GO:0062154 adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-mAMP deaminase activity [GO:0062154] GGPLVAK 0.99273 -15.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0247 0 0 0 0 0 0 0 0 0 0 0 0 15.9118 0 0 0 0 0 0 0 0 0 0 0 0 13.4274 0 0 0 0 0 0 0 0 13.3479 13.5194 0 0 0 0 0 0 0 10.5776 0 0 0 0 13.0234 0 0 0 0 13.0545 13.7743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NZY4 ZCHC8_HUMAN Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8) ZCCHC8 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; ncRNA processing [GO:0034470]; snRNA catabolic process [GO:0016076]" catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499] "catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA splicing, via spliceosome [GO:0000398]; ncRNA processing [GO:0034470]; snRNA catabolic process [GO:0016076]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008270; GO:0016076; GO:0016604; GO:0031499; GO:0034470; GO:0071013 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] AENQELK 0.99273 -6.4131 0 0 0 11.3869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.958 0 12.3099 0 0 12.3519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6799 0 0 0 0 0 0 0 0 0 0 0 12.4562 13.2655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTY3 PRS45_HUMAN "Putative serine protease 45, EC 3.4.21.- (Serine protease 45, pseudogene) (Testis serine protease 5)" PRSS45P PRSS45 TESSP5 Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508 serine-type endopeptidase activity [GO:0004252] CDRHYKK 0.99273 -15.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4H7 HAUS6_HUMAN HAUS augmin-like complex subunit 6 HAUS6 DGT6 FAM29A KIAA1574 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; spindle assembly [GO:0051225] GO:0000226; GO:0005813; GO:0005829; GO:0007098; GO:0008017; GO:0051225; GO:0051301; GO:0070652; GO:1990498 microtubule binding [GO:0008017] CHFARSR 0.99273 -59.925 0 0 0 0 0 0 0 0 0 14.3274 0 0 0 0 0 0 0 0 0 0 0 10.7846 0 0 0 10.1944 0 0 0 0 12.6656 0 0 0 0 0 12.8809 0 0 12.4633 0 0 0 0 0 15.124 0 0 0 13.4681 0 0 0 11.8716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.282 0 12.496 0 9.83638 0 12.7182 14.525 0 0 13.0783 13.578 0 12.6768 0 0 9.97857 0 0 0 0 10.8314 0 12.3177 13.6472 13.4116 14.5825 0 0 0 11.613 14.9765 13.4225 13.6437 0 0 0 12.7479 13.2109 0 0 0 13.7571 14.5816 13.6095 12.946 14.7455 0 0 14.5333 0 0 0 13.8171 0 13.3884 13.5889 13.0318 0 15.2865 14.3818 0 0 13.279 13.0862 0 0 0 14.2461 14.0573 0 10.7327 0 0 0 0 0 14.9012 0 0 0 0 0 0 0 0 0 0 0 15.6296 0 0 0 0 0 0 14.6832 0 15.2635 0 0 0 0 0 0 0 Q7Z7H5 TMED4_HUMAN "Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25, ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3, p24alpha3)" TMED4 ERS25 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0016021; GO:0030134; GO:0043123 DKLTELQLRAR 0.99273 -15.111 0 0 0 11.1455 0 0 0 11.5569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9545 0 0 0 0 0 0 0 0 15.1975 11.9146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5787 0 0 0 0 0 0 0 0 Q86VQ1 GLCI1_HUMAN Glucocorticoid-induced transcript 1 protein GLCCI1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 GSQHSPTR 0.99273 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2258 0 10.3584 0 0 0 0 0 0 0 0 0 12.0436 0 0 0 0 0 0 0 0 Q86WN1 FCSD1_HUMAN "F-BAR and double SH3 domains protein 1 (Protein nervous wreck 2, NWK2)" FCHSD1 UNQ737/PRO1431 Homo sapiens (Human) membrane organization [GO:0061024]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin filament polymerization [GO:0030833] cell projection [GO:0042995]; cuticular plate [GO:0032437]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; recycling endosome [GO:0055037] cell projection [GO:0042995]; cuticular plate [GO:0032437]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; recycling endosome [GO:0055037]; lipid binding [GO:0008289]; membrane organization [GO:0061024]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin filament polymerization [GO:0030833] GO:0007274; GO:0008289; GO:0030833; GO:0030838; GO:0031594; GO:0032437; GO:0042995; GO:0043204; GO:0055037; GO:0061024 lipid binding [GO:0008289] AQAEVLQSVRELSR 0.99273 -26.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3731 11.6051 0 0 0 0 12.6594 0 0 12.3513 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3613 0 15.9586 0 0 0 0 0 0 0 0 0 0 Q8IXZ2 ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor) ZC3H3 KIAA0150 SMICL ZC3HDC3 Homo sapiens (Human) mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927]; regulation of mRNA polyadenylation [GO:1900363] GO:0003677; GO:0005634; GO:0005847; GO:0031124; GO:0032927; GO:0046872; GO:0051028; GO:0070412; GO:1900363 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412] AFSARYPR 0.99273 -17.437 0 0 0 9.47017 0 0 0 0 0 13.1347 0 0 0 11.783 16.2693 0 12.0027 10.4655 0 0 0 0 0 0 0 0 0 13.0966 0 0 0 13.7508 0 12.4763 0 0 0 0 0 0 11.8336 0 0 0 0 0 0 0 0 12.0799 0 0 0 0 11.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5371 0 0 12.5253 12.9816 0 0 12.0131 0 0 0 0 0 10.7163 11.5058 0 0 0 0 0 0 0 0 0 14.2877 0 12.8828 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 0 0 11.6616 0 11.9202 13.3257 0 0 0 0 0 0 0 13.9049 0 0 12.4848 12.6683 0 0 0 13.1943 0 0 12.9105 0 0 0 12.1924 0 0 11.1831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8292 0 0 0 0 0 0 0 12.845 0 0 0 0 13.669 0 12.9997 Q8WWP7 GIMA1_HUMAN "GTPase IMAP family member 1 (Immunity-associated protein 1, hIMAP1)" GIMAP1 IMAP1 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; GTP binding [GO:0005525] GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0016021 GTP binding [GO:0005525] ELVAECGGRVCAFDNR 0.99273 -7.6334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0099 11.2643 0 0 0 0 12.2336 0 0 0 0 0 0 0 11.6776 14.6199 15.399 14.6976 0 14.6221 0 12.6779 15.1912 13.7887 14.4989 0 0 0 13.9541 15.0015 0 0 0 0 0 0 0 13.4445 0 0 0 0 0 0 0 13.5461 14.5688 0 0 0 0 0 0 0 0 0 0 13.1211 0 11.8194 0 0 0 0 0 0 0 0 0 0 11.7626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.61 Q8WXA8 5HT3C_HUMAN "5-hydroxytryptamine receptor 3C, 5-HT3-C, 5-HT3C (Serotonin receptor 3C)" HTR3C Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; serotonin-activated cation-selective channel complex [GO:1904602]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; serotonin receptor signaling pathway [GO:0007210]; signal transduction [GO:0007165] GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007210; GO:0007268; GO:0022850; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0098662; GO:1904315; GO:1904602 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; serotonin-gated cation-selective channel activity [GO:0022850]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] EPGELAGK 0.99273 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9562 0 0 0 0 0 0 10.5296 0 0 10.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8661 0 0 0 0 0 0 0 0 10.6133 10.9602 0 0 0 0 0 0 0 0 0 0 11.1626 0 10.8678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FZ7 CHMP6_HUMAN "Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20, Vps20, hVps20)" CHMP6 VPS20 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0007175; GO:0010008; GO:0015031; GO:0016020; GO:0016236; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0047485; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904902; GO:1904930 protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877] AILQLKQQR 0.99273 -18.395 14.1389 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3748 18.1159 18.3821 18.2203 19.0247 17.635 0 17.5066 0 0 16.8803 0 16.3579 0 17.4965 17.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7858 0 14.4184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.567 12.162 0 0 13.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RD9 FCRL5_HUMAN "Fc receptor-like protein 5, FcR-like protein 5, FcRL5 (BXMAS1) (Fc receptor homolog 5, FcRH5) (Immune receptor translocation-associated protein 2) (CD antigen CD307e)" FCRL5 FCRH5 IRTA2 UNQ503/PRO820 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166] GO:0004888; GO:0005887; GO:0007166; GO:0009986; GO:0043235 transmembrane signaling receptor activity [GO:0004888] AATMPYSVISDSPR 0.99273 -15.116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2709 11.7153 0 0 0 0 0 0 0 0 0 12.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6609 0 0 12.7642 0 13.6936 0 0 0 0 0 0 0 0 0 12.8488 0 0 0 0 0 0 0 0 0 0 13.9497 0 0 0 0 0 0 13.232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3283 0 0 11.5392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3779 0 9.68766 0 0 0 0 0 0 0 0 0 10.7897 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60986 13.055 0 0 0 0 0 0 0 13.1662 Q9H000 MKRN2_HUMAN "E3 ubiquitin-protein ligase makorin-2, EC 2.3.2.27 (RING finger protein 62) (RING-type E3 ubiquitin transferase makorin-2)" MKRN2 RNF62 HSPC070 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription factor catabolic process [GO:1901485]; protein kinase B signaling [GO:0043491]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; cell differentiation [GO:0030154]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription factor catabolic process [GO:1901485]; protein kinase B signaling [GO:0043491]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" GO:0000209; GO:0002862; GO:0003723; GO:0005634; GO:0005737; GO:0006351; GO:0007283; GO:0016567; GO:0030154; GO:0030274; GO:0043491; GO:0045944; GO:0046872; GO:0061630; GO:1901223; GO:1901485 LIM domain binding [GO:0030274]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] ACKYFEQGKGTCPFGSK 0.99273 -17.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.416 13.3399 0 13.3582 0 13.1652 0 13.2156 13.3929 0 13.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5631 0 12.9066 0 0 0 0 0 0 0 0 13.8076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3371 0 0 0 0 0 0 0 0 0 0 13.6126 0 0 0 0 0 0 0 13.4564 0 0 0 13.7208 0 0 0 0 0 0 0 14.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0W5 CCDC8_HUMAN Coiled-coil domain-containing protein 8 CCDC8 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; regulation of mitotic nuclear division [GO:0007088] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] 3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; microtubule cytoskeleton organization [GO:0000226]; regulation of mitotic nuclear division [GO:0007088] GO:0000226; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:1990393 APAVQGADNQR 0.99273 -18.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9931 0 0 0 0 0 0 0 0 0 0 0 0 12.307 0 0 12.3087 11.8816 11.892 0 12.0835 0 0 12.1592 0 0 0 0 0 0 12.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7104 0 0 0 12.9159 0 0 0 0 0 12.6763 12.1431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3674 0 0 0 0 0 0 0 14.5286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR20 DYRK4_HUMAN "Dual specificity tyrosine-phosphorylation-regulated kinase 4, EC 2.7.12.1" DYRK4 Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107] GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0018105; GO:0018107; GO:0043231; GO:0046872; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] HAWIHQSR 0.99273 -16.986 0 0 0 0 0 0 11.2395 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4856 14.4984 14.7331 14.7703 12.2616 0 0 0 12.8313 0 13.1556 0 0 0 0 0 0 12.7459 0 0 12.2224 13.1326 0 0 0 0 0 14.2226 0 0 0 0 0 0 0 12.9924 0 0 0 0 0 0 0 0 0 0 0 13.7195 0 0 13.6049 0 0 0 13.4486 0 0 0 0 12.4227 0 0 0 0 13.1468 0 12.5328 13.79 15.5447 14.1498 15.0062 0 0 0 0 0 0 0 14.7711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.924 0 0 0 0 0 0 0 0 Q9NSN8 SNTG1_HUMAN "Gamma-1-syntrophin, G1SYN (Syntrophin-4, SYN4)" SNTG1 Homo sapiens (Human) cell communication [GO:0007154] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198]; cell communication [GO:0007154] GO:0003779; GO:0005198; GO:0005634; GO:0005737; GO:0005856; GO:0007154; GO:0008022; GO:0016010; GO:0016013; GO:0032587 actin binding [GO:0003779]; protein C-terminus binding [GO:0008022]; structural molecule activity [GO:0005198] AVLWRYK 0.99273 -26.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6592 12.9617 0 0 0 0 0 0 0 0 12.1634 0 0 0 0 0 0 0 10.6745 0 0 0 0 0 0 0 0 0 0 0 0 10.4652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.26 0 0 0 0 12.0808 0 0 16.7898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3703 0 18.6447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3472 13.0875 0 0 0 0 0 10.7716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4584 10.8445 0 14.685 0 13.9821 0 0 0 0 0 0 13.5895 14.3952 0 0 10.6107 0 0 0 Q9NUN7 ACER3_HUMAN "Alkaline ceramidase 3, AlkCDase 3, Alkaline CDase 3, EC 3.5.1.-, EC 3.5.1.23 (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase, aPHC)" ACER3 APHC PHCA Homo sapiens (Human) ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270]; ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0016021; GO:0017040; GO:0030148; GO:0030173; GO:0030176; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0070774; GO:0071602; GO:0071633; GO:0102121 calcium ion binding [GO:0005509]; ceramidase activity [GO:0102121]; dihydroceramidase activity [GO:0071633]; N-acylsphingosine amidohydrolase activity [GO:0017040]; phytoceramidase activity [GO:0070774]; zinc ion binding [GO:0008270] DGLEKRYIASYLALTVVGMGSWCFHMTLK 0.99273 -7.6311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1773 0 0 0 0 0 0 0 0 0 0 0 0 10.5205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0336 0 0 0 0 0 0 0 0 14.324 0 0 0 0 0 0 0 14.4015 0 0 0 13.9706 0 0 0 0 0 0 0 13.1427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6404 0 Q9UK33 ZN580_HUMAN Zinc finger protein 580 (LDL-induced EC protein) ZNF580 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte chemotaxis [GO:0002690]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to hydrogen peroxide [GO:0070301]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte chemotaxis [GO:0002690]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001938; GO:0002690; GO:0005634; GO:0005654; GO:0006357; GO:0006935; GO:0006954; GO:0010595; GO:0010628; GO:0032757; GO:0046872; GO:0070301; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" MLLLPPR 0.99273 -17.421 0 0 0 13.4243 0 0 13.1275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y222 DMTF1_HUMAN "Cyclin-D-binding Myb-like transcription factor 1, hDMTF1 (Cyclin-D-interacting Myb-like protein 1, hDMP1)" DMTF1 DMP1 Homo sapiens (Human) "cell cycle [GO:0007049]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cell cycle [GO:0007049]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007049 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" DVEDLVNCH 0.99273 -14.746 0 0 0 0 0 0 0 0 0 0 10.2222 0 0 0 0 0 0 0 0 0 12.159 0 0 0 0 0 0 0 0 0 0 0 0 12.3899 0 0 0 0 0 0 0 0 0 0 0 12.3698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89594 0 0 0 0 0 0 0 0 0 0 0 14.0667 0 0 0 13.0758 0 13.5844 0 0 0 0 13.3153 0 17.3597 0 0 0 0 0 0 15.1801 0 0 0 0 0 0 0 0 0 0 11.3509 14.2186 0 0 0 13.6921 0 0 0 12.8696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2421 0 0 0 0 0 0 0 0 0 0 13.9166 0 0 O14561 ACPM_HUMAN "Acyl carrier protein, mitochondrial, ACP (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)" NDUFAB1 Homo sapiens (Human) "aerobic respiration [GO:0009060]; fatty acid biosynthetic process [GO:0006633]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein lipoylation [GO:0009249]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; calcium ion binding [GO:0005509]; fatty acid binding [GO:0005504]; aerobic respiration [GO:0009060]; fatty acid biosynthetic process [GO:0006633]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein lipoylation [GO:0009249]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0000035; GO:0000036; GO:0005504; GO:0005509; GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006633; GO:0009060; GO:0009249; GO:0016226; GO:0031966; GO:0032981; GO:0042776; GO:1990229 acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; calcium ion binding [GO:0005509]; fatty acid binding [GO:0005504] LYDKIDPEK 0.99274 -6.2484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1247 0 0 0 0 0 P0C7X2 ZN688_HUMAN Zinc finger protein 688 ZNF688 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" FAVEAHQWIHR 0.99274 -24.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8386 13.1149 0 0 0 0 0 12.5537 0 0 0 12.4759 0 0 12.9077 0 0 12.755 0 0 0 0 0 0 12.2856 0 0 0 12.7904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.086 0 0 0 15.4865 0 0 0 13.537 0 0 0 0 0 0 0 0 0 15.7468 0 0 0 0 0 0 0 14.6394 0 0 0 12.4631 0 0 12.1749 11.6483 14.2311 0 11.7314 0 0 0 0 0 0 0 0 0 0 0 12.6896 0 0 11.329 0 0 12.0913 0 0 12.5263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5982 0 P18583 SON_HUMAN "Protein SON (Bax antagonist selected in saccharomyces 1, BASS1) (Negative regulatory element-binding protein, NRE-binding protein) (Protein DBP-5) (SON3)" SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312 Homo sapiens (Human) "microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607] "nuclear speck [GO:0016607]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" GO:0000226; GO:0000281; GO:0003677; GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0043066; GO:0043484; GO:0048024; GO:0051726 DNA binding [GO:0003677]; RNA binding [GO:0003723] AGVPLPPNLKPAPPPTIEEK 0.99274 -62.693 0 0 0 0 0 0 0 0 0 0 13.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2064 0 0 0 0 0 0 0 12.5346 13.0151 13.9002 13.7408 0 0 13.4863 0 0 14.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0679 0 0 12.2474 0 0 14.4718 13.3563 0 11.6349 12.3827 0 14.5353 0 0 0 14.5252 13.2006 0 12.2125 0 0 12.4726 0 0 0 0 0 0 0 12.6911 13.0436 15.3686 0 0 14.7089 0 0 0 0 11.5014 13.3729 0 0 12.9073 0 0 13.1448 0 13.7776 13.8043 13.291 13.4512 0 0 0 0 0 0 12.4789 14.3823 12.2762 0 0 13.5997 0 0 0 13.5285 13.556 0 13.8361 13.1189 12.6122 12.2668 0 0 0 14.0073 0 0 15.9146 0 0 0 0 0 12.164 0 0 0 15.1215 18.2534 18.7256 18.0575 0 0 0 0 0 0 0 0 0 0 12.5675 13.4612 0 14.1748 0 13.6434 0 P19022 CADH2_HUMAN "Cadherin-2 (CDw325) (Neural cadherin, N-cadherin) (CD antigen CD325)" CDH2 CDHN NCAD Homo sapiens (Human) "blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cerebral cortex development [GO:0021987]; detection of muscle stretch [GO:0035995]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homeostasis of number of cells [GO:0048872]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mesenchymal cell migration [GO:0090497]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell development [GO:0014032]; neuroepithelial cell differentiation [GO:0060563]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein localization to plasma membrane [GO:0072659]; radial glial cell differentiation [GO:0060019]; regulation of axonogenesis [GO:0050770]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of synaptic transmission, glutamatergic [GO:0051966]; striated muscle cell differentiation [GO:0051146]; synapse assembly [GO:0007416]; type B pancreatic cell development [GO:0003323]" adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383] "adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cerebral cortex development [GO:0021987]; detection of muscle stretch [GO:0035995]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homeostasis of number of cells [GO:0048872]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mesenchymal cell migration [GO:0090497]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neural crest cell development [GO:0014032]; neuroepithelial cell differentiation [GO:0060563]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic vesicle clustering [GO:2000809]; protein localization to plasma membrane [GO:0072659]; radial glial cell differentiation [GO:0060019]; regulation of axonogenesis [GO:0050770]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; regulation of synaptic transmission, glutamatergic [GO:0051966]; striated muscle cell differentiation [GO:0051146]; synapse assembly [GO:0007416]; type B pancreatic cell development [GO:0003323]" GO:0003323; GO:0003723; GO:0005509; GO:0005737; GO:0005788; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0005916; GO:0005925; GO:0007043; GO:0007155; GO:0007156; GO:0007157; GO:0007416; GO:0007420; GO:0008013; GO:0009986; GO:0010001; GO:0014032; GO:0014069; GO:0014704; GO:0016323; GO:0016324; GO:0016327; GO:0016339; GO:0016342; GO:0019901; GO:0019903; GO:0021987; GO:0030027; GO:0030054; GO:0035995; GO:0042383; GO:0042802; GO:0043005; GO:0043410; GO:0044331; GO:0044853; GO:0045177; GO:0045294; GO:0045295; GO:0045296; GO:0048514; GO:0048854; GO:0048872; GO:0050770; GO:0051146; GO:0051966; GO:0060019; GO:0060563; GO:0062023; GO:0070445; GO:0072659; GO:0090090; GO:0090497; GO:0097118; GO:0097150; GO:0098609; GO:0098742; GO:0099059; GO:0099060; GO:1902897; GO:2000809 alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723] CRIAGALRTLLPLLAALLQASVEASGEIALCK 0.99274 -7.3059 0 0 0 11.0277 0 0 12.7497 0 0 0 0 0 0 0 0 0 0 0 0 13.6743 0 0 0 0 0 0 0 0 12.44 14.3327 0 0 11.5239 13.1239 12.2651 0 0 0 14.2942 14.6633 0 0 0 10.3921 0 0 10.6788 0 0 0 0 0 0 0 10.6026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0609 0 13.8951 11.8034 0 0 0 10.5681 0 14.2785 11.5683 0 11.9233 0 13.1944 0 14.3282 15.7419 14.71 0 0 15.5364 13.2814 14.8121 14.5712 15.1717 13.921 13.6881 0 13.6687 0 0 15.2544 0 12.4949 0 0 0 0 0 0 0 13.1043 0 12.0177 13.487 13.9141 0 13.7246 13.4534 13.2401 0 0 0 0 0 0 13.8508 0 0 12.8723 0 0 0 12.7203 13.3662 0 12.8919 12.4852 0 0 13.7174 11.5047 0 0 0 13.9008 12.7751 0 0 13.7827 10.2563 13.7767 0 0 0 0 0 0 12.0434 0 0 0 12.6485 12.9393 0 0 0 0 0 0 11.5497 0 12.7437 0 0 0 12.894 0 0 P19338 NUCL_HUMAN Nucleolin (Protein C23) NCL Homo sapiens (Human) "angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]" cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; DNA topoisomerase binding [GO:0044547]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]" GO:0001525; GO:0001533; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005694; GO:0005730; GO:0005938; GO:0008022; GO:0016020; GO:0017148; GO:0036464; GO:0042162; GO:0042802; GO:0044547; GO:0045944; GO:0048026; GO:0048027; GO:0070062; GO:0071364; GO:0140297; GO:1901838; GO:1990830; GO:1990904 DNA topoisomerase binding [GO:0044547]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] AAATSAK 0.99274 -63.078 10.1136 0 0 0 0 0 0 0 13.1494 0 0 0 15.4368 15.4969 15.075 12.4601 10.2482 11.9774 0 0 0 9.51454 10.5376 12.6131 0 14.4834 0 0 0 0 0 0 0 0 15.0384 0 0 12.6083 0 14.6304 14.2177 14.5356 14.2242 0 13.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7049 0 15.0789 0 0 14.3801 14.0525 14.0141 0 0 0 0 0 16.2744 0 0 13.6544 12.968 12.8277 0 14.3937 14.4206 0 0 13.7562 0 0 0 0 0 0 14.431 0 0 11.3207 13.9464 0 12.458 12.2074 0 0 0 0 13.2746 0 13.9729 0 0 0 0 0 0 0 11.5706 14.2199 13.683 0 0 0 14.2365 13.2174 15.5657 11.885 0 0 0 0 13.7578 0 0 15.32 0 15.1245 14.5918 0 13.7952 0 10.5418 0 0 0 14.3473 0 12.3661 0 0 14.3965 0 0 11.5988 14.1117 11.49 13.5505 0 0 13.8366 0 0 14.6892 0 14.352 0 0 P29803 ODPAT_HUMAN "Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial, EC 1.2.4.1 (PDHE1-A type II)" PDHA2 PDHAL Homo sapiens (Human) acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; pyruvate metabolic process [GO:0006090]; tricarboxylic acid cycle [GO:0006099] GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006086; GO:0006090; GO:0006099; GO:0034604 pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604] AEGLKYYR 0.99274 -25.317 0 0 0 0 0 0 0 0 0 11.5084 0 0 0 0 14.2383 10.5069 0 12.6233 0 0 0 0 0 0 0 0 0 0 0 0 13.2319 0 11.8428 0 0 11.66 0 12.2048 0 11.1427 0 0 0 0 11.8428 11.9445 0 0 0 0 0 0 11.4324 0 10.0682 0 0 0 0 0 0 0 0 0 0 0 11.3404 0 0 0 0 0 0 0 11.8162 13.32 0 0 13.3394 0 13.1521 0 0 15.0867 0 0 0 0 0 0 0 0 0 0 0 14.5393 0 0 0 14.6825 14.4995 0 0 0 0 0 13.4631 0 11.7933 0 0 0 0 0 13.9376 0 0 0 0 0 0 0 11.306 0 0 13.3857 15.1788 15.1625 0 11.5994 0 0 12.5537 0 0 0 0 0 0 14.0335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5725 14.8083 14.0267 13.936 13.9401 0 13.9044 0 0 0 14.3589 14.1943 0 13.0998 0 0 0 0 0 0 0 12.5298 0 0 P62244 RS15A_HUMAN 40S ribosomal protein S15a (Small ribosomal subunit protein uS8) RPS15A OK/SW-cl.82 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; response to virus [GO:0009615]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0008284; GO:0009615; GO:0016020; GO:0022626; GO:0022627; GO:0045787; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GKRQVLIR 0.99274 -6.4264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8643 0 0 0 0 0 0 9.40597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.629 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8997 0 0 0 0 0 0 Q02880 TOP2B_HUMAN "DNA topoisomerase 2-beta, EC 5.6.2.2 (DNA topoisomerase II, beta isozyme)" TOP2B Homo sapiens (Human) axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; axonogenesis [GO:0007409]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]" GO:0000712; GO:0000819; GO:0001764; GO:0003677; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006265; GO:0007409; GO:0008022; GO:0019899; GO:0030900; GO:0042826; GO:0045870; GO:0046872; GO:0046982; GO:1990904 "ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]" AKSGGCGAGAGVGGGNGALTWVTLFDQNNAAK 0.99274 -63.598 0 0 0 0 12.4779 0 0 10.0058 0 0 0 0 0 14.4873 0 0 0 12.8057 0 11.0594 0 0 0 0 0 0 0 0 13.4489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5564 0 0 13.8276 13.4246 0 0 0 0 0 12.8159 0 13.5036 14.1877 12.7029 14.4842 15.5108 0 0 0 0 16.3782 14.865 16.682 14.2098 16.1021 15.7995 16.1744 15.0933 0 15.1896 17.0553 12.545 0 12.8041 13.4315 13.2717 16.7207 15.16 14.2951 0 12.22 0 12.799 13.7177 14.8769 16.4166 15.6975 14.0159 14.4965 13.1972 0 13.5491 0 14.3211 14.7223 13.8057 15.8102 0 14.8688 0 13.936 14.4882 0 14.3903 0 15.2282 14.8948 0 0 11.9314 13.8378 11.615 13.9994 0 12.5574 0 0 0 0 0 0 12.8838 0 13.7022 0 15.5713 15.7882 0 0 0 0 0 0 0 14.8113 13.6336 14.7866 0 0 0 14.6787 14.4985 13.5486 14.1253 14.4461 0 13.6885 11.7635 0 0 15.2766 0 Q16665 HIF1A_HUMAN "Hypoxia-inducible factor 1-alpha, HIF-1-alpha, HIF1-alpha (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78, bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8)" HIF1A BHLHE78 MOP1 PASD8 Homo sapiens (Human) "angiogenesis [GO:0001525]; axonal transport of mitochondrion [GO:0019896]; B-1 B cell homeostasis [GO:0001922]; bone mineralization [GO:0030282]; cardiac ventricle morphogenesis [GO:0003208]; cellular glucose homeostasis [GO:0001678]; cellular iron ion homeostasis [GO:0006879]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to virus [GO:0098586]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen metabolic process [GO:0032963]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; elastin metabolic process [GO:0051541]; embryonic hemopoiesis [GO:0035162]; embryonic placenta development [GO:0001892]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial to mesenchymal transition [GO:0001837]; glandular epithelial cell maturation [GO:0002071]; heart looping [GO:0001947]; hemoglobin biosynthetic process [GO:0042541]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intestinal epithelial cell maturation [GO:0060574]; iris morphogenesis [GO:0061072]; lactate metabolic process [GO:0006089]; lactation [GO:0007595]; mesenchymal cell apoptotic process [GO:0097152]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of TOR signaling [GO:0032007]; neural crest cell migration [GO:0001755]; neural fold elevation formation [GO:0021502]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; outflow tract morphogenesis [GO:0003151]; oxygen homeostasis [GO:0032364]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of aerobic respiration [GO:1903715]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to muscle activity [GO:0014850]; response to reactive oxygen species [GO:0000302]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; vascular endothelial growth factor production [GO:0010573]; visual learning [GO:0008542]" axon cytoplasm [GO:1904115]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; motile cilium [GO:0031514]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667] "axon cytoplasm [GO:1904115]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; motile cilium [GO:0031514]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]; ubiquitin protein ligase binding [GO:0031625]; angiogenesis [GO:0001525]; axonal transport of mitochondrion [GO:0019896]; B-1 B cell homeostasis [GO:0001922]; bone mineralization [GO:0030282]; cardiac ventricle morphogenesis [GO:0003208]; cellular glucose homeostasis [GO:0001678]; cellular iron ion homeostasis [GO:0006879]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to virus [GO:0098586]; cerebral cortex development [GO:0021987]; chondrocyte differentiation [GO:0002062]; collagen metabolic process [GO:0032963]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; digestive tract morphogenesis [GO:0048546]; dopaminergic neuron differentiation [GO:0071542]; elastin metabolic process [GO:0051541]; embryonic hemopoiesis [GO:0035162]; embryonic placenta development [GO:0001892]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial to mesenchymal transition [GO:0001837]; glandular epithelial cell maturation [GO:0002071]; heart looping [GO:0001947]; hemoglobin biosynthetic process [GO:0042541]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intestinal epithelial cell maturation [GO:0060574]; iris morphogenesis [GO:0061072]; lactate metabolic process [GO:0006089]; lactation [GO:0007595]; mesenchymal cell apoptotic process [GO:0097152]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of TOR signaling [GO:0032007]; neural crest cell migration [GO:0001755]; neural fold elevation formation [GO:0021502]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; outflow tract morphogenesis [GO:0003151]; oxygen homeostasis [GO:0032364]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of aerobic respiration [GO:1903715]; regulation of gene expression [GO:0010468]; regulation of glycolytic process [GO:0006110]; regulation of protein neddylation [GO:2000434]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to muscle activity [GO:0014850]; response to reactive oxygen species [GO:0000302]; retina vasculature development in camera-type eye [GO:0061298]; signal transduction [GO:0007165]; TOR signaling [GO:0031929]; vascular endothelial growth factor production [GO:0010573]; visual learning [GO:0008542]" GO:0000302; GO:0000785; GO:0000791; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001223; GO:0001228; GO:0001525; GO:0001666; GO:0001678; GO:0001755; GO:0001837; GO:0001892; GO:0001922; GO:0001938; GO:0001947; GO:0002039; GO:0002052; GO:0002062; GO:0002071; GO:0002248; GO:0003151; GO:0003208; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006089; GO:0006110; GO:0006355; GO:0006357; GO:0006879; GO:0007165; GO:0007405; GO:0007595; GO:0008542; GO:0010039; GO:0010468; GO:0010573; GO:0010575; GO:0010628; GO:0010629; GO:0010634; GO:0014850; GO:0016239; GO:0016604; GO:0016607; GO:0016922; GO:0019896; GO:0019899; GO:0019901; GO:0019904; GO:0021502; GO:0021987; GO:0030282; GO:0030502; GO:0030949; GO:0031514; GO:0031625; GO:0031929; GO:0032007; GO:0032364; GO:0032722; GO:0032909; GO:0032963; GO:0032991; GO:0035162; GO:0035773; GO:0035774; GO:0042541; GO:0042826; GO:0043536; GO:0043619; GO:0045648; GO:0045766; GO:0045821; GO:0045893; GO:0045926; GO:0045944; GO:0046716; GO:0046886; GO:0046982; GO:0048546; GO:0051000; GO:0051402; GO:0051541; GO:0051879; GO:0060574; GO:0061030; GO:0061072; GO:0061298; GO:0061419; GO:0061629; GO:0070101; GO:0070244; GO:0070888; GO:0071347; GO:0071456; GO:0071542; GO:0090575; GO:0097152; GO:0097411; GO:0098586; GO:1900017; GO:1902895; GO:1903377; GO:1903599; GO:1903715; GO:1904115; GO:2000273; GO:2000378; GO:2000434; GO:2001054 "DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator binding [GO:0001223]; ubiquitin protein ligase binding [GO:0031625]" DRMEDIK 0.99274 -16.295 12.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1058 0 0 0 0 12.479 0 12.8929 0 0 0 0 0 11.102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2925 0 13.2629 0 0 0 14.6601 0 0 0 0 0 0 0 0 14.2641 0 0 0 0 14.5424 0 10.5231 0 0 0 0 0 0 0 0 12.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4187 0 0 12.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16825 PTN21_HUMAN "Tyrosine-protein phosphatase non-receptor type 21, EC 3.1.3.48 (Protein-tyrosine phosphatase D1)" PTPN21 PTPD1 Homo sapiens (Human) protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005737; GO:0005856; GO:0006470 protein tyrosine phosphatase activity [GO:0004725] EETIQFQTEDMETAKYIWR 0.99274 -62.841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.351 11.8802 0 13.0449 10.9213 0 10.3015 0 0 0 0 0 0 0 0 0 0 0 0 13.0745 0 0 0 14.1021 0 0 0 13.7166 0 0 0 13.7538 14.0464 15.9066 0 0 14.649 13.5204 15.805 16.1509 0 15.6019 15.7773 0 0 0 0 0 0 0 0 16.0221 13.4215 16.4725 13.3551 0 0 0 15.2356 14.8989 17.0731 15.9626 0 15.8706 0 15.8943 15.6888 0 0 0 0 0 0 15.9835 0 13.0244 0 0 13.6286 15.1464 15.3734 0 15.6056 15.5594 0 15.6351 15.2615 15.158 0 0 0 0 0 0 0 0 13.4459 14.5745 13.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9864 14.7808 14.8358 0 0 0 14.803 0 Q3KQU3 MA7D1_HUMAN MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1) MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819] cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; microtubule cytoskeleton organization [GO:0000226] GO:0000226; GO:0005737; GO:0005819; GO:0015630 AKYLAAKK 0.99274 -44.396 0 13.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6538 0 0 0 0 0 0 0 0 0 0 13.6379 0 0 0 0 0 12.2759 0 0 0 0 0 0 16.0213 0 0 14.682 14.7735 0 14.4614 14.6374 0 14.8121 0 14.3798 14.2444 0 0 14.7705 0 0 0 0 0 0 0 13.2025 14.1294 0 0 0 0 0 0 0 13.6323 0 0 15.1486 0 0 0 13.4325 0 0 0 13.6661 0 0 0 0 0 0 0 0 12.9143 13.0783 12.397 0 14.5171 0 0 0 12.6257 14.2589 0 0 0 0 14.7282 0 0 0 0 0 0 0 0 0 12.3569 0 0 0 0 0 12.0702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2Q9 PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220) PRPF8 PRPC8 Homo sapiens (Human) "cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070] ADWWTNTAHYNRERIR 0.99274 -62.967 0 0 0 0 0 0 0 0 0 11.4452 0 0 0 0 0 0 9.88269 0 0 9.91355 0 0 12.9523 0 0 0 0 12.7217 0 11.3999 0 0 11.4452 0 12.4788 0 0 11.1426 12.5218 0 0 0 0 0 11.4382 0 0 0 0 0 11.5157 0 0 0 0 0 0 0 0 0 10.2005 0 0 0 10.6401 0 0 0 10.6166 11.5476 0 10.703 10.7959 12.0679 17.4866 11.5884 0 12.7926 13.962 14.9054 0 14.3308 0 0 11.9462 13.1368 14.5236 14.8445 12.6323 13.3749 13.5557 13.2305 14.1657 0 13.0756 14.5603 0 18.3274 12.664 14.6886 16.0562 12.4752 15.4197 14.4669 13.4201 13.7614 13.6663 0 14.4761 14.6684 14.8708 0 13.8328 14.3318 13.2275 14.1018 13.2493 13.8978 0 14.9011 12.2574 13.3485 0 0 14.9835 0 12.7263 13.7271 13.5933 12.4781 14.7031 12.1155 14.3652 15.1355 14.2811 16.0752 0 12.8083 13.4148 14.868 13.3432 0 13.7106 14.7663 0 12.6772 0 12.69 0 0 13.4101 14.1257 0 0 13.8471 0 14.2528 0 11.7766 12.3809 13.1711 12.6035 0 0 13.1368 0 0 13.5063 12.7461 0 0 11.9487 14.7204 13.432 15.2674 12.7616 14.3458 13.2391 11.9131 0 Q8IWN7 RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein RP1L1 Homo sapiens (Human) axoneme assembly [GO:0035082]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] axoneme [GO:0005930]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] axoneme [GO:0005930]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; axoneme assembly [GO:0035082]; intracellular signal transduction [GO:0035556]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601] GO:0001750; GO:0005874; GO:0005930; GO:0007601; GO:0032391; GO:0035082; GO:0035556; GO:0042461; GO:0045494; GO:0060041 ACACATNEDEAER 0.99274 -62.131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0487 0 13.772 0 13.0107 0 0 0 0 0 0 0 0 0 0 14.0683 0 0 0 0 13.1531 0 0 0 0 0 0 0 0 0 12.6178 0 0 0 0 0 11.5781 11.6435 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7688 11.8806 0 0 0 15.1168 14.8547 13.152 15.4127 15.2666 15.7673 0 0 15.426 0 13.3554 0 14.7571 0 0 0 0 0 0 13.7041 0 0 0 0 14.7145 12.7543 0 14.2632 13.9909 14.4579 0 0 0 13.2483 14.5141 14.8938 13.533 0 13.5891 12.8366 0 0 14.2011 13.5226 13.3773 0 0 0 0 0 0 0 0 0 0 0 14.1994 13.8578 14.5214 0 11.1768 0 14.2349 16.7452 0 13.3872 14.3461 0 0 14.0678 0 14.1528 14.1013 0 13.4689 0 13.3519 15.0451 15.0705 0 0 12.091 0 0 0 13.2499 13.604 0 0 0 13.1105 11.1724 0 12.3209 0 13.065 15.0382 0 13.903 0 0 0 13.5925 0 0 0 Q8IYT3 CC170_HUMAN Coiled-coil domain-containing protein 170 CCDC170 C6orf97 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226] ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794] ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226] GO:0000226; GO:0005794; GO:0008017; GO:0036064 microtubule binding [GO:0008017] AEMESYK 0.99274 -24.247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2046 0 0 0 11.9613 0 0 0 0 0 16.958 0 0 0 0 0 0 13.5495 0 13.5552 0 0 0 0 0 0 0 0 11.8281 0 0 0 0 0 13.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4683 0 0 13.3574 0 0 0 0 0 12.3761 13.7255 0 13.3619 0 12.6695 0 0 0 0 0 0 11.7287 16.9424 12.3154 0 0 0 Q8N6M6 AMPO_HUMAN "Aminopeptidase O, AP-O, EC 3.4.11.-" AOPEP C9orf3 ONPEP Homo sapiens (Human) proteolysis [GO:0006508] cytosol [GO:0005829]; nucleolus [GO:0005730] cytosol [GO:0005829]; nucleolus [GO:0005730]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0005730; GO:0005829; GO:0006508; GO:0008270; GO:0070006 metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] EKEEVFEK 0.99274 -14.861 0 0 0 0 0 0 0 0 12.7477 12.628 0 12.5064 0 12.6574 12.7071 12.8617 12.5186 0 0 0 0 0 0 0 0 0 0 0 0 12.9025 13.3629 12.6802 12.7748 12.8691 12.5706 12.9911 13.0663 13.0849 0 0 0 0 12.5043 0 0 0 0 12.6531 0 12.6546 0 0 0 0 0 0 0 11.4542 0 0 0 12.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7777 0 0 12.867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6382 13.7461 0 0 0 0 13.3949 13.0033 0 13.9529 0 0 0 12.479 0 0 12.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4824 16.1776 0 0 0 0 0 0 0 0 0 0 18.7366 13.2679 0 12.4516 0 0 0 14.4959 0 12.4572 Q8NG98 OR7D4_HUMAN Olfactory receptor 7D4 (OR19-B) (Odorant receptor family subfamily D member 4RT) (Olfactory receptor OR19-7) OR7D4 OR7D4P Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LLSRADSCP 0.99274 -6.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92575 UBXN4_HUMAN UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2) UBXN4 KIAA0242 UBXD2 UBXDC1 Homo sapiens (Human) response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006986; GO:0030433 AAALLAKQAEMEVKR 0.99274 -17.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1234 0 0 0 0 0 13.164 0 0 0 0 0 13.0239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0748 0 0 0 0 0 15.9437 0 0 0 0 12.4583 0 0 14.0797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969U7 PSMG2_HUMAN "Proteasome assembly chaperone 2, PAC-2 (Hepatocellular carcinoma-susceptibility protein 3) (Tumor necrosis factor superfamily member 5-induced protein 1)" PSMG2 HCCA3 PAC2 TNFSF5IP1 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; proteasome assembly [GO:0043248] chaperone complex [GO:0101031]; cytosol [GO:0005829]; nucleus [GO:0005634] chaperone complex [GO:0101031]; cytosol [GO:0005829]; nucleus [GO:0005634]; molecular adaptor activity [GO:0060090]; chaperone-mediated protein complex assembly [GO:0051131]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; proteasome assembly [GO:0043248] GO:0005634; GO:0005829; GO:0007094; GO:0043066; GO:0043248; GO:0051131; GO:0060090; GO:0101031 molecular adaptor activity [GO:0060090] KLVALQLRSIFIK 0.99274 -14.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44093 0 0 0 0 0 0 0 0 0 0 0 0 15.5457 0 0 0 0 0 0 0 0 0 0 0 0 15.6262 14.0772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6551 0 0 13.4752 0 0 0 0 0 14.7367 0 0 0 0 0 0 14.7052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4899 0 0 Q96C34 RUND1_HUMAN RUN domain-containing protein 1 RUNDC1 LP5161 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; in utero embryonic development [GO:0001701] GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; in utero embryonic development [GO:0001701] GO:0001701; GO:0005096; GO:0090630 GTPase activator activity [GO:0005096] DYSPLLK 0.99274 -17.571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.848 13.1531 0 13.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6793 0 0 0 13.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8062 0 0 0 0 Q99996 AKAP9_HUMAN "A-kinase anchor protein 9, AKAP-9 (A-kinase anchor protein 350 kDa, AKAP 350, hgAKAP 350) (A-kinase anchor protein 450 kDa, AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein, CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9, PRKA9) (Protein yotiao)" AKAP9 AKAP350 AKAP450 KIAA0803 Homo sapiens (Human) cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076] centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165] GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007194; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0033138; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098962; GO:0098978; GO:0099147; GO:1901018; GO:1903358 DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] AKLGRSEER 0.99274 -61.346 0 0 0 0 10.6485 0 15.4415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1556 0 0 11.5644 10.8609 0 0 0 10.7092 0 0 0 13.7983 0 0 10.8969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8552 9.95407 12.8749 18.5331 17.9815 0 0 0 0 0 0 12.2446 0 0 0 0 0 14.9476 15.2457 0 0 0 14.9154 0 0 0 11.067 13.7425 17.6499 13.9723 14.175 0 13.8905 15.2448 16.2413 0 12.0841 11.6461 14.1588 14.1404 12.3101 17.6788 0 0 12.5183 15.1831 13.4132 0 0 0 0 0 0 11.8574 0 0 0 0 0 14.0904 13.8442 0 0 16.0758 0 0 0 0 0 0 0 14.3044 13.4823 0 0 14.8498 12.5387 0 0 0 13.919 0 0 0 0 12.9965 0 0 12.2755 0 14.961 0 0 0 0 0 12.7604 12.3815 0 14.8232 14.6953 13.595 11.8567 11.6071 0 11.9149 0 12.481 13.7696 14.2104 0 0 0 0 0 0 13.8799 0 12.2306 12.5448 0 13.126 0 0 0 Q9BS86 ZPBP1_HUMAN Zona pellucida-binding protein 1 (Inner acrosomal membrane IAM38) (Sp38) ZPBP ZPBP1 Homo sapiens (Human) acrosome assembly [GO:0001675]; binding of sperm to zona pellucida [GO:0007339] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; nucleus [GO:0005634]; zona pellucida receptor complex [GO:0002199] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; nucleus [GO:0005634]; zona pellucida receptor complex [GO:0002199]; acrosome assembly [GO:0001675]; binding of sperm to zona pellucida [GO:0007339] GO:0001669; GO:0001675; GO:0002080; GO:0002199; GO:0005576; GO:0005634; GO:0007339 AAGSLLSRAAILLFISAFLVRVPSSVGHLVR 0.99274 -16.301 0 0 10.2212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8762 0 13.0506 0 0 0 0 0 0 0 0 0 0 0 0 11.3825 0 0 11.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2975 0 0 0 0 0 15.3735 14.0345 14.9127 14.8045 12.5343 0 0 11.2553 0 0 0 0 12.1151 0 0 10.7879 12.7962 0 12.3351 0 12.2141 14.0458 0 12.0008 14.2961 0 0 0 0 14.5656 0 0 12.4881 0 0 0 11.3033 0 0 0 0 0 13.0163 0 0 0 0 13.4705 0 15.7423 0 0 12.094 12.8273 0 0 0 0 0 0 0 0 13.9617 0 12.17 0 0 0 11.9039 15.1609 10.2544 14.4881 13.2352 13.2363 0 0 0 0 11.1923 13.6966 14.4273 0 0 0 0 12.2272 0 0 11.7443 10.6537 0 0 0 0 0 0 0 Q9BW30 TPPP3_HUMAN Tubulin polymerization-promoting protein family member 3 (TPPP/p20) TPPP3 CGI-38 Homo sapiens (Human) decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273] cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874]; tubulin binding [GO:0015631]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273] GO:0001578; GO:0005737; GO:0005874; GO:0007566; GO:0015631; GO:0032273; GO:0046697; GO:0046785 tubulin binding [GO:0015631] FAIHGDPKASGQEMNGK 0.99274 -6.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5128 0 0 0 0 0 0 0 0 0 0 0 10.6041 0 13.518 0 13.3782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.214 0 0 0 0 12.4027 0 0 0 12.8034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXL6 CAR14_HUMAN "Caspase recruitment domain-containing protein 14 (CARD-containing MAGUK protein 2, Carma 2)" CARD14 CARMA2 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; CARD domain binding [GO:0050700]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0001934; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007250; GO:0016235; GO:0033209; GO:0043066; GO:0050700; GO:0051092 CARD domain binding [GO:0050700] CRSLQEELYLLKQELQR 0.99274 -24.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1994 0 0 0 0 12.7977 0 0 0 0 0 0 0 0 0 0 10.3251 0 0 0 12.3743 0 0 0 0 12.1506 0 0 0 0 0 0 0 13.3875 12.631 0 0 0 0 0 0 0 0 0 15.0832 14.3813 0 12.9109 0 13.8001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5695 0 0 0 12.695 0 0 14.1187 0 0 0 0 0 0 0 13.0295 0 0 0 11.9974 12.4966 0 12.8151 0 0 0 0 0 0 0 0 12.7724 0 0 11.2113 0 0 0 11.8855 12.3589 0 0 0 0 0 0 Q9BZZ2 SN_HUMAN "Sialoadhesin (Sialic acid-binding Ig-like lectin 1, Siglec-1) (CD antigen CD169)" SIGLEC1 SN Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; clathrin-dependent endocytosis of virus by host cell [GO:0075512]; inflammatory response [GO:0006954] early endosome [GO:0005769]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886] early endosome [GO:0005769]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; virion binding [GO:0046790]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; clathrin-dependent endocytosis of virus by host cell [GO:0075512]; inflammatory response [GO:0006954] GO:0005576; GO:0005769; GO:0005770; GO:0005886; GO:0006954; GO:0007160; GO:0016021; GO:0030246; GO:0046790; GO:0075512; GO:0098609 carbohydrate binding [GO:0030246]; virion binding [GO:0046790] DLQPEDSGSYNFR 0.99274 -17.048 0 0 0 0 0 11.0315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9148 0 0 0 0 0 0 0 13.3362 12.879 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0124 0 0 0 0 0 0 0 0 14.28 0 13.1206 0 13.2879 14.0885 0 0 0 0 12.2244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3949 0 0 0 0 14.279 0 0 0 0 0 0 0 0 0 0 0 14.4924 0 0 0 13.8649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2725 0 0 12.9562 0 0 0 0 Q9NRR6 INP5E_HUMAN "Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase, EC 3.1.3.86)" INPP5E Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]" GO:0000139; GO:0001726; GO:0004439; GO:0004445; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005929; GO:0005930; GO:0006661; GO:0014067; GO:0016314; GO:0017148; GO:0032580; GO:0034485; GO:0046855; GO:0046856; GO:1903565 "inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]" AAPIAPR 0.99274 -24.314 0 0 0 0 0 0 0 0 0 0 12.9664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0429 0 0 0 0 0 0 0 0 0 0 0 0 16.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9686 14.6878 0 0 0 0 0 0 0 15.0716 0 14.5105 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7634 0 12.9727 0 0 0 0 0 12.0778 0 0 0 0 0 0 0 0 0 13.912 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6365 0 0 0 0 0 0 0 0 0 0 0 13.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS91 RAD18_HUMAN "E3 ubiquitin-protein ligase RAD18, EC 2.3.2.27 (Postreplication repair protein RAD18, hHR18, hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18)" RAD18 RNF73 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell death [GO:0060548]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell death [GO:0060548]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513] GO:0000403; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0044877; GO:0046872; GO:0051865; GO:0051984; GO:0060548; GO:0061630; GO:0097505 damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403] DSLAESR 0.99274 -14.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3702 0 0 0 0 0 0 0 0 12.1653 0 11.8756 0 0 0 0 14.0095 0 0 0 0 15.4536 0 12.9822 0 13.7416 0 16.6947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5894 0 11.5295 0 0 0 0 0 0 0 0 14.1429 0 0 0 0 12.5092 17.2246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVU7 SDA1_HUMAN "Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1, hSDA)" SDAD1 NUC130 Homo sapiens (Human) protein transport [GO:0015031]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein transport [GO:0015031]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055] GO:0000055; GO:0005654; GO:0005730; GO:0015031; GO:0042273 ALILLRNKNLINPSSLLELFFELFR 0.99274 -26.374 0 0 0 0 0 0 0 0 0 14.8638 0 13.9537 13.9386 0 0 0 0 0 0 0 0 16.8716 0 0 0 0 0 0 0 0 0 0 0 14.39 0 0 0 13.3604 13.2756 16.4451 0 16.4325 16.8274 0 16.8647 12.5664 0 0 14.5548 13.9273 14.5886 0 0 0 0 16.2648 12.7686 17.567 0 16.5489 0 0 0 0 0 0 0 14.1856 10.8494 0 0 0 0 0 0 13.5786 0 12.88 0 13.6235 0 0 0 0 16.8137 13.9412 0 0 0 0 0 0 0 13.8086 0 14.7013 12.8818 0 0 13.004 0 14.2363 0 0 0 0 0 0 0 0 0 13.1559 13.8444 15.0402 0 0 11.955 15.0371 13.1775 11.7895 0 0 0 12.4931 13.7231 11.9899 14.3166 0 0 14.2516 19.0577 0 0 0 12.2915 0 0 0 0 0 0 0 0 0 13.7359 0 0 12.6768 0 0 0 0 11.7331 0 14.6434 0 13.2102 0 17.5899 0 0 0 13.0633 0 0 17.2033 17.3395 17.2356 0 0 0 0 0 0 0 0 0 0 0 0 Q9UN72 PCDA7_HUMAN "Protocadherin alpha-7, PCDH-alpha-7" PCDHA7 CNRS4 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell recognition [GO:0009988]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cell-cell recognition [GO:0009988]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0009988; GO:0042802 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] HRLLVLVK 0.99274 -6.2497 0 0 0 0 0 0 0 0 0 14.398 13.7136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2663 0 0 0 0 13.3549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7659 12.9164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2216 0 0 0 0 12.2164 0 12.674 0 0 0 0 0 13.8824 0 0 0 0 0 0 0 0 13.3491 0 0 10.6813 12.7624 12.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1553 13.9423 0 0 14.0835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6T7 DGKB_HUMAN "Diacylglycerol kinase beta, DAG kinase beta, EC 2.7.1.107 (90 kDa diacylglycerol kinase) (Diglyceride kinase beta, DGK-beta)" DGKB DAGK2 KIAA0718 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0030168; GO:0035556; GO:0045211; GO:0046339; GO:0046486; GO:0046834; GO:0070161 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951] CVARAPPSCIK 0.99274 -26.345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1056 14.1412 0 0 0 0 0 0 0 0 0 0 0 15.1209 0 0 0 0 11.8702 0 0 0 0 0 0 0 0 0 0 11.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5789 13.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8102 0 11.4884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3549 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GTL2 CT204_HUMAN Uncharacterized protein C20orf204 C20orf204 PRR17 Homo sapiens (Human) APASRDS 0.99275 -17.133 0 0 0 0 0 0 0 0 18.111 0 0 0 0 17.3673 0 0 0 17.2871 0 0 0 0 0 0 0 13.0863 0 0 0 0 0 17.0724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0287 0 0 0 0 0 0 0 0 0 0 16.2124 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3291 11.2525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9758 15.8842 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4755 13.7205 12.9772 0 0 0 0 0 0 0 14.332 0 0 0 19.5281 0 0 14.9489 0 0 0 0 0 0 0 0 19.3141 0 0 0 0 0 0 0 0 0 A7E2V4 ZSWM8_HUMAN Zinc finger SWIM domain-containing protein 8 ZSWIM8 KIAA0913 Homo sapiens (Human) positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270]; positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567] GO:0005829; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:1990756; GO:2000627 ubiquitin ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270] ALPSRPGASR 0.99275 -17.621 0 12.1273 0 0 12.2749 13.8569 13.5486 10.6691 15.7292 0 0 15.4254 0 15.0271 16.2047 0 0 0 0 0 0 10.6482 11.382 0 0 0 0 0 0 14.6085 0 15.1915 0 14.1644 0 15.2116 13.7766 0 15.2328 15.4145 0 15.7561 15.6937 0 0 15.2924 0 0 0 0 10.0526 0 0 0 0 0 0 0 0 0 11.908 12.934 12.484 0 0 0 11.6395 0 0 0 0 0 0 0 15.3612 0 11.1625 0 0 0 0 0 14.3406 0 0 13.2875 0 0 0 0 14.1444 0 0 0 0 0 0 13.2103 0 0 0 0 0 0 0 0 12.6218 0 0 0 13.0208 0 0 13.1354 0 0 0 0 14.4853 0 0 11.7727 0 12.7385 0 0 13.1935 0 0 0 0 0 0 13.3464 0 11.596 0 0 0 0 0 11.3798 0 0 0 13.3844 0 0 14.1889 0 0 0 15.2504 0 0 0 0 11.7976 0 0 0 0 0 12.4246 0 0 0 0 0 0 11.6491 0 0 0 0 0 10.5541 0 0 0 O43567 RNF13_HUMAN "E3 ubiquitin-protein ligase RNF13, EC 2.3.2.27 (RING finger protein 13)" RNF13 RZF Homo sapiens (Human) organelle localization [GO:0051640]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; organelle localization [GO:0051640]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000139; GO:0004842; GO:0005637; GO:0005654; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008432; GO:0016021; GO:0031902; GO:0043231; GO:0046872; GO:0051640; GO:0051865; GO:0061630; GO:0070304 JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] DEFTYEK 0.99275 -14.574 0 0 0 0 0 0 0 0 0 0 12.7908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4342 0 0 0 0 0 0 0 0 0 12.9283 0 0 0 11.8672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.866 0 0 0 0 0 14.5566 14.3884 0 0 15.0293 0 0 0 0 0 14.7507 0 14.9544 0 0 0 0 0 0 0 0 0 0 0 0 14.9926 14.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0246 0 0 0 0 0 0 13.0426 0 0 0 0 O60565 GREM1_HUMAN "Gremlin-1 (Cell proliferation-inducing gene 2 protein) (Cysteine knot superfamily 1, BMP antagonist 1) (DAN domain family member 2) (Down-regulated in Mos-transformed cells protein) (Increased in high glucose protein 2, IHG-2)" GREM1 CKTSF1B1 DAND2 DRM PIG2 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell morphogenesis [GO:0000902]; cell-cell signaling [GO:0007267]; collagen fibril organization [GO:0030199]; determination of dorsal identity [GO:0048263]; embryonic limb morphogenesis [GO:0030326]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone mineralization [GO:0030502]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of bone remodeling [GO:0046851]; negative regulation of bone trabecula formation [GO:1900155]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast proliferation [GO:0090291]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of receptor internalization [GO:0002092]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; sequestering of BMP from receptor via BMP binding [GO:0038098]; signal transduction [GO:0007165]; ureteric bud formation [GO:0060676]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; cytokine activity [GO:0005125]; morphogen activity [GO:0016015]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell morphogenesis [GO:0000902]; cell-cell signaling [GO:0007267]; collagen fibril organization [GO:0030199]; determination of dorsal identity [GO:0048263]; embryonic limb morphogenesis [GO:0030326]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone mineralization [GO:0030502]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of bone remodeling [GO:0046851]; negative regulation of bone trabecula formation [GO:1900155]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast proliferation [GO:0090291]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of receptor internalization [GO:0002092]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; sequestering of BMP from receptor via BMP binding [GO:0038098]; signal transduction [GO:0007165]; ureteric bud formation [GO:0060676]" GO:0000902; GO:0002042; GO:0002092; GO:0003337; GO:0005125; GO:0005615; GO:0006915; GO:0007165; GO:0007267; GO:0008284; GO:0009887; GO:0009954; GO:0009986; GO:0010717; GO:0016015; GO:0030199; GO:0030297; GO:0030308; GO:0030326; GO:0030502; GO:0030514; GO:0032331; GO:0033689; GO:0036122; GO:0038098; GO:0042803; GO:0043066; GO:0043184; GO:0045668; GO:0045766; GO:0045892; GO:0045944; GO:0046851; GO:0048018; GO:0048263; GO:0051092; GO:0051893; GO:0051973; GO:0055007; GO:0060173; GO:0060379; GO:0060394; GO:0060676; GO:0062023; GO:0090027; GO:0090090; GO:0090190; GO:0090291; GO:1900086; GO:1900155; GO:1900158; GO:1901224; GO:2000273 BMP binding [GO:0036122]; cytokine activity [GO:0005125]; morphogen activity [GO:0016015]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor 2 binding [GO:0043184] FCYGQCNSFYIPR 0.99275 -6.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7455 14.274 0 0 12.868 0 0 0 0 0 0 0 0 0 0 0 0 14.3963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4001 0 0 0 0 14.4275 0 P24298 ALAT1_HUMAN "Alanine aminotransferase 1, ALT1, EC 2.6.1.2 (Glutamate pyruvate transaminase 1, GPT 1) (Glutamic--alanine transaminase 1) (Glutamic--pyruvic transaminase 1)" GPT AAT1 GPT1 Homo sapiens (Human) biosynthetic process [GO:0009058]; cellular response to insulin stimulus [GO:0032869]; L-alanine catabolic process [GO:0042853]; positive regulation of gluconeogenesis [GO:0045722]; response to starvation [GO:0042594] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular response to insulin stimulus [GO:0032869]; L-alanine catabolic process [GO:0042853]; positive regulation of gluconeogenesis [GO:0045722]; response to starvation [GO:0042594] GO:0004021; GO:0005829; GO:0009058; GO:0030170; GO:0032869; GO:0042594; GO:0042853; GO:0045722; GO:0070062 L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170] ASSTGDR 0.99275 -14.889 15.8963 0 0 0 0 0 0 0 0 13.7712 0 0 13.1615 0 0 0 0 0 0 0 0 13.2588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.122 0 0 0 0 13.0684 14.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1047 0 13.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6683 0 0 0 12.4943 0 P30626 SORCN_HUMAN "Sorcin (22 kDa protein) (CP-22, CP22) (V19)" SRI Homo sapiens (Human) action potential [GO:0001508]; calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart development [GO:0007507]; intracellular sequestering of iron ion [GO:0006880]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart contraction [GO:0008016]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of striated muscle contraction [GO:0006942]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; action potential [GO:0001508]; calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart development [GO:0007507]; intracellular sequestering of iron ion [GO:0006880]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart contraction [GO:0008016]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of striated muscle contraction [GO:0006942]; signal transduction [GO:0007165] GO:0001508; GO:0002020; GO:0005102; GO:0005246; GO:0005509; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006816; GO:0006880; GO:0006942; GO:0007165; GO:0007507; GO:0007517; GO:0008016; GO:0010459; GO:0010649; GO:0010880; GO:0016020; GO:0016529; GO:0030018; GO:0030315; GO:0033017; GO:0035774; GO:0042802; GO:0042994; GO:0044325; GO:0046982; GO:0051281; GO:0051924; GO:0055118; GO:0060315; GO:0070062; GO:0086004; GO:0140297; GO:1901077; GO:1901841; GO:1901844; GO:2000678 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] ALTDSFR 0.99275 -4.4282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6 12.8143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34998 CRFR1_HUMAN "Corticotropin-releasing factor receptor 1, CRF-R-1, CRF-R1, CRFR-1 (Corticotropin-releasing hormone receptor 1, CRH-R-1, CRH-R1)" CRHR1 CRFR CRFR1 CRHR Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenal gland development [GO:0030325]; behavioral response to ethanol [GO:0048149]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; fear response [GO:0042596]; female pregnancy [GO:0007565]; general adaptation syndrome, behavioral process [GO:0051867]; immune response [GO:0006955]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; parturition [GO:0007567]; regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO:0010578]; regulation of corticosterone secretion [GO:2000852]" endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] "endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenal gland development [GO:0030325]; behavioral response to ethanol [GO:0048149]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; fear response [GO:0042596]; female pregnancy [GO:0007565]; general adaptation syndrome, behavioral process [GO:0051867]; immune response [GO:0006955]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; parturition [GO:0007567]; regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO:0010578]; regulation of corticosterone secretion [GO:2000852]" GO:0005768; GO:0005886; GO:0005887; GO:0006955; GO:0007166; GO:0007188; GO:0007189; GO:0007190; GO:0007565; GO:0007567; GO:0008528; GO:0010578; GO:0015056; GO:0016021; GO:0017046; GO:0030325; GO:0031226; GO:0042596; GO:0043005; GO:0043404; GO:0048149; GO:0051424; GO:0051458; GO:0051867; GO:0071376; GO:1901386; GO:2000852 corticotrophin-releasing factor receptor activity [GO:0015056]; corticotropin-releasing hormone binding [GO:0051424]; corticotropin-releasing hormone receptor activity [GO:0043404]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046] HSIRARVAR 0.99275 -14.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.565 0 0 0 0 0 16.8422 16.7454 16.8669 0 0 0 0 0 0 13.2142 16.7332 0 12.8335 0 10.4518 0 0 0 13.1569 13.1367 0 0 0 0 0 0 0 0 13.1942 0 0 13.0261 13.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0993 0 0 0 13.292 0 Q12952 FOXL1_HUMAN "Forkhead box protein L1 (Forkhead-related protein FKHL11) (Forkhead-related transcription factor 7, FREAC-7)" FOXL1 FKHL11 FREAC7 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; heart development [GO:0007507]; Peyer's patch morphogenesis [GO:0061146]; proteoglycan biosynthetic process [GO:0030166]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; visceral mesoderm-endoderm interaction involved in midgut development [GO:0007495]" GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007495; GO:0007507; GO:0008301; GO:0009653; GO:0030111; GO:0030154; GO:0030166; GO:0043565; GO:0061146 "DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" LGASLLAASSSLR 0.99275 -14.585 0 0 0 0 0 0 0 0 0 0 0 0 12.8489 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3541 0 0 0 0 0 0 0 0 0 0 12.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7396 0 0 0 0 0 0 0 0 0 0 0 0 0 11.636 0 0 0 0 0 0 0 0 0 14.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1631 0 0 0 Q13347 EIF3I_HUMAN "Eukaryotic translation initiation factor 3 subunit I, eIF3i (Eukaryotic translation initiation factor 3 subunit 2) (TGF-beta receptor-interacting protein 1, TRIP-1) (eIF-3-beta) (eIF3 p36)" EIF3I EIF3S2 TRIP1 Homo sapiens (Human) cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]" GO:0001732; GO:0002183; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0070062; GO:0071541 RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743] SITQIKYNR 0.99275 -6.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2787 0 0 0 0 0 0 0 13.6159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13901 C1D_HUMAN "Nuclear nucleic acid-binding protein C1D, hC1D" C1D Homo sapiens (Human) apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; maturation of 5.8S rRNA [GO:0000460]; regulation of gene expression [GO:0010468] GO:0000176; GO:0000178; GO:0000460; GO:0003677; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006915; GO:0010468; GO:0016922; GO:0017053 DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] NALWEPK 0.99275 -14.912 0 12.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9038 0 0 11.8609 0 0 0 0 0 0 11.9827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4873 13.1236 0 0 0 13.3622 0 0 0 0 0 0 0 0 0 0 0 13.1534 0 0 0 0 0 0 0 0 0 0 0 0 12.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3425 0 0 13.5818 13.5491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15067 ACOX1_HUMAN "Peroxisomal acyl-coenzyme A oxidase 1, AOX, EC 1.3.3.6 (Palmitoyl-CoA oxidase) (Peroxisomal fatty acyl-CoA oxidase) (Straight-chain acyl-CoA oxidase, SCOX) [Cleaved into: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain ]" ACOX1 ACOX Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; hydrogen peroxide biosynthetic process [GO:0050665]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid beta-oxidation [GO:0140493]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0003997; GO:0005504; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006091; GO:0006629; GO:0006693; GO:0007283; GO:0009062; GO:0016020; GO:0016401; GO:0016559; GO:0019395; GO:0030165; GO:0033540; GO:0042632; GO:0042803; GO:0047485; GO:0050660; GO:0050665; GO:0055088; GO:0071949; GO:0140493 acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485] AARLVEIAAKNLQK 0.99275 -6.0779 0 0 0 14.2264 0 0 0 0 0 0 11.1098 0 13.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4158 0 0 0 13.1519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1603 0 11.5522 0 0 12.8064 0 0 0 13.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4887 0 13.7618 0 13.3768 0 0 0 0 0 0 0 0 0 0 15.6726 0 0 11.2607 0 0 0 0 11.5136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3L8U1 CHD9_HUMAN "Chromodomain-helicase-DNA-binding protein 9, CHD-9, EC 3.6.4.12 (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator, CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein)" CHD9 KIAA0308 KISH2 PRIC320 AD-013 x0008 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] GO:0003677; GO:0003678; GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678] AMARLHKK 0.99275 -17.585 0 0 0 0 12.1256 0 0 0 15.5708 14.9167 0 13.6858 16.4714 15.7386 12.681 13.4006 0 0 0 13.3995 0 0 0 0 0 0 13.7313 12.5626 0 0 0 13.2569 0 0 12.4559 0 13.2144 12.4721 0 0 0 13.1481 14.9955 0 0 0 15.0322 0 0 0 0 0 0 13.1482 0 0 12.4146 15.9811 0 0 0 0 0 0 0 0 0 0 0 12.6986 14.8471 11.3839 0 12.2009 13.172 0 13.6822 0 14.7009 13.7178 13.2579 14.2394 13.6276 15.9493 14.081 14.2256 0 14.2383 13.7502 12.6437 0 0 13.4937 13.8048 0 13.1894 13.5521 13.502 0 13.5248 0 14.3001 12.1421 0 0 14.3175 0 0 0 0 0 0 13.8468 0 0 13.3469 0 0 0 13.9611 15.6787 13.8641 14.7234 0 13.8565 14.4963 13.9714 13.4163 13.6011 0 13.5548 13.3028 0 13.7631 0 14.1677 13.7818 15.0371 13.782 13.5831 14.1768 13.7769 0 0 13.5601 0 13.7631 12.2824 0 0 13.8111 15.2317 0 0 0 13.9723 0 14.6441 0 12.7783 0 0 13.8928 15.1972 14.9244 0 13.9562 0 13.0028 0 0 13.7999 13.9586 14.1943 14.6996 0 0 14.2628 14.2153 0 Q53RY4 KCP3_HUMAN "Keratinocyte-associated protein 3, KCP-3" KRTCAP3 KCP3 UNQ3066/PRO9898 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GAVTPEYTVANVISVGSGLLSVSVGLVALLASR 0.99275 -6.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3227 0 0 9.0794 0 0 0 0 0 0 11.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4427 0 0 0 0 0 0 0 0 0 12.2261 0 0 0 0 0 0 13.0362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6219 0 0 0 12.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7287 13.1193 0 0 0 0 0 0 12.7592 0 0 12.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5CZC0 FSIP2_HUMAN Fibrous sheath-interacting protein 2 FSIP2 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288] sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] sperm connecting piece [GO:0097224]; sperm end piece [GO:0097229]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; protein localization to cilium [GO:0061512]; sperm axoneme assembly [GO:0007288] GO:0007288; GO:0030317; GO:0061512; GO:0097224; GO:0097225; GO:0097228; GO:0097229 AHLKTRSK 0.99275 -70.277 13.5848 0 13.4319 0 0 0 17.0597 0 15.1929 0 11.7547 0 14.6255 12.39 0 11.472 0 15.8019 14.1401 13.9066 15.063 11.8055 15.2195 0 14.1545 14.1541 0 10.5112 13.9609 11.5523 0 13.7914 12.4296 14.079 12.352 13.3613 12.4844 0 14.1975 0 0 0 9.60644 13.6024 0 0 13.4155 0 12.5263 11.7561 0 15.0775 13.3551 0 14.6488 0 10.4214 0 0 0 0 0 0 0 0 0 0 15.4599 14.3809 15.5873 0 13.0361 14.9142 13.0022 15.4984 16.0695 16.2333 14.813 15.4831 14.5211 16.154 18.6977 14.986 14.5236 17.8534 17.5393 10.7689 14.8772 16.1162 15.3998 15.2915 15.0939 14.3257 16.1437 15.1773 13.7984 15.4116 13.1381 15.6746 15.2802 14.7248 17.1107 19.6383 16.9008 14.4546 15.3673 0 14.9873 16.5132 16.4972 16.7106 14.028 12.3279 12.6378 19.0688 13.6804 16.5888 15.2722 15.2507 15.7796 15.4659 15.193 14.4075 14.3861 15.4964 15.8934 18.7381 14.8028 15.8742 15.3011 15.7422 15.9176 16.0883 15.4427 15.6156 15.416 16.0199 15.1999 15.0305 17.3272 17.0834 16.5563 16.1758 16.2909 16.1718 14.1562 14.9224 16.9827 15.876 0 15.9325 14.391 13.9074 14.8017 16.2261 15.465 14.434 15.797 14.48 14.4354 16.2525 0 0 15.8753 15.7122 16.5341 15.9937 14.8012 15.9751 14.9511 15.8158 16.635 15.9104 12.1818 15.8267 13.4204 0 0 12.6518 0 Q5SVS4 KMCP1_HUMAN Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30) SLC25A30 KMCP1 Homo sapiens (Human) malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; thiosulfate transport [GO:0015709] GO:0005739; GO:0005743; GO:0006839; GO:0008272; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0016021; GO:0022857; GO:0035435; GO:0071422; GO:0071423 antiporter activity [GO:0015297]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; transmembrane transporter activity [GO:0022857] MMNQRVLR 0.99275 -7.3412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T7V8 GORAB_HUMAN "RAB6-interacting golgin (N-terminal kinase-like-binding protein 1, NTKL-BP1, NTKL-binding protein 1, hNTKL-BP1) (SCY1-like 1-binding protein 1, SCYL1-BP1, SCYL1-binding protein 1)" GORAB NTKLBP1 SCYL1BP1 Homo sapiens (Human) hair follicle morphogenesis [GO:0031069]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901622] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; hair follicle morphogenesis [GO:0031069]; non-motile cilium assembly [GO:1905515]; positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901622] GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0031069; GO:1901622; GO:1905515 AEAEYIAAK 0.99275 -6.0869 0 0 0 0 0 0 0 0 12.4489 0 0 0 0 0 0 0 0 13.0226 0 0 0 0 0 0 0 0 0 0 12.734 13.1989 11.5907 11.9347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9897 13.068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8673 0 0 12.3714 0 0 0 0 13.2234 13.5652 0 14.1225 0 0 12.5839 0 0 0 0 0 14.6412 0 12.6402 0 0 0 13.4722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6018 0 12.4207 0 0 11.7846 0 0 0 0 0 Q6UXF1 TM108_HUMAN Transmembrane protein 108 (Retrolinkin) TMEM108 KIAA1690 RTLN UNQ1875/PRO4318 Homo sapiens (Human) cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; dentate gyrus development [GO:0021542]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; postsynaptic density organization [GO:0097106]; receptor-mediated endocytosis [GO:0006898]; retrograde axonal transport [GO:0008090] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477] anchoring junction [GO:0070161]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; postsynaptic density [GO:0014069]; somatodendritic compartment [GO:0036477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; dendrite extension [GO:0097484]; dentate gyrus development [GO:0021542]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; postsynaptic density organization [GO:0097106]; receptor-mediated endocytosis [GO:0006898]; retrograde axonal transport [GO:0008090] GO:0005769; GO:0006898; GO:0008090; GO:0010008; GO:0014069; GO:0016021; GO:0021542; GO:0030424; GO:0030425; GO:0031175; GO:0036477; GO:0051388; GO:0070161; GO:0097106; GO:0097484; GO:0098815; GO:1904115; GO:1990416 GAGNSSR 0.99275 -14.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9051 16.7638 0 0 0 0 10.2489 0 0 16.8163 0 0 0 0 0 0 0 0 10.0662 0 0 12.5941 0 0 0 0 0 0 0 0 10.7614 0 0 0 0 11.5177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.176 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9816 0 13.1693 0 0 0 0 0 0 0 10.5166 0 0 0 0 0 0 11.6617 13.1536 0 0 11.4572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS86 GLPK5_HUMAN "Putative glycerol kinase 5, GK 5, Glycerokinase 5, EC 2.7.1.30 (ATP:glycerol 3-phosphotransferase 5)" GK5 Homo sapiens (Human) glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641] mitochondrion [GO:0005739] "mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641]" GO:0004370; GO:0005524; GO:0005739; GO:0006071; GO:0006641; GO:0016310; GO:0016773; GO:0019563; GO:0046167 "ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" EIHIPVRK 0.99275 -16.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5114 14.0381 0 12.3559 0 0 0 0 0 0 0 0 13.6322 14.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8535 0 0 0 0 0 0 0 0 11.3919 13.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N103 TAGAP_HUMAN T-cell activation Rho GTPase-activating protein (T-cell activation GTPase-activating protein) TAGAP TAGAP1 FKSG15 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005085; GO:0005096; GO:0005829; GO:0007165; GO:0051056 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] AANEKARK 0.99275 -6.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3204 0 12.7189 12.4099 0 0 12.6559 0 0 0 0 0 0 0 0 0 10.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5152 0 0 0 0 0 0 14.0379 0 17.3606 0 0 0 0 0 0 11.7091 0 0 0 0 0 0 0 11.307 0 13.0625 0 15.2139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2668 0 0 0 0 0 14.8688 0 0 0 15.6471 17.6026 0 0 0 15.5378 14.4142 0 0 0 0 0 13.6681 0 0 0 0 0 0 0 0 0 0 0 0 14.2013 0 0 0 0 0 0 0 0 0 12.3938 0 0 0 0 0 10.9889 Q8N7X1 RMXL3_HUMAN "RNA-binding motif protein, X-linked-like-3" RBMXL3 CXorf55 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" U12-type spliceosomal complex [GO:0005689] "U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; snRNA binding [GO:0017069]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003729; GO:0005689; GO:0017069 mRNA binding [GO:0003729]; snRNA binding [GO:0017069] AEFGKYGHIIKVFLMK 0.99275 -44.94 0 14.2126 11.5761 0 0 0 0 0 0 0 0 0 0 0 0 13.5884 13.7119 15.8844 13.0335 15.386 14.4232 11.7731 13.0366 11.5813 14.2213 14.5839 13.2284 13.4225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0503 0 12.9734 0 12.7611 0 13.5188 0 0 14.5829 0 13.429 0 0 0 0 0 0 12.4199 12.1051 0 0 0 0 14.4077 0 0 14.7922 0 0 0 0 0 0 0 0 0 0 0 14.3898 14.4454 13.5946 12.498 0 0 0 0 14.4529 13.734 0 0 14.5915 0 12.0595 14.5377 0 0 11.9477 0 11.6738 13.9623 0 0 11.7907 13.5545 0 14.9368 0 15.1051 0 0 11.8989 12.8298 14.6433 14.0024 0 0 0 15.4738 0 0 13.4248 0 0 0 14.1342 14.9914 0 0 14.608 12.8238 0 14.4605 0 14.2712 13.5926 13.345 13.4751 0 13.7521 0 0 0 11.1495 0 0 0 12.8293 14.5703 13.8349 0 14.5233 14.9133 14.803 0 0 13.518 0 0 0 0 0 0 12.2168 0 14.6932 0 12.817 0 13.6259 0 0 0 0 10.0489 19.4731 0 0 Q8NCK3 ZN485_HUMAN Zinc finger protein 485 ZNF485 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGIAFMNSSSLLNHHKVHAGK 0.99275 -14.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.221 0 0 0 0 0 0 0 0 0 0 0 0 12.6512 0 0 0 0 0 13.9237 0 0 0 0 0 0 0 0 0 0 0 11.9215 0 0 13.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1482 0 0 0 0 0 0 12.2902 0 0 0 0 0 12.7051 Q8NI77 KI18A_HUMAN "Kinesin-like protein KIF18A (Marrow stromal KIF18A, MS-KIF18A)" KIF18A OK/SW-cl.108 Homo sapiens (Human) cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463]; cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520] GO:0000070; GO:0000776; GO:0001726; GO:0003777; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005828; GO:0005829; GO:0005871; GO:0005874; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023 actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463] AEILLLKEK 0.99275 -39.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6435 14.7747 0 0 0 0 0 0 0 0 0 0 0 12.0216 0 0 0 0 0 14.3549 0 12.0632 0 12.9975 0 0 14.1597 0 0 0 0 0 10.3082 12.7292 0 12.9636 0 0 13.7588 0 0 0 0 10.8584 0 11.8889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0918 0 0 0 0 0 0 11.0671 0 0 0 0 11.923 0 0 12.1295 0 0 0 0 0 0 0 13.1151 12.879 0 0 0 0 0 0 0 0 11.4652 0 11.2436 0 0 0 0 0 0 0 13.5333 15.1482 Q8TB40 ABHD4_HUMAN "(Lyso)-N-acylphosphatidylethanolamine lipase, EC 3.1.1.- (Alpha/beta hydrolase domain-containing protein 4, Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4)" ABHD4 Homo sapiens (Human) lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152] GO:0004622; GO:0005739; GO:0005789; GO:0005811; GO:0006654; GO:0016042; GO:0016787; GO:0036152; GO:0042171; GO:0052689; GO:0055088; GO:0070292 carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity [GO:0016787]; lysophosphatidic acid acyltransferase activity [GO:0042171]; lysophospholipase activity [GO:0004622] APPAWVK 0.99275 -17.589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0207 0 0 0 0 0 12.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92545 TM131_HUMAN Transmembrane protein 131 (Protein RW1) TMEM131 KIAA0257 RW1 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 FNLSKVAKIDLR 0.99275 -14.583 0 0 0 0 0 0 13.1552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.813 0 0 0 0 0 18.0086 14.8562 0 0 0 0 0 0 0 0 0 0 0 0 0 12.262 0 0 0 14.6417 0 0 0 0 0 15.0184 0 0 0 0 12.2673 0 0 13.1869 0 0 0 0 0 0 13.2621 0 0 0 13.6712 0 0 0 0 0 0 19.1154 0 0 0 0 0 0 0 16.3325 0 0 0 0 0 11.8701 0 13.9303 0 0 11.7383 0 15.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JB1 DYH8_HUMAN Dynein axonemal heavy chain 8 (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] AQALLDEK 0.99275 -72.492 10.8012 0 0 0 11.7487 0 11.5879 0 13.1221 0 0 0 13.4081 0 12.9254 0 0 12.8869 0 0 0 12.97 12.7925 0 0 0 0 0 12.9874 0 0 0 0 0 0 0 12.6485 0 0 0 0 0 12.7157 0 0 13.2162 0 0 12.4882 0 0 0 0 0 0 10.1547 0 12.9533 0 0 13.7873 0 0 0 0 0 18.3575 15.4348 0 0 11.244 0 13.1086 0 0 12.0143 15.8304 13.0812 0 0 11.2673 12.8365 0 14.3545 0 15.4859 14.5425 11.9445 14.9994 15.0372 13.5695 15.8176 14.8112 16.598 14.9007 0 13.4858 0 0 13.845 11.4717 14.0645 0 0 12.8569 0 12.1894 13.7395 0 0 14.8616 13.3974 0 16.4894 0 12.0321 0 0 10.4161 15.3437 14.2616 0 0 0 0 0 0 11.5619 13.3915 13.773 15.493 11.6007 14.0686 0 13.5899 12.1222 13.8867 14.0483 13.0184 0 11.1785 14.3316 13.4718 12.3589 13.999 0 13.7676 0 0 15.385 11.8829 0 12.2579 0 0 13.8109 0 12.1631 0 0 0 0 0 0 11.2719 0 0 0 0 0 0 0 0 12.196 13.3068 0 12.1502 0 0 14.4415 Q96L96 ALPK3_HUMAN "Alpha-protein kinase 3, EC 2.7.11.1 (Muscle alpha-protein kinase)" ALPK3 KIAA1330 MAK Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; heart development [GO:0007507]; protein phosphorylation [GO:0006468] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cardiac muscle cell development [GO:0055013]; heart development [GO:0007507]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0007507; GO:0055013; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] APQVIRKIR 0.99275 -40.078 0 0 10.404 0 0 0 0 0 14.2513 14.4234 0 15.0593 0 0 0 0 0 0 0 0 0 0 11.5468 0 0 0 0 0 0 0 0 12.971 0 14.3029 14.1884 0 15.883 15.2066 10.8913 12.6349 12.0664 0 0 12.8374 0 0 12.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4194 0 0 0 0 11.8438 0 10.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0248 13.3902 0 0 0 0 11.2593 0 0 0 0 0 0 0 12.4339 0 0 9.49341 0 0 0 0 0 14.0324 13.4576 10.4171 0 0 10.7618 0 0 0 12.1023 0 0 0 0 0 0 0 0 0 0 0 0 10.2587 0 0 0 12.1626 0 0 0 12.7646 0 0 0 0 0 0 0 0 0 13.0034 0 0 16.0149 15.9007 0 15.5387 15.6472 0 15.1154 15.2126 15.9717 15.9638 15.9437 0 0 0 0 0 0 0 16.6509 0 15.7171 0 0 Q96M98 PACRG_HUMAN Parkin coregulated gene protein (Molecular chaperone/chaperonin-binding protein) (PARK2 coregulated gene protein) PACRG GLUP Homo sapiens (Human) cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; protein localization [GO:0008104]; spermatid development [GO:0007286] axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; manchette [GO:0002177]; neuron projection [GO:0043005]; nucleus [GO:0005634]; sperm midpiece [GO:0097225]; vesicle [GO:0031982] axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; manchette [GO:0002177]; neuron projection [GO:0043005]; nucleus [GO:0005634]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; protein localization [GO:0008104]; spermatid development [GO:0007286] GO:0001664; GO:0002177; GO:0003779; GO:0005634; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030544; GO:0031072; GO:0031625; GO:0031982; GO:0034620; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051087; GO:0051879; GO:0060548; GO:0097225 actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625] ALVPYYRQILPVLNIFK 0.99275 -6.2574 0 0 0 0 0 0 0 11.7917 0 0 9.7002 0 0 0 0 0 0 0 10.3218 0 0 13.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9813 0 14.2039 0 13.4685 0 14.0877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0019 0 11.2862 0 14.2907 0 0 0 0 0 0 0 14.9011 0 13.6322 0 11.7682 0 0 0 0 0 0 0 0 0 12.9814 14.3803 0 0 15.1919 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1625 0 0 0 0 14.6632 0 0 0 0 14.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8266 0 0 13.8585 0 0 0 0 0 0 0 0 0 O75618 DEDD_HUMAN Death effector domain-containing protein (DEDPro1) (Death effector domain-containing testicular molecule) (FLDED-1) DEDD DEDPRO1 DEFT KE05 Homo sapiens (Human) decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; decidualization [GO:0046697]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283] GO:0003677; GO:0005730; GO:0005737; GO:0007283; GO:0008625; GO:0042177; GO:0042981; GO:0046697; GO:1901837 DNA binding [GO:0003677] CDESNFRQVLQLLRIITR 0.99276 -5.1145 0 0 0 13.6132 14.4988 14.2421 13.7919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5162 0 14.6542 0 0 0 0 14.0775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4069 0 12.4631 12.4586 12.6789 0 15.5239 0 0 0 0 12.9193 14.8029 11.8636 0 13.4054 0 12.9663 14.7815 13.3599 0 0 0 14.9216 0 14.326 12.0509 0 0 0 0 0 14.9889 0 0 12.2667 15.3585 0 0 13.7536 15.2304 14.5277 0 0 0 14.9873 14.7358 14.5907 14.4381 12.665 15.2862 15.6063 13.5049 14.7164 15.6171 0 16.5337 0 0 0 0 0 0 0 13.1878 0 0 14.5054 14.1291 13.0642 0 0 0 0 0 0 0 15.1964 0 14.7306 13.3458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9145 0 15.1804 0 0 0 0 0 P00505 AATM_HUMAN "Aspartate aminotransferase, mitochondrial, mAspAT, EC 2.6.1.1, EC 2.6.1.7 (Fatty acid-binding protein, FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein, FABPpm) (Transaminase A)" GOT2 KYAT4 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471] GO:0003723; GO:0004069; GO:0005739; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0015908; GO:0016212; GO:0019470; GO:0019550; GO:0019551; GO:0030170; GO:0045471; GO:0070062 kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723] AEAQIAAK 0.99276 -14.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9877 12.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6494 10.5477 0 0 0 0 0 0 0 13.1963 0 0 0 0 0 0 0 14.4743 14.5622 0 12.3468 0 0 16.4815 12.7904 0 0 0 12.3777 0 0 0 0 0 12.996 0 0 0 0 0 0 0 0 0 0 0 0 14.5909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.266 13.769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15924 DESP_HUMAN "Desmoplakin, DP (250/210 kDa paraneoplastic pemphigus antigen)" DSP Homo sapiens (Human) adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060] basolateral plasma membrane [GO:0016323]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; ficolin-1-rich granule membrane [GO:0101003]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; ficolin-1-rich granule membrane [GO:0101003]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; adherens junction organization [GO:0034332]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; protein localization to cell-cell junction [GO:0150105]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588]; ventricular compact myocardium morphogenesis [GO:0003223]; wound healing [GO:0042060] GO:0001533; GO:0002934; GO:0003223; GO:0003723; GO:0005080; GO:0005198; GO:0005200; GO:0005634; GO:0005737; GO:0005882; GO:0005886; GO:0005916; GO:0008544; GO:0014704; GO:0016020; GO:0016323; GO:0018149; GO:0030057; GO:0030216; GO:0034332; GO:0042060; GO:0043588; GO:0045104; GO:0045109; GO:0070062; GO:0086073; GO:0086083; GO:0086091; GO:0090136; GO:0097110; GO:0098609; GO:0098911; GO:0101003; GO:0150105 cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] AEFQEEAK 0.99276 -78.115 0 0 0 0 0 0 0 0 13.3588 12.8981 13.4982 13.0926 14.0571 13.0761 13.1123 11.8442 0 0 0 0 11.7373 0 0 0 0 14.2707 0 0 13.5831 13.255 0 12.8917 11.321 12.7789 13.7709 13.5735 0 12.8757 0 0 12.0931 13.6599 12.4755 0 0 0 0 10.4042 0 0 0 0 0 0 12.8769 0 0 0 0 0 0 0 0 0 0 0 0 0 14.716 13.3292 13.2785 0 11.8212 0 13.4547 13.0058 14.1087 0 0 14.9061 11.2937 0 13.9622 0 0 0 0 13.0321 0 12.9611 13.1426 13.4515 18.1131 0 0 17.6979 13.519 0 15.1341 0 14.0999 14.1584 13.1711 13.0152 0 0 15.013 12.8535 14.3212 0 14.0653 12.5687 0 0 14.2057 15.3103 0 12.583 17.7648 0 14.5652 15.811 0 0 0 14.2996 0 0 13.3239 0 0 14.5465 0 12.7232 0 12.7599 0 13.2755 15.3743 12.1536 0 14.1736 13.2789 12.649 15.372 13.5816 0 14.1594 0 0 14.636 0 0 12.5129 0 0 0 14.7996 0 11.7285 14.9281 17.8765 14.765 18.256 0 0 14.232 0 0 15.1772 14.4023 12.7573 0 0 12.9839 0 0 14.833 12.6015 14.3102 P36406 TRI23_HUMAN "E3 ubiquitin-protein ligase TRIM23, EC 2.3.2.27 (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING finger protein 46) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23)" TRIM23 ARD1 ARFD1 RNF46 Homo sapiens (Human) innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192] Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886] Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; protein ubiquitination [GO:0016567]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005765; GO:0005886; GO:0006886; GO:0008047; GO:0008270; GO:0016192; GO:0016567; GO:0019003; GO:0042802; GO:0045087 enzyme activator activity [GO:0008047]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] LLTEKELR 0.99276 -14.62 0 0 0 13.4314 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7673 0 11.4739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48736 PK3CG_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, PI3-kinase subunit gamma, PI3K-gamma, PI3Kgamma, PtdIns-3-kinase subunit gamma, EC 2.7.1.137, EC 2.7.1.153, EC 2.7.1.154 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma, PtdIns-3-kinase subunit p110-gamma, p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG, EC 2.7.11.1) (p120-PI3K)" PIK3CG Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to cAMP [GO:0071320]; dendritic cell chemotaxis [GO:0002407]; endocytosis [GO:0006897]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte apoptotic process [GO:0097284]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell degranulation [GO:0043303]; natural killer cell chemotaxis [GO:0035747]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of triglyceride catabolic process [GO:0010897]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet aggregation [GO:0070527]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Rac protein signal transduction [GO:0035022]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cell adhesion mediated by integrin [GO:0033628]; respiratory burst involved in defense response [GO:0002679]; secretory granule localization [GO:0032252]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell proliferation [GO:0042098]" GO:0001525; GO:0001819; GO:0002250; GO:0002407; GO:0002675; GO:0002679; GO:0003376; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006468; GO:0006897; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0010595; GO:0010818; GO:0010897; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030593; GO:0032252; GO:0033628; GO:0035004; GO:0035005; GO:0035022; GO:0035747; GO:0036092; GO:0042098; GO:0042110; GO:0042802; GO:0043303; GO:0043406; GO:0045087; GO:0046854; GO:0046875; GO:0046934; GO:0048015; GO:0051897; GO:0052742; GO:0052812; GO:0055118; GO:0070527; GO:0071320; GO:0072672; GO:0097284; GO:0106310; GO:1903169; GO:2000270 "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; ephrin receptor binding [GO:0046875]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]" APALSSK 0.99276 -14.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6446 0 0 0 0 0 14.6303 0 0 14.9964 15.2536 0 0 0 0 0 0 0 12.7794 0 12.9946 0 0 15.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7161 0 0 0 0 0 13.4375 0 0 0 12.993 13.6852 0 10.1076 0 0 0 0 0 14.8738 0 11.6751 0 0 0 0 11.2877 13.4686 0 0 0 11.0756 15.1057 0 13.8467 0 0 15.0035 14.8943 0 0 0 0 0 0 0 14.8191 0 0 0 0 0 12.1612 13.3493 0 0 11.3412 0 0 0 13.0543 0 0 10.4643 0 0 0 14.4266 0 0 0 0 12.7562 0 0 0 0 0 0 0 14.4289 0 0 0 0 0 0 0 0 0 0 0 P52564 MP2K6_HUMAN "Dual specificity mitogen-activated protein kinase kinase 6, MAP kinase kinase 6, MAPKK 6, EC 2.7.12.2 (MAPK/ERK kinase 6, MEK 6) (Stress-activated protein kinase kinase 3, SAPK kinase 3, SAPKK-3, SAPKK3)" MAP2K6 MEK6 MKK6 PRKMK6 SKK3 Homo sapiens (Human) apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; DNA damage induced protein phosphorylation [GO:0006975]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; phosphatase activator activity [GO:0019211]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cellular response to sorbitol [GO:0072709]; cellular senescence [GO:0090398]; DNA damage induced protein phosphorylation [GO:0006975]; MAPK cascade [GO:0000165]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; osteoblast differentiation [GO:0001649]; ovulation cycle process [GO:0022602]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403] GO:0000165; GO:0001649; GO:0002931; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005654; GO:0005829; GO:0005856; GO:0006915; GO:0006975; GO:0007165; GO:0009410; GO:0019211; GO:0019901; GO:0022602; GO:0032308; GO:0038066; GO:0042802; GO:0043065; GO:0043406; GO:0043539; GO:0051403; GO:0051726; GO:0051770; GO:0060048; GO:0060348; GO:0070423; GO:0072709; GO:0090398; GO:0106310; GO:0120163; GO:1901796 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; phosphatase activator activity [GO:0019211]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] FSAEFVDFTSQCLK 0.99276 -5.1028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0555 0 0 0 0 0 0 0 0 0 13.1518 0 0 0 12.8777 0 15.0184 0 0 13.0089 0 0 0 11.8352 0 0 0 0 0 0 0 13.6618 0 0 0 0 0 0 0 15.0801 0 14.2053 0 0 0 0 0 0 0 0 0 0 0 0 0 12.268 14.2725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5BJF2 SGMR2_HUMAN "Sigma intracellular receptor 2, Sigma-2 receptor, Sigma2 receptor (Meningioma-associated protein 30) (Transmembrane protein 97)" TMEM97 MAC30 S2R Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; regulation of cell growth [GO:0001558] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; cholesterol homeostasis [GO:0042632]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005764; GO:0005783; GO:0005791; GO:0005886; GO:0016021; GO:0030867; GO:0031965; GO:0042632 DPLLQEPPAWFK 0.99276 -4.4376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.692 0 0 0 17.0659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4177 0 0 17.7154 0 0 0 0 0 17.5677 0 0 0 10.1614 0 17.3459 0 0 0 0 0 0 0 17.4653 0 0 0 0 0 0 0 12.0433 0 14.1279 13.3188 0 0 0 0 0 0 0 0 0 0 0 0 Q5SXM2 SNPC4_HUMAN "snRNA-activating protein complex subunit 4, SNAPc subunit 4 (Proximal sequence element-binding transcription factor subunit alpha, PSE-binding factor subunit alpha, PTF subunit alpha) (snRNA-activating protein complex 190 kDa subunit, SNAPc 190 kDa subunit)" SNAPC4 SNAP190 Homo sapiens (Human) snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA-activating protein complex [GO:0019185]; DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] GO:0000995; GO:0001006; GO:0003677; GO:0005634; GO:0005654; GO:0016251; GO:0019185; GO:0042795; GO:0042796 DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006] ALLRKSVVSDR 0.99276 -14.631 10.6725 0 0 0 12.0617 0 0 0 0 0 0 0 0 0 13.509 0 0 12.5309 0 0 0 13.7774 13.4922 13.3806 0 0 0 12.4156 11.8803 11.5062 0 0 0 0 0 11.35 0 0 0 0 12.1494 0 11.3851 0 0 0 0 0 12.5573 0 0 0 0 0 0 10.9898 0 0 0 0 12.5852 0 0 0 0 0 11.7246 0 15.3835 0 12.4688 0 0 12.1082 0 15.4113 9.61084 0 15.8271 0 14.6752 14.7041 0 14.0759 0 0 14.0293 14.2614 12.2471 13.6831 12.0255 0 11.7927 13.8517 13.8283 14.212 0 13.9561 16.7499 0 17.8336 0 14.2459 16.0977 0 0 0 0 13.3538 10.8066 14.2614 15.0359 14.6928 0 14.092 0 14.8655 14.897 0 0 0 0 14.7677 11.5064 0 11.7324 0 0 0 0 15.0907 14.8972 14.9672 0 0 14.6984 12.046 14.6514 0 14.6386 15.1059 13.2035 15.0184 0 14.9746 0 15.7614 11.4591 0 0 15.5125 13.5278 0 0 15.6564 14.2272 0 0 11.7424 0 0 0 0 0 0 13.7433 0 0 0 0 11.8225 0 10.4537 0 14.8341 0 13.5378 0 15.9855 11.4438 Q66PJ3 AR6P4_HUMAN "ADP-ribosylation factor-like protein 6-interacting protein 4, ARL-6-interacting protein 4, Aip-4 (HSP-975) (HSVI-binding protein) (SR-15) (SRp25, SR-25) (Splicing factor SRrp37)" ARL6IP4 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0005634; GO:0005730; GO:0006397; GO:0008380; GO:0016607 RNA binding [GO:0003723] EINKQATR 0.99276 -14.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0646 0 0 0 0 0 0 0 0 0 13.4482 0 0 0 0 12.5421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE56 ATS17_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 17, ADAM-TS 17, ADAM-TS17, ADAMTS-17, EC 3.4.24.-" ADAMTS17 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] ALLLHLPAFGR 0.99276 -14.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1421 0 0 0 0 0 0 0 11.0999 0 0 0 0 0 0 0 12.4534 0 0 0 0 0 0 0 0 14.036 15.0438 13.8574 13.8392 0 0 0 0 13.312 13.3362 13.6195 0 0 9.96867 12.7687 0 0 0 0 0 0 0 12.912 0 12.8867 0 0 0 12.9692 0 0 0 0 14.861 13.2183 13.4182 0 15.2349 14.9004 13.3136 0 0 13.3585 0 13.9269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2332 0 0 0 0 13.1699 0 0 0 12.9899 0 0 0 0 0 12.8154 0 0 0 0 0 0 0 0 13.8273 12.6734 12.8059 0 13.0669 0 0 0 0 0 0 0 0 0 14.5754 13.6594 0 0 0 0 0 0 0 12.981 0 0 0 0 0 0 Q96EB1 ELP4_HUMAN "Elongator complex protein 4, hELP4 (PAX6 neighbor gene protein)" ELP4 C11orf19 PAXNEB Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0005654; GO:0005737; GO:0006357; GO:0006368; GO:0006417; GO:0008023; GO:0008607; GO:0033588 phosphorylase kinase regulator activity [GO:0008607] CKKEFDEDVYNHK 0.99276 -14.633 0 0 0 0 0 0 0 0 0 0 0 13.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3802 0 0 0 14.1003 0 0 0 0 0 0 0 13.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0439 0 0 0 0 0 0 0 0 Q96J84 KIRR1_HUMAN Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1) KIRREL1 KIRREL NEPH1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; glomerular filtration [GO:0003094]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; renal protein absorption [GO:0097017] cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; dendritic shaft [GO:0043198]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; cell-cell junction maintenance [GO:0045217]; glomerular filtration [GO:0003094]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of actin filament polymerization [GO:0030838]; renal protein absorption [GO:0097017] GO:0001933; GO:0003094; GO:0005886; GO:0005887; GO:0005911; GO:0017022; GO:0030838; GO:0043198; GO:0045217; GO:0048471; GO:0050839; GO:0097017; GO:0098609 cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022] AFNAKPAATIIWFRDGTQQEGAVASTELLK 0.99276 -14.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6953 0 0 0 12.7113 11.8287 0 0 0 0 11.7756 0 0 0 0 0 0 0 0 15.4089 0 0 14.3978 0 15.8439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9316 0 0 0 0 0 0 0 0 0 0 12.7086 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7373 0 0 14.0511 0 0 0 12.4725 0 0 0 11.3375 0 0 0 0 0 12.5274 0 0 0 13.2769 Q96J88 ESIP1_HUMAN Epithelial-stromal interaction protein 1 EPSTI1 Homo sapiens (Human) ESVVHAGQR 0.99276 -7.3441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWU0 NADAP_HUMAN "Kanadaptin (Human lung cancer oncogene 3 protein, HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein)" SLC4A1AP HLC3 Homo sapiens (Human) cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729] GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231 mRNA binding [GO:0003729] DEPEVEEEEEEEEEEEK 0.99276 -4.4389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2616 11.9201 0 0 0 0 0 12.7244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5736 0 0 0 0 0 0 14.2803 0 14.1374 12.2534 0 14.7325 0 13.3954 13.4946 0 0 13.1432 12.9997 0 0 12.4682 13.119 11.8905 0 0 18.4938 13.0243 11.9004 18.3446 0 0 13.3066 0 11.7342 12.2389 0 0 0 0 12.4247 0 11.6027 13.2023 14.7882 0 0 14.1898 15.4175 14.2301 15.1164 14.3337 13.6498 14.3742 0 0 14.1778 0 0 14.5199 18.5785 13.2417 16.1519 13.4243 0 0 12.5831 11.1282 11.008 13.2279 13.9828 14.6691 13.1464 12.9291 0 13.5239 0 13.5603 12.3347 0 12.3479 0 13.6712 10.4386 0 0 0 14.3649 0 0 11.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5324 13.8628 13.6824 0 0 0 13.126 0 Q9BYD6 RM01_HUMAN "39S ribosomal protein L1, mitochondrial, L1mt, MRP-L1 (Mitochondrial large ribosomal subunit protein uL1m)" MRPL1 BM-022 Homo sapiens (Human) maturation of LSU-rRNA [GO:0000470]; mitochondrial translation [GO:0032543] cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762] cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; mitochondrial translation [GO:0032543] GO:0000470; GO:0003723; GO:0003735; GO:0005743; GO:0005762; GO:0022625; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ALIHHQR 0.99276 -14.286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7899 0 14.852 0 0 0 14.4622 0 0 13.7218 14.309 13.8187 0 0 13.8657 12.6817 0 0 0 0 14.0749 0 13.1684 0 14.0995 14.2796 14.3348 13.3625 0 0 12.2188 13.7149 0 0 14.449 13.127 0 0 0 14.1779 14.1145 15.2774 14.4391 0 14.3262 0 0 0 0 0 0 0 13.0564 13.6788 0 0 11.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8781 13.7665 0 14.1892 13.8309 13.7717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4018 0 0 0 0 0 0 Q9H074 PAIP1_HUMAN "Polyadenylate-binding protein-interacting protein 1, PABP-interacting protein 1, PAIP-1, Poly(A)-binding protein-interacting protein 1" PAIP1 Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" GO:0003723; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0008494; GO:0048255; GO:0070934; GO:0106002; GO:1900152; GO:2000767 RNA binding [GO:0003723]; translation activator activity [GO:0008494] DVKQMLLKLVELR 0.99276 -6.6717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0C5 BTBD1_HUMAN "BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8, HCV NS5A-transactivated protein 8)" BTBD1 C15orf1 NS5ATP8 Homo sapiens (Human) muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; protein-containing complex [GO:0032991] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; muscle organ development [GO:0007517]; neurogenesis [GO:0022008]; protein ubiquitination [GO:0016567]; regulation of protein binding [GO:0043393] GO:0000932; GO:0005654; GO:0005829; GO:0007517; GO:0016567; GO:0022008; GO:0032991; GO:0036464; GO:0042802; GO:0043393; GO:0097602 cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802] ALSLIRFPLMTIEEFAAGPAQSGILSDR 0.99276 -6.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0026 0 0 0 0 0 0 0 18.1076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0E9 BRD8_HUMAN "Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa, TrCP120) (p120)" BRD8 SMAP SMAP2 Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812] "mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; cell surface receptor signaling pathway [GO:0007166]; cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" GO:0000786; GO:0000812; GO:0005654; GO:0005739; GO:0006325; GO:0007166; GO:0016573; GO:0030374; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779 nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966] FSSPFLKPVSERQAPGYK 0.99276 -46.139 0 0 0 0 0 0 0 0 0 0 0 13.0046 0 0 0 0 0 0 0 0 0 13.1953 19.82 13.6602 0 0 0 0 0 0 12.3661 0 0 0 0 0 0 0 0 0 10.9907 0 0 0 0 0 0 0 0 0 0 0 13.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4323 0 0 0 0 0 12.9224 0 0 0 0 0 0 0 0 0 0 0 12.6962 9.84956 0 0 0 0 15.4075 11.5214 0 0 14.0708 0 0 0 0 0 0 14.0416 0 0 0 13.0629 0 0 0 0 0 0 0 0 0 13.9413 0 0 0 0 0 13.2958 18.3682 12.8509 14.6869 12.8814 0 0 0 0 0 13.9437 14.2859 0 0 16.732 0 0 13.4912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4759 0 0 Q9HCK1 ZDBF2_HUMAN DBF4-type zinc finger-containing protein 2 ZDBF2 KIAA1571 Homo sapiens (Human) DNA methylation involved in embryo development [GO:0043045]; genomic imprinting [GO:0071514] nucleus [GO:0005634] nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA methylation involved in embryo development [GO:0043045]; genomic imprinting [GO:0071514] GO:0003676; GO:0005634; GO:0008270; GO:0043045; GO:0071514 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] CNCKASTPSMTNQCK 0.99276 -80.244 0 0 0 0 0 0 0 0 0 0 0 0 9.79651 0 0 0 0 0 0 0 11.4591 0 0 0 0 0 0 11.0417 0 0 0 0 0 0 0 11.7764 10.9571 0 13.0281 0 0 0 0 0 0 10.0132 13.0334 0 0 0 0 0 0 0 12.0424 10.9874 0 0 0 0 0 0 0 0 14.7178 0 10.719 0 0 0 0 0 12.6656 0 0 11.9038 13.0536 14.2236 13.8193 14.5764 13.136 0 0 12.8251 15.2821 14.4567 12.8033 12.2308 11.7664 12.0133 0 15.3143 13.5749 14.462 0 0 0 13.1404 11.6844 0 14.4106 11.6183 0 0 0 0 13.5519 0 12.8224 0 11.0692 15.751 0 0 11.3795 0 0 0 0 10.7936 0 0 0 0 0 0 13.6578 0 12.4225 0 0 14.4671 0 0 0 0 17.3793 13.6869 12.517 0 0 0 0 12.2338 10.6441 0 0 16.7517 0 0 12.5273 0 12.4226 11.2066 0 0 0 0 0 0 12.2322 0 12.2894 0 0 12.9884 0 13.9914 12.9161 0 0 0 0 11.3713 0 0 10.0467 0 12.8466 10.6206 Q9NZV7 ZIM2_HUMAN Zinc finger imprinted 2 (Zinc finger protein 656) ZIM2 ZNF656 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006355; GO:0006357; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" ACQCCDCGR 0.99276 -14.292 0 0 0 0 0 0 0 0 14.0659 0 0 10.6372 0 0 0 0 0 0 0 0 0 10.5065 0 0 0 0 0 0 0 0 0 10.1404 0 0 0 0 0 12.4554 0 0 12.7785 0 0 0 0 0 12.7259 0 0 0 0 13.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.853 0 0 0 0 0 14.9342 11.3061 0 0 0 0 12.9244 0 0 0 10.9252 0 0 0 0 0 13.6611 0 0 11.9437 9.88771 0 11.3588 0 10.723 15.7699 0 0 0 14.6636 0 0 0 0 0 0 11.4654 11.4706 0 0 0 0 12.0383 0 0 0 0 0 0 13.7122 0 11.39 0 14.0584 15.2492 0 0 0 0 0 0 0 0 0 0 0 13.9792 0 0 10.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2164 11.0898 0 12.6077 0 0 Q9UKS6 PACN3_HUMAN Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511) PACSIN3 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endocytosis [GO:0030100] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium channel inhibitor activity [GO:0019855]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endocytosis [GO:0030100] GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0007010; GO:0008092; GO:0008289; GO:0019855; GO:0030100; GO:0042802; GO:0045806; GO:0051044; GO:0051926; GO:0070062; GO:0097320 calcium channel inhibitor activity [GO:0019855]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543] AQKPWLK 0.99276 -4.4294 0 0 0 0 0 0 0 0 0 15.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5088 0 0 0 0 0 0 0 0 0 0 14.5029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0199 0 0 0 16.8113 16.1005 0 15.6984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULI4 KI26A_HUMAN Kinesin-like protein KIF26A KIF26A KIAA1236 Homo sapiens (Human) enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560] cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; enteric nervous system development [GO:0048484]; negative regulation of signal transduction [GO:0009968]; regulation of cell growth by extracellular stimulus [GO:0001560] GO:0001560; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0008017; GO:0009968; GO:0048484 ATP binding [GO:0005524]; microtubule binding [GO:0008017] AATAAVPK 0.99276 -46.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7383 13.1348 0 0 0 0 0 0 11.2801 10.5528 0 0 10.8704 16.4835 0 0 0 14.7031 0 0 0 0 0 11.6787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2175 11.4116 0 0 0 0 11.5158 0 0 0 0 14.17 14.0368 14.0304 0 0 14.0897 14.5622 12.4313 0 0 18.3968 0 0 12.9624 15.3949 0 11.1628 13.641 13.5276 0 14.2266 13.6847 13.7631 13.9601 14.3047 0 0 0 0 14.9082 14.6635 0 0 0 11.8389 0 0 13.3656 13.0893 0 15.1445 13.1873 18.6482 15.9317 16.2943 13.581 0 0 16.1719 0 0 0 0 12.4493 13.1093 14.1313 12.4084 13.4557 14.0532 0 11.3348 13.2279 13.7699 15.288 0 0 14.1007 14.1312 14.3495 12.2871 14.1989 13.9644 0 14.1358 0 0 14.1083 13.9877 12.6894 12.0893 12.3144 0 0 13.6296 11.434 14.2953 0 0 0 0 0 0 0 12.9663 14.3055 12.1463 0 0 0 14.1505 14.0811 0 14.2585 18.6495 0 0 0 0 0 Q9Y2R2 PTN22_HUMAN "Tyrosine-protein phosphatase non-receptor type 22, EC 3.1.3.48 (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase, LyP) (PEST-domain phosphatase, PEP)" PTPN22 PTPN8 Homo sapiens (Human) "autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipid metabolic process [GO:0006629]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]" cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cellular response to muramyl dipeptide [GO:0071225]; lipid metabolic process [GO:0006629]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; phosphoanandamide dephosphorylation [GO:0035644]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of granzyme B production [GO:0071663]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of type I interferon production [GO:0032481]; protein dephosphorylation [GO:0006470]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of innate immune response [GO:0045088]; regulation of natural killer cell proliferation [GO:0032817]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to lipopolysaccharide [GO:0032496]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]" GO:0002230; GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0006629; GO:0006914; GO:0009898; GO:0010507; GO:0010628; GO:0010629; GO:0016791; GO:0017124; GO:0019900; GO:0030217; GO:0031625; GO:0031663; GO:0032481; GO:0032496; GO:0032715; GO:0032717; GO:0032720; GO:0032729; GO:0032817; GO:0034141; GO:0034145; GO:0034157; GO:0034165; GO:0035335; GO:0035644; GO:0043508; GO:0045088; GO:0048471; GO:0050852; GO:0050855; GO:0050860; GO:0050868; GO:0070374; GO:0070433; GO:0071225; GO:0071663; GO:1901222; GO:1902523; GO:1903753; GO:2000566 kinase binding [GO:0019900]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625] CYQEDDSVPICIHCSAGCGR 0.99276 -6.2682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5222 0 0 0 0 13.5762 0 0 13.8383 0 12.6348 0 0 0 0 13.5975 0 0 0 0 0 0 0 12.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6068 0 11.233 0 0 0 0 0 0 0 0 0 0 0 0 13.6454 14.0974 0 14.2266 0 0 0 0 0 0 0 13.6688 0 0 0 0 0 0 0 0 13.8041 0 0 0 0 0 0 0 0 14.74 0 0 0 13.3418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4278 14.5823 0 0 12.3207 0 0 0 0 0 0 0 0 0 0 14.7873 0 0 0 0 0 0 0 0 14.8055 0 0 0 14.2374 0 13.3846 13.4255 0 0 0 0 0 0 0 0 0 A4FU49 SH321_HUMAN SH3 domain-containing protein 21 SH3D21 C1orf113 Homo sapiens (Human) actin filament organization [GO:0007015]; cell migration [GO:0016477] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin filament organization [GO:0007015]; cell migration [GO:0016477] GO:0005654; GO:0005886; GO:0007015; GO:0016477 EPKKLMPK 0.99277 -25.792 0 0 11.5909 17.0871 0 0 0 0 0 0 11.4308 0 0 0 12.5981 0 0 0 12.4341 12.3917 0 0 0 0 12.4018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5535 0 0 12.1901 0 0 0 0 11.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5968 0 11.0828 0 0 0 14.9858 13.8663 0 0 0 14.0531 0 0 0 0 0 0 0 0 15.421 0 13.7397 0 0 15.0701 0 0 14.5927 14.9275 0 0 0 0 0 16.8366 0 0 0 0 15.7174 13.0127 0 0 14.49 0 14.8645 0 14.1738 15.1435 0 0 0 0 0 0 14.1112 13.9523 0 14.0656 0 15.4087 14.1113 0 0 0 0 0 0 0 0 0 14.0835 0 14.2523 0 14.0691 0 0 0 0 0 0 13.0484 0 0 0 14.1815 12.7923 0 0 0 0 0 14.2847 14.2595 0 0 0 0 0 O60524 NEMF_HUMAN Ribosome quality control complex subunit NEMF (Antigen NY-CO-1) (Nuclear export mediator factor) (Serologically defined colon cancer antigen 1) NEMF SDCCAG1 Homo sapiens (Human) CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112] cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] GO:0000049; GO:0005634; GO:0005829; GO:0043023; GO:0051168; GO:0065003; GO:0072344; GO:0140708; GO:1990112; GO:1990116 ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049] DQDEEDR 0.99277 -42.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.402 0 12.3761 0 0 14.0207 0 0 0 0 0 0 0 0 10.7007 0 0 0 0 0 0 0 0 0 0 0 11.7847 0 0 0 0 12.2677 12.0397 0 12.4242 0 0 0 0 0 0 0 0 0 16.548 12.799 15.6851 15.5024 0 0 0 0 15.4646 16.7063 15.2804 13.3813 12.4616 17.2891 0 0 0 14.4626 0 0 0 14.0446 13.9154 12.0708 14.917 0 0 0 15.8202 0 0 0 0 18.537 0 10.69 0 0 0 0 16.7374 0 0 0 0 14.9784 13.4019 0 12.6791 13.6795 0 14.5396 14.3338 14.1547 18.4228 18.9799 0 12.3342 0 0 0 0 13.6838 0 14.3534 0 0 0 14.7947 13.4236 13.526 13.8772 13.1634 19.3289 16.9925 0 12.1031 13.0616 13.6143 18.8811 0 0 0 14.5625 0 14.3012 15.3695 15.3447 0 0 0 0 0 0 0 13.4194 10.6024 0 0 0 0 0 0 0 14.5094 0 18.8659 10.9893 0 0 0 0 0 0 P15848 ARSB_HUMAN "Arylsulfatase B, ASB, EC 3.1.6.12 (N-acetylgalactosamine-4-sulfatase, G4S)" ARSB Homo sapiens (Human) autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268] GO:0003943; GO:0004065; GO:0005576; GO:0005739; GO:0005764; GO:0005788; GO:0005791; GO:0005794; GO:0006914; GO:0007040; GO:0007041; GO:0007417; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943] AIALITNHPPEKPLFLYLALQSVHEPLQVPEEYLK 0.99277 -13.347 0 11.5849 0 0 10.537 0 0 0 15.607 16.1946 0 0 0 16.2042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98783 0 0 16.0983 0 15.9718 16.0832 0 15.9622 0 0 0 0 0 0 11.3153 0 0 11.35 0 0 0 0 0 0 0 0 0 0 0 0 12.7055 0 0 0 0 0 0 0 0 0 0 13.6806 0 12.0927 13.5696 0 0 0 0 0 0 0 15.2524 0 0 0 0 0 0 0 12.5724 0 12.8703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3012 0 0 0 0 0 0 0 0 13.7875 0 0 12.9681 0 0 11.9756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7659 0 13.3116 0 14.5072 0 0 0 0 0 14.692 12.7083 0 0 0 13.5899 0 11.5915 17.7277 17.7725 17.5484 17.6212 17.5918 0 17.6949 0 0 17.6556 0 17.6714 17.569 13.6604 0 0 0 0 17.686 0 17.6104 0 17.6653 P46094 XCR1_HUMAN Chemokine XC receptor 1 (G-protein coupled receptor 5) (Lymphotactin receptor) (XC chemokine receptor 1) XCR1 CCXCR1 GPR5 Homo sapiens (Human) "calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]" external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; release of sequestered calcium ion into cytosol [GO:0051209]" GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007187; GO:0007204; GO:0009897; GO:0016493; GO:0019722; GO:0019957; GO:0051209; GO:0060326 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950] CRVLVTMAVWVASILSSILDTIFHK 0.99277 -4.4632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8571 0 0 0 0 0 0 0 0 0 0 0 14.2054 0 0 0 0 0 0 0 15.4821 0 0 0 0 0 0 0 0 0 0 0 0 13.5944 0 0 0 0 0 0 15.524 0 0 0 0 14.9449 0 13.5728 0 0 0 0 0 0 0 0 0 13.8578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16821 PPR3A_HUMAN "Protein phosphatase 1 regulatory subunit 3A (Protein phosphatase 1 glycogen-associated regulatory subunit) (Protein phosphatase type-1 glycogen targeting subunit, RG1)" PPP1R3A PP1G Homo sapiens (Human) glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979] integral component of membrane [GO:0016021]; protein phosphatase type 1 complex [GO:0000164] integral component of membrane [GO:0016021]; protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979] GO:0000164; GO:0005977; GO:0005979; GO:0008157; GO:0016021; GO:2001069 glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157] AIIAKLPQETARSDR 0.99277 -16.928 0 0 0 0 0 0 0 0 0 0 0 0 13.725 0 14.2946 0 12.6964 0 13.7518 0 0 0 0 0 0 14.3889 0 0 0 0 0 10.1149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8546 12.2945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6329 0 0 0 0 0 0 12.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9721 0 0 12.9896 0 0 11.1012 0 0 13.5655 11.0432 0 0 0 0 0 11.6273 0 12.1159 0 0 0 0 0 0 0 0 0 0 12.3417 13.6724 0 14.879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS49 YQ050_HUMAN Putative uncharacterized protein FLJ45831 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 EHSSGVSSVK 0.99277 -6.673 0 0 0 12.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2155 0 0 0 13.1556 0 0 0 0 0 0 0 14.0408 0 0 0 0 0 Q8IYB1 M21D2_HUMAN "Nucleotidyltransferase MB21D2, EC 2.7.7.- (Mab-21 domain-containing protein 2, hMB21D2)" MB21D2 C3orf59 Homo sapiens (Human) cadherin binding [GO:0045296]; nucleotidyltransferase activity [GO:0016779]; protein-containing complex binding [GO:0044877] GO:0016779; GO:0044877; GO:0045296 cadherin binding [GO:0045296]; nucleotidyltransferase activity [GO:0016779]; protein-containing complex binding [GO:0044877] LAKKLQQLVTENPGK 0.99277 -14.706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2649 0 0 0 0 10.3173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6307 0 12.5461 0 0 0 0 12.9316 0 0 0 0 0 0 0 0 0 13.3926 0 0 0 0 0 0 0 0 0 0 11.6823 11.4851 0 0 0 0 0 12.9316 13.0924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6727 0 0 0 0 0 0 18.767 0 0 0 0 0 13.9195 0 0 0 0 0 0 0 Q8WU17 RN139_HUMAN "E3 ubiquitin-protein ligase RNF139, EC 2.3.2.27 (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein)" RNF139 TRC8 Homo sapiens (Human) endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613] Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021] Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613] GO:0002020; GO:0004842; GO:0005783; GO:0005789; GO:0008270; GO:0008285; GO:0012505; GO:0016021; GO:0016567; GO:0017148; GO:0019787; GO:0031648; GO:0036503; GO:0036513; GO:0038023; GO:0044322; GO:0060628; GO:0061630; GO:0070613; GO:1904380; GO:2000060 protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ETLLFTSSLILTLNTVFVLAVKLK 0.99277 -4.4594 0 0 0 0 0 0 0 0 0 0 13.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8 0 0 12.4343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2655 12.7774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXD9 CSKI1_HUMAN Caskin-1 (CASK-interacting protein 1) CASKIN1 KIAA1306 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; identical protein binding [GO:0042802]; signal transduction [GO:0007165] GO:0005737; GO:0007165; GO:0016020; GO:0042802 identical protein binding [GO:0042802] APAGADK 0.99277 -25.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3439 12.8943 13.3122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3896 0 0 0 0 0 0 0 16.1523 0 0 0 15.1831 0 15.2497 15.5081 0 0 0 14.8164 0 0 15.4588 0 0 0 13.1563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2176 0 0 0 0 0 10.3826 0 0 0 0 0 13.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3604 0 0 0 13.933 0 0 0 0 0 0 12.4873 0 12.3995 13.2124 0 Q96M27 PRRC1_HUMAN Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1) PRRC1 Homo sapiens (Human) activation of protein kinase A activity [GO:0034199] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; protein kinase A regulatory subunit binding [GO:0034237]; activation of protein kinase A activity [GO:0034199] GO:0005737; GO:0005794; GO:0034199; GO:0034237 protein kinase A regulatory subunit binding [GO:0034237] RTGVIHEKQTAVSVENFIAELLPDK 0.99277 -14.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3315 0 15.3683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MH2 HEXI2_HUMAN Protein HEXIM2 (Hexamethylene bis-acetamide-inducible protein 2) HEXIM2 L3 Homo sapiens (Human) "negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0000122; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0017069; GO:0042802; GO:0045736; GO:0045892; GO:0097322 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; snRNA binding [GO:0017069] CDEEPGT 0.99277 -25.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3853 Q96RT6 CTGE2_HUMAN "cTAGE family member 2, Protein cTAGE-2 (Cancer/testis antigen 21.2, CT21.2)" CTAGE1 CTAGE2 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971 CRLEKEEK 0.99277 -15.012 0 0 11.4176 0 0 0 0 0 0 0 0 12.7145 12.4337 0 0 0 0 0 0 0 0 11.7823 11.5176 0 0 0 0 11.8305 0 0 0 0 11.8107 0 0 12.3953 0 0 0 0 0 0 0 11.6942 0 11.9116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6855 0 0 0 0 0 0 12.3467 0 0 0 0 0 0 0 0 0 0 0 0 12.4801 0 0 0 0 0 0 0 0 0 0 16.4967 0 0 0 14.451 0 0 0 0 0 0 0 0 0 0 13.9792 0 0 0 19.6745 0 13.7729 0 0 16.9897 16.8059 0 17.0176 16.5739 17.8499 0 15.6654 0 0 0 0 12.6705 0 0 0 0 0 0 0 12.1771 0 13.2861 0 12.7465 19.1037 0 0 0 0 0 0 0 0 0 0 0 0 11.9455 0 0 11.6818 17.7627 12.2382 0 0 12.4334 0 0 0 11.9957 Q9HAE3 CLXN_HUMAN Calaxin (EF-hand calcium-binding domain-containing protein 1) CLXN EFCAB1 Homo sapiens (Human) cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium movement [GO:0003352]; regulation of flagellated sperm motility [GO:1901317] cilium [GO:0005929] cilium [GO:0005929]; calcium ion binding [GO:0005509]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium movement [GO:0003352]; regulation of flagellated sperm motility [GO:1901317] GO:0003341; GO:0003352; GO:0005509; GO:0005929; GO:0036158; GO:1901317 calcium ion binding [GO:0005509] DLVEITLK 0.99277 -14.707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAU5 RENT2_HUMAN "Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog, hUpf2)" UPF2 KIAA1408 RENT2 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]" GO:0000184; GO:0001889; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006406; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471 RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] DDIKLTAKK 0.99277 -16.93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7392 0 0 0 0 12.2846 0 0 0 0 0 0 0 0 0 10.9998 0 10.6756 0 0 0 0 0 0 0 0 0 0 0 0 12.162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3744 0 0 12.9426 0 0 0 0 15.6769 13.6178 0 12.4641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.314 0 0 0 0 16.1033 0 0 0 0 12.702 12.5126 0 0 0 0 13.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3007 0 0 0 12.4345 12.81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5258 0 0 0 0 0 0 14.1187 11.6462 13.0796 12.7647 0 0 0 0 13.3558 10.4745 Q9UFE4 CCD39_HUMAN Coiled-coil domain-containing protein 39 CCDC39 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356] GO:0001947; GO:0003341; GO:0003356; GO:0005576; GO:0005829; GO:0005929; GO:0005930; GO:0007420; GO:0030317; GO:0030324; GO:0035469; GO:0036159; GO:0044458; GO:0051649; GO:0060285; GO:0060287; GO:0061512; GO:0061966; GO:0070286; GO:0071907; GO:0071910; GO:0090660 AAQDFRK 0.99277 -41.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2618 0 0 11.4213 0 0 0 0 0 0 14.02 0 0 0 0 0 0 0 0 0 0 0 0 14.2797 0 0 0 0 0 11.5421 13.2014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0234 0 0 0 10.5511 0 0 0 15.9301 0 0 0 0 0 0 13.0184 0 0 0 13.0753 0 12.5428 0 13.2975 0 0 0 13.5023 13.6 0 13.9186 0 0 12.0694 0 0 0 0 0 0 13.3782 0 0 0 0 12.6244 0 18.6315 0 13.4179 0 0 0 0 12.8841 0 0 0 0 0 0 0 0 14.0419 0 14.0363 0 0 0 16.8366 0 0 18.6013 0 0 0 0 15.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.553 0 0 0 0 14.9046 0 0 11.6519 0 0 18.42 0 0 0 0 11.6995 Q6PIY7 GLD2_HUMAN "Poly(A) RNA polymerase GLD2, hGLD-2, EC 2.7.7.19 (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2) (Terminal uridylyltransferase 2, TUTase 2)" TENT2 GLD2 PAPD4 Homo sapiens (Human) dark adaptation [GO:1990603]; hematopoietic progenitor cell differentiation [GO:0002244]; hippocampus development [GO:0021766]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; negative regulation of miRNA catabolic process [GO:2000626]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489] cytosol [GO:0005829]; nuclear RNA-directed RNA polymerase complex [GO:0031380] cytosol [GO:0005829]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; 5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; dark adaptation [GO:1990603]; hematopoietic progenitor cell differentiation [GO:0002244]; hippocampus development [GO:0021766]; histone mRNA catabolic process [GO:0071044]; mRNA polyadenylation [GO:0006378]; negative regulation of miRNA catabolic process [GO:2000626]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation [GO:0043631]; RNA stabilization [GO:0043489] GO:0002244; GO:0004652; GO:0005524; GO:0005829; GO:0006378; GO:0016779; GO:0021766; GO:0030182; GO:0031123; GO:0031380; GO:0034062; GO:0043489; GO:0043631; GO:0046872; GO:0060041; GO:0070566; GO:0071044; GO:1990603; GO:2000626 5'-3' RNA polymerase activity [GO:0034062]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652] AKVPIVKFR 0.99278 -24.231 0 14.8317 0 0 0 0 0 12.8494 10.8349 10.9138 0 11.3487 12.584 0 14.0205 11.0984 0 13.0309 0 0 13.924 0 13.8558 11.7936 13.1225 12.9741 12.6534 0 12.6938 13.2597 13.0252 12.6587 0 10.2096 12.6552 0 11.2924 13.0942 12.2801 12.1041 13.8995 0 12.1826 0 12.4166 13.2132 13.075 13.1059 13.3567 12.9333 0 0 12.6506 12.6342 12.1497 13.171 11.4549 0 0 0 0 11.7479 0 0 0 0 14.4108 15.3115 0 14.7775 15.0142 13.4458 11.5119 11.388 11.866 13.9602 13.7813 13.9119 0 13.3034 14.0616 13.087 13.7849 0 14.1407 14.1808 0 17.8801 0 14.0731 0 11.4982 0 0 13.4091 0 14.5152 13.4337 13.8958 0 0 0 13.6091 13.4546 0 14.0762 14.1785 13.7738 0 0 14.6542 12.6478 0 13.0504 0 0 0 0 13.8828 13.3065 0 0 0 0 13.999 0 0 0 0 13.0585 0 0 17.5579 14.1832 13.9848 13.1969 14.5442 13.3462 0 12.1887 12.8498 0 13.8849 12.9956 13.7718 14.7526 0 14.0918 0 0 0 0 10.9192 13.285 0 13.9298 0 0 12.5545 0 0 0 13.3531 14.0991 12.0149 12.5106 11.445 14.3604 0 0 0 13.9206 0 12.8866 0 0 0 0 0 14.4533 O43424 GRID2_HUMAN "Glutamate receptor ionotropic, delta-2, GluD2, GluR delta-2 subunit" GRID2 GLURD2 Homo sapiens (Human) "cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; glutamate receptor signaling pathway [GO:0007215]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; protein localization [GO:0008104]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; ionotropic glutamate receptor complex [GO:0008328]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cerebellar granule cell differentiation [GO:0021707]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; glutamate receptor signaling pathway [GO:0007215]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; prepulse inhibition [GO:0060134]; protein localization [GO:0008104]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuron projection development [GO:0010975]; regulation of postsynaptic density assembly [GO:0099151]; synaptic transmission, glutamatergic [GO:0035249]" GO:0004970; GO:0005886; GO:0005887; GO:0007157; GO:0007215; GO:0008066; GO:0008104; GO:0008328; GO:0010975; GO:0015276; GO:0021707; GO:0030165; GO:0035249; GO:0038023; GO:0043197; GO:0043523; GO:0045202; GO:0045211; GO:0050804; GO:0051965; GO:0060079; GO:0060134; GO:0070161; GO:0097110; GO:0098688; GO:0098978; GO:0099061; GO:0099151; GO:1900454; GO:1904315; GO:1904861 glutamate receptor activity [GO:0008066]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] DVFSQRILELQQNGDMDILKHK 0.99278 -15.116 0 0 0 0 0 0 0 0 0 0 0 0 15.8389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8603 0 0 0 0 14.733 0 0 14.6015 0 0 0 14.0186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6552 0 0 0 0 12.6893 13.0857 0 13.2341 0 0 0 15.9532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3145 13.7539 13.5006 0 0 0 0 10.5255 0 0 0 0 0 0 0 0 0 0 0 0 13.3639 0 0 0 13.2821 0 0 0 0 0 14.185 13.6999 0 12.9726 0 0 0 0 0 0 0 12.7124 0 0 0 13.2929 0 12.9768 14.2491 13.9217 12.0552 14.2286 11.5468 0 0 0 13.9111 13.779 0 0 0 0 0 0 0 0 0 0 12.1264 0 0 0 O60502 OGA_HUMAN "Protein O-GlcNAcase, OGA, EC 3.2.1.169 (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase, NCOAT)" OGA HEXC KIAA0679 MEA5 MGEA5 Homo sapiens (Human) glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493] GO:0004415; GO:0005634; GO:0005829; GO:0006044; GO:0006493; GO:0006516; GO:0006517; GO:0009100; GO:0016020; GO:0016231; GO:0102166; GO:0102167; GO:0102571 [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415] ANGSRGAFCEVR 0.99278 -26.021 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4961 0 0 0 0 0 0 0 0 0 0 13.4335 13.8994 14.1862 0 0 0 0 0 0 0 0 0 13.3581 14.0684 13.7645 0 14.3095 0 0 0 0 13.6987 0 0 0 14.2461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.533 0 0 0 0 0 0 0 15.7192 0 0 0 0 0 12.9692 0 0 13.0353 0 0 0 0 14.2661 0 0 0 0 0 14.7705 0 0 0 0 0 0 0 17.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3703 12.4856 0 0 0 0 0 0 0 0 0 16.9391 16.0203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2755 0 0 0 11.9214 0 0 0 0 16.1306 0 12.048 0 16.6095 0 0 0 0 O75533 SF3B1_HUMAN "Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit, SF3b155) (Spliceosome-associated protein 155, SAP 155)" SF3B1 SAP155 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]" B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] "B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]" GO:0000245; GO:0000375; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0005730; GO:0006338; GO:0008380; GO:0016607; GO:0034693; GO:0035066; GO:0045943; GO:0045944; GO:0045945; GO:0071004; GO:0071005; GO:0071013; GO:0110016; GO:1903241; GO:1990935 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935] AFAVVASALGIPSLLPFLK 0.99278 -59.174 0 0 0 0 0 0 0 0 13.9044 15.8042 12.7222 12.5368 13.4888 13.381 12.0677 0 0 0 0 0 13.1146 0 0 0 13.3551 0 0 0 14.9371 12.0827 10.9097 14.2507 13.603 0 0 15.624 13.3021 0 14.2714 0 11.3151 11.7432 0 0 14.3482 0 0 11.6977 13.3489 0 15.3147 0 0 0 0 0 13.2923 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9525 12.404 0 0 14.8298 0 0 0 0 0 0 15.0246 14.6813 0 17.7429 0 0 14.2101 14.283 14.9144 12.9235 15.7031 15.8167 13.7396 0 12.6305 14.5071 0 15.9831 0 0 0 0 15.1587 0 0 0 0 12.5659 0 0 15.1862 0 12.6609 13.9412 12.6526 14.7899 13.8146 0 0 0 0 0 0 0 11.9609 0 0 0 12.9183 0 14.2398 13.6432 0 0 0 0 0 13.4149 0 0 15.5943 14.7628 13.0121 0 0 11.9399 14.2963 0 12.9501 0 0 0 14.4257 0 12.0264 12.0308 12.6385 14.513 0 14.8537 15.301 0 16.0064 0 0 13.8709 14.6087 0 14.1117 0 13.0136 0 0 0 13.0253 0 13.1119 0 0 P00747 PLMN_HUMAN "Plasminogen, EC 3.4.21.7 [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B ]" PLG Homo sapiens (Human) "biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]" blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; Schaffer collateral - CA1 synapse [GO:0098685] "blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; Schaffer collateral - CA1 synapse [GO:0098685]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]" GO:0004175; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0008236; GO:0008285; GO:0009986; GO:0010812; GO:0019897; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031093; GO:0031232; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051702; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0062023; GO:0070062; GO:0071674; GO:0072562; GO:0098685; GO:0098978; GO:0099183; GO:1990405; GO:2000048 apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102] DVVLFEK 0.99278 -17.442 0 0 0 9.44603 0 0 0 0 0 0 11.5193 0 0 0 11.4206 0 0 0 0 0 0 11.8488 0 0 0 0 10.537 0 11.183 0 0 0 0 11.8683 0 11.1242 0 11.016 0 0 0 0 0 11.109 0 0 0 0 0 0 0 0 12.5346 13.2692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 14.0611 0 0 13.0425 12.8083 0 12.6904 0 0 0 0 14.3071 14.5684 13.9509 0 13.0154 0 10.8718 0 13.0358 0 0 0 12.8187 0 0 12.7855 0 0 13.8187 0 0 0 0 0 0 12.3642 0 15.6521 13.9494 11.0245 0 0 0 0 0 0 0 0 0 11.5317 0 0 12.8459 0 0 13.999 11.8296 0 12.8076 13.8004 15.0562 0 0 0 0 0 0 12.3797 0 0 12.6177 14.4578 13.5573 0 0 11.4802 0 13.3896 13.4659 11.9461 13.8516 0 13.0938 0 12.321 13.2092 0 11.9359 0 12.0266 0 0 11.7546 0 0 0 10.117 0 12.3517 14.9838 0 0 12.279 10.9888 13.7733 0 0 11.1591 P30260 CDC27_HUMAN "Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3, APC3) (CDC27 homolog, CDC27Hs) (H-NUC)" CDC27 ANAPC3 D0S1430E D17S978E Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0072686 protein phosphatase binding [GO:0019903] AAAEGLMSLLR 0.99278 -24.227 0 0 0 0 0 0 0 0 0 0 0 12.6658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7 0 0 0 0 0 0 0 0 0 0 11.0466 0 0 12.6238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1501 0 0 0 0 0 0 0 0 13.7866 12.5646 0 12.9099 0 0 0 0 0 13.5639 0 0 0 0 13.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1224 0 12.5902 13.2316 12.494 0 0 0 11.9022 0 0 0 0 0 10.5182 0 0 0 0 12.801 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7061 0 12.9805 0 0 0 0 P49411 EFTU_HUMAN "Elongation factor Tu, mitochondrial, EF-Tu (P43)" TUFM Homo sapiens (Human) mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414] extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; synapse [GO:0045202] extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414] GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0006414; GO:0016020; GO:0042645; GO:0045202; GO:0045471; GO:0070062; GO:0070125 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] DPELGLKSVQK 0.99278 -16.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1101 0 0 0 0 0 0 0 0 0 0 12.7051 0 0 0 12.6438 0 0 0 0 13.4688 14.3507 0 13.3358 0 0 0 0 0 0 0 13.6439 13.6905 0 0 13.8221 0 0 13.2503 14.6322 0 14.5143 0 12.7906 13.5088 13.5891 0 0 15.4961 0 13.1373 0 14.0452 0 0 14.5086 0 0 14.9876 0 0 0 13.4427 0 0 12.8416 0 13.876 0 13.4988 14.5215 0 16.1764 0 0 0 13.3945 0 0 0 0 15.3722 0 14.7533 0 0 0 0 0 0 12.6715 0 0 0 0 0 0 0 13.183 0 12.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98088 MUC5A_HUMAN "Mucin-5AC, MUC-5AC (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin, TBM)" MUC5AC MUC5 Homo sapiens (Human) phosphatidylinositol-mediated signaling [GO:0048015] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; phosphatidylinositol-mediated signaling [GO:0048015] GO:0005201; GO:0005615; GO:0005737; GO:0005796; GO:0005886; GO:0031012; GO:0048015; GO:0070062; GO:0070701 extracellular matrix structural constituent [GO:0005201] AGQTIRVGCNTCTCDSR 0.99278 -6.3382 0 0 0 14.3808 12.2484 12.9211 12.7217 13.0278 11.099 0 0 0 0 0 0 0 0 0 0 0 0 12.993 0 13.1871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1822 0 0 13.3016 0 0 0 12.8346 0 0 0 0 13.4936 0 0 0 12.5765 0 14.4729 0 0 0 0 13.1228 16.0768 0 13.1654 0 0 0 15.2922 14.2845 15.0727 13.8502 15.424 15.6235 14.2319 15.0062 0 15.5448 0 15.5082 0 15.5525 15.4912 13.7402 0 0 13.6319 15.9392 15.8528 0 14.0285 13.5633 0 15.6643 0 0 0 0 0 15.297 14.0609 0 14.7003 15.2494 11.8004 0 0 13.5012 10.7386 13.4723 0 0 0 0 15.3929 15.4234 0 0 0 0 0 0 15.2188 0 0 0 0 10.6964 15.3649 0 0 0 0 0 0 9.44433 0 0 0 0 0 0 0 0 12.8626 16.4721 0 0 0 0 0 0 Q00341 VIGLN_HUMAN "Vigilin (High density lipoprotein-binding protein, HDL-binding protein)" HDLBP HBP VGL Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869] cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844] cytoplasm [GO:0005737]; cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869] GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006869; GO:0008203; GO:0008289; GO:0034364; GO:0045296 cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] ANCEAARSRILSIQK 0.99278 -16.985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7334 0 0 0 0 0 0 0 0 13.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2737 0 0 0 0 0 14.2191 0 15.0254 0 0 15.7211 0 0 0 14.6281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6164 0 13.3178 0 0 0 11.1944 0 0 0 0 0 14.9427 14.0793 13.2452 0 0 11.7693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3632 0 0 0 0 0 0 0 Q14624 ITIH4_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H4, ITI heavy chain H4, ITI-HC4, Inter-alpha-inhibitor heavy chain 4 (Inter-alpha-trypsin inhibitor family heavy chain-related protein, IHRP) (Plasma kallikrein sensitive glycoprotein 120, Gp120, PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4 ]" ITIH4 IHRP ITIHL1 PK120 PRO1851 Homo sapiens (Human) acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097] GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0006953; GO:0030212; GO:0031089; GO:0034097; GO:0062023; GO:0070062; GO:0072562 endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867] ERRLDYQEGPPGVEISCWSVEL 0.99278 -4.9793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4038 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5209 0 0 0 0 0 0 0 0 10.6773 0 0 0 0 0 0 0 0 13.4441 0 0 0 10.8857 0 0 0 0 0 0 0 14.1804 0 0 0 0 0 0 0 0 0 0 0 12.1978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2509 0 0 0 11.7738 0 0 0 0 0 0 0 0 0 0 0 Q5VVJ2 MYSM1_HUMAN "Deubiquitinase MYSM1, 2A-DUB, EC 3.4.19.- (Myb-like, SWIRM and MPN domain-containing protein 1)" MYSM1 KIAA1915 Homo sapiens (Human) chromatin remodeling [GO:0006338]; immune system process [GO:0002376]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of hair follicle development [GO:0051797]; regulation of hemopoiesis [GO:1903706] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; immune system process [GO:0002376]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of hair follicle development [GO:0051797]; regulation of hemopoiesis [GO:1903706] GO:0002376; GO:0003677; GO:0003713; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0030334; GO:0032991; GO:0035522; GO:0042393; GO:0043473; GO:0045944; GO:0046872; GO:0051797; GO:0070122; GO:0140492; GO:1903706 cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; histone binding [GO:0042393]; isopeptidase activity [GO:0070122]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; transcription coactivator activity [GO:0003713] AWTPSCLRGRADPNLNAVK 0.99278 -24.221 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6151 0 0 0 13.5311 0 12.9109 12.8543 0 0 0 0 0 14.0171 0 13.474 0 0 0 0 0 0 13.4828 0 0 0 0 11.9228 0 0 0 0 12.577 0 0 0 0 0 0 0 0 10.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4016 11.6779 0 0 16.2305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2335 0 0 0 13.0028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZ89 DEN4C_HUMAN DENN domain-containing protein 4C DENND4C C9orf55 C9orf55B Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; retromer complex [GO:0030904] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; retromer complex [GO:0030904]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] GO:0005085; GO:0005794; GO:0005829; GO:0005886; GO:0015031; GO:0030659; GO:0030904; GO:0031410; GO:0032483; GO:0032593; GO:0032869; GO:0043231; GO:0072659 guanyl-nucleotide exchange factor activity [GO:0005085] AYAKFYTLLSK 0.99278 -17.456 0 0 0 0 0 0 0 0 0 0 0 13.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1521 0 0 0 0 0 0 0 11.7813 11.6008 0 0 0 0 0 0 0 11.9569 0 0 11.4156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5904 12.1799 0 12.93 0 0 0 13.8854 13.9631 10.1017 0 0 0 13.9665 0 13.9795 0 0 0 0 0 13.1258 0 0 0 0 12.3766 0 13.4658 0 0 0 0 0 0 0 0 0 0 14.691 0 0 0 0 0 0 0 13.7399 0 0 0 12.3578 0 0 0 0 13.84 0 0 0 12.4267 13.3235 12.82 0 0 11.6923 12.6854 0 0 0 11.2643 0 0 0 0 12.6954 11.4385 0 0 0 0 0 0 0 0 0 0 0 12.5449 11.3141 0 0 0 0 0 0 0 0 0 0 0 0 12.9179 0 0 0 0 13.2815 0 Q70Z53 F10C1_HUMAN Protein FRA10AC1 FRA10AC1 C10orf4 PRO2972 Homo sapiens (Human) dephosphorylation [GO:0016311] nucleus [GO:0005634] nucleus [GO:0005634]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311] GO:0005634; GO:0016311; GO:0016791 phosphatase activity [GO:0016791] DCEESSHK 0.99278 -24.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5171 0 0 0 0 13.3183 0 0 13.0761 0 0 0 0 0 0 0 0 0 0 12.9137 13.4101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6357 0 0 0 0 0 13.853 0 0 0 0 0 14.266 0 0 0 10.7134 14.4248 15.9594 0 0 10.2018 0 0 0 0 0 0 0 12.112 0 0 0 0 0 0 13.8852 0 0 0 10.1404 0 0 0 14.1565 0 0 0 0 0 0 0 0 0 0 0 14.6148 0 0 11.1289 0 0 0 11.1016 12.8729 0 0 0 0 0 0 0 13.056 0 0 0 0 13.5909 13.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q711Q0 CEFIP_HUMAN Cardiac-enriched FHL2-interacting protein CEFIP C10orf71 Homo sapiens (Human) positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] Z disc [GO:0030018] Z disc [GO:0030018]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] GO:0030018; GO:0070886 AGPPGRR 0.99278 -62.357 0 11.6484 0 0 0 0 12.4691 0 11.216 0 0 13.5576 0 0 11.7356 0 0 0 11.9988 0 14.4404 14.0846 12.6691 0 11.6753 11.3151 0 11.4534 0 0 10.6745 0 0 0 0 13.9169 0 0 0 0 0 0 0 0 11.3585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6058 0 0 0 0 0 0 11.4009 15.434 0 13.9059 13.6422 11.7719 13.0555 0 15.1468 14.1891 13.1314 12.2519 13.5396 0 16.1845 13.5226 15.2047 13.3942 13.434 0 12.868 0 14.6418 13.4997 13.2604 0 12.0845 13.3079 14.2504 0 0 0 14.2779 13.6552 0 14.9834 0 13.9702 0 12.8886 13.2631 0 13.4789 0 11.3169 0 0 14.9989 13.197 13.9628 13.3373 15.967 14.1013 13.7055 0 14.8501 0 14.4526 13.2289 14.7576 15.4396 0 14.2173 13.9905 15.1996 14.8211 0 0 13.6004 0 13.9827 12.7756 0 0 0 0 12.9019 13.5974 0 0 12.4168 13.0235 13.6867 0 0 0 13.7297 0 0 0 0 0 12.7032 13.5821 0 0 0 12.938 0 0 14.1517 0 0 15.725 0 0 13.9243 Q8IVB5 LIX1L_HUMAN LIX1-like protein LIX1L Homo sapiens (Human) autophagosome maturation [GO:0097352] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; autophagosome maturation [GO:0097352] GO:0005737; GO:0097352 AMRERQCSR 0.99278 -15.091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5689 0 0 0 0 0 Q8IWS0 PHF6_HUMAN PHD finger protein 6 (PHD-like zinc finger protein) PHF6 CENP-31 KIAA1823 Homo sapiens (Human) blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0000776; GO:0001835; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0015631; GO:0019899; GO:0042393; GO:0042826; GO:0043021; GO:0046872; GO:0051219; GO:0097110 DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphoprotein binding [GO:0051219]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; tubulin binding [GO:0015631] CGFCHVGEEENEAR 0.99278 -16.943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0166 0 0 12.3922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7746 12.7767 12.5945 0 0 0 14.882 14.6872 15.0302 15.1457 0 14.357 14.2181 14.8648 0 0 0 0 0 0 0 0 0 0 0 0 12.2576 0 0 0 14.2605 14.6089 0 14.0728 0 13.4893 20.0269 0 14.0661 0 0 0 0 11.4094 0 0 13.2435 0 0 0 0 0 0 0 0 0 0 0 0 15.3386 0 0 0 0 0 0 0 0 0 12.874 0 10.5174 0 0 0 0 0 12.3151 0 0 0 0 0 0 14.7311 0 13.1464 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6952 0 11.4821 0 0 0 0 0 0 0 0 14.3737 0 0 0 0 0 0 0 0 0 0 0 13.7708 0 0 0 0 Q8N4B4 FBX39_HUMAN F-box only protein 39 FBXO39 FBX39 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] SCF ubiquitin ligase complex [GO:0019005] SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0019005; GO:0031146 FMNPYNAVLTKK 0.99278 -6.3407 0 0 0 0 11.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86675 0 0 11.2295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6503 0 0 0 0 0 0 0 14.2712 0 0 0 12.2054 12.7826 0 0 11.5112 0 13.2408 14.5846 0 0 0 0 0 14.5039 0 0 0 0 0 0 0 0 11.9419 0 0 0 0 0 0 0 0 10.9413 0 0 0 11.1956 0 0 0 0 0 10.8679 0 12.1884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0024 0 0 14.611 0 0 0 14.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5837 0 0 0 0 0 0 Q96JC1 VPS39_HUMAN "Vam6/Vps39-like protein (TRAP1-like protein, hVam6p)" VPS39 KIAA0770 TLP VAM6 Homo sapiens (Human) autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; endocytic recycling [GO:0032456]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulation of SNARE complex assembly [GO:0035542] AP-3 adaptor complex [GO:0030123]; cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] AP-3 adaptor complex [GO:0030123]; cytoplasm [GO:0005737]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; endocytic recycling [GO:0032456]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulation of SNARE complex assembly [GO:0035542] GO:0005737; GO:0005765; GO:0005770; GO:0006886; GO:0006914; GO:0008333; GO:0016020; GO:0030123; GO:0030897; GO:0031902; GO:0032456; GO:0034058; GO:0035542; GO:0061909; GO:1902501; GO:1902774 ALLLGRMGK 0.99278 -17.43 0 0 0 0 0 0 0 0 10.6537 13.0254 0 13.3651 0 0 0 12.718 0 0 0 16.5552 0 0 0 0 0 9.76153 0 0 0 0 10.762 13.2909 0 0 11.6695 0 13.8504 11.9447 0 0 11.7608 0 0 0 0 0 0 0 12.6171 13.6425 0 0 0 11.3741 0 0 0 0 0 0 9.83048 0 11.1834 0 0 0 0 0 0 0 0 0 0 12.8278 0 11.8672 11.3617 0 0 12.7279 12.2661 15.7673 0 12.2857 0 0 0 13.645 13.0176 14.3769 0 0 0 12.5548 0 13.8146 0 13.4329 13.5153 0 0 10.9081 0 0 0 13.3132 0 0 0 0 0 0 0 0 0 11.3825 0 0 0 0 13.1631 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4231 0 0 0 0 0 0 0 0 17.248 0 0 9.85465 12.2506 0 0 0 0 0 12.8066 12.4269 0 0 0 0 12.6272 0 0 0 0 0 0 0 0 0 0 0 12.5993 0 0 0 12.5844 0 0 0 12.9839 Q96RN5 MED15_HUMAN "Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component, ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein, PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein, TIG-1) (Trinucleotide repeat-containing gene 7 protein)" MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0051123; GO:0060261; GO:0070847 transcription coregulator activity [GO:0003712] CPLKTLQK 0.99278 -16.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6783 13.9502 0 12.5981 13.2037 0 0 0 0 0 0 0 0 0 0 0 12.5465 0 0 0 0 0 12.6663 0 0 0 0 0 0 15.5789 0 0 15.3777 0 12.1374 13.189 12.3442 0 15.3953 0 0 12.7797 13.7043 0 12.6453 12.7244 0 0 0 0 0 0 0 0 0 0 12.2063 14.567 12.9518 0 12.6064 12.7338 12.9492 0 0 12.846 14.7224 13.0184 0 0 0 12.5351 0 14.686 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9966 0 0 0 0 0 0 0 0 0 0 12.5695 13.9125 0 0 0 0 0 0 Q9UBK8 MTRR_HUMAN "Methionine synthase reductase, MSR, EC 1.16.1.8 (Aquacobalamin reductase, AqCbl reductase)" MTRR Homo sapiens (Human) DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; S-adenosylmethionine cycle [GO:0033353] cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; [methionine synthase] reductase activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]; DNA methylation [GO:0006306]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; negative regulation of cystathionine beta-synthase activity [GO:1904042]; S-adenosylmethionine cycle [GO:0033353]" GO:0003958; GO:0005654; GO:0005829; GO:0006306; GO:0009086; GO:0010181; GO:0016491; GO:0016723; GO:0030586; GO:0033353; GO:0043418; GO:0045111; GO:0046655; GO:0050660; GO:0050667; GO:0070402; GO:0071949; GO:1904042 "[methionine synthase] reductase activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]" DVHDALVQIISKEVGVEK 0.99278 -4.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIJ5 ZDHC2_HUMAN "Palmitoyltransferase ZDHHC2, EC 2.3.1.225 (Acyltransferase ZDHHC2, EC 2.3.1.-) (Reduced expression associated with metastasis protein, Ream) (Reduced expression in cancer protein, Rec) (Zinc finger DHHC domain-containing protein 2, DHHC-2) (Zinc finger protein 372)" ZDHHC2 REAM REC ZNF372 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein localization to plasma membrane [GO:0072659]; protein localization to postsynaptic membrane [GO:1903539]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of cell-cell adhesion [GO:0022407]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein catabolic process [GO:0042176]; regulation of protein localization to plasma membrane [GO:1903076]; synaptic vesicle maturation [GO:0016188] anchoring junction [GO:0070161]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038] anchoring junction [GO:0070161]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of AMPA glutamate receptor clustering [GO:1904719]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein localization to plasma membrane [GO:0072659]; protein localization to postsynaptic membrane [GO:1903539]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of cell-cell adhesion [GO:0022407]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein catabolic process [GO:0042176]; regulation of protein localization to plasma membrane [GO:1903076]; synaptic vesicle maturation [GO:0016188] GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006612; GO:0014069; GO:0016188; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0022407; GO:0042176; GO:0042803; GO:0048168; GO:0055038; GO:0070161; GO:0072659; GO:0098837; GO:0140439; GO:1900273; GO:1903076; GO:1903539; GO:1904719; GO:1905751 palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439] APSGPGSSARR 0.99278 -15.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.122 0 0 0 0 0 0 14.539 12.9418 0 0 17.278 0 0 0 0 14.2381 11.6669 0 0 0 0 0 0 0 0 12.9208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6368 0 0 14.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ16 DYN3_HUMAN "Dynamin-3, EC 3.6.5.5 (Dynamin, testicular) (T-dynamin)" DNM3 KIAA0820 Homo sapiens (Human) endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; synapse assembly [GO:0007416]; synaptic vesicle endocytosis [GO:0048488] apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083] apical tubulobulbar complex [GO:0061828]; axon [GO:0030424]; basal tubulobulbar complex [GO:0061829]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802]; endocytosis [GO:0006897]; filopodium assembly [GO:0046847]; negative regulation of dendritic spine morphogenesis [GO:0061002]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; synapse assembly [GO:0007416]; synaptic vesicle endocytosis [GO:0048488] GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005874; GO:0005886; GO:0006897; GO:0007416; GO:0008017; GO:0014069; GO:0016020; GO:0030424; GO:0031623; GO:0031798; GO:0031802; GO:0042802; GO:0043083; GO:0043197; GO:0044327; GO:0045202; GO:0046847; GO:0048471; GO:0048488; GO:0050998; GO:0051491; GO:0061002; GO:0061828; GO:0061829; GO:0070062; GO:0098793; GO:0098844; GO:0098884; GO:0098978; GO:0099186; GO:1903423 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; structural constituent of postsynapse [GO:0099186]; type 1 metabotropic glutamate receptor binding [GO:0031798]; type 5 metabotropic glutamate receptor binding [GO:0031802] FFLSHPAYRHIADR 0.99278 -26.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5201 0 0 0 0 0 11.8978 0 0 0 0 0 12.2051 0 0 0 0 0 12.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.166 0 0 0 0 0 17.8358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5751 0 0 0 0 0 0 0 0 15.2952 0 0 0 0 0 13.9212 0 13.007 0 0 0 0 0 0 0 14.3404 0 0 0 0 0 0 0 10.0001 0 0 9.98925 11.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74977 0 0 0 0 0 12.982 0 10.8915 0 0 12.7417 0 0 0 13.2131 0 0 0 0 0 0 0 0 0 11.7912 0 0 0 Q9Y2Y4 ZBT32_HUMAN Zinc finger and BTB domain-containing protein 32 (FANCC-interacting protein) (Fanconi anemia zinc finger protein) (Testis zinc finger protein) (Zinc finger protein 538) ZBTB32 FAZF TZFP ZNF538 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" HQEEPEKPSRNPER 0.99278 -26.042 11.2143 0 0 0 0 12.7074 0 11.1994 0 0 0 10.1848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9709 0 11.2814 0 11.4604 0 0 0 12.6688 15.1839 12.894 0 0 13.8571 0 14.1055 15.1019 14.1964 14.3489 14.0662 0 0 0 0 0 14.1542 14.3656 0 0 13.3819 13.7849 0 0 0 0 12.0966 0 0 13.7276 0 0 0 12.0636 0 0 0 0 0 0 0 0 11.7737 0 13.7024 11.4448 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6599 0 12.1211 0 0 0 0 0 0 14.0587 0 0 0 12.1341 0 0 0 0 0 0 0 0 0 0 12.0286 0 12.2214 0 0 0 0 0 0 0 0 0 0 0 E7EW31 PROB1_HUMAN Proline-rich basic protein 1 PROB1 C5orf65 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 APRPWPSLR 0.99279 -44.918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8505 13.3004 0 13.7193 13.9939 0 12.9099 0 11.7261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3653 0 0 0 0 0 0 0 0 0 13.3399 13.4847 12.2209 0 11.0721 0 0 0 0 0 0 0 0 0 0 0 12.1349 13.4338 0 12.6342 0 0 0 0 15.3108 0 15.4437 16.7968 16.5951 16.511 0 0 0 0 12.2938 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4424 14.8846 15.7977 13.5275 15.4607 14.7553 15.0894 15.6859 15.769 15.0236 15.4585 14.9184 12.565 0 11.6334 0 16.1556 12.5321 13.7939 0 17.2883 16.7634 16.6928 16.5183 0 15.9766 16.233 16.564 16.2782 16.1377 17.6109 14.9503 14.3366 12.9274 0 15.7217 16.1016 0 14.8823 0 12.0732 0 0 15.2154 0 0 15.281 0 14.5193 0 14.4933 16.9863 16.9131 0 14.6204 16.8627 16.6035 0 0 0 0 0 0 12.6201 0 14.0845 16.5374 0 14.9531 0 0 13.2253 0 16.533 0 14.5161 13.2424 0 0 0 0 O00468 AGRIN_HUMAN "Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment, C90; Agrin C-terminal 22 kDa fragment, C22 ]" AGRN AGRIN Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888] anchoring junction [GO:0070161]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]; animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888] GO:0002162; GO:0005200; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0005886; GO:0007165; GO:0007213; GO:0007528; GO:0009887; GO:0009888; GO:0016021; GO:0033691; GO:0035374; GO:0043113; GO:0043202; GO:0043236; GO:0043395; GO:0043547; GO:0045162; GO:0045202; GO:0045887; GO:0045944; GO:0050808; GO:0051491; GO:0062023; GO:0070062; GO:0070161 calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200] AGPCEQAECGSGGSGSGEDGDCEQELCR 0.99279 -63.479 12.4734 0 12.6366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0986 0 11.1692 13.1044 0 0 0 0 0 0 0 0 0 0 0 12.6656 0 0 0 0 0 11.4213 0 0 0 0 0 0 12.5623 13.0946 0 0 0 0 0 0 0 0 0 14.0401 0 0 0 13.4281 0 0 0 12.5126 13.8962 12.9397 0 13.6498 0 0 13.8428 0 0 11.1515 0 0 0 0 14.4736 0 0 11.0647 0 0 0 13.2774 14.9599 11.3009 14.1096 14.4552 14.2432 14.1414 0 0 13.1107 0 0 0 0 0 12.7064 11.8284 0 13.8079 11.0689 0 11.3842 12.2405 15.8018 13.7124 13.4897 0 0 15.3305 0 14.4326 12.3876 13.6695 14.6378 12.2764 0 12.2357 11.547 15.5571 15.8188 13.2093 13.6536 0 13.7003 0 14.541 0 15.9751 11.7117 14.4511 11.025 12.7179 13.9424 0 0 0 0 13.5299 0 0 0 15.7655 0 0 12.5971 0 0 0 0 0 0 13.6839 12.4975 12.1108 0 11.0023 0 0 0 0 0 13.2365 0 0 15.8359 0 0 13.831 O14529 CUX2_HUMAN Homeobox protein cut-like 2 (Homeobox protein cux-2) CUX2 CUTL2 KIAA0293 Homo sapiens (Human) cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614] chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to organic substance [GO:0071310]; cognition [GO:0050890]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of synapse assembly [GO:0051965]; regulation of transcription by RNA polymerase II [GO:0006357]; short-term memory [GO:0007614]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007614; GO:0010628; GO:0043565; GO:0050775; GO:0050890; GO:0051965; GO:0061003; GO:0070062; GO:0071310; GO:1990837; GO:2000463 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" DREILRLLK 0.99279 -39.919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5764 0 0 0 0 13.0098 0 0 0 0 0 0 0 0 0 12.9998 0 0 0 0 0 0 0 0 0 0 0 0 13.0248 13.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8189 12.4077 0 0 0 0 13.0145 0 0 0 0 0 0 0 17.296 0 0 0 0 0 0 17.3821 0 0 16.5254 0 16.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9704 0 O60756 BCE1_HUMAN Putative protein BCE-1 BCE1 Homo sapiens (Human) DLPLKNTK 0.99279 -17.478 0 0 0 0 0 0 0 0 0 0 12.3067 0 0 0 12.5582 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8218 0 0 0 0 0 0 0 11.609 0 0 0 0 0 0 0 0 0 0 0 0 10.6187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8342 0 0 0 0 0 0 0 0 0 12.7561 0 0 0 0 0 0 0 12.5898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0116 0 12.7327 0 0 0 0 0 0 0 0 0 0 0 0 0 P10909 CLUS_HUMAN "Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J, Apo-J) (Complement cytolysis inhibitor, CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Sulfated glycoprotein 2, SGP-2) (Testosterone-repressed prostate message 2, TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain) ]" CLU APOJ CLI KUB1 AAG4 Homo sapiens (Human) "cell morphogenesis [GO:0000902]; central nervous system myelin maintenance [GO:0032286]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; immune complex clearance [GO:0002434]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to thapsigargin [GO:1905892]; negative regulation of cellular response to tunicamycin [GO:1905895]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neurofibrillary tangle assembly [GO:1902998]; positive regulation of neuron death [GO:1901216]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of amyloid-beta clearance [GO:1900221]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of neuron death [GO:1901214]; regulation of neuronal signal transduction [GO:1902847]; release of cytochrome c from mitochondria [GO:0001836]; response to misfolded protein [GO:0051788]; response to virus [GO:0009615]; reverse cholesterol transport [GO:0043691]" apical dendrite [GO:0097440]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; chromaffin granule [GO:0042583]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum lumen [GO:0099020]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; spherical high-density lipoprotein particle [GO:0034366]; synapse [GO:0045202] "apical dendrite [GO:0097440]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; chromaffin granule [GO:0042583]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum lumen [GO:0099020]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; spherical high-density lipoprotein particle [GO:0034366]; synapse [GO:0045202]; amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; low-density lipoprotein particle receptor binding [GO:0050750]; misfolded protein binding [GO:0051787]; protein carrier chaperone [GO:0140597]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cell morphogenesis [GO:0000902]; central nervous system myelin maintenance [GO:0032286]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; immune complex clearance [GO:0002434]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid metabolic process [GO:0006629]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to thapsigargin [GO:1905892]; negative regulation of cellular response to tunicamycin [GO:1905895]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neurofibrillary tangle assembly [GO:1902998]; positive regulation of neuron death [GO:1901216]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of amyloid-beta clearance [GO:1900221]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of neuron death [GO:1901214]; regulation of neuronal signal transduction [GO:1902847]; release of cytochrome c from mitochondria [GO:0001836]; response to misfolded protein [GO:0051788]; response to virus [GO:0009615]; reverse cholesterol transport [GO:0043691]" GO:0000902; GO:0001540; GO:0001774; GO:0001836; GO:0002434; GO:0005102; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005794; GO:0005829; GO:0006629; GO:0006956; GO:0006958; GO:0009615; GO:0009986; GO:0010628; GO:0017038; GO:0031093; GO:0031333; GO:0031334; GO:0031625; GO:0032286; GO:0032436; GO:0032760; GO:0032991; GO:0034366; GO:0042127; GO:0042583; GO:0042981; GO:0043065; GO:0043231; GO:0043691; GO:0044877; GO:0045087; GO:0045202; GO:0045429; GO:0046982; GO:0048156; GO:0048260; GO:0048471; GO:0050750; GO:0050821; GO:0051082; GO:0051087; GO:0051092; GO:0051131; GO:0051787; GO:0051788; GO:0060548; GO:0061077; GO:0061518; GO:0061740; GO:0062023; GO:0070062; GO:0072562; GO:0090201; GO:0097193; GO:0097418; GO:0097440; GO:0099020; GO:0140597; GO:1900221; GO:1901214; GO:1901216; GO:1902004; GO:1902230; GO:1902430; GO:1902847; GO:1902949; GO:1902998; GO:1903573; GO:1905892; GO:1905895; GO:1905907; GO:1905908; GO:2000060; GO:2001244 amyloid-beta binding [GO:0001540]; chaperone binding [GO:0051087]; low-density lipoprotein particle receptor binding [GO:0050750]; misfolded protein binding [GO:0051787]; protein carrier chaperone [GO:0140597]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] EGDDDRTVCR 0.99279 -6.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46100 ATRX_HUMAN "Transcriptional regulator ATRX, EC 3.6.4.12 (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein, XNP) (Znf-HX)" ATRX RAD54L XH2 Homo sapiens (Human) "cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent chromatin assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]" "chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]" "chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; chromo shadow domain binding [GO:0070087]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; DNA replication-independent chromatin assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription, DNA-templated [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]" GO:0000212; GO:0000228; GO:0000779; GO:0000781; GO:0000792; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005721; GO:0006281; GO:0006306; GO:0006334; GO:0006336; GO:0006338; GO:0006355; GO:0006366; GO:0007283; GO:0010571; GO:0015616; GO:0016604; GO:0016605; GO:0016887; GO:0030330; GO:0030900; GO:0031297; GO:0031490; GO:0032206; GO:0035064; GO:0035128; GO:0035264; GO:0042393; GO:0045944; GO:0046872; GO:0060009; GO:0070087; GO:0070192; GO:0070198; GO:0072520; GO:0072711; GO:0099115; GO:0140658; GO:1900112; GO:1901581; GO:1901582; GO:1904908 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; chromo shadow domain binding [GO:0070087]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] ANLSSDEDGSSDDEPEEGK 0.99279 -44.904 0 0 10.9112 0 0 0 0 0 11.2261 11.8889 13.5948 14.6817 0 0 11.6568 15.1807 14.2981 14.3995 0 10.6613 12.4518 10.2755 0 14.3385 14.8537 0 14.5256 10.7728 14.908 12.5876 15.1978 0 15.1291 13.3806 11.9266 11.4437 11.0202 0 14.6362 0 13.7771 15.1003 15.4295 0 0 0 9.29767 14.4303 0 12.5544 0 0 11.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9294 0 12.0447 0 0 0 0 17.1053 17.3096 0 0 12.309 15.891 11.9587 13.3607 14.0758 15.7769 16.9032 16.9015 17.1386 12.4444 17.4165 13.5575 17.5546 16.3094 17.359 15.9047 11.1607 16.1067 16.7312 16.084 16.148 15.3314 15.3095 17.8336 16.5644 18.2984 14.7484 16.7263 16.6776 16.9704 0 17.1174 14.6214 15.933 14.4103 12.5478 15.4556 17.0953 16.972 15.461 16.0854 15.963 15.011 14.9669 15.2293 15.5109 16.2413 16.4734 14.1675 16.0055 16.9667 15.3404 16.3649 13.8045 14.9642 15.0014 16.1083 16.7142 15.8642 14.7406 14.5045 14.3549 15.2071 14.6658 16.0635 14.7764 14.7122 14.9877 13.4954 16.2996 12.8082 15.539 0 15.5408 14.7904 13.2323 14.5015 0 14.2841 16.3926 14.5515 13.6106 0 0 0 14.9327 12.5405 14.6778 13.4995 14.5062 16.0735 0 12.9796 0 16.3391 15.4436 16.1251 16.2831 11.7245 13.9537 13.8982 15.4669 0 Q10713 MPPA_HUMAN Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (P-55) PMPCA INPP5E KIAA0123 MPPA Homo sapiens (Human) protein processing involved in protein targeting to mitochondrion [GO:0006627] extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739] extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627] GO:0004222; GO:0005615; GO:0005739; GO:0005743; GO:0006627; GO:0017087; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] FCPTENVAK 0.99279 -26.418 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92359 0 10.0507 0 0 0 0 0 0 0 0 0 0 10.6615 0 0 0 0 0 0 0 0 0 0 0 9.34101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5048 0 0 0 0 0 0 0 11.5657 0 0 Q14739 LBR_HUMAN "Delta(14)-sterol reductase LBR, Delta-14-SR, EC 1.3.1.70 (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase, C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase)" LBR Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]; cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]" GO:0003677; GO:0003723; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005639; GO:0005737; GO:0005789; GO:0006695; GO:0016020; GO:0016021; GO:0016126; GO:0016627; GO:0030223; GO:0031965; GO:0050613; GO:0070087; GO:0070402 "chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; RNA binding [GO:0003723]" EARDEYHCK 0.99279 -6.3557 13.5939 0 0 0 0 0 0 0 13.2989 0 0 0 0 0 0 0 12.7712 0 0 0 0 0 0 16.3832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2874 13.9612 14.0151 14.2788 0 14.3396 0 0 0 14.1894 0 0 0 14.5495 14.9949 0 0 17.2902 0 0 13.553 0 14.4069 0 13.8292 0 0 13.5641 11.8168 16.6719 0 0 13.6732 0 0 0 0 0 0 0 13.2767 0 0 14.6375 0 0 0 15.0857 15.1528 14.2449 0 15.4688 14.3076 14.4804 0 14.2149 0 14.0658 0 13.2056 0 0 15.8476 15.3428 0 15.771 14.5451 15.3682 15.3217 13.5237 0 14.3172 14.7587 0 14.5131 0 0 14.5067 14.2314 18.8315 15.2505 0 0 0 0 15.6931 0 0 14.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3367 0 14.4984 0 0 0 0 0 0 Q32M45 ANO4_HUMAN Anoctamin-4 (Transmembrane protein 16D) ANO4 TMEM16D Homo sapiens (Human) calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005229; GO:0005254; GO:0005886; GO:0006821; GO:0016021; GO:0017128; GO:0034220; GO:0046983; GO:0051649; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983] ETLPDLEENDCYTAPFSQQR 0.99279 -24.325 0 0 0 0 0 0 0 0 0 0 0 12.765 0 0 0 0 0 0 11.778 0 0 0 0 0 0 0 0 0 0 0 0 0 12.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5144 0 0 0 0 10.947 11.4173 0 0 0 10.6553 0 0 0 0 13.358 0 0 0 0 0 0 0 0 0 0 0 14.0094 13.8583 0 14.9245 0 13.3294 0 0 0 0 0 0 0 13.6987 14.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3526 0 0 0 0 13.2542 13.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6367 0 13.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6628 0 0 0 0 14.7857 0 0 0 0 0 11.0227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49AM1 MTEF2_HUMAN "Transcription termination factor 2, mitochondrial (Mitochondrial transcription termination factor 2, mTERF2) (Mitochondrial transcription termination factor-like protein, mTERF-like, mTERFL) (mTERF domain-containing protein 3, mitochondrial)" MTERF2 MTERFD3 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]" mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676]; regulation of transcription, DNA-templated [GO:0006355]; termination of mitochondrial transcription [GO:0006393]" GO:0003676; GO:0003677; GO:0003690; GO:0005739; GO:0005759; GO:0006355; GO:0006393; GO:0042645 DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleic acid binding [GO:0003676] EGISIAQIRETPMVLELTPQIVQYRIR 0.99279 -17.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0827 0 0 0 0 0 9.58864 0 0 0 0 0 0 0 0 0 0 0 0 16.5533 0 16.6811 0 12.9213 0 0 0 0 13.0879 13.0712 13.7029 13.1553 0 0 13.7112 0 0 0 0 0 0 0 0 13.1624 13.5319 13.0585 13.1497 0 0 0 0 13.1829 0 0 0 0 13.0121 0 0 0 13.8931 12.9316 0 14.7962 0 0 12.0764 0 0 0 0 13.6257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9367 0 0 0 0 0 0 0 0 14.7785 0 0 0 0 0 Q5SQS7 SH24B_HUMAN SH2 domain-containing protein 4B SH2D4B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ARLQAQR 0.99279 -39.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9563 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0138 0 0 0 0 0 12.69 0 0 14.4125 0 0 0 0 13.835 0 0 0 13.9447 0 0 0 13.4626 13.2149 13.9738 0 0 0 0 12.8006 0 0 0 0 0 0 0 0 0 0 13.0798 13.6063 13.5951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5483 13.3527 0 0 13.1894 12.6018 0 0 0 0 12.6088 0 11.7153 0 0 0 0 0 0 0 0 0 0 0 0 12.0091 0 0 0 0 0 13.6128 0 13.8388 0 0 0 0 0 0 0 11.4494 Q6ZS10 CL17A_HUMAN "C-type lectin domain family 17, member A (Prolectin)" CLEC17A Homo sapiens (Human) cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872] GO:0005537; GO:0009897; GO:0009986; GO:0016021; GO:0030246; GO:0042802; GO:0042806; GO:0046872 carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; metal ion binding [GO:0046872] DLPPKPGSSAPPR 0.99279 -6.3687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4328 0 0 0 0 0 0 0 0 0 0 0 0 12.6865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76N89 HECW1_HUMAN "E3 ubiquitin-protein ligase HECW1, EC 2.3.2.26 (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1, hNEDL1)" HECW1 KIAA0322 NEDL1 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814] GO:0000209; GO:0005737; GO:0005829; GO:0016567; GO:0043161; GO:0048814; GO:0061630; GO:0090090; GO:2000650 ubiquitin protein ligase activity [GO:0061630] DARNFER 0.99279 -25.315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7945 0 0 0 0 0 0 11.9221 11.0968 0 0 0 11.2472 0 0 0 0 0 0 0 0 0 0 0 0 10.5262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4446 0 0 0 0 0 0 0 0 0 0 0 11.7558 0 13.724 15.0101 11.8889 13.8304 0 0 0 14.5902 13.2042 13.2875 11.2452 12.2255 14.0286 0 14.4764 13.9213 0 0 0 0 0 0 0 15.3736 0 0 14.7687 0 13.8684 11.8804 0 14.0054 12.4099 0 0 0 0 0 13.5027 12.8132 0 0 0 0 0 14.8627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6942 0 0 0 12.7378 0 0 0 11.3855 0 0 0 0 0 0 0 0 0 0 0 11.9694 0 0 0 0 Q7Z601 GP142_HUMAN Probable G-protein coupled receptor 142 (G-protein coupled receptor PGR2) GPR142 PGR2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005829; GO:0005886; GO:0007186; GO:0016021; GO:0030054 G protein-coupled receptor activity [GO:0004930] LATRTRR 0.99279 -17.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2074 0 0 0 0 0 0 0 0 0 0 15.2574 0 0 0 0 12.7708 0 0 0 0 0 0 0 12.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2718 0 0 0 0 0 0 0 Q8IUA7 ABCA9_HUMAN "ATP-binding cassette sub-family A member 9, EC 7.6.2.-" ABCA9 Homo sapiens (Human) lipid transport [GO:0006869] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869] GO:0005319; GO:0005524; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] CLEMNCR 0.99279 -44.39 0 0 0 0 0 0 0 0 10.2907 0 0 0 11.8703 0 0 0 0 0 0 0 0 13.6388 0 0 0 0 0 0 0 0 0 0 0 13.9318 0 0 0 0 0 0 0 0 0 0 11.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7247 0 0 12.2153 0 0 0 0 0 0 0 0 0 0 14.5007 13.6029 15.1277 15.1217 13.6454 14.5234 0 15.5698 0 0 0 14.2116 0 0 15.0934 0 11.94 0 14.5947 0 14.8095 0 0 15.0364 14.762 10.7129 0 11.4325 11.3857 13.6349 15.2351 0 0 15.4228 0 0 13.1915 13.8731 14.1895 11.7914 0 0 0 0 13.9531 0 13.0096 0 14.7044 12.6802 0 0 0 0 0 14.6528 0 0 0 13.492 14.7812 0 0 0 0 13.8501 0 0 14.3471 12.0307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.507 0 0 0 0 0 15.0972 0 0 12.3455 0 0 0 15.0874 Q8IXQ4 GPAM1_HUMAN GPALPP motifs-containing protein 1 (Lipopolysaccharide-specific response protein 7) GPALPP1 KIAA1704 LSR7 AD029 Homo sapiens (Human) AAEDKNK 0.99279 -26.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8242 12.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.753 0 0 0 0 0 0 0 0 0 0 12.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.83 0 11.46 0 0 0 0 0 0 0 0 0 13.1491 0 0 0 0 0 0 0 0 12.0841 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXK1 ASB15_HUMAN "Ankyrin repeat and SOCS box protein 15, ASB-15" ASB15 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 HLCRLKIR 0.99279 -6.351 12.6373 0 0 0 0 0 0 0 0 0 0 0 14.0269 13.1913 0 0 0 0 0 0 0 0 11.3933 11.0394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1922 0 0 0 0 0 0 0 0 10.3028 0 0 0 0 0 0 0 0 0 12.3469 0 0 0 12.2698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1135 0 0 0 0 0 12.3398 0 0 0 0 0 0 13.7065 0 0 0 0 0 0 0 0 0 0 12.0252 0 12.5007 0 0 0 11.3111 0 0 0 0 0 0 13.6991 0 0 0 11.6364 0 0 0 0 0 0 0 0 0 14.0593 0 0 0 0 0 0 0 0 12.1665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RP7 G3ST4_HUMAN "Galactose-3-O-sulfotransferase 4, Gal3ST-4, EC 2.8.2.- (Beta-galactose-3-O-sulfotransferase 4) (Gal-beta-1,3-GalNAc 3'-sulfotransferase)" GAL3ST4 PP6968 Homo sapiens (Human) cell-cell signaling [GO:0007267]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; glycoprotein metabolic process [GO:0009100]; oligosaccharide metabolic process [GO:0009311]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146]; cell-cell signaling [GO:0007267]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; glycoprotein metabolic process [GO:0009100]; oligosaccharide metabolic process [GO:0009311]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] GO:0001733; GO:0006790; GO:0007267; GO:0008146; GO:0009100; GO:0009101; GO:0009247; GO:0009311; GO:0016020; GO:0016021; GO:0030166; GO:0032580; GO:0050656; GO:0050694; GO:0050698; GO:0070062 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; proteoglycan sulfotransferase activity [GO:0050698]; sulfotransferase activity [GO:0008146] DPAALAR 0.99279 -18.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0503 0 10.9811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.591 0 0 11.4124 0 0 0 0 13.283 14.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5244 0 0 0 0 0 0 0 0 11.6657 0 0 10.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0368 0 13.1359 0 0 12.1094 0 0 0 0 0 0 0 0 0 0 0 0 14.1887 0 0 0 10.6742 0 0 0 0 0 0 0 0 0 0 0 13.2658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5P4 PDZD7_HUMAN PDZ domain-containing protein 7 PDZD7 PDZK7 Homo sapiens (Human) auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; sensory perception of sound [GO:0007605] cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696] cilium [GO:0005929]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; USH2 complex [GO:1990696]; identical protein binding [GO:0042802]; auditory receptor cell development [GO:0060117]; auditory receptor cell stereocilium organization [GO:0060088]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; sensory perception of sound [GO:0007605] GO:0002141; GO:0002142; GO:0005615; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0007605; GO:0032420; GO:0032426; GO:0042802; GO:0045184; GO:0050910; GO:0051649; GO:0060088; GO:0060113; GO:0060117; GO:1990696 identical protein binding [GO:0042802] CGSTPSDTSSEDGVR 0.99279 -17.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8037 0 0 0 0 0 0 17.2291 0 0 0 0 0 0 0 0 0 0 0 10.9556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9824 0 0 14.7765 14.4352 13.4566 13.392 13.8304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5147 14.1712 0 0 0 13.5578 14.7176 0 15.0684 0 0 0 0 0 0 0 0 12.4345 0 0 0 0 0 0 0 0 0 12.9023 16.5912 0 0 12.8086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4623 0 0 0 13.4535 0 0 0 0 0 0 13.8774 0 0 0 13.8652 0 0 11.891 0 13.7199 13.3674 0 0 13.7178 12.589 0 0 0 0 0 0 0 0 0 0 0 Q9H6Z4 RANB3_HUMAN "Ran-binding protein 3, RanBP3" RANBP3 Homo sapiens (Human) protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267]; protein export from nucleus [GO:0006611]; regulation of catalytic activity [GO:0050790] GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0006611; GO:0031267; GO:0050790; GO:0070412 R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267] ADLANEEK 0.99279 -6.1759 0 0 0 0 0 0 0 0 0 0 0 12.7711 0 0 0 0 0 0 0 0 0 0 0 0 12.3663 12.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1937 0 0 0 0 0 0 0 0 0 13.3164 0 0 0 0 0 0 0 0 0 0 12.2182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9753 0 0 0 0 0 0 0 0 0 Q9H8Y5 ANKZ1_HUMAN Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744) ANKZF1 ZNF744 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; cellular response to hydrogen peroxide [GO:0070301]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005737; GO:0016020; GO:0030433; GO:0046872; GO:0070301 metal ion binding [GO:0046872] DLLAGPSWAK 0.99279 -17.476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2084 0 0 0 13.2262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSY1 BMP2K_HUMAN "BMP-2-inducible protein kinase, BIKe, EC 2.7.11.1" BMP2K BIKE HRIHFB2017 Homo sapiens (Human) positive regulation of Notch signaling pathway [GO:0045747]; protein phosphorylation [GO:0006468]; regulation of bone mineralization [GO:0030500]; regulation of clathrin-dependent endocytosis [GO:2000369] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; phosphatase regulator activity [GO:0019208]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of Notch signaling pathway [GO:0045747]; protein phosphorylation [GO:0006468]; regulation of bone mineralization [GO:0030500]; regulation of clathrin-dependent endocytosis [GO:2000369] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0016607; GO:0019208; GO:0030500; GO:0035612; GO:0045747; GO:0106310; GO:2000369 AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; phosphatase regulator activity [GO:0019208]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FMLEPDPEHRPDIFQVSYFAFK 0.99279 -5.5201 0 0 0 0 0 0 0 0 0 12.3965 0 0 0 0 12.605 0 0 0 0 0 11.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6819 0 0 12.2789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0716 12.6852 0 0 0 0 0 12.2581 0 0 0 0 0 12.464 0 15.8355 0 13.3676 0 0 0 0 0 12.2749 0 0 0 13.9143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8199 0 0 0 0 0 0 0 16.2734 0 0 15.1968 0 0 0 0 0 Q9UL68 MYT1L_HUMAN "Myelin transcription factor 1-like protein, MyT1-L, MyT1L" MYT1L KIAA1106 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007399; GO:0008270; GO:0030182; GO:0048663; GO:0048665; GO:0048666 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" ALLENIKQAVR 0.99279 -26.342 0 0 0 0 0 0 0 0 0 0 0 0 14.5747 0 0 0 10.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6128 14.381 14.4251 0 11.6697 0 0 0 0 0 16.5601 16.5804 16.6626 0 0 0 14.4216 0 0 0 0 0 0 17.0199 17.0804 0 17.4375 17.3485 17.3678 16.687 18.2372 16.8683 16.297 16.3494 0 0 14.7476 0 0 0 0 0 0 0 0 0 0 11.964 13.4482 0 13.941 12.9576 0 12.1027 0 11.4475 0 0 0 0 0 0 0 0 14.542 0 0 0 0 0 13.9808 0 0 0 0 11.9658 0 0 0 0 0 0 14.8292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4761 0 17.9511 15.4785 12.9664 0 0 0 0 0 0 10.2008 0 0 0 0 0 0 0 0 0 0 0 0 18.7557 0 0 0 0 0 0 0 0 0 17.9448 0 0 0 0 0 0 0 0 0 0 0 Q9ULW0 TPX2_HUMAN "Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2, DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100, p100)" TPX2 C20orf1 C20orf2 DIL2 HCA519 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of mitotic spindle organization [GO:0060236] axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] axon hillock [GO:0043203]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nuclear microtubule [GO:0005880]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of mitotic spindle organization [GO:0060236] GO:0000278; GO:0000922; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005880; GO:0006915; GO:0007020; GO:0007026; GO:0008017; GO:0015630; GO:0019901; GO:0030295; GO:0032147; GO:0043203; GO:0045171; GO:0051301; GO:0060236; GO:0061676; GO:0072686; GO:0090307 importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] ANLQQAIVTPLK 0.99279 -26.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8078 0 0 0 13.5118 0 13.7285 0 0 0 13.196 0 0 0 13.0862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6941 0 0 13.2574 0 0 10.5638 14.2191 0 0 0 13.2765 0 0 0 0 0 0 0 0 14.2939 13.8561 14.2755 0 14.5123 14.2819 14.0297 0 0 16.238 0 0 12.7949 0 0 0 0 0 0 0 16.1821 0 0 12.9933 0 13.9917 13.8652 0 16.0905 0 16.1756 0 0 13.9025 0 0 14.8919 14.3085 0 0 14.3464 0 0 12.7989 0 0 12.8081 0 13.8558 14.0447 13.9833 15.2348 0 13.1885 15.3696 16.2686 0 16.2111 12.5798 0 16.2195 0 0 13.5803 0 0 0 13.6923 13.6484 16.2162 0 0 12.709 0 0 0 0 0 0 0 0 0 16.1015 16.0863 0 12.7177 0 16.2152 16.2259 0 0 10.4788 0 P00439 PH4H_HUMAN "Phenylalanine-4-hydroxylase, PAH, EC 1.14.16.1 (Phe-4-monooxygenase)" PAH Homo sapiens (Human) catecholamine biosynthetic process [GO:0042423]; cellular amino acid biosynthetic process [GO:0008652]; L-phenylalanine catabolic process [GO:0006559]; neurotransmitter biosynthetic process [GO:0042136]; tyrosine biosynthetic process [GO:0006571] cytosol [GO:0005829] cytosol [GO:0005829]; iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; catecholamine biosynthetic process [GO:0042423]; cellular amino acid biosynthetic process [GO:0008652]; L-phenylalanine catabolic process [GO:0006559]; neurotransmitter biosynthetic process [GO:0042136]; tyrosine biosynthetic process [GO:0006571] GO:0004505; GO:0005506; GO:0005829; GO:0006559; GO:0006571; GO:0008652; GO:0042136; GO:0042423 iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505] ILADSINSEIGILCSALQKIK 0.9928 -17.624 0 0 0 15.4365 0 0 0 0 0 0 11.8222 11.8949 0 12.5711 0 12.6193 11.3902 12.508 12.8022 13.2755 12.4162 13.6283 13.7008 13.461 12.5186 13.1891 12.0607 11.248 13.3295 0 0 0 12.15 0 11.6995 0 0 0 0 12.998 0 0 12.7297 12.6382 12.7791 12.6817 14.8019 0 12.7081 12.8108 12.9666 16.9525 12.6873 0 12.2703 10.8747 0 0 0 0 0 0 0 0 0 0 14.6919 0 0 0 0 0 0 0 13.8218 14.3773 0 0 13.9495 14.3294 0 0 14.8276 0 14.2766 14.0661 0 0 0 15.0413 14.2153 0 0 0 0 0 0 0 0 15.8179 0 0 0 14.6586 0 0 15.5912 0 0 0 0 14.8359 0 14.3956 14.5842 0 0 15.9158 0 0 14.4327 14.2294 14.1864 0 0 0 0 14.711 0 14.5615 0 14.4581 0 0 14.8895 16.1789 0 14.4459 14.4519 14.1334 0 0 14.7341 0 14.82 0 14.5897 0 0 0 0 0 0 14.3164 0 0 15.1334 0 0 0 0 0 0 0 0 14.5679 0 14.3036 0 0 0 14.2806 14.3044 0 14.3761 0 0 0 0 0 A6NNB3 IFM5_HUMAN "Interferon-induced transmembrane protein 5 (Bone-restricted interferon-induced transmembrane protein-like protein, BRIL) (Dispanin subfamily A member 1, DSPA1)" IFITM5 Homo sapiens (Human) bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; in utero embryonic development [GO:0001701]; regulation of bone mineralization [GO:0030500] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; in utero embryonic development [GO:0001701]; regulation of bone mineralization [GO:0030500] GO:0001701; GO:0005829; GO:0005886; GO:0005887; GO:0030282; GO:0030500; GO:0043231; GO:0060349 CYNILAAMWTLVPPLLLLGLVVTGALHLARLAK 0.9928 -5.5209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9174 0 14.1824 0 0 0 0 0 13.3034 0 0 0 0 0 0 0 0 0 12.904 0 0 0 0 0 0 12.9665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.906 0 0 15.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2119 0 0 O15466 SIA8E_HUMAN "Alpha-2,8-sialyltransferase 8E, EC 2.4.99.- (Sialyltransferase 8E, SIAT8-E) (Sialyltransferase St8Sia V, ST8SiaV)" ST8SIA5 SIAT8E Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]; carbohydrate metabolic process [GO:0005975]; glycosphingolipid biosynthetic process [GO:0006688]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]" GO:0000139; GO:0003828; GO:0005975; GO:0006486; GO:0006491; GO:0006688; GO:0008373; GO:0009311; GO:0016021 "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]" HEILEVKVLSMVK 0.9928 -17.164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7194 0 14.2753 0 0 11.5425 0 16.8958 0 13.88 0 0 11.6358 0 0 0 0 0 0 0 12.3042 0 0 0 0 0 0 0 0 11.3453 11.4664 0 0 11.4263 0 0 0 0 0 12.0824 0 0 0 0 13.9511 0 0 0 0 0 0 0 12.3699 0 0 0 0 11.0502 11.7785 0 11.9164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1392 0 11.4483 0 0 10.8033 0 0 10.9881 0 0 0 0 0 0 11.2609 0 0 O95251 KAT7_HUMAN "Histone acetyltransferase KAT7, EC 2.3.1.48 (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2, MYST-2)" KAT7 HBO1 HBOa MYST2 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription, DNA-templated [GO:0006355]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]" GO:0000123; GO:0000775; GO:0001558; GO:0001779; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006275; GO:0006281; GO:0006325; GO:0006355; GO:0008270; GO:0016570; GO:0018393; GO:0030174; GO:0031098; GO:0032786; GO:0036409; GO:0042393; GO:0043966; GO:0043967; GO:0043981; GO:0043982; GO:0043983; GO:0044154; GO:0045648; GO:0045740; GO:0045892; GO:0045944; GO:0051726; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090240; GO:0090734; GO:1900182; GO:1902035; GO:2000278; GO:2000819 DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] IYCQNLCLLAK 0.9928 -17.163 0 0 0 0 0 0 0 0 11.329 0 0 0 0 0 0 0 0 0 0 11.5157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4871 0 0 0 0 0 0 0 14.158 0 0 0 0 0 0 0 0 0 14.0545 0 0 0 12.5426 0 0 0 13.8728 13.5668 13.4268 0 14.0047 0 12.5539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95613 PCNT_HUMAN Pericentrin (Kendrin) (Pericentrin-B) PCNT KIAA0402 PCNT2 Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; signal transduction [GO:0007165] GO:0000226; GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007052; GO:0007165; GO:0016020; GO:0034451; GO:0060090; GO:0060271; GO:0090316 calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090] AAHSAELEAVLLALARIR 0.9928 -17.566 0 0 0 0 0 0 0 0 17.7588 0 0 0 0 0 0 11.7086 13.2367 10.5834 10.1399 0 12.1032 0 0 13.2102 11.789 12.6071 12.6871 0 0 13.1007 0 10.6197 12.6267 13.112 11.4398 0 0 11.4322 12.7417 0 13.4715 0 0 12.226 12.0444 12.2895 12.3733 14.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6017 0 0 0 0 12.3246 15.0909 15.1453 15.7976 12.2275 13.2437 13.8522 0 0 12.7631 13.5078 13.4798 0 16.7044 13.4383 12.4435 14.0062 14.8659 15.1861 13.2998 11.329 16.0669 0 15.8851 15.078 15.8575 0 18.4797 13.2785 0 0 15.1237 14.3637 15.2037 14.9432 14.9387 11.06 16.8573 0 0 0 16.1991 0 15.5749 13.3511 12.3968 14.5864 0 12.9756 14.2844 13.6006 15.0102 0 0 12.0981 0 12.4187 0 14.0199 15.1925 0 14.1807 0 0 0 0 0 14.2064 13.5864 18.4134 0 13.4427 0 0 0 0 0 18.0832 0 13.536 0 0 0 12.2814 13.9661 0 0 0 0 0 12.213 0 0 0 12.197 12.6758 10.3602 0 11.7321 0 12.2398 11.0381 10.2824 12.5128 0 0 0 0 0 P50750 CDK9_HUMAN "Cyclin-dependent kinase 9, EC 2.7.11.22, EC 2.7.11.23 (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit)" CDK9 CDC2L4 TAK Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903655]; phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903654]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to xenobiotic stimulus [GO:0009410]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023] cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]; 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903655]; phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903654]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to xenobiotic stimulus [GO:0009410]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0000978; GO:0001223; GO:0003677; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006282; GO:0006367; GO:0006368; GO:0006468; GO:0008023; GO:0008024; GO:0008283; GO:0008353; GO:0009410; GO:0010613; GO:0016020; GO:0016592; GO:0016605; GO:0019901; GO:0031056; GO:0031297; GO:0031440; GO:0032968; GO:0036464; GO:0043923; GO:0045944; GO:0051147; GO:0051726; GO:0070691; GO:0070816; GO:0071345; GO:0097322; GO:0106310; GO:0120187; GO:1903654; GO:1903655; GO:1903839 7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223] AKQYDSVECPFCDEVSK 0.9928 -6.3747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2354 0 0 0 0 0 0 0 0 0 0 0 12.4263 0 0 0 13.7503 0 0 0 0 0 13.7573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6985 0 0 0 0 0 Q05BU3 F86JP_HUMAN Putative protein FAM86JP FAM86JP Homo sapiens (Human) AVLPRSHR 0.9928 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2846 0 0 0 0 0 0 0 0 0 0 0 0 Q08AI8 MB214_HUMAN Protein mab-21-like 4 MAB21L4 C2orf54 Homo sapiens (Human) AENVLLTVLER 0.9928 -17.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5963 0 0 0 0 0 0 0 0 0 0 11.4928 0 0 0 0 0 0 0 0 0 0 0 0 14.7561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.82 13.2524 11.9518 0 0 0 0 0 0 0 0 0 0 0 0 12.9757 0 0 0 0 0 0 0 13.4394 0 0 0 0 0 0 0 0 0 0 13.3204 0 0 0 0 13.9889 14.1288 15.221 0 0 0 0 0 0 0 0 0 14.3979 0 0 15.6208 0 14.5575 13.5336 0 0 0 14.9028 10.9168 0 14.7188 0 13.8562 0 0 0 12.8508 0 0 0 12.2426 0 0 0 0 0 0 0 0 0 11.0059 14.062 0 15.3115 0 0 0 Q0ZLH3 PJVK_HUMAN Pejvakin (Autosomal recessive deafness type 59 protein) PJVK DFNB59 Homo sapiens (Human) detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; neuron death [GO:0070997]; pexophagy [GO:0000425]; programmed cell death in response to reactive oxygen species [GO:0097468]; regulation of peroxisome organization [GO:1900063]; response to reactive oxygen species [GO:0000302]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] ciliary rootlet [GO:0035253]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; stereocilium base [GO:0120044] ciliary rootlet [GO:0035253]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; stereocilium base [GO:0120044]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; neuron death [GO:0070997]; pexophagy [GO:0000425]; programmed cell death in response to reactive oxygen species [GO:0097468]; regulation of peroxisome organization [GO:1900063]; response to reactive oxygen species [GO:0000302]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] GO:0000302; GO:0000425; GO:0005737; GO:0005778; GO:0007605; GO:0030864; GO:0035253; GO:0043025; GO:0050910; GO:0070997; GO:0097468; GO:0120044; GO:0120045; GO:1900063 GNHIVNDVGINVAGSDSIAVK 0.9928 -16.734 0 0 0 0 0 0 11.9427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.327 0 0 0 0 0 0 16.4092 0 0 0 0 0 0 0 0 0 0 13.4619 0 0 0 0 0 0 0 0 0 12.3211 13.3389 0 0 0 0 15.5533 15.6027 12.4214 0 0 0 0 0 0 0 0 0 11.5031 0 14.6771 0 0 0 0 0 0 11.5482 0 0 0 0 9.98769 0 0 0 0 0 0 0 0 16.0297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16352 AINX_HUMAN "Alpha-internexin, Alpha-Inx (66 kDa neurofilament protein, NF-66, Neurofilament-66) (Neurofilament 5)" INA NEF5 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; intermediate filament organization [GO:0045109]; neurofilament cytoskeleton organization [GO:0060052]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; neurofilament [GO:0005883]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; Schaffer collateral - CA1 synapse [GO:0098685] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; neurofilament [GO:0005883]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; Schaffer collateral - CA1 synapse [GO:0098685]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; structural constituent of postsynaptic intermediate filament cytoskeleton [GO:0099184]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; intermediate filament organization [GO:0045109]; neurofilament cytoskeleton organization [GO:0060052]; substantia nigra development [GO:0021762] GO:0005200; GO:0005615; GO:0005737; GO:0005882; GO:0005883; GO:0021762; GO:0030154; GO:0036464; GO:0045109; GO:0060052; GO:0098685; GO:0098973; GO:0099160; GO:0099184; GO:1990830 structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; structural constituent of postsynaptic intermediate filament cytoskeleton [GO:0099184] ALKAQQR 0.9928 -16.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.177 0 0 0 0 0 0 0 11.6931 0 14.9626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T5U3 RHG21_HUMAN Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21) ARHGAP21 ARHGAP10 KIAA1424 Homo sapiens (Human) establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; establishment of Golgi localization [GO:0051683]; Golgi localization [GO:0051645]; Golgi organization [GO:0007030]; maintenance of Golgi location [GO:0051684]; organelle transport along microtubule [GO:0072384]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0007165; GO:0015629; GO:0030054; GO:0030659; GO:0051056; GO:0051645; GO:0051683; GO:0051684; GO:0070161; GO:0072384 GTPase activator activity [GO:0005096] DKREQTTPSEEEQPISVNACLIDISYSETK 0.9928 -14.854 0 0 9.1127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 0 0 0 12.917 0 13.845 0 0 16.3327 0 12.972 0 0 0 0 0 0 0 0 0 0 0 15.1402 0 0 0 12.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3181 12.8898 0 0 0 0 0 0 0 0 0 0 0 11.5207 15.4289 0 0 0 0 0 0 0 13.6658 0 0 0 0 0 13.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8541 13.5791 0 0 0 0 0 0 0 0 14.3171 0 Q6V1X1 DPP8_HUMAN "Dipeptidyl peptidase 8, DP8, EC 3.4.14.5 (Dipeptidyl peptidase IV-related protein 1, DPRP-1) (Dipeptidyl peptidase VIII, DPP VIII) (Prolyl dipeptidase DPP8)" DPP8 DPRP1 MSTP097 MSTP135 MSTP141 Homo sapiens (Human) apoptotic process [GO:0006915]; immune response [GO:0006955]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; apoptotic process [GO:0006915]; immune response [GO:0006955]; proteolysis [GO:0006508] GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006955; GO:0008236; GO:0008239 aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] GYSHSCCISQHCDFFISK 0.9928 -17.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.447 0 0 0 0 0 0 0 12.0527 0 0 0 11.3412 0 0 0 0 11.4438 0 0 0 0 0 0 0 0 12.6294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9483 0 0 13.9343 13.797 13.4551 0 0 0 0 0 0 0 0 0 0 0 13.5359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9953 0 12.3049 13.4226 0 0 0 11.6601 12.0225 13.7726 13.5527 0 0 13.784 0 0 12.4428 0 13.9249 0 0 13.525 0 0 0 0 0 0 14.497 0 0 0 0 0 9.68031 0 0 0 0 0 12.3994 14.8597 0 0 0 0 0 0 14.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7067 0 0 0 0 0 0 0 0 0 0 0 0 Q7L099 RUFY3_HUMAN "Protein RUFY3 (RUN and FYVE domain-containing protein 3) (Rap2-interacting protein x, RIPx) (Single axon-regulated protein, Singar)" RUFY3 KIAA0871 Homo sapiens (Human) actin filament organization [GO:0007015]; cell differentiation [GO:0030154]; negative regulation of axonogenesis [GO:0050771]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; regulation of axonogenesis [GO:0050770]; regulation of establishment of cell polarity [GO:2000114] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; actin filament organization [GO:0007015]; cell differentiation [GO:0030154]; negative regulation of axonogenesis [GO:0050771]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; regulation of axonogenesis [GO:0050770]; regulation of establishment of cell polarity [GO:2000114] GO:0005737; GO:0005829; GO:0007015; GO:0007399; GO:0012505; GO:0016020; GO:0030027; GO:0030154; GO:0030175; GO:0030335; GO:0030424; GO:0030425; GO:0030426; GO:0043025; GO:0043204; GO:0045773; GO:0050770; GO:0050771; GO:0070161; GO:0090316; GO:2000114 AWLRLALMQKK 0.9928 -14.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6656 0 0 0 0 0 0 0 0 12.2746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8108 0 13.6732 0 0 0 12.9707 14.6614 0 16.8185 13.0498 0 0 13.6468 14.4955 14.3097 0 0 12.6217 0 0 14.0481 0 0 0 0 0 0 0 0 0 0 0 0 12.4623 0 0 0 0 13.8418 0 0 0 0 0 0 0 0 0 13.3954 0 11.8927 0 13.4331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BK5 PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (Protein 67-11-3) (TRF1-interacting protein 1) PINX1 LPTL LPTS Homo sapiens (Human) "mitotic metaphase plate congression [GO:0007080]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of ribosome biogenesis [GO:0090069]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004]" "chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]" "chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of ribosome biogenesis [GO:0090069]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004]" GO:0000228; GO:0000776; GO:0000781; GO:0005654; GO:0005730; GO:0005739; GO:0005819; GO:0007004; GO:0007080; GO:0008285; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0051972; GO:0051974; GO:0070034; GO:0070198; GO:0090069; GO:1902570; GO:1904357; GO:1904744; GO:1904751 protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034] EKKSFSLEEK 0.9928 -6.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FZ2 HMCES_HUMAN "Abasic site processing protein HMCES (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein, ES cell-specific 5hmC-binding protein) (Peptidase HMCES, EC 3.4.-.-) (SRAP domain-containing protein 1)" HMCES C3orf37 DC12 SRAPD1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking [GO:0018142]; proteolysis [GO:0006508] replication fork [GO:0005657] replication fork [GO:0005657]; peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking [GO:0018142]; proteolysis [GO:0006508] GO:0003697; GO:0005657; GO:0006508; GO:0006974; GO:0008233; GO:0018142; GO:0045830; GO:0097681 peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697] ESDPSKLQFNTTNCR 0.9928 -16.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1113 0 0 0 0 0 0 0 0 0 12.1921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M91 CFA53_HUMAN Cilia- and flagella-associated protein 53 (Coiled-coil domain-containing protein 11) CFAP53 CCDC11 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] axonemal microtubule [GO:0005879]; extracellular region [GO:0005576] axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] GO:0003341; GO:0005576; GO:0005879; GO:0007368; GO:0060271; GO:0060287 ALQERIEHIQQEYR 0.9928 -14.886 0 0 0 0 0 0 0 0 0 0 0 0 12.1886 0 0 0 0 0 0 0 0 0 10.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2554 0 0 10.8721 0 13.2475 14.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3869 0 0 13.8078 0 0 11.835 0 0 0 0 0 0 14.6721 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7293 0 0 0 0 0 0 0 0 0 0 0 0 13.5016 0 0 0 0 0 Q96PX9 PKH4B_HUMAN "Pleckstrin homology domain-containing family G member 4B, PH domain-containing family G member 4B" PLEKHG4B KIAA1909 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005829; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] AAEVVVCFQLRHGNDLLAMDAIR 0.9928 -16.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.547 0 0 0 0 12.8587 11.823 11.0243 0 0 0 10.0351 0 0 0 0 13.9131 0 0 0 13.4954 0 0 0 0 13.2841 0 0 0 0 0 0 0 0 13.4638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2609 0 0 14.7914 0 12.2286 12.5119 13.4672 14.448 14.5735 13.5866 0 12.5868 15.7495 15.0976 11.7907 0 0 0 12.0381 12.7999 14.3391 17.0844 13.6572 15.0867 13.8751 0 14.8849 11.4983 0 0 0 0 13.5461 0 12.7143 13.7976 12.6966 14.0297 0 0 0 0 16.825 0 15.5528 14.6047 13.4827 0 0 13.4987 0 12.953 13.0292 12.4163 13.3098 13.3228 13.0953 12.2517 0 0 10.0577 0 0 0 0 13.3116 14.5377 0 12.1997 13.8638 14.0277 0 0 0 0 0 0 0 0 0 12.2288 0 12.565 0 0 0 0 0 0 0 0 0 10.7668 0 0 0 0 0 0 14.719 13.3588 14.7341 0 0 0 0 14.4159 Q99608 NECD_HUMAN Necdin NDN Homo sapiens (Human) axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of protein deacetylation [GO:0090312]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233] cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991] "cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; gamma-tubulin binding [GO:0043015]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon extension [GO:0048675]; axonal fasciculation [GO:0007413]; central nervous system development [GO:0007417]; genomic imprinting [GO:0071514]; glial cell migration [GO:0008347]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of protein deacetylation [GO:0090312]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; respiratory system process [GO:0003016]; sensory perception of pain [GO:0019233]" GO:0000122; GO:0000978; GO:0001228; GO:0001764; GO:0003016; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007413; GO:0007417; GO:0008285; GO:0008347; GO:0009791; GO:0019233; GO:0032991; GO:0040008; GO:0042995; GO:0043015; GO:0043204; GO:0043433; GO:0048011; GO:0048675; GO:0048871; GO:0071514; GO:0090312; GO:1990841 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; gamma-tubulin binding [GO:0043015]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DVIGSYKKWCR 0.9928 -7.6311 9.47484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.285 13.0594 0 0 0 15.4234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0595 0 0 0 12.9553 0 0 0 17.5667 0 0 13.6899 0 0 0 0 0 0 0 0 0 11.9683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1A4 APC1_HUMAN "Anaphase-promoting complex subunit 1, APC1 (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein)" ANAPC1 TSG24 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; molecular adaptor activity [GO:0060090]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070979 molecular adaptor activity [GO:0060090] DAAPVEK 0.9928 -39.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9393 0 0 0 0 12.3916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0097 0 0 0 0 0 11.026 0 0 0 0 0 0 11.6291 0 0 0 12.7472 12.8425 0 12.8602 0 0 0 0 0 0 0 0 12.8218 0 0 0 0 0 13.1961 14.3462 12.1855 0 0 0 14.9754 0 0 12.7482 0 0 0 0 12.7697 12.541 0 13.5456 0 0 13.7332 0 0 13.7275 13.4714 0 13.6669 0 13.885 13.1348 0 0 13.3123 0 0 0 12.4588 0 12.7883 12.7694 0 0 0 0 13.5097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5758 0 0 0 0 0 0 0 0 0 0 13.5109 0 0 0 0 0 Q9HCX3 ZN304_HUMAN Zinc finger protein 304 (KRAB-containing zinc finger protein) ZNF304 Homo sapiens (Human) angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; angiogenesis [GO:0001525]; chromatin organization [GO:0006325]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of anoikis [GO:2000811]; negative regulation of chromatin binding [GO:0035562]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of histone H3-K27 trimethylation [GO:1902466]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Ras protein signal transduction [GO:0007265]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001525; GO:0005634; GO:0006325; GO:0006357; GO:0007229; GO:0007265; GO:0030335; GO:0035562; GO:0045766; GO:0045944; GO:0046872; GO:0050679; GO:0090309; GO:1900114; GO:1902466; GO:1990841; GO:2000811 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DTLVQHQRFHTGER 0.9928 -6.1858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8037 0 0 12.0799 15.5426 0 12.5346 0 16.1459 15.5438 15.6844 0 0 0 0 0 0 0 0 0 0 13.0014 0 0 0 0 0 0 0 12.3037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8962 0 0 0 0 0 0 0 0 0 0 0 P29375 KDM5A_HUMAN "Lysine-specific demethylase 5A, EC 1.14.11.67 (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2, RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A)" KDM5A JARID1A RBBP2 RBP2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; negative regulation of histone deacetylase activity [GO:1901726]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]" GO:0000122; GO:0000976; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0008270; GO:0031490; GO:0032452; GO:0032922; GO:0032993; GO:0034647; GO:0034720; GO:0035064; GO:0042393; GO:0045893; GO:0051090; GO:1901726 chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] EALQKAREWTAK 0.99281 -41.307 0 0 0 13.2747 13.3658 0 13.0877 13.6149 0 0 0 0 0 9.85136 0 14.5582 0 16.5435 0 0 14.5585 0 13.8779 0 0 0 0 0 0 0 12.4644 0 0 0 0 0 12.8716 0 0 0 0 0 0 0 0 0 0 11.6259 0 0 0 0 0 0 0 12.4863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2258 9.79758 0 0 0 15.2754 11.8419 13.9306 13.4336 14.2789 15.8905 14.5838 0 11.3335 11.5432 15.3172 14.1358 0 15.1865 14.5929 14.2201 14.0419 14.2 0 14.5963 14.2949 14.3765 13.0524 0 0 14.3139 14.6937 10.5419 14.564 12.4659 14.9515 15.6223 14.2504 13.8643 14.0461 0 15.5396 15.9118 14.4947 15.5138 15.2561 14.6203 14.7895 13.8945 0 11.5775 14.8627 12.9947 13.3302 14.613 0 14.3937 13.2277 13.3809 15.178 14.7142 13.6373 13.4196 0 16.2376 16.7816 0 15.0082 15.0431 0 12.8487 12.0625 14.6323 14.0069 0 13.5894 0 0 11.3241 14.3761 11.7096 0 13.7563 14.226 14.7768 0 0 0 0 0 12.463 0 12.8151 0 0 0 0 13.0298 0 0 13.3765 13.164 10.7856 15.3224 12.54 0 0 0 0 A6NG13 MGT4D_HUMAN "Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D (N-acetylglucosaminyltransferase MGAT1 inhibitory protein, GlcNAcT-I inhibitory protein, GnT1IP)" MGAT4D Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of protein glycosylation [GO:0060051]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; cell differentiation [GO:0030154]; negative regulation of protein glycosylation [GO:0060051]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283] GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005795; GO:0006487; GO:0007283; GO:0008375; GO:0016021; GO:0030154; GO:0060051 acetylglucosaminyltransferase activity [GO:0008375] EQYEKKI 0.99281 -46.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2245 0 0 12.4526 0 0 0 0 0 0 10.3538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9767 0 13.4442 13.3125 16.5559 16.6046 0 14.5323 15.3498 13.5831 13.5554 16.2818 14.5263 0 14.0304 14.9917 14.0096 0 14.235 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3017 12.44 0 0 0 12.5601 0 0 0 0 0 16.1127 0 12.4685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4096 0 0 0 0 0 0 11.936 0 0 0 0 0 0 0 0 0 0 0 0 11.9755 0 0 0 0 0 0 0 0 O75344 FKBP6_HUMAN "Inactive peptidyl-prolyl cis-trans isomerase FKBP6, Inactive PPIase FKBP6 (36 kDa FK506-binding protein, 36 kDa FKBP, FKBP-36) (FK506-binding protein 6, FKBP-6) (Immunophilin FKBP36)" FKBP6 FKBP36 Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795] cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; FK506 binding [GO:0005528]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; spermatogenesis [GO:0007283] GO:0000795; GO:0005528; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0043046; GO:0045070; GO:0051321; GO:0051879 FK506 binding [GO:0005528]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802] DFLVRAQK 0.99281 -7.2924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6404 0 0 0 0 11.8574 0 0 0 0 0 12.4859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2139 0 0 0 0 0 0 0 0 12.3528 0 0 0 12.6165 0 12.5702 0 0 0 0 0 0 0 0 0 12.8616 0 0 0 0 0 0 0 0 0 13.3343 0 0 0 0 0 0 0 0 0 12.0126 0 12.8432 0 15.5342 0 12.3628 0 0 13.6349 0 0 0 0 12.2368 0 0 0 0 0 0 0 0 13.4583 0 0 0 0 0 0 0 0 0 0 0 11.9266 0 0 0 0 0 0 12.6529 0 0 0 0 12.1136 0 0 P0DJG4 THEGL_HUMAN Testicular haploid expressed gene protein-like (Theg spermatid-like protein) THEGL Homo sapiens (Human) APVRIVYYDPDVFKTK 0.99281 -14.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2022 0 0 0 0 0 10.8257 0 0 0 14.604 14.8236 14.7886 0 0 0 13.5441 0 14.2001 13.6208 0 13.9717 13.8925 0 0 0 0 0 0 0 0 0 13.6991 13.2962 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9561 11.8311 0 12.8072 0 0 0 0 0 0 13.3105 0 0 0 0 0 15.6461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1009 0 0 15.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11684 UTER_HUMAN "Uteroglobin (Clara cell phospholipid-binding protein, CCPBP) (Clara cells 10 kDa secretory protein, CC10) (Secretoglobin family 1A member 1) (Urinary protein 1, UP-1, UP1, Urine protein 1)" SCGB1A1 CC10 CCSP UGB Homo sapiens (Human) embryo implantation [GO:0007566]; female pregnancy [GO:0007565]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of inflammatory response [GO:0050727]; regulation of mRNA stability [GO:0043488]; response to cytokine [GO:0034097]; response to fibroblast growth factor [GO:0071774]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to ozone [GO:0010193]; response to silicon dioxide [GO:0034021]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; phospholipase A2 inhibitor activity [GO:0019834]; polychlorinated biphenyl binding [GO:0097160]; embryo implantation [GO:0007566]; female pregnancy [GO:0007565]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of inflammatory response [GO:0050727]; regulation of mRNA stability [GO:0043488]; response to cytokine [GO:0034097]; response to fibroblast growth factor [GO:0071774]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to ozone [GO:0010193]; response to silicon dioxide [GO:0034021]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098] GO:0000122; GO:0005615; GO:0005635; GO:0005737; GO:0005791; GO:0007165; GO:0007565; GO:0007566; GO:0009410; GO:0010193; GO:0019834; GO:0030141; GO:0032496; GO:0032689; GO:0032696; GO:0032713; GO:0032714; GO:0034021; GO:0034097; GO:0042098; GO:0042130; GO:0043488; GO:0050727; GO:0051384; GO:0070062; GO:0071774; GO:0097160 phospholipase A2 inhibitor activity [GO:0019834]; polychlorinated biphenyl binding [GO:0097160] IAQSSLCN 0.99281 -7.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12643 BMP2_HUMAN "Bone morphogenetic protein 2, BMP-2 (Bone morphogenetic protein 2A, BMP-2A)" BMP2 BMP2A Homo sapiens (Human) "ameloblast differentiation [GO:0036305]; animal organ morphogenesis [GO:0009887]; aortic valve development [GO:0003176]; astrocyte differentiation [GO:0048708]; atrioventricular canal morphogenesis [GO:1905222]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac atrium formation [GO:0003210]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to BMP stimulus [GO:0071773]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation [GO:0002062]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchyme development [GO:0060485]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of calcium-independent cell-cell adhesion [GO:0051042]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pericardium development [GO:0060039]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontogenesis [GO:0042482]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway by BMP signaling pathway [GO:0060804]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; proteoglycan metabolic process [GO:0006029]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transcription by RNA polymerase II [GO:0006366]; Wnt signaling pathway [GO:0016055]" BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] "BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; BMP receptor binding [GO:0070700]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; ameloblast differentiation [GO:0036305]; animal organ morphogenesis [GO:0009887]; aortic valve development [GO:0003176]; astrocyte differentiation [GO:0048708]; atrioventricular canal morphogenesis [GO:1905222]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac atrium formation [GO:0003210]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiocyte differentiation [GO:0035051]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to BMP stimulus [GO:0071773]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation [GO:0002062]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchyme development [GO:0060485]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of calcium-independent cell-cell adhesion [GO:0051042]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pericardium development [GO:0060039]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontogenesis [GO:0042482]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway by BMP signaling pathway [GO:0060804]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; proteoglycan metabolic process [GO:0006029]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transcription by RNA polymerase II [GO:0006366]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0001501; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001837; GO:0001934; GO:0001938; GO:0002062; GO:0003130; GO:0003176; GO:0003181; GO:0003203; GO:0003210; GO:0003272; GO:0003308; GO:0003331; GO:0005102; GO:0005125; GO:0005576; GO:0005615; GO:0006029; GO:0006355; GO:0006366; GO:0006468; GO:0006954; GO:0007219; GO:0007267; GO:0007507; GO:0008083; GO:0008285; GO:0009617; GO:0009887; GO:0009986; GO:0010628; GO:0010629; GO:0010718; GO:0010862; GO:0010894; GO:0010922; GO:0016055; GO:0019211; GO:0021537; GO:0021978; GO:0030177; GO:0030282; GO:0030335; GO:0030501; GO:0030509; GO:0030512; GO:0030858; GO:0031648; GO:0032092; GO:0032348; GO:0033690; GO:0035051; GO:0035054; GO:0035360; GO:0035630; GO:0036305; GO:0039706; GO:0042475; GO:0042482; GO:0042487; GO:0043065; GO:0043231; GO:0043407; GO:0043410; GO:0043539; GO:0043569; GO:0045165; GO:0045600; GO:0045666; GO:0045669; GO:0045778; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0048662; GO:0048708; GO:0048711; GO:0048762; GO:0048839; GO:0051042; GO:0051091; GO:0055007; GO:0055008; GO:0060039; GO:0060128; GO:0060129; GO:0060317; GO:0060389; GO:0060391; GO:0060395; GO:0060485; GO:0060804; GO:0061036; GO:0061312; GO:0070374; GO:0070700; GO:0070724; GO:0071407; GO:0071773; GO:0072138; GO:0090090; GO:1900745; GO:1901522; GO:1902895; GO:1905072; GO:1905222; GO:2000065; GO:2000726 BMP receptor binding [GO:0070700]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332] CLLALLLPQVLLGGAAGLVPELGRR 0.99281 -14.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8867 0 12.1315 12.4206 11.9125 10.7397 13.6344 11.5998 13.6381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9256 0 0 0 0 0 0 0 0 0 0 15.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1488 15.7536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4541 0 0 0 0 P21709 EPHA1_HUMAN "Ephrin type-A receptor 1, hEpha1, EC 2.7.10.1 (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH)" EPHA1 EPH EPHT EPHT1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of cell migration [GO:0030336]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of kinase activity [GO:0033674]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of cell migration [GO:0030336]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of kinase activity [GO:0033674]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001525; GO:0001954; GO:0001968; GO:0004672; GO:0004714; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006469; GO:0007166; GO:0007169; GO:0007411; GO:0008284; GO:0018108; GO:0019901; GO:0030335; GO:0030336; GO:0033674; GO:0034446; GO:0043005; GO:0043087; GO:0043235; GO:0045766; GO:0046777; GO:0051496; GO:0090630 ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] CHCEPGYEEGGSGEACVACPSGSYR 0.99281 -14.6 10.4902 0 0 0 10.8957 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8966 0 0 0 13.0862 0 0 0 12.1493 0 0 0 0 0 0 0 0 0 0 0 11.7109 0 0 0 0 0 12.5515 0 0 0 0 0 0 10.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7596 0 0 11.5094 0 0 13.3209 12.226 12.1801 0 11.3816 12.4819 13.0757 0 12.3981 0 0 13.5578 0 0 13.6 0 13.108 0 0 0 0 0 0 0 0 12.5679 0 0 0 0 0 0 0 0 0 13.0899 11.7361 0 0 0 0 0 0 0 14.1493 0 0 0 0 0 0 0 12.8912 0 0 0 0 12.6694 0 0 0 0 0 14.0631 12.8283 0 0 0 0 0 13.9887 12.4569 13.7842 13.8028 12.2476 0 0 0 0 0 0 14.6976 0 0 14.3597 14.107 0 0 0 0 0 11.1983 0 0 0 0 11.9279 12.1971 0 0 11.4473 0 0 12.742 0 P35609 ACTN2_HUMAN Alpha-actinin-2 (Alpha-actinin skeletal muscle isoform 2) (F-actin cross-linking protein) ACTN2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament uncapping [GO:0051695]; cardiac muscle cell development [GO:0055013]; cell adhesion [GO:0007155]; focal adhesion assembly [GO:0048041]; microspike assembly [GO:0030035]; muscle cell development [GO:0055001]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of protein localization to cell surface [GO:2000009]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; positive regulation of cation channel activity [GO:2001259]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to plasma membrane [GO:0072659]; regulation of apoptotic process [GO:0042981]; regulation of membrane potential [GO:0042391]; sarcomere organization [GO:0045214] actin filament [GO:0005884]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; Z disc [GO:0030018] "actin filament [GO:0005884]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; FATZ binding [GO:0051373]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; nuclear receptor coactivator activity [GO:0030374]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein domain specific binding [GO:0019904]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325]; actin cytoskeleton organization [GO:0030036]; actin filament uncapping [GO:0051695]; cardiac muscle cell development [GO:0055013]; cell adhesion [GO:0007155]; focal adhesion assembly [GO:0048041]; microspike assembly [GO:0030035]; muscle cell development [GO:0055001]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of protein localization to cell surface [GO:2000009]; phospholipase C-activating angiotensin-activated signaling pathway [GO:0086097]; positive regulation of cation channel activity [GO:2001259]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to plasma membrane [GO:0072659]; regulation of apoptotic process [GO:0042981]; regulation of membrane potential [GO:0042391]; sarcomere organization [GO:0045214]" GO:0005178; GO:0005509; GO:0005546; GO:0005576; GO:0005829; GO:0005856; GO:0005884; GO:0005925; GO:0007155; GO:0008092; GO:0008307; GO:0019904; GO:0030018; GO:0030035; GO:0030036; GO:0030054; GO:0030175; GO:0030274; GO:0030374; GO:0030864; GO:0031093; GO:0031143; GO:0031432; GO:0042391; GO:0042802; GO:0042981; GO:0042995; GO:0043197; GO:0043267; GO:0043268; GO:0044325; GO:0045214; GO:0048041; GO:0051015; GO:0051373; GO:0051695; GO:0055001; GO:0055013; GO:0070062; GO:0070080; GO:0072659; GO:0086097; GO:1901017; GO:1901018; GO:2000009; GO:2001137; GO:2001259 "actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; FATZ binding [GO:0051373]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; nuclear receptor coactivator activity [GO:0030374]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein domain specific binding [GO:0019904]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; titin Z domain binding [GO:0070080]; transmembrane transporter binding [GO:0044325]" CQKICDQWDR 0.99281 -6.4171 0 0 0 0 0 0 0 0 11.12 13.6253 0 12.7094 14.0675 13.1999 0 10.903 0 0 10.6927 0 0 0 0 0 0 0 12.9438 0 12.1413 12.2557 0 12.3562 13.4073 12.4351 0 0 0 12.648 12.0277 11.7086 0 0 13.4771 11.8609 0 0 0 11.7373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3889 0 0 0 14.6718 0 14.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8756 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9286 0 0 0 0 0 13.2856 0 12.9079 0 14.4132 0 0 12.8321 0 0 0 0 12.3685 0 0 0 0 P51841 GUC2F_HUMAN "Retinal guanylyl cyclase 2, RETGC-2, EC 4.6.1.2 (Guanylate cyclase 2F, retinal) (Guanylate cyclase F, GC-F) (Rod outer segment membrane guanylate cyclase 2, ROS-GC2)" GUCY2F GUC2F RETGC2 Homo sapiens (Human) cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200] integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; rod photoreceptor outer segment [GO:0120200]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; detection of light stimulus involved in visual perception [GO:0050908]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005640; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007601; GO:0019934; GO:0022400; GO:0038023; GO:0042802; GO:0044877; GO:0050908; GO:0097381; GO:0120200 ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; identical protein binding [GO:0042802]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] CWFAEGK 0.99281 -15.982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7919 11.7695 10.8207 0 0 0 0 0 0 0 10.8573 11.6801 0 0 12.8597 0 12.5104 0 12.1988 12.541 13.0045 12.7306 12.9816 0 12.6695 0 12.7195 0 0 13.776 0 0 0 0 0 0 0 0 0 0 0 0 14.7669 13.273 0 0 0 12.8791 0 0 0 0 0 0 0 0 0 0 0 13.0787 0 12.8972 0 12.6966 0 0 0 0 0 0 13.1824 0 0 0 0 0 0 12.9098 0 0 0 0 13.058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3861 0 12.709 12.3235 0 0 0 0 0 0 0 0 0 13.2091 0 0 0 0 0 0 0 0 0 0 12.8691 0 0 0 11.1219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1409 0 0 0 0 11.9499 0 12.0382 0 0 0 0 0 0 0 14.6276 0 0 12.614 0 P98182 ZN200_HUMAN Zinc finger protein 200 ZNF200 ZNFMF Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] GO:0005634; GO:0046872 metal ion binding [GO:0046872] FGRLSNCTR 0.99281 -16.019 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9335 0 11.7962 15.3099 0 0 0 11.7411 0 0 0 13.833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9925 0 0 0 0 12.8294 0 0 0 0 0 0 0 0 0 13.3099 0 0 0 0 0 0 0 0 0 0 0 0 12.2894 0 14.0633 0 0 0 0 0 0 0 0 0 0 12.5886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5441 0 0 0 0 0 0 0 0 14.0335 0 0 0 0 13.6991 0 0 0 14.0652 18.3063 0 0 13.3871 0 0 0 15.3641 0 14.1037 0 0 0 0 Q1MSJ5 CSPP1_HUMAN Centrosome and spindle pole-associated protein 1 CSPP1 CSPP Homo sapiens (Human) positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467] GO:0000922; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0032467; GO:0034451; GO:0051781 ARIQQEYEEEQEKK 0.99281 -14.568 0 0 0 0 0 0 0 0 0 13.016 13.4516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9929 0 10.5019 0 0 0 0 0 13.2233 14.1346 13.9111 0 13.6152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3179 13.7729 0 0 0 0 14.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2053 0 11.0879 10.514 0 0 0 0 0 10.4235 0 0 0 0 0 0 0 0 0 0 0 10.4872 12.6555 0 0 0 16.1993 0 0 Q6ZMW3 EMAL6_HUMAN "Echinoderm microtubule-associated protein-like 6, EMAP-6 (Echinoderm microtubule-associated protein-like 5-like)" EML6 EML5L Homo sapiens (Human) cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule binding [GO:0008017] GO:0005737; GO:0005874; GO:0008017 microtubule binding [GO:0008017] AAPQPEK 0.99281 -46.446 0 0 0 0 0 0 0 10.6402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.577 0 0 0 0 0 13.4574 0 0 0 0 0 0 10.8615 0 0 0 0 0 12.6421 0 12.868 0 0 0 0 0 0 0 10.3214 0 0 0 0 0 0 0 0 0 10.5485 0 0 0 0 0 10.4917 0 0 0 14.2638 0 0 12.2382 0 0 0 11.3934 13.786 0 0 0 12.5368 0 11.7335 0 11.0613 15.2631 0 0 0 11.0939 0 0 0 10.1949 10.8444 0 13.317 10.0381 10.5001 0 14.7486 0 11.1981 11.3656 0 0 11.3365 13.2819 16.9816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5578 0 0 12.769 0 0 0 12.1417 11.2307 0 0 12.3519 0 0 12.0832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7874 0 0 0 0 0 0 0 15.59 Q86UY6 NAA40_HUMAN "N-alpha-acetyltransferase 40, EC 2.3.1.257 (N-acetyltransferase 11) (N-alpha-acetyltransferase D, NatD, hNatD) (Protein acetyltransferase 1)" NAA40 NAT11 PATT1 Homo sapiens (Human) histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; lipid metabolic process [GO:0006629]; N-terminal protein amino acid acetylation [GO:0006474] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; lipid metabolic process [GO:0006629]; N-terminal protein amino acid acetylation [GO:0006474] GO:0005634; GO:0005654; GO:0005829; GO:0006474; GO:0006629; GO:0010485; GO:0034451; GO:0043967; GO:0043968; GO:0043998; GO:1990189 H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189] FDVECGDEVLYCYEVQLESKVR 0.99281 -7.2962 0 0 0 0 0 13.9982 0 0 0 0 11.8489 0 0 0 0 0 0 0 13.5194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8135 0 12.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2248 0 0 0 0 0 0 0 0 0 0 0 0 12.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6573 0 0 0 13.6382 0 0 0 0 0 0 13.3012 11.6839 0 0 0 0 0 0 0 12.8229 0 0 0 12.8742 0 13.0757 0 0 0 0 0 0 12.22 0 0 0 0 0 0 0 11.1915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8635 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2965 0 0 0 0 12.7638 0 0 0 Q8N807 PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis PDILT Homo sapiens (Human) germ cell migration [GO:0008354]; protein folding [GO:0006457]; spermatid development [GO:0007286] endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783]; protein disulfide isomerase activity [GO:0003756]; germ cell migration [GO:0008354]; protein folding [GO:0006457]; spermatid development [GO:0007286] GO:0003756; GO:0005783; GO:0006457; GO:0007286; GO:0008354 protein disulfide isomerase activity [GO:0003756] DFPELTFGVITIGNVIGRFHVTLDSVLVFK 0.99281 -16.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5313 0 0 0 0 11.5294 0 0 0 0 0 0 0 0 13.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3693 0 0 Q8NEY8 PPHLN_HUMAN "Periphilin-1 (CDC7 expression repressor, CR) (Gastric cancer antigen Ga50)" PPHLN1 HSPC206 HSPC232 Homo sapiens (Human) "keratinization [GO:0031424]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; keratinization [GO:0031424]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]" GO:0003723; GO:0005654; GO:0005694; GO:0005794; GO:0005829; GO:0031424; GO:0045814; GO:0045892; GO:0090309; GO:0097355 RNA binding [GO:0003723] AIASKTK 0.99281 -16.017 0 0 0 0 0 0 0 0 13.8227 12.5744 12.3067 12.6608 12.5914 0 0 0 10.8602 0 0 0 0 0 0 0 0 0 0 0 12.3388 12.6202 0 0 12.5488 12.3541 0 12.4054 12.3494 0 0 0 12.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9263 0 0 0 0 0 0 13.4449 0 0 0 13.1198 14.8329 0 0 0 0 0 0 0 0 0 10.8913 0 0 0 0 0 0 0 0 0 0 0 0 12.6462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5321 13.2016 13.2092 13.679 0 13.2524 13.5185 15.7438 13.4676 0 0 0 13.53 0 13.2793 0 0 0 0 0 13.774 0 0 Q8NFZ5 TNIP2_HUMAN "TNFAIP3-interacting protein 2 (A20-binding inhibitor of NF-kappa-B activation 2, ABIN-2) (Fetal liver LKB1-interacting protein)" TNIP2 ABIN2 FLIP1 Homo sapiens (Human) apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of B cell activation [GO:0050871]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 9 signaling pathway [GO:0034162] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of B cell activation [GO:0050871]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 9 signaling pathway [GO:0034162] GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0006954; GO:0019901; GO:0023035; GO:0031593; GO:0034134; GO:0034138; GO:0034162; GO:0043032; GO:0043123; GO:0045944; GO:0046872; GO:0050821; GO:0050871; GO:0070498; GO:0070530; GO:0071222; GO:2000352 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein kinase binding [GO:0019901] AQSRIQELEEK 0.99281 -7.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0381 0 0 0 0 0 0 0 0 0 0 0 0 11.9636 0 0 0 0 12.5443 0 13.5739 0 0 13.3784 0 0 13.5981 0 0 14.5847 12.2757 0 0 11.6749 12.8769 0 0 0 0 0 0 0 0 13.1653 11.6822 0 12.2331 0 0 0 0 0 13.4316 0 14.1246 14.4779 0 0 0 12.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2446 0 0 0 0 0 0 0 0 10.9669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8209 0 0 0 0 0 0 0 0 0 0 Q96BJ3 AIDA_HUMAN "Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)" AIDA C1orf80 Homo sapiens (Human) determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333] GO:0005737; GO:0009953; GO:0016020; GO:0019904; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264 phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904] CFAFMEMDEIK 0.99281 -14.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1039 0 0 12.6398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1856 0 0 0 0 0 0 0 0 0 0 0 12.7268 0 14.0674 0 0 13.5435 0 0 0 0 0 13.5174 14.7283 13.371 0 0 0 0 0 12.837 0 0 12.0576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9238 0 11.9519 0 0 0 12.7616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7662 0 0 0 0 14.2652 0 13.7644 14.1307 0 14.1387 0 0 0 14.2547 0 0 0 0 0 0 0 13.5665 0 0 0 0 Q96NJ6 ZFP3_HUMAN "Zinc finger protein 3 homolog, Zfp-3 (Zinc finger protein 752)" ZFP3 ZNF752 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ECGKAFR 0.99281 -16.012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2945 0 0 0 0 0 0 13.0139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5222 0 0 0 0 10.164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0477 0 0 0 0 0 11.3827 0 11.2284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2092 0 0 0 0 0 10.4424 0 0 0 10.8174 0 0 0 0 11.4359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8744 0 11.1078 0 0 0 0 0 0 0 0 0 12.0677 0 0 0 11.864 0 0 0 Q9H4K7 MTG2_HUMAN "Mitochondrial ribosome-associated GTPase 2 (GTP-binding protein 5) (Protein obg homolog 1, ObgH1)" MTG2 GTPBP5 OBGH1 Homo sapiens (Human) regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; ribosome biogenesis [GO:0042254] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; ribosome biogenesis [GO:0042254] GO:0000287; GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0042254; GO:0044065; GO:0070129 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] CFSARLRTVFQGVGHWALSTWAGLK 0.99281 -41.494 0 0 0 0 0 0 0 11.4844 0 0 0 0 0 0 0 0 0 13.1231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0575 0 0 0 0 0 0 0 0 0 0 0 12.322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3243 0 0 0 0 0 0 0 11.4081 0 0 0 0 13.868 14.1933 13.717 0 13.7878 13.8978 0 14.6129 0 0 0 11.5307 0 0 13.796 0 0 0 10.4681 0 0 0 0 0 0 10.8139 13.6401 0 0 13.7974 0 12.1392 0 0 0 0 0 0 0 12.984 0 0 13.5701 12.1485 0 0 12.9487 0 0 12.2428 14.0882 0 11.9413 11.9242 0 0 0 13.2553 0 0 0 0 0 0 0 0 0 0 0 0 13.1495 0 0 0 0 11.7224 0 0 13.0278 0 0 0 0 0 0 0 0 0 0 0 0 13.9582 0 0 0 0 0 0 11.3724 0 0 0 0 0 0 0 Q9NQ86 TRI36_HUMAN "E3 ubiquitin-protein ligase TRIM36, EC 2.3.2.27 (RING finger protein 98) (RING-type E3 ubiquitin transferase TRIM36) (Tripartite motif-containing protein 36) (Zinc-binding protein Rbcc728)" TRIM36 RBCC728 RNF98 Homo sapiens (Human) acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; alpha-tubulin binding [GO:0043014]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051] GO:0000281; GO:0001669; GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0007051; GO:0007340; GO:0008270; GO:0043014; GO:0051726; GO:0070507 alpha-tubulin binding [GO:0043014]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] IHHPWGTIKAQHEYVGPTTNFRPK 0.99281 -16.028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7959 0 Q9P2K1 C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A CC2D2A KIAA1345 Homo sapiens (Human) axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038] ciliary transition zone [GO:0035869]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; MKS complex [GO:0036038]; axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224] GO:0001822; GO:0001843; GO:0005829; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403 AKFLTDKLQALR 0.99282 -59.041 18.5583 18.0782 17.8862 13.8973 18.6147 19.1944 19.019 13.0339 12.5357 12.8563 12.0943 11.9165 11.5408 0 14.4828 12.6044 11.8464 13.1956 17.7677 17.5135 17.4683 18.2524 17.9913 17.979 14.0192 12.6935 11.2944 0 12.3664 12.6285 0 14.1566 0 13.9321 0 0 0 0 12.3535 13.3479 0 12.4633 0 0 14.0162 13.5401 12.3156 12.2853 12.3712 12.6793 15.2028 13.1783 0 0 0 0 0 13.285 0 12.4557 11.9695 0 0 0 0 0 17.7279 17.8288 17.6364 17.7608 17.9148 18.1218 18.1863 18.4005 18.7598 18.8308 18.9945 19.2904 19.4026 19.4583 19.5329 16.8973 15.3594 16.0039 15.1277 12.3196 14.916 17.7967 18.7783 18.3798 19.0472 18.6011 18.5211 19.1305 19.7557 19.7776 16.9472 17.0611 17.2681 19.6925 19.6377 19.5316 19.8423 19.7758 19.698 19.2914 19.3285 19.3709 19.394 19.2551 19.2595 19.3881 19.5326 19.0929 18.8979 13.8428 18.8979 13.7399 18.8786 18.9814 18.9337 18.9409 18.894 18.6738 18.7715 18.5795 18.7324 18.7205 18.5981 18.7741 18.5803 18.6043 18.5928 18.5997 18.6758 18.3454 18.3837 17.1284 17.7085 18.3772 18.2439 17.9985 18.1112 18.0377 18.0314 16.8487 18.0969 15.2441 16.1619 14.0337 17.9363 17.9438 17.8141 18.9133 18.7249 18.5438 17.7381 14.547 14.3663 14.279 0 14.1709 13.8832 15.1711 15.0244 0 14.3201 0 0 0 11.9796 17.7788 17.9563 17.6681 14.73 12.8338 17.7142 13.8426 17.2515 0 O15040 TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297) TECPR2 KIAA0297 KIAA0329 Homo sapiens (Human) autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527] GO:0005737; GO:0006914; GO:0032527 DGLEMSGCSER 0.99282 -14.291 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1664 0 11.5162 0 0 0 0 0 0 0 0 0 0 0 11.7656 0 0 0 0 0 11.2013 0 0 11.7868 0 12.1727 11.5434 0 0 0 0 0 0 11.6615 0 0 0 12.788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1746 0 12.7769 0 13.2991 0 0 0 0 0 0 0 0 14.901 16.4025 16.017 14.2055 14.7118 15.4743 15.3486 15.6719 15.5377 0 0 0 0 0 0 11.5958 0 0 13.431 13.0652 0 12.831 0 13.5559 13.773 14.6175 13.7062 0 13.019 0 0 13.339 12.5885 0 13.4298 12.8485 13.1069 12.6807 13.8083 0 0 0 0 0 0 0 15.6413 0 0 16.6226 0 0 0 0 0 0 13.1207 0 0 0 13.4267 0 14.28 0 0 12.5846 0 12.7343 0 0 13.6787 0 0 13.1269 0 0 0 14.4516 0 0 0 14.068 0 0 0 0 14.1821 0 13.9619 0 13.0549 0 0 P09874 PARP1_HUMAN "Poly [ADP-ribose] polymerase 1, PARP-1, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 1, ARTD1) (DNA ADP-ribosyltransferase PARP1, EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1, ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1, EC 2.4.2.-)" PARP1 ADPRT PPOL Homo sapiens (Human) apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179] "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of DNA methylation [GO:0044030]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; regulation of SMAD protein complex assembly [GO:0010990]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000122; GO:0000723; GO:0000781; GO:0003677; GO:0003723; GO:0003950; GO:0005634; GO:0005635; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006281; GO:0006302; GO:0006366; GO:0006471; GO:0006915; GO:0006974; GO:0007005; GO:0007179; GO:0008270; GO:0010332; GO:0010613; GO:0010990; GO:0016020; GO:0016540; GO:0016604; GO:0018312; GO:0018424; GO:0019899; GO:0019901; GO:0023019; GO:0030225; GO:0030331; GO:0030592; GO:0032042; GO:0032869; GO:0032880; GO:0032991; GO:0032993; GO:0033148; GO:0034599; GO:0034644; GO:0035861; GO:0036211; GO:0042802; GO:0042826; GO:0043504; GO:0044030; GO:0045944; GO:0047485; GO:0050790; GO:0051287; GO:0051901; GO:0060391; GO:0061629; GO:0070212; GO:0070213; GO:0070412; GO:0071294; GO:0090734; GO:0140294; GO:1900182; GO:1901216; GO:1903376; GO:1903518; GO:1904044; GO:1904357; GO:1904646; GO:1904762; GO:1905168; GO:1990404; GO:1990966; GO:2000679; GO:2001170 DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270] ASLCISTKKEVEK 0.99282 -42.167 0 0 0 13.1766 14.2023 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2423 12.1791 14.7487 12.8145 11.499 0 11.3788 11.1869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5414 13.7898 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6934 0 15.6216 15.7536 14.887 13.2509 0 17.5966 0 0 15.3614 0 0 13.6891 0 13.5152 0 16.1313 0 0 13.4168 0 0 0 0 0 13.6164 0 11.7901 13.5285 13.4225 13.3995 0 14.1745 0 0 0 0 0 0 0 13.9178 0 0 0 0 0 0 0 0 18.3434 0 13.5182 0 16.7562 0 0 13.0038 0 13.0183 13.3855 13.574 0 13.0285 14.4004 12.3488 0 0 0 0 0 14.5958 14.2873 13.1771 0 0 13.1778 0 13.4122 13.5619 0 0 0 0 0 0 0 14.8427 0 13.8937 13.633 0 0 0 0 0 0 0 0 13.6718 0 0 0 0 0 0 13.5583 13.6362 14.0467 0 0 0 0 0 P33908 MA1A1_HUMAN "Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA, EC 3.2.1.113 (Man(9)-alpha-mannosidase, Man9-mannosidase) (Mannosidase alpha class 1A member 1) (Processing alpha-1,2-mannosidase IA, Alpha-1,2-mannosidase IA)" MAN1A1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; protein targeting to ER [GO:0045047]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; protein targeting to ER [GO:0045047]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005793; GO:0005794; GO:0005829; GO:0005975; GO:0006486; GO:0006491; GO:0015923; GO:0016020; GO:0016021; GO:0030433; GO:0031410; GO:0045047; GO:0070062; GO:1904381; GO:1904382 "calcium ion binding [GO:0005509]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" AVELGVKLLPAFHTPSGIPWALLNMKSGIGR 0.99282 -14.288 0 0 0 0 0 0 0 0 0 0 10.2766 0 0 0 11.0421 0 0 0 0 0 0 11.8125 0 0 0 0 9.9561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0736 0 14.459 0 0 0 0 0 0 0 0 0 13.0084 14.243 0 0 11.2868 0 0 0 14.262 0 16.2422 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4115 0 0 0 11.5643 0 0 16.0106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P67870 CSK2B_HUMAN "Casein kinase II subunit beta, CK II beta (Phosvitin) (Protein G5a)" CSNK2B CK2N G5A Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of DNA binding [GO:0051101]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956]; secretory granule lumen [GO:0034774]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of DNA binding [GO:0051101]; regulation of protein serine/threonine phosphatase activity [GO:0080163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0003682; GO:0004674; GO:0005102; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005956; GO:0006468; GO:0007165; GO:0008285; GO:0010862; GO:0016055; GO:0018107; GO:0019887; GO:0019904; GO:0032927; GO:0033211; GO:0034774; GO:0042802; GO:0043537; GO:0046872; GO:0051101; GO:0061154; GO:0061629; GO:0065003; GO:0070062; GO:0080163; GO:1904813 chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102] CMDVYTPK 0.99282 -7.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3365 0 0 0 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7808 0 11.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5837 0 0 12.616 0 0 0 16.8617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13029 PRDM2_HUMAN "PR domain zinc finger protein 2, EC 2.1.1.355 (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ)" PRDM2 KMT8 RIZ Homo sapiens (Human) "determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0008270; GO:0008340; GO:0010468; GO:0042054; GO:0043565; GO:0045944 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]" AVLQSKSTLASK 0.99282 -59.076 0 0 0 0 0 0 0 0 0 11.886 0 0 0 0 0 0 0 0 0 0 0 10.2841 0 0 0 0 0 0 0 0 0 10.9142 17.25 0 0 11.2297 0 0 0 0 17.2785 0 0 0 0 0 0 0 0 0 0 0 10.6519 0 0 0 10.671 17.6806 0 16.0403 0 0 0 0 0 0 0 0 0 0 11.5116 0 0 0 13.3295 14.4443 12.6502 15.0993 14.733 14.2558 14.8256 0 14.0726 0 13.7172 0 0 13.3875 0 15.683 15.2107 15.1244 13.4607 0 13.6564 13.5429 15.1748 13.4704 12.273 0 11.9633 0 0 0 0 13.4308 0 0 0 13.4944 0 0 0 12.4857 13.9206 0 0 14.2975 0 15.9272 0 14.5157 0 13.492 0 0 14.1959 0 12.9405 11.9843 11.4289 14.5859 0 0 0 0 15.5557 0 15.4023 0 0 13.9691 0 14.5225 0 13.7563 13.329 12.8094 12.4355 0 13.583 15.1115 0 13.2109 0 0 11.8957 14.0796 18.1068 11.6937 0 11.936 12.7979 18.0624 11.628 18.0504 0 14.1494 18.0813 0 0 14.4497 13.5979 15.1018 0 13.6842 0 0 0 0 Q14999 CUL7_HUMAN "Cullin-7, CUL-7" CUL7 KIAA0076 Homo sapiens (Human) epithelial to mesenchymal transition [GO:0001837]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; placenta development [GO:0001890]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]; vasculogenesis [GO:0001570] 3M complex [GO:1990393]; anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] 3M complex [GO:1990393]; anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; ubiquitin protein ligase binding [GO:0031625]; epithelial to mesenchymal transition [GO:0001837]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; placenta development [GO:0001890]; positive regulation of dendrite morphogenesis [GO:0050775]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511]; vasculogenesis [GO:0001570] GO:0000226; GO:0000281; GO:0001570; GO:0001837; GO:0001890; GO:0005680; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0006508; GO:0006511; GO:0007030; GO:0007088; GO:0016567; GO:0031461; GO:0031467; GO:0031625; GO:0048471; GO:0050775; GO:1990393 ubiquitin protein ligase binding [GO:0031625] DDDFVPR 0.99282 -25.792 0 0 9.63069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7913 0 0 0 0 0 0 0 0 0 0 12.6359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3711 15.4889 0 0 0 0 15.4257 0 12.213 12.3674 0 0 10.8247 0 0 12.0865 0 0 11.8761 0 0 0 0 0 0 0 0 12.1301 0 0 0 0 0 0 0 0 10.5083 12.7415 0 14.1453 0 0 0 0 0 0 0 0 0 0 0 0 14.8356 14.8478 0 0 0 0 0 13.9956 13.8703 0 0 13.6314 13.7588 0 0 0 13.1475 0 13.633 0 0 0 0 0 0 0 14.2164 0 0 0 0 0 0 0 0 14.5927 0 0 0 0 0 0 0 0 0 0 13.9962 0 0 11.0032 0 0 0 0 0 0 0 13.3773 0 Q68CZ2 TENS3_HUMAN Tensin-3 (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6) TNS3 TEM6 TENS1 TPP Homo sapiens (Human) dephosphorylation [GO:0016311] cytosol [GO:0005829]; focal adhesion [GO:0005925] cytosol [GO:0005829]; focal adhesion [GO:0005925]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311] GO:0005829; GO:0005925; GO:0016311; GO:0016791 phosphatase activity [GO:0016791] CYHKKYR 0.99282 -42.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7658 11.1331 0 0 0 0 0 13.978 0 0 11.8963 13.0244 0 0 0 0 12.4791 0 11.5693 0 0 0 0 13.4325 13.1443 0 14.0504 0 0 0 14.6595 0 14.0643 0 10.7846 0 0 11.1691 0 0 16.5199 10.6239 0 13.7495 10.4348 0 0 0 0 0 0 0 0 0 12.9744 14.0733 0 10.9085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7159 0 12.8743 0 0 0 0 0 0 0 0 0 0 12.1392 14.1904 13.7952 0 0 0 14.2619 0 0 0 0 0 0 13.1952 0 0 0 0 0 0 0 0 12.1837 14.5696 0 0 0 0 0 13.0759 0 0 0 0 0 14.794 0 0 Q86TB9 PATL1_HUMAN "Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b, Pat1b, hPat1b)" PATL1 OK/KNS-cl.5 Homo sapiens (Human) deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; P-body assembly [GO:0033962] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; P-body assembly [GO:0033962] GO:0000290; GO:0000932; GO:0003723; GO:0005829; GO:0008266; GO:0016605; GO:0016607; GO:0033962; GO:0034046; GO:0036464 poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] ELLRIPQAALAKPISIPTNLVSLFSR 0.99282 -7.3242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1523 0 0 0 0 0 12.3942 0 12.8493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0278 0 13.0805 12.2579 0 0 11.0806 0 11.8282 0 0 0 13.2658 0 0 0 0 0 0 0 10.6696 0 0 0 0 0 0 0 0 0 15.9765 0 0 0 0 0 0 12.419 0 0 0 0 0 12.692 14.9343 0 0 13.3745 0 0 0 0 0 14.628 0 14.9591 12.5209 11.314 15.0381 0 0 12.4067 13.7298 0 0 0 15.3849 0 0 0 14.2448 14.8753 0 14.2473 0 11.1553 0 0 0 0 0 0 14.8089 0 0 0 0 12.3 11.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3386 0 0 0 0 0 Q8IXJ9 ASXL1_HUMAN Polycomb group protein ASXL1 (Additional sex combs-like protein 1) ASXL1 KIAA0978 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; bone marrow development [GO:0048539]; cell morphogenesis [GO:0000902]; chromatin organization [GO:0006325]; heart morphogenesis [GO:0003007]; hemopoiesis [GO:0030097]; homeostasis of number of cells [GO:0048872]; lung saccule development [GO:0060430]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; podocyte development [GO:0072015]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of kidney size [GO:0035564]; response to retinoic acid [GO:0032526]; thymus development [GO:0048538] nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517] nucleoplasm [GO:0005654]; PR-DUB complex [GO:0035517]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear retinoic acid receptor binding [GO:0042974]; peroxisome proliferator activated receptor binding [GO:0042975]; transcription coactivator activity [GO:0003713]; animal organ morphogenesis [GO:0009887]; bone marrow development [GO:0048539]; cell morphogenesis [GO:0000902]; chromatin organization [GO:0006325]; heart morphogenesis [GO:0003007]; hemopoiesis [GO:0030097]; homeostasis of number of cells [GO:0048872]; lung saccule development [GO:0060430]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; podocyte development [GO:0072015]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of kidney size [GO:0035564]; response to retinoic acid [GO:0032526]; thymus development [GO:0048538] GO:0000902; GO:0003007; GO:0003677; GO:0003682; GO:0003713; GO:0005654; GO:0006325; GO:0009887; GO:0030097; GO:0032526; GO:0035359; GO:0035517; GO:0035522; GO:0035564; GO:0042974; GO:0042975; GO:0045599; GO:0045944; GO:0046872; GO:0048386; GO:0048538; GO:0048539; GO:0048872; GO:0060430; GO:0072015 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear retinoic acid receptor binding [GO:0042974]; peroxisome proliferator activated receptor binding [GO:0042975]; transcription coactivator activity [GO:0003713] AFDDELGLGGSCPPMR 0.99282 -6.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5323 0 0 0 0 0 0 0 0 0 0 10.0204 0 0 0 0 0 0 0 0 0 0 0 0 11.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4169 0 0 0 0 0 0 0 0 0 0 0 13.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8045 0 12.9124 0 0 0 0 12.7364 12.8688 0 0 0 0 0 0 0 0 0 0 11.8795 0 0 0 0 0 0 0 13.688 0 0 0 11.1145 0 0 0 0 0 0 14.3166 0 11.2013 0 0 0 0 0 0 0 0 0 Q8N3K9 CMYA5_HUMAN Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76) CMYA5 C5orf10 DTNBP2 SPRYD2 TRIM76 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016529; GO:0016607; GO:0031430; GO:0043231; GO:0048471 ADAMPQHFYQNEDYNERPK 0.99282 -14.272 0 0 0 0 11.9939 0 11.7143 0 0 0 11.1652 0 0 0 0 0 10.4387 0 0 0 0 0 0 0 0 0 0 0 0 11.7836 0 0 0 0 0 0 0 0 11.4212 0 17.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4497 0 0 17.1829 0 0 0 10.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8471 0 13.1474 0 0 0 0 0 12.4242 0 14.2194 0 11.7543 14.0664 0 13.8494 0 15.3574 14.6178 0 12.8123 0 14.5321 0 0 0 15.0825 0 0 0 0 14.6231 0 12.8848 0 0 0 0 0 14.0401 0 13.0051 16.1238 13.1011 12.3818 13.9527 0 0 12.5096 14.2567 0 0 0 0 0 0 14.3937 0 0 12.4963 13.6755 13.4834 14.3058 13.7659 0 13.7897 0 13.5015 12.9116 13.1578 0 13.115 0 11.7625 0 0 0 13.1721 15.8944 0 0 0 0 0 0 0 0 0 0 0 12.4231 0 0 0 0 0 14.3276 0 15.0577 0 0 0 0 0 13.0065 Q8N6G6 ATL1_HUMAN "ADAMTS-like protein 1, ADAMTSL-1 (Punctin-1)" ADAMTSL1 ADAMTSR1 C9orf94 UNQ528/PRO1071 Homo sapiens (Human) extracellular matrix organization [GO:0030198] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; extracellular matrix organization [GO:0030198] GO:0005576; GO:0005788; GO:0016787; GO:0030198 hydrolase activity [GO:0016787] ATPGTLLLFLAFLLLSSR 0.99282 -14.638 0 0 0 10.0522 0 0 0 0 0 0 0 14.5236 0 0 9.24686 0 0 0 0 0 0 0 12.8947 0 0 12.0277 0 12.7471 0 0 0 0 0 0 0 0 0 0 10.2771 0 0 0 0 0 0 0 0 0 0 0 0 10.2517 0 0 0 0 0 0 0 0 0 0 0 10.4952 0 0 0 0 0 13.4761 0 0 0 0 0 13.1894 0 0 9.6395 0 0 0 12.75 0 0 0 0 0 0 11.9647 0 0 0 0 11.7123 0 0 14.2397 0 13.5908 0 0 12.1173 14.9498 11.8445 12.7831 0 13.445 14.5709 11.1089 0 13.14 0 13.7437 0 0 0 14.6505 0 0 0 14.6113 0 12.5426 0 11.6412 0 0 0 10.184 0 9.95767 0 12.8315 0 12.8677 0 0 12.0666 0 0 13.3726 0 14.793 14.1439 0 12.0701 14.9184 10.4831 0 0 0 0 0 0 0 11.6299 11.795 0 0 11.2217 0 11.2758 11.6077 12.8969 0 0 0 0 10.6577 0 13.999 13.9084 14.8859 0 14.5573 14.8482 12.5481 11.3438 0 Q8NEP7 KLDC9_HUMAN Kelch domain-containing protein 9 (Kelch/ankyrin repeat-containing cyclin A1-interacting protein) KLHDC9 KARCA1 Homo sapiens (Human) cyclin binding [GO:0030332] GO:0030332 cyclin binding [GO:0030332] MAVAVPPGR 0.99282 -6.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0702 13.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5521 0 13.7625 0 0 0 13.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8325 0 0 0 13.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92747 ARC1A_HUMAN Actin-related protein 2/3 complex subunit 1A (SOP2-like protein) ARPC1A SOP2L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; regulation of actin filament polymerization [GO:0030833] GO:0003779; GO:0005634; GO:0005829; GO:0005885; GO:0015629; GO:0030036; GO:0030833; GO:0034314; GO:0035861; GO:0051015; GO:0070062 actin binding [GO:0003779]; actin filament binding [GO:0051015] GCLTFVSK 0.99282 -14.299 0 11.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6213 0 0 0 12.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5042 11.9331 0 0 0 0 0 0 0 0 0 12.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8457 0 10.3977 0 13.2406 0 0 14.2239 0 0 13.0552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7348 0 0 15.0297 0 0 0 0 0 13.7749 0 0 15.5726 10.6115 0 0 0 15.4448 13.5989 0 0 0 14.6413 0 0 0 0 0 15.151 12.9264 0 0 0 15.1102 15.7131 0 0 0 15.626 0 0 15.4407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8934 0 Q96HI0 SENP5_HUMAN "Sentrin-specific protease 5, EC 3.4.22.- (Sentrin/SUMO-specific protease SENP5)" SENP5 FKSG45 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; protein desumoylation [GO:0016926] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein desumoylation [GO:0016926] GO:0005634; GO:0005654; GO:0005730; GO:0007049; GO:0016926; GO:0016929; GO:0051301; GO:0070139 deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139] ALQIQKTWIKDEPLCAK 0.99282 -14.614 0 12.5408 0 0 0 0 0 0 0 0 0 0 12.1242 0 0 0 0 0 0 0 0 0 12.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9088 0 0 10.6213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0424 13.8122 0 0 0 0 0 0 13.7262 13.3151 13.5814 12.9786 13.1389 12.1944 0 0 0 0 0 0 0 12.2599 13.8014 0 11.2565 0 0 0 11.9235 0 0 0 0 0 0 12.9907 0 0 12.2516 0 0 13.9866 0 0 0 0 0 13.773 0 13.6637 0 13.2969 0 0 0 0 0 0 0 0 14.0701 0 12.2722 12.8638 12.6934 0 0 0 0 12.2844 13.5578 0 0 13.6274 0 0 13.2989 0 0 0 13.399 12.2695 0 0 12.9409 12.9958 0 0 0 13.6156 0 0 15.7375 0 11.9766 0 13.148 0 0 0 0 0 0 12.8886 12.7351 12.7927 0 14.0588 13.6592 0 0 0 14.3156 0 Q9BQK8 LPIN3_HUMAN "Phosphatidate phosphatase LPIN3, EC 3.1.3.4 (Lipin-3) (Lipin-3-like)" LPIN3 LIPN3L Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634] endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular lipid metabolic process [GO:0044255]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432] GO:0003713; GO:0005634; GO:0005789; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0044255; GO:0045944 phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713] ATIYLWK 0.99282 -42.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1072 0 0 0 0 0 0 0 13.571 13.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.425 0 0 0 9.90869 0 0 13.4159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0197 14.7609 19.0423 0 0 12.8407 0 0 0 17.8295 16.0205 17.8844 15.3597 13.9642 17.0085 13.8006 18.0902 17.4592 13.876 13.8415 16.7014 13.4481 0 13.8266 0 13.3032 14.6746 13.4867 14.9009 13.3551 17.0832 13.373 0 0 0 0 0 0 17.5522 13.8876 13.9337 13.8307 0 15.8479 17.2453 0 14.8841 12.503 13.9611 16.0429 15.229 13.9536 17.1285 15.1351 0 14.4051 16.845 14.2015 14.0731 17.3615 17.1701 14.1354 13.574 17.0053 14.3509 0 15.4677 16.8347 16.6472 0 14.5534 15.0086 0 14.1821 12.2592 14.8597 14.2326 0 16.079 14.1163 14.129 0 0 0 0 13.9532 14.4892 13.9986 17.0396 0 0 0 0 0 0 0 0 0 15.2088 0 0 0 0 0 12.217 0 0 13.8106 0 0 0 0 0 0 Q9BW61 DDA1_HUMAN "DET1- and DDB1-associated protein 1 (Placenta cross-immune reaction antigen 1, PCIA-1)" DDA1 C19orf58 PCIA1 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005654; GO:0032436; GO:0080008 MADFLKGLPVYNK 0.99282 -6.2464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7051 0 0 0 0 0 0 0 0 0 0 0 0 11.4839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8175 0 0 0 0 0 0 10.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BX84 TRPM6_HUMAN "Transient receptor potential cation channel subfamily M member 6, EC 2.7.11.1 (Channel kinase 2) (Melastatin-related TRP cation channel 6)" TRPM6 CHAK2 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636] GO:0004674; GO:0005261; GO:0005262; GO:0005524; GO:0005886; GO:0005887; GO:0006468; GO:0009636; GO:0016324; GO:0031526; GO:0046872; GO:0051262; GO:0070588; GO:0098655; GO:0106310 ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EKSIVLHK 0.99282 -16.916 0 0 0 11.429 0 0 0 0 0 0 0 0 13.185 0 0 0 0 0 12.382 0 0 0 0 0 0 0 0 0 0 0 14.0506 0 0 0 0 0 0 0 0 0 0 0 12.5487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6379 0 0 0 11.9796 12.108 0 0 13.9842 0 0 13.8313 13.5516 11.3011 0 15.0464 14.5609 14.0593 0 0 0 13.6129 0 0 0 0 14.7905 0 0 13.3892 14.3849 0 0 13.2374 0 0 0 0 0 0 0 13.5205 0 0 0 0 12.8171 0 0 14.0305 0 12.1783 0 0 0 0 0 10.6144 13.2685 0 13.948 0 13.0997 11.8274 0 0 0 13.8476 0 11.7401 13.4223 0 0 0 13.6341 0 0 0 0 0 13.9529 0 0 0 0 0 0 13.0398 14.6216 0 0 0 12.6924 13.7148 14.4006 13.8542 13.0602 14.4023 0 0 0 14.2856 0 13.4856 0 0 0 0 12.7175 0 0 0 0 Q9BYG3 MK67I_HUMAN "MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar phosphoprotein Nopp34) (Nucleolar protein interacting with the FHA domain of pKI-67, hNIFK)" NIFK MKI67IP NOPP34 Homo sapiens (Human) "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein-containing complex assembly [GO:0065003]; rRNA metabolic process [GO:0016072]; rRNA transcription [GO:0009303]" chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein-containing complex assembly [GO:0065003]; rRNA metabolic process [GO:0016072]; rRNA transcription [GO:0009303]" GO:0000463; GO:0000794; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0009303; GO:0016072; GO:0065003 RNA binding [GO:0003723] FRLSRSK 0.99282 -14.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9391 0 0 0 0 0 0 13.4065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2557 0 0 0 13.3105 0 0 0 0 0 0 0 13.5103 0 0 0 0 Q9C0D0 PHAR1_HUMAN Phosphatase and actin regulator 1 PHACTR1 KIAA1733 RPEL1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149] anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202] anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; cerebral cortex development [GO:0021987]; dendrite arborization [GO:0140059]; regulation of neuron migration [GO:2001222]; stress fiber assembly [GO:0043149] GO:0003779; GO:0004864; GO:0005634; GO:0005829; GO:0008157; GO:0021987; GO:0030036; GO:0031032; GO:0031532; GO:0043149; GO:0045202; GO:0048870; GO:0070161; GO:0140059; GO:2001222 actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864] DSLAIKLSNRPSK 0.99282 -14.619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1559 0 0 0 0 0 0 0 0 0 0 0 0 12.3224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2954 0 0 0 0 0 0 0 0 0 0 Q9C0D5 TANC1_HUMAN "Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)" TANC1 KIAA1728 Homo sapiens (Human) dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; regulation of postsynapse organization [GO:0099175]; visual learning [GO:0008542] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; axon terminus [GO:0043679]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; regulation of postsynapse organization [GO:0099175]; visual learning [GO:0008542] GO:0007520; GO:0008542; GO:0014069; GO:0030425; GO:0043025; GO:0043679; GO:0070161; GO:0097062; GO:0098978; GO:0099175 AHIFKGLSKK 0.99282 -42.326 0 0 0 0 0 0 0 0 0 0 0 14.1957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3788 0 0 12.2063 0 0 0 0 0 0 0 0 0 0 11.3838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.647 0 11.2017 0 0 12.2572 12.4276 0 0 0 12.9734 0 0 0 13.9917 0 0 0 13.313 0 0 14.3502 0 0 0 0 0 0 0 12.6233 0 13.8889 11.5197 14.7411 0 12.0218 0 0 0 0 13.664 0 0 0 18.14 0 0 0 0 0 0 11.7905 11.269 0 13.7886 0 0 12.6438 0 18.1998 0 0 0 0 18.2067 11.7154 0 0 0 0 11.9838 0 0 0 12.727 0 0 0 0 0 0 0 0 0 0 0 0 16.3964 0 0 0 0 0 0 0 0 0 0 0 11.5325 13.6766 0 12.89 Q9HBU6 EKI1_HUMAN "Ethanolamine kinase 1, EKI 1, EC 2.7.1.82" ETNK1 EKI1 Homo sapiens (Human) phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310] GO:0004305; GO:0005524; GO:0005737; GO:0005829; GO:0006646; GO:0016020; GO:0016310 ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305] DEEVKSFR 0.99282 -14.95 0 0 11.9622 0 0 0 0 14.438 11.3563 0 13.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3569 0 11.9978 13.6954 12.0033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.256 0 13.6995 15.2128 12.2047 13.0152 0 13.0817 13.1683 12.8998 0 0 0 0 0 0 0 0 0 13.4594 12.0586 0 0 0 0 0 12.2715 14.3863 0 0 0 0 0 0 0 14.1773 0 0 0 12.0155 0 0 0 12.5658 0 14.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6658 13.5814 0 0 0 13.8223 0 14.5289 13.1714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y383 LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 LUC7L2 CGI-59 CGI-74 Homo sapiens (Human) mRNA splice site selection [GO:0006376] nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376] GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004 enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] DQDLASCDR 0.99282 -42.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.48897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0694 0 0 9.22028 0 0 13.8048 14.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.301 0 0 10.7707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5574 0 9.84997 0 0 0 12.4982 0 0 0 0 0 0 0 0 0 0 14.1299 0 0 0 0 0 0 0 0 0 0 0 0 14.7086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXI7 MUC16_HUMAN "Mucin-16, MUC-16 (Ovarian cancer-related tumor marker CA125, CA-125) (Ovarian carcinoma antigen CA125)" MUC16 CA125 Homo sapiens (Human) cell adhesion [GO:0007155] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cell adhesion [GO:0007155] GO:0005796; GO:0005886; GO:0007155; GO:0016021; GO:0019898; GO:0031982; GO:0070062 DSSATAVDAICTHR 0.99283 -63.459 0 0 0 0 11.6386 0 0 0 0 0 0 0 12.6851 13.367 0 12.1549 0 0 0 12.5777 13.3284 0 15.0639 0 11.2612 0 0 0 10.6573 0 0 0 0 0 12.4245 0 0 0 0 11.417 0 0 13.97 0 13.2087 0 0 14.1052 0 0 0 13.267 13.5779 13.6131 13.8724 15.4841 13.6458 0 0 0 12.3779 12.4107 12.4739 11.6028 0 11.6531 12.0645 10.0511 0 12.5946 0 0 12.246 12.3234 13.1037 14.6062 14.7603 15.6081 12.8096 14.1972 0 14.9083 16.7191 15.8789 12.8207 12.8285 14.8042 14.2101 14.3273 15.0864 13.5543 13.3574 14.7931 0 13.6152 16.11 15.6386 13.2094 13.5308 15.1098 14.4479 13.0372 14.1669 15.7272 14.3321 13.9111 12.982 14.8757 11.9266 13.8483 15.1844 0 13.411 15.1132 0 13.1895 16.2077 13.9412 0 14.9881 13.576 14.6949 13.785 0 12.7669 13.919 15.2958 14.2761 15.6397 14.9281 14.0684 14.689 14.1456 0 14.3779 14.6184 14.5763 0 12.7576 14.4629 14.5831 0 12.3377 0 14.5646 14.1552 14.2053 0 0 0 0 13.9486 13.8669 14.3006 14.6125 15.1735 0 0 0 0 13.9397 0 0 16.2445 14.9878 0 0 0 0 0 14.3643 13.7528 11.8963 14.2597 0 14.1867 0 14.0719 14.2145 0 A0A1B0GV03 GG6L7_HUMAN Golgin subfamily A member 6-like protein 7 GOLGA6L7 Homo sapiens (Human) cis-Golgi network [GO:0005801] cis-Golgi network [GO:0005801] GO:0005801 ELREQEQQMQEQEEQMR 0.99283 -16.933 15.7234 13.2119 15.0552 16.1521 15.5118 13.8919 16.7862 13.3938 11.877 0 0 11.9098 11.0978 0 0 0 0 12.5082 13.3929 0 11.1501 12.9057 12.331 13.8887 0 12.8311 0 0 10.6312 11.7222 0 0 0 0 0 0 13.9316 14.031 12.9976 0 0 0 0 10.4522 0 0 0 0 0 12.4701 0 12.1166 11.965 0 0 10.6475 0 0 0 0 0 0 0 0 0 0 16.7093 15.5505 16.5413 15.1637 14.9639 17.9459 14.098 14.7783 16.4711 16.0553 15.9976 16.0944 17.9592 17.6725 15.8476 17.2321 16.7001 16.277 12.7618 13.3336 14.7022 12.6469 0 14.4345 0 14.6574 13.3207 0 13.6143 11.9023 0 16.138 0 15.0873 16.5369 13.5194 13.1598 14.4989 13.4196 15.3666 15.3108 14.6603 15.3755 17.2495 16.8827 0 16.0411 0 16.5043 0 13.5313 14.0558 16.8781 17.2473 15.0059 13.5302 13.5593 16.1042 14.7788 13.7264 14.8855 14.522 13.1233 17.3477 13.7247 14.1089 17.4359 17.3967 15.8794 13.6083 14.5271 13.6656 17.2576 0 13.4762 13.2367 12.4725 11.5856 13.8928 13.9246 0 15.5796 0 15.8514 17.5198 14.8298 0 15.7354 15.6122 15.973 0 0 0 0 0 0 0 0 0 11.9498 12.736 0 0 0 0 12.4431 16.9671 13.486 0 0 0 0 12.5206 0 A6NNC1 P12LL_HUMAN Putative POM121-like protein 1-like Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AIPDCRPSR 0.99283 -16.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3907 0 0 0 0 0 0 0 0 13.3288 0 0 0 13.7881 11.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8848 0 0 0 0 13.0235 0 0 0 0 0 0 0 0 0 0 0 18.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.485 0 0 0 0 0 0 O00750 P3C2B_HUMAN "Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, PI3K-C2-beta, PtdIns-3-kinase C2 subunit beta, EC 2.7.1.137, EC 2.7.1.154 (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta)" PIK3C2B Homo sapiens (Human) autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein kinase B signaling [GO:0043491] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein kinase B signaling [GO:0043491] GO:0001727; GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005942; GO:0009267; GO:0014065; GO:0016020; GO:0016303; GO:0016477; GO:0030139; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0046854; GO:0048015; GO:0052742; GO:1905037 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; lipid kinase activity [GO:0001727]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742] DGLKDSQFSIR 0.99283 -6.2526 0 0 0 0 0 0 0 0 0 0 11.0065 13.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2417 0 0 0 14.6072 0 0 11.2971 0 0 0 0 0 0 0 0 11.3561 0 14.1892 0 0 0 0 12.2771 10.9177 10.3765 0 0 0 0 0 0 0 0 0 0 0 0 13.8086 14.6798 13.7181 0 0 14.38 0 14.4341 0 0 13.6287 0 14.168 14.8194 13.0368 14.6866 0 0 0 0 0 0 13.9117 0 0 12.9685 0 0 0 14.6568 0 0 12.947 0 15.0217 0 0 11.3553 15.8502 0 0 0 0 12.2829 11.757 14.6849 0 12.8646 0 0 0 0 14.3741 14.4166 0 0 13.5209 0 0 0 0 13.3005 13.6559 0 0 0 0 0 0 12.9211 0 0 13.159 12.0056 13.9197 0 0 12.5172 0 0 14.0314 14.6782 0 0 0 0 0 14.3055 12.872 0 14.2627 13.4038 15.2611 15.4932 12.4623 14.0853 14.0863 11.6171 0 0 0 0 12.3367 0 0 0 12.8901 0 0 13.5114 0 0 0 13.9341 O43660 PLRG1_HUMAN Pleiotropic regulator 1 PLRG1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]" catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]" GO:0000398; GO:0000974; GO:0001650; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0031965; GO:0034504; GO:0071007; GO:0071013; GO:1900087 APTMPKPQWHPPWK 0.99283 -26.038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3851 0 0 0 0 0 0 0 0 10.5396 0 0 0 0 0 0 0 10.7207 12.9126 0 0 0 0 11.0802 0 0 0 0 0 9.90893 12.5548 0 0 0 12.7174 0 0 14.9433 0 12.4252 0 10.0564 0 11.9547 12.951 13.9128 0 0 0 0 13.3849 0 13.5871 0 0 0 0 0 0 0 16.1431 11.8632 0 0 14.3014 0 13.6764 14.7769 0 0 0 0 14.4481 0 0 13.0404 0 0 0 17.223 0 14.341 0 0 0 12.1963 0 0 0 0 0 12.719 0 0 0 0 13.7515 0 0 0 0 0 0 0 12.5072 0 0 0 11.9866 0 12.5413 0 13.1913 13.0533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60909 B4GT2_HUMAN "Beta-1,4-galactosyltransferase 2, Beta-1,4-GalTase 2, Beta4Gal-T2, b4Gal-T2, EC 2.4.1.- (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase, EC 2.4.1.38) (Lactose synthase A protein, EC 2.4.1.22) (N-acetyllactosamine synthase, EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2)" B4GALT2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cerebellar Purkinje cell layer development [GO:0021680]; glycosylation [GO:0070085]; locomotory behavior [GO:0007626]; memory [GO:0007613]; protein glycosylation [GO:0006486]; visual learning [GO:0008542] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; lactose synthase activity [GO:0004461]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; carbohydrate metabolic process [GO:0005975]; cerebellar Purkinje cell layer development [GO:0021680]; glycosylation [GO:0070085]; locomotory behavior [GO:0007626]; memory [GO:0007613]; protein glycosylation [GO:0006486]; visual learning [GO:0008542]" GO:0000139; GO:0003831; GO:0003945; GO:0004461; GO:0005654; GO:0005794; GO:0005975; GO:0006486; GO:0007613; GO:0007626; GO:0008378; GO:0008542; GO:0016021; GO:0021680; GO:0032580; GO:0043231; GO:0046872; GO:0070085 "beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; lactose synthase activity [GO:0004461]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]" FTKIQNTK 0.99283 -16.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0739 0 0 0 0 0 0 0 0 0 0 0 15.4255 0 13.6965 0 13.488 13.8047 0 0 0 0 0 0 0 16.0631 15.9701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7838 17.5017 16.1288 0 0 14.2256 0 0 0 0 0 0 0 14.4009 0 0 0 0 0 0 0 0 0 O75969 AKAP3_HUMAN "A-kinase anchor protein 3, AKAP-3 (A-kinase anchor protein 110 kDa, AKAP 110) (Cancer/testis antigen 82, CT82) (Fibrous sheath protein of 95 kDa, FSP95) (Fibrousheathin I) (Fibrousheathin-1) (Protein kinase A-anchoring protein 3, PRKA3) (Sperm oocyte-binding protein)" AKAP3 AKAP110 SOB1 Homo sapiens (Human) acrosome reaction [GO:0007340]; blastocyst hatching [GO:0001835]; protein localization [GO:0008104]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; protein kinase A binding [GO:0051018]; acrosome reaction [GO:0007340]; blastocyst hatching [GO:0001835]; protein localization [GO:0008104]; single fertilization [GO:0007338]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178] GO:0001669; GO:0001835; GO:0005634; GO:0005737; GO:0007178; GO:0007338; GO:0007340; GO:0008104; GO:0035686; GO:0051018; GO:0097225; GO:0097228 protein kinase A binding [GO:0051018] APGSGDR 0.99283 -17.419 0 0 10.4676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.512 11.0768 0 0 13.509 0 0 13.3846 13.0611 0 0 0 0 0 0 12.7926 0 13.6677 11.0443 12.5637 0 0 12.8689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7736 0 0 0 0 0 12.3593 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9956 14.3811 13.3534 0 15.6985 0 0 14.1953 0 0 10.6263 0 0 0 14.4254 0 11.7513 0 0 0 0 14.3561 0 0 0 0 0 13.4771 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0556 0 15.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9251 0 0 0 0 0 0 0 0 0 14.2507 0 0 0 0 0 0 13.2561 14.3084 0 0 0 0 O95243 MBD4_HUMAN "Methyl-CpG-binding domain protein 4, EC 3.2.2.- (Methyl-CpG-binding endonuclease 1) (Methyl-CpG-binding protein MBD4) (Mismatch-specific DNA N-glycosylase)" MBD4 MED1 Homo sapiens (Human) depyrimidination [GO:0045008]; DNA repair [GO:0006281] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281] GO:0003677; GO:0003696; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0008263; GO:0016607; GO:0019104; GO:0045008 DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696] DVSELLKPLGLYDLR 0.99283 -6.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8641 0 0 13.4909 0 0 0 13.532 13.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7928 0 0 0 0 0 11.9831 0 14.413 0 0 0 13.3919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6788 0 0 0 0 0 0 12.8673 0 0 0 13.4789 0 0 0 0 0 0 0 0 0 0 0 12.6703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02458 CO2A1_HUMAN Collagen alpha-1(II) chain (Alpha-1 type II collagen) [Cleaved into: Collagen alpha-1(II) chain; Chondrocalcin ] COL2A1 Homo sapiens (Human) anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC class II protein binding [GO:0042289]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394]; anterior head development [GO:0097065]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to BMP stimulus [GO:0071773]; central nervous system development [GO:0007417]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; embryonic skeletal joint morphogenesis [GO:0060272]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; limb bud formation [GO:0060174]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; notochord development [GO:0030903]; otic vesicle development [GO:0071599]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; tissue homeostasis [GO:0001894]; visual perception [GO:0007601] GO:0001501; GO:0001502; GO:0001894; GO:0001958; GO:0002062; GO:0003007; GO:0005201; GO:0005576; GO:0005581; GO:0005585; GO:0005592; GO:0005604; GO:0005615; GO:0005788; GO:0006029; GO:0007417; GO:0007601; GO:0007605; GO:0010468; GO:0030020; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0042289; GO:0042472; GO:0042802; GO:0043394; GO:0046872; GO:0048407; GO:0051216; GO:0060021; GO:0060174; GO:0060272; GO:0060351; GO:0062023; GO:0071599; GO:0071773; GO:0097065; GO:0097192; GO:2001240 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; MHC class II protein binding [GO:0042289]; platelet-derived growth factor binding [GO:0048407]; proteoglycan binding [GO:0043394] CQGQDVQEAGSCVQDGQRYNDKDVWK 0.99283 -16.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0361 14.8262 0 0 0 0 0 0 0 0 0 0 11.4769 0 0 14.1535 11.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0084 0 0 0 0 0 0 0 15.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.554 0 13.1912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08253 MMP2_HUMAN "72 kDa type IV collagenase, EC 3.4.24.24 (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2, MMP-2) (TBE-1) [Cleaved into: PEX ]" MMP2 CLG4A Homo sapiens (Human) aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; aging [GO:0007568]; angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771] GO:0001525; GO:0001541; GO:0001542; GO:0001553; GO:0001666; GO:0001955; GO:0001957; GO:0001968; GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0006508; GO:0007162; GO:0007507; GO:0007566; GO:0007567; GO:0007568; GO:0008237; GO:0008270; GO:0009410; GO:0009612; GO:0014012; GO:0014823; GO:0016477; GO:0022617; GO:0030017; GO:0030163; GO:0030198; GO:0030335; GO:0030574; GO:0032526; GO:0034614; GO:0035094; GO:0035987; GO:0042542; GO:0043065; GO:0043627; GO:0045906; GO:0048013; GO:0048771; GO:0051602; GO:0055093; GO:0060325; GO:0060346; GO:0060740; GO:0062023; GO:0071230; GO:0071347; GO:0071392; GO:0071492; GO:0071498; GO:1904645; GO:1904707 endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] FQGTSYDSCTTEGR 0.99283 -6.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8491 0 15.1221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DKB5 TPBGL_HUMAN Trophoblast glycoprotein-like TPBGL Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090] GO:0005886; GO:0016020; GO:0016021; GO:0090090 CASGAELR 0.99283 -16.918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.62965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1754 0 0 0 0 0 0 P24864 CCNE1_HUMAN G1/S-specific cyclin-E1 CCNE1 CCNE Homo sapiens (Human) cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein localization [GO:0032880]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055] GO:0000079; GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006270; GO:0006468; GO:0007129; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0032880; GO:0044772; GO:0051301; GO:0097134; GO:1902462 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901] ASPLPSGLLTPPQSGKK 0.99283 -6.0775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0947 0 0 12.6856 0 0 0 0 0 0 0 0 13.8459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9324 0 0 0 0 0 0 0 0 0 0 0 0 13.7008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58753 TIRAP_HUMAN "Toll/interleukin-1 receptor domain-containing adapter protein, TIR domain-containing adapter protein (Adaptor protein Wyatt) (MyD88 adapter-like protein, MyD88-2)" TIRAP MAL Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid cell differentiation [GO:0030099]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-15 production [GO:0032738]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of innate immune response [GO:0045088]; regulation of interferon-beta production [GO:0032648]; regulation of stress-activated MAPK cascade [GO:0032872]; response to lipopolysaccharide [GO:0032496]; TIRAP-dependent toll-like receptor 4 signaling pathway [GO:0035665] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; protein-macromolecule adaptor activity [GO:0030674]; Toll-like receptor 2 binding [GO:0035663]; Toll-like receptor 4 binding [GO:0035662]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-positive bacterium [GO:0050830]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid cell differentiation [GO:0030099]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-15 production [GO:0032738]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of innate immune response [GO:0045088]; regulation of interferon-beta production [GO:0032648]; regulation of stress-activated MAPK cascade [GO:0032872]; response to lipopolysaccharide [GO:0032496]; TIRAP-dependent toll-like receptor 4 signaling pathway [GO:0035665]" GO:0002755; GO:0005080; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0007166; GO:0007249; GO:0007250; GO:0030099; GO:0030139; GO:0030674; GO:0030890; GO:0031334; GO:0032496; GO:0032587; GO:0032648; GO:0032735; GO:0032738; GO:0032755; GO:0032757; GO:0032760; GO:0032872; GO:0034137; GO:0034141; GO:0034145; GO:0035662; GO:0035663; GO:0035665; GO:0042802; GO:0043123; GO:0045087; GO:0045088; GO:0045089; GO:0046330; GO:0050830; GO:0051092; GO:0070374; GO:0070935; GO:0071221; GO:0071223; GO:0090023; GO:2000340; GO:2000343 "identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; protein-macromolecule adaptor activity [GO:0030674]; Toll-like receptor 2 binding [GO:0035663]; Toll-like receptor 4 binding [GO:0035662]" AAYPPELR 0.99283 -13.351 0 0 0 0 0 0 0 0 0 0 0 12.3561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6222 13.6281 0 0 0 0 0 0 13.8164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9489 12.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03468 ERCC6_HUMAN "DNA excision repair protein ERCC-6, EC 3.6.4.- (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB)" ERCC6 CSB Homo sapiens (Human) "base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]" B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023] "B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]; base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]" GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006366; GO:0006979; GO:0007254; GO:0008022; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032784; GO:0032786; GO:0034243; GO:0035066; GO:0035264; GO:0042262; GO:0044877; GO:0045494; GO:0045739; GO:0045943; GO:0045944; GO:0045945; GO:0047485; GO:0060261; GO:0070063; GO:0090734; GO:0097680; GO:0110016; GO:0140658; GO:1905168; GO:2001033 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; RNA polymerase binding [GO:0070063]" CACVLRDTINPYLLR 0.99283 -24.238 11.9979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.549 0 12.883 9.53093 0 0 0 10.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3862 0 0 12.6056 15.5452 12.4682 10.2118 0 0 13.8569 18.6416 16.577 14.0282 13.8018 11.0759 13.8431 0 18.3109 14.3097 0 17.596 15.6361 13.5011 0 10.5957 13.3167 12.001 0 12.5764 0 0 12.9531 0 0 0 12.4618 15.1484 17.0365 13.7644 15.0238 13.8845 16.3182 0 12.1224 16.2836 15.0962 15.4162 0 18.5407 0 0 13.3999 0 0 0 15.4621 13.2627 0 15.9019 0 0 0 0 13.1043 0 16.0754 18.4355 0 0 0 0 14.3093 0 0 12.5316 13.7065 12.4275 13.4629 10.4587 0 0 0 0 0 12.219 13.6141 0 15.7851 16.882 0 0 13.2628 18.8709 0 0 13.7834 0 18.5609 0 0 0 15.0833 0 0 0 0 0 0 13.9507 11.9889 15.0819 0 12.7308 0 18.9659 0 0 Q13136 LIPA1_HUMAN "Liprin-alpha-1 (LAR-interacting protein 1, LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1, PTPRF-interacting protein alpha-1)" PPFIA1 LIP1 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165]; synapse organization [GO:0050808] GO:0005737; GO:0005829; GO:0005925; GO:0007160; GO:0007165; GO:0030424; GO:0030425; GO:0032991; GO:0048786; GO:0050808; GO:0051497; GO:1903077 ALKSLFEHHK 0.99283 -16.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3029 12.521 12.9812 0 0 0 12.6328 12.4958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4162 0 10.1675 12.4844 13.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13243 SRSF5_HUMAN "Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)" SRSF5 HRS SFRS5 SRP40 Homo sapiens (Human) "cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of cell cycle [GO:0051726]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723]; cellular response to insulin stimulus [GO:0032869]; liver regeneration [GO:0097421]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of cell cycle [GO:0051726]" GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0005730; GO:0005829; GO:0006376; GO:0006397; GO:0016607; GO:0032869; GO:0033120; GO:0043422; GO:0051726; GO:0097421 mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723] KIKLIEGSK 0.99283 -6.2613 0 0 0 0 0 0 0 0 0 11.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.807 0 0 0 0 0 0 0 0 0 0 11.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14353 GAMT_HUMAN "Guanidinoacetate N-methyltransferase, EC 2.1.1.2" GAMT Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; creatine biosynthetic process [GO:0006601]; creatine metabolic process [GO:0006600]; methylation [GO:0032259]; muscle contraction [GO:0006936]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; guanidinoacetate N-methyltransferase activity [GO:0030731]; methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; animal organ morphogenesis [GO:0009887]; creatine biosynthetic process [GO:0006601]; creatine metabolic process [GO:0006600]; methylation [GO:0032259]; muscle contraction [GO:0006936]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0005829; GO:0006600; GO:0006601; GO:0006936; GO:0007283; GO:0008168; GO:0008757; GO:0009887; GO:0030731; GO:0032259; GO:0040014 guanidinoacetate N-methyltransferase activity [GO:0030731]; methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] QTHKVIPLK 0.99283 -6.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6343 0 0 0 0 0 0 0 0 14.7356 0 0 0 0 0 13.9878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15018 ABRX2_HUMAN BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (Protein FAM175B) ABRAXAS2 ABRO1 FAM175B KIAA0157 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931] GO:0000278; GO:0000922; GO:0002931; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0007059; GO:0008017; GO:0008608; GO:0031593; GO:0051301; GO:0070536; GO:0070552; GO:0090307 microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593] AAGDSGEDSDDSDYENLIDPTEPSNSEYSHSK 0.99283 -17.429 0 0 0 0 0 0 0 0 0 0 0 12.2597 12.1704 0 0 11.7616 0 0 0 0 0 0 0 0 0 0 11.082 0 0 0 11.4254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2329 0 0 0 0 0 12.3785 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7654 0 0 0 0 0 0 0 0 0 0 11.1301 0 11.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4827 0 0 0 0 0 0 11.8855 0 13.0116 0 0 0 0 0 0 0 11.6663 0 0 0 0 0 14.9145 0 0 0 0 14.6043 0 13.4049 13.2564 0 0 13.1145 11.6485 0 0 0 0 13.6451 0 Q15063 POSTN_HUMAN "Periostin, PN (Osteoblast-specific factor 2, OSF-2)" POSTN OSF2 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; regulation of Notch signaling pathway [GO:0008593]; tissue development [GO:0009888] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; regulation of Notch signaling pathway [GO:0008593]; tissue development [GO:0009888] GO:0005615; GO:0005802; GO:0007155; GO:0008201; GO:0008593; GO:0009888; GO:0030198; GO:0031012; GO:0046872; GO:0050839; GO:0062023; GO:0071307 cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872] EIPVTVYTTKIITK 0.99283 -7.3326 0 0 0 0 0 0 0 0 0 0 0 0 13.1475 0 0 0 17.6969 17.3926 16.9607 16.9476 16.8422 15.8761 16.0498 15.7128 0 0 10.6495 0 0 0 0 0 0 0 0 0 10.3812 0 0 0 14.2046 0 16.5601 16.6889 0 0 17.1953 17.2242 0 0 0 17.1976 18.7757 18.6644 17.4414 17.0199 17.2919 0 0 0 0 18.1581 0 10.1403 14.4352 0 0 13.3292 0 12.5748 0 0 11.7221 0 11.0881 13.0531 0 11.414 0 12.8371 0 0 15.0566 13.3333 13.1756 0 0 19.8607 13.3744 19.7737 19.6366 12.3297 19.8355 19.7856 0 0 0 22.1799 20.2763 0 0 12.7869 0 0 0 0 18.795 11.4415 0 12.5736 0 19.6634 19.5854 19.5728 11.4316 19.018 0 12.2746 0 13.6812 0 0 0 19.5735 11.9997 17.8615 20.826 0 20.2474 12.947 0 13.3644 0 14.7298 0 11.9148 0 0 0 12.1287 0 0 13.9206 19.1149 19.4466 18.8811 18.5628 0 18.4113 18.3347 14.1266 13.6656 0 0 11.5832 0 19.6865 0 0 0 13.6672 12.0946 0 0 11.8518 11.9078 13.0775 0 17.9448 17.7435 0 14.644 20.496 20.5686 0 0 0 0 13.4107 0 Q49AR2 CE022_HUMAN UPF0489 protein C5orf22 C5orf22 Homo sapiens (Human) AGLRRYPK 0.99283 -13.352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4333 0 0 0 0 0 12.9527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7961 0 0 0 0 0 0 0 0 Q562F6 SGO2_HUMAN Shugoshin 2 (Shugoshin-2) (Shugoshin-like 2) (Tripin) SGO2 SGOL2 Homo sapiens (Human) "cell division [GO:0051301]; homologous chromosome segregation [GO:0045143]; meiotic sister chromatid cohesion [GO:0051177]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic sister chromatid segregation [GO:0000070]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; homologous chromosome segregation [GO:0045143]; meiotic sister chromatid cohesion [GO:0051177]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic sister chromatid segregation [GO:0000070]" GO:0000070; GO:0000775; GO:0000776; GO:0005654; GO:0005829; GO:0016604; GO:0030892; GO:0045143; GO:0051177; GO:0051301; GO:0051754 DNLLPNQKDK 0.99283 -62.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9848 0 0 0 0 0 11.6808 0 0 14.6227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5207 14.1632 0 0 0 0 12.5506 0 0 0 0 0 0 0 0 0 17.0071 15.1166 12.4469 0 0 13.9328 14.274 12.8131 0 13.8183 12.446 0 0 13.7503 0 0 0 0 11.4023 0 0 0 0 0 0 0 11.6249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8362 0 0 0 0 0 0 0 0 15.1003 0 14.5131 13.8082 12.1831 0 0 0 0 11.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZP68 ATPUN_HUMAN Putative protein ATP11AUN (Putative ATP11A upstream neighbor protein) ATP11AUN C13orf35 Homo sapiens (Human) GAIMVYIK 0.99283 -13.344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8866 0 0 15.208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.27503 0 0 0 0 0 0 11.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8024 0 11.6077 0 0 0 0 0 0 0 Q86TI0 TBCD1_HUMAN TBC1 domain family member 1 TBC1D1 KIAA1108 Homo sapiens (Human) activation of GTPase activity [GO:0090630] nucleus [GO:0005634] nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0005634; GO:0090630 GTPase activator activity [GO:0005096] AILQQILLLR 0.99283 -26.064 12.7378 0 0 0 0 0 0 0 12.0964 0 11.9303 0 0 12.1997 0 0 0 12.4372 0 0 0 0 0 0 13.0771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9844 0 14.5922 0 12.6962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1384 12.7532 0 0 0 0 13.0843 14.0654 0 0 0 0 0 0 0 0 0 0 0 14.1331 16.6447 14.0732 0 14.0563 0 0 0 0 12.6682 0 13.4524 0 11.9102 0 11.0128 0 13.2024 0 0 0 0 0 0 0 12.3659 13.3379 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0446 11.8464 14.3953 12.9437 0 0 0 0 12.801 0 13.0704 0 0 0 0 0 0 0 0 0 0 0 0 15.3648 0 0 0 0 0 0 11.0055 14.5533 13.8646 0 0 0 0 17.4271 0 0 0 0 0 0 0 0 Q8IW52 SLIK4_HUMAN SLIT and NTRK-like protein 4 SLITRK4 Homo sapiens (Human) axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807] GO:0005886; GO:0007409; GO:0016021; GO:0050807; GO:0051965; GO:0098978; GO:1905606 AWLENMPYNIYIGEAICETPSDLYGR 0.99283 -16.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4467 0 14.0493 0 0 0 0 0 0 0 13.344 0 14.2904 0 11.4273 0 14.3831 0 0 0 0 0 0 0 0 0 13.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3854 0 0 0 0 0 0 0 0 0 14.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7529 0 0 Q8N126 CADM3_HUMAN "Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B, IgSF4B) (Nectin-like protein 1, NECL-1) (Synaptic cell adhesion molecule 3, SynCAM3) (TSLC1-like protein 1, TSLL1)" CADM3 IGSF4B NECL1 SYNCAM3 TSLL1 UNQ225/PRO258 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell junction [GO:0005911]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005886; GO:0005911; GO:0007156; GO:0007157; GO:0042803; GO:0099056 protein homodimerization activity [GO:0042803] LLLHCEGR 0.99283 -17.41 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2987 0 13.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4554 0 0 0 12.7631 12.4725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6895 0 0 0 0 13.607 0 0 0 0 0 0 0 0 0 0 12.2547 0 0 12.527 0 11.9896 0 0 12.8851 0 0 11.84 0 0 0 0 0 0 Q8N1I0 DOCK4_HUMAN Dedicator of cytokinesis protein 4 DOCK4 KIAA0716 Homo sapiens (Human) cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; cell chemotaxis [GO:0060326]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005096; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007264; GO:0016020; GO:0017124; GO:0030165; GO:0030971; GO:0031267; GO:0032420; GO:0032421; GO:0060326; GO:1904694; GO:1904754 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] CWENGIILCRKIAEQYESYYDYR 0.99283 -24.218 0 0 0 0 0 0 0 0 0 15.879 0 0 0 0 0 0 13.1616 0 11.1396 12.2457 0 0 0 0 0 0 0 0 0 0 11.4806 14.1213 14.9483 0 0 10.5875 0 0 0 0 14.2587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7937 11.6342 11.9691 0 12.4056 0 0 0 0 0 0 10.0745 0 0 0 0 0 0 0 12.1943 12.5049 14.5159 13.0198 14.3878 13.2529 0 13.1898 0 0 17.1934 0 16.1588 0 0 0 11.8786 11.7996 0 0 13.6546 16.4669 0 14.3005 16.1642 14.3942 0 15.7141 0 0 0 11.6204 13.4163 0 13.7779 0 0 0 0 12.5666 0 0 0 0 0 0 0 0 0 0 14.786 0 0 0 0 13.9662 0 0 0 12.7761 0 0 11.961 0 0 0 0 12.8541 0 0 0 0 12.7542 15.9048 0 12.5852 0 0 12.2101 0 0 11.7393 15.2174 16.1032 0 0 0 0 0 15.7294 0 12.6388 11.9438 14.8229 0 0 0 0 0 0 0 0 12.0466 15.9649 Q8N6Y0 USBP1_HUMAN "Harmonin-binding protein USHBP1 (AIE-75-binding protein) (Mutated in colon cancer protein 2, MCC-2) (Usher syndrome type-1C protein-binding protein 1, USH1C-binding protein 1)" USHBP1 AIEBP MCC2 Homo sapiens (Human) PDZ domain binding [GO:0030165] GO:0030165 PDZ domain binding [GO:0030165] ALGPAHVLLLEQLR 0.99283 -14.705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.05425 0 0 0 0 0 0 10.9997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.73605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2789 0 13.1693 0 0 0 0 0 0 0 12.9212 0 0 17.6639 0 0 11.087 0 11.4875 0 0 11.2739 0 0 0 0 0 0 11.4158 0 12.4411 0 0 0 0 0 0 0 0 0 0 0 0 12.4677 0 0 12.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9426 0 10.4583 0 0 0 0 0 11.4693 0 0 0 0 11.31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8436 0 0 0 0 0 0 Q8NFT8 DNER_HUMAN Delta and Notch-like epidermal growth factor-related receptor DNER BET UNQ262/PRO299 Homo sapiens (Human) central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416] dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416] GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741 calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888] AQAPGAQLLPALALLLLLLGAGPR 0.99283 -14.701 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0335 0 0 0 0 0 12.8986 12.4743 12.0956 0 0 0 0 0 0 12.6889 0 0 0 0 0 12.8213 0 0 14.2992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1097 0 0 0 0 0 0 0 0 0 0 11.9581 0 0 0 0 0 0 11.1732 0 0 15.1772 0 0 0 0 0 0 0 13.8071 0 0 0 0 0 0 0 0 12.8443 0 0 0 12.1932 0 0 0 0 0 13.4143 11.8863 0 0 0 0 0 0 0 0 13.0469 13.111 0 12.7282 0 0 14.3167 14.3052 0 0 14.2158 0 0 14.9631 0 0 13.6151 0 0 14.1339 13.5582 0 0 0 0 13.6267 0 0 0 13.5228 0 0 0 0 0 0 13.7187 12.8519 0 0 13.3597 0 0 0 0 0 0 0 0 0 0 0 0 14.1592 0 0 0 0 0 13.2782 13.2754 0 0 0 0 0 Q8NFU7 TET1_HUMAN "Methylcytosine dioxygenase TET1, EC 1.14.11.n2 (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein)" TET1 CXXC6 KIAA1676 LCX Homo sapiens (Human) 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oxidative demethylation [GO:0070989]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; stem cell population maintenance [GO:0019827] nucleus [GO:0005634]; Sin3 complex [GO:0016580] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; oxidative demethylation [GO:0070989]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; stem cell population maintenance [GO:0019827] GO:0000122; GO:0001826; GO:0003677; GO:0005506; GO:0005634; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008284; GO:0008327; GO:0016580; GO:0019827; GO:0030336; GO:0030512; GO:0031062; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0090310; GO:1902455; GO:1902459 DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270] CGHGEEQK 0.99283 -43.246 0 0 0 0 0 0 0 0 0 0 10.7919 0 0 12.192 0 0 9.95443 0 0 0 0 12.8319 9.91782 12.7364 0 0 0 0 0 0 11.4011 0 0 0 0 12.1336 0 0 9.63813 9.81035 0 11.3057 0 0 0 12.028 0 0 0 0 0 0 0 14.299 12.3196 0 0 0 0 0 0 12.1658 0 0 0 0 0 12.0333 0 10.3801 0 0 0 12.1768 12.664 14.17 0 11.6259 0 12.7732 14.2877 12.5565 14.5379 0 17.4575 14.3094 14.5717 13.7995 0 13.8234 13.1107 13.8744 12.6429 0 12.7038 13.6583 14.0648 0 13.646 13.3259 14.2232 0 13.448 0 11.1401 12.5681 10.8123 13.8385 0 0 0 0 0 0 0 12.5695 0 0 13.3596 0 12.9448 12.4763 0 15.1376 0 0 0 16.7577 0 14.3777 12.8755 13.1368 13.859 13.9074 13.2669 0 0 13.8525 0 0 14.1097 0 0 0 11.437 0 0 0 0 0 0 14.3239 0 13.5104 0 0 13.4757 0 0 0 0 12.1027 12.401 11.2678 14.4837 11.7902 0 0 0 0 13.9271 0 13.2061 0 0 11.5059 0 10.9146 12.9696 0 Q96C55 ZN524_HUMAN Zinc finger protein 524 ZNF524 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] APHFCPVCLRAFPYLSDLER 0.99283 -6.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9364 0 0 0 11.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9883 14.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MF7 NSE2_HUMAN "E3 SUMO-protein ligase NSE2, EC 2.3.2.- (E3 SUMO-protein transferase NSE2) (MMS21 homolog, hMMS21) (Non-structural maintenance of chromosomes element 2 homolog, Non-SMC element 2 homolog)" NSMCE2 C8orf36 MMS21 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722] "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722]" GO:0000722; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0007049; GO:0008270; GO:0016604; GO:0016605; GO:0016925; GO:0019789; GO:0030915; GO:0032204; GO:0034184; GO:0045842; GO:0051301; GO:0061665; GO:0090398 SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] IPDLKLLVEKK 0.99283 -7.3412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BT23 LIMD2_HUMAN LIM domain-containing protein 2 LIMD2 SB143 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872] GO:0005654; GO:0005829; GO:0046872 metal ion binding [GO:0046872] KQHKELWAHK 0.99283 -7.3392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.23211 0 0 0 0 12.4138 0 0 0 0 0 0 0 0 0 12.7072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6561 0 0 0 0 0 0 0 0 0 13.7841 0 0 13.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3796 0 0 0 0 0 0 0 11.9868 13.4798 0 0 0 0 0 12.3248 0 13.4757 0 0 0 0 0 0 0 0 12.6905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0114 0 0 0 0 0 0 0 0 12.411 0 0 0 0 0 12.7402 0 0 0 0 12.4046 0 0 13.3044 0 12.3128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NU19 TB22B_HUMAN TBC1 domain family member 22B TBC1D22B C6orf197 Homo sapiens (Human) activation of GTPase activity [GO:0090630] 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0071889; GO:0090630 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096] AAENSKQFWK 0.99283 -16.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5442 0 0 0 0 14.2804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6948 0 0 0 0 0 0 0 0 0 12.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3147 0 0 0 0 0 0 14.197 13.6428 0 0 0 14.4895 0 0 11.8983 0 14.2511 0 0 0 0 0 0 0 0 0 12.4152 15.3635 0 0 12.9775 10.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5S2 MRCKB_HUMAN "Serine/threonine-protein kinase MRCK beta, EC 2.7.11.1 (CDC42-binding protein kinase beta, CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta, MRCK beta, Myotonic dystrophy protein kinase-like beta)" CDC42BPB KIAA1124 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0000287; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0006468; GO:0007010; GO:0007163; GO:0007165; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031267; GO:0031532; GO:0042641; GO:0044877; GO:0070062; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] ALSNSNR 0.99284 -70.776 0 13.2808 0 0 0 14.2027 0 0 9.49937 0 13.9044 0 0 0 0 0 0 0 0 13.3772 13.528 0 0 11.5441 0 12.9567 13.7211 0 0 13.453 0 0 0 13.252 0 0 0 0 13.5463 0 0 0 13.6534 10.5135 0 13.0917 0 0 13.3468 0 12.4782 0 9.85017 0 11.7662 0 0 0 11.2663 0 0 0 0 0 0 0 0 0 0 0 0 10.2037 0 0 0 14.2487 13.3123 0 15.3826 12.4324 0 13.6601 15.4951 14.476 16.0528 0 17.0366 16.8968 15.7358 0 14.3326 14.4925 0 0 0 0 0 11.6474 0 0 0 0 14.957 0 0 0 0 0 14.428 0 0 0 0 15.2103 12.0248 12.7048 14.9642 0 0 14.0731 0 0 14.1336 16.2335 14.7093 14.8216 0 15.1302 0 16.2228 15.1051 13.4025 14.8791 15.3034 13.8318 14.3853 0 14.6854 0 13.6877 12.9257 14.284 14.0892 12.955 0 13.9891 14.5326 13.3782 0 0 13.3449 14.244 0 14.5012 11.8833 0 0 0 0 0 0 0 14.8341 11.7279 10.3775 14.6134 0 15.3835 0 0 0 13.5492 15.6198 14.4661 0 13.1515 0 13.5162 14.5521 10.7874 O15305 PMM2_HUMAN "Phosphomannomutase 2, PMM 2, EC 5.4.2.8" PMM2 Homo sapiens (Human) GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487] cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487] GO:0004615; GO:0005654; GO:0005829; GO:0006013; GO:0006486; GO:0006487; GO:0009298; GO:0043025; GO:0046872 metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615] HVENDGYK 0.99284 -24.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2622 0 0 0 0 0 0 11.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3147 0 0 0 0 0 11.2662 0 0 0 0 0 0 0 13.1453 0 0 0 0 0 13.4388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7813 0 9.54185 0 0 0 11.5804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0577 0 0 0 0 11.8255 0 0 0 0 0 0 0 O60437 PEPL_HUMAN Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein) PPL KIAA0568 Homo sapiens (Human) intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; intermediate filament cytoskeleton organization [GO:0045104]; keratinization [GO:0031424]; response to mechanical stimulus [GO:0009612]; wound healing [GO:0042060] GO:0001533; GO:0005198; GO:0005200; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0009612; GO:0016020; GO:0030057; GO:0031424; GO:0042060; GO:0045104; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] DYELEAEKLR 0.99284 -16.981 0 0 13.565 10.0239 0 0 0 10.2103 0 0 0 0 0 0 0 0 0 0 0 0 13.0202 13.945 13.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9079 0 0 0 0 0 0 0 0 0 12.6497 12.7678 0 0 0 0 0 0 11.4791 0 0 0 0 12.8299 0 14.3154 0 0 14.543 17.4659 14.554 10.5844 0 0 10.9562 13.4025 0 0 0 13.0989 0 14.1519 0 0 0 0 0 0 17.4904 0 0 0 0 0 0 0 11.6848 14.1089 0 0 0 0 11.1162 0 0 0 0 0 0 0 0 0 0 10.4961 0 0 0 0 0 14.2711 0 0 0 11.2013 12.8677 0 11.8628 0 0 0 0 0 0 0 0 0 0 0 11.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6337 0 0 13.2186 0 0 0 O94979 SC31A_HUMAN Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein) SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; response to calcium ion [GO:0051592] COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; vesicle coat [GO:0030120] COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; vesicle coat [GO:0030120]; calcium-dependent protein binding [GO:0048306]; structural molecule activity [GO:0005198]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; response to calcium ion [GO:0051592] GO:0005198; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0007029; GO:0012507; GO:0030120; GO:0030127; GO:0030134; GO:0043231; GO:0048306; GO:0048471; GO:0051592; GO:0070971; GO:0090110 calcium-dependent protein binding [GO:0048306]; structural molecule activity [GO:0005198] KIALALNKVDGANVALK 0.99284 -6.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3369 0 0 0 0 0 0 0 0 0 0 0 12.7642 0 0 0 0 0 0 0 0 0 0 15.6537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0513 P04085 PDGFA_HUMAN "Platelet-derived growth factor subunit A, PDGF subunit A (PDGF-1) (Platelet-derived growth factor A chain) (Platelet-derived growth factor alpha polypeptide)" PDGFA PDGF1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell activation [GO:0001775]; cell projection assembly [GO:0030031]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic lung development [GO:1990401]; hair follicle development [GO:0001942]; inner ear development [GO:0048839]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; negative chemotaxis [GO:0050919]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [GO:0060683]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of smooth muscle cell migration [GO:0014910]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to retinoic acid [GO:0032526]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; wound healing [GO:0042060] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; microvillus [GO:0005902]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; microvillus [GO:0005902]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell activation [GO:0001775]; cell projection assembly [GO:0030031]; cell-cell signaling [GO:0007267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic lung development [GO:1990401]; hair follicle development [GO:0001942]; inner ear development [GO:0048839]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; negative chemotaxis [GO:0050919]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; platelet-derived growth factor receptor-alpha signaling pathway [GO:0035790]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [GO:0060683]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of smooth muscle cell migration [GO:0014910]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to retinoic acid [GO:0032526]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; wound healing [GO:0042060] GO:0000139; GO:0001525; GO:0001666; GO:0001775; GO:0001942; GO:0002053; GO:0005161; GO:0005518; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005902; GO:0007267; GO:0008083; GO:0008284; GO:0008584; GO:0009410; GO:0009611; GO:0009887; GO:0009986; GO:0010035; GO:0010512; GO:0010544; GO:0014068; GO:0014910; GO:0030031; GO:0030036; GO:0030335; GO:0031093; GO:0031954; GO:0032355; GO:0032526; GO:0032956; GO:0035790; GO:0035793; GO:0042060; GO:0042802; GO:0042803; GO:0043406; GO:0043410; GO:0043588; GO:0046982; GO:0048008; GO:0048146; GO:0048286; GO:0048407; GO:0048839; GO:0050730; GO:0050919; GO:0051781; GO:0051897; GO:0060683; GO:0070374; GO:0070851; GO:0071560; GO:1990265; GO:1990401 collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CTGCCNTSSVK 0.99284 -4.4112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08922 ROS1_HUMAN "Proto-oncogene tyrosine-protein kinase ROS, EC 2.7.10.1 (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase)" ROS1 MCF3 ROS Homo sapiens (Human) cell differentiation [GO:0030154]; columnar/cuboidal epithelial cell development [GO:0002066]; positive regulation of kinase activity [GO:0033674]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of TOR signaling [GO:0032006]; spermatogenesis [GO:0007283]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; columnar/cuboidal epithelial cell development [GO:0002066]; positive regulation of kinase activity [GO:0033674]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of TOR signaling [GO:0032006]; spermatogenesis [GO:0007283]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001558; GO:0002066; GO:0004713; GO:0004714; GO:0005524; GO:0005887; GO:0006468; GO:0007169; GO:0007283; GO:0016020; GO:0019903; GO:0030154; GO:0032006; GO:0033674; GO:0043235; GO:0070372 ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] AEDNGCR 0.99284 -44.386 10.4482 0 0 0 0 10.4342 0 0 0 0 0 0 0 11.6664 0 0 0 0 0 11.5343 13.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1655 0 0 0 0 10.8786 0 0 0 0 0 13.8277 0 0 0 0 0 12.6085 0 0 0 0 0 14.4136 0 0 0 15.8964 0 0 13.9725 0 0 0 0 17.6514 0 17.3602 17.7756 18.0889 0 0 14.2037 15.0397 16.1947 0 0 14.9547 14.1822 0 16.6364 15.0913 15.132 14.8601 14.8589 14.2381 16.3978 0 17.5017 16.1035 0 0 0 12.5259 12.8884 0 0 16.5067 0 0 16.0697 14.6718 14.7539 14.3822 15.1611 15.1241 0 0 13.6146 13.952 0 14.3297 14.7709 0 0 0 0 0 13.9425 16.312 0 12.7763 0 0 12.693 13.4715 12.3569 0 12.3642 0 13.8829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2924 14.3525 0 0 0 0 0 0 0 P0C7V6 SP202_HUMAN Putative transcription factor SPT20 homolog-like 2 SUPT20HL2 FAM48B2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] extracellular space [GO:0005615]; SAGA complex [GO:0000124] extracellular space [GO:0005615]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000124; GO:0003712; GO:0005615; GO:0006357 transcription coregulator activity [GO:0003712] HAWEAGCQAWDTK 0.99284 -16.983 0 0 0 0 0 0 0 0 0 12.0112 11.5705 0 0 0 0 0 0 0 0 0 11.1146 0 0 0 0 0 0 0 10.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7998 0 0 0 0 0 0 0 0 0 0 0 0 12.5345 13.0054 0 13.0216 0 0 0 0 0 0 13.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2495 0 0 0 0 0 0 0 0 0 12.6978 0 0 0 0 0 0 0 0 13.2403 0 0 0 0 0 0 0 0 0 0 0 0 12.8568 0 0 12.8136 13.3551 12.6489 0 0 0 12.9342 0 12.5933 13.8968 12.8772 0 0 0 0 0 13.3749 0 0 0 0 0 0 12.9236 0 12.5183 13.694 0 0 12.9634 0 12.7378 0 0 13.072 0 0 0 0 0 12.3364 0 0 0 0 P0DOX6 IGM_HUMAN Immunoglobulin mu heavy chain (Immunoglobulin mu heavy chain OU) Homo sapiens (Human) adaptive immune response [GO:0002250] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250] GO:0002250; GO:0005576; GO:0005886; GO:0019814 FYWSTSLRTRLSISK 0.99284 -15.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5415 13.7069 0 0 16.375 13.5037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5739 0 0 0 0 0 14.1461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1449 0 0 0 0 0 0 0 0 0 0 13.8241 0 0 0 12.2391 0 0 0 0 0 0 P14868 SYDC_HUMAN "Aspartate--tRNA ligase, cytoplasmic, EC 6.1.1.12 (Aspartyl-tRNA synthetase, AspRS) (Cell proliferation-inducing gene 40 protein)" DARS1 DARS PIG40 Homo sapiens (Human) aspartyl-tRNA aminoacylation [GO:0006422]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; synapse [GO:0045202] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; synapse [GO:0045202]; aminoacylase activity [GO:0004046]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412] GO:0003723; GO:0004046; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006422; GO:0016020; GO:0017101; GO:0045202; GO:0065003; GO:0070062 aminoacylase activity [GO:0004046]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723] AEDSNTHR 0.99284 -17.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9397 0 0 0 0 0 0 11.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9174 0 0 0 0 12.2445 0 0 0 0 16.7964 0 0 17.9213 0 0 0 0 16.9644 0 0 0 0 16.9909 0 0 0 14.2887 14.4635 0 15.9798 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0018 13.9283 0 0 0 0 13.4584 14.2786 13.9041 0 0 0 0 0 0 0 0 13.8 0 13.2452 0 0 0 0 0 0 0 0 0 0 0 11.4662 0 13.8321 0 0 12.4493 0 14.9346 0 12.3388 10.8556 0 12.6749 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0508 0 0 0 0 0 P41226 UBA7_HUMAN "Ubiquitin-like modifier-activating enzyme 7, Ubiquitin-activating enzyme 7 (D8) (Ubiquitin-activating enzyme E1 homolog)" UBA7 UBE1L UBE2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein modification by small protein conjugation [GO:0032446]; protein modification process [GO:0036211] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; ISG15-protein conjugation [GO:0032020]; modification-dependent protein catabolic process [GO:0019941]; protein modification by small protein conjugation [GO:0032446]; protein modification process [GO:0036211] GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0019782; GO:0019941; GO:0032020; GO:0032446; GO:0036211 ATP binding [GO:0005524]; ISG15 activating enzyme activity [GO:0019782]; ubiquitin-protein transferase activity [GO:0004842] DLEPLKRTEEEPLEEPLDEALVR 0.99284 -14.741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2388 0 13.2508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1862 13.1405 0 0 12.708 0 0 0 0 0 0 0 0 11.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0179 0 0 0 0 0 0 0 0 12.5149 0 13.9628 13.7917 13.7778 0 13.4346 13.3178 0 0 0 0 0 0 10.9072 0 0 0 0 0 12.3869 0 0 13.5434 0 0 13.702 0 13.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0703 0 0 0 0 0 Q5JV73 FRPD3_HUMAN FERM and PDZ domain-containing protein 3 FRMPD3 KIAA1817 Homo sapiens (Human) cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] GO:0005856; GO:0005886; GO:0030667; GO:0070821 CDMADDASDGK 0.99284 -26.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2357 0 0 0 0 0 0 0 0 0 0 10.993 0 0 0 12.9101 0 0 0 0 0 0 0 0 0 10.3512 12.6879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86115 0 0 0 0 0 0 0 0 10.5592 0 0 0 10.6811 0 0 0 0 0 10.086 0 0 0 0 0 15.1296 0 13.5209 17.2735 13.9809 13.2188 0 15.7291 0 0 0 0 0 14.174 0 0 14.1482 0 0 0 0 0 13.4747 0 0 0 13.7297 0 11.4471 0 14.1404 0 0 0 13.5189 0 0 10.2433 0 13.8095 0 0 12.0679 12.4834 0 0 10.8205 0 0 11.4451 11.5289 0 0 0 0 0 0 0 0 11.8711 0 0 0 0 0 0 12.7955 0 0 0 0 0 0 0 0 0 0 13.3209 0 0 14.6357 0 0 0 0 0 0 0 0 0 10.8944 0 0 0 0 0 0 12.7159 Q70EL1 UBP54_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54) USP54 C10orf29 Homo sapiens (Human) protein deubiquitination [GO:0016579] cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579] GO:0004843; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843] AQEQELR 0.99284 -39.908 0 0 9.31125 0 0 0 0 0 0 0 0 0 0 11.7796 0 0 11.8122 0 0 0 0 0 11.8623 0 11.8676 11.4937 0 0 12.7653 0 12.2462 0 0 0 0 0 0 0 0 11.7202 0 0 0 12.4065 12.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2229 0 0 0 0 0 0 0 0 0 0 0 0 17.0718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1452 0 13.412 0 16.7737 0 0 0 0 0 0 11.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4354 13.248 0 0 0 15.7166 0 12.4591 12.495 14.6491 15.2462 0 0 13.6246 0 0 16.855 0 0 0 0 14.3622 0 0 13.6069 13.6257 14.7333 14.4179 14.1459 13.6565 13.9715 13.9754 0 0 14.8808 13.7399 0 13.7272 0 13.6699 Q86Z14 KLOTB_HUMAN "Beta-klotho, BKL, BetaKlotho (Klotho beta-like protein)" KLB Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]" GO:0004553; GO:0005104; GO:0005886; GO:0005975; GO:0008284; GO:0008543; GO:0016021; GO:0017134; GO:0090080 "fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" AKNLQHIPLK 0.99284 -6.2787 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4359 13.8223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2248 0 0 0 0 0 0 0 0 0 13.9753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9749 0 0 0 0 11.6901 0 0 0 0 11.9148 0 14.3209 0 0 0 12.4227 0 0 0 0 0 0 11.4085 0 12.6856 12.8829 0 0 0 0 0 0 12.1185 0 0 0 14.2442 14.7349 0 0 9.38625 0 0 0 12.6334 0 13.1781 0 0 0 0 0 11.8338 0 0 0 0 13.9737 0 0 0 0 0 0 13.2688 0 0 12.485 0 0 14.1665 0 0 0 0 0 0 0 0 0 12.3853 0 0 0 0 0 0 0 0 0 0 12.2069 9.81109 0 12.4159 10.9267 Q8N3P4 VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog VPS8 KIAA0804 Homo sapiens (Human) endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]; regulation of SNARE complex assembly [GO:0035542] CORVET complex [GO:0033263]; early endosome [GO:0005769] CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058]; protein transport [GO:0015031]; regulation of SNARE complex assembly [GO:0035542] GO:0005769; GO:0015031; GO:0033263; GO:0034058; GO:0035542; GO:0046872 metal ion binding [GO:0046872] AYPLGDIPEDLVPLVKNQVFEFLIR 0.99284 -26.34 0 11.1253 0 0 11.6319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.321 13.0798 0 0 9.39036 0 0 0 0 12.3801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3075 0 13.4385 13.1022 14.3282 0 14.7373 11.5626 15.9897 0 0 0 13.0048 12.5804 14.2211 0 13.5579 0 14.2714 13.5316 13.8343 12.4902 0 0 0 13.3819 0 0 12.1761 13.9264 10.4932 12.909 0 0 13.1822 14.8978 0 0 0 13.2164 0 0 12.4519 13.5383 14.6632 12.7515 0 0 0 12.8506 0 0 14.0212 12.6879 0 0 13.3537 0 0 12.9627 0 0 15.5801 0 0 0 15.4091 0 0 11.0556 0 0 0 0 0 0 0 0 0 0 12.3336 12.0531 0 0 0 0 0 0 0 0 0 13.2827 14.2781 0 0 11.4266 0 0 10.4013 12.644 0 11.4247 0 0 13.6542 0 0 0 0 0 Q9NNW5 WDR6_HUMAN WD repeat-containing protein 6 WDR6 Homo sapiens (Human) G1 to G0 transition [GO:0070314]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; G1 to G0 transition [GO:0070314]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488] GO:0003723; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0010507; GO:0030488; GO:0070314 RNA binding [GO:0003723] DPGVGGK 0.99284 -6.278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4976 9.79071 0 0 11.6215 0 0 11.1346 0 0 0 0 0 0 0 0 10.0674 0 0 0 0 0 0 0 12.1735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1265 11.7662 0 0 0 0 0 0 0 0 0 0 0 11.1228 11.6405 0 0 0 0 0 0 0 12.4975 0 0 0 0 0 0 0 11.2766 12.8147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65827 10.4881 0 0 0 0 0 0 0 0 0 10.9538 0 0 0 0 0 0 0 0 0 0 0 11.972 0 11.2379 0 0 0 0 0 14.121 0 0 0 0 0 0 0 0 12.5778 0 0 0 0 11.6612 12.7555 0 0 0 0 0 0 0 0 0 0 10.2184 0 0 12.7747 12.9099 0 Q9NT22 EMIL3_HUMAN "EMILIN-3 (EMILIN-5) (Elastin microfibril interface-located protein 3, Elastin microfibril interfacer 3) (Elastin microfibril interface-located protein 5, Elastin microfibril interfacer 5)" EMILIN3 C20orf130 EMILIN5 Homo sapiens (Human) collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802] GO:0005576; GO:0005737; GO:0030023; GO:0042802; GO:0062023 extracellular matrix constituent conferring elasticity [GO:0030023]; identical protein binding [GO:0042802] AEYRQCR 0.99284 -26.403 0 0 0 0 0 0 0 0 0 0 10.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8237 0 0 0 0 0 0 0 0 0 0 0 0 12.0037 0 0 0 0 0 0 0 0 0 0 0 0 12.6541 12.6216 12.7675 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3179 0 0 0 0 0 0 0 0 12.6975 0 0 0 0 0 0 0 0 0 0 10.6739 0 0 0 12.0392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1339 0 0 0 Q9P1U0 RPA12_HUMAN DNA-directed RNA polymerase I subunit RPA12 (DNA-directed RNA polymerase I subunit H) (Zinc ribbon domain-containing protein 1) POLR1H RPA12 ZNRD1 Homo sapiens (Human) mRNA cleavage [GO:0006379]; nucleobase-containing compound metabolic process [GO:0006139]; termination of RNA polymerase I transcription [GO:0006363] nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; nucleobase-containing compound metabolic process [GO:0006139]; termination of RNA polymerase I transcription [GO:0006363] GO:0003676; GO:0005654; GO:0005736; GO:0006139; GO:0006363; GO:0006379; GO:0008270 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] CGHEGMAYHTRQMRSADEGQTVFYTCTNCK 0.99284 -6.2738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5176 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2D0 IBTK_HUMAN "Inhibitor of Bruton tyrosine kinase, IBtk" IBTK BTKI KIAA1417 Homo sapiens (Human) negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; negative regulation of protein phosphorylation [GO:0001933]; release of sequestered calcium ion into cytosol [GO:0051209] GO:0001933; GO:0005654; GO:0005737; GO:0016020; GO:0019901; GO:0030292; GO:0051209 protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292] CRSLKHALDVLSVVTK 0.99284 -17.45 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4971 0 0 0 0 0 0 0 0 13.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8515 0 0 0 0 0 10.8304 0 12.7739 0 12.6197 0 0 0 0 0 11.7941 0 0 0 0 0 0 0 0 0 0 0 0 13.645 0 0 0 0 0 0 0 10.6547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0059 0 0 11.8986 0 0 0 0 0 0 0 11.0937 0 0 0 0 12.9505 14.2185 14.3718 0 0 0 11.6803 0 0 0 11.4967 0 0 Q9UEY8 ADDG_HUMAN Gamma-adducin (Adducin-like protein 70) ADD3 ADDL Homo sapiens (Human) barbed-end actin filament capping [GO:0051016] brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; barbed-end actin filament capping [GO:0051016] GO:0000794; GO:0005200; GO:0005516; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0014069; GO:0016020; GO:0051015; GO:0051016 actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200] DDMHDVEDELAK 0.99284 -6.6709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5672 0 0 0 0 0 0 0 0 0 0 0 0 14.0951 0 0 0 0 0 0 0 14.4243 0 0 0 14.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGM1 ACHA9_HUMAN "Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9, NACHR alpha-9)" CHRNA9 NACHRA9 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; regulation of nitric oxide metabolic process [GO:0080164]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; membrane depolarization [GO:0051899]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; regulation of nitric oxide metabolic process [GO:0080164]; response to auditory stimulus [GO:0010996]; signal transduction [GO:0007165] GO:0004888; GO:0005231; GO:0005262; GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007204; GO:0007268; GO:0010996; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0042472; GO:0043005; GO:0045202; GO:0050877; GO:0050910; GO:0051899; GO:0070161; GO:0070373; GO:0080164; GO:0098981; GO:0099060; GO:1904315 acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ATNSKGSEWK 0.99284 -14.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6213 0 0 0 0 0 0 13.1748 0 0 12.6594 0 11.9198 0 0 0 0 0 0 0 0 0 13.2041 11.6442 0 13.0498 0 0 0 0 0 13.7974 0 13.7272 0 14.8168 15.1 12.2505 0 0 13.1482 13.6084 0 0 14.3699 0 0 0 14.2269 14.2936 0 0 14.3503 11.879 0 0 0 0 13.0921 0 14.2922 0 0 12.0103 0 0 11.7234 0 14.4105 0 0 0 0 0 0 0 0 12.4919 0 0 0 0 14.5669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6D6 BIG1_HUMAN "Brefeldin A-inhibited guanine nucleotide-exchange protein 1, Brefeldin A-inhibited GEP 1 (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1)" ARFGEF1 ARFGEP1 BIG1 Homo sapiens (Human) endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; positive regulation of wound healing [GO:0090303]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; positive regulation of wound healing [GO:0090303]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114] GO:0000139; GO:0005085; GO:0005654; GO:0005730; GO:0005794; GO:0005802; GO:0005829; GO:0006486; GO:0006887; GO:0007030; GO:0010256; GO:0015031; GO:0016363; GO:0017022; GO:0030532; GO:0030837; GO:0032012; GO:0034237; GO:0034260; GO:0048471; GO:0090303; GO:2000114 guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] AHASFYYPLLCEIMQFDLIPELRAVLR 0.99284 -4.4132 0 0 0 0 0 0 0 0 14.5878 0 0 0 0 0 10.4974 0 0 0 10.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.163 0 0 0 12.5815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4596 11.9959 0 11.5495 0 0 0 0 0 0 12.7415 0 11.7983 0 0 0 0 0 0 14.0419 0 0 14.2894 0 11.2498 0 13.7415 0 0 13.9581 0 13.61 11.8503 0 15.0571 0 13.2425 15.0879 0 15.0002 12.4497 0 0 0 0 13.7186 0 13.3991 0 14.8975 0 15.3153 14.2136 0 12.199 14.7841 14.7979 12.6891 15.6916 0 0 13.3372 0 14.5722 0 12.3869 12.7135 0 12.562 0 15.4244 15.4529 13.9262 14.0492 0 11.8042 0 14.3321 0 0 0 13.6911 0 0 14.2663 0 0 0 10.8434 15.146 13.8108 0 0 0 0 0 0 11.701 0 0 0 0 13.586 0 0 0 15.3343 0 11.102 0 0 0 12.1618 0 Q9NRC6 SPTN5_HUMAN "Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)" SPTBN5 BSPECV HUBSPECV HUSPECV Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041] apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091] apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041] GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0007030; GO:0007041; GO:0008022; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030507; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0043621; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381 actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; spectrin binding [GO:0030507] AKVPVPLIGPENIVDGDQTLILGLIWVIILR 0.99285 -72.477 0 12.7943 0 0 0 0 14.2316 12.157 12.7298 12.1286 0 0 0 0 0 0 13.4934 0 0 0 10.1515 12.2945 11.1768 13.6333 0 0 0 0 11.1181 12.5635 0 0 0 0 0 0 0 0 0 12.4274 0 0 0 10.0104 12.2419 0 0 14.6698 14.161 14.1118 12.445 11.7133 0 10.5118 10.4733 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0127 15.1251 14.7308 0 13.537 18.1486 13.9264 13.6378 15.4799 14.8059 14.2397 16.7175 19.1643 15.6103 14.187 14.9134 18.7806 18.674 19.8493 17.6776 14.2492 17.5245 18.0727 14.4404 13.1564 14.6953 17.684 17.3787 17.2256 14.8624 17.8482 13.5389 16.0634 18.5872 16.1216 0 19.1253 15.2791 15.6058 14.3971 18.6373 16.2954 14.7353 0 14.7264 17.1899 19.1244 14.4244 15.2771 0 13.4037 12.6758 17.682 15.6021 15.6218 18.7586 14.5824 11.4753 14.3608 14.2392 14.3869 18.7781 15.485 15.7399 13.5311 15.2981 16.2357 15.7277 14.5027 15.3632 16.4556 15.2656 15.7732 14.7539 14.8177 18.9824 16.6915 0 13.6947 0 0 0 15.8247 15.9612 14.0573 18.8742 16.4249 15.688 0 0 0 0 13.7478 0 0 0 0 0 0 0 0 0 11.9723 14.8958 15.0274 16.4396 15.0182 15.8575 0 0 16.0398 0 O75037 KI21B_HUMAN Kinesin-like protein KIF21B KIF21B KIAA0449 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0030425; GO:0030426; GO:0031410 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ADYEKRLR 0.99285 -46.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 11.8986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9397 0 0 0 0 0 0 11.8889 0 14.3551 13.343 0 0 13.8757 12.4027 0 13.5441 0 0 12.9623 12.0443 0 16.3066 13.245 10.9462 15.0886 13.2567 0 0 0 11.805 13.7147 13.0253 0 0 0 0 0 0 15.0617 0 14.7115 0 13.5934 13.9979 0 12.8815 0 13.2457 0 0 0 0 13.6096 13.7709 14.3575 14.0476 12.0277 0 0 13.8473 0 14.4843 0 13.5344 0 12.5735 13.6479 13.9834 12.64 10.3528 0 0 13.4528 0 0 0 13.971 0 0 0 0 0 0 0 0 0 14.5686 14.1744 0 0 0 0 0 11.0544 0 0 0 12.5728 14.5153 0 0 11.0198 0 14.1507 P15918 RAG1_HUMAN "V(D)J recombination-activating protein 1, RAG-1 (RING finger protein 74) [Includes: Endonuclease RAG1, EC 3.1.-.-; E3 ubiquitin-protein ligase RAG1, EC 2.3.2.27 (RING-type E3 ubiquitin transferase RAG1) ]" RAG1 RNF74 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542] DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] DNA recombinase complex [GO:0097519]; endodeoxyribonuclease complex [GO:1905347]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; DNA recombination [GO:0006310]; histone monoubiquitination [GO:0010390]; immune response [GO:0006955]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of T cell differentiation [GO:0045582]; pre-B cell allelic exclusion [GO:0002331]; protein autoubiquitination [GO:0051865]; regulation of behavioral fear response [GO:2000822]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]; visual learning [GO:0008542] GO:0002250; GO:0002331; GO:0003677; GO:0004519; GO:0004842; GO:0005634; GO:0005654; GO:0006310; GO:0006325; GO:0006955; GO:0008270; GO:0008542; GO:0010390; GO:0030183; GO:0033077; GO:0033151; GO:0042393; GO:0042803; GO:0043029; GO:0043154; GO:0043565; GO:0045582; GO:0046872; GO:0048538; GO:0051865; GO:0061630; GO:0070244; GO:0097519; GO:1905347; GO:2000822 DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AIHQANLR 0.99285 -16.283 0 0 0 0 0 0 0 0 0 0 14.055 0 0 0 0 13.1844 13.5494 0 0 0 0 0 0 0 0 0 13.8324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0103 0 0 14.0739 0 0 0 11.9646 11.8276 0 13.5424 0 0 0 0 0 0 0 0 0 12.1769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8924 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1659 0 0 0 14.8505 0 0 P28222 5HT1B_HUMAN "5-hydroxytryptamine receptor 1B, 5-HT-1B, 5-HT1B (S12) (Serotonin 1D beta receptor, 5-HT-1D-beta) (Serotonin receptor 1B)" HTR1B HTR1DB Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]" calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154] "calyx of Held [GO:0044305]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; G protein-coupled serotonin receptor complex [GO:0098666]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; serotonergic synapse [GO:0099154]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; bone remodeling [GO:0046849]; cellular response to alkaloid [GO:0071312]; cellular response to temperature stimulus [GO:0071502]; cellular response to xenobiotic stimulus [GO:0071466]; chemical synaptic transmission [GO:0007268]; drinking behavior [GO:0042756]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to mineralocorticoid [GO:0051385]; vasoconstriction [GO:0042310]" GO:0002031; GO:0004993; GO:0005783; GO:0005886; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007205; GO:0007268; GO:0014053; GO:0014059; GO:0014063; GO:0030425; GO:0030594; GO:0032229; GO:0042220; GO:0042310; GO:0042756; GO:0044305; GO:0045471; GO:0046849; GO:0050795; GO:0051378; GO:0051385; GO:0051967; GO:0071312; GO:0071466; GO:0071502; GO:0098666; GO:0099056; GO:0099154; GO:0099171; GO:0099626; GO:1904707; GO:2000300 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] AAVMIALVWVFSISISLPPFFWR 0.99285 -16.277 0 0 0 0 0 0 0 0 12.2971 0 0 0 0 0 11.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7438 0 0 0 0 0 12.1626 0 0 0 0 0 0 0 12.7425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3805 0 13.2965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2767 0 12.0399 0 0 0 0 0 0 0 0 0 0 0 0 11.1909 0 13.1621 15.1558 0 13.2919 13.7791 0 0 0 0 0 0 13.5042 0 0 13.6152 13.6776 13.6581 13.3877 13.6868 13.4215 0 0 0 13.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14582 MAD4_HUMAN "Max dimerization protein 4, Max dimerizer 4 (Class C basic helix-loop-helix protein 12, bHLHc12) (Max-associated protein 4) (Max-interacting transcriptional repressor MAD4)" MXD4 BHLHC12 MAD4 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0046983 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAGLVRKAPNNR 0.99285 -7.7601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.264 13.6958 0 13.3963 0 0 13.7241 13.6243 14.5271 0 0 0 0 13.3435 0 12.9961 0 0 13.5982 13.4834 0 13.2261 0 0 0 0 13.556 0 0 0 0 0 12.9974 0 14.6061 0 13.8404 0 0 14.2374 0 0 0 0 0 0 13.4861 13.6334 13.3922 0 0 13.592 0 0 11.5342 0 0 0 13.3302 0 13.5948 0 13.508 0 0 0 0 0 0 14.5447 0 0 0 0 0 0 0 0 13.1031 0 14.1097 0 0 0 0 0 0 0 0 0 0 13.6753 0 0 10.7707 0 0 13.6336 0 13.9329 0 0 0 0 12.6414 0 Q14642 I5P1_HUMAN "Inositol polyphosphate-5-phosphatase A, EC 3.1.3.56 (43 kDa inositol polyphosphate 5-phosphatase) (Type I inositol 1,4,5-trisphosphate 5-phosphatase, 5PTase)" INPP5A 5PTASE Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856] dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886] "dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; negative regulation of neuron death [GO:1901215]; phosphatidylinositol dephosphorylation [GO:0046856]" GO:0004445; GO:0005886; GO:0016020; GO:0030425; GO:0042731; GO:0043647; GO:0046855; GO:0046856; GO:0048016; GO:0052658; GO:0052659; GO:1901215 "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]" ARVYLDENYKSQEHFTALGSFYFLHESLK 0.99285 -16.723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6711 0 12.8723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7269 0 0 0 0 0 0 Q3SY00 T10IP_HUMAN Testis-specific protein 10-interacting protein (Tsga10-interacting protein) TSGA10IP Homo sapiens (Human) cilium organization [GO:0044782] photoreceptor connecting cilium [GO:0032391] photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782] GO:0032391; GO:0044782 ELQGPWDLEK 0.99285 -16.291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2591 0 0 0 0 0 18.2942 0 0 0 0 0 0 0 0 0 0 0 15.0424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5QJE6 TDIF2_HUMAN "Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2, LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2, TdIF2, TdT-interacting factor 2)" DNTTIP2 ERBP TDIF2 Homo sapiens (Human) RNA processing [GO:0006396] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA processing [GO:0006396] GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006396 RNA binding [GO:0003723] EEEEDEKSEEDSSDHDENEDEFSDEEDFLNSTK 0.99285 -16.288 0 11.637 13.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7245 0 0 0 0 0 0 0 0 0 0 0 0 11.3267 0 16.4817 16.2963 0 0 13.2145 0 0 0 0 12.1246 13.6831 0 0 0 0 13.5687 0 12.4661 0 0 0 0 13.3059 0 0 11.5182 0 0 0 0 0 0 0 11.1777 0 0 0 0 13.0971 0 0 0 0 0 0 13.271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8373 0 0 0 0 9.76263 0 0 15.1642 0 0 0 0 0 0 0 0 12.8704 0 0 0 12.7937 0 12.9082 0 0 0 0 0 0 0 0 0 0 12.8033 0 Q5VUY2 ADCL4_HUMAN "Arylacetamide deacetylase-like 4, EC 3.1.1.-" AADACL4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; carboxylic ester hydrolase activity [GO:0052689] GO:0016021; GO:0052689 carboxylic ester hydrolase activity [GO:0052689] DDSLLYK 0.99285 -16.279 0 0 0 0 0 0 0 11.9441 0 0 0 0 0 0 0 0 0 0 9.78617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0245 14.0608 0 0 0 0 13.586 12.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3032 0 0 0 13.5963 13.4462 13.8418 0 18.4331 13.26 14.6512 0 0 0 13.1141 12.8949 0 0 0 0 0 12.1909 15.247 0 0 13.3257 13.8613 0 12.6838 12.9323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9268 0 0 0 0 0 0 0 Q8IU53 CASC2_HUMAN "Protein CASC2, isoforms 1/2 (Cancer susceptibility candidate gene 2 protein isoforms 1/2)" CASC2 C10orf5 Homo sapiens (Human) KLPQGIIIVFR 0.99285 -6.2909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4095 13.1834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92600 CNOT9_HUMAN "CCR4-NOT transcription complex subunit 9 (Cell differentiation protein RQCD1 homolog, Rcd-1)" CNOT9 RCD1 RQCD1 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; sex differentiation [GO:0007548] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991] CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; sex differentiation [GO:0007548] GO:0000289; GO:0000932; GO:0005154; GO:0005634; GO:0005829; GO:0007548; GO:0016020; GO:0017148; GO:0019221; GO:0019900; GO:0019904; GO:0030014; GO:0030015; GO:0030374; GO:0031047; GO:0032991; GO:0033138; GO:0033147; GO:0042803; GO:0045742 epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803] GIPLPPQ 0.99285 -4.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1692 13.531 12.9298 0 0 0 12.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.48 0 0 14.4364 0 14.1679 0 14.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7932 0 0 0 0 0 0 0 0 0 0 0 15.4906 0 0 0 0 0 0 0 0 0 0 0 14.0059 0 0 0 0 0 0 0 14.8476 14.6731 0 0 0 0 15.4502 0 0 0 0 14.4038 0 0 0 0 0 0 0 14.8356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4666 0 Q96KR7 PHAR3_HUMAN "Phosphatase and actin regulator 3 (Scaffold-associated PP1-inhibiting protein, Scapinin)" PHACTR3 C20orf101 SCAPIN1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036] GO:0003779; GO:0004864; GO:0005654; GO:0008157; GO:0016363; GO:0030036 actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864] AQDYDRR 0.99285 -16.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8312 0 13.3062 0 0 16.8422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4414 17.0199 17.2919 0 0 0 0 0 0 0 16.1984 0 0 0 0 12.5943 0 0 0 0 0 0 0 0 0 16.9438 0 0 0 13.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1867 0 0 0 0 0 0 0 0 0 0 0 19.6529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3274 0 0 0 0 0 0 0 0 0 0 0 0 12.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSA9 TM175_HUMAN "Endosomal/lysosomal potassium channel TMEM175 (Transmembrane protein 175, hTMEM175)" TMEM175 Homo sapiens (Human) neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; regulation of lysosomal lumen pH [GO:0035751] endosome [GO:0005768]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] endosome [GO:0005768]; integral component of endosome membrane [GO:0031303]; integral component of lysosomal membrane [GO:1905103]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; regulation of lysosomal lumen pH [GO:0035751] GO:0005267; GO:0005764; GO:0005765; GO:0005768; GO:0022841; GO:0031303; GO:0035751; GO:0070050; GO:0071805; GO:0090385; GO:1905103 potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] LLVGLALATLRVLR 0.99285 -17.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0994 0 0 0 0 0 14.8532 0 0 0 0 0 0 0 0 0 0 0 13.7148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9511 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3244 0 0 0 14.0493 0 0 0 0 0 0 0 0 14.2509 0 0 0 14.3012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.925 0 0 0 14.396 0 0 0 0 0 0 0 0 12.0688 0 11.0333 10.8378 0 0 0 12.7403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2246 0 0 0 0 0 0 0 0 14.765 0 0 0 0 0 Q9BYX4 IFIH1_HUMAN "Interferon-induced helicase C domain-containing protein 1, EC 3.6.4.13 (Clinically amyopathic dermatomyositis autoantigen 140 kDa, CADM-140 autoantigen) (Helicase with 2 CARD domains, Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5, MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2, RLR-2) (RNA helicase-DEAD box protein 116)" IFIH1 MDA5 RH116 Homo sapiens (Human) cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615] GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0039528; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051607; GO:0060760; GO:0071360; GO:0098586 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] AAKEGNR 0.99285 -16.293 0 0 0 10.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1614 0 0 0 0 0 11.5496 0 0 0 0 0 11.1645 0 0 0 0 0 0 12.1374 0 11.5129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4272 11.735 0 0 0 0 0 0 0 0 0 13.454 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6563 0 0 0 12.9079 13.1427 0 0 0 0 0 0 0 0 0 0 0 13.9273 0 0 0 12.2429 12.7642 13.4531 0 0 13.1137 0 0 13.7598 0 0 0 0 13.8401 14.5608 0 0 13.8094 0 0 0 12.3809 12.619 0 14.2558 0 14.1041 0 0 13.0855 0 0 0 14.5663 12.3977 0 0 0 13.1706 0 0 13.6879 0 0 12.9149 0 0 0 0 11.4042 0 0 12.4244 0 0 0 13.9306 0 0 14.338 13.0796 0 0 0 0 0 0 0 Q6ZNL6 FGD5_HUMAN "FYVE, RhoGEF and PH domain-containing protein 5 (Zinc finger FYVE domain-containing protein 23)" FGD5 ZFYVE23 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0001726; GO:0005085; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0032587; GO:0043087; GO:0046847; GO:0046872; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] AFTLYPR 0.99286 -41.985 0 0 0 14.0449 0 0 14.2555 12.582 0 0 0 0 0 0 0 10.0518 0 0 0 0 0 0 0 0 10.4725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.385 0 0 0 0 13.2124 0 0 0 0 0 0 0 0 0 0 14.4581 14.3954 14.3555 14.4581 0 14.4608 0 0 13.2216 0 0 0 13.7752 11.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7251 0 0 0 13.5941 0 15.654 12.4813 15.3883 0 0 0 16.6561 14.7245 0 13.7061 12.7518 0 13.2982 0 0 14.0164 18.5881 0 0 13.3678 0 0 14.0918 12.6348 12.9077 0 0 0 0 14.3996 14.1119 0 14.2133 0 0 14.1594 0 0 0 0 15.9961 0 0 0 0 0 14.3364 0 16.8334 0 0 13.7941 0 0 0 14.0093 15.9619 14.3569 0 0 0 0 0 10.3785 0 0 12.2817 14.2018 0 0 0 0 0 13.5141 16.1127 0 14.0782 0 0 0 0 O00755 WNT7A_HUMAN Protein Wnt-7a WNT7A Homo sapiens (Human) "angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]" cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685] "cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0000578; GO:0001502; GO:0001525; GO:0002062; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006915; GO:0007269; GO:0007409; GO:0007548; GO:0009953; GO:0009986; GO:0010595; GO:0010628; GO:0014719; GO:0014834; GO:0021707; GO:0021846; GO:0022009; GO:0030010; GO:0030182; GO:0030666; GO:0031012; GO:0031133; GO:0032355; GO:0035019; GO:0035115; GO:0035116; GO:0035313; GO:0036465; GO:0042733; GO:0043066; GO:0043627; GO:0045165; GO:0045167; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048103; GO:0048864; GO:0050768; GO:0051247; GO:0051965; GO:0060054; GO:0060066; GO:0060070; GO:0060071; GO:0060997; GO:0061038; GO:0062009; GO:0070062; GO:0070307; GO:0071560; GO:0098685; GO:0098793; GO:0098978; GO:0099054; GO:0099068; GO:0099175; GO:1904861; GO:1904891; GO:1905386; GO:1905606; GO:2000300; GO:2000463 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102] CLGHLFLSLGMVYLR 0.99286 -16.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2621 0 0 0 0 0 0 0 0 14.0631 0 0 0 0 13.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1002 0 0 0 0 0 0 0 0 0 0 15.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5932 0 0 15.01 13.9105 0 0 0 13.975 0 0 15.0999 14.7744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7099 0 15.2841 0 0 0 0 0 0 0 0 12.2545 0 0 13.9696 0 11.535 0 0 0 0 0 13.8891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94921 CDK14_HUMAN "Cyclin-dependent kinase 14, EC 2.7.11.22 (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1, hPFTAIRE1)" CDK14 KIAA0834 PFTK1 Homo sapiens (Human) cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; protein phosphorylation [GO:0006468]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; Wnt signaling pathway [GO:0016055] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; protein phosphorylation [GO:0006468]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; Wnt signaling pathway [GO:0016055] GO:0000083; GO:0000086; GO:0000307; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310 ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] FGKADSYEKLEK 0.99286 -15.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9516 9.77271 0 0 11.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3393 0 11.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8204 0 0 0 0 0 0 0 0 0 0 0 0 15.3456 14.0979 0 13.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4865 0 0 0 0 0 10.9719 0 0 14.3879 0 12.8366 0 13.0172 0 12.6242 0 0 0 0 0 0 0 0 0 12.138 0 0 0 0 0 0 0 0 0 0 0 0 11.1964 0 0 0 0 0 0 13.616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7833 0 0 0 0 0 12.789 0 0 10.7857 0 0 0 0 0 O96024 B3GT4_HUMAN "Beta-1,3-galactosyltransferase 4, Beta-1,3-GalTase 4, Beta3Gal-T4, Beta3GalT4, GalT4, b3Gal-T4, EC 2.4.1.62 (Gal-T2) (Ganglioside galactosyltransferase) (UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase)" B3GALT4 GALT4 Homo sapiens (Human) ganglioside biosynthetic process [GO:0001574]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486] cytosolic small ribosomal subunit [GO:0022627]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "cytosolic small ribosomal subunit [GO:0022627]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ganglioside galactosyltransferase activity [GO:0047915]; glycosyltransferase activity [GO:0016757]; protein kinase binding [GO:0019901]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; ganglioside biosynthetic process [GO:0001574]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]" GO:0000139; GO:0001574; GO:0006486; GO:0008499; GO:0009312; GO:0016021; GO:0016757; GO:0019901; GO:0022627; GO:0047915 "ganglioside galactosyltransferase activity [GO:0047915]; glycosyltransferase activity [GO:0016757]; protein kinase binding [GO:0019901]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]" MQLRLFRR 0.99286 -6.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35249 RFC4_HUMAN "Replication factor C subunit 4 (Activator 1 37 kDa subunit, A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit, RF-C 37 kDa subunit, RFC37)" RFC4 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006271; GO:0006281; GO:0016887; GO:0031390; GO:0031391; GO:0032508; GO:1900264 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677] GIQVVREKVK 0.99286 -14.884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5314 0 17.5729 0 0 0 0 0 0 0 0 0 0 0 15.3844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15116 PDCD1_HUMAN "Programmed cell death protein 1, Protein PD-1, hPD-1 (CD antigen CD279)" PDCD1 PD1 Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell apoptotic process [GO:0001783]; humoral immune response [GO:0006959]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of immune response [GO:0050777]; negative regulation of tolerance induction [GO:0002644]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of immune response [GO:0050776]; regulatory T cell apoptotic process [GO:1902482] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell apoptotic process [GO:0001783]; humoral immune response [GO:0006959]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of immune response [GO:0050777]; negative regulation of tolerance induction [GO:0002644]; positive regulation of T cell apoptotic process [GO:0070234]; regulation of immune response [GO:0050776]; regulatory T cell apoptotic process [GO:1902482] GO:0001783; GO:0002250; GO:0002644; GO:0002903; GO:0005886; GO:0006915; GO:0006959; GO:0009897; GO:0016021; GO:0050776; GO:0050777; GO:0070234; GO:1902482 DFHMSVVRARR 0.99286 -4.4541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1926 0 0 0 0 0 0 12.3796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4264 0 0 0 15.0985 0 0 0 0 0 14.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4773 0 12.591 0 0 0 0 0 13.4094 0 0 0 0 0 12.8225 0 0 0 0 0 0 0 0 13.6139 0 0 0 0 0 0 0 12.2671 0 0 0 0 0 0 Q16851 UGPA_HUMAN "UTP--glucose-1-phosphate uridylyltransferase, EC 2.7.7.9 (UDP-glucose pyrophosphorylase, UDPGP, UGPase)" UGP2 UGP1 Homo sapiens (Human) brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; brain development [GO:0007420]; glucose 1-phosphate metabolic process [GO:0019255]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011] GO:0003983; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0005977; GO:0005978; GO:0006011; GO:0007420; GO:0019255; GO:0032557; GO:0042802; GO:0046872; GO:0070062 glucose binding [GO:0005536]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyrimidine ribonucleotide binding [GO:0032557]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983] EFPTVPLVKLGSSFTK 0.99286 -14.57 0 0 0 0 0 0 0 0 0 0 0 14.5513 0 0 0 13.3563 0 0 0 0 0 14.6309 0 0 0 0 12.977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4691 0 11.2404 0 0 0 0 0 14.0055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4251 0 0 0 13.7824 0 0 13.2142 13.0735 0 0 0 0 0 0 0 0 0 0 0 13.4042 0 0 0 0 0 0 13.084 0 0 0 0 15.5765 13.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3661 0 0 13.1088 11.0873 0 0 0 0 0 0 0 0 0 0 0 0 13.5587 14.612 0 0 0 0 0 0 14.373 13.7164 0 0 0 0 0 Q5VT33 CX031_HUMAN Putative uncharacterized protein encoded by LINC01545 LINC01545 CXorf31 Homo sapiens (Human) RATLNTFLDSPVHVLLVMPK 0.99286 -4.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UW49 SPESP_HUMAN "Sperm equatorial segment protein 1, SP-ESP (Equatorial segment protein, ESP) (Glycosylated 38 kDa sperm protein C-7/8)" SPESP1 UNQ732/PRO1418 Homo sapiens (Human) acrosome reaction [GO:0007340]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; acrosome reaction [GO:0007340]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; sperm-egg recognition [GO:0035036] GO:0001669; GO:0005654; GO:0005829; GO:0007340; GO:0007342; GO:0009566; GO:0035036; GO:0043231 SRRVTALLK 0.99286 -4.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.991 12.9671 0 0 0 0 0 0 0 0 0 0 14.5282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN84 CCD81_HUMAN Coiled-coil domain-containing protein 81 CCDC81 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 ALDAQIK 0.99286 -14.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4811 0 0 0 0 11.5782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4457 0 12.8549 0 0 0 13.5305 0 0 0 16.4029 12.6044 13.7341 16.6197 12.7507 0 0 0 13.5404 0 12.8721 0 0 0 0 0 12.464 12.6844 0 0 0 0 12.8277 0 0 0 0 13.0221 0 0 0 12.966 0 0 0 0 0 0 0 0 0 0 0 14.6923 0 0 0 11.0061 0 14.4396 0 0 13.4831 0 0 0 0 0 11.1584 0 0 0 14.2145 0 0 0 12.4387 11.7601 0 0 0 0 0 0 0 0 10.9949 0 0 0 0 0 0 0 0 0 0 0 12.5615 0 Q8NDW8 TT21A_HUMAN "Tetratricopeptide repeat protein 21A, TPR repeat protein 21A (Stress-inducible protein 2)" TTC21A STI2 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; intraciliary retrograde transport [GO:0035721]; protein localization to cilium [GO:0061512]; spermatid development [GO:0007286] cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; flagellated sperm motility [GO:0030317]; intraciliary retrograde transport [GO:0035721]; protein localization to cilium [GO:0061512]; spermatid development [GO:0007286] GO:0005929; GO:0007286; GO:0030317; GO:0030991; GO:0035721; GO:0061512 APDNFLVLHKLIDLLR 0.99286 -17.163 0 0 0 0 0 0 0 0 13.2484 0 0 13.1154 0 0 0 0 0 0 0 12.0536 11.4629 0 0 0 0 0 0 17.28 0 0 10.3875 12.1572 0 0 12.2195 0 0 0 0 0 0 0 0 0 0 0 12.794 0 12.8839 0 0 11.988 0 0 0 0 0 8.9978 0 0 0 0 0 0 0 0 0 0 0 15.1198 0 0 0 0 0 0 0 0 0 14.2488 13.9032 15.5417 0 0 0 12.5803 12.946 0 0 0 0 0 14.15 0 0 11.1295 0 0 0 0 0 0 0 0 0 0 14.0458 0 0 0 0 13.825 12.4405 11.8688 0 13.7594 15.9036 0 0 13.1513 0 0 0 0 0 0 0 10.7599 0 0 14.8311 0 13.426 0 0 0 12.9195 0 0 0 13.6522 0 0 0 12.9445 12.6703 0 0 0 14.918 0 0 0 0 0 13.2491 0 0 10.5485 0 0 0 0 0 0 14.1629 0 0 0 0 0 0 0 0 0 0 0 0 12.7951 0 Q92845 KIFA3_HUMAN "Kinesin-associated protein 3, KAP-3, KAP3 (Smg GDS-associated protein)" KIFAP3 KIF3AP SMAP Homo sapiens (Human) cardiac muscle cell apoptotic process [GO:0010659]; cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of thymocyte apoptotic process [GO:0070244]; neuroblast proliferation [GO:0007405]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165]; thymocyte apoptotic process [GO:0070242] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; kinesin II complex [GO:0016939]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903]; cardiac muscle cell apoptotic process [GO:0010659]; cilium organization [GO:0044782]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of thymocyte apoptotic process [GO:0070244]; neuroblast proliferation [GO:0007405]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of calcium-dependent cell-cell adhesion [GO:0046587]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; signal transduction [GO:0007165]; thymocyte apoptotic process [GO:0070242] GO:0000794; GO:0001750; GO:0001917; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0005930; GO:0007017; GO:0007018; GO:0007165; GO:0007405; GO:0007406; GO:0008104; GO:0010659; GO:0010667; GO:0015630; GO:0016939; GO:0019894; GO:0019903; GO:0032391; GO:0035869; GO:0036064; GO:0044782; GO:0046587; GO:0065003; GO:0070242; GO:0070244; GO:0072383; GO:0097542; GO:0120170; GO:1990075 intraciliary transport particle B binding [GO:0120170]; kinesin binding [GO:0019894]; protein phosphatase binding [GO:0019903] ALDRDNFELLILVVSFLK 0.99286 -6.3382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1877 9.66461 0 0 0 11.8541 0 12.3011 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0104 0 0 0 0 14.9066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6023 0 0 0 0 0 0 12.9853 0 0 0 0 0 0 0 0 0 14.096 11.5306 0 0 0 0 0 0 0 0 12.5175 0 0 0 13.6406 12.7716 0 0 0 11.7606 13.4298 0 0 17.0768 10.6291 0 0 0 0 0 16.7337 0 12.788 0 0 0 13.986 0 0 0 0 0 0 0 0 0 0 0 12.5394 0 0 0 0 0 0 0 13.6139 0 0 0 0 0 0 12.3545 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9405 0 0 0 0 0 0 0 0 13.6136 0 Q96A54 PAQR1_HUMAN Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member 1) (Progestin and adipoQ receptor family member I) ADIPOR1 PAQR1 TESBP1A CGI-45 Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid metabolic process [GO:0019216] GO:0005886; GO:0009755; GO:0010633; GO:0010719; GO:0010906; GO:0016020; GO:0016021; GO:0019216; GO:0019395; GO:0019901; GO:0030308; GO:0031226; GO:0033210; GO:0033211; GO:0038023; GO:0042593; GO:0042802; GO:0046426; GO:0046427; GO:0046628; GO:0046872; GO:0055100; GO:0097003; GO:0120162; GO:1901223 adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; signaling receptor activity [GO:0038023] EADTVELAELGPLLEEKGK 0.99286 -17.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8504 0 0 0 0 0 0 0 0 0 0 0 9.88419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1441 0 0 0 0 0 0 0 0 0 0 0 0 12.1559 0 12.0215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9363 0 0 0 0 0 0 0 0 0 0 10.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GM8 TOE1_HUMAN Target of EGR1 protein 1 TOE1 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]" Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; snRNA 3'-end processing [GO:0034472]" GO:0000175; GO:0003723; GO:0004535; GO:0005654; GO:0005730; GO:0005737; GO:0015030; GO:0016604; GO:0016607; GO:0017069; GO:0034472; GO:0046872; GO:0090503 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; snRNA binding [GO:0017069] KQVCGDSIK 0.99286 -15.236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7993 14.7869 0 0 0 0 0 0 0 0 0 12.1827 0 0 13.0993 0 13.1347 0 0 0 0 0 0 0 0 13.2158 0 0 11.213 0 0 0 0 0 0 0 0 0 13.522 14.6094 0 14.4401 13.3283 0 13.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7055 14.9325 0 0 0 0 0 0 0 0 0 0 0 0 13.3479 0 0 12.3963 12.602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4134 0 0 0 0 0 Q96I34 PP16A_HUMAN Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3) PPP1R16A MYPT3 Homo sapiens (Human) regulation of protein dephosphorylation [GO:0035304] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; regulation of protein dephosphorylation [GO:0035304] GO:0005886; GO:0008157; GO:0017020; GO:0019888; GO:0035304 myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888] AKLLELKHK 0.99286 -42.108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4438 0 0 0 0 0 0 0 13.3129 0 0 0 13.8824 0 0 0 0 13.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5145 0 0 12.1602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4152 0 0 0 0 0 0 0 0 0 13.4294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H106 SIRPD_HUMAN "Signal-regulatory protein delta, SIRP-delta (Protein tyrosine phosphatase non-receptor type substrate 1-like 2)" SIRPD PTPNS1L2 Homo sapiens (Human) extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886] GO:0005576; GO:0005886 GTGPNRK 0.99286 -15.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7515 0 0 0 0 Q9NRP7 STK36_HUMAN "Serine/threonine-protein kinase 36, EC 2.7.11.1 (Fused homolog)" STK36 KIAA1278 Homo sapiens (Human) axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224] GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007224; GO:0007228; GO:0007420; GO:0009791; GO:0035082; GO:0042995; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222] EAALIALR 0.99286 -17.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3486 0 0 0 0 0 10.6473 0 11.347 14.5086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.58489 0 0 0 Q9UPA5 BSN_HUMAN Protein bassoon (Zinc finger protein 231) BSN KIAA0434 ZNF231 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of synaptic vesicle cycle [GO:0098693] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; cytoskeleton of presynaptic active zone [GO:0048788]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; metal ion binding [GO:0046872]; structural constituent of presynaptic active zone [GO:0098882]; chemical synaptic transmission [GO:0007268]; presynapse to nucleus signaling pathway [GO:0099526]; presynaptic active zone assembly [GO:1904071]; protein localization to synapse [GO:0035418]; regulation of synaptic vesicle cycle [GO:0098693] GO:0005634; GO:0007268; GO:0008021; GO:0009986; GO:0014069; GO:0030424; GO:0030425; GO:0030672; GO:0035418; GO:0044306; GO:0046872; GO:0048786; GO:0048788; GO:0060076; GO:0070161; GO:0098685; GO:0098693; GO:0098882; GO:0098978; GO:0098982; GO:0099526; GO:1904071 metal ion binding [GO:0046872]; structural constituent of presynaptic active zone [GO:0098882] AASPTPK 0.99286 -41.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7561 11.8084 0 0 13.2223 13.3058 0 12.4798 0 0 0 12.6317 11.7584 0 13.2609 12.7985 0 12.9171 0 12.3684 0 0 0 12.4903 12.5346 11.4969 0 13.8177 13.318 11.5093 0 0 11.1623 12.6851 0 9.74431 13.6841 13.1533 0 11.8013 13.1116 0 13.1031 0 0 0 0 11.4828 0 0 0 12.3982 0 0 12.412 0 13.1162 0 13.7695 0 0 0 14.3882 0 0 13.5912 13.0179 0 0 16.6249 14.2257 14.509 0 13.2919 0 0 14.6475 0 14.7648 13.7258 13.6324 0 0 0 14.882 0 0 14.8349 15.1767 15.1206 0 0 0 13.3765 14.274 0 14.7379 0 0 14.7824 0 12.1768 0 0 14.682 0 0 14.4866 0 12.9301 0 0 0 11.5389 0 12.7172 16.6535 0 13.5464 0 11.1768 12.8466 0 14.1974 0 0 0 0 0 0 15.3956 0 13.2889 15.551 15.1013 11.2741 0 0 12.1035 0 0 13.7255 0 14.152 14.4481 0 0 0 0 11.2249 0 14.5045 0 14.5445 13.3195 13.5269 13.2971 0 14.8797 13.7026 13.7024 0 16.5467 12.1854 14.0651 P61018 RAB4B_HUMAN "Ras-related protein Rab-4B, EC 3.6.5.2" RAB4B PP1596 Homo sapiens (Human) glucose import [GO:0046323]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule membrane [GO:0030667] endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule membrane [GO:0030667]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; glucose import [GO:0046323]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005886; GO:0015031; GO:0016192; GO:0030100; GO:0030667; GO:0032482; GO:0032593; GO:0046323; GO:0048471; GO:0055037 G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] AETYDFLFK 0.99287 -4.4694 0 12.3006 0 0 11.6186 12.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9326 0 0 0 0 0 0 14.095 15.439 15.6343 16.4193 15.5064 17.0215 12.0809 0 0 0 0 0 14.4336 14.5818 16.9318 17.2327 17.3368 17.145 14.6088 17.3905 16.9517 0 0 0 16.5809 16.5959 15.5433 17.1804 15.7537 15.432 16.399 16.1704 15.4085 16.2701 16.5734 15.4845 15.2245 17.2406 17.1249 0 14.9809 15.5167 16.6075 16.5449 16.5257 14.8219 15.248 15.373 11.556 17.5614 0 17.0414 16.9734 16.4492 15.2668 0 13.3872 13.7738 15.6603 14.7508 12.5288 0 16.3243 15.1783 15.8447 16.1006 13.8655 16.156 15.7824 16.0259 15.3747 15.1287 0 0 0 17.0517 12.8513 0 16.9497 17.7018 16.8682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9949 17.0709 15.0298 0 0 0 14.8906 0 A0AVI2 FR1L5_HUMAN Fer-1-like protein 5 FER1L5 Homo sapiens (Human) macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; myoblast fusion [GO:0007520]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; T-tubule [GO:0030315] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; T-tubule [GO:0030315]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; myoblast fusion [GO:0007520]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] GO:0001778; GO:0002280; GO:0002281; GO:0005509; GO:0005544; GO:0006906; GO:0007009; GO:0007520; GO:0016021; GO:0030315; GO:0031410; GO:0033292; GO:0050765; GO:0061025 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] DGLAYRGR 0.99287 -42.478 0 0 0 0 0 0 0 0 0 12.8607 13.4661 0 12.8912 12.1275 0 0 13.3715 0 0 0 0 0 0 0 0 0 13.4127 12.5748 0 13.3458 0 12.9388 14.1482 0 0 0 12.6519 0 0 11.6383 0 13.1841 0 10.1477 11.34 0 11.2392 0 0 0 0 0 11.0682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0734 14.994 0 0 12.1958 13.9399 0 0 0 0 0 0 0 0 13.0629 0 0 0 16.3147 0 0 13.5023 12.1037 11.3862 14.799 0 0 0 0 14.3214 12.835 0 13.8946 14.5199 0 13.8592 0 0 0 13.5833 0 0 0 0 0 0 0 14.525 13.2722 17.2352 16.3132 12.9721 0 0 11.3734 11.248 12.6196 0 0 0 0 0 0 0 0 0 0 14.3799 11.8787 0 0 0 0 0 0 0 0 0 0 0 17.0982 0 0 0 0 0 11.9049 0 0 0 0 0 0 0 13.2066 0 0 0 0 17.0162 0 0 0 0 10.9156 0 A1L390 PKHG3_HUMAN "Pleckstrin homology domain-containing family G member 3, PH domain-containing family G member 3" PLEKHG3 KIAA0599 Homo sapiens (Human) regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoskeleton [GO:0005856]; cytosol [GO:0005829] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of cell migration [GO:0030334]; regulation of establishment of cell polarity [GO:2000114]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0003779; GO:0005085; GO:0005829; GO:0005856; GO:0030334; GO:0051056; GO:2000114 actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085] AGGGRPR 0.99287 -42.43 12.6973 15.2812 12.6861 13.0893 0 0 0 17.1984 11.9974 0 12.3867 0 12.6125 11.4439 0 15.3351 15.2726 15.3888 14.5386 14.2933 0 14.371 13.7528 0 0 0 0 0 11.2439 0 11.2945 11.0465 11.1423 13.4738 0 0 0 0 0 0 0 13.8359 11.2894 0 0 14.474 9.12322 0 0 0 0 13.1582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0511 0 0 0 0 12.6458 12.7067 12.9729 0 0 0 0 0 0 0 0 15.2852 12.9728 14.5093 0 15.6048 14.8935 0 13.3105 13.5153 15.1974 0 0 0 12.9236 13.1207 13.5304 0 0 11.9588 0 12.926 0 12.8475 0 13.5749 0 0 13.07 13.4477 14.6353 13.8166 15.1228 15.1884 12.6895 0 14.4041 0 0 12.9288 14.2377 14.4816 14.4658 14.4042 0 0 0 14.3142 0 14.062 0 14.0911 14.5518 0 14.3652 0 0 0 0 0 0 13.4729 0 0 0 0 13.959 0 0 12.0725 0 0 0 13.5387 0 0 0 0 0 0 13.8423 0 0 11.7092 0 0 11.9369 11.9575 14.2033 0 0 0 13.6659 13.1185 0 A6NKG5 RTL1_HUMAN Retrotransposon-like protein 1 (Mammalian retrotransposon derived protein 1) (Paternally expressed gene 11 protein) (Retrotransposon-derived protein PEG11) RTL1 MAR1 MART1 PEG11 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AFRKAPLLHHPK 0.99287 -13.225 0 0 0 0 10.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4604 12.0415 0 0 0 0 0 0 0 10.2984 0 0 0 0 11.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7945 0 0 0 12.5575 0 10.8942 13.8306 13.1021 0 0 10.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0493 10.5578 0 0 0 0 0 10.8096 0 0 12.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5115 0 15.2987 0 15.0222 14.6969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8189 0 0 0 0 13.8965 0 O94889 KLH18_HUMAN Kelch-like protein 18 KLHL18 KIAA0795 OK/SW-cl.74 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567] cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; protein ubiquitination [GO:0016567] GO:0007049; GO:0016567; GO:0051301; GO:1901992 PMTTARSR 0.99287 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10072 ZN875_HUMAN Zinc finger protein 875 (Krueppel-related zinc finger protein 1) (Protein HKR1) ZNF875 HKR1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AHSGAFVCRECGQGFCAK 0.99287 -14.618 0 0 0 0 0 0 0 0 0 11.7229 0 0 0 0 0 0 0 12.3685 12.2911 0 0 11.4217 11.1054 0 0 0 0 0 0 0 0 0 11.3268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3494 11.776 13.199 13.2639 13.2105 12.1518 0 0 0 12.3434 12.4434 0 12.1769 0 0 0 0 0 0 0 0 0 0 14.0705 0 0 0 16.1287 11.9616 0 0 14.1914 14.3801 14.2734 13.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1699 0 0 0 13.5393 0 0 0 14.276 0 0 0 0 11.8842 0 17.22 0 0 0 0 0 0 12.0428 14.461 0 0 0 0 0 0 13.4115 14.2661 0 0 0 0 0 16.8406 14.4795 0 0 0 14.551 0 13.7195 14.215 0 0 0 0 0 0 13.1917 0 0 0 11.3806 0 0 0 0 13.5619 0 0 0 0 0 0 0 0 12.1119 0 13.8977 0 0 0 0 0 0 P14625 ENPL_HUMAN "Endoplasmin (94 kDa glucose-regulated protein, GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog)" HSP90B1 GRP94 TRA1 Homo sapiens (Human) "actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; ubiquitin-dependent ERAD pathway [GO:0030433]" collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; sperm plasma membrane [GO:0097524] "collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum lumen [GO:0033018]; sperm plasma membrane [GO:0097524]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein transport [GO:0015031]; regulation of phosphoprotein phosphatase activity [GO:0043666]; response to endoplasmic reticulum stress [GO:0034976]; response to hypoxia [GO:0001666]; retrograde protein transport, ER to cytosol [GO:0030970]; sequestering of calcium ion [GO:0051208]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0001666; GO:0003723; GO:0005509; GO:0005524; GO:0005576; GO:0005634; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005925; GO:0006457; GO:0015031; GO:0016020; GO:0016887; GO:0019903; GO:0030433; GO:0030496; GO:0030970; GO:0031247; GO:0032991; GO:0033018; GO:0034663; GO:0034975; GO:0034976; GO:0042470; GO:0043066; GO:0043666; GO:0048471; GO:0050750; GO:0051082; GO:0051208; GO:0062023; GO:0070062; GO:0071318; GO:0071682; GO:0097524 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor binding [GO:0050750]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] DMLRRIK 0.99287 -43.236 0 0 0 0 0 0 0 0 12.65 13.2123 0 15.2748 0 0 0 0 0 13.0851 0 0 0 0 12.5162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6684 0 0 0 0 0 0 0 0 11.4339 0 0 0 0 0 14.9296 0 0 13.7931 0 0 0 0 0 0 0 10.5338 0 0 0 0 14.6559 15.0079 14.732 14.686 14.6551 13.3163 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0118 0 11.7967 13.7074 0 0 12.6708 12.1252 0 0 0 12.9971 0 0 11.8181 13.5703 0 12.5649 0 0 0 0 0 18.1076 13.1843 13.5291 0 13.7065 0 0 0 0 0 13.5395 13.2624 11.697 12.779 0 0 0 0 12.4045 18.8196 14.7117 13.0784 0 0 0 0 0 15.5212 11.7499 0 13.1113 0 0 0 0 0 0 0 0 0 0 0 16.0761 0 15.7226 0 0 0 0 0 13.66 0 0 0 0 0 12.373 0 0 13.5825 13.1135 0 0 P21281 VATB2_HUMAN "V-type proton ATPase subunit B, brain isoform, V-ATPase subunit B 2 (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)" ATP6V1B2 ATP6B2 VPP3 Homo sapiens (Human) ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP metabolic process [GO:0046034]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" GO:0000221; GO:0001726; GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0007035; GO:0015078; GO:0016021; GO:0016241; GO:0016324; GO:0030665; GO:0030672; GO:0042470; GO:0043231; GO:0046034; GO:0046961; GO:0070062; GO:0070161; GO:1902600 "ATP binding [GO:0005524]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" NYLSQPR 0.99287 -14.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0504 0 12.9976 12.9856 13.019 14.4912 0 0 0 0 14.6642 0 13.1492 0 12.9675 12.9775 0 0 0 13.3462 12.2413 0 0 0 0 14.0587 13.2301 0 15.0873 0 13.0873 0 0 13.5725 0 0 0 0 0 0 0 0 13.4247 13.7593 14.7147 0 0 13.3475 15.3921 13.3302 0 0 13.6969 0 0 14.5136 0 0 0 13.3715 13.2664 0 13.5084 0 0 0 0 0 0 0 0 12.5914 0 0 0 0 13.9253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7342 0 0 0 0 0 0 0 P27694 RFA1_HUMAN "Replication protein A 70 kDa DNA-binding subunit, RP-A p70 (Replication factor A protein 1, RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed ]" RPA1 REPA1 RPA70 Homo sapiens (Human) base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004] "chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]" "chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]" GO:0000723; GO:0000724; GO:0000781; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005662; GO:0006260; GO:0006261; GO:0006268; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0006310; GO:0006974; GO:0007004; GO:0016605; GO:0034502; GO:0043047; GO:0046872; GO:0051321; GO:0090734; GO:0098505 damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047] ENCMYQACPTQDCNK 0.99287 -16.039 0 0 0 0 0 0 0 0 11.8646 0 13.6133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9003 0 0 0 0 11.2372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0042 14.5345 0 0 0 14.8652 0 0 0 0 0 0 13.0554 0 0 0 14.4929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7575 0 0 0 14.794 0 0 0 0 0 0 13.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43363 MAGAA_HUMAN "Melanoma-associated antigen 10 (Cancer/testis antigen 1.10, CT1.10) (MAGE-10 antigen)" MAGEA10 MAGE10 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005654; GO:0005829; GO:0042826 histone deacetylase binding [GO:0042826] AHAEIRK 0.99287 -4.9606 0 11.4844 0 0 0 0 0 0 0 0 0 0 13.4391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4451 0 0 14.0159 11.7046 0 0 13.3479 0 0 0 14.5886 12.9692 12.692 12.4972 12.2958 0 0 0 0 0 10.2396 0 0 0 0 0 0 12.5037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5343 0 0 0 11.8978 0 0 10.8586 0 0 0 0 0 0 0 0 0 0 0 0 14.8486 0 0 0 0 0 0 0 0 12.4641 0 12.1845 0 15.2506 0 14.8622 0 14.9882 14.7962 13.0079 14.9327 14.7485 14.7769 0 0 0 0 0 0 0 15.5353 0 0 P49908 SEPP1_HUMAN "Selenoprotein P, SeP" SELENOP SELP SEPP1 Homo sapiens (Human) brain development [GO:0007420]; locomotory behavior [GO:0007626]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; response to oxidative stress [GO:0006979]; response to selenium ion [GO:0010269]; selenium compound metabolic process [GO:0001887]; sexual reproduction [GO:0019953] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; platelet dense granule lumen [GO:0031089]; selenium binding [GO:0008430]; brain development [GO:0007420]; locomotory behavior [GO:0007626]; post-embryonic development [GO:0009791]; regulation of growth [GO:0040008]; response to oxidative stress [GO:0006979]; response to selenium ion [GO:0010269]; selenium compound metabolic process [GO:0001887]; sexual reproduction [GO:0019953] GO:0001887; GO:0005576; GO:0006979; GO:0007420; GO:0007626; GO:0008430; GO:0009791; GO:0010269; GO:0019953; GO:0031089; GO:0040008; GO:0070062 selenium binding [GO:0008430] AEENITESCQUR 0.99287 -17.221 0 0 0 0 0 0 0 0 13.0212 0 14.0527 0 0 12.5499 12.0844 0 0 13.438 0 0 0 0 9.87186 0 12.6982 10.1659 0 0 0 0 0 12.259 12.0712 0 10.5885 0 0 0 0 0 0 11.0827 0 12.9932 0 10.3809 0 0 0 0 0 11.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.905 0 11.9125 14.0096 0 0 10.7345 0 10.8815 0 0 0 0 13.6413 11.5759 0 12.8709 12.8514 0 12.147 0 0 0 0 13.0248 0 0 11.4978 0 0 0 0 12.7603 0 0 12.6234 0 0 10.2201 0 0 0 0 0 0 0 0 13.0988 11.7701 0 0 0 0 0 0 0 0 0 0 10.4071 15.4733 0 0 12.5769 0 0 0 0 0 11.6227 10.3278 12.1463 0 0 11.1565 0 10.4974 0 0 0 0 9.94062 0 0 0 0 0 10.8427 0 0 0 12.4899 0 10.3244 0 12.1455 12.5635 12.9791 0 0 0 11.7127 0 11.9614 0 12.3062 13.5745 0 11.4187 0 10.2873 13.5105 10.2942 0 P52790 HXK3_HUMAN "Hexokinase-3, EC 2.7.1.1 (Hexokinase type III, HK III) (Hexokinase-C)" HK3 Homo sapiens (Human) canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005576; GO:0005739; GO:0005829; GO:0006002; GO:0006006; GO:0006096; GO:0008865; GO:0034774; GO:0046835; GO:0051156; GO:0061621; GO:1904813 ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396] FEKMIGGLYLGELVRLVLAHLAR 0.99287 -6.3505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6447 0 0 0 12.2076 17.0454 0 13.2019 0 0 0 0 0 0 0 0 0 0 0 13.1083 13.3426 0 0 0 0 0 13.1503 0 0 0 0 13.5167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7323 0 0 0 0 12.8007 0 0 0 0 0 13.5563 0 16.7949 0 15.9988 15.4355 12.5867 16.7071 0 0 16.3592 12.1035 13.4144 13.9078 14.4261 0 0 16.4331 0 12.184 14.3391 0 13.0999 15.8078 14.0283 16.2009 14.3404 0 0 0 16.1035 0 16.3312 0 16.344 16.9193 0 0 16.3625 16.3673 0 0 15.6646 0 0 0 0 13.5088 16.3421 16.3105 0 0 12.8879 0 0 16.0046 0 0 16.3446 16.599 0 0 0 0 0 0 0 0 0 0 16.4451 0 0 0 0 16.4046 16.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3605 12.6615 0 0 0 0 0 0 Q14554 PDIA5_HUMAN "Protein disulfide-isomerase A5, EC 5.3.4.1 (Protein disulfide isomerase-related protein)" PDIA5 PDIR Homo sapiens (Human) electron transport chain [GO:0022900]; protein folding [GO:0006457] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; electron transport chain [GO:0022900]; protein folding [GO:0006457] GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0015035; GO:0016491; GO:0022900 oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] DFRRLLK 0.99287 -16.017 0 0 10.4391 0 0 0 0 0 12.4415 0 0 0 0 0 0 0 0 12.0511 0 0 0 0 0 0 0 0 0 10.9763 0 0 0 0 0 0 0 0 0 0 0 0 12.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.809 10.3409 12.355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5967 12.9467 0 0 14.6911 0 0 0 15.0458 0 12.7992 0 0 0 0 0 0 0 0 13.3651 0 12.9485 0 0 0 0 11.353 0 13.5434 0 0 0 0 0 0 0 0 12.7849 0 0 12.7794 0 12.8162 0 0 0 0 0 0 0 0 0 0 12.9709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3967 0 14.5766 0 12.4924 13.3933 0 0 Q16798 MAON_HUMAN "NADP-dependent malic enzyme, mitochondrial, NADP-ME, EC 1.1.1.40 (Malic enzyme 3)" ME3 Homo sapiens (Human) aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; oxaloacetate decarboxylase activity [GO:0008948]; aerobic respiration [GO:0009060]; malate metabolic process [GO:0006108]; oxygen metabolic process [GO:0072592]; pyruvate metabolic process [GO:0006090] GO:0004470; GO:0004471; GO:0004473; GO:0005739; GO:0005759; GO:0006090; GO:0006108; GO:0008948; GO:0009060; GO:0046872; GO:0051287; GO:0070401; GO:0072592 malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; oxaloacetate decarboxylase activity [GO:0008948] AVVVTDGER 0.99287 -6.3594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.787 12.8464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9081 0 13.5686 13.3429 0 14.0776 11.6711 12.3041 0 0 0 12.5843 11.7779 0 0 0 0 0 0 0 0 0 12.0641 0 Q53GD3 CTL4_HUMAN "Choline transporter-like protein 4 (Solute carrier family 44 member 4) (Thiamine pyrophosphate transporter 1, hTPPT1)" SLC44A4 C6orf29 CTL4 NG22 TPPT1 UNQ441/PRO874 Homo sapiens (Human) acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857]; acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974]; transmembrane transport [GO:0055085] GO:0005886; GO:0006656; GO:0008292; GO:0015220; GO:0015871; GO:0016020; GO:0016021; GO:0016324; GO:0022857; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0055085; GO:0061526; GO:0070062; GO:0090422 choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; transmembrane transporter activity [GO:0022857] CIMCCFK 0.99287 -14.269 0 0 0 0 11.0156 0 0 0 0 0 0 0 0 0 0 0 0 12.2748 0 12.8942 0 0 0 0 0 0 11.2249 0 0 0 0 12.762 0 0 0 13.3239 12.0091 0 0 0 0 0 0 12.5499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6857 13.4587 0 12.7411 13.792 0 0 15.4664 12.7827 0 0 12.5893 0 12.4542 0 12.3976 0 0 11.7596 0 0 0 12.523 0 0 0 0 0 0 13.908 0 10.9034 0 14.5342 0 13.7141 0 0 13.8366 0 14.1706 12.997 13.0952 0 12.2386 0 0 13.854 0 14.3858 0 0 0 0 0 11.0812 0 0 0 0 13.0377 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9087 0 0 0 0 0 0 0 0 0 0 0 12.8338 12.4424 0 0 0 0 0 0 0 0 0 Q6UXY8 TMC5_HUMAN Transmembrane channel-like protein 5 TMC5 UNQ8238/PRO33604 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381] GO:0005887; GO:0008381; GO:0070062 mechanosensitive ion channel activity [GO:0008381] AIRNQPR 0.99287 -6.1782 14.1278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7538 0 0 0 0 0 0 0 0 13.7068 0 0 14.2649 0 0 0 0 0 11.2267 0 0 0 0 0 11.5468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2636 0 0 0 0 0 12.7055 0 0 0 0 11.7291 0 0 0 13.0365 0 0 0 0 0 0 0 0 0 0 15.8505 0 0 14.1015 13.8651 0 12.8337 0 0 12.9145 0 10.4681 0 0 0 0 0 0 13.8045 0 0 0 13.6085 0 0 0 12.5226 0 12.6067 12.2779 0 14.8547 13.221 0 0 13.1663 0 0 0 11.4999 0 0 0 0 0 16.0801 0 12.0077 0 0 0 0 0 0 0 0 0 13.3098 0 0 0 0 0 0 0 15.0888 0 17.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.131 13.1824 Q96LW4 PRIPO_HUMAN "DNA-directed primase/polymerase protein, hPrimpol1, EC 2.7.7.- (Coiled-coil domain-containing protein 111)" PRIMPOL CCDC111 Homo sapiens (Human) error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop disassembly [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] DNA-directed RNA polymerase complex [GO:0000428]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657] DNA-directed RNA polymerase complex [GO:0000428]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; replication fork [GO:0005657]; chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]; error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop disassembly [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] GO:0000428; GO:0003682; GO:0003887; GO:0003896; GO:0005634; GO:0005657; GO:0005759; GO:0006264; GO:0008270; GO:0009411; GO:0019985; GO:0030145; GO:0031297; GO:0042276; GO:0043504; GO:0062176 chromatin binding [GO:0003682]; DNA primase activity [GO:0003896]; DNA-directed DNA polymerase activity [GO:0003887]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270] DNIHVGNFLR 0.99287 -16.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4607 0 0 0 0 11.4579 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4897 0 0 0 0 Q96PD6 MOGT1_HUMAN "2-acylglycerol O-acyltransferase 1, EC 2.3.1.22 (Acyl-CoA:monoacylglycerol acyltransferase 1, MGAT1) (Diacylglycerol O-acyltransferase candidate 2, hDC2) (Diacylglycerol acyltransferase 2-like protein 1) (Monoacylglycerol O-acyltransferase 1)" MOGAT1 DC2 DGAT2L1 Homo sapiens (Human) diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; triglyceride biosynthetic process [GO:0019432] GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006629; GO:0006651; GO:0016021; GO:0019432 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] FTLFIRQR 0.99287 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9365 0 0 Q96PY0 K1908_HUMAN Putative uncharacterized protein PSMG3-AS1 (PSMG3 antisense RNA 1) PSMG3-AS1 KIAA1908 Homo sapiens (Human) GPAREEIPSSDSSAK 0.99287 -6.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.101 14.2127 14.0249 14.26 13.7195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5727 13.9264 0 0 11.6706 0 0 14.5313 0 0 0 0 14.31 14.2689 14.3074 0 0 0 14.8203 14.1475 0 0 0 14.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZH8 IL36G_HUMAN "Interleukin-36 gamma (IL-1-related protein 2, IL-1RP2) (Interleukin-1 epsilon, IL-1 epsilon) (Interleukin-1 family member 9, IL-1F9) (Interleukin-1 homolog 1, IL-1H1)" IL36G IL1E IL1F9 IL1H1 IL1RP2 UNQ2456/PRO5737 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628] GO:0002437; GO:0005125; GO:0005149; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0005886; GO:0006954; GO:0007267; GO:0010628; GO:0019221; GO:0045087; GO:0071222 cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149] PFLFYRAK 0.99287 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2335 13.8635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7659 0 0 0 0 14.8007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7064 0 0 0 0 0 0 0 0 0 0 0 0 14.2572 0 0 0 0 0 0 0 14.9858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3B9 RRP15_HUMAN RRP15-like protein (Ribosomal RNA-processing protein 15) RRP15 KIAA0507 CGI-115 Homo sapiens (Human) maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470] "preribosome, large subunit precursor [GO:0030687]" "preribosome, large subunit precursor [GO:0030687]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]" GO:0000460; GO:0000470; GO:0030687 DDFMMGASMK 0.99287 -6.3634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7032 0 14.5516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2778 0 0 0 15.1793 0 14.4386 13.595 13.4677 0 12.4877 0 0 0 0 14.7053 0 0 13.3334 0 0 0 0 0 0 0 0 0 0 0 13.9814 0 0 12.8821 0 0 0 0 12.7289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6207 0 0 0 0 0 0 0 0 13.2599 0 0 13.578 0 0 Q9Y697 NFS1_HUMAN "Cysteine desulfurase, mitochondrial, EC 2.8.1.7" NFS1 NIFS HUSSY-08 Homo sapiens (Human) [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777] GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006777; GO:0016226; GO:0018283; GO:0030170; GO:0031071; GO:0042803; GO:0044571; GO:0046872; GO:0051536; GO:1990229 cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] EIIFTSGATESNNIAIK 0.99287 -16.857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9152 0 0 0 0 0 O14818 PSA7_HUMAN Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; identical protein binding [GO:0042802]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019773; GO:0042802; GO:0043161; GO:0070062; GO:0098794 identical protein binding [GO:0042802] EKEENEKK 0.99288 -5.52 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6057 0 0 13.8635 0 0 0 0 0 0 0 0 13.7518 0 13.7751 0 13.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4544 0 13.2786 0 0 0 0 0 0 0 0 0 0 0 0 13.4294 0 0 0 0 0 0 0 O43861 ATP9B_HUMAN "Probable phospholipid-transporting ATPase IIB, EC 7.6.2.1 (ATPase class II type 9B)" ATP9B ATPIIB NEO1L HUSSY-20 Homo sapiens (Human) "endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] "endosome [GO:0005768]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000287; GO:0005524; GO:0005768; GO:0005802; GO:0005886; GO:0006890; GO:0006897; GO:0016021; GO:0016887; GO:0045332; GO:0048471; GO:0140326 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287] ADQIPLYPVR 0.99288 -6.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0002 0 0 9.84576 0 14.0086 0 12.0419 0 11.9164 0 13.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6562 14.4575 0 0 0 14.3771 0 0 13.309 0 11.7803 0 0 13.0819 0 10.921 0 12.6031 0 10.7764 0 0 0 0 13.0801 0 0 15.3942 0 14.9001 14.3066 13.4931 14.7631 0 13.4087 0 14.3554 13.9638 12.6258 0 0 0 15.1198 15.2817 12.5142 0 14.0314 10.5784 0 0 15.6425 13.8647 13.1153 13.0101 0 13.8244 0 0 0 13.4259 13.1279 0 0 0 13.1962 13.3737 13.149 14.0536 12.3673 0 0 0 0 12.8034 0 0 0 11.5695 12.1819 12.6016 13.919 13.9998 15.1451 13.8191 0 14.069 0 0 0 0 12.9949 10.7545 13.7036 0 12.8145 0 13.6464 0 0 0 0 0 0 0 0 13.2446 0 15.1053 15.0822 14.0862 14.7456 15.5059 12.8541 0 0 12.4328 0 0 0 0 14.1839 0 14.293 0 0 P0CB33 ZN735_HUMAN Putative zinc finger protein 735 (Zinc finger protein 735 pseudogene) ZNF735 ZNF735P Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNCSSTLKTHK 0.99288 -14.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.661 0 0 0 0 0 0 0 0 0 10.6336 0 0 0 0 0 12.8685 11.7497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4676 0 0 0 0 0 0 0 12.5565 0 0 0 0 13.7562 0 0 0 0 0 0 11.206 0 0 0 0 0 0 0 0 0 20.9752 0 12.367 0 0 0 0 0 12.1577 0 0 0 0 0 0 0 13.6104 0 0 12.8856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6455 0 P16591 FER_HUMAN "Tyrosine-protein kinase Fer, EC 2.7.10.2 (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer)" FER TYK3 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; adherens junction assembly [GO:0034333]; adherens junction disassembly [GO:0120179]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; germ cell development [GO:0007281]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; Sertoli cell development [GO:0060009]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; type III intermediate filament [GO:0045098] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; type III intermediate filament [GO:0045098]; actin binding [GO:0003779]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; epidermal growth factor receptor binding [GO:0005154]; gamma-catenin binding [GO:0045295]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin cytoskeleton reorganization [GO:0031532]; adherens junction assembly [GO:0034333]; adherens junction disassembly [GO:0120179]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; germ cell development [GO:0007281]; innate immune response [GO:0045087]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; Sertoli cell development [GO:0060009]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0000226; GO:0001932; GO:0003779; GO:0004713; GO:0004715; GO:0005102; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006468; GO:0006935; GO:0007155; GO:0007169; GO:0007260; GO:0007281; GO:0008157; GO:0008283; GO:0008284; GO:0008289; GO:0010591; GO:0010762; GO:0018108; GO:0019221; GO:0030154; GO:0030335; GO:0030838; GO:0031234; GO:0031267; GO:0031532; GO:0032496; GO:0032869; GO:0033007; GO:0034333; GO:0034446; GO:0034614; GO:0035426; GO:0035556; GO:0036006; GO:0036119; GO:0038028; GO:0038095; GO:0038109; GO:0042058; GO:0042995; GO:0043304; GO:0044331; GO:0045087; GO:0045098; GO:0045295; GO:0045296; GO:0046777; GO:0048008; GO:0050904; GO:0051092; GO:0060009; GO:0070097; GO:0070102; GO:0070161; GO:0120179; GO:1990782 actin binding [GO:0003779]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; epidermal growth factor receptor binding [GO:0005154]; gamma-catenin binding [GO:0045295]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] CWDYKPENR 0.99288 -14.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1675 0 0 0 0 0 0 0 0 0 0 0 11.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5401 12.2928 0 0 0 0 9.47269 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4544 19.3691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6633 0 0 0 0 0 0 0 0 0 0 0 13.1111 0 0 0 0 13.5409 0 13.8158 0 0 0 0 0 0 0 0 12.3346 12.1198 0 0 0 0 0 0 14.1362 0 0 0 0 13.7619 0 0 0 0 0 0 0 0 0 0 11.6452 0 0 0 0 0 0 0 11.3377 0 15.328 14.9171 12.954 0 0 0 0 0 0 P23229 ITA6_HUMAN "Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6, Alpha6p ]" ITGA6 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589] GO:0005178; GO:0005886; GO:0005925; GO:0007044; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0010668; GO:0010976; GO:0030335; GO:0031589; GO:0031994; GO:0033627; GO:0035878; GO:0038132; GO:0042327; GO:0043065; GO:0043547; GO:0043589; GO:0045296; GO:0045944; GO:0046872; GO:0050900; GO:0098609; GO:2001237 cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132] AEALPLQR 0.99288 -39.46 0 0 0 0 0 0 0 0 14.21 0 0 0 0 14.5147 0 0 0 0 0 0 0 0 0 0 0 18.8071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.888 0 0 11.9945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8137 0 11.7313 0 0 0 18.8303 10.985 0 0 13.3938 0 14.4754 0 14.3775 13.7991 13.7401 14.0604 0 14.2317 14.2365 14.2929 0 14.3204 0 0 0 0 13.475 0 0 0 0 0 13.6028 12.9353 14.6927 0 12.3795 0 0 0 0 12.3534 0 12.3828 0 0 0 0 0 0 14.1018 0 0 0 0 0 0 0 0 0 12.1916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7647 14.4251 14.7595 0 14.7298 0 13.9345 0 0 0 0 0 0 0 0 0 12.2723 0 15.1735 0 0 0 0 12.6703 0 11.9728 15.5867 14.177 0 P32004 L1CAM_HUMAN "Neural cell adhesion molecule L1, N-CAM-L1, NCAM-L1 (CD antigen CD171)" L1CAM CAML1 MIC5 Homo sapiens (Human) axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808] axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904]; axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808] GO:0005886; GO:0005925; GO:0006935; GO:0007155; GO:0007156; GO:0007160; GO:0007399; GO:0007411; GO:0008046; GO:0009986; GO:0016021; GO:0016477; GO:0019904; GO:0030424; GO:0030425; GO:0031175; GO:0043025; GO:0044295; GO:0045773; GO:0050808; GO:0061564; GO:0062023 axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904] EDTQVDSEAR 0.99288 -7.1023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4031 0 0 0 12.4401 0 0 0 0 0 0 0 0 0 0 0 13.3912 0 0 12.8806 0 0 0 0 0 0 0 12.9953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7847 0 0 0 0 17.3323 0 0 12.9021 0 0 0 13.5523 0 12.9322 0 12.6543 0 0 12.2612 0 12.7119 0 0 0 0 0 0 0 0 0 P36915 GNL1_HUMAN Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1) GNL1 HSR1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456] extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198]; cellular response to DNA damage stimulus [GO:0006974]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456] GO:0002456; GO:0003924; GO:0005198; GO:0005525; GO:0005615; GO:0005634; GO:0006974; GO:0007165 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural molecule activity [GO:0005198] DSREEVER 0.99288 -44.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5274 0 15.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2879 0 19.1789 0 0 0 0 0 0 14.0835 14.0018 0 0 0 0 0 0 0 0 0 11.4104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.099 0 0 0 0 0 13.557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4916 0 14.8418 0 16.3814 14.8961 16.6691 15.5893 13.8478 0 0 0 0 0 14.9726 16.4538 0 0 0 0 11.3251 0 0 0 0 P51532 SMCA4_HUMAN "Transcription activator BRG1, EC 3.6.4.- (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A, BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4)" SMARCA4 BAF190A BRG1 SNF2B SNF2L4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]" bBAF complex [GO:0140092]; chromatin [GO:0000785]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; chromatin [GO:0000785]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; GBAF complex [GO:0140288]; kinetochore [GO:0000776]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; nuclear androgen receptor binding [GO:0050681]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]" GO:0000122; GO:0000776; GO:0000785; GO:0001188; GO:0001221; GO:0001650; GO:0002039; GO:0003407; GO:0003677; GO:0003713; GO:0003714; GO:0003723; GO:0004386; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008094; GO:0008284; GO:0016020; GO:0016363; GO:0016514; GO:0016586; GO:0016887; GO:0030071; GO:0030177; GO:0030308; GO:0030957; GO:0032991; GO:0043923; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0045944; GO:0047485; GO:0050681; GO:0051091; GO:0060766; GO:0070182; GO:0070316; GO:0070577; GO:0071564; GO:0071565; GO:0140092; GO:0140288; GO:0140658; GO:1901838; GO:1902459; GO:1902661; GO:1902895; GO:2000045; GO:2000781; GO:2000819 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; helicase activity [GO:0004386]; lysine-acetylated histone binding [GO:0070577]; nuclear androgen receptor binding [GO:0050681]; p53 binding [GO:0002039]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]" AFVPQLRSGKFNVLLTTYEYIIK 0.99288 -62.556 0 0 13.0149 0 0 0 11.5907 11.9587 14.5244 14.0718 12.159 0 15.1257 0 0 0 0 14.5982 0 10.4069 12.9467 0 0 0 0 0 0 0 15.9777 0 0 0 0 0 0 0 0 14.7099 0 0 15.051 0 0 0 13.6145 0 0 0 0 13.2468 0 0 0 0 0 11.2226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6751 0 0 0 12.9256 10.3142 0 0 0 0 12.3309 0 13.3207 13.2865 12.0753 13.1584 14.1808 13.1107 11.4146 13.9905 15.9984 0 13.6996 13.0881 13.0804 0 0 0 12.3269 14.6113 0 0 18.7529 14.6413 12.8064 0 13.116 12.7808 11.312 13.5292 0 13.729 18.3293 0 0 10.8207 12.9023 17.4511 0 0 0 13.2481 11.2833 12.0795 0 10.6364 13.7033 13.1643 10.844 12.2515 0 13.0329 12.2085 0 0 0 0 13.0599 19.1202 19.1015 0 12.4872 0 0 0 0 18.2287 0 10.2504 0 0 0 0 13.5559 14.1181 13.5089 15.7116 0 15.4424 0 0 0 0 0 0 12.8973 14.0544 0 10.0537 14.4144 12.7037 0 13.0889 0 0 0 13.81 0 0 0 Q02575 HEN1_HUMAN "Helix-loop-helix protein 1, HEN-1 (Class A basic helix-loop-helix protein 35, bHLHa35) (Nescient helix loop helix 1, NSCL-1)" NHLH1 BHLHA35 HEN1 Homo sapiens (Human) cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007417; GO:0030154; GO:0045944; GO:0046983; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" GPEPGEPGRK 0.99288 -7.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4112 0 0 0 0 0 0 0 0 0 Q15274 NADC_HUMAN "Nicotinate-nucleotide pyrophosphorylase [carboxylating], EC 2.4.2.19 (Quinolinate phosphoribosyltransferase [decarboxylating], QAPRTase, QPRTase)" QPRT Homo sapiens (Human) NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; quinolinate catabolic process [GO:0034213] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD metabolic process [GO:0019674]; quinolinate catabolic process [GO:0034213] GO:0004514; GO:0005737; GO:0005829; GO:0009435; GO:0019674; GO:0034213; GO:0042802; GO:0070062; GO:1902494 identical protein binding [GO:0042802]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514] VALNTLAR 0.99288 -7.1096 0 0 0 11.1703 0 0 11.2397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1485 0 0 0 0 0 0 0 0 0 0 9.73369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9187 13.7407 0 14.1965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7412 0 0 0 0 0 0 Q1KMD3 HNRL2_HUMAN "Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2, SAF-A2)" HNRNPUL2 HNRPUL2 Homo sapiens (Human) membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0016020 RNA binding [GO:0003723] ALLPHVLCK 0.99288 -24.199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2537 0 0 0 0 0 0 0 0 10.8888 11.4533 0 0 0 12.2428 0 0 14.6147 0 0 0 0 0 0 14.0874 12.5201 0 0 0 0 0 0 0 10.79 10.9146 13.3745 0 0 0 0 0 0 0 0 0 11.5183 13.2099 0 0 0 0 12.0919 0 0 0 0 11.157 0 14.0036 0 0 0 0 0 0 0 0 0 0 0 0 13.3699 12.6879 0 0 0 13.0487 0 13.0979 0 0 0 0 0 13.2836 14.7324 0 0 0 0 0 0 0 0 0 0 0 12.4241 13.2113 0 0 0 0 13.1921 0 0 0 0 0 0 0 0 0 10.5236 0 0 0 0 9.7546 0 13.3626 12.5421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5752 0 Q5VX52 SPAT1_HUMAN Spermatogenesis-associated protein 1 (Sperm-specific protein SP-2) SPATA1 Homo sapiens (Human) acrosomal vesicle [GO:0001669] acrosomal vesicle [GO:0001669] GO:0001669 EDLELYYK 0.99288 -14.312 0 0 0 0 0 16.4932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7607 0 0 0 0 0 0 0 0 0 0 0 13.4897 0 0 0 0 0 0 0 13.4319 0 0 13.7807 0 0 0 0 0 0 0 12.3247 0 13.3934 0 0 13.7895 0 12.0009 0 12.1198 0 0 12.9018 0 0 0 0 0 13.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4061 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9615 0 0 0 0 Q6F5E8 CARL2_HUMAN "Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)" CARMIL2 LRRC16C RLTPR Homo sapiens (Human) "actin filament network formation [GO:0051639]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; wound healing, spreading of cells [GO:0044319]" actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; wound healing, spreading of cells [GO:0044319]" GO:0001726; GO:0005543; GO:0005737; GO:0005886; GO:0007163; GO:0010592; GO:0015629; GO:0016020; GO:0016477; GO:0030011; GO:0030027; GO:0030335; GO:0031234; GO:0031252; GO:0034315; GO:0044319; GO:0044354; GO:0044877; GO:0045111; GO:0051639; GO:0061339; GO:0090091; GO:1900029; GO:1902745; GO:2000249; GO:2000813 phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877] AYSMILLPAEEEATLGARPDK 0.99288 -26.07 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6871 0 0 0 0 0 0 11.3175 0 0 0 0 0 0 0 13.5319 0 0 Q6TFL3 CC171_HUMAN Coiled-coil domain-containing protein 171 CCDC171 C9orf93 Homo sapiens (Human) AFQTSQQKWK 0.99288 -44.01 0 0 0 0 10.4887 0 0 0 0 0 0 0 0 0 12.3104 0 0 0 0 0 0 0 0 0 0 0 0 13.7712 13.3775 0 0 0 0 0 12.3231 12.9938 0 11.3557 0 0 0 0 0 0 0 0 0 0 0 12.0997 0 0 0 0 0 12.4582 0 0 0 0 0 0 0 10.4489 0 0 0 11.6233 0 12.4964 0 0 0 0 0 0 14.3786 0 11.9356 0 0 13.8513 0 0 0 0 0 12.6587 0 0 0 12.3809 0 0 0 0 0 0 15.5224 13.2112 14.1762 0 0 0 0 0 12.8244 13.6269 0 0 0 0 0 0 0 0 0 0 0 0 12.6469 14.0507 0 0 0 13.3531 0 14.2796 0 0 0 0 0 0 14.8535 0 13.5882 0 0 0 0 0 0 0 0 11.5787 0 0 0 0 11.9396 0 0 0 0 0 11.5022 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7577 0 0 12.4712 10.5084 0 0 0 0 0 Q7Z353 HDX_HUMAN Highly divergent homeobox HDX CXorf43 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DLATLKKYWDNGMTSLGSVCR 0.99288 -7.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6667 0 0 0 0 0 17.9227 0 16.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3Y9 K1C26_HUMAN "Keratin, type I cytoskeletal 26 (Cytokeratin-26, CK-26) (Keratin-25B, K25B) (Keratin-26, K26) (Type I inner root sheath-specific keratin-K25irs2)" KRT26 KRT25B Homo sapiens (Human) cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0070062 structural molecule activity [GO:0005198] DSTEETIVK 0.99288 -14.321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7026 0 0 0 0 0 0 0 14.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86T65 DAAM2_HUMAN Disheveled-associated activator of morphogenesis 2 DAAM2 KIAA0381 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; determination of left/right symmetry [GO:0007368]; dorsal spinal cord development [GO:0021516]; negative regulation of oligodendrocyte differentiation [GO:0048715]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actin filament polymerization [GO:0030833]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of filopodium assembly [GO:0051489]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; Wnt signaling pathway [GO:0016055] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; actin binding [GO:0003779]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; determination of left/right symmetry [GO:0007368]; dorsal spinal cord development [GO:0021516]; negative regulation of oligodendrocyte differentiation [GO:0048715]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of actin filament polymerization [GO:0030833]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of filopodium assembly [GO:0051489]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; Wnt signaling pathway [GO:0016055] GO:0003779; GO:0007368; GO:0016055; GO:0021516; GO:0030036; GO:0030833; GO:0031267; GO:0048715; GO:0051489; GO:0060828; GO:0070062; GO:0090263; GO:0090521; GO:2000050 actin binding [GO:0003779]; small GTPase binding [GO:0031267] ADRFLYEMSR 0.99288 -24.201 0 0 0 0 0 0 0 0 0 0 0 11.8364 0 0 12.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7681 0 0 0 0 0 0 0 0 13.3422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8012 13.0521 0 0 0 10.8974 12.8962 0 13.375 12.8626 12.1565 13.0075 0 15.0184 0 0 0 12.3353 13.4477 0 11.5352 0 11.9945 13.8565 0 0 0 13.5283 0 0 0 0 12.4162 13.5365 13.1694 0 0 12.9472 12.2214 0 12.9817 14.1347 13.7147 0 0 13.4298 14.4599 0 14.1628 0 13.8607 0 0 0 13.4301 14.2966 0 0 13.2067 13.9468 14.5784 14.4267 13.4588 11.7412 0 0 0 0 14.854 0 12.7424 14.6014 11.6847 0 0 13.1062 0 0 13.1901 0 0 0 14.9442 0 0 0 0 13.9151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5093 0 14.3217 0 0 0 0 0 0 Q86X10 RLGPB_HUMAN Ral GTPase-activating protein subunit beta (p170) RALGAPB KIAA1219 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005096; GO:0046982; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982] ALGFLVR 0.99288 -16.914 0 0 0 11.8312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.537 12.7811 0 0 0 0 0 12.4522 0 0 0 16.2206 16.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3839 0 14.6152 0 0 13.1374 0 10.4194 0 0 0 0 0 0 0 0 0 0 0 13.3534 0 0 0 0 0 0 0 16.5017 0 0 0 0 13.8186 0 0 0 0 0 0 0 0 0 14.2976 0 0 0 14.4564 14.605 13.7482 0 0 0 14.4107 14.3424 14.0897 0 0 0 0 14.2102 0 0 14.0393 0 0 0 0 0 0 0 13.1305 0 0 15.2773 0 0 13.3048 0 0 0 0 0 0 13.5771 12.832 0 0 0 0 0 13.1235 0 0 0 0 0 0 13.8385 12.8004 0 13.498 0 0 Q8IYD2 KLD8A_HUMAN "Kelch domain-containing protein 8A (Substitute for delta-EGFR expression 1, S-delta-E1)" KLHDC8A Homo sapiens (Human) AGVAVTALGKRIMVIGGVGTNQLPLK 0.99288 -16.479 0 0 10.7538 0 0 0 0 0 0 10.1643 0 0 0 0 12.5772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2532 0 0 0 0 0 10.9412 0 0 0 0 0 0 11.6892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3605 0 0 0 0 0 0 0 0 0 0 0 12.1059 0 0 14.8321 0 0 0 0 0 16.071 0 0 0 0 0 0 0 14.7602 14.5454 0 14.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4797 14.2232 12.1121 0 0 0 0 0 0 13.6071 0 0 14.0482 0 0 0 0 0 0 0 11.5261 13.0918 0 14.5448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2K0 ABD12_HUMAN "Lysophosphatidylserine lipase ABHD12, EC 3.1.-.- (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12, hABHD12) (Monoacylglycerol lipase ABHD12, EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12, EC 3.1.-.-)" ABHD12 C20orf22 Homo sapiens (Human) acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996] AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; protein depalmitoylation [GO:0002084]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996] GO:0002084; GO:0004620; GO:0004622; GO:0005789; GO:0005886; GO:0006660; GO:0007628; GO:0008474; GO:0009395; GO:0010996; GO:0016020; GO:0016021; GO:0019369; GO:0032281; GO:0032839; GO:0046464; GO:0046475; GO:0047372; GO:0050727; GO:0052651 acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620] FANDENVKHISCPLLILHAEDDPVVPFQLGRK 0.99288 -6.1832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.409 0 0 0 15.1183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9094 0 17.2451 0 0 0 0 0 0 0 0 0 0 13.1231 0 0 0 14.4654 0 0 0 0 0 0 0 0 0 0 0 12.8224 0 13.1044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N960 CE120_HUMAN "Centrosomal protein of 120 kDa, Cep120 (Coiled-coil domain-containing protein 100)" CEP120 CCDC100 Homo sapiens (Human) astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; stem cell proliferation [GO:0072089] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951]; stem cell proliferation [GO:0072089] GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0008022; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:0072089; GO:1903724; GO:1904951 protein C-terminus binding [GO:0008022] AKGAPPR 0.99288 -24.204 0 0 0 0 0 0 0 0 17.5959 0 0 12.9396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3245 0 0 0 17.114 0 0 0 0 12.0331 0 0 0 0 0 0 0 0 0 0 13.4074 13.3259 12.9322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4298 0 0 0 0 0 0 0 19.8607 0 0 0 0 0 0 0 0 0 13.6104 0 0 0 0 0 0 0 14.9277 0 13.7037 0 13.5477 0 13.5731 0 0 14.0927 14.8973 14.0777 0 0 11.4918 13.9589 0 13.7548 0 13.9941 13.578 13.7187 13.8307 0 0 13.8938 0 13.1342 0 0 0 0 13.9194 13.5188 0 0 13.7764 0 0 13.4169 0 0 0 0 0 13.2126 0 14.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7527 13.8881 15.9135 0 14.2516 18.7466 0 0 18.211 Q96CT7 CC124_HUMAN Coiled-coil domain-containing protein 124 CCDC124 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366] GO:0003713; GO:0003723; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0006366; GO:0007049; GO:0030496; GO:0051301 RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] AEAKAAADAK 0.99288 -14.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1399 12.5354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1909 0 0 0 0 0 0 0 0 0 0 0 0 13.3733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9594 0 0 0 0 0 12.3102 0 0 13.6646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6992 0 0 0 0 0 0 0 0 Q96KN7 RPGR1_HUMAN "X-linked retinitis pigmentosa GTPase regulator-interacting protein 1, RPGR-interacting protein 1" RPGRIP1 Homo sapiens (Human) neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601] axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206] axoneme [GO:0005930]; ciliary transition zone [GO:0035869]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601] GO:0005930; GO:0007601; GO:0032391; GO:0035869; GO:0046548; GO:0050896; GO:0061351; GO:0120206; GO:1905515 ARVPLLPLAK 0.99288 -14.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4257 0 0 0 14.5553 14.6423 0 0 12.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8518 0 15.3543 0 15.4765 0 0 0 0 0 18.8547 15.4254 0 0 0 0 12.8265 0 0 12.0381 17.7832 17.6036 17.1543 14.4582 16.6026 16.4371 16.5499 12.233 0 0 17.6189 0 0 14.4786 0 0 17.6972 17.8261 17.7134 17.0793 17.0695 17.6524 17.6005 17.844 17.1658 0 16.9647 17.0135 0 0 0 0 0 0 13.1442 12.6049 17.1437 0 0 11.4512 0 0 0 0 0 13.0464 0 0 0 17.0108 0 0 14.3266 11.1522 0 0 0 0 0 0 0 0 14.1495 11.3697 0 0 0 0 0 13.8496 0 12.1496 0 0 18.7093 0 0 0 Q96PZ2 F111A_HUMAN "Serine protease FAM111A, EC 3.4.21.-" FAM111A KIAA1895 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; negative regulation of viral genome replication [GO:0045071]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; replication fork processing [GO:0031297] chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; negative regulation of viral genome replication [GO:0045071]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; replication fork processing [GO:0031297] GO:0000785; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006508; GO:0006974; GO:0008233; GO:0016540; GO:0031297; GO:0045071; GO:0106300 peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697] AKKCQER 0.99288 -43.978 0 0 0 0 0 0 0 0 14.2846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0088 0 0 0 0 0 0 0 9.75957 0 0 0 0 0 0 10.92 0 13.497 0 0 0 0 0 0 12.7099 0 0 0 14.2368 0 0 0 20.7216 20.4149 17.3518 17.3122 17.4002 0 0 0 13.6656 13.5183 13.5114 20.0167 0 0 0 0 14.6495 14.2344 13.5681 0 11.8812 0 0 0 0 0 0 0 11.9217 0 0 13.4123 13.9119 0 9.96539 0 10.4437 0 0 0 0 0 0 12.1259 0 0 0 0 0 0 0 0 12.8734 0 0 13.1129 12.6276 13.2465 0 0 0 0 0 0 0 12.7385 11.8945 0 9.5308 0 0 0 0 0 0 0 10.1717 0 0 0 0 0 0 12.7045 0 0 0 0 0 0 0 0 0 0 0 Q9NRD9 DUOX1_HUMAN "Dual oxidase 1, EC 1.11.1.-, EC 1.6.3.1 (Large NOX 1) (Long NOX 1) (NADPH thyroid oxidase 1) (Thyroid oxidase 1)" DUOX1 DUOX LNOX1 THOX1 Homo sapiens (Human) cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590] GO:0004601; GO:0005509; GO:0005783; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0009986; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0031252; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0050661; GO:0050665; GO:0051591; GO:0090303; GO:0106293; GO:0106294; GO:2000147 calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] AELLPSGVTHLRFQR 0.99288 -6.1906 0 0 0 0 0 0 0 0 0 0 0 12.2403 0 0 11.3703 12.3157 0 12.1611 0 0 0 0 0 0 0 0 0 0 12.4875 12.7372 0 0 0 0 0 11.4935 0 0 0 0 16.6233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94619 0 0 0 0 0 0 12.7082 0 0 12.7169 0 11.0978 0 0 0 0 14.7341 14.6408 0 13.1656 17.9291 13.7677 0 0 0 0 0 0 11.7807 0 14.8641 0 13.2456 0 0 0 0 15.8425 0 0 0 14.7163 0 0 13.7898 0 13.3361 15.1105 11.8011 14.0527 0 10.9031 0 0 0 0 0 13.771 11.9745 0 0 0 0 0 16.5645 0 0 0 0 11.9496 0 11.4528 13.4375 0 0 0 13.3151 0 0 0 14.078 0 0 0 0 0 0 13.2488 0 0 0 0 0 0 0 0 12.3119 0 0 0 0 0 0 0 0 0 0 12.642 0 0 0 0 0 0 14.1928 Q9NYQ7 CELR3_HUMAN "Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1, EGF-like protein 1) (Flamingo homolog 1, hFmi1) (Multiple epidermal growth factor-like domains protein 2, Multiple EGF-like domains protein 2)" CELSR3 CDHF11 EGFL1 FMI1 KIAA0812 MEGF2 Homo sapiens (Human) "cell-cell adhesion [GO:0098609]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cell-cell adhesion [GO:0098609]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0016021; GO:0060071; GO:0098609 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] CCGELWATGSK 0.99288 -44.384 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0553 0 13.5905 0 0 0 11.6095 0 0 0 0 0 0 0 0 13.314 0 0 0 12.9503 0 0 0 0 0 0 14.0302 12.8253 0 11.528 0 0 0 13.3271 0 0 0 0 13.5493 14.7923 14.8717 14.6666 0 13.604 0 0 0 11.9412 11.4251 11.5475 10.3599 0 0 0 0 12.7473 0 0 0 0 0 0 12.8589 14.3602 13.8283 14.317 11.7981 14.4743 14.526 0 0 0 14.4479 12.9852 0 10.5008 0 12.8203 0 0 13.843 14.8523 11.542 14.3518 15.5797 11.2644 0 0 12.1585 15.2586 14.5585 0 0 12.7768 0 0 12.8335 13.1539 13.6371 13.1484 0 13.8424 0 11.9235 0 0 0 0 0 0 15.0556 13.6527 0 13.6063 0 15.1226 0 0 0 15.0812 0 15.0777 13.7095 13.5274 16.4723 0 13.9947 0 15.8859 0 14.9043 0 0 0 15.8758 0 0 0 0 0 0 0 0 0 11.4604 0 0 0 0 13.1955 13.5919 13.866 14.2274 15.1419 13.2146 0 0 0 13.7622 0 13.4751 15.0661 14.3516 0 12.0642 10.8644 0 Q9UHF7 TRPS1_HUMAN Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79) TRPS1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of chondrocyte differentiation [GO:0032330]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501]" GO:0000122; GO:0000785; GO:0000977; GO:0001227; GO:0001501; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0019904; GO:0032330; GO:0032991 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" CDFITQVEEEISRHYRR 0.99288 -6.1858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0039 0 0 0 0 0 0 0 0 13.7279 0 0 0 12.7912 0 0 0 12.2953 0 0 0 11.5859 0 0 0 0 12.5664 0 11.5863 0 0 0 0 0 0 0 0 0 0 0 0 15.1279 0 0 0 0 0 12.2661 0 0 0 0 0 11.6476 11.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4133 0 0 11.5581 0 0 0 0 0 0 0 0 0 0 0 11.491 0 0 0 0 0 0 0 Q9ULE6 PALD_HUMAN Paladin PALD1 KIAA1274 PALD Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein tyrosine phosphatase activity [GO:0004725] GO:0004725; GO:0005737; GO:0005829 protein tyrosine phosphatase activity [GO:0004725] AKSIIPNK 0.99288 -16.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8761 0 0 0 0 12.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8999 0 0 0 0 12.2512 12.4336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6958 0 0 0 0 0 0 0 0 0 14.1398 0 0 14.6888 0 0 0 0 0 0 14.2094 14.3875 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4552 0 0 14.5536 15.1572 14.9432 15.2654 13.0684 15.5576 0 13.6231 0 0 0 0 20.2474 14.7187 13.3449 14.0706 15.4416 14.452 16.0291 0 0 0 0 14.854 0 0 0 0 0 0 0 0 0 0 12.1847 13.9519 0 15.3074 14.5576 0 0 0 0 0 0 0 0 13.7175 13.5206 13.808 0 13.649 13.4849 0 0 0 0 0 0 0 0 0 0 0 Q9Y314 NOSIP_HUMAN "Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP, EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP) (eNOS-interacting protein)" NOSIP CGI-25 Homo sapiens (Human) negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of catalytic activity [GO:0043086]; negative regulation of nitric-oxide synthase activity [GO:0051001] GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0043086; GO:0051001; GO:0061630 RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] DFDCCCLSLQPCHDPVVTPDGYLYER 0.99288 -16.892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2991 11.159 0 0 0 0 0 0 0 0 0 10.6155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NHR8 FA47D_HUMAN Putative protein FAM47D FAM47DP Homo sapiens (Human) ELLQEDTPSTTECVSDSLQHR 0.99289 -26.296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3877 0 0 0 10.42 0 0 0 13.2506 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3769 0 0 13.2753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1503 0 0 0 0 0 0 0 13.3053 12.7181 12.6926 12.406 0 13.4391 0 0 0 0 0 0 13.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9216 12.9922 0 0 11.5735 0 0 0 13.2654 0 0 0 0 10.8127 0 0 0 0 0 0 0 0 12.7852 0 14.0331 0 13.7781 0 0 0 13.1904 0 0 0 0 0 0 0 0 0 0 0 0 0 O75909 CCNK_HUMAN Cyclin-K CCNK CPR4 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0006974; GO:0007049; GO:0008024; GO:0008353; GO:0009966; GO:0016538; GO:0019901; GO:0032786; GO:0032968; GO:0044828; GO:0051301; GO:0061575; GO:0070816; GO:2001165 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] ILLQTIKFDLQVEHPYQFLLKYAK 0.99289 -6.2233 0 0 0 0 0 0 11.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76095 JTB_HUMAN "Protein JTB (Jumping translocation breakpoint protein) (Prostate androgen-regulated protein, PAR protein)" JTB HSPC222 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860]; regulation of cell population proliferation [GO:0042127] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrion [GO:0005739]; spindle [GO:0005819] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrion [GO:0005739]; spindle [GO:0005819]; protein kinase binding [GO:0019901]; apoptotic mitochondrial changes [GO:0008637]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860]; regulation of cell population proliferation [GO:0042127] GO:0000278; GO:0000281; GO:0005737; GO:0005739; GO:0005815; GO:0005819; GO:0005887; GO:0008637; GO:0016020; GO:0019901; GO:0030496; GO:0042127; GO:0045860 protein kinase binding [GO:0019901] MLAGAGR 0.99289 -17.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2038 0 0 0 14.7149 0 0 0 0 0 0 0 14.387 0 0 0 0 0 0 0 14.3319 0 0 O94762 RECQ5_HUMAN "ATP-dependent DNA helicase Q5, EC 3.6.4.12 (DNA helicase, RecQ-like type 5, RecQ5) (RecQ protein-like 5)" RECQL5 RECQ5 Homo sapiens (Human) cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to ketone [GO:1901655]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]" "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993]; cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to ketone [GO:1901655]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]" GO:0000278; GO:0000724; GO:0000993; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016591; GO:0016887; GO:0032508; GO:0034244; GO:0042802; GO:0043138; GO:0051301; GO:0051304; GO:0071466; GO:0072757; GO:1901655; GO:1990414; GO:2000042 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA polymerase II complex binding [GO:0000993] ALGQEADK 0.99289 -39.898 0 0 0 11.912 0 0 0 10.9922 0 0 0 0 0 0 0 0 0 0 12.7 12.6107 12.8399 0 12.6244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1865 0 0 11.1433 0 0 0 0 0 0 12.3094 13.6793 13.599 0 0 0 0 0 0 0 0 0 0 9.98513 0 0 0 13.512 0 0 17.5761 0 0 12.3519 0 14.0507 0 14.0678 13.4592 18.9782 0 0 13.8521 14.7055 13.4385 0 13.5621 15.3141 0 0 11.5069 0 13.9058 12.6357 0 0 13.3137 14.4491 14.0585 15.4251 14.0755 19.3862 0 15.5474 0 0 14.4221 0 13.5473 0 0 14.6163 13.762 0 0 13.9765 14.2508 0 13.4654 0 0 14.2161 14.5918 14.4284 0 13.9769 13.5904 14.0812 0 14.2834 0 0 0 14.3086 12.0524 0 13.6479 0 14.1327 15.2355 13.7859 15.0353 0 13.5245 13.3015 0 11.8447 0 0 0 12.3701 13.8024 12.1426 0 0 14.0115 0 0 0 0 0 13.955 0 0 0 14.1323 0 0 0 0 0 14.0212 14.0072 13.5313 14.9367 12.4792 0 0 0 0 O95750 FGF19_HUMAN "Fibroblast growth factor 19, FGF-19" FGF19 UNQ334/PRO533 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070] GO:0001755; GO:0001934; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007399; GO:0007507; GO:0008083; GO:0008284; GO:0008543; GO:0009617; GO:0009887; GO:0010628; GO:0010629; GO:0014070; GO:0015721; GO:0030154; GO:0030334; GO:0045471; GO:0046326; GO:0046330; GO:0070374; GO:0070858 fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083] LPVSLSSAK 0.99289 -6.2283 0 0 0 0 0 0 12.5533 12.1255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3168 0 13.3771 0 14.2352 13.7304 0 12.9109 0 0 0 0 0 0 0 0 0 0 13.9737 0 13.0472 14.6626 0 0 0 0 0 0 0 14.4333 0 0 0 0 14.0392 12.3229 0 0 0 14.1873 0 13.8485 0 0 13.509 0 12.0573 0 0 0 0 0 0 14.2378 13.1029 0 0 0 0 0 0 0 0 13.4307 13.1914 0 0 14.2368 0 12.3967 0 13.6319 0 0 0 0 0 0 0 0 14.1209 0 0 0 0 0 0 0 0 0 0 13.4606 0 0 0 0 0 13.5719 0 13.7822 0 0 0 0 0 0 P03372 ESR1_HUMAN "Estrogen receptor, ER (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)" ESR1 ESR NR3A1 Homo sapiens (Human) "androgen metabolic process [GO:0008209]; antral ovarian follicle growth [GO:0001547]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; chromatin remodeling [GO:0006338]; epithelial cell development [GO:0002064]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; fibroblast proliferation [GO:0048144]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; male gonad development [GO:0008584]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in pregnancy [GO:0060745]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; protein localization to chromatin [GO:0071168]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of epithelial cell apoptotic process [GO:1904035]; regulation of inflammatory response [GO:0050727]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; signal transduction [GO:0007165]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; uterus development [GO:0060065]; vagina development [GO:0060068]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transcription preinitiation complex [GO:0097550]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transcription preinitiation complex [GO:0097550]; transcription regulator complex [GO:0005667]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nitric-oxide synthase regulator activity [GO:0030235]; nuclear estrogen receptor activity [GO:0030284]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; TBP-class protein binding [GO:0017025]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]; androgen metabolic process [GO:0008209]; antral ovarian follicle growth [GO:0001547]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; chromatin remodeling [GO:0006338]; epithelial cell development [GO:0002064]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; fibroblast proliferation [GO:0048144]; intracellular estrogen receptor signaling pathway [GO:0030520]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; male gonad development [GO:0008584]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in pregnancy [GO:0060745]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; protein localization to chromatin [GO:0071168]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of epithelial cell apoptotic process [GO:1904035]; regulation of inflammatory response [GO:0050727]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; signal transduction [GO:0007165]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; uterus development [GO:0060065]; vagina development [GO:0060068]" GO:0000122; GO:0000785; GO:0000791; GO:0000978; GO:0000981; GO:0001093; GO:0001221; GO:0001222; GO:0001223; GO:0001228; GO:0001547; GO:0002064; GO:0003682; GO:0003700; GO:0004879; GO:0005496; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0006366; GO:0007165; GO:0007200; GO:0007204; GO:0008013; GO:0008209; GO:0008270; GO:0008584; GO:0010629; GO:0010863; GO:0016020; GO:0016021; GO:0017025; GO:0019899; GO:0019901; GO:0030235; GO:0030284; GO:0030331; GO:0030518; GO:0030520; GO:0032355; GO:0032991; GO:0034056; GO:0034121; GO:0042802; GO:0043124; GO:0043433; GO:0043627; GO:0045429; GO:0045893; GO:0045899; GO:0045944; GO:0048144; GO:0048146; GO:0048863; GO:0050727; GO:0051000; GO:0051091; GO:0051117; GO:0060065; GO:0060068; GO:0060523; GO:0060527; GO:0060687; GO:0060745; GO:0060749; GO:0060750; GO:0071168; GO:0071391; GO:0071392; GO:0097550; GO:1903799; GO:1904035; GO:1990837 "ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; identical protein binding [GO:0042802]; nitric-oxide synthase regulator activity [GO:0030235]; nuclear estrogen receptor activity [GO:0030284]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; TBP-class protein binding [GO:0017025]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]" AGLTLQQQHQRLAQLLLILSHIR 0.99289 -16.98 0 0 0 0 0 0 0 0 11.7155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.709 0 0 0 0 0 14.6771 0 0 0 0 10.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5969 0 0 10.6717 0 0 0 0 0 12.9863 0 0 0 0 12.7279 0 0 0 0 P19525 E2AK2_HUMAN "Interferon-induced, double-stranded RNA-activated protein kinase, EC 2.7.11.1 (Eukaryotic translation initiation factor 2-alpha kinase 2, eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated, PKR, Protein kinase R) (Tyrosine-protein kinase EIF2AK2, EC 2.7.10.2) (p68 kinase)" EIF2AK2 PKR PRKR Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; defense response to virus [GO:0051607]; endoplasmic reticulum unfolded protein response [GO:0030968]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of NLRP3 inflammasome complex assembly [GO:1900225]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein phosphatase regulator activity [GO:0019888]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; cellular response to amino acid starvation [GO:0034198]; defense response to virus [GO:0051607]; endoplasmic reticulum unfolded protein response [GO:0030968]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of NLRP3 inflammasome complex assembly [GO:1900225]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; translation [GO:0006412] GO:0001819; GO:0003723; GO:0003725; GO:0004672; GO:0004674; GO:0004694; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006468; GO:0008285; GO:0009615; GO:0016020; GO:0017148; GO:0019888; GO:0030968; GO:0032722; GO:0032874; GO:0033689; GO:0034198; GO:0035455; GO:0042802; GO:0043066; GO:0043410; GO:0045071; GO:0045087; GO:0046777; GO:0048471; GO:0051092; GO:0051607; GO:0106310; GO:1900225; GO:1901224; GO:1901532; GO:1902033; GO:1902036 ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein phosphatase regulator activity [GO:0019888]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] FDLPDMK 0.99289 -14.398 0 14.1907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30101 PDIA3_HUMAN "Protein disulfide-isomerase A3, EC 5.3.4.1 (58 kDa glucose-regulated protein) (58 kDa microsomal protein, p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57, ER protein 57, ERp57) (Endoplasmic reticulum resident protein 60, ER protein 60, ERp60)" PDIA3 ERP57 ERP60 GRP58 Homo sapiens (Human) cellular response to interleukin-7 [GO:0098761]; extrinsic apoptotic signaling pathway [GO:0097191]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; recycling endosome membrane [GO:0055038]; Tapasin-ERp57 complex [GO:0061779] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; recycling endosome membrane [GO:0055038]; Tapasin-ERp57 complex [GO:0061779]; cysteine-type endopeptidase activity [GO:0004197]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; phospholipase C activity [GO:0004629]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; extrinsic apoptotic signaling pathway [GO:0097191]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976] GO:0002502; GO:0003723; GO:0003756; GO:0004197; GO:0004629; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0015035; GO:0015036; GO:0034975; GO:0034976; GO:0042470; GO:0042802; GO:0042824; GO:0045335; GO:0055038; GO:0061779; GO:0070062; GO:0097191; GO:0098761; GO:2001238 cysteine-type endopeptidase activity [GO:0004197]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; phospholipase C activity [GO:0004629]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723] ALERFLQDYFDGNLKR 0.99289 -17.407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6947 0 0 0 0 0 14.5858 0 0 0 0 0 0 16.0248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35251 RFC1_HUMAN "Replication factor C subunit 1 (Activator 1 140 kDa subunit, A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit, RF-C 140 kDa subunit, RFC140) (Replication factor C large subunit)" RFC1 RFC140 Homo sapiens (Human) "DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomerase [GO:0007004]" cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; telomere maintenance via telomerase [GO:0007004]" GO:0000122; GO:0003677; GO:0003689; GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0005730; GO:0005737; GO:0006261; GO:0006281; GO:0007004; GO:0008047; GO:0016887; GO:0019904; GO:0031391; GO:0043565; GO:0045893; GO:0061860; GO:0070062; GO:0090618 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565] DSGQSKSDK 0.99289 -70.723 0 0 0 0 0 0 0 0 0 0 0 0 0 11.734 0 11.9571 0 0 0 0 0 0 0 0 12.114 12.1182 0 12.1495 12.2101 0 12.2382 0 0 0 0 0 0 0 0 0 0 12.1378 0 0 0 0 0 12.6575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1344 0 0 0 0 0 0 0 0 0 0 0 0 14.5666 0 0 0 0 0 0 0 0 0 0 0 0 12.3279 12.1541 0 0 0 0 0 0 0 0 0 0 0 13.7549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7544 0 0 0 13.4414 0 0 0 0 0 13.326 0 12.0381 0 0 0 12.7905 0 0 13.1233 0 0 0 0 0 0 13.4952 0 0 0 0 0 0 0 13.5261 13.5114 0 0 0 0 13.7231 0 14.3214 0 12.9167 0 0 13.4713 0 0 Q4J6C6 PPCEL_HUMAN "Prolyl endopeptidase-like, EC 3.4.21.- (Prolylendopeptidase-like)" PREPL KIAA0436 Homo sapiens (Human) "Golgi to plasma membrane protein transport [GO:0043001]; proteolysis [GO:0006508]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde transport, endosome to Golgi [GO:0042147]" cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; Golgi to plasma membrane protein transport [GO:0043001]; proteolysis [GO:0006508]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0004252; GO:0005634; GO:0005794; GO:0005802; GO:0005829; GO:0005856; GO:0006508; GO:0008233; GO:0042147; GO:0043001; GO:2000300 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252] FLTINIMNK 0.99289 -7.3025 0 0 0 0 0 0 0 0 0 0 15.0129 10.9579 0 0 13.6048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.56136 0 0 0 0 0 0 0 0 0 11.5026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1202 0 0 12.4271 0 11.6527 12.6709 0 0 0 0 0 0 0 12.8245 0 0 14.8648 0 15.2768 0 13.9409 0 0 14.3122 15.5875 15.5345 0 0 14.017 0 0 0 0 0 0 0 0 0 0 12.2299 0 0 0 0 0 0 0 12.4204 0 0 13.5947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4128 0 10.0855 0 0 0 12.7452 0 0 12.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SV17 TM240_HUMAN Transmembrane protein 240 TMEM240 C1orf70 Homo sapiens (Human) anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; synaptic membrane [GO:0097060] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; synaptic membrane [GO:0097060] GO:0016021; GO:0070161; GO:0097060 ELGRRPHR 0.99289 -14.347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3371 12.8969 0 0 0 0 0 0 11.4572 0 0 0 0 10.8357 0 0 0 13.1619 0 0 Q6SJ93 F111B_HUMAN "Serine protease FAM111B, EC 3.4.21.- (Cancer-associated nucleoprotein)" FAM111B CANP Homo sapiens (Human) DNA replication [GO:0006260]; proteolysis [GO:0006508] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; peptidase activity [GO:0008233]; DNA replication [GO:0006260]; proteolysis [GO:0006508] GO:0000785; GO:0005634; GO:0006260; GO:0006508; GO:0008233 peptidase activity [GO:0008233] DGETKDVEHSR 0.99289 -24.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2369 0 0 0 0 0 0 12.4119 0 0 12.7792 11.2299 0 0 13.6534 0 0 0 0 0 13.1686 13.4428 0 0 0 0 0 0 0 0 0 0 14.6825 0 0 0 0 9.63648 0 0 0 0 0 0 0 0 0 0 0 0 13.0829 0 0 0 0 14.912 0 0 0 0 11.5313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6919 0 0 0 14.8419 0 14.9409 0 11.6671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70EL4 UBP43_HUMAN "Ubiquitin carboxyl-terminal hydrolase 43, EC 3.4.19.12 (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43)" USP43 Homo sapiens (Human) protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; cysteine-type deubiquitinase activity [GO:0004843]; ISG15-specific peptidase activity [GO:0019785]; protein deubiquitination [GO:0016579]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004843; GO:0005654; GO:0006511; GO:0016579; GO:0019785; GO:0019985 cysteine-type deubiquitinase activity [GO:0004843]; ISG15-specific peptidase activity [GO:0019785] AEVTEQLAALVRALWTREYTPQLSAEFK 0.99289 -26.32 0 0 0 0 9.38115 0 0 10.3285 13.6813 0 0 12.9837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6456 0 0 0 9.39436 0 0 13.4624 13.5971 0 0 14.263 14.4944 0 12.4776 0 11.7485 0 0 11.3398 0 0 0 0 0 9.41403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2902 14.3754 0 0 0 12.5839 0 0 13.9719 0 11.7591 0 0 0 0 0 13.6566 0 0 0 0 0 0 0 12.1435 0 0 0 0 11.3384 0 0 14.4832 0 0 0 0 0 17.4975 0 0 0 16.5888 13.0884 14.3405 0 13.6025 0 0 0 0 12.1936 12.4908 0 0 0 12.9993 0 0 0 0 0 11.5779 0 15.3146 0 0 0 0 0 0 15.8995 0 0 0 0 0 16.5753 0 0 10.5428 15.7766 0 15.3467 15.3837 17.5376 0 0 14.5894 15.7342 0 0 12.6241 0 0 0 0 0 0 16.2878 13.0359 16.6354 13.9553 0 Q86VF5 MOGT3_HUMAN "2-acylglycerol O-acyltransferase 3, EC 2.3.1.20, EC 2.3.1.22 (Acyl-CoA:monoacylglycerol acyltransferase 3, MGAT3) (Diacylglycerol O-acyltransferase candidate 7, hDC7) (Diacylglycerol acyltransferase 2-like protein 7) (Monoacylglycerol O-acyltransferase 3)" MOGAT3 DC7 DGAT2L7 UNQ9383/PRO34208 Homo sapiens (Human) glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432] GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0016021; GO:0019432; GO:1990578 2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144] GFVRLALR 0.99289 -14.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7264 0 0 0 0 0 0 0 0 0 0 13.7176 14.2683 0 0 0 0 0 0 0 0 13.975 0 0 0 0 0 0 0 0 0 0 12.725 0 0 12.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NA82 MARHA_HUMAN "Probable E3 ubiquitin-protein ligase MARCHF10, EC 2.3.2.27 (Membrane-associated RING finger protein 10) (Membrane-associated RING-CH protein X, MARCH-X) (RING finger protein 190) (RING-type E3 ubiquitin transferase MARCHF10)" MARCHF10 MARCH10 RNF190 Homo sapiens (Human) protein ubiquitination [GO:0016567] transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567] GO:0008270; GO:0016567; GO:0016740 transferase activity [GO:0016740]; zinc ion binding [GO:0008270] ESDDTEEETQSEECLWVGVR 0.99289 -14.381 0 0 11.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0935 0 0 0 0 0 0 16.0143 0 0 14.1474 0 14.6363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7542 0 0 12.8531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBJ5 GT251_HUMAN "Procollagen galactosyltransferase 1, EC 2.4.1.50 (Collagen beta(1-O)galactosyltransferase 1, ColGalT 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1)" COLGALT1 GLT25D1 PSEC0241 Homo sapiens (Human) collagen fibril organization [GO:0030199]; positive regulation of collagen fibril organization [GO:1904028] endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020] endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; procollagen galactosyltransferase activity [GO:0050211]; collagen fibril organization [GO:0030199]; positive regulation of collagen fibril organization [GO:1904028] GO:0005788; GO:0016020; GO:0030199; GO:0050211; GO:1904028 procollagen galactosyltransferase activity [GO:0050211] HPVSEYK 0.99289 -14.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9363 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7232 0 0 0 0 0 0 Q8NBP5 MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] GLPLRKTHVLLGR 0.99289 -6.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7515 0 0 0 0 0 0 0 0 14.205 0 0 0 0 0 0 0 0 14.0638 0 14.8812 0 0 0 0 0 0 0 15.0564 0 0 0 0 14.7015 0 0 14.6029 0 12.1127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7243 0 0 0 13.5152 0 Q8TCX5 RHPN1_HUMAN Rhophilin-1 (GTP-Rho-binding protein 1) RHPN1 KIAA1929 Homo sapiens (Human) negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165] cytosol [GO:0005829] cytosol [GO:0005829]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165] GO:0005829; GO:0007165; GO:0051497 AHLKRAILGQEEALR 0.99289 -16.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8878 10.1276 0 0 9.93549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7865 0 0 0 0 14.2352 0 0 0 0 0 0 0 0 0 0 13.6905 0 0 0 0 0 0 0 0 13.366 0 0 0 0 0 0 0 13.6134 0 0 13.9918 0 0 12.5816 0 14.7044 0 0 0 0 0 0 14.1485 0 0 0 0 13.7069 0 0 0 11.7141 0 13.9984 0 0 0 0 0 0 0 0 0 0 0 13.7038 0 0 0 0 0 0 0 0 0 14.1984 0 0 0 0 0 0 0 0 0 0 0 11.4659 0 0 11.312 0 0 0 0 0 0 0 0 0 13.1847 0 12.6073 0 0 12.2007 Q92994 TF3B_HUMAN "Transcription factor IIIB 90 kDa subunit, TFIIIB90, hTFIIIB90 (B-related factor 1, BRF-1, hBRF) (TAF3B2) (TATA box-binding protein-associated factor, RNA polymerase III, subunit 2)" BRF1 BRF GTF3B TAF3B2 TAF3C Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; transcription preinitiation complex assembly [GO:0070897]; tRNA transcription [GO:0009304]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIIB complex [GO:0000126]; transcription preinitiation complex [GO:0097550]; metal ion binding [GO:0046872]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; transcription preinitiation complex assembly [GO:0070897]; tRNA transcription [GO:0009304]" GO:0000126; GO:0000995; GO:0001006; GO:0005634; GO:0005654; GO:0006352; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0017025; GO:0045945; GO:0046872; GO:0070897; GO:0097550 metal ion binding [GO:0046872]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TBP-class protein binding [GO:0017025] ECISSQSSDPK 0.99289 -14.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8149 14.0538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.805 13.7488 0 0 14.5497 13.4629 0 0 10.8914 13.644 0 0 0 0 0 0 0 0 0 0 0 10.5764 0 0 0 14.8093 0 0 0 0 13.4206 12.8291 0 13.3122 0 0 13.9438 0 0 13.9659 0 0 0 0 0 0 0 0 0 0 0 12.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.521 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3644 0 0 0 0 13.8041 0 13.2301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96R28 OR2M2_HUMAN Olfactory receptor 2M2 (OST423) OR2M2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AFMKILGKGK 0.99289 -7.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8576 13.826 0 0 0 0 0 0 0 0 0 0 13.8255 0 0 0 13.6443 15.8296 0 0 0 0 0 13.8615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5941 0 0 0 0 0 0 0 0 0 0 0 0 13.5942 0 0 14.1631 0 14.0227 0 0 0 0 0 12.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7772 0 0 12.7541 0 0 0 0 0 0 0 Q9BPW5 RSLBB_HUMAN "Ras-like protein family member 11B, EC 3.6.5.2" RASL11B Homo sapiens (Human) negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] G protein activity [GO:0003925]; GTP binding [GO:0005525]; transforming growth factor beta receptor binding [GO:0005160]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] GO:0003925; GO:0005160; GO:0005525; GO:0030512 G protein activity [GO:0003925]; GTP binding [GO:0005525]; transforming growth factor beta receptor binding [GO:0005160] IAVVGASGVGKTALVVRFLTK 0.99289 -7.2919 12.8167 13.2364 13.4225 0 0 0 0 13.0088 0 0 0 0 0 0 0 13.7994 0 0 12.0081 0 0 14.4814 0 0 0 12.7065 13.6425 0 13.7578 0 0 0 0 11.8767 0 0 0 12.2847 0 0 0 0 0 0 0 0 0 0 0 12.8 0 0 0 0 12.3191 0 0 0 0 0 0 0 0 0 0 0 0 16.8906 16.7977 0 16.6587 16.7743 0 15.7509 0 19.5912 19.7075 19.686 18.3396 13.7389 17.4609 0 0 0 0 0 0 0 0 0 13.3652 0 0 0 0 0 0 14.5268 0 0 0 0 0 0 0 0 0 0 13.8981 0 0 0 0 0 12.4541 0 12.4532 13.9839 11.7287 0 0 0 11.3786 11.6372 0 0 0 0 0 0 15.2525 0 0 0 0 0 0 0 0 0 12.2184 0 10.9939 0 0 0 0 14.9245 0 0 13.3187 0 15.0424 0 0 0 0 0 0 13.7988 13.1463 0 0 0 0 12.8529 0 0 0 0 0 0 0 0 0 0 0 13.7092 14.5303 0 Q9BQN1 FA83C_HUMAN Protein FAM83C FAM83C C20orf128 Homo sapiens (Human) signal transduction [GO:0007165] protein kinase binding [GO:0019901]; signal transduction [GO:0007165] GO:0007165; GO:0019901 protein kinase binding [GO:0019901] ASPSQSRGQLDLLVPFPR 0.99289 -14.389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8446 0 0 0 0 11.376 0 0 0 0 0 0 0 13.1393 12.8953 0 0 0 0 12.4693 0 12.3859 0 0 0 0 0 0 11.1883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7766 11.9401 0 0 12.253 0 0 0 0 0 0 12.1024 0 11.9079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8685 0 11.928 0 11.4912 0 0 0 0 0 0 11.0139 0 0 0 0 0 0 0 0 0 12.5647 Q9BZJ0 CRNL1_HUMAN "Crooked neck-like protein 1 (Crooked neck homolog, hCrn)" CRNKL1 CRN CGI-201 MSTP021 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0016607; GO:0071007; GO:0071013; GO:0071014 RNA binding [GO:0003723] AITTLPR 0.99289 -13.334 0 0 0 0 0 0 0 0 0 0 0 0 12.1078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.318 12.5797 0 12.4853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5785 13.4626 0 0 0 0 0 0 0 0 0 0 15.3338 0 0 13.8009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9659 0 14.0377 0 15.1124 0 0 0 0 0 0 0 0 0 13.7314 0 0 0 0 0 0 0 0 10.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0153 13.8901 0 13.6103 0 13.4944 0 0 0 0 0 0 0 0 16.9676 0 0 14.0464 0 0 0 0 Q9H019 MFR1L_HUMAN Mitochondrial fission regulator 1-like MTFR1L FAM54B HYST1888 MSTP116 Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266] GO:0000266; GO:0005739; GO:0009060 DFHRMKQSQDLNR 0.99289 -5.0093 0 0 0 0 0 0 0 0 16.292 0 0 0 0 0 16.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5395 0 0 14.7965 0 0 0 0 0 0 0 17.8056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5569 13.0904 14.5259 17.4629 0 0 0 0 0 0 18.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8889 0 0 0 0 0 0 0 13.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4Z2 ZN335_HUMAN "Zinc finger protein 335 (NRC-interacting factor 1, NIF-1)" ZNF335 Homo sapiens (Human) "brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]" histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; neuron projection morphogenesis [GO:0048812]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone H3-K4 methylation [GO:0051569]" GO:0000976; GO:0000978; GO:0001701; GO:0002052; GO:0005634; GO:0005654; GO:0007420; GO:0010468; GO:0021895; GO:0035097; GO:0040029; GO:0045944; GO:0046872; GO:0048812; GO:0048854; GO:0050671; GO:0050769; GO:0051569; GO:0080182 metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976] ATLLRHMR 0.99289 -24.305 0 0 0 0 0 0 0 0 0 0 0 0 12.8327 0 10.913 0 0 0 0 0 0 0 0 11.3971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0229 0 11.5898 0 0 0 0 0 0 0 0 0 0 0 0 10.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8465 13.0959 13.5845 12.7659 0 0 0 0 0 18.3417 0 0 0 12.313 0 0 0 0 0 0 0 0 0 0 0 0 16.1432 0 16.2282 11.5906 0 0 0 0 0 11.81 0 0 0 0 0 0 0 0 0 0 0 14.3721 0 0 0 0 15.0881 0 0 0 11.3267 0 12.305 0 0 0 0 0 0 0 0 0 0 14.5801 0 14.0004 0 0 13.3771 12.6239 0 0 0 0 0 0 15.295 13.3382 13.1916 0 12.9842 0 0 0 0 0 0 10.8725 13.4061 0 0 0 0 0 0 0 0 0 0 Q9HAH7 FBRS_HUMAN Probable fibrosin-1 FBRS FBS FBS1 Homo sapiens (Human) HQEKMKGDSHK 0.99289 -14.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9379 0 0 0 0 12.6925 0 0 0 0 0 0 0 0 12.0515 0 0 0 0 0 0 11.5885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6856 0 0 0 0 0 0 0 0 13.2461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3318 15.9606 0 0 0 0 12.4038 0 0 13.966 12.6239 13.9817 0 0 0 0 0 0 13.7447 0 0 0 13.425 0 0 13.3133 0 0 14.7863 0 0 0 0 13.1686 0 0 0 0 0 0 12.4115 0 0 13.8401 12.3814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1055 0 0 0 0 0 0 0 0 0 11.9723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPC7 MYNN_HUMAN Myoneurin (Zinc finger and BTB domain-containing protein 31) MYNN OSZF ZBTB31 SBBIZ1 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to leukemia inhibitory factor [GO:1990830]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0046872; GO:1990830 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNSPKTGQNK 0.99289 -13.343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4401 0 0 0 0 0 0 0 0 0 13.4713 14.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5591 0 13.4243 0 13.9014 0 0 11.9975 0 12.6501 0 0 0 12.0449 0 12.0067 17.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6956 0 0 0 0 0 0 0 0 0 0 13.5023 0 0 0 0 0 0 0 0 11.8231 0 0 0 0 0 0 0 0 0 0 16.9759 0 0 13.7062 11.0408 0 0 0 0 13.2189 0 13.2087 12.8835 13.0561 13.551 13.5641 13.4471 0 13.1624 12.6148 0 0 0 0 0 0 0 0 0 0 0 13.1062 0 14.2363 0 0 Q9NPG1 FZD3_HUMAN "Frizzled-3, Fz-3, hFz3" FZD3 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; commissural neuron axon guidance [GO:0071679]; dopaminergic neuron axon guidance [GO:0036514]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; midbrain morphogenesis [GO:1904693]; motor neuron migration [GO:0097475]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of neuroblast proliferation [GO:0002052]; post-anal tail morphogenesis [GO:0036342]; response to electrical stimulus [GO:0051602]; response to xenobiotic stimulus [GO:0009410]; serotonergic neuron axon guidance [GO:0036515]; sympathetic ganglion development [GO:0061549]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] "apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; filopodium tip [GO:0032433]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; commissural neuron axon guidance [GO:0071679]; dopaminergic neuron axon guidance [GO:0036514]; establishment of planar polarity [GO:0001736]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; midbrain morphogenesis [GO:1904693]; motor neuron migration [GO:0097475]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; planar cell polarity pathway involved in axon guidance [GO:1904938]; positive regulation of neuroblast proliferation [GO:0002052]; post-anal tail morphogenesis [GO:0036342]; response to electrical stimulus [GO:0051602]; response to xenobiotic stimulus [GO:0009410]; serotonergic neuron axon guidance [GO:0036515]; sympathetic ganglion development [GO:0061549]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001736; GO:0001843; GO:0001942; GO:0002052; GO:0004930; GO:0005737; GO:0005886; GO:0009410; GO:0009986; GO:0016021; GO:0016324; GO:0016328; GO:0017147; GO:0030165; GO:0030182; GO:0030424; GO:0030425; GO:0032433; GO:0033278; GO:0036342; GO:0036514; GO:0036515; GO:0042472; GO:0042813; GO:0043025; GO:0045976; GO:0048786; GO:0051602; GO:0060070; GO:0060071; GO:0061549; GO:0071679; GO:0097475; GO:1900118; GO:1904693; GO:1904938 G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] AMTWIVFSLWPLTVFMGHIGGHSLFSCEPITLR 0.99289 -13.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4257 0 16.4509 17.3649 0 0 0 0 0 13.3778 13.2861 0 0 0 0 17.0622 11.9325 0 0 0 0 14.4048 0 12.7121 0 0 0 0 0 0 0 0 0 12.8599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5622 11.772 12.8817 0 11.3684 10.9468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4565 0 0 0 0 0 0 0 13.4299 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSB2 KRT84_HUMAN "Keratin, type II cuticular Hb4 (Keratin-84, K84) (Type II hair keratin Hb4) (Type-II keratin Kb24)" KRT84 KRTHB4 Homo sapiens (Human) hair follicle development [GO:0001942]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; nail development [GO:0035878]; regulation of keratinocyte differentiation [GO:0045616] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]; hair follicle development [GO:0001942]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424]; nail development [GO:0035878]; regulation of keratinocyte differentiation [GO:0045616] GO:0001942; GO:0005200; GO:0005829; GO:0030280; GO:0031424; GO:0035878; GO:0045095; GO:0045109; GO:0045616; GO:0070062 structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280] FASFIDK 0.99289 -13.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9098 14.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7456 0 0 0 0 0 0 0 0 13.3934 13.2328 13.3842 0 0 14.0072 13.5585 0 13.4087 0 0 0 11.87 0 0 0 0 0 0 0 0 0 0 0 13.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.212 10.5665 0 0 0 0 0 10.1244 0 0 0 0 0 0 0 0 11.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUD7 CT096_HUMAN Uncharacterized protein C20orf96 C20orf96 Homo sapiens (Human) AALRELR 0.99289 -14.385 0 0 0 0 0 0 0 10.1011 0 0 13.6624 0 11.6749 0 0 0 0 0 0 0 0 0 13.1867 0 0 10.735 0 0 0 0 0 0 0 0 0 0 0 12.0463 0 0 0 0 0 0 0 0 13.4385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.86 12.2039 0 0 0 13.7508 0 0 0 0 0 0 0 0 0 0 0 11.1311 0 0 0 0 0 0 0 14.1217 0 0 0 0 0 13.3945 0 0 0 0 0 0 0 14.1585 0 13.341 0 0 0 0 0 0 14.0172 0 0 13.826 0 13.3857 0 13.7133 0 0 0 13.0532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1038 0 0 11.5281 0 12.807 11.5819 0 0 Q9UKN7 MYO15_HUMAN Unconventional myosin-XV (Unconventional myosin-15) MYO15A MYO15 Homo sapiens (Human) actin filament organization [GO:0007015]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420] actin cytoskeleton [GO:0015629]; actin-based cell projection [GO:0098858]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; response to light stimulus [GO:0009416]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0007015; GO:0007605; GO:0007626; GO:0009416; GO:0015629; GO:0016459; GO:0030050; GO:0032420; GO:0042472; GO:0051015; GO:0070062; GO:0098858 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AHQVKTLVDDFILELKK 0.99289 -71.487 0 0 0 0 0 0 0 0 13.9156 12.7251 0 0 0 12.665 0 0 0 0 0 0 10.8609 0 0 0 0 12.5177 14.3973 0 0 0 10.1605 13.6278 0 12.9633 15.1441 14.1443 14.7955 13.8898 0 12.5017 14.2313 13.0332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.99464 0 0 15.4954 15.0194 14.561 15.339 0 17.0392 0 10.2705 15.2716 13.1851 0 14.6188 14.7095 14.6113 12.9678 0 13.5172 14.559 13.7628 0 14.4498 18.9027 13.2182 14.9407 14.9488 14.5336 13.412 0 13.7064 12.1838 14.5636 0 0 0 0 0 0 13.2558 12.5055 14.9571 0 13.2353 0 15.834 15.1522 15.1756 15.5817 0 0 13.477 15.8414 12.9108 0 11.9594 14.5432 16.5494 0 0 13.6599 12.9283 0 13.0026 0 0 13.1047 13.2763 14.7266 0 13.7413 0 16.5904 12.4566 14.7077 14.2541 0 13.0252 15.119 12.3993 12.5059 0 13.1421 0 15.6245 0 0 0 0 16.1127 14.2365 14.2096 12.4079 0 0 13.0296 0 0 0 0 0 15.046 13.9663 14.617 0 0 0 12.8998 13.9721 10.5397 0 15.3363 13.3052 0 0 12.9978 Q969S2 NEIL2_HUMAN "Endonuclease 8-like 2, EC 3.2.2.-, EC 4.2.99.18 (DNA glycosylase/AP lyase Neil2) (DNA-(apurinic or apyrimidinic site) lyase Neil2) (Endonuclease VIII-like 2) (Nei homolog 2, NEH2) (Nei-like protein 2)" NEIL2 Homo sapiens (Human) base-excision repair [GO:0006284]; depyrimidination [GO:0045008] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; microtubule binding [GO:0008017]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; depyrimidination [GO:0045008] GO:0003684; GO:0003906; GO:0005654; GO:0005737; GO:0006284; GO:0008017; GO:0008270; GO:0019104; GO:0043231; GO:0045008; GO:0072686; GO:0140078 class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; microtubule binding [GO:0008017]; zinc ion binding [GO:0008270] EGAADPK 0.9929 -16.241 0 0 0 11.6558 9.31522 0 12.4623 11.2444 15.2089 11.9154 12.0427 12.3192 13.3931 13.2879 0 13.6385 14.0669 13.4103 13.2825 15.166 0 10.8069 11.8737 0 11.9494 0 0 13.4996 11.3826 13.0877 15.0021 15.1474 0 16.3014 14.9281 15.4397 15.6333 15.6541 15.4605 15.1959 13.7323 0 0 12.9913 13.0396 13.3386 13.213 13.9438 13.5986 13.3531 13.711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4081 0 0 0 0 0 0 0 0 12.8097 0 0 12.4028 0 0 0 11.6484 12.0861 0 13.7298 0 13.565 0 0 0 0 0 0 13.6417 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5127 0 0 0 13.7325 0 0 0 15.6379 0 0 0 0 0 12.5838 12.575 0 0 16.018 15.9817 0 16.6676 15.4547 16.7271 17.0083 13.8808 16.5281 14.0167 15.3226 17.1641 16.6563 15.9238 0 0 0 0 16.2278 13.5454 15.6211 0 0 P42226 STAT6_HUMAN Signal transducer and activator of transcription 6 (IL-4 Stat) STAT6 Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-4-mediated signaling pathway [GO:0035771]; isotype switching to IgE isotypes [GO:0048289]; mammary gland epithelial cell proliferation [GO:0033598]; mammary gland morphogenesis [GO:0060443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mast cell proliferation [GO:0070666]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296] chromatin [GO:0000785]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-4-mediated signaling pathway [GO:0035771]; isotype switching to IgE isotypes [GO:0048289]; mammary gland epithelial cell proliferation [GO:0033598]; mammary gland morphogenesis [GO:0060443]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mast cell proliferation [GO:0070666]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165]; T-helper 1 cell lineage commitment [GO:0002296]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002296; GO:0002829; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0006952; GO:0007165; GO:0007259; GO:0019221; GO:0019903; GO:0033598; GO:0035771; GO:0042127; GO:0042802; GO:0043434; GO:0045121; GO:0045944; GO:0048289; GO:0048295; GO:0060397; GO:0060443; GO:0070301; GO:0070666; GO:0090575; GO:0120162; GO:1902170 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ALVLKRIQIWK 0.9929 -6.6098 0 0 13.1059 0 0 0 11.5237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7249 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8521 0 0 16.1785 0 12.0209 16.1253 16.034 13.5749 0 0 0 0 0 17.4937 0 0 0 0 0 0 13.8733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9125 0 0 12.8517 0 0 17.0489 0 12.7565 13.1873 13.458 13.3799 17.597 16.68 12.0402 0 0 0 0 0 17.1402 0 12.6218 17.2948 0 0 0 10.9103 0 0 0 12.7522 12.757 13.327 16.9708 0 0 16.9342 16.8621 0 0 0 0 0 0 12.8042 14.9775 17.728 12.9933 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2883 0 0 0 0 12.8838 0 0 0 0 0 A2RU30 TESP1_HUMAN Protein TESPA1 (Thymocyte-expressed positive selection-associated protein 1) TESPA1 KIAA0748 HSPC257 Homo sapiens (Human) COP9 signalosome assembly [GO:0010387]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization [GO:0008104]; T cell differentiation in thymus [GO:0033077]; TCR signalosome assembly [GO:0036399] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; TCR signalosome [GO:0036398] COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; TCR signalosome [GO:0036398]; phospholipase binding [GO:0043274]; signaling receptor binding [GO:0005102]; COP9 signalosome assembly [GO:0010387]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization [GO:0008104]; T cell differentiation in thymus [GO:0033077]; TCR signalosome assembly [GO:0036399] GO:0005102; GO:0005737; GO:0005789; GO:0005829; GO:0008104; GO:0008180; GO:0010387; GO:0033077; GO:0033089; GO:0036398; GO:0036399; GO:0043274; GO:0050862 phospholipase binding [GO:0043274]; signaling receptor binding [GO:0005102] ARKSLFQK 0.9929 -7.3324 0 0 0 0 0 0 0 0 0 0 14.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43194 GPR39_HUMAN G-protein coupled receptor 39 GPR39 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0046872 G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872] FVQRPLLFASRR 0.9929 -7.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3234 0 0 11.9949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9268 0 0 0 0 0 0 0 0 12.428 11.9459 0 0 0 0 12.2141 0 0 0 0 0 0 0 0 0 15.8822 13.0846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8834 13.3803 0 0 0 0 13.1013 0 11.3687 O75891 AL1L1_HUMAN "Cytosolic 10-formyltetrahydrofolate dehydrogenase, 10-FTHFDH, FDH, EC 1.5.1.6 (Aldehyde dehydrogenase family 1 member L1)" ALDH1L1 FTHFD Homo sapiens (Human) 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730]" GO:0004029; GO:0005829; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155; GO:0016742; GO:0070062 "aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]" ADPLGLEAEKDGVPVFK 0.9929 -7.3377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5693 0 0 13.7311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1537 0 0 0 0 0 0 0 0 15.0787 0 13.4788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1941 0 0 0 0 13.2215 0 0 0 0 0 0 0 0 14.4788 0 12.2679 0 0 0 0 0 0 0 0 14.2082 0 0 0 0 11.9277 0 0 0 11.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8769 0 0 0 0 0 0 0 0 0 0 11.6318 0 0 0 0 0 0 0 P04053 TDT_HUMAN "DNA nucleotidylexotransferase, EC 2.7.7.31 (Terminal addition enzyme) (Terminal deoxynucleotidyltransferase, Terminal transferase)" DNTT TDT Homo sapiens (Human) DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; double-strand break repair via nonhomologous end joining [GO:0006303] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA nucleotidylexotransferase activity [GO:0003912]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA metabolic process [GO:0006259]; DNA modification [GO:0006304]; double-strand break repair via nonhomologous end joining [GO:0006303] GO:0003677; GO:0003887; GO:0003912; GO:0005634; GO:0005654; GO:0005829; GO:0006259; GO:0006303; GO:0006304; GO:0046872 DNA binding [GO:0003677]; DNA nucleotidylexotransferase activity [GO:0003912]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] CFLIFKLPR 0.9929 -41.195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7553 0 0 0 0 12.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8072 0 15.2758 0 15.9464 0 0 0 0 0 0 0 0 0 13.8169 0 0 0 0 0 0 0 0 15.2202 0 14.3372 0 0 0 14.1693 0 0 0 15.3226 13.5141 0 0 0 13.1609 0 13.7204 0 0 14.7872 0 14.906 0 0 14.5037 14.2286 14.5259 0 0 0 12.6167 12.399 0 0 0 0 0 0 15.859 15.2111 0 0 0 0 0 0 12.8532 13.4046 0 12.9972 13.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5197 0 0 0 0 13.2915 15.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2249 0 0 P28370 SMCA1_HUMAN "Probable global transcription activator SNF2L1, EC 3.6.4.- (ATP-dependent helicase SMARCA1) (Nucleosome-remodeling factor subunit SNF2L) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1)" SMARCA1 SNF2L SNF2L1 Homo sapiens (Human) "brain development [GO:0007420]; chromatin remodeling [GO:0006338]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" ATPase complex [GO:1904949]; CERF complex [GO:0090537]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589] "ATPase complex [GO:1904949]; CERF complex [GO:0090537]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; nucleosome binding [GO:0031491]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0007420; GO:0016589; GO:0016787; GO:0030182; GO:0031491; GO:0036310; GO:0043231; GO:0045893; GO:0045944; GO:0061629; GO:0090537; GO:0140658; GO:1904949 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; nucleosome binding [GO:0031491]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] ALDAKIARYK 0.9929 -26.709 0 0 0 0 0 0 0 0 0 10.6323 0 10.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9932 0 0 0 13.5237 0 0 0 0 0 0 0 0 0 0 10.3481 11.5428 0 13.3914 0 0 10.541 0 0 0 0 0 0 0 0 0 0 9.17493 0 0 14.7114 0 0 0 0 11.0519 15.9926 0 0 13.2894 12.6585 0 12.5763 0 0 10.7865 0 0 0 13.1097 10.7361 0 10.8813 15.2098 15.0166 0 0 0 13.3218 15.6076 0 12.4538 15.7904 0 0 0 0 0 12.0239 0 0 0 0 0 0 0 0 0 12.2811 0 14.1337 0 0 14.2226 14.4696 0 0 0 12.4162 0 0 0 0 12.8223 0 11.7638 0 11.4791 0 0 0 0 11.0917 0 0 0 13.6653 11.3797 0 12.4066 11.3281 0 12.2364 14.7108 0 0 0 12.5476 0 0 0 0 0 0 0 0 0 0 0 0 16.0816 0 0 0 0 0 0 0 0 12.8886 0 0 P34897 GLYM_HUMAN "Serine hydroxymethyltransferase, mitochondrial, SHMT, EC 2.1.2.1 (Glycine hydroxymethyltransferase) (Serine methylase)" SHMT2 Homo sapiens (Human) folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] GO:0000900; GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0006544; GO:0006563; GO:0006564; GO:0006565; GO:0006730; GO:0008270; GO:0008284; GO:0008732; GO:0009113; GO:0015630; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:0070905; GO:1903715 chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270] AFPMPGFDEH 0.9929 -6.4205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9524 0 17.5456 0 17.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.1534 0 0 0 0 0 0 0 0 0 12.7931 0 12.7678 0 0 0 0 0 0 0 0 0 0 12.0057 0 0 0 0 0 0 0 0 0 0 0 12.94 0 0 12.8411 0 0 0 0 0 0 12.6568 0 14.5623 14.4911 0 12.5928 0 0 0 12.2932 0 0 0 13.5778 0 0 0 0 0 19.5074 0 0 0 12.4037 18.5645 18.4113 0 0 0 0 0 0 0 0 11.2779 0 0 12.6584 0 0 0 0 0 13.5056 0 0 17.7195 0 0 0 12.9406 0 0 0 0 0 0 Q00839 HNRPU_HUMAN "Heterogeneous nuclear ribonucleoprotein U, hnRNP U (GRIP120) (Nuclear p120 ribonucleoprotein) (Scaffold-attachment factor A, SAF-A) (p120) (pp120)" HNRNPU C1orf199 HNRPU SAFA U21.1 Homo sapiens (Human) "adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA processing [GO:0006396]" catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697] "catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697]; actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714]; adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA processing [GO:0006396]" GO:0000122; GO:0000228; GO:0000381; GO:0000398; GO:0000776; GO:0000922; GO:0000978; GO:0000993; GO:0001097; GO:0001649; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003714; GO:0003723; GO:0003725; GO:0003727; GO:0003730; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005813; GO:0005829; GO:0006396; GO:0007049; GO:0007346; GO:0008143; GO:0009048; GO:0009986; GO:0016020; GO:0016363; GO:0016607; GO:0017069; GO:0017130; GO:0030496; GO:0031490; GO:0032211; GO:0032839; GO:0032922; GO:0032991; GO:0033673; GO:0034046; GO:0034244; GO:0036002; GO:0036464; GO:0042802; GO:0043021; GO:0044877; GO:0045944; GO:0048255; GO:0051301; GO:0051457; GO:0055013; GO:0070034; GO:0070934; GO:0070937; GO:0071013; GO:0071385; GO:0072686; GO:0090336; GO:0098577; GO:0098963; GO:0099122; GO:0106222; GO:1900152; GO:1901673; GO:1902275; GO:1902425; GO:1902889; GO:1990023; GO:1990280; GO:1990498; GO:1990830; GO:1990837; GO:1990841; GO:1990845; GO:1990904; GO:2000373; GO:2000648; GO:2000737; GO:2000767 actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; lncRNA binding [GO:0106222]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714] APVFPGR 0.9929 -26.719 14.3774 0 14.4897 0 0 0 11.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.68131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5053 0 0 0 0 0 0 0 0 0 15.0017 15.5138 15.1177 14.733 12.7057 12.4761 12.3148 12.0959 12.0994 12.213 0 0 0 12.1476 0 0 0 12.4525 0 0 12.7667 15.9418 0 12.6012 11.7918 12.3856 0 17.8334 13.7804 0 19.736 0 12.7301 17.9166 13.3542 14.5401 0 14.9859 15.3443 14.5769 19.6427 19.6712 0 14.073 13.2648 0 0 0 0 14.096 13.2771 12.4684 0 0 0 0 0 14.0971 0 0 0 13.8107 0 11.3535 0 0 0 9.81141 0 0 0 0 16.171 16.2382 0 0 11.7269 16.454 0 0 13.5834 13.6954 12.3287 0 14.1766 0 0 0 0 0 0 0 0 0 16.5239 16.4271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.906 11.1777 13.2396 0 0 0 11.622 0 Q13224 NMDE2_HUMAN "Glutamate receptor ionotropic, NMDA 2B, GluN2B (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B, NMDAR2B, NR2B) (N-methyl-D-aspartate receptor subunit 3, NR3, hNR3)" GRIN2B NMDAR2B Homo sapiens (Human) "brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]" anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060] "anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synaptic membrane [GO:0097060]; amyloid-beta binding [GO:0001540]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron death [GO:1901216]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]" GO:0001540; GO:0004972; GO:0005737; GO:0005764; GO:0005770; GO:0005789; GO:0005856; GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007420; GO:0007611; GO:0008270; GO:0009986; GO:0014069; GO:0015276; GO:0016594; GO:0016595; GO:0017146; GO:0022849; GO:0035235; GO:0038023; GO:0043005; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0051290; GO:0051968; GO:0060079; GO:0060291; GO:0070161; GO:0097060; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:1901216; GO:1902951; GO:1904062; GO:2000463; GO:2001056 amyloid-beta binding [GO:0001540]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; glycine binding [GO:0016594]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270] EEAALAPR 0.9929 -7.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.276 0 0 11.6814 13.7561 13.9323 0 13.896 13.5209 13.1609 0 14.6491 13.5161 0 0 0 0 13.7813 0 14.7875 0 13.4931 0 15.1926 12.9363 0 0 0 13.4741 0 0 0 0 0 0 0 0 0 0 0 0 14.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9802 0 0 0 0 0 0 0 0 10.7866 15.7429 0 0 0 0 11.4391 13.4548 0 0 14.5309 0 0 0 0 13.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2535 0 0 0 0 0 0 0 0 0 0 Q5T3U5 MRP7_HUMAN "ATP-binding cassette sub-family C member 10, EC 7.6.2.2, EC 7.6.2.3 (Multidrug resistance-associated protein 7)" ABCC10 MRP7 SIMRP7 Homo sapiens (Human) leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085] GO:0005524; GO:0005765; GO:0005886; GO:0006691; GO:0006869; GO:0008559; GO:0015431; GO:0016020; GO:0016021; GO:0016323; GO:0042626; GO:0043225; GO:0055085; GO:0071716; GO:0140359 ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626] AGPPSEILPLVQAVPK 0.9929 -6.4231 0 0 0 0 0 0 0 0 0 0 0 0 12.0094 0 0 0 0 0 0 0 0 0 0 0 0 11.0711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.492 0 13.8712 0 0 0 12.679 0 0 13.5336 12.1335 16.8911 12.1036 16.7106 0 0 0 0 15.4703 10.5653 0 0 0 0 0 12.7411 0 13.8928 13.4751 12.6828 0 0 0 0 0 13.5682 0 0 0 11.6884 0 13.8575 0 0 0 0 0 0 0 10.5363 14.882 0 0 0 0 0 0 0 0 0 0 0 12.6046 0 11.248 0 0 0 0 0 13.3551 12.8323 0 0 0 0 0 0 0 14.9733 10.909 14.2033 0 0 0 0 10.6897 11.1165 0 0 12.7937 0 13.5638 0 0 0 0 0 15.5991 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2H8 TMM53_HUMAN Transmembrane protein 53 TMEM53 Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 AAMLRLLLLVAFALVVVLFHVLLAPITALFHTHFYDR 0.9929 -7.3352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5355 0 0 0 0 0 0 12.4635 0 0 0 0 12.9162 0 0 14.7444 0 14.5918 0 0 0 0 14.0862 0 0 0 0 0 0 0 0 14.9961 0 0 0 0 0 0 0 0 0 0 0 0 13.9907 12.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4841 0 0 13.2006 0 0 0 0 0 0 0 0 0 0 13.2457 0 0 0 14.279 0 14.2876 0 0 0 0 0 0 0 0 0 11.5471 12.4108 0 0 0 0 0 0 0 0 0 0 0 0 11.4345 Q8TBZ6 TM10A_HUMAN "tRNA methyltransferase 10 homolog A, EC 2.1.1.221 (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A)" TRMT10A RG9MTD2 Homo sapiens (Human) tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939] GO:0000049; GO:0002939; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0009019; GO:0015629; GO:0030488; GO:0052905; GO:0070062 RNA binding [GO:0003723]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049] DIHIKPEHYSELIK 0.9929 -6.4252 0 0 9.95366 0 10.6334 0 0 0 0 14.6634 0 14.0909 11.418 0 0 0 0 0 0 0 0 0 0 11.4451 0 0 0 0 14.0493 0 10.7611 0 0 0 0 0 0 0 0 0 0 0 0 13.913 0 10.5621 0 0 0 0 10.5357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3086 12.0526 0 0 0 0 0 0 0 0 13.2712 0 0 15.4027 0 0 0 14.5612 0 12.8129 14.8948 0 0 0 0 0 13.5119 0 0 15.0394 12.2559 0 0 12.7737 0 12.81 13.2233 0 0 0 0 0 0 0 0 0 0 12.6234 0 0 0 12.652 0 0 0 0 0 12.6253 0 0 0 0 11.4872 0 0 0 0 0 0 0 0 12.0072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5042 0 0 0 0 Q8TE60 ATS18_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 18, ADAM-TS 18, ADAM-TS18, ADAMTS-18, EC 3.4.24.-" ADAMTS18 ADAMTS21 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508] GO:0001654; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0090331 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] ACNTNFCPAPEK 0.9929 -41.294 0 0 0 0 11.3017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5807 0 0 0 0 0 10.0926 0 0 12.3508 0 0 0 0 0 9.73271 11.3985 0 0 0 0 0 0 11.327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.603 0 12.0549 0 0 0 0 0 12.0647 13.4126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0822 0 0 12.0669 0 0 0 0 0 0 0 0 0 11.4378 0 12.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5804 13.0956 0 0 0 0 0 0 18.8936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW14 CJ082_HUMAN Uncharacterized protein C10orf82 C10orf82 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 EDDMNHCVK 0.9929 -16.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9112 0 0 10.2993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4965 0 0 0 0 0 13.5498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FE7 P3IP1_HUMAN "Phosphoinositide-3-kinase-interacting protein 1, PI3K-interacting protein 1 (Kringle domain-containing protein HGFL)" PIK3IP1 HGFL Homo sapiens (Human) negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067] GO:0005886; GO:0014067; GO:0016021; GO:0036313; GO:0043553 phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313] DLKEQHDQK 0.9929 -6.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NM4 TOX2_HUMAN "TOX high mobility group box family member 2 (Granulosa cell HMG box protein 1, GCX-1)" TOX2 C20orf100 GCX1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0031490; GO:0045944 chromatin DNA binding [GO:0031490]; transcription coactivator activity [GO:0003713] LGLLLLAR 0.9929 -7.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BPY3 F118B_HUMAN Protein FAM118B FAM118B Homo sapiens (Human) Cajal body organization [GO:0030576] Cajal body [GO:0015030] Cajal body [GO:0015030]; identical protein binding [GO:0042802]; Cajal body organization [GO:0030576] GO:0015030; GO:0030576; GO:0042802 identical protein binding [GO:0042802] DCLYEVFDDLESK 0.9929 -6.2436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9569 0 0 0 0 0 0 0 11.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7112 0 0 11.376 10.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0739 0 0 0 10.3785 13.6026 0 0 0 14.6862 14.5331 12.372 0 13.0161 0 13.7095 0 0 0 0 0 0 13.2103 13.6106 0 0 0 13.5293 0 0 12.5038 0 12.9354 13.0083 0 0 0 0 0 0 0 13.3727 11.8448 13.5482 0 0 0 0 13.6059 0 0 13.923 0 0 0 0 14.4388 0 0 11.3862 0 0 13.1873 12.4229 13.0618 11.3916 0 0 0 0 0 0 0 0 0 10.9575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQG0 MBB1A_HUMAN Myb-binding protein 1A MYBBP1A P160 Homo sapiens (Human) "cellular response to glucose starvation [GO:0042149]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]" B-WICH complex [GO:0110016]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "B-WICH complex [GO:0110016]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; cellular response to glucose starvation [GO:0042149]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]" GO:0001649; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006338; GO:0006355; GO:0016020; GO:0022904; GO:0032922; GO:0035066; GO:0042149; GO:0042254; GO:0042564; GO:0043231; GO:0043565; GO:0045892; GO:0045943; GO:0045944; GO:0045945; GO:0070888; GO:0072332; GO:0110016; GO:1903450; GO:2000210 E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714] AAAFQHLLLLVGIHLLK 0.9929 -41.219 0 0 0 12.3737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.85 0 0 0 0 13.1938 0 13.6917 0 10.3687 0 0 0 0 0 13.1212 0 10.9912 0 0 13.0728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6867 0 0 0 13.2247 0 0 0 0 12.5583 11.6437 0 0 0 0 0 14.2519 11.9295 0 0 0 14.158 13.1364 13.6239 0 0 13.3991 0 14.3979 0 0 0 0 14.5594 0 0 12.117 12.3442 11.0443 0 0 0 11.4155 0 13.9621 0 0 0 0 0 0 0 0 14.069 0 0 0 14.1876 11.5045 0 0 12.2516 0 0 0 0 13.0059 0 12.9423 0 0 13.8366 0 11.0996 0 0 0 12.4762 11.0933 13.6493 0 0 11.5817 14.2077 0 0 12.8025 0 0 14.3551 0 13.658 12.6522 14.3321 0 11.4127 0 0 0 0 0 13.1765 0 0 0 12.5063 0 0 0 14.6882 0 0 Q9BVV7 TIM21_HUMAN "Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)" TIMM21 C18orf55 TIM21 HSPC154 Homo sapiens (Human) intracellular protein transport [GO:0006886]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein import into mitochondrial matrix [GO:0030150] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; intracellular protein transport [GO:0006886]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein import into mitochondrial matrix [GO:0030150] GO:0005743; GO:0005744; GO:0006886; GO:0016021; GO:0030150; GO:0032981; GO:0033617 CRSHPEVIGVFGESVKGYGEVTR 0.9929 -16.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8258 14.8096 0 0 0 0 0 0 0 12.9159 0 0 0 0 12.6934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3208 0 17.4503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0965 12.5481 0 0 0 13.7901 13.3639 12.6833 0 0 13.7584 0 14.0487 0 0 0 0 0 10.9211 0 10.1524 0 11.9639 0 0 0 0 11.477 0 0 0 0 0 0 0 0 14.6364 0 14.1065 0 0 0 0 0 14.2628 0 0 14.0672 0 0 13.3142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5976 0 0 11.2178 0 0 0 0 0 0 13.9426 0 0 Q9NS98 SEM3G_HUMAN Semaphorin-3G (Semaphorin sem2) SEMA3G Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005102; GO:0005615; GO:0005887; GO:0007411; GO:0030215; GO:0030335; GO:0030517; GO:0045499; GO:0048843; GO:0050919; GO:0070062; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; signaling receptor binding [GO:0005102] DPYCAWDGASCTHYR 0.9929 -16.267 0 0 0 0 0 0 0 0 0 13.5951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.06738 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4703 0 0 0 0 0 13.1721 0 0 0 0 0 0 0 14.1627 0 0 0 0 0 14.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3088 0 0 0 0 0 0 0 0 0 0 0 13.6106 0 0 12.9619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8728 0 0 0 11.0606 0 0 0 0 0 0 0 0 0 14.8442 14.3749 0 0 0 0 0 0 0 0 0 0 12.9472 0 0 0 13.2374 0 0 0 0 0 0 0 16.7113 Q9NUX5 POTE1_HUMAN "Protection of telomeres protein 1, hPot1 (POT1-like telomere end-binding protein)" POT1 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; establishment of protein localization to telomere [GO:0070200]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA helicase activity [GO:1905776]; positive regulation of DNA strand elongation [GO:0060383]; positive regulation of helicase activity [GO:0051096]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of DNA helicase activity [GO:1905774]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820] "chromosome, telomeric region [GO:0000781]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]" "chromosome, telomeric region [GO:0000781]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; DEAD/H-box RNA helicase binding [GO:0017151]; G-rich single-stranded DNA binding [GO:1990955]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded telomeric DNA binding [GO:0043047]; telomerase inhibitor activity [GO:0010521]; telomeric D-loop binding [GO:0061821]; telomeric DNA binding [GO:0042162]; DNA duplex unwinding [GO:0032508]; establishment of protein localization to telomere [GO:0070200]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA helicase activity [GO:1905776]; positive regulation of DNA strand elongation [GO:0060383]; positive regulation of helicase activity [GO:0051096]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of DNA helicase activity [GO:1905774]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820]" GO:0000781; GO:0000783; GO:0005654; GO:0007004; GO:0010521; GO:0016233; GO:0017151; GO:0032202; GO:0032206; GO:0032210; GO:0032211; GO:0032212; GO:0032508; GO:0042162; GO:0043047; GO:0051096; GO:0051973; GO:0051974; GO:0060383; GO:0061820; GO:0061821; GO:0070187; GO:0070200; GO:0098505; GO:1905773; GO:1905774; GO:1905776; GO:1990955; GO:2001032 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; DEAD/H-box RNA helicase binding [GO:0017151]; G-rich single-stranded DNA binding [GO:1990955]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded telomeric DNA binding [GO:0043047]; telomerase inhibitor activity [GO:0010521]; telomeric D-loop binding [GO:0061821]; telomeric DNA binding [GO:0042162] CQQLSATILTDHQYLERTPLCAILKQK 0.9929 -6.43 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9913 13.195 0 0 0 0 0 13.6649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4953 11.1714 0 0 0 0 14.4572 0 14.9402 0 0 0 0 0 0 0 14.6828 0 0 0 0 0 0 0 0 14.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4934 0 0 0 0 0 12.1864 Q9UNF1 MAGD2_HUMAN "Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein, BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen)" MAGED2 BCG1 Homo sapiens (Human) female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294] cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093] cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294] GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294 DPKEWAAQYR 0.9929 -7.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4895 0 0 0 0 0 0 0 12.7377 0 0 0 13.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9323 0 15.3101 0 13.2066 0 0 0 0 0 0 0 12.0909 0 12.6844 0 0 0 0 0 0 0 0 12.0141 0 0 0 0 15.7507 0 13.221 13.4331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4F5 C170B_HUMAN "Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B, Cep170B)" CEP170B FAM68C KIAA0284 Homo sapiens (Human) cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874] GO:0005737; GO:0005874 EECELMLQSR 0.9929 -41.4 0 0 0 0 0 0 0 0 0 10.2752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7569 0 12.7805 0 0 0 0 0 14.0399 0 0 14.0747 12.5176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3421 13.2803 0 0 13.5608 13.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6121 0 0 0 0 A6NMB1 SIG16_HUMAN "Sialic acid-binding Ig-like lectin 16, Siglec-16 (Siglec-P16)" SIGLEC16 SIGLECP16 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of interleukin-6 production [GO:0032755] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of interleukin-6 production [GO:0032755] GO:0005886; GO:0007155; GO:0016021; GO:0030246; GO:0032755; GO:0033691; GO:1900426 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] GSCSLVIRDAQR 0.99291 -16.731 0 0 0 0 11.0808 0 0 10.7374 0 15.868 0 0 0 0 0 0 11.5159 0 0 0 0 0 0 0 11.1431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2446 0 14.0604 13.3457 14.2928 0 0 0 0 11.8539 0 0 0 0 0 0 0 0 13.0355 0 0 0 13.131 0 0 0 0 0 13.9049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6043 13.6001 11.6153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3688 0 15.9245 16.8934 13.4974 0 0 0 11.7293 0 0 0 0 14.0443 14.1577 0 11.1597 A7KAX9 RHG32_HUMAN Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP) ARHGAP32 GRIT KIAA0712 RICS Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0000139; GO:0001650; GO:0005096; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0005938; GO:0007264; GO:0010008; GO:0014069; GO:0015629; GO:0043197; GO:0051056; GO:0070161; GO:1901981 GTPase activator activity [GO:0005096]; phosphatidylinositol phosphate binding [GO:1901981] EEEHLTQSIVPPPK 0.99291 -17.154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3806 0 0 0 0 0 0 0 13.3418 0 15.9272 0 0 0 11.9997 12.7479 0 13.3437 0 14.5555 0 0 0 11.2467 10.8598 0 12.3341 0 0 11.7451 0 0 0 0 0 0 0 0 0 0 0 0 13.2969 14.8295 14.5046 0 14.4926 0 0 12.8064 0 0 0 0 0 0 0 12.1549 0 13.6153 0 0 0 13.5691 0 0 12.9053 0 12.557 0 0 0 0 0 0 0 13.6423 0 0 0 0 0 13.0293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0411 0 0 0 9.94732 0 0 0 O76083 PDE9A_HUMAN "High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, EC 3.1.4.35" PDE9A Homo sapiens (Human) cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; cGMP metabolic process [GO:0046068]; cGMP-mediated signaling [GO:0019934]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; signal transduction [GO:0007165]" GO:0004114; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0010613; GO:0019934; GO:0032587; GO:0042383; GO:0042802; GO:0043204; GO:0046068; GO:0046069; GO:0046872; GO:0047555; GO:0048471 "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" DFSINPVTLR 0.99291 -16.355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5365 0 0 0 0 0 0 0 10.1871 0 0 0 0 0 12.1618 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7123 0 0 11.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2183 12.8889 12.7255 0 13.6003 0 13.6961 13.4694 0 0 0 12.1477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8837 0 0 0 0 0 0 15.7557 0 0 0 0 0 0 0 0 0 0 12.1909 0 0 0 0 0 0 11.6433 0 0 0 0 0 0 15.0944 0 0 0 14.5877 0 0 0 0 0 0 0 0 0 14.4352 0 0 0 0 0 0 11.8279 0 0 0 0 0 0 0 14.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5592 0 10.3395 P09919 CSF3_HUMAN "Granulocyte colony-stimulating factor, G-CSF (Pluripoietin) (Filgrastim) (Lenograstim)" CSF3 C17orf33 GCSF Homo sapiens (Human) cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; granulocyte differentiation [GO:0030851]; immune response [GO:0006955]; negative regulation of neuron death [GO:1901215]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471] endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202] endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; granulocyte colony-stimulating factor receptor binding [GO:0005130]; growth factor activity [GO:0008083]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; granulocyte differentiation [GO:0030851]; immune response [GO:0006955]; negative regulation of neuron death [GO:1901215]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471] GO:0005125; GO:0005130; GO:0005576; GO:0005615; GO:0006955; GO:0008083; GO:0008284; GO:0014068; GO:0019221; GO:0019899; GO:0030838; GO:0030851; GO:0032092; GO:0033138; GO:0043202; GO:0045471; GO:0045639; GO:0045944; GO:0050731; GO:0051091; GO:0051897; GO:0071222; GO:0071345; GO:0071682; GO:1901215; GO:2000251 cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; granulocyte colony-stimulating factor receptor binding [GO:0005130]; growth factor activity [GO:0008083] RAGGVLVASHLQSFLEVSYRVLR 0.99291 -6.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4699 0 0 0 0 0 0 0 0 0 0 0 0 P21817 RYR1_HUMAN "Ryanodine receptor 1, RYR-1, RyR1 (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor)" RYR1 RYDR Homo sapiens (Human) calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; muscle contraction [GO:0006936]; ossification involved in bone maturation [GO:0043931]; outflow tract morphogenesis [GO:0003151]; protein homotetramerization [GO:0051289]; regulation of cytosolic calcium ion concentration [GO:0051480]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; skeletal muscle fiber development [GO:0048741]; skin development [GO:0043588] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; I band [GO:0031674]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; ryanodine receptor complex [GO:1990425]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; terminal cisterna [GO:0014802]; Z disc [GO:0030018] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; I band [GO:0031674]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; ryanodine receptor complex [GO:1990425]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; cellular response to calcium ion [GO:0071277]; muscle contraction [GO:0006936]; ossification involved in bone maturation [GO:0043931]; outflow tract morphogenesis [GO:0003151]; protein homotetramerization [GO:0051289]; regulation of cytosolic calcium ion concentration [GO:0051480]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to caffeine [GO:0031000]; response to hypoxia [GO:0001666]; skeletal muscle fiber development [GO:0048741]; skin development [GO:0043588] GO:0001666; GO:0003151; GO:0005219; GO:0005245; GO:0005262; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005790; GO:0005886; GO:0005887; GO:0005938; GO:0006816; GO:0006936; GO:0014701; GO:0014802; GO:0014808; GO:0015278; GO:0016529; GO:0030018; GO:0030659; GO:0031000; GO:0031301; GO:0031674; GO:0033017; GO:0042383; GO:0043588; GO:0043931; GO:0048741; GO:0048763; GO:0051209; GO:0051289; GO:0051480; GO:0070062; GO:0071277; GO:0071313; GO:1990425 ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; calcium-release channel activity [GO:0015278]; calmodulin binding [GO:0005516]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; voltage-gated calcium channel activity [GO:0005245] AGEQEEEEEEVEEK 0.99291 -41.887 0 12.4261 0 0 12.1301 0 0 0 0 0 0 11.7852 12.8408 12.6747 0 0 0 0 0 11.4596 0 11.299 12.7326 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1257 11.6357 0 0 0 0 11.6603 0 0 12.3912 0 0 0 14.5691 0 11.0982 12.3247 13.8422 0 0 11.2312 0 0 0 0 0 0 0 0 0 13.3302 0 13.7843 13.7841 10.7344 0 20.5925 12.6562 0 0 0 0 11.2784 0 11.5212 0 13.2989 14.3122 0 16.0408 13.1812 15.6954 12.3647 15.7954 0 0 15.7291 15.5243 11.9221 0 0 0 0 0 0 0 0 0 13.4486 13.7001 0 12.7123 11.2525 13.7138 12.7363 0 17.096 13.918 0 0 0 12.0944 0 0 0 0 0 13.7798 0 13.6144 13.0954 13.2267 0 0 0 13.0079 0 13.8072 14.1099 14.7519 20.6608 0 0 0 13.9046 11.9541 12.2032 0 13.5217 14.1498 0 0 12.9139 0 13.775 12.7741 14.2691 10.8057 12.9601 0 0 12.102 11.879 14.4314 14.9944 0 11.401 14.8108 0 13.2589 0 0 12.0521 0 0 14.0288 0 0 0 15.8578 0 0 0 0 P34947 GRK5_HUMAN "G protein-coupled receptor kinase 5, EC 2.7.11.16 (G protein-coupled receptor kinase GRK5)" GRK5 GPRK5 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055] GO:0004672; GO:0004674; GO:0004703; GO:0005080; GO:0005524; GO:0005543; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007186; GO:0007188; GO:0007217; GO:0008277; GO:0008284; GO:0009966; GO:0016055; GO:0016607; GO:0031965; GO:0043066; GO:0045444; GO:0046777; GO:0047696; GO:0051726 ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine/threonine kinase activity [GO:0004674] DVLDIEQFSTVK 0.99291 -16.291 0 0 0 0 0 0 0 0 14.1973 0 14.4752 0 0 13.177 0 0 12.3808 0 0 0 0 0 0 0 0 0 0 0 0 12.1112 0 12.2466 0 0 0 0 0 0 0 0 12.1917 0 0 11.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5663 0 0 0 0 0 0 0 0 13.3066 0 0 0 14.0482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54284 CACB3_HUMAN "Voltage-dependent L-type calcium channel subunit beta-3, CAB3 (Calcium channel voltage-dependent subunit beta 3)" CACNB3 CACNLB3 Homo sapiens (Human) calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of voltage-gated calcium channel activity [GO:1901385]; T cell receptor signaling pathway [GO:0050852] cytosol [GO:0005829]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] cytosol [GO:0005829]; L-type voltage-gated calcium channel complex [GO:1990454]; membrane [GO:0016020]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transmembrane transport via high voltage-gated calcium channel [GO:0061577]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of high voltage-gated calcium channel activity [GO:1901843]; protein localization to plasma membrane [GO:0072659]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of voltage-gated calcium channel activity [GO:1901385]; T cell receptor signaling pathway [GO:0050852] GO:0005245; GO:0005246; GO:0005829; GO:0005891; GO:0006816; GO:0007268; GO:0007528; GO:0008331; GO:0016020; GO:0045202; GO:0050852; GO:0060402; GO:0061577; GO:0072659; GO:0098903; GO:1901385; GO:1901843; GO:1990454 calcium channel regulator activity [GO:0005246]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245] ISITRVTADLSLAKR 0.99291 -17.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0931 14.1161 0 13.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.535 0 0 13.4094 0 0 0 0 0 0 0 13.5893 0 0 0 0 0 14.9537 0 0 11.8075 0 0 0 0 0 13.5758 0 0 0 0 0 0 0 0 15.0617 0 0 0 0 0 0 0 0 0 13.6876 0 0 13.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05BV3 EMAL5_HUMAN "Echinoderm microtubule-associated protein-like 5, EMAP-5" EML5 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; microtubule binding [GO:0008017] GO:0005737; GO:0005874; GO:0008017; GO:0070062 microtubule binding [GO:0008017] CCCFSPDGK 0.99291 -42.72 14.1459 0 0 0 0 0 0 0 12.1761 15.0298 0 12.687 0 12.6274 12.8236 0 13.1607 0 0 0 0 16.417 16.2265 0 16.4652 0 0 0 13.1087 0 0 12.8384 0 13.2337 0 0 13.4221 12.8628 11.7373 12.362 12.7776 0 11.4579 16.5804 0 17.4138 17.1953 0 0 0 0 0 0 0 0 17.0199 0 17.9937 15.3318 17.3485 15.556 11.3768 18.411 16.0936 15.3462 0 0 0 0 0 15.1398 0 18.6649 14.5112 14.3053 0 0 17.638 0 14.6242 0 0 16.8633 15.0402 0 0 12.7668 13.5042 0 0 12.1563 18.6995 14.926 11.6404 0 15.3552 0 0 0 17.6588 0 9.89775 16.2176 15.0211 15.0141 0 9.95061 0 17.8093 0 12.5956 0 0 14.9107 9.57194 19.6448 11.6156 13.3063 0 0 13.266 0 15.0898 0 12.8689 0 14.3941 12.7819 0 14.2545 0 12.5031 0 0 0 14.1167 14.435 10.6402 13.9652 14.8457 0 0 0 14.4157 14.6385 11.9207 14.6976 0 0 0 14.3353 17.7982 19.3328 0 0 14.6973 14.4093 0 0 12.7605 14.7776 14.5441 0 14.6394 0 0 12.3479 0 14.8422 13.1649 0 13.1461 14.8129 0 0 14.168 0 12.913 9.15692 14.7878 Q13237 KGP2_HUMAN "cGMP-dependent protein kinase 2, cGK 2, cGK2, EC 2.7.11.12 (cGMP-dependent protein kinase II, cGKII)" PRKG2 PRKGR2 Homo sapiens (Human) negative regulation of chloride transport [GO:2001226]; negative regulation of chondrocyte proliferation [GO:1902731]; peptidyl-serine autophosphorylation [GO:0036289]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of chondrocyte differentiation [GO:0032330]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; negative regulation of chloride transport [GO:2001226]; negative regulation of chondrocyte proliferation [GO:1902731]; peptidyl-serine autophosphorylation [GO:0036289]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of chondrocyte differentiation [GO:0032330]; signal transduction [GO:0007165]; tetrahydrobiopterin metabolic process [GO:0046146] GO:0004672; GO:0004692; GO:0005524; GO:0005829; GO:0006468; GO:0007165; GO:0016324; GO:0030553; GO:0031965; GO:0032330; GO:0036289; GO:0042802; GO:0046146; GO:0072659; GO:0106310; GO:1902731; GO:2001226 ATP binding [GO:0005524]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] EYHLKELR 0.99291 -17.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2755 0 0 0 0 0 0 0 0 0 0 0 11.0971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8631 0 0 0 0 0 0 0 0 0 12.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9785 0 15.8756 0 0 0 0 0 0 0 0 0 0 11.8031 0 0 0 0 0 0 0 12.3729 0 12.6704 0 0 0 0 0 0 0 0 0 0 14.4807 0 13.3467 0 0 0 0 0 11.3801 0 0 0 0 0 0 0 0 0 0 0 13.4534 0 0 0 0 0 0 0 0 0 0 0 13.4426 0 0 0 0 0 0 12.9628 12.8486 0 0 14.0038 13.4179 0 0 0 13.7144 13.8647 0 0 0 0 0 0 0 Q14587 ZN268_HUMAN Zinc finger protein 268 (Zinc finger protein HZF3) ZNF268 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein heterodimerization activity [GO:0043497]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0001228; GO:0001934; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0007346; GO:0008284; GO:0008285; GO:0030154; GO:0030335; GO:0043065; GO:0043066; GO:0043497; GO:0045597; GO:0045732; GO:0045944; GO:0046872; GO:0051726; GO:0071356; GO:0090073; GO:1901224 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CTECGKAFCWKSQLIMHQR 0.99291 -42.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0683 0 0 0 0 12.6318 0 12.3765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0326 0 0 0 0 0 13.967 12.6048 15.352 13.6902 13.8829 0 0 0 0 13.2821 12.9495 14.2874 13.7618 13.2734 13.6086 0 13.0991 14.2254 14.2618 18.0194 17.8056 0 0 0 0 0 0 0 0 0 0 0 14.6968 12.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9872 0 0 0 11.4473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1504 0 0 14.1583 0 0 0 0 0 Q2M1P5 KIF7_HUMAN Kinesin-like protein KIF7 KIF7 UNQ340/PRO539 Homo sapiens (Human) microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0036064; GO:0045879; GO:0045880; GO:0097542 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ALEELGEELHK 0.99291 -41.837 0 0 0 0 0 0 0 0 13.4426 13.5293 0 12.416 15.0096 15.1468 0 0 0 14.9595 0 11.9173 0 0 0 0 10.2476 15.0236 10.1365 0 0 12.8644 0 13.8443 14.5701 11.1631 13.3973 13.9754 0 0 13.1056 13.9369 14.9244 14.5625 15.1671 12.8785 14.7141 0 0 0 0 13.4355 11.7322 15.343 0 0 0 0 0 8.8794 0 0 0 0 0 0 0 0 12.143 0 0 0 0 0 13.8379 13.3055 0 0 0 10.4353 0 0 0 0 15.1485 0 0 0 0 0 13.2105 0 12.1523 0 12.3983 11.912 0 0 0 0 0 0 11.8929 0 0 0 0 13.4553 0 0 0 0 13.8881 0 0 0 14.6124 0 0 0 0 18.4243 0 0 0 0 0 12.9976 0 0 0 0 0 0 0 0 14.3165 0 14.0265 13.5233 0 0 0 0 0 0 0 0 0 13.7837 0 0 0 0 0 13.3269 0 12.7094 0 13.4494 16.8951 0 0 0 0 12.6542 0 0 12.5005 16.8839 0 16.6053 12.8329 0 0 0 16.7112 0 10.1364 13.543 0 16.6799 Q5DT21 ISK9_HUMAN Serine protease inhibitor Kazal-type 9 (Lymphoepithelial Kazal-type-related inhibitor 2) SPINK9 LEKTI2 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576 serine-type endopeptidase inhibitor activity [GO:0004867] FCHHMYDPICGSDGK 0.99291 -17.162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.553 13.6208 0 0 0 0 0 0 0 0 0 0 11.5397 0 0 0 0 0 0 0 0 13.953 13.8914 0 14.0579 0 14.0476 0 13.8569 13.5951 13.7347 0 0 0 0 0 0 0 13.6292 0 0 0 0 14.0294 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5467 13.6006 0 0 0 13.3872 0 13.2305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.981 0 14.3953 0 0 0 0 0 Q68DK2 ZFY26_HUMAN "Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein, FYVE-CENT) (Spastizin)" ZFYVE26 KIAA0321 Homo sapiens (Human) autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496] centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465] GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:0046872; GO:1905037 metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901] AYLICCK 0.99291 -41.973 0 0 0 0 0 0 0 0 12.7295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0988 0 0 0 10.5039 0 0 0 14.5401 14.5611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.652 0 0 0 0 0 14.6721 0 0 0 0 16.5514 0 13.4457 0 11.9108 0 0 11.8776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.919 0 14.8231 0 0 0 14.6385 0 14.4043 0 13.3399 0 0 0 0 0 0 13.5898 13.2595 0 13.2801 0 0 0 0 14.7202 0 0 0 16.1356 0 0 0 0 0 0 0 0 0 0 12.2826 0 0 0 0 12.0284 12.4964 0 0 0 0 13.3934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVT0 TTL10_HUMAN Inactive polyglycylase TTLL10 (Tubulin--tyrosine ligase-like protein 10) TTLL10 Homo sapiens (Human) protein polyglycylation [GO:0018094] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735]; protein polyglycylation [GO:0018094] GO:0005524; GO:0005829; GO:0018094; GO:0070735 ATP binding [GO:0005524]; protein-glycine ligase activity [GO:0070735] AGFKRGK 0.99291 -17.181 0 0 0 0 0 0 0 0 15.1711 0 0 15.1384 0 0 0 0 0 0 14.6487 0 0 0 0 0 15.0957 0 0 0 0 13.9064 14.6384 0 0 0 0 0 0 11.4033 13.9177 0 0 15.3164 0 0 15.5154 0 0 0 0 0 0 0 0 0 0 15.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9235 0 0 0 0 0 0 0 12.5133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6452 0 0 0 0 0 0 0 0 0 0 0 12.3077 15.0979 0 0 0 13.3151 0 0 0 0 14.802 0 0 0 0 0 0 0 0 0 0 12.0473 0 13.0704 0 0 0 15.5152 0 0 0 0 0 14.2215 0 0 0 0 0 0 15.5798 0 0 0 0 0 0 0 0 0 15.1144 0 0 0 15.7147 13.985 0 15.1468 0 0 0 14.9176 0 13.7487 12.7552 0 0 0 13.8439 0 0 0 0 Q76M96 CCD80_HUMAN Coiled-coil domain-containing protein 80 (Down-regulated by oncogenes protein 1) (Up-regulated in BRS-3 deficient mouse homolog) CCDC80 DRO1 URB HBE245 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; response to bacterium [GO:0009617] basement membrane [GO:0005604]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614] basement membrane [GO:0005604]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; response to bacterium [GO:0009617] GO:0001968; GO:0005576; GO:0005604; GO:0005614; GO:0008201; GO:0009617; GO:0010811; GO:0030198 fibronectin binding [GO:0001968]; heparin binding [GO:0008201] CPEDEYAGYGYHSYHQGYQDGYQDDYR 0.99291 -42.107 0 0 0 0 0 0 0 0 0 0 11.8517 0 0 0 13.2769 13.8078 0 0 0 12.7511 0 0 12.7744 0 12.0558 11.6321 0 13.3845 0 0 0 0 0 0 0 0 12.0855 12.6406 0 0 12.4051 0 13.3518 0 13.8693 11.0227 0 12.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.57 0 0 12.5039 12.5667 0 0 0 11.8118 14.6455 0 12.3463 0 0 0 0 0 0 0 0 0 0 13.086 0 12.0269 0 0 10.5635 0 0 13.6953 14.65 0 13.149 13.6051 0 11.6098 0 0 0 0 0 0 11.6541 0 0 0 0 0 0 0 12.317 0 0 13.7253 0 0 0 0 0 0 13.0276 10.4578 12.7064 0 0 0 12.3106 0 0 0 0 13.2487 12.7693 0 0 0 0 13.0201 0 0 0 0 12.268 0 0 14.5302 10.8368 13.5523 0 13.0824 14.3262 11.9391 0 0 0 14.6784 0 0 12.9524 0 0 13.4757 14.0139 12.9577 0 0 13.4333 0 12.766 0 15.0741 13.2105 0 Q96BU1 S1PBP_HUMAN S100P-binding protein (S100P-binding protein Riken) S100PBP S100PBPR Homo sapiens (Human) cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; calcium-dependent protein binding [GO:0048306] GO:0005634; GO:0005829; GO:0016607; GO:0048306 calcium-dependent protein binding [GO:0048306] DETDSSK 0.99291 -16.72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7769 0 0 12.5255 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82498 0 0 0 0 0 0 0 15.3654 0 0 0 9.21053 0 0 0 0 0 0 0 0 0 0 0 11.168 0 0 0 0 13.0527 0 0 0 0 17.7929 12.8695 0 0 0 0 10.7401 0 0 0 0 0 13.9217 0 0 13.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0489 0 0 0 0 0 0 0 0 0 0 0 0 9.96867 0 10.8119 13.0229 0 0 0 0 0 0 11.2112 0 0 10.8786 10.7613 0 0 0 0 0 0 0 0 0 0 13.0768 0 0 0 0 0 0 0 0 Q96CC6 RHDF1_HUMAN "Inactive rhomboid protein 1, iRhom1 (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho)" RHBDF1 C16orf8 DIST1 IRHOM1 Homo sapiens (Human) cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; growth factor binding [GO:0019838]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708] GO:0000139; GO:0005789; GO:0008283; GO:0015031; GO:0016021; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136 growth factor binding [GO:0019838] AAAALMK 0.99291 -42.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7015 0 0 0 14.2899 0 13.5675 0 0 0 0 0 0 0 0 0 0 0 0 12.9667 0 0 0 0 0 0 0 13.386 0 0 12.5619 12.6894 13.0477 12.6903 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0023 0 0 0 0 0 0 0 0 0 0 0 12.5742 0 0 0 0 0 0 13.9943 0 0 0 0 0 0 0 12.564 0 10.6799 0 0 0 0 0 0 0 0 0 0 0 Q96MC5 MERB1_HUMAN bMERB domain-containing protein 1 BMERB1 C16orf45 Homo sapiens (Human) cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; microtubule depolymerization [GO:0007019]; negative regulation of cell motility involved in cerebral cortex radial glia guided migration [GO:0021822]; negative regulation of microtubule depolymerization [GO:0007026] microtubule cytoskeleton [GO:0015630] microtubule cytoskeleton [GO:0015630]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; microtubule depolymerization [GO:0007019]; negative regulation of cell motility involved in cerebral cortex radial glia guided migration [GO:0021822]; negative regulation of microtubule depolymerization [GO:0007026] GO:0007019; GO:0007026; GO:0015630; GO:0021814; GO:0021822 DCCGATQCNIM 0.99291 -14.878 11.8619 0 13.7774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.662 0 0 0 0 0 0 0 0 0 0 0 10.9437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5131 0 0 0 0 0 0 0 12.1874 0 0 0 0 0 10.1709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9972 0 Q96R05 RET7_HUMAN "Retinoid-binding protein 7 (Cellular retinoic acid-binding protein 4, CRABP4, CRBP4) (Cellular retinoic acid-binding protein IV, CRABP-IV)" RBP7 Homo sapiens (Human) fatty acid transport [GO:0015908] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinol binding [GO:0019841]; fatty acid transport [GO:0015908] GO:0005504; GO:0005634; GO:0005829; GO:0015908; GO:0016918; GO:0019841 fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinol binding [GO:0019841] LTCIQKGEK 0.99291 -6.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6479 Q9BX97 PLVAP_HUMAN "Plasmalemma vesicle-associated protein (Fenestrated endothelial-linked structure protein) (Plasmalemma vesicle protein 1, PV-1)" PLVAP FELS PV1 Homo sapiens (Human) developmental process [GO:0032502]; MAPK cascade [GO:0000165]; positive regulation of cellular extravasation [GO:0002693]; regulation of vascular permeability [GO:0043114]; tumor necrosis factor-mediated signaling pathway [GO:0033209] caveola [GO:0005901]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471] caveola [GO:0005901]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; developmental process [GO:0032502]; MAPK cascade [GO:0000165]; positive regulation of cellular extravasation [GO:0002693]; regulation of vascular permeability [GO:0043114]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0000165; GO:0002693; GO:0005901; GO:0009986; GO:0016021; GO:0032502; GO:0033209; GO:0042802; GO:0043114; GO:0048471; GO:0070062 identical protein binding [GO:0042802] ILESQRPPAGIPVAPSSG 0.99291 -16.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0505 13.245 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3154 0 0 0 0 0 13.4059 13.5249 13.7145 0 0 0 0 0 13.0915 13.9299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0071 0 0 12.5541 0 0 0 11.5251 0 0 0 11.4672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5005 0 0 0 0 0 0 0 0 0 0 Q9Y2Z2 MTO1_HUMAN "Protein MTO1 homolog, mitochondrial" MTO1 CGI-02 Homo sapiens (Human) mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; RNA binding [GO:0003723]; mitochondrial tRNA wobble uridine modification [GO:0070899]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] GO:0002098; GO:0003723; GO:0005739; GO:0030488; GO:0050660; GO:0070899 flavin adenine dinucleotide binding [GO:0050660]; RNA binding [GO:0003723] AKVIQPDGVLLLLPR 0.99291 -16.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.147 0 14.0625 0 14.865 0 0 0 0 0 0 0 0 0 0 0 0 12.7459 0 0 12.8 0 12.4499 0 0 12.35 0 0 0 12.2022 0 0 0 0 0 0 0 0 0 0 0 13.8345 14.7018 13.8118 0 12.4072 12.8393 13.2682 13.1169 12.8591 0 12.0379 0 0 14.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9316 0 0 14.0998 12.9611 0 0 0 0 0 14.7697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0853 0 0 0 0 0 0 0 13.5805 0 14.2681 0 13.8732 0 0 0 14.5844 0 13.7929 0 0 0 0 0 0 15.0446 0 0 0 0 14.2427 0 0 0 0 0 0 14.7179 0 0 13.4977 14.7189 0 Q9Y5G5 PCDG8_HUMAN "Protocadherin gamma-A8, PCDH-gamma-A8" PCDHGA8 KIAA0327 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] CLININTLVEDK 0.99291 -15.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1974 0 13.2011 0 0 10.9939 0 0 0 0 0 0 0 0 0 12.9499 12.6989 0 0 12.6871 0 11.9577 13.5687 12.5356 10.3669 0 11.9795 17.6051 0 0 0 0 0 0 0 0 10.5822 0 0 10.2081 15.1271 0 0 0 0 0 13.1499 0 0 0 0 0 0 0 0 14.7456 0 0 0 12.2724 0 0 0 0 0 0 12.4875 0 0 0 0 0 0 0 9.60618 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 0 0 0 0 0 0 0 0 0 0 9.89119 0 0 0 15.6749 12.912 0 10.0307 0 0 0 0 0 Q9UQR1 ZN148_HUMAN Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89) ZNF148 ZBP89 Homo sapiens (Human) "cellular defense response [GO:0006968]; gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; substantia nigra development [GO:0021762]" Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] "Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular defense response [GO:0006968]; gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; substantia nigra development [GO:0021762]" GO:0000122; GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0005794; GO:0006357; GO:0006968; GO:0007276; GO:0010629; GO:0021762; GO:0043565; GO:0045892; GO:0045944; GO:0046872; GO:0065003 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" AGMTSSPDATTGQTFG 0.99292 -16.033 0 0 0 0 0 0 0 0 14.6009 15.4718 0 13.2342 12.0947 12.7779 12.9065 15.8656 0 14.1096 13.1366 0 13.1291 0 13.1539 0 15.8181 15.6162 16.0799 16.3177 15.9284 0 15.9499 0 0 13.2642 0 0 0 15.9303 16.087 14.4529 16.1406 15.83 16.0719 16.4495 14.1802 16.1637 0 13.9884 15.904 15.9803 16.0322 0 12.3081 0 13.7906 14.5809 16.142 17.5201 13.1794 15.9593 15.1694 15.3062 15.0935 15.1069 14.2339 15.17 0 0 0 0 0 0 0 0 13 0 0 0 0 0 11.3162 0 14.2102 0 0 14.8497 0 0 0 12.8095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2523 11.3149 0 15.3758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3022 14.3837 0 0 0 0 0 0 0 0 13.1844 0 0 0 14.0109 0 0 0 0 0 16.6675 0 0 13.0712 0 0 13.5282 0 0 12.5174 12.749 14.2007 14.1466 14.0033 16.4894 13.3323 15.5002 13.8336 16.254 16.4506 16.6544 0 0 16.1369 0 0 0 0 0 0 13.1675 0 0 B1AJZ9 FHAD1_HUMAN "Forkhead-associated domain-containing protein 1, FHA domain-containing protein 1" FHAD1 KIAA1937 Homo sapiens (Human) AAGASGR 0.99292 -43.963 0 0 0 9.28448 0 0 0 0 0 0 0 0 0 0 0 0 10.1231 0 0 0 0 0 10.695 0 0 0 9.64176 9.73718 10.4852 0 0 14.5467 0 0 0 0 9.66876 0 0 9.74436 0 0 0 0 0 0 0 0 0 0 10.1596 12.538 12.7193 0 0 0 0 10.7727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4264 0 0 11.1233 0 0 11.8916 0 0 0 15.6172 0 0 11.7001 11.3665 0 0 0 12.0568 13.357 13.9057 17.0773 0 16.2978 0 0 0 12.6023 0 0 12.7285 0 0 0 0 0 13.7217 0 12.8484 0 0 0 0 0 9.53312 0 0 11.3889 0 0 0 0 0 11.2455 0 0 0 12.4254 0 13.7254 0 0 11.0711 0 0 0 0 0 11.9328 0 0 13.5059 0 12.0861 0 0 0 12.7977 0 14.4249 0 0 0 0 0 10.2164 0 0 0 0 0 0 0 0 0 12.5668 0 0 11.3396 14.1871 0 0 10.4714 0 0 0 O00160 MYO1F_HUMAN Unconventional myosin-If (Myosin-Ie) MYO1F Homo sapiens (Human) actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0003779; GO:0005516; GO:0005524; GO:0005829; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016461; GO:0030050; GO:0051015 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AAPAPPR 0.99292 -43.199 0 0 0 15.6614 11.7841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9879 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2334 12.2553 0 12.8921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.233 0 0 0 0 0 0 0 0 0 15.4556 15.2541 15.3757 0 13.4095 0 13.8564 16.0414 0 13.2114 0 15.4886 15.7438 15.0972 13.1758 14.2967 15.6578 14.8788 14.8134 15.3421 0 0 16.3141 12.9609 13.6229 0 0 0 0 0 15.29 14.238 15.1609 13.8862 0 0 13.8772 13.2754 0 0 14.0064 0 15.0138 14.1564 0 14.4644 12.0221 12.9565 14.9294 14.0421 12.7579 11.2802 14.0734 14.3386 0 13.8464 14.982 0 14.3385 16.3081 13.4383 12.8978 14.3396 14.3437 14.758 0 0 0 0 13.2064 13.3899 13.2525 13.1604 0 15.4944 0 0 0 0 0 0 0 0 0 0 0 0 14.4793 14.3202 0 0 0 0 13.9846 0 19.0755 0 13.7031 0 0 0 14.2869 0 0 O15160 RPAC1_HUMAN "DNA-directed RNA polymerases I and III subunit RPAC1, DNA-directed RNA polymerase I subunit C, RNA polymerases I and III subunit AC1 (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide, RPA40) (RPA39) (RPC40)" POLR1C POLR1E Homo sapiens (Human) transcription by RNA polymerase I [GO:0006360] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; RNA polymerase I activity [GO:0001054]; RNA polymerase III activity [GO:0001056]; transcription by RNA polymerase I [GO:0006360] GO:0001054; GO:0001056; GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005736; GO:0005829; GO:0006360; GO:0046983 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; RNA polymerase I activity [GO:0001054]; RNA polymerase III activity [GO:0001056] FLDELDAVQMD 0.99292 -6.2871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1964 0 0 0 0 0 0 O60299 LZTS3_HUMAN "Leucine zipper putative tumor suppressor 3 (ProSAP-interacting protein 1, ProSAPiP1)" LZTS3 KIAA0552 PROSAPIP1 Homo sapiens (Human) regulation of dendritic spine morphogenesis [GO:0061001] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; synapse [GO:0045202] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; regulation of dendritic spine morphogenesis [GO:0061001] GO:0005737; GO:0005856; GO:0014069; GO:0043197; GO:0045202; GO:0061001; GO:0070161 ADPGRDPLLAFAPR 0.99292 -16.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2283 0 0 0 0 0 0 14.0268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1837 0 0 0 0 0 0 0 0 0 0 0 11.7936 0 0 0 0 0 0 0 0 0 0 0 0 O75564 JERKY_HUMAN Jerky protein homolog JRK JH8 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; positive regulation of canonical Wnt signaling pathway [GO:0090263] GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0090263; GO:1990904 DNA binding [GO:0003677]; mRNA binding [GO:0003729] PAAGKSR 0.99292 -16.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0075 0 0 0 14.1066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2616 0 0 0 0 0 0 0 0 0 11.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7675 0 0 0 0 0 0 0 12.782 0 13.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 P15880 RS2_HUMAN 40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5) RPS2 RPS4 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0017134; GO:0019899; GO:0022626; GO:0022627; GO:0045296; GO:0051443; GO:0070062 cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; fibroblast growth factor binding [GO:0017134]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] CGSVLVR 0.99292 -15.979 0 0 0 11.9554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1792 0 0 0 13.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5396 0 0 0 0 0 0 0 0 12.1369 0 12.7385 12.3054 15.1369 0 14.973 0 0 0 14.1518 14.2701 13.8861 12.8754 0 0 12.1277 0 14.4895 12.1577 14.1702 0 0 14.8925 0 12.9966 0 0 12.4112 10.294 0 0 0 0 0 11.7985 14.74 11.3115 0 0 15.6232 0 0 14.1978 0 14.0471 0 13.3153 15.1734 15.8871 0 0 14.2795 0 0 0 0 10.5695 0 0 15.3839 0 15.4945 0 0 0 0 0 0 15.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9603 0 0 14.6065 0 0 15.2564 0 0 0 P22090 RS4Y1_HUMAN "40S ribosomal protein S4, Y isoform 1 (Small ribosomal subunit protein eS4)" RPS4Y1 RPS4Y PRO2646 Homo sapiens (Human) translation [GO:0006412] cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844] cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005829; GO:0005844; GO:0006412; GO:0016020; GO:0019843; GO:0022627 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] DKRLATK 0.99292 -44.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9424 0 11.9816 0 0 0 0 0 13.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7925 0 12.3547 0 0 0 0 0 0 0 0 0 11.8091 0 0 0 0 0 0 10.9198 0 0 13.4791 0 0 0 0 13.1067 13.0312 0 0 13.3899 0 13.7061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0042 0 0 13.8687 0 0 0 0 0 0 0 0 0 0 13.2567 0 0 0 0 0 0 0 13.3703 0 0 0 0 0 0 0 0 0 13.3593 0 0 13.8315 0 0 14.3612 14.1914 14.4077 12.9653 0 0 13.9099 0 0 13.5877 13.5639 13.5821 0 0 12.9568 0 0 0 0 12.8772 0 0 14.5321 0 12.9503 0 0 P22914 CRYGS_HUMAN Gamma-crystallin S (Beta-crystallin S) (Gamma-S-crystallin) CRYGS CRYG8 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601] GO:0002009; GO:0002088; GO:0005212; GO:0007601 structural constituent of eye lens [GO:0005212] EIHSCKVLEGVWIFYELPNYR 0.99292 -6.2777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6724 10.6481 0 12.3832 0 0 0 13.8295 0 0 0 0 0 0 0 11.6222 0 0 0 0 0 11.2597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00610 CLH1_HUMAN "Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17, CLH-17)" CLTC CLH17 CLTCL2 KIAA0034 Homo sapiens (Human) "amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transferrin transport [GO:0033572]" clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; trans-Golgi network membrane [GO:0032588] "clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; trans-Golgi network membrane [GO:0032588]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381]; amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transferrin transport [GO:0033572]" GO:0000278; GO:0001649; GO:0003723; GO:0003725; GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0006886; GO:0006898; GO:0006914; GO:0016020; GO:0019901; GO:0030118; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0031623; GO:0032051; GO:0032588; GO:0032991; GO:0033572; GO:0036020; GO:0042147; GO:0042470; GO:0045334; GO:0048268; GO:0050750; GO:0051301; GO:0060236; GO:0070062; GO:0071439; GO:0072583; GO:0072686; GO:0097718; GO:0150093; GO:1900126; GO:1903077; GO:1903561; GO:1990381; GO:1990498 clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381] AIQFYLEFKPLLLNDLLMVLSPRLDHTR 0.99292 -6.2864 0 0 0 0 0 0 0 0 0 13.2749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.781 0 0 0 0 0 0 0 0 0 0 0 11.5112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5652 0 0 0 0 0 0 17.4362 11.0343 0 0 0 0 0 11.9366 0 0 0 0 0 0 13.8668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4808 10.7124 14.6308 0 10.7774 0 0 10.3409 12.5189 12.1903 14.23 0 0 13.4122 13.96 0 0 12.797 0 12.1593 13.1297 0 0 0 0 0 0 17.5687 11.2269 0 0 0 0 13.214 12.7686 13.4213 0 12.6981 0 0 13.5616 0 13.7886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8483 14.7873 10.2648 0 0 0 0 Q2M3X9 ZN674_HUMAN Zinc finger protein 674 ZNF674 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CNECGKAFSEKSPLIK 0.99292 -43.85 0 0 0 0 0 0 0 0 11.8375 11.7993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1068 0 0 0 0 11.238 0 0 0 0 0 0 0 11.5629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7763 0 0 0 11.1135 0 0 0 0 0 0 0 0 13.719 0 0 13.3383 0 0 0 0 0 0 0 0 0 0 0 0 12.6718 0 0 0 0 0 13.1401 0 0 13.0904 0 0 0 0 13.5396 14.2183 0 0 0 0 0 0 13.1911 0 0 0 13.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9018 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4147 0 12.5182 0 13.535 13.4128 0 12.5137 12.6486 0 12.6947 0 0 0 0 0 0 0 Q5T5P2 SKT_HUMAN Sickle tail protein homolog KIAA1217 SKT Homo sapiens (Human) embryonic skeletal system development [GO:0048706] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; embryonic skeletal system development [GO:0048706] GO:0005737; GO:0048706 AILRIEVEAVR 0.99292 -38.783 0 9.09107 0 0 0 0 0 0 0 11.7443 0 0 0 0 10.2186 10.9689 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3247 11.0038 13.6416 0 0 0 0 0 0 0 0 0 13.6061 0 0 0 0 0 0 0 0 0 12.8803 0 11.555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.324 0 12.8756 0 0 0 12.4698 11.796 13.2913 11.1848 0 0 0 0 0 0 0 0 12.3014 0 0 0 15.5317 14.5993 0 0 0 9.7185 15.5131 11.8734 0 14.4337 0 0 12.508 14.6932 13.2375 0 12.4303 0 0 0 0 0 14.8106 0 0 0 0 0 0 0 14.6773 0 0 0 11.8911 0 14.0276 0 0 0 0 14.4394 0 0 0 0 0 0 14.6767 0 0 0 0 0 0 0 14.1434 0 0 0 10.7765 0 13.4164 0 13.4839 12.999 0 12.0579 0 11.5514 0 0 0 11.57 0 0 0 0 0 0 0 0 12.272 14.3601 0 10.6308 0 0 14.8565 Q6NSZ9 ZSC25_HUMAN Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498) ZSCAN25 ZNF498 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ELQELCRR 0.99292 -14.559 0 0 0 0 0 0 0 0 0 11.6336 0 0 0 0 0 13.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5753 0 13.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6808 0 0 0 0 0 0 0 0 0 0 0 0 13.115 0 0 0 0 0 0 0 14.0538 0 0 0 0 14.7862 0 0 0 0 0 0 0 0 0 Q6PJT7 ZC3HE_HUMAN "Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2, MSUT-2) (Renal carcinoma antigen NY-REN-37)" ZC3H14 Homo sapiens (Human) negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488] GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0008143; GO:0016607; GO:0032839; GO:0043488; GO:0046872; GO:1900364; GO:1904115; GO:1990904 metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723] FNHDGEEEEEDDDYGSR 0.99292 -14.563 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0704 0 0 0 0 0 0 11.1089 0 10.6278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8123 12.2664 0 0 0 0 11.4084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.371 0 0 0 0 0 13.5868 13.7998 13.0276 0 0 0 12.6286 0 0 0 12.3553 0 0 12.4642 0 0 0 0 0 0 15.047 0 12.8513 Q6UE05 TM270_HUMAN Transmembrane protein 270 (Williams-Beuren syndrome chromosomal region 28 protein) TMEM270 WBSCR28 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EALPPVR 0.99292 -16.42 0 0 0 0 0 0 0 0 13.6747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.175 0 0 0 13.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4996 0 13.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2614 13.6556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6934 0 0 Q6ZP01 RBM44_HUMAN RNA-binding protein 44 (RNA-binding motif protein 44) RBM44 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003730; GO:0005737; GO:0042803; GO:0045171; GO:0071013 mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803] ACGITDLKKHPER 0.99292 -38.99 0 0 0 0 0 0 0 0 11.7244 13.8456 0 0 0 0 0 10.4875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0248 0 0 12.0512 0 0 0 10.2718 0 0 0 0 0 11.7127 12.4448 14.0624 13.0165 12.1348 0 14.9662 0 12.388 0 0 0 12.6383 12.6459 12.508 13.4293 0 0 0 14.0255 0 15.8367 0 0 11.8039 11.6548 13.6611 0 13.3569 0 0 0 0 0 0 0 0 0 0 0 0 12.7276 0 10.8724 12.198 0 0 0 0 0 0 0 0 0 0 0 12.4345 0 0 0 0 0 0 0 0 0 0 13.5563 0 0 13.1785 0 0 0 0 0 0 12.6012 11.9734 11.7852 0 14.8716 0 0 0 12.2261 0 0 0 0 0 0 0 0 0 0 12.3644 0 11.0176 13.5216 0 0 0 11.4974 13.7105 0 0 0 0 0 0 0 0 0 Q86WK6 AMGO1_HUMAN Amphoterin-induced protein 1 (AMIGO-1) (Alivin-2) AMIGO1 ALI2 AMIGO KIAA1163 Homo sapiens (Human) axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to L-glutamate [GO:1905232]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myelination [GO:0042552]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of synapse assembly [GO:0051965]; positive regulation of voltage-gated potassium channel activity [GO:1903818] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; pericellular basket [GO:1990030]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cellular response to L-glutamate [GO:1905232]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; myelination [GO:0042552]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of synapse assembly [GO:0051965]; positive regulation of voltage-gated potassium channel activity [GO:1903818] GO:0007156; GO:0007157; GO:0007409; GO:0007413; GO:0007420; GO:0008076; GO:0010976; GO:0015459; GO:0016021; GO:0030425; GO:0032809; GO:0042552; GO:0043204; GO:0050772; GO:0051965; GO:1901381; GO:1903818; GO:1905232; GO:1990030 potassium channel regulator activity [GO:0015459] DDGFDRR 0.99292 -16.371 0 0 0 0 0 0 0 0 0 0 0 12.6048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0674 0 12.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8046 11.0262 13.4372 0 0 0 12.781 0 0 0 0 0 0 0 0 0 12.5663 0 0 0 0 0 0 11.6229 0 0 12.388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0473 0 0 0 0 0 12.389 0 0 0 0 0 0 0 0 0 0 13.3529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1T3 MYO1H_HUMAN Unconventional myosin-Ih (Myosin-1H) MYO1H Homo sapiens (Human) actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0005524; GO:0005886; GO:0005902; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0051015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146] EPSKFDDFLIRHQIK 0.99292 -44.051 0 0 0 11.0917 0 11.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8916 0 0 0 0 11.3022 0 0 0 0 0 14.8955 0 0 0 0 0 9.98613 0 0 12.5235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7237 0 0 0 0 13.7627 0 0 0 0 14.9046 13.8318 0 0 0 12.0045 0 12.7968 0 0 0 0 0 0 0 10.5092 12.7042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2289 0 0 0 0 0 0 0 0 0 0 0 0 10.7094 0 0 10.9004 0 0 0 0 0 11.821 0 0 0 12.1773 0 12.9768 0 0 0 0 0 0 0 0 0 0 0 12.3219 0 0 0 0 0 0 0 0 12.1316 0 14.6364 0 0 0 Q8WXK3 ASB13_HUMAN "Ankyrin repeat and SOCS box protein 13, ASB-13" ASB13 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 CFEYYEKTPLTLSQLCRVNLR 0.99292 -6.6702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9056 0 0 0 11.7761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.141 0 0 0 0 0 0 0 0 0 11.3028 0 0 0 0 0 12.7132 0 0 0 0 0 13.6962 0 0 0 13.5487 0 0 0 0 0 0 0 12.6563 0 0 0 12.5543 0 0 0 13.3085 0 0 0 0 0 0 12.3618 14.4995 12.4602 0 0 15.038 10.9583 0 0 0 0 0 0 0 0 0 0 12.3785 0 0 0 0 0 0 0 0 0 12.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969S9 RRF2M_HUMAN "Ribosome-releasing factor 2, mitochondrial, RRF2mt (Elongation factor G 2, mitochondrial, EF-G2mt, mEF-G 2) (Elongation factor G2, hEFG2)" GFM2 EFG2 MSTP027 Homo sapiens (Human) mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126]; ribosome disassembly [GO:0032790] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial translation [GO:0032543]; mitochondrial translational termination [GO:0070126]; ribosome disassembly [GO:0032790] GO:0003924; GO:0005525; GO:0005759; GO:0032543; GO:0032790; GO:0070126 GTP binding [GO:0005525]; GTPase activity [GO:0003924] EGEKKHR 0.99292 -6.2838 0 0 0 0 10.6864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3151 0 0 11.5585 0 0 0 0 0 0 0 13.9126 0 0 0 0 12.2993 0 0 0 0 0 0 0 0 14.9146 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9852 0 0 12.6906 0 0 0 0 0 0 0 0 0 0 0 14.9001 12.2002 0 0 0 13.7721 0 0 0 0 14.2871 0 0 0 0 0 0 0 0 0 0 0 13.3794 0 0 0 0 0 0 0 11.8697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AC6 KIFC2_HUMAN Kinesin-like protein KIFC2 KIFC2 Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307] GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0072686; GO:0090307 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] APPGRLLPSAPTLR 0.99292 -17.22 0 0 0 0 0 0 0 0 0 0 11.477 13.4391 0 13.2917 14.339 12.211 12.7904 14.2412 13.2497 0 0 0 0 0 12.7383 13.9799 14.5356 13.0276 0 13.1168 13.6609 11.8179 14.0433 0 15.2098 14.2209 14.1644 0 13.241 14.3047 0 14.6974 13.9978 0 13.1926 14.6094 14.3051 14.6532 0 0 0 0 14.0541 14.0206 14.6267 12.2157 15.276 0 14.5911 15.0722 15.1893 15.5831 14.4302 13.4818 14.64 13.936 0 0 0 0 13.0962 0 0 0 0 0 11.4531 11.7817 0 0 0 15.2377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0076 14.2238 0 0 14.8823 0 0 13.0543 12.3213 0 0 0 0 0 0 0 0 0 12.1689 12.3228 13.0216 0 12.1784 0 0 12.8729 0 0 0 0 0 0 0 0 0 12.9057 0 0 0 0 0 0 0 0 13.1821 15.2237 0 14.6396 14.6349 14.9777 14.0091 15.6257 13.9197 14.3089 12.8647 15.3256 16.2714 0 0 12.4889 12.6314 0 0 15.8244 0 15.2726 0 11.4959 Q96EP0 RNF31_HUMAN "E3 ubiquitin-protein ligase RNF31, EC 2.3.2.31 (HOIL-1-interacting protein, HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein)" RNF31 ZIBRA Homo sapiens (Human) CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797] CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852] GO:0000209; GO:0004842; GO:0005829; GO:0009898; GO:0023035; GO:0031625; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0046872; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1903955; GO:1904417; GO:1990450 identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] AVPGGGCR 0.99292 -16.373 0 0 0 0 0 0 0 0 10.944 0 0 0 0 0 0 0 0 0 0 10.4426 0 0 10.9247 0 0 0 0 0 0 0 11.3038 0 0 0 0 0 0 12.6381 0 0 11.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8847 0 10.6082 14.4993 0 0 0 0 0 0 0 0 0 13.6498 0 14.4391 0 0 11.8805 0 0 13.1951 0 0 0 0 0 0 0 14.9509 0 14.0161 0 0 12.4308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1777 0 0 0 0 0 0 0 0 0 13.5786 11.1277 0 0 13.3647 0 14.9159 13.1145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4841 0 0 10.8395 0 0 0 0 0 12.6079 0 0 0 0 0 0 0 0 12.7913 0 0 0 0 0 0 0 Q96M89 CC138_HUMAN Coiled-coil domain-containing protein 138 CCDC138 Homo sapiens (Human) APKLDLQILEKLSIILQK 0.99292 -16.036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8704 0 0 0 0 0 0 0 0 9.90797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1378 0 13.3109 13.1714 13.5237 12.4913 14.0391 0 0 0 0 12.5668 0 0 0 0 12.9581 0 13.9646 13.9973 0 14.5712 0 12.4997 0 0 0 0 0 0 13.7017 0 0 0 0 0 0 0 0 13.8068 0 0 0 0 0 14.0183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.701 0 0 0 0 0 0 0 0 0 0 0 Q96QK1 VPS35_HUMAN "Vacuolar protein sorting-associated protein 35, hVPS35 (Maternal-embryonic 3) (Vesicle protein sorting 35)" VPS35 MEM3 TCCCTA00141 Homo sapiens (Human) "endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of cellular protein metabolic process [GO:0032268]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of presynapse assembly [GO:1905606]; regulation of protein stability [GO:0031647]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]" GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0007040; GO:0007416; GO:0010008; GO:0010628; GO:0010629; GO:0010821; GO:0014069; GO:0016055; GO:0016241; GO:0030904; GO:0030906; GO:0031647; GO:0031648; GO:0031748; GO:0032268; GO:0032456; GO:0032463; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045732; GO:0048471; GO:0050728; GO:0050882; GO:0060161; GO:0060548; GO:0061357; GO:0070062; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098793; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:1901215; GO:1902823; GO:1902950; GO:1903181; GO:1903828; GO:1905166; GO:1905606; GO:2000331 D1 dopamine receptor binding [GO:0031748] DLVEMCR 0.99292 -16.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1529 0 0 0 12.5252 0 0 0 0 14.2374 0 0 14.2671 0 0 0 0 0 0 0 0 0 13.3961 0 0 0 0 0 13.3693 0 0 0 0 0 0 0 0 0 14.6047 13.2998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4191 0 13.643 0 0 0 0 0 0 12.9672 0 0 0 0 16.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1636 0 14.7561 0 0 0 0 0 13.0475 0 0 12.5663 0 0 0 0 0 0 0 0 0 0 12.7364 0 0 0 0 13.2134 0 12.2502 13.0378 0 0 0 0 0 0 0 0 0 0 0 12.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1402 0 Q99470 SDF2_HUMAN "Stromal cell-derived factor 2, SDF-2" SDF2 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783]; misfolded protein binding [GO:0051787]; chaperone cofactor-dependent protein refolding [GO:0051085] GO:0005783; GO:0051085; GO:0051787; GO:0101031 misfolded protein binding [GO:0051787] AVVPLLLLGGLWSAVGASSLGVVTCGSVVKLLNTRHNVR 0.99292 -6.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0366 0 0 0 0 0 0 13.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0151 0 0 0 0 0 0 0 13.6193 0 0 0 0 0 0 0 0 0 14.868 12.5497 0 0 0 0 0 0 13.4831 0 0 0 0 0 0 0 0 0 13.5462 0 0 0 0 14.2329 0 0 13.6231 0 0 14.6877 0 0 0 0 0 0 0 0 0 0 13.4997 13.7302 0 13.655 0 0 0 13.2003 0 0 13.5315 13.0965 0 14.7384 0 0 0 0 0 0 13.7561 0 14.0063 0 14.0407 0 0 0 13.8943 0 0 12.9084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.361 0 0 0 0 0 0 0 0 Q9C091 GRB1L_HUMAN GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein) GREB1L C18orf6 KIAA1772 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac ventricle development [GO:0003231]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; paramesonephric duct development [GO:0061205]; uterus development [GO:0060065] GO:0001656; GO:0001658; GO:0001822; GO:0003231; GO:0016021; GO:0030539; GO:0060065; GO:0061205; GO:0072177 DPLGETFPR 0.99292 -39.024 13.8802 0 0 14.3316 0 10.7674 15.403 0 0 0 0 9.43192 11.2351 10.5923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9541 0 0 12.8462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1865 12.1562 0 0 13.2933 0 0 0 12.7504 0 12.0583 14.3415 15.245 12.8192 0 14.0774 0 12.7009 0 14.3635 14.1203 12.777 0 13.3876 12.5844 13.1386 0 12.8609 0 0 12.0743 14.4872 0 0 12.8613 0 13.2088 0 12.2153 0 13.6913 14.4012 18.2785 0 13.8388 13.6781 0 13.9218 0 14.6376 13.8831 13.4946 13.8856 14.0397 13.1984 12.4672 15.1723 12.7587 12.8943 0 11.983 12.9559 13.3953 14.0398 0 0 13.7849 0 16.3585 0 0 0 0 12.2675 0 0 0 0 0 13.6498 0 0 0 0 0 0 12.5305 12.9243 0 0 0 0 0 15.0205 0 0 0 0 17.9736 0 0 0 0 0 13.8806 0 Q9NR48 ASH1L_HUMAN "Histone-lysine N-methyltransferase ASH1L, EC 2.1.1.359, EC 2.1.1.367 (ASH1-like protein, huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H)" ASH1L KIAA1420 KMT2H Homo sapiens (Human) "chromatin organization [GO:0006325]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K4 methylation [GO:0051568]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; transcription by RNA polymerase II [GO:0006366]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]" bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K4 methylation [GO:0051568]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of transcription, DNA-templated [GO:0006355]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; transcription by RNA polymerase II [GO:0006366]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038]" GO:0000165; GO:0001501; GO:0002674; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005794; GO:0005923; GO:0006325; GO:0006355; GO:0006366; GO:0006954; GO:0007249; GO:0007338; GO:0009791; GO:0018024; GO:0030317; GO:0042800; GO:0043124; GO:0043409; GO:0045944; GO:0046697; GO:0046872; GO:0046974; GO:0046975; GO:0051568; GO:0061038; GO:0097676; GO:1903699; GO:1903709 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872] AARLAQIFKEICDGIISYK 0.99292 -43.92 0 0 0 0 0 0 0 0 0 0 0 0 13.7892 0 0 0 0 0 11.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0218 13.0353 13.1776 0 0 0 0 0 0 0 0 10.4189 11.7389 0 0 0 0 0 0 0 0 0 12.246 0 0 0 0 0 9.88777 0 0 0 0 0 0 0 0 0 11.9985 0 0 0 0 0 0 0 13.2942 13.5195 13.8844 0 0 0 17.6959 0 0 12.0449 0 17.6962 13.0675 0 0 0 11.0727 0 10.9005 0 12.366 0 0 0 0 13.2125 0 17.8836 9.59352 13.5947 0 0 0 11.1368 0 0 13.9816 0 0 13.0779 15.6045 12.1272 13.0861 11.3429 13.9548 14.3445 12.954 0 0 13.7879 15.345 0 13.9893 0 13.3826 0 0 13.4888 0 0 14.0546 0 0 0 14.9897 12.5996 11.9873 0 0 12.7153 0 13.9042 0 13.5731 0 12.1819 11.2622 13.9405 13.729 0 15.5747 0 10.7501 0 0 0 10.8397 0 0 0 12.4129 0 9.59352 0 0 0 13.1298 0 10.4381 0 0 0 Q9Y4J8 DTNA_HUMAN "Dystrobrevin alpha, DTN-A (Alpha-dystrobrevin) (Dystrophin-related protein 3)" DTNA DRP3 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neuromuscular synaptic transmission [GO:0007274]; signal transduction [GO:0007165]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; chemical synaptic transmission [GO:0007268]; neuromuscular synaptic transmission [GO:0007274]; signal transduction [GO:0007165]; striated muscle contraction [GO:0006941]; synaptic signaling [GO:0099536] GO:0005654; GO:0005737; GO:0005886; GO:0006941; GO:0007165; GO:0007268; GO:0007274; GO:0008270; GO:0030054; GO:0032991; GO:0045111; GO:0045202; GO:0070161; GO:0099536 zinc ion binding [GO:0008270] AQQNPTLLAELRLLR 0.99292 -7.7586 0 0 0 0 0 0 0 0 0 0 0 12.16 0 0 12.2769 0 0 0 12.2938 12.4622 0 0 0 0 11.9493 0 0 0 0 0 11.5642 0 12.4989 12.4885 0 0 0 12.5162 0 12.2257 0 0 0 0 0 0 12.2948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6478 0 0 0 0 0 0 0 0 0 0 0 15.4752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5797 0 0 0 0 0 0 0 0 0 0 15.8525 0 15.3705 16.0232 13.3892 0 13.5813 0 0 13.3531 0 0 12.995 0 0 0 0 0 0 0 0 0 Q9UGL1 KDM5B_HUMAN "Lysine-specific demethylase 5B, EC 1.14.11.67 (Cancer/testis antigen 31, CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1, RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B)" KDM5B JARID1B PLU1 RBBP2H1 Homo sapiens (Human) "branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]" GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0007338; GO:0008270; GO:0009791; GO:0010628; GO:0032452; GO:0032453; GO:0033601; GO:0034647; GO:0034720; GO:0042393; GO:0044344; GO:0045892; GO:0048511; GO:0060444; GO:0060763; GO:0060992; GO:0061038; GO:0070306; GO:1990830; GO:1990837; GO:2000864 DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] AVGSHIR 0.99293 -44.217 13.2151 0 0 0 0 0 0 11.7015 19.0828 18.716 15.5284 13.1263 18.6009 13.4652 14.4143 0 0 11.7225 10.4324 0 0 0 0 0 12.7057 0 0 13.0863 14.344 14.6048 12.9363 18.4254 18.4412 13.5291 13.585 18.442 12.3198 18.3161 0 14.3845 0 0 12.881 0 18.2882 13.0729 11.9913 0 0 11.5105 0 10.9166 13.2179 0 0 0 0 0 0 10.6721 0 0 0 0 0 10.8609 0 0 0 0 0 0 0 12.8786 13.915 14.3695 13.8581 0 14.3629 14.1808 0 14.9151 14.2446 15.4649 14.2658 14.9826 15.2252 14.6904 16.6211 14.1704 15.9448 0 12.853 14.7799 14.0665 14.9705 13.5713 12.2411 15.5739 0 0 14.3628 0 0 14.513 0 14.5245 0 0 15.924 0 0 0 14.1834 14.1814 13.6833 15.7929 0 0 13.4754 0 14.0341 0 13.3558 14.6461 0 0 0 0 14.2285 0 14.6999 13.6608 0 13.7683 0 15.2785 13.8069 14.6976 0 0 0 13.873 0 15.4001 0 15.001 0 12.9844 0 14.5343 0 14.0189 0 0 0 0 18.8955 15.7782 14.4368 12.4235 0 18.9678 0 0 0 18.8874 12.8639 14.7504 0 0 15.0685 15.0471 0 0 0 14.0749 11.3688 18.9027 0 Q8IZA3 H18_HUMAN "Histone H1.8 (Histone H1oo) (Oocyte-specific histone H1) (Oocyte-specific linker histone H1, osH1)" H1-8 H1FOO H1OO OSH1 Homo sapiens (Human) "chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; regulation of gene expression, epigenetic [GO:0040029]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; meiotic cell cycle [GO:0051321]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; regulation of gene expression, epigenetic [GO:0040029]" GO:0000786; GO:0003690; GO:0005634; GO:0005737; GO:0006334; GO:0030261; GO:0030527; GO:0031492; GO:0040029; GO:0045910; GO:0051321; GO:0070062 double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527] AAKRPAK 0.99293 -24.292 0 0 0 0 0 0 0 12.638 18.2185 13.8772 14.3834 18.1144 17.9571 18.0552 16.4339 16.2435 16.2066 16.5165 14.2372 14.7717 14.7947 0 14.235 0 15.3823 15.8769 16.4399 15.4917 16.5034 19.1462 18.8635 18.9177 18.8463 18.9112 18.8871 18.9102 18.9157 18.9671 14.8388 14.5621 19.1127 19.0183 19.1009 16.2392 15.208 15.4345 13.0228 15.9341 16.0926 15.6105 19.1091 15.4058 15.6705 15.8636 16.4762 14.9015 15.2898 15.4267 0 12.4738 14.9181 15.6802 14.4396 15.0331 15.8199 14.3095 0 0 0 0 0 0 0 0 0 10.6199 0 0 0 0 14.4507 13.5139 0 0 0 0 0 14.7775 14.774 14.2066 0 14.65 15.4305 14.4936 0 0 0 14.3794 0 16.4882 0 15.7728 0 16.1603 0 0 13.7927 0 16.4148 16.3759 16.7496 0 0 19.0987 14.518 18.5948 0 0 0 17.0826 0 11.6049 15.6993 16.2396 16.2324 0 15.0191 14.5894 0 16.3639 0 0 16.4127 14.981 0 15.958 0 0 16.8788 15.6564 0 13.8392 0 15.3081 0 0 0 16.7802 0 0 0 0 0 13.7096 14.1035 16.7726 18.4229 19.4412 19.4255 15.0451 19.7188 17.2273 17.242 16.9074 19.3904 16.5692 19.2273 17.1901 19.6864 16.3792 19.0875 0 15.2921 12.9663 16.2113 19.7204 0 17.4951 16.9763 11.978 Q9UQ26 RIMS2_HUMAN "Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2, RIM 2) (Rab-3-interacting protein 3)" RIMS2 KIAA0751 RAB3IP3 RIM2 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoskeleton of presynaptic active zone [GO:0048788]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; positive regulation of dendrite extension [GO:1903861]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of synaptic transmission [GO:0050806]; regulation of exocytosis [GO:0017157]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; spontaneous neurotransmitter secretion [GO:0061669] GO:0006886; GO:0007188; GO:0017156; GO:0017157; GO:0030073; GO:0030154; GO:0031267; GO:0042391; GO:0042734; GO:0042995; GO:0044325; GO:0046872; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0061669; GO:0070062; GO:0070161; GO:0097151; GO:1903861; GO:2000463 metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] EDGRPRNPYVK 0.99293 -4.4083 0 0 0 0 0 0 0 0 0 0 0 0 11.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5418 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.768 0 0 0 0 0 0 0 0 0 13.3837 14.648 0 0 0 15.7839 12.4374 0 14.4861 0 12.8484 15.4251 11.8739 15.2026 0 14.5378 15.5215 0 15.0936 14.4047 0 13.9427 15.4533 0 0 0 14.1227 16.2154 14.7533 14.7588 0 13.9136 13.4765 0 16.5626 16.0081 0 0 0 14.9957 12.5893 0 0 0 0 15.2224 11.7974 0 15.3765 15.0275 10.618 0 0 10.8431 0 0 0 0 0 13.1653 0 13.983 12.5265 0 0 0 12.0213 12.4433 0 11.2732 0 13.5378 0 0 0 0 0 13.1487 0 12.7025 0 0 0 0 0 0 0 14.65 0 0 0 0 12.2989 0 12.9335 0 0 10.7866 0 13.5206 0 A6NES4 MRO2A_HUMAN Maestro heat-like repeat-containing protein family member 2A (HEAT repeat-containing protein 7B1) MROH2A HEATR7B1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AFILFGK 0.99293 -44.372 12.8572 0 0 0 0 0 0 0 0 0 15.929 12.2406 0 0 0 0 0 0 0 0 0 0 0 12.5416 0 0 0 0 0 0 0 0 0 0 0 10.5284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9769 0 0 0 0 0 0 0 0 0 0 0 0 14.3996 0 0 0 0 0 0 13.4731 0 14.1347 15.2876 14.8438 0 0 14.4955 0 0 12.9594 13.5226 0 13.0824 14.141 13.5872 13.4726 15.0466 0 0 13.049 14.1062 0 13.8493 13.733 0 0 15.1863 0 0 0 0 0 13.5134 0 13.4431 0 0 16.4072 0 13.8973 15.0408 13.2376 0 0 16.6261 13.7282 0 0 0 13.9157 13.8757 0 0 0 15.9401 0 0 14.2578 0 0 0 0 14.3977 0 0 0 0 0 0 0 0 14.8726 0 12.6322 0 13.5755 0 11.8935 14.0339 13.9515 12.0925 0 13.8756 0 0 0 0 16.9399 0 0 14.022 0 0 14.1934 0 0 0 0 13.2211 0 0 0 B2RTY4 MYO9A_HUMAN Unconventional myosin-IXa (Unconventional myosin-9a) MYO9A MYR7 Homo sapiens (Human) cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601] actin filament [GO:0005884]; anchoring junction [GO:0070161]; axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461] actin filament [GO:0005884]; anchoring junction [GO:0070161]; axonal growth cone [GO:0044295]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; positive regulation of GTPase activity [GO:0043547]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601] GO:0000146; GO:0005096; GO:0005524; GO:0005829; GO:0005884; GO:0007601; GO:0016021; GO:0016461; GO:0034329; GO:0035556; GO:0043547; GO:0044295; GO:0045198; GO:0045202; GO:0046872; GO:0051015; GO:0051056; GO:0070161; GO:0150011 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146] AAAIVIQQKWR 0.99293 -71.223 0 0 0 0 0 0 0 0 13.4895 16.6281 0 0 14.5854 12.2167 11.7317 10.3542 0 0 0 0 0 0 0 0 0 0 0 11.7133 16.626 0 10.8872 13.0792 0 12.1988 0 0 13.1683 0 0 11.7762 12.7398 0 11.3496 11.745 12.4412 0 0 11.1819 0 11.0266 0 11.3802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0741 0 15.7761 0 0 0 13.0255 0 13.5819 0 12.7176 0 0 0 12.5798 0 0 0 0 0 0 0 0 0 13.3727 13.4797 13.2535 10.5937 13.6123 14.0816 15.263 0 13.4982 0 15.3941 0 13.4522 14.489 0 0 11.1602 13.9327 11.4252 0 14.1739 14.6058 11.8575 14.7646 0 0 13.2657 0 14.5792 12.34 12.6813 0 15.4641 14.3166 15.1432 13.9846 0 0 0 14.8295 12.5195 13.2149 16.9823 13.2823 0 11.6618 13.7539 0 0 0 10.7879 14.5913 14.2024 11.0566 12.4969 12.1177 15.1582 14.8766 0 0 13.6013 0 11.1158 12.8848 13.9638 0 14.2963 0 0 13.3464 0 0 0 0 0 0 0 13.5299 14.1774 14.2127 0 14.2247 13.1396 11.518 13.9836 0 0 0 17.6858 O60218 AK1BA_HUMAN "Aldo-keto reductase family 1 member B10, EC 1.1.1.300, EC 1.1.1.54 (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein, ARP, hARP) (Small intestine reductase, SI reductase)" AKR1B10 AKR1B11 Homo sapiens (Human) cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523] GO:0001523; GO:0001758; GO:0004032; GO:0004033; GO:0005576; GO:0005739; GO:0005764; GO:0005829; GO:0008106; GO:0016488; GO:0044597; GO:0044598; GO:0045550; GO:0047655; GO:0047718; GO:0052650; GO:0110095 alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; NADP-retinol dehydrogenase activity [GO:0052650]; retinal dehydrogenase activity [GO:0001758] FHIQRNVIVIPK 0.99293 -6.2908 0 0 0 12.4485 0 0 0 0 12.8404 12.5601 0 0 0 12.263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6624 0 0 0 0 0 0 0 0 0 14.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4812 0 0 0 0 0 0 0 0 0 0 0 0 13.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8795 0 0 0 13.1248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7706 0 0 13.2658 0 13.0843 0 0 0 0 0 14.0375 13.8149 0 0 0 0 0 0 0 0 0 O60268 K0513_HUMAN Uncharacterized protein KIAA0513 KIAA0513 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 EKWCHMTQEER 0.99293 -16.865 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4422 0 0 0 0 0 0 11.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.193 0 0 0 0 0 0 0 0 11.804 0 0 12.2346 0 0 12.7667 0 13.5315 0 0 0 0 0 13.6194 0 0 0 0 0 0 0 0 0 0 0 0 11.7725 0 0 0 0 0 0 0 0 0 0 0 0 13.2124 9.97183 0 0 0 0 0 13.896 0 0 0 12.1171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6578 15.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3101 0 0 12.0227 0 0 0 0 O75093 SLIT1_HUMAN "Slit homolog 1 protein, Slit-1 (Multiple epidermal growth factor-like domains protein 4, Multiple EGF-like domains protein 4)" SLIT1 KIAA0813 MEGF4 SLIL1 Homo sapiens (Human) axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028] extracellular space [GO:0005615] extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028] GO:0005509; GO:0005615; GO:0007097; GO:0007411; GO:0008045; GO:0008201; GO:0021510; GO:0022028; GO:0031290; GO:0033563; GO:0043395; GO:0048495; GO:0048843; GO:0048846; GO:0048853; GO:0050919; GO:0051964 calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495] AFRGATDLKNLQLDK 0.99293 -39.89 0 0 0 0 0 0 0 0 13.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2057 0 0 0 0 0 0 0 0 11.1546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0024 0 0 0 0 0 0 0 0 0 0 12.0928 0 0 11.9477 12.3957 16.6848 12.345 15.6103 0 0 0 12.7603 0 0 0 0 12.1398 12.7582 14.592 0 0 0 0 0 0 13.514 13.9183 12.7255 13.354 0 0 0 0 0 0 0 13.2051 11.3337 12.9861 13.3957 0 0 0 14.535 14.2111 0 0 0 0 0 0 0 11.1546 0 0 0 0 0 0 12.9747 12.6289 13.8135 13.1991 0 0 0 13.4436 0 10.7445 0 0 14.2631 12.2684 0 0 0 13.1497 0 0 10.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8957 13.021 0 0 0 0 0 O94850 DEND_HUMAN Dendrin DDN KIAA0749 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211] "anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic membrane [GO:0045211]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0005789; GO:0032591; GO:0042995; GO:0043204; GO:0045211; GO:0045944; GO:0070161 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" APRPSAQPQSDPGSAWAGPWGGR 0.99293 -16.892 0 0 0 10.317 0 0 0 0 0 0 0 0 0 0 13.4984 0 0 0 11.0112 0 0 0 0 0 0 10.963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8333 0 0 0 0 0 0 0 0 0 0 0 13.7558 0 14.0663 0 0 13.373 0 0 0 0 0 0 0 0 14.5884 0 0 13.366 0 0 0 0 0 0 13.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2608 14.4243 0 0 0 0 0 0 0 0 13.5752 0 0 0 0 12.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95965 ITGBL_HUMAN Integrin beta-like protein 1 (Osteoblast-specific cysteine-rich protein) (Ten integrin EGF-like repeat domain-containing protein) ITGBL1 OSCP TIED Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229] GO:0005178; GO:0005576; GO:0005886; GO:0005925; GO:0007155; GO:0007160; GO:0007229; GO:0016477; GO:0033627 integrin binding [GO:0005178] AVYDRYSDDFCSGHGQCNCGRCDCK 0.99293 -16.488 0 0 0 0 0 0 0 0 0 0 11.3461 0 0 0 12.8388 11.9205 0 0 0 11.8809 13.1628 11.7123 11.8478 9.47972 11.3251 11.6392 0 12.4722 0 0 0 12.1017 0 11.2026 0 0 0 11.8764 13.0311 0 10.9931 0 12.1761 13.4885 0 0 14.0861 0 0 0 0 0 9.47129 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1716 16.938 0 0 15.7149 0 0 12.5619 15.476 0 12.5936 14.4404 15.84 11.1784 15.4478 15.0518 16.3425 0 0 13.5161 0 13.5902 15.8051 14.4755 0 12.645 12.0826 0 0 15.0749 0 0 14.6158 15.3763 11.3182 14.2666 11.5872 14.4426 0 12.5109 15.3673 0 13.761 13.9611 0 0 14.5722 12.0556 0 13.3239 0 0 15.9374 16.0045 0 13.9183 14.1304 15.0556 13.9989 14.9713 14.2549 12.8987 15.7088 13.3408 15.7522 0 11.6958 0 0 0 14.4759 13.772 0 10.8299 0 10.3112 0 12.785 0 11.6664 0 0 0 0 0 0 0 0 14.8952 14.6156 12.9905 10.422 0 10.3175 0 0 0 0 13.3123 13.5814 0 0 12.9378 0 14.3805 14.4686 12.6464 14.6362 0 0 12.2372 13.2239 12.1341 0 P05089 ARGI1_HUMAN "Arginase-1, EC 3.5.3.1 (Liver-type arginase) (Type I arginase)" ARG1 Homo sapiens (Human) adaptive immune response [GO:0002250]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; arginine catabolic process to ornithine [GO:0019547]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen biosynthetic process [GO:0032964]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; liver development [GO:0001889]; lung development [GO:0030324]; mammary gland involution [GO:0060056]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; regulation of L-arginine import across plasma membrane [GO:1905541]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to herbicide [GO:0009635]; response to manganese ion [GO:0010042]; response to methylmercury [GO:0051597]; response to selenium ion [GO:0010269]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; specific granule lumen [GO:0035580] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; arginase activity [GO:0004053]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; adaptive immune response [GO:0002250]; aging [GO:0007568]; arginine catabolic process [GO:0006527]; arginine catabolic process to ornithine [GO:0019547]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen biosynthetic process [GO:0032964]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; liver development [GO:0001889]; lung development [GO:0030324]; mammary gland involution [GO:0060056]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; regulation of L-arginine import across plasma membrane [GO:1905541]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to herbicide [GO:0009635]; response to manganese ion [GO:0010042]; response to methylmercury [GO:0051597]; response to selenium ion [GO:0010269]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050] GO:0000050; GO:0001889; GO:0001938; GO:0002250; GO:0004053; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005741; GO:0005829; GO:0006527; GO:0007568; GO:0009410; GO:0009635; GO:0010042; GO:0010043; GO:0010269; GO:0014075; GO:0019547; GO:0030145; GO:0030324; GO:0032964; GO:0033189; GO:0033197; GO:0035578; GO:0035580; GO:0042130; GO:0042802; GO:0042832; GO:0043005; GO:0043025; GO:0043200; GO:0045087; GO:0046007; GO:0046686; GO:0048678; GO:0051597; GO:0060056; GO:0060135; GO:0060336; GO:0070301; GO:0070965; GO:0071222; GO:0071353; GO:0071377; GO:0071549; GO:0071560; GO:1905541; GO:2000552 arginase activity [GO:0004053]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145] EQECDVK 0.99293 -14.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7717 0 0 0 0 0 0 0 15.6477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8234 13.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4638 0 P11150 LIPC_HUMAN "Hepatic triacylglycerol lipase, HL, Hepatic lipase, EC 3.1.1.3 (Lipase member C) (Lysophospholipase, EC 3.1.1.5) (Phospholipase A1, EC 3.1.1.32)" LIPC HTGL Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron remnant clearance [GO:0034382]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; intermediate-density lipoprotein particle remodeling [GO:0034373]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidylcholine catabolic process [GO:0034638]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; apolipoprotein binding [GO:0034185]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; low-density lipoprotein particle binding [GO:0030169]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron remnant clearance [GO:0034382]; fatty acid biosynthetic process [GO:0006633]; high-density lipoprotein particle remodeling [GO:0034375]; intermediate-density lipoprotein particle remodeling [GO:0034373]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidylcholine catabolic process [GO:0034638]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372] GO:0004465; GO:0004620; GO:0004622; GO:0004806; GO:0005576; GO:0005615; GO:0005788; GO:0006633; GO:0008201; GO:0008203; GO:0008970; GO:0016042; GO:0016298; GO:0019433; GO:0030169; GO:0034185; GO:0034364; GO:0034372; GO:0034373; GO:0034374; GO:0034375; GO:0034382; GO:0034638; GO:0042632; GO:0043691; GO:0052739; GO:0052740; GO:0070328; GO:0102545 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; apolipoprotein binding [GO:0034185]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; low-density lipoprotein particle binding [GO:0030169]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806] LVGKEVAALLRWLEESVQLSR 0.99293 -14.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7749 0 0 0 0 0 0 0 0 14.2061 0 0 0 0 0 0 0 0 0 0 0 13.8879 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1514 0 0 0 0 0 0 14.2519 0 0 0 0 0 0 0 0 0 0 0 12.925 0 0 0 0 0 0 0 0 13.6618 0 14.3927 0 0 0 0 13.0496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9111 0 0 0 0 0 0 0 0 P18206 VINC_HUMAN "Vinculin (Metavinculin, MV)" VCL Homo sapiens (Human) adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702] adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915] adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome [GO:0002102]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625]; adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702] GO:0002009; GO:0002102; GO:0002162; GO:0003779; GO:0005198; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005903; GO:0005911; GO:0005912; GO:0005915; GO:0005916; GO:0005925; GO:0007155; GO:0007160; GO:0008013; GO:0030032; GO:0030055; GO:0030336; GO:0031625; GO:0032991; GO:0034333; GO:0034394; GO:0034774; GO:0035580; GO:0035633; GO:0042383; GO:0043034; GO:0043297; GO:0044291; GO:0045121; GO:0045294; GO:0045296; GO:0048675; GO:0051893; GO:0070062; GO:0070527; GO:0090136; GO:0090636; GO:0090637; GO:1903140; GO:1903561; GO:1904702; GO:1904813; GO:1990357 actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625] AVANSRPAK 0.99293 -44.353 0 0 0 0 0 0 12.9764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.68212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98242 0 0 0 0 0 0 0 0 0 0 11.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5997 0 14.7429 0 0 14.2113 0 13.388 0 12.8661 0 0 13.5518 12.4709 0 0 0 0 0 0 13.0434 0 0 0 0 0 0 0 13.6691 0 0 0 0 0 0 0 0 13.368 0 0 0 13.3784 13.0995 0 16.8316 14.7568 14.3086 14.2493 0 12.917 13.0615 0 13.3491 0 13.3105 15.2212 0 0 0 0 0 13.3643 15.5315 13.6231 13.0083 0 0 12.1976 0 0 12.8762 0 14.1411 0 0 0 0 0 0 0 0 0 0 9.72543 0 0 12.2541 13.8753 0 0 0 0 0 11.4759 0 12.8691 0 0 0 0 0 0 0 P30613 KPYR_HUMAN "Pyruvate kinase PKLR, EC 2.7.1.40 (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase)" PKLR PK1 PKL Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; pyruvate biosynthetic process [GO:0042866]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to lithium ion [GO:0010226]; response to nutrient [GO:0007584] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; ATP biosynthetic process [GO:0006754]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; pyruvate biosynthetic process [GO:0042866]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to lithium ion [GO:0010226]; response to nutrient [GO:0007584] GO:0000287; GO:0001666; GO:0004743; GO:0005524; GO:0005737; GO:0005829; GO:0006096; GO:0006754; GO:0007584; GO:0009408; GO:0009749; GO:0010226; GO:0016301; GO:0030955; GO:0032869; GO:0033198; GO:0042866; GO:0051591; GO:0070062; GO:0071872 ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743] EAEAAVYHR 0.99293 -16.903 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6217 0 13.6508 0 0 12.7029 0 0 0 0 0 0 0 13.5463 0 0 0 0 0 0 13.907 0 0 13.4453 0 13.3122 12.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02539 H11_HUMAN Histone H1.1 (Histone H1a) H1-1 H1F1 HIST1H1A Homo sapiens (Human) chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; positive regulation of receptor-mediated endocytosis [GO:0048260]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; vesicle [GO:0031982] cell surface [GO:0009986]; chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; vesicle [GO:0031982]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; heparin binding [GO:0008201]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; positive regulation of receptor-mediated endocytosis [GO:0048260]; spermatogenesis [GO:0007283] GO:0000785; GO:0000786; GO:0000791; GO:0003690; GO:0005634; GO:0005654; GO:0006334; GO:0007283; GO:0008201; GO:0009986; GO:0030261; GO:0030527; GO:0031490; GO:0031492; GO:0031982; GO:0045910; GO:0048260 chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; heparin binding [GO:0008201]; nucleosomal DNA binding [GO:0031492]; structural constituent of chromatin [GO:0030527] ERGGVSLAALKK 0.99293 -16.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0781 0 0 0 0 0 0 0 0 0 0 12.8763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1646 0 0 12.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4483 0 14.8508 0 Q08999 RBL2_HUMAN "Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein, p130) (Retinoblastoma-related protein 2, RBR-2) (pRb2)" RBL2 RB2 Homo sapiens (Human) cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000785; GO:0000977; GO:0005654; GO:0005667; GO:0005694; GO:0005730; GO:0005829; GO:0006325; GO:0006357; GO:0007049; GO:0010629; GO:0030154; GO:0043550; GO:0051302; GO:0070062; GO:1990841; GO:2000134 promoter-specific chromatin binding [GO:1990841]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] ALRISTPLTGVRYIK 0.99293 -4.4071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5466 13.1206 12.8901 0 0 0 0 13.9373 0 0 0 0 0 0 0 0 0 0 13.8762 13.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2953 0 0 0 13.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14164 IKKE_HUMAN "Inhibitor of nuclear factor kappa-B kinase subunit epsilon, I-kappa-B kinase epsilon, IKK-E, IKK-epsilon, IkBKE, EC 2.7.11.10 (Inducible I kappa-B kinase, IKK-i)" IKBKE IKKE IKKI KIAA0151 Homo sapiens (Human) cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mRNA stabilization [GO:0048255]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex assembly [GO:0043254]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; gene expression [GO:0010467]; immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mRNA stabilization [GO:0048255]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of lipid storage [GO:0010884]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex assembly [GO:0043254]; response to interferon-beta [GO:0035456]; type I interferon signaling pathway [GO:0060337] GO:0004674; GO:0004704; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006955; GO:0008384; GO:0008630; GO:0010467; GO:0010884; GO:0016605; GO:0018105; GO:0019903; GO:0031625; GO:0031966; GO:0035456; GO:0036435; GO:0042802; GO:0043123; GO:0043254; GO:0048255; GO:0051091; GO:0051607; GO:0060337; GO:0060340; GO:0097400; GO:0098586; GO:1902554 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; IkappaB kinase activity [GO:0008384]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; NF-kappaB-inducing kinase activity [GO:0004704]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625] AKGAQASPPPIAPYPSPTRK 0.99293 -16.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.516 0 0 0 0 0 0 0 11.9663 0 14.3011 0 0 0 0 12.5941 0 0 0 13.3299 13.8694 0 0 0 13.3106 0 0 0 12.8977 0 0 0 13.1163 0 0 13.1594 0 13.9225 0 0 0 0 0 0 0 0 0 0 0 12.0101 0 14.5028 0 12.3944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.223 15.1978 0 0 0 0 0 14.6922 11.3154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16643 DREB_HUMAN Drebrin (Developmentally-regulated brain protein) DBN1 D0S117E Homo sapiens (Human) actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cytoplasmic sequestering of protein [GO:0051220]; in utero embryonic development [GO:0001701]; maintenance of protein location in cell [GO:0032507]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168] actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; gap junction [GO:0005921]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427] actin cytoskeleton [GO:0015629]; actomyosin [GO:0042641]; cortical actin cytoskeleton [GO:0030864]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; gap junction [GO:0005921]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin filament organization [GO:0007015]; cell communication by chemical coupling [GO:0010643]; cell communication by electrical coupling [GO:0010644]; cytoplasmic sequestering of protein [GO:0051220]; in utero embryonic development [GO:0001701]; maintenance of protein location in cell [GO:0032507]; neural precursor cell proliferation [GO:0061351]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic plasticity [GO:0031915]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendrite development [GO:0050773]; regulation of neuronal synaptic plasticity [GO:0048168] GO:0001701; GO:0003779; GO:0005522; GO:0005737; GO:0005856; GO:0005886; GO:0005921; GO:0007015; GO:0010643; GO:0010644; GO:0014069; GO:0015629; GO:0030027; GO:0030425; GO:0030426; GO:0030427; GO:0030833; GO:0030863; GO:0030864; GO:0031915; GO:0032507; GO:0042641; GO:0045211; GO:0045296; GO:0045773; GO:0048168; GO:0048812; GO:0050773; GO:0051015; GO:0051220; GO:0061003; GO:0061351; GO:0098974; GO:0098978; GO:0099524; GO:1902685 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; profilin binding [GO:0005522] DEEEETHMK 0.99293 -16.895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2609 0 12.5235 13.3151 0 0 0 0 11.1415 10.1173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3779 0 0 0 12.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53HL2 BOREA_HUMAN "Borealin (Cell division cycle-associated protein 8) (Dasra-B, hDasra-B) (Pluripotent embryonic stem cell-related gene 3 protein)" CDCA8 PESCRG3 Homo sapiens (Human) chromosome organization [GO:0051276]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468] "chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]" "chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]; chromosome organization [GO:0051276]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]" GO:0000070; GO:0000278; GO:0000281; GO:0000775; GO:0001934; GO:0005654; GO:0005730; GO:0005829; GO:0006468; GO:0007052; GO:0007080; GO:0010369; GO:0015630; GO:0030496; GO:0032133; GO:0032991; GO:0045171; GO:0051233; GO:0051256; GO:0051276; GO:0090267; GO:1901970; GO:1902425; GO:1903490 ANTVTPAVGR 0.99293 -16.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9778 14.4137 0 0 0 0 16.1842 0 0 14.6522 14.1741 0 0 0 0 0 0 13.0011 0 13.9309 0 0 0 0 0 0 0 0 0 14.468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.897 14.289 0 14.8295 0 0 0 0 0 0 0 0 0 0 0 0 14.7537 0 0 0 14.8017 14.0404 0 0 14.5689 0 14.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.593 0 0 0 0 14.2579 0 Q5T1B0 AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 AXDND1 C1orf125 Homo sapiens (Human) AHDVKLTK 0.99293 -39.816 11.1631 0 11.1795 0 0 0 12.9717 0 13.7828 13.7511 13.9321 0 13.4922 13.5319 14.5325 0 11.5538 13.8392 0 0 14.3333 0 0 12.9651 0 0 13.6528 0 12.9327 0 12.8649 0 15.6258 14.1615 0 14.93 0 0 0 0 0 0 0 0 0 13.2248 12.5386 0 12.2581 0 12.3449 11.848 0 0 0 0 0 0 0 15.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1382 0 0 0 11.6177 0 13.6866 13.7511 14.1169 0 0 15.0246 14.6804 15.008 15.5839 13.8185 15.9882 0 0 13.2945 14.2872 14.3208 14.6883 14.8328 0 12.8141 0 14.4794 12.79 12.7324 0 13.7052 0 14.4982 0 0 13.7532 12.7254 0 13.6184 0 0 0 13.7527 0 14.7232 14.4429 0 12.5343 13.7716 13.3545 15.1434 0 15.321 13.334 14.0507 0 14.4316 0 0 13.8768 15.1858 0 0 0 0 0 0 13.7057 13.4888 0 13.9886 0 0 0 0 0 0 13.3571 0 15.2471 14.4353 14.4054 0 10.9625 13.2381 14.1323 15.3211 14.6657 0 13.1948 0 14.2126 14.8716 0 0 14.2386 0 0 13.3052 0 12.1536 0 0 Q5TC84 OGRL1_HUMAN Opioid growth factor receptor-like protein 1 OGFRL1 Homo sapiens (Human) membrane [GO:0016020] membrane [GO:0016020]; opioid growth factor receptor activity [GO:0140625] GO:0016020; GO:0140625 opioid growth factor receptor activity [GO:0140625] ELTTYEIEEFKK 0.99293 -26.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1098 0 0 0 0 0 0 0 0 0 0 10.9633 0 0 0 0 12.878 0 0 0 0 0 0 0 0 0 0 12.8162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.439 12.2972 0 0 0 0 0 0 0 0 0 0 15.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTR2 NLRC3_HUMAN "NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2, CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)" NLRC3 NOD3 Homo sapiens (Human) I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110] GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223 ATP binding [GO:0005524]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312] ALADALKINRTLTSLSLQGNTVR 0.99293 -24.199 0 0 0 0 0 0 0 0 16.8199 0 0 0 0 0 0 0 0 0 0 0 0 12.0708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4367 12.8107 13.6348 13.8306 13.9309 0 0 0 0 12.0976 0 0 11.9878 13.188 12.7524 0 0 0 0 0 0 0 0 0 16.7656 0 0 0 0 0 0 0 0 11.9351 13.9867 0 0 0 0 0 0 0 9.95887 0 0 0 14.4043 0 0 0 0 0 0 0 0 12.4555 0 14.3051 0 0 12.0171 0 0 0 0 0 0 0 0 13.802 0 0 0 0 0 0 16.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUQ7 CATIN_HUMAN Cactin (Renal carcinoma antigen NY-REN-24) CACTIN C19orf29 Homo sapiens (Human) "cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]" GO:0000398; GO:0001933; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356 RNA binding [GO:0003723] AYLWADKYR 0.99293 -16.053 0 0 0 0 0 0 0 0 0 0 11.1968 0 0 0 0 0 0 0 0 0 0 0 0 12.6248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.23053 10.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2425 0 12.1515 12.3553 0 10.9585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3901 0 10.2239 10.0053 0 0 0 0 0 0 0 0 0 9.59451 0 0 0 0 0 0 0 0 0 10.589 0 0 0 0 Q96IP4 TET5A_HUMAN "Terminal nucleotidyltransferase 5A, EC 2.7.7.19 (HBV X-transactivated gene 11 protein) (HBV XAg-transactivated protein 11)" TENT5A C6orf37 FAM46A XTP11 Homo sapiens (Human) mRNA stabilization [GO:0048255]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of ossification [GO:0030278]; response to bacterium [GO:0009617] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; mRNA stabilization [GO:0048255]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of ossification [GO:0030278]; response to bacterium [GO:0009617] GO:0003723; GO:0005737; GO:0009617; GO:0030278; GO:0030501; GO:0045669; GO:0048255; GO:1990817 RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723] FFIDFSDIGEQQR 0.99293 -14.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57412 0 0 0 12.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8557 0 0 0 0 0 0 0 0 0 0 0 Q96M96 FGD4_HUMAN "FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6)" FGD4 FRABP ZFYVE6 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0001726; GO:0003779; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0030175; GO:0031267; GO:0043087; GO:0046847; GO:0046872; GO:0051056 actin binding [GO:0003779]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] CSDYKAQLEYDGGK 0.99293 -14.262 0 0 0 16.0639 0 0 0 0 0 15.0096 15.1351 0 15.1526 0 14.9138 0 0 0 0 0 0 0 0 0 0 0 0 13.634 0 0 15.1869 0 0 15.4336 0 0 0 0 0 0 0 12.0337 0 0 0 0 11.8997 0 15.293 13.6287 15.4413 0 0 12.6311 15.8979 12.7636 15.7381 0 0 0 0 0 0 14.8938 15.2651 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3066 0 13.9174 0 13.7001 14.047 13.9457 0 0 0 12.9747 0 0 13.8697 0 0 14.2051 0 0 0 0 0 14.0984 0 0 13.8942 0 0 0 12.5517 0 0 0 10.9865 0 0 0 13.7308 0 0 0 0 15.3842 0 0 0 12.8873 0 0 13.7508 13.5535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.042 0 0 0 0 0 0 0 0 14.8964 0 0 0 0 0 0 0 0 Q96T23 RSF1_HUMAN "Remodeling and spacing factor 1, Rsf-1 (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex)" RSF1 HBXAP XAP8 Homo sapiens (Human) "chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]; histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003712; GO:0005634; GO:0005654; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0031213; GO:0031497; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0050434; GO:0140751 histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] AIENLIGK 0.99293 -39.448 11.1174 0 0 14.5228 13.953 16.3825 16.2914 0 0 0 0 0 0 0 0 0 0 0 10.5828 0 0 16.6472 17.9499 16.4151 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9721 0 11.1379 0 13.1378 11.8916 0 0 10.9103 12.7183 12.4162 12.5513 0 0 10.9637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5588 18.2477 0 11.1669 0 18.2244 0 0 17.9182 18.5159 14.1581 13.55 13.345 0 17.9855 17.8822 13.544 17.8392 0 17.7509 17.8145 12.7168 13.1446 0 0 17.687 12.2515 0 17.6037 17.5519 17.5626 14.7503 17.559 17.7475 0 0 14.6736 17.5111 17.527 14.3196 13.49 13.8296 17.4923 17.5337 11.2706 17.6477 0 13.2203 12.4386 0 12.9351 0 17.4438 13.7 17.4486 17.3782 14.9819 0 17.4923 17.7037 17.5347 17.4679 17.5435 13.0894 13.7802 17.5826 13.7572 17.4735 17.5552 14.9773 0 12.9717 16.4265 14.495 0 15.1523 0 14.5302 13.7039 17.3497 0 13.0286 0 0 17.2485 0 17.3322 17.2659 0 0 15.6636 0 0 0 0 13.1274 0 0 13.4666 10.3645 0 0 0 0 0 17.2015 17.2539 17.2491 0 0 0 0 0 13.0402 Q99598 TSNAX_HUMAN Translin-associated protein X (Translin-associated factor X) TSNAX TRAX Homo sapiens (Human) cell differentiation [GO:0030154]; siRNA processing [GO:0030422]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoribonuclease complex [GO:1902555]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoribonuclease complex [GO:1902555]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; A2A adenosine receptor binding [GO:0031687]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; cell differentiation [GO:0030154]; siRNA processing [GO:0030422]; spermatogenesis [GO:0007283] GO:0003677; GO:0003697; GO:0003723; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0007283; GO:0030154; GO:0030422; GO:0031687; GO:0043565; GO:0044877; GO:0046872; GO:0048471; GO:1902555 A2A adenosine receptor binding [GO:0031687]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697] EGSGGFR 0.99293 -16.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4476 0 0 0 0 0 0 0 0 0 14.5144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTA0 F167B_HUMAN Protein FAM167B FAM167B C1orf90 Homo sapiens (Human) LQLQTRRPSYLEWTAQVQSQAWR 0.99293 -14.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8662 0 0 0 0 0 0 0 0 0 10.8719 0 0 0 0 0 10.0926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4185 0 0 11.7868 11.7345 0 0 13.7165 0 13.3707 0 0 0 0 0 0 0 12.6635 13.1246 12.6385 0 0 0 0 0 0 14.5479 0 0 0 0 0 0 0 0 0 0 0 0 12.586 0 0 0 0 0 0 0 0 0 0 0 13.0791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H992 MARH7_HUMAN "E3 ubiquitin-protein ligase MARCHF7, EC 2.3.2.27 (Axotrophin) (Membrane-associated RING finger protein 7) (Membrane-associated RING-CH protein VII, MARCH-VII) (RING finger protein 177) (RING-type E3 ubiquitin transferase MARCHF7)" MARCHF7 AXOT MARCH7 RNF177 Homo sapiens (Human) "negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]" cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein polyubiquitination [GO:1902916]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]; regulation of tolerance induction [GO:0002643]" GO:0002643; GO:0005634; GO:0005829; GO:0005886; GO:0006513; GO:0008270; GO:0008284; GO:0016740; GO:0031624; GO:0042130; GO:0043130; GO:0043518; GO:0050821; GO:0051865; GO:0097371; GO:1901799; GO:1902166; GO:1902916; GO:1905524 MDM2/MDM4 family protein binding [GO:0097371]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270] CTPLFSRR 0.99293 -14.613 0 0 0 0 0 0 10.5473 0 0 0 0 14.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2949 0 0 16.6533 14.0478 0 0 0 0 0 13.4351 0 0 0 0 0 0 0 0 0 13.8821 0 0 0 14.5271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9384 0 14.3353 0 0 0 0 0 14.2543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P206 K1522_HUMAN Uncharacterized protein KIAA1522 KIAA1522 Homo sapiens (Human) cell differentiation [GO:0030154] cell differentiation [GO:0030154] GO:0030154 APPPVARKPSVGVPPPASPSYPR 0.99293 -16.913 0 0 13.5388 13.4054 13.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7433 0 0 0 13.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7808 0 0 0 0 0 0 0 0 13.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0502 14.0877 0 0 0 0 0 0 11.1906 0 13.8914 0 0 0 0 12.2542 0 0 0 0 15.2857 0 0 0 0 0 0 0 0 0 11.7426 0 0 0 0 13.5092 0 0 0 0 0 13.0477 12.695 13.643 14.9448 13.8294 14.0928 0 0 0 12.5112 0 0 11.2316 0 0 14.0772 0 11.8048 16.1302 0 0 13.4671 0 0 0 0 14.1612 0 0 14.1656 15.4632 14.3953 15.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5729 0 0 0 0 0 0 0 0 0 0 0 13.1083 0 0 0 0 0 0 Q9UBC5 MYO1A_HUMAN "Unconventional myosin-Ia (Brush border myosin I, BBM-I, BBMI) (Myosin I heavy chain, MIHC)" MYO1A MYHL Homo sapiens (Human) actin filament organization [GO:0007015]; microvillus assembly [GO:0030033]; sensory perception of sound [GO:0007605]; vesicle localization [GO:0051648]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; lateral plasma membrane [GO:0016328]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; microvillus assembly [GO:0030033]; sensory perception of sound [GO:0007605]; vesicle localization [GO:0051648]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016323; GO:0016324; GO:0016328; GO:0016459; GO:0030033; GO:0030050; GO:0030864; GO:0031941; GO:0044853; GO:0051015; GO:0051648 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AVLDATQRQLTVTVTEKFSVR 0.99293 -5.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4643 0 0 0 13.4798 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4858 0 11.7139 0 0 0 0 0 0 0 0 0 0 0 0 12.6145 0 0 0 0 13.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2636 14.4653 16.6876 16.9698 0 0 0 14.1148 14.3605 0 0 0 0 13.5858 14.6888 0 0 0 0 0 0 0 11.4583 11.4398 0 13.8155 0 0 0 13.9861 12.6513 12.9875 0 11.0714 12.2494 0 12.9614 12.9187 13.6826 0 0 14.7257 0 0 13.4748 0 0 13.7576 14.0195 11.0121 0 0 14.6454 0 0 0 0 0 14.5439 0 0 0 0 14.3378 0 0 0 0 0 13.4992 0 0 0 0 0 0 0 13.3096 13.9514 0 0 12.2224 0 0 0 0 0 0 0 0 0 12.1368 0 0 0 0 13.963 0 0 0 0 0 0 0 Q9UKF5 ADA29_HUMAN "Disintegrin and metalloproteinase domain-containing protein 29, ADAM 29 (Cancer/testis antigen 73, CT73)" ADAM29 Homo sapiens (Human) male gonad development [GO:0008584]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] GO:0004222; GO:0005886; GO:0005887; GO:0006508; GO:0007283; GO:0008237; GO:0008584; GO:0009897; GO:1990913 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] CIMHEGNPPITKFSNCSYGDFWEYTVERTK 0.99293 -5.1 0 11.5363 0 0 0 0 0 11.7726 0 13.3531 13.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 12.861 0 0 0 12.7181 0 0 0 0 0 0 0 0 0 0 0 10.872 0 0 0 0 0 0 13.7387 13.5927 12.5296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9719 0 0 0 0 0 11.1837 0 13.3619 14.1373 0 0 13.7365 0 12.8038 12.0218 0 0 0 0 16.0644 0 0 0 14.1923 0 12.1193 13.06 0 14.7029 0 15.4512 14.8404 14.4624 0 0 0 0 13.7247 14.0449 0 11.4868 0 0 0 13.6159 13.4779 14.1601 0 0 0 0 0 12.5421 0 13.6668 0 13.5517 12.1257 0 0 13.0948 15.6808 0 0 0 12.4976 0 0 0 13.3494 0 0 0 12.2868 12.907 0 0 0 13.0045 0 0 0 0 0 0 0 0 0 16.1 0 0 0 0 11.724 0 0 0 0 0 0 0 0 0 12.9085 12.9281 0 0 0 0 0 13.1219 0 0 Q9Y6X8 ZHX2_HUMAN "Zinc fingers and homeoboxes protein 2 (Alpha-fetoprotein regulator 1, AFP regulator 1) (Regulator of AFP) (Zinc finger and homeodomain protein 2)" ZHX2 AFR1 KIAA0854 RAF Homo sapiens (Human) "mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; mRNA catabolic process [GO:0006402]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019]" GO:0000122; GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006402; GO:0035019; GO:0042802; GO:0042803; GO:0045665; GO:0045892; GO:0046872; GO:0046982; GO:0060040 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]" ADAKKVPK 0.99293 -26.286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9457 0 12.9044 0 0 0 0 13.1402 0 0 13.0849 0 14.5028 0 16.0657 13.5701 0 0 0 13.0682 14.2071 0 13.448 0 0 0 0 0 0 14.6107 13.3418 15.7102 0 0 12.6889 0 0 0 12.6668 0 13.3987 0 0 0 14.3861 13.4635 13.6691 0 0 0 12.8835 0 0 0 0 0 0 14.1176 14.4218 14.1938 0 13.8306 0 15.1101 0 0 0 0 14.8657 0 14.1884 0 14.4029 0 0 0 0 17.0217 0 0 0 0 13.6723 0 0 0 0 11.5974 10.997 0 0 12.5309 13.6666 0 13.2449 13.6188 0 13.6355 12.2999 0 14.5137 0 12.9826 0 0 0 0 15.6432 Q5TCS8 KAD9_HUMAN "Adenylate kinase 9, AK 9, EC 2.7.4.4, EC 2.7.4.6 (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2)" AK9 AKD1 AKD2 C6orf199 C6orf224 Homo sapiens (Human) AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569] GO:0004017; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006174; GO:0006186; GO:0006756; GO:0006757; GO:0031965; GO:0050145; GO:0061508; GO:0061565; GO:0061566; GO:0061567; GO:0061568; GO:0061569; GO:0061570; GO:0061571 adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145] DEEEMSGEEDEEQETDAIER 0.99294 -72.156 15.6019 0 0 15.1678 16.0803 15.9492 16.5201 0 0 12.2632 0 0 0 0 12.8467 11.8822 12.3657 0 16.4409 13.1798 13.9044 16.6288 15.5402 16.7688 12.0976 0 0 14.3659 0 0 11.6833 12.3588 0 0 0 0 0 14.3496 0 0 0 12.1639 0 0 0 0 0 0 11.5295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8338 13.8173 13.3467 17.7744 17.7219 17.8629 18.1813 18.1713 18.2681 18.4473 18.8153 18.4941 15.0433 18.7955 18.9146 19.0476 18.5482 16.7994 17.5892 17.3691 17.3304 19.1006 16.3968 15.2917 15.3017 19.1189 19.1811 14.5505 19.2518 15.6281 19.2683 19.333 16.0225 18.9702 18.9402 18.8674 19.226 19.0888 19.0383 18.9486 18.8589 18.8792 18.8403 18.7269 18.6786 18.8904 13.5889 16.5185 18.8124 14.3305 12.569 15.1667 18.7939 18.4706 18.6173 18.5745 18.4202 18.4852 18.393 18.6708 18.3878 18.2486 18.3594 18.4016 15.4937 18.3205 18.3577 18.2865 13.6188 18.0739 18.3069 18.2382 18.1175 18.2162 9.84997 12.6089 17.8827 17.7833 13.2978 17.9449 17.7481 14.0916 0 0 17.7923 17.8118 18.241 17.9494 18.0553 16.2482 13.5326 0 12.3168 9.75515 15.1955 15.273 12.3504 13.9684 0 14.913 14.1218 0 0 13.7309 0 17.6973 17.4632 17.5422 15.082 15.0847 14.0638 13.7622 0 14.7516 Q8NFZ0 FBH1_HUMAN "F-box DNA helicase 1, hFBH1, EC 3.6.4.12 (F-box only protein 18)" FBH1 FBX18 FBXO18 Homo sapiens (Human) "cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]" chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] "chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; cell death [GO:0008219]; cellular response to DNA damage stimulus [GO:0006974]; DNA catabolic process, endonucleolytic [GO:0000737]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of chromatin binding [GO:0035562]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of protein phosphorylation [GO:0001934]; protein ubiquitination [GO:0016567]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to intra-S DNA damage checkpoint signaling [GO:0072429]" GO:0000724; GO:0000725; GO:0000737; GO:0000785; GO:0001934; GO:0003678; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006974; GO:0008219; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0035562; GO:0043138; GO:0048478; GO:0072429; GO:1902231; GO:2000042 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697] AMERTVENIVLPRHEALLFLVF 0.99294 -14.355 12.8211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7563 9.79048 0 13.135 12.6787 0 13.1882 0 13.5468 0 0 0 0 13.76 0 0 0 0 0 0 0 0 0 0 0 12.574 0 0 0 0 0 0 0 0 0 0 15.3392 15.1838 15.536 0 16.5701 0 12.4207 0 13.5206 13.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 19.113 18.233 15.6827 16.0752 14.8285 13.704 0 17.9151 17.964 17.8439 18.0336 0 13.8781 0 15.1276 16.2488 13.5205 0 0 13.684 18.0167 17.8027 17.906 13.1246 0 0 0 16.4123 0 17.188 17.8389 0 13.8864 12.8329 13.5993 16.5234 0 15.6225 15.6063 16.9491 16.9542 13.6303 0 16.5949 0 14.7864 0 0 13.8504 17.0141 16.7638 16.8347 13.6868 16.7529 16.6143 18.0807 17.0324 16.8276 17.6388 13.5624 13.539 0 13.3671 16.616 16.6321 0 13.4014 13.3261 13.0365 0 14.102 14.0588 17.1771 15.476 0 13.5599 16.0928 0 15.0403 0 0 16.0396 0 14.5226 0 0 0 0 0 14.6383 0 0 0 0 0 0 0 0 16.3033 0 0 0 0 0 0 O43824 GTPB6_HUMAN Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like) GTPBP6 PGPL Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022] GO:0005525; GO:0005737; GO:0043022; GO:0046872 GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022] AEWQVAEATALVHTLDGWSVVQTMVVSTK 0.99294 -24.301 0 0 0 0 0 0 13.0903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7219 0 0 0 0 0 0 0 0 0 12.879 0 13.663 0 0 0 14.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0812 0 0 0 0 12.8776 0 0 0 0 13.0477 0 14.1641 16.3802 0 0 16.5939 0 0 0 0 0 0 0 0 0 14.5896 0 0 0 0 0 0 0 0 12.1883 0 0 0 0 0 0 0 0 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5406 0 0 0 0 0 0 0 0 0 14.3735 0 0 0 0 0 0 0 13.9925 0 0 0 0 13.7525 0 0 13.5178 0 O75604 UBP2_HUMAN "Ubiquitin carboxyl-terminal hydrolase 2, EC 3.4.19.12 (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2)" USP2 UBP41 Homo sapiens (Human) cell cycle [GO:0007049]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cyclin binding [GO:0030332]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; cell cycle [GO:0007049]; circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000122; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0005813; GO:0006511; GO:0007049; GO:0007517; GO:0016020; GO:0016579; GO:0030332; GO:0031625; GO:0032922; GO:0042802; GO:0043153; GO:0045475; GO:0045931; GO:0046872; GO:0048471; GO:0048512; GO:0050821; GO:1901796 cyclin binding [GO:0030332]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625] FPKILVLHLK 0.99294 -14.312 0 0 0 0 0 0 0 0 0 0 0 10.9446 12.1439 0 0 0 0 0 0 0 11.6314 0 0 0 11.2063 12.8746 13.0585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8593 11.392 0 12.0002 0 12.6052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5576 0 13.7886 0 0 15.5842 11.8109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8206 0 0 0 12.9251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2245 0 12.8403 0 0 0 0 0 14.0742 0 0 0 0 0 0 0 0 0 0 0 13.2698 0 0 12.9516 0 0 0 0 0 0 0 0 0 11.3686 0 0 0 11.2841 0 0 0 O76031 CLPX_HUMAN "ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial" CLPX Homo sapiens (Human) ATP metabolic process [GO:0046034]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; ATP metabolic process [GO:0046034]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006508; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] CHHFFVVLSEADSKK 0.99294 -14.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3802 0 0 0 0 0 0 0 0 14.3248 0 0 0 0 0 0 14.4951 0 0 0 18.336 11.1899 12.8984 13.1806 0 14.7186 0 0 0 0 12.6444 0 0 0 0 0 0 0 0 0 12.9153 0 13.2109 0 0 14.3838 0 0 0 0 14.9164 13.3443 0 12.4097 0 0 0 0 0 0 0 0 0 11.8135 0 0 12.4775 0 14.2563 0 0 12.3563 0 0 0 13.0515 14.4861 0 13.9153 13.3602 0 13.2425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6333 0 0 0 0 0 O95467 GNAS3_HUMAN "Neuroendocrine secretory protein 55, NESP55 [Cleaved into: LHAL tetrapeptide; GPIPIRRH peptide ]" GNAS GNAS1 Homo sapiens (Human) female pregnancy [GO:0007565]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein secretion [GO:0009306]; response to parathyroid hormone [GO:0071107] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; female pregnancy [GO:0007565]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein secretion [GO:0009306]; response to parathyroid hormone [GO:0071107] GO:0005576; GO:0005634; GO:0005737; GO:0007565; GO:0009306; GO:0030133; GO:0040015; GO:0048471; GO:0071107; GO:0120162 GPVVPKHSTFGQSLTQRLHALK 0.99294 -13.323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15735 PHKG2_HUMAN "Phosphorylase b kinase gamma catalytic chain, liver/testis isoform, PHK-gamma-LT, PHK-gamma-T, EC 2.7.11.19 (PSK-C3) (Phosphorylase kinase subunit gamma-2)" PHKG2 Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; protein phosphorylation [GO:0006468] GO:0004674; GO:0004689; GO:0005516; GO:0005524; GO:0005829; GO:0005964; GO:0005977; GO:0005978; GO:0005980; GO:0006091; GO:0006468; GO:0019899; GO:0045819; GO:0050321 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] CEGSQPWNLTPRQRFR 0.99294 -6.3227 0 0 0 0 0 0 0 0 0 0 0 13.9687 0 0 11.4109 0 0 0 0 12.4392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7998 0 0 0 0 0 0 0 0 0 11.2622 0 0 0 0 15.918 0 0 0 10.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8838 0 0 0 0 0 0 0 0 0 0 0 0 12.9397 9.715 0 0 0 0 0 0 0 14.2351 13.9484 P20813 CP2B6_HUMAN "Cytochrome P450 2B6, EC 1.14.13.- (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1)" CYP2B6 Homo sapiens (Human) cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]; cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; organic acid metabolic process [GO:0006082]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008202; GO:0008390; GO:0008392; GO:0008395; GO:0016712; GO:0019373; GO:0020037; GO:0042178; GO:0042180; GO:0043231; GO:0062184; GO:0062187; GO:0062188; GO:0062189; GO:0101021 "anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]" AEAFSGRGK 0.99294 -13.332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1826 0 0 0 0 11.5519 0 13.2114 12.6693 0 14.3083 0 0 0 0 0 12.2308 0 0 0 0 0 0 0 0 0 0 0 12.3279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3544 0 0 0 0 17.0054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1032 0 0 0 0 0 0 0 0 0 0 0 0 P54845 NRL_HUMAN "Neural retina-specific leucine zipper protein, NRL" NRL D14S46E Homo sapiens (Human) positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; retinal rod cell development [GO:0046548]; visual perception [GO:0007601]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007601; GO:0010628; GO:0043522; GO:0045944; GO:0046548; GO:0050896; GO:1990837; GO:1990841 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AEVARLAR 0.99294 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2819 0 0 0 0 13.9817 13.7571 0 0 13.3551 0 0 0 0 0 0 0 0 0 0 0 0 13.0222 0 0 0 0 0 0 0 0 0 13.5527 13.8626 0 0 12.8721 13.0396 0 0 13.3877 0 0 0 0 0 0 0 0 0 0 0 13.7782 0 0 0 14.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.604 0 0 0 0 0 0 P55884 EIF3B_HUMAN "Eukaryotic translation initiation factor 3 subunit B, eIF3b (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog, hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116)" EIF3B EIF3S9 Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525] "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]" "cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525]" GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525 molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] FCQLLWR 0.99294 -13.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1402 0 0 0 0 0 0 0 0 14.1298 0 0 13.7396 13.5668 0 0 12.6391 0 14.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3937 0 0 0 0 0 11.6941 0 0 14.0645 13.3221 12.6261 0 0 0 0 0 0 0 13.7029 0 0 0 0 0 0 0 0 0 0 12.2202 0 0 0 0 0 0 0 0 0 0 0 0 11.3802 0 0 0 0 Q13515 BFSP2_HUMAN "Phakinin (49 kDa cytoskeletal protein) (Beaded filament structural protein 2) (Lens fiber cell beaded filament protein CP 47, CP47) (Lens fiber cell beaded filament protein CP 49, CP49) (Lens intermediate filament-like light, LIFL-L)" BFSP2 Homo sapiens (Human) cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; response to stimulus [GO:0050896]; visual perception [GO:0007601] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005200; GO:0005212; GO:0005856; GO:0005882; GO:0005886; GO:0005938; GO:0007601; GO:0045109; GO:0048469; GO:0050896; GO:0070307 structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212] HWHDMELQNLGAVVGR 0.99294 -6.3269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14654 KCJ11_HUMAN "ATP-sensitive inward rectifier potassium channel 11 (IKATP) (Inward rectifier K(+) channel Kir6.2) (Potassium channel, inwardly rectifying subfamily J member 11)" KCNJ11 Homo sapiens (Human) glucose metabolic process [GO:0006006]; inorganic cation transmembrane transport [GO:0098662]; negative regulation of insulin secretion [GO:0046676]; nervous system process [GO:0050877]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to ATP [GO:0033198]; response to xenobiotic stimulus [GO:0009410] integral component of plasma membrane [GO:0005887]; inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; T-tubule [GO:0030315] integral component of plasma membrane [GO:0005887]; inward rectifying potassium channel [GO:0008282]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; potassium ion binding [GO:0030955]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; glucose metabolic process [GO:0006006]; inorganic cation transmembrane transport [GO:0098662]; negative regulation of insulin secretion [GO:0046676]; nervous system process [GO:0050877]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; response to ATP [GO:0033198]; response to xenobiotic stimulus [GO:0009410] GO:0005242; GO:0005249; GO:0005524; GO:0005886; GO:0005887; GO:0006006; GO:0008282; GO:0009410; GO:0015272; GO:0019829; GO:0030315; GO:0030506; GO:0030955; GO:0033198; GO:0034765; GO:0042391; GO:0044325; GO:0046676; GO:0050796; GO:0050877; GO:0071805; GO:0098662; GO:1990573 ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; inward rectifier potassium channel activity [GO:0005242]; potassium ion binding [GO:0030955]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] KGIIPEEYVLTR 0.99294 -4.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9945 0 0 0 0 0 0 0 11.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53H47 SETMR_HUMAN "Histone-lysine N-methyltransferase SETMAR (SET domain and mariner transposase fusion protein, Metnase) [Includes: Histone-lysine N-methyltransferase, EC 2.1.1.357; Transposon Hsmar1 transposase, EC 3.1.-.- ]" SETMAR Homo sapiens (Human) "cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297]" nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270]; cell population proliferation [GO:0008283]; chromatin organization [GO:0006325]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 methylation [GO:0010452]; histone H3-K4 methylation [GO:0051568]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297]" GO:0000014; GO:0000729; GO:0000737; GO:0003677; GO:0003690; GO:0003697; GO:0004519; GO:0005634; GO:0005730; GO:0006303; GO:0006325; GO:0008270; GO:0008283; GO:0010452; GO:0015074; GO:0031297; GO:0035861; GO:0042800; GO:0042803; GO:0044547; GO:0044774; GO:0046975; GO:0051568; GO:0090305; GO:0097676; GO:2000373; GO:2001034; GO:2001251 DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270] CVDCNGSYFD 0.99294 -16.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9863 0 0 0 0 0 0 9.36438 0 0 0 0 0 0 0 0 0 13.3811 0 0 0 0 0 0 0 0 0 17.5987 0 12.9388 0 13.1388 0 0 12.6068 0 0 0 0 0 0 0 0 0 0 16.5761 0 0 0 12.7469 0 0 0 0 0 0 0 12.677 0 0 13.5462 0 0 0 0 0 0 0 0 0 0 0 0 12.8866 0 0 11.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EG05 CAR16_HUMAN "Caspase recruitment domain-containing protein 16 (Caspase recruitment domain-only protein 1, CARD-only protein 1) (Caspase-1 inhibitor COP) (Pseudo interleukin-1 beta converting enzyme, Pseudo-ICE, Pseudo-IL1B-converting enzyme)" CARD16 COP COP1 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-C [GO:0071494]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of protein binding [GO:0032091]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991] protease inhibitor complex [GO:0097179]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-C [GO:0071494]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of protein binding [GO:0032091]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] GO:0004869; GO:0010804; GO:0019900; GO:0031665; GO:0032091; GO:0032691; GO:0032991; GO:0042802; GO:0043123; GO:0043154; GO:0050700; GO:0051092; GO:0071222; GO:0071456; GO:0071494; GO:0089720; GO:0097179; GO:0097340 CARD domain binding [GO:0050700]; caspase binding [GO:0089720]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; identical protein binding [GO:0042802]; kinase binding [GO:0019900] LCFLEDAQRIWK 0.99294 -4.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1525 0 0 0 0 15.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1801 14.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.597 0 0 0 0 0 0 0 0 0 0 Q5JTD0 TJAP1_HUMAN Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4) TJAP1 PILT TJP4 Homo sapiens (Human) Golgi organization [GO:0007030] bicellular tight junction [GO:0005923]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] bicellular tight junction [GO:0005923]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030] GO:0005768; GO:0005794; GO:0005802; GO:0005886; GO:0005923; GO:0007030 TPPPAAVAQRTAFGR 0.99294 -4.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.025 0 0 0 0 12.8637 0 0 0 0 13.2635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JXC2 MIIP_HUMAN "Migration and invasion-inhibitory protein (IGFBP2-binding protein) (Invasion-inhibitory protein 45, IIp45)" MIIP IIP45 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] negative regulation of cell migration [GO:0030336]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] GO:0010972; GO:0030336 DVARSGVASLPPAK 0.99294 -14.696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6476 0 0 0 0 0 0 0 11.7117 0 0 0 0 0 0 0 0 11.5858 0 0 0 0 0 0 0 10.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0902 0 0 0 0 0 11.7021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5343 0 0 0 11.8077 0 0 0 0 0 11.3542 0 0 0 0 0 0 0 0 0 0 0 0 15.62 0 0 0 0 0 0 0 12.8709 15.6128 0 0 0 0 0 0 0 0 0 16.1799 0 0 0 0 13.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6N063 OGFD2_HUMAN "2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2, EC 1.14.11.-" OGFOD2 Homo sapiens (Human) "dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" GO:0005506; GO:0016705; GO:0031418; GO:0051213 "dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" DYGPILR 0.99294 -17.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5145 0 0 0 0 0 Q6ZPD8 DG2L6_HUMAN "Diacylglycerol O-acyltransferase 2-like protein 6, EC 2.3.1.- (Diacylglycerol O-acyltransferase candidate 3, hDC3)" DGAT2L6 DC3 Homo sapiens (Human) acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; diacylglycerol O-acyltransferase activity [GO:0004144]; acylglycerol acyl-chain remodeling [GO:0036155]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640] GO:0004144; GO:0005789; GO:0006629; GO:0006640; GO:0016021; GO:0036155 diacylglycerol O-acyltransferase activity [GO:0004144] IFPSITPFVGTLERIFWIPIVR 0.99294 -14.306 0 0 0 0 0 0 0 0 0 11.9387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8274 15.9049 0 11.2135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8315 0 0 0 0 0 0 0 0 0 12.5019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8621 0 0 0 14.8101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3801 0 0 0 0 0 0 12.1841 13.2578 0 0 0 0 Q8IWV2 CNTN4_HUMAN "Contactin-4 (Brain-derived immunoglobulin superfamily protein 2, BIG-2)" CNTN4 Homo sapiens (Human) axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron cell-cell adhesion [GO:0007158]; neuron projection development [GO:0031175]; regulation of synaptic plasticity [GO:0048167] anchored component of membrane [GO:0031225]; axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron cell-cell adhesion [GO:0007158]; neuron projection development [GO:0031175]; regulation of synaptic plasticity [GO:0048167] GO:0005576; GO:0005886; GO:0007156; GO:0007158; GO:0007399; GO:0007409; GO:0007411; GO:0007413; GO:0007420; GO:0030424; GO:0031175; GO:0031225; GO:0045665; GO:0048167; GO:0070593; GO:0098632 cell-cell adhesion mediator activity [GO:0098632] DGDHFER 0.99294 -14.343 0 0 0 0 0 0 0 11.1377 0 12.9583 12.4351 12.1653 12.4996 12.7653 11.4978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1937 15.1657 14.9448 0 13.6881 13.9937 0 0 0 11.2232 13.4561 12.1246 0 0 0 0 0 0 12.9847 0 0 0 0 0 13.9084 13.5631 14.5198 13.5155 13.2367 13.1155 14.5261 13.7578 13.8025 12.0843 0 12.1209 0 0 0 0 13.9255 0 0 0 0 0 0 0 0 0 11.1822 0 0 13.1861 0 0 18.5557 0 12.4359 12.7922 0 0 0 0 0 0 13.0613 0 0 0 0 0 0 0 0 13.0179 0 0 13.823 12.7931 0 12.1611 0 0 0 0 13.0088 0 0 0 0 0 0 0 9.90123 12.8923 0 0 0 0 0 12.7225 14.4652 11.6832 0 0 0 12.8265 0 0 0 12.587 0 12.735 0 13.0314 0 13.4691 0 13.7379 0 13.7078 0 0 0 0 0 0 0 0 0 12.4027 12.9505 0 0 0 14.3129 0 0 0 0 12.2066 12.7105 0 0 0 0 0 0 0 Q8TC05 MDM1_HUMAN Nuclear protein MDM1 MDM1 Homo sapiens (Human) negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600]; retina development in camera-type eye [GO:0060041] GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0008017; GO:0034451; GO:0046600; GO:0060041 microtubule binding [GO:0008017] ARMNNLQLPQHEAFNDEDEDR 0.99294 -26.294 11.0365 0 0 0 0 0 0 0 11.6564 0 0 0 0 0 0 0 10.4996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6045 0 0 0 0 0 0 0 0 0 0 11.7265 0 0 0 0 0 12.2279 0 0 0 0 0 10.9524 0 0 0 16.5302 0 14.3634 0 0 0 13.6393 13.8411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1083 0 0 0 0 0 13.6018 0 0 0 0 12.7522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9456 0 12.0807 0 0 0 0 11.6228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92784 DPF3_HUMAN "Zinc finger protein DPF3 (BRG1-associated factor 45C, BAF45C) (Zinc finger protein cer-d4)" DPF3 BAF45C CERD4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514] "brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]; histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0003712; GO:0005654; GO:0006338; GO:0006357; GO:0007399; GO:0007517; GO:0008270; GO:0016514; GO:0030071; GO:0035060; GO:0042393; GO:0045597; GO:0045663; GO:0045892; GO:0045944; GO:0070316; GO:0071565; GO:2000045; GO:2000781; GO:2000819 histone binding [GO:0042393]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] ASAFGCQA 0.99294 -6.3324 0 0 0 0 0 0 10.7718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5082 0 0 0 0 0 0 0 0 11.638 0 0 0 0 0 0 0 0 0 10.9866 0 0 0 0 0 0 12.8092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0859 0 0 13.646 0 0 0 0 0 13.7925 13.1602 0 13.2532 0 14.0922 14.3975 0 13.3961 0 0 0 13.6817 13.8241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.128 0 0 0 0 13.0687 13.03 0 0 0 0 14.157 0 0 13.0397 0 0 0 13.9212 0 0 0 12.6151 0 0 0 0 13.1845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MR7 OBAS1_HUMAN Putative uncharacterized protein OBSCN-AS1 (OBSCN antisense RNA 1) (OBSCN antisense gene protein 1) OBSCN-AS1 C1orf145 Homo sapiens (Human) GPTACRR 0.99294 -14.697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2105 0 0 0 10.6831 0 0 0 0 11.6544 0 0 11.3028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8436 0 0 0 0 20.1482 0 20.3332 13.2168 0 0 0 13.3453 16.383 0 0 0 16.3158 15.9995 0 0 13.5625 0 0 0 0 0 16.4958 16.6725 0 0 0 0 0 9.48261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8759 0 0 0 20.094 0 0 0 20.1885 0 0 20.204 0 0 20.1513 0 13.167 20.2012 0 0 0 20.1754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6967 0 0 0 0 20.1697 0 0 0 0 0 Q9H0U4 RAB1B_HUMAN "Ras-related protein Rab-1B, EC 3.6.5.2" RAB1B Homo sapiens (Human) autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of glycoprotein metabolic process [GO:1903020]; regulation of autophagosome assembly [GO:2000785]; virion assembly [GO:0019068] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site membrane [GO:0034045]; transport vesicle [GO:0030133] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site membrane [GO:0034045]; transport vesicle [GO:0030133]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of glycoprotein metabolic process [GO:1903020]; regulation of autophagosome assembly [GO:2000785]; virion assembly [GO:0019068] GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0007030; GO:0019068; GO:0030133; GO:0033116; GO:0034045; GO:0048471; GO:0070062; GO:1903020; GO:2000785 G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] MGPGAASGGER 0.99294 -17.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1881 0 0 12.5724 0 0 0 0 0 0 0 0 0 11.9141 0 11.4585 0 0 0 0 0 0 0 0 0 0 0 0 0 10.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7057 0 0 0 0 0 0 0 0 0 0 0 12.3602 0 0 Q9H2U9 ADAM7_HUMAN "Disintegrin and metalloproteinase domain-containing protein 7, ADAM 7 (Sperm maturation-related glycoprotein GP-83)" ADAM7 GP83 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508] GO:0004175; GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016021 endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] DECDFPEMCTGHSPACPK 0.99294 -6.3352 0 0 0 0 0 0 0 0 0 13.9991 0 0 0 0 0 12.8357 0 0 11.2147 12.7133 0 0 0 0 0 0 0 0 11.2149 0 0 0 0 15.0601 13.5495 14.3521 0 0 0 0 0 0 11.5988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8939 0 0 0 0 0 0 13.9547 0 0 0 12.2949 0 0 0 0 12.6254 0 0 0 0 11.0612 0 0 13.2001 0 14.0248 0 12.9244 0 0 13.7287 0 0 0 0 0 0 0 14.142 0 0 0 0 0 14.3851 0 13.7574 13.6168 13.9165 0 0 0 0 13.8199 0 0 0 0 12.6843 0 0 14.3401 0 13.9578 13.4186 0 14.2296 0 0 0 0 13.5304 0 0 0 0 0 0 0 13.1741 0 0 0 0 13.5353 15.7081 0 0 0 0 0 15.6558 0 0 13.031 0 0 0 0 11.8318 0 13.6124 0 0 0 0 0 0 Q9NXK8 FXL12_HUMAN F-box/LRR-repeat protein 12 (F-box and leucine-rich repeat protein 12) (F-box protein FBL12) FBXL12 FBL12 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0005634; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0043153; GO:0051726 ALRSLVLGGTYRVTETGLDAGLQELSYLQR 0.99294 -26.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7566 0 0 0 0 0 13.0437 0 0 0 0 0 10.2905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6639 0 0 0 0 0 0 12.2769 12.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXV6 CARF_HUMAN CDKN2A-interacting protein (Collaborator of ARF) CDKN2AIP CARF Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell growth [GO:0030308]; positive regulation of cell growth [GO:0030307]; positive regulation of signal transduction [GO:0009967]; regulation of protein stability [GO:0031647] granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell growth [GO:0030308]; positive regulation of cell growth [GO:0030307]; positive regulation of signal transduction [GO:0009967]; regulation of protein stability [GO:0031647] GO:0001652; GO:0002039; GO:0003723; GO:0005654; GO:0005730; GO:0006974; GO:0009967; GO:0030307; GO:0030308; GO:0031647 p53 binding [GO:0002039]; RNA binding [GO:0003723] AVASREALKLFLK 0.99294 -14.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5728 0 0 11.2772 0 0 0 0 13.0625 0 0 12.8441 0 0 0 0 0 0 0 0 0 13.316 0 0 0 0 0 0 0 0 0 0 0 13.0069 0 0 0 12.569 0 0 0 0 0 0 0 12.6228 13.9921 13.4993 0 0 0 0 13.4046 0 0 0 0 14.4659 0 0 12.7628 0 0 0 0 0 0 0 0 0 0 12.6597 0 0 12.9141 0 13.182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBU9 NXF1_HUMAN Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 TAP Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031] GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0010494; GO:0015031; GO:0016607; GO:0016973; GO:0042272; GO:0042405 mRNA binding [GO:0003729]; RNA binding [GO:0003723] AKGEIPEVAFMK 0.99294 -13.327 0 0 0 12.7472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8761 0 0 0 0 0 0 0 0 0 0 13.6299 0 0 13.2161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.063 0 12.5858 0 0 0 0 0 0 0 0 0 13.31 0 11.513 0 0 0 0 0 0 0 0 0 0 13.32 0 0 15.4463 0 0 12.6163 12.0088 0 0 0 13.5475 0 0 0 0 0 0 15.2823 0 0 0 0 0 0 0 11.8361 0 14.6878 0 13.3327 0 0 0 0 0 0 0 0 0 0 0 15.034 0 0 0 13.0149 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3245 13.0995 0 0 0 0 0 0 0 0 0 A6NK75 ZNF98_HUMAN Zinc finger protein 98 (Zinc finger protein 739) (Zinc finger protein F7175) ZNF98 ZNF739 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CKECEKSFCMLSHLAQHK 0.99295 -16.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6052 0 0 0 0 0 0 0 0 0 0 0 13.4062 0 0 0 0 12.3429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1238 0 0 0 13.3792 14.0104 15.9928 13.3451 13.6609 0 0 0 0 0 0 0 12.9911 12.9787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3962 13.329 12.9895 0 0 13.1516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9216 0 0 0 0 0 0 0 0 0 11.7471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MYZ6 FOXO6_HUMAN Forkhead box protein O6 FOXO6 Homo sapiens (Human) memory [GO:0007613]; positive regulation of dendritic spine development [GO:0060999]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; memory [GO:0007613]; positive regulation of dendritic spine development [GO:0060999]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0007613; GO:0060999 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" YVPYFKDK 0.99295 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG00 ZSA5D_HUMAN Putative zinc finger and SCAN domain-containing protein 5D (Zinc finger and SCAN domain-containing protein 5D pseudogene) ZSCAN5DP ZSCAN5D Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IHTGEKPYTCDICHK 0.99295 -4.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8572 0 0 14.8352 12.1786 0 0 0 0 11.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0452 0 0 0 0 0 0 0 0 0 0 0 0 8.99002 0 0 10.3261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1728 0 0 0 0 14.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30304 MPIP1_HUMAN "M-phase inducer phosphatase 1, EC 3.1.3.48 (Dual specificity phosphatase Cdc25A)" CDC25A Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; protein dephosphorylation [GO:0006470]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to radiation [GO:0009314] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; protein dephosphorylation [GO:0006470]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; response to radiation [GO:0009314] GO:0000079; GO:0000082; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008283; GO:0009314; GO:0010971; GO:0019901; GO:0034644; GO:0051087; GO:0051301; GO:0110032 chaperone binding [GO:0051087]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] KPVRPVSR 0.99295 -16.24 0 0 0 0 0 0 0 0 0 10.6818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2661 0 0 0 0 0 0 0 0 15.8407 11.0768 0 0 0 0 0 0 0 0 11.4812 0 0 0 0 0 11.6759 0 0 0 12.6897 0 0 11.4725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42680 TEC_HUMAN "Tyrosine-protein kinase Tec, EC 2.7.10.2" TEC PSCTK4 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246] GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005543; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0007229; GO:0010543; GO:0035556; GO:0042246; GO:0043621; GO:0046872; GO:0050852; GO:0050853 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713] ALPPAPETKKR 0.99295 -6.1806 0 0 0 0 0 0 12.6949 12.1955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4897 14.1454 14.6186 12.6991 0 0 0 0 0 13.7043 0 0 14.5301 0 0 13.8802 0 0 0 0 14.2731 0 14.0814 0 0 14.987 0 0 0 0 0 0 15.1501 12.4539 0 0 13.1574 12.8338 0 0 0 0 0 0 0 0 0 0 0 12.8369 0 12.4839 0 0 0 0 14.3549 0 0 13.4564 12.5102 15.3741 0 0 0 0 14.242 0 13.2047 0 0 0 0 14.3977 14.9979 0 0 0 11.9659 0 0 0 0 0 11.3664 0 0 12.8535 0 0 0 11.4532 0 0 0 0 13.3966 0 0 10.419 0 0 0 P51170 SCNNG_HUMAN "Amiloride-sensitive sodium channel subunit gamma (Epithelial Na(+) channel subunit gamma, ENaCG, Gamma-ENaC) (Gamma-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma) (SCNEG)" SCNN1G Homo sapiens (Human) cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; ion channel activity [GO:0005216]; ligand-gated sodium channel activity [GO:0015280]; sodium channel activity [GO:0005272]; WW domain binding [GO:0050699]; cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to amiloride [GO:0036254]; cellular response to vasopressin [GO:1904117]; cellular sodium ion homeostasis [GO:0006883]; multicellular organismal water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0005216; GO:0005272; GO:0005654; GO:0005886; GO:0005887; GO:0006814; GO:0006883; GO:0008217; GO:0009897; GO:0015280; GO:0016324; GO:0034706; GO:0035725; GO:0036254; GO:0050699; GO:0050891; GO:0050914; GO:0050915; GO:0055078; GO:0070062; GO:0071468; GO:0098719; GO:1904045; GO:1904117 ion channel activity [GO:0005216]; ligand-gated sodium channel activity [GO:0015280]; sodium channel activity [GO:0005272]; WW domain binding [GO:0050699] APGEKIK 0.99295 -14.408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1876 0 0 0 0 0 0 14.7556 0 0 0 11.9002 0 0 0 0 13.1726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2144 0 0 0 0 0 0 10.7206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0122 0 0 12.1165 0 0 0 0 0 0 0 0 0 0 14.1438 0 0 0 0 0 0 0 0 12.3476 13.7151 13.625 13.9047 12.6708 0 0 13.4743 13.2381 12.6945 0 0 0 0 0 0 0 0 0 0 0 12.0098 0 0 P51178 PLCD1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1, EC 3.1.4.11 (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III, PLC-III) (Phospholipase C-delta-1, PLC-delta-1)" PLCD1 Homo sapiens (Human) lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid metabolic process [GO:0006644]" GO:0004435; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0006644; GO:0016042; GO:0032794; GO:0046488; GO:0048015; GO:0070062 "calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" ALRLLQESGNGFVR 0.99295 -14.392 0 11.1193 0 0 0 0 0 0 0 0 0 0 0 10.311 0 11.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1697 0 11.3994 0 0 0 0 0 0 0 12.0272 0 11.7449 0 12.31 0 11.8213 0 12.1344 0 0 0 12.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3894 12.1247 0 11.5967 12.6827 0 0 12.1001 0 11.5593 12.0714 0 0 0 0 10.3841 0 0 0 0 10.7338 0 0 0 0 12.061 0 0 0 13.44 0 0 0 0 11.8825 0 0 0 0 0 0 0 0 0 13.7259 0 0 0 0 0 0 12.3691 0 0 0 0 0 0 10.9522 13.5462 0 0 12.2851 0 12.3316 0 14.168 0 0 0 0 0 0 0 13.4054 11.8599 0 Q13370 PDE3B_HUMAN "cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B, EC 3.1.4.17 (CGIPDE1, CGIP1) (Cyclic GMP-inhibited phosphodiesterase B, CGI-PDE B)" PDE3B Homo sapiens (Human) angiogenesis [GO:0001525]; cellular response to insulin stimulus [GO:0032869]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of lipid catabolic process [GO:0050995]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; guanyl-nucleotide exchange factor complex [GO:0032045]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; protein kinase B binding [GO:0043422]; angiogenesis [GO:0001525]; cellular response to insulin stimulus [GO:0032869]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of lipid catabolic process [GO:0050995]; signal transduction [GO:0007165]" GO:0001525; GO:0004114; GO:0004115; GO:0004119; GO:0005783; GO:0005794; GO:0005829; GO:0007162; GO:0007165; GO:0007186; GO:0016020; GO:0016021; GO:0016525; GO:0032045; GO:0032869; GO:0033629; GO:0043422; GO:0043951; GO:0046872; GO:0050995 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; protein kinase B binding [GO:0043422]" FLVIEAILATDLK 0.99295 -16.253 0 0 0 0 0 14.2027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8786 17.0213 0 0 0 0 17.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5833 0 0 14.363 14.4714 0 0 0 0 0 0 0 0 0 0 19.1124 19.1052 19.0973 0 0 0 19.1251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8039 0 0 0 0 0 0 0 11.3814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7442 0 0 0 0 0 0 0 0 Q14344 GNA13_HUMAN "Guanine nucleotide-binding protein subunit alpha-13, G alpha-13, G-protein subunit alpha-13" GNA13 Homo sapiens (Human) activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; activation of phospholipase D activity [GO:0031584]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; in utero embryonic development [GO:0001701]; multicellular organism aging [GO:0010259]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165] GO:0001569; GO:0001664; GO:0001701; GO:0003924; GO:0005085; GO:0005525; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0005886; GO:0005925; GO:0007165; GO:0007188; GO:0007189; GO:0007204; GO:0007266; GO:0008217; GO:0008360; GO:0010259; GO:0010762; GO:0016020; GO:0030154; GO:0030168; GO:0031526; GO:0031584; GO:0031683; GO:0031752; GO:0042470; GO:0046872; GO:0051056; GO:0070062; GO:1904706; GO:1904753 D5 dopamine receptor binding [GO:0031752]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872] ALWADSGIQNAYDR 0.99295 -6.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.966 0 0 0 0 0 0 0 13.0368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6231 0 0 Q15361 TTF1_HUMAN "Transcription termination factor 1, TTF-1 (RNA polymerase I termination factor) (Transcription termination factor I, TTF-I)" TTF1 Homo sapiens (Human) "DNA-templated transcription, termination [GO:0006353]; negative regulation of DNA replication [GO:0008156]; termination of RNA polymerase I transcription [GO:0006363]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-templated transcription, termination [GO:0006353]; negative regulation of DNA replication [GO:0008156]; termination of RNA polymerase I transcription [GO:0006363]" GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006353; GO:0006363; GO:0008156 chromatin binding [GO:0003682]; DNA binding [GO:0003677] AQGVAIKFGK 0.99295 -26.733 12.0331 0 0 0 0 0 0 0 0 0 12.6832 0 0 0 0 0 0 0 0 11.3778 13.1399 0 0 0 0 0 0 0 0 0 0 11.5835 0 11.178 0 0 0 0 0 11.0744 0 10.7578 0 14.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9962 0 10.326 0 0 0 12.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7743 0 0 14.5078 0 0 0 0 0 0 0 13.0369 13.6375 0 0 0 0 0 12.2564 0 0 0 0 0 13.4201 0 0 0 0 0 0 0 0 12.8039 0 13.0781 0 0 14.3315 0 12.6388 14.8679 0 0 0 0 0 0 0 0 14.007 14.5046 0 0 0 14.7338 14.1132 14.6632 0 14.7071 14.2538 13.3688 0 0 13.9899 14.7641 13.2847 14.5399 14.5357 0 0 0 0 0 0 13.8101 13.925 0 Q49AJ0 F135B_HUMAN Protein FAM135B FAM135B C8orfK32 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255] cellular lipid metabolic process [GO:0044255] GO:0044255 DNADLRK 0.99295 -41.939 0 0 0 0 0 0 0 0 0 0 0 0 12.3977 0 0 0 0 0 0 0 0 11.77 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4607 0 0 0 0 0 0 0 10.0771 0 0 0 0 0 14.8029 0 0 0 0 14.218 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.176 13.1916 0 0 13.0179 13.4743 13.3239 0 13.9071 0 0 13.1304 0 13.9722 0 0 Q5CZA5 ZN805_HUMAN Zinc finger protein 805 ZNF805 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNRRSGLTR 0.99295 -14.38 0 0 0 17.3038 0 0 0 0 0 0 12.8575 11.8809 12.1371 0 11.986 0 0 0 0 0 0 0 0 0 0 12.2013 12.6154 11.2183 0 0 0 0 0 0 0 0 0 12.1206 11.7299 12.2629 11.6085 0 12.9687 0 0 0 13.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6453 0 14.0944 14.3041 0 0 0 0 14.5961 14.3382 0 14.2534 0 0 0 0 0 0 0 0 0 0 Q5T447 HECD3_HUMAN "E3 ubiquitin-protein ligase HECTD3, EC 2.3.2.26 (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3)" HECTD3 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0004842; GO:0019905; GO:0043161; GO:0048471 syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842] DMYVPNPSCRDFAK 0.99295 -4.4552 0 0 0 11.112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9646 0 11.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.833 0 0 0 0 0 13.9563 0 0 0 0 14.6921 14.8717 11.211 0 0 0 11.979 0 0 0 0 13.812 0 0 0 0 0 0 10.3416 0 11.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1954 0 0 0 11.2773 0 13.744 0 13.2405 0 13.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4797 0 0 0 0 14.416 0 0 10.726 12.534 0 11.92 0 Q6UXE8 BTNL3_HUMAN Butyrophilin-like protein 3 (Butyrophilin-like receptor) BTNL3 BTNLR COLF4100 UNQ744/PRO1472 Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0005102; GO:0009897; GO:0016021; GO:0050852 signaling receptor binding [GO:0005102] APQEVPHSEKR 0.99295 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZRK6 CCD73_HUMAN Coiled-coil domain-containing protein 73 (Sarcoma antigen NY-SAR-79) CCDC73 Homo sapiens (Human) DNELQREK 0.99295 -14.403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6876 0 0 0 0 0 0 0 12.8365 0 0 0 0 0 0 0 0 14.2421 0 0 0 0 0 0 0 0 0 0 11.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.078 0 0 10.2917 0 0 0 0 0 0 0 0 0 12.391 12.7599 0 12.7383 0 0 14.705 14.5959 13.7777 0 0 0 0 13.5676 0 0 13.8726 14.4096 0 0 0 0 0 14.881 0 0 12.3703 0 11.3285 0 0 0 13.2547 12.8556 14.4721 0 13.6787 0 0 0 0 14.3738 0 15.0549 0 0 0 0 12.6087 0 0 12.4775 0 0 13.6085 0 0 13.3417 0 0 9.78378 0 0 0 0 0 0 0 0 0 14.403 12.4481 0 0 12.8213 0 13.6472 0 0 0 15.3536 12.3796 0 0 0 10.4482 0 0 0 0 0 11.976 0 0 14.6839 0 0 0 0 0 12.3848 Q8WUY3 PRUN2_HUMAN Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1) PRUNE2 BMCC1 BNIPXL C9orf65 KIAA0367 Homo sapiens (Human) apoptotic process [GO:0006915] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462]; apoptotic process [GO:0006915] GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0016462; GO:0046872 metal ion binding [GO:0046872]; pyrophosphatase activity [GO:0016462] ATDTGHMGPPQTHARCSSWWGGLEIDSK 0.99295 -26.707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1157 0 0 0 0 0 0 0 0 0 0 0 11.2004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7508 0 0 0 0 10.7616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2063 0 0 0 0 0 0 0 0 0 13.0901 0 0 0 0 0 0 0 0 0 16.1486 12.4158 0 0 0 12.9862 14.9193 0 14.2791 0 0 0 0 0 14.7383 0 0 0 0 0 0 0 14.5477 0 0 0 0 0 12.5781 0 0 0 0 0 12.8426 0 0 0 0 0 0 0 0 0 10.9433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3461 0 0 0 12.2786 0 0 0 0 0 0 12.1416 0 12.5765 0 0 0 0 0 0 0 0 0 Q8WZ64 ARAP2_HUMAN "Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 (Centaurin-delta-1, Cnt-d1) (Protein PARX)" ARAP2 CENTD1 KIAA0580 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]" GO:0005096; GO:0005547; GO:0005737; GO:0007165; GO:0043547; GO:0046872 "GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" ALILDSVNR 0.99295 -41.818 0 0 0 0 0 13.9009 0 12.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1791 0 0 0 0 0 10.0049 0 0 0 0 0 0 0 0 11.6981 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4862 11.6599 0 0 0 0 0 0 0 0 0 0 0 0 13.0351 0 0 0 0 0 0 0 0 13.4946 0 0 0 0 0 0 11.8191 0 13.5085 0 12.1924 14.844 0 0 11.6775 11.8774 0 0 0 0 0 15.728 14.2042 0 0 0 0 12.6651 0 13.4561 13.8032 0 13.6348 14.4294 0 0 0 0 0 0 11.6619 0 14.6175 0 12.8298 13.015 0 0 0 12.5437 0 0 0 0 14.0618 12.703 0 0 11.0585 0 0 0 13.6583 0 0 0 0 0 0 0 0 0 13.1324 0 14.0484 12.1579 0 0 13.8497 0 0 0 12.8583 0 10.6079 0 0 0 Q96CM3 RUSD4_HUMAN "Pseudouridylate synthase RPUSD4, mitochondrial, EC 5.4.99.- (RNA pseudouridylate synthase domain-containing protein 4)" RPUSD4 Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; RNA splicing [GO:0008380] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mitochondrial tRNA pseudouridine synthesis [GO:0070902]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; RNA splicing [GO:0008380] GO:0000049; GO:0000455; GO:0003723; GO:0005654; GO:0005739; GO:0005759; GO:0006397; GO:0008380; GO:0009982; GO:0035770; GO:0070131; GO:0070902; GO:1990400; GO:1990481 mitochondrial ribosomal large subunit rRNA binding [GO:1990400]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA binding [GO:0000049] DMAHQVQELFR 0.99295 -6.9452 0 0 0 0 0 0 0 0 0 0 11.6869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3609 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5209 13.5261 0 0 0 14.6477 12.6915 0 0 13.7357 13.7692 0 19.3574 0 0 19.5785 0 14.4399 0 0 14.4295 11.9674 11.3334 0 0 0 0 0 11.7623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9801 0 0 0 0 0 0 0 0 14.3073 0 0 0 0 13.6628 13.5573 0 0 0 14.2123 0 0 0 0 0 12.9655 0 0 0 0 0 14.6433 0 0 0 0 0 0 0 0 13.8036 0 0 0 14.7614 0 15.1357 0 0 0 0 Q9BXQ6 T121B_HUMAN Transmembrane protein 121B (Cat eye syndrome critical region protein 6) TMEM121B CECR6 Homo sapiens (Human) ASPSRAR 0.99295 -6.1781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4534 0 11.079 0 0 0 0 0 0 0 0 0 0 13.7164 14.4773 0 0 0 0 11.6394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0276 0 0 0 0 0 13.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5964 0 0 0 0 0 0 12.2444 12.0042 0 13.4037 13.6027 0 13.5653 13.6779 0 0 0 0 0 13.607 0 0 9.75907 0 0 0 0 13.098 0 0 Q9UNA0 ATS5_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 5, ADAM-TS 5, ADAM-TS5, ADAMTS-5, EC 3.4.24.- (A disintegrin and metalloproteinase with thrombospondin motifs 11, ADAM-TS 11, ADAMTS-11) (ADMP-2) (Aggrecanase-2)" ADAMTS5 ADAMTS11 ADMP2 Homo sapiens (Human) defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; negative regulation of cold-induced thermogenesis [GO:0120163]; proteolysis [GO:0006508]; tooth eruption [GO:0044691] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; negative regulation of cold-induced thermogenesis [GO:0120163]; proteolysis [GO:0006508]; tooth eruption [GO:0044691] GO:0004175; GO:0004222; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0006508; GO:0007520; GO:0008201; GO:0008233; GO:0008237; GO:0008270; GO:0022617; GO:0030198; GO:0031012; GO:0042742; GO:0044691; GO:0050840; GO:0062023; GO:0120163 endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270] CVDKTKK 0.99295 -41.292 12.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9696 0 0 0 0 0 0 0 0 0 0 0 0 14.8143 15.5501 0 14.3321 0 0 13.8704 0 0 0 0 13.8003 0 0 0 0 0 0 0 0 13.0297 0 0 0 0 0 0 0 0 0 0 0 18.0447 0 0 0 0 0 0 0 0 0 0 0 0 11.9918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5427 0 11.5417 11.6186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0034 13.2174 0 0 0 0 0 0 0 0 0 14.4737 0 0 Q9Y272 RASD1_HUMAN Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1) RASD1 AGS1 DEXRAS1 Homo sapiens (Human) "G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of transcription, DNA-templated [GO:0045892]; nitric oxide mediated signal transduction [GO:0007263]; signal transduction [GO:0007165]" GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0007186; GO:0007263; GO:0016529; GO:0031681; GO:0045892; GO:0048471 G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] ALFAMAK 0.99295 -6.9573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5003 0 13.5627 12.687 0 0 0 0 0 0 0 0 12.9056 0 0 0 0 0 0 0 0 0 0 0 0 14.0157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9262 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1914 0 0 10.7782 0 0 0 0 0 0 13.1211 0 14.9786 0 0 0 0 0 0 0 0 0 0 0 0 13.8622 0 0 13.7663 0 0 0 0 14.1293 0 0 0 0 0 0 0 0 0 0 0 14.3748 0 0 0 0 0 0 0 0 13.0063 0 0 0 14.1037 14.3968 14.0244 0 0 0 0 0 0 0 0 13.9063 0 0 0 0 0 0 0 14.1122 0 0 0 0 0 0 A6NHR9 SMHD1_HUMAN "Structural maintenance of chromosomes flexible hinge domain-containing protein 1, SMC hinge domain-containing protein 1, EC 3.6.1.-" SMCHD1 KIAA0650 Homo sapiens (Human) dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034] Barr body [GO:0001740]; site of double-strand break [GO:0035861] Barr body [GO:0001740]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034] GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0009048; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0060820; GO:2000042; GO:2001034 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803] AGQLVKTIKTLPLFYGSIVR 0.99296 -42.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4704 0 11.9924 0 0 11.4966 0 0 0 0 0 11.7014 11.3422 0 0 0 0 0 0 8.92873 0 0 0 0 0 0 16.165 12.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7194 0 0 12.4411 12.0063 13.9087 12.9432 0 0 12.6339 0 0 14.1167 0 16.0783 12.4212 13.4305 15.872 13.5365 12.6716 0 0 11.4558 14.1486 0 0 14.1934 14.751 15.3219 13.1556 0 0 15.4221 0 16.8017 18.5369 0 0 0 0 13.7207 0 0 12.7868 0 13.5311 0 0 12.5674 0 0 0 14.9382 0 14.5873 13.78 0 12.9483 14.2349 13.0901 15.1431 14.9501 13.2818 14.5716 13.4131 14.7116 0 0 0 14.8705 0 0 15.9269 0 17.1953 11.312 0 0 0 14.0966 15.2458 0 0 0 12.7162 0 0 15.3097 0 14.1201 0 0 0 0 0 13.3699 0 0 0 0 12.6259 0 0 0 15.0542 12.28 15.2209 0 0 0 13.4839 0 0 12.3834 O75129 ASTN2_HUMAN Astrotactin-2 ASTN2 KIAA0634 Homo sapiens (Human) establishment of body hair planar orientation [GO:0048105]; negative regulation of protein localization to cell surface [GO:2000009]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764]; protein localization to cell surface [GO:0034394]; protein transport [GO:0015031] cell cortex [GO:0005938]; cell pole [GO:0060187]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perikaryon [GO:0043204] "cell cortex [GO:0005938]; cell pole [GO:0060187]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; perikaryon [GO:0043204]; calcium ion binding [GO:0005509]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; establishment of body hair planar orientation [GO:0048105]; negative regulation of protein localization to cell surface [GO:2000009]; neuron cell-cell adhesion [GO:0007158]; neuron migration [GO:0001764]; protein localization to cell surface [GO:0034394]; protein transport [GO:0015031]" GO:0001764; GO:0005509; GO:0005768; GO:0005769; GO:0005770; GO:0005938; GO:0007158; GO:0015031; GO:0016021; GO:0030136; GO:0034394; GO:0043204; GO:0043533; GO:0048105; GO:0060187; GO:2000009 "calcium ion binding [GO:0005509]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]" DCSRNNGGCTR 0.99296 -16.716 0 0 0 0 0 0 0 0 0 0 0 0 10.5681 0 0 15.3688 0 0 9.50492 0 10.8579 0 0 0 0 14.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0111 19.3371 14.5827 13.6304 0 0 0 0 17.3645 0 0 0 0 12.2117 10.8756 0 0 0 0 0 0 0 0 12.1655 0 0 0 0 10.779 0 0 0 0 0 0 0 0 0 10.6828 0 0 0 0 10.0753 0 0 12.5007 11.6671 0 0 12.0277 0 0 12.7125 0 0 0 0 0 0 0 12.3189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08476 INHBA_HUMAN "Inhibin beta A chain (Activin beta-A chain) (Erythroid differentiation protein, EDF)" INHBA Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; multicellular organism aging [GO:0010259]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]; transcription by RNA polymerase II [GO:0006366]" activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471] "activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699]; activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; multicellular organism aging [GO:0010259]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]; transcription by RNA polymerase II [GO:0006366]" GO:0001541; GO:0001942; GO:0002244; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0006357; GO:0006366; GO:0006952; GO:0007166; GO:0007267; GO:0007399; GO:0008083; GO:0008285; GO:0008584; GO:0009410; GO:0010259; GO:0010628; GO:0010862; GO:0017046; GO:0021773; GO:0030154; GO:0030218; GO:0030308; GO:0032689; GO:0032924; GO:0035987; GO:0042326; GO:0042476; GO:0042541; GO:0042701; GO:0042802; GO:0043509; GO:0043512; GO:0044877; GO:0045578; GO:0045648; GO:0045650; GO:0045893; GO:0045944; GO:0046880; GO:0046881; GO:0046882; GO:0048333; GO:0048471; GO:0051247; GO:0060021; GO:0060279; GO:0060395; GO:0061029; GO:0070699; GO:0071372; GO:0071397; GO:0097154; GO:0097191; GO:2000134; GO:2001241 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699] AALLNAIR 0.99296 -16.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6713 0 0 0 0 0 0 0 0 0 0 0 0 12.7951 13.3001 0 0 0 0 0 0 13.6725 13.4358 13.8986 13.076 0 13.7664 13.4645 13.7095 13.6875 0 13.6554 0 0 0 0 0 0 0 0 0 12.7585 0 0 0 0 0 0 0 0 0 0 0 13.738 0 0 0 0 0 0 0 13.6295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1862 0 0 12.2594 0 0 0 0 13.3788 0 12.816 0 0 0 0 0 0 0 0 0 0 0 12.4069 0 0 0 0 13.2917 0 0 12.8466 0 Q5SVQ8 ZBT41_HUMAN Zinc finger and BTB domain-containing protein 41 ZBTB41 FRBZ1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHQCEECGKCFGRR 0.99296 -38.754 0 0 0 0 0 0 0 0 0 0 0 0 11.4751 0 0 0 0 0 0 0 0 0 0 0 0 11.8517 10.0305 0 0 0 0 0 0 0 0 0 0 11.8739 0 0 0 15.9585 0 11.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2655 0 9.7255 0 0 0 0 0 12.6256 0 0 12.3865 0 0 12.875 0 0 13.0254 0 0 0 0 14.5064 0 0 12.9801 11.6874 12.7901 0 0 0 0 11.3009 14.1629 13.5541 12.6821 0 0 0 0 13.4322 0 0 13.3945 0 0 0 13.0656 0 0 12.8133 12.6373 0 0 0 11.2509 11.3466 0 0 0 0 0 0 11.4389 0 0 0 0 0 12.792 0 12.0497 0 12.4644 11.8434 0 0 0 13.7395 0 0 0 11.3083 0 0 10.7893 11.412 0 0 0 0 12.3281 0 0 11.6036 0 0 0 0 0 0 0 0 12.7145 0 0 0 0 0 0 0 Q6NUT2 D19L2_HUMAN "Probable C-mannosyltransferase DPY19L2, EC 2.4.1.- (Dpy-19-like protein 2) (Protein dpy-19 homolog 2)" DPY19L2 UNQ3127/PRO10284 Homo sapiens (Human) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]; spermatid development [GO:0007286] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]; spermatid development [GO:0007286] GO:0000030; GO:0005634; GO:0005637; GO:0007286; GO:0016021; GO:0018406 mannosyltransferase activity [GO:0000030] ATPLRYTKTLLLPVVMVITCFIFK 0.99296 -5.5191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0387 13.2951 13.6642 0 0 13.7598 0 13.7366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5314 0 0 11.7328 0 0 0 0 0 0 0 0 0 0 0 0 12.6596 0 0 0 0 0 15.0536 0 0 0 0 0 14.6997 15.9025 14.8701 15.0654 15.8396 0 0 0 0 0 14.9694 0 0 14.8085 0 0 0 0 15.4364 14.6359 0 0 0 15.0876 15.0784 0 0 0 14.5062 0 13.0213 0 15.7862 0 17.8315 0 0 0 0 0 0 0 0 0 14.8332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9758 0 0 0 0 0 0 14.9868 0 12.103 0 0 0 12.4678 0 0 0 0 0 0 0 0 0 0 0 17.5761 0 0 0 0 0 Q8NCI6 GLBL3_HUMAN "Beta-galactosidase-1-like protein 3, EC 3.2.1.-" GLB1L3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] vacuole [GO:0005773] vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975] GO:0004565; GO:0005773; GO:0005975 beta-galactosidase activity [GO:0004565] DRLLKLK 0.99296 -42.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1088 0 0 0 0 0 11.4593 0 0 0 0 0 0 0 0 0 0 0 14.579 14.168 0 0 11.8193 13.2346 13.4601 0 0 0 13.1168 0 13.7989 13.4407 15.1432 15.2217 11.0375 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2994 0 0 0 0 0 0 0 13.1686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0718 0 0 0 0 0 0 12.2669 0 0 0 0 0 0 0 0 0 Q9BYV9 BACH2_HUMAN Transcription regulator protein BACH2 (BTB and CNC homolog 2) BACH2 Homo sapiens (Human) import into nucleus [GO:0051170]; negative regulation of transcription by RNA polymerase II [GO:0000122]; primary adaptive immune response involving T cells and B cells [GO:0090721]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; import into nucleus [GO:0051170]; negative regulation of transcription by RNA polymerase II [GO:0000122]; primary adaptive immune response involving T cells and B cells [GO:0090721]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0051170; GO:0090575; GO:0090721; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DALTQYPRYKK 0.99296 -42.094 0 0 0 0 0 0 0 0 0 12.2055 0 0 0 0 0 0 0 0 11.0467 0 0 0 0 0 0 10.1231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2883 0 0 0 0 0 0 0 0 0 0 9.64519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7668 13.5721 0 0 14.5785 0 14.26 13.2354 13.0477 0 13.5643 12.9749 12.3319 0 15.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4037 12.9337 0 0 0 13.9104 14.0896 13.6936 14.3682 0 16.0809 0 11.6197 0 11.9079 0 0 0 0 0 0 0 13.228 0 0 13.6762 0 0 14.4417 0 0 0 0 0 0 0 0 0 0 9.37749 0 0 0 0 11.2333 0 0 12.6129 0 0 11.7965 0 0 14.4899 0 0 0 0 0 0 12.4511 0 0 0 0 0 0 0 Q9H5I5 PIEZ2_HUMAN Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B) PIEZO2 C18orf30 C18orf58 FAM38B Homo sapiens (Human) cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; regulation of membrane potential [GO:0042391]; response to mechanical stimulus [GO:0009612] GO:0005261; GO:0005886; GO:0006812; GO:0008381; GO:0009612; GO:0016020; GO:0016021; GO:0042391; GO:0050974; GO:0050982; GO:0071260 cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381] AFTIKKTLEIYVPIK 0.99296 -43.183 0 0 0 0 0 0 0 0 14.6449 12.1192 11.1211 11.6059 0 0 0 0 10.706 0 13.6201 0 12.7936 0 0 0 0 0 13.2013 0 0 0 0 0 0 12.5567 12.4037 0 0 13.3578 0 0 12.9224 0 0 0 0 0 15.006 0 0 0 0 0 12.3276 0 11.1254 0 0 0 0 0 0 0 0 0 0 0 0 14.4409 0 0 12.1378 0 11.5489 0 12.99 14.8507 0 0 0 12.6343 12.1494 15.9544 16.4338 0 13.9987 16.5546 0 0 13.3185 16.4751 12.9466 15.3593 0 13.9826 0 15.1813 0 0 12.8375 0 13.8937 0 13.0062 0 0 0 13.9377 14.8584 0 0 0 14.6701 12.9318 13.6793 12.8753 14.3076 14.0297 15.9788 0 0 11.0067 0 0 14.3929 0 0 14.9061 14.581 0 0 0 11.9672 0 0 0 0 15.1754 14.6731 13.0782 0 13.5051 13.8588 11.1383 0 15.8754 14.0076 14.3002 13.513 0 0 15.0571 0 14.9286 0 0 0 0 0 0 0 12.4558 12.3822 0 0 0 0 0 0 0 0 0 15.5491 14.6839 13.5221 0 0 0 12.5572 11.2456 12.4064 Q9H6X2 ANTR1_HUMAN Anthrax toxin receptor 1 (Tumor endothelial marker 8) ANTXR1 ATR TEM8 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; blood vessel development [GO:0001568]; negative regulation of extracellular matrix assembly [GO:1901202]; positive regulation of metallopeptidase activity [GO:1905050]; reproductive process [GO:0022414]; substrate adhesion-dependent cell spreading [GO:0034446]; toxin transport [GO:1901998] cell surface [GO:0009986]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; actin cytoskeleton reorganization [GO:0031532]; blood vessel development [GO:0001568]; negative regulation of extracellular matrix assembly [GO:1901202]; positive regulation of metallopeptidase activity [GO:1905050]; reproductive process [GO:0022414]; substrate adhesion-dependent cell spreading [GO:0034446]; toxin transport [GO:1901998] GO:0001568; GO:0004888; GO:0005518; GO:0005886; GO:0009897; GO:0009986; GO:0010008; GO:0016021; GO:0022414; GO:0031258; GO:0031527; GO:0031532; GO:0034446; GO:0046872; GO:0051015; GO:1901202; GO:1901998; GO:1905050 actin filament binding [GO:0051015]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888] CINFTRVK 0.99296 -16.257 0 0 0 0 0 0 0 0 13.1755 0 0 13.3383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9279 13.6402 0 0 0 0 13.3387 0 0 13.246 0 0 0 13.6824 11.4496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7837 0 0 0 0 0 0 0 13.7479 0 0 0 0 0 0 0 0 0 13.6242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8676 13.0006 0 0 0 13.3403 12.7549 0 0 12.8512 0 0 0 0 12.4012 0 13.1573 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2178 0 0 13.5127 0 13.4719 0 0 0 13.909 0 0 0 0 0 0 12.6352 0 13.3457 0 0 11.6124 0 13.401 0 0 0 0 0 0 0 0 0 Q9UGT4 SUSD2_HUMAN Sushi domain-containing protein 2 SUSD2 Homo sapiens (Human) negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782] GO:0005615; GO:0005886; GO:0016021; GO:0051782; GO:0070062; GO:1902807 RPSNDCR 0.99296 -16.266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.92 0 0 11.998 11.4768 0 0 0 0 0 0 0 0 0 0 0 11.4755 0 0 0 0 0 0 0 0 0 0 12.1363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6371 0 0 0 13.957 0 0 0 0 0 0 0 0 0 0 0 0 10.6969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7037 0 0 0 0 0 13.6682 13.2922 0 0 0 12.8467 0 0 0 0 0 0 0 0 0 0 14.5732 0 0 0 0 0 0 13.1443 0 0 0 0 0 0 0 0 0 13.9196 0 0 0 0 0 0 0 0 0 0 13.8149 0 13.6157 0 0 0 0 0 13.5405 12.0632 0 12.9912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5126 0 0 0 0 0 0 Q9Y4C2 TCAF1_HUMAN TRPM8 channel-associated factor 1 (TRP channel-associated factor 1) TCAF1 FAM115A KIAA0738 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; positive regulation of anion channel activity [GO:1901529]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of anion channel activity [GO:0010359] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; transmembrane transporter binding [GO:0044325]; negative regulation of cell migration [GO:0030336]; positive regulation of anion channel activity [GO:1901529]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of anion channel activity [GO:0010359] GO:0005886; GO:0010359; GO:0030336; GO:0044325; GO:0090314; GO:1901529 transmembrane transporter binding [GO:0044325] ASKLFRGPLVINR 0.99296 -6.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6355 0 0 0 0 0 0 0 0 0 0 11.5669 11.1188 0 11.3873 0 0 0 0 0 0 0 0 0 0 0 0 13.7877 0 0 0 0 0 11.1814 0 0 11.2778 0 14.1561 0 0 0 0 16.3336 16.2849 0 11.7678 0 0 0 0 0 0 0 11.8138 0 15.6103 0 0 14.1353 14.1375 14.1261 0 0 0 14.8217 14.275 0 0 0 0 14.329 14.4225 0 0 13.9852 0 0 0 0 0 0 0 14.6745 0 0 0 0 11.1761 0 0 0 0 0 0 0 11.764 0 0 0 0 0 0 13.9379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5118 11.6376 0 0 0 0 0 12.6306 0 0 0 0 0 13.1999 0 0 A2RUB6 CCD66_HUMAN Coiled-coil domain-containing protein 66 CCDC66 Homo sapiens (Human) cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; microtubule bundle formation [GO:0001578]; regulation of protein localization to cilium [GO:1903564]; retina homeostasis [GO:0001895] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cell junction [GO:0030054]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; cilium assembly [GO:0060271]; detection of light stimulus involved in visual perception [GO:0050908]; microtubule bundle formation [GO:0001578]; regulation of protein localization to cilium [GO:1903564]; retina homeostasis [GO:0001895] GO:0001578; GO:0001750; GO:0001895; GO:0001917; GO:0005813; GO:0005829; GO:0005874; GO:0005929; GO:0008017; GO:0030054; GO:0034451; GO:0036064; GO:0042803; GO:0050908; GO:0060271; GO:0090543; GO:1903564 microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803] CNDQCNQFTR 0.99297 -38.97 0 0 12.3613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9633 0 0 0 0 0 12.0944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.227 0 0 0 0 0 0 0 0 13.3611 13.9866 0 0 0 0 13.2639 0 0 0 0 0 0 0 0 0 0 13.317 0 0 0 0 0 0 0 0 0 13.5964 0 0 0 0 0 0 0 0 0 0 0 14.1248 13.2894 0 0 0 0 0 0 0 0 0 12.9169 12.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6668 0 0 0 0 16.0581 0 0 0 0 0 0 0 15.039 0 0 0 0 O00329 PK3CD_HUMAN "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, PI3-kinase subunit delta, PI3K-delta, PI3Kdelta, PtdIns-3-kinase subunit delta, EC 2.7.1.137, EC 2.7.1.153 (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta, PtdIns-3-kinase subunit p110-delta, p110delta)" PIK3CD Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cytokine production [GO:0001819]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852]" GO:0001779; GO:0001819; GO:0001938; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006468; GO:0006954; GO:0006955; GO:0007165; GO:0010595; GO:0010628; GO:0010818; GO:0014065; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0030101; GO:0030183; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0038089; GO:0042110; GO:0042113; GO:0043303; GO:0045087; GO:0045766; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0052742; GO:0052812; GO:0060374; GO:0072672; GO:1905278 "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" DLVWKLR 0.99297 -6.7978 0 0 0 0 0 0 0 0 11.8814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4814 14.0618 12.8086 0 0 0 0 0 0 12.6928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08235 MCR_HUMAN "Mineralocorticoid receptor, MR (Nuclear receptor subfamily 3 group C member 2)" NR3C2 MCR MLR Homo sapiens (Human) intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235] "chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; receptor complex [GO:0043235]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0003707; GO:0004879; GO:0005496; GO:0005654; GO:0005789; GO:0005829; GO:0006357; GO:0007165; GO:0008270; GO:0030518; GO:0043235; GO:1901224; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]" AVEGQHNYLCAGRNDCIIDKIR 0.99297 -7.3228 0 0 0 0 0 0 0 0 0 0 0 12.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2519 0 13.7645 0 0 0 0 0 13.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5216 0 0 11.4782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P38935 SMBP2_HUMAN "DNA-binding protein SMUBP-2, EC 3.6.4.12, EC 3.6.4.13 (ATP-dependent helicase IGHMBP2) (Glial factor 1, GF-1) (Immunoglobulin mu-binding protein 2)" IGHMBP2 SMBP2 SMUBP2 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; RNA secondary structure unwinding [GO:0010501] axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "axon [GO:0030424]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; 5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; DNA duplex unwinding [GO:0032508]; RNA secondary structure unwinding [GO:0010501]" GO:0000049; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008094; GO:0008134; GO:0008186; GO:0008270; GO:0010501; GO:0016020; GO:0016604; GO:0016887; GO:0030424; GO:0030426; GO:0032508; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043139; GO:1990904 "5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription factor binding [GO:0008134]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]" AMIVEFMASK 0.99297 -39.442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3398 0 0 0 0 0 12.0443 0 0 0 0 0 0 15.6766 0 0 14.2548 15.6323 14.7896 0 13.5993 13.5652 15.8745 13.1952 14.091 13.2222 13.0531 14.166 0 0 13.025 14.3489 13.5974 0 0 0 0 0 12.2929 14.1612 14.8337 0 0 0 0 13.8207 14.5035 0 0 0 14.2538 0 15.853 13.267 0 13.3267 12.243 0 0 0 14.7834 13.5274 14.4013 14.0091 15.2986 0 0 0 0 0 0 0 12.5822 0 0 14.3736 0 13.6008 15.0588 0 0 0 12.1466 0 0 0 0 0 0 0 0 0 11.7275 0 0 0 0 0 13.4876 0 0 0 13.6537 13.8972 0 0 0 0 0 0 13.814 0 P46934 NEDD4_HUMAN "E3 ubiquitin-protein ligase NEDD4, EC 2.3.2.26 (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4, NEDD-4)" NEDD4 KIAA0093 NEDD4-1 PIG53 Homo sapiens (Human) cellular response to UV [GO:0034644]; formation of structure involved in a symbiotic process [GO:0044111]; glucocorticoid receptor signaling pathway [GO:0042921]; lysosomal transport [GO:0007041]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of synapse organization [GO:0050807]; response to calcium ion [GO:0051592]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755] apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151] apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]; beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; cellular response to UV [GO:0034644]; formation of structure involved in a symbiotic process [GO:0044111]; glucocorticoid receptor signaling pathway [GO:0042921]; lysosomal transport [GO:0007041]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of synapse organization [GO:0050807]; response to calcium ion [GO:0051592]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755] GO:0000151; GO:0000209; GO:0000785; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006622; GO:0007041; GO:0007528; GO:0010766; GO:0010768; GO:0014068; GO:0016241; GO:0016327; GO:0016567; GO:0019871; GO:0019899; GO:0019904; GO:0030948; GO:0031175; GO:0031623; GO:0031698; GO:0032801; GO:0032991; GO:0034644; GO:0034765; GO:0042391; GO:0042921; GO:0043130; GO:0043161; GO:0043162; GO:0043197; GO:0044111; GO:0045732; GO:0046755; GO:0046824; GO:0048471; GO:0048814; GO:0050807; GO:0050815; GO:0050816; GO:0050847; GO:0051592; GO:0061630; GO:0070062; GO:0070063; GO:0070064; GO:0070534; GO:1901016; GO:2000650 beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630] ARLWIEFDGEK 0.99297 -39.093 0 0 0 0 0 0 0 0 0 0 11.007 0 12.2964 0 13.0665 0 0 0 0 0 14.1156 0 0 0 0 10.5998 0 0 0 10.5126 10.604 0 0 0 0 0 15.1883 13.5459 0 0 0 0 11.8407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2179 0 0 0 0 0 0 0 0 0 0 0 14.978 0 0 13.7571 0 0 13.977 14.2854 0 13.2709 13.0017 13.895 13.8186 12.7401 0 15.3869 0 0 0 0 16.1781 0 0 0 0 0 12.7824 14.3376 12.8344 0 0 0 0 0 0 15.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3114 0 0 0 0 0 0 0 0 0 13.8887 0 0 15.2112 15.6808 0 0 0 14.0751 0 11.8992 12.1157 12.5956 12.6932 0 0 0 0 0 0 0 17.1257 12.6097 13.4061 14.2087 0 0 0 0 0 P53007 TXTP_HUMAN "Tricarboxylate transport protein, mitochondrial (Citrate transport protein, CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)" SLC25A1 SLC20A3 Homo sapiens (Human) fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transmembrane transport [GO:0006843] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142]; fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transmembrane transport [GO:0006843] GO:0005634; GO:0005739; GO:0005743; GO:0006094; GO:0006843; GO:0015137; GO:0015142; GO:0016021; GO:0046949; GO:0070062; GO:0071913 citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142] AFYKGTVPRLGR 0.99297 -6.2225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6894 0 0 0 13.0807 0 0 10.7277 0 0 0 19.4011 13.9928 0 12.9899 0 0 0 0 13.4426 0 0 0 0 0 0 0 0 13.6865 0 0 0 0 0 0 14.2656 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8975 0 0 0 0 0 0 0 0 0 13.207 0 13.0787 0 13.8887 0 0 13.0797 0 0 0 0 0 0 0 0 0 0 13.9553 0 0 0 0 0 0 0 11.9667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53384 NUBP1_HUMAN "Cytosolic Fe-S cluster assembly factor NUBP1 (Nucleotide-binding protein 1, NBP 1)" NUBP1 NBP NBP1 Homo sapiens (Human) cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558] centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cell projection organization [GO:0030030]; cellular iron ion homeostasis [GO:0006879]; centrosome localization [GO:0051642]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558]" GO:0000166; GO:0001558; GO:0005524; GO:0005634; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006879; GO:0010826; GO:0016226; GO:0030030; GO:0046872; GO:0051536; GO:0051539; GO:0051642; GO:0072697; GO:0140663 "4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]" EENLISS 0.99297 -16.369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.49917 0 0 0 0 0 0 0 0 11.4002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4685 0 0 0 0 0 11.7737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00059 TFAM_HUMAN "Transcription factor A, mitochondrial, mtTFA (Mitochondrial transcription factor 1, MtTF1) (Transcription factor 6, TCF-6) (Transcription factor 6-like 2)" TFAM TCF6 TCF6L2 Homo sapiens (Human) "mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial transcription [GO:0006390]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription initiation from mitochondrial promoter [GO:0006391]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; heat shock protein binding [GO:0031072]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial transcription [GO:0006390]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription initiation from mitochondrial promoter [GO:0006391]" GO:0000976; GO:0001018; GO:0001223; GO:0003682; GO:0003723; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006390; GO:0006391; GO:0008301; GO:0031072; GO:0032991; GO:0033108; GO:0034246; GO:0042645; GO:0043565; GO:0045893 "chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; heat shock protein binding [GO:0031072]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]" AQNPDAK 0.99297 -17.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08378 GOGA3_HUMAN "Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa, GCP170) (Golgin-160)" GOLGA3 Homo sapiens (Human) spermatogenesis [GO:0007283] cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; spermatogenesis [GO:0007283] GO:0000139; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0007283; GO:0016020; GO:0032580; GO:0045296; GO:0090498 cadherin binding [GO:0045296] EEQVRLQARK 0.99297 -7.3132 0 0 0 10.9844 0 0 0 11.9579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.766 0 0 0 0 0 0 0 10.4779 14.2541 0 13.5721 0 0 0 0 13.7781 0 0 13.7896 14.0893 0 0 0 14.3912 14.5057 0 16.9665 10.9089 0 15.3172 14.1719 14.2112 0 0 0 15.2377 14.1566 12.8416 15.3197 0 0 0 14.501 10.5802 11.4294 15.9268 14.2933 13.9284 0 0 13.2325 13.83 13.6355 14.253 0 0 0 12.8427 0 0 0 0 13.8485 13.641 13.4327 14.7932 14.2968 14.2354 0 0 0 0 11.9584 0 0 0 0 12.0573 0 0 9.91952 0 0 13.2056 0 13.7857 13.2384 0 0 0 0 0 0 11.8994 0 14.0503 0 12.6096 0 0 0 0 0 0 0 0 0 0 0 0 Q3SYC2 MOGT2_HUMAN "2-acylglycerol O-acyltransferase 2, EC 2.3.1.22 (Acyl-CoA:monoacylglycerol acyltransferase 2, MGAT2, hMGAT2) (Diacylglycerol O-acyltransferase candidate 5, hDC5) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 2)" MOGAT2 DC5 DGAT2L5 Homo sapiens (Human) diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum membrane [GO:1990578]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432] GO:0003846; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0016021; GO:0016407; GO:0019432; GO:0050892; GO:1990578 2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407] CWTIWKYMK 0.99297 -6.2282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q495T6 MMEL1_HUMAN "Membrane metallo-endopeptidase-like 1, EC 3.4.24.11 (Membrane metallo-endopeptidase-like 2) (NEP2(m)) (Neprilysin II, NEPII) (Neprilysin-2, NEP2, NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted, NEP2(s)) ]" MMEL1 MELL1 MMEL2 NEP2 Homo sapiens (Human) protein processing [GO:0016485]; proteolysis [GO:0006508] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; protein processing [GO:0016485]; proteolysis [GO:0006508] GO:0004175; GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0008270; GO:0016020; GO:0016021; GO:0016485 endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] AGQKRPGFLEGGLLLLLLLVTAALVALGVLYADR 0.99297 -44.214 0 0 0 0 0 0 0 0 11.2068 0 0 0 0 0 10.7437 0 0 0 0 0 0 0 11.4487 0 0 0 0 0 0 13.18 12.5997 0 0 0 0 12.043 9.98228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9881 0 0 0 0 0 10.3214 0 0 0 0 0 0 0 0 0 12.5038 11.0749 12.9535 0 0 0 0 0 0 11.6583 0 12.3373 11.7726 14.3817 0 11.0018 15.7432 0 10.056 15.6522 0 14.4114 15.2346 0 14.2699 0 13.4073 14.2401 0 0 0 0 0 0 0 0 0 10.0913 14.8573 12.7444 0 0 12.4897 0 0 13.3734 13.9441 0 10.6903 12.2676 0 0 11.3387 0 0 0 12.9938 0 0 0 0 0 0 0 0 12.9096 0 12.7093 0 0 12.4433 0 0 12.3177 14.7536 15.0455 0 0 0 0 12.0882 12.4632 0 12.8223 11.2733 11.8167 0 15.2351 0 0 13.471 14.3915 12.19 0 0 0 0 13.3149 0 0 13.9333 0 0 0 13.0179 12.1071 0 0 14.6243 0 12.423 0 0 Q6JQN1 ACD10_HUMAN "Acyl-CoA dehydrogenase family member 10, ACAD-10, EC 1.3.99.-" ACAD10 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] GO:0003995; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0033539; GO:0050660 acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660] ARWLIPLLEGK 0.99297 -15.954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1182 0 0 0 11.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5395 0 0 15.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9667 0 0 0 14.4182 0 0 0 0 14.8299 0 0 0 0 0 0 0 0 0 0 0 0 15.5596 0 0 0 0 0 0 0 0 0 13.8116 0 0 0 0 0 0 0 0 0 0 10.9836 0 0 0 0 0 13.2805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7168 Q6X4W1 NSMF_HUMAN "NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor, Nasal embryonic LHRH factor)" NSMF NELF Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to electrical stimulus [GO:0071257]; cellular response to gonadotropin stimulus [GO:0071371]; positive regulation of neuron migration [GO:2001224]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuronal synaptic plasticity [GO:0048168] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; euchromatin [GO:0000791]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; euchromatin [GO:0000791]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; calcium-dependent protein binding [GO:0048306]; cellular response to amino acid stimulus [GO:0071230]; cellular response to electrical stimulus [GO:0071257]; cellular response to gonadotropin stimulus [GO:0071371]; positive regulation of neuron migration [GO:2001224]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of dendrite morphogenesis [GO:0048814]; regulation of neuron apoptotic process [GO:0043523]; regulation of neuronal synaptic plasticity [GO:0048168] GO:0000791; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005886; GO:0014069; GO:0016020; GO:0016363; GO:0030425; GO:0030863; GO:0031965; GO:0035307; GO:0043005; GO:0043204; GO:0043523; GO:0045202; GO:0048168; GO:0048306; GO:0048814; GO:0070161; GO:0071230; GO:0071257; GO:0071371; GO:0097440; GO:2001224 calcium-dependent protein binding [GO:0048306] ADTSHDSR 0.99297 -14.555 0 0 0 0 0 0 0 0 12.6201 12.5209 0 0 12.3055 12.2449 0 0 0 0 0 0 12.3189 0 0 0 0 12.8057 0 0 0 0 0 0 12.163 0 0 11.8356 0 13.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7865 0 0 0 13.9552 0 0 0 0 0 0 0 0 0 13.7014 0 12.1364 13.7112 13.9269 13.7797 0 13.5728 0 0 10.18 0 0 0 0 0 0 0 0 0 13.7394 11.4473 0 Q86Y13 DZIP3_HUMAN "E3 ubiquitin-protein ligase DZIP3, EC 2.3.2.27 (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa, hRUL138)" DZIP3 KIAA0675 Homo sapiens (Human) protein polyubiquitination [GO:0000209] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0003723; GO:0004842; GO:0005737; GO:0019902; GO:0031593; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] EDYTEAENKFLVMK 0.99297 -39.418 0 0 0 0 0 0 0 0 0 0 0 0 14.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0069 0 0 0 0 0 0 0 0 0 0 0 11.8708 0 13.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4573 0 0 0 0 0 0 0 0 0 0 0 12.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.405 0 0 0 0 0 0 0 12.5177 0 0 0 0 0 0 0 0 0 0 0 11.7368 0 0 0 0 0 0 0 0 0 14.9594 Q8IZ83 A16A1_HUMAN Aldehyde dehydrogenase family 16 member A1 ALDH16A1 Homo sapiens (Human) membrane [GO:0016020] "membrane [GO:0016020]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]" GO:0016020; GO:0016620 "oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]" AALLWALAAALERRK 0.99297 -14.557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.73762 0 0 0 0 0 0 0 0 0 0 0 0 10.9903 0 0 0 0 0 0 0 0 0 0 0 14.1745 0 0 0 0 0 0 0 0 0 0 0 13.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5554 0 0 11.8635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9688 0 0 12.0388 0 0 0 0 0 0 0 0 Q8N2B8 YB035_HUMAN Putative uncharacterized protein FLJ33534 Homo sapiens (Human) LATWKPL 0.99297 -6.6005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9974 0 0 0 0 0 0 0 0 0 0 13.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6288 0 0 0 0 Q8NA54 IQUB_HUMAN IQ and ubiquitin-like domain-containing protein IQUB Homo sapiens (Human) cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514] acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224] GO:0001669; GO:0007224; GO:0031514; GO:0060271 AVIVIQTYYRQWHAK 0.99297 -6.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0126 0 0 0 0 0 0 14.4043 0 0 0 0 0 0 0 0 0 0 0 9.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8975 13.9503 12.9034 14.8086 0 0 0 13.0046 12.7424 0 0 19.2517 0 0 12.2357 19.3792 13.6156 14.6728 0 0 0 0 0 16.0844 12.4653 0 11.8341 0 0 0 0 11.9258 0 0 0 0 0 0 13.2596 0 0 0 14.0975 0 0 0 0 0 0 12.6735 0 0 0 0 0 11.2724 0 0 0 0 0 0 11.2206 0 0 0 0 0 0 18.7871 0 0 0 0 0 13.0969 0 0 0 0 0 0 0 0 0 0 11.485 0 0 0 0 0 0 0 12.0162 0 16.1856 0 0 0 0 15.5126 0 Q8NC06 ACBD4_HUMAN Acyl-CoA-binding domain-containing protein 4 ACBD4 HMFT0700 Homo sapiens (Human) fatty acid metabolic process [GO:0006631] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; fatty acid metabolic process [GO:0006631] GO:0000062; GO:0005737; GO:0006631; GO:0008289 fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289] GCGAARR 0.99297 -15.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.97464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8242 0 0 0 11.3955 0 0 0 0 0 0 0 10.9637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5956 0 11.8868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4834 0 0 0 0 0 0 0 0 0 0 10.2046 0 0 0 0 10.456 0 0 0 0 Q8ND82 Z280C_HUMAN Zinc finger protein 280C (Suppressor of hairy wing homolog 3) (Zinc finger protein 633) ZNF280C SUHW3 ZNF633 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AQHRTFIK 0.99297 -17.18 0 0 0 0 0 0 0 13.6783 0 0 0 0 0 12.5309 0 0 0 0 0 0 0 0 0 0 0 0 10.5908 13.0567 0 0 0 0 0 0 0 0 0 0 0 13.2835 0 0 0 0 0 0 0 0 0 0 13.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0121 13.9798 0 0 0 0 0 0 0 0 0 12.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDW5 SYTL5_HUMAN Synaptotagmin-like protein 5 SYTL5 SLP5 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886] exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] GO:0005543; GO:0005886; GO:0006886; GO:0006887; GO:0031267; GO:0042043; GO:0046872; GO:0070382 metal ion binding [GO:0046872]; neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267] EAKNLTAVK 0.99297 -14.547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8028 0 0 0 0 13.2084 0 0 0 13.1147 0 13.1156 0 0 0 0 13.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3299 12.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5299 12.2264 0 0 0 0 0 0 0 0 0 0 0 13.9105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93075 TATD2_HUMAN "Putative deoxyribonuclease TATDN2, EC 3.1.21.-" TATDN2 KIAA0218 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518] GO:0004518; GO:0005654; GO:0046872 metal ion binding [GO:0046872]; nuclease activity [GO:0004518] AKPSAAEHPSHGEGPAR 0.99297 -16.349 0 0 0 0 0 0 0 0 14.8419 10.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7294 0 0 0 0 0 0 0 9.66612 0 13.5821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.564 0 12.0556 0 0 0 0 11.0075 0 12.9696 0 0 0 18.4323 14.2898 0 18.6568 15.0097 0 0 14.9184 15.1853 0 13.9418 12.6127 15.0728 0 15.1274 0 0 12.4567 0 0 0 0 12.7472 12.7231 12.2822 0 0 0 0 12.5423 0 10.2116 0 0 0 0 11.3061 12.2519 0 15.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.034 0 0 0 0 0 0 12.355 0 0 0 11.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1556 16.1391 0 0 0 0 0 13.1487 13.3725 0 0 12.2467 Q96EN8 MOCOS_HUMAN "Molybdenum cofactor sulfurase, MCS, MOS, MoCo sulfurase, hMCS, EC 2.8.1.9 (Molybdenum cofactor sulfurtransferase)" MOCOS Homo sapiens (Human) Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545] cytosol [GO:0005829] cytosol [GO:0005829]; lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; molybdopterin cofactor metabolic process [GO:0043545] GO:0005829; GO:0006777; GO:0008265; GO:0016829; GO:0030151; GO:0030170; GO:0032324; GO:0043545; GO:0102867 lyase activity [GO:0016829]; Mo-molybdopterin cofactor sulfurase activity [GO:0008265]; molybdenum cofactor sulfurtransferase activity [GO:0102867]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170] ANIIINGK 0.99297 -16.38 0 0 0 0 0 0 0 0 11.1174 0 0 13.5013 0 0 12.5918 0 0 13.5101 0 0 0 0 0 0 0 0 0 13.3639 0 0 0 13.7476 0 0 0 0 11.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7354 11.6808 0 0 0 0 0 0 0 13.9936 0 0 0 14.2096 14.6872 0 0 14.6444 11.4352 14.7117 0 14.3981 12.6291 0 0 0 0 0 0 0 0 0 0 0 13.8701 0 0 0 0 0 0 0 0 0 0 13.0008 13.6393 0 0 0 0 0 0 0 0 0 0 0 13.071 0 0 0 0 0 0 0 0 0 0 0 14.0502 13.5256 0 0 0 0 0 0 0 13.7638 0 13.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1514 0 14.9421 0 0 0 0 Q96JN2 CC136_HUMAN Coiled-coil domain-containing protein 136 (Nasopharyngeal carcinoma-associated gene 6 protein) CCDC136 KIAA1793 NAG6 Homo sapiens (Human) acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] GO:0001675; GO:0002080; GO:0007283; GO:0007338; GO:0016021 EELDACEREFKECMECLEK 0.99297 -16.775 0 0 0 0 0 0 0 0 0 0 0 9.9544 0 0 0 0 0 0 10.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.438 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2802 0 0 0 11.6074 0 0 0 15.7766 11.8747 0 0 0 0 0 13.2932 0 14.6333 0 0 0 12.3589 0 0 0 0 0 13.1692 0 0 0 12.4202 0 0 0 0 0 0 0 15.1172 0 14.6307 0 0 0 0 0 0 0 0 0 0 12.8492 0 0 0 0 0 10.3137 0 0 0 0 0 0 0 0 0 0 10.6544 0 0 Q96N77 ZN641_HUMAN Zinc finger protein 641 ZNF641 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHVCTECGK 0.99297 -6.2261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QS6 KPSH2_HUMAN "Serine/threonine-protein kinase H2, EC 2.7.11.1 (Protein serine kinase H2, PSK-H2)" PSKH2 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0006468; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AISRNLMQR 0.99297 -16.336 0 0 0 0 0 0 0 0 13.989 11.5236 14.7349 11.9537 12.7532 12.7191 13.4013 0 0 0 0 0 0 0 10.4887 0 0 11.8942 0 0 0 0 0 0 0 0 10.4911 0 0 12.0652 11.1385 0 0 0 0 0 0 12.2094 11.9837 0 0 0 0 0 12.5576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6228 11.8829 0 14.5812 13.4774 0 0 0 0 14.1994 0 0 0 0 0 0 0 12.7618 14.5021 0 12.1393 0 0 0 0 0 0 0 0 0 0 0 13.3327 0 0 0 0 14.3487 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3404 0 0 13.2396 13.5234 0 0 0 0 0 14.6663 0 0 0 13.5444 0 12.6987 0 0 0 13.2311 12.3244 0 0 0 0 0 11.8696 14.203 0 12.8972 12.9035 12.9592 14.6629 15.2395 0 15.445 0 0 0 14.2961 14.0173 0 0 0 13.208 13.9879 0 0 0 Q99590 SCAFB_HUMAN "Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129, SRrp129)" SCAF11 CASP11 SFRS2IP SIP1 SRSF2IP Homo sapiens (Human) "mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]" nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000375; GO:0003723; GO:0005654; GO:0005730; GO:0006397; GO:0008380; GO:0016604; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723] AETASQSQR 0.99297 -43.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9392 15.3421 0 0 0 10.1747 0 0 15.5227 0 0 0 0 0 10.8441 13.5889 0 0 0 0 0 0 0 0 0 0 0 12.6134 0 0 0 0 11.038 0 0 11.7537 0 0 11.8685 12.1817 0 11.318 15.9773 0 10.8819 0 0 0 0 12.4732 13.2758 0 11.5765 0 11.3896 0 15.1653 0 0 12.4806 13.5314 15.0535 13.3368 15.8299 13.3856 13.6931 0 12.7029 0 14.2403 0 0 13.6708 11.5404 14.2734 14.647 13.4832 0 0 0 0 12.1854 13.6656 14.8863 14.7661 15.5568 14.0043 13.8713 14.0564 13.5726 14.4721 12.6016 13.6327 0 0 0 0 13.3473 14.2456 15.6616 15.7437 14.7722 0 15.129 13.9606 0 15.1937 14.8727 15.6994 0 14.9436 0 0 14.5404 15.5147 15.2797 14.3241 12.6114 13.6454 13.778 13.855 14.2731 15.6032 0 0 0 13.5495 0 0 13.6609 0 0 13.8274 13.9755 12.3553 14.4295 15.4007 12.64 0 0 0 15.015 0 14.5915 12.347 13.4597 0 13.1224 13.0778 13.7321 0 11.933 0 0 0 15.4297 0 14.3314 0 0 0 0 Q9H0G5 NSRP1_HUMAN "Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70, NSrp70)" NSRP1 CCDC55 NSRP70 Homo sapiens (Human) "developmental process [GO:0032502]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; developmental process [GO:0032502]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032502; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723] AEEEEREK 0.99297 -38.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5854 0 0 0 0 0 0 0 0 0 13.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9885 0 0 0 0 0 0 13.6861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.518 Q9H210 OR2D2_HUMAN "Olfactory receptor 2D2 (HB2) (Olfactory receptor 11-610, OR11-610) (Olfactory receptor 2D1) (Olfactory receptor OR11-88)" OR2D2 OR2D1 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IIVTVVKMK 0.99297 -6.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.916 0 0 0 0 12.1422 0 0 12.6437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8689 0 12.1576 0 0 0 0 0 0 0 0 12.162 0 12.0115 0 0 Q9H8M7 MINY3_HUMAN "Ubiquitin carboxyl-terminal hydrolase MINDY-3, EC 3.4.19.12 (Dermal papilla-derived protein 5) (Deubiquitinating enzyme MINDY-3) (Protein CARP)" MINDY3 C10orf97 CARP DERP5 FAM188A MSTP126 My042 Homo sapiens (Human) apoptotic process [GO:0006915] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; cysteine-type deubiquitinase activity [GO:0004843]; Lys48-specific deubiquitinase activity [GO:1990380]; apoptotic process [GO:0006915] GO:0004843; GO:0005654; GO:0006915; GO:0031965; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; Lys48-specific deubiquitinase activity [GO:1990380] DAVLDQYSMWGNKFGVLLFLYSVLLTKGIENIK 0.99297 -16.355 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3718 0 14.2254 14.4249 13.9103 13.7788 0 13.5668 0 12.4052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2546 0 0 0 0 0 0 0 0 12.4596 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2342 0 0 12.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCU4 CELR2_HUMAN "Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2, EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3, Multiple EGF-like domains protein 3)" CELSR2 CDHF10 EGFL2 KIAA0279 MEGF3 Homo sapiens (Human) "cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of cell-cell adhesion [GO:0022407]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007186; GO:0016021; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060071; GO:0060271; GO:0097475; GO:0098609 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] CDNPFAEVTTNGCEVNYDSCPR 0.99297 -16.391 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9269 0 11.303 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9607 0 10.9079 0 11.0718 0 11.6494 0 0 0 0 0 0 0 0 0 10.8712 0 11.8259 0 0 0 0 0 10.9814 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8622 13.1495 12.0568 11.3224 11.5754 0 0 0 0 0 0 0 0 12.4902 13.3525 0 0 11.7722 15.0008 13.8836 0 13.0349 0 0 13.3369 0 14.8882 0 12.2549 0 0 14.0747 0 0 0 0 12.5606 0 0 0 0 12.5005 0 12.6168 0 15.0197 12.5577 13.3824 0 0 0 0 0 0 0 0 11.7149 0 12.8483 0 12.3523 0 13.6219 0 0 0 0 0 0 0 0 0 11.8636 0 0 11.6408 0 0 0 0 0 0 12.3334 0 0 0 0 0 0 0 12.0404 13.1495 0 0 0 0 0 14.0076 12.1586 0 0 12.1573 0 0 12.8211 0 0 0 12.4322 0 0 15.1832 0 Q9UJS0 S2513_HUMAN "Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Calcium-binding mitochondrial carrier protein Aralar2, ARALAR-related gene 2, ARALAR2) (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13)" SLC25A13 Homo sapiens (Human) aspartate family amino acid metabolic process [GO:0009066]; aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; response to calcium ion [GO:0051592] integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] "integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate family amino acid metabolic process [GO:0009066]; aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; response to calcium ion [GO:0051592]" GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0005887; GO:0006094; GO:0006754; GO:0006839; GO:0009066; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0022857; GO:0042802; GO:0043490; GO:0045333; GO:0051592 "3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]" ADPAELR 0.99297 -17.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6055 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6702 0 0 0 0 0 0 0 0 12.8432 0 0 0 0 0 16.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4077 0 0 0 0 12.8312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKN1 MUC12_HUMAN "Mucin-12, MUC-12 (Mucin-11, MUC-11)" MUC12 MUC11 Homo sapiens (Human) regulation of cell growth [GO:0001558] Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005796; GO:0005886; GO:0005887 AAGAREK 0.99297 -16.386 0 10.9127 0 0 0 0 0 0 0 0 0 12.8961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1783 0 0 0 0 0 0 0 0 0 0 0 0 10.8001 0 0 0 0 0 0 0 10.9565 0 0 0 0 0 11.8526 0 0 0 0 0 0 0 0 12.1105 0 0 11.7479 0 0 14.2197 13.8794 0 0 10.8673 0 0 0 0 0 0 14.5857 14.919 14.2064 15.0261 0 14.31 0 15.4765 13.5785 0 0 11.7608 14.2444 0 0 13.9157 10.8992 0 0 0 13.6763 0 13.4045 12.8128 13.7106 0 0 15.4076 0 0 15.1894 0 0 15.5569 0 0 0 12.6802 0 0 0 14.2146 0 0 0 0 12.2094 0 0 15.5451 15.4719 0 0 12.6924 0 15.4998 15.4402 15.5041 0 0 12.8885 9.66174 0 0 0 11.5775 0 0 0 13.6646 11.1259 0 11.5725 12.4099 0 0 0 14.6461 0 0 11.6945 11.8675 0 0 0 0 0 0 11.1774 15.49 0 0 13.4439 10.9811 0 0 11.5531 P29597 TYK2_HUMAN "Non-receptor tyrosine-protein kinase TYK2, EC 2.7.10.2" TYK2 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; protein phosphorylation [GO:0006468]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; type 1 angiotensin receptor binding [GO:0031702]; cell differentiation [GO:0030154]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; protein phosphorylation [GO:0006468]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196] GO:0004713; GO:0004715; GO:0005126; GO:0005131; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006955; GO:0019221; GO:0030154; GO:0031702; GO:0032729; GO:0032740; GO:0032819; GO:0035556; GO:0038196; GO:0042022; GO:0042102; GO:0046427; GO:0051142; GO:0060337; GO:0060397; GO:0070062; GO:0072536; GO:0098586; GO:2000318 ATP binding [GO:0005524]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; type 1 angiotensin receptor binding [GO:0031702] ADCGPQHRSGWKQEIDILR 0.99298 -16.429 0 0 0 0 0 0 0 0 0 0 13.0235 0 0 0 0 0 13.0486 12.1048 13.3869 0 11.9031 12.2104 11.8596 12.2501 11.9502 15.5107 11.9959 11.9812 11.4252 11.5711 0 11.8517 0 0 0 0 0 0 0 0 0 0 0 11.1718 11.5546 0 0 0 12.8689 15.8888 0 13.4633 0 14.6919 0 0 0 13.7499 0 0 0 12.7829 11.9353 0 12.7337 13.4466 15.1955 14.758 14.3477 13.5078 14.6399 13.659 14.1943 13.2137 17.754 15.1987 15.5899 15.1271 15.4952 14.9913 15.1958 14.8552 17.3877 13.3995 17.4491 13.2721 14.199 14.5481 17.9467 0 14.6178 18.0928 13.5409 13.943 13.319 17.8858 14.5153 12.7969 0 0 13.4793 11.1177 0 0 12.0699 14.4272 14.0145 13.4552 15.5194 13.4746 0 0 14.2524 13.7756 0 0 14.4924 13.0061 16.1291 14.0115 14.238 13.6296 14.4816 17.0585 0 16.9803 14.4402 0 13.4712 15.1546 13.7313 14.4382 14.8456 13.2516 15.1774 14.9276 15.7076 14.5105 0 14.5899 15.8735 16.4316 15.3772 13.6383 15.7437 0 15.5146 14.3899 0 0 13.7044 13.5406 0 13.1268 14.9897 14.3922 14.4039 13.3686 0 0 12.9717 0 0 0 14.2914 14.5039 13.5227 15.342 11.4075 13.4353 13.3745 14.3643 17.7095 15.4244 0 13.4232 0 0 0 11.6994 O14879 IFIT3_HUMAN "Interferon-induced protein with tetratricopeptide repeats 3, IFIT-3 (CIG49) (ISG-60) (Interferon-induced 60 kDa protein, IFI-60K) (Interferon-induced protein with tetratricopeptide repeats 4, IFIT-4) (Retinoic acid-induced gene G protein, P60, RIG-G)" IFIT3 CIG-49 IFI60 IFIT4 ISG60 Homo sapiens (Human) cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cellular response to interferon-alpha [GO:0035457]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; response to virus [GO:0009615] GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0008285; GO:0009615; GO:0035457; GO:0042802; GO:0043066; GO:0045087; GO:0051607 identical protein binding [GO:0042802]; RNA binding [GO:0003723] AKVCFEK 0.99298 -6.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5828 0 0 0 0 0 0 0 14.8218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75179 ANR17_HUMAN Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) ANKRD17 GTAR KIAA0697 Homo sapiens (Human) blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275] GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246 chromatin binding [GO:0003682]; RNA binding [GO:0003723] AGHVCTVQFLISK 0.99298 -39.889 0 0 0 0 0 0 0 9.62412 0 12.9363 0 0 0 0 0 0 0 0 0 0 0 0 12.8966 0 0 12.2951 0 0 0 11.2998 0 0 0 0 0 0 0 0 0 0 11.0417 14.1633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5705 0 0 0 0 14.9649 15.3298 13.3729 0 0 14.4714 0 0 14.2943 0 0 0 12.4693 11.537 10.89 0 14.3721 0 0 0 12.2645 0 0 12.8907 0 13.0231 0 0 13.9264 0 0 12.9262 0 13.5788 0 11.9498 0 11.5283 0 12.5156 0 0 13.6463 0 0 13.2163 0 0 0 0 0 13.7996 0 0 0 11.8582 0 0 0 12.211 13.4895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1352 0 0 12.2482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1299 0 0 0 O94844 RHBT1_HUMAN Rho-related BTB domain-containing protein 1 RHOBTB1 KIAA0740 Homo sapiens (Human) actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0005938; GO:0007015; GO:0007163; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0043652 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] AFHVRKANR 0.99298 -16.078 0 12.2472 0 0 0 11.8036 0 0 0 0 11.2331 0 0 0 0 0 0 11.7754 0 0 0 12.5266 13.741 0 0 0 0 0 0 0 0 12.5611 13.1098 0 0 0 0 12.7442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7593 0 12.1632 11.5329 13.102 12.7327 11.7944 11.6835 0 0 0 0 0 9.93418 14.0308 15.4277 13.8515 14.3247 14.2807 0 12.0848 0 13.316 15.6198 12.6834 15.3887 14.0108 15.2335 14.6853 13.7269 0 14.6405 13.2394 0 0 14.2798 0 14.0088 15.4787 15.8656 14.1964 14.7609 12.2147 13.4209 15.2251 15.1825 15.331 15.5515 15.5623 14.2729 15.3858 15.9858 0 14.5286 15.7559 15.2373 16.0143 13.4984 15.7309 0 0 13.7151 14.5427 14.4849 15.2185 15.2255 13.7263 15.3385 12.9556 15.4803 14.7075 0 14.7255 14.2046 15.9293 14.6767 15.1383 14.6059 15.8493 13.844 15.0113 14.6853 13.7948 0 15.6953 15.5185 14.4132 13.2973 13.7508 13.9433 15.179 13.4791 0 14.5445 14.4513 12.6966 0 0 0 17.0055 0 15.281 13.8157 15.1844 0 13.3803 13.3006 0 0 0 0 0 0 12.7397 15.5671 0 0 0 0 14.9055 15.4426 15.7762 13.3518 0 14.6052 0 13.1764 0 O95926 SYF2_HUMAN Pre-mRNA-splicing factor SYF2 (CCNDBP1-interactor) (p29) SYF2 CBPIN GCIPIP Homo sapiens (Human) "embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; embryonic organ development [GO:0048568]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of cell population proliferation [GO:0008284]" GO:0000398; GO:0000974; GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0007095; GO:0007369; GO:0008284; GO:0016607; GO:0048568; GO:0071007; GO:0071013; GO:0071014 RNA binding [GO:0003723] ARLEWELK 0.99298 -6.2324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1559 0 0 12.313 0 0 0 0 0 0 0 0 0 0 0 0 11.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95970 LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 (Epitempin-1) LGI1 EPT UNQ775/PRO1569 Homo sapiens (Human) axon guidance [GO:0007411]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of cell growth [GO:0030307]; positive regulation of synaptic transmission [GO:0050806] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synaptic cleft [GO:0043083] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synaptic cleft [GO:0043083]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of cell growth [GO:0030307]; positive regulation of synaptic transmission [GO:0050806] GO:0005102; GO:0005576; GO:0005615; GO:0007399; GO:0007411; GO:0030307; GO:0031175; GO:0043083; GO:0050806; GO:0070161; GO:0098978; GO:0099645 signaling receptor binding [GO:0005102] AGFTTIYKWNGNGFYSHQSLHAWYR 0.99298 -6.6097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0851 0 13.0647 0 0 0 0 0 0 0 13.5017 0 0 12.282 0 13.1837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0981 0 0 0 13.1238 0 12.7549 0 0 0 0 0 0 0 0 0 0 0 0 13.6858 0 14.6846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1537 0 0 0 12.9386 0 0 0 0 P0DSN7 KVD37_HUMAN Probable non-functional immunoglobulinn kappa variable 1D-37 IGKV1D-37 Homo sapiens (Human) adaptive immune response [GO:0002250] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250] GO:0002250; GO:0005576; GO:0005886; GO:0019814 QKPGKVPK 0.99298 -6.2412 11.155 0 0 0 0 0 0 0 0 13.8964 0 13.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1999 0 0 0 0 13.2138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13984 T2FB_HUMAN "General transcription factor IIF subunit 2 (General transcription factor IIF 30 kDa subunit) (Transcription initiation factor IIF subunit beta, TFIIF-beta) (Transcription initiation factor RAP30)" GTF2F2 RAP30 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; transcription preinitiation complex [GO:0097550] microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; transcription preinitiation complex [GO:0097550]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0003677; GO:0003678; GO:0005634; GO:0005654; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0015630; GO:0016251; GO:0045944; GO:0097550 DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; RNA polymerase II general transcription initiation factor activity [GO:0016251] AECRPAASENYMR 0.99298 -13.224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5848 0 0 0 0 0 0 0 0 0 13.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0481 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8371 0 0 13.4651 0 14.0335 11.5212 14.3269 0 0 0 13.333 0 0 0 0 0 0 0 0 13.1623 0 0 18.3847 0 0 13.2584 11.5403 0 13.6499 0 11.5092 0 0 0 0 0 0 0 0 0 12.8449 0 0 11.111 0 0 0 0 0 0 10.6086 0 0 0 0 0 0 9.89336 0 0 0 13.3059 0 0 0 0 0 0 P28300 LYOX_HUMAN "Protein-lysine 6-oxidase, EC 1.4.3.13 (Lysyl oxidase) [Cleaved into: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form ]" LOX Homo sapiens (Human) ascending aorta development [GO:0035905]; blood vessel morphogenesis [GO:0048514]; bone mineralization [GO:0030282]; cell chemotaxis [GO:0060326]; cellular response to chemokine [GO:1990869]; collagen fibril organization [GO:0030199]; connective tissue development [GO:0061448]; descending aorta development [GO:0035906]; DNA biosynthetic process [GO:0071897]; elastic fiber assembly [GO:0048251]; heart development [GO:0007507]; lung development [GO:0030324]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; osteoblast differentiation [GO:0001649]; peptidyl-lysine oxidation [GO:0018057]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; protein kinase B signaling [GO:0043491]; protein modification process [GO:0036211]; regulation of apoptotic process [GO:0042981]; regulation of bone development [GO:1903010]; regulation of gene expression [GO:0010468]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000586]; regulation of protein phosphorylation [GO:0001932]; regulation of receptor binding [GO:1900120]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; collagen binding [GO:0005518]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; ascending aorta development [GO:0035905]; blood vessel morphogenesis [GO:0048514]; bone mineralization [GO:0030282]; cell chemotaxis [GO:0060326]; cellular response to chemokine [GO:1990869]; collagen fibril organization [GO:0030199]; connective tissue development [GO:0061448]; descending aorta development [GO:0035906]; DNA biosynthetic process [GO:0071897]; elastic fiber assembly [GO:0048251]; heart development [GO:0007507]; lung development [GO:0030324]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; osteoblast differentiation [GO:0001649]; peptidyl-lysine oxidation [GO:0018057]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; protein kinase B signaling [GO:0043491]; protein modification process [GO:0036211]; regulation of apoptotic process [GO:0042981]; regulation of bone development [GO:1903010]; regulation of gene expression [GO:0010468]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000586]; regulation of protein phosphorylation [GO:0001932]; regulation of receptor binding [GO:1900120]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060] GO:0001649; GO:0001932; GO:0004720; GO:0005507; GO:0005518; GO:0005576; GO:0005581; GO:0005615; GO:0005634; GO:0007507; GO:0009410; GO:0010468; GO:0016202; GO:0017015; GO:0018057; GO:0030199; GO:0030282; GO:0030324; GO:0035791; GO:0035905; GO:0035906; GO:0036211; GO:0042060; GO:0042981; GO:0043491; GO:0045652; GO:0046716; GO:0048251; GO:0048514; GO:0048545; GO:0055001; GO:0060326; GO:0061448; GO:0062023; GO:0071897; GO:1900120; GO:1903010; GO:1990869; GO:2000586 collagen binding [GO:0005518]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720] CAAEENCLASTAYR 0.99298 -16.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0131 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3967 21.3918 0 14.5618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2048 0 0 0 0 0 0 0 0 0 21.0492 20.7898 0 18.654 0 0 0 0 0 0 0 0 13.0712 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2714 19.3083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32927 IL3RB_HUMAN Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131) CSF2RB IL3RB IL5RB Homo sapiens (Human) cellular response to interleukin-3 [GO:0036016]; cytokine-mediated signaling pathway [GO:0019221]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; immunoglobulin mediated immune response [GO:0016064]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-5-mediated signaling pathway [GO:0038043]; positive regulation of leukocyte proliferation [GO:0070665]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023]; cellular response to interleukin-3 [GO:0036016]; cytokine-mediated signaling pathway [GO:0019221]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; immunoglobulin mediated immune response [GO:0016064]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-5-mediated signaling pathway [GO:0038043]; positive regulation of leukocyte proliferation [GO:0070665]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165] GO:0004896; GO:0005886; GO:0005887; GO:0006468; GO:0007165; GO:0007259; GO:0007585; GO:0009897; GO:0016064; GO:0019221; GO:0030526; GO:0032496; GO:0036016; GO:0038023; GO:0038043; GO:0038156; GO:0038157; GO:0070665 cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023] CYNDYTSHITCR 0.99298 -24.175 16.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5198 0 0 0 0 0 14.0827 0 0 16.1168 0 12.0792 0 0 0 0 0 14.0812 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3749 0 0 0 0 0 0 13.5621 0 0 0 0 0 0 0 0 0 15.1399 0 14.975 0 0 0 13.2814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1631 0 13.9755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5874 0 0 0 0 0 0 0 P35368 ADA1B_HUMAN "Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor, Alpha-1B adrenoceptor)" ADRA1B Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117] caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of cardiac muscle contraction [GO:0055117] GO:0001996; GO:0004930; GO:0004937; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005901; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0031965; GO:0035556; GO:0043410; GO:0045907; GO:0046982; GO:0055117; GO:0071880; GO:0150099 alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982] AILALLSVWVLSTVISIGPLLGWKEPAPNDDK 0.99298 -26.282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9974 12.1754 0 0 0 0 14.0585 0 10.3065 0 11.1089 0 0 0 0 0 0 13.8256 0 0 0 0 0 0 11.0402 0 11.669 12.8504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2691 0 0 0 0 0 13.3626 10.6915 0 11.6413 13.8312 14.8515 16.9253 14.9379 17.2204 16.1102 15.1037 17.2283 0 0 14.7681 0 14.4055 16.5439 0 0 0 13.9595 0 14.0956 0 0 0 13.8244 0 0 13.6061 0 12.6413 0 0 14.6716 0 15.4964 0 0 0 13.9113 0 13.4713 0 0 0 0 0 13.3903 0 0 0 0 0 14.4207 0 0 0 12.1167 13.3669 12.3283 14.7381 0 0 0 13.374 0 0 0 0 0 13.8527 14.0481 13.0454 0 10.3029 0 0 0 0 0 0 13.457 0 13.2723 10.1635 0 0 0 12.5505 0 0 12.7726 14.4529 9.87667 0 0 0 15.9511 0 0 13.0163 Q13620 CUL4B_HUMAN "Cullin-4B, CUL-4B" CUL4B KIAA0695 Homo sapiens (Human) astrocyte differentiation [GO:0048708]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; gene expression [GO:0010467]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; UV-damage excision repair [GO:0070914] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; astrocyte differentiation [GO:0048708]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; G1/S transition of mitotic cell cycle [GO:0000082]; gene expression [GO:0010467]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; UV-damage excision repair [GO:0070914] GO:0000082; GO:0005634; GO:0005654; GO:0005829; GO:0006974; GO:0010467; GO:0010498; GO:0016567; GO:0030674; GO:0031146; GO:0031175; GO:0031461; GO:0031464; GO:0031465; GO:0031625; GO:0034644; GO:0035518; GO:0042254; GO:0045732; GO:0048708; GO:0070062; GO:0070914; GO:0080008; GO:1900087 protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] AEFKEGKK 0.99298 -16.475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4006 0 0 0 0 0 0 12.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5715 0 0 0 0 0 0 0 0 0 0 15.9436 0 0 0 13.4774 0 13.3856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8649 0 0 11.6736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7701 0 0 0 12.6141 0 0 12.8145 0 0 11.5907 0 0 0 0 0 0 0 0 0 13.4423 Q14439 GP176_HUMAN G-protein coupled receptor 176 (HB-954) GPR176 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007193; GO:0007268; GO:0045202; GO:0048512 G protein-coupled receptor activity [GO:0004930] ALSASQKKK 0.99298 -6.2352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6968 13.5433 18.7443 13.831 13.2268 13.4429 0 13.4813 0 12.7278 0 0 0 0 0 0 12.5936 0 0 0 0 0 17.7171 0 0 0 0 13.4718 0 0 0 0 0 0 0 0 13.1269 0 0 0 0 0 0 0 0 0 0 0 12.6917 0 0 0 0 0 13.0339 0 0 12.9241 0 0 13.9792 13.7101 0 0 0 0 13.3821 0 0 0 0 0 12.9343 0 0 0 0 0 13.4897 0 0 0 0 0 0 0 0 0 0 0 0 12.1369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15109 RAGE_HUMAN Advanced glycosylation end product-specific receptor (Receptor for advanced glycosylation end products) AGER RAGE Homo sapiens (Human) "astrocyte activation [GO:0048143]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; glucose mediated signaling pathway [GO:0010255]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; microglial cell activation [GO:0001774]; negative regulation of blood circulation [GO:1903523]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of long-term synaptic potentiation [GO:1900272]; neuron projection development [GO:0031175]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of chemokine production [GO:0032722]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tumor necrosis factor production [GO:0032760]; protein localization to membrane [GO:0072657]; regulation of CD4-positive, alpha-beta T cell activation [GO:2000514]; regulation of DNA binding [GO:0051101]; regulation of inflammatory response [GO:0050727]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of p38MAPK cascade [GO:1900744]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell mediated cytotoxicity [GO:0001914]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]" apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] "apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; advanced glycation end-product receptor activity [GO:0050785]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; S100 protein binding [GO:0044548]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; astrocyte activation [GO:0048143]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; glucose mediated signaling pathway [GO:0010255]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; microglial cell activation [GO:0001774]; negative regulation of blood circulation [GO:1903523]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of long-term synaptic potentiation [GO:1900272]; neuron projection development [GO:0031175]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of chemokine production [GO:0032722]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tumor necrosis factor production [GO:0032760]; protein localization to membrane [GO:0072657]; regulation of CD4-positive, alpha-beta T cell activation [GO:2000514]; regulation of DNA binding [GO:0051101]; regulation of inflammatory response [GO:0050727]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of p38MAPK cascade [GO:1900744]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell mediated cytotoxicity [GO:0001914]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]" GO:0001540; GO:0001650; GO:0001666; GO:0001774; GO:0001914; GO:0001934; GO:0004888; GO:0005044; GO:0005576; GO:0005886; GO:0005887; GO:0006954; GO:0007166; GO:0007611; GO:0009611; GO:0009986; GO:0010255; GO:0016324; GO:0030054; GO:0031175; GO:0032693; GO:0032722; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0034116; GO:0038023; GO:0042104; GO:0042802; GO:0043507; GO:0044548; GO:0044877; GO:0045056; GO:0046330; GO:0048143; GO:0048167; GO:0050727; GO:0050785; GO:0050930; GO:0051092; GO:0051101; GO:0070374; GO:0071639; GO:0072657; GO:0098794; GO:0150003; GO:0150104; GO:1900271; GO:1900272; GO:1900453; GO:1900744; GO:1900745; GO:1901222; GO:1901224; GO:1902961; GO:1903523; GO:1904472; GO:1904645; GO:1904646; GO:2000439; GO:2000514; GO:2001200 advanced glycation end-product receptor activity [GO:0050785]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; S100 protein binding [GO:0044548]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] VRVYQIPGK 0.99298 -6.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70EK9 UBP51_HUMAN "Ubiquitin carboxyl-terminal hydrolase 51, EC 3.4.19.12 (Deubiquitinating enzyme 51) (Ubiquitin thioesterase 51) (Ubiquitin-specific-processing protease 51)" USP51 Homo sapiens (Human) DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; protein deubiquitination [GO:0016579]; regulation of cell cycle process [GO:0010564]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of response to DNA damage stimulus [GO:2001020]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694] chromosome [GO:0005694]; chromatin binding [GO:0003682]; cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; protein deubiquitination [GO:0016579]; regulation of cell cycle process [GO:0010564]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of response to DNA damage stimulus [GO:2001020]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0003682; GO:0004843; GO:0005694; GO:0006281; GO:0006511; GO:0008270; GO:0010564; GO:0010569; GO:0016578; GO:0016579; GO:0042393; GO:2001020; GO:2001032 chromatin binding [GO:0003682]; cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] CNSCQSYQESTK 0.99298 -6.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1002 0 0 11.535 0 0 0 0 0 0 0 0 0 15.6162 0 0 16.4202 18.0972 0 13.5539 0 17.6028 0 0 14.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2003 13.7023 13.3365 0 13.5188 0 0 0 0 0 0 0 14.6592 13.3673 0 0 14.2728 16.8037 0 15.9589 0 0 14.9809 0 0 0 0 0 14.335 0 15.5301 0 0 0 0 0 15.827 0 14.1123 0 15.7333 0 15.6682 15.2 0 0 15.5906 0 0 0 0 0 15.2068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYE0 CC146_HUMAN Coiled-coil domain-containing protein 146 CCDC146 KIAA1505 Homo sapiens (Human) centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] GO:0005737; GO:0005814; GO:0005856 DDSTLSER 0.99298 -71.973 0 0 0 0 0 0 0 0 15.4749 13.5845 0 11.5346 14.5747 15.2452 0 11.7329 12.777 15.9412 0 0 0 0 0 0 0 0 0 0 0 12.2697 0 0 0 0 0 0 13.0854 0 0 16.1978 0 0 13.8829 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3421 0 0 0 16.932 0 0 15.1792 15.2451 0 0 14.3192 0 0 0 0 0 0 0 15.0049 0 12.505 0 0 12.6947 0 0 0 0 12.8991 0 0 0 12.7403 0 0 0 0 0 15.8344 12.9566 0 12.5166 0 14.7874 14.6875 0 0 12.3391 18.0688 0 0 12.2609 0 0 14.1219 0 12.7582 13.7073 14.5828 0 11.6915 0 0 11.3967 0 0 0 0 17.9342 0 0 0 12.7428 0 0 0 11.7292 0 0 0 0 0 0 0 13.1175 0 0 0 0 10.9771 10.5593 13.0869 0 0 0 0 0 0 0 13.0944 0 14.985 0 14.0755 12.5814 0 15.2902 13.2808 0 12.414 0 13.1105 13.6885 0 0 0 0 0 0 13.4824 0 13.9022 11.745 Q8N441 FGRL1_HUMAN "Fibroblast growth factor receptor-like 1, FGF receptor-like protein 1 (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5, FGFR-5)" FGFRL1 FGFR5 FHFR UNQ480/PRO943 Homo sapiens (Human) cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412] cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412] GO:0001501; GO:0003179; GO:0005007; GO:0005794; GO:0005886; GO:0008201; GO:0008285; GO:0016021; GO:0017134; GO:0030133; GO:0042802; GO:0044291; GO:0060412; GO:0060539; GO:0098742 fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] ARQDDAGMYICLGANTMGYSFR 0.99298 -24.186 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5959 0 0 0 0 0 0 0 10.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9841 0 0 0 0 13.5682 0 0 0 13.0185 13.0272 13.6862 0 0 0 12.1528 0 0 13.4901 0 0 14.4182 0 13.4844 0 0 0 13.8994 0 0 0 0 0 0 0 0 11.0506 0 0 0 0 0 0 0 0 0 15.489 0 0 13.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7343 0 0 0 0 13.5207 0 0 13.3414 0 13.2615 0 0 0 0 0 0 0 0 12.662 0 0 Q8NDT2 RB15B_HUMAN "Putative RNA-binding protein 15B (One-twenty two protein 3, HsOTT3, HuOTT3) (RNA-binding motif protein 15B)" RBM15B OTT3 Homo sapiens (Human) "dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]" nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]" GO:0000381; GO:0001510; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0009048; GO:0016607; GO:0036396 mRNA binding [GO:0003729]; RNA binding [GO:0003723] ALDYYGLYDDR 0.99298 -39.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0983 0 0 0 0 0 0 0 0 13.3001 0 0 0 0 0 0 13.2317 0 11.6546 12.0612 0 0 0 0 13.9154 0 12.6812 0 13.0367 0 0 0 12.3977 0 14.1487 0 0 0 0 11.3004 10.9595 0 0 0 0 0 11.1671 0 0 0 0 11.1154 0 12.7292 0 0 0 12.923 10.8567 0 0 12.3445 10.6828 0 12.1644 0 0 0 0 12.2177 12.4 11.7849 0 0 0 0 0 0 0 14.646 0 11.4066 0 0 0 0 0 0 0 15.1587 0 0 0 0 0 0 14.6516 0 0 0 0 15.2149 14.8584 0 0 12.2615 0 15.2499 10.4667 0 0 0 Q93099 HGD_HUMAN "Homogentisate 1,2-dioxygenase, EC 1.13.11.5 (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)" HGD HGO Homo sapiens (Human) L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572]" GO:0004411; GO:0005829; GO:0006559; GO:0006572; GO:0042802; GO:0046872; GO:0070062 "homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" CWEPLKSHFTPNSR 0.99298 -16.443 0 0 12.6725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6023 0 12.2928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4171 0 0 0 10.9861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.048 0 0 0 0 0 0 0 0 0 13.0825 0 0 14.1903 0 0 0 0 14.2223 0 0 0 0 15.5669 0 0 0 15.2338 0 13.8382 0 0 0 13.6095 0 0 12.8208 0 0 0 0 0 0 0 0 0 0 12.4319 0 0 0 13.4155 0 0 14.019 12.8135 0 12.8351 0 0 13.537 12.8598 0 12.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4146 0 0 0 0 0 0 0 Q96NW4 ANR27_HUMAN Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) ANKRD27 PP12899 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422] cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031] GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0016020; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0043231; GO:0045022; GO:0048812; GO:0050775; GO:0097422 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149] DSHLKMLAK 0.99298 -16.442 0 0 0 0 0 9.74421 0 0 12.5705 0 11.1506 0 11.2222 0 12.4718 0 0 0 11.729 0 0 0 0 0 10.3384 9.88586 0 0 10.8128 0 0 0 10.0055 11.5854 10.8221 0 0 0 0 0 0 0 12.3339 11.872 0 0 0 0 0 12.6876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.088 14.2411 11.5203 0 0 0 11.3377 0 12.5932 12.5302 11.5826 0 0 0 0 12.4168 13.4432 0 0 0 0 11.3526 12.1396 11.3752 0 15.1145 0 0 0 0 0 0 0 0 0 0 0 11.7338 12.9143 11.3491 0 0 14.3737 0 11.5149 0 0 0 0 0 0 11.163 12.0322 18.511 0 0 0 0 11.7232 0 12.1127 0 0 0 0 0 0 0 11.5929 0 14.1075 0 12.9962 0 14.3291 0 13.8689 11.3573 0 0 12.7889 12.3472 0 11.7082 0 0 0 0 0 0 0 13.5543 13.5729 13.8376 0 0 0 0 0 0 0 0 12.8344 Q96PV0 SYGP1_HUMAN "Ras/Rap GTPase-activating protein SynGAP (Neuronal RasGAP) (Synaptic Ras GTPase-activating protein 1, Synaptic Ras-GAP 1)" SYNGAP1 KIAA1938 Homo sapiens (Human) axonogenesis [GO:0007409]; dendrite development [GO:0016358]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of axonogenesis [GO:0050771]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; neuron apoptotic process [GO:0051402]; pattern specification process [GO:0007389]; Ras protein signal transduction [GO:0007265]; receptor clustering [GO:0043113]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytosol [GO:0005829]; dendritic shaft [GO:0043198]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; axonogenesis [GO:0007409]; dendrite development [GO:0016358]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of axonogenesis [GO:0050771]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; neuron apoptotic process [GO:0051402]; pattern specification process [GO:0007389]; Ras protein signal transduction [GO:0007265]; receptor clustering [GO:0043113]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of MAPK cascade [GO:0043408]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542] GO:0005096; GO:0005829; GO:0005886; GO:0007265; GO:0007389; GO:0007409; GO:0008542; GO:0014069; GO:0016358; GO:0017124; GO:0043087; GO:0043113; GO:0043198; GO:0043408; GO:0043524; GO:0046580; GO:0048167; GO:0048169; GO:0050771; GO:0050803; GO:0051402; GO:0098880; GO:0098978 GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] AIEEYMR 0.99298 -39.856 0 0 0 0 13.831 0 11.6258 0 0 0 11.6452 0 0 0 0 0 0 0 0 12.2734 0 0 0 11.8761 0 0 0 0 0 0 11.607 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5567 0 11.7823 0 12.6143 0 0 0 14.3809 0 14.0896 14.5091 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4614 0 0 0 0 0 0 16.4416 0 0 0 0 0 0 13.2897 14.0894 0 13.1521 14.4589 0 12.0435 0 12.6634 13.1918 13.5183 0 0 12.3929 11.938 0 12.3857 0 0 0 0 13.3716 14.0928 12.7833 12.6596 0 0 0 0 0 0 0 0 0 0 13.3794 0 0 0 13.8632 13.423 0 0 0 12.8053 11.0165 12.5377 14.0392 11.9277 12.6803 14.8627 0 14.9085 10.8865 0 0 12.2309 0 11.7864 0 0 0 0 0 0 Q9BS16 CENPK_HUMAN "Centromere protein K, CENP-K (Interphase centromere complex protein 37) (Protein AF-5alpha) (p33)" CENPK ICEN37 FKSG14 Homo sapiens (Human) kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; kinetochore assembly [GO:0051382]; mitotic sister chromatid segregation [GO:0000070] GO:0000070; GO:0000776; GO:0005654; GO:0005829; GO:0051382 ECEEMWK 0.99298 -16.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0404 0 15.9193 13.5203 0 0 0 0 0 0 0 0 0 12.7483 0 0 0 0 0 0 0 0 0 12.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0669 0 0 0 0 0 0 0 0 0 0 0 0 10.6001 0 0 0 0 0 0 13.6892 0 0 0 0 0 Q9BTY2 FUCO2_HUMAN "Plasma alpha-L-fucosidase, EC 3.2.1.51 (Alpha-L-fucoside fucohydrolase 2, Alpha-L-fucosidase 2)" FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617] azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617] GO:0004560; GO:0005576; GO:0005615; GO:0005764; GO:0005788; GO:0006004; GO:0009617; GO:0016139; GO:0035578; GO:0070062; GO:2000535 alpha-L-fucosidase activity [GO:0004560] DNYPPSFKYEDFGPLFTAK 0.99298 -14.612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1292 0 0 0 0 0 0 0 0 0 0 14.6074 0 0 0 13.3339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9081 0 0 0 0 0 0 0 0 0 0 0 Q9BXX3 AN30A_HUMAN Ankyrin repeat domain-containing protein 30A (Serologically defined breast cancer antigen NY-BR-1) ANKRD30A Homo sapiens (Human) ANCGMKVSIPTK 0.99298 -24.192 0 0 11.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.918 0 0 0 0 0 0 0 0 0 0 14.5803 15.4348 11.9391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4568 13.0259 12.6856 0 0 0 0 0 13.8981 0 0 0 13.6388 0 14.6568 0 18.6384 0 0 0 0 0 0 0 0 0 0 0 0 18.7061 0 0 0 10.391 0 14.2752 0 0 0 11.2018 14.484 14.0022 0 0 0 0 0 0 0 13.0133 0 11.1081 0 0 12.4682 0 0 0 0 0 0 0 0 0 11.6237 11.9234 11.2597 0 0 0 0 0 0 0 0 0 0 13.4776 0 0 16.0888 0 0 13.7225 13.3228 0 0 0 11.871 0 0 0 0 0 12.3984 0 0 0 0 0 0 0 10.0576 0 0 0 0 12.7159 0 0 0 0 0 Q9H0B6 KLC2_HUMAN "Kinesin light chain 2, KLC 2" KLC2 Homo sapiens (Human) lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018] GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0016020; GO:0016938; GO:0019894; GO:0032418; GO:0032991; GO:0043005; GO:0045296 cadherin binding [GO:0045296]; kinesin binding [GO:0019894] DHPAVAATLNNLAVLYGKRGK 0.99298 -16.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4902 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0C2 ADT4_HUMAN "ADP/ATP translocase 4 (ADP,ATP carrier protein 4) (Adenine nucleotide translocator 4, ANT 4) (Solute carrier family 25 member 31) (Sperm flagellar energy carrier protein)" SLC25A31 AAC4 ANT4 SFEC Homo sapiens (Human) cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; regulation of mitochondrial membrane permeability [GO:0046902]; spermatogenesis [GO:0007283] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886] membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP:ADP antiporter activity [GO:0005471]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; regulation of mitochondrial membrane permeability [GO:0046902]; spermatogenesis [GO:0007283] GO:0005471; GO:0005634; GO:0005739; GO:0005743; GO:0005757; GO:0005886; GO:0007141; GO:0007283; GO:0016020; GO:0030154; GO:0031514; GO:0046902; GO:0140021; GO:1901029; GO:1990544 ATP:ADP antiporter activity [GO:0005471] GLLPKPK 0.99298 -16.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3293 0 0 0 0 0 0 0 0 0 0 15.7623 0 0 0 0 0 0 0 13.7576 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2785 14.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2062 0 0 0 15.3294 12.6576 0 0 0 0 0 12.4884 15.6639 0 0 15.5425 13.9802 0 0 0 0 0 0 0 0 0 0 16.2158 0 0 Q9H7E2 TDRD3_HUMAN Tudor domain-containing protein 3 TDRD3 Homo sapiens (Human) chromatin organization [GO:0006325]; DNA topological change [GO:0006265] cytosol [GO:0005829]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; DNA topoisomerase III-beta-TDRD3 complex [GO:0140225]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; DNA topological change [GO:0006265] GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006265; GO:0006325; GO:0035064; GO:0140225 chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] FQRDSQNSK 0.99298 -16.476 0 0 0 0 0 0 0 10.0856 0 0 0 0 0 0 0 0 10.8588 0 12.6786 0 0 9.8268 0 0 11.0819 12.6399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5281 0 0 0 0 0 0 0 0 0 13.1343 0 0 13.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5234 0 0 12.0477 0 0 0 0 13.7646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3727 0 0 0 0 0 0 0 0 11.789 0 0 0 0 0 0 0 11.2599 0 0 0 0 0 0 0 0 0 0 0 0 12.5476 0 0 0 0 11.1411 0 0 14.9192 0 11.2973 12.8588 0 0 10.9495 0 0 0 0 0 0 0 0 12.6028 0 11.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7596 0 0 0 0 0 0 0 0 12.8515 0 Q9UHK0 NUFP1_HUMAN FMR1-interacting protein NUFIP1 (Nuclear FMR1-interacting protein 1) (Nuclear FMRP-interacting protein 1) NUFIP1 Homo sapiens (Human) box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA processing [GO:0006396] fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; transcription elongation factor complex [GO:0008023] fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; transcription elongation factor complex [GO:0008023]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA processing [GO:0006396] GO:0000492; GO:0001650; GO:0003723; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0006396; GO:0008023; GO:0016363; GO:0030674; GO:0032991; GO:0042802; GO:0045944; GO:0046872; GO:0048786; GO:0051117; GO:0070761 ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] EPVFHFFCDTCDR 0.99298 -6.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5217 0 0 0 0 14.6186 14.0904 0 0 0 0 0 0 0 0 0 0 0 13.5377 0 0 0 0 14.0411 0 0 0 0 0 0 0 13.8251 13.5956 0 0 14.3142 0 0 11.3675 0 0 14.0836 0 0 14.1144 0 0 0 0 12.9003 0 0 11.8689 0 0 14.6126 0 11.0767 0 0 0 0 0 0 15.0961 0 0 0 0 0 0 0 14.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4953 0 Q9Y4K4 M4K5_HUMAN "Mitogen-activated protein kinase kinase kinase kinase 5, EC 2.7.11.1 (Kinase homologous to SPS1/STE20, KHS) (MAPK/ERK kinase kinase kinase 5, MEK kinase kinase 5, MEKKK 5)" MAP4K5 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0008349; GO:0035556; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ARNVHTGELAAVKIIK 0.99298 -16.469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9905 0 0 13.6498 0 0 0 13.1951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5879 0 13.5421 0 13.317 0 0 0 0 0 0 0 12.8696 0 0 0 0 0 0 0 0 13.9672 0 0 0 14.4095 13.9794 0 0 14.2569 0 12.4007 0 14.555 14.8012 0 15.7394 0 0 0 0 0 15.1204 14.8164 0 0 0 0 0 15.6131 14.3208 0 14.938 0 0 0 0 12.0102 0 0 0 0 0 11.0774 12.3811 13.2452 0 0 0 0 0 0 15.0297 0 0 0 19.5211 0 Q9Y5E4 PCDB5_HUMAN "Protocadherin beta-5, PCDH-beta-5" PCDHB5 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] ELLQLDIK 0.99298 -16.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1941 11.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6119 0 0 0 0 0 0 0 0 0 0 0 13.0577 0 0 0 0 12.8455 13.5798 0 0 12.7599 0 0 13.5254 0 0 0 0 0 0 0 0 0 0 Q9Y5G0 PCDGH_HUMAN "Protocadherin gamma-B5, PCDH-gamma-B5" PCDHGB5 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0070062 calcium ion binding [GO:0005509] EKQDGSK 0.99298 -16.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GVN3 CB092_HUMAN Uncharacterized protein C2orf92 (Long intergenic non-protein coding RNA 1125) C2orf92 LINC01125 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EEHLAKIFDEILLQVFPKFPYDPSFNEATAVR 0.99299 -16.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5441 0 0 0 0 0 0 0 0 16.7656 0 0 16.2074 0 0 12.36 0 0 0 0 0 13.5184 0 0 0 0 0 0 0 0 13.0197 0 0 14.1535 0 0 0 0 0 0 13.366 13.6867 0 14.3105 13.1614 14.1706 0 0 0 0 0 0 0 13.4601 0 0 0 13.098 0 0 13.1504 0 0 0 0 0 14.8781 15.1069 0 0 14.3693 0 0 0 13.6818 0 12.7476 11.2339 0 0 0 0 0 0 0 0 11.8844 0 10.8813 12.8641 0 0 0 0 0 0 11.9026 0 0 0 0 12.8966 0 12.7922 0 0 A4D1P6 WDR91_HUMAN WD repeat-containing protein 91 WDR91 HSPC049 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein catabolic process [GO:0042176] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein catabolic process [GO:0042176] GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0042176; GO:0043551; GO:0045022 phosphatidylinositol 3-kinase regulator activity [GO:0035014] DPTSGAK 0.99299 -13.271 0 0 12.5913 0 0 0 0 10.6689 13.4034 14.1206 0 0 0 0 0 0 12.0281 0 12.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2638 0 0 12.8898 0 13.0463 0 0 12.7401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7328 0 0 0 0 0 0 0 0 0 0 0 13.2349 0 13.4476 0 13.461 0 0 0 0 0 0 0 0 0 13.4612 0 13.3305 0 12.5246 11.9781 14.8784 0 0 0 0 15.2091 0 14.4652 0 16.119 0 12.9425 13.7245 0 0 0 13.8838 13.0478 0 0 0 0 13.4637 0 13.5463 13.6466 13.6927 14.901 13.2253 0 0 0 11.8696 0 0 0 0 0 0 0 13.1182 0 14.5915 0 0 0 0 0 0 12.9372 14.3859 13.9698 12.6544 0 13.9448 0 0 13.4453 0 0 0 0 0 11.8574 0 0 0 13.3711 0 0 0 12.6629 11.5905 0 0 0 0 0 0 0 0 0 P09871 C1S_HUMAN "Complement C1s subcomponent, EC 3.4.21.42 (C1 esterase) (Complement component 1 subcomponent s) [Cleaved into: Complement C1s subcomponent heavy chain; Complement C1s subcomponent light chain ]" C1S Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]" blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; proteolysis [GO:0006508]" GO:0004252; GO:0005509; GO:0005576; GO:0005602; GO:0005615; GO:0006508; GO:0006958; GO:0042802; GO:0045087; GO:0072562 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252] AARLPVAPLR 0.99299 -16.492 0 0 0 0 0 0 0 0 0 13.9195 0 0 0 14.7107 0 0 0 0 14.0968 0 0 0 0 0 0 0 0 0 0 0 0 15.2125 0 0 0 0 0 0 0 15.0786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3563 0 15.0108 0 15.4763 0 0 0 0 14.3829 0 0 0 0 0 15.4989 0 0 0 0 0 0 0 15.3859 14.2902 0 0 14.0322 13.9883 13.6981 0 0 0 0 14.8763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.101 0 14.4617 0 14.2267 0 13.8577 0 P48556 PSMD8_HUMAN 26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31) PSMD8 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0022624; GO:0043161 ATRGGLR 0.99299 -14.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7157 0 0 0 0 0 0 0 0 0 11.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2925 0 0 0 0 14.9637 0 0 0 0 0 0 16.0616 0 0 0 0 0 0 13.4441 0 0 0 0 12.6027 0 0 0 0 0 0 13.6201 0 0 15.8742 0 0 0 0 0 0 0 13.146 0 14.8606 0 0 12.8928 0 0 14.5531 12.8975 13.6191 14.1311 12.8849 14.5208 0 0 0 0 0 0 15.9738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9328 0 0 0 0 0 14.8807 15.2448 13.0537 0 13.1766 14.6563 0 0 0 10.1097 0 0 0 0 0 0 0 14.531 0 0 0 P49848 TAF6_HUMAN "Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit, TAF(II)70, TAFII-70, TAFII70) (Transcription initiation factor TFIID 80 kDa subunit, TAF(II)80, TAFII-80, TAFII80)" TAF6 TAF2E TAFII70 Homo sapiens (Human) "apoptotic process [GO:0006915]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006468; GO:0006915; GO:0008285; GO:0016251; GO:0017162; GO:0032991; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0043065; GO:0043966; GO:0045786; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:0060261; GO:0071339; GO:2001244 aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713] FASGGGR 0.99299 -26.46 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1428 0 11.8662 0 0 0 0 0 0 0 0 13.1331 0 0 0 0 10.744 0 0 0 0 12.7794 11.3085 0 0 0 0 0 0 0 0 0 0 12.567 0 0 0 0 0 0 14.1383 12.0465 12.5933 13.0078 0 0 0 0 0 0 0 11.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0235 0 0 11.4004 12.3255 0 11.0932 0 10.9385 0 0 0 P56937 DHB7_HUMAN "3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (17-beta-hydroxysteroid dehydrogenase 7, 17-beta-HSD 7) (3-keto-steroid reductase, EC 1.1.1.270) (Dihydrotestosterone oxidoreductase, EC 1.1.1.210) (Estradiol 17-beta-dehydrogenase 7, EC 1.1.1.62) (Short chain dehydrogenase/reductase family 37C member 1)" HSD17B7 17HSD7 SDR37C1 UNQ2563/PRO6243 Homo sapiens (Human) androgen metabolic process [GO:0008209]; cholesterol biosynthetic process [GO:0006695]; estrogen biosynthetic process [GO:0006703]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-keto sterol reductase activity [GO:0000253]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; cycloeucalenone reductase activity [GO:0102176]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; androgen metabolic process [GO:0008209]; cholesterol biosynthetic process [GO:0006695]; estrogen biosynthetic process [GO:0006703]; sterol metabolic process [GO:0016125]" GO:0000253; GO:0004303; GO:0005789; GO:0006695; GO:0006703; GO:0008209; GO:0016021; GO:0016125; GO:0047024; GO:0102176 "3-keto sterol reductase activity [GO:0000253]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; cycloeucalenone reductase activity [GO:0102176]; estradiol 17-beta-dehydrogenase activity [GO:0004303]" EPYSSSK 0.99299 -5.2288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5069 0 0 0 0 0 0 0 14.0268 0 12.6085 13.8361 14.0755 14.0321 0 0 0 0 0 0 11.663 13.7029 13.8253 0 0 0 0 13.2303 0 13.108 0 0 0 13.6417 10.0611 0 0 0 0 13.6599 0 0 0 0 0 0 0 13.4011 13.5571 0 0 0 0 0 0 0 13.0034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6FHJ7 SFRP4_HUMAN "Secreted frizzled-related protein 4, sFRP-4 (Frizzled protein, human endometrium, FrpHE)" SFRP4 FRPHE Homo sapiens (Human) bone morphogenesis [GO:0060349]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of sodium-dependent phosphate transport [GO:2000119]; negative regulation of Wnt signaling pathway [GO:0030178]; phosphate ion homeostasis [GO:0055062]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of receptor internalization [GO:0002092]; regulation of BMP signaling pathway [GO:0030510]; response to hormone [GO:0009725] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; Wnt-protein binding [GO:0017147]; bone morphogenesis [GO:0060349]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of sodium-dependent phosphate transport [GO:2000119]; negative regulation of Wnt signaling pathway [GO:0030178]; phosphate ion homeostasis [GO:0055062]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of receptor internalization [GO:0002092]; regulation of BMP signaling pathway [GO:0030510]; response to hormone [GO:0009725] GO:0002092; GO:0005615; GO:0005634; GO:0005737; GO:0008285; GO:0009725; GO:0009986; GO:0010628; GO:0017147; GO:0030154; GO:0030178; GO:0030510; GO:0043065; GO:0043433; GO:0045606; GO:0055062; GO:0060070; GO:0060349; GO:0090090; GO:0090263; GO:1902174; GO:2000051; GO:2000119 Wnt-protein binding [GO:0017147] FLSILVALCLWLHLALGVR 0.99299 -17.4 0 0 0 0 0 0 0 0 13.8092 13.9552 13.9576 13.9297 13.0731 13.4851 13.3284 0 0 10.4018 0 0 0 0 0 0 0 0 0 0 0 14.4054 0 13.3001 13.4404 13.237 13.7057 0 14.0986 13.6442 0 12.5422 0 13.0459 0 0 0 0 13.9051 13.2853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.311 0 0 14.1978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.495 0 0 0 0 0 11.8953 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4939 0 0 0 0 11.8229 0 0 0 12.5838 0 0 0 13.8394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GE4 CEP95_HUMAN "Centrosomal protein of 95 kDa, Cep95 (Coiled-coil domain-containing protein 45)" CEP95 CCDC45 CEP45 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] GO:0000922; GO:0005737; GO:0005813 HDLLTTLVKK 0.99299 -16.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0543 0 0 0 0 0 0 10.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9778 0 0 15.873 0 13.3906 0 0 11.6917 13.9724 14.0543 15.3218 0 13.9611 0 0 13.3487 0 0 0 0 0 0 0 0 14.6239 0 0 0 0 0 0 0 15.5009 13.2822 0 0 13.7818 0 0 0 0 14.1781 13.421 0 12.9031 0 0 11.4911 0 0 0 12.9833 0 0 0 0 0 0 0 0 0 0 0 14.6885 12.6667 0 0 0 0 0 0 18.5645 12.467 0 0 0 0 0 12.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6648 0 0 0 0 12.7392 0 0 0 Q9H1K0 RBNS5_HUMAN Rabenosyn-5 (110 kDa protein) (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20) RBSN ZFYVE20 Homo sapiens (Human) early endosome to Golgi transport [GO:0034498]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; early endosome to Golgi transport [GO:0034498]; endosomal transport [GO:0016197]; Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031]; regulation of Golgi organization [GO:1903358] GO:0005768; GO:0005829; GO:0005886; GO:0008270; GO:0010008; GO:0015031; GO:0016197; GO:0031267; GO:0031901; GO:0034498; GO:0043231; GO:0070062; GO:0090160; GO:1903358 small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] DVKGQIKSLVQK 0.99299 -14.65 0 14.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1488 0 0 0 0 0 13.6096 0 0 0 0 11.5631 0 0 0 0 0 15.6258 12.3383 0 0 0 0 13.1776 12.4651 0 0 0 0 12.2605 0 0 0 10.3561 0 0 0 9.52158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0555 11.6563 0 0 0 0 0 0 0 13.5072 13.577 0 13.784 0 0 0 0 0 0 0 0 13.0101 0 14.2406 0 0 0 0 0 0 0 0 0 0 14.1944 12.5628 0 0 0 11.4825 0 0 0 13.9756 0 0 0 0 0 0 0 0 13.4397 0 0 0 0 12.8012 10.4484 0 0 14.1187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.382 0 0 0 0 0 0 14.5186 0 0 0 13.4684 12.4334 0 0 0 0 0 Q9HCG7 GBA2_HUMAN "Non-lysosomal glucosylceramidase, NLGase, EC 3.2.1.45 (Beta-glucocerebrosidase 2, Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2, EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2, EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase, EC 3.2.1.46) (Non-lysosomal glycosylceramidase)" GBA2 KIAA1605 SPG46 AD035 Homo sapiens (Human) bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113] cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; extrinsic component of Golgi membrane [GO:0090498]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295]; bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113] GO:0004336; GO:0004348; GO:0005790; GO:0005829; GO:0005886; GO:0005975; GO:0006680; GO:0006687; GO:0007417; GO:0008203; GO:0008206; GO:0008422; GO:0016021; GO:0016139; GO:0019898; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0042406; GO:0046527; GO:0050295; GO:0090498; GO:0097035 beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295] AMGYQVPPFGWRICLAHEFTEK 0.99299 -14.311 10.8979 0 0 0 0 0 0 0 0 0 0 0 0 11.2502 0 0 0 0 0 0 0 12.0677 0 12.9363 0 0 0 0 0 11.2216 0 0 0 0 0 0 0 0 0 0 0 0 10.9411 0 0 0 0 0 0 0 0 0 0 0 11.991 11.7365 12.2018 11.6126 0 11.0189 11.0631 0 0 0 0 0 0 0 0 0 13.5059 17.3643 0 0 14.9954 15.3455 15.1946 15.53 15.4252 14.8669 16.2767 14.5989 14.9539 13.6783 0 0 15.6776 0 14.924 15.6226 0 13.9966 16.403 15.9079 15.7992 0 14.6108 0 13.6688 14.9559 15.585 15.3701 15.44 0 15.7437 14.2508 14.7775 0 15.1886 15.8066 0 0 14.5069 13.9184 14.1943 14.2772 0 0 18.5153 14.045 12.7768 18.0762 14.919 11.2699 14.7115 13.8528 0 0 14.3952 15.4534 18.4251 0 16.1634 15.0885 15.8986 14.7582 15.4699 0 0 14.2842 13.8259 14.1653 0 18.2078 0 0 15.6665 0 14.7038 14.242 14.8628 15.7327 14.1954 18.9864 0 0 15.9941 0 0 0 0 0 14.2457 14.2785 14.3665 14.0835 0 0 0 0 0 11.6995 0 14.2171 14.3784 14.1368 0 14.467 15.9505 0 Q9Y2D9 ZN652_HUMAN Zinc finger protein 652 ZNF652 KIAA0924 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CENCDERFQYK 0.99299 -26.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3888 13.4846 13.3993 0 13.5863 0 0 0 0 0 0 0 0 0 0 0 14.5573 15.0052 0 0 0 0 13.4783 12.5751 14.5465 0 0 13.3967 0 0 0 0 0 0 0 0 13.2268 0 13.2441 0 0 0 13.8571 13.2567 0 0 0 0 0 0 0 0 15.2677 0 0 0 0 13.2029 0 0 0 13.9352 0 0 0 0 0 0 0 0 0 0 0 0 10.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2H2 SAC2_HUMAN "Phosphatidylinositide phosphatase SAC2, EC 3.1.3.25 (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2, hSAC2)" INPP5F KIAA0966 SAC2 MSTP007 MSTP047 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896] axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037] axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896] GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0008934; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0033137; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0051896; GO:0052832; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135 inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803] ALWCSRRDGGLQLR 0.99299 -16.971 0 0 0 0 0 0 0 0 11.8525 14.2626 0 0 0 14.5205 0 0 0 0 0 10.4811 0 0 0 0 0 0 0 0 0 0 0 13.5975 0 14.783 0 0 0 12.7714 12.7861 0 0 0 0 0 14.0981 14.8828 0 0 0 0 13.6783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0471 13.6535 0 13.999 0 12.0885 0 15.6505 0 0 0 0 12.9605 0 0 0 0 0 0 0 0 0 0 0 13.9936 0 0 0 0 0 0 0 14.1255 0 14.7993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2304 0 0 0 0 0 11.3517 0 0 11.3045 0 12.6813 0 0 0 0 0 0 0 0 0 0 11.7618 0 0 0 0 0 0 0 0 0 0 13.8032 0 12.2119 0 0 0 13.9219 0 13.9606 0 11.1022 0 0 13.407 0 0 0 0 0 0 0 0 Q9Y4K0 LOXL2_HUMAN "Lysyl oxidase homolog 2, EC 1.4.3.13 (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14)" LOXL2 Homo sapiens (Human) "aging [GO:0007568]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein modification process [GO:0036211]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]" basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; aging [GO:0007568]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein modification process [GO:0036211]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]" GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005044; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005654; GO:0005783; GO:0007155; GO:0007568; GO:0009055; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0036211; GO:0043542; GO:0045892; GO:0046688; GO:0062023; GO:0070492; GO:0070828; GO:1902455 calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044] KLRLNGGR 0.99299 -26.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3219 14.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5H7 PCDA5_HUMAN "Protocadherin alpha-5, PCDH-alpha-5" PCDHA5 CNRS6 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] EELCRRR 0.99299 -26.509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1721 0 0 0 0 0 0 0 0 0 13.6921 0 0 0 13.1948 0 11.9909 13.7548 14.2329 14.0541 13.9624 0 0 0 0 0 0 14.9364 0 0 0 12.7977 11.8512 0 0 0 0 0 0 12.7901 0 0 0 0 14.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0036 0 0 0 0 0 0 0 0 0 0 14.9345 15.9437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00391 QSOX1_HUMAN "Sulfhydryl oxidase 1, hQSOX, EC 1.8.3.2 (Quiescin Q6)" QSOX1 QSCN6 UNQ2520/PRO6013 Homo sapiens (Human) extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]; protein folding [GO:0006457] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; FAD binding [GO:0071949]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]; extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]; protein folding [GO:0006457] GO:0000139; GO:0003756; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0006457; GO:0016242; GO:0016971; GO:0030173; GO:0031093; GO:0035580; GO:0043231; GO:0045171; GO:0070062; GO:0071949; GO:0085029; GO:1904724 FAD binding [GO:0071949]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756] DFNIPGFPTVR 0.993 -5.2442 0 0 0 0 0 0 0 10.1094 14.3834 14.052 14.217 13.3515 13.4197 12.7396 13.7048 13.4996 0 13.6694 13.6312 0 15.6648 0 0 0 12.5072 11.423 14.3168 0 14.1964 12.4089 14.3784 14.1253 15.2361 15.1843 16.0008 15.0983 14.7897 15.1358 15.258 13.8298 14.9283 12.9585 14.6757 13.9643 12.8282 13.6449 14.0829 14.2529 0 9.86144 0 0 0 0 0 0 0 0 11.5027 0 0 0 0 0 0 0 0 0 0 13.6111 0 12.742 0 0 0 0 10.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1577 0 0 0 0 10.6924 0 0 0 0 12.9344 0 0 0 0 0 0 14.592 14.1887 15.5026 14.26 14.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5968 0 0 14.095 15.3936 0 0 0 0 0 0 14.1963 11.946 0 0 0 0 0 0 14.1974 0 0 0 0 0 14.3308 0 0 14.8954 15.998 14.9239 14.7128 13.1988 14.6379 0 12.7815 0 12.9676 13.7033 14.3184 14.787 13.314 14.8405 0 12.39 14.843 12.9363 0 13.8668 0 0 A6NDA9 LRIT2_HUMAN "Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 (Leucine-rich repeat-containing protein 22)" LRIT2 LRRC22 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ATPLLRVLDLKR 0.993 -13.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1235 0 0 0 0 0 0 11.4223 0 0 0 0 12.6615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7009 0 0 0 0 0 0 0 0 11.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0522 0 12.7524 0 12.876 0 0 12.1357 0 0 0 0 0 11.6667 0 0 0 0 0 12.1868 0 0 12.0383 0 13.222 0 0 11.9599 0 12.4858 10.8571 0 0 0 0 0 0 0 0 12.5334 13.0949 0 0 0 12.5596 0 0 0 11.9301 0 0 12.0279 0 14.5284 0 0 12.8271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0224 0 O94903 PLPHP_HUMAN "Pyridoxal phosphate homeostasis protein, PLP homeostasis protein (Proline synthase co-transcribed bacterial homolog protein) (Pyridoxal phosphate-binding protein)" PLPBP PROSC Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; pyridoxal phosphate binding [GO:0030170] GO:0005737; GO:0005829; GO:0030170 pyridoxal phosphate binding [GO:0030170] DLPAIQPR 0.993 -6.2775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5848 13.7712 0 0 0 0 0 13.3806 13.4855 0 13.1285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.546 13.6964 0 14.0818 14.795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6001 0 0 0 0 0 0 0 11.8014 0 0 0 0 0 0 13.4597 0 0 0 0 0 0 0 0 0 0 12.9302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7669 0 0 0 0 0 0 0 0 P24347 MMP11_HUMAN "Stromelysin-3, SL-3, ST3, EC 3.4.24.- (Matrix metalloproteinase-11, MMP-11)" MMP11 STMY3 Homo sapiens (Human) basement membrane organization [GO:0071711]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of fat cell differentiation [GO:0045599]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; basement membrane organization [GO:0071711]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of fat cell differentiation [GO:0045599]; proteolysis [GO:0006508] GO:0004222; GO:0004252; GO:0005576; GO:0005796; GO:0006508; GO:0008270; GO:0022617; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0045599; GO:0071711 metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] ALMSAFYTFR 0.993 -14.684 0 0 0 0 0 0 0 0 12.3557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6467 10.4763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2766 0 0 14.5073 14.6019 0 14.6424 15.4924 0 14.2656 0 0 13.7432 12.3366 13.9842 0 0 0 0 0 16.054 16.191 0 13.1876 12.5833 0 0 0 0 0 0 0 11.2371 0 0 0 14.915 0 0 0 0 0 14.05 0 14.9663 0 0 0 0 13.1938 0 12.9444 0 0 0 0 0 0 0 0 0 14.6161 0 12.8182 12.389 0 0 12.5562 0 11.1098 0 0 0 0 0 0 0 0 0 12.6436 12.0311 0 0 0 0 12.2121 15.7616 0 0 0 0 0 0 0 0 0 0 11.5219 0 11.3746 0 P25100 ADA1D_HUMAN "Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor, Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a)" ADRA1D ADRA1A Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron-glial cell signaling [GO:0150099]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907] GO:0001996; GO:0004930; GO:0004937; GO:0005886; GO:0005887; GO:0007186; GO:0007188; GO:0007200; GO:0007204; GO:0007267; GO:0008284; GO:0042802; GO:0043410; GO:0045907; GO:0071880; GO:0150099 alpha1-adrenergic receptor activity [GO:0004937]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802] AAAILALLWVVALVVSVGPLLGWK 0.993 -16.979 0 0 0 0 0 0 0 0 10.8496 10.9579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0127 0 0 0 0 0 0 0 0 0 0 0 0 14.5683 0 0 13.1906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6927 0 0 0 14.4438 0 0 0 13.4732 11.9691 0 15.1463 0 12.6608 0 0 0 14.1676 0 0 14.1534 14.1362 10.3755 0 0 0 0 0 0 10.9857 0 0 13.9757 0 0 14.0882 14.4141 14.942 0 13.3344 12.91 0 0 0 13.4837 0 0 0 0 0 0 0 0 0 0 13.61 0 0 0 0 12.2948 0 11.8342 12.5968 11.4303 0 0 12.4875 10.6006 0 0 0 0 12.2039 13.8532 0 0 0 0 0 0 P31689 DNJA1_HUMAN "DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2, HSJ-2) (Human DnaJ protein 2, hDj-2)" DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4 Homo sapiens (Human) androgen receptor signaling pathway [GO:0030521]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; protein refolding [GO:0042026]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; protein refolding [GO:0042026]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998] GO:0001664; GO:0001671; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0015630; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042026; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051082; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259 ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] CEGRGGK 0.993 -26.698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7431 14.5194 0 0 0 12.4486 12.5982 13.6549 12.2129 10.5609 11.572 0 0 0 11.7811 11.7233 12.7847 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4075 14.0063 11.7047 0 0 0 0 0 0 13.9274 0 0 0 0 0 0 13.4588 13.1779 13.6879 0 0 0 13.7102 15.168 0 15.6712 15.8849 15.051 0 0 0 0 0 0 15.3943 0 0 0 0 0 0 10.5204 0 0 0 14.5953 0 0 14.3768 12.4743 14.9053 14.8577 15.1782 0 0 0 0 0 0 0 15.1073 15.4217 15.0839 15.118 12.0837 0 0 14.9454 15.3588 15.0415 15.3377 12.7481 15.3131 0 0 0 0 0 0 0 13.5037 0 0 0 0 0 0 0 0 0 14.674 0 12.4093 0 0 13.8696 0 0 14.7645 0 12.5862 0 0 0 P51798 CLCN7_HUMAN "H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7, ClC-7)" CLCN7 Homo sapiens (Human) response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321] chloride channel complex [GO:0034707]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] chloride channel complex [GO:0034707]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247]; response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321] GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0015108; GO:0015297; GO:0016020; GO:0030321; GO:0031410; GO:0034707; GO:0043231 antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247] CFLNGVK 0.993 -26.643 0 0 0 0 0 0 11.7182 0 0 0 0 0 0 12.8342 0 0 0 0 0 0 0 13.2261 11.0707 12.1501 12.5373 0 13.0044 11.7773 0 0 0 0 0 0 0 0 0 0 0 0 12.418 0 12.7134 0 0 0 0 0 0 0 0 0 0 0 12.3417 0 0 0 0 0 0 0 0 0 0 0 15.2623 0 0 0 0 0 0 0 13.1631 14.9975 13.0314 0 13.6966 0 0 11.5342 12.399 0 11.3257 0 0 13.2125 0 0 10.4657 15.4867 0 16.205 0 16.1301 16.1709 12.8956 11.6418 14.0777 0 12.8294 15.5119 15.2355 14.2567 16.3301 16.4791 0 11.272 11.546 13.531 16.5725 11.9328 15.5762 0 16.8809 11.6818 0 0 0 16.982 16.6288 16.7239 16.7839 0 16.8894 17.0206 11.2997 16.9985 10.7899 11.0936 16.1321 0 0 0 0 17.2525 0 9.38003 17.1568 20.5229 0 14.8792 11.5835 0 0 0 0 0 11.5862 0 0 20.4601 15.0069 0 0 12.477 13.6867 0 0 10.9039 12.4264 0 10.9494 0 0 0 0 0 12.7066 10.813 0 0 12.6464 20.3215 0 0 10.312 14.3479 13.0077 Q13330 MTA1_HUMAN Metastasis-associated protein MTA1 MTA1 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of gene expression, epigenetic [GO:0040029]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of gene expression, epigenetic [GO:0040029]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]" GO:0000122; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006302; GO:0006338; GO:0007165; GO:0010212; GO:0016575; GO:0016581; GO:0032922; GO:0040029; GO:0042659; GO:0042826; GO:0043153; GO:0043161; GO:0043231; GO:0045475; GO:0045892; GO:0045893; GO:0046872; GO:0061629; GO:1902499; GO:2000736 chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] EGEEDGR 0.993 -26.7 12.392 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7631 0 0 11.5065 0 0 0 0 12.9471 0 9.92266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6644 0 0 0 0 14.5005 13.4402 0 0 0 0 0 0 0 0 0 0 0 12.8176 0 0 13.5041 14.4287 0 13.6036 0 14.8515 0 0 0 0 14.8543 0 0 0 12.4959 14.3653 12.8552 0 0 0 0 0 13.4302 13.9475 0 0 0 0 13.4512 13.5571 0 12.8461 13.4727 0 0 0 0 0 0 0 0 0 13.0106 0 0 0 0 0 12.1408 0 0 0 12.3295 0 0 0 0 11.9133 0 0 12.9904 0 0 0 12.2659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1803 0 0 0 0 14.3224 12.9378 Q13459 MYO9B_HUMAN Unconventional myosin-IXb (Unconventional myosin-9b) MYO9B MYR5 Homo sapiens (Human) actin filament-based movement [GO:0030048]; lamellipodium morphogenesis [GO:0072673]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; Roundabout binding [GO:0048495]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; actin filament-based movement [GO:0030048]; lamellipodium morphogenesis [GO:0072673]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385] GO:0000146; GO:0001726; GO:0003779; GO:0005096; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005884; GO:0005938; GO:0007266; GO:0008270; GO:0015629; GO:0016020; GO:0016459; GO:0016887; GO:0030027; GO:0030048; GO:0031267; GO:0035023; GO:0035385; GO:0043008; GO:0043531; GO:0048471; GO:0048495; GO:0051015; GO:0051056; GO:0072673 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; Roundabout binding [GO:0048495]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] AEPFFIR 0.993 -26.651 0 0 0 0 0 0 0 0 0 0 14.545 0 0 0 0 0 14.5243 0 14.4115 13.6073 0 0 13.9913 13.5655 0 0 0 0 0 13.0267 0 0 0 0 0 0 10.7723 0 0 11.2423 0 0 0 0 0 0 0 0 0 0 11.1281 0 0 0 0 0 10.9244 0 0 0 0 0 0 0 0 0 0 0 12.9424 14.9176 0 9.66044 0 15.8909 13.9867 12.4918 12.1207 0 10.3921 0 0 13.3264 13.7183 0 0 0 13.802 0 0 0 0 0 17.6429 0 0 13.1704 12.7191 0 16.737 0 0 12.7311 0 0 16.8245 0 14.7856 0 13.3226 12.3578 0 13.9845 12.3281 0 0 0 12.969 0 12.3127 0 0 0 11.7655 13.469 14.543 15.1759 0 13.7692 0 13.7263 14.6389 13.5571 0 0 13.8131 17.3776 0 13.1939 14.0252 0 12.9966 17.2847 13.1079 0 14.4259 0 0 0 0 0 14.9765 0 15.3438 0 0 0 12.9784 0 0 0 0 16.2099 12.1542 13.9881 15.8162 0 0 0 14.4915 0 13.1161 0 0 0 17.194 0 0 12.8306 17.4573 15.5509 Q14126 DSG2_HUMAN Desmoglein-2 (Cadherin family member 5) (HDGC) DSG2 CDHF5 Homo sapiens (Human) bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Purkinje myocyte development [GO:0003165]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Purkinje myocyte development [GO:0003165]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911] GO:0001533; GO:0002934; GO:0003165; GO:0005509; GO:0005886; GO:0005911; GO:0007155; GO:0007156; GO:0009986; GO:0014704; GO:0016021; GO:0030054; GO:0030057; GO:0043231; GO:0050839; GO:0070062; GO:0086073; GO:0086083; GO:0086091; GO:0098609; GO:0098911 calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083] AYALLLLLICFNVGSGLHLQVLSTRNENK 0.993 -26.73 14.2528 0 0 14.1925 14.1677 0 0 11.3458 0 0 0 14.5959 0 0 0 0 0 0 0 0 0 0 12.8989 12.1334 13.3916 0 0 0 0 0 0 14.513 14.0159 0 0 0 13.9906 0 0 13.0055 0 12.8969 0 14.7309 0 12.4616 0 0 15.227 13.7691 0 12.6602 0 0 11.2297 0 12.4245 0 0 0 0 0 0 0 0 11.1616 12.8033 11.0189 0 0 0 0 10.9495 10.8127 0 14.3219 0 0 11.4749 15.0979 14.2167 0 13.1105 0 13.2936 12.9381 0 13.0699 0 12.0529 13.2594 0 11.341 13.1127 14.2753 13.9204 0 0 0 13.595 12.3303 0 12.0563 13.0771 0 0 0 0 13.3044 13.8901 12.2044 13.9608 0 13.1422 0 0 15.177 0 12.9516 14.3464 0 13.1816 0 0 12.4848 12.6306 11.7566 13.5464 13.4242 0 14.9533 12.8154 0 11.6535 0 0 0 11.9132 0 0 0 0 0 0 0 0 0 0 12.9492 0 13.2064 0 12.6678 13.878 12.4733 0 0 0 0 0 12.9294 0 0 13.6761 12.4715 13.3817 12.5914 12.6965 0 0 9.64936 12.3878 0 0 12.6839 0 0 12.0345 0 0 Q1X8D7 LRC36_HUMAN Leucine-rich repeat-containing protein 36 (ROR gamma-binding protein 70) LRRC36 RORBP70 Homo sapiens (Human) ALLPPEK 0.993 -14.372 0 0 0 10.8849 11.6866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0853 0 0 0 0 0 0 0 11.4112 0 0 0 0 0 0 0 0 0 12.1432 13.8017 0 16.2635 0 0 0 0 17.8536 0 0 0 0 0 0 19.0285 13.6329 0 13.2136 0 12.6776 0 13.0464 16.2819 0 0 0 13.8359 0 15.8362 0 0 0 0 0 0 14.2142 0 0 13.4152 0 0 0 0 0 13.2293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2953 0 0 12.9891 0 0 0 0 0 0 13.3514 0 13.9625 0 0 11.2697 0 0 0 0 0 0 0 0 0 0 0 0 16.2092 0 0 0 0 0 0 0 Q3KR16 PKHG6_HUMAN "Pleckstrin homology domain-containing family G member 6, PH domain-containing family G member 6 (Myosin-interacting guanine nucleotide exchange factor, MyoGEF)" PLEKHG6 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cell junction [GO:0030054]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; microvillus [GO:0005902]; spindle pole [GO:0000922] cell junction [GO:0030054]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; microvillus [GO:0005902]; spindle pole [GO:0000922]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0000922; GO:0005085; GO:0005096; GO:0005813; GO:0005829; GO:0005902; GO:0030054; GO:0032154; GO:0051056 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] DPEPEKR 0.993 -14.379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7734 0 0 0 0 0 0 0 0 0 11.0053 0 0 0 0 0 0 0 0 0 0 0 12.3275 0 14.5806 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5909 0 0 15.923 0 14.4864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7328 11.14 14.5182 0 13.665 13.7561 0 12.6149 0 0 0 0 0 0 0 0 0 0 0 14.2651 0 0 0 0 0 0 17.206 13.7042 0 0 0 0 0 0 0 12.3796 0 0 0 0 11.0559 0 0 0 0 0 0 0 0 9.8584 0 10.4363 0 0 0 13.85 0 0 0 0 0 0 0 0 0 0 Q5MAI5 CDKL4_HUMAN "Cyclin-dependent kinase-like 4, EC 2.7.11.22" CDKL4 Homo sapiens (Human) protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468] GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] GCLKMNPDDR 0.993 -13.306 0 0 0 0 0 0 0 13.4366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9876 12.8128 0 0 13.6241 0 0 0 0 0 0 0 14.0121 12.6334 0 12.414 0 0 0 0 10.3299 0 13.6193 0 13.0451 0 0 0 0 0 0 13.9462 13.6523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3344 Q6NV74 CRCDL_HUMAN CRACD-like protein CRACDL C2orf55 KIAA1211L Homo sapiens (Human) GAGTEPER 0.993 -26.647 0 12.8434 0 14.6464 0 0 0 0 12.8907 0 0 0 0 0 0 0 0 0 14.3044 0 0 0 0 0 0 0 0 0 0 0 0 11.3022 0 0 0 13.2999 0 0 0 0 12.6358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4284 0 13.348 0 0 0 0 0 0 12.5099 0 0 0 0 0 0 0 0 0 0 0 11.7655 17.3102 0 0 13.0237 0 13.2843 0 0 0 12.8712 0 0 0 15.6642 0 0 15.8897 0 0 0 0 13.4397 15.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8553 0 0 0 0 0 13.8955 14.4125 0 0 0 0 0 0 0 13.3778 12.4999 0 0 0 0 0 14.4458 0 0 10.7397 Q6P1R3 MSD2_HUMAN Myb/SANT-like DNA-binding domain-containing protein 2 MSANTD2 C11orf61 Homo sapiens (Human) EDIRYHYAEISSQVPLGKR 0.993 -14.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6566 0 0 0 0 0 0 0 0 12.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70EK8 UBP53_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) USP53 KIAA1350 Homo sapiens (Human) protein deubiquitination [GO:0016579]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; protein deubiquitination [GO:0016579]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605] GO:0005911; GO:0005923; GO:0007605; GO:0010996; GO:0016579 AWVKFLR 0.993 -26.777 0 0 0 0 0 0 0 0 14.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8262 0 0 0 0 0 0 0 0 0 0 10.937 0 0 0 0 0 10.6666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0929 0 12.1115 0 0 0 0 0 12.3201 0 0 0 0 0 0 0 0 0 11.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8969 0 0 0 0 0 11.2383 11.0408 0 0 0 0 0 0 0 0 0 0 11.3722 11.5965 0 0 14.723 0 0 0 0 12.4393 0 0 0 0 17.185 0 10.8959 0 0 0 0 0 0 0 13.4462 18.2514 0 0 0 0 0 12.447 0 0 0 0 13.2 0 0 0 0 0 0 0 0 Q86UK7 ZN598_HUMAN "E3 ubiquitin-protein ligase ZNF598, EC 2.3.2.27 (Zinc finger protein 598)" ZNF598 Homo sapiens (Human) protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829] cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] GO:0003723; GO:0005829; GO:0006417; GO:0006513; GO:0016567; GO:0043022; GO:0046872; GO:0061630; GO:0072344; GO:1990116 metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] AYLVPENFRER 0.993 -41.915 0 0 0 0 0 0 0 0 11.5688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2575 16.9423 12.8196 0 0 0 0 0 12.6138 0 0 12.931 0 13.1536 0 0 0 11.5414 0 0 0 12.2617 0 0 0 11.8127 0 0 0 0 0 0 0 0 0 13.3718 13.0612 0 0 0 0 0 0 0 0 13.3164 0 0 0 0 0 0 14.2137 14.435 0 0 0 0 0 0 13.1056 0 0 13.9078 11.4498 0 0 0 0 0 0 0 0 0 0 0 0 15.4266 0 0 0 0 13.1414 0 0 0 0 0 0 0 0 0 0 11.5753 0 0 0 0 12.6311 13.5713 0 0 0 15.9103 0 0 Q86XP0 PA24D_HUMAN "Cytosolic phospholipase A2 delta, cPLA2-delta, EC 3.1.1.4 (Phospholipase A2 group IVD)" PLA2G4D Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; glycerophospholipid catabolic process [GO:0046475]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; fatty acid metabolic process [GO:0006631]; glycerophospholipid catabolic process [GO:0046475]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149] GO:0004623; GO:0005509; GO:0005544; GO:0005829; GO:0006631; GO:0008970; GO:0016020; GO:0036148; GO:0036149; GO:0046475; GO:0047498 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] ALKQALQLDR 0.993 -13.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1607 0 0 0 0 0 0 0 0 0 14.9539 0 0 0 0 0 0 0 0 0 0 0 15.2012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBZ5 ZN502_HUMAN Zinc finger protein 502 ZNF502 Homo sapiens (Human) "positive regulation by host of viral process [GO:0044794]; regulation of transcription, DNA-templated [GO:0006355]; viral release from host cell [GO:0019076]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation by host of viral process [GO:0044794]; regulation of transcription, DNA-templated [GO:0006355]; viral release from host cell [GO:0019076]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0019076; GO:0044794; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CKECGKAFCQSPSLIK 0.993 -13.319 0 0 0 0 0 0 0 0 0 0 0 14.7288 0 0 0 11.8832 0 0 0 0 0 12.0463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1852 0 0 12.5622 0 0 0 13.3476 0 0 0 0 0 13.9238 0 12.5076 0 0 12.6222 0 0 10.4116 0 0 0 0 12.3422 0 0 13.1217 0 12.9514 0 0 12.4342 0 0 12.2396 0 0 12.712 12.7533 0 0 0 0 0 12.6529 0 0 0 0 0 0 0 0 11.8952 0 12.3899 13.5845 13.5434 0 0 0 12.951 12.8264 0 12.3553 0 0 12.8331 0 15.1205 0 15.5136 0 0 0 0 0 0 0 0 0 Q92620 PRP16_HUMAN "Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16, EC 3.6.4.13 (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)" DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0071013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] APAPRPSLLGLDLLASLKR 0.993 -14.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92975 0 0 0 0 0 0 0 0 0 0 0 14.033 0 0 12.5578 0 0 0 0 14.8672 0 0 11.6209 0 11.5003 0 12.4618 0 0 13.7013 0 0 0 0 0 9.61243 0 0 0 0 0 16.0348 0 0 0 0 0 0 0 0 0 11.6239 15.1877 0 15.3005 10.835 14.1943 0 14.8912 15.1932 13.6174 0 0 0 13.1178 14.1994 15.5142 0 0 0 0 0 15.3634 13.0244 0 12.0326 0 0 11.5246 0 12.6287 0 0 0 0 0 0 0 11.9757 0 0 15.3857 0 0 12.2279 0 11.9013 14.0994 0 0 0 0 0 0 12.9533 11.4231 0 0 13.7998 0 0 12.2985 12.5024 0 0 15.4118 11.3995 Q96GM1 PLPR2_HUMAN "Phospholipid phosphatase-related protein type 2 (Inactive phospholipid phosphatase PLPPR2) (Lipid phosphate phosphatase-related protein type 2) (Plasticity-related gene 4 protein, PRG-4)" PLPPR2 LPPR2 PRG4 Homo sapiens (Human) phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165] GO:0005887; GO:0006644; GO:0007165; GO:0008195; GO:0042577; GO:0046839 lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195] GSRLVKPSLCLALLCPAFLVGVVR 0.993 -14.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2148 0 0 0 13.6263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HQ0 ZN419_HUMAN Zinc finger protein 419 ZNF419 ZNF419A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNECGRFFR 0.993 -14.343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.549 12.9299 0 0 11.3214 0 12.4201 0 0 0 14.7136 0 12.7062 14.2982 12.4025 0 0 0 0 12.6812 12.6775 0 0 0 0 0 0 0 12.7368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2587 0 0 0 12.8842 0 0 0 0 0 0 0 0 12.6827 10.7363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7658 0 0 0 0 10.9996 0 0 0 0 0 0 0 11.3226 0 0 0 0 0 0 0 0 0 Q9HCH5 SYTL2_HUMAN Synaptotagmin-like protein 2 (Breast cancer-associated antigen SGA-72M) (Exophilin-4) SYTL2 KIAA1597 SGA72M SLP2 SLP2A Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; neurexin family protein binding [GO:0042043]; phosphatase binding [GO:0019902]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]" GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0006886; GO:0006887; GO:0006904; GO:0016020; GO:0016192; GO:0019897; GO:0019902; GO:0031267; GO:0042043; GO:0042470; GO:0070382 "neurexin family protein binding [GO:0042043]; phosphatase binding [GO:0019902]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; small GTPase binding [GO:0031267]" DDNQSFPRQR 0.993 -26.681 0 0 13.5044 0 0 0 0 0 10.8508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3366 0 0 0 0 0 0 0 0 0 0 0 0 10.2553 12.191 12.1964 12.706 13.0605 12.1086 11.8157 11.2682 0 0 0 0 0 0 12.9772 12.9075 0 0 0 13.9008 13.2507 0 0 0 0 0 0 0 0 0 0 0 13.3551 0 0 0 10.7837 15.6758 0 0 0 0 13.7116 12.9522 0 0 0 0 0 0 0 0 0 0 15.2386 0 0 10.8003 0 0 14.8889 0 0 0 0 0 0 0 0 0 11.406 0 0 0 0 11.6933 0 0 0 0 0 14.3355 0 0 0 0 0 11.8493 14.2479 0 11.7645 11.9037 0 0 0 0 0 0 0 0 0 11.6052 0 0 0 0 0 0 0 0 0 0 0 11.0543 0 0 0 0 0 0 0 13.3769 0 0 0 0 0 Q9HCM1 RESF1_HUMAN Retroelement silencing factor 1 RESF1 C12orf35 KIAA1551 Homo sapiens (Human) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309] nucleus [GO:0005634] nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase binding [GO:1990226]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309] GO:0005634; GO:0042393; GO:0045869; GO:0090309; GO:1990226 histone binding [GO:0042393]; histone methyltransferase binding [GO:1990226] CTERESISLTKLESSPR 0.993 -41.253 0 0 0 0 10.5644 0 0 0 0 0 11.1032 0 0 0 0 0 16.8343 16.9935 0 0 0 0 0 0 0 0 0 0 0 10.2118 0 0 0 0 10.6662 0 0 0 0 0 0 0 0 16.5804 0 0 0 0 14.4216 13.8645 14.2473 10.9201 11.7829 16.7528 17.4414 0 0 0 0 0 0 0 0 0 15.1235 15.2131 0 0 0 11.7446 0 0 0 0 0 14.2932 0 0 12.135 0 0 0 0 12.4972 0 0 0 0 0 14.2837 0 12.6504 0 0 12.9716 18.0739 9.56788 0 0 18.1949 11.9467 11.9039 0 0 0 0 0 0 14.5898 18.1199 0 10.2867 0 0 0 0 12.9159 12.8985 18.2068 13.0317 0 13.4843 0 0 0 13.0941 0 0 12.3852 0 0 11.4654 10.15 14.7435 13.0049 12.7195 16.5991 15.6873 0 0 0 0 15.6239 11.959 0 0 0 0 13.2869 0 0 0 0 0 0 11.8643 0 0 0 0 13.3908 0 12.8159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A3KMH1 VWA8_HUMAN "von Willebrand factor A domain-containing protein 8 (PEX7-binding protein 2, P7BP2)" VWA8 KIAA0564 Homo sapiens (Human) cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005737; GO:0005739; GO:0005777; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] AERNVLPVLNNLLENR 0.99301 -38.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4237 0 0 0 0 0 0 0 0 0 0 13.1705 0 0 0 13.5481 12.2618 0 10.8574 0 0 0 0 0 0 0 16.4325 0 0 0 0 0 0 0 12.6999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.709 12.5432 0 0 13.8581 12.9712 0 13.3185 0 0 0 0 0 0 0 0 13.0416 0 0 0 0 11.2238 14.3727 0 0 0 13.9436 15.3725 0 13.6203 14.0512 0 0 13.8564 0 14.5403 0 0 0 13.8153 0 0 0 0 0 0 0 0 13.7142 14.6846 0 12.5053 0 0 0 12.2908 11.2374 0 0 12.8536 0 0 12.6611 0 0 0 0 13.8336 0 0 0 12.9589 0 12.7869 0 0 0 0 10.9832 15.6221 0 0 12.8523 0 12.2982 0 0 16.0225 12.1442 15.9779 0 0 0 0 0 0 0 0 0 11.7719 0 0 0 0 0 0 0 0 0 O00418 EF2K_HUMAN "Eukaryotic elongation factor 2 kinase, eEF-2 kinase, eEF-2K, EC 2.7.11.20 (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase)" EEF2K Homo sapiens (Human) cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; translation factor activity, RNA binding [GO:0008135]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414]" GO:0002931; GO:0004672; GO:0004674; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031952; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:1990416; GO:1990637 "ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; translation factor activity, RNA binding [GO:0008135]" AAEAGDR 0.99301 -43.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8066 11.8417 0 0 0 0 0 0 0 13.7894 0 0 11.4799 10.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2511 13.6315 13.3207 13.4255 14.1914 0 15.4415 0 13.5058 13.2657 0 11.3538 0 0 14.6554 0 0 0 0 12.4164 0 0 0 13.1441 0 0 13.976 15.1499 13.9365 13.5006 0 13.1227 0 12.3996 0 14.362 0 0 12.6119 0 0 12.6145 14.5115 0 0 12.98 15.7755 0 0 0 0 0 16.8659 15.3818 0 0 0 0 12.8916 0 12.0836 0 13.1615 0 0 0 0 0 14.2084 0 0 0 13.4788 0 13.325 0 11.8817 13.9696 0 0 0 0 0 16.2407 0 13.0627 13.3502 14.4121 0 0 12.8559 12.6265 0 12.3336 11.1014 0 0 12.7079 0 0 9.93704 13.7901 0 0 14.6959 0 12.6068 12.7903 0 0 0 0 12.5263 12.0843 0 0 13.0762 0 0 14.3128 0 0 13.4351 11.7425 O94875 SRBS2_HUMAN "Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2, ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin)" SORBS2 ARGBP2 KIAA0777 Homo sapiens (Human) actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Z disc [GO:0030018]; cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; actin filament organization [GO:0007015]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219] GO:0003723; GO:0005200; GO:0005634; GO:0005886; GO:0005925; GO:0007015; GO:0007219; GO:0008093; GO:0008307; GO:0015629; GO:0016324; GO:0030018; GO:0030027; GO:0030425; GO:0042802; GO:0043025; GO:0045202; GO:0048471; GO:0061049 cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307] ESDVIDVMEKCDDGWFVGTSR 0.99301 -13.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4939 0 0 0 14.3186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0929 0 P46199 IF2M_HUMAN "Translation initiation factor IF-2, mitochondrial, IF-2(Mt), IF-2Mt, IF2(mt)" MTIF2 Homo sapiens (Human) mitochondrial translational initiation [GO:0070124]; regulation of translational initiation [GO:0006446]; ribosome disassembly [GO:0032790]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; regulation of translational initiation [GO:0006446]; ribosome disassembly [GO:0032790]; translational initiation [GO:0006413]" GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0006413; GO:0006446; GO:0008135; GO:0032790; GO:0043024; GO:0070124 "GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" CDKAEADPEK 0.99301 -43.164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5665 0 12.8844 12.2444 0 0 11.7962 11.852 12.4729 0 12.7431 11.5782 11.9561 11.4141 0 0 0 0 0 0 0 0 0 0 0 0 13.4022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6773 0 0 0 0 0 0 12.9359 0 0 0 0 0 0 0 0 0 0 0 0 12.6415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2194 0 0 P52735 VAV2_HUMAN "Guanine nucleotide exchange factor VAV2, VAV-2" VAV2 Homo sapiens (Human) angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to xenobiotic stimulus [GO:0071466]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to xenobiotic stimulus [GO:0071466]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0001525; GO:0001784; GO:0005085; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007264; GO:0008361; GO:0016477; GO:0030032; GO:0030168; GO:0038095; GO:0038096; GO:0043087; GO:0043552; GO:0046872; GO:0048010; GO:0051056; GO:0071466 epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784] EGDVVRIYSR 0.99301 -38.969 0 0 0 0 0 0 0 0 0 17.1248 0 0 0 0 0 0 0 0 0 0 0 12.1575 0 0 0 0 0 16.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7426 0 0 0 0 0 0 0 0 14.7732 14.2913 13.3422 12.9115 0 0 0 0 0 0 0 0 0 0 0 0 12.1631 0 0 0 0 0 0 0 10.1171 0 11.2246 0 0 0 11.5249 0 0 0 0 13.2393 22.9748 22.98 0 11.9898 0 22.827 12.6669 0 0 0 0 0 0 0 12.1219 0 0 0 0 0 0 0 0 0 0 22.0128 0 0 12.4201 0 0 12.7454 12.3434 0 15.2641 0 0 11.4787 21.8406 14.2037 0 0 0 0 0 13.9959 14.7011 14.8365 0 0 0 14.8204 0 0 0 0 13.2675 0 0 0 11.6111 0 0 0 0 0 0 22.2757 0 0 0 13.4426 0 13.0042 0 0 0 0 14.1723 0 0 20.0633 20.3788 20.2705 0 0 0 0 21.556 0 0 0 19.0647 P55210 CASP7_HUMAN "Caspase-7, CASP-7, EC 3.4.22.60 (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3, ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11 ]" CASP7 MCH3 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast apoptotic process [GO:0044346]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway [GO:0097193]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411] caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] caspase complex [GO:0008303]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast apoptotic process [GO:0044346]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway [GO:0097193]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411] GO:0004190; GO:0004197; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006954; GO:0007507; GO:0008233; GO:0008234; GO:0008303; GO:0009411; GO:0016485; GO:0043065; GO:0044346; GO:0051402; GO:0072734; GO:0097153; GO:0097191; GO:0097193; GO:0097194; GO:0097200 aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233] ADDQGCIEEQGVEDSANEDSVDAK 0.99301 -16.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7031 0 0 0 0 0 12.776 0 12.5783 0 0 0 0 0 0 0 0 0 14.7558 0 0 0 0 0 0 17.96 0 0 0 0 0 0 0 19.0424 0 0 13.5479 0 0 0 13.6899 0 0 0 0 0 0 14.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3576 0 0 0 0 0 0 0 0 14.6286 0 0 0 12.6319 13.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9562 Q13751 LAMB3_HUMAN Laminin subunit beta-3 (Epiligrin subunit bata) (Kalinin B1 chain) (Kalinin subunit beta) (Laminin B1k chain) (Laminin-5 subunit beta) (Nicein subunit beta) LAMB3 LAMNB1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; brown fat cell differentiation [GO:0050873]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-5 complex [GO:0005610] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin complex [GO:0043256]; laminin-5 complex [GO:0005610]; extracellular matrix structural constituent [GO:0005201]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; brown fat cell differentiation [GO:0050873]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005198; GO:0005201; GO:0005576; GO:0005610; GO:0008544; GO:0009887; GO:0009888; GO:0016477; GO:0034446; GO:0035987; GO:0043256; GO:0044877; GO:0050873; GO:0062023; GO:0070831 extracellular matrix structural constituent [GO:0005201]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198] ACDCDFR 0.99301 -42.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4935 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3591 0 0 0 0 0 0 0 11.1586 0 0 0 0 0 0 14.1132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2233 11.1712 0 13.9117 11.8205 0 0 14.1021 0 0 0 0 0 0 14.0938 14.4352 0 14.4824 13.9567 14.4535 0 14.2286 0 0 0 0 15.4906 11.6117 0 0 0 0 11.8568 0 0 0 0 14.5099 0 0 0 12.0122 12.0207 10.8655 0 0 10.2566 12.2646 14.4682 0 0 0 11.8498 0 0 0 0 0 0 11.2641 0 0 11.7298 11.9026 0 0 0 0 0 0 0 13.7979 0 0 0 0 11.8457 0 0 11.1578 0 0 0 0 0 0 0 0 0 0 0 0 11.1591 0 0 0 0 0 0 0 11.9415 0 0 0 14.4954 0 0 0 Q16555 DPYL2_HUMAN "Dihydropyrimidinase-related protein 2, DRP-2 (Collapsin response mediator protein 2, CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2, ULIP-2)" DPYSL2 CRMP2 ULIP2 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of axon extension [GO:0030516]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; axon guidance [GO:0007411]; brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of axon extension [GO:0030516]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165] GO:0004157; GO:0005829; GO:0005856; GO:0005886; GO:0006139; GO:0006897; GO:0007010; GO:0007165; GO:0007399; GO:0007411; GO:0007420; GO:0008017; GO:0030516; GO:0042802; GO:0045664; GO:0070062 dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] ARSRLAELR 0.99301 -6.2902 0 0 0 0 0 0 0 0 13.7897 0 13.9269 0 14.1573 0 0 13.3295 0 0 0 0 0 0 0 0 0 0 0 13.3373 0 0 13.9076 14.1007 0 14.5353 0 13.8828 12.5407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZP5 STYL2_HUMAN Serine/threonine/tyrosine-interacting-like protein 2 (Inactive dual specificity phosphatase 27) STYXL2 DUSP27 Homo sapiens (Human) negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; sarcomere [GO:0030017]; MAP kinase phosphatase activity [GO:0033549]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] GO:0005737; GO:0006470; GO:0008138; GO:0030017; GO:0033549; GO:0043409 MAP kinase phosphatase activity [GO:0033549]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] ADSMSSESTWDAWNER 0.99301 -16.685 0 10.1624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5785 0 10.5608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4461 11.8656 0 0 0 0 0 0 11.1254 0 0 0 0 0 0 0 12.3908 0 0 0 0 0 0 0 10.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.69 0 0 0 0 0 0 0 11.6012 0 11.9831 0 0 0 0 0 0 0 11.0232 0 0 0 0 0 11.9415 0 0 12.7212 11.0735 0 0 11.4765 0 0 11.3442 0 0 11.1013 0 0 0 0 0 12.2698 0 0 0 0 0 0 0 0 0 0 0 14.6569 0 0 0 12.7761 0 0 0 0 0 0 0 10.7536 0 12.2347 10.1143 0 0 0 0 12.0803 0 0 0 0 Q6ZN44 UNC5A_HUMAN Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A) UNC5A KIAA1976 UNC5H1 Homo sapiens (Human) anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; netrin-activated signaling pathway [GO:0038007]; neuron projection development [GO:0031175] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuron projection membrane [GO:0032589]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; neuron projection membrane [GO:0032589]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; netrin-activated signaling pathway [GO:0038007]; neuron projection development [GO:0031175] GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0016021; GO:0031175; GO:0031226; GO:0032589; GO:0032809; GO:0033564; GO:0038007; GO:0045121 netrin receptor activity [GO:0005042] AVRPGLWPALLGIVLAAWLR 0.99301 -16.266 0 0 10.8301 0 14.1242 0 0 0 0 11.7984 12.875 0 0 0 0 0 0 0 0 11.2594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5679 0 0 0 10.7585 0 0 0 0 0 0 0 0 12.0966 0 0 0 0 0 0 0 13.4058 0 0 0 0 10.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4166 0 0 0 11.695 0 0 0 0 0 0 0 0 14.5646 0 0 0 0 11.8453 0 0 13.1421 0 0 12.9293 0 0 0 0 12.4075 12.3494 12.2276 0 0 0 0 12.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5735 0 0 0 0 0 0 0 0 0 0 12.6306 0 0 0 0 0 12.0357 0 0 0 0 0 0 0 0 0 0 12.556 0 0 13.092 0 Q6ZRI8 RHG36_HUMAN Rho GTPase-activating protein 36 ARHGAP36 Homo sapiens (Human) signal transduction [GO:0007165] GTPase activator activity [GO:0005096]; signal transduction [GO:0007165] GO:0005096; GO:0007165 GTPase activator activity [GO:0005096] FGKRESR 0.99301 -16.239 0 0 0 13.59 13.4515 0 13.3375 12.5468 0 0 0 0 0 0 0 0 0 13.3305 12.3961 0 12.0716 10.574 0 0 15.0692 0 13.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4829 14.4259 12.4334 14.9705 0 0 0 0 12.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2288 13.237 13.3906 0 13.8256 0 13.8301 0 13.6792 14.391 0 13.0227 13.136 0 12.8667 16.1065 0 0 0 12.0299 0 14.4214 14.519 14.2018 14.7099 14.464 14.6152 14.4076 14.685 15.2387 12.6346 12.8694 0 0 0 0 11.0455 0 0 13.1152 0 14.474 12.2299 12.5147 0 0 15.1924 14.972 0 0 0 0 0 12.1992 0 13.6921 0 11.2676 0 12.8371 0 0 12.5871 13.2674 0 12.4892 13.3891 12.8599 16.7815 12.7673 0 0 0 0 0 12.4628 14.1245 13.7958 0 15.4372 0 0 0 0 13.3639 14.0493 0 0 0 0 0 0 0 0 0 0 0 0 16.6355 0 0 12.6616 0 0 0 0 13.1869 16.6653 11.4811 0 0 0 16.7142 0 Q86SQ0 PHLB2_HUMAN Pleckstrin homology-like domain family B member 2 (Protein LL5-beta) PHLDB2 LL5B Homo sapiens (Human) "establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]" basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886] "basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]" GO:0000226; GO:0005829; GO:0005886; GO:0010470; GO:0010717; GO:0031252; GO:0045111; GO:0045180; GO:0045184; GO:0045296; GO:0051497; GO:0051895; GO:0070507; GO:1903690; GO:1904261 cadherin binding [GO:0045296] ADFDHYTGRDSER 0.99301 -43.133 0 0 14.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0413 0 13.1486 0 0 0 0 12.2267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6749 0 0 0 0 0 0 0 0 0 0 11.7817 0 0 0 12.4245 13.1821 0 0 16.2485 0 14.7042 0 17.3721 0 14.3803 0 0 0 11.4149 0 11.6231 0 0 15.4309 0 13.0673 0 12.6504 14.2634 0 0 0 0 13.1669 14.2428 12.2385 0 0 0 13.4042 0 0 0 0 0 13.3618 0 0 0 0 13.5158 14.8904 0 0 0 0 0 0 0 0 12.0981 0 0 14.0036 0 0 0 0 0 13.8993 0 13.3021 0 13.326 13.4353 0 0 0 12.5069 0 0 0 0 14.7318 13.931 0 0 0 10.9321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1341 13.8644 0 13.411 Q9BX26 SYCP2_HUMAN "Synaptonemal complex protein 2, SCP-2 (Synaptonemal complex lateral element protein, hsSCP2)" SYCP2 SCP2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; meiotic nuclear division [GO:0140013]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; synaptonemal complex assembly [GO:0007130] lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795] lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; cell division [GO:0051301]; ectopic germ cell programmed cell death [GO:0035234]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; meiotic nuclear division [GO:0140013]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; synaptonemal complex assembly [GO:0007130] GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0006915; GO:0007130; GO:0007140; GO:0007143; GO:0009566; GO:0035234; GO:0043066; GO:0048808; GO:0051093; GO:0051301; GO:0140013; GO:2000242 DNA binding [GO:0003677] DLEKEFVDFWEK 0.99301 -42.91 0 0 11.8953 0 0 0 0 0 12.3914 0 12.0554 0 14.7483 11.2184 11.4382 14.4067 0 0 13.2681 13.7051 0 0 0 0 12.5727 0 0 0 12.5987 10.7463 0 0 12.7683 11.0023 11.0004 0 0 0 0 0 0 14.6152 13.2138 14.5105 11.5674 0 11.4463 0 13.3362 0 0 0 12.0037 0 13.8319 0 10.9215 12.929 12.8095 0 12.9195 12.8941 12.7983 12.4609 0 12.3399 16.6829 14.5743 16.0514 15.7026 14.8644 0 0 13.8958 15.7062 15.6674 0 16.0925 15.4028 16.2744 14.1712 15.5034 14.0135 0 14.7858 12.6831 14.6005 0 0 14.8557 12.3243 0 0 13.1243 0 14.5457 0 16.3121 13.7175 14.7626 13.5732 14.3588 16.4705 12.424 12.933 15.6809 0 15.779 15.2529 14.3723 0 14.9705 14.0815 19.8235 0 16.457 12.6592 15.0074 15.1645 12.1533 0 0 0 14.0484 13.4322 0 14.0982 15.3531 13.5105 15.3424 0 15.1911 15.2038 12.1747 0 14.4821 14.8567 15.072 15.0579 15.8389 13.7666 12.2973 12.2112 0 13.7243 14.2541 0 0 13.0198 0 15.1832 14.9925 14.3966 14.8878 12.1175 14.9624 12.0946 14.67 14.7062 14.3977 13.8042 0 15.5019 14.1203 14.8073 14.2005 14.244 13.8646 12.3198 14.3442 0 0 14.5575 14.2222 13.9077 0 12.5861 0 12.4865 0 Q9HB96 FANCE_HUMAN "Fanconi anemia group E protein, Protein FACE" FANCE FACE Homo sapiens (Human) interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] GO:0000785; GO:0005634; GO:0005654; GO:0006513; GO:0036297; GO:0043240 CWEEEEDHEK 0.99301 -16.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1965 0 0 0 0 0 0 0 0 0 0 0 0 15.2722 0 0 13.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0416 0 0 0 0 0 0 0 0 0 0 Q9NVX7 KBTB4_HUMAN Kelch repeat and BTB domain-containing protein 4 (BTB and kelch domain-containing protein 4) KBTBD4 BKLHD4 Homo sapiens (Human) EAFAESLR 0.99301 -9.2021 0 0 0 0 10.3888 0 0 0 0 0 0 0 0 0 0 11.2967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0208 0 11.3417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1108 0 0 0 0 0 0 0 0 13.5595 0 13.6602 0 14.3031 0 17.5206 0 0 0 0 0 14.205 0 0 0 11.7156 0 0 15.7415 0 0 0 0 0 0 0 14.6595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9957 0 0 0 0 12.3069 0 0 0 11.8873 0 12.4454 0 0 0 0 0 0 0 0 13.0651 0 0 14.2459 0 0 0 0 0 0 0 0 12.7124 0 14.9307 12.3853 14.2647 0 0 0 0 11.7193 0 0 Q9NZN9 AIPL1_HUMAN Aryl-hydrocarbon-interacting protein-like 1 AIPL1 AIPL2 Homo sapiens (Human) "apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; phototransduction, visible light [GO:0007603]; protein farnesylation [GO:0018343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; farnesylated protein binding [GO:0001918]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; phototransduction, visible light [GO:0007603]; protein farnesylation [GO:0018343]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" GO:0001895; GO:0001917; GO:0001918; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0007601; GO:0007603; GO:0018343; GO:0022400; GO:0043066; GO:0051082 farnesylated protein binding [GO:0001918]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082] AYYVRAR 0.99301 -16.259 0 0 0 0 0 0 0 0 0 11.8078 0 0 0 0 13.4415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1Y6 PHRF1_HUMAN PHD and RING finger domain-containing protein 1 PHRF1 KIAA1542 Homo sapiens (Human) mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366] membrane [GO:0016020]; nucleoplasm [GO:0005654] membrane [GO:0016020]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366] GO:0005654; GO:0006366; GO:0006397; GO:0016020; GO:0019904; GO:0046872; GO:0070063 metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063] AAPVSFQRNSGSLSRGEEGFK 0.99301 -43.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9197 0 0 0 0 0 0 0 12.2672 0 0 0 0 0 0 0 0 0 0 0 0 9.69789 0 0 0 0 0 0 0 0 12.5326 0 0 0 0 0 0 0 11.1535 0 0 0 0 0 0 0 0 0 0 0 11.1055 0 14.4374 0 14.2558 13.8421 0 0 12.9023 11.6337 16.019 15.2126 14.5024 0 14.6145 15.6598 0 12.2218 0 15.8395 15.9439 15.0445 13.8223 14.7448 15.4609 0 0 0 0 0 0 0 13.912 0 0 0 0 0 0 0 14.1974 14.1307 0 0 0 12.8994 0 0 0 13.5693 0 0 0 12.3827 12.6674 0 0 0 0 0 0 0 13.3884 0 0 10.6698 0 0 0 0 13.1271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8474 0 0 11.5842 10.7077 10.1425 0 0 0 14.8217 0 10.895 0 12.8145 0 0 0 0 0 12.6964 Q9UL12 SARDH_HUMAN "Sarcosine dehydrogenase, mitochondrial, SarDH, EC 1.5.8.3 (BPR-2)" SARDH DMGDHL1 Homo sapiens (Human) sarcosine catabolic process [GO:1901053] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480]; sarcosine catabolic process [GO:1901053] GO:0005737; GO:0005739; GO:0005759; GO:0008480; GO:0016491; GO:1901053 oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480] AAGHLVR 0.99302 -6.9446 0 0 0 11.6753 0 0 0 0 12.4365 0 0 0 0 0 0 0 0 0 13.0889 0 0 0 0 0 0 0 0 10.7009 0 0 12.7051 0 0 0 0 0 10.0118 0 0 0 11.5335 0 0 0 0 0 0 0 0 0 0 0 0 15.6757 10.5775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0118 0 0 18.1982 0 12.1685 0 0 0 0 12.4977 14.8156 12.3192 12.5031 0 0 0 12.7904 0 0 19.0047 0 0 13.7197 0 14.1167 0 12.3784 14.2196 19.0029 13.7223 14.3455 0 14.1461 19.0266 0 0 11.5838 17.3576 0 19.871 0 0 0 0 0 19.6737 0 0 0 0 0 0 0 0 18.8754 12.6302 0 12.2596 0 0 12.432 0 0 0 0 0 0 0 19.5282 19.5445 0 18.3141 14.9666 0 17.9736 13.6066 18.1795 18.7223 18.7784 0 0 9.64958 0 0 12.7435 0 0 0 0 0 0 0 0 17.7337 0 0 0 0 0 0 16.4435 0 18.6186 11.3186 19.3774 19.3371 0 0 0 0 Q6PL18 ATAD2_HUMAN "ATPase family AAA domain-containing protein 2, EC 3.6.1.- (AAA nuclear coregulator cancer-associated protein, ANCCA)" ATAD2 L16 PRO2000 Homo sapiens (Human) "chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006325; GO:0016887; GO:0042393; GO:0045893; GO:0045944; GO:0070062 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393] EELDEDFEQLCEEIQESR 0.99302 -39.079 0 0 0 16.3282 0 0 0 0 15.9184 15.187 15.4314 13.2336 12.9545 0 0 0 0 15.8142 0 12.1079 0 0 0 0 15.8354 15.9167 12.3865 16.7709 0 15.8361 12.9022 15.7427 0 15.9743 0 0 16.1184 16.0411 17.0833 11.7912 16.1818 0 16.0733 16.153 15.9645 14.3107 15.8111 12.1822 15.904 15.9803 16.0322 12.9757 13.5881 15.1673 0 15.9535 15.7168 16.3954 16.1817 15.9896 13.3113 14.3973 12.1622 0 14.3372 12.7597 12.3427 0 0 0 0 0 0 11.0185 14.6855 14.2966 14.6648 14.8856 14.323 13.2831 0 0 0 12.9259 12.9858 12.8407 13.5593 13.7869 13.7294 12.5915 0 15.915 12.467 15.1745 12.828 0 11.5815 15.4186 14.9448 15.1854 13.8931 0 12.3248 0 12.792 0 0 0 13.1833 0 0 14.8088 12.9136 12.2087 0 0 14.1199 0 0 0 13.7544 13.7553 15.3004 13.0306 14.0594 15.824 15.1741 0 0 13.4574 0 12.6984 0 12.3226 0 0 0 14.1188 0 0 0 10.6699 0 14.0311 0 12.229 15.1136 16.398 12.7502 0 0 11.5763 12.3872 0 0 14.2575 14.8082 16.2028 11.8386 0 0 14.4733 13.1216 13.7329 15.2748 14.1029 0 13.2442 12.0912 16.2992 12.1276 0 13.8703 13.1461 0 16.7422 0 15.3632 0 0 A8MWD9 RUXGL_HUMAN Putative small nuclear ribonucleoprotein G-like protein 15 SNRPGP15 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" catalytic step 2 spliceosome [GO:0071013]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; ribonucleoprotein complex [GO:1990904]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0000398; GO:0003723; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0034719; GO:0043186; GO:0071004; GO:0071011; GO:0071013; GO:0097526; GO:1990904 RNA binding [GO:0003723] AHPPELKK 0.99302 -6.3217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2908 0 12.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3915 0 0 0 0 0 0 0 0 12.2745 0 0 0 0 0 0 0 0 0 14.2042 0 0 12.0239 0 0 0 13.2985 0 0 0 0 0 0 0 13.1934 0 0 0 0 0 0 0 0 13.4267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4695 0 0 0 0 0 0 13.2835 0 P02686 MBP_HUMAN "Myelin basic protein, MBP (Myelin A1 protein) (Myelin membrane encephalitogenic protein)" MBP Homo sapiens (Human) aging [GO:0007568]; axon ensheathment [GO:0008366]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; immune response [GO:0006955]; maintenance of blood-brain barrier [GO:0035633]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; myelination [GO:0042552]; negative regulation of axonogenesis [GO:0050771]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of metalloendopeptidase activity [GO:1904685]; response to fatty acid [GO:0070542]; response to mercury ion [GO:0046689]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; sensory perception of sound [GO:0007605]; substantia nigra development [GO:0021762] cell periphery [GO:0071944]; cell surface [GO:0009986]; compact myelin [GO:0043218]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] cell periphery [GO:0071944]; cell surface [GO:0009986]; compact myelin [GO:0043218]; cytosol [GO:0005829]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calmodulin binding [GO:0005516]; protease binding [GO:0002020]; structural constituent of myelin sheath [GO:0019911]; aging [GO:0007568]; axon ensheathment [GO:0008366]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; immune response [GO:0006955]; maintenance of blood-brain barrier [GO:0035633]; MAPK cascade [GO:0000165]; membrane organization [GO:0061024]; myelination [GO:0042552]; negative regulation of axonogenesis [GO:0050771]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of metalloendopeptidase activity [GO:1904685]; response to fatty acid [GO:0070542]; response to mercury ion [GO:0046689]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; sensory perception of sound [GO:0007605]; substantia nigra development [GO:0021762] GO:0000165; GO:0002020; GO:0005516; GO:0005634; GO:0005829; GO:0005886; GO:0006955; GO:0007268; GO:0007417; GO:0007568; GO:0007605; GO:0008366; GO:0009636; GO:0009986; GO:0019911; GO:0021762; GO:0032570; GO:0032755; GO:0032991; GO:0033269; GO:0034115; GO:0034612; GO:0035633; GO:0042552; GO:0043025; GO:0043209; GO:0043218; GO:0045202; GO:0046689; GO:0050771; GO:0061024; GO:0070542; GO:0071944; GO:1904685; GO:2000343 calmodulin binding [GO:0005516]; protease binding [GO:0002020]; structural constituent of myelin sheath [GO:0019911] ASTNSETNRGESEK 0.99302 -16.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1652 0 0 0 0 14.9458 0 0 0 0 0 0 0 15.1244 0 0 15.2035 0 0 0 0 15.2473 0 16.1576 0 0 0 14.9146 0 14.6477 0 0 0 0 0 0 0 0 14.7581 0 14.8893 0 14.559 0 16.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6283 14.3892 0 0 0 0 0 0 Q5BKY1 LRC10_HUMAN Leucine-rich repeat-containing protein 10 LRRC10 Homo sapiens (Human) cardiac muscle cell development [GO:0055013] cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sarcomere [GO:0030017] cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sarcomere [GO:0030017]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; cardiac muscle cell development [GO:0055013] GO:0003779; GO:0005634; GO:0005739; GO:0005856; GO:0030017; GO:0051393; GO:0055013 actin binding [GO:0003779]; alpha-actinin binding [GO:0051393] ARRYALVR 0.99302 -4.4157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7367 0 0 11.4816 0 0 0 0 0 0 0 0 0 0 11.8763 11.5009 0 0 0 0 0 0 12.3305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3862 0 0 0 0 0 0 12.5736 0 0 0 0 16.2579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.418 0 0 0 0 0 0 0 0 0 16.7482 0 0 0 0 0 0 0 0 0 13.9093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9284 0 0 0 0 0 0 0 0 14.3843 13.6743 0 0 0 0 13.041 0 0 0 0 0 14.511 0 14.4055 0 0 Q6MZN7 HCP5_HUMAN HLA class I histocompatibility antigen protein P5 (HLA complex protein P5) (Protein P5-1) HCP5 Homo sapiens (Human) LKSSFLR 0.99302 -16.771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P158 DHX57_HUMAN "Putative ATP-dependent RNA helicase DHX57, EC 3.6.4.13 (DEAH box protein 57)" DHX57 Homo sapiens (Human) ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0046872 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ASYNYCRQNFLSGR 0.99302 -44.165 0 11.5796 0 0 0 0 0 0 0 13.0643 0 0 0 0 12.3032 14.0897 13.5476 12.8213 0 10.3581 0 13.3018 10.6922 12.6248 13.6239 13.3415 11.1805 12.7649 11.289 0 0 0 0 10.9628 0 0 0 0 11.9815 0 11.2502 0 13.5978 10.9227 12.9815 0 0 0 11.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44074 0 10.9801 0 0 0 0 15.2977 0 14.5077 16.5943 0 16.4292 16.8369 0 0 16.742 11.8438 0 0 11.4778 16.2294 16.016 16.0486 16.529 0 0 0 12.2652 13.5173 0 0 0 0 12.509 13.2619 14.1583 12.0446 0 0 0 11.8288 0 13.7707 12.8739 12.2515 12.0931 0 0 13.0299 0 0 0 0 0 0 0 11.9616 14.8051 0 14.6539 13.498 0 11.7732 0 0 14.6696 0 0 0 14.7442 0 12.7115 11.7752 0 13.592 0 0 0 13.9525 0 0 0 14.8032 0 12.1381 0 0 13.1465 13.6333 0 0 0 0 0 14.7355 0 0 0 0 11.8746 0 13.6616 0 0 0 0 0 Q6ZSZ5 ARHGI_HUMAN "Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor, p114-Rho-GEF, p114RhoGEF) (Septin-associated RhoGEF, SA-RhoGEF)" ARHGEF18 KIAA0521 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105]; regulation of cell shape [GO:0008360]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005829; GO:0005856; GO:0005886; GO:0007264; GO:0008360; GO:0016324; GO:0030036; GO:0030054; GO:0035023; GO:0045177; GO:0046872; GO:0051497; GO:0070062; GO:0150105 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872] AETFAGYDCTNSPTK 0.99302 -39.803 0 0 0 0 0 0 0 0 0 0 0 13.4142 0 12.8216 0 0 12.9178 0 0 0 0 0 13.4599 0 0 0 0 0 13.3519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.701 0 0 0 0 0 0 12.6943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0024 0 0 0 0 14.5119 0 0 0 14.033 0 0 0 0 0 0 12.5474 0 13.7042 0 0 0 0 14.7223 0 14.947 0 0 0 0 12.8762 0 0 0 13.8382 0 0 13.147 13.0374 0 15.6733 12.1113 0 0 0 0 0 13.684 0 0 0 12.0212 0 14.0098 0 12.0986 0 13.4992 14.6203 18.2158 14.8382 13.0705 0 0 0 18.6832 0 0 0 0 15.5034 0 12.8576 0 14.5 0 0 12.9172 0 0 0 14.1839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6033 0 0 0 14.6678 0 0 0 0 0 0 0 0 0 Q8IY82 DRC7_HUMAN Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog) DRC7 C16orf50 CCDC135 Homo sapiens (Human) cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cell motility [GO:0048870]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283] GO:0005737; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0031514; GO:0048870 EEAAEWAEWAR 0.99302 -39.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7046 0 14.5453 0 13.2557 12.8108 0 0 0 0 10.7977 0 0 12.9417 0 0 0 0 0 0 0 12.7307 0 0 0 15.0802 16.3472 15.2 11.0537 0 0 0 11.9249 0 15.6011 14.6025 0 0 0 0 10.3861 0 0 0 14.8099 14.782 0 14.2779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2912 0 0 0 0 0 0 0 0 0 0 0 0 13.3015 0 0 12.7698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8181 0 0 0 0 Q8IYX3 CC116_HUMAN Coiled-coil domain-containing protein 116 CCDC116 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737] GO:0005737; GO:0005813 AEIEDEDEDEFKDEDQDEDKDEDGV 0.99302 -13.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8752 0 0 0 0 0 0 0 0 0 0 11.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9901 13.227 0 0 0 0 0 0 0 0 0 13.6541 0 0 0 0 12.5164 0 0 0 0 0 0 0 0 0 0 0 0 12.227 0 0 12.8388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1847 0 0 0 0 0 0 0 0 14.2019 0 0 0 0 0 0 0 0 0 11.9965 11.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9904 11.5216 0 0 0 0 0 12.9566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6Q8 MET25_HUMAN "Probable methyltransferase-like protein 25, EC 2.1.1.-" METTL25 C12orf26 Homo sapiens (Human) methylation [GO:0032259] methyltransferase activity [GO:0008168]; methylation [GO:0032259] GO:0008168; GO:0032259 methyltransferase activity [GO:0008168] HVGKIYSK 0.99302 -16.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.713 0 10.7042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEA5 CS018_HUMAN Uncharacterized protein C19orf18 C19orf18 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] GO:0016021; GO:0070062 AIIRHRPALVK 0.99302 -6.3312 0 0 0 0 0 0 0 0 13.9105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.005 0 0 0 0 0 Q8NEY4 VATC2_HUMAN "V-type proton ATPase subunit C 2, V-ATPase subunit C 2 (Vacuolar proton pump subunit C 2)" ATP6V1C2 Homo sapiens (Human) positive regulation of Wnt signaling pathway [GO:0030177]; regulation of macroautophagy [GO:0016241] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; identical protein binding [GO:0042802]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of macroautophagy [GO:0016241]" GO:0000221; GO:0005765; GO:0005829; GO:0016241; GO:0030177; GO:0042802; GO:0046961; GO:0070062 "identical protein binding [GO:0042802]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" KVIEDFKTK 0.99302 -15.953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4359 0 0 0 11.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4329 0 0 0 0 0 0 0 0 0 0 12.9005 12.2331 13.7785 12.6372 12.5456 0 0 0 0 0 0 0 0 0 0 0 0 13.4828 13.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0032 0 12.7591 0 0 12.9806 13.6588 12.9919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5365 0 0 12.7388 0 0 0 0 0 0 0 0 0 0 0 12.4471 0 12.3486 0 11.5239 0 0 0 0 Q8TC26 TM163_HUMAN Transmembrane protein 163 TMEM163 Homo sapiens (Human) zinc ion import into synaptic vesicle [GO:0099180] anchoring junction [GO:0070161]; early endosome membrane [GO:0031901]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020] anchoring junction [GO:0070161]; early endosome membrane [GO:0031901]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; zinc ion binding [GO:0008270]; zinc ion import into synaptic vesicle [GO:0099180] GO:0008270; GO:0016020; GO:0030285; GO:0031901; GO:0070161; GO:0099180 zinc ion binding [GO:0008270] EPPQLEEER 0.99302 -6.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6847 0 0 0 0 0 0 0 0 0 0 0 12.535 0 0 0 0 0 0 14.0243 0 0 0 0 0 0 0 0 0 0 0 10.6582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0548 13.0399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4803 0 13.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCT7 SPP2B_HUMAN "Signal peptide peptidase-like 2B, SPP-like 2B, SPPL2b, EC 3.4.23.- (Intramembrane protease 4, IMP-4) (Presenilin homologous protein 4, PSH4) (Presenilin-like protein 1)" SPPL2B IMP4 KIAA1532 PSL1 Homo sapiens (Human) membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803] actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]" GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0010803; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]" AALYAPK 0.99302 -16.716 0 0 0 0 0 0 0 0 0 0 0 10.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9245 0 0 0 0 0 0 0 0 0 0 14.5344 0 0 0 0 0 12.6465 0 0 13.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0066 0 0 0 14.4648 0 0 0 0 0 0 0 0 0 0 0 11.8696 0 0 0 0 0 0 0 0 Q8WVC0 LEO1_HUMAN RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein) LEO1 RDL Homo sapiens (Human) endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] GO:0001650; GO:0001711; GO:0005634; GO:0005654; GO:0005813; GO:0006368; GO:0006378; GO:0010390; GO:0016055; GO:0016593; GO:0019827; GO:0031442; GO:0032968; GO:0033523; GO:0045638; GO:1990269 RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269] AHSDDEK 0.99302 -6.9418 0 0 0 0 0 0 0 0 13.8886 15.1865 0 0 0 13.9533 0 0 0 0 14.2255 0 0 0 0 0 11.4489 0 0 0 0 13.7507 0 0 0 13.9625 0 0 0 13.9085 0 0 13.7796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4889 0 0 0 0 0 0 12.8498 11.1436 0 11.8675 13.3016 12.5528 0 11.0856 12.6258 13.7585 12.6977 0 0 14.2655 0 12.4814 12.8826 12.8204 0 13.0086 12.4869 13.9392 0 0 12.5175 13.1623 0 0 13.8229 0 0 0 0 0 0 0 0 0 12.3125 0 0 0 0 0 0 13.6923 0 0 0 14.9481 0 0 13.0289 11.9552 13.393 0 0 0 0 12.932 0 0 15.8308 14.2928 0 0 0 0 0 0 0 0 0 0 0 13.4888 12.9176 0 0 0 0 0 0 0 0 0 13.6945 0 11.2565 11.5471 0 0 0 0 15.3208 0 0 0 0 0 15.6504 0 0 0 12.5006 Q96EW2 HBAP1_HUMAN HSPB1-associated protein 1 (27 kDa heat shock protein-associated protein 1) (Protein associated with small stress protein 1) HSPBAP1 PASS1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706] GO:0005737; GO:0016706 2-oxoglutarate-dependent dioxygenase activity [GO:0016706] DGEHFGK 0.99302 -4.4188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GR2 ACBG1_HUMAN "Long-chain-fatty-acid--CoA ligase ACSBG1, EC 6.2.1.3 (Acyl-CoA synthetase bubblegum family member 1, hBG1, hsBG, hsBGM) (Lipidosin)" ACSBG1 BGM KIAA0631 LPD Homo sapiens (Human) long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; ovarian follicle atresia [GO:0001552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; myelination [GO:0042552]; ovarian follicle atresia [GO:0001552]; response to glucocorticoid [GO:0051384]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0001552; GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0016405; GO:0031410; GO:0031957; GO:0035338; GO:0042552; GO:0042759; GO:0051384 ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957] GFLKLGLK 0.99302 -5.0977 9.69077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96T49 PP16B_HUMAN "Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein, hTIMAP)" PPP1R16B ANKRD4 KIAA0823 Homo sapiens (Human) establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670] cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell projection [GO:0042995]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888]; establishment of endothelial barrier [GO:0061028]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of filopodium assembly [GO:0051489]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of protein dephosphorylation [GO:0035304]; regulation of sprouting angiogenesis [GO:1903670] GO:0001938; GO:0005634; GO:0005886; GO:0008157; GO:0014066; GO:0016607; GO:0017020; GO:0019888; GO:0035304; GO:0035307; GO:0035308; GO:0042995; GO:0048471; GO:0051489; GO:0061028; GO:1902309; GO:1903589; GO:1903670 myosin phosphatase regulator activity [GO:0017020]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase regulator activity [GO:0019888] KRSTGGR 0.99302 -15.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2286 0 0 0 0 0 0 0 0 9.6153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2463 0 0 0 0 0 0 0 11.2825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7763 0 0 0 0 0 0 0 0 0 0 0 15.6817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ75 CMS1_HUMAN Protein CMSS1 (Cms1 ribosomal small subunit homolog) CMSS1 C3orf26 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] ECFLIQPKER 0.99302 -16.77 0 0 10.8846 11.8498 0 0 0 0 0 0 0 0 0 0 0 0 15.8753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78877 0 0 0 0 0 0 0 0 0 0 13.0315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8694 0 0 0 0 0 0 0 14.6154 0 0 0 0 0 15.3873 0 0 0 14.5954 12.1154 0 0 0 0 0 0 0 14.393 11.6335 11.2913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0766 0 13.7155 0 0 0 0 0 0 0 0 0 11.9761 0 12.4708 0 0 0 0 0 14.842 0 0 0 0 0 0 0 0 11.5787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.895 0 Q9H078 CLPB_HUMAN "Caseinolytic peptidase B protein homolog, EC 3.6.1.- (Suppressor of potassium transport defect 3)" CLPB HSP78 SKD3 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; RIG-I signaling pathway [GO:0039529] cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; RIG-I signaling pathway [GO:0039529] GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0034605; GO:0039529; GO:0140374 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] ALAPRLLLR 0.99302 -39.388 0 14.796 0 0 0 0 0 0 11.4708 0 0 0 0 0 12.1774 0 0 0 10.6402 12.592 0 0 0 0 0 0 0 0 0 10.577 0 0 0 0 0 0 0 0 0 0 12.1065 0 11.6392 0 0 0 0 12.183 11.3059 11.6476 12.7705 0 10.1435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3258 0 0 12.0176 0 0 0 0 0 0 0 0 0 0 13.3733 0 0 0 0 10.1935 0 0 0 0 0 0 0 0 0 13.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7035 0 0 0 0 0 0 0 0 0 0 12.7382 0 0 0 0 0 0 0 0 0 0 12.1171 0 0 0 13.3408 0 0 0 0 0 0 0 0 0 13.0038 0 0 0 0 0 0 14.3001 0 14.2763 0 13.5969 0 12.8366 13.6524 13.4431 0 13.6312 0 0 12.0395 12.2946 13.2166 13.143 0 0 0 0 0 0 13.6165 0 11.1148 Q9H0B8 CRLD2_HUMAN "Cysteine-rich secretory protein LCCL domain-containing 2 (Cysteine-rich secretory protein 11, CRISP-11) (LCCL domain-containing cysteine-rich secretory protein 2)" CRISPLD2 CRISP11 LCRISP2 UNQ2914/PRO1156/PRO9783 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; lung development [GO:0030324] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; lung development [GO:0030324] GO:0005539; GO:0005576; GO:0005615; GO:0008201; GO:0030133; GO:0030198; GO:0030324; GO:0031012; GO:0034774; GO:0060325; GO:0070062; GO:1904813 glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201] AFRIFAVR 0.99302 -16.349 0 0 0 0 0 0 0 0 0 13.6437 0 13.2868 0 0 0 0 0 0 0 0 0 0 0 0 13.017 0 0 0 0 0 0 0 12.7724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7368 0 0 0 0 0 0 0 0 0 0 12.6065 0 0 0 0 0 12.2222 9.70068 0 0 0 0 0 0 11.7784 0 0 0 0 0 13.0164 12.8876 0 0 0 0 0 0 0 0 0 0 0 12.2613 13.0163 0 0 0 0 0 0 0 13.0955 12.9375 0 0 13.5307 0 0 0 0 0 0 11.8808 0 0 0 0 12.3556 0 0 12.6328 0 0 0 0 0 16.9565 0 0 0 0 0 0 0 11.549 0 0 11.4179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0D2 ZN541_HUMAN Zinc finger protein 541 ZNF541 Homo sapiens (Human) "cell differentiation [GO:0030154]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]" GO:0000118; GO:0003714; GO:0005634; GO:0005667; GO:0006357; GO:0007283; GO:0016575; GO:0030154; GO:0045892; GO:0046872 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] AGGLPADASPLFR 0.99302 -15.937 0 0 0 0 0 0 0 0 14.9338 18.1011 15.0348 14.4676 17.8465 13.5524 14.9895 13.0181 17.5048 14.755 14.4694 13.4124 13.3476 0 14.0543 0 14.7423 14.3686 13.2291 15.2971 14.1323 14.9875 13.5314 13.5979 14.0337 13.3845 0 12.9178 12.8757 0 14.6215 14.0914 13.4013 16.4474 13.7582 0 16.0693 15.2837 17.2108 17.1713 14.711 15.6114 15.8586 15.5144 15.7342 15.0759 14.8136 15.4095 14.9801 0 0 0 11.2371 12.1254 11.6779 10.2142 0 11.6481 0 11.5285 0 0 0 0 0 12.9411 0 0 0 0 0 0 0 13.6013 0 0 0 14.2993 0 14.2546 0 0 19.7685 13.5937 16.4038 0 0 14.0268 0 0 11.8153 0 0 0 12.9556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9789 0 0 13.457 0 13.1303 18.891 0 0 0 0 0 0 0 0 19.4823 0 0 0 0 9.20984 19.8475 0 0 0 0 0 19.4643 0 0 0 0 0 0 0 12.5867 0 14.8604 15.7746 15.7611 13.5491 13.5891 15.2565 15.4372 14.7862 16.2358 14.704 17.0347 14.9814 15.002 16.0585 13.4215 0 0 0 15.3709 14.2072 0 15.5584 0 0 Q9Y2K3 MYH15_HUMAN Myosin-15 (Myosin heavy chain 15) MYH15 KIAA1000 Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] GO:0000146; GO:0005516; GO:0005524; GO:0005829; GO:0016460; GO:0030016; GO:0032982; GO:0043231; GO:0051015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AAIEAANLSEELKKK 0.99302 -39.875 0 0 0 0 0 0 0 0 0 11.0977 0 0 0 0 11.2019 0 0 0 0 0 0 10.8828 14.7001 0 9.97699 11.2515 0 10.4654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1123 0 0 12.9377 0 12.5532 0 0 15.9075 0 0 0 0 14.8568 0 0 0 13.0688 0 16.1765 16.091 0 0 15.8667 12.5256 0 12.7996 14.8308 0 0 0 0 0 12.6306 0 11.8808 0 0 12.3984 13.6399 12.5426 13.002 13.9328 15.7423 11.0434 0 11.7346 0 13.9675 0 0 0 0 12.8714 0 13.8513 0 0 15.6039 0 10.5412 0 0 11.2245 13.5916 0 0 12.0272 12.6564 0 11.4815 0 0 0 0 0 11.7374 10.6471 13.9123 12.9235 0 0 10.6795 0 0 0 0 0 0 11.6557 0 0 0 0 0 0 13.086 0 0 14.2323 0 0 0 0 12.3707 Q9Y478 AAKB1_HUMAN "5'-AMP-activated protein kinase subunit beta-1, AMPK subunit beta-1, AMPKb" PRKAB1 AMPK Homo sapiens (Human) cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165] GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006633; GO:0007165; GO:0010628; GO:0019901; GO:0031588; GO:0031669; GO:0035878; GO:0050790; GO:0120162 protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901] DSSGGTK 0.99302 -4.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5603 0 0 0 0 0 Q494V2 CP100_HUMAN Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37) CFAP100 CCDC37 Homo sapiens (Human) cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159] axonemal outer doublet [GO:0097545]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514] axonemal outer doublet [GO:0097545]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159] GO:0003341; GO:0031514; GO:0036064; GO:0036159; GO:0070840; GO:0097545 dynein complex binding [GO:0070840] ALSERQQQKTMR 0.99303 -14.542 0 0 0 12.9171 10.8741 0 13.5686 12.5675 0 0 0 12.2179 0 0 0 0 13.3318 10.5865 13.7218 15.5341 0 16.1688 15.5203 0 0 14.306 13.3674 0 0 0 0 0 0 0 0 13.535 0 0 0 0 0 0 0 0 12.2971 0 0 0 0 0 0 12.7381 0 0 0 0 0 0 0 0 0 0 9.06668 0 0 0 11.2161 10.4161 0 16.5007 0 13.6143 16.6342 16.7251 16.6375 17.2344 16.657 16.7631 17.0305 16.792 0 17.0804 16.3523 16.1763 16.2454 16.3258 17.3525 16.3088 0 14.7411 16.3074 16.4019 0 16.1506 12.6701 16.6145 16.2612 16.1164 16.1778 14.7395 16.6612 16.84 16.2704 16.6239 16.5178 16.188 16.2179 15.725 16.735 16.7253 16.6493 0 16.1847 15.9733 16.1368 11.3778 0 0 16.6398 16.6903 16.4639 16.5046 16.1504 16.3797 16.1939 16.4427 16.1874 16.3446 16.5106 13.4699 0 16.4016 16.3007 16.9549 17.0677 16.705 16.267 16.5332 16.7466 0 12.4204 0 0 16.3176 14.2592 16.4443 0 11.2205 12.4248 0 16.3728 16.6661 16.2755 14.6619 16.4686 16.0802 0 0 0 0 0 0 0 0 0 0 0 0 12.1522 0 0 16.0267 16.0155 16.7637 0 0 16.3476 0 0 0 O15072 ATS3_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 3, ADAM-TS 3, ADAM-TS3, ADAMTS-3, EC 3.4.24.- (Procollagen II N-proteinase, PC II-NP) (Procollagen II amino propeptide-processing enzyme)" ADAMTS3 KIAA0366 Homo sapiens (Human) collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573] GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748 endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] AGDHCDGEK 0.99303 -16.452 0 0 0 0 0 0 0 0 12.0275 0 0 10.793 0 0 0 0 9.9335 0 0 0 0 0 0 0 0 0 10.5236 0 0 0 0 11.129 0 0 0 11.0616 0 0 0 0 0 0 0 0 0 11.6191 0 9.87946 10.9124 0 0 0 0 0 10.356 0 0 0 0 0 0 0 10.514 0 0 0 0 0 0 0 0 0 14.1752 11.2241 0 0 0 0 13.4584 0 0 14.6838 0 0 0 0 16.8071 0 0 16.0185 0 12.2668 14.4751 0 13.9475 13.8975 0 14.1412 0 13.9443 14.1587 0 12.903 0 14.0003 14.6908 14.1119 15.2893 14.5853 13.6564 0 0 16.395 0 0 0 14.894 0 0 12.5791 0 15.6119 0 15.2999 14.4037 13.5618 14.0799 14.03 14.1145 14.4943 0 0 0 0 0 0 0 0 12.7624 0 0 0 0 12.8368 0 14.78 0 0 0 0 0 0 0 0 0 0 11.5867 0 0 12.8578 0 0 12.7295 0 11.4209 0 0 0 0 13.1104 0 0 12.6831 0 0 12.4869 0 0 0 0 O95918 OR2H2_HUMAN Olfactory receptor 2H2 (Hs6M1-12) (Olfactory receptor 2H3) (Olfactory receptor-like protein FAT11) OR2H2 FAT11 OLFR2 OR2H3 Homo sapiens (Human) defense response [GO:0006952]; mating [GO:0007618] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; defense response [GO:0006952]; mating [GO:0007618] GO:0004930; GO:0004984; GO:0005886; GO:0006952; GO:0007618; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AFRRLLGK 0.99303 -16.417 0 0 0 0 0 0 0 14.0647 0 0 0 0 0 0 0 0 0 0 0 0 12.7216 12.9262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8896 0 0 0 0 0 0 13.5031 14.6817 0 15.1583 0 0 0 0 0 13.8784 15.5701 0 0 13.7946 0 14.5693 0 0 0 0 0 0 13.9944 15.1197 0 0 15.4471 14.709 0 14.4446 14.0933 14.1205 0 0 0 0 0 14.3233 0 13.9744 0 0 14.3289 14.1357 14.7892 0 15.6516 13.8656 15.008 0 0 0 0 0 15.4333 0 13.9256 0 0 0 0 0 14.3528 0 0 0 0 0 0 0 13.7916 0 12.9373 0 15.0217 0 0 14.4475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0289 0 13.9452 0 0 0 12.9699 0 P07814 SYEP_HUMAN "Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase, EC 6.1.1.17 (Glutamyl-tRNA synthetase, GluRS); Proline--tRNA ligase, EC 6.1.1.15 (Prolyl-tRNA synthetase) ]" EPRS1 EPRS GLNS PARS QARS QPRS PIG32 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; protein-containing complex assembly [GO:0065003]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418] GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006424; GO:0006433; GO:0008270; GO:0016020; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0065003; GO:0071346; GO:0097452; GO:0140212; GO:1990904 ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270] APVHVKR 0.99303 -26.279 12.9043 0 12.4661 0 0 0 0 0 13.0834 0 13.6203 15.6338 0 0 0 0 0 0 0 15.3979 0 0 14.3055 0 0 0 0 0 0 13.2946 0 0 0 0 0 0 0 0 0 0 0 0 14.4176 0 0 0 0 0 12.5133 0 12.4901 0 12.4817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2051 0 0 0 0 0 0 0 0 13.8126 0 11.8215 13.9574 0 0 0 0 12.3047 13.8098 0 14.7231 0 12.8543 0 0 0 0 0 0 0 0 0 0 0 0 15.1495 0 12.8658 0 14.1328 0 0 0 0 0 12.5705 0 14.655 0 12.0727 0 0 0 0 0 0 0 0 0 0 16.0679 14.3639 0 0 0 0 0 13.4747 0 0 13.1418 0 11.6962 13.5101 0 0 0 12.2793 15.3655 0 0 0 14.2413 0 12.6722 0 14.5488 0 0 0 0 0 10.632 11.394 0 0 0 0 15.7066 0 13.9339 13.1309 0 0 0 11.8431 12.927 0 0 0 P25685 DNJB1_HUMAN "DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1, HSP40, Heat shock protein 40) (Human DnaJ protein 1, hDj-1)" DNAJB1 DNAJ1 HDJ1 HSPF1 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; sperm head [GO:0061827] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; sperm head [GO:0061827]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; forebrain development [GO:0030900]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of ATP-dependent activity [GO:0032781]; regulation of cellular response to heat [GO:1900034]; response to unfolded protein [GO:0006986] GO:0000122; GO:0001671; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006986; GO:0014069; GO:0030544; GO:0030900; GO:0032781; GO:0043025; GO:0043197; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051117; GO:0061827; GO:0070062; GO:0090084; GO:0097201; GO:0098978; GO:1900034 ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; protein folding chaperone [GO:0044183]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082] DVIRPGMR 0.99303 -16.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2765 0 0 0 0 13.1002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.5804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51508 ZNF81_HUMAN Zinc finger protein 81 (HFZ20) ZNF81 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ANTCTEFGKIFTQR 0.99303 -16.048 0 0 0 10.6502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1137 0 0 0 0 0 0 0 0 0 0 0 0 13.6599 0 0 0 0 0 0 10.6615 0 11.0529 0 0 0 0 0 12.8768 12.9456 12.9506 0 0 12.5302 12.7491 0 0 0 0 0 13.4312 13.1298 0 0 0 9.97327 0 0 0 0 0 13.3796 0 0 13.7425 0 0 13.4515 0 0 0 12.8939 0 13.1152 0 0 0 0 13.4247 12.7224 0 13.6185 0 0 0 0 0 15.0532 0 0 13.5989 0 0 13.248 0 0 0 0 0 0 0 0 0 13.6383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52789 HXK2_HUMAN "Hexokinase-2, EC 2.7.1.1 (Hexokinase type II, HK II) (Hexokinase-B) (Muscle form hexokinase)" HK2 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529] centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931] GO:0001666; GO:0001678; GO:0002931; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005813; GO:0005829; GO:0005886; GO:0006002; GO:0006006; GO:0006096; GO:0007595; GO:0008637; GO:0008865; GO:0016020; GO:0016529; GO:0035795; GO:0043231; GO:0045766; GO:0046324; GO:0046835; GO:0051156; GO:0061621; GO:0072655; GO:0072656; GO:1904925; GO:1990830; GO:2000378 ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396] LILVKMAK 0.99303 -24.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5342 0 0 0 0 12.1584 0 0 0 0 11.7637 0 0 0 0 0 0 0 0 0 0 14.2098 0 0 0 0 0 0 0 0 0 0 0 14.2564 0 0 0 13.6823 0 0 0 0 0 0 0 0 0 0 0 0 12.6882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15048 LRC14_HUMAN Leucine-rich repeat-containing protein 14 LRRC14 KIAA0014 Homo sapiens (Human) negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; kinase binding [GO:0019900]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122] GO:0005737; GO:0019900; GO:0032088; GO:0034122 kinase binding [GO:0019900] FNNLGLRGLSVIIPHVARFQHLASLR 0.99303 -4.426 0 0 0 0 0 10.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7398 0 0 0 0 0 13.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7068 0 0 11.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3294 0 0 0 0 0 0 0 12.2202 0 0 0 0 0 0 0 0 0 11.5123 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M3D2 EX3L2_HUMAN Exocyst complex component 3-like protein 2 (HBV X-transactivated gene 7 protein) (HBV XAg-transactivated protein 7) EXOC3L2 XTP7 Homo sapiens (Human) exocyst localization [GO:0051601]; exocytosis [GO:0006887] exocyst [GO:0000145] exocyst [GO:0000145]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887] GO:0000145; GO:0000149; GO:0006887; GO:0051601 SNARE binding [GO:0000149] HVAALLDIRGLR 0.99303 -4.4246 0 0 0 0 0 0 0 0 0 0 13.6418 0 13.0083 0 0 0 0 0 13.237 0 0 0 0 0 0 0 11.4902 13.1121 0 0 0 0 0 0 0 12.0839 0 0 0 13.412 0 0 13.5438 0 12.6715 13.5037 13.0196 0 0 13.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.498 0 0 0 0 0 0 0 0 0 11.3372 0 0 0 15.7209 0 15.2241 0 0 14.3486 0 14.4893 14.3643 0 13.3871 0 0 0 0 14.8973 14.4533 15.1391 0 13.0992 0 0 0 0 14.4403 0 0 0 0 0 11.0705 0 13.3707 0 0 0 11.0801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3071 0 0 0 0 0 0 0 0 0 0 14.7978 0 14.9592 15.4117 0 0 13.3643 0 13.9099 0 0 0 0 0 15.0423 0 0 0 0 Q6XPR3 RPTN_HUMAN Repetin RPTN Homo sapiens (Human) cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular region [GO:0005576] cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] GO:0001533; GO:0005509; GO:0005576; GO:0005829; GO:0046914 calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914] AQLLNSILSVIDVFHK 0.99303 -4.4327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9948 0 13.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3235 0 0 0 0 0 0 0 0 0 0 0 12.9752 0 0 0 0 0 12.3902 0 0 0 0 0 0 11.8306 14.6351 0 0 0 0 0 0 0 0 0 12.4212 0 0 0 0 0 0 0 0 0 0 0 0 11.4491 12.478 0 0 0 10.9321 0 0 0 0 0 0 0 0 0 12.8681 13.3825 0 0 0 0 0 0 0 0 0 12.8128 0 0 0 11.3219 0 0 0 0 0 0 0 0 0 0 0 0 11.7007 0 0 0 0 0 0 0 0 0 12.2782 0 0 0 0 0 0 0 0 Q7L8J4 3BP5L_HUMAN "SH3 domain-binding protein 5-like, SH3BP-5-like" SH3BP5L KIAA1720 UNQ2766/PRO7133 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860]; intracellular signal transduction [GO:0035556]; negative regulation of protein tyrosine kinase activity [GO:0061099] GO:0004860; GO:0005085; GO:0005737; GO:0035556; GO:0061099 guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860] AQFSQILEEHK 0.99303 -14.542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6728 0 0 0 0 0 0 11.5629 0 0 0 13.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYJ2 CJ067_HUMAN "Uncharacterized protein C10orf67, mitochondrial" C10orf67 LINC01552 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 KYGSLSVKVAR 0.99303 -6.9569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZJ4 RGDSR_HUMAN "Ral-GDS-related protein, hRGR (Ral guanine nucleotide dissociation stimulator-like 4, RalGDS-like 4)" RGL4 RGR Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] GO:0005085; GO:0005886; GO:0007265; GO:0031410; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] ARVVEHWIKVAR 0.99303 -4.4231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3T6 T132C_HUMAN Transmembrane protein 132C TMEM132C Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ESEDEDEEER 0.99303 -24.186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4314 0 0 14.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2566 16.384 16.3965 17.8981 0 0 0 0 0 0 0 0 13.9858 0 0 0 0 0 0 0 0 0 0 17.587 0 0 14.2107 0 0 0 0 0 14.992 13.6367 0 0 13.6644 13.1328 13.7608 0 0 0 13.1685 0 14.002 14.3611 0 14.1038 0 13.32 0 0 0 17.1582 0 0 0 0 0 0 13.383 13.8085 0 0 0 0 0 0 0 0 15.1499 0 0 16.9403 0 17.0189 0 18.5749 13.5002 0 0 0 13.8304 0 0 13.5026 13.3795 13.4631 0 0 0 0 13.5983 13.2328 0 0 0 0 17.6075 13.8717 14.7174 0 Q96A83 COQA1_HUMAN "Collagen alpha-1(XXVI) chain (Alpha-1 type XXVI collagen) (EMI domain-containing protein 2) (Emilin and multimerin domain-containing protein 2, Emu2)" COL26A1 EMID2 EMU2 Homo sapiens (Human) positive regulation of cell-substrate adhesion [GO:0010811] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005576; GO:0005581; GO:0005788; GO:0005794; GO:0005886; GO:0010811; GO:0062023 CCPGFTGSNCDEECMNCTR 0.99303 -15.244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.351 0 0 0 13.0278 12.1393 0 0 14.487 13.0963 0 12.9778 0 12.309 12.5337 0 0 0 12.8335 0 0 0 13.2257 0 12.8913 10.3974 12.82 0 0 13.5023 0 12.7237 11.4251 0 0 13.9035 0 0 0 0 14.1182 0 0 0 0 0 0 14.0035 0 13.2621 0 0 0 0 0 0 12.6881 0 0 0 0 0 0 0 14.1392 0 0 10.9826 0 0 0 0 0 0 0 0 0 0 13.3436 0 13.4498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99504 EYA3_HUMAN "Eyes absent homolog 3, EC 3.1.3.48" EYA3 Homo sapiens (Human) anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; visual perception [GO:0007601] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; histone tyrosine phosphatase activity (H2-Y142 specific) [GO:0140793]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; visual perception [GO:0007601] GO:0004725; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006302; GO:0006325; GO:0007601; GO:0009653; GO:0010212; GO:0030154; GO:0045739; GO:0046872; GO:0048856; GO:0140793; GO:2001240 histone tyrosine phosphatase activity (H2-Y142 specific) [GO:0140793]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] AEIEVLTDSWLGTALKSLLLIQSR 0.99303 -17.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8407 0 13.1412 0 12.5727 0 0 0 0 0 0 0 0 0 12.2475 0 0 0 0 0 0 0 12.9853 0 0 0 0 0 12.4269 0 0 0 0 0 0 13.946 0 0 0 0 0 0 0 0 0 0 14.3056 13.1412 0 0 12.8807 0 0 0 12.4156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BY76 ANGL4_HUMAN "Angiopoietin-related protein 4 (Angiopoietin-like protein 4) (Hepatic fibrinogen/angiopoietin-related protein, HFARP) [Cleaved into: ANGPTL4 N-terminal chain; ANGPTL4 C-terminal chain ]" ANGPTL4 ARP4 HFARP PGAR PP1158 PSEC0166 UNQ171/PRO197 Homo sapiens (Human) angiogenesis [GO:0001525]; endothelial cell apoptotic process [GO:0072577]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of lipoprotein lipase activity [GO:0051005]; positive regulation of angiogenesis [GO:0045766]; protein unfolding [GO:0043335]; response to hypoxia [GO:0001666]; triglyceride homeostasis [GO:0070328] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; endothelial cell apoptotic process [GO:0072577]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of lipoprotein lipase activity [GO:0051005]; positive regulation of angiogenesis [GO:0045766]; protein unfolding [GO:0043335]; response to hypoxia [GO:0001666]; triglyceride homeostasis [GO:0070328] GO:0001525; GO:0001666; GO:0004857; GO:0005102; GO:0005576; GO:0005615; GO:0006629; GO:0042802; GO:0043066; GO:0043335; GO:0045766; GO:0051005; GO:0062023; GO:0070328; GO:0072562; GO:0072577; GO:2000352 enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] IQQLFHK 0.99303 -17.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.061 0 0 0 0 15.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2L5 RASF4_HUMAN Ras association domain-containing protein 4 RASSF4 AD037 Homo sapiens (Human) cell cycle [GO:0007049]; signal transduction [GO:0007165] cell cycle [GO:0007049]; signal transduction [GO:0007165] GO:0007049; GO:0007165 EIIKLTMKFQALR 0.99303 -16.429 0 0 0 0 0 11.3326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3512 14.9002 0 0 16.2253 0 0 0 0 0 0 0 0 0 0 0 0 14.1814 0 0 0 0 14.4791 0 0 14.2325 0 14.0937 0 0 0 0 0 0 0 12.5475 0 0 0 0 0 0 0 0 0 0 12.315 0 0 0 0 0 14.3486 0 0 13.5788 0 0 0 0 0 0 0 11.6601 0 0 0 0 0 0 0 0 14.6461 0 0 14.8594 14.795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y624 JAM1_HUMAN "Junctional adhesion molecule A, JAM-A (Junctional adhesion molecule 1, JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1, PAM-1) (CD antigen CD321)" F11R JAM1 JCAM UNQ264/PRO301 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cell-cell adhesion [GO:0098609]; cellular response to mechanical stimulus [GO:0071260]; establishment of endothelial intestinal barrier [GO:0090557]; inflammatory response [GO:0006954]; intestinal absorption [GO:0050892]; leukocyte cell-cell adhesion [GO:0007159]; maintenance of blood-brain barrier [GO:0035633]; memory T cell extravasation [GO:0035683]; negative regulation of GTPase activity [GO:0034260]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of GTPase activity [GO:0043547]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of Rho protein signal transduction [GO:0035025]; protein localization to bicellular tight junction [GO:1902396]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell shape [GO:0008360]; regulation of cytokine production [GO:0001817]; regulation of cytoskeleton organization [GO:0051493]; regulation of membrane permeability [GO:0090559] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; virus receptor activity [GO:0001618]; actomyosin structure organization [GO:0031032]; cell-cell adhesion [GO:0098609]; cellular response to mechanical stimulus [GO:0071260]; establishment of endothelial intestinal barrier [GO:0090557]; inflammatory response [GO:0006954]; intestinal absorption [GO:0050892]; leukocyte cell-cell adhesion [GO:0007159]; maintenance of blood-brain barrier [GO:0035633]; memory T cell extravasation [GO:0035683]; negative regulation of GTPase activity [GO:0034260]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of GTPase activity [GO:0043547]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of Rho protein signal transduction [GO:0035025]; protein localization to bicellular tight junction [GO:1902396]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell shape [GO:0008360]; regulation of cytokine production [GO:0001817]; regulation of cytoskeleton organization [GO:0051493]; regulation of membrane permeability [GO:0090559] GO:0001618; GO:0001817; GO:0005178; GO:0005886; GO:0005911; GO:0005923; GO:0006954; GO:0007159; GO:0008360; GO:0016021; GO:0030054; GO:0030165; GO:0031032; GO:0032956; GO:0032991; GO:0034260; GO:0035025; GO:0035633; GO:0035683; GO:0042803; GO:0043547; GO:0045296; GO:0050892; GO:0051493; GO:0051497; GO:0070062; GO:0070160; GO:0071260; GO:0072659; GO:0090557; GO:0090559; GO:0098609; GO:1901731; GO:1902396; GO:1903142; GO:2000249; GO:2000810 cadherin binding [GO:0045296]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; virus receptor activity [GO:0001618] EDTGTYTCMVSEEGGNSYGEVK 0.99303 -14.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5565 0 12.0465 13.1285 0 12.9555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1085 0 0 0 15.7465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7105 0 0 0 14.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9958 0 0 13.3133 0 13.7842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0606 0 O75190 DNJB6_HUMAN "DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2, HSJ-2) (MRJ) (MSJ-1)" DNAJB6 HSJ2 MRJ MSJ1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; chaperone-mediated protein folding [GO:0061077]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; actin cytoskeleton organization [GO:0030036]; chaperone-mediated protein folding [GO:0061077]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of cellular response to heat [GO:1900034]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]" GO:0001671; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0016020; GO:0030018; GO:0030036; GO:0030198; GO:0031072; GO:0032880; GO:0034504; GO:0042802; GO:0043154; GO:0044183; GO:0045109; GO:0045892; GO:0048471; GO:0051082; GO:0051087; GO:0060710; GO:0060715; GO:0060717; GO:0061077; GO:0090084; GO:1900034 ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] KLALKWHPDK 0.99304 -26.458 0 0 0 0 0 0 0 0 11.8953 11.8623 11.5428 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3805 0 0 0 12.3444 0 0 0 0 11.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2143 0 0 0 0 0 0 0 0 0 18.2819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5745 0 0 0 0 0 0 0 13.6159 14.2999 0 0 14.3224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3641 0 0 P0CB48 UBFL6_HUMAN Putative upstream-binding factor 1-like protein 6 UBTFL6 Homo sapiens (Human) positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360] nucleus [GO:0005634] nucleus [GO:0005634]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360] GO:0001164; GO:0001181; GO:0005634; GO:0006360; GO:0045943 RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] DGEEEESSNSLDCSSGEDMEVDV 0.99304 -16.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2443 0 0 0 0 0 14.9208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6144 0 12.5518 0 0 0 0 0 0 0 0 0 0 0 12.7092 0 0 0 12.5242 0 0 0 0 0 0 0 0 0 P0DMR1 HNRC4_HUMAN Heterogeneous nuclear ribonucleoprotein C-like 4 HNRNPCL4 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723] GO:0003723; GO:0005634 RNA binding [GO:0003723] ANGQDDS 0.99304 -26.488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65953 0 0 9.91075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10997 IAPP_HUMAN "Islet amyloid polypeptide (Amylin) (Diabetes-associated peptide, DAP) (Insulinoma amyloid peptide)" IAPP Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein-containing complex assembly [GO:0031333]; osteoclast differentiation [GO:0030316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; protein destabilization [GO:0031648]; protein homooligomerization [GO:0051260]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615]; inclusion body [GO:0016234] extracellular region [GO:0005576]; extracellular space [GO:0005615]; inclusion body [GO:0016234]; amyloid-beta binding [GO:0001540]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein-containing complex assembly [GO:0031333]; osteoclast differentiation [GO:0030316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; protein destabilization [GO:0031648]; protein homooligomerization [GO:0051260]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165] GO:0001540; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0006915; GO:0007165; GO:0007189; GO:0007204; GO:0007267; GO:0008285; GO:0010628; GO:0010739; GO:0010823; GO:0010942; GO:0016234; GO:0019233; GO:0030316; GO:0031333; GO:0031648; GO:0033138; GO:0042755; GO:0042802; GO:0043065; GO:0043410; GO:0045453; GO:0045671; GO:0045779; GO:0051260; GO:0051897; GO:0070374; GO:0097647; GO:1905665; GO:1905907; GO:1990000 amyloid-beta binding [GO:0001540]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] GILKLQVFLIVLSVALNHLK 0.99304 -4.4368 0 0 0 0 0 0 9.2484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3904 14.6174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8249 0 0 0 0 0 14.9713 9.82675 0 0 0 0 11.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48552 NRIP1_HUMAN Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140) NRIP1 Homo sapiens (Human) cellular response to estradiol stimulus [GO:0071392]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; lipid storage [GO:0019915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle rupture [GO:0001543]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cellular response to estradiol stimulus [GO:0071392]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; lipid storage [GO:0019915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle rupture [GO:0001543]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000118; GO:0000122; GO:0000785; GO:0000978; GO:0001543; GO:0001650; GO:0003713; GO:0003714; GO:0005102; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007623; GO:0016607; GO:0016922; GO:0019915; GO:0030331; GO:0032922; GO:0035259; GO:0042826; GO:0045944; GO:0046965; GO:0071392 histone deacetylase binding [GO:0042826]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] ARLLQSSEDWNAAK 0.99304 -17.398 0 0 0 0 0 0 0 0 0 0 0 14.7685 0 0 0 0 0 0 0 0 0 0 0 9.41631 0 0 0 11.4759 0 0 0 0 10.4862 0 0 13.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5552 0 0 0 0 0 0 0 0 0 11.7012 0 11.233 0 14.3009 0 0 0 15.6153 0 14.1738 0 0 0 13.2128 13.6339 13.9033 13.9495 14.8419 0 0 0 0 12.5459 12.8941 0 0 0 0 15.3384 11.9674 0 0 0 12.7219 14.6764 15.891 0 13.6892 0 0 0 0 12.3571 0 0 15.5273 0 13.7657 12.4214 0 0 0 0 0 0 0 13.5278 0 0 0 0 15.3157 12.9203 0 0 0 0 12.0833 0 13.2879 0 0 0 0 0 0 0 13.8676 0 0 0 0 14.8826 0 10.6368 0 0 0 0 0 13.0121 0 0 12.7404 15.0263 13.8049 14.625 0 0 0 0 0 P48553 TPC10_HUMAN "Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein, EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1, TRAPP subunit TMEM1)" TRAPPC10 EHOC1 TMEM1 Homo sapiens (Human) early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071 DEALTESDEHFSTKLMYEVVDNSSNWAVCGK 0.99304 -13.222 0 0 0 0 0 10.6809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7193 0 0 0 0 0 0 0 9.67034 0 0 0 0 0 0 0 0 0 0 11.8916 12.8614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01668 CAC1D_HUMAN "Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)" CACNA1D CACH3 CACN4 CACNL1A2 CCHL1A2 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cardiac muscle cell action potential involved in contraction [GO:0086002]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; sensory perception of sound [GO:0007605] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; ankyrin binding [GO:0030506]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cardiac muscle cell action potential involved in contraction [GO:0086002]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during SA node cell action potential [GO:0086046]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of calcium ion transport [GO:0051928]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; sensory perception of sound [GO:0007605] GO:0005245; GO:0005262; GO:0005886; GO:0005891; GO:0006816; GO:0007188; GO:0007605; GO:0030018; GO:0030506; GO:0045762; GO:0046872; GO:0051393; GO:0051928; GO:0060372; GO:0070509; GO:0070588; GO:0086002; GO:0086007; GO:0086012; GO:0086046; GO:0086059; GO:0086091; GO:0098703; GO:1901016; GO:1901379; GO:1990454 alpha-actinin binding [GO:0051393]; ankyrin binding [GO:0030506]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in cardiac muscle cell action potential [GO:0086007]; voltage-gated calcium channel activity involved SA node cell action potential [GO:0086059] AFRVLRPLR 0.99304 -6.388 0 0 0 0 0 0 0 0 12.1509 0 0 0 0 0 0 0 0 11.3912 0 0 0 9.71399 11.4861 0 0 10.6555 0 11.1675 0 0 0 0 12.6463 0 0 0 0 0 0 0 0 0 0 13.1787 0 10.159 0 11.9771 0 0 0 0 0 0 0 0 0 0 12.033 0 0 0 0 0 0 0 0 10.7874 0 14.3414 11.0675 0 0 0 0 11.6455 0 10.9893 0 13.7529 12.7406 0 0 15.5233 0 0 13.6319 0 13.9348 0 0 12.5168 13.5204 14.4175 0 0 12.2916 0 0 0 14.8903 14.108 14.0257 0 0 13.5888 0 11.5695 0 14.0837 11.4348 0 0 0 0 0 0 0 0 0 0 0 0 13.5603 15.8221 0 0 0 0 15.1799 0 15.1056 0 0 0 0 0 0 0 12.848 14.9234 0 0 14.3695 0 0 13.5761 13.3719 0 0 0 0 0 12.6417 11.3205 0 14.4392 12.3337 0 14.0133 0 0 0 0 13.076 0 11.4225 0 0 13.3514 0 0 13.6185 12.9426 0 0 15.2412 11.4926 14.783 0 Q5VYX0 RNLS_HUMAN "Renalase, EC 1.6.3.5 (Monoamine oxidase-C, MAO-C)" RNLS C10orf59 Homo sapiens (Human) negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074] extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074]" GO:0002931; GO:0005576; GO:0005615; GO:0010459; GO:0016651; GO:0045776; GO:0051379; GO:0070404; GO:0071871; GO:0097621; GO:1902074 "epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]" AEDSGGR 0.99304 -14.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NXG1 ESRP1_HUMAN Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A) ESRP1 RBM35A Homo sapiens (Human) mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of inner ear auditory receptor cell fate specification [GO:0042669]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016604; GO:0042669; GO:0043484; GO:1990904 mRNA binding [GO:0003729]; RNA binding [GO:0003723] AFMAAQKCHK 0.99304 -16.491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3516 0 12.004 0 0 12.0729 0 0 0 0 0 0 0 0 0 0 0 12.6563 12.5151 0 0 0 10.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5909 0 0 0 0 0 0 0 0 0 0 13.1927 0 14.7105 0 14.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8191 12.8379 0 0 0 0 17.2231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6125 0 0 0 0 0 0 0 0 0 0 0 14.5036 0 0 Q6P093 ADCL2_HUMAN "Arylacetamide deacetylase-like 2, EC 3.1.1.-" AADACL2 Homo sapiens (Human) extracellular region [GO:0005576]; integral component of membrane [GO:0016021] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; carboxylic ester hydrolase activity [GO:0052689] GO:0005576; GO:0016021; GO:0052689 carboxylic ester hydrolase activity [GO:0052689] FFLLEKILTK 0.99304 -16.07 0 0 0 0 0 0 0 10.8403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3192 0 0 0 0 0 0 0 0 0 0 0 0 12.1431 12.5605 11.7622 0 0 0 0 0 10.4164 0 0 0 0 0 0 14.6551 0 0 0 0 0 0 0 14.1874 13.6726 0 0 0 11.1951 0 0 12.5662 0 0 0 0 13.2846 0 16.0833 0 0 0 0 0 0 12.4904 0 13.8026 13.8946 12.3872 12.5494 0 0 0 0 0 12.1663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2487 0 0 0 0 0 0 11.8826 0 0 0 0 Q86XI2 CNDG2_HUMAN "Condensin-2 complex subunit G2 (Chromosome-associated protein G2, CAP-G2, hCAP-G2) (Leucine zipper protein 5) (Non-SMC condensin II complex subunit G2)" NCAPG2 LUZP5 Homo sapiens (Human) cell division [GO:0051301]; chromosome condensation [GO:0030261]; erythrocyte differentiation [GO:0030218]; inner cell mass cell proliferation [GO:0001833]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; transcription by RNA polymerase II [GO:0006366] condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; enzyme activator activity [GO:0008047]; histone deacetylase regulator activity [GO:0035033]; methylated histone binding [GO:0035064]; transmembrane receptor protein tyrosine kinase inhibitor activity [GO:0030293]; cell division [GO:0051301]; chromosome condensation [GO:0030261]; erythrocyte differentiation [GO:0030218]; inner cell mass cell proliferation [GO:0001833]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; transcription by RNA polymerase II [GO:0006366] GO:0000070; GO:0000794; GO:0000796; GO:0001833; GO:0005634; GO:0005654; GO:0006366; GO:0008047; GO:0016020; GO:0016607; GO:0030218; GO:0030261; GO:0030293; GO:0035033; GO:0035064; GO:0043425; GO:0051301; GO:0051984; GO:1905820 bHLH transcription factor binding [GO:0043425]; enzyme activator activity [GO:0008047]; histone deacetylase regulator activity [GO:0035033]; methylated histone binding [GO:0035064]; transmembrane receptor protein tyrosine kinase inhibitor activity [GO:0030293] DMLLECFININYIK 0.99304 -16.086 0 0 0 0 0 0 0 0 14.4621 0 0 0 0 0 0 0 0 11.0278 0 11.3105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3456 0 0 0 0 13.8631 14.5218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6217 0 0 0 0 0 14.8558 0 0 0 0 0 0 12.5784 11.192 0 0 0 0 14.0709 0 13.4429 0 0 13.9307 0 0 0 0 0 0 12.9611 14.6896 14.6864 0 14.1351 12.5004 13.6549 0 0 14.0175 14.0735 0 13.3838 0 0 14.048 12.8204 0 13.3531 0 13.5066 12.6027 15.3429 0 0 0 14.4507 13.2184 0 0 0 0 0 0 0 0 0 0 0 13.8528 0 0 0 0 0 0 0 0 0 0 0 0 12.2491 0 0 0 12.9734 0 0 0 0 0 0 0 Q8IZ40 RCOR2_HUMAN REST corepressor 2 RCOR2 Homo sapiens (Human) "histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; transcription regulator complex [GO:0005667]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000118; GO:0000785; GO:0003714; GO:0005667; GO:0006357; GO:0016575; GO:0019899; GO:0045892 enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714] HGYNIEQALGMLLWHKHDVEK 0.99304 -16.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8351 13.7644 0 0 0 0 0 0 13.2742 0 0 12.6515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0557 0 0 0 0 0 0 0 0 13.67 0 0 0 0 0 0 0 0 13.3922 0 0 0 0 0 13.3507 0 0 0 0 0 0 13.8772 0 13.5161 0 0 0 0 0 0 0 0 0 0 0 13.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WX93 PALLD_HUMAN Palladin (SIH002) (Sarcoma antigen NY-SAR-77) PALLD KIAA0992 CGI-151 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334] GO:0001725; GO:0001726; GO:0002102; GO:0003334; GO:0003382; GO:0003779; GO:0005634; GO:0005739; GO:0005829; GO:0005884; GO:0005886; GO:0005925; GO:0007010; GO:0007156; GO:0007411; GO:0015629; GO:0016477; GO:0030018; GO:0030027; GO:0030036; GO:0030424; GO:0030426; GO:0051371; GO:0060076; GO:0070593; GO:0098632 actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371] AAKPRNR 0.99304 -16.468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8102 12.2089 0 0 0 0 0 0 13.3161 0 0 0 0 16.4007 13.8364 0 0 0 0 0 0 0 0 0 0 0 0 12.852 0 0 0 0 0 0 12.1969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8321 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7017 0 0 0 13.1057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6004 0 Q8WXI2 CNKR2_HUMAN "Connector enhancer of kinase suppressor of ras 2, Connector enhancer of KSR 2 (CNK homolog protein 2, CNK2)" CNKSR2 CNK2 KIAA0902 KSR2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; intracellular signal transduction [GO:0035556]; postsynapse organization [GO:0099173]; regulation of signal transduction [GO:0009966] GO:0005737; GO:0005886; GO:0009966; GO:0019901; GO:0035556; GO:0042802; GO:0043005; GO:0043025; GO:0070062; GO:0098978; GO:0099147; GO:0099173 identical protein binding [GO:0042802]; protein kinase binding [GO:0019901] AEGFISLPEFKIDR 0.99304 -26.509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0371 0 0 0 0 0 0 0 14.5393 0 0 14.7989 15.0483 0 0 0 0 0 0 13.7811 0 13.3249 13.1848 0 0 0 14.8435 0 0 0 12.6538 0 13.6832 17.8897 0 0 0 0 0 0 0 0 14.6547 0 0 0 0 14.9427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5091 0 0 0 0 0 0 0 0 0 0 17.0473 0 0 0 0 0 14.5248 0 0 0 0 0 14.1894 0 0 Q96JK9 MAML3_HUMAN "Mastermind-like protein 3, Mam-3" MAML3 KIAA1816 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; Notch signaling pathway [GO:0007219]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221] GO:0003713; GO:0005634; GO:0005654; GO:0007219; GO:0007221; GO:0016607; GO:0045944 transcription coactivator activity [GO:0003713] AHLSEDQKR 0.99304 -16.075 0 0 0 0 0 0 0 0 0 16.0884 0 14.6017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4779 0 0 0 0 0 14.3127 0 0 0 0 0 0 14.2897 0 13.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0605 0 15.1705 0 0 15.4776 15.5709 0 0 0 0 0 0 0 0 13.1571 0 0 Q96NG3 ODAD4_HUMAN "Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25, TPR repeat protein 25)" ODAD4 TTC25 Homo sapiens (Human) brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229] GO:0003341; GO:0005576; GO:0005737; GO:0005930; GO:0007420; GO:0007507; GO:0030324; GO:0036158; GO:0060287; GO:0090660; GO:0097728; GO:0097729; GO:0120197; GO:0120228; GO:0120229 DEPEKVVK 0.99304 -16.889 0 0 0 0 0 0 0 0 0 0 11.9579 0 0 0 0 0 0 0 0 0 0 12.1771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9669 0 0 0 0 0 0 0 13.7545 0 0 11.8702 0 0 0 0 0 0 0 13.0023 0 0 0 0 13.6066 0 0 13.4019 0 0 0 0 0 0 11.2023 0 0 0 0 0 0 0 0 0 0 0 13.2275 0 0 0 14.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2485 0 0 0 0 0 0 13.14 0 0 0 14.6408 0 0 0 14.9914 13.8527 0 0 0 0 0 0 0 0 0 0 0 13.9378 0 13.7358 13.6018 0 Q9H6H4 REEP4_HUMAN Receptor expression-enhancing protein 4 REEP4 C8orf20 PP432 Homo sapiens (Human) cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microtubule binding [GO:0008017]; cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998] GO:0005783; GO:0005789; GO:0005881; GO:0006998; GO:0007084; GO:0008017; GO:0016020; GO:0016021; GO:0051301; GO:0071782; GO:0071786 microtubule binding [GO:0008017] EGTSRSLKVR 0.99304 -16.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7634 0 0 0 0 0 0 0 0 11.2848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3306 0 0 0 0 0 0 0 0 0 0 0 12.3717 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7615 0 15.2488 0 0 0 0 0 0 0 15.3595 0 11.8189 0 0 12.1964 0 0 0 0 11.2978 0 0 0 10.577 0 0 0 0 0 9.29262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69664 0 0 11.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAR2 AGRL3_HUMAN "Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3, CIRL-3) (Latrophilin-3) (Lectomedin-3)" ADGRL3 KIAA0768 LEC3 LPHN3 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416] axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; synapse assembly [GO:0007416] GO:0001764; GO:0004930; GO:0005509; GO:0005887; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0007420; GO:0016021; GO:0030246; GO:0030424; GO:0098742; GO:0098978 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930] CGDAEDVYYK 0.99304 -16.072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4184 0 0 0 0 0 0 0 0 0 10.809 0 0 0 0 0 13.2458 0 0 0 0 0 0 13.5153 0 0 0 0 13.0108 14.5807 15.2472 15.2467 0 0 13.7617 0 13.1789 0 0 0 13.6484 13.9353 13.6102 0 0 0 0 0 0 0 0 0 0 0 0 13.8814 0 12.2527 0 0 10.3825 0 0 0 0 0 0 0 12.9229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7444 0 0 0 0 0 0 0 0 0 0 0 0 12.7141 0 0 0 0 0 0 0 0 0 0 0 0 12.4604 0 0 0 0 0 0 0 0 0 Q9HCR9 PDE11_HUMAN "Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, EC 3.1.4.35, EC 3.1.4.53 (cAMP and cGMP phosphodiesterase 11A)" PDE11A Homo sapiens (Human) metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165] cytosol [GO:0005829]; perikaryon [GO:0043204] "cytosol [GO:0005829]; perikaryon [GO:0043204]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; metabolic process [GO:0008152]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]" GO:0004112; GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0007165; GO:0008152; GO:0010754; GO:0030553; GO:0043204; GO:0043951; GO:0046872; GO:0047555 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]" CERCSVLLLEDIESPVVKFTK 0.99304 -13.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1728 0 0 0 0 0 0 0 18.1108 0 0 0 0 0 0 0 13.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7486 0 0 0 0 0 0 0 0 0 0 12.7808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8995 0 0 0 0 0 0 Q9P2K5 MYEF2_HUMAN "Myelin expression factor 2, MEF-2, MyEF-2 (MST156)" MYEF2 KIAA1341 Homo sapiens (Human) myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; myotube differentiation [GO:0014902]; neuron differentiation [GO:0030182]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006357; GO:0014902; GO:0030182; GO:0071014; GO:1990904; GO:2000815 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] ADIKEDK 0.99304 -13.227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9084 15.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6715 P25054 APC_HUMAN "Adenomatous polyposis coli protein, Protein APC (Deleted in polyposis 2.5)" APC DP2.5 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell differentiation [GO:0045595]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055] adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909] adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909]; beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; cellular response to DNA damage stimulus [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cell differentiation [GO:0045595]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055] GO:0000281; GO:0000776; GO:0001708; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0006974; GO:0007026; GO:0007094; GO:0007155; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0008286; GO:0010942; GO:0016055; GO:0016328; GO:0016342; GO:0016477; GO:0019887; GO:0019901; GO:0030027; GO:0030335; GO:0030877; GO:0031274; GO:0031625; GO:0032587; GO:0032886; GO:0043065; GO:0043161; GO:0045295; GO:0045595; GO:0045732; GO:0045736; GO:0048471; GO:0051010; GO:0051988; GO:0065003; GO:0070830; GO:0070840; GO:0090090; GO:0120162; GO:1902807; GO:1904781; GO:1990909; GO:2000134 beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625] AQRRIAR 0.99305 -14.69 0 0 0 0 0 0 0 0 0 0 14.8833 13.388 0 0 0 17.8312 0 0 0 13.4653 0 15.8761 0 13.4962 0 13.0823 0 0 0 0 0 0 16.6128 10.3795 0 14.5029 0 14.794 0 10.6523 0 0 0 12.9019 0 17.4138 0 17.1535 14.4216 0 0 0 0 0 0 17.0199 17.0804 16.2254 16.6384 0 0 0 15.791 17.217 0 0 0 0 0 0 0 0 0 16.8424 0 11.4911 0 0 0 0 17.4163 11.9516 0 0 0 0 0 0 13.2024 0 14.5374 0 15.4163 0 0 17.2883 0 0 19.6059 16.7541 0 0 0 0 0 15.1421 14.037 10.8411 10.6336 0 0 0 0 16.0253 0 13.37 12.2989 14.3577 0 14.1772 0 11.8221 12.5173 0 0 0 12.9506 0 0 0 0 11.0092 0 0 0 13.84 13.4671 14.1782 0 0 13.2009 0 0 0 0 0 18.5628 9.22089 0 10.9017 0 0 0 0 13.8936 0 0 0 0 0 0 0 0 0 0 0 0 18.1893 0 0 10.2564 10.3178 0 15.2107 0 0 0 0 0 13.9243 Q6ZTR5 CFA47_HUMAN Cilia- and flagella-associated protein 47 CFAP47 CHDC2 CXorf22 CXorf30 CXorf59 Homo sapiens (Human) cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm connecting piece [GO:0097224] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm connecting piece [GO:0097224]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288] GO:0005737; GO:0005856; GO:0005929; GO:0007288; GO:0060271; GO:0097224 ATLVIQTEEMYWK 0.99305 -42.859 0 11.3488 14.7091 0 0 0 13.5614 10.979 0 0 0 0 12.7189 0 0 11.5117 0 0 0 0 0 0 0 10.551 0 0 12.1148 0 0 0 0 0 9.74231 0 0 0 14.0909 11.886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9743 0 0 0 0 0 0 0 0 0 0 0 0 15.8487 0 12.7534 13.2907 12.7385 0 16.9578 13.696 0 0 0 0 13.6218 17.26 12.3372 14.3825 11.6524 11.2013 13.2631 14.673 15.3174 14.1893 0 13.3915 0 16.5814 14.9796 15.6587 12.9579 0 12.3008 14.7332 12.1767 15.6081 12.0544 14.1298 10.839 0 12.4743 0 12.8812 0 0 0 0 16.4976 14.1741 0 0 15.3904 15.4258 13.8893 0 15.3713 0 14.7654 0 0 0 14.002 15.0403 16.3314 0 0 0 14.1931 0 0 0 0 18.5839 12.923 11.5361 0 0 0 14.85 13.0606 0 16.4629 0 12.2835 0 0 0 14.8195 14.8951 12.1861 13.8431 14.1002 0 0 0 13.9376 14.0657 12.3445 0 0 12.0473 10.2984 0 14.5848 0 11.6971 14.0915 0 0 14.1862 13.1073 13.8535 0 0 10.6841 0 Q5HYW3 RTL5_HUMAN Retrotransposon Gag-like protein 5 (Retrotransposon gag domain-containing protein 4) RTL5 KIAA2001 RGAG4 Homo sapiens (Human) DEEDEDEDGGQK 0.99305 -13.306 10.3759 0 0 0 0 0 0 0 0 0 0 11.4011 0 11.9974 0 0 0 0 0 0 0 0 0 0 0 0 16.1638 0 0 12.1478 0 0 0 0 0 0 0 15.9329 0 0 0 11.643 11.57 0 0 0 0 0 0 12.1001 12.2342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2154 0 0 0 0 14.0636 0 0 0 0 0 0 0 0 0 0 12.2118 0 0 0 0 0 0 0 0 0 0 0 0 14.4692 0 0 0 13.2457 11.9071 13.5393 0 0 0 11.9953 0 0 0 0 0 14.7337 16.1815 0 0 0 14.723 0 0 12.9159 0 12.5271 0 0 0 0 13.7034 0 0 0 14.0726 0 0 0 13.59 0 13.2826 0 14.0146 0 10.4272 0 0 14.6084 0 0 0 0 14.0398 16.975 13.7862 0 0 0 0 0 0 12.4468 14.2317 14.5612 14.3887 14.1967 14.3674 12.932 18.2378 14.3321 18.1026 14.087 14.9797 13.6106 13.8889 0 12.9688 0 0 14.8239 14.7791 0 0 0 0 A0A075B6I0 LV861_HUMAN Immunoglobulin lambda variable 8-61 IGLV8-61 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 SSGVPDR 0.99305 -6.5936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JVW0 INAM1_HUMAN Putative transmembrane protein INAFM1 (InaF-motif-containing protein 1) (Proline-rich protein 24) INAFM1 PRR24 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PQLQLPLSR 0.99305 -13.258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75443 TECTA_HUMAN Alpha-tectorin TECTA Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605] anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605] GO:0005201; GO:0005576; GO:0005886; GO:0007160; GO:0007605; GO:0031012; GO:0031225; GO:0062023; GO:0070062 extracellular matrix structural constituent [GO:0005201] CAAIRLK 0.99305 -7.3121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5194 0 0 0 13.8184 0 14.4962 0 14.1455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8775 0 0 12.2682 0 0 10.7342 0 0 0 0 0 0 13.5875 0 13.7637 0 0 0 11.7801 0 13.0691 0 13.0664 0 11.9008 0 0 12.8365 0 13.7767 0 11.1055 0 0 0 0 14.8313 0 0 0 0 13.1971 13.8188 0 0 0 0 10.4472 14.8598 14.6733 0 0 0 13.604 0 13.3334 13.7781 0 0 0 14.5869 0 14.7712 0 0 0 0 0 0 13.9065 0 14.6658 0 0 0 13.7586 0 0 0 0 0 0 0 0 14.1846 0 12.9409 0 0 0 0 0 0 0 0 0 0 0 12.8107 0 12.9896 0 0 0 14.3362 0 0 0 0 0 0 0 P26640 SYVC_HUMAN "Valine--tRNA ligase, EC 6.1.1.9 (Protein G7a) (Valyl-tRNA synthetase, ValRS)" VARS1 G7A VARS VARS2 Homo sapiens (Human) tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438] cytosol [GO:0005829] cytosol [GO:0005829]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438] GO:0002161; GO:0004832; GO:0005524; GO:0005829; GO:0006418; GO:0006438 aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832] ALSPLEEWLR 0.99305 -26.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2519 0 0 0 0 0 0 0 0 0 0 13.3113 0 0 0 0 0 0 0 0 0 0 0 0 12.4589 14.1088 13.5969 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7708 0 0 0 13.8408 0 0 0 0 0 0 0 0 13.2925 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5111 14.6146 0 12.8563 13.0844 13.8817 13.2141 13.2189 13.2618 14.0381 0 0 10.6977 0 0 0 0 0 0 0 0 0 0 12.9953 13.1608 14.065 12.632 0 0 0 0 0 13.6455 0 0 14.0676 12.9918 0 0 0 12.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49773 HINT1_HUMAN "Adenosine 5'-monophosphoramidase HINT1, EC 3.9.1.- (Desumoylating isopeptidase HINT1, EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1, PKCI-1)" HINT1 HINT PKCI1 PRKCNH1 Homo sapiens (Human) "intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of calcium-mediated signaling [GO:0050850]; protein desumoylation [GO:0016926]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine 5'-monophosphoramidase activity [GO:0043530]; deSUMOylase activity [GO:0016929]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; protein kinase C binding [GO:0005080]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; positive regulation of calcium-mediated signaling [GO:0050850]; protein desumoylation [GO:0016926]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" GO:0000118; GO:0000166; GO:0005080; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007165; GO:0009154; GO:0016787; GO:0016926; GO:0016929; GO:0043530; GO:0050850; GO:0070062; GO:0072332 adenosine 5'-monophosphoramidase activity [GO:0043530]; deSUMOylase activity [GO:0016929]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; protein kinase C binding [GO:0005080] IIRKEIPAK 0.99305 -6.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8149 0 0 0 0 0 0 14.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57768 SNX16_HUMAN Sorting nexin-16 SNX16 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764] cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622] GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006622; GO:0008333; GO:0031313; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0043231; GO:0045022 identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] AFCETLEETNYRLQKELLEK 0.99305 -7.3222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3445 0 0 0 0 0 0 0 0 13.3322 0 0 17.1937 0 13.3157 0 0 0 0 0 0 0 0 13.1438 13.6372 0 13.2629 0 0 0 12.2757 13.1269 13.5238 13.7548 0 0 0 0 0 0 12.71 0 0 13.1529 0 0 0 0 13.3076 0 13.1239 12.5252 0 0 0 0 0 0 0 0 0 0 11.6472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78330 SERB_HUMAN "Phosphoserine phosphatase, PSP, PSPase, EC 3.1.3.3 (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase)" PSPH Homo sapiens (Human) dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; identical protein binding [GO:0042802]; L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; in utero embryonic development [GO:0001701]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574] GO:0000287; GO:0001701; GO:0005737; GO:0005829; GO:0006563; GO:0006564; GO:0009612; GO:0016311; GO:0031667; GO:0033574; GO:0036424; GO:0042802; GO:0042803; GO:0043005 identical protein binding [GO:0042802]; L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] EEGIDELAKICGVEDAVSEMTR 0.99305 -6.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4367 0 0 0 0 0 0 13.8725 0 0 0 0 0 13.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07889 SOS1_HUMAN "Son of sevenless homolog 1, SOS-1" SOS1 Homo sapiens (Human) axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of MAP kinase activity [GO:0043405]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296] GO:0001782; GO:0001942; GO:0003209; GO:0003344; GO:0003677; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008543; GO:0014069; GO:0017124; GO:0019221; GO:0033081; GO:0035264; GO:0038095; GO:0042127; GO:0042129; GO:0043025; GO:0043405; GO:0043547; GO:0045742; GO:0046982; GO:0048011; GO:0048514; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:1904693; GO:1905360; GO:2000973 DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124] AGIPIIK 0.99305 -26.794 0 0 0 0 0 0 0 10.5888 0 14.604 0 0 13.6464 12.5678 13.0065 0 0 0 0 0 0 0 11.7471 0 12.0615 0 0 0 13.0172 0 0 0 0 12.6658 13.28 12.9035 13.5384 12.9841 13.0117 13.0855 0 11.1469 0 17.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1824 0 0 13.2515 13.2267 12.361 0 0 15.4868 14.6664 0 0 12.4968 0 11.9547 0 0 0 0 0 0 0 0 12.0844 0 13.0456 12.8813 0 0 0 0 13.9953 0 0 0 0 13.7177 0 12.7358 11.7777 12.7915 0 14.0014 0 13.7879 0 13.0172 0 0 12.2639 12.8242 0 0 15.8946 15.7987 18.1804 13.4209 0 12.1863 13.7432 13.7753 0 0 13.9361 0 13.5488 0 0 12.858 0 0 13.6452 12.9121 0 0 0 14.3551 0 16.2001 14.3466 0 0 0 0 0 0 0 0 0 15.7277 13.3031 0 11.8113 10.957 0 14.4121 0 16.3882 Q13322 GRB10_HUMAN Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR) GRB10 GRBIR KIAA0207 Homo sapiens (Human) ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of phosphorylation [GO:0042326]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of phosphorylation [GO:0042327]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; response to insulin [GO:0032868]; vascular associated smooth muscle cell migration [GO:1904738] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159]; ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of phosphorylation [GO:0042326]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of phosphorylation [GO:0042327]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; response to insulin [GO:0032868]; vascular associated smooth muscle cell migration [GO:1904738] GO:0005158; GO:0005737; GO:0005829; GO:0005886; GO:0008286; GO:0010467; GO:0030159; GO:0030178; GO:0030949; GO:0032868; GO:0032991; GO:0042326; GO:0042327; GO:0042802; GO:0045719; GO:0046325; GO:0046627; GO:0048009; GO:0070371; GO:0120162; GO:1904738 identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; signaling receptor complex adaptor activity [GO:0030159] AFVLTLCHHQKIK 0.99305 -14.68 0 0 0 0 12.4628 0 0 0 0 0 0 0 0 0 0 0 12.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9133 0 0 0 0 0 0 0 0 0 11.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9416 15.0276 0 0 14.7001 0 13.7833 12.332 15.0467 0 0 0 0 0 0 0 0 0 0 15.1363 0 13.6782 0 0 0 14.6091 14.5016 0 12.8627 0 15.647 0 0 0 0 0 0 0 0 0 0 13.343 13.9376 0 0 0 0 14.4627 0 0 0 0 0 13.9327 0 14.0422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0907 0 0 0 0 0 0 0 0 0 0 0 0 13.5442 Q13591 SEM5A_HUMAN "Semaphorin-5A (Semaphorin-F, Sema F)" SEMA5A SEMAF Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell signaling [GO:0007267]; diencephalon development [GO:0021536]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endothelial cell apoptotic process [GO:2000352]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive chemotaxis [GO:0050918]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein kinase B signaling [GO:0051897]; semaphorin-plexin signaling pathway [GO:0071526]; signal clustering [GO:1990256] GO:0001755; GO:0001938; GO:0002043; GO:0005886; GO:0007155; GO:0007162; GO:0007267; GO:0007399; GO:0007411; GO:0007413; GO:0016020; GO:0016021; GO:0021536; GO:0030215; GO:0030335; GO:0030836; GO:0035373; GO:0043395; GO:0045499; GO:0045545; GO:0045766; GO:0048675; GO:0048842; GO:0048843; GO:0050918; GO:0051897; GO:0060326; GO:0070062; GO:0071526; GO:0090263; GO:1990256; GO:2000352; GO:2001028 chemorepellent activity [GO:0045499]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparan sulfate proteoglycan binding [GO:0043395]; semaphorin receptor binding [GO:0030215]; syndecan binding [GO:0045545] CSATCGGGHYMR 0.99305 -13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6194 0 12.4111 0 13.1243 12.2486 0 0 0 0 0 12.0318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0594 0 0 12.3909 0 12.5892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7095 0 0 0 0 0 0 0 0 0 0 14.2447 14.5126 0 0 0 0 0 0 11.2244 13.6857 0 0 14.2448 0 0 13.6971 0 0 0 15.5975 15.0265 13.4324 0 14.5473 0 0 14.0159 0 12.9283 13.9451 14.4637 0 0 0 0 14.1157 0 0 0 0 13.6915 0 12.899 0 0 0 0 0 0 0 0 13.8244 0 14.3717 13.4006 0 13.8823 0 10.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2694 0 0 0 0 0 13.6908 0 0 0 0 0 0 0 Q14103 HNRPD_HUMAN "Heterogeneous nuclear ribonucleoprotein D0, hnRNP D0 (AU-rich element RNA-binding protein 1)" HNRNPD AUF1 HNRPD Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; CRD-mediated mRNA stabilization [GO:0070934]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere capping [GO:1904355]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]" cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] "cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; CRD-mediated mRNA stabilization [GO:0070934]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere capping [GO:1904355]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of telomere maintenance [GO:0032204]; regulation of transcription, DNA-templated [GO:0006355]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]" GO:0001889; GO:0003680; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006396; GO:0006401; GO:0010468; GO:0021549; GO:0032204; GO:0035925; GO:0042162; GO:0042752; GO:0042789; GO:0042826; GO:0045202; GO:0045727; GO:0045893; GO:0045944; GO:0051592; GO:0051602; GO:0061158; GO:0070934; GO:0071230; GO:0071392; GO:0071732; GO:0097167; GO:0106002; GO:1900152; GO:1901355; GO:1904355; GO:1904383; GO:1904586; GO:1905663; GO:1990828; GO:1990904; GO:2000767 chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] AKAMKTK 0.99305 -14.65 0 0 0 0 0 0 0 0 0 0 0 0 15.0743 0 0 0 12.1705 0 0 0 0 0 0 0 12.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4931 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1137 0 12.3872 11.9832 0 0 0 0 0 0 0 0 12.9863 0 0 0 12.9045 0 0 13.2657 13.3764 0 0 0 0 0 0 0 0 0 0 Q16181 SEPT7_HUMAN Septin-7 (CDC10 protein homolog) SEPTIN7 CDC10 SEPT7 Homo sapiens (Human) cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725] axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283] GO:0000776; GO:0001725; GO:0003924; GO:0005198; GO:0005525; GO:0005634; GO:0005819; GO:0005829; GO:0005930; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0042802; GO:0045296; GO:0060090; GO:0060271; GO:0061640; GO:0070062; GO:0097227; GO:0097730; GO:1902857 cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198] DSEAELQRR 0.99305 -6.2202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8136 13.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q495C1 RN212_HUMAN "Probable E3 SUMO-protein ligase RNF212, EC 2.3.2.- (Probable E3 SUMO-protein transferase RNF212) (RING finger protein 212)" RNF212 Homo sapiens (Human) chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic gene conversion [GO:0006311]; protein sumoylation [GO:0016925]; reciprocal meiotic recombination [GO:0007131] synaptonemal complex [GO:0000795] synaptonemal complex [GO:0000795]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; chiasma assembly [GO:0051026]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic gene conversion [GO:0006311]; protein sumoylation [GO:0016925]; reciprocal meiotic recombination [GO:0007131] GO:0000795; GO:0006311; GO:0007129; GO:0007131; GO:0016925; GO:0019789; GO:0046872; GO:0051026 metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789] APCRTVLLSK 0.99305 -13.267 0 0 0 0 0 0 0 0 0 0 14.4546 0 0 0 0 0 0 0 0 12.9197 0 0 0 0 0 0 0 0 0 0 0 0 13.7302 13.2758 13.3699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3811 0 12.7474 0 0 0 0 0 0 0 0 12.5815 12.5076 0 0 0 0 13.2715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1072 13.0564 13.6434 0 0 0 0 0 0 0 0 0 0 0 0 13.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 14.673 0 0 0 0 0 0 0 0 11.1641 12.5488 0 0 0 0 0 0 0 0 Q4VX62 CF099_HUMAN Putative uncharacterized protein LINC02901 (Long intergenic non-protein coding RNA 2901) LINC02901 C6orf99 Homo sapiens (Human) AVHLLFR 0.99305 -14.331 0 0 0 0 0 0 0 0 0 0 0 0 12.3565 0 0 0 0 0 0 0 0 12.8901 0 12.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6751 14.5023 0 14.2942 14.6729 15.3504 0 0 0 0 0 0 14.3427 14.8723 14.7799 0 13.4793 0 0 0 0 0 0 13.6442 0 0 13.7096 0 0 0 0 0 0 0 0 15.4652 0 0 14.7 13.2871 14.164 0 13.3038 0 13.7202 0 13.7676 13.8185 13.4105 14.7927 0 15.0909 0 13.9409 13.9505 15.3246 0 14.6586 12.6532 13.6579 14.2823 0 0 0 0 14.2979 0 0 13.8728 0 0 0 14.9353 14.2712 15.236 14.3125 0 0 0 0 14.4569 0 0 0 13.4282 14.2148 0 15.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2479 0 13.6111 0 0 0 0 0 Q6ZMV9 KIF6_HUMAN Kinesin-like protein KIF6 KIF6 C6orf102 Homo sapiens (Human) microtubule-based movement [GO:0007018] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ALKVEIEHLQLLMDKAK 0.99305 -13.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1033 0 9.87073 0 0 0 0 0 0 0 0 0 0 0 10.4851 0 0 11.3358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2892 12.535 0 0 0 0 0 0 13.2137 0 13.1048 0 0 0 12.386 0 0 0 13.2532 0 0 0 0 0 15.2558 0 0 13.2789 0 14.0875 0 0 11.6711 0 11.6761 0 0 0 13.0824 0 0 0 0 0 0 12.8591 0 0 0 0 0 0 12.5342 0 0 0 0 0 0 0 0 0 0 0 12.2039 0 0 0 13.8347 13.7687 0 0 12.3499 0 0 0 0 13.3954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9672 0 0 0 0 0 0 0 0 0 0 0 12.4314 0 0 0 0 0 Q7L1Q6 5MP2_HUMAN eIF5-mimic protein 2 (Basic leucine zipper and W2 domain-containing protein 1) (Protein Orf) BZW1 5MP2 BZAP45 KIAA0005 Homo sapiens (Human) regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; regulation of translational initiation [GO:0006446] GO:0003723; GO:0005737; GO:0006446; GO:0016020; GO:0045296 cadherin binding [GO:0045296]; RNA binding [GO:0003723] ELQEQMSRGDPFKDIILYVK 0.99305 -26.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0763 0 12.1909 0 0 0 0 0 14.4506 0 0 0 0 0 0 0 0 0 15.3589 0 0 12.6067 0 0 14.0747 0 0 0 0 0 14.1357 0 0 0 0 0 0 0 14.0232 0 0 0 0 0 0 0 13.2036 0 12.7859 0 0 0 0 11.9958 0 0 0 0 0 13.353 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4P5 GDF7_HUMAN "Growth/differentiation factor 7, GDF-7" GDF7 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]" extracellular space [GO:0005615] "extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]" GO:0005125; GO:0005615; GO:0007411; GO:0008083; GO:0010628; GO:0010862; GO:0021509; GO:0021527; GO:0022612; GO:0030509; GO:0030855; GO:0030901; GO:0032924; GO:0042802; GO:0045165; GO:0045666; GO:0045893; GO:0048608; GO:0048754; GO:0048853; GO:0060389; GO:0060395; GO:0060571; GO:2001051 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802] AAGSGFR 0.99305 -16.977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.234 0 0 0 0 0 0 13.7321 0 0 0 0 0 0 0 0 0 12.1569 0 0 0 12.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3967 0 0 0 0 0 0 Q86SG6 NEK8_HUMAN "Serine/threonine-protein kinase Nek8, EC 2.7.11.1 (Never in mitosis A-related kinase 8, NimA-related protein kinase 8) (Nima-related protein kinase 12a)" NEK8 JCK NEK12A Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of hippo signaling [GO:0035330] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; chromosome segregation [GO:0007059]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of hippo signaling [GO:0035330] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005929; GO:0006468; GO:0007059; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ADQKLVIIK 0.99305 -13.263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8876 0 0 11.3256 0 0 0 0 0 11.1805 0 0 0 0 0 0 0 0 12.2292 0 0 0 11.8251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5171 0 0 0 11.0711 0 0 0 0 0 0 0 13.6603 0 0 11.7701 12.4041 0 0 12.3434 0 0 0 0 0 0 11.2504 0 0 13.2422 10.2075 11.6573 0 0 13.5907 11.6421 0 0 0 0 13.7923 0 0 0 0 0 0 0 10.6196 0 0 0 12.5816 0 0 11.5333 0 0 0 0 12.9078 0 0 0 0 12.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5767 0 12.672 0 0 0 13.381 0 0 0 0 12.4495 0 0 0 0 0 13.4516 0 0 0 0 0 0 0 11.0893 0 0 0 12.5073 0 0 0 Q8IV03 LUR1L_HUMAN Leucine rich adaptor protein 1-like LURAP1L C9orf150 HYST0841 Homo sapiens (Human) positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of signal transduction [GO:0009966] positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of signal transduction [GO:0009966] GO:0009966; GO:0043123 GEEPVPRERDR 0.99305 -6.605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0073 11.6844 11.351 0 0 11.1132 0 0 0 0 12.8138 0 0 17.6425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1021 0 0 0 12.5636 13.8182 0 0 0 0 0 0 0 0 12.751 0 0 0 0 0 0 0 0 0 0 0 12.9181 0 0 0 12.6915 12.792 Q8NEG7 DEN6B_HUMAN Protein DENND6B (DENN domain-containing protein 6B) DENND6B FAM116B Homo sapiens (Human) cytosol [GO:0005829]; recycling endosome [GO:0055037] cytosol [GO:0005829]; recycling endosome [GO:0055037]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829; GO:0055037 guanyl-nucleotide exchange factor activity [GO:0005085] FCCDFRPYFTIHDSEFK 0.99305 -14.694 0 0 0 0 0 11.483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.592 0 0 0 0 0 0 13.6732 0 0 0 14.5684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1078 0 0 0 0 0 0 12.9608 0 0 0 0 0 0 0 0 12.9553 0 0 12.8358 0 0 0 0 13.176 0 0 0 0 13.8217 0 0 0 0 11.7337 0 0 0 0 0 0 10.8216 12.481 0 0 0 0 0 0 0 0 0 0 0 0 Q96DN5 TBC31_HUMAN TBC1 domain family member 31 (WD repeat-containing protein 67) TBC1D31 WDR67 Homo sapiens (Human) centrosome [GO:0005813] centrosome [GO:0005813] GO:0005813 GQYPVFNQYPK 0.99305 -14.333 0 0 0 0 11.691 0 0 0 0 11.8393 0 0 0 0 0 0 11.7345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9817 11.5915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.737 0 0 0 0 0 0 0 0 0 14.3638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7772 0 0 13.8735 12.8876 0 0 0 0 0 12.4198 0 0 0 0 0 12.8068 0 0 0 0 Q96LY2 CC74B_HUMAN Coiled-coil domain-containing protein 74B CCDC74B Homo sapiens (Human) DGPSGNHLSR 0.99305 -13.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.685 0 0 0 0 0 0 0 11.8219 0 0 10.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7151 0 0 0 0 0 0 0 0 9.59235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3649 0 0 0 0 15.002 0 15.0371 0 0 0 0 0 12.8224 14.6977 0 12.8887 0 0 0 0 0 0 0 0 0 0 14.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9907 0 0 0 0 0 11.3746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RP3 UCN2_HUMAN "Urocortin-2 (Stresscopin-related peptide) (Urocortin II, Ucn II) (Urocortin-related peptide)" UCN2 SRP URP Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179]; hormone binding [GO:0042562]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755] GO:0005179; GO:0005576; GO:0005615; GO:0007189; GO:0007586; GO:0009755; GO:0031669; GO:0042562; GO:0051429; GO:0051431 corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179]; hormone binding [GO:0042562] CALLLLMVLMLGRVLVVPVTPIPTFQLR 0.99305 -5.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7136 0 0 0 0 0 13.7815 0 0 0 16.6067 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4227 0 12.8252 0 0 0 0 0 0 0 0 0 0 12.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6498 0 0 0 0 0 0 0 0 12.5547 0 0 0 0 0 0 0 0 0 0 0 0 12.4019 0 0 0 0 0 0 0 12.5421 0 0 12.0987 0 0 0 0 0 0 0 0 0 11.9682 0 0 12.5143 0 0 0 0 0 12.254 0 0 Q9BYN7 ZN341_HUMAN Zinc finger protein 341 ZNF341 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0001216; GO:0003677; GO:0005634; GO:0006355; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CPFSTHTGCSK 0.99305 -26.681 0 0 0 0 0 11.2789 0 0 9.96751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8978 0 0 0 14.0776 13.2472 13.4057 12.7303 14.6624 0 13.3584 0 0 13.3401 0 0 12.6762 0 0 14.3401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3143 13.4259 0 0 12.4368 0 0 13.1402 0 0 13.0903 0 10.9975 13.0019 0 0 0 13.2732 13.1346 13.9427 13.4945 13.3608 13.4376 0 0 12.982 14.7946 13.3292 0 13.277 13.3584 15.0757 0 13.1859 0 0 0 13.208 0 0 0 13.3085 13.388 13.6418 13.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5054 0 0 0 0 0 0 Q9BZF2 OSBL7_HUMAN "Oxysterol-binding protein-related protein 7, ORP-7, OSBP-related protein 7" OSBPL7 ORP7 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; cellular response to cholesterol [GO:0071397]; positive regulation of proteasomal protein catabolic process [GO:1901800]; regulation of autophagy [GO:0010506] autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; cellular response to cholesterol [GO:0071397]; positive regulation of proteasomal protein catabolic process [GO:1901800]; regulation of autophagy [GO:0010506] GO:0005654; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0010506; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0071397; GO:0097038; GO:1901800 cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] DSDGLDRCSHELSECQGK 0.99305 -6.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9021 14.0199 0 0 0 0 0 0 0 15.8 15.5489 0 12.3422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.359 0 0 0 0 13.0816 14.2401 12.276 0 0 0 0 0 0 0 0 0 0 0 14.7925 11.376 0 0 0 0 0 0 0 11.6577 0 0 0 0 15.2285 14.8812 14.3002 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1778 17.0295 0 0 11.5729 0 0 14.277 12.6755 12.7305 0 0 11.312 0 14.6592 10.2508 0 0 0 0 0 0 0 0 0 16.0395 14.7793 14.3994 0 14.0676 0 0 0 0 14.947 0 0 0 0 13.0455 10.8745 0 0 0 0 0 0 12.4867 0 12.7341 0 0 12.3297 0 0 14.7511 0 0 0 14.3822 13.1986 0 0 11.011 0 0 0 0 0 0 12.5157 0 0 0 0 0 0 0 0 0 0 13.2707 0 0 0 Q9H2U1 DHX36_HUMAN "ATP-dependent DNA/RNA helicase DHX36, EC 3.6.4.12, EC 3.6.4.13 (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1, G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein)" DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]" "axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]" GO:0000287; GO:0000781; GO:0000976; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0008094; GO:0010494; GO:0010501; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032206; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0044806; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070062; GO:0070883; GO:0090669; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]" AGRVQPGHCYHLYNGLR 0.99305 -6.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9915 0 0 0 0 0 0 0 0 12.4149 0 0 0 0 0 0 0 0 12.7282 0 0 0 0 0 0 0 0 0 15.2676 0 0 0 0 0 0 0 0 0 14.8858 0 0 0 12.169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1088 0 0 0 0 0 0 0 0 0 0 10.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3R0 KDM4C_HUMAN "Lysine-specific demethylase 4C, EC 1.14.11.66 (Gene amplified in squamous cell carcinoma 1 protein, GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) ([histone H3]-trimethyl-L-lysine(9) demethylase 4C)" KDM4C GASC1 JHDM3C JMJD2C KIAA0780 Homo sapiens (Human) blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; nuclear androgen receptor binding [GO:0050681]; zinc ion binding [GO:0008270]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; positive regulation of cell population proliferation [GO:0008284]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827] GO:0000785; GO:0001825; GO:0005634; GO:0005654; GO:0005721; GO:0006338; GO:0006357; GO:0008270; GO:0008284; GO:0019827; GO:0019899; GO:0032452; GO:0032454; GO:0033169; GO:0050681; GO:0051864; GO:0060765; GO:0070544; GO:0140684; GO:1900113; GO:2000736 enzyme binding [GO:0019899]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; nuclear androgen receptor binding [GO:0050681]; zinc ion binding [GO:0008270] AGLAKVIPPK 0.99305 -43.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4215 0 13.181 0 0 0 0 0 0 0 0 0 0 13.6799 13.4462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4809 0 0 0 0 0 13.8234 0 0 0 0 0 0 9.91724 13.959 0 0 0 12.367 13.2504 0 0 11.7185 0 0 12.7458 0 0 0 0 0 0 0 0 0 0 14.6755 0 14.9875 0 0 0 0 0 0 11.6675 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3201 0 0 0 13.4592 0 12.3545 12.2717 13.3974 0 0 0 0 Q9UMS5 PHTF1_HUMAN Protein PHTF1 PHTF1 PHTF Homo sapiens (Human) cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0005801; GO:0016021 AKPEIPWTSLTR 0.99305 -26.695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2213 0 0 0 0 0 0 0 0 0 10.2751 0 0 0 0 12.7874 0 0 0 0 0 12.5405 0 0 0 0 0 14.9892 0 12.444 0 0 0 15.0565 0 0 13.2503 0 0 0 0 0 0 0 13.3478 0 12.5786 13.3542 0 11.9164 0 15.5783 0 11.1626 0 0 0 0 0 0 0 0 14.6992 0 0 12.5268 0 0 0 0 15.0708 0 0 0 0 13.5067 0 0 14.9417 0 0 0 0 0 0 0 12.7364 0 17.0035 12.9232 0 0 0 0 0 13.2689 12.6156 0 0 14.1124 0 12.7823 0 0 0 0 0 0 0 0 0 0 0 14.349 0 12.8406 0 0 0 0 0 0 0 0 0 12.1834 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5979 Q96T58 MINT_HUMAN Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) SPEN KIAA0929 MINT SHARP Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]" extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0003677; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0007219; GO:0017053; GO:0045892; GO:0050769; GO:0061629; GO:0070062 DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] AHNSVNK 0.99306 -38.906 0 0 0 0 0 0 0 0 11.9089 0 11.0136 0 0 0 10.3453 0 16.025 10.6891 13.1321 0 13.2027 12.4489 0 13.8578 0 12.5686 0 0 0 0 0 0 0 0 0 0 0 11.3778 0 0 0 0 0 15.5791 15.3232 16.0631 0 12.3053 0 0 0 0 0 15.9875 14.6822 14.9974 10.2313 0 0 0 0 12.2138 0 0 12.5802 12.0158 14.2133 0 0 0 11.3039 0 15.9885 15.7151 13.7395 14.2892 12.6121 14.3633 14.8707 17.9825 0 0 0 11.2307 12.4639 0 20.7656 18.9112 18.2813 17.9776 18.5195 12.2653 18.6928 19.0744 19.2572 19.7738 21.1022 21.3562 16.947 16.704 12.4444 13.4146 16.0947 13.5035 15.7395 14.8961 14.8373 16.7999 15.4784 14.7571 14.7518 19.4107 13.8567 19.0569 15.5075 17.8549 0 17.6137 0 13.219 18.0743 15.0557 18.2388 12.6014 19.3959 17.0211 19.3984 12.4878 14.8409 12.3876 13.3366 0 13.4276 15.4843 18.0563 0 0 13.9113 15.9846 15.1159 14.8781 14.9885 15.1653 17.8324 15.0941 14.9188 17.4205 12.0869 0 13.4021 12.9767 13.4944 0 16.1993 19.3729 12.3856 0 0 0 13.168 0 13.6901 0 0 0 13.5115 0 0 12.8686 0 0 13.514 14.6809 16.5988 0 0 0 0 15.7647 0 Q2TAY7 SMU1_HUMAN "WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed ]" SMU1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0000398; GO:0005634; GO:0005737; GO:0008380; GO:0016607; GO:0071005; GO:0071011 EGGDFVCCALSPR 0.99306 -14.372 0 0 0 12.0055 0 0 0 0 13.0584 0 16.8781 0 0 12.9294 13.6875 0 12.7265 0 0 13.7661 0 0 13.6499 0 14.3188 0 15.7928 0 13.9998 0 0 0 0 11.9494 12.1989 0 0 9.56775 0 13.3143 13.5322 14.045 0 12.8948 12.0677 16.5701 11.6516 0 0 12.2139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3694 0 0 0 0 0 0 13.3908 17.7893 13.5497 0 0 13.1039 0 0 0 0 13.1885 0 0 0 0 0 11.8372 0 12.646 0 0 0 0 13.8637 P02751 FINC_HUMAN "Fibronectin, FN (Cold-insoluble globulin, CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3 ]" FN1 FN Homo sapiens (Human) "acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation, fibrin clot formation [GO:0072378]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; heart development [GO:0007507]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of monocyte activation [GO:0150102]; negative regulation of transforming growth factor beta production [GO:0071635]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]" apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093] "apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation, fibrin clot formation [GO:0072378]; calcium-independent cell-matrix adhesion [GO:0007161]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; heart development [GO:0007507]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of monocyte activation [GO:0150102]; negative regulation of transforming growth factor beta production [GO:0071635]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein phosphorylation [GO:0001932]; response to wounding [GO:0009611]; substrate adhesion-dependent cell spreading [GO:0034446]" GO:0001525; GO:0001932; GO:0002020; GO:0005102; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005577; GO:0005604; GO:0005615; GO:0005788; GO:0005793; GO:0005886; GO:0006953; GO:0007044; GO:0007155; GO:0007160; GO:0007161; GO:0007229; GO:0007399; GO:0007507; GO:0008022; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010628; GO:0014068; GO:0016324; GO:0016504; GO:0018149; GO:0019899; GO:0031012; GO:0031093; GO:0033622; GO:0034446; GO:0035987; GO:0042802; GO:0043394; GO:0045773; GO:0048146; GO:0051087; GO:0051702; GO:0062023; GO:0070062; GO:0070372; GO:0070527; GO:0071635; GO:0072378; GO:0072562; GO:0097718; GO:0150102; GO:1901166; GO:1904237 chaperone binding [GO:0051087]; collagen binding [GO:0005518]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102] ARITGYIIK 0.99306 -38.9 0 0 0 0 11.5663 0 0 0 0 10.1495 0 12.1914 0 0 0 0 0 12.4051 12.2416 0 12.011 12.2177 12.0514 13.3914 0 0 0 0 0 0 0 11.9184 0 12.4013 0 0 0 10.0876 0 0 0 0 0 11.5631 0 0 0 0 0 0 0 0 0 0 0 9.85734 0 0 0 0 0 0 0 0 0 0 12.2238 0 0 0 0 0 0 0 14.6791 14.2483 14.1335 14.3134 13.8715 13.7136 15.3068 0 0 0 0 0 0 15.4935 14.4524 17.4614 14.0736 0 13.3622 17.4113 13.4709 14.1901 14.383 15.6883 12.7238 14.8058 15.7276 15.6501 15.5643 0 0 14.5195 14.0747 15.2358 0 13.7159 14.7389 15.0883 14.738 11.7105 0 15.6292 14.7021 0 0 15.0885 14.908 15.3515 0 16.7067 14.7676 15.8873 14.9607 15.6213 14.7661 13.6569 14.7249 13.9936 13.5751 14.5209 15.1343 15.4303 14.814 14.1347 0 14.0206 14.9395 14.4946 13.3565 14.7835 14.3025 15.634 14.3654 13.3056 0 0 14.4196 14.9262 0 11.18 13.4647 13.852 14.8814 0 0 11.8588 0 0 0 0 10.5865 13.6001 10.4986 0 0 12.0014 11.6966 15.0989 13.3845 13.0535 0 0 10.5695 0 0 11.4615 B1AL46 NTM2E_HUMAN NUT family member 2E NUTM2E FAM22E Homo sapiens (Human) AHTGMAR 0.99306 -26.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2816 0 0 12.6114 0 0 0 14.9455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0551 0 0 0 0 0 0 0 14.3162 0 0 0 0 0 0 0 12.8021 0 14.5697 12.7064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4919 0 0 0 0 14.4323 0 0 0 0 0 0 0 0 0 0 14.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9959 0 0 0 0 0 13.0071 O95714 HERC2_HUMAN "E3 ubiquitin-protein ligase HERC2, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2)" HERC2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0031625; GO:0032183; GO:0043161; GO:0061630 guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] AAGLESAATIR 0.99306 -43.126 0 0 0 0 0 0 15.1805 0 0 0 11.9604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3571 0 0 0 12.1203 10.3413 0 0 0 10.65 0 0 0 0 0 0 12.1133 0 0 0 0 0 0 0 0 12.4502 0 0 0 10.2319 0 0 0 0 0 0 0 0 0 0 0 0 13.6144 13.6741 13.8475 0 0 17.89 11.1896 9.91546 15.2383 17.5062 0 13.8245 13.6851 13.2176 17.2728 0 17.0964 15.2078 15.68 14.5435 15.2008 13.1012 17.0964 11.4917 14.2097 14.0168 14.7076 13.9468 0 0 14.4506 16.2888 16.2611 15.289 12.8309 0 0 0 0 0 12.6218 0 14.4798 0 0 0 13.3112 0 11.9129 15.2554 13.3276 13.3842 14.9902 9.52115 0 11.8772 14.4314 15.8655 14.7955 14.2814 14.4912 15.4366 13.279 16.7579 10.5804 0 11.0027 9.91758 9.40487 12.8957 12.2536 14.8905 12.7056 0 13.0173 13.6175 13.8208 16.207 14.0762 12.8638 0 0 0 0 0 14.6292 14.8289 0 0 12.4277 11.2587 10.9227 13.5707 0 0 0 12.1838 0 0 9.37979 0 0 14.943 0 0 0 11.3539 13.8881 0 0 11.6691 13.6881 0 P51449 RORG_HUMAN Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) RORC NR1F3 RORG RZRG Homo sapiens (Human) "adipose tissue development [GO:0060612]; cellular response to sterol [GO:0036315]; circadian regulation of gene expression [GO:0032922]; lymph node development [GO:0048535]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Peyer's patch development [GO:0048541]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fat cell differentiation [GO:0045598]; regulation of glucose metabolic process [GO:0010906]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper cell differentiation [GO:0042093]; xenobiotic metabolic process [GO:0006805]" chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; adipose tissue development [GO:0060612]; cellular response to sterol [GO:0036315]; circadian regulation of gene expression [GO:0032922]; lymph node development [GO:0048535]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Peyer's patch development [GO:0048541]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fat cell differentiation [GO:0045598]; regulation of glucose metabolic process [GO:0010906]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 17 cell differentiation [GO:0072539]; T-helper cell differentiation [GO:0042093]; xenobiotic metabolic process [GO:0006805]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006357; GO:0006805; GO:0008142; GO:0008270; GO:0010906; GO:0016604; GO:0019218; GO:0032922; GO:0036315; GO:0042093; GO:0042753; GO:0045598; GO:0045893; GO:0048535; GO:0048541; GO:0060612; GO:0070244; GO:0072539; GO:0098531; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; ligand-activated transcription factor activity [GO:0098531]; nuclear receptor activity [GO:0004879]; oxysterol binding [GO:0008142]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" CNAAYSCTR 0.99306 -14.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8104 0 0 0 0 0 0 12.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2081 P51825 AFF1_HUMAN "AF4/FMR2 family member 1 (ALL1-fused gene from chromosome 4 protein, Protein AF-4) (Protein FEL) (Proto-oncogene AF4)" AFF1 AF4 FEL MLLT2 PBM1 Homo sapiens (Human) regulation of gene expression [GO:0010468] super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; regulation of gene expression [GO:0010468] GO:0008023; GO:0010468; GO:0032783 AKLTKLK 0.99306 -38.881 0 0 0 0 0 0 0 0 0 13.1395 0 0 0 0 12.6537 0 12.8941 0 0 12.8758 0 12.2902 0 13.0075 12.9441 12.6903 12.4546 0 0 0 11.6831 0 0 0 0 10.5614 13.3278 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3458 13.4138 13.4189 13.8959 0 13.4387 0 13.7788 0 14.2895 0 11.8748 0 0 0 0 13.5748 13.9785 0 11.9621 12.8203 0 0 0 0 0 11.4557 0 0 0 12.0565 0 0 0 0 15.437 0 0 0 0 0 0 13.3235 14.152 14.0782 13.7451 0 0 0 0 13.3525 16.5089 11.1018 13.8855 13.1861 0 0 0 14.6997 13.7803 0 12.9844 14.3455 11.6048 0 11.1875 0 13.0362 15.5207 0 0 13.0745 0 12.6704 12.1156 0 13.1046 0 13.4349 13.448 0 0 0 12.1383 0 14.4735 0 0 11.2218 0 0 0 0 14.6091 0 0 0 15.6235 14.0777 13.2717 0 0 11.3721 0 0 0 P59510 ATS20_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 20, ADAM-TS 20, ADAM-TS20, ADAMTS-20, EC 3.4.24.-" ADAMTS20 Homo sapiens (Human) apoptotic process [GO:0006915]; extracellular matrix organization [GO:0030198]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; signal transduction [GO:0007165] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; extracellular matrix organization [GO:0030198]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of signal transduction [GO:0009967]; proteolysis [GO:0006508]; signal transduction [GO:0007165] GO:0004222; GO:0005615; GO:0006508; GO:0006915; GO:0007165; GO:0008270; GO:0009967; GO:0030198; GO:0030318; GO:0031012; GO:0043066; GO:0045636 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] ANSWNECSVTCGSGVQQR 0.99306 -39.126 0 0 0 0 0 0 0 0 0 0 0 12.1836 0 0 0 0 0 0 0 0 0 10.521 0 0 0 0 12.1926 0 0 0 0 14.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1915 0 0 0 10.7099 13.4397 13.067 13.8414 12.7046 12.5872 0 12.7948 12.6371 13.1423 12.3559 0 12.7032 16.5622 16.8192 0 0 12.5974 0 0 0 0 0 12.5148 0 0 12.2296 0 0 0 12.2557 0 12.3839 0 13.4608 0 0 15.0416 13.6315 15.5195 0 13.2932 0 0 0 0 0 14.3905 13.6409 12.7121 14.709 0 0 12.1737 12.8967 0 0 0 0 14.5014 12.6336 13.0331 0 0 10.9656 0 0 0 0 13.9433 14.1275 0 11.7389 0 0 0 12.6421 0 0 0 0 0 0 0 0 0 0 12.7322 0 12.4623 0 0 0 0 0 0 12.6043 12.8646 0 0 0 0 12.8445 10.2698 11.6448 0 0 15.7984 0 14.4614 15.6636 0 13.5585 0 13.8661 0 12.1748 0 0 13.3283 0 0 13.0033 12.0211 0 0 12.4375 P83859 OX26_HUMAN Orexigenic neuropeptide QRFP (P518) [Cleaved into: QRF-amide (Neuropeptide RF-amide) (Pyroglutamylated arginine-phenylalanine-amide peptide) ] QRFP Homo sapiens (Human) grooming behavior [GO:0007625]; locomotory behavior [GO:0007626]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; regulation of feeding behavior [GO:0060259] extracellular region [GO:0005576] extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; orexigenic neuropeptide QRFP receptor binding [GO:0031854]; grooming behavior [GO:0007625]; locomotory behavior [GO:0007626]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; regulation of feeding behavior [GO:0060259] GO:0005184; GO:0005576; GO:0007218; GO:0007625; GO:0007626; GO:0031854; GO:0045777; GO:0060259 neuropeptide hormone activity [GO:0005184]; orexigenic neuropeptide QRFP receptor binding [GO:0031854] PHSVWGSSR 0.99306 -5.0111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00653 NFKB2_HUMAN "Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10, Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit ]" NFKB2 LYT10 Homo sapiens (Human) "extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; spleen development [GO:0048536]" Bcl3/NF-kappaB2 complex [GO:0033257]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Bcl3/NF-kappaB2 complex [GO:0033257]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; spleen development [GO:0048536]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002268; GO:0002467; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0030198; GO:0033257; GO:0038061; GO:0045944; GO:0048511; GO:0048536; GO:0071159; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ELKKVMDLSIVR 0.99306 -13.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4249 0 10.9417 0 0 0 11.0128 0 0 0 0 0 12.0612 0 0 10.7231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6969 0 0 12.8674 12.4807 0 0 13.4952 13.9706 14.921 12.9415 0 13.4883 14.1019 0 0 0 13.5663 0 13.4528 13.6824 13.4355 13.8229 15.0054 13.5052 14.2454 13.9741 13.967 0 0 13.0453 12.5636 11.7575 13.1433 13.8754 0 0 0 0 13.1532 13.8686 0 14.0731 14.2725 13.5823 13.0846 13.3888 0 13.6872 13.8471 13.5706 0 0 0 13.8902 0 12.0603 0 0 0 12.5844 0 0 15.1273 0 0 0 12.61 12.5703 0 0 0 12.4262 0 0 13.3449 0 0 13.3899 0 14.2564 0 10.894 0 0 0 0 0 12.44 0 0 0 0 0 11.5328 0 0 0 0 0 0 0 0 13.0676 0 Q5JUR7 TEX30_HUMAN Testis-expressed protein 30 TEX30 C13orf27 Homo sapiens (Human) hydrolase activity [GO:0016787] GO:0016787 hydrolase activity [GO:0016787] AYKSVLNYLK 0.99306 -16.659 0 0 0 0 0 0 0 9.8647 0 0 0 0 0 0 0 11.5807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9173 0 0 0 0 0 0 0 0 0 18.8173 0 13.5432 14.0449 0 0 0 0 0 0 0 15.8707 0 0 0 0 13.3068 12.6081 0 18.0982 0 0 0 0 0 0 0 0 0 0 12.5108 0 0 0 0 0 0 18.1387 0 0 0 0 0 0 12.6269 0 0 0 12.7388 0 0 0 0 0 0 12.5596 0 0 0 0 0 0 0 0 0 17.8276 0 0 0 0 0 0 0 0 0 0 0 0 12.0797 12.8944 0 12.104 0 0 0 0 0 0 0 0 0 0 0 Q5T5C0 STXB5_HUMAN Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1) STXBP5 LLGL3 Homo sapiens (Human) exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of protein secretion [GO:0050708]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807] GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0050708; GO:0070161; GO:0098674; GO:0098686; GO:2000300 GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] ILAVGTQTGALR 0.99306 -13.362 0 0 0 0 11.2371 0 0 0 0 0 0 0 0 10.6567 0 0 11.6142 0 0 0 0 0 0 0 10.4789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4483 0 0 0 0 0 0 0 11.3082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6717 0 0 0 0 0 0 0 0 0 14.1213 0 0 0 0 0 0 17.0926 0 12.5748 0 0 0 10.0101 0 0 0 13.1623 0 0 15.8406 0 0 0 0 0 0 0 0 0 14.2805 0 0 0 15.0598 0 0 14.4113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5205 0 0 0 0 0 0 0 0 0 0 0 0 12.772 0 0 0 0 0 0 0 0 0 13.9598 0 0 0 0 0 10.6074 0 0 0 14.0851 0 13.5596 13.3551 0 0 0 0 0 0 0 0 0 0 0 Q6P1Q9 MET2B_HUMAN "tRNA N(3)-methylcytidine methyltransferase METTL2B, EC 2.1.1.- (Methyltransferase-like protein 2B)" METTL2B Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA methylation [GO:0030488] GO:0005737; GO:0016427; GO:0030488; GO:0052735 tRNA (cytosine) methyltransferase activity [GO:0016427]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735] AINRLSR 0.99306 -14.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0897 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9167 0 15.0582 0 0 11.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9112 0 0 0 0 0 0 0 14.6335 0 14.6106 0 14.3049 14.6586 0 0 0 0 0 0 12.0526 14.6557 0 0 0 10.5614 13.7236 0 12.7977 0 0 0 0 0 0 0 12.0628 12.7677 0 0 0 0 12.849 0 0 12.5343 0 13.6555 0 0 0 0 0 11.4661 0 0 0 0 0 0 13.3204 0 0 0 0 0 0 0 12.7392 0 0 0 0 15.76 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2977 0 0 0 0 0 0 0 Q6P3X3 TTC27_HUMAN "Tetratricopeptide repeat protein 27, TPR repeat protein 27" TTC27 Homo sapiens (Human) ALGLAHVAIKCSKNK 0.99306 -38.746 0 10.879 0 0 0 0 0 0 0 0 0 15.2335 14.9812 14.3804 0 0 0 14.7247 0 0 0 0 0 0 0 0 13.3048 15.2699 14.8737 0 0 0 0 0 0 0 0 13.7157 13.9866 0 0 12.1098 0 0 0 12.9966 0 0 0 14.0466 0 12.6103 0 14.133 0 0 0 0 11.6693 0 0 0 0 0 0 0 0 0 0 0 14.98 0 0 15.8331 12.487 0 0 0 0 0 0 11.8084 0 0 0 0 0 0 11.5631 0 0 0 0 12.2667 0 0 0 0 13.7791 0 0 11.8111 12.5264 0 11.9848 13.2091 0 0 0 0 0 0 11.1115 0 11.8042 0 0 0 0 0 0 0 0 13.1941 0 0 0 0 0 0 0 0 0 0 0 0 11.4959 0 0 0 0 0 0 0 0 0 0 0 15.375 11.4468 0 0 0 0 0 0 0 0 14.1681 0 15.1243 0 0 0 0 13.4454 0 13.932 14.4409 0 0 14.673 9.50635 0 10.8158 0 0 0 0 0 Q702N8 XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 (Cardiomyopathy-associated protein 1) XIRP1 CMYA1 XIN Homo sapiens (Human) actin filament organization [GO:0007015]; negative regulation of protein binding [GO:0032091] anchoring junction [GO:0070161] anchoring junction [GO:0070161]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; actin filament organization [GO:0007015]; negative regulation of protein binding [GO:0032091] GO:0003723; GO:0007015; GO:0032091; GO:0051015; GO:0070161 actin filament binding [GO:0051015]; RNA binding [GO:0003723] AEAQSCTWMFK 0.99306 -38.969 0 0 0 0 0 0 0 0 13.7884 0 0 13.9477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1849 0 0 11.3517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0268 0 16.0272 12.0466 0 13.9281 0 0 0 0 0 0 0 0 0 13.2952 0 0 0 15.1603 0 14.9327 0 0 10.1131 0 0 0 0 0 0 0 0 0 0 0 14.7126 0 0 0 0 0 0 0 0 0 12.6262 0 0 12.9965 13.6938 0 0 0 0 13.294 13.3371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.538 0 0 0 0 0 0 0 12.285 0 11.8604 0 0 0 14.4689 13.3195 15.323 0 0 0 0 0 0 12.5516 0 0 0 0 0 13.6973 12.2769 0 0 0 0 0 0 0 0 0 0 Q7Z6Z7 HUWE1_HUMAN "E3 ubiquitin-protein ligase HUWE1, EC 2.3.2.26 (ARF-binding protein 1, ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9, HectH9) (Large structure of UREB1, LASU1) (Mcl-1 ubiquitin ligase E3, Mule) (Upstream regulatory element-binding protein 1, URE-B1, URE-binding protein 1)" HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 Homo sapiens (Human) base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] GO:0000139; GO:0000209; GO:0003677; GO:0003723; GO:0004842; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006284; GO:0006513; GO:0007030; GO:0010637; GO:0016020; GO:0016567; GO:0016574; GO:0030154; GO:0031398; GO:0032922; GO:0034774; GO:0043161; GO:0061025; GO:0061630; GO:0070062; GO:0098779; GO:1903955; GO:1904813 DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AESPEEVACR 0.99306 -38.938 0 0 0 12.6888 0 0 0 13.4517 0 0 0 0 0 0 14.8294 0 0 0 0 0 0 0 12.5124 0 13.8949 0 10.6212 0 0 0 0 0 12.1217 0 0 0 13.1848 0 0 0 0 0 12.381 0 0 0 0 12.6755 0 0 0 0 0 0 0 12.7728 0 0 0 0 0 11.8986 0 0 0 0 0 12.666 0 14.6361 0 12.4805 0 10.775 12.1804 0 14.584 0 0 13.6752 0 14.0401 15.9211 13.19 14.357 0 17.5196 13.3569 0 0 14.1277 11.1997 0 15.0429 14.7058 0 13.9738 0 0 0 0 0 0 13.8334 14.3042 12.4612 12.814 0 0 12.8639 0 10.5663 13.7313 13.2028 13.8571 0 12.1792 0 14.4286 16.1106 0 0 14.4449 0 0 15.7529 15.9875 15.9461 0 14.4073 0 15.6964 13.0093 12.1354 0 12.884 0 13.5666 0 0 13.8218 0 15.1471 14.8396 13.1803 15.6974 12.9832 0 13.3418 14.8464 0 14.4402 0 0 16.3942 13.5951 0 0 0 0 0 12.7842 0 0 14.3459 0 13.7582 0 0 12.5271 0 12.6791 11.5833 14.0256 0 0 0 0 13.2298 12.1646 Q86UV5 UBP48_HUMAN "Ubiquitin carboxyl-terminal hydrolase 48, EC 3.4.19.12 (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific peptidase 48) (Ubiquitin-specific protease 48) (Ubiquitin-specific-processing protease 48)" USP48 USP31 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] ALLVSANQTLKELK 0.99306 -27.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4819 13.1922 0 0 0 14.1417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9227 0 12.07 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IV32 CCD71_HUMAN Coiled-coil domain-containing protein 71 CCDC71 Homo sapiens (Human) AARAQAKVAR 0.99306 -43.493 0 0 11.1281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9485 0 0 0 0 13.9555 0 10.4542 14.8761 0 13.2695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1203 0 0 0 11.4945 0 0 0 0 0 0 0 0 0 14.7316 0 13.6556 0 0 0 0 0 0 0 10.1268 0 13.8742 13.6329 11.3944 0 0 13.4599 13.4935 18.2379 17.9947 14.7455 0 14.3216 15.2938 13.3113 17.3939 0 0 0 0 0 0 0 0 0 14.7625 15.5517 0 0 13.4643 0 0 0 0 0 0 0 0 0 10.9953 0 11.6855 0 12.7152 0 0 0 0 0 12.5459 14.0843 0 0 13.5077 13.0807 0 11.9276 0 0 12.7627 17.9342 0 13.3596 0 0 12.5933 0 0 12.4488 0 0 14.9371 0 0 13.7877 0 12.2874 13.3684 13.2999 0 0 0 0 0 0 0 14.1003 0 0 0 0 0 0 0 14.2677 0 0 13.9941 0 0 0 0 0 Q8IYF1 ELOA2_HUMAN "Elongin-A2, EloA2 (RNA polymerase II transcription factor SIII subunit A2) (Transcription elongation factor B polypeptide 3B)" ELOA2 TCEB3B TCEB3L Homo sapiens (Human) "regulation of DNA-templated transcription, elongation [GO:0032784]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" elongin complex [GO:0070449]; nucleoplasm [GO:0005654] "elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; regulation of DNA-templated transcription, elongation [GO:0032784]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0005654; GO:0006366; GO:0006368; GO:0032784; GO:0070449 AIRDYKR 0.99306 -39.075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8464 0 10.4697 0 0 13.3405 0 12.9682 12.423 0 12.6065 0 0 10.9302 0 0 0 0 0 0 0 0 0 0 0 10.1769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1994 0 0 0 16.531 0 0 0 12.7778 0 12.8494 13.157 0 0 12.9836 0 14.2117 0 0 0 0 11.9404 0 13.9779 0 0 13.2731 0 0 11.9638 0 0 0 15.0568 0 15.2487 0 0 0 12.4127 0 14.6885 0 14.3214 13.6573 0 0 0 0 14.7728 0 0 0 0 14.7835 14.7035 14.8002 0 0 0 0 0 0 0 14.5556 15.293 14.7609 10.1284 13.9682 0 15.1958 15.3074 0 14.5465 0 0 0 0 0 0 13.8702 0 0 0 0 0 14.3836 13.4691 0 14.4035 0 0 0 12.7192 0 0 14.0631 10.4032 0 0 0 0 0 0 0 13.267 0 13.0143 0 0 0 0 0 0 Q96AC1 FERM2_HUMAN "Fermitin family homolog 2 (Kindlin-2) (Mitogen-inducible gene 2 protein, MIG-2) (Pleckstrin homology domain-containing family C member 1, PH domain-containing family C member 1)" FERMT2 KIND2 MIG2 PLEKHC1 Homo sapiens (Human) "adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]" adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] "adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]; adherens junction maintenance [GO:0034334]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]" GO:0001725; GO:0003779; GO:0005178; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009986; GO:0010718; GO:0016055; GO:0019901; GO:0022604; GO:0030054; GO:0030055; GO:0030335; GO:0031234; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035505; GO:0043116; GO:0043547; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0060548; GO:0070374; GO:0072657; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]" ENEALLLR 0.99306 -6.2346 12.2798 0 0 0 0 0 11.9243 0 0 0 16.5471 0 16.2647 0 0 0 0 0 0 13.6552 0 0 0 0 0 0 0 0 0 11.1187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2859 0 0 0 0 11.5105 11.4347 0 0 9.18416 0 0 0 0 10.1647 0 0 0 0 12.6162 0 0 0 0 0 0 0 0 0 0 14.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3207 0 0 13.1657 0 0 0 0 0 0 0 0 0 11.7909 0 0 13.4709 0 13.4322 0 12.0484 0 0 0 0 0 0 0 0 0 0 15.1368 0 0 0 13.6613 0 0 0 0 0 0 0 0 13.799 14.3797 13.9164 0 0 0 0 0 0 0 0 0 13.7109 12.8584 12.5394 14.7603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3318 0 15.0054 14.9683 13.3844 0 Q96F25 ALG14_HUMAN UDP-N-acetylglucosamine transferase subunit ALG14 homolog ALG14 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488] GO:0005789; GO:0006488; GO:0016021; GO:0031965; GO:0043541 MVCVLVLAAAAGAVAVFLILRIWVVLR 0.99306 -6.2411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5755 13.0417 0 0 0 0 0 11.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1786 13.6458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3163 0 0 14.0163 0 0 0 0 0 0 0 0 0 0 13.4128 0 0 0 0 0 0 0 0 0 13.7389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0897 0 0 0 0 0 0 0 15.7924 15.9521 15.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J92 WNK4_HUMAN "Serine/threonine-protein kinase WNK4, EC 2.7.11.1 (Protein kinase lysine-deficient 4) (Protein kinase with no lysine 4)" WNK4 PRKWNK4 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; aldosterone secretion [GO:0035932]; calcium ion homeostasis [GO:0055074]; cellular cation homeostasis [GO:0030003]; cellular chloride ion homeostasis [GO:0030644]; cellular response to xenobiotic stimulus [GO:0071466]; chloride transport [GO:0006821]; distal tubule morphogenesis [GO:0072156]; ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; macrophage activation [GO:0042116]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; potassium ion transmembrane transport [GO:0071805]; protein kinase C signaling [GO:0070528]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; renal sodium ion absorption [GO:0070294]; response to dietary excess [GO:0002021]; sodium ion transmembrane transport [GO:0035725] bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991] bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; chloride ion binding [GO:0031404]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; aldosterone secretion [GO:0035932]; calcium ion homeostasis [GO:0055074]; cellular cation homeostasis [GO:0030003]; cellular chloride ion homeostasis [GO:0030644]; cellular response to xenobiotic stimulus [GO:0071466]; chloride transport [GO:0006821]; distal tubule morphogenesis [GO:0072156]; ERK1 and ERK2 cascade [GO:0070371]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; macrophage activation [GO:0042116]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of sodium ion transport [GO:0010766]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; potassium ion transmembrane transport [GO:0071805]; protein kinase C signaling [GO:0070528]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; renal sodium ion absorption [GO:0070294]; response to dietary excess [GO:0002021]; sodium ion transmembrane transport [GO:0035725] GO:0002021; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005923; GO:0006468; GO:0006469; GO:0006811; GO:0006821; GO:0006954; GO:0008104; GO:0010467; GO:0010766; GO:0016020; GO:0019869; GO:0019870; GO:0030003; GO:0030644; GO:0031404; GO:0032147; GO:0032991; GO:0035556; GO:0035725; GO:0035932; GO:0042116; GO:0044297; GO:0050801; GO:0055074; GO:0070294; GO:0070371; GO:0070528; GO:0071466; GO:0071805; GO:0072156; GO:0090188; GO:0106310; GO:1903288; GO:2000651 ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; chloride ion binding [GO:0031404]; potassium channel inhibitor activity [GO:0019870]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FREMKPR 0.99306 -27.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LW1 Z354B_HUMAN Zinc finger protein 354B ZNF354B Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005634; GO:0006357; GO:0046872 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFIHNSSLRK 0.99306 -13.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7462 0 0 0 0 0 0 0 0 0 0 0 0 10.9728 0 0 0 0 0 0 0 0 0 0 0 0 14.7912 0 0 11.967 0 0 0 0 0 0 0 0 12.4334 13.9453 0 0 0 0 0 0 0 0 13.5523 0 0 0 0 0 0 11.9741 0 0 0 0 0 0 0 12.2361 0 12.8156 13.1381 17.3768 0 12.8438 16.0119 15.4274 0 0 12.5776 12.9458 0 0 0 0 12.1152 0 0 0 0 0 0 14.2195 0 0 0 0 10.5814 0 0 12.6453 0 0 0 11.4226 0 0 12.0748 0 0 0 0 0 0 0 12.4494 13.6222 0 0 0 0 0 0 0 0 12.7844 0 0 0 0 0 0 0 0 0 13.5962 0 11.167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96ND8 ZN583_HUMAN Zinc finger protein 583 (Zinc finger protein L3-5) ZNF583 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHKHEPQKK 0.99306 -27.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5744 0 15.1466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9612 0 15.4243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.466 0 0 0 0 13.3536 13.5742 0 0 12.5794 0 0 0 0 0 0 16.9071 0 0 14.3226 0 0 0 0 0 0 0 0 0 14.3137 0 0 0 0 14.4538 12.6503 0 0 0 12.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5386 0 14.0735 0 0 0 0 0 0 0 0 0 0 13.393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8903 0 0 0 0 0 0 0 0 0 0 0 11.7204 0 0 0 0 0 0 0 0 0 0 0 Q96QE3 ATAD5_HUMAN ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) ATAD5 C17orf41 Elg1 FRAG1 Homo sapiens (Human) cell population proliferation [GO:0008283]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770] Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634] Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]; cell population proliferation [GO:0008283]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770] GO:0003677; GO:0005524; GO:0005634; GO:0008283; GO:0016887; GO:0030890; GO:0031391; GO:0033260; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:0090305; GO:0090618; GO:1901990; GO:1902166; GO:1902751 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860] AAAEALSFTK 0.99306 -44.105 0 0 0 12.9041 0 13.1728 0 0 0 13.1794 0 0 0 0 11.2229 0 12.4138 11.943 0 0 0 11.9592 0 0 11.382 12.9494 12.7276 0 0 12.4759 0 0 0 0 0 0 11.9617 0 0 0 12.2122 11.6604 11.0447 0 13.6659 0 0 0 0 0 0 14.4294 12.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0949 0 15.4918 0 0 13.7581 13.3346 14.8532 14.7134 14.9555 13.9854 14.2265 13.5919 0 14.0391 13.0957 0 0 14.3296 15.9849 15.8744 0 0 13.214 0 0 15.8915 0 12.5723 13.6812 0 15.2253 0 0 15.0904 0 0 0 13.9578 0 14.9029 14.6647 12.7996 16.4743 14.2211 0 14.5609 17.1837 14.0839 13.5557 13.8648 17.0667 13.4466 13.0908 11.6114 0 14 14.979 12.5371 0 12.7314 13.2045 0 14.2339 13.2664 13.67 14.0798 0 0 0 0 13.4194 11.2801 13.29 12.164 0 0 15.0555 13.8802 0 0 16.6365 12.3689 15.3949 0 12.2916 0 0 0 0 11.2219 12.3177 12.5269 0 13.2603 0 0 0 13.2204 0 13.5879 0 0 0 0 13.5703 0 0 Q9BYC9 RM20_HUMAN "39S ribosomal protein L20, mitochondrial, L20mt, MRP-L20 (Mitochondrial large ribosomal subunit protein bL20m)" MRPL20 Homo sapiens (Human) mitochondrial translation [GO:0032543]; ribosomal large subunit assembly [GO:0000027] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal large subunit assembly [GO:0000027] GO:0000027; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0019843; GO:0032543 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] CYRLAVR 0.99306 -6.2313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0987 13.1295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2136 17.7228 0 15.0365 14.9194 14.7716 14.6694 14.7244 14.5064 14.5899 14.0596 14.1561 13.3578 16.9332 0 0 0 13.3109 0 0 14.4034 13.2618 0 15.2902 0 15.1967 0 0 16.9081 0 0 14.011 0 14.5253 14.4295 13.8084 13.8447 0 0 0 14.306 0 13.6294 0 0 0 0 0 13.603 0 13.5676 13.4694 13.3519 14.4585 0 13.1632 13.4662 14.4297 13.2036 14.7364 14.3534 0 15.4943 0 0 0 0 13.0216 13.1467 14.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5516 0 0 0 0 0 0 Q9NVL8 CC198_HUMAN Uncharacterized protein CCDC198 CCDC198 C14orf105 Homo sapiens (Human) DMYFDIPLEHR 0.99306 -16.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7727 0 0 0 0 0 0 0 0 0 15.4887 0 14.3361 0 13.8662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5573 12.723 0 Q9P1A6 DLGP2_HUMAN "Disks large-associated protein 2, DAP-2 (PSD-95/SAP90-binding protein 2) (SAP90/PSD-95-associated protein 2, SAPAP2)" DLGAP2 C8orf68 DAP2 ERICH1-AS1 Homo sapiens (Human) neuron-neuron synaptic transmission [GO:0007270]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; neuron-neuron synaptic transmission [GO:0007270]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] GO:0005883; GO:0005886; GO:0007270; GO:0014069; GO:0060090; GO:0070161; GO:0098962; GO:0098978; GO:0099572 molecular adaptor activity [GO:0060090] ADDHHHAHHAK 0.99306 -43.799 0 0 0 0 0 0 0 10.6158 0 15.6529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.802 0 0 0 15.1816 0 0 16.2729 0 0 0 0 13.3442 13.6644 0 0 0 12.2526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.172 0 0 0 0 0 0 11.891 0 0 0 11.3696 0 0 0 0 0 0 12.2977 0 13.3365 0 0 0 0 0 0 0 13.4863 0 0 0 0 0 0 14.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.11 0 0 12.9412 0 0 0 0 0 13.2968 0 0 0 0 0 0 0 0 0 13.3081 0 0 0 0 0 0 0 12.7922 12.8385 0 0 12.6148 0 0 0 0 0 0 0 0 0 17.6309 12.5668 0 0 0 0 0 0 14.2536 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJQ4 SALL4_HUMAN Sal-like protein 4 (Zinc finger protein 797) (Zinc finger protein SALL4) SALL4 ZNF797 Homo sapiens (Human) embryonic limb morphogenesis [GO:0030326]; inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; ventricular septum development [GO:0003281] cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; embryonic limb morphogenesis [GO:0030326]; inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; ventricular septum development [GO:0003281]" GO:0000122; GO:0000792; GO:0000978; GO:0000981; GO:0001833; GO:0001843; GO:0003281; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0030326; GO:0032991; GO:0035019; GO:0043231; GO:0045944; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSTKGNLKTHLGVHR 0.99306 -6.2394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2738 0 0 0 0 Q9ULE3 DEN2A_HUMAN DENN domain-containing protein 2A DENND2A KIAA1277 Homo sapiens (Human) "protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" actin cytoskeleton [GO:0015629]; cytosol [GO:0005829] "actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005085; GO:0005829; GO:0015031; GO:0015629; GO:0042147 guanyl-nucleotide exchange factor activity [GO:0005085] AEAGSTLPENLGGGSGSEVSQR 0.99306 -13.315 0 0 0 13.4966 0 12.2295 0 0 0 0 0 12.4354 0 0 0 0 13.0312 14.3593 0 0 0 0 12.5072 13.4149 11.1965 0 12.6071 17.7157 12.7012 0 0 13.7053 12.6854 0 0 0 0 0 0 0 0 13.4542 13.4001 17.6677 0 14.6067 0 0 0 17.8452 0 0 0 17.7289 0 0 0 0 0 0 0 0 0 0 17.1812 0 13.2767 0 0 0 0 0 0 12.3973 10.977 0 0 0 0 0 12.3731 13.2046 0 13.7997 0 17.4243 0 0 0 0 13.9474 13.2302 15.2581 12.9116 0 0 0 17.756 0 0 0 14.3095 12.485 0 0 0 0 12.8848 12.78 0 0 0 13.4841 0 12.857 13.4102 14.2896 0 0 0 13.3898 14.0111 0 0 0 0 0 14.3403 0 0 0 0 0 13.7155 14.4836 0 0 13.5761 0 13.1027 0 0 0 0 0 13.3339 0 0 0 0 0 0 0 0 0 0 14.3749 14.1329 0 0 0 0 12.5674 0 13.5899 0 0 0 0 0 14.1681 0 0 0 13.5875 13.0815 0 0 0 0 Q9Y5Z7 HCFC2_HUMAN "Host cell factor 2, HCF-2 (C2 factor)" HCFC2 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; viral process [GO:0016032]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Set1C/COMPASS complex [GO:0048188] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Set1C/COMPASS complex [GO:0048188]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; viral process [GO:0016032]" GO:0000122; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006338; GO:0006355; GO:0006357; GO:0016032; GO:0016604; GO:0035097; GO:0044665; GO:0048188; GO:0051568; GO:0071339 transcription coactivator activity [GO:0003713] ALNSQVCCK 0.99306 -16.231 0 0 0 0 0 0 0 0 0 0 0 11.2245 0 0 0 0 0 0 0 0 0 11.0179 0 0 0 0 0 0 0 0 0 0 0 11.48 0 11.2934 0 0 0 11.2076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9211 0 0 0 12.5609 12.9958 11.9955 0 0 0 0 0 0 0 0 0 0 11.5099 0 0 0 0 0 0 12.3082 13.5868 0 0 0 0 0 0 0 12.4697 0 0 0 12.2666 11.2678 0 0 0 0 0 0 0 0 0 0 11.1126 0 0 0 0 12.8894 10.2677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0244 0 0 0 0 0 0 0 0 0 0 12.4469 0 0 0 O43916 CHST1_HUMAN "Carbohydrate sulfotransferase 1 (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1, GST-1) (Keratan sulfate Gal-6 sulfotransferase, KS6ST, KSGal6ST, KSST, EC 2.8.2.21)" CHST1 Homo sapiens (Human) galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; galactose metabolic process [GO:0006012]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; keratan sulfate metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044]; polysaccharide metabolic process [GO:0005976]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001517; GO:0005802; GO:0005976; GO:0006012; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0042339; GO:0045130 keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] ERSHVAIKTVR 0.99307 -16.266 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8788 0 0 0 0 12.6895 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6952 0 0 0 0 0 12.501 11.6943 13.9853 11.7601 12.2655 0 0 0 0 11.5504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2021 0 0 0 0 0 0 0 10.9458 0 0 0 0 0 0 0 12.7724 0 0 0 0 13.6509 12.4508 12.0547 13.3123 0 14.6283 14.1209 14.0965 0 0 12.8242 0 0 0 14.3035 0 0 0 0 0 0 0 0 0 14.659 0 0 0 0 0 15.2079 0 0 14.9301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9084 0 0 0 0 13.0454 0 0 0 0 0 13.2177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60469 DSCAM_HUMAN Cell adhesion molecule DSCAM (CHD2) (Down syndrome cell adhesion molecule) DSCAM Homo sapiens (Human) axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782]; axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cell adhesion [GO:0007155]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; negative regulation of cell adhesion [GO:0007162]; nervous system development [GO:0007399]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of phosphorylation [GO:0042327]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007162; GO:0007399; GO:0007411; GO:0007416; GO:0007626; GO:0010842; GO:0016020; GO:0030424; GO:0030425; GO:0030426; GO:0042327; GO:0043025; GO:0045202; GO:0048813; GO:0048842; GO:0060060; GO:0060219; GO:0070161; GO:0070593; GO:0098632; GO:1990782; GO:1990890 cell-cell adhesion mediator activity [GO:0098632]; netrin receptor binding [GO:1990890]; protein tyrosine kinase binding [GO:1990782] AAGSVDK 0.99307 -16.713 0 0 0 0 0 0 0 0 12.5716 17.7485 0 0 0 14.2814 0 0 0 0 0 11.6637 14.8543 0 15.1076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.127 14.2329 0 0 0 10.9247 0 0 13.5206 14.8377 14.0986 12.5268 14.0276 12.5282 0 13.85 11.6392 13.0899 13.4626 0 12.3021 0 0 0 12.8133 17.4362 17.5768 17.2898 13.003 0 12.7262 0 14.0279 0 13.3099 0 13.9257 0 11.4539 12.2097 11.763 0 12.5141 0 0 13.1661 16.6802 14.4977 0 12.4203 0 14.1341 0 17.044 17.3759 13.3576 17.9623 0 12.859 13.2736 12.9837 0 13.4614 12.9751 0 14.3782 13.9002 15.4867 0 0 0 13.9438 0 0 16.622 16.2159 15.314 16.0973 12.032 0 0 0 0 14.5072 15.0226 0 0 0 11.4738 17.0216 13.888 14.6457 12.5384 13.8464 14.5198 0 0 0 0 0 13.9269 0 0 0 0 0 0 0 0 0 14.5806 0 0 P53597 SUCA_HUMAN "Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial, EC 6.2.1.4, EC 6.2.1.5 (Succinyl-CoA synthetase subunit alpha, SCS-alpha)" SUCLG1 Homo sapiens (Human) succinyl-CoA catabolic process [GO:1901289]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; succinate-CoA ligase complex (GDP-forming) [GO:0045244] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA catabolic process [GO:1901289]; tricarboxylic acid cycle [GO:0006099] GO:0000166; GO:0003723; GO:0004775; GO:0004776; GO:0005739; GO:0005759; GO:0006099; GO:0009361; GO:0045244; GO:1901289 nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776] IICQGFTGK 0.99307 -16.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9651 0 14.3613 13.9682 13.7107 0 0 0 0 0 0 0 14.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14562 DHX8_HUMAN "ATP-dependent RNA helicase DHX8, EC 3.6.4.13 (DEAH box protein 8) (RNA helicase HRH1)" DHX8 DDX8 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390]" GO:0000390; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] DAEHRDRTK 0.99307 -13.399 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1626 0 0 0 0 12.0337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3533 0 0 0 0 0 0 0 14.2718 0 0 0 0 0 0 16.3852 0 0 0 0 0 13.8187 0 0 0 0 0 0 11.6799 0 0 13.0046 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1764 0 0 0 0 0 0 0 0 0 0 14.7635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2977 0 0 0 0 0 0 0 Q32NC0 CR021_HUMAN UPF0711 protein C18orf21 (HBV X-transactivated gene 13 protein) (HBV XAg-transactivated protein 13) C18orf21 XTP13 PNAS-124 PNAS-131 Homo sapiens (Human) DSKSVLLITCK 0.99307 -14.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0N5 FBP1L_HUMAN "Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1, Toca-1)" FNBP1L C1orf39 TOCA1 Homo sapiens (Human) autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289]; autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0031410; GO:0045296; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320 cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289] DALNKMK 0.99307 -39.798 0 0 13.3482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0061 16.4409 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3525 0 0 0 0 0 0 13.6499 0 0 0 0 0 0 13.1946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZB9 DMRTA_HUMAN Doublesex- and mab-3-related transcription factor A1 DMRTA1 DMO Homo sapiens (Human) germ cell development [GO:0007281]; male mating behavior [GO:0060179]; ovarian follicle development [GO:0001541]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; germ cell development [GO:0007281]; male mating behavior [GO:0060179]; ovarian follicle development [GO:0001541]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]" GO:0000785; GO:0000978; GO:0000981; GO:0001541; GO:0005634; GO:0006357; GO:0007281; GO:0007548; GO:0042802; GO:0046872; GO:0060179; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GLSGFMSPYLTPGLVPTLPFR 0.99307 -17.19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1714 0 13.6613 14.652 14.4753 14.2879 13.5324 11.1454 13.4255 10.7396 13.0964 10.8135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.346 0 0 0 0 16.5532 0 0 0 0 0 0 0 11.8481 0 0 0 0 12.6553 0 0 0 0 0 0 0 0 14.318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXT8 ALKL1_HUMAN "ALK and LTK ligand 1 (Augmentor beta, AUG-beta)" ALKAL1 FAM150A UNQ9433/PRO34745 Homo sapiens (Human) positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976] GO:0005125; GO:0005615; GO:0005886; GO:0010976; GO:0030298; GO:0030971; GO:0070374; GO:0070378 cytokine activity [GO:0005125]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971] ECSTPAYYK 0.99307 -7.7676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2645 0 0 0 0 0 0 0 0 0 14.0736 12.4986 0 0 0 0 0 0 11.2232 0 0 12.7106 12.5974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.892 0 0 0 0 0 0 0 0 11.6652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z407 CSMD3_HUMAN CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3) CSMD3 KIAA1894 Homo sapiens (Human) "negative regulation of complement activation, classical pathway [GO:0045959]; regulation of dendrite development [GO:0050773]" extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of complement activation, classical pathway [GO:0045959]; regulation of dendrite development [GO:0050773]" GO:0005615; GO:0005886; GO:0016021; GO:0045959; GO:0050773 EGDGFSNR 0.99307 -9.2015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8325 0 0 0 14.8804 14.7749 0 0 0 0 0 14.435 13.7671 0 0 0 14.3491 0 0 0 0 12.8552 0 0 0 0 0 14.9184 0 14.6922 14.0989 0 0 0 0 15.5615 0 0 14.3638 0 14.9391 0 0 0 0 14.3028 0 0 0 0 13.5401 13.8223 0 0 0 0 0 13.3339 0 0 0 0 0 0 0 13.5913 0 0 0 11.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6528 0 0 0 0 0 0 0 Q86VH4 LRRT4_HUMAN Leucine-rich repeat transmembrane neuronal protein 4 LRRTM4 UNQ3075/PRO9907 Homo sapiens (Human) anchoring junction [GO:0070161]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211] GO:0005615; GO:0016021; GO:0031012; GO:0045211; GO:0070161 ECEMPHHMK 0.99307 -13.394 0 0 0 0 0 0 0 0 9.92147 0 0 14.5483 13.8279 0 0 0 0 0 0 0 0 10.6075 0 0 13.5527 14.9177 13.454 13.8987 0 14.1331 14.1654 0 0 0 0 0 14.4626 13.9597 0 0 10.2164 0 12.6131 0 0 0 12.7604 0 0 13.8063 0 0 0 0 0 0 0 0 0 10.1032 0 0 0 10.2776 0 0 13.256 0 0 13.5164 0 0 0 0 12.482 14.4662 0 12.1531 0 0 14.586 14.2269 14.1318 0 14.1439 13.8888 14.0583 0 0 13.7673 0 0 14.6066 0 0 0 13.1605 0 0 0 0 0 14.1725 0 0 9.87581 14.011 12.9501 0 14.4672 0 0 0 12.5994 13.8511 0 12.6606 15.2324 13.8905 12.6769 12.4402 0 0 12.5979 0 0 14.1031 11.0059 0 0 0 0 0 0 13.4372 0 13.1335 14.2 12.7453 12.1335 13.7312 10.2374 13.0396 12.4307 12.1725 0 0 13.6239 0 0 0 13.9273 0 14.3122 13.2215 0 13.3734 9.59141 0 9.28554 13.8046 0 0 13.2493 13.28 0 10.6814 0 0 0 13.3965 0 0 14.6587 0 0 0 13.082 0 0 Q96DT7 ZBT10_HUMAN Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF) ZBTB10 RINZF RINZFC Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; telomeric DNA binding [GO:0042162]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000781; GO:0000977; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042162; GO:0046872 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; telomeric DNA binding [GO:0042162]" DFPWLRYSKDTGLMSCGWCQK 0.99307 -13.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3173 0 0 0 0 0 0 0 0 0 13.6407 0 12.553 0 12.4466 0 12.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2492 0 0 0 0 0 0 0 13.3247 0 0 0 0 13.3865 0 0 11.4061 13.8164 0 0 0 0 0 0 17.109 0 0 0 0 0 0 13.0591 0 0 0 0 0 0 0 0 12.9702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7082 0 0 10.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RT1 ERBIN_HUMAN Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2) ERBIN ERBB2IP KIAA1225 LAP2 Homo sapiens (Human) basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; positive regulation of Ras protein signal transduction [GO:0046579]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165] GO:0005102; GO:0005176; GO:0005200; GO:0005604; GO:0005634; GO:0005737; GO:0005886; GO:0006605; GO:0007155; GO:0007165; GO:0007173; GO:0007229; GO:0009925; GO:0016323; GO:0016607; GO:0030054; GO:0030056; GO:0031965; GO:0032088; GO:0032495; GO:0032496; GO:0045104; GO:0045175; GO:0045197; GO:0046579; GO:0070433; GO:0071356; GO:0071638; GO:0098794; GO:0098978; GO:0099072 ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200] EFWMDANR 0.99307 -16.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8013 11.3095 0 0 11.6717 0 0 0 13.8826 0 0 0 0 13.2026 0 0 0 0 0 0 0 0 0 0 0 0 12.766 0 0 0 0 0 0 0 0 0 0 13.6885 0 13.9019 0 0 0 0 0 0 0 0 13.9775 0 0 0 0 0 0 0 0 0 11.5865 0 0 0 12.8721 0 0 0 0 12.4451 13.4444 0 0 0 0 0 0 0 0 0 0 0 0 12.0574 13.5946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C000 NLRP1_HUMAN "NACHT, LRR and PYD domains-containing protein 1, EC 3.4.-.-, EC 3.6.4.- (Caspase recruitment domain-containing protein 7) (Death effector filament-forming ced-4-like apoptosis protein) (Nucleotide-binding domain and caspase recruitment domain) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus, NLRP1-CT; NACHT, LRR and PYD domains-containing protein 1, N-terminus, NLRP1-NT ]" NLRP1 CARD7 DEFCAP KIAA0926 NAC NALP1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; neuron apoptotic process [GO:0051402]; NLRP1 inflammasome complex assembly [GO:1904784]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; response to muramyl dipeptide [GO:0032495]; self proteolysis [GO:0097264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP1 inflammasome complex [GO:0072558]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; NLRP1 inflammasome complex [GO:0072558]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; neuron apoptotic process [GO:0051402]; NLRP1 inflammasome complex assembly [GO:1904784]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; response to muramyl dipeptide [GO:0032495]; self proteolysis [GO:0097264] GO:0002221; GO:0003690; GO:0003725; GO:0004175; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0006954; GO:0008233; GO:0008656; GO:0016887; GO:0019899; GO:0019904; GO:0032495; GO:0032731; GO:0042742; GO:0042981; GO:0043621; GO:0050727; GO:0050729; GO:0051260; GO:0051402; GO:0051607; GO:0061702; GO:0070269; GO:0072558; GO:0097264; GO:0140374; GO:0140608; GO:1904784 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cysteine-type endopeptidase activator activity [GO:0140608]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621] ELELCYR 0.99307 -39.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8792 0 12.3011 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7297 13.5031 17.2037 12.3407 13.0986 11.4498 0 0 0 0 0 0 11.3058 0 0 15.5911 0 0 0 0 0 0 0 0 14.5986 0 12.4138 0 0 0 0 13.4672 0 13.2592 0 0 0 0 0 0 10.9127 0 0 12.7507 0 0 0 0 0 0 11.6903 15.2522 0 0 15.5178 0 0 0 0 0 0 13.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSD9 SYFB_HUMAN "Phenylalanine--tRNA ligase beta subunit, EC 6.1.1.20 (Phenylalanyl-tRNA synthetase beta subunit, PheRS)" FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412] GO:0000287; GO:0003723; GO:0004826; GO:0005524; GO:0005737; GO:0005829; GO:0006412; GO:0006432; GO:0009328; GO:0016020; GO:0051290 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723] ERIKAPVYK 0.99307 -26.115 0 0 0 0 0 0 0 0 0 13.58 0 0 0 0 0 0 12.2648 0 0 0 0 0 0 0 0 10.4175 0 0 0 0 0 11.266 0 12.5175 0 0 0 0 0 13.0684 0 0 0 0 12.9624 0 0 0 0 12.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4846 0 0 16.4426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5352 11.4375 0 0 0 0 0 11.7625 0 0 0 0 0 0 0 0 0 15.3056 0 0 0 0 0 0 13.4628 0 0 0 0 0 12.2655 0 0 0 9.42662 0 0 15.5626 0 0 0 0 0 0 0 0 0 0 13.0908 13.5116 0 0 0 0 0 0 0 12.2277 0 0 0 0 0 0 0 0 14.8466 0 0 Q9UHR5 S30BP_HUMAN SAP30-binding protein (Transcriptional regulator protein HCNGP) SAP30BP HCNGP HTRG HTRP Homo sapiens (Human) "modulation by host of symbiont transcription [GO:0052472]; positive regulation of histone deacetylation [GO:0031065]; regulation of transcription, DNA-templated [GO:0006355]; response to virus [GO:0009615]" intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; modulation by host of symbiont transcription [GO:0052472]; positive regulation of histone deacetylation [GO:0031065]; regulation of transcription, DNA-templated [GO:0006355]; response to virus [GO:0009615]" GO:0005634; GO:0005654; GO:0006355; GO:0009615; GO:0031065; GO:0045111; GO:0052472 CSNHLQDK 0.99307 -13.377 0 0 0 0 0 0 0 0 0 14.3987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6789 0 0 15.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2702 11.5467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5086 0 0 11.1713 0 0 0 14.4003 0 P24928 RPB1_HUMAN "DNA-directed RNA polymerase II subunit RPB1, RNA polymerase II subunit B1, EC 2.7.7.6 (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1, EC 2.7.7.48)" POLR2A POLR2 Homo sapiens (Human) "DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" "chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]" "chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0003677; GO:0003723; GO:0003899; GO:0003968; GO:0005634; GO:0005654; GO:0005665; GO:0005694; GO:0005737; GO:0006353; GO:0006355; GO:0006366; GO:0008022; GO:0019900; GO:0031625; GO:0033120; GO:0046872; GO:1990841 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625] ALQEWILETDGVSLMRVLSEK 0.99308 -26.223 0 0 0 0 0 0 0 0 10.9811 15.565 11.9577 12.5554 0 15.4048 0 0 15.159 0 17.4108 0 0 0 16.9077 0 13.7496 15.7746 0 0 0 0 13.9728 14.4116 0 0 0 0 0 0 0 0 0 0 0 12.67 0 0 0 0 0 0 14.7687 15.673 0 13.7242 16.0209 0 14.5344 16.3234 0 15.9717 13.8755 0 15.949 16.2204 15.4694 13.9241 0 0 0 14.0252 0 0 0 0 16.1832 16.3722 16.1309 0 15.1433 0 14.493 14.8091 14.1855 0 12.6302 14.5844 0 0 15.0109 12.1417 12.6593 12.0598 0 12.0926 14.449 12.1538 0 0 0 14.4301 15.273 14.6609 14.3915 0 0 14.7146 0 0 0 0 0 0 14.0261 0 0 15.2685 18.8359 19.6116 0 16.0302 0 14.0498 0 14.2193 0 16.7008 10.3274 0 0 0 0 14.9663 15.4902 19.5573 0 0 0 0 0 15.5511 0 0 0 0 0 12.3746 16.8313 0 14.6244 0 15.1275 0 0 9.40788 0 15.4787 15.3078 15.181 13.784 13.3143 0 17.3147 15.9829 0 0 15.0959 18.1682 18.2384 0 14.1901 13.5588 0 0 13.5432 18.1353 15.2819 0 0 18.1121 18.0607 B1ANY3 F220P_HUMAN Putative protein FAM220BP (Protein FAM220B pseudogene) FAM220BP C9orf51 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470] nucleus [GO:0005634] nucleus [GO:0005634]; STAT family protein binding [GO:0097677]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein dephosphorylation [GO:0006470] GO:0000122; GO:0005634; GO:0006470; GO:0097677 STAT family protein binding [GO:0097677] DWLGGGPRATHGHRGQCPK 0.99308 -13.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H3BMG3 SMKR1_HUMAN Small lysine-rich protein 1 SMKR1 Homo sapiens (Human) MPAKGKK 0.99308 -5.2438 0 0 0 0 0 0 0 0 13.5037 13.4035 0 15.1429 14.0406 0 0 0 13.665 0 14.1132 0 0 0 0 0 0 14.3459 13.1042 13.8159 13.5459 0 14.2456 13.8255 14.1894 0 12.6918 11.9879 14.9035 0 0 14.4104 14.3783 0 13.5121 0 13.7541 0 15.323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1543 14.3946 14.4442 15.2069 0 0 16.4117 0 0 0 14.2415 13.8088 15.0713 14.147 0 0 0 0 0 0 0 0 0 O95256 I18RA_HUMAN "Interleukin-18 receptor accessory protein, IL-18 receptor accessory protein, IL-18RAcP, EC 3.2.2.6 (Accessory protein-like, AcPL) (CD218 antigen-like family member B) (CDw218b) (IL-1R accessory protein-like, IL-1RAcPL) (Interleukin-1 receptor 7, IL-1R-7, IL-1R7) (Interleukin-18 receptor accessory protein-like) (Interleukin-18 receptor beta, IL-18R-beta, IL-18Rbeta) (CD antigen CD218b)" IL18RAP IL1R7 Homo sapiens (Human) immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; positive regulation of NF-kappaB transcription factor activity [GO:0051092] interleukin-18 receptor complex [GO:0045092]; plasma membrane [GO:0005886] "interleukin-18 receptor complex [GO:0045092]; plasma membrane [GO:0005886]; interleukin-18 receptor activity [GO:0042008]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]" GO:0005886; GO:0006954; GO:0006955; GO:0035655; GO:0042008; GO:0045092; GO:0050135; GO:0051092; GO:0061809 "interleukin-18 receptor activity [GO:0042008]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]" DVAPGGVYAEDIVSIIK 0.99308 -15.976 0 10.7856 0 0 0 10.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9588 0 0 0 0 0 0 16.9648 0 0 0 0 0 0 0 10.1591 0 0 0 13.6116 15.2081 0 0 0 0 0 0 0 12.5942 0 0 0 0 14.7533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C870 JMJD7_HUMAN "Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7, EC 1.14.11.63, EC 3.4.-.- (JmjC domain-containing protein 7) (Jumonji domain-containing protein 7) (L-lysine (3S)-hydroxylase JMJD7)" JMJD7 Homo sapiens (Human) protein hydroxylation [GO:0018126]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; peptidyl-lysine 3-dioxygenase activity [GO:0106155]; protein hydroxylation [GO:0018126]; proteolysis [GO:0006508] GO:0004175; GO:0004177; GO:0004497; GO:0005634; GO:0005737; GO:0006508; GO:0016706; GO:0018126; GO:0035064; GO:0046872; GO:0106155 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; monooxygenase activity [GO:0004497]; peptidyl-lysine 3-dioxygenase activity [GO:0106155] DWVCPNRPCIIR 0.99308 -15.969 0 10.4023 0 0 0 10.4065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8116 12.8049 12.399 0 0 11.3285 12.4879 0 11.8053 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5564 12.9694 0 0 0 0 0 0 0 0 0 0 0 0 13.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7294 0 0 11.4261 0 0 12.6468 0 0 0 0 0 0 0 0 0 0 0 0 13.1339 0 0 0 0 12.686 13.1135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5506 0 0 P18089 ADA2B_HUMAN "Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor, Alpha-2B adrenoceptor, Alpha-2BAR)" ADRA2B ADRA2L1 ADRA2RL1 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; MAPK cascade [GO:0000165]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056] cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; MAPK cascade [GO:0000165]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of blood pressure [GO:0045777]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of uterine smooth muscle contraction [GO:0070474]; receptor transactivation [GO:0035624]; regulation of vascular associated smooth muscle contraction [GO:0003056] GO:0000165; GO:0001525; GO:0003056; GO:0004930; GO:0004938; GO:0005829; GO:0005886; GO:0005887; GO:0007186; GO:0007267; GO:0007565; GO:0009986; GO:0010700; GO:0030168; GO:0032148; GO:0032811; GO:0035624; GO:0043231; GO:0043410; GO:0045666; GO:0045777; GO:0051379; GO:0070474; GO:0071875; GO:0071880 alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930] AKGGPGQGESKQPR 0.99308 -16.347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9956 0 0 0 0 0 0 0 0 0 10.7307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5306 0 0 0 11.9766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42357 HUTH_HUMAN "Histidine ammonia-lyase, Histidase, EC 4.3.1.3" HAL HIS Homo sapiens (Human) histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] cytosol [GO:0005829] cytosol [GO:0005829]; ammonia-lyase activity [GO:0016841]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557] GO:0004397; GO:0005829; GO:0006548; GO:0016841; GO:0019556; GO:0019557 ammonia-lyase activity [GO:0016841]; histidine ammonia-lyase activity [GO:0004397] CRMLLALRINVLAK 0.99308 -16.404 0 0 0 0 0 11.4572 0 0 0 0 0 11.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8708 0 0 0 0 0 16.6605 0 15.4538 15.7988 0 0 15.7098 0 0 15.1225 0 0 10.8107 14.8519 14.2258 0 15.4486 15.3286 12.2037 0 13.7409 0 10.9076 0 15.2345 16.4464 13.2862 0 14.6287 0 0 0 13.4903 0 0 0 10.4252 9.93549 0 14.5627 14.2258 0 0 0 13.1796 0 0 0 0 0 13.7208 0 0 12.8444 0 0 12.6402 0 0 0 0 14.8845 0 0 0 0 0 0 0 0 13.4067 10.3129 0 0 11.3862 13.8771 0 0 0 12.9864 0 0 0 0 0 0 0 0 0 0 0 14.8815 P51888 PRELP_HUMAN Prolargin (Proline-arginine-rich end leucine-rich repeat protein) PRELP SLRR2A Homo sapiens (Human) cellular senescence [GO:0090398]; skeletal system development [GO:0001501] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; heparin binding [GO:0008201]; cellular senescence [GO:0090398]; skeletal system development [GO:0001501] GO:0001501; GO:0005201; GO:0005576; GO:0005615; GO:0005796; GO:0008201; GO:0030021; GO:0031012; GO:0043202; GO:0062023; GO:0070062; GO:0090398; GO:1903561 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; heparin binding [GO:0008201] ECYCPPDFPSALYCDSR 0.99308 -16.403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8207 0 0 0 0 0 0 10.8635 0 0 0 0 0 0 0 0 0 0 0 0 12.0444 0 11.3112 0 0 0 0 0 0 13.8094 0 0 0 0 0 0 14.7289 0 0 0 0 0 0 0 12.9579 10.7938 0 0 0 0 0 0 0 0 0 13.0746 0 12.1074 0 0 0 0 12.8214 0 0 12.6298 0 12.6604 0 0 12.1756 0 12.116 0 0 0 0 0 0 12.8761 0 0 0 0 0 0 0 0 0 12.8542 0 0 0 0 0 0 0 0 11.0135 0 0 0 0 0 Q6PJQ5 FOXR2_HUMAN Forkhead box protein R2 (Forkhead box protein N6) FOXR2 FOXN6 Homo sapiens (Human) chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0005634; GO:0005654; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" DEDNARPR 0.99308 -17.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3362 0 0 0 0 0 0 0 0 0 0 0 0 14.5257 0 0 0 0 0 0 0 0 0 0 15.1238 0 0 0 14.325 0 13.9095 0 0 13.6595 0 0 0 0 0 0 0 0 0 12.8935 0 0 Q7Z5K2 WAPL_HUMAN Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor) WAPL FOE KIAA0261 WAPAL Homo sapiens (Human) cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of chromosome segregation [GO:0051983]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of chromosome segregation [GO:0051983]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]" GO:0000278; GO:0000775; GO:0000785; GO:0000795; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0009636; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0048146; GO:0051301; GO:0051983; GO:0060623; GO:0071168; GO:0071922; GO:0072686 CAMPSFRMHLR 0.99308 -16.766 0 0 0 0 0 0 0 0 0 0 14.0092 13.669 11.2523 13.2906 13.2831 0 0 0 0 12.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2404 0 0 0 12.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8678 0 0 0 11.3036 11.9956 0 0 11.366 0 0 11.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4402 0 0 0 11.08 0 11.1901 0 0 0 13.4606 0 0 0 13.2754 0 0 0 0 0 0 0 0 0 12.8995 0 0 0 0 0 0 0 11.9314 0 13.1114 12.2693 0 13.1576 0 0 0 12.8924 12.9562 13.7591 0 0 0 0 0 12.5338 0 0 16.285 11.996 0 12.0222 0 0 12.9401 0 0 0 0 0 0 16.7969 0 0 11.9928 0 17.1482 17.1759 16.8753 17.9778 0 0 12.3197 0 0 17.0546 0 0 16.9588 17.3338 16.7874 Q86WP2 GPBP1_HUMAN Vasculin (GC-rich promoter-binding protein 1) (Vascular wall-linked protein) GPBP1 GPBP SSH6 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0003700; GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0006351; GO:0006355; GO:0043231; GO:0045944 DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723] DRVEEEHEDESR 0.99308 -16.772 10.4956 0 0 12.3476 0 0 0 0 0 0 0 9.78643 0 0 0 0 0 0 13.7871 13.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.28392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9357 0 0 0 0 0 0 13.9474 14.1231 0 0 0 0 0 0 0 0 0 0 14.1766 0 0 0 0 0 0 0 0 0 0 0 14.5196 0 14.6815 13.4308 15.0472 0 0 0 0 0 13.2504 0 0 0 0 0 0 12.0699 0 12.0863 0 0 0 0 0 0 0 0 0 13.9304 14.0696 0 0 0 12.6427 0 0 0 15.1959 0 13.7928 0 0 0 0 0 0 0 13.4186 0 0 0 0 Q8NH05 OR4Q3_HUMAN Olfactory receptor 4Q3 (Olfactory receptor 4Q4) (Olfactory receptor OR14-3) OR4Q3 C14orf13 OR4Q4 Homo sapiens (Human) integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NTDMKTAMK 0.99308 -16.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9892 0 0 0 0 0 0 0 0 0 0 0 0 10.2317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXG1 RSAD2_HUMAN "Radical S-adenosyl methionine domain-containing protein 2, EC 4.2.-.- (Cytomegalovirus-induced gene 5 protein) (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)" RSAD2 CIG5 Homo sapiens (Human) "CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]" GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0043621; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553 "4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]" ALNPVRWK 0.99308 -16.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.309 0 0 0 0 0 0 11.2949 0 0 0 0 0 0 0 0 0 0 11.7431 0 10.0315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.801 0 0 0 0 14.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3161 0 0 0 0 0 0 0 0 0 0 0 11.858 0 0 0 0 0 11.677 0 0 0 11.3698 0 0 0 14.3995 0 0 0 0 0 0 0 0 0 0 0 13.7241 0 0 0 0 0 14.912 14.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.108 0 11.7464 0 0 0 0 0 0 0 0 0 0 0 0 Q92830 KAT2A_HUMAN "Histone acetyltransferase KAT2A, EC 2.3.1.48 (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5, hGCN5) (Histone glutaryltransferase KAT2A, EC 2.3.1.-) (Histone succinyltransferase KAT2A, EC 2.3.1.-) (Lysine acetyltransferase 2A) (STAF97)" KAT2A GCN5 GCN5L2 Homo sapiens (Human) "alpha-tubulin acetylation [GO:0071929]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; fibroblast proliferation [GO:0048144]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]" ATAC complex [GO:0140672]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "ATAC complex [GO:0140672]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713]; alpha-tubulin acetylation [GO:0071929]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; fibroblast proliferation [GO:0048144]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; in utero embryonic development [GO:0001701]; internal peptidyl-lysine acetylation [GO:0018393]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537]" GO:0000123; GO:0000124; GO:0000785; GO:0001701; GO:0001756; GO:0001819; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006094; GO:0006282; GO:0006338; GO:0006355; GO:0006357; GO:0007507; GO:0007616; GO:0010484; GO:0014070; GO:0016573; GO:0016578; GO:0018393; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0031063; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035066; GO:0035264; GO:0035521; GO:0035522; GO:0042826; GO:0043484; GO:0043966; GO:0043997; GO:0044154; GO:0045589; GO:0045722; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048144; GO:0048167; GO:0048312; GO:0050863; GO:0051302; GO:0051726; GO:0060173; GO:0061035; GO:0061733; GO:0071356; GO:0071929; GO:0072686; GO:0090043; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:0140297; GO:0140672; GO:1903010; GO:1990090; GO:2000036; GO:2000727 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K12 specific) [GO:0043997]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone succinyltransferase activity [GO:0106078]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713] AQVRGLPRAK 0.99308 -15.965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3879 0 0 0 0 0 11.6864 0 13.2022 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8685 0 13.1775 0 0 0 0 0 0 0 0 12.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2596 0 13.5503 13.5108 12.9317 12.6882 0 13.5356 16.2696 13.0038 0 0 0 15.1189 14.2543 13.0813 13.5152 11.9762 0 0 13.2235 14.9216 13.8073 0 0 0 0 0 0 0 0 12.1444 13.191 13.7529 0 0 14.6044 14.9161 14.3309 0 13.8501 15.0241 0 0 0 0 0 0 16.4639 14.5668 0 13.6952 0 0 12.7582 13.22 0 0 15.8947 14.2193 13.7348 0 0 13.3498 0 13.3301 0 0 0 12.6563 0 0 0 0 0 0 17.7515 0 12.3959 0 0 11.6589 0 0 0 13.5074 0 0 0 0 0 0 11.2722 0 0 0 0 0 0 0 0 0 Q96EP1 CHFR_HUMAN "E3 ubiquitin-protein ligase CHFR, EC 2.3.2.27 (Checkpoint with forkhead and RING finger domains protein) (RING finger protein 196) (RING-type E3 ubiquitin transferase CHFR)" CHFR RNF196 Homo sapiens (Human) cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic G2/M transition checkpoint [GO:0044818]; modification-dependent protein catabolic process [GO:0019941]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; PML body [GO:0016605] nucleus [GO:0005634]; PML body [GO:0016605]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; meiotic spindle checkpoint signaling [GO:0044779]; mitotic G2/M transition checkpoint [GO:0044818]; modification-dependent protein catabolic process [GO:0019941]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000166; GO:0000209; GO:0004842; GO:0005634; GO:0006511; GO:0016567; GO:0016605; GO:0019941; GO:0031398; GO:0031648; GO:0032436; GO:0044779; GO:0044818; GO:0046872; GO:0051301; GO:0061630 metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] FNHICEQTRFK 0.99308 -6.6674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8163 0 0 0 0 0 0 0 0 0 0 0 11.7637 11.9311 0 0 0 0 0 0 0 0 0 13.2308 0 0 0 0 0 0 0 0 0 0 15.9511 11.9475 0 16.1453 0 0 0 11.9707 0 0 0 0 0 0 0 0 0 0 13.346 0 0 0 0 15.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.933 0 0 12.4611 0 0 0 0 0 0 0 0 11.5005 0 0 0 0 0 0 0 14.2216 0 0 0 0 0 0 0 0 12.4384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GC6 ZN274_HUMAN "Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274) (Zinc finger protein HFB101) (Zinc finger protein with KRAB and SCAN domains 19) (Zinc finger protein zfp2, Zf2)" ZNF274 ZKSCAN19 SP2114 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleolus [GO:0005730] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of histone H3-K9 trimethylation [GO:1900112]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0003682; GO:0005730; GO:0005737; GO:0006355; GO:0006357; GO:0043565; GO:0046872; GO:1900112; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" EEWGLLGPTQR 0.99308 -26.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4069 0 0 0 0 0 0 0 13.1389 0 0 0 13.6925 0 0 0 0 0 0 0 0 0 0 0 0 13.0851 0 11.2858 0 13.2509 0 0 0 0 0 0 0 13.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9671 0 0 0 0 0 11.6167 0 0 14.0575 0 0 0 12.871 0 0 0 0 0 12.751 0 0 0 0 Q96GZ6 S41A3_HUMAN Solute carrier family 41 member 3 SLC41A3 Homo sapiens (Human) mitochondrial magnesium ion transmembrane transport [GO:0045016] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; magnesium:sodium antiporter activity [GO:0061768]; mitochondrial magnesium ion transmembrane transport [GO:0045016] GO:0005743; GO:0005886; GO:0016021; GO:0045016; GO:0061768 magnesium:sodium antiporter activity [GO:0061768] MDGTETR 0.99308 -9.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9313 0 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 0 12.6813 0 0 0 0 0 0 0 0 0 Q96MZ0 GD1L1_HUMAN "Ganglioside-induced differentiation-associated protein 1-like 1, GDAP1-L1" GDAP1L1 Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; glutathione metabolic process [GO:0006749] GO:0005737; GO:0006749 FAFRKVLGDIHTTLLSAVIPNAFR 0.99308 -5.228 0 0 0 0 0 0 0 0 11.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0817 0 13.0822 0 0 0 0 0 0 0 0 0 13.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9466 0 0 0 14.2564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6087 0 0 0 0 11.3839 0 0 0 0 0 0 0 14.0314 12.691 12.9437 0 0 0 0 0 0 0 0 13.3726 0 0 13.4422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1458 0 0 0 0 0 0 0 0 0 0 12.8993 0 0 0 0 0 0 0 0 0 Q96PV6 LENG8_HUMAN Leukocyte receptor cluster member 8 LENG8 KIAA1932 Homo sapiens (Human) nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleus [GO:0005634]; protein-containing complex [GO:0032991] GO:0005634; GO:0032991 CFTACESEEDK 0.99308 -16.396 0 0 12.3952 0 12.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8767 0 0 0 13.5404 14.3961 12.7693 12.2761 12.8757 14.3405 0 14.0435 0 14.037 0 12.9341 0 14.292 0 13.3578 0 14.3201 0 14.8796 0 14.0276 0 13.9093 0 13.7161 13.8005 14.0895 14.1446 14.3712 14.3367 0 13.8234 0 12.0735 0 0 0 0 14.778 0 0 13.3975 0 0 0 0 0 12.9831 13.7971 0 0 13.719 13.8971 13.8799 0 14.1356 20.1535 0 0 0 0 13.8409 13.7773 0 0 0 0 0 15.3133 0 14.0914 0 0 0 0 0 12.4766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4069 0 14.279 0 14.0264 0 0 11.7217 0 0 0 Q9BY44 EIF2A_HUMAN "Eukaryotic translation initiation factor 2A, eIF-2A (65 kDa eukaryotic translation initiation factor 2A) [Cleaved into: Eukaryotic translation initiation factor 2A, N-terminally processed ]" EIF2A CDA02 MSTP004 MSTP089 Homo sapiens (Human) positive regulation of signal transduction [GO:0009967]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to amino acid starvation [GO:1990928]; ribosome assembly [GO:0042255]; SREBP signaling pathway [GO:0032933] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; extracellular space [GO:0005615]; cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; positive regulation of signal transduction [GO:0009967]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417]; response to amino acid starvation [GO:1990928]; ribosome assembly [GO:0042255]; SREBP signaling pathway [GO:0032933] GO:0000049; GO:0003729; GO:0003743; GO:0005615; GO:0005737; GO:0005850; GO:0006417; GO:0006468; GO:0009967; GO:0022627; GO:0032933; GO:0042255; GO:0043022; GO:0045296; GO:0072562; GO:1990928 cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049] GAPSFVR 0.99308 -14.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4162 0 13.2608 0 0 0 10.0556 0 0 0 0 0 10.1051 13.3779 0 0 14.1636 13.412 0 0 0 0 12.754 0 0 0 0 0 0 0 10.6291 0 0 0 13.5098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4074 0 0 0 0 0 0 0 0 0 13.2745 0 0 12.8609 0 0 11.1365 0 0 0 0 13.0503 12.9307 13.7965 0 0 0 0 12.7163 0 0 0 0 0 12.7192 13.6979 0 0 0 0 0 0 0 12.17 0 0 Q9C075 K1C23_HUMAN "Keratin, type I cytoskeletal 23 (Cytokeratin-23, CK-23) (Keratin-23, K23)" KRT23 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109 structural molecule activity [GO:0005198] AITQETINGR 0.99308 -13.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6021 13.7101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8871 0 0 0 0 0 0 0 0 Q9NVU0 RPC5_HUMAN "DNA-directed RNA polymerase III subunit RPC5, RNA polymerase III subunit C5 (DNA-directed RNA polymerase III 80 kDa polypeptide)" POLR3E KIAA1452 Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription, DNA-templated [GO:0006351]" GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0045087; GO:0051607 DCCVSYGGMWYLK 0.99308 -17.218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9085 0 0 0 0 0 0 0 14.0485 0 14.9566 0 0 14.0175 14.4549 17.9094 0 0 0 0 0 0 12.7593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6966 14.966 0 0 0 0 0 0 13.4132 14.3975 0 15.1426 0 0 0 12.44 0 0 0 0 0 0 14.2995 13.9166 0 12.8676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.771 14.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0564 13.7257 14.767 0 0 0 0 0 0 Q9UJW3 DNM3L_HUMAN DNA (cytosine-5)-methyltransferase 3-like DNMT3L Homo sapiens (Human) "C-5 methylation of cytosine [GO:0090116]; chorionic trophoblast cell differentiation [GO:0060718]; DNA methylation [GO:0006306]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; genomic imprinting [GO:0071514]; in utero embryonic development [GO:0001701]; male meiosis I [GO:0007141]; negative regulation of DNA methylation [GO:1905642]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposition [GO:0010529]; placenta development [GO:0001890]; positive regulation of DNA methylation [GO:1905643]; regulation of gene expression by genomic imprinting [GO:0006349]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]" catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleus [GO:0005634] "catalytic complex [GO:1902494]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; C-5 methylation of cytosine [GO:0090116]; chorionic trophoblast cell differentiation [GO:0060718]; DNA methylation [GO:0006306]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; genomic imprinting [GO:0071514]; in utero embryonic development [GO:0001701]; male meiosis I [GO:0007141]; negative regulation of DNA methylation [GO:1905642]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposition [GO:0010529]; placenta development [GO:0001890]; positive regulation of DNA methylation [GO:1905643]; regulation of gene expression by genomic imprinting [GO:0006349]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863]" GO:0000792; GO:0000794; GO:0001701; GO:0001890; GO:0005634; GO:0005737; GO:0005829; GO:0006306; GO:0006349; GO:0007141; GO:0007283; GO:0008047; GO:0010529; GO:0019899; GO:0032776; GO:0035098; GO:0043046; GO:0045892; GO:0046872; GO:0048863; GO:0060718; GO:0071514; GO:0090116; GO:1902494; GO:1905642; GO:1905643 enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872] ESENPLEMFETVPVWR 0.99308 -26.275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9383 0 0 0 0 13.6475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5322 14.7202 14.7612 13.2019 0 0 0 13.0328 0 0 0 0 11.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3755 0 0 0 0 13.154 0 0 0 14.0598 0 0 0 0 0 0 14.3259 0 0 0 0 0 0 0 0 0 0 0 0 11.6885 0 0 0 14.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7596 0 0 0 0 14.5134 0 0 0 0 0 0 0 0 0 0 12.3379 0 0 0 0 0 0 0 11.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4204 Q9Y613 FHOD1_HUMAN "FH1/FH2 domain-containing protein 1 (Formin homolog overexpressed in spleen 1, FHOS) (Formin homology 2 domain-containing protein 1)" FHOD1 FHOS FHOS1 Homo sapiens (Human) actin filament network formation [GO:0051639]; cortical actin cytoskeleton organization [GO:0030866]; establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stress fiber assembly [GO:0051492] bleb [GO:0032059]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] bleb [GO:0032059]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; actin filament network formation [GO:0051639]; cortical actin cytoskeleton organization [GO:0030866]; establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stress fiber assembly [GO:0051492] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0007097; GO:0014704; GO:0016020; GO:0019904; GO:0030866; GO:0032059; GO:0042802; GO:0043621; GO:0045944; GO:0051015; GO:0051492; GO:0051496; GO:0051639; GO:0051660 actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621] AEPIWELPTRAPR 0.99308 -15.935 0 0 0 0 0 0 0 0 13.8361 0 14.4874 12.5918 15.6444 11.0653 12.7013 14.9913 12.5668 12.3464 13.7639 0 13.3498 0 0 0 0 13.2667 12.2316 12.2232 13.1116 12.836 14.9965 13.0392 13.1646 13.4128 0 0 14.4426 10.2676 0 0 12.3802 14.6234 14.5548 15.3159 12.2304 13.0101 12.3809 0 11.6297 0 11.4847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8807 0 0 0 0 15.3793 0 14.7848 15.1042 15.5385 14.9159 0 15.3458 0 0 0 0 0 13.2407 0 12.9693 13.0594 12.8834 13.3228 0 0 0 0 0 0 12.5908 0 0 15.0288 15.0084 0 0 0 0 0 14.9552 0 14.2123 12.6767 14.8375 0 0 13.6862 13.9369 0 15.2317 0 14.8366 15.7283 0 15.0463 14.1918 0 0 13.9508 16.6236 14.5576 0 15.1117 12.9096 14.2421 12.7574 15.132 13.7164 14.911 14.9419 13.6446 15.9267 13.9784 13.2276 15.2443 13.4784 14.2795 16.625 0 0 0 0 0 15.0195 15.414 15.8391 15.7732 16.5415 14.9586 16.3056 16.6092 14.0149 16.5588 16.8018 16.1993 13.1479 16.7422 16.5219 14.4069 14.1434 12.989 14.9077 12.8297 14.622 0 13.4381 0 13.7445 0 16.3882 Q9UI33 SCNBA_HUMAN "Sodium channel protein type 11 subunit alpha (Peripheral nerve sodium channel 5, PN5) (Sensory neuron sodium channel 2) (Sodium channel protein type XI subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.9) (hNaN)" SCN11A SCN12A SNS2 Homo sapiens (Human) establishment of localization in cell [GO:0051649]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; C-fiber [GO:0044299]; extracellular exosome [GO:0070062]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; C-fiber [GO:0044299]; extracellular exosome [GO:0070062]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; establishment of localization in cell [GO:0051649]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; regulation of sensory perception of pain [GO:0051930]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0006814; GO:0009410; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0044299; GO:0051649; GO:0051930; GO:0070062; GO:0086010 voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] AISVVSR 0.99309 -16.461 0 0 0 12.4518 0 0 13.243 0 15.8391 15.9247 14.5477 16.1404 11.9605 15.5312 15.8593 0 0 12.2593 14.26 13.7225 0 0 13.9127 13.6207 12.8456 12.1711 14.3282 17.006 10.9705 0 16.876 17.1147 14.0042 13.5981 0 14.7341 11.1536 0 14.7252 13.0671 11.4148 17.0866 17.2554 17.0463 17.1617 17.2299 17.1958 17.1455 17.3614 17.2149 17.602 16.9249 16.464 16.5136 16.5636 16.6844 16.7079 0 15.6573 0 16.017 16.0529 0 16.5363 16.2586 15.685 14.9432 14.4359 0 15.511 15.2944 16.0003 16.0905 13.0301 0 0 0 0 0 0 13.5031 13.0562 0 12.9192 0 14.4198 0 13.3178 0 0 0 11.1844 13.9637 0 12.4556 15.3571 13.5354 14.115 0 13.4268 11.4183 0 0 11.1901 0 11.716 0 0 0 0 0 0 11.9506 0 0 12.4842 0 0 0 12.7738 0 12.9012 0 14.1009 0 16.1859 13.1888 13.7222 0 11.6872 0 13.006 0 0 0 0 15.1542 0 10.4745 13.963 0 0 17.2856 0 17.2554 0 17.2921 17.5003 17.3954 0 14.583 12.3533 17.3931 0 0 16.9649 0 0 0 14.531 0 12.0778 12.796 0 0 11.2409 17.2801 17.3141 14.3171 0 13.6211 0 0 0 17.2953 0 10.2174 17.5474 18.3387 0 A1A4F0 S66AL_HUMAN Putative uncharacterized protein SLC66A1L (PQ-loop repeat-containing protein 2-like) (Solute carrier family 66 member 1-like) SLC66A1L C3orf55 PQLC2L Homo sapiens (Human) integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; basic amino acid transmembrane transporter activity [GO:0015174]; L-lysine transmembrane transporter activity [GO:0015189] GO:0005765; GO:0015174; GO:0015189; GO:0016021 basic amino acid transmembrane transporter activity [GO:0015174]; L-lysine transmembrane transporter activity [GO:0015189] MKVVGNYR 0.99309 -7.1022 0 0 0 0 0 0 0 0 0 11.3656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9829 0 0 O14990 IPP2C_HUMAN "Protein phosphatase inhibitor 2 family member C (PPP1R2 family member B) (Protein phosphatase 1, regulatory subunit 2 pseudogene 9) (Type-1 protein phosphatase inhibitor 4, I-4)" PPP1R2C PPP1R2P9 Homo sapiens (Human) regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966] protein phosphatase inhibitor activity [GO:0004864]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966] GO:0004864; GO:0009966; GO:0043666 protein phosphatase inhibitor activity [GO:0004864] EATDASDHSCEVDEQESSEAYMR 0.99309 -16.463 0 13.6543 12.1355 0 0 12.8832 0 0 0 0 0 0 0 0 11.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2114 0 0 0 0 13.4011 0 0 0 0 0 0 0 0 12.1374 0 11.0183 13.3639 12.8129 13.4867 0 0 0 0 0 14.7478 0 13.8745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5135 0 0 0 0 14.7464 0 0 0 0 0 13.4006 0 0 0 0 0 13.8507 0 0 13.7773 0 15.1135 0 0 0 13.1187 0 12.5023 12.6443 0 0 0 0 0 0 0 0 0 0 0 0 12.3455 0 0 0 0 0 0 0 0 0 14.4912 0 O95786 DDX58_HUMAN "Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58, EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1, RLR-1) (Retinoic acid-inducible gene 1 protein, RIG-1) (Retinoic acid-inducible gene I protein, RIG-I)" DDX58 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] GO:0002230; GO:0002735; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0039528; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051091; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] DSQEKPK 0.99309 -16.433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8938 0 0 0 0 0 13.1643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1276 0 0 0 0 0 0 0 0 0 0 0 15.3467 0 0 0 13.2181 0 0 0 0 0 0 0 0 0 0 12.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6803 0 0 0 0 0 0 0 0 P21397 AOFA_HUMAN "Amine oxidase [flavin-containing] A, EC 1.4.3.21, EC 1.4.3.4 (Monoamine oxidase type A, MAO-A)" MAOA Homo sapiens (Human) cellular biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; positive regulation of signal transduction [GO:0009967] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; aliphatic-amine oxidase activity [GO:0052595]; flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; cellular biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; neurotransmitter catabolic process [GO:0042135]; positive regulation of signal transduction [GO:0009967] GO:0005739; GO:0005741; GO:0005829; GO:0006576; GO:0008131; GO:0009967; GO:0016021; GO:0042135; GO:0042420; GO:0050660; GO:0052595; GO:0052596; GO:0097621 aliphatic-amine oxidase activity [GO:0052595]; flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131] ELIDKICWTK 0.99309 -16.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.423 14.2524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7758 0 18.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2484 0 0 12.242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29084 T2EB_HUMAN "Transcription initiation factor IIE subunit beta, TFIIE-beta (General transcription factor IIE subunit 2)" GTF2E2 TF2E2 Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0003677; GO:0003723; GO:0005654; GO:0005669; GO:0005673; GO:0005829; GO:0006366; GO:0006367; GO:0016251; GO:0016607 DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251] ALSGSSGYK 0.99309 -16.068 0 14.1788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36956 SRBP1_HUMAN "Sterol regulatory element-binding protein 1, SREBP-1 (Class D basic helix-loop-helix protein 1, bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1) ]" SREBF1 BHLHD1 SREBP1 Homo sapiens (Human) aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol biosynthetic process [GO:0006695]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; insulin secretion [GO:0030073]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription coregulator binding [GO:0001221]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol biosynthetic process [GO:0006695]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; insulin secretion [GO:0030073]; lipid biosynthetic process [GO:0008610]; lipid localization [GO:0010876]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of lipid storage [GO:0010883]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933]" GO:0000122; GO:0000139; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0006357; GO:0006629; GO:0006695; GO:0007568; GO:0007623; GO:0008286; GO:0008610; GO:0009267; GO:0009410; GO:0009749; GO:0010867; GO:0010876; GO:0010883; GO:0012507; GO:0016021; GO:0019217; GO:0019901; GO:0030073; GO:0030324; GO:0031065; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032933; GO:0032991; GO:0033762; GO:0042789; GO:0044877; GO:0045444; GO:0045471; GO:0045542; GO:0045944; GO:0046676; GO:0046983; GO:0051591; GO:0071398; GO:1902895; GO:1903146; GO:1903214; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription coregulator binding [GO:0001221]" AVQLFLCDLLLVVR 0.99309 -14.551 0 0 0 0 0 0 0 0 17.0713 0 0 0 16.0717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66599 0 0 0 0 0 0 0 0 15.6012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9632 0 0 0 0 11.0381 0 0 14.0132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3973 0 13.4617 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6347 Q14123 PDE1C_HUMAN "Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C, Cam-PDE 1C, EC 3.1.4.17 (Hcam3)" PDE1C Homo sapiens (Human) signal transduction [GO:0007165] cytosol [GO:0005829]; lysosome [GO:0005764]; neuronal cell body [GO:0043025] "cytosol [GO:0005829]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]; signal transduction [GO:0007165]" GO:0004114; GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005829; GO:0007165; GO:0043025; GO:0046872; GO:0047555; GO:0048101 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]" AWDLHHR 0.99309 -26.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9913 0 0 0 0 0 0 11.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7154 13.4049 0 13.1788 0 0 11.2859 10.7759 0 0 0 0 0 0 0 10.1449 12.8721 13.825 13.0669 0 12.9371 0 14.9062 0 0 0 0 0 13.7128 0 0 0 0 0 0 12.459 0 0 0 0 13.2383 0 0 12.4622 12.1953 13.3042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1165 0 13.9242 0 0 0 0 0 0 0 12.5237 0 0 0 0 12.2618 0 11.9676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q504Q3 PAN2_HUMAN "PAN2-PAN3 deadenylation complex catalytic subunit PAN2, EC 3.1.13.4 (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2, PAN deadenylation complex subunit 2)" PAN2 KIAA0710 USP52 Homo sapiens (Human) mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606] GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0005829; GO:0006397; GO:0010606; GO:0031251; GO:0046872 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535] EEEPHLHMVSKKYR 0.99309 -16.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4739 10.3623 0 0 0 0 12.1022 0 0 0 0 0 0 0 0 0 0 0 13.5697 0 15.3242 0 0 0 0 0 0 0 0 14.3764 0 0 10.7703 0 0 0 0 0 0 0 0 13.2182 12.094 0 13.6302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3725 0 0 12.8017 0 0 0 0 0 0 0 0 0 0 0 0 12.7889 0 0 11.5855 0 0 0 13.7504 0 0 0 0 12.8425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W0U4 BSPRY_HUMAN B box and SPRY domain-containing protein BSPRY Homo sapiens (Human) calcium ion transport [GO:0006816]; cellular response to leukemia inhibitory factor [GO:1990830]; protein ubiquitination [GO:0016567] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; calcium ion transport [GO:0006816]; cellular response to leukemia inhibitory factor [GO:1990830]; protein ubiquitination [GO:0016567] GO:0005737; GO:0006816; GO:0016020; GO:0016567; GO:0031252; GO:0046872; GO:0048471; GO:0061630; GO:1990830 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AEELRNK 0.99309 -16.439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1742 0 0 13.4982 0 0 0 0 0 0 0 0 0 0 12.2425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7481 11.1235 0 0 0 0 0 0 0 0 0 0 14.0937 0 0 0 0 0 0 0 0 0 0 0 0 13.1179 0 0 14.7589 14.2232 0 16.697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7519 0 0 0 0 0 Q8TCU6 PREX1_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein, P-Rex1, PtdIns(3,4,5)-dependent Rac exchanger 1" PREX1 KIAA1415 Homo sapiens (Human) actin filament polymerization [GO:0030041]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of small GTPase mediated signal transduction [GO:0051056]; superoxide metabolic process [GO:0006801]; T cell differentiation [GO:0030217] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; actin filament polymerization [GO:0030041]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of small GTPase mediated signal transduction [GO:0051056]; superoxide metabolic process [GO:0006801]; T cell differentiation [GO:0030217] GO:0005085; GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0006801; GO:0007186; GO:0019899; GO:0030041; GO:0030217; GO:0030593; GO:0035556; GO:0042119; GO:0043547; GO:0051056; GO:1900026 enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543] DKFCVYEEYCSNHEK 0.99309 -26.561 0 0 0 12.7265 0 0 0 0 0 0 14.4985 0 13.2789 14.1709 0 0 11.9313 0 0 0 0 0 0 12.8859 0 11.9964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6699 14.1107 0 0 0 0 0 0 0 0 0 0 11.9486 0 0 0 0 0 14.5441 14.0196 0 15.5039 15.4492 0 0 13.4853 0 14.2994 0 10.6684 14.4106 0 0 13.2229 14.8227 13.6722 0 11.993 13.8686 15.9802 13.3708 14.7042 11.953 0 0 11.8447 14.0602 14.5098 13.9542 11.7654 0 0 0 14.5828 13.4634 0 0 0 13.7118 12.7507 14.5173 12.8322 0 14.855 11.1322 0 0 12.2983 16.1022 0 0 12.3417 0 12.2673 13.9144 0 13.2098 0 0 15.2425 12.6781 14.9135 0 0 0 0 0 0 0 0 0 0 0 0 14.9381 0 15.0359 13.8831 14.5366 13.7419 0 0 0 0 0 0 0 11.784 0 12.1067 0 0 13.4329 13.1992 0 0 14.6153 13.068 0 14.6167 0 14.4144 0 0 Q96IZ5 RBM41_HUMAN RNA-binding protein 41 (RNA-binding motif protein 41) RBM41 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" U12-type spliceosomal complex [GO:0005689] "U12-type spliceosomal complex [GO:0005689]; pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0005689; GO:0030626; GO:0097157 pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626] FAKSKQLTR 0.99309 -16.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1104 0 0 0 0 0 0 0 0 0 0 12.0405 0 0 0 0 0 0 15.5797 0 0 0 0 0 0 18.8992 0 0 0 11.2449 0 0 0 0 0 0 0 0 0 0 18.2781 0 0 Q9H4D0 CSTN2_HUMAN "Calsyntenin-2 (Alcadein-gamma, Alc-gamma)" CLSTN2 CS2 Homo sapiens (Human) homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806] anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806] GO:0000139; GO:0001540; GO:0005509; GO:0005789; GO:0007156; GO:0009986; GO:0019894; GO:0030425; GO:0042988; GO:0045211; GO:0050806; GO:0051965; GO:0070161; GO:0098978; GO:0099061 amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988] AVVHIQVK 0.99309 -16.451 0 0 0 0 0 0 0 0 13.1174 0 0 0 0 0 0 0 0 0 16.0218 0 0 0 15.8654 0 12.3284 0 0 9.50416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8274 16.6957 16.8647 17.3728 17.359 17.0341 0 14.7286 0 0 16.7998 16.3242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3894 0 11.2259 15.1176 14.6243 0 13.277 12.2721 0 0 0 18.7435 12.3709 0 13.8948 0 0 0 21.5692 12.5922 0 0 0 0 0 0 0 16.7824 0 0 0 0 17.7615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1176 0 0 0 0 0 0 0 18.6648 0 0 0 0 0 0 18.1008 0 0 0 0 17.1074 0 0 0 0 0 0 14.8565 13.4159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6365 0 17.3891 12.853 0 0 0 0 Q9H6R4 NOL6_HUMAN "Nucleolar protein 6 (Nucleolar RNA-associated protein, Nrap)" NOL6 Homo sapiens (Human) rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409] condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456] condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409] GO:0000794; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006364; GO:0006409; GO:0032040; GO:0032545; GO:0034456 RNA binding [GO:0003723] AFDHVLHLR 0.99309 -16.85 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVE7 PANK4_HUMAN "4'-phosphopantetheine phosphatase, EC 3.1.3.- (Inactive pantothenic acid kinase 4, hPanK4)" PANK4 Homo sapiens (Human) coenzyme A biosynthetic process [GO:0015937] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937] GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016787; GO:0046872 ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872] AECGASGSGSSGDSLDK 0.99309 -16.886 0 0 0 9.39051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1876 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7054 13.5759 0 13.6944 0 12.3733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7749 0 10.7449 0 0 11.4503 10.8773 0 14.041 0 0 0 14.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00442 RTCA_HUMAN "RNA 3'-terminal phosphate cyclase, RNA cyclase, RNA-3'-phosphate cyclase, EC 6.5.1.4 (RNA terminal phosphate cyclase domain-containing protein 1, RTC domain-containing protein 1)" RTCA RPC RPC1 RTC1 RTCD1 Homo sapiens (Human) RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963]; RNA processing [GO:0006396] GO:0003723; GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396 ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963] FIVKKSEDEEDAAK 0.9931 -16.112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9097 11.1999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1306 0 15.645 0 0 12.1388 0 0 0 14.961 0 0 15.4599 0 13.0629 12.5399 0 0 0 15.4535 14.1097 0 0 0 0 0 0 0 13.673 14.3673 0 0 0 13.7619 0 0 11.9558 0 0 0 0 0 0 0 0 0 0 0 0 11.8714 0 0 0 0 0 11.5653 0 0 12.6644 0 0 0 0 0 13.7322 0 0 0 0 0 0 0 13.5432 0 0 12.5092 0 13.7293 0 0 0 0 O14966 RAB7L_HUMAN Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29) RAB29 RAB7L1 Homo sapiens (Human) "cell differentiation [GO:0030154]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]" cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773] "cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]; cell differentiation [GO:0030154]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of neuron death [GO:1901214]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; toxin transport [GO:1901998]" GO:0001921; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0043231; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0070062; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1901214; GO:1901998; GO:1903441; GO:1905279 dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] SSSWSCC 0.9931 -16.57 0 0 0 0 0 0 0 0 0 0 0 0 12.2528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6591 0 0 0 13.1427 0 0 0 0 0 12.2156 0 12.5193 14.0257 0 15.2686 12.8346 0 0 0 0 0 0 0 0 0 14.4091 0 0 0 0 0 0 12.7664 11.4928 13.0758 0 0 0 0 0 12.2732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7356 0 0 0 0 0 0 0 0 0 13.2013 0 0 0 0 0 0 0 0 11.9261 0 0 0 14.912 0 0 0 0 0 0 0 0 0 0 10.7981 0 0 0 O43766 LIAS_HUMAN "Lipoyl synthase, mitochondrial, EC 2.8.1.8 (Lipoate synthase, LS, Lip-syn) (Lipoic acid synthase)" LIAS LAS HUSSY-01 Homo sapiens (Human) inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]; inflammatory response [GO:0006954]; lipoate biosynthetic process [GO:0009107]; neural tube closure [GO:0001843]; protein lipoylation [GO:0009249]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]" GO:0001843; GO:0005739; GO:0005759; GO:0006954; GO:0006979; GO:0009107; GO:0009249; GO:0016992; GO:0032496; GO:0046872; GO:0051539; GO:0102552; GO:0102553 "4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; lipoyl synthase activity (acting on glycine-cleavage complex H protein [GO:0102552]; lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein) [GO:0102553]; metal ion binding [GO:0046872]" ILVECLTPDFR 0.9931 -14.255 0 12.3134 13.0091 13.5335 0 12.9514 0 12.9777 0 0 0 0 0 9.45701 0 0 0 0 0 0 12.7591 0 10.9614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4843 0 0 0 0 0 0 13.7037 11.5283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9326 0 0 11.6026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5087 0 11.3471 0 0 0 0 0 11.3165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75081 MTG16_HUMAN "Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein, hMTG16) (Zinc finger MYND domain-containing protein 4)" CBFA2T3 MTG16 MTGR2 ZMYND4 Homo sapiens (Human) "granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]" Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]" GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:0046872; GO:1903715 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] AHELITTERAKMER 0.9931 -38.881 0 0 0 0 0 0 0 0 0 0 12.0492 0 0 0 0 0 0 12.1714 15.6976 0 15.5448 0 11.9643 0 0 0 0 0 11.7659 0 0 0 0 0 11.4058 11.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5914 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6244 17.5256 0 0 0 0 18.1275 14.0627 13.7274 14.0293 13.4934 0 13.3042 13.5203 0 13.486 0 11.0814 0 13.593 13.0517 11.8298 0 0 13.1588 13.3095 0 17.8975 17.8789 0 0 0 0 13.5212 0 0 17.3932 15.8587 0 13.5053 17.6027 13.6179 16.2832 13.5267 0 0 0 0 18.0985 0 0 0 0 0 13.4479 0 17.7191 0 12.5734 13.1224 13.5983 13.1653 13.6703 13.4589 0 13.5343 13.4602 13.3379 0 17.8035 13.684 0 0 0 0 0 0 13.3209 0 17.7237 0 0 0 0 17.6913 14.3791 0 14.854 14.9448 14.4603 0 10.601 0 0 13.9963 0 0 0 0 0 0 15.1016 0 0 0 0 0 0 0 0 0 0 0 0 O75460 ERN1_HUMAN "Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1, hIRE1p) (Ire1-alpha, IRE1a) [Includes: Serine/threonine-protein kinase, EC 2.7.11.1; Endoribonuclease, EC 3.1.26.- ]" ERN1 IRE1 Homo sapiens (Human) "cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]" AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637] "AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]" GO:0000287; GO:0001935; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0006379; GO:0006402; GO:0006468; GO:0016241; GO:0019899; GO:0030176; GO:0030544; GO:0033120; GO:0034620; GO:0034976; GO:0035924; GO:0036289; GO:0036498; GO:0042802; GO:0042803; GO:0043507; GO:0043531; GO:0046777; GO:0051082; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0098787; GO:0106310; GO:1900103; GO:1901142; GO:1904707; GO:1990332; GO:1990579; GO:1990597; GO:1990604; GO:1990630 ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082] ELPAEVR 0.9931 -16.567 0 0 0 0 0 0 0 0 11.5538 0 13.3122 0 11.7988 0 13.4573 0 0 13.0689 0 0 0 0 0 0 0 0 0 13.5536 0 0 0 12.8735 0 0 12.7828 0 0 0 0 11.6126 13.0881 0 0 12.8668 12.1503 0 0 12.7283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5543 0 0 0 0 0 0 0 0 0 12.499 0 0 0 0 0 0 0 0 0 0 15.1887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6263 0 0 0 13.4278 0 0 0 0 0 0 0 0 0 0 0 15.8236 0 0 0 0 0 0 13.2534 0 0 0 0 0 0 0 0 11.7873 0 0 0 13.3396 0 0 0 0 0 0 0 13.5206 0 13.0556 0 13.0681 0 0 0 0 0 0 13.4449 0 0 0 0 13.352 0 0 O95995 DRC4_HUMAN "Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11, GAS-11) (Growth arrest-specific protein 8, GAS-8)" GAS8 DRC4 GAS11 Homo sapiens (Human) axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization [GO:0008104]; regulation of microtubule binding [GO:1904526] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization [GO:0008104]; regulation of microtubule binding [GO:1904526] GO:0003351; GO:0005576; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0005930; GO:0007368; GO:0007420; GO:0008017; GO:0008104; GO:0008285; GO:0030317; GO:0031267; GO:0031514; GO:0035082; GO:0036064; GO:0036126; GO:0045880; GO:0051649; GO:0060294; GO:1903566; GO:1904526 microtubule binding [GO:0008017]; small GTPase binding [GO:0031267] AREEMSEMQK 0.9931 -38.731 0 0 0 11.8041 0 0 0 12.5284 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2471 12.8591 0 0 0 0 0 0 0 0 0 0 0 9.22771 0 0 0 0 9.20999 0 0 0 0 0 11.6084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8679 0 16.4084 0 0 0 0 0 0 13.8263 0 0 16.0088 0 0 0 13.2172 0 14.1711 0 0 14.8862 0 0 0 0 0 0 13.8602 14.8969 0 0 0 13.4011 13.3242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0016 0 0 0 0 0 0 0 0 0 0 12.9869 14.2394 0 0 11.4219 0 0 0 0 0 13.0509 10.4995 0 0 0 0 0 0 13.8176 12.4669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1011 0 0 0 13.5914 0 0 0 0 0 0 0 0 P19174 PLCG1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1, EC 3.1.4.11 (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II, PLC-II) (Phospholipase C-gamma-1, PLC-gamma-1)" PLCG1 PLC1 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; T cell receptor signaling pathway [GO:0050852] cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] cell projection [GO:0042995]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; T cell receptor signaling pathway [GO:0050852] GO:0001726; GO:0002862; GO:0004435; GO:0004629; GO:0005168; GO:0005509; GO:0005737; GO:0005829; GO:0005886; GO:0007173; GO:0008180; GO:0009395; GO:0010634; GO:0016477; GO:0019722; GO:0019901; GO:0030027; GO:0032587; GO:0038095; GO:0042995; GO:0043536; GO:0045766; GO:0046488; GO:0050429; GO:0050852; GO:0051281; GO:0071364; GO:1905564; GO:2000353 calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901] AEKYVNKAK 0.9931 -43.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6439 0 0 0 0 0 0 0 0 0 0 0 10.1097 0 0 0 0 13.0787 0 0 13.7763 14.3315 0 0 13.5712 13.3551 0 0 14.9691 0 0 0 0 0 0 12.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1218 0 0 19.6397 0 0 12.7488 0 0 14.8871 0 0 0 0 14.8513 14.4021 0 0 13.7194 0 14.695 0 0 0 14.0741 0 15.2166 15.0904 14.2211 10.6748 0 14.4927 0 0 0 0 0 0 13.8022 0 0 0 0 9.98057 14.7709 0 0 14.732 0 0 0 10.5897 0 0 0 14.7096 0 13.9241 0 0 14.8759 12.9039 0 0 13.1207 15.6303 15.4514 13.6861 0 0 0 12.8212 0 0 0 14.6777 0 13.7896 0 9.50126 0 11.1874 0 0 0 0 13.4799 0 0 0 0 0 0 0 16.0196 0 0 0 0 0 0 0 0 16.3112 0 0 0 0 0 13.809 P21675 TAF1_HUMAN "Transcription initiation factor TFIID subunit 1, EC 2.3.1.48, EC 2.7.11.1 (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa, p250) (Transcription initiation factor TFIID 250 kDa subunit, TAF(II)250, TAFII-250, TAFII250)" TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to ATP [GO:0071318]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; midbrain development [GO:0030901]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription factor catabolic process [GO:0036369]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription regulator complex [GO:0005667] chromatin [GO:0000785]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; histone acetyltransferase activity [GO:0004402]; kinase activity [GO:0016301]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin conjugating enzyme activity [GO:0061631]; cell cycle [GO:0007049]; cellular response to ATP [GO:0071318]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; midbrain development [GO:0030901]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription factor catabolic process [GO:0036369]; transcription initiation from RNA polymerase I promoter [GO:0006361]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000122; GO:0000209; GO:0000785; GO:0000979; GO:0001091; GO:0001181; GO:0002039; GO:0004402; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005669; GO:0006361; GO:0006366; GO:0006367; GO:0006468; GO:0006511; GO:0006974; GO:0007049; GO:0010629; GO:0016251; GO:0016301; GO:0016922; GO:0017025; GO:0018105; GO:0018107; GO:0030901; GO:0032092; GO:0032436; GO:0034644; GO:0036369; GO:0042789; GO:0043433; GO:0043565; GO:0046777; GO:0046982; GO:0050821; GO:0051123; GO:0060261; GO:0061629; GO:0061631; GO:0070577; GO:0071318; GO:0071339; GO:0106310; GO:0140416; GO:1901796; GO:1902806; GO:1903026; GO:1905524; GO:2000059; GO:2000825 ATP binding [GO:0005524]; histone acetyltransferase activity [GO:0004402]; kinase activity [GO:0016301]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin conjugating enzyme activity [GO:0061631] ANTHIRDFLQVFIYRLFWK 0.9931 -38.898 0 0 0 0 0 0 0 0 0 10.7635 0 0 0 0 10.207 0 0 0 0 12.7421 0 0 0 0 10.9227 0 0 0 0 0 0 0 0 0 12.1088 0 0 0 0 0 0 0 9.37819 0 0 0 0 0 11.4031 10.75 0 0 0 0 10.7538 10.8507 0 0 0 0 10.8745 0 0 10.6912 0 0 0 0 0 11.3684 11.1403 0 0 11.3675 0 0 0 13.0926 13.9966 0 12.9611 15.0727 0 0 12.345 18.4686 14.0266 14.6192 13.8339 13.513 0 11.3608 14.0033 0 15.8804 14.2845 0 0 0 14.5962 12.8279 15.238 0 0 0 0 10.931 0 13.8271 13.0915 15.8043 0 14.2077 14.0067 0 12.761 0 14.1412 0 0 10.3307 0 0 0 13.0336 0 0 0 0 12.6943 0 0 13.2818 12.9103 14.0897 0 0 14.2129 0 17.3439 14.3258 12.7841 0 13.8242 0 0 0 14.418 0 0 0 0 0 14.2915 14.0532 0 0 0 12.854 0 0 0 0 12.2927 12.9743 0 11.8756 0 0 10.395 0 17.9096 0 12.3048 0 13.0744 12.5945 0 0 13.3801 P35573 GDE_HUMAN "Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase, EC 2.4.1.25 (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase, Amylo-1,6-glucosidase, EC 3.2.1.33 (Dextrin 6-alpha-D-glucosidase) ]" AGL GDE Homo sapiens (Human) glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]" GO:0004133; GO:0004134; GO:0004135; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005978; GO:0005980; GO:0007584; GO:0016234; GO:0016529; GO:0030247; GO:0031593; GO:0034774; GO:0043033; GO:0051384; GO:0102500; GO:1904813 "4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1,6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]" ALWRFSCDVAEGKYK 0.9931 -42.83 0 13.2004 0 0 10.1356 0 0 0 13.8053 15.1378 14.2095 0 14.3566 14.5086 0 0 0 0 11.3038 0 0 0 0 0 0 13.4788 0 0 10.4683 0 0 0 13.3662 10.2197 10.7561 12.1628 0 13.2293 10.3965 0 0 0 13.3859 0 0 0 0 0 0 12.7203 0 12.2952 12.3241 11.8722 10.5857 11.0871 0 12.4853 13.5928 12.1915 13.3814 14.0824 0 13.6034 13.4413 13.9399 0 12.8668 0 0 0 0 12.1243 11.1211 0 0 0 0 0 0 0 0 0 13.2262 0 13.1913 0 0 14.8034 0 14.0966 0 0 13.1076 13.1612 12.5607 0 0 0 0 0 13.7427 15.9269 13.1097 14.8855 12.6897 14.1526 0 0 0 0 14.1288 13.0197 12.5297 0 15.2317 0 0 0 0 0 0 0 0 0 0 0 12.8471 0 0 0 0 0 12.7037 11.6218 0 14.5744 14.6917 0 0 0 0 0 0 0 13.7755 0 16.1153 0 0 0 0 11.1309 16.2668 13.1065 13.2645 12.97 14.6939 13.468 17.798 14.976 10.5821 16.3079 13.8422 0 16.0199 13.1598 12.9041 0 0 12.6872 0 13.5491 0 0 13.6283 18.7093 12.9015 0 0 P46063 RECQ1_HUMAN "ATP-dependent DNA helicase Q1, EC 3.6.4.12 (DNA helicase, RecQ-like type 1, RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)" RECQL RECQ1 RECQL1 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724] GO:0000724; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006268; GO:0006281; GO:0006310; GO:0009378; GO:0016020; GO:0016887; GO:0032508; GO:0043138; GO:1990814 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378] EDLEKIIAHFLIQQYLK 0.9931 -14.26 0 0 0 0 0 0 0 0 0 14.4686 0 0 10.283 10.4506 0 0 0 10.0172 12.3168 0 0 0 0 11.2762 0 0 0 0 11.252 0 15.3925 0 0 0 0 0 0 14.5546 11.0766 0 0 0 0 9.6872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9944 10.4598 0 11.8717 0 0 0 0 0 0 0 0 0 0 0 12.5813 0 0 13.3311 13.0704 0 0 0 0 0 13.7859 0 15.2803 0 0 11.0331 0 0 12.3371 11.0691 12.3483 0 0 0 0 0 0 12.9468 0 10.7426 11.9923 13.431 0 0 13.8683 11.2868 0 0 0 13.3907 0 0 13.6731 13.4486 13.5319 13.6131 0 0 0 0 14.2729 0 12.3801 13.5115 0 0 0 13.873 13.2537 0 0 0 0 0 0 0 0 0 0 12.2193 0 0 10.9875 12.7464 13.1449 0 0 0 12.8802 14.1345 14.0181 12.8717 14.6033 0 0 0 0 0 0 11.6856 12.7937 0 0 0 12.0101 13.1764 0 0 0 P51523 ZNF84_HUMAN Zinc finger protein 84 (Zinc finger protein HPF2) ZNF84 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" DIAFGCGNCGK 0.9931 -26.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1502 0 0 0 14.0157 0 0 14.2701 0 0 13.7923 0 14.2461 0 13.9051 13.8751 0 14.0982 13.9726 12.6297 0 0 17.9842 13.7205 0 0 0 11.8944 0 0 0 0 13.5239 0 0 0 0 0 0 14.303 0 0 0 0 0 0 0 0 0 0 13.8913 0 13.7063 0 0 11.9108 0 11.1847 0 0 11.6307 0 0 12.0011 0 0 0 0 13.1243 0 0 0 0 11.5276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5152 0 0 0 0 0 0 0 0 12.0722 0 0 0 0 0 0 P51946 CCNH_HUMAN Cyclin-H (MO15-associated protein) (p34) (p37) CCNH Homo sapiens (Human) cell cycle [GO:0007049]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell cycle [GO:0007049]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0000079; GO:0000439; GO:0005634; GO:0005654; GO:0005675; GO:0006357; GO:0006366; GO:0006367; GO:0007049; GO:0016538; GO:0019907; GO:0050821; GO:0070516; GO:0070816; GO:0070985; GO:2000045 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] FYLNNSVMEYHPRIIMLTCAFLACK 0.9931 -13.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5362 0 12.6883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4075 0 0 0 14.3973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1029 0 0 0 13.7893 0 0 0 0 0 0 0 0 0 0 Q06124 PTN11_HUMAN "Tyrosine-protein phosphatase non-receptor type 11, EC 3.1.3.48 (Protein-tyrosine phosphatase 1D, PTP-1D) (Protein-tyrosine phosphatase 2C, PTP-2C) (SH-PTP2, SHP-2, Shp2) (SH-PTP3)" PTPN11 PTP2C SHPTP2 Homo sapiens (Human) abortive mitotic cell cycle [GO:0033277]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159]; abortive mitotic cell cycle [GO:0033277]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641] GO:0000077; GO:0001784; GO:0004721; GO:0004725; GO:0004726; GO:0005158; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0006641; GO:0007173; GO:0007229; GO:0007409; GO:0007420; GO:0007507; GO:0008543; GO:0009755; GO:0019221; GO:0019901; GO:0021697; GO:0030159; GO:0030220; GO:0030971; GO:0031295; GO:0032331; GO:0032528; GO:0032728; GO:0032755; GO:0032760; GO:0032991; GO:0033277; GO:0033628; GO:0033629; GO:0035264; GO:0035265; GO:0035335; GO:0035855; GO:0036302; GO:0038127; GO:0042445; GO:0042593; GO:0043254; GO:0045296; GO:0045778; GO:0045931; GO:0046326; GO:0046628; GO:0046676; GO:0046825; GO:0046887; GO:0048008; GO:0048011; GO:0048013; GO:0048609; GO:0048806; GO:0048839; GO:0048873; GO:0050731; GO:0050839; GO:0051428; GO:0051463; GO:0060020; GO:0060125; GO:0060325; GO:0060338; GO:0061582; GO:0070374; GO:0071364; GO:1990782 cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159] QGFWEEFETLQQQECKLLYSRK 0.9931 -6.9567 0 0 0 0 0 0 0 0 0 0 12.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8307 0 0 11.9888 0 0 13.348 0 0 0 0 0 13.5148 0 0 0 0 0 12.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.709 13.7285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08493 PDE4C_HUMAN "cAMP-specific 3',5'-cyclic phosphodiesterase 4C, EC 3.1.4.53 (DPDE1) (PDE21)" PDE4C DPDE1 Homo sapiens (Human) cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165] cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cilium [GO:0005929]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; signal transduction [GO:0007165]" GO:0004114; GO:0004115; GO:0005615; GO:0005634; GO:0005829; GO:0005929; GO:0006198; GO:0007165; GO:0046872; GO:0048471 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" FYSDPDK 0.9931 -13.257 0 0 0 0 0 0 0 0 0 13.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9382 15.1884 14.7457 0 14.9059 14.9556 15.1449 15.5775 15.0514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q147U1 ZN846_HUMAN Zinc finger protein 846 ZNF846 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ACECKECGK 0.9931 -6.3288 0 0 0 0 0 0 0 0 0 0 0 0 11.1401 0 0 0 0 0 0 0 0 10.6172 0 0 0 0 0 0 0 0 0 0 0 0 10.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3217 0 0 0 0 0 0 11.9115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.066 0 0 0 0 0 0 0 0 0 0 10.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5096 0 0 0 Q5T1R4 ZEP3_HUMAN "Transcription factor HIVEP3 (Human immunodeficiency virus type I enhancer-binding protein 3) (Kappa-B and V(D)J recombination signal sequences-binding protein) (Kappa-binding protein 1, KBP-1) (Zinc finger protein ZAS3)" HIVEP3 KBP1 KIAA1555 KRC ZAS3 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0035914; GO:0045893; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" APCPLIPIGGIQMVQAR 0.9931 -26.68 0 0 0 0 0 0 0 11.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2225 0 0 0 13.2678 0 0 14.68 0 0 0 0 0 0 0 0 0 0 0 0 10.719 0 0 0 0 11.8047 0 0 0 0 15.2207 0 0 0 0 0 0 0 0 0 9.92493 0 0 0 0 0 0 0 0 0 0 0 0 13.1898 14.7372 0 0 0 0 0 0 13.3742 0 0 0 0 13.339 14.4468 0 0 12.3134 0 0 0 12.7663 0 0 0 0 0 0 0 0 11.7453 0 0 12.6119 0 0 12.8634 0 12.8919 0 12.835 13.1304 13.3779 12.6098 0 0 0 0 0 0 12.8533 13.3643 13.6559 13.5566 14.7139 0 13.1413 0 0 0 0 0 0 12.8491 0 0 17.07 0 11.339 0 0 0 13.4372 0 0 0 17.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7836 0 0 0 0 0 Q6P2H3 CEP85_HUMAN "Centrosomal protein of 85 kDa, Cep85 (Coiled-coil domain-containing protein 21)" CEP85 CCDC21 Homo sapiens (Human) chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602] GO:0000242; GO:0000922; GO:0005730; GO:0005794; GO:0005813; GO:0005829; GO:0006469; GO:0007059; GO:0046602 CQKESEQNREK 0.9931 -26.81 0 0 0 0 0 0 0 0 0 0 0 0 14.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6629 0 0 0 0 0 0 0 13.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3311 0 0 0 0 0 0 0 0 13.2117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7293 0 13.8581 0 13.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVN7 SEML_HUMAN "Putative protein SEM1, isoform 2" SEM1 C7orf76 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248] "proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]" "proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248]" GO:0000502; GO:0000724; GO:0006406; GO:0008541; GO:0043248 GRRPSIR 0.9931 -5.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5802 0 0 13.3562 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V59 PNM8A_HUMAN Paraneoplastic antigen-like protein 8A (PNMA-like protein 1) PNMA8A PNMAL1 Homo sapiens (Human) ATNESRKV 0.9931 -17.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2804 0 0 0 0 15.1258 0 0 0 0 0 0 0 0 11.783 12.4039 13.1123 0 0 0 0 0 0 0 0 0 0 0 0 0 15.087 0 11.9046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3737 0 0 0 0 0 0 0 0 0 0 0 11.8628 0 0 0 11.782 0 0 0 0 0 0 0 0 0 0 11.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4239 0 0 Q86Z02 HIPK1_HUMAN "Homeodomain-interacting protein kinase 1, EC 2.7.11.1 (Nuclear body-associated kinase 2)" HIPK1 KIAA0630 MYAK NBAK2 Homo sapiens (Human) adherens junction assembly [GO:0034333]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; retina layer formation [GO:0010842]; smoothened signaling pathway [GO:0007224] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; adherens junction assembly [GO:0034333]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; endothelial cell apoptotic process [GO:0072577]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; retina layer formation [GO:0010842]; smoothened signaling pathway [GO:0007224] GO:0001654; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007224; GO:0008283; GO:0008284; GO:0009952; GO:0010803; GO:0010842; GO:0016605; GO:0016607; GO:0018105; GO:0018107; GO:0030182; GO:0034333; GO:0042771; GO:0045766; GO:0048596; GO:0060059; GO:0060216; GO:0060235; GO:0061072; GO:0072577; GO:0097191; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] FSPLPLKYIRPILQQVATALMK 0.9931 -13.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.25927 0 0 0 14.0351 11.831 0 0 0 0 0 0 14.0521 0 12.5304 0 13.527 14.5401 0 13.8975 13.879 0 0 0 12.7707 0 0 0 0 12.9013 13.2436 14.0242 0 0 0 0 0 0 0 0 14.8089 0 0 0 0 0 0 14.1777 0 0 0 0 12.1497 0 0 0 0 0 0 0 0 0 0 0 10.535 13.2107 0 13.6246 0 0 0 0 0 0 Q8IWG1 DNAI3_HUMAN Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63) DNAI3 WDR63 Homo sapiens (Human) cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156] axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156]; Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669] GO:0005737; GO:0005858; GO:0007018; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933 Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] AGGSRSK 0.9931 -16.087 12.8117 0 12.8266 0 0 12.691 12.6645 0 0 0 10.7885 0 0 0 0 0 0 0 0 12.8457 0 0 0 0 0 0 0 0 0 0 0 0 10.3201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.941 9.89627 0 12.8969 0 0 0 0 14.5544 0 15.0133 14.9544 0 15.4078 14.8172 15.7099 0 15.0395 14.9852 15.1687 15.1547 14.9833 15.1547 0 0 0 10.9644 14.8952 0 0 0 0 14.8542 14.2753 15.0722 14.8399 0 14.9706 11.1997 15.4722 15.0027 14.9701 14.8171 13.586 0 0 15.3063 15.0217 0 14.9767 13.438 0 13.5674 0 14.982 14.9014 14.4001 12.0291 0 0 0 14.4045 13.4691 12.9902 0 0 12.5863 0 14.6801 13.3052 14.8652 14.7871 0 12.1934 15.6871 12.9608 14.7486 0 14.9021 14.6824 13.3844 0 15.0901 0 14.2569 0 14.7604 14.6254 0 14.3426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8361 13.6659 0 13.6627 0 0 0 0 14.5359 Q8IYA8 IHO1_HUMAN "Interactor of HORMAD1 protein 1 (Cancer/testis antigen 74, CT74) (Coiled-coil domain-containing protein 36)" IHO1 CCDC36 Homo sapiens (Human) DNA recombination [GO:0006310]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283] condensed nuclear chromosome [GO:0000794] condensed nuclear chromosome [GO:0000794]; DNA recombination [GO:0006310]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation [GO:0042138]; oogenesis [GO:0048477]; regulation of homologous chromosome segregation [GO:0060629]; spermatogenesis [GO:0007283] GO:0000794; GO:0006310; GO:0007129; GO:0007283; GO:0042138; GO:0048477; GO:0060629 LISVPPVK 0.9931 -6.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6023 12.1848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9083 0 15.0953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4356 15.2267 0 0 0 0 0 0 0 0 15.4858 0 0 0 0 0 0 0 15.4069 0 0 0 15.0469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4832 0 0 0 0 0 0 Q8N6H7 ARFG2_HUMAN "ADP-ribosylation factor GTPase-activating protein 2, ARF GAP 2 (GTPase-activating protein ZNF289) (Zinc finger protein 289)" ARFGAP2 ZNF289 Nbla10535 Homo sapiens (Human) COPI coating of Golgi vesicle [GO:0048205]; protein transport [GO:0015031] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; protein transport [GO:0015031] GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0005886; GO:0015031; GO:0046872; GO:0048205 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] ACFDCGAK 0.9931 -6.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4468 0 0 0 12.2423 0 0 0 0 0 0 0 0 0 0 0 0 17.1409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ39 DDX50_HUMAN "ATP-dependent RNA helicase DDX50, EC 3.6.4.13 (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)" DDX50 Homo sapiens (Human) membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005886; GO:0016020; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AGRTGICICFYQPR 0.9931 -13.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0723 0 0 0 0 0 0 0 0 0 15.4695 0 11.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.627 11.4925 0 0 0 0 0 0 0 12.932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAT1 LMA1L_HUMAN "Protein ERGIC-53-like (ERGIC53-like protein) (Lectin mannose-binding 1-like, LMAN1-like protein)" LMAN1L ERGL UNQ2784/PRO7174 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030] GO:0000139; GO:0005537; GO:0005789; GO:0005793; GO:0006888; GO:0007029; GO:0007030; GO:0016021; GO:0030134; GO:0033116; GO:0062023 mannose binding [GO:0005537] ARITYWGQR 0.9931 -16.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2971 0 11.8764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7755 0 0 0 12.6693 0 13.1271 0 12.7163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYY3 PLK2_HUMAN "Serine/threonine-protein kinase PLK2, EC 2.7.11.21 (Polo-like kinase 2, PLK-2, hPlk2) (Serine/threonine-protein kinase SNK, hSNK) (Serum-inducible kinase)" PLK2 SNK Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cellular senescence [GO:2000773]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein catabolic process [GO:0045732]; protein phosphorylation [GO:0006468]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of centriole replication [GO:0046599]; regulation of cytokinesis [GO:0032465]; regulation of synaptic plasticity [GO:0048167]" centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; spindle pole [GO:0000922] "centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of cellular senescence [GO:2000773]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein catabolic process [GO:0045732]; protein phosphorylation [GO:0006468]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of centriole replication [GO:0046599]; regulation of cytokinesis [GO:0032465]; regulation of synaptic plasticity [GO:0048167]" GO:0000082; GO:0000278; GO:0000785; GO:0000922; GO:0002862; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006468; GO:0006977; GO:0007052; GO:0007265; GO:0007613; GO:0010508; GO:0016525; GO:0018105; GO:0030425; GO:0032465; GO:0032486; GO:0043008; GO:0043066; GO:0043123; GO:0045732; GO:0046599; GO:0048167; GO:0060291; GO:0060292; GO:0071866; GO:0090050; GO:0106310; GO:2000773 ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ARKVLTEPEVR 0.9931 -14.252 0 0 0 12.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70646 10.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2434 0 0 0 0 0 0 0 0 0 0 0 14.044 0 0 12.2586 0 0 0 0 0 0 15.04 0 0 0 15.452 0 0 11.658 0 0 0 15.4295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9779 0 12.6316 0 0 0 0 0 12.6366 0 0 0 0 0 0 0 0 0 0 0 13.2323 0 0 11.1724 0 0 13.6364 0 0 0 0 0 0 0 0 0 0 0 0 11.9706 0 0 Q9NZL6 RGL1_HUMAN "Ral guanine nucleotide dissociation stimulator-like 1, RalGDS-like 1" RGL1 KIAA0959 RGL Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005829; GO:0005886; GO:0007264; GO:0007265; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] HLAPTIR 0.9931 -5.0966 0 0 0 0 0 0 0 0 0 14.3487 0 0 0 0 13.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3019 12.3608 0 0 0 0 0 0 12.7982 0 0 12.9457 13.9264 0 13.9707 13.8995 0 0 0 0 0 0 13.4902 0 13.8004 0 0 0 0 0 0 0 0 12.8646 14.0276 0 12.8915 14.1131 0 13.8423 13.1107 0 0 0 0 0 13.9554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7346 0 0 Q9UK12 ZN222_HUMAN Zinc finger protein 222 ZNF222 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEDCGKRYK 0.9931 -13.23 0 0 0 0 0 0 0 9.84226 0 0 0 0 0 0 0 0 0 12.6684 0 0 0 0 0 0 0 0 0 9.62835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7765 0 0 12.9861 0 0 0 0 0 12.7532 0 0 0 12.3352 0 0 0 0 0 0 0 0 0 0 12.8139 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4693 19.216 17.9542 17.6317 18.4191 16.9738 0 0 0 0 0 15.0324 0 0 0 0 0 0 0 0 16.2327 0 0 A6NNA2 SRRM3_HUMAN Serine/arginine repetitive matrix protein 3 SRRM3 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; mRNA binding [GO:0003729] GO:0003729; GO:0005634 mRNA binding [GO:0003729] AAGGAGR 0.99311 -43.782 0 10.8674 11.4015 0 0 0 0 0 0 0 0 0 0 0 10.3476 0 0 0 0 0 0 0 0 0 0 10.9355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8014 0 12.9961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5969 0 14.6243 14.2305 14.6795 11.272 14.3551 13.6196 14.6617 12.4641 16.8233 0 14.4912 0 0 0 13.1325 12.5584 12.2718 15.5104 0 13.7711 0 11.7461 0 12.9211 0 0 13.6361 0 12.8284 12.124 15.6464 0 13.0524 11.9896 0 0 12.2467 13.372 0 12.0394 13.9243 0 0 13.5293 0 0 13.8849 15.4208 11.92 0 0 0 12.3322 13.6443 0 13.6165 13.6829 12.5642 0 12.5298 14.2617 14.2384 0 14.2367 15.2612 0 13.5393 0 0 14.1695 13.7441 0 0 13.8457 11.4241 0 14.9556 13.3218 0 0 0 0 0 0 0 0 0 0 0 13.0397 0 0 0 0 11.3662 0 0 0 14.8793 14.8864 0 13.3457 0 0 0 0 0 O14936 CSKP_HUMAN "Peripheral plasma membrane protein CASK, hCASK, EC 2.7.11.1 (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog)" CASK LIN2 Homo sapiens (Human) calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; establishment of localization in cell [GO:0051649]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; establishment of localization in cell [GO:0051649]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300] GO:0001953; GO:0004385; GO:0004674; GO:0005102; GO:0005516; GO:0005524; GO:0005604; GO:0005652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0007155; GO:0008104; GO:0010839; GO:0015629; GO:0016323; GO:0016363; GO:0031982; GO:0042043; GO:0042734; GO:0045944; GO:0046928; GO:0051649; GO:0060170; GO:0061045; GO:0070509; GO:0090280; GO:0090288; GO:0098685; GO:0106310; GO:2000300 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102] GPFSVVR 0.99311 -16.642 0 0 0 0 0 0 0 0 0 0 13.9795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8347 0 0 0 0 0 0 0 0 14.933 12.896 0 0 0 0 14.549 0 0 0 0 0 14.1609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1726 0 0 14.6239 0 0 14.2472 0 14.7727 0 0 0 0 0 0 0 0 0 12.2343 0 0 0 0 0 0 O43812 DUX1_HUMAN Double homeobox protein 1 DUX1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0045944 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ARHRGQSGR 0.99311 -16.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1734 0 0 0 0 0 0 0 0 0 13.5148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42695 CNDD3_HUMAN "Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3, hCAP-D3)" NCAPD3 CAPD3 KIAA0056 Homo sapiens (Human) cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076] "condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]" "condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]" GO:0000779; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0035064; GO:0042393; GO:0051301 histone binding [GO:0042393]; methylated histone binding [GO:0035064] APLAVTSQVINCR 0.99311 -14.68 0 0 11.4358 0 0 0 0 0 15.0181 12.0214 17.3773 0 17.5968 0 12.7026 0 0 0 12.985 0 0 0 0 10.7269 0 0 0 0 0 0 13.7833 12.3744 12.799 0 14.9368 0 0 13.3541 0 14.4313 0 14.4157 14.1248 0 0 0 0 11.6473 10.5497 0 0 13.3647 0 13.9876 16.5209 0 0 0 0 0 0 0 0 0 0 0 12.4219 0 0 0 0 0 0 0 0 13.7332 0 0 0 14.204 14.7859 0 0 0 14.3628 0 0 11.1964 12.4112 14.2462 0 12.4928 13.6258 15.7079 12.5937 14.93 0 0 12.5755 0 13.4662 13.5464 15.5303 0 14.4549 0 0 11.2955 0 0 0 0 0 14.4475 15.3679 0 15.2387 14.4348 0 14.7888 12.5594 13.8716 14.2279 13.4919 0 15.3124 13.0901 0 11.664 13.8578 0 12.9825 14.4181 12.8825 0 0 11.3848 0 0 0 0 0 13.8172 0 0 0 0 12.7604 14.1062 0 0 0 0 15.0561 11.0517 0 0 0 15.6526 0 11.0169 14.1685 14.6178 0 12.2123 16.1249 15.9792 13.5799 11.6061 13.5886 18.4966 13.4025 13.9361 14.5912 0 14.7089 0 0 0 0 P50570 DYN2_HUMAN "Dynamin-2, EC 3.6.5.5" DNM2 DYN2 Homo sapiens (Human) "antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane organization [GO:0061024]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; post-Golgi vesicle-mediated transport [GO:0006892]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]" "centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]" "centrosome [GO:0005813]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cellular response to carbon monoxide [GO:0071245]; cellular response to dopamine [GO:1903351]; cellular response to nitric oxide [GO:0071732]; cellular response to X-ray [GO:0071481]; endocytosis [GO:0006897]; G protein-coupled receptor internalization [GO:0002031]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi to plasma membrane transport [GO:0006893]; macropinocytosis [GO:0044351]; membrane organization [GO:0061024]; negative regulation of membrane tubulation [GO:1903526]; negative regulation of non-motile cilium assembly [GO:1902856]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription, DNA-templated [GO:0045893]; post-Golgi vesicle-mediated transport [GO:0006892]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of Golgi organization [GO:1903358]; regulation of Rac protein signal transduction [GO:0035020]; regulation of transcription, DNA-templated [GO:0006355]; response to cocaine [GO:0042220]; response to light stimulus [GO:0009416]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]" GO:0000086; GO:0000139; GO:0001891; GO:0002031; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005905; GO:0005925; GO:0006355; GO:0006892; GO:0006893; GO:0006897; GO:0006898; GO:0006909; GO:0007165; GO:0007283; GO:0008017; GO:0009416; GO:0010592; GO:0016020; GO:0017124; GO:0019886; GO:0019899; GO:0019901; GO:0030027; GO:0030426; GO:0030496; GO:0030512; GO:0030516; GO:0030666; GO:0030670; GO:0031623; GO:0031749; GO:0032587; GO:0032991; GO:0033572; GO:0035020; GO:0036312; GO:0042220; GO:0043065; GO:0044351; GO:0044877; GO:0045202; GO:0045211; GO:0045334; GO:0045429; GO:0045893; GO:0048471; GO:0048488; GO:0048489; GO:0048812; GO:0050699; GO:0050766; GO:0050998; GO:0061024; GO:0070062; GO:0071245; GO:0071481; GO:0071732; GO:0098793; GO:0098978; GO:0099092; GO:1900026; GO:1902856; GO:1903351; GO:1903358; GO:1903408; GO:1903526; GO:2000370 D2 dopamine receptor binding [GO:0031749]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699] AALAAER 0.99311 -27.012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3511 0 0 0 0 0 0 0 0 0 12.118 0 11.9249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5543 0 0 0 0 0 0 16.342 12.2926 14.1135 0 14.1941 0 0 0 0 0 0 11.5589 0 0 0 0 13.2146 13.986 0 0 15.7301 15.1742 0 13.3667 0 0 0 0 14.0609 0 0 0 0 12.1103 0 14.0987 0 0 0 0 0 0 0 15.1298 0 0 0 0 0 14.2198 14.0758 0 0 12.116 12.9797 15.4471 0 0 13.4855 13.8115 0 0 0 0 0 13.8555 0 11.1001 0 0 0 0 0 0 0 0 0 11.5418 0 0 0 0 0 0 Q01167 FOXK2_HUMAN "Forkhead box protein K2 (G/T-mismatch specific binding protein, nGTBP) (Interleukin enhancer-binding factor 1)" FOXK2 ILF ILF1 Homo sapiens (Human) "canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to starvation [GO:0042594]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to starvation [GO:0042594]" GO:0000287; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0006357; GO:0010507; GO:0010906; GO:0042594; GO:0043231; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0061621 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" AEAQENGDHR 0.99311 -14.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3341 13.4163 0 0 0 0 0 14.8764 14.3325 0 0 0 0 0 0 14.8649 0 0 0 0 0 0 11.9237 0 0 0 0 0 0 0 0 13.6491 0 0 0 0 0 0 0 0 0 0 0 0 14.326 10.9472 0 0 0 0 0 0 0 0 0 0 0 12.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.978 0 0 0 0 12.1618 0 0 Q14671 PUM1_HUMAN "Pumilio homolog 1, HsPUM, Pumilio-1" PUM1 KIAA0099 PUMH1 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; miRNA processing [GO:0035196]; mRNA destabilization [GO:0061157]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; post-transcriptional gene silencing [GO:0016441]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; miRNA processing [GO:0035196]; mRNA destabilization [GO:0061157]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; post-transcriptional gene silencing [GO:0016441]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of cell cycle [GO:0051726]; regulation of chromosome segregation [GO:0051983]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of mRNA stability [GO:0043488]; spermatogenesis [GO:0007283]; stem cell differentiation [GO:0048863] GO:0000932; GO:0003723; GO:0003729; GO:0003730; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008344; GO:0010494; GO:0010608; GO:0016441; GO:0035196; GO:0035198; GO:0043488; GO:0048863; GO:0051726; GO:0051983; GO:0060964; GO:0061157; GO:1900246; GO:2000637 miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] DADSDENDK 0.99311 -39.327 0 0 0 0 0 0 0 0 0 10.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4129 0 11.0177 10.9462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4631 0 0 0 0 0 11.1826 0 0 0 0 0 0 14.3947 0 10.5958 0 0 0 0 0 0 14.4907 0 0 0 12.1286 0 0 0 0 0 0 0 0 12.2163 0 12.9962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5475 0 0 0 0 0 0 0 0 0 10.997 0 0 0 0 13.127 0 0 0 0 0 0 0 Q5W0B7 TM236_HUMAN Transmembrane protein 236 TMEM236 FAM23A FAM23B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LGLIIALGTITPVLGLCK 0.99311 -14.676 0 0 0 0 9.52902 0 0 0 0 0 0 0 0 0 11.4771 0 0 0 0 0 12.5283 0 0 0 0 11.204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3634 0 0 10.2891 0 0 0 0 0 0 0 0 0 0 0 10.8199 0 0 0 0 0 0 0 0 14.2347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WA8 LONP2_HUMAN "Lon protease homolog 2, peroxisomal, EC 3.4.21.53 (Lon protease-like protein 2, Lon protease 2) (Peroxisomal Lon protease, pLon)" LONP2 LONP Homo sapiens (Human) peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein processing [GO:0016485]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; response to organic cyclic compound [GO:0014070] GO:0002020; GO:0004176; GO:0004252; GO:0005524; GO:0005634; GO:0005777; GO:0005782; GO:0005829; GO:0006515; GO:0006625; GO:0007031; GO:0008233; GO:0014070; GO:0016020; GO:0016485; GO:0016558; GO:0016887; GO:0019899; GO:0031998 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252] EAKLDRSDVTER 0.99311 -27.017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1176 0 11.2174 0 0 0 0 10.7875 0 0 0 10.7986 0 12.5706 0 0 0 12.6426 14.4144 0 12.0417 12.7041 12.5253 0 13.5305 14.1844 0 0 0 0 13.8114 0 14.6333 15.0591 15.1929 13.7698 12.6423 0 0 0 0 0 14.5582 0 12.3167 13.2092 12.6711 0 0 11.5795 0 0 0 0 0 0 12.1418 12.4139 0 0 0 0 0 0 0 13.762 12.3533 0 0 11.7687 0 0 0 0 0 13.5114 0 0 0 0 14.7754 14.279 0 14.9029 14.7921 0 0 0 0 0 0 0 0 12.7039 0 0 0 0 0 0 0 13.976 13.3136 13.7991 12.0306 0 0 0 0 0 Q8N3C0 ASCC3_HUMAN "Activating signal cointegrator 1 complex subunit 3, EC 3.6.4.12 (ASC-1 complex subunit p200, ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)" ASCC3 HELIC1 RQT2 Homo sapiens (Human) cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006307; GO:0008283; GO:0016020; GO:0016607; GO:0016887; GO:0032508; GO:0032790; GO:0043138; GO:0072344; GO:0099053; GO:1990116; GO:1990391 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723] ANPLAYGISHK 0.99311 -26.993 0 0 9.85222 0 0 0 12.1992 0 0 0 0 0 0 0 0 0 0 0 0 17.3066 0 0 14.2649 0 0 0 0 0 0 0 0 0 0 0 10.326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3824 0 0 0 0 14.0078 13.8245 0 15.0476 13.1617 0 0 0 0 0 13.975 14.1643 14.2209 0 14.2335 14.2625 0 15.8322 0 0 13.5198 0 0 0 13.9972 0 19.9583 0 0 0 12.4786 0 0 13.1807 0 0 0 12.5053 13.8834 14.0208 14.7385 13.2834 14.7274 0 0 0 0 0 0 13.4588 13.4022 14.2066 0 0 13.4534 0 0 0 0 13.0736 0 0 0 0 16.6756 16.3632 15.13 0 0 0 14.2879 0 12.4003 0 0 0 0 0 12.5005 13.2204 0 13.5116 0 0 16.2563 13.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9129 0 0 0 0 0 0 0 Q8N608 DPP10_HUMAN "Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3, DPRP-3) (Dipeptidyl peptidase X, DPP X) (Dipeptidyl peptidase-like protein 2, DPL2)" DPP10 DPRP3 KIAA1492 Homo sapiens (Human) positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; regulation of potassium ion transmembrane transport [GO:1901379] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; transmembrane transporter binding [GO:0044325]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; regulation of potassium ion transmembrane transport [GO:1901379] GO:0005886; GO:0006508; GO:0008076; GO:0008236; GO:0015459; GO:0016020; GO:0044325; GO:0072659; GO:1901379; GO:1903078 potassium channel regulator activity [GO:0015459]; serine-type peptidase activity [GO:0008236]; transmembrane transporter binding [GO:0044325] EENILIIHGTADTKVHFQHSAELIKHLIK 0.99311 -16.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.522 0 0 12.5371 0 0 0 0 0 0 0 0 11.5414 0 0 0 0 0 0 0 0 0 0 0 12.318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0998 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2703 0 0 0 0 13.6496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6843 0 0 0 0 11.483 10.5854 0 12.0951 11.7722 12.736 0 0 0 0 0 0 0 0 17.083 0 0 0 0 0 12.5717 0 0 0 0 0 0 0 0 12.7437 0 11.7311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCF5 NF2IP_HUMAN "NFATC2-interacting protein (45 kDa NF-AT-interacting protein, 45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein)" NFATC2IP NIP45 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925] GO:0005634; GO:0005737; GO:0016925; GO:0045944 DNSNSDSEGEDR 0.99311 -14.371 0 0 0 0 0 0 0 0 0 11.4928 0 0 0 0 0 0 0 0 15.1693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1282 0 0 0 0 0 15.5111 0 14.6784 14.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4348 0 0 0 0 0 0 0 0 12.4711 0 15.2008 15.1214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9796 0 0 0 0 0 Q8NDX1 PSD4_HUMAN "PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B, Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein)" PSD4 EFA6B TIC Homo sapiens (Human) regulation of ARF protein signal transduction [GO:0032012] membrane [GO:0016020]; ruffle membrane [GO:0032587] membrane [GO:0016020]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; regulation of ARF protein signal transduction [GO:0032012] GO:0005085; GO:0005543; GO:0016020; GO:0032012; GO:0032587 guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543] EPKLSLK 0.99311 -39.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0073 0 0 0 0 13.2289 0 0 0 0 0 0 0 0 0 0 0 11.6082 0 0 0 0 0 0 0 0 13.1841 13.2709 13.2373 14.1161 14.1032 14.0064 0 0 0 12.7594 0 0 11.6582 0 0 0 0 0 0 0 0 0 0 13.9605 0 13.967 0 13.8508 0 0 0 13.5394 0 0 0 0 0 16.7431 0 0 14.8617 0 0 0 0 0 13.3343 15.7071 0 0 0 0 13.5342 13.62 13.7357 0 0 0 0 0 14.8677 0 0 0 12.1526 13.0104 0 0 0 0 15.3432 0 0 0 0 0 12.6158 0 0 0 0 0 0 0 0 0 0 11.3994 0 0 0 0 0 13.7339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5612 0 0 0 13.8142 0 0 0 13.4951 0 10.6037 0 0 0 0 0 0 12.8978 Q8TBP0 TBC16_HUMAN TBC1 domain family member 16 TBC1D16 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of receptor recycling [GO:0001919] cytosol [GO:0005829]; early endosome [GO:0005769] cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of receptor recycling [GO:0001919] GO:0001919; GO:0005096; GO:0005769; GO:0005829; GO:0090630 GTPase activator activity [GO:0005096] DEDMEKQLLYLRELLR 0.99311 -39.175 0 12.4351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9424 13.9478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4741 13.0052 0 0 0 15.0082 0 0 0 0 14.9849 0 14.4387 14.5193 13.9862 14.509 14.2765 14.9298 14.3982 11.6015 13.8925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6831 0 0 0 0 0 0 0 0 0 0 0 0 11.0359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3308 13.5033 0 14.1795 0 15.8591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1075 0 0 12.0735 Q8WXI9 P66B_HUMAN Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68) GATAD2B KIAA1150 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]" GO:0000122; GO:0000781; GO:0000785; GO:0005654; GO:0006338; GO:0008270; GO:0016575; GO:0016581; GO:0016607; GO:0032991; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:2000736 sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] GIEERQQLIKQLR 0.99311 -14.367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1489 0 0 0 11.7688 0 0 0 17.6442 17.6426 10.1186 0 17.7863 17.9609 10.8544 0 11.8168 0 10.824 0 0 0 0 0 0 0 18.0752 10.0949 0 18.122 18.1315 11.24 18.0171 18.1264 18.0775 11.4427 17.7773 14.7744 17.9818 13.6504 12.5203 0 0 0 12.9081 13.3915 0 0 12.4508 0 10.6977 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0531 12.8802 0 0 0 17.9087 0 0 0 0 0 0 0 0 12.757 12.7888 13.6728 13.8418 0 11.2905 0 0 15.0091 0 0 0 0 0 0 0 14.5167 0 0 0 0 0 0 18.0445 0 0 14.5868 0 0 0 0 0 0 0 0 11.6937 0 0 10.5263 0 11.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8643 0 0 13.9274 11.4685 0 12.1105 0 0 0 0 11.0313 0 11.0006 0 0 11.5743 0 0 0 16.9894 0 0 0 13.6349 12.3675 0 0 0 0 Q96PH1 NOX5_HUMAN "NADPH oxidase 5, EC 1.6.3.-" NOX5 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; positive regulation of cytokine production [GO:0001819]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proton transmembrane transport [GO:1902600]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; superoxide anion generation [GO:0042554] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cytoskeleton-dependent cytokinesis [GO:0061640]; endothelial cell proliferation [GO:0001935]; positive regulation of cytokine production [GO:0001819]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proton transmembrane transport [GO:1902600]; regulation of fusion of sperm to egg plasma membrane [GO:0043012]; superoxide anion generation [GO:0042554] GO:0001525; GO:0001819; GO:0001935; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0015252; GO:0016021; GO:0016175; GO:0020037; GO:0042554; GO:0043012; GO:0050660; GO:0050661; GO:0061640; GO:1902600; GO:2000379 calcium ion binding [GO:0005509]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; NADP binding [GO:0050661]; proton channel activity [GO:0015252]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] GHCEKFGFRFFQENF 0.99311 -27.042 0 0 0 11.5577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1118 0 0 0 0 0 0 0 0 0 12.8648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.333 0 0 0 0 0 13.0822 0 0 0 0 0 0 0 0 12.8224 12.426 0 0 0 13.6271 0 0 12.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1572 0 0 0 11.9221 12.0406 0 0 0 0 12.1484 0 0 12.284 0 0 0 0 0 0 13.3711 0 0 0 0 0 0 13.0784 0 0 0 12.0424 0 0 0 0 0 0 12.1921 0 0 0 12.967 0 12.3333 0 0 0 0 0 0 0 11.8844 11.4839 0 0 0 0 0 0 0 Q9NWA0 MED9_HUMAN Mediator of RNA polymerase II transcription subunit 9 (Mediator complex subunit 9) MED9 MED25 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0003712; GO:0005634; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 transcription coregulator activity [GO:0003712] SKFQEMR 0.99311 -6.9587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2C9 TLR6_HUMAN Toll-like receptor 6 (CD antigen CD286) TLR6 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355] "Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]" GO:0001540; GO:0001775; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005794; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0032717; GO:0032731; GO:0032755; GO:0034136; GO:0034150; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045429; GO:0046982; GO:0050135; GO:0051092; GO:0061809; GO:0071221; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903223; GO:1903428; GO:1904646 "amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]" CDYPESYR 0.99311 -6.9586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5162 0 0 10.6051 0 15.0394 0 0 0 0 0 0 0 0 0 13.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3333 0 0 12.9203 0 0 0 0 12.2593 11.1218 0 0 0 0 0 11.4951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5785 0 0 14.7473 0 0 0 0 0 0 14.5448 0 0 0 0 0 0 14.4488 0 17.0472 A4D0V7 CPED1_HUMAN Cadherin-like and PC-esterase domain-containing protein 1 CPED1 C7orf58 UNQ9432/PRO34713 Homo sapiens (Human) endoplasmic reticulum [GO:0005783] endoplasmic reticulum [GO:0005783] GO:0005783 ENLLNILVIIK 0.99312 -6.3998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3035 12.9249 0 0 0 0 0 0 14.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2217 12.1408 0 0 0 0 0 0 10.7629 13.5865 0 13.8578 0 0 0 0 16.0608 0 0 0 0 0 0 13.7999 0 13.405 0 0 0 0 11.9912 16.4289 0 0 13.4259 15.0526 0 0 0 0 0 13.7562 0 0 0 0 12.9407 0 0 0 0 0 0 0 0 12.8849 13.5916 0 0 0 0 0 0 11.2459 15.3357 0 0 0 0 0 0 0 0 0 0 0 0 11.5062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58751 0 0 14.4089 0 0 0 0 0 O75391 SPAG7_HUMAN Sperm-associated antigen 7 SPAG7 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; nucleic acid binding [GO:0003676] GO:0003676; GO:0005634 nucleic acid binding [GO:0003676] EQAARLKK 0.99312 -7.3181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.09845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.614 13.2928 0 17.6158 0 13.6294 0 0 0 0 14.2658 0 0 0 0 0 13.5975 0 0 0 0 0 0 0 0 0 0 9.9332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0929 0 0 0 0 0 0 0 0 13.085 0 0 0 0 0 0 9.11707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C6S8 LIGO3_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 (Leucine-rich repeat neuronal protein 2) (Leucine-rich repeat neuronal protein 6B) LINGO3 LERN2 LRRN6B Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] GO:0005615; GO:0016021; GO:0031012 AFAGLLALEELTLERCNLTALSGESLGHLR 0.99312 -13.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2131 0 10.9364 0 0 10.8091 0 13.5933 0 19.4958 13.2688 10.5224 0 0 12.5734 0 0 0 0 0 0 13.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35052 GPC1_HUMAN Glypican-1 [Cleaved into: Secreted glypican-1 ] GPC1 Homo sapiens (Human) cell migration [GO:0016477]; heparan sulfate proteoglycan catabolic process [GO:0030200]; myelin assembly [GO:0032288]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; regulation of protein localization to membrane [GO:1905475]; Schwann cell differentiation [GO:0014037] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; copper ion binding [GO:0005507]; fibroblast growth factor binding [GO:0017134]; laminin binding [GO:0043236]; cell migration [GO:0016477]; heparan sulfate proteoglycan catabolic process [GO:0030200]; myelin assembly [GO:0032288]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; regulation of protein localization to membrane [GO:1905475]; Schwann cell differentiation [GO:0014037] GO:0005507; GO:0005576; GO:0005615; GO:0005654; GO:0005768; GO:0005796; GO:0005829; GO:0005886; GO:0009986; GO:0014037; GO:0016477; GO:0017134; GO:0030200; GO:0031012; GO:0031226; GO:0032288; GO:0040037; GO:0043202; GO:0043236; GO:0045121; GO:0045202; GO:0046658; GO:0062023; GO:0070062; GO:1905475; GO:2001016 copper ion binding [GO:0005507]; fibroblast growth factor binding [GO:0017134]; laminin binding [GO:0043236] AFRDLYSELRLYYR 0.99312 -14.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4003 13.0243 0 0 0 0 0 12.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86674 0 0 0 0 0 13.7618 0 0 0 12.6844 0 0 13.4747 0 0 0 0 0 12.8536 0 0 0 0 0 0 11.3834 13.0256 0 0 0 0 0 0 0 0 0 12.8708 0 0 0 0 0 0 0 0 0 0 0 0 11.5111 0 0 0 13.7447 12.0881 0 13.1349 12.5503 0 0 0 0 0 11.9159 0 0 0 0 0 0 0 0 0 0 12.5462 0 0 0 11.8093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0719 0 13.8839 0 P54619 AAKG1_HUMAN "5'-AMP-activated protein kinase subunit gamma-1, AMPK gamma1, AMPK subunit gamma-1, AMPKg" PRKAG1 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of glycolytic process [GO:0006110]; regulation of protein serine/threonine kinase activity [GO:0071900]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; cellular response to glucose starvation [GO:0042149]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; import into nucleus [GO:0051170]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of glycolytic process [GO:0006110]; regulation of protein serine/threonine kinase activity [GO:0071900]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] GO:0004672; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006110; GO:0006468; GO:0006633; GO:0007165; GO:0007283; GO:0008603; GO:0010628; GO:0016020; GO:0016208; GO:0019887; GO:0019901; GO:0031588; GO:0031669; GO:0042149; GO:0043531; GO:0045860; GO:0050790; GO:0051170; GO:0071900 ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] ILKFLKLFITEFPK 0.99312 -16.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3717 12.7928 0 0 13.5503 0 0 0 0 0 0 0 0 0 14.4728 0 0 0 13.4897 14.3055 14.5905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2811 0 0 0 0 0 0 0 0 0 0 0 14.7446 0 0 0 0 0 13.0015 0 0 0 0 0 0 0 0 0 0 0 13.6264 0 0 0 0 0 0 15.2673 0 0 0 0 0 0 0 0 0 0 13.7922 0 0 0 0 0 0 10.6165 13.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9386 0 0 13.6629 0 0 0 0 0 P82930 RT34_HUMAN "28S ribosomal protein S34, mitochondrial, MRP-S34, S34mt (Mitochondrial small ribosomal subunit protein mS34)" MRPS34 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543 structural constituent of ribosome [GO:0003735] ALREQLNR 0.99312 -4.4219 0 0 0 0 0 0 0 0 0 0 11.7026 0 0 0 0 0 0 0 10.997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0926 13.498 0 0 14.2968 0 0 16.2044 0 0 0 0 0 0 0 0 0 0 0 0 14.0682 13.8531 13.8097 14.2047 13.988 11.6421 13.6628 0 0 14.247 11.5687 14.3593 0 0 0 12.6643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4502 0 0 0 0 0 0 0 0 0 0 0 11.169 0 0 0 0 0 0 13.9899 0 0 0 0 0 0 11.9345 0 0 10.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8737 0 0 0 0 0 0 0 14.9054 0 0 0 Q04446 GLGB_HUMAN "1,4-alpha-glucan-branching enzyme, EC 2.4.1.18 (Brancher enzyme) (Glycogen-branching enzyme)" GBE1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; negative regulation of neuron apoptotic process [GO:0043524] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; negative regulation of neuron apoptotic process [GO:0043524]" GO:0003844; GO:0004553; GO:0005737; GO:0005829; GO:0005975; GO:0005977; GO:0005978; GO:0006091; GO:0030246; GO:0043169; GO:0043524; GO:0070062; GO:0102752 "1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" FLNNFDR 0.99312 -16.657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3946 0 0 0 0 0 0 0 0 11.9572 0 0 13.1174 0 0 0 0 0 0 0 0 0 0 0 0 13.5941 0 0 0 0 10.7474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5865 0 0 0 0 0 0 0 12.3155 0 0 0 12.1386 0 0 11.2807 0 0 0 0 0 10.2706 0 14.8718 0 0 0 0 0 0 12.2689 0 14.5588 14.541 0 0 13.6666 13.2858 0 0 0 0 15.0875 13.9037 14.8688 0 13.9208 0 0 13.914 0 0 0 0 11.8192 0 0 0 0 0 0 12.7282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4519 0 0 0 0 0 0 0 Q06828 FMOD_HUMAN "Fibromodulin, FM (Collagen-binding 59 kDa protein) (Keratan sulfate proteoglycan fibromodulin, KSPG fibromodulin)" FMOD FM SLRR2E Homo sapiens (Human) collagen fibril organization [GO:0030199]; transforming growth factor beta receptor complex assembly [GO:0007181] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; collagen fibril organization [GO:0030199]; transforming growth factor beta receptor complex assembly [GO:0007181] GO:0005576; GO:0005615; GO:0005796; GO:0007181; GO:0030199; GO:0031012; GO:0043202; GO:0062023 DCPQECDCPPNFPTAMYCDNR 0.99312 -16.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1678 0 0 0 0 0 0 0 0 0 13.4504 0 0 0 0 12.1959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12923 PTN13_HUMAN "Tyrosine-protein phosphatase non-receptor type 13, EC 3.1.3.48 (Fas-associated protein-tyrosine phosphatase 1, FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E, PTP-E1, hPTPE1) (Protein-tyrosine phosphatase PTPL1)" PTPN13 PNP1 PTP1E PTPL1 Homo sapiens (Human) negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] GO:0001650; GO:0001933; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006470; GO:0014066; GO:0030027; GO:0035335; GO:0036312; GO:0043005; GO:0044297; GO:0070062 phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725] AASKTVR 0.99312 -39.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8584 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81369 0 13.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0822 0 0 0 10.652 0 0 0 0 0 0 0 0 0 0 13.6816 10.8568 0 12.3693 0 0 0 0 12.6884 0 15.4488 13.3252 14.7051 11.7762 14.9035 0 0 0 0 0 0 0 0 13.3697 11.8679 13.6724 13.3273 0 13.7593 0 0 0 0 12.6287 0 13.8519 0 13.6524 14.4738 13.1829 13.7754 0 0 14.1103 0 13.1493 14.2499 13.3581 14.0761 10.952 13.5119 0 13.1137 0 18.0703 12.2125 0 15.0132 14.0631 0 11.4801 0 12.0585 0 12.4895 0 13.4647 15.59 13.017 0 15.1073 0 14.9754 14.3565 0 14.379 0 0 0 0 0 0 0 0 13.1243 13.6897 12.9678 0 0 0 0 0 13.456 12.3289 0 11.8547 14.6428 0 13.1404 12.1665 14.5953 0 13.3904 0 0 0 0 0 0 Q3MIX3 ADCK5_HUMAN "Uncharacterized aarF domain-containing protein kinase 5, EC 2.7.11.-" ADCK5 Homo sapiens (Human) phosphorylation [GO:0016310] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein serine/threonine kinase activity [GO:0004674]; phosphorylation [GO:0016310] GO:0004674; GO:0016021; GO:0016310 protein serine/threonine kinase activity [GO:0004674] AELVLLDHGLYQFLEEK 0.99312 -39.755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5563 0 0 0 0 0 0 0 0 0 0 0 11.9038 0 0 10.8274 0 0 0 12.1282 0 12.5475 12.2037 12.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4875 0 0 0 0 0 0 0 0 0 0 13.3923 14.0559 0 0 0 0 0 0 14.2596 0 0 0 0 0 0 0 0 0 13.4645 0 12.0757 0 0 12.3538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9286 0 0 0 0 11.4509 0 0 0 12.5897 0 0 0 0 0 0 0 0 0 0 0 0 14.0821 12.9898 0 0 0 14.4477 0 0 0 0 0 0 0 0 0 13.088 0 0 0 0 0 0 0 0 0 0 12.6875 0 0 0 16.2689 0 15.0265 Q5SYE7 NHSL1_HUMAN NHS-like protein 1 NHSL1 C6orf63 KIAA1357 Homo sapiens (Human) cell differentiation [GO:0030154] cell differentiation [GO:0030154] GO:0030154 ANIQSLEPR 0.99312 -26.115 0 12.3916 0 0 0 0 0 12.1495 0 0 0 13.0791 11.2743 0 0 11.1058 0 0 0 0 11.7389 0 0 0 0 12.4686 0 11.737 0 0 0 0 0 0 0 0 10.8109 0 0 0 13.4163 0 10.777 0 0 12.05 12.0805 0 0 0 0 0 0 0 0 0 0 0 11.338 0 12.0434 0 0 0 0 0 0 0 0 0 0 13.171 13.2417 0 13.2024 14.2019 14.7933 14.2164 13.2259 12.3009 13.2431 12.5512 13.0969 0 13.7351 15.4218 0 0 0 12.6134 0 17.2504 0 0 0 0 0 0 0 0 0 0 12.8472 0 0 0 0 13.59 0 0 0 0 0 13.4376 0 0 16.2622 0 0 0 0 0 11.374 15.0601 0 0 0 13.6401 0 14.6776 0 0 0 12.5728 0 0 0 0 0 0 0 0 0 0 0 14.3686 0 12.5166 0 0 0 14.7925 0 0 0 0 0 15.2387 15.0896 0 0 0 10.4476 15.3012 0 15.5051 0 15.2425 14.9097 14.8904 15.0495 0 0 13.7465 0 0 0 14.1103 0 0 Q5SZL2 CE85L_HUMAN Centrosomal protein of 85 kDa-like (Serologically defined breast cancer antigen NY-BR-15) CEP85L C6orf204 Homo sapiens (Human) neuron migration [GO:0001764] centrosome [GO:0005813]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242] centrosome [GO:0005813]; cytoplasm [GO:0005737]; pericentriolar material [GO:0000242]; neuron migration [GO:0001764] GO:0000242; GO:0001764; GO:0005737; GO:0005813 EESRNGLEK 0.99312 -16.679 0 0 0 0 0 0 0 0 0 0 13.2614 11.7334 12.5158 12.2801 13.5972 11.8573 11.7433 14.3464 12.1519 0 11.8884 0 0 0 0 12.8357 11.8472 0 0 14.4264 13.5898 0 0 12.233 12.5781 12.7394 0 0 0 13.7171 0 0 14.331 11.1051 14.4085 12.886 13.3291 13.6701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6234 12.8208 0 0 0 14.1734 0 0 0 0 0 0 14.3786 11.3744 0 0 0 13.5546 0 0 13.4163 0 0 0 0 0 0 0 0 0 0 0 0 13.3354 0 12.9075 0 0 0 0 0 0 0 0 0 0 0 0 0 11.145 0 0 0 12.96 12.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7384 0 0 0 11.0958 0 0 0 0 0 0 11.3108 0 0 12.5002 0 0 11.4861 13.8835 0 0 0 0 0 0 11.0389 0 0 0 0 14.2359 0 0 Q6ZUL3 CH086_HUMAN Uncharacterized protein C8orf86 C8orf86 Homo sapiens (Human) FGTEGKERVEQR 0.99312 -4.4203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0482 0 Q7LBE3 S26A9_HUMAN Solute carrier family 26 member 9 (Anion transporter/exchanger protein 9) SLC26A9 Homo sapiens (Human) anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; ion transport [GO:0006811]; positive regulation of gene expression [GO:0010628] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; ATPase binding [GO:0051117]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; ion transport [GO:0006811]; positive regulation of gene expression [GO:0010628] GO:0005254; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006821; GO:0008271; GO:0009986; GO:0010628; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015701; GO:0016324; GO:0019531; GO:0051117; GO:0070062 anion:anion antiporter activity [GO:0015301]; ATPase binding [GO:0051117]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] AVVFGLLPVLSWLPKYKIK 0.99312 -13.314 0 0 0 0 0 0 0 0 0 0 0 0 10.6466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86174 0 0 11.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8451 13.7113 13.7186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8685 12.9671 0 0 0 0 0 0 12.1738 13.2986 0 14.2195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9262 13.1623 0 0 0 0 0 10.7887 0 11.2377 0 0 0 0 0 0 0 13.4727 0 13.5361 0 0 0 0 0 13.0607 10.5237 0 0 0 11.5666 0 0 0 14.3794 0 0 0 0 0 0 0 0 0 0 0 12.6834 0 12.621 0 0 0 0 0 0 0 0 0 0 0 0 0 13.493 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6C8 LIRA3_HUMAN "Leukocyte immunoglobulin-like receptor subfamily A member 3 (CD85 antigen-like family member E) (Immunoglobulin-like transcript 6, ILT-6) (Leukocyte immunoglobulin-like receptor 4, LIR-4) (Monocyte inhibitory receptor HM43/HM31) (CD antigen CD85e)" LILRA3 ILT6 LIR4 Homo sapiens (Human) adaptive immune response [GO:0002250]; cytokine-mediated signaling pathway [GO:0019221] extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; inhibitory MHC class I receptor activity [GO:0032396]; adaptive immune response [GO:0002250]; cytokine-mediated signaling pathway [GO:0019221] GO:0002250; GO:0005576; GO:0005886; GO:0019221; GO:0032396; GO:0035579; GO:0070821; GO:0101003 inhibitory MHC class I receptor activity [GO:0032396] ARPFLSVR 0.99312 -16.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5915 0 0 10.9047 13.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHS3 MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 (Ceroid-lipofuscinosis neuronal protein 7) MFSD8 CLN7 Homo sapiens (Human) autophagosome maturation [GO:0097352]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; regulation of lysosomal protein catabolic process [GO:1905165]; TORC1 signaling [GO:0038202] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; transmembrane transporter activity [GO:0022857]; autophagosome maturation [GO:0097352]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; regulation of lysosomal protein catabolic process [GO:1905165]; TORC1 signaling [GO:0038202] GO:0005765; GO:0007040; GO:0010506; GO:0016020; GO:0016021; GO:0022857; GO:0038202; GO:0048666; GO:0097352; GO:1905165 transmembrane transporter activity [GO:0022857] GVTWDVIKLQINMYTTPVLLSAFLGILNIILILAILR 0.99312 -6.9896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0297 0 0 11.9204 13.6804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.714 0 0 0 0 0 0 0 0 0 13.6876 11.8427 0 14.5807 0 0 0 0 0 0 0 0 16.9804 0 14.2841 0 13.5718 0 0 0 0 0 0 0 0 0 12.2859 0 0 11.0562 0 0 0 10.9082 0 0 0 0 11.3249 0 12.1394 0 12.1677 0 0 0 0 0 12.2341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4721 0 0 0 0 0 0 0 0 0 12.1742 0 0 0 10.2471 0 Q93008 USP9X_HUMAN "Probable ubiquitin carboxyl-terminal hydrolase FAF-X, EC 3.4.19.12 (Deubiquitinating enzyme FAF-X) (Fat facets in mammals, hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)" USP9X DFFRX FAM USP9 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005929; GO:0007049; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0032092; GO:0032435; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0061578; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:1901537; GO:1904515; GO:1990000; GO:1990380 co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578] CIINNTHR 0.99312 -4.4244 0 0 0 0 0 0 13.4342 0 0 13.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1702 12.3451 11.8425 11.3498 0 11.4974 12.5789 0 10.9604 12.4483 11.6589 0 0 0 0 0 15.9351 0 0 0 0 12.2613 0 0 0 0 0 15.1817 11.8603 0 0 0 0 12.8175 12.4525 0 0 0 0 0 11.5481 0 0 12.6786 0 0 0 0 0 0 0 12.9335 0 0 0 0 0 0 0 0 0 14.2308 0 0 0 0 0 0 0 12.7582 0 0 0 0 11.645 11.9335 11.7943 0 0 0 13.0455 0 0 13.0378 0 11.6552 0 14.043 11.9014 14.3394 0 0 13.6577 0 0 0 0 0 15.0463 0 10.9795 0 0 0 0 0 10.48 12.0375 0 11.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2867 0 0 0 15.7542 Q96DY7 MTBP_HUMAN "Mdm2-binding protein, hMTBP" MTBP Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089] chromatin [GO:0000785]; kinetochore [GO:0000776] chromatin [GO:0000785]; kinetochore [GO:0000776]; cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089] GO:0000776; GO:0000785; GO:0007049; GO:0007089; GO:0008285; GO:0031396; GO:0034501; GO:0045839 GLFEEMK 0.99312 -26.15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4372 0 13.0731 12.9777 0 0 15.1444 0 12.4613 15.0421 0 0 0 12.426 0 0 0 0 0 12.7764 0 0 0 0 0 0 13.5855 0 0 0 13.8881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.719 0 0 11.3425 0 0 14.3466 14.7298 0 13.835 0 0 10.9983 0 0 0 11.577 0 0 0 11.5541 0 14.5008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8757 0 0 0 0 0 0 0 0 0 11.3436 0 0 0 0 0 Q9H0X4 F234A_HUMAN Protein FAM234A (Protein ITFG3) FAM234A C16orf9 ITFG3 Homo sapiens (Human) cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] GO:0009986; GO:0016021; GO:0070062 DRFSRLR 0.99312 -5.1225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB63 NET4_HUMAN Netrin-4 (Beta-netrin) (Hepar-derived netrin-like protein) NTN4 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; neuron remodeling [GO:0016322]; regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling [GO:0060668]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] extracellular region [GO:0005576]; laminin complex [GO:0043256]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; laminin-1 binding [GO:0043237]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; neuron remodeling [GO:0016322]; regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling [GO:0060668]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005576; GO:0005886; GO:0009887; GO:0009888; GO:0016322; GO:0016477; GO:0034446; GO:0043237; GO:0043256; GO:0060668; GO:0070831 laminin-1 binding [GO:0043237] AFCGMKYSYVLKIK 0.99312 -26.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6826 0 0 0 0 0 11.338 0 0 0 0 0 14.5248 0 0 0 14.1708 0 14.3682 0 0 0 12.1503 0 0 0 0 0 0 0 0 13.3599 0 13.6636 0 14.1901 12.2547 0 0 13.771 0 0 0 0 0 0 0 0 0 0 0 0 18.1792 0 0 0 0 0 0 0 12.5289 0 0 0 0 18.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0709 0 0 0 0 14.0658 11.1272 0 0 13.7015 0 0 13.4436 0 0 11.3004 0 0 0 0 0 0 0 0 0 11.4872 0 0 0 0 0 0 Q9NXT0 ZN586_HUMAN Zinc finger protein 586 ZNF586 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAAAALR 0.99312 -27.312 0 0 12.5444 0 0 0 0 0 0 0 0 0 0 0 0 12.1299 0 11.5333 0 0 0 10.8171 0 0 0 0 0 0 0 0 0 0 0 12.5184 0 11.4993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3104 0 0 0 13.8038 0 0 0 0 0 0 0 0 0 0 13.2925 0 13.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5002 0 0 0 0 12.5368 0 0 0 13.6623 0 0 11.702 12.5338 0 13.8327 13.5344 0 0 12.3126 12.1437 0 11.6771 12.1306 0 0 0 0 0 12.7559 12.5052 14.3466 0 0 0 0 14.4057 14.0353 0 0 12.6366 0 0 0 12.2955 0 0 0 12.3798 0 11.8223 0 14.5616 0 11.1217 0 0 0 0 0 0 0 0 12.4098 0 0 11.151 0 0 15.2989 0 14.4549 12.2846 0 0 0 13.8559 Q9UP65 PA24C_HUMAN "Cytosolic phospholipase A2 gamma, cPLA2-gamma, EC 3.1.1.4 (Cytosolic lysophospholipase, EC 3.1.1.5) (Cytosolic lysophospholipid O-acyltransferase, EC 2.3.1.-) (Phospholipase A2 group IVC)" PLA2G4C Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; lipid droplet formation [GO:0140042]; parturition [GO:0007567]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phospholipid metabolic process [GO:0006644]; platelet activating factor biosynthetic process [GO:0006663] cell cortex [GO:0005938]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; lipid droplet formation [GO:0140042]; parturition [GO:0007567]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phospholipid metabolic process [GO:0006644]; platelet activating factor biosynthetic process [GO:0006663] GO:0004622; GO:0004623; GO:0005509; GO:0005543; GO:0005544; GO:0005635; GO:0005654; GO:0005789; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006644; GO:0006663; GO:0006954; GO:0007567; GO:0008374; GO:0008970; GO:0016020; GO:0019369; GO:0031966; GO:0035556; GO:0036151; GO:0036152; GO:0046475; GO:0047498; GO:0047499; GO:0102545; GO:0140042 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543] ELMNVAGLYYPKDSARSCCLA 0.99312 -16.672 0 0 0 0 0 0 0 0 0 10.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6441 0 0 0 0 0 0 12.8716 0 13.3464 0 0 0 0 0 13.0606 0 0 12.4961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1868 0 0 0 0 11.2111 10.6537 0 0 0 0 0 0 0 0 0 0 0 9.46064 0 0 0 0 0 10.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4507 0 0 0 0 0 0 0 0 0 0 0 0 11.0425 13.8472 0 13.6439 0 0 0 0 0 0 0 0 0 11.0107 0 0 10.5865 0 0 0 0 11.4193 0 0 0 0 0 14.0027 11.6177 0 0 0 0 0 11.0401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.403 O75094 SLIT3_HUMAN "Slit homolog 3 protein, Slit-3 (Multiple epidermal growth factor-like domains protein 5, Multiple EGF-like domains protein 5)" SLIT3 KIAA0814 MEGF5 SLIL2 UNQ691/PRO1336 Homo sapiens (Human) aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] extracellular space [GO:0005615]; mitochondrion [GO:0005739] extracellular space [GO:0005615]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412] GO:0003180; GO:0003181; GO:0005509; GO:0005615; GO:0005739; GO:0007411; GO:0008201; GO:0008285; GO:0010629; GO:0030308; GO:0032870; GO:0035385; GO:0048495; GO:0048846; GO:0050919; GO:0051414; GO:0060412; GO:0061364; GO:0070100 calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495] APGWAGVGAAVRARLALALALASVLSGPPAVACPTK 0.99313 -16.781 0 11.4311 0 0 0 0 0 0 10.9049 0 0 0 0 0 0 12.9784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5111 15.6173 0 0 0 0 0 0 13.0681 0 0 0 0 0 0 0 0 13.0293 0 13.8871 12.9389 0 11.3964 0 0 0 11.9066 0 0 12.8845 0 0 0 0 11.4473 11.4435 0 0 0 0 0 12.2955 0 0 13.8278 0 0 0 0 12.6894 0 0 13.428 0 12.2709 14.0012 0 0 0 0 0 13.4862 0 0 16.6598 12.9097 13.2915 0 0 0 0 0 0 0 0 0 0 0 0 12.9461 0 0 0 0 0 0 0 0 0 12.5836 13.6027 11.7549 0 0 15.6863 0 0 0 0 0 0 0 O75874 IDHC_HUMAN "Isocitrate dehydrogenase [NADP] cytoplasmic, IDH, IDH1, EC 1.1.1.42 (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)" IDH1 PICD Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; 2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099] GO:0000287; GO:0004450; GO:0005576; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0006749; GO:0006979; GO:0008585; GO:0034774; GO:0042802; GO:0042803; GO:0045296; GO:0048545; GO:0050661; GO:0051287; GO:0060696; GO:0070062; GO:0071071; GO:1904724; GO:1904813 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803] GLAHRAK 0.99313 -7.9356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7533 0 0 0 0 0 13.0465 12.4879 0 0 0 12.7247 0 0 0 0 0 0 0 0 0 0 13.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7334 0 13.902 0 12.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0927 0 0 0 0 0 0 13.158 0 0 0 0 0 0 0 11.7771 0 0 0 0 0 0 0 13.5231 0 0 0 0 0 0 P15622 ZN250_HUMAN Zinc finger protein 250 (Zinc finger protein 647) ZNF250 ZNF647 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AAARLLPVPAGPQPLSFQAK 0.99313 -13.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.489 0 0 0 0 0 0 0 11.5146 0 0 0 0 0 0 0 0 13.1441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5395 0 0 0 0 0 14.3355 0 0 0 14.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2485 0 0 0 0 0 0 0 0 0 11.7761 0 0 0 0 0 0 0 0 0 0 0 11.7982 0 0 0 0 14.6747 14.1859 0 0 0 0 0 0 0 P35637 FUS_HUMAN RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein) FUS TLS Homo sapiens (Human) "mRNA stabilization [GO:0048255]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein homooligomerization [GO:0051260]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; mRNA stabilization [GO:0048255]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein homooligomerization [GO:0051260]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]" GO:0003677; GO:0003682; GO:0003712; GO:0003713; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008380; GO:0042802; GO:0043484; GO:0046872; GO:0048255; GO:0051260; GO:1905168 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] AGDWKCPNPTCENMNFSWR 0.99313 -6.5986 12.2597 11.0419 12.268 0 12.2119 12.7209 11.8587 11.9974 9.87699 0 0 0 11.7903 0 0 0 0 0 12.1659 11.8604 0 13.1756 11.6586 12.0278 0 11.1425 13.0608 0 0 11.8265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8792 0 12.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4863 0 14.0267 13.6581 13.7333 13.9801 0 0 13.9534 14.0722 14.5723 14.5181 14.6954 15.0477 15.0296 14.6404 14.68 0 13.4962 13.6092 0 13.9452 13.8014 15.903 14.0709 15.4537 0 14.6138 14.0809 14.5187 13.1951 0 13.7 14.6163 15.4704 16.2257 15.5722 14.6354 14.6894 13.9325 0 15.9168 14.3927 15.9656 14.6337 0 14.5381 0 13.9688 14.8453 14.8383 14.852 15.4381 14.6265 15.9125 16.1548 13.8623 14.8524 14.8262 0 15.2447 13.5746 13.6111 15.6561 15.5519 14.6957 0 13.4181 14.5423 14.2202 13.8871 0 15.2661 14.731 0 14.5461 15.387 13.1318 15.1332 0 13.9477 0 0 13.9461 14.6799 14.6133 12.9203 13.5816 0 14.6148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4966 13.8013 12.8312 14.5103 0 0 0 0 10.7205 P51991 ROA3_HUMAN "Heterogeneous nuclear ribonucleoprotein A3, hnRNP A3" HNRNPA3 HNRPA3 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0071013; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723] GEEGHDPK 0.99313 -14.471 0 14.5978 14.8306 14.2507 13.4539 0 13.4466 14.8309 0 0 0 0 13.263 13.2923 0 14.7742 14.4591 15.2101 14.0687 14.9162 0 15.1811 15.4579 14.5653 0 0 0 12.1634 13.147 12.7649 0 0 12.81 12.1402 12.8019 0 0 12.193 0 0 0 11.2802 0 0 0 13.2549 0 0 14.0381 0 0 13.4569 0 0 0 0 0 10.8407 0 0 0 0 0 0 0 0 0 10.2562 13.4252 0 0 15.6588 0 15.8584 16.3063 17.2272 17.3956 16.9615 16.7326 16.5943 16.6693 16.372 17.5254 18.0271 17.7076 16.7959 16.0099 17.1413 17.2808 14.6738 16.1958 17.0696 16.2762 17.4624 17.3265 16.7387 17.458 17.3652 16.7422 15.0912 15.6339 14.5139 16.7466 17.5777 16.8839 16.8179 16.8873 16.1784 16.8241 16.4955 16.1001 16.5273 14.7787 17.8086 17.1038 15.8668 16.5802 16.8659 16.6537 16.4219 16.3438 15.4786 15.4877 15.7837 17.0045 17.4348 16.7415 15.4056 17.4049 15.7264 12.2496 15.9378 17.2172 16.7642 17.2299 17.1785 16.0904 16.4477 15.5841 15.967 17.1668 16.8757 16.706 15.8547 15.5242 16.9708 14.6242 0 15.4572 0 16.9028 17.6065 15.7046 16.0814 16.868 14.702 0 0 13.5272 0 13.4406 0 0 0 0 0 0 13.0632 11.5662 12.7291 0 17.4098 16.9295 15.9654 15.5295 0 0 0 16.152 0 P52294 IMA5_HUMAN "Importin subunit alpha-5 (Karyopherin subunit alpha-1) (Nucleoprotein interactor 1, NPI-1) (RAG cohort protein 2) (SRP1-beta) [Cleaved into: Importin subunit alpha-5, N-terminally processed ]" KPNA1 RCH2 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of apoptotic process [GO:0042981]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA recombination [GO:0000018]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell proliferation [GO:0014841] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; NLS-bearing protein import into nucleus [GO:0006607]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of apoptotic process [GO:0042981]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA recombination [GO:0000018]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell proliferation [GO:0014841] GO:0000018; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006607; GO:0008139; GO:0014069; GO:0014841; GO:0014901; GO:0030425; GO:0042564; GO:0042981; GO:0060828; GO:0061608; GO:0098978; GO:0099527 nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139] EEQLFKR 0.99313 -13.41 0 0 0 0 0 0 0 0 12.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5474 0 12.469 12.4815 12.8351 0 0 0 0 0 0 0 0 0 0 12.538 0 0 0 12.4294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4533 12.4931 0 0 0 0 0 0 0 0 0 14.2281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2939 0 0 0 0 0 0 0 12.8578 0 0 0 0 0 0 0 0 0 0 P59095 STAR6_HUMAN "StAR-related lipid transfer protein 6 (START domain-containing protein 6, StARD6)" STARD6 Homo sapiens (Human) lipid transport [GO:0006869] lipid binding [GO:0008289]; lipid transport [GO:0006869] GO:0006869; GO:0008289 lipid binding [GO:0008289] LSPSIIEK 0.99313 -5.5113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.762 0 0 14.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4503 0 0 13.4507 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5668 12.2112 13.2674 0 0 Q07325 CXCL9_HUMAN "C-X-C motif chemokine 9 (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma, HuMIG, MIG) (Small-inducible cytokine B9)" CXCL9 CMK MIG SCYB9 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; cytokine activity [GO:0005125]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of another organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165] GO:0005125; GO:0005576; GO:0005615; GO:0006935; GO:0006952; GO:0006954; GO:0006968; GO:0007165; GO:0007186; GO:0007189; GO:0007267; GO:0008009; GO:0009897; GO:0030593; GO:0031640; GO:0042127; GO:0045236; GO:0045663; GO:0048248; GO:0051281; GO:0051607; GO:0061844; GO:0070098; GO:0071222; GO:1901741 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; CXCR3 chemokine receptor binding [GO:0048248]; cytokine activity [GO:0005125] ELIKKWEK 0.99313 -5.5119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8249 12.8545 0 0 0 0 0 0 0 0 11.3927 0 0 0 0 0 12.3378 0 0 12.9221 0 12.7436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7395 0 0 0 0 0 0 0 0 0 0 0 15.4012 15.6754 0 0 11.523 13.4007 15.3093 0 0 0 0 0 0 0 13.8602 0 0 0 0 12.328 0 0 13.2689 13.5843 0 11.6238 0 0 0 0 0 0 0 0 11.5133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0658 11.6093 0 0 12.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9252 13.2604 0 0 0 0 0 0 12.6084 0 13.0655 13.0681 0 0 0 0 0 0 0 Q13443 ADAM9_HUMAN "Disintegrin and metalloproteinase domain-containing protein 9, ADAM 9, EC 3.4.24.- (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase)" ADAM9 KIAA0021 MCMP MDC9 MLTNG Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intrinsic component of external side of plasma membrane [GO:0031233] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intrinsic component of external side of plasma membrane [GO:0031233]; collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0004222; GO:0005080; GO:0005178; GO:0005518; GO:0005615; GO:0005925; GO:0006509; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008237; GO:0009986; GO:0010042; GO:0016021; GO:0016477; GO:0016485; GO:0017124; GO:0030216; GO:0030335; GO:0031233; GO:0031293; GO:0033627; GO:0033630; GO:0033631; GO:0034241; GO:0034612; GO:0042117; GO:0042542; GO:0042987; GO:0043236; GO:0043406; GO:0046872; GO:0050714; GO:0051044; GO:0051384; GO:0051549; GO:0051592; GO:0070062; GO:0071222; GO:1902945 collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124] AVLPQTR 0.99313 -15.948 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9638 0 0 0 0 0 12.1314 0 0 0 0 0 10.9576 0 0 11.9762 0 0 0 0 0 0 0 0 0 0 0 10.4329 0 0 0 0 0 0 0 0 0 11.2059 0 0 0 0 0 0 0 0 0 0 0 9.23355 0 0 0 0 0 0 0 0 0 0 12.0684 12.798 12.8965 12.7925 12.7163 13.1307 0 0 0 14.6763 13.9543 0 0 0 12.7603 15.1066 11.7487 0 0 0 0 0 0 16.1075 0 0 0 10.7089 0 0 0 0 13.2075 0 0 15.7278 12.6733 0 0 11.4815 0 13.3529 0 0 0 0 0 12.8928 0 0 15.0666 14.0216 13.001 14.4433 0 0 15.1214 12.5263 13.5278 0 0 0 13.5994 0 13.7076 13.3078 0 0 12.6888 0 15.0732 12.6088 0 0 0 0 13.1271 0 12.3801 0 0 0 0 0 0 0 0 11.57 0 0 0 16.2761 0 0 11.3623 0 0 0 11.6736 0 0 0 0 12.3458 0 14.8919 0 Q14258 TRI25_HUMAN "E3 ubiquitin/ISG15 ligase TRIM25, EC 6.3.2.n3 (Estrogen-responsive finger protein) (RING finger protein 147) (RING-type E3 ubiquitin transferase, EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM25) (Tripartite motif-containing protein 25) (Ubiquitin/ISG15-conjugating enzyme TRIM25) (Zinc finger protein 147)" TRIM25 EFP RNF147 ZNF147 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein monoubiquitination [GO:0006513]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; response to estrogen [GO:0043627]; response to vitamin D [GO:0033280]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral release from host cell [GO:0019076] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; RIG-I binding [GO:0039552]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to leukemia inhibitory factor [GO:1990830]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein monoubiquitination [GO:0006513]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; response to estrogen [GO:0043627]; response to vitamin D [GO:0033280]; suppression of viral release by host [GO:0044790]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral release from host cell [GO:0019076] GO:0003713; GO:0003723; GO:0004842; GO:0005654; GO:0005829; GO:0006511; GO:0006513; GO:0010494; GO:0016604; GO:0016874; GO:0019076; GO:0030433; GO:0032880; GO:0033280; GO:0039552; GO:0043123; GO:0043627; GO:0044790; GO:0045087; GO:0045296; GO:0046596; GO:0046597; GO:0046872; GO:0051091; GO:0051092; GO:0061630; GO:1990830 cadherin binding [GO:0045296]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; RIG-I binding [GO:0039552]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] FDTIYQILLKK 0.99313 -26.267 0 0 0 0 0 0 0 0 0 0 0 0 14.7519 0 0 0 12.0022 0 0 0 0 11.0651 0 0 0 11.3228 0 0 0 0 0 0 12.1777 0 0 0 0 0 12.2588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8221 0 0 15.5196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4909 0 0 0 0 0 0 0 13.2598 0 0 0 0 12.1414 0 14.4396 0 0 0 0 0 12.7549 0 0 0 0 0 0 0 14.1736 0 0 0 0 0 13.2089 12.0546 0 0 0 9.99619 0 0 0 0 14.6908 0 0 0 15.375 0 0 15.2721 0 0 0 0 0 0 0 0 13.5111 0 12.0537 0 12.7135 0 0 Q15846 CLUL1_HUMAN Clusterin-like protein 1 (Retinal-specific clusterin-like protein) CLUL1 Homo sapiens (Human) extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular space [GO:0005615]; nucleus [GO:0005634]; misfolded protein binding [GO:0051787] GO:0005615; GO:0005634; GO:0051787 misfolded protein binding [GO:0051787] AIEDLPKQDK 0.99313 -17.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1193 0 0 12.8589 0 0 0 0 10.8602 0 0 0 0 0 14.2885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8573 0 0 0 0 0 0 0 0 Q5T653 RM02_HUMAN "39S ribosomal protein L2, mitochondrial, L2mt, MRP-L2 (Mitochondrial large ribosomal subunit protein uL2m)" MRPL2 CGI-22 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] DHTGRIRVHGIGGGHK 0.99313 -13.393 0 0 0 0 0 0 0 0 12.3547 0 0 0 0 0 0 0 0 0 0 0 0 11.2924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9859 0 14.1791 12.2773 12.8169 0 0 0 13.6795 13.6977 0 0 0 0 0 0 13.4546 0 13.3733 13.921 0 13.5567 14.4191 0 15.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2375 0 0 0 10.9285 0 0 0 0 0 0 0 12.3371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3591 0 0 0 0 0 0 16.2816 0 Q5T9S5 CCD18_HUMAN Coiled-coil domain-containing protein 18 (Sarcoma antigen NY-SAR-24) CCDC18 Homo sapiens (Human) CFHTSFSKCTK 0.99313 -13.397 13.9045 14.4376 0 12.1256 0 0 0 0 0 0 0 0 0 0 0 11.7041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2824 0 0 0 0 11.6919 12.6556 0 0 11.8225 0 0 11.7478 0 13.637 0 0 0 0 0 13.2827 0 0 0 0 0 0 0 14.6988 0 0 0 0 0 13.7836 0 0 0 0 13.5343 11.9729 0 11.8913 13.695 12.7101 11.6284 0 0 0 0 0 0 12.7921 15.2296 0 0 0 11.3347 0 0 11.1152 11.7106 0 0 0 12.7592 15.5535 0 13.2382 12.7456 14.8831 0 14.0698 0 11.845 13.14 13.1506 0 0 17.0463 0 12.8368 0 0 15.088 14.052 12.0386 0 0 13.1536 12.5794 12.8465 14.4079 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2182 13.6018 0 0 0 0 0 0 0 0 13.2298 0 0 0 13.4658 0 13.933 13.6051 0 14.2968 0 0 0 0 0 Q5TA89 HES5_HUMAN "Transcription factor HES-5 (Class B basic helix-loop-helix protein 38, bHLHb38) (Hairy and enhancer of split 5)" HES5 BHLHB38 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; central nervous system myelination [GO:0022010]; comma-shaped body morphogenesis [GO:0072049]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glial cell fate commitment [GO:0021781]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell stereocilium organization [GO:0060122]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cell differentiation [GO:0045595]; regulation of epithelial cell proliferation [GO:0050678]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; specification of loop of Henle identity [GO:0072086]; telencephalon development [GO:0021537]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; astrocyte differentiation [GO:0048708]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell maturation [GO:0048469]; central nervous system myelination [GO:0022010]; comma-shaped body morphogenesis [GO:0072049]; establishment of epithelial cell polarity [GO:0090162]; forebrain radial glial cell differentiation [GO:0021861]; glial cell fate commitment [GO:0021781]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell stereocilium organization [GO:0060122]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oligodendrocyte development [GO:0014003]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of cell differentiation [GO:0045595]; regulation of epithelial cell proliferation [GO:0050678]; regulation of myelination [GO:0031641]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; S-shaped body morphogenesis [GO:0072050]; smoothened signaling pathway [GO:0007224]; specification of loop of Henle identity [GO:0072086]; telencephalon development [GO:0021537]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0005654; GO:0006357; GO:0007155; GO:0007219; GO:0007224; GO:0007420; GO:0008284; GO:0009952; GO:0014003; GO:0021537; GO:0021781; GO:0021861; GO:0021915; GO:0022010; GO:0030509; GO:0030513; GO:0031641; GO:0042491; GO:0042531; GO:0043010; GO:0045595; GO:0045608; GO:0045665; GO:0045747; GO:0045893; GO:0045944; GO:0046427; GO:0046983; GO:0048469; GO:0048661; GO:0048708; GO:0048712; GO:0048715; GO:0050678; GO:0050767; GO:0051216; GO:0060122; GO:0065003; GO:0072049; GO:0072050; GO:0072086; GO:0072282; GO:0090162; GO:0097150; GO:1990837; GO:2000737; GO:2000974; GO:2000978 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ADILEMAVSYLKHSK 0.99313 -6.5933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5214 0 0 0 0 0 13.0622 0 0 0 0 0 0 0 0 0 14.1729 0 14.3933 0 0 0 13.0739 0 0 0 13.8077 0 0 0 0 Q86VR8 FJX1_HUMAN Four-jointed box protein 1 (Four-jointed protein homolog) FJX1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842] extracellular space [GO:0005615] extracellular space [GO:0005615]; cell-cell signaling [GO:0007267]; retina layer formation [GO:0010842] GO:0005615; GO:0007267; GO:0010842 FADGTRACVR 0.99313 -17.212 11.7453 0 0 0 0 0 0 0 12.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.608 0 0 0 0 0 0 13.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7742 0 11.0536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9245 0 0 0 0 0 0 0 0 0 0 11.5287 0 11.4698 0 0 13.4839 12.6098 0 12.6967 12.197 0 0 0 12.2354 12.1103 13.6778 0 12.3353 0 0 0 12.184 0 11.382 11.792 0 0 0 0 0 0 0 0 0 0 0 0 11.3119 12.9637 0 0 0 11.2505 0 0 0 0 0 0 0 0 12.5482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.437 0 0 0 0 0 Q86Y46 K2C73_HUMAN "Keratin, type II cytoskeletal 73 (Cytokeratin-73, CK-73) (Keratin-73, K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)" KRT73 K6IRS3 KB36 KRT6IRS3 Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; nucleus [GO:0005634]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005634; GO:0005829; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0070062 structural constituent of skin epidermis [GO:0030280] AQYEEIAR 0.99313 -6.2195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3512 0 0 0 0 0 0 0 0 0 0 0 12.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGC0 O5AU1_HUMAN Olfactory receptor 5AU1 (Olfactory receptor OR14-38) OR5AU1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] KALIKVWGR 0.99313 -5.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92823 NRCAM_HUMAN "Neuronal cell adhesion molecule, Nr-CAM (Neuronal surface protein Bravo, hBravo) (NgCAM-related cell adhesion molecule, Ng-CAM-related)" NRCAM KIAA0343 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]; synapse assembly [GO:0007416] axon [GO:0030424]; axon initial segment [GO:0043194]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] axon [GO:0030424]; axon initial segment [GO:0043194]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ankyrin binding [GO:0030506]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; clustering of voltage-gated sodium channels [GO:0045162]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; retinal ganglion cell axon guidance [GO:0031290]; synapse assembly [GO:0007416] GO:0001525; GO:0001764; GO:0005576; GO:0005886; GO:0005887; GO:0007409; GO:0007411; GO:0007413; GO:0007416; GO:0007417; GO:0007420; GO:0008104; GO:0009897; GO:0010975; GO:0019227; GO:0030424; GO:0030506; GO:0030516; GO:0031290; GO:0043005; GO:0043194; GO:0045162; GO:0045666; GO:0086080; GO:0098609; GO:0098632; GO:0098978; GO:0099061; GO:0099175 ankyrin binding [GO:0030506]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080] GLMPGTAYK 0.99313 -26.222 0 0 0 11.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4062 0 0 0 0 0 0 13.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5501 Q99490 AGAP2_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2, AGAP-2 (Centaurin-gamma-1, Cnt-g1) (GTP-binding and GTPase-activating protein 2, GGAP2) (Phosphatidylinositol 3-kinase enhancer, PIKE)" AGAP2 CENTG1 KIAA0167 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; endosomal transport [GO:0016197]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of protein kinase activity [GO:0045860]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; endosomal transport [GO:0016197]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of protein kinase activity [GO:0045860]; protein transport [GO:0015031] GO:0003924; GO:0005096; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005829; GO:0015031; GO:0016020; GO:0016197; GO:0019901; GO:0030036; GO:0030295; GO:0035014; GO:0042177; GO:0043524; GO:0045860; GO:0046872; GO:0061903; GO:0070062; GO:0090543; GO:0090630 ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901] AIPIKQSFLLKR 0.99313 -15.935 0 0 0 0 0 0 0 0 0 0 0 13.1855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9209 0 0 0 0 0 0 0 0 0 0 13.7913 13.7132 13.8638 0 0 0 0 13.1301 0 12.7285 12.4939 0 0 0 15.9689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0618 0 0 0 11.3619 0 0 13.3129 0 0 0 0 0 0 0 0 12.3743 11.863 0 0 0 0 0 0 0 0 0 0 0 11.9277 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQT8 ODC_HUMAN "Mitochondrial 2-oxodicarboxylate carrier, ODC (Mitochondrial 2-oxoadipate carrier) (Solute carrier family 25 member 21)" SLC25A21 ODC Homo sapiens (Human) lysine catabolic process [GO:0006554]; mitochondrial alpha-ketoglutarate transmembrane transport [GO:1990550] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; alpha-ketoglutarate transmembrane transporter activity [GO:0015139]; lysine catabolic process [GO:0006554]; mitochondrial alpha-ketoglutarate transmembrane transport [GO:1990550] GO:0005743; GO:0006554; GO:0015139; GO:0016021; GO:1990550 alpha-ketoglutarate transmembrane transporter activity [GO:0015139] CATDPNSYK 0.99313 -15.976 0 0 0 0 0 0 0 0 0 8.73044 0 0 0 0 0 12.1256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6693 0 0 0 0 0 0 0 14.0797 0 0 0 11.4399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4066 11.4334 0 0 0 0 0 0 0 0 13.2004 0 13.8567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8296 0 0 0 13.0405 13.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2592 0 0 0 0 0 0 13.9548 0 0 14.1027 0 0 0 0 0 0 0 0 0 0 0 0 14.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H156 SLIK2_HUMAN SLIT and NTRK-like protein 2 SLITRK2 CXorf2 KIAA1854 SLITL1 UNQ9197/PRO34756 Homo sapiens (Human) axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]; synaptic membrane adhesion [GO:0099560] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]; synaptic membrane adhesion [GO:0099560] GO:0005886; GO:0007409; GO:0016021; GO:0050807; GO:0051965; GO:0098978; GO:0098982; GO:0099560; GO:1905606 INKTVLYGTPRK 0.99313 -13.377 0 0 0 0 0 0 0 0 13.407 12.2538 13.0123 13.3512 0 11.9332 0 0 0 0 11.8291 0 12.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9097 0 0 0 14.1494 0 14.2755 0 0 0 0 0 0 0 0 0 0 11.4222 0 0 0 14.4684 0 0 12.8435 0 0 13.428 0 0 12.7323 0 0 0 0 0 0 0 0 0 0 15.4141 0 0 14.8835 0 0 0 0 0 0 13.1314 0 14.7422 14.6951 0 0 0 0 0 14.9987 0 0 13.963 14.8139 0 13.6754 0 0 0 0 0 14.7795 0 0 13.0564 0 0 13.6908 0 0 0 11.267 0 0 0 0 16.0969 0 0 13.4986 0 0 0 0 0 0 0 0 12.6401 0 0 0 0 0 Q9NSA0 S22AB_HUMAN Solute carrier family 22 member 11 (Organic anion transporter 4) SLC22A11 OAT4 Homo sapiens (Human) organic anion transport [GO:0015711]; urate metabolic process [GO:0046415] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; organic anion transport [GO:0015711]; urate metabolic process [GO:0046415] GO:0005452; GO:0005886; GO:0005887; GO:0008514; GO:0009897; GO:0015347; GO:0015711; GO:0016324; GO:0046415; GO:0070062 inorganic anion exchanger activity [GO:0005452]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] FGRKPMLSWCCLQLAVAGTSTIFAPTFVIYCGLR 0.99313 -16.779 0 0 0 0 0 0 0 0 0 0 0 11.7804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2345 0 0 12.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7968 0 0 0 0 0 0 0 11.2783 0 0 0 13.5422 0 0 0 0 0 0 0 0 0 0 0 0 12.7446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0363 0 0 0 0 0 0 0 0 0 10.5489 0 0 0 0 13.0328 0 0 0 Q9NV72 ZN701_HUMAN Zinc finger protein 701 ZNF701 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHTGENPYTCNECGK 0.99313 -17.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9699 0 11.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWH7 SPAT6_HUMAN Spermatogenesis-associated protein 6 SPATA6 Homo sapiens (Human) cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] extracellular region [GO:0005576]; sperm connecting piece [GO:0097224] extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283] GO:0005576; GO:0007283; GO:0030154; GO:0032027; GO:0044458; GO:0097224 myosin light chain binding [GO:0032027] DCERDGWSR 0.99313 -6.4046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1243 0 0 0 0 0 0 0 12.287 0 0 0 0 0 0 0 0 0 0 0 0 13.2884 0 11.7505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3178 0 0 0 0 0 0 0 13.2946 0 0 0 0 0 0 12.1454 0 0 0 0 0 0 0 0 0 11.7796 12.8872 0 0 0 15.062 0 0 0 13.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4278 14.5015 12.8211 12.2776 13.2782 0 0 0 0 0 0 0 12.9442 12.0102 0 0 0 0 0 0 0 0 0 0 0 12.747 0 0 0 0 0 0 0 0 0 0 0 12.0272 0 0 Q9UJU3 ZN112_HUMAN "Zinc finger protein 112, Zfp-112 (Zinc finger protein 228)" ZNF112 ZFP112 ZNF228 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDSVSWLSHHNDK 0.99313 -6.605 0 0 0 0 0 0 0 0 0 13.324 0 0 0 0 0 0 0 13.3769 0 0 0 0 0 0 12.5734 10.329 10.1472 0 0 0 0 0 0 0 0 11.6897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8233 0 0 0 0 0 0 14.5066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9009 11.8834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1391 0 0 0 0 0 0 0 0 14.2575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1082 0 0 0 13.3753 13.5591 0 12.6729 0 0 0 Q9UMZ2 SYNRG_HUMAN Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin) SYNRG AP1GBP1 SYNG Homo sapiens (Human) endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886] GO:0005737; GO:0005794; GO:0006886; GO:0006897; GO:0030121; GO:0030130; GO:0048471 FDFLVATSQSK 0.99313 -13.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6P5 SESN1_HUMAN "Sestrin-1, EC 1.11.1.- (p53-regulated protein PA26)" SESN1 PA26 SEST1 Homo sapiens (Human) cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of response to reactive oxygen species [GO:1901031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of response to reactive oxygen species [GO:1901031]" GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016239; GO:0016684; GO:0034198; GO:0042149; GO:0070728; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253 "leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]" AVSRHFEDTSYGYKDFSR 0.99313 -6.6035 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2856 0 0 0 0 0 0 0 12.0082 0 0 11.5233 15.0606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9127 0 0 0 11.7195 0 0 0 0 0 0 0 0 0 13.7164 0 0 14.5829 0 0 0 0 0 0 0 0 0 0 0 13.5614 0 0 0 0 0 0 0 0 0 14.2381 0 0 0 0 0 0 0 0 0 0 12.7207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9913 0 13.2371 0 0 12.6594 0 0 0 14.0605 0 0 Q9H1H9 KI13A_HUMAN Kinesin-like protein KIF13A (Kinesin-like protein RBKIN) KIF13A RBKIN Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588] centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459] GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005871; GO:0005874; GO:0006886; GO:0007018; GO:0007049; GO:0008017; GO:0008333; GO:0010008; GO:0016887; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] DDEDGDDMDSYQEEDLNCVR 0.99314 -29.309 0 0 0 0 0 0 11.8686 12.6651 14.4487 0 0 14.007 0 12.8776 11.8495 0 0 0 15.2251 0 0 0 0 0 0 12.1538 0 0 13.1534 0 0 0 13.5723 13.3161 12.198 14.0044 0 12.3993 12.3735 12.632 14.601 13.2912 0 0 14.7703 0 13.9478 13.5223 0 0 0 0 15.845 0 0 0 0 0 15.2222 14.9263 13.1174 12.9194 0 0 14.0458 0 0 0 0 0 0 12.6662 0 0 12.93 14.2734 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3613 13.388 0 14.5095 0 0 0 13.3655 0 12.6764 0 10.2893 0 0 0 0 0 0 11.6719 0 11.4567 0 0 0 12.3381 0 0 19.3823 0 0 18.706 0 0 0 0 0 0 0 0 0 0 10.9103 0 12.9311 0 0 11.0847 0 0 0 14.6457 18.9714 18.2257 17.0595 18.0978 0 17.6524 0 0 0 18.4953 0 0 0 12.3691 0 0 12.6129 15.0765 15.7723 12.8663 0 0 0 12.7322 12.7342 13.1887 15.5335 14.1091 0 12.4066 15.1103 16.8045 0 0 15.8875 0 0 0 0 0 A6NGU7 CX028_HUMAN Putative uncharacterized protein encoded by LINC01546 LINC01546 CXorf28 Homo sapiens (Human) GTPGDLSK 0.99314 -6.4321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9212 13.1631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIN4 RN227_HUMAN RING finger protein 227 (Long intergenic non-protein coding RNA 2581) RNF227 LINC02581 Homo sapiens (Human) protein ubiquitination [GO:0016567] metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567] GO:0016567; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] APSQLPR 0.99314 -26.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3336 0 0 0 0 0 0 0 0 0 0 13.7332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.735 0 0 0 0 0 0 0 0 0 13.4468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75122 CLAP2_HUMAN "CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2, hOrbit2)" CLASP2 KIAA0627 Homo sapiens (Human) "cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]" axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802] "axonal growth cone [GO:0044295]; basal cortex [GO:0045180]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cortical microtubule plus-end [GO:1903754]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; spindle microtubule [GO:0005876]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782]; cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; protein localization to plasma membrane [GO:0072659]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axon extension [GO:0030516]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of microtubule-based process [GO:0032886]; vesicle targeting [GO:0006903]" GO:0000226; GO:0000776; GO:0002162; GO:0005737; GO:0005794; GO:0005802; GO:0005815; GO:0005828; GO:0005829; GO:0005874; GO:0005876; GO:0005881; GO:0005886; GO:0005938; GO:0006903; GO:0007020; GO:0007026; GO:0007030; GO:0007052; GO:0007163; GO:0008017; GO:0010458; GO:0010470; GO:0010634; GO:0010717; GO:0016020; GO:0030516; GO:0031023; GO:0031110; GO:0031113; GO:0031252; GO:0032587; GO:0032886; GO:0032956; GO:0034453; GO:0035791; GO:0040001; GO:0044295; GO:0045180; GO:0045921; GO:0051010; GO:0051015; GO:0051301; GO:0051497; GO:0051895; GO:0072659; GO:0090091; GO:0090307; GO:1903690; GO:1903754; GO:1904261; GO:1990782 actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein tyrosine kinase binding [GO:1990782] ALALKVLREILR 0.99314 -16.821 0 0 0 0 0 0 0 0 0 0 12.1529 0 11.3821 11.1158 0 0 0 0 10.3366 0 0 0 0 0 0 0 0 0 11.4252 13.5727 0 0 0 0 0 0 9.41117 0 0 0 11.6344 0 0 0 0 0 13.1676 0 15.1261 0 0 14.2094 0 0 0 0 0 10.5349 0 0 0 0 0 0 0 0 0 10.5911 0 0 0 0 13.287 11.3791 13.704 0 14.449 0 14.5814 12.0763 0 12.208 11.3245 13.5695 12.4603 13.2559 12.2077 14.6308 14.8078 15.8983 14.0761 0 15.1537 15.2859 15.1659 13.6623 14.1483 12.2538 15.7282 12.0839 13.7454 13.6862 15.3637 16.0167 14.9014 0 0 11.6197 13.4503 14.2791 13.9678 0 13.9924 15.149 13.8232 12.7764 13.5715 15.6566 15.1543 15.9046 15.467 0 0 14.3594 15.6486 0 14.3995 0 14.1795 14.3171 16.0271 13.9817 14.7534 0 15.5114 0 13.563 13.8617 15.9497 15.3447 15.2814 13.3247 0 0 12.6468 14.3663 13.9153 15.6374 14.6908 0 0 0 13.7247 15.7751 15.8815 13.9734 14.735 12.6654 0 0 14.9781 0 14.5742 0 0 0 0 15.4891 11.4312 0 0 13.9545 15.4556 15.4109 11.7835 12.7339 0 12.0763 15.2145 0 O95863 SNAI1_HUMAN "Zinc finger protein SNAI1 (Protein snail homolog 1, Protein sna)" SNAI1 SNAH Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle morphogenesis [GO:0031069]; heterochromatin organization [GO:0070828]; left/right pattern formation [GO:0060972]; mesoderm formation [GO:0001707]; negative regulation of cell differentiation involved in embryonic placenta development [GO:0060806]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; Notch signaling involved in heart development [GO:0061314]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; trophoblast giant cell differentiation [GO:0060707]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; aortic valve morphogenesis [GO:0003180]; cartilage morphogenesis [GO:0060536]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle morphogenesis [GO:0031069]; heterochromatin organization [GO:0070828]; left/right pattern formation [GO:0060972]; mesoderm formation [GO:0001707]; negative regulation of cell differentiation involved in embryonic placenta development [GO:0060806]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; Notch signaling involved in heart development [GO:0061314]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; trophoblast giant cell differentiation [GO:0060707]" GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001649; GO:0001650; GO:0001707; GO:0001837; GO:0003180; GO:0003198; GO:0003700; GO:0005634; GO:0005654; GO:0005721; GO:0005737; GO:0005829; GO:0006357; GO:0010631; GO:0010718; GO:0010957; GO:0019900; GO:0030335; GO:0031069; GO:0043231; GO:0043518; GO:0045893; GO:0046872; GO:0060021; GO:0060536; GO:0060707; GO:0060806; GO:0060972; GO:0061314; GO:0070828; GO:0070888; GO:1902230; GO:1990837; GO:2000810 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AFNCKYCNK 0.99314 -6.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0203 0 0 0 0 0 0 0 0 0 0 O95897 NOE2_HUMAN Noelin-2 (Olfactomedin-2) OLFM2 NOE2 Homo sapiens (Human) positive regulation of smooth muscle cell differentiation [GO:0051152]; protein secretion [GO:0009306]; regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905174]; signal transduction [GO:0007165] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein secretion [GO:0009306]; regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905174]; signal transduction [GO:0007165] GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0009306; GO:0032281; GO:0045202; GO:0051152; GO:0070161; GO:1905174 ELRQLMEKVQNVSQSMEVLELR 0.99314 -16.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.635 12.1717 12.2317 12.4236 12.3851 13.1067 13.2366 0 0 12.0626 0 10.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3549 0 0 0 0 0 0 12.6663 13.1123 0 0 0 0 0 0 0 12.6191 0 0 0 0 12.3625 0 0 0 0 0 0 0 0 12.6789 0 0 0 0 0 0 11.7261 0 0 0 0 0 0 14.9406 0 0 0 0 0 0 0 0 0 0 0 P50579 MAP2_HUMAN "Methionine aminopeptidase 2, MAP 2, MetAP 2, EC 3.4.11.18 (Initiation factor 2-associated 67 kDa glycoprotein, p67, p67eIF2) (Peptidase M)" METAP2 MNPEP P67EIF2 Homo sapiens (Human) N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal involved in protein maturation [GO:0035551]; protein processing [GO:0016485] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal involved in protein maturation [GO:0035551]; protein processing [GO:0016485] GO:0003723; GO:0004177; GO:0005737; GO:0005829; GO:0005886; GO:0008235; GO:0016485; GO:0018206; GO:0031365; GO:0035551; GO:0046872; GO:0070006 aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723] DEDDEDGDGDGDGATGK 0.99314 -7.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58643 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5874 0 0 0 11.4472 0 12.3088 0 0 0 0 11.9441 0 0 0 0 0 0 0 0 11.8812 0 0 0 0 0 0 0 0 0 0 13.0025 0 0 12.8041 0 0 0 0 0 0 0 0 0 0 12.5796 11.3908 11.3893 0 0 0 13.1208 0 0 0 12.2615 0 0 0 12.7668 0 0 0 0 0 10.2048 0 0 0 0 0 0 11.931 0 0 0 0 0 0 11.3617 0 0 12.7937 0 11.3445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0052 0 0 13.0203 0 0 0 0 0 Q13241 KLRD1_HUMAN Natural killer cells antigen CD94 (KP43) (Killer cell lectin-like receptor subfamily D member 1) (NK cell receptor) (CD antigen CD94) KLRD1 CD94 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; natural killer cell mediated immunity [GO:0002228]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of natural killer cell activation [GO:0032814]; stimulatory C-type lectin receptor signaling pathway [GO:0002223] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; carbohydrate binding [GO:0030246]; HLA-E specific inhibitory MHC class Ib receptor activity [GO:0062082]; MHC class I protein complex binding [GO:0023024]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; protein antigen binding [GO:1990405]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; natural killer cell mediated immunity [GO:0002228]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; regulation of natural killer cell activation [GO:0032814]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]" GO:0001915; GO:0002223; GO:0002228; GO:0002250; GO:0004888; GO:0005886; GO:0005887; GO:0007166; GO:0009897; GO:0023024; GO:0023030; GO:0030246; GO:0032814; GO:0043235; GO:0045953; GO:0045954; GO:0062082; GO:1990405 "carbohydrate binding [GO:0030246]; HLA-E specific inhibitory MHC class Ib receptor activity [GO:0062082]; MHC class I protein complex binding [GO:0023024]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; protein antigen binding [GO:1990405]; transmembrane signaling receptor activity [GO:0004888]" AVFKTTLWR 0.99314 -6.6223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0407 0 0 0 12.7133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5582 0 12.6328 12.6867 0 0 14.1228 0 0 0 12.6529 0 0 13.8177 0 0 0 13.5803 0 0 12.1508 0 0 Q5T1V6 DDX59_HUMAN "Probable ATP-dependent RNA helicase DDX59, EC 3.6.4.13 (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5)" DDX59 ZNHIT5 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0046872 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ELMSGLPRMKTVLLVGGLPLPPQLYR 0.99314 -6.2387 0 0 0 0 0 0 0 0 11.8053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8263 0 0 0 0 0 0 9.71175 0 13.5941 0 0 0 0 0 0 11.6292 12.8924 0 0 0 0 0 0 0 0 0 14.7647 0 12.4033 0 15.8013 15.5993 13.913 13.8115 0 14.4418 14.2406 0 0 15.1269 0 0 0 0 0 14.3009 14.2452 0 12.5951 12.5856 14.0239 0 13.7576 0 15.337 0 0 0 14.4686 13.5461 13.525 0 0 12.2088 12.2278 0 0 15.2009 0 14.9924 0 14.5823 13.0371 0 0 0 0 0 0 13.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6R2W3 SCND3_HUMAN SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9) ZBED9 Buster4 KIAA1925 SCAND3 ZNF305P2 ZNF452 Homo sapiens (Human) DNA integration [GO:0015074]; positive regulation of cell cycle [GO:0045787]; positive regulation of epithelial cell proliferation [GO:0050679] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; DNA integration [GO:0015074]; positive regulation of cell cycle [GO:0045787]; positive regulation of epithelial cell proliferation [GO:0050679] GO:0003676; GO:0005634; GO:0005737; GO:0015074; GO:0045787; GO:0050679 nucleic acid binding [GO:0003676] ELQAKYK 0.99314 -26.557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2912 0 0 0 0 0 0 14.96 14.0981 0 0 0 0 14.3052 13.1813 14.5158 13.1641 0 13.9738 0 0 0 0 0 0 0 0 0 13.5817 0 0 0 0 0 13.5984 0 0 0 0 14.8349 11.9247 0 12.4917 0 0 0 14.5319 14.3451 0 0 0 14.1676 0 12.8186 14.3447 14.3679 13.5546 0 0 0 0 0 0 13.7352 13.6027 13.112 13.4139 0 13.8396 0 0 0 0 12.9579 0 14.2151 0 0 14.7548 0 12.7772 0 0 0 0 0 0 10.778 0 0 0 0 13.0655 0 0 0 0 13.9446 0 12.6679 0 14.0176 12.0762 0 0 Q7RTU4 BHA09_HUMAN "Class A basic helix-loop-helix protein 9, bHLHa9 (Class F basic helix-loop-helix factor 42, bHLHf42)" BHLHA9 BHLHF42 Homo sapiens (Human) developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0032502; GO:0046982 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ALRHDLGGKR 0.99314 -16.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTZ4 CA5BL_HUMAN Putative inactive carbonic anhydrase 5B-like protein (CA-VB-like protein) CA5BP1 CA5B CA5BL Homo sapiens (Human) EMVPEAWRCFPNR 0.99314 -13.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1511 0 12.8517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0761 0 0 0 0 12.9351 0 0 0 0 0 0 0 0 0 0 0 0 14.5836 14.6903 0 13.6281 13.8995 0 0 0 0 0 0 13.9686 0 0 13.5501 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6509 0 0 0 0 0 14.2472 13.2955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7791 0 0 0 0 0 0 0 0 0 14.8439 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7987 0 0 0 0 0 0 0 0 Q96Q35 FACC1_HUMAN Flagellum-associated coiled-coil domain-containing protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein) FLACC1 ALS2CR12 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; outer dense fiber [GO:0001520]; sperm fibrous sheath [GO:0035686]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; outer dense fiber [GO:0001520]; sperm fibrous sheath [GO:0035686]; sperm flagellum [GO:0036126] GO:0001520; GO:0005737; GO:0031410; GO:0035686; GO:0036126 DHQSAQK 0.99314 -16.414 0 0 0 0 13.6799 0 0 0 0 0 0 0 0 0 0 0 13.3802 0 0 14.0274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6815 0 0 0 13.0585 0 0 0 0 0 0 0 13.9492 0 0 0 0 0 0 0 14.3822 0 0 0 11.7161 12.2131 0 0 0 0 0 0 0 12.9748 0 0 11.3693 0 0 0 0 0 0 0 0 0 13.1467 0 0 0 0 13.4381 12.8936 13.3619 0 0 0 0 0 0 0 0 13.2181 0 0 0 13.7511 0 0 0 13.9101 0 0 11.4801 0 0 0 12.9116 0 13.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8894 0 11.6285 0 0 0 0 0 Q99527 GPER1_HUMAN "G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1, FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor, LYGPR) (Membrane estrogen receptor, mER)" GPER1 CEPR CMKRL2 DRY12 GPER GPR30 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic chromosome condensation [GO:0030263]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell cycle process [GO:0010948]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion [GO:0032024]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; steroid hormone mediated signaling pathway [GO:0043401]; vasodilation [GO:0042311] anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; keratin filament [GO:0045095]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine head [GO:0044327]; dendritic spine membrane [GO:0032591]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; keratin filament [GO:0045095]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; chromatin binding [GO:0003682]; G protein-coupled estrogen receptor activity [GO:0038054]; G protein-coupled receptor activity [GO:0004930]; nuclear estrogen receptor activity [GO:0030284]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic chromosome condensation [GO:0030263]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of cell cycle process [GO:0010948]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; nuclear fragmentation involved in apoptotic nuclear change [GO:0030264]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac vascular smooth muscle cell differentiation [GO:2000724]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of insulin secretion [GO:0032024]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of cell cycle [GO:0051726]; regulation of cytosolic calcium ion concentration [GO:0051480]; steroid hormone mediated signaling pathway [GO:0043401]; vasodilation [GO:0042311] GO:0000139; GO:0001934; GO:0001956; GO:0002695; GO:0003682; GO:0004930; GO:0005496; GO:0005634; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0007049; GO:0007186; GO:0007189; GO:0007204; GO:0007399; GO:0008284; GO:0008285; GO:0010628; GO:0010629; GO:0010948; GO:0014068; GO:0014069; GO:0019228; GO:0030154; GO:0030263; GO:0030264; GO:0030284; GO:0030335; GO:0030424; GO:0030425; GO:0030518; GO:0030659; GO:0031966; GO:0032024; GO:0032591; GO:0032962; GO:0038054; GO:0042311; GO:0042734; GO:0043065; GO:0043198; GO:0043231; GO:0043280; GO:0043401; GO:0043410; GO:0043679; GO:0044327; GO:0045087; GO:0045095; GO:0045599; GO:0045742; GO:0045745; GO:0045944; GO:0048471; GO:0048786; GO:0050728; GO:0050769; GO:0051055; GO:0051281; GO:0051480; GO:0051726; GO:0051898; GO:0055037; GO:0070161; GO:0070373; GO:0070374; GO:0070474; GO:0071333; GO:0071356; GO:0071375; GO:0071389; GO:0071392; GO:0090200; GO:0098686; GO:1903078; GO:1904706; GO:1990239; GO:2000353; GO:2000724; GO:2001238 chromatin binding [GO:0003682]; G protein-coupled estrogen receptor activity [GO:0038054]; G protein-coupled receptor activity [GO:0004930]; nuclear estrogen receptor activity [GO:0030284]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239] LRLYIEQK 0.99314 -17.236 0 0 0 0 0 0 0 0 0 0 0 14.7124 14.6441 14.6522 0 14.2466 0 0 0 0 0 0 0 0 0 0 0 0 14.8419 0 0 0 14.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9817 13.5591 0 14.6611 13.4453 13.7569 0 12.595 14.0628 0 0 0 0 0 0 0 0 12.0626 11.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7792 18.4667 0 18.4133 18.8145 0 18.4391 0 18.618 0 0 0 0 0 0 0 0 0 0 17.8968 0 0 17.3305 0 0 17.7488 0 17.4453 0 0 0 0 0 0 17.6447 0 0 0 0 0 0 17.2378 0 0 0 0 0 0 16.9496 0 13.7096 17.124 16.9475 0 0 16.0515 16.2919 16.324 0 0 0 0 0 0 0 0 0 0 0 16.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.319 0 0 0 15.8294 0 Q9BQA9 CYBC1_HUMAN "Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein, Eros)" CYBC1 C17orf62 EROS Homo sapiens (Human) innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728] GO:0005783; GO:0005789; GO:0016021; GO:0045087; GO:0045728 GYMVVLR 0.99314 -9.2015 0 0 13.7485 0 0 0 0 0 0 0 0 0 0 13.4246 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3651 0 13.4574 0 0 0 12.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8949 0 0 0 12.974 0 13.2489 0 12.2027 11.8944 11.8602 0 12.1243 0 0 12.2945 0 0 0 0 0 13.3408 11.3706 0 13.673 0 0 0 0 0 0 0 14.6125 14.6975 14.8808 14.8725 14.9815 0 15.1095 0 0 0 14.936 15.4618 0 0 15.2545 0 0 13.0413 0 0 13.4086 0 14.5682 0 0 12.6162 0 0 0 0 0 0 0 0 0 13.3159 0 13.4213 0 14.523 0 14.8862 13.1821 0 0 13.6006 0 0 0 0 0 0 10.9933 0 0 15.6852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.634 0 0 0 13.7888 0 0 0 0 0 0 Q9H0A6 RNF32_HUMAN RING finger protein 32 RNF32 FKSG33 HSD15 Homo sapiens (Human) aggresome [GO:0016235]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear body [GO:0016604] aggresome [GO:0016235]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear body [GO:0016604]; metal ion binding [GO:0046872] GO:0005768; GO:0005829; GO:0016235; GO:0016604; GO:0046872 metal ion binding [GO:0046872] IQVQALR 0.99314 -14.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2C0 GAN_HUMAN Gigaxonin (Kelch-like protein 16) GAN GAN1 KLHL16 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeleton organization [GO:0007010]; protein ubiquitination [GO:0016567] GO:0005737; GO:0005829; GO:0005856; GO:0007010; GO:0016567; GO:0031463 DDGSTYK 0.99314 -16.811 0 0 0 0 0 0 0 0 0 0 0 11.4586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4619 0 0 0 12.5773 0 0 0 10.4288 0 0 0 11.6499 0 0 0 0 0 0 13.6582 0 0 11.7144 0 0 13.8102 0 0 13.1273 0 11.6891 12.3629 0 0 0 12.9522 0 0 0 0 0 0 0 0 12.2989 0 0 0 0 0 0 0 12.3651 0 12.1963 0 0 0 0 0 0 0 12.1904 0 0 0 0 0 0 12.1712 11.5567 0 0 0 0 0 0 14.1031 0 11.8078 0 0 0 0 0 0 12.8199 14.847 14.8036 0 0 0 14.8335 13.7274 0 0 0 0 0 0 0 0 0 0 0 11.3311 0 0 0 Q9H8S9 MOB1A_HUMAN "MOB kinase activator 1A (Mob1 alpha, Mob1A) (Mob1 homolog 1B) (Mps one binder kinase activator-like 1B)" MOB1A C2orf6 MOB4B MOBK1B MOBKL1B Homo sapiens (Human) hippo signaling [GO:0035329]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; hippo signaling [GO:0035329]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007165; GO:0030295; GO:0035329; GO:0046872; GO:0070062 metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] NFMSVAKTILKR 0.99314 -7.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4332 0 14.897 0 15.2115 15.4182 15.5706 0 0 0 0 0 0 0 0 0 0 0 0 0 16.051 0 0 0 0 12.0219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3725 0 0 0 0 0 0 0 13.6627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRA2 S17A5_HUMAN "Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter, AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter)" SLC17A5 Homo sapiens (Human) amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739] anchoring junction [GO:0070161]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739] GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016021; GO:0022857; GO:0030672; GO:0070161 carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; transmembrane transporter activity [GO:0022857] IGGKMLLGFGILGTAVLTLFTPIAADLGVGPLIVLR 0.99314 -9.201 0 0 0 0 0 0 0 0 0 0 0 13.4111 13.0181 0 0 0 0 12.3446 0 0 0 0 0 0 12.0609 0 0 0 0 0 0 0 0 0 0 12.5353 12.8756 0 0 0 0 12.8098 0 0 0 0 12.2935 0 11.4935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5211 0 11.5129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1749 0 0 0 0 0 0 0 13.6348 13.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1281 0 12.5807 0 0 Q9UQ80 PA2G4_HUMAN "Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog, hG4-1) (ErbB3-binding protein 1)" PA2G4 EBP1 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]" azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] "azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]" GO:0003676; GO:0003714; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0016020; GO:0031625; GO:0035578; GO:0043066; GO:0045597; GO:0045892; GO:0070062 nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625] AFFSEVERR 0.99314 -6.6144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4501 0 13.7648 0 0 0 0 0 10.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8483 0 0 12.2515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.314 0 14.1739 0 0 0 0 14.7136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75128 COBL_HUMAN Protein cordon-bleu COBL KIAA0633 Homo sapiens (Human) actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; collateral sprouting in absence of injury [GO:0048669]; digestive tract development [GO:0048565]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; liver development [GO:0001889]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; positive regulation of dendrite development [GO:1900006]; positive regulation of ruffle assembly [GO:1900029]; somite specification [GO:0001757] actin filament [GO:0005884]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; terminal web [GO:1990357] actin filament [GO:0005884]; axon [GO:0030424]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; terminal web [GO:1990357]; actin monomer binding [GO:0003785]; actin filament network formation [GO:0051639]; actin filament polymerization [GO:0030041]; collateral sprouting in absence of injury [GO:0048669]; digestive tract development [GO:0048565]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; liver development [GO:0001889]; neural tube closure [GO:0001843]; notochord development [GO:0030903]; positive regulation of dendrite development [GO:1900006]; positive regulation of ruffle assembly [GO:1900029]; somite specification [GO:0001757] GO:0000578; GO:0001726; GO:0001757; GO:0001843; GO:0001889; GO:0003785; GO:0005884; GO:0005886; GO:0005938; GO:0016020; GO:0030041; GO:0030424; GO:0030425; GO:0030903; GO:0033504; GO:0043025; GO:0044294; GO:0044295; GO:0048471; GO:0048565; GO:0048669; GO:0051639; GO:1900006; GO:1900029; GO:1990357 actin monomer binding [GO:0003785] APPPPGK 0.99315 -43.096 13.6681 12.9351 0 16.1908 13.1689 0 13.053 13.3544 0 0 0 16.0194 15.9329 16.4233 16.0351 15.9758 12.3615 16.5253 0 14.4629 12.9722 0 0 0 14.2674 12.045 14.7489 0 16.3962 16.4952 16.2697 16.7515 16.3099 12.0172 13.0008 0 0 13.8205 16.12 12.5078 16.1375 14.8892 16.2795 16.0383 16.4431 15.9711 15.8054 15.898 11.9593 15.8502 15.9378 12.3584 0 15.9187 15.0328 11.4588 15.7867 15.4526 14.9934 0 11.9201 11.7825 15.6711 14.9208 14.8094 14.8739 12.0539 0 12.8816 12.4564 0 0 13.6373 13.7283 17.7418 17.9293 17.6983 16.85 16.1757 15.9941 14.2798 17.6168 16.5174 14.6612 15.7628 15.1649 14.861 14.5395 15.08 13.471 14.9637 16.0831 15.9751 13.6316 14.6959 14.9272 11.9145 15.7262 16.63 15.6894 14.8312 14.0231 16.2049 15.7317 15.5401 13.759 15.3357 15.2921 15.8591 16.0205 16.0324 14.2129 15.1683 17.3457 17.6226 14.8679 17.4545 14.8011 12.7146 17.3725 16.522 15.0678 15.6461 15.0072 15.7489 15.1369 20.1837 14.7329 16.5258 16.4705 15.5872 14.8765 17.5487 17.6396 16.0022 17.1528 13.6834 13.5607 16.1527 16.5883 14.0097 13.7201 14.5482 17.2827 14.5976 13.1203 15.3155 17.0131 17.0864 0 15.0989 14.9145 0 14.8867 16.0639 16.5661 0 0 12.5346 11.8667 12.8049 12.3804 12.5681 14.2006 0 12.3035 17.031 17.2718 16.9524 17.0999 12.05 13.7638 15.5304 15.9053 0 17.44 0 0 17.3615 0 P04049 RAF1_HUMAN "RAF proto-oncogene serine/threonine-protein kinase, EC 2.7.11.1 (Proto-oncogene c-RAF, cRaf) (Raf-1)" RAF1 RAF Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of Rho protein signal transduction [GO:0035023]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; wound healing [GO:0042060] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; activation of adenylate cyclase activity [GO:0007190]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; face development [GO:0060324]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of Rho protein signal transduction [GO:0035023]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; wound healing [GO:0042060] GO:0000165; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007165; GO:0007190; GO:0008285; GO:0008625; GO:0019899; GO:0030154; GO:0030878; GO:0031143; GO:0031333; GO:0033138; GO:0035019; GO:0035023; GO:0035773; GO:0035994; GO:0042060; GO:0042802; GO:0042981; GO:0043066; GO:0043154; GO:0043410; GO:0045104; GO:0045595; GO:0045944; GO:0046872; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:0106310; GO:1902042; GO:2000145 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FLLNGFRCQTCGYK 0.99315 -16.089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8673 0 0 10.8772 0 0 0 0 0 0 0 0 0 0 0 0 13.3358 0 0 0 0 0 0 0 0 0 0 12.3463 15.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1753 0 0 0 0 0 0 0 13.9803 13.9601 0 0 0 14.291 15.6417 0 0 0 0 12.7297 14.1302 13.531 0 0 13.1244 0 0 13.702 13.7981 13.4366 15.3337 0 0 0 12.8187 0 0 0 0 0 0 0 15.1423 0 0 15.4201 0 0 0 14.6631 11.2799 0 0 16.4876 10.3381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3806 0 0 0 14.8825 0 0 0 0 0 P23469 PTPRE_HUMAN "Receptor-type tyrosine-protein phosphatase epsilon, Protein-tyrosine phosphatase epsilon, R-PTP-epsilon, EC 3.1.3.48" PTPRE Homo sapiens (Human) negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005001; GO:0005634; GO:0005737; GO:0005886; GO:0006470; GO:0016021; GO:0046627 protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] KARVIQIIPYDFNR 0.99315 -6.6642 0 0 0 0 0 0 0 0 0 13.4594 0 0 0 0 0 0 0 0 0 0 12.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0558 13.6885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9246 0 0 0 0 0 0 0 13.357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51530 DNA2_HUMAN "DNA replication ATP-dependent helicase/nuclease DNA2, hDNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2, EC 3.1.-.-; DNA replication ATP-dependent helicase DNA2, EC 3.6.4.12 ]" DNA2 DNA2L KIAA0083 Homo sapiens (Human) "base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]" GO:0000076; GO:0000723; GO:0000729; GO:0000781; GO:0003677; GO:0003678; GO:0003723; GO:0004386; GO:0004518; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0032201; GO:0033567; GO:0042645; GO:0043137; GO:0043139; GO:0043504; GO:0044806; GO:0045740; GO:0046872; GO:0051539; GO:0071932; GO:0090305; GO:0090656; GO:1902990 "4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]" EQLNELELLMEKSFWEEAELPAELFQKK 0.99315 -17.395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6095 0 12.4826 0 0 15.3659 0 0 0 0 0 0 0 13.9972 0 13.7459 0 18.2478 0 0 0 0 0 0 0 0 0 13.0446 0 0 15.2154 0 0 0 0 0 0 0 0 0 15.2944 0 0 0 0 0 0 14.861 0 0 0 0 0 0 11.9255 0 0 0 0 0 0 15.4137 0 0 14.088 0 0 0 10.6299 0 0 14.7472 14.0457 0 0 0 0 0 0 0 0 0 13.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78562 PHEX_HUMAN "Phosphate-regulating neutral endopeptidase PHEX, EC 3.4.24.- (Metalloendopeptidase homolog PEX) (Vitamin D-resistant hypophosphatemic rickets protein) (X-linked hypophosphatemia protein, HYP)" PHEX PEX Homo sapiens (Human) bone development [GO:0060348]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; lung development [GO:0030324]; odontogenesis [GO:0042476]; organophosphate metabolic process [GO:0019637]; protein modification process [GO:0036211]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; lung development [GO:0030324]; odontogenesis [GO:0042476]; organophosphate metabolic process [GO:0019637]; protein modification process [GO:0036211]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to growth hormone [GO:0060416]; response to insulin-like growth factor stimulus [GO:1990418]; response to sodium phosphate [GO:1904383]; skeletal system development [GO:0001501] GO:0001501; GO:0004222; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006508; GO:0007267; GO:0008270; GO:0016485; GO:0019637; GO:0030282; GO:0030324; GO:0036211; GO:0042476; GO:0048471; GO:0060348; GO:0060416; GO:0071305; GO:0071374; GO:1904383; GO:1990418 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] AFNCPPNSTMNR 0.99315 -9.2137 0 0 0 0 13.7835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.35 0 0 0 0 10.978 0 0 0 0 0 11.5269 0 0 0 10.833 0 0 0 0 0 0 0 0 11.7234 0 0 11.7384 10.5709 0 0 0 0 0 0 0 0 0 0 0 0 10.2359 0 0 0 0 0 12.4448 0 12.8177 14.9778 0 0 0 0 12.981 12.611 0 0 0 0 12.7184 12.0922 0 14.1443 13.9322 14.5555 0 14.159 16.1745 15.0591 13.032 14.5905 14.454 13.6418 14.3859 12.5274 14.0372 0 14.2024 0 13.8824 0 15.331 0 14.2793 15.1015 0 15.0101 12.7165 14.8278 14.4787 0 0 0 14.8321 14.0301 15.3557 14.1189 0 0 10.2008 0 12.2543 14.2981 15.4069 0 15.2163 12.1838 0 10.7289 13.1087 0 13.8264 0 12.4325 0 11.1225 13.0161 13.4126 0 13.2722 14.3203 0 12.2342 12.5074 0 0 11.5762 0 0 0 0 0 12.3123 12.3157 0 0 0 12.527 12.6207 0 0 0 11.9733 0 0 0 12.1163 0 12.1624 0 0 13.0492 0 0 11.9395 0 13.1547 0 12.8536 Q15050 RRS1_HUMAN Ribosome biogenesis regulatory protein homolog RRS1 KIAA0112 RRR Homo sapiens (Human) "endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]" "condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]" "condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]" GO:0000027; GO:0000055; GO:0000447; GO:0000794; GO:0002244; GO:0003723; GO:0005654; GO:0005730; GO:0005783; GO:0007080; GO:0008097; GO:0030687; GO:0042273; GO:1901796; GO:1902570 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723] AEQDEAEKLQR 0.99315 -43.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.58958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8982 0 0 0 0 14.6342 0 0 13.3472 15.2567 0 0 14.3676 13.7683 13.3712 0 0 0 13.1532 13.0121 13.9616 13.2051 14.3546 0 0 14.5577 0 0 13.0256 14.2638 12.9161 16.0393 13.3846 0 0 0 0 0 0 0 0 13.4033 13.5193 0 13.6118 0 13.3636 0 14.2929 0 13.9044 13.1463 13.5573 0 0 0 13.7951 13.9945 15.0764 0 0 0 0 14.2659 0 0 0 0 0 0 14.8786 12.84 0 0 0 15.9312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5336 0 0 Q8IXI2 MIRO1_HUMAN "Mitochondrial Rho GTPase 1, MIRO-1, hMiro-1, EC 3.6.5.- (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1)" RHOT1 ARHT1 Homo sapiens (Human) cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0007264; GO:0010821; GO:0016020; GO:0019725; GO:0031307; GO:0047497; GO:0097345 calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] ASFGATVFAVLGFAMYKALLK 0.99315 -16.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2464 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9152 13.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9208 0 0 0 0 13.1884 0 0 0 0 0 0 0 0 0 12.8783 0 0 0 0 0 0 0 12.5139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.774 0 0 0 0 0 13.6754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD22 SFXN5_HUMAN Sideroflexin-5 SFXN5 Homo sapiens (Human) amino acid transport [GO:0006865]; citrate transport [GO:0015746]; mitochondrial transmembrane transport [GO:1990542] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; citrate transmembrane transporter activity [GO:0015137]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865]; citrate transport [GO:0015746]; mitochondrial transmembrane transport [GO:1990542] GO:0005739; GO:0006865; GO:0015137; GO:0015746; GO:0022857; GO:0031305; GO:1990542 citrate transmembrane transporter activity [GO:0015137]; transmembrane transporter activity [GO:0022857] FTPATRLLIQR 0.99315 -6.6667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7697 12.8726 12.5008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1193 0 0 0 0 0 0 0 0 0 0 0 11.2667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWL7 CCNB3_HUMAN G2/mitotic-specific cyclin-B3 CCNB3 CYCB3 Homo sapiens (Human) cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G2/M transition of mitotic cell cycle [GO:0010389] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0005813; GO:0010389; GO:0016538; GO:0016607; GO:0019901; GO:0044772; GO:0051301; GO:0051321 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] CTTQEMMSICPELLDFQDMIGEDK 0.99315 -38.579 0 0 0 0 12.2983 0 0 0 0 0 13.3343 0 0 0 0 0 0 13.3389 0 0 14.1236 0 0 0 0 0 0 0 0 12.1559 0 11.7595 11.396 0 0 0 12.3501 0 12.0286 12.5735 0 0 0 12.2249 0 0 14.8778 0 0 0 0 12.7116 0 11.6964 0 12.1445 0 12.1782 0 0 0 0 0 0 0 0 12.8618 0 14.7156 0 14.1781 0 0 0 0 0 14.4288 14.0811 0 14.9563 15.6532 13.4726 0 0 0 11.8176 0 12.7494 14.136 11.4421 0 13.92 14.4319 13.4506 14.377 13.3851 0 0 0 13.0903 18.9289 12.7972 0 0 15.0645 0 13.3809 13.531 12.9863 0 0 0 13.5675 0 14.8699 0 12.2013 0 0 0 0 12.2735 14.9378 13.3578 0 0 0 0 0 13.0972 13.2526 0 13.5866 0 0 16.8122 0 0 0 0 0 0 11.3352 0 0 13.7184 11.9564 12.0175 0 12.1772 0 0 0 13.7004 13.4581 12.9242 0 0 0 0 0 0 13.1681 13.6541 0 12.4562 0 0 0 0 0 14.093 0 0 14.4619 0 16.5766 0 0 0 Q93088 BHMT1_HUMAN "Betaine--homocysteine S-methyltransferase 1, EC 2.1.1.5" BHMT Homo sapiens (Human) 'de novo' L-methionine biosynthetic process [GO:0071266]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]; regulation of homocysteine metabolic process [GO:0050666] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; 'de novo' L-methionine biosynthetic process [GO:0071266]; amino-acid betaine catabolic process [GO:0006579]; amino-acid betaine metabolic process [GO:0006577]; L-methionine salvage [GO:0071267]; methionine biosynthetic process [GO:0009086]; protein methylation [GO:0006479]; regulation of homocysteine metabolic process [GO:0050666] GO:0005634; GO:0005829; GO:0006479; GO:0006577; GO:0006579; GO:0008270; GO:0009086; GO:0047150; GO:0050666; GO:0070062; GO:0071266; GO:0071267 betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270] AGASIIGVNCHFDPTISLKTVK 0.99315 -16.083 0 0 0 0 0 0 0 0 0 0 0 12.6654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5361 12.7769 0 12.4974 11.8394 12.5251 13.8955 0 0 0 0 11.8087 0 0 0 13.7638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7328 14.9139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2189 0 0 0 0 0 0 0 11.4901 0 0 0 0 0 0 14.3036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7754 0 0 0 0 Q96MP8 KCTD7_HUMAN BTB/POZ domain-containing protein KCTD7 KCTD7 Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; glutamate homeostasis [GO:0090461]; membrane hyperpolarization [GO:0060081]; positive regulation of transporter activity [GO:0032411]; protein homooligomerization [GO:0051260] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; cellular potassium ion homeostasis [GO:0030007]; glutamate homeostasis [GO:0090461]; membrane hyperpolarization [GO:0060081]; positive regulation of transporter activity [GO:0032411]; protein homooligomerization [GO:0051260] GO:0005737; GO:0005829; GO:0005886; GO:0030007; GO:0032411; GO:0042802; GO:0051260; GO:0060081; GO:0090461 identical protein binding [GO:0042802] ARFAKLK 0.99315 -38.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8073 0 0 14.0859 13.4946 0 0 13.4111 13.3591 13.8525 0 0 13.2138 0 0 14.506 0 0 0 0 0 0 12.6748 0 0 0 0 0 0 0 12.7221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99728 BARD1_HUMAN "BRCA1-associated RING domain protein 1, BARD-1, EC 2.3.2.27 (RING-type E3 ubiquitin transferase BARD1)" BARD1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894] BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894] GO:0000151; GO:0000152; GO:0000209; GO:0001894; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006282; GO:0006974; GO:0016567; GO:0016607; GO:0019900; GO:0031436; GO:0031441; GO:0035518; GO:0035825; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0044818; GO:0045732; GO:0045786; GO:0046826; GO:0046872; GO:0046982; GO:0051726; GO:0051865; GO:0070531; GO:0070532; GO:0070533; GO:0070537; GO:0071479; GO:0085020; GO:0110025; GO:2000001 kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842] ALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASR 0.99315 -16.092 0 0 0 0 0 0 0 0 0 12.6347 0 0 12.3803 0 0 0 0 0 0 0 0 0 0 0 12.0132 0 0 0 11.7912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5744 0 0 13.9673 14.0951 0 0 13.6927 13.0498 0 13.6794 13.8789 13.685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7631 0 0 0 0 0 0 0 13.5852 0 0 0 13.232 12.9334 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0196 0 0 13.2197 0 13.7122 13.3857 0 0 14.7983 13.5708 0 14.8976 13.8009 13.9956 0 0 0 14.1796 0 0 0 0 12.8073 0 0 0 13.5503 0 0 0 0 13.6125 0 13.9444 0 0 0 0 12.5208 0 0 0 0 0 13.0566 0 0 0 0 11.4296 Q9NWY4 HPF1_HUMAN Histone PARylation factor 1 HPF1 C4orf27 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of histone modification [GO:0031056]; regulation of protein ADP-ribosylation [GO:0010835] chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of histone modification [GO:0031056]; regulation of protein ADP-ribosylation [GO:0010835] GO:0000785; GO:0003682; GO:0005634; GO:0006302; GO:0006974; GO:0010835; GO:0018312; GO:0031056; GO:0042393; GO:0072572; GO:0090734 chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572] FCEELDPEKPSDSLSASLGLQLVGPYDILAGK 0.99315 -16.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3507 13.4961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4695 0 0 0 0 0 0 0 0 0 0 0 0 11.8752 0 0 0 0 0 0 0 10.1066 11.9253 0 0 10.0828 0 0 0 10.9533 0 13.3511 0 0 0 0 0 0 0 0 12.3371 14.4751 0 0 14.1165 12.7141 14.8195 13.8726 13.6919 13.7738 14.7994 0 12.389 0 14.7439 0 13.6079 13.5371 0 0 13.8016 0 12.254 0 0 0 16.0176 13.411 9.95391 0 12.9064 0 0 14.1005 13.1447 0 0 0 12.9857 0 0 12.935 0 0 0 0 0 0 0 0 0 0 11.7816 12.557 0 0 0 0 10.7812 0 0 0 13.2425 0 12.0651 10.7551 13.8681 15.0517 12.2906 12.1232 12.3583 0 0 0 0 0 11.3656 0 12.4689 0 13.9388 15.1161 0 0 14.1329 13.9626 0 0 14.1886 0 13.7061 0 0 13.6902 0 0 0 14.5926 0 0 12.8676 14.0747 13.4127 12.0727 Q9UK58 CCNL1_HUMAN "Cyclin-L1, Cyclin-L" CCNL1 BM-001 UNQ530/PRO1073 Homo sapiens (Human) regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396] GO:0000079; GO:0000307; GO:0005634; GO:0006357; GO:0006396; GO:0016538; GO:0016607; GO:0042981; GO:0043484; GO:0046605; GO:0051726 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] HERGHHR 0.99315 -16.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9042 0 12.1631 0 0 0 0 0 12.7106 0 0 14.3602 0 0 0 17.0842 0 0 0 0 0 0 0 0 0 0 0 10.6364 0 0 0 0 0 0 0 13.3039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8832 0 13.3252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y230 RUVB2_HUMAN "RuvB-like 2, EC 3.6.4.12 (48 kDa TATA box-binding protein-interacting protein, 48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein, ECP-51) (INO80 complex subunit J) (Repressing pontin 52, Reptin 52) (TIP49b) (TIP60-associated protein 54-beta, TAP54-beta)" RUVBL2 INO80J TIP48 TIP49B CGI-46 Homo sapiens (Human) "box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]" centrosome [GO:0005813]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812] "centrosome [GO:0005813]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; Ino80 complex [GO:0031011]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; Swr1 complex [GO:0000812]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; promoter-enhancer loop anchoring activity [GO:0140585]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of histone acetylation [GO:0035066]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]" GO:0000492; GO:0000723; GO:0000786; GO:0000791; GO:0000812; GO:0000978; GO:0000979; GO:0001094; GO:0003678; GO:0003714; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0006457; GO:0008013; GO:0016020; GO:0016363; GO:0016573; GO:0016887; GO:0017025; GO:0031011; GO:0031490; GO:0033044; GO:0034644; GO:0035066; GO:0035267; GO:0040008; GO:0042802; GO:0042803; GO:0042981; GO:0043486; GO:0043531; GO:0043967; GO:0043968; GO:0045893; GO:0045944; GO:0045995; GO:0050821; GO:0051082; GO:0051117; GO:0051726; GO:0060382; GO:0070062; GO:0071169; GO:0071339; GO:0071392; GO:0090090; GO:0097255; GO:0101031; GO:0120293; GO:0140585; GO:1904507; GO:1904874; GO:1905168; GO:1990062; GO:1990904; GO:2000779 ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; promoter-enhancer loop anchoring activity [GO:0140585]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082] AVLIAGQPGTGK 0.99315 -7.7673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5546 0 0 12.1321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3108 0 0 0 0 13.6263 0 0 0 0 0 0 10.5911 0 0 0 12.1577 0 0 0 0 10.9188 0 0 0 0 0 0 15.8402 10.6984 11.1563 0 0 11.1002 0 0 12.6897 0 0 0 0 12.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2104 0 15.0118 0 13.0353 0 0 0 0 0 0 0 0 0 0 0 0 9.91731 0 0 0 0 0 11.9205 0 0 14.393 0 0 0 0 0 0 0 10.6694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5728 0 0 Q9Y4D1 DAAM1_HUMAN Disheveled-associated activator of morphogenesis 1 DAAM1 KIAA0666 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] "ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001725; GO:0003779; GO:0005829; GO:0005886; GO:0016020; GO:0030036; GO:0031267; GO:0031514; GO:0036064; GO:0042802; GO:0060071 actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] ADRFLFEMSRINHYQQR 0.99315 -43.781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.918 0 0 11.7807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.892 0 13.1471 15.071 0 0 0 0 0 0 0 0 0 0 0 10.7494 0 0 0 0 0 14.0038 0 14.7029 0 0 0 13.8023 0 13.8656 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1274 0 0 0 0 0 0 0 0 0 13.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3398 0 0 13.8175 13.846 0 0 0 13.6959 0 0 0 15.2491 0 0 11.1034 18.0496 0 0 0 11.8884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7389 0 0 0 0 0 0 14.2104 Q13698 CAC1S_HUMAN "Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1)" CACNA1S CACH1 CACN1 CACNL1A3 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extraocular skeletal muscle development [GO:0002074]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of ion transmembrane transport [GO:0034765]; skeletal muscle adaptation [GO:0043501]; skeletal muscle fiber development [GO:0048741]; skeletal system development [GO:0001501]; striated muscle contraction [GO:0006941] cytoplasm [GO:0005737]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891] cytoplasm [GO:0005737]; I band [GO:0031674]; L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; extraocular skeletal muscle development [GO:0002074]; muscle contraction [GO:0006936]; myoblast fusion [GO:0007520]; neuromuscular junction development [GO:0007528]; positive regulation of muscle contraction [GO:0045933]; regulation of ion transmembrane transport [GO:0034765]; skeletal muscle adaptation [GO:0043501]; skeletal muscle fiber development [GO:0048741]; skeletal system development [GO:0001501]; striated muscle contraction [GO:0006941] GO:0001501; GO:0002074; GO:0005245; GO:0005516; GO:0005737; GO:0005886; GO:0005891; GO:0006816; GO:0006936; GO:0006941; GO:0007029; GO:0007520; GO:0007528; GO:0008331; GO:0016529; GO:0030315; GO:0031674; GO:0034765; GO:0043501; GO:0045933; GO:0046872; GO:0048741; GO:0070588; GO:0071313; GO:0098703; GO:1990454 calmodulin binding [GO:0005516]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] AFRVLRPLR 0.99316 -39.747 0 0 0 0 12.0007 0 0 0 0 0 0 0 0 13.7683 0 0 0 0 13.2838 0 0 0 0 0 10.6415 0 0 0 13.0162 0 0 13.4011 0 0 0 0 0 0 0 0 13.8807 11.5982 13.0919 0 0 0 0 0 0 0 12.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.361 12.1045 0 0 0 15.2619 12.8343 13.7951 14.519 0 0 0 14.8546 0 15.026 11.9627 0 0 0 11.6279 13.0815 0 0 13.2009 15.1168 14.4539 12.5155 0 14.8998 0 13.3467 15.3869 0 15.3032 0 14.0459 12.9746 13.01 12.8878 12.91 14.1111 12.4058 12.7995 0 13.3733 11.9076 13.742 11.9409 0 13.4644 0 0 15.3337 0 12.0892 0 0 12.189 0 15.5179 13.0017 0 0 0 12.746 11.8454 0 12.045 0 0 0 0 0 12.6775 0 14.1876 0 0 0 0 0 0 12.2225 0 0 14.3289 0 14.4564 0 0 0 0 0 13.4329 12.7403 0 14.516 13.8085 0 14.6348 13.5668 0 13.4788 0 0 0 12.7222 0 12.7495 11.6284 0 A6ND48 O14I1_HUMAN Olfactory receptor 14I1 (Olfactory receptor 5BU1) OR14I1 OR5BU1 OR5BU1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ALSIQDLVIALTYTVLPPFLNPIIYSLRNK 0.99316 -5.2277 0 0 0 0 0 0 0 0 0 0 0 11.4986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9269 0 0 0 0 0 0 0 0 0 0 0 0 16.0633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NHQ4 EPOP_HUMAN Elongin BC and Polycomb repressive complex 2-associated protein (Proline-rich protein 28) EPOP C17orf96 PRR28 Homo sapiens (Human) histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863] chromosome [GO:0005694]; elongin complex [GO:0070449]; ESC/E(Z) complex [GO:0035098] chromosome [GO:0005694]; elongin complex [GO:0070449]; ESC/E(Z) complex [GO:0035098]; chromatin binding [GO:0003682]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; neuron fate commitment [GO:0048663]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863] GO:0003682; GO:0005694; GO:0006357; GO:0035098; GO:0035616; GO:0048663; GO:0048863; GO:0070449 chromatin binding [GO:0003682] GPARGAAKK 0.99316 -13.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5482 0 0 0 0 0 0 0 0 15.9081 0 0 0 0 0 0 0 0 14.9475 13.3306 0 0 0 0 0 13.4822 0 0 0 0 0 0 0 0 0 11.6244 0 0 0 0 13.8081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95248 MTMR5_HUMAN "Myotubularin-related protein 5 (Inactive phosphatidylinositol 3-phosphatase 5) (SET-binding factor 1, Sbf1)" SBF1 MTMR5 Homo sapiens (Human) protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470]; regulation of GTPase activity [GO:0043087]; spermatid development [GO:0007286] GO:0005085; GO:0005737; GO:0005789; GO:0005829; GO:0006470; GO:0007286; GO:0008138; GO:0016021; GO:0016604; GO:0019208; GO:0043087; GO:0048471 guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] AQPDAISRLLEELQR 0.99316 -39.201 11.7778 0 0 0 0 0 0 0 10.5401 0 13.3651 0 0 11.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7298 0 0 0 12.7356 0 0 10.0895 0 10.1836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9613 12.5768 0 0 0 0 0 0 0 13.664 0 0 13.1727 0 14.7177 0 14.435 14.5114 10.9446 14.5615 12.4049 14.3622 0 12.2105 0 14.1097 0 12.8455 0 0 0 0 14.7325 14.1899 0 0 0 0 0 0 12.5332 14.7102 0 12.7286 15.2416 12.7966 14.2085 15.2125 0 13.1269 13.2889 11.8984 0 12.984 0 12.1409 0 0 15.1292 12.9043 13.2949 14.2808 0 15.3374 0 0 12.1592 12.9229 13.9267 0 0 0 0 14.5049 14.2388 0 13.1221 13.3127 0 0 12.8072 0 13.9399 0 0 0 13.1518 13.7121 0 0 0 14.3103 0 0 13.5971 0 0 12.299 0 0 0 13.4974 P12755 SKI_HUMAN Ski oncogene (Proto-oncogene c-Ski) SKI Homo sapiens (Human) "anterior/posterior axis specification [GO:0009948]; bone morphogenesis [GO:0060349]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell motility [GO:0048870]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; lens morphogenesis in camera-type eye [GO:0002089]; myelination in peripheral nervous system [GO:0022011]; myotube differentiation [GO:0014902]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neural tube closure [GO:0001843]; nose morphogenesis [GO:0043585]; olfactory bulb development [GO:0021772]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; retina development in camera-type eye [GO:0060041]; roof of mouth development [GO:0060021]; skeletal muscle fiber development [GO:0048741]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase inhibitor activity [GO:0046811]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; anterior/posterior axis specification [GO:0009948]; bone morphogenesis [GO:0060349]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell motility [GO:0048870]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; lens morphogenesis in camera-type eye [GO:0002089]; myelination in peripheral nervous system [GO:0022011]; myotube differentiation [GO:0014902]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neural tube closure [GO:0001843]; nose morphogenesis [GO:0043585]; olfactory bulb development [GO:0021772]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; retina development in camera-type eye [GO:0060041]; roof of mouth development [GO:0060021]; skeletal muscle fiber development [GO:0048741]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001843; GO:0002089; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0006351; GO:0007179; GO:0008270; GO:0008285; GO:0009948; GO:0010626; GO:0014902; GO:0016604; GO:0016605; GO:0017053; GO:0019901; GO:0019904; GO:0021772; GO:0022011; GO:0030177; GO:0030326; GO:0030512; GO:0030514; GO:0031625; GO:0032926; GO:0032991; GO:0035019; GO:0042802; GO:0043010; GO:0043388; GO:0043585; GO:0045668; GO:0045944; GO:0046332; GO:0046811; GO:0048147; GO:0048593; GO:0048741; GO:0048870; GO:0060021; GO:0060041; GO:0060325; GO:0060349; GO:0060395; GO:0140297 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase inhibitor activity [GO:0046811]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]" DSFYSYK 0.99316 -13.213 0 0 0 0 0 0 0 0 11.4552 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4079 0 11.9195 0 0 0 0 0 0 0 0 0 0 0 0 14.5641 0 14.4283 13.1599 15.2349 13.9412 14.7516 0 13.445 14.1141 13.4439 0 0 0 0 0 0 0 14.2734 0 0 0 13.9842 0 0 0 0 0 14.1688 13.2298 0 13.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4748 0 13.6336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8291 0 0 0 0 0 0 0 0 0 13.2219 0 0 0 0 0 12.9159 0 13.374 0 13.2051 0 0 0 0 0 0 P12821 ACE_HUMAN "Angiotensin-converting enzyme, ACE, EC 3.4.15.1 (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form ]" ACE DCP DCP1 Homo sapiens (Human) aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310] basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; substance P catabolic process [GO:0010814]; vasoconstriction [GO:0042310] GO:0001666; GO:0001822; GO:0001974; GO:0002003; GO:0002019; GO:0002446; GO:0002474; GO:0003081; GO:0003084; GO:0003779; GO:0004175; GO:0004180; GO:0004222; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005886; GO:0005887; GO:0006508; GO:0007283; GO:0007420; GO:0007565; GO:0007568; GO:0008217; GO:0008233; GO:0008237; GO:0008238; GO:0008240; GO:0008241; GO:0008270; GO:0008584; GO:0009410; GO:0009792; GO:0009897; GO:0009925; GO:0010608; GO:0010629; GO:0010814; GO:0010815; GO:0014910; GO:0016021; GO:0019229; GO:0019233; GO:0031100; GO:0031404; GO:0031434; GO:0031526; GO:0031667; GO:0031711; GO:0032091; GO:0032092; GO:0032496; GO:0032943; GO:0034616; GO:0035814; GO:0042310; GO:0042445; GO:0042447; GO:0042755; GO:0043065; GO:0043171; GO:0045907; GO:0046325; GO:0048167; GO:0048286; GO:0050435; GO:0050482; GO:0050729; GO:0050769; GO:0051019; GO:0060047; GO:0060177; GO:0060218; GO:0060978; GO:0061098; GO:0070062; GO:0070573; GO:0071333; GO:0071548; GO:0071838; GO:0090281; GO:0097066; GO:0097225; GO:0097746; GO:1900086; GO:1901363; GO:1902033; GO:1903597; GO:1904045; GO:2000170 actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270] DLPVALR 0.99316 -14.26 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5382 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1384 0 0 0 0 11.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8497 0 0 0 11.8927 13.8932 0 0 0 11.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5048 0 0 12.3417 0 0 0 0 11.4141 0 0 0 0 13.003 0 0 0 0 0 0 0 0 0 0 0 12.1129 0 0 0 0 0 14.7133 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6056 0 0 0 0 10.3661 0 0 0 0 0 0 0 0 0 0 0 0 12.2019 0 0 0 13.6271 0 0 0 0 0 0 0 0 0 P30291 WEE1_HUMAN "Wee1-like protein kinase, WEE1hu, EC 2.7.10.2 (Wee1A kinase)" WEE1 Homo sapiens (Human) cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuron projection morphogenesis [GO:0048812] GO:0000086; GO:0000226; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0030010; GO:0048812; GO:0051301; GO:2000134 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713] KAQMAKAAAEER 0.99316 -13.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7444 0 0 0 0 0 11.3125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3638 0 0 0 0 0 0 0 0 12.3456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57773 CXA9_HUMAN "Gap junction alpha-9 protein (Connexin-58, Cx58) (Connexin-59, Cx59) (Gap junction alpha-10 protein)" GJA9 GJA10 Homo sapiens (Human) cell-cell signaling [GO:0007267] connexin complex [GO:0005922]; integral component of membrane [GO:0016021] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267] GO:0005243; GO:0005922; GO:0007267; GO:0016021 gap junction channel activity [GO:0005243] AKQNVAK 0.99316 -16.566 0 0 0 0 0 0 0 0 0 10.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3005 0 0 0 0 10.4015 0 0 0 0 0 0 0 0 0 0 11.5277 0 0 0 0 11.2594 0 0 0 15.5366 14.1958 15.5408 0 0 0 0 0 0 0 12.559 0 0 14.2406 0 0 0 0 0 0 15.3655 13.5573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1328 0 0 0 0 0 0 0 0 0 0 0 13.6389 0 0 0 0 0 13.1734 0 0 15.2259 16.3365 0 0 14.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0741 0 0 0 0 0 0 13.4588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6372 0 Q4L235 ACSF4_HUMAN "Beta-alanine-activating enzyme, EC 6.2.1.- (Acyl-CoA synthetase family member 4) (Protein NRPS998)" AASDH ACSF4 U26 HSPC318 Homo sapiens (Human) amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631] acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; amino acid activation for nonribosomal peptide biosynthetic process [GO:0043041]; beta-alanine metabolic process [GO:0019482]; fatty acid metabolic process [GO:0006631] GO:0005524; GO:0006631; GO:0016878; GO:0019482; GO:0043041 acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524] EDLWEKLQYLWKSTLNLPEDLLR 0.99316 -27.01 0 0 0 0 0 0 0 0 0 11.1695 11.531 0 0 0 13.7834 0 0 0 0 0 0 0 0 0 0 12.3563 0 0 0 0 0 0 0 0 0 0 0 12.0382 12.6344 11.9984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5701 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9865 0 0 0 0 15.2247 0 0 15.0838 0 12.7641 0 13.9292 0 13.7311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7416 12.8264 13.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9846 0 0 0 0 0 0 0 0 0 0 0 0 14.7064 0 0 0 0 0 0 0 0 0 0 0 0 0 14.72 12.7065 0 0 0 0 0 0 0 0 0 0 0 0 13.3411 0 0 0 0 Q8IWJ2 GCC2_HUMAN "GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein, GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4, RanBP2L4) (Renal carcinoma antigen NY-REN-53)" GCC2 KIAA0336 RANBP2L4 Homo sapiens (Human) "Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006622; GO:0016020; GO:0031023; GO:0031267; GO:0034067; GO:0034453; GO:0034499; GO:0042147; GO:0042802; GO:0070861; GO:0071955; GO:0090161 identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] AEQATVTSEFESYK 0.99316 -26.97 11.1515 0 0 0 13.1116 0 0 0 0 0 0 0 0 0 0 0 11.3427 0 0 0 0 13.7403 0 10.9464 0 0 0 13.3336 0 11.1508 0 0 0 0 0 0 0 11.7767 0 9.80195 0 0 0 0 0 0 12.5392 0 0 0 0 0 0 0 0 11.6076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2088 0 0 14.9173 0 0 0 0 0 0 16.3014 12.4892 0 0 14.0053 0 14.4622 0 0 0 13.4916 0 16.5933 13.3807 14.7029 0 0 15.9155 0 0 0 0 0 0 0 0 11.9633 0 0 0 0 0 0 0 15.2387 0 0 11.4524 11.9605 0 0 14.2145 0 0 0 0 0 0 0 0 13.7778 0 0 0 0 0 0 12.8584 0 0 0 0 0 13.7874 11.2521 0 0 0 0 0 0 0 11.1996 0 0 0 0 0 0 0 0 0 0 0 0 13.2657 0 0 0 0 0 0 0 0 0 0 14.3162 0 0 Q8NA31 TERB1_HUMAN Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79) TERB1 CCDC79 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141] "chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187]" "chromosome, telomeric region [GO:0000781]; nuclear inner membrane [GO:0005637]; shelterin complex [GO:0070187]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141]" GO:0000781; GO:0005637; GO:0007129; GO:0045141; GO:0070187; GO:0070197 AEDEDKSHSRQLQSYK 0.99316 -39.232 0 0 0 0 12.7125 0 0 0 0 14.1821 0 0 0 0 0 13.7569 0 0 0 0 12.3679 12.218 0 12.1418 0 0 0 0 0 10.6317 0 0 0 0 0 0 14.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2485 0 0 0 18.9464 14.7764 15.0332 12.4463 12.6417 12.3645 12.3197 0 0 13.618 0 0 0 0 0 0 0 0 0 0 0 12.5174 0 12.7968 0 0 0 0 0 14.2231 13.2379 13.8843 0 0 0 0 12.5933 0 0 0 0 12.2236 0 11.7335 0 13.0955 0 13.6 13.1243 0 0 0 0 14.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8798 13.8434 12.95 0 13.3978 12.9636 0 0 0 13.3624 13.6601 13.1045 0 0 0 0 12.8244 11.1186 0 0 12.7852 0 16.1074 12.4092 0 14.4151 0 11.936 12.2777 0 13.2251 0 0 0 0 0 0 12.807 0 13.3669 13.4543 0 0 0 0 0 0 0 0 13.0079 0 0 0 0 0 Q8NA92 THAP8_HUMAN THAP domain-containing protein 8 THAP8 Homo sapiens (Human) DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] ARRGLQR 0.99316 -14.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAX2 KDF1_HUMAN Keratinocyte differentiation factor 1 KDF1 C1orf172 Homo sapiens (Human) developmental growth [GO:0048589]; establishment of skin barrier [GO:0061436]; keratinocyte development [GO:0003334]; keratinocyte proliferation [GO:0043616]; limb epidermis development [GO:0060887]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of epidermal cell division [GO:0010482]; stem cell proliferation [GO:0072089] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; developmental growth [GO:0048589]; establishment of skin barrier [GO:0061436]; keratinocyte development [GO:0003334]; keratinocyte proliferation [GO:0043616]; limb epidermis development [GO:0060887]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; positive regulation of epidermal cell differentiation [GO:0045606]; regulation of epidermal cell division [GO:0010482]; stem cell proliferation [GO:0072089] GO:0003334; GO:0005737; GO:0005938; GO:0010482; GO:0010839; GO:0016331; GO:0030054; GO:0031252; GO:0043616; GO:0045606; GO:0048589; GO:0060887; GO:0061436; GO:0070161; GO:0072089; GO:2000647 CRDCLQR 0.99316 -14.657 0 0 0 0 11.264 0 0 0 0 0 0 0 14.849 0 14.0419 13.0799 0 14.2632 0 14.634 0 0 11.3346 0 15.964 0 0 14.6745 0 0 0 0 0 0 13.9907 12.9957 0 10.6158 13.7027 0 0 0 0 0 13.1294 0 0 0 0 0 0 0 12.9493 0 13.5858 12.6943 12.529 0 0 0 0 0 0 0 0 0 0 0 13.1529 0 15.1885 14.776 0 0 14.9221 14.5047 14.714 15.9559 12.774 12.559 15.7603 14.2092 0 0 0 0 0 15.1542 15.2885 0 15.5816 14.4066 15.3047 12.6118 0 0 0 0 11.7879 0 14.9645 0 14.7514 0 0 0 0 0 14.3196 12.5874 0 0 0 0 13.3658 0 0 13.445 0 12.6676 0 0 13.9344 14.8705 0 14.2177 15.3676 0 14.3803 0 0 0 0 0 12.3732 0 13.9445 14.0753 12.335 0 0 0 12.3176 0 13.2777 12.5734 0 0 0 0 0 0 0 12.8392 12.8959 13.3855 0 13.6683 13.5575 0 0 14.0295 0 12.956 13.3373 0 13.9442 0 0 13.1938 12.8795 0 0 0 0 0 0 13.7543 14.7851 0 Q8NHU2 CFA61_HUMAN Cilia- and flagella-associated protein 61 CFAP61 C20orf26 Homo sapiens (Human) cilium movement [GO:0003341]; cilium organization [GO:0044782] axoneme [GO:0005930]; motile cilium [GO:0031514] axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782] GO:0003341; GO:0005930; GO:0031514; GO:0044782 AAGSLTK 0.99316 -13.216 0 0 0 0 0 0 0 0 0 0 14.5883 12.3655 0 11.8833 0 0 12.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6677 0 0 0 0 0 0 0 11.674 0 0 0 0 0 11.8261 11.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9319 0 0 13.1523 0 0 0 0 0 0 0 0 0 0 0 13.0438 0 12.8322 0 0 0 0 0 0 0 13.096 0 0 0 16.3846 0 0 0 0 0 0 15.6487 0 0 0 0 13.3103 14.1912 12.8745 12.3419 0 12.7944 0 0 0 13.4416 14.4556 0 0 12.9342 0 0 0 0 0 0 0 0 12.903 13.0785 12.3774 0 0 0 0 0 0 0 0 13.2899 0 17.5556 0 0 0 0 12.4687 0 13.166 0 0 13.3437 0 13.3134 13.3483 13.1385 13.3187 0 12.9492 0 13.3405 0 0 12.916 0 0 0 13.0525 0 12.9473 0 0 Q9GZU5 NYX_HUMAN Nyctalopin NYX CLRP Homo sapiens (Human) response to stimulus [GO:0050896]; visual perception [GO:0007601] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005615; GO:0007601; GO:0031012; GO:0050896 ACPAACACSTVERGCSVRCDR 0.99316 -26.991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3778 0 0 0 0 0 0 0 0 0 0 0 10.9677 0 0 0 11.1142 0 12.5409 0 0 0 0 0 0 12.9313 13.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6434 0 0 12.052 0 0 11.7461 12.4672 0 0 0 14.9089 0 0 0 0 0 0 0 0 14.9056 0 0 0 11.0724 0 0 14.5494 0 0 0 0 0 0 0 0 0 0 0 11.8509 0 0 0 0 0 0 0 0 0 14.2602 0 0 0 0 10.5391 0 0 0 0 0 0 0 0 0 0 0 12.5757 0 0 0 0 0 14.6182 0 0 0 0 0 0 0 0 0 0 0 15.3405 0 11.9039 0 15.0906 0 12.7994 15.6433 12.6753 12.1235 0 0 0 12.14 0 0 0 11.0455 12.7302 0 0 Q9NYL2 M3K20_HUMAN "Mitogen-activated protein kinase kinase kinase 20, EC 2.7.11.25 (Human cervical cancer suppressor gene 4 protein, HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase, MLK-related kinase, MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)" MAP3K20 MLTK ZAK HCCS4 Homo sapiens (Human) cell cycle [GO:0007049]; cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; JNK cascade [GO:0007254]; limb development [GO:0060173]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; JNK cascade [GO:0007254]; limb development [GO:0060173]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] GO:0000077; GO:0000287; GO:0003723; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0007010; GO:0007049; GO:0007254; GO:0008219; GO:0018105; GO:0030154; GO:0038066; GO:0042733; GO:0043065; GO:0051403; GO:0060173; GO:0071480; GO:0106310; GO:1904291 ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] ASEEDSK 0.99316 -14.249 0 0 0 0 0 0 0 0 12.506 0 0 14.6752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5216 0 0 0 0 0 0 13.5912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0726 0 0 0 0 13.4667 0 0 0 0 0 0 13.0063 0 12.6163 0 0 0 14.3787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.225 0 14.6827 0 0 0 0 0 0 0 0 0 0 Q9NYQ8 FAT2_HUMAN "Protocadherin Fat 2, hFat2 (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1, Multiple EGF-like domains protein 1)" FAT2 CDHF8 KIAA0811 MEGF1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005794; GO:0005886; GO:0005912; GO:0007156; GO:0010631; GO:0016021; GO:0031589; GO:0070062; GO:0098609 calcium ion binding [GO:0005509] AVYRVQLSEFSPPGSR 0.99316 -26.959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4099 0 13.6062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0813 0 0 13.1838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1671 14.6411 0 0 0 0 0 11.7996 18.7638 18.6188 13.0874 0 12.417 0 0 0 0 0 0 13.1498 0 0 0 12.5254 0 11.7461 11.5625 0 0 0 0 0 13.1175 0 0 0 13.2649 0 0 0 11.626 0 0 0 0 0 0 13.7294 15.0729 13.9529 0 0 11.2019 13.6321 0 0 0 0 15.2635 0 0 0 0 0 0 10.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6464 13.6988 0 0 11.4809 0 0 13.3819 0 12.8033 0 0 11.591 0 0 0 0 0 0 10.9112 0 0 Q9UQQ1 NALDL_HUMAN "Aminopeptidase NAALADL1, EC 3.4.11.- (100 kDa ileum brush border membrane protein, I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein, NAALADase L)" NAALADL1 NAALADASEL NAALADL Homo sapiens (Human) peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] GO:0004177; GO:0004180; GO:0005509; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0016021; GO:0016324; GO:0042803; GO:0043171 aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] ELQTQGIKLEGTIALTRYGGVGR 0.99316 -13.244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8055 0 0 0 0 11.6442 0 12.8651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7177 11.3615 0 12.7562 0 0 10.9923 0 0 12.8613 14.4626 13.8423 0 0 14.2793 0 0 0 0 11.6091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7311 0 0 0 0 0 0 0 0 11.7722 0 0 13.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1113 0 0 0 0 0 10.6453 0 0 0 0 12.5637 0 0 0 12.7849 0 0 0 0 0 0 11.5824 0 0 0 0 0 0 0 0 0 0 0 0 13.1298 0 Q9Y5B9 SP16H_HUMAN "FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16, hSPT16)" SUPT16H FACT140 FACTP140 Homo sapiens (Human) "DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent chromatin organization [GO:0034724]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent chromatin organization [GO:0034724]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0003723; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006334; GO:0006337; GO:0006366; GO:0006368; GO:0031491; GO:0032786; GO:0032968; GO:0034724; GO:0035101 nucleosome binding [GO:0031491]; RNA binding [GO:0003723] ASNIKAPGEQTVPALNLQNAFRIIK 0.99316 -39.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.861 0 0 0 0 12.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1725 0 0 0 0 0 0 0 0 12.9233 0 0 15.0484 0 12.2569 0 0 12.3312 0 0 0 0 0 0 14.3705 0 13.5757 0 0 0 0 0 12.8166 13.4014 13.0647 0 0 0 0 0 0 0 0 0 0 0 0 13.161 0 0 12.6823 0 0 0 0 11.831 14.5028 0 0 12.8324 0 13.8354 0 0 0 0 0 0 0 12.3363 0 0 14.0613 0 12.6437 0 13.0797 13.1468 0 0 0 0 0 0 11.8021 0 14.3259 14.5186 0 0 0 0 0 0 12.8607 13.7811 0 0 0 0 12.6622 10.5285 0 12.7358 0 12.7376 0 13.0994 0 0 0 0 0 12.4892 0 0 0 12.9335 10.9509 0 A0A1W2PPF3 DUXB_HUMAN Double homeobox protein B DUXB Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EIGVPESNIQVWFK 0.99317 -16.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2192 0 11.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 L0R8F8 MIDUO_HUMAN "MIEF1 upstream open reading frame protein (Alternative MIEF1 protein, AltMIEF1) (MIEF1 microprotein, MIEF1-MP)" MIEF1 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; positive regulation of mitochondrial translation [GO:0070131]; ribosome biogenesis [GO:0042254] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; positive regulation of mitochondrial translation [GO:0070131]; ribosome biogenesis [GO:0042254] GO:0005739; GO:0005759; GO:0042254; GO:0070131; GO:0071456 ALLRQGRQLR 0.99317 -6.5009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.567 0 0 0 0 0 0 0 0 0 0 17.2274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1912 0 0 0 0 0 0 0 0 0 0 0 0 13.3962 0 0 0 0 0 0 0 0 0 0 0 0 12.5389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00634 NET3_HUMAN Netrin-3 (Netrin-2-like protein) NTN3 NTN2L Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888] basement membrane [GO:0005604]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794] basement membrane [GO:0005604]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888] GO:0005102; GO:0005576; GO:0005604; GO:0005794; GO:0007411; GO:0008045; GO:0009887; GO:0009888; GO:0016358 signaling receptor binding [GO:0005102] CKCNGHASRCLLDTQGHLICDCR 0.99317 -16.627 0 0 0 0 0 0 0 0 0 0 12.0416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0531 0 13.2449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7712 13.5126 0 13.3147 14.0516 0 12.8215 0 0 13.3742 12.996 0 0 0 0 0 0 12.8588 12.9338 0 0 0 0 0 0 0 13.2537 11.9099 0 0 0 0 13.6546 0 0 0 0 0 0 12.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0771 0 0 0 0 0 0 0 0 0 0 O43286 B4GT5_HUMAN "Beta-1,4-galactosyltransferase 5, Beta-1,4-GalTase 5, Beta4Gal-T5, b4Gal-T5, EC 2.4.1.- (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.274) (Lactosylceramide synthase, LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5)" B4GALT5 Homo sapiens (Human) central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; glycoprotein biosynthetic process [GO:0009101]; glycosylation [GO:0070085]; neuron maturation [GO:0042551]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; protein glycosylation [GO:0006486]; regulation of protein stability [GO:0031647] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; glycoprotein biosynthetic process [GO:0009101]; glycosylation [GO:0070085]; neuron maturation [GO:0042551]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; protein glycosylation [GO:0006486]; regulation of protein stability [GO:0031647]" GO:0000139; GO:0003945; GO:0005794; GO:0006486; GO:0008378; GO:0008489; GO:0009101; GO:0010706; GO:0016021; GO:0016266; GO:0021955; GO:0022010; GO:0030311; GO:0031647; GO:0032580; GO:0040019; GO:0042551; GO:0046872; GO:0070085 "galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]" GLLRLPRR 0.99317 -16.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3472 0 0 0 0 0 0 9.81657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2621 0 0 0 0 0 13.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6529 13.1948 0 0 0 0 0 13.172 0 13.0805 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4917 0 0 0 0 0 11.7731 0 12.5006 0 0 0 0 0 0 0 0 0 0 0 11.9353 12.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.726 0 0 0 0 0 0 0 0 0 0 P04406 G3P_HUMAN "Glyceraldehyde-3-phosphate dehydrogenase, GAPDH, EC 1.2.1.12 (Peptidyl-cysteine S-nitrosylase GAPDH, EC 2.6.99.-)" GAPDH GAPD CDABP0047 OK/SW-cl.12 Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interferon-gamma [GO:0071346]; defense response to fungus [GO:0050832]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821]; regulation of macroautophagy [GO:0016241] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GAIT complex [GO:0097452]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GAIT complex [GO:0097452]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to interferon-gamma [GO:0071346]; defense response to fungus [GO:0050832]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821]; regulation of macroautophagy [GO:0016241] GO:0000226; GO:0001819; GO:0004365; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0006006; GO:0006096; GO:0008017; GO:0010951; GO:0015630; GO:0016020; GO:0016241; GO:0017148; GO:0019828; GO:0031640; GO:0031965; GO:0031982; GO:0032481; GO:0035605; GO:0035606; GO:0042802; GO:0043123; GO:0043231; GO:0048471; GO:0050661; GO:0050821; GO:0050832; GO:0051287; GO:0051402; GO:0051873; GO:0061844; GO:0070062; GO:0071346; GO:0097452; GO:0097718; GO:1990904 aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605] GALQNIIPASTGAAKAVGKVIPELNGK 0.99317 -6.4976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1639 0 0 0 0 0 0 0 0 0 12.8934 0 0 0 0 0 0 11.8198 0 0 0 0 12.7915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4159 14.7423 15.3507 0 0 0 0 13.8505 13.4598 0 0 0 0 0 0 0 0 0 13.7828 0 0 0 0 P11801 KPSH1_HUMAN "Serine/threonine-protein kinase H1, EC 2.7.11.1 (Protein serine kinase H1, PSK-H1)" PSKH1 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0005789; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006468; GO:0007368; GO:0007507; GO:0016607; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EGREVCESELR 0.99317 -16.641 0 0 0 0 0 0 0 0 0 10.3047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8962 0 0 0 0 0 0 0 0 0 0 10.4792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9549 0 0 13.0431 0 13.0885 12.8424 0 0 0 0 0 0 0 0 0 0 13.0765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3941 0 0 0 0 0 0 0 0 0 0 0 13.9019 0 13.4783 13.9149 13.8252 0 0 0 0 0 12.4251 0 0 0 0 0 0 0 0 0 13.0449 13.577 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4726 13.0557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48995 TRPC1_HUMAN "Short transient receptor potential channel 1, TrpC1 (Transient receptor protein 1, TRP-1)" TRPC1 TRP1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; melanin biosynthetic process [GO:0042438]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to calcium ion [GO:0051592] cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; signaling receptor binding [GO:0005102]; store-operated calcium channel activity [GO:0015279]; transmembrane transporter binding [GO:0044325]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; melanin biosynthetic process [GO:0042438]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to calcium ion [GO:0051592]" GO:0005102; GO:0005261; GO:0005262; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0015279; GO:0034703; GO:0042438; GO:0043235; GO:0044325; GO:0051117; GO:0051281; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903779 "ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; signaling receptor binding [GO:0005102]; store-operated calcium channel activity [GO:0015279]; transmembrane transporter binding [GO:0044325]" FHDFADR 0.99317 -16.23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4724 0 0 0 0 0 0 0 0 0 0 0 0 P57679 EVC_HUMAN EvC complex member EVC (DWF-1) (Ellis-van Creveld syndrome protein) EVC Homo sapiens (Human) cartilage development [GO:0051216]; endochondral bone growth [GO:0003416]; muscle organ development [GO:0007517]; positive regulation of smoothened signaling pathway [GO:0045880]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224] ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane protein complex [GO:0098797] ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane protein complex [GO:0098797]; cartilage development [GO:0051216]; endochondral bone growth [GO:0003416]; muscle organ development [GO:0007517]; positive regulation of smoothened signaling pathway [GO:0045880]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224] GO:0001501; GO:0003416; GO:0005737; GO:0005929; GO:0007224; GO:0007517; GO:0016021; GO:0036064; GO:0045880; GO:0051216; GO:0060170; GO:0098797 AGRQRTR 0.99317 -13.28 0 9.89775 0 0 0 0 10.3534 0 0 0 0 0 0 0 0 11.6711 0 0 12.6943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1838 16.1714 16.0938 17.0985 0 0 0 0 0 0 0 0 11.5852 0 12.7026 0 0 0 0 0 0 0 0 0 0 0 14.4574 0 0 0 0 11.0857 15.4446 0 0 0 0 0 0 0 0 0 15.0002 0 11.7828 10.7925 0 0 0 9.84123 10.9142 0 0 0 9.78198 13.0255 0 0 0 0 0 0 0 0 0 0 0 0 11.9732 0 0 0 0 12.8319 0 12.9982 0 0 0 0 0 0 0 14.5108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7451 0 0 0 0 0 0 0 0 Q00444 HXC5_HUMAN Homeobox protein Hox-C5 (Homeobox protein CP11) (Homeobox protein Hox-3D) HOXC5 HOX3D Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system development [GO:0048706]; regulation of transcription by RNA polymerase II [GO:0006357] cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system development [GO:0048706]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0009952; GO:0030054; GO:0048706 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" PALEERAK 0.99317 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4671 0 0 0 0 0 0 0 0 0 0 0 12.9998 0 0 0 0 0 0 0 0 Q02535 ID3_HUMAN "DNA-binding protein inhibitor ID-3 (Class B basic helix-loop-helix protein 25, bHLHb25) (Helix-loop-helix protein HEIR-1) (ID-like protein inhibitor HLH 1R21) (Inhibitor of DNA binding 3) (Inhibitor of differentiation 3)" ID3 1R21 BHLHB25 HEIR1 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to leptomycin B [GO:0072750]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; epithelial cell differentiation [GO:0030855]; heart development [GO:0007507]; metanephros development [GO:0001656]; muscle organ development [GO:0007517]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; odontogenesis [GO:0042476]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of cell cycle [GO:0051726]; regulation of DNA replication [GO:0006275]; response to wounding [GO:0009611]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; leptomycin B binding [GO:1901707]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; transcription regulator inhibitor activity [GO:0140416]; cell differentiation [GO:0030154]; cellular response to leptomycin B [GO:0072750]; central nervous system development [GO:0007417]; circadian regulation of gene expression [GO:0032922]; epithelial cell differentiation [GO:0030855]; heart development [GO:0007507]; metanephros development [GO:0001656]; muscle organ development [GO:0007517]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; odontogenesis [GO:0042476]; positive regulation of apoptotic process [GO:0043065]; positive regulation of gene expression [GO:0010628]; regulation of cell cycle [GO:0051726]; regulation of DNA replication [GO:0006275]; response to wounding [GO:0009611]" GO:0000122; GO:0001656; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0007417; GO:0007507; GO:0007517; GO:0009611; GO:0010628; GO:0010629; GO:0019904; GO:0030154; GO:0030182; GO:0030855; GO:0030903; GO:0032922; GO:0042476; GO:0043065; GO:0043425; GO:0043433; GO:0045662; GO:0045668; GO:0045892; GO:0046983; GO:0051726; GO:0072750; GO:0140416; GO:1901707 bHLH transcription factor binding [GO:0043425]; leptomycin B binding [GO:1901707]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; transcription regulator inhibitor activity [GO:0140416] SLAIARGR 0.99317 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3565 0 0 0 0 0 0 0 0 12.3529 12.5794 16.369 17.2714 16.4058 0 0 0 0 12.5736 0 15.2687 15.5358 18.7793 13.6256 14.4585 14.3148 14.5862 16.9987 0 0 0 13.7554 16.306 15.908 16.0136 17.7989 0 18.0836 15.2173 14.3552 16.0886 15.2279 15.3665 16.9354 18.4468 14.5072 18.7803 12.6988 0 14.1364 14.3289 18.5126 16.8091 0 17.3412 16.4989 16.4061 19.6412 0 14.5845 14.1163 15.6786 15.4832 13.3365 17.0692 15.5836 0 16.1578 15.3054 12.9675 12.3 16.2896 15.7011 14.7321 15.0504 13.3745 12.5345 13.4654 0 0 0 0 0 15.5128 16.1942 14.958 13.7049 19.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8689 17.569 16.8988 16.3113 0 0 0 0 0 Q05655 KPCD_HUMAN "Protein kinase C delta type, EC 2.7.11.13 (Tyrosine-protein kinase PRKCD, EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1, SDK1) ]" PRKCD PKCD Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021] azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; termination of signal transduction [GO:0023021] GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0004699; GO:0004715; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0006915; GO:0007049; GO:0007165; GO:0008047; GO:0008631; GO:0010469; GO:0016064; GO:0016363; GO:0018105; GO:0018107; GO:0019899; GO:0019901; GO:0023021; GO:0030837; GO:0032079; GO:0032091; GO:0032147; GO:0032930; GO:0032956; GO:0034351; GO:0034644; GO:0035307; GO:0035556; GO:0035578; GO:0036019; GO:0038096; GO:0042100; GO:0042119; GO:0042307; GO:0042742; GO:0043407; GO:0043488; GO:0043560; GO:0043687; GO:0046627; GO:0046872; GO:0048471; GO:0050728; GO:0050732; GO:0050821; GO:0051490; GO:0060326; GO:0070062; GO:0070301; GO:0071447; GO:0090331; GO:0090398; GO:0106310; GO:1900163; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001022; GO:2001235 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CEDCGMNVHHK 0.99317 -26.208 0 0 0 0 0 0 0 0 0 0 11.6481 0 0 0 0 0 0 10.9346 0 0 0 0 0 0 0 0 0 0 10.9406 0 0 0 0 0 0 0 0 0 0 0 10.4048 0 0 0 0 0 12.086 0 0 0 0 0 0 0 0 13.0269 0 0 0 0 11.5939 0 0 12.0819 0 0 0 0 13.6283 0 0 0 13.2945 12.98 0 13.0707 0 12.6639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7359 0 0 0 0 16.1222 0 16.0596 11.3427 0 0 0 0 0 0 14.8697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8924 0 0 0 0 0 13.4642 0 15.8651 0 0 0 0 11.3759 0 0 0 0 0 0 0 0 12.2839 0 0 0 0 0 0 12.2575 0 0 0 0 0 0 0 17.9207 0 0 0 0 14.3384 0 0 0 Q09472 EP300_HUMAN "Histone acetyltransferase p300, p300 HAT, EC 2.3.1.48 (E1A-associated protein p300) (Histone butyryltransferase p300, EC 2.3.1.-) (Histone crotonyltransferase p300, EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300, EC 2.3.1.-) (Protein lactyltransferas p300, EC 2.3.1.-) (Protein propionyltransferase p300, EC 2.3.1.-)" EP300 P300 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; cell cycle [GO:0007049]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H2B acetylation [GO:0043969]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein binding [GO:0032092]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription by RNA polymerase II [GO:0006366]" chromosome [GO:0005694]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] "chromosome [GO:0005694]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; acetyltransferase activity [GO:0016407]; acyltransferase activity [GO:0016746]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; histone lactyltransferase activity [GO:0120301]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein C-terminus binding [GO:0008022]; protein propionyltransferase activity [GO:0061920]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; cell cycle [GO:0007049]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H2B acetylation [GO:0043969]; histone H3-K56 acetylation [GO:0097043]; histone H4 acetylation [GO:0043967]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein binding [GO:0032092]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000123; GO:0001221; GO:0001223; GO:0001666; GO:0001756; GO:0001966; GO:0002039; GO:0002209; GO:0002223; GO:0003677; GO:0003682; GO:0003684; GO:0003713; GO:0004402; GO:0004468; GO:0005634; GO:0005654; GO:0005667; GO:0005694; GO:0005829; GO:0006110; GO:0006366; GO:0006473; GO:0006475; GO:0006915; GO:0006990; GO:0007049; GO:0007399; GO:0007507; GO:0007519; GO:0007611; GO:0007623; GO:0008013; GO:0008022; GO:0008270; GO:0009887; GO:0010484; GO:0010485; GO:0010506; GO:0010742; GO:0010821; GO:0010976; GO:0016407; GO:0016573; GO:0016746; GO:0016922; GO:0018076; GO:0018393; GO:0018394; GO:0030183; GO:0030220; GO:0030324; GO:0030511; GO:0031333; GO:0031490; GO:0031648; GO:0032092; GO:0032993; GO:0034212; GO:0034644; GO:0035264; GO:0035855; GO:0036268; GO:0042771; GO:0043627; GO:0043923; GO:0043967; GO:0043969; GO:0045444; GO:0045721; GO:0045815; GO:0045893; GO:0045944; GO:0048156; GO:0050681; GO:0050821; GO:0051059; GO:0051091; GO:0051092; GO:0060325; GO:0060765; GO:0061629; GO:0061733; GO:0061920; GO:0061921; GO:0090043; GO:0097043; GO:0097157; GO:0097677; GO:0106226; GO:0120301; GO:0140065; GO:0140066; GO:0140067; GO:0140068; GO:0140069; GO:0140297; GO:1900034; GO:1901224; GO:1901796; GO:1905636 "acetyltransferase activity [GO:0016407]; acyltransferase activity [GO:0016746]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; histone lactyltransferase activity [GO:0120301]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein C-terminus binding [GO:0008022]; protein propionyltransferase activity [GO:0061920]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" ENKFSAKR 0.99317 -6.4978 0 0 0 0 0 0 0 0 13.3985 0 0 11.1771 0 0 0 10.7228 0 0 0 0 0 10.2146 0 0 11.6286 0 0 0 0 0 0 0 0 0 12.351 0 13.0703 0 0 0 0 0 0 0 0 0 0 0 0 11.806 0 0 0 0 0 0 0 12.927 12.7732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3581 0 0 0 0 0 0 0 0 14.1795 11.9286 13.8038 12.9286 0 0 0 0 0 12.8811 11.8439 0 0 0 0 0 0 0 10.8463 0 0 0 0 0 12.204 12.9955 0 0 0 0 0 0 13.8174 0 0 0 0 0 0 13.0239 0 0 0 0 0 12.8484 12.9161 0 0 0 0 13.1546 0 0 0 0 13.117 0 0 0 0 0 0 0 12.7588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2923 0 0 0 0 0 10.4912 0 0 0 Q3ZCN5 OTOGL_HUMAN Otogelin-like protein OTOGL C12orf64 Homo sapiens (Human) L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; alpha-L-arabinofuranosidase activity [GO:0046556]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] GO:0005615; GO:0007605; GO:0031012; GO:0046373; GO:0046556 alpha-L-arabinofuranosidase activity [GO:0046556] CFDNDIVCSK 0.99317 -13.302 0 0 0 0 12.3264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7753 0 0 13.8165 0 0 11.8481 0 0 12.931 0 0 10.6932 0 0 0 0 0 0 0 12.64 0 0 0 0 0 0 0 0 0 0 11.5707 0 12.5699 13.8702 0 0 0 11.309 0 0 0 0 0 11.1591 0 0 0 0 0 0 0 0 14.3156 0 0 0 0 0 12.3077 0 0 0 0 0 0 14.8536 0 13.4239 13.3058 0 13.1514 13.5264 11.5701 13.8359 0 14.261 14.0042 14.7354 13.3663 0 0 0 14.0678 13.9798 13.4727 0 12.1887 0 0 0 0 0 14.9268 14.5122 0 12.5739 0 14.8776 14.3584 11.583 13.4094 0 0 13.3929 13.3548 12.4927 11.7775 0 15.8699 12.0771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1463 0 0 13.6001 0 0 12.5007 0 14.0538 13.3799 12.9823 0 13.0614 12.6601 13.0059 13.1938 13.332 13.8111 0 0 0 0 12.6812 12.8886 12.6534 0 13.9405 0 13.0131 0 12.8084 0 12.6377 Q6ZT52 FA43B_HUMAN Protein FAM43B FAM43B Homo sapiens (Human) AGGAAASVPRAPLRR 0.99317 -26.143 0 0 0 0 0 0 0 0 0 0 0 0 11.2979 0 0 0 0 0 0 0 11.3656 0 0 0 12.0595 0 0 0 0 0 0 0 0 0 14.4251 0 0 12.362 0 0 12.0523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7818 0 0 0 0 0 0 0 0 16.3462 12.2456 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6875 0 0 0 0 0 0 0 0 0 0 13.5113 13.7683 0 0 0 13.3154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3882 0 0 Q8IX01 SUGP2_HUMAN "SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)" SUGP2 KIAA0365 SFRS14 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear body [GO:0016604]; nucleoplasm [GO:0005654] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0005654; GO:0006397; GO:0008380; GO:0016604 RNA binding [GO:0003723] EDPAYWFLSDENSLEYK 0.99317 -27.31 0 0 0 0 0 0 0 0 0 0 0 0 12.5599 0 0 0 0 12.9398 0 11.5019 0 0 0 0 0 12.2769 0 0 0 0 13.8798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8739 11.7371 0 0 0 10.5496 0 0 10.2404 0 11.3214 0 13.3276 0 13.6026 0 0 0 0 0 12.0668 14.7928 15.4279 15.1993 15.0482 0 12.4673 0 0 13.6149 13.6668 0 0 12.9329 0 13.8548 13.1264 14.3477 0 0 0 0 13.9645 0 0 0 0 0 0 0 0 0 13.2774 16.5152 13.2795 0 0 14.2283 0 0 0 0 0 12.5473 0 0 0 0 0 0 0 0 0 12.539 0 0 0 0 11.2486 0 0 0 0 12.7101 0 0 0 0 0 13.6858 0 0 0 0 12.5758 0 0 12.6232 0 0 13.9099 0 12.3117 0 0 0 0 12.9786 0 0 Q8NDZ4 DIK2A_HUMAN "Divergent protein kinase domain 2A (Deleted in autism protein 1) (Golgi Protein of 49 kDa, GoPro49) (Hypoxia and AKT-induced stem cell factor, HASF)" DIPK2A C3orf58 DIA1 Homo sapiens (Human) cardiac muscle cell proliferation [GO:0060038]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of protein kinase C activity [GO:1900020]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139] COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; cardiac muscle cell proliferation [GO:0060038]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of protein kinase C activity [GO:1900020]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] GO:0000139; GO:0005615; GO:0014066; GO:0030126; GO:0034392; GO:0060038; GO:1900020 CPACFGTSWCR 0.99317 -16.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9675 11.4412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92833 JARD2_HUMAN Protein Jumonji (Jumonji/ARID domain-containing protein 2) JARID2 JMJ Homo sapiens (Human) "cardiac muscle cell proliferation [GO:0060038]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; dosage compensation by inactivation of X chromosome [GO:0009048]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein localization to pericentric heterochromatin [GO:1902682]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]" ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; ubiquitin binding [GO:0043130]; ubiquitin modification-dependent histone binding [GO:0061649]; cardiac muscle cell proliferation [GO:0060038]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; dosage compensation by inactivation of X chromosome [GO:0009048]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K9 methylation [GO:0051574]; protein localization to pericentric heterochromatin [GO:1902682]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]" GO:0000122; GO:0001889; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005739; GO:0006338; GO:0007417; GO:0009048; GO:0010614; GO:0031061; GO:0032452; GO:0035097; GO:0035098; GO:0043130; GO:0045892; GO:0048536; GO:0048538; GO:0048863; GO:0051574; GO:0060038; GO:0060044; GO:0061649; GO:1902682; GO:1990830 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; ubiquitin binding [GO:0043130]; ubiquitin modification-dependent histone binding [GO:0061649] CIYKGRSVSLTTFYR 0.99317 -26.175 0 13.1517 0 0 0 13.0952 0 0 14.8349 0 0 0 0 0 10.6402 0 0 13.053 0 0 0 0 0 0 0 12.5709 0 0 0 0 10.0503 0 0 0 0 14.5029 0 0 0 0 13.7148 0 0 0 0 12.7776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5804 0 0 15.0405 0 0 14.0504 0 0 0 0 0 0 0 0 13.0441 13.9179 10.5325 11.0703 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5955 0 13.7767 0 0 0 0 14.933 14.3264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7571 0 0 13.3529 13.4738 14.866 11.4183 0 0 0 0 0 0 14.7025 0 0 0 0 0 14.7693 0 14.641 0 0 14.172 0 13.3522 0 0 0 10.6401 0 0 14.2658 14.4485 0 0 0 0 0 0 0 11.5157 0 0 0 0 0 0 0 0 13.8891 0 13.6941 0 11.9699 0 13.3522 0 0 0 0 14.3161 0 Q96DU7 IP3KC_HUMAN "Inositol-trisphosphate 3-kinase C, EC 2.7.1.127 (Inositol 1,4,5-trisphosphate 3-kinase C, IP3 3-kinase C, IP3K C, InsP 3-kinase C)" ITPKC IP3KC Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; cellular response to calcium ion [GO:0071277]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]" GO:0000828; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008440; GO:0016301; GO:0016310; GO:0016607; GO:0032958; GO:0046854; GO:0071277 "ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]" KADGTCNTNFKK 0.99317 -16.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5886 0 0 0 0 0 13.4389 13.6533 0 14.0674 13.7398 13.8822 0 0 17.3032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.338 0 0 0 0 0 0 13.4817 0 0 0 13.6817 0 0 0 12.5402 12.8802 0 12.8708 0 0 13.1068 0 0 0 13.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99956 DUS9_HUMAN "Dual specificity protein phosphatase 9, EC 3.1.3.16, EC 3.1.3.48 (Mitogen-activated protein kinase phosphatase 4, MAP kinase phosphatase 4, MKP-4)" DUSP9 MKP4 Homo sapiens (Human) ERK1 and ERK2 cascade [GO:0070371]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; ERK1 and ERK2 cascade [GO:0070371]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of apoptotic process [GO:0043065]; protein dephosphorylation [GO:0006470]; regulation of heart growth [GO:0060420] GO:0000165; GO:0004721; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0006470; GO:0007254; GO:0008138; GO:0008330; GO:0017017; GO:0017018; GO:0043065; GO:0043409; GO:0060420; GO:0070371; GO:0070373 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] ELYESARIGGALSVALPALLLR 0.99317 -16.656 0 0 0 0 0 0 0 0 0 10.8718 0 0 0 11.8975 0 0 0 0 0 0 0 9.99492 0 0 0 0 0 13.7772 0 0 0 11.0655 0 0 0 0 0 0 0 0 0 0 12.6862 0 0 0 0 11.4609 12.1937 0 0 0 12.2668 0 12.7668 11.5339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8482 0 0 13.6117 0 0 0 0 13.4875 0 0 12.2197 0 12.1663 0 0 0 0 12.6257 0 0 0 0 0 0 12.1662 0 0 13.5047 0 0 12.3884 12.3258 12.3309 0 0 13.951 0 12.3554 0 0 0 0 0 0 13.8841 0 12.1145 0 0 0 0 11.8184 12.7035 0 0 0 0 0 0 0 0 0 10.7039 0 0 0 0 0 13.0181 0 0 0 0 0 0 0 0 0 0 0 12.3198 0 14.3626 0 0 0 0 0 0 0 0 10.947 0 0 0 0 11.887 0 0 0 12.1188 0 0 11.9357 Q9UF02 CCG5_HUMAN "Voltage-dependent calcium channel gamma-5 subunit (Neuronal voltage-gated calcium channel gamma-5 subunit) (Transmembrane AMPAR regulatory protein gamma-5, TARP gamma-5)" CACNG5 Homo sapiens (Human) "neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; transmission of nerve impulse [GO:0019226]" AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; channel regulator activity [GO:0016247]; ion transmembrane transporter activity [GO:0015075]; voltage-gated calcium channel activity [GO:0005245]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; transmission of nerve impulse [GO:0019226]" GO:0005245; GO:0014069; GO:0015075; GO:0016247; GO:0019226; GO:0032281; GO:0051968; GO:0070161; GO:0098839; GO:0098943; GO:0098962; GO:0098970; GO:0098978; GO:0099055; GO:0099590; GO:2000311 channel regulator activity [GO:0016247]; ion transmembrane transporter activity [GO:0015075]; voltage-gated calcium channel activity [GO:0005245] CPDYDQMSSSPC 0.99317 -6.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7225 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9554 0 0 0 0 0 0 10.0935 0 0 0 0 0 0 0 0 0 9.7043 0 0 0 0 0 0 0 0 0 0 13.6552 0 0 0 0 0 0 0 0 0 0 0 0 10.505 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2197 0 0 0 0 0 0 0 11.4792 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63764 0 0 0 11.4245 0 Q8TDB6 DTX3L_HUMAN "E3 ubiquitin-protein ligase DTX3L, EC 2.3.2.27 (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2, Rhysin2)" DTX3L BBAP Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006325; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034 enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842] AASPPLK 0.99318 -14.43 0 0 0 0 0 0 0 11.9319 0 0 0 0 0 13.8196 0 0 0 0 0 0 0 15.0291 16.1994 15.5125 0 0 0 0 0 0 0 0 0 0 13.5475 0 0 0 0 0 0 0 12.9182 0 0 0 0 0 0 0 13.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3442 18.9438 19.4542 15.2585 18.998 15.1436 15.5303 19.4339 16.1655 17.0942 16.253 19.3382 15.6594 20.0336 20.1669 16.7966 0 19.4088 14.0984 14.3864 16.14 15.5496 11.092 15.7128 16.8253 16.7074 16.6976 16.2798 15.7405 0 16.4376 0 15.0264 15.807 16.6637 19.4651 0 0 18.454 18.8436 17.7187 16.1496 17.3144 19.5053 16.1848 16.5576 16.0212 15.1299 19.499 14.7733 14.9269 14.9466 14.9433 16.9665 17.146 19.8546 19.4143 15.2712 16.0212 17.2086 16.3768 16.0013 19.2083 18.8302 19.2066 16 0 19.1894 15.8149 15.9464 16.9153 16.7089 18.6519 0 19.5438 17.0352 18.5989 16.5357 15.6629 19.0164 17.7991 0 16.7546 13.5754 18.3064 19.7494 15.0698 17.0298 16.8006 14.7505 16.7494 0 0 0 0 0 0 16.1814 0 0 16.6217 10.5279 0 0 0 16.2149 18.9384 17.1424 17.3474 0 0 16.0975 16.2264 0 Q4AC94 C2CD3_HUMAN C2 domain-containing protein 3 C2CD3 Homo sapiens (Human) brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589] GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515 EDVGIQTFNLPLTPRIENRK 0.99318 -15.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3686 0 0 0 0 0 0 0 0 0 12.1983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8548 14.0046 12.1714 14.4481 15.1144 10.9528 13.7911 0 0 0 0 0 12.1933 16.8455 0 0 0 11.8478 0 0 0 12.289 0 0 15.9746 0 0 0 13.1587 0 0 0 0 0 0 0 11.3993 13.3442 0 12.0725 11.9498 14.315 14.2652 14.2628 13.4282 0 14.108 12.1134 0 0 0 14.3146 0 0 0 0 11.818 0 0 13.9099 0 14.1536 0 0 0 13.9375 15.0607 0 12.1229 13.5354 13.854 13.869 0 11.8535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6922 0 0 12.3258 0 0 0 0 0 11.2963 13.405 0 A0A286YF58 TM271_HUMAN Transmembrane protein 271 TMEM271 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DYQRGLVLSTVFNSLECLLGLLSLLLVKNYK 0.99318 -6.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95394 AGM1_HUMAN "Phosphoacetylglucosamine mutase, PAGM, EC 5.4.2.3 (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3, PGM 3)" PGM3 AGM1 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] cytosol [GO:0005829] cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048] GO:0000287; GO:0004610; GO:0005829; GO:0005975; GO:0006041; GO:0006048; GO:0006487; GO:0006493; GO:0007283; GO:0030097 magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610] DLGAITK 0.99318 -6.9557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5758 0 0 0 0 0 0 11.7605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4835 0 0 0 12.2121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35227 PCGF2_HUMAN Polycomb group RING finger protein 2 (DNA-binding protein Mel-18) (RING finger protein 110) (Zinc finger protein 144) PCGF2 MEL18 RNF110 ZNF144 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; cellular response to hydrogen peroxide [GO:0070301]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; cellular response to hydrogen peroxide [GO:0070301]; embryonic skeletal system morphogenesis [GO:0048704]; histone acetylation [GO:0016573]; histone H2A-K119 monoubiquitination [GO:0036353]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0000785; GO:0001701; GO:0001739; GO:0003677; GO:0005634; GO:0005654; GO:0009952; GO:0016573; GO:0016604; GO:0031519; GO:0035102; GO:0036353; GO:0046872; GO:0048704; GO:0070301; GO:0097190; GO:1990841; GO:2001234 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841] EKTGVRFLR 0.99318 -6.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7395 0 0 12.9445 0 0 0 0 0 0 0 12.5187 13.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49368 TCPG_HUMAN "T-complex protein 1 subunit gamma, TCP-1-gamma (CCT-gamma) (hTRiC5)" CCT3 CCTG TRIC5 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199] cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998] GO:0002199; GO:0003723; GO:0005524; GO:0005829; GO:0005832; GO:0005856; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0032212; GO:0044183; GO:0044297; GO:0046931; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:0140662; GO:1901998; GO:1904851; GO:1904871; GO:1904874 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082] ACGARIVSRPEELR 0.99318 -17.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2384 0 0 0 0 0 0 0 0 0 0 0 0 13.1115 13.3502 0 0 0 0 0 13.8248 0 0 13.6383 0 13.0803 13.4079 13.2068 0 0 0 0 11.6477 0 0 12.7664 0 0 12.9974 18.3474 0 0 13.6554 0 0 12.5362 0 13.0343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4099 12.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5394 0 0 0 0 0 12.1441 0 Q15906 VPS72_HUMAN Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1) (Transcription factor-like 1) VPS72 TCFL1 YL1 Homo sapiens (Human) "epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]" NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]" GO:0000122; GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0016573; GO:0016607; GO:0032991; GO:0035019; GO:0035267; GO:0042393; GO:0042981; GO:0043486; GO:0043967; GO:0043968; GO:0045815; GO:0045893; GO:0051726; GO:0140713; GO:1905168; GO:2000779 DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713] ALRQKIVIK 0.99318 -16.705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5392 0 0 0 0 0 0 13.0626 13.2926 13.712 13.1521 0 13.5947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3015 0 0 0 0 0 0 0 0 0 14.2315 0 0 0 0 0 0 0 0 13.3632 0 13.5353 0 0 0 0 0 0 0 0 0 13.5567 0 0 14.2614 0 0 0 0 0 0 0 0 0 0 14.4212 13.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3551 0 0 0 0 0 0 0 0 Q2KHT3 CL16A_HUMAN Protein CLEC16A (C-type lectin domain family 16 member A) CLEC16A KIAA0350 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagosome maturation [GO:1901096] cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982] cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagosome maturation [GO:1901096] GO:0005794; GO:0005829; GO:0006914; GO:0008333; GO:0009267; GO:0016021; GO:0016197; GO:0031982; GO:0036020; GO:1901096; GO:1901097; GO:1904263; GO:1904766 CFIKPTETLER 0.99318 -13.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5438 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9957 0 0 0 0 0 0 0 13.0676 0 0 0 0 12.7719 0 0 11.3886 0 0 0 0 0 0 11.3429 0 0 0 0 0 0 0 0 0 0 0 11.709 0 0 0 0 0 11.1585 0 0 0 11.6868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TED0 UTP15_HUMAN U3 small nucleolar RNA-associated protein 15 homolog UTP15 Homo sapiens (Human) positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364] GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0006364; GO:0045943; GO:2000234 RNA binding [GO:0003723] DDILINRPAKK 0.99318 -6.9514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4143 0 0 0 0 0 0 0 0 12.584 12.5775 0 14.3789 0 0 0 0 0 12.2758 0 0 15.1307 0 0 0 0 0 0 13.9573 0 0 13.0894 0 0 0 0 0 12.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3566 12.1265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0671 14.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1836 0 0 12.1316 0 0 Q96C92 ENTR1_HUMAN Endosome-associated-trafficking regulator 1 (Antigen NY-CO-3) (Serologically defined colon cancer antigen 3) ENTR1 SDCCAG3 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; endocytic recycling [GO:0032456]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; endocytic recycling [GO:0032456]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] GO:0005768; GO:0005769; GO:0005813; GO:0007049; GO:0015031; GO:0030030; GO:0030496; GO:0032456; GO:0032465; GO:0036064; GO:0045724; GO:0051301; GO:0055037; GO:1903566 KLEAKMIK 0.99318 -6.9607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.704 0 0 0 0 13.6747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPU5 UBP24_HUMAN "Ubiquitin carboxyl-terminal hydrolase 24, EC 3.4.19.12 (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24)" USP24 KIAA1057 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] CSTANSR 0.99318 -26.219 0 0 12.0858 0 0 0 0 0 14.0932 11.7484 13.4265 11.8143 12.9262 11.8008 11.7112 0 13.8292 0 0 0 0 0 0 0 0 0 0 0 11.6168 0 0 0 12.7214 11.8679 10.6327 0 12.431 0 11.2678 12.0767 0 0 0 10.8544 0 0 0 0 0 0 10.2521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.979 11.8966 12.9513 0 14.5498 0 12.0053 0 14.817 15.3438 0 12.5703 0 14.261 0 0 0 0 14.5709 0 0 0 0 14.0316 0 0 0 0 0 0 12.9153 0 0 0 11.6603 0 13.2709 13.274 0 0 0 0 13.4302 0 0 0 13.7771 0 0 15.0805 0 0 14.415 0 0 0 0 13.6286 0 0 13.0696 14.6383 0 0 13.6858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2972 14.5354 0 0 0 0 0 13.5785 0 0 0 13.8857 13.7348 0 12.6091 0 13.9935 0 0 0 13.787 0 11.885 13.059 11.7211 15.2937 0 0 13.7775 0 0 0 0 A6NJB7 PRR19_HUMAN Proline-rich protein 19 PRR19 Homo sapiens (Human) meiotic cell cycle [GO:0051321] chromosome [GO:0005694]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleus [GO:0005634]; meiotic cell cycle [GO:0051321] GO:0005634; GO:0005694; GO:0051321 GSLAPPR 0.99319 -13.393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 I1YAP6 TRI77_HUMAN Tripartite motif-containing protein 77 TRIM77 TRIM77P Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] EMYEKLKEMSCK 0.99319 -16.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7918 0 0 0 0 0 0 0 0 0 0 11.3647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0626 0 0 0 0 0 13.9194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14862 AIM2_HUMAN Interferon-inducible protein AIM2 (Absent in melanoma 2) AIM2 Homo sapiens (Human) activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to interferon-beta [GO:0035458]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to virus [GO:0051607]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; NLRP3 inflammasome complex assembly [GO:0044546]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; tumor necrosis factor-mediated signaling pathway [GO:0033209] AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to interferon-beta [GO:0035458]; cellular response to xenobiotic stimulus [GO:0071466]; defense response to virus [GO:0051607]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; NLRP3 inflammasome complex assembly [GO:0044546]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0002218; GO:0002221; GO:0002230; GO:0003690; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0006954; GO:0006955; GO:0032088; GO:0032731; GO:0033209; GO:0035458; GO:0042802; GO:0044546; GO:0045087; GO:0050729; GO:0051092; GO:0051607; GO:0070269; GO:0071466; GO:0097169; GO:1904270; GO:2001056 double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802] DKFIPKR 0.99319 -26.6 0 0 0 0 0 0 0 0 13.2399 11.6406 0 0 12.4554 0 0 0 12.5777 0 0 0 0 0 0 0 0 12.0849 0 12.3475 14.0244 0 0 0 0 0 0 11.0974 0 0 0 0 0 0 12.8998 11.8887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9134 0 11.1665 0 13.6698 13.7246 0 0 0 13.6325 0 11.0061 0 0 0 0 0 0 0 0 0 0 13.6493 0 0 14.5121 0 16.3205 0 12.792 0 0 13.0109 0 13.5269 0 0 0 0 15.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9603 11.7328 0 0 0 0 0 0 0 0 13.6168 0 0 0 0 0 0 14.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60506 HNRPQ_HUMAN "Heterogeneous nuclear ribonucleoprotein Q, hnRNP Q (Glycine- and tyrosine-rich RNA-binding protein, GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)" SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) "cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; cellular response to interferon-gamma [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]" GO:0000398; GO:0001649; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006396; GO:0008143; GO:0008380; GO:0016020; GO:0016556; GO:0017148; GO:0045293; GO:0048027; GO:0070934; GO:0070937; GO:0071013; GO:0071204; GO:0071346; GO:0097452; GO:0106002; GO:1900152; GO:1901537; GO:1990904; GO:2000623; GO:2000767 mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723] GGPGSAR 0.99319 -29.25 0 0 0 0 0 0 0 0 0 0 13.1793 0 0 0 0 0 0 0 12.646 0 12.8563 0 0 0 0 0 0 0 0 0 0 0 10.6207 0 0 0 0 0 0 12.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6131 10.5072 0 0 0 0 14.362 0 0 14.2516 14.0084 12.0674 14.8483 14.359 14.9301 14.3869 0 0 13.3022 14.862 14.4771 14.3142 14.3117 14.5701 0 0 0 0 14.5335 14.4514 0 0 0 14.3029 14.8337 0 14.8784 0 0 14.6138 15.0986 0 0 0 14.7929 0 0 0 0 0 0 11.5241 0 12.1454 12.4455 0 12.5001 0 0 0 14.5364 0 0 0 14.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8582 15.5308 11.4438 0 0 12.9511 0 0 14.9494 0 12.3844 0 13.012 0 0 0 0 0 12.9843 12.7901 0 11.5852 0 0 12.0157 0 14.7561 0 0 0 0 0 0 0 O75947 ATP5H_HUMAN "ATP synthase subunit d, mitochondrial, ATPase subunit d (ATP synthase peripheral stalk subunit d)" ATP5PD ATP5H My032 Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]" "mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; proton transmembrane transporter activity [GO:0015078]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0000274; GO:0005739; GO:0005743; GO:0005753; GO:0015078; GO:0015986; GO:0042776 proton transmembrane transporter activity [GO:0015078] ARIVEYEK 0.99319 -15.947 0 0 0 0 0 0 0 0 0 0 0 13.2426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7162 0 0 0 0 0 0 0 11.5216 0 12.8225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.133 0 0 13.2393 0 0 13.2158 0 0 0 13.2748 0 13.2879 0 13.1307 0 0 0 0 0 0 0 13.056 0 0 0 0 0 0 0 0 0 0 13.3072 0 12.926 0 0 0 0 0 11.3455 0 0 0 0 0 13.2576 0 0 0 0 0 0 0 12.1317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1554 0 0 0 0 0 0 12.111 0 0 0 0 0 11.5563 0 0 0 13.0085 0 0 0 0 0 0 0 O94856 NFASC_HUMAN Neurofascin NFASC KIAA0756 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226] axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454] axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; ficolin-1-rich granule membrane [GO:0101003]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226] GO:0005886; GO:0005887; GO:0005925; GO:0007411; GO:0007420; GO:0007422; GO:0019226; GO:0019904; GO:0030424; GO:0030425; GO:0033010; GO:0033268; GO:0042552; GO:0043194; GO:0050808; GO:0072659; GO:0097454; GO:0098609; GO:0098632; GO:0101003 cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904] AENQVRLEVKDPTR 0.99319 -13.405 0 12.5371 0 0 0 0 15.3693 0 0 0 0 0 0 0 0 0 0 0 13.0463 12.0638 13.9485 0 11.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4694 0 0 0 0 0 0 0 13.4653 11.421 0 0 13.2153 12.7933 14.0387 0 12.7752 0 11.2817 16.4339 0 0 13.368 13.1113 14.3167 0 13.7256 13.8512 13.8456 14.0781 0 14.9835 0 14.2676 0 13.5084 0 12.1672 12.1475 0 13.3868 12.3838 13.2307 13.2905 0 0 0 0 15.193 15.9223 15.0537 14.5494 14.3956 14.5116 13.6247 14.9684 14.6486 15.0347 0 14.8619 14.4852 13.6266 14.232 13.1495 14.0476 15.0874 12.8181 0 0 0 15.5985 12.3836 15.1053 13.8152 0 13.9254 12.8694 12.511 0 12.5191 14.1145 13.2576 0 0 0 0 0 10.8842 15.0637 14.4633 0 0 0 13.4267 0 0 11.6957 12.5297 12.9979 0 0 10.9128 0 0 0 0 12.8852 0 0 0 0 13.3786 0 0 O95477 ABCA1_HUMAN "Phospholipid-transporting ATPase ABCA1, EC 7.6.2.1 (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1, ABC-1, ATP-binding cassette 1) (Cholesterol efflux regulatory protein)" ABCA1 ABC1 CERP Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]" endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] "endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; export across plasma membrane [GO:0140115]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; protein transmembrane transport [GO:0071806]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; response to laminar fluid shear stress [GO:0034616]; reverse cholesterol transport [GO:0043691]; signal release [GO:0023061]" GO:0002790; GO:0005102; GO:0005319; GO:0005524; GO:0005548; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006869; GO:0006911; GO:0007040; GO:0007186; GO:0007189; GO:0008203; GO:0008320; GO:0009306; GO:0009897; GO:0010745; GO:0010875; GO:0010887; GO:0015485; GO:0016197; GO:0019905; GO:0023061; GO:0030139; GO:0031210; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034380; GO:0034616; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0046623; GO:0048471; GO:0051117; GO:0055091; GO:0060155; GO:0071222; GO:0071300; GO:0071404; GO:0071806; GO:0090107; GO:0090108; GO:0090554; GO:0090556; GO:0097708; GO:0120020; GO:0140115; GO:0140328; GO:0140359 ABC-type transporter activity [GO:0140359]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase-coupled transmembrane transporter activity [GO:0042626]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; floppase activity [GO:0140328]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine floppase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; protein transmembrane transporter activity [GO:0008320]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; sphingolipid floppase activity [GO:0046623]; syntaxin binding [GO:0019905] ACWPQLRLLLWK 0.99319 -16.803 0 0 0 13.8599 0 0 0 13.4984 0 11.1057 0 0 0 12.2249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9859 12.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2396 0 0 0 0 14.2036 14.5404 0 0 0 0 0 0 0 12.4199 0 0 0 0 0 0 0 0 0 13.9653 11.2852 15.3988 11.8242 0 0 18.024 0 14.2906 12.8216 13.7104 14.5243 0 0 14.7185 14.2287 0 0 0 13.7681 14.2277 0 0 15.3828 0 15.1431 13.329 14.0906 13.8074 14.3266 0 14.8003 14.332 13.2258 13.186 16.5229 13.939 13.6345 14.1374 12.7779 13.8895 13.6731 12.5943 0 0 13.7844 12.6632 14.7034 13.4001 0 0 0 12.6777 13.0303 13.3515 0 0 16.7059 0 0 13.6116 15.8596 13.9454 0 14.3712 0 0 12.4065 13.3261 0 12.5306 0 0 0 0 12.3599 0 0 0 0 0 12.9741 0 13.468 13.9059 0 12.8502 0 0 0 O95935 TBX18_HUMAN "T-box transcription factor TBX18, T-box protein 18" TBX18 Homo sapiens (Human) "cell fate specification [GO:0001708]; cochlea morphogenesis [GO:0090103]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060829]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of SA node cell action potential [GO:0098907]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; sinoatrial node cell fate commitment [GO:0060930]; sinoatrial node development [GO:0003163]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; ureter development [GO:0072189]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell fate specification [GO:0001708]; cochlea morphogenesis [GO:0090103]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060829]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of SA node cell action potential [GO:0098907]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; sinoatrial node cell fate commitment [GO:0060930]; sinoatrial node development [GO:0003163]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; ureter development [GO:0072189]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0001756; GO:0003163; GO:0005634; GO:0005654; GO:0006357; GO:0016331; GO:0042803; GO:0045893; GO:0051145; GO:0060829; GO:0060930; GO:0060931; GO:0072189; GO:0090103; GO:0090571; GO:0098907; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GGGAGEK 0.99319 -13.389 0 0 0 0 0 0 0 0 19.3839 19.2046 19.1934 19.1948 19.1227 19.3296 19.1369 10.7115 19.2789 13.7947 0 0 0 0 0 0 14.1044 13.3359 19.3761 12.3363 0 14.0699 14.1648 19.3216 19.3844 19.2651 19.324 19.3255 19.2733 19.3425 19.3258 19.3451 19.292 13.3218 13.854 0 15.626 14.3417 12.5442 14.5389 14.5113 13.1974 12.2756 0 12.0039 0 13.1715 12.2896 11.9534 15.1364 13.7115 14.2766 11.9679 13.7323 14.0145 13.3001 13.704 11.4579 0 0 0 12.9041 12.9526 12.985 19.5034 0 14.6653 0 0 0 0 0 0 13.0721 12.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6044 0 0 12.6163 0 0 0 0 0 13.2972 0 0 11.8382 0 0 15.2663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5562 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0406 12.0975 0 0 0 0 0 13.5547 0 19.9135 19.9837 19.9774 19.9172 19.9511 19.9401 20.1159 19.927 20.0354 19.8742 17.1094 16.9702 17.1523 16.2495 14.6435 0 0 12.4033 0 14.584 0 20.0498 0 19.8912 P14778 IL1R1_HUMAN "Interleukin-1 receptor type 1, IL-1R-1, IL-1RT-1, IL-1RT1, EC 3.2.2.6 (CD121 antigen-like family member A) (Interleukin-1 receptor alpha, IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form, mIL-1R1, mIL-1RI; Interleukin-1 receptor type 1, soluble form, sIL-1R1, sIL-1RI ]" IL1R1 IL1R IL1RA IL1RT1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1-mediated signaling pathway [GO:2000661]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; interleukin-1 binding [GO:0019966]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type I, activating receptor activity [GO:0004909]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; platelet-derived growth factor receptor binding [GO:0005161]; protease binding [GO:0002020]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1-mediated signaling pathway [GO:2000661]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]" GO:0002020; GO:0004888; GO:0004908; GO:0004909; GO:0005161; GO:0005576; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007166; GO:0009897; GO:0016020; GO:0019966; GO:0032729; GO:0050135; GO:0050727; GO:0061809; GO:0070498; GO:0070555; GO:2000391; GO:2000556; GO:2000661 "interleukin-1 binding [GO:0019966]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type I, activating receptor activity [GO:0004909]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; platelet-derived growth factor receptor binding [GO:0005161]; protease binding [GO:0002020]; transmembrane signaling receptor activity [GO:0004888]" IDIVLWYR 0.99319 -16.81 0 0 0 14.1478 14.6383 0 0 14.8573 0 0 0 0 12.0078 11.5828 11.1326 12.8012 0 10.9236 11.2088 14.7171 0 0 0 15.8931 0 0 0 10.9633 0 12.7889 0 0 0 0 12.5672 12.8354 0 0 0 13.0641 11.1951 10.3987 12.2337 0 0 12.2652 12.0074 10.9549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6234 0 0 0 13.1692 12.7874 12.5033 16.6892 15.2974 17.0936 0 15.748 18.0795 14.2233 15.2732 0 15.7513 15.6901 0 12.745 12.1388 0 0 15.2565 0 0 0 14.4374 15.7832 0 11.3833 0 14.0906 0 14.9255 15.8758 17.2966 15.9367 14.2373 17.0599 0 14.5919 16.5683 0 10.9369 0 0 15.2172 12.815 0 0 14.4616 16.3529 16.6547 14.5201 16.026 15.4629 0 18.06 14.2433 0 15.3355 15.0139 12.9478 14.6621 15.3794 14.809 15.3982 9.9279 16.05 0 0 0 0 16.162 0 12.2361 14.4785 14.6367 14.2982 12.9303 0 0 11.2687 0 0 15.7565 16.313 14.203 0 14.1524 0 0 12.413 0 0 0 0 11.7142 0 0 11.7884 0 0 0 14.3216 0 0 13.334 0 11.9406 0 0 P27708 PYR1_HUMAN "CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase, EC 6.3.5.5; Aspartate carbamoyltransferase, EC 2.1.3.2; Dihydroorotase, EC 3.5.2.3 ]" CAD Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; terminal bouton [GO:0043195] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228] GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006225; GO:0006228; GO:0006541; GO:0006807; GO:0008270; GO:0016020; GO:0016363; GO:0018107; GO:0019240; GO:0019899; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046777; GO:0070062; GO:0070335 aspartate binding [GO:0070335]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; zinc ion binding [GO:0008270] ERSLDILK 0.99319 -38.56 0 0 14.0723 0 0 0 0 0 0 0 0 0 0 0 14.3582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.274 0 0 0 0 0 0 0 13.3281 0 0 0 0 0 0 0 9.99563 11.8581 0 0 0 0 11.0463 0 9.75256 0 0 0 10.325 0 0 0 0 11.1744 0 14.2446 13.9336 0 0 0 10.5394 0 0 11.9981 12.9446 15.4889 0 0 0 0 13.2815 14.5113 0 0 13.2461 11.8625 0 0 11.6813 12.5582 0 12.7618 12.8463 0 0 0 0 0 0 0 0 0 0 0 12.4829 0 12.6894 0 11.8358 0 0 0 0 0 14.5876 0 12.8154 13.8252 0 0 0 0 0 0 0 0 11.8179 0 0 0 0 0 0 0 0 0 0 17.1829 0 0 15.0305 0 0 0 0 15.5496 0 0 12.4493 0 0 0 12.3177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8905 0 0 0 0 0 P41970 ELK3_HUMAN "ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2, SAP-2, SRF accessory protein 2)" ELK3 NET SAP2 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060]" chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045892; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" HGLAALR 0.99319 -29.306 0 0 0 0 0 0 0 0 0 0 11.3544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8058 10.8537 0 0 0 0 0 12.2223 0 0 0 0 0 13.0362 0 0 0 0 14.8346 0 0 0 0 0 0 0 0 0 12.382 15.1762 13.14 0 0 11.4579 13.5125 15.0523 13.8482 0 0 13.0499 0 11.7947 0 13.9314 14.2267 13.0636 0 0 0 0 13.5371 0 12.4201 0 0 0 0 13.3092 0 0 0 0 0 0 0 0 0 13.0738 0 0 0 0 0 0 0 13.3161 0 0 14.8122 13.1421 0 0 0 13.5296 0 0 0 0 0 0 0 0 0 0 11.2558 0 0 0 0 0 0 0 0 13.3607 0 0 0 0 14.1217 P49454 CENPF_HUMAN "Centromere protein F, CENP-F (AH antigen) (Kinetochore protein CENPF) (Mitosin)" CENPF Homo sapiens (Human) "cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591]" "axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]" "axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription, DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591]" GO:0000278; GO:0000775; GO:0000776; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008017; GO:0008022; GO:0009410; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0070840; GO:0071897; GO:0097539; GO:0140297 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803] ALLSALELKKK 0.99319 -29.218 9.67918 0 0 0 0 0 0 0 0 0 0 9.66434 0 0 0 0 14.1147 0 0 0 12.9654 9.74655 0 0 12.7174 0 0 0 0 0 0 0 0 0 0 0 0 11.3676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6777 0 0 0 0 0 0 0 0 14.8239 0 11.6512 0 0 0 0 12.5798 12.9489 12.365 0 16.8638 14.5983 15.1061 0 0 13.7529 0 14.6698 14.224 12.3722 0 0 17.3453 13.0969 0 13.1421 0 14.8565 0 0 12.6023 0 13.6254 14.8611 0 0 15.3154 14.4307 0 0 14.4667 0 0 0 0 0 0 0 15.4696 0 17.8124 0 17.4219 0 0 0 13.8919 11.7784 12.2589 0 0 0 0 0 0 0 12.9356 0 0 0 0 0 0 0 0 0 0 14.1523 15.9978 0 0 0 0 0 0 12.4356 0 0 0 0 0 0 0 0 0 0 12.788 0 0 0 0 13.7393 0 0 P54764 EPHA4_HUMAN "Ephrin type-A receptor 4, EC 2.7.10.1 (EPH-like kinase 8, EK8, hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK)" EPHA4 HEK8 SEK TYRO1 Homo sapiens (Human) adherens junction organization [GO:0034332]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron projection development [GO:0010977]; negative regulation of proteolysis involved in protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; neuron projection fasciculation [GO:0106030]; neuron projection guidance [GO:0097485]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] adherens junction [GO:0005912]; axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] adherens junction [GO:0005912]; axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein tyrosine kinase binding [GO:1990782]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; adherens junction organization [GO:0034332]; adult walking behavior [GO:0007628]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; cochlea development [GO:0090102]; corticospinal tract morphogenesis [GO:0021957]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; negative regulation of axon regeneration [GO:0048681]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron projection development [GO:0010977]; negative regulation of proteolysis involved in protein catabolic process [GO:1903051]; nephric duct morphogenesis [GO:0072178]; neuron projection fasciculation [GO:0106030]; neuron projection guidance [GO:0097485]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001108]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of astrocyte differentiation [GO:0048710]; regulation of axonogenesis [GO:0050770]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of modification of synaptic structure [GO:1905244]; synapse pruning [GO:0098883]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001540; GO:0004672; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005737; GO:0005741; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005912; GO:0007155; GO:0007162; GO:0007169; GO:0007411; GO:0007628; GO:0008045; GO:0008284; GO:0008347; GO:0009986; GO:0010719; GO:0010977; GO:0016301; GO:0018108; GO:0021957; GO:0030175; GO:0030335; GO:0030336; GO:0030424; GO:0030425; GO:0031594; GO:0031901; GO:0033674; GO:0034332; GO:0042731; GO:0042802; GO:0043005; GO:0043087; GO:0043197; GO:0043198; GO:0043204; GO:0043235; GO:0043507; GO:0043679; GO:0044295; GO:0045785; GO:0046777; GO:0046875; GO:0048013; GO:0048681; GO:0048710; GO:0050770; GO:0050775; GO:0050821; GO:0061001; GO:0061098; GO:0070373; GO:0072178; GO:0090102; GO:0097155; GO:0097156; GO:0097161; GO:0097485; GO:0098685; GO:0098839; GO:0098883; GO:0098978; GO:0099055; GO:0099056; GO:0106030; GO:1900038; GO:1900272; GO:1902004; GO:1902961; GO:1903051; GO:1904646; GO:1905244; GO:1990782; GO:2001108 amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; DH domain binding [GO:0097161]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; PH domain binding [GO:0042731]; protein kinase activity [GO:0004672]; protein tyrosine kinase binding [GO:1990782]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] CPPHSYSVWEGATSCTCDR 0.99319 -13.387 0 0 11.6205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4947 0 0 0 0 0 0 0 0 0 12.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9738 12.6169 0 0 0 13.8167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9355 0 0 0 0 0 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 13.6804 0 14.251 0 0 0 13.0837 0 0 12.9733 13.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8755 0 0 18.8176 Q09327 MGAT3_HUMAN "Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, EC 2.4.1.144 (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III, GNT-III, GlcNAc-T III, N-acetylglucosaminyltransferase III)" MGAT3 GGNT3 Homo sapiens (Human) amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; glycosyltransferase activity [GO:0016757]; amyloid-beta metabolic process [GO:0050435]; cellular response to oxidative stress [GO:0034599]; cognition [GO:0050890]; N-acetylglucosamine metabolic process [GO:0006044]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization [GO:0008104]; protein N-linked glycosylation [GO:0006487]; regulation of cell migration [GO:0030334]" GO:0000139; GO:0003830; GO:0006044; GO:0006487; GO:0008104; GO:0016021; GO:0016757; GO:0030334; GO:0034599; GO:0050435; GO:0050890; GO:1902966; GO:1905166 "beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0003830]; glycosyltransferase activity [GO:0016757]" GPEGRPPARGK 0.99319 -17.247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78183 0 0 0 0 0 19.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VG06 FP100_HUMAN Fanconi anemia core complex-associated protein 100 (Fanconi anemia-associated protein of 100 kDa) FAAP100 C17orf70 Homo sapiens (Human) interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] GO:0000785; GO:0003677; GO:0005654; GO:0005829; GO:0006513; GO:0036297; GO:0043240 DNA binding [GO:0003677] AGAAPRVR 0.99319 -17.245 0 0 0 0 0 9.77264 0 0 0 0 0 0 0 0 13.2698 0 0 0 13.1313 0 0 14.3471 14.6582 0 0 0 0 11.3188 0 0 0 0 0 0 0 0 11.9862 0 12.667 0 12.2271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7062 0 14.8039 15.1122 13.5683 15.3298 13.1264 15.5518 14.9364 12.7663 0 11.621 0 0 15.2501 12.5723 15.169 0 0 14.324 15.0254 15.4136 14.5904 11.6494 0 0 13.6295 0 14.9931 0 14.9182 0 14.9529 14.8775 0 0 11.9494 0 0 0 14.9884 14.9264 0 0 13.8136 13.5754 14.8117 0 0 15.044 14.6407 0 0 15.0667 0 14.047 0 0 0 0 15.1766 0 15.0749 14.9791 0 0 14.9268 14.997 0 0 0 13.7848 0 0 0 0 0 13.2526 14.9477 15.0331 0 13.6623 0 0 0 0 0 0 0 0 0 13.2774 0 13.8305 12.9279 13.0896 14.2982 0 0 0 0 13.782 0 0 Q12882 DPYD_HUMAN "Dihydropyrimidine dehydrogenase [NADP(+)], DHPDHase, DPD, EC 1.3.1.2 (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase)" DPYD Homo sapiens (Human) beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212]" GO:0002058; GO:0005737; GO:0005829; GO:0006145; GO:0006208; GO:0006210; GO:0006212; GO:0006214; GO:0006248; GO:0006249; GO:0017113; GO:0019483; GO:0042803; GO:0046050; GO:0046079; GO:0046872; GO:0050660; GO:0050661; GO:0051536; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]" AVTSIAR 0.99319 -29.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5181 0 0 0 12.7961 0 13.1407 0 0 0 0 13.1645 0 0 0 0 0 0 11.6907 11.7524 0 13.4495 0 10.9218 16.2139 17.6511 18.247 0 17.7179 17.5784 12.589 16.0387 17.4874 0 0 10.9977 17.8529 0 17.8871 17.711 17.9572 11.59 10.7989 10.248 13.1448 10.2965 0 16.048 16.2213 14.774 0 0 12.6711 0 0 14.0172 0 15.3324 0 0 12.7228 0 0 0 14.8781 14.6526 15.4181 13.0473 12.1189 0 13.9648 0 0 0 0 0 0 0 12.727 0 0 0 11.8304 14.9726 0 0 12.496 0 0 0 0 0 0 12.1563 10.9452 0 0 0 0 0 0 0 0 0 12.0997 10.7214 0 0 11.6788 0 0 0 12.1904 0 0 11.1545 0 0 0 0 0 0 0 Q13398 ZN211_HUMAN Zinc finger protein 211 (Zinc finger protein C2H2-25) ZNF211 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CAVAFYSGK 0.99319 -26.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5887 0 0 0 0 0 13.1349 0 0 0 0 0 0 0 0 14.8557 0 0 0 0 0 0 13.4656 0 0 0 0 0 0 0 13.4337 0 0 0 0 13.2426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0841 13.2879 10.9646 0 0 0 0 0 0 0 0 0 0 0 13.3008 10.503 0 0 0 0 0 0 Q13495 MAMD1_HUMAN Mastermind-like domain-containing protein 1 (F18) (Protein CG1) MAMLD1 CG1 CXorf6 Homo sapiens (Human) male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005654; GO:0005794; GO:0005813; GO:0006357; GO:0008584; GO:0016604 HQGTVKR 0.99319 -13.423 0 0 0 0 0 0 0 0 0 13.8831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0133 0 0 0 0 0 0 0 0 0 0 0 13.3226 0 0 0 0 0 0 0 0 0 0 0 0 13.1035 0 0 0 0 12.4652 0 0 0 0 0 0 0 0 0 12.754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15427 SF3B4_HUMAN "Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49, SAP 49)" SF3B4 SAP49 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]" GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0048026; GO:0071005; GO:1903241; GO:1990935 RNA binding [GO:0003723]; splicing factor binding [GO:1990935] GERHGSAAER 0.99319 -5.0936 0 0 0 0 0 0 0 0 0 0 0 0 10.3971 0 9.95283 0 0 11.9854 0 0 11.4069 0 0 0 0 11.6322 0 0 0 0 11.0827 12.7138 0 0 0 0 0 0 0 0 0 11.2978 13.1959 0 0 14.3075 13.9223 13.0408 0 0 0 0 0 0 10.6945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4618 0 0 0 0 0 15.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9274 0 0 12.8918 0 0 0 0 0 0 0 0 0 0 0 0 10.6636 11.6701 0 11.8285 0 0 0 0 0 11.4567 0 0 14.7386 0 0 0 0 0 0 0 Q3MIN7 RGL3_HUMAN "Ral guanine nucleotide dissociation stimulator-like 3, RalGDS-like 3" RGL3 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] AILSALQSNPIYRLKR 0.99319 -16.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4589 0 12.7195 0 0 0 0 12.8166 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4535 0 13.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3435 0 16.3568 0 12.3858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2678 14.7795 0 0 13.9897 13.1124 0 0 14.4008 0 13.5953 17.4171 0 0 13.2223 0 0 13.0563 10.2022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8427 0 0 0 0 0 12.8174 0 10.9261 0 0 0 0 0 0 12.6778 0 0 0 0 14.5215 0 0 0 0 0 0 Q6GYQ0 RGPA1_HUMAN "Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12, GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240)" RALGAPA1 GARNL1 KIAA0884 TULIP1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982] DNLGISTDNLTSPSPPVLIPPLRILTPWLFK 0.99319 -29.323 0 0 0 0 0 0 0 0 14.4927 13.6281 13.6108 14.5744 10.7368 14.3105 0 13.8365 14.424 14.3385 14.4228 14.2578 14.368 0 15.5859 13.8053 14.5912 14.9859 15.0567 14.8077 14.7215 13.9877 13.1633 13.9308 13.3365 14.0975 0 0 0 14.6582 0 0 13.6274 16.7814 0 13.2591 14.729 14.112 14.8798 15.4974 12.8369 13.7844 0 13.7398 16.7746 16.7098 13.6161 13.5555 12.6108 0 0 0 0 14.4408 0 0 0 0 0 0 0 18.6225 0 0 0 0 14.0948 14.4369 0 15.1059 0 0 0 18.78 0 13.8223 14.453 0 0 0 14.4001 13.8946 0 0 14.1064 0 14.128 0 18.4923 16.3947 14.6821 14.4144 14.3745 0 0 15.148 0 14.0654 0 13.8784 0 18.5951 14.4797 13.9297 14.4486 0 14.2779 14.4877 0 0 0 14.0729 0 14.822 14.3665 0 14.6064 0 18.3925 0 0 0 0 0 0 0 14.0152 14.3093 11.9507 13.6171 0 13.4411 0 13.8784 12.6413 19.4603 0 11.7971 13.9361 15.8894 0 13.7316 14.4238 11.7731 0 0 14.1 0 15.3293 0 0 0 14.809 14.4439 15.807 0 15.3863 15.9336 15.4373 15.0806 15.229 14.6452 14.5068 14.0667 14.2984 0 14.5568 0 0 15.7816 0 0 Q7L985 LIGO2_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C) LINGO2 LERN3 LRRN6C UNQ9234/PRO31993 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] GO:0005615; GO:0016021; GO:0031012 DFHSTALSFYFTCKK 0.99319 -13.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4144 0 0 0 0 0 0 11.9315 0 11.9829 0 0 0 0 0 12.4493 0 13.2117 13.0881 0 0 0 0 12.0562 11.3841 10.5059 0 11.3877 13.1123 0 0 0 0 12.8872 0 15.1964 14.704 0 12.9009 9.78246 12.9764 11.0798 14.0205 0 0 11.6526 0 14.5406 0 0 0 0 0 12.4301 11.5882 12.534 0 12.9621 0 13.2608 12.2514 13.8434 0 18.3349 0 0 0 0 0 0 0 0 0 13.6472 0 12.737 0 0 0 0 0 0 0 0 10.5785 13.7916 13.318 0 14.2212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3025 0 14.6726 0 0 0 13.7474 0 Q7RTW8 OTOAN_HUMAN Otoancorin OTOA Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226] GO:0005576; GO:0005886; GO:0007160; GO:0007605; GO:0009986; GO:0016324; GO:0019226; GO:0031225 IGTLLCSTHVLAEFK 0.99319 -17.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4099 0 13.1728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6255 0 0 0 0 0 14.7655 0 0 0 0 0 0 0 12.1487 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3442 0 0 0 0 0 0 0 14.0644 0 0 0 0 0 14.8363 0 13.1089 0 0 13.3991 0 0 0 0 0 0 0 0 0 0 0 0 11.4756 0 0 14.8048 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4605 13.0693 0 12.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W56 PARG_HUMAN "Poly(ADP-ribose) glycohydrolase, EC 3.2.1.143" PARG Homo sapiens (Human) "ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair, gap-filling [GO:0006287]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair, gap-filling [GO:0006287]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]" GO:0004649; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005829; GO:0005975; GO:0006282; GO:0006287; GO:0009225; GO:0031056; GO:0043231; GO:1990966 poly(ADP-ribose) glycohydrolase activity [GO:0004649] DLWDNKHVK 0.99319 -38.083 0 0 0 0 0 0 0 0 0 13.4454 0 0 0 14.8943 16.4132 17.5384 18.351 18.8646 16.9908 17.0964 18.0705 18.0057 18.0965 0 17.6178 18.0223 16.8787 16.7875 15.8728 16.94 18.2114 0 0 0 0 0 0 0 0 0 19.88 18.7885 19.4184 18.4927 19.1436 19.8902 18.9296 19.8048 16.547 17.8539 16.5336 17.4909 16.2607 17.3885 18.1641 17.9729 18.0529 16.0859 0 14.4217 16.705 16.622 14.4765 13.8509 13.7618 17.6949 13.0683 12.0373 0 12.8221 0 13.2066 0 0 0 0 0 0 0 13.6796 12.822 16.5802 0 15.7335 13.489 15.8779 15.599 19.6382 18.9254 19.4331 19.0992 19.0114 17.8427 18.2674 0 17.3674 15.8992 15.2906 0 0 0 0 15.082 16.8984 17.5075 0 18.366 18.2193 18.5151 17.5612 18.2966 18.0157 17.9712 18.0802 18.8204 18.3752 18.3526 18.3071 19.0812 18.9002 19.2401 18.1859 13.2072 18.7438 18.3169 18.7715 19.436 0 0 13.7796 12.7934 12.5811 12.5862 12.5984 0 19.3127 19.0473 18.9622 0 17.6259 18.8554 19.4145 19.0304 18.7401 18.9513 18.3664 18.0912 18.2634 18.2749 18.1565 0 0 0 0 0 13.1888 19.0526 0 12.6463 15.0661 0 0 0 12.7746 14.3423 16.9899 13.1576 18.0184 16.7619 16.6019 16.7562 19.6588 19.5055 19.5517 18.0457 17.8826 18.946 14.1926 17.9143 18.0607 Q8IZK6 MCLN2_HUMAN "Mucolipin-2 (Transient receptor potential channel mucolipin 2, TRPML2)" MCOLN2 Homo sapiens (Human) adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345]; adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; innate immune response [GO:0045087]; macrophage migration [GO:1905517]; neutrophil migration [GO:1990266]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; protein transport [GO:0015031] GO:0002250; GO:0005262; GO:0005764; GO:0005886; GO:0015031; GO:0016020; GO:0016021; GO:0031902; GO:0042802; GO:0045087; GO:0055038; GO:0070588; GO:0071639; GO:0071642; GO:0071651; GO:0072345; GO:1905517; GO:1990266; GO:2000343 calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; NAADP-sensitive calcium-release channel activity [GO:0072345] AHSGKIK 0.99319 -14.468 0 0 0 0 0 13.5129 0 0 15.9906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1653 0 0 0 0 0 0 12.5607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8707 0 0 0 0 0 11.0304 14.4672 0 0 0 0 0 0 0 0 0 0 12.1396 14.75 11.972 17.6412 0 0 0 0 0 13.4795 0 14.3439 11.5183 0 0 0 14.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4945 11.1744 0 0 0 0 0 0 0 14.9729 0 0 0 0 0 0 10.9593 0 14.164 0 0 0 0 0 0 0 0 0 0 0 15.4524 11.5183 0 0 0 0 0 11.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5823 0 0 0 Q8N319 CF223_HUMAN Uncharacterized protein C6orf223 C6orf223 Homo sapiens (Human) ESLLRGLCR 0.99319 -29.236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8455 0 0 12.2454 0 0 0 0 0 0 0 0 10.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5416 0 0 0 0 0 0 11.1626 0 0 13.675 0 0 0 0 0 0 0 0 11.3383 0 0 0 0 0 0 0 0 0 14.1001 0 0 0 14.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5899 0 0 0 0 0 0 0 0 0 13.9818 0 0 0 0 14.0858 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAG6 ANKL1_HUMAN "Ankyrin repeat and LEM domain-containing protein 1, EC 3.1.-.- (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3)" ANKLE1 ANKRD41 LEM3 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; negative regulation of mitotic recombination [GO:0045950]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453]; resolution of meiotic recombination intermediates [GO:0000712] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of mitotic recombination [GO:0045950]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000712; GO:0000724; GO:0004519; GO:0004520; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0045950; GO:0090305; GO:1905453; GO:1905456; GO:2001022 endodeoxyribonuclease activity [GO:0004520]; endonuclease activity [GO:0004519] DQDGLRPLDLALQQGHLECARVLQDLDTR 0.99319 -6.9894 0 0 0 0 0 0 0 12.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3305 0 0 0 0 0 0 0 13.4836 0 9.63347 12.4125 12.8951 0 0 18.431 0 0 0 0 0 0 0 13.3229 0 13.7338 11.9669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2662 12.6989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9543 0 0 0 0 0 14.5986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBL3 T178A_HUMAN Transmembrane protein 178A TMEM178A TMEM178 PSEC0131 UNQ5926/PRO19820 Homo sapiens (Human) negative regulation of osteoclast differentiation [GO:0045671]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; negative regulation of osteoclast differentiation [GO:0045671]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0005789; GO:0016020; GO:0016021; GO:0045671; GO:0051480 DIDTLILK 0.99319 -16.84 0 0 0 0 0 0 0 0 0 0 0 0 13.1993 0 0 0 0 0 13.1301 0 0 0 0 0 0 12.2329 0 0 0 12.5952 0 0 0 0 0 0 0 0 0 12.8778 12.5361 0 0 0 12.1999 0 0 14.1551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1444 0 0 15.551 12.9397 0 0 0 0 12.7387 0 0 16.2162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4502 0 0 13.9599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7538 0 0 0 0 0 13.4105 0 0 0 0 0 0 0 0 0 0 12.2488 0 0 0 0 0 0 0 0 0 Q8NH41 OR4KF_HUMAN Olfactory receptor 4K15 (Olfactory receptor OR14-20) OR4K15 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NVLFLETK 0.99319 -5.0843 0 0 0 0 0 12.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3129 0 13.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9416 0 13.5137 0 0 0 0 0 0 0 12.9742 0 0 0 0 0 0 0 0 0 0 0 13.3031 0 0 12.1911 0 0 0 14.3179 0 12.868 0 0 13.4165 0 0 0 0 13.6542 0 0 13.8198 0 0 15.2603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.424 0 0 0 0 0 0 Q969R2 OSBP2_HUMAN "Oxysterol-binding protein 2 (Oxysterol-binding protein-related protein 4, ORP-4, OSBP-related protein 4)" OSBP2 KIAA1664 ORP4 OSBPL4 Homo sapiens (Human) spermatid development [GO:0007286] apical dendrite [GO:0097440]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] apical dendrite [GO:0097440]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; spermatid development [GO:0007286] GO:0005829; GO:0005886; GO:0007286; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0043231; GO:0097038; GO:0097440 cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] AEGSTGTSSVDWSSADNVLDGASLVPK 0.99319 -5.0958 0 9.22673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.242 0 0 0 0 0 0 12.249 11.2995 0 10.7713 0 0 0 0 0 0 0 0 0 0 0 0 10.6546 0 12.9612 0 12.8423 13.2854 13.2298 0 15.1453 0 15.6196 15.4626 19.1274 15.9772 15.7723 16.3713 13.7051 0 14.5888 15.0873 15.8291 16.0122 16.4008 15.7366 15.2367 0 14.2392 15.7232 14.8022 12.3359 0 11.147 19.445 16.5674 16.3683 15.3318 15.7964 0 13.7324 0 14.1602 16.5946 16.6246 16.2742 14.8472 0 15.2213 12.1336 13.9277 15.3998 14.9149 15.4224 15.8404 14.9692 15.4461 15.6423 14.2538 13.5516 0 0 12.8916 0 13.2437 14.849 14.1918 15.3427 0 14.1846 0 13.7256 12.4703 12.0899 13.9804 11.8455 13.6545 0 0 0 13.5113 0 0 13.5341 19.7979 14.9282 0 0 0 0 13.6945 0 0 0 0 13.8205 11.8637 0 0 0 13.9177 13.8515 14.4835 13.7819 0 0 0 0 0 0 Q96AZ6 ISG20_HUMAN "Interferon-stimulated gene 20 kDa protein, EC 3.1.13.1 (Estrogen-regulated transcript 45 protein) (Promyelocytic leukemia nuclear body-associated protein ISG20)" ISG20 HEM45 Homo sapiens (Human) "defense response to virus [GO:0051607]; DNA catabolic process, exonucleolytic [GO:0000738]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]" Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; exoribonuclease II activity [GO:0008859]; metal ion binding [GO:0046872]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U3 snoRNA binding [GO:0034511]; defense response to virus [GO:0051607]; DNA catabolic process, exonucleolytic [GO:0000738]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]" GO:0000175; GO:0000738; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0006401; GO:0008310; GO:0008859; GO:0009615; GO:0015030; GO:0016605; GO:0030619; GO:0030620; GO:0034511; GO:0045071; GO:0045087; GO:0046872; GO:0051607 3'-5'-exoribonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; exoribonuclease II activity [GO:0008859]; metal ion binding [GO:0046872]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U3 snoRNA binding [GO:0034511] EVVAMDCEMVGLGPHR 0.99319 -6.5345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4732 0 0 0 0 13.5584 15.7151 15.0422 0 0 11.7977 0 0 0 0 0 11.5806 0 0 13.6722 0 0 0 0 12.2375 0 0 0 0 0 0 0 0 12.8522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MW5 COG8_HUMAN "Conserved oligomeric Golgi complex subunit 8, COG complex subunit 8 (Component of oligomeric Golgi complex 8)" COG8 Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" GO:0000139; GO:0000301; GO:0005794; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0070085 ELSGSGLER 0.99319 -13.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0084 0 0 0 0 0 13.5575 13.9394 13.8746 14.8696 14.8896 14.9512 13.2347 15.8831 15.1539 0 0 13.1486 13.4268 13.4045 0 0 14.2547 13.9968 0 0 0 0 0 13.1094 0 0 0 0 0 0 15.5596 14.7328 15.5518 14.8437 14.7723 0 13.4301 13.4817 15.2714 0 0 0 0 13.5234 14.674 14.8154 0 14.5404 0 0 13.8268 0 14.1134 0 0 0 13.7241 0 0 0 0 0 0 13.4589 13.8597 0 0 14.6117 14.9813 0 0 0 0 0 0 0 0 13.3685 13.2849 0 0 0 0 0 0 0 13.3574 0 0 0 0 0 0 Q99575 POP1_HUMAN "Ribonucleases P/MRP protein subunit POP1, hPOP1" POP1 KIAA0061 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; tRNA 5'-leader removal [GO:0001682]; tRNA catabolic process [GO:0016078]; tRNA processing [GO:0008033]" extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172] "extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; tRNA 5'-leader removal [GO:0001682]; tRNA catabolic process [GO:0016078]; tRNA processing [GO:0008033]" GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204; GO:0090502 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] ALPNPEK 0.99319 -13.409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8464 0 0 0 0 0 0 16.6957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2207 0 0 0 0 0 0 0 0 17.0089 0 0 0 13.8767 18.0313 12.1249 0 0 0 0 0 0 0 0 0 14.9429 12.4304 0 0 0 15.5658 0 0 0 0 0 0 0 0 0 0 0 0 11.1071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4147 16.3022 9.38967 0 0 0 0 0 0 0 0 0 10.7508 0 0 0 0 0 0 0 0 0 12.7099 0 0 0 0 0 0 0 14.1313 0 0 17.2309 12.1566 0 12.4869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1424 0 0 Q9BY07 S4A5_HUMAN Electrogenic sodium bicarbonate cotransporter 4 (NBCe2) (Solute carrier family 4 member 5) SLC4A5 NBC4 Homo sapiens (Human) bicarbonate transport [GO:0015701]; cerebrospinal fluid secretion [GO:0033326]; epithelial cell development [GO:0002064]; ion homeostasis [GO:0050801]; mitochondrion distribution [GO:0048311]; regulation of gene expression [GO:0010468]; regulation of intracellular pH [GO:0051453]; regulation of systemic arterial blood pressure [GO:0003073]; renal system process [GO:0003014]; retina development in camera-type eye [GO:0060041]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; cerebrospinal fluid secretion [GO:0033326]; epithelial cell development [GO:0002064]; ion homeostasis [GO:0050801]; mitochondrion distribution [GO:0048311]; regulation of gene expression [GO:0010468]; regulation of intracellular pH [GO:0051453]; regulation of systemic arterial blood pressure [GO:0003073]; renal system process [GO:0003014]; retina development in camera-type eye [GO:0060041]; transmembrane transport [GO:0055085] GO:0002064; GO:0003014; GO:0003073; GO:0005452; GO:0005886; GO:0008510; GO:0010468; GO:0015301; GO:0015701; GO:0016021; GO:0016324; GO:0022857; GO:0033326; GO:0048311; GO:0050801; GO:0051453; GO:0055085; GO:0060041 anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857] CKLFLMPAK 0.99319 -26.634 0 0 0 0 0 0 0 0 0 12.4357 0 0 0 0 0 0 0 0 9.88826 0 11.2284 0 0 0 0 0 0 0 10.2354 0 0 0 0 0 0 0 0 0 10.6573 12.7465 0 0 0 0 0 0 0 0 0 12.6568 0 0 11.3437 12.1735 0 0 0 0 0 0 0 0 0 0 0 0 0 13.479 13.7245 13.8371 12.1437 0 0 11.8342 0 0 14.2975 12.0885 14.7652 0 12.0768 12.7612 0 13.7973 0 0 14.7665 14.4689 0 0 0 0 15.208 14.9805 16.5084 0 13.8727 16.4925 0 0 0 13.0459 0 14.5429 14.4526 12.2528 13.7154 0 0 0 0 0 14.0607 0 0 0 0 0 0 10.3281 14.5392 0 13.3446 0 0 13.4161 13.7117 14.324 0 0 0 0 0 0 14.6461 0 0 16.1295 0 12.7642 0 0 0 12.098 14.3606 13.6564 0 0 0 0 0 0 0 0 13.2886 13.165 0 12.1361 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7513 0 0 12.1412 0 12.3134 12.0945 0 11.8462 Q9NWT6 HIF1N_HUMAN "Hypoxia-inducible factor 1-alpha inhibitor, EC 1.14.11.30, EC 1.14.11.n4 (Factor inhibiting HIF-1, FIH-1) (Hypoxia-inducible factor asparagine hydroxylase)" HIF1AN FIH1 Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214] GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0016706; GO:0019826; GO:0031406; GO:0036138; GO:0036139; GO:0036140; GO:0042264; GO:0042265; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0061428; GO:0071532; GO:0102113; GO:2001214 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] GAPTPKR 0.99319 -14.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P219 DAPLE_HUMAN "Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues, hDaple) (Hook-related protein 2, HkRP2)" CCDC88C DAPLE KIAA1509 Homo sapiens (Human) apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098] anchoring junction [GO:0070161]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737] anchoring junction [GO:0070161]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621]; apical constriction [GO:0003383]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; protein destabilization [GO:0031648]; regulation of protein phosphorylation [GO:0001932]; small GTPase mediated signal transduction [GO:0007264]; stress-activated protein kinase signaling cascade [GO:0031098] GO:0001932; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005737; GO:0005813; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031098; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043621; GO:0051959; GO:0070161; GO:0090090 dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein self-association [GO:0043621] ADKARQIK 0.99319 -38.511 0 0 0 0 0 0 0 0 15.5103 16.9859 13.012 0 16.8911 0 12.5307 0 0 0 12.4305 0 0 0 0 0 0 0 13.7705 13.7337 12.2064 0 16.7172 12.442 16.6947 14.4214 17.0202 0 0 0 15.0875 10.7999 0 16.6551 16.6702 12.5435 11.9658 0 12.7814 0 0 12.6952 13.5317 0 0 0 0 0 0 0 0 13.8846 0 0 0 0 12.7077 13.462 0 0 14.4758 0 0 0 0 0 0 13.8698 14.1539 13.3877 12.2047 0 0 15.7151 0 13.3718 0 13.3515 0 13.4926 13.5665 13.4099 0 0 13.2755 0 0 0 0 0 0 14.4677 0 0 0 14.3254 14.0381 14.7156 14.4071 0 13.375 0 0 0 0 0 0 0 0 0 0 0 0 13.8172 16.8089 0 0 0 0 13.621 0 0 0 13.5989 15.5736 0 0 13.6829 0 0 0 0 0 14.6271 13.5349 0 0 0 0 0 0 12.0492 14.2772 13.4346 15.3397 14.5259 14.0735 0 0 15.8219 0 15.745 14.7448 14.7965 0 18.9519 0 13.1789 14.7563 14.7757 0 14.7996 14.8986 0 0 0 0 0 0 0 0 0 Q9ULK4 MED23_HUMAN "Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component, ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3, CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog, hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component, DRIP130)" MED23 ARC130 CRSP3 DRIP130 KIAA1216 SUR2 Homo sapiens (Human) "positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription coactivator activity [GO:0003713]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0006367; GO:0010628; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 transcription coactivator activity [GO:0003713] FLTEVLLPIVK 0.99319 -13.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0212 0 0 0 0 0 0 12.5893 0 10.9506 0 0 0 0 0 0 0 0 11.5876 0 12.1675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4891 0 Q9UPX6 MNAR1_HUMAN Major intrinsically disordered Notch2-binding receptor 1 (Membrane integral NOTCH2-associated receptor 1) (Ubiquitination and mTOR signaling protein) MINAR1 KIAA1024 UBTOR Homo sapiens (Human) angiogenesis [GO:0001525]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TOR signaling [GO:0032007] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of TOR signaling [GO:0032007] GO:0001525; GO:0005886; GO:0008285; GO:0010977; GO:0016021; GO:0016525; GO:0030308; GO:0031397; GO:0032007 CLGKPNKQTPWPAK 0.99319 -14.471 0 0 0 0 0 0 0 0 0 11.8739 0 0 0 0 0 11.2614 13.5668 0 14.0263 12.9201 0 0 12.5591 0 12.8987 0 13.6587 0 0 0 11.7278 0 0 0 0 0 0 0 0 0 0 0 0 13.468 13.2816 13.5441 13.0045 0 12.6123 12.276 12.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9986 0 14.7669 0 13.3581 13.3994 13.5844 0 13.7018 0 0 0 13.0141 14.393 13.1831 14.6346 0 0 13.2642 0 0 14.2114 13.7146 0 0 0 0 11.3394 0 0 14.9878 0 0 0 0 15.0741 11.8923 0 0 0 0 0 0 0 0 0 0 0 15.7102 0 0 13.2554 0 0 15.0017 13.1747 0 14.7929 0 13.2507 0 17.5224 13.6344 13.1802 0 0 0 0 0 12.9695 0 0 0 14.6385 0 0 0 0 0 10.8829 13.6162 0 12.9787 13.4512 13.2504 13.62 12.63 0 0 0 13.0868 12.6194 0 0 12.4783 0 12.5801 13.0496 17.8342 13.6445 0 0 0 0 0 0 Q9Y6K1 DNM3A_HUMAN "DNA (cytosine-5)-methyltransferase 3A, Dnmt3a, EC 2.1.1.37 (Cysteine methyltransferase DNMT3A, EC 2.1.1.-) (DNA methyltransferase HsaIIIA, DNA MTase HsaIIIA, M.HsaIIIA)" DNMT3A Homo sapiens (Human) "aging [GO:0007568]; C-5 methylation of cytosine [GO:0090116]; cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; hepatocyte apoptotic process [GO:0097284]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of cell death [GO:0010942]; regulation of gene expression by genomic imprinting [GO:0006349]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]" "catalytic complex [GO:1902494]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; XY body [GO:0001741]" "catalytic complex [GO:1902494]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; XY body [GO:0001741]; chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-cysteine methyltransferase activity [GO:0106363]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; aging [GO:0007568]; C-5 methylation of cytosine [GO:0090116]; cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation involved in gamete generation [GO:0043046]; DNA methylation on cytosine [GO:0032776]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; hepatocyte apoptotic process [GO:0097284]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; positive regulation of cell death [GO:0010942]; regulation of gene expression by genomic imprinting [GO:0006349]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283]" GO:0000122; GO:0000278; GO:0000775; GO:0000791; GO:0000792; GO:0000978; GO:0001741; GO:0003677; GO:0003682; GO:0003714; GO:0003886; GO:0005634; GO:0005654; GO:0005737; GO:0006306; GO:0006346; GO:0006349; GO:0007283; GO:0007568; GO:0009410; GO:0009636; GO:0010212; GO:0010288; GO:0010942; GO:0016363; GO:0030182; GO:0032355; GO:0032776; GO:0033189; GO:0042220; GO:0042802; GO:0043045; GO:0043046; GO:0045892; GO:0046872; GO:0061629; GO:0071230; GO:0071361; GO:0071456; GO:0090116; GO:0097284; GO:0106363; GO:1902494; GO:1903926 chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-cysteine methyltransferase activity [GO:0106363]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714] EDPWNCYMCGHK 0.99319 -29.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6697 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4786 11.9149 0 0 12.9014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5956 0 0 0 0 0 0 0 0 0 0 0 14.4312 0 13.4724 0 0 0 0 0 0 0 0 15.1684 12.3903 13.2208 12.5781 0 13.5163 0 13.8346 0 15.0403 16.076 14.3543 14.4537 0 15.1552 16.0549 15.6467 0 0 11.9277 0 0 0 0 14.2688 0 0 0 11.8924 0 0 0 0 13.8575 16.0052 12.7262 0 0 0 0 0 0 15.4642 0 14.9237 0 12.209 14.1115 0 13.3978 12.804 12.2088 14.4196 0 13.6577 15.5183 0 13.0353 13.9622 0 0 0 0 0 14.512 0 0 0 0 0 0 13.5877 0 0 0 15.0933 0 0 0 0 0 0 13.7803 0 13.3232 0 0 0 0 0 0 0 14.9225 13.4033 0 0 11.1433 12.9089 0 0 A0A6I8PU40 TUG1_HUMAN Taurine up-regulated 1 protein TUG1 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965] GO:0016021; GO:0031965; GO:0031966 AIGWRLFLLLWHPALGAQAR 0.9932 -6.3974 0 10.4544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7711 0 0 0 0 0 0 0 0 14.5798 14.4932 14.5739 0 0 15.2432 12.5871 0 0 0 0 0 0 0 15.056 17.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00311 CDC7_HUMAN "Cell division cycle 7-related protein kinase, CDC7-related kinase, HsCdc7, huCdc7, EC 2.7.11.1" CDC7 CDC7L1 Homo sapiens (Human) cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; double-strand break repair via break-induced replication [GO:0000727]; G1/S transition of mitotic cell cycle [GO:0000082]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; signal transduction [GO:0007165] GO:0000082; GO:0000727; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007165; GO:0008284; GO:0010571; GO:0010971; GO:0016301; GO:0018105; GO:0044770; GO:0045171; GO:0046872; GO:0051301; GO:0072686; GO:0106310 ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] APEVLTK 0.9932 -14.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8403 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8123 0 0 15.7733 O43805 SSNA1_HUMAN Microtubule nucleation factor SSNA1 (Nuclear autoantigen of 14 kDa) (Sjoegren syndrome nuclear autoantigen 1) SSNA1 NA14 Homo sapiens (Human) axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020] axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; supramolecular fiber [GO:0099512] axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; supramolecular fiber [GO:0099512]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020] GO:0000226; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005930; GO:0007020; GO:0007409; GO:0008017; GO:0030424; GO:0030496; GO:0036064; GO:0042073; GO:0042802; GO:0043621; GO:0048675; GO:0051301; GO:0060830; GO:0099512; GO:0140060 identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein self-association [GO:0043621] LARVNENLAR 0.9932 -16.467 0 0 0 0 0 0 0 0 0 0 12.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.011 0 0 0 0 0 0 0 0 0 0 13.6461 0 0 0 0 0 0 0 0 0 12.6948 0 0 0 0 0 0 0 0 0 0 13.4091 0 12.345 0 0 0 0 0 O75387 LAT3_HUMAN Large neutral amino acids transporter small subunit 3 (L-type amino acid transporter 3) (Prostate cancer overexpressed gene 1 protein) (Solute carrier family 43 member 1) SLC43A1 LAT3 PB39 POV1 Homo sapiens (Human) amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175]; amino acid transport [GO:0006865]; negative regulation of amino acid transport [GO:0051956]; negative regulation of leucine import [GO:0060358]; neutral amino acid transport [GO:0015804] GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015175; GO:0015179; GO:0015804; GO:0051956; GO:0060358 amino acid transmembrane transporter activity [GO:0015171]; L-amino acid transmembrane transporter activity [GO:0015179]; neutral amino acid transmembrane transporter activity [GO:0015175] APTLQQAYR 0.9932 -6.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9392 0 13.4756 0 12.79 0 14.5454 0 0 0 0 0 0 0 0 0 13.0967 0 0 0 13.557 0 0 13.7187 12.7783 0 0 0 0 0 0 0 0 14.1766 13.896 0 0 0 0 0 0 0 0 0 0 13.3784 14.9601 0 13.6834 0 0 13.958 13.6761 0 13.2189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2605 0 0 12.1214 0 0 0 0 14.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94927 HAUS5_HUMAN HAUS augmin-like complex subunit 5 HAUS5 KIAA0841 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0005813; GO:0005829; GO:0007098; GO:0051225; GO:0051301; GO:0070652; GO:1990498 AQFLQNLLLPQAKR 0.9932 -14.54 0 0 0 0 0 0 0 0 12.8957 0 0 12.4934 0 0 13.7081 13.365 14.8167 14.4361 0 12.449 14.431 0 12.6574 0 0 0 0 13.2431 0 0 14.6727 15.6746 14.3789 0 0 0 0 15.0194 0 13.8291 14.815 14.4424 14.732 13.4507 12.1847 0 14.5022 13.5774 0 0 10.615 13.6559 15.8996 14.7168 0 0 0 0 0 0 0 12.8473 13.7827 0 12.4482 13.68 0 0 17.9527 0 0 0 0 0 14.2841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.254 0 0 0 0 0 13.7016 12.301 0 0 0 0 0 13.5348 14.3784 0 0 0 0 0 0 0 0 0 13.2362 0 0 13.4643 0 0 0 10.876 0 14.2116 0 14.138 0 0 0 0 13.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9968 0 0 12.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4224 0 0 13.9313 Q15911 ZFHX3_HUMAN "Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3, ZFH-3)" ZFHX3 ATBF1 C16orf47 Homo sapiens (Human) "brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to transforming growth factor beta [GO:0071559]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0007420; GO:0007517; GO:0008270; GO:0016604; GO:0019899; GO:0032922; GO:0045662; GO:0045663; GO:0045664; GO:0045785; GO:0045893; GO:0045944; GO:0051726; GO:0071559; GO:1904059 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" ALFKAKTALEAHIR 0.9932 -43.754 11.4091 0 0 0 11.9005 11.9949 0 0 0 0 0 11.4875 0 0 0 0 0 11.3686 0 0 0 0 0 0 0 0 0 0 12.1964 0 0 0 0 0 15.609 0 0 0 10.73 0 0 0 0 10.7819 0 0 12.3615 0 11.329 0 0 11.1449 0 0 0 0 0 0 0 0 0 0 0 0 11.5783 0 13.9876 12.4352 10.684 12.0731 0 0 0 0 0 12.7194 13.2899 0 0 0 14.7329 14.7504 14.7132 14.689 14.4234 12.7771 12.507 0 14.4318 0 0 12.6828 12.9091 16.0069 0 0 14.5681 14.4177 14.4829 0 0 14.8583 0 0 0 0 0 13.2445 12.8602 0 13.1284 0 13.4834 0 0 11.9478 14.7979 15.0793 15.0854 0 14.5311 0 0 15.4621 0 16.0701 15.9166 15.7689 14.2435 0 0 0 13.2408 0 11.9922 0 14.2716 0 14.905 0 0 0 0 0 10.2557 0 13.4693 0 13.5641 13.6815 0 0 0 14.6602 12.0804 13.5841 0 13.8805 0 0 0 0 13.9142 0 15.9273 0 13.7309 12.4567 0 0 0 0 0 0 13.7296 0 0 0 0 13.5291 Q6QNY0 BL1S3_HUMAN "Biogenesis of lysosome-related organelles complex 1 subunit 3, BLOC-1 subunit 3" BLOC1S3 BLOS3 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosome to melanosome transport [GO:0035646]; eye development [GO:0001654]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; response to xenobiotic stimulus [GO:0009410]; secretion of lysosomal enzymes [GO:0033299] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytosol [GO:0005829]; transport vesicle [GO:0030133] axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytosol [GO:0005829]; transport vesicle [GO:0030133]; protein transmembrane transporter activity [GO:0008320]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosome to melanosome transport [GO:0035646]; eye development [GO:0001654]; melanosome organization [GO:0032438]; melanosome transport [GO:0032402]; neuron projection development [GO:0031175]; pigmentation [GO:0043473]; platelet activation [GO:0030168]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; response to xenobiotic stimulus [GO:0009410]; secretion of lysosomal enzymes [GO:0033299] GO:0001654; GO:0005829; GO:0008089; GO:0008320; GO:0009410; GO:0030133; GO:0030168; GO:0031083; GO:0031175; GO:0032402; GO:0032438; GO:0032816; GO:0033299; GO:0035646; GO:0043473; GO:0048490; GO:0060155; GO:1904115 protein transmembrane transporter activity [GO:0008320] DVAALASRLAAAQAAGLAAAHSVRLAR 0.9932 -5.1223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3215 0 0 15.4106 0 0 0 0 0 0 0 0 15.343 14.7778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1436 15.3009 14.8329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7726 Q8NCV1 ADAD2_HUMAN Adenosine deaminase domain-containing protein 2 (Testis nuclear RNA-binding protein-like) ADAD2 TENRL Homo sapiens (Human) adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; RNA processing [GO:0006396]; spermatid development [GO:0007286] GO:0003725; GO:0003726; GO:0005634; GO:0005730; GO:0005737; GO:0006382; GO:0006396; GO:0007286; GO:0008251 double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; tRNA-specific adenosine deaminase activity [GO:0008251] MASASQGADDDGSR 0.9932 -5.121 0 0 0 0 0 0 0 0 0 0 0 11.0441 13.0009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9323 0 0 11.4472 0 0 0 0 0 0 0 0 0 Q96KR1 ZFR_HUMAN "Zinc finger RNA-binding protein, hZFR (M-phase phosphoprotein homolog)" ZFR Homo sapiens (Human) chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005694; GO:0005737; GO:0008270 DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] ALKLVSDSLSEHEK 0.9932 -39.284 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3837 0 0 0 0 0 0 12.1187 12.0284 0 14.4251 0 10.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6083 0 16.8536 11.9205 10.6051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5668 0 0 0 0 0 0 11.9772 0 0 0 11.3535 0 0 0 0 0 0 0 0 0 12.4248 0 0 0 0 0 11.719 0 0 0 0 0 0 0 12.8309 11.0035 0 0 0 12.8103 0 0 0 12.9334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7003 0 0 0 0 0 12.9016 12.1269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2397 0 14.5064 0 10.9082 0 0 0 0 0 0 0 14.8517 0 0 0 0 0 13.9845 Q96LD8 SENP8_HUMAN "Sentrin-specific protease 8, EC 3.4.22.- (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8)" SENP8 DEN1 NEDP1 PRSC2 FKSG8 Homo sapiens (Human) post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579] cytosol [GO:0005829] cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; deNEDDylase activity [GO:0019784]; post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579] GO:0000338; GO:0005829; GO:0008234; GO:0016579; GO:0019784; GO:0043687 cysteine-type peptidase activity [GO:0008234]; deNEDDylase activity [GO:0019784] DLITTLAK 0.9932 -6.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1962 0 16.6745 0 16.8182 16.4441 0 16.4152 0 0 0 0 15.9474 0 0 0 0 16.3957 16.1408 0 0 0 16.5465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4386 0 0 0 Q96RD6 PANX2_HUMAN Pannexin-2 PANX2 Homo sapiens (Human) cation transport [GO:0006812]; cell-cell signaling [GO:0007267]; positive regulation of interleukin-1 production [GO:0032732]; response to ischemia [GO:0002931] cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; wide pore channel activity [GO:0022829]; cation transport [GO:0006812]; cell-cell signaling [GO:0007267]; positive regulation of interleukin-1 production [GO:0032732]; response to ischemia [GO:0002931] GO:0002931; GO:0005198; GO:0005737; GO:0005886; GO:0005921; GO:0006812; GO:0007267; GO:0016021; GO:0022829; GO:0032732 structural molecule activity [GO:0005198]; wide pore channel activity [GO:0022829] APKIEKQIQSK 0.9932 -38.634 0 0 13.0445 0 0 0 0 0 0 13.3935 0 0 0 12.8517 0 12.164 0 13.8229 0 13.6734 0 13.0706 0 11.1298 0 0 0 0 0 0 0 13.4201 14.7536 13.8259 0 0 0 0 14.4738 14.5603 14.4776 0 0 0 0 0 14.2476 13.7783 14.4063 14.4929 0 0 11.7232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1522 12.0144 17.2046 0 10.8158 0 13.2335 12.7587 0 0 0 12.8185 0 0 15.542 0 12.9927 0 0 11.2904 0 13.7551 0 14.3747 0 12.9907 11.319 14.5784 0 15.1868 13.3079 0 15.2155 0 10.9902 0 11.7909 13.625 14.4328 12.5183 0 0 0 0 0 12.814 0 14.8461 0 0 15.5492 0 13.1361 0 13.5824 0 0 0 0 13.6595 0 0 12.3767 13.9348 12.8249 0 0 0 0 0 0 0 0 0 0 0 0 13.1494 0 0 0 13.6439 13.254 0 0 0 0 14.5468 14.4134 14.6021 0 0 Q99549 MPP8_HUMAN "M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM, Twa3)" MPHOSPH8 MPP8 Homo sapiens (Human) "negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of DNA methylation [GO:0044030]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of DNA methylation [GO:0044030]" GO:0000786; GO:0000792; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0035064; GO:0044030; GO:0045814; GO:0045869; GO:0045892; GO:0090309 chromatin binding [GO:0003682]; methylated histone binding [GO:0035064] DKSKPDLESSLESLVFDLR 0.9932 -43.7 0 0 0 0 0 0 0 0 0 0 11.7958 0 12.2154 0 11.4588 0 0 0 0 0 0 0 0 0 0 11.202 0 10.2906 0 0 0 0 12.2144 0 0 0 0 0 0 0 0 0 12.5276 0 0 0 0 0 0 12.122 0 0 12.4631 0 0 0 12.0794 0 0 0 0 0 0 0 0 0 0 11.8964 0 0 0 0 0 0 0 0 0 0 0 13.0729 0 13.0426 0 0 0 16.4618 0 0 0 0 0 14.0992 0 0 0 0 0 0 0 0 13.0454 0 0 0 0 0 0 0 0 0 11.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1031 0 0 0 0 0 0 12.0893 12.9885 0 0 0 0 0 0 0 0 0 14.7001 0 0 0 0 0 0 0 0 0 0 0 13.8552 0 11.0746 14.9501 12.4412 12.4852 13.5129 0 0 0 0 0 13.3875 11.5523 0 0 0 0 0 0 0 Q9H3Z7 ABHGB_HUMAN "Protein ABHD16B, EC 3.-.-.- (Alpha/beta hydrolase domain-containing protein 16B, Abhydrolase domain-containing protein 16B)" ABHD16B C20orf135 Homo sapiens (Human) monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] membrane [GO:0016020]; nucleoplasm [GO:0005654] membrane [GO:0016020]; nucleoplasm [GO:0005654]; acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660] GO:0004620; GO:0005654; GO:0006660; GO:0008474; GO:0016020; GO:0047372; GO:0052651 acylglycerol lipase activity [GO:0047372]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620] ALLPLLQQGQER 0.9932 -26.954 0 0 0 0 0 0 0 0 0 14.5485 0 0 0 0 0 12.8447 0 0 0 0 0 0 0 0 0 0 11.2358 0 0 0 12.2527 0 0 0 0 10.5005 13.3071 0 0 0 0 0 0 0 0 0 0 0 13.3089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6713 0 0 13.1533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2446 0 0 11.1883 0 0 0 0 0 0 0 0 0 0 0 13.5836 12.6549 0 0 0 11.0997 0 0 0 0 0 0 0 0 0 0 0 13.6798 0 12.8601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2421 0 0 0 0 0 0 0 0 0 0 0 10.2751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQV5 PRD11_HUMAN "PR domain-containing protein 11, EC 2.1.1.-" PRDM11 PFM8 Homo sapiens (Human) "methylation [GO:0032259]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]" GO:0003682; GO:0005634; GO:0005829; GO:0008168; GO:0010468; GO:0030308; GO:0032259; GO:0043408; GO:0045892; GO:0045893; GO:0051726; GO:2000271 chromatin binding [GO:0003682]; methyltransferase activity [GO:0008168] ACLRCSPLFLYQR 0.9932 -13.432 0 0 0 0 0 0 0 0 0 0 0 0 11.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.706 0 0 0 0 0 0 0 10.1621 0 0 0 14.0706 13.2975 0 0 13.8444 0 0 0 0 0 10.8701 0 0 0 0 12.8033 13.3912 0 0 13.9991 10.4829 0 16.2225 0 0 0 12.363 0 0 12.7941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14241 ELOA1_HUMAN "Elongin-A, EloA (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3)" ELOA TCEB3 MSTP059 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] elongin complex [GO:0070449]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734] elongin complex [GO:0070449]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0005615; GO:0005654; GO:0006357; GO:0006367; GO:0006368; GO:0070449; GO:0090734 DLVAQWK 0.99321 -39.722 0 0 0 0 0 0 0 0 11.324 0 13.8309 0 0 0 0 0 0 0 0 0 14.992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6946 14.5621 0 12.1229 0 0 0 10.7863 0 0 17.9521 0 0 0 0 0 0 0 13.8346 17.9909 0 0 0 0 0 0 0 12.1123 18.4881 0 0 0 18.4594 18.4463 18.4463 17.8539 0 12.9231 0 0 0 12.8171 17.8769 0 0 0 13.1314 0 0 0 0 0 17.0456 0 0 0 0 0 0 0 0 0 12.7245 0 17.1023 0 0 14.2524 13.0636 0 17.8823 0 0 17.9515 0 0 0 0 0 0 0 0 12.9948 0 0 0 0 0 0 17.0935 0 13.1442 0 0 0 13.6141 0 0 O00481 BT3A1_HUMAN Butyrophilin subfamily 3 member A1 (CD antigen CD277) BTN3A1 BTF5 Homo sapiens (Human) activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; positive regulation of cytokine production [GO:0001819]; positive regulation of interferon-gamma production [GO:0032729]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0001819; GO:0002250; GO:0005102; GO:0005886; GO:0009897; GO:0016021; GO:0032729; GO:0050798; GO:0050852 signaling receptor binding [GO:0005102] FNWHYCVLGCESFISGRHYWEVEVGDR 0.99321 -6.6022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3887 0 0 0 0 0 0 11.417 11.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60711 LPXN_HUMAN Leupaxin LPXN LDLP Homo sapiens (Human) cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell adhesion [GO:0007162]; protein-containing complex assembly [GO:0065003]; regulation of cell adhesion mediated by integrin [GO:0033628]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0002102; GO:0003712; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007155; GO:0007162; GO:0007165; GO:0007179; GO:0016020; GO:0016607; GO:0033628; GO:0034446; GO:0042995; GO:0043542; GO:0046872; GO:0048471; GO:0050859; GO:0065003 metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] ESPPPSK 0.99321 -9.2124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3424 0 0 0 0 0 0 0 0 0 0 10.456 0 0 0 0 0 0 0 0 0 0 0 0 12.22 0 0 0 0 11.277 0 0 0 0 0 15.2425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.955 0 0 0 0 0 0 0 0 0 0 0 0 0 12.193 0 0 9.90038 13.0774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5471 0 0 0 0 0 0 0 0 0 0 0 0 11.6704 0 0 0 0 0 P23588 IF4B_HUMAN "Eukaryotic translation initiation factor 4B, eIF-4B" EIF4B Homo sapiens (Human) eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446] GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0016281; GO:0033592; GO:0034057; GO:0043024; GO:0097010 ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743] DDYRRDDR 0.99321 -16.1 0 0 0 0 0 11.2805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8345 0 0 0 0 0 0 0 0 0 0 0 10.6175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1222 0 0 11.2528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1019 0 13.1767 0 0 0 0 12.339 0 0 0 0 0 0 0 12.497 0 0 0 0 0 0 0 0 0 0 11.5552 0 0 0 0 0 0 0 0 0 0 0 0 15.4046 0 0 0 0 0 12.5281 0 0 0 0 0 0 0 0 0 12.0657 12.1092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0323 0 0 0 0 0 P49638 TTPA_HUMAN "Alpha-tocopherol transfer protein, Alpha-TTP" TTPA TPP1 Homo sapiens (Human) embryonic placenta development [GO:0001892]; intermembrane lipid transfer [GO:0120009]; lipid metabolic process [GO:0006629]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of amyloid-beta clearance [GO:1900223]; response to toxic substance [GO:0009636]; vitamin E metabolic process [GO:0042360]; vitamin transport [GO:0051180] cytosol [GO:0005829]; late endosome [GO:0005770] "cytosol [GO:0005829]; late endosome [GO:0005770]; lipid transfer activity [GO:0120013]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; vitamin E binding [GO:0008431]; embryonic placenta development [GO:0001892]; intermembrane lipid transfer [GO:0120009]; lipid metabolic process [GO:0006629]; negative regulation of establishment of blood-brain barrier [GO:0090212]; positive regulation of amyloid-beta clearance [GO:1900223]; response to toxic substance [GO:0009636]; vitamin E metabolic process [GO:0042360]; vitamin transport [GO:0051180]" GO:0001892; GO:0005546; GO:0005770; GO:0005829; GO:0006629; GO:0008431; GO:0009636; GO:0042360; GO:0043325; GO:0051180; GO:0090212; GO:0120009; GO:0120013; GO:1900223; GO:1902936 "lipid transfer activity [GO:0120013]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; vitamin E binding [GO:0008431]" ARDFDLDLAWR 0.99321 -16.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2406 0 13.1574 0 0 0 0 0 0 12.1242 13.5548 0 12.3046 0 0 0 13.1414 0 0 12.8557 0 0 0 0 0 0 0 0 13.3319 0 0 11.4165 11.8048 0 0 0 13.5785 0 0 0 0 0 0 0 0 11.7104 0 0 0 0 0 0 0 14.4092 0 0 0 0 0 0 14.7172 0 0 0 0 0 13.5105 0 0 13.3154 15.1857 13.4746 0 0 11.1066 0 0 0 11.2271 12.5446 13.0438 0 0 0 0 0 0 0 0 0 12.8615 0 12.7041 0 0 0 0 0 0 0 0 11.9773 0 0 0 0 0 0 0 0 13.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9348 0 12.1404 0 0 13.1726 0 0 14.432 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0813 0 0 0 12.202 0 0 0 11.9726 0 0 0 14.714 0 12.7166 0 0 0 0 P62280 RS11_HUMAN 40S ribosomal protein S11 (Small ribosomal subunit protein uS17) RPS11 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0070062 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] DYLHYIRK 0.99321 -7.9352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5287 0 0 0 0 0 12.4565 0 0 0 0 0 0 10.6128 0 0 0 0 0 0 0 0 0 0 9.76835 0 0 0 0 0 0 0 12.7927 0 0 0 0 14.4936 0 0 21.134 0 10.5207 0 0 0 0 0 16.0496 0 0 0 13.7616 0 11.6168 0 0 0 0 14.5731 0 0 0 11.2008 0 0 15.0692 0 0 16.643 0 0 0 0 0 14.1005 0 14.6441 0 0 12.782 0 0 0 0 0 11.2818 0 0 0 0 13.8551 0 0 10.9417 0 0 0 0 0 0 0 0 0 0 0 13.1887 0 0 0 0 14.4845 0 0 0 0 0 13.0527 0 13.311 0 14.4851 0 0 0 0 0 0 13.731 0 0 0 9.89768 0 0 Q13185 CBX3_HUMAN "Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma, HP1 gamma) (Modifier 2 protein)" CBX3 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; site of DNA damage [GO:0090734]; spindle [GO:0005819]" "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; site of DNA damage [GO:0090734]; spindle [GO:0005819]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; heterochromatin assembly [GO:0031507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" GO:0000122; GO:0000775; GO:0000779; GO:0000781; GO:0000785; GO:0000791; GO:0000792; GO:0001221; GO:0003682; GO:0005634; GO:0005635; GO:0005637; GO:0005654; GO:0005721; GO:0005819; GO:0006325; GO:0006338; GO:0006974; GO:0019899; GO:0019904; GO:0031507; GO:0035064; GO:0042802; GO:0045892; GO:0048511; GO:0061793; GO:0090575; GO:0090734; GO:1990226 chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221] GFARGLDPER 0.99321 -6.5894 0 0 0 0 0 0 0 11.3895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4116 0 0 0 0 0 0 0 0 0 0 0 0 12.6164 0 0 0 0 0 12.669 0 0 0 0 14.2133 0 14.1521 0 0 10.8862 10.6644 0 0 12.3643 0 0 0 0 0 0 0 0 13.008 12.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7442 0 0 0 0 12.8646 0 0 0 0 0 0 0 Q15326 ZMY11_HUMAN Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69) ZMYND11 BRAM1 BS69 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of signal transduction [GO:0009966]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of signal transduction [GO:0009966]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" GO:0003690; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0008270; GO:0009966; GO:0034243; GO:0035064; GO:0043124; GO:0045892; GO:0046329; GO:0051607; GO:2001237 double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] FFGHHHQR 0.99321 -39.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6081 13.4705 0 0 0 0 0 0 0 15.8947 16.4767 15.9088 0 0 0 0 0 0 0 0 13.026 0 13.0803 12.957 13.4761 15.5034 14.6346 0 14.3591 0 13.493 12.4652 0 15.8999 15.3689 16.0287 0 13.7046 0 15.4302 12.7153 13.8443 14.3523 15.3774 15.8746 12.1053 0 0 15.3907 14.812 0 0 13.9236 0 15.7317 0 11.9646 12.4669 0 0 0 0 15.5391 12.2901 14.2241 0 13.4451 12.8729 0 0 10.6858 0 0 12.5964 0 0 13.7855 0 0 0 0 0 10.9826 14.0475 14.7752 16.2537 15.6243 0 0 0 0 0 0 13.3014 0 0 12.5318 0 0 0 0 0 12.6464 12.0181 14.0378 0 0 0 0 0 0 Q5VXH4 PRAM6_HUMAN PRAME family member 6 PRAMEF6 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]" Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737] "Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]" GO:0005737; GO:0008284; GO:0016567; GO:0031462; GO:0043066; GO:0043161; GO:0045596; GO:0045892; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] AELMKRVR 0.99321 -13.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0999 0 11.0621 0 0 0 0 0 0 0 0 0 10.4482 0 0 0 12.0385 0 0 0 0 0 0 0 0 11.4847 0 9.29614 0 0 0 0 0 0 0 0 0 0 0 0 10.2164 10.4107 11.0511 9.95719 0 10.2033 0 0 12.0407 0 0 0 0 0 13.2206 12.9156 0 0 0 0 10.8738 11.351 0 0 0 11.978 0 0 10.3296 0 0 0 0 0 0 0 11.8728 12.4107 0 12.4216 0 10.8943 12.8201 11.1275 0 0 10.3 11.7737 11.9728 0 0 0 10.7546 0 0 12.2244 0 0 11.5135 12.6463 12.413 0 0 0 0 11.9729 0 0 11.0862 0 0 0 0 0 12.3712 0 0 11.7661 0 0 10.0473 12.7293 0 10.3224 0 0 0 0 0 11.6971 0 13.8493 0 0 10.5351 0 0 11.6651 0 0 0 0 0 0 0 0 0 0 0 10.8503 0 0 12.084 0 0 0 11.9904 0 0 0 0 11.8044 Q6VY07 PACS1_HUMAN "Phosphofurin acidic cluster sorting protein 1, PACS-1" PACS1 KIAA1175 Homo sapiens (Human) protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; transmembrane transporter binding [GO:0044325]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659] GO:0005794; GO:0005829; GO:0030137; GO:0034067; GO:0044325; GO:0072659 transmembrane transporter binding [GO:0044325] ERQLSKPLSER 0.99321 -6.2152 0 0 0 0 15.2864 0 0 0 0 13.7933 13.3082 0 0 13.5061 0 0 0 13.8569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7847 0 0 0 0 0 0 0 14.0405 0 13.1957 12.6244 12.8757 13.0982 12.7636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0255 0 0 0 0 0 0 14.8636 0 0 0 0 0 12.7214 0 0 13.5139 13.7635 12.9004 13.6 0 0 0 0 0 0 0 0 0 13.4433 0 14 0 0 13.9398 0 0 0 0 0 0 19.4224 10.9094 0 0 0 0 0 0 12.5767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2342 0 0 0 0 0 0 0 0 0 0 Q86YF9 DZIP1_HUMAN Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1) DZIP1 DZIP DZIP2 KIAA0996 Homo sapiens (Human) ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; maintenance of protein location in cell [GO:0032507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; regulation of protein binding [GO:0043393]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; BBSome binding [GO:0062063]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; maintenance of protein location in cell [GO:0032507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; regulation of protein binding [GO:0043393]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283] GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0016607; GO:0032053; GO:0032507; GO:0034451; GO:0036064; GO:0043231; GO:0043393; GO:0045184; GO:0045724; GO:0046872; GO:0051220; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566 BBSome binding [GO:0062063]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090] AYASPGPLPVPPPQNK 0.99321 -39.731 0 0 0 0 0 0 0 0 0 0 0 0 17.9137 0 0 0 0 0 0 0 0 0 0 0 12.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8466 0 0 12.5097 0 0 0 0 13.4507 0 0 0 0 0 0 0 0 13.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6127 0 0 0 0 12.8549 0 0 11.7282 12.9148 13.0724 0 Q8IUQ4 SIAH1_HUMAN "E3 ubiquitin-protein ligase SIAH1, EC 2.3.2.27 (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1, Siah-1) (Siah-1a)" SIAH1 HUMSIAH Homo sapiens (Human) amyloid fibril formation [GO:1990000]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cell cycle [GO:0007049]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; amyloid fibril formation [GO:1990000]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cell cycle [GO:0007049]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0007049; GO:0007283; GO:0007399; GO:0007411; GO:0008022; GO:0008270; GO:0009653; GO:0030163; GO:0030877; GO:0031624; GO:0042802; GO:0043065; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:1990000; GO:2001244 identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ADHEELCEFR 0.99321 -6.2195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5867 0 12.8951 0 0 0 0 0 0 0 11.0407 0 0 0 0 0 0 0 0 0 0 13.0109 0 11.0353 13.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG66 NEK11_HUMAN "Serine/threonine-protein kinase Nek11, EC 2.7.11.1 (Never in mitosis A-related kinase 11, NimA-related protein kinase 11)" NEK11 Homo sapiens (Human) chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990] GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006468; GO:0007059; GO:0016572; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EAAHIINAMQK 0.99321 -5.511 0 0 0 14.1981 0 0 0 0 0 0 0 10.8604 13.0613 0 0 0 0 0 16.9607 0 16.8422 15.9589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4138 0 0 0 13.5425 14.299 17.1976 0 17.5456 17.4414 0 0 0 0 0 0 15.8279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5715 13.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5628 0 0 0 0 0 0 0 14.6801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.465 Q8WXE0 CSKI2_HUMAN Caskin-2 (CASK-interacting protein 2) CASKIN2 KIAA1139 Homo sapiens (Human) cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020] GO:0005737; GO:0016020 EGATGPR 0.99321 -16.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9003 0 0 0 0 0 13.3366 0 0 0 0 0 0 0 11.1459 0 0 0 0 12.997 0 12.3285 0 0 0 11.93 14.175 0 0 0 14.4754 16.0423 0 0 0 14.0118 0 14.6189 0 0 0 9.5228 0 13.0739 0 0 0 0 0 13.989 0 0 9.96982 0 0 0 0 0 0 0 12.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3984 0 0 0 0 14.0907 0 0 0 0 0 0 0 0 0 0 0 0 13.9946 0 0 0 0 0 13.5665 0 0 Q96EP5 DAZP1_HUMAN DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1) DAZAP1 Homo sapiens (Human) "cell differentiation [GO:0030154]; fibroblast proliferation [GO:0048144]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; cell differentiation [GO:0030154]; fibroblast proliferation [GO:0048144]; maternal placenta development [GO:0001893]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; spermatogenesis [GO:0007283]" GO:0001673; GO:0001893; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007283; GO:0008266; GO:0030154; GO:0032991; GO:0034046; GO:0035613; GO:0048026; GO:0048144; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613] GFGFVKFK 0.99321 -6.4045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0322 0 0 10.699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1936 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3507 0 0 0 0 14.8046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0299 13.229 0 0 0 12.9382 0 0 0 0 0 0 0 0 0 0 12.8994 0 12.9456 0 0 0 0 0 0 12.2139 0 0 0 0 16.7249 13.7703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6721 0 0 0 0 10.9157 12.8986 0 0 0 0 0 10.2435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0906 0 0 0 0 16.4113 0 0 0 0 0 0 0 0 0 0 0 12.6364 12.8892 0 11.7299 0 0 0 0 0 0 0 Q96MW7 TIGD1_HUMAN Tigger transposable element-derived protein 1 TIGD1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] CSSERKSR 0.99321 -7.9453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P53 WDFY2_HUMAN "WD repeat and FYVE domain-containing protein 2 (Propeller-FYVE protein, Prof) (WD40- and FYVE domain-containing protein 2) (Zinc finger FYVE domain-containing protein 22)" WDFY2 WDF2 ZFYVE22 Homo sapiens (Human) positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934] early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982] early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934] GO:0001934; GO:0005769; GO:0031982; GO:0043231; GO:0045600; GO:0046872 metal ion binding [GO:0046872] DSGQYWPSVYHAMPSPCSCMSFNPETRR 0.99321 -6.5928 0 0 12.7854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2357 0 0 0 0 10.8752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0084 0 0 0 0 0 0 0 0 11.4342 0 0 0 0 0 0 11.5872 0 0 0 0 0 0 0 0 0 0 0 12.7975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2379 0 12.3618 0 13.1239 0 0 0 0 0 0 0 0 0 0 Q96RI8 TAAR6_HUMAN "Trace amine-associated receptor 6, TaR-6, Trace amine receptor 6 (Trace amine receptor 4, TaR-4)" TAAR6 TA4 TAR4 TRAR4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594] KAIKVIVTGQVLK 0.99321 -5.1352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.906 0 0 0 0 0 0 0 0 0 0 11.9533 0 0 12.2587 13.4077 0 0 0 13.2316 12.9028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0291 0 0 0 0 12.3601 0 0 0 0 13.0378 0 0 0 0 0 0 0 0 0 0 0 14.9187 0 0 13.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0799 0 0 0 0 0 13.3779 13.7312 12.763 0 11.6669 0 0 11.3375 0 0 0 Q9H2S6 TNMD_HUMAN "Tenomodulin, TeM, hTeM (Chondromodulin-1-like protein, ChM1L, hChM1L) (Chondromodulin-I-like protein) (Myodulin) (Tendin)" TNMD CHM1L UNQ771/PRO1565 Homo sapiens (Human) endothelial cell morphogenesis [GO:0001886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; endothelial cell morphogenesis [GO:0001886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937] GO:0001886; GO:0001937; GO:0005635; GO:0005737; GO:0016021; GO:0016525 GNRYCRR 0.99321 -9.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P209 CEP72_HUMAN "Centrosomal protein of 72 kDa, Cep72" CEP72 KIAA1519 Homo sapiens (Human) centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051] GO:0005654; GO:0005739; GO:0005813; GO:0005829; GO:0007051; GO:0007099; GO:0033566; GO:0034451; GO:1904779 AEVEQMHWSYQELK 0.99321 -14.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.499 0 0 0 0 0 0 0 0 0 0 13.2047 0 13.0343 12.1389 0 12.9311 14.4301 14.521 0 0 12.6984 0 14.3224 0 12.1883 0 12.6122 0 12.7412 0 0 12.4595 11.3274 0 0 0 14.4016 12.6154 12.5397 0 13.4227 12.7437 0 0 0 0 0 0 0 0 0 12.0402 13.2089 0 0 0 14.6721 0 0 12.3098 12.5774 12.5375 0 13.366 0 0 0 14.1328 0 13.9493 0 0 0 0 0 0 0 0 0 0 11.9784 0 0 0 0 12.4922 12.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4029 0 0 0 0 0 0 0 0 0 0 0 0 F5H4B4 F227A_HUMAN Protein FAM227A FAM227A Homo sapiens (Human) ALREKTR 0.99322 -14.669 0 0 0 0 0 0 0 0 0 0 12.9987 12.4473 0 0 12.1335 11.9994 12.272 12.3718 0 0 12.1869 0 0 0 0 12.0072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6239 0 0 0 12.0592 13.5341 0 12.2464 0 12.3517 0 0 0 12.015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9953 0 0 12.1275 0 0 0 0 0 0 0 0 0 0 0 13.1831 0 0 0 0 11.632 0 0 0 0 0 0 0 0 0 12.1586 0 0 0 0 0 0 0 0 0 0 0 11.6212 0 13.0514 0 0 0 0 13.7741 0 10.4714 0 0 0 0 0 0 0 0 12.87 0 0 15.4685 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3225 0 0 0 0 0 0 0 14.3515 0 0 0 0 0 0 0 0 14.4667 0 13.8201 11.1978 0 14.2459 0 0 0 0 14.1057 0 0 0 0 O00232 PSD12_HUMAN 26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55) PSMD12 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear proteasome complex [GO:0031595]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005576; GO:0005654; GO:0005737; GO:0005829; GO:0005838; GO:0008541; GO:0016020; GO:0022624; GO:0031595; GO:0034774; GO:0043161; GO:0070062; GO:1904813 ARLTKTLATIK 0.99322 -16.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6798 0 0 0 0 0 0 0 0 0 0 0 18.2882 0 0 0 0 0 0 0 0 0 0 0 15.8423 0 16.0131 0 0 16.3234 0 0 0 0 15.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0221 0 0 0 0 0 0 0 0 0 0 0 0 18.0464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.893 0 O15060 ZBT39_HUMAN Zinc finger and BTB domain-containing protein 39 ZBTB39 KIAA0352 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AMPCQVCK 0.99322 -6.6223 0 0 0 0 11.8484 0 0 0 0 10.9093 0 0 0 0 0 0 0 0 0 0 10.3349 0 0 0 0 0 0 0 0 13.2362 0 0 0 0 0 0 0 0 12.546 0 0 0 9.38922 0 0 0 12.3865 0 0 0 0 0 0 12.0935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1394 0 0 0 0 0 0 0 0 0 0 13.2367 13.7171 0 0 0 0 0 0 0 0 0 0 14.2112 12.5635 0 0 0 0 0 14.2816 12.0713 0 0 0 0 0 0 0 12.5002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3366 12.3265 0 0 0 13.6763 0 0 0 0 0 0 13.9989 0 12.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1489 0 0 0 0 0 12.0712 0 0 12.2193 0 0 12.9689 12.0075 O95263 PDE8B_HUMAN "High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B, HsPDE8B, EC 3.1.4.53 (Cell proliferation-inducing gene 22 protein)" PDE8B PIG22 Homo sapiens (Human) behavioral fear response [GO:0001662]; cAMP catabolic process [GO:0006198]; negative regulation of steroid hormone biosynthetic process [GO:0090032]; neuromuscular process controlling balance [GO:0050885]; operant conditioning [GO:0035106]; signal transduction [GO:0007165]; visual learning [GO:0008542] cytosol [GO:0005829] "cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; behavioral fear response [GO:0001662]; cAMP catabolic process [GO:0006198]; negative regulation of steroid hormone biosynthetic process [GO:0090032]; neuromuscular process controlling balance [GO:0050885]; operant conditioning [GO:0035106]; signal transduction [GO:0007165]; visual learning [GO:0008542]" GO:0001662; GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0008542; GO:0035106; GO:0046872; GO:0050885; GO:0090032 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" CNIFKNIDR 0.99322 -14.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4223 0 0 0 0 11.3668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7418 0 0 0 0 0 0 12.1317 12.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5175 0 12.9528 15.0647 0 0 0 0 12.7927 12.0612 0 0 0 0 0 0 13.1248 12.6603 0 0 0 0 12.8101 0 0 0 12.833 0 0 0 0 10.1306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3596 13.3429 0 0 0 0 0 0 0 P08254 MMP3_HUMAN "Stromelysin-1, SL-1, EC 3.4.24.17 (Matrix metalloproteinase-3, MMP-3) (Transin-1)" MMP3 STMY1 Homo sapiens (Human) cellular response to nitric oxide [GO:0071732]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; positive regulation of oxidative stress-induced cell death [GO:1903209]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; cellular response to nitric oxide [GO:0071732]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; positive regulation of oxidative stress-induced cell death [GO:1903209]; positive regulation of protein-containing complex assembly [GO:0031334]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645] GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0010727; GO:0022617; GO:0030198; GO:0030574; GO:0031012; GO:0031334; GO:0071492; GO:0071732; GO:0150077; GO:1903209; GO:1904645 endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] DSGPVVK 0.99322 -26.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6154 0 0 0 0 0 0 0 0 12.4952 0 0 0 0 0 0 0 0 0 0 0 0 11.4004 0 10.8933 0 0 0 0 14.7717 0 0 0 0 0 0 0 0 0 0 12.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1235 0 0 0 0 0 0 0 P0C875 F228B_HUMAN Protein FAM228B FAM228B Homo sapiens (Human) RRQGELDGFLK 0.99322 -16.591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4725 0 9.34047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87015 0 0 0 0 0 0 0 0 0 11.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0334 0 0 10.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7042 0 0 0 0 0 0 0 0 0 0 P14222 PERF_HUMAN "Perforin-1, P1 (Cytolysin) (Lymphocyte pore-forming protein, PFP)" PRF1 PFP Homo sapiens (Human) apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; cytolysis [GO:0019835]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; immune response to tumor cell [GO:0002418]; immunological synapse formation [GO:0001771]; positive regulation of killing of cells of another organism [GO:0051712]; protein homooligomerization [GO:0051260]; T cell mediated cytotoxicity [GO:0001913] cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; wide pore channel activity [GO:0022829]; apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; cytolysis [GO:0019835]; defense response to tumor cell [GO:0002357]; defense response to virus [GO:0051607]; immune response to tumor cell [GO:0002418]; immunological synapse formation [GO:0001771]; positive regulation of killing of cells of another organism [GO:0051712]; protein homooligomerization [GO:0051260]; T cell mediated cytotoxicity [GO:0001913] GO:0001771; GO:0001913; GO:0002357; GO:0002418; GO:0005509; GO:0005576; GO:0005829; GO:0005886; GO:0006915; GO:0006968; GO:0016020; GO:0016021; GO:0019835; GO:0022829; GO:0031904; GO:0042802; GO:0044194; GO:0051260; GO:0051607; GO:0051712 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; wide pore channel activity [GO:0022829] AARLLLLGILLLLLPLPVPAPCHTAAR 0.99322 -14.667 0 0 0 0 0 0 11.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4489 0 0 0 0 0 0 0 0 12.2095 0 0 0 0 0 0 14.3298 0 12.3054 0 0 13.5774 12.3387 0 0 0 13.0316 0 0 0 0 0 0 16.0643 0 12.8274 0 0 0 0 0 0 0 0 13.4239 0 0 11.2259 0 0 0 16.1335 16.26 0 0 0 0 0 0 13.0774 13.245 0 0 0 0 0 0 0 0 0 0 0 0 14.4915 14.1169 14.6936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3809 0 15.972 0 14.2584 0 P17028 ZNF24_HUMAN "Zinc finger protein 24 (Retinoic acid suppression protein A, RSG-A) (Zinc finger and SCAN domain-containing protein 3) (Zinc finger protein 191) (Zinc finger protein KOX17)" ZNF24 KOX17 ZNF191 ZSCAN3 Homo sapiens (Human) "myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0042552; GO:0042802; GO:0043565; GO:0045892; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" ELCRLWLR 0.99322 -26.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.578 0 0 0 0 0 0 0 0 0 0 15.3706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8966 0 0 13.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4493 0 0 12.851 0 0 0 0 0 0 0 0 12.6809 13.6479 0 0 0 0 0 0 0 0 0 P20839 IMDH1_HUMAN "Inosine-5'-monophosphate dehydrogenase 1, IMP dehydrogenase 1, IMPD 1, IMPDH 1, EC 1.1.1.205 (IMPDH-I)" IMPDH1 IMPD1 Homo sapiens (Human) GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183] GO:0000166; GO:0003676; GO:0003677; GO:0003723; GO:0003938; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0006177; GO:0006183; GO:0034774; GO:0035578; GO:0042802; GO:0046872; GO:1904813 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723] DHTTLLSEVMTPRIELVVAPAGVTLK 0.99322 -16.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.28 0 0 10.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6319 0 13.0925 P28906 CD34_HUMAN Hematopoietic progenitor cell antigen CD34 (CD antigen CD34) CD34 Homo sapiens (Human) cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; endothelium development [GO:0003158]; extracellular exosome assembly [GO:0071971]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; mesangial cell-matrix adhesion [GO:0035759]; metanephric glomerular mesangial cell differentiation [GO:0072254]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular response to heat [GO:1900035]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of neuron death [GO:1901215]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of tumor necrosis factor production [GO:0032720]; paracrine signaling [GO:0038001]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of odontogenesis [GO:0042482]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; transdifferentiation [GO:0060290]; vascular wound healing [GO:0061042] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; glomerular endothelium fenestra [GO:0036053]; integral component of plasma membrane [GO:0005887]; intercellular bridge [GO:0045171]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; glomerular endothelium fenestra [GO:0036053]; integral component of plasma membrane [GO:0005887]; intercellular bridge [GO:0045171]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sulfate binding [GO:0043199]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; endothelial cell proliferation [GO:0001935]; endothelium development [GO:0003158]; extracellular exosome assembly [GO:0071971]; glomerular endothelium development [GO:0072011]; glomerular filtration [GO:0003094]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; leukocyte migration [GO:0050900]; mesangial cell-matrix adhesion [GO:0035759]; metanephric glomerular mesangial cell differentiation [GO:0072254]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular response to heat [GO:1900035]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of neuron death [GO:1901215]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of tumor necrosis factor production [GO:0032720]; paracrine signaling [GO:0038001]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of odontogenesis [GO:0042482]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; stem cell proliferation [GO:0072089]; tissue homeostasis [GO:0001894]; transdifferentiation [GO:0060290]; vascular wound healing [GO:0061042] GO:0001894; GO:0001935; GO:0003094; GO:0003158; GO:0005737; GO:0005764; GO:0005886; GO:0005887; GO:0007160; GO:0007165; GO:0008217; GO:0009897; GO:0009925; GO:0010628; GO:0010629; GO:0016324; GO:0030097; GO:0030195; GO:0030246; GO:0032703; GO:0032720; GO:0032733; GO:0035759; GO:0036053; GO:0038001; GO:0042482; GO:0043199; GO:0045019; GO:0045171; GO:0045766; GO:0048471; GO:0048870; GO:0050900; GO:0060290; GO:0061042; GO:0061629; GO:0071425; GO:0071636; GO:0071657; GO:0071971; GO:0072011; GO:0072089; GO:0072254; GO:0098609; GO:1900035; GO:1900038; GO:1900168; GO:1901215; GO:2001214 carbohydrate binding [GO:0030246]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sulfate binding [GO:0043199] GARAGPR 0.99322 -27.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4834 12.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6957 0 0 0 0 0 0 0 0 16.8812 0 0 0 0 13.2005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7952 0 0 0 0 0 0 0 10.8479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.797 0 0 0 10.5529 0 0 0 11.8384 0 0 0 0 0 10.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40306 PSB10_HUMAN "Proteasome subunit beta type-10, EC 3.4.25.1 (Low molecular mass protein 10) (Macropain subunit MECl-1) (Multicatalytic endopeptidase complex subunit MECl-1) (Proteasome MECl-1) (Proteasome subunit beta-2i)" PSMB10 LMP10 MECL1 Homo sapiens (Human) cell morphogenesis [GO:0000902]; humoral immune response [GO:0006959]; proteasomal protein catabolic process [GO:0010498]; T cell proliferation [GO:0042098] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; spermatoproteasome complex [GO:1990111]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; cell morphogenesis [GO:0000902]; humoral immune response [GO:0006959]; proteasomal protein catabolic process [GO:0010498]; T cell proliferation [GO:0042098]" GO:0000502; GO:0000902; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005829; GO:0005839; GO:0006959; GO:0010498; GO:0019774; GO:0042098; GO:1990111 endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298] IHFIAPK 0.99322 -16.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8582 0 0 0 0 0 0 0 0 13.7834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2806 9.92898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48048 KCNJ1_HUMAN "ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium channel, inwardly rectifying subfamily J member 1)" KCNJ1 ROMK1 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765]" GO:0005242; GO:0005524; GO:0005546; GO:0005886; GO:0015272; GO:0016021; GO:0034765; GO:1990573 "ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" DGRCNIEFGNVEAQSRFIFFVDIWTTVLDLK 0.99322 -16.594 0 0 0 0 0 0 11.4923 0 0 0 0 0 12.4882 0 0 0 0 0 0 0 0 0 0 11.3125 0 0 0 0 0 0 0 0 0 0 11.5359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4077 0 0 0 0 0 0 0 0 0 0 0 12.7832 0 0 0 11.9423 0 0 0 12.1245 0 0 0 12.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1621 0 0 0 11.6546 13.4107 0 0 13.471 13.52 0 0 0 12.2819 0 13.7692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7002 0 0 0 0 0 0 P62841 RS15_HUMAN 40S ribosomal protein S15 (RIG protein) (Small ribosomal subunit protein uS19) RPS15 RIG Homo sapiens (Human) cytoplasmic translation [GO:0002181]; osteoblast differentiation [GO:0001649]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cytoplasmic translation [GO:0002181]; osteoblast differentiation [GO:0001649]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0000028; GO:0000056; GO:0001649; GO:0002181; GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0016020; GO:0022626; GO:0022627; GO:0042274; GO:0097371; GO:1901798; GO:1990948 DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] KFTYRGVDLDQLLDMSYEQLMQLYSAR 0.99322 -5.5165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4119 0 0 0 0 0 0 0 0 0 0 0 0 Q14195 DPYL3_HUMAN "Dihydropyrimidinase-related protein 3, DRP-3 (Collapsin response mediator protein 4, CRMP-4) (Unc-33-like phosphoprotein 1, ULIP-1)" DPYSL3 CRMP4 DRP3 ULIP ULIP1 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of neuron projection development [GO:0010976]; response to axon injury [GO:0048678] cell body [GO:0044297]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; synapse [GO:0045202] "cell body [GO:0044297]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; synapse [GO:0045202]; chondroitin sulfate binding [GO:0035374]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; cellular response to cytokine stimulus [GO:0071345]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron projection development [GO:0010977]; neuron development [GO:0048666]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of neuron projection development [GO:0010976]; response to axon injury [GO:0048678]" GO:0005615; GO:0005829; GO:0010976; GO:0010977; GO:0016810; GO:0017124; GO:0030027; GO:0030336; GO:0030426; GO:0031005; GO:0031941; GO:0035374; GO:0042802; GO:0044297; GO:0045202; GO:0048666; GO:0048678; GO:0051017; GO:0051491; GO:0051764; GO:0070382; GO:0071345 "chondroitin sulfate binding [GO:0035374]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]" FIPCSPFSDYVYKR 0.99322 -16.627 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.496 0 13.5929 0 0 0 0 0 0 10.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7481 0 0 0 0 0 0 0 0 0 0 14.0211 16.1625 0 13.502 14.9629 13.0658 0 0 16.7771 12.9439 14.5358 0 0 12.8971 16.4596 0 0 0 0 0 12.0239 0 0 0 10.9287 0 0 0 0 0 0 11.3421 0 0 0 0 0 0 0 0 0 12.9465 0 0 0 0 0 0 0 9.88883 0 0 0 0 0 0 0 0 0 0 0 14.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9199 Q4ZG55 GREB1_HUMAN Protein GREB1 (Gene regulated in breast cancer 1 protein) GREB1 KIAA0575 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] GO:0005654; GO:0016021; GO:0070062 AEGRVDGFHPR 0.99322 -13.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6032 9.78238 0 0 0 0 0 0 12.8583 0 12.6398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3371 0 0 12.0702 0 0 0 0 0 0 0 0 13.6923 13.3392 11.5199 0 0 0 0 0 0 0 12.4166 0 0 0 0 13.4809 0 0 0 0 0 0 0 13.6784 0 10.7823 14.2117 9.47216 0 0 0 0 0 0 14.6488 0 0 0 0 0 0 0 0 11.2358 0 0 11.2509 0 0 0 0 0 0 0 13.893 0 0 12.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1728 0 13.4372 0 0 0 0 0 Q6DHV5 C2D2B_HUMAN Protein CC2D2B CC2D2B C10orf130 C10orf131 Homo sapiens (Human) non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491] ciliary transition zone [GO:0035869] ciliary transition zone [GO:0035869]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491] GO:0035869; GO:1904491; GO:1905515 ALVLLGTSVLEGHVAYVVTQETNEYLLWNPSTGQCYK 0.99322 -27.285 0 0 12.2464 0 0 11.2432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78749 9.59505 0 0 0 0 13.4108 13.3602 0 0 0 0 0 12.3607 12.8758 0 12.6964 18.2298 0 13.3454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1221 0 14.5807 0 0 0 13.5834 0 11.3884 14.3558 0 10.8672 11.9507 0 0 0 12.7961 0 0 0 0 0 0 0 11.8467 0 0 10.634 0 0 0 0 0 0 0 0 0 0 10.6541 0 0 11.6304 13.4112 0 0 0 0 0 0 14.4042 0 0 0 11.6778 0 0 13.928 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7396 0 0 0 11.4266 0 0 13.9191 8.94486 0 Q6IV72 ZN425_HUMAN Zinc finger protein 425 ZNF425 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0045892; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AHLCLHSGER 0.99322 -26.169 0 0 0 0 0 0 0 0 0 0 0 0 0 10.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0889 0 12.8257 0 0 0 0 11.8509 0 11.7752 0 13.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6462 0 0 14.1434 0 0 11.4088 14.5335 0 0 0 0 0 0 0 0 0 0 0 0 10.4265 0 0 0 0 0 0 0 0 0 0 11.121 0 0 0 0 0 0 0 0 0 0 12.1799 12.4249 0 0 0 10.3289 0 0 16.484 0 0 0 0 0 0 0 12.4503 13.0005 0 0 0 0 0 0 14.0787 0 13.8454 0 0 0 0 0 12.8753 12.794 10.9914 0 0 10.6469 0 0 0 0 0 11.3339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7964 0 0 0 14.8032 0 0 0 0 0 15.3208 Q6ZV89 SH2D5_HUMAN SH2 domain-containing protein 5 SH2D5 Homo sapiens (Human) anchoring junction [GO:0070161]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; postsynaptic density [GO:0014069] GO:0014069; GO:0070161 AVILKFSLQGLK 0.99322 -6.2309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8958 0 0 0 0 0 0 0 0 10.7297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1111 13.7085 0 13.3987 12.9739 13.6961 0 0 0 13.1526 0 0 0 0 0 13.3257 0 0 0 12.5389 10.7388 0 0 0 0 0 0 0 0 12.5019 0 0 12.5816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7464 0 0 0 0 0 0 Q8N344 MIER2_HUMAN "Mesoderm induction early response protein 2, Mi-er2" MIER2 KIAA1193 Homo sapiens (Human) histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0032991; GO:0042826 histone deacetylase binding [GO:0042826]; transcription corepressor activity [GO:0003714] GECEEASR 0.99322 -6.6189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2613 0 0 0 0 0 0 0 13.1117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9108 13.95 0 0 0 0 0 0 10.9492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3C7 CLIP4_HUMAN CAP-Gly domain-containing linker protein 4 (Restin-like protein 2) CLIP4 RSNL2 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; microtubule plus-end binding [GO:0051010]; cytoplasmic microtubule organization [GO:0031122] GO:0005634; GO:0005737; GO:0031122; GO:0035371; GO:0043231; GO:0051010 microtubule plus-end binding [GO:0051010] CEGELRLGERVLVVGQR 0.99322 -16.229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9754 12.5009 13.6708 0 0 0 0 0 0 0 0 0 0 0 0 13.9486 0 0 0 0 0 0 13.3752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92835 SHIP1_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1, EC 3.1.3.86 (Inositol polyphosphate-5-phosphatase D, EC 3.1.3.56) (Inositol polyphosphate-5-phosphatase of 145 kDa, SIP-145) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase, EC 3.1.3.36) (SH2 domain-containing inositol 5'-phosphatase 1, SH2 domain-containing inositol phosphatase 1, SHIP-1) (p150Ship, hp51CN)" INPP5D SHIP SHIP1 Homo sapiens (Human) apoptotic process [GO:0006915]; determination of adult lifespan [GO:0008340]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of bone resorption [GO:0045779]; negative regulation of immune response [GO:0050777]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of signal transduction [GO:0009968]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; determination of adult lifespan [GO:0008340]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of bone resorption [GO:0045779]; negative regulation of immune response [GO:0050777]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of neutrophil differentiation [GO:0045659]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of signal transduction [GO:0009968]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]" GO:0004439; GO:0004445; GO:0005829; GO:0005856; GO:0005886; GO:0006661; GO:0006796; GO:0006915; GO:0007165; GO:0008340; GO:0009966; GO:0009968; GO:0016064; GO:0016314; GO:0017124; GO:0030889; GO:0032715; GO:0034485; GO:0035556; GO:0043065; GO:0045121; GO:0045579; GO:0045648; GO:0045656; GO:0045659; GO:0045671; GO:0045779; GO:0046856; GO:0050776; GO:0050777; GO:0050852; GO:0052658; GO:0052659 "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]" ATGMKYNLPSWCDR 0.99322 -14.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4941 0 0 0 0 0 0 12.7908 0 12.5642 0 0 0 0 0 13.1563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4755 0 0 0 0 0 14.5794 12.9844 15.1238 0 13.2141 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4988 14.1866 0 15.161 0 0 0 0 13.7576 14.4259 13.7335 15.6311 15.4285 15.1867 0 0 13.9147 14.6585 0 0 0 15.4777 0 14.911 0 0 14.6772 0 0 0 0 0 14.2696 0 0 15.4242 0 0 14.457 0 15.2041 0 0 0 0 0 0 0 14.0153 0 0 0 0 0 13.1017 0 0 12.7133 0 0 0 0 0 0 13.4439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCM2 PLXA4_HUMAN Plexin-A4 PLXNA4 KIAA1550 PLXNA4A PLXNA4B UNQ2820/PRO34003 Homo sapiens (Human) anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; embryonic heart tube development [GO:0035050]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; sympathetic neuron axon guidance [GO:0097492]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644] GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0017154; GO:0021612; GO:0021615; GO:0021637; GO:0021644; GO:0021784; GO:0021793; GO:0021960; GO:0030334; GO:0035050; GO:0043087; GO:0048485; GO:0048841; GO:0050772; GO:0050923; GO:0071526; GO:0097492; GO:1902287 semaphorin receptor activity [GO:0017154] AGAVLGR 0.99322 -14.662 0 0 0 0 0 0 0 0 0 0 0 13.1012 0 0 0 0 0 12.7718 12.1884 0 11.1093 0 0 11.9391 0 0 11.8147 0 0 0 0 0 0 11.7618 0 12.2828 0 0 0 0 11.9708 11.2716 0 11.0001 10.8183 12.7163 0 0 0 0 0 0 0 0 0 0 0 0 10.1805 0 0 0 0 0 0 0 0 0 0 0 14.0602 0 0 10.7837 13.1951 0 12.6331 14.5332 13.2221 14.7766 0 0 13.4442 0 0 13.6199 13.2076 0 15.2809 0 13.6545 16.1807 0 0 0 0 14.2831 13.6629 0 14.3367 0 13.4101 15.0038 16.3214 0 12.2021 15.7331 0 0 14.6593 0 0 11.0408 14.4423 12.2068 14.2619 14.0067 13.2453 0 16.0184 0 15.6899 0 0 12.317 14.8277 14.5751 13.1681 0 14.8062 0 12.8653 0 0 15.2836 14.195 13.9316 12.9939 0 13.9648 15.157 14.0949 0 0 0 0 0 0 14.3049 13.655 0 0 0 0 0 13.5634 15.4205 12.4262 13.9189 13.7238 0 13.6294 0 0 14.0047 0 0 0 12.2646 0 12.8609 13.0055 12.3078 14.2148 13.5493 0 0 0 10.1542 14.2217 Q9NY28 GALT8_HUMAN "Probable polypeptide N-acetylgalactosaminyltransferase 8, EC 2.4.1.41 (Polypeptide GalNAc transferase 8, GalNAc-T8, pp-GaNTase 8) (Protein-UDP acetylgalactosaminyltransferase 8) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8)" GALNT8 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] ALFIGLTLAIAVNLLLVFSSK 0.99322 -7.7726 0 12.1206 14.8185 0 13.2347 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1721 0 10.8467 0 0 0 0 14.8122 0 0 0 0 11.691 0 0 0 0 0 0 0 0 0 0 13.3298 0 0 12.0709 0 0 0 12.4444 0 0 11.314 0 0 0 11.1836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5691 14.2971 13.7646 15.6268 14.7942 0 15.4147 14.2332 0 0 0 0 0 14.1254 0 15.5692 13.8193 0 0 0 0 14.0577 13.6299 0 13.665 0 14.9273 0 0 0 13.8363 14.0162 0 13.9173 13.0473 0 0 0 14.5852 13.5367 12.7628 12.9068 0 0 0 14.2394 0 0 0 14.5457 0 0 0 13.0747 14.9801 13.7895 0 14.3894 12.1371 0 14.9033 0 13.7447 0 0 12.9077 0 13.4261 13.5584 0 0 13.1005 12.2934 0 13.4289 13.3987 0 0 0 14.0501 14.121 0 11.1988 0 18.1158 0 10.873 11.7897 0 0 0 0 0 0 0 0 0 13.7288 0 17.8794 11.6605 14.8758 0 0 0 Q9NZ32 ARP10_HUMAN "Actin-related protein 10 (Actin-related protein 11, hARP11)" ACTR10 ACTR11 ARP10 ARP11 Homo sapiens (Human) microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958] axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813] axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; microtubule-based movement [GO:0007018]; retrograde axonal transport of mitochondrion [GO:0098958] GO:0005576; GO:0005829; GO:0005869; GO:0007018; GO:0035578; GO:0098958; GO:1904115; GO:1904813 ALGTKTFR 0.99322 -26.204 0 0 0 0 0 0 0 0 0 0 0 13.8494 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1818 0 0 0 0 0 0 0 0 0 10.1102 0 0 0 0 0 0 0 0 0 0 10.6546 14.0314 12.9868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3167 13.2061 0 0 0 0 0 0 0 0 0 0 13.6691 13.8734 0 13.7498 0 0 0 0 0 13.4912 14.7007 0 13.2112 0 0 0 0 0 0 0 0 11.638 13.6407 0 13.1527 0 0 0 0 0 0 12.0952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5807 0 12.5789 12.6572 0 14.7863 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5424 0 12.2181 13.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9716 11.8236 0 0 0 0 0 0 Q9ULF5 S39AA_HUMAN "Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10, ZIP-10)" SLC39A10 KIAA1265 ZIP10 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; zinc ion import across plasma membrane [GO:0071578] GO:0002903; GO:0005385; GO:0005887; GO:0006882; GO:0030890; GO:0050861; GO:0071578; GO:1903615 zinc ion transmembrane transporter activity [GO:0005385] GMTELEPSK 0.99322 -16.631 0 0 0 0 0 0 0 0 0 0 0 0 11.9082 0 11.4869 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8789 0 0 0 0 0 0 0 0 0 12.2474 0 0 0 0 0 0 0 11.5807 0 11.8606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0014 0 0 0 0 0 13.7527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6552 0 0 0 0 0 0 0 0 0 13.5345 0 13.8482 0 14.2227 0 15.8623 0 14.2827 0 14.0776 14.0993 13.3798 13.8676 0 0 0 0 0 0 13.7744 0 0 Q9UM82 SPAT2_HUMAN Spermatogenesis-associated protein 2 SPATA2 KIAA0757 PD1 Homo sapiens (Human) necroptotic process [GO:0070266]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of inflammatory response [GO:0050727]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin-specific protease binding [GO:1990381]; necroptotic process [GO:0070266]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of inflammatory response [GO:0050727]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283] GO:0001650; GO:0005654; GO:0005737; GO:0007283; GO:0010803; GO:0030159; GO:0044877; GO:0050727; GO:0060544; GO:0070266; GO:0070536; GO:0072520; GO:1990108; GO:1990381 protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin-specific protease binding [GO:1990381] EFRSIKTYTGPFVYYVK 0.99322 -16.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0294 12.8489 12.7675 12.3733 12.5074 12.1009 0 11.3632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7008 0 14.274 14.8933 13.9297 0 0 0 14.6616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3207 0 11.9307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.146 0 0 0 0 0 Q5HYK9 ZN667_HUMAN Zinc finger protein 667 ZNF667 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AFSHRISLTRHK 0.99323 -29.211 0 12.6317 0 0 0 0 0 0 0 0 12.2025 0 13.5841 13.5447 10.5351 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0113 0 13.8251 0 0 13.2078 0 0 0 0 0 0 0 0 0 0 13.3628 0 0 12.3373 0 0 0 0 0 0 0 0 14.8157 0 14.5385 0 0 0 0 0 0 12.8246 0 0 0 0 0 0 0 0 13.3538 16.4874 15.9126 16.2231 13.3522 15.4587 13.655 14.7665 0 0 0 0 16.2327 0 0 0 13.527 0 0 0 0 0 0 0 14.3243 0 13.49 0 0 15.4278 14.7757 13.5775 13.9205 0 0 0 14.3869 0 12.227 14.0777 13.4714 13.7317 0 0 0 0 13.9966 12.4909 13.8709 0 0 0 0 13.7769 0 14.0024 13.7962 13.7577 0 0 15.4205 0 0 14.0619 0 13.8247 14.189 13.9035 0 0 0 0 15.5136 0 0 0 0 0 15.7486 0 13.8676 18.7852 13.3144 13.161 12.172 13.9083 0 0 15.4838 0 12.8859 0 16.3902 0 14.6499 13.9785 15.9197 0 13.7502 0 16.4661 13.4027 0 13.0562 0 11.6497 Q5TYW1 ZN658_HUMAN Zinc finger protein 658 ZNF658 Homo sapiens (Human) "cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254]" GO:0000976; GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0042254; GO:0045892; GO:0046872; GO:0071294 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" AALIVHQR 0.99323 -38.08 0 0 0 0 11.2339 0 0 0 0 12.8981 13.1206 0 0 0 12.7424 0 0 0 0 12.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0435 0 0 13.9868 14.1911 14.0824 0 0 0 13.4657 13.5375 12.8796 0 13.8348 13.4019 0 0 0 13.3295 0 0 0 0 12.8458 0 13.6988 0 14.3666 0 12.236 14.29 0 0 0 0 14.9597 12.9438 0 0 12.5202 0 0 0 0 0 14.7065 12.742 0 13.8583 0 0 0 0 11.4131 0 0 0 0 11.4662 0 0 0 0 11.4491 0 0 0 0 13.6213 0 0 0 0 0 13.4466 0 12.0598 0 0 0 0 0 0 0 0 13.9141 11.3342 0 0 0 0 0 0 0 0 0 12.9156 0 0 0 0 0 0 Q8N9H9 CA127_HUMAN Uncharacterized protein C1orf127 C1orf127 Homo sapiens (Human) heart development [GO:0007507] heart development [GO:0007507] GO:0007507 CPMLRSR 0.99323 -13.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3072 0 12.1757 12.2969 0 0 0 0 0 0 14.8345 0 0 0 0 0 0 0 0 0 0 12.7289 0 0 0 13.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H079 KTBL1_HUMAN KATNB1-like protein 1 (Katanin p80 subunit B-like 1) KATNBL1 C15orf29 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; positive regulation of cytoskeleton organization [GO:0051495] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; positive regulation of cytoskeleton organization [GO:0051495] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008017; GO:0008352; GO:0015630; GO:0030496; GO:0031122; GO:0032154; GO:0051495; GO:0072686; GO:0097431 microtubule binding [GO:0008017] LNVALTFWRK 0.99323 -13.301 0 0 0 0 11.0269 0 0 0 10.9148 11.3828 10.4156 0 0 0 13.6809 0 0 0 0 0 0 0 0 0 0 11.7068 0 0 12.4385 0 10.3317 0 0 0 10.85 0 9.22089 0 0 0 0 11.5384 0 0 0 11.3561 11.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3819 0 0 0 0 0 0 0 0 0 0 0 11.9551 0 0 0 0 0 12.4186 0 0 0 0 0 12.4271 0 13.613 0 0 12.4661 13.9353 0 0 0 0 0 0 12.7116 0 0 0 0 0 0 13.4607 0 0 0 0 0 0 10.3038 0 0 0 0 0 0 0 0 0 12.8555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6499 0 0 0 0 0 0 0 0 0 0 0 0 14.93 0 0 11.9161 0 13.0168 0 0 0 0 11.9445 0 0 0 0 13.3127 0 0 0 0 Q9P0J1 PDP1_HUMAN "[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial, PDP 1, EC 3.1.3.43 (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1, PDPC 1)" PDP1 PDP PPM2C Homo sapiens (Human) peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (lipoamide) phosphatase complex [GO:0045253]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] GO:0004722; GO:0004741; GO:0005739; GO:0005759; GO:0006470; GO:0035970; GO:0045253; GO:0046872; GO:1904184 [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] ALLPILQWHKHPNDYFSKEASK 0.99323 -6.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A7MD48 SRRM4_HUMAN "Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa, Neural-specific SR-related protein of 100 kDa, nSR100)" SRRM4 KIAA1853 Homo sapiens (Human) "cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]" nucleus [GO:0005634] "nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; nervous system development [GO:0007399]; neuron maturation [GO:0042551]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; sensory perception of sound [GO:0007605]" GO:0000381; GO:0003729; GO:0005634; GO:0006397; GO:0007399; GO:0007605; GO:0008380; GO:0030154; GO:0042551; GO:0042802; GO:0043484 identical protein binding [GO:0042802]; mRNA binding [GO:0003729] AVATPRPESIIVASITAR 0.99324 -15.942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1159 0 0 13.9347 0 0 0 0 0 0 14.043 0 0 0 0 0 14.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6211 0 0 0 0 0 0 0 0 B7ZBB8 PP13G_HUMAN Protein phosphatase 1 regulatory subunit 3G PPP1R3G Homo sapiens (Human) glucose homeostasis [GO:0042593]; glycogen biosynthetic process [GO:0005978]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; regulation of glycogen biosynthetic process [GO:0005979] protein phosphatase type 1 complex [GO:0000164] protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; glucose homeostasis [GO:0042593]; glycogen biosynthetic process [GO:0005978]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; regulation of glycogen biosynthetic process [GO:0005979] GO:0000164; GO:0005978; GO:0005979; GO:0008157; GO:0042593; GO:0045725; GO:2000467; GO:2001069 glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157] AEDLEQLGGLLAAAAVAAPLSAPPSR 0.99324 -6.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43309 ZSC12_HUMAN Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 305) (Zinc finger protein 96) ZSCAN12 KIAA0426 ZNF305 ZNF96 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSQKAGLFHHIK 0.99324 -6.4788 0 13.8865 0 0 0 0 0 0 0 0 0 11.7495 0 0 11.6826 0 0 0 0 0 0 11.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2021 0 0 0 0 0 0 0 0 0 10.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7421 11.6502 0 0 0 0 0 0 0 0 13.4584 0 0 16.6888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8498 13.3132 13.7751 0 0 0 12.6383 0 0 0 0 13.662 0 0 12.4644 0 0 0 0 0 0 0 0 0 14.4255 0 0 0 0 12.4435 0 0 0 0 12.6426 0 0 0 13.8385 0 0 0 0 0 0 0 0 12.0621 0 0 0 0 0 0 12.5513 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8823 0 P13686 PPA5_HUMAN "Tartrate-resistant acid phosphatase type 5, TR-AP, EC 3.1.3.2 (Tartrate-resistant acid ATPase, TrATPase) (Type 5 acid phosphatase)" ACP5 Homo sapiens (Human) bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; dephosphorylation [GO:0016311]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide biosynthetic process [GO:0006809]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; superoxide anion generation [GO:0042554] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosome [GO:0005764] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; acid phosphatase activity [GO:0003993]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; dephosphorylation [GO:0016311]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide biosynthetic process [GO:0006809]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; superoxide anion generation [GO:0042554] GO:0003993; GO:0005764; GO:0005829; GO:0006809; GO:0008198; GO:0008199; GO:0010936; GO:0016021; GO:0016311; GO:0032496; GO:0032691; GO:0032695; GO:0032720; GO:0032929; GO:0034097; GO:0042554; GO:0045019; GO:0045453; GO:0050728; GO:0050830; GO:0060349 acid phosphatase activity [GO:0003993]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198] LARTQLSWLKK 0.99324 -5.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0462 0 0 0 0 14.3375 0 0 0 0 0 12.989 13.7262 0 0 0 0 0 0 0 0 0 0 0 13.1786 0 0 0 0 12.343 12.0036 0 12.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4819 0 0 13.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16104 H2AX_HUMAN "Histone H2AX, H2a/x (Histone H2A.X)" H2AX H2AFX Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; cerebral cortex development [GO:0021987]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleosome assembly [GO:0006334]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; XY body [GO:0001741] centrosome [GO:0005813]; condensed nuclear chromosome [GO:0000794]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; XY body [GO:0001741]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; cerebral cortex development [GO:0021987]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; meiotic cell cycle [GO:0051321]; nucleosome assembly [GO:0006334]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283] GO:0000077; GO:0000724; GO:0000786; GO:0000794; GO:0001673; GO:0001741; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005657; GO:0005813; GO:0006302; GO:0006334; GO:0006974; GO:0007283; GO:0010212; GO:0016607; GO:0019899; GO:0021987; GO:0030527; GO:0035861; GO:0042393; GO:0045739; GO:0046982; GO:0051321; GO:0070062; GO:0071480; GO:0090398; GO:0090734 damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AGLQFPVGR 0.99324 -7.1002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4565 15.6967 0 0 15.6211 0 15.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7622 15.2126 0 0 0 14.5592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3166 0 0 0 14.9601 15.2585 0 0 0 0 0 0 0 0 0 0 0 14.5989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30622 CLIP1_HUMAN "CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2, CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin)" CLIP1 CYLN1 RSN Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ruffle [GO:0001726] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ruffle [GO:0001726]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116] GO:0000278; GO:0000776; GO:0001578; GO:0001726; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005882; GO:0008017; GO:0008270; GO:0015630; GO:0015631; GO:0030659; GO:0031116; GO:0031122; GO:0042802; GO:0051010 identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] AGVVRFLGETDFAK 0.99324 -17.206 0 0 0 0 0 0 11.2143 0 0 0 0 0 0 12.4405 0 0 0 0 0 0 0 0 0 0 15.0639 0 14.8154 0 0 0 0 0 0 0 0 0 0 0 0 15.1132 0 0 0 0 15.1806 0 0 14.0759 14.6148 0 0 0 0 0 0 0 0 0 14.1215 12.3311 14.6637 12.958 0 12.7191 0 0 11.6473 0 0 0 0 0 0 0 0 0 0 0 13.5709 0 17.9427 0 0 0 12.4645 0 0 0 14.7799 13.0433 15.1934 14.9102 13.9548 16.2275 16.5845 16.5268 17.3837 0 13.071 0 13.2136 0 15.6323 15.7714 0 0 12.0813 0 0 13.7514 0 15.8326 16.1105 16.6137 12.1854 12.7841 13.2713 14.6551 13.6662 15.6972 14.9556 14.9134 0 0 0 0 0 0 14.1648 0 14.6734 11.881 0 0 0 0 0 0 12.7437 14.8994 0 0 0 0 0 0 13.5571 11.5522 15.6483 0 13.9568 0 14.7149 0 0 15.2352 15.3755 0 12.653 0 0 0 0 0 0 0 0 0 12.7554 0 0 14.0519 13.2758 0 14.4308 0 15.1682 17.91 13.8105 0 P34972 CNR2_HUMAN "Cannabinoid receptor 2, CB-2, CB2, hCB2 (CX5)" CNR2 CB2A CB2B Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; leukocyte chemotaxis [GO:0030595]; negative regulation of action potential [GO:0045759]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation [GO:0033004]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; regulation of metabolic process [GO:0019222]; response to amphetamine [GO:0001975]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cannabinoid signaling pathway [GO:0038171]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; immune response [GO:0006955]; inflammatory response [GO:0006954]; leukocyte chemotaxis [GO:0030595]; negative regulation of action potential [GO:0045759]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation [GO:0033004]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; regulation of metabolic process [GO:0019222]; response to amphetamine [GO:0001975]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]" GO:0001975; GO:0004930; GO:0004949; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007187; GO:0007189; GO:0019222; GO:0019233; GO:0030425; GO:0030595; GO:0031234; GO:0032229; GO:0032496; GO:0033004; GO:0038171; GO:0043204; GO:0045759; GO:0050728; GO:0051001 cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930] DLDLSDC 0.99324 -5.0152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2074 15.3603 0 14.539 0 0 0 0 0 0 0 0 12.9743 12.7521 13.6486 0 14.4026 12.3571 12.6897 12.178 0 12.1066 0 0 0 0 0 0 13.1031 0 0 12.3022 0 0 0 0 0 0 0 14.0395 0 14.2693 0 0 0 0 0 0 0 0 0 0 0 13.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9367 0 0 0 12.0165 11.5056 0 0 13.8518 0 0 0 0 Q13255 GRM1_HUMAN "Metabotropic glutamate receptor 1, mGluR1" GRM1 GPRC1A MGLUR1 Homo sapiens (Human) "cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; L-glutamate import across plasma membrane [GO:0098712]; locomotory behavior [GO:0007626]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of MAPK cascade [GO:0043410]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]" dendrite [GO:0030425]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor homodimeric complex [GO:0038038]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685] "dendrite [GO:0030425]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor homodimeric complex [GO:0038038]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0098872]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583]; cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; L-glutamate import across plasma membrane [GO:0098712]; locomotory behavior [GO:0007626]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of MAPK cascade [GO:0043410]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]" GO:0001640; GO:0004930; GO:0005634; GO:0005886; GO:0005887; GO:0007186; GO:0007216; GO:0007268; GO:0007626; GO:0008066; GO:0019233; GO:0030425; GO:0038037; GO:0038038; GO:0043410; GO:0051482; GO:0051930; GO:0051966; GO:0071257; GO:0098685; GO:0098712; GO:0098839; GO:0098872; GO:0098978; GO:0099530; GO:0099583 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0098872]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO:0099530]; glutamate receptor activity [GO:0008066]; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:0099583] AMLDIVK 0.99324 -6.4795 0 0 0 0 0 0 0 0 0 0 0 0 12.3791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.62 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4407 0 0 11.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8671 0 12.6216 0 14.7339 14.9577 0 0 14.4004 14.139 0 15.0125 0 14.5175 0 0 0 0 13.3749 0 0 0 0 12.8321 0 0 0 0 0 0 0 0 13.7581 0 0 0 0 14.0895 0 0 0 14.4145 0 0 11.5737 0 0 11.8846 0 0 0 0 0 0 14.2893 0 0 0 0 13.0799 11.6763 0 12.8286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3862 11.7697 0 0 12.2945 0 Q3ZCV2 LEXM_HUMAN Lymphocyte expansion molecule LEXM LEM C1orf177 Homo sapiens (Human) ETCFSKKK 0.99324 -14.482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1171 0 0 0 0 12.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3403 14.4086 0 0 0 0 13.8575 0 0 0 0 0 0 0 0 0 13.851 11.6813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.581 0 0 0 0 0 0 0 0 0 0 0 0 0 13.132 0 0 0 0 0 0 0 0 0 0 13.2183 0 14.1397 0 0 0 0 14.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VXA5 KHDC1_HUMAN KH homology domain-containing protein 1 KHDC1 C6orf147 C6orf148 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; RNA binding [GO:0003723]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919] GO:0003723; GO:0005737; GO:0006919; GO:0016021 RNA binding [GO:0003723] NSRSGKTR 0.99324 -17.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1809 0 0 0 0 0 0 0 0 0 0 0 0 Q5T5Y3 CAMP1_HUMAN Calmodulin-regulated spectrin-associated protein 1 CAMSAP1 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113] cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113] GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0051011 calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507] AEDELAKKR 0.99324 -29.303 0 0 0 0 11.6035 13.9148 0 0 12.4798 11.2198 0 0 0 0 13.6444 12.1103 11.8945 12.8865 13.2515 0 12.8403 14.0985 11.2929 14.5564 12.0766 12.2922 13.5151 0 0 11.6718 0 12.0966 0 0 0 0 0 0 0 0 0 11.4132 0 13.5342 0 13.8454 0 0 0 12.4037 0 15.808 13.4528 12.8562 12.5368 0 0 0 0 0 0 0 0 0 0 0 14.4954 13.7863 0 0 0 0 0 0 0 0 0 0 0 13.2774 0 0 0 0 0 0 0 13.3046 0 0 13.4851 0 13.6904 0 13.5071 0 13.208 0 0 12.4004 14.8668 0 0 0 0 0 0 0 14.0876 0 0 14.3525 0 13.9063 13.1756 0 14.856 0 0 0 0 0 0 0 0 11.4101 14.4418 0 18.2198 13.5404 13.9399 15.5552 0 12.975 0 0 0 0 14.1884 0 13.7697 13.658 14.1125 0 0 13.5166 0 14.3278 0 0 14.6149 16.4061 0 0 0 13.364 15.3588 12.5053 0 0 0 0 12.7487 0 13.9772 14.9193 13.8125 0 13.9244 11.6975 14.2679 0 0 0 13.6823 14.2284 14.7037 0 0 0 Q66K14 TBC9B_HUMAN TBC1 domain family member 9B TBC1D9B KIAA0676 Homo sapiens (Human) activation of GTPase activity [GO:0090630] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0005509; GO:0016021; GO:0090630 calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096] AKNECYR 0.99324 -15.933 0 0 0 0 0 0 0 0 0 0 12.2046 0 0 0 16.293 0 0 0 13.3879 0 13.4143 0 13.579 0 0 13.4236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5803 0 0 13.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6751 0 0 0 0 0 0 13.0437 0 0 0 13.7607 0 0 0 0 0 0 0 0 0 12.3278 0 12.5406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2203 13.2803 0 0 0 0 0 0 0 0 0 0 0 0 10.5732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1934 0 Q70CQ1 UBP49_HUMAN "Ubiquitin carboxyl-terminal hydrolase 49, EC 3.4.19.12 (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49)" USP49 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000398; GO:0004197; GO:0004843; GO:0005654; GO:0005737; GO:0006325; GO:0006511; GO:0008270; GO:0016579; GO:0035616; GO:0042393 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] DMLSSLDK 0.99324 -26.599 0 0 0 0 11.9224 0 0 0 0 0 14.3373 0 0 0 0 0 11.8602 0 0 12.9223 12.4583 0 0 0 12.5946 0 12.9212 0 0 0 0 0 0 0 0 13.916 0 0 0 0 0 10.4041 0 0 12.791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5936 13.8059 0 0 12.2791 13.0154 11.5696 14.1783 0 0 13.729 0 0 0 0 0 12.4594 0 0 0 0 0 0 12.7488 0 0 0 0 0 10.9029 10.7839 0 0 0 0 0 0 0 12.3282 0 0 12.7251 0 0 0 0 0 0 0 0 14.9425 0 12.0184 0 0 0 0 14.2808 0 0 0 0 0 0 0 0 0 0 0 13.6602 0 0 0 0 0 13.8417 0 0 14.8333 0 0 0 14.6804 14.8627 13.3826 14.8773 14.5843 13.9308 15.2183 15.2858 13.5911 13.0923 15.1715 14.6322 13.831 0 13.3071 15.5302 0 0 0 15.3456 Q8NE35 CPEB3_HUMAN "Cytoplasmic polyadenylation element-binding protein 3, CPE-BP3, CPE-binding protein 3, hCPEB-3" CPEB3 KIAA0940 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167]" anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] "anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167]" GO:0000122; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007616; GO:0008135; GO:0014069; GO:0017148; GO:0030014; GO:0030425; GO:0030496; GO:0035613; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0045727; GO:0048167; GO:0060213; GO:0060998; GO:0060999; GO:0061158; GO:0070161; GO:0071230; GO:0097440; GO:1900153; GO:1900248; GO:1900365; GO:1990124; GO:2000766 "mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135]" AAPLTSK 0.99324 -16.802 0 0 0 15.1946 0 0 0 0 0 0 14.6666 0 0 0 0 0 0 10.6463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1062 13.3071 14.6541 0 10.7789 0 0 14.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3236 17.7101 0 0 0 0 0 0 0 0 0 0 0 12.751 0 0 0 0 0 12.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7231 0 0 0 0 0 0 14.3594 0 0 0 0 12.3218 0 0 0 0 0 0 0 0 Q8TCB0 IFI44_HUMAN "Interferon-induced protein 44, p44 (Microtubule-associated protein 44)" IFI44 MTAP44 Homo sapiens (Human) immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615] GO:0005737; GO:0006955; GO:0009615; GO:0009617 EGGLCRDDIFYILNGNIR 0.99324 -14.424 0 0 0 0 0 0 0 0 10.7022 0 0 0 12.0336 12.207 0 0 0 0 0 0 16.9886 0 13.2716 10.8337 0 0 0 0 0 0 14.3138 0 11.735 0 0 10.8258 0 10.3635 0 0 0 0 0 0 0 0 11.7261 11.9278 0 16.5035 0 0 0 0 0 0 0 13.117 0 12.0087 0 0 0 0 0 0 0 0 0 0 0 0 13.785 0 0 0 0 0 0 13.2376 0 0 0 13.5817 0 0 0 0 0 0 0 0 0 18.2559 0 13.0934 0 0 0 0 12.927 12.7532 0 0 0 12.3372 0 0 0 0 12.5523 0 0 0 0 13.6773 12.8436 0 18.2566 0 0 0 0 0 0 18.2407 0 0 0 13.898 0 0 0 0 13.3022 0 14.6657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3977 0 0 0 18.2013 0 10.8716 0 0 12.7815 0 13.5206 0 0 0 0 13.7166 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW38 FOG2_HUMAN "Zinc finger protein ZFPM2 (Friend of GATA protein 2, FOG-2, Friend of GATA 2, hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2)" ZFPM2 FOG2 ZNF89B Homo sapiens (Human) "cell differentiation [GO:0030154]; embryonic organ development [GO:0048568]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; embryonic organ development [GO:0048568]; gonadal mesoderm development [GO:0007506]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of female gonad development [GO:2000195]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of male gonad development [GO:2000020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]" GO:0000122; GO:0000785; GO:0001570; GO:0001673; GO:0001701; GO:0003148; GO:0003221; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0007506; GO:0007507; GO:0008270; GO:0030154; GO:0030324; GO:0045599; GO:0045892; GO:0045944; GO:0048568; GO:0060045; GO:0060412; GO:0060548; GO:0061629; GO:2000020; GO:2000195 DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] KFYCSSHAAEHVK 0.99324 -29.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 0 0 0 0 0 0 0 0 0 11.8098 0 0 0 0 11.4577 0 0 10.8372 0 0 11.242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2203 0 0 13.9252 0 13.5622 0 13.7839 13.5459 0 0 0 0 0 0 13.55 0 0 0 0 0 0 0 12.6957 12.6858 0 0 9.90046 0 0 0 0 0 0 0 0 0 12.9366 0 11.5994 0 0 0 13.1721 0 0 0 0 0 13.0171 0 0 0 0 0 0 0 0 0 0 0 0 13.3062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0338 0 0 12.1265 0 0 0 12.6407 0 0 0 0 0 0 13.0609 0 0 Q96GQ7 DDX27_HUMAN "Probable ATP-dependent RNA helicase DDX27, EC 3.6.4.13 (DEAD box protein 27)" DDX27 cPERP-F RHLP HSPC259 PP3241 Homo sapiens (Human) rRNA processing [GO:0006364] chromosome [GO:0005694]; nucleolus [GO:0005730] chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA processing [GO:0006364] GO:0003723; GO:0003724; GO:0005524; GO:0005694; GO:0005730; GO:0006364; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ARILPQDVILK 0.99324 -14.434 0 0 0 0 0 0 0 0 0 16.7132 12.4613 12.6092 12.5764 12.3602 12.7717 0 12.6948 12.8796 12.6862 0 0 0 0 0 0 0 12.7 13.1679 0 0 12.6932 12.6529 0 12.1654 0 0 0 12.9874 0 0 0 0 0 0 12.8873 0 0 0 0 12.3961 13.4936 12.5079 12.7309 12.2064 0 0 16.8081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2698 0 0 0 0 0 0 0 0 0 0 14.6402 0 0 0 13.7271 0 0 11.1915 0 0 0 0 0 0 0 16.0477 14.1643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.475 0 0 0 0 0 0 0 14.7543 0 0 14.9016 13.4791 0 0 11.5952 0 0 0 0 0 0 0 0 14.0351 0 0 0 14.4421 0 0 0 0 0 0 0 16.3087 0 14.3394 0 14.5729 14.4256 14.5504 0 14.3097 14.4919 14.5424 0 0 0 0 14.2956 0 14.5272 0 0 14.5124 0 14.5771 0 12.4818 Q96H55 MYO19_HUMAN Unconventional myosin-XIX (Myosin head domain-containing protein 1) MYO19 MYOHD1 Homo sapiens (Human) actin filament organization [GO:0007015]; mitochondrion migration along actin filament [GO:0034642]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; plus-end directed microfilament motor activity [GO:0060002]; actin filament organization [GO:0007015]; mitochondrion migration along actin filament [GO:0034642]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0003779; GO:0005524; GO:0005739; GO:0005741; GO:0005829; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0032027; GO:0032465; GO:0034642; GO:0051015; GO:0060002; GO:0090140 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; plus-end directed microfilament motor activity [GO:0060002] AECDTRR 0.99324 -38.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6453 0 0 14.767 0 0 0 0 0 0 12.0134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6945 0 0 0 0 0 0 0 13.5552 0 0 0 0 0 0 0 0 13.1607 0 0 0 0 0 0 0 0 0 0 0 12.7174 0 0 0 0 0 0 0 12.6394 0 0 0 13.0844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3036 0 0 0 0 Q96IZ7 RSRC1_HUMAN "Serine/Arginine-related protein 53, SRrp53 (Arginine/serine-rich coiled-coil protein 1)" RSRC1 SRRP53 BM-011 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; nucleocytoplasmic transport [GO:0006913]; protein phosphorylation [GO:0006468]; response to antibiotic [GO:0046677]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; nucleocytoplasmic transport [GO:0006913]; protein phosphorylation [GO:0006468]; response to antibiotic [GO:0046677]; RNA splicing [GO:0008380]" GO:0000380; GO:0000398; GO:0005634; GO:0005737; GO:0006468; GO:0006913; GO:0008380; GO:0016607; GO:0046677 AKERNEEEAK 0.99324 -14.457 0 0 0 0 0 0 0 0 0 0 10.026 0 10.7924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7802 0 0 0 0 0 11.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5435 0 0 0 0 0 13.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8785 0 0 0 0 0 0 0 0 0 0 0 11.0924 0 0 0 0 0 0 0 0 0 0 11.4496 0 0 12.3755 13.4115 12.4565 12.8469 0 0 0 0 0 12.9233 0 0 0 0 0 11.5 0 0 0 0 Q99972 MYOC_HUMAN "Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment) ]" MYOC GLC1A TIGR Homo sapiens (Human) bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791] cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791]; fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971]; bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; skeletal muscle hypertrophy [GO:0014734] GO:0001649; GO:0001953; GO:0001968; GO:0005109; GO:0005615; GO:0005741; GO:0005743; GO:0005758; GO:0005783; GO:0005791; GO:0005794; GO:0005929; GO:0007165; GO:0014068; GO:0014734; GO:0022011; GO:0030335; GO:0030971; GO:0031175; GO:0031410; GO:0032027; GO:0033268; GO:0035024; GO:0038031; GO:0038133; GO:0043408; GO:0045162; GO:0046872; GO:0051496; GO:0051497; GO:0051894; GO:0051897; GO:0051901; GO:0060348; GO:0062023; GO:0070062; GO:1900026 fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971] ANDQSGRCQYTFSVASPNESSCPEQSQAMSVIHNLQR 0.99324 -13.388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.348 0 0 0 12.2807 12.938 0 0 0 0 11.9027 11.5355 0 0 0 0 0 0 17.2495 0 0 0 15.352 0 0 0 14.6001 0 0 0 0 0 0 0 11.1065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8312 0 0 0 0 0 0 0 10.299 10.7923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H672 ASB7_HUMAN "Ankyrin repeat and SOCS box protein 7, ASB-7" ASB7 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 ARIARLMLESEYR 0.99324 -5.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2923 0 0 0 0 12.2216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.96 0 0 0 0 0 0 0 0 10.1721 0 0 0 0 0 0 0 0 0 13.7407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAC8 UBTD1_HUMAN Ubiquitin domain-containing protein 1 UBTD1 Homo sapiens (Human) LSTGKDVR 0.99324 -6.4766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5375 13.6583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3168 14.1295 0 15.2468 0 0 0 0 0 0 0 0 0 0 14.3217 0 0 0 0 0 0 0 0 0 14.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBB8 CDHR5_HUMAN "Cadherin-related family member 5 (Mu-protocadherin) (Mucin and cadherin-like protein) (Mucin-like protocadherin, MLPCDH)" CDHR5 MUCDHL MUPCDH UNQ2781/PRO7168 Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; regulation of microvillus length [GO:0032532] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; spanning component of plasma membrane [GO:0044214] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; spanning component of plasma membrane [GO:0044214]; beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; regulation of microvillus length [GO:0032532] GO:0005509; GO:0005887; GO:0005905; GO:0007155; GO:0007156; GO:0008013; GO:0016324; GO:0030154; GO:0031526; GO:0031528; GO:0032532; GO:0044214; GO:0050839; GO:0070062; GO:0090675 beta-catenin binding [GO:0008013]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839] DDILFYTLQEMTAGASDYFSLVSVNR 0.99324 -26.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3792 14.4353 0 0 12.8897 0 0 0 0 0 12.94 0 0 0 0 0 0 12.7111 0 0 0 0 0 0 0 11.3178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3366 15.1839 14.93 0 14.3639 11.8362 14.4428 13.4997 0 0 0 0 11.8107 0 0 0 0 14.1749 11.9552 0 13.5444 0 0 0 0 14.3604 0 13.6487 0 0 14.5902 0 0 0 0 14.1187 0 0 0 0 14.703 13.7551 13.5232 13.5797 0 0 0 12.5313 0 0 0 0 14.021 0 13.7713 14.215 13.2561 0 0 11.8213 14.2007 15.4679 13.7043 0 0 13.8835 14.7216 0 0 0 13.5678 0 14.249 0 0 13.7646 0 0 13.6837 0 14.131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4807 13.8531 0 0 0 0 12.726 Q9NQS1 AVEN_HUMAN Cell death regulator Aven AVEN Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020] cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972] GO:0005829; GO:0006915; GO:0010972; GO:0012505; GO:0016020; GO:0043066 FAEEKEWDSEASCPK 0.99324 -5.0173 0 0 0 0 11.7958 0 0 0 0 0 0 0 0 0 12.4726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6179 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8201 0 0 0 0 0 14.7781 12.5355 0 0 0 0 0 0 11.9801 13.4779 12.1539 14.2625 0 13.8233 0 0 0 0 0 0 14.1801 0 0 0 0 13.7708 0 0 0 0 0 0 12.9364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5245 0 0 0 0 0 0 0 13.3973 13.0541 0 0 0 0 13.7721 12.5555 0 0 0 13.5442 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWB7 IFT57_HUMAN Intraflagellar transport protein 57 homolog (Dermal papilla-derived protein 8) (Estrogen-related receptor beta-like protein 1) (HIP1-interacting protein) (MHS4R2) IFT57 DERP8 ESRRBL1 HIPPI Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of keratinocyte proliferation [GO:0010839]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of keratinocyte proliferation [GO:0010839]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224] GO:0001843; GO:0001947; GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0006919; GO:0007224; GO:0010839; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042981; GO:0043616; GO:0044292; GO:0044458; GO:0060271; GO:0060972; GO:0097542; GO:0097546; GO:1905515 DNA binding [GO:0003677] IGIVEHTLLQSKLK 0.99324 -14.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5375 0 12.1891 0 11.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1184 0 0 0 0 0 0 0 0 0 0 0 10.9224 0 0 0 0 12.0116 0 0 0 0 0 11.6775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76027 0 0 0 0 0 0 0 0 Q9NXG0 CNTLN_HUMAN Centlein (Centrosomal protein) CNTLN C9orf101 C9orf39 Homo sapiens (Human) centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; centriole-centriole cohesion [GO:0010457]; protein localization to organelle [GO:0033365] GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0033365; GO:0070062 protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] AKSEMATMKVR 0.99324 -29.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0603 0 0 12.3816 12.3383 0 0 0 0 13.356 0 0 11.9739 0 0 0 0 0 0 0 0 13.4297 0 10.8554 0 0 0 0 0 0 0 0 0 0 0 12.1953 0 14.0107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0208 12.645 0 0 10.2505 0 0 0 0 0 12.0526 14.2547 0 0 0 0 9.85557 0 12.6021 0 0 0 0 0 0 0 0 0 0 13.204 0 15.2415 0 0 0 12.5605 0 0 13.3997 13.9824 12.8364 11.8211 0 12.9172 0 14.9109 0 0 0 16.6704 0 0 0 0 0 0 0 0 0 12.2317 0 12.9289 13.922 13.6069 0 0 14.4617 14.1282 0 0 0 0 14.1202 14.5097 0 14.6308 15.6421 0 14.2047 0 13.7029 0 0 0 0 13.6973 14.5084 0 12.4589 0 0 0 0 0 12.9331 0 0 0 13.5337 0 14.5356 0 0 0 0 0 17.6749 0 13.5798 Q9UBY0 SL9A2_HUMAN "Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2, NHE-2) (Solute carrier family 9 member 2)" SLC9A2 NHE2 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] GO:0005886; GO:0006811; GO:0008104; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] ALGVFVLTQVINRFR 0.99324 -13.373 12.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.13 0 0 0 0 0 0 0 0 17.7086 0 0 0 0 13.6621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8925 0 13.4897 0 0 0 0 0 0 0 0 12.7404 0 0 13.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4768 0 0 14.5369 0 0 0 0 0 0 11.4919 0 0 0 0 13.5146 0 0 0 0 0 0 0 0 12.9062 0 0 0 0 0 11.9605 0 0 0 0 0 11.2794 Q9UHI8 ATS1_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 1, ADAM-TS 1, ADAM-TS1, ADAMTS-1, EC 3.4.24.- (METH-1)" ADAMTS1 KIAA1346 METH1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; heart trabecula formation [GO:0060347]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; ovulation from ovarian follicle [GO:0001542]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508] basement membrane [GO:0005604]; cytoplasmic vesicle [GO:0031410]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] basement membrane [GO:0005604]; cytoplasmic vesicle [GO:0031410]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; extracellular matrix organization [GO:0030198]; heart trabecula formation [GO:0060347]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; ovulation from ovarian follicle [GO:0001542]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508] GO:0001542; GO:0001822; GO:0004222; GO:0005576; GO:0005604; GO:0006508; GO:0007229; GO:0008201; GO:0008237; GO:0008270; GO:0008285; GO:0016525; GO:0030198; GO:0031012; GO:0031410; GO:0060347; GO:1900087; GO:1904707; GO:1904754 heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] CVNKTDR 0.99324 -29.235 0 0 0 0 11.307 0 0 0 13.2526 0 0 0 14.4814 0 0 0 14.3656 0 0 13.2751 13.5901 0 13.3703 0 13.245 14.1113 0 0 0 0 0 0 0 0 0 12.322 0 0 0 0 0 10.322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1224 12.3061 11.8783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4497 12.5997 0 0 0 0 0 13.4362 0 0 0 14.0229 0 0 0 15.4158 0 0 0 0 0 13.797 0 0 12.0777 14.4924 14.4979 14.8955 0 10.9055 0 0 0 0 0 0 12.9227 0 0 0 15.3717 0 12.1715 0 0 0 0 0 0 0 14.4451 0 0 0 0 0 0 0 14.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4217 0 0 0 0 0 0 14.735 0 0 0 0 0 0 0 0 14.2533 0 0 0 0 0 0 0 0 0 0 0 17.8131 Q9UJX3 APC7_HUMAN "Anaphase-promoting complex subunit 7, APC7 (Cyclosome subunit 7)" ANAPC7 APC7 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; protein phosphatase binding [GO:0019903]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0015630; GO:0016567; GO:0019903; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979 protein phosphatase binding [GO:0019903] AIQLNSNSVQALLLKGAALR 0.99324 -14.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6584 0 0 0 0 0 0 0 0 0 0 0 0 12.9329 0 0 11.6648 12.2882 12.3789 0 12.9882 0 0 16.8264 0 0 0 0 0 0 0 0 0 0 12.468 0 0 0 12.117 12.8253 11.6781 0 0 11.6723 0 0 11.5566 11.4406 0 12.8709 9.68965 12.9478 0 0 0 12.6101 16.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9055 11.7503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UL58 ZN215_HUMAN "Zinc finger protein 215 (BWSCR2-associated zinc finger protein 2, BAZ-2) (Zinc finger protein with KRAB and SCAN domains 11)" ZNF215 BAZ2 ZKSCAN11 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FFNRRTNLTK 0.99324 -14.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5302 0 0 0 0 0 0 0 0 0 0 0 12.5056 0 0 0 12.829 0 0 0 0 0 0 0 0 0 0 0 15.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y324 FCF1_HUMAN rRNA-processing protein FCF1 homolog FCF1 C14orf111 CGI-35 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]" GO:0000447; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0032040 RNA binding [GO:0003723] AKLDLVQSMMDCLYAKCIPCITDCVMAEIEK 0.99324 -6.4867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1809 12.8556 13.4897 0 0 0 0 0 0 0 0 0 12.5596 0 0 0 13.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JLW8 MCRI1_HUMAN Mapk-regulated corepressor-interacting protein 1 (Granulin-2) (Protein FAM195B) MCRIP1 FAM195B GRAN2 Homo sapiens (Human) regulation of epithelial to mesenchymal transition [GO:0010717] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; regulation of epithelial to mesenchymal transition [GO:0010717] GO:0005634; GO:0005737; GO:0010494; GO:0010717 GLVEEYVEKVPNPSLKTFK 0.99325 -13.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9911 0 0 0 0 0 0 0 0 0 0 0 0 12.1262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.572 0 0 0 0 0 0 O00217 NDUS8_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial, EC 7.1.1.2 (Complex I-23kD, CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)" NDUFS8 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006979; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0046872; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]" GPLSPRFR 0.99325 -14.495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0729 12.8026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0851 0 0 0 12.8418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3 0 0 0 0 O00515 LAD1_HUMAN "Ladinin-1, Lad-1 (Linear IgA disease antigen, LADA)" LAD1 LAD Homo sapiens (Human) actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; extracellular exosome [GO:0070062] actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198] GO:0005198; GO:0005604; GO:0015629; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; structural molecule activity [GO:0005198] AEPASSR 0.99325 -26.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2427 0 12.0587 0 0 0 0 0 0 0 0 0 0 10.4155 0 0 0 0 0 0 10.8282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4337 0 0 0 0 0 0 0 14.3587 14.9145 0 0 0 0 0 0 0 14.7911 12.7834 0 0 0 0 14.5379 0 0 0 0 0 0 10.9875 0 0 0 0 0 0 0 0 0 0 0 0 10.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14727 APAF_HUMAN "Apoptotic protease-activating factor 1, APAF-1" APAF1 KIAA0413 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to G1 DNA damage checkpoint signaling [GO:0072432]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584] apoptosome [GO:0043293]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774] apoptosome [GO:0043293]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; aging [GO:0007568]; apoptotic process [GO:0006915]; cardiac muscle cell apoptotic process [GO:0010659]; cell differentiation [GO:0030154]; cellular response to transforming growth factor beta stimulus [GO:0071560]; forebrain development [GO:0030900]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of apoptotic process [GO:0042981]; response to G1 DNA damage checkpoint signaling [GO:0072432]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584] GO:0000166; GO:0001666; GO:0001822; GO:0001843; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0006915; GO:0006919; GO:0007399; GO:0007568; GO:0007584; GO:0008635; GO:0008656; GO:0010659; GO:0030154; GO:0030900; GO:0031072; GO:0032991; GO:0034774; GO:0042802; GO:0042981; GO:0043065; GO:0043293; GO:0043531; GO:0051402; GO:0070059; GO:0070062; GO:0071560; GO:0072432; GO:0097193; GO:0097202; GO:1902510; GO:1904813; GO:2001235 ADP binding [GO:0043531]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166] AHEDEVLCCAFSTDDR 0.99325 -14.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8688 0 10.7066 0 0 12.1963 10.6798 0 0 0 0 0 0 0 0 0 0 0 0 12.0445 0 12.5192 0 0 0 0 14.6081 0 0 0 0 0 0 0 0 12.0421 0 0 0 9.91518 0 11.6185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3073 12.1812 0 0 0 0 0 0 0 11.4806 0 0 0 0 0 0 13.3048 0 0 0 0 0 0 0 0 14.2024 0 0 0 0 11.675 0 0 0 0 15.1111 0 O43306 ADCY6_HUMAN "Adenylate cyclase type 6, EC 4.6.1.1 (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase)" ADCY6 KIAA0422 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; blood vessel diameter maintenance [GO:0097746]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; intracellular signal transduction [GO:0035556]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; renal water homeostasis [GO:0003091] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; blood vessel diameter maintenance [GO:0097746]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; intracellular signal transduction [GO:0035556]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; renal water homeostasis [GO:0003091] GO:0003091; GO:0004016; GO:0005080; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007193; GO:0007212; GO:0010977; GO:0016020; GO:0019901; GO:0031226; GO:0032420; GO:0035556; GO:0035811; GO:0046872; GO:0071380; GO:0071870; GO:0097746; GO:1904117; GO:1904322 adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080] ALQRLSRSIVR 0.99325 -26.936 0 0 0 0 0 0 0 0 12.4162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1899 0 0 0 0 0 0 12.3154 12.7903 0 13.7606 0 0 0 0 0 12.349 0 0 0 0 0 12.1148 0 0 0 0 0 10.7325 0 0 0 0 0 0 0 0 12.4137 0 0 0 0 10.7446 0 0 12.9913 11.2801 12.2767 14.8293 0 0 0 0 0 14.7201 13.242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9493 0 0 12.2151 0 0 0 0 0 0 12.5226 0 0 0 0 P10645 CMGA_HUMAN "Chromogranin-A, CgA (Pituitary secretory protein I, SP-I) [Cleaved into: Vasostatin-1 (Vasostatin I); Vasostatin-2 (Vasostatin II); EA-92; ES-43; Pancreastatin; SS-18; WA-8; WE-14; LF-19; Catestatin (SL21); AL-11; GV-19; GR-44; ER-37; GE-25; Serpinin-RRG; Serpinin; p-Glu serpinin precursor ]" CHGA Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation [GO:0086030]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; mast cell activation [GO:0045576]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron death [GO:1901215]; organelle organization [GO:0006996]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of relaxation of cardiac muscle [GO:1901899]; protein localization to secretory granule [GO:0033366]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026] chromaffin granule [GO:0042583]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; transport vesicle [GO:0030133] chromaffin granule [GO:0042583]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation [GO:0086030]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing of cells of another organism [GO:0031640]; mast cell activation [GO:0045576]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; negative regulation of catecholamine secretion [GO:0033604]; negative regulation of insulin secretion [GO:0046676]; negative regulation of neuron death [GO:1901215]; organelle organization [GO:0006996]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of relaxation of cardiac muscle [GO:1901899]; protein localization to secretory granule [GO:0033366]; regulation of blood pressure [GO:0008217]; regulation of the force of heart contraction [GO:0002026] GO:0002026; GO:0002551; GO:0005576; GO:0005615; GO:0006996; GO:0008217; GO:0030133; GO:0030141; GO:0031640; GO:0033366; GO:0033604; GO:0042583; GO:0042742; GO:0043303; GO:0045087; GO:0045576; GO:0046676; GO:0048471; GO:0050829; GO:0050830; GO:0050832; GO:0060452; GO:0086030; GO:0098992; GO:1900738; GO:1901215; GO:1901899; GO:2000707 AEGNNQAPGEEEEEEEEATNTHPPASLPSQK 0.99325 -6.5061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11940 PABP1_HUMAN "Polyadenylate-binding protein 1, PABP-1, Poly(A)-binding protein 1" PABPC1 PAB1 PABP PABP1 PABPC2 Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; gene silencing by RNA [GO:0031047]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]" catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; CRD-mediated mRNA stabilization [GO:0070934]; gene silencing by RNA [GO:0031047]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]" GO:0000184; GO:0000398; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006378; GO:0008022; GO:0008143; GO:0008266; GO:0008494; GO:0010494; GO:0016020; GO:0030027; GO:0031047; GO:0031252; GO:0036464; GO:0045070; GO:0048255; GO:0060213; GO:0070062; GO:0070934; GO:0071013; GO:0106002; GO:1900152; GO:1900153; GO:1990904; GO:2000623; GO:2000767 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494] AVDEMNGK 0.99325 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1865 0 0 0 0 0 0 0 0 0 0 12.255 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31629 ZEP2_HUMAN "Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2, HIV-EP2) (MHC-binding protein 2, MBP-2)" HIVEP2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DFSPSSHHSSPGYDSSPCRDNSPK 0.99325 -26.844 0 0 11.4395 0 0 0 0 11.5568 0 0 0 0 0 0 0 0 0 10.5407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9473 0 0 0 0 0 0 0 0 0 0 11.0872 0 0 0 12.1683 12.5623 11.3108 0 0 0 11.7664 11.6365 13.7292 12.255 12.9053 0 0 0 11.8137 0 0 0 0 10.5663 12.0865 10.4215 0 0 0 0 0 0 0 13.1385 13.3688 11.8947 11.8046 0 16.2736 0 0 0 15.8144 12.7884 12.7951 0 14.3645 15.5007 0 0 13.5002 13.5666 12.5328 12.7288 0 0 0 0 13.7626 12.1596 0 14.2055 0 0 0 11.0403 0 0 14.6291 0 13.0729 0 0 0 0 0 0 0 10.8219 0 12.5243 0 0 0 0 0 12.9653 13.0118 0 0 0 10.3478 0 0 0 0 0 0 0 0 11.5397 0 11.3601 0 0 11.9009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5482 14.7004 0 11.9847 11.3625 11.7703 0 0 0 0 16.7655 0 12.0661 P49914 MTHFS_HUMAN "5-formyltetrahydrofolate cyclo-ligase, EC 6.3.3.2 (5,10-methenyl-tetrahydrofolate synthetase, MTHFS, Methenyl-THF synthetase)" MTHFS Homo sapiens (Human) folic acid catabolic process [GO:0046657]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; formate metabolic process [GO:0015942]; glutamate metabolic process [GO:0006536]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872]; folic acid catabolic process [GO:0046657]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; formate metabolic process [GO:0015942]; glutamate metabolic process [GO:0006536]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006536; GO:0009396; GO:0015942; GO:0030272; GO:0035999; GO:0046653; GO:0046655; GO:0046657; GO:0046872 5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872] QSRVLSQK 0.99325 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7C3 TRIMM_HUMAN "Probable E3 ubiquitin-protein ligase TRIML2, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TRIML2) (SPRY domain-containing protein 6) (Tripartite motif family-like protein 2)" TRIML2 SPRYD6 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0051092; GO:0061630 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CFQSQEHK 0.99325 -13.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.729 0 0 14.5594 0 0 0 14.4189 14.3537 14.1863 13.9732 14.3021 0 14.3498 0 0 0 0 0 0 0 0 0 0 0 13.8209 13.6813 0 0 0 0 13.7632 0 0 0 14.7757 0 13.7034 0 13.7928 13.6296 0 13.7955 0 14.1287 0 0 13.7852 14.0124 0 0 13.4726 13.8391 13.4659 13.5578 0 13.4892 14.0616 0 14.0918 13.8907 0 0 0 0 13.8112 13.4011 0 0 0 13.9929 0 0 13.5628 0 13.3822 0 13.4601 0 0 0 0 0 0 13.149 14.5869 0 13.5291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE71 ABCF1_HUMAN ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein) ABCF1 ABC50 Homo sapiens (Human) inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]; inflammatory response [GO:0006954]; positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413]" GO:0003723; GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0006413; GO:0006954; GO:0008135; GO:0008494; GO:0016020; GO:0042788; GO:0043022; GO:0045727 "ATP binding [GO:0005524]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; translation factor activity, RNA binding [GO:0008135]" AEQGSEEEGEGEEEEEEGGESK 0.99325 -13.429 0 0 0 0 0 14.0773 0 0 0 0 0 0 0 15.1104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1535 13.1487 0 0 0 0 0 0 0 0 0 17.4375 0 0 15.6486 0 0 0 0 0 0 0 0 11.731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7672 0 0 0 0 0 0 13.815 0 0 0 0 0 0 0 0 14.852 0 13.3851 13.2255 18.5124 0 0 11.4217 13.4696 10.935 0 0 0 0 0 0 0 0 11.802 14.8896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9767 0 0 12.0614 12.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JQ0 PCD16_HUMAN Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1) DCHS1 CDH19 CDH25 FIB1 KIAA1773 PCDH16 Homo sapiens (Human) adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration involved in endocardial cushion formation [GO:0003273]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; cochlea development [GO:0090102]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mitral valve formation [GO:0003192]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; ossification involved in bone maturation [GO:0043931]; pattern specification process [GO:0007389]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659] GO:0000902; GO:0001658; GO:0003192; GO:0003273; GO:0005509; GO:0005912; GO:0007043; GO:0007156; GO:0007157; GO:0007389; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0021915; GO:0022008; GO:0034332; GO:0035329; GO:0036342; GO:0043931; GO:0045177; GO:0045296; GO:0048565; GO:0072137; GO:0072659; GO:0090102; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] ALTVRAEGPGGAGAR 0.99325 -14.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1495 0 0 0 0 0 0 10.6297 0 0 0 0 10.6944 11.8591 0 0 0 0 0 9.70122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8341 0 0 0 0 0 0 0 0 0 0 0 14.519 17.2069 13.8587 0 14.0889 0 0 14.0125 0 0 0 13.7215 0 13.1683 0 0 0 0 0 13.9355 0 13.4475 0 0 0 0 0 0 13.127 0 0 0 0 0 17.616 0 0 0 0 0 15.6891 0 13.5401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9494 0 10.024 0 0 14.9239 13.9882 12.8625 0 0 12.7251 13.7374 13.4153 13.8505 14.2875 14.0177 0 0 0 0 17.9434 14.8702 0 0 12.938 0 0 0 0 Q96SB4 SRPK1_HUMAN "SRSF protein kinase 1, EC 2.7.11.1 (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1, SR-protein-specific kinase 1)" SRPK1 Homo sapiens (Human) "chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000287; GO:0000785; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007059; GO:0008380; GO:0016363; GO:0016607; GO:0035092; GO:0035556; GO:0045070; GO:0045071; GO:0045087; GO:0048024; GO:0050684; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] ESGPGQK 0.99325 -39.264 0 9.93261 0 0 0 0 0 0 12.8748 0 0 0 0 0 11.3932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5125 0 0 12.4706 0 13.1591 0 0 0 0 12.2559 0 0 0 0 0 0 12.6337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3511 0 0 0 12.5603 0 0 12.3464 13.328 13.6937 0 13.4597 0 14.3169 13.5523 0 0 0 0 0 0 0 0 0 0 0 14.2202 0 0 0 0 0 0 0 0 0 12.5061 12.2196 0 0 12.4068 0 0 13.9604 12.5496 0 0 12.8206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8015 0 0 0 0 12.1498 0 0 0 0 0 12.1337 0 0 11.1821 0 11.6542 13.1285 0 0 0 12.8517 0 0 0 0 13.7307 0 0 0 11.8041 0 0 0 13.6874 0 0 0 0 0 13.3283 0 0 0 0 0 13.3428 15.5768 0 0 Q9H9S5 FKRP_HUMAN "Ribitol 5-phosphate transferase FKRP, EC 2.7.8.- (Fukutin-related protein) (Ribitol-5-phosphate transferase)" FKRP Homo sapiens (Human) protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262] cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383] "cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]" GO:0000139; GO:0002162; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0016021; GO:0016485; GO:0016780; GO:0035269; GO:0042383; GO:0042802; GO:0046872; GO:0051262 "dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]" CDALDGDAVVLLR 0.99325 -6.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8604 0 0 0 0 0 0 0 0 0 0 0 0 13.6253 12.8522 0 0 13.8128 12.8259 13.4374 0 0 0 13.8701 0 0 0 0 0 16.4146 0 14.3931 0 0 0 0 0 13.6613 0 12.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4313 0 0 0 0 0 0 0 11.3382 0 0 0 0 0 0 0 0 0 0 0 0 10.4947 0 Q9NQ79 CRAC1_HUMAN "Cartilage acidic protein 1 (68 kDa chondrocyte-expressed protein, CEP-68) (ASPIC)" CRTAC1 ASPIC1 CEP68 Homo sapiens (Human) axonal fasciculation [GO:0007413] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; axonal fasciculation [GO:0007413] GO:0005509; GO:0007413; GO:0070062 calcium ion binding [GO:0005509] DVAAEAGVSK 0.99325 -16.828 0 0 0 0 0 0 0 0 0 0 14.6121 14.9825 0 15.7778 0 0 0 0 0 0 14.2032 0 0 0 0 0 0 0 13.5612 0 12.4555 0 0 0 0 13.2835 0 0 0 0 0 0 0 12.8356 0 0 13.1527 0 0 13.5206 0 15.7076 14.6169 13.574 13.7283 0 0 0 12.3815 0 0 11.945 0 0 0 0 11.6818 12.5799 11.6906 0 0 0 0 0 18.3999 0 0 0 17.1873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3875 0 0 17.4841 17.5749 0 0 0 0 0 17.2621 0 16.9508 0 0 19.0105 17.7823 0 17.3708 0 11.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9756 0 11.0477 16.4889 16.6276 0 0 16.2146 0 18.0565 16.1971 16.1495 0 0 15.8616 0 0 0 0 16.573 0 0 0 16.1887 0 0 15.7784 0 15.998 0 16.6994 16.3511 0 0 0 0 15.9201 16.9154 15.9614 0 0 0 0 Q9UBT7 CTNL1_HUMAN "Alpha-catulin (Alpha-catenin-related protein, ACRP) (Catenin alpha-like protein 1)" CTNNAL1 Homo sapiens (Human) cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266] GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0007266; GO:0045296; GO:0051015 actin filament binding [GO:0051015]; cadherin binding [GO:0045296] AARLLLSSVTKVLLLADR 0.99325 -16.836 0 0 0 0 9.68048 0 0 0 13.9621 0 0 0 0 0 0 0 0 0 11.1667 0 0 0 0 0 10.2175 0 0 0 0 11.4792 0 0 0 0 0 11.8299 0 0 0 0 13.0693 0 0 0 0 0 0 0 0 0 0 0 10.4333 0 0 0 0 0 11.6593 0 0 0 0 0 0 0 0 11.2954 0 0 0 0 0 0 10.5404 0 11.5755 0 0 0 14.4574 11.9041 13.2085 0 0 0 11.6676 12.5731 13.2357 0 0 0 14.1415 11.3068 0 0 13.111 0 0 0 0 0 0 0 13.8056 0 13.7976 0 0 0 0 0 0 0 0 0 0 0 14.0591 0 11.6919 0 0 13.831 0 0 0 0 0 0 0 0 10.3737 0 0 0 13.9992 0 13.7888 0 0 0 0 13.5152 14.0493 0 0 11.1492 14.0146 0 13.6844 0 0 11.0948 0 0 0 13.309 0 0 0 0 13.8634 0 0 0 0 0 13.3132 13.1765 13.3455 0 12.9966 13.4707 0 0 0 0 13.5215 13.2506 Q9UPR3 SMG5_HUMAN "Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog, hSMG-5)" SMG5 EST1B KIAA1089 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]" GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0042162; GO:0042826; GO:0051721; GO:0070034 histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625] ASEGSDSGSDK 0.99325 -5.239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3849 0 0 0 0 15.0545 0 14.151 0 0 0 0 0 0 0 14.094 13.4472 11.9505 0 0 0 0 0 13.9768 0 13.2129 0 12.4905 0 14.6781 14.5083 14.108 0 0 0 0 13.2157 12.4133 0 0 0 0 12.7434 9.51623 0 0 0 0 0 0 14.1606 0 0 10.2489 11.0172 11.9054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1343 12.5419 13.7814 14.973 0 0 13.5122 0 0 0 10.9049 0 0 0 0 0 0 10.7979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3677 0 0 0 0 0 0 0 0 0 0 0 O60701 UGDH_HUMAN "UDP-glucose 6-dehydrogenase, UDP-Glc dehydrogenase, UDP-GlcDH, UDPGDH, EC 1.1.1.22" UGDH Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065] GO:0001702; GO:0003979; GO:0005634; GO:0005654; GO:0005829; GO:0005975; GO:0006024; GO:0006065; GO:0015012; GO:0030206; GO:0034214; GO:0042802; GO:0048666; GO:0051287; GO:0070062 identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979] DLKNPDR 0.99326 -17.39 0 13.4675 0 0 0 0 0 0 0 0 0 0 14.3308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8817 0 0 0 0 0 11.6552 0 0 13.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00387 NB5R3_HUMAN "NADH-cytochrome b5 reductase 3, B5R, Cytochrome b5 reductase, EC 1.6.2.2 (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form ]" CYB5R3 DIA1 Homo sapiens (Human) blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; nitric oxide biosynthetic process [GO:0006809] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958] "azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; nitric oxide biosynthetic process [GO:0006809]" GO:0004128; GO:0005576; GO:0005737; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0005811; GO:0005833; GO:0006695; GO:0006809; GO:0008015; GO:0016020; GO:0035578; GO:0071949; GO:1903958 "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]" FPAGGKMSQYLESMQIGDTIEFR 0.99326 -6.9678 0 0 0 0 0 0 0 0 0 11.9185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5866 0 0 0 0 0 0 15.1917 0 0 0 0 0 0 12.6292 12.7741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0199 0 13.8128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54756 EPHA5_HUMAN "Ephrin type-A receptor 5, EC 2.7.10.1 (Brain-specific kinase) (EPH homology kinase 1, EHK-1) (EPH-like kinase 7, EK7, hEK7)" EPHA5 BSK EHK1 HEK7 TYRO4 Homo sapiens (Human) axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of kinase activity [GO:0033674]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791] axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cAMP-mediated signaling [GO:0019933]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; neuron development [GO:0048666]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of kinase activity [GO:0033674]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005003; GO:0005004; GO:0005005; GO:0005524; GO:0005791; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0009897; GO:0019933; GO:0021766; GO:0030424; GO:0030425; GO:0032793; GO:0032956; GO:0033674; GO:0043005; GO:0043025; GO:0043087; GO:0043235; GO:0048013; GO:0048471; GO:0048666; GO:0061178 ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] CMCKAGYEEK 0.99326 -16.099 0 0 0 0 0 0 0 0 0 0 0 11.6216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2561 0 0 0 0 0 0 11.014 0 0 0 0 0 11.4451 0 0 0 0 12.9511 0 0 0 11.3866 11.5652 0 0 0 0 12.1099 0 0 0 0 0 0 0 12.9029 0 0 0 0 0 0 0 0 0 13.3403 0 13.6511 0 0 0 9.73767 0 0 0 12.9743 0 0 0 0 0 0 0 13.3468 0 13.285 14.1321 0 0 0 13.2368 0 12.7482 14.2838 0 0 12.6191 0 0 0 12.8546 13.1112 0 0 0 0 0 12.5926 0 0 12.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.679 0 11.6577 0 0 0 0 P59551 T2R60_HUMAN "Taste receptor type 2 member 60, T2R60 (Taste receptor type 2 member 56, T2R56)" TAS2R60 Homo sapiens (Human) sensory perception of bitter taste [GO:0050913] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of bitter taste [GO:0050913] GO:0004930; GO:0005886; GO:0016021; GO:0050913 G protein-coupled receptor activity [GO:0004930] AIILVTILLLLR 0.99326 -5.2435 12.2597 0 0 0 12.3858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0841 12.5041 0 0 0 0 0 0 0 0 0 0 0 0 11.2475 0 0 0 0 10.3336 0 0 12.8548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8519 9.96047 0 13.6502 0 0 12.944 0 0 0 0 0 12.4728 0 12.5029 11.3808 0 0 0 13.6881 13.7723 14.1707 0 11.2011 0 0 0 0 0 0 14.0848 0 14.4195 0 0 0 0 0 0 0 12.973 0 14.5471 0 0 0 0 14.2841 0 14.3359 0 0 0 11.0044 11.8012 10.2081 0 10.5216 13.5504 0 0 12.7872 12.6065 0 14.1558 14.3859 0 0 14.4927 0 0 11.8751 0 13.7179 0 13.043 11.9492 0 0 0 0 0 15.6959 0 0 10.9955 13.8804 13.0323 11.9468 0 0 0 0 0 0 0 0 0 0 11.8364 0 0 0 12.2253 12.7194 0 14.0913 0 0 0 12.8176 0 0 0 Q6ZRR5 TLCD5_HUMAN TLC domain-containing protein 5 (Transmembrane protein 136) TLCD5 TMEM136 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 HRSYEWSCR 0.99326 -16.109 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6401 0 0 11.7412 0 0 0 12.589 0 0 0 0 0 0 0 0 Q6ZTY9 CG065_HUMAN Putative uncharacterized protein LINC02902 (Long intergenic non-protein coding RNA 2902) LINC02902 C7orf65 Homo sapiens (Human) ACWGSRELLFLFK 0.99326 -14.226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3565 0 0 0 0 0 0 13.7326 13.9593 0 0 0 0 0 0 0 0 0 13.3285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9051 0 0 0 0 0 12.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZU69 F205A_HUMAN Protein FAM205A FAM205A C9orf144B Homo sapiens (Human) integral component of membrane [GO:0016021]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; nucleus [GO:0005634] GO:0005634; GO:0016021 AQSRPAQK 0.99326 -27.28 0 0 0 0 0 0 0 0 14.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1566 0 0 12.9006 13.937 14.9 13.9864 12.1008 12.2855 0 0 0 12.1241 12.8259 0 0 0 0 12.2465 0 0 0 0 0 0 0 0 13.1213 0 0 0 0 0 12.4676 0 0 0 0 13.9944 14.7454 14.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7644 14.565 12.7038 0 0 0 0 0 0 0 0 14.1771 0 0 11.3044 0 0 0 0 0 0 0 0 0 0 0 0 Q8NAT2 TDRD5_HUMAN Tudor domain-containing protein 5 TDRD5 TUDOR3 Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; P granule [GO:0043186]; pi-body [GO:0071546] chromatoid body [GO:0033391]; P granule [GO:0043186]; pi-body [GO:0071546]; DNA methylation involved in gamete generation [GO:0043046]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] GO:0007283; GO:0007286; GO:0030719; GO:0033391; GO:0034587; GO:0043046; GO:0043186; GO:0071546 ACVSSPPRNSLSTAAVK 0.99326 -17.385 0 0 0 0 0 0 0 0 13.9877 0 0 0 0 0 0 0 9.42819 0 0 0 0 14.8597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9763 0 0 0 0 0 0 0 0 11.9271 12.7072 0 0 0 0 11.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8221 0 0 0 0 0 13.5054 0 0 10.7841 0 0 0 0 13.6311 0 13.9738 12.8931 0 0 0 0 0 0 12.1569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4615 12.3355 0 0 0 0 10.6122 0 0 0 0 0 0 0 0 0 0 0 0 11.759 12.7389 13.6066 11.7522 0 0 0 0 12.3595 0 0 0 0 0 0 0 0 0 0 11.1828 0 15.2674 0 12.1614 13.6299 15.1305 0 0 0 0 11.0774 12.4044 0 0 0 0 0 12.6144 0 0 0 0 0 13.3347 Q8TCG1 CIP2A_HUMAN Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen) CIP2A KIAA1524 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803] GO:0005737; GO:0005829; GO:0005886; GO:0016021; GO:0042803; GO:0045296 cadherin binding [GO:0045296]; protein homodimerization activity [GO:0042803] DPDSSSK 0.99326 -6.3208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.031 0 12.7499 13.5902 15.2163 0 14.4941 14.5832 0 14.5352 12.3744 0 14.6861 0 0 0 14.8681 13.081 0 0 12.65 0 0 13.6822 0 0 0 0 0 0 0 0 15.5 12.645 0 0 0 0 0 12.3087 0 0 0 0 0 0 0 12.2009 0 13.4495 0 0 0 0 0 13.813 0 0 0 0 12.6833 0 0 0 0 0 0 0 0 0 0 12.6479 0 0 0 14.2363 0 0 0 0 0 0 0 0 0 0 0 0 11.963 0 12.4459 0 0 0 0 0 0 0 11.7695 0 Q96S42 NODAL_HUMAN Nodal homolog NODAL Homo sapiens (Human) axial mesodermal cell fate specification [GO:0048327]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cell migration involved in gastrulation [GO:0042074]; cell population proliferation [GO:0008283]; digestive tract morphogenesis [GO:0048546]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic pattern specification [GO:0009880]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endodermal cell differentiation [GO:0035987]; epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [GO:0060802]; floor plate morphogenesis [GO:0033505]; formation of anatomical boundary [GO:0048859]; germ cell development [GO:0007281]; heart looping [GO:0001947]; inhibition of neuroepithelial cell differentiation [GO:0002085]; left lung morphogenesis [GO:0060460]; liver development [GO:0001889]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; mesendoderm development [GO:0048382]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell development [GO:0010721]; negative regulation of chorionic trophoblast cell proliferation [GO:1901383]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of trophoblast cell migration [GO:1901164]; neural fold formation [GO:0001842]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; placenta development [GO:0001890]; polarity specification of proximal/distal axis [GO:0010085]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of gastrulation [GO:0010470]; regulation of stem cell population maintenance [GO:2000036]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway involved in primitive streak formation [GO:0090010]; trophectodermal cellular morphogenesis [GO:0001831]; vasculature development [GO:0001944] extracellular space [GO:0005615] extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]; type I activin receptor binding [GO:0070698]; axial mesodermal cell fate specification [GO:0048327]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cell migration involved in gastrulation [GO:0042074]; cell population proliferation [GO:0008283]; digestive tract morphogenesis [GO:0048546]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic pattern specification [GO:0009880]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endodermal cell differentiation [GO:0035987]; epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [GO:0060802]; floor plate morphogenesis [GO:0033505]; formation of anatomical boundary [GO:0048859]; germ cell development [GO:0007281]; heart looping [GO:0001947]; inhibition of neuroepithelial cell differentiation [GO:0002085]; left lung morphogenesis [GO:0060460]; liver development [GO:0001889]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; mesendoderm development [GO:0048382]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell development [GO:0010721]; negative regulation of chorionic trophoblast cell proliferation [GO:1901383]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of trophoblast cell migration [GO:1901164]; neural fold formation [GO:0001842]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; placenta development [GO:0001890]; polarity specification of proximal/distal axis [GO:0010085]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of gastrulation [GO:0010470]; regulation of stem cell population maintenance [GO:2000036]; SMAD protein signal transduction [GO:0060395]; somatic stem cell population maintenance [GO:0035019]; transforming growth factor beta receptor signaling pathway involved in primitive streak formation [GO:0090010]; trophectodermal cellular morphogenesis [GO:0001831]; vasculature development [GO:0001944] GO:0000122; GO:0001831; GO:0001842; GO:0001889; GO:0001890; GO:0001892; GO:0001893; GO:0001944; GO:0001947; GO:0002085; GO:0005125; GO:0005615; GO:0007281; GO:0007420; GO:0008083; GO:0008283; GO:0009880; GO:0010085; GO:0010470; GO:0010575; GO:0010721; GO:0010862; GO:0016015; GO:0022409; GO:0030509; GO:0032927; GO:0033505; GO:0035019; GO:0035987; GO:0042074; GO:0043280; GO:0045766; GO:0045944; GO:0048327; GO:0048382; GO:0048546; GO:0048701; GO:0048859; GO:0050679; GO:0051091; GO:0060136; GO:0060137; GO:0060391; GO:0060395; GO:0060460; GO:0060766; GO:0060802; GO:0070374; GO:0070698; GO:0090010; GO:1900164; GO:1900224; GO:1901164; GO:1901383; GO:2000036 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]; type I activin receptor binding [GO:0070698] DMIVEECGCL 0.99326 -6.9553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3S7 PTN23_HUMAN "Tyrosine-protein phosphatase non-receptor type 23, EC 3.1.3.48 (His domain-containing protein tyrosine phosphatase, HD-PTP) (Protein tyrosine phosphatase TD14, PTP-TD14)" PTPN23 KIAA1471 Homo sapiens (Human) cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein dephosphorylation [GO:0006470]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein dephosphorylation [GO:0006470]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006470; GO:0010633; GO:0016604; GO:0019901; GO:0032456; GO:0036064; GO:0043162; GO:0043231; GO:0043328; GO:0045022; GO:0060271; GO:0061357; GO:0070062; GO:1903387; GO:1903393; GO:2000643 protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] AELAEVRR 0.99326 -27.142 0 0 0 0 0 0 0 10.0274 14.2006 0 0 14.1036 14.0334 0 0 0 12.4382 12.1963 12.7149 0 14.0024 0 13.1584 0 12.9997 0 12.9735 0 0 13.3971 0 0 0 0 13.6387 0 0 0 0 13.8719 0 0 13.5105 13.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4019 0 13.8113 0 0 0 0 0 13.4045 14.4481 0 0 0 0 0 0 0 13.6421 0 0 0 0 13.5633 0 12.9729 0 14.5246 0 15.8507 0 0 13.3923 0 0 0 0 14.1752 0 0 12.9806 0 13.5885 0 0 13.478 14.0411 0 13.6892 0 13.6952 0 0 13.2786 14.0118 13.0718 0 0 11.1473 12.925 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3313 0 0 0 14.0026 0 0 0 15.252 14.659 0 0 15.0429 0 0 0 0 14.519 0 0 0 0 11.6931 13.0447 0 0 13.9809 0 0 0 0 0 11.6534 A4QMS7 CE049_HUMAN Uncharacterized protein C5orf49 C5orf49 Homo sapiens (Human) ciliary basal body [GO:0036064] ciliary basal body [GO:0036064] GO:0036064 EHSYYYR 0.99327 -13.21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8507 0 0 0 0 0 0 14.8893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07099 HYEP_HUMAN "Epoxide hydrolase 1, EC 3.3.2.9 (Epoxide hydratase) (Microsomal epoxide hydrolase, mEH)" EPHX1 EPHX EPOX Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; aromatic compound catabolic process [GO:0019439]; epoxide metabolic process [GO:0097176]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; arachidonic acid metabolic process [GO:0019369]; aromatic compound catabolic process [GO:0019439]; epoxide metabolic process [GO:0097176]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] GO:0004301; GO:0005789; GO:0006805; GO:0009636; GO:0014070; GO:0016021; GO:0019369; GO:0019439; GO:0033961; GO:0097176 cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301] FRFTPPLEDSCFHYGFNSNYLK 0.99327 -16.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.245 15.4263 14.1651 14.7166 0 15.2594 0 13.6908 0 0 13.7924 0 14.7975 0 13.9081 0 0 13.5203 0 11.7751 0 0 14.4167 13.841 0 0 13.3861 0 0 0 13.4115 0 0 13.9284 0 0 0 0 0 13.5742 0 13.4194 0 0 0 0 0 0 13.2489 0 0 0 0 13.0292 0 0 0 0 0 0 12.7781 0 0 0 12.4586 0 0 0 0 0 0 0 0 0 0 0 11.8206 0 0 0 0 0 12.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7714 0 P14678 RSMB_HUMAN "Small nuclear ribonucleoprotein-associated proteins B and B', snRNP-B (Sm protein B/B', Sm-B/B', SmB/B')" SNRPB COD SNRPB1 Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; brain development [GO:0007420]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone pre-mRNA 3'end processing complex [GO:0071204]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683]; histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U1 snRNP binding [GO:1990446]; U2 snRNP binding [GO:1990447]; 7-methylguanosine cap hypermethylation [GO:0036261]; brain development [GO:0007420]; mRNA splicing, via spliceosome [GO:0000398]; protein methylation [GO:0006479]; RNA splicing [GO:0008380]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005683; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005697; GO:0005737; GO:0005829; GO:0006479; GO:0007420; GO:0008380; GO:0030532; GO:0034709; GO:0034719; GO:0036261; GO:0046540; GO:0070034; GO:0071004; GO:0071005; GO:0071007; GO:0071013; GO:0071204; GO:0071208; GO:1903241; GO:1990446; GO:1990447 histone pre-mRNA DCP binding [GO:0071208]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; U1 snRNP binding [GO:1990446]; U2 snRNP binding [GO:1990447] HMNLILCDCDEFRK 0.99327 -27.373 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2336 0 0 0 0 0 0 12.5204 0 0 0 0 0 0 0 0 0 0 0 0 14.0928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2225 0 13.723 0 0 0 0 0 0 0 0 0 0 11.1705 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1736 0 13.049 0 0 0 0 12.3893 0 11.7185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6814 0 0 11.9143 0 0 0 0 0 0 0 11.5911 0 0 11.3096 P52742 ZN135_HUMAN Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1) ZNF135 ZNF61 ZNF78L1 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007010; GO:0022604; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" PYECNDCGKAFSHSSSLTK 0.99327 -6.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2371 0 0 11.8759 0 13.684 0 0 0 0 13.6855 0 0 0 0 0 0 0 12.7742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6182 0 0 0 0 0 0 0 0 0 0 0 0 P58499 FAM3B_HUMAN "Protein FAM3B (Cytokine-like protein 2-21) (Pancreatic-derived factor, PANDER)" FAM3B C21orf11 C21orf76 PRED44 UNQ320/PRO365 Homo sapiens (Human) apoptotic process [GO:0006915]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; apoptotic process [GO:0006915]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073] GO:0005125; GO:0005576; GO:0005615; GO:0006915; GO:0030073; GO:0042593; GO:0070062 cytokine activity [GO:0005125] CDHWTPCPSDTYAYR 0.99327 -16.6 0 0 0 0 0 0 0 0 10.1904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7396 0 12.4639 12.576 12.4903 12.8949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2147 0 0 0 0 0 0 0 0 0 0 0 13.5744 0 0 0 13.1391 0 0 0 0 0 0 0 14.4631 13.1605 0 0 10.3223 0 0 0 0 0 0 0 0 0 13.2357 0 0 0 0 0 0 13.0923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16880 CGT_HUMAN "2-hydroxyacylsphingosine 1-beta-galactosyltransferase, EC 2.4.1.47 (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase)" UGT8 CGT UGT4 Homo sapiens (Human) central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid metabolic process [GO:0006687]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid metabolic process [GO:0006687]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]" GO:0002175; GO:0003851; GO:0005783; GO:0005886; GO:0006682; GO:0006687; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0016021; GO:0030913; GO:0047263; GO:0048812 "2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity [GO:0003851]; N-acylsphingosine galactosyltransferase activity [GO:0047263]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]" AQKLSEIHK 0.99327 -16.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5042 0 0 0 12.4616 12.2731 0 0 13.8516 0 0 0 0 14.9951 0 12.4058 0 14.5036 0 0 0 13.9929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0013 0 14.9484 0 0 0 0 0 0 0 0 0 12.302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3884 0 Q3LFD5 UBP41_HUMAN "Putative ubiquitin carboxyl-terminal hydrolase 41, EC 3.4.19.12 (Deubiquitinating enzyme 41) (Ubiquitin thioesterase 41) (Ubiquitin-specific-processing protease 41)" USP41 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] CFCENCGK 0.99327 -5.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6368 0 0 16.0567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q494W8 CRFM7_HUMAN CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10) CHRFAM7A Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]" GO:0004888; GO:0005231; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007271; GO:0022848; GO:0030594; GO:0034220; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:1904315 acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] CQDESEAVCSEWK 0.99327 -5.0696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5911 0 0 10.892 0 0 0 0 0 0 0 0 0 0 0 0 11.0799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9233 0 0 13.6572 14.0037 13.8003 0 0 0 0 0 0 0 11.5695 0 0 0 0 13.0162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.376 14.3191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3807 0 13.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5PRF9 SMAG2_HUMAN "Protein Smaug homolog 2, Smaug 2, hSmaug2 (Sterile alpha motif domain-containing protein 4B, SAM domain-containing protein 4B)" SAMD4B SMAUG2 Homo sapiens (Human) nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0030371 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371] LLRTFPR 0.99327 -5.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1355 0 0 0 0 12.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8428 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W111 SPRY7_HUMAN "SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein, CLL deletion region gene 6 protein)" SPRYD7 C13orf1 CLLD6 Homo sapiens (Human) EMPAVQLDTQHMGTDVVIVK 0.99327 -6.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3472 0 12.3108 0 0 0 0 0 0 0 0 0 0 17.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6R327 RICTR_HUMAN "Rapamycin-insensitive companion of mTOR (AVO3 homolog, hAVO3)" RICTOR KIAA1999 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of protein kinase B signaling [GO:0051896]; TORC2 signaling [GO:0038203] cytosol [GO:0005829]; TORC2 complex [GO:0031932] cytosol [GO:0005829]; TORC2 complex [GO:0031932]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; actin cytoskeleton reorganization [GO:0031532]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of GTPase activity [GO:0043087]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of protein kinase B signaling [GO:0051896]; TORC2 signaling [GO:0038203] GO:0005829; GO:0007010; GO:0009792; GO:0010468; GO:0016310; GO:0018105; GO:0019901; GO:0030307; GO:0030838; GO:0031532; GO:0031669; GO:0031932; GO:0032008; GO:0032956; GO:0033135; GO:0038203; GO:0043022; GO:0043066; GO:0043087; GO:0043539; GO:0050727; GO:0050731; GO:0051896; GO:0051897; GO:2000114 protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022] ADVELER 0.99327 -14.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4696 0 0 0 0 0 0 12.255 0 0 13.8053 0 0 0 0 0 0 0 0 0 0 0 0 0 12.091 13.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8111 0 0 0 0 11.5298 12.8155 12.9014 15.0064 0 0 18.6623 12.5668 13.3425 13.4057 0 0 0 14.1729 17.1906 0 15.0209 14.7236 12.75 13.8689 0 13.1252 12.7087 13.2287 13.2669 0 0 0 13.7582 12.383 0 0 14.464 0 0 13.6177 12.8502 13.5446 15.2008 14.4909 0 14.1046 0 0 13.9654 0 14.2774 0 0 12.376 13.4707 0 12.3514 20.0566 13.3491 14.5973 20.6031 12.5282 13.2664 15.4487 0 14.0937 0 0 0 13.4508 0 0 11.4863 15.0068 14.6338 16.0656 19.1144 19.4181 18.9382 0 12.2157 0 0 0 0 15.9307 17.1807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58432 0 0 0 15.8507 13.0792 0 0 0 0 13.7449 0 Q8IYX1 TBC21_HUMAN TBC1 domain family member 21 (Male germ cell Rab GTPase-activating protein) TBC1D21 MGCRABGAP Homo sapiens (Human) activation of GTPase activity [GO:0090630]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; sperm midpiece [GO:0097225] acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; sperm midpiece [GO:0097225]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283] GO:0001669; GO:0003779; GO:0005096; GO:0005856; GO:0007283; GO:0007288; GO:0030317; GO:0070062; GO:0090630; GO:0097225; GO:0120317 actin binding [GO:0003779]; GTPase activator activity [GO:0005096] ALCQMYEK 0.99327 -14.246 0 0 0 0 0 0 0 0 11.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6474 0 0 0 0 0 0 0 0 0 10.8775 0 10.1698 14.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1284 0 0 0 0 0 0 0 0 11.8145 0 0 0 12.0336 0 0 0 0 11.9671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0053 0 0 0 0 11.0885 12.6076 0 15.3124 0 0 0 12.7837 0 0 0 0 0 0 0 0 0 14.2017 0 0 0 0 0 0 0 0 Q8N6N6 NATD1_HUMAN Protein NATD1 (N-acetyltransferase domain-containing protein 1) NATD1 C17orf103 GTLF3B Homo sapiens (Human) AHLTCWYIQK 0.99327 -16.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6185 0 0 12.7255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AA8 JKIP2_HUMAN Janus kinase and microtubule-interacting protein 2 (CTCL tumor antigen HD-CL-04) (Neuroendocrine long coiled-coil protein 1) JAKMIP2 JAMIP2 KIAA0555 NECC1 Homo sapiens (Human) Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; kinase binding [GO:0019900]; microtubule binding [GO:0008017] GO:0005794; GO:0008017; GO:0019900 kinase binding [GO:0019900]; microtubule binding [GO:0008017] AVTKENSEMREK 0.99327 -14.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2217 0 0 0 0 12.7879 0 0 0 0 0 0 0 0 0 0 0 10.1769 0 0 12.4978 11.0643 0 0 13.157 0 0 0 0 0 0 0 11.5432 0 0 11.7811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1939 0 0 0 0 0 0 0 0 0 0 13.3479 0 0 0 13.7371 0 12.8162 13.7936 0 0 0 0 14.1891 12.842 12.3772 12.07 0 14.2384 0 0 0 13.2381 12.8301 13.4337 0 0 12.8994 0 0 0 0 0 0 0 0 0 0 0 11.9452 0 0 0 19.139 0 0 0 12.9067 0 11.9231 0 0 0 0 0 0 0 0 10.7763 0 0 0 0 0 0 0 0 0 0 13.6774 14.1491 0 0 0 14.3008 0 0 0 0 0 0 0 13.3151 0 0 0 12.2643 Q96KC8 DNJC1_HUMAN DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417] GO:0001671; GO:0003677; GO:0005783; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0012505; GO:0016020; GO:0016021; GO:0031965; GO:0045861; GO:0050708; GO:0051087 ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677] DDERRQR 0.99327 -16.625 0 0 0 0 0 0 0 0 0 0 10.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3168 0 0 0 0 0 12.5084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7872 0 0 0 0 0 13.4861 0 0 0 0 11.502 0 0 0 0 0 0 12.2742 0 0 0 0 0 0 11.5657 0 12.3644 12.5301 0 11.5177 0 0 0 0 12.352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.909 0 13.0601 0 0 0 0 0 0 0 0 0 10.2318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.343 0 0 0 0 0 Q99426 TBCB_HUMAN Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B) TBCB CG22 CKAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0015630; GO:0030154 MEVTGVSAPTVTVFISSSLNTFRSEK 0.99327 -5.0735 0 0 0 0 0 0 0 0 10.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2269 11.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8488 0 0 0 0 0 0 0 0 0 0 10.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQE4 SELS_HUMAN "Selenoprotein S, SelS (VCP-interacting membrane protein)" SELENOS SELS VIMP AD-015 SBBI8 Homo sapiens (Human) "cell redox homeostasis [GO:0045454]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; establishment of protein localization [GO:0045184]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of gluconeogenesis [GO:0006111]; regulation of nitric oxide metabolic process [GO:0080164]; response to glucose [GO:0009749]; response to redox state [GO:0051775]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361] "cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; antioxidant activity [GO:0016209]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin-specific protease binding [GO:1990381]; cell redox homeostasis [GO:0045454]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; establishment of protein localization [GO:0045184]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of gluconeogenesis [GO:0006111]; regulation of nitric oxide metabolic process [GO:0080164]; response to glucose [GO:0009749]; response to redox state [GO:0051775]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0002865; GO:0005783; GO:0005789; GO:0005881; GO:0005886; GO:0006111; GO:0006983; GO:0009749; GO:0016209; GO:0019899; GO:0030176; GO:0030433; GO:0030968; GO:0030970; GO:0032715; GO:0032720; GO:0032869; GO:0034361; GO:0034362; GO:0034599; GO:0036502; GO:0036513; GO:0038023; GO:0045184; GO:0045454; GO:0045719; GO:0046325; GO:0050728; GO:0051117; GO:0051771; GO:0051775; GO:0071222; GO:0080164; GO:1902236; GO:1990381; GO:2000110 antioxidant activity [GO:0016209]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin-specific protease binding [GO:1990381] ALRQRQLDR 0.99327 -27.344 0 0 0 0 0 11.2481 0 0 0 0 0 0 0 0 0 14.9943 15.4151 13.6454 15.1066 15.5713 15.5908 13.9923 17.0643 16.4983 14.3833 15.6299 0 13.2195 0 0 9.78116 0 0 0 0 0 0 0 0 0 0 0 12.3243 0 0 12.4382 11.6074 12.3399 13.062 12.3773 12.7118 0 0 0 0 11.0048 0 0 0 0 0 0 0 0 14.1275 0 15.9223 15.9761 0 15.4439 0 0 15.3685 0 15.9916 15.9523 10.7836 0 16.1201 16.8065 16.456 16.2747 0 16.1649 18.1437 18.1328 0 17.5391 11.4709 16.5026 16.0366 15.6677 16.4052 13.556 15.3296 15.2973 15.5709 15.5365 0 0 17.1607 17.7751 15.6876 16.8133 16.1953 17.2192 17.049 10.1149 0 17.3466 11.0595 17.0322 18.2671 17.0132 15.0262 0 13.8246 0 15.829 16.8527 17.7615 17.1521 13.9984 16.9251 0 17.6386 16.4086 14.6714 10.7375 15.62 13.3903 0 15.5427 16.6313 16.562 13.4751 16.5201 17.0063 16.9084 10.4824 16.5498 10.5292 15.8971 17.027 15.0625 17.186 17.4068 13.1498 15.352 0 17.6436 16.6676 15.3446 16.705 16.385 15.6474 12.6813 0 0 0 0 0 0 0 11.8131 12.1778 9.75699 0 0 0 0 17.0401 15.8684 16.1177 14.0698 0 16.1031 0 0 0 Q9GZQ8 MLP3B_HUMAN "Microtubule-associated proteins 1A/1B light chain 3B (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B, MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta)" MAP1LC3B MAP1ALC3 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]; ceramide binding [GO:0097001]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; mitophagy [GO:0000423] GO:0000045; GO:0000421; GO:0000422; GO:0000423; GO:0005739; GO:0005776; GO:0005829; GO:0005874; GO:0005930; GO:0006914; GO:0006995; GO:0008017; GO:0009267; GO:0012505; GO:0016236; GO:0031090; GO:0031410; GO:0031625; GO:0031966; GO:0043231; GO:0097001; GO:0097352 ceramide binding [GO:0097001]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625] EQHPTKIPVIIER 0.99327 -13.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9106 10.6452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4374 0 0 0 0 0 0 0 16.4573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1R3 MYLK2_HUMAN "Myosin light chain kinase 2, skeletal/cardiac muscle, MLCK2, EC 2.7.11.18" MYLK2 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of muscle filament sliding [GO:0032971]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941] cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; synapse [GO:0045202] cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017]; synapse [GO:0045202]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687]; cardiac muscle contraction [GO:0060048]; cardiac muscle tissue morphogenesis [GO:0055008]; neuromuscular synaptic transmission [GO:0007274]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of gene expression [GO:0010628]; protein autophosphorylation [GO:0046777]; regulation of muscle filament sliding [GO:0032971]; skeletal muscle cell differentiation [GO:0035914]; skeletal muscle satellite cell differentiation [GO:0014816]; striated muscle contraction [GO:0006941] GO:0004683; GO:0004687; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006941; GO:0007274; GO:0010628; GO:0014816; GO:0018107; GO:0030017; GO:0032027; GO:0032971; GO:0035914; GO:0045202; GO:0046777; GO:0055008; GO:0060048 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; myosin light chain binding [GO:0032027]; myosin light chain kinase activity [GO:0004687] EALGGGK 0.99327 -16.59 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6355 0 0 0 0 14.7469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3222 0 0 0 0 0 0 0 0 0 0 0 13.5379 13.4302 0 0 0 0 0 13.5162 0 0 0 16.7756 0 0 13.4414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3478 15.0016 0 0 0 0 Q9NV06 DCA13_HUMAN DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1) DCAF13 WDSOF1 HSPC064 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]" cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] "cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; protein ubiquitination [GO:0016567]" GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0005813; GO:0005829; GO:0016567; GO:0030054; GO:0030331; GO:0032040; GO:0080008 nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723] AAKDYNQK 0.99327 -26.194 0 0 0 0 0 0 11.4298 0 0 0 0 0 0 0 0 0 0 0 12.0172 0 0 12.1814 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2139 0 11.645 0 0 0 0 0 0 0 0 0 0 11.5399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4037 0 13.2839 0 13.7388 0 0 0 0 0 0 12.7656 12.8553 0 0 0 11.8209 0 0 0 0 0 12.6725 0 0 0 0 0 12.8873 12.0371 0 0 0 0 12.7176 0 0 0 12.7575 13.1346 0 0 0 13.0335 0 12.0307 0 0 12.6231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6989 0 12.9248 0 0 0 0 0 0 0 11.7799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.551 0 0 0 0 P60827 C1QT8_HUMAN "Complement C1q tumor necrosis factor-related protein 8 (C1q/TNF-related protein 8, CTRP8)" C1QTNF8 UNQ5829/PRO19648 Homo sapiens (Human) positive regulation of cell motility [GO:2000147] collagen trimer [GO:0005581]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; positive regulation of cell motility [GO:2000147] GO:0005581; GO:0005615; GO:2000147 AAPALLLLALLLPVGAWPGLPR 0.99328 -6.5856 0 0 0 0 0 0 0 12.0698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0463 0 0 0 0 14.7237 0 0 0 0 0 0 0 15.2083 0 13.1531 0 0 13.8224 0 0 0 0 10.9764 13.5497 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4855 0 0 0 0 0 12.8641 0 0 0 0 0 14.5797 0 0 0 0 0 0 0 0 0 13.0518 0 0 0 0 13.0064 0 0 13.5899 0 0 0 14.2459 0 0 0 0 0 0 12.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.922 0 0 0 0 0 0 0 P78536 ADA17_HUMAN "Disintegrin and metalloproteinase domain-containing protein 17, ADAM 17, EC 3.4.24.86 (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b)" ADAM17 CSVP TACE Homo sapiens (Human) "amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; receptor transactivation [GO:0035624]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]" actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124]; amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; receptor transactivation [GO:0035624]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0000139; GO:0001666; GO:0001934; GO:0002446; GO:0002467; GO:0002690; GO:0004175; GO:0004222; GO:0005112; GO:0005138; GO:0005178; GO:0005737; GO:0005788; GO:0005829; GO:0005886; GO:0005887; GO:0006508; GO:0006509; GO:0007155; GO:0007173; GO:0007219; GO:0007220; GO:0008233; GO:0008237; GO:0008284; GO:0009410; GO:0009986; GO:0010820; GO:0015629; GO:0016020; GO:0016324; GO:0016485; GO:0017124; GO:0030165; GO:0030183; GO:0030307; GO:0030335; GO:0030511; GO:0030512; GO:0032496; GO:0032722; GO:0033025; GO:0033077; GO:0033627; GO:0035313; GO:0035624; GO:0042987; GO:0043536; GO:0045121; GO:0045737; GO:0045741; GO:0046872; GO:0048536; GO:0048870; GO:0050830; GO:0071403; GO:0120163; GO:1900087; GO:1902945; GO:1903265; GO:1905564 endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124] AASFKLQRQNR 0.99328 -6.8025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.328 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8343 0 0 0 0 0 0 0 0 0 12.7624 11.568 12.9143 0 0 0 12.4569 12.8974 11.7363 0 12.7211 0 0 0 0 0 0 11.7925 0 0 0 14.6283 15.0543 13.3962 0 14.1771 13.1679 14.2738 15.4139 14.2427 0 0 14.9451 14.9126 14.3955 0 0 12.23 0 13.1128 0 12.4568 0 0 0 13.4128 0 0 0 0 0 0 0 14.2216 12.6125 12.7469 13.5474 14.6608 0 13.4348 0 12.3 13.4802 0 12.4619 0 0 0 0 0 0 13.8968 0 0 0 0 0 13.3327 0 0 0 0 0 0 0 0 0 13.4455 0 0 11.8298 0 11.0802 0 0 0 0 0 0 0 0 0 0 12.7763 0 0 0 0 0 0 0 0 0 Q00005 2ABB_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform (PP2A subunit B isoform B55-beta) (PP2A subunit B isoform PR55-beta) (PP2A subunit B isoform R2-beta) (PP2A subunit B isoform beta) PPP2R2B Homo sapiens (Human) apoptotic process [GO:0006915] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein phosphatase type 2A complex [GO:0000159] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; apoptotic process [GO:0006915] GO:0000159; GO:0005739; GO:0005741; GO:0005829; GO:0005856; GO:0006915; GO:0019888 protein phosphatase regulator activity [GO:0019888] ASALCDR 0.99328 -6.5881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7767 0 14.0115 0 14.9215 0 0 12.1097 0 13.0279 12.2699 13.3514 13.2839 13.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13835 PKP1_HUMAN "Plakophilin-1 (Band 6 protein, B6P)" PKP1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; intermediate filament bundle assembly [GO:0045110]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165] adherens junction [GO:0005912]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; intermediate filament [GO:0005882]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; ficolin-1-rich granule membrane [GO:0101003]; intermediate filament [GO:0005882]; messenger ribonucleoprotein complex [GO:1990124]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; lamin binding [GO:0005521]; structural constituent of skin epidermis [GO:0030280]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; intermediate filament bundle assembly [GO:0045110]; negative regulation of mRNA catabolic process [GO:1902373]; positive regulation of gene expression [GO:0010628]; signal transduction [GO:0007165] GO:0001533; GO:0005521; GO:0005634; GO:0005654; GO:0005737; GO:0005882; GO:0005886; GO:0005912; GO:0007043; GO:0007155; GO:0007165; GO:0010628; GO:0019215; GO:0030057; GO:0030280; GO:0045110; GO:0045296; GO:0098609; GO:0101003; GO:1902373; GO:1990124 cadherin binding [GO:0045296]; intermediate filament binding [GO:0019215]; lamin binding [GO:0005521]; structural constituent of skin epidermis [GO:0030280] EAVSLLRR 0.99328 -16.631 0 0 0 0 0 12.3299 12.3396 0 10.7903 13.9684 0 13.7348 0 13.7677 0 0 0 12.8081 0 0 0 11.3025 0 0 0 0 0 0 13.2251 12.4706 0 0 0 0 0 0 0 0 0 0 13.1308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4138 0 0 0 0 0 0 0 0 0 0 0 0 12.8388 14.4145 0 13.3465 0 0 0 0 0 0 12.8877 0 0 0 0 0 0 0 0 0 0 0 12.2945 0 0 0 12.2447 0 13.2925 0 0 0 13.5983 0 0 0 0 0 0 0 12.8584 0 0 0 0 0 0 12.0871 0 0 0 0 0 0 13.4418 0 0 0 0 0 0 0 13.0631 0 12.6095 11.7992 0 0 0 0 0 0 0 0 13.454 0 0 0 0 0 11.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14831 GRM7_HUMAN "Metabotropic glutamate receptor 7, mGluR7" GRM7 GPRC1G MGLUR7 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axon development [GO:0061564]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glycosylation [GO:0070085]; negative regulation of glutamate secretion [GO:0014050]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]" asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235] "asymmetric synapse [GO:0032279]; axon [GO:0030424]; cell cortex [GO:0005938]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; axon development [GO:0061564]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glycosylation [GO:0070085]; negative regulation of glutamate secretion [GO:0014050]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]" GO:0001640; GO:0001642; GO:0005509; GO:0005886; GO:0005887; GO:0005938; GO:0007193; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0008066; GO:0010855; GO:0014050; GO:0016021; GO:0016595; GO:0030165; GO:0030424; GO:0030425; GO:0032279; GO:0043198; GO:0043235; GO:0045211; GO:0046983; GO:0048786; GO:0051966; GO:0061564; GO:0070085; GO:0070905 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905] IIKQLLDTPNSR 0.99328 -29.233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1311 0 11.3247 0 0 0 0 0 0 0 0 0 0 13.0854 0 0 0 10.9415 0 0 0 0 0 0 0 0 0 0 12.6865 0 0 13.2104 13.1385 0 0 0 0 0 0 0 0 12.2431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6623 12.6818 0 0 0 0 0 0 0 0 0 11.7213 12.3403 12.7465 14.451 12.768 12.4044 12.5482 13.4037 14.6287 13.8863 14.925 0 0 0 14.3111 0 14.0822 0 13.941 0 0 0 0 0 0 11.2312 0 0 0 12.603 0 0 0 0 0 0 0 0 0 0 14.2473 0 0 0 0 14.3453 0 0 0 0 0 0 14.0189 0 14.9362 0 0 0 0 0 0 0 0 12.7383 0 0 0 12.6595 0 12.6538 0 12.5492 0 0 10.807 0 0 14.309 0 13.0475 12.521 14.5933 0 0 0 0 0 0 0 11.5271 0 0 Q15633 TRBP2_HUMAN RISC-loading complex subunit TARBP2 (TAR RNA-binding protein 2) (Trans-activation-responsive RNA-binding protein) TARBP2 TRBP Homo sapiens (Human) global gene silencing by mRNA cleavage [GO:0098795]; miRNA processing [GO:0035196]; multicellular organism growth [GO:0035264]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of protein kinase activity [GO:0006469]; neural precursor cell proliferation [GO:0061351]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; regulation of miRNA maturation [GO:1903798]; regulation of production of small RNA involved in gene silencing by RNA [GO:0070920]; regulation of viral transcription [GO:0046782]; RISC complex assembly [GO:0070922]; single fertilization [GO:0007338]; siRNA processing [GO:0030422]; skeletal muscle tissue regeneration [GO:0043403]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; pre-mRNA binding [GO:0036002]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197]; global gene silencing by mRNA cleavage [GO:0098795]; miRNA processing [GO:0035196]; multicellular organism growth [GO:0035264]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of protein kinase activity [GO:0006469]; neural precursor cell proliferation [GO:0061351]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; regulation of miRNA maturation [GO:1903798]; regulation of production of small RNA involved in gene silencing by RNA [GO:0070920]; regulation of viral transcription [GO:0046782]; RISC complex assembly [GO:0070922]; single fertilization [GO:0007338]; siRNA processing [GO:0030422]; skeletal muscle tissue regeneration [GO:0043403]; spermatid development [GO:0007286] GO:0003725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006469; GO:0007286; GO:0007338; GO:0016442; GO:0016604; GO:0019899; GO:0030422; GO:0031054; GO:0035196; GO:0035197; GO:0035198; GO:0035264; GO:0036002; GO:0042802; GO:0042803; GO:0043403; GO:0045070; GO:0045727; GO:0046782; GO:0047485; GO:0048471; GO:0050689; GO:0051149; GO:0061351; GO:0070578; GO:0070883; GO:0070920; GO:0070922; GO:0098795; GO:1903798 double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; pre-miRNA binding [GO:0070883]; pre-mRNA binding [GO:0036002]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; siRNA binding [GO:0035197] HKAAEVALK 0.99328 -16.207 0 0 0 0 0 0 0 0 0 12.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5781 12.4281 11.7937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JWR5 DOP1_HUMAN Protein dopey-1 DOP1A DOPEY1 KIAA1117 Homo sapiens (Human) Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] GO:0000139; GO:0005768; GO:0005802; GO:0005829; GO:0006895; GO:0015031 AETVIQTVKEVLK 0.99328 -38.072 0 0 0 0 0 0 15.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.378 10.524 0 0 0 0 0 0 0 0 0 0 0 12.3856 0 12.7858 0 0 0 0 12.7343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6094 0 12.8683 0 0 0 11.5856 0 17.5709 15.4617 12.9921 14.384 12.2415 0 0 0 14.3677 12.9878 15.4072 14.8094 13.2462 16.1133 14.9737 14.0125 13.5003 14.018 14.0462 13.2005 0 14.7146 12.0305 0 10.8344 12.4132 0 14.3782 15.1269 11.1875 12.4452 12.8162 0 13.1514 16.1703 14.62 0 17.705 14.7394 15.9309 0 13.7226 0 0 0 12.9056 12.7113 0 0 0 13.2346 15.7519 13.4691 0 13.7593 12.6817 0 13.7049 12.327 12.8261 13.3096 13.0336 17.8905 16.2521 0 14.3241 13.8932 13.1211 0 14.12 0 13.6617 0 12.4261 0 12.6373 14.4096 11.7537 15.3035 14.4152 14.4359 15.0441 0 14.5745 12.2288 0 0 14.1863 0 10.3796 12.3689 12.876 0 0 0 0 0 12.98 13.8615 14.5515 15.4384 0 0 0 0 0 Q6Y7W6 GGYF2_HUMAN GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) GIGYF2 KIAA0642 PERQ2 TNRC15 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing [GO:0016441]; protein metabolic process [GO:0019538]; spinal cord motor neuron differentiation [GO:0021522] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; vesicle [GO:0031982] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; feeding behavior [GO:0007631]; homeostasis of number of cells within a tissue [GO:0048873]; insulin-like growth factor receptor signaling pathway [GO:0048009]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA destabilization [GO:0061157]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of translation [GO:0017148]; neuromuscular process controlling balance [GO:0050885]; post-embryonic development [GO:0009791]; post-transcriptional gene silencing [GO:0016441]; protein metabolic process [GO:0019538]; spinal cord motor neuron differentiation [GO:0021522] GO:0003723; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0007631; GO:0008344; GO:0009791; GO:0010494; GO:0016020; GO:0016021; GO:0016441; GO:0017148; GO:0019538; GO:0021522; GO:0031571; GO:0031982; GO:0032991; GO:0035264; GO:0043204; GO:0045296; GO:0048009; GO:0048873; GO:0050881; GO:0050885; GO:0061157; GO:0070064; GO:1990635 cadherin binding [GO:0045296]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723] EEEEAQRRLEENR 0.99328 -16.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9217 0 0 12.1146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1801 12.0259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6581 0 10.9392 0 0 0 0 0 0 0 0 0 0 11.8401 0 16.476 16.7856 16.2146 0 16.6074 16.6741 14.5823 12.7365 0 14.2217 14.4612 0 0 13.0405 0 16.0319 0 0 0 0 0 16.9647 15.7158 12.9098 0 0 12.6438 0 0 0 0 0 0 0 12.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9738 0 0 10.3602 0 0 0 0 0 0 0 15.6489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.828 0 0 0 0 0 0 12.1173 0 12.4081 0 Q7RTV3 ZN367_HUMAN Zinc finger protein 367 (C2H2 zinc finger protein ZFF29) ZNF367 ZFF29 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" SLQAHKR 0.99328 -6.3994 0 10.4037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9352 12.6229 0 0 0 12.3169 0 0 0 0 0 0 0 0 0 12.5351 13.6231 0 0 14.978 0 0 0 0 0 0 0 0 0 0 0 0 14.467 14.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7L7 ZER1_HUMAN Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein) (Zyg11b-like protein) ZER1 C9orf60 ZYG ZYG11BL Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] Cul2-RING ubiquitin ligase complex [GO:0031462] Cul2-RING ubiquitin ligase complex [GO:0031462]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] GO:0006515; GO:0031462; GO:0032436 ALKLVITALK 0.99328 -6.8049 0 0 0 0 0 0 0 14.2481 0 0 0 0 0 0 0 0 0 0 0 15.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5493 0 0 0 0 0 0 0 0 0 14.8394 0 13.833 0 0 0 12.3769 12.722 15.9707 0 0 0 0 0 0 0 13.9818 14.2907 0 0 0 13.1276 0 13.6202 0 0 0 11.9837 0 0 0 0 0 0 12.958 0 0 0 0 0 0 10.4719 0 0 14.0562 0 12.5703 0 0 0 0 0 0 0 14.1598 0 0 0 14.5419 0 12.8934 0 0 0 0 11.3182 0 0 12.4249 0 13.3088 0 0 15.1565 0 0 0 0 0 0 0 0 0 10.8916 0 0 10.0925 0 0 0 0 0 0 0 0 12.9268 12.2343 0 0 0 0 0 Q86WV6 STING_HUMAN "Stimulator of interferon genes protein, hSTING (Endoplasmic reticulum interferon stimulator, ERIS) (Mediator of IRF3 activation, hMITA) (Transmembrane protein 173)" STING1 ERIS MITA STING TMEM173 Homo sapiens (Human) activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990701]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine/threonine protein kinase complex [GO:1902554]; STING complex [GO:1990231] "autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane [GO:1990701]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine/threonine protein kinase complex [GO:1902554]; STING complex [GO:1990231]; 2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; autophagosome assembly [GO:0000045]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein complex oligomerization [GO:0051259]; regulation of inflammatory response [GO:0050727]; reticulophagy [GO:0061709]" GO:0000045; GO:0000139; GO:0000421; GO:0002218; GO:0002230; GO:0005654; GO:0005741; GO:0005768; GO:0005776; GO:0005777; GO:0005789; GO:0005829; GO:0005886; GO:0016239; GO:0019901; GO:0030176; GO:0030659; GO:0030667; GO:0031625; GO:0032092; GO:0032481; GO:0032728; GO:0035438; GO:0035458; GO:0042802; GO:0042803; GO:0045087; GO:0045944; GO:0048471; GO:0050727; GO:0051091; GO:0051259; GO:0051607; GO:0060340; GO:0061507; GO:0061629; GO:0061709; GO:0071360; GO:0071407; GO:1902554; GO:1990231; GO:1990701 "2',3'-cyclic GMP-AMP binding [GO:0061507]; cyclic-di-GMP binding [GO:0035438]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]" GSYWRTVR 0.99328 -7.9416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5545 13.0831 0 0 0 0 0 0 10.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYP9 ZDH23_HUMAN "Palmitoyltransferase ZDHHC23, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 23, DHHC-23, zDHHC23)" ZDHHC23 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0018345; GO:0019706; GO:0072659 protein-cysteine S-palmitoyltransferase activity [GO:0019706] CQLVRPAR 0.99328 -6.5876 0 0 0 0 0 13.548 14.8574 0 0 0 0 0 0 0 0 0 0 0 14.5686 0 0 0 0 0 0 0 10.8842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7199 0 0 0 0 0 0 0 13.0547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7109 0 0 0 0 0 0 0 0 0 0 0 0 13.8423 0 0 0 14.1025 14.1515 0 0 0 0 14.548 15.0115 0 0 0 0 0 12.7886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7459 0 0 0 0 0 0 0 13.8408 13.9839 13.9308 0 0 0 0 0 12.8663 0 0 0 Q8N7P7 YH007_HUMAN Uncharacterized protein FLJ40521 Homo sapiens (Human) DHEDDGCLLKQESR 0.99328 -16.229 0 0 0 0 0 0 0 0 0 0 0 0 12.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9748 0 0 0 0 0 0 0 12.5017 12.4371 0 12.3772 12.6935 16.758 12.7676 0 0 0 0 0 0 13.4723 0 0 0 0 13.6077 0 0 0 0 0 0 12.7453 12.5188 0 14.9614 15.1947 0 0 0 12.6793 12.6229 0 0 0 0 0 0 0 0 0 0 13.8719 13.8723 17.5028 12.879 13.3132 0 0 0 0 12.8296 14.1257 17.5043 13.0025 13.1083 0 13.2174 13.1857 0 0 12.3814 0 0 0 0 0 0 0 0 0 0 0 12.8349 0 0 13.6832 13.3403 13.4182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEE8 TTC16_HUMAN "Tetratricopeptide repeat protein 16, TPR repeat protein 16" TTC16 Homo sapiens (Human) EALSHGPR 0.99328 -29.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.692 0 0 0 12.3576 0 13.9101 14.1709 13.246 10.4016 0 0 0 0 13.2255 0 15.1956 15.2055 16.1717 15.0334 14.0587 14.9885 14.4045 14.1282 14.5426 13.8325 0 15.9636 12.8838 14.2199 14.0438 0 14.4277 13.9885 14.349 13.9477 14.1366 15.6612 14.4176 12.8568 13.7863 15.5194 15.4125 13.2981 13.0724 0 12.8869 14.7009 15.3398 16.1708 0 12.4316 0 14.8318 13.9611 0 15.2206 0 0 13.1471 0 11.7627 14.9562 13.4429 12.7971 0 0 0 14.5239 13.6793 0 14.5801 14.3369 0 13.5516 13.8644 14.3192 13.6216 14.0461 0 0 0 0 11.695 0 13.9421 13.5534 14.3329 11.3649 0 0 0 12.3519 0 0 0 0 0 0 0 0 0 0 0 0 13.2666 0 0 0 0 0 0 Q8NHV1 GIMA7_HUMAN "GTPase IMAP family member 7 (Immunity-associated nucleotide 7 protein, IAN-7)" GIMAP7 IAN7 Homo sapiens (Human) GTP metabolic process [GO:0046039] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039] GO:0003924; GO:0005525; GO:0005783; GO:0005794; GO:0005811; GO:0005829; GO:0042802; GO:0042803; GO:0046039 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] ECGNRCCAFSNSK 0.99328 -5.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8522 0 0 0 0 0 0 10.8482 14.9081 15.0667 15.365 0 15.5459 14.3754 13.4144 0 0 14.4966 14.5811 13.7978 0 0 18.4001 0 17.3241 0 0 0 9.79251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8502 0 0 0 0 0 0 10.6751 18.5002 10.7522 0 0 0 0 0 0 0 0 0 0 0 0 14.1626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4129 0 0 0 0 0 Q8TC41 RN217_HUMAN "E3 ubiquitin-protein ligase RNF217, EC 2.3.2.31 (IBR domain-containing protein 1) (Opposite STL) (RING finger protein 217)" RNF217 C6orf172 IBRDC1 OSTL Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0016021; GO:0031624; GO:0032436; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AASAEPSGGGCGSDWGCADTSAPEPAR 0.99328 -29.171 0 0 0 0 11.9866 0 0 0 0 0 0 0 0 0 13.6854 0 0 0 0 0 12.112 0 0 13.3958 0 0 0 0 0 0 0 0 0 11.9421 0 11.9503 0 0 11.5759 0 0 0 0 0 0 0 0 11.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4282 0 0 0 0 0 0 15.0274 0 0 0 15.2295 12.022 0 10.596 12.2514 0 15.1052 0 0 0 0 0 11.7977 0 13.8071 10.7623 15.1139 0 0 0 0 12.2689 15.0137 0 0 0 0 0 14.7425 0 15.1372 0 0 13.7476 0 0 0 15.6727 16.7443 0 10.8676 15.4068 0 0 15.1152 0 14.1042 0 14.8393 0 15.2699 0 0 0 15.14 0 15.6285 14.7579 10.8608 13.8526 14.9694 12.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3181 0 0 0 0 0 13.3712 0 0 0 0 0 0 0 12.2529 0 Q96EY9 ADAT3_HUMAN Probable inactive tRNA-specific adenosine deaminase-like protein 3 (tRNA-specific adenosine-34 deaminase subunit ADAT3) ADAT3 TAD3 Homo sapiens (Human) tRNA processing [GO:0008033] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]; tRNA processing [GO:0008033] GO:0003824; GO:0005654; GO:0008033; GO:0046872 catalytic activity [GO:0003824]; metal ion binding [GO:0046872] AAARGLR 0.99328 -7.9446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4868 0 0 0 0 16.3704 0 16.2411 0 0 0 0 0 0 12.1662 0 0 0 0 0 0 0 22.5583 0 0 0 0 0 0 0 0 0 17.2239 0 0 0 0 0 0 0 0 0 0 14.4036 0 0 0 0 0 13.3387 0 0 11.9197 0 0 0 0 0 0 12.1996 0 0 0 0 0 0 0 13.9427 0 0 0 0 19.6407 0 0 0 0 12.3975 0 0 0 11.833 0 19.4293 0 13.1478 0 0 0 12.6203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6565 11.1914 0 0 Q9H9J2 RM44_HUMAN "39S ribosomal protein L44, mitochondrial, L44mt, MRP-L44, EC 3.1.26.- (Mitochondrial large ribosomal subunit protein mL44)" MRPL44 Homo sapiens (Human) mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; rRNA processing [GO:0006364] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; endonuclease activity [GO:0004519]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; mitochondrial translational elongation [GO:0070125]; rRNA processing [GO:0006364] GO:0003723; GO:0003725; GO:0003735; GO:0004519; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0005886; GO:0006364; GO:0016604; GO:0032543; GO:0070125 double-stranded RNA binding [GO:0003725]; endonuclease activity [GO:0004519]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] CLLAPVAPKLVPPVR 0.99328 -7.9343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.552 0 0 0 0 0 0 0 12.5389 0 0 0 0 0 0 13.9472 0 0 0 14.4681 12.837 0 0 0 0 12.3288 0 0 0 0 0 0 0 14.0669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6014 0 0 13.6738 0 0 0 0 0 0 13.4644 0 0 0 12.5975 0 0 0 0 0 0 12.4416 0 0 14.2063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4108 0 0 12.3034 0 0 0 0 0 0 12.3749 0 0 0 0 0 0 0 O43174 CP26A_HUMAN "Cytochrome P450 26A1, EC 1.14.13.- (Cytochrome P450 retinoic acid-inactivating 1, Cytochrome P450RAI, hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome)" CYP26A1 CYP26 P450RAI1 Homo sapiens (Human) kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789] "endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; all-trans retinoic acid 4-hydrolase activity [GO:0062182]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]" GO:0001822; GO:0001972; GO:0004497; GO:0005506; GO:0005789; GO:0006766; GO:0006805; GO:0008401; GO:0016125; GO:0016491; GO:0016709; GO:0019825; GO:0020037; GO:0032526; GO:0033189; GO:0034653; GO:0042573; GO:0048387; GO:0062182; GO:0062183 "all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; all-trans retinoic acid 4-hydrolase activity [GO:0062182]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]" GLLVYPEVKRLMFR 0.99329 -15.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4265 0 0 0 0 0 0 0 0 0 0 0 0 12.7318 0 0 0 0 0 0 0 0 0 0 13.5675 0 0 0 13.3641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3053 0 0 0 0 0 0 0 O43505 B4GA1_HUMAN "Beta-1,4-glucuronyltransferase 1, EC 2.4.1.- (I-beta-1,3-N-acetylglucosaminyltransferase, iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)" B4GAT1 B3GNT1 B3GNT6 Homo sapiens (Human) axon guidance [GO:0007411]; keratan sulfate biosynthetic process [GO:0018146]; protein O-linked mannosylation [GO:0035269] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] "extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; axon guidance [GO:0007411]; keratan sulfate biosynthetic process [GO:0018146]; protein O-linked mannosylation [GO:0035269]" GO:0000139; GO:0005794; GO:0007411; GO:0008532; GO:0015020; GO:0018146; GO:0030173; GO:0035269; GO:0046872; GO:0070062 "glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]" ARRMPMNK 0.99329 -14.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1043 0 0 0 0 0 0 0 0 16.5103 0 0 0 0 0 0 0 0 16.2064 0 0 0 0 0 0 0 0 12.3449 0 0 0 0 0 0 12.3814 0 0 0 12.744 0 0 0 0 0 0 0 0 0 12.5226 0 0 0 0 0 0 0 0 0 0 0 0 13.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43542 XRCC3_HUMAN DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3) XRCC3 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; response to organic substance [GO:0010033]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere trimming [GO:0090737]; telomeric loop disassembly [GO:0090657] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; response to organic substance [GO:0010033]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere trimming [GO:0090737]; telomeric loop disassembly [GO:0090657]" GO:0000722; GO:0000724; GO:0000781; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0006974; GO:0010033; GO:0010824; GO:0033065; GO:0036297; GO:0045003; GO:0048471; GO:0071140; GO:0090267; GO:0090656; GO:0090657; GO:0090737; GO:0140664 ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677] CEFDSQASAPR 0.99329 -5.1199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5321 0 14.7438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7204 0 0 0 0 0 0 0 0 0 0 13.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9849 0 0 14.4166 0 13.9877 0 14.0279 0 0 0 0 0 13.8732 0 15.5355 0 11.8166 0 0 0 0 0 0 0 0 0 0 0 0 12.0417 13.1402 0 0 0 0 0 0 0 0 0 0 0 12.3275 0 0 0 0 0 11.5473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4304 0 0 0 0 0 0 0 0 10.994 0 0 13.1442 0 0 0 0 0 0 0 10.6988 0 0 0 P0C1S8 WEE2_HUMAN "Wee1-like protein kinase 2, EC 2.7.10.2 (Wee1-like protein kinase 1B) (Wee1B kinase)" WEE2 WEE1B Homo sapiens (Human) female meiotic nuclear division [GO:0007143]; female pronucleus assembly [GO:0035038]; mitotic cell cycle [GO:0000278]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of phosphorylation [GO:0042327]; regulation of fertilization [GO:0080154]; regulation of meiosis I [GO:0060631] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713]; female meiotic nuclear division [GO:0007143]; female pronucleus assembly [GO:0035038]; mitotic cell cycle [GO:0000278]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of phosphorylation [GO:0042327]; regulation of fertilization [GO:0080154]; regulation of meiosis I [GO:0060631] GO:0000278; GO:0000287; GO:0004672; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007143; GO:0035038; GO:0042327; GO:0045736; GO:0060631; GO:0080154; GO:1900194 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713] DDKDIDKELR 0.99329 -29.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5948 0 0 0 0 0 0 0 14.7389 0 0 15.6663 15.4039 0 0 0 0 0 0 0 0 0 12.9621 0 0 0 0 11.9423 0 0 0 12.9158 0 0 0 12.7066 0 0 16.996 0 0 0 0 0 0 0 0 0 0 0 0 0 12.769 0 0 13.4219 0 0 0 0 0 0 0 12.6613 0 0 0 0 0 0 0 15.2339 0 0 0 0 0 0 12.8218 0 0 0 0 11.9634 0 0 0 12.8953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1311 0 0 0 0 12.6654 0 P16402 H13_HUMAN Histone H1.3 (Histone H1c) (Histone H1s-2) H1-3 H1F3 HIST1H1D Homo sapiens (Human) chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334] chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634] chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334] GO:0000122; GO:0000785; GO:0000786; GO:0000791; GO:0003690; GO:0003723; GO:0005634; GO:0006334; GO:0030261; GO:0030527; GO:0031490; GO:0031492; GO:0045910; GO:0080182; GO:0098532 chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] AASGEGK 0.99329 -38.491 0 0 0 0 12.5065 0 0 0 12.5275 12.716 12.4418 12.5007 12.4772 10.9256 0 12.1653 0 0 0 0 12.478 0 0 16.3826 12.1645 12.2696 0 0 11.5014 9.37554 13.6079 13.0547 13.5948 0 12.1016 0 13.3228 12.6955 11.4944 11.0882 0 0 12.3624 0 0 12.5609 12.4447 0 0 0 15.3035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8906 16.7977 16.7789 16.6587 0 16.0581 15.433 15.7523 0 11.9886 0 0 19.5773 18.3627 15.042 23.324 13.9402 0 12.8037 0 0 14.7596 14.4331 15.4492 15.1906 15.09 18.8017 17.2106 18.3903 0 13.9475 0 14.7729 14.3228 19.3483 19.3896 16.6929 18.9821 13.5634 16.2566 14.5965 18.9092 18.4657 18.6583 19.5531 18.7357 19.8938 20.3032 0 14.5493 14.0272 19.422 0 13.8022 13.3641 14.6426 13.7786 12.5895 0 0 0 0 13.9414 0 19.6845 20.2161 14.4255 12.9793 0 0 12.8028 19.2536 17.4112 19.5996 13.7332 13.9313 19.8386 0 19.421 0 19.0934 19.1078 0 19.5023 18.9637 0 20.1962 19.5072 19.7367 13.822 13.4621 14.9726 12.2343 12.8002 14.3041 0 14.9147 0 13.9048 15.1959 0 0 13.9213 0 0 15.1226 0 13.1749 0 0 0 0 0 P35250 RFC2_HUMAN "Replication factor C subunit 2 (Activator 1 40 kDa subunit, A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit, RF-C 40 kDa subunit, RFC40)" RFC2 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:0032508; GO:1900264 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899] CAVLRYTKLTDAQILTR 0.99329 -6.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8014 0 0 0 0 0 0 0 0 0 0 12.799 0 0 0 13.759 0 0 0 0 0 0 0 13.3832 0 0 0 0 0 0 0 0 0 0 0 12.8384 0 Q01518 CAP1_HUMAN "Adenylyl cyclase-associated protein 1, CAP 1" CAP1 CAP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin cytoskeleton organization [GO:0030036]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165] GO:0000902; GO:0001667; GO:0003779; GO:0005576; GO:0005737; GO:0005886; GO:0005925; GO:0006898; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0019933; GO:0030036; GO:0030864; GO:0035578; GO:0045761; GO:0070062 actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179] AQSGPVRSGPK 0.99329 -5.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.394 0 0 0 0 0 0 12.5448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0615 14.1517 14.3456 0 0 0 0 0 0 0 0 0 11.8123 0 13.2792 13.8299 13.4703 15.4007 0 0 0 0 0 0 13.4231 13.368 13.3428 0 0 12.1799 0 13.1359 0 12.5586 12.8563 14.3814 13.9976 0 0 0 0 14.4049 14.862 13.8596 0 13.9936 14.5745 0 0 0 0 0 0 13.6388 0 0 11.5968 10.8642 0 0 14.1069 13.3872 0 0 11.6147 0 0 0 0 0 0 0 0 0 0 0 13.6527 0 0 13.4804 0 0 13.5049 0 0 0 0 0 0 17.1174 0 0 0 0 0 0 13.8385 0 0 0 0 0 Q15398 DLGP5_HUMAN "Disks large-associated protein 5, DAP-5 (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein, HURP)" DLGAP5 DLG7 KIAA0008 Homo sapiens (Human) centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]; microtubule binding [GO:0008017]; centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052] GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0007052; GO:0007059; GO:0007079; GO:0007346; GO:0008017; GO:0023052; GO:0031616; GO:0034451; GO:0045842; GO:0051382; GO:0051642 microtubule binding [GO:0008017] AEPKKAIPSSVR 0.99329 -5.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7185 14.3142 0 0 13.3597 14.6953 0 13.707 13.9049 0 0 0 14.5968 0 13.4235 0 0 0 14.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4622 0 13.8241 11.5779 0 0 0 0 0 0 0 0 0 0 0 0 14.2291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY51 TIGD4_HUMAN Tigger transposable element-derived protein 4 TIGD4 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] ITLVVGTNMDGSEKLPLLVIGKK 0.99329 -13.293 0 0 0 12.9112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8438 0 0 0 0 12.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4266 0 0 12.5272 15.1268 0 0 0 0 0 0 0 0 0 0 14.4912 0 0 0 0 0 14.9058 0 13.0862 14.8895 0 0 0 0 0 0 14.6472 0 0 0 0 15.5101 0 0 0 0 0 0 0 14.9448 0 0 0 0 14.0004 0 12.7031 0 0 0 0 0 14.0166 0 0 0 0 14.9265 0 0 0 14.8116 14.0736 12.9235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1074 0 11.9257 0 0 0 0 0 0 0 Q8IYH5 ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 ZZZ3 Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" GO:0003677; GO:0005654; GO:0005730; GO:0006355; GO:0006357; GO:0008270; GO:0031063; GO:0035064; GO:0043966; GO:0043967; GO:0044154; GO:0045995; GO:0051302; GO:0051726; GO:0070577; GO:0072686; GO:0090043; GO:0140672 DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] AAPTRGSPTK 0.99329 -7.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2899 10.9104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1507 0 0 0 0 13.5808 0 0 14.2085 13.6643 0 0 0 10.2952 0 0 0 0 14.1512 14.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9423 0 0 0 0 0 0 0 Q8N4J0 CARME_HUMAN "Carnosine N-methyltransferase, EC 2.1.1.22" CARNMT1 C9orf41 Homo sapiens (Human) carnosine metabolic process [GO:0035498]; histidine catabolic process [GO:0006548]; methylation [GO:0032259] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498]; histidine catabolic process [GO:0006548]; methylation [GO:0032259] GO:0005634; GO:0005829; GO:0006548; GO:0008757; GO:0030735; GO:0032259; GO:0035498; GO:0042803 carnosine N-methyltransferase activity [GO:0030735]; protein homodimerization activity [GO:0042803]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] EILKNFPK 0.99329 -13.297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.594 13.6136 13.7687 13.8366 0 0 0 0 0 13.1628 0 13.7365 0 0 0 0 0 13.3673 0 0 0 0 Q8N5R6 CCD33_HUMAN "Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61, CT61)" CCDC33 Homo sapiens (Human) peroxisome [GO:0005777] peroxisome [GO:0005777] GO:0005777 ALPTLDPK 0.99329 -5.1317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5534 0 12.1933 0 0 0 0 0 0 0 0 0 0 0 13.3048 0 0 0 10.9735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9118 0 0 0 0 0 0 0 0 11.713 11.0595 0 13.8162 0 0 0 10.5689 0 0 0 0 0 0 0 0 11.3508 0 0 0 0 0 0 12.4335 0 0 0 0 0 0 0 0 13.3997 0 12.1569 0 13.5491 13.2397 0 0 14.1059 14.6682 15.2805 14.1925 12.3572 0 13.0614 12.9166 13.364 13.5103 13.2792 15.0951 13.3871 0 0 0 0 0 0 13.4051 0 13.0542 0 0 0 0 0 0 0 0 0 0 0 0 13.2516 0 13.4771 0 0 13.2572 0 0 0 0 13.536 0 0 0 14.6411 15.1003 0 0 0 0 0 0 Q8NDF8 PAPD5_HUMAN "Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5, EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase, EC 2.7.7.-) (Terminal uridylyltransferase 3, TUTase 3) (Topoisomerase-related function protein 4-2, TRF4-2)" TENT4B GLD4 PAPD5 TRF4-2 TUT3 Homo sapiens (Human) carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050] GO:0003677; GO:0003723; GO:0003887; GO:0004652; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006364; GO:0006378; GO:0007049; GO:0010587; GO:0031123; GO:0031499; GO:0032211; GO:0033500; GO:0043629; GO:0043630; GO:0046872; GO:0051301; GO:0060212; GO:0070034; GO:0070568; GO:0071044; GO:0071050; GO:0071076; GO:1905870 DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] KYPVLPYLVLVLK 0.99329 -5.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXH2 JPH3_HUMAN "Junctophilin-3, JP-3 (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein)" JPH3 JP3 TNRC22 Homo sapiens (Human) calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of synaptic plasticity [GO:0048167] GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0014701; GO:0016021; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060314; GO:0060402 AVEAAER 0.99329 -13.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6993 0 0 0 0 0 0 0 10.4984 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3657 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0811 0 12.2741 0 0 14.5286 0 14.6425 0 14.5734 14.1878 0 0 0 14.1701 14.2441 0 0 13.8284 0 0 0 0 0 0 0 12.428 0 0 0 0 12.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 12.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7318 0 Q96JJ7 TMX3_HUMAN "Protein disulfide-isomerase TMX3, EC 5.3.4.1 (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3)" TMX3 KIAA1830 TXNDC10 Homo sapiens (Human) peptidyl-cysteine oxidation [GO:0018171] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; peptidyl-cysteine oxidation [GO:0018171] GO:0003756; GO:0005783; GO:0005789; GO:0005886; GO:0009986; GO:0015035; GO:0016021; GO:0018171; GO:0031092 protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] DVLEKKK 0.99329 -26.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8529 0 0 0 0 0 0 0 0 0 11.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6072 14.7895 0 0 0 0 13.3989 0 0 0 0 0 0 0 13.5668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6331 0 0 11.3235 12.7806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RL1 UIMC1_HUMAN BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1) UIMC1 RAP80 RXRIP110 Homo sapiens (Human) "chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA repair [GO:0045739]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]" BRCA1-A complex [GO:0070531]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "BRCA1-A complex [GO:0070531]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA repair [GO:0045739]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]" GO:0003677; GO:0005634; GO:0005654; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0010212; GO:0016604; GO:0042393; GO:0044818; GO:0045739; GO:0045892; GO:0046872; GO:0070530; GO:0070531; GO:0070537 DNA binding [GO:0003677]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872] CTGHSAEHTQCGK 0.99329 -17.205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6978 0 0 0 11.2437 14.7357 0 13.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8958 0 0 0 0 0 0 0 0 0 0 0 Q96SI9 STRBP_HUMAN Spermatid perinuclear RNA-binding protein STRBP SPNR Homo sapiens (Human) mechanosensory behavior [GO:0007638]; spermatid development [GO:0007286] cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634] cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mechanosensory behavior [GO:0007638]; spermatid development [GO:0007286] GO:0002177; GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005737; GO:0007286; GO:0007638; GO:0008017 DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] ANGLKSCVIVLRILR 0.99329 -29.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.891 0 0 0 11.7642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6334 0 0 0 0 0 0 0 15.0358 0 12.6648 0 0 14.6498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9965 12.3757 17.8207 12.076 0 0 0 0 12.7642 0 0 0 0 0 0 0 0 12.6249 0 0 0 0 0 0 0 14.912 0 0 0 0 0 0 0 0 0 0 0 12.1678 14.3407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3323 0 10.6443 0 0 0 0 Q96SZ4 ZSC10_HUMAN Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206) ZSCAN10 ZNF206 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0045892; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" FVRRASLAR 0.99329 -5.1277 0 0 0 0 12.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6568 0 0 0 0 13.9488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4703 0 0 0 0 13.1894 0 0 0 0 0 13.1843 0 0 0 0 0 0 0 0 0 12.4087 0 0 0 0 12.9532 0 0 0 0 17.0245 0 0 0 0 0 0 0 0 0 0 0 13.0294 0 0 0 0 0 0 0 0 12.7805 0 0 0 0 0 0 12.4816 0 13.2339 0 0 0 0 0 0 0 0 0 13.3405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZW2 S13A1_HUMAN "Solute carrier family 13 member 1 (Renal sodium/sulfate cotransporter, Na(+)/sulfate cotransporter, hNaSi-1)" SLC13A1 NAS1 NASI1 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sodium:sulfate symporter activity [GO:0015382]; anion transmembrane transport [GO:0098656]; sulfate transport [GO:0008272] GO:0005886; GO:0008272; GO:0015382; GO:0016021; GO:0098656 sodium:sulfate symporter activity [GO:0015382] FLFVVFTVLVLLPLPIVLHTK 0.99329 -6.2141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4965 0 0 0 0 0 0 0 0 0 0 0 0 12.0401 0 0 0 0 0 0 0 0 12.0797 12.1762 0 12.8509 0 0 0 0 0 13.9731 12.2869 0 0 0 10.9498 0 0 0 0 0 0 0 0 12.3504 12.3696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7314 0 13.541 0 0 0 0 12.0492 0 0 0 0 0 0 0 0 0 0 12.4666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H939 PPIP2_HUMAN "Proline-serine-threonine phosphatase-interacting protein 2, PEST phosphatase-interacting protein 2" PSTPIP2 Homo sapiens (Human) actin filament polymerization [GO:0030041]; cell migration [GO:0016477] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477] GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0016477; GO:0030041; GO:0051015 actin filament binding [GO:0051015] EEARKMEEFR 0.99329 -17.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63205 0 12.6206 0 0 0 0 0 11.8664 0 11.0668 0 0 0 11.4912 0 0 0 0 0 0 0 13.1608 0 0 0 0 0 0 0 0 12.0261 11.7618 0 0 0 0 0 0 11.2561 0 0 11.4449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5419 0 0 0 12.0644 0 14.4821 0 13.9047 0 0 0 0 0 0 14.767 0 14.3339 0 0 0 0 0 0 13.475 0 12.9697 13.0306 0 0 0 0 13.358 14.6448 0 0 13.2324 0 10.854 0 13.1771 0 10.6254 13.4694 0 0 0 13.0931 0 0 0 13.2196 0 0 0 0 0 0 12.8538 0 0 14.9008 13.3283 13.6 13.1155 0 0 0 14.543 13.1006 13.5054 0 13.0532 0 10.9527 0 0 0 14.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6792 0 0 0 0 11.7304 13.0501 0 0 0 0 10.0681 0 0 0 Q9NP61 ARFG3_HUMAN "ADP-ribosylation factor GTPase-activating protein 3, ARF GAP 3" ARFGAP3 ARFGAP1 Homo sapiens (Human) COPI coating of Golgi vesicle [GO:0048205]; intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; intracellular protein transport [GO:0006886]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005096; GO:0005794; GO:0005829; GO:0006886; GO:0009306; GO:0016020; GO:0016192; GO:0046872; GO:0048205 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] KETSKDTETVLK 0.99329 -29.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4322 14.2445 0 13.6638 0 0 14.3137 14.2402 0 0 0 14.3312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8759 0 0 11.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5736 0 0 0 0 0 14.7298 0 11.4878 0 0 0 0 0 0 0 0 13.4337 0 0 0 0 0 0 0 0 0 0 14.2635 0 0 0 0 0 0 0 0 0 0 10.0066 0 0 0 0 0 0 0 0 0 0 0 11.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYK1 TLR7_HUMAN Toll-like receptor 7 TLR7 UNQ248/PRO285 Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein phosphorylation [GO:0001932]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytoplasm [GO:0005737]; early phagosome [GO:0032009]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; double-stranded RNA binding [GO:0003725]; pattern recognition receptor activity [GO:0038187]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein phosphorylation [GO:0001932]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor signaling pathway [GO:0002224] GO:0000139; GO:0001932; GO:0002224; GO:0003725; GO:0003727; GO:0004888; GO:0005737; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005886; GO:0006954; GO:0007249; GO:0007252; GO:0007254; GO:0010008; GO:0016021; GO:0032009; GO:0032722; GO:0032727; GO:0032728; GO:0032729; GO:0032755; GO:0032757; GO:0034154; GO:0035197; GO:0036020; GO:0038187; GO:0043235; GO:0045087; GO:0045944; GO:0050729; GO:0051607; GO:0060907; GO:0071260; GO:0098586; GO:1901224 double-stranded RNA binding [GO:0003725]; pattern recognition receptor activity [GO:0038187]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transmembrane signaling receptor activity [GO:0004888] AKIKGYQR 0.99329 -26.585 0 0 12.6122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7914 0 0 0 12.5235 0 11.5578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.829 0 10.3837 0 0 0 0 0 0 0 0 0 0 15.4999 0 14.6836 14.761 0 0 0 0 14.2368 0 0 12.2586 0 0 0 0 0 0 14.4846 0 0 0 13.2228 0 0 14.3358 0 13.0303 0 13.6876 0 0 13.9193 13.0215 0 0 0 0 0 0 0 0 0 0 0 0 15.4281 0 0 0 0 13.5639 0 0 0 12.8665 0 0 0 0 0 0 12.8923 12.2908 0 10.5121 0 0 0 13.7057 0 0 15.0978 14.5833 0 0 11.9648 0 0 0 0 0 12.1928 0 0 0 0 0 0 0 0 0 0 0 0 13.1919 0 13.3399 0 0 10.9276 0 0 0 0 0 14.1847 0 0 0 0 0 0 0 O75398 DEAF1_HUMAN "Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator, NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5)" DEAF1 SPN ZMYND5 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; anatomical structure morphogenesis [GO:0009653]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007281; GO:0009653; GO:0033599; GO:0045892; GO:0045893; GO:0046872; GO:0048706 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DEDSEEDADSEAER 0.9933 -5.5107 0 0 0 0 0 0 0 0 0 0 12.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5379 13.6012 0 0 0 0 12.6343 13.5222 0 0 0 0 13.1277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4274 13.2557 0 0 0 0 0 0 0 0 0 12.2876 0 0 0 0 0 0 0 0 0 0 0 0 12.3116 0 0 0 0 0 0 0 0 0 0 0 0 14.2223 0 0 0 0 0 0 18.1102 0 17.141 17.1824 0 0 0 13.3183 0 0 0 14.0695 13.9798 0 0 0 0 11.2258 14.7258 0 0 0 0 0 0 0 0 0 16.073 0 0 0 0 16.7724 0 0 0 0 0 17.7499 0 14.337 0 0 0 0 11.1986 0 0 0 0 0 11.8718 14.1123 0 0 0 11.3391 0 0 0 11.1219 0 0 14.875 O75665 OFD1_HUMAN Centriole and centriolar satellite protein OFD1 (Oral-facial-digital syndrome 1 protein) (Protein 71-7A) OFD1 CXorf5 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287] GO:0005576; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0015630; GO:0016020; GO:0031514; GO:0034451; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060271; GO:0060287 alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802] ASVKSLTTQVADLKLQLK 0.9933 -14.456 0 0 0 12.1984 0 0 12.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7728 0 12.6965 0 0 0 0 0 0 0 0 12.629 13.8887 0 0 12.0832 12.1646 19.0811 18.5087 15.7442 12.6914 13.2537 0 12.9718 13.2493 13.3963 14.504 0 0 0 0 0 0 0 0 12.1999 0 12.9675 13.2778 14.7869 0 0 0 0 0 13.3697 0 0 13.3117 13.8834 19.5084 0 14.558 0 0 15.3498 0 0 0 0 0 13.4071 12.0405 14.8469 14.5603 14.29 14.7443 0 14.1414 0 0 0 13.6371 15.7164 0 0 0 0 0 13.6669 0 14.3471 0 0 13.5702 0 0 13.3055 12.7962 12.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.513 0 15.0213 0 0 0 0 0 P49641 MA2A2_HUMAN "Alpha-mannosidase 2x, EC 3.2.1.114 (Alpha-mannosidase IIx, Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)" MAN2A2 MANA2X Homo sapiens (Human) mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]" GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0006517; GO:0016021; GO:0016799; GO:0030246; GO:0046872 "alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]" AITEANVAERAALLLDQYRK 0.9933 -6.6223 12.028 0 0 0 0 0 0 0 0 0 16.559 11.6719 0 16.7458 0 0 0 0 12.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0989 0 0 0 0 0 0 11.3819 0 0 0 0 0 0 0 10.1144 0 0 0 0 0 0 0 0 11.208 0 17.1328 0 0 0 0 0 0 0 0 0 11.0604 13.3055 0 0 0 0 0 0 14.3219 0 0 0 0 0 14.1922 13.703 0 13.5157 0 14.9124 14.0658 0 14.5025 14.4325 12.6578 14.4165 0 0 0 0 15.5854 0 0 13.8145 0 0 0 0 0 0 13.3844 0 0 12.0305 12.9963 14.2466 13.0867 0 0 0 0 12.8923 0 14.0513 0 13.1516 0 0 0 0 12.8483 0 0 0 0 0 0 0 0 0 12.0043 0 0 0 0 0 0 0 0 0 0 17.5352 0 11.3407 0 0 0 0 0 0 0 0 17.3789 0 0 12.882 0 12.849 0 0 17.3141 0 0 0 13.19 0 0 0 0 0 0 0 P55795 HNRH2_HUMAN "Heterogeneous nuclear ribonucleoprotein H2, hnRNP H2 (FTP-3) (Heterogeneous nuclear ribonucleoprotein H', hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed ]" HNRNPH2 FTP3 HNRPH2 Homo sapiens (Human) regulation of RNA splicing [GO:0043484] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; regulation of RNA splicing [GO:0043484] GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0014069; GO:0016020; GO:0043484; GO:1990904 RNA binding [GO:0003723] AEVRTHYDPPR 0.9933 -13.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14202 ZMYM3_HUMAN Zinc finger MYM-type protein 3 (Zinc finger protein 261) ZMYM3 DXS6673E KIAA0385 ZNF261 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] GO:0003677; GO:0005654; GO:0007010; GO:0008270; GO:0022604 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] AGRSAVGTKMTCAHCR 0.9933 -26.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7365 0 0 0 0 0 0 12.4903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5561 13.5979 13.9426 11.3915 0 0 12.1747 0 13.7584 0 13.5376 13.7389 0 13.594 0 0 0 0 0 0 0 0 0 11.0396 0 0 0 13.3142 0 10.516 13.3961 0 12.3926 13.619 0 0 13.4737 0 11.5207 13.5078 0 13.2864 13.2096 12.2849 12.2566 13.8623 14.5448 0 13.2054 0 0 0 14.8839 13.6108 13.6686 12.825 14.9097 0 13.6019 0 0 13.0781 14.1404 14.3051 0 13.6085 0 13.2577 13.6106 0 0 0 14.4401 0 0 0 13.3068 13.5828 13.1884 11.2002 0 0 0 13.946 0 0 14.0708 12.9668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9682 13.7757 0 17.5773 0 0 0 0 0 Q14444 CAPR1_HUMAN "Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137, GPI-p137, p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105)" CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; postsynapse [GO:0098794] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; postsynapse [GO:0098794]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003] GO:0000932; GO:0003723; GO:0005737; GO:0005829; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030154; GO:0030425; GO:0031252; GO:0050775; GO:0061003; GO:0098794; GO:0098978 RNA binding [GO:0003723] GGYDGYR 0.9933 -14.442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7938 0 0 0 0 0 0 14.2541 0 0 12.0233 0 13.7876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4612 0 0 0 0 0 Q5SXM1 ZN678_HUMAN Zinc finger protein 678 ZNF678 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNQFSSLTR 0.9933 -13.371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.27368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1439 0 11.749 0 0 0 0 0 0 0 12.6603 0 12.2704 0 0 0 0 0 0 0 0 0 0 0 0 9.89069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9741 0 0 0 0 13.0692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9882 0 0 0 0 0 0 0 Q76KX8 ZN534_HUMAN Zinc finger protein 534 (KRAB domain only protein 3) ZNF534 KRBO3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DIHTGEKPYSCNECGK 0.9933 -26.861 0 9.94484 0 0 0 0 0 0 0 0 0 0 0 11.4531 11.7196 0 0 0 0 0 0 0 0 0 0 0 0 13.0456 0 0 0 0 0 12.064 0 0 0 0 0 12.3368 0 0 0 0 12.2091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6892 0 0 0 0 0 0 0 13.2057 0 0 0 0 0 0 0 0 14.103 14.5185 10.9438 13.5968 0 16.6517 0 0 0 0 0 0 0 14.053 0 0 13.5843 0 0 0 12.4888 0 0 0 0 0 0 0 0 0 16.0029 13.7369 0 0 0 0 12.6835 0 14.2314 0 0 0 0 0 0 0 0 0 0 12.4026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7101 0 0 0 0 0 0 0 0 14.699 0 0 0 0 14.0016 14.0639 0 12.835 0 0 0 0 0 0 0 0 0 11.1579 0 0 12.9053 0 0 Q8IUK5 PLDX1_HUMAN Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7) PLXDC1 TEM3 TEM7 Homo sapiens (Human) angiogenesis [GO:0001525]; spinal cord development [GO:0021510] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; angiogenesis [GO:0001525]; spinal cord development [GO:0021510] GO:0001525; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005923; GO:0016021; GO:0021510; GO:0030425; GO:0043025; GO:0043235 EGFMEAEQC 0.9933 -17.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3619 12.7568 12.1291 0 0 0 0 0 0 0 0 0 0 0 12.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9965 13.4818 0 0 0 0 0 0 0 0 0 0 0 13.6802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3137 0 0 10.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWU5 SULF2_HUMAN "Extracellular sulfatase Sulf-2, hSulf-2, EC 3.1.6.-" SULF2 KIAA1247 UNQ559/PRO1120 Homo sapiens (Human) bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177] GO:0001822; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0030177; GO:0030201; GO:0032836; GO:0035860; GO:0040037; GO:0048706; GO:0051216; GO:0060348; GO:0060384 arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449] ALSNLVPK 0.9933 -14.072 0 0 0 0 0 0 0 10.9916 15.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4409 0 0 0 0 16.4944 13.1078 0 12.5061 0 0 0 0 12.5703 0 0 11.7497 0 0 0 0 15.1556 0 0 15.5896 0 0 0 0 0 0 17.0984 15.8851 16.7032 16.8331 16.9149 16.1184 16.374 16.1171 0 17.0194 14.7975 0 15.6875 0 0 15.679 0 15.4009 0 14.8917 0 15.339 0 0 0 15.8375 16.633 16.4204 0 12.3566 15.7542 15.9957 17.2321 15.8469 17.0361 15.7699 15.3725 14.8329 16.2441 0 0 12.8829 0 12.7886 12.5149 0 0 13.4328 0 0 13.8607 0 0 0 0 0 0 12.5318 12.8028 12.8969 0 11.2725 0 12.4787 0 0 0 0 0 0 0 0 13.4564 0 0 0 0 0 13.3164 15.4392 0 14.3016 0 0 0 13.8772 0 Q8N7R7 CCYL1_HUMAN Cyclin-Y-like protein 1 CCNYL1 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; spermatogenesis [GO:0007283] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901]; flagellated sperm motility [GO:0030317]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein kinase activity [GO:0045859]; spermatogenesis [GO:0007283] GO:0005886; GO:0007283; GO:0019901; GO:0030317; GO:0045859; GO:0060828; GO:0061575 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901] FIYRFVR 0.9933 -14.495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2481 0 0 0 16.0809 0 0 0 0 0 0 0 0 0 0 15.9194 0 16.1289 Q8ND04 SMG8_HUMAN Nonsense-mediated mRNA decay factor SMG8 (Amplified in breast cancer gene 2 protein) (Protein smg-8 homolog) SMG8 ABC2 C17orf71 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]" cytosol [GO:0005829] "cytosol [GO:0005829]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]" GO:0000184; GO:0005829; GO:0045859 AANYDFYQLLEEKCCGK 0.9933 -5.1343 0 0 0 0 0 0 0 0 12.6754 12.9695 0 12.9078 12.7356 0 11.9625 0 0 0 0 0 0 0 0 0 0 0 10.6146 0 0 0 12.3214 11.6554 12.7935 12.673 11.5428 0 0 0 0 0 0 0 0 0 0 0 0 11.5646 0 0 0 11.8655 0 0 0 0 0 12.6149 0 12.0748 0 0 0 0 0 0 0 0 11.6189 0 0 14.3252 0 0 0 0 0 0 13.4328 0 0 11.1751 16.2132 13.4842 15.9542 13.9707 16.1368 14.5558 14.013 14.7041 13.4629 15.2007 14.6552 15.8432 14.5395 14.9001 13.0055 0 15.1973 0 13.4159 0 15.3247 0 0 0 0 13.9586 12.4155 0 0 14.341 14.8694 13.5985 0 0 14.619 0 0 13.4929 0 13.6782 14.281 13.7109 0 0 0 12.9724 0 0 10.2681 0 0 13.1962 12.4313 13.6503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.811 0 14.328 13.8191 0 0 13.6523 0 0 0 0 14.3648 13.3784 0 0 0 0 0 0 14.2838 12.1653 0 0 0 0 Q8WXE9 STON2_HUMAN Stonin-2 (Stoned B) STON2 STN2 STNB Homo sapiens (Human) regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] GO:0005730; GO:0005829; GO:0008021; GO:0016020; GO:0016192; GO:0030100; GO:0030136; GO:0031410; GO:0035615; GO:0043005; GO:0048488; GO:0070161 clathrin adaptor activity [GO:0035615] IHSLRIDR 0.9933 -14.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7042 0 0 19.0627 0 19.8244 0 0 0 0 0 0 0 0 0 0 19.4617 0 0 0 0 0 0 0 0 19.7179 0 0 0 0 0 18.832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5199 13.0829 0 0 0 0 0 0 0 15.6108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYA6 CTBL1_HUMAN "Beta-catenin-like protein 1 (Nuclear-associated protein, NAP) (Testis development protein NYD-SP19)" CTNNBL1 C20orf33 PP8304 Homo sapiens (Human) "apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]" centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681] "centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; enzyme binding [GO:0019899]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]" GO:0000398; GO:0000974; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016020; GO:0016445; GO:0019899; GO:0043065 enzyme binding [GO:0019899] DGEEEEEEEEPLDESSVK 0.9933 -14.464 0 0 0 0 0 0 0 0 0 0 11.8541 0 11.5775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3077 0 0 0 0 12.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0327 0 14.5765 0 0 0 0 0 12.3722 0 13.4091 0 0 0 13.9049 0 0 0 0 0 0 0 0 0 0 0 0 12.1263 0 0 0 12.9609 0 0 0 0 0 0 0 12.0265 0 0 0 12.0737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NK8 NDF6_HUMAN "Neurogenic differentiation factor 6, NeuroD6 (Class A basic helix-loop-helix protein 2, bHLHa2) (Protein atonal homolog 2)" NEUROD6 ATOH2 BHLHA2 My051 Homo sapiens (Human) dentate gyrus development [GO:0021542]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; dentate gyrus development [GO:0021542]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021542; GO:0030182; GO:0046983 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECEDQKQIK 0.9933 -26.95 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6484 0 0 0 0 0 0 0 0 0 0 0 12.3132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6608 13.4401 0 0 0 14.4684 15.3285 0 0 0 15.2015 0 13.818 0 15.4939 13.3046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2907 0 15.2333 0 0 0 0 0 14.4334 0 0 0 0 13.8082 0 0 0 0 0 0 0 13.5788 0 14.9487 0 0 0 0 0 0 0 0 0 0 15.0046 0 14.8296 14.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0961 0 0 0 0 0 0 0 0 Q96Q89 KI20B_HUMAN "Kinesin-like protein KIF20B (Cancer/testis antigen 90, CT90) (Kinesin family member 20B) (Kinesin-related motor interacting with PIN1) (M-phase phosphoprotein 1, MPP1)" KIF20B KRMP1 MPHOSPH1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088] centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233] centrosome [GO:0005813]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron migration [GO:2001224]; protein localization to microtubule [GO:0035372]; regulation of cell cycle [GO:0051726]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitotic nuclear division [GO:0007088] GO:0001843; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007049; GO:0007088; GO:0008017; GO:0008284; GO:0008574; GO:0016887; GO:0030426; GO:0030496; GO:0032467; GO:0035372; GO:0042803; GO:0045171; GO:0048471; GO:0048812; GO:0050699; GO:0051233; GO:0051301; GO:0051726; GO:0070938; GO:0090316; GO:0097431; GO:1903438; GO:1990023; GO:2000114; GO:2001224 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein homodimerization activity [GO:0042803]; WW domain binding [GO:0050699] AELAKTKGELIK 0.9933 -16.826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6833 0 0 11.5314 0 11.7801 0 12.7373 0 0 14.2538 0 0 0 0 0 0 0 14.8192 13.4922 0 0 10.0498 14.9346 14.5804 11.2306 14.313 0 10.6276 0 15.0825 0 12.2483 0 15.2745 0 0 0 0 11.2392 0 0 0 0 0 0 0 0 0 0 0 0 14.4073 0 0 0 0 0 11.9331 0 0 12.9186 0 0 14.5419 0 11.0222 13.0357 16.0814 13.9159 0 15.5346 17.3469 15.0427 0 0 13.2153 0 12.8508 13.7124 14.5393 0 0 14.9943 17.0084 12.7801 0 0 0 12.9267 14.1299 14.326 12.7954 0 15.3498 0 0 0 0 12.6638 13.6765 13.2612 12.4645 0 0 0 12.8053 0 13.1708 0 13.7537 14.1035 15.4048 12.8247 13.9391 13.0625 14.1152 14.2354 13.7795 13.8405 13.5417 14.2786 0 0 14.1329 0 12.9311 0 13.3784 0 0 12.7307 12.4246 0 12.3388 0 12.5182 0 0 11.8925 0 12.1888 14.5999 15.2683 0 0 0 13.7609 11.7471 0 0 0 0 0 15.2923 0 13.3188 12.4983 0 13.4793 0 0 11.384 0 12.6068 11.1254 Q9HCG8 CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb) CWC22 KIAA1604 NCM Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0016607; GO:0048024; GO:0071005; GO:0071006; GO:0071007; GO:0071013 RNA binding [GO:0003723] EVDKLIR 0.9933 -16.835 0 0 0 0 0 0 0 0 17.1905 0 0 0 0 14.193 0 16.6555 0 11.979 10.751 0 0 0 12.9288 12.8671 0 0 0 0 0 0 0 0 0 13.4136 0 14.3189 0 16.9137 0 0 0 17.1799 17.1229 0 0 0 0 16.7977 0 0 0 12.6474 13.4489 13.6624 13.7646 0 12.1808 14.0588 0 0 12.6917 0 16.5858 0 13.1829 13.1037 0 0 0 0 0 0 0 0 0 0 0 14.2254 0 0 10.5356 0 0 0 0 0 0 0 0 0 0 0 12.2208 0 0 0 0 0 0 12.8513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1057 0 0 0 0 0 0 0 0 0 0 0 0 12.962 0 0 0 0 0 0 0 0 0 13.2936 10.4513 0 0 0 0 0 13.9004 0 17.2729 0 17.424 0 0 0 0 17.1959 0 0 17.2808 0 14.5917 0 0 0 0 0 0 0 17.2663 0 0 Q9HCQ7 NPVF_HUMAN Pro-FMRFamide-related neuropeptide VF [Cleaved into: Neuropeptide NPSF; Neuropeptide RFRP-1; Neuropeptide RFRP-2; Neuropeptide NPVF (Neuropeptide RFRP-3) ] NPVF C7orf9 RFRP Homo sapiens (Human) negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218] extracellular region [GO:0005576] extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218] GO:0005102; GO:0005576; GO:0007218; GO:0032277 signaling receptor binding [GO:0005102] ENYDKYSEPR 0.9933 -14.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5557 0 0 0 0 0 11.9214 0 0 0 0 0 0 0 0 0 0 12.9223 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBU8 MO4L1_HUMAN Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Protein MSL3-1) (Transcription factor-like protein MRG15) MORF4L1 MRG15 FWP006 HSPC008 HSPC061 PP368 Homo sapiens (Human) "chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; fibroblast proliferation [GO:0048144]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Sin3 complex [GO:0016580] "histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]; chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; fibroblast proliferation [GO:0048144]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" GO:0000123; GO:0000724; GO:0000786; GO:0003682; GO:0005654; GO:0006325; GO:0016573; GO:0016575; GO:0016580; GO:0016607; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0047485; GO:0048144; GO:0051726; GO:1905168; GO:2000779 chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485] FQEGERVLCFHGPLLYEAKCVK 0.9933 -26.932 0 9.53282 0 0 0 0 0 0 0 0 0 13.5032 0 0 0 0 0 0 0 11.5759 0 0 0 13.5166 13.1586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9321 0 0 0 0 0 11.1205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3957 14.6047 0 0 0 0 0 0 12.7407 0 0 0 0 0 13.3059 0 0 0 0 0 0 0 15.0322 0 0 0 0 0 14.3497 13.9047 0 14.493 0 0 0 0 0 14.0369 14.2924 0 0 0 0 13.3811 13.798 0 0 0 13.7121 0 0 13.062 0 14.4544 0 0 0 0 14.4265 14.5539 0 0 0 0 14.1205 0 14.4532 0 0 0 0 0 0 13.4723 13.8935 0 0 12.4658 0 0 0 0 0 10.5901 0 13.8394 10.9666 0 0 0 0 0 0 0 13.0481 0 0 0 0 0 O75146 HIP1R_HUMAN "Huntingtin-interacting protein 1-related protein, HIP1-related protein (Huntingtin-interacting protein 12, HIP-12)" HIP1R HIP12 KIAA0655 Homo sapiens (Human) actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; digestive system development [GO:0055123]; endocytosis [GO:0006897]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein binding [GO:0032092]; protein stabilization [GO:0050821]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of gastric acid secretion [GO:0060453] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060] "apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]; actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; clathrin coat assembly [GO:0048268]; digestive system development [GO:0055123]; endocytosis [GO:0006897]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of apoptotic process [GO:0043065]; positive regulation of clathrin coat assembly [GO:1905445]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein binding [GO:0032092]; protein stabilization [GO:0050821]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of gastric acid secretion [GO:0060453]" GO:0005546; GO:0005547; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0005905; GO:0005938; GO:0006897; GO:0006898; GO:0006915; GO:0006919; GO:0007015; GO:0014069; GO:0016324; GO:0017124; GO:0030100; GO:0030136; GO:0030276; GO:0030665; GO:0030837; GO:0032051; GO:0032092; GO:0032587; GO:0032839; GO:0032956; GO:0034316; GO:0035091; GO:0035615; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043066; GO:0043197; GO:0043231; GO:0043325; GO:0045742; GO:0046982; GO:0048268; GO:0048471; GO:0050821; GO:0051015; GO:0055123; GO:0060453; GO:0080025; GO:0097060; GO:1901030; GO:1905445; GO:2000369; GO:2000588 "actin filament binding [GO:0051015]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SH3 domain binding [GO:0017124]" AIRLLVTTSTSLQK 0.99331 -27.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0075 9.19436 0 0 11.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4932 0 0 12.9004 0 0 0 0 0 0 0 10.706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.339 0 13.3595 11.7358 0 0 0 0 0 0 0 0 0 0 14.1455 0 0 0 0 0 14.2359 0 0 14.4245 13.2837 12.2243 0 0 0 0 0 13.5529 0 0 0 15.1276 12.7833 0 12.354 0 0 0 P08697 A2AP_HUMAN "Alpha-2-antiplasmin, Alpha-2-AP (Alpha-2-plasmin inhibitor, Alpha-2-PI) (Serpin F2)" SERPINF2 AAP PLI Homo sapiens (Human) acute-phase response [GO:0006953]; blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; fibrinolysis [GO:0042730]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636] blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093] blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule lumen [GO:0031093]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; blood vessel morphogenesis [GO:0048514]; collagen fibril organization [GO:0030199]; fibrinolysis [GO:0042730]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta production [GO:0071636] GO:0002020; GO:0002034; GO:0004866; GO:0004867; GO:0005576; GO:0005577; GO:0005615; GO:0006953; GO:0009986; GO:0010757; GO:0010951; GO:0030199; GO:0031093; GO:0032967; GO:0042730; GO:0042803; GO:0045597; GO:0045944; GO:0046330; GO:0048514; GO:0048661; GO:0051496; GO:0051918; GO:0062023; GO:0070062; GO:0070374; GO:0071636; GO:0072562; GO:2000049 endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867] LFGPDLK 0.99331 -14.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.143 0 0 0 0 0 0 0 0 0 0 0 0 14.8721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32248 CCR7_HUMAN "C-C chemokine receptor type 7, C-C CKR-7, CC-CKR-7, CCR-7 (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1, EBI1, EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197)" CCR7 CMKBR7 EBI1 EVI1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte migration into lymph node [GO:0097022]; mature conventional dendritic cell differentiation [GO:0097029]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interleukin-12 production [GO:0032695]; negative thymic T cell selection [GO:0045060]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [GO:2000526]; positive regulation of humoral immune response [GO:0002922]; positive regulation of hypersensitivity [GO:0002885]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of T cell costimulation [GO:2000525]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of dendritic cell dendrite assembly [GO:2000547]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-1 beta production [GO:0032651]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-C motif chemokine 19 receptor activity [GO:0038117]; C-C motif chemokine 21 receptor activity [GO:0038121]; chemokine (C-C motif) ligand 19 binding [GO:0035757]; chemokine (C-C motif) ligand 21 binding [GO:0035758]; G protein-coupled receptor activity [GO:0004930]; activation of GTPase activity [GO:0090630]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte migration into lymph node [GO:0097022]; mature conventional dendritic cell differentiation [GO:0097029]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interleukin-12 production [GO:0032695]; negative thymic T cell selection [GO:0045060]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell motility [GO:2000147]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation [GO:2000526]; positive regulation of humoral immune response [GO:0002922]; positive regulation of hypersensitivity [GO:0002885]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of T cell costimulation [GO:2000525]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of dendritic cell dendrite assembly [GO:2000547]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-1 beta production [GO:0032651]; release of sequestered calcium ion into cytosol [GO:0051209]; response to lipopolysaccharide [GO:0032496]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529] GO:0001768; GO:0001954; GO:0002407; GO:0002408; GO:0002606; GO:0002885; GO:0002922; GO:0004930; GO:0005739; GO:0005886; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0009897; GO:0009986; GO:0016021; GO:0016493; GO:0019722; GO:0019957; GO:0030838; GO:0031274; GO:0031529; GO:0032496; GO:0032649; GO:0032651; GO:0032695; GO:0032735; GO:0034695; GO:0035757; GO:0035758; GO:0038117; GO:0038121; GO:0043123; GO:0043552; GO:0045060; GO:0045785; GO:0045860; GO:0046330; GO:0048872; GO:0050862; GO:0051209; GO:0051491; GO:0051897; GO:0060326; GO:0070374; GO:0071345; GO:0071731; GO:0090023; GO:0090630; GO:0097022; GO:0097029; GO:2000147; GO:2000510; GO:2000522; GO:2000525; GO:2000526; GO:2000547; GO:2000669 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-C motif chemokine 19 receptor activity [GO:0038117]; C-C motif chemokine 21 receptor activity [GO:0038121]; chemokine (C-C motif) ligand 19 binding [GO:0035757]; chemokine (C-C motif) ligand 21 binding [GO:0035758]; G protein-coupled receptor activity [GO:0004930] LIFAIYK 0.99331 -14.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2Z5 KIZ_HUMAN Centrosomal protein kizuna (Polo-like kinase 1 substrate 1) KIZ C20orf19 NCRNA00153 PLK1S1 HT013 Homo sapiens (Human) spindle organization [GO:0007051] cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737] cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051] GO:0005737; GO:0005813; GO:0007051; GO:0019901; GO:0042995 protein kinase binding [GO:0019901] ALTEECGRR 0.99331 -27.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8612 0 0 0 0 0 0 0 0 13.5779 0 0 15.1649 0 0 0 0 0 0 0 0 0 0 13.2192 15.389 12.8804 0 0 12.2842 0 12.422 14.9741 0 14.4779 12.8919 13.5105 0 0 0 0 0 16.2646 0 0 12.8306 0 0 0 0 13.921 0 0 0 0 0 0 12.4622 0 0 14.3624 14.8638 0 0 0 0 0 0 0 0 0 0 0 0 14.9024 0 14.0057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4931 0 0 0 0 0 0 0 0 0 0 0 0 Q5JSJ4 INT6L_HUMAN Integrator complex subunit 6-like (Protein DDX26B) INTS6L DDX26B Homo sapiens (Human) snRNA 3'-end processing [GO:0034472] integrator complex [GO:0032039] integrator complex [GO:0032039]; snRNA 3'-end processing [GO:0034472] GO:0032039; GO:0034472 KLLKEITGETALR 0.99331 -17.331 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7554 0 0 0 0 0 0 0 14.2326 9.75123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9134 0 0 15.3719 0 0 0 0 12.5727 0 14.2005 0 0 0 0 0 12.5979 0 10.6282 0 0 0 0 13.2333 0 0 0 0 0 0 10.8053 0 0 0 13.3242 12.5583 0 0 0 16.9606 13.9248 13.0462 12.7576 13.5976 0 11.177 0 9.95768 13.7547 0 0 0 0 12.4196 13.1922 13.2371 0 0 0 0 0 0 0 0 11.9134 13.7004 0 0 0 0 0 12.4427 10.9058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.254 0 13.7424 Q5VZ52 MORN5_HUMAN MORN repeat-containing protein 5 MORN5 C9orf113 C9orf18 Homo sapiens (Human) DYRNRFLR 0.99331 -17.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6RI45 BRWD3_HUMAN Bromodomain and WD repeat-containing protein 3 BRWD3 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005634; GO:0006357; GO:0007010; GO:0008360 AAKIVTDVLLR 0.99331 -27.276 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2098 0 12.0917 0 12.6119 12.9524 0 0 0 0 0 0 0 0 12.5279 0 0 0 0 12.3284 0 0 12.5552 0 0 12.5352 0 13.7677 12.1966 13.4156 0 0 13.512 0 0 0 0 13.3461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3536 0 10.6821 15.0282 11.0089 0 0 0 0 0 13.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5974 0 0 17.5337 0 0 0 17.4602 0 0 0 0 0 0 11.041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7666 14.8629 0 0 0 0 15.0444 0 0 0 0 14.5183 0 0 0 0 0 14.6432 14.5393 13.6437 16.1553 13.9603 0 0 0 0 14.3135 0 14.3975 0 0 Q6ZVZ8 ASB18_HUMAN "Ankyrin repeat and SOCS box protein 18, ASB-18" ASB18 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 CLQHLCRCALRR 0.99331 -5.1594 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8305 0 0 10.1689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9697 0 19.2509 18.7479 19.1622 0 0 0 0 12.95 0 0 0 20.9347 13.6113 13.1467 14.0366 11.9629 0 0 0 13.4866 0 11.8005 0 0 0 0 14.825 14.9759 13.3348 12.0621 0 0 0 0 0 0 13.3284 12.9077 0 13.5228 0 0 0 0 0 0 0 0 0 0 10.6516 0 0 0 0 0 10.5892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0739 0 0 0 0 0 0 Q7Z5J8 ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein ANKAR Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AFLEKSLTKYLLK 0.99331 -27.127 0 0 11.8025 14.4357 11.5502 11.8444 12.2664 0 14.9461 14.6092 14.5003 14.6832 12.9809 13.8743 12.7056 12.853 0 0 13.9294 0 12.8438 14.2247 13.0612 14.0498 14.4018 0 14.7429 13.1844 0 14.7669 12.5421 13.6178 13.62 13.8465 13.3011 13.8361 14.346 13.7664 14.3734 14.2058 13.0256 12.2164 13.1875 12.7538 13.6796 12.3289 12.8965 12.8108 0 0 12.3495 14.3255 0 0 0 0 0 0 18.5331 0 0 0 0 0 0 0 15.0342 0 16.0039 13.8163 0 0 14.1988 14.1562 16.3641 15.1611 14.9582 0 14.6348 0 13.956 15.512 0 13.4654 11.8175 12.6151 0 0 0 13.7514 0 12.8216 0 11.3283 13.4055 12.6198 0 10.9923 0 0 0 0 12.2996 13.4329 13.7627 10.5283 14.6429 0 0 13.6738 0 0 0 9.35231 14.1597 0 0 0 13.4737 13.6824 0 0 0 0 0 0 0 14.4012 13.6169 13.5118 0 10.9246 13.2292 13.8117 0 14.5521 14.6421 13.4077 12.6207 0 11.4015 0 12.1732 14.2541 15.2017 15.6279 0 0 0 0 13.1823 13.2513 9.45111 13.9737 14.0132 13.7673 0 13.3775 14.0249 12.969 13.3079 14.0201 0 0 0 13.6131 0 0 12.6349 11.8573 13.088 0 13.7951 12.4084 0 0 0 0 0 0 Q8N884 CGAS_HUMAN "Cyclic GMP-AMP synthase, cGAMP synthase, cGAS, h-cGAS, EC 2.7.7.86 (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1)" CGAS C6orf150 MB21D1 Homo sapiens (Human) activation of innate immune response [GO:0002218]; cAMP-mediated signaling [GO:0019933]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cGMP-mediated signaling [GO:0019934]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; paracrine signaling [GO:0038001]; positive regulation of cellular senescence [GO:2000774]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immunoglobulin production [GO:0002637]; regulation of T cell activation [GO:0050863] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; 2',3'-cyclic GMP-AMP synthase activity [GO:0061501]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; activation of innate immune response [GO:0002218]; cAMP-mediated signaling [GO:0019933]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to exogenous dsRNA [GO:0071360]; cGMP-mediated signaling [GO:0019934]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; paracrine signaling [GO:0038001]; positive regulation of cellular senescence [GO:2000774]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immunoglobulin production [GO:0002637]; regulation of T cell activation [GO:0050863]" GO:0002218; GO:0002230; GO:0002637; GO:0003677; GO:0003682; GO:0003690; GO:0005524; GO:0005525; GO:0005546; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0008340; GO:0019933; GO:0019934; GO:0031491; GO:0032481; GO:0035861; GO:0038001; GO:0042803; GO:0045087; GO:0046872; GO:0050863; GO:0051607; GO:0061501; GO:0071360; GO:2000042; GO:2000774 "2',3'-cyclic GMP-AMP synthase activity [GO:0061501]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]" AQDTQPSDATSAPGAEGLEPPAAREPALSR 0.99331 -27.127 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1664 0 0 0 10.5324 0 0 0 0 0 0 0 0 10.7167 0 0 0 0 0 0 0 11.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3009 0 0 0 0 0 0 0 0 0 0 0 0 12.8405 0 13.6464 0 0 0 0 0 0 0 0 0 14.6116 0 0 0 0 0 0 0 0 0 0 13.0705 0 14.019 0 0 0 0 0 12.7867 0 0 12.4448 12.5869 13.4025 13.1263 0 0 13.8604 12.2901 12.7192 0 11.5841 0 0 0 12.4414 0 0 0 0 0 0 12.9536 11.8568 0 12.278 12.8491 11.8972 0 0 0 0 12.9956 0 12.6119 12.7436 12.5896 0 0 0 0 0 0 0 12.6372 0 0 0 0 0 12.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8932 0 0 0 10.8368 0 0 0 0 0 Q8TDJ6 DMXL2_HUMAN DmX-like protein 2 (Rabconnectin-3) DMXL2 KIAA0856 Homo sapiens (Human) vacuolar acidification [GO:0007035] anchoring junction [GO:0070161]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; small GTPase binding [GO:0031267]; vacuolar acidification [GO:0007035] GO:0005615; GO:0007035; GO:0008021; GO:0030672; GO:0031267; GO:0043291; GO:0070161; GO:0098992 small GTPase binding [GO:0031267] ACLKILMTELRTLATGYEVDGGK 0.99331 -17.385 0 0 0 0 0 13.8676 12.9574 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6351 13.3159 0 0 0 0 13.0022 0 0 11.6829 12.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7694 13.7882 13.5991 13.8359 13.8325 14.2359 13.9628 16.3928 16.1516 0 13.7312 0 15.9393 15.9906 13.2449 14.9964 15.3826 12.008 0 15.3837 15.3198 15.1309 15.1705 0 12.9729 13.5536 0 0 0 15.8977 0 0 0 0 14.9393 13.6333 13.1851 0 0 0 15.1064 0 0 13.3178 13.7149 0 0 17.3269 13.6272 13.8112 13.5878 0 12.8393 0 14.8095 0 14.8657 0 13.0504 11.0325 14.5377 13.8497 14.1368 14.5239 0 13.4569 0 0 11.9763 15.4728 14.5238 14.582 14.9787 15.3535 14.0607 13.8795 0 0 0 0 13.6026 0 11.3472 14.2113 0 13.8211 12.3234 14.8676 0 13.6983 12.9524 0 0 0 0 15.276 12.878 14.9266 0 15.244 15.7427 16.0413 13.7554 13.7773 14.6875 14.8369 0 0 13.7937 0 0 0 0 0 12.7428 0 13.7356 0 0 0 15.0937 14.5495 12.0321 13.2983 0 0 0 12.7766 12.7803 Q92925 SMRD2_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B, BAF60B)" SMARCD2 BAF60B PRO2451 Homo sapiens (Human) chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chromatin remodeling [GO:0006338]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000776; GO:0000785; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0070316; GO:0140092; GO:2000045; GO:2000781; GO:2000819 transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] FSEIPMK 0.99331 -27.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.617 0 0 0 0 0 0 13.2739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6062 0 0 12.9919 12.9329 0 0 0 13.6379 14.0159 0 0 0 0 0 0 0 12.9699 14.1041 0 0 0 0 0 0 12.0151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1895 0 12.6199 0 Q9BSL1 UBAC1_HUMAN "Ubiquitin-associated domain-containing protein 1, UBA domain-containing protein 1 (E3 ubiquitin-protein ligase subunit KPC2) (Glialblastoma cell differentiation-related protein 1) (Kip1 ubiquitination-promoting complex protein 2)" UBAC1 GBDR1 KPC2 UBADC1 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; protein ubiquitination [GO:0016567] GO:0000151; GO:0005794; GO:0005829; GO:0005886; GO:0016567; GO:0070062 APSPLPK 0.99331 -27.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0133 0 0 0 0 0 0 0 14.2051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.496 14.5401 0 0 0 0 0 0 0 0 0 0 15.2903 0 13.5838 12.1666 13.5058 12.4112 0 0 0 0 0 0 14.8898 0 12.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1393 0 0 0 0 0 15.0222 0 0 0 0 12.2624 0 0 0 13.5051 0 0 0 0 0 0 0 0 0 12.6945 0 0 0 15.8691 0 0 15.5215 0 13.1282 0 0 12.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0211 0 0 0 13.2899 0 Q9NW08 RPC2_HUMAN "DNA-directed RNA polymerase III subunit RPC2, RNA polymerase III subunit C2, EC 2.7.7.6 (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B)" POLR3B Homo sapiens (Human) "defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006351; GO:0032549; GO:0032728; GO:0045087; GO:0045089; GO:0046872; GO:0051607 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549] AKCIYTAVMVR 0.99331 -27.367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5791 0 0 0 0 0 0 0 0 0 0 11.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7611 0 0 13.4689 0 12.5748 0 0 13.2961 12.8681 13.6545 14.213 14.2676 15.2027 14.5622 0 12.8826 11.5023 13.5884 13.9335 0 0 13.4937 0 0 0 13.2402 0 0 0 11.638 0 0 0 0 13.859 0 14.4043 14.2496 0 0 0 0 0 0 0 11.341 0 14.0918 14.2637 15.0814 15.4686 0 0 0 14.0599 0 0 0 0 0 0 0 0 0 12.7631 0 0 0 0 12.5694 0 0 0 0 0 0 0 0 13.3127 0 15.0837 14.3205 0 10.7234 15.5531 0 0 13.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3338 18.3028 18.2079 Q9UHY7 ENOPH_HUMAN "Enolase-phosphatase E1, EC 3.1.3.77 (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)" ENOPH1 MASA MSTP145 Homo sapiens (Human) L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284] cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; 2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]" GO:0000287; GO:0005634; GO:0005829; GO:0019284; GO:0019509; GO:0043715; GO:0043716; GO:0043874 "2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]" KWREAGMK 0.99331 -6.6613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5642 0 0 0 0 0 0 0 0 0 13.7663 0 0 0 0 0 0 0 0 0 12.5388 0 0 0 0 0 0 0 0 12.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ49 NEUR3_HUMAN "Sialidase-3, EC 3.2.1.18 (Ganglioside sialidasedis) (Membrane sialidase) (N-acetyl-alpha-neuraminidase 3)" NEU3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; oligosaccharide catabolic process [GO:0009313]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742] caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] caveola [GO:0005901]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; external side of plasma membrane [GO:0009897]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; carbohydrate metabolic process [GO:0005975]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; oligosaccharide catabolic process [GO:0009313]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742] GO:0004308; GO:0005737; GO:0005765; GO:0005886; GO:0005901; GO:0005975; GO:0006687; GO:0006689; GO:0009313; GO:0009897; GO:0016020; GO:0016997; GO:0031901; GO:0043231; GO:0045742; GO:0052794; GO:0052795; GO:0052796; GO:0055038; GO:1900186 alpha-sialidase activity [GO:0016997]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308] IGQLVQWGPLK 0.99331 -6.4502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4935 14.6582 0 0 15.2967 14.4932 14.4911 14.4973 0 0 0 14.8746 0 15.2786 0 0 14.1461 0 13.2802 0 14.4381 15.2347 15.2669 0 14.4482 13.5239 14.1891 0 0 0 0 0 0 0 0 0 13.7813 0 13.6754 0 0 0 13.356 0 0 14.8805 0 0 0 15.1257 0 0 0 0 0 0 0 14.3945 0 0 0 0 0 0 0 0 0 0 13.6307 0 0 0 0 15.0519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6336 0 13.4562 0 0 0 0 0 B7Z6K7 ZN814_HUMAN Zinc finger protein 814 ZNF814 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGDCGKSFNEK 0.99332 -16.589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9138 0 0 0 0 0 0 0 0 0 0 0 10.0921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8172 0 0 0 0 0 0 0 14.4827 0 0 0 0 0 11.9038 0 0 0 0 0 0 13.2489 0 0 0 0 0 0 0 0 0 0 0 11.7474 0 0 11.2815 0 17.0658 0 0 0 0 12.3814 0 0 12.502 0 0 0 13.0428 0 0 0 0 0 17.1175 0 0 12.9609 12.7901 13.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2966 14.0339 14.0291 13.6796 0 13.275 0 12.8321 0 0 0 0 0 12.8747 12.8485 0 12.7641 0 13.1373 11.4842 0 0 0 0 O75995 SASH3_HUMAN SAM and SH3 domain-containing protein 3 (SH3 protein expressed in lymphocytes homolog) SASH3 CXorf9 SLY Homo sapiens (Human) "B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; T cell proliferation [GO:0042098]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; homeostasis of number of cells within a tissue [GO:0048873]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tumor necrosis factor production [GO:0032760]; T cell proliferation [GO:0042098]" GO:0001782; GO:0002639; GO:0002726; GO:0002821; GO:0005634; GO:0005737; GO:0030890; GO:0032729; GO:0032733; GO:0032743; GO:0032753; GO:0032760; GO:0042098; GO:0042100; GO:0042102; GO:0043367; GO:0043372; GO:0046622; GO:0048873 PSSPVVSEK 0.99332 -6.4758 0 0 0 0 12.5149 0 10.9751 12.8 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7649 0 13.6983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5528 0 0 0 0 0 0 0 0 14.1064 0 0 13.5015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1046 0 0 0 0 0 0 0 0 0 0 0 13.9161 0 0 0 0 15.3215 0 0 0 0 0 15.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6544 0 0 0 0 0 0 0 14.5056 15.009 14.9507 0 0 14.9437 0 0 0 15.072 15.1553 0 14.627 14.9432 0 15.3608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2142 14.9875 0 15.6645 0 0 0 16.1832 0 O94986 CE152_HUMAN "Centrosomal protein of 152 kDa, Cep152" CEP152 KIAA0912 Homo sapiens (Human) cell projection organization [GO:0030030]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; deuterosome [GO:0098536]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; protein kinase binding [GO:0019901]; cell projection organization [GO:0030030]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535] GO:0000242; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019901; GO:0030030; GO:0051298; GO:0098535; GO:0098536; GO:0120098; GO:0120099 protein kinase binding [GO:0019901] ARSEWNKEK 0.99332 -16.526 0 0 0 0 12.0662 0 0 0 0 0 0 0 0 0 0 0 0 12.424 0 10.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1647 0 0 0 0 0 0 0 9.7354 11.6894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4233 0 12.7984 11.4106 0 10.9307 0 13.2583 0 0 0 0 0 0 0 0 12.9659 0 13.6013 0 12.8095 0 0 11.7912 0 0 15.5365 15.2669 12.4689 15.5067 17.4967 0 0 0 13.088 0 0 12.2038 13.3832 0 0 12.7658 0 0 0 0 0 0 0 13.6753 14.521 0 0 0 0 10.92 0 17.9608 0 0 14.2643 13.3292 0 0 0 18.8387 18.8657 0 0 0 0 0 11.0798 0 0 0 0 11.3693 13.2976 0 0 0 17.2839 0 0 0 0 0 0 0 14.5866 0 0 0 0 0 0 0 0 0 12.6636 18.6324 0 0 0 0 0 0 0 P32019 I5P2_HUMAN "Type II inositol 1,4,5-trisphosphate 5-phosphatase, EC 3.1.3.36 (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase, 5PTase)" INPP5B OCRL2 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of protein processing [GO:0070613]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]" GO:0001701; GO:0004439; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007283; GO:0016020; GO:0016021; GO:0030317; GO:0030670; GO:0031901; GO:0043647; GO:0046855; GO:0046856; GO:0046872; GO:0052658; GO:0052659; GO:0070613 "inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]" DEELEEAGR 0.99332 -27.372 14.2835 0 0 13.6103 11.0646 11.0082 13.8087 0 0 0 0 0 0 0 14.3252 0 0 0 0 0 10.8992 0 0 0 0 0 0 0 0 0 0 12.5832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4374 13.772 14.1127 0 0 12.7568 12.9374 0 13.3931 13.0195 13.4014 13.6736 0 0 15.6407 11.6534 11.2845 15.8582 13.6736 0 0 0 17.7029 13.7137 13.9123 13.1659 13.3326 13.6745 0 0 12.7788 13.4243 13.1953 13.9863 12.1664 0 0 0 0 0 13.6935 0 0 13.8005 0 13.1813 13.9111 14.6492 11.8271 14.9447 13.7872 13.0608 0 11.7213 0 13.5371 17.6806 12.9212 13.8907 13.3362 0 13.6901 12.8683 0 0 0 0 0 14.2171 14.0471 13.9147 14.8983 0 12.1063 11.5766 13.5762 14.1931 13.6297 0 12.5302 0 0 0 0 12.3746 18.3772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7416 14.3028 0 12.6418 0 0 12.4082 0 0 P55000 SLUR1_HUMAN "Secreted Ly-6/uPAR-related protein 1, SLURP-1 (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein, ANUP)" SLURP1 ARS Homo sapiens (Human) cell activation [GO:0001775]; cell adhesion [GO:0007155]; locomotory behavior [GO:0007626]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; neuromuscular process controlling posture [GO:0050884]; urokinase plasminogen activator signaling pathway [GO:0038195] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; acetylcholine receptor activator activity [GO:0030549]; cytokine activity [GO:0005125]; cell activation [GO:0001775]; cell adhesion [GO:0007155]; locomotory behavior [GO:0007626]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; neuromuscular process controlling posture [GO:0050884]; urokinase plasminogen activator signaling pathway [GO:0038195] GO:0001775; GO:0005125; GO:0005576; GO:0005615; GO:0007155; GO:0007626; GO:0008285; GO:0010839; GO:0030336; GO:0030549; GO:0038195; GO:0050884; GO:0070062 acetylcholine receptor activator activity [GO:0030549]; cytokine activity [GO:0005125] CYTCKEPMTSASCR 0.99332 -16.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14181 DPOA2_HUMAN DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit) POLA2 Homo sapiens (Human) "DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; protein import into nucleus [GO:0006606]" alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; protein import into nucleus [GO:0006606]" GO:0003677; GO:0005654; GO:0005658; GO:0005829; GO:0006260; GO:0006269; GO:0006270; GO:0006606 DNA binding [GO:0003677] ARHSTCK 0.99332 -6.4907 0 0 10.4368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.24372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2942 0 0 0 0 12.4422 0 12.3925 0 0 0 10.1506 9.64084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8159 0 0 0 0 0 0 0 0 0 0 0 10.4805 0 0 0 0 10.241 0 0 0 0 0 0 11.1745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15047 SETB1_HUMAN "Histone-lysine N-methyltransferase SETDB1, EC 2.1.1.366 (ERG-associated protein with SET domain, ESET) (Histone H3-K9 methyltransferase 4, H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1)" SETDB1 ESET KIAA0067 KMT1E Homo sapiens (Human) heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; negative regulation of gene expression [GO:0010629]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265] chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; heterochromatin organization [GO:0070828]; histone H3-K9 methylation [GO:0051567]; negative regulation of gene expression [GO:0010629]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; Ras protein signal transduction [GO:0007265] GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007265; GO:0008270; GO:0010629; GO:0018024; GO:0043231; GO:0045869; GO:0046974; GO:0051567; GO:0070828; GO:0090309; GO:1990841 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270] CKCDPNMCTNR 0.99332 -16.563 0 0 0 0 0 0 0 0 13.0625 0 0 0 0 0 0 0 0 11.1523 0 0 0 0 0 10.5145 14.9089 11.1566 11.125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8214 0 11.3856 0 13.7826 12.8185 13.1377 12.0816 0 0 0 12.9492 0 12.3279 12.5508 12.2122 11.8676 0 0 0 0 14.5378 0 0 14.4903 0 0 0 14.8521 0 0 0 0 12.813 0 0 13.2994 0 11.1585 0 0 0 0 0 0 0 0 13.103 0 0 13.038 0 0 0 0 0 0 13.1974 0 0 0 0 0 11.9758 0 0 0 0 15.5358 0 0 0 14.203 13.7179 14.0486 15.6613 0 0 0 15.9524 13.6071 0 0 0 0 0 15.6757 14.2198 0 14.4794 0 0 12.5978 0 13.3861 0 0 13.2378 15.4281 0 0 0 0 0 0 0 0 0 0 0 0 13.7015 0 0 0 0 0 0 0 0 0 0 14.4009 0 0 0 0 0 0 15.0401 0 0 0 0 0 0 0 Q6N069 NAA16_HUMAN "N-alpha-acetyltransferase 16, NatA auxiliary subunit (NMDA receptor-regulated 1-like protein, NARG1-like protein)" NAA16 NARG1L NAT2 Homo sapiens (Human) "N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ribosome binding [GO:0043022]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]" GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006474; GO:0017196; GO:0031415; GO:0043022; GO:0043066; GO:0045893; GO:0050821; GO:0070062 ribosome binding [GO:0043022] AITPRRLPLTLVPGER 0.99332 -16.585 8.72342 0 0 0 13.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7545 0 0 0 0 0 14.4574 0 0 0 14.5406 0 13.5633 0 0 0 0 0 0 0 0 0 14.1889 0 0 0 13.7333 0 0 0 0 0 0 0 0 11.8233 0 0 0 0 0 0 0 0 0 0 0 0 10.9865 0 0 13.8808 14.1584 14.2001 14.2999 14.4819 15.6561 14.818 14.7057 14.8047 0 13.3531 0 13.3853 0 0 11.891 0 14.9255 0 0 0 0 0 0 0 15.1344 0 0 0 0 10.9984 0 14.5036 15.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8426 13.769 0 0 0 0 0 0 0 10.4948 0 0 0 13.9298 0 13.9584 13.6765 14.6372 13.537 0 0 0 13.5524 0 0 0 0 0 11.8978 0 0 0 12.7779 0 0 12.2116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4451 0 0 10.8842 0 0 0 Q6ZT89 S2548_HUMAN Solute carrier family 25 member 48 SLC25A48 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; transmembrane transporter activity [GO:0022857] GO:0005739; GO:0005743; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] EGLKVFFR 0.99332 -7.0983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZP7 H6ST3_HUMAN "Heparan-sulfate 6-O-sulfotransferase 3, HS6ST-3, EC 2.8.2.-" HS6ST3 Homo sapiens (Human) "heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]" Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; heparan sulfate 6-O-sulfotransferase activity [GO:0017095]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]" GO:0005794; GO:0015015; GO:0016021; GO:0017095 heparan sulfate 6-O-sulfotransferase activity [GO:0017095] ASNVEINEGAR 0.99332 -14.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0145 0 11.6315 0 0 0 0 0 0 12.5031 0 11.0802 12.5481 15.4262 0 0 14.168 12.39 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4881 0 0 0 0 0 0 12.1551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1916 0 0 0 0 0 0 0 0 0 0 0 Q8NI17 IL31R_HUMAN "Interleukin-31 receptor subunit alpha, IL-31 receptor subunit alpha, IL-31R subunit alpha, IL-31R-alpha, IL-31RA (Cytokine receptor-like 3) (GLM-R, hGLM-R) (Gp130-like monocyte receptor, Gp130-like receptor) (ZcytoR17)" IL31RA CRL3 GPL UNQ6368/PRO21073/PRO21384 Homo sapiens (Human) "acute inflammatory response to antigenic stimulus [GO:0002438]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to other organism [GO:0098542]; glandular epithelial cell differentiation [GO:0002067]; homeostatic process [GO:0042592]; macrophage differentiation [GO:0030225]; MAPK cascade [GO:0000165]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of macrophage activation [GO:0043031]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" anchoring junction [GO:0070161]; axon [GO:0030424]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235] "anchoring junction [GO:0070161]; axon [GO:0030424]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; acute inflammatory response to antigenic stimulus [GO:0002438]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to other organism [GO:0098542]; glandular epithelial cell differentiation [GO:0002067]; homeostatic process [GO:0042592]; macrophage differentiation [GO:0030225]; MAPK cascade [GO:0000165]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of macrophage activation [GO:0043031]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0000165; GO:0002067; GO:0002438; GO:0003713; GO:0004896; GO:0005886; GO:0006952; GO:0007169; GO:0007259; GO:0008284; GO:0009897; GO:0016021; GO:0019221; GO:0019901; GO:0019955; GO:0030224; GO:0030225; GO:0030424; GO:0042531; GO:0042592; GO:0042734; GO:0043031; GO:0043066; GO:0043235; GO:0045893; GO:0051916; GO:0070161; GO:0098542 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713] EFLVSEKLPEHTKGEV 0.99332 -14.224 0 0 0 0 0 0 11.4966 0 14.9591 14.604 14.39 0 0 11.0664 15.4757 14.496 0 12.0156 0 0 0 0 11.8776 0 0 0 0 0 0 14.2837 13.8021 11.4662 0 0 11.9296 0 0 0 12.4477 14.0831 0 0 14.1006 0 14.1244 14.3574 0 12.3888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2006 0 0 0 0 0 0 11.0879 0 0 0 12.7029 0 0 0 14.1931 0 0 0 0 0 0 0 0 0 0 0 13.1863 0 0 0 0 15.4821 0 0 13.6784 0 13.6078 0 0 0 0 0 12.7872 0 0 0 0 0 0 0 0 0 15.0385 0 0 0 13.0122 14.3997 0 15.1388 0 0 14.9567 0 0 0 12.9337 0 0 0 12.4986 15.1909 14.3276 0 0 0 11.8722 0 13.6035 0 14.3648 0 0 12.075 0 0 0 0 0 0 0 0 13.8041 0 14.3365 15.2109 14.7987 14.9014 0 15.4441 0 14.9338 12.2041 0 0 0 0 13.1827 0 0 15.0777 0 0 Q8TE54 S26A7_HUMAN Anion exchange transporter (Solute carrier family 26 member 7) SLC26A7 SUT2 Homo sapiens (Human) anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; oxalate transport [GO:0019532]; sulfate transport [GO:0008272] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; chloride transport [GO:0006821]; gastric acid secretion [GO:0001696]; ion transport [GO:0006811]; oxalate transport [GO:0019532]; sulfate transport [GO:0008272] GO:0001696; GO:0005254; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0006821; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015701; GO:0016323; GO:0019531; GO:0019532; GO:0055038 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] EMEFKVK 0.99332 -6.475 0 0 0 0 0 0 0 0 0 14.4469 11.7717 14.258 0 15.2895 14.4142 15.5672 0 12.1068 0 0 15.1769 0 0 0 9.96545 0 0 0 0 15.5256 12.4853 0 14.4997 0 12.0854 0 0 15.7807 14.4947 0 14.4316 0 0 14.2326 15.5195 11.5203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7192 13.2401 15.934 0 0 16.9303 0 15.9754 16.2535 0 15.2244 16.2269 15.8888 0 11.5061 12.5005 13.5498 12.7259 0 16.9254 16.5613 0 16.5694 13.0862 0 15.7328 0 0 0 0 0 0 14.8435 0 0 15.5959 0 15.5832 15.2571 0 12.6059 0 0 15.3453 10.7042 0 0 0 0 0 0 0 11.1185 0 0 13.5487 0 0 0 0 0 0 0 0 0 0 0 15.1908 0 11.5478 0 14.64 0 0 0 0 0 0 0 0 0 14.4631 0 0 0 0 12.943 0 14.0185 10.5789 0 0 0 0 0 0 14.2861 0 14.545 0 14.4169 0 0 Q9HDB5 NRX3B_HUMAN "Neurexin-3-beta (Neurexin III-beta) [Cleaved into: Neurexin-3-beta, soluble form; Neurexin-3-beta, C-terminal fragment, NRXN3-CTF ]" NRXN3 KIAA0743 Homo sapiens (Human) adult behavior [GO:0030534]; angiogenesis [GO:0001525]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; angiogenesis [GO:0001525]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] GO:0001525; GO:0004888; GO:0005886; GO:0007158; GO:0007165; GO:0007612; GO:0016021; GO:0030534; GO:0035176; GO:0050839; GO:0071625; GO:0097109 cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888] DFRPNKVSETSR 0.99332 -7.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRD8 DUOX2_HUMAN "Dual oxidase 2, EC 1.11.1.-, EC 1.6.3.1 (Large NOX 2) (Long NOX 2) (NADH/NADPH thyroid oxidase p138-tox) (NADPH oxidase/peroxidase DUOX2) (NADPH thyroid oxidase 2) (Thyroid oxidase 2) (p138 thyroid oxidase)" DUOX2 LNOX2 THOX2 Homo sapiens (Human) cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to virus [GO:0009615]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590] anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of cell motility [GO:2000147]; positive regulation of wound healing [GO:0090303]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; response to virus [GO:0009615]; superoxide anion generation [GO:0042554]; thyroid hormone generation [GO:0006590] GO:0004601; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006590; GO:0006952; GO:0006979; GO:0009615; GO:0009986; GO:0016174; GO:0016175; GO:0016324; GO:0019221; GO:0020037; GO:0031252; GO:0042335; GO:0042446; GO:0042554; GO:0042744; GO:0043020; GO:0045177; GO:0050665; GO:0051591; GO:0070062; GO:0070161; GO:0090303; GO:0106293; GO:0106294; GO:2000147 calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH oxidase H202-forming activity [GO:0106293]; NADPH oxidase H202-forming activity [GO:0106294]; peroxidase activity [GO:0004601]; superoxide-generating NAD(P)H oxidase activity [GO:0016175] DEFFTMMR 0.99332 -14.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5371 0 12.7919 0 0 0 0 13.7283 13.708 13.0976 0 12.9167 12.9719 0 0 0 0 0 0 0 0 0 0 0 0 13.6402 0 0 0 0 0 13.5486 0 0 14.5532 14.852 0 14.0139 0 0 0 16.0501 0 0 11.7806 0 15.9159 0 13.6216 14.9966 15.1976 14.5756 14.8758 14.9034 0 13.6239 0 14.0825 0 13.8819 14.1658 0 0 0 13.8805 0 0 14.2087 13.1383 0 14.9074 14.4096 14.8592 14.8215 13.7849 14.5995 11.3274 14.5804 16.1943 0 15.134 0 0 15.7676 13.2205 13.8193 0 14.0594 0 0 0 0 0 0 0 0 0 0 0 12.8202 0 0 0 0 15.15 14.8274 13.9228 0 0 0 15.1368 0 Q9UBZ4 APEX2_HUMAN "DNA-(apurinic or apyrimidinic site) endonuclease 2, EC 3.1.11.2 (AP endonuclease XTH2) (APEX nuclease 2) (APEX nuclease-like 2) (Apurinic-apyrimidinic endonuclease 2, AP endonuclease 2)" APEX2 APE2 APEXL2 XTH2 Homo sapiens (Human) base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310] fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cell cycle [GO:0007049]; DNA recombination [GO:0006310] GO:0001650; GO:0003677; GO:0003906; GO:0004519; GO:0005634; GO:0005654; GO:0005739; GO:0006284; GO:0006310; GO:0007049; GO:0008081; GO:0008270; GO:0008311; GO:0043231 DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270] ALLTQHKIRTWEGK 0.99332 -6.4854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9753 16.6461 15.4712 16.0611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9255 0 0 0 0 0 0 0 0 12.984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1911 0 0 0 0 0 0 0 12.2268 15.6303 14.3209 0 14.3972 0 0 0 12.8176 0 12.9425 0 0 0 0 0 0 0 0 0 0 0 12.9132 O43511 S26A4_HUMAN Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4) SLC26A4 PDS Homo sapiens (Human) inorganic anion transport [GO:0015698]; ion transport [GO:0006811]; regulation of pH [GO:0006885]; regulation of protein localization [GO:0032880]; sensory perception of sound [GO:0007605]; sulfate transport [GO:0008272] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; iodide transmembrane transporter activity [GO:0015111]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; inorganic anion transport [GO:0015698]; ion transport [GO:0006811]; regulation of pH [GO:0006885]; regulation of protein localization [GO:0032880]; sensory perception of sound [GO:0007605]; sulfate transport [GO:0008272] GO:0005886; GO:0005887; GO:0006811; GO:0006885; GO:0007605; GO:0008271; GO:0008272; GO:0015106; GO:0015108; GO:0015111; GO:0015116; GO:0015301; GO:0015698; GO:0016021; GO:0016324; GO:0019531; GO:0031526; GO:0032880; GO:0070062 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; iodide transmembrane transporter activity [GO:0015111]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] AFGVLKTLVPILEWLPKYR 0.99333 -16.623 0 0 0 12.143 0 11.3378 0 0 0 0 13.2779 11.2305 0 0 13.6391 0 0 0 0 12.7561 11.2935 12.5577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7692 11.245 0 0 0 0 11.9936 0 0 0 0 0 0 11.7199 0 11.9142 0 0 0 0 0 0 0 0 0 0 0 14.152 0 12.0933 14.2893 0 0 0 0 13.689 0 0 13.637 0 13.2825 0 0 0 0 0 0 0 0 0 13.2768 13.3006 0 0 14.4378 14.0277 14.8418 0 0 0 0 0 13.7562 0 0 14.1451 14.4916 0 0 13.502 14.4925 0 14.1008 13.7331 14.2977 12.698 0 0 14.1557 0 14.0582 13.8307 14.116 13.9955 0 0 13.6457 0 0 14.7193 0 0 14.2131 0 0 0 16.3602 15.1911 0 14.7351 0 0 0 0 0 13.799 14.2873 0 11.9141 13.821 14.8258 10.9884 0 14.3073 14.0794 0 0 11.0361 12.6429 0 0 0 0 0 0 12.9275 0 0 13.3134 0 0 13.3187 12.7699 0 0 0 0 11.0528 0 0 O95170 CDRT1_HUMAN F-box and WD repeat domain containing protein 10B (CMT1A duplicated region transcript 1 protein) FBXW10B C17orf1 C17orf1A CDRT1 HREP Homo sapiens (Human) ANYTLLLLQMCNPKLLLTAANVIRVLFLR 0.99333 -6.9278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0091 0 0 0 0 0 15.0565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7188 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0258 0 0 0 15.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8707 0 0 0 0 0 0 0 0 O95436 NPT2B_HUMAN "Sodium-dependent phosphate transport protein 2B, Sodium-phosphate transport protein 2B (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B, Na(+)/Pi cotransporter 2B, NaPi-2b) (Solute carrier family 34 member 2)" SLC34A2 Homo sapiens (Human) cellular phosphate ion homeostasis [GO:0030643]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341] GO:0001701; GO:0005436; GO:0005886; GO:0005887; GO:0005903; GO:0006817; GO:0016021; GO:0016324; GO:0030643; GO:0031402; GO:0031526; GO:0031982; GO:0042301; GO:0043627; GO:0044341 phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436] CCCCCRVCCR 0.99333 -6.3013 0 13.4718 0 0 13.1573 13.633 0 0 0 0 12.4346 0 0 0 0 10.3175 13.0549 14.3786 0 14.0841 12.4812 0 12.8352 12.0548 0 12.3538 14.4324 0 0 11.7632 0 0 0 0 0 12.3317 0 11.9192 0 0 0 0 0 0 0 0 12.7076 0 0 0 0 0 0 0 0 0 0 0 0 11.585 0 0 10.5347 0 0 10.6567 0 0 15.8393 0 0 11.5228 13.205 13.1128 15.1611 15.6481 15.5251 13.2868 14.8445 14.7189 0 15.3303 14.5671 13.1872 15.0626 11.6154 19.5536 11.9934 13.7952 13.02 15.2695 14.3754 12.5646 13.9164 14.1319 14.2968 0 16.2697 15.133 0 12.1904 0 12.7849 12.5688 0 15.3741 13.6336 12.1959 12.5552 15.252 12.4863 0 15.0203 0 12.9103 14.5708 13.8981 14.1142 14.6874 15.0048 0 14.0419 0 16.0446 12.8447 13.5349 13.5413 12.249 14.1163 13.8674 12.3006 0 0 17.4549 14.9398 0 0 15.3034 13.836 14.5151 15.4204 0 15.3783 0 13.2644 13.1698 0 14.0277 0 0 0 14.0445 0 14.1938 11.4165 12.3294 13.7835 0 0 0 14.2533 0 0 0 13.4671 0 13.6229 0 0 0 0 13.4165 0 12.3004 0 13.3025 0 0 0 0 P29460 IL12B_HUMAN "Interleukin-12 subunit beta, IL-12B (Cytotoxic lymphocyte maturation factor 40 kDa subunit, CLMF p40) (IL-12 subunit p40) (NK cell stimulatory factor chain 2, NKSF2)" IL12B NKSF2 Homo sapiens (Human) cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cytokine production [GO:0001817]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to UV-B [GO:0010224]; sensory perception of pain [GO:0019233]; sexual reproduction [GO:0019953]; T cell proliferation [GO:0042098]; T-helper 1 type immune response [GO:0042088]; T-helper cell differentiation [GO:0042093] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 complex [GO:0070743]; interleukin-23 receptor complex [GO:0072536]; late endosome lumen [GO:0031906]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 complex [GO:0070743]; interleukin-23 receptor complex [GO:0072536]; late endosome lumen [GO:0031906]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; interleukin-12 alpha subunit binding [GO:0042164]; interleukin-12 receptor binding [GO:0005143]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cytokine production [GO:0001817]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to UV-B [GO:0010224]; sensory perception of pain [GO:0019233]; sexual reproduction [GO:0019953]; T cell proliferation [GO:0042098]; T-helper 1 type immune response [GO:0042088]; T-helper cell differentiation [GO:0042093] GO:0001817; GO:0001916; GO:0002230; GO:0002323; GO:0002827; GO:0002860; GO:0002862; GO:0004896; GO:0005125; GO:0005143; GO:0005576; GO:0005615; GO:0005788; GO:0005829; GO:0005886; GO:0006955; GO:0009897; GO:0010224; GO:0010536; GO:0016477; GO:0019221; GO:0019233; GO:0019953; GO:0019955; GO:0030101; GO:0031906; GO:0032693; GO:0032700; GO:0032725; GO:0032729; GO:0032733; GO:0032735; GO:0032740; GO:0032760; GO:0032816; GO:0032819; GO:0032946; GO:0034105; GO:0034393; GO:0042022; GO:0042088; GO:0042093; GO:0042098; GO:0042102; GO:0042104; GO:0042164; GO:0042509; GO:0042531; GO:0042802; GO:0042832; GO:0043235; GO:0043382; GO:0043514; GO:0044877; GO:0045672; GO:0045785; GO:0046427; GO:0046982; GO:0048662; GO:0050671; GO:0050709; GO:0050729; GO:0050829; GO:0051135; GO:0051142; GO:0051607; GO:0070743; GO:0071222; GO:0071346; GO:0072536; GO:1900747; GO:1901224; GO:1903588; GO:2000318; GO:2000330 cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; interleukin-12 alpha subunit binding [GO:0042164]; interleukin-12 receptor binding [GO:0005143]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877] GSSDPQGVTCGAATLSAERVR 0.99333 -6.4965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8495 0 0 0 0 12.7442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6575 0 0 12.576 0 0 0 0 0 0 0 0 13.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3527 0 0 P35221 CTNA1_HUMAN Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13) CTNNA1 Homo sapiens (Human) actin filament organization [GO:0007015]; aging [GO:0007568]; apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; gap junction assembly [GO:0016264]; integrin-mediated signaling pathway [GO:0007229]; male gonad development [GO:0008584]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein localization to nucleus [GO:1900181]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization [GO:0008104]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224] acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915] acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166]; actin filament organization [GO:0007015]; aging [GO:0007568]; apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; gap junction assembly [GO:0016264]; integrin-mediated signaling pathway [GO:0007229]; male gonad development [GO:0008584]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein localization to nucleus [GO:1900181]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization [GO:0008104]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224] GO:0001541; GO:0001669; GO:0003723; GO:0005198; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005915; GO:0005925; GO:0007015; GO:0007155; GO:0007163; GO:0007224; GO:0007229; GO:0007405; GO:0007406; GO:0007568; GO:0008013; GO:0008104; GO:0008584; GO:0014704; GO:0015629; GO:0016264; GO:0016342; GO:0016477; GO:0016600; GO:0017166; GO:0030027; GO:0030054; GO:0031103; GO:0042475; GO:0042802; GO:0043231; GO:0043297; GO:0043627; GO:0045295; GO:0045296; GO:0045880; GO:0051015; GO:0071681; GO:0090136; GO:0097192; GO:0098609; GO:1900181; GO:2000146; GO:2001045; GO:2001240; GO:2001241 actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166] AAAGEFADDPCSSVK 0.99333 -16.206 0 0 0 0 0 0 0 0 0 12.2706 0 0 0 0 0 0 0 0 0 0 11.2494 0 0 0 0 0 0 0 0 10.2192 0 12.594 0 0 0 12.7228 0 0 0 0 0 0 0 0 0 11.9412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4647 13.8602 0 11.3908 0 0 12.3279 0 0 12.1592 0 0 0 0 0 0 0 0 12.8756 0 0 0 0 0 0 13.5048 0 0 0 0 0 10.8771 0 0 15.623 0 0 0 14.1031 0 14.0557 0 12.8831 0 0 0 13.9431 13.9516 12.8225 0 0 0 0 12.9427 0 15.5424 0 0 0 0 0 13.0682 0 0 0 0 0 12.4707 0 0 0 0 13.6485 0 0 15.5905 0 14.6489 12.6361 12.8349 14.4446 0 0 13.6881 0 0 12.5132 0 0 16.0091 14.2506 14.2095 13.9433 13.9376 13.9415 0 14.3142 0 13.836 0 0 0 0 0 14.6306 13.8637 13.4954 15.5448 0 14.1701 0 0 Q07837 SLC31_HUMAN "Neutral and basic amino acid transport protein rBAT, NBAT (D2h) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transport protein)" SLC3A1 RBAT Homo sapiens (Human) amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; basic amino acid transport [GO:0015802]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-cystine transmembrane transporter activity [GO:0015184]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; amino acid transport [GO:0006865]; aspartate transmembrane transport [GO:0015810]; basic amino acid transport [GO:0015802]; carbohydrate metabolic process [GO:0005975]; gene expression [GO:0010467]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813] GO:0005774; GO:0005886; GO:0005887; GO:0005975; GO:0006865; GO:0010467; GO:0015171; GO:0015174; GO:0015184; GO:0015802; GO:0015810; GO:0015811; GO:0015813; GO:0016020; GO:0016324; GO:0031526; GO:0044877; GO:0046982; GO:0070062 amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-cystine transmembrane transporter activity [GO:0015184]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877] GCQTNNGFVHNEDILEQTPDPGSSTDNLK 0.99333 -16.214 0 0 0 0 0 0 12.2051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7945 0 14.1061 0 13.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0507 15.0105 0 0 0 0 12.9021 14.203 0 15.275 12.6315 0 0 0 0 0 0 13.6945 13.1396 0 0 0 13.8323 0 12.1835 0 0 0 0 0 14.1727 0 0 0 0 0 13.0053 0 0 0 0 0 13.171 0 13.3383 0 13.2573 0 12.4663 0 0 0 0 13.3185 0 0 0 12.1407 14.074 11.7654 0 12.4457 0 0 12.6816 0 0 0 0 0 12.5771 0 13.5911 0 0 0 0 0 0 Q15022 SUZ12_HUMAN "Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein, ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog)" SUZ12 CHET9 JJAZ1 KIAA0160 Homo sapiens (Human) cell population proliferation [GO:0008283]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell population proliferation [GO:0008284] chromatin silencing complex [GO:0005677]; ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; sex chromatin [GO:0001739] chromatin silencing complex [GO:0005677]; ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; cell population proliferation [GO:0008283]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell population proliferation [GO:0008284] GO:0000122; GO:0000978; GO:0001222; GO:0001739; GO:0003723; GO:0005634; GO:0005654; GO:0005677; GO:0005730; GO:0008047; GO:0008283; GO:0008284; GO:0009048; GO:0016574; GO:0016604; GO:0031490; GO:0032993; GO:0035064; GO:0035098; GO:0042054; GO:0045596; GO:0046872; GO:0048709; GO:1990841 chromatin DNA binding [GO:0031490]; enzyme activator activity [GO:0008047]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222] DDLHCPWCTLNCR 0.99333 -13.206 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8238 0 0 0 0 0 0 0 0 0 0 0 0 17.9693 0 0 0 0 0 0 0 0 0 0 0 0 10.6684 0 0 0 0 0 10.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1687 0 0 0 0 0 0 0 13.4122 0 13.202 13.5157 0 13.3767 13.6101 0 0 0 11.5623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6355 0 0 0 0 0 14.2776 13.9108 0 11.7042 0 0 0 0 14.1831 0 14.2693 14.4341 0 0 13.6804 12.1011 0 0 14.038 0 14.0175 0 0 10.7467 0 0 0 13.7474 0 0 0 14.1546 11.9826 0 11.1946 0 14.0159 0 0 0 0 0 0 11.625 0 0 13.6908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1121 13.587 13.8753 0 0 0 0 0 0 Q17R55 F187B_HUMAN Protein FAM187B (Transmembrane protein 162) FAM187B TMEM162 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ADSVLKGLKLVLLVVTVLALLGALLK 0.99333 -6.9354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9152 0 0 0 11.4147 0 0 11.8358 11.9791 13.18 0 0 0 0 0 13.6069 0 0 0 0 0 0 0 0 13.0976 0 0 0 0 0 0 0 0 0 0 0 0 12.5901 0 10.4446 11.4604 14.1678 13.719 0 0 13.9016 12.0658 0 12.2165 11.2815 0 0 11.5996 0 0 0 0 0 0 0 0 0 0 12.6236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5421 0 0 0 0 0 12.6787 0 0 0 0 0 0 0 0 0 0 0 0 12.5131 0 0 0 0 0 13.5252 0 0 0 11.438 13.3383 13.2259 0 0 0 12.3121 0 14.2959 11.9509 14.0538 0 0 0 0 0 12.2837 0 13.653 12.4739 0 0 0 0 0 0 0 12.5566 0 0 0 Q53EP0 FND3B_HUMAN Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37) FNDC3B FAD104 NS5ABP37 UNQ2421/PRO4979/PRO34274 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; RNA binding [GO:0003723] GO:0003723; GO:0016021 RNA binding [GO:0003723] AKTRPLPPLPPR 0.99333 -16.62 12.9687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.377 0 0 0 0 0 0 0 0 14.1051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9117 0 0 0 0 0 0 0 0 0 13.2334 0 0 0 0 0 0 0 0 0 17.3385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q58EX7 PKHG4_HUMAN "Puratrophin-1 (Pleckstrin homology domain-containing family G member 4, PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1)" PLEKHG4 PRTPHN1 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005829; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] ADELYDRVDGLLHQLTLQSNQR 0.99333 -5.0134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0467 0 0 0 0 0 14.0947 0 0 0 0 0 0 0 0 0 9.21723 0 10.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2492 0 15.2203 15.2192 0 0 10.5709 0 0 0 14.2754 0 0 0 0 14.4992 0 14.0682 0 0 0 0 0 0 12.3573 0 14.2854 0 0 0 0 0 0 0 0 0 0 0 13.444 12.6936 0 0 0 0 13.966 0 0 0 13.7911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1071 0 0 0 0 0 14.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TEA3 DAAF9_HUMAN "Dynein axonemal assembly factor 9, DNAAF9" DNAAF9 C20orf194 Homo sapiens (Human) ITSFVDMVRDCSR 0.99333 -16.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0899 13.1933 14.2443 0 0 0 0 0 0 0 14.1232 0 11.8724 0 0 13.6313 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4981 0 0 0 0 0 0 0 0 0 0 0 0 13.4583 0 0 0 0 15.2811 0 0 0 0 0 12.3919 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4423 0 0 13.4836 0 12.757 0 12.7562 0 13.386 13.742 0 13.4333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q674R7 ATG9B_HUMAN "Autophagy-related protein 9B (APG9-like 2) (Nitric oxide synthase 3-overlapping antisense gene protein, Protein sONE)" ATG9B APG9L2 NOS3AS Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; bone morphogenesis [GO:0060349]; late nucleophagy [GO:0044805]; positive regulation of necrotic cell death [GO:0010940]; protein localization to phagophore assembly site [GO:0034497] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; phospholipid scramblase activity [GO:0017128]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; bone morphogenesis [GO:0060349]; late nucleophagy [GO:0044805]; positive regulation of necrotic cell death [GO:0010940]; protein localization to phagophore assembly site [GO:0034497] GO:0000045; GO:0000139; GO:0000407; GO:0000422; GO:0005776; GO:0005789; GO:0005802; GO:0010940; GO:0016021; GO:0017128; GO:0034045; GO:0034497; GO:0044805; GO:0055038; GO:0060349 phospholipid scramblase activity [GO:0017128] ARLARAYR 0.99333 -29.207 13.1239 0 12.4426 0 9.60489 0 0 0 10.4934 13.5422 0 0 0 0 0 0 12.3583 0 0 0 0 0 0 10.0916 0 10.6506 0 0 11.695 0 0 0 0 0 0 0 0 0 0 12.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2333 11.0434 11.8537 11.1576 13.3576 0 11.7577 0 0 0 0 0 0 12.763 0 0 0 0 0 0 0 14.4268 0 13.3451 0 0 0 0 0 0 0 0 11.0577 13.892 0 0 0 0 0 0 12.8953 11.164 0 0 14.3641 14.0994 0 0 0 14.1828 12.7723 0 14.2834 0 0 0 0 0 14.1102 14.2481 13.9547 14.4422 13.6911 13.6462 0 0 0 0 0 0 13.4981 13.6263 13.3749 13.5885 0 11.3679 12.3328 13.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.547 0 0 0 0 0 0 0 0 13.7453 0 Q6PF04 ZN613_HUMAN Zinc finger protein 613 ZNF613 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AFRDKSCLNR 0.99333 -6.5039 0 0 0 0 0 0 0 0 0 0 0 12.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8394 0 12.3709 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6747 12.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4381 0 12.9673 0 0 0 0 13.6081 0 0 13.3659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8961 0 0 0 0 13.2884 0 0 0 0 0 0 0 0 15.2904 0 0 0 0 0 0 0 0 0 14.1723 0 0 0 0 0 0 Q7Z418 KCNKI_HUMAN Potassium channel subfamily K member 18 (TWIK-related individual potassium channel) (TWIK-related spinal cord potassium channel) KCNK18 TRESK TRIK Homo sapiens (Human) cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841]; cellular response to pH [GO:0071467]; potassium ion export across plasma membrane [GO:0097623]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; stabilization of membrane potential [GO:0030322] GO:0005886; GO:0005887; GO:0006813; GO:0015269; GO:0015271; GO:0022841; GO:0030322; GO:0071467; GO:0071805; GO:0097623 calcium-activated potassium channel activity [GO:0015269]; outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841] GKFYHLVK 0.99333 -6.3055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3908 0 0 0 0 0 0 0 15.9003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEL9 DDHD1_HUMAN "Phospholipase DDHD1, EC 3.1.1.- (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1 homolog, PA-PLA1)" DDHD1 KIAA1705 Homo sapiens (Human) lipid catabolic process [GO:0016042]; positive regulation of mitochondrial fission [GO:0090141] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; lipid catabolic process [GO:0016042]; positive regulation of mitochondrial fission [GO:0090141] GO:0004620; GO:0005737; GO:0005829; GO:0016042; GO:0046872; GO:0090141 metal ion binding [GO:0046872]; phospholipase activity [GO:0004620] ASSSGTR 0.99333 -5.0241 0 0 0 0 0 0 0 0 13.9345 0 0 0 0 0 0 0 0 0 11.5811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1486 0 13.0604 0 0 0 0 13.6876 0 0 0 0 11.4636 0 0 0 0 0 0 0 0 0 0 0 11.969 0 0 0 0 0 0 0 0 11.8039 0 0 14.4265 0 0 0 13.133 0 0 0 0 18.096 0 0 0 0 0 0 0 12.3872 0 0 0 0 0 13.0571 0 0 0 0 0 14.6518 10.6456 0 0 0 0 17.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3712 0 0 Q92564 DCNL4_HUMAN "DCN1-like protein 4, DCNL4 (DCUN1 domain-containing protein 4) (Defective in cullin neddylation protein 1-like protein 4)" DCUN1D4 KIAA0276 Homo sapiens (Human) positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116] nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116] GO:0000151; GO:0005634; GO:0031624; GO:0032182; GO:0045116; GO:0051443; GO:0097602; GO:2000436 cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182] CMLGLLLGKIWPLFPVFHQFLEQSKYK 0.99333 -6.4956 12.4776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8388 0 0 0 0 0 0 0 0 0 0 0 0 12.5859 18.9585 0 15.6386 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9204 0 0 15.4695 17.0939 12.7118 0 13.3113 0 0 0 15.3142 12.8972 0 15.6514 13.4652 0 0 0 14.7153 0 0 0 0 15.018 13.7079 0 0 0 12.9382 0 16.3841 0 20.3295 0 15.5874 0 0 14.2401 0 0 13.9496 14.4053 14.9792 0 15.5197 19.6251 0 15.1069 0 0 0 15.9277 0 14.3318 0 16.0833 0 0 0 15.5672 15.3087 0 15.9634 0 15.786 0 13.6651 14.8271 15.5656 0 15.6559 14.4263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0966 14.3691 0 13.5132 0 14.074 0 0 0 Q92569 P55G_HUMAN "Phosphatidylinositol 3-kinase regulatory subunit gamma, PI3-kinase regulatory subunit gamma, PI3K regulatory subunit gamma, PtdIns-3-kinase regulatory subunit gamma (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma, PI3-kinase subunit p55-gamma, PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK)" PIK3R3 Homo sapiens (Human) B cell differentiation [GO:0030183]; cell migration involved in sprouting angiogenesis [GO:0002042]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; T cell differentiation [GO:0030217] "cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]" "cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784]; B cell differentiation [GO:0030183]; cell migration involved in sprouting angiogenesis [GO:0002042]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; protein kinase B signaling [GO:0043491]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; T cell differentiation [GO:0030217]" GO:0001784; GO:0001934; GO:0002042; GO:0005829; GO:0005942; GO:0005943; GO:0006955; GO:0008286; GO:0010628; GO:0016303; GO:0030183; GO:0030217; GO:0030335; GO:0043491; GO:0043551; GO:0046854; GO:0046935; GO:2000811 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784] EIERIMMNYDK 0.99333 -6.9414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4189 0 0 0 0 12.23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4258 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2157 0 0 0 0 0 0 0 13.474 14.0816 0 0 0 0 0 0 0 0 0 0 0 0 12.248 10.9186 0 0 0 0 13.7618 14.8237 0 0 13.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7645 0 13.4593 0 0 0 0 0 0 0 13.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969S3 ZN622_HUMAN Cytoplasmic 60S subunit biogenesis factor ZNF622 (Zinc finger protein 622) (Zinc finger-like protein 9) ZNF622 ZPR9 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]" "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273]" GO:0003723; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0008270; GO:0008631; GO:0030687; GO:0033674; GO:0042273; GO:0043065; GO:0043410; GO:0046330 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] ALGWTGSTGAALMR 0.99333 -16.227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8715 12.7935 13.2768 0 0 0 11.3791 0 0 11.109 0 0 0 0 0 0 0 0 0 12.1012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2241 0 0 0 0 0 0 0 0 0 0 0 16.2414 0 0 0 0 0 0 13.7028 0 0 18.2583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CB9 NSUN4_HUMAN "5-methylcytosine rRNA methyltransferase NSUN4, EC 2.1.1.- (5-methylcytosine tRNA methyltransferase NSUN4, EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4)" NSUN4 Homo sapiens (Human) RNA methylation [GO:0001510]; rRNA methylation [GO:0031167] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759] mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; rRNA binding [GO:0019843]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167] GO:0001510; GO:0005759; GO:0005762; GO:0008168; GO:0009383; GO:0019843; GO:0031167 methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; rRNA binding [GO:0019843] ELLKRVDLATVPR 0.99333 -6.5058 0 0 0 0 0 0 0 0 0 0 0 11.6486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4673 0 0 0 13.6128 0 0 0 0 0 0 0 0 0 0 0 0 14.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6097 0 0 0 0 0 0 0 0 0 11.9514 0 0 0 0 0 0 0 0 0 0 0 0 14.4014 11.7937 0 0 0 0 0 0 0 0 0 0 0 0 13.3472 0 0 0 0 0 0 10.8667 0 0 Q96E22 NGBR_HUMAN "Dehydrodolichyl diphosphate synthase complex subunit NUS1, EC 2.5.1.87 (Cis-prenyltransferase subunit NgBR) (Nogo-B receptor, NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog)" NUS1 C6orf68 NGBR Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; dolichol biosynthetic process [GO:0019408]; dolichyl diphosphate biosynthetic process [GO:0006489]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein glycosylation [GO:0006486]; protein mannosylation [GO:0035268]; regulation of intracellular cholesterol transport [GO:0032383]; vascular endothelial growth factor signaling pathway [GO:0038084] dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dehydrodolichyl diphosphate synthase activity [GO:0045547]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; dolichol biosynthetic process [GO:0019408]; dolichyl diphosphate biosynthetic process [GO:0006489]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein glycosylation [GO:0006486]; protein mannosylation [GO:0035268]; regulation of intracellular cholesterol transport [GO:0032383]; vascular endothelial growth factor signaling pathway [GO:0038084] GO:0001525; GO:0005789; GO:0006486; GO:0006489; GO:0016021; GO:0019408; GO:0030154; GO:0032383; GO:0035268; GO:0038084; GO:0042632; GO:0043536; GO:0045547; GO:0046872; GO:0051000; GO:1904423 dehydrodolichyl diphosphate synthase activity [GO:0045547]; metal ion binding [GO:0046872] FGTWNWIWR 0.99333 -6.3067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KJ4 MSLNL_HUMAN Mesothelin-like protein (Pre-pro-megakaryocyte-potentiating-factor-like) MSLNL C16orf37 MPFL Homo sapiens (Human) cell-matrix adhesion [GO:0007160] cell surface [GO:0009986]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; cell-matrix adhesion [GO:0007160] GO:0007160; GO:0009986; GO:0016021 LTAAQRIALNSLLAGGK 0.99333 -6.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6114 0 0 0 0 0 0 10.9865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5693 0 0 0 0 0 0 0 0 0 0 0 12.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQW3 COE4_HUMAN "Transcription factor COE4 (Early B-cell factor 4, EBF-4) (Olf-1/EBF-like 4, O/E-4, OE-4)" EBF4 COE4 KIAA1442 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" HPGDPER 0.99333 -16.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0655 11.8279 0 0 0 0 0 0 0 0 0 0 11.8786 12.0821 11.6272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.267 0 0 0 0 10.9495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2556 0 0 0 0 0 0 0 0 0 0 14.042 0 0 0 15.16 0 0 0 0 14.2493 0 0 14.2715 0 0 0 0 13.8424 0 13.5439 14.2398 0 0 0 0 14.2827 0 13.7562 0 0 0 0 0 0 14.1419 14.6833 0 0 0 0 0 0 0 0 0 0 12.6577 0 0 13.6667 0 0 0 0 0 0 0 0 0 0 0 0 14.2075 0 0 13.6684 0 0 0 0 14.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSK1 ZN577_HUMAN Zinc finger protein 577 ZNF577 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CRLNRHQR 0.99333 -6.3176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6796 0 0 0 0 0 0 0 0 0 0 13.9007 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2729 0 0 0 0 0 0 0 0 0 0 0 0 13.2983 0 0 0 0 0 0 0 0 0 0 0 0 11.8141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0322 0 0 0 0 0 0 0 0 0 0 12.8816 0 0 0 0 0 0 12.4804 Q9H7Y0 DIK2B_HUMAN Divergent protein kinase domain 2B (Deleted in autism-related protein 1) DIPK2B CXorf36 DIA1R UNQ1862/PRO3743 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 CNACIGTSICKKFFK 0.99333 -16.63 0 0 0 0 0 11.7285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8232 0 0 0 0 0 0 0 0 0 12.0391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0473 0 0 0 0 0 0 0 15.0411 0 0 0 0 0 0 0 0 0 0 0 0 13.0883 0 0 0 0 13.0856 0 0 0 0 0 0 0 12.8828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9496 0 0 0 0 0 0 14.2452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8211 0 0 0 0 0 Q9HC35 EMAL4_HUMAN "Echinoderm microtubule-associated protein-like 4, EMAP-4 (Restrictedly overexpressed proliferation-associated protein) (Ropp 120)" EML4 C2orf2 EMAPL4 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080] GO:0000226; GO:0000278; GO:0005737; GO:0005815; GO:0005829; GO:0005874; GO:0007017; GO:0007080; GO:0008017; GO:0008608; GO:0015630; GO:0016020; GO:0030496; GO:0043014; GO:0043621; GO:0048487; GO:0051301; GO:0072686 alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; protein self-association [GO:0043621] AKAPSHK 0.99333 -6.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8015 0 0 0 0 0 12.1481 0 0 0 0 0 0 0 0 0 0 0 13.198 11.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5419 0 0 0 0 11.3539 0 0 0 0 11.2268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9486 0 0 0 17.3588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5755 0 0 14.0003 0 0 0 0 0 15.6051 0 0 10.9566 0 0 0 10.5641 14.4416 0 0 0 0 0 0 0 13.6099 0 0 0 12.687 0 0 0 0 0 0 0 0 0 0 0 10.726 0 0 0 14.4285 0 0 0 11.9876 0 0 0 0 0 11.4 0 12.7193 0 0 0 0 14.6259 0 11.1831 0 0 0 12.7943 0 0 13.9309 0 0 0 Q9HCS7 SYF1_HUMAN Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2) XAB2 HCNP KIAA1177 SYF1 PP3898 Homo sapiens (Human) "blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]" catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing, via spliceosome [GO:0000398]; transcription, DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283]" GO:0000349; GO:0000398; GO:0000974; GO:0001824; GO:0005634; GO:0005654; GO:0006283; GO:0006351; GO:0016020; GO:0021987; GO:0043231; GO:0071007; GO:0071013; GO:0071014 ALRALPITQHSR 0.99333 -38.462 0 0 0 0 0 0 0 0 0 0 12.8685 12.8663 0 0 13.0141 0 0 14.704 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3969 0 0 0 0 0 0 0 0 0 0 0 0 13.84 0 0 0 0 0 0 0 0 0 0 0 12.3946 14.6979 12.4602 11.6052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1097 0 0 0 0 0 12.357 0 14.5295 0 13.8658 0 0 0 0 0 0 0 0 12.5534 0 0 15.1349 12.1201 0 13.7175 0 0 12.8314 12.0008 0 0 13.6947 0 0 0 0 0 0 15.3483 0 0 12.5255 0 0 0 0 0 13.0437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1481 0 0 0 0 0 0 0 0 19.543 0 0 14.3305 0 0 0 0 Q9NRM2 ZN277_HUMAN Zinc finger protein 277 (Nuclear receptor-interacting factor 4) ZNF277 NRIF4 ZNF277P Homo sapiens (Human) cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772] GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772 metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] DGSCSTVGGVGYGDSK 0.99333 -6.9298 0 0 12.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9656 0 12.7722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9067 15.6536 14.0979 0 0 15.1597 15.4055 15.5711 15.5099 14.7993 15.3992 15.1626 16.5855 13.7043 15.7313 15.7589 0 15.2506 14.4809 0 0 15.3031 14.4714 15.5037 0 15.721 14.9415 15.4508 14.0751 15.4213 14.6106 14.1128 12.7786 16.0257 0 15.5214 16.0101 14.7929 15.5323 15.2796 14.345 15.5084 0 14.1225 0 0 0 12.1757 0 0 0 15.4471 14.9525 14.2445 16.7018 14.7787 13.7168 0 13.4962 15.5647 14.8527 15.7643 15.8022 14.2332 0 16.5916 0 0 16.0661 16.1409 14.3565 14.8803 14.9188 14.8631 16.4837 14.1964 15.6143 15.5843 14.1783 14.9508 0 0 15.0036 0 15.7893 15.6933 14.8957 15.9834 14.688 15.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7368 15.8655 15.3307 0 0 0 0 0 Q9NS87 KIF15_HUMAN "Kinesin-like protein KIF15 (Kinesin-like protein 2, hKLP2) (Kinesin-like protein 7) (Serologically defined breast cancer antigen NY-BR-62)" KIF15 KLP2 KNSL7 Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; regulation of mitotic spindle assembly [GO:1901673] centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819] centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; regulation of mitotic spindle assembly [GO:1901673] GO:0000278; GO:0003774; GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0007018; GO:0008017; GO:0016020; GO:0016887; GO:1901673 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] AFQEKEQLRSK 0.99333 -29.168 0 0 0 0 0 0 0 0 0 0 12.6434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7395 10.7944 11.4737 12.3123 0 12.0092 0 0 12.4645 0 0 0 0 0 0 0 0 12.5089 0 15.1889 0 12.3944 0 16.8025 0 0 13.7047 13.8364 0 0 0 0 0 12.447 0 13.3026 0 0 14.8137 0 0 12.1861 15.5669 13.1907 0 0 15.788 13.3731 0 0 11.688 15.061 0 0 14.579 0 0 0 0 0 0 11.9661 0 10.8759 0 0 0 0 13.7412 14.8699 0 0 0 10.078 0 0 0 0 0 0 0 13.1497 0 13.3012 0 11.0397 0 0 13.0016 0 0 0 11.6334 0 12.5758 12.2583 0 0 11.1163 0 0 0 0 0 0 0 0 0 0 0 14.0752 0 0 11.4358 Q9NVM1 EVA1B_HUMAN Protein eva-1 homolog B (Protein FAM176B) EVA1B C1orf78 FAM176B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PRGPAQRR 0.99333 -6.3174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULH1 ASAP1_HUMAN "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1, ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1, DEF-1, Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)" ASAP1 DDEF1 KIAA1249 PAG2 Homo sapiens (Human) cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803] cell projection membrane [GO:0031253]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; podosome [GO:0002102] "cell projection membrane [GO:0031253]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; podosome [GO:0002102]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803]" GO:0001786; GO:0002102; GO:0005096; GO:0005546; GO:0005547; GO:0005829; GO:0031253; GO:0043197; GO:0043547; GO:0045296; GO:0046872; GO:0060271; GO:0061000; GO:0071803; GO:1903527 "cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]" ELSTLLKNLLQGLSHNVIFTLDSLLKGDLK 0.99333 -38.451 0 0 0 0 9.74772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3987 0 0 0 0 0 0 0 0 0 0 0 12.0623 0 0 0 0 0 0 0 0 10.9495 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9637 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2816 13.2177 0 0 0 0 13.5911 0 0 0 0 0 0 12.2767 0 0 0 0 0 10.0553 0 0 0 0 10.412 13.5303 13.1203 0 0 13.6556 13.3884 0 0 0 0 12.9522 0 0 12.3625 13.3686 0 0 14.1098 0 0 13.9007 0 0 13.3048 0 0 0 0 12.7361 0 13.3486 14.3008 0 0 14.5352 0 0 0 0 0 0 13.6862 14.5198 14.7187 0 12.8734 0 13.6026 0 0 0 0 0 0 0 0 12.9247 0 12.2568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3999 0 0 0 0 0 0 Q9UNY4 TTF2_HUMAN "Transcription termination factor 2, EC 3.6.4.- (Lodestar homolog) (RNA polymerase II termination factor) (Transcription release factor 2, F2, HuF2)" TTF2 Homo sapiens (Human) "DNA repair [GO:0006281]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]" cytosol [GO:0005829]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription elongation factor complex [GO:0008023] "cytosol [GO:0005829]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription elongation factor complex [GO:0008023]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; DNA-templated transcription, termination [GO:0006353]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]" GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006281; GO:0006353; GO:0006369; GO:0006397; GO:0008023; GO:0008094; GO:0008270; GO:0008380; GO:0016787; GO:0140658 "ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]" ADTCSFVR 0.99333 -16.188 0 0 0 0 0 0 0 0 11.9272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81975 0 0 10.9056 0 0 0 11.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2193 0 13.6832 13.1348 14.1442 0 10.251 0 11.0568 12.4039 0 0 0 0 0 0 0 12.3112 0 14.0746 16.5244 13.695 11.5707 0 0 13.2645 0 0 0 0 15.9313 14.6274 0 0 13.7036 0 0 0 13.4946 13.6831 0 12.4982 0 0 12.6123 0 0 0 0 0 0 0 0 14.7312 0 0 0 0 13.9988 0 0 0 0 12.6845 0 0 0 0 0 0 0 0 10.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0859 0 9.78139 0 0 13.5122 0 0 0 13.4161 0 15.0271 0 13.8253 0 0 0 A8MPX8 PP2D1_HUMAN Protein phosphatase 2C-like domain-containing protein 1 PP2D1 C3orf48 Homo sapiens (Human) protein dephosphorylation [GO:0006470] protein serine/threonine phosphatase activity [GO:0004722]; protein dephosphorylation [GO:0006470] GO:0004722; GO:0006470 protein serine/threonine phosphatase activity [GO:0004722] CEYEDTHK 0.99334 -13.289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4695 0 0 11.1834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7369 0 0 0 0 0 0 0 12.5922 0 0 0 0 0 0 0 0 0 0 0 P00813 ADA_HUMAN "Adenosine deaminase, EC 3.5.4.4 (Adenosine aminohydrolase)" ADA ADA1 Homo sapiens (Human) adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; alpha-beta T cell differentiation [GO:0046632]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; B cell proliferation [GO:0042100]; biomineralization [GO:0110148]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; germinal center formation [GO:0002467]; GMP salvage [GO:0032263]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; leukocyte migration [GO:0050900]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mature B cell apoptotic process [GO:0002901]; mucus secretion [GO:0070254]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; penile erection [GO:0043084]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; smooth muscle contraction [GO:0006939]; T cell activation [GO:0042110]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymocyte apoptotic process [GO:0070242]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111] anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; alpha-beta T cell differentiation [GO:0046632]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; B cell proliferation [GO:0042100]; biomineralization [GO:0110148]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; germinal center formation [GO:0002467]; GMP salvage [GO:0032263]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; leukocyte migration [GO:0050900]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mature B cell apoptotic process [GO:0002901]; mucus secretion [GO:0070254]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; penile erection [GO:0043084]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; smooth muscle contraction [GO:0006939]; T cell activation [GO:0042110]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymocyte apoptotic process [GO:0070242]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111] GO:0000255; GO:0001666; GO:0001829; GO:0001889; GO:0001890; GO:0002314; GO:0002467; GO:0002636; GO:0002686; GO:0002901; GO:0002906; GO:0004000; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0006157; GO:0006196; GO:0006939; GO:0007155; GO:0008270; GO:0009897; GO:0009986; GO:0010035; GO:0010460; GO:0014074; GO:0016020; GO:0019722; GO:0030890; GO:0032261; GO:0032263; GO:0033077; GO:0033089; GO:0033632; GO:0042100; GO:0042110; GO:0043084; GO:0043101; GO:0043103; GO:0044209; GO:0045987; GO:0046059; GO:0046061; GO:0046085; GO:0046103; GO:0046111; GO:0046632; GO:0046638; GO:0046936; GO:0048286; GO:0048541; GO:0048566; GO:0050728; GO:0050850; GO:0050852; GO:0050862; GO:0050900; GO:0060169; GO:0060205; GO:0060407; GO:0070161; GO:0070242; GO:0070244; GO:0070254; GO:0070256; GO:0110148 2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270] PETILYYGR 0.99334 -17.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8665 14.2753 0 0 14.0934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1783 12.7814 12.5897 13.4688 13.7839 0 0 19.0719 0 0 0 0 0 0 0 0 0 0 14.3739 13.9547 13.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15102 PA1B3_HUMAN "Platelet-activating factor acetylhydrolase IB subunit alpha1, EC 3.1.1.47 (PAF acetylhydrolase 29 kDa subunit, PAF-AH 29 kDa subunit) (PAF-AH subunit gamma, PAFAH subunit gamma)" PAFAH1B3 PAFAHG Homo sapiens (Human) brain development [GO:0007420]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; spermatogenesis [GO:0007283] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] 1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; identical protein binding [GO:0042802]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; nervous system development [GO:0007399]; spermatogenesis [GO:0007283] GO:0003847; GO:0005737; GO:0005829; GO:0006629; GO:0007283; GO:0007399; GO:0007420; GO:0008247; GO:0016020; GO:0016042; GO:0042802; GO:0042803; GO:0044877; GO:0046982; GO:0047179 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; identical protein binding [GO:0042802]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] AALAGHPR 0.99334 -6.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6353 0 0 0 0 0 0 0 0 11.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9809 12.7162 12.955 0 0 0 13.1489 0 0 0 13.0154 0 0 0 13.1829 0 0 0 13.3401 0 0 0 0 0 0 0 13.0012 0 11.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T848 GP158_HUMAN Probable G-protein coupled receptor 158 GPR158 KIAA1136 Homo sapiens (Human) protein localization to plasma membrane [GO:0072659] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659] GO:0004930; GO:0005886; GO:0016021; GO:0072659 G protein-coupled receptor activity [GO:0004930] ASGLILLETILFGSLLLYFPVVILYFEPSTFRCILLR 0.99334 -29.344 0 0 0 0 0 0 0 0 13.4038 16.7353 13.0631 13.0575 13.4311 12.773 12.7322 0 0 10.3495 13.2569 14.1094 13.3221 0 12.9844 0 0 0 0 12.8007 12.4247 12.7242 12.6711 12.4511 12.675 13.496 12.5953 12.9168 12.6005 0 12.8924 12.4881 0 12.8673 0 12.8299 0 14.1117 14.3514 13.6904 0 16.3978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8302 0 12.9 12.5631 11.9898 14.8368 0 13.0084 14.6558 12.3108 15.1203 14.7323 14.8447 0 14.7157 0 15.5245 15.5613 0 0 13.9937 12.29 0 15.9269 13.1826 14.1546 14.4366 14.8456 0 0 0 14.975 13.7795 14.8951 0 0 14.141 0 12.7711 0 0 13.2879 0 0 15.8645 0 0 14.9288 15.4972 14.241 14.7773 13.5886 13.1764 18.2529 13.1964 14.0021 13.5569 0 13.7138 13.4552 15.0315 14.0108 0 0 0 10.7201 0 0 15.9315 0 0 13.6752 0 13.3285 0 15.0301 0 0 0 12.3454 0 12.5458 0 0 0 0 14.0314 13.8915 0 15.5673 15.1641 0 0 0 0 0 15.144 0 15.1001 0 14.6746 0 15.1819 0 0 11.4033 0 0 0 15.4807 0 0 Q5VZR2 NTM2G_HUMAN NUT family member 2G NUTM2G FAM22G Homo sapiens (Human) GDPLASRRK 0.99334 -5.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5844 0 0 0 0 0 0 0 0 0 13.5961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6899 0 0 0 0 0 0 0 12.1401 0 0 0 0 11.1141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7969 0 0 0 12.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6208 0 12.1495 0 13.1058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W0Z9 ZDH20_HUMAN "Palmitoyltransferase ZDHHC20, EC 2.3.1.225 (Acyltransferase ZDHHC20, EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 20, DHHC20) (Zinc finger DHHC domain-containing protein 20)" ZDHHC20 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0008270; GO:0016020; GO:0016409; GO:0018230; GO:0018345; GO:0019705; GO:0019706; GO:0030173; GO:0033116; GO:0043231; GO:0048471; GO:0140439 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270] APWTLWRCCQR 0.99334 -6.5183 0 0 0 0 0 11.0239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2291 0 0 0 0 12.9891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SE9 PCGF5_HUMAN Polycomb group RING finger protein 5 (RING finger protein 159) PCGF5 RNF159 Homo sapiens (Human) histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805] centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]; metal ion binding [GO:0046872]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000805; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0006357; GO:0031519; GO:0035102; GO:0036353; GO:0045944; GO:0046872; GO:0060819 metal ion binding [GO:0046872] FLSLKLK 0.99334 -6.9662 0 0 0 0 13.735 0 0 11.9572 0 0 0 0 0 0 0 14.2819 14.0071 0 14.6311 0 13.1619 14.2142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0264 0 0 0 0 0 0 13.6118 13.9702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8407 0 20.3347 0 0 0 0 0 13.8709 15.179 15.0935 14.9587 13.9846 0 15.4362 0 14.5992 0 0 0 0 0 0 0 0 15.2331 12.9738 11.539 0 0 0 0 0 0 0 13.1558 0 13.5049 0 0 0 13.1384 0 14.1405 15.4262 0 15.2923 0 11.7585 0 0 0 14.8944 13.8075 0 0 14.6025 14.3234 0 0 13.3782 14.5295 0 0 0 15.0123 13.9846 14.0912 0 0 0 16.8861 14.7024 13.816 14.7196 19.3242 13.9212 14.0032 14.6705 13.793 0 0 0 14.0201 0 13.2105 0 14.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6299 15.3398 0 0 16.1163 0 0 0 13.8856 0 Q86TN4 TRPT1_HUMAN "tRNA 2'-phosphotransferase 1, EC 2.7.1.160" TRPT1 Homo sapiens (Human) "regulation of protein kinase activity [GO:0045859]; tRNA processing [GO:0008033]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" "tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA processing [GO:0008033]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0000215; GO:0006388; GO:0008033; GO:0045859 tRNA 2'-phosphotransferase activity [GO:0000215] EALQLRPTR 0.99334 -5.2387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.142 0 13.0761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0325 14.2231 0 12.1594 0 0 0 0 0 0 0 0 12.9407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR61 DLL4_HUMAN "Delta-like protein 4 (Drosophila Delta homolog 4, Delta4)" DLL4 UNQ1895/PRO4341 Homo sapiens (Human) angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; blood circulation [GO:0008015]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; cardiac ventricle morphogenesis [GO:0003208]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; pericardium morphogenesis [GO:0003344]; positive regulation of gene expression [GO:0010628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]; ventral spinal cord interneuron fate commitment [GO:0060579]; ventricular trabecula myocardium morphogenesis [GO:0003222]; visual perception [GO:0007601] GO:0000122; GO:0001525; GO:0001569; GO:0001974; GO:0003180; GO:0003208; GO:0003209; GO:0003222; GO:0003344; GO:0005112; GO:0005509; GO:0005886; GO:0007165; GO:0007219; GO:0007601; GO:0008015; GO:0008285; GO:0010596; GO:0010628; GO:0010629; GO:0016021; GO:0030217; GO:0035912; GO:0035924; GO:0044344; GO:0045746; GO:0045747; GO:0050767; GO:0060579; GO:0061074; GO:0061314; GO:0072554; GO:0090051; GO:1903588; GO:2000179 calcium ion binding [GO:0005509]; Notch binding [GO:0005112] CEFPVGLPPSFPWVAVSLGVGLAVLLVLLGMVAVAVRQLR 0.99334 -5.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6277 0 0 0 10.8721 0 0 0 11.3138 0 0 11.4401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.313 0 0 0 0 12.4845 0 0 0 0 0 11.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1C3 YN010_HUMAN Putative uncharacterized protein PRO2829 PRO2829 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 PHLLKKK 0.99334 -9.1745 13.3225 0 13.2658 12.8774 13.9432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1772 0 0 13.1938 13.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8734 17.0574 0 0 13.8723 0 0 13.2445 17.9467 18.2604 18.3576 0 0 18.582 16.498 17.2899 16.3631 15.9041 16.2046 17.0352 16.1749 16.1318 16.1292 16.265 16.0929 17.1289 0 17.8622 0 15.9343 16.8777 15.9034 0 18.514 18.4559 0 0 0 18.2155 0 0 0 0 0 17.8464 17.5448 0 0 0 0 0 0 0 17.8907 0 0 0 17.6467 17.5782 0 17.7144 17.6492 17.3621 0 17.6479 17.5967 0 0 0 0 0 17.3853 0 17.4015 16.5569 0 0 17.0705 16.4861 15.9082 0 0 0 17.3962 0 17.0015 17.2373 17.6099 16.1822 15.7513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4252 0 0 14.9074 0 0 0 A0A1B0GUS4 UB2L5_HUMAN "Ubiquitin-conjugating enzyme E2 L5, EC 2.3.2.23 (Ubiquitin-protein ligase L5)" UBE2L5 Homo sapiens (Human) protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0005524; GO:0005634; GO:0006511; GO:0016874; GO:0031625; GO:0061631; GO:0070979 ATP binding [GO:0005524]; ligase activity [GO:0016874]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625] AASRRLMK 0.99335 -17.262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8606 0 0 0 0 0 0 0 0 A1A5B4 ANO9_HUMAN Anoctamin-9 (Transmembrane protein 16J) (Tumor protein p53-inducible protein 5) (p53-induced gene 5 protein) ANO9 PIG5 TMEM16J TP53I5 Homo sapiens (Human) calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; lipid metabolic process [GO:0006629]; negative regulation of intracellular calcium activated chloride channel activity [GO:1902939]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; lipid metabolic process [GO:0006629]; negative regulation of intracellular calcium activated chloride channel activity [GO:1902939]; transmembrane transport [GO:0055085] GO:0005229; GO:0005254; GO:0005886; GO:0006629; GO:0006821; GO:0016021; GO:0017128; GO:0034220; GO:0051649; GO:0055085; GO:0061589; GO:0061590; GO:0061591; GO:1902476; GO:1902939 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; phospholipid scramblase activity [GO:0017128] DFQDPDGIEGSENVTLCRYRDYR 0.99335 -6.5436 0 0 0 0 0 0 0 0 0 0 13.0406 0 0 12.562 12.9852 0 0 12.0176 0 0 0 0 0 0 0 11.7808 11.4251 0 0 0 0 0 0 0 0 0 0 0 0 9.81695 0 0 0 0 0 0 0 0 0 0 11.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0795 0 10.3363 0 0 0 0 0 15.4319 0 0 14.1206 11.6488 0 0 0 0 0 0 0 0 0 13.449 0 0 12.5787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7225 0 0 12.0384 0 0 12.2997 0 0 0 0 0 0 0 0 0 13.4767 12.9691 0 0 0 0 0 0 0 0 0 12.4427 0 0 0 12.456 0 0 0 0 0 12.4204 0 A6ND01 JUNO_HUMAN "Sperm-egg fusion protein Juno (Folate receptor 4) (Folate receptor delta, FR-delta) (IZUMO1 receptor protein JUNO)" IZUMO1R FOLR4 JUNO Homo sapiens (Human) cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; single fertilization [GO:0007338]; sperm-egg recognition [GO:0035036] GO:0005576; GO:0005886; GO:0007155; GO:0007338; GO:0007342; GO:0031362; GO:0035036; GO:0038023 signaling receptor activity [GO:0038023] GGWDWSQGK 0.99335 -14.45 0 0 0 0 0 0 0 0 13.9854 0 0 12.9854 12.9783 0 0 0 11.1616 0 0 0 0 0 0 0 0 14.1136 0 13.4414 0 0 0 11.6896 13.3399 0 12.0771 0 0 0 0 0 13.6951 0 0 14.9554 0 13.393 14.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8931 0 0 0 14.0395 0 0 0 0 14.285 0 11.5303 0 0 0 0 0 0 12.8656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8494 0 0 0 0 0 0 0 0 0 O43310 CTIF_HUMAN CBP80/20-dependent translation initiation factor CTIF KIAA0427 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]" cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] "cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446]" GO:0000184; GO:0003723; GO:0005829; GO:0006446; GO:0008494; GO:0048471 RNA binding [GO:0003723]; translation activator activity [GO:0008494] GEAGAHR 0.99335 -9.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0309 0 0 0 0 0 12.6043 13.7047 0 0 10.8851 12.7749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4471 0 0 0 0 0 0 0 0 12.6483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.856 0 0 0 0 0 12.8204 0 0 0 0 0 0 0 0 12.7435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3169 0 0 0 0 0 0 0 0 0 0 0 12.338 0 0 0 0 O95235 KI20A_HUMAN "Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2, MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6)" KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0019901; GO:0030496; GO:0032465; GO:0045171; GO:0061952 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901] ACCHSTGAGK 0.99335 -14.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6722 0 0 0 0 0 0 0 0 0 0 0 10.3642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1932 0 0 12.11 0 0 0 0 11.4724 0 0 0 0 10.6157 0 0 0 0 0 0 12.1899 0 12.5623 0 0 12.4724 0 0 0 0 0 0 12.0971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2402 0 0 0 0 0 0 0 0 0 0 11.8733 0 0 0 0 0 0 0 0 0 12.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3057 0 0 0 0 P07108 ACBP_HUMAN "Acyl-CoA-binding protein, ACBP (Diazepam-binding inhibitor, DBI) (Endozepine, EP)" DBI Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; negative regulation of protein lipidation [GO:1903060]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of phospholipid transport [GO:2001140] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear endoplasmic reticulum [GO:0097038]; protein-lipid complex [GO:0032994] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear endoplasmic reticulum [GO:0097038]; protein-lipid complex [GO:0032994]; benzodiazepine receptor binding [GO:0030156]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA binding [GO:0036042]; fatty acid metabolic process [GO:0006631]; negative regulation of protein lipidation [GO:1903060]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of phospholipid transport [GO:2001140] GO:0000062; GO:0005783; GO:0005788; GO:0005794; GO:0006631; GO:0008289; GO:0030156; GO:0032994; GO:0036042; GO:0036151; GO:0042802; GO:0070062; GO:0097038; GO:1903060; GO:1905920; GO:2001140 benzodiazepine receptor binding [GO:0030156]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA binding [GO:0036042] HLKTKPSDEEMLFIYGHYK 0.99335 -6.5417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2435 0 0 0 0 0 13.2725 0 13.1346 13.0701 0 13.215 17.2456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2868 10.3485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6107 13.1041 0 0 0 0 0 0 0 P40238 TPOR_HUMAN "Thrombopoietin receptor, TPO-R (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110)" MPL TPOR Homo sapiens (Human) basophil homeostasis [GO:1990960]; cellular response to hypoxia [GO:0071456]; cytokine-mediated signaling pathway [GO:0019221]; eosinophil homeostasis [GO:1990959]; hemopoiesis [GO:0030097]; monocyte homeostasis [GO:0035702]; neutrophil homeostasis [GO:0001780]; platelet aggregation [GO:0070527]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of platelet formation [GO:1905221]; thrombopoietin-mediated signaling pathway [GO:0038163] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; thrombopoietin receptor activity [GO:0038164]; basophil homeostasis [GO:1990960]; cellular response to hypoxia [GO:0071456]; cytokine-mediated signaling pathway [GO:0019221]; eosinophil homeostasis [GO:1990959]; hemopoiesis [GO:0030097]; monocyte homeostasis [GO:0035702]; neutrophil homeostasis [GO:0001780]; platelet aggregation [GO:0070527]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of platelet formation [GO:1905221]; thrombopoietin-mediated signaling pathway [GO:0038163] GO:0001780; GO:0004896; GO:0005794; GO:0005886; GO:0008284; GO:0009897; GO:0009986; GO:0016021; GO:0019221; GO:0030097; GO:0031965; GO:0035702; GO:0038163; GO:0038164; GO:0043005; GO:0043025; GO:0050671; GO:0070527; GO:0071456; GO:1905221; GO:1990959; GO:1990960 cytokine receptor activity [GO:0004896]; thrombopoietin receptor activity [GO:0038164] CCPRDRYPIWENCEEEEK 0.99335 -7.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4755 0 0 0 0 16.6902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5774 0 0 0 0 16.623 11.9383 0 0 0 13.2122 0 13.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2021 0 0 0 0 0 0 0 0 P78347 GTF2I_HUMAN "General transcription factor II-I, GTFII-I, TFII-I (Bruton tyrosine kinase-associated protein 135, BAP-135, BTK-associated protein 135) (SRF-Phox1-interacting protein, SPIN) (Williams-Beuren syndrome chromosomal region 6 protein)" GTF2I BAP135 WBSCR6 Homo sapiens (Human) negative regulation of angiogenesis [GO:0016525]; positive regulation of DNA repair by transcription from RNA polymerase II promoter [GO:0100026] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; negative regulation of angiogenesis [GO:0016525]; positive regulation of DNA repair by transcription from RNA polymerase II promoter [GO:0100026]" GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0016020; GO:0016525; GO:0061629; GO:0100026 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" FGEAIGMGFPVKVPYR 0.99335 -5.0693 0 14.6212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.047 0 0 0 0 14.488 0 0 11.1875 0 0 0 12.0756 12.7814 0 0 14.5231 14.8029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0506 0 0 0 0 0 0 0 0 10.2612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1035 0 12.8522 0 0 0 0 0 0 0 0 0 0 0 14.4141 0 0 14.0481 0 0 0 0 Q13207 TBX2_HUMAN "T-box transcription factor TBX2, T-box protein 2" TBX2 Homo sapiens (Human) "aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; cardiac jelly development [GO:1905072]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle tissue development [GO:0048738]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; cochlea morphogenesis [GO:0090103]; developmental growth involved in morphogenesis [GO:0060560]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart looping [GO:0001947]; mammary placode formation [GO:0060596]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation involved in lung development [GO:0060916]; muscle cell fate determination [GO:0007521]; negative regulation of cardiac chamber formation [GO:1901211]; negative regulation of cellular senescence [GO:2000773]; negative regulation of heart looping [GO:1901208]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharynx development [GO:0060465]; pigment metabolic process involved in pigmentation [GO:0043474]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; roof of mouth development [GO:0060021]; smooth muscle cell differentiation [GO:0051145]; ureteric peristalsis [GO:0072105]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; cardiac jelly development [GO:1905072]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle tissue development [GO:0048738]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; cochlea morphogenesis [GO:0090103]; developmental growth involved in morphogenesis [GO:0060560]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart looping [GO:0001947]; mammary placode formation [GO:0060596]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation involved in lung development [GO:0060916]; muscle cell fate determination [GO:0007521]; negative regulation of cardiac chamber formation [GO:1901211]; negative regulation of cellular senescence [GO:2000773]; negative regulation of heart looping [GO:1901208]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharynx development [GO:0060465]; pigment metabolic process involved in pigmentation [GO:0043474]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of transcription by RNA polymerase II [GO:0006357]; response to retinoic acid [GO:0032526]; roof of mouth development [GO:0060021]; smooth muscle cell differentiation [GO:0051145]; ureteric peristalsis [GO:0072105]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0001947; GO:0003148; GO:0003151; GO:0003203; GO:0003272; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0007219; GO:0007521; GO:0008016; GO:0008543; GO:0022008; GO:0032526; GO:0035050; GO:0035909; GO:0036302; GO:0042733; GO:0042826; GO:0043474; GO:0043565; GO:0045892; GO:0045944; GO:0048596; GO:0048738; GO:0051145; GO:0060021; GO:0060045; GO:0060379; GO:0060441; GO:0060465; GO:0060560; GO:0060596; GO:0060916; GO:0072105; GO:0090103; GO:0090398; GO:0097325; GO:0140297; GO:1901208; GO:1901211; GO:1902808; GO:1905072; GO:1905222; GO:1990837; GO:2000773 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ADPEMPK 0.99335 -14.44 0 13.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77824 0 10.1037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4049 0 0 11.1189 0 13.0529 0 0 13.1576 0 0 0 0 11.489 0 0 0 0 13.7093 11.436 0 0 0 0 0 0 11.3062 0 0 0 0 0 0 0 12.143 0 11.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14028 CNGB1_HUMAN "Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4, CNG channel 4, CNG-4, CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1, CNG channel beta-1) (Glutamic acid-rich protein, GARP)" CNGB1 CNCG2 CNCG3L CNCG4 RCNC2 Homo sapiens (Human) "cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; detection of light stimulus involved in visual perception [GO:0050908]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; membrane depolarization [GO:0051899]; olfactory nerve maturation [GO:0021630]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; protein localization to organelle [GO:0033365]; response to odorant [GO:1990834]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495] "ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein-containing complex binding [GO:0044877]; cation transmembrane transport [GO:0098655]; cation transport [GO:0006812]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; detection of light stimulus involved in visual perception [GO:0050908]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; membrane depolarization [GO:0051899]; olfactory nerve maturation [GO:0021630]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; protein localization to organelle [GO:0033365]; response to odorant [GO:1990834]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" GO:0001750; GO:0001895; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0007601; GO:0007602; GO:0010628; GO:0015276; GO:0017071; GO:0021630; GO:0030552; GO:0030553; GO:0030660; GO:0033365; GO:0035845; GO:0044877; GO:0045494; GO:0050908; GO:0050911; GO:0051899; GO:0060170; GO:0098655; GO:0099105; GO:1902495; GO:1990834 cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; ligand-gated ion channel activity [GO:0015276]; protein-containing complex binding [GO:0044877] AGSVFGEISLLAVGGGNR 0.99335 -17.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5902 0 0 0 0 13.0711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.651 0 0 0 0 0 0 0 13.4984 12.3969 0 0 0 0 0 0 0 0 0 12.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6654 0 0 0 0 0 0 0 0 12.9672 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8404 0 12.724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6239 0 0 0 0 0 0 0 0 0 0 0 0 12.0941 0 12.7601 0 0 0 0 0 0 0 0 0 13.4696 0 0 0 0 0 0 Q15751 HERC1_HUMAN "Probable E3 ubiquitin-protein ligase HERC1, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619)" HERC1 Homo sapiens (Human) autophagy [GO:0006914]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842]; autophagy [GO:0006914]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175] GO:0004842; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010507; GO:0016020; GO:0021702; GO:0031175; GO:0050885 guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842] AIEYRLHEMDR 0.99335 -26.905 0 13.1338 0 0 9.67197 0 0 0 0 15.0154 0 0 0 0 0 0 14.4735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.635 0 0 0 14.9329 0 0 0 0 12.898 0 0 0 10.5634 13.8711 0 0 0 0 0 0 11.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2245 0 0 0 0 11.6453 0 13.9968 13.4821 13.9085 13.9442 15.1665 14.16 13.2542 14.8696 0 13.8267 0 14.108 14.1071 14.4769 15.8354 0 16.2177 14.8316 14.2646 15.4914 15.3516 15.8406 14.3171 0 0 14.4814 15.2279 0 17.0245 15.372 15.9484 14.4418 13.8861 0 16.2278 0 15.0998 14.6088 14.8412 15.7169 0 0 13.6143 15.0192 14.7362 16.1053 14.2605 14.9024 15.7379 16.8802 15.7498 13.0477 14.508 14.9153 15.3103 13.1027 15.3067 14.8814 15.5444 0 13.3645 0 0 0 15.1312 14.2 13.7405 0 14.3492 14.0982 0 13.2194 14.2824 11.0237 0 15.0325 15.569 15.0415 15.1466 15.3871 14.8004 15.8456 0 12.7349 0 0 0 0 0 0 0 0 13.3444 0 9.97885 11.0251 0 0 0 14.8758 12.6654 0 15.0078 0 13.1138 0 Q5T2E6 ARMD3_HUMAN Armadillo-like helical domain-containing protein 3 ARMH3 C10orf76 Homo sapiens (Human) regulation of Golgi organization [GO:1903358] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; regulation of Golgi organization [GO:1903358] GO:0000139; GO:0005829; GO:0016021; GO:1903358 EAASKVTHALVNIR 0.99335 -17.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3393 0 12.4022 0 0 13.3806 0 0 0 0 0 0 0 0 0 0 0 0 12.4587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.025 0 0 0 0 0 0 0 0 12.4305 0 0 12.5162 0 0 0 0 0 0 13.3247 0 0 0 0 0 12.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TH69 BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) ARFGEF3 BIG3 C6orf92 KIAA1244 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658] integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; regulation of ARF protein signal transduction [GO:0032012] GO:0005085; GO:0016021; GO:0030036; GO:0030658; GO:0032012 guanyl-nucleotide exchange factor activity [GO:0005085] AGGGDLLLPPSPKVEKK 0.99335 -26.932 0 0 0 0 0 0 13.7486 0 14.9384 14.9993 0 0 0 0 12.3794 0 11.6156 14.1702 0 0 13.4549 0 12.9135 0 14.2532 0 0 12.3503 0 0 0 14.3189 0 0 0 0 12.1944 0 0 0 11.27 0 14.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9734 0 0 0 14.6129 11.4496 0 13.0067 0 0 0 0 11.9049 15.8752 0 11.8081 14.911 0 0 0 0 0 0 0 0 15.4989 12.4996 19.4699 14.4795 13.0519 0 14.197 0 0 15.3891 0 0 12.0705 0 0 12.5259 15.2925 14.4875 13.1466 13.3644 0 11.6905 13.7895 0 10.2841 0 12.1873 0 14.4035 13.7828 0 0 0 13.6168 0 0 12.7519 0 0 12.7267 11.593 14.2394 0 0 0 14.1944 0 0 14.7356 13.7215 13.858 12.9425 17.5828 0 14.1349 0 0 12.0118 0 0 0 0 0 0 11.429 0 0 13.9439 0 0 0 0 0 0 0 12.7763 16.3466 0 0 13.0744 0 0 0 0 0 0 0 0 11.9676 12.393 12.9642 0 0 Q6UWP8 SBSN_HUMAN Suprabasin SBSN UNQ698/PRO1343 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 FGQGVHHAASQFGKETEK 0.99335 -9.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.131 12.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2792 0 0 0 0 13.8272 0 0 14.9912 0 13.8953 0 0 13.7826 10.7721 0 13.6167 0 0 0 13.6688 0 0 10.8195 0 0 13.8798 14.0437 0 0 0 0 13.033 0 12.6493 0 12.4734 0 13.2331 0 0 0 0 0 0 0 11.6867 0 11.6256 0 0 0 0 0 13.2091 0 13.4143 0 12.4235 0 0 0 0 0 13.4947 0 0 0 0 0 0 0 0 0 0 11.8497 0 13.0649 0 0 0 12.0462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5251 0 0 0 0 0 0 0 Q6ZVF9 GRIN3_HUMAN "G protein-regulated inducer of neurite outgrowth 3, GRIN3" GPRIN3 KIAA2027 Homo sapiens (Human) neuron projection development [GO:0031175] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; neuron projection development [GO:0031175] GO:0005886; GO:0031175 ENKLASLPGGVLK 0.99335 -14.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7919 13.3775 0 0 0 0 15.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5984 14.4638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4828 0 0 0 0 0 0 13.6502 0 0 0 0 0 0 0 0 17.1141 0 0 0 0 0 0 0 0 Q86UD7 TBC26_HUMAN TBC1 domain family member 26 TBC1D26 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0090630 GTPase activator activity [GO:0005096] AWSLLLDIDR 0.99335 -6.9892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4C9 CQ078_HUMAN Uncharacterized protein C17orf78 C17orf78 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ILIAVTLLLSGVAIIVFVIFEVPCPYQCLGAR 0.99335 -17.266 0 0 0 0 0 0 12.1068 0 0 0 0 13.9613 0 0 0 0 13.2199 13.1396 0 13.468 0 0 0 0 0 13.3028 13.2316 0 0 0 0 0 0 0 0 0 0 0 0 14.0852 13.2945 0 13.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3875 14.4692 14.5792 0 0 0 0 0 0 0 13.332 14.859 14.6503 14.9043 0 0 13.1106 14.0617 0 0 13.5927 0 14.2453 0 0 0 0 0 0 12.7853 0 0 13.8019 0 0 0 0 13.3899 0 0 13.4872 0 0 0 0 0 0 0 17.2948 0 0 0 0 0 16.6056 14.3521 0 0 0 0 11.1297 0 0 0 0 0 0 0 0 11.0718 13.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDW4 ZN248_HUMAN Zinc finger protein 248 ZNF248 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" IHTRVKALSTS 0.99335 -15.931 0 0 0 0 0 0 0 0 0 0 12.0294 12.1061 12.3692 12.7285 10.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8155 0 0 10.4216 0 0 0 0 0 0 0 0 0 11.6476 0 0 0 0 0 0 0 11.5843 10.8595 0 0 0 0 0 0 0 0 0 0 0 0 9.74086 0 10.4116 0 0 0 0 0 0 0 0 0 12.3688 0 0 0 13.1155 0 0 0 0 0 13.2268 0 13.1793 13.4748 12.9441 0 14.9306 13.1643 0 0 0 0 0 14.0852 0 0 0 0 12.7839 12.6834 12.7381 0 13.3693 0 14.4677 11.821 0 0 16.0258 0 15.7239 0 0 0 0 0 0 0 0 0 14.1124 0 0 0 0 0 0 0 0 0 14.5905 0 0 0 0 0 0 0 0 0 14.6506 0 11.0764 15.0195 0 0 12.3664 0 15.3569 0 0 0 14.2309 12.1725 14.1541 12.9019 0 13.9713 13.4985 13.8944 0 0 0 13.658 0 0 0 0 13.9022 0 11.0248 0 0 Q8WVJ9 TWST2_HUMAN "Twist-related protein 2 (Class A basic helix-loop-helix protein 39, bHLHa39) (Dermis-expressed protein 1, Dermo-1)" TWIST2 BHLHA39 DERMO1 Homo sapiens (Human) "cell differentiation [GO:0030154]; developmental process [GO:0032502]; negative regulation of apoptotic process [GO:0043066]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; negative regulation of apoptotic process [GO:0043066]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell migration [GO:0030335]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0030154; GO:0030335; GO:0032502; GO:0043066; GO:0045668; GO:0045892; GO:0046983 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ILANVRER 0.99335 -5.257 14.4844 14.4396 0 0 0 0 0 0 0 0 0 0 0 0 11.8194 0 0 0 0 0 11.9545 12.8076 0 14.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6712 0 0 0 12.0484 15.6388 13.3618 0 13.3437 15.585 16.3945 0 0 15.2269 0 0 0 0 0 0 0 13.4952 0 0 0 0 0 0 0 0 14.4793 0 14.9619 15.4576 0 0 0 0 0 15.6489 15.554 12.6813 0 0 0 0 0 14.5561 12.9612 15.4245 15.2842 15.0683 0 0 0 0 0 13.9149 0 14.8747 0 0 0 15.2659 0 0 14.7213 14.7251 0 12.4208 14.9379 13.2598 0 14.7574 0 13.1275 14.5671 0 0 14.816 0 0 14.3429 0 15.3148 0 14.1482 0 13.0565 0 0 18.3048 17.0133 14.6056 0 15.3238 14.7044 14.6101 0 14.1904 0 13.5857 13.8925 13.6037 14.0902 0 0 18.414 18.3455 13.343 0 Q8WWN8 ARAP3_HUMAN "Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (Centaurin-delta-3, Cnt-d3)" ARAP3 CENTD3 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; cytoskeleton organization [GO:0007010]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; vesicle-mediated transport [GO:0016192]" GO:0001726; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005886; GO:0007010; GO:0007165; GO:0008360; GO:0016192; GO:0030027; GO:0035021; GO:0035024; GO:0043325; GO:0043547; GO:0046872 "GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]" AGPSPPR 0.99335 -26.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84629 10.0027 0 0 0 0 10.4894 12.0293 0 0 0 12.7545 0 13.099 0 0 0 0 10.1635 0 0 0 10.7307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2758 10.0298 0 0 0 10.6439 0 0 12.6813 0 0 12.9334 0 14.8538 13.3768 0 17.9363 13.8938 16.1689 0 16.8663 15.4948 15.0689 14.3851 13.9269 0 13.7058 13.8088 0 0 13.6017 0 0 14.9254 0 14.7868 0 0 15.3938 0 11.5106 0 9.94575 0 0 0 0 0 0 0 0 0 0 13.875 0 0 0 14.9183 14.5792 14.1918 16.1336 13.9177 0 0 13.7298 13.5131 0 0 0 0 0 0 0 0 17.3508 11.8141 0 0 13.5394 0 0 0 0 12.1711 0 13.0767 12.0987 14.0893 0 0 17.1912 0 11.7743 0 11.7539 0 0 17.1622 0 0 0 0 0 0 0 12.3441 12.3857 0 0 0 0 0 15.1158 0 Q9BQ16 TICN3_HUMAN "Testican-3 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 3)" SPOCK3 TICN3 UNQ409/PRO771 Homo sapiens (Human) negative regulation of cell motility [GO:2000146]; negative regulation of endopeptidase activity [GO:0010951]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; metalloendopeptidase inhibitor activity [GO:0008191]; negative regulation of cell motility [GO:2000146]; negative regulation of endopeptidase activity [GO:0010951]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800] GO:0005509; GO:0005539; GO:0005576; GO:0005615; GO:0008191; GO:0010951; GO:0019800; GO:0031012; GO:2000146 calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; metalloendopeptidase inhibitor activity [GO:0008191] AFFNSCDTYK 0.99335 -26.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9532 0 12.0523 0 0 13.0473 13.4316 0 0 0 0 0 12.3798 0 0 0 0 11.9767 0 0 0 0 12.7761 0 0 0 0 0 0 0 0 0 13.9801 0 12.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9796 0 0 0 0 Q9BWV7 TTLL2_HUMAN "Probable tubulin polyglutamylase TTLL2, EC 6.-.-.- (Testis-specific protein NYD-TSPG) (Tubulin--tyrosine ligase-like protein 2)" TTLL2 C6orf104 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] cilium [GO:0005929] cilium [GO:0005929]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; protein polyglutamylation [GO:0018095] GO:0000226; GO:0005524; GO:0005929; GO:0015631; GO:0018095; GO:0046872; GO:0070740 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] FATEKFDLSNLQNNYAHLTNSSINK 0.99335 -26.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3781 0 0 0 13.0579 13.6702 0 13.6091 0 13.1038 0 0 13.0084 13.8903 0 0 14.4143 0 0 0 0 0 15.588 14.1871 15.1684 12.2792 0 12.5242 12.7154 0 0 13.9866 0 0 0 0 14.2917 12.4657 0 13.2216 0 0 13.3711 0 0 0 13.3821 0 0 0 0 0 0 0 0 0 0 14.4989 0 0 0 12.8012 0 0 0 0 11.7056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2704 0 0 0 0 0 0 0 Q9NPA2 MMP25_HUMAN "Matrix metalloproteinase-25, MMP-25, EC 3.4.24.- (Leukolysin) (Membrane-type matrix metalloproteinase 6, MT-MMP 6, MTMMP6) (Membrane-type-6 matrix metalloproteinase, MT6-MMP, MT6MMP)" MMP25 MMP20 MMPL1 MT6MMP Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508] GO:0004222; GO:0005576; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0031225; GO:0035579; GO:0060022 metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] APQTPYDK 0.99335 -6.9881 0 0 0 0 0 0 0 0 0 0 0 11.5848 0 11.3242 0 10.6946 12.9688 10.7093 0 0 0 0 0 0 0 0 11.2998 0 12.4953 15.0263 0 0 14.8491 0 0 14.7903 12.0801 0 0 11.7743 11.1778 9.91758 0 0 0 0 11.8798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9485 13.7817 0 0 12.1803 0 0 0 0 0 0 0 10.3829 0 0 0 0 10.1093 12.2151 12.7404 0 0 0 0 0 0 0 13.8627 11.375 0 0 0 13.6476 0 0 14.7067 10.881 0 0 0 0 0 15.0516 13.4256 0 0 0 0 13.6667 14.1359 0 0 11.7186 11.8832 11.2345 0 0 0 12.2714 12.5728 0 0 9.4537 0 13.911 0 0 13.1122 13.9188 0 0 0 0 10.2984 13.6358 0 0 0 0 0 13.4898 0 12.674 0 0 0 0 10.445 11.7638 0 12.0192 13.6566 0 12.4886 0 0 0 0 0 0 14.3868 0 13.7605 12.7124 0 0 10.2524 13.7208 13.9892 13.1598 0 12.8784 12.0109 0 Q9NUG4 CCM2L_HUMAN "Cerebral cavernous malformations 2 protein-like, CCM2-like" CCM2L C20orf160 Homo sapiens (Human) heart morphogenesis [GO:0003007] heart morphogenesis [GO:0003007] GO:0003007 DELLQLLDTARQLKELPLK 0.99335 -26.857 0 0 0 0 0 0 0 0 0 14.1447 0 14.513 12.4778 0 0 0 0 0 0 0 0 0 0 12.167 11.6444 0 0 0 0 11.5192 0 0 0 12.3449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8632 0 0 0 0 0 12.1245 0 12.2496 0 0 0 0 0 0 0 0 0 9.9847 0 11.5315 0 0 0 0 0 0 0 12.1988 13.2285 0 0 13.7915 13.55 0 13.6175 0 13.1119 0 0 14.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1361 0 0 13.5707 0 0 0 0 0 0 17.3122 11.7798 15.9697 15.0884 14.8124 0 13.8199 0 14.5069 13.4466 0 14.1538 13.4043 0 0 0 0 0 0 0 13.4651 0 0 0 0 0 0 0 0 0 0 0 14.7261 0 0 0 14.3063 0 0 0 0 11.0435 0 15.2868 15.0394 16.8172 16.574 15.7712 16.854 16.0325 15.1813 0 15.8699 16.0683 17.2661 17.2688 0 13.4341 0 0 17.1733 0 16.4242 13.9528 0 Q9UBK2 PRGC1_HUMAN "Peroxisome proliferator-activated receptor gamma coactivator 1-alpha, PGC-1-alpha, PPAR-gamma coactivator 1-alpha, PPARGC-1-alpha (Ligand effect modulator 6)" PPARGC1A LEM6 PGC1 PGC1A PPARGC1 Homo sapiens (Human) "adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cellular glucose homeostasis [GO:0001678]; cellular respiration [GO:0045333]; cellular response to oxidative stress [GO:0034599]; circadian regulation of gene expression [GO:0032922]; digestion [GO:0007586]; energy homeostasis [GO:0097009]; fatty acid oxidation [GO:0019395]; gluconeogenesis [GO:0006094]; mitochondrion organization [GO:0007005]; mRNA processing [GO:0006397]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of smooth muscle cell proliferation [GO:0048662]; neuron apoptotic process [GO:0051402]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of mitochondrial DNA metabolic process [GO:1901860]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of muscle tissue development [GO:1901863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; response to dietary excess [GO:0002021]; response to muscle activity [GO:0014850]; response to starvation [GO:0042594]; RNA splicing [GO:0008380]; temperature homeostasis [GO:0001659]; transcription initiation from RNA polymerase II promoter [GO:0006367]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; cellular glucose homeostasis [GO:0001678]; cellular respiration [GO:0045333]; cellular response to oxidative stress [GO:0034599]; circadian regulation of gene expression [GO:0032922]; digestion [GO:0007586]; energy homeostasis [GO:0097009]; fatty acid oxidation [GO:0019395]; gluconeogenesis [GO:0006094]; mitochondrion organization [GO:0007005]; mRNA processing [GO:0006397]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of smooth muscle cell proliferation [GO:0048662]; neuron apoptotic process [GO:0051402]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of gene expression [GO:0010628]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone acetylation [GO:0035066]; positive regulation of mitochondrial DNA metabolic process [GO:1901860]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of muscle tissue development [GO:1901863]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; response to dietary excess [GO:0002021]; response to muscle activity [GO:0014850]; response to starvation [GO:0042594]; RNA splicing [GO:0008380]; temperature homeostasis [GO:0001659]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000785; GO:0001659; GO:0001678; GO:0002021; GO:0003677; GO:0003712; GO:0003713; GO:0003723; GO:0005102; GO:0005634; GO:0005654; GO:0005737; GO:0006094; GO:0006355; GO:0006367; GO:0006397; GO:0007005; GO:0007586; GO:0008380; GO:0010628; GO:0010822; GO:0014850; GO:0016605; GO:0016922; GO:0019395; GO:0022904; GO:0030374; GO:0031490; GO:0031625; GO:0032922; GO:0034599; GO:0035066; GO:0042594; GO:0042752; GO:0043231; GO:0043524; GO:0043565; GO:0045333; GO:0045722; GO:0045893; GO:0045944; GO:0046321; GO:0048662; GO:0050821; GO:0050873; GO:0051091; GO:0051402; GO:0060612; GO:0065003; GO:0097009; GO:0120162; GO:0140297; GO:1901215; GO:1901857; GO:1901860; GO:1901863; GO:2001171 chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625] DDGDSYGFITYR 0.99335 -26.876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2396 0 0 14.3599 0 0 13.7754 0 0 12.452 0 0 0 0 0 15.3356 13.4935 0 0 0 13.1801 0 0 0 0 0 13.6364 0 13.8967 12.3459 0 13.1636 14.0902 0 0 0 13.1519 0 0 0 13.9529 0 0 14.3332 13.7897 0 0 0 0 0 0 13.5848 0 0 0 0 12.3226 13.4799 0 13.2335 0 13.6585 0 13.2801 14.7346 14.0821 14.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3867 0 17.3891 0 0 0 0 0 A2VDJ0 T131L_HUMAN Transmembrane protein 131-like TMEM131L KIAA0922 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; Wnt signaling pathway [GO:0016055] GO:0005737; GO:0005783; GO:0005886; GO:0016020; GO:0016021; GO:0016055; GO:0033088; GO:0090090 CVDKFCSDSSSDCGSSSGSVRASR 0.99336 -6.3937 0 0 0 0 0 0 0 0 13.2164 14.8233 0 13.5214 13.0992 13.4971 12.7969 13.0457 0 12.9449 0 13.0423 0 0 0 0 0 14.3534 12.4983 0 0 13.2087 12.6865 0 0 0 0 0 0 0 0 0 12.9307 0 0 0 12.9596 0 0 13.1157 14.4584 0 13.4689 0 14.3197 0 0 0 0 11.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9204 0 0 11.7688 0 0 14.3627 0 15.0112 0 14.9765 0 0 0 0 0 0 0 13.3684 0 0 0 0 0 0 0 0 0 0 0 14.4818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7791 15.1625 0 0 11.5212 0 0 14.0746 15.1251 11.4196 0 0 0 14.6446 0 0 0 0 0 0 0 0 0 0 14.2447 0 0 0 13.5614 0 0 0 14.5788 0 0 0 14.5736 0 14.8133 0 11.1307 0 0 10.8757 0 13.8033 0 0 0 0 0 0 0 O43915 VEGFD_HUMAN "Vascular endothelial growth factor D, VEGF-D (c-Fos-induced growth factor, FIGF)" VEGFD FIGF Homo sapiens (Human) dopaminergic neuron differentiation [GO:0071542]; fibroblast proliferation [GO:0048144]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172]; dopaminergic neuron differentiation [GO:0071542]; fibroblast proliferation [GO:0048144]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] GO:0001666; GO:0001934; GO:0001938; GO:0002040; GO:0005161; GO:0005172; GO:0005576; GO:0005615; GO:0008083; GO:0008284; GO:0009617; GO:0016020; GO:0031093; GO:0038084; GO:0042056; GO:0042802; GO:0043185; GO:0045766; GO:0048010; GO:0048144; GO:0050930; GO:0051781; GO:0060754; GO:0071542 chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172] ITHSEDWK 0.99336 -14.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8831 0 0 0 0 10.6859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5109 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7741 13.4015 0 0 14.0249 0 0 0 0 0 0 0 0 0 14.2912 0 13.2341 0 0 O75132 ZBED4_HUMAN Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001228; GO:0001917; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0042802; GO:0045944; GO:0046872; GO:0046983 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" QTDSGGER 0.99336 -5.076 0 0 0 0 0 9.50305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9393 0 0 0 0 0 0 0 0 0 10.346 0 0 10.85 0 0 0 0 0 0 0 0 0 0 0 11.4074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75448 MED24_HUMAN "Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component, ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4, CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component, Trap100, hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component, DRIP100)" MED24 ARC100 CRSP4 DRIP100 KIAA0130 THRAP4 TRAP100 Homo sapiens (Human) "positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; histone acetyltransferase activity [GO:0004402]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; RNA polymerase II preinitiation complex assembly [GO:0051123]" GO:0000151; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0016592; GO:0030374; GO:0032968; GO:0042809; GO:0044877; GO:0045893; GO:0046966; GO:0051123; GO:0060261; GO:0061630; GO:0070847 histone acetyltransferase activity [GO:0004402]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] ADREHAPQQKSGENANIQPNIQLILR 0.99336 -17.383 0 0 0 0 0 0 0 0 12.0715 11.2009 11.0621 11.567 0 11.9669 11.5806 0 0 0 0 11.5475 0 10.4881 0 0 0 0 0 0 0 0 0 11.2911 12.1304 11.7565 0 0 12.1174 0 11.3181 0 0 0 0 11.6824 0 0 0 11.7184 12.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 9.35522 0 0 0 13.0277 11.3325 0 0 0 0 0 0 13.78 0 0 0 0 10.6201 0 13.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2606 0 0 0 0 0 0 0 0 14.6732 0 0 0 13.5572 0 0 0 0 0 0 14.7067 0 0 0 0 0 0 0 0 13.9347 0 0 12.5075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2172 0 0 0 0 0 0 0 0 0 13.8806 14.58 13.1062 13.0468 12.8231 15.0483 14.6735 0 13.8007 0 14.4257 0 0 13.4528 12.7056 0 0 0 0 0 12.6865 0 0 O95780 ZN682_HUMAN Zinc finger protein 682 ZNF682 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFHWCSPFVRHK 0.99336 -7.951 13.5415 0 0 0 0 0 0 0 0 0 13.225 12.613 13.5218 11.5054 0 0 0 0 12.428 0 0 0 0 0 12.0111 12.4289 13.288 0 12.8618 0 0 13.4387 0 0 0 12.1795 0 14.721 13.2586 12.5438 10.862 0 0 11.9148 11.2774 0 0 0 0 0 0 0 0 0 15.1629 13.7171 14.826 14.6282 0 0 0 0 11.4624 12.5491 12.7425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9123 13.1688 0 0 0 0 0 0 0 16.1925 0 0 0 0 0 0 0 0 0 13.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0832 0 0 0 0 P0CB47 UBFL1_HUMAN Upstream-binding factor 1-like protein 1 UBTFL1 C11orf27 Homo sapiens (Human) blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; positive regulation of transcription by RNA polymerase I [GO:0045943]; transcription by RNA polymerase I [GO:0006360] GO:0001164; GO:0001181; GO:0001832; GO:0005634; GO:0005737; GO:0006360; GO:0007566; GO:0045943 RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] EKEESSNSSDCSSGEEIEVDV 0.99336 -7.9496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0969 0 0 0 0 0 0 0 0 14.2696 0 0 0 0 0 13.3073 0 0 0 0 0 0 0 0 0 0 0 0 11.8432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0859 0 0 0 P11717 MPRI_HUMAN "Cation-independent mannose-6-phosphate receptor, CI Man-6-P receptor, CI-MPR, M6PR (300 kDa mannose 6-phosphate receptor, MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor, IGF-II receptor) (M6P/IGF2 receptor, M6P/IGF2R) (CD antigen CD222)" IGF2R MPRI Homo sapiens (Human) animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133] cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283] GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005010; GO:0005520; GO:0005537; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0005925; GO:0006898; GO:0007041; GO:0007165; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030133; GO:0030139; GO:0030140; GO:0030667; GO:0030669; GO:0031100; GO:0031995; GO:0032526; GO:0032588; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:0070062; GO:1904772; GO:1905394 enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023] DGIIVLK 0.99336 -17.369 0 10.1445 10.1524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5288 13.5366 0 0 0 0 0 13.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.253 0 0 0 0 13.7104 0 0 0 0 0 0 0 0 0 14.7258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3573 0 0 0 0 0 11.1468 0 0 0 0 11.5976 13.8298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1585 0 0 0 0 11.4526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5308 0 0 0 0 0 0 0 P55058 PLTP_HUMAN Phospholipid transfer protein (Lipid transfer protein II) PLTP Homo sapiens (Human) ceramide transport [GO:0035627]; flagellated sperm motility [GO:0030317]; glycolipid transport [GO:0046836]; high-density lipoprotein particle remodeling [GO:0034375]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; vitamin E biosynthetic process [GO:0010189] extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634] extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; ceramide binding [GO:0097001]; ceramide transfer activity [GO:0120017]; cerebroside transfer activity [GO:0140340]; cholesterol transfer activity [GO:0120020]; diacylglyceride transfer activity [GO:0140337]; diacylglycerol binding [GO:0019992]; high-density lipoprotein particle binding [GO:0008035]; low-density lipoprotein particle binding [GO:0030169]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylglycerol binding [GO:1901611]; phosphatidylglycerol transfer activity [GO:0140339]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid transfer activity [GO:0120014]; sphingomyelin transfer activity [GO:0140338]; very-low-density lipoprotein particle binding [GO:0034189]; ceramide transport [GO:0035627]; flagellated sperm motility [GO:0030317]; glycolipid transport [GO:0046836]; high-density lipoprotein particle remodeling [GO:0034375]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; vitamin E biosynthetic process [GO:0010189] GO:0005576; GO:0005615; GO:0005634; GO:0006629; GO:0006869; GO:0008035; GO:0008429; GO:0008525; GO:0008526; GO:0010189; GO:0010875; GO:0015914; GO:0019992; GO:0030169; GO:0030317; GO:0031210; GO:0034189; GO:0034364; GO:0034375; GO:0035627; GO:0046836; GO:0070300; GO:0097001; GO:0120014; GO:0120017; GO:0120019; GO:0120020; GO:0140337; GO:0140338; GO:0140339; GO:0140340; GO:1901611; GO:1904121; GO:1990050 ceramide binding [GO:0097001]; ceramide transfer activity [GO:0120017]; cerebroside transfer activity [GO:0140340]; cholesterol transfer activity [GO:0120020]; diacylglyceride transfer activity [GO:0140337]; diacylglycerol binding [GO:0019992]; high-density lipoprotein particle binding [GO:0008035]; low-density lipoprotein particle binding [GO:0030169]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylethanolamine transfer activity [GO:1904121]; phosphatidylglycerol binding [GO:1901611]; phosphatidylglycerol transfer activity [GO:0140339]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid transfer activity [GO:0120014]; sphingomyelin transfer activity [GO:0140338]; very-low-density lipoprotein particle binding [GO:0034189] ALRTQLDLRR 0.99336 -9.2428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8792 0 0 0 0 11.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60568 IL2_HUMAN "Interleukin-2, IL-2 (T-cell growth factor, TCGF) (Aldesleukin)" IL2 Homo sapiens (Human) "activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; immune response [GO:0006955]; leukocyte activation involved in immune response [GO:0002366]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of heart contraction [GO:0045822]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000561]; regulation of T cell homeostatic proliferation [GO:0046013]; response to ethanol [GO:0045471]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; tyrosine phosphorylation of STAT protein [GO:0007260]" extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; cytokine activity [GO:0005125]; glycosphingolipid binding [GO:0043208]; growth factor activity [GO:0008083]; interleukin-2 receptor binding [GO:0005134]; kappa-type opioid receptor binding [GO:0031851]; kinase activator activity [GO:0019209]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; immune response [GO:0006955]; leukocyte activation involved in immune response [GO:0002366]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of heart contraction [GO:0045822]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000561]; regulation of T cell homeostatic proliferation [GO:0046013]; response to ethanol [GO:0045471]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366]; tyrosine phosphorylation of STAT protein [GO:0007260]" GO:0001933; GO:0002250; GO:0002366; GO:0002639; GO:0002903; GO:0005125; GO:0005134; GO:0005576; GO:0005615; GO:0006366; GO:0006955; GO:0007155; GO:0007204; GO:0007205; GO:0007260; GO:0007267; GO:0008083; GO:0008284; GO:0019209; GO:0030101; GO:0030217; GO:0030246; GO:0030307; GO:0030890; GO:0031851; GO:0032729; GO:0032740; GO:0034105; GO:0042104; GO:0042531; GO:0043066; GO:0043208; GO:0045471; GO:0045591; GO:0045822; GO:0045944; GO:0046013; GO:0048304; GO:0050672; GO:0050728; GO:0050729; GO:0050798; GO:0060999; GO:0097192; GO:1900100; GO:2000320; GO:2000561 carbohydrate binding [GO:0030246]; cytokine activity [GO:0005125]; glycosphingolipid binding [GO:0043208]; growth factor activity [GO:0008083]; interleukin-2 receptor binding [GO:0005134]; kappa-type opioid receptor binding [GO:0031851]; kinase activator activity [GO:0019209] DLISNINVIVLELK 0.99336 -14.07 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9532 0 0 0 0 11.4686 0 0 11.3234 0 0 0 0 0 0 0 0 11.6453 11.9205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7578 0 0 0 0 0 0 0 0 11.0469 0 0 0 0 0 0 12.5753 P62891 RL39_HUMAN 60S ribosomal protein L39 (Large ribosomal subunit protein eL39) RPL39 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; translation [GO:0006412] cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular space [GO:0005615]; polysomal ribosome [GO:0042788] cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular space [GO:0005615]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; translation [GO:0006412] GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005829; GO:0006412; GO:0019731; GO:0022625; GO:0022626; GO:0042788; GO:0050830; GO:0061844 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] FLAKKQK 0.99336 -6.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 0 0 0 0 0 0 P99999 CYC_HUMAN Cytochrome c CYCS CYC Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; cellular respiration [GO:0045333]; intrinsic apoptotic signaling pathway [GO:0097193]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]" apoptosome [GO:0043293]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; respirasome [GO:0070469] "apoptosome [GO:0043293]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; cellular respiration [GO:0045333]; intrinsic apoptotic signaling pathway [GO:0097193]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]" GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006122; GO:0006123; GO:0008635; GO:0009055; GO:0020037; GO:0043280; GO:0043293; GO:0045333; GO:0046872; GO:0070469; GO:0097193; GO:0097202 electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872] CSQCHTVEK 0.99336 -13.369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.333 0 0 0 0 0 0 0 0 0 11.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13232 NDK3_HUMAN "Nucleoside diphosphate kinase 3, NDK 3, NDP kinase 3, EC 2.7.4.6 (DR-nm23) (Nucleoside diphosphate kinase C, NDPKC) (nm23-H3)" NME3 Homo sapiens (Human) apoptotic process [GO:0006915]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; apoptotic process [GO:0006915]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleoside diphosphate phosphorylation [GO:0006165]; UTP biosynthetic process [GO:0006228] GO:0004550; GO:0005524; GO:0005829; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0006915; GO:0046872 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550] EIALWFR 0.99336 -5.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4788 0 0 Q14643 ITPR1_HUMAN "Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1, IP3R 1, InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor, Type 1 InsP3 receptor)" ITPR1 INSP3R1 Homo sapiens (Human) calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882] calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] "calcineurin complex [GO:0005955]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; platelet dense granule membrane [GO:0031088]; platelet dense tubular network [GO:0031094]; platelet dense tubular network membrane [GO:0031095]; postsynaptic density [GO:0014069]; sarcoplasmic reticulum [GO:0016529]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; calcium ion transport [GO:0006816]; cell morphogenesis [GO:0000902]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial fluid transport [GO:0042045]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of calcium-mediated signaling [GO:0050849]; post-embryonic development [GO:0009791]; regulation of autophagy [GO:0010506]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; voluntary musculoskeletal movement [GO:0050882]" GO:0000902; GO:0001666; GO:0005220; GO:0005509; GO:0005637; GO:0005730; GO:0005783; GO:0005789; GO:0005955; GO:0006816; GO:0007165; GO:0009791; GO:0010506; GO:0014069; GO:0015085; GO:0015278; GO:0016020; GO:0016021; GO:0016529; GO:0019855; GO:0019904; GO:0030658; GO:0030659; GO:0030667; GO:0031088; GO:0031094; GO:0031095; GO:0032469; GO:0035091; GO:0042045; GO:0048471; GO:0050849; GO:0050882; GO:0051209; GO:0070059; GO:0070679; GO:0098685; GO:0098695 "calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-release channel activity [GO:0015278]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels [GO:0098695]; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]" ACNNTSDRKHADSILEK 0.99336 -27.248 11.7921 0 0 0 0 0 0 10.9609 0 0 0 0 0 0 0 0 0 0 0 0 14.8228 0 11.1715 0 0 0 0 0 0 0 0 0 0 0 0 11.7631 0 0 12.8363 11.0859 11.1801 0 0 0 11.7991 0 0 0 0 0 0 10.3481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4087 12.3725 0 0 15.1973 14.2251 0 0 0 0 0 0 0 0 12.883 11.9863 0 0 0 0 0 0 12.6062 0 12.9012 12.5466 14.1112 11.3463 0 13.4285 0 12.2802 12.8196 15.0199 0 13.6758 0 0 13.922 0 0 13.1111 13.0366 12.2445 0 0 0 0 0 11.3276 0 0 0 14.3833 0 0 0 13.1958 0 0 0 0 0 12.463 12.7312 12.9796 13.0078 13.3934 0 12.81 0 0 0 0 0 12.6959 13.718 11.5906 0 0 15.0455 0 0 13.446 12.6312 0 14.1371 12.28 14.2519 13.9442 13.8147 0 0 0 0 0 12.9079 0 0 0 0 0 14.2275 0 0 13.8821 0 0 15.0333 0 13.281 0 0 0 Q3SY05 CA157_HUMAN Putative uncharacterized protein encoded by LINC00303 LINC00303 C1orf157 NCRNA00303 Homo sapiens (Human) KVMQRHPTLR 0.99336 -5.0779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VC05 BCL7A_HUMAN B-cell CLL/lymphoma 7 protein family member A BCL7A Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; GBAF complex [GO:0140288]; SWI/SNF complex [GO:0016514] "chromatin [GO:0000785]; GBAF complex [GO:0140288]; SWI/SNF complex [GO:0016514]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0030071; GO:0045596; GO:0045892; GO:0070316; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 EHPGAEDASDEQNSQSSMEHSMNSSEK 0.99336 -6.58 0 0 0 0 0 0 0 0 13.7196 13.0376 0 0 12.3965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.187 0 12.5421 12.799 0 0 0 0 12.0719 0 0 0 0 0 0 0 12.9071 0 0 12.9338 0 0 0 0 10.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.589 0 0 0 0 0 0 0 0 13.0966 0 0 Q59H18 TNI3K_HUMAN "Serine/threonine-protein kinase TNNI3K, EC 2.7.11.1 (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase)" TNNI3K CARK Homo sapiens (Human) bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of postsynapse organization [GO:0099175] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013]; bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of postsynapse organization [GO:0099175] GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0086069; GO:0098978; GO:0099175; GO:0106310; GO:1903779 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; troponin I binding [GO:0031013] EIIQISGTESLTKENIFSETAFHSACTYGK 0.99336 -14.504 0 0 0 0 0 0 0 0 12.3223 0 12.5999 0 0 0 0 0 0 0 0 0 13.4355 13.1289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4988 14.1038 0 0 15.0411 14.9279 14.9111 0 0 13.2672 0 0 0 14.4927 14.3835 13.572 0 13.7537 0 0 13.9644 14.2387 0 0 0 12.4799 0 0 14.8747 0 0 0 11.6844 0 0 0 15.3445 0 0 0 0 0 0 0 13.7224 0 0 0 14.001 16.3615 0 14.3224 14.3678 14.5858 14.3075 0 0 0 11.6273 0 12.4962 0 0 0 0 0 14.8255 11.7375 13.1182 0 16.0488 0 15.0684 12.0229 0 13.9105 0 0 0 11.2619 0 15.8926 0 0 0 0 10.5093 0 0 0 0 15.3355 0 0 0 0 0 0 0 16.8754 0 0 0 0 0 0 Q5JNZ3 ZN311_HUMAN Zinc finger protein 311 (Zinc finger protein zfp-31) ZNF311 ZFP31 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSRSSDLSK 0.99336 -7.9446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9329 0 0 0 0 0 11.6179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4297 0 0 0 0 0 0 0 0 0 0 0 0 17.8924 0 0 0 0 0 0 0 0 0 11.0702 0 0 0 0 0 0 0 0 0 0 Q6PJ61 FBX46_HUMAN F-box only protein 46 (F-box only protein 34-like) FBXO46 FBX46 FBXO34L Homo sapiens (Human) APDSGLPSGGGGR 0.99336 -17.359 0 0 0 11.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1107 0 0 0 0 11.859 0 0 0 0 0 0 0 0 0 9.3996 0 0 0 0 11.1751 12.1813 11.9479 0 0 0 0 0 0 13.8701 0 0 0 0 0 0 13.8238 0 0 0 14.3308 0 0 0 13.7398 13.2897 0 13.3741 0 12.6727 13.4741 0 0 11.9084 0 11.4623 0 0 0 0 13.4499 13.5676 0 12.1804 12.4571 0 0 13.2828 0 0 0 0 0 0 12.6835 0 14.0234 13.4107 0 0 0 0 0 0 0 0 0 0 12.4071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5197 0 0 0 0 0 0 0 0 0 0 0 0 12.1624 0 0 0 0 0 0 0 12.1567 0 0 0 0 12.0181 0 0 10.1732 Q6WKZ4 RFIP1_HUMAN "Rab11 family-interacting protein 1, Rab11-FIP1 (Rab-coupling protein)" RAB11FIP1 RCP Homo sapiens (Human) negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle membrane [GO:0030670]; recycling endosome [GO:0055037]; small GTPase binding [GO:0031267]; negative regulation of adiponectin secretion [GO:0070164]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055] GO:0005829; GO:0015031; GO:0030670; GO:0031267; GO:0043231; GO:0045055; GO:0055037; GO:0070164 small GTPase binding [GO:0031267] APQTRAVK 0.99336 -6.5843 0 0 0 0 0 12.3632 12.0733 0 13.649 0 0 0 0 0 0 0 0 0 13.9877 0 0 0 0 0 0 0 13.289 0 0 0 0 0 0 0 0 14.5029 0 0 0 11.1071 10.0627 13.8826 0 0 0 0 0 11.0067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3919 15.3462 0 0 0 11.2113 0 0 0 0 0 0 0 13.2703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3341 0 0 0 0 0 0 0 0 0 12.3237 19.099 0 0 0 0 0 0 0 14.3023 0 0 0 0 0 0 0 13.637 0 13.9302 0 13.5978 0 11.4888 0 0 0 0 0 0 0 0 0 0 0 14.5204 0 0 Q7Z3Y8 K1C27_HUMAN "Keratin, type I cytoskeletal 27 (Cytokeratin-27, CK-27) (Keratin-25C, K25C) (Keratin-27, K27) (Type I inner root sheath-specific keratin-K25irs3)" KRT27 KRT25C Homo sapiens (Human) hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; hair follicle morphogenesis [GO:0031069]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0031069; GO:0045109; GO:0070062 structural molecule activity [GO:0005198] DAEAWFNEK 0.99336 -7.9525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5448 0 0 0 0 0 0 0 0 0 10.9928 0 0 0 0 0 0 0 0 0 0 0 16.6888 0 16.3379 0 0 0 0 0 0 0 10.3298 0 0 0 0 0 0 0 0 0 12.0716 0 0 0 0 0 0 13.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UT6 NLRX1_HUMAN "NLR family member X1 (Caterpiller protein 11.3, CLR11.3) (Nucleotide-binding oligomerization domain protein 5) (Nucleotide-binding oligomerization domain protein 9)" NLRX1 NOD5 NOD9 Homo sapiens (Human) innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of RIG-I signaling pathway [GO:0039536] cell junction [GO:0030054]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell junction [GO:0030054]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of RIG-I signaling pathway [GO:0039536] GO:0005524; GO:0005739; GO:0005741; GO:0005886; GO:0010936; GO:0030054; GO:0032688; GO:0032715; GO:0035556; GO:0039536; GO:0043124; GO:0045087; GO:0045824; GO:0050728 ATP binding [GO:0005524] DLGGAAEGGAR 0.99336 -17.367 0 12.8663 0 0 0 0 12.6829 0 13.35 0 0 15.137 0 0 0 0 0 0 0 0 0 13.9595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6108 0 16.3437 0 0 0 0 0 0 0 15.9648 15.9388 0 15.0856 0 0 13.5744 0 0 0 0 0 0 12.8653 13.9556 0 0 12.7754 0 0 0 0 0 0 0 0 0 12.7756 0 0 0 0 0 0 0 0 0 13.3965 0 0 0 14.9199 0 0 0 0 0 12.6504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9887 12.77 0 0 12.73 13.3035 0 0 0 13.121 0 0 0 0 0 13.681 0 0 0 0 13.6905 0 0 0 0 0 0 0 0 0 17.4494 0 0 0 0 0 0 0 0 0 0 0 0 12.9817 0 0 0 0 13.0427 0 Q86YJ5 MARH9_HUMAN "E3 ubiquitin-protein ligase MARCHF9, EC 2.3.2.27 (Membrane-associated RING finger protein 9) (Membrane-associated RING-CH protein IX, MARCH-IX) (RING finger protein 179) (RING-type E3 ubiquitin transferase MARCHF9)" MARCHF9 MARCH9 RNF179 Homo sapiens (Human) Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; trans-Golgi network [GO:0005802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000139; GO:0004842; GO:0005765; GO:0005795; GO:0005802; GO:0008270; GO:0016021 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] DGDGDEEEYYGSEPR 0.99336 -15.251 0 0 0 0 0 0 0 0 0 0 10.9659 0 13.5716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.299 0 0 0 12.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74255 12.7189 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7611 0 0 0 0 12.6301 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZF5 AGRF3_HUMAN Adhesion G-protein coupled receptor F3 (G-protein coupled receptor 113) (G-protein coupled receptor PGR23) ADGRF3 GPR113 PGR23 UNQ9196/PRO34000 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] DKAWNERIDR 0.99336 -6.5711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5612 0 13.2156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6562 11.9902 0 0 0 0 0 10.6425 0 0 0 0 11.5261 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8979 10.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG95 OR7G3_HUMAN Olfactory receptor 7G3 (OST085) (Olfactory receptor OR19-9) OR7G3 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DMLKALRK 0.99336 -27.272 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6778 0 0 0 0 0 0 14.5018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVP5 TP8L1_HUMAN "Tumor necrosis factor alpha-induced protein 8-like protein 1, TIPE1, TNF alpha-induced protein 8-like protein 1, TNFAIP8-like protein 1 (Oxidative stress-regulated gene-beta, Oxy-beta)" TNFAIP8L1 Homo sapiens (Human) negative regulation of TOR signaling [GO:0032007]; regulation of apoptotic process [GO:0042981] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; negative regulation of TOR signaling [GO:0032007]; regulation of apoptotic process [GO:0042981] GO:0005737; GO:0032007; GO:0042802; GO:0042981 identical protein binding [GO:0042802] LLSKMASK 0.99336 -6.5721 0 0 0 0 11.4772 0 0 0 13.838 13.6306 14.4827 13.5225 13.454 14.3185 13.4235 0 0 0 0 0 0 0 0 11.6392 13.9199 0 14.0225 0 0 13.5515 13.0973 0 13.656 0 0 13.8484 12.6121 0 0 13.3453 0 13.4637 0 0 13.4868 13.7507 0 0 0 0 0 10.3505 0 0 0 9.88622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1763 13.0039 0 0 0 0 0 0 0 0 0 0 14.8075 0 0 0 11.2868 0 13.2343 0 0 13.9942 0 0 0 0 0 0 13.571 0 14.3781 0 0 0 0 0 12.894 13.5852 13.3109 0 0 0 0 0 0 13.1495 0 13.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3619 12.9682 0 0 0 0 0 0 13.5399 13.2811 0 0 0 0 0 12.215 0 0 13.2078 13.3803 0 15.0088 0 0 0 0 13.6215 13.2049 13.8969 0 13.4691 0 0 0 0 0 13.8935 0 0 0 9.39146 Q96Q15 SMG1_HUMAN "Serine/threonine-protein kinase SMG1, SMG-1, hSMG-1, EC 2.7.11.1 (Lambda/iota protein kinase C-interacting protein, Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1)" SMG1 ATX KIAA0421 LIP Homo sapiens (Human) "DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]" chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] "chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; mRNA export from nucleus [GO:0006406]; negative regulation of macroautophagy [GO:0016242]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204]; TOR signaling [GO:0031929]" GO:0000184; GO:0003723; GO:0004672; GO:0004674; GO:0004697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006406; GO:0006468; GO:0016242; GO:0018105; GO:0031929; GO:0031931; GO:0031932; GO:0032204; GO:0033391; GO:0042162; GO:0046777; GO:0046854; GO:0046872; GO:0106310; GO:2001020 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162] AIFQKHR 0.99336 -27.217 0 0 12.3516 18.3663 13.4996 11.5134 14.5584 13.572 0 0 17.5116 17.7148 0 0 12.8863 0 0 0 0 0 0 13.0166 11.9885 0 0 0 17.2206 11.4077 0 17.0714 0 9.30777 17.7313 17.7839 12.5094 0 17.5917 0 0 0 0 9.77368 0 0 0 0 0 0 0 0 0 0 12.9298 0 12.5002 12.3971 0 0 0 0 0 0 0 0 10.5737 0 10.7757 14.6141 11.316 0 12.2781 0 12.2551 13.0475 0 0 12.1256 12.7047 14.2249 13.6302 13.1855 15.0431 14.9115 14.3873 15.5208 14.3396 11.8888 13.1488 0 11.5669 0 14.218 0 13.4659 14.4092 0 13.1309 17.184 16.6866 13.0234 13.7199 13.4718 0 0 11.2469 14.2131 12.4754 13.1597 13.4906 9.89139 0 14.24 0 13.191 0 14.6053 13.2535 14.2572 0 14.1102 0 13.579 0 13.8436 15.7927 13.9654 14.8514 0 15.421 0 13.7094 14.6507 14.4445 14.0354 14.1856 0 14.0669 14.3436 15.5541 14.8674 13.8004 13.5912 0 13.4435 14.222 0 13.014 0 0 14.5734 0 12.9163 0 14.7378 0 13.9691 13.4116 18.6061 18.7184 18.6589 0 18.644 13.4085 14.2964 18.5556 13.1501 15.9542 0 18.5085 12.7942 13.7981 0 15.0584 0 15.1748 18.7139 10.5602 18.5653 14.1466 0 Q96T91 GPHA2_HUMAN Glycoprotein hormone alpha-2 (Putative secreted protein Zsig51) (Thyrostimulin subunit alpha) GPHA2 GPA2 ZSIG51 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166] GO:0005179; GO:0005576; GO:0005615; GO:0007166; GO:0007189; GO:0031531; GO:0046982; GO:0051427 hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531] ACQCDMCR 0.99336 -6.3968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2334 0 0 0 0 15.76 15.0074 0 15.1527 0 15.8708 0 0 14.0256 14.9034 0 15.4946 0 0 0 0 0 0 13.5386 13.0103 13.1085 0 0 15.0671 0 0 0 0 15.5707 0 0 0 0 0 0 0 0 15.1633 13.317 0 0 0 0 0 10.5913 0 0 0 14.9792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1295 0 0 0 0 0 0 0 12.5893 0 12.2832 0 0 0 0 0 11.9418 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZX5 ZN350_HUMAN Zinc finger protein 350 (KRAB zinc finger protein ZFQR) (Zinc finger and BRCA1-interacting protein with a KRAB domain 1) (Zinc finger protein ZBRK1) ZNF350 ZBRK1 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0001162; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0016363; GO:0016604; GO:0017053; GO:0045892; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]" AFSTKQK 0.99336 -14.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6779 0 12.9948 0 0 0 0 0 0 0 0 0 0 0 12.6366 0 0 0 13.9305 0 0 0 0 0 0 0 0 0 16.7098 0 12.6636 0 0 0 0 0 0 12.7949 0 0 0 0 0 0 0 12.6224 0 0 0 0 0 0 0 Q9H172 ABCG4_HUMAN "ATP-binding cassette sub-family G member 4, EC 7.6.2.-" ABCG4 WHITE2 Homo sapiens (Human) "cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane transport [GO:0055085]" cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane transport [GO:0055085]" GO:0005524; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0016020; GO:0016021; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042626; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830 ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CLSGKFCRR 0.99336 -17.32 0 0 0 0 0 0 0 0 11.0884 14.268 13.5583 14.3003 12.2746 11.8453 13.173 13.3892 0 0 0 0 0 0 12.67 0 12.9103 13.5552 14.3594 0 0 13.3491 14.6336 14.4393 0 0 13.1185 0 12.3015 0 13.0254 14.0258 11.7176 0 0 13.4765 13.2724 14.2538 12.6094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H825 METL8_HUMAN "tRNA N(3)-methylcytidine methyltransferase METTL8, mitochondrial, EC 2.1.1.- (Methyltransferase-like protein 8) (mRNA N(3)-methylcytidine methyltransferase METTL8, EC 2.1.1.-)" METTL8 Homo sapiens (Human) mRNA methylation [GO:0080009]; positive regulation of mitochondrial translation [GO:0070131]; tRNA C3-cytosine methylation [GO:0106217] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; mRNA methyltransferase activity [GO:0008174]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; mRNA methylation [GO:0080009]; positive regulation of mitochondrial translation [GO:0070131]; tRNA C3-cytosine methylation [GO:0106217] GO:0005739; GO:0008174; GO:0052735; GO:0070131; GO:0080009; GO:0106217 mRNA methyltransferase activity [GO:0008174]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735] EEEAAAR 0.99336 -14.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0667 12.8667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8344 0 17.929 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8169 0 0 0 0 0 0 Q9Y6Z5 AFDDT_HUMAN Putative uncharacterized protein AFDN-DT (AFDN divergent transcript) (Protein HGC6.4) AFDN-DT AFDN-AS1 C6orf124 Homo sapiens (Human) ARCSSCPR 0.99336 -17.37 0 0 0 0 0 0 0 0 12.3269 0 0 0 0 0 0 0 12.0719 0 0 10.4637 11.2022 0 0 13.4106 0 0 0 12.3471 0 12.6177 0 0 0 13.5359 0 0 0 13.5171 0 0 13.5775 13.7569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.962 0 13.1818 0 15.4658 0 0 0 0 0 0 0 0 0 0 0 0 12.2832 0 0 0 0 0 0 15.1343 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5237 0 0 0 15.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5236 0 0 0 O14795 UN13B_HUMAN "Protein unc-13 homolog B (Munc13-2, munc13)" UNC13B UNC13 Homo sapiens (Human) "acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" anchoring junction [GO:0070161]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuromuscular junction development [GO:0007528]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" GO:0005509; GO:0005516; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0007268; GO:0007528; GO:0010808; GO:0016020; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0030742; GO:0031267; GO:0031594; GO:0035249; GO:0042734; GO:0043065; GO:0043195; GO:0048786; GO:0050714; GO:0060478; GO:0061789; GO:0070161; GO:0071333; GO:0097151; GO:0098831; GO:0099011; GO:0099525 calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075] ACLNSTYEYIFNNCHDLYSRQYQLK 0.99337 -38.051 0 0 0 0 0 0 14.1128 0 0 0 0 11.9208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6177 0 0 0 10.936 0 0 14 0 10.6699 11.1177 0 0 0 0 0 10.666 13.806 13.2628 15.6544 14.3306 0 0 11.4626 0 14.244 14.2549 13.3659 14.3066 14.5665 14.7727 14.3871 14.5111 18.4297 15.4857 13.3177 13.2308 12.6683 16.0735 13.514 0 0 0 13.4619 13.2264 13.171 13.6162 13.7209 0 12.523 13.9074 0 14.7017 0 14.834 0 14.1235 14.7525 13.679 15.4114 15.3513 0 18.3783 15.0577 14.5465 13.8014 13.645 13.6991 13.897 13.6544 13.9511 14.7536 18.2275 18.0966 13.7657 13.5022 15.467 13.4105 10.4731 14.649 14.9949 12.782 14.0973 0 13.807 13.7528 13.3938 15.5863 13.7084 14.9777 13.7959 0 13.7528 0 13.9515 0 15.1485 13.9376 14.0746 0 0 14.8457 0 0 15.0826 13.4455 13.68 0 0 0 0 0 0 0 0 13.2011 0 0 12.4066 0 0 0 14.0718 15.4108 13.6608 15.3644 0 0 0 14.3166 0 O15229 KMO_HUMAN "Kynurenine 3-monooxygenase, EC 1.14.13.9 (Kynurenine 3-hydroxylase)" KMO Homo sapiens (Human) "'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; aging [GO:0007568]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]; tryptophan catabolic process [GO:0006569]" cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] "cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; aging [GO:0007568]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of neuron death [GO:1901216]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]; tryptophan catabolic process [GO:0006569]" GO:0004502; GO:0005615; GO:0005741; GO:0005829; GO:0006569; GO:0007568; GO:0009651; GO:0016021; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1901216; GO:1903296 FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174] ARMIHSLSGK 0.99337 -7.7748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5123 0 0 0 0 0 12.1841 11.5761 0 0 0 0 13.0379 13.1682 0 0 0 12.8663 0 0 10.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.73829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3426 0 13.6469 0 0 O15409 FOXP2_HUMAN Forkhead box protein P2 (CAG repeat protein 44) (Trinucleotide repeat-containing gene 10 protein) FOXP2 CAGH44 TNRC10 Homo sapiens (Human) "caudate nucleus development [GO:0021757]; cerebral cortex development [GO:0021987]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; putamen development [GO:0021758]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; caudate nucleus development [GO:0021757]; cerebral cortex development [GO:0021987]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; putamen development [GO:0021758]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0021757; GO:0021758; GO:0021987; GO:0042802; GO:0042803; GO:0043565; GO:0045892; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" HNLSLHKCFVRVENVK 0.99337 -16.126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7598 0 12.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0959 P49450 CENPA_HUMAN "Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A, CENP-A)" CENPA Homo sapiens (Human) "establishment of mitotic spindle orientation [GO:0000132]; kinetochore assembly [GO:0051382]; mitotic cytokinesis [GO:0000281]; protein localization to CENP-A containing chromatin [GO:0061644]; protein localization to chromosome, centromeric region [GO:0071459]" "CENP-A containing nucleosome [GO:0043505]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; inner kinetochore [GO:0000939]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]" "CENP-A containing nucleosome [GO:0043505]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; inner kinetochore [GO:0000939]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; establishment of mitotic spindle orientation [GO:0000132]; kinetochore assembly [GO:0051382]; mitotic cytokinesis [GO:0000281]; protein localization to CENP-A containing chromatin [GO:0061644]; protein localization to chromosome, centromeric region [GO:0071459]" GO:0000132; GO:0000281; GO:0000775; GO:0000776; GO:0000779; GO:0000786; GO:0000939; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005829; GO:0030527; GO:0043505; GO:0046982; GO:0051382; GO:0061644; GO:0071459 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GVDFNWQAQALLALQEAAEAFLVHLFEDAYLLTLHAGR 0.99337 -6.2008 0 0 0 0 0 0 0 0 16.6251 0 0 0 0 13.0002 0 0 0 0 11.8711 12.1909 0 0 0 0 0 0 12.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3902 13.1423 13.1816 14.4396 13.7017 14.7261 13.4821 0 0 0 14.1806 0 0 13.344 0 0 13.5188 13.3529 0 0 0 0 14.6063 0 0 13.8558 0 14.1265 14.8398 0 15.0619 15.2232 0 0 0 0 0 0 14.2409 0 0 13.1892 0 0 0 13.7667 13.7905 14.8256 13.8093 0 13.6598 13.8466 14.2368 14.3535 0 14.0873 0 0 13.6648 14.1462 14.0684 15.1238 14.119 13.8648 15.0594 14.0339 0 15.0339 0 14.0885 0 0 13.8024 0 0 0 14.0298 14.1522 0 0 14.2961 13.9782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.03 13.9368 14.2808 0 0 0 0 0 0 P62910 RL32_HUMAN 60S ribosomal protein L32 (Large ribosomal subunit protein eL32) RPL32 PP9932 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AALRPLVK 0.99337 -16.514 0 0 0 0 0 0 0 0 12.7632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2295 12.6537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1732 0 12.3037 0 0 0 0 0 0 0 0 0 14.6363 0 0 0 0 0 0 13.3298 0 0 0 14.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14330 GPR18_HUMAN "N-arachidonyl glycine receptor, NAGly receptor (G-protein coupled receptor 18)" GPR18 GPCRW Homo sapiens (Human) "CD8-positive, alpha-beta intraepithelial T cell differentiation [GO:0002300]; CD8-positive, gamma-delta intraepithelial T cell differentiation [GO:0002305]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]" cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; CD8-positive, alpha-beta intraepithelial T cell differentiation [GO:0002300]; CD8-positive, gamma-delta intraepithelial T cell differentiation [GO:0002305]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]" GO:0002300; GO:0002305; GO:0002689; GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0016021; GO:0030659; GO:0032720; GO:0035025; GO:0051482 G protein-coupled receptor activity [GO:0004930] AVLACVGVWIMTLTTTTPLLLLYK 0.99337 -6.2139 0 0 0 0 0 0 0 0 15.2659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4517 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8299 0 0 0 0 0 14.1709 0 0 13.7804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8675 14.7567 0 0 0 15.075 14.8376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0027 0 0 0 0 0 0 12.5915 0 0 0 13.5359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15084 PDIA6_HUMAN "Protein disulfide-isomerase A6, EC 5.3.4.1 (Endoplasmic reticulum protein 5, ER protein 5, ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7)" PDIA6 ERP5 P5 TXNDC7 Homo sapiens (Human) protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976] GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006457; GO:0015035; GO:0034663; GO:0034976; GO:0042470; GO:0070062 protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] EQTKGKVK 0.99337 -16.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.292 0 0 0 0 12.0081 0 0 0 0 0 10.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2501 0 0 13.2015 0 13.8424 0 13.285 0 0 0 13.0634 0 14.2559 0 0 0 12.999 12.8752 0 0 14.1857 0 13.3518 0 0 14.3538 0 0 0 0 0 0 0 14.4711 0 0 0 13.3908 0 0 0 0 14.0954 0 0 12.737 0 0 0 0 0 0 0 0 0 13.7641 0 0 0 0 0 0 0 13.1927 13.253 0 0 0 0 0 0 0 13.4778 0 0 0 0 0 0 0 12.5013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T6X4 F162B_HUMAN Protein FAM162B FAM162B C6orf189 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AVGSLLRLGRGLTVR 0.99337 -16.556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4209 0 0 0 0 0 0 0 0 12.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4106 0 0 13.851 0 0 0 0 13.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3305 13.2194 0 0 0 13.2565 0 13.9566 0 13.3489 13.2785 0 0 0 14.4587 0 0 0 13.1972 0 0 0 0 14.4204 13.3239 0 0 12.694 0 0 13.2588 13.4506 14.7436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6459 0 13.7762 0 0 0 11.716 0 0 Q7Z4F1 LRP10_HUMAN "Low-density lipoprotein receptor-related protein 10, LRP-10" LRP10 MSTP087 SP220 UNQ389/PRO724 Homo sapiens (Human) inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; low-density lipoprotein particle receptor activity [GO:0005041]; inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869] GO:0005041; GO:0005886; GO:0005905; GO:0006629; GO:0006869; GO:0016020; GO:0016021; GO:0048839 low-density lipoprotein particle receptor activity [GO:0005041] APLPSASTSPAPTTVPEAPGPLPSLPLEPSLLSGVVQALR 0.99337 -16.515 0 11.1503 0 18.3428 0 0 0 0 0 13.166 12.9222 0 0 18.0111 0 0 0 0 0 0 15.5111 0 0 0 0 0 0 0 11.3996 9.65456 0 0 0 0 0 11.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2299 0 0 0 0 0 0 0 11.1394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9204 0 0 0 0 0 0 0 0 0 0 16.1528 0 0 0 0 0 0 0 0 0 0 13.8353 0 0 0 10.8015 0 0 0 0 0 Q8IYY4 DZI1L_HUMAN Cilium assembly protein DZIP1L (DAZ-interacting zinc finger protein 1-like) DZIP1L Homo sapiens (Human) ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; floor plate development [GO:0033504]; neural tube patterning [GO:0021532]; protein localization to cilium [GO:0061512]; regulation of protein localization [GO:0032880]; smoothened signaling pathway [GO:0007224] GO:0005737; GO:0005814; GO:0005930; GO:0007224; GO:0021532; GO:0032880; GO:0033504; GO:0036064; GO:0046872; GO:0060271; GO:0061512; GO:1905349 metal ion binding [GO:0046872] ARKFSEFLSLR 0.99337 -16.532 0 0 0 0 0 0 12.5941 0 0 0 13.0543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6804 12.8061 0 0 0 0 0 0 0 0 0 11.1421 0 0 0 11.2018 0 0 0 11.9721 0 0 0 0 0 0 0 0 0 0 15.0637 0 0 0 0 15.095 0 0 0 0 0 12.8897 0 17.5619 0 14.0414 0 13.7866 0 12.4013 0 0 0 11.8733 13.5504 13.6572 0 0 0 13.9684 0 0 0 0 0 0 0 0 0 16.3534 0 13.8601 0 0 0 0 0 0 0 13.8975 13.8715 14.124 0 0 0 13.2712 0 0 0 0 0 0 15.7348 0 0 14.1243 0 0 0 13.248 0 15.7422 0 0 0 13.9619 0 0 0 0 0 0 15.1432 0 0 0 0 0 0 14.5379 0 0 0 0 0 0 0 0 0 Q8NAC3 I17RC_HUMAN "Interleukin-17 receptor C, IL-17 receptor C, IL-17RC (Interleukin-17 receptor homolog, IL17Rhom) (Interleukin-17 receptor-like protein, IL-17RL) (ZcytoR14)" IL17RC UNQ6118/PRO20040/PRO38901 Homo sapiens (Human) defense response to fungus [GO:0050832]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-6 production [GO:0032755] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; interleukin-17 receptor activity [GO:0030368]; signaling receptor binding [GO:0005102]; defense response to fungus [GO:0050832]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-6 production [GO:0032755] GO:0005102; GO:0005886; GO:0006954; GO:0009986; GO:0016021; GO:0030368; GO:0032755; GO:0050832; GO:0071621; GO:1900017 interleukin-17 receptor activity [GO:0030368]; signaling receptor binding [GO:0005102] ETDCDLCLR 0.99337 -6.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.174 0 0 0 0 0 14.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6295 0 0 0 0 0 0 0 0 0 Q8NCN4 RN169_HUMAN "E3 ubiquitin-protein ligase RNF169, EC 2.3.2.27 (RING finger protein 169) (RING-type E3 ubiquitin transferase RNF169)" RNF169 KIAA1991 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; negative regulation of double-strand break repair [GO:2000780] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; negative regulation of double-strand break repair [GO:2000780] GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006302; GO:0006974; GO:0016604; GO:0031491; GO:0035861; GO:0046872; GO:0070530; GO:2000780 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin-protein transferase activity [GO:0004842] EEYESLR 0.99337 -16.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.872 0 0 0 0 13.5996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9801 13.7658 0 0 0 15.3151 13.6151 0 0 0 0 0 0 0 11.5787 0 0 0 0 0 10.7017 0 13.5271 12.4378 13.6783 0 14.1152 11.3453 0 0 13.8882 0 0 0 0 0 0 0 0 0 11.0652 14.0361 0 0 14.8886 0 10.4001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3962 0 0 0 0 0 Q96FE5 LIGO1_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A) LINGO1 LERN1 LRRN6A UNQ201/PRO227 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154] GO:0005154; GO:0005615; GO:0005886; GO:0016021; GO:0031012 epidermal growth factor receptor binding [GO:0005154] KHLVSAK 0.99337 -16.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.32353 0 0 0 0 0 0 10.0984 0 0 0 0 10.326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0147 0 0 0 0 0 0 0 10.0174 0 0 0 0 0 10.3837 0 0 0 0 0 0 0 0 0 0 0 Q96JQ2 CLMN_HUMAN Calmin (Calponin-like transmembrane domain protein) CLMN KIAA1188 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; neuron projection development [GO:0031175]; nuclear migration [GO:0007097] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear outer membrane [GO:0005640] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear outer membrane [GO:0005640]; actin filament binding [GO:0051015]; negative regulation of cell population proliferation [GO:0008285]; neuron projection development [GO:0031175]; nuclear migration [GO:0007097] GO:0005640; GO:0005737; GO:0007097; GO:0008285; GO:0016021; GO:0031175; GO:0034993; GO:0051015 actin filament binding [GO:0051015] AIKALLAWVQR 0.99337 -16.553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7626 13.5826 13.5749 13.0624 12.8752 12.5834 12.9039 13.157 12.6556 12.176 12.0329 12.0784 0 0 0 0 0 0 0 0 11.8684 12.74 11.0156 12.2387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MR9 ZN560_HUMAN Zinc finger protein 560 ZNF560 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFASFSARIAHLKTH 0.99337 -14.535 0 11.9666 12.3699 0 0 0 11.2588 0 13.3602 15.6151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9073 0 0 0 0 0 0 0 0 0 0 0 9.96982 0 0 0 0 0 15.6153 0 12.5675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8201 0 14.1431 0 0 0 0 0 12.9997 0 14.33 13.441 0 0 18.8763 15.3354 0 11.5814 0 14.4364 14.3714 0 0 0 14.1302 14.3464 0 0 0 0 0 0 0 0 0 12.8962 0 0 14.8591 12.9259 0 0 10.7768 0 0 0 0 0 0 0 0 0 0 15.8027 0 13.3403 0 0 0 12.8463 0 0 0 9.57429 0 0 0 0 0 0 0 10.1734 0 0 0 12.625 12.5274 0 0 0 0 0 0 0 0 0 13.8364 13.6336 0 12.663 0 0 0 16.8435 0 0 0 13.1525 11.615 0 13.3537 0 12.5523 0 0 0 10.0642 0 Q9Y397 ZDHC9_HUMAN "Palmitoyltransferase ZDHHC9, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 9, DHHC-9, DHHC9) (Zinc finger protein 379) (Zinc finger protein 380)" ZDHHC9 CXorf11 ZDHHC10 ZNF379 ZNF380 CGI-89 UNQ261/PRO298 Homo sapiens (Human) MAPK cascade [GO:0000165]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849]; MAPK cascade [GO:0000165]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612] GO:0000139; GO:0000165; GO:0002178; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006612; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0031228; GO:0043849 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849] NTFCCDGR 0.99337 -16.53 0 0 0 0 0 0 0 0 12.8389 12.1411 12.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4816 15.3675 0 0 0 14.4284 0 13.4099 0 0 0 0 0 0 0 0 0 13.5675 0 13.7209 0 0 Q9Y6R6 Z780B_HUMAN Zinc finger protein 780B (Zinc finger protein 779) ZNF780B ZNF779 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNLPTQLNRHKNIHTVK 0.99337 -6.2162 0 0 0 0 0 0 0 0 13.157 0 0 11.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7049 0 0 0 0 0 11.6052 0 0 0 0 12.3414 0 0 0 11.5957 0 12.8688 11.2909 0 0 11.8065 0 10.9881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0927 0 15.1646 0 0 0 19.5661 14.0651 19.7657 0 15.6645 15.1707 13.9266 0 14.986 19.6892 13.9823 0 13.2831 0 0 0 0 13.3599 13.4724 13.2148 0 0 12.9303 13.9922 14.7197 0 17.8955 0 15.2924 0 0 0 0 0 12.5531 0 0 0 13.5118 0 0 0 0 0 0 0 0 0 0 0 12.0758 0 0 0 0 0 0 0 0 13.5382 0 0 0 0 13.3795 0 0 14.3263 13.9921 0 0 0 11.8262 0 12.3709 0 11.6611 0 0 0 0 0 0 12.0489 14.3057 0 0 12.2566 0 11.2719 0 0 A2RUS2 DEND3_HUMAN DENN domain-containing protein 3 DENND3 KIAA0870 Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483] GO:0005085; GO:0005829; GO:0008333; GO:0030163; GO:0031410; GO:0032483 guanyl-nucleotide exchange factor activity [GO:0005085] DVKNHLNYEHR 0.99338 -16.197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3925 12.5824 0 0 13.7149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4826 0 0 0 0 0 0 0 0 0 0 0 14.2796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7485 0 0 0 0 0 0 0 0 0 0 0 13.9996 0 0 0 A6NC57 ANR62_HUMAN Ankyrin repeat domain-containing protein 62 ANKRD62 Homo sapiens (Human) DEIARLRLEIDTIK 0.99338 -13.503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.13 14.297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9456 0 0 0 0 0 0 0 0 0 13.7774 14.6609 0 0 0 0 11.8409 0 0 0 0 0 0 0 0 0 0 0 14.0223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8732 0 14.5593 11.7375 0 0 A6NCF6 MA13P_HUMAN Putative MAGE domain-containing protein MAGEA13P MAGEA13P Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 IWEVLNIIR 0.99338 -16.205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9182 0 0 0 12.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.904 12.9846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5276 0 0 14.7441 0 0 0 12.9888 13.1976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NN73 GOG8C_HUMAN Golgin subfamily A member 8C GOLGA8CP GOLGA8C Homo sapiens (Human) Golgi organization [GO:0007030] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580] cis-Golgi network [GO:0005801]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi organization [GO:0007030] GO:0000137; GO:0005801; GO:0007030; GO:0032580 ELQEKLGKR 0.99338 -5.1364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6378 0 0 0 0 0 13.4588 0 0 0 0 0 12.5576 0 0 0 15.4613 0 0 0 0 0 0 0 0 0 0 11.6066 0 0 14.2736 0 0 0 0 0 10.3108 10.5387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8586 0 0 11.0355 0 0 0 0 0 0 0 0 0 0 0 0 9.32299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5792 O60942 MCE1_HUMAN "mRNA-capping enzyme (HCAP1) (HCE) [Includes: mRNA 5'-triphosphate monophosphatase, EC 3.6.1.74 (mRNA 5'-phosphatase); mRNA guanylyltransferase, EC 2.7.7.50 (GTP--RNA guanylyltransferase, GTase) ]" RNGTT CAP1A Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; protein dephosphorylation [GO:0006470]; RNA processing [GO:0006396] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA guanylyltransferase activity [GO:0008192]; triphosphatase activity [GO:0050355]; 7-methylguanosine mRNA capping [GO:0006370]; protein dephosphorylation [GO:0006470]; RNA processing [GO:0006396] GO:0004484; GO:0004651; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0006370; GO:0006396; GO:0006470; GO:0008138; GO:0008192; GO:0050355 ATP binding [GO:0005524]; GTP binding [GO:0005525]; mRNA guanylyltransferase activity [GO:0004484]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA guanylyltransferase activity [GO:0008192]; triphosphatase activity [GO:0050355] ERLKLGAIFLEGVTVK 0.99338 -16.623 0 0 0 0 0 0 0 0 0 0 0 0 14.8714 0 11.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9399 14.7231 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0368 0 0 0 0 0 0 0 0 12.5318 0 0 14.0428 0 0 0 0 0 0 12.9663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7458 0 0 0 0 0 0 0 15.8308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8025 0 0 0 0 0 0 0 0 0 0 0 0 0 O75131 CPNE3_HUMAN Copine-3 (Copine III) CPNE3 CPN3 KIAA0636 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335] azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335] GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363 calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723] AAQCVTK 0.99338 -6.6374 0 0 0 0 12.8014 0 0 13.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2773 13.7055 0 0 0 0 0 0 0 0 0 12.0537 0 0 0 0 0 0 0 12.9547 0 0 0 0 14.858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1558 0 13.5765 0 0 0 0 12.8337 0 12.4303 10.8445 16.5031 0 12.7088 12.8772 13.68 12.86 0 0 0 0 0 0 0 0 16.112 0 12.6185 0 0 0 11.303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.316 0 0 16.4937 0 0 0 O75369 FLNB_HUMAN "Filamin-B, FLN-B (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1, Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein, Truncated ABP)" FLNB FLN1L FLN3 TABP TAP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519] GO:0001725; GO:0003334; GO:0003382; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0005938; GO:0007165; GO:0007519; GO:0015629; GO:0016021; GO:0030018; GO:0030036; GO:0042802; GO:0045296; GO:0045335; GO:0051015; GO:0070062; GO:0071346 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] AEISCIDNK 0.99338 -29.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4865 12.4309 0 0 0 0 0 12.3187 0 0 11.78 0 0 0 0 0 11.3747 0 0 0 0 0 0 12.0595 0 0 0 0 0 0 13.5304 0 0 0 0 0 0 0 0 0 10.7146 0 0 0 0 0 0 0 14.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0629 15.6725 12.3626 13.9003 0 17.6668 17.5261 0 0 0 12.628 0 0 0 0 0 0 0 15.4914 16.0863 0 0 0 13.1503 0 13.9358 0 0 0 12.9612 0 14.4516 0 12.3239 0 0 15.2524 0 14.3051 0 0 0 14.0445 0 0 0 17.5462 15.0592 0 14.095 0 0 0 0 0 0 0 12.1198 0 12.1401 0 0 0 0 0 0 9.80642 0 12.046 11.9369 0 0 0 17.8267 12.6603 0 13.5064 0 0 0 0 0 0 0 0 0 0 13.8037 13.5961 0 13.9355 0 0 17.3766 14.9279 14.5479 0 0 0 0 P41587 VIPR2_HUMAN "Vasoactive intestinal polypeptide receptor 2, VIP-R-2 (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor, PACAP type III receptor, PACAP-R-3, PACAP-R3) (VPAC2)" VIPR2 VIP2R Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; signal transduction [GO:0007165] GO:0004930; GO:0004999; GO:0005886; GO:0005887; GO:0007165; GO:0007166; GO:0007188; GO:0007190; GO:0007267; GO:0008528; GO:0017046; GO:0048662 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; peptide hormone binding [GO:0017046]; vasoactive intestinal polypeptide receptor activity [GO:0004999] CPTPSASR 0.99338 -6.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2022 0 0 0 0 0 0 0 0 12.6631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4855 12.3161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.084 14.288 0 0 13.2952 0 0 0 0 0 0 0 13.1425 0 0 0 13.119 0 0 0 0 12.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8448 0 0 0 0 0 P51580 TPMT_HUMAN "Thiopurine S-methyltransferase, EC 2.1.1.67 (Thiopurine methyltransferase)" TPMT Homo sapiens (Human) methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829] cytosol [GO:0005829]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] GO:0005829; GO:0006139; GO:0006805; GO:0008119; GO:0032259; GO:0042178; GO:1904047 S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119] FDMIWDR 0.99338 -5.1311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57775 FBXW4_HUMAN F-box/WD repeat-containing protein 4 (Dactylin) (F-box and WD-40 domain-containing protein 4) FBXW4 FBW4 SHFM3 Homo sapiens (Human) embryonic limb morphogenesis [GO:0030326]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; embryonic limb morphogenesis [GO:0030326]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] GO:0000151; GO:0005829; GO:0006511; GO:0016055; GO:0019005; GO:0030326; GO:0031146 EGILLKWR 0.99338 -13.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0853 0 0 0 0 0 0 0 0 0 17.5134 0 0 0 0 0 0 0 13.5861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4338 12.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78345 RPP38_HUMAN "Ribonuclease P protein subunit p38, RNaseP protein p38" RPP38 Homo sapiens (Human) rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682] fibrillar center [GO:0001650]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172] fibrillar center [GO:0001650]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682] GO:0000172; GO:0001650; GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0005730; GO:0006364; GO:0030681; GO:0033204 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204] ALERRELLLVLVCK 0.99338 -29.154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3637 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4107 0 0 0 14.3856 0 12.8602 12.8953 0 0 0 0 0 0 0 0 12.6504 0 0 0 0 0 12.6603 0 0 0 0 0 0 0 0 13.3105 0 0 14.6973 0 0 0 0 0 12.8207 13.967 0 0 0 0 13.5678 0 0 0 0 0 12.7908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9279 0 0 0 0 0 14.815 0 0 0 0 0 0 0 0 0 0 13.4248 0 P84095 RHOG_HUMAN Rho-related GTP-binding protein RhoG RHOG ARHG Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcription, DNA-templated [GO:0045893]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of ruffle assembly [GO:1900027]; Rho protein signal transduction [GO:0007266]" cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; motor neuron axon guidance [GO:0008045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcription, DNA-templated [GO:0045893]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of ruffle assembly [GO:1900027]; Rho protein signal transduction [GO:0007266]" GO:0003924; GO:0005525; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0007015; GO:0007163; GO:0007266; GO:0008045; GO:0008284; GO:0008360; GO:0016601; GO:0019901; GO:0030031; GO:0030036; GO:0030667; GO:0030865; GO:0031410; GO:0032956; GO:0042995; GO:0043652; GO:0045893; GO:0060326; GO:0070062; GO:0090630; GO:1900027; GO:1902622; GO:1903078 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901] AVLNPTPIK 0.99338 -5.5088 0 0 0 0 0 0 0 0 0 0 11.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8684 0 0 0 0 0 11.9993 0 0 12.2888 0 0 0 0 18.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3495 14.7204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.662 0 0 9.69619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15389 ANGP1_HUMAN "Angiopoietin-1, ANG-1" ANGPT1 KIAA0003 Homo sapiens (Human) activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; neuron apoptotic process [GO:0051402]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; neuron apoptotic process [GO:0051402]; positive chemotaxis [GO:0050918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014] GO:0001525; GO:0001701; GO:0001933; GO:0001934; GO:0002040; GO:0002092; GO:0002719; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0005902; GO:0007162; GO:0007171; GO:0010595; GO:0010628; GO:0014068; GO:0014842; GO:0030097; GO:0030154; GO:0030210; GO:0030971; GO:0031398; GO:0031589; GO:0032680; GO:0033138; GO:0034394; GO:0042308; GO:0042802; GO:0043066; GO:0043116; GO:0043122; GO:0043393; GO:0043524; GO:0043536; GO:0045121; GO:0045785; GO:0048014; GO:0050731; GO:0050918; GO:0051402; GO:0051897; GO:0062023; GO:0070062; GO:0070374; GO:0072012; GO:1905605; GO:2000352; GO:2000446 identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] EELDTLKEEK 0.99338 -14.229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6142 14.1572 0 0 0 0 0 0 0 0 0 11.6961 0 0 0 0 0 0 0 0 0 0 0 13.9185 0 0 14.3737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T2L2 AKCL1_HUMAN "Putative aldo-keto reductase family 1 member C8 (Aldo-keto reductase family 1 member C-like protein 1, EC 1.1.1.-)" AKR1C8 AKR1C8P AKR1CL1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491] GO:0005737; GO:0016491 oxidoreductase activity [GO:0016491] LGPDYVDLFIIHVPFAMK 0.99338 -6.6384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0716 0 0 13.4607 0 0 0 0 0 0 0 13.0154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN54 DEFI8_HUMAN "Differentially expressed in FDCP 8 homolog, DEF-8" DEF8 Homo sapiens (Human) lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029] metal ion binding [GO:0046872]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029] GO:0032418; GO:0045780; GO:0046872; GO:1900029 metal ion binding [GO:0046872] CAECRAPISLR 0.99338 -5.1356 0 11.3825 0 0 0 0 0 0 0 0 0 10.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2681 0 0 0 0 11.6917 0 12.2368 0 0 0 0 0 0 0 0 0 0 14.1719 10.4687 0 13.5119 0 0 0 0 0 0 0 0 0 0 11.032 0 0 0 0 0 0 0 0 0 0 10.4489 0 0 0 0 10.2466 11.5078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1041 0 0 0 0 0 0 0 0 0 0 13.7662 0 0 0 0 0 0 0 0 11.7721 0 0 0 0 0 0 0 0 12.5678 0 13.7948 0 0 0 0 0 11.4542 0 0 0 0 0 0 13.0625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SR1 GLT10_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 10, EC 2.4.1.41 (Polypeptide GalNAc transferase 10, GalNAc-T10, pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)" GALNT10 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] EKRLLQAVALVLAALVLLPNVGLWALYR 0.99338 -6.6269 0 0 0 0 0 0 0 0 0 11.3161 0 0 0 0 0 0 0 0 0 16.1895 0 0 0 11.8267 10.9853 12.1866 0 0 12.092 0 0 0 0 0 16.5095 14.8308 0 0 0 0 0 0 0 0 10.8894 0 0 0 0 9.38137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7979 14.7495 13.3987 0 14.4535 10.4404 0 0 0 0 0 0 0 0 12.3264 14.4814 0 13.8351 0 0 14.1863 0 13.3853 0 0 0 0 11.5511 0 0 0 13.7202 13.6444 0 0 0 12.9225 0 0 0 0 13.9757 13.7836 0 0 0 0 0 0 0 0 0 0 0 0 12.7271 13.7097 0 0 11.5481 0 12.4582 0 0 0 12.8961 12.4352 0 13.1412 0 0 0 0 0 0 0 12.9259 12.5476 13.9416 0 0 0 0 0 12.3697 0 11.2124 0 0 12.6707 0 0 0 13.4819 0 0 0 0 0 11.1072 0 0 12.4748 0 13.4652 0 0 0 0 0 0 0 0 0 Q86V85 GP180_HUMAN Integral membrane protein GPR180 (Intimal thickness-related receptor) GPR180 ITR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236] GO:0007186; GO:0016021; GO:0019236 INNIAVAVGKEAK 0.99338 -5.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWT3 CUL9_HUMAN "Cullin-9, CUL-9 (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein)" CUL9 H7AP1 KIAA0708 PARC Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829] cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000226; GO:0005524; GO:0005829; GO:0006511; GO:0007088; GO:0016567; GO:0016740; GO:0031461; GO:0031625; GO:0046872 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625] AKAEAPK 0.99338 -38.291 0 11.4204 0 11.325 0 0 0 0 0 0 11.3473 0 17.1025 16.866 0 12.9731 0 12.6066 0 0 16.1437 0 0 0 0 0 13.3366 0 0 0 0 0 11.666 0 0 0 0 0 0 0 16.4302 0 0 0 0 0 0 12.3471 0 0 0 10.194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.827 0 0 14.3216 0 0 0 13.108 0 11.7022 0 13.2284 0 0 0 0 0 0 0 0 0 16.5512 0 0 0 0 0 0 0 10.7171 12.4785 0 14.3631 0 0 0 0 13.0271 0 0 0 10.6339 0 0 0 12.6767 0 12.5217 0 0 0 16.8881 12.8948 0 11.913 14.2131 12.9007 12.2343 0 12.914 0 0 0 0 0 11.3936 0 12.0338 0 11.9043 0 12.0038 0 14.3978 0 0 0 0 0 16.3916 15.0718 14.1433 0 0 0 0 0 0 13.5226 10.3915 12.0158 18.4366 0 14.5494 14.6616 0 0 18.8563 18.4525 14.5919 0 0 0 13.9966 0 0 0 0 0 0 14.2833 0 11.1156 Q8NDB6 FA156_HUMAN Protein FAM156A/FAM156B (Transmembrane protein 29/29B) FAM156A TMEM29 PP12994 PRO0659; FAM156B TMEM29B Homo sapiens (Human) integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635] integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; methylated histone binding [GO:0035064] GO:0005635; GO:0016021; GO:0035064 methylated histone binding [GO:0035064] AFLRHVRR 0.99338 -13.505 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2594 0 0 0 0 0 0 0 0 0 0 0 14.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2056 14.2488 0 0 0 15.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEL0 CCD54_HUMAN Coiled-coil domain-containing protein 54 (Testis development protein NYD-SP17) CCDC54 Homo sapiens (Human) HQDSTGYPTVTSDDCNQDDDSYDGK 0.99338 -6.6318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9755 0 0 0 0 0 14.2243 0 0 0 0 0 0 0 0 0 0 15.5756 0 0 0 0 0 0 0 0 0 0 0 14.8187 0 13.4053 14.6604 13.7699 0 14.574 0 0 0 0 0 0 0 0 0 14.2181 0 13.4878 0 13.9079 13.2087 0 0 0 0 14.1009 0 0 0 0 0 0 0 0 0 0 0 13.8245 0 0 0 0 0 0 0 0 0 0 0 13.2022 0 0 0 0 0 0 0 0 0 0 0 0 13.0786 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HE9 PRR11_HUMAN Proline-rich protein 11 PRR11 Homo sapiens (Human) regulation of cell cycle [GO:0051726] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005737; GO:0016020; GO:0051726 AVLPPTLPQPASHFPPPPPPPPLPPPPPPLAPVLLR 0.99338 -13.501 0 0 0 18.1561 0 0 0 0 10.7654 11.7153 12.388 10.8876 11.8719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5579 0 12.1055 11.196 11.6147 0 10.8131 14.3222 0 10.765 0 11.3841 0 0 0 11.9031 0 0 0 11.6194 0 0 0 0 0 0 0 0 0 0 0 10.5562 0 0 0 0 0 0 0 0 0 0 0 0 12.9367 0 0 0 0 0 0 12.7638 0 13.0849 0 13.3301 0 0 13.0695 0 0 0 0 0 0 0 0 0 12.5343 13.5543 0 0 0 0 14.74 0 0 0 0 0 0 0 0 12.7532 0 0 0 0 0 0 0 0 0 0 0 0 12.392 0 0 0 0 0 0 0 12.5637 0 13.6294 0 0 0 0 0 0 0 0 0 0 13.0192 0 12.6075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2127 0 0 0 0 0 0 0 0 Q9BR09 NEUL2_HUMAN Neuralized-like protein 2 NEURL2 C20orf163 Homo sapiens (Human) intracellular signal transduction [GO:0035556] cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556] GO:0005829; GO:0035556; GO:0061630 ubiquitin protein ligase activity [GO:0061630] EPLAPGQVFLVEIEEK 0.99338 -14.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5919 0 0 0 0 0 0 0 0 0 0 12.6484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1684 0 0 0 0 0 0 12.7251 0 0 12.7643 12.5066 0 0 0 0 0 12.8864 14.319 0 0 0 0 0 0 0 0 0 0 0 0 14.3385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6994 0 0 0 0 0 0 0 0 0 14.0244 0 0 0 0 0 0 0 0 Q9HD87 CF050_HUMAN Putative uncharacterized protein C6orf50 (Nasopharyngeal carcinoma-associated gene 19 protein) C6orf50 NAG19 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FNLMLMDEDIISLLAIFIK 0.99338 -6.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8833 0 16.5949 0 14.0721 14.6298 0 13.9989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTJ3 SMC4_HUMAN "Structural maintenance of chromosomes protein 4, SMC protein 4, SMC-4 (Chromosome-associated polypeptide C, hCAP-C) (XCAP-C homolog)" SMC4 CAPC SMC4L1 Homo sapiens (Human) cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] "chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]" GO:0000070; GO:0000775; GO:0000794; GO:0000796; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007076; GO:0010032; GO:0016607; GO:0016887; GO:0045132; GO:0051301; GO:0051383; GO:0051984; GO:1905820; GO:1905821 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697] EKLKHATSK 0.99338 -38.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6755 0 0 0 0 15.4874 10.2587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9985 13.6431 19.8605 0 0 14.0969 19.3876 0 19.3831 15.9872 0 0 0 0 0 0 11.1894 14.9495 13.6032 13.5571 0 0 0 18.9447 0 14.357 13.7259 0 11.7264 0 12.7925 15.5648 14.2037 14.0904 0 0 11.9879 0 13.4139 0 19.3766 13.4695 14.7924 14.2716 12.6482 13.7608 13.859 12.7819 0 0 0 14.2238 13.6303 12.6848 14.6252 0 13.6151 0 0 0 0 0 0 0 0 0 13.8746 0 0 0 19.5079 0 18.9631 0 16.1487 0 0 0 0 0 0 0 0 0 11.5735 0 0 19.0247 13.049 19.0707 0 0 0 0 0 0 Q9ULL1 PKHG1_HUMAN Pleckstrin homology domain-containing family G member 1 PLEKHG1 KIAA1209 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005654; GO:0005829; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] ENWCQDHLYNSLGRKGISAK 0.99338 -16.181 0 0 0 0 11.2447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6961 0 11.0653 0 9.36562 9.92833 12.8087 12.2606 0 0 0 12.4661 12.4034 0 0 0 0 0 12.46 0 0 13.1932 12.9638 13.7831 13.4209 0 11.5674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8877 0 0 0 0 0 14.8356 0 0 0 11.6823 0 13.7548 12.69 0 13.993 14.8686 0 0 13.5575 12.3644 0 0 10.6548 0 11.6497 0 0 0 0 13.3591 15.0805 0 0 0 0 0 0 13.476 0 0 0 13.5134 11.7118 0 13.1665 0 13.2972 0 0 0 13.4793 0 0 13.8292 0 11.7232 0 12.9089 0 12.1777 0 0 12.1559 0 13.6104 0 0 0 11.7712 0 12.2888 12.4656 0 13.4307 0 0 0 0 0 12.3275 12.293 0 0 0 12.2681 0 0 0 0 0 0 12.5626 0 0 12.8141 0 12.7425 11.9655 0 0 0 0 0 0 12.6121 12.2819 0 12.1515 0 A6NP61 ZAR1L_HUMAN ZAR1-like protein ZAR1L Homo sapiens (Human) post-transcriptional gene silencing by RNA [GO:0035194]; translation [GO:0006412] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; post-transcriptional gene silencing by RNA [GO:0035194]; translation [GO:0006412] GO:0005737; GO:0006412; GO:0035194 EVGVQVSPRVDK 0.99339 -9.1259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.127 0 0 0 0 0 13.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0853 0 0 12.1229 0 0 0 0 14.0888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2472 12.4775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21860 ERBB3_HUMAN "Receptor tyrosine-protein kinase erbB-3, EC 2.7.10.1 (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3)" ERBB3 HER3 Homo sapiens (Human) cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; motor neuron apoptotic process [GO:0097049]; negative regulation of cell adhesion [GO:0007162]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; motor neuron apoptotic process [GO:0097049]; negative regulation of cell adhesion [GO:0007162]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060] GO:0003197; GO:0004672; GO:0004888; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006468; GO:0007162; GO:0007165; GO:0007169; GO:0007399; GO:0007422; GO:0007507; GO:0008284; GO:0009925; GO:0009968; GO:0010628; GO:0014037; GO:0014065; GO:0014068; GO:0016323; GO:0016324; GO:0016328; GO:0019838; GO:0021545; GO:0030296; GO:0031625; GO:0033674; GO:0038131; GO:0038132; GO:0038133; GO:0038143; GO:0042060; GO:0042127; GO:0042802; GO:0043125; GO:0043235; GO:0043524; GO:0044214; GO:0046982; GO:0051048; GO:0051402; GO:0055025; GO:0061098; GO:0070886; GO:0097049; GO:0097192; GO:2000672 ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625] DGPHCVSSCPHGVLGAK 0.99339 -16.213 0 0 0 0 0 0 0 0 0 17.5543 12.0632 0 13.644 15.0643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5971 13.4095 13.4157 13.7577 0 17.0624 0 13.7279 13.6063 10.9854 13.4961 0 11.5762 0 13.7932 0 0 0 0 0 0 0 0 0 12.7171 12.8492 12.0594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8851 0 14.5748 0 14.1021 16.0455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3106 0 13.0435 13.1423 13.3473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9019 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2003 0 14.8846 0 0 14.9534 19.4971 19.4799 19.5115 18.9135 19.5255 14.4041 14.675 15.1133 0 0 0 0 14.957 0 14.7035 0 0 P34981 TRFR_HUMAN "Thyrotropin-releasing hormone receptor, TRH-R (Thyroliberin receptor)" TRHR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; thyrotropin-releasing hormone receptor activity [GO:0004997]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] GO:0004997; GO:0005886; GO:0005887; GO:0007186; GO:0007200 thyrotropin-releasing hormone receptor activity [GO:0004997] FRAAFRK 0.99339 -9.1137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3676 0 12.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6789 0 0 0 0 0 0 0 0 0 0 14.7271 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35443 TSP4_HUMAN Thrombospondin-4 THBS4 TSP4 Homo sapiens (Human) behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771] GO:0001938; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0050731; GO:0051451; GO:0051781; GO:0062023; GO:0070062; GO:0071603; GO:0090023 calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178] CGPCKPGYTGDQIRGCK 0.99339 -7.0963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8778 0 0 0 0 0 0 0 0 0 0 14.9511 0 0 0 0 0 0 0 0 0 0 0 0 14.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8371 0 0 0 0 0 0 0 0 0 0 12.0893 12.3187 0 0 0 0 0 14.5244 0 0 0 0 0 0 0 0 0 0 0 0 14.5468 0 13.0181 0 0 0 14.8675 0 12.5247 0 0 13.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8825 12.9459 0 0 11.7093 0 0 0 0 0 0 0 0 0 0 0 11.6878 11.8824 0 0 0 0 0 0 0 0 11.2502 13.1216 0 0 12.4697 0 0 12.1962 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4021 0 0 0 0 0 0 0 P40879 S26A3_HUMAN "Chloride anion exchanger (Down-regulated in adenoma, Protein DRA) (Solute carrier family 26 member 3)" SLC26A3 DRA Homo sapiens (Human) anion transport [GO:0006820]; cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; anion transport [GO:0006820]; cellular response to cAMP [GO:0071320]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; membrane hyperpolarization [GO:0060081]; sperm capacitation [GO:0048240] GO:0005452; GO:0005886; GO:0005887; GO:0006811; GO:0006820; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016020; GO:0016324; GO:0019531; GO:0031526; GO:0048240; GO:0051454; GO:0060081; GO:0071320; GO:0097225 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] FNPSQEK 0.99339 -6.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.157 12.7611 13.4503 12.6637 12.2556 0 12.6823 0 0 0 0 13.6312 0 14.5636 0 0 0 0 14.0142 0 0 13.2919 0 0 0 0 0 15.8833 0 0 0 0 0 0 0 13.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2031 0 0 0 0 0 0 13.2907 0 0 0 0 0 13.7866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49716 CEBPD_HUMAN "CCAAT/enhancer-binding protein delta, C/EBP delta (Nuclear factor NF-IL6-beta, NF-IL6-beta)" CEBPD Homo sapiens (Human) "fat cell differentiation [GO:0045444]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear development [GO:0048839]; integrated stress response signaling [GO:0140467]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; fat cell differentiation [GO:0045444]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear development [GO:0048839]; integrated stress response signaling [GO:0140467]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0002244; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0042802; GO:0045444; GO:0045595; GO:0045669; GO:0045892; GO:0048839; GO:0090575; GO:0140467; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LHQRVEQLTRDLAGLR 0.99339 -5.1591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5G4 GOGA7_HUMAN Golgin subfamily A member 7 (Golgi complex-associated protein of 16 kDa) GOLGA7 GCP16 HDCKB03P HSPC041 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; tertiary granule lumen [GO:1904724] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intrinsic component of Golgi membrane [GO:0031228]; palmitoyltransferase complex [GO:0002178]; tertiary granule lumen [GO:1904724]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612] GO:0000139; GO:0002178; GO:0005576; GO:0005795; GO:0006612; GO:0006893; GO:0018230; GO:0031228; GO:0043001; GO:0050821; GO:0070062; GO:1904724 DYSSGTR 0.99339 -9.1236 0 13.6379 0 0 0 0 0 0 15.1351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YH2 Z280B_HUMAN Zinc finger protein 280B (5'OY11.1) (Suppressor of hairy wing homolog 2) (Zinc finger protein 279) (Zinc finger protein 632) ZNF280B SUHW2 ZNF279 ZNF632 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EQSCEEEK 0.99339 -7.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0619 0 0 15.7199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8724 0 0 14.7588 0 19.7007 18.6214 18.7586 19.2664 17.4979 17.7899 17.8158 0 0 0 22.0641 0 0 0 0 17.3877 16.8984 0 0 12.7471 0 0 14.0489 18.3403 17.8328 0 18.0802 13.2919 18.3963 0 18.3071 17.7371 17.4326 18.3753 0 0 0 0 0 0 0 18.9302 0 0 0 0 0 0 13.1732 19.1711 0 0 17.6259 0 19.4145 0 0 0 0 0 0 18.2749 0 13.5267 17.9591 0 0 17.2209 16.7098 19.0206 0 0 0 13.8087 0 0 0 0 0 0 0 0 13.0914 16.388 19.6588 13.395 13.195 18.0457 0 17.9163 0 14.0263 0 Q8IXM7 OD3L1_HUMAN Outer dense fiber protein 3-like protein 1 ODF3L1 Homo sapiens (Human) cytoskeleton [GO:0005856] cytoskeleton [GO:0005856] GO:0005856 IKGPGPAK 0.99339 -6.6612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9305 0 0 0 Q8NDZ2 SIMC1_HUMAN SUMO-interacting motif-containing protein 1 (Platform element for inhibition of autolytic degradation) SIMC1 C5orf25 PLEIAD Homo sapiens (Human) negative regulation of peptidase activity [GO:0010466] cytoplasm [GO:0005737]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; sarcomere [GO:0030017]; peptidase inhibitor activity [GO:0030414]; SUMO polymer binding [GO:0032184]; negative regulation of peptidase activity [GO:0010466] GO:0005737; GO:0010466; GO:0030017; GO:0030414; GO:0032184 peptidase inhibitor activity [GO:0030414]; SUMO polymer binding [GO:0032184] EISLSEPAK 0.99339 -9.1244 0 11.6738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 0 0 0 0 0 12.3561 0 0 0 0 0 0 0 0 0 13.7427 11.6961 0 0 0 0 0 0 0 0 12.0032 0 13.8084 0 14.291 14.0488 0 13.8799 13.3359 12.8742 13.0314 12.548 0 11.4846 11.2534 0 0 0 0 0 13.403 0 0 0 0 0 0 0 0 10.7077 0 0 10.5949 0 0 0 0 0 0 0 0 0 15.9196 12.4982 0 0 0 0 0 0 0 10.6415 13.9251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5632 0 0 0 0 0 0 0 13.2578 0 0 12.2663 0 0 17.9391 0 0 0 0 17.5508 0 0 0 0 0 0 0 0 0 0 0 0 10.2528 0 0 0 13.4234 0 0 0 0 14.0038 0 0 13.5614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG92 O13H1_HUMAN Olfactory receptor 13H1 (Olfactory receptor ORX-1) OR13H1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DVKRAIR 0.99339 -9.1252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5521 0 0 0 0 0 0 13.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4083 0 0 0 0 0 0 0 0 13.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.437 Q96JD6 AKCL2_HUMAN "1,5-anhydro-D-fructose reductase, AF reductase, EC 1.1.1.263 (Aldo-keto reductase family 1 member C-like protein 2) (Aldo-keto reductase family 1 member E2) (LoopADR) (Testis aldo-keto reductase, htAKR) (Testis-specific protein, hTSP)" AKR1E2 AKR1CL2 AKRDC1 Homo sapiens (Human) cytosol [GO:0005829] "cytosol [GO:0005829]; 1,5-anhydro-D-fructose reductase activity [GO:0050571]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]" GO:0004032; GO:0005829; GO:0016491; GO:0050571 "1,5-anhydro-D-fructose reductase activity [GO:0050571]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491]" HFDCAYFYHNEREVGAGIR 0.99339 -7.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8693 12.9958 0 0 0 0 0 0 0 0 0 0 14.0313 14.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2747 Q96L46 CPNS2_HUMAN "Calpain small subunit 2, CSS2 (Calcium-dependent protease small subunit 2)" CAPNS2 Homo sapiens (Human) calpain complex [GO:0110158]; cytosol [GO:0005829]; plasma membrane [GO:0005886] calpain complex [GO:0110158]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] GO:0004198; GO:0005509; GO:0005829; GO:0005886; GO:0110158 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] YLWNNIKK 0.99339 -7.0963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2916 0 13.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99497 PARK7_HUMAN "Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1, DJ-1) (Protein/nucleic acid deglycase DJ-1, EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)" PARK7 Homo sapiens (Human) "activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]" adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793] "adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]; activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of supramolecular fiber organization [GO:1902903]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]" GO:0000785; GO:0001933; GO:0002866; GO:0003713; GO:0003729; GO:0005102; GO:0005507; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005783; GO:0005829; GO:0005886; GO:0005912; GO:0006281; GO:0006469; GO:0006508; GO:0006517; GO:0006914; GO:0006954; GO:0006979; GO:0007005; GO:0007265; GO:0007338; GO:0008233; GO:0008344; GO:0009438; GO:0010273; GO:0010628; GO:0010629; GO:0016532; GO:0016570; GO:0016605; GO:0016684; GO:0019249; GO:0019826; GO:0019899; GO:0019900; GO:0019955; GO:0030073; GO:0030424; GO:0031334; GO:0031397; GO:0032091; GO:0032148; GO:0032435; GO:0032757; GO:0033138; GO:0033182; GO:0033234; GO:0033864; GO:0034599; GO:0035065; GO:0036470; GO:0036471; GO:0036478; GO:0036524; GO:0036526; GO:0036527; GO:0036528; GO:0036529; GO:0036530; GO:0036531; GO:0042593; GO:0042743; GO:0042802; GO:0042803; GO:0043066; GO:0043523; GO:0043524; GO:0044297; GO:0044388; GO:0044390; GO:0044877; GO:0045121; GO:0045296; GO:0045340; GO:0045944; GO:0046295; GO:0046826; GO:0048471; GO:0050681; GO:0050727; GO:0050787; GO:0050821; GO:0051091; GO:0051444; GO:0051583; GO:0051881; GO:0051897; GO:0051899; GO:0051920; GO:0060081; GO:0060548; GO:0060765; GO:0061727; GO:0070062; GO:0070301; GO:0070994; GO:0097110; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:0110095; GO:0140041; GO:0140297; GO:1900182; GO:1901215; GO:1901671; GO:1901984; GO:1902177; GO:1902236; GO:1902903; GO:1902958; GO:1903073; GO:1903094; GO:1903122; GO:1903135; GO:1903136; GO:1903168; GO:1903178; GO:1903181; GO:1903189; GO:1903197; GO:1903200; GO:1903202; GO:1903206; GO:1903208; GO:1903377; GO:1903384; GO:1903427; GO:1903428; GO:1903599; GO:1905259; GO:1990381; GO:1990422; GO:2000157; GO:2000277; GO:2000679; GO:2000825; GO:2001237; GO:2001268 "cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]" ALVILAKGAEEMETVIPVDVMRR 0.99339 -16.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0666 12.0522 0 10.2906 0 0 0 10.8272 10.5647 0 11.0214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0346 0 15.631 0 0 0 0 0 0 0 0 0 15.6367 0 0 0 14.212 0 0 0 0 0 0 0 14.3186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5489 0 0 0 0 0 0 13.9361 0 0 0 0 12.2232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXT2 CCG6_HUMAN Voltage-dependent calcium channel gamma-6 subunit (Neuronal voltage-gated calcium channel gamma-6 subunit) CACNG6 Homo sapiens (Human) calcium ion transport [GO:0006816]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] L-type voltage-gated calcium channel complex [GO:1990454]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245]; calcium ion transport [GO:0006816]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514] GO:0005245; GO:0005246; GO:0005886; GO:0005891; GO:0006816; GO:1902514; GO:1990454 calcium channel regulator activity [GO:0005246]; voltage-gated calcium channel activity [GO:0005245] IFQRTTKK 0.99339 -13.525 0 0 0 0 0 10.4892 0 0 0 0 0 0 0 11.0166 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6429 0 0 0 0 0 0 0 11.6837 11.9942 0 12.05 0 0 0 0 0 0 0 0 11.5814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2525 0 15.0753 0 0 14.8914 0 15.1844 0 0 0 0 0 0 12.8652 0 0 0 0 0 0 0 0 0 0 0 14.7444 12.977 0 0 0 0 0 0 0 0 0 0 12.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVF7 FBX28_HUMAN F-box only protein 28 FBXO28 CENP-30 KIAA0483 Homo sapiens (Human) protein polyubiquitination [GO:0000209] kinetochore [GO:0000776] kinetochore [GO:0000776]; identical protein binding [GO:0042802]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0000776; GO:0042802 identical protein binding [GO:0042802] EISELRTK 0.99339 -16.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.204 12.4346 14.0593 0 0 0 0 0 0 0 0 0 13.7582 0 13.138 13.4156 0 13.2334 0 0 0 0 13.2658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7568 0 0 0 0 0 0 0 0 12.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2E5 CHPF2_HUMAN "Chondroitin sulfate glucuronyltransferase, EC 2.4.1.226 (CSGlcA-T) (Chondroitin glucuronyltransferase) (Chondroitin polymerizing factor 2, ChPF-2) (Chondroitin synthase 3, ChSy-3) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase)" CHPF2 CHSY3 CSGLCAT KIAA1402 UNQ299/PRO339 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206] GO:0000139; GO:0008376; GO:0016020; GO:0016021; GO:0030206; GO:0032580; GO:0047238; GO:0050510 acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] FSGLHLFRAVEPGLVQKFSLR 0.99339 -9.1164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2859 0 0 0 0 0 0 0 0 10.9273 0 0 10.9629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0267 0 11.4427 0 13.8344 0 14.7075 0 14.4502 0 13.5684 13.817 0 0 0 0 14.8247 0 12.6435 0 0 0 18.962 0 0 0 0 0 13.879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0662 0 0 0 0 0 18.4158 0 0 0 0 0 0 0 0 0 0 0 0 11.3314 0 0 0 11.2606 0 0 0 0 0 0 0 0 0 11.9336 0 0 0 0 0 0 0 0 11.7188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5S8 NOX1_HUMAN "NADPH oxidase 1, NOX-1, EC 1.-.-.- (Mitogenic oxidase 1, MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1)" NOX1 MOX1 NOH1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to hyperoxia [GO:0071455]; cellular stress response to acidic pH [GO:1990451]; defense response [GO:0006952]; extracellular matrix organization [GO:0030198]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; intracellular pH elevation [GO:0051454]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; NADP metabolic process [GO:0006739]; oxygen metabolic process [GO:0072592]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of JNK cascade [GO:0046330]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of blood pressure [GO:0008217]; regulation of ion transmembrane transport [GO:0034765]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; respiratory burst [GO:0045730]; signal transduction [GO:0007165]; superoxide anion generation [GO:0042554] anchoring junction [GO:0070161]; cell projection [GO:0042995]; early endosome [GO:0005769]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; cell projection [GO:0042995]; early endosome [GO:0005769]; NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; voltage-gated ion channel activity [GO:0005244]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to hyperoxia [GO:0071455]; cellular stress response to acidic pH [GO:1990451]; defense response [GO:0006952]; extracellular matrix organization [GO:0030198]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; intracellular pH elevation [GO:0051454]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; NADP metabolic process [GO:0006739]; oxygen metabolic process [GO:0072592]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of JNK cascade [GO:0046330]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of blood pressure [GO:0008217]; regulation of ion transmembrane transport [GO:0034765]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; respiratory burst [GO:0045730]; signal transduction [GO:0007165]; superoxide anion generation [GO:0042554] GO:0001525; GO:0003081; GO:0005244; GO:0005769; GO:0005886; GO:0006739; GO:0006952; GO:0006954; GO:0007165; GO:0007254; GO:0008217; GO:0008284; GO:0008631; GO:0010575; GO:0016175; GO:0016477; GO:0030198; GO:0031267; GO:0034765; GO:0042554; GO:0042743; GO:0042995; GO:0043020; GO:0045726; GO:0045730; GO:0046330; GO:0046872; GO:0048661; GO:0050661; GO:0051454; GO:0070161; GO:0071455; GO:0072592; GO:1902177; GO:1990451 metal ion binding [GO:0046872]; NADP binding [GO:0050661]; small GTPase binding [GO:0031267]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; voltage-gated ion channel activity [GO:0005244] CAESFEMWDDR 0.99339 -16.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5813 0 0 0 0 0 0 0 0 0 13.0827 0 0 0 0 0 0 0 0 0 0 0 12.2476 0 0 0 13.3038 0 0 0 0 0 0 12.7388 0 13.5659 13.6885 14.49 0 0 14.124 0 0 0 0 0 0 0 0 11.0884 0 0 0 0 0 0 12.2682 0 0 12.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8842 0 0 0 0 12.3192 0 0 12.2393 0 0 13.0724 12.2267 0 0 0 0 0 0 0 0 0 11.6228 0 0 0 0 0 0 0 0 12.9218 0 12.8124 0 0 0 0 13.7184 0 0 0 0 0 0 0 12.8389 11.5734 0 0 0 0 0 0 0 P58215 LOXL3_HUMAN "Lysyl oxidase homolog 3, EC 1.4.3.-, EC 1.4.3.13 (Lysyl oxidase-like protein 3)" LOXL3 LOXL Homo sapiens (Human) "collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]" collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] "collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510]" GO:0001837; GO:0001968; GO:0004720; GO:0005044; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0045892; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046 copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; scavenger receptor activity [GO:0005044] ASFCLEDTECQEDVSKRYECANFGEQGITVGCWDLYR 0.9934 -6.9276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2052 0 0 12.0971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1081 0 13.8425 0 0 0 0 0 0 Q14943 KI3S1_HUMAN "Killer cell immunoglobulin-like receptor 3DS1 (Natural killer-associated transcript 10, NKAT-10)" KIR3DS1 NKAT10 Homo sapiens (Human) immune response [GO:0006955]; natural killer cell activation [GO:0030101] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class I receptor activity [GO:0032393]; immune response [GO:0006955]; natural killer cell activation [GO:0030101] GO:0005886; GO:0005887; GO:0006955; GO:0030101; GO:0032393 MHC class I receptor activity [GO:0032393] CCCNGPRACR 0.9934 -6.9272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8633 0 0 0 0 0 0 0 10.9703 12.4797 0 12.5939 0 0 0 13.4578 0 0 0 0 13.0697 0 0 0 0 0 11.6988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6063 0 0 0 0 0 0 11.6468 11.9414 0 0 0 0 11.2849 0 0 0 0 12.6393 0 0 0 0 11.5673 0 0 0 0 0 11.9829 0 0 0 0 12.8262 12.7843 0 13.3983 0 0 0 0 0 0 0 14.2718 13.9326 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3611 0 0 13.0374 12.8803 0 12.8236 0 0 13.1339 0 0 0 0 0 0 0 12.0242 0 0 0 0 0 12.8213 0 0 0 0 0 0 12.3485 0 0 Q6P2E9 EDC4_HUMAN "Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit, Hedls)" EDC4 HEDLS Homo sapiens (Human) deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087] GO:0000932; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016020; GO:0031087; GO:0036464 AEVWDLDMLR 0.9934 -15.931 0 13.9352 0 0 0 0 10.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3811 11.1252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7201 0 0 0 0 0 0 0 0 0 0 0 13.9448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0309 0 0 0 11.6554 0 12.7646 0 0 0 0 0 13.5191 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0152 0 0 0 0 14.8297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6952 0 0 0 0 Q8NE22 SETD9_HUMAN "SET domain-containing protein 9, EC 2.1.1.-" SETD9 C5orf35 Homo sapiens (Human) methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; lysine N-methyltransferase activity [GO:0016278]; methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796] GO:0005654; GO:0016278; GO:0032259; GO:1901796 lysine N-methyltransferase activity [GO:0016278] DINQGEELFSNYYTIVS 0.9934 -10.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TD43 TRPM4_HUMAN "Transient receptor potential cation channel subfamily M member 4, hTRPM4 (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4, LTrpC-4, LTrpC4) (Melastatin-4)" TRPM4 LTRPC4 Homo sapiens (Human) adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transmembrane transport [GO:0098655]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; spanning component of membrane [GO:0089717]; spanning component of plasma membrane [GO:0044214]; ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; sodium channel activity [GO:0005272]; adaptive immune response [GO:0002250]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cation transmembrane transport [GO:0098655]; cellular response to ATP [GO:0071318]; dendritic cell chemotaxis [GO:0002407]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during AV node cell action potential [GO:0086045]; membrane depolarization during bundle of His cell action potential [GO:0086048]; membrane depolarization during Purkinje myocyte cell action potential [GO:0086047]; negative regulation of bone mineralization [GO:0030502]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of atrial cardiac muscle cell action potential [GO:1903949]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of heart rate [GO:0010460]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization [GO:1904199]; positive regulation of vasoconstriction [GO:0045907]; protein homotetramerization [GO:0051289]; protein sumoylation [GO:0016925]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of T cell cytokine production [GO:0002724]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; sodium ion import across plasma membrane [GO:0098719]; vasoconstriction [GO:0042310] GO:0002250; GO:0002407; GO:0002724; GO:0005227; GO:0005261; GO:0005272; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0007204; GO:0008284; GO:0010460; GO:0016925; GO:0019722; GO:0030502; GO:0034706; GO:0035774; GO:0042310; GO:0042802; GO:0043025; GO:0044214; GO:0045600; GO:0045668; GO:0045907; GO:0051289; GO:0070588; GO:0071318; GO:0086045; GO:0086047; GO:0086048; GO:0086091; GO:0089717; GO:0090263; GO:0098655; GO:0098662; GO:0098719; GO:0098911; GO:0099604; GO:1903949; GO:1904179; GO:1904199 ATP binding [GO:0005524]; calcium activated cation channel activity [GO:0005227]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; sodium channel activity [GO:0005272] AQRYRLIR 0.9934 -15.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9972 0 0 0 0 0 0 0 0 13.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3034 12.7771 0 12.9373 0 0 0 0 0 9.48484 0 13.0309 0 12.7012 0 0 0 0 0 0 13.2222 14.5539 0 0 0 0 12.8076 0 0 0 13.8032 0 12.7882 12.882 16.0918 0 0 0 0 0 13.065 0 12.606 0 0 0 0 15.1936 0 13.0082 0 0 0 13.4524 0 0 13.613 14.4407 0 12.6544 0 12.8423 0 12.6749 12.8836 0 0 0 0 13.2857 0 0 0 13.3075 14.013 0 0 0 0 0 12.6454 0 0 0 0 0 0 12.5254 0 0 0 0 0 0 12.4152 0 0 0 0 0 0 0 0 0 0 0 Q8WW33 GTSF1_HUMAN Gametocyte-specific factor 1 (Protein FAM112B) GTSF1 FAM112B Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005737; GO:0007283; GO:0030154; GO:0046872 metal ion binding [GO:0046872] LLQCPYDK 0.9934 -6.4906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4745 0 13.6177 0 0 14.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96K49 TM87B_HUMAN Transmembrane protein 87B TMEM87B Homo sapiens (Human) "retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0005794; GO:0005829; GO:0016020; GO:0016021; GO:0042147 FSLYRHFK 0.9934 -6.4749 0 0 0 0 0 0 0 0 0 0 0 11.856 0 0 0 0 0 0 0 0 0 0 0 0 11.7646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5075 0 0 0 13.5109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0051 0 12.9616 13.0784 0 0 0 0 0 0 0 0 13.0559 0 0 11.172 14.8969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5148 14.5372 14.7412 15.3499 14.9908 14.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1782 0 0 Q9HBF4 ZFYV1_HUMAN Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236] autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407] "autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]; cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]" GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0048471; GO:0097629; GO:0140042; GO:1990462 "1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]" ACGEGFCDSCSSK 0.9934 -13.288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4524 0 0 12.5394 0 0 0 0 0 0 0 0 0 14.4804 0 0 13.2217 12.8191 15.5112 0 11.9478 0 0 0 0 0 0 12.0591 0 0 0 0 0 0 0 0 0 12.5274 0 0 0 0 0 0 0 0 0 14.5713 0 13.9189 18.8587 0 0 0 14.7387 12.3729 13.4165 12.0544 14.4386 0 0 13.6147 0 0 0 14.4393 12.4865 12.1586 14.7872 13.7832 13.0368 0 0 0 0 0 0 13.2975 0 0 0 0 0 13.8513 13.6393 11.194 0 0 0 0 0 0 13.6034 0 0 10.5632 0 0 13.2445 0 12.7509 12.7367 0 0 0 0 12.8375 0 0 0 0 0 0 0 12.1762 0 0 0 0 17.6648 11.1753 0 0 13.1535 0 13.6843 0 13.357 14.2323 0 0 0 13.6747 0 0 0 0 14.3091 0 14.4226 11.3679 0 0 0 12.898 0 12.8591 0 13.4838 0 15.3882 Q9Y282 ERGI3_HUMAN Endoplasmic reticulum-Golgi intermediate compartment protein 3 (Serologically defined breast cancer antigen NY-BR-84) ERGIC3 C20orf47 ERV46 SDBCAG84 CGI-54 PRO0989 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of intracellular protein transport [GO:0090316]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" "COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; retrograte transporter complex, Golgi to ER [GO:0061852]; transporter complex [GO:1990351]" "COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; retrograte transporter complex, Golgi to ER [GO:0061852]; transporter complex [GO:1990351]; protein self-association [GO:0043621]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of intracellular protein transport [GO:0090316]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0005783; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0030173; GO:0030176; GO:0033116; GO:0043621; GO:0061852; GO:0090316; GO:1990351 protein self-association [GO:0043621] CCNTCEDVR 0.9934 -6.4835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0085 0 0 0 0 0 0 13.5093 0 0 0 0 13.5481 0 0 0 0 0 0 0 0 13.2039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9193 0 0 0 0 0 0 0 0 0 12.9614 Q9NR99 MXRA5_HUMAN "Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan, Adlican)" MXRA5 Homo sapiens (Human) response to transforming growth factor beta [GO:0071559] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; response to transforming growth factor beta [GO:0071559] GO:0005201; GO:0005576; GO:0062023; GO:0070062; GO:0071559 extracellular matrix structural constituent [GO:0005201] EDIVEDEGGSGMGDEENTSR 0.99341 -27.262 0 0 0 0 0 0 0 0 0 14.6278 0 0 13.4891 0 13.496 0 0 0 0 0 0 0 12.8819 0 0 12.2435 0 0 0 0 0 0 10.7712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8122 0 0 15.8919 11.4396 12.706 0 0 0 14.3793 16.8911 12.5518 15.1997 0 0 13.763 13.0978 0 0 16.0221 15.3584 0 16.1183 16.4658 16.6121 16.8306 0 0 0 15.1482 0 18.0056 18.0464 0 14.492 0 14.497 0 14.0008 18.5411 0 18.4098 16.1044 0 0 14.5356 0 0 15.0846 15.2183 15.0179 13.5027 18.4627 16.6531 0 15.1631 0 13.4115 0 0 17.905 18.0399 18.2144 13.7699 0 15.0373 14.8534 16.8511 13.5813 16.7163 17.6958 0 11.4725 14.4505 0 0 0 0 0 0 0 14.6182 18.0004 13.6056 14.6359 0 0 0 0 12.1354 0 13.8493 12.2854 0 14.1493 13.3979 0 0 0 0 0 11.7196 15.0647 17.7793 14.8317 15.8304 12.6599 14.4123 0 0 12.0594 O14948 TFEC_HUMAN "Transcription factor EC, TFE-C (Class E basic helix-loop-helix protein 34, bHLHe34) (Transcription factor EC-like, hTFEC-L)" TFEC BHLHE34 TCFEC TFECL Homo sapiens (Human) cellular response to heat [GO:0034605]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cellular response to heat [GO:0034605]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0034605; GO:0045944; GO:0046983; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EDDNAQWHMEDVIEDIIGMESSFK 0.99341 -6.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6373 0 0 0 0 0 0 0 0 15.7128 0 15.2719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7743 0 0 17.2919 0 0 0 0 0 0 0 11.3416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2894 0 0 0 0 22.1836 0 0 0 0 0 0 11.4282 0 0 0 0 0 0 12.7472 11.2456 19.5569 12.7263 0 12.8844 0 0 12.1842 0 12.0531 0 0 0 0 0 0 11.0226 0 0 0 0 0 0 0 14.681 0 0 11.8157 0 0 0 13.0183 0 0 18.5628 0 0 0 0 12.9494 13.4327 0 0 0 0 0 0 0 0 11.9284 13.1005 0 10.8301 0 12.7516 0 0 0 0 0 0 0 0 0 0 0 0 0 O95376 ARI2_HUMAN "E3 ubiquitin-protein ligase ARIH2, ARI-2, Protein ariadne-2 homolog, EC 2.3.2.31 (RING-type E3 ubiquitin transferase ARIH2) (Triad1 protein)" ARIH2 ARI2 TRIAD1 HT005 Homo sapiens (Human) developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0032436; GO:0048588; GO:0061630; GO:0070534; GO:0070936; GO:0071425; GO:1903955 ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CKHDFCWMCLGDWKTHGSEYYECSR 0.99341 -6.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3607 0 0 0 0 11.0077 0 0 0 12.6517 11.0895 11.7901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7614 0 0 0 10.7726 14.8891 14.8954 14.0026 12.1941 11.7086 12.6807 14.0365 14.3764 0 12.6603 0 0 0 0 0 0 0 0 0 0 0 11.1687 10.9179 0 0 0 0 0 0 0 11.7921 0 0 0 0 0 0 0 12.2389 0 13.4788 0 0 0 0 0 12.373 0 0 15.3805 15.4741 13.771 14.6547 0 0 15.3337 0 0 0 0 14.1224 0 0 13.8388 0 0 0 14.0138 0 0 0 0 0 0 0 15.6265 14.9969 0 0 0 0 0 13.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5162 0 0 14.7439 0 14.6476 13.1442 0 0 12.718 0 0 0 0 12.6758 12.4909 12.4058 0 13.6256 12.8757 0 0 0 13.8557 13.2039 13.1532 0 12.9953 0 0 0 0 P15391 CD19_HUMAN B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19) CD19 Homo sapiens (Human) antigen receptor-mediated signaling pathway [GO:0050851]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell differentiation [GO:0001923]; immunoglobulin mediated immune response [GO:0016064]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of B cell activation [GO:0050864]; regulation of B cell receptor signaling pathway [GO:0050855] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell differentiation [GO:0001923]; immunoglobulin mediated immune response [GO:0016064]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of B cell activation [GO:0050864]; regulation of B cell receptor signaling pathway [GO:0050855] GO:0001923; GO:0002322; GO:0005886; GO:0005887; GO:0009897; GO:0016064; GO:0032991; GO:0043552; GO:0045121; GO:0050851; GO:0050853; GO:0050855; GO:0050864; GO:0051281; GO:0070062 LYVWAKDR 0.99341 -6.9368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25205 MCM3_HUMAN "DNA replication licensing factor MCM3, EC 3.6.4.12 (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102)" MCM3 Homo sapiens (Human) DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-templated DNA replication initiation [GO:0030174] "alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]" "alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-templated DNA replication initiation [GO:0030174]" GO:0000727; GO:0000781; GO:0003677; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005658; GO:0005813; GO:0006268; GO:0006270; GO:0006271; GO:0016020; GO:0016887; GO:0030174; GO:0042555; GO:0048471; GO:0071162; GO:1902975 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] AFKVALLDVFREAHAQSIGMNR 0.99341 -17.265 0 12.3454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3185 0 0 0 0 0 0 0 0 0 0 0 0 16.4431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6098 0 0 0 0 0 0 14.4383 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7116 0 12.7361 0 0 0 0 0 0 0 P30305 MPIP2_HUMAN "M-phase inducer phosphatase 2, EC 3.1.3.48 (Dual specificity phosphatase Cdc25B)" CDC25B CDC25HU2 Homo sapiens (Human) cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein kinase activity [GO:0045860]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein kinase activity [GO:0045860]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468] GO:0000086; GO:0000278; GO:0000922; GO:0001556; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006470; GO:0007144; GO:0008284; GO:0010971; GO:0019901; GO:0032467; GO:0045860; GO:0045931; GO:0051301; GO:0110032 phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] DDDAVPPGMESLISAPLVKTLEK 0.99341 -14.069 0 0 0 0 10.9994 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4801 0 0 13.5576 15.9752 0 0 0 13.5328 15.5579 0 14.2938 14.3514 13.922 14.178 16.2122 13.111 13.79 14.1948 17.2275 13.9464 17.0991 16.1241 13.9042 0 13.4975 16.112 13.3457 13.628 0 0 0 15.0395 13.0699 15.2226 0 0 0 14.6554 0 0 12.8291 13.4876 13.2688 0 11.9921 13.6283 0 0 0 13.6577 0 0 0 0 12.3176 0 0 0 0 11.5095 12.9495 0 12.5833 0 0 0 0 0 12.0524 0 0 0 0 0 12.781 0 0 0 0 0 0 0 0 12.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60059 SC61G_HUMAN Protein transport protein Sec61 subunit gamma SEC61G Homo sapiens (Human) "post-translational protein targeting to membrane, translocation [GO:0031204]; protein targeting to ER [GO:0045047]" cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Ssh1 translocon complex [GO:0071261] "cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Ssh1 translocon complex [GO:0071261]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein targeting to ER [GO:0045047]" GO:0005829; GO:0008320; GO:0016020; GO:0016021; GO:0031204; GO:0043022; GO:0045047; GO:0071261 protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022] PDRKEFQK 0.99341 -17.26 0 0 0 0 0 0 0 0 12.57 0 13.0057 0 0 0 12.355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1016 0 0 0 0 0 0 0 0 0 12.3431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3382 0 0 0 0 0 0 0 0 0 0 13.127 0 0 0 0 0 0 0 0 0 0 0 12.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6484 0 0 0 0 0 13.388 0 0 0 0 0 0 12.1223 0 0 0 0 0 0 0 0 0 0 0 12.5898 0 12.6942 12.6098 0 0 12.8049 0 0 12.2598 0 0 0 0 Q0D2K5 EGFEM_HUMAN Putative EGF-like and EMI domain-containing protein 1 EGFEM1P C3orf50 NCRNA00259 Homo sapiens (Human) CQEGKSECSCPAGCR 0.99341 -6.3169 0 0 0 0 0 0 0 0 0 12.5406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7875 0 0 0 0 0 0 0 0 0 0 0 0 11.2088 0 0 0 0 0 0 0 10.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6118 0 0 0 0 0 0 0 11.505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0266 0 0 0 0 0 0 0 Q14240 IF4A2_HUMAN "Eukaryotic initiation factor 4A-II, eIF-4A-II, eIF4A-II, EC 3.6.4.13 (ATP-dependent RNA helicase eIF4A-2)" EIF4A2 DDX2B EIF4F Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translational initiation [GO:0002183]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; cytoplasmic translational initiation [GO:0002183]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] GO:0002183; GO:0003723; GO:0003724; GO:0003743; GO:0004386; GO:0005524; GO:0005829; GO:0006413; GO:0006446; GO:0016281; GO:0016887; GO:0048471; GO:1900260; GO:1990830 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; translation initiation factor activity [GO:0003743] DQIYEIFQK 0.99341 -17.348 0 0 0 0 0 0 0 0 0 12.7171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 10.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7588 0 0 0 0 12.3257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3597 0 0 0 0 14.974 14.187 0 0 0 0 0 13.118 0 0 0 0 0 13.8462 0 0 0 0 0 0 14.379 0 0 14.11 0 0 0 0 0 14.0207 13.746 0 0 0 0 0 14.1524 0 0 0 14.4626 0 0 0 0 0 0 12.3857 13.2301 0 0 0 13.4238 0 0 0 0 0 0 0 0 0 0 0 12.755 12.3122 0 0 0 0 0 0 0 0 0 12.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7561 0 0 0 0 0 0 Q16540 RM23_HUMAN "39S ribosomal protein L23, mitochondrial, L23mt, MRP-L23 (L23 mitochondrial-related protein) (Mitochondrial large ribosomal subunit protein uL23m) (Ribosomal protein L23-like)" MRPL23 L23MRP RPL23L Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0001650; GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] IKKPDYK 0.99341 -27.268 0 0 0 0 0 0 0 0 0 0 12.1638 0 0 0 0 0 0 11.7659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8381 0 0 0 0 0 0 0 0 0 10.3759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6092 14.2251 14.0916 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1007 0 0 0 0 0 0 0 0 0 13.7435 0 0 0 13.116 13.0995 0 13.6444 0 0 0 0 0 0 13.6616 0 0 0 0 0 13.4727 0 0 0 0 0 12.8161 0 0 0 0 0 0 13.228 0 13.1912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8398 0 0 0 13.0373 0 0 0 0 0 0 12.909 0 0 0 0 0 0 0 0 0 Q6ZN66 GBP6_HUMAN "Guanylate-binding protein 6, EC 3.6.5.- (GTP-binding protein 6, GBP-6) (Guanine nucleotide-binding protein 6)" GBP6 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062] cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955] GO:0003924; GO:0005525; GO:0006955; GO:0031410; GO:0042742; GO:0042832; GO:0050830; GO:0070062; GO:0071346 GTP binding [GO:0005525]; GTPase activity [GO:0003924] EHLLREQIMMLEHTQK 0.99341 -6.9408 11.7852 0 0 13.9011 0 0 0 0 0 0 0 0 15.6682 0 0 0 0 0 0 0 0 0 0 11.7717 0 0 0 0 0 0 0 14.5915 0 0 0 0 0 0 0 0 0 0 0 0 12.8357 0 0 0 0 13.4727 13.4301 0 0 0 12.907 0 0 0 0 0 0 14.947 14.9569 0 0 0 0 0 13.6772 11.4653 10.5266 0 0 0 0 0 0 0 0 0 0 14.7804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8749 11.3773 0 0 0 0 0 12.7591 0 0 0 0 11.1549 0 14.5506 15.059 0 0 0 0 0 0 0 0 0 14.7637 11.3948 0 0 0 0 0 0 15.1213 0 13.3426 0 0 14.7539 0 0 0 0 0 14.1801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1647 12.9481 14.911 0 13.3168 13.7831 0 0 11.4551 Q7KZI7 MARK2_HUMAN "Serine/threonine-protein kinase MARK2, EC 2.7.11.1, EC 2.7.11.26 (ELKL motif kinase 1, EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b, Par-1b, Par1b)" MARK2 EMK1 Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055] actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule bundle [GO:0097427]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; activation of protein kinase activity [GO:0032147]; autophagy of mitochondrion [GO:0000422]; axon development [GO:0061564]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion localization [GO:0051646]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule binding [GO:1904526]; regulation of microtubule cytoskeleton organization [GO:0070507]; Wnt signaling pathway [GO:0016055] GO:0000226; GO:0000287; GO:0000422; GO:0001764; GO:0003723; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005884; GO:0005886; GO:0006468; GO:0008289; GO:0010976; GO:0016020; GO:0016055; GO:0016328; GO:0018105; GO:0018107; GO:0030010; GO:0030295; GO:0030425; GO:0032147; GO:0035556; GO:0045197; GO:0045296; GO:0046777; GO:0048156; GO:0050321; GO:0050770; GO:0051493; GO:0051646; GO:0061564; GO:0070507; GO:0071963; GO:0097427; GO:0106310; GO:1904526 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] DRWMNVGHEDDELK 0.99341 -27.247 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3142 0 12.8584 0 0 0 0 0 0 0 0 0 0 11.2257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4172 0 0 0 0 11.1778 0 0 0 0 0 12.028 0 0 0 0 0 0 0 0 0 0 11.1823 0 0 0 0 0 0 0 0 0 10.5551 0 0 0 0 0 0 0 0 0 0 0 0 12.3737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7996 14.8269 11.8461 0 9.50108 0 0 0 12.348 0 0 0 10.4301 0 0 12.4801 0 0 0 0 0 0 0 0 0 0 0 11.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWF7 U2D2L_HUMAN Putative ubiquitin-conjugating enzyme E2 D2-like protein (Ubiquitin carrier protein D2-like) (Ubiquitin-conjugating enzyme E2D N-terminal-like) (Ubiquitin-protein ligase D2-like) UBE2DNL UBE2D2L Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; protein polyubiquitination [GO:0000209]; regulation of mitotic metaphase/anaphase transition [GO:0030071] nucleus [GO:0005634] nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; protein polyubiquitination [GO:0000209]; regulation of mitotic metaphase/anaphase transition [GO:0030071] GO:0000209; GO:0005634; GO:0030071; GO:0031145; GO:0061631 ubiquitin conjugating enzyme activity [GO:0061631] FPSDYLFKPPKIK 0.99341 -6.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0192 0 0 0 0 0 0 0 0 0 12.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TC59 PIWL2_HUMAN "Piwi-like protein 2, EC 3.1.26.- (Cancer/testis antigen 80, CT80)" PIWIL2 HILI Homo sapiens (Human) DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of meiosis I [GO:0060903]; positive regulation of translation [GO:0045727]; rhythmic process [GO:0048511]; RNA 5'-end processing [GO:0000966]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; perinucleolar chromocenter [GO:0010370]; PET complex [GO:1990923]; pi-body [GO:0071546]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transposition [GO:0010529]; oogenesis [GO:0048477]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of meiosis I [GO:0060903]; positive regulation of translation [GO:0045727]; rhythmic process [GO:0048511]; RNA 5'-end processing [GO:0000966]; spermatogenesis [GO:0007283] GO:0000966; GO:0003723; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0007283; GO:0010370; GO:0010529; GO:0030718; GO:0031047; GO:0033391; GO:0034584; GO:0034587; GO:0042754; GO:0043046; GO:0043186; GO:0045727; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060903; GO:0071442; GO:0071546; GO:0097433; GO:1905538; GO:1990511; GO:1990923; GO:2000617 endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; RNA binding [GO:0003723] CFEAFENYQPKMVVFVVQKK 0.99341 -27.216 0 0 0 0 0 0 12.6191 0 0 0 0 0 0 0 12.1802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7112 0 0 12.5856 0 12.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5587 0 0 12.594 0 0 0 0 0 13.0703 14.8059 0 0 0 0 0 0 0 0 13.5944 0 11.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7377 0 0 11.4201 11.4121 0 0 0 0 11.4769 0 0 0 0 0 12.2775 11.7632 15.2346 0 12.3342 0 12.3663 0 0 12.6085 13.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3369 0 0 0 0 0 0 0 0 0 0 0 0 10.3455 0 11.9098 0 14.7954 0 12.4486 0 Q96D21 RHES_HUMAN GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2) RASD2 TEM2 Homo sapiens (Human) "locomotory behavior [GO:0007626]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]" plasma membrane [GO:0005886]; synapse [GO:0045202] "plasma membrane [GO:0005886]; synapse [GO:0045202]; G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; locomotory behavior [GO:0007626]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein sumoylation [GO:0033235]; regulation of cAMP-mediated signaling [GO:0043949]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]" GO:0001963; GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0007626; GO:0031681; GO:0033235; GO:0043949; GO:0045202; GO:0051897 G-protein beta-subunit binding [GO:0031681]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] ISVQYGDAFHPRPFCMRR 0.99341 -6.3025 0 0 0 0 0 0 0 0 0 0 0 12.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H089 LSG1_HUMAN "Large subunit GTPase 1 homolog, hLsg1, EC 3.6.1.-" LSG1 Homo sapiens (Human) nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear export [GO:0051168]; protein transport [GO:0015031]; ribosomal subunit export from nucleus [GO:0000054] GO:0000054; GO:0003924; GO:0005525; GO:0005654; GO:0005783; GO:0005829; GO:0015030; GO:0015031; GO:0016020; GO:0016604; GO:0051168 GTP binding [GO:0005525]; GTPase activity [GO:0003924] APAGGSLGRALMR 0.99341 -27.195 0 10.3758 0 0 0 0 0 0 0 0 0 0 0 11.3677 11.5158 0 0 0 11.4725 11.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6689 0 0 0 10.0314 12.3081 0 0 0 0 0 0 0 0 0 0 10.8815 0 0 0 0 0 0 12.2685 14.0766 0 0 0 0 0 14.1829 0 0 0 0 0 19.4835 0 15.3441 13.8478 13.7887 15.3139 0 0 0 0 0 14.4586 0 0 14.1445 0 0 0 0 13.1438 0 13.1604 0 0 12.5665 13.2634 0 13.3261 0 0 0 14.6531 0 12.5158 0 0 0 0 0 0 0 12.5821 0 0 11.5185 0 12.4717 0 0 0 0 13.2346 11.5461 0 0 12.8701 12.1641 0 0 12.4701 0 11.0797 0 0 12.7697 0 0 12.3466 12.2684 11.8156 14.6493 0 0 13.6933 0 0 0 0 13.4988 0 14.0642 0 0 0 0 0 0 0 0 12.7845 0 14.3419 0 0 Q9HCD6 TANC2_HUMAN "Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)" TANC2 KIAA1148 KIAA1636 Homo sapiens (Human) dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001] anchoring junction [GO:0070161]; axon [GO:0030424]; dendritic spine [GO:0043197] anchoring junction [GO:0070161]; axon [GO:0030424]; dendritic spine [GO:0043197]; dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001] GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0070161; GO:0099519 AHIFKGLSKK 0.99341 -27.199 0 0 0 0 0 0 0 0 0 11.5376 0 0 0 13.5928 0 14.3606 11.8769 0 11.8225 11.8936 13.0244 0 13.6808 0 12.2682 0 0 12.0087 11.5356 0 14.9496 14.644 0 14.1502 15.4797 0 0 12.0254 13.1901 0 11.3003 15.0349 15.7167 0 0 15.7561 11.5502 0 11.7712 0 0 13.3218 0 0 0 0 13.8415 12.6401 0 0 0 0 0 0 0 0 0 0 13.5908 0 0 0 0 10.9055 0 9.71063 0 12.4559 0 11.8202 0 0 14.17 0 0 15.9213 0 0 0 14.5283 13.0496 14.4135 11.4783 0 0 0 0 12.7028 0 13.1763 13.1675 14.7574 12.9524 15.78 13.2198 0 14.6369 15.0724 0 0 0 14.5429 13.181 0 0 0 0 13.5126 0 12.9675 0 0 10.166 12.6182 0 0 14.6656 0 0 13.3749 13.5652 0 13.6287 0 0 0 0 0 14.0787 0 0 0 0 15.532 0 0 0 13.6113 14.9928 0 0 0 0 14.9635 0 0 0 13.7008 12.6182 14.2641 13.8355 0 14.1853 12.8033 14.0639 0 0 13.8762 14.9428 13.0377 0 0 0 13.876 0 14.2255 0 0 0 13.6503 Q9NUN5 LMBD1_HUMAN "Lysosomal cobalamin transport escort protein LMBD1, LMBD1 (HDAg-L-interacting protein NESI) (LMBR1 domain-containing protein 1) (Nuclear export signal-interacting protein)" LMBRD1 C6orf209 NESI BM-021 CD001 MSTP044 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; gastrulation [GO:0007369]; insulin receptor internalization [GO:0038016]; protein localization to lysosome [GO:0061462]; protein localization to vacuole [GO:0072665] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; AP-2 adaptor complex binding [GO:0035612]; clathrin heavy chain binding [GO:0032050]; cobalamin binding [GO:0031419]; insulin receptor binding [GO:0005158]; protein transporter activity [GO:0140318]; clathrin-dependent endocytosis [GO:0072583]; gastrulation [GO:0007369]; insulin receptor internalization [GO:0038016]; protein localization to lysosome [GO:0061462]; protein localization to vacuole [GO:0072665] GO:0005158; GO:0005765; GO:0005774; GO:0005789; GO:0005886; GO:0007369; GO:0016020; GO:0016021; GO:0030136; GO:0031419; GO:0032050; GO:0035612; GO:0038016; GO:0043231; GO:0045334; GO:0061462; GO:0072583; GO:0072665; GO:0140318 AP-2 adaptor complex binding [GO:0035612]; clathrin heavy chain binding [GO:0032050]; cobalamin binding [GO:0031419]; insulin receptor binding [GO:0005158]; protein transporter activity [GO:0140318] DDDDTSK 0.99341 -9.1741 9.79983 0 0 0 0 0 0 0 0 12.9048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5184 0 0 0 0 0 0 12.6622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7434 0 0 0 13.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3498 11.7673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4272 0 0 0 0 13.7385 0 0 0 0 12.7855 0 0 0 0 0 12.4568 0 0 0 Q9NXL2 ARH38_HUMAN Rho guanine nucleotide exchange factor 38 ARHGEF38 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829 guanyl-nucleotide exchange factor activity [GO:0005085] DDEMDYSETLSNALNSCHDFASHLQR 0.99341 -9.1926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5212 0 0 9.67359 0 0 0 0 0 0 12.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3455 0 12.0062 0 0 0 0 0 12.3288 0 0 18.3502 12.2474 0 16.9619 0 0 0 0 0 0 0 17.2511 0 0 0 13.8271 14.3417 0 0 0 0 0 12.7533 0 0 0 0 15.5233 0 0 0 0 0 0 0 0 13.3639 13.1553 0 17.8327 0 0 12.3978 0 0 0 13.8243 0 0 0 10.8721 12.9989 0 0 0 0 0 0 0 0 0 0 0 11.0267 0 0 10.2629 0 0 0 0 0 0 0 0 10.4875 0 0 0 0 0 0 0 0 0 0 0 0 17.5934 0 0 0 0 0 0 Q5XX13 FBW10_HUMAN F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor) FBXW10 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 AAWIRKIK 0.99342 -38.046 14.1245 0 0 0 15.9309 15.8428 12.5946 14.232 0 0 0 0 0 9.67453 0 0 0 13.0276 12.2512 13.6581 15.0681 15.5865 12.7422 14.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.073 0 0 0 11.4785 0 0 0 9.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4712 0 18.3273 0 16.3745 13.1683 17.8969 17.0331 15.5193 17.0537 14.842 17.1256 17.6229 18.2906 18.2791 13.5614 19.2308 18.0028 17.3071 17.1833 14.9891 16.4386 13.56 0 14.4993 15.7817 0 13.4861 17.4162 12.7374 0 13.2694 16.8556 14.8691 17.2074 14.2432 15.0074 13.6476 14.6165 14.6745 17.0061 15.4477 14.9115 0 17.8963 14.1909 17.1612 16.0333 13.514 0 16.7965 14.3284 17.5957 13.5727 17.2442 17.1956 12.4804 15.5433 14.7224 14.3057 16.7402 16.8927 14.3596 17.4339 17.9259 16.9557 12.7139 16.7184 17.6584 14.6708 16.9349 17.0729 0 14.5349 14.7526 12.6212 13.6309 12.9518 14.2304 13.5702 0 13.8286 16.9138 16.674 16.8188 13.6283 0 14.3652 17.1434 0 14.5134 0 0 13.9548 16.1744 12.9398 15.0892 0 11.9035 0 0 0 12.7581 14.1297 16.1153 13.2302 13.2297 0 0 14.8886 13.2685 0 Q8TEK3 DOT1L_HUMAN "Histone-lysine N-methyltransferase, H3 lysine-79 specific, EC 2.1.1.360 (DOT1-like protein) (Histone H3-K79 methyltransferase, H3-K79-HMTase) (Lysine N-methyltransferase 4)" DOT1L KIAA1814 KMT4 Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin assembly [GO:0031507]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin assembly [GO:0031507]; histone H3-K79 methylation [GO:0034729]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200] GO:0000077; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0008284; GO:0010467; GO:0018024; GO:0031151; GO:0031507; GO:0032200; GO:0032991; GO:0034729; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:2000677 DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K79 specific) [GO:0031151]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713] AGAATVK 0.99342 -38.023 0 0 0 0 0 0 0 0 0 15.0298 14.8833 0 0 0 0 17.8587 0 12.2315 0 0 0 0 0 0 0 0 0 0 0 13.8846 0 0 16.6128 13.819 12.8225 0 0 0 0 0 0 0 0 16.5804 0 0 0 0 0 0 0 0 0 0 0 17.0199 17.2919 18.9937 17.4375 16.8113 0 17.4817 15.9388 16.3923 16.1501 16.8271 12.504 0 0 0 11.724 0 0 0 13.8731 13.8222 0 10.9981 13.6711 15.6116 0 0 0 0 0 0 0 0 12.8966 0 0 0 0 0 0 0 12.8592 0 0 0 0 12.3575 0 0 0 0 0 0 0 13.056 13.4967 0 0 0 0 0 11.3209 0 0 0 0 0 0 0 0 12.3267 0 15.7216 0 11.8791 0 13.0118 13.4472 14.5909 0 0 0 12.4443 12.1158 0 0 0 0 0 0 14.4856 0 13.7499 0 0 13.6751 0 0 0 11.0927 0 19.6789 12.8877 0 12.7815 0 0 0 0 0 12.0983 14.0244 0 0 0 0 0 0 14.0059 0 0 0 0 0 0 A9Z1Z3 FR1L4_HUMAN Fer-1-like protein 4 FER1L4 C20orf124 Homo sapiens (Human) plasma membrane organization [GO:0007009] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; plasma membrane organization [GO:0007009] GO:0007009; GO:0016021; GO:0046872 metal ion binding [GO:0046872] AEGLPALRLGLLGSLVR 0.99342 -38.35 13.0085 0 14.106 14.9493 0 0 0 0 0 0 11.5632 0 0 10.2355 0 13.0736 0 0 12.2094 0 15.456 0 13.4528 0 13.136 0 14.4112 12.3594 14.1793 13.8502 0 13.7654 0 10.3474 0 0 10.9141 0 0 0 0 0 13.0954 13.6947 12.4388 0 0 0 13.3032 13.3782 11.8375 0 0 12.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4185 13.6131 0 0 14.1109 0 16.3302 16.7116 16.4714 12.822 15.3889 0 13.8962 13.6833 0 12.744 15.744 0 13.2376 0 14.0677 11.6001 14.7747 15.5271 15.1352 16.8654 16.5506 11.078 0 0 0 16.1889 11.9583 0 16.5325 0 12.1376 15.3333 0 13.3603 13.279 12.5505 15.9394 0 16.9514 12.6917 0 13.823 0 0 0 0 15.8234 0 15.8814 13.704 15.3605 12.0248 15.5229 15.9657 0 13.6695 0 0 13.2618 14.1402 11.8043 0 15.6651 0 15.3767 15.2074 13.5424 15.0449 15.5515 12.5724 0 14.4592 13.0465 13.1748 0 0 14.1732 0 14.8023 0 16.2344 15.7941 0 0 0 11.4235 0 9.81497 0 0 13.8246 0 12.0891 10.2646 0 0 0 14.4291 13.6286 0 12.464 13.9185 14.2024 10.9391 0 0 A1A4S6 RHG10_HUMAN Rho GTPase-activating protein 10 (GTPase regulator associated with focal adhesion kinase 2) (Graf-related protein 2) (Rho-type GTPase-activating protein 10) ARHGAP10 GRAF2 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0005886; GO:0007010; GO:0007165; GO:0043066; GO:0048471; GO:0051056 GTPase activator activity [GO:0005096] GLQPLEFSDCYLDSPWFR 0.99342 -38.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5412 0 0 0 0 0 0 0 0 0 12.5248 0 10.7983 0 14.0524 14.2216 0 0 0 0 0 0 0 0 0 0 10.2973 0 12.795 13.783 10.6525 10.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6159 0 10.4416 0 0 0 14.6566 0 0 12.2656 0 0 0 0 0 0 12.1932 0 0 10.9097 0 0 0 12.5409 0 0 14.4606 0 12.7992 0 0 11.1726 0 0 0 10.6167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93924 0 0 12.3601 0 11.8045 0 10.3517 0 11.1269 0 0 0 0 0 0 0 11.3299 11.2835 0 0 0 12.1652 0 0 0 0 0 0 0 0 0 0 0 0 12.7774 13.7929 12.8428 0 0 0 12.429 0 12.7832 0 0 0 0 0 0 0 0 10.9052 13.6118 0 0 0 0 0 12.5918 11.7101 0 0 0 0 0 12.5193 12.477 O00398 P2Y10_HUMAN "Putative P2Y purinoceptor 10, P2Y10 (P2Y-like receptor)" P2RY10 Homo sapiens (Human) positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0004930; GO:0005886; GO:0005887; GO:0035025; GO:0045028; GO:0051482 G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930] ALCLLCFYLK 0.99342 -6.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8849 0 0 0 0 12.0844 0 0 0 15.9361 0 0 0 0 0 0 0 0 12.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1249 0 12.0654 0 0 0 0 0 11.2232 0 0 13.4074 0 15.6079 13.1471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15228 GNPAT_HUMAN "Dihydroxyacetone phosphate acyltransferase, DAP-AT, DHAP-AT, EC 2.3.1.42 (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)" GNPAT DAPAT DHAPAT Homo sapiens (Human) cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; glycerone-phosphate O-acyltransferase activity [GO:0016287]; cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416] GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006631; GO:0006654; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0009410; GO:0016020; GO:0016287; GO:0021587; GO:0030913; GO:0031966; GO:0042594; GO:0061024; GO:0070542 glycerone-phosphate O-acyltransferase activity [GO:0016287] ILEETLYVYELLGVPK 0.99342 -5.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43159 RRP8_HUMAN "Ribosomal RNA-processing protein 8, EC 2.1.1.- (Cerebral protein 1) (Nucleomethylin)" RRP8 KIAA0409 NML hucep-1 Homo sapiens (Human) "cellular response to glucose starvation [GO:0042149]; energy homeostasis [GO:0097009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]" chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553] "chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to glucose starvation [GO:0042149]; energy homeostasis [GO:0097009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of G1 to G0 transition [GO:1903450]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]" GO:0000183; GO:0003723; GO:0005654; GO:0005677; GO:0005730; GO:0005829; GO:0005886; GO:0006364; GO:0008757; GO:0031062; GO:0031065; GO:0032259; GO:0033553; GO:0035064; GO:0042149; GO:0045786; GO:0045892; GO:0046015; GO:0061773; GO:0072332; GO:0097009; GO:1903450 methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] AVTKLGFK 0.99342 -14.534 0 0 0 0 11.0496 0 0 0 0 0 0 13.5333 0 0 0 12.1967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6224 0 11.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7819 0 0 0 0 14.7286 12.8251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2021 0 0 0 12.7145 0 0 0 0 0 0 15.6393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4946 0 0 0 0 0 0 0 0 0 0 0 13.4748 0 0 13.4668 11.5389 0 0 13.9863 0 0 13.0885 0 0 0 0 0 0 0 0 0 0 0 O60861 GAS7_HUMAN "Growth arrest-specific protein 7, GAS-7" GAS7 KIAA0394 Homo sapiens (Human) actin filament polymerization [GO:0030041]; neuron projection morphogenesis [GO:0048812] actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; neuron projection morphogenesis [GO:0048812] GO:0005737; GO:0005884; GO:0005886; GO:0030041; GO:0042802; GO:0048812; GO:0051015 actin filament binding [GO:0051015]; identical protein binding [GO:0042802] ARKALTER 0.99342 -16.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4769 0 15.6375 0 0 0 0 13.4507 13.3795 0 0 13.4865 0 0 0 17.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95447 LCA5L_HUMAN Lebercilin-like protein (Leber congenital amaurosis 5-like protein) LCA5L C21orf13 Homo sapiens (Human) intraciliary transport [GO:0042073] axoneme [GO:0005930] axoneme [GO:0005930]; intraciliary transport [GO:0042073] GO:0005930; GO:0042073 EEMELEHSDSGYEPSFGK 0.99342 -37.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4565 0 0 0 0 0 0 0 0 10.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2635 0 0 0 0 0 0 11.5287 0 0 12.6225 0 0 0 15.2066 0 0 0 0 0 0 11.931 0 0 0 0 14.3261 0 0 0 10.7405 0 0 0 15.9442 0 0 14.198 14.724 0 15.4253 11.6002 16.0084 0 12.5054 13.2975 0 0 0 0 0 12.6664 0 0 0 0 0 0 12.1356 13.8141 0 0 0 0 0 0 0 0 0 9.79693 0 12.0586 0 11.5741 0 0 0 0 12.1925 12.3458 0 0 0 0 0 0 13.3619 12.2241 13.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7342 11.4953 0 0 0 0 0 0 0 12.5793 0 0 0 0 12.298 11.9936 0 0 0 0 0 15.3049 0 P29371 NK3R_HUMAN "Neuromedin-K receptor, NKR (NK-3 receptor, NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3)" TACR3 NK3R TAC3R Homo sapiens (Human) aging [GO:0007568]; hyperosmotic salinity response [GO:0042538]; positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of heart rate [GO:0010460]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of dopamine metabolic process [GO:0042053]; regulation of feeding behavior [GO:0060259]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to morphine [GO:0043278]; tachykinin receptor signaling pathway [GO:0007217] cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; tachykinin receptor activity [GO:0004995]; aging [GO:0007568]; hyperosmotic salinity response [GO:0042538]; positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of heart rate [GO:0010460]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of dopamine metabolic process [GO:0042053]; regulation of feeding behavior [GO:0060259]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to morphine [GO:0043278]; tachykinin receptor signaling pathway [GO:0007217] GO:0004995; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007217; GO:0007568; GO:0010460; GO:0032355; GO:0032590; GO:0032809; GO:0042053; GO:0042220; GO:0042538; GO:0043278; GO:0045777; GO:0060259; GO:0070474; GO:0097225; GO:1902093 tachykinin receptor activity [GO:0004995] IALWSLAYGVVVAVAVLGNLIVIWIILAHKR 0.99342 -6.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5734 11.9255 0 0 0 0 0 0 0 11.5734 12.0101 0 10.082 0 0 0 0 0 0 0 0 0 0 10.8605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.646 0 0 0 0 12.6423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9365 0 0 0 10.9566 13.282 0 0 0 0 0 0 0 P31270 HXA11_HUMAN Homeobox protein Hox-A11 (Homeobox protein Hox-1I) HOXA11 HOX1I Homo sapiens (Human) "anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte development [GO:0002063]; developmental growth [GO:0048589]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal joint morphogenesis [GO:0060272]; male gonad development [GO:0008584]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; organ induction [GO:0001759]; positive regulation of cell development [GO:0010720]; positive regulation of chondrocyte development [GO:1902761]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; uterus development [GO:0060065]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte development [GO:0002063]; developmental growth [GO:0048589]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal joint morphogenesis [GO:0060272]; male gonad development [GO:0008584]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; organ induction [GO:0001759]; positive regulation of cell development [GO:0010720]; positive regulation of chondrocyte development [GO:1902761]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription, DNA-templated [GO:0045893]; prostate gland development [GO:0030850]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to testosterone [GO:0033574]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; spermatogenesis [GO:0007283]; uterus development [GO:0060065]" GO:0000978; GO:0000981; GO:0001501; GO:0001656; GO:0001658; GO:0001759; GO:0002063; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007283; GO:0007338; GO:0007501; GO:0008584; GO:0009653; GO:0009952; GO:0009953; GO:0009954; GO:0010720; GO:0030326; GO:0030850; GO:0032332; GO:0032991; GO:0032993; GO:0033574; GO:0035115; GO:0042733; GO:0043627; GO:0045893; GO:0048589; GO:0048856; GO:0060065; GO:0060272; GO:0060351; GO:1902761; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AGGSSGQR 0.99342 -9.2225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7215 0 13.9454 0 0 13.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1277 Q00013 EM55_HUMAN "55 kDa erythrocyte membrane protein, p55 (Membrane protein, palmitoylated 1)" MPP1 DXS552E EMP55 Homo sapiens (Human) regulation of neutrophil chemotaxis [GO:0090022]; signal transduction [GO:0007165] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cortical cytoskeleton [GO:0030863]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cortical cytoskeleton [GO:0030863]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; guanylate kinase activity [GO:0004385]; signaling receptor binding [GO:0005102]; regulation of neutrophil chemotaxis [GO:0090022]; signal transduction [GO:0007165] GO:0004385; GO:0005102; GO:0005886; GO:0005911; GO:0007165; GO:0016020; GO:0030863; GO:0032420; GO:0034451; GO:0090022 guanylate kinase activity [GO:0004385]; signaling receptor binding [GO:0005102] DNLIPCK 0.99342 -9.2225 0 0 0 0 0 0 0 0 12.1917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9081 14.2379 0 0 0 0 0 0 0 11.7887 19.2593 0 12.8168 12.5064 19.2174 14.2295 13.776 0 0 0 0 0 13.0859 0 0 14.3568 0 14.2318 0 14.3426 15.2891 0 0 0 11.6382 0 0 12.4763 12.59 0 0 0 11.7257 0 0 14.187 14.7956 14.5282 15.226 14.2876 0 0 0 11.9968 0 13.6176 15.8277 0 0 12.8182 14.2556 0 0 10.8338 0 0 0 0 0 0 0 0 0 0 0 14.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3556 0 0 0 14.3861 Q01101 INSM1_HUMAN Insulinoma-associated protein 1 (Zinc finger protein IA-1) INSM1 IA1 Homo sapiens (Human) adrenal chromaffin cell differentiation [GO:0061104]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; noradrenergic neuron development [GO:0003358]; norepinephrine biosynthetic process [GO:0042421]; pancreatic A cell differentiation [GO:0003310]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of gene expression [GO:0010468]; regulation of protein-containing complex assembly [GO:0043254]; sympathetic ganglion development [GO:0061549]; transdifferentiation [GO:0060290]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell differentiation [GO:0003309] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin DNA binding [GO:0031490]; cyclin binding [GO:0030332]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adrenal chromaffin cell differentiation [GO:0061104]; cell cycle [GO:0007049]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; noradrenergic neuron development [GO:0003358]; norepinephrine biosynthetic process [GO:0042421]; pancreatic A cell differentiation [GO:0003310]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of gene expression [GO:0010468]; regulation of protein-containing complex assembly [GO:0043254]; sympathetic ganglion development [GO:0061549]; transdifferentiation [GO:0060290]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell differentiation [GO:0003309]" GO:0000122; GO:0000978; GO:0001227; GO:0001933; GO:0003309; GO:0003310; GO:0003323; GO:0003358; GO:0003700; GO:0005634; GO:0005654; GO:0007049; GO:0008283; GO:0008285; GO:0010468; GO:0010564; GO:0016477; GO:0017053; GO:0030182; GO:0030332; GO:0030335; GO:0031490; GO:0042421; GO:0042826; GO:0043254; GO:0045597; GO:0046872; GO:0051726; GO:0060290; GO:0061104; GO:0061549; GO:2000179 "chromatin DNA binding [GO:0031490]; cyclin binding [GO:0030332]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAHFGNPEAAHPAPLYSPTRPVSREHEK 0.99342 -14.503 0 0 0 0 0 0 0 0 0 0 11.3712 0 11.1112 11.4891 12.572 0 0 13.9138 11.6977 13.4427 12.3796 0 12.4436 0 13.4211 0 0 0 13.5509 0 12.6316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1844 0 12.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4317 14.4146 0 0 0 0 0 0 0 0 0 0 0 0 12.1718 0 0 0 0 0 0 0 0 0 Q08708 CLM6_HUMAN "CMRF35-like molecule 6, CLM-6 (CD300 antigen-like family member C) (CMRF35-A1, CMRF-35) (Immunoglobulin superfamily member 16, IgSF16) (CD antigen CD300c)" CD300C CMRF35 CMRF35A CMRF35A1 IGSF16 Homo sapiens (Human) cellular defense response [GO:0006968]; immune system process [GO:0002376] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; cellular defense response [GO:0006968]; immune system process [GO:0002376] GO:0002376; GO:0004888; GO:0005886; GO:0005887; GO:0006968 transmembrane signaling receptor activity [GO:0004888] FLLLVLLELPLLLSMLGAVLWVNRPQR 0.99342 -5.0277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3555 0 0 13.6478 0 0 12.9822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0166 0 0 12.0011 0 14.4515 0 0 0 0 0 0 0 0 0 0 13.0541 0 0 0 0 0 0 16.0357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15853 USF2_HUMAN "Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12, bHLHb12) (FOS-interacting protein, FIP) (Major late transcription factor 2) (Upstream transcription factor 2)" USF2 BHLHB12 Homo sapiens (Human) lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]" GO:0000430; GO:0000432; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0007595; GO:0019086; GO:0042803; GO:0043231; GO:0043425; GO:0043565; GO:0045944; GO:0046982; GO:0055088; GO:1990837 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AQHNEVER 0.99342 -9.2369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.213 0 0 0 11.1812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16656 NRF1_HUMAN "Nuclear respiratory factor 1, NRF-1 (Alpha palindromic-binding protein, Alpha-pal)" NRF1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0042803; GO:0045944; GO:0070062 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ATLDEYTTR 0.99342 -9.2394 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5231 15.5768 15.6363 13.6068 0 0 0 0 0 0 0 0 0 0 0 0 13.9201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9889 0 0 Q3ZLR7 SP201_HUMAN Transcription factor SPT20 homolog-like 1 SUPT20HL1 FAM48B1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] SAGA complex [GO:0000124] SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000124; GO:0003712; GO:0006357 transcription coregulator activity [GO:0003712] ARSGLQPQPQPAVLSLLGSAQVPQQGVQLPSVLR 0.99342 -16.513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1864 0 0 0 0 0 0 0 11.9114 0 0 0 0 0 0 0 11.7053 0 0 0 0 0 0 11.7556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.803 0 0 0 0 0 0 12.3829 0 0 0 0 0 12.3247 0 0 0 0 0 0 0 0 0 0 0 0 12.5291 0 13.8766 13.3622 15.1558 11.4356 0 0 0 13.8188 0 0 0 12.6707 12.8894 0 0 0 0 12.9793 0 0 0 0 0 0 0 10.4339 0 0 13.1583 0 14.1499 0 0 0 14.1826 13.976 0 0 0 0 0 0 0 12.1255 0 0 0 0 0 0 13.0453 0 0 0 0 0 0 14.1505 0 0 0 0 0 0 Q5MNV8 FBX47_HUMAN F-box only protein 47 FBXO47 Homo sapiens (Human) ALPLEIFQIILKYLSVK 0.99342 -16.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6089 13.2867 0 0 0 0 0 17.3267 0 0 0 0 14.4678 14.755 14.8215 14.2653 0 0 0 0 0 14.4829 0 0 0 0 0 13.6073 0 14.0242 0 13.5772 13.4742 0 0 13.7583 13.3533 13.6136 0 0 0 0 0 13.4202 0 0 14.442 16.6836 14.6801 12.0612 0 13.7839 0 13.1263 0 0 0 0 0 14.5898 12.6782 0 0 0 0 0 0 12.3077 12.163 0 0 0 12.2494 0 0 0 0 0 11.8969 0 0 0 0 0 0 0 13.0353 12.3716 0 0 0 0 12.1974 0 0 0 0 11.8952 0 0 0 13.6366 11.9372 0 12.0211 0 0 0 0 11.6001 Q5TB30 DEP1A_HUMAN DEP domain-containing protein 1A DEPDC1 DEPDC1A Homo sapiens (Human) "intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0005096; GO:0005634; GO:0017053; GO:0035556; GO:0045892 GTPase activator activity [GO:0005096] GVVILQNK 0.99342 -29.152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2796 0 0 16.9476 10.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5456 17.4414 13.7027 0 0 17.4375 0 15.925 0 0 15.1792 0 0 0 0 0 0 0 0 12.2846 0 0 0 0 0 0 0 0 0 0 0 12.5729 0 14.2626 0 0 0 0 12.7357 13.6566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6256 12.526 12.4387 0 0 0 0 12.2959 0 0 0 0 0 0 12.7224 0 0 0 0 0 0 0 0 12.3364 20.3748 12.3186 12.4744 0 0 12.1057 19.912 0 19.099 12.7383 12.8928 13.1887 13.9739 0 0 0 12.1157 0 0 12.8295 13.7965 0 0 0 0 12.8274 0 0 0 0 0 0 0 0 0 0 12.4099 0 0 0 0 0 0 13.06 0 Q86UD0 SAPC2_HUMAN "Suppressor APC domain-containing protein 2 (Tumor specificity and mitosis phase-dependent expression protein, TS/MDEP) (p42.3)" SAPCD2 C9orf140 Homo sapiens (Human) establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725] apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] apical cortex [GO:0045179]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of protein localization to cell cortex [GO:1904777]; positive regulation of cell population proliferation [GO:0008284]; regulation of establishment of planar polarity [GO:0090175]; symmetric cell division [GO:0098725] GO:0000132; GO:0005654; GO:0005730; GO:0005829; GO:0005923; GO:0008284; GO:0016324; GO:0043296; GO:0045179; GO:0090175; GO:0098725; GO:1904777 DWYQQQLQR 0.99342 -6.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3473 0 0 0 0 0 0 10.9582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9082 10.8265 0 0 0 0 0 0 10.7765 0 0 11.7923 11.1018 13.0503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW03 SIAH3_HUMAN "Seven in absentia homolog 3, Siah-3" SIAH3 Homo sapiens (Human) negative regulation of protein targeting to mitochondrion [GO:1903215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of protein targeting to mitochondrion [GO:1903215]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein stability [GO:0031647] GO:0005654; GO:0005737; GO:0005739; GO:0031624; GO:0031647; GO:0043161; GO:0046872; GO:0061630; GO:1903215 metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] HEGHPQFFATMMLIGTPTQADCFTYRLELNRNHR 0.99342 -5.0232 11.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N573 OXR1_HUMAN Oxidation resistance protein 1 OXR1 Nbla00307 Homo sapiens (Human) adult walking behavior [GO:0007628]; cellular response to hydroperoxide [GO:0071447]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron apoptotic process [GO:0051402]; response to oxidative stress [GO:0006979] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; adult walking behavior [GO:0007628]; cellular response to hydroperoxide [GO:0071447]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron apoptotic process [GO:0051402]; response to oxidative stress [GO:0006979] GO:0005634; GO:0005730; GO:0005739; GO:0006979; GO:0007628; GO:0016491; GO:0043524; GO:0051402; GO:0071447; GO:1900408; GO:1902083; GO:1903204 oxidoreductase activity [GO:0016491] ENIQQVSQK 0.99342 -14.087 12.3067 0 0 14.6736 0 0 0 13.6703 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3125 0 0 0 11.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7489 12.5455 13.9561 0 13.3606 0 13.8666 13.7614 14.6672 13.9818 14.2996 15.3604 14.5944 13.4728 13.449 13.3912 0 13.181 13.3052 0 17.303 13.6139 13.0325 14.7504 12.603 15.0633 13.6546 0 0 12.4674 0 0 14.2253 12.8936 15.1715 14.6285 0 0 0 13.9735 12.995 14.3313 0 14.7761 14.5748 0 13.9556 13.5723 12.6465 0 15.1692 13.1686 14.2951 14.0321 15.2899 0 13.144 13.3485 13.1932 0 14.2107 12.6982 14.8336 14.2855 14.8495 15.3002 13.8597 12.7828 0 15.7526 0 12.8876 14.1605 0 13.513 13.5373 14.7573 0 15.0211 14.8758 12.9719 0 12.0861 0 14.0064 12.8 14.5333 12.941 12.8958 16.1238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7115 0 0 0 0 13.4243 0 Q8NE28 STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 (Serine/threonine kinase-like domain-containing protein 1) (Sugen kinase 071) STKLD1 C9orf96 SGK071 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0006468 ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] DVCASGLGLLWALLLDGIIVNK 0.99342 -14.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92831 KAT2B_HUMAN "Histone acetyltransferase KAT2B, EC 2.3.1.48 (Histone acetyltransferase PCAF, Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor, P/CAF) (Spermidine acetyltransferase KAT2B, EC 2.3.1.57)" KAT2B PCAF Homo sapiens (Human) "cell cycle [GO:0007049]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]" A band [GO:0031672]; actomyosin [GO:0042641]; ATAC complex [GO:0140672]; centrosome [GO:0005813]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; I band [GO:0031674]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124] "A band [GO:0031672]; actomyosin [GO:0042641]; ATAC complex [GO:0140672]; centrosome [GO:0005813]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; I band [GO:0031674]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cell cycle [GO:0007049]; cellular response to insulin stimulus [GO:0032869]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K9 acetylation [GO:0043970]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centriole replication [GO:0046600]; negative regulation of rRNA processing [GO:2000233]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of protein ADP-ribosylation [GO:0010835]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]" GO:0000123; GO:0000124; GO:0000776; GO:0000977; GO:0003682; GO:0003712; GO:0003713; GO:0004145; GO:0004402; GO:0004468; GO:0004861; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006094; GO:0006282; GO:0006338; GO:0006355; GO:0006473; GO:0007049; GO:0007507; GO:0008285; GO:0010484; GO:0010835; GO:0016407; GO:0016573; GO:0018076; GO:0018393; GO:0018394; GO:0019901; GO:0031672; GO:0031674; GO:0032869; GO:0032991; GO:0042641; GO:0042826; GO:0043484; GO:0043966; GO:0043970; GO:0045722; GO:0045815; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048511; GO:0051726; GO:0060173; GO:0061733; GO:0072686; GO:0140297; GO:0140672; GO:1902425; GO:2000233 "acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; diamine N-acetyltransferase activity [GO:0004145]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein kinase binding [GO:0019901]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]" DKLPLEK 0.99342 -5.0192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4891 0 0 0 0 0 0 0 12.3884 0 12.0637 0 0 0 0 0 0 0 10.9067 0 0 0 0 0 0 0 0 0 16.2122 0 0 0 0 0 0 0 0 14.1585 13.4148 0 0 0 0 0 0 12.5635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4212 0 0 0 0 0 0 0 0 0 0 0 12.3744 0 0 0 0 0 0 0 0 0 11.9524 0 0 0 0 0 0 0 10.2739 0 0 11.8144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HP4 OXND1_HUMAN "Oxidoreductase NAD-binding domain-containing protein 1, EC 1.-.-.-" OXNAD1 Homo sapiens (Human) oxidoreductase activity [GO:0016491] GO:0016491 oxidoreductase activity [GO:0016491] ITEKEIR 0.99342 -5.2265 0 0 0 0 0 0 0 0 12.3487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2099 0 0 0 0 0 0 13.4865 0 0 0 0 0 0 0 0 0 0 0 11.8638 0 0 11.0181 0 0 0 0 0 0 15.2077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4361 0 0 0 0 0 14.5317 0 0 13.4422 0 0 0 0 0 0 0 11.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZV8 PRD14_HUMAN "PR domain zinc finger protein 14, EC 2.1.1.- (PR domain-containing protein 14)" PRDM14 Homo sapiens (Human) cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0030718; GO:0031490; GO:0034972; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459 chromatin DNA binding [GO:0031490]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977] EDDGCSCSICGK 0.99342 -5.0284 0 0 0 0 0 0 0 0 0 11.3735 0 0 0 0 11.601 0 0 0 0 0 0 0 0 0 0 0 0 12.0621 0 0 0 0 11.01 0 0 0 0 0 11.4295 0 0 0 11.8624 0 0 11.1831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4662 0 0 0 0 0 0 0 0 Q9H8U3 ZFAN3_HUMAN AN1-type zinc finger protein 3 (Testis-expressed protein 27) ZFAND3 TEX27 Homo sapiens (Human) DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0003677; GO:0008270 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] CPCGFWGSSKTMNLCSK 0.99342 -7.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8831 0 0 14.3655 0 12.6742 0 0 0 0 0 0 0 0 14.053 15.1033 14.0449 0 0 0 0 0 12.8201 0 14.2658 0 0 0 0 12.3 0 0 0 14.1598 14.8768 0 13.0598 0 0 0 13.0951 13.6628 13.0716 13.2405 14.2791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2117 13.9865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY99 SNTG2_HUMAN "Gamma-2-syntrophin, G2SYN (Syntrophin-5, SYN5)" SNTG2 Homo sapiens (Human) central nervous system development [GO:0007417] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198]; central nervous system development [GO:0007417] GO:0003779; GO:0005198; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0007417; GO:0016010; GO:0016013; GO:0030165; GO:0042383; GO:0097109 actin binding [GO:0003779]; neuroligin family protein binding [GO:0097109]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198] AVSANIRELTLQNMK 0.99342 -15.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.655 0 0 0 0 12.7629 0 0 0 15.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5276 19.5388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.356 0 14.2835 0 0 0 14.1145 0 13.7264 0 0 0 13.7514 0 0 0 0 0 0 0 0 12.1847 0 14.1172 0 11.1974 0 0 0 0 0 12.5792 0 0 0 0 14.7734 13.9282 0 0 14.5625 0 0 0 0 0 0 0 13.6995 14.5445 0 15.0256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7914 0 0 0 0 0 0 14.022 0 0 0 15.1609 0 0 0 Q9P2N5 RBM27_HUMAN RNA-binding protein 27 (RNA-binding motif protein 27) RBM27 KIAA1311 Homo sapiens (Human) mRNA processing [GO:0006397] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397] GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0016607; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723] CRDYDER 0.99342 -16.508 0 0 0 11.4175 0 0 0 0 11.7607 0 11.9911 0 0 0 0 0 0 0 0 0 12.6394 0 0 0 0 0 0 0 0 0 0 11.1548 0 0 0 0 0 0 0 0 0 0 11.5408 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9156 0 13.5483 0 0 0 0 0 11.2961 0 12.0887 0 0 0 0 0 0 14.2128 12.9219 14.1479 0 0 0 0 14.2606 15.4415 14.2403 0 13.5622 0 0 11.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8638 0 0 0 0 0 0 0 0 0 0 0 0 11.7109 0 0 0 0 0 0 0 0 0 11.0376 0 0 0 12.2355 0 0 0 0 11.0116 0 0 0 0 0 11.1655 0 0 0 Q9UH99 SUN2_HUMAN "SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein, Rab5IP) (Sad1/unc-84 protein-like 2)" SUN2 FRIGG KIAA0668 RAB5IP UNC84B Homo sapiens (Human) centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; positive regulation of cell migration [GO:0030335] endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] endosome membrane [GO:0010008]; integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495]; centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; positive regulation of cell migration [GO:0030335] GO:0005521; GO:0005635; GO:0005639; GO:0006998; GO:0007052; GO:0007097; GO:0008017; GO:0010008; GO:0030335; GO:0031022; GO:0031965; GO:0034993; GO:0042802; GO:0043495; GO:0051321; GO:0051642; GO:0090292; GO:0140444 cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495] EAAASLSLTLQK 0.99342 -14.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4121 0 0 0 0 10.0584 0 0 0 0 0 0 0 13.4663 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98257 0 0 0 0 13.7461 13.8408 0 12.4829 0 0 13.2968 12.4848 0 0 0 11.3957 0 0 0 0 0 0 0 13.6692 0 0 0 14.8743 0 0 0 0 0 0 0 0 0 0 0 0 11.1756 0 0 13.4794 0 0 11.894 0 0 0 11.8588 0 0 0 0 0 0 13.9728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3299 0 0 0 0 0 0 0 0 0 0 10.8979 0 0 0 0 10.802 0 11.7948 12.3475 0 0 0 Q9UNX4 WDR3_HUMAN WD repeat-containing protein 3 WDR3 Homo sapiens (Human) maturation of SSU-rRNA [GO:0030490] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA [GO:0030490] GO:0003723; GO:0005654; GO:0005730; GO:0030490; GO:0030515; GO:0031965; GO:0032040; GO:0034388 RNA binding [GO:0003723]; snoRNA binding [GO:0030515] AAITTLK 0.99342 -6.9736 11.9012 0 0 0 11.6561 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7749 13.3225 14.4754 13.7174 0 14.5868 0 0 0 0 11.9566 0 0 0 10.7412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.256 0 0 0 13.099 0 0 0 0 0 14.0364 0 0 0 0 0 0 0 0 11.5534 0 0 0 0 0 0 13.4844 0 0 0 0 0 0 0 0 0 0 0 0 13.1334 0 0 0 0 0 0 0 0 0 0 14.3904 13.5337 11.6759 0 0 0 13.7346 0 0 0 0 0 0 0 0 0 0 0 0 13.418 0 0 12.9024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8339 0 0 15.2002 15.4776 0 0 0 0 Q9UQD0 SCN8A_HUMAN Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6) SCN8A MED Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; peripheral nervous system development [GO:0007422]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018] axon [GO:0030424]; axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; ATP binding [GO:0005524]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; myelination [GO:0042552]; nervous system development [GO:0007399]; neuronal action potential [GO:0019228]; peripheral nervous system development [GO:0007422]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0005524; GO:0005886; GO:0006814; GO:0007399; GO:0007422; GO:0016021; GO:0019228; GO:0030018; GO:0030054; GO:0030424; GO:0031410; GO:0033268; GO:0034765; GO:0035725; GO:0042552; GO:0043194; GO:0086010 ATP binding [GO:0005524]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] ALKTISVIPGLK 0.99342 -38.288 0 0 0 0 0 0 0 0 0 0 0 0 12.3733 0 0 0 0 12.7119 0 0 0 0 0 0 0 0 0 0 11.4073 11.6631 12.6464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.195 0 0 13.7592 0 12.4861 0 0 0 0 0 11.478 0 0 13.7861 0 0 0 0 0 0 0 15.047 0 0 0 0 0 0 0 13.5812 0 13.4083 13.5957 11.7617 0 0 0 0 0 0 0 0 10.1457 0 0 13.0872 0 0 0 12.3242 12.5323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0452 0 0 0 0 13.4831 13.1868 0 0 12.3845 13.0562 0 0 13.6156 0 0 0 12.8582 0 0 0 0 0 14.4577 0 0 0 0 0 0 0 14.6134 0 0 0 0 0 0 0 12.9957 14.1684 0 14.0979 12.1782 0 Q9Y266 NUDC_HUMAN Nuclear migration protein nudC (Nuclear distribution protein C homolog) NUDC Homo sapiens (Human) cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; protein folding [GO:0006457]; response to peptide hormone [GO:0043434] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle [GO:0005819] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; protein folding [GO:0006457]; response to peptide hormone [GO:0043434] GO:0005654; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005874; GO:0006457; GO:0007052; GO:0007080; GO:0007097; GO:0030496; GO:0043434; GO:0045296; GO:0051082; GO:0051301; GO:0072686 cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082] AARLAKEAK 0.99342 -17.38 0 0 0 0 0 0 0 0 0 0 0 0 12.3353 0 12.0706 14.4877 14.2863 0 14.6609 0 0 0 0 0 0 0 0 13.8486 0 0 0 0 0 0 0 0 0 0 0 12.3056 11.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4951 0 13.6505 0 0 0 0 0 13.7898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0258 11.8012 0 0 0 0 0 0 0 0 0 13.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9345 0 0 12.1488 0 0 0 0 0 0 0 0 0 11.4644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43298 ZBT43_HUMAN Zinc finger and BTB domain-containing protein 43 (Zinc finger and BTB domain-containing protein 22B) (Zinc finger protein 297B) (ZnF-x) ZBTB43 KIAA0414 ZBTB22B ZNF297B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase III general transcription initiation factor binding [GO:0001025]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001025; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase III general transcription initiation factor binding [GO:0001025]; sequence-specific double-stranded DNA binding [GO:1990837]" PSIMAHK 0.99343 -9.2452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95340 PAPS2_HUMAN "Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2, PAPS synthase 2, PAPSS 2 (Sulfurylase kinase 2, SK 2, SK2) [Includes: Sulfate adenylyltransferase, EC 2.7.7.4 (ATP-sulfurylase) (Sulfate adenylate transferase, SAT); Adenylyl-sulfate kinase, EC 2.7.1.25 (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase) ]" PAPSS2 ATPSK2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; blood coagulation [GO:0007596]; bone development [GO:0060348]; hormone metabolic process [GO:0042445]; phosphorylation [GO:0016310]; sulfate assimilation [GO:0000103] cytosol [GO:0005829] cytosol [GO:0005829]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; blood coagulation [GO:0007596]; bone development [GO:0060348]; hormone metabolic process [GO:0042445]; phosphorylation [GO:0016310]; sulfate assimilation [GO:0000103] GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0005829; GO:0007596; GO:0016310; GO:0016779; GO:0042445; GO:0050428; GO:0060348 adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781] EERCSRVWGTTCTK 0.99343 -5.2373 0 0 12.2182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7988 0 0 0 0 0 0 0 0 0 0 0 0 16.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95544 NADK_HUMAN "NAD kinase, EC 2.7.1.23 (Poly(P)/ATP NAD kinase)" NADK Homo sapiens (Human) ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; ATP metabolic process [GO:0046034]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310] GO:0003951; GO:0005524; GO:0005829; GO:0006741; GO:0016310; GO:0019674; GO:0046034; GO:0046872 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951] EMEQEKMTMNK 0.99343 -7.9425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9012 0 12.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7882 10.4958 0 0 0 10.8427 0 0 0 10.0297 0 16.8162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1387 0 12.5047 0 0 0 0 0 11.9288 0 0 12.8213 0 13.7159 0 0 0 0 0 0 11.0943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6473 0 0 14.1108 0 0 0 0 0 0 0 12.7337 14.0732 0 13.5481 13.9485 0 0 0 14.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8634 10.9568 0 0 0 0 0 0 0 0 13.9028 0 0 0 0 0 P0DP91 ERPG3_HUMAN Chimeric ERCC6-PGBD3 protein (Chimeric CSB-PGBD3 protein) ERCC6 Homo sapiens (Human) positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141] nuclear body [GO:0016604]; nucleoplasm [GO:0005654] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; sequence-specific DNA binding [GO:0043565]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141] GO:0002230; GO:0005654; GO:0010628; GO:0016604; GO:0033141; GO:0043565; GO:0045739 sequence-specific DNA binding [GO:0043565] CSVEYHTE 0.99343 -7.9486 0 0 0 0 10.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5703 0 0 0 0 0 0 14.5605 11.0459 0 0 0 0 0 0 0 0 0 0 0 0 11.4438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16403 H12_HUMAN Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1) H1-2 H1F2 HIST1H1C Homo sapiens (Human) chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334] euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634] euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334] GO:0000122; GO:0000786; GO:0000791; GO:0003690; GO:0003723; GO:0005634; GO:0006334; GO:0030261; GO:0030527; GO:0031490; GO:0031492; GO:0045910; GO:0080182; GO:0098532 chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] AAKPKVVK 0.99343 -38.417 11.6435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.383 0 0 0 0 14.8865 0 13.0658 0 0 12.7918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4176 13.6682 13.7972 14.2213 0 13.407 13.2644 0 13.3526 15.404 13.4082 14.8898 0 0 13.2403 14.2232 0 0 0 0 0 0 0 0 0 0 13.7092 0 13.1258 14.1688 0 0 0 13.9245 0 0 0 0 0 0 13.6488 0 0 0 13.4393 0 14.9051 0 0 13.4136 0 14.5425 0 14.2283 0 14.6787 0 0 0 13.3613 14.3679 13.6497 0 0 0 0 0 12.8559 0 0 13.8285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2894 12.867 0 0 12.737 0 0 0 0 12.645 12.315 0 0 0 P41218 MNDA_HUMAN Myeloid cell nuclear differentiation antigen MNDA Homo sapiens (Human) activation of innate immune response [GO:0002218]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interferon-beta [GO:0035458]; negative regulation of B cell proliferation [GO:0030889]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interleukin-1 beta production [GO:0032731] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; double-stranded DNA binding [GO:0003690]; activation of innate immune response [GO:0002218]; B cell receptor signaling pathway [GO:0050853]; cellular defense response [GO:0006968]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interferon-beta [GO:0035458]; negative regulation of B cell proliferation [GO:0030889]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interleukin-1 beta production [GO:0032731] GO:0002218; GO:0003690; GO:0005576; GO:0005654; GO:0005730; GO:0005829; GO:0006968; GO:0006974; GO:0030889; GO:0032731; GO:0035458; GO:0035578; GO:0043065; GO:0043231; GO:0050853; GO:0070062; GO:1904813 double-stranded DNA binding [GO:0003690] EGPMNVN 0.99343 -5.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.768 0 0 0 15.551 12.4356 12.0558 12.4939 0 0 0 12.9128 0 0 0 0 0 0 0 0 0 0 12.9777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48745 CCN3_HUMAN "CCN family member 3 (Cellular communication network factor 3) (Insulin-like growth factor-binding protein 9, IBP-9, IGF-binding protein 9, IGFBP-9) (Nephro blastoma-overexpressed gene protein homolog) (Protein NOV homolog, NovH)" CCN3 IGFBP9 NOV NOVH Homo sapiens (Human) angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell chemotaxis [GO:0035767]; endothelial cell-cell adhesion [GO:0071603]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342] axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025] axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; Notch binding [GO:0005112]; angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell chemotaxis [GO:0035767]; endothelial cell-cell adhesion [GO:0071603]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342] GO:0001525; GO:0002062; GO:0005112; GO:0005178; GO:0005576; GO:0005737; GO:0005921; GO:0007155; GO:0007165; GO:0008083; GO:0008201; GO:0010468; GO:0010761; GO:0010832; GO:0014909; GO:0030308; GO:0030424; GO:0030425; GO:0031012; GO:0033627; GO:0035767; GO:0043025; GO:0043231; GO:0044342; GO:0045747; GO:0046676; GO:0048659; GO:0050728; GO:0060326; GO:0060392; GO:0060548; GO:0061484; GO:0062023; GO:0071603; GO:0090027; GO:1901223; GO:1902731; GO:1904057; GO:1990523 growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; Notch binding [GO:0005112] AIHLQFK 0.99343 -7.9492 0 0 0 0 11.8558 0 11.7495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1482 12.6062 12.9938 0 0 0 0 0 0 0 0 0 14.7461 0 12.65 0 0 0 0 0 0 13.4277 12.8427 0 13.6572 0 0 17.0603 0 0 0 0 0 0 0 0 0 0 13.2301 0 13.731 0 0 0 0 P60852 ZP1_HUMAN "Zona pellucida sperm-binding protein 1 (Zona pellucida glycoprotein 1, Zp-1) [Cleaved into: Processed zona pellucida sperm-binding protein 1 ]" ZP1 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acrosin binding [GO:0032190]; structural constituent of egg coat [GO:0035804]; binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468] GO:0005576; GO:0005886; GO:0007339; GO:0016021; GO:0032190; GO:0035804; GO:0035805; GO:0060468; GO:0062023 acrosin binding [GO:0032190]; structural constituent of egg coat [GO:0035804] AGGSATTWGYPVALLLLVATLGLGR 0.99343 -5.2565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6047 0 0 0 0 0 0 12.6935 0 0 0 0 0 0 0 13.4315 13.7747 0 0 0 0 0 10.3672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.503 0 0 0 Q13075 BIRC1_HUMAN Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein) NAIP BIRC1 Homo sapiens (Human) defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nervous system development [GO:0007399]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of cellular protein metabolic process [GO:0032268] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; inflammasome complex [GO:0061702]; IPAF inflammasome complex [GO:0072557]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nervous system development [GO:0007399]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of cellular protein metabolic process [GO:0032268] GO:0002221; GO:0005524; GO:0005737; GO:0006954; GO:0007399; GO:0010804; GO:0016045; GO:0016323; GO:0032268; GO:0032731; GO:0042742; GO:0042981; GO:0043027; GO:0043066; GO:0043154; GO:0043524; GO:0045087; GO:0046330; GO:0046456; GO:0046872; GO:0050729; GO:0061702; GO:0070269; GO:0072557; GO:0120283 ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283] ATAEILK 0.99343 -16.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.554 0 0 0 0 0 0 12.7269 13.3945 12.4121 0 13.2994 0 0 10.5171 0 12.4738 0 0 0 0 0 0 0 12.9541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1944 0 14.3823 0 13.0995 12.0908 13.2897 0 13.9302 12.7782 0 0 0 0 0 0 13.8013 0 0 0 13.5417 0 0 0 0 0 13.3659 11.0353 0 12.1904 12.1036 13.4829 11.2983 0 0 0 10.3464 0 13.0595 0 0 12.9863 0 12.867 14.3252 11.3229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q569K4 Z385B_HUMAN Zinc finger protein 385B (Zinc finger protein 533) ZNF385B ZNF533 Homo sapiens (Human) intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332] nucleus [GO:0005634] nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332] GO:0002039; GO:0003676; GO:0005634; GO:0008270; GO:0072332 nucleic acid binding [GO:0003676]; p53 binding [GO:0002039]; zinc ion binding [GO:0008270] LAFQKDMMK 0.99343 -7.9524 0 0 0 0 0 0 0 0 0 9.54257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4507 0 0 0 0 0 0 0 0 0 12.4101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6719 12.9577 0 0 0 0 0 15.5246 0 0 0 13.9959 15.5925 0 15.6102 15.8337 15.7384 0 0 0 0 0 0 0 0 0 13.3876 13.4574 0 11.9084 0 0 0 12.7468 0 0 0 0 0 13.7447 0 0 0 0 0 11.0282 0 14.1068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5335 0 0 0 0 15.6908 0 0 12.8403 12.8081 0 0 0 0 0 0 Q6ZSI9 CAN12_HUMAN "Calpain-12, EC 3.4.22.- (Calcium-activated neutral proteinase 12, CANP 12)" CAPN12 Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508] GO:0004198; GO:0005509; GO:0005737; GO:0006508 calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198] AHTSTPR 0.99343 -29.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94777 0 0 0 0 0 13.4058 9.68006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2472 0 0 0 0 12.3644 0 12.5261 0 0 0 0 0 0 0 0 12.3825 12.7904 0 0 11.9797 0 0 0 0 0 13.4079 14.6981 0 0 0 0 0 0 0 0 12.1139 0 0 14.057 0 0 12.7032 0 11.2277 11.5639 0 0 0 13.7773 0 0 0 0 0 0 0 12.7536 0 13.0385 13.4248 0 0 0 0 13.8372 0 0 0 0 0 0 0 0 0 0 0 12.2386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q70CQ4 UBP31_HUMAN "Ubiquitin carboxyl-terminal hydrolase 31, EC 3.4.19.12 (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31)" USP31 KIAA1203 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] nucleus [GO:0005634] nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004843; GO:0005634; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843] AGGSSVK 0.99343 -16.559 0 0 0 0 0 0 0 0 0 0 0 0 11.1822 0 0 0 0 0 0 12.3499 0 0 0 0 0 14.0627 0 10.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4717 14.5702 14.6573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7582 13.4762 0 0 0 13.7991 0 13.2668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0181 0 13.7459 0 0 0 0 0 15.0178 0 0 14.1273 0 0 0 0 13.9235 0 0 0 0 0 0 0 0 0 14.2037 0 0 0 0 0 13.8553 0 0 Q8IWE5 PKHM2_HUMAN "Pleckstrin homology domain-containing family M member 2, PH domain-containing family M member 2 (Salmonella-induced filaments A and kinesin-interacting protein, SifA and kinesin-interacting protein)" PLEKHM2 KIAA0842 SKIP Homo sapiens (Human) Golgi organization [GO:0007030]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880] endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765] endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; kinesin binding [GO:0019894]; Golgi organization [GO:0007030]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of membrane tubulation [GO:1903527]; regulation of protein localization [GO:0032880] GO:0005765; GO:0007030; GO:0010008; GO:0019894; GO:0032418; GO:0032880; GO:0042267; GO:1903527 kinesin binding [GO:0019894] EGPVSEPEPGTQEVLCQLK 0.99343 -7.9446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6674 0 0 10.8416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYR0 CF206_HUMAN Cilia- and flagella-associated protein 206 CFAP206 C6orf165 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; radial spoke [GO:0001534] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288] GO:0001534; GO:0003341; GO:0003356; GO:0005930; GO:0007288; GO:0031514; GO:0035082; GO:0036064; GO:1901317 AANDPLMRAELQPYMLKEALYNIR 0.99343 -7.9515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8403 0 0 0 0 0 0 0 0 0 0 15.3741 0 0 0 0 0 0 0 0 0 0 0 0 0 14.402 0 0 0 0 0 0 0 11.1939 0 0 0 0 0 0 0 0 0 13.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4682 0 0 0 0 0 0 0 0 0 0 0 0 Q8N961 ABTB2_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein 2 ABTB2 Homo sapiens (Human) cellular response to toxic substance [GO:0097237] protein heterodimerization activity [GO:0046982]; cellular response to toxic substance [GO:0097237] GO:0046982; GO:0097237 protein heterodimerization activity [GO:0046982] ALIRVAREAQR 0.99343 -5.2412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.984 13.4366 0 0 0 0 0 0 0 0 0 0 0 13.6533 0 0 0 0 0 0 0 0 0 0 0 13.2268 0 0 0 0 0 0 14.4414 13.7342 0 0 0 0 14.0389 0 0 0 0 14.5652 0 0 0 0 0 0 0 0 0 13.782 0 0 0 0 0 0 0 14.1701 0 0 0 14.8205 0 0 0 0 16.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8123 0 Q8NBZ0 IN80E_HUMAN INO80 complex subunit E (Coiled-coil domain-containing protein 95) INO80E CCDC95 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" GO:0000723; GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507 LLKVSRDK 0.99343 -6.5402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5032 0 0 0 0 0 0 Q8TAM6 ERMIN_HUMAN "Ermin (Juxtanodin, JN)" ERMN KIAA1189 Homo sapiens (Human) actin filament organization [GO:0007015]; morphogenesis of a branching structure [GO:0001763]; regulation of cell projection organization [GO:0031344]; regulation of cell shape [GO:0008360] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glial cell projection [GO:0097386]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; glial cell projection [GO:0097386]; internode region of axon [GO:0033269]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; morphogenesis of a branching structure [GO:0001763]; regulation of cell projection organization [GO:0031344]; regulation of cell shape [GO:0008360] GO:0001763; GO:0005737; GO:0005856; GO:0005938; GO:0007015; GO:0008360; GO:0030175; GO:0031344; GO:0033269; GO:0033270; GO:0043025; GO:0043209; GO:0051015; GO:0070062; GO:0097386 actin filament binding [GO:0051015] EGHQWEK 0.99343 -9.2495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0037 0 0 0 0 0 0 0 0 0 0 0 0 12.1267 0 0 0 0 0 0 0 0 12.0417 0 13.8991 0 0 0 0 0 0 0 0 11.6195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7626 0 0 0 0 0 0 11.886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AY4 TTC28_HUMAN "Tetratricopeptide repeat protein 28, TPR repeat protein 28 (TPR repeat-containing big gene cloned at Keio)" TTC28 KIAA1043 TPRBK Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346] GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301 kinase binding [GO:0019900] AHGNLGSAFFSK 0.99343 -27.9 0 0 0 0 0 0 0 0 11.9701 15.2694 0 0 0 0 0 0 0 0 0 0 0 12.5519 0 0 0 0 0 0 0 0 0 0 0 11.4298 0 0 0 0 0 0 0 0 9.24024 0 0 0 0 0 0 0 0 0 0 12.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4707 0 0 0 11.4281 0 0 0 0 0 0 12.6654 0 0 0 0 0 12.6654 0 0 14.2114 0 0 0 13.992 0 0 0 14.8635 0 0 0 0 11.7658 13.6954 12.3954 0 0 0 0 0 0 0 13.2939 0 14.2856 11.5709 0 13.9345 16.3709 0 11.8918 0 0 0 0 0 0 0 0 0 13.2986 0 0 0 0 0 0 0 0 0 13.1365 0 0 0 0 0 0 0 0 0 12.4148 0 0 0 0 0 12.0363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3834 0 0 0 0 0 0 0 Q96BW5 PTER_HUMAN "Phosphotriesterase-related protein, EC 3.1.-.- (Parathion hydrolase-related protein, hPHRP)" PTER Homo sapiens (Human) catabolic process [GO:0009056]; epithelial cell differentiation [GO:0030855] extracellular exosome [GO:0070062] "extracellular exosome [GO:0070062]; hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056]; epithelial cell differentiation [GO:0030855]" GO:0008270; GO:0009056; GO:0016788; GO:0030855; GO:0070062 "hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]" ILIENPK 0.99343 -9.2604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0833 0 12.5597 0 0 0 0 0 0 0 0 0 0 0 0 0 11.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BT17 MTG1_HUMAN Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1) MTG1 GTPBP7 Homo sapiens (Human) mitochondrial translation [GO:0032543]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial translation [GO:0032543]; regulation of mitochondrial translation [GO:0070129]; regulation of respiratory system process [GO:0044065]; translation [GO:0006412] GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005761; GO:0006412; GO:0032543; GO:0044065; GO:0070129 GTP binding [GO:0005525]; GTPase activity [GO:0003924] IPLSGRNPLFQETLGLKPHLLVLNK 0.99343 -9.2472 0 0 12.5472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4099 13.1774 0 12.8415 13.4846 16.7737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5681 14.8394 0 14.6948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2939 0 0 0 13.9439 0 0 13.3002 0 0 0 13.7127 0 0 14.4996 0 13.9954 0 0 0 0 0 12.9108 13.8257 0 0 0 14.5471 0 13.0286 13.5013 13.429 0 0 0 11.6802 0 13.7888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCI5 MAGE1_HUMAN "Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein, DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen)" MAGEE1 HCA1 KIAA1587 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] dendrite [GO:0030425]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005886; GO:0030425; GO:0045211; GO:0048471 ALRYVARIHR 0.99343 -14.223 0 0 0 0 0 0 0 0 0 14.901 0 0 0 14.3161 14.5445 0 0 0 0 0 0 0 0 0 0 0 0 14.4913 0 0 0 11.0541 0 0 0 15.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5258 0 11.8079 0 0 0 0 0 15.1984 0 0 0 0 0 0 0 0 0 12.9337 15.8573 0 0 16.4043 14.7406 0 17.8622 0 0 14.6328 0 0 0 0 0 17.8336 0 0 13.8506 10.5187 0 10.4271 0 14.4602 15.3854 0 0 0 0 0 0 0 0 0 0 15.3058 0 0 0 17.4459 0 10.8323 11.67 0 0 0 0 0 11.0079 0 0 0 0 0 14.6866 0 0 0 0 0 0 0 0 15.0725 0 0 15.5305 0 0 13.9776 0 0 13.9472 0 0 0 0 0 13.2503 0 0 0 0 0 0 13.0146 0 13.5245 0 0 0 0 0 0 0 Q9NRW7 VPS45_HUMAN "Vacuolar protein sorting-associated protein 45, h-VPS45, hlVps45" VPS45 VPS45A VPS45B Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021] endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005794; GO:0006886; GO:0008021; GO:0010008; GO:0016021; GO:0016192 DAVAITKQFLKGLK 0.99343 -9.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4298 0 0 0 0 0 0 0 0 0 0 0 13.1188 0 0 0 0 0 14.0382 0 0 0 0 13.4771 14.3789 0 0 0 0 0 12.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5735 0 0 0 13.0872 12.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2Y5 UVRAG_HUMAN UV radiation resistance-associated gene protein (p63) UVRAG Homo sapiens (Human) "autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; multivesicular body sorting pathway [GO:0071985]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of autophagosome maturation [GO:1901098]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]" "autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]" "autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosome [GO:0005764]; lytic vacuole [GO:0000323]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; multivesicular body sorting pathway [GO:0071985]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of autophagosome maturation [GO:1901098]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of protein serine/threonine kinase activity [GO:0071900]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; viral entry into host cell [GO:0046718]" GO:0000149; GO:0000323; GO:0000421; GO:0000775; GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006468; GO:0006890; GO:0006914; GO:0007051; GO:0007059; GO:0007098; GO:0010506; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0035032; GO:0035493; GO:0036092; GO:0045335; GO:0046718; GO:0051684; GO:0071900; GO:0071985; GO:0097352; GO:0097680; GO:1901098 SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149] EFPLYPK 0.99343 -29.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4987 14.467 0 14.4574 0 0 0 12.1449 0 0 0 0 0 12.2452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGK8 SRGEF_HUMAN "Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor, DelGEF) (Guanine nucleotide exchange factor-related protein)" SERGEF DELGEF GNEFR Homo sapiens (Human) negative regulation of protein secretion [GO:0050709]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of protein secretion [GO:0050709]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0007165; GO:0016567; GO:0050709; GO:0061630 guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin protein ligase activity [GO:0061630] ERQSETSTQSQSDWSR 0.99343 -9.2573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5621 13.576 0 0 0 0 0 0 0 0 0 0 0 14.8426 0 0 0 0 14.8083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8468 13.3129 12.9872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8432 0 0 0 0 0 12.7006 0 0 0 0 0 0 0 0 0 0 0 10.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6A2 CP46A_HUMAN "Cholesterol 24-hydroxylase, CH24H, EC 1.14.14.25 (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1)" CYP46A1 CYP46 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] anchoring junction [GO:0070161]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; postsynapse [GO:0098794]; presynapse [GO:0098793] anchoring junction [GO:0070161]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; postsynapse [GO:0098794]; presynapse [GO:0098793]; cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805] GO:0005506; GO:0005783; GO:0005789; GO:0006699; GO:0006707; GO:0006805; GO:0007399; GO:0008395; GO:0016021; GO:0016125; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0062184; GO:0070161; GO:0098793; GO:0098794; GO:1900271; GO:1903044 cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184] ESLRLYPPAWGTFR 0.99343 -9.2552 0 0 0 0 0 0 0 12.0639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6815 0 14.1046 16.6964 0 0 12.9697 0 0 0 0 0 10.8117 10.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4122 0 0 0 0 0 0 0 0 15.7744 10.7225 0 0 0 0 0 0 0 0 0 0 0 16.2987 0 0 0 0 13.3347 0 0 0 0 0 0 0 12.8238 0 0 0 0 0 0 12.6264 0 0 16.3808 0 0 0 0 0 0 0 0 0 0 12.6395 0 16.6001 0 14.0052 0 0 0 0 0 0 12.8407 0 0 0 0 0 0 0 0 0 0 A6NCI4 VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A VWA3A Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AVEVDFK 0.99344 -7.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1968 0 10.4357 10.373 0 0 0 0 11.2322 13.1365 12.2641 0 11.672 12.0326 0 0 0 0 0 12.4769 0 0 16.1858 0 0 0 0 13.3608 13.9545 0 0 0 0 14.1409 0 0 0 14.9859 15.0332 0 0 12.9818 0 0 13.5647 0 0 13.4457 0 0 0 0 0 13.7097 0 0 14.7383 0 13.847 0 0 10.9887 11.7115 13.6764 14.9448 0 0 0 15.3147 14.9993 11.6688 12.6375 12.8628 13.4066 14.9725 12.8061 0 0 13.0878 12.8636 13.4295 0 0 0 12.505 0 13.8127 0 0 16.0838 0 0 0 0 0 0 0 0 0 12.5267 0 11.493 0 0 0 13.1221 13.1124 13.3962 13.7878 11.9256 0 0 0 0 A8MY62 BLML_HUMAN Putative beta-lactamase-like 1 LACTBL1 Homo sapiens (Human) IFPVLMLYR 0.99344 -13.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.221 0 0 12.1828 0 0 0 0 0 0 0 13.3168 13.4769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1986 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6092 14.6466 14.6593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JR72 KBTBD_HUMAN Kelch repeat and BTB domain-containing protein 13 KBTBD13 Homo sapiens (Human) actin filament organization [GO:0007015]; protein ubiquitination [GO:0016567]; regulation of the force of skeletal muscle contraction [GO:0014728]; relaxation of skeletal muscle [GO:0090076] cytosol [GO:0005829] cytosol [GO:0005829]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; protein ubiquitination [GO:0016567]; regulation of the force of skeletal muscle contraction [GO:0014728]; relaxation of skeletal muscle [GO:0090076] GO:0005829; GO:0007015; GO:0014728; GO:0016567; GO:0051015; GO:0090076 actin filament binding [GO:0051015] AYVAALR 0.99344 -6.5752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2221 0 0 0 0 0 0 0 0 0 12.1151 0 0 0 0 0 0 0 0 0 0 12.7768 0 0 O60282 KIF5C_HUMAN Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2) KIF5C KIAA0531 NKHC2 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; motor neuron axon guidance [GO:0008045]; mRNA transport [GO:0051028]; organelle organization [GO:0006996]; synaptic vesicle transport [GO:0048489] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; dendrite cytoplasm [GO:0032839]; distal axon [GO:0150034]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025] axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; dendrite cytoplasm [GO:0032839]; distal axon [GO:0150034]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; motor neuron axon guidance [GO:0008045]; mRNA transport [GO:0051028]; organelle organization [GO:0006996]; synaptic vesicle transport [GO:0048489] GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0006996; GO:0007018; GO:0007411; GO:0008017; GO:0008045; GO:0008574; GO:0016887; GO:0030705; GO:0032839; GO:0035253; GO:0043025; GO:0044295; GO:0048489; GO:0051028; GO:0098971; GO:0099641; GO:0150034; GO:1904115 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] DEIEEKQK 0.99344 -5.0647 0 0 0 0 0 0 0 0 0 0 12.404 0 0 0 0 0 0 0 0 0 15.2228 0 0 15.5474 0 0 0 0 11.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0318 0 0 0 0 18.5362 18.4955 19.134 15.8881 18.5679 19.2613 15.9224 18.7617 18.7907 18.8704 19.3932 19.2979 18.8429 19.1335 19.149 17.6502 0 0 17.8589 17.4524 14.2849 0 14.5222 0 15.3409 0 0 0 14.9381 0 0 0 13.6405 0 19.4152 0 0 0 0 18.9404 0 0 0 0 0 17.2735 0 0 0 13.3559 0 13.2928 17.2817 0 17.1687 0 0 0 17.239 0 17.3014 17.2358 18.4782 18.966 17.328 17.1482 17.1922 18.2365 0 14.1686 0 19.087 0 14.3943 12.5707 0 0 0 0 0 14.5936 0 0 0 18.8159 0 17.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0648 0 13.1191 0 0 14.4939 0 0 0 0 0 O95674 CDS2_HUMAN "Phosphatidate cytidylyltransferase 2, EC 2.7.7.41 (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2, CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2)" CDS2 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655] GO:0004605; GO:0005743; GO:0005783; GO:0005789; GO:0006655; GO:0016020; GO:0016021; GO:0016024; GO:0140042 phosphatidate cytidylyltransferase activity [GO:0004605] ALSNLSSR 0.99344 -6.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19099 C11B2_HUMAN "Cytochrome P450 11B2, mitochondrial (Aldosterone synthase, ALDOS) (Aldosterone-synthesizing enzyme) (CYPXIB2) (Corticosterone 18-monooxygenase, CYP11B2, EC 1.14.15.5) (Cytochrome P-450Aldo) (Cytochrome P-450C18) (Steroid 11-beta-hydroxylase, CYP11B2, EC 1.14.15.4) (Steroid 18-hydroxylase)" CYP11B2 Homo sapiens (Human) aldosterone biosynthetic process [GO:0032342]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to hormone stimulus [GO:0032870]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to potassium ion [GO:0035865]; cholesterol metabolic process [GO:0008203]; cortisol biosynthetic process [GO:0034651]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; mineralocorticoid biosynthetic process [GO:0006705]; potassium ion homeostasis [GO:0055075]; regulation of blood volume by renal aldosterone [GO:0002017]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; sterol metabolic process [GO:0016125] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507]; steroid hydroxylase activity [GO:0008395]; aldosterone biosynthetic process [GO:0032342]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to hormone stimulus [GO:0032870]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to potassium ion [GO:0035865]; cholesterol metabolic process [GO:0008203]; cortisol biosynthetic process [GO:0034651]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; mineralocorticoid biosynthetic process [GO:0006705]; potassium ion homeostasis [GO:0055075]; regulation of blood volume by renal aldosterone [GO:0002017]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; sterol metabolic process [GO:0016125] GO:0002017; GO:0003091; GO:0004507; GO:0005506; GO:0005739; GO:0005743; GO:0006700; GO:0006704; GO:0006705; GO:0008203; GO:0008395; GO:0016125; GO:0020037; GO:0032342; GO:0032870; GO:0034650; GO:0034651; GO:0035865; GO:0047783; GO:0055075; GO:0055078; GO:0071375 corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507]; steroid hydroxylase activity [GO:0008395] ARALGTR 0.99344 -14.233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9919 12.4776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4379 0 0 0 0 0 0 0 0 0 0 0 14.8152 0 0 0 0 13.0326 0 0 0 0 0 0 0 0 15.6025 0 0 0 12.4177 0 0 0 0 0 0 0 18.4216 0 0 0 0 0 0 12.7058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2283 0 P49591 SYSC_HUMAN "Serine--tRNA ligase, cytoplasmic, EC 6.1.1.11 (Seryl-tRNA synthetase, SerRS) (Seryl-tRNA(Ser/Sec) synthetase)" SARS1 SARS SERS Homo sapiens (Human) negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; translation [GO:0006412]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]; translation [GO:0006412]; tRNA processing [GO:0008033] GO:0000049; GO:0000122; GO:0000978; GO:0003723; GO:0004828; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006434; GO:0008033; GO:0016525; GO:0019899; GO:0042803; GO:0070062; GO:0097056; GO:1904046 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049] ADSEWRR 0.99344 -28.137 0 0 0 0 0 0 0 0 0 0 0 11.2913 0 0 0 0 0 0 11.8236 0 0 0 0 0 0 10.9432 0 0 0 0 0 12.4145 0 11.164 0 0 10.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2417 0 0 0 11.1723 0 0 0 0 0 0 0 0 0 14.2956 12.4797 0 0 13.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1988 0 0 12.1184 0 0 0 0 0 12.0199 0 0 0 0 0 0 0 0 0 0 13.7657 0 0 0 12.1311 0 0 0 0 12.9909 0 0 0 0 0 11.116 0 0 0 12.4827 11.9506 11.9142 0 12.999 0 0 0 13.8865 0 0 0 0 0 13.4764 0 0 0 0 0 0 0 0 0 13.501 10.8351 0 13.9919 10.8264 0 0 0 0 0 10.849 0 0 0 0 0 0 0 10.1625 0 0 0 P55107 GDF10_HUMAN "Growth/differentiation factor 10, GDF-10 (Bone morphogenetic protein 3B, BMP-3B) (Bone-inducing protein, BIP)" GDF10 BMP3B Homo sapiens (Human) cerebellum development [GO:0021549]; fat cell differentiation [GO:0045444]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast differentiation [GO:0001649]; ovulation cycle [GO:0042698]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of ossification [GO:0030278]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; cerebellum development [GO:0021549]; fat cell differentiation [GO:0045444]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast differentiation [GO:0001649]; ovulation cycle [GO:0042698]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of ossification [GO:0030278]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001501; GO:0001649; GO:0005125; GO:0005615; GO:0007179; GO:0008083; GO:0010862; GO:0021549; GO:0030278; GO:0042698; GO:0045444; GO:0045668; GO:0045669; GO:0060395; GO:0062023 cytokine activity [GO:0005125]; growth factor activity [GO:0008083] AHVPARTSPGPGPQLLLLLLPLFLLLLR 0.99344 -13.479 0 0 0 0 0 0 0 0 13.4917 0 13.6829 0 0 0 0 13.8734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0051 0 0 0 0 0 0 10.0228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7048 0 12.4654 0 0 0 0 0 13.4807 0 0 15.0896 15.6411 15.9669 14.1991 15.3682 14.8021 11.7305 15.4496 13.5874 14.4764 14.1654 0 14.4945 0 14.5697 0 0 12.6141 13.8418 12.3543 0 13.9843 13.7144 0 15.4788 0 0 12.0285 0 15.0693 14.8615 0 12.4623 0 0 0 14.164 0 0 0 0 14.5121 13.6984 0 0 14.5822 0 0 13.4842 0 13.461 14.0327 13.5557 12.3082 14.0046 0 0 0 0 13.5695 0 0 14.7575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2701 0 0 0 12.0099 15.3967 0 0 0 0 12.4765 13.5071 0 0 0 12.6097 0 0 0 10.2689 P56945 BCAR1_HUMAN Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas) BCAR1 CAS CASS1 CRKAS Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0001558; GO:0001726; GO:0005737; GO:0005829; GO:0005925; GO:0007015; GO:0007155; GO:0007169; GO:0007173; GO:0007186; GO:0007229; GO:0008286; GO:0010595; GO:0015629; GO:0016020; GO:0016477; GO:0017124; GO:0019901; GO:0030027; GO:0030335; GO:0030424; GO:0035729; GO:0042981; GO:0048008; GO:0048010; GO:0048011; GO:0048012; GO:0050851; GO:0050852; GO:0050853; GO:0051301; GO:0060326; GO:0086100; GO:0090527 protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] FTSQDSPDGQYENSEGGWMEDYDYVHLQGKEEFEK 0.99344 -16.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7036 11.3392 0 0 0 14.125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9361 0 0 0 0 15.8092 0 11.1533 0 0 0 11.1942 0 0 0 0 0 0 16.9153 0 0 0 0 13.371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13895 BYST_HUMAN Bystin BYSL ENP1 Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; stem cell proliferation [GO:0072089]; trophectodermal cell differentiation [GO:0001829]" "apical part of cell [GO:0045177]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]" "apical part of cell [GO:0045177]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of protein localization to nucleolus [GO:1904749]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; stem cell proliferation [GO:0072089]; trophectodermal cell differentiation [GO:0001829]" GO:0000462; GO:0001829; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0016020; GO:0030515; GO:0030688; GO:0042254; GO:0043231; GO:0045177; GO:0072089; GO:1904749 RNA binding [GO:0003723]; snoRNA binding [GO:0030515] DVEDVPITVE 0.99344 -16.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5662 0 0 0 0 0 0 0 16.4051 0 0 0 0 0 12.0112 0 0 0 0 0 0 0 0 14.3712 13.0066 0 13.4656 0 0 0 0 0 13.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0952 0 0 Q15464 SHB_HUMAN SH2 domain-containing adapter protein B SHB Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of oocyte maturation [GO:1900194]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphotyrosine residue binding [GO:0001784]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of oocyte maturation [GO:1900194]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] GO:0001525; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006469; GO:0006915; GO:0007165; GO:0030154; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0050852; GO:0071425; GO:1900194 phosphotyrosine residue binding [GO:0001784] AFSASSASGAAGCCCASSGAGAAASSSSSSGSPHLYR 0.99344 -7.7758 0 0 0 11.2557 0 0 0 0 0 0 0 11.5428 0 0 0 0 0 0 0 11.0247 0 9.84674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1163 0 0 0 0 0 12.5012 12.1884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5837 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5733 0 0 12.5817 0 0 0 0 0 0 0 0 0 0 0 11.8225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9473 13.6178 0 0 0 12.2147 0 13.563 0 14.2435 12.3995 0 12.3571 0 0 0 0 13.1484 0 0 0 11.4514 0 0 0 0 0 13.2942 13.9757 0 0 0 0 13.8282 0 13.8666 0 0 12.9716 0 0 13.3768 0 0 0 0 0 13.767 0 11.1515 11.9163 0 12.3804 12.708 13.6864 12.4886 0 0 0 0 0 0 0 10.7641 0 0 0 0 Q16134 ETFD_HUMAN "Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial, ETF-QO, ETF-ubiquinone oxidoreductase, EC 1.5.5.1 (Electron-transferring-flavoprotein dehydrogenase, ETF dehydrogenase)" ETFDH Homo sapiens (Human) electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966] "integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979]" GO:0004174; GO:0005759; GO:0006979; GO:0009055; GO:0016491; GO:0022900; GO:0022904; GO:0031305; GO:0031966; GO:0033539; GO:0046872; GO:0048038; GO:0048039; GO:0050660; GO:0051539 "4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]" FGILTEK 0.99344 -28.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8442 0 0 0 0 0 0 13.4653 0 0 0 0 0 0 0 0 0 14.6046 14.6163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16584 M3K11_HUMAN "Mitogen-activated protein kinase kinase kinase 11, EC 2.7.11.25 (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase)" MAP3K11 MLK3 PTK1 SPRK Homo sapiens (Human) cell cycle G1/S phase transition [GO:0044843]; cell death [GO:0008219]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule-based process [GO:0007017]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874] centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; cell cycle G1/S phase transition [GO:0044843]; cell death [GO:0008219]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule-based process [GO:0007017]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron apoptotic process [GO:0043525]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] GO:0000165; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005813; GO:0005829; GO:0005874; GO:0006468; GO:0007017; GO:0007254; GO:0008219; GO:0016020; GO:0031267; GO:0031434; GO:0031435; GO:0042802; GO:0042803; GO:0043065; GO:0043507; GO:0043525; GO:0044843; GO:0046330; GO:0046777; GO:0106310 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] ALAGRRVPPHVLVNWAVQIAR 0.99344 -13.518 0 0 0 0 0 0 0 0 12.6792 0 0 0 12.4714 11.1331 0 0 11.8516 0 0 0 0 0 0 0 0 0 0 0 0 14.2646 0 13.0771 12.596 14.39 0 14.7031 11.2206 0 0 16.4834 16.619 16.4325 0 16.7361 16.8647 0 0 0 14.5548 0 14.5886 0 0 0 0 0 0 0 16.2035 0 11.8211 13.1723 13.5964 15.1985 15.0863 12.5507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8383 0 0 0 0 0 0 0 0 12.9093 0 13.3088 0 0 0 0 0 0 0 0 0 0 0 0 12.3451 0 14.7754 0 0 0 0 0 0 12.73 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6706 0 12.8272 0 0 0 0 0 0 0 0 18.0903 0 0 0 15.6534 0 0 0 0 0 0 0 0 0 0 12.8531 0 0 0 13.8527 0 0 0 Q562E7 WDR81_HUMAN WD repeat-containing protein 81 WDR81 Homo sapiens (Human) aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739] autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000421; GO:0005739; GO:0005765; GO:0005829; GO:0006511; GO:0007005; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0035973; GO:0043551; GO:0045022; GO:0050821; GO:0070530 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase regulator activity [GO:0035014] AMDACHR 0.99344 -5.0629 0 0 13.3994 0 0 0 0 0 0 0 0 0 0 11.5248 0 0 0 0 0 0 0 11.0508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0457 0 12.6244 0 0 0 0 10.4272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2399 0 0 0 0 0 0 12.0965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7216 12.1711 0 13.3092 0 0 12.495 0 0 0 0 12.4072 0 13.9555 0 0 12.593 0 0 12.0838 0 0 0 0 0 0 0 0 13.2902 0 13.5335 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9887 11.9146 0 12.0165 0 0 0 0 0 0 0 0 0 0 0 11.2827 0 0 0 0 0 12.1033 0 0 11.2737 0 0 0 0 0 0 0 0 12.8693 0 0 0 0 0 13.2553 0 0 0 0 0 0 0 13.0506 0 0 13.715 0 Q70CQ2 UBP34_HUMAN "Ubiquitin carboxyl-terminal hydrolase 34, EC 3.4.19.12 (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34)" USP34 KIAA0570 KIAA0729 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055] GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016055; GO:0016579; GO:0071108; GO:0090263 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] AAGDHAK 0.99344 -13.488 0 0 0 0 0 16.4133 16.6907 0 15.3199 0 0 13.4059 0 0 0 0 0 14.222 0 0 14.8093 13.3619 14.8339 0 0 14.178 14.8333 14.1937 13.5958 13.5671 13.4547 0 0 0 0 0 0 12.2798 13.4229 0 13.6919 13.6652 13.8206 14.3597 13.749 13.7959 0 13.8528 13.5447 0 0 13.6981 13.6936 15.7068 13.7793 0 15.5121 0 0 0 14.7957 0 0 0 0 12.5604 12.016 15.3621 15.8273 14.0576 12.4304 13.5746 13.9362 0 14.2072 14.2043 14.2879 14.2311 0 0 15.2827 0 0 0 14.0046 13.6431 0 11.8128 0 0 14.5101 0 0 13.4975 17.8913 13.6223 14.434 14.7779 14.3946 10.7656 0 0 15.9044 0 19.2764 0 14.2117 15.2911 0 0 13.4868 15.8453 19.3162 12.3011 11.6895 10.9209 13.5162 0 15.0315 0 19.3755 0 0 0 14.3106 14.723 14.7154 0 14.9315 13.866 16.6278 14.7494 0 14.9992 14.6363 15.5592 18.1938 0 15.0884 15.5206 14.3127 0 14.7295 14.6836 14.8572 0 14.6198 0 0 15.5086 13.5885 14.9928 0 13.0691 0 0 15.8651 0 10.1692 0 9.50259 0 0 13.3478 18.6814 0 12.5112 0 0 0 0 14.1431 0 0 15.3829 0 0 0 0 0 Q7Z410 TMPS9_HUMAN "Transmembrane protease serine 9, EC 3.4.21.- (Polyserase-I) (Polyserine protease 1, Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3 ]" TMPRSS9 Homo sapiens (Human) proteolysis [GO:0006508] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005887; GO:0006508 serine-type endopeptidase activity [GO:0004252] AHLGTASLLGLGGSPVK 0.99344 -14.236 0 0 0 0 0 0 0 10.4532 0 0 0 0 0 0 0 0 0 0 0 0 11.6937 0 0 0 0 0 0 0 0 0 0 0 0 10.7591 0 0 0 0 10.8464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0486 0 0 0 0 0 0 10.8254 0 0 13.2658 0 0 0 0 0 0 14.0929 0 0 0 0 0 0 14.0295 11.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 11.055 11.1011 0 0 0 0 0 10.5692 0 0 0 0 0 0 10.0195 0 0 0 0 11.1004 0 0 0 0 13.1576 0 0 12.5377 14.4007 0 0 0 0 0 0 12.3321 0 0 0 0 0 0 11.2965 0 0 0 0 0 0 11.2132 0 13.3401 0 0 0 0 0 0 0 0 0 0 0 0 12.5483 0 0 0 10.7471 0 0 0 Q86UK5 LBN_HUMAN "Limbin (Ellis-van Creveld syndrome protein 2, EVC2)" EVC2 LBN Homo sapiens (Human) smoothened signaling pathway [GO:0007224] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane protein complex [GO:0098797] ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane protein complex [GO:0098797]; smoothened signaling pathway [GO:0007224] GO:0005634; GO:0005737; GO:0005856; GO:0005929; GO:0007224; GO:0016021; GO:0060170; GO:0098797 DDAPEAVTEEQAELRR 0.99344 -5.0775 0 0 0 0 0 0 0 0 0 0 0 13.0742 0 0 0 0 12.4187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6 0 0 0 0 0 0 0 0 0 0 12.7838 0 0 0 0 13.053 0 0 0 0 13.8459 0 0 0 0 0 0 0 11.9484 12.0739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6941 13.7866 0 0 0 0 0 0 0 0 0 0 13.8663 0 0 0 0 0 0 15.141 0 0 13.4021 0 15.4242 0 0 0 13.2866 0 0 13.1721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6109 0 Q8WXI4 ACO11_HUMAN "Acyl-coenzyme A thioesterase 11, Acyl-CoA thioesterase 11, EC 3.1.2.- (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase, BFIT) (Palmitoyl-coenzyme A thioesterase, EC 3.1.2.2)" ACOT11 BFIT KIAA0707 THEA Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; lipid binding [GO:0008289]; long-chain acyl-CoA hydrolase activity [GO:0052816]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266] GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0006637; GO:0008289; GO:0009266; GO:0009409; GO:0016290; GO:0035556; GO:0036042; GO:0047617; GO:0052689; GO:0052816; GO:0070062; GO:0102991; GO:0120163 acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; lipid binding [GO:0008289]; long-chain acyl-CoA hydrolase activity [GO:0052816]; long-chain fatty acyl-CoA binding [GO:0036042]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] DNWVLSSEISQVRLYTLEDDK 0.99344 -16.196 0 0 0 0 0 0 0 0 0 0 0 0 0 13.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7462 0 0 0 0 0 14.6421 0 0 0 0 0 0 0 0 0 11.6584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3733 0 0 0 0 0 0 0 0 0 15.3509 0 0 0 0 0 0 0 0 0 0 13.807 0 0 15.338 0 0 0 0 0 0 0 0 0 0 12.515 0 0 0 0 0 0 13.8033 0 0 0 0 0 14.8669 0 0 0 11.7945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93077 H2A1C_HUMAN Histone H2A type 1-C (H2A-clustered histone 6) (Histone H2A/l) H2AC6 H2AFL HIST1H2AC Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; negative regulation of cell population proliferation [GO:0008285] GO:0000786; GO:0003677; GO:0005634; GO:0005654; GO:0008285; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AGLQFPVGR 0.99344 -7.777 0 0 0 0 0 0 0 0 0 0 0 11.2088 0 0 0 0 0 0 0 0 0 11.3597 0 0 0 0 0 0 0 0 0 13.5088 0 0 0 0 0 0 0 11.3178 0 0 12.7185 11.7902 0 12.6259 0 0 11.7044 0 0 13.7753 13.1981 13.8225 11.33 0 10.9157 0 0 0 0 0 0 9.78211 0 0 0 0 0 0 0 0 0 0 0 0 14.6017 0 0 0 0 0 15.5884 15.758 16.161 14.584 16.2422 0 14.6531 0 15.9758 14.1284 12.6034 13.7744 0 14.2611 15.5609 14.8879 0 0 0 0 0 0 0 0 12.8308 14.8394 0 0 0 14.0587 0 14.8855 0 0 0 0 0 12.8707 0 0 0 13.9578 13.0409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.09 0 0 0 0 0 0 0 0 0 11.4872 0 0 0 Q96MH7 CE034_HUMAN Uncharacterized protein C5orf34 C5orf34 Homo sapiens (Human) ALSLSCPVPHLHRWNFCDSLLQR 0.99344 -5.0633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MT3 PRIC1_HUMAN Prickle-like protein 1 (REST/NRSF-interacting LIM domain protein 1) PRICKLE1 RILP Homo sapiens (Human) "aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell myoblast differentiation [GO:2000691]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] "cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell myoblast differentiation [GO:2000691]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001843; GO:0005634; GO:0005829; GO:0006606; GO:0008270; GO:0031398; GO:0031965; GO:0032436; GO:0035904; GO:0045892; GO:0060071; GO:0060976; GO:0090090; GO:2000691 zinc ion binding [GO:0008270] CSACDEIIFADECTEAEGR 0.99344 -5.0691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0422 0 0 17.3691 0 0 0 0 0 0 0 0 13.2706 0 12.8427 21.4652 0 0 0 0 0 0 0 0 20.0486 0 0 0 0 0 0 0 0 20.7898 0 13.2612 0 0 0 19.704 15.2597 20.0539 0 0 0 19.15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3216 0 Q96QV1 HHIP_HUMAN "Hedgehog-interacting protein, HHIP, HIP" HHIP HIP UNQ5825/PRO19644 Homo sapiens (Human) dorsal/ventral pattern formation [GO:0009953]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of apoptotic process [GO:0043066]; negative regulation of signal transduction [GO:0009968]; negative regulation of smoothened signaling pathway [GO:0045879]; neuroblast proliferation [GO:0007405]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634] cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; hedgehog family protein binding [GO:0097108]; zinc ion binding [GO:0008270]; dorsal/ventral pattern formation [GO:0009953]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of apoptotic process [GO:0043066]; negative regulation of signal transduction [GO:0009968]; negative regulation of smoothened signaling pathway [GO:0045879]; neuroblast proliferation [GO:0007405]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705] GO:0005576; GO:0005634; GO:0005737; GO:0005887; GO:0007165; GO:0007405; GO:0008270; GO:0009953; GO:0009968; GO:0009986; GO:0040036; GO:0043066; GO:0045879; GO:0048705; GO:0060170; GO:0060441; GO:0097108 hedgehog family protein binding [GO:0097108]; zinc ion binding [GO:0008270] CCCSPGWEGDFCR 0.99344 -13.533 0 0 0 0 0 0 0 0 0 0 0 9.99039 13.7027 0 0 13.7818 0 0 0 13.87 0 0 0 0 0 0 0 14.6058 0 0 0 0 0 12.8822 13.5158 0 0 0 0 0 13.5661 0 0 12.2324 0 14.1784 0 0 0 14.2223 10.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1237 0 0 0 0 0 14.1867 0 14.6971 14.0237 0 15.7204 12.6204 0 14.7429 13.0854 0 16.2503 0 0 0 0 14.6254 0 0 0 0 0 0 0 0 0 11.2271 0 0 11.6277 13.8059 0 0 0 14.4581 11.9013 10.3458 0 0 15.1906 15.2676 0 15.1155 0 11.8763 0 0 0 0 14.0602 12.5254 0 0 14.2114 13.2943 12.2924 13.0499 0 13.8411 12.1592 12.7949 0 0 15.2004 14.6067 0 0 0 11.6767 14.6663 0 0 0 13.4066 0 0 0 0 11.9805 0 0 0 0 0 0 13.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4368 0 10.2102 0 Q9H6N6 MYH16_HUMAN Putative uncharacterized protein MYH16 (Myosin heavy chain 16 pseudogene) (myosin heavy polypeptide 5) MYH16 MYH5 Homo sapiens (Human) centriole [GO:0005814]; centrosome [GO:0005813]; myosin complex [GO:0016459] centriole [GO:0005814]; centrosome [GO:0005813]; myosin complex [GO:0016459] GO:0005813; GO:0005814; GO:0016459 AMMDAAR 0.99344 -13.5 10.7592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2945 13.6591 0 0 0 0 0 0 0 0 12.9252 0 0 0 0 0 0 10.7955 11.3782 0 0 0 0 0 0 0 0 11.2336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7495 0 0 0 0 0 0 0 12.7564 0 0 0 0 0 0 0 13.2344 0 0 0 13.9788 12.483 0 0 9.7118 0 0 0 0 0 0 0 0 13.8845 0 0 0 0 0 0 0 0 0 12.9966 0 0 0 12.9967 0 0 0 0 0 0 0 0 0 0 0 11.9798 0 0 0 0 0 0 0 0 12.9988 0 0 0 0 0 0 0 0 0 0 0 0 12.7373 12.299 0 0 0 12.2738 0 12.7897 13.4798 0 0 0 0 0 14.067 0 0 0 13.9918 0 13.7895 14.218 0 0 12.7959 0 0 Q9NS73 MBIP1_HUMAN "MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein, MUK-binding inhibitory protein)" MBIP BM-015 Homo sapiens (Human) "histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "ATAC complex [GO:0140672]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" GO:0004860; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0010628; GO:0031063; GO:0042802; GO:0043966; GO:0044154; GO:0045995; GO:0046330; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140672 identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860] FSIGDLQEEEK 0.99344 -13.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3422 0 0 0 0 0 12.6441 0 0 13.1619 0 0 0 0 0 13.4576 14.1203 0 0 0 0 0 0 0 0 12.4838 13.1407 0 0 0 13.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVM4 ANM7_HUMAN "Protein arginine N-methyltransferase 7, EC 2.1.1.321 (Histone-arginine N-methyltransferase PRMT7) ([Myelin basic protein]-arginine N-methyltransferase PRMT7)" PRMT7 KIAA1933 Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of protein binding [GO:0043393]; spliceosomal snRNP assembly [GO:0000387] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; [myelin basic protein]-arginine N-methyltransferase activity [GO:0016277]; histone binding [GO:0042393]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; histone arginine methylation [GO:0034969]; histone methylation [GO:0016571]; peptidyl-arginine methylation [GO:0018216]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of protein binding [GO:0043393]; spliceosomal snRNP assembly [GO:0000387] GO:0000387; GO:0001650; GO:0005634; GO:0005654; GO:0005829; GO:0006349; GO:0008469; GO:0008757; GO:0016277; GO:0016571; GO:0018216; GO:0030154; GO:0034969; GO:0035241; GO:0035243; GO:0042393; GO:0043021; GO:0043046; GO:0043393; GO:0044020 [myelin basic protein]-arginine N-methyltransferase activity [GO:0016277]; histone binding [GO:0042393]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] HLVEENCEAVPHRATVYAQLVESGRMWSWNK 0.99344 -13.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0859 0 12.805 12.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P246 STIM2_HUMAN Stromal interaction molecule 2 STIM2 KIAA1482 Homo sapiens (Human) activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; positive regulation of calcium ion transport [GO:0051928]; store-operated calcium entry [GO:0002115] GO:0002115; GO:0005246; GO:0005509; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0015279; GO:0016021; GO:0032237; GO:0051928 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; store-operated calcium channel activity [GO:0015279] MALKKAEK 0.99344 -13.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15144 ARPC2_HUMAN "Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit, p34-ARC)" ARPC2 ARC34 PRO2446 Homo sapiens (Human) actin filament polymerization [GO:0030041]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; muscle cell projection membrane [GO:0036195]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] GO:0003779; GO:0005200; GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0005885; GO:0005925; GO:0010592; GO:0015629; GO:0030027; GO:0030041; GO:0030838; GO:0034314; GO:0035861; GO:0036195; GO:0043005; GO:0070062; GO:0070358; GO:0098978; GO:1900026 actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200] EPPLELK 0.99345 -13.193 13.4267 13.8773 11.7833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9777 0 0 0 0 0 0 0 0 0 0 0 14.4847 0 0 0 0 0 13.1686 0 13.6296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6778 13.3723 13.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9767 11.4984 O75689 ADAP1_HUMAN "Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1, Cnt-a1) (Putative MAPK-activating protein PM25)" ADAP1 CENTA1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]" GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0043087; GO:0043231; GO:0043533; GO:0043547; GO:0046872; GO:1902936 "GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" AKYERQEFIYPEK 0.99345 -13.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.078 13.9274 13.8896 0 0 0 0 0 0 0 0 0 0 11.8485 0 0 16.5336 14.85 0 0 0 16.0207 0 0 0 0 0 12.8844 0 12.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY84 NIM1_HUMAN "Serine/threonine-protein kinase NIM1, EC 2.7.11.1 (NIM1 serine/threonine-protein kinase)" NIM1K NIM1 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468] GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0035556; GO:0042149; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DSVESGCQTESSK 0.99345 -27.208 0 0 0 0 0 0 0 0 0 0 12.0281 10.3461 12.0809 0 0 0 0 0 10.09 0 0 0 0 0 0 0 0 0 0 11.0653 0 0 10.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5586 0 0 0 11.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7528 0 0 0 0 0 0 0 12.0681 0 0 0 0 0 0 11.6421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5338 0 0 0 0 0 0 0 0 0 0 13.0174 0 0 0 14.3353 0 0 12.3572 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEN9 PDZD8_HUMAN PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104) PDZD8 PDZK8 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604] GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008289; GO:0016020; GO:0016021; GO:0022604; GO:0044233; GO:0046872; GO:0051560; GO:1990456 lipid binding [GO:0008289]; metal ion binding [GO:0046872] GDRLIAIGGVKITSTLQVLK 0.99345 -13.196 0 0 0 0 0 10.8305 0 0 0 0 13.1974 0 0 0 0 0 13.036 0 0 13.7721 0 0 0 0 11.8453 0 0 0 0 0 12.1259 0 0 0 0 0 0 0 0 9.64677 0 13.166 12.949 0 0 0 12.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0454 0 0 0 0 0 0 0 0 13.3849 0 0 0 0 13.6238 13.667 13.5807 0 14.0242 0 12.819 0 13.5299 15.5103 0 0 14.0061 0 14.1983 0 13.8166 13.0599 0 13.4584 14.4247 0 0 0 0 0 13.8721 0 0 0 10.5007 0 14.7073 0 0 0 0 0 0 14.1012 0 0 0 0 0 0 13.7844 0 0 0 0 0 0 9.3557 0 12.5472 10.3111 0 0 0 13.6048 0 0 0 0 0 0 0 0 11.9642 0 0 10.7579 0 0 0 0 0 0 0 0 13.3325 13.5915 0 0 0 0 0 0 0 10.2748 0 0 0 0 0 0 12.198 10.4866 0 0 0 0 0 Q96CM4 NXNL1_HUMAN Nucleoredoxin-like protein 1 (Thioredoxin-like protein 6) NXNL1 TXNL6 Homo sapiens (Human) photoreceptor cell maintenance [GO:0045494] photoreceptor outer segment [GO:0001750] photoreceptor outer segment [GO:0001750]; photoreceptor cell maintenance [GO:0045494] GO:0001750; GO:0045494 DLGRQFSVER 0.99345 -6.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5145 0 0 0 13.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0B6 BRNP2_HUMAN BMP/retinoic acid-inducible neural-specific protein 2 (DBCCR1-like protein 2) BRINP2 DBCCR1L2 FAM5B KIAA1747 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to retinoic acid [GO:0071300]; negative regulation of mitotic cell cycle [GO:0045930]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; cell cycle [GO:0007049]; cellular response to retinoic acid [GO:0071300]; negative regulation of mitotic cell cycle [GO:0045930]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] GO:0005576; GO:0005783; GO:0007049; GO:0007399; GO:0030425; GO:0043025; GO:0045666; GO:0045930; GO:0071300 AQEYADFMERYR 0.99345 -6.2005 0 0 0 0 0 0 0 0 12.9444 0 0 0 0 0 0 0 11.7464 0 0 0 0 0 11.6554 0 0 0 0 0 0 0 0 0 11.6972 0 0 0 0 12.0699 0 0 0 0 0 0 0 0 0 13.3918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1703 0 0 0 0 0 0 0 12.8245 0 0 0 12.2955 0 12.387 0 0 0 0 0 0 0 0 0 12.65 0 0 0 12.2533 12.2931 0 0 0 0 0 0 0 14.004 15.1035 0 0 0 0 13.0848 0 13.1675 13.3929 0 0 0 12.2546 0 0 0 0 0 13.1477 0 0 0 0 12.5708 0 0 0 12.4318 12.6962 0 0 0 12.1381 11.7823 11.8523 0 0 0 0 0 13.4351 0 0 13.2323 12.6449 0 0 0 0 0 11.8834 0 0 0 0 0 0 0 0 0 0 0 12.5388 0 0 0 12.3553 0 13.3678 0 Q9H4L5 OSBL3_HUMAN "Oxysterol-binding protein-related protein 3, ORP-3, OSBP-related protein 3" OSBPL3 KIAA0704 ORP3 OSBP3 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; filopodium tip [GO:0032433]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699] GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0015248; GO:0015485; GO:0016020; GO:0031965; GO:0032433; GO:0032934; GO:0043231; GO:0097038 cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] GFLLKKR 0.99345 -27.193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8609 0 0 0 0 0 0 0 13.1312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4339 0 0 0 0 13.2336 0 0 0 0 0 0 12.6032 0 0 11.46 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.182 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPT8 ZC3H4_HUMAN Zinc finger CCCH domain-containing protein 4 ZC3H4 C19orf7 KIAA1064 Homo sapiens (Human) "DNA-templated transcription, termination [GO:0006353]; lncRNA catabolic process [GO:0110064]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of lncRNA transcription [GO:0140744]; nuclear RNA surveillance [GO:0071027]" chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; DNA-templated transcription, termination [GO:0006353]; lncRNA catabolic process [GO:0110064]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of lncRNA transcription [GO:0140744]; nuclear RNA surveillance [GO:0071027]" GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006353; GO:0032785; GO:0046872; GO:0071027; GO:0110064; GO:0140744; GO:1990841 metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723] AATAGPPNAR 0.99345 -13.542 10.9634 0 0 0 11.2104 0 12.8507 0 11.7523 0 12.3667 12.9228 0 0 0 0 0 0 12.3646 10.5518 13.5194 11.3617 0 0 0 0 12.4997 0 0 0 0 11.0506 0 0 10.7658 0 13.461 12.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4021 0 0 0 11.6532 0 12.4155 0 14.7047 12.8399 13.2101 0 0 11.2021 0 0 12.4355 12.0753 13.9354 15.551 0 13.9679 14.0159 13.5505 12.7675 0 11.4143 14.5071 0 12.7293 0 12.1916 10.8655 14.0195 0 0 13.9905 14.3725 12.5318 11.4049 0 0 0 13.4227 0 13.4455 13.6711 0 12.1755 12.0723 11.3762 13.2996 0 0 0 13.8437 0 13.8316 0 13.2174 13.4194 13.4971 0 0 0 11.9069 0 0 0 0 13.4332 0 0 13.7932 12.8661 0 11.6113 13.7513 15.4855 0 0 15.2334 13.3166 0 0 12.8521 13.1519 0 12.459 0 12.6339 12.6911 0 0 12.7787 0 12.9628 0 0 0 13.5105 0 0 0 0 11.826 15.5335 0 12.2829 0 0 13.1602 12.9185 P10145 IL8_HUMAN "Interleukin-8, IL-8 (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1, GCP-1) (Monocyte-derived neutrophil chemotactic factor, MDNCF) (Monocyte-derived neutrophil-activating peptide, MONAP) (Neutrophil-activating protein 1, NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Cleaved into: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor, LYNAP) (MDNCF-c) (Neutrophil-activating factor, NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI) ]" CXCL8 IL8 Homo sapiens (Human) angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; embryonic digestive tract development [GO:0048566]; G protein-coupled receptor signaling pathway [GO:0007186]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of another organism [GO:0031640]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of gene expression [GO:0010629]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil chemotaxis [GO:0090023]; receptor internalization [GO:0031623]; regulation of cell adhesion [GO:0030155]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045091]; response to endoplasmic reticulum stress [GO:0034976]; response to molecule of bacterial origin [GO:0002237]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; interleukin-8 receptor binding [GO:0005153]; angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; embryonic digestive tract development [GO:0048566]; G protein-coupled receptor signaling pathway [GO:0007186]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of another organism [GO:0031640]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of gene expression [GO:0010629]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil chemotaxis [GO:0090023]; receptor internalization [GO:0031623]; regulation of cell adhesion [GO:0030155]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045091]; response to endoplasmic reticulum stress [GO:0034976]; response to molecule of bacterial origin [GO:0002237]; signal transduction [GO:0007165] GO:0001525; GO:0002237; GO:0005153; GO:0005576; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007186; GO:0008009; GO:0008201; GO:0008285; GO:0010628; GO:0010629; GO:0019722; GO:0030155; GO:0030593; GO:0031328; GO:0031623; GO:0031640; GO:0034976; GO:0035556; GO:0042119; GO:0044344; GO:0045091; GO:0045236; GO:0045744; GO:0045766; GO:0048566; GO:0050930; GO:0060354; GO:0061844; GO:0070098; GO:0071222; GO:0071347; GO:0071356; GO:0090023; GO:2000535 chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; interleukin-8 receptor binding [GO:0005153] CQCIKTYSK 0.99346 -6.8519 0 0 0 0 0 0 0 0 0 11.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95622 0 0 0 0 0 0 0 0 0 0 0 11.8922 0 0 0 0 0 0 0 0 0 0 0 0 12.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6361 0 0 10.1028 0 0 0 P13929 ENOB_HUMAN "Beta-enolase, EC 4.2.1.11 (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase, MSE) (Skeletal muscle enolase)" ENO3 Homo sapiens (Human) canonical glycolysis [GO:0061621]; glycolytic process [GO:0006096] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; canonical glycolysis [GO:0061621]; glycolytic process [GO:0006096] GO:0000015; GO:0000287; GO:0004634; GO:0005615; GO:0005829; GO:0005886; GO:0006096; GO:0016020; GO:0061621; GO:0070062 magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634] GVIKAKYGK 0.99346 -6.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1626 0 0 0 0 0 0 14.0609 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7387 0 0 14.8184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5964 0 0 0 0 0 0 0 0 0 0 0 0 12.9609 0 0 0 P56181 NDUV3_HUMAN "NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial (Complex I-9kD, CI-9kD) (NADH-ubiquinone oxidoreductase 9 kDa subunit) (Renal carcinoma antigen NY-REN-4)" NDUFV3 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; RNA binding [GO:0003723]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0003723; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0042775; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137]; RNA binding [GO:0003723] KPAPVPAEPFDNTTYK 0.99346 -9.1151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3531 0 0 0 0 0 0 0 0 0 13.8139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57678 GEMI4_HUMAN "Gem-associated protein 4, Gemin-4 (Component of gems 4) (p97)" GEMIN4 Homo sapiens (Human) rRNA processing [GO:0006364]; spliceosomal snRNP assembly [GO:0000387] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; ribonucleoprotein complex binding [GO:0043021]; rRNA processing [GO:0006364]; spliceosomal snRNP assembly [GO:0000387] GO:0000387; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0016604; GO:0030532; GO:0032797; GO:0034719; GO:0043021; GO:0070062; GO:0097504 ribonucleoprotein complex binding [GO:0043021] GLTQIQSR 0.99346 -6.6315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0406 0 0 11.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4288 0 0 0 0 0 15.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.095 0 0 0 0 15.8892 0 0 0 0 0 0 0 0 Q14296 FASTK_HUMAN "Fas-activated serine/threonine kinase, FAST kinase, EC 2.7.11.1, EC 2.7.11.8" FASTK Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; mitochondrial RNA processing [GO:0000963]; protein phosphorylation [GO:0006468]; regulation of mitochondrial mRNA stability [GO:0044528]; regulation of RNA splicing [GO:0043484] mitochondrial matrix [GO:0005759]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; Fas-activated serine/threonine kinase activity [GO:0033867]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic signaling pathway [GO:0097190]; mitochondrial RNA processing [GO:0000963]; protein phosphorylation [GO:0006468]; regulation of mitochondrial mRNA stability [GO:0044528]; regulation of RNA splicing [GO:0043484] GO:0000963; GO:0003723; GO:0004674; GO:0005524; GO:0005759; GO:0006468; GO:0033867; GO:0035770; GO:0043484; GO:0044528; GO:0097190; GO:0106310 ATP binding [GO:0005524]; Fas-activated serine/threonine kinase activity [GO:0033867]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] EPQLLEAIAHFLVVQETQLSSKVVQKLVLPFGR 0.99346 -6.4376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8812 0 0 0 0 0 0 0 0 0 13.2478 0 0 13.9875 13.8201 0 0 0 13.2466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2299 0 0 0 0 13.8342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1434 0 0 0 Q5T749 KPRP_HUMAN "Keratinocyte proline-rich protein, hKPRP" KPRP C1orf45 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] GO:0005737; GO:0070062 CPVEIPPIR 0.99346 -6.6417 0 0 0 0 0 0 0 0 0 0 0 9.77283 0 0 0 0 0 0 0 0 0 0 10.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.23836 0 0 0 0 0 0 0 0 10.4158 0 0 0 0 0 0 0 0 0 0 11.5852 0 0 0 0 0 0 0 0 0 0 12.2362 11.0908 14.9535 14.1297 13.818 0 12.7144 0 0 0 0 0 0 0 10.9612 14.7458 0 13.7936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7964 0 0 0 0 0 0 0 0 0 Q5T8P6 RBM26_HUMAN RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26) RBM26 C13orf10 PRO1777 Homo sapiens (Human) mRNA processing [GO:0006397] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397] GO:0003723; GO:0005634; GO:0006397; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723] AASPGRCLPKSIK 0.99346 -17.31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9863 14.8361 0 13.9453 0 0 0 0 0 0 0 13.5108 0 12.8663 0 0 0 0 0 15.0782 0 14.02 12.8637 0 0 0 0 12.8279 0 0 0 12.9604 0 12.6991 13.707 0 0 0 0 0 14.2499 12.8224 0 0 0 0 0 0 0 11.5203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7214 12.9439 11.5619 11.0827 13.2794 0 0 0 0 0 13.5252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.353 0 10.4266 0 0 0 0 0 0 0 0 0 0 Q6NS38 ALKB2_HUMAN "DNA oxidative demethylase ALKBH2, EC 1.14.11.33 (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1)" ALKBH2 ABH2 Homo sapiens (Human) DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; oxidative DNA demethylase activity [GO:0035516]; rDNA binding [GO:0000182]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA demethylation [GO:0080111]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511] GO:0000182; GO:0005634; GO:0005654; GO:0005730; GO:0006307; GO:0008198; GO:0035511; GO:0035516; GO:0043734; GO:0051747; GO:0070989; GO:0080111 cytosine C-5 DNA demethylase activity [GO:0051747]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; oxidative DNA demethylase activity [GO:0035516]; rDNA binding [GO:0000182] EVEYFTGALARVQVFGKWHSVPR 0.99346 -10.804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4475 0 0 13.3035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1955 0 0 0 Q6ZN55 ZN574_HUMAN Zinc finger protein 574 ZNF574 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFAISMRLAEHRR 0.99346 -27.243 0 0 0 0 0 0 0 0 0 15.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0227 0 0 0 0 0 0 0 15.2822 0 0 0 0 0 0 12.6917 0 0 13.5833 13.7716 0 0 0 0 0 0 0 0 12.0123 12.1071 0 0 0 0 0 0 0 0 0 0 13.9669 0 0 0 0 0 0 13.8621 0 0 0 0 0 0 0 13.1245 0 14.3566 13.2007 0 12.8053 0 0 0 0 0 12.4282 12.1486 0 11.6741 0 0 0 0 0 0 0 0 0 0 16.8006 0 11.3299 0 0 0 0 0 12.2587 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZR37 PKHG7_HUMAN "Pleckstrin homology domain-containing family G member 7, PH domain-containing family G member 7" PLEKHG7 C12orf74 Homo sapiens (Human) Rho protein signal transduction [GO:0007266] cellular anatomical entity [GO:0110165] cellular anatomical entity [GO:0110165]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho protein signal transduction [GO:0007266] GO:0005085; GO:0007266; GO:0110165 guanyl-nucleotide exchange factor activity [GO:0005085] FFIPECLKHIFK 0.99346 -15.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6516 0 0 0 0 0 0 0 0 0 0 0 13.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9405 0 0 12.098 0 0 0 0 0 11.1884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7858 0 0 0 0 13.6779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5A5 ZGPAT_HUMAN Zinc finger CCCH-type with G patch domain-containing protein (G patch domain-containing protein 6) (Zinc finger CCCH domain-containing protein 9) (Zinc finger and G patch domain-containing protein) ZGPAT GPATC6 GPATCH6 KIAA1847 ZC3H9 ZC3HDC9 ZIP Homo sapiens (Human) "negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005886; GO:0006357; GO:0007175; GO:0043565; GO:0045892; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" CRGRGAR 0.99346 -6.4382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6633 0 0 0 0 0 0 0 12.4797 0 0 0 13.7128 13.7348 0 0 0 0 0 14.4635 0 0 0 11.7226 0 11.2639 0 15.8625 0 0 0 0 0 0 0 0 0 12.5517 0 0 12.9848 0 10.6625 10.9583 0 0 0 0 0 12.5362 0 0 0 10.4446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9973 0 0 0 0 0 0 0 0 14.324 0 0 0 0 0 9.30711 0 0 0 12.5489 0 0 0 0 0 0 0 0 0 0 0 0 13.2903 0 0 Q8WXI3 ASB10_HUMAN "Ankyrin repeat and SOCS box protein 10, ASB-10" ASB10 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005737; GO:0005829; GO:0016567; GO:0035556 CALRSHLEGSLPQALPRLPLPPR 0.99346 -10.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3896 0 0 0 13.671 0 0 0 0 0 0 14.14 0 0 0 0 12.9699 0 0 0 0 0 0 13.2929 0 12.7124 0 0 0 0 0 0 0 0 0 0 0 13.6161 0 0 0 0 0 0 0 14.0557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1914 0 0 12.2611 13.3266 0 0 0 13.0333 0 0 0 0 0 0 Q9BVV6 TALD3_HUMAN Protein TALPID3 KIAA0586 TALPID3 Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of establishment of protein localization [GO:0070201]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; cilium assembly [GO:0060271]; regulation of establishment of protein localization [GO:0070201]; smoothened signaling pathway [GO:0007224] GO:0001917; GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0060271; GO:0070201 AKDGAAMYSLINALSTNR 0.99346 -6.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0385 14.2508 13.1254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9215 0 11.6537 0 0 0 0 13.4256 12.0483 0 0 0 0 0 0 0 0 0 11.6602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1096 0 12.3782 12.7031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6507 0 Q9Y2V3 RX_HUMAN Retinal homeobox protein Rx (Retina and anterior neural fold homeobox protein) RAX RX Homo sapiens (Human) camera-type eye development [GO:0043010]; hypothalamus development [GO:0021854]; limb development [GO:0060173]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; camera-type eye development [GO:0043010]; hypothalamus development [GO:0021854]; limb development [GO:0060173]; pattern specification process [GO:0007389]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007389; GO:0007601; GO:0021854; GO:0043010; GO:0045944; GO:0060173; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DRRLGAR 0.99346 -9.1129 0 0 0 0 0 0 0 0 12.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9086 0 0 0 0 0 0 0 13.9743 13.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9237 0 0 0 0 0 0 0 0 0 0 0 0 0 12.032 0 0 0 13.3247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2048 10.7808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A1L4Q6 YK033_HUMAN Putative uncharacterized protein FLJ41423 Homo sapiens (Human) GENDGGEER 0.99347 -5.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60488 ACSL4_HUMAN "Long-chain-fatty-acid--CoA ligase 4, EC 6.2.1.3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4, LACS 4)" ACSL4 ACS4 FACL4 LACS4 Homo sapiens (Human) embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024] GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0008610; GO:0016020; GO:0016021; GO:0030182; GO:0030307; GO:0031957; GO:0032024; GO:0032307; GO:0035336; GO:0035338; GO:0044233; GO:0047676; GO:0060136; GO:0070062; GO:0090433 arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957] AKPTSDKPGSPYR 0.99347 -14.065 13.5071 13.5721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8481 0 0 0 0 0 11.3521 0 0 0 0 0 0 0 12.3042 0 0 12.254 15.6949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9387 0 0 0 0 0 0 0 0 12.7583 0 0 0 0 0 0 0 0 14.4757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1692 0 0 0 0 0 0 0 0 11.273 0 0 0 0 14.0463 0 0 0 0 0 0 0 0 0 0 0 0 O60840 CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F (Voltage-gated calcium channel subunit alpha Cav1.4) CACNA1F CACNAF1 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601] integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; voltage-gated calcium channel complex [GO:0005891] integral component of membrane [GO:0016021]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; voltage-gated calcium channel complex [GO:0005891]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import across plasma membrane [GO:0098703]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; regulation of ion transmembrane transport [GO:0034765]; visual perception [GO:0007601] GO:0001750; GO:0005245; GO:0005891; GO:0007601; GO:0008331; GO:0016021; GO:0034765; GO:0043204; GO:0046872; GO:0050908; GO:0098703; GO:1901386 high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] AFRVLRPLR 0.99347 -29.087 0 12.5231 12.8851 0 0 0 0 0 13.6512 13.5159 0 13.4184 13.6273 14.5048 0 0 0 0 0 0 0 0 0 0 12.9152 0 0 13.8682 0 0 0 0 13.2512 0 0 11.2032 0 0 0 0 0 0 0 0 0 0 0 0 13.3116 14.5225 0 12.5539 11.8927 11.5277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.313 0 0 0 0 13.2322 0 15.2695 14.5998 0 0 0 0 0 13.7123 0 14.5377 0 0 13.1487 0 0 0 0 12.5366 0 0 0 0 0 0 14.7436 14.5048 0 0 13.3108 0 14.5941 13.5585 0 13.5969 13.7236 0 0 0 13.2464 0 13.3574 0 0 14.6564 0 12.8953 15.1168 0 0 0 14.7409 14.7088 13.3299 12.7515 13.2063 13.9452 0 0 0 0 0 14.5291 15.2521 13.3935 0 0 0 0 0 0 0 0 0 14.1154 0 12.4391 0 0 0 0 0 0 0 0 0 0 12.3458 12.5069 13.803 13.7172 0 14.2223 0 0 0 14.0573 0 0 0 0 0 0 13.7262 0 P00451 FA8_HUMAN "Coagulation factor VIII (Antihemophilic factor, AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain ]" F8 F8C Homo sapiens (Human) "acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370] "COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491]; acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007596; GO:0007597; GO:0016020; GO:0016491; GO:0030134; GO:0031093; GO:0031638; GO:0032991; GO:0033116; GO:1905370 copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491] DLASGLIGPLLICYK 0.99347 -37.941 0 0 0 0 0 0 0 0 11.8294 0 0 0 0 11.377 0 10.8171 0 0 11.6566 0 0 11.0124 0 0 0 0 0 0 0 0 0 0 0 0 0 11.994 0 11.5432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7328 13.3773 12.831 13.8575 12.7556 11.5518 0 12.8185 12.6137 12.9412 12.6926 0 12.7314 0 0 0 10.389 0 0 12.9031 12.9842 0 0 0 0 13.6726 13.6631 14.0554 0 14.0006 0 15.3047 13.3949 13.9683 12.9571 13.384 0 13.7176 0 0 12.8162 0 14.5194 0 0 13.128 13.2078 0 14.8324 0 0 0 12.9798 0 13.6628 12.4438 0 0 0 12.4126 14.374 0 15.1369 0 13.9336 0 0 0 14.6703 13.3832 12.2881 0 0 0 0 0 0 12.5062 0 14.2001 15.428 0 13.6657 12.3907 0 13.8389 0 14.6312 13.2767 0 13.1446 12.6258 0 14.4748 0 14.3453 14.541 0 0 12.8445 12.9052 13.6626 14.1272 0 0 0 0 0 0 0 0 0 0 14.2099 0 0 0 13.492 0 13.5109 0 13.7296 0 0 0 11.8351 12.6943 P42285 MTREX_HUMAN "Exosome RNA helicase MTR4, EC 3.6.4.13 (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase)" MTREX DOB1 KIAA0052 MTR4 SKIV2L2 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cellular response to DNA damage stimulus [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]" GO:0000398; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006401; GO:0006974; GO:0016076; GO:0016607; GO:0016887; GO:0031499; GO:0071013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AAKEYPFILDAFQR 0.99347 -7.1018 0 0 0 11.4764 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2902 12.7559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6902 0 0 0 0 0 0 0 12.3877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5296 12.2932 0 14.0876 10.9462 11.8886 0 12.9099 14.1297 14.3659 12.6688 0 0 12.4984 13.3378 15.1345 0 0 0 0 13.8344 13.157 13.5274 0 0 0 14.2396 17.2159 0 0 14.922 0 15.4302 0 0 0 0 0 0 0 0 12.4505 0 13.57 0 0 0 13.3845 13.5271 0 0 13.2358 13.1112 0 13.574 0 0 0 12.9942 13.8101 12.3583 14.3631 13.1068 0 0 14.4202 0 13.7669 0 0 13.3298 13.3842 12.8057 0 0 13.6521 0 13.19 0 12.1787 0 0 0 13.5647 0 0 0 0 0 0 15.0215 0 12.1613 15.1893 12.2155 13.1912 0 0 12.9503 0 0 0 0 0 0 0 0 14.8451 0 0 0 0 0 P43490 NAMPT_HUMAN "Nicotinamide phosphoribosyltransferase, NAmPRTase, Nampt, EC 2.4.2.12 (Pre-B-cell colony-enhancing factor 1, Pre-B cell-enhancing factor) (Visfatin)" NAMPT PBEF PBEF1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; circadian regulation of gene expression [GO:0032922]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD biosynthetic process [GO:0009435]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607] cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; cell-cell signaling [GO:0007267]; circadian regulation of gene expression [GO:0032922]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD biosynthetic process [GO:0009435]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165] GO:0004514; GO:0005125; GO:0005829; GO:0007165; GO:0007267; GO:0008284; GO:0009435; GO:0016607; GO:0030054; GO:0032922; GO:0034356; GO:0042802; GO:0045944; GO:0047280; GO:0051770; GO:0070062 cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514] LHDFGYR 0.99347 -17.314 0 11.8927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8278 0 0 0 0 0 9.75694 0 0 0 0 0 0 0 10.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5956 13.5382 12.9891 0 0 0 0 12.5909 0 0 12.7687 0 0 12.9458 13.3143 12.9828 12.429 14.2409 0 12.9189 0 0 12.6227 12.7406 13.1516 0 0 0 0 0 13.3608 12.9233 12.9096 0 0 0 0 0 0 0 0 11.5403 0 0 0 0 0 0 0 0 0 12.7293 0 13.3333 13.1345 0 12.4508 0 0 0 0 0 0 0 11.7057 0 0 0 0 0 0 0 0 0 0 12.9057 0 12.2562 0 0 0 P62424 RL7A_HUMAN 60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3) RPL7A SURF-3 SURF3 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412] GO:0000470; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0045296 cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AILYKRLK 0.99347 -38.411 0 0 0 13.7621 0 0 0 0 0 0 11.2291 0 14.0306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.423 0 0 0 0 0 0 0 0 13.7159 13.7847 0 0 14.6199 14.1998 0 13.919 13.1724 12.745 0 12.6759 0 0 11.9956 0 0 12.0503 0 0 11.7384 0 0 0 0 0 0 0 0 0 0 13.4504 0 0 0 0 0 0 0 0 0 0 0 0 14.3508 0 0 0 0 0 0 0 0 0 0 0 0 15.0919 0 0 0 0 0 0 0 0 0 0 13.8883 0 0 0 13.4159 0 0 0 0 0 0 0 0 13.2845 0 0 0 0 17.3812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.477 0 0 0 0 0 0 0 0 0 0 0 12.022 0 0 0 13.6952 0 0 0 0 0 0 0 0 0 0 P82987 ATL3_HUMAN "ADAMTS-like protein 3, ADAMTSL-3 (Punctin-2)" ADAMTSL3 KIAA1233 Homo sapiens (Human) extracellular matrix organization [GO:0030198] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; extracellular matrix organization [GO:0030198] GO:0005576; GO:0030198; GO:0031012; GO:0043231 ACAPKDR 0.99347 -38.214 0 0 0 0 0 0 0 0 0 0 10.3246 11.5267 0 0 11.6933 11.8628 0 12.4025 0 0 0 12.233 0 12.2261 0 0 0 0 0 11.6255 11.1875 0 0 11.7852 0 11.1048 0 0 0 0 0 0 0 11.7178 0 0 12.5133 0 11.3796 11.7805 11.7881 0 0 0 0 0 0 0 10.8988 0 0 0 0 0 0 0 0 0 0 0 0 12.2664 12.0559 13.7421 14.9872 0 0 12.819 13.6997 0 0 14.2751 13.704 0 0 0 0 14.8915 12.949 16.0595 0 16.6251 0 15.9192 12.9897 0 0 0 11.7996 0 0 12.8444 0 0 11.0018 12.8901 14.967 14.3237 11.2326 0 0 15.9162 13.9196 0 0 13.6683 12.9009 12.9986 12.6211 13.2313 14.1556 0 10.1435 13.6765 12.0961 12.2559 13.4548 14.512 0 12.1787 0 0 0 12.7058 0 16.9761 14.268 0 11.4014 0 0 13.2336 12.5102 13.8733 12.7889 0 0 0 14.1423 0 13.5981 0 0 0 12.147 0 0 0 0 12.2072 0 0 12.8003 0 0 12.0856 0 11.4753 13.883 0 0 13.442 11.9426 12.2628 11.272 0 0 0 0 11.2455 Q15391 P2Y14_HUMAN "P2Y purinoceptor 14, P2Y14 (G-protein coupled receptor 105) (UDP-glucose receptor)" P2RY14 GPR105 KIAA0001 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UDP receptor activity [GO:0045029]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0005886; GO:0007186; GO:0016021; GO:0045028; GO:0045029 G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UDP receptor activity [GO:0045029] EILCKKLHIPLK 0.99347 -17.347 0 0 0 0 0 0 0 11.351 0 0 0 0 0 13.737 13.7901 13.5886 0 0 0 0 0 12.8343 0 0 0 0 0 0 0 12.2108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7469 12.5846 0 0 0 0 0 0 0 0 0 0 0 0 9.505 0 0 0 0 0 0 12.433 0 12.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4791 14.9827 0 0 14.36 0 12.5912 0 0 0 0 0 0 19.192 0 0 0 0 0 0 0 0 0 0 0 14.0653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1915 11.0956 0 0 16.0545 0 15.7694 14.8953 15.8378 13.6058 0 0 0 0 0 0 13.6162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8584 0 0 0 0 15.404 15.4323 15.9702 0 0 0 0 0 12.7925 Q16589 CCNG2_HUMAN Cyclin-G2 CCNG2 Homo sapiens (Human) cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0016538; GO:0044772; GO:0051301 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] FLALMKVK 0.99347 -7.0959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2042 11.8045 16.505 13.3902 0 0 0 0 0 0 0 0 0 0 0 0 13.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4962 0 0 15.353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4764 0 0 0 0 0 0 15.5424 0 0 14.9123 0 0 0 0 0 13.2045 0 0 0 0 0 0 0 0 15.2223 0 0 0 0 0 0 0 0 Q53H80 AKIR2_HUMAN Akirin-2 AKIRIN2 C6orf166 Homo sapiens (Human) adaptive immune response [GO:0002250]; cerebral cortex development [GO:0021987]; defense response to bacterium [GO:0042742]; embryo development ending in birth or egg hatching [GO:0009792]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell activation [GO:0050871]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606]; regulation of muscle cell differentiation [GO:0051147]; response to lipopolysaccharide [GO:0032496] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coregulator activity [GO:0003712]; adaptive immune response [GO:0002250]; cerebral cortex development [GO:0021987]; defense response to bacterium [GO:0042742]; embryo development ending in birth or egg hatching [GO:0009792]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of B cell activation [GO:0050871]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606]; regulation of muscle cell differentiation [GO:0051147]; response to lipopolysaccharide [GO:0032496] GO:0000122; GO:0000785; GO:0002250; GO:0002821; GO:0003712; GO:0005634; GO:0005654; GO:0005737; GO:0006606; GO:0008284; GO:0009792; GO:0010629; GO:0010950; GO:0016020; GO:0017053; GO:0019899; GO:0021987; GO:0030674; GO:0031144; GO:0032496; GO:0032755; GO:0042742; GO:0042802; GO:0045087; GO:0045089; GO:0045944; GO:0050871; GO:0051147; GO:0071630 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coregulator activity [GO:0003712] ACGATLKR 0.99347 -7.1008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8687 0 12.977 0 0 0 0 0 0 11.4627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2779 0 0 0 0 0 0 0 0 14.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3506 14.0016 0 0 0 0 0 0 0 0 13.5169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1952 0 10.5152 0 0 0 0 0 0 0 0 12.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUJ8 BCAP_HUMAN Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1) PIK3AP1 BCAP Homo sapiens (Human) positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162] GO:0005102; GO:0005829; GO:0005886; GO:0014068; GO:0016020; GO:0034134; GO:0034142; GO:0034154; GO:0034162; GO:0036312; GO:0042802; GO:0050727 identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; signaling receptor binding [GO:0005102] AASGVPR 0.99347 -14.085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4446 10.7506 13.2449 0 12.755 0 0 0 13.2635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9073 0 0 0 0 12.1121 0 0 0 0 0 15.3707 15.3606 11.7275 0 0 15.2409 0 15.1138 0 15.3268 0 14.1889 0 0 0 0 0 0 15.5319 15.2652 0 0 0 0 14.6768 14.7066 0 0 0 0 14.9332 0 0 0 0 12.5589 0 0 0 14.9614 0 12.9869 0 0 13.514 14.9427 0 0 0 14.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6091 0 0 0 0 0 15.3781 15.4147 0 0 0 0 0 0 0 0 0 0 13.4723 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7P1 PLD5_HUMAN "Inactive phospholipase D5, Inactive PLD 5 (Inactive choline phosphatase 5) (Inactive phosphatidylcholine-hydrolyzing phospholipase D5) (PLDc)" PLD5 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intracellular organelle [GO:0043229]; catalytic activity [GO:0003824] GO:0003824; GO:0005737; GO:0016021; GO:0043229 catalytic activity [GO:0003824] EALVLRSVRVR 0.99347 -14.092 0 10.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 14.047 0 0 0 0 15.6497 0 0 0 0 0 0 0 0 0 11.9327 0 0 0 0 0 0 0 0 0 0 0 10.6069 0 0 0 14.3163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4951 0 15.3199 0 0 9.48987 0 14.2823 15.8227 15.888 15.9129 16.0461 16.3975 0 16.1779 0 0 14.0612 0 0 16.6256 0 16.1687 0 16.3469 0 0 16.3986 0 16.3609 16.2199 16.2147 0 16.3158 16.5135 16.2533 16.3084 0 16.2302 0 0 16.1096 16.112 15.9955 16.0453 0 0 16.0438 0 13.8562 0 16.3465 15.9403 15.7135 13.9753 13.4831 0 0 0 15.6378 15.6334 15.6167 15.736 15.7834 0 0 15.6534 15.4424 15.4649 15.4484 15.4129 0 15.7303 15.4144 15.4555 15.2723 15.1935 15.3224 15.2169 14.1165 15.6996 0 0 14.8855 15.1716 15.9057 0 0 0 0 14.9909 11.3233 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8307 14.4473 13.3048 14.7369 0 0 0 0 12.7051 Q8NB66 UN13C_HUMAN Protein unc-13 homolog C (Munc13-3) UNC13C Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" anchoring junction [GO:0070161]; calyx of Held [GO:0044305]; neuromuscular junction [GO:0031594]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; calyx of Held [GO:0044305]; neuromuscular junction [GO:0031594]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; negative regulation of synaptic plasticity [GO:0031914]; neuromuscular junction development [GO:0007528]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]" GO:0005509; GO:0005516; GO:0005543; GO:0005886; GO:0007268; GO:0007528; GO:0016081; GO:0016082; GO:0016188; GO:0017075; GO:0019992; GO:0030672; GO:0031594; GO:0031914; GO:0035249; GO:0042734; GO:0043195; GO:0044305; GO:0048786; GO:0061789; GO:0070161; GO:0098688; GO:0098831; GO:0099525 calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; phospholipid binding [GO:0005543]; syntaxin-1 binding [GO:0017075] DQDFPTAGQTKSPK 0.99347 -29.126 13.7492 0 0 0 0 0 0 0 0 0 0 0 12.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0085 0 12.1016 11.0024 0 12.3767 0 0 12.1706 0 0 0 0 13.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5877 12.2787 0 0 13.5237 16.8021 15.4167 0 0 0 0 0 0 0 0 0 0 16.7443 0 0 0 0 13.5905 0 0 0 0 0 0 14.2021 0 0 0 13.4238 0 0 0 12.7461 0 13.7905 11.8101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0836 0 0 0 0 0 0 0 0 0 0 13.2087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8453 0 0 12.7882 11.7231 0 0 0 0 0 12.6958 0 0 0 0 0 0 0 18.0078 0 Q8NEB9 PK3C3_HUMAN "Phosphatidylinositol 3-kinase catalytic subunit type 3, PI3-kinase type 3, PI3K type 3, PtdIns-3-kinase type 3, EC 2.7.1.137 (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34)" PIK3C3 VPS34 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein targeting to lysosome [GO:0006622]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201] "autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]" "autolysosome [GO:0044754]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; late endosome [GO:0005770]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; macroautophagy [GO:0016236]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein targeting to lysosome [GO:0006622]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; regulation of protein secretion [GO:0050708]; response to leucine [GO:0043201]" GO:0000045; GO:0000407; GO:0004672; GO:0005524; GO:0005737; GO:0005768; GO:0005770; GO:0005777; GO:0005829; GO:0005930; GO:0006468; GO:0006497; GO:0006622; GO:0006897; GO:0006914; GO:0007032; GO:0007049; GO:0010506; GO:0016020; GO:0016236; GO:0016241; GO:0016301; GO:0016303; GO:0016485; GO:0030242; GO:0030496; GO:0030670; GO:0032465; GO:0034271; GO:0034272; GO:0034497; GO:0035032; GO:0036092; GO:0042149; GO:0043201; GO:0044754; GO:0045022; GO:0046854; GO:0048015; GO:0050708; GO:0051301; GO:0052742; GO:0097352 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol kinase activity [GO:0052742]; protein kinase activity [GO:0004672] ACKNSTLANYLYWYVIVECEDQDTQQR 0.99347 -38.194 0 0 0 0 0 12.5305 11.9555 10.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9277 0 0 0 0 0 0 0 10.6776 0 0 0 0 0 10.0511 0 0 0 10.4328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8995 0 0 0 0 0 0 0 15.1495 0 10.1215 0 10.8187 0 0 14.1332 0 0 0 0 13.7357 0 0 12.661 12.3201 0 0 0 10.7249 0 0 0 14.3332 0 0 0 0 0 0 0 0 0 0 0 11.389 10.5821 0 0 13.7529 0 0 0 0 13.5627 13.8861 0 0 0 0 0 0 0 0 13.9494 0 0 0 13.6927 0 0 12.5079 10.0254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7036 14.1182 0 0 0 0 0 Q8WUH6 TM263_HUMAN Transmembrane protein 263 TMEM263 C12orf23 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GGVSAVAGGVTAVGSAVVNK 0.99347 -6.6599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2434 0 0 0 0 15.3158 15.7951 14.4912 14.5492 0 0 0 0 14.3608 14.4433 14.4707 0 0 14.4589 14.2636 14.48 0 0 14.5218 0 14.4375 0 0 14.3658 0 0 15.0139 14.964 0 0 14.7415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6784 0 0 0 14.4792 14.5802 0 0 0 0 0 14.495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYP5 ELYS_HUMAN Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1) AHCTF1 ELYS TMBS62 MSTP108 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465] GO:0000776; GO:0003677; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007049; GO:0015031; GO:0016363; GO:0031965; GO:0032465; GO:0051028; GO:0051292; GO:0051301; GO:0070062 DNA binding [GO:0003677] AKSLAMSVTTSGFSEFTPQSILR 0.99347 -38.023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8607 15.3508 13.7533 0 0 13.3677 0 15.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1047 0 0 14.7974 0 14.2002 0 14.1451 0 0 0 15.2622 0 13.7024 0 0 0 14.0734 13.4473 18.3065 18.5816 18.2578 18.5972 0 0 0 13.5046 0 13.7404 13.9606 0 0 0 0 18.7473 18.1878 16.5267 16.933 16.0603 15.7996 16.4491 16.8644 16.8952 15.9214 15.7096 14.7321 15.9229 0 14.0026 13.794 13.802 17.1291 0 15.9796 16.3776 14.2612 0 15.1485 16.5151 0 16.8639 0 0 15.253 0 16.4465 16.3337 14.2386 14.0904 15.454 0 14.3665 15.6679 15.2976 0 15.464 0 0 14.6733 13.5798 0 0 0 0 0 0 0 0 0 0 0 0 16.8239 0 0 0 0 0 12.7056 0 12.623 13.4883 0 0 0 0 14.6897 0 0 14.2809 0 0 13.146 0 12.669 12.459 0 Q92619 HMHA1_HUMAN "Rho GTPase-activating protein 45 [Cleaved into: Minor histocompatibility antigen HA-1, mHag HA-1 ]" ARHGAP45 HMHA1 KIAA0223 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005576; GO:0005829; GO:0005886; GO:0007165; GO:0016020; GO:0032587; GO:0034774; GO:0035578; GO:0046872; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] ALRTKGIYR 0.99347 -38.312 0 0 0 13.7344 12.9786 10.0359 15.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0924 0 0 11.4949 11.7736 0 0 0 0 15.0584 0 12.866 12.0468 12.082 0 11.5959 11.7976 14.8761 0 0 0 0 0 13.2912 0 0 0 13.275 0 0 0 0 0 0 0 0 12.9757 13.9453 0 0 13.1176 11.1173 0 0 0 0 0 12.9355 0 14.0587 0 0 0 0 0 13.8888 0 0 0 0 0 0 0 13.0203 14.032 0 13.0083 0 0 0 11.0851 0 0 0 0 0 14.1494 0 11.4901 0 0 0 0 0 0 0 0 0 0 13.4944 0 12.8526 16.6181 0 0 0 0 0 0 0 0 Q96GM5 SMRD1_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (60 kDa BRG-1/Brm-associated factor subunit A) (BRG1-associated factor 60A, BAF60A) (SWI/SNF complex 60 kDa subunit)" SMARCD1 BAF60A Homo sapiens (Human) cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000776; GO:0000785; GO:0003682; GO:0003712; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0035060; GO:0043231; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045815; GO:0060090; GO:0070316; GO:0071398; GO:0071564; GO:0071565; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819 chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] EFMLSFAR 0.99347 -38.191 0 0 0 0 0 0 10.7072 10.6064 0 0 0 0 0 0 0 0 11.4342 0 0 0 0 0 0 12.8776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3279 0 0 0 0 0 0 0 9.38329 0 0 9.65793 0 0 0 0 0 0 0 0 0 0 13.8569 0 10.7484 0 0 0 0 0 13.2669 0 0 0 0 0 0 0 0 0 0 0 0 12.4164 14.7939 0 0 0 0 0 0 13.7445 0 0 14.4453 0 0 13.6972 0 0 0 0 0 14.6085 14.0998 0 0 10.5785 13.691 13.7655 14.1263 0 14.1334 0 0 14.009 14.2232 0 0 0 0 0 13.6837 13.7958 14.0476 13.8747 13.9101 0 0 0 0 0 14.1711 0 13.8332 0 0 0 0 0 13.2092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.216 0 0 0 0 13.7472 0 0 0 0 0 0 0 0 Q9C0C7 AMRA1_HUMAN Activating molecule in BECN1-regulated autophagy protein 1 (DDB1- and CUL4-associated factor 3) AMBRA1 DCAF3 KIAA1736 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; mitophagy [GO:0000423]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; neural tube development [GO:0021915]; positive regulation of autophagy [GO:0010508]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780] autophagosome [GO:0005776]; axoneme [GO:0005930]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335] autophagosome [GO:0005776]; axoneme [GO:0005930]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; GTPase binding [GO:0051020]; protein phosphatase binding [GO:0019903]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to starvation [GO:0009267]; mitophagy [GO:0000423]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; neural tube development [GO:0021915]; positive regulation of autophagy [GO:0010508]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780] GO:0000045; GO:0000209; GO:0000422; GO:0000423; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0005930; GO:0006357; GO:0006914; GO:0007049; GO:0008285; GO:0009267; GO:0010508; GO:0010667; GO:0019903; GO:0021915; GO:0030154; GO:0031625; GO:0035307; GO:0043231; GO:0043524; GO:0043552; GO:0045335; GO:0045591; GO:0048471; GO:0051020; GO:0080008; GO:0098780; GO:1901526; GO:1904544; GO:1990756; GO:2000045 GTPase binding [GO:0051020]; protein phosphatase binding [GO:0019903]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625] AMGAQRLLQELVEDK 0.99347 -29.149 0 0 0 0 0 0 0 0 0 0 0 15.55 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9321 0 0 0 0 0 0 0 0 0 0 0 13.5821 0 0 0 0 14.6185 0 0 0 0 14.3921 0 0 0 0 0 13.8291 14.6651 0 0 0 0 11.1021 0 0 0 0 0 0 0 0 13.8596 0 0 12.0817 0 0 0 13.3991 0 16.2918 0 13.6347 16.3218 0 16.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0N0 RAB6C_HUMAN Ras-related protein Rab-6C (Rab6-like protein WTH3) RAB6C WTH3 Homo sapiens (Human) "intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; regulation of centrosome duplication [GO:0010824]; response to xenobiotic stimulus [GO:0009410]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; small GTPase mediated signal transduction [GO:0007264]" centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] "centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; regulation of centrosome duplication [GO:0010824]; response to xenobiotic stimulus [GO:0009410]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; small GTPase mediated signal transduction [GO:0007264]" GO:0000278; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005813; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0007264; GO:0009410; GO:0010824; GO:0042147 GTP binding [GO:0005525]; GTPase activity [GO:0003924] GSDVIITLVGNRTDLADK 0.99347 -6.4534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2215 0 0 0 0 0 0 0 0 12.7156 0 12.723 0 0 0 0 0 0 0 0 0 0 0 12.0002 0 0 0 0 0 0 0 0 0 0 0 11.0603 0 0 0 0 12.3796 0 0 0 0 Q9H3H3 CK068_HUMAN UPF0696 protein C11orf68 (Basophilic leukemia-expressed protein Bles03) (Protein p5326) C11orf68 BLES03 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] AAAAAAAVAGVGRGGGGAEPR 0.99347 -6.4471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9499 12.3542 0 0 0 0 13.2449 12.1364 0 12.8145 11.7042 0 0 12.4447 0 12.8385 0 0 0 0 0 0 0 0 0 0 0 0 12.4781 0 0 0 0 11.4692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D1E1 Z804B_HUMAN Zinc finger protein 804B ZNF804B Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872] GO:0005634; GO:0046872 metal ion binding [GO:0046872] AHWQGCR 0.99348 -27.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7264 0 0 0 11.5517 13.5665 0 0 0 0 0 0 10.2913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9081 0 0 0 0 12.1775 12.2218 13.3607 13.2603 14.1157 13.4402 0 0 0 0 15.1291 0 13.6982 13.6177 0 13.2625 13.4252 13.7396 14.6948 13.7261 13.34 0 13.7334 14.4004 16.1223 0 15.9806 0 13.7956 10.9546 13.8992 0 12.5824 13.3842 0 14.2712 12.578 0 12.7037 0 0 12.9796 14.3186 13.3731 0 0 0 0 0 13.4124 12.5229 0 13.7977 0 12.6062 12.2176 12.7951 0 0 0 12.7703 0 13.7344 10.0864 15.0602 14.4038 12.6335 13.7948 0 15.3686 14.3462 13.2149 13.933 14.0615 0 0 0 0 0 0 0 0 12.2614 0 0 0 0 11.5052 0 12.143 0 0 0 0 12.846 0 11.7934 10.744 0 0 0 0 12.9625 10.6282 0 0 12.3585 0 O43303 CP110_HUMAN "Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa, CP110, Cep110)" CCP110 CEP110 CP110 KIAA0419 Homo sapiens (Human) centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of centriole elongation [GO:1903723]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; protein-containing complex [GO:0032991] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; ciliary basal body organization [GO:0032053]; negative regulation of centriole elongation [GO:1903723]; negative regulation of cilium assembly [GO:1902018]; positive regulation of cilium assembly [GO:0045724]; regulation of cytokinesis [GO:0032465] GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007099; GO:0032053; GO:0032465; GO:0032991; GO:0045724; GO:0051298; GO:1902018; GO:1903723 ALDVEARKQVNR 0.99348 -16.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8106 0 0 0 0 0 0 0 0 0 0 0 0 12.0412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9155 9.71352 0 0 16.8914 0 0 0 13.7736 13.9354 14.9917 13.9206 0 0 12.5312 0 0 13.3368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1261 0 0 0 0 0 0 0 14.1626 0 0 0 0 0 13.3238 0 0 0 0 0 0 0 0 0 13.1519 0 0 14.1811 0 0 0 17.4802 0 0 0 0 0 0 12.6434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6959 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8587 0 0 0 0 0 O75123 ZN623_HUMAN Zinc finger protein 623 ZNF623 KIAA0628 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFCHSSDLIR 0.99348 -16.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5233 13.1981 13.2835 0 0 0 0 10.8479 0 0 0 0 0 0 0 12.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1895 13.409 14.7845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7557 0 0 0 0 0 0 0 0 0 0 0 0 12.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3299 0 0 0 0 0 0 0 0 0 0 0 0 11.8463 0 11.1128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75317 UBP12_HUMAN "Ubiquitin carboxyl-terminal hydrolase 12, EC 3.4.19.12 (Deubiquitinating enzyme 12) (Ubiquitin thioesterase 12) (Ubiquitin-hydrolyzing enzyme 1) (Ubiquitin-specific-processing protease 12)" USP12 UBH1 USP12L1 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579; GO:0046872 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872] KFITRLR 0.99348 -9.1922 12.2426 0 0 0 0 0 0 0 0 15.0874 14.6313 14.6991 12.8619 12.4296 14.5769 13.4006 0 13.0609 0 11.7019 0 0 0 0 0 13.8893 0 0 13.692 14.3043 0 14.8938 14.6619 14.4063 13.2059 13.5184 0 0 15.0744 14.5546 13.3581 0 12.6128 13.6592 13.0736 0 14.8959 14.8315 0 0 0 0 0 13.4774 0 13.6478 13.2523 10.9438 12.4189 0 12.0812 0 11.3428 10.3904 10.2663 0 13.4756 15.6554 13.3526 15.6569 0 15.6034 0 0 0 0 0 0 15.4668 13.2664 12.8401 0 0 0 0 0 0 0 0 0 0 0 0 17.1364 0 10.8586 0 13.1703 13.5682 0 0 14.0051 13.527 0 14.0526 14.8138 0 13.6667 13.3005 12.4671 0 13.4812 0 0 14.8377 14.9014 14.0145 13.7033 0 11.247 13.6304 11.2753 0 0 14.2749 13.7906 12.7285 0 13.6035 0 14.3451 0 12.6909 12.6504 0 0 11.2344 0 13.7893 13.832 13.8659 13.6658 13.9947 15.0606 0 0 13.5892 15.8393 0 0 13.7345 9.99421 0 13.5348 13.6108 0 13.4393 15.6332 15.4304 15.5057 15.8838 16.1554 15.4603 15.9904 15.3885 13.962 13.4167 0 0 14.2098 14.8484 0 13.2907 0 0 12.8588 0 18.2895 0 15.9285 P02462 CO4A1_HUMAN Collagen alpha-1(IV) chain [Cleaved into: Arresten ] COL4A1 Homo sapiens (Human) basement membrane organization [GO:0071711]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]; renal tubule morphogenesis [GO:0061333]; retinal blood vessel morphogenesis [GO:0061304] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407]; basement membrane organization [GO:0071711]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; cellular response to amino acid stimulus [GO:0071230]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; neuromuscular junction development [GO:0007528]; renal tubule morphogenesis [GO:0061333]; retinal blood vessel morphogenesis [GO:0061304] GO:0001569; GO:0005201; GO:0005576; GO:0005587; GO:0005604; GO:0005615; GO:0005788; GO:0007420; GO:0007528; GO:0030020; GO:0030198; GO:0030855; GO:0031012; GO:0038063; GO:0048407; GO:0048514; GO:0061304; GO:0061333; GO:0062023; GO:0071230; GO:0071711 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; platelet-derived growth factor binding [GO:0048407] CDCHGVK 0.99348 -27.896 0 0 0 0 0 0 14.0054 12.4842 0 0 0 11.0091 0 0 0 0 0 0 12.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9936 0 0 0 0 13.4491 0 0 13.1174 12.7132 13.4488 13.4394 0 0 0 13.9072 12.2223 13.0784 13.034 13.7174 0 13.8991 0 0 0 0 0 0 0 12.4855 0 14.0403 0 0 13.8522 14.4637 0 12.7699 0 0 0 0 0 13.4567 14.9719 0 12.6443 0 13.8666 0 0 0 0 0 0 14.6183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3269 15.2716 0 0 0 11.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14CM0 FRPD4_HUMAN "FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis, Preso)" FRMPD4 KIAA0316 PDZD10 PDZK10 Homo sapiens (Human) positive regulation of synapse structural plasticity [GO:0051835] anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; protein-containing complex [GO:0032991] "anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; protein-containing complex [GO:0032991]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; positive regulation of synapse structural plasticity [GO:0051835]" GO:0005546; GO:0005856; GO:0032991; GO:0043197; GO:0051835; GO:0070161 "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" ALSHLVKANQNLVPPGKK 0.99348 -16.129 0 0 0 13.3973 0 0 0 0 13.1153 0 14.1167 0 0 0 14.7773 0 0 0 0 0 0 0 10.7965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6971 0 0 13.117 0 0 0 0 14.413 0 0 13.7986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 14.2359 0 0 13.217 0 15.8434 12.4916 17.5881 15.4183 14.8485 14.5007 11.5403 12.632 0 0 0 0 14.384 19.5831 0 0 0 13.6451 0 14.7444 0 0 0 0 0 0 15.557 0 11.7281 0 0 0 14.1264 0 0 15.3863 12.2453 15.5601 0 15.2733 14.7581 0 0 0 0 11.9244 13.65 0 14.4836 0 0 0 0 0 13.567 13.991 0 15.3151 0 15.7196 0 0 0 0 0 11.5791 0 0 13.8754 0 0 0 0 0 0 0 11.208 0 0 0 0 13.1887 0 0 0 0 0 0 0 12.2415 14.7165 0 14.892 0 0 0 0 0 0 13.676 0 Q15269 PWP2_HUMAN Periodic tryptophan protein 2 homolog PWP2 PWP2H Homo sapiens (Human) "maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]" nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] "nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]" GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388 RNA binding [GO:0003723] AFDLHRYR 0.99348 -9.1886 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8831 12.6056 0 0 0 13.7655 0 0 0 14.0621 0 0 11.6228 0 11.2898 0 0 0 0 0 0 0 0 0 0 14.3892 0 0 11.4531 11.4303 11.2321 0 0 0 0 0 0 0 0 13.3116 0 13.6502 12.5794 12.8192 0 0 0 11.0218 0 0 0 0 0 11.1287 0 0 11.1732 0 0 13.2843 0 0 0 12.3798 0 0 13.9154 0 13.6468 0 0 12.8222 0 0 0 14.379 0 0 0 0 0 0 0 0 0 0 0 0 14.6418 13.7983 0 0 14.1272 0 0 0 0 12.5586 11.2969 0 0 0 0 0 13.6715 0 13.225 0 12.9711 0 14.4186 0 13.4668 0 0 0 0 0 14.2719 12.7944 0 0 0 0 14.7393 13.5367 13.1207 0 12.6388 0 0 14.9173 0 0 0 13.8426 13.687 0 13.7189 11.5479 13.2721 0 12.8035 0 0 0 0 14.0072 0 0 0 0 0 0 0 0 0 0 0 0 14.1036 13.044 0 0 0 0 0 Q6PGN9 PSRC1_HUMAN Proline/serine-rich coiled-coil protein 1 PSRC1 DDA3 FP3214 Homo sapiens (Human) "cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell growth [GO:0030308]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic spindle organization [GO:0060236]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell growth [GO:0030308]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mitotic spindle organization [GO:0060236]" GO:0000922; GO:0001578; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007080; GO:0008017; GO:0015630; GO:0030308; GO:0030496; GO:0031116; GO:0045737; GO:0045893; GO:0051301; GO:0060236 microtubule binding [GO:0008017] PLRRGLSHR 0.99348 -14.526 0 0 0 0 0 0 12.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0351 0 0 0 0 11.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZWJ8 KCP_HUMAN "Kielin/chordin-like protein (Cysteine-rich BMP regulator 2) (Cysteine-rich motor neuron 2 protein, CRIM-2) (Kielin/chordin-like protein 1, KCP-1)" KCP CRIM2 KCP1 Homo sapiens (Human) positive regulation of BMP signaling pathway [GO:0030513] extracellular space [GO:0005615] extracellular space [GO:0005615]; BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; positive regulation of BMP signaling pathway [GO:0030513] GO:0005615; GO:0030513; GO:0036122; GO:0070700 BMP binding [GO:0036122]; BMP receptor binding [GO:0070700] ACAPALCPFPAR 0.99348 -6.9237 0 0 11.824 11.2481 0 0 0 0 0 13.3108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3751 0 12.4529 0 0 0 12.3898 0 0 0 12.0591 0 13.2739 0 0 13.9485 13.7871 12.1579 0 0 15.3669 0 0 0 0 13.1942 0 0 0 12.1161 0 0 0 0 13.9406 0 0 0 0 11.978 0 12.4473 13.6309 0 11.894 0 0 0 12.6684 13.1945 0 12.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7538 0 0 0 0 0 0 0 0 0 12.9055 13.7539 0 12.3941 0 0 0 Q86Y25 Z354C_HUMAN "Zinc finger protein 354C (Kidney, ischemia, and developmentally-regulated protein 3, hKID3)" ZNF354C KID3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AYSYRSNLCR 0.99348 -6.474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6027 0 0 12.4273 0 0 0 0 0 0 14.7876 0 13.1481 0 0 0 0 0 0 0 0 12.7323 14.2648 14.062 0 0 0 0 0 0 13.1592 11.7323 12.3663 0 0 0 0 0 0 0 0 0 0 13.0551 0 0 0 0 0 0 11.1183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7513 0 0 0 0 14.4513 0 0 0 13.9518 0 0 12.3866 12.0671 0 0 0 12.8686 0 0 0 0 0 0 0 0 11.4705 0 0 0 0 0 0 0 0 Q86YT6 MIB1_HUMAN "E3 ubiquitin-protein ligase MIB1, EC 2.3.2.27 (DAPK-interacting protein 1, DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2)" MIB1 DIP1 KIAA1323 ZZANK2 Homo sapiens (Human) blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; neuron differentiation [GO:0030182]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; neuron differentiation [GO:0030182]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0030182; GO:0031410; GO:0045665; GO:0045807 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] DHCPVLGEQNGNR 0.99348 -9.1775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4765 13.5256 13.4988 13.3146 0 13.2561 10.8738 13.3386 0 13.2602 13.1035 13.1786 0 0 11.9233 0 0 0 0 10.9146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0003 0 10.649 0 0 0 0 0 11.7747 0 0 0 0 0 0 0 0 0 13.5393 0 0 18.532 11.8953 0 0 13.4067 0 0 0 0 0 0 0 13.8317 12.9692 0 0 0 19.3789 0 0 0 0 0 0 0 0 0 0 0 0 10.0608 0 0 0 0 13.8051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0866 0 0 0 0 0 0 0 14.3949 0 0 12.3128 0 0 0 0 0 0 11.7352 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IX12 CCAR1_HUMAN "Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1, CARP-1) (Death inducer with SAP domain)" CCAR1 CARP1 DIS Homo sapiens (Human) "apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]" nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005641; GO:0005654; GO:0006355; GO:0006915; GO:0007049; GO:0008284; GO:0030335; GO:0030374; GO:0043065; GO:0048471 nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] ALSSKGLKSQLIAR 0.99348 -29.402 0 14.4606 10.9127 0 0 0 0 13.6802 0 0 13.9897 12.2018 15.387 13.2632 14.4107 0 12.5102 12.9293 0 13.1199 0 0 0 11.1698 0 0 13.0662 13.9986 0 13.6071 13.56 9.88638 14.2356 0 13.0333 12.947 14.1285 14.1582 14.5732 0 0 0 0 12.1771 0 13.8254 0 0 0 0 0 0 11.7411 0 10.0331 0 13.1194 0 0 0 0 0 0 0 0 0 0 11.6087 14.6541 0 0 13.8964 0 10.3907 0 0 11.2374 0 0 0 11.9886 0 0 12.8667 0 15.2096 0 0 0 0 13.8285 14.2294 12.5792 14.8386 0 0 0 12.5898 0 14.2895 0 11.6801 0 11.3746 12.9393 13.6349 0 0 0 14.0593 0 0 12.7305 14.4225 0 0 0 14.1096 12.0922 13.6974 13.5506 0 0 0 0 0 13.0925 13.803 13.5439 0 12.4964 0 0 0 0 0 0 0 0 12.7221 0 0 0 0 0 0 0 0 13.8158 0 0 0 15.1552 11.2546 0 0 11.8429 14.4832 0 0 0 0 0 0 14.5847 0 0 0 0 0 0 0 0 11.9797 0 11.1761 0 14.6066 0 0 Q8NEX5 WFDC9_HUMAN Protein WFDC9 WFDC9 WAP9 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] GO:0004867; GO:0005615; GO:0019731; GO:0045087 serine-type endopeptidase inhibitor activity [GO:0004867] DPFLDMIR 0.99348 -6.9343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFY9 KBTB8_HUMAN "Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein, TA-KRP)" KBTBD8 KIAA1842 TAKRP Homo sapiens (Human) neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; spindle [GO:0005819] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; spindle [GO:0005819]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; regulation of translation [GO:0006417] GO:0005794; GO:0005819; GO:0005829; GO:0006417; GO:0006513; GO:0014029; GO:0014032; GO:0031463 ARIGCKLVYCCGK 0.99348 -9.1832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6326 0 0 0 0 0 0 0 13.99 13.8237 0 0 0 0 0 0 0 0 0 0 14.1455 0 0 0 12.7515 0 0 12.5574 0 0 13.0205 0 0 0 0 0 0 0 0 0 0 0 0 12.9147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8437 0 0 0 0 0 0 13.0492 0 Q969F0 FATE1_HUMAN "Fetal and adult testis-expressed transcript protein (Cancer/testis antigen 43, CT43) (Tumor antigen BJ-HCC-2)" FATE1 FATE Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial calcium ion concentration [GO:0051562] GO:0005741; GO:0005783; GO:0005789; GO:0006915; GO:0016021; GO:0031625; GO:0042802; GO:0043066; GO:0044233; GO:0051562 identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625] AGGPPNTK 0.99348 -9.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C026 TRIM9_HUMAN "E3 ubiquitin-protein ligase TRIM9, EC 2.3.2.27 (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9)" TRIM9 KIAA0282 RNF91 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0019904; GO:0030425; GO:0042803; GO:0043161; GO:0061630; GO:0070161 protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] EATVMCEQCDVFYCDPCR 0.99348 -5.1767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3491 0 0 0 0 0 0 0 0 12.1952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7199 12.2828 0 0 12.7594 0 0 0 0 0 0 0 0 13.5872 16.3496 0 0 14.483 15.0304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1939 0 0 0 0 0 13.5153 0 13.5504 14.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5838 0 0 0 0 0 0 Q9P244 LRFN1_HUMAN Leucine-rich repeat and fibronectin type III domain-containing protein 1 (Synaptic adhesion-like molecule 2) LRFN1 KIAA1484 SALM2 Homo sapiens (Human) anchoring junction [GO:0070161]; cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; cell surface [GO:0009986]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886] GO:0005886; GO:0009986; GO:0070161; GO:0099061 AHFLGGTMIIAIGGVIVASVLVFIVLLMIR 0.99348 -6.9368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9294 0 0 0 0 0 0 12.1514 0 0 16.9331 13.7481 13.2392 0 0 13.4506 0 0 0 13.9881 0 0 0 0 0 0 11.8687 0 0 0 13.4774 0 0 0 0 13.5416 0 0 0 0 0 11.1313 0 0 0 0 0 0 0 0 0 13.2375 15.6115 12.3639 0 0 0 0 0 12.3678 0 0 0 0 0 11.657 14.0281 14.4159 0 0 0 0 0 0 0 0 0 0 10.8724 0 0 0 0 12.2522 0 0 0 13.691 0 0 0 0 10.8675 0 11.0646 0 0 0 0 11.7166 0 0 10.8311 0 0 0 0 0 Q9UKU0 ACSL6_HUMAN "Long-chain-fatty-acid--CoA ligase 6, EC 6.2.1.3 (Arachidonate--CoA ligase, EC 6.2.1.15) (Long-chain acyl-CoA synthetase 6, LACS 6)" ACSL6 ACS2 FACL6 KIAA0837 LACS5 Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuroblast proliferation [GO:0007405]; very long-chain fatty acid metabolic process [GO:0000038] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein homodimerization activity [GO:0042803]; acyl-CoA metabolic process [GO:0006637]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; neuroblast proliferation [GO:0007405]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0001676; GO:0004467; GO:0005524; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0006637; GO:0007405; GO:0008610; GO:0016020; GO:0016021; GO:0019899; GO:0035338; GO:0042803; GO:0047676 arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; long-chain fatty acid-CoA ligase activity [GO:0004467]; protein homodimerization activity [GO:0042803] ALCPTIFPVVPR 0.99348 -14.534 14.6246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0667 0 11.7919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0493 12.3868 0 0 0 0 0 0 0 13.0509 0 0 13.8009 13.8033 0 0 14.3977 0 0 0 0 0 0 0 14.4013 0 0 0 0 0 0 0 0 0 0 13.877 0 0 0 0 0 12.1322 0 0 0 0 0 0 0 0 13.0407 0 14.1539 12.613 0 0 0 13.0879 0 12.7468 0 0 0 0 0 0 0 0 0 13.9956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4199 0 0 0 0 11.6595 11.1429 0 0 0 0 0 13.7852 0 0 0 0 0 0 Q9UPT5 EXOC7_HUMAN Exocyst complex component 7 (Exocyst complex component Exo70) EXOC7 EXO70 KIAA1067 Homo sapiens (Human) exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886] "centriolar satellite [GO:0034451]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone membrane [GO:0032584]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; exocytosis [GO:0006887]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of macroautophagy [GO:0016241]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522]" GO:0000145; GO:0000281; GO:0005546; GO:0005815; GO:0005829; GO:0005886; GO:0006887; GO:0006904; GO:0015031; GO:0016020; GO:0016241; GO:0032584; GO:0034451; GO:0090148; GO:0090522; GO:0090543; GO:2000535 "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" HDFSTVLTVFPILRHLKQTK 0.99348 -27.984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3775 13.1105 0 0 0 0 0 11.028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y247 FA50B_HUMAN Protein FAM50B (Protein XAP-5-like) FAM50B X5L Homo sapiens (Human) chromatin organization [GO:0006325] intercellular bridge [GO:0045171]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] intercellular bridge [GO:0045171]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin organization [GO:0006325] GO:0005634; GO:0005654; GO:0006325; GO:0030496; GO:0045171 DREEEENR 0.99348 -6.9271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8287 0 0 0 0 0 12.0539 0 0 0 0 0 0 0 12.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1411 0 0 Q9Y4C5 CHST2_HUMAN "Carbohydrate sulfotransferase 2, EC 2.8.2.- (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2, GST-2) (N-acetylglucosamine 6-O-sulfotransferase 1, GlcNAc6ST-1, Gn6ST-1)" CHST2 GN6ST Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of leukocyte tethering or rolling [GO:1903238]; sulfur compound metabolic process [GO:0006790] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intrinsic component of Golgi membrane [GO:0031228]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146]; carbohydrate metabolic process [GO:0005975]; inflammatory response [GO:0006954]; keratan sulfate biosynthetic process [GO:0018146]; N-acetylglucosamine metabolic process [GO:0006044]; positive regulation of leukocyte tethering or rolling [GO:1903238]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001517; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0005975; GO:0006044; GO:0006790; GO:0006954; GO:0008146; GO:0016021; GO:0018146; GO:0031228; GO:1903238 N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; sulfotransferase activity [GO:0008146] AHARLDLRTPYR 0.99348 -5.1565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8121 0 0 0 0 12.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3512 0 0 13.7303 13.9429 0 0 0 0 11.9335 0 0 0 0 0 0 0 0 12.362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85474 0 0 11.6889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2526 0 0 Q9Y4W2 LAS1L_HUMAN Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog) LAS1L MSTP060 Homo sapiens (Human) maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470] "Las1 complex [GO:0090730]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]" "Las1 complex [GO:0090730]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; endonuclease activity [GO:0004519]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]" GO:0000460; GO:0000470; GO:0003723; GO:0004519; GO:0005654; GO:0005730; GO:0016020; GO:0030687; GO:0071339; GO:0090730 endonuclease activity [GO:0004519]; RNA binding [GO:0003723] ARELLVSYEEEQFTVLEKFR 0.99348 -14.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.433 0 0 0 0 17.6639 0 0 14.6869 0 13.736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1618 O00337 S28A1_HUMAN "Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1, CNT 1, hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1)" SLC28A1 CNT1 Homo sapiens (Human) azole transmembrane transport [GO:0045117]; cytidine transport [GO:0015861]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transport [GO:0015855]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862] brush border membrane [GO:0031526]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886] brush border membrane [GO:0031526]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; azole transmembrane transporter activity [GO:1901474]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213]; azole transmembrane transport [GO:0045117]; cytidine transport [GO:0015861]; nucleobase-containing compound metabolic process [GO:0006139]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transport [GO:0015855]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transport [GO:0015862] GO:0005337; GO:0005345; GO:0005415; GO:0005829; GO:0005886; GO:0005887; GO:0006139; GO:0015212; GO:0015213; GO:0015293; GO:0015389; GO:0015855; GO:0015858; GO:0015861; GO:0015862; GO:0016020; GO:0016607; GO:0031526; GO:0045117; GO:0072531; GO:1901474; GO:1901642; GO:1904823 azole transmembrane transporter activity [GO:1901474]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside transmembrane transporter activity [GO:0005337]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine- and adenine-specific:sodium symporter activity [GO:0015389]; symporter activity [GO:0015293]; uridine transmembrane transporter activity [GO:0015213] ALALFVLTCVVLTFLGHRLLK 0.99349 -5.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6144 0 12.8357 0 0 0 13.0824 0 0 0 0 0 13.6787 0 14.6504 16.3288 0 14.0748 0 0 0 12.1386 0 0 0 0 0 0 0 13.2624 13.1802 11.8917 12.8335 13.1112 11.9761 14.0292 0 0 0 0 0 0 0 0 0 0 13.9837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5858 0 0 0 0 13.8402 0 0 14.5721 0 0 0 0 0 13.2789 11.6154 11.2814 0 11.3937 0 0 0 0 0 0 0 12.6733 0 0 0 0 0 0 0 0 0 0 12.0484 0 0 0 0 0 0 0 0 0 13.5765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0328 0 0 0 0 0 0 0 0 0 0 18.8164 0 O75916 RGS9_HUMAN "Regulator of G-protein signaling 9, RGS9" RGS9 Homo sapiens (Human) dark adaptation [GO:1990603]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; light adaption [GO:0036367]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; dark adaptation [GO:1990603]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; light adaption [GO:0036367]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; visual perception [GO:0007601] GO:0003924; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0007601; GO:0008277; GO:0009968; GO:0035556; GO:0036367; GO:0043005; GO:0043547; GO:0098839; GO:0098978; GO:1990603 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] DSYARYLK 0.99349 -13.469 0 0 0 0 0 0 0 0 13.0482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7335 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2233 0 0 0 0 14.0621 0 O75928 PIAS2_HUMAN "E3 SUMO-protein ligase PIAS2, EC 2.3.2.- (Androgen receptor-interacting protein 3, ARIP3) (DAB2-interacting protein, DIP) (E3 SUMO-protein transferase PIAS2) (Msx-interacting zinc finger protein, Miz1) (PIAS-NY protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2)" PIAS2 PIASX Homo sapiens (Human) "negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0008270; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0031625; GO:0043433; GO:0060766; GO:0061629; GO:0061665 DNA binding [GO:0003677]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] DYTVQVQLR 0.99349 -16.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6312 0 13.7175 0 0 0 13.201 13.1831 13.0965 13.3225 13.3508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4489 0 0 0 0 0 0 0 0 0 0 0 17.0471 0 13.5137 0 16.0091 0 0 0 0 16.7293 17.0576 0 0 13.0164 12.9899 0 0 17.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9305 14.7905 0 0 0 0 0 0 0 0 12.8825 0 0 0 11.1964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 P17706 PTN2_HUMAN "Tyrosine-protein phosphatase non-receptor type 2, EC 3.1.3.48 (T-cell protein-tyrosine phosphatase, TCPTP)" PTPN2 PTPT Homo sapiens (Human) B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]; B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217] GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0035335; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046426; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0061099; GO:0070104; GO:0070373; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587 integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905] ETGFSVK 0.99349 -28.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1653 0 0 0 0 0 0 0 0 P43897 EFTS_HUMAN "Elongation factor Ts, mitochondrial, EF-Ts, EF-TsMt" TSFM Homo sapiens (Human) "mitochondrial translational elongation [GO:0070125]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of mitochondrial translation [GO:0070129]; translational elongation [GO:0006414]" mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of mitochondrial translation [GO:0070129]; translational elongation [GO:0006414]" GO:0003723; GO:0003746; GO:0005654; GO:0005739; GO:0005759; GO:0006414; GO:0032784; GO:0070125; GO:0070129 RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] AAKLQGR 0.99349 -9.2367 0 0 0 9.85445 0 0 9.73363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2424 0 11.0137 0 0 0 0 0 0 0 0 0 12.0291 0 0 0 0 0 0 0 0 0 0 10.9123 9.89171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0188 0 14.7298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P84996 ALEX_HUMAN Protein ALEX (Alternative gene product encoded by XL-exon) GNAS GNAS1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone development [GO:0060348]; cognition [GO:0050890]; developmental growth [GO:0048589]; hair follicle placode formation [GO:0060789]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of signal transduction [GO:0009966] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone development [GO:0060348]; cognition [GO:0050890]; developmental growth [GO:0048589]; hair follicle placode formation [GO:0060789]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of signal transduction [GO:0009966] GO:0001726; GO:0005829; GO:0005886; GO:0007189; GO:0009966; GO:0016020; GO:0048589; GO:0050890; GO:0060348; GO:0060789; GO:0070527; GO:0120162 AAAAAACTTMK 0.99349 -28.18 0 0 0 0 0 0 0 0 0 0 13.541 0 0 0 0 0 0 14.638 14.8648 0 0 0 14.7009 10.5501 0 10.0974 11.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8255 0 0 0 0 10.8896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.245 12.8532 12.7371 0 0 13.2768 0 0 0 0 0 0 0 0 13.8937 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0427 14.7917 0 0 0 15.0287 0 0 0 0 0 13.2061 17.0588 0 14.0616 14.2857 14.9979 13.5336 13.1353 0 14.5575 0 14.0691 15.5005 0 0 11.1213 13.0775 13.2205 0 0 0 13.5764 0 12.7429 13.2042 16.3046 0 14.1106 14.6313 0 0 13.3192 0 12.9518 13.6755 13.4873 0 0 0 14.0302 13.5695 0 12.7235 0 13.8936 0 0 0 12.6973 0 0 0 0 0 11.9603 0 0 0 0 0 0 11.7336 14.3428 0 0 0 0 0 0 Q01081 U2AF1_HUMAN Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit) U2AF1 U2AF35 U2AFBP FP793 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0006397; GO:0008380; GO:0015030; GO:0016607; GO:0030628; GO:0046872; GO:0050733; GO:0071013; GO:0089701 metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; RS domain binding [GO:0050733] DRERSGR 0.99349 -16.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5601 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0804 17.9937 16.6384 0 0 0 0 0 15.0511 15.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6682 0 13.9475 0 0 0 0 13.6494 0 14.2337 14.4967 0 14.0518 0 0 0 13.4407 14.3351 13.9583 14.318 0 14.5505 0 0 0 0 0 0 0 0 14.0908 0 0 0 0 0 0 0 0 14.3998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9448 0 0 0 0 0 0 0 0 0 0 0 Q15008 PSMD6_HUMAN 26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A) PSMD6 KIAA0107 PFAAP4 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0000502; GO:0005576; GO:0005654; GO:0005829; GO:0005838; GO:0022624; GO:0030234; GO:0034774; GO:0043161; GO:1904813 enzyme regulator activity [GO:0030234] ANEDELKRLDEELEDAEK 0.99349 -9.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4306 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8024 0 13.8011 14.1292 13.8864 13.5543 0 0 12.2497 0 0 13.8525 13.2835 14.3453 0 13.0974 13.5979 0 0 0 0 13.2226 12.607 0 0 14.1584 12.9043 12.9515 0 12.7024 0 13.1682 13.7586 0 0 13.1117 13.9873 0 13.6522 13.0099 0 14.3077 13.6263 0 13.8217 14.2581 13.6949 0 0 13.3485 0 0 13.1104 0 0 0 0 0 0 0 13.5877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3935 0 0 12.9999 0 0 0 0 0 Q7LGC8 CHST3_HUMAN "Carbohydrate sulfotransferase 3, EC 2.8.2.17, EC 2.8.2.21 (Chondroitin 6-O-sulfotransferase 1, C6ST-1) (Chondroitin 6-sulfotransferase, C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0, GST-0)" CHST3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001517; GO:0005802; GO:0005975; GO:0006044; GO:0006790; GO:0008459; GO:0016021; GO:0030206 chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517] KEHMALK 0.99349 -28.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0614 0 11.0876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7128 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1496 0 0 0 0 0 0 0 0 0 14.1346 0 0 0 0 0 12.7416 0 0 0 0 0 0 0 0 0 0 0 15.1445 0 0 0 0 0 0 0 0 12.4357 0 0 0 0 12.7854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8103 0 0 0 0 0 14.2654 Q8IW00 VSTM4_HUMAN V-set and transmembrane domain-containing protein 4 [Cleaved into: Peptide Lv ] VSTM4 C10orf72 Homo sapiens (Human) endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; retina blood vessel maintenance [GO:0097601]; retina vasculature development in camera-type eye [GO:0061298]; sprouting angiogenesis [GO:0002040]; vasodilation [GO:0042311] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; retina blood vessel maintenance [GO:0097601]; retina vasculature development in camera-type eye [GO:0061298]; sprouting angiogenesis [GO:0002040]; vasodilation [GO:0042311] GO:0001935; GO:0002040; GO:0005576; GO:0005886; GO:0016021; GO:0042311; GO:0043542; GO:0061298; GO:0097601 KVTLPKIAEENLTYAELELIK 0.99349 -6.9405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9193 0 13.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4962 0 0 0 0 0 0 11.4695 0 0 0 0 0 0 0 11.9538 0 0 0 13.3491 0 0 0 0 0 14.327 15.4324 0 0 0 0 0 0 0 0 0 14.4365 0 14.8059 0 0 0 0 14.1219 0 0 14.3675 0 0 0 14.5546 14.6624 0 0 13.2864 0 0 0 0 13.215 0 0 0 0 0 0 0 13.9851 0 0 0 0 0 0 0 0 0 12.4515 0 0 0 0 0 0 0 13.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.675 0 0 0 0 0 0 0 Q8N283 ANR35_HUMAN Ankyrin repeat domain-containing protein 35 ANKRD35 Homo sapiens (Human) AAPGSIK 0.99349 -6.3033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3435 0 0 0 0 0 10.9094 12.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9184 0 0 0 0 11.8545 0 0 0 0 0 0 0 0 0 0 0 0 11.062 0 0 12.8172 12.8403 0 0 0 15.8714 0 0 0 0 0 11.2375 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0279 0 13.7967 0 0 0 0 0 0 0 0 0 0 11.3654 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9081 12.5701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7429 0 0 0 0 11.7923 0 0 0 0 0 13.4351 0 0 10.4207 0 0 Q8NB25 F184A_HUMAN Protein FAM184A FAM184A C6orf60 Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 EELRLQHEEDK 0.99349 -6.5129 0 0 0 0 0 0 0 0 0 14.8617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6541 0 0 0 0 0 0 0 0 0 0 0 14.0068 0 0 13.4294 0 0 0 0 0 0 13.5627 13.5022 12.7931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEK8 TET5D_HUMAN "Terminal nucleotidyltransferase 5D, EC 2.7.7.19 (Non-canonical poly(A) polymerase FAM46D)" TENT5D FAM46D Homo sapiens (Human) mRNA stabilization [GO:0048255] polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; mRNA stabilization [GO:0048255] GO:0004652; GO:0048255; GO:1990817 polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817] GNFPTMEVK 0.99349 -6.3125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1118 14.7258 0 0 0 0 0 0 0 0 0 0 11.9469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6935 0 0 0 0 0 0 0 0 13.941 0 0 0 0 0 0 0 10.4858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVF2 UCMA_HUMAN "Unique cartilage matrix-associated protein [Cleaved into: Unique cartilage matrix-associated protein C-terminal fragment, Ucma-C (Gla-rich protein, GRP) ]" UCMA C10orf49 Homo sapiens (Human) embryonic skeletal system development [GO:0048706]; negative regulation of biomineralization [GO:0110150]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392]; osteoblast differentiation [GO:0001649] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; embryonic skeletal system development [GO:0048706]; negative regulation of biomineralization [GO:0110150]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392]; osteoblast differentiation [GO:0001649] GO:0001649; GO:0005615; GO:0005737; GO:0031012; GO:0036122; GO:0045668; GO:0048706; GO:0060392; GO:0110150 BMP binding [GO:0036122] EYYEEQR 0.99349 -9.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7163 11.2882 0 0 0 11.5638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9778 0 0 0 0 0 0 0 12.6854 0 0 0 12.6788 0 0 0 0 13.5387 0 0 0 0 0 13.0548 0 0 12.9597 0 0 0 0 0 0 0 0 0 0 0 0 12.9424 12.7818 0 0 0 0 0 0 0 0 0 12.1208 0 0 0 0 12.8844 0 0 0 0 11.9202 0 0 0 0 0 0 0 0 0 Q92974 ARHG2_HUMAN "Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1, GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40)" ARHGEF2 KIAA0651 LFP40 Homo sapiens (Human) actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; spindle [GO:0005819]; vesicle [GO:0031982]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; asymmetric neuroblast division [GO:0055059]; cell cycle [GO:0007049]; cell morphogenesis [GO:0000902]; cellular hyperosmotic response [GO:0071474]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of necroptotic process [GO:0060546]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron migration [GO:2001224]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0000902; GO:0005085; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005856; GO:0005874; GO:0005923; GO:0005925; GO:0006886; GO:0007015; GO:0007026; GO:0007049; GO:0008017; GO:0008270; GO:0031267; GO:0031410; GO:0031982; GO:0032587; GO:0032755; GO:0032760; GO:0032991; GO:0035023; GO:0042127; GO:0045087; GO:0045666; GO:0045944; GO:0050731; GO:0051056; GO:0051092; GO:0055059; GO:0060546; GO:0071225; GO:0071356; GO:0071474; GO:1902042; GO:1902219; GO:2001224 guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] EDFPLIETEDEAYLRR 0.99349 -13.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.533 0 0 0 0 0 14.184 0 0 0 0 0 0 0 0 0 0 15.654 0 0 0 0 0 15.4678 0 0 0 0 0 12.3098 14.4621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2786 13.5049 0 0 0 13.8209 0 11.6254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.142 0 18.2519 17.8989 17.8936 18.27 0 13.3813 13.9745 0 0 0 0 0 0 0 0 18.0076 0 0 Q96AJ1 CLUA1_HUMAN Clusterin-associated protein 1 (Qilin) CLUAP1 KIAA0643 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle A [GO:0030991]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle A [GO:0030991]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224] GO:0001843; GO:0001947; GO:0005654; GO:0005813; GO:0005929; GO:0007224; GO:0021508; GO:0030991; GO:0030992; GO:0035082; GO:0035720; GO:0043231; GO:0060271; GO:0060972; GO:0097542; GO:0097546 AHIKLNTKK 0.99349 -28.132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1632 0 0 0 0 0 0 0 0 0 0 0 0 11.8349 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2508 0 0 0 0 0 0 0 0 0 0 12.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8466 0 0 0 13.7913 0 0 0 0 0 0 0 0 0 0 0 14.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUA8 ZBT40_HUMAN Zinc finger and BTB domain-containing protein 40 ZBTB40 KIAA0478 Homo sapiens (Human) bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; bone mineralization [GO:0030282]; cellular response to DNA damage stimulus [GO:0006974]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006974; GO:0030282; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AEHADMK 0.99349 -14.22 0 0 0 0 0 0 0 0 0 0 0 0 13.5714 0 12.5964 0 0 0 0 0 0 0 0 0 0 0 12.4144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5696 0 12.5042 0 0 0 0 0 0 0 0 0 0 11.5887 0 0 14.2625 0 12.9244 9.46587 0 0 9.86876 0 0 0 14.8257 0 0 0 0 0 0 12.136 9.97456 12.6539 0 0 0 0 0 0 0 12.0192 12.7901 0 0 0 13.3042 0 13.0171 15.3711 0 0 0 0 12.5695 0 0 0 0 9.11707 0 15.3103 12.5756 0 13.6765 0 0 0 0 14.7284 0 0 0 0 0 0 0 0 0 14.7566 0 0 0 12.1631 11.7593 0 0 13.1829 12.4902 13.9918 0 0 0 0 0 0 12.7305 0 0 0 0 0 12.7139 0 0 0 0 12.9641 0 0 0 14.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8884 14.6241 0 0 0 0 0 0 0 Q9Y3U8 RL36_HUMAN 60S ribosomal protein L36 (Large ribosomal subunit protein eL36) RPL36 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ALKFIKK 0.99349 -28.169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0341 0 0 0 0 12.6683 0 0 0 12.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MUU9 YV023_HUMAN Putative uncharacterized protein ENSP00000383309 Homo sapiens (Human) SLPRASRTR 0.9935 -13.499 0 0 0 0 0 0 0 0 0 0 0 0 10.3914 14.2863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0566 0 0 0 13.1525 0 0 0 0 0 0 12.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8742 0 0 0 0 0 0 0 13.1077 0 0 0 0 14.2662 0 12.4478 12.2225 0 0 0 0 0 0 0 0 0 0 0 12.5601 12.9033 0 0 12.7046 0 0 0 B7Z8K6 TRDC_HUMAN T cell receptor delta constant TRDC Homo sapiens (Human) "adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; gamma-delta T cell activation [GO:0046629]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; T cell receptor signaling pathway [GO:0050852]" "external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; immunoglobulin complex, circulating [GO:0042571]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]" "external side of plasma membrane [GO:0009897]; gamma-delta T cell receptor complex [GO:0042106]; immunoglobulin complex, circulating [GO:0042571]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; gamma-delta T cell activation [GO:0046629]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]; T cell receptor signaling pathway [GO:0050852]" GO:0002250; GO:0003823; GO:0005886; GO:0006910; GO:0006911; GO:0006958; GO:0009897; GO:0016021; GO:0034987; GO:0042106; GO:0042571; GO:0042742; GO:0045087; GO:0046629; GO:0050852; GO:0050853; GO:0050871 antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987] AIVHTEK 0.9935 -9.2489 0 0 0 13.2673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9519 0 0 0 0 0 0 0 0 10.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6657 0 0 0 0 13.8213 0 0 0 0 10.8773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00155 GPR25_HUMAN Probable G-protein coupled receptor 25 GPR25 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0007186 G protein-coupled receptor activity [GO:0004930] ARALDGACGRTGR 0.9935 -13.193 0 0 0 0 0 0 0 11.0244 14.2465 0 14.1066 14.0475 13.8111 13.6175 13.7875 0 0 0 0 0 0 0 0 0 0 0 0 13.3426 0 0 12.977 0 12.8408 12.8967 0 12.9616 0 12.7613 13.2222 12.8384 0 12.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0744 0 0 0 0 11.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7664 0 0 0 0 0 0 0 0 0 0 12.3766 11.7285 0 0 0 0 0 0 0 0 11.8338 12.3409 0 0 0 0 0 0 0 0 0 0 0 0 13.1437 0 0 0 0 0 12.5278 15.1959 15.2352 15.4438 0 0 0 0 15.4418 0 15.7127 0 15.0523 14.8892 0 0 0 0 11.3982 0 0 0 0 0 O43592 XPOT_HUMAN Exportin-T (Exportin(tRNA)) (tRNA exportin) XPOT Homo sapiens (Human) intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]; intracellular protein transport [GO:0006886]; tRNA export from nucleus [GO:0006409]; tRNA re-export from nucleus [GO:0071528] GO:0000049; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006409; GO:0006886; GO:0016363; GO:0031267; GO:0071528 small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] AAQVFALLFVTEYLTKWPKFFFDILSVVDLNPR 0.9935 -7.9341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.02 0 0 0 0 0 0 0 0 0 0 11.2297 0 0 0 13.8305 14.0507 0 13.3496 0 0 0 0 0 0 0 12.0082 0 0 0 0 0 0 0 11.8932 0 0 0 0 0 0 0 0 0 0 0 0 14.2779 0 0 0 0 0 14.9949 0 0 0 0 0 13.2311 0 0 13.04 0 0 14.303 0 0 0 0 0 0 14.1239 0 0 0 0 0 12.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2165 0 O60449 LY75_HUMAN "Lymphocyte antigen 75, Ly-75 (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205)" LY75 CD205 CLEC13B Homo sapiens (Human) endocytosis [GO:0006897]; immune response [GO:0006955]; inflammatory response [GO:0006954] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; endocytosis [GO:0006897]; immune response [GO:0006955]; inflammatory response [GO:0006954] GO:0005887; GO:0006897; GO:0006954; GO:0006955; GO:0009897; GO:0030246; GO:0038023; GO:0070062 carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023] DEDENKFVSRLMR 0.9935 -9.2546 0 0 11.0095 0 0 12.4248 0 0 0 0 0 0 0 0 12.3853 11.9243 0 12.6844 12.4193 12.1038 0 0 0 0 12.1282 12.6791 11.4946 12.1289 0 0 0 0 0 0 0 0 0 0 0 0 12.2694 0 0 12.4525 0 0 11.2209 0 11.8491 0 0 0 0 0 0 11.4311 0 0 0 0 0 0 14.1397 14.4731 0 0 0 0 0 0 0 0 11.496 0 0 0 0 0 14.0559 14.4286 14.7892 0 0 0 0 13.8942 14.9723 0 0 0 0 0 14.5465 13.7212 16.1977 0 13.5576 0 0 14.8047 0 12.8758 15.4749 14.6404 13.1776 14.152 0 13.5313 14.3599 15.2627 14.7522 14.5922 0 0 14.6535 14.6767 16.6416 13.3779 0 14.1247 13.1637 0 0 0 0 13.6365 13.9019 0 0 14.4722 0 13.4662 15.1353 14.5863 13.9643 15.3183 13.2149 12.2168 0 14.0945 12.3305 14.1666 0 0 0 14.4519 14.2978 12.5759 0 0 13.5439 12.4651 0 0 0 14.8683 12.8833 0 0 0 0 12.7876 0 0 13.2123 0 12.8742 0 12.3987 0 0 12.7712 13.6111 0 13.3253 0 0 0 0 12.5186 O75949 NALF2_HUMAN NALCN channel auxiliary factor 2 (Protein TED) (Transmembrane protein 28) (Transmembrane protein FAM155B) NALF2 FAM155B TED TMEM28 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion import across plasma membrane [GO:0098703] GO:0005886; GO:0016021; GO:0098703 AWLCSEYFSVTQQECQRWVPCKQYCLEVQTR 0.9935 -6.9873 9.96838 0 0 0 12.7835 0 0 0 0 0 0 0 0 0 0 12.3499 0 13.5814 0 0 0 0 0 0 12.5409 13.7216 14.3736 0 13.9884 13.749 0 0 0 0 13.829 10.9393 0 0 0 0 0 0 0 13.0375 0 0 13.761 13.7865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0336 0 11.5564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.707 0 0 0 0 14.3269 0 0 0 0 11.4201 11.474 0 13.0258 13.1502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0612 12.3543 0 12.0586 14.6959 0 0 0 0 12.9019 0 0 0 0 14.8104 0 0 0 0 0 0 0 0 0 12.8457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.207 0 0 0 0 0 0 O95936 EOMES_HUMAN "Eomesodermin homolog (T-box brain protein 2, T-brain-2, TBR-2)" EOMES TBR2 Homo sapiens (Human) "adaptive immune response [GO:0002250]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; chromatin remodeling [GO:0006338]; DNA demethylation [GO:0080111]; DNA methylation [GO:0006306]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; gene expression [GO:0010467]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive immune response [GO:0002250]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; cardioblast differentiation [GO:0010002]; CD8-positive, alpha-beta T cell differentiation involved in immune response [GO:0002302]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell fate specification [GO:0001708]; cerebral cortex neuron differentiation [GO:0021895]; cerebral cortex regionalization [GO:0021796]; chromatin remodeling [GO:0006338]; DNA demethylation [GO:0080111]; DNA methylation [GO:0006306]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; gene expression [GO:0010467]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; stem cell population maintenance [GO:0019827]; trophectodermal cell differentiation [GO:0001829]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001706; GO:0001707; GO:0001708; GO:0001714; GO:0001764; GO:0001829; GO:0002250; GO:0002302; GO:0003677; GO:0005634; GO:0006306; GO:0006338; GO:0006357; GO:0007420; GO:0010002; GO:0010467; GO:0016573; GO:0016575; GO:0019827; GO:0021772; GO:0021796; GO:0021895; GO:0031490; GO:0035914; GO:0043433; GO:0043565; GO:0045893; GO:0045944; GO:0048382; GO:0048708; GO:0060706; GO:0060809; GO:0061629; GO:0080111; GO:1990837 "chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" HQTEMIITK 0.9935 -13.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.947 0 0 0 18.2268 0 0 0 0 0 0 0 0 0 0 0 0 13.5575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22670 RFX1_HUMAN "MHC class II regulatory factor RFX1 (Enhancer factor C, EF-C) (Regulatory factor X 1, RFX) (Transcription factor RFX1)" RFX1 Homo sapiens (Human) immune response [GO:0006955]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; immune response [GO:0006955]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005654; GO:0006357; GO:0006955; GO:0043231; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ASSPLLR 0.9935 -13.491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.064 0 0 0 0 0 10.583 11.0375 0 0 0 0 0 12.4543 0 11.6432 0 0 0 0 0 11.8977 0 0 15.9598 0 0 0 0 0 0 0 12.2693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8023 0 0 0 10.086 0 0 0 10.7944 0 0 0 11.0735 0 0 13.9102 13.4163 12.7251 14.4934 14.5838 0 0 0 0 0 0 0 14.1158 12.8047 0 13.4155 0 0 0 14.867 0 0 0 12.556 0 0 14.0975 0 0 0 0 11.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4645 0 0 13.9838 0 13.339 0 0 0 0 0 13.7746 0 0 0 0 0 0 0 12.8149 0 0 0 0 0 0 0 0 0 12.174 0 0 0 0 0 0 0 0 0 0 0 0 13.6772 0 0 0 0 0 0 P31941 ABC3A_HUMAN "DNA dC->dU-editing enzyme APOBEC-3A, A3A, EC 3.5.4.38 (Phorbolin-1)" APOBEC3A Homo sapiens (Human) cellular response to xenobiotic stimulus [GO:0071466]; clearance of foreign intracellular DNA [GO:0044355]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to xenobiotic stimulus [GO:0071466]; clearance of foreign intracellular DNA [GO:0044355]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071] GO:0000932; GO:0003723; GO:0004126; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0010529; GO:0016554; GO:0044355; GO:0045071; GO:0045087; GO:0045869; GO:0047844; GO:0051607; GO:0070383; GO:0071466; GO:0080111 cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] HCWDTFVDHQGCPFQPWDGLDEHSQALSGR 0.9935 -6.9796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9638 0 0 0 13.2213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15390 MTFR1_HUMAN Mitochondrial fission regulator 1 (Chondrocyte protein with a poly-proline region) MTFR1 CHPPR FAM54A2 KIAA0009 Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005] GO:0000266; GO:0005739; GO:0005829; GO:0005886; GO:0007005; GO:0009060 EEGECSAR 0.9935 -6.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2VPJ9 LR75B_HUMAN Leucine-rich repeat-containing protein 75B (Leucine-rich repeat-containing protein FAM211B) LRRC75B C22orf36 FAM211B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ICRQLIYHLTPHSK 0.9935 -6.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.489 0 0 0 0 0 17.0922 0 0 0 0 13.393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9682 0 0 0 0 0 0 0 0 0 0 Q53EL6 PDCD4_HUMAN Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a) PDCD4 H731 Homo sapiens (Human) "apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]" GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0030509; GO:0043066; GO:0043508; GO:0045892; GO:0050729; GO:0060940; GO:0071222; GO:1900016; GO:1901224; GO:1904706; GO:1904761; GO:1905064; GO:1905461; GO:2000353 RNA binding [GO:0003723] ATVLLSMSKGGK 0.9935 -9.2603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8628 0 13.0674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1571 0 0 0 0 0 16.7903 15.7593 17.1354 16.396 16.066 15.8998 14.8372 0 0 16.1046 0 16.825 0 15.342 15.006 15.6192 0 15.9279 0 0 0 15.6442 0 0 0 16.1346 16.5484 0 14.8629 14.8751 15.4906 15.5813 15.1631 0 14.9572 15.7605 16.3698 0 0 0 15.0026 0 15.6666 16.0818 15.5187 15.5209 0 14.6501 15.0425 16.8373 12.0628 16.4879 0 14.8538 0 16.0447 0 15.3131 0 15.3874 0 14.5906 16.6872 14.692 14.9559 15.1104 15.1604 15.8736 15.3665 14.2222 16.5719 15.5183 15.2747 14.4395 0 0 13.6491 15.1233 0 15.0158 14.5166 14.872 15.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1222 14.1075 0 15.8809 0 0 0 15.6673 0 Q6ZSA7 LRC55_HUMAN Leucine-rich repeat-containing protein 55 (BK channel auxiliary gamma subunit LRRC55) LRRC55 Homo sapiens (Human) positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805] integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076] integral component of plasma membrane [GO:0005887]; voltage-gated potassium channel complex [GO:0008076]; potassium channel activator activity [GO:0099104]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805] GO:0005249; GO:0005887; GO:0008076; GO:0044325; GO:0071805; GO:0099104; GO:1903818 potassium channel activator activity [GO:0099104]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] GLFLHAK 0.9935 -13.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2715 0 0 0 0 0 0 13.3005 14.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1738 0 0 13.0637 12.465 0 0 0 0 0 0 Q86UF2 CTGE6_HUMAN "cTAGE family member 6, Protein cTAGE-6" CTAGE6 CTAGE6P Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] GO:0005789; GO:0006888; GO:0009306; GO:0016021; GO:0035459; GO:0070971 GEPSCDR 0.9935 -13.517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87971 0 0 0 0 0 0 0 0 14.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4126 0 0 0 0 0 13.1277 0 12.4781 0 15.4273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H169 STMN4_HUMAN "Stathmin-4 (Stathmin-like protein B3, RB3)" STMN4 Homo sapiens (Human) microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; microtubule depolymerization [GO:0007019]; neuron projection development [GO:0031175]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0005737; GO:0005794; GO:0007019; GO:0015631; GO:0030426; GO:0031110; GO:0031175; GO:0043005 tubulin binding [GO:0015631] DKHAEEVRK 0.9935 -6.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3U1 UN45A_HUMAN "Protein unc-45 homolog A, Unc-45A (GCUNC-45) (Smooth muscle cell-associated protein 1, SMAP-1)" UNC45A SMAP1 Homo sapiens (Human) cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517] GO:0005737; GO:0005794; GO:0005829; GO:0007517; GO:0016607; GO:0030154; GO:0045296; GO:0048471; GO:0051879; GO:0061077 cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879] AAQALAK 0.9935 -9.2521 0 0 0 12.0889 0 12.0587 0 0 0 0 10.3145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8754 0 0 0 0 14.8891 13.5313 14.0644 0 13.5338 0 0 0 0 0 0 0 0 0 0 13.5248 0 0 0 0 0 14.565 13.4598 0 14.2561 14.0385 14.3011 0 0 14.9018 14.7884 14.1011 14.343 0 13.4809 0 16.2551 0 0 0 0 14.8551 0 0 0 0 0 0 0 0 0 14.0296 0 14.877 0 0 0 0 0 0 15.4025 13.9873 0 16.4163 13.4186 12.6198 12.7168 15.2137 0 0 0 13.0642 14.8657 0 0 14.6387 14.6361 13.1673 12.51 0 0 0 0 0 0 0 0 11.4565 0 11.4028 0 0 0 0 0 0 14.0396 0 0 0 0 12.3408 Q9NP91 S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3 (Sodium/imino-acid transporter 1) (Solute carrier family 6 member 20) (Transporter rB21A homolog) SLC6A20 SIT1 XT3 XTRP3 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; amino-acid betaine transport [GO:0015838]; glycine transport [GO:0015816]; L-isoleucine import across plasma membrane [GO:1903806]; L-proline import across plasma membrane [GO:1904271]; proline import across plasma membrane [GO:1905647]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; amino-acid betaine transmembrane transporter activity [GO:0015199]; L-isoleucine transmembrane transporter activity [GO:0015188]; L-proline transmembrane transporter activity [GO:0015193]; neutral amino acid transmembrane transporter activity [GO:0015175]; proline:sodium symporter activity [GO:0005298]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; amino-acid betaine transport [GO:0015838]; glycine transport [GO:0015816]; L-isoleucine import across plasma membrane [GO:1903806]; L-proline import across plasma membrane [GO:1904271]; proline import across plasma membrane [GO:1905647]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104] GO:0005298; GO:0005886; GO:0005887; GO:0006865; GO:0015171; GO:0015175; GO:0015188; GO:0015193; GO:0015199; GO:0015816; GO:0015824; GO:0015838; GO:0016324; GO:0035725; GO:0089718; GO:0150104; GO:1903806; GO:1904271; GO:1905647 amino acid transmembrane transporter activity [GO:0015171]; amino-acid betaine transmembrane transporter activity [GO:0015199]; L-isoleucine transmembrane transporter activity [GO:0015188]; L-proline transmembrane transporter activity [GO:0015193]; neutral amino acid transmembrane transporter activity [GO:0015175]; proline:sodium symporter activity [GO:0005298] GDADPVA 0.9935 -13.509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2I9 TBC30_HUMAN TBC1 domain family member 30 TBC1D30 KIAA0984 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; plasma membrane [GO:0005886] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0031267; GO:0036064; GO:0043547; GO:0090630; GO:1902018 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] DRLLHKVQR 0.99351 -37.926 0 0 0 0 0 0 14.4236 0 0 0 0 10.5786 0 11.0503 0 0 15.0042 11.0918 12.1985 0 13.2002 0 0 0 0 0 0 0 11.76 0 0 0 0 0 0 0 10.5356 11.003 0 0 0 0 0 11.7649 0 0 0 14.3671 0 0 0 14.2502 0 11.4048 12.504 0 0 0 0 0 0 0 0 0 0 0 12.7796 14.8889 13.0289 0 14.5031 0 13.2061 13.5139 14.1688 14.0782 14.0375 11.9996 15.2975 17.077 14.3834 0 13.5162 13.9698 12.2998 15.3782 15.5054 13.9462 13.5585 14.7182 14.2263 15.7386 14.0204 12.7514 12.8907 0 0 0 15.4483 12.4674 14.6059 13.8885 15.0668 0 15.4309 15.1891 13.7565 15.0439 14.1742 15.2461 17.1802 12.5721 14.1677 15.0576 14.3726 14.7577 14.312 14.6605 13.1521 14.4257 14.2569 15.4078 15.0271 15.5187 13.0635 0 15.1994 13.5927 12.8388 14.6066 15.3385 15.2117 14.4522 14.2912 15.2953 14.2033 14.0066 14.8221 14.8204 14.7205 0 15.3039 15.1745 14.8317 14.2827 12.9878 16.8033 12.6506 0 12.5846 15.5214 0 14.0967 14.513 14.2427 15.1547 11.4582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3539 15.3888 15.5053 13.3966 12.216 0 12.13 14.1443 11.9876 P05771 KPCB_HUMAN "Protein kinase C beta type, PKC-B, PKC-beta, EC 2.7.11.13" PRKCB PKCB PRKCB1 Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; post-translational protein modification [GO:0043687]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; spectrin [GO:0008091]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell activation [GO:0042113]; B cell receptor signaling pathway [GO:0050853]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; cellular response to carbohydrate stimulus [GO:0071322]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; lipoprotein transport [GO:0042953]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; post-translational protein modification [GO:0043687]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] GO:0002250; GO:0003682; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006357; GO:0006468; GO:0006816; GO:0006874; GO:0006915; GO:0007077; GO:0007165; GO:0008091; GO:0008270; GO:0010827; GO:0010829; GO:0018105; GO:0030374; GO:0030949; GO:0035403; GO:0035556; GO:0042113; GO:0042393; GO:0042953; GO:0043123; GO:0043687; GO:0044305; GO:0045766; GO:0046627; GO:0050681; GO:0050853; GO:0050861; GO:0051092; GO:0070062; GO:0071322; GO:0099171; GO:0099523; GO:0106310; GO:2000300 ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein kinase C activity [GO:0004698]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone kinase activity (H3-T6 specific) [GO:0035403]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] CSLNPEWNETFR 0.99351 -13.94 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0582 0 0 0 12.184 0 0 12.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5162 0 0 0 0 0 0 11.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4589 14.279 15.6052 16.5895 15.9386 13.7303 12.9231 13.9792 14.1801 12.8366 13.7168 0 0 13.3274 0 0 0 13.0493 0 0 0 0 0 0 0 0 12.4476 13.1582 0 13.8862 0 0 0 0 0 0 0 0 0 12.5334 0 12.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5322 13.0424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2173 0 0 0 0 10.2907 0 0 15.3063 P53350 PLK1_HUMAN "Serine/threonine-protein kinase PLK1, EC 2.7.11.21 (Polo-like kinase 1, PLK-1) (Serine/threonine-protein kinase 13, STPK13)" PLK1 PLK Homo sapiens (Human) centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]; anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194] GO:0000070; GO:0000086; GO:0000122; GO:0000132; GO:0000278; GO:0000281; GO:0000287; GO:0000776; GO:0000785; GO:0000795; GO:0000922; GO:0000940; GO:0001578; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0006468; GO:0007052; GO:0007062; GO:0007076; GO:0007077; GO:0007094; GO:0007095; GO:0007098; GO:0007346; GO:0008017; GO:0010800; GO:0010997; GO:0015630; GO:0016321; GO:0016567; GO:0018105; GO:0019901; GO:0030071; GO:0030496; GO:0031648; GO:0032436; GO:0032465; GO:0034451; GO:0042802; GO:0043066; GO:0043393; GO:0045143; GO:0045184; GO:0045736; GO:0045862; GO:0051081; GO:0051233; GO:0051443; GO:0051726; GO:0070194; GO:0071168; GO:0090435; GO:0097431; GO:0106310; GO:1900182; GO:1901673; GO:1901990; GO:1904668; GO:1904776; GO:1905784 anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DGTESYLTVSSHPNSLMK 0.99351 -17.269 0 0 0 0 13.913 0 0 0 0 0 0 0 0 13.0098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5019 0 10.8468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0359 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7727 0 0 0 12.9798 0 0 0 0 14.9032 0 0 0 0 0 11.6534 13.0164 0 0 0 0 0 0 0 12.8911 12.1169 14.2332 16.2107 16.1732 11.8384 0 0 0 0 0 0 14.8664 12.54 0 14.7923 14.1298 0 16.4116 13.3346 0 11.9949 0 13.0574 0 0 14.8593 0 0 0 0 0 0 0 0 14.3029 13.6839 13.6291 0 0 0 0 0 0 0 0 12.6237 0 0 0 0 0 12.4271 0 12.2374 0 0 0 0 0 13.9319 0 0 0 0 0 0 0 0 0 0 13.7633 13.7348 14.237 0 0 0 0 14.9942 0 P54760 EPHB4_HUMAN "Ephrin type-B receptor 4, EC 2.7.10.1 (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)" EPHB4 HTK MYK1 TYRO11 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001525; GO:0002042; GO:0003007; GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007411; GO:0033674; GO:0043005; GO:0043235; GO:0046777; GO:0048013; GO:0070062 ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] EDLTYALRCRECR 0.99351 -7.963 0 0 0 0 0 0 0 0 15.0694 15.6245 14.8056 0 14.7381 14.9316 13.6895 12.1106 0 0 0 0 0 0 0 0 0 0 0 0 14.465 14.6157 14.6505 13.361 14.967 13.8612 0 0 0 0 0 0 0 14.5906 0 0 14.7859 0 10.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9434 0 0 0 0 0 0 0 0 0 0 0 14.108 13.2369 0 0 0 0 10.5757 0 13.2794 0 0 0 0 0 13.1942 0 0 0 0 0 Q49A92 CH034_HUMAN Uncharacterized protein C8orf34 (Protein VEST-1) C8orf34 Homo sapiens (Human) ETVTFNSSLLRPRVIGEWIGR 0.99351 -5.0258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0411 0 11.4864 0 0 0 0 0 0 0 14.0973 0 14.2155 0 14.0828 0 0 14.1115 0 0 0 14.5554 0 0 0 14.0519 14.0882 0 0 0 0 0 0 0 0 14.3359 0 13.1779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6176 0 0 0 14.3086 0 0 0 0 0 Q53R41 FAKD1_HUMAN "FAST kinase domain-containing protein 1, mitochondrial" FASTKD1 KIAA1800 Homo sapiens (Human) mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528] GO:0000959; GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0035770; GO:0044528 RNA binding [GO:0003723] ALCRNIPHMK 0.99351 -28.969 0 0 0 0 0 0 0 0 0 0 0 12.3357 12.7424 12.4306 0 0 12.4078 0 12.1203 0 0 0 0 12.668 0 0 12.5851 0 0 0 11.1515 0 11.6502 0 0 0 0 12.0775 13.0244 12.7221 0 0 0 11.9522 11.6856 0 0 9.82346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4693 0 0 0 0 0 0 0 13.3792 0 0 0 0 0 0 0 0 12.2802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2569 0 0 0 0 0 0 0 14.1171 0 0 0 0 0 15.6395 0 14.3228 13.8708 0 13.4891 13.752 0 10.1897 0 14.6766 0 13.8705 0 14.4526 0 0 0 0 0 14.1998 11.3552 12.5049 13.2243 0 0 0 0 0 0 0 0 0 0 13.7869 0 0 0 0 0 0 13.0177 0 0 0 0 0 0 0 15.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VXU9 SHOC1_HUMAN "Protein shortage in chiasmata 1 ortholog, EC 3.6.-.- (Protein ZIP2 homolog, MZIP2)" SHOC1 C9orf84 ZIP2 Homo sapiens (Human) reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712] chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794] chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000712; GO:0000794; GO:0003697; GO:0005694; GO:0007131; GO:0016887 ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697] ASFEHGK 0.99351 -15.927 0 12.6159 0 0 0 0 14.6889 0 0 0 0 0 11.4943 0 0 0 0 0 0 0 0 0 0 11.7458 11.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3309 0 0 0 13.1559 0 0 0 0 0 12.9994 0 13.5955 0 0 0 17.4979 17.2136 14.027 0 15.8809 0 13.2194 0 0 0 0 12.8912 14.4957 13.4446 13.3341 0 0 0 0 0 0 14.0314 14.5867 14.1941 11.7825 0 0 11.1643 11.4069 13.6573 0 13.6891 0 15.0634 11.9372 15.0368 14.0914 0 13.0712 0 0 13.2699 0 0 13.6783 0 0 0 0 12.4542 0 0 13.3886 0 12.6723 13.3015 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2924 0 0 0 0 0 0 0 13.6077 14.4726 0 0 0 0 0 0 13.9433 13.5438 11.5692 0 0 0 13.8376 0 0 0 13.6932 0 12.188 Q6ZRS4 ITPI1_HUMAN Protein ITPRID1 (Coiled-coil domain-containing protein 129) (ITPR-interacting domain-containing protein 1) ITPRID1 CCDC129 Homo sapiens (Human) signaling receptor binding [GO:0005102] GO:0005102 signaling receptor binding [GO:0005102] LKSLSHLAGK 0.99351 -5.2265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3258 0 0 14.0599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVF2 AHNK2_HUMAN Protein AHNAK2 AHNAK2 C14orf78 KIAA2019 Homo sapiens (Human) regulation of RNA splicing [GO:0043484] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; regulation of RNA splicing [GO:0043484] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0030315; GO:0042383; GO:0043484 ALVDVSAPK 0.99351 -37.744 12.1249 0 0 0 0 0 12.6088 13.7505 11.786 0 0 0 0 12.2594 0 0 0 12.0531 0 0 0 0 0 0 0 0 0 12.2414 0 0 0 0 0 0 0 0 0 0 0 0 12.1847 0 0 0 12.2969 0 0 0 11.5594 0 0 0 0 0 0 0 11.5922 0 0 0 0 0 0 0 0 0 0 0 0 13.6022 14.477 14.8484 13.4885 0 0 12.6795 14.1505 12.2807 0 0 0 0 0 13.6154 13.5812 13.5476 11.9062 11.3835 0 0 12.1875 0 0 0 0 13.7629 0 0 15.0832 0 12.2571 0 0 14.6418 14.2822 0 0 0 0 0 0 14.531 0 0 0 0 0 13.0885 0 0 0 0 0 0 13.9564 13.8992 0 0 0 0 0 14.0509 0 11.9243 13.6581 0 0 0 14.8192 12.9642 13.1969 0 0 15.3412 0 14.0396 12.5406 13.1617 0 0 0 0 13.3744 0 14.0302 0 0 0 0 0 14.7798 0 0 15.1596 13.0301 14.7875 0 14.6084 14.5692 15.112 14.4677 0 0 0 12.8882 14.9862 0 0 15.2646 16.613 Q8NB91 FANCB_HUMAN "Fanconi anemia group B protein, Protein FACB (Fanconi anemia-associated polypeptide of 95 kDa, FAAP95)" FANCB Homo sapiens (Human) interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein monoubiquitination [GO:0006513]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein monoubiquitination [GO:0006513]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414] GO:0000785; GO:0005654; GO:0006513; GO:0036297; GO:0043240; GO:1905168; GO:1990414; GO:2000042 ALINLVQGK 0.99351 -13.939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9424 14.243 0 0 12.6164 0 0 0 0 13.5125 12.7927 0 0 0 13.539 0 0 0 0 0 0 13.8458 0 0 0 12.6229 12.2838 13.4805 0 0 14.8587 0 12.9853 13.716 12.9808 15.3483 14.5748 0 0 0 0 0 0 0 0 0 0 0 13.8276 13.5946 15.6595 15.5682 15.8772 0 14.4798 0 0 0 12.7045 0 0 13.758 0 13.8092 0 10.9157 0 0 0 0 0 12.6568 9.57749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2697 0 0 0 0 14.6214 0 0 0 0 0 0 0 Q96EF0 MTMR8_HUMAN "Myotubularin-related protein 8 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64)" MTMR8 Homo sapiens (Human) negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of macroautophagy [GO:0016241] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; negative regulation of autophagy [GO:0010507]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of macroautophagy [GO:0016241]" GO:0004438; GO:0005635; GO:0005737; GO:0005829; GO:0010507; GO:0016241; GO:0032991; GO:0046856; GO:0052629; GO:0106018 "phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphatase activity [GO:0004438]" AIMDAGIFITKAVKVEK 0.99351 -15.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4385 0 0 0 0 16.7396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2739 0 0 13.8409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8392 0 0 0 0 0 0 0 Q9UI54 YT001_HUMAN Putative uncharacterized protein PRO0628 PRO0628 Homo sapiens (Human) FSHISFIILFKVFLFPRITISK 0.99351 -5.0272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3809 0 0 0 0 0 0 0 0 0 0 0 12.245 0 0 0 0 0 0 11.4626 0 11.4366 0 0 0 10.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1236 0 0 12.928 0 0 11.4586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKV3 ACINU_HUMAN "Apoptotic chromatin condensation inducer in the nucleus, Acinus" ACIN1 ACINUS KIAA0670 Homo sapiens (Human) "apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]" ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]" GO:0003676; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0019899; GO:0030218; GO:0030263; GO:0043065; GO:0045657; GO:0048025; GO:0061574 ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723] CEAEEAEPPAATQPQTSETQTSHLPESERIHHTVEEK 0.99351 -15.922 0 0 10.8007 0 0 0 0 0 0 0 0 0 0 0 9.98982 0 0 0 13.9785 0 0 0 0 0 0 0 0 0 0 0 0 0 10.662 10.5837 0 0 0 0 0 0 0 0 0 0 0 0 12.1911 0 0 0 11.1359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6361 0 14.2244 14.4312 12.0465 0 12.5905 0 0 10.8904 0 11.94 0 0 12.7264 10.7625 0 14.8017 0 0 0 13.6997 13.8902 14.5656 0 0 0 0 0 13.6461 0 13.8612 0 0 0 13.0764 15.377 0 0 0 12.464 12.2132 0 12.774 0 0 0 0 0 12.9684 0 0 0 12.0949 0 14.1707 0 0 14.0002 13.5191 0 0 12.6426 0 0 12.0973 10.5864 0 0 0 0 0 0 0 0 12.5753 0 12.7756 0 0 0 0 0 11.8238 0 0 0 0 0 13.5552 0 0 0 0 10.4084 0 0 0 0 0 0 10.0067 0 0 0 0 0 0 0 0 0 11.4473 0 0 Q9Y221 NIP7_HUMAN 60S ribosome subunit biogenesis protein NIP7 homolog (KD93) (Nucleolar pre-rRNA processing protein NIP7) NIP7 CGI-37 HSPC031 HSPC180 OK/SW-cl.76 OK/SW-cl.78 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]" "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255]" GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0030687; GO:0042255; GO:0042273 RNA binding [GO:0003723] KVDPMAIVVFHQADIGEYVR 0.99351 -5.2348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0A6 SETD5_HUMAN "Histone-lysine N-methyltransferase SETD5, EC 2.1.1.359, EC 2.1.1.367 (SET domain-containing protein 5)" SETD5 KIAA1757 Homo sapiens (Human) "chromatin organization [GO:0006325]; cognition [GO:0050890]; histone H3-K36 trimethylation [GO:0097198]; regulation of chromatin organization [GO:1902275]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of histone acetylation [GO:0035065]; regulation of synapse assembly [GO:0051963]; regulation of transcription, DNA-templated [GO:0006355]" Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967] "Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rpd3L-Expanded complex [GO:0070210]; Set3 complex [GO:0034967]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; cognition [GO:0050890]; histone H3-K36 trimethylation [GO:0097198]; regulation of chromatin organization [GO:1902275]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of histone acetylation [GO:0035065]; regulation of synapse assembly [GO:0051963]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000791; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016593; GO:0032784; GO:0034967; GO:0035064; GO:0035065; GO:0046974; GO:0046975; GO:0050890; GO:0051963; GO:0070210; GO:0097198; GO:1902275 histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; methylated histone binding [GO:0035064] FGSPFIPER 0.99352 -6.809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2679 0 11.5039 0 11.472 11.7584 0 0 12.289 0 11.7566 0 16.2257 11.8393 0 12.522 0 11.2996 0 0 0 12.0467 0 11.8031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8635 0 0 0 0 12.5604 15.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9158 0 0 0 14.7975 11.4363 0 0 0 0 0 0 0 0 14.8694 0 0 0 0 0 0 0 10.8889 0 0 0 0 0 0 0 0 0 0 0 12.0318 12.8045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6906 0 0 0 0 0 0 12.9456 0 0 0 13.7416 12.1691 0 12.5329 12.8672 12.3134 0 16.67 16.7016 16.7366 13.5915 0 12.1078 0 0 0 0 0 0 0 16.819 0 0 Q8IXT1 DDIAS_HUMAN DNA damage-induced apoptosis suppressor protein (Nitric oxide-inducible gene protein) DDIAS C11orf82 NOXIN Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of DNA stability [GO:0097752] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of DNA stability [GO:0097752] GO:0005634; GO:0005737; GO:0006915; GO:0007049; GO:0097752; GO:1902230 CLAAYHFPDQQELPRKK 0.99352 -29.101 0 0 0 15.1046 13.6402 0 11.9579 14.1076 0 0 0 0 0 0 10.9047 12.652 13.4144 12.7977 13.3428 13.6086 0 0 0 0 0 0 11.6422 0 0 0 0 0 12.3155 0 0 12.864 0 0 12.8154 0 0 0 0 12.9684 11.9688 0 0 0 11.2618 0 0 12.9121 12.4798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8232 15.6081 0 0 0 15.8956 16.1687 16.6971 0 0 0 0 0 0 0 0 0 0 0 0 12.9364 0 17.9095 0 0 0 16.9992 17.6364 16.6921 14.8965 16.1278 15.8174 14.7375 0 12.7078 13.3508 14.8681 13.7796 12.4033 18.0611 17.6633 15.9227 15.5832 14.8525 0 13.1834 15.0491 15.3438 16.6128 15.1312 13.3591 0 13.8718 0 16.4098 16.0513 15.0599 0 14.2934 16.0369 14.1521 0 0 0 17.0538 0 0 14.1287 15.4538 15.2113 14.6974 0 12.4235 14.3249 0 0 0 14.6468 13.9266 13.8511 0 14.2572 0 15.4087 0 12.344 0 0 0 0 0 11.7043 0 0 0 0 0 0 16.6124 16.9706 13.7133 15.3407 0 0 0 0 0 O15488 GLYG2_HUMAN "Glycogenin-2, GN-2, GN2, EC 2.4.1.186" GYG2 Homo sapiens (Human) glycogen biosynthetic process [GO:0005978] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; glycogenin glucosyltransferase activity [GO:0008466]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978] GO:0005737; GO:0005829; GO:0005978; GO:0008466; GO:0016757; GO:0046872; GO:0102751 glycogenin glucosyltransferase activity [GO:0008466]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751] ELSPEEER 0.99352 -5.2599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.89 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1862 0 0 0 0 0 10.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6223 0 0 0 0 0 12.3754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1657 0 0 0 0 0 0 11.6016 0 0 0 0 0 11.5528 0 0 0 0 0 11.5699 0 0 0 0 0 0 0 0 0 0 0 0 0 9.59986 0 0 0 0 0 0 0 0 0 0 10.9251 0 0 0 0 0 0 0 10.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 10.028 0 O76074 PDE5A_HUMAN "cGMP-specific 3',5'-cyclic phosphodiesterase, EC 3.1.4.35 (cGMP-binding cGMP-specific phosphodiesterase, CGB-PDE)" PDE5A PDE5 Homo sapiens (Human) cGMP catabolic process [GO:0046069]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; oocyte development [GO:0048599]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098] cytosol [GO:0005829] "cytosol [GO:0005829]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; oocyte development [GO:0048599]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098]" GO:0004114; GO:0005829; GO:0007165; GO:0010613; GO:0010749; GO:0030553; GO:0042098; GO:0042130; GO:0043406; GO:0046069; GO:0046872; GO:0047555; GO:0048599; GO:0055118; GO:0055119; GO:0060282 "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]" FDHDEGDQCSR 0.99352 -17.31 0 18.2586 18.3409 11.8524 18.4999 19.6 19.4117 13.9173 14.1842 0 15.7239 15.4052 15.5019 0 14.9366 13.7233 14.2666 0 0 10.6334 0 19.0727 0 19.08 13.2379 0 0 14.6007 15.3395 15.2053 0 14.1955 0 0 14.0178 0 14.679 14.7225 14.5899 0 0 0 12.7015 14.4923 14.0218 0 0 0 0 0 10.8122 12.904 10.7363 0 10.1992 0 9.93799 0 0 0 0 0 0 0 0 0 18.6213 18.7297 18.6841 14.0613 18.8373 19.0373 12.7638 19.3858 19.514 19.7404 19.8216 16.3768 16.3491 20.0167 20.1589 16.9785 17.1297 17.0758 11.7525 17.112 16.9989 19.036 17.9454 18.8949 17.2516 18.4833 18.839 17.6064 20.0469 20.0347 18.4866 16.778 16.2515 20.2609 16.548 20.3013 20.4206 14.2928 15.094 20.1203 20.011 16.0676 19.9334 16.018 20.0289 19.5504 19.6546 19.7144 19.8043 16.0169 19.6686 19.6086 19.6376 19.6718 19.6197 19.5978 19.5411 14.3388 19.5151 13.1463 19.4963 19.4445 19.3994 19.3529 19.3755 13.894 19.3464 19.22 15.3226 12.3692 14.8378 19.2434 19.0871 19.1985 19.0442 12.4163 18.8513 18.832 14.6208 14.1257 18.723 0 0 0 18.825 18.6963 0 19.2024 18.7168 18.8348 0 0 0 14.0712 0 0 11.724 0 0 0 13.5286 0 0 0 12.2932 18.4821 18.4618 13.9102 11.6879 0 0 0 0 0 P0DOX5 IGG1_HUMAN Immunoglobulin gamma-1 heavy chain (Immunoglobulin gamma-1 heavy chain NIE) Homo sapiens (Human) adaptive immune response [GO:0002250] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250] GO:0002250; GO:0005576; GO:0005886; GO:0019814 EEQYNSTYR 0.99352 -5.2558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6775 13.8373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49761 CLK3_HUMAN "Dual specificity protein kinase CLK3, EC 2.7.12.1 (CDC-like kinase 3)" CLK3 Homo sapiens (Human) peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] GO:0001669; GO:0003723; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0006468; GO:0016020; GO:0016607; GO:0018108; GO:0042802; GO:0043484; GO:0045111; GO:0046777; GO:0106310 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA binding [GO:0003723] FLCVLMSDWFNFHGHMCIAFELLGK 0.99352 -29.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5262 0 0 0 0 0 0 0 0 0 12.4777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3397 11.8623 0 13.1539 0 14.6055 13.8884 0 0 12.17 0 0 0 12.0241 13.0976 13.9081 0 0 14.8934 0 0 0 0 0 0 0 0 0 11.3434 0 0 14.4095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5194 0 0 0 0 0 12.0857 0 0 0 0 0 15.7709 0 0 13.9988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7662 0 11.5933 0 0 0 0 0 0 0 0 0 0 0 17.1482 0 13.3177 0 0 0 0 0 0 0 0 0 12.6601 0 0 0 0 0 13.8217 0 0 0 0 0 0 0 0 Q13523 PRP4B_HUMAN "Serine/threonine-protein kinase PRP4 homolog, EC 2.7.11.1 (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog)" PRPF4B KIAA0536 PRP4 PRP4H PRP4K Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]" catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380]" GO:0000398; GO:0003723; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005694; GO:0006468; GO:0008380; GO:0016607; GO:0045292; GO:0071013; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] DNARANQEVAVKIIR 0.99352 -38.407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4663 13.9533 0 0 0 0 0 0 0 0 14.3467 0 13.5184 11.9308 0 0 12.9756 0 0 0 13.3433 14.0222 13.5177 0 15.0661 0 0 0 0 12.7811 0 0 0 0 0 0 0 0 0 0 0 13.2261 14.6951 0 0 0 0 12.8326 0 0 14.1715 0 0 0 0 13.0582 0 13.2253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7514 0 0 0 17.2454 0 0 0 0 0 0 0 11.7827 0 0 0 12.9793 0 0 0 0 0 0 0 16.7346 12.3861 0 Q5VT52 RPRD2_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 2 RPRD2 KIAA0460 HSPC099 Homo sapiens (Human) mRNA 3'-end processing [GO:0031124] "nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]" "nucleoplasm [GO:0005654]; RNA polymerase II, holoenzyme [GO:0016591]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]" GO:0000993; GO:0005654; GO:0016591; GO:0031124 RNA polymerase II complex binding [GO:0000993] DHGGIFSR 0.99352 -29.112 0 0 0 0 0 0 0 0 11.1916 0 0 0 11.3656 0 0 0 13.2051 0 0 9.84171 0 12.3183 11.7228 0 12.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4466 12.588 0 0 0 0 10.0708 0 0 14.2693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6545 0 0 0 15.5087 0 0 0 0 0 0 0 0 12.6688 13.866 0 0 0 0 0 0 0 15.3128 15.2002 15.0055 13.816 15.4646 0 15.2536 13.2876 0 0 17.3023 14.6061 0 11.8995 0 12.9866 0 0 13.1009 0 0 0 0 14.3499 13.4945 0 13.9016 0 0 0 0 0 0 0 13.1789 13.476 0 0 0 0 0 0 12.7591 9.96438 0 12.2543 0 0 0 0 11.3285 0 0 0 0 0 0 0 0 12.1753 0 0 11.8139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF30 WHAMM_HUMAN "WASP homolog-associated protein with actin, membranes and microtubules (WAS protein homology region 2 domain-containing protein 1, WH2 domain-containing protein 1)" WHAMM KIAA1971 WHDC1 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; focal adhesion assembly [GO:0048041]; lamellipodium assembly [GO:0030032]; plasma membrane tubulation [GO:0097320]; positive regulation of actin nucleation [GO:0051127] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; microtubule [GO:0005874] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; actin filament reorganization [GO:0090527]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; focal adhesion assembly [GO:0048041]; lamellipodium assembly [GO:0030032]; plasma membrane tubulation [GO:0097320]; positive regulation of actin nucleation [GO:0051127] GO:0000139; GO:0003779; GO:0005737; GO:0005829; GO:0005874; GO:0006888; GO:0007015; GO:0008017; GO:0030032; GO:0030659; GO:0031267; GO:0033116; GO:0034314; GO:0048041; GO:0051127; GO:0071933; GO:0090527; GO:0097320 actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267] ARWVEADARLR 0.99352 -17.312 0 0 0 0 0 0 0 0 11.8322 0 0 0 0 0 0 0 0 0 0 0 12.7171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6259 0 12.7327 0 0 0 0 0 0 14.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7161 13.2054 0 0 0 0 0 0 0 0 0 0 0 14.0996 0 0 0 0 0 0 0 14.6751 0 0 12.5683 0 0 0 0 0 0 0 0 0 0 0 14.0636 0 0 13.6571 0 0 0 0 0 0 0 0 13.6124 0 14.6245 0 0 0 0 0 0 0 14.2037 0 13.8533 0 0 0 0 15.0378 14.1347 0 0 0 0 0 0 Q96DR7 ARHGQ_HUMAN Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; endothelial cell morphogenesis [GO:0001886]; ruffle assembly [GO:0097178] cytosol [GO:0005829]; ruffle [GO:0001726] cytosol [GO:0005829]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; endothelial cell morphogenesis [GO:0001886]; ruffle assembly [GO:0097178] GO:0001726; GO:0001886; GO:0005085; GO:0005829; GO:0090630; GO:0097178 guanyl-nucleotide exchange factor activity [GO:0005085] EKFSSLGR 0.99352 -6.5697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8669 0 10.0855 11.8013 0 0 0 0 0 11.4426 0 0 0 0 0 0 0 0 0 10.3437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8444 0 0 0 0 0 0 0 0 0 0 0 13.3004 0 0 12.7984 0 0 0 0 0 0 0 0 0 17.1994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7436 0 0 0 0 0 0 0 13.1185 15.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNQ2 DIM1_HUMAN "Probable dimethyladenosine transferase, EC 2.1.1.183 (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)" DIMT1 DIMT1L HUSSY-05 Homo sapiens (Human) positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; positive regulation of rRNA processing [GO:2000234]; rRNA methylation [GO:0031167]" GO:0000179; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0031167; GO:0052909; GO:2000234 "18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]" CAILMFQR 0.99352 -29.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9562 0 0 0 0 0 13.5031 0 12.8799 0 13.213 0 12.0447 0 11.9863 0 0 0 0 12.3096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4524 14.2101 13.8853 0 0 13.2301 0 0 0 0 0 0 13.9664 13.163 0 12.7712 14.1856 0 0 0 0 0 0 0 15.4844 0 0 0 0 0 0 0 0 0 0 13.2821 12.9735 0 0 0 13.6785 12.8697 0 0 0 0 0 0 12.7489 0 0 11.9431 0 0 0 0 12.9637 14.0669 0 0 0 0 12.8324 0 0 0 0 12.0237 0 0 0 16.739 0 0 14.3617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5748 0 15.8745 0 0 0 0 0 0 A5A3E0 POTEF_HUMAN POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein) POTEF A26C1B Homo sapiens (Human) retina homeostasis [GO:0001895] blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; cell cortex [GO:0005938]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; retina homeostasis [GO:0001895] GO:0001895; GO:0005615; GO:0005938; GO:0070062; GO:0072562 EAQSKRGILTLK 0.99353 -27.874 0 0 0 13.5324 12.8863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7575 0 0 0 0 0 11.8637 11.2248 0 0 0 0 0 0 13.0796 0 9.99661 11.367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2689 0 0 10.3006 0 0 0 0 0 0 0 0 0 0 15.4761 0 0 0 0 0 0 14.4356 0 19.719 12.0749 12.8521 0 0 14.7526 0 13.8052 0 20.4192 0 0 0 0 13.8317 14.6914 19.3345 19.2187 18.6077 0 18.9088 0 18.5281 0 20.3114 19.757 20.2998 9.87596 0 0 0 0 0 15.1638 13.1354 0 0 0 0 11.6921 12.667 0 0 0 0 0 13.535 13.6559 15.056 0 18.9061 0 14.2669 0 0 0 17.9361 17.8124 0 13.867 10.5977 14.1422 0 0 0 0 13.9797 0 12.6354 0 12.3457 0 0 0 14.2561 0 17.9877 14.7991 0 13.269 0 18.9797 0 0 18.2638 0 0 12.9691 0 0 B0YJ81 HACD1_HUMAN "Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1, EC 4.2.1.134 (3-hydroxyacyl-CoA dehydratase 1, HACD1) (Cementum-attachment protein, CAP) (Protein-tyrosine phosphatase-like member A)" HACD1 PTPLA Homo sapiens (Human) cementum mineralization [GO:0071529]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811]; protein-containing complex assembly [GO:0065003]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; hydroxyapatite binding [GO:0046848]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158]; cementum mineralization [GO:0071529]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811]; protein-containing complex assembly [GO:0065003]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761] GO:0005783; GO:0005789; GO:0010811; GO:0018812; GO:0019899; GO:0030148; GO:0030176; GO:0030497; GO:0035338; GO:0042761; GO:0046848; GO:0065003; GO:0071529; GO:0080023; GO:0102158; GO:0102343; GO:0102344; GO:0102345 3-hydroxy-arachidoyl-CoA dehydratase activity [GO:0102343]; 3-hydroxy-behenoyl-CoA dehydratase activity [GO:0102344]; 3-hydroxy-lignoceroyl-CoA dehydratase activity [GO:0102345]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3R-hydroxyacyl-CoA dehydratase activity [GO:0080023]; enzyme binding [GO:0019899]; hydroxyapatite binding [GO:0046848]; very-long-chain 3-hydroxyacyl-CoA dehydratase activity [GO:0102158] FYMEKGTHR 0.99353 -6.8423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2077 0 0 0 0 0 0 B8ZZ34 SHSA8_HUMAN Protein shisa-8 (Shisa family member 8) SHISA8 C22orf17 Homo sapiens (Human) regulation of AMPA receptor activity [GO:2000311]; regulation of short-term neuronal synaptic plasticity [GO:0048172] AMPA glutamate receptor complex [GO:0032281]; dendritic spine membrane [GO:0032591]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] AMPA glutamate receptor complex [GO:0032281]; dendritic spine membrane [GO:0032591]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; regulation of AMPA receptor activity [GO:2000311]; regulation of short-term neuronal synaptic plasticity [GO:0048172] GO:0014069; GO:0032281; GO:0032591; GO:0045211; GO:0048172; GO:2000311 CRGYYDVMGQWDPPFNCSSGAYSFCCGTCGYR 0.99353 -6.8511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8285 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5984 0 0 12.1388 0 0 0 0 0 0 0 0 0 11.6538 0 0 0 0 12.6979 0 13.1785 0 0 0 0 0 0 0 0 0 10.2471 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1115 0 13.6577 13.358 15.1737 0 0 14.5808 13.9929 14.7895 15.5839 15.101 0 10.9085 14.8046 14.1575 0 0 0 11.2541 0 13.1194 15.7066 0 0 0 0 0 0 14.2656 0 13.3746 0 10.9559 12.7916 0 0 15.0951 14.0185 14.6054 13.0953 12.6272 13.7722 0 15.3001 13.4049 11.1283 14.7342 14.8423 12.8584 14.9891 13.3744 0 12.5138 13.2854 0 0 13.4188 0 14.8492 0 0 0 14.9282 13.7233 0 11.872 0 0 0 11.4598 0 0 10.9534 13.2198 0 14.8833 15.7343 10.5669 0 0 0 0 0 0 0 0 0 0 11.513 0 0 0 0 0 0 0 14.0322 0 13.7591 0 15.4091 0 0 0 O95685 PPR3D_HUMAN "Protein phosphatase 1 regulatory subunit 3D (Protein phosphatase 1 regulatory subunit 6, PP1 subunit R6) (Protein phosphatase 1-binding subunit R6)" PPP1R3D PPP1R6 Homo sapiens (Human) glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] glycogen granule [GO:0042587]; intracellular membrane-bounded organelle [GO:0043231]; protein phosphatase type 1 complex [GO:0000164] glycogen granule [GO:0042587]; intracellular membrane-bounded organelle [GO:0043231]; protein phosphatase type 1 complex [GO:0000164]; glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981] GO:0000164; GO:0004722; GO:0005977; GO:0005979; GO:0005981; GO:0008157; GO:0042587; GO:0043231; GO:2001069 glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722] LQRQLVCLER 0.99353 -14.064 0 0 0 0 0 0 0 0 0 0 0 12.7667 0 0 0 0 0 13.1351 0 0 0 0 12.0815 0 0 0 0 0 0 11.8757 0 0 11.6462 0 0 0 12.811 0 0 0 11.8568 0 0 0 0 0 0 0 0 0 10.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6112 0 13.3394 0 0 0 0 0 0 0 14.489 0 0 0 13.8779 0 0 13.0772 0 0 0 0 0 13.3022 0 13.3749 0 13.6509 0 0 13.0649 12.9575 0 0 0 0 0 0 0 0 0 12.8714 0 13.3025 0 0 0 0 13.1302 0 0 13.1425 0 0 0 0 12.8464 0 0 13.0673 0 0 0 0 0 0 0 0 0 0 0 0 12.6321 12.3126 0 0 0 0 0 0 0 0 0 13.3548 13.2075 12.8039 0 0 0 0 0 0 0 0 13.405 12.8451 0 0 0 0 0 0 12.5065 0 0 0 0 0 0 0 P12270 TPR_HUMAN Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404] GO:0000122; GO:0000776; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006999; GO:0007094; GO:0010965; GO:0015631; GO:0017056; GO:0019898; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0032880; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070840; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673 chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631] AIVAAKSKIAHLAGVK 0.99353 -27.981 0 0 0 0 0 0 0 0 0 10.9802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6178 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3473 0 0 0 0 0 0 0 0 0 0 11.696 0 0 0 0 0 0 12.6964 0 0 0 0 0 13.477 0 14.8547 14.4488 0 0 11.938 0 0 0 0 13.405 0 12.8186 0 0 0 13.0084 0 0 10.9625 0 0 0 0 0 0 0 0 0 12.11 0 15.8317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.348 0 0 0 0 0 0 0 14.3357 0 10.9692 15.6705 0 0 0 0 0 0 0 0 0 11.335 0 0 0 0 10.8987 0 0 0 0 11.3167 14.9745 0 0 0 0 0 0 0 0 0 P14920 OXDA_HUMAN "D-amino-acid oxidase, DAAO, DAMOX, DAO, EC 1.4.3.3" DAO DAMOX Homo sapiens (Human) D-alanine catabolic process [GO:0055130]; D-amino acid catabolic process [GO:0019478]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; dopamine biosynthetic process [GO:0042416]; proline catabolic process [GO:0006562] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; identical protein binding [GO:0042802]; D-alanine catabolic process [GO:0055130]; D-amino acid catabolic process [GO:0019478]; D-serine catabolic process [GO:0036088]; D-serine metabolic process [GO:0070178]; dopamine biosynthetic process [GO:0042416]; proline catabolic process [GO:0006562] GO:0003884; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006562; GO:0019478; GO:0036088; GO:0042416; GO:0042802; GO:0055130; GO:0070178; GO:0071949 D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; identical protein binding [GO:0042802] GVKFFQRK 0.99353 -27.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0587 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9476 12.1477 0 0 0 0 0 0 0 0 0 11.8304 0 0 0 0 0 0 0 0 0 12.4932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5558 14.5056 0 10.8959 0 0 0 0 11.4961 0 0 0 0 13.2814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2503 0 0 0 0 0 0 12.8517 0 14.1545 0 14.1281 0 14.1554 14.0146 0 0 0 0 0 0 0 0 12.8272 Q06203 PUR1_HUMAN "Amidophosphoribosyltransferase, ATase, EC 2.4.2.14 (Glutamine phosphoribosylpyrophosphate amidotransferase, GPAT)" PPAT GPAT Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164] cytosol [GO:0005829] "cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]" GO:0004044; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006541; GO:0009113; GO:0044208; GO:0046872; GO:0051539; GO:0097294 "4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]" IVLVDDSIVRGNTISPIIKLLK 0.99353 -6.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4388 0 0 0 0 0 11.795 0 0 0 13.2881 0 0 0 0 0 0 0 12.2784 0 0 12.8697 Q12893 TM115_HUMAN Transmembrane protein 115 (Placental protein 6) (Protein PL6) TMEM115 PL6 LUCA11.2 Homo sapiens (Human) "negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005634; GO:0005794; GO:0006890; GO:0008285; GO:0015031; GO:0016021; GO:0032580; GO:0042802 identical protein binding [GO:0042802] APTPPGK 0.99353 -9.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3558 0 0 0 0 13.241 13.5071 0 0 13.7664 0 13.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6975 0 13.5475 0 0 0 14.192 0 0 0 12.9858 0 0 14.5004 0 0 0 0 0 14.3979 13.7584 0 0 0 0 13.397 0 0 14.5851 0 0 0 0 0 14.0521 14.4741 0 0 15.0558 0 13.587 13.7844 0 13.796 0 0 10.774 0 14.2697 14.4783 0 14.7546 14.5841 14.9142 0 0 14.615 14.26 14.2342 14.1959 0 0 0 0 14.1999 0 0 0 0 14.5193 0 0 14.5289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2978 0 0 14.0316 0 0 0 0 0 Q16873 LTC4S_HUMAN "Leukotriene C4 synthase, LTC4 synthase, EC 4.4.1.20 (Glutathione S-transferase LTC4, EC 2.5.1.-) (Leukotriene-C(4) synthase) (Leukotriene-C4 synthase)" LTC4S Homo sapiens (Human) leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid biosynthetic process [GO:0042759] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; enzyme activator activity [GO:0008047]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; lipid binding [GO:0008289]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid biosynthetic process [GO:0042759] GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005640; GO:0005783; GO:0005789; GO:0006691; GO:0008047; GO:0008289; GO:0016021; GO:0019370; GO:0031965; GO:0042759; GO:0042802; GO:0043231 enzyme activator activity [GO:0008047]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; lipid binding [GO:0008289] AALLGRLRTLLPWA 0.99353 -6.8518 0 0 0 0 0 0 0 0 0 0 14.6309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2148 0 0 0 0 0 0 0 0 11.9587 0 0 0 0 12.0916 0 0 0 0 0 0 0 0 0 0 10.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5501 0 0 0 0 0 12.0003 0 0 0 11.6838 0 0 0 0 0 0 0 12.7401 0 0 0 0 0 0 0 0 14.6186 0 0 0 0 0 0 0 0 0 12.0559 0 10.7997 14.3537 12.4041 0 0 13.6973 0 13.3741 0 14.2438 0 11.3286 12.2892 0 0 12.3376 0 0 0 0 0 10.5059 0 0 0 0 0 0 0 0 0 14.1863 0 0 0 0 13.8524 0 0 0 0 0 11.5051 0 0 0 0 0 0 0 11.1147 0 13.639 0 0 0 0 0 0 0 0 11.726 0 0 0 0 13.3589 0 0 0 0 Q4VC44 FWCH1_HUMAN FLYWCH-type zinc finger-containing protein 1 FLYWCH1 KIAA1552 Homo sapiens (Human) cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005654; GO:0005829; GO:0016604; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AAGEKVYWMCR 0.99353 -15.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6622 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0547 0 0 0 0 12.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.12 0 0 0 0 0 Q5T2W1 NHRF3_HUMAN "Na(+)/H(+) exchange regulatory cofactor NHE-RF3, NHERF-3 (CFTR-associated protein of 70 kDa) (Na(+)/H(+) exchanger regulatory factor 3) (Na/Pi cotransporter C-terminal-associated protein 1, NaPi-Cap1) (PDZ domain-containing protein 1) (Sodium-hydrogen exchanger regulatory factor 3)" PDZK1 CAP70 NHERF3 PDZD1 Homo sapiens (Human) carnitine transport [GO:0015879]; positive regulation of cation transmembrane transport [GO:1904064]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; regulation of anion transport [GO:0044070]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; scavenger receptor binding [GO:0005124]; carnitine transport [GO:0015879]; positive regulation of cation transmembrane transport [GO:1904064]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; regulation of anion transport [GO:0044070]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] GO:0005124; GO:0005886; GO:0005903; GO:0015879; GO:0016324; GO:0030165; GO:0031526; GO:0031528; GO:0032414; GO:0043495; GO:0044070; GO:0044877; GO:0045121; GO:0070062; GO:0072659; GO:0090314; GO:1904064; GO:1905477; GO:1990961 PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495]; scavenger receptor binding [GO:0005124] EGGSYGFSLKTVQGK 0.99353 -7.8226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2101 0 0 0 0 0 0 0 0 0 13.6701 0 0 0 0 0 0 0 14.7419 13.356 0 0 0 0 0 16.172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5266 0 0 0 0 14.6781 0 0 0 0 0 0 15.4292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4V0 ZN438_HUMAN Zinc finger protein 438 ZNF438 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0045892; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DHMNTHTNR 0.99353 -27.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8884 0 0 0 0 0 0 0 0 0 11.3465 0 0 0 0 0 0 14.7556 0 14.3069 0 0 0 0 0 0 0 11.7609 0 0 13.9927 0 0 0 0 0 13.4242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG06 TRI58_HUMAN "E3 ubiquitin-protein ligase TRIM58, EC 2.3.2.27 (Protein BIA2) (RING-type E3 ubiquitin transferase TRIM58) (Tripartite motif-containing protein 58)" TRIM58 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of erythrocyte enucleation [GO:0061931]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of nuclear migration along microtubule [GO:1902838]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; dynein heavy chain binding [GO:0045504]; dynein intermediate chain binding [GO:0045505]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; positive regulation of erythrocyte enucleation [GO:0061931]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of nuclear migration along microtubule [GO:1902838]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0005737; GO:0006511; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0045504; GO:0045505; GO:0051865; GO:0061630; GO:0061931; GO:1902838 dynein heavy chain binding [GO:0045504]; dynein intermediate chain binding [GO:0045505]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ATLQRLR 0.99353 -14.522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4532 0 0 0 0 0 0 14.1867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTT0 CLC4C_HUMAN "C-type lectin domain family 4 member C (Blood dendritic cell antigen 2, BDCA-2) (C-type lectin superfamily member 7) (Dendritic lectin) (CD antigen CD303)" CLEC4C BDCA2 CLECSF11 CLECSF7 DLEC HECL UNQ9361/PRO34150 Homo sapiens (Human) adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; immune response [GO:0006955] external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821] external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; immune response [GO:0006955] GO:0002250; GO:0005886; GO:0006955; GO:0009897; GO:0016021; GO:0030246; GO:0030667; GO:0046872; GO:0061760; GO:0070821; GO:0101003 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] CAIINFR 0.99353 -14.519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6508 14.279 14.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A04 TSACC_HUMAN "TSSK6-activating co-chaperone protein (SSTK-interacting protein, SIP, SSTK-IP)" TSACC C1orf182 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; chaperone binding [GO:0051087] GO:0005737; GO:0051087 chaperone binding [GO:0051087] ERHTSHPNR 0.99353 -7.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5391 0 0 0 0 0 0 14.9382 0 0 0 13.5525 0 0 0 0 0 12.4729 0 0 0 12.8108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6076 0 0 0 10.4611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.37599 0 0 0 Q96BZ4 PLD4_HUMAN "5'-3' exonuclease PLD4, EC 3.1.16.1 (Choline phosphatase 4) (Phosphatidylcholine-hydrolyzing phospholipase D4) (Phospholipase D family member 4) (Phospholipase D4, PLD 4)" PLD4 C14orf175 UNQ2488/PRO5775 Homo sapiens (Human) establishment of localization in cell [GO:0051649]; hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588] early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; trans-Golgi network membrane [GO:0032588]; single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145]; establishment of localization in cell [GO:0051649]; hematopoietic progenitor cell differentiation [GO:0002244]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; phagocytosis [GO:0006909]; regulation of cytokine production involved in inflammatory response [GO:1900015] GO:0002244; GO:0005634; GO:0005769; GO:0005783; GO:0005789; GO:0006909; GO:0006954; GO:0016021; GO:0032588; GO:0045087; GO:0045145; GO:0045335; GO:0051649; GO:1900015 single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO:0045145] LLVGCGLNTDPTMFPYLR 0.99353 -9.1395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6095 0 0 0 0 0 0 0 0 0 0 0 0 10.9506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6469 0 0 0 0 0 10.8662 0 0 0 0 0 12.3924 0 0 0 0 0 0 0 0 0 0 11.8224 0 0 0 0 0 0 0 0 0 0 0 Q9BS40 LXN_HUMAN "Latexin (Endogenous carboxypeptidase inhibitor, ECI) (Protein MUM) (Tissue carboxypeptidase inhibitor, TCI)" LXN Homo sapiens (Human) detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; metalloendopeptidase inhibitor activity [GO:0008191]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954] GO:0005615; GO:0005737; GO:0006954; GO:0008191; GO:0008201; GO:0050965 heparin binding [GO:0008201]; metalloendopeptidase inhibitor activity [GO:0008191] MVKIQTVK 0.99353 -6.2064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0097 16.1813 15.9123 0 16.0712 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1706 0 15.5853 14.224 15.2096 0 0 0 0 0 0 0 10.8375 0 0 0 0 0 0 0 11.4105 12.6293 0 0 0 16.52 0 0 0 0 0 0 0 11.3372 0 0 0 0 0 0 0 13.5718 12.6535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6D7 HAUS4_HUMAN HAUS augmin-like complex subunit 4 HAUS4 C14orf94 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498] centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0005813; GO:0005829; GO:0007098; GO:0051011; GO:0051225; GO:0051301; GO:0070652; GO:1990498 microtubule minus-end binding [GO:0051011] ARLQQEVEEQLK 0.99353 -6.8504 12.051 9.39397 0 0 0 0 0 0 0 0 11.7309 0 0 0 0 0 0 0 0 0 0 0 10.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9245 0 0 0 0 0 0 0 0 0 0 0 10.6666 0 0 0 0 0 0 0 0 11.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4974 0 0 0 0 0 0 0 0 0 0 15.2993 0 0 0 0 0 0 0 0 0 0 0 12.8253 0 0 0 11.1544 0 0 0 0 15.7084 15.6616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4554 0 15.3631 Q9HCC8 GDPD2_HUMAN "Glycerophosphoinositol inositolphosphodiesterase GDPD2, EC 3.1.4.43 (Glycerophosphodiester phosphodiesterase 3) (Glycerophosphodiester phosphodiesterase domain-containing protein 2) (Osteoblast differentiation promoting factor)" GDPD2 GDE3 OBDPF UNQ1935/PRO4418 Homo sapiens (Human) actin filament reorganization [GO:0090527]; lipid metabolic process [GO:0006629]; positive regulation of osteoblast differentiation [GO:0045669] actin filament [GO:0005884]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886] actin filament [GO:0005884]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol inositolphosphodiesterase activity [GO:0047394]; metal ion binding [GO:0046872]; actin filament reorganization [GO:0090527]; lipid metabolic process [GO:0006629]; positive regulation of osteoblast differentiation [GO:0045669] GO:0005737; GO:0005884; GO:0005886; GO:0006629; GO:0008889; GO:0016020; GO:0016021; GO:0030027; GO:0045669; GO:0046872; GO:0047394; GO:0090527 glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol inositolphosphodiesterase activity [GO:0047394]; metal ion binding [GO:0046872] IHRRGPK 0.99353 -14.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0581 0 0 0 0 12.3779 0 11.966 11.5844 0 0 0 0 0 0 0 0 0 0 12.7824 0 0 0 0 0 0 0 0 0 0 0 0 14.9674 0 13.1877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5911 0 13.6305 14.7604 13.3565 14.0375 14.1213 14.0991 14.0766 13.7801 0 0 0 0 0 13.3726 14.8513 0 13.8373 13.6903 0 0 0 14.3232 0 14.3582 13.9167 15.2766 0 13.8382 14.3535 0 0 12.9471 0 14.0206 14.7278 0 15.7378 0 14.2499 14.683 14.11 13.3025 14.1234 0 13.9789 0 13.1765 14.8409 14.0001 14.2226 14.2446 14.6496 0 13.1584 0 0 0 0 0 13.1009 13.2783 0 13.3796 0 0 0 0 13.0432 0 0 0 0 13.6256 0 0 14.1696 13.7964 13.7265 12.9729 0 14.2814 0 0 13.8136 0 0 14.097 12.6856 14.2437 0 0 0 13.5548 13.2334 14.091 0 0 0 0 13.291 13.827 11.8339 Q9NPB0 SMDC1_HUMAN SAYSvFN domain-containing protein 1 SAYSD1 C6orf64 Homo sapiens (Human) cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] GO:0016021; GO:0030659; GO:0043231 AAPGWLK 0.99353 -27.924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.528 0 0 0 0 0 0 0 0 0 10.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5731 0 0 0 0 0 0 0 0 0 13.1175 0 0 0 0 13.4405 0 0 0 0 0 12.8006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P243 ZFAT_HUMAN Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406) ZFAT KIAA1485 ZFAT1 ZNF406 Homo sapiens (Human) "hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast layer development [GO:0060712]" GO:0000978; GO:0000981; GO:0001228; GO:0002244; GO:0005634; GO:0005829; GO:0006355; GO:0046872; GO:0060712 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHMNRHSTEKTHLCDMCGK 0.99353 -10.801 0 0 0 0 0 0 0 11.5417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4708 0 0 12.0029 0 0 0 0 10.3072 0 11.5844 0 0 10.8984 0 0 0 0 0 0 0 0 0 0 0 0 14.9832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2476 0 0 0 11.5741 12.0943 10.663 0 0 0 0 14.7621 15.4072 0 0 0 16.9685 0 0 0 0 0 13.3519 0 0 0 12.4783 13.6072 0 0 0 0 10.082 16.3522 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7323 0 0 0 0 0 0 0 13.3424 0 12.7053 0 12.8608 0 12.5626 0 0 0 0 11.2629 14.3312 0 14.0151 0 0 16.5001 14.8576 0 0 11.805 0 0 11.9812 0 0 0 0 0 0 0 0 0 11.9939 0 15.1025 13.0807 0 0 0 0 0 0 18.0512 0 0 0 0 0 0 13.5412 Q9P2F9 ZN319_HUMAN Zinc finger protein 319 ZNF319 KIAA1388 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNVCELHFKESSELLQHPCTPSGERPFR 0.99353 -5.0627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.998 0 10.4166 0 0 0 0 0 0 0 0 0 0 0 10.6688 0 0 0 0 0 0 0 0 0 0 11.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3107 0 15.7697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1558 11.5041 0 11.4797 0 0 0 0 0 0 0 0 11.4741 10.1162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPM6 LHX6_HUMAN "LIM/homeobox protein Lhx6, LIM homeobox protein 6 (LIM/homeobox protein Lhx6.1)" LHX6 LHX6.1 Homo sapiens (Human) cell maturation [GO:0048469]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; forebrain neuron development [GO:0021884]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell maturation [GO:0048469]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex radially oriented cell migration [GO:0021799]; cerebral cortex tangential migration [GO:0021800]; forebrain neuron development [GO:0021884]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0021799; GO:0021800; GO:0021853; GO:0021884; GO:0030182; GO:0046872; GO:0048469; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" FGTKCAR 0.99353 -7.819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0976 0 0 0 0 0 0 0 0 0 0 11.8396 0 0 0 0 12.4183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3454 0 0 0 0 0 0 0 0 0 0 0 0 11.4812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2E8 SL9A8_HUMAN "Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8, NHE-8) (Solute carrier family 9 member 8)" SLC9A8 KIAA0939 NHE8 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453] GO:0000139; GO:0005794; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] FEISFVIWCIVLVLFGRAVNIFPLSYLLNFFRDHK 0.99353 -6.2052 0 0 0 0 0 0 9.75123 0 0 0 0 0 0 0 0 0 0 0 12.3766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1155 0 0 0 0 0 0 12.2741 12.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.482 0 0 0 0 0 0 0 0 0 0 0 14.9852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4972 12.4162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5803 0 0 0 0 A4D1U4 DEN11_HUMAN "DENN domain-containing protein 11, DENND11 (Protein LCHN)" DENND11 KIAA1147 LCHN Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737 guanyl-nucleotide exchange factor activity [GO:0005085] GGGGGAR 0.99354 -9.1736 18.6115 15.36 15.645 14.8842 15.1707 18.5366 18.7506 14.5515 12.0357 0 13.9091 0 13.4555 13.7065 12.855 14.048 14.4238 12.0327 15.0962 14.9815 14.5709 15.4999 18.7214 15.824 15.4561 15.0048 14.6729 14.1825 14.6274 14.4337 13.2113 13.6546 13.5906 14.0249 0 12.3632 12.255 12.9767 13.9397 13.5491 12.8281 13.074 14.7625 14.6366 14.6377 14.674 13.2776 14.7241 14.7633 14.1573 14.4653 16.4199 18.9944 18.9816 15.6247 12.3633 13.9662 0 0 0 13.7463 12.0573 0 0 12.626 0 19.1695 14.5792 19.0768 18.9765 18.8822 14.3049 19.0012 19.034 16.7349 19.1805 19.256 19.3638 19.3251 16.7921 17.5512 15.5446 17.1368 16.3157 16.9598 16.9629 19.4374 19.3303 19.4052 19.4383 15.6661 19.5487 19.5331 19.3509 19.436 19.4115 19.3489 15.247 19.3647 19.5072 19.4003 19.3389 0 19.5017 19.488 17.7168 19.3948 19.4935 17.426 16.7453 17.4206 14.7488 19.239 16.4561 19.4309 17.206 16.9496 16.0001 17.34 16.9324 17.4219 19.4854 17.6472 15.87 17.9075 19.6024 17.4562 17.5834 16.9967 17.734 16.5669 17.6192 17.5745 17.3278 17.205 17.7469 16.7009 16.5887 17.3226 16.4398 15.7104 17.318 17.2019 17.3083 17.4621 16.553 14.5182 17.0694 0 13.468 16.2236 17.4257 13.5549 19.3439 19.4055 19.2886 16.4872 15.0738 14.7696 13.6019 13.4629 14.6855 16.7511 16.1085 16.6502 16.4637 16.8848 15.9053 13.1089 15.694 15.5836 17.2989 16.9808 17.0478 16.0538 15.9691 0 14.4569 13.2016 0 A8MTA8 F166B_HUMAN Protein FAM166B FAM166B Homo sapiens (Human) axonemal microtubule [GO:0005879] axonemal microtubule [GO:0005879] GO:0005879 ESLPVRR 0.99354 -28.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3607 12.936 10.6136 0 0 0 0 0 0 0 0 0 0 13.0683 0 0 11.794 12.6953 0 0 0 0 0 12.6444 0 0 0 11.4619 0 0 0 12.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6115 0 0 0 0 0 0 14.1812 11.3574 0 0 0 0 0 0 0 0 0 0 0 12.5949 0 0 0 0 0 12.6832 0 0 0 O15260 SURF4_HUMAN Surfeit locus protein 4 SURF4 SURF-4 Homo sapiens (Human) Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; positive regulation of organelle organization [GO:0010638]; regulation of lipid transport [GO:0032368] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; cargo receptor activity [GO:0038024]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; positive regulation of organelle organization [GO:0010638]; regulation of lipid transport [GO:0032368] GO:0000139; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0005886; GO:0007030; GO:0010638; GO:0016021; GO:0030133; GO:0031965; GO:0032368; GO:0033116; GO:0035577; GO:0038024; GO:0042953; GO:0055088 cargo receptor activity [GO:0038024] MGQNDLMGTAEDFADQFLRVTK 0.99354 -6.4363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9381 0 13.4581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4507 0 0 0 0 12.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15344 TRI18_HUMAN "E3 ubiquitin-protein ligase Midline-1, EC 2.3.2.27 (Midin) (Putative transcription factor XPRF) (RING finger protein 59) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18)" MID1 FXY RNF59 TRIM18 XPRF Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]; regulation of microtubule cytoskeleton organization [GO:0070507] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; pattern specification process [GO:0007389]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0000226; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0007026; GO:0007389; GO:0008017; GO:0008270; GO:0016740; GO:0019899; GO:0031625; GO:0032874; GO:0034451; GO:0035372; GO:0042802; GO:0042803; GO:0051219; GO:0070507 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] ATHPNKK 0.99354 -6.437 0 0 0 0 0 0 0 0 0 0 0 0 12.4096 18.0225 13.1854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2489 0 11.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0505 0 0 0 0 12.731 0 0 0 0 0 0 0 0 12.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6745 0 0 0 0 0 0 13.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0452 0 0 0 0 0 0 0 0 0 0 0 18.5965 0 O75900 MMP23_HUMAN "Matrix metalloproteinase-23, MMP-23, EC 3.4.24.- (Femalysin) (MIFR-1) (Matrix metalloproteinase-21, MMP-21) (Matrix metalloproteinase-22, MMP-22) [Cleaved into: Matrix metalloproteinase-23, soluble form ]" MMP23B MMP21 MMP22 Homo sapiens (Human) collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; reproduction [GO:0000003] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508]; reproduction [GO:0000003] GO:0000003; GO:0004222; GO:0005615; GO:0005789; GO:0006508; GO:0008237; GO:0008270; GO:0016021; GO:0030198; GO:0030574; GO:0031012; GO:0062023 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] ALAAAFR 0.99354 -16.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6132 0 13.6463 0 0 0 0 0 0 13.4597 0 13.4803 13.2684 0 0 10.9454 0 0 13.1541 0 0 0 0 0 0 0 0 0 13.8998 12.7046 0 0 0 0 12.2197 0 11.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3983 0 0 0 0 0 0 0 13.0712 0 0 11.6858 0 0 0 0 0 0 0 12.7688 14.6059 11.8827 0 0 0 0 0 0 0 0 12.5968 0 0 0 0 0 0 0 0 0 11.1541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4622 0 0 0 0 0 0 0 0 0 0 10.0393 0 0 10.2027 14.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6481 14.4007 0 14.8365 14.6455 14.4929 0 14.4861 0 14.1057 0 0 0 0 14.474 0 0 0 0 P06133 UD2B4_HUMAN "UDP-glucuronosyltransferase 2B4, UDPGT 2B4, UGT2B4, EC 2.4.1.17 (HLUG25) (Hyodeoxycholic acid-specific UDPGT) (UDPGTh-1)" UGT2B4 UGT2B11 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210] GO:0005789; GO:0008210; GO:0015020; GO:0016021; GO:0052695 glucuronosyltransferase activity [GO:0015020] ANVIASALAKIPQK 0.99354 -14.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0744 11.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6051 0 0 0 0 0 0 0 0 0 0 0 0 11.8338 0 0 0 0 0 0 0 0 0 0 11.4773 0 0 P0CF97 F200B_HUMAN Protein FAM200B FAM200B C4orf53 Homo sapiens (Human) ALLSSYLVAYR 0.99354 -28.21 0 0 0 0 0 0 0 0 10.0794 9.80245 0 12.5245 0 0 0 0 0 0 0 0 0 0 12.7265 0 0 0 0 12.815 0 0 10.9138 0 12.3668 12.7313 0 13.8664 11.9454 13.1622 12.4561 0 13.8194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9256 0 0 12.8084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2612 0 0 13.4779 0 0 0 0 0 14.2681 0 14.3249 14.3062 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8208 0 0 0 0 0 15.9638 0 12.1183 0 0 13.8395 12.8262 0 0 0 0 12.7645 0 0 0 0 0 0 0 0 0 0 0 12.0629 0 0 0 0 0 0 0 0 0 10.3215 0 0 0 0 0 0 14.8936 13.911 0 0 0 0 0 0 0 0 14.2946 14.3817 13.5575 0 0 0 0 0 0 0 0 0 0 P13798 ACPH_HUMAN "Acylamino-acid-releasing enzyme, AARE, EC 3.4.19.1 (Acyl-peptide hydrolase, APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase, OPH)" APEH D3F15S2 D3S48E DNF15S2 Homo sapiens (Human) amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]; translational termination [GO:0006415] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508]; translational termination [GO:0006415] GO:0003723; GO:0004252; GO:0005576; GO:0005829; GO:0006415; GO:0006508; GO:0008242; GO:0031965; GO:0042802; GO:0050435; GO:0070062; GO:1904813 identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252] AGGTGPGEEK 0.99354 -28.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3072 0 0 0 0 0 0 0 0 0 0 10.5507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2048 0 0 0 0 0 0 0 0 0 0 0 14.4767 14.8875 14.7545 0 0 0 12.7434 0 0 15.2259 0 14.7295 12.9061 14.6401 15.1524 13.5977 12.4388 12.9844 0 14.3276 12.1899 13.5992 15.1655 13.11 13.0515 0 12.6371 0 0 0 0 13.9466 0 0 0 0 0 0 0 0 0 0 13.9019 0 0 15.2342 0 14.8288 13.5319 0 13.6915 15.2251 0 13.721 0 0 0 13.7043 0 0 13.0207 13.2996 0 0 0 0 14.3405 0 0 0 0 0 0 0 0 0 0 13.9146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2249 0 13.2682 14.1407 0 0 0 0 0 P19012 K1C15_HUMAN "Keratin, type I cytoskeletal 15 (Cytokeratin-15, CK-15) (Keratin-15, K15)" KRT15 KRTB Homo sapiens (Human) epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005200; GO:0005634; GO:0005829; GO:0005856; GO:0005882; GO:0008544; GO:0030855; GO:0045109; GO:0070062; GO:0097110 scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200] ALEEANADLEVK 0.99354 -6.4405 0 0 0 0 0 13.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9672 0 12.0352 12.4801 0 0 0 0 0 0 0 0 0 12.3806 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4398 13.8196 0 0 13.8886 12.3204 12.7093 0 0 0 0 0 0 0 0 0 12.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3969 0 0 0 0 0 0 0 12.7748 0 0 0 0 0 0 0 0 0 0 11.0047 0 0 0 0 0 0 0 P49862 KLK7_HUMAN "Kallikrein-7, hK7, EC 3.4.21.117 (Serine protease 6) (Stratum corneum chymotryptic enzyme, hSCCE)" KLK7 PRSS6 SCCE Homo sapiens (Human) epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803]; proteolysis [GO:0006508] cornified envelope [GO:0001533]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] cornified envelope [GO:0001533]; epidermal lamellar body [GO:0097209]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; epidermis development [GO:0008544]; extracellular matrix disassembly [GO:0022617]; positive regulation of antibacterial peptide production [GO:0002803]; proteolysis [GO:0006508] GO:0001533; GO:0002803; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008236; GO:0008544; GO:0022617; GO:0030141; GO:0097209 metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] ARSLLLPLQILLLSLALETAGEEAQGDK 0.99354 -16.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4788 0 13.6853 12.4623 13.3366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8094 13.055 0 0 11.1862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6497 10.38 0 0 0 0 0 0 0 0 0 0 13.1566 0 0 0 0 0 0 0 0 0 13.2603 12.8138 0 0 0 0 0 0 0 0 0 0 0 0 11.406 0 0 0 0 0 0 0 0 P62333 PRS10_HUMAN 26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Homo sapiens (Human) positive regulation of inclusion body assembly [GO:0090261]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent ERAD pathway [GO:0030433] "cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]" "cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; protein-macromolecule adaptor activity [GO:0030674]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000502; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016234; GO:0016887; GO:0022624; GO:0030433; GO:0030674; GO:0031597; GO:0036402; GO:0042802; GO:0043161; GO:0045899; GO:0070062; GO:0090261; GO:1901800 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; protein-macromolecule adaptor activity [GO:0030674] AVRKVADSK 0.99354 -14.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1444 0 10.952 0 0 16.9075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9787 13.0113 0 0 0 12.6192 0 0 0 13.9421 0 14.0323 14.3031 0 0 12.924 0 0 0 0 12.4282 0 0 0 0 0 0 14.0384 0 0 0 0 15.5382 0 0 0 0 12.1866 12.7469 15.11 0 14.8702 0 14.7213 0 0 14.4868 0 0 0 0 14.3055 0 0 12.8749 0 13.8345 13.3828 12.966 13.2386 13.0896 0 13.1007 13.0123 0 13.9345 0 0 14.3771 13.3641 12.9394 0 0 0 0 13.3526 14.8522 0 0 0 0 0 0 0 0 0 0 14.0958 0 0 0 13.7061 0 0 0 0 0 0 13.1028 0 0 0 0 0 0 13.6767 0 13.1803 0 0 0 P82650 RT22_HUMAN "28S ribosomal protein S22, mitochondrial, MRP-S22, S22mt (Mitochondrial small ribosomal subunit protein mS22)" MRPS22 C3orf5 RPMS22 GK002 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005763; GO:0032543 structural constituent of ribosome [GO:0003735] FIVVREPSGTLRK 0.99354 -6.8584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1587 0 0 12.3479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.752 0 0 14.3593 13.9129 0 0 0 0 0 0 0 0 16.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5616 0 12.3392 18.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08830 FGL1_HUMAN "Fibrinogen-like protein 1 (HP-041) (Hepassocin, HPS) (Hepatocyte-derived fibrinogen-related protein 1, HFREP-1) (Liver fibrinogen-related protein 1, LFIRE-1)" FGL1 HFREP1 Homo sapiens (Human) adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776] GO:0002250; GO:0005102; GO:0005576; GO:0005577; GO:0005615; GO:0050776; GO:0050868; GO:0062023; GO:0072574 signaling receptor binding [GO:0005102] AQVRLLETR 0.99354 -28.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8826 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3522 0 0 0 0 13.4812 12.034 0 0 13.3993 13.9522 12.8684 12.6176 0 0 14.3815 13.6159 0 0 0 13.6828 0 14.9977 0 0 0 0 0 0 0 0 13.771 0 11.4591 0 0 0 13.9914 14.3654 14.0305 0 0 0 0 0 13.7782 13.9153 0 0 0 0 0 0 13.2075 0 0 0 11.2279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7781 Q0P6D6 CCD15_HUMAN Coiled-coil domain-containing protein 15 CCDC15 Homo sapiens (Human) centrosome [GO:0005813] centrosome [GO:0005813] GO:0005813 DQHVLHK 0.99354 -14.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6194 14.9861 14.9854 0 0 0 15.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8831 0 0 0 0 0 0 0 0 0 15.942 12.7708 16.6036 0 0 0 0 12.8632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.371 15.9762 0 0 0 0 0 15.5238 15.508 0 0 0 0 0 0 0 14.5976 14.7105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2033 0 0 0 0 14.551 0 Q14934 NFAC4_HUMAN "Nuclear factor of activated T-cells, cytoplasmic 4, NF-ATc4, NFATc4 (T-cell transcription factor NFAT3, NF-AT3)" NFATC4 NFAT3 Homo sapiens (Human) brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular respiration [GO:0045333]; cellular response to lithium ion [GO:0071285]; cellular response to UV [GO:0034644]; dendrite morphogenesis [GO:0048813]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synapse maturation [GO:2000297]; negative regulation of Wnt signaling pathway [GO:0030178]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse maturation [GO:0060074]; transcription by RNA polymerase II [GO:0006366]; vascular associated smooth muscle cell development [GO:0097084] chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; branching involved in blood vessel morphogenesis [GO:0001569]; calcineurin-NFAT signaling cascade [GO:0033173]; cellular respiration [GO:0045333]; cellular response to lithium ion [GO:0071285]; cellular response to UV [GO:0034644]; dendrite morphogenesis [GO:0048813]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synapse maturation [GO:2000297]; negative regulation of Wnt signaling pathway [GO:0030178]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse maturation [GO:0060074]; transcription by RNA polymerase II [GO:0006366]; vascular associated smooth muscle cell development [GO:0097084]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001569; GO:0005634; GO:0005667; GO:0005829; GO:0006357; GO:0006366; GO:0006954; GO:0007507; GO:0007616; GO:0008630; GO:0016607; GO:0030178; GO:0031547; GO:0032091; GO:0032760; GO:0033173; GO:0034644; GO:0035562; GO:0042975; GO:0043524; GO:0043525; GO:0045333; GO:0045944; GO:0048813; GO:0050774; GO:0051402; GO:0060074; GO:0060291; GO:0071285; GO:0097084; GO:1902894; GO:1990837; GO:2000297; GO:2001235 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AHHRAHYETEGSR 0.99354 -14.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8639 0 13.2128 0 0 0 0 0 0 0 10.399 0 14.581 14.2334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5148 14.4871 0 0 0 0 0 11.4833 0 0 0 0 14.0443 0 0 12.0325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2588 0 0 0 0 0 0 0 13.7697 13.6175 13.7548 0 0 0 0 0 0 9.92177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15669 RHOH_HUMAN Rho-related GTP-binding protein RhoH (GTP-binding protein TTF) (Translocation three four protein) RHOH ARHH TTF Homo sapiens (Human) "actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]" cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886] "cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; cell projection assembly [GO:0030031]; cortical cytoskeleton organization [GO:0030865]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity [GO:0007163]; mast cell activation [GO:0045576]; motor neuron axon guidance [GO:0008045]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of T cell differentiation [GO:0045582]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neutrophil migration [GO:1902622]; regulation of transcription, DNA-templated [GO:0006355]; T cell differentiation [GO:0030217]" GO:0001772; GO:0003924; GO:0005095; GO:0005525; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0006355; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0016601; GO:0019210; GO:0019901; GO:0030031; GO:0030217; GO:0030865; GO:0031267; GO:0031410; GO:0032956; GO:0042995; GO:0043124; GO:0043652; GO:0045576; GO:0045582; GO:1902622 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267] TAVNQARR 0.99354 -7.0963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4031 0 0 0 0 12.6609 0 0 0 0 0 0 13.7722 13.5875 13.7505 0 0 0 0 0 0 0 0 0 0 0 13.7165 0 0 0 0 13.2973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q63HQ0 AP1AR_HUMAN "AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein, GBAR, Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor, Gadkin)" AP1AR C4orf16 PRO0971 Homo sapiens (Human) "negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle targeting, trans-Golgi to endosome [GO:0048203]" cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133] "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle targeting, trans-Golgi to endosome [GO:0048203]" GO:0001920; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0005829; GO:0015031; GO:0019894; GO:0030133; GO:0034315; GO:0034446; GO:0035650; GO:0048203; GO:1900025; GO:2000146 AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894] DLDKKIQK 0.99354 -6.6457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ECI4 ZN470_HUMAN "Zinc finger protein 470 (Chondrogenesis zinc finger protein 1, CZF-1)" ZNF470 CZF1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSQNAHLVQHQRVHTGEKPYQCK 0.99354 -6.6596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9152 0 0 0 Q6ZSJ9 SHSA6_HUMAN Protein shisa-6 SHISA6 Homo sapiens (Human) excitatory chemical synaptic transmission [GO:0098976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055] "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; dendritic spine membrane [GO:0032591]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]" "AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; dendritic spine membrane [GO:0032591]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; excitatory chemical synaptic transmission [GO:0098976]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; regulation of AMPA glutamate receptor clustering [GO:1904717]; regulation of AMPA receptor activity [GO:2000311]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]" GO:0007283; GO:0014069; GO:0016055; GO:0030165; GO:0032281; GO:0032591; GO:0035255; GO:0045211; GO:0048172; GO:0070161; GO:0090090; GO:0098962; GO:0098970; GO:0098976; GO:0098985; GO:0099061; GO:1904717; GO:2000311 ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165] AGGALAR 0.99354 -6.6443 0 0 0 0 12.102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1135 0 0 16.2596 15.6919 15.9167 15.0279 0 0 13.5194 13.7767 12.6117 13.8931 0 14.2383 13.8969 0 0 0 0 0 12.9504 0 0 13.5939 0 0 14.8135 12.5851 0 0 15.1047 13.7034 0 0 0 0 0 14.7971 14.0457 0 0 0 13.7193 0 14.6887 0 0 0 0 0 0 0 0 0 14.4983 0 14.197 0 0 0 0 14.3809 13.3908 13.8056 0 13.7467 0 0 0 0 0 0 0 0 13.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 14.14 0 0 0 0 0 0 0 0 13.276 0 0 0 0 0 13.5671 0 0 0 Q8TF61 FBX41_HUMAN F-box only protein 41 FBXO41 FBX41 KIAA1940 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 HPAVWTR 0.99354 -28.104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9972 0 0 11.9485 0 0 0 0 0 11.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5617 11.8151 0 12.7698 12.4893 12.7938 0 0 0 11.0193 0 0 14.9028 11.8326 0 11.4695 0 0 0 0 0 0 0 0 0 0 0 13.2597 11.4776 0 0 11.8047 0 0 0 12.8616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3293 0 0 0 0 0 0 0 0 0 0 10.8666 0 0 0 13.913 0 0 0 0 0 0 0 11.7136 0 0 0 0 0 0 0 11.9714 0 0 0 0 0 12.3785 0 12.9486 0 Q8TF74 WIPF2_HUMAN WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein) WIPF2 WICH WIRE PP10631 Homo sapiens (Human) actin filament-based movement [GO:0030048] actin filament [GO:0005884]; cytosol [GO:0005829] actin filament [GO:0005884]; cytosol [GO:0005829]; actin binding [GO:0003779]; actin filament-based movement [GO:0030048] GO:0003779; GO:0005829; GO:0005884; GO:0030048 actin binding [GO:0003779] GLAPPPPTSASPSLLSNR 0.99354 -14.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8849 0 0 0 0 0 15.8165 0 0 0 0 0 0 0 0 13.5421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.972 0 0 0 0 0 0 0 0 0 13.8079 0 0 0 0 13.112 0 0 0 12.0125 0 11.7226 0 0 0 0 0 0 0 0 0 13.4547 0 0 12.8988 0 0 0 0 0 0 14.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92824 PCSK5_HUMAN "Proprotein convertase subtilisin/kexin type 5, EC 3.4.21.- (Proprotein convertase 5, PC5) (Proprotein convertase 6, PC6, hPC6) (Subtilisin/kexin-like protease PC5)" PCSK5 PC5 PC6 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; cell-cell signaling [GO:0007267]; cytokine precursor processing [GO:0140447]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cell-cell signaling [GO:0007267]; cytokine precursor processing [GO:0140447]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058] GO:0001822; GO:0002001; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005794; GO:0005796; GO:0005802; GO:0006465; GO:0007267; GO:0007507; GO:0007566; GO:0008233; GO:0009952; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0030173; GO:0030323; GO:0035108; GO:0042277; GO:0043043; GO:0048566; GO:0048706; GO:0051004; GO:0140447 endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252] ACDSNCGSCDQNGCYWCEEGFFLLGGSCVR 0.99354 -28.101 0 0 0 10.2619 0 0 0 0 12.2548 0 11.8776 0 0 0 11.4689 0 0 14.7632 11.6981 10.8073 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5616 0 0 0 0 0 0 12.9011 0 0 11.9858 0 13.0136 0 0 0 0 10.6255 11.8653 0 0 0 0 0 0 0 0 0 0 10.2882 0 0 0 0 14.6634 0 10.7633 11.4688 14.0005 0 13.2727 15.034 0 12.8196 0 11.908 12.999 13.1974 14.8575 11.8313 0 14.889 12.2544 0 15.5973 14.3081 14.3024 13.4065 12.875 13.9902 0 14.3188 12.9448 14.5148 15.5115 15.3935 14.1496 13.5415 10.9501 14.7868 13.2992 12.8031 14.1913 10.888 12.703 13.25 13.5425 0 14.0468 0 11.0329 15.1813 11.5748 0 12.0533 12.6308 0 15.0584 0 0 0 13.0445 14.4863 13.8469 13.5616 11.4836 11.5666 12.835 0 0 13.6837 14.9431 13.0197 0 0 14.1904 11.8269 11.917 13.1124 12.4776 0 0 0 0 13.2406 12.6941 11.3518 0 0 0 12.6675 13.2089 12.9126 13.9082 14.1442 13.9356 13.9202 0 14.0486 9.59932 13.7446 0 0 12.9335 13.8303 13.4472 0 10.899 12.5264 12.5451 14.3026 13.0134 0 10.7757 14.4452 13.2321 0 Q9BZH6 WDR11_HUMAN WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15) WDR11 BRWD2 KIAA1351 WDR15 Homo sapiens (Human) cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041] GO:0005634; GO:0005737; GO:0005765; GO:0005802; GO:0005829; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0015630; GO:0016020; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041 ALLVLLSLGCFFSVAETLHSMRYFDR 0.99354 -14.131 0 0 0 0 0 0 0 0 11.5637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6756 12.3604 15.1959 0 0 0 0 15.508 0 0 0 12.355 0 0 0 16.1484 0 0 0 13.1095 13.4091 11.2055 0 0 12.4974 13.4066 0 0 13.292 0 12.7727 0 0 0 12.4311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0066 0 13.1655 0 0 0 14.2265 12.4459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2551 0 0 0 0 12.001 0 0 0 0 0 12.5384 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZR8 B2L14_HUMAN "Apoptosis facilitator Bcl-2-like protein 14, Bcl2-L-14 (Apoptosis regulator Bcl-G)" BCL2L14 BCLG Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular organelle [GO:0043229]; membrane [GO:0016020] cytosol [GO:0005829]; endomembrane system [GO:0012505]; intracellular organelle [GO:0043229]; membrane [GO:0016020]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] GO:0005829; GO:0006915; GO:0012505; GO:0016020; GO:0019901; GO:0043229; GO:2001236; GO:2001238 protein kinase binding [GO:0019901] AALVIDVTAK 0.99354 -9.1582 13.376 13.0883 13.1191 0 14.3714 0 0 13.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9831 0 0 0 0 0 0 0 0 0 0 0 14.1566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4442 0 15.9185 15.9862 0 15.895 0 14.1305 0 0 0 0 15.9798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3196 0 0 0 0 13.1195 13.7605 0 0 0 13.6616 16.4295 0 0 0 0 0 0 0 12.703 0 12.3001 0 0 0 0 0 0 0 14.6707 16.5229 0 0 16.575 0 0 16.5649 0 16.4106 0 0 16.596 0 12.9483 0 0 0 0 0 0 0 0 0 11.7837 16.3816 0 0 0 0 0 0 0 0 0 12.2121 0 0 0 0 0 0 0 0 12.216 11.4794 14.5603 12.8836 0 0 0 0 0 0 11.1341 Q9H7C4 SYNCI_HUMAN Syncoilin (Syncoilin intermediate filament 1) (Syncoilin-1) SYNC SYNC1 Homo sapiens (Human) intermediate filament-based process [GO:0045103] cytosol [GO:0005829]; intermediate filament [GO:0005882]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; Z disc [GO:0030018] cytosol [GO:0005829]; intermediate filament [GO:0005882]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; intermediate filament-based process [GO:0045103] GO:0005829; GO:0005882; GO:0030018; GO:0031594; GO:0042383; GO:0045103; GO:0048471 DEEVQQYR 0.99354 -7.095 0 0 0 0 0 0 0 0 0 0 0 12.5994 0 13.3167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7018 0 11.6882 0 0 11.4115 0 11.6079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5193 0 0 0 13.3663 0 0 0 0 0 0 0 0 12.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1935 0 15.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4099 0 17.1347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7488 0 0 0 0 0 A0A087WSZ9 TVA30_HUMAN T cell receptor alpha variable 30 TRAV30 Homo sapiens (Human) adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; response to bacterium [GO:0009617] GO:0002250; GO:0009617; GO:0042101 ISASFNEK 0.99355 -6.4586 0 0 0 0 11.9458 0 0 0 0 0 0 0 0 0 0 0 12.8146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4017 0 0 0 0 0 12.2623 11.8764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7817 0 0 0 0 12.7742 0 13.4614 0 0 0 12.7484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K4G0 CLM7_HUMAN "CMRF35-like molecule 7, CLM-7 (CD300 antigen-like family member B) (CMRF35-A2) (Immune receptor expressed on myeloid cells 3, IREM-3) (Leukocyte mono-Ig-like receptor 5) (Triggering receptor expressed on myeloid cells 5, TREM-5) (CD antigen CD300b)" CD300LB CD300B CLM7 CMRF35A2 IREM3 LMIR5 TREM5 UNQ2530/PRO6029 Homo sapiens (Human) immune system process [GO:0002376] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; immune system process [GO:0002376] GO:0002376; GO:0004888; GO:0005886; GO:0016021; GO:0042802 identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888] NHYMLLVFVKVPILLILVTAILWLK 0.99355 -9.1776 0 0 0 0 0 0 0 0 14.3524 0 0 10.4725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.54768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.121 11.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5517 0 0 0 12.8789 0 0 0 0 10.8811 13.6908 13.6305 14.3714 0 14.9339 0 14.1718 13.6315 0 0 13.6134 14.3277 0 0 0 0 13.9459 0 13.8983 0 12.0529 0 13.407 0 14.0267 0 0 0 0 0 0 0 0 0 11.88 12.7863 0 13.6462 0 0 13.5994 0 12.9164 0 12.4979 13.6603 0 14.2904 0 0 0 12.3681 0 13.5814 0 13.3855 10.3981 12.5286 0 14.538 12.146 0 0 0 0 0 11.7782 15.3072 0 0 11.5689 10.4818 0 0 14.0133 0 12.5773 0 0 0 10.1663 0 0 0 11.6932 0 11.1094 0 0 0 0 0 15.2438 10.6238 0 0 0 0 0 O95867 LY66C_HUMAN Lymphocyte antigen 6 complex locus protein G6c LY6G6C C6orf24 G6C NG24 UNQ1947/PRO4430 Homo sapiens (Human) anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802] GO:0005576; GO:0005886; GO:0031225; GO:0032991; GO:0042802 identical protein binding [GO:0042802] DNCNSAGPR 0.99355 -5.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6597 0 0 11.162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96014 WNT11_HUMAN Protein Wnt-11 WNT11 Homo sapiens (Human) "adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; atrial septum development [GO:0003283]; bicellular tight junction assembly [GO:0070830]; bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cloacal septation [GO:0060197]; convergent extension involved in axis elongation [GO:0060028]; embryonic skeletal system development [GO:0048706]; epithelial cell apoptotic process [GO:1904019]; epithelial to mesenchymal transition [GO:0001837]; lung-associated mesenchyme development [GO:0060484]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesenchymal cell proliferation [GO:0010463]; mesonephric duct development [GO:0072177]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta2 production [GO:0032915]; primary heart field specification [GO:0003138]; protein localization to cell surface [GO:0034394]; protein phosphorylation [GO:0006468]; response to nutrient levels [GO:0031667]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somite development [GO:0061053]; stem cell proliferation [GO:0072089]; ureteric bud morphogenesis [GO:0060675]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]; adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; atrial septum development [GO:0003283]; bicellular tight junction assembly [GO:0070830]; bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cloacal septation [GO:0060197]; convergent extension involved in axis elongation [GO:0060028]; embryonic skeletal system development [GO:0048706]; epithelial cell apoptotic process [GO:1904019]; epithelial to mesenchymal transition [GO:0001837]; lung-associated mesenchyme development [GO:0060484]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesenchymal cell proliferation [GO:0010463]; mesonephric duct development [GO:0072177]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta2 production [GO:0032915]; primary heart field specification [GO:0003138]; protein localization to cell surface [GO:0034394]; protein phosphorylation [GO:0006468]; response to nutrient levels [GO:0031667]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somite development [GO:0061053]; stem cell proliferation [GO:0072089]; ureteric bud morphogenesis [GO:0060675]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001649; GO:0001837; GO:0003138; GO:0003139; GO:0003151; GO:0003283; GO:0003402; GO:0005096; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0006468; GO:0007223; GO:0010463; GO:0010628; GO:0030182; GO:0030282; GO:0030295; GO:0030308; GO:0030325; GO:0030335; GO:0030336; GO:0031012; GO:0031667; GO:0032915; GO:0034394; GO:0043066; GO:0043547; GO:0045165; GO:0045199; GO:0045892; GO:0045893; GO:0048341; GO:0048570; GO:0048706; GO:0048844; GO:0051496; GO:0060028; GO:0060070; GO:0060071; GO:0060197; GO:0060412; GO:0060484; GO:0060548; GO:0060675; GO:0060775; GO:0061037; GO:0061053; GO:0061101; GO:0062009; GO:0070830; GO:0071260; GO:0071300; GO:0072089; GO:0072177; GO:0072201; GO:0090037; GO:0090082; GO:0090090; GO:0090272; GO:1904019; GO:1904037; GO:2000647 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295] ACTSGDLPGCSCGPVPGEPPGPGNR 0.99355 -13.466 0 0 11.4569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7726 0 0 11.7405 10.6015 0 0 11.2775 0 0 0 10.9409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6198 0 0 0 0 0 0 13.4324 0 0 11.8262 0 11.7323 0 12.2493 0 0 0 0 0 0 0 0 0 0 0 0 14.5778 0 0 0 0 0 13.2631 0 0 0 13.0115 0 0 0 0 0 0 0 0 0 0 11.1292 0 11.1651 0 0 0 0 0 0 0 0 0 0 0 11.505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8835 0 0 10.1367 0 0 0 11.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4852 0 P04839 CY24B_HUMAN "Cytochrome b-245 heavy chain, EC 1.-.-.- (CGD91-phox) (Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)" CYBB NOX2 Homo sapiens (Human) cellular response to cadmium ion [GO:0071276]; cellular response to ethanol [GO:0071361]; cellular response to L-glutamine [GO:1904845]; defense response [GO:0006952]; electron transport chain [GO:0022900]; hydrogen peroxide biosynthetic process [GO:0050665]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of angiogenesis [GO:0045766]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ion transmembrane transport [GO:0034765]; respiratory burst [GO:0045730]; response to aldosterone [GO:1904044]; response to angiotensin [GO:1990776]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear endoplasmic reticulum [GO:0097038]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; perinuclear endoplasmic reticulum [GO:0097038]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; voltage-gated ion channel activity [GO:0005244]; cellular response to cadmium ion [GO:0071276]; cellular response to ethanol [GO:0071361]; cellular response to L-glutamine [GO:1904845]; defense response [GO:0006952]; electron transport chain [GO:0022900]; hydrogen peroxide biosynthetic process [GO:0050665]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of angiogenesis [GO:0045766]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ion transmembrane transport [GO:0034765]; respiratory burst [GO:0045730]; response to aldosterone [GO:1904044]; response to angiotensin [GO:1990776]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] GO:0005244; GO:0005635; GO:0005789; GO:0005791; GO:0005794; GO:0005886; GO:0005887; GO:0006801; GO:0006952; GO:0006954; GO:0007584; GO:0009410; GO:0016175; GO:0020037; GO:0022900; GO:0030425; GO:0030670; GO:0032760; GO:0034765; GO:0035579; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0045766; GO:0046872; GO:0046982; GO:0050660; GO:0050665; GO:0070821; GO:0071276; GO:0071361; GO:0097038; GO:0097411; GO:1904044; GO:1904845; GO:1990776 flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; voltage-gated ion channel activity [GO:0005244] GSSACCSTR 0.99355 -13.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0435 0 0 0 0 0 0 0 11.621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.789 0 0 0 0 0 0 0 0 0 0 0 15.0062 14.2458 15.4056 15.8045 0 0 13.3422 0 11.5992 14.0799 0 0 0 12.1713 15.108 0 10.2935 0 0 0 0 0 0 11.228 0 0 0 0 0 0 0 0 0 0 0 0 11.091 0 11.6043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7561 0 0 0 0 11.9156 0 0 0 11.2044 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 P15954 COX7C_HUMAN "Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc)" COX7C Homo sapiens (Human) "cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" GO:0005739; GO:0005743; GO:0005751; GO:0006091; GO:0006123; GO:0016021; GO:0031966; GO:0045333 LGQSIRR 0.99355 -9.1872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2454 0 0 0 0 11.6665 0 0 0 12.4552 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5076 0 0 0 11.0814 0 0 0 0 0 0 0 15.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35968 VGFR2_HUMAN "Vascular endothelial growth factor receptor 2, VEGFR-2, EC 2.7.10.1 (Fetal liver kinase 1, FLK-1) (Kinase insert domain receptor, KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309)" KDR FLK1 VEGFR2 Homo sapiens (Human) angiogenesis [GO:0001525]; blood vessel endothelial cell differentiation [GO:0060837]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; epithelial cell maturation [GO:0002070]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; mesenchymal cell proliferation [GO:0010463]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; semaphorin-plexin signaling pathway [GO:0071526]; stem cell proliferation [GO:0072089]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570] anchoring junction [GO:0070161]; cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443] anchoring junction [GO:0070161]; cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021]; angiogenesis [GO:0001525]; blood vessel endothelial cell differentiation [GO:0060837]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; epithelial cell maturation [GO:0002070]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; mesenchymal cell proliferation [GO:0010463]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; semaphorin-plexin signaling pathway [GO:0071526]; stem cell proliferation [GO:0072089]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570] GO:0001525; GO:0001541; GO:0001569; GO:0001570; GO:0001934; GO:0001938; GO:0001945; GO:0002042; GO:0002053; GO:0002070; GO:0002244; GO:0003157; GO:0003158; GO:0004713; GO:0004714; GO:0005021; GO:0005178; GO:0005524; GO:0005576; GO:0005634; GO:0005768; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0008360; GO:0009897; GO:0010463; GO:0010595; GO:0010629; GO:0014068; GO:0015026; GO:0016239; GO:0016477; GO:0018108; GO:0019838; GO:0030054; GO:0030335; GO:0030513; GO:0033674; GO:0035162; GO:0035584; GO:0035924; GO:0036324; GO:0038033; GO:0038083; GO:0038084; GO:0038085; GO:0042802; GO:0043066; GO:0043129; GO:0043235; GO:0043410; GO:0043491; GO:0043524; GO:0043536; GO:0045121; GO:0045165; GO:0045296; GO:0045446; GO:0045766; GO:0046777; GO:0048010; GO:0048286; GO:0048597; GO:0050673; GO:0050927; GO:0051770; GO:0051879; GO:0051894; GO:0051901; GO:0055074; GO:0060837; GO:0061042; GO:0070161; GO:0070371; GO:0070374; GO:0071526; GO:0072089; GO:0090050; GO:0090141; GO:0097443; GO:1901532; GO:1903010; GO:1904881; GO:2000352; GO:2000648; GO:2001214 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; coreceptor activity [GO:0015026]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021] AASVGLPSVSLDLPRLSIQK 0.99355 -9.1798 0 0 0 0 0 0 0 0 0 0 12.3264 0 0 0 0 0 0 0 0 0 0 12.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.435 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4765 0 0 0 0 15.3368 0 12.923 0 0 0 15.0535 13.847 0 21.412 0 0 0 0 0 0 14.6506 13.3134 0 0 11.4288 13.7979 14.631 0 20.8845 13.2295 15.0708 0 0 0 13.3947 14.6801 0 0 12.9996 0 0 0 0 13.0381 0 0 0 0 15.5778 0 0 0 0 0 10.3686 15.3963 14.256 0 0 0 0 0 0 14.3411 0 0 12.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.275 0 0 0 14.4738 0 0 0 0 0 0 0 11.8864 P55345 ANM2_HUMAN "Protein arginine N-methyltransferase 2, EC 2.1.1.319 (Histone-arginine N-methyltransferase PRMT2)" PRMT2 HMT1 HRMT1L1 Homo sapiens (Human) "developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation [GO:0018216]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; developmental cell growth [GO:0048588]; histone methylation [GO:0016571]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-arginine methylation [GO:0018216]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; signal transduction [GO:0007165]" GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006479; GO:0007165; GO:0008469; GO:0016274; GO:0016571; GO:0018216; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:2000134 histone methyltransferase activity [GO:0042054]; histone-arginine N-methyltransferase activity [GO:0008469]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713] ATSGDCPR 0.99355 -6.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3411 0 0 0 0 0 0 0 0 0 10.8515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6019 0 11.7307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3301 0 0 11.2156 13.9936 0 0 0 0 9.01424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6259 0 0 0 13.7116 0 0 0 0 0 0 0 0 0 Q15370 ELOB_HUMAN "Elongin-B, EloB (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2)" ELOB TCEB2 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0001222; GO:0005654; GO:0005829; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0032436; GO:0065003; GO:0070449 transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625] DDQLLDDGK 0.99355 -13.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15649 ZNHI3_HUMAN "Zinc finger HIT domain-containing protein 3 (HNF-4a coactivator) (Thyroid hormone receptor interactor 3) (Thyroid receptor-interacting protein 3, TR-interacting protein 3, TRIP-3)" ZNHIT3 TRIP3 Homo sapiens (Human) "box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of transcription, DNA-templated [GO:0006355]; snoRNA localization [GO:0048254]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]; box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of transcription, DNA-templated [GO:0006355]; snoRNA localization [GO:0048254]" GO:0000463; GO:0000492; GO:0005634; GO:0005737; GO:0006355; GO:0046872; GO:0046966; GO:0048254; GO:0070761 metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966] DDDDSIADFLNSDEEEDRVSLQNLK 0.99355 -6.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5725 0 13.8839 0 0 13.7844 13.3106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9158 0 0 13.7069 0 0 0 13.4597 0 0 14.209 0 0 13.9437 11.5009 0 13.9499 14.2139 14.0446 0 0 0 13.6813 0 0 0 0 13.8188 0 0 0 0 14.1812 0 0 0 0 0 0 14.0845 0 14.0357 0 0 0 13.5637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5UE93 PI3R6_HUMAN "Phosphoinositide 3-kinase regulatory subunit 6 (Phosphoinositide 3-kinase gamma adapter protein of 87 kDa) (p84 PI3K adapter protein, p84 PIKAP) (p87 PI3K adapter protein, p87PIKAP)" PIK3R6 C17orf38 Homo sapiens (Human) angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of T cell differentiation [GO:0045582]; regulation of natural killer cell mediated cytotoxicity [GO:0042269] "cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]" "cytosol [GO:0005829]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; angiogenesis [GO:0001525]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of T cell differentiation [GO:0045582]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]" GO:0001525; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0005944; GO:0006955; GO:0007186; GO:0016020; GO:0042269; GO:0043406; GO:0045582; GO:0045766; GO:0046934; GO:0046935 "1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" AESQDLRHVIIPLLHTVMYVLTK 0.99355 -13.144 0 0 0 0 0 0 0 0 0 0 0 0 10.9845 0 0 0 0 0 14.8985 0 13.2411 0 0 0 14.9468 0 0 0 0 0 0 13.1954 0 0 0 0 11.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0722 0 0 0 10.9221 0 11.3552 0 0 0 0 0 0 0 0 0 0 0 0 13.4959 0 0 0 0 0 0 0 0 13.5561 14.2515 0 0 0 0 0 0 0 13.5666 0 13.8974 0 0 0 13.7758 0 0 12.497 13.8068 0 13.2196 0 0 0 0 0 0 13.464 0 14.2348 0 0 0 0 0 12.8317 14.4802 12.506 15.6058 12.7724 0 0 0 0 13.7434 0 0 14.6409 0 0 0 12.911 0 0 0 0 13.5976 0 0 0 13.4119 13.1886 0 0 0 0 0 15.2787 0 0 0 11.3048 0 0 12.7304 13.0622 0 15.2144 0 13.0957 0 0 0 0 0 0 0 0 14.1636 11.9554 0 0 0 0 12.6541 0 0 0 0 0 0 Q7L4I2 RSRC2_HUMAN Arginine/serine-rich coiled-coil protein 2 RSRC2 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] RKMLWQGK 0.99355 -7.1002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2917 0 0 0 0 0 0 0 0 0 0 0 11.1805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W42 THOC6_HUMAN "THO complex subunit 6 homolog (Functional spliceosome-associated protein 35, fSAP35) (WD repeat-containing protein 58)" THOC6 WDR58 PSEC0006 Homo sapiens (Human) apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; central nervous system development [GO:0007417]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] GO:0000346; GO:0000347; GO:0000445; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0006406; GO:0006915; GO:0007417; GO:0008380; GO:0016604; GO:0016607; GO:0043066; GO:0046784 RNA binding [GO:0003723] GCKELWR 0.99355 -9.1855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.277 0 0 0 0 0 0 0 0 12.9582 0 0 0 0 0 0 0 0 0 13.4165 0 13.2383 0 0 0 12.9083 0 0 0 0 0 13.2601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6806 13.2144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYB0 YK038_HUMAN Putative uncharacterized protein MGC39545 Homo sapiens (Human) SLLPPVCSK 0.99355 -5.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4116 12.3758 12.3119 0 0 0 0 0 0 0 12.8314 0 0 0 Q8IZ16 SACDR_HUMAN Sperm acrosome developmental regulator SPACDR C7orf61 Homo sapiens (Human) spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; nucleus [GO:0005634] acrosomal vesicle [GO:0001669]; nucleus [GO:0005634]; spermatid development [GO:0007286] GO:0001669; GO:0005634; GO:0007286 HLRRLYR 0.99355 -9.1849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9448 0 0 0 0 0 0 0 0 0 0 10.5072 0 0 0 0 0 0 11.6561 0 0 0 0 11.4963 0 0 0 0 0 0 0 12.719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFH3 NUP43_HUMAN Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43) (p42) NUP43 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031] GO:0000776; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007049; GO:0007059; GO:0015031; GO:0016607; GO:0031080; GO:0051028; GO:0051301 EEIYAKFVSQKISK 0.99355 -9.1827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBF2 PXL2B_HUMAN "Prostamide/prostaglandin F synthase, Prostamide/PG F synthase, Prostamide/PGF synthase, EC 1.11.1.20 (Peroxiredoxin-like 2B) (Protein FAM213B)" PRXL2B C1orf93 FAM213B Homo sapiens (Human) prostaglandin biosynthetic process [GO:0001516] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; antioxidant activity [GO:0016209]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-F synthase activity [GO:0047017]; prostaglandin biosynthetic process [GO:0001516]" GO:0001516; GO:0005737; GO:0005783; GO:0005829; GO:0016209; GO:0016616; GO:0043209; GO:0047017; GO:0070062 "antioxidant activity [GO:0016209]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-F synthase activity [GO:0047017]" PVRDVAAK 0.99355 -13.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MF2 STAC3_HUMAN SH3 and cysteine-rich domain-containing protein 3 STAC3 Homo sapiens (Human) neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]; skeletal muscle fiber development [GO:0048741] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; T-tubule [GO:0030315]; voltage-gated calcium channel complex [GO:0005891]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009]; skeletal muscle fiber development [GO:0048741] GO:0003009; GO:0005654; GO:0005829; GO:0005891; GO:0007274; GO:0030315; GO:0031234; GO:0042802; GO:0045202; GO:0046872; GO:0048741; GO:1901387; GO:1903078 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] CKNCKTNIHEHCQSYVEMQR 0.99355 -9.1906 0 0 0 0 0 12.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2418 0 0 0 0 0 0 0 0 0 0 0 0 12.5612 0 12.3594 0 0 0 12.5723 0 0 0 0 0 0 0 14.2956 14.444 0 0 0 0 0 0 0 11.0643 0 0 0 0 0 0 0 12.1471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9215 0 0 0 0 0 12.8221 0 0 0 0 12.2714 0 0 12.9289 0 0 0 0 0 0 0 0 0 0 0 0 Q9BU70 TRMO_HUMAN "tRNA (adenine(37)-N6)-methyltransferase, EC 2.1.1.- (tRNA methyltransferase O)" TRMO C9orf156 HSPC219 Homo sapiens (Human) tRNA methylation [GO:0030488] tRNA m6t6A37 methyltransferase activity [GO:0089715]; tRNA methylation [GO:0030488] GO:0030488; GO:0089715 tRNA m6t6A37 methyltransferase activity [GO:0089715] ACLRIRK 0.99355 -6.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3953 0 0 13.9982 0 0 0 15.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4891 0 0 0 0 0 0 0 Q9BVM2 DPCD_HUMAN Protein DPCD DPCD Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; lateral ventricle development [GO:0021670]; left/right pattern formation [GO:0060972]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678] extracellular region [GO:0005576]; nucleus [GO:0005634] extracellular region [GO:0005576]; nucleus [GO:0005634]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; lateral ventricle development [GO:0021670]; left/right pattern formation [GO:0060972]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678] GO:0003351; GO:0005576; GO:0005634; GO:0007283; GO:0007368; GO:0021670; GO:0021678; GO:0030317; GO:0051649; GO:0060972 IRNLPYPK 0.99355 -14.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1719 0 0 0 0 0 0 0 0 0 0 11.4233 0 0 0 11.245 0 0 0 0 0 0 0 0 0 0 0 0 14.2336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3312 0 15.2778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7792 0 0 0 0 0 Q9NV23 SAST_HUMAN "S-acyl fatty acid synthase thioesterase, medium chain, EC 3.1.2.14 (Augmented in rheumatoid arthritis 1, AURA1) (Oleoyl-ACP hydrolase) (Thioesterase 2, TE2) (Thioesterase II) (Thioesterase domain-containing protein 1)" OLAH THEDC1 Homo sapiens (Human) lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792] cytosol [GO:0005829] cytosol [GO:0005829]; dodecanoyl-[acyl-carrier-protein] hydrolase activity [GO:0047381]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; myristoyl-CoA hydrolase activity [GO:0102991]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; palmitoyl-CoA hydrolase activity [GO:0016290]; lipid biosynthetic process [GO:0008610]; medium-chain fatty acid biosynthetic process [GO:0051792] GO:0004320; GO:0005829; GO:0008610; GO:0016290; GO:0016295; GO:0016296; GO:0047381; GO:0051792; GO:0102991 dodecanoyl-[acyl-carrier-protein] hydrolase activity [GO:0047381]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; myristoyl-CoA hydrolase activity [GO:0102991]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; palmitoyl-CoA hydrolase activity [GO:0016290] CLEVSSISNF 0.99355 -13.477 0 0 0 0 0 0 0 0 0 15.6347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4116 16.6481 0 13.1711 14.269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1225 0 0 0 0 14.1001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2139 0 0 0 0 0 0 0 0 0 0 0 14.6168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7416 Q9Y3V2 RWDD3_HUMAN "RWD domain-containing protein 3 (RWD domain-containing sumoylation enhancer, RSUME)" RWDD3 RSUME Homo sapiens (Human) negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902073]; positive regulation of protein sumoylation [GO:0033235] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902073]; positive regulation of protein sumoylation [GO:0033235] GO:0005634; GO:0005737; GO:0032088; GO:0033235; GO:1902073 IILILLQGDR 0.99355 -13.472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6539 13.5838 0 0 0 0 0 0 0 0 0 13.8025 0 0 0 0 0 14.6411 0 0 13.8487 14.2688 0 10.7244 0 0 14.276 13.9493 14.0651 0 0 0 0 14.3307 13.7599 0 0 13.601 0 0 0 0 0 0 0 0 13.9297 0 0 0 14.524 0 0 0 0 0 0 13.9518 0 0 0 0 0 13.52 0 0 0 13.7453 0 0 0 11.1066 0 0 14.3965 0 12.0922 0 0 0 12.5782 0 0 0 0 0 12.7024 13.9874 12.1015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8934 0 0 0 0 0 Q6P5Z2 PKN3_HUMAN "Serine/threonine-protein kinase N3, EC 2.7.11.13 (Protein kinase PKN-beta) (Protein-kinase C-related kinase 3)" PKN3 PKNBETA Homo sapiens (Human) epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005794; GO:0005829; GO:0006468; GO:0007165; GO:0010631; GO:0018105; GO:0031267; GO:0035556; GO:0048471; GO:0106310 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] DSQLKVALLRMK 0.99356 -37.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.664 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5715 0 0 0 0 0 12.5636 0 12.7345 0 0 0 0 0 0 0 0 0 0 14.7415 0 12.8373 14.8465 14.6595 12.2149 18.72 0 10.9939 12.7719 13.0628 12.8632 14.4165 14.9172 0 0 14.649 13.9377 14.9624 14.7941 13.88 14.9399 13.2667 0 0 11.0647 0 15.2167 15.1664 15.2241 0 0 17.692 0 14.9348 15.0675 0 14.7945 0 0 14.7337 0 0 0 15.0097 14.993 14.6051 14.6307 11.2283 0 0 0 14.8726 0 14.8609 0 15.1326 13.157 13.0986 14.9619 14.7368 0 15.7575 14.8136 0 0 15.2023 14.6677 0 14.8166 15.8043 0 12.2008 0 0 13.1282 14.5901 0 0 0 12.6636 13.2866 0 10.8969 0 0 13.7874 0 0 0 0 0 0 0 0 0 0 13.5804 0 13.6201 0 0 14.0615 13.3865 0 13.0594 0 14.848 0 12.2915 0 0 0 0 A8MXE2 B3GT9_HUMAN "Beta-1,3-galactosyltransferase 9, EC 2.4.1.- (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10)" B3GALT9 B3GNT10 Homo sapiens (Human) protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758]; protein glycosylation [GO:0006486] GO:0000139; GO:0006486; GO:0016021; GO:0016757; GO:0016758 glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758] DFVPLSEYPEK 0.99356 -13.517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9288 13.4138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9312 0 0 0 0 0 13.7107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15197 EPHB6_HUMAN Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6) EPHB6 Homo sapiens (Human) axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0021952; GO:0033674; GO:0038023; GO:0043005; GO:0043235 ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] GDKACQACPR 0.99356 -5.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8838 0 0 0 0 0 0 0 0 0 0 0 12.0324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3458 0 0 0 0 0 0 12.0219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8385 11.6737 0 0 0 0 0 0 0 0 0 0 0 0 10.9031 0 0 0 0 14.2066 0 0 0 0 0 12.385 0 0 13.9665 15.0097 0 0 14.8165 0 0 13.6167 0 0 0 0 0 0 0 14.6273 0 0 O43529 CHSTA_HUMAN "Carbohydrate sulfotransferase 10, EC 2.8.2.- (HNK-1 sulfotransferase, HNK-1ST, HNK1ST, HuHNK-1ST)" CHST10 Homo sapiens (Human) androgen metabolic process [GO:0008209]; carbohydrate biosynthetic process [GO:0016051]; cell adhesion [GO:0007155]; estrogen metabolic process [GO:0008210]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146]; androgen metabolic process [GO:0008209]; carbohydrate biosynthetic process [GO:0016051]; cell adhesion [GO:0007155]; estrogen metabolic process [GO:0008210]; learning [GO:0007612]; long-term memory [GO:0007616]; proteoglycan biosynthetic process [GO:0030166] GO:0000139; GO:0005794; GO:0007155; GO:0007612; GO:0007616; GO:0008146; GO:0008209; GO:0008210; GO:0016020; GO:0016021; GO:0016051; GO:0016232; GO:0030166 HNK-1 sulfotransferase activity [GO:0016232]; sulfotransferase activity [GO:0008146] FEPWYRHEIAPGIIRK 0.99356 -9.2332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2229 0 0 0 11.9968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8561 0 0 16.0883 0 0 0 0 0 0 0 0 14.2084 14.4672 0 13.7683 0 0 0 0 14.3056 14.0242 0 0 0 0 0 0 15.765 14.4259 0 0 0 0 0 0 0 13.0091 0 13.4098 0 14.4415 0 14.4429 0 0 0 0 13.3935 13.5188 13.8949 0 0 14.4247 0 0 0 0 0 14.1322 14.0869 0 0 0 0 13.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8348 0 0 0 0 0 O75923 DYSF_HUMAN Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1) DYSF FER1L1 Homo sapiens (Human) macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315] centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543]; macrophage activation involved in immune response [GO:0002281]; membrane fusion [GO:0061025]; monocyte activation involved in immune response [GO:0002280]; negative regulation of phagocytosis [GO:0050765]; plasma membrane organization [GO:0007009]; plasma membrane repair [GO:0001778]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906] GO:0001778; GO:0002280; GO:0002281; GO:0005509; GO:0005543; GO:0005544; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006906; GO:0007009; GO:0016021; GO:0030139; GO:0030315; GO:0030659; GO:0031410; GO:0033292; GO:0034451; GO:0042383; GO:0050765; GO:0061025; GO:0070062 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phospholipid binding [GO:0005543] CYMYQAR 0.99356 -13.19 0 14.9013 0 0 15.7098 0 0 0 0 0 0 0 0 10.8941 0 0 0 0 0 0 0 0 0 13.6385 0 0 0 0 0 0 0 0 0 0 0 11.272 0 13.492 0 0 13.175 0 12.0608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6489 18.5354 0 0 11.9054 0 0 0 0 18.3838 0 0 13.7523 0 18.4263 13.0595 19.0259 0 16.3349 0 13.8858 13.8327 0 13.717 0 0 0 0 0 13.4361 15.8709 14.6983 17.9171 0 0 0 0 0 0 0 13.2149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4685 0 0 17.9914 0 0 0 13.1333 0 13.0936 13.6328 0 0 0 0 0 17.0456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95395 GCNT3_HUMAN "Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3, EC 2.4.1.102, EC 2.4.1.148, EC 2.4.1.150 (C2GnT-mucin type, C2GnT-M, hC2GnT-M) (Core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase, C2/4GnT)" GCNT3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; intestinal absorption [GO:0050892]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; tissue morphogenesis [GO:0048729] extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0106325]; acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0106326]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]; carbohydrate metabolic process [GO:0005975]; intestinal absorption [GO:0050892]; kidney morphogenesis [GO:0060993]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; tissue morphogenesis [GO:0048729]" GO:0000139; GO:0003829; GO:0005975; GO:0006493; GO:0008109; GO:0008375; GO:0016020; GO:0016021; GO:0016266; GO:0048729; GO:0050892; GO:0060993; GO:0070062; GO:0106325; GO:0106326 "acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0106325]; acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0106326]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]" DCEHFKAERK 0.99356 -6.4733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3722 0 0 11.1647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26038 MOES_HUMAN Moesin (Membrane-organizing extension spike protein) MSN Homo sapiens (Human) cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200]; cellular response to testosterone stimulus [GO:0071394]; establishment of endothelial barrier [GO:0061028]; establishment of epithelial cell apical/basal polarity [GO:0045198]; gland morphogenesis [GO:0022612]; immunological synapse formation [GO:0001771]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; membrane to membrane docking [GO:0022614]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of lymphocyte migration [GO:2000401]; regulation of organelle assembly [GO:1902115]; T cell aggregation [GO:0070489]; T cell migration [GO:0072678]; T cell proliferation [GO:0042098] GO:0001771; GO:0001931; GO:0003725; GO:0003779; GO:0005102; GO:0005200; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0005925; GO:0007159; GO:0008360; GO:0008361; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0019899; GO:0019901; GO:0022612; GO:0022614; GO:0030175; GO:0031143; GO:0031528; GO:0031982; GO:0042098; GO:0045177; GO:0045198; GO:0045732; GO:0048471; GO:0050839; GO:0050900; GO:0061028; GO:0070062; GO:0070489; GO:0071394; GO:0071803; GO:0071944; GO:0072562; GO:0072678; GO:1902115; GO:1902966; GO:2000401; GO:2000643 actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; protein kinase binding [GO:0019901]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200] EKEELMER 0.99356 -6.9234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4095 P41235 HNF4A_HUMAN "Hepatocyte nuclear factor 4-alpha, HNF-4-alpha (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14, TCF-14) (Transcription factor HNF-4)" HNF4A HNF4 NR2A1 TCF14 Homo sapiens (Human) "anatomical structure development [GO:0048856]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; ornithine metabolic process [GO:0006591]; phospholipid homeostasis [GO:0055091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of gastrulation [GO:0010470]; regulation of growth hormone receptor signaling pathway [GO:0060398]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; sex differentiation [GO:0007548]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; triglyceride homeostasis [GO:0070328]; type B pancreatic cell development [GO:0003323]; xenobiotic metabolic process [GO:0006805]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; fatty acid binding [GO:0005504]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; blood coagulation [GO:0007596]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; glucose homeostasis [GO:0042593]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; ornithine metabolic process [GO:0006591]; phospholipid homeostasis [GO:0055091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of gastrulation [GO:0010470]; regulation of growth hormone receptor signaling pathway [GO:0060398]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; rhythmic process [GO:0048511]; sex differentiation [GO:0007548]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; triglyceride homeostasis [GO:0070328]; type B pancreatic cell development [GO:0003323]; xenobiotic metabolic process [GO:0006805]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003323; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005102; GO:0005504; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0006591; GO:0006629; GO:0006805; GO:0007548; GO:0007596; GO:0008270; GO:0008285; GO:0009749; GO:0010470; GO:0019216; GO:0023019; GO:0030154; GO:0030308; GO:0042593; GO:0042632; GO:0042752; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0048511; GO:0048856; GO:0050796; GO:0055088; GO:0055091; GO:0060395; GO:0060398; GO:0061629; GO:0070328; GO:0070365; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; fatty acid binding [GO:0005504]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" EQLLVLVEWAKYIPAFCELPLDDQVALLR 0.99356 -13.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9889 0 0 14.7344 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3036 0 0 0 0 0 0 15.3881 0 0 0 0 0 0 0 0 0 0 14.5888 0 0 0 0 0 0 0 12.9277 13.9933 0 0 0 0 0 0 0 0 0 0 0 0 13.9863 0 0 0 0 0 14.5881 0 13.8453 12.6354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01118 SCN7A_HUMAN Sodium channel protein type 7 subunit alpha (Putative voltage-gated sodium channel subunit alpha Nax) (Sodium channel protein cardiac and skeletal muscle subunit alpha) (Sodium channel protein type VII subunit alpha) SCN7A SCN6A Homo sapiens (Human) cellular homeostasis [GO:0019725]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; response to bacterium [GO:0009617]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; glial cell projection [GO:0097386]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; glial cell projection [GO:0097386]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cellular homeostasis [GO:0019725]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; response to bacterium [GO:0009617]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0006814; GO:0006936; GO:0009617; GO:0019228; GO:0019725; GO:0030424; GO:0034765; GO:0035725; GO:0055078; GO:0086010; GO:0097386 voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] AYKNYRLR 0.99356 -37.906 0 0 0 0 0 14.245 0 0 0 0 12.0294 11.1972 0 0 0 0 10.5543 0 13.0342 0 0 0 12.1886 0 0 10.3185 0 0 0 0 0 0 0 0 0 0 12.154 0 0 0 12.4893 10.3071 0 0 0 11.4017 0 0 0 9.93161 14.4422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7973 13.8529 0 13.8519 13.8606 14.0031 12.5603 0 11.5031 13.0777 0 17.1511 17.1891 11.6227 0 0 16.3764 12.2302 13.2869 15.8866 14.2383 10.4882 12.3169 13.679 0 13.817 0 0 0 0 0 15.0478 14.3956 12.3315 0 0 0 0 13.739 13.1901 10.7273 12.6279 0 13.7265 14.9524 0 13.0875 0 11.6597 0 0 0 12.8297 14.051 0 13.6171 12.0162 0 0 0 13.1551 11.4134 11.3923 13.9067 0 0 0 0 0 0 0 13.3071 15.1638 0 0 0 12.7866 0 10.537 0 0 11.4546 11.0659 0 17.358 17.138 17.2163 14.9633 14.7796 0 11.5139 10.3395 12.2235 0 0 15.6421 0 13.4659 0 14.3247 10.5892 0 0 0 16.0578 0 0 Q13506 NAB1_HUMAN NGFI-A-binding protein 1 (EGR-1-binding protein 1) (Transcriptional regulatory protein p54) NAB1 Homo sapiens (Human) "endochondral ossification [GO:0001958]; myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of epidermis development [GO:0045682]; regulation of transcription, DNA-templated [GO:0006355]; Schwann cell differentiation [GO:0014037]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; endochondral ossification [GO:0001958]; myelination [GO:0042552]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of epidermis development [GO:0045682]; regulation of transcription, DNA-templated [GO:0006355]; Schwann cell differentiation [GO:0014037]" GO:0001958; GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0014037; GO:0042552; GO:0045682; GO:0045892 transcription coregulator activity [GO:0003712] ELLKTNKK 0.99356 -13.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1201 0 0 0 0 0 0 0 0 0 0 10.8366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9552 0 0 13.0885 0 0 0 0 12.6646 0 0 0 0 12.9196 0 13.4888 0 0 0 0 0 10.4738 0 0 13.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0907 0 0 0 0 0 0 0 13.1363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2973 15.324 0 13.1134 0 0 0 0 0 0 12.7366 0 0 0 12.9767 0 0 0 13.0121 0 0 0 0 0 12.534 0 0 Q13724 MOGS_HUMAN "Mannosyl-oligosaccharide glucosidase, EC 3.2.1.106 (Processing A-glucosidase I)" MOGS GCS1 Homo sapiens (Human) oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; Glc3Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0004573]; glucosidase activity [GO:0015926]; oligosaccharide metabolic process [GO:0009311]; protein folding [GO:0006457]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082] GO:0004573; GO:0005783; GO:0005789; GO:0006457; GO:0006487; GO:0009311; GO:0015926; GO:0016020; GO:0016021; GO:0019082; GO:0070062 Glc3Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0004573]; glucosidase activity [GO:0015926] AARGGPGR 0.99356 -15.884 0 0 0 0 0 0 0 0 0 12.9123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1532 0 0 13.0204 0 0 0 0 0 14.072 0 13.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1697 Q3KPI0 CEA21_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 21 CEACAM21 UNQ3098/PRO10075 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 SDDNTLGILIGVLVGSLLVAALVCFLLLRK 0.99356 -5.1563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.907 0 0 0 0 0 0 Q5U651 RAIN_HUMAN "Ras-interacting protein 1, Rain" RASIP1 Homo sapiens (Human) angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; negative regulation of autophagy [GO:0010507]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; positive regulation of integrin activation [GO:0033625]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] cell-cell junction [GO:0005911]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] cell-cell junction [GO:0005911]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; negative regulation of autophagy [GO:0010507]; negative regulation of membrane permeability [GO:1905709]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; positive regulation of integrin activation [GO:0033625]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0005795; GO:0005911; GO:0007165; GO:0010507; GO:0032991; GO:0033625; GO:0035024; GO:0042803; GO:0043087; GO:0048471; GO:0048754; GO:0051020; GO:1905709; GO:2000299 GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803] ASWSSLR 0.99356 -6.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8751 0 0 0 0 0 13.4805 0 13.1928 13.7001 15.6726 13.2383 0 0 0 12.7482 12.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9944 0 0 0 14.761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.331 0 0 0 0 0 0 13.339 0 0 0 0 0 0 0 0 0 0 0 13.4144 13.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1927 0 0 Q68CP9 ARID2_HUMAN "AT-rich interactive domain-containing protein 2, ARID domain-containing protein 2 (BRG1-associated factor 200, BAF200) (Zinc finger protein with activation potential) (Zipzap/p200)" ARID2 BAF200 KIAA1557 Homo sapiens (Human) cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0046872; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:1905168; GO:2000045; GO:2000781; GO:2000819 DNA binding [GO:0003677]; metal ion binding [GO:0046872] CLMSRDR 0.99356 -6.9222 0 0 13.4665 0 10.1362 0 0 0 0 0 0 0 0 0 0 0 10.39 0 0 0 0 0 0 0 0 14.5313 0 0 0 0 14.0051 0 0 0 0 14.223 0 0 0 0 15.0412 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5035 0 0 0 14.3992 0 0 0 0 0 0 0 0 20.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6491 0 0 0 14.2844 16.1221 0 0 12.4285 0 0 0 0 0 0 0 0 13.0309 0 0 12.6453 0 0 0 12.8379 0 0 0 0 0 0 10.9324 0 0 0 0 0 0 0 10.9003 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0056 0 0 0 0 0 0 0 0 0 0 0 0 12.4083 0 14.4887 0 13.5533 0 13.6337 0 14.9959 0 0 0 0 0 0 0 0 0 12.6007 0 0 14.6652 Q6NZ36 FAP20_HUMAN Fanconi anemia core complex-associated protein 20 (FANCA-associated protein of 20 kDa) (Fanconi anemia-associated protein of 20 kDa) FAAP20 C1orf86 FP7162 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; translesion synthesis [GO:0019985] cell junction [GO:0030054]; chromatin [GO:0000785]; chromosome [GO:0005694]; Fanconi anaemia nuclear complex [GO:0043240]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cell junction [GO:0030054]; chromatin [GO:0000785]; chromosome [GO:0005694]; Fanconi anaemia nuclear complex [GO:0043240]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130]; ubiquitin-dependent protein binding [GO:0140036]; cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; translesion synthesis [GO:0019985] GO:0000785; GO:0005654; GO:0005694; GO:0006513; GO:0006974; GO:0016604; GO:0019985; GO:0030054; GO:0031593; GO:0036297; GO:0043130; GO:0043240; GO:0046872; GO:0070530; GO:0140036 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130]; ubiquitin-dependent protein binding [GO:0140036] EAARRPR 0.99356 -9.2361 0 0 0 0 16.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.213 0 0 0 0 13.8984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5673 0 0 0 19.4596 0 0 18.896 19.5463 0 0 0 0 0 0 0 0 19.7382 0 0 0 0 Q8IXQ5 KLHL7_HUMAN Kelch-like protein 7 KLHL7 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein ubiquitination [GO:0016567] GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0016567; GO:0031463; GO:0042802; GO:0042803; GO:0048471 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] DSLAACAAEGK 0.99356 -28.956 0 0 0 13.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9046 0 0 0 0 0 0 0 0 0 0 12.6339 0 0 0 0 0 13.599 0 11.8628 0 13.8718 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6387 0 0 0 0 0 0 0 14.3355 0 0 0 0 11.3402 0 0 12.6441 0 11.5009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7191 0 0 0 0 0 0 0 0 0 0 12.3802 12.8747 0 11.2154 0 0 0 0 14.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9049 0 0 11.9986 0 0 0 0 0 0 0 0 Q92838 EDA_HUMAN "Ectodysplasin-A (Ectodermal dysplasia protein, EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form ]" EDA ED1 EDA2 Homo sapiens (Human) animal organ development [GO:0048513]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; cytokine-mediated signaling pathway [GO:0019221]; gene expression [GO:0010467]; hair follicle placode formation [GO:0060789]; immune response [GO:0006955]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of NIK/NF-kappaB signaling [GO:1901222]; salivary gland cavitation [GO:0060662]; trachea gland development [GO:0061153] apical part of cell [GO:0045177]; collagen trimer [GO:0005581]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; collagen trimer [GO:0005581]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; death receptor agonist activity [GO:0038177]; death receptor binding [GO:0005123]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; animal organ development [GO:0048513]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; cytokine-mediated signaling pathway [GO:0019221]; gene expression [GO:0010467]; hair follicle placode formation [GO:0060789]; immune response [GO:0006955]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of NIK/NF-kappaB signaling [GO:1901222]; salivary gland cavitation [GO:0060662]; trachea gland development [GO:0061153] GO:0005102; GO:0005123; GO:0005164; GO:0005581; GO:0005615; GO:0005789; GO:0005811; GO:0005856; GO:0005886; GO:0005887; GO:0006955; GO:0007160; GO:0010467; GO:0010628; GO:0016020; GO:0016021; GO:0019221; GO:0030154; GO:0038177; GO:0042475; GO:0043123; GO:0043231; GO:0043473; GO:0045177; GO:0048018; GO:0048513; GO:0051092; GO:0060070; GO:0060662; GO:0060789; GO:0061153; GO:0090263; GO:1901222; GO:1901224 death receptor agonist activity [GO:0038177]; death receptor binding [GO:0005123]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] GYPEVER 0.99356 -15.873 0 0 0 0 0 0 0 12.1571 0 0 0 0 10.522 0 0 0 11.3582 0 0 0 0 16.9386 0 0 0 0 0 0 0 10.2583 0 0 0 0 0 0 0 0 0 0 0 0 10.9147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4585 13.2458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6738 0 0 0 0 0 0 0 0 0 0 0 Q96RQ3 MCCA_HUMAN "Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial, MCCase subunit alpha, EC 6.4.1.4 (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)" MCCC1 MCCA Homo sapiens (Human) biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552] "3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]" "3-methylcrotonyl-CoA carboxylase complex, mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; leucine catabolic process [GO:0006552]" GO:0002169; GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202 ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485] AAAKESLCQAALGLILKEK 0.99356 -6.9267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.548 0 0 0 0 0 13.8743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5 0 0 0 0 0 12.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SQ9 CP2S1_HUMAN "Cytochrome P450 2S1, EC 1.14.14.- (CYPIIS1) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152) (Thromboxane-A synthase, EC 5.3.99.5)" CYP2S1 UNQ891/PRO1906 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; organic acid metabolic process [GO:0006082]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; thromboxane-A synthase activity [GO:0004796]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; organic acid metabolic process [GO:0006082]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0004796; GO:0005506; GO:0005737; GO:0005783; GO:0005789; GO:0006082; GO:0006690; GO:0006693; GO:0006805; GO:0008392; GO:0008395; GO:0008401; GO:0016712; GO:0016836; GO:0019373; GO:0020037; GO:0036134; GO:0042573; GO:0043231; GO:0106256 "12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; thromboxane-A synthase activity [GO:0004796]" EATGTWALLLALALLLLLTLALSGTRAR 0.99356 -15.88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6434 0 0 0 0 0 0 0 0 0 0 13.5338 0 0 0 13.0039 0 0 0 0 0 13.0779 0 0 0 0 0 0 0 0 0 12.8088 0 0 0 0 12.8929 12.8947 0 12.7788 13.0683 13.6897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0645 14.6395 0 0 0 0 12.5467 0 0 0 12.7413 0 13.136 0 0 0 0 0 0 0 13.9822 13.8388 0 12.7522 0 0 13.7768 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4787 0 0 0 12.5394 0 Q9H0E7 UBP44_HUMAN "Ubiquitin carboxyl-terminal hydrolase 44, EC 3.4.19.12 (Deubiquitinating enzyme 44) (Ubiquitin thioesterase 44) (Ubiquitin-specific-processing protease 44)" USP44 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0007049; GO:0007059; GO:0008270; GO:0016579; GO:0043161; GO:0051301; GO:0090266; GO:1904667 cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270] GFGSGHYTAYCYNSEGGFWVHCNDSK 0.99356 -37.881 9.8495 0 0 0 11.0049 0 0 0 12.2285 11.5687 11.8749 0 0 11.1133 0 12.4345 0 13.8445 13.7669 13.279 0 0 10.8573 11.0246 0 0 0 0 13.1987 0 11.2788 12.7889 0 0 0 0 0 0 0 0 0 0 10.9224 0 0 11.1735 0 0 12.3243 10.6931 0 12.5825 15.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1318 0 0 0 14.0343 14.3927 14.023 16.0858 15.8945 15.1569 15.7333 15.8261 15.3987 14.7662 13.9142 15.4853 0 15.0309 14.8079 15.2281 15.6586 16.2431 11.6199 16.8694 0 15.0989 0 14.737 16.4051 15.9073 12.7907 14.7357 17.4031 15.8445 0 16.0017 15.7143 15.9312 15.408 16.6516 16.851 0 15.7164 0 14.8385 14.5701 15.358 16.2274 16.7445 15.8724 0 16.7185 15.35 0 15.548 16.4055 16.4603 16.0863 0 15.4924 16.5386 0 16.5019 0 16.4005 15.5719 16.1666 15.1152 15.4175 16.2212 16.2919 12.4837 0 15.385 15.939 14.8851 0 14.8264 13.0906 14.8244 0 0 0 0 0 0 0 14.0399 0 12.306 13.6837 12.7321 13.5399 12.7021 0 12.7357 13.9105 14.1102 0 0 13.6514 13.3313 12.5567 13.4517 13.4818 14.5281 14.7572 0 13.6342 0 12.4952 14.1688 0 Q9NRM7 LATS2_HUMAN "Serine/threonine-protein kinase LATS2, EC 2.7.11.1 (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase)" LATS2 KPM Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; canonical Wnt signaling pathway [GO:0060070]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of organ growth [GO:0046620]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015] GO:0000082; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0018105; GO:0030216; GO:0034451; GO:0035329; GO:0035556; GO:0043065; GO:0045736; GO:0046620; GO:0046872; GO:0051301; GO:0060070; GO:0090090; GO:0106310; GO:1900181 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AKMDKSMFVK 0.99356 -27.517 10.0105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3163 0 0 0 0 0 12.6602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0284 11.1022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8103 13.6828 0 0 13.4454 0 0 0 0 14.4401 0 0 0 0 0 0 0 0 0 0 0 15.3993 12.406 13.7145 11.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0241 0 0 0 0 13.9001 16.5799 0 0 13.5596 0 0 0 0 14.8739 0 0 14.5599 0 0 0 0 0 13.9732 0 0 0 10.5965 0 0 0 13.0129 0 14.084 0 0 0 Q9UBU2 DKK2_HUMAN "Dickkopf-related protein 2, Dickkopf-2, Dkk-2, hDkk-2" DKK2 UNQ682/PRO1316 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615] extracellular space [GO:0005615]; co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055] GO:0005615; GO:0016055; GO:0039706; GO:0048019; GO:0090090; GO:0090263 co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019] ARLHVCQK 0.99356 -9.2316 0 0 0 0 0 0 0 0 9.92677 14.4063 0 0 0 0 0 0 0 0 0 0 10.9878 0 0 0 0 10.5472 0 0 0 0 0 0 0 10.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7899 0 0 0 0 0 0 0 0 0 0 11.9257 0 0 0 0 0 0 0 12.0301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7183 0 0 13.2767 0 0 0 0 0 0 0 0 13.1312 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8529 0 0 0 0 0 0 0 0 10.28 0 0 0 0 0 11.0018 0 0 0 0 0 0 0 0 0 0 0 10.0463 Q3T8J9 GON4L_HUMAN GON-4-like protein (GON-4 homolog) GON4L GON4 KIAA1606 Homo sapiens (Human) "B cell differentiation [GO:0030183]; regulation of transcription, DNA-templated [GO:0006355]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; B cell differentiation [GO:0030183]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0006355; GO:0016604; GO:0030183 transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] DCACSCHEGGPDSK 0.99357 -17.31 0 0 0 0 14.0022 0 0 0 16.2715 16.5096 12.4798 16.2984 16.3833 12.5623 16.5449 0 12.4025 0 0 11.6856 0 0 0 13.2255 0 0 0 0 10.873 0 0 0 15.2876 0 15.6908 0 15.3854 0 15.3917 0 0 11.7125 0 0 12.7972 0 0 0 0 0 0 0 0 0 0 12.0797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7971 15.4055 0 14.3433 14.2597 14.3034 14.068 14.6453 15.0181 12.0741 15.0906 15.9068 15.4517 14.3028 14.1651 0 14.1702 15.5327 14.4296 14.5763 14.2539 0 13.0447 10.1762 0 0 16.1462 14.9742 14.6296 11.9506 0 0 14.7877 15.6025 14.9405 15.2014 14.056 15.2967 0 13.8062 12.6297 14.7011 15.6807 13.1306 15.7194 0 0 15.0257 14.4338 0 14.2905 13.3644 13.4857 0 13.9959 13.0468 13.1175 0 12.074 0 0 14.2341 14.6945 0 0 14.967 0 15.0819 14.9847 15.0326 14.5699 14.7325 0 0 14.4737 13.0101 0 0 14.7163 0 0 18.1048 0 13.4436 14.3764 14.0023 15.2241 14.1042 14.3424 0 14.8088 14.4856 14.5145 15.8866 14.2573 14.1826 0 14.7425 18.0848 13.1564 0 14.7129 0 0 0 14.981 0 A6NHS7 MANS4_HUMAN MANSC domain-containing protein 4 MANSC4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LSHMPVPPGLNSSKQLLNK 0.99357 -5.1765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7662 0 12.5532 0 0 0 0 0 0 0 0 10.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1916 0 0 0 0 0 0 13.9068 0 12.6364 0 0 0 0 0 0 0 0 0 0 O15016 TRI66_HUMAN Tripartite motif-containing protein 66 TRIM66 C11orf29 KIAA0298 Homo sapiens (Human) aggresome [GO:0016235]; nucleoplasm [GO:0005654] aggresome [GO:0016235]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270] GO:0005654; GO:0008270; GO:0016235 zinc ion binding [GO:0008270] AFNSEHK 0.99357 -9.2706 0 0 0 0 0 0 0 0 0 0 0 13.9719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4017 0 0 0 13.6183 0 0 0 0 0 0 0 0 0 0 0 0 11.8098 0 0 0 10.7888 11.4444 0 11.9957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8174 16.2013 0 0 0 0 13.3606 12.2016 0 0 0 0 0 12.0518 13.4431 0 0 0 0 13.188 0 0 0 0 0 0 13.6746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.354 0 11.7866 0 0 0 0 0 0 0 0 12.9852 0 0 13.9474 0 13.1076 11.3543 0 0 12.063 0 10.9143 0 0 0 0 0 0 12.7993 12.3002 0 0 0 0 0 12.4197 0 0 0 11.6102 0 0 11.7123 0 0 0 0 0 0 0 0 0 0 P12814 ACTN1_HUMAN Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1) ACTN1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981] brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018] brush border [GO:0005903]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fascia adherens [GO:0005916]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; pseudopodium [GO:0031143]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal regulatory protein binding [GO:0005519]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; transmembrane transporter binding [GO:0044325]; vinculin binding [GO:0017166]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; focal adhesion assembly [GO:0048041]; muscle cell development [GO:0055001]; platelet formation [GO:0030220]; platelet morphogenesis [GO:0036344]; regulation of apoptotic process [GO:0042981] GO:0001725; GO:0001726; GO:0003725; GO:0005178; GO:0005509; GO:0005519; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005911; GO:0005916; GO:0005925; GO:0007015; GO:0017166; GO:0019904; GO:0030018; GO:0030036; GO:0030054; GO:0030220; GO:0030374; GO:0030864; GO:0031093; GO:0031143; GO:0036344; GO:0042803; GO:0042981; GO:0042995; GO:0043197; GO:0044325; GO:0048041; GO:0051015; GO:0051017; GO:0051639; GO:0055001; GO:0070062; GO:0098978; GO:0099186 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cytoskeletal regulatory protein binding [GO:0005519]; double-stranded RNA binding [GO:0003725]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; structural constituent of postsynapse [GO:0099186]; transmembrane transporter binding [GO:0044325]; vinculin binding [GO:0017166] DHYDSQQTNDYMQPEEDWDR 0.99357 -27.592 0 0 0 0 0 0 0 0 14.9129 15.636 0 0 0 14.3164 0 0 0 14.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4376 13.3569 13.9711 13.4847 0 13.3979 0 13.4977 13.4838 0 0 0 0 13.0947 0 0 14.4684 0 0 13.4995 0 0 0 15.3005 0 12.3742 0 0 0 0 0 11.1814 0 0 0 0 0 0 0 11.6793 11.1317 0 0 0 0 0 0 0 13.1467 13.3576 0 12.811 0 0 12.4272 0 0 0 0 0 0 0 11.1712 12.5687 13.0987 12.665 0 0 0 12.945 13.1623 15.7621 0 0 0 0 12.1494 0 0 0 0 11.3432 0 10.6524 0 0 13.8913 14.5406 0 0 14.3142 0 0 0 0 0 0 0 0 11.5305 0 0 0 0 0 0 0 0 0 0 0 0 14.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0755 0 0 11.0075 0 19.2237 0 0 0 0 0 0 19.7156 15.8389 0 0 Q13427 PPIG_HUMAN "Peptidyl-prolyl cis-trans isomerase G, PPIase G, Peptidyl-prolyl isomerase G, EC 5.2.1.8 (CASP10) (Clk-associating RS-cyclophilin, CARS-Cyp, CARS-cyclophilin, SR-cyclophilin, SR-cyp, SRcyp) (Cyclophilin G) (Rotamase G)" PPIG Homo sapiens (Human) protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380] GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0008380; GO:0016018; GO:0016363; GO:0016607; GO:0043231 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723] DIRRNSEK 0.99357 -17.303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4642 0 0 12.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1168 0 11.2828 12.7631 0 0 0 0 0 0 0 11.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1246 0 0 12.0014 0 0 0 0 0 0 0 12.8228 0 0 14.403 0 0 0 0 0 12.8116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7745 13.4661 0 0 0 0 0 0 0 12.5007 0 0 0 0 0 0 0 0 0 0 12.4386 0 0 11.8377 12.0013 0 0 0 0 11.436 0 Q13753 LAMC2_HUMAN "Laminin subunit gamma-2 (Cell-scattering factor 140 kDa subunit, CSF 140 kDa subunit) (Epiligrin subunit gamma) (Kalinin subunit gamma) (Kalinin/nicein/epiligrin 100 kDa subunit) (Ladsin 140 kDa subunit) (Laminin B2t chain) (Laminin-5 subunit gamma) (Large adhesive scatter factor 140 kDa subunit) (Nicein subunit gamma)" LAMC2 LAMB2T LAMNB2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; epidermis development [GO:0008544]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; tissue development [GO:0009888] basement membrane [GO:0005604]; cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-2 complex [GO:0005607]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] basement membrane [GO:0005604]; cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-2 complex [GO:0005607]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; epidermis development [GO:0008544]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; tissue development [GO:0009888] GO:0005102; GO:0005576; GO:0005604; GO:0005607; GO:0005615; GO:0005938; GO:0007155; GO:0008045; GO:0008201; GO:0008284; GO:0008544; GO:0009887; GO:0009888; GO:0016020; GO:0016358; GO:0030335; GO:0048471; GO:0062023 heparin binding [GO:0008201]; signaling receptor binding [GO:0005102] CDCDPAGIAGPCDAGR 0.99357 -27.673 0 0 0 0 0 0 0 0 12.2981 0 13.9776 0 0 11.8741 0 0 0 0 0 0 0 0 0 0 0 0 11.638 0 0 0 10.0965 11.9858 0 0 0 0 0 0 0 11.6566 0 0 0 0 0 0 0 9.85219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4713 0 0 10.4095 0 0 0 11.1964 0 0 0 17.9596 18.5057 16.1847 0 9.93097 0 0 0 0 0 12.1469 13.8542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2673 0 0 0 0 0 0 0 0 0 0 0 11.7251 0 0 0 0 0 12.7013 0 0 0 12.926 0 0 0 13.3662 0 0 0 0 0 0 0 0 0 0 0 12.1525 0 0 0 0 0 0 13.7285 0 0 0 0 0 0 0 0 0 0 10.5105 0 0 0 0 0 0 0 0 0 0 0 0 Q14691 PSF1_HUMAN DNA replication complex GINS protein PSF1 (GINS complex subunit 1) GINS1 KIAA0186 PSF1 Homo sapiens (Human) DNA strand elongation involved in mitotic DNA replication [GO:1902983]; DNA unwinding involved in DNA replication [GO:0006268]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] CMG complex [GO:0071162]; cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] CMG complex [GO:0071162]; cytoplasm [GO:0005737]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA strand elongation involved in mitotic DNA replication [GO:1902983]; DNA unwinding involved in DNA replication [GO:0006268]; inner cell mass cell proliferation [GO:0001833]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0000811; GO:0001833; GO:0005634; GO:0005654; GO:0005737; GO:0006268; GO:0071162; GO:1900264; GO:1902983; GO:1903934 CTVAYLYDRLLRIR 0.99357 -9.2636 0 0 0 0 0 0 0 0 12.7561 12.7818 0 0 0 12.7666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9313 0 0 12.6244 0 0 11.1455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1452 0 0 0 15.1617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.796 0 0 13.757 0 0 0 0 0 0 0 0 0 Q15392 DHC24_HUMAN "Delta(24)-sterol reductase, EC 1.3.1.72 (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1)" DHCR24 KIAA0018 Homo sapiens (Human) amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]; amyloid precursor protein catabolic process [GO:0042987]; apoptotic process [GO:0006915]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of neuron death [GO:1901214]; response to hormone [GO:0009725]; response to oxidative stress [GO:0006979]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888]" GO:0000139; GO:0000246; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0005856; GO:0006695; GO:0006915; GO:0006979; GO:0007265; GO:0008104; GO:0008202; GO:0008285; GO:0009725; GO:0009888; GO:0016020; GO:0016021; GO:0016628; GO:0019899; GO:0030539; GO:0031639; GO:0033489; GO:0033490; GO:0042605; GO:0042987; GO:0043066; GO:0043154; GO:0043588; GO:0050614; GO:0051726; GO:0061024; GO:0071949; GO:1901214 "delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]" EGLEYIPLRHYYHRHTR 0.99357 -13.934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3713 0 0 0 0 0 0 0 12.2913 0 0 0 0 0 0 0 0 0 0 11.5985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9488 0 0 0 14.2407 0 14.3892 11.8192 0 0 0 0 13.3001 0 0 0 0 12.9325 0 0 14.8501 0 0 13.2971 12.485 0 0 10.7172 0 0 0 0 0 0 0 0 0 0 0 14.526 0 13.8531 0 0 12.2801 12.4668 0 14.009 0 12.0789 0 11.9228 0 0 0 0 0 0 0 0 0 0 12.9522 0 0 13.8286 13.9687 13.6485 0 0 0 0 0 12.6081 10.913 0 0 0 14.2507 12.7865 0 0 0 0 0 0 13.1635 0 0 13.4952 11.1978 0 0 0 0 0 0 0 0 14.1274 13.6098 0 0 0 0 0 0 Q5BKX6 S45A4_HUMAN Solute carrier family 45 member 4 SLC45A4 KIAA1126 Homo sapiens (Human) sucrose transport [GO:0015770] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; sucrose:proton symporter activity [GO:0008506]; sucrose transport [GO:0015770] GO:0008506; GO:0015770; GO:0016020; GO:0016021 sucrose:proton symporter activity [GO:0008506] ANAVVLIK 0.99357 -5.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8151 0 0 10.6779 0 0 14.1981 0 0 0 0 0 12.0978 0 0 0 13.2711 0 0 13.3038 0 12.5588 0 0 0 0 13.0892 0 0 0 0 0 0 10.7874 0 0 13.3192 0 0 0 0 0 9.96395 0 12.7902 0 0 0 0 12.1255 0 0 0 11.6753 12.9574 0 0 0 0 0 0 12.6321 0 14.5825 0 0 12.7902 0 0 0 0 0 0 0 0 0 0 0 14.1763 9.97957 0 12.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7617 Q6GMV2 SMYD5_HUMAN "Histone-lysine N-trimethyltransferase SMYD5, EC 2.1.1.372 (Protein NN8-4AG) (Retinoic acid-induced protein 15) (SET and MYND domain-containing protein 5) ([histone H4]-lysine20 N-trimethyltransferase SMYD5)" SMYD5 RAI15 Homo sapiens (Human) "histone H4-K20 trimethylation [GO:0034773]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transposition [GO:0010529]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]" "histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transposition [GO:0010529]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]" GO:0010529; GO:0034773; GO:0042799; GO:0045814; GO:0046872; GO:2000035; GO:2000736 histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872] ACDHCLR 0.99357 -7.9335 12.34 0 0 0 0 0 12.3317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3361 0 16.115 12.6335 0 0 0 0 0 0 0 0 0 14.3821 0 0 0 12.3183 0 0 0 14.5892 0 0 0 0 0 0 0 0 0 0 13.2528 0 0 0 0 0 12.2641 0 0 0 0 13.9373 0 11.8693 0 0 0 13.8195 0 0 14.8773 0 14.7745 0 0 0 14.1528 0 0 0 0 0 0 0 0 0 0 0 0 11.3877 0 0 0 0 0 0 0 0 13.6203 14.3767 0 0 0 0 0 0 Q7Z494 NPHP3_HUMAN Nephrocystin-3 NPHP3 KIAA2000 Homo sapiens (Human) "atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of protein binding [GO:0032092]; regulation of planar cell polarity pathway involved in neural tube closure [GO:2000167]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]" ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576] "ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; atrial septum development [GO:0003283]; cilium assembly [GO:0060271]; convergent extension [GO:0060026]; convergent extension involved in gastrulation [GO:0060027]; determination of intestine left/right asymmetry [GO:0071908]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; determination of stomach left/right asymmetry [GO:0071909]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment or maintenance of cell polarity [GO:0007163]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; maintenance of animal organ identity [GO:0048496]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of protein binding [GO:0032092]; regulation of planar cell polarity pathway involved in neural tube closure [GO:2000167]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; ureter development [GO:0072189]; Wnt signaling pathway [GO:0016055]" GO:0001822; GO:0001947; GO:0003283; GO:0005576; GO:0005829; GO:0005929; GO:0006629; GO:0007163; GO:0007368; GO:0016055; GO:0030198; GO:0030324; GO:0032092; GO:0035469; GO:0045494; GO:0048496; GO:0060026; GO:0060027; GO:0060271; GO:0060287; GO:0060993; GO:0071908; GO:0071909; GO:0071910; GO:0072189; GO:0090090; GO:0097543; GO:0097546; GO:1905515; GO:2000095; GO:2000167 APSRHSSSGDTFSLK 0.99357 -9.2678 0 0 0 14.3378 0 0 15.0228 0 0 0 0 14.8854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8422 11.9836 0 12.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8545 11.5977 0 13.3784 0 0 0 0 0 13.7561 13.4302 13.0531 0 0 0 13.6006 13.8383 0 0 0 12.7047 0 0 0 14.0271 0 0 13.7396 0 0 18.269 18.359 0 0 0 0 0 0 0 17.4457 0 0 0 13.8943 0 12.5086 0 0 0 0 13.627 0 12.6218 0 0 0 0 0 13.5928 14.2194 13.821 0 0 14.6945 0 0 13.5954 0 0 14.0409 0 13.6565 0 0 0 0 0 0 0 12.2212 0 14.5377 0 0 0 14.2973 0 0 0 0 0 0 14.0002 0 14.1012 0 0 14.2136 0 0 0 14.3292 13.8801 0 0 0 0 0 0 12.789 0 0 0 0 Q7Z4V5 HDGR2_HUMAN "Hepatoma-derived growth factor-related protein 2, HDGF-related protein 2, HRP-2 (Hepatoma-derived growth factor 2, HDGF-2)" HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 Homo sapiens (Human) DNA recombination [GO:0006310]; DNA repair [GO:0006281]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; positive regulation of cell growth [GO:0030307]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; H3K27me3 modified histone binding [GO:0061628]; H3K9me3 modified histone binding [GO:0062072]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; muscle cell differentiation [GO:0042692]; muscle organ development [GO:0007517]; positive regulation of cell growth [GO:0030307]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue regeneration [GO:0043403] GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006281; GO:0006310; GO:0006357; GO:0007517; GO:0030307; GO:0035064; GO:0042692; GO:0043403; GO:0061628; GO:0062072; GO:1905168 double-stranded DNA binding [GO:0003690]; H3K27me3 modified histone binding [GO:0061628]; H3K9me3 modified histone binding [GO:0062072]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712] DSEEGPR 0.99357 -29.077 0 0 0 0 0 0 11.0604 0 0 0 0 0 0 9.41071 0 0 0 0 0 0 0 0 0 0 0 0 10.7611 0 0 0 0 0 0 0 0 10.7977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8656 10.9633 0 0 0 10.1162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5412 0 0 11.1418 0 12.4131 0 0 0 0 0 0 0 10.6546 0 0 0 0 0 0 0 11.5271 0 0 0 0 0 0 0 0 0 0 0 12.1171 0 11.6768 0 0 0 0 0 13.0697 0 10.8022 0 0 13.1551 0 0 0 0 0 0 12.3637 0 10.8781 0 0 0 14.0625 13.5155 0 0 0 0 10.3915 0 0 0 11.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7F7 RM55_HUMAN "39S ribosomal protein L55, mitochondrial, L55mt, MRP-L55 (Mitochondrial large ribosomal subunit protein bL31m) (Mitochondrial large ribosomal subunit protein mL55)" MRPL55 UNQ5835/PRO19675 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0032543 structural constituent of ribosome [GO:0003735] ATGPALR 0.99357 -17.304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TE59 ATS19_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 19, ADAM-TS 19, ADAM-TS19, ADAMTS-19, EC 3.4.24.-" ADAMTS19 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] CEGQDCMTVWEAGVWSECSVK 0.99357 -27.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.48 0 0 0 0 0 0 0 0 13.4405 10.7873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.962 0 0 0 0 0 0 0 0 15.4544 0 0 0 0 0 0 0 16.78 11.9953 0 0 0 0 12.9424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5493 0 13.5267 0 12.7052 13.0956 0 0 0 0 0 13.6514 0 0 0 12.6906 12.1571 15.2253 0 0 0 0 0 0 13.0684 0 0 0 0 12.0871 0 0 13.2552 0 0 12.2828 0 0 0 0 0 0 0 0 0 Q8WU79 SMAP2_HUMAN Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like) SMAP2 SMAP1L Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] GO:0005096; GO:0005654; GO:0005829; GO:0046872 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] ANRLYEAYLPETFR 0.99357 -27.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6674 12.1816 13.0177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6929 15.0411 16.1398 0 0 0 0 10.527 0 0 0 0 0 0 0 11.3367 0 0 0 0 0 0 11.5505 0 0 0 12.4655 0 0 0 0 11.7118 0 0 0 0 13.5732 0 0 13.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4362 0 0 0 0 0 0 0 0 Q96MS0 ROBO3_HUMAN Roundabout homolog 3 (Roundabout-like protein 3) ROBO3 Homo sapiens (Human) axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005886; GO:0007156; GO:0007411; GO:0016021; GO:0016199; GO:0030424; GO:0070593; GO:0098632 cell-cell adhesion mediator activity [GO:0098632] AHRLLLPSGALFFPR 0.99357 -9.2516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87581 0 0 0 0 0 0 0 13.7001 10.9955 13.5324 0 0 0 0 12.6369 0 0 0 0 0 0 0 0 0 12.9533 0 0 0 14.6621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.986 0 0 0 0 0 0 0 0 0 13.4769 15.0936 14.5009 14.7557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5532 0 Q96PE1 AGRA2_HUMAN Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5) ADGRA2 GPR124 KIAA1531 TEM5 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] cell surface [GO:0009986]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] cell surface [GO:0009986]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; G protein-coupled receptor activity [GO:0004930]; cell surface receptor signaling pathway [GO:0007166]; central nervous system development [GO:0007417]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell migration [GO:0010595]; regulation of angiogenesis [GO:0045765]; regulation of chemotaxis [GO:0050920]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055] GO:0002040; GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007417; GO:0009986; GO:0010595; GO:0016021; GO:0016055; GO:0030175; GO:0043542; GO:0045765; GO:0050920; GO:0090210; GO:0090263; GO:1900747; GO:1990909 G protein-coupled receptor activity [GO:0004930] AHKSRAK 0.99357 -27.806 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0216 14.878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.872 14.3676 0 0 0 0 11.0719 12.6263 0 0 0 12.639 0 0 0 15.2001 15.0215 14.0082 0 14.4966 14.5689 13.8433 14.0523 14.4109 13.446 12.6121 13.5516 0 0 0 0 12.1758 12.3706 13.3558 14.4055 0 0 13.7145 13.1724 0 13.7121 0 0 0 0 0 13.2209 13.187 0 0 0 0 0 0 14.2695 12.9735 0 0 0 0 14.0165 0 0 0 0 0 0 0 0 0 0 14.0166 0 12.6163 0 0 13.9058 0 12.4234 0 12.9537 0 0 13.0931 14.0191 13.2341 11.1075 0 0 0 0 0 0 0 0 0 0 13.251 0 0 0 0 0 0 0 12.8466 12.9663 0 0 0 0 0 0 Q9BXR6 FHR5_HUMAN "Complement factor H-related protein 5, FHR-5" CFHR5 CFHL5 FHR5 Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; cytolysis by host of symbiont cells [GO:0051838]; negative regulation of protein binding [GO:0032091]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; complement component C3b binding [GO:0001851]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; cytolysis by host of symbiont cells [GO:0051838]; negative regulation of protein binding [GO:0032091]" GO:0001851; GO:0005576; GO:0005615; GO:0006956; GO:0006957; GO:0032091; GO:0032991; GO:0042802; GO:0046982; GO:0051838 complement component C3b binding [GO:0001851]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982] CKIAGVNIKTLLK 0.99357 -6.5104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7287 0 0 0 0 0 0 0 15.014 0 0 0 0 0 0 0 0 0 0 12.838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1003 0 14.2827 0 0 0 0 0 0 0 0 0 0 0 12.1238 0 12.5806 0 0 0 0 0 0 0 12.4481 0 0 0 0 0 0 0 0 0 0 11.9257 0 12.7107 0 0 0 0 13.5396 13.3159 Q9H8M2 BRD9_HUMAN Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8) BRD9 UNQ3040/PRO9856 Homo sapiens (Human) chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; lysine-acetylated histone binding [GO:0070577]; nucleic acid binding [GO:0003676]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000785; GO:0003676; GO:0005634; GO:0005654; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0070577; GO:0140288; GO:1902459 lysine-acetylated histone binding [GO:0070577]; nucleic acid binding [GO:0003676] EHCDTEGEADDFDPGK 0.99357 -6.9776 0 0 0 0 0 0 0 0 18.6994 0 18.9693 19.0277 19.0052 19.0741 0 0 0 12.0856 0 11.0914 11.1165 0 11.3498 0 0 0 0 0 11.3547 11.4826 0 19.0409 19.2172 19.0769 19.1194 19.1506 19.0785 19.1715 19.0934 19.1349 0 19.1765 0 11.3357 11.2449 11.5438 11.5644 0 12.3622 12.005 12.2167 0 12.4636 12.2977 17.7046 17.6594 17.8375 18.2806 16.7025 0 15.5521 12.1374 12.2939 15.8653 16.3878 13.4006 0 0 0 12.3662 12.2363 12.2449 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9762 0 15.0512 0 0 0 13.5533 0 17.3952 0 0 14.9469 13.1687 13.7308 13.924 13.3353 0 0 12.8778 0 0 0 0 15.2742 0 14.9043 0 0 13.7541 0 0 0 14.1918 0 0 0 0 0 0 12.5359 13.7053 13.2554 0 0 0 0 12.5941 0 0 13.3109 14.1411 0 12.5658 12.8281 13.6262 12.6632 12.5562 15.5395 13.1657 15.1706 0 0 12.6199 15.0819 0 Q9NY59 NSMA2_HUMAN "Sphingomyelin phosphodiesterase 3, EC 3.1.4.12 (Neutral sphingomyelinase 2, nSMase-2, nSMase2) (Neutral sphingomyelinase II)" SMPD3 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein kinase B signaling [GO:0043491]; regulation of cartilage development [GO:0061035]; regulation of leukocyte migration [GO:0002685]; regulation of protein phosphorylation [GO:0001932]; sphingolipid mediated signaling pathway [GO:0090520]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; BMP signaling pathway [GO:0030509]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to magnesium ion [GO:0071286]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to redox state [GO:0071461]; cellular response to tumor necrosis factor [GO:0071356]; ceramide metabolic process [GO:0006672]; chondrocyte development involved in endochondral bone morphogenesis [GO:0003433]; collagen metabolic process [GO:0032963]; dentinogenesis [GO:0097187]; DNA biosynthetic process [GO:0071897]; endochondral ossification [GO:0001958]; extracellular matrix assembly [GO:0085029]; G1 to G0 transition [GO:0070314]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; mitotic nuclear division [GO:0140014]; multicellular organism growth [GO:0035264]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; peptide hormone secretion [GO:0030072]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; polysaccharide transport [GO:0015774]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein kinase B signaling [GO:0043491]; regulation of cartilage development [GO:0061035]; regulation of leukocyte migration [GO:0002685]; regulation of protein phosphorylation [GO:0001932]; sphingolipid mediated signaling pathway [GO:0090520]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684] GO:0000137; GO:0000139; GO:0001786; GO:0001932; GO:0001958; GO:0002244; GO:0002685; GO:0003433; GO:0004620; GO:0004767; GO:0005576; GO:0005737; GO:0005886; GO:0006672; GO:0006684; GO:0006685; GO:0008081; GO:0015774; GO:0030072; GO:0030282; GO:0030509; GO:0032963; GO:0035264; GO:0042802; GO:0043491; GO:0045840; GO:0046872; GO:0048008; GO:0048286; GO:0048661; GO:0061035; GO:0061751; GO:0070300; GO:0070301; GO:0070314; GO:0071286; GO:0071356; GO:0071461; GO:0071897; GO:0085029; GO:0090520; GO:0097187; GO:0098868; GO:0140014; GO:0140052; GO:1900126; GO:1901653; GO:1903543 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; phospholipase activity [GO:0004620]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767] AVPGSIK 0.99357 -15.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5606 0 0 13.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5372 0 0 12.4442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2113 0 0 11.1663 0 0 0 0 0 0 0 0 0 11.6798 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8587 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2443 14.5375 0 0 14.6706 11.7324 0 0 0 0 0 0 0 0 0 16.1028 0 0 0 0 0 0 0 0 0 0 0 14.5066 0 0 Q9UJV9 DDX41_HUMAN "Probable ATP-dependent RNA helicase DDX41, EC 3.6.4.13 (DEAD box protein 41) (DEAD box protein abstrakt homolog)" DDX41 ABS Homo sapiens (Human) "apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005681; GO:0005829; GO:0006915; GO:0008283; GO:0016020; GO:0016887; GO:0030154; GO:0046872; GO:0071013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ALLLEAK 0.99357 -15.915 0 0 0 0 0 0 0 0 0 0 0 13.1662 0 0 0 0 0 0 0 0 0 0 0 12.8913 0 0 0 0 0 0 0 0 0 0 13.6073 13.6367 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9766 0 0 0 0 12.1168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7372 14.2451 0 0 11.2478 0 0 0 0 0 0 13.5954 0 0 14.4153 0 12.5541 0 0 0 0 0 0 0 0 0 17.3022 13.0123 12.5762 0 0 0 0 0 0 0 0 0 11.9607 0 16.266 14.1939 0 0 0 0 0 0 13.8709 10.7515 0 0 0 0 0 0 12.5757 0 0 0 0 0 0 0 13.7522 13.9563 0 13.4468 0 13.9767 0 0 0 0 0 13.2448 0 0 0 0 0 0 12.1246 0 13.1046 0 0 0 0 0 14.196 0 0 0 0 0 0 13.4404 0 0 0 0 0 0 0 0 D6RIA3 CD054_HUMAN Uncharacterized protein C4orf54 (Familial obliterative portal venopathy) C4orf54 FOPV Homo sapiens (Human) AAAFENLARERPR 0.99358 -7.9617 0 0 0 0 0 0 0 0 0 12.9153 12.6471 0 0 0 0 0 0 0 0 0 0 0 12.1031 0 0 13.2202 13.1518 0 0 0 0 0 11.4306 0 0 0 0 0 0 0 0 0 0 0 12.7465 0 0 0 0 12.5191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5607 0 0 0 0 12.445 13.1227 17.2548 11.4712 13.2331 13.219 13.3596 14.12 11.0415 0 11.2928 0 0 13.2971 12.4887 12.8952 12.7897 0 0 0 0 13.712 13.6893 0 0 0 0 0 11.2637 13.3394 10.9917 0 14.7661 15.5331 13.3809 0 19.0345 13.9367 13.1236 0 15.2986 0 13.3933 0 13.2999 13.5701 14.804 14.1026 18.3103 0 0 14.7488 0 0 0 0 0 18.8593 13.7338 0 0 0 0 0 16.6256 0 13.9898 0 13.1763 15.1617 0 17.9612 0 11.4335 0 15.3798 0 15.3529 15.1977 0 13.4831 0 13.143 13.7457 0 0 0 0 0 0 13.1354 0 0 0 0 13.2067 14.1494 0 0 0 0 15.6702 O75820 ZN189_HUMAN Zinc finger protein 189 ZNF189 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDECGKAFSR 0.99358 -14.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5041 0 0 0 0 0 12.1502 0 0 0 0 13.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8915 0 10.4936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6534 0 0 0 0 0 P01024 CO3_HUMAN "Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c, C3bc; Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein, ASP (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2 ]" C3 CPAMD1 Homo sapiens (Human) "amyloid-beta clearance [GO:0097242]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of apoptotic process in another organism [GO:0044533]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of immune response [GO:0050778]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; vertebrate eye-specific patterning [GO:0150064]" azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370] "azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102]; amyloid-beta clearance [GO:0097242]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; complement-dependent cytotoxicity [GO:0097278]; complement-mediated synapse pruning [GO:0150062]; fatty acid metabolic process [GO:0006631]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; neuron remodeling [GO:0016322]; opsonization [GO:0008228]; oviduct epithelium development [GO:0035846]; positive regulation of activation of membrane attack complex [GO:0001970]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of apoptotic process in another organism [GO:0044533]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of immune response [GO:0050778]; positive regulation of lipid storage [GO:0010884]; positive regulation of opsonization [GO:1903028]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of type IIa hypersensitivity [GO:0001798]; positive regulation of vascular endothelial growth factor production [GO:0010575]; proteolysis [GO:0006508]; regulation of complement activation [GO:0030449]; regulation of complement activation, alternative pathway [GO:0030451]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617]; signal transduction [GO:0007165]; vertebrate eye-specific patterning [GO:0150064]" GO:0001798; GO:0001934; GO:0001970; GO:0004866; GO:0005102; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006508; GO:0006631; GO:0006954; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0007165; GO:0007186; GO:0008228; GO:0009617; GO:0009986; GO:0010575; GO:0010828; GO:0010866; GO:0010884; GO:0016322; GO:0030449; GO:0030451; GO:0031715; GO:0032991; GO:0034774; GO:0035578; GO:0035846; GO:0044533; GO:0045745; GO:0045766; GO:0048260; GO:0050766; GO:0050778; GO:0060100; GO:0070062; GO:0072562; GO:0097242; GO:0097278; GO:0150062; GO:0150064; GO:1903028; GO:1905114; GO:1905370; GO:2000427 C5L2 anaphylatoxin chemotactic receptor binding [GO:0031715]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102] AHEAKIR 0.99358 -27.838 0 0 0 11.9052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4949 11.4628 0 0 0 0 0 0 12.5459 0 0 0 12.7495 0 0 0 0 0 0 0 0 0 13.0641 13.2874 0 0 13.1847 13.3012 0 0 0 0 0 0 0 0 0 0 0 13.5105 0 0 0 0 10.4652 0 0 0 0 11.7007 0 0 0 0 10.399 0 0 0 0 0 0 0 0 0 0 14.4381 0 0 0 0 0 0 11.3128 0 0 0 0 0 0 0 0 0 0 0 0 13.0137 13.4392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18850 ATF6A_HUMAN "Cyclic AMP-dependent transcription factor ATF-6 alpha, cAMP-dependent transcription factor ATF-6 alpha (Activating transcription factor 6 alpha, ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha ]" ATF6 Homo sapiens (Human) ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; protein folding [GO:0006457]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; visual perception [GO:0007601] chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; protein folding [GO:0006457]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; visual perception [GO:0007601]" GO:0000139; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001654; GO:0003700; GO:0005634; GO:0005635; GO:0005654; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0006457; GO:0007165; GO:0007601; GO:0010508; GO:0016020; GO:0030176; GO:0030968; GO:0031625; GO:0035497; GO:0036500; GO:0036503; GO:0042802; GO:0043065; GO:0043565; GO:0045944; GO:0046982; GO:0090575; GO:1903893; GO:1990440; GO:1990837 "cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]" HEVERTKSR 0.99358 -27.953 0 0 0 13.6637 0 0 0 12.3928 0 0 0 0 0 0 0 13.2881 0 0 0 0 0 0 0 0 11.1484 11.378 0 0 0 0 12.0646 0 11.9392 0 0 0 0 0 0 0 0 0 10.9034 0 12.2771 13.2926 13.2791 12.3545 0 0 0 0 13.2457 12.6695 10.9851 0 0 0 0 0 0 0 10.3162 0 0 9.80731 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7011 10.9806 0 0 15.0149 0 0 0 15.2836 0 0 0 13.5589 0 0 12.5662 0 15.2174 12.5434 0 0 0 13.9926 0 0 0 0 11.4412 13.5951 0 0 0 0 0 0 0 0 0 0 0 13.8222 0 0 0 0 13.8122 12.3805 0 0 13.788 13.7586 0 0 0 12.2484 12.9503 0 0 14.8144 14.0568 11.0188 0 12.6346 13.8568 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0123 10.6991 0 14.1003 0 13.504 14.1883 13.5697 14.0524 14.0841 13.4638 14.0688 0 0 0 0 0 13.2409 0 13.8676 0 13.4389 0 0 P24278 ZBT25_HUMAN Zinc finger and BTB domain-containing protein 25 (Zinc finger protein 46) (Zinc finger protein KUP) ZBTB25 C14orf51 KUP ZNF46 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DTEPVELNCNFSFSRK 0.99358 -6.9944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6437 14.0257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8 0 0 0 0 12.6077 0 0 0 0 0 0 P28330 ACADL_HUMAN "Long-chain specific acyl-CoA dehydrogenase, mitochondrial, LCAD, EC 1.3.8.8" ACADL Homo sapiens (Human) "carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]" cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process, CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cholesterol metabolic process [GO:0090181]; temperature homeostasis [GO:0001659]" GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005737; GO:0005739; GO:0005759; GO:0016401; GO:0019254; GO:0031966; GO:0033539; GO:0042413; GO:0042758; GO:0042802; GO:0044242; GO:0045717; GO:0046322; GO:0050660; GO:0090181; GO:0120162 acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401] APRQLPAAR 0.99358 -27.87 0 0 10.7293 0 0 0 0 0 0 0 0 0 0 0 0 12.1208 0 0 0 0 0 12.2258 0 15.3767 0 0 13.2968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4433 14.0226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9026 13.1423 15.7181 10.2531 0 0 0 0 9.80579 0 0 0 0 16.2342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2208 0 0 0 0 15.7559 13.1863 0 0 0 0 14.4002 14.4587 11.6444 14.2947 0 0 0 0 0 0 15.5226 0 0 14.8516 0 0 0 0 0 0 14.121 0 14.326 14.796 15.2028 0 0 0 0 0 0 0 0 0 16.3183 12.5491 14.0481 0 0 0 0 0 0 0 0 0 0 0 10.8811 0 0 0 0 0 0 0 14.3261 0 14.4605 0 11.6317 0 14.8364 12.6566 Q13233 M3K1_HUMAN "Mitogen-activated protein kinase kinase kinase 1, EC 2.7.11.25 (MAPK/ERK kinase kinase 1, MEK kinase 1, MEKK 1)" MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; cellular response to mechanical stimulus [GO:0071260]; Fc-epsilon receptor signaling pathway [GO:0038095]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0008270; GO:0019901; GO:0038095; GO:0071260; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] ATCMPAWK 0.99358 -28.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.405 13.7197 13.3699 0 12.9375 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7518 0 0 0 0 11.5305 0 13.6454 0 11.1403 0 0 13.8652 13.9589 0 0 10.706 0 0 0 0 0 0 13.7419 11.0769 0 0 0 17.4957 0 0 0 0 0 0 12.8447 0 0 14.5135 0 0 13.374 0 0 0 0 0 10.595 0 0 0 14.062 0 0 0 11.3632 0 12.7663 13.898 12.0111 0 13.055 0 0 10.9239 0 0 13.5603 13.4152 0 12.1118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6074 11.5668 0 0 0 0 0 13.8746 13.2056 0 0 0 0 0 0 0 Q13361 MFAP5_HUMAN "Microfibrillar-associated protein 5, MFAP-5 (MP25) (Microfibril-associated glycoprotein 2, MAGP-2)" MFAP5 MAGP2 Homo sapiens (Human) definitive hemopoiesis [GO:0060216]; embryonic eye morphogenesis [GO:0048048]; supramolecular fiber organization [GO:0097435] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527]; extracellular matrix structural constituent [GO:0005201]; definitive hemopoiesis [GO:0060216]; embryonic eye morphogenesis [GO:0048048]; supramolecular fiber organization [GO:0097435] GO:0001527; GO:0005201; GO:0005576; GO:0048048; GO:0060216; GO:0062023; GO:0097435 extracellular matrix structural constituent [GO:0005201] EHEAMKDELCR 0.99358 -6.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1509 0 0 0 0 13.1805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 13.087 0 0 0 0 0 0 0 0 0 12.3698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4983 0 0 0 0 0 0 0 0 0 0 0 Q13438 OS9_HUMAN Protein OS-9 (Amplified in osteosarcoma 9) OS9 Homo sapiens (Human) "endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; carbohydrate binding [GO:0030246]; protease binding [GO:0002020]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000836; GO:0002020; GO:0005783; GO:0005788; GO:0005789; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030433; GO:0030968; GO:0030970; GO:0034976; GO:1904153 carbohydrate binding [GO:0030246]; protease binding [GO:0002020] AMLALTSTLNKLIK 0.99358 -28.086 0 0 0 0 0 0 0 0 0 0 0 11.1555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9549 0 0 11.3338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.072 0 0 0 0 0 0 11.5313 0 0 0 0 0 12.8183 0 12.9933 11.5157 13.9954 11.2622 12.162 11.541 0 12.3852 0 15.3208 0 15.1535 0 0 10.9616 12.0787 0 13.2063 11.2424 10.7851 0 0 0 10.9468 0 0 0 0 0 13.1483 13.4122 13.7044 19.3133 10.0928 0 0 15.2926 11.2251 0 9.6561 0 12.4953 0 18.6617 12.3116 12.053 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8894 0 0 11.5196 0 0 0 11.6307 0 0 0 0 11.6013 0 13.4951 0 0 0 0 11.0928 0 0 0 0 0 0 0 0 0 0 0 10.9775 12.3928 0 18.4814 0 0 0 0 Q14566 MCM6_HUMAN "DNA replication licensing factor MCM6, EC 3.6.4.12 (p105MCM)" MCM6 Homo sapiens (Human) DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-templated DNA replication initiation [GO:0030174] "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-templated DNA replication initiation [GO:0030174]" GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006268; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0042802; GO:0071162; GO:1902969 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697] EAFRLLNKSIIR 0.99358 -14.063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0959 0 14.4961 0 0 0 0 0 0 16.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5803 0 11.6082 0 0 0 0 0 0 0 12.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6907 0 0 0 0 0 0 0 0 Q5VV67 PPRC1_HUMAN "Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator, PRC)" PPRC1 KIAA0595 Homo sapiens (Human) positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003723; GO:0005634; GO:0005654; GO:0030374; GO:0045944; GO:0051091 nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723] CSSSSSSSSSSSSSSSSSSSSR 0.99358 -14.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4561 13.7773 12.0891 0 15.1016 0 13.4491 13.0351 0 0 0 0 0 0 0 10.8768 10.7491 0 0 0 0 0 0 0 0 0 0 12.8746 0 11.0408 11.0539 0 0 0 11.8231 0 0 0 0 10.1244 0 0 0 0 0 0 0 17.5755 13.6156 17.5123 14.8215 14.3008 0 0 18.2199 18.4849 19.2758 15.3184 15.3566 18.7734 18.6267 15.9721 19.6844 19.4651 19.4088 20.2371 20.0754 14.2455 19.0628 15.3384 19.0842 14.3631 15.9691 15.7139 14.0016 19.2073 15.0968 15.278 19.0017 0 15.8833 19.5465 15.7413 18.982 19.0266 12.6247 18.6701 16.3536 14.7402 19.9393 15.0494 19.9213 0 13.4175 14.7427 15.1994 16.1984 15.985 15.4674 19.2389 19.2109 15.4539 18.9583 16.1906 16.6408 15.729 15.7946 19.0545 18.9798 18.9083 19.0293 18.9972 15.923 18.5578 15.6229 15.1866 16.2305 16.335 16.6593 19.6615 16.4782 16.0773 15.6982 15.7079 14.845 15.4152 15.3606 13.6986 0 14.4989 0 19.5183 19.6757 19.5999 16.4245 14.3346 19.5473 13.7051 0 0 0 0 0 0 0 0 16.1383 0 0 0 0 0 15.1035 18.6813 15.6328 15.9948 0 0 0 15.056 0 Q5VZ66 JKIP3_HUMAN Janus kinase and microtubule-interacting protein 3 (Neuroendocrine long coiled-coil protein 2) JAKMIP3 C10orf14 C10orf39 JAMIP3 NECC2 Homo sapiens (Human) Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; kinase binding [GO:0019900]; microtubule binding [GO:0008017] GO:0005794; GO:0008017; GO:0019900 kinase binding [GO:0019900]; microtubule binding [GO:0008017] AVFVLER 0.99358 -27.94 10.896 0 0 0 0 13.1662 13.1538 0 0 0 0 0 0 0 13.667 11.6798 0 14.4049 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2603 0 13.6 0 0 0 0 11.6561 0 0 0 0 0 13.3769 14.348 12.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7207 0 0 0 0 13.6831 0 0 0 0 13.0659 11.0862 0 0 10.7069 11.7501 13.7704 0 12.6105 14.9527 13.4433 0 0 0 0 0 0 0 11.6674 0 0 13.4181 0 14.1307 0 0 0 0 12.5567 0 0 0 0 0 0 13.4103 12.8835 0 13.9483 0 0 0 15.4192 14.1863 0 15.8164 15.271 15.682 12.7169 13.5147 0 13.259 13.5098 0 12.6996 15.8961 14.4126 13.0965 0 13.8551 14.7706 13.2384 0 0 0 0 12.8796 0 0 0 0 0 13.9334 0 11.8916 14.3989 0 0 0 0 0 0 12.5102 13.1211 11.2504 0 14.0222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2066 15.0954 11.1888 0 0 0 0 Q8IUR0 TPPC5_HUMAN Trafficking protein particle complex subunit 5 TRAPPC5 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005783; GO:0005829; GO:0006888; GO:0006901; GO:0030008; GO:0048208; GO:0099022; GO:1990070; GO:1990071; GO:1990072 ETKVLGALLFVK 0.99358 -6.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8755 0 14.3494 0 0 0 0 0 0 0 11.1623 11.7794 0 12.6619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7512 0 0 0 0 0 0 12.1912 0 0 0 0 0 0 Q8NA56 TTC29_HUMAN "Tetratricopeptide repeat protein 29, TPR repeat protein 29 (Protein TBPP2A) (Testis development protein NYD-SP14)" TTC29 Homo sapiens (Human) cilium movement [GO:0003341]; cilium organization [GO:0044782] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; cilium movement [GO:0003341]; cilium organization [GO:0044782] GO:0003341; GO:0005737; GO:0005856; GO:0005929; GO:0036126; GO:0044782 CFKIAQLIK 0.99358 -28.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2871 0 0 10.1836 0 0 10.3747 0 0 0 0 0 0 0 0 9.76539 0 0 0 0 0 0 0 13.918 12.1024 0 0 0 13.7532 0 0 0 0 0 0 0 0 0 0 0 15.8955 0 0 0 0 13.1835 0 13.59 13.1072 0 0 0 13.8052 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0247 0 0 0 0 0 0 0 10.9062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2575 0 0 0 10.6414 0 0 0 0 0 0 0 11.2981 0 0 11.745 0 0 10.5295 12.1633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYN0 ATG4A_HUMAN "Cysteine protease ATG4A, EC 3.4.22.- (AUT-like 2 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 2, Autophagin-2) (Autophagy-related protein 4 homolog A, HsAPG4A, hAPG4A)" ATG4A APG4A AUTL2 Homo sapiens (Human) autophagy [GO:0006914]; lipid metabolic process [GO:0006629]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; Atg8-specific peptidase activity [GO:0019786]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; autophagy [GO:0006914]; lipid metabolic process [GO:0006629]; protein delipidation [GO:0051697]; protein transport [GO:0015031]; proteolysis [GO:0006508] GO:0004197; GO:0005737; GO:0006508; GO:0006629; GO:0006914; GO:0008234; GO:0015031; GO:0019786; GO:0051697 Atg8-specific peptidase activity [GO:0019786]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] DCCYSIHQMAQMGVGEGK 0.99358 -6.5329 11.056 0 0 0 0 0 0 0 12.321 9.715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7582 0 0 0 0 0 0 0 0 0 0 13.8151 0 12.8852 0 0 13.6795 0 0 0 0 0 0 0 0 0 0 0 10.8586 12.9954 0 0 0 0 0 0 0 0 0 10.5392 0 10.0221 0 0 0 0 0 0 0 11.9658 0 0 0 0 0 0 0 0 0 13.2621 0 0 12.5355 0 16.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9825 0 0 0 0 0 0 0 0 0 10.2305 9.72911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQS8 FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7) FYCO1 ZFYVE7 Homo sapiens (Human) plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098] autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020] autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098] GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0016020; GO:0043231; GO:0046872; GO:0072383; GO:1901098 metal ion binding [GO:0046872] ADEAQQREEELR 0.99358 -28.082 0 0 0 0 0 0 0 0 13.3916 13.1507 0 0 12.9024 13.4517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.26 0 12.9927 12.9028 13.0094 12.3994 12.943 12.6677 12.6566 13.0688 0 12.0266 11.2537 11.047 12.6055 0 12.1668 12.4034 0 0 0 0 0 0 0 10.3618 0 12.6541 0 0 0 10.7659 0 11.0389 0 0 0 0 0 0 0 14.0208 0 0 10.9386 0 10.8147 0 0 0 0 0 0 0 13.9204 13.9359 0 0 0 13.435 0 0 0 13.9078 14.4314 0 0 0 13.661 0 16.1767 0 0 14.3914 14.1444 0 0 0 0 0 0 14.5269 0 0 12.3518 0 0 0 12.9812 0 0 12.7707 15.9862 13.1577 14.9279 14.9139 0 11.917 0 0 0 0 0 0 13.1352 13.4091 12.6592 0 0 0 0 0 11.8647 0 11.6178 0 0 0 11.9879 0 0 13.1592 0 0 0 12.7394 0 0 14.6167 0 0 14.5783 14.9027 14.6471 0 14.9203 0 0 0 13.2016 0 0 13.5266 0 14.2408 0 0 18.9092 0 0 0 Q9C0J9 BHE41_HUMAN "Class E basic helix-loop-helix protein 41, bHLHe41 (Class B basic helix-loop-helix protein 3, bHLHb3) (Differentially expressed in chondrocytes protein 2, hDEC2) (Enhancer-of-split and hairy-related protein 1, SHARP-1)" BHLHE41 BHLHB3 DEC2 SHARP1 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; MRF binding [GO:0043426]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0009952; GO:0010832; GO:0010944; GO:0032922; GO:0042803; GO:0042826; GO:0043425; GO:0043426; GO:0045892; GO:0046982; GO:0050767; GO:0061629; GO:0070888; GO:1990837 "bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; MRF binding [GO:0043426]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" DDTKDTYK 0.99358 -6.9793 0 0 0 0 0 0 0 0 0 0 12.0757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0868 0 0 0 0 0 0 0 0 0 0 0 0 13.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6369 0 0 0 0 0 0 0 0 0 0 12.7211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4424 0 Q9UPR0 PLCL2_HUMAN "Inactive phospholipase C-like protein 2, PLC-L(2), PLC-L2, Phospholipase C-L2 (Phospholipase C-epsilon-2, PLC-epsilon-2)" PLCL2 KIAA1092 PLCE2 Homo sapiens (Human) "B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of synaptic transmission, GABAergic [GO:0032228]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of synaptic transmission, GABAergic [GO:0032228]" GO:0002322; GO:0002337; GO:0004435; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0048015; GO:0050811; GO:0050859; GO:0070679; GO:0120163; GO:1900122 "GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]" ANDETGE 0.99358 -27.964 13.045 14.0575 13.1474 0 0 13.9339 11.7397 0 0 11.6064 0 11.6837 0 0 0 0 0 0 0 11.7971 0 12.1146 0 11.9556 11.4189 0 12.6794 0 10.7525 0 10.7926 0 0 0 0 0 13.9389 0 11.2965 0 0 0 11.9248 0 0 0 11.0066 0 0 0 0 0 0 12.0255 12.3516 0 0 0 11.7255 0 0 0 0 0 0 9.80695 0 0 15.7112 0 0 0 14.9798 0 0 0 13.4578 0 0 0 0 0 0 0 15.1157 0 0 17.1562 0 0 0 11.9582 0 0 0 0 0 0 15.4076 0 0 0 13.8014 0 0 0 12.1865 0 11.715 0 0 13.9657 0 0 14.5666 0 0 13.9342 13.648 14.6459 12.5798 0 0 0 0 14.132 14.4023 12.6181 0 11.209 0 0 0 0 0 0 10.8087 15.7675 0 13.432 15.7582 0 0 0 0 15.3261 14.2575 0 14.7048 0 15.6548 13.5499 15.0885 14.5772 0 13.5104 0 0 14.5696 13.0709 10.5361 12.4585 11.8014 13.8125 0 0 13.3417 15.5263 0 0 11.6672 0 15.5664 0 13.419 14.0354 0 15.6294 13.5546 0 O15321 TM9S1_HUMAN "Transmembrane 9 superfamily member 1 (MP70 protein family member, hMP70)" TM9SF1 Homo sapiens (Human) autophagy [GO:0006914]; protein localization to membrane [GO:0072657] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; autophagy [GO:0006914]; protein localization to membrane [GO:0072657] GO:0000421; GO:0005765; GO:0006914; GO:0016020; GO:0016021; GO:0031410; GO:0072657 EIPPQPWYK 0.99359 -5.2238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75400 PR40A_HUMAN "Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10, HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6)" PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]" membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] "membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]" GO:0000398; GO:0003723; GO:0005654; GO:0005685; GO:0007010; GO:0007049; GO:0008360; GO:0016020; GO:0016363; GO:0016477; GO:0016607; GO:0032465; GO:0045292; GO:0051301; GO:0071004 RNA binding [GO:0003723] DSGNWDTSGSELSEGELEK 0.99359 -6.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0997 0 0 0 0 0 0 0 0 0 0 0 0 11.0449 0 0 0 0 0 0 0 0 0 10.2635 0 0 0 0 0 0 0 0 12.5995 0 12.7372 0 0 0 0 0 12.1639 13.0202 0 0 12.9593 0 0 12.7936 13.3997 0 0 0 0 0 0 0 0 0 0 0 12.9782 0 0 0 0 10.3824 0 0 0 11.3001 0 13.4684 0 0 0 12.0066 0 0 13.0909 0 0 0 0 0 0 12.1525 0 13.3038 0 0 0 0 0 0 0 0 12.9611 0 0 0 0 0 0 0 0 0 0 12.737 0 12.745 0 0 0 0 13.3887 13.5274 0 0 0 0 12.7754 0 0 0 0 0 0 0 0 0 0 13.1604 0 0 0 0 0 11.7328 0 0 0 0 0 0 0 0 P00492 HPRT_HUMAN "Hypoxanthine-guanine phosphoribosyltransferase, HGPRT, HGPRTase, EC 2.4.2.8" HPRT1 HPRT Homo sapiens (Human) adenine metabolic process [GO:0046083]; AMP salvage [GO:0044209]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; dopaminergic neuron differentiation [GO:0071542]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; adenine metabolic process [GO:0046083]; AMP salvage [GO:0044209]; central nervous system neuron development [GO:0021954]; cerebral cortex neuron differentiation [GO:0021895]; dendrite morphogenesis [GO:0048813]; dopamine metabolic process [GO:0042417]; dopaminergic neuron differentiation [GO:0071542]; GMP catabolic process [GO:0046038]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; locomotory behavior [GO:0007626]; lymphocyte proliferation [GO:0046651]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166]; response to amphetamine [GO:0001975]; striatum development [GO:0021756]; T cell mediated cytotoxicity [GO:0001913] GO:0000166; GO:0000287; GO:0001913; GO:0001975; GO:0004422; GO:0005737; GO:0005829; GO:0006164; GO:0006166; GO:0006178; GO:0007625; GO:0007626; GO:0021756; GO:0021895; GO:0021954; GO:0032263; GO:0032264; GO:0042417; GO:0042802; GO:0043103; GO:0044209; GO:0045964; GO:0046038; GO:0046040; GO:0046083; GO:0046100; GO:0046651; GO:0048813; GO:0051289; GO:0052657; GO:0070062; GO:0071542 guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166] PDFVGFEIPDK 0.99359 -7.0216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7153 0 0 0 0 0 0 0 14.488 0 0 0 0 0 0 0 0 0 0 0 0 13.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24863 CCNC_HUMAN "Cyclin-C (SRB11 homolog, hSRB11)" CCNC Homo sapiens (Human) G0 to G1 transition [GO:0045023]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; identical protein binding [GO:0042802]; G0 to G1 transition [GO:0045023]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000307; GO:0005634; GO:0005654; GO:0006357; GO:0016538; GO:0016592; GO:0042802; GO:0045023; GO:0045746; GO:0045944 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; identical protein binding [GO:0042802] FLSEEEYWKLQIFFTNVIQALGEHLKLR 0.99359 -7.0121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6351 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7294 0 0 0 0 11.7277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.085 19.7741 0 19.237 0 0 13.7889 0 0 15.7965 0 0 0 0 18.2324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5781 0 0 8.83864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P26358 DNMT1_HUMAN "DNA (cytosine-5)-methyltransferase 1, Dnmt1, EC 2.1.1.37 (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI, DNA MTase HsaI, M.HsaI) (MCMT)" DNMT1 AIM CXXC9 DNMT Homo sapiens (Human) "cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; transcription, DNA-templated [GO:0006351]" female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657] "female germ cell nucleus [GO:0001674]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; replication fork [GO:0005657]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to amino acid stimulus [GO:0071230]; cellular response to bisphenol A [GO:1903926]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; transcription, DNA-templated [GO:0006351]" GO:0000122; GO:0001674; GO:0003677; GO:0003723; GO:0003886; GO:0005634; GO:0005654; GO:0005657; GO:0005721; GO:0006306; GO:0006346; GO:0006351; GO:0007265; GO:0008270; GO:0008327; GO:0009008; GO:0010216; GO:0010628; GO:0010629; GO:0043045; GO:0051571; GO:0051573; GO:0071230; GO:0090309; GO:1903926; GO:1904707; GO:1905460; GO:1905931; GO:1990841 DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methyl-CpG binding [GO:0008327]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] CGVCEVCQQPECGKCK 0.99359 -28.245 0 0 0 0 0 0 0 0 12.7795 0 0 0 0 0 0 0 0 0 0 0 0 12.2436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0607 0 0 0 0 0 13.3512 0 0 0 0 0 0 0 0 0 0 11.8631 0 12.1388 18.1993 0 0 0 0 0 0 0 10.6156 0 0 13.1847 0 0 13.6765 13.7221 0 0 0 0 0 0 11.2878 14.6832 0 13.824 0 13.3837 14.32 0 0 0 0 13.885 12.9908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2555 0 0 0 12.5493 0 0 0 0 0 13.6617 14.9725 0 0 0 0 15.3121 0 0 0 0 0 0 14.7503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8747 0 12.0207 0 0 0 12.4139 11.9021 0 0 0 0 13.3545 14.7146 0 13.5709 0 0 0 15.3284 0 14.1825 0 0 0 15.6791 P48764 SL9A3_HUMAN "Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3, NHE-3) (Solute carrier family 9 member 3)" SLC9A3 NHE3 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] GO:0005886; GO:0005903; GO:0006811; GO:0009986; GO:0015385; GO:0015386; GO:0016021; GO:0016324; GO:0030165; GO:0031526; GO:0051453; GO:0070062; GO:0071805; GO:0098719 PDZ domain binding [GO:0030165]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] DTASDSPAGIDNPVFSPDEALDRSLLAR 0.99359 -5.2243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5061 12.9645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7984 0 0 0 0 0 0 0 0 0 0 0 15.0142 0 0 0 14.3749 0 0 0 0 0 0 0 11.9376 0 0 0 0 0 12.7644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q676U5 A16L1_HUMAN Autophagy-related protein 16-1 (APG16-like 1) ATG16L1 APG16L UNQ9393/PRO34307 Homo sapiens (Human) autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095] Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787]; autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; defense response to virus [GO:0051607]; lysosomal microautophagy [GO:0016237]; macroautophagy [GO:0016236]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792] GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0051020; GO:0051607; GO:0061739; GO:0097225; GO:0098792; GO:0120095 GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ubiquitin-like protein transferase activity [GO:0019787] HISEQLRRR 0.99359 -14.124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9482 0 0 0 15.1367 0 0 11.3776 10.7492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7715 0 0 0 0 0 0 0 0 0 0 0 0 11.4062 0 0 14.6396 0 0 14.0475 0 0 0 0 0 0 0 0 0 0 0 0 12.6873 0 0 0 0 0 0 0 12.2711 0 0 0 0 0 12.3654 12.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7095 0 0 13.6291 0 0 13.3242 13.0979 0 0 0 0 10.9911 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMT1 STAC2_HUMAN SH3 and cysteine-rich domain-containing protein 2 (24b2/STAC2) (Src homology 3 and cysteine-rich domain-containing protein 2) STAC2 Homo sapiens (Human) positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383] cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; sarcolemma [GO:0042383]; metal ion binding [GO:0046872]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; skeletal muscle contraction [GO:0003009] GO:0003009; GO:0005829; GO:0031234; GO:0042383; GO:0046872; GO:1901387; GO:1903078 metal ion binding [GO:0046872] MTEMSEK 0.99359 -10.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5H4 VN1R5_HUMAN "Vomeronasal type-1 receptor 5 (G-protein coupled receptor GPCR26, hGPCR26) (V1r-like receptor 5)" VN1R5 V1RL5 Homo sapiens (Human) response to pheromone [GO:0019236] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pheromone receptor activity [GO:0016503]; response to pheromone [GO:0019236] GO:0005886; GO:0016021; GO:0016503; GO:0019236 pheromone receptor activity [GO:0016503] LMLKFNR 0.99359 -10.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YG4 NT5D4_HUMAN 5'-nucleotidase domain-containing protein 4 NT5DC4 Homo sapiens (Human) 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] GO:0008253; GO:0046872 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872] CFGFDMDYTLAAYK 0.99359 -14.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6171 14.4583 0 0 13.528 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6547 0 0 0 13.8926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9241 0 0 0 11.6408 0 0 0 0 0 0 0 0 Q96J02 ITCH_HUMAN "E3 ubiquitin-protein ligase Itchy homolog, Itch, EC 2.3.2.26 (Atrophin-1-interacting protein 4, AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1, NAPP1)" ITCH Homo sapiens (Human) "apoptotic process [GO:0006915]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of protein deubiquitination [GO:0090085]; T cell anergy [GO:0002870]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]" cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; arrestin family protein binding [GO:1990763]; CXCR chemokine receptor binding [GO:0045236]; ligase activity [GO:0016874]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of defense response to virus [GO:0050687]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon production [GO:0032480]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of T cell anergy [GO:0002669]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell growth [GO:0001558]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of protein deubiquitination [GO:0090085]; T cell anergy [GO:0002870]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral entry into host cell [GO:0046718]" GO:0000209; GO:0001558; GO:0002669; GO:0002870; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006511; GO:0006915; GO:0006954; GO:0016020; GO:0016567; GO:0016874; GO:0019787; GO:0031410; GO:0031901; GO:0032088; GO:0032480; GO:0032991; GO:0035519; GO:0035739; GO:0043021; GO:0043066; GO:0043161; GO:0043231; GO:0044389; GO:0045087; GO:0045236; GO:0045732; GO:0046329; GO:0046718; GO:0050687; GO:0051607; GO:0051865; GO:0061630; GO:0070062; GO:0070423; GO:0070534; GO:0070936; GO:0090085; GO:1902036; GO:1990763; GO:2000562; GO:2000646 arrestin family protein binding [GO:1990763]; CXCR chemokine receptor binding [GO:0045236]; ligase activity [GO:0016874]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842] DETRVSTNGSDDPEDAGAGENR 0.99359 -7.7889 0 0 0 0 0 0 0 0 0 0 0 11.7717 0 0 12.3575 0 0 0 0 0 0 0 12.4793 0 0 0 0 12.5713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5249 0 13.3016 0 0 0 0 11.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2546 0 0 0 0 0 12.2289 0 0 0 0 16.1364 0 0 0 13.2634 13.4701 12.676 0 0 12.5184 0 0 13.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.004 13.6697 0 0 12.608 0 0 0 0 0 0 0 14.9959 14.6498 0 0 13.3323 0 13.9587 0 13.7298 0 0 0 0 13.3567 0 0 0 0 0 0 12.7663 12.8615 12.7914 0 0 0 0 0 0 0 0 14.119 0 0 0 0 0 0 0 0 0 12.8799 12.385 0 13.2745 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYB5 SO1C1_HUMAN "Solute carrier organic anion transporter family member 1C1 (Organic anion transporter F, OATP-F) (Organic anion transporter polypeptide-related protein 5, OAT-RP-5, OATPRP5) (Organic anion-transporting polypeptide 14, OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter)" SLCO1C1 OATP14 OATP1C1 OATPF SLC21A14 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; positive regulation of thyroid hormone generation [GO:2000611]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349]; bile acid and bile salt transport [GO:0015721]; positive regulation of thyroid hormone generation [GO:2000611]; sodium-independent organic anion transport [GO:0043252]; thyroid hormone transport [GO:0070327]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0005886; GO:0005887; GO:0015125; GO:0015347; GO:0015349; GO:0015721; GO:0016323; GO:0043252; GO:0055085; GO:0070327; GO:0150104; GO:2000611 bile acid transmembrane transporter activity [GO:0015125]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; thyroid hormone transmembrane transporter activity [GO:0015349] CKCSETK 0.99359 -7.7823 0 0 0 0 0 0 0 0 10.3128 0 0 0 0 0 10.9911 0 0 0 0 0 0 0 0 0 11.7535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8979 0 12.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0174 16.7114 17.679 0 0 10.224 13.9419 10.9961 0 0 0 0 15.8212 0 11.4666 0 15.1578 11.5575 15.0683 16.9394 14.9589 0 12.6486 0 12.0843 0 0 0 0 0 0 0 0 0 12.2375 0 0 0 0 0 0 11.0434 12.4221 0 0 0 0 0 0 0 0 11.182 0 10.6347 0 0 0 0 0 0 0 0 11.7349 0 0 0 0 0 0 0 0 0 0 0 11.4976 11.438 0 0 13.2946 0 0 0 0 0 0 13.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7633 14.3621 0 0 0 0 0 0 0 0 Q9UIF7 MUTYH_HUMAN "Adenine DNA glycosylase, EC 3.2.2.31 (MutY homolog, hMYH)" MUTYH MYH Homo sapiens (Human) base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546]" GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539; GO:0060546 "4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]" ASRKPPR 0.99359 -10.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6174 0 0 0 0 0 12.6118 0 0 0 14.7455 0 0 0 0 0 0 0 0 0 0 0 15.4577 0 0 0 15.4698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2033 14.4586 14.404 0 0 0 0 0 14.7613 14.6046 0 0 0 14.8295 14.6083 0 14.7022 14.6524 0 0 0 0 0 0 0 14.233 14.9214 0 14.8963 19.0451 0 0 0 0 14.4888 14.8254 14.7392 15.058 0 14.62 14.4407 14.8084 0 0 0 14.8434 0 14.7594 15.009 14.8215 14.7748 0 14.7662 14.8658 0 0 0 0 14.7073 0 0 0 14.7831 0 15.0244 0 14.8311 15.7867 0 0 14.7965 0 14.9693 14.8072 0 0 0 14.7583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2I8 WDR37_HUMAN WD repeat-containing protein 37 WDR37 KIAA0982 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634] GO:0005634; GO:0005737 AACQLVK 0.99359 -28.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0358 0 0 0 0 0 0 14.2218 11.9631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3769 0 0 14.3276 13.5109 12.9783 0 0 0 0 0 0 0 0 0 0 13.0159 0 0 0 0 0 0 0 0 0 12.8623 12.1186 12.7227 0 0 0 0 12.2141 0 0 0 0 0 0 0 0 12.9494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00763 ACACB_HUMAN "Acetyl-CoA carboxylase 2, EC 6.4.1.2 (ACC-beta)" ACACB ACC2 ACCB Homo sapiens (Human) acetyl-CoA metabolic process [GO:0006084]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of glucose metabolic process [GO:0010906]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; acetyl-CoA metabolic process [GO:0006084]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; positive regulation of heart growth [GO:0060421]; positive regulation of lipid storage [GO:0010884]; protein homotetramerization [GO:0051289]; regulation of glucose metabolic process [GO:0010906]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] GO:0003989; GO:0005524; GO:0005634; GO:0005739; GO:0005741; GO:0005829; GO:0006084; GO:0006633; GO:0009374; GO:0009410; GO:0010629; GO:0010884; GO:0010906; GO:0014070; GO:0031667; GO:0031999; GO:0042802; GO:0043086; GO:0046872; GO:0051289; GO:0060421; GO:0097009; GO:2001295 acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] AQVVHLLSTMDSPAST 0.9936 -37.701 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6295 0 0 0 12.5676 0 0 0 0 14.5754 0 14.9168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.969 0 0 0 0 0 0 0 0 9.74871 0 0 0 0 0 0 10.0436 0 0 0 0 0 0 0 0 0 0 12.2141 0 0 9.55286 0 0 0 0 0 0 0 0 0 0 12.4859 12.6455 14.8838 0 14.3914 13.4342 0 14.5358 10.7515 14.7428 0 0 0 14.2292 13.8127 9.14229 0 0 11.2068 13.1404 0 0 0 0 13.4699 10.5502 15.0465 0 12.8209 0 0 13.8995 0 0 0 0 14.7516 0 0 0 0 14.3542 12.7307 0 0 0 0 0 13.9199 0 0 0 13.9244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9112 0 0 0 0 13.9358 0 0 0 0 13.5792 0 13.407 10.9183 0 0 0 0 0 0 0 12.8555 0 0 0 0 0 0 0 O14976 GAK_HUMAN "Cyclin-G-associated kinase, EC 2.7.11.1" GAK Homo sapiens (Human) cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191] GO:0004674; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006468; GO:0006898; GO:0007029; GO:0007030; GO:0007049; GO:0010977; GO:0016020; GO:0016191; GO:0030276; GO:0030332; GO:0031982; GO:0034067; GO:0043231; GO:0048471; GO:0051085; GO:0051087; GO:0072318; GO:0072583; GO:0072659; GO:0090160; GO:0098793; GO:0106310; GO:1905224 ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AIIQEVCFMKK 0.9936 -7.8119 13.5619 13.024 0 0 0 0 0 0 0 15.9655 0 0 0 0 0 0 11.9953 0 10.6017 0 12.1173 0 0 0 0 0 0 0 0 0 0 0 0 0 16.271 0 0 0 0 0 10.8501 0 10.0316 9.88883 0 0 0 0 10.3278 0 11.0702 11.4076 0 0 11.1478 0 0 0 0 0 11.4103 10.6285 10.8854 0 0 0 0 0 0 0 0 0 0 0 17.2803 12.2929 0 0 0 12.2086 0 0 0 11.9558 11.8304 0 0 0 14.7172 12.0577 12.4252 0 11.4544 0 0 13.8544 13.0796 0 0 14.0442 12.3337 0 0 0 11.0938 0 0 0 0 12.6259 11.0086 0 0 12.9953 13.9874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3127 0 0 0 0 0 13.2094 0 0 0 15.1217 0 0 12.3219 0 0 0 11.5489 0 12.9467 0 0 0 0 13.3559 0 12.3207 0 14.4885 0 0 13.3792 11.12 0 0 0 0 0 12.1958 0 0 13.4607 15.559 0 12.344 0 13.3943 14.8226 13.6054 0 0 O15374 MOT5_HUMAN "Monocarboxylate transporter 5, MCT 5 (Monocarboxylate transporter 4, MCT 4) (Solute carrier family 16 member 4)" SLC16A4 MCT4 MCT5 Homo sapiens (Human) monocarboxylic acid transport [GO:0015718] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718] GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020; GO:0016021 monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] FLIDLYDWTGALILFGAIALNLVPSSMLLRPIHIK 0.9936 -9.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2539 0 13.046 0 0 0 11.0022 0 0 10.8579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7956 0 0 0 12.048 0 0 0 0 0 0 0 0 0 O43557 TNF14_HUMAN "Tumor necrosis factor ligand superfamily member 14 (Herpes virus entry mediator ligand, HVEM-L, Herpesvirus entry mediator ligand) (CD antigen CD258) [Cleaved into: Tumor necrosis factor ligand superfamily member 14, membrane form; Tumor necrosis factor ligand superfamily member 14, soluble form ]" TNFSF14 HVEML LIGHT UNQ391/PRO726 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell chemotaxis [GO:0010820]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell costimulation [GO:0031295]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell chemotaxis [GO:0010820]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell costimulation [GO:0031295]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098] GO:0005102; GO:0005125; GO:0005164; GO:0005615; GO:0005737; GO:0005886; GO:0006915; GO:0006955; GO:0007165; GO:0010818; GO:0010820; GO:0016021; GO:0031295; GO:0042098; GO:0042110; GO:0042802; GO:0043027; GO:0043029; GO:0045663; GO:0071260; GO:1901224; GO:1901741 cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164] AGYYYIYSK 0.9936 -7.809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3872 13.3834 0 0 13.9515 14.1294 13.4986 0 0 0 0 0 0 0 12.2867 0 13.3355 0 11.6719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.669 O75164 KDM4A_HUMAN "Lysine-specific demethylase 4A, EC 1.14.11.66, EC 1.14.11.69 (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) ([histone H3]-trimethyl-L-lysine(36) demethylase 4A) ([histone H3]-trimethyl-L-lysine(9) demethylase 4A)" KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) "cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; response to nutrient levels [GO:0031667]" cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] "cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-36 demethylase activity [GO:0140681]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone demethylation [GO:0016577]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; response to nutrient levels [GO:0031667]" GO:0001650; GO:0005634; GO:0005654; GO:0005721; GO:0005829; GO:0006338; GO:0008270; GO:0010507; GO:0010628; GO:0010629; GO:0014898; GO:0016577; GO:0031625; GO:0031667; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0045666; GO:0045892; GO:0048712; GO:0051864; GO:0060548; GO:0070544; GO:0140681; GO:0140684; GO:1900113 histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-36 demethylase activity [GO:0140681]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] AGNEEECPEEDMEGVEDGEEGDLK 0.9936 -13.454 0 0 9.77722 0 0 0 0 0 13.3589 0 13.9972 13.2359 0 17.926 15.0444 14.4805 13.5289 16.1453 15.8861 13.9468 15.158 0 15.4122 0 14.958 13.4546 19.3142 18.9009 18.7858 14.2561 14.4557 13.2161 13.2499 0 0 0 11.8767 13.8372 14.915 19.0077 13.1669 14.2569 14.9094 14.4848 14.7236 14.5596 15.5691 19.0257 14.6946 14.6048 14.6823 14.8853 15.1769 15.9931 14.8706 13.3125 14.5412 12.4768 0 12.8222 14.496 15.0885 13.1591 13.0754 14.0977 12.1321 9.98328 9.57724 0 0 0 0 0 12.3057 0 0 11.0112 0 0 0 0 0 0 0 0 0 0 0 12.622 0 0 11.4473 0 0 13.3624 0 0 0 0 9.91772 0 0 0 0 0 0 0 0 12.6497 0 0 0 0 0 0 0 0 0 12.0771 0 0 0 0 0 0 0 0 0 0 10.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6558 0 0 0 0 0 0 0 10.1866 0 15.0656 14.9012 0 19.229 19.3625 19.2809 19.4268 13.7747 19.4448 16.0683 19.4401 15.8859 19.318 14.7099 0 0 11.5195 0 14.9661 0 19.6295 0 19.6701 O75373 ZN737_HUMAN Zinc finger protein 737 (Zinc finger protein 102) ZNF737 ZNF102 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFKRSFILTR 0.9936 -5.0329 0 0 0 0 0 0 0 11.6295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2103 0 0 0 14.4834 0 0 15.5437 0 0 13.6988 12.9431 0 0 0 0 0 0 0 13.1493 0 0 13.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8584 0 14.0503 0 0 0 0 0 0 0 0 0 13.4652 0 13.8041 0 0 0 0 0 0 0 0 13.8535 12.9801 0 0 0 0 0 0 0 14.4536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75718 CRTAP_HUMAN Cartilage-associated protein CRTAP CASP Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; collagen fibril organization [GO:0030199]; negative regulation of post-translational protein modification [GO:1901874]; peptidyl-proline hydroxylation to 3-hydroxy-L-proline [GO:0018400]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; chaperone-mediated protein folding [GO:0061077]; collagen fibril organization [GO:0030199]; negative regulation of post-translational protein modification [GO:1901874]; peptidyl-proline hydroxylation to 3-hydroxy-L-proline [GO:0018400]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283] GO:0005615; GO:0005783; GO:0005788; GO:0007283; GO:0018400; GO:0030199; GO:0032991; GO:0050821; GO:0061077; GO:1901874 AIAAAHTFLLK 0.9936 -7.8071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1684 0 0 13.6858 0 0 0 0 0 0 0 0 0 0 0 0 14.9202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9088 0 O75815 BCAR3_HUMAN Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) BCAR3 NSP2 SH2D3B UNQ271/PRO308 Homo sapiens (Human) endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; endothelin receptor signaling pathway [GO:0086100]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007165; GO:0007264; GO:0008286; GO:0009410; GO:0016020; GO:0019900; GO:0033138; GO:0043410; GO:0043547; GO:0045740; GO:0045742; GO:0086100 guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784] CYVGNRR 0.9936 -37.849 0 0 0 0 0 0 0 0 0 0 10.2471 11.8739 0 0 0 0 0 0 0 0 13.1282 0 0 0 0 0 0 0 0 13.5486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8495 0 11.2967 0 0 0 0 0 0 0 0 0 0 0 0 13.3635 0 0 12.4446 0 0 12.2548 0 0 0 12.9902 14.4521 0 0 16.5908 0 0 0 0 0 0 12.7069 14.5596 0 0 0 0 0 0 0 0 0 0 0 12.2459 0 0 0 0 0 0 15.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5333 0 0 0 0 0 0 0 0 0 0 0 0 10.5741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75911 DHRS3_HUMAN "Short-chain dehydrogenase/reductase 3, EC 1.1.1.300 (DD83.1) (Retinal short-chain dehydrogenase/reductase 1, retSDR1) (Retinol dehydrogenase 17) (Short chain dehydrogenase/reductase family 16C member 1)" DHRS3 RDH17 SDR16C1 UNQ2424/PRO4983 Homo sapiens (Human) bone morphogenesis [GO:0060349]; cardiac septum morphogenesis [GO:0060411]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; outflow tract morphogenesis [GO:0003151]; regulation of ossification [GO:0030278]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; roof of mouth development [GO:0060021]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; photoreceptor outer segment membrane [GO:0042622] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; photoreceptor outer segment membrane [GO:0042622]; electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; bone morphogenesis [GO:0060349]; cardiac septum morphogenesis [GO:0060411]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; outflow tract morphogenesis [GO:0003151]; regulation of ossification [GO:0030278]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; roof of mouth development [GO:0060021]; visual perception [GO:0007601]" GO:0000166; GO:0001523; GO:0003151; GO:0004745; GO:0005789; GO:0005811; GO:0007601; GO:0009055; GO:0016021; GO:0016616; GO:0030278; GO:0042572; GO:0042622; GO:0048385; GO:0048387; GO:0052650; GO:0060021; GO:0060349; GO:0060411 "electron transfer activity [GO:0009055]; NAD-retinol dehydrogenase activity [GO:0004745]; NADP-retinol dehydrogenase activity [GO:0052650]; nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" AAVGLVLPAK 0.9936 -9.1365 12.2377 0 0 0 0 0 0 0 0 11.659 0 0 0 0 0 0 17.6969 0 13.2968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1324 0 0 0 0 0 0 0 0 0 0 10.159 0 0 17.1976 17.6147 17.5456 17.4414 0 0 0 0 0 0 0 0 0 0 15.2131 0 0 0 10.5779 0 0 0 0 13.3375 0 0 11.9276 0 0 0 0 12.2694 0 14.4255 0 12.9225 13.5473 0 0 0 12.594 12.9686 0 0 12.7015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3517 13.4569 0 0 10.6768 0 18.4442 9.94781 0 15.0175 0 13.5907 11.9608 0 0 12.8769 12.5351 0 11.4216 0 13.4986 13.1793 0 0 0 13.8519 0 0 13.3387 0 13.6954 0 11.8095 0 0 11.4511 0 0 0 0 0 0 0 0 0 0 19.6789 0 0 0 0 0 13.6749 0 0 10.5652 0 0 0 12.4502 11.5393 10.5779 13.3063 0 0 0 0 0 0 0 P08473 NEP_HUMAN "Neprilysin, EC 3.4.24.11 (Atriopeptidase) (Common acute lymphocytic leukemia antigen, CALLA) (Enkephalinase) (Neutral endopeptidase 24.11, NEP, Neutral endopeptidase) (Skin fibroblast elastase, SFE) (CD antigen CD10)" MME EPN Homo sapiens (Human) aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; learning or memory [GO:0007611]; lung development [GO:0030324]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; placenta development [GO:0001890]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neurogenesis [GO:0050769]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; response to estrogen [GO:0043627]; sensory perception of pain [GO:0019233]; substance P catabolic process [GO:0010814] axon [GO:0030424]; brush border [GO:0005903]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] axon [GO:0030424]; brush border [GO:0005903]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cardiolipin binding [GO:1901612]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; oligopeptidase activity [GO:0070012]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular response to cytokine stimulus [GO:0071345]; cellular response to UV-A [GO:0071492]; cellular response to UV-B [GO:0071493]; creatinine metabolic process [GO:0046449]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; learning or memory [GO:0007611]; lung development [GO:0030324]; neuropeptide processing [GO:0061837]; peptide metabolic process [GO:0006518]; placenta development [GO:0001890]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neurogenesis [GO:0050769]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; replicative senescence [GO:0090399]; response to estrogen [GO:0043627]; sensory perception of pain [GO:0019233]; substance P catabolic process [GO:0010814] GO:0001786; GO:0001822; GO:0001890; GO:0004175; GO:0004222; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005887; GO:0005903; GO:0005925; GO:0006508; GO:0006518; GO:0007568; GO:0007611; GO:0008021; GO:0008238; GO:0008270; GO:0009986; GO:0010814; GO:0010815; GO:0016021; GO:0016485; GO:0019233; GO:0030163; GO:0030324; GO:0030424; GO:0030425; GO:0030667; GO:0031410; GO:0042277; GO:0042447; GO:0042803; GO:0043025; GO:0043627; GO:0044306; GO:0045121; GO:0045202; GO:0046449; GO:0050435; GO:0050769; GO:0061837; GO:0070012; GO:0070062; GO:0071345; GO:0071492; GO:0071493; GO:0090399; GO:0097242; GO:0098793; GO:0150094; GO:1900273; GO:1901612 cardiolipin binding [GO:1901612]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222]; oligopeptidase activity [GO:0070012]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] DLQNLMSWR 0.9936 -7.8159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7513 0 0 0 12.8858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5537 0 0 0 0 0 0 14.0257 0 0 0 0 0 0 0 13.4479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.089 15.3286 14.3537 14.1844 13.2893 0 0 0 0 0 0 13.4833 0 10.7999 0 0 11.0699 13.3188 0 13.3284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5134 0 0 0 0 0 0 0 P08519 APOA_HUMAN "Apolipoprotein(a), Apo(a), Lp(a), EC 3.4.21.-" LPA Homo sapiens (Human) blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma lipoprotein particle [GO:0034358] extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma lipoprotein particle [GO:0034358]; apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508] GO:0001968; GO:0004175; GO:0004252; GO:0004866; GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0006629; GO:0006869; GO:0008015; GO:0008201; GO:0019897; GO:0034185; GO:0034358 apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102] EHKEVVLLLLLFLK 0.9936 -7.819 0 0 0 0 0 0 0 0 0 0 0 0 11.3334 0 0 0 0 0 0 0 9.52964 9.82093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.005 0 0 0 0 0 0 0 0 0 0 0 10.5741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7288 0 0 0 13.9283 15.2262 14.6068 0 0 0 0 0 0 0 0 0 12.8231 0 14.6028 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5867 0 0 0 0 0 0 0 0 0 0 0 11.7607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.36 0 0 12.2789 0 0 0 0 0 0 0 0 P09172 DOPO_HUMAN "Dopamine beta-hydroxylase, EC 1.14.17.1 (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase ]" DBH Homo sapiens (Human) behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; chemical synaptic transmission [GO:0007268]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of vascular associated smooth muscle cell proliferation [GO:1904705]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; vasoconstriction [GO:0042310]; visual learning [GO:0008542] centriolar satellite [GO:0034451]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658] centriolar satellite [GO:0034451]; chromaffin granule lumen [GO:0034466]; chromaffin granule membrane [GO:0042584]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]; catalytic activity [GO:0003824]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418]; behavioral response to ethanol [GO:0048149]; blood vessel remodeling [GO:0001974]; chemical synaptic transmission [GO:0007268]; dopamine catabolic process [GO:0042420]; fear response [GO:0042596]; glucose homeostasis [GO:0042593]; homoiothermy [GO:0042309]; leukocyte mediated immunity [GO:0002443]; leukocyte migration [GO:0050900]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; memory [GO:0007613]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vasoconstriction [GO:0045907]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of vascular associated smooth muscle cell proliferation [GO:1904705]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to amphetamine [GO:0001975]; response to pain [GO:0048265]; vasoconstriction [GO:0042310]; visual learning [GO:0008542] GO:0001974; GO:0001975; GO:0002443; GO:0003824; GO:0004500; GO:0005507; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006589; GO:0007268; GO:0007613; GO:0007626; GO:0008542; GO:0016020; GO:0016021; GO:0030658; GO:0030667; GO:0031418; GO:0034451; GO:0034466; GO:0034774; GO:0042309; GO:0042310; GO:0042420; GO:0042421; GO:0042584; GO:0042593; GO:0042596; GO:0042711; GO:0043231; GO:0045202; GO:0045907; GO:0048149; GO:0048265; GO:0050900; GO:0120162; GO:1904705; GO:1905562; GO:2001236 catalytic activity [GO:0003824]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; L-ascorbic acid binding [GO:0031418] CTQLALPPSGIHIFASQLHTHLTGRKVVTVLVR 0.9936 -6.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2663 0 0 0 0 0 0 0 0 0 12.4381 12.5412 0 0 11.5651 12.2838 0 11.689 0 13.4314 12.9446 0 0 0 12.3994 0 0 0 12.1196 11.633 0 0 0 0 0 0 0 0 0 0 11.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2246 0 0 0 0 0 0 0 0 14.776 0 0 0 0 0 0 12.9174 0 0 0 11.1111 0 0 0 0 P0DP42 T225B_HUMAN Transmembrane protein 225B TMEM225B Homo sapiens (Human) negative regulation of phosphatase activity [GO:0010923] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; negative regulation of phosphatase activity [GO:0010923] GO:0010923; GO:0016021 MLTLEDK 0.9936 -9.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9896 0 0 0 0 0 0 0 0 0 0 13.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2051 0 0 0 0 0 0 0 0 0 0 0 14.4731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27105 STOM_HUMAN Stomatin (Erythrocyte band 7 integral membrane protein) (Erythrocyte membrane protein band 7.2) (Protein 7.2b) STOM BND7 EPB72 Homo sapiens (Human) positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of acid-sensing ion channel activity [GO:1901585] azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982] azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of acid-sensing ion channel activity [GO:1901585] GO:0005615; GO:0005739; GO:0005783; GO:0005856; GO:0005886; GO:0005887; GO:0016020; GO:0031982; GO:0035577; GO:0035579; GO:0042470; GO:0042802; GO:0042803; GO:0044829; GO:0045121; GO:0048471; GO:0048524; GO:0070062; GO:0070063; GO:0070821; GO:0072562; GO:0090314; GO:1901585 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063] DSPSKGLGPCGWILVAFSFLFTVITFPISIWMCIK 0.9936 -7.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9612 0 0 0 0 0 0 0 0 13.2879 0 12.9303 0 0 11.6009 0 11.6472 11.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0759 0 0 0 0 0 0 0 0 9.87684 0 0 0 0 0 0 0 12.6962 0 12.5944 13.352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1177 0 14.1386 0 0 0 0 0 0 0 0 0 14.6713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7139 0 P51587 BRCA2_HUMAN Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein) BRCA2 FACD FANCD1 Homo sapiens (Human) "brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; histone H2A monoubiquitination [GO:0035518]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of transcription, DNA-templated [GO:0006355]; replication fork protection [GO:0048478]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]" "BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]" "BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; gamma-tubulin binding [GO:0043015]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697]; brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; histone H2A monoubiquitination [GO:0035518]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of transcription, DNA-templated [GO:0006355]; replication fork protection [GO:0048478]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]" GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0006978; GO:0007141; GO:0007283; GO:0007420; GO:0008022; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030141; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0035518; GO:0042771; GO:0042802; GO:0043015; GO:0043966; GO:0043967; GO:0045893; GO:0045931; GO:0048478; GO:0051298; GO:0051865; GO:0070200; GO:0071425; GO:0071479; GO:0090398; GO:1990391; GO:1990426; GO:2000001 gamma-tubulin binding [GO:0043015]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; single-stranded DNA binding [GO:0003697] ALNNHRQMLNDK 0.9936 -37.631 0 0 10.6875 0 0 0 10.7262 10.5367 0 13.2424 14.3749 14.9484 14.7221 0 0 0 11.933 0 0 11.753 0 0 0 12.2153 0 12.2178 13.5359 0 11.8756 12.6531 0 16.6583 0 12.0066 0 0 0 12.509 0 13.0306 12.6215 13.4247 12.5135 13.0301 0 13.1621 0 0 0 13.4684 0 0 11.923 0 12.0688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0779 0 0 0 0 13.3081 0 0 0 13.3511 13.1397 13.2279 0 0 16.803 0 16.0836 15.3191 14.8893 16.1107 15.0407 0 11.6547 12.952 14.0495 0 14.0487 0 14.4505 13.0227 10.9526 12.5142 15.0142 0 13.2301 0 13.0489 11.7389 0 0 0 13.9245 0 15.2214 0 15.3799 0 15.4557 0 0 0 14.1199 0 0 14.0829 12.8105 16.0293 0 0 13.1627 14.0006 12.2862 0 0 0 0 0 18.4065 0 14.9652 0 14.3065 0 0 0 0 11.6665 0 17.5737 0 0 13.374 0 0 0 11.6037 0 0 13.1414 0 16.3961 0 0 0 16.0715 0 0 16.1975 0 0 0 0 0 0 14.8745 0 0 0 12.4001 13.294 15.914 P52657 T2AG_HUMAN "Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (TFIIA p12 subunit, TFIIA-12, TFIIAS) (Transcription initiation factor IIA gamma chain, TFIIA-gamma)" GTF2A2 TF2A2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] cell junction [GO:0030054]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669] cell junction [GO:0030054]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0001091; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0006366; GO:0006367; GO:0016251; GO:0017025; GO:0030054; GO:0042803; GO:0045944; GO:0046982; GO:0051123; GO:0060261; GO:0061629 protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025] NTGSNTTE 0.9936 -7.8048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1102 0 0 0 0 0 11.5897 0 0 0 11.4072 0 0 0 0 10.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4406 0 0 0 11.1189 0 0 0 0 0 0 0 0 0 0 0 11.116 0 0 0 11.6 Q12980 NPRL3_HUMAN GATOR complex protein NPRL3 (-14 gene protein) (Alpha-globin regulatory element-containing gene protein) (Nitrogen permease regulator 3-like protein) (Protein CGTHBA) NPRL3 C16orf35 CGTHBA MARE Homo sapiens (Human) aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765] GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; GTPase activator activity [GO:0005096]; aorta morphogenesis [GO:0035909]; cardiac muscle tissue development [GO:0048738]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; roof of mouth development [GO:0060021]; TORC1 signaling [GO:0038202]; ventricular septum development [GO:0003281] GO:0003281; GO:0005096; GO:0005765; GO:0010508; GO:0032007; GO:0034198; GO:0035909; GO:0038202; GO:0048738; GO:0060021; GO:1904262; GO:1990130 GTPase activator activity [GO:0005096] EDDVPFTARVGGR 0.9936 -16.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0571 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13490 BIRC2_HUMAN "Baculoviral IAP repeat-containing protein 2, EC 2.3.2.27 (Cellular inhibitor of apoptosis 1, C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2, hIAP-2, hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2)" BIRC2 API1 MIHB RNF48 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209] CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741] CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; XY body [GO:0001741]; chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; NIK/NF-kappaB signaling [GO:0038061]; placenta development [GO:0001890]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0000209; GO:0001666; GO:0001741; GO:0001890; GO:0003713; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0008270; GO:0009898; GO:0016740; GO:0031398; GO:0033209; GO:0034121; GO:0035631; GO:0038061; GO:0039535; GO:0042127; GO:0042802; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0043130; GO:0043161; GO:0044877; GO:0045088; GO:0045121; GO:0045471; GO:0045595; GO:0047485; GO:0050727; GO:0051087; GO:0051591; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070266; GO:0070424; GO:0098770; GO:1901222; GO:1902443; GO:1902523; GO:1902524; GO:1902527; GO:2000116; GO:2000377 chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CFCCDGGLR 0.9936 -5.0337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7335 0 12.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1141 0 0 0 0 0 0 12.8785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15424 SAFB1_HUMAN "Scaffold attachment factor B1, SAF-B, SAF-B1 (HSP27 estrogen response element-TATA box-binding protein, HSP27 ERE-TATA-binding protein)" SAFB HAP HET SAFB1 Homo sapiens (Human) chromatin organization [GO:0006325]; intracellular estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; chromatin organization [GO:0006325]; intracellular estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003682; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0030496; GO:0030520; GO:0043565; GO:0050684 chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] DWGDHGRREDDR 0.9936 -37.655 0 0 0 0 0 0 11.6991 0 14.2667 14.4124 12.1965 0 0 14.2065 14.3242 12.3899 0 12.2331 0 9.36164 0 0 0 0 12.3698 11.9176 13.7404 12.803 13.7112 13.3127 0 14.4479 13.8226 12.6233 0 13.5308 13.7024 15.034 14.1371 13.3734 10.2096 13.6407 0 12.7491 13.8425 0 0 13.5529 0 0 0 0 11.4251 0 0 10.9873 0 0 0 0 0 0 9.81638 0 0 0 0 0 0 0 0 0 0 11.6978 0 0 12.5352 0 14.6929 0 0 11.312 0 15.5705 0 13.0904 16.1702 15.5025 0 15.824 15.4541 14.6455 12.6197 15.7467 14.1265 0 0 0 14.5218 0 14.6844 14.0319 16.0274 14.363 15.4832 14.5583 0 0 0 12.3414 0 0 13.3842 14.2694 0 14.1923 13.9587 0 0 0 14.8137 14.0948 0 12.9753 13.7925 0 14.8155 0 13.899 0 0 12.6299 0 0 0 0 0 0 13.5445 13.4685 0 0 0 13.0535 0 0 0 11.6982 10.9552 0 0 0 0 13.5233 0 13.8005 14.5455 14.6504 14.7511 0 0 0 0 0 0 0 0 13.2649 0 13.9174 14.5381 0 12.664 0 13.8875 0 0 15.0824 0 0 Q58F21 BRDT_HUMAN "Bromodomain testis-specific protein (Cancer/testis antigen 9, CT9) (RING3-like protein)" BRDT Homo sapiens (Human) "chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; histone binding [GO:0042393]; histone reader activity [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" GO:0000785; GO:0003713; GO:0005634; GO:0006338; GO:0006355; GO:0006397; GO:0007140; GO:0007141; GO:0008380; GO:0035093; GO:0042393; GO:0043484; GO:0051039; GO:0070577; GO:0140566 histone binding [GO:0042393]; histone reader activity [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; transcription coactivator activity [GO:0003713] AAIEKEVK 0.9936 -37.823 0 0 0 0 0 0 0 0 13.1745 14.2134 13.5916 13.3574 13.3711 13.0859 13.1836 0 10.3621 0 0 0 11.2326 12.8951 0 12.3923 0 0 0 0 13.9755 13.7583 14.3905 14.5137 13.3923 13.3938 0 0 13.6934 13.3233 0 13.2247 13.4952 0 12.9178 13.426 14.9939 0 13.1439 0 13.0072 13.0598 0 0 0 12.6915 0 12.6955 0 0 0 0 0 0 0 12.4037 0 0 0 0 16.4918 13.5291 16.565 0 0 0 16.5022 0 16.6668 0 0 0 0 0 0 15.6361 0 0 14.9258 0 12.9858 0 17.0343 0 17.0507 12.1245 0 13.6919 0 12.6393 18.2416 0 0 13.356 0 0 13.2483 11.6876 0 13.1756 14.3842 17.2143 17.2218 0 0 0 12.9807 0 13.6648 0 13.7887 0 12.8305 0 0 0 0 0 17.1679 0 17.0754 0 12.7646 13.5413 0 0 13.1712 0 0 13.1857 13.2051 12.9839 0 13.9433 0 0 0 13.5595 12.7378 15.3439 13.6079 0 0 14.256 0 14.0831 0 17.1359 0 14.8771 14.9044 15.0551 15.5019 0 15.0811 15.1229 14.921 0 0 0 14.8914 14.7855 0 0 10.6591 0 13.3346 12.016 19.7156 14.9719 13.1107 0 Q58FF3 ENPLL_HUMAN Putative endoplasmin-like protein (Putative heat shock protein 90 kDa beta member 2) HSP90B2P GRP94B GRP94P1 TRAP1 Homo sapiens (Human) protein folding [GO:0006457] mitochondrial inner membrane [GO:0005743] mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] GO:0005524; GO:0005743; GO:0006457; GO:0016887; GO:0019901; GO:0051082 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082] DMLRRIK 0.9936 -5.2348 0 0 0 0 14.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6019 0 0 0 0 0 0 0 0 0 0 0 0 14.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7524 0 0 0 0 13.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5H8C1 FREM1_HUMAN FRAS1-related extracellular matrix protein 1 (Protein QBRICK) FREM1 C9orf143 C9orf145 C9orf154 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094] GO:0005576; GO:0005604; GO:0007154; GO:0007160; GO:0009653; GO:0016021; GO:0030246; GO:0046872; GO:0062023; GO:0097094 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] CPGGSCTPGLKK 0.9936 -13.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9315 0 0 0 0 0 0 0 0 0 11.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0286 0 0 0 13.2646 0 0 12.2395 0 12.0714 0 0 14.7119 13.7652 0 0 0 0 0 0 12.6983 12.9458 0 0 16.4419 0 0 0 0 12.3757 0 0 12.2732 0 0 10.6448 0 0 0 0 0 0 14.0233 0 0 12.1792 10.8904 0 0 10.9072 13.9522 0 0 0 0 13.2299 0 0 0 0 0 0 0 0 13.8916 0 0 0 0 13.532 0 0 0 0 0 13.4194 0 0 15.1887 11.4447 0 0 0 0 0 0 0 0 0 0 10.1253 0 0 0 0 12.2303 0 0 0 0 0 0 0 0 0 0 Q6NUJ1 SAPL1_HUMAN Proactivator polypeptide-like 1 [Cleaved into: Saposin A-like; Saposin B-Val-like; Saposin B-like; Saposin C-like; Saposin D-like ] PSAPL1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764] cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665] GO:0005615; GO:0005764; GO:0005829; GO:0006665; GO:0007193; GO:0019216; GO:0060736; GO:0060742 ARAVHDAYAIVPSPEWDAENQGSFCNGCKR 0.9936 -6.8201 0 0 0 0 0 0 11.0217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3495 0 0 0 11.6232 13.6659 0 0 0 0 0 0 18.4949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5439 0 0 11.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZWK6 TM11F_HUMAN "Transmembrane protease serine 11F, EC 3.4.21.- (Airway trypsin-like protease 4)" TMPRSS11F HATL4 Homo sapiens (Human) proteolysis [GO:0006508]; regulation of water loss via skin [GO:0033561] cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508]; regulation of water loss via skin [GO:0033561] GO:0004252; GO:0005576; GO:0005887; GO:0006508; GO:0009986; GO:0033561 serine-type endopeptidase activity [GO:0004252] ALYQSLKTK 0.9936 -13.451 0 0 0 0 12.4632 0 0 0 0 0 0 0 0 0 0 13.2566 0 0 13.0021 0 0 0 12.6874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1177 0 0 0 0 0 0 0 0 13.7178 0 0 11.3105 10.9955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.092 0 0 0 0 0 0 13.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7803 0 0 0 0 0 0 0 0 0 0 0 13.221 0 0 13.5641 0 0 0 0 0 0 0 0 0 0 0 13.0513 0 0 0 0 0 0 0 0 13.3958 0 0 13.1456 0 13.2222 0 0 0 0 12.9392 0 0 Q8IV33 K0825_HUMAN Uncharacterized protein KIAA0825 KIAA0825 C5orf36 Homo sapiens (Human) AEGQLKLLLSQPRCNWNLLLETLLHHDGLLLR 0.9936 -37.833 0 0 0 0 0 0 0 0 14.2217 0 11.6248 0 0 0 18.5303 0 0 0 0 0 0 0 0 0 0 10.0827 0 13.8279 18.3565 18.5085 18.3865 0 0 14.5762 13.8628 13.774 13.7344 13.919 13.7806 0 13.5572 18.3816 18.285 18.3502 13.6564 18.3693 18.3233 0 0 0 18.3914 0 0 0 10.3728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8508 0 0 0 12.4828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.964 0 0 0 14.0246 13.7096 0 13.7125 0 12.568 0 0 15.2265 13.5891 0 0 11.4715 13.5709 0 0 0 0 0 14.0716 0 0 0 0 0 14.5053 13.6172 13.2528 0 11.9959 0 0 0 0 12.2256 0 0 12.9746 0 12.0235 12.5828 11.8907 0 0 0 0 0 12.074 0 0 0 0 14.0418 0 0 0 0 13.2566 11.9642 0 18.9212 14.6822 14.8381 0 14.3966 0 0 15.2558 14.7443 12.1146 14.5691 14.7282 0 14.0756 14.2707 12.4237 12.1733 18.9329 0 11.8325 0 14.7271 0 0 Q8NCS7 CTL5_HUMAN Choline transporter-like protein 5 (Solute carrier family 44 member 5) SLC44A5 CTL5 Homo sapiens (Human) phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085] GO:0005886; GO:0006656; GO:0015220; GO:0016020; GO:0016021; GO:0022857; GO:0055085 choline transmembrane transporter activity [GO:0015220]; transmembrane transporter activity [GO:0022857] CCFWCLENAIK 0.9936 -16.171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0296 0 0 12.0741 11.1338 14.1437 0 0 0 14.978 0 0 10.8653 0 13.0359 0 0 0 0 0 0 11.9631 14.1746 13.2312 0 15.1023 12.6255 12.7866 12.6562 0 0 0 0 13.7493 15.1278 12.4365 14.0644 13.918 15.0315 14.1832 0 0 0 0 0 0 13.6589 13.9369 12.9334 0 12.7192 13.9859 0 0 0 0 0 14.0419 0 13.6281 12.2182 13.5807 11.5035 12.4867 0 0 0 12.3313 12.7446 13.401 13.5352 13.5296 13.4226 13.4378 13.2722 12.905 14.1447 0 0 13.2919 12.7537 0 0 0 11.0327 0 0 13.2442 0 0 0 0 0 0 13.6076 0 0 12.7228 0 0 0 13.1208 0 0 0 14.1478 13.1235 0 12.917 0 0 13.4517 11.0595 0 Q8WWM7 ATX2L_HUMAN Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein) ATXN2L A2D A2LG A2LP A2RP Homo sapiens (Human) mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071]; stress granule assembly [GO:0034063] GO:0003723; GO:0005829; GO:0010494; GO:0016020; GO:0016071; GO:0016607; GO:0034063; GO:0045296 cadherin binding [GO:0045296]; RNA binding [GO:0003723] ELRAAQLAR 0.9936 -14.162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9149 0 12.6248 0 0 0 0 0 0 0 0 0 0 12.5571 0 12.2098 0 0 0 0 0 0 15.2495 0 13.4915 12.1209 0 0 0 0 0 0 0 12.6767 0 0 0 0 0 0 0 0 0 13.5157 0 13.5302 10.4588 13.3819 11.1268 0 0 0 0 0 0 0 0 0 0 0 10.8473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.547 0 0 0 0 0 0 0 0 Q9ULH0 KDIS_HUMAN Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein) KIDINS220 ARMS KIAA1250 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887]; cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976] GO:0001701; GO:0005770; GO:0005829; GO:0010976; GO:0016020; GO:0016021; GO:0019887; GO:0030165; GO:0032991; GO:0038180; GO:0048813; GO:1990090 PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887] AEGKVERVPK 0.9936 -14.171 0 0 0 10.5315 0 0 10.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9583 0 11.9367 0 0 0 0 0 0 0 0 0 0 0 11.4873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7551 14.8423 14.0504 14.6312 11.7043 0 0 0 0 13.4571 15.8941 14.0217 0 14.7713 0 12.8989 0 14.5112 14.2123 0 0 0 0 0 13.8531 0 14.4526 0 0 14.0982 14.1157 0 12.6742 12.4901 0 0 0 13.4119 14.9333 0 15.8674 0 0 0 14.7825 14.3919 14.53 0 0 15.2092 14.1945 0 0 0 0 13.7976 12.526 0 0 0 13.2283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1117 0 0 0 0 0 0 11.9184 0 12.9696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPV0 CE164_HUMAN "Centrosomal protein of 164 kDa, Cep164" CEP164 KIAA1052 NPHP15 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281] GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007049; GO:0051301; GO:0060271; GO:0097539 AIEEEEARMR 0.9936 -9.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2421 0 13.3754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.787 0 0 13.5639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3022 0 0 14.5606 14.5218 13.7485 0 0 13.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4413 0 0 0 0 17.3501 0 0 14.7053 10.2351 0 0 12.6592 0 14.8307 0 0 0 0 0 0 0 12.7505 12.8494 0 0 14.9135 0 14.6498 0 14.8729 0 0 0 0 0 0 14.7535 0 14.7197 0 0 0 14.2845 0 0 0 0 0 0 0 0 0 13.6384 0 13.8459 14.1137 14.1054 0 0 0 0 0 0 0 0 Q9Y4P3 TBL2_HUMAN "Transducin beta-like protein 2 (WS beta-transducin repeats protein, WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein)" TBL2 WBSCR13 UNQ563/PRO1125 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968] GO:0003723; GO:0005783; GO:0019901; GO:0030176; GO:0030968; GO:0031369; GO:0042149; GO:0051219; GO:0071456 phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369] AFIVWLANGDTLR 0.9936 -6.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4066 10.2633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5E3 PCDB6_HUMAN "Protocadherin beta-6, PCDH-beta-6" PCDHB6 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell recognition [GO:0009988]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell recognition [GO:0009988]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0009988; GO:0016021; GO:0016339; GO:0042802; GO:0045202 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] FLKPIMPNFPPQGTER 0.9936 -9.1113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36578 RL4_HUMAN 60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4) RPL4 RPL1 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005791; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0070062; GO:1990904 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AAVAGKKPVVGK 0.99361 -27.592 12.5704 0 0 16.3907 14.0458 16.4133 14.3452 14.6669 0 16.3233 16.718 0 15.6163 0 11.692 13.9212 12.4928 12.055 0 0 0 14.9624 13.9157 0 12.1337 0 14.6988 0 12.7363 15.5294 15.4894 0 15.4591 0 14.6755 13.5677 14.9754 15.1547 14.9807 0 0 15.1528 15.1443 0 12.7003 15.5252 0 0 0 0 12.062 0 11.6515 0 11.7232 0 0 0 0 0 10.2841 0 0 14.3339 0 0 18.5827 15.4549 18.7106 14.1531 14.6556 0 16.5929 14.9649 13.5175 19.1145 0 0 0 0 0 13.521 16.8345 0 0 0 14.2848 0 15.331 15.4286 15.181 15.0829 12.5052 11.3443 15.9285 13.0103 16.1928 14.5261 0 16.6173 14.9947 16.4089 0 16.1092 15.286 0 16.5823 16.5132 0 11.7278 0 15.1431 16.1705 15.6686 16.9805 17.0528 17.7185 16.0826 16.2 16.7052 16.0468 15.8906 16.5753 16.8651 19.4778 16.7283 16.0009 16.4226 16.6197 14.7664 16.4846 15.3505 16.6857 16.9168 9.88622 0 16.3611 16.027 15.4924 15.3719 0 16.0413 16.2076 15.4144 16.8215 15.1809 16.949 15.0796 15.1815 12.9015 14.9874 19.5033 15.0765 13.5691 16.4883 14.4734 15.7878 17.7287 0 0 16.8127 0 0 0 0 0 0 0 0 0 13.2351 16.4947 0 17.4871 14.7063 12.9772 15.3783 0 17.4216 13.0015 A1IGU5 ARH37_HUMAN Rho guanine nucleotide exchange factor 37 ARHGEF37 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005829 guanyl-nucleotide exchange factor activity [GO:0005085] ALLGPQNLIKK 0.99361 -5.06 0 0 0 0 0 10.4459 0 10.4579 0 0 0 11.1587 0 11.1367 0 0 0 0 0 0 9.17946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.367 0 0 0 0 10.9221 0 0 0 0 10.1718 0 0 0 0 0 0 0 0 0 0 0 12.488 0 0 0 0 12.7258 0 13.1921 0 0 0 0 0 0 0 0 0 11.2355 0 0 12.7731 14.4072 0 0 0 0 0 0 0 0 0 0 0 10.2945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3693 O00141 SGK1_HUMAN "Serine/threonine-protein kinase Sgk1, EC 2.7.11.1 (Serum/glucocorticoid-regulated kinase 1)" SGK1 SGK Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to DNA damage stimulus [GO:0006974]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transporter activity [GO:0032411]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of catalytic activity [GO:0050790]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gastric acid secretion [GO:0060453]; regulation of signal transduction by p53 class mediator [GO:1901796]; renal sodium ion absorption [GO:0070294]; sodium ion transport [GO:0006814] GO:0001558; GO:0004674; GO:0004712; GO:0005246; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005789; GO:0005829; GO:0005886; GO:0006468; GO:0006814; GO:0006915; GO:0006974; GO:0007616; GO:0008217; GO:0015459; GO:0016607; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0032411; GO:0035556; GO:0042127; GO:0042981; GO:0048812; GO:0050790; GO:0051090; GO:0060453; GO:0070294; GO:0106310; GO:1901796; GO:1904045 ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; sodium channel regulator activity [GO:0017080] DDFMEIK 0.99361 -15.872 0 0 0 16.5036 0 0 0 0 0 0 11.5208 12.9047 13.3794 12.6215 15.0473 0 0 0 0 0 0 0 0 0 0 0 0 16.0794 0 0 16.7618 0 0 0 11.6441 0 16.1108 0 13.4581 0 15.8253 15.8865 15.9746 15.9978 13.0087 12.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0787 0 15.009 0 0 0 0 0 0 0 0 0 0 12.8902 13.2856 0 0 0 0 0 0 0 0 0 0 0 0 14.1761 0 0 0 0 0 13.0798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1726 14.9628 0 12.8039 0 0 0 11.1954 0 0 0 12.5761 0 13.9215 0 0 0 0 0 0 14.6443 0 0 11.8468 0 0 0 0 14.0612 0 0 0 12.5648 0 0 0 0 0 0 12.5353 0 0 0 0 0 0 O15047 SET1A_HUMAN "Histone-lysine N-methyltransferase SETD1A, EC 2.1.1.364 (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A, hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1)" SETD1A KIAA0339 KMT2F SET1 SET1A Homo sapiens (Human) brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; regulation of chromatin organization [GO:1902275]; regulation of hematopoietic stem cell differentiation [GO:1902036] chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; regulation of chromatin organization [GO:1902275]; regulation of hematopoietic stem cell differentiation [GO:1902036] GO:0000785; GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006974; GO:0007420; GO:0008013; GO:0016607; GO:0035097; GO:0042800; GO:0044648; GO:0048188; GO:0051568; GO:0061629; GO:0080182; GO:0097692; GO:1902036; GO:1902275 beta-catenin binding [GO:0008013]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] ANGQNQASPCSSGDDMEISDDDR 0.99361 -28.953 0 0 0 0 0 0 0 13.2254 0 0 0 0 14.0152 0 10.4065 12.4724 0 0 13.5687 13.1463 13.55 0 0 13.8676 13.7198 0 0 0 0 0 12.8836 0 9.24902 11.7631 13.1862 0 10.83 0 0 11.8077 14.1647 0 11.8484 0 12.0896 0 0 11.9403 11.9997 12.2551 12.4568 0 12.3137 13.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 13.333 14.4968 0 12.8153 0 0 0 15.8697 15.1756 14.9553 14.427 14.7217 11.1413 15.0737 15.169 14.8705 14.8537 13.3926 13.1418 16.4133 0 0 13.5582 0 0 0 14.6107 12.3818 12.6524 15.8677 0 14.9462 12.2351 14.2219 15.5037 14.4915 16.0131 14.5958 13.8887 0 15.3824 12.2234 0 14.7616 0 13.0692 14.4772 0 14.492 0 0 15.006 13.2382 11.0783 12.2242 14.9732 15.6396 14.3558 14.7167 0 14.5353 0 13.4508 13.06 15.5514 0 15.7048 13.7117 13.5308 0 14.9056 0 12.2069 0 14.632 0 14.6881 15.0401 13.4682 14.4391 14.3665 0 11.0107 15.3747 13.8677 13.3746 0 0 0 13.2638 0 0 0 14.2288 0 0 12.3868 11.8566 0 0 13.2267 12.768 0 0 14.6021 14.1836 0 15.579 0 0 0 12.369 0 O15195 VILL_HUMAN Villin-like protein VILL Homo sapiens (Human) actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]" GO:0005200; GO:0005546; GO:0005737; GO:0008154; GO:0015629; GO:0051014; GO:0051015; GO:0051016 "actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]" AAFSRAVGFIQAK 0.99361 -9.1602 0 0 0 16.7575 0 0 0 0 11.7204 0 0 0 0 0 11.4908 11.4994 11.5454 16.6454 0 12.1364 16.681 0 0 13.345 11.4658 12.1206 17.224 0 16.8857 12.6274 0 0 16.9963 0 0 0 0 12.2244 11.4532 16.9947 16.982 16.8786 17.0213 0 16.9918 16.9722 16.9714 17.004 0 0 17.0143 12.9045 0 16.4624 0 0 0 0 16.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8186 14.3904 13.0437 13.9375 11.9604 0 13.7633 12.5787 0 0 14.321 12.7417 12.8073 0 0 0 19.1283 0 15.0411 0 12.9724 12.6289 19.2683 12.3353 19.1736 12.0009 0 0 0 0 0 12.3508 12.999 18.7924 12.0436 18.6526 12.7137 0 10.4539 0 0 18.7397 0 14.6371 0 0 0 0 0 0 0 0 0 0 0 12.0391 0 0 13.8935 0 18.2167 0 17.9942 0 13.9652 0 18.0942 12.3532 0 0 0 14.6443 0 0 17.9992 17.9604 0 0 14.7718 0 14.7498 0 12.8722 11.9292 0 0 0 11.8136 17.7722 0 0 0 17.5548 17.7539 0 0 17.485 0 0 12.2006 17.5151 0 17.5023 0 0 0 O76024 WFS1_HUMAN Wolframin WFS1 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; ubiquitin-dependent ERAD pathway [GO:0030433]; visual perception [GO:0007601] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of synaptic vesicle membrane [GO:0030285]; secretory granule [GO:0030141] dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of synaptic vesicle membrane [GO:0030285]; secretory granule [GO:0030141]; ATPase binding [GO:0051117]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; DNA-binding transcription factor binding [GO:0140297]; proteasome binding [GO:0070628]; ubiquitin protein ligase binding [GO:0031625]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; ubiquitin-dependent ERAD pathway [GO:0030433]; visual perception [GO:0007601] GO:0000122; GO:0001822; GO:0003091; GO:0005516; GO:0005783; GO:0005788; GO:0005789; GO:0006983; GO:0007601; GO:0007605; GO:0022417; GO:0030141; GO:0030176; GO:0030285; GO:0030425; GO:0030433; GO:0030968; GO:0031016; GO:0031398; GO:0031625; GO:0032469; GO:0034976; GO:0042048; GO:0042593; GO:0043066; GO:0043069; GO:0043433; GO:0043524; GO:0045927; GO:0048306; GO:0050821; GO:0050877; GO:0051117; GO:0051247; GO:0051928; GO:0055074; GO:0070628; GO:0140297; GO:1902236; GO:1903573; GO:1903892; GO:2000675 ATPase binding [GO:0051117]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; DNA-binding transcription factor binding [GO:0140297]; proteasome binding [GO:0070628]; ubiquitin protein ligase binding [GO:0031625] AKAGDPK 0.99361 -5.2557 12.372 0 0 12.9651 0 0 0 12.6492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0108 0 0 0 10.8024 15.3187 15.0956 0 14.5127 0 0 0 14.7217 0 0 10.7522 0 11.2869 0 0 0 0 14.0714 0 0 0 0 11.3735 14.594 0 0 0 0 15.2042 0 0 0 0 0 15.3553 0 0 0 14.4029 0 0 0 0 0 0 0 12.505 0 0 0 0 0 0 0 0 13.8206 0 0 0 0 0 0 11.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6029 0 0 0 0 0 0 0 14.302 0 0 0 0 14.8948 O95057 DIRA1_HUMAN "GTP-binding protein Di-Ras1 (Distinct subgroup of the Ras family member 1) (Ras-related inhibitor of cell growth, Rig) (Small GTP-binding tumor suppressor 1)" DIRAS1 GBTS1 RIG Homo sapiens (Human) signal transduction [GO:0007165] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165] GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] CAFMETSAKMNYNVK 0.99361 -5.0612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8176 0 P04198 MYCN_HUMAN "N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37, bHLHe37)" MYCN BHLHE37 NMYC Homo sapiens (Human) "negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0010628; GO:0010629; GO:0019900; GO:0045893; GO:0045944; GO:0046983; GO:1903800; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ALSTSGEDTLSDSDDEDDEEEDEEEEIDVVTVEK 0.99361 -5.0588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07988 PSPB_HUMAN "Pulmonary surfactant-associated protein B, SP-B (18 kDa pulmonary-surfactant protein) (6 kDa protein) (Pulmonary surfactant-associated proteolipid SPL(Phe))" SFTPB SFTP3 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; respiratory gaseous exchange by respiratory system [GO:0007585]; sphingolipid metabolic process [GO:0006665] alveolar lamellar body [GO:0097208]; clathrin-coated endocytic vesicle [GO:0045334]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body lumen [GO:0097486] alveolar lamellar body [GO:0097208]; clathrin-coated endocytic vesicle [GO:0045334]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; multivesicular body lumen [GO:0097486]; animal organ morphogenesis [GO:0009887]; respiratory gaseous exchange by respiratory system [GO:0007585]; sphingolipid metabolic process [GO:0006665] GO:0005576; GO:0005615; GO:0005764; GO:0005771; GO:0005789; GO:0006665; GO:0007585; GO:0009887; GO:0042599; GO:0045334; GO:0097208; GO:0097486 LVLPVLPGALQARPGPHTQDLSEQQFPIPLPYCWLCR 0.99361 -6.8444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16157 ANK1_HUMAN "Ankyrin-1, ANK-1 (Ankyrin-R) (Erythrocyte ankyrin)" ANK1 ANK Homo sapiens (Human) cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731] basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165] GO:0005198; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006888; GO:0007010; GO:0007165; GO:0008093; GO:0009898; GO:0014731; GO:0016323; GO:0016529; GO:0019899; GO:0019903; GO:0030507; GO:0031430; GO:0043005; GO:0044325; GO:0045199; GO:0051117; GO:0072659 ATPase binding [GO:0051117]; cytoskeletal anchor activity [GO:0008093]; enzyme binding [GO:0019899]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] AAQQRSFHFQSFR 0.99361 -13.143 0 0 0 0 0 0 12.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7074 0 0 0 11.9283 0 0 0 0 13.1746 0 0 0 0 10.6649 0 0 11.8157 10.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0805 0 0 12.8159 0 13.8961 0 0 0 0 0 16.8305 0 12.5729 13.2621 0 0 0 14.8807 0 0 0 0 13.2003 12.8537 0 0 0 0 14.5296 0 0 0 0 0 0 0 13.5227 13.6209 16.5843 0 0 15.2283 0 0 0 0 0 0 0 13.9436 0 0 17.5453 0 0 0 0 10.0816 0 0 12.173 12.2959 0 0 0 0 13.8647 15.8193 0 0 9.62469 11.21 0 0 0 0 0 0 0 0 13.5473 12.8737 0 0 0 0 0 0 11.2377 0 10.1306 15.8662 0 0 12.8584 12.3269 13.4822 0 0 0 0 13.1772 12.9676 12.2105 P32929 CGL_HUMAN "Cystathionine gamma-lyase, CGL, CSE, EC 4.4.1.1 (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase, EC 4.4.1.2)" CTH Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein homotetramerization [GO:0051289]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; homocysteine desulfhydrase activity [GO:0047982]; identical protein binding [GO:0042802]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; selenocystathionine gamma-lyase activity [GO:0098606]; cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein homotetramerization [GO:0051289]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346] GO:0004123; GO:0005516; GO:0005737; GO:0005829; GO:0006534; GO:0006629; GO:0016846; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0030968; GO:0042802; GO:0043123; GO:0044524; GO:0044540; GO:0047982; GO:0051092; GO:0051289; GO:0070062; GO:0070814; GO:0080146; GO:0098606; GO:1904831; GO:1990830; GO:2001234 calmodulin binding [GO:0005516]; carbon-sulfur lyase activity [GO:0016846]; cystathionine gamma-lyase activity [GO:0004123]; homocysteine desulfhydrase activity [GO:0047982]; identical protein binding [GO:0042802]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; selenocystathionine gamma-lyase activity [GO:0098606] GTLQHAEIFLKNLK 0.99361 -6.8576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6051 0 0 0 0 0 14.9824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49189 AL9A1_HUMAN "4-trimethylaminobutyraldehyde dehydrogenase, TMABA-DH, TMABALDH, EC 1.2.1.47 (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1, EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase, EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed ]" ALDH9A1 ALDH4 ALDH7 ALDH9 Homo sapiens (Human) carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; protein homotetramerization [GO:0051289] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; hormone metabolic process [GO:0042445]; neurotransmitter biosynthetic process [GO:0042136]; protein homotetramerization [GO:0051289] GO:0004029; GO:0005737; GO:0005829; GO:0006081; GO:0019145; GO:0033737; GO:0042136; GO:0042445; GO:0043878; GO:0045329; GO:0047105; GO:0051289; GO:0070062 1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878] AAFKIWSQK 0.99361 -7.8226 0 0 0 0 13.5889 0 0 0 0 12.1177 0 0 0 0 0 0 13.6137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.811 0 0 0 0 0 0 0 11.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52757 CHIO_HUMAN Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3) CHN2 ARHGAP3 BCH Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202] cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; positive regulation of GTPase activity [GO:0043547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0007165; GO:0016020; GO:0043087; GO:0043547; GO:0045202; GO:0046872; GO:0051056 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] MAFDRDGEK 0.99361 -9.1735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2239 0 0 0 0 0 Q05209 PTN12_HUMAN "Tyrosine-protein phosphatase non-receptor type 12, EC 3.1.3.48 (PTP-PEST) (Protein-tyrosine phosphatase G1, PTPG1)" PTPN12 Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102] cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246] GO:0002102; GO:0004721; GO:0004725; GO:0004726; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006470; GO:0017124; GO:0035335; GO:0042058; GO:0042246; GO:0042995; GO:0071364; GO:1901185; GO:2000587 non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124] LERNLSFEIKK 0.99361 -6.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08211 DHX9_HUMAN "ATP-dependent RNA helicase A, EC 3.6.4.13 (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin, LKP) (Nuclear DNA helicase II, NDH II) (RNA helicase A)" DHX9 DDX9 LKP NDH2 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; global gene silencing by mRNA cleavage [GO:0098795]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; protein-containing complex assembly [GO:0065003]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]" actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] "actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription, termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; global gene silencing by mRNA cleavage [GO:0098795]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; protein-containing complex assembly [GO:0065003]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]" GO:0000380; GO:0000978; GO:0000993; GO:0001069; GO:0001649; GO:0003677; GO:0003678; GO:0003688; GO:0003690; GO:0003697; GO:0003712; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005844; GO:0006260; GO:0006353; GO:0006357; GO:0006954; GO:0010501; GO:0015629; GO:0016020; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0032508; GO:0032727; GO:0032728; GO:0032741; GO:0032755; GO:0032760; GO:0032991; GO:0033679; GO:0034458; GO:0035197; GO:0035613; GO:0036464; GO:0039695; GO:0042788; GO:0043138; GO:0044806; GO:0045087; GO:0045089; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050434; GO:0050684; GO:0050691; GO:0050729; GO:0051028; GO:0051092; GO:0060760; GO:0061629; GO:0061676; GO:0065003; GO:0070063; GO:0070269; GO:0070578; GO:0070922; GO:0070934; GO:0070937; GO:0071356; GO:0071360; GO:0097165; GO:0098795; GO:1900152; GO:1903608; GO:1904973; GO:1905172; GO:1905538; GO:1905698; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000373; GO:2000637; GO:2000765; GO:2000767 3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142] AISAKGMTLVTPLQLLLFASK 0.99361 -29.072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7507 11.1158 0 13.6062 0 0 12.5386 0 0 0 11.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.211 0 0 0 0 13.4965 0 0 0 14.1511 14.6788 0 0 0 0 0 0 12.7836 0 0 0 10.2003 0 10.849 0 0 12.7333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4921 0 0 0 12.8027 0 0 0 12.7878 12.8275 12.4506 0 0 0 13.2319 0 12.8269 0 13.9429 0 0 0 0 0 0 0 0 0 0 0 14.2701 0 13.9984 0 0 0 0 0 0 0 0 0 0 11.1706 0 0 0 0 0 0 14.1539 0 12.394 10.2524 11.6991 12.4066 12.307 13.0756 0 14.5902 0 11.3001 0 0 0 0 13.1872 0 0 0 14.9472 0 0 0 0 0 0 12.0061 0 13.9451 14.7627 0 0 0 0 0 0 0 0 0 13.9308 0 12.9774 Q15306 IRF4_HUMAN "Interferon regulatory factor 4, IRF-4 (Lymphocyte-specific interferon regulatory factor, LSIRF) (Multiple myeloma oncogene 1) (NF-EM5)" IRF4 MUM1 Homo sapiens (Human) "defense response to protozoan [GO:0042832]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immune system process [GO:0002376]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA binding [GO:0043388]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of T-helper cell differentiation [GO:0045622]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]" chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; defense response to protozoan [GO:0042832]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immune system process [GO:0002376]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA binding [GO:0043388]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of T-helper cell differentiation [GO:0045622]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell activation [GO:0042110]; T-helper 17 cell lineage commitment [GO:0072540]" GO:0000785; GO:0000786; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003700; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016020; GO:0032733; GO:0032736; GO:0032743; GO:0032753; GO:0034122; GO:0042110; GO:0042832; GO:0043011; GO:0043388; GO:0043565; GO:0043966; GO:0043967; GO:0045622; GO:0045893; GO:0045944; GO:0072540; GO:0120162; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]" FREGIDK 0.99361 -7.8312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.57 0 0 0 0 0 0 0 0 0 0 0 12.9608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JSZ5 PRC2B_HUMAN Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B) PRRC2B BAT2L BAT2L1 KIAA0515 Homo sapiens (Human) cell differentiation [GO:0030154] RNA binding [GO:0003723]; cell differentiation [GO:0030154] GO:0003723; GO:0030154 RNA binding [GO:0003723] EAKLAAPR 0.99361 -28.999 0 0 0 14.0982 0 0 0 0 12.7167 0 0 13.6161 0 11.0909 0 0 0 0 0 0 0 0 12.5044 0 0 13.6684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5191 0 0 0 10.6551 0 0 0 0 0 0 12.6826 0 0 0 0 0 0 0 0 0 0 0 0 12.5753 0 17.0812 18.2937 12.9161 13.9654 0 0 13.0028 0 13.1155 0 0 0 13.3283 0 0 17.2149 0 13.4578 12.8118 0 13.1003 0 13.1767 13.0492 0 0 0 13.8047 0 0 13.67 13.6026 0 0 13.2717 14.9916 14.8405 21.1142 0 0 0 16.8487 0 12.4222 0 13.0925 0 0 13.1981 13.1847 0 0 13.2183 0 0 19.6604 0 13.0087 16.8927 0 0 12.718 0 12.761 0 0 0 0 0 14.5986 0 0 0 0 11.5935 12.5566 0 0 0 0 0 0 0 0 11.4916 0 0 0 0 13.9693 0 0 0 9.38323 0 0 0 12.7121 Q64LD2 WDR25_HUMAN WD repeat-containing protein 25 WDR25 C14orf67 Homo sapiens (Human) FKQVKLSR 0.99361 -13.472 0 0 0 11.1119 0 0 0 0 0 0 0 0 0 0 0 0 13.6265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9203 0 0 0 0 0 0 11.4278 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3534 12.4581 0 0 0 0 0 0 12.5601 0 0 0 0 0 0 0 0 0 0 0 11.5228 0 0 0 12.0371 11.2993 11.782 14.2269 0 0 0 0 13.6432 0 12.4158 0 0 0 0 0 14.1593 0 13.1934 11.6508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.958 0 0 0 0 0 0 0 0 0 12.1099 11.6645 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68D51 DEN2C_HUMAN DENN domain-containing protein 2C DENND2C Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005654 guanyl-nucleotide exchange factor activity [GO:0005085] APKLPPK 0.99361 -29.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.753 0 0 0 0 10.5394 0 0 0 0 0 0 0 0 10.0301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3861 0 0 0 0 0 0 12.8986 12.788 0 0 0 10.5055 0 0 0 0 0 0 12.5569 0 0 15.3963 15.0934 0 0 13.7865 0 13.9342 18.3705 13.3415 13.3137 0 0 0 0 13.5131 0 13.511 0 0 0 0 14.3866 0 0 0 12.8434 15.0555 0 0 15.4732 13.4073 0 0 13.6025 12.2875 15.4655 13.1117 15.5275 0 13.9547 13.2202 0 0 0 0 12.8986 0 0 0 0 0 14.5115 0 12.2755 0 12.782 14.3614 0 14.0862 0 0 0 14.4118 0 0 0 0 0 0 0 0 0 0 16.6227 0 9.68138 12.2897 0 0 0 0 0 11.7646 17.0478 11.8789 0 0 0 0 0 0 11.9262 11.1676 13.9264 0 0 Q6UXB8 PI16_HUMAN "Peptidase inhibitor 16, PI-16 (Cysteine-rich secretory protein 9, CRISP-9) (PSP94-binding protein) (CD antigen CD364)" PI16 CRISP9 PSPBP PSEC0164 UNQ289/PRO328 Homo sapiens (Human) negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of peptidase activity [GO:0010466] extracellular space [GO:0005615] extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of peptidase activity [GO:0010466] GO:0005615; GO:0010466; GO:0030414; GO:0061052 peptidase inhibitor activity [GO:0030414] AQVSPTASDMLHMR 0.99361 -9.1609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9189 0 0 0 0 0 13.5071 0 13.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6865 0 0 14.6714 0 14.7394 14.0452 13.0671 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6904 0 13.1566 0 0 0 13.259 0 0 13.9154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXH8 CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog) CCBE1 KIAA1983 UNQ1921/PRO4395 Homo sapiens (Human) lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell migration [GO:1904977]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845] collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell migration [GO:1904977]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845] GO:0001946; GO:0002020; GO:0002040; GO:0003016; GO:0005509; GO:0005518; GO:0005581; GO:0005615; GO:0010575; GO:0010595; GO:0010954; GO:0030324; GO:0031012; GO:0045766; GO:0048845; GO:1900748; GO:1901492; GO:1904977 calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020] EEPEDGDR 0.99361 -6.8422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.01 0 0 13.0385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V20 SHLD2_HUMAN Shieldin complex subunit 2 (Protein FAM35A) (RINN1-REV7-interacting novel NHEJ regulator 2) (Shield complex subunit 2) SHLD2 FAM35A RINN2 Homo sapiens (Human) DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; regulation of double-strand break repair via homologous recombination [GO:0010569]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] chromatin [GO:0000785]; chromosome [GO:0005694]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; regulation of double-strand break repair via homologous recombination [GO:0010569]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247] GO:0000785; GO:0002208; GO:0005634; GO:0005694; GO:0006281; GO:0010569; GO:0035861; GO:0043247; GO:0045830; GO:2000042; GO:2001034 DEKQHKNLENYK 0.99361 -6.8502 0 0 0 0 12.4165 0 0 0 0 0 0 0 0 14.6544 0 0 0 0 0 0 13.2939 0 0 0 14.1931 0 0 0 0 0 0 0 12.7684 0 0 0 0 0 0 0 0 0 0 0 13.2662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.817 13.8751 0 13.925 0 0 0 0 0 0 0 0 0 0 0 12.3517 0 0 0 14.444 0 15.6273 0 14.0264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2842 0 0 0 0 0 0 0 0 0 0 0 13.1962 0 0 0 14.4858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.517 0 0 12.7423 0 12.923 0 0 0 0 0 0 0 0 0 0 0 Q8IZ08 GP135_HUMAN G-protein coupled receptor 135 GPR135 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arrestin family protein binding [GO:1990763]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005768; GO:0005886; GO:0007186; GO:0010008; GO:0016021; GO:1990763 arrestin family protein binding [GO:1990763]; G protein-coupled receptor activity [GO:0004930] FFSSCFGIVSTLSVALISLDR 0.99361 -13.471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1439 0 0 0 0 0 0 0 0 0 0 0 0 11.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9932 0 0 0 12.5471 0 0 0 0 0 12.648 0 0 0 0 0 11.1838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGL0 OR5L2_HUMAN Olfactory receptor 5L2 (HTPCRX16) (Olfactory receptor OR11-153) OR5L2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ALRKVMGSK 0.99361 -9.1569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3746 0 0 0 0 15.32 0 0 0 0 0 0 0 0 15.5199 0 0 0 0 0 0 13.4882 12.7466 0 0 0 0 0 0 0 0 10.9391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7884 0 0 0 0 0 0 0 14.8481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHY6 ZFP28_HUMAN "Zinc finger protein 28 homolog, Zfp-28 (Krueppel-like zinc finger factor X6)" ZFP28 KIAA1431 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRQNIHLASHLR 0.99361 -29.052 0 0 0 0 0 0 0 0 0 0 0 11.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1466 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7658 0 0 0 0 0 12.4289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1374 15.0631 0 0 0 0 0 0 0 0 0 13.4285 13.2777 0 0 0 0 12.8869 0 11.2241 0 12.8808 0 0 0 0 0 0 0 0 0 0 0 0 13.9996 0 Q96QI5 HS3S6_HUMAN "Heparan sulfate glucosamine 3-O-sulfotransferase 6, EC 2.8.2.23 (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6, 3-OST-6, Heparan sulfate 3-O-sulfotransferase 6, h3-OST-6)" HS3ST6 HS3ST5 Homo sapiens (Human) blastocyst hatching [GO:0001835]; glycosaminoglycan biosynthetic process [GO:0006024] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467]; blastocyst hatching [GO:0001835]; glycosaminoglycan biosynthetic process [GO:0006024] GO:0000139; GO:0001835; GO:0006024; GO:0008467; GO:0016021 [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO:0008467] ALLEFLR 0.99361 -27.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7266 0 0 0 0 0 0 0 12.6255 0 0 0 0 0 0 0 9.15424 0 12.2609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4472 0 0 0 0 0 0 0 0 10.4295 0 0 0 0 0 12.3047 0 0 12.0212 0 0 0 0 14.3466 0 0 0 12.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3765 12.8872 0 0 0 11.2245 12.8262 Q9H974 QTRT2_HUMAN Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1) QTRT2 QTRTD1 Homo sapiens (Human) tRNA-guanine transglycosylation [GO:0101030] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234] cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030] GO:0005737; GO:0005739; GO:0005741; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030; GO:1990234 metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479] GCSCYCCK 0.99361 -6.8566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8775 0 0 0 0 0 0 0 0 0 0 0 0 9.81279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6214 11.6369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4264 0 0 0 0 0 0 0 0 0 0 0 Q9P1Q0 VPS54_HUMAN Vacuolar protein sorting-associated protein 54 (Hepatocellular carcinoma protein 8) (Tumor antigen HOM-HCC-8) (Tumor antigen SLP-8p) VPS54 HCC8 Homo sapiens (Human) "Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lysosomal transport [GO:0007041]; musculoskeletal movement [GO:0050881]; negative regulation of motor neuron apoptotic process [GO:2000672]; neurofilament cytoskeleton organization [GO:0060052]; protein transport [GO:0015031]; regulation of growth [GO:0040008]; retrograde transport, endosome to Golgi [GO:0042147]; spermatid differentiation [GO:0048515]" cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; syntaxin binding [GO:0019905]; Golgi to vacuole transport [GO:0006896]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lysosomal transport [GO:0007041]; musculoskeletal movement [GO:0050881]; negative regulation of motor neuron apoptotic process [GO:2000672]; neurofilament cytoskeleton organization [GO:0060052]; protein transport [GO:0015031]; regulation of growth [GO:0040008]; retrograde transport, endosome to Golgi [GO:0042147]; spermatid differentiation [GO:0048515]" GO:0000938; GO:0001701; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006896; GO:0007041; GO:0015031; GO:0016020; GO:0019905; GO:0032588; GO:0040008; GO:0042147; GO:0048471; GO:0048515; GO:0048873; GO:0050881; GO:0060052; GO:2000672 syntaxin binding [GO:0019905] AHFEARLPPK 0.99361 -14.216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4273 0 17.707 0 0 17.5276 0 0 14.3019 0 0 13.3247 0 0 0 12.9492 0 14.4101 0 0 0 0 0 0 0 0 0 0 0 14.0609 0 0 0 0 0 12.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9638 0 0 0 0 0 0 0 0 0 0 0 0 13.3246 0 0 0 0 14.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4692 0 Q9UGY1 NOL12_HUMAN Nucleolar protein 12 NOL12 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; single-stranded DNA binding [GO:0003697] GO:0003697; GO:0003723; GO:0005730; GO:0019843; GO:0042802 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; single-stranded DNA binding [GO:0003697] AAIEEIKQRLK 0.99361 -27.394 0 0 0 0 0 0 0 0 0 0 10.7012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3061 0 0 0 0 0 0 0 11.723 0 0 0 0 0 0 0 0 12.0349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4816 0 0 0 0 0 0 0 0 0 10.5964 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8068 0 13.5745 12.2532 14.7322 0 0 0 12.8872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y234 LIPT_HUMAN "Lipoyltransferase 1, mitochondrial, EC 2.3.1.- (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase)" LIPT1 Homo sapiens (Human) carboxylic acid metabolic process [GO:0019752]; lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]; protein modification process [GO:0036211] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyltransferase activity [GO:0016746]; lipoyltransferase activity [GO:0017118]; carboxylic acid metabolic process [GO:0019752]; lipid metabolic process [GO:0006629]; protein lipoylation [GO:0009249]; protein modification process [GO:0036211] GO:0005737; GO:0005739; GO:0005759; GO:0006629; GO:0009249; GO:0016746; GO:0017118; GO:0019752; GO:0036211 acyltransferase activity [GO:0016746]; lipoyltransferase activity [GO:0017118] FCPTETTMLTNILLRTCPQDHKLNSK 0.99361 -6.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.478 0 0 0 0 0 0 0 0 0 10.0526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8712 0 0 0 0 0 0 0 0 0 Q9Y236 OSGI2_HUMAN Oxidative stress-induced growth inhibitor 2 (hT41) OSGIN2 C8orf1 Homo sapiens (Human) meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308] growth factor activity [GO:0008083]; meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308] GO:0008083; GO:0030308; GO:0051321 growth factor activity [GO:0008083] FLKGGALGVTR 0.99361 -6.2093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0694 0 0 0 0 0 0 12.3987 0 11.857 0 0 12.4333 0 11.1846 0 0 0 12.3925 10.5281 0 0 0 0 0 0 0 0 12.8065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3393 0 0 0 0 0 0 13.3884 0 0 0 0 0 0 0 0 0 0 0 10.339 0 0 0 0 12.4628 0 0 0 0 14.6619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2613 0 0 0 0 0 0 14.4423 0 13.047 0 12.2936 0 0 11.3712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6946 0 0 0 0 0 0 A6NCN8 TEX52_HUMAN Testis-expressed protein 52 TEX52 Homo sapiens (Human) DRTALPLHHLSKAQASK 0.99362 -6.6537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0574 0 0 15.6824 0 0 0 0 0 0 0 0 0 0 0 A6NHN6 NPB15_HUMAN Nuclear pore complex-interacting protein family member B15 (Nuclear pore complex-interacting protein-like 2) NPIPB15 NPIPL2 Homo sapiens (Human) extracellular region [GO:0005576]; nucleoplasm [GO:0005654] extracellular region [GO:0005576]; nucleoplasm [GO:0005654] GO:0005576; GO:0005654 DVITLRR 0.99362 -13.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1295 0 0 0 0 0 0 0 0 0 0 11.5005 12.4546 0 14.6196 14.7213 0 0 0 0 0 13.5652 0 14.1974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.234 0 0 0 0 13.3715 0 0 0 13.8241 0 0 13.0188 0 0 11.701 0 0 0 0 0 0 12.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5954 14.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7797 0 0 0 0 0 0 0 0 0 0 0 O14788 TNF11_HUMAN "Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor, ODF) (Osteoprotegerin ligand, OPGL) (Receptor activator of nuclear factor kappa-B ligand, RANKL) (TNF-related activation-induced cytokine, TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form ]" TNFSF11 OPGL RANKL TRANCE Homo sapiens (Human) bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; JNK cascade [GO:0007254]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; JNK cascade [GO:0007254]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0000122; GO:0001503; GO:0002158; GO:0002548; GO:0005125; GO:0005164; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0007249; GO:0007254; GO:0010628; GO:0019221; GO:0019722; GO:0030316; GO:0032813; GO:0033209; GO:0033598; GO:0034112; GO:0036035; GO:0038001; GO:0042802; GO:0043123; GO:0043406; GO:0043491; GO:0044691; GO:0045453; GO:0045672; GO:0045780; GO:0045944; GO:0046330; GO:0050870; GO:0051091; GO:0051092; GO:0051466; GO:0051897; GO:0055074; GO:0060749; GO:0070371; GO:0071812; GO:0071847; GO:0071848; GO:1902533; GO:1904616; GO:1990830; GO:2001206 cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813] LIPDSCRR 0.99362 -7.0963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95139 NDUB6_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 (Complex I-B17, CI-B17) (NADH-ubiquinone oxidoreductase B17 subunit)" NDUFB6 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042775; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] KMVHGVYKK 0.99362 -13.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0043 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9741 0 0 0 0 0 13.4896 11.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3586 0 0 0 0 0 0 11.5917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49588 SYAC_HUMAN "Alanine--tRNA ligase, cytoplasmic, EC 6.1.1.7 (Alanyl-tRNA synthetase, AlaRS) (Renal carcinoma antigen NY-REN-42)" AARS1 AARS Homo sapiens (Human) alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] GO:0000049; GO:0002161; GO:0002196; GO:0004813; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006400; GO:0006418; GO:0006419; GO:0008033; GO:0008270; GO:0016020; GO:0016597; GO:0021680; GO:0043524; GO:0045182; GO:0050885; GO:0051402; GO:0070062; GO:0140018 alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] DVQREIADLGEALATAVIPQWQKDELR 0.99362 -15.879 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8375 0 0 0 0 0 0 0 0 0 0 11.3628 0 0 0 0 0 0 0 0 0 0 0 11.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1045 0 13.5633 13.6847 13.4112 0 13.3635 0 0 0 15.479 0 0 0 0 0 0 0 0 14.7239 0 10.5135 0 0 0 0 0 0 13.5462 0 0 0 0 0 13.8949 0 13.9481 0 0 0 0 0 0 0 13.5844 13.5528 0 0 13.3523 0 0 0 13.3126 0 0 14.2986 0 13.5906 13.5353 0 0 0 0 0 14.2686 0 0 0 0 0 11.927 0 0 0 0 0 0 12.8774 0 13.2425 0 0 12.7072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53609 PGTB1_HUMAN "Geranylgeranyl transferase type-1 subunit beta, EC 2.5.1.59 (Geranylgeranyl transferase type I subunit beta, GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta)" PGGT1B Homo sapiens (Human) protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342] CAAX-protein geranylgeranyltransferase complex [GO:0005953] CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342] GO:0004661; GO:0004662; GO:0005953; GO:0008270; GO:0018342; GO:0018344 CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270] AITYIRR 0.99362 -27.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4197 0 0 0 0 0 0 0 10.6801 0 0 0 0 0 10.8822 0 0 0 0 0 0 0 0 0 13.2897 0 0 13.0375 0 0 0 0 0 0 0 12.7959 0 0 0 0 15.2624 0 0 0 0 0 0 0 0 0 0 12.7393 0 0 0 0 0 0 0 0 0 0 0 13.2851 13.0605 0 0 0 0 0 12.5211 13.1584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P80108 PHLD_HUMAN "Phosphatidylinositol-glycan-specific phospholipase D, PI-G PLD, EC 3.1.4.50 (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D, GPI-PLD, GPI-specific phospholipase D)" GPLD1 PIGPLD1 Homo sapiens (Human) C-terminal protein lipidation [GO:0006501]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; hematopoietic stem cell migration [GO:0035701]; hematopoietic stem cell migration to bone marrow [GO:0097241]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; phospholipase D activity [GO:0004630]; sodium channel regulator activity [GO:0017080]; C-terminal protein lipidation [GO:0006501]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; hematopoietic stem cell migration [GO:0035701]; hematopoietic stem cell migration to bone marrow [GO:0097241]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633] GO:0001503; GO:0002042; GO:0002062; GO:0002430; GO:0004621; GO:0004630; GO:0005576; GO:0005615; GO:0005737; GO:0005765; GO:0006501; GO:0006507; GO:0008285; GO:0008286; GO:0009749; GO:0010595; GO:0010694; GO:0010867; GO:0010897; GO:0010907; GO:0010983; GO:0017080; GO:0031012; GO:0032869; GO:0035701; GO:0035774; GO:0043065; GO:0043231; GO:0046470; GO:0051044; GO:0051047; GO:0070062; GO:0070633; GO:0071277; GO:0071397; GO:0071401; GO:0071466; GO:0071467; GO:0097241; GO:1900076 glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; phospholipase D activity [GO:0004630]; sodium channel regulator activity [GO:0017080] AMGKLGTSLSSGHVLMNGTLK 0.99362 -7.0948 0 0 0 0 0 0 0 0 0 0 0 13.5576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3343 0 13.5345 0 0 0 0 0 0 13.3915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1091 0 0 0 0 0 0 0 0 0 16.5493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7374 0 0 0 Q14956 GPNMB_HUMAN Transmembrane glycoprotein NMB (Hematopoietic growth factor inducible neurokinin-1 type) GPNMB HGFIN NMB UNQ1725/PRO9925 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokine production [GO:0001818]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuron death [GO:1901215]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor production [GO:0032720]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; regulation of angiogenesis [GO:0045765]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886] early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886]; chemoattractant activity [GO:0042056]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018]; syndecan binding [GO:0045545]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytokine production [GO:0001818]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of neuron death [GO:1901215]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor production [GO:0032720]; positive chemotaxis [GO:0050918]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; regulation of angiogenesis [GO:0045765]; regulation of tissue remodeling [GO:0034103]; signal transduction [GO:0007165] GO:0001818; GO:0001934; GO:0005178; GO:0005886; GO:0005887; GO:0007155; GO:0007165; GO:0007267; GO:0008201; GO:0008285; GO:0016021; GO:0030335; GO:0031901; GO:0031954; GO:0032720; GO:0033162; GO:0034103; GO:0042056; GO:0042130; GO:0045545; GO:0045765; GO:0048018; GO:0050868; GO:0050918; GO:0070374; GO:1901215; GO:2000134 chemoattractant activity [GO:0042056]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018]; syndecan binding [GO:0045545] DPASPLRMANSALISVGCLAIFVTVISLLVYK 0.99362 -6.4464 0 0 0 0 0 0 0 0 0 10.9776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79693 0 0 0 0 0 0 0 0 0 0 0 10.7668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.406 0 0 0 13.6887 0 12.9228 11.1494 0 0 0 0 11.4856 0 0 0 0 0 0 0 0 0 0 0 11.8094 0 0 12.808 0 0 0 0 0 12.6107 0 0 12.8121 0 0 0 12.673 0 0 0 0 0 0 0 12.7481 12.2925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0029 12.1917 0 0 0 0 0 13.711 0 13.3122 0 0 0 0 0 0 13.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15643 TRIPB_HUMAN "Thyroid receptor-interacting protein 11, TR-interacting protein 11, TRIP-11 (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210, GMAP-210) (Trip230)" TRIP11 CEV14 Homo sapiens (Human) cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133] cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713]; cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041] GO:0000139; GO:0002079; GO:0002081; GO:0003281; GO:0003413; GO:0003713; GO:0005654; GO:0005793; GO:0005794; GO:0005801; GO:0005856; GO:0006366; GO:0006486; GO:0006888; GO:0007030; GO:0016607; GO:0030133; GO:0031267; GO:0033116; GO:0051216; GO:0060122; GO:0090161; GO:0099041 small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713] AETERLVKGIK 0.99362 -27.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8406 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 0 0 0 0 0 0 0 0 0 11.8724 13.9882 0 0 13.1583 11.6904 0 0 0 0 13.3958 11.6838 0 0 14.3986 0 16.5549 13.5265 0 0 11.9357 0 0 14.3639 0 12.4832 0 0 13.1036 0 15.7876 11.001 0 0 12.162 0 0 0 0 0 14.6628 0 0 0 0 0 0 0 0 0 10.8262 0 0 11.2549 0 0 11.2272 11.3632 0 0 0 0 0 0 0 13.7015 13.0126 14.4681 12.5537 0 14.523 11.2885 13.3109 12.5781 0 14.3661 0 13.2862 13.288 0 0 0 0 0 0 0 14.3795 14.4546 0 0 12.7407 17.2718 0 0 0 0 0 0 13.2332 9.91452 0 0 0 13.6539 0 13.805 0 0 0 11.5125 0 0 Q4LDE5 SVEP1_HUMAN "Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein, SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)" SVEP1 C9orf13 CCP22 SELOB Homo sapiens (Human) cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193] GO:0003017; GO:0003682; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0007155; GO:0008544; GO:0010467; GO:0016020; GO:0036303; GO:0048014; GO:0120193 calcium ion binding [GO:0005509]; chromatin binding [GO:0003682] ALHEDLPSGSFIQDDMVHCSYLCDEGKDCCDRMGSCK 0.99362 -15.915 0 0 0 0 0 0 0 0 12.8573 0 11.7083 11.1597 0 0 0 16.382 0 0 0 0 11.8019 15.5771 0 0 12.315 0 0 0 0 0 0 0 0 0 12.7141 0 0 0 0 13.2945 0 0 0 0 0 0 0 0 11.8973 0 11.8791 0 0 0 0 17.2868 0 0 10.1949 0 0 10.5958 0 0 9.1954 0 13.1117 11.3528 0 0 0 15.0871 10.9211 14.6948 13.127 0 0 0 13.5633 11.4814 0 0 13.912 0 0 0 0 0 15.1826 0 13.4184 0 0 17.2241 13.5936 13.8456 0 0 12.2495 13.3011 16.4513 0 15.1208 15.1891 16.1787 15.023 15.2773 0 13.9059 0 14.681 12.797 13.9836 15.5134 15.521 16.5135 0 0 14.6583 14.1969 13.9641 13.8348 12.6147 16.1204 17.0252 16.5673 0 14.9375 14.2465 0 13.2602 12.6069 12.9515 0 12.8256 15.0609 13.6808 13.9181 13.608 12.5549 12.4765 0 0 0 0 13.8498 0 12.6546 11.1124 0 11.2977 0 0 0 13.1136 0 16.2558 0 0 0 14.0547 11.9664 0 0 0 12.9446 12.4257 0 0 0 0 12.4291 13.5405 14.2847 14.8098 0 16.1908 0 0 14.3494 Q53T94 TAF1B_HUMAN "TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa, TAFI63) (TATA box-binding protein-associated factor 1B, TBP-associated factor 1B) (Transcription initiation factor SL1/TIF-IB subunit B)" TAF1B Homo sapiens (Human) "nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668]; metal ion binding [GO:0046872]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; TBP-class protein binding [GO:0017025]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription, DNA-templated [GO:0006351]" GO:0001164; GO:0001188; GO:0005634; GO:0005654; GO:0005668; GO:0005730; GO:0006351; GO:0017025; GO:0042790; GO:0046872; GO:0070860 metal ion binding [GO:0046872]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; TBP-class protein binding [GO:0017025] ALNRGLK 0.99362 -17.299 0 0 0 0 0 0 0 0 0 10.8858 10.7323 0 0 0 0 11.0243 0 0 0 0 0 0 10.4119 0 0 0 0 0 0 0 10.1732 0 0 0 10.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1663 9.82822 0 0 0 0 0 0 0 0 0 0 13.5684 12.6644 0 0 11.9612 0 0 13.251 13.0403 0 0 0 0 0 0 0 0 0 14.4809 0 13.1165 11.5947 11.5729 11.7346 11.9526 0 13.3504 0 13.6817 0 0 0 0 0 0 0 0 0 12.7969 0 12.5718 0 0 0 0 0 10.1683 0 12.0861 12.4861 9.71144 0 0 0 0 0 0 0 0 0 0 14.2963 10.8379 0 0 0 0 0 0 0 0 0 11.1638 0 0 0 11.7788 10.6292 0 0 0 11.7867 11.8066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q60I27 AL2CL_HUMAN ALS2 C-terminal-like protein ALS2CL Homo sapiens (Human) endosomal transport [GO:0016197]; endosome organization [GO:0007032]; regulation of GTPase activity [GO:0043087] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; regulation of GTPase activity [GO:0043087] GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007032; GO:0016197; GO:0031267; GO:0031410; GO:0042802; GO:0043087; GO:0043231 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] ALSNSLHPLGKLLR 0.99362 -6.8658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0312 0 0 0 0 12.4823 12.8269 0 0 0 11.8813 0 0 0 0 11.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7417 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6373 0 0 0 11.8127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9116 Q7Z2W7 TRPM8_HUMAN "Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6, LTrpC-6, LTrpC6) (Transient receptor potential p8, Trp-p8)" TRPM8 LTRPC6 TRPP8 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; thermoception [GO:0050955] endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; cellular calcium ion homeostasis [GO:0006874]; detection of temperature stimulus [GO:0016048]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to cold [GO:0009409]; thermoception [GO:0050955] GO:0005261; GO:0005262; GO:0005789; GO:0005886; GO:0005887; GO:0006874; GO:0009409; GO:0009897; GO:0016048; GO:0042802; GO:0045121; GO:0050955; GO:0070588; GO:0098655; GO:0099604; GO:0120162 calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604] CCCKEKNMESSVCCFK 0.99362 -27.805 0 0 0 0 0 0 0 0 0 0 0 0 12.6943 0 12.9271 0 9.62545 0 12.7979 0 0 12.6514 0 14.0441 0 9.62965 0 0 12.0866 10.5697 12.4655 0 12.1989 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4014 0 12.0936 0 16.2359 0 0 0 15.4889 0 0 0 0 0 0 0 0 0 13.4124 0 0 0 0 13.9533 0 0 0 0 0 13.0199 0 0 0 0 0 14.8876 14.7379 0 14.075 0 0 0 14.1229 13.6409 13.8107 0 0 0 11.2259 0 0 0 0 14.3848 0 13.7339 0 0 11.2519 0 0 0 0 0 13.5632 0 14.8245 10.0108 0 0 13.9977 0 0 0 0 11.602 0 0 0 0 14.224 13.2439 14.8907 0 0 14.2902 0 0 0 0 0 0 13.9996 0 0 0 15.4078 0 12.2255 0 0 0 0 Q96B18 DACT3_HUMAN Dapper homolog 3 (Antagonist of beta-catenin Dapper homolog 3) (Arginine-rich region 1 protein) (Dapper antagonist of catenin 3) DACT3 RRR1 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of Wnt signaling pathway [GO:0030178] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; delta-catenin binding [GO:0070097]; identical protein binding [GO:0042802]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080]; canonical Wnt signaling pathway [GO:0060070]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of Wnt signaling pathway [GO:0030178] GO:0001837; GO:0005080; GO:0005737; GO:0010719; GO:0030178; GO:0030308; GO:0042802; GO:0051018; GO:0060070; GO:0070097; GO:0090090 delta-catenin binding [GO:0070097]; identical protein binding [GO:0042802]; protein kinase A binding [GO:0051018]; protein kinase C binding [GO:0005080] KPPPLTRGR 0.99362 -13.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.62576 0 0 0 0 0 0 0 0 0 0 0 0 11.7904 0 0 0 0 0 0 0 0 0 0 13.657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4059 0 0 13.2436 0 0 0 11.5382 0 0 0 0 0 0 0 0 0 0 11.9765 0 0 0 0 11.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8049 Q96E66 LRC51_HUMAN Leucine-rich repeat-containing protein 51 (Protein LRTOMT1) LRRC51 LRTOMT Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 LAVLPRLR 0.99362 -6.436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9685 0 0 0 0 0 0 0 14.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FL9 GLT14_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 14, EC 2.4.1.41 (Polypeptide GalNAc transferase 14, GalNAc-T14, pp-GaNTase 14) (Protein-UDP acetylgalactosaminyltransferase 14) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14)" GALNT14 UNQ2434/PRO4994 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] HPYVFPDGNANTYIK 0.99362 -27.815 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7017 0 0 13.4781 0 12.3689 0 0 0 11.6876 0 0 0 12.2988 0 0 0 12.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3965 12.8189 0 11.8161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4695 0 0 13.1495 14.2892 0 0 0 13.8293 0 0 0 0 0 0 11.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5943 0 0 0 0 0 0 0 0 0 0 14.0564 13.173 0 13.6013 0 12.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3534 0 0 0 0 0 0 0 0 0 0 12.4635 0 0 0 0 0 0 0 0 12.4034 11.2848 0 0 0 0 0 0 12.5405 0 0 0 0 0 0 0 0 0 0 0 0 Q96MK2 RIPR3_HUMAN RIPOR family member 3 RIPOR3 C20orf175 C20orf176 FAM65C Homo sapiens (Human) AFARCPPSRAAR 0.99362 -15.887 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1157 11.9175 11.9452 0 0 0 0 15.237 11.9886 0 12.8584 0 0 0 0 12.2637 0 0 0 0 0 0 0 0 0 11.9755 0 0 0 0 0 0 0 0 0 12.2009 0 12.6226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7857 0 13.8896 0 0 0 0 13.3525 0 0 12.5171 0 13.3235 0 0 0 13.7252 0 0 0 15.3951 0 14.201 14.1251 0 15.455 0 15.0535 0 0 13.7093 13.6832 0 12.0735 0 0 0 0 13.9742 14.0755 14.3155 14.1656 12.3668 0 0 0 0 0 13.9732 14.1053 0 13.8098 0 0 0 14.4299 0 13.9497 0 13.9719 14.1034 0 0 13.7213 14.1023 13.9161 18.6296 0 0 13.9806 17.8126 14.0874 13.7944 0 0 0 0 17.3171 0 0 14.0923 13.8025 0 0 14.3063 0 18.2697 14.5434 0 0 14.1315 14.3248 14.4259 14.5076 0 17.4517 14.2413 14.2313 14.7735 0 14.1071 14.6927 0 19.0579 17.5462 17.4125 0 0 0 0 Q9H8L6 MMRN2_HUMAN "Multimerin-2 (EMILIN-3) (Elastin microfibril interface located protein 3, Elastin microfibril interfacer 3) (EndoGlyx-1 p125/p140 subunit)" MMRN2 EMILIN3 Homo sapiens (Human) cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of morphogenesis of an epithelium [GO:1905332] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of morphogenesis of an epithelium [GO:1905332] GO:0002042; GO:0005604; GO:0005615; GO:0007155; GO:0008285; GO:0030336; GO:0030948; GO:0062023; GO:0070062; GO:0090051; GO:1900426; GO:1903588; GO:1905278; GO:1905332 ELYSESDETFDQISKVER 0.99362 -6.6586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHN6 CEIP2_HUMAN "Cell surface hyaluronidase, EC 3.2.1.35 (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2)" CEMIP2 KIAA1412 TMEM2 Homo sapiens (Human) angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670] GO:0001525; GO:0004415; GO:0005509; GO:0005730; GO:0005829; GO:0005886; GO:0005887; GO:0016021; GO:0030214; GO:0043231; GO:0045296; GO:0070062; GO:1903670 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415] DLELLKQASK 0.99362 -7.0929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1729 0 0 0 0 0 0 0 0 11.6961 0 0 0 0 10.2939 10.8409 0 0 0 0 0 0 0 0 10.892 10.8789 0 0 10.8522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2342 10.1358 0 11.4438 0 0 0 0 0 0 0 0 0 0 0 13.3068 0 0 0 0 11.1985 0 0 0 0 0 0 13.653 13.9966 0 0 0 0 0 0 11.3305 14.172 14.4499 15.5075 13.9831 0 0 0 0 0 0 14.4209 14.1996 14.0663 0 14.0151 15.9504 0 14.1353 0 0 14.9495 0 14.7023 0 0 13.7853 11.5974 0 13.5376 0 10.9692 13.7282 0 0 14.05 13.6995 13.6406 0 0 0 13.5641 13.7388 0 0 13.5963 0 0 0 0 13.1513 0 12.9799 13.8087 13.9699 0 12.1683 10.88 0 0 0 0 0 0 0 11.5656 12.135 0 0 0 11.0757 13.2597 0 0 0 11.2719 0 0 0 Q9Y6J9 TAF6L_HUMAN "TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L, TAF6L (PCAF-associated factor 65-alpha, PAF65-alpha)" TAF6L PAF65A Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]" extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669] "extracellular exosome [GO:0070062]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]; chromatin remodeling [GO:0006338]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]" GO:0000118; GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006338; GO:0006355; GO:0006357; GO:0016251; GO:0016573; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:0070062; GO:1904672 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713] DGAALLLSHIFWTHGDLVSGLYQHILLSLQKILADPVR 0.99362 -13.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0202 0 0 0 0 0 0 13.1227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1189 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5161 15.7555 0 0 0 0 0 0 14.3288 0 0 0 11.3851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5549 0 0 0 0 0 0 0 0 0 E9PQX1 TM262_HUMAN Cation channel sperm-associated auxiliary subunit TMEM262 (Cation channel sperm-associated auxiliary subunit eta) (Transmembrane protein 262) TMEM262 CATSPERH Homo sapiens (Human) CatSper complex [GO:0036128]; motile cilium [GO:0031514] CatSper complex [GO:0036128]; motile cilium [GO:0031514] GO:0031514; GO:0036128 IATFFFPK 0.99363 -6.9218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4612 O00478 BT3A3_HUMAN Butyrophilin subfamily 3 member A3 BTN3A3 BTF3 Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0002456; GO:0005102; GO:0005886; GO:0009897; GO:0016020; GO:0016021; GO:0050852 signaling receptor binding [GO:0005102] DLPDNPER 0.99363 -6.9205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0351 0 0 0 0 0 15.7711 0 12.9372 0 13.0542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0644 0 0 0 0 0 0 0 0 0 0 P13995 MTDC_HUMAN "Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase, EC 1.5.1.15; Methenyltetrahydrofolate cyclohydrolase, EC 3.5.4.9 ]" MTHFD2 NMDMC Homo sapiens (Human) folic acid metabolic process [GO:0046655]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; folic acid metabolic process [GO:0046655]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] GO:0000287; GO:0004477; GO:0004487; GO:0004488; GO:0005615; GO:0005739; GO:0005759; GO:0035999; GO:0042301; GO:0046653; GO:0046655 magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301] KVLRLEER 0.99363 -6.9138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78314 3BP2_HUMAN "SH3 domain-binding protein 2, 3BP-2" SH3BP2 3BP2 RES4-23 Homo sapiens (Human) signal transduction [GO:0007165] phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; signal transduction [GO:0007165] GO:0001784; GO:0007165; GO:0017124 phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124] GGTQLQLLKWPLRFVIIHK 0.99363 -6.9071 0 0 12.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3102 0 0 0 0 0 14.9096 0 0 0 13.8665 0 14.9843 0 0 13.8524 14.082 0 0 0 0 0 0 0 0 13.8698 0 0 0 0 0 0 0 0 0 0 0 0 13.8736 0 0 0 0 13.7771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5558 12.3347 0 0 0 0 11.5271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12874 SF3A3_HUMAN "Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61, SAP 61)" SF3A3 SAP61 Homo sapiens (Human) "mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]" GO:0000375; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0016607; GO:0071005; GO:0071013; GO:1903241 RNA binding [GO:0003723]; zinc ion binding [GO:0008270] HFAEWRHAHGMR 0.99363 -6.9025 0 0 0 0 0 0 0 0 14.3336 0 10.0473 0 11.2649 13.1155 0 17.2759 15.897 16.4838 18.6817 18.7372 11.4254 0 16.1439 0 17.1133 0 15.716 15.676 0 0 0 0 0 0 0 0 0 0 0 16.1815 15.5641 0 0 13.7225 15.7756 0 0 0 0 0 14.8753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8987 0 14.7218 13.4075 13.3225 22.924 0 22.6842 17.9652 16.9704 23.0396 23.0031 22.9697 0 0 23.6556 14.4064 22.5314 0 22.8113 22.3506 23.3719 23.1575 23.4306 0 22.9123 22.1721 0 22.1439 21.6059 22.1219 22.0712 21.8786 21.7733 21.7919 0 21.6946 0 0 0 22.4913 21.9299 20.5091 0 22.3742 22.3376 22.5298 22.2968 22.6624 21.7254 21.997 0 21.9954 21.1992 21.799 22.7974 21.5354 19.709 21.0698 20.1084 17.2844 21.7259 19.3853 14.5053 22.8664 21.7634 21.3528 0 13.0001 22.284 0 20.9455 20.9911 22.1072 0 22.1031 19.1522 21.8867 0 0 18.9184 22.4407 0 0 0 0 0 11.7884 0 0 0 0 0 0 0 0 0 0 21.3879 13.7893 21.8674 13.9513 0 0 21.3346 0 Q13615 MTMR3_HUMAN "Myotubularin-related protein 3, EC 3.1.3.48 (FYVE domain-containing dual specificity protein phosphatase 1, FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase, EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase, EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)" MTMR3 KIAA0371 ZFYVE10 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]" GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0006470; GO:0006661; GO:0008138; GO:0010506; GO:0016020; GO:0016236; GO:0019898; GO:0019903; GO:0042149; GO:0046856; GO:0046872; GO:0052629; GO:0060304; GO:1904562; GO:2000785 "metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]" AGNKAFK 0.99363 -28.063 0 0 9.61701 0 0 11.1411 0 0 17.9217 0 0 0 0 0 0 0 0 0 11.0625 0 0 0 0 0 0 16.6188 0 0 0 0 0 0 0 0 0 12.9288 14.5236 0 10.9419 0 15.7982 0 11.2543 0 14.4385 0 12.0027 15.7721 0 0 0 0 0 0 0 14.5552 0 0 0 0 0 0 0 0 13.2298 0 12.8496 12.8619 14.6762 0 0 0 0 0 0 0 0 0 14.6917 0 0 0 0 10.2701 17.7606 0 12.7816 0 0 0 14.3802 0 14.9971 0 0 0 0 0 0 11.5092 0 0 0 12.1775 0 0 0 11.2936 0 13.0512 0 12.155 0 14.1439 0 0 0 0 11.4248 12.1322 12.8654 12.6551 0 0 0 0 0 0 0 0 12.9022 0 0 0 0 0 0 12.8669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1916 0 0 0 0 0 0 13.5148 0 0 12.5962 18.767 18.7554 0 12.9352 13.6132 0 0 9.84489 0 0 18.2563 0 0 18.6655 Q15878 CAC1E_HUMAN "Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II, BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3)" CACNA1E CACH6 CACNL1A6 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]; regulation of ion transmembrane transport [GO:0034765] neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]; regulation of ion transmembrane transport [GO:0034765] GO:0005245; GO:0005509; GO:0005886; GO:0005891; GO:0007268; GO:0008331; GO:0022843; GO:0034765; GO:0043025; GO:0045202; GO:0098703 calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843] AARLIKLLR 0.99363 -28.029 0 0 0 0 0 0 0 0 14.6461 12.5055 0 0 0 0 0 0 0 0 0 0 0 11.3009 12.176 0 0 12.8913 0 12.8476 0 0 0 0 12.6825 0 0 0 14.8857 0 0 0 0 0 0 0 0 0 11.6546 0 0 0 0 11.9264 0 11.2151 0 0 0 0 0 0 0 0 0 0 0 0 10.9577 10.8667 0 0 0 10.3934 0 0 13.0107 0 0 0 0 14.6968 13.4712 0 14.7338 0 14.5926 0 12.6855 13.4491 13.8246 12.9848 0 0 0 0 13.6652 0 12.3195 0 14.4448 0 13.6673 0 0 12.6648 14.0948 14.247 13.2454 13.2337 0 0 14.8254 0 0 12.8278 13.8992 12.612 0 16.3971 14.05 0 0 0 11.6246 0 0 0 12.399 0 0 12.2803 14.4086 0 0 0 0 11.6974 0 11.1899 0 0 0 14.5183 0 0 0 0 0 0 14.1563 16.2637 0 0 0 0 14.9639 14.115 0 0 0 0 0 0 0 0 0 10.9806 0 0 0 12.1147 0 11.661 0 0 0 0 0 0 13.4901 13.7766 Q6NYC8 PPR18_HUMAN Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18) PPP1R18 HKMT1098 KIAA1949 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; phosphatase binding [GO:0019902] GO:0003779; GO:0005737; GO:0005856; GO:0019902 actin binding [GO:0003779]; phosphatase binding [GO:0019902] AGPGVGAPRR 0.99363 -14.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9256 0 0 0 0 13.4323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3422 0 0 0 0 14.0973 0 0 0 14.7984 0 0 0 0 13.5423 0 0 0 0 0 0 0 0 0 0 0 0 13.5918 0 0 0 0 0 0 0 0 13.0406 0 0 0 0 0 13.5088 13.7133 0 12.8866 0 0 0 0 0 0 12.8431 0 0 0 0 12.557 0 0 13.8078 0 0 0 0 0 12.7559 0 0 13.9151 0 12.534 0 12.9432 0 13.7309 0 0 Q8IX06 GOR_HUMAN "Putative exonuclease GOR, EC 3.1.-.- (Antigen GOR homolog) (RNA exonuclease 1 homolog-like 1)" REXO1L1P GOR REXO1L1 Homo sapiens (Human) cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] GO:0003676; GO:0004527; GO:0005634; GO:0005737 exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676] ASLPSLSLKKPIILR 0.99363 -28.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5411 0 0 12.6802 0 0 0 0 12.4978 0 12.6608 12.8898 0 12.3766 0 0 0 0 15.3537 0 0 0 0 0 0 0 0 0 0 13.0724 15.2772 0 12.8326 13.1152 0 13.5316 0 0 0 14.3368 0 0 0 0 0 0 0 0 14.1978 0 0 0 0 0 0 11.6577 0 0 12.6379 0 0 10.7782 0 13.2464 0 0 0 0 0 0 0 0 0 11.6882 0 0 0 0 0 0 11.7602 0 0 0 13.3903 0 0 0 0 0 0 0 0 0 0 0 15.0133 12.0798 0 0 0 0 0 0 0 0 Q8IZI9 IFNL3_HUMAN "Interferon lambda-3, IFN-lambda-3 (Cytokine Zcyto22) (Interleukin-28B, IL-28B) (Interleukin-28C, IL-28C)" IFNL3 IL28B IL28C ZCYTO22 Homo sapiens (Human) cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; receptor signaling pathway via JAK-STAT [GO:0007259]; type III interferon signaling pathway [GO:0038196] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; receptor signaling pathway via JAK-STAT [GO:0007259]; type III interferon signaling pathway [GO:0038196] GO:0005102; GO:0005125; GO:0005576; GO:0005615; GO:0007259; GO:0038196; GO:0045071; GO:0045087; GO:0050778; GO:0051607; GO:0098586 cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102] CRSRLFPR 0.99363 -7.1002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3378 13.3782 13.7356 0 14.1423 0 0 0 13.3706 0 0 0 0 13.1999 0 0 14.2532 0 0 0 12.4003 0 0 0 0 0 0 0 0 0 13.059 12.9781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6646 0 0 0 0 11.9476 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FC7 PHIPL_HUMAN Phytanoyl-CoA hydroxylase-interacting protein-like PHYHIPL KIAA1796 UNQ6309/PRO20934 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AEVIAGRMLK 0.99363 -6.4581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.376 0 0 0 0 0 0 0 10.9888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6811 0 0 0 0 14.4589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2432 0 0 0 0 0 0 0 0 0 0 0 0 13.068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZP6 NPAP1_HUMAN Nuclear pore-associated protein 1 NPAP1 C15orf2 Homo sapiens (Human) cell differentiation [GO:0030154]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283] intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] intracellular membrane-bounded organelle [GO:0043231]; nuclear inner membrane [GO:0005637]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; cell differentiation [GO:0030154]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; spermatogenesis [GO:0007283] GO:0005637; GO:0005643; GO:0005654; GO:0005886; GO:0006405; GO:0006606; GO:0007283; GO:0008139; GO:0017056; GO:0030154; GO:0043231 nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] EATPQPK 0.99363 -28.045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3191 0 0 0 13.1682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4551 0 0 0 13.4803 13.7034 0 0 14.4486 0 0 12.7541 14.5062 0 0 0 0 0 0 0 12.4957 0 13.1048 0 0 14.7264 13.0769 0 0 0 0 12.9618 0 0 0 0 0 0 0 0 13.4272 14.1796 0 0 0 0 0 13.6815 0 13.4765 13.4557 0 0 0 0 0 0 12.6561 11.6999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9886 0 0 0 0 0 0 0 0 0 0 0 Q9Y6Q3 ZFP37_HUMAN "Zinc finger protein 37 homolog, Zfp-37" ZFP37 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0008270 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" EVAVKKK 0.99363 -6.9064 0 0 0 10.1557 0 0 0 0 0 0 12.4179 0 0 0 0 0 0 11.2612 0 0 0 0 0 0 0 0 0 9.38819 0 0 0 12.7596 0 0 0 11.4151 0 0 0 11.5647 0 0 0 0 0 0 0 0 0 0 0 0 11.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5054 0 11.6033 0 0 0 0 0 14.7096 12.2204 14.3977 0 0 0 0 0 14.7767 12.79 0 0 13.162 12.4032 0 15.1618 0 13.1145 15.698 0 14.8779 0 13.9502 13.4041 0 13.0135 0 0 0 0 0 0 13.2134 12.63 0 13.9345 0 0 0 12.307 13.8238 13.3937 13.4255 0 0 13.8886 0 13.4087 0 14.8463 13.7985 12.5689 13.116 12.7097 12.1723 0 12.4299 0 14.1196 0 0 12.2003 0 0 0 0 13.8784 0 0 0 0 10.9419 12.5667 11.2022 0 12.2842 13.2002 0 0 0 0 0 12.2477 0 0 0 0 0 0 0 0 0 12.0734 0 0 0 12.7386 0 0 0 0 0 0 11.0684 0 P25705 ATPA_HUMAN "ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)" ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM Homo sapiens (Human) aging [GO:0007568]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nitric oxide [GO:0071732]; lipid metabolic process [GO:0006629]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to ethanol [GO:0045471]; response to muscle activity [GO:0014850] "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]" "cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; aging [GO:0007568]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nitric oxide [GO:0071732]; lipid metabolic process [GO:0006629]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to ethanol [GO:0045471]; response to muscle activity [GO:0014850]" GO:0001937; GO:0002020; GO:0003723; GO:0005524; GO:0005634; GO:0005739; GO:0005743; GO:0005753; GO:0005754; GO:0005759; GO:0005886; GO:0006629; GO:0006754; GO:0006915; GO:0007568; GO:0009986; GO:0014850; GO:0015986; GO:0016020; GO:0016887; GO:0042288; GO:0042776; GO:0043531; GO:0043532; GO:0043536; GO:0045121; GO:0045259; GO:0045261; GO:0045471; GO:0046933; GO:0070062; GO:0071549; GO:0071732 "ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]" APGIIPR 0.99364 -15.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5397 12.7346 0 0 0 14.1008 13.0477 14.0104 13.9642 13.0449 12.5324 13.8845 0 12.6919 12.5186 14.6114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8065 0 0 12.5173 13.6853 0 0 0 0 0 0 0 0 0 0 0 12.9864 0 0 12.8962 0 0 13.1849 0 12.9953 0 0 13.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0929 0 Q12981 SEC20_HUMAN "Vesicle transport protein SEC20 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 1) (Transformation-related gene 8 protein, TRG-8)" BNIP1 NIP1 SEC20L TRG8 Homo sapiens (Human) "apoptotic process [GO:0006915]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic process [GO:0043066]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; SNARE complex [GO:0031201] "cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; nuclear envelope [GO:0005635]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; apoptotic process [GO:0006915]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic process [GO:0043066]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0005484; GO:0005635; GO:0005737; GO:0005783; GO:0005789; GO:0006890; GO:0006915; GO:0007029; GO:0016320; GO:0030176; GO:0031201; GO:0031966; GO:0043066; GO:0043231; GO:0097194 SNAP receptor activity [GO:0005484] ALIQDIRDCSGPLSALTELNTK 0.99364 -14.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6043 0 12.8898 0 0 0 0 0 11.3662 0 0 0 0 0 0 10.5755 0 0 0 0 0 0 10.8714 0 11.0498 12.0359 0 0 0 0 0 0 12.1526 0 0 0 12.5483 0 0 0 0 0 0 0 0 0 0 0 14.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15916 ZBTB6_HUMAN Zinc finger and BTB domain-containing protein 6 (Zinc finger protein 482) (Zinc finger protein with interaction domain) ZBTB6 ZID ZNF482 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CHCCDMDFK 0.99364 -7.9329 0 0 0 0 0 0 0 0 0 12.7548 0 0 0 0 0 0 0 0 0 0 11.3695 0 11.4861 0 0 0 13.0233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2961 12.2592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3996 0 11.9136 14.2072 0 0 0 12.6917 0 0 0 12.1285 0 0 13.5203 12.7602 0 0 0 0 0 0 12.7275 0 0 0 0 0 14.5072 11.6844 15.8257 0 0 0 0 0 0 0 0 11.6889 12.5557 0 0 0 15.0165 0 0 12.1634 0 0 0 0 13.1295 0 13.8843 0 13.2394 14.3472 0 0 0 0 0 0 12.3619 0 0 13.8602 0 0 13.8244 0 0 12.1348 0 0 14.7518 0 12.4775 12.5384 0 14.0822 0 14.111 0 0 0 0 0 0 0 0 0 12.075 0 0 12.4144 0 0 0 0 0 0 0 11.7991 0 0 0 Q5H9K5 ZMAT1_HUMAN Zinc finger matrin-type protein 1 ZMAT1 KIAA1789 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] GO:0003677; GO:0005634; GO:0008270 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] ENSVDTHGYR 0.99364 -9.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96Q83 ALKB3_HUMAN "Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3, EC 1.14.11.33, EC 1.14.11.54 (Alkylated DNA repair protein alkB homolog 3, hABH3) (DEPC-1) (Prostate cancer antigen 1)" ALKBH3 ABH3 DEPC1 Homo sapiens (Human) cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA repair [GO:0006281]; oxidative single-stranded DNA demethylation [GO:0035552]; oxidative single-stranded RNA demethylation [GO:0035553] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; mRNA N1-methyladenosine dioxygenase activity [GO:1990930]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515]; cell population proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA repair [GO:0006281]; oxidative single-stranded DNA demethylation [GO:0035552]; oxidative single-stranded RNA demethylation [GO:0035553] GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006307; GO:0008198; GO:0008283; GO:0031418; GO:0035515; GO:0035516; GO:0035552; GO:0035553; GO:0043734; GO:1990930 DNA-N1-methyladenine dioxygenase activity [GO:0043734]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; mRNA N1-methyladenosine dioxygenase activity [GO:1990930]; oxidative DNA demethylase activity [GO:0035516]; oxidative RNA demethylase activity [GO:0035515] PPPEENGDYTYVERVK 0.99364 -10.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6401 0 0 0 0 0 10.9604 0 0 0 0 0 12.6071 0 0 0 0 0 0 0 0 0 0 0 0 Q9NV64 TM39A_HUMAN Transmembrane protein 39A TMEM39A SUSR2 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]; positive regulation of viral genome replication [GO:0045070] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]; positive regulation of viral genome replication [GO:0045070] GO:0005789; GO:0006914; GO:0016020; GO:0016021; GO:0045070; GO:1901097; GO:1902902 ADFNHRIK 0.99364 -14.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.764 0 12.1233 13.2138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7027 13.0837 0 0 13.3106 11.9776 0 0 0 0 0 0 0 0 0 0 12.7144 12.5276 0 0 0 0 0 12.8992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9271 0 0 0 0 0 0 0 12.8097 0 0 0 12.6158 12.529 0 0 12.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9077 Q9UIL8 PHF11_HUMAN PHD finger protein 11 (BRCA1 C-terminus-associated protein) (Renal carcinoma antigen NY-REN-34) PHF11 BCAP Homo sapiens (Human) nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872] GO:0005634; GO:0005654; GO:0031965; GO:0046872 metal ion binding [GO:0046872] IHASQQRWQQLKEEIELLQDLK 0.99364 -7.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8477 0 0 0 0 0 0 0 0 0 14.7621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5163 0 0 10.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0333 0 0 0 0 B2RXH2 KDM4E_HUMAN "Lysine-specific demethylase 4E, EC 1.14.11.66 (KDM4D-like protein) (Lysine-specific demethylase 4D-like) ([histone H3]-trimethyl-L-lysine(9) demethylase 4E)" KDM4E KDM4DL Homo sapiens (Human) chromatin remodeling [GO:0006338]; histone H3-K9 demethylation [GO:0033169] nucleus [GO:0005634] nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; histone H3-K9 demethylation [GO:0033169] GO:0005634; GO:0006338; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0140684 histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872] GQGQGRGCSRGR 0.99365 -16.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JQI7 TM232_HUMAN Transmembrane protein 232 TMEM232 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 IANTLSKLFFPPIEAHFLPLKK 0.99365 -10.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7683 0 0 0 0 0 0 0 0 12.3266 0 0 12.9629 12.1792 0 15.6062 0 11.6785 0 11.5178 0 10.7856 12.0273 0 0 0 0 0 0 0 0 13.189 0 14.6252 0 0 0 0 0 12.507 0 0 0 0 0 0 0 0 15.3129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0212 0 0 0 0 0 0 O43570 CAH12_HUMAN "Carbonic anhydrase 12, EC 4.2.1.1 (Carbonate dehydratase XII) (Carbonic anhydrase XII, CA-XII) (Tumor antigen HOM-RCC-3.1.3)" CA12 Homo sapiens (Human) chloride ion homeostasis [GO:0055064]; one-carbon metabolic process [GO:0006730] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; chloride ion homeostasis [GO:0055064]; one-carbon metabolic process [GO:0006730] GO:0004089; GO:0005886; GO:0006730; GO:0008270; GO:0016021; GO:0016836; GO:0055064 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] EQPSSPAPVNGSK 0.99365 -14.149 0 0 12.2795 0 0 0 0 0 0 0 10.9554 0 0 0 0 0 0 0 0 0 12.0224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6526 0 0 0 0 0 0 0 0 0 0 0 16.2025 0 15.3135 13.9419 14.309 0 9.98071 0 14.3246 15.3004 10.9685 0 0 14.6365 14.0441 0 0 14.7799 11.2932 15.0903 0 0 0 0 15.0066 14.498 0 14.1523 0 14.2477 11.6626 14.3089 0 0 0 14.956 12.4072 0 14.8907 14.9393 12.3979 0 0 13.2961 11.6821 0 0 13.504 14.7082 0 0 0 0 11.9153 12.323 0 13.6788 0 0 0 0 0 12.9064 0 0 0 15.3598 13.725 12.7847 0 0 0 0 14.4741 0 0 13.6975 13.3929 13.9516 15.0289 12.9885 0 0 0 0 0 12.9313 0 13.092 0 0 0 0 10.8247 0 12.8995 11.7809 0 0 0 0 0 0 0 0 0 13.3786 13.5085 14.0206 0 10.6601 0 0 10.1981 O60507 TPST1_HUMAN "Protein-tyrosine sulfotransferase 1, EC 2.8.2.20 (Tyrosylprotein sulfotransferase 1, TPST-1)" TPST1 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inflammatory response [GO:0006954]; peptidyl-tyrosine sulfation [GO:0006478] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inflammatory response [GO:0006954]; peptidyl-tyrosine sulfation [GO:0006478] GO:0000139; GO:0005794; GO:0006478; GO:0006954; GO:0008146; GO:0008476; GO:0016020; GO:0030173; GO:0042803; GO:0050427 protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476]; sulfotransferase activity [GO:0008146] AGGVSLSKVERSTDQVIK 0.99365 -14.124 0 0 0 13.2812 0 0 0 11.8767 0 0 0 0 0 0 0 10.9449 10.8436 0 0 0 12.6122 0 0 0 12.6549 0 11.9834 0 0 11.9211 0 0 0 0 0 0 0 0 0 0 0 11.6902 0 0 0 0 10.4935 0 0 11.2271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6546 12.4051 12.3736 13.1304 12.6643 0 0 0 0 0 0 0 0 0 10.8163 0 0 0 10.8986 0 14.8892 0 12.3128 12.825 0 0 0 0 0 0 0 0 0 12.2621 12.7855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7548 0 12.2039 0 12.6715 12.802 13.8185 13.115 0 0 13.1626 13.4394 13.1257 0 13.8326 0 0 0 12.8899 0 12.6064 0 0 0 0 0 0 0 0 0 0 10.0729 0 0 0 0 0 0 0 0 0 0 0 12.219 0 0 12.1434 0 0 0 0 0 12.9776 0 0 O95231 VENTX_HUMAN Homeobox protein VENTX (VENT homeobox homolog) (VENT-like homeobox protein 2) VENTX HPX42B VENTX2 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005654; GO:0006357; GO:0043565; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" TMAGLSK 0.99365 -16.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21781 FGF7_HUMAN "Fibroblast growth factor 7, FGF-7 (Heparin-binding growth factor 7, HBGF-7) (Keratinocyte growth factor)" FGF7 KGF Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; myoblast proliferation [GO:0051450]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]; actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; myoblast proliferation [GO:0051450]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]" GO:0001934; GO:0001935; GO:0001938; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0005794; GO:0007165; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008544; GO:0009611; GO:0009887; GO:0010463; GO:0010628; GO:0010838; GO:0030154; GO:0030324; GO:0030334; GO:0031069; GO:0031532; GO:0034394; GO:0042056; GO:0045893; GO:0050679; GO:0050731; GO:0050918; GO:0051450; GO:0051549; GO:0051781; GO:0060445; GO:0060501; GO:0060665; GO:0061033; GO:2000288 chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111] ECNEDCNFK 0.99365 -5.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9765 0 0 0 0 15.5077 0 0 15.8205 16.136 15.4575 15.8641 0 0 0 0 15.4082 16.023 15.5079 0 0 14.8706 0 0 0 15.0676 0 0 0 15.4899 0 0 0 0 14.2899 0 15.3473 15.3639 15.5072 0 15.1794 0 0 0 0 15.0743 0 0 0 0 0 0 0 0 0 14.5372 0 0 0 14.5497 0 14.7295 14.4653 13.8176 0 0 0 0 0 14.7581 0 13.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5106 14.133 0 0 12.3184 0 14.393 0 12.9076 0 P51957 NEK4_HUMAN "Serine/threonine-protein kinase Nek4, EC 2.7.11.1 (Never in mitosis A-related kinase 4, NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2)" NEK4 STK2 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of response to DNA damage stimulus [GO:2001020]" cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] "cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of response to DNA damage stimulus [GO:2001020]" GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005929; GO:0006468; GO:0006974; GO:0030145; GO:0045893; GO:0051301; GO:0106310; GO:2000772; GO:2001020 ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DMNSLVYRIIEGKLPPMPR 0.99365 -14.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2588 0 0 0 14.1031 13.8433 14.2086 0 0 14.0488 0 0 0 13.79 0 0 0 0 0 0 13.365 0 0 0 14.5731 0 0 0 0 0 11.1536 0 0 14.314 0 0 14.2226 0 0 12.642 13.2854 0 0 0 0 0 13.3995 0 0 0 0 0 0 0 0 0 0 0 0 12.8225 0 13.4086 0 0 14.7272 0 12.8731 12.6729 0 0 0 0 0 0 12.3971 0 0 0 0 0 0 15.0417 14.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1647 0 0 0 13.1465 13.666 13.0114 0 0 14.2212 13.7555 0 Q13822 ENPP2_HUMAN "Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, E-NPP 2, EC 3.1.4.39 (Autotaxin) (Extracellular lysophospholipase D, LysoPLD)" ENPP2 ATX PDNP2 Homo sapiens (Human) cell motility [GO:0048870]; chemotaxis [GO:0006935]; immune response [GO:0006955]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; sphingolipid catabolic process [GO:0030149] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622]; nucleic acid binding [GO:0003676]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270]; cell motility [GO:0048870]; chemotaxis [GO:0006935]; immune response [GO:0006955]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; sphingolipid catabolic process [GO:0030149] GO:0003676; GO:0004528; GO:0004551; GO:0004622; GO:0005044; GO:0005509; GO:0005615; GO:0005886; GO:0006935; GO:0006955; GO:0008270; GO:0009395; GO:0010634; GO:0016787; GO:0030149; GO:0030247; GO:0030334; GO:0034638; GO:0045765; GO:0047391; GO:0048870; GO:0050731; GO:2000394 alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; calcium ion binding [GO:0005509]; hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622]; nucleic acid binding [GO:0003676]; nucleotide diphosphatase activity [GO:0004551]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; zinc ion binding [GO:0008270] CDGPLSVSSFILPHRPDNEESCNSSEDESK 0.99365 -5.1476 0 0 0 0 0 0 0 0 0 11.3582 11.9688 0 0 0 0 0 0 11.8049 0 0 0 12.4175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8688 0 0 0 0 0 0 0 0 0 0 0 9.34132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3362 0 13.3791 0 0 0 0 13.6092 0 0 13.5288 13.6663 0 14.5501 14.0032 0 0 0 0 0 0 0 0 0 15.1019 0 0 15.2941 15.0058 14.8574 0 0 14.476 0 0 0 11.8225 14.0267 12.8824 0 14.5122 0 0 0 14.8085 0 13.1249 0 0 0 0 0 12.2919 13.741 13.7667 11.5328 0 14.0325 0 0 0 0 12.7638 0 0 0 0 12.8044 0 0 0 11.4024 0 0 15.1974 15.2274 0 0 0 0 0 0 0 11.2619 0 0 0 0 0 0 0 0 11.5854 0 0 0 0 0 0 11.6497 Q14657 LAGE3_HUMAN EKC/KEOPS complex subunit LAGE3 (L antigen family member 3) (Protein ESO-3) (Protein ITBA2) LAGE3 DXS9879E ESO3 ITBA2 Homo sapiens (Human) tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525] GO:0000408; GO:0005634; GO:0005654; GO:0005737; GO:0008033; GO:0016604; GO:0070525 DADADAGGGADGGDGR 0.99365 -10.782 0 0 0 0 0 0 0 0 0 9.52095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NSJ0 MYORG_HUMAN "Myogenesis-regulating glycosidase, EC 3.2.1.- (Uncharacterized family 31 glucosidase KIAA1161)" MYORG KIAA1161 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of protein kinase B signaling [GO:0051897]; skeletal muscle fiber development [GO:0048741]" GO:0004553; GO:0005789; GO:0005975; GO:0016021; GO:0031965; GO:0043568; GO:0048741; GO:0051897 "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" NQKGEQVFR 0.99365 -10.815 0 0 0 0 0 0 0 0 0 0 0 0 13.5946 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5216 0 0 0 0 13.76 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1496 0 0 0 14.7644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5793 0 0 0 0 0 0 0 0 0 13.3222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUT6 CCD9B_HUMAN Coiled-coil domain-containing protein 9B CCDC9B C15orf52 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] DAQGDWR 0.99365 -37.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6644 17.4414 0 0 17.9937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1129 0 12.8862 14.3355 0 0 13.7339 13.9594 0 0 0 13.1861 0 0 0 0 11.2099 0 0 0 0 0 0 0 0 0 0 0 12.9516 0 0 0 0 12.9098 0 0 0 13.0868 0 0 0 0 0 0 0 0 12.0171 0 0 0 0 13.2784 0 0 11.3887 0 0 0 0 0 0 0 11.5593 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0165 0 0 11.4063 0 0 0 0 11.2226 0 0 0 0 0 0 0 10.5803 Q86SG4 DPCA2_HUMAN "Putative Dresden prostate carcinoma protein 2, D-PCa-2 (High mobility group nucleosome-binding domain-containing protein 2 pseudogene 46)" HMGN2P46 C15orf21 Homo sapiens (Human) chromatin organization [GO:0006325] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin organization [GO:0006325] GO:0003682; GO:0005634; GO:0006325 chromatin binding [GO:0003682] AEQCEEEEAMTPR 0.99365 -5.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N184 ZN567_HUMAN Zinc finger protein 567 ZNF567 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] HTCNECGK 0.99365 -14.11 0 0 10.3861 0 0 0 0 0 0 0 13.4383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9635 0 0 0 0 0 0 12.5551 0 0 0 0 11.3348 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0001 0 13.2672 0 0 0 0 0 0 12.7751 0 0 0 0 14.2677 0 0 0 0 0 11.6512 0 0 0 12.1065 12.3468 0 0 0 0 0 0 0 0 0 0 0 10.8696 0 10.749 13.2078 0 0 0 0 12.4279 12.4756 0 0 12.4419 12.5746 0 0 12.0177 0 0 0 0 0 13.3108 0 0 0 0 13.8881 13.3741 0 0 0 0 12.5462 0 0 0 0 0 0 11.3235 13.1723 0 0 0 0 0 0 0 0 0 0 11.399 0 0 0 16.9859 0 0 12.4724 13.073 0 12.6709 0 12.421 0 0 0 0 0 0 0 12.1728 0 0 0 Q8N6G5 CGAT2_HUMAN "Chondroitin sulfate N-acetylgalactosaminyltransferase 2, EC 2.4.1.174 (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, GalNAcT-2)" CSGALNACT2 CHGN2 GALNACT2 PRO0082 Homo sapiens (Human) "chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]" Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] "Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050653]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0050652]; proteoglycan biosynthetic process [GO:0030166]" GO:0000139; GO:0008376; GO:0016020; GO:0030166; GO:0030173; GO:0030206; GO:0032580; GO:0046872; GO:0047237; GO:0047238; GO:0050650; GO:0050651; GO:0050652; GO:0050653 acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; metal ion binding [GO:0046872] ADLTEYRHVTLFRPFGPLMK 0.99365 -14.117 0 0 0 0 0 0 0 0 0 13.0284 0 0 0 0 0 0 0 11.1962 0 0 0 0 0 0 0 10.7758 0 0 11.1261 0 0 10.823 0 0 11.9373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9574 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6093 12.8171 0 0 0 0 0 0 14.656 0 0 0 0 11.8106 0 0 12.7131 0 0 0 0 11.7695 13.093 0 0 0 0 0 0 0 0 0 11.2144 12.7694 0 0 0 0 0 0 0 0 0 0 0 12.7814 11.1674 0 0 0 11.7333 0 11.7129 12.2156 0 0 15.4232 0 0 0 15.2857 0 0 14.4802 0 0 10.5104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3434 Q96AQ6 PBIP1_HUMAN Pre-B-cell leukemia transcription factor-interacting protein 1 (Hematopoietic PBX-interacting protein) PBXIP1 HPIP Homo sapiens (Human) "articular cartilage development [GO:0061975]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; gene expression involved in extracellular matrix organization [GO:1901148]; hemopoiesis [GO:0030097]; histone H3-K56 acetylation [GO:0097043]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of Wnt signaling pathway [GO:0030177]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001106]" chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor binding [GO:0140297]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; articular cartilage development [GO:0061975]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; gene expression involved in extracellular matrix organization [GO:1901148]; hemopoiesis [GO:0030097]; histone H3-K56 acetylation [GO:0097043]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of Wnt signaling pathway [GO:0030177]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001106]" GO:0000785; GO:0002532; GO:0003713; GO:0003714; GO:0005634; GO:0005667; GO:0005829; GO:0005874; GO:0007155; GO:0016020; GO:0016477; GO:0022617; GO:0030097; GO:0030154; GO:0030177; GO:0045892; GO:0061975; GO:0097043; GO:0140297; GO:1901148; GO:1902732; GO:2001106 DNA-binding transcription factor binding [GO:0140297]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] ARLQGLEADCVR 0.99365 -5.1416 0 0 0 0 0 0 0 0 0 13.2796 0 13.5928 13.2411 0 12.6568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0355 0 0 0 0 12.9046 0 0 13.0264 0 0 0 0 0 12.5545 0 13.0876 0 0 12.8022 0 0 0 0 0 12.1693 0 0 0 0 10.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1452 0 0 0 0 0 0 0 0 0 0 0 12.2072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JN8 NEUL4_HUMAN Neuralized-like protein 4 NEURL4 KIAA1787 Homo sapiens (Human) centriole [GO:0005814]; cytoplasm [GO:0005737] centriole [GO:0005814]; cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630] GO:0005737; GO:0005814; GO:0061630 ubiquitin protein ligase activity [GO:0061630] ALSPEGALR 0.99365 -37.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2873 16.8149 16.0829 15.3691 15.8635 15.6014 0 0 14.3073 0 13.179 13.3695 13.2416 0 13.6736 0 0 0 0 0 0 0 0 12.9026 0 12.4142 0 0 11.2063 0 0 12.7359 0 0 12.1929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2522 13.0107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7902 12.9772 0 11.1779 0 0 0 0 0 0 0 0 0 13.2159 13.0255 11.2786 0 0 0 0 0 0 11.2333 0 0 0 0 13.0293 0 0 0 13.1151 0 0 0 0 0 0 0 0 0 13.0465 0 0 12.2159 0 0 0 0 0 0 0 0 0 Q96R09 OR5B2_HUMAN Olfactory receptor 5B2 (OST073) (Olfactory receptor OR11-240) OR5B2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] EVQNAFKKVLR 0.99365 -5.1559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9746 0 0 0 0 0 0 0 0 0 0 0 12.7532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9741 0 0 0 0 0 0 0 0 0 Q99623 PHB2_HUMAN Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity) PHB2 BAP REA Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; intracellular estrogen receptor signaling pathway [GO:0030520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mammary gland epithelial cell proliferation [GO:0033598]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]" axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991] "axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; amide binding [GO:0033218]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; intracellular estrogen receptor signaling pathway [GO:0030520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mammary gland epithelial cell proliferation [GO:0033598]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; response to wounding [GO:0009611]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062]" GO:0000423; GO:0002639; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005886; GO:0006606; GO:0007005; GO:0007062; GO:0007202; GO:0008022; GO:0009611; GO:0009986; GO:0014069; GO:0016363; GO:0016477; GO:0023035; GO:0030331; GO:0030424; GO:0030520; GO:0031536; GO:0032991; GO:0033147; GO:0033218; GO:0033598; GO:0033600; GO:0035632; GO:0039529; GO:0042113; GO:0042802; GO:0042803; GO:0043066; GO:0043433; GO:0045892; GO:0046625; GO:0046982; GO:0047485; GO:0048786; GO:0050821; GO:0051091; GO:0060744; GO:0060749; GO:0060762; GO:0070374; GO:0071300; GO:0071456; GO:0071944; GO:0098978; GO:0098982; GO:0140374; GO:1900208; GO:1901224; GO:1902808; GO:1904959; GO:1990051 amide binding [GO:0033218]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; sphingolipid binding [GO:0046625] DFSLILDDVAITELSFSR 0.99365 -14.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0164 0 0 0 0 11.2646 0 0 0 0 11.9436 0 0 0 0 0 0 0 0 17.5849 0 0 0 0 0 0 0 0 0 0 0 12.4355 0 0 0 15.4821 0 0 0 0 0 0 13.159 0 0 0 0 0 12.2001 0 0 11.5333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2627 0 0 0 0 0 13.8227 0 0 0 0 0 0 0 Q9H9Y2 RPF1_HUMAN Ribosome production factor 1 (Brix domain-containing protein 5) (Ribosome biogenesis protein RPF1) RPF1 BXDC5 Homo sapiens (Human) maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364] "nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364]" GO:0000460; GO:0000470; GO:0003723; GO:0005730; GO:0006364; GO:0030687; GO:0042134 RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134] FTLKLRSLQK 0.99365 -6.5095 0 9.92346 0 12.0932 0 0 0 11.9556 19.9647 15.5003 16.4194 16.0012 16.4118 16.0173 19.925 13.687 14.4379 13.9916 11.9932 13.1318 12.3542 11.5452 12.9862 0 13.7618 13.3378 19.2439 15.4263 19.737 19.8317 19.8662 19.7647 14.0741 15.152 13.918 15.3031 13.2064 12.9677 14.9046 14.7894 19.7645 19.7913 19.7648 19.7536 15.5055 13.045 13.8356 19.803 14.529 15.2172 13.3001 13.6923 11.6366 16.4291 19.8526 19.709 19.5291 19.5041 15.7563 18.5522 18.2788 18.4351 18.2331 18.0831 18.3524 18.5952 0 0 10.6471 20.9139 0 0 0 0 0 0 0 13.6266 0 0 0 0 14.3734 13.107 0 0 0 12.7206 0 0 13.744 0 0 0 13.6194 13.319 0 0 0 12.3873 0 0 14.2336 0 0 0 0 15.4606 0 13.3629 0 15.033 15.4769 0 0 0 0 0 0 0 0 0 13.02 0 0 15.4628 0 0 0 13.7638 0 0 12.6473 13.6772 12.0718 0 13.7808 13.9406 0 14.2296 15.7278 13.6124 13.6 0 13.6253 15.2538 0 15.8928 0 0 11.8881 0 0 0 0 0 20.1651 20.2718 16.6448 17.244 15.7637 20.3065 17.5866 16.8807 20.2992 20.2347 15.8313 17.3228 17.5531 17.4687 20.2744 13.5771 15.3873 0 0 20.4365 17.2252 20.3522 0 0 Q9ULM2 ZN490_HUMAN Zinc finger protein 490 ZNF490 KIAA1198 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSCPTYLR 0.99365 -6.9783 0 0 0 0 0 0 0 0 0 0 0 12.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9073 0 0 0 0 0 0 12.5858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6574 15.8654 0 16.8173 16.7658 0 13.0623 12.5011 0 15.1678 12.1263 0 13.3408 0 0 14.572 0 0 11.3695 14.8555 0 0 13.9176 0 15.5909 0 0 0 14.6055 0 0 0 13.4179 0 0 13.5293 0 0 0 14.6121 15.4811 0 13.5506 10.7612 15.628 13.3221 0 0 0 0 14.5152 0 0 13.2764 0 13.7808 14.6147 0 16.204 0 0 0 0 0 0 0 11.8796 0 0 0 10.2369 0 0 0 13.2454 0 0 12.7062 13.4294 0 11.2484 0 13.7257 0 13.0073 0 0 12.5938 14.3628 0 0 0 14.7451 15.0873 0 0 0 0 13.4095 Q13464 ROCK1_HUMAN "Rho-associated protein kinase 1, EC 2.7.11.1 (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I, ROCK-I) (p160 ROCK-1, p160ROCK)" ROCK1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; motor neuron apoptotic process [GO:0097049]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; podocyte cell migration [GO:0090521]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatase activity [GO:0010922]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939] bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774] bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; motor neuron apoptotic process [GO:0097049]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; podocyte cell migration [GO:0090521]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatase activity [GO:0010922]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament-based process [GO:0032970]; regulation of amyloid-beta formation [GO:1902003]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939] GO:0000139; GO:0000281; GO:0001726; GO:0001837; GO:0003180; GO:0003383; GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005737; GO:0005814; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007159; GO:0007165; GO:0007249; GO:0007266; GO:0010494; GO:0010506; GO:0010508; GO:0010613; GO:0010628; GO:0010922; GO:0016525; GO:0018105; GO:0018107; GO:0019828; GO:0022614; GO:0030027; GO:0030036; GO:0030155; GO:0030334; GO:0030866; GO:0031032; GO:0031175; GO:0031267; GO:0032059; GO:0032060; GO:0032091; GO:0032956; GO:0032970; GO:0034774; GO:0035306; GO:0035509; GO:0042326; GO:0043410; GO:0045616; GO:0045664; GO:0046872; GO:0048156; GO:0048598; GO:0050321; GO:0050900; GO:0050901; GO:0051045; GO:0051451; GO:0051492; GO:0051893; GO:0051894; GO:0061157; GO:0070168; GO:0070507; GO:0071559; GO:0072518; GO:0072659; GO:0090521; GO:0097049; GO:0097746; GO:0106310; GO:0110061; GO:0140058; GO:1900223; GO:1900242; GO:1901888; GO:1902003; GO:1902430; GO:1902992; GO:1903140; GO:1903347; GO:1905205; GO:1990776; GO:2000114; GO:2000145; GO:2000672 aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] AEQENEKR 0.99366 -29.051 0 0 0 11.7768 12.7378 0 0 13.3877 0 0 12.2854 0 0 0 0 12.7559 16.2784 16.896 16.6188 16.7584 16.49 13.4034 15.8842 0 16.7239 16.5352 16.9957 16.6137 16.5252 16.526 0 11.7452 12.5257 12.6301 0 0 0 0 15.7897 12.3665 16.4924 16.4074 16.687 16.7336 12.7875 16.4609 16.5911 16.4944 16.4648 16.7743 16.6451 16.7243 0 16.6314 16.696 16.6684 0 0 0 0 16.0082 16.1622 0 0 0 0 13.58 13.4455 13.607 17.8944 13.6231 18.1274 17.7597 0 17.8018 13.6003 0 13.9026 12.9114 13.3688 12.7632 15.1513 0 18.3835 14.3234 18.5912 19.8742 0 18.7583 18.7274 18.9012 18.2972 18.746 18.7737 18.2869 17.8965 17.1081 18.9062 19.2003 18.8084 0 18.6817 18.76 18.6107 16.2311 18.34 18.2408 18.6492 18.7261 20.1722 16.5163 19.0081 18.3731 19.3018 18.7311 18.6695 18.6043 18.7372 18.3423 18.717 18.4134 18.4667 18.762 18.7923 18.4302 18.4787 18.3562 18.4618 0 12.8066 0 0 12.8676 14.4222 16.9883 18.7636 18.7657 18.4448 0 16.6381 18.696 18.7594 18.786 18.7548 18.7701 18.392 18.7131 18.7363 18.7487 18.3986 13.5975 18.4562 0 18.551 15.6303 18.5581 18.9078 13.0396 0 15.1875 14.5787 0 0 0 0 17.3297 16.8269 16.7939 16.8815 16.8075 18.7668 18.7685 18.7813 18.3997 18.9013 16.7998 16.7832 0 16.8369 0 P11137 MTAP2_HUMAN "Microtubule-associated protein 2, MAP-2" MAP2 Homo sapiens (Human) central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513]; regulation of protein localization [GO:0032880] apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769] apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513]; regulation of protein localization [GO:0032880] GO:0000226; GO:0001578; GO:0002162; GO:0005198; GO:0005516; GO:0005737; GO:0005829; GO:0005874; GO:0005875; GO:0008017; GO:0016358; GO:0021954; GO:0030425; GO:0030517; GO:0031113; GO:0031115; GO:0031175; GO:0032839; GO:0032880; GO:0043005; GO:0043025; GO:0043194; GO:0043198; GO:0043203; GO:0044294; GO:0044307; GO:0048156; GO:0048813; GO:0097441; GO:0150001; GO:0150002; GO:0150014; GO:1901953; GO:1902513; GO:1902737; GO:1903744; GO:1904527; GO:1990635; GO:1990769 calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156] AMTEPSALIEK 0.99366 -29.037 0 0 12.5875 14.3192 0 0 0 0 0 0 12.4541 0 11.1551 11.1381 0 0 0 13.0814 0 0 14.1265 0 0 0 0 11.9311 0 0 11.508 0 11.1009 11.3993 11.7838 0 0 0 0 0 0 0 0 0 0 0 0 12.1276 0 0 10.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.477 0 0 12.7234 0 0 0 0 14.2544 14.7189 11.4579 0 12.2494 0 13.0205 10.7266 16.6003 14.4602 0 14.1099 0 0 0 16.3497 14.6702 0 0 0 0 16.0804 0 14.9808 12.5112 0 0 13.9738 0 15.0227 0 0 11.8815 0 0 0 0 0 14.942 0 14.9026 12.5651 11.6973 0 14.9026 0 0 0 0 0 13.6698 0 13.4011 0 0 0 0 14.8408 15.3156 0 0 14.1704 0 0 0 0 14.7584 14.4802 13.0006 0 14.5259 12.8444 0 0 0 0 0 13.1443 0 0 0 10.6087 0 0 0 0 11.6126 0 0 0 13.4243 0 0 0 0 0 0 0 14.4994 13.9052 0 0 12.4363 0 O15382 BCAT2_HUMAN "Branched-chain-amino-acid aminotransferase, mitochondrial, BCAT(m), EC 2.6.1.42 (Placental protein 18, PP18)" BCAT2 BCATM BCT2 ECA40 Homo sapiens (Human) branched-chain amino acid biosynthetic process [GO:0009082]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; leucine biosynthetic process [GO:0009098]; lipid metabolic process [GO:0006629]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-leucine:2-oxoglutarate aminotransferase activity [GO:0050048]; L-valine transaminase activity [GO:0052655]; branched-chain amino acid biosynthetic process [GO:0009082]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; leucine biosynthetic process [GO:0009098]; lipid metabolic process [GO:0006629]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099] GO:0004084; GO:0005654; GO:0005739; GO:0005759; GO:0006550; GO:0006629; GO:0009082; GO:0009098; GO:0009099; GO:0010817; GO:0050048; GO:0052654; GO:0052655; GO:0052656; GO:1990830 branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-leucine:2-oxoglutarate aminotransferase activity [GO:0050048]; L-valine transaminase activity [GO:0052655] ALEEGRVR 0.99366 -6.5311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4699 0 15.2365 11.613 0 0 0 0 0 0 14.9765 0 0 0 0 0 0 0 0 13.5056 0 0 0 0 0 0 13.6209 0 0 13.3819 0 16.6429 0 12.7731 0 13.6076 0 0 0 13.3202 0 0 0 0 0 0 13.0153 0 0 0 0 18.2144 0 0 0 13.4265 0 0 0 0 13.2678 0 0 0 0 0 0 12.6228 0 0 0 0 0 14.0696 0 0 0 0 0 0 13.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6715 0 0 O75509 TNR21_HUMAN Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358) TNFRSF21 DR6 UNQ437/PRO868 Homo sapiens (Human) adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852] axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852] GO:0001783; GO:0002250; GO:0005737; GO:0005886; GO:0005887; GO:0006915; GO:0006959; GO:0007413; GO:0030424; GO:0030889; GO:0031226; GO:0031642; GO:0032693; GO:0032696; GO:0032714; GO:0042130; GO:0042552; GO:0048713; GO:0050852; GO:0051402; GO:0071356; GO:0097252 GKEDVNK 0.99366 -5.1759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0334 13.0801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3676 0 0 0 0 12.2818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1134 0 11.0092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01031 CO5_HUMAN Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain ] C5 CPAMD4 Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of angiogenesis [GO:0045766]; positive regulation of chemokine production [GO:0032722]; positive regulation of immune response [GO:0050778]; positive regulation of vascular endothelial growth factor production [GO:0010575]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; chemokine activity [GO:0008009]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102]; cell surface receptor signaling pathway [GO:0007166]; chemotaxis [GO:0006935]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of angiogenesis [GO:0045766]; positive regulation of chemokine production [GO:0032722]; positive regulation of immune response [GO:0050778]; positive regulation of vascular endothelial growth factor production [GO:0010575]" GO:0001701; GO:0004866; GO:0005102; GO:0005576; GO:0005579; GO:0005615; GO:0005886; GO:0006935; GO:0006954; GO:0006956; GO:0006957; GO:0006958; GO:0007166; GO:0007186; GO:0008009; GO:0010575; GO:0010760; GO:0019835; GO:0032722; GO:0045766; GO:0050778; GO:0070062 chemokine activity [GO:0008009]; endopeptidase inhibitor activity [GO:0004866]; signaling receptor binding [GO:0005102] ARYFYNK 0.99366 -29.009 0 0 0 0 0 0 0 0 0 0 12.6091 0 10.0884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5124 10.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1762 11.3609 13.7068 0 0 0 0 0 0 0 0 0 12.4656 0 0 0 12.7363 0 0 0 0 0 12.5138 0 0 0 0 0 12.1685 0 0 11.8282 0 13.1471 0 12.7568 0 0 0 12.7305 0 0 0 0 0 0 14.5584 0 0 0 0 0 0 0 0 0 0 0 13.2152 0 11.573 0 0 0 0 13.4794 11.1443 0 0 11.8629 0 0 0 0 0 0 0 0 0 0 0 0 19.7685 0 0 0 0 0 0 0 0 0 0 0 0 12.5829 0 0 0 0 0 0 12.4353 0 0 0 11.9885 0 0 13.4579 0 0 0 0 0 0 0 0 0 0 11.4304 0 9.86278 0 0 P10827 THA_HUMAN "Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (V-erbA-related protein 7, EAR-7) (c-erbA-1) (c-erbA-alpha)" THRA EAR7 ERBA1 NR1A1 THRA1 THRA2 Homo sapiens (Human) "cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; erythrocyte differentiation [GO:0030218]; female courtship behavior [GO:0008050]; hormone-mediated signaling pathway [GO:0009755]; learning or memory [GO:0007611]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of female receptivity [GO:0045925]; positive regulation of thyroid hormone mediated signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of lipid catabolic process [GO:0050994]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cold [GO:0009409]; thyroid gland development [GO:0030878]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; type I pneumocyte differentiation [GO:0060509]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001502; GO:0001503; GO:0002154; GO:0002155; GO:0002157; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007611; GO:0008016; GO:0008050; GO:0008270; GO:0009409; GO:0009755; GO:0017025; GO:0017055; GO:0019904; GO:0030154; GO:0030218; GO:0030878; GO:0031490; GO:0033032; GO:0042789; GO:0044877; GO:0045892; GO:0045925; GO:0045944; GO:0050994; GO:0060509; GO:0070324; GO:0090575; GO:0120162; GO:0140296; GO:2000143 "chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; TBP-class protein binding [GO:0017025]; thyroid hormone binding [GO:0070324]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]" ATGYHYRCITCEGCK 0.99366 -27.512 0 0 0 0 0 0 0 0 0 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.988 0 0 0 0 0 0 0 0 0 0 0 0 12.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4341 0 0 0 0 0 11.5584 12.3233 0 12.2376 0 0 12.5516 0 0 0 0 0 0 12.8644 0 0 0 0 0 0 0 0 0 0 14.5618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6618 0 0 0 0 0 10.2161 0 0 0 0 0 0 0 P17038 ZNF43_HUMAN Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27) ZNF43 KOX27 ZNF39 ZNF39L1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ATLRRYK 0.99366 -13.447 0 0 0 0 0 0 0 0 0 11.0464 0 0 0 0 0 0 0 11.1197 0 0 0 0 9.47994 0 0 0 0 0 0 0 0 0 11.2628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2868 0 0 0 12.0251 12.2431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8906 11.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35568 IRS1_HUMAN "Insulin receptor substrate 1, IRS-1" IRS1 Homo sapiens (Human) cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; signal transduction [GO:0007165] GO:0001784; GO:0005068; GO:0005080; GO:0005158; GO:0005159; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005899; GO:0005901; GO:0007165; GO:0008284; GO:0008286; GO:0010907; GO:0014065; GO:0030159; GO:0032000; GO:0032868; GO:0032869; GO:0042169; GO:0042593; GO:0043231; GO:0043434; GO:0043548; GO:0043552; GO:0045725; GO:0046326; GO:0046627; GO:0046628; GO:0046676; GO:0048009; GO:0071398 insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] ADPQGCR 0.99366 -27.665 0 0 0 0 0 11.832 0 0 0 0 0 13.1475 0 13.6563 0 0 0 0 0 12.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7996 0 0 0 0 0 0 0 0 0 14.0305 0 0 0 0 0 13.1922 0 0 0 0 0 0 0 0 13.6204 0 0 0 13.7662 14.7695 0 0 0 0 0 0 0 0 0 0 0 0 12.8191 0 0 0 0 15.1791 0 0 17.7888 0 0 13.3068 0 13.052 0 13.3591 0 13.1938 0 0 0 0 0 0 0 0 17.8534 17.8771 17.0428 0 0 0 0 15.7824 0 14.7437 0 15.1721 0 0 0 16.0234 0 0 0 17.527 0 12.9951 0 0 0 0 0 P42679 MATK_HUMAN "Megakaryocyte-associated tyrosine-protein kinase, EC 2.7.10.2 (CSK homologous kinase, CHK) (Hematopoietic consensus tyrosine-lacking kinase) (Protein kinase HYL) (Tyrosine-protein kinase CTK)" MATK CTK HYL Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468] GO:0004713; GO:0004715; GO:0005524; GO:0005829; GO:0006468; GO:0008284; GO:0016020 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713] LLGVILHQGLYIVMEHVSK 0.99366 -27.668 0 0 0 0 0 0 0 0 0 0 0 12.5424 0 0 0 0 0 0 0 0 13.3133 0 11.952 0 0 0 0 0 12.1693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0753 0 0 0 0 0 0 0 0 0 0 0 12.1409 12.9061 0 0 0 0 0 0 0 0 0 0 13.2386 0 0 0 0 0 0 0 0 12.3959 0 0 0 0 0 0 0 0 0 12.6214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4218 0 0 0 0 0 0 12.4332 0 0 0 12.4435 0 0 0 0 0 0 0 12.4443 0 0 0 12.4114 0 0 0 0 0 0 0 13.5666 0 0 13.7598 12.5078 13.5022 0 0 0 0 0 0 0 12.1982 0 0 P49754 VPS41_HUMAN Vacuolar protein sorting-associated protein 41 homolog (S53) VPS41 Homo sapiens (Human) cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630] clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal HOPS complex [GO:1902501]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; late endosome to lysosome transport [GO:1902774]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192] GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005798; GO:0005829; GO:0006623; GO:0008017; GO:0008333; GO:0009267; GO:0010008; GO:0015630; GO:0016020; GO:0016192; GO:0016236; GO:0030136; GO:0030897; GO:0031901; GO:0031902; GO:0034058; GO:0035542; GO:0042802; GO:0046872; GO:0048193; GO:1902501; GO:1902774 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017] DKIVLLMDFDSEK 0.99366 -27.575 0 0 12.5323 0 0 0 0 0 10.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8052 0 0 11.1919 0 0 0 0 0 0 10.3315 0 0 12.1258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6342 0 0 0 0 0 0 0 0 0 10.9488 0 0 0 0 12.5123 0 0 14.1118 0 0 0 0 0 0 0 0 0 0 11.9478 0 13.497 0 0 0 0 13.9979 0 0 0 0 0 0 0 0 0 0 0 0 13.849 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0487 0 0 0 0 13.8601 0 0 0 0 0 0 0 12.3758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59773 MNARL_HUMAN Major intrinsically disordered NOTCH2-binding receptor 1-like (Membrane integral NOTCH2-associated receptor 2) MINAR2 KIAA1024L Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 EEKQEKHSK 0.99366 -7.9674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8723 0 0 0 0 0 0 11.211 0 0 0 10.7742 0 0 0 10.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3649 0 0 0 0 0 0 0 14.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8916 0 14.1864 0 0 0 0 14.1313 0 14.1798 0 0 0 0 0 13.8645 0 0 0 0 11.8113 0 13.3967 14.0359 0 14.026 0 0 0 14.0882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1374 0 0 0 0 0 0 0 0 11.6709 0 0 0 0 0 0 0 0 0 0 0 0 12.2774 12.2268 10.6748 0 0 P83436 COG7_HUMAN "Conserved oligomeric Golgi complex subunit 7, COG complex subunit 7 (Component of oligomeric Golgi complex 7)" COG7 UNQ3082/PRO10013 Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; trans-Golgi network membrane [GO:0032588] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; trans-Golgi network membrane [GO:0032588]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0000301; GO:0005730; GO:0005794; GO:0006486; GO:0006886; GO:0006890; GO:0007030; GO:0017119; GO:0032588; GO:0033365; GO:0034067; GO:0043231; GO:0050821; GO:0070085 EAASGKADGHAATLVMK 0.99366 -14.216 0 11.0454 0 0 0 0 0 0 0 11.8649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0936 0 0 0 0 0 0 0 0 0 0 10.6831 0 0 0 0 0 0 0 0 0 0 0 0 11.5963 0 0 0 0 11.0713 0 0 0 0 0 0 0 0 0 10.8921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8754 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7537 13.2347 0 0 0 0 0 0 0 0 0 12.5656 0 0 0 0 12.3107 0 0 0 0 0 0 0 0 0 14.5029 12.9301 0 0 12.4846 0 0 0 12.4364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4107 0 0 0 0 12.5293 0 0 0 0 0 P98153 IDD_HUMAN Integral membrane protein DGCR2/IDD DGCR2 IDD KIAA0163 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cognition [GO:0050890] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cognition [GO:0050890] GO:0007155; GO:0009887; GO:0016020; GO:0016021; GO:0030246; GO:0050890 carbohydrate binding [GO:0030246] CNPGQFACR 0.99366 -14.215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3408 12.4568 12.1675 0 12.7703 0 12.4626 12.383 0 0 11.3044 0 0 0 0 0 12.6688 0 0 0 0 0 0 11.424 11.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07812 BAX_HUMAN "Apoptosis regulator BAX (Bcl-2-like protein 4, Bcl2-L-4)" BAX BCL2L4 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in mammary gland involution [GO:0060057]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell apoptotic process [GO:1904019]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; motor neuron apoptotic process [GO:0097049]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of reproductive process [GO:2000243]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; supramolecular fiber organization [GO:0097435]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068] BAK complex [GO:0097145]; BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930] BAK complex [GO:0097145]; BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in mammary gland involution [GO:0060057]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell apoptotic process [GO:1904019]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; motor neuron apoptotic process [GO:0097049]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of reproductive process [GO:2000243]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; supramolecular fiber organization [GO:0097435]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068] GO:0001541; GO:0001764; GO:0001777; GO:0001782; GO:0001783; GO:0001822; GO:0001836; GO:0001844; GO:0001974; GO:0002262; GO:0002352; GO:0002358; GO:0002904; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0006687; GO:0006808; GO:0006915; GO:0006919; GO:0007281; GO:0008053; GO:0008289; GO:0008625; GO:0008630; GO:0008635; GO:0008637; GO:0009566; GO:0009636; GO:0009651; GO:0010248; GO:0010332; GO:0010524; GO:0010917; GO:0015267; GO:0016020; GO:0018105; GO:0021854; GO:0021987; GO:0030544; GO:0031334; GO:0032091; GO:0032469; GO:0032471; GO:0032976; GO:0033137; GO:0033599; GO:0034620; GO:0034644; GO:0035234; GO:0042475; GO:0042802; GO:0042803; GO:0042981; GO:0043065; GO:0043524; GO:0043525; GO:0043653; GO:0045136; GO:0046666; GO:0046930; GO:0046982; GO:0048087; GO:0048147; GO:0048515; GO:0048597; GO:0048678; GO:0048873; GO:0051087; GO:0051209; GO:0051281; GO:0051434; GO:0051726; GO:0051881; GO:0060011; GO:0060041; GO:0060057; GO:0060058; GO:0060068; GO:0060402; GO:0070059; GO:0070062; GO:0070242; GO:0070584; GO:0072332; GO:0090200; GO:0097049; GO:0097136; GO:0097144; GO:0097145; GO:0097190; GO:0097191; GO:0097192; GO:0097193; GO:0097296; GO:0097435; GO:0098586; GO:1900103; GO:1902262; GO:1902263; GO:1902445; GO:1902512; GO:1903896; GO:1904019; GO:1904037; GO:1990117; GO:2000243; GO:2000673; GO:2001234; GO:2001244 BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] DGSGEQPR 0.99366 -6.5319 0 0 0 0 0 0 0 0 0 14.2303 13.39 0 0 0 13.7321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2422 0 0 0 0 0 11.5771 13.9301 0 0 0 0 0 0 0 0 11.9083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7949 14.5769 0 0 13.5245 13.8402 0 14.0692 0 0 0 0 0 0 0 0 13.8369 13.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3001 0 0 0 0 0 0 Q12912 IRAG2_HUMAN "Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2 ]" IRAG2 JAW1 LRMP Homo sapiens (Human) immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005815; GO:0005886; GO:0005887; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0016021; GO:0035577 microtubule binding [GO:0008017] FISTYSWADAEEEKCELK 0.99366 -27.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6356 0 0 0 14.8927 14.7085 0 0 0 0 0 0 17.3846 17.4427 17.3791 16.1027 0 0 0 15.7294 21.2734 17.1395 0 0 0 0 18.6628 0 0 0 14.1951 14.4826 14.5087 0 0 0 0 0 0 0 0 0 18.2053 17.4317 0 16.5503 12.0465 0 0 0 15.7252 0 13.226 0 13.7601 17.5237 12.6381 0 0 18.0992 0 0 0 19.3529 0 0 0 17.5303 0 0 0 0 0 0 18.2926 14.4001 12.9161 16.783 0 0 0 0 0 0 12.3901 0 0 17.0147 12.7982 0 0 0 10.9714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15035 TRAM2_HUMAN Translocating chain-associated membrane protein 2 TRAM2 KIAA0057 Homo sapiens (Human) "collagen biosynthetic process [GO:0032964]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" integral component of endoplasmic reticulum membrane [GO:0030176] "integral component of endoplasmic reticulum membrane [GO:0030176]; collagen biosynthetic process [GO:0032964]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" GO:0006616; GO:0030176; GO:0032964; GO:0045048 ISKRLHLSK 0.99366 -7.0006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5181 Q5THJ4 VP13D_HUMAN Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) VPS13D KIAA0453 Homo sapiens (Human) lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898] extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623] GO:0006623; GO:0006869; GO:0007005; GO:0019898; GO:0045053; GO:0070062; GO:1901526 AITCAELVLDVSPK 0.99366 -27.437 0 16.7658 0 0 14.2136 14.5093 0 0 0 0 0 0 0 0 0 0 0 0 12.4605 11.9545 13.8399 0 0 11.8349 0 0 12.6806 0 0 0 0 0 0 0 12.4679 0 0 13.0208 0 0 0 0 15.0526 0 0 0 11.793 0 0 0 0 0 0 0 0 11.3852 0 0 0 0 0 0 0 0 15.1505 0 13.0454 0 0 0 0 0 0 0 14.3202 15.0319 13.3676 14.1941 16.1197 13.8994 15.5877 13.8927 0 0 0 0 0 13.7795 0 15.6048 0 13.6316 15.8527 0 0 0 0 14.1075 14.8236 13.6574 14.7318 14.16 15.3016 15.8626 14.5626 13.7383 12.9816 14.4664 14.3732 12.7243 11.9218 0 12.5622 12.944 13.9277 13.4684 14.9389 13.1108 15.5475 16.169 16.3487 16.6022 17.0471 16.6124 14.3536 15.2868 14.4934 14.4017 13.3164 15.2807 15.6081 15.1056 15.3049 15.3496 13.5804 14.9072 12.5779 15.635 15.4727 15.0196 13.7168 0 14.4484 12.6956 15.8561 14.4244 18.2391 12.1875 0 0 14.249 15.3615 0 14.9307 13.7605 13.6631 15.3708 0 0 0 0 0 0 0 12.8419 13.8675 0 0 0 0 0 0 15.7557 0 15.4402 0 0 0 15.0329 0 Q6I9Y2 THOC7_HUMAN "THO complex subunit 7 homolog (Functional spliceosome-associated protein 24, fSAP24) (Ngg1-interacting factor 3-like protein 1-binding protein 1, NIF3L1-binding protein 1) (hTREX30)" THOC7 NIF3L1BP1 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784] GO:0000346; GO:0000347; GO:0000445; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0006406; GO:0008380; GO:0016607; GO:0046784 RNA binding [GO:0003723] LLIDGDGAGDDR 0.99366 -7.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6249 0 0 0 0 0 0 0 0 0 0 0 0 12.8406 0 0 0 0 0 0 12.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2983 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4718 0 12.9308 0 0 0 0 0 0 0 0 0 0 12.4763 0 0 11.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0306 0 0 12.9932 0 0 0 0 0 0 0 0 12.0415 0 0 0 0 0 0 0 0 0 0 0 0 Q6NX49 ZN544_HUMAN Zinc finger protein 544 ZNF544 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNRSTQLIRHLQIHTGEK 0.99366 -14.216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7689 0 0 0 0 0 0 11.4077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8664 0 0 0 0 12.4267 0 0 12.7979 11.9806 13.7327 0 13.4222 13.468 0 0 0 0 0 0 0 0 0 12.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.225 0 0 0 0 0 0 0 0 0 0 0 0 13.5614 0 0 0 0 0 0 0 0 0 Q6ZMY3 SPOC1_HUMAN SPOC domain-containing protein 1 SPOCD1 Homo sapiens (Human) "cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" chromosome [GO:0005694]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; DNA methylation [GO:0006306]; gene silencing by RNA [GO:0031047]; negative regulation of transposition [GO:0010529]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0005694; GO:0006306; GO:0006351; GO:0007283; GO:0010529; GO:0030154; GO:0031047 AQLVSGHSCRLVQALPTVIR 0.99366 -27.589 0 0 0 0 11.8269 0 0 0 0 0 0 0 0 0 13.2768 0 0 0 0 0 0 0 0 0 0 0 0 10.5935 0 0 0 0 12.5148 13.4042 0 0 0 0 0 0 0 0 0 0 0 12.1273 0 0 0 0 0 12.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1648 0 0 0 0 10.7062 0 0 12.2449 0 0 0 0 0 0 13.0995 0 0 0 0 0 0 0 0 0 0 0 0 11.7529 0 0 0 0 0 11.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1873 11.5719 0 0 0 0 0 0 0 0 0 0 12.2147 14.0177 0 0 0 0 0 0 13.5968 11.7284 0 14.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5042 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1411 0 0 0 0 13.4301 0 0 0 0 0 0 0 Q86UK0 ABCAC_HUMAN "Glucosylceramide transporter ABCA12, EC 7.6.2.1 (ATP-binding cassette sub-family A member 12) (ATP-binding cassette transporter 12, ATP-binding cassette 12)" ABCA12 ABC12 Homo sapiens (Human) cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; cholesterol efflux [GO:0033344]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658] cytoplasm [GO:0005737]; cytosol [GO:0005829]; epidermal lamellar body [GO:0097209]; epidermal lamellar body membrane [GO:0097234]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658]; ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]; cellular homeostasis [GO:0019725]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; cholesterol efflux [GO:0033344]; corneocyte desquamation [GO:0003336]; establishment of skin barrier [GO:0061436]; intracellular protein transport [GO:0006886]; keratinization [GO:0031424]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lung alveolus development [GO:0048286]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of intracellular lipid transport [GO:0032379]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of keratinocyte differentiation [GO:0045616]; secretion by cell [GO:0032940]; surfactant homeostasis [GO:0043129] GO:0000139; GO:0003336; GO:0005102; GO:0005319; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006672; GO:0006869; GO:0006886; GO:0010875; GO:0016021; GO:0019725; GO:0030658; GO:0031424; GO:0032379; GO:0032940; GO:0033344; GO:0033700; GO:0034040; GO:0034191; GO:0035627; GO:0042626; GO:0043129; GO:0043231; GO:0045055; GO:0045616; GO:0048286; GO:0055088; GO:0061178; GO:0061436; GO:0072659; GO:0097209; GO:0097234; GO:0140326; GO:0140359; GO:2000010 ABC-type transporter activity [GO:0140359]; apolipoprotein A-I receptor binding [GO:0034191]; ATP binding [GO:0005524]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102] CCGSPFYLKEAFGDGYHLTLTKK 0.99366 -29.024 0 0 0 0 0 0 13.0562 10.8899 0 0 0 0 0 13.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6718 0 0 0 12.3664 0 10.6911 0 0 0 0 0 0 12.3613 0 13.0146 0 0 0 0 0 0 0 0 10.4125 0 0 0 0 0 0 0 0 0 10.9608 0 0 0 13.9352 13.3882 0 0 11.8184 11.3936 14.1887 0 13.2865 0 0 0 13.2104 0 0 0 0 0 0 0 11.2653 13.0426 12.7166 0 14.3669 0 0 0 12.5533 0 0 0 14.6324 0 14.5762 0 0 0 11.2545 11.826 0 0 0 0 0 0 0 0 0 0 0 13.7812 12.419 0 0 0 0 0 0 0 0 0 12.2953 11.9519 14.5077 11.4248 0 12.0997 13.5188 0 14.4234 0 0 0 11.9809 14.034 0 13.3773 0 0 0 0 10.6353 0 13.3887 0 0 0 0 0 0 12.5909 0 0 0 0 0 0 0 0 0 12.3591 0 0 0 12.5952 0 0 0 0 0 0 0 15.4386 Q8N9T8 KRI1_HUMAN Protein KRI1 homolog KRI1 Homo sapiens (Human) "endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]" 90S preribosome [GO:0030686]; nucleolus [GO:0005730] "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]" GO:0000447; GO:0003723; GO:0005730; GO:0030686 RNA binding [GO:0003723] AKKQEELK 0.99366 -28.953 0 12.3864 0 0 0 0 11.2404 0 10.1619 12.2725 0 12.3412 12.6742 0 0 13.9005 12.9307 0 0 0 0 0 0 0 0 0 0 0 12.1777 0 0 0 11.7967 0 0 0 12.6278 0 0 0 12.5642 0 14.0611 13.3618 13.0292 12.3891 12.9359 0 11.5752 14.1264 0 12.5951 14.2747 14.2164 0 0 0 13.5879 12.693 0 12.8894 0 0 0 0 0 13.2304 0 0 12.2364 12.8095 0 14.7668 13.9432 0 0 14.0187 15.5286 15.7878 14.7928 15.4547 15.0848 0 14.0086 13.5143 0 0 16.486 14.9237 17.7144 16.6073 17.4417 15.4552 16.5824 16.0271 16.483 17.7454 15.2791 0 12.4174 15.5112 12.6111 15.3751 15.6145 15.3816 14.8996 14.1062 13.2754 15.0261 15.5431 15.101 0 16.657 14.1589 13.7794 14.3288 13.3703 15.4005 14.9231 15.1914 0 14.836 16.1054 16.1904 16.1586 14.1626 12.6348 0 13.0184 0 15.5568 15.5623 12.8344 0 14.3935 13.4189 14.7482 14.3214 16.9744 15.6278 15.6653 13.0481 0 0 13.1995 14.1615 13.66 0 0 13.1269 15.7451 15.3407 13.6695 15.1321 13.7259 13.045 15.4584 14.3475 0 13.2592 14.3916 0 0 13.9147 0 0 0 0 0 0 0 12.9255 14.2493 14.7658 14.1201 0 0 0 13.5231 13.9472 Q8NCD3 HJURP_HUMAN Holliday junction recognition protein (14-3-3-associated AKT substrate) (Fetal liver-expressing gene 1 protein) (Up-regulated in lung cancer 9) HJURP FAKTS FLEG1 URLC9 Homo sapiens (Human) cell cycle [GO:0007049]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA binding [GO:0051101]; regulation of protein-containing complex assembly [GO:0043254] "chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]; CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA binding [GO:0051101]; regulation of protein-containing complex assembly [GO:0043254]" GO:0000775; GO:0000776; GO:0003677; GO:0005654; GO:0005730; GO:0005739; GO:0007049; GO:0007059; GO:0034080; GO:0042393; GO:0042802; GO:0043254; GO:0051101 DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802] AKSLSEAFENLGK 0.99366 -7.0117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2989 0 0 0 0 0 0 15.6121 0 0 0 0 0 0 14.7145 0 0 0 0 0 0 0 0 15.3438 0 0 0 0 0 0 0 15.5421 0 0 0 0 14.7181 0 0 0 11.8083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4544 0 0 0 0 0 0 0 0 0 0 0 0 14.814 0 14.5627 0 0 0 15.4325 0 0 Q8NFH8 REPS2_HUMAN RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2) REPS2 POB1 Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermal growth factor receptor signaling pathway [GO:0007173]; protein-containing complex assembly [GO:0065003] cytosol [GO:0005829] cytosol [GO:0005829]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermal growth factor receptor signaling pathway [GO:0007173]; protein-containing complex assembly [GO:0065003] GO:0005509; GO:0005829; GO:0006897; GO:0007173; GO:0016197; GO:0065003 calcium ion binding [GO:0005509] EANAVLARLNSELQQQLK 0.99366 -6.526 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3766 0 0 0 0 0 0 0 0 0 0 0 13.4351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4268 0 0 0 0 0 0 0 0 0 10.5497 0 0 0 0 0 0 0 0 0 0 0 12.7757 11.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3328 0 0 Q8NFM4 ADCY4_HUMAN "Adenylate cyclase type 4, EC 4.6.1.1 (ATP pyrophosphate-lyase 4) (Adenylate cyclase type IV) (Adenylyl cyclase 4)" ADCY4 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556] GO:0004016; GO:0005080; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007188; GO:0007189; GO:0016020; GO:0030425; GO:0035556; GO:0046872 adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080] AEEEDEK 0.99366 -27.569 0 0 0 0 0 0 0 0 0 0 16.9665 0 16.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7801 17.0912 17.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9988 0 0 0 0 10.0053 0 0 0 0 16.6661 0 0 0 0 0 16.4534 0 0 0 0 15.8417 0 0 12.18 0 0 0 0 0 12.3249 0 0 0 0 0 0 11.9674 0 13.0313 0 0 0 0 0 0 0 0 0 16.8197 0 0 0 0 14.7396 0 0 12.1813 0 0 15.6769 0 0 0 12.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1874 0 0 0 12.1142 0 0 0 11.65 0 12.6083 14.0978 0 0 12.8296 0 0 0 12.4609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6608 12.1999 12.7152 12.6541 0 0 0 12.982 0 0 11.96 13.2554 0 12.9165 0 0 0 0 Q8TCA0 LRC20_HUMAN Leucine-rich repeat-containing protein 20 LRRC20 UNQ2429/PRO4989 Homo sapiens (Human) LAAMPALRSINLR 0.99366 -5.1825 13.3246 0 0 15.0517 0 15.3526 13.5588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6528 0 0 0 0 0 0 0 0 0 0 15.1585 0 14.9896 15.8541 0 0 0 0 14.962 0 14.8817 0 14.3548 14.7639 0 15.0093 0 14.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1729 0 0 0 0 0 0 13.8122 0 0 0 11.7756 0 0 0 0 0 12.4025 0 0 0 0 13.3942 0 0 0 0 14.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6705 0 0 0 13.3801 0 0 0 0 0 0 0 0 Q8WUY9 DEP1B_HUMAN DEP domain-containing protein 1B (HBV X-transactivated gene 8 protein) (HBV XAg-transactivated protein 8) DEPDC1B XTP8 Homo sapiens (Human) cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; positive regulation of Wnt signaling pathway [GO:0030177] GTPase activator activity [GO:0005096]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; positive regulation of Wnt signaling pathway [GO:0030177] GO:0005096; GO:0016477; GO:0030177; GO:0035556 GTPase activator activity [GO:0005096] CSQNFGPEVTR 0.99366 -7.0059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.581 0 0 0 0 0 0 0 0 0 9.93951 12.929 0 0 0 0 0 0 10.0291 0 0 0 0 0 0 0 0 0 0 0 0 12.9288 0 0 0 0 0 0 0 14.1779 0 0 13.8636 13.3228 0 0 0 0 0 0 0 10.4531 15.9548 0 0 0 0 0 0 9.98442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5823 12.3353 0 0 0 0 0 0 0 0 9.67513 0 10.8488 11.6358 0 0 10.2495 0 0 0 0 0 0 Q92615 LAR4B_HUMAN La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5) LARP4B KIAA0217 LARP5 Homo sapiens (Human) positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of translation [GO:0045727] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of translation [GO:0045727] GO:0003723; GO:0003730; GO:0005730; GO:0005829; GO:0010494; GO:0016020; GO:0042788; GO:0045727; GO:1905870 mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723] EISESTPVEEVEALFKGDNLPK 0.99366 -28.993 0 0 0 0 0 0 0 0 11.5366 10.5101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4718 0 0 0 15.2281 15.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1688 0 0 0 0 0 0 0 12.2393 0 11.7746 0 0 13.7636 0 12.5416 0 0 0 0 0 13.1894 0 0 Q96S52 PIGS_HUMAN GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein) PIGS UNQ1873/PRO4316 Homo sapiens (Human) attachment of GPI anchor to protein [GO:0016255] endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; attachment of GPI anchor to protein [GO:0016255] GO:0005789; GO:0016020; GO:0016255; GO:0042765 ASLPYSQISGLNALQLRLMVPVTVVFTR 0.99366 -6.5328 0 0 10.6716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6716 0 0 0 11.6484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.204 0 0 0 0 11.9865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2424 0 0 0 0 0 0 0 0 13.5028 12.9243 0 0 0 0 0 0 11.2411 0 0 Q9BYB0 SHAN3_HUMAN "SH3 and multiple ankyrin repeat domains protein 3, Shank3 (Proline-rich synapse-associated protein 2, ProSAP2)" SHANK3 KIAA1650 PROSAP2 PSAP2 Homo sapiens (Human) "adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" anchoring junction [GO:0070161]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069] "anchoring junction [GO:0070161]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]" GO:0000165; GO:0003779; GO:0005829; GO:0007416; GO:0007612; GO:0007613; GO:0008022; GO:0008270; GO:0014069; GO:0017124; GO:0021773; GO:0030160; GO:0030534; GO:0031234; GO:0032232; GO:0035176; GO:0035255; GO:0042297; GO:0043005; GO:0043197; GO:0043621; GO:0044309; GO:0045794; GO:0048170; GO:0048854; GO:0051835; GO:0051968; GO:0060170; GO:0060997; GO:0060999; GO:0061001; GO:0070161; GO:0071625; GO:0097107; GO:0097110; GO:0097113; GO:0097114; GO:0097117; GO:1900271; GO:1900273; GO:1900451; GO:1900452; GO:2000463; GO:2000969 actin binding [GO:0003779]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160]; zinc ion binding [GO:0008270] ETPSYAKRR 0.99366 -27.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2218 10.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2385 11.7927 0 0 14.6242 16.7387 0 11.1514 0 13.6413 0 11.4622 0 0 12.5781 0 0 0 0 0 0 0 0 11.3677 0 0 0 0 0 0 12.4322 13.2537 0 0 0 0 13.3224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8445 0 15.1206 14.5486 0 14.8434 12.4349 0 0 0 0 0 0 0 0 0 0 0 11.053 0 Q9H2S1 KCNN2_HUMAN "Small conductance calcium-activated potassium channel protein 2, SK2, SKCa 2, SKCa2 (KCa2.2)" KCNN2 Homo sapiens (Human) ion transport [GO:0006811]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018] cell surface [GO:0009986]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286]; ion transport [GO:0006811]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] GO:0005242; GO:0005516; GO:0005886; GO:0006811; GO:0006813; GO:0009986; GO:0015269; GO:0016021; GO:0016286; GO:0019904; GO:0030018; GO:0042803; GO:0043005; GO:0043025; GO:0043197; GO:0051393; GO:0071805; GO:0098914; GO:1901379 alpha-actinin binding [GO:0051393]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; small conductance calcium-activated potassium channel activity [GO:0016286] ALFEKRK 0.99366 -27.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4397 13.1789 0 15.4242 13.8125 14.0172 0 0 0 0 0 0 0 0 0 0 0 13.4823 14.0036 0 0 0 13.5734 0 0 0 0 0 15.8122 0 14.3641 0 0 0 0 0 0 0 0 0 0 15.8284 0 0 0 13.502 0 0 15.6396 0 13.273 0 0 0 0 10.8203 0 0 0 0 0 0 0 0 0 15.4573 0 0 0 14.3698 0 0 0 12.1464 0 0 0 0 0 0 0 0 11.792 0 0 0 0 0 13.5486 12.8893 0 0 0 0 0 14.0739 0 0 0 0 0 0 14.5738 0 0 Q9H7Z7 PGES2_HUMAN "Prostaglandin E synthase 2, EC 5.3.99.3 (Membrane-associated prostaglandin E synthase-2, mPGE synthase-2) (Microsomal prostaglandin E synthase 2, mPGES-2) (Prostaglandin-H(2) E-isomerase) [Cleaved into: Prostaglandin E synthase 2 truncated form ]" PTGES2 C9orf15 PGES2 Homo sapiens (Human) "cyclooxygenase pathway [GO:0019371]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; secretion [GO:0046903]" azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220]; cyclooxygenase pathway [GO:0019371]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; secretion [GO:0046903]" GO:0000139; GO:0003677; GO:0005576; GO:0005634; GO:0005739; GO:0005829; GO:0006629; GO:0006749; GO:0016021; GO:0016829; GO:0019371; GO:0020037; GO:0035578; GO:0036134; GO:0043295; GO:0045893; GO:0046903; GO:0048471; GO:0050220 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220] GSPRLLGAAALALGGALGLYHTARWHLR 0.99366 -7.9682 0 0 0 0 0 0 0 11.1414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.166 0 0 0 0 11.9913 0 0 12.0744 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7063 0 0 0 0 0 0 0 0 0 13.1442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3919 0 0 0 0 13.8976 0 0 0 0 0 0 13.4929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULN7 PNM8B_HUMAN Paraneoplastic antigen-like protein 8B (PNMA-like protein 2) PNMA8B KIAA1183 PNMAL2 Homo sapiens (Human) AMSLLQDWCRSLDVDAHR 0.99366 -7.0025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2931 0 0 0 0 0 0 0 0 0 0 11.8925 0 0 0 0 0 0 11.4523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0475 0 0 0 0 0 0 15.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8042 0 0 0 0 0 0 0 0 Q9Y4C1 KDM3A_HUMAN "Lysine-specific demethylase 3A, EC 1.14.11.65 (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)" KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA Homo sapiens (Human) "androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; iron ion binding [GO:0005506]; nuclear androgen receptor binding [GO:0050681]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]" GO:0000118; GO:0000785; GO:0001673; GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0007290; GO:0009755; GO:0016020; GO:0030521; GO:0031490; GO:0032454; GO:0033169; GO:0036123; GO:0045893; GO:0045944; GO:0046293; GO:0050681; GO:0051573; GO:0120162; GO:0140683; GO:1990830; GO:2000036; GO:2000736 chromatin DNA binding [GO:0031490]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; iron ion binding [GO:0005506]; nuclear androgen receptor binding [GO:0050681]; transcription coregulator activity [GO:0003712] AGVNSDSPNNCSGK 0.99366 -27.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9696 14.5184 14.7694 11.2382 0 0 14.5522 13.7331 0 13.9067 0 13.0933 0 0 0 14.8161 11.7265 0 14.4511 0 0 0 0 0 0 0 0 0 0 0 15.3344 0 13.3778 0 0 0 0 0 0 14.2688 12.4906 11.4322 0 0 0 0 12.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3703 0 0 0 0 0 0 12.3802 0 0 14.352 0 0 0 0 0 0 0 11.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7012 Q9Y6D9 MD1L1_HUMAN "Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1, MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog, HsMAD1, hMAD1) (Tax-binding protein 181)" MAD1L1 MAD1 TXBP181 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538] GO:0000776; GO:0000922; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007094; GO:0042130; GO:0042802; GO:0043515; GO:0044615; GO:0048538; GO:0051220; GO:0051301; GO:0051315; GO:0072686; GO:0090235; GO:0090267; GO:1902426; GO:1990706; GO:1990728 identical protein binding [GO:0042802]; kinetochore binding [GO:0043515] AASTSAR 0.99366 -27.485 0 0 0 0 0 0 0 0 0 0 13.2417 0 13.4043 0 0 0 0 0 0 13.6491 0 0 0 0 13.3475 0 0 0 14.0536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5401 0 14.8938 0 0 0 0 0 0 0 12.6437 13.1595 11.3266 0 14.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.48353 0 0 12.7846 0 0 0 14.4532 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4249 0 0 0 0 0 0 0 13.0888 12.7539 0 0 0 0 0 14.3954 13.9173 0 0 0 0 0 0 0 12.9171 0 13.0954 0 0 0 14.7925 0 13.3243 0 0 0 0 0 0 15.1049 0 0 0 0 0 13.5955 0 0 0 0 0 0 0 0 0 10.9435 0 0 0 0 0 0 0 Q76NI1 KNDC1_HUMAN "Kinase non-catalytic C-lobe domain-containing protein 1, KIND domain-containing protein 1 (Cerebral protein 9) (Protein very KIND, v-KIND) (Ras-GEF domain-containing family member 2)" KNDC1 C10orf23 KIAA1768 RASGEF2 VKIND hucep-9 Homo sapiens (Human) cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204] dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; guanyl-nucleotide exchange factor activity [GO:0005085]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264] GO:0001934; GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773 guanyl-nucleotide exchange factor activity [GO:0005085] AALEYVAEPTLEPR 0.99367 -27.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5856 10.8037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0746 0 0 0 0 0 0 0 0 0 0 13.5864 0 0 0 0 0 13.8448 13.5298 0 0 0 0 0 0 0 0 0 0 13.6778 14.9998 12.0462 0 0 17.3734 11.1749 0 13.8952 13.8805 14.5167 0 0 0 0 16.5102 15.8263 0 0 0 11.8782 0 0 0 19.833 0 0 0 0 14.0851 0 0 0 0 16.1366 13.8458 0 12.8173 0 13.1024 16.0464 15.7689 0 0 15.9921 0 0 14.2065 13.6382 17.5487 0 0 18.1025 13.2024 0 14.3433 13.7901 13.9873 14.0608 12.6881 12.3498 17.5888 0 18.0375 0 0 0 18.3008 17.4266 0 0 0 13.0433 9.87883 0 14.2786 0 14.8007 13.0265 0 14.6516 0 0 15.7129 0 0 12.9574 13.335 0 0 9.07076 0 14.6978 15.0452 16.3903 13.2347 16.3145 16.6955 9.58128 0 0 0 13.7248 0 0 15.73 0 0 11.0789 0 A2RU49 HYKK_HUMAN "Hydroxylysine kinase, 5-hydroxy-L-lysine kinase, EC 2.7.1.81 (Aminoglycoside phosphotransferase domain-containing protein 1)" HYKK AGPHD1 Homo sapiens (Human) lysine catabolic process [GO:0006554]; phosphorylation [GO:0016310] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; amino acid kinase activity [GO:0019202]; hydroxylysine kinase activity [GO:0047992]; lysine catabolic process [GO:0006554]; phosphorylation [GO:0016310] GO:0005759; GO:0006554; GO:0016310; GO:0019202; GO:0047992 amino acid kinase activity [GO:0019202]; hydroxylysine kinase activity [GO:0047992] FHHPKLSSLHRENFIWNLK 0.99367 -15.895 0 0 0 0 0 0 0 0 0 11.2704 0 0 0 11.9156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0133 0 0 11.9645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7538 0 0 0 14.1423 0 0 0 12.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8794 0 0 0 0 0 0 0 0 13.9928 0 0 0 0 0 0 0 13.559 0 14.0062 13.6893 0 0 13.6072 0 0 0 0 0 0 13.5331 0 0 O75319 DUS11_HUMAN "RNA/RNP complex-1-interacting phosphatase, EC 3.1.3.- (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1)" DUSP11 PIR1 Homo sapiens (Human) polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396] fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396]" GO:0001650; GO:0003723; GO:0004651; GO:0004725; GO:0005634; GO:0005654; GO:0006396; GO:0006470; GO:0008138; GO:0016070; GO:0016607; GO:0016791; GO:0045171; GO:0098507; GO:0098519 "nucleotide phosphatase activity, acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]" CRGHCLER 0.99367 -13.143 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6636 0 0 0 13.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2805 0 0 0 0 0 0 0 0 14.6 0 13.1451 13.3225 0 0 0 12.3339 0 0 0 0 0 0 0 12.076 0 0 0 0 13.205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2737 0 P09543 CN37_HUMAN "2',3'-cyclic-nucleotide 3'-phosphodiesterase, CNP, CNPase, EC 3.1.4.37" CNP Homo sapiens (Human) adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202]; 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; aging [GO:0007568]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; microtubule cytoskeleton organization [GO:0000226]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762]" GO:0000226; GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005874; GO:0005886; GO:0005902; GO:0007268; GO:0007409; GO:0007568; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0021762; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0045202; GO:0046902; GO:0048471; GO:0048709; GO:0070062 "2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]" GGALQSCTII 0.99367 -7.7962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25686 DNJB2_HUMAN "DnaJ homolog subfamily B member 2 (Heat shock 40 kDa protein 3) (Heat shock protein J1, HSJ-1)" DNAJB2 HSJ1 HSPF3 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; neuron cellular homeostasis [GO:0070050]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; inclusion body [GO:0016234]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein binding [GO:0032091]; negative regulation of protein deubiquitination [GO:0090086]; neuron cellular homeostasis [GO:0070050]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein refolding [GO:0042026]; regulation of chaperone-mediated protein folding [GO:1903644]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0001671; GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0008285; GO:0016234; GO:0030308; GO:0030433; GO:0030544; GO:0031227; GO:0031396; GO:0031398; GO:0031593; GO:0031625; GO:0031965; GO:0032091; GO:0032436; GO:0032781; GO:0032880; GO:0042026; GO:0042406; GO:0043130; GO:0043161; GO:0048471; GO:0051082; GO:0051087; GO:0061077; GO:0070050; GO:0070628; GO:0090084; GO:0090086; GO:0098554; GO:0140036; GO:1903644 ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-dependent protein binding [GO:0140036]; unfolded protein binding [GO:0051082] ALQWHPDK 0.99367 -15.862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1915 0 0 0 0 0 0 0 0 0 11.9524 0 11.6526 0 0 0 0 0 0 0 10.0143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7063 0 0 0 0 12.2934 11.896 0 12.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P33240 CSTF2_HUMAN "Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit, CSTF 64 kDa subunit, CstF-64)" CSTF2 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cellular response to nerve growth factor stimulus [GO:1990090]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] GO:0003723; GO:0003729; GO:0005654; GO:0005847; GO:0006378; GO:0016604; GO:0071920; GO:0098789; GO:1990090 mRNA binding [GO:0003729]; RNA binding [GO:0003723] GIDARGMEARAMEAR 0.99367 -9.1562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.161 0 0 0 0 0 0 0 14.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9032 0 0 0 0 P81408 F189B_HUMAN Protein FAM189B (Protein COTE1) FAM189B C1orf2 COTE1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; WW domain binding [GO:0050699] GO:0016021; GO:0050699 WW domain binding [GO:0050699] GPFEESPLPRR 0.99367 -15.892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8734 0 0 16.5441 0 16.5662 0 16.2323 0 16.7758 12.6825 0 0 16.1001 0 13.656 0 0 0 0 0 0 0 0 10.896 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0672 0 0 0 12.9637 12.4996 0 0 0 11.3272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P1W5 CA094_HUMAN Uncharacterized protein C1orf94 C1orf94 Homo sapiens (Human) EPTGLSPFLLLPPRPPPARPDK 0.99367 -7.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0809 11.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7636 0 0 0 13.245 0 0 0 0 11.468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8336 0 13.4525 0 0 0 12.8469 12.7099 0 0 0 0 0 0 0 0 0 12.3015 13.4329 0 0 12.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0587 0 11.2388 0 0 0 0 0 13.284 13.4534 0 0 12.7364 0 0 0 12.9084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0768 0 0 0 13.319 12.7343 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN79 Z705A_HUMAN Zinc finger protein 705A ZNF705A Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ESALKKK 0.99367 -27.86 0 0 0 0 0 0 0 0 10.1374 0 0 0 0 0 0 0 0 0 13.1416 0 0 0 0 0 0 16.5084 0 0 11.2128 0 0 0 0 0 0 0 0 10.2684 10.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1731 0 0 0 0 0 0 0 0 0 10.8969 15.1495 0 0 15.1355 13.2793 12.8973 0 11.4451 0 15.2059 0 15.0687 0 0 0 0 15.1068 15.0487 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2124 0 0 0 13.6774 13.9734 0 13.3714 0 0 0 0 0 0 11.6025 0 0 0 14.1354 12.0071 0 0 0 0 0 0 0 0 0 13.9112 15.1208 11.1548 0 18.8647 0 0 0 0 0 0 0 0 0 12.8898 11.2395 0 0 0 0 0 0 0 0 0 12.4694 0 0 0 0 0 0 0 0 0 0 0 12.0904 0 0 Q8IUR6 CRERF_HUMAN "CREB3 regulatory factor (Luman recruitment factor, LRF)" CREBRF C5orf41 Homo sapiens (Human) negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of intracellular transport [GO:0032388]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein transport [GO:0051222]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of endoplasmic reticulum unfolded protein response [GO:1900102]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of intracellular transport [GO:0032388]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein transport [GO:0051222]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]" GO:0000122; GO:0000977; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006986; GO:0016604; GO:0032388; GO:0034976; GO:0045732; GO:0045944; GO:0051222; GO:1900102 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DYVKKAK 0.99367 -15.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9019 0 0 0 0 0 0 11.1991 0 0 0 0 0 0 0 0 12.7935 0 0 0 0 0 12.5656 0 13.6535 0 0 11.4138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0531 0 0 0 0 0 0 0 0 0 0 12.8558 0 0 0 0 0 0 0 Q8N614 TM156_HUMAN Transmembrane protein 156 TMEM156 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ITWYILVLLVFIFLIILTIR 0.99367 -13.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.364 0 11.4959 0 0 0 0 0 0 11.0733 0 13.1006 0 0 0 0 11.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8963 0 16.5078 15.724 15.4327 0 14.6695 0 9.72363 15.5285 0 0 0 0 0 0 14.9381 0 0 0 0 12.8949 0 0 14.2647 0 0 0 0 0 0 15.2232 0 0 0 0 0 0 10.5867 0 0 0 0 0 0 11.2743 0 0 0 0 0 0 0 14.6749 12.8936 0 0 0 13.9737 0 13.2101 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4128 0 13.0862 13.2367 0 0 12.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.801 0 0 10.3787 0 0 0 0 0 Q8NFD2 ANKK1_HUMAN "Ankyrin repeat and protein kinase domain-containing protein 1, EC 2.7.11.1 (Protein kinase PKK2) (Sugen kinase 288, SgK288) (X-kinase)" ANKK1 PKK2 SGK288 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of cell cycle process [GO:0010564] cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of cell cycle process [GO:0010564] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0010564; GO:0042995; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALQLSDRKNLVPR 0.99367 -27.855 0 0 0 0 0 0 13.3771 0 0 0 0 11.0244 0 0 0 0 0 0 0 0 14.2837 0 13.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1969 0 0 0 0 0 0 11.91 14.1478 0 0 0 0 0 0 0 0 0 0 11.0484 0 0 14.3859 12.7124 13.1208 0 15.5463 11.5945 0 0 0 0 11.0023 0 0 0 0 0 0 0 0 0 16.2829 0 0 0 14.7376 0 0 0 0 0 0 0 13.3389 0 0 0 0 0 0 0 0 0 0 0 0 12.0151 11.1843 14.8144 0 0 0 14.1409 0 0 13.9812 14.3078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1956 0 0 0 0 0 0 0 0 0 0 0 13.317 Q8NFU5 IPMK_HUMAN "Inositol polyphosphate multikinase, EC 2.7.1.140, EC 2.7.1.151, EC 2.7.1.153 (Inositol 1,3,4,6-tetrakisphosphate 5-kinase)" IPMK IMPK Homo sapiens (Human) inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; phosphorylation [GO:0016310] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; phosphorylation [GO:0016310]" GO:0000823; GO:0000824; GO:0000825; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008440; GO:0016301; GO:0016310; GO:0032957; GO:0032958; GO:0043647; GO:0046872; GO:0046934; GO:0047326; GO:0051765; GO:0052812; GO:0070266; GO:0097243; GO:0102732 "ATP binding [GO:0005524]; flavonoid binding [GO:0097243]; inositol tetrakisphosphate 3-kinase activity [GO:0000824]; inositol tetrakisphosphate 5-kinase activity [GO:0047326]; inositol tetrakisphosphate 6-kinase activity [GO:0000825]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; inositol-1,4,5-trisphosphate 6-kinase activity [GO:0000823]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity [GO:0102732]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" FFHNGYCLR 0.99367 -13.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TA86 RP9_HUMAN "Retinitis pigmentosa 9 protein (Pim-1-associated protein, PAP-1)" RP9 Homo sapiens (Human) cognition [GO:0050890]; RNA splicing [GO:0008380] nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785] nucleus [GO:0005634]; signal recognition particle receptor complex [GO:0005785]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cognition [GO:0050890]; RNA splicing [GO:0008380] GO:0003723; GO:0005634; GO:0005785; GO:0008380; GO:0046872; GO:0050890 metal ion binding [GO:0046872]; RNA binding [GO:0003723] DVRIQQLK 0.99367 -7.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDN2 KCNV2_HUMAN Potassium voltage-gated channel subfamily V member 2 (Voltage-gated potassium channel subunit Kv8.2) KCNV2 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805 voltage-gated potassium channel activity [GO:0005249] GQTVGSVGKVGQVLRVMR 0.99367 -7.7892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CS4 ZN689_HUMAN Zinc finger protein 689 ZNF689 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0035914; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHSGECPYVCDQCGKRFSQR 0.99367 -15.878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7672 0 0 0 0 0 0 9.36083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2716 0 0 0 12.7288 0 0 0 0 0 13.1509 0 0 0 0 11.4043 0 0 0 0 0 0 0 15.5961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5715 0 0 0 0 0 0 0 0 0 0 12.0026 0 0 0 0 0 0 14.2757 0 0 0 0 0 14.2137 0 0 13.3765 0 0 0 0 0 0 0 0 10.6775 0 0 0 12.8741 Q96PB7 NOE3_HUMAN Noelin-3 (Olfactomedin-3) (Optimedin) OLFM3 NOE3 UNQ1924/PRO4399 Homo sapiens (Human) eye photoreceptor cell development [GO:0042462]; signal transduction [GO:0007165] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]; eye photoreceptor cell development [GO:0042462]; signal transduction [GO:0007165] GO:0005615; GO:0005794; GO:0007165; GO:0032281; GO:0042462; GO:0045202; GO:0070161 MSPPLLK 0.99367 -13.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4416 0 16.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S66 CLCC1_HUMAN Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1) CLCC1 KIAA0761 MCLC Homo sapiens (Human) chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nuclear membrane [GO:0031965] chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; nuclear membrane [GO:0031965]; chloride channel activity [GO:0005254] GO:0000139; GO:0005254; GO:0005783; GO:0005789; GO:0016020; GO:0031965; GO:0034707; GO:0043231; GO:0044233 chloride channel activity [GO:0005254] ALMKEIPALLHLPVLIIMALAILSFCYGAGK 0.99367 -7.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7163 0 0 0 0 0 0 12.5817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8981 0 0 0 0 0 0 12.8579 0 0 0 0 13.2505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXW6 OSBL1_HUMAN "Oxysterol-binding protein-related protein 1, ORP-1, OSBP-related protein 1" OSBPL1A ORP1 OSBP8 OSBPL1 OSBPL1B Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; cholesterol metabolic process [GO:0008203]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232] cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; cholesterol binding [GO:0015485]; phospholipid binding [GO:0005543]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; cholesterol metabolic process [GO:0008203]; vesicle-mediated transport [GO:0016192] GO:0005543; GO:0005768; GO:0005770; GO:0005829; GO:0006699; GO:0008203; GO:0015248; GO:0015485; GO:0016020; GO:0016192; GO:0032934; GO:0043231; GO:0044232; GO:0070062 cholesterol binding [GO:0015485]; phospholipid binding [GO:0005543]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] HILVGNKVIYKALK 0.99367 -7.8046 0 0 0 0 0 0 0 0 0 0 10.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4282 0 0 0 0 0 15.8577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7282 0 0 0 0 0 0 0 0 0 0 12.0221 0 0 0 0 0 0 Q9H0C1 ZMY12_HUMAN Zinc finger MYND domain-containing protein 12 ZMYND12 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] GRRLCCEVCEAPAER 0.99367 -9.1428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBT7 ZN287_HUMAN Zinc finger protein 287 (Zinc finger protein with KRAB and SCAN domains 13) ZNF287 ZKSCAN13 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001817; GO:0005634; GO:0006357; GO:0045893; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ATFNHVSYGIVHRKILPGEK 0.99367 -15.872 0 0 0 0 0 0 0 0 0 0 12.7636 13.031 0 0 0 0 0 0 0 0 0 0 0 0 12.2991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1066 0 0 0 0 12.5291 0 0 0 0 0 12.4443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5949 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7508 0 0 0 0 0 12.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.882 0 0 0 0 0 0 16.5176 0 0 0 0 0 0 13.69 13.1955 0 0 0 0 0 0 0 0 0 0 0 12.2605 0 0 0 Q9NZN5 ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF) ARHGEF12 KIAA0382 LARG Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062 G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] ETRRIFLEFHQFFLDR 0.99367 -29.458 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4418 0 0 0 0 0 0 11.6431 0 12.7632 0 0 12.7494 0 0 0 0 0 0 0 0 0 0 0 0 13.0326 0 0 0 11.5019 0 0 0 0 0 10.3969 0 0 0 11.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9005 12.4104 0 0 13.8167 0 13.7546 0 0 0 0 0 0 0 0 12.9987 0 0 0 0 12.9721 11.1468 0 0 11.8909 16.3514 0 0 0 0 0 0 0 12.9154 0 0 0 0 11.8668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6751 0 14.1813 0 0 0 0 0 0 0 0 0 12.7723 0 12.3664 0 12.7122 13.0292 0 0 0 12.7647 0 0 0 0 0 0 0 0 0 0 0 13.076 0 0 13.1423 14.0967 13.2893 12.7143 0 0 12.6064 0 0 0 0 11.1118 0 0 0 0 0 0 0 0 0 0 Q9Y3Y2 CHTOP_HUMAN "Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein, SRAG)" CHTOP C1orf77 FOP HT031 PP7704 Homo sapiens (Human) in utero embryonic development [GO:0001701]; mRNA export from nucleus [GO:0006406]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of helicase activity [GO:0051096]; positive regulation of histone methylation [GO:0031062] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; in utero embryonic development [GO:0001701]; mRNA export from nucleus [GO:0006406]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of helicase activity [GO:0051096]; positive regulation of histone methylation [GO:0031062] GO:0000346; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006406; GO:0008284; GO:0008327; GO:0016607; GO:0031062; GO:0032781; GO:0036464; GO:0051096 methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GAIGGRGLPIIQR 0.99367 -15.915 0 0 0 0 0 10.8888 0 0 0 11.4201 0 0 11.806 11.3643 0 0 0 0 0 0 0 0 0 0 0 14.6375 11.1674 0 0 0 0 0 0 0 0 12.294 0 11.5267 0 0 0 0 0 0 0 11.5203 0 0 12.7429 0 0 14.8444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.837 0 0 0 11.2594 14.0518 0 0 0 14.518 12.157 13.0222 0 0 0 0 12.6366 0 0 0 0 0 0 0 0 0 12.4126 0 0 12.7046 0 0 0 0 0 0 0 0 12.558 0 0 14.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3572 0 0 0 0 0 0 12.3061 0 0 0 0 0 12.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1287 0 0 0 0 0 0 0 15.7542 14.4716 14.8377 14.9887 16.0489 15.1889 0 0 0 0 0 0 0 13.1953 11.2198 15.059 0 0 Q9Y5I3 PCDA1_HUMAN "Protocadherin alpha-1, PCDH-alpha-1" PCDHA1 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005576; GO:0005783; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] DINDNPPVFRGR 0.99367 -7.7879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.66 0 0 13.7038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B2RBV5 MRUPP_HUMAN "Putative MORF4 family-associated protein 1-like protein UPP (Unnamed protein product, UPP)" Homo sapiens (Human) regulation of cell cycle [GO:0051726] regulation of cell cycle [GO:0051726] GO:0051726 AHWRARR 0.99368 -8.7425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1571 13.9959 0 13.8841 0 0 14.2903 14.0071 0 14.0671 0 0 0 0 0 14.3398 14.1956 0 0 0 0 0 0 0 0 0 0 13.7185 0 0 0 0 13.8424 13.0141 0 0 14.1867 13.8962 0 13.5691 0 0 14.0482 0 14.1681 0 0 0 0 0 0 14.4982 14.1176 0 0 0 0 0 0 0 13.7905 0 0 0 0 0 0 13.5025 0 0 0 0 0 0 13.4264 0 13.8733 0 0 0 0 0 0 0 11.8671 0 0 0 0 0 0 0 0 12.5129 0 0 0 0 0 0 0 0 O00221 IKBE_HUMAN "NF-kappa-B inhibitor epsilon, NF-kappa-BIE (I-kappa-B-epsilon, IkB-E, IkB-epsilon, IkappaBepsilon)" NFKBIE IKBE Homo sapiens (Human) cytoplasmic sequestering of transcription factor [GO:0042994] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; cytoplasmic sequestering of transcription factor [GO:0042994] GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0042994 AGRPLCQADPQPGKAAR 0.99368 -8.7456 0 0 12.4274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8339 14.1025 14.1622 0 0 0 0 14.8643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2404 0 12.9555 13.821 0 0 13.4176 0 0 0 0 0 0 12.0662 0 0 16.5619 16.702 16.513 0 18.0525 0 16.3986 0 0 0 0 0 0 15.0946 0 0 0 0 18.2471 0 0 0 0 0 0 14.675 0 0 0 0 0 14.4381 0 14.312 0 15.6532 0 13.9552 0 13.8515 0 0 13.993 0 13.4875 0 0 0 0 0 0 14.2621 0 0 14.6326 0 0 0 14.4291 14.5561 0 14.4288 14.0876 0 0 11.958 0 0 10.7189 13.7407 0 14.0811 0 0 0 0 0 0 0 0 0 0 12.2368 0 0 0 0 0 0 13.9836 12.4515 11.8463 0 0 0 0 0 0 O15460 P4HA2_HUMAN "Prolyl 4-hydroxylase subunit alpha-2, 4-PH alpha-2, EC 1.14.11.2 (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)" P4HA2 UNQ290/PRO330 Homo sapiens (Human) peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401] GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0018401; GO:0031418; GO:0043231 electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656] APQLLIAPFK 0.99368 -7.8355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3826 0 13.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7674 0 0 0 0 0 0 0 14.2907 13.1146 0 0 12.7054 0 0 0 0 0 0 12.8546 0 0 0 0 0 0 13.2314 12.761 0 0 0 0 12.6261 12.3225 0 0 0 0 0 0 13.4676 0 0 0 0 0 0 0 0 0 14.4899 0 0 0 0 0 0 0 0 0 0 14.2924 0 13.6743 0 0 0 0 0 0 O43781 DYRK3_HUMAN "Dual specificity tyrosine-phosphorylation-regulated kinase 3, EC 2.7.12.1 (Regulatory erythroid kinase, REDK)" DYRK3 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; erythrocyte differentiation [GO:0030218]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; nuclear speck organization [GO:0035063]; organelle disassembly [GO:1903008]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; protein phosphorylation [GO:0006468]; regulation of cellular response to stress [GO:0080135]; regulation of TORC1 signaling [GO:1903432]; stress granule disassembly [GO:0035617]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cell cycle [GO:0007049]; cell division [GO:0051301]; erythrocyte differentiation [GO:0030218]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; nuclear speck organization [GO:0035063]; organelle disassembly [GO:1903008]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; protein phosphorylation [GO:0006468]; regulation of cellular response to stress [GO:0080135]; regulation of TORC1 signaling [GO:1903432]; stress granule disassembly [GO:0035617]" GO:0000242; GO:0000287; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0007049; GO:0010494; GO:0016607; GO:0018105; GO:0018107; GO:0030218; GO:0035063; GO:0035617; GO:0043066; GO:0043231; GO:0043518; GO:0051301; GO:0080135; GO:0106310; GO:1902751; GO:1903008; GO:1903432 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] APEIILGSR 0.99368 -13.93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6701 0 0 0 11.8482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7541 12.4272 0 14.8008 14.2005 0 0 0 0 15.0237 14.3654 0 0 0 0 0 0 0 13.3482 0 13.6353 0 14.5578 0 0 0 11.9943 12.8942 0 12.6945 0 12.4279 0 0 12.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6395 0 15.1657 0 14.7084 15.3888 14.7432 0 0 11.4013 14.3632 14.341 0 0 0 0 0 14.6585 15.2353 0 15.0328 0 13.475 14.0706 0 0 0 0 0 0 13.9164 0 0 14.5054 0 14.2767 0 0 0 0 11.3595 0 0 13.9269 0 0 0 0 0 0 0 0 0 13.8694 0 0 0 0 14.1445 0 O95069 KCNK2_HUMAN Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1) KCNK2 TREK TREK1 Homo sapiens (Human) cardiac ventricle development [GO:0003231]; cellular response to hypoxia [GO:0071456]; cochlea development [GO:0090102]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of cell death [GO:0010942]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; response to axon injury [GO:0048678]; response to mechanical stimulus [GO:0009612]; stabilization of membrane potential [GO:0030322] apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] apical plasma membrane [GO:0016324]; astrocyte projection [GO:0097449]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841]; cardiac ventricle development [GO:0003231]; cellular response to hypoxia [GO:0071456]; cochlea development [GO:0090102]; G protein-coupled receptor signaling pathway [GO:0007186]; memory [GO:0007613]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of cell death [GO:0010942]; positive regulation of cellular response to hypoxia [GO:1900039]; potassium ion transmembrane transport [GO:0071805]; response to axon injury [GO:0048678]; response to mechanical stimulus [GO:0009612]; stabilization of membrane potential [GO:0030322] GO:0003231; GO:0005634; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0007186; GO:0007613; GO:0008076; GO:0009612; GO:0009986; GO:0010942; GO:0015271; GO:0016324; GO:0019870; GO:0022841; GO:0030322; GO:0043025; GO:0044305; GO:0048678; GO:0060044; GO:0071456; GO:0071805; GO:0090102; GO:0097449; GO:1900039; GO:2000279 outward rectifier potassium channel activity [GO:0015271]; potassium channel inhibitor activity [GO:0019870]; potassium ion leak channel activity [GO:0022841] AGVAAPDLLDPK 0.99368 -7.8182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9403 0 0 0 0 11.0297 0 0 0 12.9078 0 0 0 0 12.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9843 0 0 0 0 0 16.3574 15.1919 0 0 0 0 0 14.9459 0 0 0 0 0 0 0 0 14.0895 0 12.6444 0 0 0 0 0 0 0 14.5312 0 0 0 0 0 0 0 13.903 0 0 0 0 0 0 12.759 0 0 0 0 0 0 13.1809 0 0 0 0 14.685 0 0 0 0 0 0 0 0 9.882 0 14.8182 0 0 0 10.8503 0 0 0 0 0 0 0 0 0 0 0 0 11.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95455 TGDS_HUMAN "dTDP-D-glucose 4,6-dehydratase, EC 4.2.1.46" TGDS Homo sapiens (Human) nucleotide-sugar metabolic process [GO:0009225] "dTDP-glucose 4,6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]" GO:0008460; GO:0009225 "dTDP-glucose 4,6-dehydratase activity [GO:0008460]" EFDESSPK 0.99368 -28.058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0549 0 0 13.8137 13.8264 0 0 0 0 0 0 0 12.9152 14.6003 0 0 0 0 12.5737 12.8412 0 12.5768 0 0 0 12.5882 0 0 0 0 0 0 0 0 12.0235 0 0 0 0 0 12.6932 13.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1625 0 0 12.9497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18615 NELFE_HUMAN "Negative elongation factor E, NELF-E (RNA-binding protein RD)" NELFE RD RDBP Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944] chromosome [GO:0005694]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] chromosome [GO:0005694]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000122; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005886; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0051571; GO:0070374 chromatin binding [GO:0003682]; RNA binding [GO:0003723] DRSHERNR 0.99368 -13.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.04128 0 0 0 0 0 0 0 0 0 0 0 0 15.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6975 15.8165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4798 13.446 0 0 13.0026 13.457 0 13.3082 0 0 0 0 0 0 0 0 0 12.4879 0 0 0 0 0 13.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5789 12.949 0 0 0 0 0 0 0 0 0 0 0 0 P35558 PCKGC_HUMAN "Phosphoenolpyruvate carboxykinase, cytosolic [GTP], PEPCK-C, EC 4.1.1.32 (Serine-protein kinase PCK1, EC 2.7.11.-)" PCK1 PEPCK1 Homo sapiens (Human) cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to potassium ion starvation [GO:0051365]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; regulation of lipid biosynthetic process [GO:0046890]; response to bacterium [GO:0009617]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to potassium ion starvation [GO:0051365]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; oxaloacetate metabolic process [GO:0006107]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of transcription from RNA polymerase II promoter in response to acidic pH [GO:0061402]; propionate catabolic process [GO:0019543]; regulation of lipid biosynthetic process [GO:0046890]; response to bacterium [GO:0009617]; response to insulin [GO:0032868]; response to lipid [GO:0033993]; response to starvation [GO:0042594] GO:0000287; GO:0004613; GO:0005525; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006006; GO:0006094; GO:0006107; GO:0009617; GO:0018105; GO:0019543; GO:0030145; GO:0031406; GO:0032868; GO:0032869; GO:0033993; GO:0042593; GO:0042594; GO:0043382; GO:0046327; GO:0046890; GO:0051365; GO:0061402; GO:0070062; GO:0070365; GO:0071333; GO:0071549; GO:0106264 carboxylic acid binding [GO:0031406]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein serine kinase activity (using GTP as donor) [GO:0106264] ASTKLTPIGYIPK 0.99368 -17.296 0 0 0 11.7082 0 0 0 0 12.3619 12.6157 0 12.4116 12.5656 0 0 0 0 0 0 0 0 0 0 0 12.6113 13.964 0 12.9924 0 0 0 0 0 0 0 0 12.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5811 0 0 0 0 0 11.5791 0 0 0 0 0 0 12.3177 10.4366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5494 0 0 0 0 0 0 0 13.3489 0 11.6884 0 0 0 0 0 12.4581 0 11.7264 10.3059 0 0 0 13.543 0 0 11.2597 0 0 12.0596 0 14.0375 0 0 0 0 0 0 0 0 0 0 11.5237 0 0 0 0 0 0 0 0 0 0 0 12.9463 13.2592 0 12.0842 0 0 0 0 0 0 0 P49023 PAXI_HUMAN Paxillin PXN Homo sapiens (Human) cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of stress fiber assembly [GO:0051496]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein phosphatase binding [GO:0019903]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of stress fiber assembly [GO:0051496]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001725; GO:0003712; GO:0005829; GO:0005875; GO:0005886; GO:0005911; GO:0005925; GO:0005938; GO:0007155; GO:0007160; GO:0007165; GO:0007172; GO:0007179; GO:0008013; GO:0017166; GO:0019903; GO:0030027; GO:0034446; GO:0034614; GO:0038191; GO:0043542; GO:0046872; GO:0051496; GO:0060396 beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein phosphatase binding [GO:0019903]; transcription coregulator activity [GO:0003712]; vinculin binding [GO:0017166] AYCRKDYFDMFAPK 0.99368 -6.82 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7361 0 0 0 0 0 0 0 0 0 13.5779 0 12.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50591 TNF10_HUMAN "Tumor necrosis factor ligand superfamily member 10 (Apo-2 ligand, Apo-2L) (TNF-related apoptosis-inducing ligand, Protein TRAIL) (CD antigen CD253)" TNFSF10 APO2L TRAIL Homo sapiens (Human) apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; male gonad development [GO:0008584]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; response to insulin [GO:0032868]; signal transduction [GO:0007165] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; TRAIL binding [GO:0045569]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; male gonad development [GO:0008584]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; response to insulin [GO:0032868]; signal transduction [GO:0007165] GO:0005102; GO:0005125; GO:0005164; GO:0005576; GO:0005887; GO:0006915; GO:0006955; GO:0007165; GO:0007267; GO:0008270; GO:0008584; GO:0032868; GO:0042802; GO:0043065; GO:0043123; GO:0043280; GO:0045569; GO:0070062; GO:0090200; GO:2001238 cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; TRAIL binding [GO:0045569]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270] DAEYGLYSIYQGGIFELKENDR 0.99368 -7.8133 0 0 0 0 12.4448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4682 0 0 0 0 0 0 12.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6742 0 0 0 0 0 11.9397 0 0 10.8509 0 0 0 0 0 0 0 0 11.5672 11.1614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52740 ZN132_HUMAN Zinc finger protein 132 ZNF132 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LFECSNCGK 0.99368 -17.295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0618 0 0 0 0 0 0 0 13.9674 0 0 14.9518 0 0 0 0 0 0 0 0 0 0 10.8466 0 0 0 0 0 0 0 11.5752 0 0 0 0 0 0 11.2565 15.1307 14.7961 0 0 0 0 0 13.3422 0 0 0 0 0 0 14.4025 14.5631 14.4622 0 0 0 0 0 0 11.1907 0 14.3917 0 0 13.9466 0 0 0 10.8717 0 0 0 0 0 0 14.3816 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3907 0 0 0 0 0 12.8799 0 0 0 0 0 0 0 0 P55008 AIF1_HUMAN "Allograft inflammatory factor 1, AIF-1 (Ionized calcium-binding adapter molecule 1) (Protein G1)" AIF1 G1 IBA1 Homo sapiens (Human) "actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cellular response to oxidative stress [GO:0034599]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178]" actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] "actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cellular response to oxidative stress [GO:0034599]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178]" GO:0001726; GO:0001774; GO:0001891; GO:0001934; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0010629; GO:0014739; GO:0016601; GO:0021549; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0031668; GO:0032587; GO:0032722; GO:0032755; GO:0032870; GO:0034599; GO:0042102; GO:0043066; GO:0043204; GO:0045429; GO:0048471; GO:0048661; GO:0048662; GO:0048678; GO:0050921; GO:0051015; GO:0051017; GO:0051384; GO:0051602; GO:0051764; GO:0071315; GO:0071346; GO:0071447; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406 actin filament binding [GO:0051015]; calcium ion binding [GO:0005509] KAISELP 0.99368 -9.1596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5298 0 0 0 0 0 0 0 0 0 0 0 13.2678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61011 SRP54_HUMAN "Signal recognition particle 54 kDa protein, SRP54, EC 3.6.5.-" SRP54 Homo sapiens (Human) "exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]" GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0006616; GO:0006617; GO:0008312; GO:0016607; GO:0019003; GO:0030593; GO:0030851; GO:0030942; GO:0031017; GO:0043021; GO:0045047 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] GSGVSTR 0.99368 -13.924 0 0 0 13.1103 13.1155 0 0 12.7502 0 0 0 0 0 0 0 0 0 0 11.4285 0 11.2822 0 11.581 0 13.6143 12.2082 13.4603 11.272 0 0 0 0 11.5334 0 0 0 0 0 10.7013 0 0 0 12.0172 0 11.7065 0 0 13.4886 0 0 0 12.0508 9.92702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6391 12.4189 12.1295 14.0026 13.6479 15.2354 12.7992 0 12.9346 15.3269 0 0 14.1554 16.6619 0 0 0 0 0 0 0 0 12.7156 0 0 0 0 12.5608 13.1665 13.9828 13.7055 12.8872 0 12.9166 0 0 0 0 0 0 0 0 11.6453 13.3926 0 13.0082 0 0 12.8271 0 0 13.0093 0 13.1953 0 12.7996 0 0 12.4938 12.8896 14.346 0 13.4385 12.5347 0 0 0 12.7175 13.1234 14.1807 13.7566 12.8575 13.8101 0 0 19.6233 0 0 0 0 0 0 0 0 0 0 0 13.4493 0 0 0 13.0177 0 0 0 0 0 13.4226 0 0 0 0 0 0 10.66 0 Q15382 RHEB_HUMAN GTP-binding protein Rheb (Ras homolog enriched in brain) RHEB RHEB2 Homo sapiens (Human) negative regulation of cold-induced thermogenesis [GO:0120163]; oligodendrocyte differentiation [GO:0048709]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of cell cycle [GO:0051726]; regulation of macroautophagy [GO:0016241]; regulation of type B pancreatic cell development [GO:2000074]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; negative regulation of cold-induced thermogenesis [GO:0120163]; oligodendrocyte differentiation [GO:0048709]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of cell cycle [GO:0051726]; regulation of macroautophagy [GO:0016241]; regulation of type B pancreatic cell development [GO:2000074]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] GO:0000139; GO:0000287; GO:0003924; GO:0005525; GO:0005681; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0007165; GO:0007264; GO:0014069; GO:0016020; GO:0016241; GO:0019003; GO:0019901; GO:0032008; GO:0048709; GO:0048714; GO:0051726; GO:0070062; GO:0120163; GO:2000074 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901] KIAILGYR 0.99368 -9.1728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9593 0 0 0 0 0 0 0 0 0 0 0 12.8214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8786 0 0 0 0 0 11.1149 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1672 0 0 0 0 0 Q3KP66 INAVA_HUMAN Innate immunity activator protein INAVA C1orf106 Homo sapiens (Human) adherens junction maintenance [GO:0034334]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stress-activated MAPK cascade [GO:0032874]; reactive oxygen species biosynthetic process [GO:1903409]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adherens junction maintenance [GO:0034334]; innate immune response [GO:0045087]; intestinal epithelial structure maintenance [GO:0060729]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stress-activated MAPK cascade [GO:0032874]; reactive oxygen species biosynthetic process [GO:1903409]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494] GO:0002221; GO:0002720; GO:0005634; GO:0005654; GO:0005737; GO:0016604; GO:0031398; GO:0032494; GO:0032495; GO:0032731; GO:0032733; GO:0032755; GO:0032874; GO:0034334; GO:0043123; GO:0043410; GO:0045087; GO:0060729; GO:0070431; GO:1903409 EDPLSSLER 0.99368 -13.183 0 0 0 0 0 0 0 0 0 10.6124 0 0 12.086 0 0 0 11.8794 0 12.279 0 0 0 0 11.4189 0 0 0 0 0 0 0 11.2127 0 0 11.1558 11.7099 11.6872 0 11.6416 13.318 0 0 0 0 0 0 0 0 11.9144 0 0 11.7438 10.4631 0 0 0 11.2893 0 0 0 0 0 0 0 0 0 0 10.399 0 0 10.2172 0 0 0 0 0 0 0 0 13.704 0 13.3099 0 0 13.207 13.496 13.5936 0 14.6746 0 14.3723 12.4117 14.741 0 0 12.8056 0 0 0 0 0 0 0 0 14.1007 12.8946 12.9568 0 13.0301 12.3397 0 0 12.9173 0 0 14.7408 12.8473 0 0 12.7552 13.4511 0 0 14.0651 14.6836 0 0 0 11.0536 0 0 0 12.42 0 0 12.3948 0 0 11.4112 0 0 11.9287 0 0 0 0 0 0 0 0 14.0584 0 0 14.325 13.5475 0 11.669 0 0 11.819 12.4847 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7287 0 0 0 0 0 Q5T5N4 CF118_HUMAN Uncharacterized protein C6orf118 C6orf118 Homo sapiens (Human) AALEQNDRLR 0.99368 -7.8293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4693 0 0 0 11.8917 0 0 0 0 0 0 11.9374 0 0 0 13.6079 0 0 0 0 0 0 0 0 11.9317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5693 0 12.935 0 0 0 0 0 0 0 0 0 0 13.1614 0 0 0 0 0 0 0 0 15.0095 0 0 0 0 0 0 12.338 0 12.7998 0 0 0 0 0 0 0 0 0 14.2317 0 0 0 0 12.3161 0 0 12.5642 0 0 0 0 0 0 12.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.195 0 0 0 0 0 0 0 0 0 15.2048 Q7Z2R9 SSAS1_HUMAN Putative uncharacterized protein SSBP3-AS1 (SSBP3 antisense RNA 1) (SSBP3 antisense gene protein 1) SSBP3-AS1 C1orf191 MSTP128 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 GLLDVGNIQHRAARAR 0.99368 -7.8312 0 0 0 0 0 0 0 0 0 15.1952 14.8833 15.6557 14.7479 15.1104 15.074 17.8689 17.7362 17.3926 17.1128 0 0 0 11.8366 0 15.2777 15.4205 15.5227 13.9204 0 0 16.8216 16.4471 16.6918 14.381 14.4251 14.5029 14.6083 14.794 0 16.2521 16.3519 16.2178 16.6236 16.623 16.6626 17.4847 17.2142 17.2113 0 14.2832 14.299 13.3132 17.9206 18.7181 17.75 17.0463 18.19 18.365 18.444 17.6784 19.2159 19.7413 19.9678 19.0514 18.6688 18.7529 0 0 0 0 12.3921 0 0 0 0 0 0 0 13.5053 12.7056 0 0 0 0 0 0 13.1159 0 0 0 20.0696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2764 0 0 14.2928 0 0 0 0 12.7808 0 0 0 0 0 0 0 0 13.1968 0 0 0 0 0 17.8685 12.2494 12.0216 12.3814 0 0 0 0 0 0 0 0 11.9228 0 0 0 0 0 18.3274 0 0 0 0 0 0 19.6789 19.6415 18.7893 17.8225 18.3811 17.1667 18.6065 17.6285 18.7737 0 18.4324 15.6657 18.0335 17.7195 17.5548 20.5646 0 0 0 14.4151 0 13.6854 0 17.8962 Q86TZ1 TTC6_HUMAN "Tetratricopeptide repeat protein 6, TPR repeat protein 6" TTC6 C14orf25 NCRNA00291 Homo sapiens (Human) AITNTILKK 0.99368 -13.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5334 0 0 14.3503 0 0 14.1227 13.639 0 0 0 0 0 0 0 12.8792 0 0 0 0 0 0 0 0 0 0 0 14.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5317 0 0 0 0 0 0 13.1654 0 0 0 0 0 0 0 0 14.0756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3942 0 0 0 0 0 13.9459 0 0 0 13.0548 0 0 0 0 Q8N2Z9 CENPS_HUMAN "Centromere protein S, CENP-S (Apoptosis-inducing TAF9-like domain-containing protein 1) (FANCM-associated histone fold protein 1) (FANCM-interacting histone fold protein 1) (Fanconi anemia-associated polypeptide of 16 kDa)" CENPS APITD1 FAAP16 MHF1 Homo sapiens (Human) cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; kinetochore assembly [GO:0051382]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; kinetochore assembly [GO:0051382]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000712; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0031297; GO:0031398; GO:0036297; GO:0043240; GO:0046982; GO:0051301; GO:0051382; GO:0071821 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982] KSEDGSKNSR 0.99368 -7.8342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6322 0 0 0 0 0 0 0 0 0 0 0 0 11.7364 11.8781 11.7929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.782 0 0 14.8366 0 0 0 0 0 0 0 12.1677 0 11.9863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7334 0 0 0 0 0 0 0 0 0 0 0 11.5346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8V4 ANS4B_HUMAN "Ankyrin repeat and SAM domain-containing protein 4B (Harmonin-interacting ankyrin repeat-containing protein, Harp)" ANKS4B HARP Homo sapiens (Human) brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; response to endoplasmic reticulum stress [GO:0034976] brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886] brush border [GO:0005903]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; response to endoplasmic reticulum stress [GO:0034976] GO:0005789; GO:0005886; GO:0005902; GO:0005903; GO:0030154; GO:0034976; GO:0065003; GO:1904106; GO:1904970 AATAQNIMNPK 0.99368 -13.551 0 10.1161 0 0 0 0 0 0 0 0 0 0 0 14.5801 12.5957 12.3586 12.5447 12.5342 12.2724 12.504 13.8471 0 10.2031 0 0 0 13.0826 13.256 14.7562 15.0329 13.6006 0 0 0 0 0 0 0 0 13.0293 0 14.6308 14.74 11.8278 11.5291 0 14.0287 0 0 12.7766 12.8004 13.8795 15.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2692 0 11.9633 0 12.0486 0 0 0 0 0 0 0 14.6852 0 14.3987 0 0 0 0 0 0 0 0 0 0 0 11.5135 11.0066 0 14.1705 0 0 0 14.2706 0 13.6701 12.7058 0 0 0 12.2911 0 0 0 0 0 12.447 13.16 0 0 12.7167 0 16.5359 13.0199 0 13.8154 0 14.8438 14.8625 12.0402 12.792 0 0 0 0 12.3141 0 0 0 0 13.4416 0 0 0 0 16.8574 0 0 0 0 16.7006 0 0 0 0 0 0 0 14.1328 0 17.0831 11.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2917 0 0 14.0314 0 0 0 0 10.9085 Q8NBF1 GLIS1_HUMAN Zinc finger protein GLIS1 (GLI-similar 1) GLIS1 Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0030154; GO:0045944; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFSRLENLK 0.99368 -6.8277 0 0 0 0 0 12.7592 0 0 0 0 0 10.3145 0 0 0 0 0 0 0 9.82302 0 0 0 0 0 0 0 0 0 0 13.2772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0676 13.068 0 0 10.4378 0 0 0 13.1243 13.5628 0 0 0 13.7499 13.6449 0 14.637 14.4481 0 14.4272 0 11.4946 0 0 0 0 13.5482 13.9764 0 14.8021 0 12.9938 13.0484 0 12.8627 0 13.217 0 0 14.5025 13.3315 0 13.596 0 0 14.5304 14.1345 12.0968 10.1434 0 0 0 11.7416 12.5298 0 0 0 0 0 0 15.3184 0 13.8569 13.8069 11.443 13.7572 13.6006 13.7269 0 13.5193 13.3533 0 0 0 0 0 0 0 0 13.7332 0 0 0 11.8359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEM2 SHCBP_HUMAN SHC SH2 domain-binding protein 1 SHCBP1 Homo sapiens (Human) fibroblast growth factor receptor signaling pathway [GO:0008543]; regulation of neural precursor cell proliferation [GO:2000177] cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819] cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; SH2 domain binding [GO:0042169]; fibroblast growth factor receptor signaling pathway [GO:0008543]; regulation of neural precursor cell proliferation [GO:2000177] GO:0005737; GO:0005819; GO:0008543; GO:0030496; GO:0042169; GO:2000177 SH2 domain binding [GO:0042169] FFYQNIWRSWDEEEEDEYDYFVR 0.99368 -5.2238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7759 0 0 0 0 0 0 13.3253 0 0 0 13.0707 14.582 0 10.7191 0 0 0 0 14.627 0 14.5189 0 14.0239 14.7021 14.6083 13.7223 14.2434 12.7934 13.9446 0 0 0 0 0 14.0008 0 0 0 0 0 13.1685 14.062 13.8108 0 0 12.927 0 0 14.53 14.2212 0 0 0 0 0 14.1041 0 14.7962 0 13.6806 13.5677 0 0 13.7733 0 15.7339 0 13.5153 14.0599 14.0777 14.5342 0 0 12.2441 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4553 14.7043 0 0 0 0 0 0 0 0 0 0 12.393 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFK1 CXG3_HUMAN "Gap junction gamma-3 protein (Connexin-30.2, Cx30.2) (Connexin-31.3, Cx31.3) (Gap junction epsilon-1 protein)" GJC3 GJE1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; myelination [GO:0042552]; sensory perception of sound [GO:0007605] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; cell-cell signaling [GO:0007267]; myelination [GO:0042552]; sensory perception of sound [GO:0007605] GO:0005243; GO:0005922; GO:0007267; GO:0007605; GO:0016021; GO:0042552; GO:0042802; GO:0043209 gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802] EEETLIQGR 0.99368 -17.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.173 0 0 0 0 0 13.1378 0 0 0 0 0 0 0 0 0 13.1433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBK2 SETD6_HUMAN "N-lysine methyltransferase SETD6, EC 2.1.1.- (SET domain-containing protein 6)" SETD6 Homo sapiens (Human) histone lysine methylation [GO:0034968]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-lysine monomethylation [GO:0018026]; regulation of inflammatory response [GO:0050727]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; protein-lysine N-methyltransferase activity [GO:0016279]; S-adenosyl-L-methionine binding [GO:1904047]; histone lysine methylation [GO:0034968]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-lysine monomethylation [GO:0018026]; regulation of inflammatory response [GO:0050727]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827] GO:0005634; GO:0005654; GO:0005829; GO:0016279; GO:0018026; GO:0019827; GO:0032088; GO:0034968; GO:0048863; GO:0050727; GO:0051059; GO:1904047 NF-kappaB binding [GO:0051059]; protein-lysine N-methyltransferase activity [GO:0016279]; S-adenosyl-L-methionine binding [GO:1904047] DQDGGGDDK 0.99368 -6.8391 0 0 0 0 0 0 0 0 14.6712 0 0 0 0 11.1948 0 0 17.3304 0 16.2402 0 0 0 0 0 10.4817 0 11.9539 0 0 0 0 0 0 0 0 0 0 0 13.7523 0 13.569 0 0 0 13.2048 0 0 0 0 0 0 0 16.6391 0 0 0 0 0 0 0 0 15.1702 0 0 0 14.1488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.9549 0 0 12.8419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4355 0 16.678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WW52 F151A_HUMAN Protein FAM151A FAM151A C1orf179 UNQ3034/PRO9836 Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0005615; GO:0016020; GO:0016021; GO:0070062 DALEVTWYHAANSK 0.99368 -6.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7883 0 0 0 0 0 0 0 0 0 10.6445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9847 0 0 13.4148 0 13.2083 0 14.9424 0 0 14.9776 0 0 0 0 0 0 0 13.7743 0 0 0 13.3096 0 17.2496 0 13.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.437 0 0 0 0 0 0 Q96PD2 DCBD2_HUMAN "Discoidin, CUB and LCCL domain-containing protein 2 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1) (Endothelial and smooth muscle cell-derived neuropilin-like protein)" DCBLD2 CLCP1 ESDN Homo sapiens (Human) intracellular receptor signaling pathway [GO:0030522]; negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; signaling receptor activity [GO:0038023]; intracellular receptor signaling pathway [GO:0030522]; negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060] GO:0005887; GO:0009986; GO:0030308; GO:0030522; GO:0038023; GO:0042060 signaling receptor activity [GO:0038023] DGECDVFKEIL 0.99368 -6.8339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1969 0 0 0 0 0 0 0 0 0 0 0 12.6027 13.1395 0 0 11.6493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6199 0 0 0 0 0 0 13.6588 0 0 0 0 0 0 0 12.8613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BW83 IFT27_HUMAN Intraflagellar transport protein 27 homolog (Putative GTP-binding protein RAY-like) (Rab-like protein 4) IFT27 RABL4 RAYL Homo sapiens (Human) cilium assembly [GO:0060271]; cochlea development [GO:0090102]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228] centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016192; GO:0030992; GO:0031514; GO:0035720; GO:0036126; GO:0042073; GO:0060122; GO:0060271; GO:0090102; GO:0097225; GO:0097228; GO:0097542 GTP binding [GO:0005525]; GTPase activity [GO:0003924] EMENFEAPFHCLAKQFHQLYREK 0.99368 -7.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0602 13.1693 0 13.4118 0 0 0 12.9974 0 0 0 12.882 0 0 0 0 0 0 0 0 0 0 0 0 Q9NYL5 CP39A_HUMAN "24-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.26 (Cytochrome P450 39A1, hCYP39A1) (Oxysterol 7-alpha-hydroxylase)" CYP39A1 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid 7-alpha-hydroxylase activity [GO:0008387]; steroid hydroxylase activity [GO:0008395]; bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; sterol metabolic process [GO:0016125] GO:0005506; GO:0005789; GO:0006699; GO:0006707; GO:0007586; GO:0008387; GO:0008395; GO:0008396; GO:0016021; GO:0016125; GO:0020037; GO:0033782; GO:0042632; GO:0043231 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid 7-alpha-hydroxylase activity [GO:0008387]; steroid hydroxylase activity [GO:0008395] APLEFIEKARIK 0.99368 -6.8336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6211 0 0 13.8412 0 0 0 0 12.651 0 0 0 0 0 12.947 0 0 0 0 0 0 0 13.2932 0 0 0 0 0 0 0 0 0 0 0 0 13.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6853 0 0 0 0 0 13.0186 0 14.5092 0 0 0 0 0 0 0 0 0 0 0 0 13.3919 0 11.6892 0 13.7553 12.9606 13.2579 0 0 0 0 0 11.7364 0 0 0 12.3551 0 0 14.0774 0 0 0 0 0 14.4773 14.902 0 0 0 0 13.5541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7888 0 0 0 0 0 0 0 0 0 0 0 0 13.8299 14.243 0 0 13.6288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2S2 NRX2A_HUMAN Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha) NRXN2 KIAA0921 Homo sapiens (Human) adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] GO:0004888; GO:0005246; GO:0005886; GO:0007158; GO:0007165; GO:0007268; GO:0007269; GO:0007416; GO:0016021; GO:0030534; GO:0032991; GO:0035176; GO:0042297; GO:0046872; GO:0050839; GO:0071625; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:0098793 calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; transmembrane signaling receptor activity [GO:0004888] ASGSRWRPTPPPLLLLLLLALAAR 0.99368 -7.8216 0 0 0 0 0 0 0 0 12.4067 12.6721 12.9737 13.6715 12.5742 0 12.6779 12.3493 11.9558 0 12.3223 0 0 0 0 0 0 0 0 12.3949 12.6214 0 12.4019 0 11.9303 12.3613 12.5892 12.6365 12.0612 12.6436 12.6598 13.9683 0 11.7927 0 0 0 0 0 12.1792 0 0 0 0 12.7571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7635 14.2664 13.6054 12.1536 0 0 0 0 0 0 0 14.9396 0 14.1715 0 0 0 14.7726 0 0 0 0 0 13.4046 0 0 0 0 0 0 0 0 13.2468 0 0 0 0 0 0 0 0 12.8361 0 0 0 0 14.3495 0 0 0 0 0 14.8153 12.1396 12.253 0 0 12.0602 0 0 13.3389 0 0 0 0 0 14.3735 14.706 0 0 12.3794 0 0 12.2543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9J069 AJM1_HUMAN Apical junction component 1 homolog AJM1 C9orf172 Homo sapiens (Human) cell-cell junction organization [GO:0045216] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886]; cell-cell junction organization [GO:0045216] GO:0005886; GO:0005912; GO:0005929; GO:0016324; GO:0043296; GO:0045216 AFYCDGPLPGPR 0.99369 -6.8645 0 0 0 0 0 0 0 0 0 0 0 13.3025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1953 0 0 10.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2177 10.3892 0 0 0 0 0 0 0 15.5429 10.6059 0 0 0 0 11.4237 14.8114 0 12.3382 0 16.4422 16.2174 0 14.7254 0 14.9961 15.2447 12.0463 0 11.5481 0 0 0 0 10.6699 0 11.9273 11.1413 0 11.8338 0 0 10.6496 10.2463 0 0 0 15.4135 0 0 0 11.0384 0 0 0 0 0 0 10.0013 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3187 14.0577 0 0 0 0 13.3803 0 12.0901 0 15.6345 10.3631 17.1797 0 0 0 0 0 0 10.6699 0 10.3801 10.4193 0 0 0 11.6861 11.0679 P0DJH9 RD3L_HUMAN Protein RD3-like (Retinal degeneration protein 3-like) RD3L Homo sapiens (Human) ERLIQEIENEQK 0.99369 -7.8608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9135 0 16.0135 0 0 14.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31040 SDHA_HUMAN "Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial, EC 1.3.5.1 (Flavoprotein subunit of complex II, Fp)" SDHA SDH2 SDHF Homo sapiens (Human) "mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]" "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]" "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]" GO:0005730; GO:0005739; GO:0005743; GO:0005749; GO:0006099; GO:0006105; GO:0006121; GO:0007399; GO:0008177; GO:0009055; GO:0022904; GO:0042776; GO:0050660 electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177] GGQAHRCCCVADR 0.99369 -7.8559 0 0 0 0 0 0 0 0 0 0 0 0 15.1431 0 0 0 0 0 0 13.9133 0 0 0 0 0 0 0 0 0 0 0 0 13.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2905 0 0 11.575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.68 12.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5639 0 0 0 0 0 0 0 0 0 0 13.8543 0 0 0 0 0 0 0 0 13.154 0 0 0 0 0 0 13.9507 0 0 0 0 P35789 ZNF93_HUMAN Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34) ZNF93 ZNF505 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CEECGKAFIWSSVLTR 0.99369 -14.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9206 0 0 0 0 0 0 0 12.0198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9899 14.6362 0 0 13.4464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49247 RPIA_HUMAN "Ribose-5-phosphate isomerase, EC 5.3.1.6 (Phosphoriboisomerase)" RPIA RPI Homo sapiens (Human) "D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; ribose phosphate metabolic process [GO:0019693]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; ribose phosphate metabolic process [GO:0019693]" GO:0004751; GO:0005829; GO:0006014; GO:0006098; GO:0009052; GO:0019693; GO:0042802; GO:0043231; GO:0048029 identical protein binding [GO:0042802]; monosaccharide binding [GO:0048029]; ribose-5-phosphate isomerase activity [GO:0004751] IVAGYASR 0.99369 -7.069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52272 HNRPM_HUMAN "Heterogeneous nuclear ribonucleoprotein M, hnRNP M" HNRNPM HNRPM NAGR1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]" catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681] "catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815]" GO:0000380; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005737; GO:0016020; GO:0016363; GO:0019904; GO:0042382; GO:0062023; GO:0070062; GO:0071013; GO:0071014; GO:1990904; GO:2000815 mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723] ACQIFVR 0.99369 -37.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0063 13.0366 0 0 0 0 0 0 0 0 12.3499 0 12.7591 0 13.2981 0 0 0 0 0 0 0 0 0 0 0 12.1963 0 0 0 0 0 0 12.8358 11.6509 0 0 0 12.1778 14.2322 0 14.5236 0 12.9847 0 13.0522 0 12.8718 0 11.6547 0 13.1822 0 0 0 0 0 0 0 10.7956 0 0 0 0 13.012 0 0 0 0 15.7177 0 0 0 13.8777 13.8213 13.0761 0 0 0 0 0 12.4876 Q12934 BFSP1_HUMAN "Filensin (Beaded filament structural protein 1) (Lens fiber cell beaded-filament structural protein CP 115, CP115) (Lens intermediate filament-like heavy, LIFL-H) [Cleaved into: Filensin C-terminal fragment; Filensin N-terminal fragment ]" BFSP1 Homo sapiens (Human) cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212]; cell maturation [GO:0048469]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307] GO:0005200; GO:0005212; GO:0005737; GO:0005882; GO:0005886; GO:0005938; GO:0045109; GO:0048469; GO:0070307 structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212] ALEQRHAGLRR 0.99369 -7.0891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9174 0 13.5638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2KHR3 QSER1_HUMAN Glutamine and serine-rich protein 1 QSER1 Homo sapiens (Human) chromosome [GO:0005694] chromosome [GO:0005694] GO:0005694 AEPPPKKR 0.99369 -14.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5938 0 0 0 0 0 0 0 0 14.5764 0 0 0 0 0 0 14.9937 0 15.3006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3761 0 0 15.112 0 0 0 15.4236 0 0 0 0 0 0 0 0 0 15.2475 16.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9668 0 12.5299 0 0 0 0 13.3993 0 Q86VH2 KIF27_HUMAN Kinesin-like protein KIF27 KIF27 Homo sapiens (Human) cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591] GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0051649; GO:0060271 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] EAERKQQLYNEEMK 0.99369 -37.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98142 12.9758 0 12.5075 12.4067 0 0 11.1632 0 0 0 0 11.5573 0 0 0 0 0 14.3716 0 0 0 0 13.1963 13.3853 13.5909 12.9884 13.8999 12.9003 13.1465 12.3731 0 14.3458 13.0347 0 12.5217 0 0 0 0 0 0 12.6876 13.5044 0 0 0 13.647 13.4388 12.8772 0 0 0 0 0 12.7596 0 0 0 0 11.524 0 12.5707 0 0 12.0414 0 0 0 0 0 0 13.8739 0 12.2517 0 12.3106 0 0 11.7781 0 0 0 0 0 9.9156 0 0 0 0 0 0 0 0 0 0 0 12.2877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGE3 O10P1_HUMAN Olfactory receptor 10P1 (Olfactory receptor 10P2) (Olfactory receptor 10P3) (Olfactory receptor OR12-7) OR10P1 OR10P1P OR10P2P OR10P3P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALRHLVK 0.99369 -14.025 0 8.78211 0 0 0 0 0 0 0 11.2162 0 12.2072 0 16.2438 16.2055 16.4459 16.4854 16.5858 0 16.5815 0 0 0 0 0 16.7296 0 16.9399 16.8378 16.9031 16.8775 16.9228 9.26292 0 12.4262 0 0 12.9776 12.2802 16.9947 0 0 0 0 16.9662 16.9722 0 0 17.0078 0 17.0143 16.5598 16.4892 16.571 16.7231 12.4748 0 16.6672 16.432 13.9142 16.1331 0 15.7886 16.1026 0 15.8241 0 0 0 0 12.3796 12.8423 0 0 0 0 0 12.801 0 12.6724 13.0227 0 11.912 0 0 0 11.9886 19.1285 0 0 13.9054 0 0 13.375 12.7495 0 0 13.3555 19.1736 18.8895 0 0 0 0 0 0 0 18.7924 0 0 0 12.3159 0 0 0 0 18.6373 18.5132 0 0 0 0 0 0 0 0 0 11.6644 0 0 12.9273 0 0 0 18.1258 0 17.9942 12.5813 0 0 18.0942 0 0 0 17.6798 12.6438 17.6404 12.1215 17.9059 0 0 0 0 0 0 0 17.756 0 10.8304 0 12.0332 0 17.753 17.6331 17.599 17.6186 17.5548 17.7114 17.5007 0 0 0 0 0 0 17.6496 0 17.4875 9.67603 17.6697 Q9BTE1 DCTN5_HUMAN Dynactin subunit 5 (Dynactin subunit p25) DCTN5 Homo sapiens (Human) aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; ventricular septum development [GO:0003281] centrosome [GO:0005813]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; ventricular septum development [GO:0003281] GO:0000776; GO:0003281; GO:0005654; GO:0005813; GO:0005829; GO:0005869; GO:0031965; GO:0035904; GO:0060976 MELGELLYNK 0.99369 -7.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1302 0 0 0 10.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1085 Q9GZY1 PBOV1_HUMAN "Prostate and breast cancer overexpressed gene 1 protein (Protein UROC28, UC28)" PBOV1 UROC28 Homo sapiens (Human) centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829; GO:0034451 LPGILAPETVLLPFCYKVFR 0.99369 -6.8411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4041 0 0 0 0 12.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAZ2 PRD16_HUMAN "Histone-lysine N-methyltransferase PRDM16, EC 2.1.1.367 (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1, MDS1/EVI1-like gene 1)" PRDM16 KIAA1675 MEL1 PFM13 Homo sapiens (Human) "brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; regulation of transcription by RNA polymerase II [GO:0006357]" aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cellular respiration [GO:0043457]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016235; GO:0017053; GO:0018024; GO:0030512; GO:0030853; GO:0043457; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0046974; GO:0050873; GO:0070828; GO:0120162; GO:0140297 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]" ADMQIVDGSAQCPGLASEKQEDVEEEDDDDLEEDDEDSLAGK 0.99369 -14.011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8634 0 0 0 0 0 0 0 0 0 0 13.1302 0 13.7501 0 0 0 0 12.1921 0 0 12.2392 0 14.1931 0 0 0 0 0 0 0 13.1654 0 0 0 0 0 0 0 0 0 15.5241 0 0 0 0 0 0 13.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2577 0 0 13.3825 0 0 0 0 0 0 0 12.7344 0 0 0 0 0 0 0 Q9UHB9 SRP68_HUMAN "Signal recognition particle subunit SRP68, SRP68 (Signal recognition particle 68 kDa protein)" SRP68 Homo sapiens (Human) response to xenobiotic stimulus [GO:0009410]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to xenobiotic stimulus [GO:0009410]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]" GO:0003723; GO:0005047; GO:0005730; GO:0005783; GO:0005786; GO:0005829; GO:0005840; GO:0005925; GO:0006614; GO:0008312; GO:0009410; GO:0019904; GO:0030942; GO:0048500 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047] AFQKEIGLKTLVFK 0.99369 -5.0349 0 0 0 0 0 0 0 0 12.229 12.3824 0 11.2441 0 11.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7246 0 0 0 0 0 12.086 0 11.8218 0 0 0 0 0 0 0 0 12.5285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.926 0 0 0 0 0 0 0 0 0 0 15.2575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2413 17.3994 0 0 0 0 0 0 0 0 0 0 0 0 13.5372 0 0 0 13.5744 0 14.1818 13.0172 0 0 0 0 0 0 0 0 13.6203 0 0 Q9Y227 ENTP4_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 4, NTPDase 4, EC 3.6.1.15, EC 3.6.1.6 (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase, UDPase, EC 3.6.1.42)" ENTPD4 KIAA0392 LALP70 LYSAL1 Homo sapiens (Human) CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; UDP catabolic process [GO:0006256] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of autophagosome membrane [GO:0097637]; integral component of Golgi membrane [GO:0030173]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; CTPase activity [GO:0043273]; cytidine-diphosphatase activity [GO:0036384]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134]; CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside diphosphate catabolic process [GO:0009134]; UDP catabolic process [GO:0006256] GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0009134; GO:0016020; GO:0017110; GO:0017111; GO:0030173; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712; GO:0097637 CTPase activity [GO:0043273]; cytidine-diphosphatase activity [GO:0036384]; GTPase activity [GO:0003924]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; nucleoside-triphosphatase activity [GO:0017111]; uridine-diphosphatase activity [GO:0045134] GLYASHADLHRLK 0.99369 -6.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14654 IRS4_HUMAN "Insulin receptor substrate 4, IRS-4 (160 kDa phosphotyrosine protein, py160) (Phosphoprotein of 160 kDa, pp160)" IRS4 Homo sapiens (Human) insulin receptor signaling pathway [GO:0008286]; signal transduction [GO:0007165] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548]; insulin receptor signaling pathway [GO:0008286]; signal transduction [GO:0007165] GO:0005158; GO:0005829; GO:0005886; GO:0007165; GO:0008286; GO:0043548 insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase binding [GO:0043548] CSEPPPVAR 0.9937 -30.292 11.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0689 13.9061 13.4571 12.7483 13.5418 0 11.9373 0 0 0 0 14.2669 0 14.6292 14.1161 14.1111 0 0 0 13.9469 0 14.3059 0 13.5941 0 14.7498 0 14.6233 0 14.0268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3364 15.876 16.2441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3171 0 0 11.8795 12.0507 0 0 0 0 0 0 0 0 0 0 0 11.6346 0 0 0 0 0 0 0 12.2303 17.1409 0 0 0 0 0 12.1296 0 0 13.8706 0 0 0 0 0 0 13.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1117 13.7103 0 0 0 10.8778 0 0 0 0 15.9977 0 0 0 0 0 14.5119 0 14.4776 0 0 0 15.2899 0 0 0 15.2407 0 0 0 0 0 P05181 CP2E1_HUMAN "Cytochrome P450 2E1, EC 1.14.14.1 (4-nitrophenol 2-hydroxylase, EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J)" CYP2E1 CYP2E Homo sapiens (Human) 4-nitrophenol metabolic process [GO:0018960]; benzene metabolic process [GO:0018910]; carbon tetrachloride metabolic process [GO:0018885]; epoxygenase P450 pathway [GO:0019373]; halogenated hydrocarbon metabolic process [GO:0042197]; heterocycle metabolic process [GO:0046483]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; organic acid metabolic process [GO:0006082]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; mitochondrial inner membrane [GO:0005743] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; mitochondrial inner membrane [GO:0005743]; 4-nitrophenol 2-monooxygenase activity [GO:0018601]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; 4-nitrophenol metabolic process [GO:0018960]; benzene metabolic process [GO:0018910]; carbon tetrachloride metabolic process [GO:0018885]; epoxygenase P450 pathway [GO:0019373]; halogenated hydrocarbon metabolic process [GO:0042197]; heterocycle metabolic process [GO:0046483]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; organic acid metabolic process [GO:0006082]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; steroid metabolic process [GO:0008202]; triglyceride metabolic process [GO:0006641]; xenobiotic metabolic process [GO:0006805]" GO:0000139; GO:0001676; GO:0002933; GO:0004497; GO:0005506; GO:0005737; GO:0005743; GO:0005789; GO:0006082; GO:0006641; GO:0006805; GO:0008202; GO:0008392; GO:0008395; GO:0009617; GO:0010193; GO:0010243; GO:0016098; GO:0016491; GO:0016709; GO:0016712; GO:0018601; GO:0018885; GO:0018910; GO:0018960; GO:0019373; GO:0019825; GO:0019899; GO:0020037; GO:0030544; GO:0031227; GO:0042197; GO:0042759; GO:0043231; GO:0045471; GO:0046483; GO:0051879; GO:0070330; GO:0120319 "4-nitrophenol 2-monooxygenase activity [GO:0018601]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]" FGPVFTLYVGSQRMVVMHGYK 0.9937 -5.2626 0 0 0 0 0 0 0 0 0 0 14.7339 0 0 14.6803 0 0 0 0 0 0 0 0 0 12.1618 0 0 0 0 0 12.6693 12.7102 0 13.1162 0 12.3565 0 0 0 12.625 0 12.5385 0 12.6299 0 0 0 0 0 0 0 0 13.267 0 12.3702 12.7771 11.7762 0 0 0 0 0 0 0 0 0 0 10.5349 0 0 0 0 0 0 11.8354 0 0 0 0 0 0 15.8463 12.3465 17.3516 17.4785 0 18.4841 17.7265 0 0 0 0 17.502 0 13.1705 17.4314 0 17.6176 17.5813 0 13.1037 14.2173 0 0 17.0091 15.6242 14.9379 0 13.7899 0 0 0 0 16.5944 0 0 0 0 0 0 0 13.9727 0 14.3066 0 13.426 13.4089 0 0 13.317 0 0 12.1604 15.4295 0 0 0 0 0 12.7195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9753 13.6273 0 15.9649 16.0648 0 16.1084 16.219 16.095 16.197 0 16.1051 16.1475 0 0 0 15.5434 0 0 0 0 0 0 16.0004 0 0 P37059 DHB2_HUMAN "17-beta-hydroxysteroid dehydrogenase type 2, 17-beta-HSD 2 (20 alpha-hydroxysteroid dehydrogenase, 20-alpha-HSD) (E2DH) (Estradiol 17-beta-dehydrogenase 2, EC 1.1.1.62) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase, EC 1.1.1.239)" HSD17B2 EDH17B2 SDR9C2 Homo sapiens (Human) androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; in utero embryonic development [GO:0001701]; placenta development [GO:0001890]; response to retinoic acid [GO:0032526]; steroid metabolic process [GO:0008202]" GO:0001701; GO:0001890; GO:0004303; GO:0005789; GO:0006703; GO:0008202; GO:0008209; GO:0016021; GO:0016229; GO:0016491; GO:0032526; GO:0043231; GO:0044594; GO:0047006; GO:0047035 "17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]" DFSPVLR 0.9937 -10.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2107 0 0 13.2429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52815 RM12_HUMAN "39S ribosomal protein L12, mitochondrial, L12mt, MRP-L12 (5c5-2) (Mitochondrial large ribosomal subunit protein bL12m)" MRPL12 MRPL7 RPML12 Homo sapiens (Human) "mitochondrial transcription [GO:0006390]; mitochondrial translation [GO:0032543]; positive regulation of transcription, DNA-templated [GO:0045893]; translation [GO:0006412]" mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial transcription [GO:0006390]; mitochondrial translation [GO:0032543]; positive regulation of transcription, DNA-templated [GO:0045893]; translation [GO:0006412]" GO:0003723; GO:0003729; GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0006390; GO:0006412; GO:0032543; GO:0045893 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AAAFRLARR 0.9937 -6.6556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05513 KPCZ_HUMAN "Protein kinase C zeta type, EC 2.7.11.13 (nPKC-zeta)" PRKCZ PKC2 Homo sapiens (Human) activation of phospholipase D activity [GO:0031584]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein transport [GO:0051222]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; signal transduction [GO:0007165]; vesicle transport along microtubule [GO:0047496] apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; stress fiber [GO:0001725]; tight junction [GO:0070160]; vesicle [GO:0031982] apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; stress fiber [GO:0001725]; tight junction [GO:0070160]; vesicle [GO:0031982]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; activation of phospholipase D activity [GO:0031584]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein transport [GO:0051222]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; signal transduction [GO:0007165]; vesicle transport along microtubule [GO:0047496] GO:0000226; GO:0001725; GO:0001954; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005635; GO:0005737; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0006468; GO:0006954; GO:0007165; GO:0007166; GO:0007616; GO:0008284; GO:0014069; GO:0015459; GO:0016020; GO:0016324; GO:0016363; GO:0016477; GO:0018105; GO:0019901; GO:0030010; GO:0030054; GO:0031252; GO:0031333; GO:0031584; GO:0031982; GO:0032148; GO:0032733; GO:0032736; GO:0032753; GO:0032754; GO:0032869; GO:0035556; GO:0035748; GO:0043066; GO:0043203; GO:0043274; GO:0043560; GO:0044877; GO:0045121; GO:0045179; GO:0045630; GO:0046627; GO:0046628; GO:0046872; GO:0047496; GO:0048471; GO:0050732; GO:0051092; GO:0051222; GO:0051346; GO:0051899; GO:0060081; GO:0060291; GO:0070062; GO:0070160; GO:0070374; GO:0070528; GO:0071889; GO:0072659; GO:0098685; GO:0098696; GO:0098978; GO:0106310; GO:1990138; GO:2000463; GO:2000553 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] DDSEDLK 0.9937 -14.104 0 0 0 0 0 0 0 16.0532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5491 14.4229 0 0 0 0 13.3164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6Q4G3 AMPQ_HUMAN "Aminopeptidase Q, AP-Q, APQ, EC 3.4.11.- (CHL2 antigen) (Laeverin)" LVRN AQPEP Homo sapiens (Human) peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] GO:0005737; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008270; GO:0016021; GO:0042277; GO:0043171; GO:0070006 metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] AEVRGPLSPGTGNATVGR 0.9937 -6.6501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9689 0 0 0 11.8478 0 0 0 0 0 0 0 0 0 0 0 14.5686 0 0 12.9555 0 12.2917 0 0 12.6352 0 0 0 0 12.5031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4546 14.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3102 0 0 0 0 0 0 0 14.2996 0 0 13.9708 0 0 0 0 0 0 15.4715 0 0 0 12.4887 0 13.6624 0 0 0 0 0 13.4612 13.0208 0 0 13.7331 0 12.621 0 0 13.3058 0 0 13.2069 0 0 12.5018 0 0 0 0 0 0 0 14.1724 0 0 11.6224 0 0 0 0 16.9246 0 0 0 0 0 13.2552 0 0 0 13.9414 0 10.1431 Q6UVJ0 SAS6_HUMAN "Spindle assembly abnormal protein 6 homolog, HsSAS-6" SASS6 SAS6 Homo sapiens (Human) centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; procentriole replication complex [GO:0120099]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236] GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0046601; GO:0051298; GO:0060236; GO:0098536; GO:0120099; GO:1900087; GO:1905832 EDSIPLR 0.9937 -6.9025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3035 0 11.9383 0 12.0603 0 0 0 0 0 0 0 11.1795 0 0 0 0 0 0 0 12.7737 0 0 12.345 0 11.0374 12.2183 0 0 0 13.1452 0 0 0 0 0 0 0 0 0 12.0427 0 0 0 0 0 0 0 0 14.2894 0 0 0 0 0 0 12.2872 11.6111 0 0 13.3016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4829 0 0 12.8505 0 0 0 11.5872 0 0 0 0 11.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VQ0 LCA5_HUMAN Lebercilin (Leber congenital amaurosis 5 protein) LCA5 C6orf152 Homo sapiens (Human) intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex binding [GO:0044877]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031] GO:0005929; GO:0005930; GO:0015031; GO:0032391; GO:0036064; GO:0042073; GO:0044877; GO:0045494 protein-containing complex binding [GO:0044877] ILSARLLKINELQNEVSELQVK 0.9937 -14.062 0 0 0 0 0 0 0 0 13.905 13.967 14.0479 13.445 13.602 13.9078 14.0565 15.1002 14.9132 14.5469 14.6154 14.1628 14.9083 0 14.7375 0 14.0766 0 14.7383 15.8095 15.4099 15.0538 14.3528 14.0484 0 14.1653 14.4684 14.1278 0 13.1674 13.3072 13.9525 15.5053 14.8387 0 16.0023 15.0058 0 12.9717 12.9371 0 0 14.7782 13.5676 0 13.8607 12.7036 13.7376 13.3435 12.0385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7171 0 0 0 0 0 0 0 0 0 0 0 0 12.8472 13.7757 0 0 0 0 0 0 13.4821 0 0 0 0 0 0 14.0152 0 0 12.0812 0 0 0 15.2995 0 0 0 0 0 0 0 0 14.4449 0 0 0 0 0 0 15.6958 0 0 0 0 0 12.7123 0 0 0 0 0 13.7576 12.2473 0 0 13.568 14.9681 0 13.3502 15.0215 14.1377 13.8021 0 0 0 0 14.1315 0 0 0 0 0 0 0 11.6647 14.1678 0 0 Q96A00 PP14A_HUMAN "Protein phosphatase 1 regulatory subunit 14A (17 kDa PKC-potentiated inhibitory protein of PP1) (Protein kinase C-potentiated inhibitor protein of 17 kDa, CPI-17)" PPP1R14A CPI17 PPP1INL Homo sapiens (Human) regulation of phosphorylation [GO:0042325] cytosol [GO:0005829] cytosol [GO:0005829]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; regulation of phosphorylation [GO:0042325] GO:0004865; GO:0005829; GO:0042325 protein serine/threonine phosphatase inhibitor activity [GO:0004865] AAQRLGK 0.9937 -27.424 0 0 0 0 0 13.8712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4861 0 12.1714 0 13.497 12.6455 0 0 0 0 0 12.8243 12.8612 0 0 11.9083 0 12.6593 13.0881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2288 13.995 14.2158 15.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6355 0 0 0 0 0 0 0 0 0 14.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZZ0 HXD1_HUMAN Homeobox protein Hox-D1 (Homeobox protein Hox-GG) HOXD1 HOX4 HOX4G Homo sapiens (Human) embryonic skeletal system development [GO:0048706]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of pain [GO:0019233] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; embryonic skeletal system development [GO:0048706]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of pain [GO:0019233]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0019233; GO:0030182; GO:0048706; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" FCRSDAR 0.9937 -6.4452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0375 15.4954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4I0 RD21L_HUMAN Double-strand-break repair protein rad21-like protein 1 RAD21L1 RAD21L Homo sapiens (Human) meiotic cell cycle [GO:0051321]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sister chromatid cohesion [GO:0007062] chromosome [GO:0005694]; cohesin complex [GO:0008278]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleus [GO:0005634] chromosome [GO:0005694]; cohesin complex [GO:0008278]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; meiotic cell cycle [GO:0051321]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sister chromatid cohesion [GO:0007062] GO:0003682; GO:0005634; GO:0005694; GO:0007062; GO:0008278; GO:0030893; GO:0034991; GO:0051321; GO:1990414 chromatin binding [GO:0003682] ILQMLNR 0.9937 -15.264 15.1757 0 0 13.6612 0 0 11.765 0 0 0 0 0 0 0 0 0 0 0 0 13.1755 13.2938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6911 0 0 0 0 0 0 0 0 0 0 0 11.9217 0 10.5266 0 10.1063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWH2 TM242_HUMAN Transmembrane protein 242 TMEM242 C6orf35 BM-033 HSPC287 Homo sapiens (Human) mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615] GO:0005743; GO:0016021; GO:0033615 KSPEWFNK 0.9937 -7.0963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6522 0 0 0 0 0 0 13.5501 13.364 13.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8156 0 0 0 0 0 0 0 0 0 0 0 0 0 12.834 13.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y496 KIF3A_HUMAN Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A) KIF3A KIF3 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507]; anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031] GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006996; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0019903; GO:0030507; GO:0031267; GO:0034454; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507] DLLGKDQTQR 0.9937 -14.098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3787 0 0 0 0 0 0 0 0 10.6742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6067 0 0 0 0 12.4366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8429 0 0 0 0 0 0 0 0 14.4824 12.4018 0 0 0 14.3271 12.7694 13.8533 13.6753 0 12.3987 15.135 0 13.9413 0 0 13.7497 0 0 0 0 0 0 14.0777 0 0 13.1621 0 0 12.014 14.1483 0 0 0 0 0 0 12.0083 0 0 11.7744 0 0 0 0 0 12.7328 0 0 0 0 0 0 12.8457 0 0 0 0 0 0 14.1815 0 0 0 0 0 12.6507 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5877 11.7839 0 0 0 11.5331 0 0 Q9Y5Q9 TF3C3_HUMAN "General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit, TFIIIC 102 kDa subunit, TFIIIC102) (Transcription factor IIIC subunit gamma, TF3C-gamma)" GTF3C3 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797] GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0031965; GO:0042791; GO:0042797 DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] ALELPPLVVEGIELDQLDLRR 0.9937 -5.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7827 0 0 0 13.2699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6086 0 0 0 0 0 0 0 13.0352 0 0 0 0 0 0 0 13.9531 0 13.9326 14.6424 0 0 0 0 0 0 11.8731 0 0 0 11.7604 0 0 0 0 11.7555 0 0 14.4876 13.6981 13.0867 14.1543 0 0 0 0 0 11.9227 0 0 0 0 0 0 0 0 0 0 0 0 13.0137 14.5272 12.7621 0 0 14.6551 0 12.9243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4082 0 0 0 0 0 0 0 0 0 0 0 14.1048 14.3188 0 0 12.9004 0 0 0 0 0 0 A6NCQ9 RN222_HUMAN RING finger protein 222 RNF222 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872] GO:0016021; GO:0046872 metal ion binding [GO:0046872] ALLLITLIAVVAVVAAILPWVLLVR 0.99371 -7.9278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0934 0 12.6691 11.1351 0 0 0 10.45 0 0 0 0 0 0 0 0 0 0 0 11.537 0 0 0 0 0 0 0 12.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2172 12.8173 13.1902 0 0 11.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0771 0 0 0 11.8529 0 13.79 0 0 13.825 0 0 13.5613 0 0 0 0 0 0 0 0 0 11.4142 0 0 0 0 0 0 0 0 10.8918 0 0 0 0 0 0 0 11.471 0 0 0 0 0 0 11.0868 0 0 O00305 CACB4_HUMAN "Voltage-dependent L-type calcium channel subunit beta-4, CAB4 (Calcium channel voltage-dependent subunit beta 4)" CACNB4 CACNLB4 Homo sapiens (Human) "adult walking behavior [GO:0007628]; cAMP metabolic process [GO:0046058]; cellular response to leukemia inhibitory factor [GO:1990830]; chemical synaptic transmission [GO:0007268]; detection of light stimulus involved in visual perception [GO:0050908]; gamma-aminobutyric acid secretion [GO:0014051]; gamma-aminobutyric acid signaling pathway [GO:0007214]; muscle cell development [GO:0055001]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuromuscular junction development [GO:0007528]; neuronal action potential propagation [GO:0019227]; Peyer's patch development [GO:0048541]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of voltage-gated calcium channel activity [GO:1901385]; spleen development [GO:0048536]; synaptic transmission, glutamatergic [GO:0035249]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]" cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] "cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; adult walking behavior [GO:0007628]; cAMP metabolic process [GO:0046058]; cellular response to leukemia inhibitory factor [GO:1990830]; chemical synaptic transmission [GO:0007268]; detection of light stimulus involved in visual perception [GO:0050908]; gamma-aminobutyric acid secretion [GO:0014051]; gamma-aminobutyric acid signaling pathway [GO:0007214]; muscle cell development [GO:0055001]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; neuromuscular junction development [GO:0007528]; neuronal action potential propagation [GO:0019227]; Peyer's patch development [GO:0048541]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of voltage-gated calcium channel activity [GO:1901387]; regulation of voltage-gated calcium channel activity [GO:1901385]; spleen development [GO:0048536]; synaptic transmission, glutamatergic [GO:0035249]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]" GO:0005730; GO:0005829; GO:0005886; GO:0005891; GO:0007214; GO:0007268; GO:0007528; GO:0007628; GO:0008285; GO:0009898; GO:0014051; GO:0016607; GO:0019227; GO:0019901; GO:0035249; GO:0045202; GO:0046058; GO:0048536; GO:0048538; GO:0048541; GO:0050852; GO:0050908; GO:0055001; GO:0098793; GO:0098978; GO:0099635; GO:1901385; GO:1901387; GO:1904751; GO:1990830; GO:2000134 protein kinase binding [GO:0019901]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635] EKYNNDWWIGRLVK 0.99371 -27.648 0 0 0 0 0 0 0 0 0 0 0 0 11.5024 0 0 0 0 0 12.0218 0 0 0 11.8637 0 0 0 0 0 0 0 0 0 11.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1876 15.2327 13.2721 15.1299 14.2007 0 15.7629 14.6334 15.3346 0 0 0 0 0 0 0 0 14.159 0 13.8783 0 14.3334 0 14.5317 0 0 14.2397 14.1502 14.2917 14.9852 0 13.9661 14.2271 14.229 0 0 0 0 0 0 0 14.3747 0 0 14.1462 0 0 0 0 0 13.7699 0 0 13.9425 14.1794 13.932 0 14.8972 0 0 0 0 13.3745 0 0 14.112 13.8259 13.6119 0 0 0 13.8124 0 0 0 0 12.1584 0 13.7056 13.7867 11.9533 0 12.8548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0092 0 0 0 13.4295 0 0 O15226 NKRF_HUMAN "NF-kappa-B-repressing factor, NFkB-repressing factor, NRF (Protein ITBA4)" NKRF ITBA4 NRF Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000978; GO:0001228; GO:0001671; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0045892; GO:0045944 "ATPase activator activity [GO:0001671]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CQNIYLTTGYAGSK 0.99371 -10.789 0 0 11.6385 12.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9492 0 0 0 0 0 0 0 0 0 10.8476 0 0 0 0 0 0 0 0 10.589 0 0 0 0 12.5929 12.3801 0 0 11.2894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1401 0 14.057 14.603 0 11.7593 0 0 0 0 0 0 0 0 0 0 11.2256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6464 0 0 0 0 0 0 0 0 0 0 12.6047 0 0 0 0 0 0 0 13.04 0 0 9.80879 0 0 0 0 0 12.525 0 0 13.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3773 0 0 0 0 0 0 0 0 12.5122 0 11.6944 0 0 0 0 12.9215 0 12.3304 0 0 0 0 0 0 13.1423 0 0 O60721 NCKX1_HUMAN Sodium/potassium/calcium exchanger 1 (Na(+)/K(+)/Ca(2+)-exchange protein 1) (Retinal rod Na-Ca+K exchanger) (Solute carrier family 24 member 1) SLC24A1 KIAA0702 NCKX1 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transport [GO:0006811]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; potassium ion transmembrane transport [GO:0071805]; response to light intensity [GO:0009642]; sodium ion transmembrane transport [GO:0035725]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; outer membrane [GO:0019867]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; outer membrane [GO:0019867]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cellular calcium ion homeostasis [GO:0006874]; ion transport [GO:0006811]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; potassium ion transmembrane transport [GO:0071805]; response to light intensity [GO:0009642]; sodium ion transmembrane transport [GO:0035725]; visual perception [GO:0007601]" GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006816; GO:0006874; GO:0007601; GO:0008273; GO:0009642; GO:0015293; GO:0016020; GO:0019867; GO:0035725; GO:0043025; GO:0060291; GO:0060292; GO:0070588; GO:0071805; GO:0098703 "calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]" DLSSEEMMMMSSSPSKPSSEMGGK 0.99371 -14.152 0 0 0 0 0 0 9.61829 0 0 0 0 12.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4553 0 0 10.9305 11.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4008 0 0 14.7733 0 0 0 0 12.5146 0 0 0 0 0 0 0 0 0 0 0 0 11.6406 0 0 11.6657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60930 RNH1_HUMAN "Ribonuclease H1, RNase H1, EC 3.1.26.4 (Ribonuclease H type II)" RNASEH1 RNH1 Homo sapiens (Human) "DNA replication, removal of RNA primer [GO:0043137]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; RNA catabolic process [GO:0006401]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" GO:0000287; GO:0003676; GO:0003723; GO:0004523; GO:0004540; GO:0005737; GO:0006401; GO:0043137; GO:0090502 magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523] GRKTGVFLTWNECR 0.99371 -6.4708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95600 KLF8_HUMAN Krueppel-like factor 8 (Basic krueppel-like factor 3) (Zinc finger protein 741) KLF8 BKLF3 ZNF741 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] aggresome [GO:0016235]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "aggresome [GO:0016235]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005654; GO:0005829; GO:0006357; GO:0016235; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHRRIHTGEK 0.99371 -27.553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6728 0 12.5395 0 0 0 0 0 0 0 0 0 0 13.9936 0 0 0 13.3654 0 0 0 11.452 0 0 0 0 0 14.7332 0 0 0 0 0 14.1184 13.1981 0 0 13.4612 12.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5943 13.8931 0 14.0123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4935 13.3512 0 0 0 0 0 13.6011 0 0 0 P06213 INSR_HUMAN "Insulin receptor, IR, EC 2.7.10.1 (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta ]" INSR Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]" axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor activity [GO:0005009]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; carbohydrate metabolic process [GO:0005975]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor-mediated endocytosis [GO:0006898]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; regulation of transcription, DNA-templated [GO:0006355]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718]" GO:0001540; GO:0001934; GO:0002092; GO:0003007; GO:0004713; GO:0004714; GO:0005009; GO:0005159; GO:0005198; GO:0005524; GO:0005525; GO:0005764; GO:0005770; GO:0005886; GO:0005887; GO:0005899; GO:0005901; GO:0005975; GO:0006355; GO:0006468; GO:0006898; GO:0007169; GO:0007186; GO:0007612; GO:0007613; GO:0008284; GO:0008286; GO:0008544; GO:0008584; GO:0009897; GO:0010008; GO:0014068; GO:0016020; GO:0018108; GO:0019904; GO:0030238; GO:0030325; GO:0030335; GO:0030424; GO:0031017; GO:0031994; GO:0031995; GO:0032147; GO:0032148; GO:0032590; GO:0032809; GO:0032869; GO:0033674; GO:0038024; GO:0038083; GO:0042593; GO:0042802; GO:0043235; GO:0043243; GO:0043406; GO:0043410; GO:0043548; GO:0043559; GO:0043560; GO:0044877; GO:0045429; GO:0045725; GO:0045821; GO:0045840; GO:0045893; GO:0045995; GO:0046326; GO:0046718; GO:0046777; GO:0048639; GO:0051425; GO:0051446; GO:0051897; GO:0060267; GO:0070062; GO:0071363; GO:0097062; GO:0097242; GO:0150104; GO:1990535; GO:2000194 amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor activity [GO:0005009]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] CSVAAYVSAR 0.99371 -14.108 0 0 0 0 0 0 0 11.9078 0 0 0 0 0 0 0 0 0 0 10.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9225 0 0 12.3724 0 0 0 0 0 0 0 0 0 12.7942 11.2596 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0901 0 0 0 11.9502 0 0 0 0 13.763 0 0 0 0 13.792 0 0 0 11.6828 0 0 0 0 0 0 0 0 0 16.5823 0 0 0 0 0 0 12.4412 13.2745 13.6286 0 0 0 0 0 0 0 0 0 0 12.5892 14.3345 0 0 12.365 0 0 0 0 0 11.4168 0 0 0 0 14.853 12.9599 0 0 0 12.5546 0 0 P12035 K2C3_HUMAN "Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3, CK-3) (Keratin-3, K3) (Type-II keratin Kb3)" KRT3 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; epithelial cell differentiation [GO:0030855]; intermediate filament cytoskeleton organization [GO:0045104]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005829; GO:0005882; GO:0030280; GO:0030855; GO:0031424; GO:0045095; GO:0045104; GO:0045109; GO:0070062 structural constituent of skin epidermis [GO:0030280] AQYEDIAQR 0.99371 -10.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0731 12.9948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7003 0 0 0 0 0 11.6691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6632 14.0851 0 14.1324 12.7249 12.9316 12.9462 12.7766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6208 0 0 0 0 0 0 13.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.254 0 P20930 FILA_HUMAN Filaggrin FLG Homo sapiens (Human) establishment of skin barrier [GO:0061436]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149] collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634] collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; structural constituent of skin epidermis [GO:0030280]; transition metal ion binding [GO:0046914]; establishment of skin barrier [GO:0061436]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149] GO:0001533; GO:0005509; GO:0005634; GO:0005829; GO:0018149; GO:0030216; GO:0030280; GO:0036457; GO:0036464; GO:0046914; GO:0061436; GO:0062023 calcium ion binding [GO:0005509]; structural constituent of skin epidermis [GO:0030280]; transition metal ion binding [GO:0046914] AGHGHSADR 0.99371 -27.712 0 0 0 0 0 0 12.9409 0 0 14.5254 11.4752 13.7195 13.3643 13.0348 0 10.5201 0 0 13.6297 0 0 0 10.0556 0 0 0 0 0 0 0 0 13.6363 0 11.0518 0 0 0 0 0 14.0357 0 0 0 0 11.3634 0 0 0 0 0 0 0 0 0 0 0 13.2562 0 0 10.309 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8411 11.0344 12.8153 0 0 13.6113 13.8246 13.3813 15.0768 14.492 14.5542 14.5311 0 0 15.1135 14.3135 0 0 13.6867 0 14.3301 14.0812 14.0049 14.6559 14.7026 13.3228 0 0 0 0 0 0 13.4771 0 14.2152 12.1908 12.8375 0 0 12.792 12.9852 14.0515 0 0 0 0 0 0 12.7454 0 10.4206 0 15.5232 0 12.2055 12.0329 0 11.8506 0 0 0 11.038 0 11.7868 0 0 0 0 0 0 0 13.4404 15.6017 13.0287 0 0 13.5533 12.1304 0 0 0 0 0 0 13.6434 0 13.9163 0 11.3409 0 0 0 13.4014 0 12.1904 0 13.2876 14.1202 0 12.6521 0 13.8309 0 0 0 0 13.7394 P45974 UBP5_HUMAN "Ubiquitin carboxyl-terminal hydrolase 5, EC 3.4.19.12 (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)" USP5 ISOT Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634] cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005764; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016579; GO:0032436; GO:0043130; GO:0071108 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] DLGYIYFYQR 0.99371 -16.169 0 0 0 0 0 0 0 0 0 0 16.559 0 0 16.7458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1469 0 0 0 0 16.9137 0 0 0 17.1799 17.1229 0 0 0 0 0 0 17.2347 0 0 0 0 17.2414 0 0 0 0 0 16.6521 0 0 16.4244 16.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.812 0 0 0 0 0 14.5139 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7161 0 0 0 0 0 12.8224 11.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5838 0 0 0 0 0 0 0 0 17.1875 0 0 0 0 17.3927 0 0 17.2334 0 17.3141 0 0 0 0 0 0 0 0 17.2663 0 17.3447 P61764 STXB1_HUMAN "Syntaxin-binding protein 1 (MUNC18-1) (N-Sec1) (Protein unc-18 homolog 1, Unc18-1) (Protein unc-18 homolog A, Unc-18A) (p67)" STXBP1 UNC18A Homo sapiens (Human) "axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of acrosomal vesicle exocytosis [GO:2000367]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; regulation of synaptic vesicle priming [GO:0010807]; response to estradiol [GO:0032355]; SNARE complex assembly [GO:0035493]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0002576; GO:0003006; GO:0003723; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0007274; GO:0007412; GO:0010807; GO:0016082; GO:0016188; GO:0016192; GO:0017075; GO:0019901; GO:0019904; GO:0019905; GO:0030141; GO:0030424; GO:0031091; GO:0031333; GO:0031630; GO:0032229; GO:0032355; GO:0032991; GO:0035493; GO:0035542; GO:0042802; GO:0043274; GO:0043306; GO:0043524; GO:0045335; GO:0045956; GO:0047485; GO:0048471; GO:0048787; GO:0050821; GO:0051402; GO:0060292; GO:0070062; GO:0070527; GO:0071346; GO:0072659; GO:0098794; GO:0098978; GO:0099525; GO:0106022; GO:1903296; GO:2000367 identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] APIGLKAVVGEK 0.99371 -27.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1098 0 0 0 0 0 12.7981 0 9.73256 0 0 0 0 11.9161 0 0 0 0 0 0 10.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3567 0 0 0 0 0 0 0 0 11.9702 13.5418 0 0 0 0 0 0 12.5044 0 11.2078 0 0 0 0 16.808 0 0 0 0 0 12.1873 11.209 10.9245 0 11.8413 0 0 0 0 0 14.0223 12.7682 12.0821 11.6832 0 0 13.8639 15.3593 10.6057 0 0 0 0 0 0 0 0 11.1752 0 0 0 0 11.5289 11.6791 0 0 0 0 0 0 0 0 0 0 0 10.6644 0 12.4974 0 10.9989 0 0 0 0 0 0 0 0 0 9.05515 0 0 0 0 0 0 0 0 0 10.4975 0 0 0 13.4597 P63151 2ABA_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha) PPP2R2A Homo sapiens (Human) protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278] GO:0000159; GO:0005654; GO:0005829; GO:0006470; GO:0019888; GO:0043278; GO:0098978 protein phosphatase regulator activity [GO:0019888] ASALCDR 0.99371 -27.56 9.46354 0 10.7875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3372 0 0 0 0 0 0 13.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3326 0 0 0 0 0 0 0 Q15311 RBP1_HUMAN "RalA-binding protein 1, RalBP1 (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase, DNP-SG ATPase, EC 7.6.2.2, EC 7.6.2.3) (Ral-interacting protein 1)" RALBP1 RLIP RLIP1 RLIP76 Homo sapiens (Human) chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910]; chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] GO:0000922; GO:0001934; GO:0005096; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006897; GO:0006935; GO:0007264; GO:0008559; GO:0015431; GO:0016020; GO:0022857; GO:0031267; GO:0032489; GO:0042626; GO:0042910; GO:0043087; GO:0043547; GO:0051056; GO:0055085; GO:0090141; GO:1900753; GO:1990961 ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910] DLPENLLTKELMPR 0.99371 -28.944 0 0 0 10.6986 0 0 0 0 13.3904 16.6249 0 13.1595 13.0465 13.757 0 0 0 14.3826 13.4707 13.4544 14.2186 0 12.9214 11.9303 14.213 13.4743 14.9977 14.8376 0 0 12.5387 14.4444 13.3855 13.8116 17.188 13.3686 0 13.1965 0 17.3055 12.4059 12.7448 17.3077 13.3442 14.6874 12.0934 13.8354 12.5805 14.6063 0 13.3959 0 0 0 0 0 0 0 10.5969 0 0 0 15.9881 0 0 0 0 0 0 11.1373 0 0 0 0 0 0 0 0 16.2226 11.857 13.8016 12.0373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6022 14.0289 0 0 0 0 0 0 0 11.402 13.5178 0 15.8858 0 0 14.7099 0 14.4983 0 0 12.0477 0 18.2886 13.3126 13.3264 13.5697 0 12.3137 14.112 0 0 0 0 0 0 0 14.8223 0 14.6596 0 13.911 0 0 0 0 0 0 0 15.9581 0 0 0 0 0 0 14.4747 14.6086 11.3978 14.6328 0 11.575 15.182 16.0162 17.183 14.747 15.2331 14.8988 13.1106 15.7938 0 15.3852 15.4671 0 0 0 10.4282 14.195 0 17.134 0 0 Q5VZQ5 TEX36_HUMAN Testis-expressed protein 36 TEX36 C10orf122 Homo sapiens (Human) EIWNAFTFLPERSYTEVLK 0.99371 -7.9131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZNG2 DBX2_HUMAN Homeobox protein DBX2 (Developing brain homeobox protein 2) DBX2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0006357 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" ESQVKIWFQNR 0.99371 -6.4707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6J4 FGD2_HUMAN "FYVE, RhoGEF and PH domain-containing protein 2 (Zinc finger FYVE domain-containing protein 4)" FGD2 ZFYVE4 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; positive regulation of JUN kinase activity [GO:0043507]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0001726; GO:0005085; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0031901; GO:0032587; GO:0043087; GO:0043507; GO:0046847; GO:0046872; GO:0051056; GO:1901981 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267] AASGWSPSWPNDGDLSD 0.99371 -6.4727 0 0 0 0 0 0 0 0 0 0 10.5436 0 0 0 10.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2751 12.6434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0985 0 0 0 0 0 0 0 0 0 0 0 0 11.6357 0 0 0 0 11.9616 12.5009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5113 0 0 0 0 0 0 0 0 0 0 12.6088 0 0 0 0 0 0 0 12.1205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0297 0 0 12.2242 0 12.633 0 14.3093 0 0 0 12.9901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAG9 EXOC6_HUMAN Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1) EXOC6 SEC15A SEC15L SEC15L1 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522] GO:0000145; GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0030426; GO:0048471; GO:0090148; GO:0090522; GO:0090543 FGKNMYINR 0.99371 -27.561 0 0 0 0 9.86876 0 0 0 0 0 0 0 0 0 9.88695 11.4133 11.0183 11.9372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8319 0 11.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAV0 FA76A_HUMAN Protein FAM76A FAM76A Homo sapiens (Human) nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] GO:0005654; GO:0016607 CTNSEKKYGPPYSCEQCK 0.99371 -14.181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3716 0 0 0 0 13.1063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1787 0 0 0 0 0 0 0 0 0 12.8436 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDW7 FAT3_HUMAN "Protocadherin Fat 3, hFat3 (Cadherin family member 15) (FAT tumor suppressor homolog 3)" FAT3 CDHF15 KIAA1989 Homo sapiens (Human) cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842] GO:0000904; GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016021; GO:0016358; GO:0030425; GO:0098609; GO:1904936; GO:2000171 calcium ion binding [GO:0005509] AEEVIIADFCFLRIR 0.99371 -14.115 0 0 0 0 0 0 0 0 0 0 0 14.3034 0 10.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2473 0 0 0 0 0 0 11.1954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1857 0 0 0 0 11.886 15.6135 0 11.5614 0 14.5045 13.3068 0 0 13.6792 13.3149 0 15.0546 13.5778 0 13.5893 0 14.46 0 0 14.1154 0 14.9202 15.5108 0 0 12.3501 10.9704 0 0 11.4906 0 14.1327 0 0 0 0 0 0 0 15.4405 14.0508 14.158 14.5641 0 0 15.2172 13.0697 12.8985 0 0 13.7162 11.1132 0 0 0 13.5313 0 16.0585 0 0 0 0 14.0637 12.091 0 0 0 11.6644 0 0 12.3487 12.0834 12.9458 19.5612 0 0 0 12.7584 0 0 0 0 0 12.4481 0 0 10.6539 0 0 0 0 0 0 0 0 0 12.5122 14.2372 13.0536 0 0 0 0 0 15.036 10.8327 11.5332 Q8WV28 BLNK_HUMAN "B-cell linker protein (B-cell adapter containing a SH2 domain protein) (B-cell adapter containing a Src homology 2 domain protein) (Cytoplasmic adapter protein) (Src homology 2 domain-containing leukocyte protein of 65 kDa, SLP-65)" BLNK BASH SLP65 Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of gene expression [GO:0010628]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; positive regulation of gene expression [GO:0010628]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005068; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006959; GO:0007169; GO:0010628; GO:0016020; GO:0019899; GO:0019901; GO:0030183; GO:0035556; GO:0035591; GO:0042169; GO:0043231; GO:0043274; GO:0050853; GO:1990782 enzyme binding [GO:0019899]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] APMVNRSTK 0.99371 -14.149 0 0 0 0 0 0 0 0 0 0 0 0 11.284 0 0 0 0 0 0 0 0 0 0 13.0281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1895 18.5039 16.6344 18.3564 13.7008 0 12.6254 17.0973 0 0 0 0 0 13.5801 14.5065 0 0 0 13.5239 13.8539 13.6499 13.6578 0 0 13.0742 13.0823 0 0 13.582 0 0 0 13.5853 0 13.4565 0 0 0 13.2012 0 0 0 0 0 13.535 0 13.2465 0 13.6629 0 0 0 0 17.4171 0 0 0 13.1815 15.0693 0 0 0 16.3875 16.5392 0 0 0 15.8627 15.815 0 15.7805 0 15.6266 0 0 0 0 0 10.6512 12.4521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7722 16.034 15.1068 0 0 0 0 0 0 0 Q969Q4 ARL11_HUMAN ADP-ribosylation factor-like protein 11 (ADP-ribosylation factor-like tumor suppressor protein 1) ARL11 ARLTS1 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192] GO:0002244; GO:0003924; GO:0005525; GO:0005886; GO:0006886; GO:0016192 GTP binding [GO:0005525]; GTPase activity [GO:0003924] AHGAERGDSK 0.99371 -9.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.723 0 0 0 0 13.9559 0 13.736 0 13.1366 0 0 0 0 0 0 0 0 0 13.3522 0 0 0 0 13.3451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7533 0 0 0 10.2817 0 0 0 0 0 10.5343 0 13.0394 0 0 0 0 0 0 11.0676 0 0 0 11.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H12 MSD3_HUMAN Myb/SANT-like DNA-binding domain-containing protein 3 MSANTD3 C9orf30 L8 Homo sapiens (Human) ELCDDEK 0.99371 -14.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSI4 TINF2_HUMAN TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2) TINF2 TIN2 Homo sapiens (Human) "negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance via telomere lengthening [GO:1904356]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; perinucleolar chromocenter [GO:0010370]; shelterin complex [GO:0070187]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; perinucleolar chromocenter [GO:0010370]; shelterin complex [GO:0070187]; telomeric DNA binding [GO:0042162]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance via telomere lengthening [GO:1904356]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]" GO:0000781; GO:0000783; GO:0005654; GO:0010370; GO:0010836; GO:0016233; GO:0016363; GO:0016604; GO:0032202; GO:0032206; GO:0032211; GO:0042162; GO:0050680; GO:0070187; GO:0070198; GO:1904356 telomeric DNA binding [GO:0042162] ENCLDCYMDPLR 0.99371 -7.9287 0 9.48033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4079 0 0 0 0 0 0 0 11.9957 0 0 0 0 0 0 0 11.9335 0 11.463 0 0 0 0 0 12.5988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5383 0 0 0 0 0 0 13.7515 14.0045 0 0 0 0 0 0 0 0 0 16.0647 0 0 0 0 16.4006 0 16.3365 0 0 0 16.6836 0 0 14.7777 0 0 14.8001 16.7611 17.5262 17.2382 0 14.9 16.269 15.349 0 14.7827 14.8734 0 14.9866 0 14.6043 14.4347 14.6887 16.2458 0 0 0 16.4664 0 0 14.9286 0 0 14.2767 17.746 0 16.3909 0 0 14.3394 16.4167 0 14.0491 16.1567 14.0229 14.1951 14.0083 16.3807 0 0 0 16.0652 13.5736 0 0 15.8905 14.2381 15.77 0 12.4618 0 12.6033 0 12.8247 12.6606 12.9624 0 13.3666 12.8636 0 12.3833 12.6895 16.1066 13.7408 0 13.8616 0 0 0 0 0 Q9UBX0 HESX1_HUMAN "Homeobox expressed in ES cells 1 (Homeobox protein ANF, hAnf)" HESX1 HANF Homo sapiens (Human) brain development [GO:0007420]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cadmium ion [GO:0071276]; ERK1 and ERK2 cascade [GO:0070371]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; gonad development [GO:0008406]; leukemia inhibitory factor signaling pathway [GO:0048861]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; otic vesicle formation [GO:0030916]; pituitary gland development [GO:0021983]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; thyroid gland development [GO:0030878] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; cellular response to cadmium ion [GO:0071276]; ERK1 and ERK2 cascade [GO:0070371]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; gonad development [GO:0008406]; leukemia inhibitory factor signaling pathway [GO:0048861]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; otic vesicle formation [GO:0030916]; pituitary gland development [GO:0021983]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; thyroid gland development [GO:0030878]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0005634; GO:0006357; GO:0007420; GO:0008022; GO:0008406; GO:0010467; GO:0019827; GO:0021983; GO:0030878; GO:0030916; GO:0035264; GO:0042803; GO:0043010; GO:0043584; GO:0045995; GO:0047485; GO:0048853; GO:0048861; GO:0048863; GO:0060070; GO:0070371; GO:0071276; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" NFNTNLLE 0.99371 -6.9063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5023 13.1296 0 0 0 14.2538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UM54 MYO6_HUMAN Unconventional myosin-VI (Unconventional myosin-6) MYO6 KIAA0389 Homo sapiens (Human) "actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]" "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]" "actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II, holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; sensory perception of sound [GO:0007605]; vesicle transport along actin filament [GO:0030050]" GO:0000146; GO:0001726; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005794; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005905; GO:0005938; GO:0006886; GO:0006897; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016461; GO:0016591; GO:0030048; GO:0030050; GO:0030139; GO:0030175; GO:0030330; GO:0030665; GO:0031410; GO:0031941; GO:0031965; GO:0032587; GO:0042472; GO:0042491; GO:0042802; GO:0043531; GO:0045944; GO:0048471; GO:0051015; GO:0051046; GO:0060001; GO:0070062 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; minus-end directed microfilament motor activity [GO:0060001] DHFRLTIPR 0.99371 -27.563 0 13.7513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3355 0 11.6326 0 0 0 12.9301 0 0 0 0 0 0 0 0 11.5767 0 0 0 0 0 0 0 0 0 11.5249 0 0 0 0 0 0 0 0 0 0 0 0 11.7565 0 0 0 0 0 0 0 0 0 0 11.4028 0 0 0 0 0 0 0 0 0 0 9.66033 0 0 0 0 0 0 0 12.803 0 0 0 12.4619 16.1714 0 0 0 0 12.6633 0 15.5582 0 0 10.4704 0 0 0 0 0 0 0 0 15.7057 0 0 0 16.2126 0 0 0 0 0 0 0 0 0 0 13.0638 0 0 0 12.5217 0 0 0 0 14.0716 0 0 10.8184 0 0 0 13.2869 0 0 0 11.9651 0 0 0 0 0 0 0 10.2325 0 0 15.0069 0 11.7279 13.4018 0 0 11.0974 0 0 0 0 0 0 13.0517 0 0 0 0 0 13.3771 0 0 0 0 B4E2M5 ANR66_HUMAN Ankyrin repeat domain-containing protein 66 ANKRD66 Homo sapiens (Human) DEDWDAK 0.99372 -14.201 0 0 0 0 0 0 0 0 0 0 0 12.1559 12.9589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2333 0 0 0 0 13.4499 0 0 0 0 0 0 13.2767 13.5175 0 0 0 0 0 0 12.4484 13.4383 12.9507 13.3393 0 12.5307 0 0 0 0 13.0976 12.0798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07197 NFM_HUMAN "Neurofilament medium polypeptide, NF-M (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein)" NEFM NEF3 NFM Homo sapiens (Human) intermediate filament organization [GO:0045109]; neurofilament bundle assembly [GO:0033693] axon [GO:0030424]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]; postsynaptic intermediate filament cytoskeleton [GO:0099160] axon [GO:0030424]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofibrillary tangle [GO:0097418]; neurofilament [GO:0005883]; postsynaptic intermediate filament cytoskeleton [GO:0099160]; microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200]; intermediate filament organization [GO:0045109]; neurofilament bundle assembly [GO:0033693] GO:0005200; GO:0005737; GO:0005882; GO:0005883; GO:0008017; GO:0030424; GO:0033693; GO:0045109; GO:0045111; GO:0097418; GO:0099160 microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200] ALRKDIEEASLVK 0.99372 -27.801 0 0 0 0 0 0 10.7546 0 14.0623 0 0 0 14.7611 0 0 0 0 0 0 0 0 0 0 11.3924 0 0 11.8 11.9457 0 0 0 0 0 0 11.7735 0 0 0 0 0 0 0 0 0 9.50633 0 10.3357 10.5764 0 0 12.784 0 0 0 11.1903 0 0 0 0 0 0 0 0 0 0 0 0 14.5114 11.0717 11.6258 0 15.9811 10.9685 0 14.5689 0 0 0 14.7666 0 0 0 0 10.7096 14.3371 14.0261 0 0 0 0 0 0 0 10.5531 0 14.2911 12.1332 0 0 14.1831 0 0 0 0 0 0 0 12.6042 14.5878 15.0189 13.3103 0 0 13.0691 0 13.8763 0 0 0 15.5286 17.2115 13.6499 14.8403 0 11.1259 0 10.5311 14.0944 14.0771 0 0 11.5857 12.822 13.0157 10.7201 12.0333 0 0 12.4654 0 13.2601 12.7049 0 11.3685 0 16.815 11.6839 0 11.3714 0 0 0 11.7481 18.0758 0 0 13.0564 14.3604 0 14.3235 13.7204 0 0 11.5013 12.311 0 12.7736 0 0 0 15.2007 0 0 0 0 13.5929 0 0 13.9699 10.1411 P35269 T2FA_HUMAN "General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha, TFIIF-alpha) (Transcription initiation factor RAP74)" GTF2F1 RAP74 Homo sapiens (Human) negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to virus [GO:0009615]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674] cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674]; DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TFIIF-class transcription factor complex binding [GO:0001096]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to virus [GO:0009615]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0001091; GO:0001096; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005669; GO:0005674; GO:0006366; GO:0006367; GO:0006368; GO:0009615; GO:0016251; GO:0019211; GO:0019903; GO:0019904; GO:0030054; GO:0032091; GO:0032968; GO:0032991; GO:0043231; GO:0045944; GO:1990841 DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TFIIF-class transcription factor complex binding [GO:0001096] DSSEESDSSEESDIDSEASSALFMAK 0.99372 -15.872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0934 0 0 0 11.2126 0 0 0 0 0 12.5247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3613 13.3593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9391 0 0 0 0 11.8687 13.9366 0 0 0 12.9655 13.9473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.77 0 0 0 0 0 14.1039 0 0 0 0 12.1641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52888 THOP1_HUMAN "Thimet oligopeptidase, EC 3.4.24.15 (Endopeptidase 24.15) (MP78)" THOP1 Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] GO:0000209; GO:0004222; GO:0005758; GO:0005829; GO:0006508; GO:0006518; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] DPKQDAFLLSK 0.99372 -15.863 0 10.9497 0 0 0 0 0 0 0 12.2051 11.7599 0 11.7335 11.9438 13.6059 0 0 13.0591 0 12.5844 0 0 0 0 0 0 13.7512 0 0 0 0 13.3995 12.5191 13.3962 13.1486 0 13.3012 0 13.3565 0 12.9396 12.1206 0 13.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1091 0 0 0 0 0 0 0 0 0 13.4533 0 12.2189 0 0 0 0 0 13.4827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8469 12.952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4707 14.4868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5964 0 0 13.9867 15.4645 15.1509 14.4707 13.4043 14.8155 14.0449 15.1749 15.451 14.6658 15.2392 15.28 13.8902 14.2449 15.3259 0 0 0 0 12.8477 0 14.7577 0 0 Q12767 TMM94_HUMAN Transmembrane protein 94 TMEM94 KIAA0195 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 APAWFEDFANGLLSAQKLTAALIVLHTVFISITHVHRTK 0.99372 -13.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7305 0 0 0 0 0 0 0 0 0 0 0 0 12.0929 11.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7706 0 0 13.2814 0 0 15.7258 0 14.5163 11.9971 0 0 0 0 15.9196 0 0 14.9243 16.1311 0 0 0 0 0 0 0 0 0 0 0 15.2909 0 0 0 13.2696 0 0 0 11.8145 13.7709 0 11.9922 0 0 0 0 0 12.4559 0 0 0 0 15.8322 0 13.852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7931 0 15.6368 0 11.9786 0 0 14.1024 0 0 11.4604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2173 0 0 16.3702 0 0 0 0 0 0 0 Q6P1J6 PLB1_HUMAN "Phospholipase B1, membrane-associated, Phospholipase B, hPLB (Lysophospholipase, EC 3.1.1.5) (Phospholipase A2, EC 3.1.1.4) (Phospholipase B/lipase, PLB/LIP) (Triacylglycerol lipase, EC 3.1.1.3)" PLB1 PLB Homo sapiens (Human) diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]; diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523]; triglyceride catabolic process [GO:0019433] GO:0001523; GO:0004620; GO:0004622; GO:0004623; GO:0004806; GO:0005886; GO:0006644; GO:0016021; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0036151; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:0102545; GO:2000344 calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; phospholipase activity [GO:0004620]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806] IHFQEDWK 0.99372 -14.212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8216 17.8627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8362 0 11.1016 0 0 0 0 Q70EL2 UBP45_HUMAN "Ubiquitin carboxyl-terminal hydrolase 45, EC 3.4.19.12 (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45)" USP45 Homo sapiens (Human) cell migration [GO:0016477]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; neural retina development [GO:0003407]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270]; cell migration [GO:0016477]; DNA repair [GO:0006281]; global genome nucleotide-excision repair [GO:0070911]; neural retina development [GO:0003407]; photoreceptor cell maintenance [GO:0045494]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001917; GO:0003407; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006511; GO:0008270; GO:0016477; GO:0016579; GO:0045494; GO:0070911 cysteine-type deubiquitinase activity [GO:0004843]; zinc ion binding [GO:0008270] ALSAQAYLLFYERVL 0.99372 -29.458 0 0 0 0 0 0 0 0 0 0 0 0 12.179 0 0 0 0 0 0 0 12.8853 9.47764 0 14.3861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4516 11.268 0 0 0 0 0 0 0 0 0 10.0063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7595 0 12.6598 0 13.4372 0 0 0 11.7719 0 13.1001 0 14.9725 15.1283 14.309 0 0 0 0 14.5127 0 14.2133 14.6823 14.015 0 0 0 14.279 0 12.6779 10.7668 0 0 13.1747 0 14.1689 0 0 11.8999 13.1898 0 0 12.9139 0 0 12.2115 0 0 13.7676 0 0 14.8628 14.0314 14.2421 0 15.469 13.8295 12.7967 0 0 0 14.4189 0 0 12.4807 13.5048 0 14.6654 0 0 0 12.825 13.3011 0 0 0 12.1751 12.845 10.4745 0 0 13.0636 0 11.8771 12.2946 14.7543 0 0 0 13.4204 0 11.1207 0 0 0 0 0 0 0 10.6523 0 0 0 0 13.7768 0 0 11.914 13.8771 0 Q8IV35 WDR49_HUMAN WD repeat-containing protein 49 WDR49 Homo sapiens (Human) EILHHER 0.99372 -15.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.70743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2541 0 0 0 0 0 0 0 0 0 0 0 11.8798 0 0 0 0 0 0 0 0 12.2028 0 0 0 0 Q96FS4 SIPA1_HUMAN "Signal-induced proliferation-associated protein 1, Sipa-1 (GTPase-activating protein Spa-1) (p130 SPA-1)" SIPA1 SPA1 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; cellular response to water deprivation [GO:0042631]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]; GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; cellular response to water deprivation [GO:0042631]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0002250; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0007010; GO:0007162; GO:0007165; GO:0008022; GO:0016020; GO:0030133; GO:0030308; GO:0032991; GO:0035556; GO:0042631; GO:0045786; GO:0048471; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096]; protein C-terminus binding [GO:0008022] AGQGSEEEMYNNQEAGPAFMQFLTLLGDVVR 0.99372 -15.864 0 0 0 0 0 0 0 0 11.6291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5043 13.7598 13.0518 0 0 0 0 0 0 13.1563 12.2987 14.7594 0 12.9464 0 0 13.5311 0 14.2928 0 0 0 0 0 0 0 0 13.2318 0 0 0 0 0 0 0 11.9347 0 13.0328 13.0136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2463 0 0 0 0 0 0 0 12.1172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1469 0 13.0691 0 0 0 0 0 0 Q9BT92 TCHP_HUMAN "Trichoplein keratin filament-binding protein, Protein TCHP (Mitochondrial protein with oncostatic activity, Mitostatin) (Tumor suppressor protein)" TCHP Homo sapiens (Human) apoptotic process [GO:0006915]; cell projection organization [GO:0030030]; negative regulation of cell growth [GO:0030308]; negative regulation of cilium assembly [GO:1902018] apical cortex [GO:0045179]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] apical cortex [GO:0045179]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; apoptotic process [GO:0006915]; cell projection organization [GO:0030030]; negative regulation of cell growth [GO:0030308]; negative regulation of cilium assembly [GO:1902018] GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006915; GO:0030030; GO:0030057; GO:0030308; GO:0045095; GO:0045179; GO:1902018 ARREALER 0.99372 -29.447 0 0 0 0 0 0 0 0 0 0 0 13.4667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4035 0 0 0 0 13.6741 0 0 0 0 0 0 0 0 10.6554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8931 14.2134 0 13.8443 0 0 14.0631 0 0 0 0 0 0 14.0941 14.1984 0 0 0 0 0 0 0 14.3291 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9664 13.8741 14.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4807 0 13.7445 0 0 0 0 0 A8MVM7 YD021_HUMAN Putative uncharacterized protein ENSP00000382790 Homo sapiens (Human) KCLEDNK 0.99373 -13.171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6856 0 0 0 0 11.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8088 10.1107 0 0 0 11.3193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1732 0 0 0 0 14.5398 10.722 0 0 0 0 0 14.6899 0 0 11.3853 0 0 0 0 0 0 0 0 0 12.6342 0 0 0 0 14.4059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2262 0 0 0 0 12.8244 0 13.4298 0 0 13.0745 0 0 13.8576 14.2592 13.6341 0 0 13.736 0 0 0 13.3442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9412 0 0 11.5892 0 0 0 0 0 P01588 EPO_HUMAN Erythropoietin (Epoetin) EPO Homo sapiens (Human) "acute-phase response [GO:0006953]; aging [GO:0007568]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; myeloid cell apoptotic process [GO:0033028]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]" cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295]; acute-phase response [GO:0006953]; aging [GO:0007568]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; myeloid cell apoptotic process [GO:0033028]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]" GO:0000122; GO:0001666; GO:0005125; GO:0005128; GO:0005179; GO:0005576; GO:0005615; GO:0006953; GO:0007165; GO:0007566; GO:0007568; GO:0008015; GO:0008284; GO:0009651; GO:0009986; GO:0010523; GO:0010976; GO:0018105; GO:0030218; GO:0030295; GO:0032496; GO:0033028; GO:0033189; GO:0033574; GO:0038162; GO:0042104; GO:0042531; GO:0042541; GO:0043249; GO:0043627; GO:0044297; GO:0045666; GO:0045893; GO:0046579; GO:0048678; GO:0051602; GO:0055093; GO:0070374; GO:0070555; GO:0071474; GO:0071548; GO:1901215; GO:1902219; GO:1902251; GO:2001258 cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295] AVSGLRSLTTLLRALGAQK 0.99373 -9.1068 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3706 0 0 0 0 0 0 0 10.2853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7325 0 0 0 12.4743 0 0 0 0 12.7277 0 14.1407 0 0 0 0 0 0 0 0 0 0 0 12.6972 0 0 0 0 0 0 12.8407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0828 0 0 0 0 0 0 0 0 0 0 0 0 P19823 ITIH2_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H2, ITI heavy chain H2, ITI-HC2, Inter-alpha-inhibitor heavy chain 2 (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein, SHAP)" ITIH2 IGHEP2 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] GO:0004866; GO:0004867; GO:0005540; GO:0005576; GO:0005788; GO:0030212; GO:0062023; GO:0070062; GO:0072562 endopeptidase inhibitor activity [GO:0004866]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867] KEKVVTITLDK 0.99373 -15.901 0 0 0 13.3919 12.2251 0 12.2903 0 0 0 0 12.4832 12.6033 0 0 14.3734 0 0 0 0 0 0 10.3977 0 0 11.004 0 0 0 0 0 13.256 0 0 0 12.1952 12.406 0 0 12.3944 0 12.8729 0 12.5265 0 0 12.9051 13.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8094 0 0 0 0 0 0 0 0 0 0 0 11.385 0 0 0 0 0 0 0 0 0 0 0 14.9892 0 0 0 11.3814 0 0 0 0 0 0 0 0 13.4771 0 0 14.1528 0 0 0 0 0 14.1573 0 0 0 0 0 0 13.8931 15.5726 0 0 0 12.9046 0 0 0 0 12.6906 0 0 0 0 0 11.6435 0 0 0 13.532 0 0 0 0 0 0 13.9729 0 0 0 0 0 0 P23921 RIR1_HUMAN "Ribonucleoside-diphosphate reductase large subunit, EC 1.17.4.1 (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit)" RRM1 RR1 Homo sapiens (Human) 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; mitochondrial DNA replication [GO:0006264]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185] cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribonucleoside-diphosphate reductase complex [GO:0005971] "cytosol [GO:0005829]; mitochondrion [GO:0005739]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; 2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; mitochondrial DNA replication [GO:0006264]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185]" GO:0000731; GO:0004748; GO:0005524; GO:0005739; GO:0005829; GO:0005971; GO:0006264; GO:0006281; GO:0009185; GO:0009263; GO:0009265; GO:0010971; GO:0042802; GO:0051290; GO:0061731; GO:0070318; GO:0097718; GO:1900087 "ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; ribonucleoside-diphosphate reductase activity [GO:0061731]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]" ERNTAAMVCSLENRDECLMCGS 0.99373 -13.17 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0822 0 0 12.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5129 0 0 0 0 0 0 0 0 0 0 14.5812 0 0 0 0 0 0 13.6025 13.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4858 14.4629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5577 0 Q14679 TTLL4_HUMAN "Tubulin monoglutamylase TTLL4, EC 6.3.2.- (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4)" TTLL4 KIAA0173 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222] GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0120222 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] CSGQTSR 0.99373 -13.142 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9118 0 0 0 0 0 12.8406 12.1344 12.6379 0 0 0 0 11.1038 0 0 0 11.2857 0 0 0 0 0 0 0 0 0 0 13.2917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4437 0 10.7656 0 0 0 15.0953 0 0 0 0 14.1817 0 0 0 12.2753 0 0 0 0 0 12.1867 0 0 0 13.5895 0 0 0 0 0 0 0 0 15.8767 0 0 0 0 0 0 16.6382 10.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1214 0 0 0 15.6928 18.0529 16.2843 0 0 0 0 0 Q16560 U1SBP_HUMAN "U11/U12 small nuclear ribonucleoprotein 35 kDa protein, U11/U12 snRNP 35 kDa protein, U11/U12-35K (Protein HM-1) (U1 snRNP-binding protein homolog)" SNRNP35 HM1 U1SNRNPBP Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; mRNA binding [GO:0003729]; snRNA binding [GO:0017069]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0005689; GO:0005730; GO:0008380; GO:0017069 mRNA binding [GO:0003729]; snRNA binding [GO:0017069] DLVTGFSK 0.99373 -13.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6549 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7167 0 0 0 0 0 0 0 0 0 12.4728 14.4472 0 12.462 0 0 0 0 0 11.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VC12 MSS51_HUMAN "Putative protein MSS51 homolog, mitochondrial (Zinc finger MYND domain-containing protein 17)" MSS51 ZMYND17 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] CPQEMFQR 0.99373 -9.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 13.424 0 0 13.5475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2923 0 0 0 0 0 0 0 0 0 0 0 0 10.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9234 0 0 0 0 0 0 0 0 12.5597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9122 11.0861 14.4654 0 0 0 0 0 0 10.7178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z589 EMSY_HUMAN BRCA2-interacting transcriptional repressor EMSY EMSY C11orf30 GL002 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005654; GO:0006281; GO:0006325; GO:0006355 GIGSTVQPAAK 0.99373 -13.139 0 0 12.0834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.512 0 0 0 0 0 0 13.2743 0 0 0 0 0 0 0 13.0168 0 0 12.1964 0 11.0973 0 0 13.6549 13.4901 0 12.7049 11.8163 12.5592 0 12.5731 0 0 0 11.9948 13.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0712 0 0 0 0 11.6465 0 0 11.0253 0 0 0 0 0 0 0 0 0 0 11.4185 0 0 0 0 0 0 Q7Z5M5 TMC3_HUMAN Transmembrane channel-like protein 3 TMC3 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; mechanosensitive ion channel activity [GO:0008381] GO:0005887; GO:0008381 mechanosensitive ion channel activity [GO:0008381] APSSPLPGVPKSR 0.99373 -13.173 0 0 0 0 0 0 0 0 12.7283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6455 0 13.537 0 0 0 0 0 0 11.5778 0 0 0 0 11.8806 12.879 0 0 0 12.7474 0 0 13.6506 0 0 0 0 0 0 0 0 12.2395 0 0 11.2547 0 0 0 0 0 0 0 0 0 12.6864 0 14.6662 15.6132 0 0 14.9432 13.166 0 0 14.5877 0 14.1485 0 0 0 14.4678 13.0938 11.8701 0 0 0 12.4263 0 0 0 0 0 0 11.9294 0 0 0 0 0 13.3201 0 0 13.1091 14.0491 0 13.0327 0 0 0 0 15.001 18.4646 12.5054 0 0 0 12.2407 0 0 0 0 0 0 15.5512 0 12.9193 12.9097 0 0 0 0 12.8882 14.7285 0 0 0 13.7796 0 0 13.6639 13.1836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7676 0 0 0 0 0 Q8N6L0 KASH5_HUMAN Protein KASH5 (Coiled-coil domain-containing protein 155) (KASH domain-containing protein 5) KASH5 CCDC155 Homo sapiens (Human) actin filament organization [GO:0007015]; chromosome localization to nuclear envelope involved in homologous chromosome segregation [GO:0090220]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome pairing at meiosis [GO:0007129]; microtubule cytoskeleton organization involved in homologous chromosome segregation [GO:0090172]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]; spindle localization [GO:0051653]; telomere localization [GO:0034397] "chromosome, telomeric region [GO:0000781]; integral component of membrane [GO:0016021]; lateral element [GO:0000800]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; meiotic spindle pole [GO:0090619]; nuclear outer membrane [GO:0005640]" "chromosome, telomeric region [GO:0000781]; integral component of membrane [GO:0016021]; lateral element [GO:0000800]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; meiotic spindle pole [GO:0090619]; nuclear outer membrane [GO:0005640]; dynein complex binding [GO:0070840]; identical protein binding [GO:0042802]; actin filament organization [GO:0007015]; chromosome localization to nuclear envelope involved in homologous chromosome segregation [GO:0090220]; double-strand break repair via homologous recombination [GO:0000724]; homologous chromosome pairing at meiosis [GO:0007129]; microtubule cytoskeleton organization involved in homologous chromosome segregation [GO:0090172]; oogenesis [GO:0048477]; spermatogenesis [GO:0007283]; spindle assembly [GO:0051225]; spindle localization [GO:0051653]; telomere localization [GO:0034397]" GO:0000724; GO:0000781; GO:0000800; GO:0005640; GO:0007015; GO:0007129; GO:0007283; GO:0016021; GO:0034397; GO:0034993; GO:0042802; GO:0048477; GO:0051225; GO:0051653; GO:0070840; GO:0090172; GO:0090220; GO:0090619 dynein complex binding [GO:0070840]; identical protein binding [GO:0042802] KEPSMWLTR 0.99373 -15.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969P6 TOP1M_HUMAN "DNA topoisomerase I, mitochondrial, TOP1mt, EC 5.6.2.1" TOP1MT Homo sapiens (Human) DNA replication [GO:0006260]; DNA topological change [GO:0006265] chromosome [GO:0005694]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]" GO:0003677; GO:0003917; GO:0005654; GO:0005694; GO:0005739; GO:0006260; GO:0006265; GO:0042645 "DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]" AALTLLGEVPR 0.99373 -17.295 0 0 0 0 0 0 0 0 0 0 10.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6485 0 0 0 0 0 11.2024 0 0 11.1809 0 0 0 0 0 0 10.0115 0 0 0 0 0 0 0 0 10.3307 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2087 0 0 0 0 0 11.9875 13.1433 14.9449 13.3095 0 0 0 15.3009 0 0 14.0312 0 0 0 15.4272 0 12.8265 0 0 11.0461 0 13.5185 0 0 0 16.4131 14.1271 0 0 15.5125 13.0549 12.4986 0 14.3229 0 14.5626 0 0 0 0 0 0 0 0 0 14.8658 0 0 0 11.9723 14.5877 0 0 15.0396 13.3692 0 0 0 0 13.2496 0 12.8117 0 0 12.177 0 14.0368 12.3464 13.288 12.2529 12.5502 0 0 0 12.8898 13.9017 13.8207 0 0 14.023 0 0 0 0 0 12.0883 0 0 0 0 0 0 13.7419 12.9764 0 0 0 0 0 15.78 0 14.6355 0 Q96K37 S35E1_HUMAN Solute carrier family 35 member E1 SLC35E1 PSEC0038 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; antiporter activity [GO:0015297] GO:0005794; GO:0015297; GO:0016021 antiporter activity [GO:0015297] KVLRDSR 0.99373 -13.914 11.0913 0 0 12.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1639 0 0 0 0 0 0 0 0 0 0 0 10.9156 0 0 11.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6512 0 0 0 0 14.2891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4511 0 0 0 0 0 14.6435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4209 12.6142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.618 0 0 0 0 0 14.0248 0 0 0 0 0 13.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BU20 CPLN2_HUMAN Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1) CPLANE2 C1orf89 RSG1 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cranial skeletal system development [GO:1904888]; endocardial cushion fusion [GO:0003274]; exocytosis [GO:0006887]; limb development [GO:0060173]; protein localization [GO:0008104]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of vesicle fusion [GO:0031338]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737] centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cranial skeletal system development [GO:1904888]; endocardial cushion fusion [GO:0003274]; exocytosis [GO:0006887]; limb development [GO:0060173]; protein localization [GO:0008104]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of vesicle fusion [GO:0031338]; smoothened signaling pathway [GO:0007224] GO:0003274; GO:0003924; GO:0005525; GO:0005737; GO:0005814; GO:0006887; GO:0007224; GO:0008104; GO:0015031; GO:0016485; GO:0017157; GO:0031338; GO:0035082; GO:0035869; GO:0036064; GO:0060173; GO:0060271; GO:0097546; GO:1901620; GO:1904888 GTP binding [GO:0005525]; GTPase activity [GO:0003924] LQASSRVVMFR 0.99373 -5.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9283 12.5868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B3KU38 IQIP1_HUMAN IQCJ-SCHIP1 readthrough transcript protein IQCJ-SCHIP1 Homo sapiens (Human) negative regulation of cytoskeleton organization [GO:0051494]; positive regulation of hippo signaling [GO:0035332] axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] axon initial segment [GO:0043194]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; negative regulation of cytoskeleton organization [GO:0051494]; positive regulation of hippo signaling [GO:0035332] GO:0005737; GO:0005886; GO:0030054; GO:0035332; GO:0043194; GO:0051494 AWREYLQR 0.99374 -37.536 0 0 0 0 0 0 0 0 14.6423 10.725 0 0 0 12.0834 0 13.9942 0 11.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8171 0 0 0 0 0 0 0 0 0 11.919 12.8838 0 0 0 0 0 0 0 0 10.3713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5803 14.4151 0 14.4399 0 13.9111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9739 0 14.4984 0 0 0 0 0 0 0 0 0 0 0 O00459 P85B_HUMAN "Phosphatidylinositol 3-kinase regulatory subunit beta, PI3-kinase regulatory subunit beta, PI3K regulatory subunit beta, PtdIns-3-kinase regulatory subunit beta (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta, PI3-kinase subunit p85-beta, PtdIns-3-kinase regulatory subunit p85-beta)" PIK3R2 Homo sapiens (Human) B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of MAPK cascade [GO:0043409]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]; T cell differentiation [GO:0030217] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]" "cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of MAPK cascade [GO:0043409]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell adhesion [GO:0045785]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976]; T cell differentiation [GO:0030217]" GO:0001678; GO:0001784; GO:0005634; GO:0005829; GO:0005925; GO:0005942; GO:0005943; GO:0006955; GO:0008286; GO:0010506; GO:0014065; GO:0015031; GO:0019903; GO:0030183; GO:0030217; GO:0030833; GO:0030971; GO:0032869; GO:0034976; GO:0036312; GO:0042307; GO:0043409; GO:0043551; GO:0045785; GO:0045944; GO:0046854; GO:0046935; GO:0046982; GO:0051492; GO:1903076 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971] ALTLRFLLQHLGR 0.99374 -29.954 0 0 0 0 0 0 0 0 0 0 10.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9661 10.1419 0 0 11.2498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86748 0 0 12.3388 0 0 0 13.3712 0 0 0 0 0 13.9983 0 13.7434 0 12.8604 13.2741 12.9752 13.5511 0 13.8607 11.1252 11.9761 9.79957 11.3098 0 0 0 0 0 0 0 0 12.591 0 0 12.742 13.3951 0 0 0 0 0 0 11.6088 12.4532 0 0 0 0 0 0 13.0465 13.0506 0 0 12.7448 0 0 0 0 13.5746 13.7557 0 0 11.9524 0 0 0 0 0 0 0 14.1739 0 0 0 0 0 0 0 0 0 0 0 0 13.2188 12.6894 12.6902 12.6568 0 12.528 0 0 0 0 0 0 0 0 12.3021 0 0 0 11.8439 10.4055 0 0 0 O15119 TBX3_HUMAN "T-box transcription factor TBX3, T-box protein 3" TBX3 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification, embryo [GO:0008595]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; blood vessel development [GO:0001568]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cardiac chamber development [GO:0003205]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell fate commitment [GO:0060923]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion formation [GO:0003272]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; forelimb morphogenesis [GO:0035136]; heart looping [GO:0001947]; hepatoblast differentiation [GO:0061017]; in utero embryonic development [GO:0001701]; limbic system development [GO:0021761]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mammary gland development [GO:0030879]; mammary placode formation [GO:0060596]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein complex stability [GO:0061635]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; semicircular canal morphogenesis [GO:0048752]; sinoatrial node cell development [GO:0060931]; skeletal system development [GO:0001501]; smooth muscle cell differentiation [GO:0051145]; specification of animal organ position [GO:0010159]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; transcription, DNA-templated [GO:0006351]; ureteric peristalsis [GO:0072105]; ventricular septum morphogenesis [GO:0060412]" chromatin [GO:0000785]; cilium [GO:0005929]; nucleus [GO:0005634] "chromatin [GO:0000785]; cilium [GO:0005929]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification, embryo [GO:0008595]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; blood vessel development [GO:0001568]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cardiac chamber development [GO:0003205]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell fate commitment [GO:0060923]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion formation [GO:0003272]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; forelimb morphogenesis [GO:0035136]; heart looping [GO:0001947]; hepatoblast differentiation [GO:0061017]; in utero embryonic development [GO:0001701]; limbic system development [GO:0021761]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mammary gland development [GO:0030879]; mammary placode formation [GO:0060596]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein complex stability [GO:0061635]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; semicircular canal morphogenesis [GO:0048752]; sinoatrial node cell development [GO:0060931]; skeletal system development [GO:0001501]; smooth muscle cell differentiation [GO:0051145]; specification of animal organ position [GO:0010159]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; transcription, DNA-templated [GO:0006351]; ureteric peristalsis [GO:0072105]; ventricular septum morphogenesis [GO:0060412]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001501; GO:0001568; GO:0001701; GO:0001708; GO:0001947; GO:0003151; GO:0003167; GO:0003205; GO:0003272; GO:0005634; GO:0005929; GO:0006351; GO:0006357; GO:0007417; GO:0008284; GO:0008595; GO:0009887; GO:0010159; GO:0019827; GO:0021761; GO:0030539; GO:0030540; GO:0030857; GO:0030879; GO:0031647; GO:0032275; GO:0035115; GO:0035116; GO:0035136; GO:0036302; GO:0042733; GO:0043066; GO:0043565; GO:0045662; GO:0045787; GO:0045892; GO:0045944; GO:0046884; GO:0048332; GO:0048752; GO:0051145; GO:0060021; GO:0060317; GO:0060412; GO:0060444; GO:0060596; GO:0060923; GO:0060931; GO:0061017; GO:0061629; GO:0061635; GO:0072089; GO:0072105; GO:0090398; GO:1905072; GO:1905222; GO:1990837; GO:2000137; GO:2000648; GO:2000737 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ADPEMPK 0.99374 -5.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7911 0 0 0 0 0 0 0 0 0 14.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9528 0 11.7538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94827 PKHG5_HUMAN "Pleckstrin homology domain-containing family G member 5, PH domain-containing family G member 5 (Guanine nucleotide exchange factor 720, GEF720)" PLEKHG5 KIAA0720 Homo sapiens (Human) endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043123; GO:0043542; GO:0048471; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] AERTRVIR 0.99374 -13.923 0 9.84731 10.782 11.6735 0 0 0 0 0 0 14.3473 0 0 0 13.8516 0 0 0 13.1502 0 0 0 0 14.1994 0 12.8251 12.6172 14.0984 0 12.9398 12.9861 0 0 0 0 0 0 13.8525 0 12.4976 0 0 12.8109 0 0 0 0 13.6175 0 0 15.3966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.429 0 0 0 0 0 0 13.5545 0 0 0 14.8002 0 14.8028 0 13.9857 13.58 0 17.4939 13.8804 0 0 13.9438 13.014 11.1628 13.2432 0 0 0 0 13.1045 0 0 0 0 12.9586 14.4265 0 13.0192 0 14.6817 15.1386 0 0 0 11.769 15.1321 0 0 0 14.0136 13.2432 0 0 14.3589 0 0 15.9253 13.0303 0 15.1449 0 0 0 0 0 13.5321 0 0 0 0 0 0 16.0227 13.0185 0 0 13.2451 0 12.3173 0 0 13.1695 0 0 11.2088 13.4264 0 11.0092 0 0 0 0 14.8889 0 0 0 0 0 0 0 0 14.2407 0 0 0 0 13.9936 0 0 14.3301 0 O94876 TMCC1_HUMAN Transmembrane and coiled-coil domains protein 1 TMCC1 KIAA0779 Homo sapiens (Human) endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791] cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148] GO:0005789; GO:0005791; GO:0005829; GO:0007029; GO:0012505; GO:0016021; GO:0016197; GO:0042802; GO:0090148; GO:0097750; GO:0140284; GO:0140285 identical protein binding [GO:0042802] AAIAHLQQK 0.99374 -9.1561 0 0 0 0 0 0 0 0 0 0 0 0 13.1294 0 0 0 0 0 0 0 0 0 0 11.6473 0 0 0 0 0 13.7111 0 0 0 0 0 0 12.7371 0 0 0 12.8133 0 0 0 0 0 0 0 0 0 13.2064 0 0 0 0 0 11.9193 0 0 0 0 0 0 0 0 0 18.8869 0 0 15.0252 0 0 0 0 0 13.8817 0 13.3242 0 14.4619 0 14.5502 14.5237 0 0 0 0 0 0 14.2273 0 0 11.6832 0 0 0 0 0 14.9169 12.9006 0 0 14.1155 0 12.913 0 0 12.3268 14.8342 0 0 0 14.1445 0 0 0 0 0 0 0 13.9349 0 14.4117 0 0 0 0 0 0 0 0 0 0 0 0 14.0553 0 0 14.4269 0 0 13.2239 14.5845 0 0 0 0 0 0 12.7934 0 0 15.6513 14.8815 13.8954 0 0 0 0 0 11.977 0 0 13.3741 13.4152 13.1012 0 15.3335 0 14.0399 0 0 0 0 0 0 14.9217 0 14.7604 0 P02748 CO9_HUMAN Complement component C9 [Cleaved into: Complement component C9a; Complement component C9b ] C9 Homo sapiens (Human) "cell killing [GO:0001906]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]; protein homooligomerization [GO:0051260]" blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; cell killing [GO:0001906]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; positive regulation of immune response [GO:0050778]; protein homooligomerization [GO:0051260]" GO:0001906; GO:0005576; GO:0005579; GO:0005615; GO:0005886; GO:0006956; GO:0006957; GO:0006958; GO:0019835; GO:0050778; GO:0051260; GO:0070062; GO:0072562 CNGDNDCGDFSDEDDCESEPR 0.99374 -7.7871 0 0 11.3788 0 0 0 0 0 0 0 0 0 11.207 0 0 0 13.3228 13.976 0 0 11.4934 0 0 0 0 0 14.5127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2429 10.8898 0 0 0 0 0 11.5626 11.3153 0 0 0 0 0 10.2734 0 0 0 0 14.4754 10.7745 0 14.4511 0 0 11.4292 12.1869 0 11.8169 15.3954 15.3186 0 0 0 0 0 16.6607 13.9714 0 14.3977 12.8774 0 0 0 13.8259 0 14.4772 0 0 0 0 0 15.066 15.0926 15.8979 15.9715 0 0 15.9832 14.1518 14.5439 14.9866 0 14.1658 0 0 13.3693 14.9113 0 0 0 14.2889 14.6114 13.1363 0 0 0 0 0 0 0 14.8958 0 0 0 0 0 14.4118 16.2991 14.7716 17.2824 14.9015 0 0 0 14.6911 0 15.2074 15.7379 0 12.6715 11.4948 0 14.6608 12.2077 0 0 0 0 0 0 0 0 0 13.583 0 0 0 0 13.947 0 12.7905 0 0 15.2448 0 0 10.4655 0 0 0 0 0 P0DUX1 SPD12_HUMAN Speedy protein E12 SPDYE12 SPDYE12P Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0019901; GO:0045737 protein kinase binding [GO:0019901] ECLDESDDEPEK 0.99374 -7.0019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8524 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2333 0 0 0 0 0 0 0 0 0 11.1526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11511 CP19A_HUMAN "Aromatase, EC 1.14.14.14 (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase)" CYP19A1 ARO1 CYAR CYP19 Homo sapiens (Human) androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]; female genitalia development [GO:0030540]; female gonad development [GO:0008585]; mammary gland development [GO:0030879]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of estradiol secretion [GO:2000866]; prostate gland growth [GO:0060736]; response to estradiol [GO:0032355]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; syncytium formation [GO:0006949]; testosterone biosynthetic process [GO:0061370]; uterus development [GO:0060065] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; aromatase activity [GO:0070330]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]; female genitalia development [GO:0030540]; female gonad development [GO:0008585]; mammary gland development [GO:0030879]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of estradiol secretion [GO:2000866]; prostate gland growth [GO:0060736]; response to estradiol [GO:0032355]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; syncytium formation [GO:0006949]; testosterone biosynthetic process [GO:0061370]; uterus development [GO:0060065]" GO:0002677; GO:0005506; GO:0005783; GO:0005789; GO:0006694; GO:0006703; GO:0006710; GO:0006949; GO:0008395; GO:0008585; GO:0009055; GO:0010760; GO:0016020; GO:0016021; GO:0016125; GO:0016712; GO:0019825; GO:0020037; GO:0030540; GO:0030879; GO:0032355; GO:0060065; GO:0060736; GO:0061370; GO:0070330; GO:2000866 "aromatase activity [GO:0070330]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]" AILVTLLRRFHVK 0.99374 -7.0052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.318 0 0 0 0 0 0 0 0 0 0 0 0 13.5624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8974 0 0 0 0 0 0 0 0 0 0 0 0 12.4376 0 0 0 0 14.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1486 13.8753 0 0 0 0 0 0 P15291 B4GT1_HUMAN "Beta-1,4-galactosyltransferase 1, Beta-1,4-GalTase 1, Beta4Gal-T1, b4Gal-T1, EC 2.4.1.- (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase, EC 2.4.1.38) (Lactose synthase A protein, EC 2.4.1.22) (N-acetyllactosamine synthase, EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1 ]" B4GALT1 GGTB2 Homo sapiens (Human) acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; glycosylation [GO:0070085]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046] azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; desmosome [GO:0030057]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667] "azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; desmosome [GO:0030057]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]; alpha-tubulin binding [GO:0043014]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; galactosyltransferase activity [GO:0008378]; identical protein binding [GO:0042802]; lactose synthase activity [GO:0004461]; manganese ion binding [GO:0030145]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250]; acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; glycosylation [GO:0070085]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046]" GO:0000138; GO:0000139; GO:0002064; GO:0002526; GO:0003831; GO:0003945; GO:0004461; GO:0005615; GO:0005794; GO:0005886; GO:0005989; GO:0006012; GO:0006487; GO:0006629; GO:0007155; GO:0007339; GO:0007341; GO:0008092; GO:0008378; GO:0009312; GO:0009897; GO:0016020; GO:0016021; GO:0016323; GO:0030057; GO:0030145; GO:0030175; GO:0030198; GO:0030667; GO:0031526; GO:0032580; GO:0032991; GO:0035250; GO:0035577; GO:0042802; GO:0043014; GO:0043065; GO:0045136; GO:0048487; GO:0050673; GO:0050680; GO:0060046; GO:0060054; GO:0060055; GO:0070062; GO:0070085; GO:1905517 "alpha-tubulin binding [GO:0043014]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; galactosyltransferase activity [GO:0008378]; identical protein binding [GO:0042802]; lactose synthase activity [GO:0004461]; manganese ion binding [GO:0030145]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250]" CRMIRHSR 0.99374 -9.1543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P80098 CCL7_HUMAN "C-C motif chemokine 7 (Monocyte chemoattractant protein 3) (Monocyte chemotactic protein 3, MCP-3) (NC28) (Small-inducible cytokine A7)" CCL7 MCP3 SCYA6 SCYA7 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell chemotaxis [GO:2000503]; regulation of cell shape [GO:0008360]; response to gamma radiation [GO:0010332]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; CCR2 chemokine receptor binding [GO:0031727]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to ethanol [GO:0071361]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell chemotaxis [GO:2000503]; regulation of cell shape [GO:0008360]; response to gamma radiation [GO:0010332]; signal transduction [GO:0007165] GO:0002548; GO:0005576; GO:0005615; GO:0006874; GO:0006935; GO:0006954; GO:0007010; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0008201; GO:0008360; GO:0010332; GO:0030335; GO:0030593; GO:0031726; GO:0031727; GO:0043547; GO:0048020; GO:0048245; GO:0048247; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0071361; GO:2000503 CCR chemokine receptor binding [GO:0048020]; CCR1 chemokine receptor binding [GO:0031726]; CCR2 chemokine receptor binding [GO:0031727]; chemokine activity [GO:0008009]; heparin binding [GO:0008201] EAVIFKTK 0.99374 -5.1499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00532 CDKL1_HUMAN "Cyclin-dependent kinase-like 1, EC 2.7.11.22 (Protein kinase p42 KKIALRE) (Serine/threonine-protein kinase KKIALRE)" CDKL1 Homo sapiens (Human) protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017] ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017] GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0035869; GO:0043231; GO:0070062; GO:0106310; GO:1902017 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310] EIEDLAKEHNK 0.99374 -30.258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2985 0 12.8981 0 0 0 0 0 0 0 0 0 0 0 0 13.0314 0 0 14.5738 0 13.3979 10.9931 0 0 0 14.1466 0 0 0 0 0 11.9198 0 0 0 12.2634 12.9479 0 0 0 0 13.3706 0 0 0 0 0 14.8846 0 0 0 0 0 10.0716 0 0 0 12.7412 0 0 0 0 0 0 0 0 0 15.4095 13.3025 13.4971 0 12.8358 0 0 0 12.3506 0 12.3051 0 0 0 14.9661 0 13.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8045 0 Q08AG5 ZN844_HUMAN Zinc finger protein 844 ZNF844 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ACPCLSIYLIHERVHTGEK 0.99374 -7.0168 0 0 0 9.92455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8292 0 13.3046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7621 0 0 0 0 Q12830 BPTF_HUMAN Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen) BPTF FAC1 FALZ Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" ATPase complex [GO:1904949]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589] "ATPase complex [GO:1904949]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; embryonic placenta development [GO:0001892]; endoderm development [GO:0007492]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000978; GO:0001892; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0006357; GO:0007420; GO:0007492; GO:0009952; GO:0016589; GO:0035064; GO:0043565; GO:0045944; GO:0046872; GO:0070062; GO:1904949 metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565] AMDFEGK 0.99374 -37.524 0 0 0 0 0 14.1193 0 13.4475 0 0 0 0 0 0 0 0 13.9724 0 13.5885 11.9885 12.3113 13.8069 0 0 10.5581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9729 0 0 0 0 0 0 0 10.9625 0 13.5741 0 0 0 0 0 0 0 0 0 0 14.3445 14.8199 13.4204 17.8649 0 14.9763 0 0 14.8906 14.7015 0 0 16.1571 0 0 0 13.4393 16.4946 12.3408 14.4607 13.6119 0 0 0 16.6345 0 12.8122 13.5671 14.8355 0 0 16.9353 0 12.4274 12.9222 15.9529 13.9216 15.4236 0 15.5929 0 13.997 15.5451 15.6105 13.9531 15.4145 15.2373 0 0 0 17.2723 15.2983 11.7307 11.7925 14.1398 16.2229 13.6487 16.5784 15.3511 10.342 15.7743 13.3232 0 13.9764 12.593 0 13.4708 0 0 16.7821 0 0 0 0 0 0 11.804 14.5513 13.6923 0 0 0 0 15.6147 0 13.5607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4647 0 0 0 13.5227 0 0 0 0 0 Q13435 SF3B2_HUMAN "Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit, SF3b145) (Spliceosome-associated protein 145, SAP 145)" SF3B2 SAP145 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0016607; GO:0071005; GO:0071011; GO:0071013; GO:1903241 RNA binding [GO:0003723] ATEHPEPPKAELQLPPPPPPGHYGAWAAQELQAK 0.99374 -13.929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7109 11.4839 0 0 0 0 0 0 12.1875 0 0 0 0 0 10.3932 0 0 0 0 10.5481 0 0 0 0 10.0676 0 0 0 0 0 0 0 0 14.0645 0 0 0 11.6915 0 11.7637 0 13.7663 14.3416 13.8042 13.3697 0 13.7483 12.2386 0 13.5082 13.2713 17.4331 0 16.5312 13.3489 14.1692 0 15.1443 13.0781 15.6858 11.5676 0 14.2172 0 11.0108 0 14.5636 0 0 14.5164 14.1229 0 0 0 0 14.3113 12.6175 0 13.0346 15.2143 11.8605 0 0 0 0 13.1642 12.5289 0 14.5058 0 0 0 14.3647 12.4787 0 14.8955 0 12.3961 13.3018 0 11.9023 15.1128 0 0 11.332 0 0 0 0 14.6944 0 0 0 15.8261 0 0 13.2806 13.1735 0 0 0 10.5658 14.9546 0 11.9703 0 13.7069 0 0 0 0 0 11.259 0 0 0 0 0 0 11.7402 0 0 0 0 0 0 13.3961 Q14194 DPYL1_HUMAN "Dihydropyrimidinase-related protein 1, DRP-1 (Collapsin response mediator protein 1, CRMP-1) (Inactive dihydropyrimidinase) (Unc-33-like phosphoprotein 3, ULIP-3)" CRMP1 DPYSL1 ULIP3 Homo sapiens (Human) axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139] centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; midbody [GO:0030496]; perikaryon [GO:0043204]; spindle [GO:0005819] "centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; midbody [GO:0030496]; perikaryon [GO:0043204]; spindle [GO:0005819]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]; axon guidance [GO:0007411]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of actin filament binding [GO:1904530]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]" GO:0000226; GO:0005813; GO:0005819; GO:0005829; GO:0006139; GO:0007399; GO:0007411; GO:0010977; GO:0016810; GO:0030426; GO:0030496; GO:0031005; GO:0042802; GO:0043204; GO:1904530 "filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; identical protein binding [GO:0042802]" GMGRFIPRK 0.99374 -9.1496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5484 0 0 0 0 0 13.1858 0 0 0 0 0 0 0 0 0 0 0 0 14.6905 0 0 0 0 0 0 0 0 0 13.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0936 12.655 0 12.1514 0 12.1103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5796 0 0 0 11.6356 11.9537 Q5RKV6 EXOS6_HUMAN "Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog, hMtr3) (p11)" EXOSC6 MTR3 Homo sapiens (Human) "DNA deamination [GO:0045006]; isotype switching [GO:0045190]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; DNA deamination [GO:0045006]; isotype switching [GO:0045190]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]" GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034475; GO:0045006; GO:0045190; GO:0045830; GO:0071028; GO:0071051; GO:0101019 RNA binding [GO:0003723] APFAGRR 0.99374 -7.7912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6 0 0 0 0 0 0 13.6185 0 0 0 0 0 0 0 0 0 13.3577 0 0 0 0 0 0 0 0 13.3519 0 16.2847 0 0 0 0 13.3497 0 0 0 0 0 0 0 0 0 14.004 0 12.723 0 0 0 13.7738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.161 12.1005 0 0 0 0 0 0 0 0 0 16.1616 0 16.3792 12.2195 13.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3699 0 0 0 Q5T0Z8 CF132_HUMAN Uncharacterized protein C6orf132 C6orf132 Homo sapiens (Human) DSGPAGQPEK 0.99374 -7.7961 0 0 0 0 0 0 0 0 0 0 0 11.5709 0 0 0 0 0 0 0 0 0 0 10.1514 10.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4207 0 0 0 0 0 15.5614 0 11.9195 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2417 0 0 12.251 14.3537 0 14.9705 0 0 0 12.7385 13.5427 0 0 0 0 0 0 13.0977 0 14.7698 15.3628 14.4898 14.2472 14.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3149 0 0 12.8178 0 0 0 0 0 0 0 0 0 0 0 0 12.3928 13.8279 0 0 11.8241 0 0 0 12.9682 13.6956 0 13.5427 0 0 0 0 0 0 14.2625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3893 0 0 0 0 0 0 0 11.3254 0 0 0 12.172 0 0 0 0 0 0 Q5VZL5 ZMYM4_HUMAN Zinc finger MYM-type protein 4 (Zinc finger protein 262) ZMYM4 KIAA0425 ZNF262 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] GO:0003677; GO:0007010; GO:0008270; GO:0022604 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] DGFPQPRRR 0.99374 -37.568 0 0 0 0 0 0 0 10.952 0 0 11.2859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.079 0 12.1192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5072 0 0 0 0 0 0 13.2229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8525 14.2604 0 0 0 0 12.9618 13.0524 0 0 0 14.8182 0 0 0 0 0 0 0 0 0 11.9406 0 0 0 0 0 10.8041 0 0 0 0 12.0838 14.2412 13.4365 0 12.6561 0 13.4779 0 0 13.8142 0 0 0 0 14.9306 9.55859 0 0 0 0 0 0 0 12.0209 11.8997 13.4255 0 0 0 0 0 11.3115 0 0 0 0 0 0 0 0 0 0 0 0 12.7436 0 Q86XG9 NBPF5_HUMAN Putative neuroblastoma breakpoint family member 5 NBPF5P NBPF5 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 ALVHSQAKELTQLR 0.99374 -5.1737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9227 0 0 0 0 0 0 0 0 0 0 0 12.9711 0 13.1531 13.361 0 0 0 0 12.8608 0 0 0 0 0 0 0 12.4113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2437 0 0 0 0 0 13.3676 11.4827 0 0 0 0 13.3437 0 0 0 0 0 0 0 0 0 0 0 12.7515 13.2637 0 0 13.1715 0 0 0 0 0 0 0 Q8NGY5 OR6N1_HUMAN Olfactory receptor 6N1 OR6N1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EIKEAVRR 0.99374 -5.1751 0 0 0 0 0 0 0 0 0 0 0 0 12.042 0 10.7559 11.1621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0278 0 0 0 0 0 0 0 0 0 0 14.2046 13.0765 0 0 0 0 0 0 12.4571 0 0 0 0 13.6276 0 13.1904 0 0 0 0 0 0 0 0 0 0 0 0 12.9194 0 0 0 0 0 0 0 12.7959 0 0 0 0 0 0 0 0 0 0 0 11.9158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.909 0 0 0 11.9198 12.0308 0 0 0 0 12.057 0 0 0 0 0 0 0 0 0 0 0 0 11.4428 0 0 0 12.5294 0 0 0 0 0 Q8NHX9 TPC2_HUMAN Two pore channel protein 2 (Two pore calcium channel protein 2) TPCN2 TPC2 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cellular calcium ion homeostasis [GO:0006874]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; ion transmembrane transport [GO:0034220]; lysosome organization [GO:0007040]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of ion transmembrane transport [GO:0034765]; response to vitamin D [GO:0033280]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725] cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] "cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; cellular calcium ion homeostasis [GO:0006874]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; ion transmembrane transport [GO:0034220]; lysosome organization [GO:0007040]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of ion transmembrane transport [GO:0034765]; response to vitamin D [GO:0033280]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725]" GO:0005245; GO:0005764; GO:0005765; GO:0005829; GO:0006874; GO:0006939; GO:0007040; GO:0010008; GO:0010506; GO:0015280; GO:0016021; GO:0017157; GO:0019065; GO:0019722; GO:0019901; GO:0031902; GO:0033280; GO:0034220; GO:0034765; GO:0035725; GO:0036020; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0090117; GO:0097682 "identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]" IYFVLWWLVSSVIWVNLFLALILENFLHKWDPR 0.99374 -7.0056 0 0 0 0 0 0 0 0 0 0 0 0 13.2388 0 0 0 0 0 0 0 0 10.9363 0 11.0253 0 0 0 0 0 0 0 10.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2777 0 0 10.3778 0 0 0 13.8518 0 0 0 0 0 14.8118 0 0 0 0 0 0 14.1045 0 0 0 0 0 0 0 0 0 0 14.7321 0 0 0 0 0 0 0 0 14.6527 0 0 0 0 0 0 0 0 0 0 0 0 13.6243 0 0 0 0 0 0 0 0 0 0 0 12.0258 0 0 0 0 0 0 0 0 0 0 0 12.3258 0 0 0 0 12.1919 11.0529 0 0 0 0 0 0 0 0 0 0 0 10.9276 0 0 0 Q92982 NINJ1_HUMAN Ninjurin-1 (Nerve injury-induced protein 1) [Cleaved into: Secreted ninjurin-1 (Soluble ninjurin-1) ] NINJ1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cytolysis [GO:0019835]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; muscle cell differentiation [GO:0042692]; necrotic cell death [GO:0070265]; nervous system development [GO:0007399]; positive regulation of angiogenesis [GO:0045766]; positive regulation of inflammatory response [GO:0050729]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; programmed cell death [GO:0012501]; protein homooligomerization [GO:0051260]; regulation of monocyte chemotaxis [GO:0090025]; tissue regeneration [GO:0042246] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; synaptic membrane [GO:0097060] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; synaptic membrane [GO:0097060]; cell adhesion mediator activity [GO:0098631]; lipopolysaccharide binding [GO:0001530]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cytolysis [GO:0019835]; heterotypic cell-cell adhesion [GO:0034113]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; muscle cell differentiation [GO:0042692]; necrotic cell death [GO:0070265]; nervous system development [GO:0007399]; positive regulation of angiogenesis [GO:0045766]; positive regulation of inflammatory response [GO:0050729]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; programmed cell death [GO:0012501]; protein homooligomerization [GO:0051260]; regulation of monocyte chemotaxis [GO:0090025]; tissue regeneration [GO:0042246] GO:0001525; GO:0001530; GO:0002232; GO:0005576; GO:0006954; GO:0007155; GO:0007399; GO:0012501; GO:0016021; GO:0019835; GO:0034113; GO:0034145; GO:0042246; GO:0042692; GO:0045766; GO:0050729; GO:0051260; GO:0070161; GO:0070265; GO:0090025; GO:0097060; GO:0098631 cell adhesion mediator activity [GO:0098631]; lipopolysaccharide binding [GO:0001530] LDFLNNLATGLVFIIVVVNIFITAFGVQK 0.99374 -5.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2048 0 0 0 11.4232 0 0 0 0 0 0 0 0 0 0 0 Q96PS1 FACOS_HUMAN FANCD2 opposite strand protein (Fanconi anemia group D2 protein opposite strand transcript protein) FANCD2OS C3orf24 HSD19 Homo sapiens (Human) SILLLYATYKKCTFALQHSK 0.99374 -6.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6774 0 0 0 0 0 0 0 12.5844 0 0 0 0 0 0 0 0 14.8201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQP9 BPIA3_HUMAN "BPI fold-containing family A member 3 (Short palate, lung and nasal epithelium carcinoma-associated protein 3)" BPIFA3 C20orf71 SPLUNC3 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; lipid binding [GO:0008289] GO:0005576; GO:0008289 lipid binding [GO:0008289] LLIFLGLLALPLAPHK 0.99374 -5.1678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRD0 BUD13_HUMAN BUD13 homolog BUD13 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RES complex [GO:0070274]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RES complex [GO:0070274]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0070274; GO:0071005; GO:1903241 RNA binding [GO:0003723] AAAPPLSK 0.99374 -7.0004 0 10.1313 0 0 0 0 0 0 0 0 0 0 0 0 11.1984 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 12.1285 0 0 0 10.7997 0 0 0 0 0 0 0 0 0 0 0 0 10.4979 12.1785 0 12.1944 11.3191 0 0 0 11.3793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1038 0 0 0 0 13.9992 0 0 0 12.7907 14.9025 0 14.269 0 0 12.9595 14.3729 0 0 0 0 14.7458 0 0 0 0 0 0 13.3076 0 0 0 12.4376 0 13.5028 0 0 0 0 13.9654 0 0 14.5097 0 14.3184 15.7168 10.9075 16.1696 13.175 13.7097 0 0 0 0 13.4429 14.1675 0 0 0 0 13.6869 13.0467 0 12.3137 0 0 0 0 0 0 0 0 0 0 0 0 13.0811 0 0 0 12.7877 0 13.0926 0 12.7475 0 0 12.281 0 0 0 0 0 0 0 0 14.9182 0 0 0 0 0 Q9ULL4 PLXB3_HUMAN Plexin-B3 PLXNB3 KIAA1206 PLXN6 Homo sapiens (Human) cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154]; cell chemotaxis [GO:0060326]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of GTPase activity [GO:0034260]; negative regulation of lamellipodium assembly [GO:0010593]; positive chemotaxis [GO:0050918]; positive regulation of axonogenesis [GO:0050772]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] GO:0001938; GO:0002116; GO:0005886; GO:0005887; GO:0007156; GO:0007162; GO:0008360; GO:0009986; GO:0010593; GO:0010976; GO:0017154; GO:0019904; GO:0030334; GO:0030336; GO:0034260; GO:0043087; GO:0050772; GO:0050918; GO:0051022; GO:0060326; GO:0071526; GO:0098632; GO:1902287 cell-cell adhesion mediator activity [GO:0098632]; protein domain specific binding [GO:0019904]; Rho GDP-dissociation inhibitor binding [GO:0051022]; semaphorin receptor activity [GO:0017154] CSSLREREPAR 0.99374 -13.961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6767 0 0 12.3423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8488 13.7622 0 13.895 12.9847 0 12.9384 0 0 0 0 0 0 0 0 0 0 0 0 14.1079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7455 12.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7776 0 0 0 0 12.7336 0 0 14.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4439 0 15.449 0 0 0 13.5569 0 0 0 0 0 0 14.5158 12.0142 0 0 0 0 0 0 12.5053 0 0 0 0 13.4221 0 0 0 0 0 0 11.6481 Q9UNL4 ING4_HUMAN Inhibitor of growth protein 4 (p29ING4) ING4 My036 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intermediate filament cytoskeleton [GO:0045111]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000123; GO:0001558; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006325; GO:0006355; GO:0006473; GO:0006915; GO:0006978; GO:0007049; GO:0008285; GO:0016570; GO:0035064; GO:0043065; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0045111; GO:0045892; GO:0045926; GO:0046872; GO:0051726; GO:0070776; GO:1902164; GO:1902749; GO:2000278 metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713] GKWFCPRCSQER 0.99374 -7.0175 0 0 0 0 0 0 0 0 0 18.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.376 0 11.2541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q460N5 PAR14_HUMAN "Protein mono-ADP-ribosyltransferase PARP14, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 8, ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14, PARP-14)" PARP14 BAL2 KIAA1268 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; transcription corepressor activity [GO:0003714]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein mono-ADP-ribosylation [GO:0140289]; protein poly-ADP-ribosylation [GO:0070212] GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006471; GO:0010629; GO:0016020; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:0140289; GO:1902216; GO:1990404 enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; transcription corepressor activity [GO:0003714] ARFYQSEIKR 0.99375 -14.031 0 0 0 0 0 0 12.5259 0 0 0 0 0 0 16.5769 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6913 0 0 0 0 0 0 13.8976 14.7933 14.2164 13.7153 0 13.4862 14.3016 0 15.1861 0 0 13.4766 0 0 0 13.6231 0 0 0 12.3111 0 0 0 0 0 13.9884 0 13.8993 0 15.6643 0 14.1874 13.5824 14.2897 0 14.3931 0 13.3449 12.9607 0 15.2281 16.3181 0 0 0 12.8785 0 13.0374 0 12.9248 0 0 0 0 12.4197 14.5615 14.0731 0 0 0 0 0 15.0532 0 14.0579 13.5396 15.3578 15.0713 0 0 14.4885 14.1081 0 0 0 0 12.8306 0 16.5269 14.38 0 0 0 11.4147 0 0 0 0 0 0 13.5277 0 0 0 0 13.6897 0 0 14.9064 14.5212 0 0 0 0 0 Q9ULB5 CADH7_HUMAN Cadherin-7 CDH7 CDH7L1 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098609; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] DVTPEIQFLSRPAFKSIPDNVIFR 0.99375 -9.1693 0 0 0 0 10.4656 0 11.8162 0 0 0 0 0 0 0 0 0 0 0 11.6854 0 0 0 0 0 0 12.4749 0 11.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9716 11.0571 0 0 0 10.8253 0 12.6949 0 0 0 0 0 0 0 10.2807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.099 0 0 0 0 0 0 0 0 0 13.7427 0 0 0 0 0 0 0 12.0111 12.9574 0 0 0 12.5323 0 0 13.333 0 0 0 0 0 0 13.4719 13.8434 0 0 12.8558 12.7036 0 0 0 0 0 0 0 11.2003 0 0 0 0 12.402 11.902 0 0 0 13.1932 0 0 0 0 13.5343 0 0 0 0 14.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2715 0 0 0 0 0 O14531 DPYL4_HUMAN "Dihydropyrimidinase-related protein 4, DRP-4 (Collapsin response mediator protein 3, CRMP-3) (UNC33-like phosphoprotein 4, ULIP-4)" DPYSL4 CRMP3 ULIP4 Homo sapiens (Human) nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485] cytosol [GO:0005829] "cytosol [GO:0005829]; filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nervous system development [GO:0007399]; neuron death [GO:0070997]; neuron projection guidance [GO:0097485]" GO:0005829; GO:0007399; GO:0016810; GO:0031005; GO:0070997; GO:0097485 "filamin binding [GO:0031005]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]" ARNRLAEIHGVPR 0.99375 -30.288 0 0 0 12.46 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8872 0 13.8748 0 0 13.6621 0 0 0 0 0 0 13.5054 0 17.0223 0 0 0 0 0 0 0 0 14.5513 0 0 13.8705 0 0 0 0 0 14.2694 13.5731 0 0 0 0 0 0 0 0 14.7901 0 0 0 0 14.2331 14.0408 14.1867 0 0 0 0 12.9274 0 14.5539 0 0 13.9891 0 0 14.1099 0 0 0 0 0 13.6556 14.2467 0 0 0 0 0 13.6772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7451 0 0 0 0 0 0 0 0 O15194 CTDSL_HUMAN "CTD small phosphatase-like protein, CTDSP-like, EC 3.1.3.16 (Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3) (NIF-like protein) (Nuclear LIM interactor-interacting factor 1, NLI-interacting factor 1) (Protein YA22, hYA22) (RBSP3) (Small C-terminal domain phosphatase 3, SCP3, Small CTD phosphatase 3)" CTDSPL C3orf8 NIF1 NIFL SCP3 YA22 Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933] extracellular exosome [GO:0070062]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein phosphorylation [GO:0001933] GO:0001933; GO:0004721; GO:0005634; GO:0008420; GO:0017018; GO:0046872; GO:0070062; GO:2000134 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] EDDVYSMLHR 0.99375 -8.7464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43193 MTLR_HUMAN Motilin receptor (G-protein coupled receptor 38) MLNR GPR38 MTLR MTLR1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005829; GO:0005886; GO:0007186; GO:0008528; GO:0016021; GO:0042562 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562] AAAFKLLLAR 0.99375 -14.029 0 0 14.2454 0 0 0 11.3633 0 0 0 0 0 0 0 11.0988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90781 0 0 0 0 0 0 0 0 0 0 12.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0007 0 0 13.2351 0 0 0 0 0 0 0 0 13.184 0 0 0 12.2612 0 13.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6964 0 0 0 0 0 0 0 0 0 0 0 0 14.2341 0 0 0 0 0 0 0 O60331 PI51C_HUMAN "Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma, PIP5K1gamma, PtdIns(4)P-5-kinase 1 gamma, EC 2.7.1.68 (Type I phosphatidylinositol 4-phosphate 5-kinase gamma)" PIP5K1C KIAA0589 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079] adherens junction [GO:0005912]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931] "adherens junction [GO:0005912]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; cell-cell adhesion [GO:0098609]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neutrophil chemotaxis [GO:0030593]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]" GO:0001891; GO:0001931; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005925; GO:0006661; GO:0006909; GO:0010008; GO:0014066; GO:0016079; GO:0016308; GO:0016310; GO:0030036; GO:0030593; GO:0032587; GO:0034333; GO:0046854; GO:0048488; GO:0052812; GO:0061024; GO:0072583; GO:0098609; GO:0098793 "1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]" GERLLLHIGIIDILQSYRFIK 0.99375 -8.0274 0 0 0 0 0 0 0 0 12.899 0 0 0 0 0 0 0 0 0 0 0 0 11.2413 0 14.5997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0018 0 0 14.7532 0 0 0 0 0 0 12.5988 0 0 0 0 12.2688 14.549 15.2674 0 0 0 11.6289 12.3773 13.2699 13.7897 0 12.8095 12.2311 12.0949 11.6259 14.8313 14.5465 0 12.3048 0 0 0 0 0 14.6838 0 12.8014 13.3343 13.2171 0 15.6028 0 13.0799 15.1009 0 0 0 12.4476 0 14.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6758 12.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75223 GGCT_HUMAN "Gamma-glutamylcyclotransferase, EC 4.3.2.9 (Cytochrome c-releasing factor 21)" GGCT C7orf24 CRF21 Homo sapiens (Human) release of cytochrome c from mitochondria [GO:0001836] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803]; release of cytochrome c from mitochondria [GO:0001836] GO:0001836; GO:0003839; GO:0005829; GO:0042803; GO:0070062 gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803] IICMGAK 0.99375 -8.0282 0 0 10.9399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4556 0 13.1155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95319 CELF2_HUMAN "CUGBP Elav-like family member 2, CELF-2 (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2, CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3, ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein, hNAPOR) (RNA-binding protein BRUNOL-3)" CELF2 BRUNOL3 CUGBP2 ETR3 NAPOR Homo sapiens (Human) "mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]" cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of heart contraction [GO:0008016]; RNA processing [GO:0006396]" GO:0000381; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006396; GO:0008016; GO:0036002; GO:0043231; GO:0090543; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] ELKELFEPYGAVYQINVLR 0.99375 -7.8046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0462 13.9016 14.1031 14.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0617 0 0 0 13.6932 0 11.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8757 0 0 0 13.8075 13.8248 0 14.0598 0 13.1217 0 13.8409 0 13.6527 13.5771 0 13.6449 0 0 0 0 0 0 0 13.568 0 0 0 0 0 0 0 13.9366 0 0 0 0 0 0 0 0 0 0 0 0 13.5639 0 0 0 0 O95399 UTS2_HUMAN "Urotensin-2 (Urotensin II, U-II, UII)" UTS2 UNQ525/PRO1068 Homo sapiens (Human) blood vessel diameter maintenance [GO:0097746]; chemical synaptic transmission [GO:0007268]; muscle contraction [GO:0006936]; regulation of blood pressure [GO:0008217] extracellular region [GO:0005576]; extracellular space [GO:0005615]; synapse [GO:0045202] extracellular region [GO:0005576]; extracellular space [GO:0005615]; synapse [GO:0045202]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; blood vessel diameter maintenance [GO:0097746]; chemical synaptic transmission [GO:0007268]; muscle contraction [GO:0006936]; regulation of blood pressure [GO:0008217] GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0006936; GO:0007268; GO:0008217; GO:0045202; GO:0097746 hormone activity [GO:0005179]; signaling receptor binding [GO:0005102] IWKPYKK 0.99375 -8.744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04070 PROC_HUMAN "Vitamin K-dependent protein C, EC 3.4.21.69 (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide ]" PROC Homo sapiens (Human) blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; serine-type endopeptidase complex [GO:1905370] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood coagulation [GO:0030195]; negative regulation of coagulation [GO:0050819]; negative regulation of inflammatory response [GO:0050728]; positive regulation of establishment of endothelial barrier [GO:1903142]; proteolysis [GO:0006508] GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0005794; GO:0005796; GO:0006508; GO:0007596; GO:0030195; GO:0043066; GO:0050728; GO:0050819; GO:1903142; GO:1905370 calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252] ECIEEICDFEEAK 0.99375 -8.0251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9134 13.8056 0 0 13.4035 0 0 0 0 0 0 13.8023 0 0 0 0 0 0 0 0 0 0 13.4593 0 0 0 0 0 0 0 0 0 0 0 13.4058 0 0 14.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9552 0 0 0 0 0 13.5417 13.4814 0 0 0 0 0 0 12.9317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08582 TRFM_HUMAN Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228) MELTF MAP97 MFI2 Homo sapiens (Human) iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; iron ion binding [GO:0005506]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756] GO:0005506; GO:0005576; GO:0005615; GO:0005769; GO:0005788; GO:0005886; GO:0006826; GO:0009986; GO:0010756; GO:0046658; GO:0055037; GO:0055072; GO:0070062; GO:0090091; GO:1900025 iron ion binding [GO:0005506] DSSHAFTLDELR 0.99375 -7.0335 0 0 0 0 0 0 0 0 0 13.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1378 0 0 0 0 0 0 0 0 10.5109 0 0 0 0 0 0 11.904 0 0 0 0 0 0 0 0 0 0 11.9486 0 11.0558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9984 0 0 10.1718 0 14.5132 0 0 0 0 0 0 0 0 0 0 13.8676 0 0 0 0 0 0 0 0 11.4358 P27144 KAD4_HUMAN "Adenylate kinase 4, mitochondrial, AK 4, EC 2.7.4.10, EC 2.7.4.6 (Adenylate kinase 3-like) (GTP:AMP phosphotransferase AK4)" AK4 AK3 AK3L1 Homo sapiens (Human) ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cellular response to hypoxia [GO:0071456]; GTP metabolic process [GO:0046039]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; regulation of ATP biosynthetic process [GO:2001169]; regulation of oxidative phosphorylation [GO:0002082] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cellular response to hypoxia [GO:0071456]; GTP metabolic process [GO:0046039]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; regulation of ATP biosynthetic process [GO:2001169]; regulation of oxidative phosphorylation [GO:0002082] GO:0002082; GO:0004017; GO:0004550; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006165; GO:0006172; GO:0009142; GO:0015949; GO:0046033; GO:0046034; GO:0046039; GO:0046899; GO:0050145; GO:0071456; GO:2001169 adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; nucleoside triphosphate adenylate kinase activity [GO:0046899] GTVCQRIAQNFGLQHLSSGHFLR 0.99375 -8.7421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0101 0 0 0 0 0 0 0 11.4655 0 0 13.4388 0 0 0 0 14.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5852 0 0 0 0 0 0 12.4724 12.8736 0 0 0 0 14.4884 0 0 0 0 0 0 12.6394 0 14.4047 0 12.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5719 0 0 0 0 0 0 0 0 0 0 13.0449 13.4217 14.0946 13.9796 11.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.263 0 0 0 0 0 P38936 CDN1A_HUMAN "Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6, MDA-6) (p21)" CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 Homo sapiens (Human) "cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; stress-induced premature senescence [GO:0090400]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]" cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA-p21 complex [GO:0070557]; protein-containing complex [GO:0032991] "cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA-p21 complex [GO:0070557]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase activity [GO:0019912]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to amino acid starvation [GO:0034198]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to gamma radiation [GO:0071480]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; stress-induced premature senescence [GO:0090400]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]" GO:0000079; GO:0000082; GO:0000307; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006606; GO:0006974; GO:0006977; GO:0006978; GO:0007095; GO:0007265; GO:0007507; GO:0008285; GO:0010389; GO:0010629; GO:0016604; GO:0019901; GO:0019912; GO:0030308; GO:0030332; GO:0030890; GO:0031625; GO:0031668; GO:0032091; GO:0032991; GO:0034198; GO:0042060; GO:0042246; GO:0042326; GO:0042771; GO:0043068; GO:0044877; GO:0045736; GO:0045860; GO:0046872; GO:0048146; GO:0051726; GO:0070557; GO:0071479; GO:0071480; GO:0071493; GO:0090398; GO:0090399; GO:0090400; GO:0097193; GO:0140311; GO:1902806; GO:1904030; GO:1904706; GO:1905179; GO:2000045; GO:2000134; GO:2000279; GO:2000379 cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase activity [GO:0019912]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] DELGGGR 0.99375 -9.1728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.975 0 0 0 0 0 0 14.4453 0 0 0 0 0 10.0638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9063 0 0 15.1667 0 15.0149 0 0 0 14.4316 14.513 0 11.753 0 12.5983 0 15.3087 0 0 15.1949 0 0 0 0 0 0 0 14.8493 0 14.7995 0 0 0 0 0 14.3623 0 15.1349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7181 0 14.5734 11.1679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52798 EFNA4_HUMAN "Ephrin-A4 (EPH-related receptor tyrosine kinase ligand 4, LERK-4)" EFNA4 EPLG4 LERK4 Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; ephrin receptor binding [GO:0046875]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013] GO:0005005; GO:0005576; GO:0005886; GO:0007267; GO:0007411; GO:0031225; GO:0031226; GO:0046875; GO:0048013 ephrin receptor binding [GO:0046875]; transmembrane-ephrin receptor activity [GO:0005005] GGDTPSPLCLLLLLLLLILRLLR 0.99375 -7.0355 10.6548 0 0 0 0 0 0 0 12.8616 0 0 0 0 0 11.3608 0 0 12.8204 0 13.3894 12.1679 14.452 0 14.2125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5306 10.219 0 0 0 0 0 0 0 0 0 14.1566 0 14.1443 14.2893 13.4045 13.2285 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6841 0 0 11.5773 0 0 0 13.9947 14.1159 0 0 0 11.7808 0 13.2322 14.0033 0 15.3047 0 0 12.75 13.0629 0 0 0 13.7354 13.7616 0 0 0 0 0 0 13.1639 13.8716 14.6098 0 13.3493 13.8276 0 13.5796 13.9713 13.3201 0 13.4458 0 0 0 13.3953 12.637 14.5434 13.68 0 13.9423 0 0 0 14.7664 0 14.9909 13.6868 14.6849 0 12.4919 0 0 14.4573 14.4977 0 14.4479 0 14.6609 12.8264 13.3201 0 0 0 0 0 14.1146 13.361 14.2637 12.2246 0 11.2888 0 Q04118 PRB3_HUMAN Basic salivary proline-rich protein 3 (Parotid salivary glycoprotein G1) (Proline-rich protein G1) PRB3 Homo sapiens (Human) defense response to Gram-negative bacterium [GO:0050829] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to Gram-negative bacterium [GO:0050829] GO:0005576; GO:0050829 PHRPPQGQPPQ 0.99375 -9.1619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7677 0 0 0 13.6424 0 0 0 0 0 0 13.7207 0 0 0 0 0 0 0 0 0 0 0 0 13.1151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4233 0 0 0 0 0 0 13.211 0 0 13.2106 0 0 0 0 0 0 0 13.9029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6979 0 0 0 0 0 Q68DI1 ZN776_HUMAN Zinc finger protein 776 ZNF776 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DFLSSLR 0.99375 -8.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99209 0 0 0 0 0 0 0 10.5027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8203 0 0 0 0 0 0 0 0 0 0 0 12.3872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.26292 0 0 0 0 0 0 0 0 0 13.5119 0 0 0 0 0 0 0 Q6UWU2 GLB1L_HUMAN "Beta-galactosidase-1-like protein, EC 3.2.1.-" GLB1L UNQ229/PRO262 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] extracellular region [GO:0005576]; vacuole [GO:0005773] extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975] GO:0004565; GO:0005576; GO:0005773; GO:0005975 beta-galactosidase activity [GO:0004565] ACDFSYMR 0.99375 -28.943 0 0 0 0 0 0 0 0 0 0 0 0 9.15725 0 0 0 0 0 11.2963 0 0 0 0 0 0 11.6407 11.5091 0 0 0 11.5396 0 0 0 11.7052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.82944 0 0 0 0 0 0 0 12.0158 0 0 0 0 0 0 0 12.8916 0 0 0 13.7862 0 0 13.0735 0 12.6185 0 14.3844 0 0 0 0 14.2747 0 0 13.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9222 0 0 0 0 0 12.5445 12.371 13.8082 12.7174 13.1346 0 0 0 11.6593 0 13.8169 0 0 0 0 0 0 12.4628 0 0 0 0 0 0 0 0 0 0 0 0 12.039 0 0 0 13.049 12.097 0 12.3518 0 12.7423 0 0 0 0 0 0 0 12.8551 13.0579 0 12.7559 13.1009 0 0 0 0 0 0 Q6WRX3 ZY11A_HUMAN Protein zyg-11 homolog A ZYG11A ZYG11 Homo sapiens (Human) Cul2-RING ubiquitin ligase complex [GO:0031462] Cul2-RING ubiquitin ligase complex [GO:0031462] GO:0031462 EALHRLFTETFSMEVTMPAILKLVAIGMR 0.99375 -30.306 0 0 0 0 0 0 0 0 0 0 9.80895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9692 0 0 0 14.1017 14.3474 0 0 0 14.476 0 0 0 0 0 13.6087 0 0 13.3644 13.4966 12.9919 13.7636 0 0 0 12.9538 0 12.3234 0 0 0 13.0636 0 0 0 0 0 13.6779 0 13.5436 14.6491 0 0 0 12.9549 0 12.6798 12.5373 12.8048 0 13.8349 13.2269 10.8476 15.1087 0 12.5699 0 14.5653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5362 0 0 14.0771 0 0 0 0 0 0 0 Q92562 FIG4_HUMAN "Polyphosphoinositide phosphatase, EC 3.1.3.-, EC 3.1.3.36, EC 3.1.3.86 (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4, EC 3.1.3.16)" FIG4 KIAA0274 SAC3 Homo sapiens (Human) locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033] early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037] "early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]; locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033]" GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005783; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037 "phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]" DWLLYIIHGFCGQSK 0.99375 -13.999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5734 12.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1344 0 0 13.8289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0894 0 14.0518 0 0 0 0 0 0 0 0 0 0 13.9894 0 0 0 0 14.7374 14.6088 0 0 0 0 16.2154 16.2803 0 0 0 0 0 15.156 0 0 15.199 0 0 0 0 0 12.8544 0 0 0 14.1896 0 0 0 0 0 0 13.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7907 0 Q96BX8 MOB3A_HUMAN MOB kinase activator 3A (MOB-LAK) (Mob1 homolog 2A) (Mps one binder kinase activator-like 2A) MOB3A MOBKL2A Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0030295; GO:0046872 metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] EFGLIDTK 0.99375 -11.205 11.6645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.329 0 0 0 0 11.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2194 0 13.6535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1637 0 0 13.1826 0 14.4546 0 13.6569 13.7567 0 0 0 13.2291 13.0841 0 0 0 0 0 0 15.4404 0 0 0 0 0 15.6419 12.6174 15.787 0 0 0 0 0 12.7222 0 0 0 0 0 0 0 0 11.0593 0 0 0 12.4185 0 0 13.6303 13.7897 0 0 0 0 0 10.6376 13.3726 16.4514 14.3339 0 0 12.9928 0 0 0 13.0954 13.0467 16.7517 0 0 12.8135 15.0342 14.8026 11.935 11.7653 0 12.5906 0 0 0 0 0 0 12.3108 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4778 0 0 0 13.6303 13.9413 0 13.4842 0 0 0 0 0 0 Q99759 M3K3_HUMAN "Mitogen-activated protein kinase kinase kinase 3, EC 2.7.11.25 (MAPK/ERK kinase kinase 3, MEK kinase 3, MEKK 3)" MAP3K3 MAPKKK3 MEKK3 Homo sapiens (Human) blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777] GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0071864; GO:0090050; GO:0106310; GO:1900745; GO:2000773 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ETQLYDK 0.99375 -14.016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9568 13.4617 13.7181 13.9817 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZF3 OSBL6_HUMAN "Oxysterol-binding protein-related protein 6, ORP-6, OSBP-related protein 6" OSBPL6 ORP6 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; regulation of cholesterol transport [GO:0032374] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; regulation of cholesterol transport [GO:0032374] GO:0005789; GO:0005829; GO:0005886; GO:0006699; GO:0015248; GO:0015485; GO:0016020; GO:0031901; GO:0031965; GO:0032374; GO:0032934; GO:0043231; GO:0097038 cholesterol binding [GO:0015485]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] ACLPAPCPDTSNINLWNILR 0.99375 -6.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6006 0 0 0 0 0 0 0 0 15.2618 12.4002 13.0451 0 14.2666 0 0 0 14.768 0 0 0 0 0 13.3092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5439 0 0 12.6003 12.658 0 0 0 0 0 0 0 0 0 0 0 13.4663 14.1355 14.9769 0 13.7009 0 14.8683 13.4516 0 15.008 0 0 15.0377 0 0 14.7651 0 0 0 0 0 13.4798 0 0 0 0 0 14.0064 0 16.8407 0 0 0 0 0 0 0 0 0 0 0 0 12.8576 0 0 0 0 0 0 0 0 0 0 13.0979 0 13.2101 0 0 0 0 14.1172 0 0 0 13.2316 0 0 0 0 0 0 0 13.5643 0 0 14.294 14.3888 13.6208 12.7561 0 0 0 0 0 13.5701 0 0 0 0 0 Q9NUQ9 CYRIB_HUMAN CYFIP-related Rac1 interactor B (L1) CYRIB CYRI FAM49B BM-009 Homo sapiens (Human) cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140] cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; platelet alpha granule lumen [GO:0031093] "cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; platelet alpha granule lumen [GO:0031093]; MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267]; cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140]" GO:0001916; GO:0005576; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031093; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0070062; GO:0071219; GO:0090140; GO:2000114; GO:2000568 "MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267]" AWGAVVPLVGKLKK 0.99375 -14.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0159 0 0 0 0 12.283 0 0 0 0 0 12.3402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3688 0 13.7828 13.6636 0 13.7425 0 0 0 0 0 0 0 0 0 0 13.6504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4412 0 0 0 0 0 14.4362 0 0 0 0 0 0 0 0 0 14.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UK59 DBR1_HUMAN "Lariat debranching enzyme, EC 3.1.-.-" DBR1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008419; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA lariat debranching enzyme activity [GO:0008419] HMQTFYR 0.99375 -8.0297 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2044 12.8994 0 0 0 0 0 11.4004 0 13.2063 0 0 0 0 12.1216 0 0 0 0 0 0 0 12.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9623 0 16.3243 15.4293 0 15.0611 0 0 14.9042 0 0 0 0 0 0 0 0 0 0 0 13.6651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1839 0 0 14.1839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2523 0 0 0 0 0 0 0 0 11.6919 Q01538 MYT1_HUMAN "Myelin transcription factor 1, MyT1 (Myelin transcription factor I, MyTI) (PLPB1) (Proteolipid protein-binding protein)" MYT1 KIAA0835 KIAA1050 MTF1 MYTI PLPB1 Homo sapiens (Human) "cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0007399; GO:0008270; GO:0030154 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AKKSGVK 0.99376 -7.8278 0 12.8062 17.8098 0 0 0 12.4966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2038 0 13.5659 0 9.98114 0 0 0 0 0 0 0 13.2256 0 0 0 10.3645 0 0 0 0 0 0 0 0 0 12.3203 0 0 0 12.6644 0 0 0 0 0 0 0 0 10.3061 0 0 0 0 0 15.3165 16.1504 15.4287 0 15.087 0 15.4565 15.7828 16.4091 16.7523 16.4792 16.5631 16.7968 15.927 15.6952 16.0781 17.3037 12.5532 17.0676 17.0818 16.7224 14.4907 15.8535 14.6797 16.7189 15.6616 0 16.9458 16.8386 14.9457 16.5436 17.1365 17.557 15.3946 17.9989 17.1633 0 0 17.1694 17.3072 0 17.0386 15.6849 17.0681 17.2134 11.5607 14.7881 15.0308 16.9265 13.7183 17.4679 16.5096 16.9967 17.4761 17.0404 0 0 16.88 16.7134 16.5217 15.6269 15.3326 16.4471 16.0787 14.5361 16.2816 14.8441 16.4403 15.9744 16.906 14.8005 16.4783 15.7976 16.863 15.7637 16.6733 17.4171 16.54 14.6827 17.6278 16.1433 0 0 0 15.9725 16.622 16.9145 16.4202 15.0101 15.7467 11.12 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3963 16.4443 14.9493 16.3964 0 0 0 0 15.7424 0 A4D0S4 LAMB4_HUMAN Laminin subunit beta-4 (Laminin beta-1-related protein) LAMB4 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] extracellular region [GO:0005576]; laminin complex [GO:0043256] extracellular region [GO:0005576]; laminin complex [GO:0043256]; extracellular matrix structural constituent [GO:0005201]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005201; GO:0005576; GO:0009887; GO:0009888; GO:0016477; GO:0034446; GO:0043256; GO:0070831 extracellular matrix structural constituent [GO:0005201] AANILLNLDK 0.99376 -27.545 0 0 0 0 0 0 0 0 0 0 13.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.22617 0 0 0 0 0 12.7167 0 0 0 10.9946 0 0 0 0 0 10.5514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.039 0 0 0 13.0363 13.1448 13.4778 13.7382 0 14.1987 12.4328 0 0 0 0 0 0 0 0 0 0 0 11.0169 13.0452 13.3894 14.5101 13.4236 0 0 0 14.0593 0 0 13.7433 13.835 0 12.9903 0 13.8789 14.8865 0 0 13.3472 0 12.9157 10.6202 13.5179 15.5269 10.5437 0 13.9564 0 0 12.1059 0 0 0 13.6365 12.6977 12.9968 13.8468 0 0 14.6871 0 0 13.6172 0 0 0 0 0 13.0061 0 11.409 13.7763 0 12.4882 13.6511 0 13.8927 0 0 0 0 0 0 0 12.5906 0 0 0 0 0 0 0 0 12.1099 0 0 0 0 0 19.1638 0 12.7219 0 12.5185 15.043 0 0 12.764 F5GYI3 UBA1L_HUMAN "Ubiquitin-associated protein 1-like, UBAP-1L" UBAP1L Homo sapiens (Human) ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] ESCRT I complex [GO:0000813] ESCRT I complex [GO:0000813]; ubiquitin binding [GO:0043130]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] GO:0000813; GO:0043130; GO:0043162 ubiquitin binding [GO:0043130] EVLLVHGNR 0.99376 -7.0684 0 0 0 0 0 0 0 0 14.3597 13.6711 0 0 0 14.4377 13.6797 13.3902 13.3792 0 13.6974 0 0 0 12.2938 0 0 0 0 13.0268 0 0 0 13.2119 13.9988 14.4277 13.926 0 0 0 15.0771 0 13.3701 0 0 0 0 0 0 0 12.4623 11.8523 13.4862 0 0 0 0 0 14.0772 12.6725 0 12.6234 0 0 12.1644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96000 NDUBA_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW, CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit)" NDUFB10 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] CLAKQRQR 0.99376 -6.8371 0 0 13.2047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.832 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7567 0 0 0 14.4351 0 0 0 0 0 0 0 0 0 11.9604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5783 0 0 11.5468 0 12.6077 0 0 0 0 0 0 0 0 0 0 0 0 P22102 PUR2_HUMAN "Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase, EC 6.3.4.13 (Glycinamide ribonucleotide synthetase, GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase, EC 6.3.3.1 (AIR synthase, AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase, EC 2.1.2.2 (5'-phosphoribosylglycinamide transformylase) (GAR transformylase, GART) ]" GART PGFT PRGS Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654] GO:0003360; GO:0004637; GO:0004641; GO:0004644; GO:0005524; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006544; GO:0009168; GO:0010033; GO:0010035; GO:0021549; GO:0021987; GO:0044208; GO:0046084; GO:0046654; GO:0046872; GO:0070062; GO:0097294 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644] ASGLAAGKGVIVAKSK 0.99376 -27.709 0 0 0 13.7977 13.6928 0 0 0 0 11.9242 0 0 0 0 0 0 14.1126 14.1463 13.5824 14.1294 0 16.1771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7538 0 0 0 0 0 0 0 0 0 0 0 0 0 11.893 12.8407 12.6297 13.5861 0 13.2455 14.844 12.4821 12.0112 0 12.847 13.0444 0 12.2945 0 0 14.3088 13.328 14.6718 0 0 13.8087 0 0 11.2247 17.5741 0 0 0 0 13.3119 15.5559 0 20.0777 0 0 19.731 0 0 0 0 16.33 13.2677 18.2695 15.5008 13.0969 14.781 0 18.039 17.8326 17.3008 17.2426 17.0597 17.5063 0 17.4125 16.7824 16.7796 16.441 12.3709 17.818 17.8329 13.042 18.2875 0 0 0 13.8038 0 17.8667 17.935 0 0 18.6252 0 0 12.7349 18.548 14.108 14.2784 15.006 0 18.0021 18.0552 0 14.4367 14.8558 0 17.7511 13.6935 18.5414 18.194 0 0 0 0 0 0 0 0 14.2543 16.9488 17.8654 18.385 18.0039 0 0 0 0 0 0 0 13.3883 0 0 0 0 0 0 0 13.3264 18.8581 14.2948 14.498 0 0 0 0 0 P55199 ELL_HUMAN RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) ELL C19orf17 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription elongation from RNA polymerase II promoter [GO:0006368]" Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] "Cajal body [GO:0015030]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; phosphatase binding [GO:0019902]; in utero embryonic development [GO:0001701]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000791; GO:0000987; GO:0001701; GO:0005654; GO:0005829; GO:0006368; GO:0008023; GO:0015030; GO:0016604; GO:0016607; GO:0019902; GO:0032786; GO:0032968; GO:0035363; GO:0042795; GO:0042796; GO:0045945 cis-regulatory region sequence-specific DNA binding [GO:0000987]; phosphatase binding [GO:0019902] AELLLRLQK 0.99376 -5.2168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8407 0 11.7099 0 12.9845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.284 0 0 0 0 0 0 0 0 0 17.2495 0 0 0 0 0 0 15.0331 14.3693 14.4318 13.837 13.6515 14.3125 14.581 0 0 13.4023 0 15.3815 0 14.6659 14.8251 13.4601 13.697 13.5241 13.4631 13.5579 0 0 0 14.3525 0 13.6676 0 14.3966 0 0 0 15.9254 14.4767 13.2805 13.9863 14.0874 14.2636 0 15.2266 0 0 0 0 16.8789 14.7826 14.9587 14.2433 12.976 14.7924 14.4029 0 14.3074 13.8919 14.1129 14.1985 14.6664 13.2325 18.396 14.077 14.2779 15.3127 13.7295 0 15.0018 15.1923 0 15.3954 0 0 0 13.7863 15.2294 14.461 0 0 0 15.6315 14.1448 14.6736 0 14.2012 0 14.6633 0 0 0 0 0 0 0 0 0 0 0 11.7022 0 0 0 0 14.5989 16.2759 0 0 0 0 0 Q4W5G0 TIGD2_HUMAN Tigger transposable element-derived protein 2 TIGD2 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] KQKIQNNK 0.99376 -7.8558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6762 0 0 12.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0289 0 0 0 0 0 0 0 0 0 0 0 0 11.6493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1122 0 0 0 0 0 Q5VTE0 EF1A3_HUMAN "Putative elongation factor 1-alpha-like 3, EF-1-alpha-like 3 (Eukaryotic elongation factor 1 A-like 3, eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)" EEF1A1P5 EEF1AL3 Homo sapiens (Human) translation [GO:0006412]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414] GO:0003746; GO:0003924; GO:0005525; GO:0005615; GO:0005634; GO:0005737; GO:0006412; GO:0006414; GO:0070062 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746] EAAEMGK 0.99376 -27.723 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3043 0 0 0 0 0 0 0 0 0 0 12.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3339 0 0 0 0 0 0 0 12.9208 0 15.9243 0 0 0 0 0 0 0 0 Q7LFX5 CHSTF_HUMAN "Carbohydrate sulfotransferase 15, EC 2.8.2.33 (B-cell RAG-associated gene protein, hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase, GalNAc4S-6ST)" CHST15 BRAG GALNAC4S6ST KIAA0598 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; chondroitin sulfate biosynthetic process [GO:0030206]; hexose biosynthetic process [GO:0019319] GO:0000139; GO:0016021; GO:0019319; GO:0030206; GO:0050656; GO:0050659 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659] FSAIKEPHWWTRK 0.99376 -5.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3068 0 12.6538 0 12.6544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4952 0 0 0 0 0 0 0 15.3569 0 12.0781 0 0 12.9177 0 14.3771 0 0 13.1378 0 14.3836 14.6607 0 13.1487 0 13.5114 0 0 0 15.0059 0 0 14.3981 0 0 0 0 0 0 10.0422 0 0 0 0 0 0 0 0 0 0 0 13.5564 0 11.2483 13.1058 0 0 14.9675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDN6 BRX1_HUMAN Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2) BRIX1 BRIX BXDC2 Homo sapiens (Human) ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] chromosome [GO:0005694]; nucleolus [GO:0005730] chromosome [GO:0005694]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364] GO:0000027; GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:0019843 RNA binding [GO:0003723]; rRNA binding [GO:0019843] HATAEEVEEEERDR 0.99376 -6.8197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUF8 F172A_HUMAN Cotranscriptional regulator FAM172A (Protein FAM172A) FAM172A C5orf21 Homo sapiens (Human) "heterochromatin assembly by small RNA [GO:0031048]; mRNA processing [GO:0006397]; neural crest cell development [GO:0014032]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] "endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; heterochromatin assembly by small RNA [GO:0031048]; mRNA processing [GO:0006397]; neural crest cell development [GO:0014032]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0005634; GO:0005783; GO:0006397; GO:0008380; GO:0014032; GO:0031048 HIKTGEPFVFNYR 0.99376 -16.168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.367 14.2961 0 0 0 14.1433 0 0 13.767 0 0 0 0 0 13.4508 0 0 0 14.5857 0 0 0 0 0 0 0 0 0 0 0 0 13.8621 0 0 0 0 0 0 13.7337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9635 0 0 0 13.5701 0 0 0 0 0 0 0 0 13.7096 0 0 15.4493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H300 PARL_HUMAN "Presenilins-associated rhomboid-like protein, mitochondrial, EC 3.4.21.105 (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta, Pbeta ]" PARL PSARL PRO2207 Homo sapiens (Human) membrane protein proteolysis [GO:0033619]; mitochondrial fusion [GO:0008053]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; proteolysis [GO:0006508]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]; signal peptide processing [GO:0006465] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; membrane protein proteolysis [GO:0033619]; mitochondrial fusion [GO:0008053]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; proteolysis [GO:0006508]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of mitochondrion organization [GO:0010821]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]; signal peptide processing [GO:0006465] GO:0004175; GO:0004252; GO:0005634; GO:0005739; GO:0005743; GO:0006465; GO:0006508; GO:0008053; GO:0010821; GO:0016021; GO:0030162; GO:0033619; GO:0090201; GO:1903146; GO:1903214; GO:2000377; GO:2001243 endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] NREPLVK 0.99376 -5.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.184 0 0 0 0 0 0 0 0 0 12.9186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4993 16.7602 0 16.3124 13.5266 0 0 0 0 0 0 0 0 0 0 13.3326 13.5754 0 13.2358 0 13.365 0 0 0 0 0 0 0 0 0 0 13.896 18.8449 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9074 14.4626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4213 0 0 0 0 Q9H3M9 ATX3L_HUMAN "Ataxin-3-like protein, EC 3.4.19.12 (Machado-Joseph disease protein 1-like)" ATXN3L ATX3L MJDL Homo sapiens (Human) protein deubiquitination [GO:0016579] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; protein deubiquitination [GO:0016579] GO:0004843; GO:0005634; GO:0005829; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843] LVKQKEHR 0.99376 -8.7619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.485 0 0 0 0 0 0 13.2199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0073 0 0 0 0 0 0 0 0 0 0 14.7672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8676 0 0 0 0 0 0 0 0 Q9H9H5 MA6D1_HUMAN "MAP6 domain-containing protein 1 (21 kDa STOP-like protein, SL21)" MAP6D1 Homo sapiens (Human) cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of microtubule cytoskeleton organization [GO:0070507] cis-Golgi network [GO:0005801]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874] cis-Golgi network [GO:0005801]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0000226; GO:0005516; GO:0005798; GO:0005801; GO:0005874; GO:0007026; GO:0008017; GO:0018009; GO:0030705; GO:0070507 calmodulin binding [GO:0005516]; microtubule binding [GO:0008017] GPGAGGRR 0.99376 -7.0565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0558 13.2403 12.794 0 0 0 0 0 0 0 0 0 12.4026 0 0 0 0 13.9405 0 0 11.3028 0 0 0 13.4209 0 13.5001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5317 13.7113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW75 GPTC2_HUMAN G patch domain-containing protein 2 GPATCH2 GPATC2 Homo sapiens (Human) nuclear speck [GO:0016607]; nucleolus [GO:0005730] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleic acid binding [GO:0003676] GO:0003676; GO:0005730; GO:0016607 nucleic acid binding [GO:0003676] AERGHKK 0.99376 -6.8369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.468 0 0 0 12.967 0 0 10.9569 0 0 13.0605 13.0334 0 12.7471 13.0238 0 13.0054 13.2114 0 0 0 0 16.3764 16.4556 13.1884 12.8936 13.4215 12.7369 0 0 0 0 12.7438 14.3757 13.5768 12.8969 13.1185 0 13.0035 0 0 14.1474 12.8606 0 12.5694 0 0 0 12.9275 0 0 0 13.5814 0 0 0 11.6966 13.2205 12.6851 0 0 0 0 0 15.3308 13.5272 0 0 0 0 0 0 0 0 0 0 13.1108 0 0 0 11.1233 13.0707 0 0 0 0 0 0 0 13.1407 0 10.6911 13.7746 14.73 0 0 0 0 0 0 0 0 0 0 13.0591 0 Q9NZQ8 TRPM5_HUMAN "Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5, LTrpC-5, LTrpC5) (MLSN1- and TRP-related gene 1 protein)" TRPM5 LTRPC5 MTR1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of taste [GO:0050909] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ligand-gated calcium channel activity [GO:0099604]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; calcium ion transmembrane transport [GO:0070588]; cation transmembrane transport [GO:0098655]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of taste [GO:0050909] GO:0005216; GO:0005227; GO:0005244; GO:0005261; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0016021; GO:0030425; GO:0034765; GO:0043025; GO:0050909; GO:0070588; GO:0098655; GO:0099604 calcium activated cation channel activity [GO:0005227]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ligand-gated calcium channel activity [GO:0099604]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244] ALVKACK 0.99376 -14.06 0 0 0 0 0 0 0 0 12.1944 0 0 12.5321 0 0 12.9848 14.0095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9399 0 0 0 12.7513 0 0 0 0 0 0 0 12.3869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.398 0 0 0 0 0 0 0 0 14.9224 14.9479 0 0 15.6225 0 16.1941 0 13.3184 0 11.7795 0 0 13.3163 0 14.4666 0 0 0 0 0 0 0 0 14.0295 0 0 0 0 0 0 11.9664 0 14.2339 14.3567 14.163 0 0 12.0819 0 0 0 14.6805 14.4505 0 0 0 0 10.9012 11.6436 0 0 0 0 0 13.8419 0 15.0211 14.8875 0 0 0 0 14.7234 14.484 0 14.3228 10.4324 14.1986 0 0 0 0 0 0 0 0 0 10.8336 14.056 0 0 14.3498 0 0 13.7303 0 0 14.5333 14.6348 14.7712 14.687 0 0 0 13.4689 0 0 0 0 12.5336 0 13.4498 0 0 Q9UBX5 FBLN5_HUMAN "Fibulin-5, FIBL-5 (Developmental arteries and neural crest EGF-like protein, Dance) (Urine p50 protein, UP50)" FBLN5 DANCE UNQ184/PRO210 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; protein localization to cell surface [GO:0034394]; regulation of cell growth [GO:0001558]; regulation of removal of superoxide radicals [GO:2000121]; secretion [GO:0046903] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cell-matrix adhesion [GO:0007160]; elastic fiber assembly [GO:0048251]; protein localization to cell surface [GO:0034394]; regulation of cell growth [GO:0001558]; regulation of removal of superoxide radicals [GO:2000121]; secretion [GO:0046903] GO:0001558; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0007160; GO:0008022; GO:0031012; GO:0034394; GO:0042803; GO:0046903; GO:0048251; GO:0062023; GO:0070062; GO:2000121 calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803] CMCPAENPGCR 0.99376 -8.7771 0 0 0 0 0 0 12.8013 10.8187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0079 0 13.627 0 0 0 0 0 0 0 0 11.7317 12.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1727 0 0 0 0 0 0 0 12.8701 0 0 13.9499 0 12.6693 0 0 0 13.7928 0 13.3975 0 13.5389 0 12.255 0 0 0 0 12.3561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJU6 DBNL_HUMAN "Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa, HIP-55) (SH3 domain-containing protein 7)" DBNL CMAP SH3P7 PP5423 Homo sapiens (Human) adaptive immune response [GO:0002250]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; ruffle assembly [GO:0097178]; synapse assembly [GO:0007416] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; site of polarized growth [GO:0030427]; tertiary granule lumen [GO:1904724] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; site of polarized growth [GO:0030427]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; adaptive immune response [GO:0002250]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; positive regulation of axon extension [GO:0045773]; positive regulation of dendritic spine morphogenesis [GO:0061003]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; receptor-mediated endocytosis [GO:0006898]; regulation of actin filament polymerization [GO:0030833]; ruffle assembly [GO:0097178]; synapse assembly [GO:0007416] GO:0000139; GO:0001726; GO:0002102; GO:0002250; GO:0003779; GO:0005576; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005938; GO:0006898; GO:0007416; GO:0008022; GO:0008047; GO:0014069; GO:0016601; GO:0019904; GO:0030027; GO:0030425; GO:0030427; GO:0030665; GO:0030833; GO:0030864; GO:0034774; GO:0043204; GO:0043231; GO:0045211; GO:0045296; GO:0045773; GO:0048812; GO:0051015; GO:0061003; GO:0070062; GO:0070161; GO:0071800; GO:0097178; GO:0098974; GO:1904724; GO:1904813 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904] DPNSGLPK 0.99376 -7.071 9.83232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4213 0 12.3785 0 0 0 12.3959 12.3234 12.8639 0 0 11.6048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.437 0 0 0 0 0 0 0 0 0 0 0 0 A6NMS7 L37A1_HUMAN Leucine-rich repeat-containing protein 37A LRRC37A LRRC37A1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AYSWTEKLILR 0.99377 -10.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8835 0 0 14.4974 16.6347 0 14.5297 13.6307 0 16.5691 0 0 15.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7419 0 0 0 16.6132 12.0532 0 0 0 16.5156 0 0 0 0 0 0 0 0 0 0 11.8156 0 0 14.8058 13.5811 14.4856 14.7166 16.1411 16.6293 0 14.6935 16.2133 16.202 13.1129 13.2464 13.0508 15.4852 13.0446 0 0 0 12.7599 0 14.7585 15.4234 14.858 15.8895 14.7527 15.2479 0 13.9605 14.9721 15.6476 0 0 14.8153 0 15.7419 16.45 0 18.0898 0 14.8689 0 13.3949 14.4544 13.7279 16.9659 0 15.7644 13.9281 18.0964 14.1096 13.9477 16.269 14.6163 0 12.8833 14.374 14.1997 16.3139 15.4469 15.5174 13.5759 0 15.3252 12.941 16.6196 15.3587 0 17.5228 17.8279 13.6357 15.4681 15.0522 14.1636 0 14.1801 14.5537 14.9639 17.5525 17.6364 12.8908 14.9465 12.3158 12.4083 14.2708 13.2851 14.4909 15.985 16.0536 16.1961 15.2451 0 0 0 0 0 0 12.1915 0 0 0 0 0 0 0 0 15.1658 0 13.0349 12.8107 0 15.3552 12.8191 14.7881 13.3252 O15066 KIF3B_HUMAN "Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed ]" KIF3B KIAA0359 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819] anchoring junction [GO:0070161]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267]; anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192] GO:0003777; GO:0005524; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0070161; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0120170; GO:1904115 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267] AFFDEEEDHWK 0.99377 -29.44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 0 0 0 0 0 0 0 11.2219 11.3378 0 11.1102 0 0 0 0 0 15.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7938 0 14.1531 0 15.3395 0 0 0 0 0 0 0 0 17.8763 0 0 12.9107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7902 0 0 0 15.4196 15.7067 0 0 0 0 0 0 0 0 0 0 0 0 11.2845 0 0 0 0 0 0 13.8817 0 0 0 0 0 0 0 0 12.8444 0 12.6706 0 0 14.8742 0 14.2151 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3454 0 0 0 0 0 O75570 RF1M_HUMAN "Peptide chain release factor 1, mitochondrial, MRF-1, MtRF-1" MTRF1 Homo sapiens (Human) mitochondrial translational termination [GO:0070126]; regulation of translational termination [GO:0006449] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; translation release factor activity [GO:0003747]; mitochondrial translational termination [GO:0070126]; regulation of translational termination [GO:0006449] GO:0003747; GO:0005739; GO:0006449; GO:0070126 translation release factor activity [GO:0003747] EFLCGGK 0.99377 -10.768 0 0 0 0 0 0 0 0 0 12.6514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2756 0 12.7972 0 0 0 0 0 0 0 12.2748 0 12.4276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94983 CMTA2_HUMAN Calmodulin-binding transcription activator 2 CAMTA2 KIAA0909 Homo sapiens (Human) cardiac muscle hypertrophy in response to stress [GO:0014898]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; cardiac muscle hypertrophy in response to stress [GO:0014898]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000785; GO:0003682; GO:0003690; GO:0003712; GO:0003713; GO:0005634; GO:0006357; GO:0014898; GO:0042826; GO:0043565; GO:0045944 chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] CSSTKHR 0.99377 -10.775 0 0 0 0 10.7764 0 0 0 0 0 13.0038 0 0 13.6512 13.0346 0 0 0 0 0 0 0 0 0 0 13.4314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.553 11.7183 0 0 0 12.9246 0 13.2802 0 12.7946 0 17.5623 13.344 0 13.8451 14.5018 0 0 0 0 0 0 13.2264 0 12.9925 0 13.9758 13.3541 0 0 0 0 0 0 12.3935 0 12.6541 13.7044 0 0 0 15.2479 12.773 13.4288 13.1013 0 0 0 13.6806 0 13.3125 13.202 0 12.0465 0 13.7337 0 0 0 0 0 0 0 0 0 11.7884 0 13.5497 13.8038 0 0 0 0 16.3069 0 0 0 0 0 0 0 0 14.1827 0 0 0 0 0 0 0 0 12.688 0 0 0 13.9608 0 13.2705 0 0 0 0 0 0 0 0 13.7259 0 0 P20333 TNR1B_HUMAN "Tumor necrosis factor receptor superfamily member 1B (Tumor necrosis factor receptor 2, TNF-R2) (Tumor necrosis factor receptor type II, TNF-RII, TNFR-II) (p75) (p80 TNF-alpha receptor) (CD antigen CD120b) (Etanercept) [Cleaved into: Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2 (TBP-2) (TBPII) ]" TNFRSF1B TNFBR TNFR2 Homo sapiens (Human) aging [GO:0007568]; aortic valve development [GO:0003176]; cellular response to growth factor stimulus [GO:0071363]; cellular response to lipopolysaccharide [GO:0071222]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell-neuron signaling [GO:0150098]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell death [GO:0060548]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; pulmonary valve development [GO:0003177]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of myelination [GO:0031641]; regulation of neuroinflammatory response [GO:0150077]; regulation of RNA biosynthetic process [GO:2001141]; regulation of T cell cytokine production [GO:0002724]; regulation of T cell proliferation [GO:0042129]; RNA destabilization [GO:0050779]; tumor necrosis factor-mediated signaling pathway [GO:0033209] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tumor necrosis factor receptor superfamily complex [GO:0002947]; varicosity [GO:0043196] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tumor necrosis factor receptor superfamily complex [GO:0002947]; varicosity [GO:0043196]; tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor activity [GO:0005031]; ubiquitin protein ligase binding [GO:0031625]; aging [GO:0007568]; aortic valve development [GO:0003176]; cellular response to growth factor stimulus [GO:0071363]; cellular response to lipopolysaccharide [GO:0071222]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell-neuron signaling [GO:0150098]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell death [GO:0060548]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; pulmonary valve development [GO:0003177]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of myelination [GO:0031641]; regulation of neuroinflammatory response [GO:0150077]; regulation of RNA biosynthetic process [GO:2001141]; regulation of T cell cytokine production [GO:0002724]; regulation of T cell proliferation [GO:0042129]; RNA destabilization [GO:0050779]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0002718; GO:0002724; GO:0002947; GO:0003176; GO:0003177; GO:0003332; GO:0005031; GO:0005576; GO:0005634; GO:0005886; GO:0006954; GO:0006955; GO:0007568; GO:0008630; GO:0010614; GO:0016020; GO:0016021; GO:0031625; GO:0031641; GO:0031643; GO:0033209; GO:0035579; GO:0042129; GO:0043025; GO:0043120; GO:0043196; GO:0045121; GO:0048471; GO:0048714; GO:0050779; GO:0051044; GO:0060548; GO:0071222; GO:0071363; GO:0097191; GO:0150077; GO:0150079; GO:0150098; GO:1901215; GO:1902339; GO:2001141 tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor activity [GO:0005031]; ubiquitin protein ligase binding [GO:0031625] EYYDQTAQMCCSK 0.99377 -14.184 10.3071 0 0 0 0 0 0 0 12.0594 0 0 0 0 0 0 11.2773 0 0 0 0 0 0 0 0 10.8 0 0 0 0 0 0 0 0 0 12.9028 0 0 0 12.0988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7306 14.5967 14.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9973 0 12.2819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1759 0 0 0 0 0 0 0 12.4798 14.9359 0 0 0 0 0 0 0 0 0 0 12.1377 14.0856 0 0 0 0 0 12.146 0 0 13.0654 13.3479 0 13.4516 0 0 13.6307 13.8291 13.2651 0 13.8372 0 15.2777 0 0 0 0 0 0 0 0 12.8825 12.4726 0 P29508 SPB3_HUMAN "Serpin B3 (Protein T4-A) (Squamous cell carcinoma antigen 1, SCCA-1)" SERPINB3 SCCA SCCA1 Homo sapiens (Human) autocrine signaling [GO:0035425]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; paracrine signaling [GO:0038001]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of epithelial to mesenchymal transition [GO:0010718] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; vesicle [GO:0031982] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; vesicle [GO:0031982]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; virus receptor activity [GO:0001618]; autocrine signaling [GO:0035425]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; paracrine signaling [GO:0038001]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endopeptidase activity [GO:0010950]; positive regulation of epithelial to mesenchymal transition [GO:0010718] GO:0001618; GO:0002020; GO:0004867; GO:0004869; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008284; GO:0010466; GO:0010718; GO:0010950; GO:0010951; GO:0030335; GO:0031410; GO:0031982; GO:0035425; GO:0035578; GO:0038001; GO:0043086; GO:0043508; GO:0045861; GO:0070062 cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; virus receptor activity [GO:0001618] KFNKEDTK 0.99377 -7.0915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4185 0 0 13.0228 0 0 0 0 13.4676 0 13.8056 0 0 0 0 0 0 0 11.3487 0 0 0 0 0 0 13.4602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8824 0 12.5576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29973 CNGA1_HUMAN "cGMP-gated cation channel alpha-1 (Cyclic nucleotide-gated cation channel 1) (Cyclic nucleotide-gated channel alpha-1, CNG channel alpha-1, CNG-1, CNG1) (Cyclic nucleotide-gated channel, photoreceptor) (Rod photoreceptor cGMP-gated channel subunit alpha)" CNGA1 CNCG CNCG1 Homo sapiens (Human) cation transmembrane transport [GO:0098655]; response to stimulus [GO:0050896]; visual perception [GO:0007601] integral component of plasma membrane [GO:0005887]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877]; cation transmembrane transport [GO:0098655]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005222; GO:0005223; GO:0005886; GO:0005887; GO:0007601; GO:0017071; GO:0030553; GO:0042622; GO:0044877; GO:0050896; GO:0098655 cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877] EVLKYLPDKLR 0.99377 -7.0904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3712 0 14.2981 0 11.5954 0 11.5447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4476 10.6982 0 13.3475 0 10.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0709 14.3429 11.8831 0 12.4952 14.2995 0 16.5424 0 0 15.7636 0 0 0 0 0 0 0 11.0341 16.1924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.044 13.5738 0 0 0 0 0 0 0 0 0 13.8304 0 0 0 0 0 0 0 11.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1045 0 0 0 0 0 14.0127 12.6827 0 13.2005 12.5052 0 0 10.6041 0 0 0 10.666 0 0 0 0 0 0 0 0 P57740 NU107_HUMAN Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107) NUP107 Homo sapiens (Human) "female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080] "cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000776; GO:0000973; GO:0005635; GO:0005643; GO:0005829; GO:0006355; GO:0006406; GO:0006606; GO:0006913; GO:0008585; GO:0016020; GO:0017056; GO:0031080; GO:0031965; GO:0034399; GO:0051292; GO:0072006 structural constituent of nuclear pore [GO:0017056] AATLEGWK 0.99377 -14.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.766 11.629 0 0 0 0 12.7417 0 0 0 0 0 0 0 10.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9893 0 0 0 0 0 0 0 0 0 0 0 0 13.896 0 0 0 0 0 0 14.3969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13705 AVR2B_HUMAN "Activin receptor type-2B, EC 2.7.11.30 (Activin receptor type IIB, ACTR-IIB)" ACVR2B Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]" activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] "activin receptor complex [GO:0048179]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; activin binding [GO:0048185]; activin receptor activity [GO:0017002]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; activation of protein kinase activity [GO:0032147]; activin receptor signaling pathway [GO:0032924]; anterior/posterior pattern specification [GO:0009952]; artery development [GO:0060840]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; embryonic foregut morphogenesis [GO:0048617]; gastrulation with mouth forming second [GO:0001702]; heart development [GO:0007507]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; pancreas development [GO:0031016]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; regulation of transcription, DNA-templated [GO:0006355]; response to glucose [GO:0009749]; retina vasculature development in camera-type eye [GO:0061298]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; venous blood vessel development [GO:0060841]" GO:0000122; GO:0001702; GO:0001822; GO:0001946; GO:0001974; GO:0004674; GO:0004712; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006355; GO:0006468; GO:0007165; GO:0007178; GO:0007368; GO:0007498; GO:0007507; GO:0009749; GO:0009791; GO:0009952; GO:0017002; GO:0019838; GO:0030073; GO:0030324; GO:0030501; GO:0030509; GO:0031016; GO:0032147; GO:0032924; GO:0032927; GO:0032991; GO:0035265; GO:0042475; GO:0043235; GO:0045669; GO:0046872; GO:0048179; GO:0048185; GO:0048617; GO:0048705; GO:0060021; GO:0060836; GO:0060840; GO:0060841; GO:0061298; GO:0071363; GO:0120163 activin binding [GO:0048185]; activin receptor activity [GO:0017002]; ATP binding [GO:0005524]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712] CEGEQDK 0.99377 -14.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 0 0 0 12.2913 0 12.042 12.6954 0 12.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7422 0 0 0 0 0 10.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.937 0 0 0 0 0 0 0 0 12.1149 0 0 13.1188 13.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2813 0 14.1106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VYM1 CI131_HUMAN Uncharacterized protein C9orf131 C9orf131 Homo sapiens (Human) AEQGSQR 0.99377 -27.798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3401 0 0 0 16.6217 0 0 0 0 0 0 0 0 13.1964 0 0 0 12.4211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6832 0 0 0 0 0 0 0 0 12.7524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.276 0 0 0 0 0 14.3458 0 0 0 12.635 12.7181 Q70CQ3 UBP30_HUMAN "Ubiquitin carboxyl-terminal hydrolase 30, EC 3.4.19.12 (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30, Ub-specific protease 30)" USP30 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; negative regulation of mitophagy [GO:1901525]; pexophagy [GO:0000425]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; negative regulation of mitophagy [GO:1901525]; pexophagy [GO:0000425]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000422; GO:0000425; GO:0004197; GO:0004843; GO:0005634; GO:0005739; GO:0005741; GO:0005778; GO:0005829; GO:0006511; GO:0008053; GO:0016021; GO:0016579; GO:0035871; GO:0044313; GO:0101005; GO:1901525 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005] ASLQEVLSSSAYLLFYERVLSRMQHQSQECK 0.99377 -7.0926 0 0 0 0 0 0 0 0 11.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1431 0 0 0 0 0 0 0 0 0 10.2228 0 0 0 0 0 10.5864 12.0263 0 14.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1224 0 11.3008 0 0 0 0 0 14.8183 0 15.2445 0 0 0 0 0 0 14.8846 0 0 0 0 15.4142 0 14.7107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3337 12.4509 0 11.6923 0 0 0 0 0 0 0 0 11.0679 12.4197 11.7854 0 0 0 0 0 13.1067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0101 0 0 0 0 0 0 0 Q8IY47 KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 (BTB and kelch domain-containing protein 1) KBTBD2 BKLHD1 KIAA1489 CGI-73 Homo sapiens (Human) gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; response to insulin [GO:0032868] gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; phosphatidylinositol 3-kinase signaling [GO:0014065]; response to insulin [GO:0032868] GO:0006006; GO:0006629; GO:0010467; GO:0014065; GO:0032868 ETHLNER 0.99377 -10.766 0 0 0 0 0 0 0 0 0 0 0 11.866 0 0 0 0 0 11.5501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9084 0 12.8447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5521 0 0 0 0 0 Q8N490 PNKD_HUMAN "Probable hydrolase PNKD, EC 3.-.-.- (Myofibrillogenesis regulator 1, MR-1) (Paroxysmal nonkinesiogenic dyskinesia protein) (Trans-activated by hepatitis C virus core protein 2)" PNKD KIAA1184 MR1 TAHCCP2 FKSG19 UNQ2491/PRO5778 Homo sapiens (Human) "methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929]; neuromuscular process controlling posture [GO:0050884]; regulation of dopamine metabolic process [GO:0042053]; regulation of synaptic transmission, dopaminergic [GO:0032225]" membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929]; neuromuscular process controlling posture [GO:0050884]; regulation of dopamine metabolic process [GO:0042053]; regulation of synaptic transmission, dopaminergic [GO:0032225]" GO:0004416; GO:0005634; GO:0005739; GO:0016020; GO:0016787; GO:0019243; GO:0032225; GO:0042053; GO:0046872; GO:0046929; GO:0050884 hydrolase activity [GO:0016787]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] AQLLEELRRLK 0.99377 -29.456 0 0 0 0 0 0 0 0 13.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0859 0 0 9.91328 0 0 0 0 0 0 0 14.9062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9804 13.5333 12.0737 0 0 0 0 11.2668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4848 12.2701 0 12.3531 0 0 0 12.4685 0 0 0 0 0 0 13.315 14.0496 0 0 0 0 0 0 0 0 0 12.682 0 0 0 0 0 12.4806 12.3303 11.7331 0 0 0 0 0 0 12.5074 0 0 0 0 0 0 0 14.391 0 12.3228 0 0 0 0 0 0 12.4042 0 0 13.2709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7772 0 0 0 0 0 12.9779 12.3222 0 0 0 0 12.6962 0 0 0 10.9377 0 0 0 0 0 0 Q8NEE6 DRC6_HUMAN Dynein regulatory complex subunit 6 (F-box and leucine-rich repeat protein 13) (F-box/LRR-repeat protein 13) FBXL13 DRC6 FBL13 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; motile cilium [GO:0031514]; SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0005829; GO:0005856; GO:0019005; GO:0031146; GO:0031514 CDISLLPERAILQIFFYLSLK 0.99377 -27.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0142 0 0 0 0 0 0 11.7223 0 0 0 12.5799 0 0 0 0 0 0 0 0 0 0 0 0 11.1348 0 0 0 0 0 14.0366 0 0 0 0 0 0 0 0 0 0 0 11.7055 0 0 0 12.1699 11.8552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3671 0 0 0 0 0 0 0 0 0 0 13.0625 0 13.1697 0 0 12.9977 0 0 14.8768 0 13.4955 0 0 0 0 0 0 0 13.7009 0 0 0 14.2288 0 0 13.0916 0 0 0 0 0 15.1932 0 14.1695 0 0 0 0 0 0 0 0 13.0376 0 0 0 0 13.4097 14.315 0 11.8027 0 0 0 0 0 13.3848 0 0 0 0 13.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1415 0 0 0 0 0 0 12.5084 0 0 13.1898 0 0 0 0 0 0 Q8NFH5 NUP35_HUMAN "Nucleoporin NUP35 (35 kDa nucleoporin) (Mitotic phosphoprotein 44, MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53)" NUP35 MP44 NUP53 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003697; GO:0005543; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0006607; GO:0006913; GO:0006999; GO:0017056; GO:0031965; GO:0042802; GO:0044613; GO:0044615; GO:0051028; GO:1990830 identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056] ASTSDYQVISDRQTPK 0.99377 -10.754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6669 0 0 0 0 0 0 12.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1621 0 0 0 0 12.2327 12.1418 14.7255 14.7662 14.3068 11.5444 0 14.4507 0 12.6152 0 14.2589 14.2763 0 0 0 14.0269 0 0 0 12.6427 0 12.3323 0 0 0 13.8429 0 0 0 11.12 0 13.3308 13.4103 14.189 0 0 0 0 0 0 0 0 0 14.5686 0 0 13.6746 13.2894 0 0 13.9954 0 0 0 0 0 0 0 0 0 0 0 13.8184 0 0 0 13.5926 12.425 0 0 0 0 0 0 12.76 13.6276 0 0 0 0 0 0 0 0 0 13.0969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TB45 DPTOR_HUMAN DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6) DEPTOR DEPDC6 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; regulation of extrinsic apoptotic signaling pathway [GO:2001236] GO:0006469; GO:0032007; GO:0035556; GO:0045792; GO:1903940; GO:1904262; GO:2001236 EAEQLCHR 0.99377 -10.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.447 0 0 0 0 0 0 0 0 0 0 11.1712 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2968 0 0 0 0 0 11.9229 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9198 0 11.7187 0 0 0 0 0 0 0 0 0 0 0 0 11.3961 0 11.2678 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4138 0 0 0 0 0 12.1841 0 0 0 0 0 0 0 13.3414 0 0 0 0 0 12.3533 0 0 Q92527 ANKR7_HUMAN Ankyrin repeat domain-containing protein 7 (Testis-specific protein TSA806) ANKRD7 Homo sapiens (Human) centrosome [GO:0005813]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; nucleoplasm [GO:0005654] GO:0005654; GO:0005813 DGYTPLLVAVINNNPKMVKFLLEK 0.99377 -10.767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1616 0 0 17.5577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3975 0 0 12.4911 0 13.3159 0 16.7311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7318 13.2872 13.1721 0 0 0 0 12.9389 0 0 0 13.8978 0 0 0 0 0 0 0 0 0 13.0244 0 0 Q92734 TFG_HUMAN Protein TFG (TRK-fused gene protein) TFG Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971 identical protein binding [GO:0042802] AQLGEDIR 0.99377 -6.8688 0 0 0 0 0 0 10.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.698 0 0 0 12.1544 13.3887 0 0 11.827 12.042 0 12.6345 12.2853 0 0 11.3228 0 0 0 0 0 0 0 12.9217 0 0 0 0 0 0 0 0 0 13.6496 0 0 0 0 0 0 13.0783 0 0 0 0 0 0 11.7858 0 0 13.9535 0 0 0 0 0 0 0 0 0 0 13.3527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3292 0 0 0 0 0 12.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5585 0 0 0 Q99645 EPYC_HUMAN "Epiphycan (Dermatan sulfate proteoglycan 3) (Proteoglycan-Lb, PG-Lb) (Small chondroitin/dermatan sulfate proteoglycan)" EPYC DSPG3 PGLB SLRR3B Homo sapiens (Human) articular cartilage development [GO:0061975]; bone development [GO:0060348]; female pregnancy [GO:0007565]; sensory perception of sound [GO:0007605] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glycosaminoglycan binding [GO:0005539]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; female pregnancy [GO:0007565]; sensory perception of sound [GO:0007605] GO:0005539; GO:0005576; GO:0007565; GO:0007605; GO:0031012; GO:0060348; GO:0061975 glycosaminoglycan binding [GO:0005539] ELLTPPPQPEK 0.99377 -10.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQR3 PRS27_HUMAN "Serine protease 27, EC 3.4.21.- (Marapsin) (Pancreasin)" PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005886; GO:0006508 serine-type endopeptidase activity [GO:0004252] ILQKLAVPIIDTPK 0.99377 -6.8707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0501 0 0 12.0911 12.5742 0 0 0 0 0 0 0 0 0 0 0 0 13.1573 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7302 0 0 0 0 Q9BV68 RN126_HUMAN "E3 ubiquitin-protein ligase RNF126, EC 2.3.2.27 (RING finger protein 126)" RNF126 Homo sapiens (Human) "cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; epidermal growth factor receptor binding [GO:0005154]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]" GO:0005154; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0006513; GO:0042059; GO:0042127; GO:0042147; GO:0043161; GO:0043162; GO:0046872; GO:0061630; GO:0070534; GO:0070936; GO:0071629 epidermal growth factor receptor binding [GO:0005154]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] ARLTTRR 0.99377 -27.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6309 0 0 0 0 0 0 16.5464 0 11.7326 0 0 12.4748 14.6566 12.1046 11.8463 0 0 0 0 0 10.6586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6Q3 SLAP2_HUMAN "Src-like-adapter 2 (Modulator of antigen receptor signaling, MARS) (Src-like adapter protein 2, SLAP-2)" SLA2 C20orf156 SLAP2 Homo sapiens (Human) antigen receptor-mediated signaling pathway [GO:0050851]; B cell mediated immunity [GO:0019724]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; protein N-terminus binding [GO:0047485]; signaling adaptor activity [GO:0035591]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell mediated immunity [GO:0019724]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110] GO:0000122; GO:0005654; GO:0005737; GO:0005770; GO:0005794; GO:0005829; GO:0005886; GO:0005942; GO:0010008; GO:0019724; GO:0035591; GO:0042110; GO:0043231; GO:0046854; GO:0046935; GO:0047485; GO:0050776; GO:0050849; GO:0050851; GO:0050860 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; protein N-terminus binding [GO:0047485]; signaling adaptor activity [GO:0035591] AGPLPGK 0.99377 -14.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5047 0 0 0 0 0 0 11.1121 0 0 0 0 0 0 13.2247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2K8 E2AK4_HUMAN "eIF-2-alpha kinase GCN2, EC 2.7.11.1 (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein)" EIF2AK4 GCN2 KIAA1338 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular protein metabolic process [GO:0032268]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; polysome [GO:0005844] cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; polysome [GO:0005844]; ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049]; adaptive immune response [GO:0002250]; cell cycle [GO:0007049]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to leucine starvation [GO:1990253]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular protein metabolic process [GO:0032268]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081] GO:0000049; GO:0000077; GO:0001934; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004672; GO:0004674; GO:0004694; GO:0005524; GO:0005829; GO:0005844; GO:0006446; GO:0006468; GO:0007049; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032268; GO:0032792; GO:0034198; GO:0034644; GO:0036492; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138; GO:1990253 ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049] DTVRLWR 0.99377 -14.21 0 0 0 0 0 0 0 12.9016 0 11.4534 0 0 0 14.3929 0 14.8124 13.1636 0 14.9569 11.1219 11.1785 0 12.8949 0 14.2409 12.3314 0 0 11.3104 0 0 0 0 0 0 0 0 10.2212 0 0 0 0 0 0 0 0 11.8179 0 13.9857 0 0 0 0 9.28351 0 0 0 0 0 0 0 0 0 0 0 0 10.3972 12.6537 0 0 0 0 9.53993 14.2998 14.4471 0 14.2239 14.941 0 0 0 14.0748 14.3663 14.6762 0 0 14.3668 12.802 0 12.4921 12.6967 13.0123 0 0 11.1959 12.8371 0 16.1956 0 11.1549 0 0 13.6226 0 13.8613 0 0 12.1168 12.5825 0 0 0 0 14.7532 12.2915 13.2507 13.843 0 0 0 0 0 12.3907 0 0 12.8989 14.5003 14.1516 13.3228 11.2807 11.9374 10.9965 0 12.9345 0 0 0 12.1167 0 0 10.2688 0 0 0 12.1007 0 0 11.2437 0 12.4098 0 0 13.34 0 0 0 0 0 0 17.4815 0 15.1443 0 11.985 0 0 11.5207 13.8555 13.428 0 0 0 14.3094 0 12.6024 12.234 0 13.617 11.6008 12.9703 Q15811 ITSN1_HUMAN Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17) ITSN1 ITSN SH3D1A Homo sapiens (Human) clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056] anchoring junction [GO:0070161]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037] anchoring junction [GO:0070161]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; intracellular signal transduction [GO:0035556]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0008104; GO:0015031; GO:0016197; GO:0030027; GO:0035556; GO:0043005; GO:0051056; GO:0055037; GO:0060090; GO:0070064; GO:0070161; GO:0098793; GO:0150007 calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064] AEQERKER 0.99378 -28.327 0 0 0 0 0 14.1704 0 0 0 0 0 0 0 0 0 0 0 13.5349 0 0 13.7759 12.0622 0 0 0 0 13.6633 0 0 0 0 0 0 0 11.9093 0 0 10.4956 0 0 0 0 0 0 14.7552 0 0 0 0 10.9245 0 0 0 0 12.0455 0 0 0 0 0 14.6282 0 0 0 0 0 0 0 0 0 11.4846 15.8305 0 0 13.1055 0 0 0 0 0 15.9374 0 14.937 16.318 16.3303 12.7669 16.16 15.5749 13.5817 0 13.2478 0 11.7966 0 0 0 0 0 0 0 11.2117 0 0 0 10.6216 12.9853 0 0 0 14.9267 0 0 0 0 13.2759 0 0 13.2029 15.6559 13.0179 15.3332 0 0 0 0 0 0 13.6893 0 13.1215 0 13.4573 0 0 0 13.5227 13.4605 0 0 0 0 15.0613 0 0 0 0 11.951 12.7702 15.4606 0 0 10.4807 0 0 0 14.0657 0 0 0 0 0 14.1437 0 0 0 0 17.8351 12.8334 12.0227 0 12.9099 13.7961 0 0 0 11.7561 0 12.8541 0 0 O43541 SMAD6_HUMAN "Mothers against decapentaplegic homolog 6, MAD homolog 6, Mothers against DPP homolog 6 (SMAD family member 6, SMAD 6, Smad6, hSMAD6)" SMAD6 MADH6 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; fat cell differentiation [GO:0045444]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of miRNA transcription [GO:1902895]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; heteromeric SMAD protein complex [GO:0071144]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; heteromeric SMAD protein complex [GO:0071144]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; anatomical structure morphogenesis [GO:0009653]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; fat cell differentiation [GO:0045444]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of miRNA transcription [GO:1902895]; pulmonary valve morphogenesis [GO:0003184]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352] GO:0000785; GO:0000976; GO:0001657; GO:0003148; GO:0003180; GO:0003183; GO:0003184; GO:0003281; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0007179; GO:0007352; GO:0008285; GO:0009653; GO:0010991; GO:0016604; GO:0030154; GO:0030279; GO:0030509; GO:0030512; GO:0030514; GO:0031589; GO:0031625; GO:0032496; GO:0032991; GO:0034616; GO:0034713; GO:0035904; GO:0042802; GO:0043066; GO:0043627; GO:0045444; GO:0045668; GO:0046872; GO:0060394; GO:0060395; GO:0060976; GO:0070410; GO:0070411; GO:0070412; GO:0070698; GO:0071144; GO:0140416; GO:1902895 chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625] ALVVRKVPPGYSIK 0.99378 -7.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2732 0 0 0 0 0 17.0151 16.5507 0 16.499 0 14.5874 13.8459 16.2583 14.0731 0 0 0 14.4281 0 14.074 0 12.027 0 12.205 0 0 14.3066 10.9585 0 0 13.8529 0 13.8121 0 0 0 0 14.5189 14.108 0 13.5456 0 0 12.0034 12.7587 14.5197 15.1988 0 13.77 12.3866 13.9958 16.4571 0 13.0208 0 0 0 13.0098 0 12.7945 0 12.3813 0 0 0 0 0 0 0 11.7648 10.8879 0 0 15.5369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.631 0 0 0 O75335 LIPA4_HUMAN "Liprin-alpha-4 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4, PTPRF-interacting protein alpha-4)" PPFIA4 KIAA0897 Homo sapiens (Human) synapse organization [GO:0050808] cell surface [GO:0009986]; cytosol [GO:0005829]; presynaptic active zone [GO:0048786]; synapse [GO:0045202] cell surface [GO:0009986]; cytosol [GO:0005829]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synapse organization [GO:0050808] GO:0005829; GO:0009986; GO:0045202; GO:0048786; GO:0050808 ALKSLFEHHK 0.99378 -28.284 0 0 0 0 0 0 0 0 14.3879 0 13.6809 0 13.6012 0 0 0 0 0 0 0 0 15.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0999 0 0 0 0 0 0 0 0 13.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.886 0 0 0 0 0 0 0 0 0 0 0 0 12.255 0 0 0 0 0 0 15.4559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0042 0 0 0 11.3555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1714 0 0 0 0 0 0 0 0 0 0 13.9217 0 0 0 0 0 0 0 O75462 CRLF1_HUMAN "Cytokine receptor-like factor 1 (Cytokine-like factor 1, CLF-1) (ZcytoR5)" CRLF1 UNQ288/PRO327 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; ureteric bud development [GO:0001657] CRLF-CLCF1 complex [GO:0097058]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor complex [GO:0043235] CRLF-CLCF1 complex [GO:0097058]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; ureteric bud development [GO:0001657] GO:0001657; GO:0004896; GO:0005576; GO:0005615; GO:0005829; GO:0008284; GO:0009897; GO:0019221; GO:0019955; GO:0042531; GO:0043235; GO:0043524; GO:0097058; GO:2000672 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896] AWMQKSHK 0.99378 -6.65 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5555 13.8285 12.0164 13.251 13.4511 13.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5091 0 0 0 0 O75602 SPAG6_HUMAN Sperm-associated antigen 6 (Protein PF16 homolog) (Repro-SA-1) (Sperm flagellar protein) SPAG6 PF16 Homo sapiens (Human) cilium movement [GO:0003341]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; filopodium assembly [GO:0046847]; neuron projection extension [GO:1990138]; sperm axoneme assembly [GO:0007288] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; extracellular region [GO:0005576]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm principal piece [GO:0097228] acrosomal vesicle [GO:0001669]; axoneme [GO:0005930]; extracellular region [GO:0005576]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm principal piece [GO:0097228]; microtubule binding [GO:0008017]; cilium movement [GO:0003341]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; filopodium assembly [GO:0046847]; neuron projection extension [GO:1990138]; sperm axoneme assembly [GO:0007288] GO:0001669; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005874; GO:0005930; GO:0007288; GO:0008017; GO:0015630; GO:0046847; GO:0097228; GO:1990138 microtubule binding [GO:0008017] AAAFVLRAVGK 0.99378 -7.9141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9638 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9294 0 0 0 0 0 0 0 0 0 0 0 12.0129 11.8619 11.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.242 13.2872 0 13.4351 0 12.7664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1644 0 0 0 0 0 0 0 12.2829 0 0 0 0 0 0 0 0 0 14.2867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2996 0 12.4248 0 0 0 0 12.3889 0 12.3534 0 0 12.2291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7789 0 0 0 0 O75631 UPK3A_HUMAN "Uroplakin-3a, UP3a (Uroplakin III, UPIII)" UPK3A UPK3 Homo sapiens (Human) cell morphogenesis [GO:0000902]; epithelial cell differentiation [GO:0030855]; kidney development [GO:0001822]; potassium ion homeostasis [GO:0055075]; sodium ion homeostasis [GO:0055078]; urea transport [GO:0015840]; urinary bladder development [GO:0060157]; water transport [GO:0006833] apical plasma membrane urothelial plaque [GO:0120001]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] apical plasma membrane urothelial plaque [GO:0120001]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell morphogenesis [GO:0000902]; epithelial cell differentiation [GO:0030855]; kidney development [GO:0001822]; potassium ion homeostasis [GO:0055075]; sodium ion homeostasis [GO:0055078]; urea transport [GO:0015840]; urinary bladder development [GO:0060157]; water transport [GO:0006833] GO:0000902; GO:0001822; GO:0005789; GO:0005886; GO:0006833; GO:0015840; GO:0016021; GO:0030855; GO:0055075; GO:0055078; GO:0060157; GO:0070062; GO:0120001 PLCMFDSK 0.99378 -6.9055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7103 0 0 0 0 0 0 0 0 0 13.5349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.782 0 0 0 0 0 0 0 0 0 0 13.9991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95198 KLHL2_HUMAN Kelch-like protein 2 (Actin-binding protein Mayven) KLHL2 Homo sapiens (Human) protein ubiquitination [GO:0016567] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; protein ubiquitination [GO:0016567] GO:0001726; GO:0003779; GO:0005737; GO:0005829; GO:0015629; GO:0016567; GO:0030027; GO:0031463; GO:0042802 actin binding [GO:0003779]; identical protein binding [GO:0042802] AFADMHACTDLLNK 0.99378 -15.852 17.6258 16.5048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8063 0 0 0 0 0 0 0 0 0 0 0 12.9844 0 0 0 0 0 0 0 0 0 0 0 0 12.5625 13.1042 0 0 0 0 12.393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6458 0 13.7447 0 0 0 0 0 0 0 0 P07478 TRY2_HUMAN "Trypsin-2, EC 3.4.21.4 (Anionic trypsinogen) (Serine protease 2) (Trypsin II)" PRSS2 TRY2 TRYP2 Homo sapiens (Human) antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508] GO:0004222; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0008236; GO:0019730; GO:0022617; GO:0030307; GO:0030574; GO:0031012; GO:0035578; GO:0045785 calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] DTIAANS 0.99378 -6.8996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7327 0 0 0 0 0 0 0 0 11.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0581 0 0 0 0 0 0 0 0 10.7005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2287 0 0 0 16.6059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6773 0 16.2841 0 12.7196 0 P11926 DCOR_HUMAN "Ornithine decarboxylase, ODC, EC 4.1.1.17" ODC1 Homo sapiens (Human) cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process from ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615] GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009615; GO:0033387; GO:0042176; GO:0042803 ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803] IIAEPGR 0.99378 -28.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5028 15.0155 0 14.0215 0 0 0 0 0 0 0 0 0 0 0 13.9511 0 0 11.3943 13.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8309 0 16.3076 0 0 0 13.4548 14.0405 0 0 0 13.4231 0 0 0 0 0 13.4947 0 14.0984 0 13.9779 14.4015 0 0 0 0 13.6115 14.0355 0 0 13.4148 0 0 0 0 13.7413 0 0 0 0 0 12.8061 13.2785 0 0 0 0 0 0 0 0 0 0 0 12.2502 0 0 0 0 0 12.4264 0 0 0 0 0 0 0 0 Q6XQN6 PNCB_HUMAN "Nicotinate phosphoribosyltransferase, NAPRTase, EC 6.3.4.21 (FHA-HIT-interacting protein) (Nicotinate phosphoribosyltransferase domain-containing protein 1)" NAPRT FHIP NAPRT1 Homo sapiens (Human) NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD salvage [GO:0034355]; response to oxidative stress [GO:0006979] GO:0004514; GO:0004516; GO:0005576; GO:0005829; GO:0006979; GO:0034355; GO:0035578; GO:0046872; GO:0070062 metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514] DAAEFELFFR 0.99378 -15.901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3577 0 0 0 0 0 0 0 11.4198 0 0 0 0 0 0 0 0 0 0 12.442 0 0 0 0 0 12.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8251 0 0 0 14.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W54 SPA24_HUMAN Spermatogenesis-associated protein 24 (Testis protein T6441 homolog) SPATA24 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154; GO:0042802 DNA binding [GO:0003677]; identical protein binding [GO:0042802] AAHAKTK 0.99378 -9.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6M5 ALLC_HUMAN Probable inactive allantoicase (Allantoate amidinohydrolase) ALLC Homo sapiens (Human) allantoin catabolic process [GO:0000256] allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256] GO:0000256; GO:0004037 allantoicase activity [GO:0004037] EHEYTEFGK 0.99378 -15.871 0 0 11.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2114 0 13.7993 0 13.7234 0 0 0 0 0 0 0 0 0 15.7459 0 17.9782 0 0 0 12.8797 0 0 0 0 0 0 0 0 0 13.8316 0 0 0 0 0 0 13.0546 0 0 0 13.1582 0 12.8822 0 0 0 12.8416 12.0563 12.7221 14.0169 0 0 0 0 12.6026 0 0 14.4448 0 0 0 13.7511 0 13.3424 0 0 13.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3604 0 13.0013 14.0272 0 0 0 0 0 Q8WWZ8 OIT3_HUMAN Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein) OIT3 LZP UNQ826/PRO1753 Homo sapiens (Human) urate homeostasis [GO:1903118] cell surface [GO:0009986]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635] cell surface [GO:0009986]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; urate homeostasis [GO:1903118] GO:0005201; GO:0005509; GO:0005615; GO:0005635; GO:0009986; GO:1903118 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201] DGCVSDDSVK 0.99378 -10.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8578 0 0 0 0 0 0 0 0 12.9088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9944 0 0 0 0 0 14.0564 0 0 0 0 0 12.7166 0 0 15.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.539 0 0 0 0 0 Q8WXX7 AUTS2_HUMAN Autism susceptibility gene 2 protein AUTS2 KIAA0442 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001764; GO:0003682; GO:0005634; GO:0005737; GO:0005856; GO:0010592; GO:0030426; GO:0031532; GO:0035022; GO:0045944; GO:0048675; GO:0051571; GO:0097484; GO:2000620 chromatin binding [GO:0003682] DGPSVQNFSNPHEPWNR 0.99378 -7.9194 0 0 0 0 0 0 0 0 0 0 12.5641 0 0 12.0375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5364 0 12.0323 0 11.9467 0 0 0 11.3111 0 0 0 11.4027 0 0 0 0 0 0 10.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4507 0 0 0 0 0 0 14.7003 0 0 10.0094 21.3884 21.3189 21.4317 0 21.4013 20.7505 0 21.2899 21.1125 0 13.4882 0 18.0033 12.2969 0 0 0 20.5887 13.7305 0 18.0018 12.5263 11.207 0 0 20.6685 0 0 0 0 16.4326 0 12.1846 0 0 0 0 0 0 0 0 0 0 0 10.4339 0 0 14.0944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1529 0 0 14.3785 0 13.2113 13.4556 0 0 12.6018 0 0 0 14.9999 0 0 0 0 0 13.0984 0 12.762 0 0 Q96AX9 MIB2_HUMAN "E3 ubiquitin-protein ligase MIB2, EC 2.3.2.27 (Mind bomb homolog 2) (Novel zinc finger protein, Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1)" MIB2 SKD ZZANK1 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein ubiquitination [GO:0016567] GO:0003779; GO:0004842; GO:0005737; GO:0005768; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0043123 actin binding [GO:0003779]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CQVVVSKKLR 0.99378 -37.371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2789 0 12.7102 12.8186 13.031 13.8823 16.6601 14.8633 14.9482 0 13.1796 12.4558 13.0253 0 13.3271 13.6864 11.6273 0 0 0 0 0 0 13.8845 0 0 0 12.8622 0 0 13.3024 14.1668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.406 0 0 0 0 13.3455 0 13.3396 0 0 0 18.1982 0 0 13.9949 0 13.2622 13.2325 10.7211 13.328 0 0 14.5002 15.0962 15.971 20.1088 14.4748 19.1271 19.0047 19.3036 19.3606 19.306 19.1219 19.1713 19.1141 18.9912 13.6311 19.0905 19.4366 12.2416 12.725 12.9164 19.0266 0 0 13.941 18.6203 0 19.871 0 0 0 0 0 19.6628 13.696 0 13.7936 19.1097 0 0 0 13.7604 13.2758 19.2069 0 13.9644 13.6818 14.1841 11.1222 0 14.0577 0 0 18.9612 13.1522 14.7294 19.5527 19.5684 19.6693 18.4026 18.3652 18.3006 14.6812 0 0 18.7514 18.7784 18.7799 13.4998 13.5767 0 0 19.3734 19.4426 18.7798 0 0 0 0 12.8145 0 0 14.1793 13.6564 14.3154 0 0 14.2863 15.1159 18.6756 13.0675 18.6734 19.3774 0 0 0 0 0 Q96C45 ULK4_HUMAN "Serine/threonine-protein kinase ULK4, EC 2.7.11.1 (Unc-51-like kinase 4)" ULK4 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase C signaling [GO:0090036] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; microtubule cytoskeleton organization [GO:0000226]; protein phosphorylation [GO:0006468]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein kinase C signaling [GO:0090036] GO:0000226; GO:0004674; GO:0005524; GO:0006468; GO:0010975; GO:0043408; GO:0046328; GO:0090036; GO:0106310; GO:1900744; GO:2001222 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EDPKEQK 0.99378 -15.911 0 0 0 14.7216 0 0 0 10.8701 0 0 10.5322 0 13.5033 13.4312 0 12.4613 0 10.1468 0 12.1573 12.1343 12.1246 0 12.2917 11.7916 13.1963 12.7255 13.3115 12.9896 10.6493 11.1499 0 0 0 0 0 0 0 11.6772 0 0 10.5788 13.4665 11.7874 0 12.7975 11.6967 12.5047 11.5746 11.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9862 11.7779 13.1524 12.1313 0 0 0 0 14.922 13.3667 12.4904 10.8728 0 14.2272 0 0 13.4713 0 0 0 0 0 0 0 0 0 0 13.0305 13.3112 11.9425 12.0593 0 11.0355 0 0 0 0 0 0 0 0 11.531 11.2537 14.2552 0 0 0 0 0 0 12.2065 0 0 12.6556 0 0 12.0148 11.4885 11.1331 0 11.3884 12.5552 12.631 0 12.4564 0 0 13.7175 0 0 0 13.3939 12.6017 0 0 0 11.569 0 12.8888 0 0 14.0404 0 0 0 0 11.0156 13.567 15.1639 13.6073 13.9514 14.6077 11.0631 13.5766 12.8972 13.6055 13.5103 13.6406 11.5709 13.4502 12.6602 16.7647 12.7202 0 0 11.9204 14.6709 11.5622 12.2875 0 0 Q96DE9 EOLA2_HUMAN Protein EOLA2 (Protein CXorf40B) EOLA2 CXorf40B Homo sapiens (Human) DWEGDACR 0.99378 -7.9216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6579 0 0 0 0 0 0 0 0 0 11.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.722 0 0 0 0 11.5773 0 Q96NW7 LRRC7_HUMAN "Leucine-rich repeat-containing protein 7 (Densin-180, Densin) (Protein LAP1)" LRRC7 KIAA1365 LAP1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120] anchoring junction [GO:0070161]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; postsynaptic density [GO:0014069]; specific granule lumen [GO:0035580] anchoring junction [GO:0070161]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular region [GO:0005576]; postsynaptic density [GO:0014069]; specific granule lumen [GO:0035580]; cell-cell adhesion [GO:0098609]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; positive regulation of neuron projection development [GO:0010976]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120] GO:0005576; GO:0005829; GO:0010976; GO:0014069; GO:0016323; GO:0030054; GO:0035580; GO:0043113; GO:0043194; GO:0045197; GO:0070161; GO:0097120; GO:0098609 DIKSNKFK 0.99378 -15.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.866 0 0 0 0 0 0 12.8871 0 0 0 0 0 0 10.9977 0 0 0 13.3916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.294 0 0 0 0 13.9045 0 12.0899 14.305 0 12.2379 12.1291 15.096 0 0 0 13.2492 0 14.8866 13.5935 13.917 13.9685 13.499 13.6328 14.7145 13.545 13.7775 0 13.0293 16.2733 10.6197 0 0 0 0 0 12.3265 0 12.8726 13.6637 13.5539 14.1263 0 14.6496 15.0244 14.1061 13.4924 15.9493 13.9437 15.3122 0 0 0 14.1655 13.1318 14.3285 0 0 0 14.5807 13.7147 13.5204 14.6964 15.4097 0 0 15.4179 0 14.6889 0 0 0 0 12.7134 0 0 0 0 0 0 14.218 0 0 0 0 12.5944 15.8529 0 11.1513 0 0 0 0 0 13.8217 0 13.8171 13.5303 0 0 0 0 0 12.6402 13.7046 10.7068 13.6855 0 13.4163 0 0 Q9BZL3 SMIM3_HUMAN Small integral membrane protein 3 (NGF-induced differentiation clone 67 protein) (Small membrane protein NID67) SMIM3 C5orf62 NID67 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; identical protein binding [GO:0042802] GO:0016021; GO:0042802 identical protein binding [GO:0042802] HILDIWVIVLIILATIVIMTSLLLCPATAVIIYRMR 0.99378 -5.0479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4065 12.9202 14.0555 13.1222 0 0 13.1153 0 0 0 0 0 0 0 12.0324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1384 0 0 0 0 0 0 0 0 12.3105 12.5958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0694 0 0 11.298 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5129 0 0 0 0 0 0 0 0 0 0 0 Q9NPQ8 RIC8A_HUMAN Synembryn-A (Protein Ric-8A) RIC8A Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; vasculature development [GO:0001944]; visual learning [GO:0008542] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; basement membrane organization [GO:0071711]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion involved in gastrulation [GO:0070586]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; vasculature development [GO:0001944]; visual learning [GO:0008542] GO:0001701; GO:0001944; GO:0001965; GO:0005085; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0008542; GO:0042074; GO:0070586; GO:0071711 G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085] ALLIFLEK 0.99378 -28.27 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0602 0 0 0 0 14.8064 0 14.1237 0 0 0 12.5546 0 14.6327 0 0 14.1921 0 0 0 16.066 0 13.0913 0 0 0 0 0 11.3381 0 0 14.5672 0 0 0 14.6474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6768 0 0 0 0 0 16.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y334 VWA7_HUMAN von Willebrand factor A domain-containing protein 7 (Protein G7c) VWA7 C6orf27 G7C NG37 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 ARLVGALRETVVAAR 0.99378 -7.9128 0 0 0 0 0 0 0 0 0 11.5688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9205 0 14.2339 0 0 0 14.538 15.6828 16.0372 14.6951 14.4894 0 0 0 14.6203 14.228 13.8035 0 0 0 0 0 0 0 0 0 0 0 0 13.6604 0 0 0 0 0 14.8723 0 0 14.0522 0 14.3788 12.9526 0 0 0 0 13.8952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3891 0 0 0 0 0 0 0 0 0 0 13.7477 0 0 13.7738 0 14.2427 12.9876 13.6363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2817 0 0 0 Q9Y5X5 NPFF2_HUMAN Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) NPFFR2 GPR74 NPFF2 NPGPR Homo sapiens (Human) detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408] actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479 G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628]; peptide binding [GO:0042277] AAVPHTGR 0.99378 -15.849 0 0 0 0 0 0 0 0 0 13.1575 0 0 13.1968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0247 0 0 0 0 0 0 0 0 13.3734 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7157 0 0 0 0 12.8147 0 0 12.542 0 0 0 0 0 0 12.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9319 0 0 0 0 0 0 11.01 11.1001 0 0 11.3365 0 0 0 0 0 12.3215 0 0 0 0 0 0 0 12.7129 A6NE52 WDR97_HUMAN WD repeat-containing protein 97 WDR97 KIAA1875 Homo sapiens (Human) ANAARCPMSVLHR 0.99379 -30.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5285 13.2105 0 0 0 0 12.5674 0 0 11.9697 13.5317 0 0 14.5624 0 0 0 0 0 0 0 0 15.0053 0 0 0 13.4462 14.2639 0 0 0 11.9883 0 0 14.1258 16.3186 16.4781 0 0 0 0 0 0 0 14.9461 15.6041 0 0 0 14.3165 15.2092 11.9134 0 0 13.393 14.8803 15.7641 0 0 13.1587 0 0 14.2016 0 0 0 0 0 0 12.702 14.8953 0 12.1821 0 12.9342 12.6755 14.3833 0 0 0 0 0 0 0 15.7637 14.0582 14.1219 15.1089 0 0 0 0 0 0 0 0 11.5843 0 0 0 0 0 0 0 13.1211 0 14.103 0 0 0 0 0 O43684 BUB3_HUMAN Mitotic checkpoint protein BUB3 BUB3 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; protein localization to kinetochore [GO:0034501] bub1-bub3 complex [GO:1990298]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654] bub1-bub3 complex [GO:1990298]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; ubiquitin binding [GO:0043130]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; protein localization to kinetochore [GO:0034501] GO:0000070; GO:0000776; GO:0005654; GO:0005829; GO:0007094; GO:0008608; GO:0033597; GO:0034501; GO:0043130; GO:0051301; GO:0051321; GO:0051444; GO:1990298 ubiquitin binding [GO:0043130] LIVGTAGRRVLVWDLR 0.99379 -5.2894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0222 12.8162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7381 0 0 12.3705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2385 0 11.6919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9416 0 O95620 DUS4L_HUMAN "tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like, EC 1.3.1.90 (pp35) (tRNA-dihydrouridine synthase 4-like)" DUS4L Homo sapiens (Human) tRNA dihydrouridine synthesis [GO:0002943] flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA dihydrouridine synthesis [GO:0002943] GO:0002943; GO:0017150; GO:0050660 flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150] HQPVHYDSIKIIK 0.99379 -13.151 0 0 11.2056 0 0 0 0 0 12.2057 0 13.0884 12.8289 0 0 13.4603 0 12.9689 0 0 13.076 0 11.2654 0 0 0 12.8919 0 0 0 0 12.996 13.7107 13.3729 12.568 0 13.1814 0 13.7074 0 0 11.9124 0 13.0588 0 12.8324 13.4565 0 13.3405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4648 0 0 0 0 0 0 0 0 14.1773 14.2085 14.2244 0 0 0 14.1942 14.8604 0 0 14.2896 0 0 0 0 13.9195 0 0 0 0 O95907 MOT3_HUMAN "Monocarboxylate transporter 3, MCT 3 (Solute carrier family 16 member 8)" SLC16A8 MCT3 Homo sapiens (Human) lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; lactate transport [GO:0015727]; monocarboxylic acid transport [GO:0015718] GO:0005886; GO:0005887; GO:0008028; GO:0015129; GO:0015293; GO:0015718; GO:0015727; GO:0016020; GO:0016021; GO:0016323; GO:0016324 lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] AVSVFFRALMR 0.99379 -13.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5804 0 0 0 0 0 0 0 0 0 13.2844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7788 0 0 0 0 0 0 0 0 0 0 0 0 12.7036 0 0 0 0 0 0 0 12.3285 0 14.0485 0 16.1582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02671 FIBA_HUMAN Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain ] FGA Homo sapiens (Human) "adaptive immune response [GO:0002250]; blood coagulation, common pathway [GO:0072377]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of blood coagulation, common pathway [GO:2000261]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093] "blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation, common pathway [GO:0072377]; blood coagulation, fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of blood coagulation, common pathway [GO:2000261]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" GO:0002250; GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0005886; GO:0007160; GO:0009897; GO:0009986; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0042730; GO:0043152; GO:0045087; GO:0045907; GO:0045921; GO:0046872; GO:0050714; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0072377; GO:0072378; GO:0072562; GO:0090277; GO:1900026; GO:1902042; GO:1903561; GO:2000261; GO:2000352 extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] AVRMKIR 0.99379 -30.25 0 0 0 0 0 0 0 0 12.5788 12.143 12.5085 13.6125 13.9339 16.6902 14.0387 13.1191 12.8267 13.0048 0 0 0 0 12.6825 0 13.0765 0 0 13.8955 12.4078 13.9132 12.733 13.1239 0 12.8101 12.4902 0 0 0 12.6537 15.0744 13.0829 13.2709 12.1139 0 13.8311 13.7987 12.3096 12.2875 12.0679 0 0 0 0 12.7433 12.3668 12.5726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2731 0 10.5528 0 15.0229 0 0 0 15.8962 0 0 14.8391 0 0 0 0 0 0 13.8038 0 0 0 0 12.4721 0 14.0967 0 0 0 0 11.0266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6034 14.1981 0 11.3414 0 0 0 0 0 0 0 0 0 0 0 10.8625 0 0 0 0 0 0 0 0 0 12.4107 0 0 0 14.4803 0 0 0 0 0 0 11.4387 0 11.374 0 14.3433 14.5359 0 14.5729 14.4385 14.5518 0 0 14.4824 14.2499 14.5325 14.249 14.3923 0 0 0 0 0 0 14.3103 0 0 P17787 ACHB2_HUMAN Neuronal acetylcholine receptor subunit beta-2 CHRNB2 Homo sapiens (Human) "acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; central nervous system projection neuron axonogenesis [GO:0021952]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; lateral geniculate nucleus development [GO:0021771]; learning [GO:0007612]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; memory [GO:0007613]; negative regulation of action potential [GO:0045759]; nervous system process [GO:0050877]; optic nerve morphogenesis [GO:0021631]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of dopamine secretion [GO:0033603]; regulation of circadian sleep/wake cycle, REM sleep [GO:0042320]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synapse assembly [GO:0051963]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory perception of pain [GO:0019233]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; social behavior [GO:0035176]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]; vestibulocochlear nerve development [GO:0021562]; visual learning [GO:0008542]; visual perception [GO:0007601]" acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; synapse [GO:0045202] "acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cholinergic synapse [GO:0098981]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; heterocyclic compound binding [GO:1901363]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; quaternary ammonium group binding [GO:0050997]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; associative learning [GO:0008306]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; central nervous system projection neuron axonogenesis [GO:0021952]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; lateral geniculate nucleus development [GO:0021771]; learning [GO:0007612]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; memory [GO:0007613]; negative regulation of action potential [GO:0045759]; nervous system process [GO:0050877]; optic nerve morphogenesis [GO:0021631]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of dopamine secretion [GO:0033603]; regulation of circadian sleep/wake cycle, REM sleep [GO:0042320]; regulation of dendrite morphogenesis [GO:0048814]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; regulation of synapse assembly [GO:0051963]; regulation of synaptic transmission, dopaminergic [GO:0032225]; response to acetylcholine [GO:1905144]; response to cocaine [GO:0042220]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; sensory perception of pain [GO:0019233]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939]; social behavior [GO:0035176]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]; vestibulocochlear nerve development [GO:0021562]; visual learning [GO:0008542]; visual perception [GO:0007601]" GO:0001666; GO:0005231; GO:0005886; GO:0005887; GO:0005892; GO:0006811; GO:0006816; GO:0006939; GO:0007165; GO:0007268; GO:0007271; GO:0007601; GO:0007605; GO:0007612; GO:0007613; GO:0007626; GO:0008306; GO:0008542; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016021; GO:0019233; GO:0021562; GO:0021631; GO:0021771; GO:0021952; GO:0022848; GO:0030594; GO:0030890; GO:0032225; GO:0033603; GO:0034220; GO:0035094; GO:0035095; GO:0035176; GO:0042053; GO:0042113; GO:0042166; GO:0042220; GO:0042320; GO:0042391; GO:0043005; GO:0044853; GO:0044877; GO:0045202; GO:0045471; GO:0045759; GO:0048814; GO:0050877; GO:0050890; GO:0050997; GO:0051899; GO:0051963; GO:0060084; GO:0070161; GO:0095500; GO:0098981; GO:0099056; GO:0099060; GO:1901363; GO:1904315; GO:1905144 acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; heterocyclic compound binding [GO:1901363]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter receptor activity [GO:0030594]; protein-containing complex binding [GO:0044877]; quaternary ammonium group binding [GO:0050997]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] CGPVALLLGFGLLR 0.99379 -13.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7269 0 0 0 0 0 0 0 10.6791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41238 ABEC1_HUMAN "C->U-editing enzyme APOBEC-1, EC 3.5.4.36 (Apolipoprotein B mRNA-editing enzyme 1) (HEPR) (mRNA(cytosine(6666)) deaminase 1)" APOBEC1 Homo sapiens (Human) "cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; establishment of localization in cell [GO:0051649]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein transport [GO:0042953]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of DNA demethylation [GO:1901537]; regulation of cell population proliferation [GO:0042127]; response to gamma radiation [GO:0010332]; RNA processing [GO:0006396]; triglyceride metabolic process [GO:0006641]" cytoplasm [GO:0005737]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cytidine deaminase activity [GO:0004126]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cytidine to uridine editing [GO:0016554]; DNA demethylation [GO:0080111]; establishment of localization in cell [GO:0051649]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein transport [GO:0042953]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of DNA demethylation [GO:1901537]; regulation of cell population proliferation [GO:0042127]; response to gamma radiation [GO:0010332]; RNA processing [GO:0006396]; triglyceride metabolic process [GO:0006641]" GO:0003723; GO:0004126; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0006629; GO:0006641; GO:0008270; GO:0010332; GO:0016554; GO:0016556; GO:0035925; GO:0042127; GO:0042158; GO:0042953; GO:0045293; GO:0048255; GO:0051649; GO:0080111; GO:0090209; GO:0090310; GO:1901537; GO:2000623 cytidine deaminase activity [GO:0004126]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] ASEYYHCWR 0.99379 -13.169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7395 0 0 0 0 0 0 0 0 0 12.2266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3009 0 0 14.3893 0 13.8421 0 0 0 0 0 0 0 0 0 0 0 0 12.7619 0 13.8217 0 0 0 12.9496 0 0 13.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4557 11.9655 0 0 0 0 0 0 0 0 0 0 12.0517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49757 NUMB_HUMAN "Protein numb homolog, h-Numb (Protein S171)" NUMB C14orf41 Homo sapiens (Human) adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of cell migration [GO:0030335]; positive regulation of neurogenesis [GO:0050769]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of cell migration [GO:0030335]; positive regulation of neurogenesis [GO:0050769]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149] GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0005905; GO:0005925; GO:0007409; GO:0008013; GO:0010008; GO:0016323; GO:0019897; GO:0021670; GO:0021849; GO:0030136; GO:0030335; GO:0034332; GO:0045177; GO:0045294; GO:0045296; GO:0050769; GO:0098978; GO:0099149; GO:1903077 alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296] AERKFFK 0.99379 -13.911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6682 13.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9098 0 0 0 0 0 0 0 0 0 0 0 13.379 0 0 0 0 Q13393 PLD1_HUMAN "Phospholipase D1, PLD 1, hPLD1, EC 3.1.4.4 (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1)" PLD1 Homo sapiens (Human) chemotaxis [GO:0006935]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; positive regulation of translation [GO:0045727]; Ras protein signal transduction [GO:0007265]; regulation of microvillus assembly [GO:0032534]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of vesicle-mediated transport [GO:0060627]; small GTPase mediated signal transduction [GO:0007264] apical plasma membrane [GO:0016324]; cholinergic synapse [GO:0098981]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] apical plasma membrane [GO:0016324]; cholinergic synapse [GO:0098981]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; chemotaxis [GO:0006935]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; positive regulation of translation [GO:0045727]; Ras protein signal transduction [GO:0007265]; regulation of microvillus assembly [GO:0032534]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of vesicle-mediated transport [GO:0060627]; small GTPase mediated signal transduction [GO:0007264] GO:0000139; GO:0004630; GO:0005765; GO:0005768; GO:0005789; GO:0005794; GO:0005886; GO:0006654; GO:0006935; GO:0007264; GO:0007265; GO:0009395; GO:0016020; GO:0016324; GO:0030139; GO:0031902; GO:0032534; GO:0035091; GO:0035579; GO:0043231; GO:0045727; GO:0048017; GO:0048471; GO:0060627; GO:0070290; GO:0070821; GO:0098693; GO:0098981 N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630] ACYRWSKR 0.99379 -37.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7012 0 0 13.5922 0 13.0636 12.9316 0 12.9448 12.5296 11.9844 0 12.4507 0 0 0 0 0 0 0 0 13.2259 0 0 0 0 0 0 0 0 15.9022 16.4027 16.2867 0 0 0 0 0 0 0 0 0 0 12.3682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2288 0 0 17.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1533 0 0 0 0 0 0 0 0 14.6683 0 0 0 0 0 0 0 0 0 12.7305 0 0 0 0 0 0 15.5959 0 Q7Z7A3 CTU1_HUMAN "Cytoplasmic tRNA 2-thiolation protein 1, EC 2.7.7.- (ATP-binding domain-containing protein 3) (Cancer-associated gene protein) (Cytoplasmic tRNA adenylyltransferase 1)" CTU1 ATPBD3 NCS6 Homo sapiens (Human) protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144] cytosol [GO:0005829]; cytosolic tRNA wobble base thiouridylase complex [GO:0002144]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098] GO:0000049; GO:0002098; GO:0002143; GO:0002144; GO:0005829; GO:0016779; GO:0032447; GO:0034227 nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049] ALEEGAR 0.99379 -5.0578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7323 0 0 0 0 0 0 0 0 12.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8262 0 11.6952 0 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0479 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8819 0 13.1414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IX30 SCUB3_HUMAN "Signal peptide, CUB and EGF-like domain-containing protein 3" SCUBE3 CEGF3 Homo sapiens (Human) positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165] GO:0005509; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0030513; GO:0036122; GO:0042802; GO:0045669; GO:0070700 BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802] AEPMESCR 0.99379 -30.227 0 0 0 0 0 0 0 0 12.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9166 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7239 0 14.0892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4738 0 14.5848 11.8483 0 0 0 14.0271 14.1978 14.6921 13.5439 0 0 12.1963 0 0 0 0 0 14.3366 16.3619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5372 14.5306 0 0 0 0 0 0 14.5687 0 18.0191 0 0 0 13.6117 0 0 11.4732 0 13.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3607 0 0 0 0 0 0 Q8N7J2 AMER2_HUMAN "APC membrane recruitment protein 2, Amer2 (Protein FAM123A)" AMER2 FAM123A Homo sapiens (Human) ectoderm development [GO:0007398]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] "plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; ectoderm development [GO:0007398]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]" GO:0005546; GO:0005886; GO:0007398; GO:0008013; GO:0016055; GO:0060828; GO:0090090 "beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AAFKLFK 0.99379 -30.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3729 0 0 10.9626 0 0 0 0 0 12.1662 0 0 0 0 0 0 0 12.2881 13.2716 0 0 0 0 0 0 0 0 0 0 0 0 0 14.148 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8787 0 0 0 0 0 0 0 0 14.3404 0 14.6865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9L9 ACOT4_HUMAN "Peroxisomal succinyl-coenzyme A thioesterase, EC 3.1.2.3 (Acyl-coenzyme A thioesterase 4, Acyl-CoA thioesterase 4, EC 3.1.2.2) (PTE-2b) (Peroxisomal acyl coenzyme A thioester hydrolase Ib) (Peroxisomal long-chain acyl-CoA thioesterase Ib, PTE-Ib)" ACOT4 PTE2B PTEIB Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; succinyl-CoA hydrolase activity [GO:0004778]; acyl-CoA metabolic process [GO:0006637]; dicarboxylic acid catabolic process [GO:0043649]; dicarboxylic acid metabolic process [GO:0043648]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid metabolic process [GO:0001676]; saturated monocarboxylic acid metabolic process [GO:0032788]; short-chain fatty acid metabolic process [GO:0046459]; succinyl-CoA metabolic process [GO:0006104]; unsaturated monocarboxylic acid metabolic process [GO:0032789]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0001676; GO:0004778; GO:0005777; GO:0005782; GO:0005829; GO:0006104; GO:0006631; GO:0006633; GO:0006637; GO:0016290; GO:0032788; GO:0032789; GO:0043648; GO:0043649; GO:0044466; GO:0046459; GO:0047617; GO:0052689; GO:0102991 acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; glutaryl-CoA hydrolase activity [GO:0044466]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; succinyl-CoA hydrolase activity [GO:0004778] FLKRDVQIPFVVELEVLDGHDPEPGR 0.99379 -6.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99542 MMP19_HUMAN "Matrix metalloproteinase-19, MMP-19, EC 3.4.24.- (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18, MMP-18)" MMP19 MMP18 RASI Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725] GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591 metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270] CGLEDPFNQKTLKYLLLGR 0.99379 -7.9275 0 0 0 0 14.4083 0 0 0 0 0 0 0 0 0 0 11.5918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7053 0 0 0 0 0 0 14.1648 0 0 0 0 0 0 0 0 0 0 13.8181 0 0 0 0 15.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3235 0 0 12.8772 0 0 0 0 0 0 0 0 13.5465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99741 CDC6_HUMAN "Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein, HsCdc18) (p62(cdc6), HsCDC6)" CDC6 CDC18L Homo sapiens (Human) cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166]; cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic cell cycle [GO:0000278]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089] GO:0000076; GO:0000079; GO:0000166; GO:0000278; GO:0000922; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0019900; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0045737; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:1904117; GO:1904385 ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; kinase binding [GO:0019900]; nucleotide binding [GO:0000166] IKEVTLGKLYEAYSK 0.99379 -5.2886 0 0 0 0 0 0 0 0 0 13.9378 13.9996 0 12.5101 0 13.846 0 0 0 0 0 0 0 0 10.4513 0 0 0 0 0 0 0 13.3783 13.9154 0 0 0 0 0 12.8738 0 0 13.9111 0 12.9772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.891 0 0 0 10.8368 0 0 0 0 0 0 0 12.7604 0 0 0 0 0 0 0 0 0 14.9325 0 14.5164 14.7742 0 15.1144 0 0 0 0 0 0 0 0 0 14.7616 0 0 14.5633 0 14.28 12.976 0 Q9HB03 ELOV3_HUMAN "Elongation of very long chain fatty acids protein 3, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL3) (Cold-inducible glycoprotein of 30 kDa) (ELOVL fatty acid elongase 3, ELOVL FA elongase 3) (Very long chain 3-ketoacyl-CoA synthase 3) (Very long chain 3-oxoacyl-CoA synthase 3)" ELOVL3 CIG30 Homo sapiens (Human) "alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; alpha-linolenic acid metabolic process [GO:0036109]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0036109; GO:0042761; GO:0043651; GO:0102336; GO:0102338; GO:0102756; GO:0120162 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756] AANVKPPK 0.99379 -6.4704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8317 13.7027 0 14.5096 0 13.959 13.893 13.8824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4338 0 0 14.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0934 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKP5 ATS6_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 6, ADAM-TS 6, ADAM-TS6, ADAMTS-6, EC 3.4.24.-" ADAMTS6 Homo sapiens (Human) aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508] GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] DFREKQCADFDNMPFR 0.99379 -13.555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57272 13.5671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1009 0 0 0 0 11.034 0 0 0 0 0 0 0 0 0 0 0 12.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9688 0 0 0 0 0 0 0 0 0 0 0 0 11.3209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8292 0 0 0 0 0 0 11.7079 0 0 0 0 0 0 0 0 0 0 0 0 11.4377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2E6 DTX4_HUMAN "E3 ubiquitin-protein ligase DTX4, EC 2.3.2.27 (Protein deltex-4, Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4)" DTX4 KIAA0937 RNF155 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479] GO:0004842; GO:0005654; GO:0005829; GO:0007219; GO:0008270; GO:0016567; GO:0032479; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GKTPEEVLK 0.99379 -13.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2I7 FYV1_HUMAN "1-phosphatidylinositol 3-phosphate 5-kinase, Phosphatidylinositol 3-phosphate 5-kinase, EC 2.7.1.150 (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III, PIPkin-III, Type III PIP kinase) (Serine-protein kinase PIKFYVE, EC 2.7.11.1)" PIKFYVE KIAA0981 PIP5K3 Homo sapiens (Human) "1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]" cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506] "cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; myelin assembly [GO:0032288]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0005911; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032288; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0048471; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785 "1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]" AEPTFGGHDPRTAVQLRSLSTVLK 0.99379 -30.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.349 14.043 0 14.9305 0 0 11.0782 13.2471 0 14.0715 0 15.3571 15.5996 14.1804 0 13.4014 0 12.1741 11.5008 13.2335 14.382 13.3674 0 13.4426 13.6574 0 15.7527 0 10.4055 11.7914 0 12.8425 0 0 18.4383 0 13.2704 0 12.2245 0 14.0175 12.2322 13.3485 12.9412 10.6937 14.6059 12.9388 14.4459 0 14.161 13.7442 13.8839 14.2932 14.1648 12.2854 0 13.6488 13.1003 13.6536 14.0038 13.9936 13.6471 13.241 14.2427 0 13.6743 13.0487 13.5701 0 12.0866 0 14.1752 12.3092 0 13.3429 0 12.4687 0 14.0033 12.9629 14.9378 0 13.8454 13.7532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.878 13.9789 12.4932 0 0 0 0 0 11.6079 14.0441 P24592 IBP6_HUMAN "Insulin-like growth factor-binding protein 6, IBP-6, IGF-binding protein 6, IGFBP-6" IGFBP6 IBP6 Homo sapiens (Human) cell migration [GO:0016477]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; insulin-like growth factor binary complex [GO:0042568] extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; insulin-like growth factor binary complex [GO:0042568]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102]; cell migration [GO:0016477]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; signal transduction [GO:0007165] GO:0001968; GO:0005102; GO:0005576; GO:0005615; GO:0005794; GO:0007165; GO:0008285; GO:0016477; GO:0031994; GO:0031995; GO:0032874; GO:0042568; GO:0042802; GO:0043410; GO:0043567; GO:0090090 fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; signaling receptor binding [GO:0005102] CPGCGQGVQAGCPGGCVEEEDGGSPAEGCAEAEGCLRR 0.9938 -9.1063 0 0 0 12.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2683 0 0 0 0 0 0 0 0 0 0 0 11.97 0 0 0 0 0 11.1478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4741 0 0 9.56131 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T1C6 THEM4_HUMAN "Acyl-coenzyme A thioesterase THEM4, Acyl-CoA thioesterase THEM4, EC 3.1.2.2 (Carboxyl-terminal modulator protein) (Thioesterase superfamily member 4)" THEM4 CTMP Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; fatty acid metabolic process [GO:0006631]; protein kinase B signaling [GO:0043491]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108] GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0005829; GO:0005886; GO:0006631; GO:0016290; GO:0032587; GO:0043491; GO:0102991; GO:1902108 myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290] KCEDGSWK 0.9938 -13.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1007 11.2104 0 0 0 0 0 0 0 0 0 0 0 9.67416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z739 YTHD3_HUMAN "YTH domain-containing family protein 3, DF3" YTHDF3 Homo sapiens (Human) mRNA destabilization [GO:0061157]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of mRNA stability [GO:0043488]; regulation of trophoblast cell migration [GO:1901163]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; mRNA destabilization [GO:0061157]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of mRNA stability [GO:0043488]; regulation of trophoblast cell migration [GO:1901163]; stress granule assembly [GO:0034063] GO:0000932; GO:0003723; GO:0003729; GO:0005737; GO:0005829; GO:0010494; GO:0034063; GO:0043022; GO:0043488; GO:0045727; GO:0045948; GO:0060339; GO:0061157; GO:0070925; GO:1901163; GO:1990247 mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] AKQVLKIIATFK 0.9938 -13.997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6304 0 0 0 0 12.7713 13.604 0 0 13.1357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.014 13.1282 0 13.5827 0 0 0 0 0 12.6826 0 0 0 0 0 0 0 0 0 0 14.3369 0 13.2969 0 0 0 0 0 0 0 0 0 13.4699 12.2366 0 0 0 0 0 11.6932 12.7168 0 0 12.9861 0 0 0 0 0 0 0 0 0 0 0 0 12.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NC60 NOA1_HUMAN Nitric oxide-associated protein 1 NOA1 C4orf14 Homo sapiens (Human) apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]; regulation of cell death [GO:0010941]; regulation of cellular respiration [GO:0043457] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]; regulation of cell death [GO:0010941]; regulation of cellular respiration [GO:0043457] GO:0003723; GO:0005525; GO:0005739; GO:0005743; GO:0006915; GO:0010941; GO:0032543; GO:0043457 GTP binding [GO:0005525]; RNA binding [GO:0003723] CAAASSFQHSSSLGR 0.9938 -30.359 0 0 0 0 0 0 0 10.7496 0 0 0 0 0 0 12.9344 12.6895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.506 12.6367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7781 0 0 13.4538 0 0 0 0 0 0 0 0 13.5871 14.3043 13.3848 0 13.8126 13.4099 0 0 0 0 12.6652 13.3086 0 0 0 13.1912 12.3861 0 0 0 0 0 12.7081 0 0 12.2268 0 0 0 0 10.9666 0 0 0 13.4029 0 0 12.3383 12.1822 0 0 0 13.0583 0 0 13.3483 0 0 12.0697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0509 0 11.4906 0 0 0 0 0 0 0 0 0 0 12.6194 0 0 0 0 13.5761 0 0 0 0 0 0 0 12.4885 0 0 0 0 Q8TD84 DSCL1_HUMAN Cell adhesion molecule DSCAML1 (Down syndrome cell adhesion molecule 2) (Down syndrome cell adhesion molecule-like protein 1) DSCAML1 DSCAM2 KIAA1132 Homo sapiens (Human) axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; dorsal/ventral pattern formation [GO:0009953]; embryonic skeletal system morphogenesis [GO:0048704]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0001709; GO:0005615; GO:0005886; GO:0007156; GO:0007409; GO:0007411; GO:0007417; GO:0007420; GO:0009953; GO:0009986; GO:0016021; GO:0030424; GO:0042803; GO:0045202; GO:0048704; GO:0070161; GO:0070593; GO:0098632 cell-cell adhesion mediator activity [GO:0098632]; protein homodimerization activity [GO:0042803] AGGPHTK 0.9938 -28.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4827 0 0 0 12.481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.086 0 0 0 0 0 0 13.0716 0 0 0 13.3884 0 13.4022 0 0 0 0 0 0 0 0 13.5365 13.9614 0 0 0 13.5681 0 0 0 12.3192 14.7634 0 0 0 0 0 0 11.6915 0 0 0 0 0 14.2303 0 0 0 0 0 13.1473 0 0 0 14.4215 0 0 0 12.6356 0 0 12.9013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4995 0 0 0 11.7854 0 13.3312 0 0 0 0 0 0 Q96CN4 EVI5L_HUMAN EVI5-like protein (Ecotropic viral integration site 5-like protein) EVI5L Homo sapiens (Human) activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547] GO:0005096; GO:0031267; GO:0043547; GO:0090630; GO:1902018 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] ALKVREGQAVASTR 0.9938 -30.688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8653 0 0 0 11.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2569 0 0 0 0 0 0 0 0 0 0 13.7628 0 0 0 0 13.3861 12.7013 0 0 0 0 0 0 14.0478 0 0 0 0 0 12.715 11.9129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6397 0 14.5997 0 14.2141 0 13.4462 0 14.1349 0 12.7322 0 0 14.0554 14.1185 14.2451 0 0 12.7109 0 0 0 13.0715 0 12.758 0 0 13.4444 0 0 0 0 0 13.9361 0 0 0 0 13.5561 0 0 0 0 0 0 0 0 0 14.8696 0 0 0 0 0 14.0807 14.0633 0 0 0 0 0 0 14.8342 Q96Q05 TPPC9_HUMAN Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein) (Tularik gene 1 protein) TRAPPC9 KIAA1882 NIBP T1 Homo sapiens (Human) cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005783; GO:0005802; GO:0005829; GO:0006888; GO:0006901; GO:0021987; GO:0030008; GO:0030182; GO:0051092; GO:0099022; GO:1990071 AVRVLAIQKR 0.9938 -13.96 0 0 10.9302 0 0 0 0 0 0 0 0 13.5239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2506 0 0 0 0 11.9428 0 0 0 0 0 0 0 11.018 11.6511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1284 0 0 0 0 0 12.945 0 0 14.6686 12.1923 12.4053 0 0 0 14.2696 15.1792 15.3975 14.2122 14.9527 13.9903 14.4776 14.2087 14.1411 0 0 14.8239 12.7686 10.5726 0 0 0 0 0 0 14.4621 14.1494 0 14.6549 0 0 0 13.4067 0 0 0 0 15.8335 12.6387 0 0 0 0 0 0 14.2922 10.5748 12.2758 0 0 12.2218 0 0 0 14.5685 0 0 14.3008 0 14.6885 0 0 0 0 14.2096 0 14.3435 0 0 0 0 0 0 0 0 0 0 0 0 10.2737 0 0 0 0 0 0 0 0 0 0 13.9806 0 13.4911 13.2822 0 0 0 0 0 11.9696 Q9BRS8 LARP6_HUMAN "La-related protein 6 (Acheron, Achn) (La ribonucleoprotein domain family member 6)" LARP6 Homo sapiens (Human) positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396] GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005844; GO:0006396; GO:0017022; GO:0032967; GO:0035613; GO:0045727; GO:0048027; GO:1902416; GO:1990825; GO:1990904 mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825] AVLIGMKPPK 0.9938 -30.704 0 0 0 0 0 0 0 0 0 0 0 0 0 12.614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8851 0 13.2119 0 12.6625 0 0 13.5727 0 13.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8858 0 0 0 0 0 0 12.3619 0 0 0 0 0 0 16.5131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCK4 ROBO2_HUMAN Roundabout homolog 2 ROBO2 KIAA1568 Homo sapiens (Human) aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; axon guidance receptor activity [GO:0008046]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cellular response to hormone stimulus [GO:0032870]; central nervous system development [GO:0007417]; endocardial cushion formation [GO:0003272]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; metanephros development [GO:0001656]; negative regulation of negative chemotaxis [GO:0050925]; negative regulation of synapse assembly [GO:0051964]; olfactory bulb interneuron development [GO:0021891]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; pulmonary valve morphogenesis [GO:0003184]; retinal ganglion cell axon guidance [GO:0031290]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412] GO:0001656; GO:0001657; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005886; GO:0007156; GO:0007411; GO:0007417; GO:0007420; GO:0008046; GO:0009986; GO:0016021; GO:0016199; GO:0021891; GO:0030424; GO:0030673; GO:0031290; GO:0032870; GO:0035481; GO:0035904; GO:0042802; GO:0050772; GO:0050925; GO:0051964; GO:0060412; GO:0061364; GO:0070062; GO:0098609; GO:0098632 axon guidance receptor activity [GO:0008046]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802] DGERVETDKDDPR 0.9938 -13.945 0 0 0 0 0 0 0 0 0 0 0 0 12.4808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3102 12.7916 0 13.4375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3879 0 0 0 0 0 0 0 0 0 0 0 0 11.2388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6851 0 15.6937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1881 0 0 0 13.2373 0 0 0 0 0 13.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ48 LZTL1_HUMAN Leucine zipper transcription factor-like protein 1 LZTFL1 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; BBSome binding [GO:0062063]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; flagellated sperm motility [GO:0030317]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]; spermatogenesis [GO:0007283] GO:0002177; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0030317; GO:0042802; GO:0044877; GO:0062063; GO:1903565; GO:1903568 BBSome binding [GO:0062063]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] KPILDVTK 0.9938 -9.1058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0552 0 0 0 0 0 0 0 0 0 0 0 0 12.8438 0 0 0 A6NFU0 F187A_HUMAN Ig-like V-type domain-containing protein FAM187A FAM187A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GIYYCWR 0.99381 -27.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7103 0 0 0 0 0 0 0 0 0 0 P01127 PDGFB_HUMAN "Platelet-derived growth factor subunit B, PDGF subunit B (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide) (Proto-oncogene c-Sis) (Becaplermin)" PDGFB PDGF2 SIS Homo sapiens (Human) "activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; cell chemotaxis [GO:0060326]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mycophenolic acid [GO:0071506]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; interleukin-18-mediated signaling pathway [GO:0035655]; metanephric glomerular mesangial cell development [GO:0072255]; monocyte chemotaxis [GO:0002548]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; paracrine signaling [GO:0038001]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric mesenchymal cell migration [GO:2000591]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905176]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; response to wounding [GO:0009611]" basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265] "basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265]; chemoattractant activity [GO:0042056]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; cell chemotaxis [GO:0060326]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mycophenolic acid [GO:0071506]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; interleukin-18-mediated signaling pathway [GO:0035655]; metanephric glomerular mesangial cell development [GO:0072255]; monocyte chemotaxis [GO:0002548]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; paracrine signaling [GO:0038001]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric mesenchymal cell migration [GO:2000591]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905176]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; response to wounding [GO:0009611]" GO:0000139; GO:0001892; GO:0001938; GO:0002548; GO:0003104; GO:0005161; GO:0005518; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0006468; GO:0007507; GO:0008083; GO:0008284; GO:0009611; GO:0009986; GO:0010512; GO:0010544; GO:0010628; GO:0010629; GO:0010811; GO:0014068; GO:0014911; GO:0016176; GO:0016323; GO:0018105; GO:0018108; GO:0030335; GO:0031093; GO:0031954; GO:0032091; GO:0032147; GO:0032148; GO:0035655; GO:0035793; GO:0036120; GO:0038001; GO:0042056; GO:0042802; GO:0042803; GO:0043406; GO:0043410; GO:0043536; GO:0043552; GO:0045737; GO:0045840; GO:0045892; GO:0045893; GO:0046982; GO:0048008; GO:0048146; GO:0048407; GO:0048661; GO:0050731; GO:0050921; GO:0051781; GO:0060326; GO:0061098; GO:0062023; GO:0070374; GO:0070528; GO:0070851; GO:0071363; GO:0071506; GO:0072126; GO:0072255; GO:0072593; GO:0090280; GO:1900127; GO:1902894; GO:1902895; GO:1904707; GO:1904754; GO:1905064; GO:1905176; GO:1990265; GO:2000379; GO:2000573; GO:2000591 chemoattractant activity [GO:0042056]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; superoxide-generating NADPH oxidase activator activity [GO:0016176] CSGCCNNR 0.99381 -11.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9835 13.8659 13.3903 0 0 0 0 0 12.4767 0 0 13.3276 0 0 0 12.2218 0 13.1066 0 12.7863 0 0 12.0747 0 0 0 0 0 10.9307 0 0 0 0 0 0 10.7945 12.6831 0 13.2844 0 12.7949 0 0 12.9049 0 0 0 12.6694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5151 14.7591 0 0 0 0 12.6541 0 0 0 13.3394 0 0 13.2773 12.984 12.9764 0 0 12.6964 0 0 0 0 0 0 0 0 P0DMB2 CH088_HUMAN Uncharacterized protein C8orf88 C8orf88 Homo sapiens (Human) negative regulation of translational initiation [GO:0045947] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; eukaryotic initiation factor 4E binding [GO:0008190]; negative regulation of translational initiation [GO:0045947] GO:0005737; GO:0008190; GO:0045947 eukaryotic initiation factor 4E binding [GO:0008190] IKYSRDFLLK 0.99381 -6.9998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8962 0 0 0 0 0 0 0 0 0 0 0 0 13.9054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8344 0 0 0 0 0 0 0 0 0 13.1802 0 12.5734 12.358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14147 DHX34_HUMAN "Probable ATP-dependent RNA helicase DHX34, EC 3.6.4.13 (DEAH box protein 34) (DExH-box helicase 34)" DHX34 DDX34 KIAA0134 Homo sapiens (Human) "negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327]" membrane [GO:0016020] "membrane [GO:0016020]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of phosphorylation [GO:0042327]" GO:0000184; GO:0000956; GO:0003723; GO:0003724; GO:0005524; GO:0016020; GO:0016887; GO:0042327; GO:0044877; GO:2000623 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AALPIAQYGNR 0.99381 -27.736 0 12.1275 0 0 0 0 0 0 13.4336 0 13.7559 13.2255 12.8853 11.7587 13.829 0 13.7931 13.3799 11.4911 11.6149 11.3755 0 13.1301 0 0 12.4659 0 12.5056 0 0 11.4662 13.0132 13.2333 0 0 0 0 0 11.476 0 10.425 12.0496 0 12.4117 0 11.0997 0 0 0 0 0 0 0 11.1616 0 0 0 0 0 0 0 0 0 0 0 0 15.676 12.3988 0 0 0 0 12.8414 12.7675 12.3219 0 15.7086 0 15.0164 0 0 0 15.0023 0 0 16.0466 0 17.3603 15.3136 0 0 0 0 0 0 0 0 0 0 11.5499 0 0 0 15.3421 15.4459 0 0 12.5225 11.9332 14.3328 0 0 0 16.0749 15.8296 0 14.5664 0 0 0 0 0 0 0 0 0 0 0 15.178 15.0497 12.4382 0 0 0 0 14.0456 13.2675 0 12.2188 15.3512 15.2748 12.2755 0 13.07 12.6069 12.9456 0 0 0 0 14.6877 0 0 0 12.5567 15.8695 0 0 0 0 0 0 0 11.133 0 12.2573 0 0 0 0 13.3775 0 0 0 0 10.9077 0 11.9741 0 0 Q5SZB4 CI050_HUMAN Uncharacterized protein C9orf50 C9orf50 Homo sapiens (Human) ALYPGAK 0.99381 -11.206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3058 0 0 0 0 0 0 11.6483 0 0 0 0 0 0 0 0 0 12.4932 0 0 0 0 0 14.6405 0 13.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.778 0 13.6835 0 0 0 0 0 0 0 13.7941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7015 0 0 0 0 0 14.4304 0 0 13.8204 0 11.4311 12.8996 0 0 Q6P1L6 ZN343_HUMAN Zinc finger protein 343 ZNF343 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AFPSPLQRQSASPR 0.99381 -14.02 0 0 0 0 0 0 0 0 0 0 0 11.8907 0 0 0 0 0 0 15.5069 0 0 0 0 0 0 0 0 0 0 0 11.7007 0 0 11.0496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.74 0 0 12.7255 0 0 10.3858 0 0 0 0 0 0 0 0 0 0 13.6553 0 0 0 0 0 0 13.5194 0 0 0 11.5564 0 0 0 0 0 15.2841 0 0 0 12.6854 0 0 0 12.8026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3615 0 0 0 0 0 12.7905 0 0 0 0 0 0 13.9216 0 0 12.9466 12.3653 0 12.1126 0 17.2687 0 0 0 0 Q96LA9 MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 (Sensory neuron-specific G-protein coupled receptor 5/6) MRGPRX4 MRGX4 SNSR5 SNSR6 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930] CRRPTHLSAVVCVLLWGLSLLFSMLEWR 0.99381 -14.021 0 0 0 0 0 0 10.9256 0 0 0 0 0 0 0 0 11.9998 0 0 12.5126 0 14.0718 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2462 10.1551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7808 0 0 0 12.8029 15.5784 0 0 11.6172 0 15.0841 0 15.9945 0 14.3491 0 0 15.6995 0 14.7902 0 0 12.3349 0 0 0 0 12.5819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1739 0 11.5103 0 0 14.6215 0 0 0 0 0 0 0 0 11.5509 0 0 0 0 0 0 14.6335 0 12.4199 0 0 0 0 0 0 0 13.9334 0 0 14.9892 0 0 0 11.5389 0 0 0 0 0 0 0 12.7489 0 0 0 0 0 0 0 0 0 13.2552 0 Q9NYU1 UGGG2_HUMAN "UDP-glucose:glycoprotein glucosyltransferase 2, UGT2, hUGT2, EC 2.4.1.- (UDP--Glc:glycoprotein glucosyltransferase 2) (UDP-glucose ceramide glucosyltransferase-like 1)" UGGT2 UGCGL2 UGT2 Homo sapiens (Human) endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0071712; GO:1904380 UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] AGASFYK 0.99381 -14.056 0 0 0 0 0 0 11.7731 0 0 12.5607 12.7805 0 14.0218 0 0 0 0 0 0 11.701 0 0 0 0 10.0707 0 12.5987 12.4391 0 0 13.8053 0 0 0 13.3934 0 0 0 0 0 12.541 0 13.2942 0 12.4441 0 0 0 0 0 0 0 0 0 0 0 0 12.145 12.5521 0 13.6528 0 0 0 11.8256 13.8802 0 0 0 0 0 0 0 0 13.8781 14.2189 12.9727 0 0 0 0 0 14.182 0 0 16.5005 0 13.1938 0 13.4865 15.7081 14.1309 0 0 0 14.1953 13.9373 0 15.3458 12.8455 0 0 0 0 0 0 0 0 12.4627 13.5046 13.5113 0 14.5835 13.223 11.1762 0 0 0 0 0 12.3105 0 14.311 0 0 14.8099 12.2288 0 13.8162 13.1536 0 12.9898 0 0 0 0 0 0 0 12.2372 0 0 0 0 0 0 13.6647 14.3478 0 0 13.6595 0 0 0 0 0 0 0 13.7507 0 0 0 0 11.47 0 11.6667 0 0 12.8303 0 0 0 14.4871 0 0 14.2444 11.8826 0 0 0 C9J442 CV046_HUMAN Uncharacterized protein C22orf46 C22orf46 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AVPSMRCETVFK 0.99382 -9.1669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7878 0 0 0 0 0 0 0 O94759 TRPM2_HUMAN "Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2, LTrpC-2, LTrpC2) (Transient receptor potential channel 7, TrpC7) (Transient receptor potential melastatin 2)" TRPM2 EREG1 KNP3 LTRPC2 TRPC7 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577] cytoplasmic vesicle membrane [GO:0030659]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cytoplasmic vesicle membrane [GO:0030659]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cation transmembrane transport [GO:0098655]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; protein homotetramerization [GO:0051289]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; response to purine-containing compound [GO:0014074]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577] GO:0001659; GO:0002407; GO:0005261; GO:0005262; GO:0005272; GO:0005384; GO:0005509; GO:0005764; GO:0005765; GO:0005886; GO:0005887; GO:0006816; GO:0009408; GO:0014074; GO:0015278; GO:0030659; GO:0032024; GO:0033194; GO:0035579; GO:0035584; GO:0043005; GO:0043204; GO:0044849; GO:0051209; GO:0051289; GO:0051489; GO:0070301; GO:0070588; GO:0070821; GO:0071277; GO:0071415; GO:0071502; GO:0071577; GO:0072571; GO:0097028; GO:0097553; GO:0098655; GO:0098703; GO:0099604; GO:0101003; GO:1903223; GO:2000249 calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; mono-ADP-D-ribose binding [GO:0072571]; sodium channel activity [GO:0005272] DFSLSSSYK 0.99382 -29.468 0 0 0 0 0 0 0 0 0 13.4788 13.4409 0 0 0 0 0 0 14.8478 0 0 13.883 0 0 0 0 0 0 0 11.2434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85596 0 0 0 10.1809 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9633 0 0 0 0 10.5564 0 0 13.4025 13.9386 15.6562 0 16.58 14.7307 0 13.7138 0 0 12.9511 0 13.7007 13.4751 0 14.63 13.7765 16.0698 0 14.3572 14.2347 0 14.1915 0 0 14.0051 0 15.4073 13.9757 0 15.4304 14.9316 14.7322 0 0 0 0 14.68 0 0 14.8923 15.3333 0 0 13.5632 0 15.2633 14.4537 13.5649 14.5238 0 0 14.7356 16.7651 0 13.3496 0 0 12.3405 0 0 14.0736 13.5703 13.34 13.1726 0 12.7608 14.8742 0 12.8089 0 14.5185 0 0 0 0 13.5807 13.0034 10.1809 14.5155 0 15.1688 0 0 11.9775 0 0 10.7857 0 0 0 0 0 13.2458 0 0 0 0 0 0 0 0 0 14.1641 13.2669 P00736 C1R_HUMAN "Complement C1r subcomponent, EC 3.4.21.41 (Complement component 1 subcomponent r) [Cleaved into: Complement C1r subcomponent heavy chain; Complement C1r subcomponent light chain ]" C1R Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]" blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "blood microparticle [GO:0072562]; complement component C1 complex [GO:0005602]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; complement activation, classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]" GO:0004252; GO:0005509; GO:0005576; GO:0005602; GO:0005615; GO:0006955; GO:0006958; GO:0008236; GO:0031638; GO:0042802; GO:0045087; GO:0070062; GO:0072562 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] AGGSIPIPQK 0.99382 -6.5303 0 0 0 0 10.9678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8158 0 0 0 0 0 0 0 0 0 0 0 0 14.0409 13.796 13.9762 13.7757 14.1209 13.5975 0 0 0 0 0 0 11.7965 0 12.9194 0 0 12.7008 19.5159 0 0 12.5317 0 13.4648 13.0685 0 12.4168 0 0 0 16.7567 0 15.9512 12.8866 0 0 0 0 0 0 0 0 0 13.1319 0 0 0 12.6296 0 0 13.1089 0 0 13.2612 0 0 0 0 0 19.1234 0 0 0 13.0449 0 0 0 0 13.3235 12.9562 0 14.1145 0 12.7169 13.7257 0 13.0411 0 0 0 0 0 0 0 13.0681 13.6455 0 14.8855 0 0 0 0 0 0 0 0 0 0 0 0 11.4338 0 0 0 0 12.8486 13.2981 0 0 0 0 0 0 0 P0C671 BNIP5_HUMAN Protein BNIP5 BNIP5 C6orf222 Homo sapiens (Human) EGISQHPEPLEAAGEPALRK 0.99382 -16.164 0 0 0 0 0 0 0 11.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.001 15.1571 14.925 15.0513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.499 15.9635 0 10.8298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3148 0 0 0 0 11.1488 0 0 0 10.9753 11.0429 10.9853 0 0 0 11.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6055 0 0 0 0 0 0 0 14.6204 14.9593 0 0 0 0 0 0 11.6031 0 0 P49918 CDN1C_HUMAN Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2) CDKN1C KIP2 Homo sapiens (Human) "cell cycle [GO:0007049]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]" GO:0004860; GO:0004861; GO:0005634; GO:0005737; GO:0007049; GO:0030511; GO:0033673; GO:0042326; GO:0044877; GO:0045736; GO:0045892; GO:0045893; GO:0045930; GO:0050680; GO:1904030 cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877] CRLLLAPR 0.99382 -7.8023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6994 14.5333 15.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9428 0 0 0 0 13.109 13.0629 0 0 0 0 0 0 12.5208 0 12.7637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8061 0 0 0 0 9.34804 0 0 13.7562 0 0 12.6649 0 0 0 0 0 12.7652 12.9205 0 0 0 0 0 0 0 0 0 0 0 0 11.052 0 0 0 0 0 0 0 12.5909 0 0 0 0 0 0 0 0 0 0 0 11.9921 0 0 12.167 0 0 0 9.61701 Q2VYF4 LETM2_HUMAN "LETM1 domain-containing protein LETM2, mitochondrial (LETM1 and EF-hand domain-containing protein 2) (Leucine zipper-EF-hand-containing transmembrane protein 1-like)" LETM2 Homo sapiens (Human) cellular metal ion homeostasis [GO:0006875] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ribosome binding [GO:0043022]; cellular metal ion homeostasis [GO:0006875] GO:0005743; GO:0006875; GO:0016021; GO:0043022 ribosome binding [GO:0043022] ENVPPSLLLLSRTFYLIDVK 0.99382 -8.024 0 0 0 0 0 0 14.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q66K79 CBPZ_HUMAN "Carboxypeptidase Z, CPZ, EC 3.4.17.-" CPZ Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508]; Wnt signaling pathway [GO:0016055] GO:0004181; GO:0005615; GO:0006508; GO:0006518; GO:0008270; GO:0016055; GO:0016485 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] EDEGCYDPLEK 0.99382 -7.0335 0 0 0 0 0 11.582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1752 0 0 0 0 15.1025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8152 0 0 0 0 0 0 0 11.9841 0 0 0 0 0 0 0 12.7373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2773 0 12.4478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6199 11.1602 0 0 0 0 0 11.4995 0 Q8NCX0 CC150_HUMAN Coiled-coil domain-containing protein 150 CCDC150 Homo sapiens (Human) ANNAQNIERMK 0.99382 -8.0249 0 0 0 0 0 0 10.0764 0 0 13.0484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44093 14.5345 0 11.3901 0 0 12.2167 11.1167 0 0 0 0 14.8525 0 0 0 12.1441 0 10.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9831 0 0 0 0 0 0 0 0 11.644 0 12.554 12.6582 0 0 10.7925 0 0 0 12.8894 17.8902 16.7695 13.3852 0 0 0 11.0381 16.0106 15.8024 12.3296 15.5203 16.4357 15.6414 15.276 0 0 16.5217 14.0487 13.7339 14.6481 13.4645 0 14.4041 11.4908 14.5288 0 12.8244 10.0771 13.6487 0 15.2879 15.3735 0 14.9428 13.5549 0 12.1978 0 12.9736 13.4807 13.6276 13.1752 14.5032 13.5871 0 13.5978 0 0 0 0 0 11.8994 13.8544 12.1593 0 0 0 0 0 10.2118 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4847 0 0 0 0 0 11.5571 0 0 0 0 0 0 15.1327 14.7118 0 0 0 11.891 10.6786 0 0 13.5353 0 12.0596 Q8TED9 AF1L1_HUMAN "Actin filament-associated protein 1-like 1, AFAP1-like protein 1" AFAP1L1 Homo sapiens (Human) anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytosol [GO:0005829]; podosome [GO:0002102] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytosol [GO:0005829]; podosome [GO:0002102]; SH3 domain binding [GO:0017124] GO:0002102; GO:0005829; GO:0017124; GO:0042995; GO:0070161 SH3 domain binding [GO:0017124] ALEEAVATLEAQCR 0.99382 -8.742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2565 11.7354 0 0 0 0 0 13.1956 0 0 11.1954 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8139 12.799 0 0 0 0 0 0 0 0 11.8681 0 14.6382 0 0 0 0 0 0 0 0 0 10.9253 0 0 0 0 13.2968 0 11.4034 0 0 0 0 0 0 0 0 12.1222 0 0 0 11.8214 0 0 0 0 0 0 0 15.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4962 0 0 0 Q96MZ4 F218A_HUMAN Protein FAM218A FAM218A C4orf39 Homo sapiens (Human) AKLRSWCR 0.99382 -7.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2K8 TAOK3_HUMAN "Serine/threonine-protein kinase TAO3, EC 2.7.11.1 (Cutaneous T-cell lymphoma-associated antigen HD-CL-09, CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A, hKFC-A) (Thousand and one amino acid protein 3)" TAOK3 DPK JIK KDS MAP3K18 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of JNK cascade [GO:0046329]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] GO:0000165; GO:0004674; GO:0004860; GO:0005524; GO:0005737; GO:0005886; GO:0006281; GO:0006468; GO:0006974; GO:0007095; GO:0016740; GO:0032874; GO:0035556; GO:0043408; GO:0043507; GO:0046329; GO:0046330; GO:0046777; GO:0048812; GO:0106310 ATP binding [GO:0005524]; protein kinase inhibitor activity [GO:0004860]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transferase activity [GO:0016740] AEMDEHR 0.99382 -29.478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3346 0 0 0 0 0 0 0 17.1844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5446 14.6925 0 0 0 19.9503 0 13.2355 0 0 0 0 0 0 0 13.9877 14.0573 15.0802 0 14.4218 11.868 0 0 0 0 0 0 0 0 12.9464 0 0 0 0 0 0 0 0 0 12.4019 0 0 12.5356 0 0 10.7655 0 0 0 0 0 0 14.4936 0 0 0 0 0 0 0 19.4801 0 0 0 0 11.5656 0 0 0 10.7889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0908 0 15.5655 0 0 14.3229 0 0 0 0 0 11.9821 Q9P0W2 HM20B_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related, SMARCE1-related protein (BRCA2-associated factor 35) (HMG box-containing protein 20B) (HMG domain-containing protein 2) (HMG domain-containing protein HMGX2) (Sox-like transcriptional factor) (Structural DNA-binding protein BRAF35)" HMG20B BRAF35 HMGX2 HMGXB2 SMARCE1R Homo sapiens (Human) cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein sumoylation [GO:0033234]; positive regulation of neuron differentiation [GO:0045666]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468]; skeletal muscle cell differentiation [GO:0035914] chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein sumoylation [GO:0033234]; positive regulation of neuron differentiation [GO:0045666]; protein sumoylation [GO:0016925]; regulation of gene expression [GO:0010468]; skeletal muscle cell differentiation [GO:0035914] GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0007049; GO:0010468; GO:0016604; GO:0016925; GO:0033234; GO:0035914; GO:0045666 DNA binding [GO:0003677] AYQQSEAYK 0.99382 -9.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4568 0 0 14.08 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4D8 HECD4_HUMAN "Probable E3 ubiquitin-protein ligase HECTD4, EC 2.3.2.26 (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4)" HECTD4 C12orf51 KIAA0614 Homo sapiens (Human) glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006] GO:0004842; GO:0006006; GO:0016021; GO:0042593 ubiquitin-protein transferase activity [GO:0004842] ACNAHGGVFKDEIYIPLQEEDTK 0.99382 -29.66 0 0 11.4531 0 0 0 0 10.0784 0 0 0 14.6692 10.5688 0 0 0 0 0 0 0 0 11.3103 11.6424 11.3048 12.3852 0 0 12.2932 13.7085 13.0254 0 0 0 0 0 9.93799 13.3501 14.2589 13.9706 11.6089 0 0 14.4628 0 13.0359 0 12.4286 0 0 0 12.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0276 12.1704 0 12.6801 13.459 0 0 14.1037 13.3554 14.752 0 13.913 14.5707 0 0 12.271 14.8613 12.5645 16.9951 15.4392 13.4207 0 11.6007 13.6571 13.4526 13.3806 14.7352 14.1025 14.1808 0 14.4902 0 0 12.3253 13.2419 0 0 12.1805 16.2988 0 0 12.394 15.2141 15.7738 12.4151 12.583 13.449 12.7481 13.1999 17.1055 12.6516 15.354 12.5944 0 0 0 14.8095 0 13.9365 12.3983 14.1486 14.5137 0 0 0 0 0 13.5116 0 0 14.9081 10.4506 14.1797 14.0417 14.0462 0 11.4386 0 0 13.5477 0 14.1436 16.7378 0 0 12.0963 0 12.8157 0 10.8886 0 12.0865 13.9897 14.2664 11.5953 0 0 0 0 0 11.9526 0 0 14.4733 12.0309 0 11.357 0 0 11.9576 0 15.1507 11.6624 0 Q9Y5R2 MMP24_HUMAN "Matrix metalloproteinase-24, MMP-24, EC 3.4.24.- (Membrane-type matrix metalloproteinase 5, MT-MMP 5, MTMMP5) (Membrane-type-5 matrix metalloproteinase, MT5-MMP, MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24 ]" MMP24 MT5MMP Homo sapiens (Human) cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; collagen catabolic process [GO:0030574]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; extracellular matrix organization [GO:0030198]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508] GO:0004222; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0010001; GO:0030198; GO:0030574; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0070062; GO:0097150; GO:0098742 cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] DRWFWRLR 0.99382 -7.8041 0 11.3458 0 0 0 0 0 0 13.5603 0 0 0 0 0 12.5043 0 0 0 0 12.2166 0 0 10.8723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2885 11.5775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2984 0 0 15.232 0 0 14.6437 12.6893 0 0 0 0 12.3961 0 14.6582 0 0 0 0 13.6583 0 0 0 0 0 0 0 0 0 0 14.5379 0 13.7986 13.3171 0 0 12.5712 0 0 13.6669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2036 0 0 0 0 0 0 0 0 0 0 0 13.4332 0 0 0 0 0 0 0 0 0 13.375 0 0 0 0 0 0 0 13.1637 0 0 0 0 0 0 0 Q9C086 IN80B_HUMAN "INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog, hIes2) (PAP-1-associated protein 1, PAPA-1) (Zinc finger HIT domain-containing protein 4)" INO80B HMGA1L4 PAPA1 ZNHIT4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0016604; GO:0031011; GO:0033044; GO:0045893; GO:0046872; GO:0051726; GO:0060382 metal ion binding [GO:0046872] AAAPAPMVR 0.99383 -10.765 11.4812 13.5349 10.8724 15.4203 12.0331 0 12.0056 11.3333 0 0 0 0 0 0 0 0 0 0 10.6631 10.5705 11.1841 15.8761 0 15.7555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2704 0 10.3817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3704 12.6703 0 0 19.2744 0 0 0 16.0919 0 13.4015 18.7173 12.9421 12.5496 12.3043 14.3626 13.6948 13.0732 14.7563 12.6136 12.8946 12.7439 14.8682 14.713 14.789 13.3385 0 14.5762 12.7857 13.0227 12.9242 22.4064 0 0 0 0 19.5347 13.522 0 14.3598 18.816 18.07 13.7577 13.7569 13.2678 0 12.6049 0 0 13.0452 0 0 14.5714 17.2301 0 0 19.5881 0 21.0606 17.8615 12.772 12.459 12.5098 13.4812 13.0707 12.4189 19.9234 19.658 0 0 0 12.5032 0 0 0 19.9208 12.8018 0 13.1986 18.9165 0 0 0 0 13.1724 12.1316 0 0 12.5832 13.9647 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.248 0 12.7138 0 12.5391 0 0 0 0 O14979 HNRDL_HUMAN "Heterogeneous nuclear ribonucleoprotein D-like, hnRNP D-like, hnRNP DL (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1)" HNRNPDL HNRPDL JKTBP Homo sapiens (Human) regulation of gene expression [GO:0010468]; RNA processing [GO:0006396] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; regulation of gene expression [GO:0010468]; RNA processing [GO:0006396] GO:0003677; GO:0003690; GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008143; GO:0010468; GO:0034046 DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] AKALKGK 0.99383 -8.0574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3024 14.7331 13.2008 14.7211 14.047 14.9694 13.4733 15.1468 0 13.4652 0 13.1772 12.9483 0 0 13.5798 0 12.0461 0 13.44 0 0 0 0 13.2469 0 0 12.8698 14.4021 0 0 0 11.868 0 0 0 0 0 13.0159 0 0 0 0 0 0 0 0 0 10.3701 0 0 0 12.5287 13.0783 13.8368 13.8632 0 0 0 0 0 0 0 0 0 13.5321 14.7817 0 0 0 12.5741 0 0 0 0 0 15.3165 0 0 13.004 12.9308 0 13.8385 10.1443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8804 13.5382 0 0 0 0 0 12.0045 O15524 SOCS1_HUMAN "Suppressor of cytokine signaling 1, SOCS-1 (JAK-binding protein, JAB) (STAT-induced STAT inhibitor 1, SSI-1) (Tec-interacting protein 3, TIP-3)" SOCS1 SSI1 TIP3 Homo sapiens (Human) "cellular response to amino acid stimulus [GO:0071230]; cytokine-mediated signaling pathway [GO:0019221]; fat cell differentiation [GO:0045444]; intracellular signal transduction [GO:0035556]; macrophage differentiation [GO:0030225]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of activation of Janus kinase activity [GO:0010533]; regulation of cytokine production [GO:0001817]; regulation of growth [GO:0040008]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein phosphorylation [GO:0001932]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; insulin-like growth factor receptor binding [GO:0005159]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular response to amino acid stimulus [GO:0071230]; cytokine-mediated signaling pathway [GO:0019221]; fat cell differentiation [GO:0045444]; intracellular signal transduction [GO:0035556]; macrophage differentiation [GO:0030225]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of activation of Janus kinase activity [GO:0010533]; regulation of cytokine production [GO:0001817]; regulation of growth [GO:0040008]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of protein phosphorylation [GO:0001932]" GO:0001817; GO:0001932; GO:0004860; GO:0005159; GO:0005654; GO:0005737; GO:0005829; GO:0005942; GO:0007259; GO:0010533; GO:0016567; GO:0019210; GO:0019221; GO:0019901; GO:0030225; GO:0031410; GO:0035556; GO:0036464; GO:0040008; GO:0042532; GO:0043372; GO:0043377; GO:0045444; GO:0045591; GO:0046426; GO:0046627; GO:0046854; GO:0046935; GO:0060334; GO:0071230 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; insulin-like growth factor receptor binding [GO:0005159]; kinase inhibitor activity [GO:0019210]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] ENLARIPLNPVLR 0.99383 -5.1731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43776 SYNC_HUMAN "Asparagine--tRNA ligase, cytoplasmic, EC 6.1.1.22 (Asparaginyl-tRNA synthetase, AsnRS) (Asparaginyl-tRNA synthetase 1)" NARS1 NARS NRS Homo sapiens (Human) asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418] GO:0003676; GO:0004816; GO:0005524; GO:0005737; GO:0005829; GO:0006418; GO:0006421; GO:0016477; GO:0021987; GO:0031728; GO:0046983; GO:0070062 asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983] AEQSRTRR 0.99383 -10.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 11.2263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95816 BAG2_HUMAN "BAG family molecular chaperone regulator 2, BAG-2 (Bcl-2-associated athanogene 2)" BAG2 Homo sapiens (Human) negative regulation of protein binding [GO:0032091]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821] axon [GO:0030424]; chaperone complex [GO:0101031]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588] axon [GO:0030424]; chaperone complex [GO:0101031]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein folding [GO:0006457]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821] GO:0000774; GO:0005829; GO:0006457; GO:0010954; GO:0019538; GO:0030424; GO:0030425; GO:0031072; GO:0031397; GO:0031625; GO:0032091; GO:0042802; GO:0044325; GO:0048156; GO:0050821; GO:0051087; GO:0101031; GO:1901588; GO:1901800; GO:1904667 adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; tau protein binding [GO:0048156]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] ANEGRFCR 0.99383 -7.0483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7969 0 0 0 0 0 0 0 12.3651 0 0 14.1463 0 0 0 0 14.5048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0351 0 0 0 14.1771 0 0 0 0 0 0 13.8762 0 0 0 0 0 0 0 13.5171 0 13.5061 0 0 0 12.7014 0 0 0 13.6453 0 12.7163 0 0 0 11.1563 0 0 0 0 0 0 0 0 0 0 0 0 12.4938 0 0 0 0 0 0 0 0 14.2251 0 0 13.3238 0 13.1424 0 0 0 0 0 0 0 0 0 0 P01189 COLI_HUMAN "Pro-opiomelanocortin, POMC (Corticotropin-lipotropin) [Cleaved into: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone, ACTH); Melanocyte-stimulating hormone alpha, Alpha-MSH (Melanotropin alpha); Corticotropin-like intermediary peptide, CLIP; Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanocyte-stimulating hormone beta, Beta-MSH (Melanotropin beta); Beta-endorphin; Met-enkephalin ]" POMC Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cellular pigmentation [GO:0033059]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; killing of cells of another organism [GO:0031640]; modulation of process of another organism [GO:0035821]; negative regulation of tumor necrosis factor production [GO:0032720]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; positive regulation of oxytocin production [GO:0140668]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of appetite [GO:0032098]; regulation of blood pressure [GO:0008217]; regulation of corticosterone secretion [GO:2000852]; regulation of glycogen metabolic process [GO:0070873]; response to melanocyte-stimulating hormone [GO:1990680]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisomal matrix [GO:0005782]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisomal matrix [GO:0005782]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cellular pigmentation [GO:0033059]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; killing of cells of another organism [GO:0031640]; modulation of process of another organism [GO:0035821]; negative regulation of tumor necrosis factor production [GO:0032720]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; positive regulation of oxytocin production [GO:0140668]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of appetite [GO:0032098]; regulation of blood pressure [GO:0008217]; regulation of corticosterone secretion [GO:2000852]; regulation of glycogen metabolic process [GO:0070873]; response to melanocyte-stimulating hormone [GO:1990680]; signal transduction [GO:0007165] GO:0001664; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0005782; GO:0006091; GO:0007165; GO:0007218; GO:0007267; GO:0008217; GO:0019722; GO:0030141; GO:0031640; GO:0031781; GO:0031782; GO:0032098; GO:0032720; GO:0033059; GO:0034774; GO:0035821; GO:0042593; GO:0043950; GO:0045944; GO:0061844; GO:0070873; GO:0070965; GO:0070996; GO:0140668; GO:1990680; GO:2000852 G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782] KYVMGHFR 0.99383 -14.2 0 0 0 0 0 0 0 0 0 13.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4455 0 0 0 0 0 12.0589 13.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG31 Z286B_HUMAN Putative zinc finger protein 286B ZNF286B ZNF286C ZNF286L Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNECGKSFK 0.99383 -8.0556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1721 0 0 0 0 0 0 0 0 0 12.6936 0 0 0 13.7277 0 13.4442 0 13.4742 13.7443 0 14.6113 0 0 13.7964 0 13.8645 13.2578 0 0 0 0 0 0 0 0 0 10.2146 0 0 0 0 0 12.517 0 0 0 0 0 0 0 0 12.3489 12.2705 12.0259 12.8848 13.4099 0 13.6417 14.4231 0 0 0 14.0497 0 0 0 0 0 0 0 0 13.5935 0 0 0 0 14.7739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8127 0 0 0 0 0 0 0 0 0 0 0 0 12.4448 0 0 10.9739 0 0 0 P16989 YBOX3_HUMAN Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB) YBX3 CSDA DBPA Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reproductive process [GO:2000242]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; mRNA 3'-UTR binding [GO:0003730]; nucleic acid binding [GO:0003676]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; small GTPase binding [GO:0031267]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cellular hyperosmotic response [GO:0071474]; cellular response to tumor necrosis factor [GO:0071356]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reproductive process [GO:2000242]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of organ growth [GO:0046622]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283] GO:0000122; GO:0000977; GO:0001701; GO:0003676; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005923; GO:0006915; GO:0007283; GO:0008584; GO:0009566; GO:0010468; GO:0031267; GO:0035234; GO:0046622; GO:0048471; GO:0048642; GO:0060546; GO:0070935; GO:0071356; GO:0071474; GO:1902219; GO:1905538; GO:2000242; GO:2000767 mRNA 3'-UTR binding [GO:0003730]; nucleic acid binding [GO:0003676]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; small GTPase binding [GO:0031267] PQYRPQYRQR 0.99383 -6.5649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.016 0 0 0 0 0 0 0 0 0 0 0 0 13.0097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8338 0 0 0 0 0 0 0 0 0 0 0 0 0 P17017 ZNF14_HUMAN "Zinc finger protein 14 (Gonadotropin-inducible ovary transcription repressor 4, GIOT-4) (Zinc finger protein KOX6)" ZNF14 GIOT4 KOX6 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFIYYQPFQRHER 0.99383 -28.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1401 0 0 0 0 0 13.7624 13.0021 0 0 0 0 0 13.7833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8761 0 0 0 0 0 0 0 P48681 NEST_HUMAN Nestin NES Nbla00170 Homo sapiens (Human) brain development [GO:0007420]; cell projection morphogenesis [GO:0048858]; central nervous system development [GO:0007417]; embryonic camera-type eye development [GO:0031076]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; positive regulation of intermediate filament depolymerization [GO:0030844]; positive regulation of neural precursor cell proliferation [GO:2000179]; stem cell proliferation [GO:0072089] cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111] cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; CCR5 chemokine receptor binding [GO:0031730]; intermediate filament binding [GO:0019215]; brain development [GO:0007420]; cell projection morphogenesis [GO:0048858]; central nervous system development [GO:0007417]; embryonic camera-type eye development [GO:0031076]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of catalytic activity [GO:0043086]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; positive regulation of intermediate filament depolymerization [GO:0030844]; positive regulation of neural precursor cell proliferation [GO:2000179]; stem cell proliferation [GO:0072089] GO:0000086; GO:0005737; GO:0005882; GO:0007417; GO:0007420; GO:0019215; GO:0030844; GO:0031076; GO:0031730; GO:0032091; GO:0043086; GO:0043524; GO:0045111; GO:0048858; GO:0051402; GO:0072089; GO:2000179 CCR5 chemokine receptor binding [GO:0031730]; intermediate filament binding [GO:0019215] AHADDELAALRALVDQRWR 0.99383 -37.347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4754 0 0 0 0 0 0 0 0 0 0 0 0 11.5261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1532 0 0 0 13.5063 0 0 13.958 0 0 0 16.2075 12.2525 0 12.1086 0 0 0 0 0 0 0 11.6324 0 0 0 0 0 0 0 0 0 0 12.7307 0 0 0 0 0 12.4756 0 0 0 12.8247 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2693 14.068 0 0 0 0 0 0 0 0 0 0 12.4965 0 0 0 14.0204 0 0 12.8146 0 0 0 0 13.4378 0 0 0 0 0 0 12.5662 12.2752 0 0 0 15.1812 0 13.6994 11.5635 11.3978 0 11.0997 0 0 0 0 0 0 0 0 0 12.1982 0 0 0 0 Q52LR7 EPC2_HUMAN Enhancer of polycomb homolog 2 (EPC-like) EPC2 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]" NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777] "NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000786; GO:0006281; GO:0006325; GO:0006357; GO:0016573; GO:0032777; GO:0035267; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779 AITILEMIK 0.99383 -7.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7328 0 0 0 0 0 0 14.2072 0 0 17.4909 0 0 0 0 0 0 0 12.892 0 17.0552 0 0 0 0 0 0 0 0 0 0 16.7074 0 0 0 0 0 0 0 0 12.3011 0 0 0 0 0 0 0 0 12.169 13.2915 13.7275 16.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.226 0 0 0 0 0 0 0 0 12.5094 0 0 0 0 0 0 0 12.2331 0 0 0 0 0 0 Q58EX2 SDK2_HUMAN Protein sidekick-2 SDK2 KIAA1514 Homo sapiens (Human) camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416] GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0016021; GO:0045202; GO:0060219; GO:0070161 ATSVTVKGLVPAR 0.99383 -7.8372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4868 0 0 0 0 0 13.0708 0 13.3508 0 0 0 0 0 0 0 0 0 0 11.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4766 12.738 0 0 0 0 0 13.9363 13.9143 13.7696 0 13.4132 13.4282 14.0921 13.7725 0 16.122 13.3098 0 0 0 13.8498 12.9488 0 13.7282 0 0 13.4722 12.5266 14.6055 14.0622 0 14.7348 15.5303 0 0 0 13.5316 0 13.2275 0 0 0 0 12.6999 0 12.5878 13.569 13.4812 13.5256 13.788 0 14.6547 12.6682 12.047 0 0 12.6163 0 0 13.0047 0 15.7484 0 0 12.354 12.1751 0 0 0 0 0 0 0 0 0 0 13.9079 13.2202 12.6236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8335 0 0 0 0 0 0 Q6ZVC0 NYAP1_HUMAN Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1 NYAP1 C7orf51 Homo sapiens (Human) neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] neuron projection morphogenesis [GO:0048812]; phosphatidylinositol 3-kinase signaling [GO:0014065] GO:0014065; GO:0048812 DGKLLEVIER 0.99383 -37.422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3566 0 0 0 0 0 0 0 0 0 15.0161 0 0 0 0 0 0 14.4267 0 0 0 14.1718 0 14.244 0 0 0 12.7304 0 0 0 0 0 0 0 14.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5832 0 0 0 0 11.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3274 0 9.99492 0 0 12.2167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZW76 ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 ANKS3 KIAA1977 Homo sapiens (Human) cilium [GO:0005929]; cytoplasm [GO:0005737] cilium [GO:0005929]; cytoplasm [GO:0005737] GO:0005737; GO:0005929 ALARITGIGLGGR 0.99383 -7.0353 0 0 13.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.66631 0 0 0 0 12.6431 0 14.719 0 14.8837 13.9475 0 0 12.8127 0 0 13.9252 13.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9604 0 0 0 0 0 0 12.0754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.832 0 0 0 0 0 0 0 0 0 0 16.9391 0 0 0 0 15.218 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 0 0 0 0 0 0 0 13.8774 14.7589 0 14.8667 0 0 0 0 0 0 0 13.2144 0 0 0 0 Q8IWB9 TEX2_HUMAN Testis-expressed protein 2 (Transmembrane protein 96) TEX2 KIAA1738 TMEM96 Homo sapiens (Human) lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665] GO:0005783; GO:0005789; GO:0006665; GO:0006869; GO:0007165; GO:0008289; GO:0016021; GO:0031965 lipid binding [GO:0008289] AFCLADSDEESSSAGSSEEDDAPEPSGGDK 0.99383 -37.499 0 0 0 0 0 0 0 0 0 0 0 13.1423 0 13.179 13.4543 0 13.6086 13.5638 0 0 0 0 0 0 0 0 0 0 13.839 0 0 0 0 14.027 0 0 14.0537 0 0 0 0 0 0 0 0 15.208 0 14.2154 0 0 0 0 0 0 10.4337 0 0 12.7029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6189 0 0 0 0 0 0 0 0 0 0 12.801 12.227 0 0 0 0 0 0 0 0 0 16.3372 12.4226 12.3385 0 14.4501 14.1109 15.6328 0 15.6404 0 0 0 14.7575 14.0393 0 12.5735 0 0 16.3574 15.8922 13.0177 0 0 0 0 0 0 0 10.996 0 11.2866 0 0 12.5065 0 0 0 0 0 0 0 0 14.9614 11.9699 11.933 0 0 15.138 0 0 0 0 0 0 0 0 0 15.2175 0 0 0 0 0 0 0 0 14.6246 0 14.6525 0 13.8588 14.5031 15.1191 14.2145 14.1403 0 0 0 0 0 0 Q92521 PIGB_HUMAN "GPI mannosyltransferase 3, EC 2.4.1.- (GPI mannosyltransferase III, GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein, PIG-B)" PIGB Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; mannosylation [GO:0097502]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]; GPI anchor biosynthetic process [GO:0006506]; mannosylation [GO:0097502]; preassembly of GPI anchor in ER membrane [GO:0016254]" GO:0000026; GO:0000030; GO:0004376; GO:0005789; GO:0006506; GO:0016021; GO:0016254; GO:0097502 "alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]" DSVQLLIWIPR 0.99383 -6.8196 0 0 0 0 0 0 0 0 0 12.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4065 0 12.9599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3529 0 0 0 0 0 0 11.5906 14.0172 12.2079 11.7921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4059 0 0 0 0 0 0 13.0943 13.9324 0 0 0 0 0 0 12.0682 0 13.7539 11.5106 0 Q9BUG6 ZSA5A_HUMAN Zinc finger and SCAN domain-containing protein 5A (Zinc finger protein 495) ZSCAN5A ZNF495 ZSCAN5 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AANCTSSWSLGESCNRPGLELPR 0.99383 -10.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5608 0 0 0 0 0 0 0 12.9834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.374 0 13.1902 0 0 14.862 0 0 15.4753 15.2239 0 0 0 0 0 0 0 0 0 13.2618 0 0 0 14.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1635 0 0 0 0 0 0 0 0 0 0 0 Q9BXY5 CAYP2_HUMAN Calcyphosin-2 (Calcyphosine-2) CAPS2 UG0636c06 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] AVISDPEQNLAIEQKESDHILPDSK 0.99383 -29.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4615 0 0 0 0 0 0 0 0 12.2478 0 0 0 0 0 0 0 0 0 0 0 0 11.2505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1972 0 0 0 0 0 14.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9Y6 RPA2_HUMAN "DNA-directed RNA polymerase I subunit RPA2, RNA polymerase I subunit 2, EC 2.7.7.6 (DNA-directed RNA polymerase I 135 kDa polypeptide, RPA135)" POLR1B Homo sapiens (Human) embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; neural crest formation [GO:0014029]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303] GO:0001650; GO:0003677; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005829; GO:0007566; GO:0009303; GO:0014029; GO:0017126; GO:0032549; GO:0046872 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549] AHVESFNYAVHEGLGLAVQAIPPFEFAFK 0.99383 -7.0344 0 0 12.7995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5644 0 0 0 14.0131 16.9097 12.9834 12.0851 0 0 0 0 0 0 0 0 0 0 10.0906 13.5814 11.7998 14.4567 0 0 0 0 0 15.7576 0 0 0 0 0 11.9549 0 13.2089 0 0 15.2389 0 0 0 0 0 0 0 0 13.4363 13.7839 14.0801 0 0 0 0 0 0 0 13.7988 14.6461 0 13.0386 0 0 0 14.0571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCE6 ARGAL_HUMAN Rho guanine nucleotide exchange factor 10-like protein (GrinchGEF) ARHGEF10L GRINCHGEF KIAA1626 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056]; SREBP signaling pathway [GO:0032933] cytosol [GO:0005829] cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056]; SREBP signaling pathway [GO:0032933] GO:0005085; GO:0005096; GO:0005829; GO:0030036; GO:0032933; GO:0051056; GO:0051496 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] CQVVFFR 0.99383 -37.432 0 0 0 0 12.6582 0 0 0 0 0 0 0 13.8678 0 0 0 11.9678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6595 0 0 0 0 0 0 12.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.092 13.3093 0 0 0 12.1607 0 0 0 14.5935 14.2696 13.0376 12.2922 14.2412 12.4753 0 0 0 0 0 11.836 0 0 0 0 10.4268 0 0 0 0 0 0 0 12.4653 13.5028 13.3749 14.1843 0 0 15.1128 0 0 14.6938 11.6425 11.1235 0 0 12.8382 0 0 13.2034 0 14.1579 13.202 12.5773 0 14.1262 14.6656 12.8459 15.2854 0 0 0 13.8465 11.3792 0 12.3757 0 13.5979 0 14.8177 0 0 13.0565 0 14.0341 14.3371 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5553 0 0 0 11.6977 0 0 0 0 0 0 0 0 13.4846 0 12.0276 13.1327 0 0 0 0 0 0 0 Q9NQL2 RRAGD_HUMAN "Ras-related GTP-binding protein D, Rag D, RagD, EC 3.6.5.-" RRAGD Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein heterodimerization activity [GO:0046982]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506] GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005813; GO:0005829; GO:0008104; GO:0009267; GO:0010506; GO:0019003; GO:0032008; GO:0043231; GO:0046982; GO:0051020; GO:0071230; GO:0071233; GO:1904263; GO:1990131; GO:1990253 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein heterodimerization activity [GO:0046982] ILLMGLRR 0.99383 -14.206 0 0 0 0 0 0 0 0 0 0 11.9908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0446 0 0 0 0 14.2597 0 0 0 0 0 0 0 0 0 15.6936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9454 0 0 0 0 0 12.5105 14.4322 0 0 0 0 0 0 0 0 0 0 13.0257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2G3 KLH14_HUMAN "Kelch-like protein 14 (Protein interactor of Torsin-1A, Printor, Protein interactor of torsinA)" KLHL14 KIAA1384 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] actin cytoskeleton [GO:0015629]; aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025] GO:0005737; GO:0005783; GO:0005789; GO:0005829; GO:0015629; GO:0016235; GO:0043005; GO:0043025 ASFYACR 0.99383 -8.7693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.804 0 0 0 0 15.3085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9222 0 0 0 0 0 10.4809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1949 0 0 Q9UIH9 KLF15_HUMAN Krueppel-like factor 15 (Kidney-enriched krueppel-like factor) KLF15 KKLF Homo sapiens (Human) cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; podocyte differentiation [GO:0072112]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; response to insulin [GO:0032868] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular glucose homeostasis [GO:0001678]; cellular response to peptide [GO:1901653]; glial cell differentiation [GO:0010001]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; podocyte differentiation [GO:0072112]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of Wnt signaling pathway [GO:0030111]; response to insulin [GO:0032868]" GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001678; GO:0005634; GO:0005654; GO:0006357; GO:0010001; GO:0014898; GO:0016607; GO:0030111; GO:0032868; GO:0043231; GO:0045944; GO:0046326; GO:0046872; GO:0072112; GO:1901653; GO:1990837; GO:2000757 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" FPKNPAAELIKMHK 0.99383 -8.7617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5901 0 0 0 0 0 0 16.0916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9082 0 0 0 0 16.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3141 0 0 0 0 0 0 0 0 0 Q9Y2W1 TR150_HUMAN "Thyroid hormone receptor-associated protein 3 (BCLAF1 and THRAP3 family member 2) (Thyroid hormone receptor-associated protein complex 150 kDa component, Trap150)" THRAP3 BCLAF2 TRAP150 Homo sapiens (Human) "circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" extracellular exosome [GO:0070062]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; mediator complex [GO:0016592]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; phosphoprotein binding [GO:0051219]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0000956; GO:0000978; GO:0003677; GO:0003712; GO:0003713; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0006397; GO:0007623; GO:0008380; GO:0016592; GO:0016607; GO:0030374; GO:0042753; GO:0042809; GO:0045893; GO:0045944; GO:0046966; GO:0048026; GO:0048255; GO:0051219; GO:0070062 ATP binding [GO:0005524]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; phosphoprotein binding [GO:0051219]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] EQEFRSIFQHIQSAQSQRSPSELFAQHIVTIVHHVK 0.99383 -37.406 0 0 0 0 0 0 0 0 0 11.4222 0 15.5224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8865 14.5325 0 0 0 0 0 10.0304 0 0 0 0 0 0 0 0 0 0 0 0 13.399 0 0 10.7877 0 0 11.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.829 14.6762 0 16.0648 15.6137 17.3433 15.6583 13.4976 0 0 15.3643 15.098 0 12.4319 0 0 16.2994 14.6841 0 16.1908 0 0 0 16.5163 16.7776 0 0 0 0 0 0 12.5961 11.5588 14.7969 12.8418 14.8888 14.7034 0 13.7555 14.4649 12.7108 0 0 0 0 0 0 14.4359 0 0 0 0 13.9433 0 0 12.4937 13.8914 0 16.5169 0 0 0 16.5569 0 0 0 0 0 0 0 0 0 0 0 17.1352 0 14.3417 16.4449 0 0 0 0 0 0 0 0 14.331 0 0 0 0 0 0 12.9773 0 13.2001 0 0 0 0 0 Q9UL36 ZN236_HUMAN Zinc finger protein 236 ZNF236 Homo sapiens (Human) cellular response to glucose stimulus [GO:0071333]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular response to glucose stimulus [GO:0071333]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:0071333 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CAYCVMGFTQKSNMK 0.99384 -30.276 0 0 0 0 0 0 11.2464 0 0 11.7373 0 0 13.2852 11.9842 11.9629 0 12.6808 0 12.6837 12.9905 12.7337 0 13.4578 0 0 0 12.7317 14.1295 11.6231 11.9195 0 0 0 0 13.4653 0 0 11.7077 0 0 13.5672 0 11.4193 0 12.6273 0 10.7344 10.5678 0 11.9197 12.3021 11.9796 12.0849 12.2735 12.2578 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1944 0 0 12.4777 0 0 14.4924 0 0 0 0 0 0 10.9467 0 0 0 14.4727 0 0 0 0 0 0 0 10.703 0 0 19.2286 0 0 0 0 0 0 0 0 0 17.6348 0 0 0 0 14.5968 10.754 0 0 0 0 0 12.6514 0 0 0 8.80458 0 0 0 0 13.885 0 0 0 0 0 10.0879 0 0 0 0 0 13.0625 0 0 0 0 0 0 0 0 0 0 9.64812 0 0 0 0 0 15.2243 0 0 10.1501 0 0 0 0 13.9769 14.2219 14.2569 14.7485 0 0 0 17.6147 0 0 10.5895 0 0 9.60679 0 0 A0A1B0GW35 EXC1L_HUMAN Exocyst complex component 1-like EXOC1L Homo sapiens (Human) exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893] exocyst [GO:0000145]; plasma membrane [GO:0005886] "exocyst [GO:0000145]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]" GO:0000145; GO:0005546; GO:0005886; GO:0006887; GO:0006893 "phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" IVMVKHYR 0.99384 -6.8404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3945 0 0 0 0 0 0 0 0 0 0 0 0 13.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43463 SUV91_HUMAN "Histone-lysine N-methyltransferase SUV39H1, EC 2.1.1.355 (Histone H3-K9 methyltransferase 1, H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1, Su(var)3-9 homolog 1)" SUV39H1 KMT1A SUV39H Homo sapiens (Human) "cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of cell cycle [GO:0045786]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by glucose [GO:0046015]; rhythmic process [GO:0048511]; rRNA processing [GO:0006364]" "chromatin silencing complex [GO:0005677]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; eNoSc complex [GO:0061773]; heterochromatin [GO:0000792]; nuclear lamina [GO:0005652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rDNA heterochromatin [GO:0033553]" "chromatin silencing complex [GO:0005677]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; eNoSc complex [GO:0061773]; heterochromatin [GO:0000792]; nuclear lamina [GO:0005652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rDNA heterochromatin [GO:0033553]; chromatin binding [GO:0003682]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; protein N-terminus binding [GO:0047485]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; energy homeostasis [GO:0097009]; histone H3-K9 dimethylation [GO:0036123]; histone H3-K9 trimethylation [GO:0036124]; histone lysine methylation [GO:0034968]; negative regulation of cell cycle [GO:0045786]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by glucose [GO:0046015]; rhythmic process [GO:0048511]; rRNA processing [GO:0006364]" GO:0000122; GO:0000183; GO:0000775; GO:0000792; GO:0000794; GO:0000976; GO:0003682; GO:0005634; GO:0005652; GO:0005654; GO:0005677; GO:0005730; GO:0006325; GO:0006364; GO:0006974; GO:0007049; GO:0008270; GO:0008757; GO:0018024; GO:0030154; GO:0031062; GO:0031065; GO:0033553; GO:0034968; GO:0036123; GO:0036124; GO:0042054; GO:0042149; GO:0042754; GO:0045786; GO:0045892; GO:0046015; GO:0046974; GO:0047485; GO:0048511; GO:0061773; GO:0071456; GO:0097009 chromatin binding [GO:0003682]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; protein N-terminus binding [GO:0047485]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270] AGLPIYECNSRCRCGYDCPNR 0.99384 -10.786 0 0 0 0 0 0 0 11.5245 0 0 0 0 0 9.94388 0 0 0 0 0 0 0 0 0 15.9937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1303 0 12.6471 0 0 14.2435 13.4891 13.6414 0 0 0 13.5749 0 0 15.4556 10.4698 0 16.0571 0 16.1422 15.8919 0 15.9544 0 18.8767 0 17.5897 16.8911 18.0922 0 13.8459 13.7764 21.6692 0 0 17.181 16.1209 16.7529 17.4167 16.2806 15.805 14.384 17.1079 14.7561 0 0 15.332 19.0349 18.0056 12.0164 0 16.8984 13.8072 18.7107 18.366 0 18.5151 12.2895 0 17.8328 0 0 0 0 0 0 0 0 12.9323 0 17.9484 0 18.3169 0 0 19.1609 18.9302 17.8463 18.0399 19.2219 18.6917 18.5036 0 0 0 0 18.2237 0 0 0 0 0 0 0 0 0 0 0 18.6771 17.9591 0 14.9787 17.2209 16.7098 0 0 0 12.5041 0 0 0 0 0 0 0 0 13.1696 0 0 0 12.4839 0 0 0 0 0 0 0 O60477 BRNP1_HUMAN BMP/retinoic acid-inducible neural-specific protein 1 (Deleted in bladder cancer protein 1) BRINP1 DBC1 DBCCR1 FAM5A IB3089A Homo sapiens (Human) behavioral fear response [GO:0001662]; cell cycle [GO:0007049]; cell death [GO:0008219]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; maternal behavior [GO:0042711]; negative regulation of cell cycle [GO:0045786]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neurogenesis [GO:0050768]; neurogenesis [GO:0022008]; positive regulation of neuron differentiation [GO:0045666]; short-term memory [GO:0007614]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025] cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; behavioral fear response [GO:0001662]; cell cycle [GO:0007049]; cell death [GO:0008219]; cellular response to retinoic acid [GO:0071300]; exploration behavior [GO:0035640]; maternal behavior [GO:0042711]; negative regulation of cell cycle [GO:0045786]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neurogenesis [GO:0050768]; neurogenesis [GO:0022008]; positive regulation of neuron differentiation [GO:0045666]; short-term memory [GO:0007614]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] GO:0001662; GO:0005737; GO:0005783; GO:0007049; GO:0007614; GO:0008219; GO:0022008; GO:0030425; GO:0035176; GO:0035640; GO:0042711; GO:0043025; GO:0045666; GO:0045786; GO:0045930; GO:0050768; GO:0071300; GO:0071625 EFDWLISDR 0.99384 -30.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0959 0 0 0 0 0 0 13.2337 0 0 0 12.5188 0 0 0 0 0 0 13.313 0 0 0 0 0 0 0 0 0 0 0 0 12.2218 12.813 12.508 0 12.5465 0 0 16.8118 16.2044 16.0008 0 12.6172 16.2443 0 15.918 15.8046 13.1061 0 0 0 0 13.8946 13.8564 13.8619 15.7973 13.6989 0 0 0 13.4027 0 16.0683 0 0 16.2137 0 0 0 0 16.0674 0 0 0 0 12.8632 15.538 15.7948 15.3607 0 0 0 0 0 0 0 0 0 0 0 15.9219 16.1811 0 0 0 0 0 0 0 14.229 0 0 13.531 15.8582 0 15.0267 0 0 12.3627 13.2939 0 0 0 0 0 0 0 0 0 15.5277 0 15.3798 0 0 0 0 0 0 0 0 0 0 13.5591 0 0 0 15.6993 13.8334 13.9257 0 0 0 0 0 0 P48740 MASP1_HUMAN "Mannan-binding lectin serine protease 1, EC 3.4.21.- (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1, MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100, RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain ]" MASP1 CRARF CRARF1 PRSS5 Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; negative regulation of complement activation [GO:0045916]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; serine-type endopeptidase complex [GO:1905370] "cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; negative regulation of complement activation [GO:0045916]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]" GO:0001867; GO:0002752; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0006508; GO:0008233; GO:0009897; GO:0042802; GO:0042803; GO:0045916; GO:0048306; GO:1903028; GO:1905370 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252] DMICAGEKEGGK 0.99384 -10.817 0 0 0 0 0 0 0 0 0 12.8277 0 0 12.546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.549 0 0 0 0 0 0 0 0 0 11.1495 0 0 0 12.3393 0 12.0936 0 0 0 0 0 0 11.9168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4701 0 0 12.9342 0 0 0 15.0487 12.5817 13.7915 0 0 0 0 0 0 0 13.2531 0 14.3074 0 0 0 0 0 15.0087 0 0 0 0 12.5378 0 0 0 0 0 0 0 0 0 0 9.70323 0 0 0 10.5095 0 0 0 14.3309 11.6932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2251 0 0 0 0 0 0 0 0 11.3736 14.0841 11.1892 0 0 0 14.3067 0 0 11.8844 0 0 Q14746 COG2_HUMAN "Conserved oligomeric Golgi complex subunit 2, COG complex subunit 2 (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein)" COG2 LDLC Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; protein-containing complex binding [GO:0044877]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" GO:0000139; GO:0000301; GO:0005795; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0017119; GO:0032588; GO:0044877; GO:0070085 protein-containing complex binding [GO:0044877] EKSRMNLPK 0.99384 -30.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6804 0 0 0 0 0 10.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3686 15.165 0 0 0 12.4146 0 0 0 0 13.4635 0 14.4223 17.4165 14.7017 13.613 0 14.067 13.5293 16.9111 17.0637 0 14.1325 11.9933 17.0076 15.9216 13.969 14.9972 14.2022 12.8428 16.8606 14.4886 14.7772 14.26 14.5811 13.5652 13.0907 0 13.4247 17.1139 14.5991 15.8608 12.7195 0 13.7406 14.2353 0 13.492 15.9104 17.8922 13.4005 14.037 14.2434 12.2602 0 13.6585 13.2884 12.9738 0 14.4004 12.1115 14.5392 14.6384 0 0 11.759 0 14.0076 0 14.2181 14.0369 0 0 12.1061 0 0 14.8896 0 0 0 0 18.4612 0 0 0 0 0 0 0 0 0 11.0064 0 12.9637 13.2191 12.6535 11.4634 13.3711 0 0 0 12.2768 0 0 0 0 Q5JRM2 CX066_HUMAN Uncharacterized protein CXorf66 CXorf66 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GIAAKSSK 0.99384 -30.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6789 0 0 0 0 0 0 0 11.0593 0 0 0 0 0 0 0 0 0 0 13.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6189 0 0 0 0 0 0 15.1556 0 0 0 0 0 0 13.3016 0 0 0 0 0 0 0 0 0 13.5861 0 0 0 0 0 14.5902 0 0 13.6799 0 0 0 0 0 0 0 0 0 0 0 14.5861 0 0 0 0 14.4215 0 0 0 0 0 0 0 0 0 0 0 14.1894 0 0 0 0 0 0 0 15.0301 14.6134 0 0 12.5731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUI2 GPAT2_HUMAN "Glycerol-3-phosphate acyltransferase 2, mitochondrial, GPAT-2, EC 2.3.1.15 (1-acylglycerol-3-phosphate O-acyltransferase GPAT2, EC 2.3.1.51) (xGPAT1)" GPAT2 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; piRNA biosynthetic process [GO:1990511]; triglyceride biosynthetic process [GO:0019432] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; piRNA biosynthetic process [GO:1990511]; triglyceride biosynthetic process [GO:0019432] GO:0003841; GO:0004366; GO:0005739; GO:0005741; GO:0006072; GO:0006631; GO:0006654; GO:0008654; GO:0016021; GO:0016024; GO:0019432; GO:0031966; GO:0102420; GO:1990511 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420] AAQAGLPLVLLSTHK 0.99384 -13.092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4021 0 0 0 11.1518 0 0 11.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1646 0 12.2343 0 13.0203 13.7728 0 0 0 0 0 0 0 12.2003 13.2574 11.7076 12.0742 0 0 13.1234 13.2899 0 0 0 12.7746 0 0 0 0 0 0 0 13.7247 0 0 0 0 0 0 0 0 13.5958 16.3704 0 14.8039 0 0 0 0 0 12.9859 0 13.5486 12.7203 0 0 0 0 0 0 0 16.6653 16.4137 0 14.5842 0 0 0 12.2236 13.3133 0 0 0 12.9245 0 0 0 0 0 0 13.6595 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4193 0 0 14.7254 13.2245 0 13.1299 0 0 0 11.3659 0 Q6UXN2 TRML4_HUMAN "Trem-like transcript 4 protein, TLT-4 (Triggering receptor expressed on myeloid cells-like protein 4)" TREML4 TLT4 UNQ9425/PRO34675 Homo sapiens (Human) innate immune response [GO:0045087]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; innate immune response [GO:0045087]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157] GO:0005576; GO:0005886; GO:0009986; GO:0034157; GO:0038023; GO:0045087 signaling receptor activity [GO:0038023] AWGGVHTCCFHLCCCCSWPQGAVPEELHK 0.99384 -7.8558 0 0 0 12.4478 0 0 0 0 0 0 0 13.0045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2583 0 0 0 12.0072 0 0 0 0 0 0 0 0 0 11.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7398 0 0 0 0 0 0 Q6ZPD9 D19L3_HUMAN "Probable C-mannosyltransferase DPY19L3, EC 2.4.1.- (Dpy-19-like protein 3) (Protein dpy-19 homolog 3)" DPY19L3 Homo sapiens (Human) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] GO:0000030; GO:0005637; GO:0016021; GO:0018406 mannosyltransferase activity [GO:0000030] FCEEIKR 0.99384 -13.131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.814 0 0 0 0 0 0 0 0 0 0 0 0 11.4001 0 0 11.7717 0 0 0 0 0 12.7702 0 0 0 0 0 0 0 0 0 13.2684 0 0 0 0 0 0 0 11.4063 0 0 11.259 0 15.8332 0 0 0 0 0 0 11.8243 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZV65 FA47E_HUMAN Protein FAM47E FAM47E Homo sapiens (Human) epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; positive regulation of histone methylation [GO:0031062]; protein localization to chromatin [GO:0071168] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme activator activity [GO:0008047]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; positive regulation of histone methylation [GO:0031062]; protein localization to chromatin [GO:0071168] GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0031062; GO:0045815; GO:0071168 enzyme activator activity [GO:0008047] APQLAPK 0.99384 -30.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5821 0 0 0 0 0 0 0 12.8655 0 13.1861 0 0 0 0 11.5112 0 0 0 0 0 0 0 13.259 0 0 0 0 0 0 0 0 0 0 13.945 0 13.3622 0 0 0 12.7359 0 0 0 0 13.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1898 0 0 0 0 13.1031 0 Q8IW92 GLBL2_HUMAN "Beta-galactosidase-1-like protein 2, EC 3.2.1.-" GLB1L2 MSTP014 UNQ210/PRO236 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] extracellular region [GO:0005576]; vacuole [GO:0005773] extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975] GO:0004565; GO:0005576; GO:0005773; GO:0005975 beta-galactosidase activity [GO:0004565] HRQLGLQAK 0.99384 -7.0647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97341 0 0 0 0 0 0 0 0 17.0396 0 0 0 0 0 0 0 0 0 0 12.0565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1924 0 0 0 12.1185 11.1626 0 0 10.1316 0 0 0 10.3374 0 0 13.4363 11.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9652 0 0 0 0 0 0 0 11.1654 0 0 14.0533 0 0 0 12.8108 0 0 0 14.0108 0 0 0 0 0 0 0 0 0 0 0 10.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9434 0 0 0 0 0 18.1157 0 0 0 0 0 12.1035 0 0 0 0 0 0 0 0 11.5941 0 0 0 0 0 0 11.4053 0 0 0 Q8TC29 ENKUR_HUMAN Enkurin ENKUR C10orf63 Homo sapiens (Human) establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; acrosomal vesicle [GO:0001669]; axonemal microtubule [GO:0005879]; sperm principal piece [GO:0097228] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; acrosomal vesicle [GO:0001669]; axonemal microtubule [GO:0005879]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317] GO:0001669; GO:0005516; GO:0005879; GO:0017124; GO:0030317; GO:0061966; GO:0097228; GO:0097728; GO:0097729 calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124] EKTLPPK 0.99384 -30.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8717 0 0 0 14.4326 0 14.3431 14.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7524 0 0 0 0 11.7263 0 0 11.8414 0 0 0 0 10.7304 0 13.5033 12.4915 0 0 0 13.1912 10.6042 13.5838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0366 0 16.3093 0 0 0 Q96II8 LRCH3_HUMAN DISP complex protein LRCH3 (Leucine-rich repeat and calponin homology domain-containing protein 3) LRCH3 Homo sapiens (Human) septin cytoskeleton organization [GO:0032185] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; septin cytoskeleton organization [GO:0032185] GO:0005737; GO:0005829; GO:0032185 ALEEAAVTGVLSLSGR 0.99384 -7.0632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5406 0 12.301 0 11.3804 0 0 0 0 0 12.0505 0 0 0 0 0 0 11.8156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7451 0 0 0 12.7781 0 0 0 0 0 0 12.5505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6123 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6472 0 0 0 12.6698 0 0 0 14.517 0 0 14.4222 13.0357 0 0 0 0 0 13.4502 0 16.4829 15.2831 15.6856 0 0 0 0 0 0 0 12.8659 0 12.0005 0 0 0 13.5075 13.3486 0 14.9102 0 13.7474 0 0 0 0 0 12.4165 0 0 0 0 12.1491 0 0 0 0 0 0 0 0 15.3954 0 0 Q9BXM9 FSD1L_HUMAN FSD1-like protein (Coiled-coil domain-containing protein 10) (FSD1 N-terminal-like protein) FSD1L CCDC10 CSDUFD1 FSD1CL FSD1NL Homo sapiens (Human) HNNKVKALDVTVPEK 0.99384 -7.8615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6945 0 13.7618 0 0 0 0 0 13.6753 0 0 0 0 0 0 0 0 0 0 11.4556 0 0 0 0 0 13.0533 0 0 0 0 0 0 0 0 0 13.2207 0 0 14.0954 0 0 0 0 0 12.8774 0 0 0 0 0 0 0 0 13.7226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4537 14.293 14.4188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAU8 RNPL1_HUMAN "Aminopeptidase RNPEPL1, EC 3.4.11.- (Arginyl aminopeptidase-like 1) (Methionyl aminopeptidase, EC 3.4.11.18)" RNPEPL1 Homo sapiens (Human) proteolysis [GO:0006508] metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508] GO:0006508; GO:0008270; GO:0070006 metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270] AAQCCCR 0.99384 -7.0683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6409 12.3896 0 0 0 0 0 0 12.9192 14.6732 13.3292 12.6947 0 12.7322 13.2321 12.0963 14.691 0 12.6435 0 0 13.1311 13.0764 13.9656 13.5505 12.6019 0 0 14.0953 13.2253 0 12.909 12.2267 12.3456 0 13.0109 0 0 10.2907 0 12.9821 14.08 14.7213 0 13.0438 14.6145 0 12.7625 0 12.8582 0 0 0 0 0 0 13.4898 0 12.3841 0 0 0 14.5664 13.9637 0 0 14.9663 12.9289 13.9564 13.9427 13.3025 13.4204 13.0301 0 0 0 14.0538 0 0 0 13.2572 0 13.9312 0 0 0 0 0 0 0 13.3902 0 0 13.7893 0 0 0 12.9832 0 15.0027 13.2417 0 0 13.4671 0 0 Q9P086 MED11_HUMAN Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) MED11 HSPC296 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0000151; GO:0003712; GO:0005634; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0061630; GO:0070847 transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] LRALEDIER 0.99384 -13.098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2351 0 0 0 0 0 13.3211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4C8 RBM19_HUMAN Probable RNA-binding protein 19 (RNA-binding motif protein 19) RBM19 KIAA0682 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]" GO:0000398; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0016020; GO:0016607; GO:0040019 RNA binding [GO:0003723] AGVLLSMGFGFVEYR 0.99384 -30.336 0 0 0 0 0 0 0 10.1704 0 0 0 13.132 13.0825 0 0 0 0 0 0 0 0 0 0 0 0 12.4468 0 0 0 12.7678 0 13.1962 0 0 0 0 0 0 0 12.8831 0 0 0 0 11.7525 0 0 0 0 0 0 13.1363 0 12.0573 0 11.3578 0 10.0058 0 0 10.2663 0 0 0 0 0 0 0 0 0 0 0 0 11.719 0 0 0 0 0 0 12.8597 0 18.8537 18.852 18.842 0 18.9349 0 12.835 0 0 10.8319 0 13.263 13.1044 0 0 0 0 0 0 0 0 0 18.0991 0 12.6567 0 0 13.2973 0 0 0 11.7961 0 0 0 0 0 0 0 0 10.6803 0 12.9867 12.4689 0 0 0 0 0 13.11 0 0 0 0 0 0 13.1369 0 0 0 0 0 0 0 0 15.6039 0 0 0 0 0 0 0 0 0 0 0 12.9113 0 0 0 16.0969 15.9507 15.7759 0 0 0 0 0 0 0 0 0 0 0 15.9099 0 0 Q9Y6W3 CAN7_HUMAN "Calpain-7, EC 3.4.22.- (PalB homolog, PalBH)" CAPN7 PALBH Homo sapiens (Human) positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541]; positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264] GO:0004175; GO:0004197; GO:0004198; GO:0005634; GO:0005813; GO:0005829; GO:0006508; GO:0010634; GO:0070062; GO:0090541; GO:0097264 calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541] FAYPMPFCDRWGK 0.99384 -13.129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9597 12.6946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7765 0 0 0 0 0 14.4626 0 13.5315 14.7787 0 0 0 0 13.3567 13.0694 0 0 13.6541 0 0 0 0 0 15.2156 0 0 14.5088 0 0 0 0 0 0 13.572 0 0 0 0 0 0 0 0 0 13.2976 0 0 0 0 0 0 0 0 13.5895 0 16.5276 0 0 0 0 0 0 0 0 14.202 0 0 0 12.4839 0 0 0 0 0 0 0 0 0 14.2941 13.4876 14.6878 0 0 0 0 0 0 11.8376 0 0 11.7085 0 0 0 11.2657 0 14.0441 0 0 0 0 0 0 0 0 0 0 0 O75881 CP7B1_HUMAN "Cytochrome P450 7B1 (24-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.26) (25/26-hydroxycholesterol 7-alpha-hydroxylase, EC 1.14.14.29) (3-hydroxysteroid 7-alpha hydroxylase) (Oxysterol 7-alpha-hydroxylase)" CYP7B1 Homo sapiens (Human) B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell proliferation [GO:0050673]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid hydroxylase activity [GO:0008395]; B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell proliferation [GO:0050673]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125] GO:0005506; GO:0005789; GO:0006699; GO:0008203; GO:0008395; GO:0008396; GO:0016021; GO:0016125; GO:0020037; GO:0030520; GO:0033147; GO:0033782; GO:0033783; GO:0035754; GO:0042632; GO:0047092; GO:0050673; GO:0050679; GO:0060740 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid hydroxylase activity [GO:0008395] AGEVSAATGRFSLERLGLPGLALAAALLLLALCLLVR 0.99385 -7.9117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9365 0 13.5066 0 0 0 0 12.9802 0 13.0532 0 0 11.1211 0 0 0 0 0 0 0 11.9428 0 11.5777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.204 0 0 13.9692 18.5214 14.4862 13.9627 0 14.2579 14.4115 14.6392 0 16.715 0 15.256 0 13.8653 15.6055 15.5192 13.3801 0 0 14.1719 14.723 0 14.0492 13.9732 14.4314 14.3164 0 14.5018 0 14.2548 0 0 0 0 18.9205 14.7807 19.3457 0 14.8616 0 13.8776 0 14.6672 14.7272 15.5103 0 0 0 14.5278 14.4052 11.1302 14.7711 0 0 0 14.6202 14.6716 14.3703 0 14.6462 14.4922 12.8444 14.5505 14.7588 15.1978 14.8349 0 14.9013 12.8924 15.0264 14.8742 14.8209 0 18.8884 0 0 0 0 0 14.7209 0 0 14.7003 14.8277 15.1688 14.4692 0 0 0 0 0 0 11.5906 0 11.935 0 0 0 0 0 0 0 14.752 0 0 0 0 0 O43747 AP1G1_HUMAN AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) AP1G1 ADTG CLAPG1 Homo sapiens (Human) basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267]; basolateral protein secretion [GO:0110010]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005737; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0006886; GO:0006896; GO:0006898; GO:0016020; GO:0016192; GO:0019894; GO:0030121; GO:0030136; GO:0030659; GO:0030665; GO:0030742; GO:0031267; GO:0032438; GO:0032588; GO:0035615; GO:0035646; GO:0043231; GO:0043323; GO:0045954; GO:0048471; GO:0055037; GO:0060155; GO:0090160; GO:0110010; GO:0140312; GO:1903232 cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267] DLAGEVEKLLKTSNSYLR 0.99385 -7.0886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5378 0 0 0 0 10.8629 0 0 0 0 13.4167 0 13.328 13.5898 15.2869 14.3609 14.8626 12.1925 14.3465 14.5391 0 0 17.2003 0 0 0 13.83 0 12.3571 15.3549 15.6154 13.3194 15.7526 0 0 0 0 14.1839 0 0 14.5424 15.442 12.9082 14.294 16.2763 0 0 0 0 0 13.7038 0 0 13.374 0 12.3238 0 0 14.7281 0 14.1282 13.9695 0 12.6802 0 14.3283 13.2348 13.7979 13.2015 0 14.335 0 0 0 12.7521 13.3315 14.088 12.3742 0 13.57 12.1107 0 0 0 0 0 0 0 0 0 15.265 0 0 0 14.0981 0 0 11.8002 0 0 0 12.6926 0 0 0 0 0 0 11.1047 0 0 0 0 P22083 FUT4_HUMAN "Alpha-(1,3)-fucosyltransferase 4 (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase, EC 2.4.1.152) (ELAM-1 ligand fucosyltransferase) (Fucosyltransferase 4) (Fucosyltransferase IV, Fuc-TIV, FucT-IV) (Galactoside 3-L-fucosyltransferase)" FUT4 ELFT FCT3A Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; glycosphingolipid biosynthetic process [GO:0006688]; inflammatory response [GO:0006954]; L-fucose catabolic process [GO:0042355]; lymphocyte migration into lymph node [GO:0097022]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; regulation of leukocyte cell-cell adhesion [GO:1903037] cell periphery [GO:0071944]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802] cell periphery [GO:0071944]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; glycosphingolipid biosynthetic process [GO:0006688]; inflammatory response [GO:0006954]; L-fucose catabolic process [GO:0042355]; lymphocyte migration into lymph node [GO:0097022]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; regulation of leukocyte cell-cell adhesion [GO:1903037] GO:0000139; GO:0005794; GO:0005802; GO:0005975; GO:0006486; GO:0006487; GO:0006493; GO:0006688; GO:0006954; GO:0008417; GO:0009311; GO:0009312; GO:0009986; GO:0016020; GO:0016021; GO:0017083; GO:0032580; GO:0036065; GO:0042355; GO:0046920; GO:0071944; GO:0097022; GO:1902624; GO:1903037; GO:1903238 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] KPSGAGWEK 0.99385 -5.2151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29728 OAS2_HUMAN "2'-5'-oligoadenylate synthase 2, (2-5')oligo(A) synthase 2, 2-5A synthase 2, EC 2.7.7.84 (p69 OAS / p71 OAS, p69OAS / p71OAS)" OAS2 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of lactation [GO:1903487]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RNA catabolic process [GO:0006401]; type I interferon signaling pathway [GO:0060337] GO:0001730; GO:0003725; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006139; GO:0006401; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0042742; GO:0043231; GO:0045071; GO:0046872; GO:0048471; GO:0051607; GO:0060337; GO:0060700; GO:0070106; GO:1903487 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] CQEKLCIYWMVNYNFEDETIR 0.99385 -28.932 0 13.1661 0 0 0 0 0 0 14.4128 0 13.5521 13.3326 13.3864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2447 0 0 0 0 13.6209 13.3569 13.0184 0 13.4422 0 13.1384 0 13.1436 13.3508 0 0 0 0 0 0 0 0 0 11.233 12.235 11.4745 10.0913 0 0 11.0356 0 10.6205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0987 0 0 12.6521 14.26 12.9337 12.9877 13.0581 0 13.2616 12.4954 12.8156 12.0696 13.0737 0 0 0 12.0942 0 11.7384 0 0 0 0 0 11.6537 0 12.4503 0 12.9798 14.7374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.047 0 0 14.7754 0 0 13.0775 0 11.5294 0 0 0 12.2794 0 0 0 0 11.529 0 0 0 0 10.7054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0677 14.2355 0 0 0 0 0 P49815 TSC2_HUMAN Tuberin (Tuberous sclerosis 2 protein) TSC2 TSC4 Homo sapiens (Human) anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; anoikis [GO:0043276]; endocytosis [GO:0006897]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of GTPase activity [GO:0043547]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192] GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005794; GO:0005829; GO:0006469; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0014067; GO:0014069; GO:0016020; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0043491; GO:0043547; GO:0046626; GO:0046627; GO:0048009; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525 GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] AYMEDAPLLRGAVFFVGMALWGAHRLYSLR 0.99385 -28.924 12.2123 0 0 0 0 0 0 0 13.7054 13.5859 0 13.4614 0 0 0 0 0 0 13.3034 0 0 0 0 13.453 0 0 0 13.4471 0 0 0 13.2718 9.4837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6903 0 0 0 0 15.3542 0 0 0 14.4398 0 13.964 0 13.6289 14.8314 0 0 0 14.206 15.4089 14.1198 15.3394 14.4989 15.9784 15.6915 15.8554 0 13.4936 14.4583 0 0 14.2551 13.933 0 14.4653 0 13.3334 0 13.4653 0 0 0 13.1464 14.9063 0 0 0 0 0 0 13.6062 0 0 0 0 0 0 0 0 14.3655 0 0 0 0 0 13.5211 0 0 12.1262 14.509 12.1891 0 14.1041 0 13.814 0 0 0 0 14.2973 0 0 14.5231 15.0257 12.7365 0 14.1863 0 13.4552 13.7768 0 0 0 0 14.857 0 0 15.2346 0 0 0 15.8946 13.562 0 0 13.7646 14.9159 0 14.0079 0 14.6732 0 10.5027 14.1545 0 13.802 13.9645 0 14.3011 0 0 14.3278 0 0 0 P60880 SNP25_HUMAN "Synaptosomal-associated protein 25, SNAP-25 (Super protein, SUP) (Synaptosomal-associated 25 kDa protein)" SNAP25 SNAP Homo sapiens (Human) associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter uptake [GO:0001504]; regulation of insulin secretion [GO:0050796]; regulation of neuron projection development [GO:0010975]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; specific granule membrane [GO:0035579]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic membrane [GO:0042734]; ribbon synapse [GO:0097470]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; specific granule membrane [GO:0035579]; synaptic vesicle [GO:0008021]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; calcium-dependent protein binding [GO:0048306]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; voltage-gated potassium channel activity [GO:0005249]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; exocytosis [GO:0006887]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; neurotransmitter receptor internalization [GO:0099590]; neurotransmitter uptake [GO:0001504]; regulation of insulin secretion [GO:0050796]; regulation of neuron projection development [GO:0010975]; synaptic vesicle docking [GO:0016081]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906] GO:0001504; GO:0001917; GO:0005249; GO:0005484; GO:0005737; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006887; GO:0006906; GO:0007268; GO:0007626; GO:0008021; GO:0008306; GO:0010975; GO:0016020; GO:0016079; GO:0016081; GO:0016082; GO:0017075; GO:0019905; GO:0030426; GO:0031201; GO:0031234; GO:0031629; GO:0035579; GO:0036477; GO:0042734; GO:0043005; GO:0048306; GO:0048471; GO:0050796; GO:0060291; GO:0070032; GO:0070161; GO:0070821; GO:0097470; GO:0098794; GO:0098967; GO:0098978; GO:0099590 calcium-dependent protein binding [GO:0048306]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; voltage-gated potassium channel activity [GO:0005249] NELEEMQR 0.99385 -13.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15637 SF01_HUMAN "Splicing factor 1 (Mammalian branch point-binding protein, BBP, mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162)" SF1 ZFM1 ZNF162 Homo sapiens (Human) "Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000389; GO:0000398; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005840; GO:0008270; GO:0016604; GO:0030238; GO:0030575; GO:0033327; GO:0042802; GO:0045131; GO:0048024; GO:0048662; GO:0050810; GO:0089701 identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] KMQLRELAR 0.99385 -5.2201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.47269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53H82 LACB2_HUMAN "Endoribonuclease LACTB2, EC 3.1.27.- (Beta-lactamase-like protein 2)" LACTB2 CGI-83 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" mitochondrial matrix [GO:0005759] "mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" GO:0003727; GO:0004521; GO:0005759; GO:0008270; GO:0090502 endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] HNLLLHLKK 0.99385 -13.908 12.1158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9331 11.7624 0 0 0 0 12.6605 0 0 0 0 0 0 11.6822 0 0 0 0 0 14.5387 0 11.3753 0 0 0 0 0 0 0 0 0 0 11.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9184 12.7422 12.9592 13.5267 0 0 0 0 10.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5996 0 0 0 0 0 13.3287 0 0 10.7146 0 0 0 0 0 0 0 12.4138 14.1111 0 0 0 12.812 0 0 0 0 0 0 0 0 0 0 0 12.971 0 0 0 13.119 0 Q569H4 LARGN_HUMAN Protein Largen (Mesenchymal stem cell protein DSC54) (Proline-rich protein 16) PRR16 Homo sapiens (Human) positive regulation of cell size [GO:0045793]; positive regulation of translation [GO:0045727] positive regulation of cell size [GO:0045793]; positive regulation of translation [GO:0045727] GO:0045727; GO:0045793 DRCPQAGPR 0.99385 -8.1111 0 0 0 0 0 0 0 0 13.6704 0 0 13.3161 0 0 0 0 0 0 0 0 11.9946 0 0 0 0 0 0 0 0 0 0 0 0 13.4608 0 0 0 0 13.4553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6669 0 0 0 0 0 0 0 15.7894 14.5151 0 0 0 0 0 13.2558 0 0 0 0 0 0 0 12.7421 0 0 10.5724 0 0 0 0 0 13.2825 0 14.6274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6377 0 0 0 0 11.3428 13.2881 0 0 15.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0537 0 0 0 0 Q66K74 MAP1S_HUMAN "Microtubule-associated protein 1S, MAP-1S (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1, VCY2-interacting protein 1, VCY2IP-1) [Cleaved into: MAP1S heavy chain; MAP1S light chain ]" MAP1S BPY2IP1 C19orf5 MAP8 VCY2IP1 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite development [GO:0016358]; metaphase plate congression [GO:0051310]; microtubule anchoring at centrosome [GO:0034454]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; regulation of microtubule depolymerization [GO:0031114] cell junction [GO:0030054]; cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle microtubule [GO:1990498]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; synapse [GO:0045202] cell junction [GO:0030054]; cell projection [GO:0042995]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle microtubule [GO:1990498]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite development [GO:0016358]; metaphase plate congression [GO:0051310]; microtubule anchoring at centrosome [GO:0034454]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; regulation of microtubule depolymerization [GO:0031114] GO:0000226; GO:0001578; GO:0003677; GO:0003779; GO:0005634; GO:0005654; GO:0005730; GO:0005813; GO:0005815; GO:0005819; GO:0005829; GO:0005874; GO:0005875; GO:0006914; GO:0006915; GO:0007052; GO:0007399; GO:0007409; GO:0007420; GO:0008017; GO:0015631; GO:0016358; GO:0030054; GO:0030425; GO:0031114; GO:0034454; GO:0042802; GO:0042995; GO:0043025; GO:0045202; GO:0047497; GO:0048471; GO:0048487; GO:0048812; GO:0051015; GO:0051310; GO:1990498 actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631] AEAPRKTEK 0.99385 -30.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9305 0 12.2571 0 13.0145 0 0 0 0 12.3335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9792 0 0 0 0 0 0 14.5824 0 0 0 0 0 0 0 0 0 0 0 0 15.8114 0 0 0 0 0 0 0 0 0 0 0 0 13.5379 13.5552 0 0 0 0 0 17.7134 0 0 0 0 0 13.6945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5797 0 0 0 0 0 0 0 0 14.4054 0 0 0 0 0 0 0 0 0 0 0 Q6NSX1 CCD70_HUMAN Coiled-coil domain-containing protein 70 CCDC70 Homo sapiens (Human) mitochondrion [GO:0005739]; plasma membrane [GO:0005886] mitochondrion [GO:0005739]; plasma membrane [GO:0005886] GO:0005739; GO:0005886 EKIEDFREEMWTFR 0.99385 -7.9106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMB0 B3GN6_HUMAN "Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase, EC 2.4.1.147 (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, BGnT-6, Beta-1,3-Gn-T6, Beta-1,3-N-acetylglucosaminyltransferase 6, Beta3Gn-T6)" B3GNT6 Homo sapiens (Human) "glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0106328]; acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0106327]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; glycoprotein biosynthetic process [GO:0009101]; O-glycan processing [GO:0016266]; O-glycan processing, core 3 [GO:0016269]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" GO:0000139; GO:0008194; GO:0008378; GO:0008499; GO:0009101; GO:0016020; GO:0016021; GO:0016266; GO:0016269; GO:0016757; GO:0030311; GO:0047223; GO:0106327; GO:0106328 "acetylgalactosaminyl-O-glycosyl-seryl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0106328]; acetylgalactosaminyl-O-glycosyl-threonyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0106327]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; galactosyltransferase activity [GO:0008378]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" ALHSPALSCDRGHR 0.99385 -13.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7475 0 0 12.4329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4905 0 0 0 Q86X95 CIR1_HUMAN Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin) CIR1 CIR Homo sapiens (Human) "in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA splicing [GO:0008380]" GO:0000122; GO:0001701; GO:0003714; GO:0005634; GO:0005737; GO:0005815; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0042826; GO:0044877; GO:0045892 histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714] CSGHNNSDSEEK 0.99385 -30.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5122 0 0 0 13.6788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2298 0 0 13.4998 0 0 0 0 17.8998 0 0 0 0 17.4713 0 0 0 0 0 0 0 0 0 0 13.313 0 0 0 0 0 0 17.1872 0 14.7528 0 0 0 0 0 0 0 0 0 0 0 0 13.1031 0 0 0 0 18.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0114 0 0 0 0 0 0 0 14.2514 14.6258 14.0997 0 0 0 14.5624 0 0 0 13.0998 0 0 0 0 0 0 0 0 Q8IYX8 CE57L_HUMAN "Centrosomal protein CEP57L1 (Centrosomal protein 57kDa-like protein 1) (Centrosomal protein of 57 kDa-related protein, Cep57R) (Cep57-related protein)" CEP57L1 C6orf182 CEP57R Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874] centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] GO:0005737; GO:0005813; GO:0005874; GO:0008017; GO:0042802; GO:0043015 gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] DPHILQKPFNVTETRCLPK 0.99385 -13.904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3041 14.6192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.455 0 0 0 0 0 13.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2933 0 12.5792 13.602 0 0 0 0 0 0 0 0 0 0 0 14.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1749 0 0 0 Q8IZD9 DOCK3_HUMAN "Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein, PBP)" DOCK3 KIAA0299 MOCA Homo sapiens (Human) positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007264; GO:0017124; GO:0031267; GO:0051056; GO:1903997 guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267] EEQARMAWEHGRGEQ 0.99385 -6.872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.404 0 0 0 13.0457 0 0 0 13.0685 0 0 0 12.5812 0 0 0 0 0 0 0 0 0 14.4512 0 12.5085 11.8442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8874 0 15.4662 0 0 0 18.0935 0 0 0 13.0787 17.1833 13.1753 0 0 0 0 0 0 0 16.9179 0 0 0 0 12.1105 0 0 0 13.3615 0 13.8255 0 12.1011 0 0 17.1585 0 0 0 0 0 0 0 0 0 13.0497 0 0 0 14.6024 0 13.3636 0 13.3146 0 0 12.9861 13.7403 0 15.1864 0 0 0 0 0 0 0 0 0 0 0 13.4393 13.0986 0 15.3315 0 0 13.9558 0 0 0 0 15.1433 0 0 0 14.3138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1896 12.409 11.6557 0 0 0 0 0 Q8N431 RGF1C_HUMAN Ras-GEF domain-containing family member 1C RASGEF1C Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] GO:0005085; GO:0005886; GO:0007265; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] AQVIEFFIDVAR 0.99385 -13.947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2557 14.6708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVI0 SMIM4_HUMAN Small integral membrane protein 4 SMIM4 C3orf78 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AQVRRILQR 0.99385 -13.91 0 0 0 0 0 0 0 0 9.85323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0957 0 15.779 0 0 0 0 0 0 Q8WXE1 ATRIP_HUMAN ATR-interacting protein (ATM and Rad3-related-interacting protein) ATRIP AGS1 Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779] ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779] GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779 K63-linked polyubiquitin modification-dependent protein binding [GO:0070530] DVSSDHK 0.99385 -30.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3753 0 0 0 15.0001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1218 0 0 12.7268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5639 0 0 0 0 0 0 0 0 Q92667 AKAP1_HUMAN "A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa, AKAP 149) (Dual specificity A-kinase-anchoring protein 1, D-AKAP-1) (Protein kinase A-anchoring protein 1, PRKA1) (Spermatid A-kinase anchor protein 84, S-AKAP84)" AKAP1 AKAP149 PRKA1 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915] GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0016020; GO:0016021; GO:0034237; GO:0140374 protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723] ELSTVSKLPAEPPALLQTHPPCR 0.99385 -5.2145 0 0 0 0 0 0 0 11.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5119 0 0 0 0 12.7809 0 0 0 0 12.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.775 0 0 0 0 0 0 0 0 0 0 0 0 12.826 0 0 0 0 0 21.9272 0 0 0 0 0 0 0 0 12.177 0 13.951 0 0 0 0 0 0 15.3583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.77 0 Q9BRP9 YK016_HUMAN Putative uncharacterized protein MGC13053 Homo sapiens (Human) GAMKGRR 0.99385 -13.569 0 0 0 0 0 10.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6676 0 13.7788 0 0 0 0 0 0 0 0 0 10.1141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3041 15.431 15.4775 0 11.4827 0 0 0 0 0 0 0 11.7678 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4888 13.4177 0 11.7602 0 11.435 11.941 13.1972 0 0 0 13.8714 0 0 0 0 12.2475 0 0 0 0 13.4418 0 0 12.3143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0013 0 0 0 0 0 0 15.0025 0 Q9HB21 PKHA1_HUMAN "Pleckstrin homology domain-containing family A member 1, PH domain-containing family A member 1 (Tandem PH domain-containing protein 1, TAPP-1)" PLEKHA1 TAPP1 Homo sapiens (Human) androgen metabolic process [GO:0008209]; B cell receptor signaling pathway [GO:0050853]; cellular response to hydrogen peroxide [GO:0070301]; establishment of protein localization [GO:0045184]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; multicellular organism growth [GO:0035264]; negative regulation of protein kinase B signaling [GO:0051898]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; ruffle organization [GO:0031529]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; androgen metabolic process [GO:0008209]; B cell receptor signaling pathway [GO:0050853]; cellular response to hydrogen peroxide [GO:0070301]; establishment of protein localization [GO:0045184]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; multicellular organism growth [GO:0035264]; negative regulation of protein kinase B signaling [GO:0051898]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; ruffle organization [GO:0031529]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]" GO:0001553; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007283; GO:0008209; GO:0008210; GO:0008289; GO:0009791; GO:0014065; GO:0016020; GO:0030165; GO:0031529; GO:0032587; GO:0033327; GO:0035264; GO:0043325; GO:0045184; GO:0048008; GO:0048705; GO:0050853; GO:0051898; GO:0060021; GO:0060325; GO:0070062; GO:0070301 "lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]" GFYESLAKVKPGNFK 0.99385 -13.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8593 0 0 0 0 14.4519 0 0 0 0 0 0 13.6788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8638 0 0 0 0 0 Q9NWX5 ASB6_HUMAN "Ankyrin repeat and SOCS box protein 6, ASB-6" ASB6 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] BRCA1-BARD1 complex [GO:0031436]; cytosol [GO:0005829] BRCA1-BARD1 complex [GO:0031436]; cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0031436; GO:0035556 FCFQVTR 0.99385 -10.847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y597 KCTD3_HUMAN BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45) KCTD3 Homo sapiens (Human) protein homooligomerization [GO:0051260] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; protein homooligomerization [GO:0051260] GO:0005886; GO:0051260 ARRTESFHSYR 0.99385 -13.921 0 0 0 0 0 0 0 0 0 0 0 0 15.097 0 0 13.5978 0 0 0 0 12.4726 0 0 0 0 13.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5502 0 0 14.5438 0 0 0 0 15.9755 13.0913 0 0 14.6605 0 0 0 13.3372 13.3032 12.6192 0 15.1111 0 0 0 0 14.4824 15.7327 0 0 14.0736 0 14.3703 0 0 0 0 13.464 13.5008 0 0 0 11.6101 0 11.4466 14.9538 13.7777 13.9111 0 0 14.6395 0 0 13.1388 0 0 13.7955 0 0 14.1703 0 13.2268 0 0 14.0745 0 14.4292 14.2891 0 0 14.2311 0 12.5249 0 14.7159 0 0 0 13.9036 0 0 0 0 0 0 0 0 12.7915 0 0 0 0 0 11.7904 0 0 13.8131 0 13.3899 0 0 0 0 0 Q9Y6Q2 STON1_HUMAN Stonin-1 (Stoned B-like factor) STON1 SALF SBLF STN1 Homo sapiens (Human) focal adhesion assembly [GO:0048041]; focal adhesion disassembly [GO:0120181]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; regulation of endocytosis [GO:0030100]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] cell leading edge [GO:0031252]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; synaptic vesicle [GO:0008021] cell leading edge [GO:0031252]; cell projection [GO:0042995]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; focal adhesion assembly [GO:0048041]; focal adhesion disassembly [GO:0120181]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; regulation of endocytosis [GO:0030100]; ruffle assembly [GO:0097178]; substrate-dependent cell migration [GO:0006929]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] GO:0005905; GO:0006929; GO:0008021; GO:0016192; GO:0030100; GO:0030136; GO:0031252; GO:0031410; GO:0035615; GO:0042995; GO:0048008; GO:0048041; GO:0048488; GO:0097178; GO:0120181 clathrin adaptor activity [GO:0035615] ACYNIQVEIEKKWIK 0.99385 -5.2217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5716 0 0 0 0 13.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1291 14.6475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14893 GEMI2_HUMAN "Gem-associated protein 2, Gemin-2 (Component of gems 2) (Survival of motor neuron protein-interacting protein 1, SMN-interacting protein 1)" GEMIN2 SIP1 Homo sapiens (Human) "mRNA processing [GO:0006397]; negative regulation of RNA binding [GO:1905215]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681] "cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; mRNA processing [GO:0006397]; negative regulation of RNA binding [GO:1905215]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]" GO:0000245; GO:0000375; GO:0000387; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0032797; GO:0034719; GO:0097504; GO:1905215 AELAGLK 0.99386 -13.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0034 0 0 0 0 0 10.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2956 0 0 0 0 0 0 0 0 0 0 0 0 13.7675 0 13.9821 0 0 13.5465 0 13.8993 13.7127 0 0 0 0 0 0 0 0 13.3149 0 0 0 13.7848 0 0 0 0 0 0 0 0 14.9802 15.0235 13.5178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3779 0 0 0 0 0 0 0 P25189 MYP0_HUMAN "Myelin protein P0 (Myelin peripheral protein, MPP) (Myelin protein zero)" MPZ Homo sapiens (Human) cell aggregation [GO:0098743]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; chemical synaptic transmission [GO:0007268]; myelination [GO:0042552]; negative regulation of apoptotic process [GO:0043066] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; structural molecule activity [GO:0005198]; cell aggregation [GO:0098743]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; chemical synaptic transmission [GO:0007268]; myelination [GO:0042552]; negative regulation of apoptotic process [GO:0043066] GO:0005198; GO:0005764; GO:0005791; GO:0005886; GO:0005887; GO:0007268; GO:0016323; GO:0042552; GO:0043066; GO:0043209; GO:0045202; GO:0098742; GO:0098743 structural molecule activity [GO:0005198] ERIQWVGDPRWK 0.99386 -7.9268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3578 0 0 0 0 0 0 0 0 0 0 0 12.5389 0 0 0 0 0 0 0 0 0 0 11.7396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2344 0 0 0 0 0 12.4523 0 0 0 0 0 0 10.9522 0 0 0 0 11.2464 11.7098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8232 0 0 13.8609 0 0 0 0 0 12.7889 0 0 0 15.4958 13.2705 0 0 13.4672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1547 0 14.9572 P32314 FOXN2_HUMAN Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]" GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0035914; GO:0043231; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" NSHVGSDGSEGFHSEEDTDVDYEDDPLGDSGYASQPCAK 0.99386 -7.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6723 0 0 0 0 0 12.9091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3828 0 0 0 0 0 11.6926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1441 0 0 0 0 0 0 0 0 0 13.7726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6352 0 0 0 0 0 0 0 0 0 0 0 0 0 13.181 0 0 0 0 0 0 0 0 0 0 0 0 0 Q09428 ABCC8_HUMAN ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) ABCC8 HRINS SUR SUR1 Homo sapiens (Human) cellular glucose homeostasis [GO:0001678]; cellular response to organic substance [GO:0071310]; female pregnancy [GO:0007565]; inorganic cation transmembrane transport [GO:0098662]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of wound healing [GO:0061045]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672] inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcolemma [GO:0042383]; synaptic vesicle membrane [GO:0030672]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325]; cellular glucose homeostasis [GO:0001678]; cellular response to organic substance [GO:0071310]; female pregnancy [GO:0007565]; inorganic cation transmembrane transport [GO:0098662]; memory [GO:0007613]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of insulin secretion [GO:0046676]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuroblast migration [GO:0061855]; negative regulation of wound healing [GO:0061045]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of uterine smooth muscle relaxation [GO:1900721]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; transmembrane transport [GO:0055085]; visual learning [GO:0008542] GO:0001678; GO:0005267; GO:0005524; GO:0005739; GO:0005886; GO:0006813; GO:0007565; GO:0007613; GO:0008281; GO:0008282; GO:0008542; GO:0009268; GO:0009410; GO:0010043; GO:0010989; GO:0015272; GO:0016020; GO:0016525; GO:0019829; GO:0030672; GO:0031004; GO:0032496; GO:0032760; GO:0032868; GO:0042383; GO:0042626; GO:0044325; GO:0046676; GO:0055085; GO:0060253; GO:0061045; GO:0061855; GO:0071310; GO:0071805; GO:0098662; GO:0140359; GO:1900721; GO:1903818; GO:1905075; GO:1905604; GO:1990573 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP-activated inward rectifier potassium channel activity [GO:0015272]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] AEIPWRACAK 0.99386 -27.746 0 0 11.9791 0 10.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3014 0 0 0 0 0 0 0 12.6966 0 0 12.4573 0 12.2242 0 0 0 0 10.8547 0 10.9009 0 0 0 0 0 0 0 0 0 12.0086 0 12.4468 0 0 0 15.5025 0 0 0 0 0 0 0 0 12.3807 0 0 0 0 0 0 11.7699 12.4235 14.8384 0 13.4392 0 0 0 13.7737 0 0 0 12.6009 0 13.3209 16.1217 12.4597 0 16.4268 12.6772 0 0 0 0 0 0 0 0 13.7363 0 0 0 0 14.5142 0 0 0 0 14.7733 0 0 0 0 11.9796 12.1283 0 0 0 0 15.3613 14.1722 12.8773 0 12.0878 0 0 0 0 0 0 12.372 0 0 0 0 16.1225 0 13.3235 10.6898 0 0 0 0 0 13.7161 0 0 0 0 0 0 0 13.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9671 0 0 0 0 10.7886 11.0464 Q5VTB9 RN220_HUMAN "E3 ubiquitin-protein ligase RNF220, EC 2.3.2.27 (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220)" RNF220 C1orf164 Homo sapiens (Human) dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of transcription regulatory region DNA binding [GO:2000677] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of transcription regulatory region DNA binding [GO:2000677] GO:0003358; GO:0004842; GO:0005737; GO:0006513; GO:0016567; GO:0021904; GO:0032991; GO:0046872; GO:0051091; GO:0051865; GO:0061630; GO:0090263; GO:2000677 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AAALFDSQAPICPICQVLLR 0.99386 -13.99 11.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2097 0 0 0 0 0 0 0 12.0537 0 0 0 0 0 0 14.559 0 0 14.4779 14.2537 0 0 14.4321 0 0 14.1366 0 14.3604 14.2039 0 14.9853 14.1626 14.8303 0 0 0 0 0 13.6506 14.2256 0 12.8151 0 0 0 0 0 0 0 0 0 0 13.217 0 0 0 0 0 13.9473 0 12.7316 0 0 13.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2815 0 0 0 0 0 13.787 13.3163 12.5895 0 0 0 0 0 0 0 Q86VR2 RETR3_HUMAN Reticulophagy regulator 3 RETREG3 FAM134C Homo sapiens (Human) collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; positive regulation of neuron projection development [GO:0010976]; reticulophagy [GO:0061709] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; protein-containing complex [GO:0032991]; endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; positive regulation of neuron projection development [GO:0010976]; reticulophagy [GO:0061709] GO:0005783; GO:0007029; GO:0010976; GO:0016021; GO:0030574; GO:0032991; GO:0061709; GO:0140506 endoplasmic reticulum-autophagosome adaptor activity [GO:0140506] NVLLFKK 0.99386 -13.997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.57833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N653 LZTR1_HUMAN "Leucine-zipper-like transcriptional regulator 1, LZTR-1" LZTR1 TCFL2 Homo sapiens (Human) negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567] Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038] Cul3-RING ubiquitin ligase complex [GO:0031463]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; recycling endosome membrane [GO:0055038]; small GTPase binding [GO:0031267]; negative regulation of Ras protein signal transduction [GO:0046580]; protein ubiquitination [GO:0016567] GO:0005794; GO:0012505; GO:0016567; GO:0031267; GO:0031463; GO:0046580; GO:0055038 small GTPase binding [GO:0031267] FQFSCYPK 0.99386 -13.992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8427 0 0 0 0 13.4778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6473 0 11.1347 0 0 0 0 0 0 0 13.5767 12.8718 0 13.4043 0 0 0 0 0 0 0 0 13.9898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9966 0 0 13.2098 0 0 0 Q8TDR0 MIPT3_HUMAN "TRAF3-interacting protein 1 (Interleukin-13 receptor alpha 1-binding protein 1) (Intraflagellar transport protein 54 homolog) (Microtubule-interacting protein associated with TRAF3, MIP-T3)" TRAF3IP1 IFT54 MIPT3 Homo sapiens (Human) cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type I interferon production [GO:0032480]; regulation of microtubule cytoskeleton organization [GO:0070507] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type I interferon production [GO:0032480]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0001738; GO:0001822; GO:0001933; GO:0005813; GO:0005929; GO:0005930; GO:0008017; GO:0030992; GO:0031333; GO:0032480; GO:0035720; GO:0035869; GO:0036064; GO:0042073; GO:0050687; GO:0060271; GO:0070507; GO:0097542; GO:0097546 microtubule binding [GO:0008017] AIDVVVMVSGEPLLAK 0.99386 -13.992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1629 0 0 0 0 0 0 0 0 0 11.7229 0 0 0 0 0 0 0 0 11.6274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0881 11.2331 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9481 0 0 0 0 0 0 0 0 0 12.8245 0 0 0 0 12.0515 0 0 0 0 0 0 0 0 0 0 0 13.2903 0 0 0 0 0 11.9526 0 0 0 0 0 0 0 0 0 0 Q8TE58 ATS15_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 15, ADAM-TS 15, ADAM-TS15, ADAMTS-15, EC 3.4.24.-" ADAMTS15 Homo sapiens (Human) extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; proteolysis [GO:0006508] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; myoblast fusion [GO:0007520]; proteolysis [GO:0006508] GO:0004175; GO:0004222; GO:0005615; GO:0006508; GO:0007520; GO:0008201; GO:0008270; GO:0009986; GO:0022617; GO:0030198; GO:0031012; GO:0050840; GO:0062023 endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] FHGADLEHYLLTLLATAARLYR 0.99386 -7.9177 0 0 0 13.5072 0 0 0 0 0 0 0 0 12.4798 0 0 0 0 0 0 0 13.0498 9.46271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.055 0 13.4944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9061 0 12.7156 0 0 0 9.72395 0 0 13.5232 12.5681 12.4477 14.6508 0 0 14.7517 11.0259 0 11.375 15.0841 15.2356 0 11.1768 0 0 0 0 0 0 13.0063 0 10.8656 14.1759 0 0 0 0 0 0 0 0 0 0 0 0 14.2941 0 0 15.705 15.8605 16.2637 11.7892 12.6037 0 0 12.8572 0 0 0 14.4912 0 0 0 0 0 14.6201 0 14.7806 0 0 13.1988 13.9303 13.7801 0 12.4365 13.2735 13.2771 0 0 16.2184 0 0 11.5393 0 13.3678 0 11.7491 0 0 0 0 0 0 0 13.462 0 13.2041 0 0 14.2815 12.7369 0 0 13.2591 16.3879 0 0 0 Q9H422 HIPK3_HUMAN "Homeodomain-interacting protein kinase 3, EC 2.7.11.1 (Androgen receptor-interacting nuclear protein kinase, ANPK) (Fas-interacting serine/threonine-protein kinase, FIST) (Homolog of protein kinase YAK1)" HIPK3 DYRK6 FIST3 PKY Homo sapiens (Human) apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; apoptotic process [GO:0006915]; mRNA transcription [GO:0009299]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0009299; GO:0016604; GO:0016605; GO:0018105; GO:0018107; GO:0043066; GO:0043508; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] DVEEVSCIETQDNQNSEGEAR 0.99386 -27.729 0 0 0 0 0 0 0 0 13.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76266 0 11.4251 0 0 0 0 0 0 11.2105 0 0 0 12.7208 0 0 0 0 0 0 0 0 12.0762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0206 0 0 0 13.3044 12.6871 12.6397 0 0 12.3916 0 0 0 0 0 0 0 14.6151 0 0 0 0 0 0 0 0 12.666 0 0 0 13.1696 12.1863 0 0 0 13.7005 0 13.1054 14.7523 13.8755 0 11.471 0 0 0 0 0 0 0 0 12.3545 12.2253 12.6155 0 13.4747 13.5543 0 0 14.2934 0 0 0 0 0 11.2822 0 0 0 0 0 0 0 0 0 0 0 0 15.0276 0 0 15.8316 0 0 0 0 12.7717 13.2114 12.653 0 0 0 0 0 12.1014 Q9P2C4 TM181_HUMAN Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; toxic substance binding [GO:0015643] GO:0015643; GO:0016021 toxic substance binding [GO:0015643] CLTFYLPK 0.99386 -27.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5243 0 11.2668 0 0 14.6939 0 0 0 13.0275 13.6137 0 0 13.2772 0 13.0565 0 0 0 0 0 0 12.1566 0 0 0 0 0 0 15.9708 0 0 0 0 0 0 0 0 0 0 0 13.4675 0 0 0 0 0 15.4381 0 0 0 11.6857 0 0 0 0 0 13.4807 0 0 0 0 0 0 12.8782 0 12.8447 0 0 0 0 0 0 11.8882 0 0 0 0 0 14.5593 0 0 13.1224 0 0 0 0 11.4023 0 0 0 0 0 0 13.5757 0 10.8897 0 0 12.2105 14.0472 0 13.3502 0 0 0 0 0 0 0 0 12.2302 0 0 12.805 0 13.3622 12.3817 0 12.9652 0 0 0 13.544 0 0 0 0 0 0 0 0 12.7822 10.8375 0 0 0 0 0 0 12.7896 0 0 0 14.9198 0 0 12.85 0 0 0 0 0 0 0 0 Q9P2W7 B3GA1_HUMAN "Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1, EC 2.4.1.135 (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P, GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase, GlcUAT-P)" B3GAT1 GLCATP Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486] endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; protein glycosylation [GO:0006486]" GO:0000139; GO:0005576; GO:0005789; GO:0005975; GO:0006486; GO:0008499; GO:0015018; GO:0016021; GO:0043231; GO:0046872; GO:0050650 "galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; metal ion binding [GO:0046872]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]" DEGSDPR 0.99386 -6.8853 0 0 0 0 0 0 0 0 0 10.3931 0 0 0 0 0 0 0 0 11.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8483 13.9426 14.8869 14.002 14.7854 13.4263 13.8841 0 13.8592 0 13.9692 13.5343 0 0 0 0 0 0 0 12.8081 12.9488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1698 0 0 0 0 0 0 0 12.5893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2494 0 0 13.3316 0 0 12.6726 0 0 0 0 0 0 13.4752 0 0 0 0 Q9UIW0 VAX2_HUMAN Ventral anterior homeobox 2 VAX2 Homo sapiens (Human) axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic eye morphogenesis [GO:0048048]; forebrain development [GO:0030900]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic eye morphogenesis [GO:0048048]; forebrain development [GO:0030900]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000978; GO:0000981; GO:0001162; GO:0001227; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007398; GO:0007409; GO:0007417; GO:0007601; GO:0009950; GO:0016055; GO:0030182; GO:0030900; GO:0031490; GO:0048048; GO:0060041; GO:1990837 "chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific double-stranded DNA binding [GO:1990837]" AESGGGGGRCGDR 0.99386 -6.8943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4724 0 0 0 11.4058 0 0 0 0 0 0 11.795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.56989 0 0 0 0 0 0 12.2465 0 0 0 0 11.6711 12.7566 0 0 0 14.0218 0 0 0 0 13.796 13.8661 14.3731 0 13.9556 0 0 0 13.5718 0 0 0 13.4528 14.1667 13.0418 0 0 0 0 0 13.0209 0 12.7125 12.6748 0 0 0 0 0 0 0 0 0 0 12.2208 0 0 0 14.0643 0 11.8266 0 11.324 11.5174 13.7459 0 12.2632 0 0 0 0 12.5817 13.8814 0 0 0 0 0 0 0 13.5578 0 11.8842 13.0051 0 0 0 0 0 13.2835 0 0 14.2223 0 0 12.6693 0 0 0 10.774 0 0 0 13.4964 13.6536 15.3682 0 0 0 0 0 0 11.8121 Q9ULV5 HSF4_HUMAN "Heat shock factor protein 4, HSF 4, hHSF4 (Heat shock transcription factor 4, HSTF 4)" HSF4 Homo sapiens (Human) cell development [GO:0048468]; epithelial cell proliferation [GO:0050673]; histone H3-K9 demethylation [GO:0033169]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell development [GO:0048468]; epithelial cell proliferation [GO:0050673]; histone H3-K9 demethylation [GO:0033169]; lens fiber cell differentiation [GO:0070306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual perception [GO:0007601]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007601; GO:0016607; GO:0019903; GO:0033169; GO:0042802; GO:0045597; GO:0045944; GO:0048468; GO:0050673; GO:0050679; GO:0070306; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DHVEFQHPSFVR 0.99386 -6.886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2T2 AP3M1_HUMAN AP-3 complex subunit mu-1 (AP-3 adaptor complex mu3A subunit) (Adaptor-related protein complex 3 subunit mu-1) (Mu-adaptin 3A) (Mu3A-adaptin) AP3M1 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; small GTPase binding [GO:0031267]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting to lysosome [GO:0006622]; vesicle-mediated transport [GO:0016192]" GO:0005764; GO:0005765; GO:0005769; GO:0005794; GO:0006622; GO:0006897; GO:0008089; GO:0016192; GO:0030123; GO:0030131; GO:0030659; GO:0031267; GO:0031410; GO:0035654; GO:0046907; GO:0048490; GO:0060155; GO:1903232; GO:1904115 small GTPase binding [GO:0031267] AGKFQVR 0.99386 -13.959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3619 0 0 0 11.5354 13.6682 0 0 14.4013 0 0 0 0 0 14.4901 0 0 0 0 15.2017 0 0 0 0 0 0 0 0 0 0 0 0 11.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7891 0 0 0 A1L4H1 SRCRL_HUMAN "Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D (Soluble scavenger protein with 5 SRCR domains, SSc5D)" SSC5D Homo sapiens (Human) defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; negative regulation of interleukin-8 production [GO:0032717] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response [GO:0006952]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; negative regulation of interleukin-8 production [GO:0032717] GO:0001968; GO:0005044; GO:0005615; GO:0005737; GO:0006952; GO:0016020; GO:0031012; GO:0032717; GO:0042494; GO:0043236; GO:0045087; GO:0050829; GO:0050830; GO:0050840; GO:0062023 extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044] APGKMPK 0.99387 -6.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0412 0 0 9.73016 0 0 0 0 0 0 10.7437 16.8192 0 13.2487 0 0 0 13.0254 0 0 0 0 12.9004 0 0 0 0 0 13.8866 0 0 0 0 0 16.473 0 0 0 0 12.7368 0 0 0 0 0 0 0 0 0 0 13.4785 0 0 0 0 0 0 13.5068 13.2906 13.6553 0 14.2412 0 0 13.1061 13.0065 0 0 0 13.9176 0 11.4788 0 0 0 0 0 0 14.3188 0 0 14.5569 0 0 0 0 12.0185 0 14.4793 0 0 0 0 0 0 0 0 0 0 14.427 14.4826 0 0 0 0 0 12.4939 0 0 0 0 14.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2055 0 0 0 O43426 SYNJ1_HUMAN "Synaptojanin-1, EC 3.1.3.36 (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)" SYNJ1 KIAA0910 Homo sapiens (Human) brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191] clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane coat [GO:0030117]; microtubule [GO:0005874]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506] "clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane coat [GO:0030117]; microtubule [GO:0005874]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; EH domain binding [GO:1990175]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191]" GO:0003723; GO:0004438; GO:0004439; GO:0005829; GO:0005874; GO:0006661; GO:0006836; GO:0007420; GO:0007612; GO:0008022; GO:0012506; GO:0014015; GO:0016082; GO:0016191; GO:0017124; GO:0030117; GO:0030132; GO:0032526; GO:0034097; GO:0034595; GO:0034596; GO:0043195; GO:0043647; GO:0043812; GO:0043813; GO:0044877; GO:0046488; GO:0046855; GO:0046856; GO:0048260; GO:0048471; GO:0048488; GO:0048489; GO:0052629; GO:0052658; GO:0061024; GO:0097060; GO:0098688; GO:0098793; GO:1904980; GO:1990175 "EH domain binding [GO:1990175]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]" AEKLHSVLKPQVQK 0.99387 -29.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0703 0 12.6159 12.9251 13.0347 0 0 0 0 0 13.1095 0 12.8644 0 13.3444 0 13.6776 0 0 0 15.8758 0 13.5741 0 11.4995 0 0 0 0 0 0 13.44 0 0 0 0 0 13.7144 12.1757 0 13.7448 0 0 13.1812 14.6764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93427 13.4773 0 0 13.1215 13.7777 0 0 0 0 0 0 0 0 14.0402 12.763 0 13.4791 15.5223 0 0 0 0 0 0 0 13.6295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6482 13.131 0 O75818 RPP40_HUMAN "Ribonuclease P protein subunit p40, RNaseP protein p40 (RNase P subunit 1)" RPP40 RNASEP1 Homo sapiens (Human) "endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage involved in tRNA processing [GO:1905267]; tRNA 5'-leader removal [GO:0001682]" multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172] "multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage involved in tRNA processing [GO:1905267]; tRNA 5'-leader removal [GO:0001682]" GO:0000172; GO:0000447; GO:0001682; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0030681; GO:0033204; GO:1905267 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204] KPLKFDFLLAWHK 0.99387 -9.1051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0809 0 0 14.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55157 MTP_HUMAN Microsomal triglyceride transfer protein large subunit MTTP MTP Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; chylomicron assembly [GO:0034378]; circadian rhythm [GO:0007623]; establishment of localization in cell [GO:0051649]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle remodeling [GO:0034374]; phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; response to calcium ion [GO:0051592]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle assembly [GO:0034379] basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982] basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; microvillus membrane [GO:0031528]; receptor complex [GO:0043235]; rough endoplasmic reticulum [GO:0005791]; vesicle [GO:0031982]; apolipoprotein binding [GO:0034185]; ceramide 1-phosphate transfer activity [GO:1902388]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transfer activity [GO:0120014]; phospholipid transporter activity [GO:0005548]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; triglyceride transfer activity [GO:0140344]; cholesterol homeostasis [GO:0042632]; chylomicron assembly [GO:0034378]; circadian rhythm [GO:0007623]; establishment of localization in cell [GO:0051649]; lipid metabolic process [GO:0006629]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle remodeling [GO:0034374]; phospholipid transport [GO:0015914]; plasma lipoprotein particle assembly [GO:0034377]; protein lipidation [GO:0006497]; protein secretion [GO:0009306]; response to calcium ion [GO:0051592]; triglyceride metabolic process [GO:0006641]; triglyceride transport [GO:0034197]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0005319; GO:0005548; GO:0005783; GO:0005788; GO:0005791; GO:0005794; GO:0005829; GO:0006497; GO:0006629; GO:0006641; GO:0007623; GO:0008289; GO:0009306; GO:0015914; GO:0016323; GO:0031526; GO:0031528; GO:0031982; GO:0034185; GO:0034197; GO:0034374; GO:0034377; GO:0034378; GO:0034379; GO:0042157; GO:0042632; GO:0042953; GO:0043235; GO:0044877; GO:0046982; GO:0051592; GO:0051649; GO:0120014; GO:0120019; GO:0120020; GO:0140344; GO:1902388; GO:1904121 apolipoprotein binding [GO:0034185]; ceramide 1-phosphate transfer activity [GO:1902388]; cholesterol transfer activity [GO:0120020]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylethanolamine transfer activity [GO:1904121]; phospholipid transfer activity [GO:0120014]; phospholipid transporter activity [GO:0005548]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; triglyceride transfer activity [GO:0140344] DEAPFRQFEKK 0.99387 -5.0571 0 0 0 0 0 0 0 0 0 11.6973 11.9058 0 0 11.6624 0 0 0 11.0019 0 0 0 0 0 0 10.3307 0 0 0 0 0 0 0 0 0 0 10.1162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3376 0 0 0 0 0 0 0 0 0 0 12.1012 0 0 0 0 0 14.559 0 11.9395 0 0 0 0 12.9576 0 0 0 0 13.9907 13.1534 13.3971 14.2801 0 0 0 0 0 0 0 12.5986 0 0 13.3565 12.6934 0 0 13.5859 0 0 14.1761 14.0437 0 0 13.4226 0 0 14.3752 0 0 13.956 0 0 0 0 14.1027 0 12.6692 0 0 0 10.5147 0 13.1155 0 13.9532 0 13.1672 10.0737 0 13.3828 0 0 0 0 0 0 0 0 0 0 13.9898 11.5756 0 0 0 11.8774 0 0 0 12.4961 0 0 0 0 0 0 14.0112 0 0 0 0 0 0 0 0 0 11.3765 0 0 0 0 0 11.5022 0 P56706 WNT7B_HUMAN Protein Wnt-7b WNT7B Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; central nervous system vasculogenesis [GO:0022009]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; in utero embryonic development [GO:0001701]; inner medullary collecting duct development [GO:0072061]; lens fiber cell development [GO:0070307]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; mammary gland epithelium development [GO:0061180]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; response to glucocorticoid [GO:0051384]; stem cell proliferation [GO:0072089]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; central nervous system vasculogenesis [GO:0022009]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; in utero embryonic development [GO:0001701]; inner medullary collecting duct development [GO:0072061]; lens fiber cell development [GO:0070307]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; mammary gland epithelium development [GO:0061180]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; response to glucocorticoid [GO:0051384]; stem cell proliferation [GO:0072089]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055] GO:0001701; GO:0003338; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0016055; GO:0016332; GO:0021871; GO:0022009; GO:0030182; GO:0030324; GO:0030666; GO:0032364; GO:0032536; GO:0042592; GO:0045165; GO:0045669; GO:0046330; GO:0048018; GO:0048144; GO:0048568; GO:0048812; GO:0050808; GO:0051384; GO:0060070; GO:0060425; GO:0060428; GO:0060482; GO:0060535; GO:0060560; GO:0060669; GO:0060710; GO:0061180; GO:0070062; GO:0070307; GO:0071300; GO:0072053; GO:0072054; GO:0072060; GO:0072061; GO:0072089; GO:0072205; GO:0072207; GO:0072236 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] FHWCCFVK 0.99387 -29.675 0 0 11.6852 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3332 0 0 10.4688 0 0 0 0 0 0 0 0 0 0 10.2457 0 0 0 10.6033 0 0 11.0759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8594 0 0 0 0 0 0 0 0 0 0 12.0645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0464 0 0 0 14.386 0 13.6431 0 0 0 0 0 0 14.0606 0 0 0 0 13.7876 0 13.7253 14.1536 14.5148 0 0 0 0 0 14.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8186 0 0 14.4747 0 0 0 14.0134 0 0 0 0 0 0 12.0025 0 0 0 0 0 0 14.4611 0 0 0 0 0 12.663 0 0 0 0 0 0 0 0 0 0 13.9236 0 0 0 0 11.497 11.2912 0 P62633 CNBP_HUMAN "CCHC-type zinc finger nucleic acid binding protein (Cellular nucleic acid-binding protein, CNBP) (Zinc finger protein 9)" CNBP RNF163 ZNF9 Homo sapiens (Human) "cholesterol homeostasis [GO:0042632]; G-quadruplex DNA formation [GO:0071919]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; G-quadruplex DNA binding [GO:0051880]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270]; cholesterol homeostasis [GO:0042632]; G-quadruplex DNA formation [GO:0071919]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0003697; GO:0003723; GO:0003727; GO:0003729; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006355; GO:0008270; GO:0008284; GO:0042632; GO:0045182; GO:0045893; GO:0045944; GO:0051880; GO:0071919; GO:2000767 G-quadruplex DNA binding [GO:0051880]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation regulator activity [GO:0045182]; zinc ion binding [GO:0008270] CGESGHLAKDCDLQEDACYNCGR 0.99387 -5.0478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9951 0 0 0 0 0 11.3333 0 0 0 0 13.3669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2829 0 0 0 0 0 0 0 0 0 0 0 0 10.5286 0 0 0 0 0 0 0 0 11.2943 0 0 0 0 0 0 0 11.9098 0 0 0 10.7293 0 0 0 0 0 0 11.1443 11.7856 11.9204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15046 SYK_HUMAN "Lysine--tRNA ligase, EC 2.7.7.-, EC 6.1.1.6 (Lysyl-tRNA synthetase, LysRS)" KARS1 KARS KIAA0070 Homo sapiens (Human) "basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA processing [GO:0008033]" aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription, DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tRNA processing [GO:0008033]" GO:0000049; GO:0002276; GO:0002863; GO:0003877; GO:0004824; GO:0005524; GO:0005615; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006430; GO:0008033; GO:0010165; GO:0015966; GO:0016597; GO:0017101; GO:0042802; GO:0042803; GO:0043032; GO:0045893; GO:0070371 amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049] DKETRYR 0.99387 -29.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9759 0 0 0 0 0 0 12.9431 0 0 12.874 0 0 0 0 0 0 0 13.218 0 12.8563 0 0 0 0 0 0 0 0 0 0 0 11.5274 0 12.3649 0 0 0 0 0 13.0029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15759 MK11_HUMAN "Mitogen-activated protein kinase 11, MAP kinase 11, MAPK 11, EC 2.7.11.24 (Mitogen-activated protein kinase p38 beta, MAP kinase p38 beta, p38b) (Stress-activated protein kinase 2b, SAPK2b) (p38-2)" MAPK11 PRKM11 SAPK2 SAPK2B Homo sapiens (Human) bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cellular response to interleukin-1 [GO:0071347]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cellular response to interleukin-1 [GO:0071347]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; stress-activated MAPK cascade [GO:0051403] GO:0001649; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0010628; GO:0032735; GO:0035556; GO:0038066; GO:0051149; GO:0051403; GO:0060038; GO:0060044; GO:0060348; GO:0071347; GO:0090398; GO:0098586; GO:0106310 ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AGFYRQELNKTVWEVPQR 0.99387 -9.1044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2265 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4687 0 Q5T5A4 CF276_HUMAN Cilia- and flagella-associated protein 276 CFAP276 C1orf194 Homo sapiens (Human) heme export [GO:0097037] axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; heme export [GO:0097037] GO:0005737; GO:0005856; GO:0005879; GO:0015232; GO:0020037; GO:0097037 heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232] DGGFFST 0.99387 -14.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7797 13.5645 0 0 0 0 0 0 0 12.8681 0 0 0 0 0 0 0 0 0 0 0 0 12.9471 0 0 0 0 0 0 12.9391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7579 0 0 0 0 12.4124 0 0 0 0 0 0 0 0 0 Q8IYM9 TRI22_HUMAN "E3 ubiquitin-protein ligase TRIM22, EC 2.3.2.27 (50 kDa-stimulated trans-acting factor) (RING finger protein 94) (RING-type E3 ubiquitin transferase TRIM22) (Staf-50) (Tripartite motif-containing protein 22)" TRIM22 RNF94 STAF50 Homo sapiens (Human) "defense response to virus [GO:0051607]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; regulation of viral entry into host cell [GO:0046596]; response to virus [GO:0009615]" Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of transcription, DNA-templated [GO:0006355]; regulation of viral entry into host cell [GO:0046596]; response to virus [GO:0009615]" GO:0000209; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006355; GO:0006955; GO:0008270; GO:0009615; GO:0010468; GO:0010508; GO:0015030; GO:0016567; GO:0016604; GO:0016607; GO:0019901; GO:0030674; GO:0032880; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0051091; GO:0051092; GO:0051607; GO:0061630 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GSSVEMLQDVIDVMKRSESWTLK 0.99387 -14.048 0 0 0 0 0 0 0 0 0 0 0 12.8167 0 0 0 0 0 0 0 0 0 0 0 0 16.2268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7031 12.9642 14.1529 0 0 14.5916 0 0 0 15.2405 15.631 15.7904 15.5233 15.8502 0 14.2816 0 14.581 14.2053 14.4803 0 0 0 0 0 11.9072 0 0 0 0 13.7847 0 0 0 16.5913 0 0 0 0 13.9951 0 0 0 0 16.7032 0 0 0 0 13.692 0 0 0 17.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3R3 TCAIM_HUMAN "T-cell activation inhibitor, mitochondrial (Tolerance associated gene-1 protein, TOAG-1)" TCAIM C3orf23 TOAG1 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 FCHLRPMR 0.99387 -29.638 0 0 10.9875 0 0 13.2484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4812 0 0 0 Q8NG27 PJA1_HUMAN "E3 ubiquitin-protein ligase Praja-1, Praja1, EC 2.3.2.27 (RING finger protein 70) (RING-type E3 ubiquitin transferase Praja-1)" PJA1 RNF70 Homo sapiens (Human) protein catabolic process [GO:0030163] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; protein catabolic process [GO:0030163] GO:0005737; GO:0030163; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] IRNLASPNCVKPK 0.99387 -14.033 0 0 10.78 0 0 0 0 0 14.4289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3002 0 0 11.9755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1126 0 0 0 0 0 0 0 0 0 0 15.9454 0 0 0 0 15.7989 12.9022 13.8243 16.1675 15.9494 15.5458 15.1926 0 13.3015 0 14.9945 0 0 0 11.2367 12.8152 0 0 0 0 0 0 0 0 0 0 0 15.5079 0 0 14.2865 0 0 0 0 12.776 0 0 10.5218 0 0 0 0 0 0 14.0668 0 0 0 0 0 14.0956 0 0 0 0 0 0 14.6278 0 0 0 0 0 0 0 0 0 13.9688 0 0 0 0 0 0 0 0 10.5058 0 0 0 0 0 0 13.7418 0 0 0 0 0 0 0 0 Q8TCF1 ZFAN1_HUMAN AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1) ZFAND1 Homo sapiens (Human) cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; proteasome binding [GO:0070628]; zinc ion binding [GO:0008270]; cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617] GO:0005737; GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843 proteasome binding [GO:0070628]; zinc ion binding [GO:0008270] AELDIGQHCQVEHCRQRDFLPFVCDDCSGIFCLEHR 0.99387 -5.0425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4297 13.4053 12.0744 0 13.816 13.6461 0 0 0 0 0 12.8704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTQ4 CP078_HUMAN Uncharacterized protein C16orf78 C16orf78 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 MSDLTCVLEWLERRQGK 0.99387 -15.274 0 0 0 0 0 0 0 0 0 0 0 0 0 13.066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6673 0 0 0 0 0 0 0 0 0 0 17.7989 0 0 0 0 0 0 0 0 0 0 17.6156 0 0 0 0 0 17.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2228 0 0 0 0 0 0 0 0 0 13.1127 0 0 0 0 0 0 0 12.1014 12.0053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8872 0 0 0 0 18.5561 0 11.2871 0 0 0 0 0 0 0 0 0 0 0 14.4252 0 0 0 0 0 0 0 0 0 0 0 18.611 0 0 18.6252 0 0 0 0 0 0 14.8256 0 0 18.6827 0 0 0 0 Q9BW19 KIFC1_HUMAN Kinesin-like protein KIFC1 (Kinesin-like protein 2) (Kinesin-related protein HSET) KIFC1 HSET KNSL2 Homo sapiens (Human) cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307] early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634] early endosome [GO:0005769]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307] GO:0000070; GO:0003777; GO:0005524; GO:0005634; GO:0005769; GO:0005815; GO:0005871; GO:0005874; GO:0007018; GO:0007080; GO:0008017; GO:0016020; GO:0016887; GO:0051301; GO:0072686; GO:0090307 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] ACVLELEERLSTQEGLVQELQK 0.99387 -15.281 0 10.5972 0 13.3403 0 0 0 0 0 14.3751 14.6104 0 14.6192 13.7422 0 13.6729 13.2916 13.7128 13.7995 0 0 0 0 0 13.107 0 13.7438 13.3973 0 0 13.8852 0 0 12.8649 0 0 0 11.9811 13.2687 0 12.907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5889 0 0 0 0 0 0 0 0 0 0 0 0 13.1945 19.3171 13.2838 0 0 13.3428 0 0 0 13.3725 13.3404 0 11.629 0 0 0 0 0 0 13.2006 12.8968 0 0 0 0 0 0 0 0 0 0 12.9696 0 0 13.581 0 0 12.297 0 0 0 0 0 0 0 0 14.4346 0 0 0 0 0 12.3729 0 0 0 0 12.3741 0 0 0 13.2999 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0571 15.1338 0 0 12.3116 0 0 15.5239 0 0 0 0 Q9H6U6 BCAS3_HUMAN BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3) (GAOB1) BCAS3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; autophagy [GO:0006914]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to estrogen [GO:0043627]; response to starvation [GO:0042594]; tube formation [GO:0035148] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear receptor binding [GO:0016922]; phosphatidylinositol binding [GO:0035091]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; autophagy [GO:0006914]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to estrogen [GO:0043627]; response to starvation [GO:0042594]; tube formation [GO:0035148] GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007030; GO:0010595; GO:0010698; GO:0016922; GO:0031023; GO:0031252; GO:0034260; GO:0035035; GO:0035091; GO:0035148; GO:0042393; GO:0042594; GO:0043085; GO:0043547; GO:0043627; GO:0045111; GO:0045944; GO:0048487; GO:0051491; GO:0051895; GO:0071391; GO:0090316; GO:0090630; GO:2000114; GO:2000251 acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear receptor binding [GO:0016922]; phosphatidylinositol binding [GO:0035091] FQKSAGLEEIEQELTSK 0.99387 -5.0455 0 0 0 0 0 0 0 0 0 0 0 0 13.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4513 0 14.6708 14.4237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3978 0 13.6877 0 0 0 0 0 0 0 14.9097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5926 0 0 0 0 12.9537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8724 0 0 0 0 0 0 0 0 0 0 0 13.8589 0 0 0 0 0 0 0 0 0 0 12.0126 0 11.8368 0 0 12.9809 0 12.8328 0 0 0 0 0 0 14.1079 0 0 0 0 14.6362 0 0 0 0 Q9H765 ASB8_HUMAN "Ankyrin repeat and SOCS box protein 8, ASB-8" ASB8 PP14212 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567] GO:0005829; GO:0016567; GO:0035556 KNGTMPR 0.99387 -5.051 0 0 0 0 0 11.7705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1506 0 0 0 0 0 0 13.1904 0 0 12.8763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4808 0 0 0 0 0 0 0 0 0 13.9108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0474 Q9NQ50 RM40_HUMAN "39S ribosomal protein L40, mitochondrial, L40mt, MRP-L40 (Mitochondrial large ribosomal subunit protein mL40) (Nuclear localization signal-containing protein deleted in velocardiofacial syndrome) (Up-regulated in metastasis)" MRPL40 NLVCF URIM Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; mitochondrial translation [GO:0032543] GO:0003723; GO:0005634; GO:0005730; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0009653; GO:0032543 RNA binding [GO:0003723] ATQELIPIEDFITPLKFLDK 0.99387 -14.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ94 A1CF_HUMAN APOBEC1 complementation factor (APOBEC1-stimulating protein) A1CF ACF ASP Homo sapiens (Human) "cytidine to uridine editing [GO:0016554]; embryo implantation [GO:0007566]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; protein stabilization [GO:0050821]" apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; cytidine to uridine editing [GO:0016554]; embryo implantation [GO:0007566]; mRNA localization resulting in post-transcriptional regulation of gene expression [GO:0010609]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; protein stabilization [GO:0050821]" GO:0003723; GO:0003727; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006397; GO:0007566; GO:0010609; GO:0016554; GO:0016556; GO:0030895; GO:0045293; GO:0050821; GO:1901537; GO:2000623 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] ALVQRTGYSLVQENGQRK 0.99387 -14.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR45 SIAS_HUMAN "Sialic acid synthase (N-acetylneuraminate synthase, EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase, EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase)" NANS SAS Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; glycosylation [GO:0070085] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]; carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; glycosylation [GO:0070085] GO:0005737; GO:0005829; GO:0006055; GO:0008781; GO:0016051; GO:0047444; GO:0050462; GO:0070062; GO:0070085 N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444] ECGADCAK 0.99387 -14.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6936 0 0 0 0 0 0 11.2901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3082 0 0 13.9582 0 0 0 0 0 13.4372 13.0653 12.6365 0 14.7088 10.3741 0 14.4604 0 16.6731 16.7149 16.739 0 0 15.466 0 0 0 0 0 0 0 0 0 0 0 10.5813 0 0 12.016 0 0 0 0 0 0 0 14.1589 0 0 0 0 15.0606 0 0 0 16.5168 13.8448 0 15.0303 14.7135 0 14.6729 0 12.3806 12.6395 12.7228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9486 0 0 0 0 0 0 0 0 0 0 10.3915 0 0 0 0 0 0 0 0 0 0 0 0 10.5143 0 Q9NW64 RBM22_HUMAN Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) (Zinc finger CCCH domain-containing protein 16) RBM22 ZC3H16 199G4 Homo sapiens (Human) "cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cellular response to xenobiotic stimulus [GO:0071466]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]" GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0017070; GO:0033120; GO:0036002; GO:0042307; GO:0045292; GO:0046827; GO:0046872; GO:0048306; GO:0071006; GO:0071007; GO:0071013; GO:0071466 calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070] DRYYGINDPVADKLLK 0.99387 -29.508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6992 0 0 0 0 0 0 0 0 0 12.3322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3189 0 0 0 0 0 0 0 0 0 0 0 0 13.3786 0 0 0 0 0 0 0 0 0 0 0 0 14.4441 0 0 0 0 0 0 12.7776 13.6608 0 13.5622 0 0 0 15.0205 0 0 0 0 0 0 0 0 0 0 0 11.4046 0 0 0 14.7932 13.4993 0 0 0 0 0 0 0 0 13.4841 0 13.0681 0 0 0 13.2358 0 13.5439 0 0 0 0 0 14.3419 0 0 0 0 0 0 12.9083 0 0 0 13.052 0 0 0 0 11.524 0 0 12.2537 0 0 0 0 14.3269 0 Q9P0G3 KLK14_HUMAN "Kallikrein-14, hK14, EC 3.4.21.- (Kallikrein-like protein 6, KLK-L6)" KLK14 KLKL6 Homo sapiens (Human) epidermis morphogenesis [GO:0048730]; fertilization [GO:0009566]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proteolysis [GO:0006508]; seminal clot liquefaction [GO:0070684] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; serine-type endopeptidase activity [GO:0004252]; epidermis morphogenesis [GO:0048730]; fertilization [GO:0009566]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; proteolysis [GO:0006508]; seminal clot liquefaction [GO:0070684] GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0009566; GO:0030141; GO:0045744; GO:0045745; GO:0048730; GO:0070684 serine-type endopeptidase activity [GO:0004252] CALPGYPGVYTNLCKYRSWIEETMR 0.99387 -5.0557 0 0 0 0 9.59679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.783 13.0248 0 0 0 0 0 11.9609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1723 0 0 0 0 0 0 0 0 11.6405 0 0 0 0 9.47683 0 0 0 9.73829 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0294 0 10.192 0 0 0 Q9ULD0 OGDHL_HUMAN "2-oxoglutarate dehydrogenase-like, mitochondrial, EC 1.2.4.2 (2-oxoglutarate dehydrogenase complex component E1-like, OGDC-E1-like) (Alpha-ketoglutarate dehydrogenase-like)" OGDHL KIAA1290 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099] GO:0004591; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0006103; GO:0030976; GO:0045252; GO:0046872 metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976] DVVVDLVCYR 0.99387 -11.201 0 0 0 0 0 0 0 0 0 0 17.5116 0 17.9137 11.8111 9.88007 0 0 0 12.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5917 17.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4311 17.6156 0 16.8015 13.8429 0 0 12.4254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.592 0 0 0 0 0 15.9656 16.3038 12.3269 0 0 0 0 0 13.5783 0 12.599 0 0 0 0 0 0 0 0 0 0 0 0 13.3772 0 0 0 0 0 0 0 0 0 0 0 0 11.7243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8174 0 0 0 0 0 0 0 0 0 18.6708 0 0 0 12.3087 0 0 0 0 0 0 0 0 0 Q9ULD2 MTUS1_HUMAN Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1) MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 Homo sapiens (Human) regulation of macrophage chemotaxis [GO:0010758] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; microtubule binding [GO:0008017]; regulation of macrophage chemotaxis [GO:0010758] GO:0005615; GO:0005634; GO:0005730; GO:0005739; GO:0005794; GO:0005815; GO:0005819; GO:0005874; GO:0005886; GO:0008017; GO:0010758; GO:0015630 microtubule binding [GO:0008017] AKVMSRAVLQPK 0.99387 -5.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.145 0 0 0 11.5539 0 0 0 0 0 0 11.2369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1478 0 0 0 0 0 0 0 0 13.1723 0 0 0 0 0 0 0 14.0711 11.7598 0 0 0 0 0 0 13.757 0 0 0 0 0 0 13.9899 0 0 0 0 0 0 0 0 12.4853 0 0 0 0 0 0 0 12.6 11.6937 0 0 0 0 0 0 0 0 0 13.3764 0 0 0 0 0 0 0 12.7838 0 0 10.3485 0 0 0 0 0 0 0 0 0 12.2836 0 0 0 0 0 13.0096 12.2254 0 0 0 13.5332 0 0 0 11.6937 0 12.9358 0 0 Q9ULV1 FZD4_HUMAN "Frizzled-4, Fz-4, hFz4 (FzE4) (CD antigen CD344)" FZD4 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to retinoic acid [GO:0071300]; cerebellum vasculature morphogenesis [GO:0061301]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]" cell surface [GO:0009986]; cell-cell junction [GO:0005911]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cell-cell junction [GO:0005911]; clathrin-coated endocytic vesicle membrane [GO:0030669]; dendrite [GO:0030425]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to retinoic acid [GO:0071300]; cerebellum vasculature morphogenesis [GO:0061301]; extracellular matrix-cell signaling [GO:0035426]; locomotion involved in locomotory behavior [GO:0031987]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-substrate adhesion [GO:0010812]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; Norrin signaling pathway [GO:0110135]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription, DNA-templated [GO:0045893]; progesterone secretion [GO:0042701]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal blood vessel morphogenesis [GO:0061304]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]" GO:0001540; GO:0001570; GO:0004896; GO:0004930; GO:0005615; GO:0005886; GO:0005887; GO:0005911; GO:0007223; GO:0007605; GO:0009986; GO:0010812; GO:0016055; GO:0017147; GO:0019955; GO:0030165; GO:0030182; GO:0030335; GO:0030425; GO:0030669; GO:0030947; GO:0031625; GO:0031987; GO:0034446; GO:0035426; GO:0035567; GO:0038023; GO:0042701; GO:0042803; GO:0042813; GO:0043507; GO:0044877; GO:0045893; GO:0046982; GO:0051091; GO:0060070; GO:0061299; GO:0061301; GO:0061304; GO:0071300; GO:0090090; GO:0098978; GO:0110135; GO:0150012; GO:1990830 amyloid-beta binding [GO:0001540]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] GAGPSVPGAPGGVGLSLGLLLQLLLLLGPAR 0.99387 -15.272 0 0 0 0 0 0 0 0 13.3577 0 0 0 0 0 0 0 0 0 0 0 0 12.7736 0 11.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0671 0 0 0 12.9055 0 0 0 0 0 0 0 0 0 0 11.5943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5869 10.7688 0 14.9854 10.8033 0 0 12.2698 10.5695 14.3138 14.4081 12.2683 11.9957 0 0 14.3536 15.8652 11.3872 15.1153 0 0 0 0 0 0 0 0 12.1096 12.6404 0 12.9337 0 0 13.7925 0 0 0 12.6679 0 0 0 0 0 0 0 0 0 12.5405 0 11.9775 0 13.0763 0 0 0 12.169 0 0 0 0 9.93686 10.8291 12.6819 0 12.5274 0 0 0 0 0 0 0 0 0 11.2304 0 0 0 0 0 0 0 0 12.723 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 12.0616 0 Q9UMS4 PRP19_HUMAN "Pre-mRNA-processing factor 19, EC 2.3.2.27 (Nuclear matrix protein 200) (PRP19/PSO4 homolog, hPso4) (RING-type E3 ubiquitin transferase PRP19) (Senescence evasion factor)" PRPF19 NMP200 PRP19 SNEV Homo sapiens (Human) "DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neuron differentiation [GO:0045666]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neuron differentiation [GO:0045666]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000077; GO:0000209; GO:0000244; GO:0000245; GO:0000398; GO:0000974; GO:0004842; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005811; GO:0005819; GO:0006303; GO:0008104; GO:0008610; GO:0010498; GO:0016020; GO:0016607; GO:0034450; GO:0035861; GO:0042802; GO:0045666; GO:0048026; GO:0048711; GO:0061630; GO:0070534; GO:0071006; GO:0071007; GO:0071013 identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] ATVLTTER 0.99387 -12.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4803 0 13.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.155 0 13.187 0 0 12.2938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NH3 BROMI_HUMAN Protein broad-minded (TBC1 domain family member 32) TBC1D32 BROMI C6orf170 C6orf171 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] cilium [GO:0005929]; cytoplasm [GO:0005737] cilium [GO:0005929]; cytoplasm [GO:0005737]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831] GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007368; GO:0007507; GO:0042733; GO:0060021; GO:0060831; GO:0061512; GO:1905515 HCRNKQK 0.99388 -37.487 13.9761 0 10.9851 14.6482 0 0 14.6591 13.8024 0 0 10.5717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4733 14.4793 0 0 15.9644 16.3159 15.8495 0 0 13.4786 0 0 0 0 0 0 0 0 0 0 0 0 13.0538 0 13.8236 0 16.5421 13.9781 0 0 0 0 0 0 0 0 0 12.6733 0 0 0 0 0 16.2963 16.752 0 14.1041 0 0 0 0 0 16.4502 0 0 15.7408 0 15.6357 14.7219 14.7218 0 15.1419 0 16.7133 13.2451 0 0 0 0 0 0 15.3838 0 0 13.0899 12.176 13.855 0 14.3364 0 0 0 0 0 11.5187 0 0 0 13.655 0 12.6441 0 0 12.9783 0 0 0 0 13.9356 0 0 0 0 11.5407 0 0 P04114 APOB_HUMAN "Apolipoprotein B-100, Apo B-100 [Cleaved into: Apolipoprotein B-48, Apo B-48 ]" APOB Homo sapiens (Human) artery morphogenesis [GO:0048844]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379] chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983] chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983]; cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0001701; GO:0005543; GO:0005576; GO:0005615; GO:0005737; GO:0005769; GO:0005788; GO:0005789; GO:0005790; GO:0005811; GO:0005829; GO:0005886; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009743; GO:0009791; GO:0010008; GO:0010269; GO:0010628; GO:0010744; GO:0010884; GO:0010886; GO:0019433; GO:0030301; GO:0030317; GO:0030669; GO:0031904; GO:0031983; GO:0032355; GO:0032496; GO:0033344; GO:0034359; GO:0034360; GO:0034361; GO:0034362; GO:0034363; GO:0034364; GO:0034374; GO:0034379; GO:0034383; GO:0035473; GO:0042158; GO:0042159; GO:0042627; GO:0042632; GO:0042953; GO:0043025; GO:0043202; GO:0043231; GO:0045540; GO:0048844; GO:0050750; GO:0051649; GO:0070062; GO:0070971; GO:0071356; GO:0071379; GO:0071682; GO:0120020 cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543] AAIQALRK 0.99388 -29.94 12.7294 13.4717 12.8562 13.9852 0 13.4721 0 0 15.1174 13.5619 0 0 0 0 0 0 0 11.7885 0 13.6756 14.3073 13.3257 11.0272 14.5773 13.0891 13.1229 0 14.9356 0 11.8368 0 0 0 0 0 0 0 0 11.477 0 14.7523 13.476 0 12.2491 0 10.8371 0 0 12.0257 0 0 0 10.5109 0 10.9316 0 0 0 0 10.4654 0 11.314 0 0 0 0 15.6944 0 11.868 0 0 0 13.1748 13.3832 15.4461 18.9464 13.0236 19.3946 15.4496 13.7437 13.025 0 15.1109 15.839 16.1199 16.3619 14.226 16.7437 14.7329 15.926 16.3395 15.0128 12.6553 15.9838 15.1858 13.8836 16.8805 16.8981 16.4924 14.2389 14.5792 15.8725 15.0194 15.9779 15.8344 15.7712 0 15.5704 14.3315 15.6863 16.2317 0 15.8642 14.4081 17.4687 16.4681 15.7271 14.4446 13.6362 13.3014 16.904 14.6179 16.3431 15.1436 16.5258 15.6695 13.5937 15.0251 14.515 13.3278 16.8782 14.7504 13.5579 12.5202 14.2121 15.5955 14.9128 14.8462 14.223 16.5036 16.9201 11.922 0 11.4174 14.1012 0 17.6684 0 14.2518 0 14.3383 12.8283 0 13.8342 15.2777 14.18 16.0117 0 14.1586 11.1801 14.4408 13.6284 0 0 0 0 0 11.4048 0 0 0 18.2412 13.7888 0 11.1554 10.785 15.4362 0 0 0 O60346 PHLP1_HUMAN "PH domain leucine-rich repeat-containing protein phosphatase 1, EC 3.1.3.16 (Pleckstrin homology domain-containing family E member 1, PH domain-containing family E member 1) (Suprachiasmatic nucleus circadian oscillatory protein, hSCOP)" PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP Homo sapiens (Human) apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of T cell anergy [GO:0002667]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of T cell anergy [GO:0002667]; signal transduction [GO:0007165] GO:0002667; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0009649; GO:0017018; GO:0042981; GO:0043231; GO:0043408; GO:0046328; GO:0046872; GO:0051898; GO:1900744 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] IKQHKAIITEDGK 0.99388 -7.9776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6021 0 0 0 0 0 0 0 0 O60825 F262_HUMAN "6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2, 6PF-2-K/Fru-2,6-P2ase 2, PFK/FBPase 2 (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase, EC 2.7.1.105; Fructose-2,6-bisphosphatase, EC 3.1.3.46 ]" PFKFB2 Homo sapiens (Human) "fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of glucokinase activity [GO:0033133]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]" GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006007; GO:0006089; GO:0006096; GO:0009749; GO:0019901; GO:0032024; GO:0033133 "6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]" AQDMQEGAD 0.99388 -30.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.16972 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1976 0 0 0 0 0 0 0 0 10.442 0 0 0 0 0 0 0 0 12.0029 11.5078 0 0 0 0 0 0 0 11.6904 10.8674 0 15.5205 0 0 13.1501 0 0 0 12.375 0 14.5555 13.0741 11.9584 11.6708 0 0 0 0 0 0 0 0 13.4251 0 12.8109 13.1419 0 0 13.3595 0 0 10.7816 0 0 0 0 11.6256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2026 0 O95171 SCEL_HUMAN Sciellin SCEL Homo sapiens (Human) embryo development ending in birth or egg hatching [GO:0009792]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; response to mechanical stimulus [GO:0009612] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; embryo development ending in birth or egg hatching [GO:0009792]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; response to mechanical stimulus [GO:0009612] GO:0001533; GO:0005737; GO:0008544; GO:0009612; GO:0009792; GO:0030216; GO:0046872; GO:0048471; GO:0070062; GO:0090263 metal ion binding [GO:0046872] DMCTYCR 0.99388 -29.999 0 0 0 0 0 0 0 0 0 10.3633 0 0 0 0 0 0 0 0 12.6564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5197 0 0 0 0 0 0 0 0 0 0 0 0 13.6587 0 0 P11586 C1TC_HUMAN "C-1-tetrahydrofolate synthase, cytoplasmic, C1-THF synthase (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed ] [Includes: Methylenetetrahydrofolate dehydrogenase, EC 1.5.1.5; Methenyltetrahydrofolate cyclohydrolase, EC 3.5.4.9; Formyltetrahydrofolate synthetase, EC 6.3.4.3 ]" MTHFD1 MTHFC MTHFD Homo sapiens (Human) 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; heart development [GO:0007507]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; serine family amino acid biosynthetic process [GO:0009070]; serine family amino acid metabolic process [GO:0009069]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346] GO:0000105; GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0006730; GO:0007507; GO:0009069; GO:0009070; GO:0009086; GO:0009152; GO:0009257; GO:0016020; GO:0019346; GO:0035999; GO:0048702; GO:0048703; GO:0061053; GO:0070062 ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486] AKVLLSALERLK 0.99388 -30.158 12.7881 0 0 0 0 0 12.6019 0 0 12.2278 0 0 0 0 13.3723 13.6598 12.2913 13.0288 14.567 0 0 0 14.1168 0 0 13.8912 9.72395 13.28 0 13.8059 0 0 0 13.9243 13.4931 12.1674 0 0 12.9547 0 0 0 0 15.0527 13.688 0 0 13.7248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81141 0 0 0 12.368 0 0 0 13.2513 0 0 11.8471 0 0 0 0 14.2749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8284 0 0 14.4431 0 0 0 14.8634 0 0 13.2809 0 13.2124 0 13.5206 0 0 0 0 0 0 0 0 0 0 0 15.5576 0 0 0 15.5849 0 0 0 13.457 0 0 0 0 0 11.4676 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7028 0 0 13.7734 14.7974 12.6788 14.6164 0 0 13.9215 0 14.3628 0 0 13.6404 0 0 13.6409 0 0 0 13.1128 13.5022 0 15.0802 0 0 0 0 P55290 CAD13_HUMAN "Cadherin-13 (Heart cadherin, H-cadherin) (P105) (Truncated cadherin, T-cad, T-cadherin)" CDH13 CDHH Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; endothelial cell migration [GO:0043542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte proliferation [GO:0043616]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rac protein signal transduction [GO:0016601]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040] anchored component of membrane [GO:0031225]; catenin complex [GO:0016342]; caveola [GO:0005901]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; catenin complex [GO:0016342]; caveola [GO:0005901]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; adiponectin binding [GO:0055100]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; protein homodimerization activity [GO:0042803]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; endothelial cell migration [GO:0043542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte proliferation [GO:0043616]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rac protein signal transduction [GO:0016601]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; Rho protein signal transduction [GO:0007266]; sprouting angiogenesis [GO:0002040] GO:0001938; GO:0001954; GO:0002040; GO:0005509; GO:0005576; GO:0005615; GO:0005737; GO:0005886; GO:0005901; GO:0005925; GO:0007156; GO:0007162; GO:0007266; GO:0008285; GO:0009897; GO:0016339; GO:0016342; GO:0016601; GO:0030032; GO:0030100; GO:0030169; GO:0030335; GO:0031225; GO:0042058; GO:0042803; GO:0043005; GO:0043542; GO:0043616; GO:0045296; GO:0045944; GO:0048661; GO:0050850; GO:0050927; GO:0051668; GO:0055096; GO:0055100; GO:0062023; GO:0070062; GO:0071813; GO:0098742 adiponectin binding [GO:0055100]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; protein homodimerization activity [GO:0042803] ETLENPK 0.99388 -28.297 0 0 0 0 0 0 0 0 0 12.079 0 0 12.7875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3108 0 0 0 14.0914 0 0 0 0 0 13.2355 0 0 0 0 0 12.7649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2603 0 0 0 0 0 0 13.194 0 12.1474 0 0 12.3804 0 0 0 0 0 0 0 0 0 0 0 0 12.6407 0 11.7453 10.6763 0 0 0 11.2123 0 0 12.6461 0 0 0 0 0 0 0 0 0 0 0 0 12.1188 0 0 0 0 0 0 0 0 13.4177 0 0 12.9401 12.785 0 0 0 0 12.005 0 Q66K89 E4F1_HUMAN "Transcription factor E4F1, EC 2.3.2.27 (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (p120E4F) (p50E4F)" E4F1 E4F Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transferase activity [GO:0016740]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle, embryonic [GO:0009794]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000978; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0005737; GO:0005819; GO:0006260; GO:0006357; GO:0007049; GO:0009794; GO:0010564; GO:0016567; GO:0016740; GO:0035497; GO:0040008; GO:0045944; GO:0046872; GO:0051301; GO:0051726; GO:0061629 "cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transferase activity [GO:0016740]" AHMVTHSSR 0.99388 -15.848 0 0 0 0 0 0 0 0 10.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5745 0 12.0912 0 11.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9358 0 0 12.0628 0 0 0 0 0 11.407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5722 0 0 0 0 0 0 12.2801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.304 10.9546 0 12.6239 12.7172 0 0 0 0 0 0 0 0 0 0 0 0 13.1089 0 0 0 0 0 12.549 0 0 12.4321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZR52 ZN493_HUMAN Zinc finger protein 493 ZNF493 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEEYCKAYK 0.99388 -5.2893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7338 0 0 12.0563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9069 0 0 0 0 0 12.4383 0 0 0 0 0 0 0 0 0 12.094 0 0 0 0 0 0 0 0 9.87072 0 0 12.5748 0 0 0 0 0 0 0 0 12.4557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3453 0 0 Q8IWR0 Z3H7A_HUMAN Zinc finger CCCH domain-containing protein 7A ZC3H7A ZC3H7 ZC3HDC7 HSPC055 Homo sapiens (Human) miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608] GO:0003723; GO:0005634; GO:0010608; GO:0035196; GO:0035198; GO:0046872 metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] ARHSWTK 0.99388 -30.049 0 0 0 0 12.5658 0 0 13.7081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4402 0 0 0 0 0 0 0 11.9926 0 0 0 0 0 14.0016 0 0 0 0 0 0 0 0 0 13.769 13.0295 0 0 13.8994 13.6523 0 0 0 0 0 0 0 0 0 0 13.4851 13.5643 13.2323 0 0 0 12.9248 0 14.5007 13.8563 13.6224 0 0 13.6407 0 0 13.6711 14.1938 0 13.7867 14.1368 13.8981 0 0 0 0 13.7439 13.7531 0 0 14.7558 0 0 13.6713 13.9177 0 0 0 0 0 16.9956 0 0 0 0 14.2672 0 12.9102 13.8933 13.7268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5105 0 13.8266 Q8NEV8 EXPH5_HUMAN "Exophilin-5 (Synaptotagmin-like protein homolog lacking C2 domains b, SlaC2-b, Slp homolog lacking C2 domains b)" EXPH5 KIAA0624 SLAC2B Homo sapiens (Human) intracellular protein transport [GO:0006886]; keratinocyte development [GO:0003334]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714] endosome [GO:0005768] endosome [GO:0005768]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]; keratinocyte development [GO:0003334]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714] GO:0003334; GO:0005768; GO:0006886; GO:0031267; GO:0045921; GO:0050714; GO:0071985 small GTPase binding [GO:0031267] AGEIPQPVSQTGISNSLPDFQNPLSQDSAK 0.99388 -37.295 0 0 0 0 0 0 0 0 12.9376 0 0 0 0 13.364 0 0 0 0 0 0 0 0 12.7576 0 0 0 0 0 0 0 0 0 0 0 13.6133 0 0 0 13.699 0 12.6034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3497 0 0 0 0 0 0 11.2631 13.2623 0 0 18.6623 0 0 0 0 0 0 0 0 15.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0406 16.5115 0 0 0 13.8308 0 0 0 0 15.1198 0 0 0 0 0 0 15.6766 14.0779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6391 19.0506 0 0 0 0 0 0 0 12.9738 0 0 0 0 13.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6865 0 0 0 0 14.66 0 12.9426 0 0 0 0 0 0 0 12.837 Q8TDX9 PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 (PC1-like 1 protein) (Polycystin-1L1) PKD1L1 UNQ5785/PRO19563 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986] calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730] calcium channel complex [GO:0034704]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; membrane [GO:0016020]; non-motile cilium [GO:0097730]; calcium channel activity [GO:0005262]; cell-cell adhesion [GO:0098609]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; left/right axis specification [GO:0070986] GO:0003127; GO:0005262; GO:0005929; GO:0016020; GO:0034704; GO:0050982; GO:0060170; GO:0070986; GO:0097730; GO:0098609 calcium channel activity [GO:0005262] ARWLRGILLFLFTLK 0.99388 -30.18 0 0 0 0 0 0 0 10.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0784 12.1621 0 0 11.5074 0 0 0 0 0 0 0 13.3966 0 0 0 0 0 13.2451 0 0 0 0 19.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4767 14.2359 0 0 13.2549 13.3076 13.6531 11.3947 0 0 13.181 0 11.724 0 0 16.1296 0 0 0 11.5652 14.7846 0 0 0 13.5636 0 11.7163 0 0 10.9833 0 0 11.5981 0 0 12.6291 0 0 0 0 0 0 0 0 0 0 12.5074 17.6193 0 0 0 0 0 0 12.4838 0 0 0 0 0 13.4997 13.5528 0 0 0 13.3659 13.074 0 0 0 0 0 0 13.3554 0 0 0 14.7708 0 10.2927 13.7646 0 0 0 13.6043 13.3291 0 0 11.0213 0 0 11.8835 10.8135 0 11.2089 0 11.5109 0 0 0 0 0 0 12.0928 0 0 0 0 0 12.3609 Q8TEP8 CE192_HUMAN "Centrosomal protein of 192 kDa, Cep192, Cep192/SPD-2" CEP192 KIAA1569 PP8407 Homo sapiens (Human) centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617] GO:0000242; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0009617; GO:0019901; GO:0019902; GO:0071539; GO:0090222; GO:0090307; GO:0120098; GO:0120099 phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901] AIIRPHATEEIKVLFIPSSPGVFR 0.99388 -30.212 10.399 0 0 0 0 0 0 0 0 10.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2462 0 0 0 10.9206 0 0 0 14.0547 0 0 0 0 0 0 13.6792 0 0 13.1227 0 0 14.0008 0 0 14.5927 0 0 0 11.5254 0 0 0 0 0 0 0 0 12.8193 0 0 0 0 0 0 0 0 0 0 11.216 0 0 14.764 0 0 13.0663 0 0 0 0 0 0 0 0 0 0 0 11.7719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7821 0 0 0 0 0 0 10.617 0 0 0 0 0 0 0 0 0 0 11.9981 0 10.8159 Q8WV41 SNX33_HUMAN Sorting nexin-33 (SH3 and PX domain-containing protein 3) SNX33 SH3PX3 SH3PXD3C SNX30 Homo sapiens (Human) cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038] GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0019898; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010 identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091] HFDWLYNRLLHK 0.99388 -7.9785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6202 0 0 0 0 0 0 0 0 0 0 12.6206 0 14.4192 13.9605 11.8801 12.2437 0 0 14.1615 0 14.3439 0 0 14.2089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0331 0 0 0 0 0 0 0 0 0 0 13.6256 0 0 0 14.6732 0 0 0 0 0 0 0 11.0288 0 0 0 0 11.5458 0 0 0 0 0 0 0 0 0 0 0 Q8WVD3 RN138_HUMAN "E3 ubiquitin-protein ligase RNF138, EC 2.3.2.27 (Nemo-like kinase-associated RING finger protein, NLK-associated RING finger protein, hNARF) (RING finger protein 138) (RING-type E3 ubiquitin transferase RNF138)" RNF138 NARF HSD-4 HSD4 Homo sapiens (Human) DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via homologous recombination [GO:0000724]; protein ubiquitination [GO:0016567]; Wnt signaling pathway [GO:0016055] nucleus [GO:0005634]; site of double-strand break [GO:0035861] nucleus [GO:0005634]; site of double-strand break [GO:0035861]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; double-strand break repair via homologous recombination [GO:0000724]; protein ubiquitination [GO:0016567]; Wnt signaling pathway [GO:0016055] GO:0000724; GO:0003697; GO:0005634; GO:0010792; GO:0016055; GO:0016567; GO:0019901; GO:0035861; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630] CCAKQIK 0.99388 -9.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9405 0 0 0 0 0 0 0 0 0 0 0 0 12.4846 0 0 0 0 0 14.0632 0 0 0 0 0 0 11.5907 12.438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3215 0 0 0 0 0 0 0 0 11.8299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9457 0 0 0 0 0 Q8WXG9 AGRV1_HUMAN "Adhesion G-protein coupled receptor V1, ADGRV1, EC 3.4.-.- (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1) [Cleaved into: ADGRV1 subunit alpha; ADGRV1 subunit beta ]" ADGRV1 GPR98 KIAA0686 KIAA1943 MASS1 VLGR1 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; periciliary membrane compartment [GO:1990075]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171]; synapse [GO:0045202]; USH2 complex [GO:1990696]; adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of protein localization [GO:0045184]; G protein-coupled receptor signaling pathway [GO:0007186]; inner ear development [GO:0048839]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; maintenance of animal organ identity [GO:0048496]; negative regulation of adenylate cyclase activity [GO:0007194]; nervous system development [GO:0007399]; nervous system process [GO:0050877]; photoreceptor cell maintenance [GO:0045494]; positive regulation of bone mineralization [GO:0030501]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] GO:0001917; GO:0001965; GO:0002141; GO:0002142; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0007166; GO:0007186; GO:0007194; GO:0007399; GO:0007601; GO:0007605; GO:0009986; GO:0010739; GO:0010855; GO:0016020; GO:0016021; GO:0016787; GO:0030501; GO:0031647; GO:0032420; GO:0043235; GO:0045184; GO:0045202; GO:0045494; GO:0048496; GO:0048839; GO:0050877; GO:0050910; GO:0050953; GO:0060113; GO:0060122; GO:0060171; GO:0070062; GO:0071277; GO:0090037; GO:0097264; GO:0098609; GO:1990075; GO:1990696 adenylate cyclase inhibitor activity [GO:0010855]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787] ASGEVGIAPSSR 0.99388 -28.295 0 0 0 0 0 0 0 0 0 0 0 12.5118 0 13.1627 12.2511 13.452 11.7126 12.9286 0 11.4847 15.2743 0 13.3783 0 14.4496 11.1134 12.9863 0 0 0 0 0 0 11.9806 0 0 0 0 0 12.6706 0 0 0 12.6277 0 0 0 10.3386 0 11.2679 0 12.2357 0 13.5349 14.5245 0 12.3761 0 0 0 0 0 0 0 0 0 0 15.085 0 11.077 0 0 10.932 0 0 0 0 0 0 13.161 0 0 0 0 15.0096 0 11.7659 12.1808 0 0 12.8753 0 0 0 0 11.326 12.4842 0 15.2897 0 0 14.004 0 0 13.5254 0 0 16.4473 0 0 0 12.6608 0 0 16.2265 0 0 0 0 15.8796 15.4787 0 15.629 13.8558 0 12.8586 12.6207 11.7615 0 17.3811 0 14.9975 14.7999 0 11.5819 0 0 12.82 0 0 11.8787 0 0 14.6048 13.0956 0 0 0 0 12.597 0 0 13.3168 0 0 0 12.4458 13.0045 0 13.0017 12.6153 0 14.6973 13.2925 0 13.5369 15.3197 15.0867 12.9474 13.0935 0 0 0 13.5839 0 15.4578 0 0 0 0 Q92900 RENT1_HUMAN "Regulator of nonsense transcripts 1, EC 3.6.4.12, EC 3.6.4.13 (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1, NORF1) (Up-frameshift suppressor 1 homolog, hUpf1)" UPF1 KIAA0221 RENT1 Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]" GO:0000184; GO:0000294; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0032508; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270] AAKAGLSQSLFERLVVLGIR 0.99388 -15.833 18.4121 19.402 13.1307 0 18.2319 0 16.7425 15.748 0 0 0 0 0 0 16.5691 15.1127 15.2082 0 0 0 0 19.0495 0 12.9973 0 0 0 0 0 0 0 0 15.2161 0 0 0 0 0 0 16.3836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3414 0 0 0 0 0 0 0 0 18.6033 18.6714 12.9765 10.1476 18.8373 0 13.4031 19.3934 12.6093 19.577 19.6929 19.7711 13.4644 19.9478 0 17.3175 0 0 0 0 0 18.0716 16.1036 18.222 14.8182 15.2143 15.774 14.5883 19.634 19.7312 18.0992 13.6536 14.9194 20.2075 13.7616 20.1122 20.3243 20.289 13.7262 20.0338 19.9679 15.0157 19.8853 12.5652 19.8052 19.5504 15.975 14.0814 19.7172 10.7142 19.5983 19.6086 19.5795 0 19.5153 19.6155 19.5045 19.4398 19.4422 0 19.3962 0 19.3802 19.2883 19.3293 15.4231 19.2585 19.3314 0 0 0 19.2036 0 19.144 19.0154 0 18.7823 18.7272 12.6563 18.6892 18.723 0 18.7293 0 18.6882 18.6633 0 19.1023 18.6491 18.5076 13.648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5927 0 0 0 0 0 0 Q9BT25 HAUS8_HUMAN HAUS augmin-like complex subunit 8 (HEC1/NDC80-interacting centrosome-associated protein 1) (Sarcoma antigen NY-SAR-48) HAUS8 HICE1 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225] GO:0000922; GO:0005737; GO:0005813; GO:0005829; GO:0005880; GO:0007098; GO:0008017; GO:0051225; GO:0051301; GO:0070652; GO:1990498 microtubule binding [GO:0008017] EQYRTFATALDTTR 0.99388 -28.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1996 0 0 0 0 0 0 0 12.9506 0 0 13.5022 14.7047 0 0 0 17.8323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.557 0 0 0 13.4922 13.1138 0 0 13.3807 0 12.926 0 0 0 0 12.468 0 0 0 0 0 0 0 0 0 12.8544 0 11.1233 13.5777 14.0698 0 0 14.6909 0 0 0 0 14.8587 0 0 0 14.6765 0 0 0 13.9721 0 0 0 0 11.8901 0 0 0 0 0 0 0 0 0 13.5844 13.544 0 13.3962 0 0 14.6122 12.8348 0 14.7329 0 0 11.7036 0 11.4878 Q9H361 PABP3_HUMAN "Polyadenylate-binding protein 3, PABP-3, Poly(A)-binding protein 3 (Testis-specific poly(A)-binding protein)" PABPC3 PABP3 PABPL3 Homo sapiens (Human) mRNA metabolic process [GO:0016071] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071] GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:0016071; GO:0070062; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] AVDEMNGK 0.99388 -28.371 0 0 0 0 0 0 0 0 13.6436 15.3218 14.7391 14.1856 13.5993 0 14.2575 12.8158 14.1608 0 0 0 14.4679 0 0 0 0 0 0 12.5052 0 13.7983 13.758 14.3936 16.1309 14.3869 14.7394 13.6559 15.6459 14.3858 14.322 15.1905 12.8075 12.9159 14.3019 0 12.5658 14.1908 12.6152 14.395 13.664 13.5707 14.3437 12.0731 13.2858 12.0545 13.8083 13.5483 13.9684 0 11.6422 0 10.8355 0 0 10.186 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7469 12.8634 13.0944 11.8721 0 0 0 0 0 0 0 0 0 0 10.8308 0 0 0 0 0 0 0 12.0288 0 0 11.5887 0 0 0 0 12.8585 0 0 0 14.5567 0 0 0 0 0 0 13.6467 0 0 0 0 0 0 0 0 0 13.3997 0 0 11.6179 0 0 0 12.7484 0 0 13.5994 0 0 0 0 0 0 0 0 12.5981 0 0 0 0 0 12.4152 0 0 0 16.1378 15.5562 15.1144 15.1841 15.7854 15.2324 0 0 13.9336 0 0 14.0345 15.1948 0 0 0 0 14.6778 14.0675 0 15.4195 0 0 Q9HCD5 NCOA5_HUMAN "Nuclear receptor coactivator 5, NCoA-5 (Coactivator independent of AF-2, CIA)" NCOA5 KIAA1637 Homo sapiens (Human) glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966] actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966] GO:0000122; GO:0003682; GO:0003714; GO:0003723; GO:0005615; GO:0005654; GO:0008286; GO:0009966; GO:0015629; GO:0042593; GO:0046627 chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] DQRDPMYDR 0.99388 -37.281 0 0 0 0 0 0 0 0 0 0 0 11.1135 10.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5936 0 0 0 0 0 0 0 0 0 0 10.8061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6101 0 0 0 12.6852 0 0 0 0 11.1058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7747 0 11.3154 0 0 0 0 0 0 0 0 0 0 0 11.7154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHD1 CHRD1_HUMAN "Cysteine and histidine-rich domain-containing protein 1 (CHORD domain-containing protein 1, CHORD-containing protein 1, CHP-1) (Protein morgana)" CHORDC1 CHP1 Homo sapiens (Human) centrosome duplication [GO:0051298]; chaperone-mediated protein folding [GO:0061077]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824] ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; zinc ion binding [GO:0008270]; centrosome duplication [GO:0051298]; chaperone-mediated protein folding [GO:0061077]; negative regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000299]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824] GO:0005524; GO:0008270; GO:0010824; GO:0043531; GO:0051298; GO:0051879; GO:0061077; GO:1900034; GO:2000299 ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; zinc ion binding [GO:0008270] ALLCYNR 0.99388 -12.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5987 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0038 0 13.395 0 12.8063 0 0 0 0 0 0 13.2808 0 0 0 0 13.8668 0 16.2855 0 14.9686 0 0 0 0 0 0 14.3701 15.6477 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8833 11.8693 11.6216 0 0 0 0 0 0 0 14.5414 0 0 0 0 0 0 0 0 0 0 0 13.9752 0 0 14.6306 13.6612 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0718 0 13.2427 0 0 0 0 O14813 PHX2A_HUMAN Paired mesoderm homeobox protein 2A (ARIX1 homeodomain protein) (Aristaless homeobox protein homolog) (Paired-like homeobox 2A) PHOX2A ARIX PMX2A Homo sapiens (Human) dopaminergic neuron differentiation [GO:0071542]; enteric nervous system development [GO:0048484]; locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; noradrenergic neuron differentiation [GO:0003357]; oculomotor nerve formation [GO:0021623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic motor neuron differentiation [GO:0021523]; sympathetic nervous system development [GO:0048485]; trochlear nerve formation [GO:0021642] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; dopaminergic neuron differentiation [GO:0071542]; enteric nervous system development [GO:0048484]; locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; noradrenergic neuron differentiation [GO:0003357]; oculomotor nerve formation [GO:0021623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic motor neuron differentiation [GO:0021523]; sympathetic nervous system development [GO:0048485]; trochlear nerve formation [GO:0021642]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0003357; GO:0003700; GO:0005634; GO:0006357; GO:0021523; GO:0021623; GO:0021642; GO:0021703; GO:0030901; GO:0043576; GO:0045944; GO:0048484; GO:0048485; GO:0071542; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" CSSEDDDSK 0.99389 -5.5079 0 0 0 0 0 0 0 9.45791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9134 0 0 0 0 0 0 0 0 0 0 0 0 10.6347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1232 0 0 0 0 0 O43181 NDUS4_HUMAN "NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa, CI-18 kDa) (Complex I-AQDQ, CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)" NDUFS4 Homo sapiens (Human) "aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]" GO:0001932; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0007420; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0045333; GO:0048146; GO:0051591; GO:0072593 NADH dehydrogenase (ubiquinone) activity [GO:0008137] AVAVAALSVSRVPTR 0.99389 -14.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4035 0 14.2145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.431 0 0 0 0 0 10.3441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1792 0 0 18.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7765 0 0 0 0 0 P00734 THRB_HUMAN "Prothrombin, EC 3.4.21.5 (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain ]" F2 Homo sapiens (Human) "acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of lipid kinase activity [GO:0090218]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611]; zymogen activation [GO:0031638]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053]; acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of lipid kinase activity [GO:0090218]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611]; zymogen activation [GO:0031638]" GO:0001530; GO:0001934; GO:0004252; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0006953; GO:0007166; GO:0007596; GO:0008083; GO:0008201; GO:0008284; GO:0008360; GO:0009611; GO:0010544; GO:0014068; GO:0016020; GO:0030168; GO:0030193; GO:0030194; GO:0030195; GO:0030307; GO:0031638; GO:0032967; GO:0042730; GO:0045861; GO:0046427; GO:0048712; GO:0051281; GO:0051480; GO:0051838; GO:0051918; GO:0061844; GO:0062023; GO:0070053; GO:0070062; GO:0070945; GO:0072377; GO:0072562; GO:0090218; GO:1900016; GO:1900182; GO:1900738; GO:1905370; GO:2000379 calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053] DIALMKLK 0.99389 -8.7419 0 0 0 0 0 0 0 0 0 0 0 17.9771 0 0 17.9524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.505 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3877 0 19.4905 0 0 0 19.4825 0 0 0 0 0 0 0 19.5142 0 0 0 0 0 0 0 13.8157 0 19.6447 18.1479 P03971 MIS_HUMAN "Muellerian-inhibiting factor (Anti-Muellerian hormone, AMH) (Muellerian-inhibiting substance, MIS)" AMH MIF Homo sapiens (Human) aging [GO:0007568]; cell-cell signaling [GO:0007267]; gonadal mesoderm development [GO:0007506]; Leydig cell differentiation [GO:0033327]; Mullerian duct regression [GO:0001880]; negative regulation of ovarian follicle development [GO:2000355]; ovarian follicle development [GO:0001541]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; preantral ovarian follicle growth [GO:0001546]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; urogenital system development [GO:0001655] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type II transforming growth factor beta receptor binding [GO:0005114]; aging [GO:0007568]; cell-cell signaling [GO:0007267]; gonadal mesoderm development [GO:0007506]; Leydig cell differentiation [GO:0033327]; Mullerian duct regression [GO:0001880]; negative regulation of ovarian follicle development [GO:2000355]; ovarian follicle development [GO:0001541]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; preantral ovarian follicle growth [GO:0001546]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; urogenital system development [GO:0001655] GO:0001541; GO:0001546; GO:0001655; GO:0001880; GO:0005102; GO:0005114; GO:0005179; GO:0005576; GO:0005615; GO:0007267; GO:0007506; GO:0007530; GO:0007548; GO:0007568; GO:0008083; GO:0009410; GO:0010628; GO:0014070; GO:0033327; GO:0051092; GO:0060389; GO:2000355 growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type II transforming growth factor beta receptor binding [GO:0005114] ALLLLKALQGLR 0.99389 -10.753 0 0 0 0 11.5388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6369 0 0 0 0 0 0 0 0 0 0 12.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2862 14.5429 0 0 0 14.0627 0 0 0 0 16.0455 0 11.4044 13.3998 0 0 0 0 0 0 0 0 15.6379 15.039 0 0 0 0 0 0 15.5712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4451 0 0 0 0 13.5335 0 0 0 0 0 12.8213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1605 0 11.8184 12.8945 0 0 0 0 0 0 15.8746 0 0 0 0 0 0 0 13.1899 0 P07203 GPX1_HUMAN "Glutathione peroxidase 1, GPx-1, GSHPx-1, EC 1.11.1.9 (Cellular glutathione peroxidase)" GPX1 Homo sapiens (Human) "aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; protein oxidation [GO:0018158]; regulation of gene expression, epigenetic [GO:0040029]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311]" GO:0001659; GO:0001885; GO:0002862; GO:0004601; GO:0004602; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006641; GO:0006749; GO:0007568; GO:0007605; GO:0008631; GO:0009410; GO:0009609; GO:0009650; GO:0009725; GO:0010269; GO:0010332; GO:0017124; GO:0018158; GO:0019369; GO:0019372; GO:0032355; GO:0033194; GO:0033599; GO:0034599; GO:0035094; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043154; GO:0043403; GO:0043534; GO:0045444; GO:0045445; GO:0045454; GO:0047066; GO:0048144; GO:0048741; GO:0051402; GO:0051450; GO:0051593; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0071333; GO:0090201; GO:1902042; GO:1902176; GO:1902905 glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124] LITWSPVCR 0.99389 -5.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5888 0 15.4275 14.9027 0 0 0 0 0 14.5275 12.6664 0 0 15.6681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1453 13.7125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P13569 CFTR_HUMAN "Cystic fibrosis transmembrane conductance regulator, CFTR (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase, EC 5.6.1.6) (cAMP-dependent chloride channel)" CFTR ABCC7 Homo sapiens (Human) amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138]; amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904] GO:0005254; GO:0005260; GO:0005524; GO:0005634; GO:0005737; GO:0005765; GO:0005769; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006695; GO:0006904; GO:0009986; GO:0010008; GO:0015106; GO:0015108; GO:0015701; GO:0016020; GO:0016021; GO:0016324; GO:0016853; GO:0016887; GO:0017081; GO:0019869; GO:0019899; GO:0030165; GO:0030301; GO:0030660; GO:0030669; GO:0031901; GO:0032991; GO:0034707; GO:0034976; GO:0035377; GO:0035774; GO:0042626; GO:0043225; GO:0045921; GO:0048240; GO:0050891; GO:0051087; GO:0051454; GO:0051649; GO:0055037; GO:0055038; GO:0055085; GO:0060081; GO:0070175; GO:0071320; GO:0097186; GO:0106138; GO:0140359; GO:1902161; GO:1902476; GO:1902943; GO:1904322 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chaperone binding [GO:0051087]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; Sec61 translocon complex binding [GO:0106138] AKQNNNNR 0.99389 -8.0186 0 0 0 0 0 0 13.6917 15.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3594 0 0 0 0 0 0 0 0 0 0 0 0 13.0246 0 12.5404 0 0 0 0 0 0 0 10.9543 11.9481 0 0 10.5428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5502 17.3711 0 0 18.2528 14.58 0 0 0 0 0 0 0 12.7751 0 0 0 0 13.0482 0 13.4392 0 0 0 14.3432 0 12.9347 0 0 13.5146 0 13.8295 13.2008 0 13.7245 0 15.3197 14.1161 13.6703 0 0 14.3211 0 0 0 15.1128 12.5257 0 14.4372 14.5749 0 14.4111 0 0 14.844 14.9098 0 14.8289 13.3122 17.6119 0 13.6418 16.8648 0 14.2093 13.4776 0 13.4592 14.7719 12.2006 0 0 12.2572 0 11.9597 0 0 0 13.2887 0 13.9172 0 13.1907 0 0 0 13.9122 0 0 0 0 0 0 0 0 0 0 0 0 13.2744 0 0 13.1501 0 0 0 13.8291 0 P62753 RS6_HUMAN 40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6) RPS6 OK/SW-cl.2 Homo sapiens (Human) activation-induced cell death of T cells [GO:0006924]; cytoplasmic translation [GO:0002181]; erythrocyte development [GO:0048821]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; glucose homeostasis [GO:0042593]; mammalian oogenesis stage [GO:0022605]; negative regulation of apoptotic process [GO:0043066]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; T cell differentiation in thymus [GO:0033077]; T cell proliferation involved in immune response [GO:0002309]; TOR signaling [GO:0031929]; translation [GO:0006412] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; activation-induced cell death of T cells [GO:0006924]; cytoplasmic translation [GO:0002181]; erythrocyte development [GO:0048821]; G1/S transition of mitotic cell cycle [GO:0000082]; gastrulation [GO:0007369]; glucose homeostasis [GO:0042593]; mammalian oogenesis stage [GO:0022605]; negative regulation of apoptotic process [GO:0043066]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; T cell differentiation in thymus [GO:0033077]; T cell proliferation involved in immune response [GO:0002309]; TOR signaling [GO:0031929]; translation [GO:0006412] GO:0000082; GO:0001890; GO:0002181; GO:0002309; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005844; GO:0006364; GO:0006412; GO:0006924; GO:0007369; GO:0008284; GO:0015935; GO:0016020; GO:0019901; GO:0022605; GO:0022626; GO:0022627; GO:0030425; GO:0031929; GO:0033077; GO:0036464; GO:0042274; GO:0042593; GO:0043065; GO:0043066; GO:0044297; GO:0048471; GO:0048821; GO:1990904 protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GHSCYRPRR 0.99389 -30.274 10.6013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9225 13.4463 0 0 0 11.0647 13.5121 0 0 13.423 0 0 0 14.9016 0 0 0 0 0 13.6705 0 0 13.2355 0 0 0 0 0 0 0 0 0 13.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2932 0 0 0 13.0657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q587J7 TDR12_HUMAN "Putative ATP-dependent RNA helicase TDRD12, EC 3.6.4.13 (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12)" TDRD12 ECAT8 Homo sapiens (Human) cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] PET complex [GO:1990923] PET complex [GO:1990923]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; fertilization [GO:0009566]; gene silencing by RNA [GO:0031047]; male meiotic nuclear division [GO:0007140]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283] GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0031047; GO:0034587; GO:0043046; GO:1990923 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724] GLQPPVVVLRNKIK 0.99389 -7.7987 0 0 0 0 0 0 0 11.3722 0 0 0 0 0 0 0 13.8608 0 0 0 0 16.3115 0 0 0 0 15.1878 0 0 11.1324 0 0 0 0 0 0 12.0213 0 0 0 0 0 0 0 0 0 10.7661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0678 0 0 0 0 0 13.9707 14.1677 0 15.1433 0 0 15.3149 0 0 13.4783 0 0 13.221 0 0 11.7232 12.4154 0 0 0 0 11.9283 15.4179 0 0 0 0 0 0 0 0 0 0 13.9298 14.7962 0 0 0 11.7712 0 0 0 0 0 0 0 14.5022 0 0 13.2247 0 0 0 11.8298 0 11.9477 0 0 0 0 0 14.9126 0 0 0 13.5175 13.7532 12.6416 0 11.3573 0 0 0 0 0 0 12.6441 0 0 12.6528 0 0 0 0 13.1071 0 0 0 0 0 0 0 0 0 0 0 0 11.4307 0 0 0 0 0 0 0 0 0 Q6W4X9 MUC6_HUMAN "Mucin-6, MUC-6 (Gastric mucin-6)" MUC6 Homo sapiens (Human) maintenance of gastrointestinal epithelium [GO:0030277] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; maintenance of gastrointestinal epithelium [GO:0030277] GO:0005201; GO:0005615; GO:0005796; GO:0005886; GO:0030277; GO:0031012 extracellular matrix structural constituent [GO:0005201] ATECHHSAVPVDGCNCPDGTYLNQKGECVR 0.99389 -30.444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2687 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7123 0 0 0 0 0 0 15.7096 16.3897 16.8188 0 0 15.8369 0 0 0 0 0 0 14.2653 0 0 0 0 13.2098 13.1055 0 0 0 0 0 0 0 13.0915 0 0 0 0 0 0 0 0 0 13.461 0 0 10.702 0 12.2717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3115 0 0 10.8854 0 0 0 0 0 0 0 Q6ZRI0 OTOG_HUMAN Otogelin OTOG OTGN Homo sapiens (Human) adult locomotory behavior [GO:0008344]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] apical plasma membrane [GO:0016324]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; alpha-L-arabinofuranosidase activity [GO:0046556]; structural molecule activity [GO:0005198]; adult locomotory behavior [GO:0008344]; L-arabinose metabolic process [GO:0046373]; sensory perception of sound [GO:0007605] GO:0005198; GO:0005615; GO:0007605; GO:0008344; GO:0016324; GO:0031012; GO:0046373; GO:0046556 alpha-L-arabinofuranosidase activity [GO:0046556]; structural molecule activity [GO:0005198] ACAQAGR 0.99389 -8.0231 0 0 0 0 0 0 0 0 0 0 0 15.0349 14.6545 0 0 0 0 0 10.3431 9.47318 0 0 0 0 0 0 0 0 13.4642 11.9572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1471 14.4172 0 0 0 0 0 0 0 10.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9026 0 0 12.5419 0 0 0 0 0 13.5742 0 0 14.6212 0 0 0 0 13.4619 0 14.2013 0 0 0 0 0 0 0 15.8248 15.6958 13.3514 0 0 0 0 0 0 0 12.6191 0 14.4967 0 0 0 0 0 0 13.7447 11.5448 12.692 0 0 0 13.4269 0 13.6299 12.1245 0 0 0 0 0 0 0 13.8034 0 0 0 0 0 0 13.4887 16.0352 0 0 0 0 0 0 0 0 0 0 14.1359 12.6969 14.1411 0 13.6516 0 0 14.8526 13.2989 11.5296 0 0 0 0 0 0 0 15.3601 0 15.4293 10.3708 15.6976 Q8TF40 FNIP1_HUMAN Folliculin-interacting protein 1 FNIP1 KIAA1961 Homo sapiens (Human) B cell apoptotic process [GO:0001783]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; B cell apoptotic process [GO:0001783]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929] GO:0000122; GO:0001783; GO:0001932; GO:0001934; GO:0002327; GO:0002904; GO:0005085; GO:0005737; GO:0005765; GO:0005829; GO:0008285; GO:0009267; GO:0019899; GO:0031334; GO:0031929; GO:0032007; GO:0032008; GO:0033138; GO:0042030; GO:0043154; GO:0051087; GO:2000973 ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085] DPDCGFSWPLPEFDPSQIR 0.99389 -8.0216 0 0 0 0 0 11.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5582 0 0 0 0 12.8344 12.7223 0 0 0 0 0 0 13.5826 13.5043 13.587 13.6072 0 0 0 0 0 0 0 13.163 14.1139 0 0 13.7849 14.6199 14.9581 0 0 0 0 0 0 14.4928 0 0 0 14.5155 14.9972 0 0 0 10.4996 0 0 0 0 0 0 0 0 0 0 0 13.2559 0 0 0 13.4529 0 0 0 0 13.7084 0 0 0 0 0 0 0 0 0 12.9944 0 0 0 0 0 0 0 0 0 0 12.9277 0 13.8685 0 Q92626 PXDN_HUMAN "Peroxidasin homolog, EC 1.11.2.- (Melanoma-associated antigen MG50) (Peroxidasin 1, hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment ]" PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1 Homo sapiens (Human) angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979] basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] "basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]; angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979]" GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711 "extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]" EIQPGAFRRLR 0.99389 -8.7505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6408 0 0 0 0 0 0 11.4671 0 0 0 0 0 0 11.5445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5518 0 0 13.397 13.3987 0 0 0 0 13.1323 0 0 0 0 0 0 0 12.2554 0 0 13.7715 0 0 0 15.1027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5423 12.5468 0 0 0 12.2537 14.5761 0 0 0 0 0 0 0 13.4404 0 12.6273 0 13.7304 14.2491 0 0 0 0 16.5232 0 0 12.9504 14.8977 0 14.0516 14.5362 0 14.1516 0 0 0 0 0 0 0 12.6856 0 0 0 0 0 0 0 11.6534 0 0 0 0 0 0 0 0 0 0 0 15.2308 14.0688 0 0 0 0 Q96PV7 F193B_HUMAN Protein FAM193B FAM193B IRIZIO KIAA1931 Homo sapiens (Human) cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0016607 ASFSVCELSMDSNGFSK 0.99389 -7.8013 0 0 0 0 0 0 0 0 11.5493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8571 0 0 10.7151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6426 0 16.2186 0 12.4767 0 0 12.6922 0 0 0 13.5994 0 0 15.7818 11.6808 0 0 12.773 0 13.1774 0 14.4209 0 12.9281 16.4072 0 13.0223 0 0 0 0 13.3126 0 13.0736 0 12.2572 0 0 0 0 12.7113 0 13.4756 14.5572 0 0 0 0 12.2455 0 0 13.2686 0 0 0 0 0 0 12.1693 0 0 0 0 0 0 0 0 12.5614 0 0 0 11.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4066 0 0 0 0 0 12.9178 0 0 0 0 0 0 12.3348 0 0 0 0 0 0 0 0 Q96QV6 H2A1A_HUMAN Histone H2A type 1-A (H2A-clustered histone 1) (Histone H2A/r) H2AC1 H2AFR HIST1H2AA Homo sapiens (Human) chromatin organization [GO:0006325] "chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; female germ cell nucleus [GO:0001674]; nucleosome [GO:0000786]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; female germ cell nucleus [GO:0001674]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; chromatin organization [GO:0006325]" GO:0000781; GO:0000786; GO:0001674; GO:0003677; GO:0005634; GO:0006325; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AGLQFPVGR 0.99389 -13.066 0 0 0 0 0 0 0 0 12.9542 0 0 0 0 13.0899 0 0 0 0 0 0 0 0 0 0 12.0503 0 0 0 0 0 0 12.5668 0 0 0 0 0 12.12 12.2649 0 0 0 0 0 0 0 0 0 12.8067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7639 0 0 0 0 13.2769 0 0 0 0 0 0 0 11.5389 10.9716 0 0 0 0 0 0 0 0 0 0 13.5875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2512 0 0 0 0 0 12.8774 0 0 0 0 0 0 0 0 0 0 0 0 10.7261 13.7497 0 Q9H8Y1 VRTN_HUMAN Vertnin VRTN C14orf115 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785] chromatin [GO:0000785]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000785; GO:0006357; GO:0043565 sequence-specific DNA binding [GO:0043565] FPGISRSTYYNWRR 0.99389 -14.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4638 0 0 0 0 0 10.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2013 14.0135 0 0 13.2408 0 0 0 0 0 0 0 0 0 0 14.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8915 0 0 15.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULG1 INO80_HUMAN "Chromatin-remodeling ATPase INO80, hINO80, EC 3.6.4.- (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80) (INO80 complex subunit A)" INO80 INO80A INOC1 KIAA1259 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]" cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] "cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]" GO:0000070; GO:0000723; GO:0000724; GO:0003677; GO:0003779; GO:0005524; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005874; GO:0006275; GO:0006281; GO:0006302; GO:0006338; GO:0006351; GO:0008094; GO:0010571; GO:0016604; GO:0016887; GO:0030307; GO:0031011; GO:0033044; GO:0034644; GO:0042393; GO:0043014; GO:0043618; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051225; GO:0051301; GO:0051726; GO:0060382; GO:0070914; GO:0071479; GO:0140658; GO:1904507; GO:2000045 "actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]" AAALRAANK 0.99389 -30.433 0 0 13.7545 0 0 0 0 0 0 0 12.0392 0 0 0 0 0 11.67 0 0 10.8991 11.5998 0 0 0 0 12.7835 0 11.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3411 11.8916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0199 0 11.0597 13.764 13.2624 0 16.4735 0 12.4791 11.5704 0 13.011 0 0 12.7996 17.1587 0 0 0 0 0 12.1594 0 0 0 0 11.4448 0 0 0 0 0 11.8311 0 12.459 0 0 0 0 0 0 0 0 0 0 0 0 13.4877 13.4521 0 11.9576 0 0 0 0 0 0 0 13.4171 0 0 0 12.4936 0 0 0 0 0 14.5428 13.739 0 11.9556 0 12.8979 0 0 0 0 0 0 0 0 0 16.328 16.229 0 0 0 0 11.8821 0 11.4322 13.4416 0 0 12.5942 0 0 0 0 0 0 0 0 0 12.0188 0 0 0 0 Q9Y2W2 WBP11_HUMAN "WW domain-binding protein 11, WBP-11 (Npw38-binding protein, NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1)" WBP11 NPWBP SIPP1 SNP70 Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; rRNA processing [GO:0006364]" cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699]; mRNA cis splicing, via spliceosome [GO:0045292]; rRNA processing [GO:0006364]" GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006364; GO:0043231; GO:0045292; GO:0050699 RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699] AVSILPLLGHGVPRLPPGR 0.99389 -6.9992 0 0 0 14.9191 0 14.2424 0 0 0 0 0 0 13.3219 13.2687 15.1549 0 0 0 12.6213 0 12.7588 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3008 0 0 0 0 0 12.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3879 13.9655 11.9341 0 0 13.5255 0 15.7544 13.9168 13.5655 11.8132 14.515 0 11.0469 0 0 15.1204 13.7463 0 14.8217 0 13.904 0 13.5376 15.0146 13.5595 15.4993 11.1975 0 0 0 14.9383 12.9903 13.0992 13.2778 13.4553 0 12.7702 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6976 13.0867 14.7241 0 0 14.5658 0 0 12.5817 0 15.6223 0 14.1624 11.5272 0 14.7661 11.3899 0 0 0 0 12.3734 0 0 0 0 12.7576 0 0 16.4626 0 0 0 0 0 11.561 13.3997 0 0 14.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDI7 TMC2_HUMAN Transmembrane channel-like protein 2 (Transmembrane cochlear-expressed protein 2) TMC2 C20orf145 UNQ907/PRO1928 Homo sapiens (Human) detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005] integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426] integral component of plasma membrane [GO:0005887]; stereocilium tip [GO:0032426]; mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of calcium ion transmembrane transport [GO:1903169]; vestibular reflex [GO:0060005] GO:0005245; GO:0005887; GO:0008381; GO:0032426; GO:0050910; GO:0060005; GO:1903169 mechanosensitive ion channel activity [GO:0008381]; voltage-gated calcium channel activity [GO:0005245] AEEEKAMDFSVLWDFEGYIK 0.9939 -30.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4247 0 0 0 0 0 0 16.8113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6976 14.2208 12.9848 13.4105 15.0034 0 13.3429 18.7906 19.188 18.3913 18.445 0 18.6568 14.6339 0 15.4205 0 14.5486 13.8482 14.0998 0 13.0633 17.9726 14.2943 18.1082 14.4123 0 13.2425 13.601 14.0387 0 0 0 0 0 14.2738 13.8486 0 15.0841 0 0 0 14.4334 0 13.5799 13.1973 13.6505 13.2843 14.5974 13.6578 13.7612 13.5075 12.9611 12.9935 0 0 0 0 0 13.9828 13.4991 13.2836 0 13.3608 13.4316 14.3353 0 14.066 12.3047 13.0243 0 13.556 0 0 0 0 0 0 0 0 12.8185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3504 13.2932 13.6888 14.2847 0 0 0 0 13.8214 Q5VYS8 TUT7_HUMAN "Terminal uridylyltransferase 7, TUTase 7, EC 2.7.7.52 (Zinc finger CCHC domain-containing protein 6)" TUT7 HS2 KIAA1711 ZCCHC6 Homo sapiens (Human) "miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]" GO:0000289; GO:0001556; GO:0003723; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0016779; GO:0031054; GO:0031123; GO:0035198; GO:0050265; GO:0070569; GO:0071076; GO:1990074 miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; uridylyltransferase activity [GO:0070569]; zinc ion binding [GO:0008270] AFINGRRVFGIPVK 0.9939 -28.919 0 14.2865 0 0 0 11.8595 15.2438 11.9933 0 15.1691 0 0 14.0801 0 13.0994 0 0 15.6096 0 0 13.0371 11.4706 0 0 0 0 0 16.3709 15.0619 0 0 0 0 0 0 0 0 14.1244 0 0 0 0 0 0 0 13.6559 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8535 0 0 14.1531 15.3971 0 0 17.8662 18.3405 16.2846 14.6677 16.0741 16.657 14.758 16.4587 14.5677 15.3491 0 17.7977 17.7033 15.2518 14.9836 14.7826 17.4177 0 18.3617 17.6599 0 13.8206 0 0 14.222 0 13.6832 14.4949 17.3982 0 15.3603 0 0 0 17.5162 15.4408 13.3058 0 0 13.9394 13.9865 15.1587 14.5667 0 0 11.6079 13.7201 17.0711 0 14.124 14.8396 14.5527 13.6032 16.1743 15.7458 13.7021 13.7146 14.6234 15.573 16.4343 13.526 14.6184 14.8007 13.4988 16.8533 0 17.4958 16.6658 13.2968 14.6632 15.2874 13.85 13.3254 14.4191 16.0023 13.6138 14.7754 13.3247 15.0194 15.0844 13.0674 12.1482 14.412 0 14.4099 11.2597 14.9069 15.5625 14.5571 0 0 0 0 13.5256 0 0 0 0 0 13.6832 14.9214 12.8086 0 0 0 0 14.5953 13.828 14.8504 0 0 0 14.9016 0 Q96KM6 Z512B_HUMAN Zinc finger protein 512B ZNF512B KIAA1196 Homo sapiens (Human) negative regulation of miRNA transcription [GO:1902894] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of miRNA transcription [GO:1902894]" GO:0000977; GO:0001227; GO:0005654; GO:0046872; GO:1902894 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AGHDYHVRSEHTAPPPEEPTDK 0.9939 -13.127 14.4659 14.1374 13.135 0 11.1097 0 0 0 0 12.4471 0 0 11.9065 0 13.5221 12.8728 0 0 13.0499 12.0918 11.618 0 0 0 0 13.7394 10.8022 13.6564 11.1324 11.7622 16.0775 14.2163 0 14.4374 12.9811 13.8827 13.6897 15.9034 0 15.7394 0 0 11.2144 0 0 0 11.7356 10.7856 0 0 16.2424 13.4148 14.6323 16.2342 16.1304 16.7566 16.2588 16.4499 16.4992 15.5057 16.6702 16.3413 15.7262 16.4474 15.525 15.8567 0 0 0 12.9715 0 0 0 0 0 0 14.3667 14.5829 10.9176 13.8897 14.9486 15.1206 14.6287 13.2477 0 13.7481 14.2133 13.495 13.4488 13.9163 14.0049 0 0 14.4757 0 0 13.7056 0 0 14.5491 0 0 0 0 0 13.6691 0 14.2427 0 0 0 15.8601 0 14.2567 0 0 0 13.2498 13.9169 14.0702 13.1237 0 13.825 0 0 0 14.5339 0 13.1008 12.9079 0 0 13.5798 0 0 14.0458 0 14.5693 11.7079 13.6892 0 14.4389 14.067 13.4253 12.6102 13.4528 0 15.6452 0 12.2405 13.5305 13.8364 15.2545 13.749 14.0216 0 12.0753 15.397 13.0992 15.9182 12.3531 14.6864 15.6783 13.5902 16.0399 13.1281 15.4073 14.4942 0 0 0 0 13.174 15.8777 0 15.8786 0 15.0398 0 0 O14933 UB2L6_HUMAN "Ubiquitin/ISG15-conjugating enzyme E2 L6, EC 2.3.2.23 (E2 ubiquitin-conjugating enzyme L6) (Retinoic acid-induced gene B protein, RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6)" UBE2L6 UBCH8 Homo sapiens (Human) ISG15-protein conjugation [GO:0032020]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ISG15 transferase activity [GO:0042296]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ISG15-protein conjugation [GO:0032020]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0031625; GO:0032020; GO:0036211; GO:0042296; GO:0043130; GO:0061631 ISG15 transferase activity [GO:0042296]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] KPPPYLR 0.9939 -6.5512 0 0 0 0 0 0 0 0 0 15.0298 14.8833 15.3956 0 0 0 17.8312 0 0 0 0 0 0 0 0 15.223 0 0 0 0 0 16.8216 16.3399 16.6128 14.381 0 0 0 0 0 0 16.3519 16.2178 16.5601 0 16.6626 17.4138 0 0 14.4216 0 0 0 0 0 17.4414 0 18.19 18.365 15.3318 0 0 0 17.2674 16.2318 15.2451 15.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8396 0 0 13.6417 0 0 19.3904 0 0 0 0 0 0 0 0 0 0 0 0 0 20.5646 0 0 0 0 0 13.7723 0 0 O95153 RIMB1_HUMAN "Peripheral-type benzodiazepine receptor-associated protein 1, PRAX-1 (Peripheral benzodiazepine receptor-interacting protein, PBR-IP) (RIMS-binding protein 1, RIM-BP1) (TSPO-associated protein 1)" TSPOAP1 BZRAP1 KIAA0612 RBP1 RIMBP1 Homo sapiens (Human) calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739] calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] GO:0005737; GO:0005739; GO:0005829; GO:0030156; GO:0044305; GO:0098978; GO:0099626 benzodiazepine receptor binding [GO:0030156]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626] EQLTTLPR 0.9939 -8.758 0 0 0 0 0 0 0 0 0 0 13.1781 0 0 0 0 0 0 0 0 12.6678 12.3625 0 0 0 0 0 15.1148 0 0 13.6101 12.9343 0 0 0 0 0 0 0 0 0 0 0 13.0169 0 0 12.7119 0 11.8641 0 12.9201 12.8841 0 12.7075 0 12.0592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2985 12.4062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6395 14.0932 0 0 14.7727 0 0 0 0 0 0 15.0856 0 0 13.0163 0 0 0 0 0 0 14.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 13.42 0 0 0 0 0 0 0 13.5837 0 13.1717 0 0 14.1713 0 0 0 0 0 0 0 0 0 0 0 0 O95999 BCL10_HUMAN "B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10, Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein, hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER) (Cellular homolog of vCARMEN, cCARMEN) (Cellular-E10, c-E10) (Mammalian CARD-containing adapter molecule E10, mE10)" BCL10 CIPER CLAP Homo sapiens (Human) "adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; B cell apoptotic process [GO:0001783]; cell death [GO:0008219]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of mature B cell apoptotic process [GO:0002906]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; response to food [GO:0032094]; T cell apoptotic process [GO:0070231]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]" CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991] "CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; B cell apoptotic process [GO:0001783]; cell death [GO:0008219]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of mature B cell apoptotic process [GO:0002906]; neural tube closure [GO:0001843]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of kinase activity [GO:0033674]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; response to food [GO:0032094]; T cell apoptotic process [GO:0070231]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]" GO:0001772; GO:0001783; GO:0001843; GO:0002020; GO:0002096; GO:0002224; GO:0002250; GO:0002906; GO:0003713; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0005881; GO:0006968; GO:0007249; GO:0008022; GO:0008219; GO:0016064; GO:0019899; GO:0019900; GO:0019901; GO:0031398; GO:0031625; GO:0031663; GO:0032094; GO:0032449; GO:0032755; GO:0032757; GO:0032761; GO:0032765; GO:0032991; GO:0033674; GO:0042327; GO:0042802; GO:0043065; GO:0043123; GO:0043280; GO:0043422; GO:0043621; GO:0044877; GO:0045087; GO:0045121; GO:0045893; GO:0048471; GO:0050700; GO:0050852; GO:0050862; GO:0050870; GO:0051059; GO:0051092; GO:0051260; GO:0061760; GO:0070231; GO:0071222; GO:0071260; GO:0140296; GO:2001238 CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625] KILSREDTEEISCR 0.9939 -8.0553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 12.4963 0 0 0 0 0 0 0 0 0 0 15.5129 0 0 0 14.7696 12.9774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7255 0 12.7763 12.9069 0 0 0 12.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25445 TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95) FAS APT1 FAS1 TNFRSF6 Homo sapiens (Human) activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; Fas signaling pathway [GO:0036337]; immune response [GO:0006955]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of protein phosphorylation [GO:0001934]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165] CD95 death-inducing signaling complex [GO:0031265]; cell surface [GO:0009986]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; nuclear body [GO:0016604]; plasma membrane [GO:0005886] CD95 death-inducing signaling complex [GO:0031265]; cell surface [GO:0009986]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; Fas signaling pathway [GO:0036337]; immune response [GO:0006955]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of protein phosphorylation [GO:0001934]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165] GO:0001934; GO:0005031; GO:0005516; GO:0005829; GO:0005886; GO:0006915; GO:0006924; GO:0006955; GO:0007165; GO:0009897; GO:0009986; GO:0016021; GO:0016604; GO:0019900; GO:0031264; GO:0031265; GO:0032872; GO:0034198; GO:0036337; GO:0038023; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0045121; GO:0065003; GO:0070062; GO:0071260; GO:0071455; GO:0097049; GO:0097191; GO:0097192; GO:0097527; GO:2001235; GO:2001269 calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031] CRLCDEGHGLEVEINCTR 0.9939 -8.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2904 0 0 0 15.4909 12.6371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2724 14.1443 0 15.5407 14.6526 0 14.4431 14.5608 14.1744 0 14.182 0 13.6202 14.2803 13.6938 0 0 13.6563 12.9495 0 0 0 13.2041 0 0 13.8179 12.7527 0 13.9432 12.041 13.9002 13.4451 0 0 0 0 0 0 0 0 0 0 0 0 16.7029 12.2526 12.8864 0 0 13.1595 0 12.2951 0 0 0 0 0 0 0 0 0 0 0 12.4826 0 0 0 0 0 0 0 0 0 16.8811 0 0 0 0 0 0 0 0 12.2456 0 0 0 0 0 0 0 12.3956 13.1453 0 0 12.0882 0 14.7123 0 P30307 MPIP3_HUMAN "M-phase inducer phosphatase 3, EC 3.1.3.48 (Dual specificity phosphatase Cdc25C)" CDC25C Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; protein dephosphorylation [GO:0006470]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; WW domain binding [GO:0050699]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; protein dephosphorylation [GO:0006470]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]; spermatogenesis [GO:0007283] GO:0000079; GO:0000086; GO:0004721; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005758; GO:0005829; GO:0006470; GO:0007088; GO:0007283; GO:0008283; GO:0010971; GO:0016607; GO:0019901; GO:0048471; GO:0050699; GO:0051301; GO:0110032 phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; WW domain binding [GO:0050699] FYVIDCR 0.9939 -8.7561 0 12.8303 0 0 0 11.9118 0 10.5217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7534 0 13.0506 13.616 14.5762 0 13.9215 0 0 0 0 0 0 13.7627 13.2657 13.329 0 12.1156 0 13.4026 13.4838 0 0 0 0 0 0 0 0 0 0 0 0 12.4072 0 11.0955 0 0 0 0 14.831 0 0 0 0 0 0 0 0 14.5192 10.7261 0 0 0 14.26 12.9294 0 0 0 0 0 0 18.1715 0 0 12.666 0 0 0 0 12.9467 12.4196 0 0 0 0 0 0 0 13.6203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55789 ALR_HUMAN "FAD-linked sulfhydryl oxidase ALR, EC 1.8.3.2 (Augmenter of liver regeneration, hERV1) (Hepatopoietin)" GFER ALR HERV1 HPO Homo sapiens (Human) cellular response to actinomycin D [GO:0072717]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035]; cellular response to actinomycin D [GO:0072717]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; positive regulation of DNA biosynthetic process [GO:2000573] GO:0001889; GO:0005615; GO:0005739; GO:0005758; GO:0005829; GO:0008083; GO:0015035; GO:0016971; GO:0043066; GO:0045953; GO:0050660; GO:0071222; GO:0071356; GO:0072717; GO:0097237; GO:0097421; GO:1903204; GO:2000573 flavin adenine dinucleotide binding [GO:0050660]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; growth factor activity [GO:0008083]; protein-disulfide reductase activity [GO:0015035] DGWKDGSCD 0.9939 -8.7687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8145 0 0 0 0 0 0 0 10.2773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4093 11.6954 0 0 0 0 10.4894 0 0 0 11.2434 0 11.8177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3682 0 0 0 0 0 0 0 0 0 0 11.4054 0 0 0 0 0 0 0 0 0 0 0 0 11.7693 0 0 0 0 0 0 0 0 0 0 0 0 12.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58166 INHBE_HUMAN Inhibin beta E chain (Activin beta-E chain) INHBE Homo sapiens (Human) positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] GO:0005125; GO:0005179; GO:0005615; GO:0008083; GO:0010862; GO:0060395; GO:0062023 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179] DHYVDFQELGWR 0.9939 -7.0287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6306 0 0 0 0 12.2689 0 0 0 0 0 0 0 11.1424 11.5735 12.0647 0 0 0 0 13.498 0 0 0 0 0 0 0 0 0 13.4506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0935 0 0 0 0 0 0 0 0 0 0 13.8421 0 13.44 0 0 0 0 0 0 0 0 0 12.6863 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5606 P62917 RL8_HUMAN 60S ribosomal protein L8 (Large ribosomal subunit protein uL2) RPL8 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0014069; GO:0016020; GO:0019843; GO:0022625; GO:0022626; GO:0042788; GO:0098794 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] KVISSANR 0.9939 -13.873 0 0 0 0 0 0 0 0 0 13.3099 13.7152 13.1274 14.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5226 0 12.8157 0 0 13.0272 13.0525 13.4098 0 0 13.2112 13.3368 0 0 0 14.1489 0 13.6629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5689 0 0 0 0 0 11.2063 0 0 0 0 0 0 0 0 0 0 16.1728 16.1364 16.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1434 0 0 0 0 0 12.3683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3083 12.0738 0 0 15.0697 0 0 0 0 16.2444 0 0 16.3746 16.1944 0 0 0 16.2022 0 0 0 0 0 0 0 0 0 Q09161 NCBP1_HUMAN "Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein, CBP80, NCBP 80 kDa subunit)" NCBP1 CBP80 NCBP Homo sapiens (Human) "7-methylguanosine mRNA capping [GO:0006370]; alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; defense response to virus [GO:0051607]; histone mRNA metabolic process [GO:0008334]; miRNA-mediated gene silencing [GO:0035195]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA binding [GO:1905216]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]; spliceosomal complex assembly [GO:0000245]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; defense response to virus [GO:0051607]; histone mRNA metabolic process [GO:0008334]; miRNA-mediated gene silencing [GO:0035195]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA binding [GO:1905216]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]; spliceosomal complex assembly [GO:0000245]" GO:0000184; GO:0000245; GO:0000339; GO:0000340; GO:0000380; GO:0000398; GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005845; GO:0005846; GO:0006370; GO:0006401; GO:0006406; GO:0006408; GO:0006446; GO:0008334; GO:0008380; GO:0030307; GO:0031053; GO:0031124; GO:0031442; GO:0032968; GO:0034518; GO:0035195; GO:0042789; GO:0048026; GO:0050684; GO:0051607; GO:0098789; GO:1901409; GO:1905216; GO:1990904 mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339] EVLEKCMRLSYHQR 0.9939 -13.096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5059 12.724 13.0071 0 0 0 0 0 0 12.7273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7597 0 0 0 0 0 0 14.6496 0 0 0 0 0 13.1608 12.1485 0 12.0254 0 0 0 0 0 0 12.8783 0 13.9882 0 0 0 13.2439 13.178 0 0 12.8109 0 0 0 0 0 0 12.0985 0 0 0 0 11.7791 0 0 13.5594 0 0 0 0 0 13.158 0 0 0 0 0 0 0 0 11.1186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5378 0 0 0 0 13.6093 0 0 13.2975 12.9954 0 0 0 0 13.1168 0 0 0 0 0 0 0 0 Q2Q1W2 LIN41_HUMAN "E3 ubiquitin-protein ligase TRIM71, EC 2.3.2.27 (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)" TRIM71 LIN41 Homo sapiens (Human) 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] P-body [GO:0000932] P-body [GO:0000932]; miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089] GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637 miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] LRQNLNK 0.9939 -7.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1825 11.9186 11.3298 0 0 0 11.7227 0 0 0 0 0 0 11.8075 0 11.9408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9904 14.2413 0 0 0 0 0 0 0 12.1167 0 0 0 0 0 12.8242 0 0 0 0 0 0 0 12.8927 0 0 0 0 0 0 0 0 0 0 0 0 12.5075 0 12.5953 0 0 0 0 11.6247 13.0105 0 0 0 0 0 0 0 0 0 0 12.6007 0 0 0 0 0 0 15.0975 0 0 0 0 0 0 0 0 12.9913 0 0 0 0 0 0 0 0 0 0 12.9095 0 0 0 14.3769 0 0 13.0705 0 0 0 0 0 0 0 0 0 11.2364 0 12.5745 0 0 0 0 0 0 0 0 0 0 Q499Z4 ZN672_HUMAN Zinc finger protein 672 ZNF672 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" AFSVASKLALHRK 0.9939 -28.883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4053 0 0 13.9666 14.7993 0 0 0 0 0 13.5064 0 0 0 0 0 0 0 0 0 0 14.7078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.794 0 0 0 0 14.1684 0 0 0 0 0 0 0 0 0 11.0853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q49A26 GLYR1_HUMAN "Cytokine-like nuclear factor N-PAC, NPAC (3-hydroxyisobutyrate dehydrogenase-like protein) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60) (Nuclear protein of 60 kDa) (Nucleosome-destabilizing factor, hNDF) (Putative oxidoreductase GLYR1)" GLYR1 HIBDL NDF NP60 NPAC Homo sapiens (Human) positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; nucleosome binding [GO:0031491]; oxidoreductase activity [GO:0016491]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0000786; GO:0003677; GO:0003682; GO:0005654; GO:0005829; GO:0016491; GO:0031491; GO:0035064; GO:0035066; GO:0042393; GO:0045944; GO:0050661; GO:0051287 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; nucleosome binding [GO:0031491]; oxidoreductase activity [GO:0016491] DQTSSHNSSDDKNRR 0.9939 -7.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6966 0 0 12.796 0 0 14.1819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1837 0 0 13.1523 0 0 0 12.7184 0 0 0 0 0 0 0 0 14.1542 0 0 0 0 0 11.5088 0 0 0 0 0 0 0 0 0 14.1448 0 0 0 0 0 0 0 0 0 0 0 13.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TIA1 MEI1_HUMAN Meiosis inhibitor protein 1 (Meiosis defective protein 1) MEI1 Homo sapiens (Human) meiosis I [GO:0007127] meiosis I [GO:0007127] GO:0007127 AAAVLLSSTGLMELLEKMLALTLAK 0.9939 -8.0518 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4988 12.5876 13.7995 12.6236 0 0 14.8155 0 0 0 0 0 0 0 12.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0646 0 0 0 13.6281 14.1464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2916 0 0 0 14.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IPR3 TYW3_HUMAN "tRNA wybutosine-synthesizing protein 3 homolog, tRNA-yW-synthesizing protein 3, EC 2.1.1.282 (tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase)" TYW3 C1orf171 Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488] GO:0005737; GO:0008175; GO:0030488 tRNA methyltransferase activity [GO:0008175] ANGDATLK 0.9939 -13.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3197 0 0 0 0 0 0 0 0 13.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9425 0 0 0 0 13.6148 0 0 0 0 0 0 0 0 13.6533 0 0 0 0 0 0 0 0 0 0 13.0158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PIJ6 FBX38_HUMAN F-box only protein 38 FBXO38 SP329 Homo sapiens (Human) adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0019005; GO:0031146; GO:0070936 AVNEVFSCIKYLAIYNCPHLHNPYNWISDHSR 0.9939 -8.0539 0 0 0 0 0 0 0 0 0 0 13.9661 0 0 12.6319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5511 0 11.7955 0 0 13.3387 0 14.2297 0 12.3484 0 14.3113 0 0 14.4878 0 0 14.794 0 12.138 0 12.8523 14.4724 0 0 0 0 0 0 0 13.5159 0 0 12.1008 12.3419 14.2334 0 14.5441 13.6876 14.3833 0 13.5935 14.8191 14.4544 15.0366 0 0 13.1188 0 0 0 0 12.5767 0 0 0 12.1161 0 0 14.5015 13.1788 14.008 11.8536 13.5584 13.6059 0 0 12.0724 0 0 12.5609 11.4194 0 0 0 0 0 13.9858 13.88 13.6172 0 0 0 0 0 15.7753 0 0 0 0 0 0 0 0 0 13.005 14.7244 0 13.245 9.97384 0 0 0 0 Q86X02 CDR2L_HUMAN Cerebellar degeneration-related protein 2-like (Paraneoplastic 62 kDa antigen) CDR2L HUMPPA Homo sapiens (Human) identical protein binding [GO:0042802] GO:0042802 identical protein binding [GO:0042802] AEREYTAVLQEYSELER 0.9939 -7.0316 0 0 0 0 0 0 0 12.6538 0 13.8449 13.6198 18.5778 0 18.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2507 0 18.3402 18.3266 0 18.3195 0 0 12.2202 18.2966 0 13.1861 0 0 10.9068 0 0 0 0 0 0 0 0 0 0 0 15.0264 17.4471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5369 0 0 13.6985 0 0 0 0 0 0 0 0 19.3109 0 0 0 13.8689 15.4978 0 0 13.5734 0 0 13.229 0 0 0 0 0 0 0 0 19.2167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0809 0 13.9261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9411 18.9641 18.9451 18.9399 15.634 18.9324 18.9411 18.9356 18.8874 18.8693 0 0 0 0 0 14.4031 0 18.9367 0 18.9346 0 0 Q8N4U5 T11L2_HUMAN T-complex protein 11-like protein 2 TCP11L2 Homo sapiens (Human) signal transduction [GO:0007165] signal transduction [GO:0007165] GO:0007165 IKLYMRR 0.9939 -8.7518 0 0 0 12.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5823 0 0 0 0 0 0 0 0 0 0 0 0 13.0874 0 0 0 0 0 0 0 15.4903 0 0 0 0 0 0 0 14.0505 14.9269 0 0 0 0 0 0 0 0 0 0 0 13.8972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5568 0 0 13.1722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7444 0 0 0 0 0 0 0 0 0 0 14.8446 0 0 0 0 0 0 0 0 10.0256 13.7964 0 0 0 0 0 12.3022 0 12.4211 10.0189 11.1248 12.1483 0 0 0 Q8TAB7 CCD26_HUMAN Putative coiled-coil domain-containing protein 26 (Retinoic acid modulator) CCDC26 RAM Homo sapiens (Human) EEKEAPFFRLLSR 0.9939 -13.091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2396 0 0 0 0 0 0 0 0 12.5202 0 0 0 0 0 0 0 0 12.6006 0 12.9206 13.1146 0 0 0 13.2423 0 0 0 0 0 0 13.4433 0 12.2639 0 0 0 0 0 12.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96FJ0 STALP_HUMAN "AMSH-like protease, AMSH-LP, EC 3.4.19.- (STAM-binding protein-like 1)" STAMBPL1 AMSHLP KIAA1373 Homo sapiens (Human) protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536] cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020] cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536] GO:0005768; GO:0005829; GO:0016020; GO:0016579; GO:0046872; GO:0061578; GO:0070122; GO:0070536; GO:0140492 isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492] DIKIIVLDLR 0.9939 -10.771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0766 0 0 0 0 0 0 0 0 0 10.3217 13.5018 0 13.2378 14.7192 14.6781 15.4959 0 0 0 0 0 0 13.9163 0 0 0 0 0 12.9531 13.9207 0 12.6648 13.9324 12.8872 0 11.7636 0 0 12.3278 0 0 0 0 0 0 0 13.738 0 10.9241 0 0 0 17.0514 0 13.6069 13.3597 0 0 0 0 13.4812 0 13.5156 12.7758 0 0 0 0 14.4855 0 0 0 13.8895 13.5212 0 0 14.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99757 THIOM_HUMAN "Thioredoxin, mitochondrial, MTRX, Mt-Trx (Thioredoxin-2)" TXN2 TRX2 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410] dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730] dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein-containing complex binding [GO:0044877]; protein-disulfide reductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to nutrient levels [GO:0031669]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410] GO:0001666; GO:0005730; GO:0005739; GO:0005759; GO:0006979; GO:0008113; GO:0009410; GO:0009725; GO:0009749; GO:0014070; GO:0015035; GO:0030425; GO:0031669; GO:0033743; GO:0043025; GO:0044877; GO:0045454; GO:0048678 peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; protein-containing complex binding [GO:0044877]; protein-disulfide reductase activity [GO:0015035] ILGPRLEK 0.9939 -8.7658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2879 13.5193 0 13.4019 0 0 0 0 0 0 0 0 13.8456 0 0 0 0 13.4051 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0289 0 0 12.9544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAU0 PKHA5_HUMAN "Pleckstrin homology domain-containing family A member 5, PH domain-containing family A member 5 (Phosphoinositol 3-phosphate-binding protein 2, PEPP-2)" PLEKHA5 KIAA1686 PEPP2 Homo sapiens (Human) reproductive system development [GO:0061458] cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069] "cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; reproductive system development [GO:0061458]" GO:0005654; GO:0005829; GO:0010314; GO:0014069; GO:0016020; GO:0032266; GO:0061458; GO:0070273; GO:0080025; GO:0098978 "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]" DNPFRTTQTRR 0.9939 -8.7649 0 0 0 12.8088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1669 0 0 0 0 12.6962 0 0 10.4955 0 0 12.6469 0 10.6493 0 0 0 0 0 0 0 0 0 0 0 0 11.3964 0 0 10.3648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6482 0 0 0 0 0 0 0 0 0 13.2846 12.3822 12.0026 0 0 0 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3809 0 0 0 0 0 0 12.9335 0 0 0 0 0 0 0 0 0 0 0 0 12.4566 13.6664 0 0 12.6968 0 0 0 0 0 0 13.5725 0 0 0 0 0 0 0 0 13.025 0 13.8152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UMX0 UBQL1_HUMAN "Ubiquilin-1 (Protein linking IAP with cytoskeleton 1, PLIC-1, hPLIC-1)" UBQLN1 DA41 PLIC1 Homo sapiens (Human) aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991] aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000045; GO:0000502; GO:0005654; GO:0005737; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0006511; GO:0016235; GO:0016236; GO:0016241; GO:0019900; GO:0030433; GO:0031396; GO:0031398; GO:0031410; GO:0031593; GO:0032991; GO:0034140; GO:0034976; GO:0035973; GO:0042802; GO:0048471; GO:0071456; GO:0097352; GO:1901340; GO:1902175; GO:1903071 identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593] AESGESGGPPGSQDSAAGAEGAGAPAAAASAEPK 0.9939 -8.7613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0452 12.8145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4133 0 0 0 0 0 11.3588 0 10.8833 0 0 0 14.8586 0 0 0 0 0 0 0 0 0 14.8194 14.6991 0 0 0 0 0 0 0 15.6503 0 0 0 0 13.3699 0 0 0 0 0 0 0 0 13.3224 0 13.2795 0 12.3277 0 0 0 0 0 0 0 0 0 11.2294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8066 13.0132 0 0 0 15.217 0 0 0 0 Q9UNI6 DUS12_HUMAN "Dual specificity protein phosphatase 12, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity tyrosine phosphatase YVH1)" DUSP12 Homo sapiens (Human) dephosphorylation [GO:0016311]; positive regulation of glucokinase activity [GO:0033133]; protein dephosphorylation [GO:0006470]; protein modification process [GO:0036211] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase binding [GO:0019900]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]; dephosphorylation [GO:0016311]; positive regulation of glucokinase activity [GO:0033133]; protein dephosphorylation [GO:0006470]; protein modification process [GO:0036211] GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0008138; GO:0008270; GO:0016311; GO:0016791; GO:0017018; GO:0019900; GO:0033133; GO:0036211 kinase binding [GO:0019900]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270] AYEKLQILK 0.9939 -10.786 0 12.8352 0 0 0 0 0 0 0 0 0 12.4575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6406 0 0 13.8652 0 0 0 14.7936 12.6705 0 0 0 13.1713 0 0 0 13.5103 0 12.4574 0 12.5604 0 0 13.1575 0 0 13.9013 0 0 12.6386 0 0 0 0 19.1058 0 0 0 0 0 0 0 0 0 0 0 12.3046 0 0 0 0 14.1695 0 13.9601 17.0718 0 11.6064 0 0 0 Q9Y586 MB212_HUMAN Protein mab-21-like 2 MAB21L2 Homo sapiens (Human) camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; embryonic body morphogenesis [GO:0010172]; eye development [GO:0001654]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; camera-type eye development [GO:0043010]; cell population proliferation [GO:0008283]; embryonic body morphogenesis [GO:0010172]; eye development [GO:0001654]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284] GO:0001654; GO:0005634; GO:0005737; GO:0007399; GO:0008283; GO:0008284; GO:0010172; GO:0043010 CLSVLKTLR 0.9939 -8.0611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1101 0 11.2394 0 0 0 0 0 0 13.5921 0 0 0 0 0 0 0 0 0 10.9036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MTT3 CEBOS_HUMAN Protein CEBPZOS (CEBPZ antisense RNA 1) (CEBPZ opposite strand) CEBPZOS CEBPZ-AS1 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966] GO:0016021; GO:0031966 TLEPLAKK 0.99391 -7.0565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2255 0 12.1861 12.4403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8189 0 0 0 0 O00622 CCN1_HUMAN "CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10, IBP-10, IGF-binding protein 10, IGFBP-10) (Protein CYR61) (Protein GIG1)" CCN1 CYR61 GIG1 IGFBP10 Homo sapiens (Human) "apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]" collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] "collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix binding [GO:0050840]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]" GO:0001649; GO:0001934; GO:0002041; GO:0003181; GO:0003278; GO:0003281; GO:0005178; GO:0005576; GO:0005788; GO:0006935; GO:0007155; GO:0007165; GO:0008201; GO:0010518; GO:0010811; GO:0019838; GO:0030198; GO:0030335; GO:0030501; GO:0030513; GO:0031012; GO:0033690; GO:0043065; GO:0043066; GO:0043280; GO:0044319; GO:0045669; GO:0045860; GO:0045944; GO:0050840; GO:0060413; GO:0060548; GO:0060591; GO:0060710; GO:0060716; GO:0061036; GO:0062023; GO:0070372; GO:0072593; GO:2000304 extracellular matrix binding [GO:0050840]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; integrin binding [GO:0005178] AQSEGRPCEYNSRIYQNGESFQPNCK 0.99391 -13.952 0 0 0 0 0 0 0 0 0 0 0 10.7411 0 0 0 0 12.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.241 0 0 0 0 0 12.906 12.7674 13.2598 13.3541 0 13.4628 13.4291 12.2457 0 0 0 12.0043 0 0 0 0 0 0 11.8756 0 10.5313 0 0 0 0 0 0 0 0 0 13.8452 0 0 13.8512 13.681 13.2784 15.0677 0 0 0 13.9968 0 0 0 0 0 0 0 0 13.3399 0 0 0 13.7983 0 13.3522 0 0 0 13.2912 13.8953 0 0 0 0 0 0 0 0 0 13.9454 13.648 0 13.1105 10.807 0 13.3323 0 0 14.4436 0 0 0 0 0 0 0 0 0 0 0 0 10.2782 0 0 16.6338 0 0 0 0 0 17.8826 0 0 0 0 P0CW18 PRS56_HUMAN "Serine protease 56, EC 3.4.21.-" PRSS56 Homo sapiens (Human) blood coagulation [GO:0007596]; camera-type eye development [GO:0043010]; positive regulation of leukocyte chemotaxis [GO:0002690]; proteolysis [GO:0006508] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; camera-type eye development [GO:0043010]; positive regulation of leukocyte chemotaxis [GO:0002690]; proteolysis [GO:0006508] GO:0002690; GO:0004252; GO:0005615; GO:0005783; GO:0006508; GO:0007596; GO:0043010 serine-type endopeptidase activity [GO:0004252] GEANGCPGLEPLR 0.99391 -7.8449 0 0 0 0 0 0 0 0 0 12.9688 13.6476 0 0 0 0 0 0 0 0 0 11.7829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7887 0 0 0 0 0 0 0 0 0 0 12.351 0 0 0 0 0 0 0 10.9061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7594 13.5381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DPI3 CENL2_HUMAN Centromere protein V-like protein 2 (Centromere protein V pseudogene 2) CENPVL2 CENPVP2 Homo sapiens (Human) carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872] GO:0016846; GO:0046872 carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872] HFLVPASRFTLLQGAESIVTYR 0.99391 -27.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20618 PSB1_HUMAN Proteasome subunit beta type-1 (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain) PSMB1 PSC5 Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0034774; GO:0043161; GO:0070062; GO:1904813 MYKHSNNK 0.99391 -7.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56555 DSCR4_HUMAN Down syndrome critical region protein 4 (Down syndrome critical region protein B) DSCR4 DCRB DSCRB Homo sapiens (Human) DKQISASPST 0.99391 -10.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00765 REEP5_HUMAN Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2) REEP5 C5orf18 DP1 TB2 Homo sapiens (Human) endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; regulation of intracellular transport [GO:0032386] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; regulation of intracellular transport [GO:0032386] GO:0005783; GO:0007029; GO:0016021; GO:0032386; GO:0033017; GO:0071782; GO:0090158 AIESPNK 0.99391 -7.0517 0 0 0 0 0 0 0 0 0 0 13.6632 12.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7131 0 0 0 14.3514 0 0 0 0 0 0 0 0 0 0 0 13.2656 13.6858 0 0 Q02221 CX6A2_HUMAN "Cytochrome c oxidase subunit 6A2, mitochondrial (Cytochrome c oxidase polypeptide VIa-heart, COXVIAH) (Cytochrome c oxidase subunit VIA-muscle, COX VIa-M)" COX6A2 COX6A COX6AH Homo sapiens (Human) "generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751] "integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" GO:0004129; GO:0005751; GO:0006091; GO:0006123; GO:0016021; GO:0030234 cytochrome-c oxidase activity [GO:0004129]; enzyme regulator activity [GO:0030234] GGHGGAGAR 0.99391 -6.8166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5FWF7 FBX48_HUMAN F-box only protein 48 FBXO48 FBX48 Homo sapiens (Human) SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] SCF ubiquitin ligase complex [GO:0019005] SCF ubiquitin ligase complex [GO:0019005]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0019005; GO:0031146 SWNDTIR 0.99391 -10.847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NYC1 JMJD6_HUMAN "Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6, EC 1.14.11.- (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor, Protein PTDSR)" JMJD6 KIAA0585 PSR PTDSR Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; chromatin organization [GO:0006325]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone H3-methyl-arginine-2 demethylase activity [GO:0033746]; histone H3-methyl-arginine-3 demethylase activity [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription regulator activator activity [GO:0140537]; cell surface receptor signaling pathway [GO:0007166]; chromatin organization [GO:0006325]; erythrocyte development [GO:0048821]; heart development [GO:0007507]; histone H3-R2 demethylation [GO:0070078]; histone H4-R3 demethylation [GO:0070079]; kidney development [GO:0001822]; lung development [GO:0030324]; macrophage activation [GO:0042116]; mRNA processing [GO:0006397]; oxidative RNA demethylation [GO:0035513]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; protein homooligomerization [GO:0051260]; recognition of apoptotic cell [GO:0043654]; regulation of mRNA splicing, via spliceosome [GO:0048024]; retina development in camera-type eye [GO:0060041]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]; T cell differentiation in thymus [GO:0033077]" GO:0001822; GO:0002040; GO:0003723; GO:0003727; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006397; GO:0006482; GO:0006909; GO:0007166; GO:0007507; GO:0008380; GO:0018395; GO:0030324; GO:0032451; GO:0032452; GO:0033077; GO:0033746; GO:0033749; GO:0035513; GO:0035515; GO:0038023; GO:0042116; GO:0042802; GO:0043654; GO:0045893; GO:0045944; GO:0048024; GO:0048821; GO:0051260; GO:0060041; GO:0070078; GO:0070079; GO:0070815; GO:0106140; GO:0140537; GO:1990904 demethylase activity [GO:0032451]; histone demethylase activity [GO:0032452]; histone H3-methyl-arginine-2 demethylase activity [GO:0033746]; histone H3-methyl-arginine-3 demethylase activity [GO:0033749]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; oxidative RNA demethylase activity [GO:0035515]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023]; single-stranded RNA binding [GO:0003727]; transcription regulator activator activity [GO:0140537] CGEDNDGYSVK 0.99391 -9.2748 11.3162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3427 0 0 0 0 0 0 0 0 13.1078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5064 0 0 12.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8277 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZV29 PLPL7_HUMAN "Patatin-like phospholipase domain-containing protein 7, EC 3.1.1.-, EC 3.1.1.5" PNPLA7 C9orf111 Homo sapiens (Human) phosphatidylcholine catabolic process [GO:0034638] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phosphatidylcholine catabolic process [GO:0034638] GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0016021; GO:0034638; GO:0102545 lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545] AHFYEIMR 0.99391 -13.903 0 0 0 0 0 11.1117 0 0 0 0 0 0 0 11.7445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7205 0 0 12.0619 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7739 0 0 0 0 14.3168 16.8407 13.839 0 0 0 0 13.7526 0 13.2558 15.17 0 0 14.7642 13.4449 13.4464 0 0 0 14.172 0 13.0111 0 12.7698 13.0539 0 0 14.8133 14.1593 0 12.8973 0 0 0 0 14.2673 0 0 12.5997 14.5306 14.2291 14.953 13.9968 0 13.5733 0 0 12.6349 13.7526 0 0 14.1339 13.5725 0 0 14.4939 0 12.3801 0 0 0 0 0 11.8901 11.8401 0 0 0 0 12.952 14.7409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q76I76 SSH2_HUMAN "Protein phosphatase Slingshot homolog 2, EC 3.1.3.16, EC 3.1.3.48 (SSH-like protein 2, SSH-2L, hSSH-2L)" SSH2 KIAA1725 SSH2L Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837]; protein dephosphorylation [GO:0006470] GO:0003779; GO:0004721; GO:0004725; GO:0005615; GO:0005737; GO:0005856; GO:0006470; GO:0008138; GO:0017018; GO:0030036; GO:0030837 actin binding [GO:0003779]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] AKKHGSK 0.99391 -7.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8785 0 11.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SK9 SCD5_HUMAN "Stearoyl-CoA desaturase 5, EC 1.14.19.1 (Acyl-CoA-desaturase 4) (HSCD5) (Stearoyl-CoA 9-desaturase) (Stearoyl-CoA desaturase 2)" SCD5 ACOD4 SCD2 SCD4 Homo sapiens (Human) monounsaturated fatty acid biosynthetic process [GO:1903966]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768]; monounsaturated fatty acid biosynthetic process [GO:1903966]; unsaturated fatty acid biosynthetic process [GO:0006636] GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016021; GO:0016491; GO:1903966 iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768] NVVLMSLLHLGAVYSLVLIPKAK 0.99391 -10.821 0 0 0 0 0 0 0 0 14.7865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N309 LRC43_HUMAN Leucine-rich repeat-containing protein 43 LRRC43 Homo sapiens (Human) positive regulation of protein dephosphorylation [GO:0035307] protein phosphatase type 1 complex [GO:0000164] protein phosphatase type 1 complex [GO:0000164]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of protein dephosphorylation [GO:0035307] GO:0000164; GO:0004865; GO:0035307 protein serine/threonine phosphatase inhibitor activity [GO:0004865] ASAEELAK 0.99391 -7.8556 11.8841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4615 0 0 0 0 0 12.8988 13.4095 12.7647 0 0 0 0 13.4947 0 14.4333 16.0486 0 0 0 13.2663 0 0 13.3943 0 0 0 0 0 15.6656 15.8296 0 0 13.3233 0 0 0 0 0 0 0 0 0 0 12.5344 0 13.5473 0 0 0 0 0 0 13.183 0 0 0 14.201 0 12.5134 0 0 0 13.1693 0 0 0 0 0 0 0 0 12.8204 0 0 14.1481 0 0 0 0 0 0 14.6917 12.4333 0 0 13.9523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7439 0 0 0 0 0 0 0 0 0 Q8NFR3 SPTSB_HUMAN "Serine palmitoyltransferase small subunit B (Protein ADMP) (Small subunit of serine palmitoyltransferase B, ssSPTb)" SPTSSB ADMP C3orf57 SSSPTB Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; regulation of serine C-palmitoyltransferase activity [GO:1904220]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; regulation of serine C-palmitoyltransferase activity [GO:1904220]; sphingolipid biosynthetic process [GO:0030148]; sphingosine biosynthetic process [GO:0046512] GO:0004758; GO:0005789; GO:0007029; GO:0016021; GO:0017059; GO:0030148; GO:0046512; GO:0046513; GO:1904220 serine C-palmitoyltransferase activity [GO:0004758] LAWEFFSK 0.99391 -7.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92968 PEX13_HUMAN Peroxisomal membrane protein PEX13 (Peroxin-13) PEX13 Homo sapiens (Human) "cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]" cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] "cytosol [GO:0005829]; integral component of peroxisomal membrane [GO:0005779]; membrane [GO:0016020]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]" GO:0001561; GO:0001764; GO:0001967; GO:0005777; GO:0005778; GO:0005779; GO:0005829; GO:0007626; GO:0016020; GO:0016560; GO:0021795; GO:0060152; GO:1990429 LKIHFTKVFSAFALVR 0.99391 -7.0441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0435 0 10.9476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93050 VPP1_HUMAN "V-type proton ATPase 116 kDa subunit a 1, V-ATPase 116 kDa subunit a 1 (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1)" ATP6V0A1 ATP6N1 ATP6N1A VPP1 Homo sapiens (Human) endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035] "anchoring junction [GO:0070161]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "anchoring junction [GO:0070161]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035]" GO:0000220; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016021; GO:0016241; GO:0016471; GO:0016607; GO:0030665; GO:0030667; GO:0030670; GO:0030672; GO:0033176; GO:0042470; GO:0043231; GO:0046961; GO:0048388; GO:0048471; GO:0051117; GO:0070062; GO:0070161; GO:0101003; GO:1901998; GO:1902600 "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" DLNPDVNVFQRKFVNEVR 0.99391 -10.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9986 0 0 15.7965 14.2369 0 14.9888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6861 15.7054 10.8861 0 0 0 0 0 15.4049 0 0 0 0 0 0 0 0 0 15.6432 0 0 14.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96C36 P5CR2_HUMAN "Pyrroline-5-carboxylate reductase 2, P5C reductase 2, P5CR 2, EC 1.5.1.2" PYCR2 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561] GO:0004735; GO:0005739; GO:0005759; GO:0006561; GO:0034599; GO:0055129 pyrroline-5-carboxylate reductase activity [GO:0004735] KTLLDRVK 0.99391 -13.974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4263 13.7192 12.8237 0 0 0 0 0 0 0 0 13.5417 0 0 0 13.2816 0 0 0 0 13.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5477 0 0 14.2714 0 0 10.7836 0 0 0 0 0 0 0 0 0 15.0991 0 0 0 0 0 0 0 0 0 0 0 0 15.1754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8803 0 Q96FA3 PELI1_HUMAN "E3 ubiquitin-protein ligase pellino homolog 1, Pellino-1, EC 2.3.2.27 (Pellino-related intracellular-signaling molecule) (RING-type E3 ubiquitin transferase pellino homolog 1)" PELI1 PRISM Homo sapiens (Human) negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of necroptotic process [GO:0060544]; regulation of Toll signaling pathway [GO:0008592]; response to dsRNA [GO:0043331]; response to lipopolysaccharide [GO:0032496]; T cell proliferation [GO:0042098] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of necroptotic process [GO:0060544]; regulation of Toll signaling pathway [GO:0008592]; response to dsRNA [GO:0043331]; response to lipopolysaccharide [GO:0032496]; T cell proliferation [GO:0042098] GO:0000209; GO:0001819; GO:0005634; GO:0005829; GO:0008592; GO:0030890; GO:0031398; GO:0032088; GO:0032496; GO:0034141; GO:0034145; GO:0034450; GO:0042098; GO:0042130; GO:0043123; GO:0043161; GO:0043331; GO:0060544; GO:0060546; GO:0061630; GO:0070534; GO:0070936 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450] FALFKRPK 0.99391 -8.1078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4719 0 0 0 12.1611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4298 15.6639 15.3309 0 13.7838 0 13.2114 0 0 15.1809 15.2015 15.4394 15.3732 15.1295 0 14.8211 13.6893 11.1447 14.9451 16.496 15.4262 15.1805 0 0 0 12.0176 13.7449 0 0 15.7729 15.3893 13.3486 0 0 12.7285 0 0 15.7489 15.1236 0 0 13.319 0 0 0 0 14.6141 14.8456 0 0 0 0 0 0 0 15.4604 0 0 0 0 14.3132 0 13.7381 0 0 0 0 15.4894 0 0 0 0 0 0 0 0 0 13.9566 13.6015 0 14.5973 15.4873 0 14.2983 0 0 13.1076 0 0 0 0 0 0 0 0 0 0 15.0614 0 14.7729 0 0 0 0 0 0 Q96G01 BICD1_HUMAN "Protein bicaudal D homolog 1, Bic-D 1" BICD1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; RNA processing [GO:0006396]; stress granule assembly [GO:0034063]; viral process [GO:0016032] centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802] centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802]; cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267]; structural constituent of cytoskeleton [GO:0005200]; anatomical structure morphogenesis [GO:0009653]; intracellular mRNA localization [GO:0008298]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; RNA processing [GO:0006396]; stress granule assembly [GO:0034063]; viral process [GO:0016032] GO:0005200; GO:0005794; GO:0005802; GO:0005813; GO:0005829; GO:0005856; GO:0006396; GO:0008093; GO:0008298; GO:0009653; GO:0016020; GO:0016032; GO:0019901; GO:0031267; GO:0031410; GO:0031871; GO:0033365; GO:0034063; GO:0034452; GO:0045505; GO:0048260; GO:0048471; GO:0070507; GO:0070840; GO:0072385; GO:0072393; GO:0099503; GO:1900275; GO:1900276; GO:1900737; GO:1904781 cytoskeletal anchor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; small GTPase binding [GO:0031267]; structural constituent of cytoskeleton [GO:0005200] AMVTETMTKLRNELK 0.99391 -7.8386 0 0 0 0 0 0 12.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4141 18.0588 0 0 0 0 0 0 0 14.4553 14.5077 14.0035 15.6383 14.3879 0 14.0937 0 0 0 16.467 0 0 0 0 0 0 0 0 0 0 0 16.5474 14.1406 13.8253 0 0 0 0 0 0 14.2226 0 0 15.1264 15.1389 15.5157 0 0 0 14.016 13.9367 13.7911 13.5675 15.7426 15.0558 0 0 0 14.7973 14.0942 14.7182 14.9621 14.2803 14.4462 14.1491 0 14.9811 14.7905 14.6478 14.4031 0 15.8322 15.5515 14.3256 15.9017 0 0 0 0 0 0 0 14.8021 0 19.2801 14.8937 0 14.2611 14.2418 14.7013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5392 0 0 0 0 0 15.021 0 Q96GC5 RM48_HUMAN "39S ribosomal protein L48, mitochondrial, L48mt, MRP-L48 (Mitochondrial large ribosomal subunit protein mL48)" MRPL48 CGI-118 HSPC290 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; mitochondrial translation [GO:0032543] GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543 EHTEEDFKGRFK 0.99391 -10.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7002 13.2942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LA5 FCRL2_HUMAN "Fc receptor-like protein 2, FcR-like protein 2, FcRL2 (Fc receptor homolog 2, FcRH2) (IFGP family protein 4) (Immunoglobulin receptor translocation-associated protein 4) (SH2 domain-containing phosphatase anchor protein 1) (CD antigen CD307b)" FCRL2 FCRH2 IFGP4 IRTA4 SPAP1 UNQ9236/PRO31998 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; protein phosphatase binding [GO:0019903]; signaling adaptor activity [GO:0035591]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267] GO:0004888; GO:0005887; GO:0007166; GO:0007267; GO:0009986; GO:0016021; GO:0019903; GO:0035591 protein phosphatase binding [GO:0019903]; signaling adaptor activity [GO:0035591]; transmembrane signaling receptor activity [GO:0004888] ADNGHVPIQSKVVNIPVRIPVSR 0.99391 -10.823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8523 0 0 14.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2077 0 0 0 0 0 0 0 0 0 0 0 0 11.8139 0 0 0 0 0 0 0 0 0 11.6826 0 0 0 0 13.5736 0 0 0 0 0 0 0 0 0 13.1612 0 0 0 0 0 0 0 0 12.5674 0 0 0 0 0 0 0 0 0 0 0 11.6859 0 0 0 0 0 0 Q9BV36 MELPH_HUMAN "Melanophilin (Exophilin-3) (Slp homolog lacking C2 domains a, SlaC2-a) (Synaptotagmin-like protein 2a)" MLPH SLAC2A Homo sapiens (Human) intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402] cortical actin cytoskeleton [GO:0030864]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471] cortical actin cytoskeleton [GO:0030864]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402] GO:0003779; GO:0006886; GO:0017022; GO:0030425; GO:0030674; GO:0030864; GO:0031267; GO:0032402; GO:0046872; GO:0048471; GO:0070062 actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267] AAGLTVKPSGKPR 0.99391 -6.5626 0 0 0 0 0 0 0 0 0 0 0 10.6699 0 0 0 0 0 10.409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6349 0 0 0 0 0 0 0 0 0 0 0 0 10.5951 0 0 0 0 12.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9829 16.4889 0 0 0 0 0 0 0 0 0 13.8937 0 0 14.3538 0 0 13.0238 0 13.02 14.9703 0 0 0 0 12.504 15.1716 13.9043 0 13.4857 0 0 0 0 0 0 12.3214 18.6269 0 0 0 0 0 0 0 0 0 0 0 0 12.3905 0 0 0 0 0 0 0 0 14.083 13.1907 0 0 17.1856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8756 0 0 0 0 0 0 0 0 0 0 0 Q9BXR0 TGT_HUMAN "Queuine tRNA-ribosyltransferase catalytic subunit 1, EC 2.4.2.64 (Guanine insertion enzyme) (tRNA-guanine transglycosylase)" QTRT1 TGT TGUT Homo sapiens (Human) tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234] mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030] GO:0005634; GO:0005741; GO:0006400; GO:0008479; GO:0032991; GO:0042803; GO:0046872; GO:0046982; GO:0101030; GO:1990234 metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479] CIAAHQR 0.99391 -13.921 0 0 0 0 0 0 0 0 0 0 0 12.6034 0 12.2136 12.1777 0 0 0 0 0 0 0 0 0 0 12.5001 0 0 12.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9891 0 0 0 0 0 0 18.9796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0167 0 0 0 0 0 0 0 13.7597 13.9067 13.2228 0 0 0 0 0 0 0 0 16.7134 0 13.2088 0 0 0 0 0 0 0 0 0 0 0 0 Q9H190 SDCB2_HUMAN "Syntenin-2 (Similar to TACIP18, SITAC) (Syndecan-binding protein 2)" SDCBP2 SITAC18 Homo sapiens (Human) cell population proliferation [GO:0008283]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; nervous system development [GO:0007399] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell population proliferation [GO:0008283]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; nervous system development [GO:0007399]" GO:0005546; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007399; GO:0008022; GO:0008283; GO:0016607; GO:0035556; GO:0042802; GO:0042803; GO:0046907; GO:0046982; GO:0070062 "identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]" AEIKPGVR 0.99391 -6.5648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9808 0 0 0 0 0 0 0 0 0 11.4025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4242 0 0 11.6769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7183 0 0 0 0 0 0 13.7762 0 0 0 0 0 14.1702 0 0 0 14.6642 13.9065 0 0 14.5853 0 15.2024 14.3001 0 12.9138 0 13.9749 0 0 14.977 0 13.9452 0 14.2278 13.463 0 14.5838 0 14.2553 13.9281 13.8543 13.9043 14.0705 13.8936 14.0668 13.3387 0 13.2694 0 0 0 0 13.6203 13.0837 0 13.836 0 0 12.3059 0 13.5521 0 0 0 0 0 0 0 0 0 0 12.6359 0 0 0 0 0 0 13.4836 14.7416 0 14.0782 14.0306 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2S5 RNF39_HUMAN RING finger protein 39 (Protein HZFw) RNF39 HZFW Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0010468; GO:0016567; GO:0045087; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] IRVDLDWERGR 0.99391 -7.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.947 0 0 0 0 0 0 0 0 0 0 11.6745 0 12.7707 13.1341 0 0 0 0 0 0 0 0 0 13.8951 12.7002 13.8803 0 14.4839 0 0 0 0 12.8763 0 0 12.6464 13.2894 0 0 14.9661 0 12.9039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H560 ANR19_HUMAN Putative ankyrin repeat domain-containing protein 19 (Ankyrin repeat domain-containing protein 19 pseudogene) ANKRD19P ANKRD19 Homo sapiens (Human) CQINIYDRLNR 0.99391 -7.0536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRP2 COXM2_HUMAN COX assembly mitochondrial protein 2 homolog CMC2 C16orf61 DC13 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 CLKNEYVENR 0.99391 -7.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3898 0 0 12.8444 0 0 0 0 12.7276 0 0 12.6321 13.0683 14.1584 13.1271 0 0 0 0 0 13.1354 0 0 0 14.0736 14.1591 0 12.7069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0978 0 0 0 0 0 0 0 0 0 0 0 12.4967 14.2155 13.0617 13.4046 12.4181 12.8449 12.4675 0 0 0 12.3237 0 0 0 0 0 0 0 11.855 0 0 0 0 0 0 0 0 0 0 0 12.4782 12.7196 0 0 0 0 0 12.1771 0 0 0 0 0 0 0 0 0 Q9NX62 IMPA3_HUMAN "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase, Golgi-resident PAP phosphatase, gPAPP, EC 3.1.3.7 (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Myo-inositol monophosphatase A3) (Phosphoadenosine phosphate 3'-nucleotidase)" BPNT2 IMPA3 IMPAD1 Homo sapiens (Human) chondrocyte development [GO:0002063]; chondroitin sulfate metabolic process [GO:0030204]; embryonic digit morphogenesis [GO:0042733]; endochondral ossification [GO:0001958]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; post-embryonic development [GO:0009791]; skeletal system development [GO:0001501] cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; 3',5'-nucleotide bisphosphate phosphatase activity [GO:0097657]; 3'-nucleotidase activity [GO:0008254]; metal ion binding [GO:0046872]; chondrocyte development [GO:0002063]; chondroitin sulfate metabolic process [GO:0030204]; embryonic digit morphogenesis [GO:0042733]; endochondral ossification [GO:0001958]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; post-embryonic development [GO:0009791]; skeletal system development [GO:0001501]" GO:0001501; GO:0001958; GO:0002063; GO:0005654; GO:0005794; GO:0005796; GO:0005829; GO:0008254; GO:0008441; GO:0009791; GO:0012505; GO:0016020; GO:0016021; GO:0016604; GO:0030204; GO:0032588; GO:0042733; GO:0046854; GO:0046855; GO:0046872; GO:0097657 "3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; 3',5'-nucleotide bisphosphate phosphatase activity [GO:0097657]; 3'-nucleotidase activity [GO:0008254]; metal ion binding [GO:0046872]" MAPMGIRLSPLGVAVFCLLGLGVLYHLYSGFLAGR 0.99391 -7.0622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0M2 AKA7G_HUMAN "A-kinase anchor protein 7 isoform gamma, AKAP-7 isoform gamma (A-kinase anchor protein 18 kDa, AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma, PRKA7 isoform gamma)" AKAP7 AKAP18 Homo sapiens (Human) modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738] GO:0000166; GO:0005634; GO:0005829; GO:0010738; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686 nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901] LSKSPWLRK 0.99391 -7.8473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.669 10.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJP4 KLH21_HUMAN Kelch-like protein 21 KLHL21 KIAA0469 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to spindle midzone [GO:0035853]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; polar microtubule [GO:0005827] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; polar microtubule [GO:0005827]; cullin family protein binding [GO:0097602]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to spindle midzone [GO:0035853]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465] GO:0005827; GO:0005829; GO:0007049; GO:0016567; GO:0031463; GO:0032465; GO:0035853; GO:0051301; GO:0097602 cullin family protein binding [GO:0097602] AVLAAASPYFR 0.99391 -13.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2625 0 0 0 0 13.5773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.435 0 0 0 0 0 0 0 14.5353 15.1588 0 0 0 0 0 0 0 0 0 0 0 0 14.6349 13.9256 13.9788 14.186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5721 0 0 0 0 0 0 14.2461 0 0 0 14.9954 0 0 0 0 0 0 0 0 0 16.4061 0 0 0 0 16.2728 14.2619 0 0 0 14.1054 0 0 0 15.4632 0 0 0 0 0 0 0 0 0 0 13.7264 0 13.7224 14.1771 0 12.6964 13.0161 0 12.8363 0 12.5193 0 0 0 0 0 0 0 0 13.08 0 0 0 0 Q9UNP9 PPIE_HUMAN "Peptidyl-prolyl cis-trans isomerase E, PPIase E, EC 5.2.1.8 (Cyclophilin E) (Cyclophilin-33) (Rotamase E)" PPIE CYP33 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000398; GO:0000413; GO:0003723; GO:0003729; GO:0003755; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006457; GO:0008143; GO:0016018; GO:0016607; GO:0034774; GO:0045070; GO:0071007; GO:0071013; GO:1904813 cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723] IGNKPAGR 0.99391 -6.8182 0 0 0 0 0 0 0 0 12.1072 0 0 11.9658 0 11.9307 0 0 0 0 12.1361 0 0 0 0 0 0 0 0 0 0 0 11.6325 0 0 0 0 0 11.7132 0 11.7058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6405 0 0 0 0 0 0 17.0688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9595 0 0 0 17.879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8531 0 14.292 14.04 0 14.3693 0 0 0 0 0 0 13.7153 13.8784 0 0 0 0 13.8894 0 0 0 0 Q9Y3B7 RM11_HUMAN "39S ribosomal protein L11, mitochondrial, L11mt, MRP-L11 (Mitochondrial large ribosomal subunit protein uL11m)" MRPL11 CGI-113 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0015934; GO:0032543; GO:0070180 large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EGIPLPTKILVK 0.99391 -7.0586 0 0 0 0 0 0 0 0 9.89098 0 0 14.2922 10.7469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8549 0 0 0 0 0 0 0 0 0 0 10.9507 0 0 12.2222 0 10.593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0005 11.6957 0 0 0 0 0 0 15.3341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8192 0 0 0 0 0 0 11.485 0 0 0 0 0 10.5005 0 12.3014 0 0 0 0 0 0 0 0 13.3722 0 0 0 0 0 0 13.8792 0 0 10.4894 0 0 0 0 0 0 0 0 0 0 0 10.6038 0 0 0 0 0 0 0 0 0 0 0 0 0 13.794 0 0 13.0087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3429 0 0 P01009 A1AT_HUMAN "Alpha-1-antitrypsin (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) [Cleaved into: Short peptide from AAT, SPAAT ]" SERPINA1 AAT PI PRO0684 PRO2209 Homo sapiens (Human) acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; blood coagulation [GO:0007596]; negative regulation of endopeptidase activity [GO:0010951] GO:0002020; GO:0004867; GO:0005576; GO:0005615; GO:0005783; GO:0005788; GO:0005794; GO:0006953; GO:0007596; GO:0010951; GO:0030134; GO:0031093; GO:0033116; GO:0042802; GO:0043231; GO:0062023; GO:0070062; GO:1904813 identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] AVHKAVLTIDEK 0.99392 -7.9016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8151 0 0 0 12.4034 0 0 0 0 0 0 0 0 0 0 12.6845 0 11.3508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.801 0 12.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9218 0 0 0 0 0 0 0 10.2262 12.0223 0 0 0 0 0 0 12.1929 0 0 0 0 0 0 0 0 0 0 0 0 0 P51606 RENBP_HUMAN "N-acylglucosamine 2-epimerase, AGE, EC 5.1.3.8 (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein, RnBP)" RENBP Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262]; regulation of blood pressure [GO:0008217] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; endopeptidase inhibitor activity [GO:0004866]; identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262]; regulation of blood pressure [GO:0008217] GO:0004866; GO:0005524; GO:0005829; GO:0005975; GO:0006044; GO:0006051; GO:0008217; GO:0019262; GO:0030414; GO:0042802; GO:0050121; GO:0070062 ATP binding [GO:0005524]; endopeptidase inhibitor activity [GO:0004866]; identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414] CAFVLTR 0.99392 -15.281 12.7051 13.7962 0 0 0 12.173 0 14.2833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4661 12.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5456 17.4377 0 16.5492 16.0532 13.8842 16.6985 14.2245 14.34 10.9195 0 0 13.9418 15.4489 14.8956 16.6566 14.359 0 0 14.8432 0 0 0 14.4438 14.3324 0 14.873 13.9404 13.5347 14.4638 13.513 14.7662 14.7964 14.4283 14.3122 14.177 13.3896 0 16.1785 14.3857 13.9027 17.0899 13.9583 14.6149 16.4386 0 13.3143 13.3354 0 13.8709 0 13.5345 13.9858 0 13.6765 15.1961 13.8714 13.4387 13.9236 15.8035 14.1184 16.3409 0 14.6002 16.9451 14.0299 0 15.7167 15.6161 15.7747 14.5978 15.6976 0 0 0 13.3655 0 16.7191 14.7964 13.5214 13.2781 0 0 10.949 0 0 0 0 0 0 0 0 0 0 0 0 16.0893 0 0 13.5152 0 0 0 13.2165 0 Q10571 MN1_HUMAN Transcriptional activator MN1 (Probable tumor suppressor protein MN1) MN1 Homo sapiens (Human) "intramembranous ossification [GO:0001957]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; intramembranous ossification [GO:0001957]; negative regulation of osteoblast proliferation [GO:0033689]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001957; GO:0005634; GO:0006355; GO:0033689; GO:0070564; GO:1902806 ASRSPLVTGSPKLPPR 0.99392 -8.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8771 12.3072 0 0 0 0 0 15.1018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2519 0 13.2336 0 12.42 13.7785 13.4906 0 0 0 0 0 0 11.6587 0 0 0 0 13.2919 0 0 0 0 0 0 0 0 12.9731 0 0 13.011 13.889 12.7008 0 0 0 0 0 0 0 0 0 0 14.4037 0 0 0 12.05 0 0 14.7377 0 0 0 0 0 0 0 12.6378 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3984 0 0 0 0 0 0 0 14.1067 0 0 0 Q5T4T6 SYC2L_HUMAN "Synaptonemal complex protein 2-like, SCP-2-like (145 kDa nucleolar protein homolog, hsNO145)" SYCP2L C6orf177 NO145 Homo sapiens (Human) meiotic nuclear division [GO:0140013]; negative regulation of cell death [GO:0060548] "condensed chromosome, centromeric region [GO:0000779]; female germ cell nucleus [GO:0001674]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]" "condensed chromosome, centromeric region [GO:0000779]; female germ cell nucleus [GO:0001674]; lateral element [GO:0000800]; nucleoplasm [GO:0005654]; meiotic nuclear division [GO:0140013]; negative regulation of cell death [GO:0060548]" GO:0000779; GO:0000800; GO:0001674; GO:0005654; GO:0060548; GO:0140013 EFETDSRRFLNHLNNR 0.99392 -13.987 13.4682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0815 0 0 0 12.3 0 0 0 0 0 0 0 0 12.1476 0 0 0 0 0 10.9479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0532 0 0 0 0 11.1132 0 0 0 16.4873 0 14.0384 0 0 0 0 0 0 0 0 0 0 0 0 12.8136 0 0 0 0 0 0 0 10.9897 0 0 0 0 0 0 0 0 12.9763 0 Q6UY01 LRC31_HUMAN Leucine-rich repeat-containing protein 31 LRRC31 UNQ9367/PRO34156 Homo sapiens (Human) DIVGSLNSIAQGLKSTSNLKVLK 0.99392 -8.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1605 0 11.6606 0 0 0 0 0 0 0 11.0044 0 0 0 15.0272 0 0 0 0 0 0 0 0 0 11.9237 0 0 0 0 0 0 0 0 0 0 Q8HWS3 RFX6_HUMAN DNA-binding protein RFX6 (Regulatory factor X 6) (Regulatory factor X domain-containing protein 1) RFX6 RFXDC1 Homo sapiens (Human) "endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309]" GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" CMAWTEQQLSR 0.99392 -29.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7558 11.2855 0 0 0 0 0 0 0 11.5498 0 0 0 0 0 0 0 12.7711 0 0 0 0 0 0 0 0 11.9592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8115 15.7346 0 16.0142 0 0 0 0 0 0 0 0 16.5361 0 0 0 0 0 0 0 11.6844 13.221 11.1424 12.1814 0 0 0 0 0 0 16.3836 13.7742 12.3545 0 0 15.4988 16.0527 13.9544 15.0671 0 0 15.3583 0 11.9829 14.6176 13.4537 13.2807 0 0 0 16.522 13.9369 13.0291 0 15.604 13.1267 13.2321 15.545 15.8033 16.0593 14.8634 0 0 0 15.6241 15.5955 15.5266 0 0 0 0 0 14.6167 0 0 15.4978 0 13.2729 14.3269 0 12.5946 0 0 0 0 12.6624 0 0 0 0 0 0 0 12.8634 16.0839 0 0 0 0 12.7667 0 0 Q8N392 RHG18_HUMAN Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18) ARHGAP18 Homo sapiens (Human) regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0001726; GO:0005096; GO:0005737; GO:0005829; GO:0005881; GO:0005886; GO:0007264; GO:0008360; GO:0016607; GO:0030833; GO:0032956; GO:0045296; GO:0051056; GO:2000145 cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096] AMKKLLK 0.99392 -29.605 0 0 0 0 0 0 0 0 0 0 0 12.1426 0 0 0 0 0 0 0 0 0 13.2638 0 0 0 0 0 0 0 0 0 0 0 11.9151 0 10.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7726 0 0 17.9405 12.6562 0 0 0 0 0 16.499 0 0 0 0 0 0 15.1117 0 0 0 0 0 15.0622 15.3627 0 9.96161 0 0 0 0 0 0 12.9274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8275 0 0 0 0 11.9063 0 15.0162 0 0 13.2132 0 0 0 0 0 0 0 14.3727 19.099 0 0 0 0 0 0 0 10.6123 0 0 15.2218 0 0 0 12.2767 13.0959 0 13.2095 0 0 15.2037 0 13.5228 12.8287 0 0 12.2204 14.2074 11.6737 0 0 14.3925 0 14.1299 0 0 Q96HC4 PDLI5_HUMAN PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein) PDLIM5 ENH L9 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell growth involved in cardiac muscle cell development [GO:0061049]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080]; actin cytoskeleton organization [GO:0030036]; cell growth involved in cardiac muscle cell development [GO:0061049]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963] GO:0001725; GO:0003779; GO:0005080; GO:0005829; GO:0005912; GO:0007507; GO:0014069; GO:0015629; GO:0016020; GO:0030018; GO:0030036; GO:0031941; GO:0042805; GO:0042995; GO:0046872; GO:0051371; GO:0051963; GO:0061001; GO:0061049; GO:0061061; GO:0098641; GO:0098793 actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080] GSQGDSKQQNGPPRK 0.99392 -5.1721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1727 0 0 0 11.9008 0 0 0 0 0 0 0 0 0 0 16.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P44 COLA1_HUMAN Collagen alpha-1(XXI) chain COL21A1 COL1AL FP633 Homo sapiens (Human) collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615] GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0005829; GO:0062023 GFDILLGLDVNKKVK 0.99392 -37.201 0 0 0 0 0 0 0 0 13.4236 0 14.2496 0 0 0 0 0 13.5266 0 0 13.6691 0 0 0 0 13.2064 12.468 0 0 12.6511 13.0447 12.8715 12.9108 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5686 0 0 0 12.6468 12.6334 0 0 12.2027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9491 0 0 0 12.8492 0 0 0 0 0 0 0 15.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1452 0 0 0 0 0 15.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3452 14.1631 14.8677 0 13.752 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7Z6 KAT8_HUMAN "Histone acetyltransferase KAT8, EC 2.3.1.48 (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1, MYST-1, hMOF)" KAT8 MOF MYST1 PP7073 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" GO:0000123; GO:0000776; GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006325; GO:0010484; GO:0010485; GO:0010506; GO:0016363; GO:0016573; GO:0019899; GO:0030099; GO:0035064; GO:0042393; GO:0043981; GO:0043982; GO:0043984; GO:0043995; GO:0043996; GO:0044545; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046972; GO:0051571; GO:0061629; GO:0071339; GO:0072487; GO:1900095 enzyme binding [GO:0019899]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone acetyltransferase activity (H4-K5 specific) [GO:0043995]; histone acetyltransferase activity (H4-K8 specific) [GO:0043996]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] DAVQKNSEK 0.99392 -7.0806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2909 0 0 0 0 0 0 0 0 0 0 0 13.0812 0 13.1275 13.9681 14.0555 0 0 0 0 0 14.0826 14.2179 0 0 0 14.1678 0 0 0 13.835 14.6336 0 0 14.3773 0 14.1558 14.8157 14.2242 14.2061 0 0 0 14.4049 12.9992 14.1763 14.3558 0 0 0 13.8172 0 0 0 0 13.8413 0 0 0 0 0 0 0 14.1012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7475 13.7132 0 0 11.5846 0 0 Q9NX78 TM260_HUMAN Transmembrane protein 260 TMEM260 C14orf101 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ELQSLRNRK 0.99392 -7.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2484 0 0 0 0 0 0 10.5285 0 0 0 0 0 0 0 0 0 12.8389 0 0 0 0 0 12.6018 0 0 0 0 0 0 0 0 0 10.0959 0 0 0 0 0 0 0 0 0 12.8496 0 0 0 0 0 0 0 13.597 0 0 0 0 13.7872 0 0 0 0 0 12.805 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.38249 0 0 0 0 0 0 0 0 0 0 0 0 12.8612 0 14.1296 0 0 0 0 14.6891 0 0 12.5051 0 14.0708 0 0 0 0 0 0 0 0 0 12.9696 0 0 0 0 0 12.5699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHC6 CNTP2_HUMAN Contactin-associated protein-like 2 (Cell recognition molecule Caspr2) CNTNAP2 CASPR2 KIAA0868 Homo sapiens (Human) adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; positive regulation of gap junction assembly [GO:1903598]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076] axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; voltage-gated potassium channel complex [GO:0008076]; enzyme binding [GO:0019899]; adult behavior [GO:0030534]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; clustering of voltage-gated potassium channels [GO:0045163]; learning [GO:0007612]; limbic system development [GO:0021761]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; positive regulation of gap junction assembly [GO:1903598]; protein localization to juxtaparanode region of axon [GO:0071205]; social behavior [GO:0035176]; striatum development [GO:0021756]; superior temporal gyrus development [GO:0071109]; thalamus development [GO:0021794]; transmission of nerve impulse [GO:0019226]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625] GO:0005769; GO:0005794; GO:0007155; GO:0007420; GO:0007612; GO:0008038; GO:0008076; GO:0008283; GO:0009986; GO:0016020; GO:0016021; GO:0019226; GO:0019899; GO:0021756; GO:0021761; GO:0021794; GO:0021987; GO:0030424; GO:0030425; GO:0030534; GO:0030673; GO:0031175; GO:0033010; GO:0035176; GO:0042297; GO:0043025; GO:0043204; GO:0044224; GO:0045163; GO:0048812; GO:0071109; GO:0071205; GO:0071625; GO:1903598 enzyme binding [GO:0019899] CACGIERNCTDPKYYCNCDADYK 0.99392 -8.1125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8889 0 0 0 0 0 0 0 0 0 0 0 0 12.3755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7026 11.6452 0 0 0 0 10.411 0 0 11.5117 0 12.2175 11.2637 0 0 0 0 12.6443 0 0 0 0 0 0 0 0 0 0 11.6764 0 0 0 0 0 15.3236 0 0 0 0 0 0 0 0 13.6678 0 0 0 0 0 0 0 0 12.5367 0 13.7475 0 0 0 0 0 Q9UHE5 NAT8_HUMAN "N-acetyltransferase 8, EC 2.3.1.- (Acetyltransferase 2, ATase2) (Camello-like protein 1) (Cysteinyl-conjugate N-acetyltransferase, CCNAT, EC 2.3.1.80)" NAT8 CML1 GLA TSC501 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; glutathione metabolic process [GO:0006749]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]; response to xenobiotic stimulus [GO:0009410] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; cysteine-S-conjugate N-acetyltransferase activity [GO:0047198]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]; amyloid fibril formation [GO:1990000]; amyloid-beta metabolic process [GO:0050435]; glutathione metabolic process [GO:0006749]; negative regulation of apoptotic process [GO:0043066]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628]; response to xenobiotic stimulus [GO:0009410]" GO:0004468; GO:0005783; GO:0005789; GO:0005793; GO:0006749; GO:0008080; GO:0009410; GO:0010628; GO:0016021; GO:0018003; GO:0033116; GO:0043066; GO:0047198; GO:0050435; GO:1990000 "cysteine-S-conjugate N-acetyltransferase activity [GO:0047198]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]" ALVRTVLQFAR 0.99392 -10.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.045 0 0 0 20.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5026 0 0 15.1751 0 0 0 0 0 16.5828 0 0 0 0 0 0 0 0 0 0 0 13.3012 0 0 0 0 0 16.1015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKF6 CPSF3_HUMAN "Cleavage and polyadenylation specificity factor subunit 3, EC 3.1.27.- (Cleavage and polyadenylation specificity factor 73 kDa subunit, CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73)" CPSF3 CPSF73 Homo sapiens (Human) mRNA 3'-end processing [GO:0031124]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087] GO:0003723; GO:0004521; GO:0004534; GO:0005654; GO:0005847; GO:0006378; GO:0006379; GO:0006398; GO:0008409; GO:0031124; GO:0046872; GO:1900087 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] EMVELAAQRLYEALTPVH 0.99392 -29.588 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9259 10.2051 0 0 10.7539 0 0 0 0 12.0527 0 0 0 10.5434 0 0 0 0 0 0 14.0731 0 0 0 11.5569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9337 0 0 0 0 0 14.9499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9055 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4658 0 0 0 0 0 0 0 12.5208 0 0 0 0 0 0 0 0 0 0 0 12.4585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0636 0 0 0 0 0 0 14.481 0 0 0 13.1023 0 0 0 Q9UPT9 UBP22_HUMAN "Ubiquitin carboxyl-terminal hydrolase 22, EC 3.4.19.12 (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22)" USP22 KIAA1063 USP3L Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin organization [GO:0006325]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]" nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; embryo development ending in birth or egg hatching [GO:0009792]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; histone ubiquitination [GO:0016574]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000124; GO:0003713; GO:0004843; GO:0005654; GO:0006282; GO:0006325; GO:0006357; GO:0006511; GO:0007049; GO:0008270; GO:0009792; GO:0016574; GO:0016578; GO:0016579; GO:0019899; GO:0030374; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0043967; GO:0045893; GO:0045931 cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] CSGCHSYQESTK 0.99392 -8.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7995 11.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0117 0 0 0 13.4935 13.4927 14.7277 0 12.1242 0 0 15.8978 0 0 0 14.7588 0 14.9913 0 0 15.2795 14.1206 14 14.334 0 0 14.4473 15.753 0 0 0 11.2974 13.49 13.8482 14.0042 15.229 0 11.1526 0 12.4027 13.9537 13.9817 0 14.6466 14.625 0 0 15.4005 0 0 0 0 13.7584 14.7277 0 12.3732 0 13.453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9898 0 0 15.8001 15.8225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8768 0 0 0 0 0 0 0 Q5VZK9 CARL1_HUMAN "F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)" CARMIL1 CARMIL LRRC16 LRRC16A Homo sapiens (Human) actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415] GO:0005654; GO:0005829; GO:0005886; GO:0007015; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031252; GO:0031529; GO:0031941; GO:0034315; GO:0044351; GO:0044354; GO:0044877; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:0070062; GO:1900026; GO:1902745; GO:2000249; GO:2000813 protein-containing complex binding [GO:0044877] ALQINTKLRTVIWDK 0.99393 -30.154 16.7757 0 0 13.2133 16.7087 16.8098 16.7703 16.1788 0 0 12.7109 0 0 14.659 0 13.4686 0 12.7231 14.5451 16.0517 0 14.7829 14.0274 16.2869 12.5005 0 0 13.0021 0 0 12.128 12.421 13.7584 11.3224 12.3527 14.9273 0 14.5703 0 14.7456 0 0 0 13.0496 0 14.1811 0 12.3263 0 11.7978 0 0 12.0654 0 12.3769 11.3579 0 0 0 0 0 0 0 0 0 0 17.0627 17.1513 17.3398 0 16.7907 17.0125 17.1042 17.3952 16.6796 16.4518 18.3502 16.7737 18.3716 18.1282 18.5454 18.5069 16.974 16.6749 16.6715 16.8452 14.3696 18.5386 18.5275 18.3828 16.5955 15.4481 18.5841 18.5178 18.1441 18.2758 18.3716 18.4331 18.4737 18.057 18.1718 18.4687 18.1086 18.3879 18.2878 18.2675 17.9395 15.8214 18.1045 18.155 17.8266 17.8034 13.7054 17.8449 17.8199 17.9061 17.566 12.824 17.6268 17.8378 17.8096 17.7615 17.5462 17.5616 14.9706 17.4303 17.7539 17.6505 17.5941 17.4752 0 14.291 17.5232 17.3068 17.5722 17.4387 13.9177 17.1979 17.2843 17.6438 17.0964 17.2074 17.2299 17.0748 16.8439 16.9969 17.2337 0 0 0 16.9511 17.0094 0 17.1735 17.3188 13.5831 16.7251 12.3161 0 0 0 0 0 0 0 0 12.9478 0 13.0326 12.7944 0 16.7012 16.7457 16.6566 13.0589 0 16.5662 0 13.6787 14.07 A4D1S0 KLRG2_HUMAN Killer cell lectin-like receptor subfamily G member 2 (C-type lectin domain family 15 member B) KLRG2 CLEC15B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246] GO:0016021; GO:0030246 carbohydrate binding [GO:0030246] AAGAGLEPSSKKK 0.99393 -5.2116 0 0 0 0 0 0 0 0 0 0 13.6261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6811 12.5161 0 0 0 0 0 0 0 0 0 0 0 0 13.4654 0 0 0 14.4005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7918 0 0 0 0 0 0 13.7562 0 0 0 0 0 0 0 0 0 12.4337 0 12.8489 0 0 0 0 0 12.9986 0 13.2354 14.8017 12.7056 0 0 12.8136 13.3426 0 0 0 12.1549 0 0 0 0 0 0 0 0 0 0 13.2543 13.9982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8432 0 13.4661 0 0 0 0 A6NDY0 EPAB2_HUMAN "Embryonic polyadenylate-binding protein 2, Embryonic poly(A)-binding protein 2, ePABP-2, ePABP2 (Embryonic poly(A)-binding protein type II) (Poly(A)-binding protein nuclear-like 1)" PABPN1L EPABP2 PABPNL1 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; RNA binding [GO:0003723] GO:0003723; GO:0005737 RNA binding [GO:0003723] FSPWFSPY 0.99393 -30.046 0 10.2264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8997 0 0 0 0 10.8713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7036 14.6176 14.2033 12.5979 14.436 0 0 0 0 12.5744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1535 0 0 0 0 0 0 0 0 0 0 0 0 12.4693 0 0 13.7249 0 0 12.7423 0 13.2962 0 0 13.1591 0 0 0 13.2206 0 14.2453 0 13.2648 13.1366 0 13.9439 13.109 0 0 0 0 0 0 0 0 0 14.4434 12.365 0 0 0 0 0 0 0 12.1696 0 0 0 0 0 0 0 0 13.6777 0 12.6844 0 12.1642 0 0 0 P11678 PERE_HUMAN "Eosinophil peroxidase, EPO, EC 1.11.1.7 [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain ]" EPX EPER EPO EPP Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of macrophage cytokine production [GO:0010936]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of macrophage cytokine production [GO:0010936]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979] GO:0002215; GO:0004601; GO:0005576; GO:0005615; GO:0006979; GO:0010936; GO:0020037; GO:0032693; GO:0032714; GO:0032753; GO:0034774; GO:0042742; GO:0042744; GO:0046872; GO:0070062; GO:0072677 heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] DCIPFFRSAPSCPQNK 0.99393 -29.995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2384 0 11.7412 0 0 0 0 0 13.7386 0 14.16 13.6324 13.4605 0 14.2415 14.8173 0 0 14.8702 0 13.2528 0 0 0 0 0 0 0 0 0 0 0 14.955 12.766 0 0 0 0 0 0 13.0232 0 0 0 0 14.6588 0 0 14.1607 15.3334 0 0 0 14.0645 0 0 15.1538 13.9551 14.8525 13.5991 16.3235 13.2085 13.6292 15.0441 11.8875 15.1078 0 14.9543 14.6539 0 0 0 14.1066 13.8841 14.5539 0 0 0 0 0 14.0968 13.8641 0 0 13.713 11.4723 0 0 14.0201 0 0 0 12.7327 0 0 0 0 0 0 11.1749 0 0 0 0 0 0 0 0 14.7046 0 0 0 0 0 P15056 BRAF_HUMAN "Serine/threonine-protein kinase B-raf, EC 2.7.11.1 (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1)" BRAF BRAF1 RAFB1 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trehalose metabolism in response to stress [GO:0070413]; visual learning [GO:0008542]" cell body [GO:0044297]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793] "cell body [GO:0044297]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trehalose metabolism in response to stress [GO:0070413]; visual learning [GO:0008542]" GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006468; GO:0007173; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0035019; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0070413; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0106310; GO:1900026; GO:2000301; GO:2000352 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110] DERPLFPQILASIELLAR 0.99393 -7.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3849 0 0 0 16.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4216 0 11.5912 0 0 0 0 0 0 0 0 0 0 0 0 12.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8771 P16473 TSHR_HUMAN "Thyrotropin receptor (Thyroid-stimulating hormone receptor, TSH-R)" TSHR LGR3 Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to glycoprotein [GO:1904588]; cellular response to thyrotropin-releasing hormone [GO:1905229]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; thyroid-stimulating hormone signaling pathway [GO:0038194]" basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] "basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled peptide receptor activity [GO:0008528]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; thyroid-stimulating hormone receptor activity [GO:0004996]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular response to glycoprotein [GO:1904588]; cellular response to thyrotropin-releasing hormone [GO:1905229]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; thyroid-stimulating hormone signaling pathway [GO:0038194]" GO:0004996; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007187; GO:0007189; GO:0007190; GO:0007267; GO:0008284; GO:0008528; GO:0009755; GO:0009986; GO:0016323; GO:0038023; GO:0038194; GO:0043235; GO:0044877; GO:0120162; GO:1904588; GO:1905229 G protein-coupled peptide receptor activity [GO:0008528]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; thyroid-stimulating hormone receptor activity [GO:0004996] IAKRMAVLIFTDFICMAPISFYALSAILNK 0.99393 -12.936 0 0 10.8206 0 0 0 0 0 11.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2697 0 0 0 13.3024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4281 0 0 0 14.0947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.226 0 0 0 0 10.8703 10.7334 13.7443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9984 15.6392 0 0 0 0 0 0 0 11.8268 0 0 0 0 0 0 0 0 0 0 13.0091 0 0 13.7483 0 0 0 0 13.8499 0 13.4182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23416 GLRA2_HUMAN Glycine receptor subunit alpha-2 GLRA2 Homo sapiens (Human) "cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission, glycinergic [GO:0060012]" GO:0004888; GO:0005231; GO:0005886; GO:0005887; GO:0007165; GO:0007218; GO:0007268; GO:0016594; GO:0016934; GO:0022852; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043200; GO:0045202; GO:0045211; GO:0046872; GO:0050877; GO:0060012; GO:0070161; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:1902476; GO:1904315 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] EEDVTRESR 0.99393 -5.2145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1204 0 0 0 0 0 12.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40337 VHL_HUMAN von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL) VHL Homo sapiens (Human) "cell morphogenesis [GO:0000902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; transcription elongation regulator activity [GO:0003711]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; cell morphogenesis [GO:0000902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of cell differentiation [GO:0045597]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000902; GO:0003711; GO:0004842; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0006355; GO:0006508; GO:0008285; GO:0010629; GO:0016020; GO:0016567; GO:0019899; GO:0034244; GO:0043066; GO:0045597; GO:0045893; GO:0046426; GO:0050821; GO:0061418; GO:0061428; GO:0140297; GO:1990756 DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; transcription elongation regulator activity [GO:0003711]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842] ERCLQVVR 0.99393 -7.9265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7062 0 0 0 0 0 0 P49585 PCY1A_HUMAN "Choline-phosphate cytidylyltransferase A, EC 2.7.7.15 (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A, CCT A, CT A) (Phosphorylcholine transferase A)" PCYT1A CTPCT PCYT1 Homo sapiens (Human) CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803]; CDP-choline pathway [GO:0006657]; phosphatidylcholine biosynthetic process [GO:0006656] GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006656; GO:0006657; GO:0031210; GO:0042587; GO:0042802; GO:0042803 calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803] DYDVYAR 0.99393 -5.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5172 0 11.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2473 0 0 0 0 0 0 0 0 0 0 0 0 0 P52306 GDS1_HUMAN Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein) RAP1GDS1 SMGGDS Homo sapiens (Human) angiotensin-activated signaling pathway involved in heart process [GO:0086098]; CAAX-box protein maturation [GO:0080120]; cardiac muscle hypertrophy [GO:0003300]; myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of GTPase activity [GO:0034260]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein localization to nucleus [GO:0034504]; regulation of ERK5 cascade [GO:0070376]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of mitochondrion organization [GO:0010821]; vascular associated smooth muscle contraction [GO:0014829] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; angiotensin-activated signaling pathway involved in heart process [GO:0086098]; CAAX-box protein maturation [GO:0080120]; cardiac muscle hypertrophy [GO:0003300]; myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of GTPase activity [GO:0034260]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein localization to nucleus [GO:0034504]; regulation of ERK5 cascade [GO:0070376]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of mitochondrion organization [GO:0010821]; vascular associated smooth muscle contraction [GO:0014829] GO:0003300; GO:0005085; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0010821; GO:0014829; GO:0031034; GO:0032471; GO:0034260; GO:0034504; GO:0043547; GO:0051561; GO:0070062; GO:0070376; GO:0080120; GO:0086098; GO:1904464 guanyl-nucleotide exchange factor activity [GO:0005085] KLKITAVDK 0.99393 -6.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5S007 LRRK2_HUMAN "Leucine-rich repeat serine/threonine-protein kinase 2, EC 2.7.11.1, EC 3.6.5.- (Dardarin)" LRRK2 PARK8 Homo sapiens (Human) "autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]" "amphisome [GO:0044753]; anchoring junction [GO:0070161]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]" "amphisome [GO:0044753]; anchoring junction [GO:0070161]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]; actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation [GO:1903125]; neuromuscular junction development [GO:0007528]; neuron death [GO:0070997]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron death [GO:1901214]; regulation of neuron maturation [GO:0014041]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]" GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0001933; GO:0001934; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0004722; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007165; GO:0007254; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010738; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016234; GO:0016242; GO:0016301; GO:0016310; GO:0017075; GO:0018105; GO:0018107; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031398; GO:0031410; GO:0031647; GO:0031966; GO:0032091; GO:0032092; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043406; GO:0044325; GO:0044753; GO:0044754; GO:0045121; GO:0045860; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051770; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070161; GO:0070585; GO:0070971; GO:0070973; GO:0070997; GO:0071287; GO:0071407; GO:0072593; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:1900244; GO:1901214; GO:1901215; GO:1901727; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903125; GO:1903206; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300 actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631] AAYEGEEVAVKIFNKHTSLR 0.99393 -14.042 0 0 0 0 0 0 0 0 0 12.1255 0 0 0 0 0 15.0218 0 14.931 0 11.1083 0 0 0 0 0 0 12.119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1313 0 13.5772 0 0 0 0 0 0 0 0 0 0 14.1007 0 0 0 0 0 0 0 0 0 11.5372 0 14.3276 14.7971 0 0 0 0 10.7348 13.6692 13.8675 0 0 0 0 0 0 0 12.513 12.5192 14.4134 0 0 0 0 0 0 12.6567 0 0 13.192 0 0 0 13.8284 13.8551 15.5251 13.4493 13.9087 14.0211 0 0 0 13.6376 0 0 0 14.082 12.6081 15.425 0 15.3585 0 0 0 10.8547 15.3917 0 15.0996 0 0 0 13.2168 0 0 0 11.5992 0 11.7405 13.8881 13.0403 0 0 13.915 0 13.8636 0 0 14.84 0 0 12.9566 0 11.3263 0 0 14.2206 11.783 10.7301 11.312 15.0647 15.4239 13.0823 12.8798 13.0822 0 0 0 13.0211 0 0 0 0 0 0 0 0 0 0 0 0 13.0899 0 0 Q6NUJ2 CK087_HUMAN Uncharacterized protein C11orf87 C11orf87 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DHCSGSR 0.99393 -11.199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4949 0 0 0 0 0 0 0 0 12.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.601 0 0 11.8381 0 0 0 12.4495 12.3699 0 0 12.0855 12.2851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6662 0 0 0 11.8429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1897 0 0 0 0 0 0 0 Q6NXP0 EFC12_HUMAN EF-hand calcium-binding domain-containing protein 12 EFCAB12 C3orf25 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] CGNRHFDEHCLPSTIHGDMR 0.99393 -8.6245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1678 0 0 18.4732 0 0 0 0 19.1559 0 0 0 11.2771 0 0 0 0 0 0 0 0 0 0 18.9084 10.351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7LDI9 GAK6_HUMAN "Endogenous retrovirus group K member 6 Gag polyprotein (HERV-K(C7) Gag protein) (HERV-K(HML-2.HOM) Gag protein) (HERV-K108 Gag protein) (HERV-K_7p22.1 provirus ancestral Gag polyprotein, Gag polyprotein)" ERVK-6 ERVK6 Homo sapiens (Human) viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032] GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032 nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] GPELVGPSESK 0.99393 -6.8848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6301 0 0 0 0 0 0 0 0 0 0 0 0 14.4453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BW04 SARG_HUMAN Specifically androgen-regulated gene protein SARG C1orf116 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] GO:0005737; GO:0005829; GO:0005886; GO:0070062 ALPITQPTPR 0.99393 -5.2119 0 0 0 0 0 0 0 0 0 11.4451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.289 0 0 14.0098 13.1927 0 0 0 0 0 0 0 0 0 0 0 13.8855 13.8518 14.7895 0 14.5367 0 13.4131 14.1294 0 0 0 0 13.8503 0 14.1308 0 0 13.4689 0 0 15.2222 0 15.0665 13.5799 13.8834 0 12.5601 0 0 0 0 0 0 0 12.8692 12.9913 0 0 0 0 13.9637 12.6845 0 13.2271 0 0 0 0 0 0 0 0 0 13.4147 0 0 0 0 0 0 0 0 12.9434 0 0 12.7374 0 0 0 13.4081 0 0 12.372 13.5549 0 0 0 0 0 0 0 0 0 0 0 13.285 0 0 0 0 13.2247 0 0 0 0 0 0 0 Q9H1K6 TLRN1_HUMAN Talin rod domain-containing protein 1 (Mesoderm development candidate 1) TLNRD1 MESDC1 Homo sapiens (Human) stress fiber [GO:0001725] stress fiber [GO:0001725]; actin binding [GO:0003779]; identical protein binding [GO:0042802] GO:0001725; GO:0003779; GO:0042802 actin binding [GO:0003779]; identical protein binding [GO:0042802] DTIIARTK 0.99393 -8.6259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1673 0 0 0 0 0 0 0 0 15.7517 0 0 0 0 0 15.3159 0 0 0 0 0 15.2608 0 14.9173 0 15.1493 14.6748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4761 Q9H5Z1 DHX35_HUMAN "Probable ATP-dependent RNA helicase DHX35, EC 3.6.4.13 (DEAH box protein 35)" DHX35 C20orf15 DDX35 Homo sapiens (Human) "in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013] "catalytic step 2 spliceosome [GO:0071013]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0005524; GO:0016887; GO:0071013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AAPVGPVKFWRPGTEGPGVSISEER 0.99393 -30.033 0 0 0 0 0 0 0 0 0 0 0 10.5574 0 0 0 0 12.6775 12.9388 12.2404 0 0 0 0 0 0 0 0 12.0791 0 13.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 12.449 0 13.0746 0 12.9588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2533 0 0 0 0 12.2032 0 0 0 13.5231 12.1267 12.1591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4032 0 0 0 0 0 0 13.7459 0 11.1888 14.452 11.2643 14.1624 0 0 0 0 0 0 0 0 0 0 13.7376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0481 0 0 0 0 0 0 13.6589 0 0 0 0 12.2802 0 0 0 0 0 13.6822 0 0 0 0 0 0 0 13.8652 Q9UBP0 SPAST_HUMAN "Spastin, EC 5.6.1.1 (Spastic paraplegia 4 protein)" SPAST ADPSP FSP2 KIAA1083 SPG4 Homo sapiens (Human) anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922] axon [GO:0030424]; axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877]; anterograde axonal transport [GO:0008089]; axonal transport of mitochondrion [GO:0019896]; axonogenesis [GO:0007409]; cytokinetic process [GO:0032506]; cytoskeleton-dependent cytokinesis [GO:0061640]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; metabolic process [GO:0008152]; microtubule bundle formation [GO:0001578]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle disassembly [GO:0051228]; nuclear membrane reassembly [GO:0031468]; positive regulation of cytokinesis [GO:0032467]; positive regulation of microtubule depolymerization [GO:0031117]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260] GO:0000281; GO:0000922; GO:0001578; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005789; GO:0005811; GO:0005813; GO:0005829; GO:0005874; GO:0006888; GO:0007084; GO:0007409; GO:0008017; GO:0008089; GO:0008152; GO:0008568; GO:0010458; GO:0016021; GO:0016853; GO:0016887; GO:0019896; GO:0030424; GO:0030496; GO:0031117; GO:0031410; GO:0031468; GO:0031965; GO:0032467; GO:0032506; GO:0034214; GO:0043014; GO:0044877; GO:0048471; GO:0048487; GO:0051013; GO:0051228; GO:0051260; GO:0061640; GO:0070062; GO:0071782; GO:0090148; GO:1904115 alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; protein-containing complex binding [GO:0044877] ALFAVAR 0.99393 -14.04 0 0 0 0 0 0 0 0 0 0 0 12.0344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6405 0 14.3025 0 0 11.5483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0398 0 0 0 0 0 0 0 0 0 0 0 13.0485 0 13.0111 0 13.0629 0 0 0 0 0 0 0 0 0 12.4853 0 12.5219 0 0 0 0 0 0 0 12.7384 0 0 0 0 0 0 0 0 0 11.2998 0 0 0 0 0 12.3052 0 0 0 0 0 0 12.3493 14.0312 12.5349 0 0 12.9679 0 0 0 12.0043 0 0 13.1902 0 0 0 13.2228 0 0 0 0 0 0 0 12.7675 0 0 0 0 0 0 0 0 0 0 0 0 11.726 0 0 0 0 0 0 11.9092 0 0 0 0 0 0 0 11.6534 11.5662 0 Q9UIC8 LCMT1_HUMAN "Leucine carboxyl methyltransferase 1, EC 2.1.1.233 (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1)" LCMT1 LCMT CGI-68 Homo sapiens (Human) C-terminal protein methylation [GO:0006481]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; protein modification process [GO:0036211]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; C-terminal protein methylation [GO:0006481]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of protein-containing complex assembly [GO:0031333]; protein methylation [GO:0006479]; protein modification process [GO:0036211]; regulation of apoptotic process [GO:0042981]; regulation of glucose metabolic process [GO:0010906]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] GO:0000086; GO:0003880; GO:0005654; GO:0005829; GO:0006479; GO:0006481; GO:0008757; GO:0010906; GO:0018423; GO:0031333; GO:0036211; GO:0042981; GO:0090266 protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757] ESSITSCCSTSSCDADDEGVRGTCEDASLCK 0.99393 -7.907 0 0 0 0 0 0 0 0 0 0 12.9489 0 11.3263 0 12.6814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8014 12.8527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3975 0 0 0 0 0 0 12.7542 0 0 0 12.1488 0 0 0 0 0 0 0 12.1364 0 11.7609 12.2198 0 10.8672 12.4323 0 0 0 0 0 0 0 0 0 0 10.7863 0 0 0 0 0 0 0 0 0 13.3176 0 0 0 0 0 11.2381 0 0 0 10.6705 0 0 0 11.5828 0 0 0 0 0 0 0 0 0 0 12.3455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9524 0 0 0 12.6915 0 0 0 0 0 0 12.8402 12.1251 0 0 0 10.8874 0 11.1089 0 12.7463 0 0 Q9UKZ4 TEN1_HUMAN "Teneurin-1, Ten-1 (Protein Odd Oz/ten-m homolog 1) (Tenascin-M1, Ten-m1) (Teneurin transmembrane protein 1) [Cleaved into: Ten-1 intracellular domain, IDten-1, Ten-1 ICD; Teneurin C-terminal-associated peptide, TCPA-1 (Ten-1 extracellular domain, Ten-1 ECD) ]" TENM1 ODZ1 TNM1 Homo sapiens (Human) heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuropeptide signaling pathway [GO:0007218]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of transcription by RNA polymerase III [GO:0006359] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neuropeptide signaling pathway [GO:0007218]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of transcription by RNA polymerase III [GO:0006359] GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005856; GO:0005886; GO:0005887; GO:0006359; GO:0006955; GO:0007157; GO:0007218; GO:0007399; GO:0008201; GO:0008285; GO:0016363; GO:0016607; GO:0030838; GO:0033138; GO:0042803; GO:0043005; GO:0043406; GO:0046982; GO:0048471; GO:0048666; GO:0050839; GO:0051491; GO:0090316 cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] ANSALSLTDTDHERK 0.99393 -6.8774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3523 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.32 0 0 0 12.0456 0 12.4133 0 0 0 0 14.3407 0 0 0 0 0 0 13.4644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9785 0 13.0954 0 0 0 0 11.5929 0 0 0 0 13.5489 0 0 0 0 0 0 0 0 0 0 12.8512 0 0 0 0 0 0 11.749 0 0 13.8644 0 11.0539 0 0 0 0 0 0 0 0 0 0 0 10.7394 0 0 0 14.6074 0 0 0 0 0 0 0 0 0 0 12.3955 0 Q9Y252 RNF6_HUMAN "E3 ubiquitin-protein ligase RNF6, EC 2.3.2.27 (RING-type E3 ubiquitin transferase RNF6)" RNF6 SPG2 Homo sapiens (Human) "axon extension [GO:0048675]; negative regulation of axon extension [GO:0030517]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon extension [GO:0048675]; negative regulation of axon extension [GO:0030517]; positive regulation of transcription, DNA-templated [GO:0045893]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006511; GO:0016567; GO:0016605; GO:0030424; GO:0030517; GO:0031965; GO:0043231; GO:0044314; GO:0045893; GO:0046872; GO:0048675; GO:0050681; GO:0060765; GO:0061630; GO:0070936; GO:0085020 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear androgen receptor binding [GO:0050681]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] EGSSQDR 0.99393 -11.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6707 0 0 0 0 0 0 0 0 0 11.2032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7641 0 0 O43633 CHM2A_HUMAN "Charged multivesicular body protein 2a (Chromatin-modifying protein 2a, CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1, Vps2-1, hVps2-1)" CHMP2A BC2 CHMP2 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of centriole elongation [GO:1903723]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]; phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; negative regulation of centriole elongation [GO:1903723]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005635; GO:0005643; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0010324; GO:0010458; GO:0010824; GO:0015031; GO:0016020; GO:0016236; GO:0019076; GO:0019904; GO:0030117; GO:0030496; GO:0031210; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0043162; GO:0045184; GO:0045324; GO:0046761; GO:0051258; GO:0051260; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1903543; GO:1903723; GO:1904903; GO:1904930 phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904] AMRELDRER 0.99394 -28.826 0 0 0 0 0 10.43 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6183 13.4288 0 0 0 0 0 13.8844 13.5613 14.0429 13.6534 13.2433 0 0 13.1607 13.8941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4795 12.9323 11.7346 0 12.773 0 0 12.4859 0 0 12.8772 0 0 12.3768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7908 0 12.9253 12.9831 0 0 0 0 0 0 0 14.9448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6738 O43825 B3GT2_HUMAN "Beta-1,3-galactosyltransferase 2, Beta-1,3-GalTase 2, Beta3Gal-T2, Beta3GalT2, EC 2.4.1.86 (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2)" B3GALT2 Homo sapiens (Human) galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; galactosylceramide biosynthetic process [GO:0006682]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]" GO:0000139; GO:0006486; GO:0006682; GO:0008194; GO:0008499; GO:0009312; GO:0016021; GO:0016757; GO:0047275 "glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" GTGHPNSYHFK 0.99394 -15.832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2047 0 0 0 0 0 0 0 0 12.9139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5908 14.0622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60241 AGRB2_HUMAN Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2) ADGRB2 BAI2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422] GO:0004930; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016021; GO:0016525; GO:0033173 G protein-coupled receptor activity [GO:0004930] ADESEDSPDSCK 0.99394 -12.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6658 12.9397 12.0714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4189 0 0 11.4837 0 0 0 0 0 14.4395 0 0 0 0 12.4637 0 0 10.663 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7488 0 0 0 12.1433 16.8259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5774 0 10.2181 0 0 0 0 0 0 0 0 0 10.9124 0 0 0 0 13.1821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94993 SOX30_HUMAN Transcription factor SOX-30 SOX30 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286] chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0043231; GO:0045944; GO:0120211; GO:1990837 "beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DYSSECTHSENSR 0.99394 -14.197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3782 0 0 0 0 0 0 0 0 0 13.5749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.162 0 0 0 0 0 0 0 0 11.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1194 0 0 0 0 0 0 0 0 13.5639 0 13.4774 0 0 0 12.3883 0 0 0 0 0 0 0 0 O95622 ADCY5_HUMAN "Adenylate cyclase type 5, EC 4.6.1.1 (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5, AC5)" ADCY5 Homo sapiens (Human) adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886] cilium [GO:0005929]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] GO:0001973; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007193; GO:0007195; GO:0007204; GO:0007626; GO:0008179; GO:0016021; GO:0035556; GO:0045111; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322 adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110] FDKLAAENHCLRIK 0.99394 -28.793 0 0 0 0 0 0 0 0 0 9.8337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9173 12.9978 12.4754 0 10.6801 11.6864 11.5329 11.6248 0 12.4515 14.8296 0 12.0499 11.5639 0 0 0 13.6725 0 0 0 13.8876 14.9043 14.8523 0 14.962 14.2718 13.4184 14.1981 12.951 14.7241 13.6348 14.313 12.9609 12.9115 13.2449 0 0 0 0 0 0 0 0 0 0 0 0 13.571 14.5355 0 0 0 0 0 0 0 0 0 13.3851 0 0 0 0 0 0 14.2876 0 12.5452 0 12.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.122 12.7753 0 13.6726 0 0 12.99 12.5551 0 0 0 0 0 0 0 12.3887 0 0 0 0 0 0 0 0 0 0 0 12.8702 0 0 0 0 0 0 0 11.4181 0 0 0 12.8735 0 0 0 0 12.6046 0 11.9741 0 0 0 0 12.6828 0 0 0 0 11.0287 0 0 0 0 14.6054 P15514 AREG_HUMAN "Amphiregulin, AR (Colorectum cell-derived growth factor, CRDGF)" AREG AREGB SDGF Homo sapiens (Human) cell-cell signaling [GO:0007267]; dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [GO:0060598]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERBB2-EGFR signaling pathway [GO:0038134]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell proliferation [GO:0014009]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; negative regulation of osteoblast differentiation [GO:0045668]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte proliferation [GO:0010838]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to peptide hormone [GO:0043434] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cell-cell signaling [GO:0007267]; dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [GO:0060598]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; ERBB2-EGFR signaling pathway [GO:0038134]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell proliferation [GO:0014009]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; negative regulation of osteoblast differentiation [GO:0045668]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte proliferation [GO:0010838]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to peptide hormone [GO:0043434] GO:0005125; GO:0005154; GO:0005576; GO:0005615; GO:0005634; GO:0005789; GO:0007173; GO:0007186; GO:0007267; GO:0008083; GO:0008284; GO:0009986; GO:0010838; GO:0012507; GO:0014009; GO:0016021; GO:0030297; GO:0030669; GO:0031175; GO:0032355; GO:0033116; GO:0038134; GO:0042542; GO:0043434; GO:0045668; GO:0045741; GO:0048018; GO:0051384; GO:0051591; GO:0060598; GO:0060744; GO:0060749; GO:0060750 cytokine activity [GO:0005125]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297] CQQEYFGER 0.99394 -6.8938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49354 FNTA_HUMAN "Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha, EC 2.5.1.58, EC 2.5.1.59 (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha, GGTase-I-alpha)" FNTA Homo sapiens (Human) neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179] CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965] CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0004660; GO:0004661; GO:0004662; GO:0004663; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0005953; GO:0005965; GO:0007179; GO:0008017; GO:0018343; GO:0018344; GO:0030548; GO:0030971; GO:0043014; GO:0045213; GO:0071340; GO:0090044; GO:0090045 acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971] DAIELNAANYTVWHFRRVLLK 0.99394 -9.1011 0 0 0 0 0 0 10.302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0809 0 0 12.6783 0 0 0 0 0 13.3106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.306 0 0 0 0 12.6843 0 0 Q13474 DRP2_HUMAN "Dystrophin-related protein 2, DRP-2" DRP2 Homo sapiens (Human) central nervous system development [GO:0007417]; synapse organization [GO:0050808]; synaptic signaling [GO:0099536] anchoring junction [GO:0070161]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; zinc ion binding [GO:0008270]; central nervous system development [GO:0007417]; synapse organization [GO:0050808]; synaptic signaling [GO:0099536] GO:0005886; GO:0007417; GO:0008270; GO:0014069; GO:0030425; GO:0043204; GO:0050808; GO:0070161; GO:0098978; GO:0099536 zinc ion binding [GO:0008270] DFATTLK 0.99394 -15.847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2958 0 Q5JVS0 HABP4_HUMAN "Intracellular hyaluronan-binding protein 4, IHABP-4, IHABP4 (Hyaluronan-binding protein 4) (Ki-1/57 intracellular antigen)" HABP4 Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; mRNA processing [GO:0006397]; negative regulation of DNA binding [GO:0043392]; PML body organization [GO:0030578]; positive regulation of RNA splicing [GO:0033120]; positive regulation of translational initiation [GO:0045948]; RNA splicing [GO:0008380] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Gemini of coiled bodies [GO:0097504]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sarcomere [GO:0030017]; sarcoplasm [GO:0016528] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Gemini of coiled bodies [GO:0097504]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; sarcomere [GO:0030017]; sarcoplasm [GO:0016528]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; cellular response to mechanical stimulus [GO:0071260]; mRNA processing [GO:0006397]; negative regulation of DNA binding [GO:0043392]; PML body organization [GO:0030578]; positive regulation of RNA splicing [GO:0033120]; positive regulation of translational initiation [GO:0045948]; RNA splicing [GO:0008380] GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0010494; GO:0015030; GO:0016528; GO:0016607; GO:0030017; GO:0030578; GO:0031965; GO:0032183; GO:0033120; GO:0043392; GO:0045948; GO:0071260; GO:0097504 RNA binding [GO:0003723]; SUMO binding [GO:0032183] AERRSYR 0.99394 -30.637 0 0 14.2403 0 12.6492 0 0 0 0 0 0 0 0 0 0 11.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5963 13.9872 0 0 0 0 0 0 0 13.1735 0 13.7204 0 0 0 0 0 0 0 0 0 13.0926 0 0 0 0 0 13.3786 0 0 0 0 0 0 13.4565 0 0 0 0 13.6805 0 0 0 0 14.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9579 0 11.7105 0 0 0 0 0 0 0 0 0 0 13.1916 0 13.3073 0 Q5KSL6 DGKK_HUMAN "Diacylglycerol kinase kappa, DAG kinase kappa, DGK-kappa, EC 2.7.1.107 (142 kDa diacylglycerol kinase) (Diglyceride kinase kappa)" DGKK Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to oxidative stress [GO:0006979] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; response to oxidative stress [GO:0006979] GO:0003951; GO:0004143; GO:0005524; GO:0005886; GO:0006979; GO:0007205; GO:0030168; GO:0035556; GO:0046339; GO:0046834; GO:0046872 ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951] EDEAEGDDPLTPSR 0.99394 -30.426 0 0 0 0 0 0 0 0 0 0 12.5208 0 0 0 0 0 0 0 0 0 13.2972 11.0342 0 0 12.4833 13.3252 12.7515 0 11.2074 0 0 0 0 13.1249 0 0 0 0 0 0 12.1244 13.1485 0 0 0 13.217 0 0 0 13.2114 11.9837 0 13.5672 13.8088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.208 0 0 0 0 0 0 0 0 11.9731 0 13.3451 0 14.8424 0 0 0 0 14.2091 0 13.313 11.9122 13.5968 13.4852 12.7895 0 0 0 13.192 12.9745 0 13.1334 0 13.0125 0 0 0 0 13.1803 0 0 0 0 0 0 12.6547 0 0 19.8244 0 0 0 12.5336 0 0 0 0 14.2862 0 13.4838 12.0365 16.5939 0 0 0 12.7593 0 0 13.3602 13.4886 0 0 0 0 0 0 0 0 0 14.5014 0 0 0 0 0 0 0 0 13.7481 0 0 0 0 0 0 0 0 0 0 0 0 14.3611 0 0 13.1364 0 0 13.7457 0 14.0483 0 0 Q7Z5A4 PRS42_HUMAN "Putative serine protease 42, EC 3.4.21.- (Serine protease 42, pseudogene) (Testis serine protease 2)" PRSS42P PRSS42 TESSP2 Homo sapiens (Human) cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; cell differentiation [GO:0030154]; proteolysis [GO:0006508]; spermatogenesis [GO:0007283] GO:0004252; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0007283; GO:0030154; GO:0031225 serine-type endopeptidase activity [GO:0004252] GMVCGYK 0.99394 -9.1025 0 0 0 0 0 0 0 0 0 11.6654 0 0 0 0 12.1094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3309 0 0 0 13.0342 0 12.0112 0 0 0 0 0 0 0 12.7759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4809 13.0632 0 0 0 0 0 0 16.9523 0 0 0 0 0 0 0 0 0 12.8229 0 0 12.3683 0 0 0 0 0 0 0 0 0 0 12.6834 0 12.9008 0 12.3982 0 0 0 0 0 0 0 12.4086 0 0 0 0 0 12.7928 13.2939 0 0 0 0 0 0 0 0 0 14.0777 17.3448 0 12.9196 0 0 0 0 0 0 0 0 Q86X29 LSR_HUMAN Lipolysis-stimulated lipoprotein receptor (Angulin-1) LSR ILDR3 LISCH Homo sapiens (Human) epithelial structure maintenance [GO:0010669]; establishment of blood-brain barrier [GO:0060856]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; maintenance of blood-brain barrier [GO:0035633]; protein localization to tricellular tight junction [GO:0061833]; tricellular tight junction assembly [GO:1904274] bicellular tight junction [GO:0005923]; chylomicron [GO:0042627]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; very-low-density lipoprotein particle [GO:0034361] bicellular tight junction [GO:0005923]; chylomicron [GO:0042627]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; tricellular tight junction [GO:0061689]; very-low-density lipoprotein particle [GO:0034361]; epithelial structure maintenance [GO:0010669]; establishment of blood-brain barrier [GO:0060856]; establishment of skin barrier [GO:0061436]; liver development [GO:0001889]; maintenance of blood-brain barrier [GO:0035633]; protein localization to tricellular tight junction [GO:0061833]; tricellular tight junction assembly [GO:1904274] GO:0001889; GO:0005886; GO:0005923; GO:0010669; GO:0016020; GO:0016021; GO:0034361; GO:0034362; GO:0035633; GO:0042627; GO:0060856; GO:0061436; GO:0061689; GO:0061833; GO:0070062; GO:0070160; GO:1904274 DDLYDQDDSR 0.99394 -28.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0821 14.1028 0 0 0 14.318 0 0 0 0 0 0 12.0802 14.168 0 0 12.4341 0 0 0 17.8001 0 10.8055 0 14.2251 0 0 0 0 0 14.5922 14.4543 0 0 0 0 14.9284 0 14.4646 0 0 14.3273 0 0 14.5369 0 0 0 15.5513 0 13.9612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9793 0 0 0 0 15.2088 0 Q8N0Z3 SPICE_HUMAN Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein) SPICE1 CCDC52 SPICE Homo sapiens (Human) cell division [GO:0051301]; metaphase plate congression [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819]; cell division [GO:0051301]; metaphase plate congression [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599] GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0046599; GO:0051301; GO:0051310; GO:0090307 CSTVSPVSGINTRR 0.99394 -15.847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8615 0 0 0 0 0 0 0 13.8005 12.73 0 10.3432 0 13.8999 12.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3819 0 0 12.0693 0 0 0 0 0 0 0 0 0 0 0 13.9959 0 0 0 17.1719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0067 0 17.8087 0 0 0 0 17.0649 0 12.3615 0 0 0 0 17.0626 0 0 12.8216 0 0 0 0 0 13.5263 14.0111 0 0 17.2331 0 16.306 0 0 0 0 0 0 0 0 0 0 0 18.0478 17.9319 18.0076 0 0 0 0 14.0956 0 0 0 0 14.4859 0 0 0 0 0 0 0 17.7968 0 0 0 14.8769 0 0 Q8NEG2 CG057_HUMAN Uncharacterized protein C7orf57 C7orf57 Homo sapiens (Human) ADSDKRTPK 0.99394 -28.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0538 0 0 0 0 0 0 0 0 0 11.1465 0 0 0 12.1835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6351 0 0 0 0 0 0 0 10.9021 0 0 0 14.3714 0 14.8929 0 0 0 0 0 0 0 0 14.686 13.8555 0 10.5502 14.7198 14.5977 0 0 0 0 0 11.8925 0 0 0 0 0 0 0 0 14.6674 0 14.6554 0 0 13.3876 12.7062 14.3437 0 0 0 12.4953 0 10.6428 12.5349 13.0153 0 0 0 14.7836 13.1508 0 0 0 0 0 0 0 15.2366 0 13.2311 0 10.5529 0 0 0 0 0 0 0 0 0 12.4455 0 0 0 11.1856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3567 0 0 0 0 Q96MT7 CFA44_HUMAN Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52) CFAP44 WDR52 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; microtubule cytoskeleton organization [GO:0000226]; sperm axoneme assembly [GO:0007288] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; peptidase activity [GO:0008233]; cilium assembly [GO:0060271]; cilium-dependent cell motility [GO:0060285]; microtubule cytoskeleton organization [GO:0000226]; sperm axoneme assembly [GO:0007288] GO:0000226; GO:0005737; GO:0005856; GO:0007288; GO:0008233; GO:0031514; GO:0060271; GO:0060285 peptidase activity [GO:0008233] DQTVFFFEVER 0.99394 -28.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5436 11.3657 0 0 0 0 0 0 0 0 10.6551 0 0 13.4391 0 0 0 0 0 0 0 10.4432 0 0 11.2619 11.4683 0 0 0 13.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7453 11.3225 0 12.89 0 10.4683 0 0 0 0 0 0 0 0 12.967 0 14.2628 12.3824 12.8886 0 11.5196 0 0 0 13.9764 12.8568 14.6908 0 0 0 0 13.7015 0 14.2102 0 0 0 0 0 0 13.8689 13.431 0 0 13.0445 13.6484 14.0937 12.8512 0 0 12.1974 0 0 0 0 14.3652 0 0 0 0 0 12.5955 0 0 0 0 11.3004 0 12.8886 11.1346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8975 0 0 0 12.5263 0 14.587 0 0 13.8843 14.0374 13.8189 0 13.8404 15.1363 0 13.0613 0 0 0 13.6026 0 0 0 0 0 16.02 Q96RT7 GCP6_HUMAN "Gamma-tubulin complex component 6, GCP-6" TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin large complex [GO:0000931]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225] GO:0000278; GO:0000922; GO:0000923; GO:0000930; GO:0000931; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321 gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017] AALEEGSSQPTER 0.99394 -12.974 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2177 0 0 0 0 0 0 12.5207 0 0 0 0 0 0 0 0 11.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5954 0 0 12.2601 0 15.5783 0 12.4862 0 0 12.5718 0 12.4672 12.5184 0 0 0 0 13.725 0 0 0 0 0 0 15.2532 0 0 12.7466 0 0 0 13.9569 13.2519 13.0946 0 0 0 0 0 11.7284 14.7778 0 0 0 12.7053 14.4343 0 0 0 0 11.9925 0 12.1288 0 12.1968 0 0 11.7036 0 0 0 11.7411 0 12.5341 0 0 0 0 0 0 14.2273 12.2066 0 0 13.0339 12.9001 0 0 0 0 13.4945 0 0 12.2907 12.847 0 11.9431 0 0 0 0 0 0 12.2103 0 12.9473 14.7598 13.1909 0 0 Q9H6A9 PCX3_HUMAN Pecanex-like protein 3 (Pecanex homolog protein 3) PCNX3 PCNXL3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALWGGPISLGAIAHWLLRTWERLHK 0.99394 -28.829 0 14.6699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6999 0 0 14.0493 0 0 0 0 0 0 0 13.2892 0 0 0 0 0 0 0 13.0772 0 0 11.9877 0 0 0 0 0 0 13.1261 13.6965 15.6335 0 0 12.8644 0 0 15.079 13.6766 0 0 0 0 11.2927 12.3982 0 13.0766 0 0 12.5637 0 0 0 13.594 12.6771 13.5735 0 13.937 0 0 12.2327 0 0 0 0 0 0 0 0 12.4424 0 0 0 13.5798 0 12.8899 16.2159 0 12.6959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3002 0 0 13.1891 0 14.4224 0 0 14.4073 O43615 TIM44_HUMAN Mitochondrial import inner membrane translocase subunit TIM44 TIMM44 MIMT44 TIM44 Homo sapiens (Human) intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626] GO:0001650; GO:0005524; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0006626; GO:0006886; GO:0030150; GO:0051087 ATP binding [GO:0005524]; chaperone binding [GO:0051087] ENNVVFNR 0.99395 -13.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6551 0 0 0 0 0 0 0 0 12.5099 0 0 0 0 0 0 0 0 0 13.1801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4442 0 0 11.7893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8666 14.2606 0 0 0 0 0 0 0 0 0 0 11.8696 0 0 18.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9699 0 0 P00746 CFAD_HUMAN "Complement factor D, EC 3.4.21.46 (Adipsin) (C3 convertase activator) (Properdin factor D)" CFD DF PFD Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; Notch signaling pathway [GO:0007219]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; Notch signaling pathway [GO:0007219]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]" GO:0004252; GO:0005576; GO:0006508; GO:0006956; GO:0006957; GO:0007219; GO:0008236; GO:0009617; GO:0031093; GO:0034774; GO:0070062; GO:1904813 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] ATLGPAVRPLPWQR 0.99395 -5.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0334 0 12.9915 0 0 0 0 0 0 0 13.7627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8208 12.872 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6948 0 13.1771 12.9646 0 0 0 0 0 12.2411 0 0 0 0 0 0 0 0 0 P15260 INGR1_HUMAN "Interferon gamma receptor 1, IFN-gamma receptor 1, IFN-gamma-R1 (CDw119) (Interferon gamma receptor alpha-chain, IFN-gamma-R-alpha) (CD antigen CD119)" IFNGR1 Homo sapiens (Human) astrocyte activation [GO:0048143]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; microglial cell activation [GO:0001774]; negative regulation of amyloid-beta clearance [GO:1900222]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of gene expression [GO:0010628]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interferon-gamma receptor activity [GO:0004906]; astrocyte activation [GO:0048143]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; interferon-gamma-mediated signaling pathway [GO:0060333]; microglial cell activation [GO:0001774]; negative regulation of amyloid-beta clearance [GO:1900222]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of gene expression [GO:0010628]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; signal transduction [GO:0007165] GO:0001774; GO:0004896; GO:0004906; GO:0005886; GO:0005887; GO:0007165; GO:0009615; GO:0010628; GO:0019221; GO:0019955; GO:0032760; GO:0048143; GO:0060333; GO:0098586; GO:1900222; GO:1902004 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interferon-gamma receptor activity [GO:0004906] APTSFGYDK 0.99395 -10.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4835 0 0 12.7022 0 13.3032 0 0 0 0 0 0 0 0 12.4221 0 0 0 0 0 0 0 0 0 12.5572 0 0 0 0 11.3888 0 0 0 0 13.0521 0 0 0 0 0 0 0 0 13.4597 11.9527 0 11.9546 0 0 13.0255 0 0 13.9968 0 12.0326 0 0 0 0 0 0 10.8999 13.7232 0 13.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3811 0 0 Q5TCQ9 MAGI3_HUMAN "Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3, MAGI-3)" MAGI3 KIAA1634 Homo sapiens (Human) apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; molecular adaptor activity [GO:0060090]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165] GO:0004385; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0006915; GO:0007165; GO:0016020; GO:0030054; GO:0035556; GO:0046328; GO:0060090 ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; molecular adaptor activity [GO:0060090] DLDVFLR 0.99395 -30.713 0 0 0 0 0 0 0 0 11.8175 0 0 16.0604 0 0 0 0 0 13.4404 0 0 0 10.3746 0 12.0229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6418 12.873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1134 0 0 0 0 0 0 11.6138 0 12.0989 0 14.2245 0 14.6716 0 0 0 0 13.7294 0 13.6564 10.9261 13.0505 0 0 0 13.6911 0 12.1295 0 0 0 13.0201 0 0 13.9577 13.3055 0 0 12.0606 0 11.6868 0 0 14.1214 0 13.5638 15.5728 0 12.7993 0 0 0 0 14.4166 0 13.7613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9413 13.9035 12.8949 12.6115 12.0827 13.4303 0 0 0 0 0 14.7563 0 0 0 0 Q6PF05 TT23L_HUMAN Tetratricopeptide repeat protein 23-like TTC23L Homo sapiens (Human) response to endoplasmic reticulum stress [GO:0034976] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle [GO:0005819] cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle [GO:0005819]; response to endoplasmic reticulum stress [GO:0034976] GO:0005737; GO:0005815; GO:0005819; GO:0030496; GO:0034976 DAVEIYFIR 0.99395 -13.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7728 13.1321 0 0 0 0 0 0 0 14.5134 0 0 0 0 12.9656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4872 0 0 0 0 0 0 0 0 Q92610 ZN592_HUMAN Zinc finger protein 592 ZNF592 KIAA0211 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] CLECHKQMR 0.99395 -10.995 0 0 0 0 0 0 0 0 0 11.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.39 0 0 0 0 0 0 9.75739 11.3303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6858 12.5764 0 0 10.3621 0 0 0 12.2974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7001 14.5758 0 0 0 0 0 0 0 10.9803 0 0 0 0 0 0 10.7731 12.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.494 0 14.0194 0 0 0 0 0 0 0 0 0 0 12.1673 0 11.4933 12.1649 0 0 0 0 0 0 0 0 0 10.9018 0 0 0 0 0 0 Q96MT4 CF195_HUMAN Uncharacterized protein encoded by LINC01600 LINC01600 C6orf195 Homo sapiens (Human) EISNEAF 0.99395 -13.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV90 SNR25_HUMAN "U11/U12 small nuclear ribonucleoprotein 25 kDa protein, U11/U12 snRNP 25 kDa protein, U11/U12-25K (Minus-99 protein)" SNRNP25 C16orf33 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689] "cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0005829; GO:0008380; GO:0045171 DYGIRNR 0.99395 -13.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.226 0 12.4628 0 0 0 0 0 0 0 0 0 0 0 0 13.3925 0 13.256 0 0 0 0 0 13.6455 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2332 0 0 0 13.2654 0 0 0 11.366 0 0 0 0 0 0 0 12.8961 0 0 11.4358 0 0 0 0 0 0 0 0 12.8409 12.6867 0 13.4277 12.5593 0 0 0 0 0 0 13.3674 0 0 0 0 0 12.733 0 0 0 12.9562 0 0 Q9BX10 GTPB2_HUMAN GTP-binding protein 2 GTPBP2 Homo sapiens (Human) translational elongation [GO:0006414] extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746]; translational elongation [GO:0006414] GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; translation elongation factor activity [GO:0003746] ARLNLFR 0.99395 -13.086 0 0 0 0 0 0 0 0 0 0 0 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5248 0 0 0 0 13.9283 14.3916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2571 0 14.0289 0 0 0 0 0 0 0 0 0 0 0 0 12.3615 11.0843 0 0 0 0 0 0 0 16.3823 0 0 15.861 0 0 0 0 15.1442 0 0 16.1578 0 13.9793 0 14.3783 0 0 0 0 0 0 Q9BYN8 RT26_HUMAN "28S ribosomal protein S26, mitochondrial, MRP-S26, S26mt (28S ribosomal protein S13, mitochondrial, MRP-S13, S13mt) (Mitochondrial small ribosomal subunit protein mS26)" MRPS26 C20orf193 RPMS13 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543] GO:0003723; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543 RNA binding [GO:0003723] AGVLAER 0.99395 -30.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4817 0 0 0 0 12.8826 0 0 0 0 13.0117 0 0 16.8775 13.8876 0 13.0664 12.7186 13.2733 13.535 0 0 0 0 0 0 13.6989 13.7973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9888 15.1323 0 0 0 0 0 14.8061 0 0 0 0 0 0 0 0 14.6756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5871 0 13.3382 14.209 0 0 12.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2564 0 0 0 0 0 0 0 13.3403 13.3451 0 0 0 0 0 0 13.4285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P283 SEM5B_HUMAN Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; axon guidance [GO:0007411]; detection of light stimulus involved in visual perception [GO:0050908]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0007411; GO:0016021; GO:0030215; GO:0030335; GO:0045499; GO:0048675; GO:0048843; GO:0050908; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] ACENGNSCLGCGVEFK 0.99395 -6.4687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7453 0 0 0 0 11.4105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15049 N4BP3_HUMAN "NEDD4-binding protein 3, N4BP3" N4BP3 KIAA0341 Homo sapiens (Human) innate immune response [GO:0045087]; nervous system development [GO:0007399] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; innate immune response [GO:0045087]; nervous system development [GO:0007399] GO:0007399; GO:0030424; GO:0030425; GO:0031410; GO:0045087 EAQAELAQKLAEIFSLK 0.99396 -13.104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2026 0 0 0 0 11.9447 0 0 0 0 0 0 0 0 0 0 11.7612 0 10.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9773 13.961 0 0 0 0 0 16.5561 0 0 0 0 13.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3789 0 0 0 0 12.5818 0 0 0 0 0 0 0 0 0 0 0 13.5736 0 12.6968 0 0 11.875 0 0 0 0 0 14.0557 0 0 0 0 0 0 11.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1574 0 0 13.363 0 12.8849 0 0 0 0 0 18.9144 P48507 GSH0_HUMAN Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit) GCLM GLCLR Homo sapiens (Human) aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109] cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410] GO:0004357; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007568; GO:0007584; GO:0008637; GO:0009410; GO:0014823; GO:0017109; GO:0030234; GO:0035226; GO:0035229; GO:0035729; GO:0035733; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237 enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877] AAKALLAR 0.99396 -13.869 0 0 0 0 0 0 0 13.5215 0 0 0 0 0 0 0 0 0 0 0 0 14.1601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1557 0 0 0 0 13.4423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13188 STK3_HUMAN "Serine/threonine-protein kinase 3, EC 2.7.11.1 (Mammalian STE20-like protein kinase 2, MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit, MST2/N; Serine/threonine-protein kinase 3 20kDa subunit, MST2/C ]" STK3 KRS1 MST2 Homo sapiens (Human) apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165] GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006606; GO:0006915; GO:0007165; GO:0007254; GO:0007417; GO:0008625; GO:0032092; GO:0032991; GO:0035265; GO:0035329; GO:0035556; GO:0042802; GO:0043065; GO:0043408; GO:0043491; GO:0043539; GO:0045600; GO:0046330; GO:0046621; GO:0050673; GO:0050680; GO:0050821; GO:0051091; GO:0051262; GO:0051897; GO:0060070; GO:0060215; GO:0060706; GO:0060800; GO:0090090; GO:0097284; GO:0106310; GO:1902043 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674] EQPPAPKSKLK 0.99396 -13.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9088 0 0 0 0 0 0 0 0 0 0 11.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.308 0 0 0 0 0 0 0 13.0045 Q14644 RASA3_HUMAN Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein) RASA3 Homo sapiens (Human) negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235] cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0007165; GO:0015278; GO:0031235; GO:0043087; GO:0046580; GO:0046872 calcium-release channel activity [GO:0015278]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] DWIDILTK 0.99396 -13.901 0 0 0 0 0 0 0 11.2634 0 0 0 0 14.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5041 13.9504 0 0 0 0 13.1757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4862 0 0 0 0 0 0 0 0 0 0 0 13.9303 0 0 15.5832 0 0 0 0 0 0 0 14.0066 0 0 10.7554 0 0 0 0 0 0 14.6261 0 0 0 0 0 0 0 0 15.1464 0 0 0 0 0 0 0 0 0 0 13.973 15.1235 0 0 0 0 0 0 0 0 0 0 12.5689 0 0 14.1855 0 0 0 0 0 0 0 0 0 0 12.0133 0 0 0 0 0 13.6393 0 0 0 12.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15291 RBBP5_HUMAN "Retinoblastoma-binding protein 5, RBBP-5 (Retinoblastoma-binding protein RBQ-3)" RBBP5 RBQ3 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; response to estrogen [GO:0043627] histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone H3-K4 methylation [GO:0051568]; response to estrogen [GO:0043627] GO:0000976; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006974; GO:0035064; GO:0035097; GO:0043627; GO:0044665; GO:0044666; GO:0048188; GO:0051568; GO:0071339 methylated histone binding [GO:0035064]; transcription cis-regulatory region binding [GO:0000976] GDGKSKK 0.99396 -5.0571 0 0 0 0 0 0 0 12.1999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7847 0 0 0 0 0 0 13.3482 0 0 15.1148 0 0 0 0 0 0 17.3357 17.2965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8145 13.5223 0 0 14.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JST6 EFHC2_HUMAN EF-hand domain-containing family member C2 EFHC2 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of neuron projection development [GO:0010975] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; mitotic spindle [GO:0072686]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium-dependent cell motility [GO:0060285]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of neuron projection development [GO:0010975] GO:0000281; GO:0005509; GO:0005879; GO:0005930; GO:0007052; GO:0010975; GO:0036064; GO:0043014; GO:0060285; GO:0072686; GO:1990830 alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509] MFLRRSK 0.99396 -8.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4664 0 0 0 0 15.7831 0 0 0 0 0 0 0 0 0 0 0 0 12.4427 0 13.4795 0 0 0 0 0 0 14.4001 12.9158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6808 0 0 0 0 0 14.031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3425 0 0 0 0 0 Q66K66 TM198_HUMAN Transmembrane protein 198 TMEM198 Homo sapiens (Human) positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055] GO:0005886; GO:0016021; GO:0016055; GO:0031410; GO:0090263 QTGSSLSSFMASPTDADYEYGSR 0.99396 -8.7419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.634 0 0 0 12.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0157 0 0 0 0 0 11.5365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6789 0 0 0 0 0 0 0 0 0 0 0 12.2069 0 0 0 0 0 13.3192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P4E1 GOLM2_HUMAN "Protein GOLM2 (Cancer susceptibility candidate gene 4 protein, CASC4) (Golgi membrane protein 2)" GOLM2 CASC4 UNQ2573/PRO6308 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] GO:0005794; GO:0016021 GGDAGMPGIEENDLAK 0.99396 -13.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1067 0 12.8411 0 0 0 11.7696 0 11.8863 0 0 0 15.4613 0 0 16.6855 0 0 16.0631 0 13.0975 15.7861 15.8212 15.7498 15.7206 0 15.7617 0 13.625 14.665 13.5968 0 0 0 0 13.7051 0 0 0 0 14.9389 14.9249 0 0 0 0 14.033 0 0 0 0 14.6257 0 0 0 13.6344 0 0 13.4799 0 0 0 0 0 0 0 0 0 0 0 13.4151 0 13.5302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4086 0 0 0 0 0 12.5879 0 12.9643 0 0 0 0 13.3225 0 0 0 0 0 0 Q7Z4I7 LIMS2_HUMAN "LIM and senescent cell antigen-like-containing domain protein 2 (LIM-like protein 2) (Particularly interesting new Cys-His protein 2, PINCH-2)" LIMS2 PINCH2 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cholangiocyte proliferation [GO:1990705]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte proliferation [GO:1904055]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural precursor cell proliferation [GO:0061351]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cholangiocyte proliferation [GO:1990705]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte proliferation [GO:1904055]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural precursor cell proliferation [GO:0061351]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005925; GO:0007229; GO:0043066; GO:0045216; GO:0046872; GO:0061351; GO:0098609; GO:1900026; GO:1904055; GO:1990705; GO:2000178; GO:2000346; GO:2001046 metal ion binding [GO:0046872] ATDLNSA 0.99396 -13.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3336 0 0 0 14.2223 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9108 14.9269 14.9571 0 0 15.0432 0 0 11.8512 0 0 0 14.9014 0 0 0 0 14.6383 0 0 0 0 14.1775 0 13.9274 14.9076 0 0 0 0 0 0 15.8893 0 0 0 0 14.6091 14.6214 0 0 0 0 14.3838 14.1943 0 0 0 0 14.596 0 0 0 11.1373 14.4058 0 0 0 0 0 0 14.4089 0 0 0 0 0 11.8095 14.7708 0 14.1524 0 0 0 0 0 0 0 14.0342 0 14.7883 0 0 0 0 0 14.694 0 0 0 0 0 11.3313 0 0 0 0 0 0 0 0 0 0 0 11.3953 0 13.1767 0 0 Q7Z6G8 ANS1B_HUMAN "Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1, AIDA-1) (E2A-PBX1-associated protein, EB-1)" ANKS1B Homo sapiens (Human) ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383] anchoring junction [GO:0070161]; Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383] GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013; GO:0070161; GO:1900383 ephrin receptor binding [GO:0046875] ALIDMHLSK 0.99396 -5.2682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.962 0 0 0 0 0 0 0 0 0 0 0 0 11.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6025 12.654 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2489 0 15.4664 0 0 0 13.9019 0 0 0 13.6115 0 0 0 0 14.5742 0 16.5564 0 0 0 0 0 15.316 12.8658 14.1243 0 0 13.9217 0 0 0 0 15.2573 13.184 0 14.009 14.7463 0 0 0 13.9254 0 0 0 11.0492 13.6353 12.6603 0 13.0997 0 0 13.6498 0 13.1418 0 11.9418 0 0 0 0 0 11.5297 17.9182 0 17.3175 0 0 14.2177 12.9206 12.6914 14.8209 0 0 0 0 12.7965 0 0 0 0 0 12.1744 12.3516 0 0 0 0 0 0 12.905 0 0 0 0 0 0 12.6625 0 0 0 0 0 0 0 13.8515 0 0 Q8IV77 CNGA4_HUMAN "Cyclic nucleotide-gated cation channel alpha-4 (Cyclic nucleotide-gated channel alpha-4, CNG channel alpha-4, CNG-4, CNG4)" CNGA4 Homo sapiens (Human) cation transmembrane transport [GO:0098655]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; Golgi-associated vesicle membrane [GO:0030660]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877]; cation transmembrane transport [GO:0098655]; response to stimulus [GO:0050896]; sensory perception of smell [GO:0007608] GO:0005222; GO:0005223; GO:0005886; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0030660; GO:0044877; GO:0050896; GO:0060170; GO:0098655 cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellular cAMP-activated cation channel activity [GO:0005222]; intracellular cGMP-activated cation channel activity [GO:0005223]; protein-containing complex binding [GO:0044877] DEEGRASQEGPPGPE 0.99396 -13.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6437 0 14.0949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5325 0 0 0 0 0 0 10.9302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2615 0 0 14.3508 14.4361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N157 AHI1_HUMAN "Jouberin (Abelson helper integration site 1 protein homolog, AHI-1)" AHI1 Homo sapiens (Human) central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; motile cilium assembly [GO:0044458]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization [GO:0008104]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730] adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730]; identical protein binding [GO:0042802]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; Kupffer's vesicle development [GO:0070121]; left/right axis specification [GO:0070986]; morphogenesis of a polarized epithelium [GO:0001738]; motile cilium assembly [GO:0044458]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric duct morphogenesis [GO:0039023]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization [GO:0008104]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vesicle-mediated transport [GO:0016192] GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0008104; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0039023; GO:0042802; GO:0043066; GO:0044458; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0070121; GO:0070986; GO:0071599; GO:0097730 identical protein binding [GO:0042802] ANEGREETDLEEDEELMQAYQCHVTEEMAK 0.99396 -13.127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9875 0 0 0 0 0 0 0 0 0 0 0 0 13.8591 10.7463 0 0 0 14.9295 0 0 0 0 0 0 0 12.1557 0 0 0 0 0 0 13.2994 0 12.1249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0444 0 0 0 0 13.8175 0 0 0 0 0 0 0 0 12.6407 0 0 0 0 0 0 0 15.1638 0 0 0 13.3483 0 0 16.1558 0 0 0 14.4049 0 0 16.049 13.3147 0 0 0 0 0 0 0 15.2365 12.831 0 0 0 0 0 0 0 12.8296 13.8361 12.9066 11.8251 0 14.7642 12.7081 0 11.8207 0 0 0 0 0 0 0 0 0 0 12.4945 15.0002 0 0 14.7642 9.62183 13.0383 0 0 0 12.2544 0 0 0 14.3485 0 13.7763 12.926 0 12.7367 11.8963 0 0 0 0 0 0 0 0 12.7755 0 0 0 12.7619 12.9853 9.11486 12.845 0 11.8621 Q8N957 ANKF1_HUMAN Ankyrin repeat and fibronectin type-III domain-containing protein 1 ANKFN1 Homo sapiens (Human) establishment of mitotic spindle orientation [GO:0000132]; regulation of establishment of bipolar cell polarity [GO:0061172] spindle [GO:0005819] spindle [GO:0005819]; establishment of mitotic spindle orientation [GO:0000132]; regulation of establishment of bipolar cell polarity [GO:0061172] GO:0000132; GO:0005819; GO:0061172 AWEWRYR 0.99396 -5.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7767 0 0 0 0 0 0 0 0 14.2617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5447 16.0271 0 0 0 0 0 0 11.2722 0 0 0 0 0 0 15.6088 0 0 14.1028 0 0 0 12.5189 0 0 0 0 0 10.2152 0 0 0 0 0 0 0 12.0043 0 0 11.3779 0 0 0 0 0 0 0 0 0 0 11.9258 0 0 0 0 0 0 0 0 0 Q8TCN5 ZN507_HUMAN Zinc finger protein 507 ZNF507 KIAA1084 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] GO:0003677; GO:0005634; GO:0010468; GO:0045944; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] CDVCDYTSTTYVGVR 0.99396 -5.0531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1402 14.4325 0 0 0 0 0 0 13.4083 0 0 0 17.6898 14.4225 16.6885 16.7577 0 17.1539 17.1187 0 0 17.3343 0 0 16.5555 14.5196 16.3397 0 0 0 0 16.0666 13.9759 16.5772 0 13.5702 13.4042 16.9966 13.6575 0 0 0 0 0 11.9603 0 14.9549 0 0 0 0 0 0 0 0 0 0 13.8267 0 13.9563 0 0 0 14.1599 11.6563 0 0 0 0 0 0 0 0 0 0 11.2757 0 0 0 0 13.4556 0 0 0 0 13.3151 0 0 0 0 0 0 0 10.6475 0 0 0 0 0 17.7968 0 0 0 0 0 0 Q8WUK0 PTPM1_HUMAN "Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1, EC 3.1.3.27 (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1, EC 3.1.3.16, EC 3.1.3.48)" PTPMT1 MOSP PLIP PNAS-129 Homo sapiens (Human) cardiolipin biosynthetic process [GO:0032049]; protein dephosphorylation [GO:0006470]; regulation of intrinsic apoptotic signaling pathway [GO:2001242] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; myosin phosphatase activity [GO:0017018]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cardiolipin biosynthetic process [GO:0032049]; protein dephosphorylation [GO:0006470]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]" GO:0004439; GO:0004725; GO:0005634; GO:0005739; GO:0005743; GO:0006470; GO:0008138; GO:0008962; GO:0017018; GO:0032049; GO:2001242 "myosin phosphatase activity [GO:0017018]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]" AATALLEAGLARVLFYPTLLYTLFRGK 0.99396 -8.0173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2716 0 0 0 11.6717 0 11.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQI6 SLF1_HUMAN SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) (Smc5/6 localization factor 1) SLF1 ANKRD32 BRCTD1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" GO:0000724; GO:0000781; GO:0000786; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006974; GO:0016925; GO:0030915; GO:0031334; GO:0031625; GO:0032204; GO:0034184; GO:0035861; GO:0042405; GO:0044877; GO:1990166; GO:2000781 protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625] DLKFVKMR 0.99396 -13.096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3375 0 0 0 13.2815 13.852 0 0 0 0 0 0 12.7439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3919 0 0 0 0 0 0 0 0 0 0 0 14.4478 0 0 0 0 0 0 0 0 12.2788 0 0 0 0 0 0 0 13.4827 13.6131 0 0 0 11.4359 0 13.5435 0 13.5637 12.1773 0 0 0 0 0 14.0533 0 0 0 13.7277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5451 12.7128 12.82 0 0 0 0 0 0 13.6376 12.5235 0 0 0 0 0 0 0 0 0 0 0 11.7789 0 0 0 0 0 0 0 12.3069 0 0 0 0 0 0 0 9.98142 0 0 0 0 10.3029 0 0 0 0 0 0 Q9BRJ6 CG050_HUMAN Uncharacterized protein C7orf50 C7orf50 FP15621 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] KVPEVTEK 0.99396 -5.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZT9 EGLN1_HUMAN "Egl nine homolog 1, EC 1.14.11.29 (Hypoxia-inducible factor prolyl hydroxylase 2, HIF-PH2, HIF-prolyl hydroxylase 2, HPH-2) (Prolyl hydroxylase domain-containing protein 2, PHD2) (SM-20)" EGLN1 C1orf12 PNAS-118 PNAS-137 Homo sapiens (Human) "cardiac muscle tissue morphogenesis [GO:0055008]; cellular iron ion homeostasis [GO:0006879]; cellular response to hypoxia [GO:0071456]; heart trabecula formation [GO:0060347]; labyrinthine layer development [GO:0060711]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oxygen homeostasis [GO:0032364]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of neuron death [GO:1901214]; regulation of postsynapse organization [GO:0099175]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; cardiac muscle tissue morphogenesis [GO:0055008]; cellular iron ion homeostasis [GO:0006879]; cellular response to hypoxia [GO:0071456]; heart trabecula formation [GO:0060347]; labyrinthine layer development [GO:0060711]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; oxygen homeostasis [GO:0032364]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of neuron death [GO:1901214]; regulation of postsynapse organization [GO:0099175]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; ventricular septum morphogenesis [GO:0060412]" GO:0001666; GO:0005634; GO:0005737; GO:0005829; GO:0006879; GO:0008198; GO:0014069; GO:0016706; GO:0018401; GO:0019899; GO:0031418; GO:0031543; GO:0031545; GO:0032364; GO:0043433; GO:0045765; GO:0045944; GO:0051344; GO:0055008; GO:0060347; GO:0060412; GO:0060711; GO:0071456; GO:0071731; GO:0098978; GO:0099175; GO:0099576; GO:1901214 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; enzyme binding [GO:0019899]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543] AQFADIEPK 0.99396 -29.573 0 0 0 0 0 0 0 0 0 0 0 0 11.2819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6411 0 0 0 0 0 0 13.5697 0 0 0 0 0 0 0 0 14.7138 0 12.705 0 0 0 0 0 12.8048 13.8163 13.4055 0 12.6959 0 0 0 0 0 0 0 0 0 14.0488 0 0 10.9781 0 0 9.76539 0 13.3208 0 14.518 0 0 0 14.0516 0 0 0 0 0 0 0 0 0 0 0 0 13.7602 0 0 0 13.3667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2643 0 0 0 0 0 Q9Y520 PRC2C_HUMAN Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C) PRRC2C BAT2D1 BAT2L2 KIAA1096 XTP2 Homo sapiens (Human) cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; stress granule assembly [GO:0034063] GO:0002244; GO:0003723; GO:0005829; GO:0008022; GO:0010494; GO:0016020; GO:0030154; GO:0034063 protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723] AGPIKAQK 0.99396 -29.571 0 0 0 0 0 0 0 11.6715 0 0 0 0 0 0 0 0 0 0 0 0 10.9152 11.5318 0 0 0 0 0 0 0 0 0 12.8827 14.0338 11.4669 0 0 0 0 0 13.6231 13.2912 0 0 13.419 0 0 0 0 0 17.2347 0 0 12.8598 0 12.1102 0 11.3562 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4635 11.1865 0 0 0 0 0 0 0 0 0 0 0 15.1231 0 0 0 11.6085 14.238 0 12.871 14.4258 15.6744 15.3339 15.5008 14.7579 0 0 0 0 13.2683 0 13.1217 0 0 0 12.8984 0 0 13.7596 13.7852 10.2938 15.3931 13.1323 0 0 13.6851 0 0 12.6503 0 0 13.0099 13.2182 0 0 13.93 0 13.8566 17.3432 13.4557 13.0712 0 0 0 13.3963 13.0026 0 13.1575 0 0 0 0 12.7868 0 13.9869 0 0 0 0 13.7653 13.8125 0 0 14.8526 0 0 0 14.7697 13.1388 13.7856 12.9044 13.4201 0 14.0107 13.4981 0 0 13.9552 0 0 0 12.4928 0 0 0 0 0 0 11.6582 Q86UE8 TLK2_HUMAN "Serine/threonine-protein kinase tousled-like 2, EC 2.7.11.1 (HsHPK) (PKU-alpha) (Tousled-like kinase 2)" TLK2 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275] intermediate filament [GO:0005882]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] intermediate filament [GO:0005882]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275] GO:0004674; GO:0005524; GO:0005634; GO:0005882; GO:0006325; GO:0006468; GO:0006974; GO:0007049; GO:0007059; GO:0010507; GO:0018105; GO:0032435; GO:0035556; GO:0042802; GO:0048471; GO:0071480; GO:0106310; GO:1902275 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ELDHPRIVK 0.99397 -37.259 0 0 0 15.4612 0 13.6074 11.1762 0 0 0 0 0 0 0 0 18.4242 15.0496 12.6142 15.1984 11.6702 18.5857 18.3456 18.45 0 14.2322 18.4947 19.2571 18.4948 15.1669 0 0 13.7401 0 0 0 0 0 12.7551 0 0 0 0 0 15.0461 0 18.7434 18.7278 18.8899 18.7494 18.9139 15.1829 18.6364 12.5763 12.8406 12.704 18.546 12.5895 0 0 0 0 0 0 0 0 12.4073 14.3512 15.0963 0 13.4013 14.2673 14.8435 0 0 18.7339 0 14.2391 14.6459 14.4041 0 0 0 0 0 0 0 0 19.3381 19.3762 12.1989 0 19.366 19.3257 19.2794 0 0 19.308 19.3846 0 19.3936 11.6558 19.4807 19.3872 0 19.2368 19.282 16.1148 19.3563 16.2004 14.5904 15.3519 0 15.1093 0 19.2155 19.044 19.0265 14.3322 19.2362 19.3028 19.2376 0 19.0768 19.0064 15.7786 14.4132 19.2924 14.2407 13.8472 14.0367 0 12.7781 11.625 14.318 0 19.0399 0 19.1067 0 19.0239 19.1196 0 0 19.2532 16.5102 19.3598 19.1861 12.9148 19.0103 0 0 19.4387 0 13.8791 0 0 14.2763 0 0 13.0758 0 0 12.3402 11.926 12.071 13.9099 0 0 0 14.1757 14.459 19.0088 19.0006 19.0171 19.1974 0 0 0 0 0 A0A494C086 SPD21_HUMAN Putative speedy protein E21 SPDYE21 Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0019901; GO:0045737 protein kinase binding [GO:0019901] EWSDESEEEPEK 0.99397 -29.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.931 0 12.1031 12.7499 13.6705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2057 12.8113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0961 0 0 0 0 0 0 0 0 0 0 0 0 D6RGX4 F90AP_HUMAN Putative protein FAM90A26 FAM90A26 FAM90A26P Homo sapiens (Human) AALVPPTLGK 0.99397 -37.182 0 0 0 0 0 0 13.2326 0 0 0 0 0 0 0 0 12.9458 0 0 0 13.8282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8365 0 0 0 0 0 0 0 0 0 15.1651 0 0 0 0 0 0 0 13.1388 0 0 0 0 0 0 0 0 0 0 13.211 0 14.1586 0 0 0 0 0 0 0 0 10.4191 0 0 0 0 0 0 0 0 0 14.7464 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3018 0 14.6618 10.8641 0 0 14.3482 0 12.8013 0 0 0 0 0 13.4065 0 13.818 0 0 0 13.8117 0 0 13.449 0 0 0 0 0 13.0475 13.012 13.2463 0 0 13.5707 0 0 0 0 0 0 0 0 0 0 0 0 O15085 ARHGB_HUMAN Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF) ARHGEF11 KIAA0380 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; establishment of cell polarity [GO:0030010]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; striated muscle contraction [GO:0006941]" GO:0001558; GO:0001664; GO:0005085; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006941; GO:0007186; GO:0007266; GO:0030010; GO:0030036; GO:0045893; GO:0051056 G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] DALEDKK 0.99397 -29.928 0 0 0 0 0 0 0 0 13.9369 0 0 13.8097 0 13.8533 13.5957 13.3143 0 0 0 0 0 0 0 0 0 0 0 12.5439 13.5817 13.6607 0 0 12.2042 13.6461 14.5803 14.6614 0 14.6079 13.5122 14.7265 0 0 0 0 0 0 0 0 0 11.5606 0 0 0 0 0 0 0 0 0 10.8969 11.812 11.5501 11.9082 0 10.3201 0 15.1273 0 15.0447 0 0 0 0 0 0 0 0 0 0 0 0 15.375 15.5016 0 12.332 17.2769 0 15.0798 13.7322 0 0 12.9568 0 0 14.3344 15.182 0 15.1441 0 0 0 0 15.1582 13.9083 0 15.2012 15.6411 0 0 14.8584 12.9863 15.4481 0 15.1489 12.5355 0 0 0 15.0164 0 0 0 0 0 0 15.1211 13.3556 14.6413 14.8674 14.9701 0 0 0 0 0 0 13.0246 13.261 0 14.5895 0 0 14.8662 0 0 14.6039 0 0 0 0 0 0 12.4732 0 0 12.8243 0 0 0 0 0 0 0 0 13.5546 0 0 0 0 0 0 0 0 12.2216 12.5743 0 0 0 0 0 O75363 BCAS1_HUMAN Breast carcinoma-amplified sequence 1 (Amplified and overexpressed in breast cancer) (Novel amplified in breast cancer 1) BCAS1 AIBC1 NABC1 Homo sapiens (Human) myelination [GO:0042552] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myelination [GO:0042552] GO:0005737; GO:0042552; GO:0070062 GLGPKRMLDAQVQTDPVSIGPVGK 0.99397 -10.827 0 0 0 0 0 0 0 0 12.4776 0 0 11.8746 0 0 0 0 10.7627 0 0 0 0 0 0 0 11.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3137 0 0 0 0 0 0 0 0 0 0 0 11.0058 0 10.5836 0 0 0 0 0 0 0 0 0 0 0 12.6753 0 0 0 0 0 0 10.9822 13.0237 0 12.6545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2561 0 0 0 13.5169 0 0 11.2765 0 0 0 0 14.2824 0 12.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6439 0 0 0 12.4528 0 12.5285 0 13.4206 0 0 0 0 0 13.2315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P01137 TGFB1_HUMAN "Transforming growth factor beta-1 proprotein [Cleaved into: Latency-associated peptide, LAP; Transforming growth factor beta-1, TGF-beta-1 ]" TGFB1 TGFB Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; ATP biosynthetic process [GO:0006754]; BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; common-partner SMAD protein phosphorylation [GO:0007182]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; embryonic liver development [GO:1990402]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial to mesenchymal transition [GO:0001837]; extracellular matrix assembly [GO:0085029]; extrinsic apoptotic signaling pathway [GO:0097191]; heart development [GO:0007507]; heart valve morphogenesis [GO:0003179]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymph node development [GO:0048535]; macrophage derived foam cell differentiation [GO:0010742]; MAPK cascade [GO:0000165]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cytolysis [GO:0045918]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; ossification involved in bone remodeling [GO:0043932]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglia differentiation [GO:0014008]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular permeability [GO:0043117]; protein export from nucleus [GO:0006611]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; regulation of binding [GO:0051098]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA binding [GO:0051101]; regulation of protein import into nucleus [GO:0042306]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in heart development [GO:1905313]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]" blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021] "blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021]; antigen binding [GO:0003823]; cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714]; aortic valve morphogenesis [GO:0003180]; ATP biosynthetic process [GO:0006754]; BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; common-partner SMAD protein phosphorylation [GO:0007182]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; embryonic liver development [GO:1990402]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial to mesenchymal transition [GO:0001837]; extracellular matrix assembly [GO:0085029]; extrinsic apoptotic signaling pathway [GO:0097191]; heart development [GO:0007507]; heart valve morphogenesis [GO:0003179]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymph node development [GO:0048535]; macrophage derived foam cell differentiation [GO:0010742]; MAPK cascade [GO:0000165]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cytolysis [GO:0045918]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; ossification involved in bone remodeling [GO:0043932]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglia differentiation [GO:0014008]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular permeability [GO:0043117]; protein export from nucleus [GO:0006611]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; regulation of binding [GO:0051098]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA binding [GO:0051101]; regulation of protein import into nucleus [GO:0042306]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in heart development [GO:1905313]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]" GO:0000165; GO:0001570; GO:0001837; GO:0001843; GO:0001933; GO:0001934; GO:0002062; GO:0002244; GO:0002248; GO:0003179; GO:0003180; GO:0003823; GO:0005114; GO:0005125; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005796; GO:0005886; GO:0006468; GO:0006611; GO:0006754; GO:0006796; GO:0006954; GO:0007173; GO:0007179; GO:0007182; GO:0007183; GO:0007435; GO:0007507; GO:0008083; GO:0008284; GO:0008285; GO:0009611; GO:0009986; GO:0010575; GO:0010628; GO:0010629; GO:0010716; GO:0010718; GO:0010742; GO:0010763; GO:0010800; GO:0010862; GO:0010936; GO:0014008; GO:0016202; GO:0016477; GO:0017015; GO:0019899; GO:0021915; GO:0022408; GO:0030214; GO:0030308; GO:0030334; GO:0030335; GO:0030501; GO:0030509; GO:0031012; GO:0031093; GO:0031293; GO:0031334; GO:0031663; GO:0032355; GO:0032570; GO:0032740; GO:0032801; GO:0032930; GO:0032967; GO:0033138; GO:0034713; GO:0034714; GO:0035307; GO:0042127; GO:0042306; GO:0042307; GO:0042802; GO:0043117; GO:0043406; GO:0043491; GO:0043536; GO:0043537; GO:0043552; GO:0043932; GO:0045216; GO:0045596; GO:0045599; GO:0045662; GO:0045786; GO:0045892; GO:0045893; GO:0045918; GO:0045944; GO:0048298; GO:0048535; GO:0048642; GO:0048661; GO:0050680; GO:0050714; GO:0050731; GO:0050921; GO:0051098; GO:0051101; GO:0051247; GO:0051781; GO:0051897; GO:0055010; GO:0060312; GO:0060389; GO:0060390; GO:0060391; GO:0060395; GO:0060965; GO:0062023; GO:0070021; GO:0070168; GO:0070374; GO:0070723; GO:0071407; GO:0071560; GO:0072562; GO:0085029; GO:0090263; GO:0097191; GO:0099126; GO:1900126; GO:1900182; GO:1901203; GO:1901666; GO:1902894; GO:1902895; GO:1903077; GO:1903799; GO:1903800; GO:1904894; GO:1905313; GO:1990402; GO:2000679; GO:2000727 antigen binding [GO:0003823]; cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714] AELRLLR 0.99397 -8.7796 0 0 0 0 11.9666 0 0 0 15.1182 0 0 0 14.1437 14.5579 0 0 0 11.5469 0 0 0 0 12.4155 0 0 0 0 0 0 13.9258 0 0 0 13.7674 0 0 0 0 0 0 0 11.0341 0 0 0 0 0 0 0 0 12.9467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5215 0 0 15.2358 14.992 0 0 0 14.4404 0 0 14.8175 14.8262 0 0 0 0 0 0 0 0 10.3891 0 0 0 0 0 0 0 0 15.0188 14.3574 16.4471 16.0723 15.8687 0 0 15.0913 0 15.1277 0 0 0 0 0 0 0 0 0 14.6387 0 15.4547 0 0 0 14.0532 0 0 0 0 12.951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2322 0 0 0 0 0 0 0 11.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6109 14.7069 0 0 0 0 0 14.2917 0 P07307 ASGR2_HUMAN "Asialoglycoprotein receptor 2, ASGP-R 2, ASGPR 2 (C-type lectin domain family 4 member H2) (Hepatic lectin H2, HL-2)" ASGR2 CLEC4H2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166] endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; cell surface receptor signaling pathway [GO:0007166] GO:0004873; GO:0005886; GO:0007166; GO:0009897; GO:0016021; GO:0030246; GO:0044322; GO:0048471 asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246] ADHDALLFHLKHFPVDLR 0.99397 -10.839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2381 0 0 0 0 0 0 0 0 0 0 0 10.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16415 ZN823_HUMAN Zinc finger protein 823 (Zinc finger protein ZFP-36) ZNF823 ZFP36 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFSCFKYLSQHK 0.99397 -8.7557 0 0 0 0 0 0 0 0 11.0285 0 0 0 0 11.2314 0 0 0 0 0 0 0 0 0 0 0 0 10.9764 0 11.3332 0 0 0 0 11.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1765 0 14.3362 0 14.618 0 0 0 0 0 0 0 0 0 0 0 0 12.5695 0 12.7697 0 12.9208 12.979 0 0 0 0 0 0 0 12.0829 0 0 0 0 0 0 0 0 0 0 0 11.9206 0 0 0 0 0 0 14.1347 0 12.5671 0 0 0 0 12.1879 0 0 0 0 0 0 0 0 0 0 0 0 12.8272 0 0 0 0 0 0 0 0 0 0 P17482 HXB9_HUMAN Homeobox protein Hox-B9 (Homeobox protein Hox-2.5) (Homeobox protein Hox-2E) HOXB9 HOX2E Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; cell chemotaxis [GO:0060326]; embryonic skeletal system morphogenesis [GO:0048704]; mammary gland development [GO:0030879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; cell chemotaxis [GO:0060326]; embryonic skeletal system morphogenesis [GO:0048704]; mammary gland development [GO:0030879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0009952; GO:0009954; GO:0030879; GO:0045944; GO:0048704; GO:0060326; GO:0090575; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CPYTKYQTLELEK 0.99397 -5.2933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35670 ATP7B_HUMAN "Copper-transporting ATPase 2, EC 7.2.2.8 (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa ]" ATP7B PWD WC1 WND Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; cellular copper ion homeostasis [GO:0006878]; cellular zinc ion homeostasis [GO:0006882]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; lactation [GO:0007595]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] GO:0000139; GO:0005375; GO:0005507; GO:0005524; GO:0005739; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0006825; GO:0006878; GO:0006882; GO:0007595; GO:0015677; GO:0015680; GO:0016020; GO:0016887; GO:0032588; GO:0034220; GO:0043682; GO:0046688; GO:0051208; GO:0051649; GO:0055070; GO:0060003; GO:0140581; GO:1990961 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581] AVAPQKCFLQIK 0.99397 -8.0382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9012 0 0 0 0 0 0 0 13.1099 0 0 0 12.0587 0 14.3993 0 0 0 0 0 0 10.9558 0 0 0 0 0 0 0 0 0 0 0 0 9.78624 0 0 0 0 0 P61073 CXCR4_HUMAN "C-X-C chemokine receptor type 4, CXC-R4, CXCR-4 (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor, LESTR) (Lipopolysaccharide-associated protein 3, LAP-3, LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor, SDF-1 receptor) (CD antigen CD184)" CXCR4 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cardiac muscle contraction [GO:0060048]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to xenobiotic stimulus [GO:0071466]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; dendritic cell chemotaxis [GO:0002407]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; endothelial cell differentiation [GO:0045446]; endothelial tube morphogenesis [GO:0061154]; epithelial cell development [GO:0002064]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; myelin maintenance [GO:0043217]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; neuron recognition [GO:0008038]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite extension [GO:1903861]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of vascular wound healing [GO:0035470]; regulation of calcium ion transport [GO:0051924]; regulation of cell adhesion [GO:0030155]; regulation of chemotaxis [GO:0050920]; regulation of programmed cell death [GO:0043067]; regulation of viral process [GO:0050792]; response to activity [GO:0014823]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; telencephalon cell migration [GO:0022029] anchoring junction [GO:0070161]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] anchoring junction [GO:0070161]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; myosin light chain binding [GO:0032027]; small molecule binding [GO:0036094]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; apoptotic process [GO:0006915]; brain development [GO:0007420]; calcium-mediated signaling [GO:0019722]; cardiac muscle contraction [GO:0060048]; cell chemotaxis [GO:0060326]; cellular response to cytokine stimulus [GO:0071345]; cellular response to xenobiotic stimulus [GO:0071466]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; dendritic cell chemotaxis [GO:0002407]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; endothelial cell differentiation [GO:0045446]; endothelial tube morphogenesis [GO:0061154]; epithelial cell development [GO:0002064]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; myelin maintenance [GO:0043217]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; neuron recognition [GO:0008038]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite extension [GO:1903861]; positive regulation of macrophage migration inhibitory factor signaling pathway [GO:2000448]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of vascular wound healing [GO:0035470]; regulation of calcium ion transport [GO:0051924]; regulation of cell adhesion [GO:0030155]; regulation of chemotaxis [GO:0050920]; regulation of programmed cell death [GO:0043067]; regulation of viral process [GO:0050792]; response to activity [GO:0014823]; response to hypoxia [GO:0001666]; response to morphine [GO:0043278]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; telencephalon cell migration [GO:0022029] GO:0001618; GO:0001666; GO:0001764; GO:0002064; GO:0002407; GO:0003779; GO:0004930; GO:0005634; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005886; GO:0006915; GO:0006954; GO:0006955; GO:0007186; GO:0007204; GO:0007420; GO:0008038; GO:0009615; GO:0009897; GO:0009986; GO:0014823; GO:0015026; GO:0016021; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0022008; GO:0022029; GO:0030155; GO:0031252; GO:0031410; GO:0031625; GO:0032027; GO:0032991; GO:0035470; GO:0036094; GO:0038147; GO:0038160; GO:0043067; GO:0043130; GO:0043217; GO:0043278; GO:0045446; GO:0048714; GO:0050792; GO:0050920; GO:0050921; GO:0050965; GO:0050966; GO:0051924; GO:0060048; GO:0060326; GO:0061154; GO:0070062; GO:0070161; GO:0071345; GO:0071466; GO:0120162; GO:1903861; GO:1905322; GO:1990478; GO:2000448 actin binding [GO:0003779]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; C-X-C motif chemokine 12 receptor activity [GO:0038147]; coreceptor activity [GO:0015026]; G protein-coupled receptor activity [GO:0004930]; myosin light chain binding [GO:0032027]; small molecule binding [GO:0036094]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618] IFLPTIYSIIFLTGIVGNGLVILVMGYQKKLR 0.99397 -8.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q10472 GALT1_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 1, EC 2.4.1.41 (Polypeptide GalNAc transferase 1, GalNAc-T1, pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form ]" GALNT1 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; viral protein processing [GO:0019082] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; viral protein processing [GO:0019082] GO:0000139; GO:0004653; GO:0005576; GO:0005789; GO:0006493; GO:0016020; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0019082; GO:0030145; GO:0030246; GO:0032580; GO:0033116; GO:0048471 carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] KLKVPVHVIR 0.99397 -13.95 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3014 0 0 12.3505 11.9745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3902 13.8053 0 0 0 0 13.1019 0 0 0 0 0 0 0 13.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14990 ODFP1_HUMAN "Outer dense fiber protein 1 (Heat shock protein beta-10, HspB10)" ODF1 HSPB10 ODFP Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] nucleus [GO:0005634]; outer dense fiber [GO:0001520] nucleus [GO:0005634]; outer dense fiber [GO:0001520]; protein domain specific binding [GO:0019904]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0001520; GO:0005634; GO:0007283; GO:0019904; GO:0030154 protein domain specific binding [GO:0019904] AIRAIEDEK 0.99397 -10.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1377 10.5421 0 13.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.576 0 0 0 0 0 13.9787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8473 0 0 0 0 0 0 16.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16620 NTRK2_HUMAN "BDNF/NT-3 growth factors receptor, EC 2.7.10.1 (GP145-TrkB, Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B)" NTRK2 TRKB Homo sapiens (Human) "brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; regulation of protein kinase B signaling [GO:0051896]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO:0099551]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]" anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; terminal bouton [GO:0043195] "anchoring junction [GO:0070161]; axon [GO:0030424]; axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cellular response to amino acid stimulus [GO:0071230]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; circadian rhythm [GO:0007623]; feeding behavior [GO:0007631]; glutamate secretion [GO:0014047]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; mechanoreceptor differentiation [GO:0042490]; myelination in peripheral nervous system [GO:0022011]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron apoptotic process [GO:0043524]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuronal action potential propagation [GO:0019227]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peripheral nervous system neuron development [GO:0048935]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of GTPase activity [GO:0043087]; regulation of protein kinase B signaling [GO:0051896]; retinal rod cell development [GO:0046548]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO:0099551]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]" GO:0001570; GO:0001764; GO:0001934; GO:0002020; GO:0004714; GO:0005030; GO:0005524; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007612; GO:0007623; GO:0007631; GO:0008284; GO:0010628; GO:0010976; GO:0014047; GO:0014068; GO:0014069; GO:0018105; GO:0019227; GO:0021954; GO:0021987; GO:0022011; GO:0030182; GO:0030424; GO:0030425; GO:0031547; GO:0031901; GO:0033138; GO:0033674; GO:0042490; GO:0042803; GO:0043087; GO:0043121; GO:0043195; GO:0043197; GO:0043235; GO:0043410; GO:0043524; GO:0043679; GO:0046548; GO:0046777; GO:0048403; GO:0048471; GO:0048709; GO:0048935; GO:0050772; GO:0051896; GO:0051965; GO:0060175; GO:0060291; GO:0070161; GO:0071230; GO:0099183; GO:0099551; GO:1902430; GO:1990090; GO:1990416; GO:2000811 ATP binding [GO:0005524]; brain-derived neurotrophic factor binding [GO:0048403]; brain-derived neurotrophic factor receptor activity [GO:0060175]; neurotrophin binding [GO:0043121]; neurotrophin receptor activity [GO:0005030]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] AAFACPTSCK 0.99397 -8.7684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4937 0 0 0 0 14.7477 0 0 0 0 15.355 0 0 0 0 0 0 0 0 0 0 12.4306 0 0 0 0 0 0 12.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZTQ4 CDHR3_HUMAN Cadherin-related family member 3 (Cadherin-like protein 28) CDHR3 CDH28 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; virus receptor activity [GO:0001618]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0001618; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; virus receptor activity [GO:0001618] AEALVETGTVTLSIKVIPHPTTIITTTPRPR 0.99397 -8.7797 0 0 0 0 0 0 0 0 0 0 14.559 0 0 0 11.7541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2934 10.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8585 0 0 0 0 0 0 0 0 0 12.629 0 0 0 12.6811 0 0 0 0 13.6452 14.0197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6275 0 0 0 0 0 0 0 0 13.0915 0 0 11.8213 0 14.7919 12.9901 0 0 13.4691 0 0 0 0 11.0334 0 0 0 0 0 0 0 0 12.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0446 0 0 0 0 0 0 0 11.4812 0 0 0 0 0 0 Q86YT9 JAML_HUMAN Junctional adhesion molecule-like (Adhesion molecule interacting with CXADR antigen 1) (Dendritic cell-specific protein CREA7-1) JAML AMICA1 UNQ722/PRO1387 Homo sapiens (Human) gamma-delta T cell activation [GO:0046629]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; monocyte extravasation [GO:0035696]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; gamma-delta T cell activation [GO:0046629]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; monocyte extravasation [GO:0035696]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054] GO:0005178; GO:0005654; GO:0005886; GO:0005923; GO:0007157; GO:0016021; GO:0030593; GO:0035696; GO:0042803; GO:0046629; GO:0050839; GO:0060054; GO:0072672 cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803] ESDGGNYTCSIHLGNLVFK 0.99397 -10.826 0 0 0 11.1934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0228 0 0 0 0 0 12.7599 12.8829 12.9015 0 0 0 14.285 0 0 11.3479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9716 12.1375 0 12.3689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4934 0 0 10.7615 0 0 0 0 0 0 0 11.9844 0 0 10.7434 0 0 0 13.6702 0 0 0 0 14.5289 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5236 0 0 0 Q8N4S0 CCD82_HUMAN Coiled-coil domain-containing protein 82 CCDC82 HT025 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 DFEDSEK 0.99397 -13.985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.456 0 0 0 0 0 12.3852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5H7 SH2D3_HUMAN "SH2 domain-containing protein 3C (Cas/HEF1-associated signal transducer, Chat-H) (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1, SHEP1)" SH2D3C NSP3 UNQ272/PRO309/PRO34088 Homo sapiens (Human) JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264] axon [GO:0030424]; cytosol [GO:0005829]; ruffle membrane [GO:0032587] axon [GO:0030424]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784]; JNK cascade [GO:0007254]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; small GTPase mediated signal transduction [GO:0007264] GO:0001784; GO:0005085; GO:0005829; GO:0007254; GO:0007264; GO:0030424; GO:0032587; GO:0033138 guanyl-nucleotide exchange factor activity [GO:0005085]; phosphotyrosine residue binding [GO:0001784] GFGSLSNLPR 0.99397 -10.83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6959 0 0 0 0 0 0 0 0 0 0 0 0 13.6063 0 0 13.7882 0 0 14.1349 0 0 0 13.0339 13.6608 12.9186 13.6191 0 0 0 0 0 13.2328 0 0 0 0 0 0 13.5643 0 14.0646 0 0 0 14.0218 0 0 0 0 13.7511 11.7246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAE6 PP14C_HUMAN Protein phosphatase 1 regulatory subunit 14C (Kinase-enhanced PP1 inhibitor) (PKC-potentiated PP1 inhibitory protein) (Serologically defined breast cancer antigen NY-BR-81) PPP1R14C KEPI Homo sapiens (Human) regulation of phosphorylation [GO:0042325] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; regulation of phosphorylation [GO:0042325] GO:0004865; GO:0005737; GO:0016020; GO:0042325 protein serine/threonine phosphatase inhibitor activity [GO:0004865] LSPPQKK 0.99397 -10.831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9095 0 0 0 0 0 0 0 0 12.818 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3578 13.4273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92794 KAT6A_HUMAN "Histone acetyltransferase KAT6A, EC 2.3.1.48 (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3, MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)" KAT6A MOZ MYST3 RUNXBP2 ZNF220 Homo sapiens (Human) "cellular senescence [GO:0090398]; chromosome organization [GO:0051276]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605] "cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; cellular senescence [GO:0090398]; chromosome organization [GO:0051276]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000786; GO:0003677; GO:0003712; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006334; GO:0006355; GO:0006473; GO:0008270; GO:0010484; GO:0010485; GO:0010628; GO:0016407; GO:0016573; GO:0016605; GO:0016607; GO:0030099; GO:0042393; GO:0043966; GO:0045892; GO:0045893; GO:0045944; GO:0050793; GO:0051276; GO:0061629; GO:0070776; GO:0090398; GO:0140297; GO:1901796; GO:1903706 acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; H3 histone acetyltransferase activity [GO:0010484]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] ALRWQCIECK 0.99397 -13.982 0 0 0 0 0 0 0 0 0 10.18 0 0 0 0 11.3309 0 0 0 0 0 0 11.1903 0 11.8655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2086 0 0 0 0 0 0 0 0 0 0 0 11.5349 0 0 0 0 0 0 0 0 0 10.9085 0 0 10.9563 0 10.6291 0 0 0 0 12.7003 0 0 0 0 14.8359 0 0 14.5669 0 0 12.4319 11.96 0 15.5788 0 12.7861 13.9993 13.098 13.3022 0 0 13.9905 14.3459 0 0 13.9605 0 0 0 0 13.7529 0 0 0 13.3666 0 14.6549 13.7819 0 14.868 0 0 14.1882 12.8538 0 13.3641 14.1156 0 0 14.0125 0 14.1288 0 12.2408 14.3381 0 0 11.5314 0 13.5707 12.9689 13.6531 0 0 0 0 11.5876 13.1105 0 12.2871 0 0 0 13.0924 14.0839 0 13.1324 0 14.7452 0 0 0 0 13.7042 0 0 0 0 0 0 12.7697 13.1325 0 0 0 14.5617 11.2835 0 13.4476 0 0 13.4942 0 Q92889 XPF_HUMAN "DNA repair endonuclease XPF, EC 3.1.-.- (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein)" ERCC4 ERCC11 XPF Homo sapiens (Human) "cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]" "chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-stranded telomeric DNA binding [GO:1905768]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 3'-to lesion [GO:0006295]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; regulation of autophagy [GO:0010506]; resolution of meiotic recombination intermediates [GO:0000712]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]" GO:0000014; GO:0000109; GO:0000110; GO:0000712; GO:0000723; GO:0000724; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0004520; GO:0005634; GO:0005654; GO:0006281; GO:0006289; GO:0006295; GO:0006296; GO:0006303; GO:0008022; GO:0009411; GO:0009650; GO:0010506; GO:0032205; GO:0033683; GO:0034644; GO:0042802; GO:0047485; GO:0061819; GO:0070522; GO:1901255; GO:1904357; GO:1905765; GO:1905768; GO:1990841 damaged DNA binding [GO:0003684]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; TFIID-class transcription factor complex binding [GO:0001094] KELVLESNPKWEALTEVLK 0.99397 -29.859 0 0 0 0 0 0 0 0 12.6327 0 11.9642 12.3681 12.1925 12.1614 12.3224 0 0 0 0 0 0 0 0 0 0 0 0 14.2344 0 0 0 12.3112 12.2846 0 0 12.4102 12.2386 0 12.3228 0 0 16.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1856 0 15.2474 0 0 15.5229 15.3222 15.4196 0 0 0 0 0 0 0 13.561 0 0 0 0 14.35 0 0 0 0 13.9847 0 0 13.0607 0 0 0 0 0 0 0 0 0 13.1009 11.6122 0 0 0 0 15.6292 0 0 0 0 11.4212 0 0 0 0 0 0 0 0 0 0 0 0 10.8328 0 0 0 0 0 0 0 0 10.9042 0 0 0 0 0 10.2199 15.8651 0 0 15.3264 0 0 0 0 0 0 0 18.0676 0 0 0 13.5287 13.3333 0 13.3288 0 13.6233 0 0 0 13.3195 0 0 0 0 0 0 0 0 0 0 13.5258 0 0 Q96S86 HPLN3_HUMAN Hyaluronan and proteoglycan link protein 3 HAPLN3 EXLD1 UNQ238/PRO271 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284]; response to estrogen [GO:0043627]; skeletal system development [GO:0001501] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; positive regulation of cell population proliferation [GO:0008284]; response to estrogen [GO:0043627]; skeletal system development [GO:0001501] GO:0001501; GO:0005540; GO:0005615; GO:0007155; GO:0007417; GO:0008284; GO:0031012; GO:0043627 hyaluronic acid binding [GO:0005540] EACQEDDATIAKVGQLFAAWKFHGLDR 0.99397 -10.83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8309 11.5892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7848 Q99574 NEUS_HUMAN "Neuroserpin (Peptidase inhibitor 12, PI-12) (Serpin I1)" SERPINI1 PI12 Homo sapiens (Human) central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; regulation of cell adhesion [GO:0030155] cytoplasmic vesicle lumen [GO:0060205]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774] cytoplasmic vesicle lumen [GO:0060205]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; secretory granule lumen [GO:0034774]; serine-type endopeptidase inhibitor activity [GO:0004867]; central nervous system development [GO:0007417]; negative regulation of endopeptidase activity [GO:0010951]; peripheral nervous system development [GO:0007422]; positive regulation of neuron projection development [GO:0010976]; regulation of cell adhesion [GO:0030155] GO:0004867; GO:0005615; GO:0007417; GO:0007422; GO:0010951; GO:0010976; GO:0030155; GO:0034774; GO:0043025; GO:0043204; GO:0060205; GO:0070062 serine-type endopeptidase inhibitor activity [GO:0004867] QKVEVYLPRFTVEQEIDLK 0.99397 -10.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2507 14.2745 13.5169 0 0 0 0 0 0 0 0 14.4772 0 0 0 0 0 0 0 0 14.5658 0 0 0 0 13.7164 13.199 0 0 0 0 0 0 0 0 14.2188 0 0 0 0 13.9719 14.0977 0 14.1294 14.5794 15.3288 14.6805 0 0 0 0 12.9892 12.9863 12.423 0 14.0471 12.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6758 0 0 0 0 0 12.8022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRX5 PSF3_HUMAN DNA replication complex GINS protein PSF3 (GINS complex subunit 3) GINS3 PSF3 Homo sapiens (Human) DNA unwinding involved in DNA replication [GO:0006268]; mitotic DNA replication initiation [GO:1902975]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] CMG complex [GO:0071162]; GINS complex [GO:0000811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA unwinding involved in DNA replication [GO:0006268]; mitotic DNA replication initiation [GO:1902975]; positive regulation of DNA primase activity [GO:1903934]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0000811; GO:0005634; GO:0005654; GO:0006268; GO:0071162; GO:1900264; GO:1902975; GO:1903934 GQASQITASNLVQNYKKR 0.99397 -10.82 0 0 0 0 0 0 0 0 0 0 11.7671 0 0 0 0 0 0 0 0 0 11.4781 0 0 11.5445 0 12.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4635 0 0 0 0 0 0 0 0 0 0 0 0 13.3478 0 0 0 0 0 0 0 0 0 0 0 0 13.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0765 13.2465 0 0 0 0 0 0 0 0 13.2899 0 0 0 0 0 0 0 0 0 0 0 0 Q9H040 SPRTN_HUMAN "DNA-dependent metalloprotease SPRTN, EC 3.4.24.- (DNA damage protein targeting VCP, DVC1) (Protein with SprT-like domain at the N terminus, Spartan)" SPRTN C1orf124 DVC1 UNQ1880/PRO4323 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to DNA damage stimulus [GO:0006974]; positive regulation of protein ubiquitination [GO:0031398]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; response to UV [GO:0009411]; translesion synthesis [GO:0019985] GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0005654; GO:0006508; GO:0006974; GO:0009411; GO:0016540; GO:0016607; GO:0019985; GO:0031398; GO:0031593; GO:0043130; GO:0046872; GO:0070530; GO:0106300 double-stranded DNA binding [GO:0003690]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130] DDDLMLALR 0.99397 -29.989 0 0 0 0 0 0 0 0 0 10.5833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2996 0 0 0 0 0 0 0 0 0 0 11.0221 0 12.8377 0 0 0 0 0 0 0 0 10.57 0 12.1088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBT8 Z286A_HUMAN Zinc finger protein 286A ZNF286A KIAA1874 ZNF286 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CNECGKSFK 0.99397 -5.5079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0815 0 0 0 0 12.3884 0 11.8701 0 0 0 0 0 10.0539 0 0 0 0 0 0 9.95957 0 0 0 0 0 0 0 0 0 0 10.1096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6368 0 0 0 0 0 0 0 10.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NY27 PP4R2_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 2 PPP4R2 SBBI57 Homo sapiens (Human) mRNA processing [GO:0006397]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; protein modification process [GO:0036211]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569]; RNA splicing [GO:0008380] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289] centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674]; mRNA processing [GO:0006397]; negative regulation of histone phosphorylation [GO:0033128]; protein dephosphorylation [GO:0006470]; protein modification process [GO:0036211]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569]; RNA splicing [GO:0008380] GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006397; GO:0006470; GO:0008380; GO:0010569; GO:0019888; GO:0030289; GO:0030674; GO:0033128; GO:0036211; GO:2000779 protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674] CTRQHCTEEDEEEDEEEEEESFMTSR 0.99397 -8.7823 0 0 0 0 0 8.98088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8044 0 0 11.7543 0 0 0 0 0 0 11.1049 0 11.6384 13.6001 0 0 0 13.7274 14.439 0 13.885 13.5613 0 0 0 15.5382 12.8172 15.4227 0 0 14.013 0 0 12.8608 0 15.4774 0 0 13.6328 0 0 0 0 0 0 0 0 0 0 0 10.9119 0 0 0 0 0 0 0 0 12.725 0 0 11.2517 0 0 0 0 12.5782 0 0 0 0 10.6676 0 0 0 0 13.0779 0 0 12.4691 0 0 0 0 0 0 0 0 0 0 0 12.3975 0 0 0 0 10.9503 0 0 0 0 0 0 0 0 Q9UBN6 TR10D_HUMAN "Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2, DcR2) (TNF-related apoptosis-inducing ligand receptor 4, TRAIL receptor 4, TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264)" TNFRSF10D DCR2 TRAILR4 TRUNDD UNQ251/PRO288 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165] GO:0004888; GO:0005886; GO:0006915; GO:0007165; GO:0009986; GO:0016021; GO:0043066; GO:0045569 TRAIL binding [GO:0045569]; transmembrane signaling receptor activity [GO:0004888] DTVCQCEK 0.99397 -10.833 0 0 0 0 0 11.7923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.802 10.028 0 10.4169 0 0 0 10.8614 0 0 12.5061 0 0 10.4609 0 10.3159 0 0 0 0 0 0 0 0 0 0 0 0 12.0197 0 10.9278 0 0 0 0 0 0 0 0 0 0 11.2926 13.4268 0 0 0 0 0 11.8752 0 0 0 11.5162 0 0 0 0 0 11.642 11.7448 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2883 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4779 0 0 11.4958 0 0 0 0 0 0 0 12.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2096 0 0 0 0 13.8313 12.9267 0 0 0 12.7879 0 0 0 0 0 0 0 0 0 13.0462 0 0 Q86XA9 HTR5A_HUMAN HEAT repeat-containing protein 5A HEATR5A C14orf125 KIAA1316 Homo sapiens (Human) "endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endocytic vesicle [GO:0030139] "cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005829; GO:0006897; GO:0008104; GO:0030139; GO:0042147 AVLACLRQLVQR 0.99398 -28.624 0 0 0 0 0 0 12.8433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7038 0 0 0 0 0 0 11.5751 0 0 0 0 0 0 0 0 0 10.5806 0 0 0 0 11.8456 0 0 0 0 0 0 9.31655 0 0 0 10.6673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9822 0 15.8941 0 14.2035 12.413 12.3689 0 10.4962 0 0 0 17.276 18.134 0 15.6116 15.4677 14.6125 0 0 15.2529 17.0719 14.6593 17.0228 13.8087 13.7068 14.3613 11.8163 0 14.5864 0 0 0 14.5002 15.001 12.3734 11.6837 0 14.6453 0 13.6775 0 12.4756 12.5502 16.9379 0 13.5462 12.0632 9.95067 13.3875 11.9244 13.3548 0 13.5456 12.7201 14.6731 14.8479 0 12.068 0 0 14.885 0 12.635 0 12.4578 12.9251 13.1332 0 11.5947 12.3204 0 12.9244 12.4394 0 0 0 0 12.619 0 11.6775 0 14.2424 0 0 0 0 0 0 0 0 12.8408 14.1914 0 0 12.0611 16.3496 13.9724 12.1534 0 13.8638 16.8037 13.7423 0 0 0 0 0 A8MTY0 ZN724_HUMAN Zinc finger protein 724 ZNF724 ZNF724P Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASLQRIILRK 0.99398 -10.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7974 0 0 0 0 0 0 0 0 0 0 0 0 11.6405 0 0 0 0 0 0 0 13.4219 0 12.2708 14.0053 0 0 0 0 14.0798 13.9476 0 0 0 0 0 0 0 0 13.5438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2967 0 0 0 0 0 O14524 NEMP1_HUMAN Nuclear envelope integral membrane protein 1 NEMP1 KIAA0286 TMEM194 TMEM194A Homo sapiens (Human) nuclear membrane organization [GO:0071763] integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane organization [GO:0071763] GO:0005635; GO:0005637; GO:0016021; GO:0071763 DTKYSVIVIR 0.99398 -10.847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1266 0 0 0 0 0 0 0 0 0 0 0 0 12.4565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27816 MAP4_HUMAN "Microtubule-associated protein 4, MAP-4" MAP4 Homo sapiens (Human) cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175] axon [GO:0030424]; axoneme [GO:0005930]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005] axon [GO:0030424]; axoneme [GO:0005930]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell division [GO:0051301]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175] GO:0000226; GO:0003723; GO:0005198; GO:0005815; GO:0005874; GO:0005875; GO:0005930; GO:0007052; GO:0008017; GO:0030424; GO:0031175; GO:0043005; GO:0051012; GO:0051294; GO:0051301; GO:0072686; GO:1902856 microtubule binding [GO:0008017]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198] EIEMASEERPPAQALEIMMGLK 0.99398 -15.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2946 10.6915 0 0 0 0 0 0 12.0844 10.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2852 0 0 0 0 0 0 0 0 0 0 0 0 12.503 12.6182 13.6546 16.543 0 0 0 15.5814 0 0 0 0 15.9868 0 0 16.0195 0 0 15.0676 0 0 0 0 12.6121 15.6288 15.4158 0 0 0 0 14.5752 0 0 0 12.0427 0 0 0 0 0 0 0 0 0 0 0 0 15.5661 0 0 0 0 0 11.4055 0 0 13.1384 0 12.1724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1412 P55259 GP2_HUMAN Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75) GP2 Homo sapiens (Human) antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]; antigen binding [GO:0003823]; extracellular matrix structural constituent [GO:0005201]; antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; innate immune response [GO:0045087]; neutrophil migration [GO:1990266] GO:0002412; GO:0003823; GO:0005201; GO:0005576; GO:0005615; GO:0005768; GO:0005886; GO:0009986; GO:0016324; GO:0031362; GO:0042589; GO:0045087; GO:0045121; GO:0070062; GO:1990266 antigen binding [GO:0003823]; extracellular matrix structural constituent [GO:0005201] ADLVKYFIIR 0.99398 -10.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8599 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7808 0 0 13.0597 0 18.7461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5935 Q03112 MECOM_HUMAN "Histone-lysine N-methyltransferase MECOM, EC 2.1.1.367 (Ecotropic virus integration site 1 protein homolog, EVI-1) (MDS1 and EVI1 complex locus protein) (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1)" MECOM EVI1 MDS1 PRDM3 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; heterochromatin organization [GO:0070828]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006915; GO:0016607; GO:0018024; GO:0030154; GO:0042803; GO:0043069; GO:0045892; GO:0045893; GO:0046329; GO:0046872; GO:0046974; GO:0051726; GO:0070828; GO:0071425 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DCGQMFSTTSSLNK 0.99398 -6.5505 0 0 0 12.0634 0 0 0 12.0972 0 0 0 0 0 0 0 0 0 0 0 0 12.6223 0 0 0 0 0 0 0 11.1285 0 11.3218 12.213 11.6956 0 0 11.1563 0 10.6324 0 13.5841 11.4632 0 14.4892 14.5096 0 15.3603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1202 12.8226 0 14.1847 12.7214 19.8939 13.5677 12.9935 0 0 21.2055 13.8836 0 13.3959 0 0 0 14.3408 15.017 14.7799 15.0218 14.8871 0 0 0 14.7586 12.866 13.5022 0 0 0 12.7259 0 13.2851 13.0356 12.8887 0 0 13.3965 0 15.0455 0 15.0741 0 14.449 11.8052 14.1162 0 0 13.5772 0 13.9806 13.9892 14.3733 0 14.0464 12.9789 13.3063 17.148 0 0 0 0 15.2938 0 0 0 12.861 13.2803 12.6399 0 13.0391 0 12.4932 0 0 13.0585 0 0 15.4986 15.2213 0 12.4774 0 14.413 0 0 0 14.8513 0 0 0 13.7138 0 15.098 0 0 14.8585 0 0 0 0 12.3078 0 0 0 Q0VAF6 SYCN_HUMAN Syncollin (Insulin synthesis-associated protein 1) SYCN INSSA1 SYL Homo sapiens (Human) exocytosis [GO:0006887] secretory granule membrane [GO:0030667] secretory granule membrane [GO:0030667]; exocytosis [GO:0006887] GO:0006887; GO:0030667 TCAKLYDK 0.99398 -7.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6V0I7 FAT4_HUMAN "Protocadherin Fat 4, hFat4 (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J)" FAT4 CDHF14 FATJ Nbla00548 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008] GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0016021; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609 calcium ion binding [GO:0005509] ADDGLQSSDMR 0.99398 -30.068 0 0 0 0 0 0 0 14.0302 0 0 0 10.1826 0 0 0 13.2123 14.0895 0 12.0233 0 12.3554 0 0 11.9251 0 0 0 10.8358 12.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.886 0 0 0 0 0 0 0 0 0 12.5295 0 16.7138 13.7867 14.7293 13.5348 14.6749 13.448 14.5924 15.3638 0 13.1175 16.2948 16.2231 0 14.4212 0 15.6248 13.7277 0 0 0 0 0 13.9469 13.9121 0 12.5355 0 12.5263 15.3891 15.5026 14.8429 14.4216 0 0 13.6248 0 14.2079 0 0 0 0 0 0 0 12.6714 12.4349 12.9663 12.6877 14.5015 0 0 0 0 0 0 0 0 13.2873 0 0 13.6234 0 0 0 12.4453 0 0 0 0 0 0 0 0 16.3507 14.9738 0 0 0 0 13.3208 0 0 0 0 0 0 0 11.5105 0 13.9624 14.4211 0 0 0 0 0 0 0 Q86TL0 ATG4D_HUMAN "Cysteine protease ATG4D, EC 3.4.22.- (AUT-like 4 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 4, Autophagin-4) (Autophagy-related protein 4 homolog D, HsAPG4D) [Cleaved into: Cysteine protease ATG4D, mitochondrial ]" ATG4D APG4D AUTL4 Homo sapiens (Human) apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitophagy [GO:0000423]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; proteolysis [GO:0006508] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type peptidase activity [GO:0008234]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitophagy [GO:0000423]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; proteolysis [GO:0006508] GO:0000423; GO:0005654; GO:0005739; GO:0005759; GO:0006508; GO:0006914; GO:0006915; GO:0008234; GO:0015031; GO:0034497; GO:0051697 cysteine-type peptidase activity [GO:0008234] ISSIHLCGR 0.99398 -10.85 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5954 0 0 0 0 0 0 14.8863 13.2697 0 0 0 0 14.8933 0 0 0 0 0 0 0 14.8329 0 0 0 0 0 14.4573 0 0 0 0 0 0 0 14.4136 0 13.8968 0 0 0 12.8471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2286 0 0 0 0 0 0 0 0 16.5517 13.5693 0 0 0 0 0 Q86UF4 CC190_HUMAN Coiled-coil domain-containing protein 190 CCDC190 C1orf110 Homo sapiens (Human) ARNAHYLR 0.99398 -30.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1731 14.2369 14.8814 11.1665 11.0897 0 0 11.2848 0 11.0381 0 0 11.6701 0 12.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0097 0 0 12.4224 13.0133 0 0 13.3068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4003 0 0 14.3823 0 0 0 0 13.4354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4023 0 0 11.2848 12.8366 0 0 0 0 0 0 0 0 0 14.8662 0 0 0 12.2787 0 0 0 0 0 14.5767 14.1447 13.7159 13.5515 13.6283 0 13.6369 0 16.2477 14.6626 14.363 13.4177 13.9434 14.2318 0 0 0 0 15.0362 0 12.797 0 0 Q8TET4 GANC_HUMAN "Neutral alpha-glucosidase C, EC 3.2.1.20" GANC Homo sapiens (Human) N-glycan processing [GO:0006491] "alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]; N-glycan processing [GO:0006491]" GO:0004553; GO:0004558; GO:0006491; GO:0030246; GO:0032450; GO:0090599 "alpha-1,4-glucosidase activity [GO:0004558]; alpha-glucosidase activity [GO:0090599]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; maltose alpha-glucosidase activity [GO:0032450]" CVVEKILVLGFR 0.99398 -14.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6723 0 0 0 0 0 0 0 0 12.7312 0 10.2759 13.8893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1817 14.7144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0074 0 0 0 0 0 11.4935 0 0 0 0 0 14.8634 0 14.5787 0 10.9982 12.795 0 0 0 0 0 0 11.1519 0 0 11.7716 0 0 0 0 0 0 0 0 0 13.1975 0 0 0 0 0 0 0 0 12.8479 0 0 0 13.5838 0 0 12.8858 0 0 0 11.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6907 0 0 0 12.4909 12.8717 0 0 0 0 0 0 0 14.3641 0 0 0 0 0 13.0539 0 0 0 0 Q9P1P5 TAAR2_HUMAN "Trace amine-associated receptor 2, TaR-2, Trace amine receptor 2 (G-protein coupled receptor 58)" TAAR2 GPR58 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594] ENQNNQVK 0.99398 -7.0284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8643 0 0 0 0 0 0 0 0 0 0 0 11.3487 0 0 11.5193 0 0 0 13.6659 0 0 0 0 0 0 O75843 AP1G2_HUMAN "AP-1 complex subunit gamma-like 2 (Gamma2-adaptin, G2ad)" AP1G2 Homo sapiens (Human) Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; transport vesicle [GO:0030133] AP-1 adaptor complex [GO:0030121]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; transport vesicle [GO:0030133]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005794; GO:0005798; GO:0006886; GO:0006896; GO:0006898; GO:0010008; GO:0016020; GO:0016192; GO:0030121; GO:0030133; GO:0035615; GO:0140312 cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615] DGDPVHR 0.99399 -8.117 0 0 0 0 0 0 13.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0033 0 13.2448 0 0 0 0 0 0 0 0 0 0 0 0 11.6085 0 0 0 9.69115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8114 0 0 0 11.6709 12.1989 0 13.4822 0 0 14.6115 0 0 0 0 0 0 14.2243 0 11.5898 0 0 12.8889 0 0 0 0 0 14.3404 0 0 0 0 0 0 14.1868 0 0 0 0 0 0 0 0 13.1137 0 14.6818 0 0 0 10.9903 0 0 14.7627 13.397 0 0 13.7688 11.9996 0 12.607 0 0 0 0 0 0 14.9923 0 0 14.2294 0 0 14.5237 0 0 0 0 0 0 0 0 0 0 11.2664 0 0 0 0 0 0 12.0823 13.4667 0 0 11.1853 0 0 11.0679 0 0 0 0 0 0 12.6743 13.3791 0 0 P04181 OAT_HUMAN "Ornithine aminotransferase, mitochondrial, EC 2.6.1.13 (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form ]" OAT Homo sapiens (Human) arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; visual perception [GO:0007601] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; visual perception [GO:0007601] GO:0004587; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0007601; GO:0010121; GO:0019544; GO:0030170; GO:0042802; GO:0050155; GO:0055129 identical protein binding [GO:0042802]; ornithine(lysine) transaminase activity [GO:0050155]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170] ETKDWDAWKVCLR 0.99399 -6.5624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1355 0 0 0 15.3791 0 0 0 0 0 9.64758 0 0 0 0 0 0 0 0 0 0 0 10.8247 0 0 0 0 0 0 0 0 0 0 0 0 9.00972 0 0 0 0 0 0 0 0 0 0 0 12.5847 13.9281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06493 CDK1_HUMAN "Cyclin-dependent kinase 1, CDK1, EC 2.7.11.22, EC 2.7.11.23 (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)" CDK1 CDC2 CDC28A CDKN1 P34CDC2 Homo sapiens (Human) animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015] "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]" "centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast proliferation [GO:0048144]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein deubiquitination [GO:0016579]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]" GO:0000086; GO:0000226; GO:0000307; GO:0000781; GO:0001618; GO:0003682; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005759; GO:0005789; GO:0005813; GO:0005829; GO:0005876; GO:0006260; GO:0006281; GO:0006468; GO:0006915; GO:0007095; GO:0007098; GO:0007344; GO:0008353; GO:0009410; GO:0009636; GO:0010628; GO:0010629; GO:0010971; GO:0014038; GO:0014075; GO:0014823; GO:0016020; GO:0016477; GO:0016579; GO:0018105; GO:0018107; GO:0030261; GO:0030332; GO:0030496; GO:0030544; GO:0030855; GO:0031100; GO:0034501; GO:0035173; GO:0042307; GO:0042752; GO:0043066; GO:0045471; GO:0045740; GO:0045995; GO:0046686; GO:0046688; GO:0048144; GO:0048511; GO:0048678; GO:0051301; GO:0055015; GO:0060045; GO:0065003; GO:0070062; GO:0070301; GO:0070371; GO:0071407; GO:0072686; GO:0090166; GO:0097125; GO:0097472; GO:0106310; GO:1900182; GO:1905448 ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618] EDYTKIEK 0.99399 -8.1087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42345 MTOR_HUMAN "Serine/threonine-protein kinase mTOR, EC 2.7.11.1 (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin, mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1)" MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 Homo sapiens (Human) "'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; neuronal action potential [GO:0019228]; nucleus localization [GO:0051647]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; voluntary musculoskeletal movement [GO:0050882]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; PML body [GO:0016605]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; neuronal action potential [GO:0019228]; nucleus localization [GO:0051647]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of GTPase activity [GO:0043087]; regulation of locomotor rhythm [GO:1904059]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; rhythmic process [GO:0048511]; ruffle organization [GO:0031529]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; voluntary musculoskeletal movement [GO:0050882]" GO:0000139; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005789; GO:0005829; GO:0006112; GO:0006207; GO:0006468; GO:0006954; GO:0006974; GO:0007010; GO:0007040; GO:0007281; GO:0007584; GO:0008361; GO:0009267; GO:0009408; GO:0009791; GO:0010507; GO:0010592; GO:0010628; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016301; GO:0016310; GO:0016605; GO:0018105; GO:0018107; GO:0019228; GO:0030163; GO:0030307; GO:0030425; GO:0030838; GO:0031529; GO:0031641; GO:0031667; GO:0031669; GO:0031929; GO:0031931; GO:0031932; GO:0032148; GO:0032516; GO:0032868; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043087; GO:0043200; GO:0043276; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0046777; GO:0046889; GO:0048266; GO:0048511; GO:0048709; GO:0048714; GO:0050731; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051647; GO:0051896; GO:0055013; GO:0060048; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0106310; GO:1900034; GO:1901796; GO:1901838; GO:1903691; GO:1904059; GO:1904690; GO:1905857; GO:1990253 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156] ACLILTTQREPK 0.99399 -15.825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.623 0 0 0 0 13.2533 0 0 0 0 0 0 10.5253 0 0 0 12.1828 0 0 10.8498 0 0 0 0 0 9.86555 0 9.96044 0 0 10.5791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.92 0 0 11.789 0 0 0 13.7908 0 0 14.5061 0 0 0 13.418 0 0 11.8171 12.8584 14.5667 0 12.7754 12.7488 11.8825 12.962 0 0 12.8786 10.6278 12.6709 14.1421 0 10.8405 0 0 13.2226 0 0 13.0175 0 0 0 13.4916 10.8072 13.7257 14.4812 12.6829 15.5719 0 0 14.932 0 0 0 0 0 0 0 14.2296 0 0 15.9171 11.5257 11.2326 0 13.6353 0 0 0 14.9008 0 0 0 13.3624 0 0 12.7867 0 0 0 0 0 13.0345 0 0 0 0 12.7897 0 0 0 0 0 14.637 14.6765 0 13.1035 12.9981 0 11.9261 14.3989 0 0 13.7234 0 0 0 0 0 12.0735 0 14.3235 P58546 MTPN_HUMAN Myotrophin (Protein V-1) MTPN Homo sapiens (Human) catecholamine metabolic process [GO:0006584]; cellular response to mechanical stimulus [GO:0071260]; cerebellar granule cell differentiation [GO:0021707]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]; regulation of striated muscle tissue development [GO:0016202]; regulation of translation [GO:0006417]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell differentiation [GO:0051146] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sequence-specific DNA binding [GO:0043565]; catecholamine metabolic process [GO:0006584]; cellular response to mechanical stimulus [GO:0071260]; cerebellar granule cell differentiation [GO:0021707]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]; regulation of striated muscle tissue development [GO:0016202]; regulation of translation [GO:0006417]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell differentiation [GO:0051146] GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0006584; GO:0008290; GO:0008361; GO:0010557; GO:0010613; GO:0016202; GO:0021707; GO:0030182; GO:0030307; GO:0030424; GO:0043403; GO:0043565; GO:0048471; GO:0051092; GO:0051146; GO:0051247; GO:0071260; GO:2000812 sequence-specific DNA binding [GO:0043565] HHITPLLSAVYEGHVSCVKLLLSK 0.99399 -7.0665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6115 0 0 11.4263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3582 0 0 0 0 0 0 0 0 0 0 0 11.6483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.133 0 14.456 13.5747 13.4881 13.1243 13.5067 0 13.6445 0 0 0 0 14.2958 0 0 0 0 0 0 0 0 0 0 Q13439 GOGA4_HUMAN Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230) GOLGA4 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; small GTPase binding [GO:0031267]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005654; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0016192; GO:0031267; GO:0043001; GO:0045773; GO:0048193; GO:0051020; GO:0070062 GTPase binding [GO:0051020]; small GTPase binding [GO:0031267] DQINQLELLLKERDK 0.99399 -30.625 0 0 11.7075 11.4628 0 0 0 0 0 14.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5003 0 0 0 0 0 0 0 0 12.5747 12.1186 13.6128 0 13.1027 13.1976 0 0 0 14.8471 0 0 17.2244 0 16.9615 0 18.601 20.1732 14.7339 14.5083 0 0 13.6141 13.4085 0 14.0352 13.5677 12.593 0 0 12.8938 0 15.1224 14.522 17.0526 0 12.4572 15.0055 0 13.6037 0 13.634 0 14.3343 13.2317 12.9199 0 0 0 0 0 0 0 15.2879 0 11.9335 15.0449 14.7796 0 0 0 0 0 13.6903 0 12.5648 0 0 0 10.668 0 0 0 12.3705 14.4609 0 0 0 0 0 0 0 0 12.0445 12.9186 14.286 0 0 12.8778 11.1833 13.4553 13.8037 12.0853 0 0 0 0 14.2072 0 Q6PI98 IN80C_HUMAN "INO80 complex subunit C (IES6 homolog, hIes6)" INO80C C18orf37 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654] "Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]" GO:0005654; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045893; GO:0051726; GO:0060382; GO:0071339 AAKPLPFK 0.99399 -7.0616 0 0 0 0 0 0 0 0 0 13.1278 12.3905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.694 12.5925 12.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q71H61 ILDR2_HUMAN Immunoglobulin-like domain-containing receptor 2 (Angulin-3) ILDR2 C1orf32 Homo sapiens (Human) cell differentiation [GO:0030154]; homeostasis of number of cells within a tissue [GO:0048873]; insulin secretion [GO:0030073]; negative regulation of T cell activation [GO:0050868]; pancreas development [GO:0031016]; regulation of RNA splicing [GO:0043484]; response to glucose [GO:0009749] bicellular tight junction [GO:0005923]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; tight junction [GO:0070160] bicellular tight junction [GO:0005923]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; tight junction [GO:0070160]; cell differentiation [GO:0030154]; homeostasis of number of cells within a tissue [GO:0048873]; insulin secretion [GO:0030073]; negative regulation of T cell activation [GO:0050868]; pancreas development [GO:0031016]; regulation of RNA splicing [GO:0043484]; response to glucose [GO:0009749] GO:0005634; GO:0005789; GO:0005923; GO:0009749; GO:0016020; GO:0016021; GO:0030073; GO:0030154; GO:0031016; GO:0043484; GO:0048873; GO:0050868; GO:0070160 AHSGFYQDDSLEEYYGQRSR 0.99399 -6.8161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9879 12.1324 11.165 0 0 0 0 0 13.2733 0 0 0 0 0 0 11.3351 0 0 0 0 0 0 0 0 0 0 0 12.9359 0 12.9025 0 12.3848 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1366 0 0 13.8589 0 13.1676 0 0 0 0 0 0 0 13.0331 0 0 0 0 0 0 13.2634 0 0 0 13.0921 0 0 13.4611 0 13.9257 0 0 0 13.4848 13.4284 13.3947 14.2344 0 13.9735 0 0 0 13.6103 13.3734 0 0 0 0 0 0 0 12.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8271 0 13.31 0 0 0 0 0 Q7Z7H8 RM10_HUMAN "39S ribosomal protein L10, mitochondrial, L10mt, MRP-L10 (39S ribosomal protein L8, mitochondrial, L8mt, MRP-L8) (Mitochondrial large ribosomal subunit protein uL10m)" MRPL10 MRPL8 RPML8 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] large ribosomal subunit [GO:0015934]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005654; GO:0005739; GO:0005743; GO:0005762; GO:0006412; GO:0015934; GO:0032543; GO:1990904 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AVTRHRR 0.99399 -28.825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8719 11.2767 12.0594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1443 0 0 0 0 0 12.6431 0 0 0 13.0857 0 0 0 Q8NH74 O10A6_HUMAN Olfactory receptor 10A6 (Olfactory receptor OR11-96) OR10A6 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALMKLWR 0.99399 -8.1069 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2D6 TARA_HUMAN TRIO and F-actin-binding protein (Protein Tara) (Trio-associated repeat on actin) TRIOBP KIAA1662 TARA HRIHFB2122 Homo sapiens (Human) actin filament organization [GO:0007015]; actin modification [GO:0030047]; auditory receptor cell stereocilium organization [GO:0060088]; barbed-end actin filament capping [GO:0051016]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of sound [GO:0007605] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; stereocilium base [GO:0120044] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; stereocilium base [GO:0120044]; actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]; actin filament organization [GO:0007015]; actin modification [GO:0030047]; auditory receptor cell stereocilium organization [GO:0060088]; barbed-end actin filament capping [GO:0051016]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; sensory perception of sound [GO:0007605] GO:0005634; GO:0005737; GO:0005815; GO:0005925; GO:0007015; GO:0007049; GO:0007605; GO:0015629; GO:0030047; GO:0030496; GO:0031267; GO:0031625; GO:0045159; GO:0051015; GO:0051016; GO:0051301; GO:0060088; GO:0120044; GO:1900026 actin filament binding [GO:0051015]; myosin II binding [GO:0045159]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625] AEVERLFGQER 0.99399 -30.425 0 0 0 0 0 0 0 0 0 0 0 0 10.1765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0663 0 0 0 0 0 10.8079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1664 0 0 0 0 12.5379 0 0 0 0 0 0 0 0 0 0 12.2134 0 11.7885 0 0 0 0 0 14.9932 0 16.2259 12.4717 14.5793 14.3254 11.6241 0 0 0 14.3808 15.7285 0 12.377 12.9124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5588 0 14.9571 0 0 12.2181 0 0 11.4633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6015 0 12.3857 0 0 0 12.626 0 0 0 0 0 0 14.6372 0 15.9628 0 0 0 0 0 13.2652 0 0 0 0 0 0 0 0 0 0 0 11.7275 11.1212 0 0 0 0 0 Q9H6R0 DHX33_HUMAN "ATP-dependent RNA helicase DHX33, EC 3.6.4.13 (DEAH box protein 33)" DHX33 DDX33 Homo sapiens (Human) positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413] GO:0000182; GO:0003723; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] FDKMTVPEIQR 0.99399 -15.83 0 0 0 0 0 0 0 0 14.2327 0 0 13.6723 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0244 0 0 0 13.1477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5302 0 0 0 0 0 0 12.729 0 0 0 0 0 0 0 0 0 0 14.0628 0 0 0 0 0 0 0 0 0 0 13.4743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6893 13.4449 13.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4797 0 13.5332 0 0 0 13.6165 0 0 Q9NR82 KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5) KCNQ5 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] clathrin coat [GO:0030118]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0008076; GO:0016021; GO:0030118; GO:0034765; GO:0071805 calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] DLGKSLSVQNLIR 0.99399 -8.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7795 0 0 0 0 0 0 0 0 0 12.0428 0 12.5549 0 0 0 11.398 0 0 0 0 0 0 0 0 0 0 0 11.0226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6274 0 0 0 0 0 0 0 Q9NUL7 DDX28_HUMAN "Probable ATP-dependent RNA helicase DDX28, EC 3.6.4.13 (Mitochondrial DEAD box protein 28)" DDX28 MDDX28 Homo sapiens (Human) mitochondrial large ribosomal subunit assembly [GO:1902775] cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; mitochondrial large ribosomal subunit assembly [GO:1902775] GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0016887; GO:0019843; GO:0035770; GO:0042645; GO:1902775 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843] AVAQPLGRSLGLLVRDLEGGHGMR 0.99399 -28.868 12.0332 0 0 0 0 0 0 11.7461 13.9731 14.0949 0 0 12.5864 0 0 0 0 0 13.0067 13.0521 0 0 11.1457 11.7874 14.4007 0 0 0 0 15.9187 0 0 0 0 0 0 12.6878 15.9329 13.3662 12.494 12.8792 12.0143 0 16.032 0 0 0 0 0 0 16.1788 0 14.1439 15.8416 0 0 0 12.8702 0 0 0 0 0 0 0 0 13.7757 12.3957 17.0152 14.1968 13.1673 14.5321 12.7147 14.3691 14.5891 16.1955 14.7209 15.769 0 0 13.8132 12.8559 13.4089 15.3635 11.2725 0 15.9399 13.4112 0 0 0 0 0 13.8871 0 0 0 13.8053 14.2958 12.2994 11.9082 0 0 14.9075 13.3056 12.9074 12.7548 12.284 12.1835 14.3456 12.4006 0 0 0 0 14.7379 13.5581 13.3929 13.8358 14.7889 0 11.9219 0 0 13.1492 0 14.9957 0 14.4787 12.6619 0 14.4949 15.6658 12.2718 14.9775 13.9608 13.8703 12.227 13.8779 14.0133 15.2596 15.1742 0 11.8482 13.8732 0 0 14.2128 0 12.2126 0 13.6199 12.6622 0 12.5608 15.1493 0 14.2679 14.5341 14.8186 0 13.8435 0 14.2507 0 0 14.0959 12.2263 14.0296 13.5409 0 12.448 13.6025 13.9898 0 14.0073 0 14.4099 14.6145 12.6397 Q9UBN7 HDAC6_HUMAN "Histone deacetylase 6, HD6, EC 3.5.1.98 (Tubulin-lysine deacetylase HDAC6, EC 3.5.1.-)" HDAC6 KIAA0901 JM21 Homo sapiens (Human) "aggresome assembly [GO:0070842]; autophagy [GO:0006914]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]" aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471] "aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; axonal transport of mitochondrion [GO:0019896]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of signaling receptor activity [GO:2000273]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression, epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]" GO:0000118; GO:0000122; GO:0000209; GO:0000978; GO:0001222; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0006914; GO:0007026; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0016234; GO:0016235; GO:0016241; GO:0016575; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032984; GO:0033138; GO:0033558; GO:0034983; GO:0035967; GO:0036064; GO:0040029; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0051354; GO:0051787; GO:0051788; GO:0051879; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061523; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0070846; GO:0070848; GO:0071218; GO:0090042; GO:1901300; GO:1903146; GO:1904115; GO:2000273 actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] EGPSSSK 0.99399 -15.841 0 0 12.6888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4843 13.6708 14.676 0 13.3946 0 15.696 0 0 13.4584 14.9065 13.6854 0 14.8211 13.6864 14.236 0 14.5564 13.8334 14.3418 0 0 15.3127 0 0 14.0665 14.6166 0 0 0 15.0617 14.8617 12.9222 0 13.8208 0 15.0951 0 0 0 13.9067 13.3622 0 0 13.0113 0 0 0 13.5746 14.3886 12.5257 14.7319 12.1904 14.2969 13.2453 0 0 13.5214 13.5798 13.6435 0 13.8919 0 0 0 0 0 0 0 0 0 0 14.2955 14.5821 0 0 16.2091 16.232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2281 14.86 0 13.3269 0 0 0 0 0 Q9UI32 GLSL_HUMAN "Glutaminase liver isoform, mitochondrial, GLS, EC 3.5.1.2 (L-glutaminase) (L-glutamine amidohydrolase)" GLS2 GA Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutaminase activity [GO:0004359]; cellular amino acid metabolic process [GO:0006520]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981] GO:0004359; GO:0005739; GO:0005759; GO:0006520; GO:0006537; GO:0006543; GO:0042981; GO:0072593 glutaminase activity [GO:0004359] AGSHCGR 0.99399 -7.0559 0 0 0 0 0 0 0 0 0 0 0 0 11.7495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3709 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2859 0 0 0 0 0 0 0 15.5661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9719 13.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQ90 SPG7_HUMAN "Paraplegin, EC 3.4.24.- (Cell matrix adhesion regulator) (Spastic paraplegia 7 protein)" SPG7 CAR CMAR PGN Homo sapiens (Human) anterograde axonal transport [GO:0008089]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902] axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739] axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; anterograde axonal transport [GO:0008089]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; nervous system development [GO:0007399]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of mitochondrial membrane permeability [GO:0046902] GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0005757; GO:0006508; GO:0007399; GO:0008089; GO:0008233; GO:0008270; GO:0016887; GO:0034982; GO:0046902; GO:0051082; GO:0065003; GO:1902686; GO:1904115 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] ALRRGPGPGPR 0.99399 -12.936 0 0 0 0 0 0 0 11.9338 12.0019 13.1001 0 13.0241 12.9034 14.5521 0 12.7874 13.8419 0 0 0 9.20291 12.1884 0 0 11.227 0 12.2883 0 11.2616 0 12.3568 14.811 13.0187 13.0081 13.6484 11.8717 0 13.6372 13.2376 11.4573 0 0 0 12.8331 0 0 12.1964 0 0 0 0 10.5594 0 0 0 12.5616 0 0 0 0 10.8718 10.8375 0 0 0 0 0 0 11.7283 0 14.005 0 0 0 14.1461 13.559 0 13.6907 15.6558 14.3415 0 13.6062 0 15.1319 16.1752 16.1683 16.0051 12.2623 15.4777 14.3167 0 10.544 15.1526 14.6057 0 15.4798 15.3256 14.9436 16.1331 13.3006 14.4078 10.2596 0 0 0 15.9947 15.2722 0 0 13.3428 15.5607 0 14.3797 14.1707 12.8706 13.8668 13.924 0 0 12.1355 0 14.8076 15.747 13.7421 14.9279 19.0083 15.4755 13.2314 14.8694 0 14.953 15.6467 12.1987 14.8144 13.2249 0 16.6408 14.1143 11.3196 15.2123 0 15.3052 14.4387 13.5681 14.6061 0 11.6325 18.0896 0 0 0 14.6661 0 16.3458 19.1965 15.8286 14.0821 0 12.4921 13.1677 14.815 12.6446 12.1644 12.07 12.2936 11.7846 0 12.1366 12.4382 10.6735 13.6506 0 14.7614 10.0662 0 12.2055 0 12.0584 0 0 Q9Y5W8 SNX13_HUMAN Sorting nexin-13 (RGS domain- and PHOX domain-containing protein) (RGS-PX1) SNX13 KIAA0713 Homo sapiens (Human) intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547] GO:0005769; GO:0006886; GO:0009968; GO:0031901; GO:0032266; GO:0035091; GO:0043231; GO:0043547 phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] DERFYPSFRQNALYVR 0.99399 -7.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0254 0 0 0 0 0 0 0 11.4151 0 0 11.9972 0 0 0 0 0 0 0 0 0 0 12.7994 0 13.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0623 0 0 13.9593 0 0 0 0 0 0 12.8936 0 0 0 0 13.6176 16.0523 0 0 13.5572 0 0 12.4862 0 0 0 0 0 0 0 0 0 0 12.1782 11.6847 0 0 0 0 0 0 0 0 0 0 0 11.5564 0 0 0 0 0 0 0 0 0 13.8831 0 0 0 0 0 0 12.9276 0 0 0 0 0 0 0 0 0 0 13.5171 0 13.1379 0 0 0 0 11.9791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18507 GBRG2_HUMAN Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) GABRG2 Homo sapiens (Human) "adult behavior [GO:0030534]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; post-embryonic development [GO:0009791]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; axon [GO:0030424]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202] "anchoring junction [GO:0070161]; axon [GO:0030424]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; adult behavior [GO:0030534]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; post-embryonic development [GO:0009791]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005254; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0009791; GO:0022851; GO:0030424; GO:0030534; GO:0030594; GO:0030659; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060077; GO:0060078; GO:0070161; GO:0071420; GO:0098794; GO:0098978; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315; GO:1904862 benzodiazepine receptor activity [GO:0008503]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] DCASFFCCFEDCR 0.994 -7.0865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4928 0 0 0 0 0 0 0 0 0 13.3164 0 0 10.8483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.029 0 0 0 0 0 0 0 0 0 11.6914 11.1293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2736 0 0 0 0 11.2997 0 11.5633 0 0 0 11.1593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4916 0 0 0 0 0 0 0 0 0 12.5164 0 12.6167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6952 11.4077 11.9335 0 0 0 0 0 0 0 0 0 0 13.7425 0 0 14.9765 0 0 P56730 NETR_HUMAN "Neurotrypsin, EC 3.4.21.- (Leydin) (Motopsin) (Serine protease 12)" PRSS12 Homo sapiens (Human) exocytosis [GO:0006887]; zymogen activation [GO:0031638] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195] axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; exocytosis [GO:0006887]; zymogen activation [GO:0031638] GO:0004252; GO:0005044; GO:0005886; GO:0006887; GO:0008236; GO:0030424; GO:0030425; GO:0031410; GO:0031638; GO:0043083; GO:0043195 scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] GKVDWGYCDCRHGSVR 0.994 -12.972 0 0 11.8186 0 11.303 12.2627 0 0 0 0 0 0 0 0 10.2407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4432 0 0 0 0 0 0 10.8588 0 0 0 12.9306 0 0 0 9.28852 0 0 14.5548 14.7286 14.6603 0 0 0 0 0 13.8981 0 0 0 0 0 9.026 13.1711 0 12.6118 0 0 0 0 0 0 0 0 11.7989 0 0 0 0 15.1105 15.1698 0 0 0 14.7595 0 15.2405 0 0 14.9351 12.0536 0 0 13.6178 14.1326 11.8315 0 0 0 15.1252 14.7746 0 0 14.8202 0 13.7618 0 0 15.1211 13.5084 0 0 0 12.8246 13.7252 0 14.9117 0 12.4401 13.8587 12.6488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.557 0 10.4799 0 0 0 0 0 0 0 0 0 0 15.5554 0 0 0 10.2999 0 15.5372 0 0 0 0 0 0 0 0 0 0 0 13.7181 0 0 0 0 0 0 0 0 11.3139 0 0 14.6066 0 Q6PII5 HAGHL_HUMAN "Hydroxyacylglutathione hydrolase-like protein, EC 3.1.2.-" HAGHL Homo sapiens (Human) hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] GO:0004416; GO:0046872 hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872] AKLSWAK 0.994 -7.9015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9466 0 11.8584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4517 12.5846 12.6267 0 13.8486 0 0 0 0 12.4598 12.5296 0 11.3642 0 0 13.5332 0 13.0197 11.8205 14.5482 13.3542 0 0 0 0 0 0 0 0 11.3831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8131 0 12.7827 0 0 0 0 0 12.7438 0 0 14.3972 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6148 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN30 BNC2_HUMAN Zinc finger protein basonuclin-2 BNC2 Homo sapiens (Human) "endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]; tongue development [GO:0043586]" GO:0000182; GO:0000785; GO:0003416; GO:0005634; GO:0005654; GO:0006355; GO:0043586; GO:0046872; GO:0060021; GO:0060485 metal ion binding [GO:0046872]; rDNA binding [GO:0000182] ILLDRLFSVLK 0.994 -7.0854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3247 0 0 13.6999 0 0 0 0 11.5199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5718 0 0 0 0 0 0 0 0 0 14.5591 12.7185 14.2457 0 15.248 0 0 0 0 0 13.2175 0 0 0 0 0 0 0 11.639 0 0 0 0 16.3004 12.8249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4736 0 0 0 0 0 0 0 0 0 0 Q8IZ26 ZNF34_HUMAN Zinc finger protein 34 (Zinc finger protein KOX32) ZNF34 KOX32 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSQSCEFINHRRMHSGEIPYR 0.994 -7.9063 0 0 0 0 0 0 0 0 14.5748 14.3355 14.9679 14.5157 14.5681 15.1121 14.9754 15.1002 13.2477 14.8556 15.0447 0 0 0 0 0 15.0882 14.2342 0 12.6945 14.088 14.4493 10.2037 12.9401 0 13.7016 0 0 0 14.3266 0 13.578 15.1905 0 0 14.4809 14.2919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96489 0 0 0 0 0 0 0 0 0 0 14.6822 13.2988 0 0 0 0 15.3385 12.2574 10.701 0 0 13.4437 0 0 12.4275 0 0 0 0 0 0 0 11.5251 0 11.0298 12.3345 0 12.6361 10.4572 0 0 0 16.0789 12.6217 0 0 0 12.4911 0 0 0 12.9358 0 0 0 0 13.5811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2467 0 0 13.2398 0 0 0 0 14.4229 13.0535 13.2114 0 0 0 0 14.0113 0 11.8635 12.7646 0 0 0 0 13.4115 0 0 14.6854 0 Q9NY61 AATF_HUMAN Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1) AATF CHE1 DED HSPC277 Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosome biogenesis [GO:0042254] GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0005794; GO:0006357; GO:0006974; GO:0007155; GO:0007346; GO:0019901; GO:0032929; GO:0040016; GO:0042254; GO:0042985; GO:0043066; GO:0043522; GO:0045944; GO:0048156; GO:2000378; GO:2001234 leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156] FADFTVYR 0.994 -14.196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2663 0 0 0 0 0 13.1557 0 0 0 0 0 11.1573 0 0 13.4742 0 0 13.3031 0 0 0 0 12.0816 13.5161 0 11.7094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2754 0 12.8197 0 0 0 0 13.7403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9393 0 0 0 0 0 12.4766 0 0 13.7021 0 0 0 13.2335 13.2808 13.5183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3963 0 Q9NZS9 BFAR_HUMAN Bifunctional apoptosis regulator (RING finger protein 47) BFAR BAR RNF47 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0005783; GO:0005887; GO:0006511; GO:0006915; GO:0016020; GO:0030176; GO:0030674; GO:0043066; GO:0043161; GO:0046872; GO:0051865; GO:0061630; GO:0070534; GO:0070936; GO:0089720; GO:1903895 caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630] MWSHFWK 0.994 -11.199 0 0 12.51 0 0 0 0 0 0 0 0 0 0 0 10.8811 0 11.9545 0 10.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0037 0 0 0 0 11.9398 0 0 0 0 10.1536 11.5132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1288 0 13.5874 14.1411 0 12.4607 0 0 0 0 0 0 0 0 0 0 0 0 12.3034 13.2933 0 0 0 0 0 0 0 13.6393 0 0 0 13.3399 0 0 0 0 0 0 0 14.1588 14.0816 14.0555 0 14.4991 0 14.0864 13.6398 14.2204 0 0 0 0 13.6373 13.6389 0 14.2146 13.2572 0 0 0 0 12.4353 0 0 14.6575 0 0 0 13.1452 0 14.4301 0 0 0 0 0 12.7471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2025 0 0 0 0 12.8681 0 15.4129 0 0 0 0 0 0 0 Q9Y5H0 PCDG3_HUMAN "Protocadherin gamma-A3, PCDH-gamma-A3" PCDHGA3 Homo sapiens (Human) cell adhesion [GO:0007155]; endosome to lysosome transport [GO:0008333]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lipid tube assembly involved in organelle fusion [GO:0060989]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; endosome to lysosome transport [GO:0008333]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lipid tube assembly involved in organelle fusion [GO:0060989]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0008333; GO:0060989 calcium ion binding [GO:0005509] EELCAQIPLCLVK 0.994 -7.0878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UEG4 ZN629_HUMAN Zinc finger protein 629 (Zinc finger protein 65) ZNF629 KIAA0326 ZNF65 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" PFKCPECK 0.99401 -13.079 0 0 0 0 0 0 0 0 0 13.841 0 14.0399 0 0 12.3477 0 11.5709 0 0 0 0 0 0 0 0 0 0 0 0 13.1231 13.2823 0 13.4423 0 0 0 0 13.8343 13.3174 13.5226 0 0 0 0 11.4616 0 0 0 0 0 11.9978 11.6759 0 0 0 0 0 10.7384 0 0 0 0 14.3198 0 0 0 0 0 0 12.0936 12.6181 13.8316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.896 0 0 0 0 0 0 0 0 0 0 0 16.8006 0 0 15.3922 0 0 0 15.6014 15.5493 15.7941 15.3035 0 0 0 0 0 15.4473 0 0 0 0 P07510 ACHG_HUMAN Acetylcholine receptor subunit gamma CHRNG ACHRG Homo sapiens (Human) acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] GO:0005231; GO:0005886; GO:0005887; GO:0005892; GO:0006936; GO:0007165; GO:0007268; GO:0015267; GO:0015464; GO:0022848; GO:0030594; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:0095500; GO:1904315 acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; channel activity [GO:0015267]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] GVRKVFLR 0.99401 -6.8772 0 0 0 0 0 0 0 0 0 0 11.8811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2922 11.231 0 0 0 0 0 0 0 0 12.9501 0 0 0 0 13.588 0 0 0 0 0 0 0 0 15.4071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.752 0 0 0 0 13.2385 0 0 0 0 0 0 0 0 0 12.4392 0 0 0 0 0 0 0 0 0 0 0 0 11.4782 0 0 11.0428 0 12.992 0 13.2986 P09622 DLDH_HUMAN "Dihydrolipoyl dehydrogenase, mitochondrial, EC 1.8.1.4 (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)" DLD GCSL LAD PHE3 Homo sapiens (Human) "acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]" acrosomal matrix [GO:0043159]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254] "acrosomal matrix [GO:0043159]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; branched-chain amino acid catabolic process [GO:0009083]; cell redox homeostasis [GO:0045454]; gastrulation [GO:0007369]; histone succinylation [GO:0106077]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]" GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0005947; GO:0005967; GO:0006086; GO:0006120; GO:0006508; GO:0007369; GO:0009083; GO:0031514; GO:0042391; GO:0043159; GO:0045252; GO:0045254; GO:0045454; GO:0048240; GO:0050660; GO:0061732; GO:0106077 dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660] AAQLGFK 0.99401 -13.061 0 0 0 0 0 0 0 0 0 11.7979 12.4488 12.2581 0 0 0 11.3579 11.472 0 0 0 0 0 11.8874 0 0 11.7754 12.3674 0 11.1735 0 0 0 11.3097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3639 12.4674 0 0 0 0 0 0 0 0 0 0 0 0 0 13.181 0 0 0 0 0 0 0 0 0 0 12.8811 0 0 0 0 0 0 12.6912 0 0 0 14.223 0 0 0 0 0 0 0 0 0 0 0 0 0 13.906 0 0 0 0 0 0 0 0 0 0 0 14.015 0 13.3038 12.7803 13.0069 11.8292 13.0399 0 13.3908 12.7879 13.6072 13.8568 13.0764 0 12.563 0 0 0 12.9857 0 0 P43630 KI3L2_HUMAN "Killer cell immunoglobulin-like receptor 3DL2 (CD158 antigen-like family member K) (Natural killer-associated transcript 4, NKAT-4) (p70 natural killer cell receptor clone CL-5, p70 NK receptor CL-5) (CD antigen CD158k)" KIR3DL2 CD158K NKAT4 Homo sapiens (Human) cellular defense response [GO:0006968]; negative regulation of neuron death [GO:1901215] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; MHC class Ib protein binding [GO:0023029]; cellular defense response [GO:0006968]; negative regulation of neuron death [GO:1901215] GO:0005886; GO:0005887; GO:0006968; GO:0023029; GO:1901215 MHC class Ib protein binding [GO:0023029] AVPKVNR 0.99401 -10.994 0 0 0 0 0 0 12.9211 13.0459 0 0 0 0 0 11.8713 12.3252 0 12.5747 0 0 0 0 0 0 0 12.0508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.503 0 0 0 12.1805 0 0 0 12.6411 12.1317 13.7101 0 14.7982 0 0 0 0 0 0 0 0 0 13.0345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4809 12.6932 0 12.6415 12.4981 12.8785 0 0 13.9363 0 0 0 0 0 12.7521 0 0 0 0 0 0 0 0 0 0 0 13.0122 0 0 0 0 0 15.8816 12.5815 0 0 0 0 16.0185 0 13.1747 0 12.0716 12.4664 12.602 0 0 0 0 0 10.3123 Q13642 FHL1_HUMAN "Four and a half LIM domains protein 1, FHL-1 (Skeletal muscle LIM-protein 1, SLIM, SLIM-1)" FHL1 SLIM1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; positive regulation of potassium ion transport [GO:0043268]; regulation of membrane depolarization [GO:0003254]; regulation of potassium ion transmembrane transporter activity [GO:1901016] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; positive regulation of potassium ion transport [GO:0043268]; regulation of membrane depolarization [GO:0003254]; regulation of potassium ion transmembrane transporter activity [GO:1901016] GO:0003254; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007517; GO:0009887; GO:0010972; GO:0030154; GO:0030308; GO:0043268; GO:0044325; GO:0046872; GO:1901016; GO:2000134 metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325] CFDKFCANTCVECR 0.99401 -29.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2382 13.6571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.781 0 0 0 0 0 0 0 0 0 13.0611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7792 0 0 14.1135 13.5221 13.8531 0 0 13.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8071 12.6953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0168 0 14.5709 0 0 11.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3883 0 0 0 0 0 Q2V2M9 FHOD3_HUMAN "FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2, hFHOS2)" FHOD3 FHOS2 KIAA1695 Homo sapiens (Human) actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actin filament network formation [GO:0051639]; cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214] GO:0005737; GO:0005856; GO:0030018; GO:0030837; GO:0030866; GO:0045214; GO:0051015; GO:0051639; GO:0055003 actin filament binding [GO:0051015] AIAKHEMK 0.99401 -27.762 0 0 0 0 0 11.1424 0 0 13.0351 14.1895 11.6541 14.7279 0 14.4587 0 0 0 13.4112 13.5821 0 12.8128 0 13.8579 0 13.8472 0 0 13.937 0 0 12.7495 0 14.2554 0 0 14.0755 0 0 0 0 0 13.0453 0 0 14.2253 0 0 0 0 0 0 0 0 12.5559 0 0 0 0 0 9.80523 0 0 0 0 0 0 14.4704 0 10.1453 0 11.7314 0 0 10.4788 12.7402 13.1116 13.4151 13.5085 0 13.0629 12.5748 13.551 14.6713 13.6763 0 0 0 16.6038 12.9532 0 11.4345 13.8614 11.0361 0 13.3063 0 10.4239 16.4221 13.1441 0 13.1798 13.0928 0 15.6096 11.1623 0 10.1205 13.2501 13.5631 12.0105 13.2676 11.6121 0 0 0 0 0 0 0 0 13.4013 13.5828 13.3934 0 14.118 11.3466 13.2525 11.1433 0 0 0 0 13.5275 0 13.3207 0 0 0 0 9.67664 0 11.198 13.4066 12.9957 13.9908 0 0 0 11.5825 0 0 0 0 0 10.7354 15.6756 0 13.4575 0 14.7311 0 0 11.5484 12.3478 0 0 13.5902 12.6913 0 12.5363 0 0 11.35 13.8016 0 0 0 0 11.8719 14.109 Q7Z2E3 APTX_HUMAN "Aprataxin, EC 3.6.1.71, EC 3.6.1.72 (Forkhead-associated domain histidine triad-like protein, FHA-HIT)" APTX AXA1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; regulation of protein stability [GO:0031647]; response to hydrogen peroxide [GO:0042542]; single strand break repair [GO:0000012] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; phosphoglycolate phosphatase activity [GO:0008967]; phosphoprotein binding [GO:0051219]; polynucleotide 3'-phosphatase activity [GO:0046403]; protein N-terminus binding [GO:0047485]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; regulation of protein stability [GO:0031647]; response to hydrogen peroxide [GO:0042542]; single strand break repair [GO:0000012] GO:0000012; GO:0000785; GO:0003682; GO:0003684; GO:0003690; GO:0003697; GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006266; GO:0006302; GO:0006974; GO:0008967; GO:0030983; GO:0031647; GO:0033699; GO:0042542; GO:0046403; GO:0046872; GO:0047485; GO:0051219; GO:0120108; GO:1990165 chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA 5'-adenosine monophosphate hydrolase activity [GO:0033699]; DNA-3'-diphospho-5'-guanosine diphosphatase [GO:0120108]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; mismatched DNA binding [GO:0030983]; phosphoglycolate phosphatase activity [GO:0008967]; phosphoprotein binding [GO:0051219]; polynucleotide 3'-phosphatase activity [GO:0046403]; protein N-terminus binding [GO:0047485]; single-strand break-containing DNA binding [GO:1990165]; single-stranded DNA binding [GO:0003697] DEQVVVIKDKYPK 0.99401 -6.8738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5202 0 0 0 0 0 0 0 0 0 0 0 13.6994 0 0 15.4212 0 0 0 0 0 0 0 0 0 0 0 0 14.6871 0 0 0 0 14.2795 0 0 0 0 0 0 0 0 0 0 14.5877 15.9242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z569 BRAP_HUMAN "BRCA1-associated protein, EC 2.3.2.27 (BRAP2) (Impedes mitogenic signal propagation, IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63)" BRAP RNF52 Homo sapiens (Human) MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265] GO:0000151; GO:0000165; GO:0003676; GO:0004842; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630 identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AQADADSFYMTCNGR 0.99401 -6.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5867 0 12.9418 0 0 0 0 0 0 0 0 0 0 0 0 11.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3931 0 0 0 0 0 0 12.2444 0 0 0 0 0 12.0179 0 0 0 0 0 0 0 0 0 0 12.0506 0 14.2848 0 0 0 0 0 0 0 10.6428 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5088 0 0 0 15.2242 0 12.882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3591 0 0 0 11.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6679 0 0 0 0 0 0 0 Q86SM8 MRGRE_HUMAN Mas-related G-protein coupled receptor member E (G-protein coupled receptor 167) MRGPRE GPR167 MRGE Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930] FFCYIVGLSLLAAVSVEQCLAALFPAWYSCRRPR 0.99401 -13.082 0 11.4574 11.4651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5437 0 0 0 0 0 0 0 0 0 0 0 0 11.5417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6881 0 13.1585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9967 0 0 0 0 0 0 11.0792 0 0 0 0 0 0 0 0 0 14.5641 11.9999 0 11.635 0 11.9889 0 0 0 0 12.6796 15.0981 0 12.3473 0 0 0 0 0 0 0 0 17.025 12.4879 0 0 0 0 0 0 0 0 0 Q8IXR9 CL056_HUMAN Uncharacterized protein C12orf56 C12orf56 Homo sapiens (Human) AVSEPSCTTNTK 0.99401 -5.1948 0 12.5233 0 0 0 0 13.5866 13.0744 0 0 0 10.0844 10.9983 0 0 0 0 0 11.228 0 0 11.1582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8322 0 0 0 0 0 0 0 13.8046 11.2947 0 14.5478 0 14.5313 0 13.099 0 0 0 11.3915 0 0 0 0 0 11.459 0 0 0 12.4966 15.3764 0 14.7094 0 0 12.5465 0 0 13.3332 0 0 12.7319 10.7014 0 0 0 15.0585 0 12.8905 0 0 0 0 0 0 0 0 0 0 10.1624 0 0 0 0 0 0 0 11.6968 0 0 10.9169 0 0 0 0 0 13.7265 0 0 0 0 0 0 0 11.9837 12.3187 0 0 0 0 0 11.0109 12.698 0 0 0 0 0 11.9369 0 0 0 0 0 0 0 0 10.5241 0 0 0 12.8569 Q8N9S9 SNX31_HUMAN Sorting nexin-31 SNX31 Homo sapiens (Human) intracellular protein transport [GO:0006886] early endosome [GO:0005769]; protein-containing complex [GO:0032991] early endosome [GO:0005769]; protein-containing complex [GO:0032991]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886] GO:0005769; GO:0006886; GO:0032991; GO:0035091 phosphatidylinositol binding [GO:0035091] EGKLSVVK 0.99401 -6.8809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCA5 FA98A_HUMAN Protein FAM98A FAM98A Homo sapiens (Human) "lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723]; lysosome localization [GO:0032418]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0003723; GO:0005634; GO:0005737; GO:0006388; GO:0006479; GO:0008276; GO:0008284; GO:0010628; GO:0032418; GO:0072669; GO:1900029 protein methyltransferase activity [GO:0008276]; RNA binding [GO:0003723] GGGRGGYEHSSYGGRGGHEQGGGR 0.99401 -13.07 0 0 0 12.9357 16.6531 16.6644 16.6934 14.6873 0 0 11.8222 0 0 0 0 0 13.3846 0 11.2004 0 16.7325 13.3117 0 13.7762 13.844 16.8066 0 0 0 12.0618 12.2552 10.6808 0 0 0 12.9287 11.2265 0 0 10.9703 10.7453 11.6657 12.0035 0 0 11.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5245 0 0 17.592 0 13.5718 0 11.1626 13.4103 16.5899 13.0473 0 0 13.9783 15.3036 11.5417 16.2554 18.1753 18.1765 18.2174 18.1107 12.6042 18.1843 0 14.0444 18.0658 0 0 13.4094 18.1027 17.9459 11.8672 0 0 18.0938 18.2034 12.1379 17.9017 0 0 17.8654 13.1734 0 14.0964 18.017 18.0921 12.9831 0 0 0 18.0078 0 18.0038 17.9704 0 13.3748 12.4138 0 0 17.9302 17.9356 12.5714 0 12.6425 13.7281 18.0233 13.6472 17.8673 0 17.948 0 0 17.8748 0 17.945 18.1144 17.954 17.9004 0 15.5626 0 0 0 17.9576 17.9272 0 13.1048 14.4882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8852 14.0271 15.3912 0 0 11.5364 0 0 Q8NI36 WDR36_HUMAN "WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein, TA-WDRP)" WDR36 Homo sapiens (Human) response to stimulus [GO:0050896]; rRNA processing [GO:0006364]; visual perception [GO:0007601] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; response to stimulus [GO:0050896]; rRNA processing [GO:0006364]; visual perception [GO:0007601] GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0050896 RNA binding [GO:0003723] DFELAQAYLALFLK 0.99401 -10.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7244 0 13.9988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2591 0 0 14.1893 0 0 0 0 0 0 0 13.6798 13.3997 0 13.2819 0 0 0 0 0 0 0 0 0 0 12.5704 0 0 0 0 0 0 12.4037 0 0 0 0 0 0 0 0 12.5478 12.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4713 0 0 0 0 0 0 0 0 14.6967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H237 PORCN_HUMAN "Protein-serine O-palmitoleoyltransferase porcupine, EC 2.3.1.250 (Protein MG61)" PORCN MG61 PORC PPN Homo sapiens (Human) glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; protein palmitoylation [GO:0018345]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; acyltransferase activity [GO:0016746]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147]; glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; protein palmitoylation [GO:0018345]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055] GO:0005783; GO:0005789; GO:0006497; GO:0009100; GO:0016020; GO:0016055; GO:0016746; GO:0017147; GO:0018345; GO:0030176; GO:0030258; GO:0032281; GO:0045234; GO:0061355; GO:0098978; GO:0099072; GO:1990698 acyltransferase activity [GO:0016746]; palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147] ARGTMVRWLR 0.99401 -5.1941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3272 0 0 0 11.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8579 12.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7745 0 0 0 14.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2877 14.3506 13.8729 0 0 14.1761 0 0 0 0 14.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8758 0 0 13.4732 0 0 0 0 0 Q9NZM4 BICRA_HUMAN BRD4-interacting chromatin-remodeling complex-associated protein (Glioma tumor suppressor candidate region gene 1 protein) BICRA GLTSCR1 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; transcription regulator activator activity [GO:0140537]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:0140537; GO:1902459 transcription regulator activator activity [GO:0140537] AASSGPGK 0.99401 -29.564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6379 11.3149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5631 0 0 0 0 0 0 0 12.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6742 0 0 0 0 0 0 0 0 10.7929 11.8929 0 0 0 13.886 0 0 0 15.2519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6601 Q9UKF7 PITC1_HUMAN "Cytoplasmic phosphatidylinositol transfer protein 1 (Mammalian rdgB homolog beta, M-rdgB beta, MrdgBbeta) (Retinal degeneration B homolog beta, RdgBbeta)" PITPNC1 Homo sapiens (Human) phospholipid transport [GO:0015914]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; phospholipid transport [GO:0015914]; signal transduction [GO:0007165] GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008526; GO:0015914; GO:0035091; GO:0070300; GO:1901611; GO:1990050 phosphatidic acid binding [GO:0070300]; phosphatidic acid transfer activity [GO:1990050]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526] EFERATQEATNKK 0.99401 -6.8747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5787 0 11.7156 0 0 0 12.8864 0 0 0 0 11.0567 0 0 11.2562 0 0 0 0 0 0 0 12.2629 0 0 0 0 0 0 0 0 0 0 13.1783 0 0 0 0 11.5531 0 12.6462 0 0 0 0 0 0 0 0 0 0 12.4293 0 12.6727 0 0 0 0 0 11.0567 0 0 0 0 0 0 0 0 0 0 0 11.5601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKN8 TF3C4_HUMAN "General transcription factor 3C polypeptide 4, EC 2.3.1.48 (TF3C-delta) (Transcription factor IIIC 90 kDa subunit, TFIIIC 90 kDa subunit, TFIIIC90) (Transcription factor IIIC subunit delta)" GTF3C4 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] GO:0000127; GO:0000995; GO:0003677; GO:0004402; GO:0005654; GO:0005739; GO:0006383; GO:0006384; GO:0008047; GO:0042791; GO:0042797 DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; histone acetyltransferase activity [GO:0004402]; RNA polymerase III general transcription initiation factor activity [GO:0000995] GFKYTSWSPMGCDANGR 0.99401 -5.1866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.23869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4954 0 0 0 0 0 0 0 0 13.6792 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1609 0 0 0 0 0 0 0 0 0 0 0 12.6937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UM73 ALK_HUMAN "ALK tyrosine kinase receptor, EC 2.7.10.1 (Anaplastic lymphoma kinase) (CD antigen CD246)" ALK Homo sapiens (Human) adult behavior [GO:0030534]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; neuron development [GO:0048666]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein tyrosine kinase activity [GO:0004713]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; adult behavior [GO:0030534]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; neuron development [GO:0048666]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of dendrite development [GO:1900006]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of neuron differentiation [GO:0045664]; response to environmental enrichment [GO:0090648]; signal transduction [GO:0007165]; swimming behavior [GO:0036269]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004704; GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0008201; GO:0016310; GO:0021766; GO:0030298; GO:0030534; GO:0032991; GO:0033674; GO:0036269; GO:0038083; GO:0042127; GO:0042802; GO:0042981; GO:0043235; GO:0043410; GO:0045664; GO:0046777; GO:0048666; GO:0050995; GO:0051092; GO:0060159; GO:0070062; GO:0090648; GO:0097009; GO:1900006 ATP binding [GO:0005524]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; NF-kappaB-inducing kinase activity [GO:0004704]; protein tyrosine kinase activity [GO:0004713]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] GGSVRKLR 0.99401 -9.3646 0 0 0 0 0 0 0 0 15.3448 0 15.6308 0 16.2454 0 11.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4263 0 0 0 15.1408 0 0 0 0 0 0 0 0 0 0 15.1937 0 14.2689 0 0 13.4473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6143 0 0 0 0 0 0 0 0 0 13.8766 0 0 13.7756 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1929 0 0 0 0 0 0 0 0 0 0 0 0 14.2908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2448 0 0 0 0 0 0 0 0 0 13.5067 0 Q9Y543 HES2_HUMAN "Transcription factor HES-2 (Class B basic helix-loop-helix protein 40, bHLHb40) (Hairy and enhancer of split 2)" HES2 BHLHB40 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0009952; GO:0046983; GO:0050767; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ENSNCSKLEK 0.99401 -6.8836 0 0 0 0 0 0 0 0 0 0 0 0 14.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5713 0 0 0 0 0 14.2791 0 0 12.1004 0 0 12.2029 11.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0068 0 0 0 0 0 0 0 13.8388 0 0 0 0 0 14.0135 0 13.3197 0 0 0 0 0 0 0 0 0 0 0 0 O00472 ELL2_HUMAN RNA polymerase II elongation factor ELL2 ELL2 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368] nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation from RNA polymerase II promoter [GO:0006368] GO:0000987; GO:0005654; GO:0006368; GO:0008023; GO:0032968; GO:0042795 cis-regulatory region sequence-specific DNA binding [GO:0000987] ALETYQSHK 0.99402 -29.808 0 0 0 0 0 0 0 0 11.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2351 12.424 0 0 12.7518 0 0 0 0 12.4653 12.7507 13.0082 0 0 12.1004 0 0 0 0 14.3115 0 0 10.8323 11.97 0 0 0 0 0 0 13.6245 0 12.9304 0 0 0 0 12.7988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3614 0 0 0 13.6935 0 0 0 12.1501 0 0 0 0 13.6712 14.1883 0 16.4197 0 13.7715 0 0 0 0 0 0 16.0848 0 0 0 0 0 13.8982 13.6589 13.608 0 0 0 0 14.3073 0 0 0 0 12.0944 0 13.5936 0 0 0 10.9857 0 13.7139 0 0 0 0 0 13.6058 O14513 NCKP5_HUMAN "Nck-associated protein 5, NAP-5 (Peripheral clock protein)" NCKAP5 ERIH NAP5 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] microtubule plus-end [GO:0035371] microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019] GO:0001578; GO:0007019; GO:0035371 APRMCTYSASGGSNSDSDLDYGDNGFGAGR 0.99402 -30.082 0 12.8751 11.2904 0 0 12.2411 0 0 14.4249 0 0 0 13.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1844 0 0 0 0 0 15.0267 11.0196 0 0 0 0 14.6104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0272 0 0 0 0 0 0 0 0 0 13.5409 14.4676 0 0 0 15.158 12.1633 0 12.7308 0 12.807 0 13.8818 0 0 12.5332 12.4973 0 0 0 0 0 0 0 14.7064 12.4771 13.1488 0 0 11.991 12.1687 12.2391 0 0 0 0 0 0 14.084 0 0 0 0 13.1295 0 0 0 0 0 0 0 0 15.6288 15.1247 0 0 0 12.8376 0 0 12.4181 0 0 12.5036 13.8728 0 11.7936 0 11.4108 15.8304 16.8405 13.0962 13.0952 0 0 13.5027 14.8306 0 0 11.2051 14.4861 14.1343 0 0 11.9765 0 0 0 0 0 0 0 0 0 0 0 0 15.1555 0 0 0 0 13.4592 0 0 0 0 13.5075 0 0 13.3549 13.2182 0 0 O14562 UBFD1_HUMAN Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog) UBFD1 UBPH Homo sapiens (Human) cadherin binding [GO:0045296]; RNA binding [GO:0003723] GO:0003723; GO:0045296 cadherin binding [GO:0045296]; RNA binding [GO:0003723] ELVDLKIIWNK 0.99402 -13.11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6421 0 0 0 0 0 0 0 0 0 12.853 12.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22105 TENX_HUMAN "Tenascin-X, TN-X (Hexabrachion-like protein)" TNXB HXBL TNX TNXB1 TNXB2 XB Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; extracellular matrix organization [GO:0030198]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]; extracellular matrix organization [GO:0030198]; fatty acid metabolic process [GO:0006631]; positive regulation of cell fate determination [GO:1905935]; positive regulation of collagen fibril organization [GO:1904028]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of JUN kinase activity [GO:0043506]; triglyceride metabolic process [GO:0006641] GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005615; GO:0006631; GO:0006641; GO:0007155; GO:0007160; GO:0008201; GO:0030036; GO:0030155; GO:0030198; GO:0030199; GO:0031012; GO:0032963; GO:0043506; GO:0045595; GO:0048251; GO:0062023; GO:0070062; GO:0098609; GO:0098633; GO:1904028; GO:1905935 collagen binding [GO:0005518]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178] ACPGDCR 0.99402 -37.173 0 0 0 0 14.8822 0 0 0 14.7092 11.9568 13.2786 12.2587 13.6454 0 0 0 12.6958 13.5797 11.4597 11.0817 12.8011 0 13.1738 12.4996 0 14.2902 0 0 0 12.3698 11.8024 0 11.6381 0 11.5581 0 11.5455 0 0 14.079 8.80916 10.3717 0 11.2823 10.3642 13.2377 0 11.2639 0 11.0277 11.5913 13.5002 0 13.4598 12.1629 0 0 0 0 0 0 10.259 0 0 0 0 0 0 14.728 0 12.8684 11.4875 12.9994 13.9716 16.2432 12.9208 12.0818 14.8374 14.5991 0 13.4852 14.4114 15.4039 14.9796 15.7352 15.5913 15.883 14.9005 11.4298 15.7074 15.7125 13.4025 15.6418 15.3218 15.5491 13.6991 14.0648 15.2527 16.3542 15.4723 14.5333 12.723 13.363 15.8454 14.7653 0 16.2617 0 15.4267 15.4131 15.8696 15.5151 12.7773 0 0 15.9073 15.6127 16.124 14.0139 16.6135 13.5182 15.45 13.1844 17.9957 15.5743 14.4905 14.9186 14.5148 14.853 15.0507 14.3188 14.4413 14.9859 11.4239 12.4672 15.3136 15.4767 16.1544 13.4807 12.7713 15.045 0 15.8714 15.2463 13.8886 0 15.4653 13.0925 13.9468 13.6775 12.0234 0 13.1667 13.3768 15.0979 14.5382 12.3371 11.6551 14.676 13.8617 13.5848 13.978 13.3969 13.9753 14.3386 14.2189 13.2 0 13.9121 14.6257 12.1284 15.4496 14.0953 14.7496 14.1366 13.6633 12.4048 15.0638 16.1368 13.8555 P22307 SCP2_HUMAN "Sterol carrier protein 2, SCP-2 (Acetyl-CoA C-myristoyltransferase, EC 2.3.1.155) (Non-specific lipid-transfer protein, NSL-TP) (Propanoyl-CoA C-acyltransferase, EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase, EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X, SCP-X)" SCP2 Homo sapiens (Human) alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular cholesterol transport [GO:0032367]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; regulation of phospholipid biosynthetic process [GO:0071071]; steroid biosynthetic process [GO:0006694] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular cholesterol transport [GO:0032367]; lipid hydroperoxide transport [GO:1901373]; phospholipid transport [GO:0015914]; positive regulation of intracellular cholesterol transport [GO:0032385]; positive regulation of steroid metabolic process [GO:0045940]; progesterone biosynthetic process [GO:0006701]; protein localization to plasma membrane [GO:0072659]; regulation of phospholipid biosynthetic process [GO:0071071]; steroid biosynthetic process [GO:0006694] GO:0000062; GO:0003988; GO:0005102; GO:0005654; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0005829; GO:0006635; GO:0006694; GO:0006699; GO:0006701; GO:0008206; GO:0008526; GO:0015485; GO:0015914; GO:0016020; GO:0032367; GO:0032385; GO:0032934; GO:0032959; GO:0032991; GO:0033540; GO:0033814; GO:0036042; GO:0036109; GO:0043231; GO:0045940; GO:0050632; GO:0050633; GO:0070538; GO:0071071; GO:0072659; GO:0120019; GO:0120020; GO:1901373 acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; oleic acid binding [GO:0070538]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylinositol transfer activity [GO:0008526]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; propionyl-CoA C2-trimethyltridecanoyltransferase activity [GO:0050632]; signaling receptor binding [GO:0005102]; sterol binding [GO:0032934] ANLVFKEIEK 0.99402 -28.379 0 0 0 0 0 0 0 0 0 10.2849 0 0 10.8111 0 0 10.5966 0 0 0 0 0 0 0 0 0 0 0 0 0 10.247 0 0 0 0 0 0 0 0 0 0 0 0 10.7775 0 10.6201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7901 0 0 0 0 0 13.7471 14.8529 0 0 0 0 14.2992 14.4196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1895 0 0 0 0 0 0 11.3779 0 0 0 0 0 0 0 10.4334 0 0 0 0 0 0 0 11.1914 13.6499 10.9705 0 13.3359 13.541 0 0 12.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30953 OR1E1_HUMAN "Olfactory receptor 1E1 (Olfactory receptor 13-66, OR13-66) (Olfactory receptor 17-2/17-32, OR17-2, OR17-32) (Olfactory receptor 1E5) (Olfactory receptor 1E6) (Olfactory receptor 5-85, OR5-85) (Olfactory receptor OR17-18) (Olfactory receptor-like protein HGMP07I)" OR1E1 OR1E5 OR1E6 OR1E9P Homo sapiens (Human) sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IVSSILKVPSSK 0.99402 -10.752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3958 0 0 0 0 0 0 0 0 0 0 12.0753 0 12.7888 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9429 0 0 0 0 Q13507 TRPC3_HUMAN "Short transient receptor potential channel 3, TrpC3 (Transient receptor protein 3, TRP-3, hTrp-3, hTrp3)" TRPC3 TRP3 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338] cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cation channel complex [GO:0034703]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; manganese ion transport [GO:0006828]; phototransduction [GO:0007602]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; single fertilization [GO:0007338]" GO:0005262; GO:0005886; GO:0005887; GO:0006816; GO:0006828; GO:0007338; GO:0007602; GO:0010524; GO:0015279; GO:0033198; GO:0034703; GO:0051480; GO:0051592; GO:0070588; GO:0070679; GO:1903244 "calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" CGDCMEK 0.99402 -5.2091 0 0 0 0 0 12.3546 0 0 10.282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.794 0 0 12.4152 10.4169 11.9995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1863 0 12.1547 0 0 0 0 0 11.4148 0 0 0 12.8009 0 12.6182 0 0 0 13.7364 0 0 0 0 12.9875 13.1929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3922 0 0 0 11.3794 0 0 13.2992 0 0 14.5587 0 0 0 0 0 0 12.9351 13.4442 0 0 0 0 0 12.7077 11.2564 0 0 0 0 0 13.183 0 13.2684 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5997 0 0 0 11.9955 0 0 0 12.1132 0 0 0 13.608 0 0 12.9041 12.5743 11.7759 12.0921 0 0 0 0 0 14.9815 Q15124 PGM5_HUMAN "Phosphoglucomutase-like protein 5 (Aciculin) (Phosphoglucomutase-related protein, PGM-RP)" PGM5 PGMRP Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; striated muscle tissue development [GO:0014706] adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; sarcolemma [GO:0042383]; spot adherens junction [GO:0005914]; stress fiber [GO:0001725]; Z disc [GO:0030018] "adherens junction [GO:0005912]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; sarcolemma [GO:0042383]; spot adherens junction [GO:0005914]; stress fiber [GO:0001725]; Z disc [GO:0030018]; intramolecular transferase activity, phosphotransferases [GO:0016868]; magnesium ion binding [GO:0000287]; structural molecule activity [GO:0005198]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; striated muscle tissue development [GO:0014706]" GO:0000287; GO:0001725; GO:0005198; GO:0005829; GO:0005912; GO:0005914; GO:0005925; GO:0005975; GO:0007155; GO:0009898; GO:0014704; GO:0014706; GO:0016010; GO:0016868; GO:0030018; GO:0030055; GO:0030239; GO:0042383; GO:0043034 "intramolecular transferase activity, phosphotransferases [GO:0016868]; magnesium ion binding [GO:0000287]; structural molecule activity [GO:0005198]" CNLCGEESFGTGSDHLREK 0.99402 -13.9 14.3302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1392 0 0 0 0 0 0 13.8613 12.8164 0 0 12.9711 0 0 0 13.8643 0 0 0 0 0 0 0 0 11.0467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6039 0 12.3203 0 0 0 0 11.1091 0 0 0 0 12.0993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q24JP5 T132A_HUMAN Transmembrane protein 132A (HSPA5-binding protein 1) TMEM132A HSPA5BP1 KIAA1583 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] GO:0000139; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016021; GO:0070062 DIRALIPLAK 0.99402 -29.822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8592 12.7762 0 0 13.7944 0 0 12.9642 0 0 0 0 0 12.4844 0 0 0 0 0 12.6633 0 0 0 9.55351 0 0 0 0 0 0 12.9251 15.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9092 0 0 0 14.549 0 14.2314 0 0 0 0 14.352 0 14.2892 0 0 0 0 0 0 0 13.235 13.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0733 0 0 0 0 0 0 0 0 14.7746 0 0 0 0 12.696 13.8376 0 0 0 0 0 0 0 13.5813 0 0 0 0 0 0 0 0 13.6503 0 0 0 0 0 0 13.0894 0 0 0 0 0 0 0 13.1355 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5609 Q5FVE4 ACBG2_HUMAN "Long-chain-fatty-acid--CoA ligase ACSBG2, EC 6.2.1.3 (Acyl-CoA synthetase bubblegum family member 2) (Arachidonate--CoA ligase ACSBG2, EC 6.2.1.15) (Bubblegum-related protein) (PRTD-NY3)" ACSBG2 BGR UNQ2443/PRO5005 Homo sapiens (Human) cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; acyl-CoA hydrolase activity [GO:0047617]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; spermatogenesis [GO:0007283] GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006631; GO:0007283; GO:0016020; GO:0016405; GO:0030154; GO:0031957; GO:0035338; GO:0042759; GO:0047617; GO:0047676 acyl-CoA hydrolase activity [GO:0047617]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957] DGEVLLR 0.99402 -13.869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.294 0 0 0 0 0 11.9767 13.0041 13.112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8558 0 12.0721 0 0 0 0 0 0 0 0 0 12.0573 0 0 0 0 0 0 0 11.0651 0 0 0 0 0 0 0 13.8172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3964 0 0 0 0 0 0 12.6387 0 0 0 0 0 12.8952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4539 0 0 Q5TAT6 CODA1_HUMAN Collagen alpha-1(XIII) chain (COLXIIIA1) COL13A1 Homo sapiens (Human) cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; morphogenesis of a branching structure [GO:0001763]; notochord development [GO:0030903]; skeletal system development [GO:0001501] cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen type XIII trimer [GO:0005600]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen type XIII trimer [GO:0005600]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; morphogenesis of a branching structure [GO:0001763]; notochord development [GO:0030903]; skeletal system development [GO:0001501] GO:0001501; GO:0001763; GO:0001958; GO:0005201; GO:0005576; GO:0005581; GO:0005600; GO:0005615; GO:0005788; GO:0005886; GO:0005911; GO:0007160; GO:0008201; GO:0030154; GO:0030198; GO:0030199; GO:0030903; GO:0031012; GO:0045211; GO:0062023; GO:0098609 extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201] DGPPGVK 0.99402 -29.922 0 0 0 0 0 0 0 0 14.0308 0 0 0 0 0 0 14.7023 12.4531 0 0 0 12.6871 13.7145 12.9921 13.4862 12.5108 0 12.5682 0 0 15.0815 0 0 0 0 0 0 0 0 0 13.364 0 0 0 12.8227 12.6729 0 11.6341 0 0 0 0 12.7038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6747 15.1276 15.2952 15.9264 0 0 14.9912 0 0 0 0 0 0 0 0 0 11.3915 0 14.5391 14.0526 0 0 0 14.5972 0 0 0 0 0 0 13.7146 0 15.0379 14.8823 0 0 0 0 0 0 0 0 12.687 14.2377 0 0 0 0 0 0 0 10.4976 12.2769 13.6247 0 12.9847 0 0 0 11.5011 0 0 0 0 15.6968 0 0 15.0308 13.1895 14.8955 14.9149 0 14.343 0 0 0 14.4772 11.1605 14.0393 14.1459 0 0 0 0 0 10.9845 0 0 0 13.0681 0 0 13.812 0 13.3851 0 0 0 0 13.5969 0 13.6484 0 0 0 0 15.19 14.0153 Q6ZU67 BEND4_HUMAN BEN domain-containing protein 4 (Coiled-coil domain-containing protein 4) BEND4 CCDC4 Homo sapiens (Human) DNA binding [GO:0003677] GO:0003677 DNA binding [GO:0003677] QRSPYSVLK 0.99402 -5.2114 13.5893 0 0 0 0 13.2439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6147 0 0 0 10.6247 13.6686 0 12.0724 0 14.9487 0 0 0 13.1103 0 12.8588 0 13.0511 0 0 0 14.2598 0 0 0 0 0 0 0 0 0 0 14.2876 15.4512 0 18.2624 17.4125 0 0 0 0 0 0 0 11.3509 0 14.5532 13.2844 0 0 0 0 0 0 0 14.3975 19.0979 13.7322 14.2437 0 0 0 0 0 0 0 0 13.3028 0 0 0 0 0 0 12.7494 14.8032 0 0 0 0 10.5323 0 0 15.0851 12.2464 14.9965 14.2968 0 0 0 11.7076 0 0 0 0 0 0 0 0 12.4482 10.8981 0 0 0 0 12.2363 0 0 0 0 Q9BX82 ZN471_HUMAN Zinc finger protein 471 (EZFIT-related protein 1) ZNF471 ERP1 KIAA1396 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSVHIGLILHRR 0.99402 -29.804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5618 0 0 0 0 0 0 0 0 0 0 0 0 9.95894 10.0708 0 0 0 0 0 0 0 0 0 0 10.3407 0 0 0 0 0 13.8642 0 0 0 0 0 0 0 0 0 0 0 14.3091 0 0 13.9263 0 14.2045 0 0 13.4809 0 0 0 0 0 0 0 0 0 0 13.4843 0 0 0 0 0 0 0 12.6556 13.5656 12.8103 0 12.6932 0 0 0 0 12.8732 0 13.9034 12.6041 14.7538 0 0 0 12.959 0 0 14.8046 0 0 12.2902 0 0 0 0 14.7122 0 0 13.8335 11.305 0 0 13.1548 0 13.6618 0 0 0 0 0 14.3207 0 12.7232 0 0 10.8694 0 0 12.9713 0 0 0 0 0 0 0 0 0 0 0 0 0 12.676 0 0 Q9BY89 K1671_HUMAN Uncharacterized protein KIAA1671 KIAA1671 Homo sapiens (Human) CLSTTPPGDMAHAR 0.99402 -29.799 0 13.5159 0 0 0 13.3937 0 14.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9169 0 12.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5373 14.2988 0 0 0 11.0333 12.9271 12.1186 11.7591 13.328 21.6154 0 13.5227 0 0 13.2336 13.3771 11.3228 14.5578 0 0 11.4918 0 14.9023 0 12.9978 12.5465 12.023 0 0 0 0 12.4266 0 0 0 16.7796 12.9071 0 13.5132 0 14.318 0 0 0 0 0 11.9549 0 13.5551 0 11.925 0 0 0 0 0 11.5428 0 0 0 18.0021 17.9765 11.6535 0 0 0 0 13.9844 0 0 0 14.1476 0 0 0 12.7677 0 0 0 0 11.8643 0 13.2464 0 0 14.2188 0 13.7107 0 0 14.6765 12.7321 0 14.8887 14.3115 0 0 0 0 0 0 13.4984 0 0 0 0 13.2745 Q9H7Z3 NRDE2_HUMAN Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog) NRDE2 C14orf102 Homo sapiens (Human) cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; post-transcriptional gene silencing by RNA [GO:0035194]; RNA splicing [GO:0008380] GO:0000278; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006974; GO:0008380; GO:0016607; GO:0035194; GO:0046833; GO:0051301; GO:1902369 AIESNQSSVDLKLAKLK 0.99402 -29.788 0 0 0 0 0 0 11.0059 0 0 0 10.2509 0 10.7967 0 0 0 11.1274 11.9817 0 0 0 14.176 11.5472 0 0 0 12.699 0 0 12.1342 0 0 0 12.3701 12.0565 0 0 0 0 11.0439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7632 12.9251 10.399 11.9685 0 0 13.6865 11.1536 0 13.5372 0 0 14.3949 0 0 0 14.0671 0 0 0 0 13.7806 14.3138 0 15.4313 17.0835 0 14.161 0 0 0 13.6288 0 0 14.1674 0 0 0 0 0 0 11.3824 0 0 0 14.1176 0 14.853 10.8921 0 0 0 0 0 0 0 0 0 9.52621 0 0 0 0 14.676 0 0 0 0 0 0 0 0 0 13.6899 0 0 0 0 0 0 0 0 0 0 0 13.1553 0 0 13.5461 0 0 0 12.0438 11.2292 0 13.036 0 0 12.3896 12.9554 0 0 0 13.5326 15.8917 13.204 0 0 Q9NWN3 FBX34_HUMAN F-box only protein 34 FBXO34 FBX34 Homo sapiens (Human) AKGTEAEEEY 0.99402 -37.239 0 10.3592 0 0 0 0 0 0 0 0 11.2467 0 0 0 0 0 10.2966 0 0 11.9175 0 0 11.4452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1906 0 0 0 11.3258 0 0 0 0 0 0 0 0 0 0 18.5331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.196 0 0 0 12.9725 0 0 0 11.9594 0 0 11.8631 0 0 12.3759 0 14.2467 12.1696 12.043 13.1979 12.1471 0 0 0 0 0 13.4722 14.5442 11.6068 0 13.2774 0 14.8246 0 12.8869 0 0 0 13.3581 14.882 0 14.2769 0 10.2152 14.0112 11.2325 0 13.2128 0 12.975 11.0047 0 0 12.7907 0 0 0 0 0 0 15.8093 18.1119 0 17.8522 0 14.3373 0 0 0 0 0 0 0 11.9262 0 0 0 13.0059 0 14.0157 12.4917 12.1551 0 0 0 0 0 12.3282 0 12.4602 13.9034 15.1423 0 0 0 0 0 0 0 11.3005 0 0 13.4307 0 0 0 Q9Y224 RTRAF_HUMAN "RNA transcription, translation and transport factor protein (CLE7 homolog, CLE, hCLE)" RTRAF C14orf166 CGI-99 Homo sapiens (Human) "negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA transport [GO:0050658]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA transport [GO:0050658]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0000993; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006388; GO:0006469; GO:0042802; GO:0045944; GO:0048471; GO:0050658; GO:0072669; GO:0072686 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993] AIRILVQER 0.99402 -13.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2088 Q8TEH3 DEN1A_HUMAN "DENN domain-containing protein 1A (Connecdenn 1, Connecdenn) (Protein FAM31A)" DENND1A FAM31A KIAA1608 Homo sapiens (Human) endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] anchoring junction [GO:0070161]; cell projection [GO:0042995]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; cell projection [GO:0042995]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483] GO:0005085; GO:0005829; GO:0006897; GO:0015031; GO:0030136; GO:0030665; GO:0032266; GO:0032456; GO:0032483; GO:0042734; GO:0042995; GO:0043231; GO:0070161; GO:1901981 guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266] EQPGTFDYQR 0.99403 -30.11 16.0414 0 16.383 0 18.1002 17.2514 18.2349 14.4839 0 0 0 0 0 10.8393 0 0 0 0 16.9752 17.1216 17.0556 0 17.3055 16.9489 17.1972 17.0396 0 0 0 0 0 0 0 11.4337 0 0 0 0 0 0 0 0 0 10.4623 0 0 0 0 0 0 10.9991 17.1974 16.9607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.122 0 0 14.938 0 18.1392 18.1389 0 18.296 0 17.7375 17.7604 0 0 0 17.3669 18.2247 0 18.2055 0 18.2631 0 0 0 0 0 13.6566 12.9244 0 13.9817 18.2017 12.7503 0 0 17.9782 14.3335 0 13.721 13.0857 0 18.2094 18.4516 14.2983 15.0881 15.459 0 14.0424 0 18.1655 0 0 18.1633 0 0 0 18.3123 18.2219 13.6292 13.5993 13.4686 13.9543 12.9922 18.2399 0 13.7209 14.6641 15.7234 0 18.1351 13.2398 18.2991 14.8865 14.2946 18.1547 11.699 15.1466 0 0 0 14.6807 0 18.234 0 0 0 0 0 0 0 14.9222 0 0 0 12.3371 0 0 0 0 13.2293 0 13.5803 14.1559 0 13.599 12.4125 0 0 13.1532 0 A3KN83 SBNO1_HUMAN "Protein strawberry notch homolog 1 (Monocyte protein 3, MOP-3)" SBNO1 MOP3 Homo sapiens (Human) "regulation of response to stimulus [GO:0048583]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; regulation of response to stimulus [GO:0048583]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355; GO:0031490; GO:0042393; GO:0048583 chromatin DNA binding [GO:0031490]; histone binding [GO:0042393] DLSRFNFDNKYGR 0.99403 -6.4679 11.4558 11.0243 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0577 0 12.2734 12.1582 0 13.1763 0 13.4338 0 0 0 0 0 0 12.8281 12.9429 13.3389 13.6911 12.6033 14.8105 0 0 12.4695 13.6568 14.9114 14.4471 14.9405 13.2391 0 0 0 0 0 12.6091 12.5622 13.3399 11.6307 0 13.0504 13.0101 0 10.7478 12.6845 0 12.7103 0 12.4717 13.6371 12.6646 13.1551 0 0 0 12.5926 12.7342 0 0 12.5954 0 0 0 0 0 12.2714 13.8937 0 0 13.0093 0 14.4762 0 0 0 0 0 0 0 0 0 12.1042 0 0 0 11.7936 0 0 0 0 0 0 0 0 0 12.4583 0 0 14.9763 0 11.5831 0 0 13.526 13.6672 16.3876 12.3768 0 11.7181 0 0 A6NIV6 LRIQ4_HUMAN Leucine-rich repeat and IQ domain-containing protein 4 (Leucine-rich repeat-containing protein 64) LRRIQ4 LRRC64 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] GO:0004722; GO:0005737; GO:0007165; GO:0043231 protein serine/threonine phosphatase activity [GO:0004722] EIPVVIFKNLHHLELLGLTGNHLK 0.99403 -13.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7214 11.3425 11.299 0 0 11.4006 0 0 0 0 11.7099 0 0 0 10.6951 11.2018 0 0 0 0 0 0 0 0 0 0 12.4896 13.4046 0 10.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4024 0 0 0 0 0 0 0 13.6584 0 12.081 15.18 0 0 0 0 0 12.5483 0 12.0077 0 11.7354 0 0 0 0 13.7682 0 0 12.4625 0 0 0 0 0 0 0 0 0 11.5445 0 13.3508 12.124 0 12.5614 0 0 11.7316 0 0 13.1041 0 0 0 0 0 0 0 0 0 0 0 13.9801 0 0 0 0 0 0 0 0 0 0 0 0 13.9977 0 0 0 11.6293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.869 0 0 13.4504 0 12.6877 0 11.2738 0 0 O14986 PI51B_HUMAN "Phosphatidylinositol 4-phosphate 5-kinase type-1 beta, PIP5K1-beta, PtdIns(4)P-5-kinase 1 beta, EC 2.7.1.68 (Phosphatidylinositol 4-phosphate 5-kinase type I beta, PIP5KIbeta) (Protein STM-7) (Type I phosphatidylinositol 4-phosphate 5-kinase beta)" PIP5K1B STM7 Homo sapiens (Human) phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; uropod [GO:0001931] "cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; uropod [GO:0001931]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]" GO:0000285; GO:0001931; GO:0005524; GO:0005829; GO:0005886; GO:0006661; GO:0012505; GO:0014066; GO:0016308; GO:0016310; GO:0046854; GO:0052810; GO:0052812 "1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]" ASPSKKR 0.99403 -28.616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2133 0 0 0 0 0 12.2111 11.8568 12.4745 12.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6554 12.5648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4627 0 0 0 0 0 0 0 0 12.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9062 10.8466 0 0 0 12.2623 0 0 0 0 0 O94832 MYO1D_HUMAN Unconventional myosin-Id MYO1D KIAA0727 Homo sapiens (Human) actin filament organization [GO:0007015]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790] actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904]; actin filament organization [GO:0007015]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; protein transport [GO:0015031]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0005516; GO:0005524; GO:0005768; GO:0005769; GO:0005790; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030050; GO:0030424; GO:0030673; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0048306; GO:0051015; GO:0051641; GO:0061502; GO:0070062; GO:0097440 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904] CRHQVEYLGLLENVR 0.99403 -28.637 0 0 0 0 0 11.3417 0 0 0 0 0 0 0 0 0 0 13.5365 13.5227 0 0 0 0 0 0 0 12.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0137 0 0 0 12.3242 0 0 0 0 0 12.6442 0 0 13.0213 0 0 0 0 13.078 0 0 0 0 0 0 14.4522 0 0 15.2191 0 0 13.3554 17.0599 0 0 0 0 16.1648 14.1627 0 0 0 0 0 13.5891 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6546 0 0 0 0 13.1191 0 0 0 0 0 14.2072 0 0 14.0218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.346 0 0 0 0 13.0986 0 0 0 P0C091 FREM3_HUMAN FRAS1-related extracellular matrix protein 3 FREM3 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154] GO:0005604; GO:0005615; GO:0007154; GO:0007155; GO:0009653; GO:0016021; GO:0046872; GO:0062023 metal ion binding [GO:0046872] AEDQDSPHRLLKYK 0.99403 -30.115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.628 0 18.4129 18.4679 18.4397 18.4598 11.2897 0 18.7578 0 18.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1817 0 15.1124 0 0 0 0 0 14.9613 16.9739 0 0 0 0 0 0 0 11.0153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3392 0 0 0 0 0 0 14.6148 13.0726 0 0 0 13.4544 17.8307 14.983 0 17.8702 14.662 12.845 0 19.5868 13.4215 13.0215 13.7123 14.1118 0 15.6681 14.933 13.1807 0 16.0421 0 0 0 0 15.7015 12.3349 0 0 19.5388 11.9588 14.3834 0 19.5593 0 19.5417 19.5137 19.5124 0 19.5191 0 12.86 0 0 14.7711 0 12.5518 12.4065 0 0 13.2074 12.8156 0 0 19.5166 19.5401 19.5585 19.5673 19.5635 19.6674 19.6156 19.6223 13.1306 19.5865 13.1825 0 12.801 19.6326 0 0 16.8358 0 15.1391 13.2509 0 13.5442 14.0422 0 0 0 14.7455 0 0 0 0 13.6828 0 0 0 0 0 12.1815 19.607 0 13.8897 15.5999 0 0 0 0 P33402 GCYA2_HUMAN "Guanylate cyclase soluble subunit alpha-2, GCS-alpha-2, EC 4.6.1.2" GUCY1A2 GUC1A2 GUCSA2 Homo sapiens (Human) cGMP-mediated signaling [GO:0019934]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; response to oxygen levels [GO:0070482]; signal transduction [GO:0007165] "guanylate cyclase complex, soluble [GO:0008074]" "guanylate cyclase complex, soluble [GO:0008074]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; cGMP-mediated signaling [GO:0019934]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; response to oxygen levels [GO:0070482]; signal transduction [GO:0007165]" GO:0004383; GO:0005525; GO:0007165; GO:0007263; GO:0008074; GO:0010750; GO:0019934; GO:0020037; GO:0070482 GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037] AAGKKIYR 0.99403 -8.7409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3171 0 0 0 0 0 0 14.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.894 0 0 0 0 0 0 13.4043 0 0 13.2164 0 0 0 0 10.9131 0 0 0 0 12.773 0 0 0 0 0 0 12.1981 0 14.7782 0 0 0 0 0 13.6048 0 0 0 0 12.6019 0 0 0 0 0 0 0 0 0 0 14.2377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78362 SRPK2_HUMAN "SRSF protein kinase 2, EC 2.7.11.1 (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2, SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal ]" SRPK2 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop disassembly [GO:0062176]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]" GO:0000245; GO:0000287; GO:0000785; GO:0001525; GO:0003723; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006468; GO:0008284; GO:0008380; GO:0010628; GO:0016607; GO:0018105; GO:0030154; GO:0035063; GO:0035556; GO:0043525; GO:0045070; GO:0045071; GO:0045087; GO:0045787; GO:0048024; GO:0050684; GO:0062176; GO:0071889; GO:0106310 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723] ASAGECLR 0.99403 -13.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.713 0 0 0 11.8014 0 0 0 0 0 0 0 0 0 0 0 12.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7042 0 0 0 0 0 0 0 0 0 0 0 0 13.7799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00975 CAC1B_HUMAN "Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III, BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2)" CACNA1B CACH5 CACNL1A5 Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891] neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated calcium channel complex [GO:0005891]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; protein C-terminus binding [GO:0008022]; voltage-gated calcium channel activity [GO:0005245]; calcium ion import across plasma membrane [GO:0098703]; chemical synaptic transmission [GO:0007268]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ion transmembrane transport [GO:0034765]; response to amyloid-beta [GO:1904645] GO:0001540; GO:0005245; GO:0005509; GO:0005524; GO:0005886; GO:0005891; GO:0007268; GO:0008022; GO:0008331; GO:0034765; GO:0043025; GO:0045202; GO:0050804; GO:0098703; GO:1904645 amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; high voltage-gated calcium channel activity [GO:0008331]; protein C-terminus binding [GO:0008022]; voltage-gated calcium channel activity [GO:0005245] AARLIKLLR 0.99403 -28.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6517 0 0 0 0 0 0 0 0 0 0 12.4925 0 0 0 0 0 12.4088 0 0 0 0 10.9625 0 11.6579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2631 0 0 0 0 0 0 11.637 0 0 0 0 0 13.6502 0 13.2237 12.34 0 15.4727 16.3074 0 12.0244 0 0 10.1343 0 0 0 14.4693 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9058 0 14.1134 0 0 0 0 13.1097 0 0 0 0 0 0 0 0 0 13.0688 12.8937 0 0 11.7669 0 11.4798 12.3113 0 0 0 0 0 12.9633 0 14.1396 0 0 0 0 15.0976 0 0 0 0 0 13.6989 0 0 0 0 0 12.8808 0 0 0 12.8369 13.7445 0 13.771 0 0 0 0 0 12.8842 0 0 0 0 12.7186 0 0 0 0 Q13362 2A5G_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]" GO:0000159; GO:0000775; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006470; GO:0006977; GO:0007165; GO:0008285; GO:0019888; GO:0042771; GO:0043161; GO:0072542 protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] DVPPADQEKLFIQK 0.99403 -8.7495 11.662 0 0 0 0 0 0 0 13.8872 0 0 0 0 0 0 0 0 13.525 0 0 0 0 0 0 12.5193 0 12.7392 14.9051 13.0181 0 0 0 0 0 0 0 12.7531 0 13.4095 13.1462 0 9.43998 0 13.7524 13.9066 0 0 10.7077 13.2259 13.3726 0 0 0 12.9874 0 12.1217 14.0326 13.3081 12.7891 12.295 0 12.6785 13.4353 12.2625 13.9324 13.9435 0 0 0 0 0 0 0 0 0 0 0 11.2713 14.76 0 0 0 0 0 14.8074 11.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5064 0 0 18.8221 13.9973 13.7423 0 0 0 0 15.7749 13.4357 0 14.1761 0 13.2837 12.7937 0 0 0 11.6971 0 0 0 0 14.1449 0 13.7214 16.2453 0 0 11.1626 0 13.4922 0 0 0 14.9011 0 0 0 0 0 0 0 0 0 0 0 15.6356 0 11.2151 0 0 0 0 13.6194 13.0687 0 14.5501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6737 0 0 0 0 Q6P1S2 CC033_HUMAN Protein C3orf33 (Protein AC3-33) C3orf33 MSTP052 Homo sapiens (Human) negative regulation of ERK1 and ERK2 cascade [GO:0070373]; regulation of DNA-binding transcription factor activity [GO:0051090] extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; regulation of DNA-binding transcription factor activity [GO:0051090] GO:0005615; GO:0016021; GO:0051090; GO:0070373 AELTALKK 0.99403 -8.0171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4184 0 0 0 0 0 0 0 0 14.3351 0 0 11.9354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9526 0 0 0 0 0 0 0 0 0 0 11.2732 Q6ZSZ6 TSH1_HUMAN Teashirt homolog 1 (Antigen NY-CO-33) (Serologically defined colon cancer antigen 33) TSHZ1 SDCCAG33 TSH1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; middle ear morphogenesis [GO:0042474]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; anterior/posterior pattern specification [GO:0009952]; middle ear morphogenesis [GO:0042474]; regulation of transcription by RNA polymerase II [GO:0006357]; soft palate development [GO:0060023]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0009952; GO:0042474; GO:0046872; GO:0060023 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" HAVKLHLSK 0.99403 -13.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92878 RAD50_HUMAN "DNA repair protein RAD50, hRAD50, EC 3.6.-.-" RAD50 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860] "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; membrane [GO:0016020]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]" "BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; membrane [GO:0016020]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]" GO:0000019; GO:0000722; GO:0000723; GO:0000729; GO:0000781; GO:0000794; GO:0003677; GO:0003691; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006302; GO:0006310; GO:0006974; GO:0007004; GO:0007131; GO:0016020; GO:0016887; GO:0030674; GO:0030870; GO:0031860; GO:0031954; GO:0032206; GO:0032508; GO:0033674; GO:0035825; GO:0035861; GO:0042802; GO:0043047; GO:0044818; GO:0046872; GO:0051880; GO:0070192; GO:0070533; GO:0090305; GO:0098687; GO:0110025; GO:0140664; GO:1904354 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047] AQIRLQFRDVNGELIAVQR 0.99403 -30.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.38 0 0 13.7374 0 0 0 0 0 0 11.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.701 12.6783 12.5301 12.614 12.8434 0 12.2071 11.963 12.0399 0 0 0 12.3902 14.8393 0 13.4555 0 0 0 0 0 12.1576 0 0 9.71282 12.6156 13.0692 0 11.1253 15.9967 0 0 13.4221 12.1101 16.5046 0 14.1543 0 16.219 0 15.9797 0 0 13.0164 18.015 13.8574 13.8056 14.3525 14.964 0 0 0 16.4771 16.3552 10.2553 12.2516 11.9312 0 0 0 12.012 15.9896 0 13.3472 0 13.7826 0 13.2681 16.1166 0 0 13.5313 0 16.0818 0 0 14.0647 0 12.9218 16.2222 0 0 0 0 0 14.0015 0 0 13.5072 0 13.1129 0 0 0 13.3004 11.0814 0 14.3121 13.1615 0 0 13.0701 13.7132 13.5234 13.2145 0 14.1984 13.3671 0 0 0 14.3947 12.9175 0 13.4855 13.4102 0 13.8287 0 0 0 0 13.7668 0 13.597 0 13.4626 Q96HP0 DOCK6_HUMAN Dedicator of cytokinesis protein 6 DOCK6 KIAA1395 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005829; GO:0007264; GO:0043547; GO:0048471 guanyl-nucleotide exchange factor activity [GO:0005085] AHGTHPAISTLARSAIFSVTYPSPDIFLVIKLEK 0.99403 -28.667 0 0 0 15.1004 11.8926 0 0 0 0 13.4642 13.5557 0 14.1417 13.9393 11.7443 0 0 0 10.6739 11.535 0 0 11.4623 0 13.8409 0 13.6163 0 0 0 0 0 0 0 0 0 0 14.1819 0 0 0 0 0 0 0 0 0 0 0 11.2671 13.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7007 11.5811 0 0 0 0 13.028 0 0 0 0 0 0 0 0 0 0 13.3919 0 0 14.9923 13.9437 0 0 0 12.1122 14.6167 0 0 0 0 0 0 14.0286 13.8431 12.9347 12.8693 12.6353 0 0 0 0 0 13.14 0 0 0 0 12.716 0 0 13.9266 11.7767 0 13.4901 0 12.8717 0 0 0 0 12.929 0 0 13.0861 14.2707 0 13.9217 0 13.0742 0 13.6698 0 0 0 14.4482 0 0 12.7063 0 0 0 0 14.5282 0 0 0 0 0 13.1407 0 12.1536 0 13.1011 15.3277 0 0 13.8085 0 0 14.6383 0 16.5495 0 0 0 0 0 Q9HCJ5 ZSWM6_HUMAN Zinc finger SWIM domain-containing protein 6 ZSWIM6 KIAA1577 Homo sapiens (Human) striatal medium spiny neuron differentiation [GO:0021773] Cul2-RING ubiquitin ligase complex [GO:0031462] Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270]; striatal medium spiny neuron differentiation [GO:0021773] GO:0008270; GO:0021773; GO:0031462 zinc ion binding [GO:0008270] ASWLKQLK 0.99403 -30.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.553 15.1132 0 15.6535 0 0 0 0 0 0 0 0 0 0 14.1478 0 0 14.5915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5051 0 0 0 0 12.2667 0 0 0 0 13.9959 0 0 0 0 0 0 0 0 0 0 18.7767 0 0 0 0 0 0 13.6849 0 0 0 0 13.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0181 13.5354 0 0 0 0 17.8735 0 15.7385 0 15.4793 0 0 0 0 0 0 0 0 14.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4996 0 0 0 0 13.1226 0 0 0 0 0 0 0 0 0 0 0 Q9UBC2 EP15R_HUMAN "Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein, Eps15R)" EPS15L1 EPS15R Homo sapiens (Human) endocytosis [GO:0006897]; endosomal transport [GO:0016197] clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; endosomal transport [GO:0016197] GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] KKTVFPGAVPVLPASPPPK 0.99403 -13.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8076 0 0 0 0 0 0 14.8426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2917 0 0 0 0 11.8263 0 0 0 0 0 0 0 0 0 0 0 0 15.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0JD36 TRDV2_HUMAN T cell receptor delta variable 2 TRDV2 hDV102S1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955]; innate immune response [GO:0045087] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101] extracellular space [GO:0005615]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; immune response [GO:0006955]; innate immune response [GO:0045087] GO:0002250; GO:0005615; GO:0006955; GO:0042101; GO:0045087 DEGSYYCACDT 0.99404 -8.7837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4049 0 0 0 0 16.0104 0 0 0 0 0 0 0 0 0 10.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9586 0 0 0 0 0 12.3604 0 0 13.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9832 0 0 0 0 0 0 0 0 0 13.0345 10.8303 0 11.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5286 0 0 13.9767 0 0 0 13.4866 0 O60706 ABCC9_HUMAN ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) ABCC9 SUR2 Homo sapiens (Human) cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cation transmembrane transport [GO:0098655]; defense response to virus [GO:0051607]; inorganic cation transmembrane transport [GO:0098662]; negative regulation of blood pressure [GO:0045776]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; response to ATP [GO:0033198]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcomere [GO:0030017] inward rectifying potassium channel [GO:0008282]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium ion-transporting ATPase complex [GO:0031004]; sarcomere [GO:0030017]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325]; cardiac conduction [GO:0061337]; cardiac muscle cell contraction [GO:0086003]; cation transmembrane transport [GO:0098655]; defense response to virus [GO:0051607]; inorganic cation transmembrane transport [GO:0098662]; negative regulation of blood pressure [GO:0045776]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; response to ATP [GO:0033198]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0005267; GO:0005524; GO:0005886; GO:0008281; GO:0008282; GO:0015459; GO:0016020; GO:0019829; GO:0030017; GO:0031004; GO:0033198; GO:0042626; GO:0043225; GO:0044325; GO:0045776; GO:0051607; GO:0055085; GO:0061337; GO:0071805; GO:0086003; GO:0098655; GO:0098662; GO:0140359; GO:0150104; GO:1903760; GO:1990573 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; sulfonylurea receptor activity [GO:0008281]; transmembrane transporter binding [GO:0044325] AFRHETR 0.99404 -28.786 0 0 0 0 0 0 0 10.5234 12.9324 0 0 10.2357 12.8687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.735 15.0073 13.2456 12.5757 0 12.8133 0 0 0 12.9944 14.7816 12.7737 12.5529 0 0 0 13.1356 15.9649 0 0 13.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8976 14.5675 14.9944 0 0 0 0 0 0 10.5296 0 16.4056 0 13.2622 0 0 0 0 14.2165 0 0 13.207 19.1571 0 13.8299 0 0 0 0 15.5167 0 0 0 0 0 14.7411 0 0 12.227 0 15.2281 15.3231 0 15.2527 11.0954 0 0 15.1117 0 0 0 0 0 0 15.1468 0 0 0 15.5531 14.5478 0 15.1978 0 0 0 15.1325 13.7025 15.1638 0 13.9647 0 0 0 0 0 14.3466 0 0 0 0 0 0 0 12.0028 12.4382 13.3382 11.7553 14.6477 13.6661 0 13.0572 0 12.4872 13.365 13.6812 13.8137 0 15.7922 0 0 0 0 0 0 0 P23458 JAK1_HUMAN "Tyrosine-protein kinase JAK1, EC 2.7.10.2 (Janus kinase 1, JAK-1)" JAK1 JAK1A JAK1B Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; cell differentiation [GO:0030154]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to antibiotic [GO:0046677]; type I interferon signaling pathway [GO:0060337]; type III interferon signaling pathway [GO:0038196]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0004713; GO:0004715; GO:0005126; GO:0005131; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0007259; GO:0007260; GO:0016020; GO:0019221; GO:0019903; GO:0030154; GO:0031625; GO:0031730; GO:0034112; GO:0035556; GO:0038110; GO:0038196; GO:0046677; GO:0046872; GO:0060333; GO:0060337; GO:0060397; GO:0070102; GO:0098586; GO:0150105; GO:1903672 ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; cytokine receptor binding [GO:0005126]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625] CLAPIRDPK 0.99404 -30.605 0 0 0 0 0 0 0 0 0 0 0 0 12.3197 0 0 0 0 0 0 13.9818 0 13.7798 0 0 0 0 0 0 10.5957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2117 0 0 11.9752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3001 0 0 0 0 0 0 0 12.4818 0 13.3915 12.0583 0 0 0 0 0 12.9151 19.2239 11.2425 14.6586 12.6505 14.9856 0 0 0 15.2004 0 15.1054 13.2122 0 0 0 0 0 0 0 13.8213 13.756 0 14.2705 0 0 12.1877 0 0 13.6617 0 0 0 14.2269 0 0 0 13.7395 0 0 0 0 0 0 0 0 12.6758 0 0 0 14.0763 0 0 0 0 0 0 0 0 0 0 0 12.1445 0 0 13.0057 0 0 0 0 0 0 0 14.46 0 0 12.5486 0 0 0 0 13.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51398 RT29_HUMAN "28S ribosomal protein S29, mitochondrial, MRP-S29, S29mt (Death-associated protein 3, DAP-3) (Ionizing radiation resistance conferring protein) (Mitochondrial small ribosomal subunit protein mS29)" DAP3 MRPS29 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic signaling pathway [GO:0097190]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005525; GO:0005654; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0097190 GTP binding [GO:0005525]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] APTEEGK 0.99404 -15.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3166 14.4838 14.9055 14.1565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3753 0 0 0 0 0 14.1159 14.9661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14626 I11RA_HUMAN "Interleukin-11 receptor subunit alpha, IL-11 receptor subunit alpha, IL-11R subunit alpha, IL-11R-alpha, IL-11RA [Cleaved into: Soluble interleukin-11 receptor subunit alpha, sIL-11R, sIL-11RA, sIL11RA ]" IL11RA Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888]; cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284] GO:0004888; GO:0004896; GO:0004921; GO:0005576; GO:0005886; GO:0005887; GO:0008284; GO:0009897; GO:0019221; GO:0019955; GO:0019970; GO:0032502; GO:0043235; GO:0060322 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888] GGKDGSPK 0.99404 -10.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.747 0 0 0 0 0 0 12.9702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.09 0 0 0 0 12.8767 0 0 0 0 0 0 0 0 0 0 13.2899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4841 0 0 0 0 0 0 0 0 0 0 13.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15075 EEA1_HUMAN Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) EEA1 ZFYVE2 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; modulation by host of viral process [GO:0044788]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906] axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; serine-pyruvate aminotransferase complex [GO:0005969] axonal spine [GO:0044308]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; modulation by host of viral process [GO:0044788]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion [GO:0006906] GO:0005516; GO:0005545; GO:0005737; GO:0005769; GO:0005829; GO:0005969; GO:0006897; GO:0006906; GO:0008270; GO:0016020; GO:0016189; GO:0019897; GO:0030742; GO:0031901; GO:0042803; GO:0044308; GO:0044788; GO:0045022; GO:0070062 1-phosphatidylinositol binding [GO:0005545]; calmodulin binding [GO:0005516]; GTP-dependent protein binding [GO:0030742]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] ALLERCLKGEGEIEK 0.99404 -30.477 0 0 0 0 0 0 0 0 0 0 0 11.1943 0 0 0 0 11.3394 0 0 0 0 13.4865 12.6697 0 10.9154 0 0 0 0 0 0 0 0 0 0 0 10.6737 0 0 0 0 0 0 0 0 10.5413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9024 0 0 0 0 0 14.0332 0 11.1413 12.3256 0 0 0 14.2396 13.1435 0 14.7031 0 0 19.004 13.3136 18.5878 14.3953 0 18.0279 14.3088 12.563 0 0 14.2829 14.7565 14.892 0 14.4302 14.0617 13.1204 0 14.2094 0 12.1523 14.9103 15.3681 0 14.7272 0 0 0 0 0 14.4384 14.2144 0 14.8017 14.4317 0 14.4838 16.7087 14.4784 0 14.5432 14.2377 14.3999 0 14.279 0 0 0 15.7316 14.415 0 0 0 0 0 14.7702 14.7561 15.7894 14.4631 0 0 12.7521 0 0 14.8113 14.4379 14.6389 0 0 0 0 0 14.7725 0 14.3118 0 0 0 13.5684 13.0916 0 0 0 0 11.7972 0 0 12.2546 0 13.2281 11.898 14.4754 0 0 12.4754 11.5803 0 10.1053 12.549 0 Q2TAC6 KIF19_HUMAN Kinesin-like protein KIF19 KIF19 Homo sapiens (Human) axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462] axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874] axoneme [GO:0005930]; cilium [GO:0005929]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462] GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0016887; GO:0060404; GO:0070462 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] ALKWREEQR 0.99404 -28.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2928 0 0 0 0 12.4639 0 0 0 0 0 0 0 0 0 12.8305 0 13.6844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9645 15.4925 0 17.7899 0 0 17.3674 0 0 0 0 0 0 0 0 0 0 0 0 13.0603 0 0 14.4624 0 18.5789 0 0 0 0 0 0 13.2863 0 0 0 0 0 0 0 0 12.8794 0 0 0 0 0 0 0 0 0 0 12.2658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5TF21 SOGA3_HUMAN Protein SOGA3 SOGA3 C6orf174 Homo sapiens (Human) regulation of autophagy [GO:0010506] extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; regulation of autophagy [GO:0010506] GO:0005615; GO:0010506; GO:0016021 AAAAAAAAQMHAKNGGGSSSR 0.99404 -30.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8578 0 0 0 0 0 0 11.9136 0 10.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2206 0 0 0 9.8351 14.07 14.2155 0 17.7054 0 0 0 0 0 0 0 0 0 0 0 0 10.8059 0 0 0 0 0 0 0 0 0 0 0 0 11.598 0 0 0 0 0 0 0 0 0 0 13.095 0 12.4137 0 0 0 0 0 0 13.3274 0 0 12.5473 0 0 0 0 0 0 0 0 12.1883 0 13.2742 0 0 15.4452 0 0 0 12.7645 0 0 0 0 0 0 13.1775 0 0 0 0 0 0 14.6036 14.8521 0 15.3964 13.8808 12.6101 15.1606 14.2933 15.6926 0 0 0 0 0 0 13.8101 0 16.0317 12.5595 16.3643 0 0 0 0 14.0938 0 0 0 0 13.1456 0 13.7701 13.3787 13.1833 13.978 0 0 13.5276 13.7408 0 15.6873 14.0386 12.0628 13.5222 0 0 0 12.8009 Q8N9I9 DTX3_HUMAN "Probable E3 ubiquitin-protein ligase DTX3, EC 2.3.2.27 (Protein deltex-3, Deltex3) (RING finger protein 154) (RING-type E3 ubiquitin transferase DTX3)" DTX3 RNF154 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567] GO:0005654; GO:0005737; GO:0007219; GO:0016567; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AAPLLPPGARGLPPPPPPLPPPLPPRLR 0.99404 -30.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9959 0 0 0 0 0 12.4571 0 0 0 0 0 0 0 0 0 0 0 11.4719 0 0 0 0 0 0 0 11.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5564 0 0 0 0 0 0 0 0 0 0 11.1163 0 0 0 0 0 0 0 13.3266 0 0 0 0 0 10.8473 0 0 0 0 11.859 0 0 0 0 0 0 0 0 0 0 0 15.2944 10.9352 0 0 0 0 0 0 11.5485 0 0 0 0 0 0 11.2363 0 0 0 0 0 12.9659 0 0 0 11.8917 0 0 0 0 15.1709 0 0 0 0 0 0 12.9899 0 0 0 0 0 0 0 0 12.437 0 11.6306 0 0 0 0 18.8189 0 0 0 0 0 0 0 Q92481 AP2B_HUMAN "Transcription factor AP-2-beta, AP2-beta (Activating enhancer-binding protein 2-beta)" TFAP2B Homo sapiens (Human) "anatomical structure development [GO:0048856]; aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonium homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; renal water homeostasis [GO:0003091]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; skin development [GO:0043588]; smooth muscle tissue development [GO:0048745]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; aorta morphogenesis [GO:0035909]; calcium ion homeostasis [GO:0055074]; cellular ammonium homeostasis [GO:0097275]; cellular creatinine homeostasis [GO:0097276]; cellular urea homeostasis [GO:0097277]; collecting duct development [GO:0072044]; distal tubule development [GO:0072017]; ductus arteriosus closure [GO:0097070]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; hindlimb morphogenesis [GO:0035137]; kidney development [GO:0001822]; magnesium ion homeostasis [GO:0010960]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; potassium ion homeostasis [GO:0055075]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; renal water homeostasis [GO:0003091]; response to xenobiotic stimulus [GO:0009410]; retina layer formation [GO:0010842]; skin development [GO:0043588]; smooth muscle tissue development [GO:0048745]; sodium ion homeostasis [GO:0055078]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001822; GO:0003091; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006006; GO:0006357; GO:0006366; GO:0008284; GO:0008285; GO:0009410; GO:0010842; GO:0010960; GO:0030510; GO:0035136; GO:0035137; GO:0035810; GO:0035909; GO:0042127; GO:0042593; GO:0042803; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045444; GO:0045595; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0048485; GO:0048745; GO:0048856; GO:0050796; GO:0051402; GO:0055062; GO:0055074; GO:0055075; GO:0055078; GO:0072017; GO:0072044; GO:0072210; GO:0097070; GO:0097275; GO:0097276; GO:0097277; GO:1990837 "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AALPQLSGLDPRR 0.99404 -8.7846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3219 0 0 0 Q9UIW2 PLXA1_HUMAN Plexin-A1 (Semaphorin receptor NOV) PLXNA1 NOV PLXN1 Homo sapiens (Human) dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; olfactory nerve formation [GO:0021628]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; olfactory nerve formation [GO:0021628]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of smooth muscle cell migration [GO:0014910]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] GO:0002116; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0007162; GO:0008360; GO:0014910; GO:0017154; GO:0021628; GO:0021828; GO:0030334; GO:0043087; GO:0050772; GO:0060666; GO:0070062; GO:1902287; GO:1990138 semaphorin receptor activity [GO:0017154] ADPRFECGWCVAER 0.99404 -5.0402 0 0 0 0 0 0 0 0 13.5624 12.007 0 11.8923 0 0 0 0 0 11.22 0 10.8052 0 0 0 0 0 0 0 11.4317 0 0 0 11.6656 0 13.6178 0 13.6664 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6252 0 0 0 0 0 0 12.2561 0 0 11.5145 0 0 0 0 11.6 0 0 13.5745 0 0 0 0 0 0 0 0 0 13.2312 12.6567 10.5226 12.4995 12.1292 0 0 0 12.6716 0 12.8571 0 0 0 0 12.9475 0 0 0 11.8304 0 0 12.9737 0 11.9847 0 0 0 12.7134 10.5394 0 0 0 11.676 0 0 0 0 0 13.3563 0 0 14.5152 0 14.3038 11.2755 13.8403 0 0 12.8873 14.5904 0 0 0 13.3639 11.0931 14.6954 0 0 0 13.0317 0 0 0 0 0 11.6378 0 0 0 0 0 0 0 12.6719 0 0 0 0 0 0 14.0461 14.7343 0 0 0 0 12.9737 13.2197 0 12.2536 0 0 0 0 0 0 0 0 13.1226 0 13.1465 0 Q9ULE4 F184B_HUMAN Protein FAM184B FAM184B KIAA1276 Homo sapiens (Human) EDIIKQLTEERR 0.99404 -8.047 0 0 0 0 0 0 0 0 10.9099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4222 0 0 14.8356 0 0 0 0 0 0 0 0 0 15.0746 0 0 0 0 0 0 0 0 0 0 14.2394 0 13.5702 14.0674 0 0 0 0 0 0 11.7611 0 13.4998 0 0 0 0 0 0 0 0 0 14.3001 0 0 0 0 13.4516 0 0 0 0 13.133 0 0 12.9432 0 14.2491 0 0 0 14.2512 12.7797 13.2873 12.8392 0 0 0 0 13.076 13.1901 0 0 0 0 0 15.0403 0 0 0 0 0 0 12.2872 12.7675 13.3937 0 0 0 0 0 0 0 12.0076 0 12.5162 13.0555 0 0 0 0 0 0 0 14.0265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MT33 SYC1L_HUMAN Synaptonemal complex central element protein 1-like (Meiosis-related protein) SYCE1L Homo sapiens (Human) synaptonemal complex assembly [GO:0007130] intermediate filament cytoskeleton [GO:0045111]; synaptonemal complex [GO:0000795] intermediate filament cytoskeleton [GO:0045111]; synaptonemal complex [GO:0000795]; synaptonemal complex assembly [GO:0007130] GO:0000795; GO:0007130; GO:0045111 DEEDPEPPVAAPDAL 0.99405 -12.934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5898 0 0 0 0 0 0 0 0 13.3212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.664 0 0 0 0 0 0 0 13.6844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2646 O43598 DNPH1_HUMAN "2'-deoxynucleoside 5'-phosphate N-hydrolase 1, EC 3.2.2.- (c-Myc-responsive protein RCL)" DNPH1 C6orf108 RCL Homo sapiens (Human) deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide catabolic process [GO:0006195] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; positive regulation of cell growth [GO:0030307]; purine nucleotide catabolic process [GO:0006195] GO:0005634; GO:0005829; GO:0006195; GO:0009116; GO:0009159; GO:0030307; GO:0030855; GO:0042802; GO:0042803; GO:0070062; GO:0070694 deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] GAADGSR 0.99405 -11.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52298 NCBP2_HUMAN "Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (Cell proliferation-inducing gene 55 protein) (NCBP 20 kDa subunit, CBP20) (NCBP-interacting protein 1, NIP1)" NCBP2 CBP20 PIG55 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; histone mRNA metabolic process [GO:0008334]; miRNA-mediated gene silencing [GO:0035195]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mRNA cap binding complex [GO:0005845]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; snRNA binding [GO:0017069]; alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; histone mRNA metabolic process [GO:0008334]; miRNA-mediated gene silencing [GO:0035195]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901409]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]" GO:0000184; GO:0000339; GO:0000340; GO:0000380; GO:0000398; GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005845; GO:0005846; GO:0006406; GO:0006408; GO:0006446; GO:0008334; GO:0008380; GO:0017069; GO:0031053; GO:0031124; GO:0031442; GO:0032968; GO:0034518; GO:0035195; GO:0042789; GO:0045292; GO:0046833; GO:0098789; GO:1901409 mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; snRNA binding [GO:0017069] DEYRQDYDAGR 0.99405 -5.2817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9281 0 0 13.5565 0 0 0 0 0 0 0 0 0 15.83 13.4277 13.424 13.5485 0 12.9008 14.5421 0 0 12.7342 0 0 0 15.7978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5968 0 0 0 0 14.167 0 0 0 0 Q2M2W7 CQ058_HUMAN UPF0450 protein C17orf58 C17orf58 Homo sapiens (Human) collagen-containing extracellular matrix [GO:0062023] collagen-containing extracellular matrix [GO:0062023] GO:0062023 EPASEDAPRR 0.99405 -8.083 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2682 0 0 0 0 0 0 12.4657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6305 0 0 0 0 0 0 0 0 15.8377 0 14.8958 14.947 0 0 0 14.9567 15.2944 14.682 12.4089 0 0 15.347 14.923 0 0 0 0 0 0 0 0 0 0 0 0 10.2884 0 0 0 0 0 0 0 13.7094 0 0 0 0 11.325 0 0 0 0 0 0 0 0 0 0 9.38847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5135 0 0 0 0 0 0 0 0 0 0 Q6XXX2 CU024_HUMAN Putative uncharacterized protein encoded by LINC00114 LINC00114 C21orf24 NCRNA00114 Homo sapiens (Human) GAIPLRWR 0.99405 -7.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWW8 HOT_HUMAN "Hydroxyacid-oxoacid transhydrogenase, mitochondrial, HOT, EC 1.1.99.24 (Alcohol dehydrogenase iron-containing protein 1, ADHFe1) (Fe-containing alcohol dehydrogenase)" ADHFE1 HMFT2263 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]; lipid metabolic process [GO:0006629] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; 2-oxoglutarate metabolic process [GO:0006103]; glutamate catabolic process via 2-oxoglutarate [GO:0006539]; lipid metabolic process [GO:0006629] GO:0004022; GO:0005739; GO:0005759; GO:0006103; GO:0006539; GO:0006629; GO:0046872; GO:0047988 alcohol dehydrogenase (NAD+) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872] AAAARARVAYLLR 0.99405 -12.951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.923 11.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7922 16.3508 0 0 0 0 0 0 13.5422 13.5848 0 0 0 0 14.6057 0 13.2864 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1323 0 0 0 0 0 0 0 0 0 0 0 16.0458 0 0 0 0 0 0 13.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96AD5 PLPL2_HUMAN "Patatin-like phospholipase domain-containing protein 2, EC 3.1.1.3 (Adipose triglyceride lipase) (Calcium-independent phospholipase A2-zeta, iPLA2-zeta, EC 3.1.1.4) (Desnutrin) (Pigment epithelium-derived factor receptor, PEDF-R) (TTS2.2) (Transport-secretion protein 2, TTS2)" PNPLA2 ATGL FP17548 Homo sapiens (Human) acylglycerol acyl-chain remodeling [GO:0036155]; diacylglycerol biosynthetic process [GO:0006651]; lipid droplet disassembly [GO:1905691]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol O-acyltransferase activity [GO:0016411]; diolein transacylation activity [GO:0051265]; lipoprotein lipase activity [GO:0004465]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806]; acylglycerol acyl-chain remodeling [GO:0036155]; diacylglycerol biosynthetic process [GO:0006651]; lipid droplet disassembly [GO:1905691]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of sequestering of triglyceride [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433] GO:0004465; GO:0004623; GO:0004806; GO:0005654; GO:0005737; GO:0005788; GO:0005789; GO:0005811; GO:0005829; GO:0005886; GO:0006651; GO:0010891; GO:0010898; GO:0016020; GO:0016021; GO:0016411; GO:0019433; GO:0019915; GO:0036155; GO:0050253; GO:0051264; GO:0051265; GO:0055088; GO:1905691 acylglycerol O-acyltransferase activity [GO:0016411]; diolein transacylation activity [GO:0051265]; lipoprotein lipase activity [GO:0004465]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triglyceride lipase activity [GO:0004806] ALFPPEPLVLR 0.99405 -11.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8981 0 12.8525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4814 0 0 0 0 0 0 14.0336 0 0 0 0 0 13.1369 0 0 0 0 0 0 0 0 0 0 13.9843 0 14.2353 14.5078 0 0 0 0 0 0 0 0 0 12.8254 0 0 0 0 13.2812 0 0 12.3683 0 0 13.0588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4324 0 0 14.0643 0 0 0 0 14.6057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7539 0 Q99680 GPR22_HUMAN G-protein coupled receptor 22 GPR22 Homo sapiens (Human) cell projection organization [GO:0030030]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277]; cell projection organization [GO:0030030]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0030030; GO:0042277 G protein-coupled receptor activity [GO:0004930]; peptide binding [GO:0042277] FQKVLKSK 0.99405 -12.969 0 0 0 0 0 0 0 0 13.8431 0 0 12.9364 0 0 13.8135 0 0 0 0 0 0 0 0 0 0 0 0 11.7191 0 12.4098 0 0 0 0 13.1162 0 12.6385 0 13.0485 0 0 0 0 0 0 13.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8893 0 0 0 0 0 0 16.5218 0 0 0 0 0 0 0 0 12.2505 0 0 13.0828 0 0 0 0 0 0 0 15.8888 0 0 0 0 12.8434 0 0 0 0 0 0 0 0 0 0 0 0 12.9446 0 0 0 0 0 15.499 0 0 0 0 0 10.8043 0 0 0 0 0 0 0 15.4514 0 0 0 0 0 15.2996 0 0 0 0 15.2008 0 0 0 0 0 15.3034 0 0 0 15.7142 0 0 0 0 0 0 0 0 0 0 0 14.9043 0 13.6873 14.8942 0 0 0 15.5335 14.8665 0 14.9991 12.8497 0 Q9BXB5 OSB10_HUMAN "Oxysterol-binding protein-related protein 10, ORP-10, OSBP-related protein 10" OSBPL10 ORP10 OSBP9 Homo sapiens (Human) phosphatidylserine acyl-chain remodeling [GO:0036150] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; phosphatidylserine acyl-chain remodeling [GO:0036150] GO:0001786; GO:0005548; GO:0005829; GO:0005856; GO:0015248; GO:0015485; GO:0016020; GO:0032934; GO:0036150; GO:0043231 cholesterol binding [GO:0015485]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] ACAKYHMEMNSK 0.99405 -8.367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.614 0 17.0243 0 0 12.8849 0 0 16.922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1406 0 0 0 0 0 11.4531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4198 0 0 0 0 0 0 0 0 0 0 0 13.8663 0 0 14.61 0 0 14.4357 0 0 0 14.5426 0 0 0 0 0 0 0 0 0 15.5357 0 0 0 0 0 13.5436 0 0 0 0 0 14.5937 13.5595 14.0818 0 0 0 0 0 0 14.2884 0 14.3778 14.2606 0 0 14.6309 0 0 0 14.4187 0 0 0 0 0 0 14.6866 17.5506 0 0 0 0 0 0 0 0 0 0 0 14.5242 0 0 0 0 0 14.3668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQR7 CC177_HUMAN Coiled-coil domain-containing protein 177 (Myelin proteolipid protein-like protein) CCDC177 C14orf162 PLPL Homo sapiens (Human) AAAHGQWELQR 0.99405 -12.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8783 0 0 0 12.8296 0 0 0 0 0 0 0 0 0 0 0 13.4338 0 0 13.0999 13.0403 12.9355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0017 11.5164 0 0 13.8905 0 0 0 0 13.5275 0 0 0 0 0 0 11.7305 13.528 13.4045 15.7151 0 14.1519 13.2795 13.432 0 0 13.37 0 0 0 0 0 12.6171 0 0 0 0 13.9643 0 14.4246 0 0 0 0 0 0 0 0 0 0 0 11.9552 0 0 0 0 0 0 0 0 0 14.6968 12.8408 0 0 0 0 Q9Y4K1 CRBG1_HUMAN Beta/gamma crystallin domain-containing protein 1 (Absent in melanoma 1 protein) CRYBG1 AIM1 Homo sapiens (Human) carbohydrate binding [GO:0030246] GO:0030246 carbohydrate binding [GO:0030246] CRIAEDCCLTIVGSLVTSGSK 0.99405 -7.8511 0 0 0 0 0 0 0 0 14.7077 16.9378 16.9353 15.9532 16.424 15.9815 15.999 17.419 17.3549 15.3077 0 0 0 0 0 0 0 16.5293 16.7231 15.224 15.8728 15.9452 18.0725 18.1086 17.2911 15.8152 16.4382 16.4194 16.4974 14.1121 16.1704 18.1128 19.1796 18.2502 18.8174 18.0239 18.7353 14.288 18.3544 19.4386 16.2618 16.6818 0 0 0 15.994 17.7219 17.3889 17.9062 16.9274 17.7646 17.3745 16.4943 16.0205 16.912 16.5888 17.7598 17.0523 0 0 0 0 0 0 11.3296 0 12.2546 0 0 0 12.6211 0 15.159 0 0 0 0 12.7386 0 0 13.4748 0 0 0 13.9907 0 0 14.2712 15.2604 12.3839 0 14.4909 0 0 0 0 0 0 0 0 13.657 0 0 10.4898 0 0 0 0 0 0 10.4065 0 12.3382 13.3595 0 12.6715 0 0 12.8503 0 0 0 0 14.4538 0 0 0 0 0 0 0 0 0 11.969 0 0 0 0 0 0 16.9041 0 0 0 13.7913 0 0 14.1025 13.4818 0 0 17.3351 17.1266 16.8814 17.773 13.933 18.5297 18.5482 17.8351 18.0513 16.6863 16.6576 0 0 0 0 11.3362 17.8826 11.7746 17.0133 17.893 18.0607 Q9Y580 RBM7_HUMAN RNA-binding protein 7 (RNA-binding motif protein 7) RBM7 Homo sapiens (Human) "meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; snRNA catabolic process [GO:0016076]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; meiotic cell cycle [GO:0051321]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; snRNA catabolic process [GO:0016076]" GO:0000381; GO:0003723; GO:0003727; GO:0005634; GO:0005654; GO:0016076; GO:0017069; GO:0051321; GO:0071889; GO:0097157 14-3-3 protein binding [GO:0071889]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069] MNSYPYLADRHYSR 0.99405 -15.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7439 13.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0147 13.8569 0 0 0 12.7449 0 A2A288 ZC12D_HUMAN "Probable ribonuclease ZC3H12D, EC 3.1.-.- (MCP-induced protein 4) (Transformed follicular lymphoma) (Zinc finger CCCH domain-containing protein 12D) (p34)" ZC3H12D C6orf95 MCPIP4 TFL Homo sapiens (Human) "3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; mRNA catabolic process [GO:0006402]; negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" GO:0000932; GO:0003729; GO:0004521; GO:0005634; GO:0005654; GO:0005737; GO:0006402; GO:0030308; GO:0036464; GO:0046872; GO:0061158; GO:0090502; GO:2000134 endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729] IALYSVFPR 0.99406 -8.1083 0 0 0 0 0 0 0 0 0 0 0 0 11.0402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9907 0 14.6315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B0I1T2 MYO1G_HUMAN "Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2, mHag HA-2 ]" MYO1G HA2 Homo sapiens (Human) actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament organization [GO:0007015]; cell gliding [GO:0071976]; cell-substrate adhesion [GO:0031589]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; T cell meandering migration [GO:0120117]; T cell mediated immunity [GO:0002456]; T cell migration [GO:0072678]; vesicle transport along actin filament [GO:0030050]" GO:0000146; GO:0001891; GO:0002456; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005654; GO:0005886; GO:0005902; GO:0006887; GO:0007015; GO:0015629; GO:0016020; GO:0016459; GO:0030027; GO:0030050; GO:0030175; GO:0031256; GO:0031589; GO:0038096; GO:0043325; GO:0051015; GO:0070062; GO:0071976; GO:0072678; GO:0120117 "actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AHLAELQR 0.99406 -37.168 0 0 0 0 10.7576 0 0 11.6792 13.2321 11.8942 14.4177 0 0 0 0 0 0 0 12.692 0 0 12.4484 0 11.2355 0 10.7039 11.5203 0 0 0 0 11.8272 12.4663 13.5037 11.3711 11.8515 13.1258 12.9244 0 12.2189 0 0 13.334 0 0 0 0 0 0 11.0148 0 0 0 11.1244 13.7198 10.9635 11.8244 0 0 0 0 0 0 0 0 0 10.4594 12.4803 0 12.4061 13.2417 13.4642 11.5468 0 13.3041 11.3968 0 13.8924 0 0 0 0 14.8036 14.6083 15.5029 0 0 14.6774 15.5079 16.1034 15.8372 16.1904 12.9855 15.7561 15.8594 15.1727 0 0 14.9584 14.3534 15.1276 0 13.7145 0 15.717 15.2691 14.1412 0 0 13.4327 14.3626 15.0391 14.8359 14.7905 0 12.4232 0 11.6523 12.3432 14.7062 14.7967 0 9.85667 10.6664 12.7647 11.6143 13.8113 0 13.2922 13.5022 0 13.207 12.9193 0 0 0 0 12.7675 0 0 11.9362 11.0395 14.0905 13.1766 0 0 13.9034 11.8888 15.2509 15.1523 12.9306 0 0 15.0816 14.1713 0 0 14.6035 14.4193 14.2266 13.7028 0 12.3613 13.525 0 10.4723 0 11.5231 0 11.4286 12.7248 0 0 12.9732 0 0 0 13.4362 0 10.7694 O14490 DLGP1_HUMAN "Disks large-associated protein 1, DAP-1 (Guanylate kinase-associated protein, hGKAP) (PSD-95/SAP90-binding protein 1) (SAP90/PSD-95-associated protein 1, SAPAP1)" DLGAP1 DAP1 GKAP Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572] anchoring junction [GO:0070161]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] GO:0005886; GO:0007268; GO:0014069; GO:0044877; GO:0060090; GO:0070161; GO:0098962; GO:0098978; GO:0099572 molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877] AIEKGCSQDDECVSLR 0.99406 -37.106 0 0 11.077 0 0 0 0 0 0 0 0 0 0 11.6962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6505 0 12.3073 12.1229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1463 10.6221 0 13.0734 13.0864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0637 0 14.264 0 14.8407 14.2569 0 0 0 14.6051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6616 0 0 0 0 14.3402 0 0 0 0 0 0 0 0 0 14.1121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43374 RASL2_HUMAN Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2) RASA4 CAPRI GAPL KIAA0538 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; negative regulation of Ras protein signal transduction [GO:0046580] GO:0005096; GO:0005543; GO:0005829; GO:0005886; GO:0034260; GO:0035556; GO:0046580; GO:0046872; GO:0071277 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] EGPLFIHRTKGK 0.99406 -11.194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1417 0 0 0 0 10.5093 0 0 0 12.7748 12.7746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7235 0 0 0 13.3028 13.2004 0 0 0 0 0 0 0 14.1102 0 13.0592 13.6069 0 0 13.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9484 0 0 0 0 13.856 0 0 0 0 0 0 0 0 11.6097 0 0 0 0 0 0 0 0 13.6629 14.1313 12.2323 14.2132 0 14.3083 0 0 0 13.9376 0 0 0 0 0 0 0 0 P11279 LAMP1_HUMAN "Lysosome-associated membrane glycoprotein 1, LAMP-1, Lysosome-associated membrane protein 1 (CD107 antigen-like family member A) (CD antigen CD107a)" LAMP1 Homo sapiens (Human) establishment of protein localization to organelle [GO:0072594]; Golgi to lysosome transport [GO:0090160]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; protein stabilization [GO:0050821]; regulation of organelle transport along microtubule [GO:1902513] autolysosome [GO:0044754]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagolysosome membrane [GO:0061474]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021] autolysosome [GO:0044754]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagolysosome membrane [GO:0061474]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; virus receptor activity [GO:0001618]; establishment of protein localization to organelle [GO:0072594]; Golgi to lysosome transport [GO:0090160]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; protein stabilization [GO:0050821]; regulation of organelle transport along microtubule [GO:1902513] GO:0000421; GO:0001618; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005829; GO:0005886; GO:0005887; GO:0008021; GO:0009897; GO:0010008; GO:0016020; GO:0019899; GO:0019904; GO:0031902; GO:0035577; GO:0042383; GO:0042470; GO:0043323; GO:0044754; GO:0045954; GO:0048471; GO:0050821; GO:0061474; GO:0070062; GO:0072594; GO:0090160; GO:0101003; GO:0101004; GO:0140507; GO:1902513 enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; virus receptor activity [GO:0001618] KRSHAGYQTI 0.99406 -12.987 0 10.4091 0 0 0 0 0 0 0 0 0 0 11.6215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51149 RAB7A_HUMAN "Ras-related protein Rab-7a, EC 3.6.5.2" RAB7A RAB7 Homo sapiens (Human) "autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; epidermal growth factor catabolic process [GO:0007174]; establishment of vesicle localization [GO:0051650]; intracellular transport [GO:0046907]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]" alveolar lamellar body [GO:0097208]; anchored component of synaptic vesicle membrane [GO:0098993]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] "alveolar lamellar body [GO:0097208]; anchored component of synaptic vesicle membrane [GO:0098993]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of lysosome membrane [GO:0032419]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; retromer complex binding [GO:1905394]; small GTPase binding [GO:0031267]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; epidermal growth factor catabolic process [GO:0007174]; establishment of vesicle localization [GO:0051650]; intracellular transport [GO:0046907]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]" GO:0000045; GO:0000421; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005811; GO:0005829; GO:0005886; GO:0006622; GO:0006897; GO:0007174; GO:0008333; GO:0009617; GO:0010008; GO:0015031; GO:0016042; GO:0019003; GO:0019076; GO:0022615; GO:0030667; GO:0030670; GO:0031267; GO:0031902; GO:0031966; GO:0032419; GO:0033162; GO:0034045; GO:0042147; GO:0045022; GO:0045335; GO:0045453; GO:0045732; GO:0046907; GO:0048524; GO:0051650; GO:0061724; GO:0070062; GO:0090382; GO:0090383; GO:0090385; GO:0097208; GO:0098993; GO:0099638; GO:1903542; GO:1903543; GO:1905366; GO:1905394 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; retromer complex binding [GO:1905394]; small GTPase binding [GO:0031267] ASAESCSC 0.99406 -5.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.841 0 0 0 0 0 0 0 0 0 0 9.90445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4137 0 10.8909 0 0 11.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3698 0 0 11.861 0 0 0 0 0 10.3344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7834 0 0 0 0 0 11.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.728 0 0 0 P57738 TCTA_HUMAN T-cell leukemia translocation-altered gene protein (T-cell leukemia translocation-associated gene protein) TCTA Homo sapiens (Human) negative regulation of osteoclast differentiation [GO:0045671]; osteoclast fusion [GO:0072675] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; negative regulation of osteoclast differentiation [GO:0045671]; osteoclast fusion [GO:0072675] GO:0016021; GO:0045671; GO:0072675 EWEAQDMR 0.99406 -6.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0627 11.1602 0 0 0 0 0 0 0 0 0 0 0 10.9221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15738 NSDHL_HUMAN "Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating, EC 1.1.1.170 (Protein H105e3)" NSDHL H105E3 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity [GO:0102175]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]; cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224]" GO:0000252; GO:0001942; GO:0003854; GO:0005783; GO:0005789; GO:0005811; GO:0006695; GO:0007224; GO:0008203; GO:0016021; GO:0016616; GO:0047012; GO:0060716; GO:0102175; GO:0103066; GO:0103067 "3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity [GO:0102175]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]" DSTLGGK 0.99406 -9.3177 0 0 0 0 10.9012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.9518 0 11.7223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9002 0 0 0 0 0 0 0 Q5VT97 SYDE2_HUMAN "Rho GTPase-activating protein SYDE2 (Synapse defective protein 1 homolog 2, Protein syd-1 homolog 2)" SYDE2 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; regulation of Ras protein signal transduction [GO:0046578]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; synaptic membrane [GO:0097060] cytosol [GO:0005829]; synaptic membrane [GO:0097060]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; cell migration [GO:0016477]; regulation of Ras protein signal transduction [GO:0046578]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0007165; GO:0016477; GO:0046578; GO:0051056; GO:0090630; GO:0097060 GTPase activator activity [GO:0005096] DSKAVGLCENQYPDINVITGVLKDYLR 0.99406 -11.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2095 0 0 0 11.4083 0 0 0 11.3524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4329 12.509 0 0 0 11.5852 0 18.124 0 0 0 0 13.6065 0 0 0 0 15.5829 13.0628 0 0 0 0 13.7302 0 11.4241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9966 10.5648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6408 0 0 0 0 0 0 0 0 0 0 0 0 14.9054 Q6ZRV2 FA83H_HUMAN Protein FAM83H FAM83H Homo sapiens (Human) biomineral tissue development [GO:0031214]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of cell migration [GO:0030335]; protein localization to cytoskeleton [GO:0044380]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; keratin filament binding [GO:1990254]; protein kinase binding [GO:0019901]; biomineral tissue development [GO:0031214]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of cell migration [GO:0030335]; protein localization to cytoskeleton [GO:0044380]; signal transduction [GO:0007165] GO:0005737; GO:0005856; GO:0007165; GO:0019901; GO:0030335; GO:0031214; GO:0044380; GO:0045104; GO:1990254 keratin filament binding [GO:1990254]; protein kinase binding [GO:0019901] CRVNLQHVDFLRVR 0.99406 -37.103 0 0 0 12.2728 0 0 0 0 12.9351 12.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0325 13.0543 0 14.4537 0 13.2624 0 0 13.3142 0 14.0182 0 13.4598 0 0 0 12.9939 0 0 0 0 12.4257 12.1756 0 12.5654 0 0 0 0 0 0 0 0 0 0 0 0 0 12.738 0 12.5839 14.6507 13.8391 0 0 0 0 0 0 0 0 13.51 0 0 16.1069 0 0 14.2508 0 0 0 0 11.873 0 12.9904 0 0 14.285 0 0 0 0 12.615 0 13.9819 0 13.9227 0 11.4768 0 13.6666 14.3791 0 13.9239 0 15.0399 0 0 0 0 0 0 0 12.8585 0 15.0483 12.9504 13.7383 0 0 0 14.3608 0 0 0 0 0 0 0 0 12.9055 14.5298 0 0 0 0 0 0 0 12.5168 0 14.7503 0 0 0 0 0 0 0 0 0 0 0 0 14.3715 10.6493 12.7816 0 0 13.7855 14.7497 14.7349 0 14.2902 0 0 14.3715 0 0 Q6ZTK2 YP015_HUMAN Putative uncharacterized protein LOC400499 Homo sapiens (Human) ADSGSDGAYR 0.99406 -9.3169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6427 0 0 0 0 0 0 0 0 0 0 0 0 13.1422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5146 0 0 0 0 0 0 14.2447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1004 0 0 0 0 14.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3596 0 0 0 0 0 0 0 Q8N350 CBARP_HUMAN Voltage-dependent calcium channel beta subunit-associated regulatory protein CBARP C19orf26 Homo sapiens (Human) negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of voltage-gated calcium channel activity [GO:1901386] anchoring junction [GO:0070161]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter binding [GO:0044325]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of voltage-gated calcium channel activity [GO:1901386] GO:0005886; GO:0016021; GO:0030141; GO:0030426; GO:0030672; GO:0044325; GO:0045955; GO:0070161; GO:1901386; GO:1903170 transmembrane transporter binding [GO:0044325] GAGSAGPEQQQPPLEPDAERDAGPEQAQTSYR 0.99406 -5.3069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5017 0 0 0 0 0 0 0 0 0 0 0 10.7161 0 0 0 0 0 0 0 11.6928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5692 12.8894 0 13.1947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBS9 TXND5_HUMAN "Thioredoxin domain-containing protein 5, EC 1.8.4.-, EC 5.3.4.1 (Endoplasmic reticulum resident protein 46, ER protein 46, ERp46) (Thioredoxin-like protein p46)" TXNDC5 TLP46 UNQ364/PRO700 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202] azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457] GO:0003756; GO:0005576; GO:0005783; GO:0005788; GO:0006457; GO:0015035; GO:0035578; GO:0043066; GO:0043202; GO:0070062 protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035] LLPLLAR 0.99406 -8.1068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5141 13.4558 12.2609 0 0 0 0 0 0 0 0 0 11.3284 0 0 11.414 0 0 0 0 0 0 0 10.4224 0 0 0 0 0 0 0 11.6352 0 0 0 0 0 0 10.8853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8924 0 0 11.1867 14.0902 0 0 0 13.6652 15.3116 0 0 0 0 0 0 0 0 0 0 0 0 12.6414 10.2294 10.3858 0 0 0 0 0 11.6631 0 0 0 0 0 12.4836 0 12.9044 12.9021 0 0 0 13.7288 0 0 0 0 0 0 13.6515 0 0 0 0 12.7777 0 0 0 0 0 13.7151 14.3736 0 13.375 0 0 0 0 13.0833 0 0 12.2319 0 12.6661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4014 0 0 11.865 0 0 0 0 13.383 Q8TCT0 CERK1_HUMAN "Ceramide kinase, hCERK, EC 2.7.1.138 (Acylsphingosine kinase) (Lipid kinase 4, LK4)" CERK KIAA1646 Homo sapiens (Human) ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951]; ceramide metabolic process [GO:0006672]; glycosphingolipid metabolic process [GO:0006687]; phosphorylation [GO:0016310]; sphingolipid metabolic process [GO:0006665] GO:0000287; GO:0001727; GO:0001729; GO:0003951; GO:0005524; GO:0005737; GO:0005886; GO:0006665; GO:0006672; GO:0006687; GO:0016021; GO:0016310; GO:0102773 ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; lipid kinase activity [GO:0001727]; magnesium ion binding [GO:0000287]; NAD+ kinase activity [GO:0003951] AGCFVCR 0.99406 -12.992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2716 8.5979 0 13.574 0 0 12.966 0 0 0 13.468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1089 0 0 0 0 0 0 13.2352 0 0 0 0 0 0 0 Q9BVL4 SELO_HUMAN "Protein adenylyltransferase SelO, mitochondrial, EC 2.7.7.-, EC 2.7.7.n1 (Selenoprotein O, SelO)" SELENOO SELO Homo sapiens (Human) protein adenylylation [GO:0018117] chromosome [GO:0005694]; mitochondrion [GO:0005739] chromosome [GO:0005694]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein adenylyltransferase activity [GO:0070733]; protein adenylylation [GO:0018117] GO:0005524; GO:0005694; GO:0005739; GO:0018117; GO:0046872; GO:0070733 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein adenylyltransferase activity [GO:0070733] AALGASLAAARLLPLGR 0.99406 -12.995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3547 0 0 0 0 0 13.6278 13.894 0 13.7083 0 14.3416 0 0 0 0 0 0 0 0 13.3392 0 0 0 0 13.7164 0 0 0 13.2224 0 13.3167 0 13.8985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2601 0 13.4829 0 0 0 12.8755 12.8181 0 13.1525 12.7744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9662 0 0 0 0 0 0 Q9BW66 CINP_HUMAN "Cyclin-dependent kinase 2-interacting protein, CDK2-interacting protein" CINP Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; ribosomal large subunit biogenesis [GO:0042273] nucleus [GO:0005634] nucleus [GO:0005634]; preribosome binding [GO:1990275]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; ribosomal large subunit biogenesis [GO:0042273] GO:0005634; GO:0006260; GO:0006281; GO:0007049; GO:0042273; GO:0051301; GO:1990275 preribosome binding [GO:1990275] KPVLSVSAR 0.99406 -13.045 0 0 0 0 0 0 0 0 0 0 0 12.6919 11.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6746 12.3626 0 0 11.9828 0 0 11.8506 12.485 0 0 0 0 0 0 0 0 14.0341 0 0 0 0 0 0 0 0 0 0 0 0 13.0712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.641 0 12.3806 0 12.3324 0 0 0 0 0 0 0 0 13.0792 0 0 0 0 0 0 0 0 0 12.2298 0 0 0 0 0 0 12.7669 0 0 0 0 13.2131 0 0 0 0 0 0 0 0 0 0 0 0 13.4355 0 12.7794 0 0 0 13.0946 13.379 0 0 0 0 0 0 0 0 13.4105 0 12.5079 12.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2804 0 0 14.1898 0 0 14.0155 15.7959 0 17.2433 13.6731 0 0 0 0 0 0 0 0 15.2916 0 17.2611 0 0 Q9BYJ4 TRI34_HUMAN Tripartite motif-containing protein 34 (Interferon-responsive finger protein 1) (RING finger protein 21) TRIM34 IFP1 RNF21 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0032880; GO:0042802; GO:0042803; GO:0043123; GO:0045087; GO:0046596; GO:0051091; GO:0051092; GO:0051607; GO:0061630 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ACITVSNK 0.99406 -29.776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6022 0 0 0 0 0 14.2341 0 0 0 0 0 0 0 0 0 0 0 12.8854 0 0 0 0 0 0 0 0 0 0 13.7124 0 0 0 0 12.264 0 0 0 0 0 0 0 0 12.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB58 SP110_HUMAN Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110) SP110 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" DNSPEPNDPEEPQEVSSTPSDK 0.99406 -14.194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8713 0 0 0 0 11.5462 0 0 0 0 0 0 0 0 0 0 16.3807 0 0 0 0 0 11.3258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2888 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7095 13.7259 11.6602 11.9143 0 0 0 0 0 11.4237 0 0 0 0 0 12.9283 0 0 0 0 11.1831 0 0 0 0 0 0 0 0 11.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3282 0 0 0 0 0 0 0 Q9NP08 HMX1_HUMAN Homeobox protein HMX1 (Homeobox protein H6) HMX1 H6 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0005634; GO:0006357; GO:0045892; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AQMPGLV 0.99406 -8.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7973 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6112 0 0 0 12.1972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5498 0 0 0 0 0 0 Q9UPX8 SHAN2_HUMAN "SH3 and multiple ankyrin repeat domains protein 2, Shank2 (Cortactin-binding protein 1, CortBP1) (Proline-rich synapse-associated protein 1)" SHANK2 CORTBP1 KIAA1022 PROSAP1 Homo sapiens (Human) adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; regulation of synapse organization [GO:0050807]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; structural constituent of postsynaptic density [GO:0098919]; synaptic receptor adaptor activity [GO:0030160]; adult behavior [GO:0030534]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; regulation of synapse organization [GO:0050807]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625] GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007420; GO:0007584; GO:0007612; GO:0008022; GO:0008284; GO:0008306; GO:0008344; GO:0009410; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0048786; GO:0050807; GO:0060170; GO:0060291; GO:0060292; GO:0070161; GO:0071625; GO:0098686; GO:0098919; GO:0098978 ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; SH3 domain binding [GO:0017124]; structural constituent of postsynaptic density [GO:0098919]; synaptic receptor adaptor activity [GO:0030160] APFLGIPR 0.99406 -37.088 0 0 0 0 0 0 0 0 12.0832 0 13.2454 0 12.4465 12.8055 0 13.5609 12.4709 17.4792 13.6024 14.2658 0 0 13.5025 0 15.7119 12.1654 0 0 0 0 16.8216 16.3399 16.6128 0 10.619 0 0 0 0 0 0 12.3876 12.4606 13.5298 16.6626 14.8053 17.1953 11.7636 0 0 0 0 17.9206 18.6644 17.4414 17.0199 18.19 18.365 17.4375 16.8113 16.9587 0 18.2374 15.5012 0 0 0 0 0 0 0 12.6301 0 0 10.5445 0 13.4419 15.1313 0 0 14.5836 13.2414 0 0 12.3236 0 12.4351 0 0 0 20.1055 0 14.1907 0 12.5402 0 14.542 14.6879 14.6498 0 0 0 0 0 15.6761 0 0 0 0 0 0 0 13.5732 0 0 0 0 0 0 9.59677 0 0 13.6371 0 0 12.8958 13.7661 0 0 12.6762 11.3131 0 0 0 11.8455 11.5878 20.1678 0 15.9699 10.1804 0 0 0 0 0 13.0152 15.3699 0 14.04 18.3404 0 0 0 14.1964 15.7755 0 13.7242 13.4981 18.7783 17.7528 13.3768 17.1667 0 10.8984 13.2818 14.0809 0 13.8138 0 14.0323 17.5162 20.5685 0 0 0 0 12.0819 13.9313 0 11.626 Q9Y2G4 ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 (Diversin) ANKRD6 KIAA0957 Homo sapiens (Human) "negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]" GO:0005634; GO:0005737; GO:0043231; GO:0046330; GO:0090090; GO:2000096 ATLKEHIK 0.99406 -7.8683 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2606 0 0 0 0 0 0 0 12.7014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1814 0 0 0 0 0 0 0 0 0 12.3203 0 12.9436 0 0 0 0 0 0 0 0 0 0 12.1995 0 0 0 0 0 0 0 0 0 0 0 0 14.8705 0 12.6673 0 0 0 0 0 0 0 14.2251 0 0 0 0 0 0 13.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0793 13.9404 12.3743 0 0 12.4881 0 0 0 0 0 13.4127 0 0 0 13.4558 0 0 0 0 0 0 0 0 14.4256 0 9.12861 13.3294 0 0 0 0 0 14.1766 0 0 0 0 0 0 0 A2RRH5 WDR27_HUMAN WD repeat-containing protein 27 WDR27 Homo sapiens (Human) nucleoplasm [GO:0005654] nucleoplasm [GO:0005654] GO:0005654 FAACGAEDRHAYVYEMGSSTFSHR 0.99407 -7.9014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9245 15.2141 0 0 0 0 0 0 0 0 0 0 0 0 14.1814 0 11.5839 11.8748 0 0 0 0 0 14.2235 0 0 19.0991 0 0 0 0 0 0 13.3538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2104 0 0 0 13.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A5D8V7 ODAD3_HUMAN Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151) ODAD3 CCDC151 Homo sapiens (Human) brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; multicellular organism growth [GO:0035264]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228] axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228]; brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; multicellular organism growth [GO:0035264]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283] GO:0003341; GO:0005576; GO:0005814; GO:0005929; GO:0005930; GO:0007283; GO:0007368; GO:0007420; GO:0030317; GO:0035253; GO:0035264; GO:0036064; GO:0036158; GO:0060287; GO:0061371; GO:0090660; GO:0097542; GO:0120228; GO:1902017 ALELKLLDLLK 0.99407 -28.386 0 0 0 0 15.3356 0 0 0 0 0 0 0 14.637 0 12.2307 11.6726 0 0 0 0 0 0 12.4388 0 0 0 0 0 0 0 0 0 0 0 11.1855 11.0276 0 0 0 0 0 0 0 0 0 11.2291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9867 0 0 0 0 0 0 0 0 14.266 0 0 14.288 12.7939 0 0 0 10.891 0 12.5909 0 0 15.6739 0 12.9205 0 0 0 0 0 0 0 12.6048 0 0 12.896 0 0 13.9535 0 12.9063 0 13.9883 14.0898 14.8092 0 0 0 12.6662 0 12.4592 0 13.0681 13.2955 0 0 12.6369 14.9261 0 0 12.7317 12.5827 13.0187 0 13.7747 13.3105 12.7203 14.1601 13.8575 14.3897 0 13.2015 13.6628 11.8455 12.2788 17.2508 0 0 0 0 0 0 12.0925 0 0 0 0 11.7636 0 0 0 0 0 0 0 0 0 0 0 12.03 13.9149 0 13.7586 0 11.7498 0 0 0 A6NHJ4 ZN860_HUMAN Zinc finger protein 860 ZNF860 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ALYRAMMLENYR 0.99407 -13.058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1203 0 15.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.002 0 0 0 12.4485 0 0 0 0 0 0 0 0 0 0 14.2043 0 0 0 0 0 0 13.8536 0 0 13.8694 13.9059 0 0 0 0 13.6797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NKF1 SAC31_HUMAN SAC3 domain-containing protein 1 (SAC3 homology domain-containing protein 1) SAC3D1 SHD1 Homo sapiens (Human) cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; spindle assembly [GO:0051225] GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0032991; GO:0051225; GO:0051298; GO:0051301 ALAVDAAFR 0.99407 -9.3603 0 0 0 0 0 0 0 0 17.9475 0 16.8742 16.8282 15.6217 15.8231 15.8961 0 0 0 0 0 0 0 0 0 0 0 0 13.6549 16.1086 16.1673 16.3008 16.4387 16.2055 13.0419 17.2591 17.2407 17.9487 18.052 13.7945 15.7472 11.7542 15.8502 15.9748 15.8857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1264 0 0 0 0 13.9475 0 0 0 0 0 0 13.2044 0 0 0 0 13.2576 0 0 0 0 0 0 0 12.7473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8889 0 0 0 0 0 0 0 13.133 0 0 0 0 13.026 9.81806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.027 0 0 0 0 18.2808 18.1895 14.0779 17.8723 17.9484 17.1848 0 17.4277 0 18.2054 18.4427 0 14.7905 16.3638 0 0 0 0 0 0 17.5845 0 0 O00204 ST2B1_HUMAN "Sulfotransferase 2B1, EC 2.8.2.2 (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1, ST2B1)" SULT2B1 HSST2 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923] GO:0003676; GO:0004027; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0008146; GO:0008202; GO:0008203; GO:0008285; GO:0015485; GO:0043231; GO:0045606; GO:0050294; GO:0050427; GO:0051923; GO:0070062; GO:1990239 alcohol sulfotransferase activity [GO:0004027]; cholesterol binding [GO:0015485]; nucleic acid binding [GO:0003676]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146] AKVIYMGRNPR 0.99407 -9.0929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0719 0 0 0 0 0 0 11.9103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60890 OPHN1_HUMAN Oligophrenin-1 OPHN1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell junction assembly [GO:0034329]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cerebellar granule cell differentiation [GO:0021707]; cerebral cortex neuron differentiation [GO:0021895]; establishment of epithelial cell apical/basal polarity [GO:0045198]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; synaptic vesicle endocytosis [GO:0048488]" actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; terminal bouton [GO:0043195] "actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; terminal bouton [GO:0043195]; actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; ionotropic glutamate receptor binding [GO:0035255]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell junction assembly [GO:0034329]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cerebellar granule cell differentiation [GO:0021707]; cerebral cortex neuron differentiation [GO:0021895]; establishment of epithelial cell apical/basal polarity [GO:0045198]; maintenance of postsynaptic specialization structure [GO:0098880]; negative regulation of proteasomal protein catabolic process [GO:1901799]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; synaptic vesicle endocytosis [GO:0048488]" GO:0003779; GO:0005096; GO:0005543; GO:0005737; GO:0006930; GO:0007165; GO:0007399; GO:0007411; GO:0015629; GO:0021707; GO:0021895; GO:0030036; GO:0030100; GO:0030182; GO:0031175; GO:0034329; GO:0035023; GO:0035255; GO:0043195; GO:0043197; GO:0045198; GO:0048488; GO:0048667; GO:0051966; GO:0070161; GO:0098880; GO:0098978; GO:0099149; GO:1901799 actin binding [GO:0003779]; GTPase activator activity [GO:0005096]; ionotropic glutamate receptor binding [GO:0035255]; phospholipid binding [GO:0005543] CPGDVDFHNSDWDIK 0.99407 -13.078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1392 0 0 12.4983 0 0 0 12.0682 0 0 0 0 0 0 0 12.4635 0 0 0 0 0 0 0 0 11.4315 0 0 0 0 0 0 0 0 14.1933 0 0 13.185 0 0 0 0 12.0863 0 0 0 0 0 0 0 0 13.2593 13.9936 13.391 0 0 0 0 10.4934 11.8432 0 0 0 0 12.5518 0 0 0 0 0 0 0 11.3356 0 0 0 0 0 0 10.7298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75342 LX12B_HUMAN "Arachidonate 12-lipoxygenase, 12R-type, 12R-LOX, 12R-lipoxygenase, EC 1.13.11.- (Epidermis-type lipoxygenase 12)" ALOX12B Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxygenase pathway [GO:0019372]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; protein lipidation [GO:0006497]; sphingolipid metabolic process [GO:0006665] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471] "cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; arachidonate 12(R)-lipoxygenase activity [GO:0106237]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleate 9S-lipoxygenase activity [GO:1990136]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; arachidonic acid metabolic process [GO:0019369]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; lipid oxidation [GO:0034440]; lipoxygenase pathway [GO:0019372]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mucus secretion [GO:0070257]; protein lipidation [GO:0006497]; sphingolipid metabolic process [GO:0006665]" GO:0004052; GO:0005506; GO:0005829; GO:0006497; GO:0006665; GO:0010628; GO:0016702; GO:0016829; GO:0016853; GO:0019369; GO:0019372; GO:0034440; GO:0043231; GO:0043410; GO:0043651; GO:0046513; GO:0047677; GO:0048471; GO:0051122; GO:0061436; GO:0070257; GO:0106237; GO:1990136 "arachidonate 12(R)-lipoxygenase activity [GO:0106237]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleate 9S-lipoxygenase activity [GO:1990136]; lyase activity [GO:0016829]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]" ESSGFPR 0.99407 -13.869 0 0 0 0 0 0 0 0 12.1217 0 0 13.8232 0 0 0 0 0 0 10.1182 0 10.1356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2355 0 0 0 0 0 0 0 0 0 0 15.1842 0 0 0 0 13.8615 0 13.8298 13.7975 15.4107 14.0082 14.284 0 0 14.5886 14.5056 15.1232 15.2287 0 13.8183 0 0 13.5047 0 0 0 0 0 13.4089 0 0 0 0 0 14.465 0 0 0 0 0 0 0 9.90186 12.4635 0 12.6261 0 0 0 0 0 0 0 0 0 0 12.5735 0 0 10.0494 0 0 0 0 0 11.873 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5063 0 0 0 13.5863 13.8679 0 14.8478 13.2971 14.3136 0 14.4067 0 14.1822 12.0817 12.2908 0 0 0 14.1745 0 13.8195 11.7791 0 O94826 TOM70_HUMAN Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70) TOMM70 KIAA0719 TOM70 TOMM70A Homo sapiens (Human) activation of innate immune response [GO:0002218]; cellular response to virus [GO:0098586]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein import [GO:1904591]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068] extracellular exosome [GO:0070062]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320]; activation of innate immune response [GO:0002218]; cellular response to virus [GO:0098586]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein import [GO:1904591]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068] GO:0002218; GO:0002230; GO:0005739; GO:0005741; GO:0005742; GO:0006626; GO:0008320; GO:0016020; GO:0030150; GO:0030943; GO:0031307; GO:0032728; GO:0042981; GO:0045039; GO:0045040; GO:0061052; GO:0070062; GO:0097068; GO:0098586; GO:1904591 mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320] ADEMYDK 0.99407 -29.916 12.7186 0 0 12.6266 12.3845 12.4189 0 0 0 0 0 0 0 16.4246 0 0 0 13.4719 0 0 13.1407 0 0 12.858 0 13.8927 13.1843 14.007 13.8671 16.0894 16.4891 0 14.7975 0 13.8043 0 14.5588 0 15.3191 15.8167 14.6338 0 15.9377 14.9924 0 15.506 14.0071 0 13.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5716 0 0 14.3115 14.9038 14.8037 0 0 14.6579 14.4077 0 0 14.0821 0 0 0 0 0 0 11.7719 0 0 13.9214 0 0 0 0 0 14.6835 14.9885 0 0 0 0 0 0 14.0846 0 0 0 0 0 13.9574 0 13.716 0 0 13.4561 0 13.4748 0 0 0 0 0 0 0 0 0 0 0 14.2774 0 0 0 14.8968 14.2237 0 13.9057 0 13.8511 11.8972 0 0 0 0 0 0 0 0 0 12.4776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3216 0 0 0 0 0 0 0 13.3795 0 O95292 VAPB_HUMAN "Vesicle-associated membrane protein-associated protein B/C, VAMP-B/VAMP-C, VAMP-associated protein B/C, VAP-B/VAP-C" VAPB UNQ484/PRO983 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular calcium ion homeostasis [GO:0006874]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; IRE1-mediated unfolded protein response [GO:0036498]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076] GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006874; GO:0006888; GO:0007029; GO:0008017; GO:0016021; GO:0019076; GO:0019899; GO:0030968; GO:0033149; GO:0036498; GO:0042803; GO:0044790; GO:0044828; GO:0044829; GO:0044830; GO:0045070; GO:0045296; GO:0046725; GO:0046982; GO:0048487; GO:0061817; GO:0090114; GO:0090158 beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CVFELPAENDK 0.99407 -7.0784 0 0 0 0 0 0 0 0 0 11.4748 0 13.3088 12.9873 0 0 0 0 0 0 0 12.4227 0 0 0 0 12.3817 0 0 0 0 0 0 0 13.1219 0 12.4181 0 0 0 0 12.3948 13.0154 0 12.5083 0 0 0 0 0 0 0 0 0 11.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1075 0 0 13.255 13.4051 0 0 0 13.8569 0 10.9182 0 0 0 12.9004 0 0 12.7414 0 0 0 0 13.8049 0 0 12.6776 0 0 0 0 0 12.6067 0 13.554 12.0139 0 0 0 11.9088 0 0 0 0 15.1296 0 12.6762 12.2534 0 0 0 13.2572 0 0 0 0 0 0 0 0 0 0 14.1562 14.1534 0 14.8131 14.1022 0 0 0 13.1264 0 0 0 0 15.2322 0 11.9933 0 0 0 12.7324 12.4854 0 0 0 0 0 0 0 11.9656 12.717 11.5373 0 14.5158 0 0 0 0 12.0614 0 16.68 13.0508 12.554 12.659 0 13.5486 P27930 IL1R2_HUMAN "Interleukin-1 receptor type 2, IL-1R-2, IL-1RT-2, IL-1RT2 (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta, IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form, mIL-1R2, mIL-1RII; Interleukin-1 receptor type 2, soluble form, sIL-1R2, sIL-1RII ]" IL1R2 IL1RB Homo sapiens (Human) immune response [GO:0006955]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of protein processing [GO:0010955]; protein processing [GO:0016485] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; interleukin-1 binding [GO:0019966]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]; immune response [GO:0006955]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of protein processing [GO:0010955]; protein processing [GO:0016485]" GO:0004908; GO:0004910; GO:0005576; GO:0005737; GO:0005886; GO:0006955; GO:0010955; GO:0016021; GO:0016485; GO:0019966; GO:0032690; GO:1900016; GO:2000660 "interleukin-1 binding [GO:0019966]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]" CPQVPYWLWASVSPRINLTWHK 0.99407 -7.0607 0 0 0 0 0 0 0 0 0 0 0 0 14.5381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5745 0 0 12.7836 0 0 0 0 0 0 0 14.0821 12.9228 0 0 0 0 0 0 0 0 0 0 0 0 Q567V2 M17L2_HUMAN Mpv17-like protein 2 MPV17L2 FKSG24 Homo sapiens (Human) mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131] GO:0005737; GO:0005739; GO:0005743; GO:0005762; GO:0016021; GO:0061668; GO:0070131 ARPGQVFDPR 0.99407 -9.3634 0 0 0 0 0 0 0 0 15.6284 0 15.1925 0 0 14.5683 14.9283 0 0 0 0 12.4233 0 0 12.8145 0 14.4326 0 0 12.7172 0 0 0 0 0 0 0 12.3156 0 0 0 13.6094 11.9625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5838 0 13.0779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1225 11.5585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9522 0 0 0 0 0 0 0 0 14.756 0 0 0 0 0 0 0 0 0 0 0 0 14.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9605 0 0 Q5JXA9 SIRB2_HUMAN "Signal-regulatory protein beta-2, SIRP-beta-2 (Protein tyrosine phosphatase non-receptor type substrate 1-like 3) (Protein tyrosine phosphatase non-receptor type substrate protein)" SIRPB2 PTPN1L PTPNS1L3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 AITLAALLLALATSRR 0.99407 -9.1007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5319 13.9445 14.3101 11.9214 0 14.0413 0 0 0 0 0 0 0 0 14.0123 0 14.266 0 0 0 0 0 0 0 0 0 0 0 0 11.4655 0 0 13.7851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6623 0 0 0 13.5498 11.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5115 0 0 0 0 0 0 0 0 0 0 13.2649 14.2795 0 0 0 Q5VV42 CDKAL_HUMAN "Threonylcarbamoyladenosine tRNA methylthiotransferase, EC 2.8.4.5 (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase)" CDKAL1 Homo sapiens (Human) maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]; maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600]" GO:0005783; GO:0005789; GO:0005791; GO:0016020; GO:0016021; GO:0035598; GO:0035600; GO:0046872; GO:0051539; GO:0061712; GO:1990145 "4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]" DVVPKVR 0.99407 -28.389 0 10.6494 0 13.0772 0 0 0 0 0 12.5082 0 0 0 0 0 0 0 0 0 0 0 0 11.9286 0 0 0 0 11.2541 0 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 13.0978 12.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3001 0 0 0 0 0 0 0 0 0 0 0 13.5619 0 0 0 0 0 0 0 0 16.0569 14.2172 11.4267 0 0 0 12.4557 0 0 0 13.8198 0 0 0 10.719 0 0 0 0 0 12.8789 0 0 13.2829 12.1558 0 0 0 0 0 14.492 0 0 12.3569 0 0 0 0 0 0 0 12.5738 0 14.3453 0 12.6166 0 0 0 0 0 0 0 0 0 12.544 0 0 0 0 0 0 0 0 0 11.76 0 0 0 0 0 0 0 0 0 0 0 12.5521 0 0 0 0 0 0 0 0 0 0 0 Q6UVY6 MOXD1_HUMAN "DBH-like monooxygenase protein 1, EC 1.14.17.- (Monooxygenase X)" MOXD1 MOX UNQ2493/PRO5780 Homo sapiens (Human) dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667] endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589] GO:0004500; GO:0005507; GO:0005615; GO:0005789; GO:0006589; GO:0016021; GO:0030667; GO:0042420; GO:0042421 copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500] EGLSFNKLVLSLPVNVR 0.99407 -6.8153 0 0 0 0 0 0 0 0 14.2198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2617 11.7279 0 0 0 0 15.3077 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2598 0 0 0 0 0 0 0 0 0 0 0 12.4317 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3143 0 0 0 12.2366 0 0 0 0 14.1603 0 0 0 0 Q6ZS30 NBEL1_HUMAN Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein) NBEAL1 ALS2CR16 ALS2CR17 Homo sapiens (Human) protein localization [GO:0008104] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; protein kinase binding [GO:0019901]; protein localization [GO:0008104] GO:0005829; GO:0008104; GO:0016020; GO:0019901 protein kinase binding [GO:0019901] DNDKNMSTEDTKK 0.99407 -28.422 0 0 11.5498 0 0 0 0 0 0 0 0 11.2889 0 0 0 10.5881 0 0 0 0 0 12.5047 0 0 11.0343 0 0 0 0 0 0 0 0 0 11.6636 0 0 0 0 0 0 9.77437 0 0 0 0 9.60642 0 12.7096 12.5806 11.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5637 0 12.4009 0 0 12.5995 12.2751 11.7938 0 14.4895 15.0307 0 0 0 15.0373 15.3007 14.4248 14.3624 10.867 0 14.5163 15.6731 0 14.9068 15.4384 10.6381 10.6487 15.145 14.0649 0 14.4892 0 0 0 15.1506 13.4652 0 0 14.3406 0 15.0376 0 14.7566 13.9791 12.9254 0 14.2318 0 0 0 0 0 12.2666 12.7974 13.6206 15.0859 14.1752 0 11.0822 0 0 0 0 0 0 12.4491 0 0 11.69 0 0 0 13.723 0 12.7615 15.1594 12.889 14.1618 13.0084 14.976 11.0972 0 0 0 0 11.0809 11.6121 15.3678 14.7802 14.1356 0 0 13.1932 12.7716 0 0 11.9966 11.0778 0 0 10.4491 13.0724 0 0 0 0 13.2463 0 12.2104 9.9544 0 0 0 0 Q8NC51 PAIRB_HUMAN "Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1, PAI-RBP1) (SERPINE1 mRNA-binding protein 1)" SERBP1 PAIRBP1 CGI-55 Homo sapiens (Human) PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488] GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0070062 cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183] DRKNPLPPSVGVVDK 0.99407 -10.984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.375 0 18.8012 0 0 0 0 0 0 0 0 0 14.1843 14.8763 0 0 0 0 0 18.6047 18.4906 16.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MF6 CQ10A_HUMAN "Coenzyme Q-binding protein COQ10 homolog A, mitochondrial" COQ10A UNQ6192/PRO20219 Homo sapiens (Human) cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone binding [GO:0048039]; cellular respiration [GO:0045333]; ubiquinone biosynthetic process [GO:0006744] GO:0005739; GO:0005743; GO:0006744; GO:0045333; GO:0048039 ubiquinone binding [GO:0048039] AAAERCCR 0.99407 -9.3614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8154 0 0 0 0 0 0 0 0 0 12.9015 12.1385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3619 0 0 0 0 0 0 0 0 15.292 0 0 0 0 0 0 13.9233 0 0 0 15.0281 15.1556 0 0 0 0 14.978 14.4404 0 15.3876 0 0 0 0 15.3442 0 0 0 0 0 12.3642 14.967 14.4744 0 14.6863 0 14.4482 0 0 0 0 0 0 0 0 15.217 0 0 0 0 0 0 0 0 0 12.1668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.164 0 Q96S53 TESK2_HUMAN "Dual specificity testis-specific protein kinase 2, EC 2.7.12.1 (Testicular protein kinase 2)" TESK2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283] GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] LDDFTCEK 0.99407 -8.6223 0 0 0 0 0 9.45311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3511 0 0 0 13.5169 0 0 0 13.5077 0 0 10.7205 0 0 13.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9312 0 0 0 0 0 0 0 0 0 14.196 0 0 0 0 0 0 13.8956 0 14.3815 0 0 0 14.0376 14.4386 14.4448 13.9357 0 14.0429 13.374 13.9959 13.7424 0 0 13.9103 0 0 0 13.8497 0 14.2213 0 13.4671 0 0 10.7245 13.5454 0 0 0 13.1232 0 0 0 0 11.7451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4534 0 0 0 13.2952 0 Q99457 NP1L3_HUMAN Nucleosome assembly protein 1-like 3 NAP1L3 BNAP Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0042393 chromatin binding [GO:0003682]; histone binding [GO:0042393] ADSKDCMEATPEVKEDPK 0.99407 -7.9062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9825 0 0 0 0 0 0 0 0 0 0 0 0 11.619 13.8783 0 0 0 0 0 0 0 0 0 0 0 11.5941 0 0 13.8141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.289 0 0 0 0 0 0 0 0 0 11.9356 15.6076 9.63232 0 0 0 0 0 0 0 0 12.6703 0 0 0 0 0 0 0 0 0 12.1803 0 0 0 0 0 0 Q9H2F9 CCD68_HUMAN "Coiled-coil domain-containing protein 68 (Cutaneous T-cell lymphoma-associated antigen se57-1, CTCL-associated antigen se57-1)" CCDC68 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; microtubule anchoring at centrosome [GO:0034454]; protein localization [GO:0008104] GO:0005737; GO:0005814; GO:0008104; GO:0034454; GO:0035556; GO:0120103 EQKLKQHVENLNQVAEK 0.99407 -10.984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7194 0 0 0 0 0 0 0 11.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6216 0 0 0 0 0 0 0 0 0 12.7243 0 0 0 0 0 Q9NQZ8 ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71) ZNF71 EZFIT Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GACPPVR 0.99407 -13.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3955 12.965 0 0 0 0 0 0 11.8372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8593 0 13.7179 12.5304 13.4376 0 0 0 0 0 0 0 0 13.5729 11.9913 15.0247 0 13.1198 0 11.3499 0 13.0669 13.5171 0 0 0 0 0 0 0 14.6424 0 0 12.4552 15.0634 0 12.8427 0 0 12.5317 0 0 12.7401 13.926 0 12.6509 12.7827 0 0 0 0 12.8759 0 0 14.9912 12.5818 0 0 0 11.7164 0 12.6999 12.6587 0 13.3257 13.7282 0 0 13.1772 14.4322 0 0 11.745 0 0 0 0 0 0 0 13.2728 0 0 0 0 0 12.4032 0 0 0 0 0 0 0 12.3 0 0 12.6447 14.1839 0 0 0 10.587 0 0 0 Q9NVS2 RT18A_HUMAN "39S ribosomal protein S18a, mitochondrial, MRP-S18-a, Mrps18a, S18mt-a (39S ribosomal protein S18-3, mitochondrial, MRP-S18-3) (Mitochondrial large ribosomal subunit protein bS18a) (Mitochondrial large ribosomal subunit protein mL66)" MRPS18A Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0005763; GO:0006412; GO:0032543; GO:0070181 small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735] KGPRWNR 0.99407 -13.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBT6 POLK_HUMAN "DNA polymerase kappa, EC 2.7.7.7 (DINB protein, DINP)" POLK DINB1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]" GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0016604; GO:0034644; GO:0042276; GO:0046872 damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] EKCDSYK 0.99407 -30.104 0 0 0 0 0 0 0 0 0 0 0 0 12.5314 0 0 0 0 0 0 0 0 0 0 0 10.5857 0 0 0 12.5799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0361 0 0 0 0 0 0 0 13.793 0 0 0 0 15.2202 0 0 0 0 0 0 0 0 0 0 11.4252 14.7694 0 0 0 0 0 0 0 10.8407 14.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9021 0 13.3136 14.6186 0 14.9643 0 15.4273 15.8279 0 14.7673 15.1206 0 13.0065 15.0681 0 15.5095 0 15.908 15.4658 14.9921 0 0 0 11.2838 16.8385 15.6304 15.9862 14.7631 15.2998 0 15.2454 15.4788 13.1268 0 0 11.9379 14.0009 12.229 15.5895 0 15.1568 14.6937 14.4583 14.9197 15.4098 15.3247 15.5688 14.68 0 13.4644 0 0 0 0 0 0 10.5956 0 15.8295 11.6339 11.3651 0 0 0 0 11.5198 0 12.2902 12.3395 14.0572 13.0366 0 0 0 16.0197 15.6563 0 0 0 15.6285 0 15.7472 0 Q9UH36 SRR1L_HUMAN SRR1-like protein (SRR1 domain-containing protein) SRRD SRR1L Homo sapiens (Human) heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]; rhythmic process [GO:0048511] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; heme biosynthetic process [GO:0006783]; microtubule-based process [GO:0007017]; regulation of circadian rhythm [GO:0042752]; regulation of heme biosynthetic process [GO:0070453]; rhythmic process [GO:0048511] GO:0005634; GO:0005737; GO:0006783; GO:0007017; GO:0042752; GO:0048511; GO:0070453 CVCYGIGNFATCIVARNQLTFLLLLLEKCQIPR 0.99407 -8.12 0 0 0 0 0 0 0 11.8458 0 0 0 10.1591 0 0 0 0 0 0 0 0 0 0 0 9.82418 0 0 12.8579 0 0 0 12.6216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7719 0 0 0 0 0 0 0 0 0 10.4366 0 11.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9221 0 0 0 0 0 0 13.758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7116 0 0 0 0 0 12.6344 0 0 0 0 0 0 0 0 0 10.3896 0 0 0 0 10.3544 0 0 0 0 0 0 0 0 0 Q9UHL9 GT2D1_HUMAN "General transcription factor II-I repeat domain-containing protein 1, GTF2I repeat domain-containing protein 1 (General transcription factor III) (MusTRD1/BEN) (Muscle TFII-I repeat domain-containing protein 1) (Slow-muscle-fiber enhancer-binding protein) (USE B1-binding protein) (Williams-Beuren syndrome chromosomal region 11 protein) (Williams-Beuren syndrome chromosomal region 12 protein)" GTF2IRD1 CREAM1 GTF3 MUSTRD1 RBAP2 WBSCR11 WBSCR12 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transition between slow and fast fiber [GO:0014886]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transition between slow and fast fiber [GO:0014886]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006366; GO:0014886 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASVVPLPYERLLREPGLLAVQGLPEGLAFR 0.99407 -15.567 0 0 0 0 0 0 0 14.609 0 0 0 0 0 0 0 0 0 12.7919 0 0 0 0 0 0 0 0 14.1872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8586 0 0 0 0 11.1828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0652 0 0 0 0 11.3039 0 15.4174 15.0636 14.3723 11.8907 14.0726 0 14.7205 14.9672 0 14.8955 0 0 0 0 13.0906 0 0 0 13.4087 14.4064 13.9549 0 0 0 12.0467 14.137 0 14.9358 0 14.4279 15.7579 12.1117 0 0 0 14.5053 0 0 13.9471 16.2466 0 14.8471 0 0 12.7866 0 0 0 0 0 0 15.3451 0 0 0 0 0 16.9237 16.299 0 12.652 0 0 0 16.3755 16.0005 15.6532 15.1594 14.8911 0 0 11.1607 0 16.4022 0 14.9004 14.8817 14.6934 15.7264 14.8083 14.1106 0 0 0 0 0 0 0 0 0 0 12.9025 0 0 0 0 0 15.8663 14.4782 0 0 0 0 0 11.92 Q9Y6N9 USH1C_HUMAN Harmonin (Antigen NY-CO-38/NY-CO-37) (Autoimmune enteropathy-related antigen AIE-75) (Protein PDZ-73) (Renal carcinoma antigen NY-REN-3) (Usher syndrome type-1C protein) USH1C AIE75 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] apical part of cell [GO:0045177]; brush border [GO:0005903]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202] apical part of cell [GO:0045177]; brush border [GO:0005903]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; protein-containing complex assembly [GO:0065003]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605] GO:0000086; GO:0001750; GO:0001917; GO:0002142; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005929; GO:0007605; GO:0030046; GO:0030507; GO:0032420; GO:0032426; GO:0032532; GO:0042472; GO:0042491; GO:0045177; GO:0045202; GO:0045494; GO:0046549; GO:0050953; GO:0050957; GO:0051015; GO:0051017; GO:0060122; GO:0065003; GO:1904106; GO:1904970 actin filament binding [GO:0051015]; spectrin binding [GO:0030507] EMEQIVEEEEKFKK 0.99407 -13.865 0 0 0 0 0 0 0 0 13.8023 0 0 0 0 10.7181 0 0 0 0 0 0 11.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.393 0 16.8507 0 0 0 0 11.7549 0 0 0 0 12.7004 13.9628 12.2228 0 16.2059 13.7852 0 16.2365 0 0 0 0 0 13.5942 0 0 14.0654 0 15.4122 15.9299 13.789 0 14.1232 0 12.1848 13.838 0 12.7898 0 0 0 0 0 0 12.6376 0 0 0 0 0 0 0 13.2563 0 14.5386 0 13.6863 0 0 0 0 0 0 0 0 0 0 0 14.191 0 0 13.4829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5912 0 0 0 0 0 0 0 0 0 0 10.4463 0 O00566 MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) "maturation of SSU-rRNA [GO:0030490]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732] "chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000375; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005732; GO:0006396; GO:0008380; GO:0030490; GO:0032040; GO:0034457 RNA binding [GO:0003723] DDNDEEEEDIDFFEDIDSDEDEGGLFGSKK 0.99408 -30.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.056 0 0 0 0 12.3331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8239 12.8414 0 0 14.012 0 0 0 0 0 0 0 0 10.6181 0 0 0 0 0 0 17.3522 0 0 12.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1474 0 0 0 0 0 0 0 12.4812 0 0 0 13.5746 0 12.9086 0 0 0 0 15.1442 0 12.4954 12.8065 0 0 12.4322 0 0 0 0 15.466 12.4471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2022 12.5476 0 0 0 0 0 0 13.6911 0 0 0 12.4783 0 O60476 MA1A2_HUMAN "Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB, EC 3.2.1.113 (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB, Alpha-1,2-mannosidase IB)" MAN1A2 MAN1B Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]" GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0016021; GO:0048286; GO:0070062; GO:1904381 "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" AEIQTEK 0.99408 -28.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2695 0 0 0 0 0 9.6414 0 0 0 0 0 0 0 0 11.6719 0 0 0 0 0 0 0 0 0 0 0 0 13.9907 0 12.3766 11.3465 0 0 0 0 0 0 0 0 0 14.2235 0 0 0 0 0 0 0 0 0 13.0692 0 0 0 12.5008 0 0 0 0 0 10.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6644 11.3955 12.5803 0 0 0 0 0 0 0 0 0 10.8491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30542 AA1R_HUMAN Adenosine receptor A1 ADORA1 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; apoptotic signaling pathway [GO:0097190]; biomineralization [GO:0110148]; cell-cell signaling [GO:0007267]; cognition [GO:0050890]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; excitatory postsynaptic potential [GO:0060079]; fatty acid homeostasis [GO:0055089]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; lipid catabolic process [GO:0016042]; long-term synaptic depression [GO:0060292]; mucus secretion [GO:0070254]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of heart contraction [GO:0045822]; negative regulation of hormone secretion [GO:0046888]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mucus secretion [GO:0070256]; negative regulation of neurotrophin production [GO:0032900]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of systemic arterial blood pressure [GO:0003085]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron death [GO:1901216]; positive regulation of nucleoside transport [GO:0032244]; positive regulation of peptide secretion [GO:0002793]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of systemic arterial blood pressure [GO:0003084]; protein targeting to membrane [GO:0006612]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of glomerular filtration [GO:0003093]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of sensory perception of pain [GO:0051930]; relaxation of vascular associated smooth muscle [GO:0060087]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; signal transduction [GO:0007165]; temperature homeostasis [GO:0001659]; triglyceride homeostasis [GO:0070328]" axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; terminal bouton [GO:0043195] "axolemma [GO:0030673]; basolateral plasma membrane [GO:0016323]; calyx of Held [GO:0044305]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; terminal bouton [GO:0043195]; G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heat shock protein binding [GO:0031072]; heterotrimeric G-protein binding [GO:0032795]; neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099582]; protein heterodimerization activity [GO:0046982]; purine nucleoside binding [GO:0001883]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; apoptotic signaling pathway [GO:0097190]; biomineralization [GO:0110148]; cell-cell signaling [GO:0007267]; cognition [GO:0050890]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; excitatory postsynaptic potential [GO:0060079]; fatty acid homeostasis [GO:0055089]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; lipid catabolic process [GO:0016042]; long-term synaptic depression [GO:0060292]; mucus secretion [GO:0070254]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of circadian sleep/wake cycle, non-REM sleep [GO:0042323]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of heart contraction [GO:0045822]; negative regulation of hormone secretion [GO:0046888]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mucus secretion [GO:0070256]; negative regulation of neurotrophin production [GO:0032900]; negative regulation of renal sodium excretion [GO:0035814]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; negative regulation of systemic arterial blood pressure [GO:0003085]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron death [GO:1901216]; positive regulation of nucleoside transport [GO:0032244]; positive regulation of peptide secretion [GO:0002793]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of systemic arterial blood pressure [GO:0003084]; protein targeting to membrane [GO:0006612]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of glomerular filtration [GO:0003093]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of sensory perception of pain [GO:0051930]; relaxation of vascular associated smooth muscle [GO:0060087]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to purine-containing compound [GO:0014074]; signal transduction [GO:0007165]; temperature homeostasis [GO:0001659]; triglyceride homeostasis [GO:0070328]" GO:0001609; GO:0001659; GO:0001664; GO:0001666; GO:0001883; GO:0002087; GO:0002674; GO:0002686; GO:0002793; GO:0003084; GO:0003085; GO:0003093; GO:0004930; GO:0005783; GO:0005886; GO:0005887; GO:0006612; GO:0006909; GO:0006954; GO:0007165; GO:0007186; GO:0007193; GO:0007267; GO:0007399; GO:0008285; GO:0010035; GO:0014050; GO:0014069; GO:0014074; GO:0016042; GO:0016323; GO:0030425; GO:0030673; GO:0031072; GO:0031683; GO:0032229; GO:0032244; GO:0032795; GO:0032900; GO:0035307; GO:0035814; GO:0042323; GO:0043025; GO:0043066; GO:0043195; GO:0043197; GO:0043268; GO:0043410; GO:0044305; GO:0045202; GO:0045741; GO:0045822; GO:0046888; GO:0046982; GO:0048786; GO:0050890; GO:0050900; GO:0050965; GO:0050995; GO:0050996; GO:0051930; GO:0051967; GO:0055089; GO:0060079; GO:0060087; GO:0060292; GO:0070254; GO:0070256; GO:0070328; GO:0086004; GO:0097190; GO:0099055; GO:0099056; GO:0099582; GO:0110148; GO:1900272; GO:1900453; GO:1901216 G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heat shock protein binding [GO:0031072]; heterotrimeric G-protein binding [GO:0032795]; neurotransmitter receptor activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099582]; protein heterodimerization activity [GO:0046982]; purine nucleoside binding [GO:0001883] MVVTPRR 0.99408 -10.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P32456 GBP2_HUMAN "Guanylate-binding protein 2, EC 3.6.5.- (GTP-binding protein 2, GBP-2, HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2)" GBP2 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; protein localization to nucleus [GO:0034504] GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006955; GO:0031410; GO:0034504; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0071346; GO:0071347; GO:0071356 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] CFVFDWPAPKKYLAHLEQLK 0.99408 -13.119 0 0 0 0 0 0 0 0 0 0 0 0 12.7041 14.6613 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2682 0 0 0 0 0 0 0 0 11.2003 12.1377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2318 0 0 0 0 0 0 0 14.1774 0 0 0 0 0 0 0 13.2478 0 0 0 0 12.4596 0 12.936 0 13.2016 13.6996 11.7349 0 0 0 0 0 0 0 0 0 0 0 0 12.685 0 0 14.1872 12.592 11.842 11.0156 0 0 0 0 0 0 0 0 12.3975 0 0 0 0 0 12.4258 0 0 12.8859 0 0 0 14.3405 0 0 10.5283 0 0 0 14.5237 0 0 0 13.2491 0 0 0 0 0 0 12.6003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4474 0 P40855 PEX19_HUMAN Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein) PEX19 HK33 PXF OK/SW-cl.22 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; peroxisome membrane targeting sequence binding [GO:0033328]; protein carrier chaperone [GO:0140597]; protein N-terminus binding [GO:0047485]; chaperone-mediated protein folding [GO:0061077]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625] GO:0005634; GO:0005654; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0016021; GO:0016557; GO:0016559; GO:0031526; GO:0032991; GO:0033328; GO:0036105; GO:0045046; GO:0047485; GO:0050821; GO:0051117; GO:0061077; GO:0072663; GO:0140597; GO:1900131 ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; peroxisome membrane targeting sequence binding [GO:0033328]; protein carrier chaperone [GO:0140597]; protein N-terminus binding [GO:0047485] DVLYPSLK 0.99408 -10.749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G0A6 MINY4_HUMAN "Probable ubiquitin carboxyl-terminal hydrolase MINDY-4, EC 3.4.19.12 (Probable deubiquitinating enzyme MINDY-4)" MINDY4 C7orf67 FAM188B Homo sapiens (Human) cysteine-type deubiquitinase activity [GO:0004843]; Lys48-specific deubiquitinase activity [GO:1990380] GO:0004843; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; Lys48-specific deubiquitinase activity [GO:1990380] KNQLLPSDK 0.99408 -10.992 0 0 0 0 0 0 0 0 0 0 0 14.7298 0 14.5436 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7423 0 0 0 0 0 0 0 0 0 0 13.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9343 0 0 0 0 Q6ZRS2 SRCAP_HUMAN "Helicase SRCAP, EC 3.6.4.- (Domino homolog 2) (Snf2-related CBP activator)" SRCAP KIAA0309 Homo sapiens (Human) "histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812] "Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; histone exchange [GO:0043486]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000786; GO:0000812; GO:0003677; GO:0003713; GO:0004386; GO:0004402; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0006355; GO:0006357; GO:0016604; GO:0016887; GO:0032991; GO:0042393; GO:0043486; GO:0048471; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713] APMPTPTLVRPLLK 0.99408 -28.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5956 0 13.1581 0 0 0 0 0 0 0 13.0002 0 0 0 12.3458 0 0 0 0 0 0 0 0 12.849 0 16.0546 10.3094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0378 12.9298 10.6479 0 11.5309 0 15.3829 0 0 0 0 0 0 0 0 0 13.2929 0 12.5349 12.1868 12.7773 11.1295 15.516 0 0 13.4374 15.768 14.5717 14.4284 11.4123 0 15.259 0 15.155 14.5671 15.4629 14.2724 17.1396 14.952 0 11.012 11.8437 13.4724 0 0 16.0363 15.0789 14.5646 0 14.4318 13.4785 15.8357 15.6425 14.2893 14.4615 14.8322 12.9835 14.1237 14.6065 13.5164 15.1249 12.5516 11.6936 0 15.387 0 12.483 13.8242 0 0 0 0 0 13.8847 13.9669 13.6192 13.3648 0 0 0 0 0 0 12.6736 0 0 15.9355 0 16.0424 0 0 0 0 10.9034 0 0 0 0 0 0 0 0 11.2363 14.583 0 11.5967 12.7821 14.9785 0 0 13.0351 14.9007 0 Q6ZUB1 S31E1_HUMAN Spermatogenesis-associated protein 31E1 (Protein FAM75E1) SPATA31E1 C9orf79 FAM75E1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 EHLENKLQIHLAR 0.99408 -28.752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.181 0 0 0 10.408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0049 0 0 0 0 13.1369 0 0 0 0 0 15.0487 12.8206 14.0625 0 0 0 0 0 14.7506 12.2316 0 0 12.4761 0 0 12.4127 0 0 0 13.4936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8147 0 0 0 0 0 12.6165 12.5208 0 11.8281 0 11.9425 11.3299 0 0 13.3734 14.3583 0 0 0 0 0 0 0 0 0 0 13.7495 0 0 0 0 0 0 13.1762 0 0 0 13.896 0 10.3159 13.0096 12.4627 0 0 12.0188 0 0 0 0 0 0 13.7729 13.9099 0 0 0 12.8519 0 11.491 Q8N0X7 SPART_HUMAN Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1) SPART KIAA0610 SPG20 TAHCCP1 Homo sapiens (Human) abscission [GO:0009838]; adipose tissue development [GO:0060612]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; collateral sprouting in absence of injury [GO:0048669]; lipid droplet organization [GO:0034389]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of collateral sprouting in absence of injury [GO:0048698]; neuromuscular process [GO:0050905]; regulation of mitochondrial membrane potential [GO:0051881] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; synapse [GO:0045202]; ubiquitin protein ligase binding [GO:0031625]; abscission [GO:0009838]; adipose tissue development [GO:0060612]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; collateral sprouting in absence of injury [GO:0048669]; lipid droplet organization [GO:0034389]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of collateral sprouting in absence of injury [GO:0048698]; neuromuscular process [GO:0050905]; regulation of mitochondrial membrane potential [GO:0051881] GO:0005737; GO:0005741; GO:0005811; GO:0005829; GO:0005886; GO:0009838; GO:0030496; GO:0030509; GO:0030514; GO:0031625; GO:0034389; GO:0045202; GO:0048669; GO:0048698; GO:0050905; GO:0051301; GO:0051881; GO:0060612 ubiquitin protein ligase binding [GO:0031625] ELAPHVK 0.99408 -13.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9545 0 0 0 0 13.4045 13.5587 0 0 0 0 15.8611 0 0 0 0 0 12.6534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8069 12.563 0 0 0 0 12.7066 0 0 Q96IV0 NGLY1_HUMAN "Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase, PNGase, hPNGase, EC 3.5.1.52 (N-glycanase 1) (Peptide:N-glycanase)" NGLY1 PNG1 Homo sapiens (Human) ER-associated misfolded protein catabolic process [GO:0071712]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein folding [GO:0006457]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; ER-associated misfolded protein catabolic process [GO:0071712]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein folding [GO:0006457]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515] GO:0000224; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006515; GO:0006516; GO:0006517; GO:0046872; GO:0071712 metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224] ALACIPVQELKR 0.99408 -10.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4566 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1199 0 0 0 14.272 0 0 0 0 0 13.6512 13.312 0 14.7603 0 13.5474 0 0 11.3978 0 0 0 0 0 13.3951 11.8706 0 13.054 0 13.0153 0 0 0 11.9594 0 0 0 0 0 0 14.6477 0 0 11.8858 12.7598 15.2329 0 13.2838 13.1826 12.0824 0 0 13.1778 0 0 0 0 0 0 13.9534 0 0 0 13.2159 0 0 0 14.556 0 15.2031 15.0364 15.3866 12.5428 13.5184 15.8673 13.8586 0 13.3136 0 0 0 0 0 0 0 0 9.73672 12.4512 12.1627 0 0 12.842 0 0 12.8328 13.5786 12.4719 0 12.5526 0 0 0 0 12.8056 0 0 0 0 0 0 0 0 0 0 O00186 STXB3_HUMAN "Syntaxin-binding protein 3 (Platelet Sec1 protein, PSP) (Protein unc-18 homolog 3, Unc18-3) (Protein unc-18 homolog C, Unc-18C)" STXBP3 Homo sapiens (Human) brain development [GO:0007420]; cellular glucose homeostasis [GO:0001678]; cellular response to interferon-gamma [GO:0071346]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of glucose import [GO:0046325]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; protein to membrane docking [GO:0022615]; response to insulin [GO:0032868]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; brain development [GO:0007420]; cellular glucose homeostasis [GO:0001678]; cellular response to interferon-gamma [GO:0071346]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of glucose import [GO:0046325]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; protein to membrane docking [GO:0022615]; response to insulin [GO:0032868]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] GO:0001678; GO:0005829; GO:0005886; GO:0006886; GO:0006904; GO:0007269; GO:0007420; GO:0016192; GO:0016323; GO:0016324; GO:0017075; GO:0019905; GO:0022615; GO:0030073; GO:0030141; GO:0031091; GO:0032868; GO:0042581; GO:0043312; GO:0044877; GO:0045335; GO:0045955; GO:0046325; GO:0070062; GO:0070527; GO:0070820; GO:0071346; GO:0098793 protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075] CAYEVSQAHK 0.99409 -30.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2473 0 0 15.9734 0 0 0 0 0 0 0 15.2982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2544 0 0 0 0 0 0 17.5709 0 0 0 0 0 0 0 11.7893 0 0 0 15.5958 0 0 0 0 0 0 0 0 0 17.1873 0 12.6998 0 0 0 0 0 0 0 17.4051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1737 0 0 P33897 ABCD1_HUMAN "ATP-binding cassette sub-family D member 1, EC 3.1.2.-, EC 7.6.2.- (Adrenoleukodystrophy protein, ALDP)" ABCD1 ALD Homo sapiens (Human) alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid elongation [GO:0030497]; fatty acid homeostasis [GO:0055089]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisomal membrane transport [GO:0015919]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of mitochondrial depolarization [GO:0051900]; regulation of oxidative phosphorylation [GO:0002082]; sterol homeostasis [GO:0055092]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA catabolic process [GO:0036113] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of peroxisomal membrane [GO:0005779]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type fatty-acyl-CoA transporter activity [GO:0015607]; acyl-CoA hydrolase activity [GO:0047617]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid elongation [GO:0030497]; fatty acid homeostasis [GO:0055089]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisomal membrane transport [GO:0015919]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of mitochondrial depolarization [GO:0051900]; regulation of oxidative phosphorylation [GO:0002082]; sterol homeostasis [GO:0055092]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA catabolic process [GO:0036113] GO:0000038; GO:0002082; GO:0005324; GO:0005524; GO:0005737; GO:0005765; GO:0005777; GO:0005778; GO:0005779; GO:0005789; GO:0005829; GO:0006635; GO:0007031; GO:0015607; GO:0015910; GO:0015919; GO:0016020; GO:0016887; GO:0019899; GO:0030497; GO:0031966; GO:0031998; GO:0032000; GO:0036109; GO:0036113; GO:0042626; GO:0042758; GO:0042760; GO:0042802; GO:0042803; GO:0043217; GO:0043531; GO:0043651; GO:0046982; GO:0047617; GO:0048471; GO:0051900; GO:0055089; GO:0055092; GO:1900016; GO:1900407; GO:1903427; GO:1990535; GO:2001280 ABC-type fatty-acyl-CoA transporter activity [GO:0015607]; acyl-CoA hydrolase activity [GO:0047617]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; long-chain fatty acid transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CHFKRPR 0.99409 -30.592 0 15.6815 14.6211 0 0 0 0 0 0 0 0 14.4681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1102 0 0 11.031 0 0 0 9.40359 0 0 0 0 0 0 0 0 0 0 0 0 10.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3572 0 0 0 14.2774 0 0 0 0 0 0 11.4792 14.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1855 0 0 0 0 0 0 17.1762 0 0 17.1704 0 0 0 0 0 0 0 0 10.6102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8803 0 0 0 0 0 0 0 0 0 0 0 13.5947 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M2H8 MGAL_HUMAN "Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase, EC 3.2.1.3 (Glucan 1,4-alpha-glucosidase) ]" MGAM2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]" GO:0004339; GO:0004553; GO:0004558; GO:0005975; GO:0016021; GO:0030246 "alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" GGYILPWQEPAMNTHSSR 0.99409 -6.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5074 10.8466 12.9447 0 0 0 0 0 0 0 0 0 0 13.5156 0 0 0 0 0 14.0332 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS81 WDFY4_HUMAN WD repeat- and FYVE domain-containing protein 4 WDFY4 C10orf64 KIAA1607 Homo sapiens (Human) "antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]" early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783] "early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; antigen processing and presentation [GO:0019882]; autophagy [GO:0006914]; CD8-positive, alpha-beta T cell activation [GO:0036037]; cellular response to virus [GO:0098586]" GO:0005769; GO:0005783; GO:0006914; GO:0019882; GO:0036037; GO:0098586 AWQHYLASEK 0.99409 -30.778 0 0 0 0 0 10.2434 0 0 0 0 0 0 0 16.2742 0 0 0 10.8761 0 0 10.8158 0 0 0 0 0 0 0 11.3572 0 0 0 0 0 0 0 0 12.7829 0 0 0 0 0 0 0 0 0 0 0 11.2087 0 13.4576 0 12.1362 0 0 11.6307 0 0 0 0 0 0 0 0 0 13.2923 11.4723 11.7927 13.2242 0 0 0 11.8712 0 0 12.1527 0 11.529 14.3354 11.9545 0 11.5499 0 0 0 14.6397 0 0 0 0 0 12.1046 12.7086 12.9215 13.9318 0 0 12.7063 13.9002 0 14.6628 15.7967 15.7984 15.644 0 0 0 14.5816 0 12.9123 0 0 0 10.8362 0 0 12.5939 0 15.1805 0 13.4353 14.7762 0 0 0 0 13.4569 0 12.2344 0 0 12.9443 0 11.4157 0 0 0 0 15.8349 0 13.0561 10.5166 12.7029 12.7965 0 0 0 12.055 14.5848 10.4359 13.1402 0 16.8298 12.0098 0 12.9928 0 11.2309 0 0 0 0 0 0 10.5865 0 12.5724 0 14.8691 0 0 0 0 12.4872 0 11.9556 0 0 0 Q9HB75 PIDD1_HUMAN "p53-induced death domain-containing protein 1, EC 3.4.21.- (Leucine-rich repeat and death domain-containing protein) [Cleaved into: PIDD-N; PIDD-C; PIDD-CC ]" PIDD1 LRDD PIDD Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase complex [GO:1905369]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase complex [GO:1905369]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; death receptor binding [GO:0005123]; endopeptidase activity [GO:0004175]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autoprocessing [GO:0016540]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; signal transduction [GO:0007165]" GO:0004175; GO:0005123; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006915; GO:0006919; GO:0006974; GO:0006977; GO:0007165; GO:0008625; GO:0016540; GO:0043065; GO:0043066; GO:0043122; GO:0051092; GO:1905369 death receptor binding [GO:0005123]; endopeptidase activity [GO:0004175] EVQRIRHEFR 0.99409 -15.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4095 0 0 0 0 0 14.0912 0 0 0 0 0 0 14.9852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7846 15.1813 15.2848 15.8964 14.6042 0 14.0873 13.2421 14.997 0 0 14.9839 0 0 0 0 0 0 0 0 0 0 0 0 12.0109 0 12.7061 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6599 0 0 0 0 0 0 0 0 12.899 0 12.456 0 0 0 0 0 0 0 0 0 0 0 0 15.2004 0 15.6273 0 15.4594 0 0 0 14.111 0 0 13.393 14.187 14.2899 0 0 13.1661 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC16 ABC3G_HUMAN "DNA dC->dU-editing enzyme APOBEC-3G, EC 3.5.4.38 (APOBEC-related cytidine deaminase, APOBEC-related protein, ARCD) (APOBEC-related protein 9, ARP-9) (CEM-15, CEM15) (Deoxycytidine deaminase, A3G)" APOBEC3G MDS019 Homo sapiens (Human) base conversion or substitution editing [GO:0016553]; cytidine deamination [GO:0009972]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of defense response to virus by host [GO:0002230] apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; cytidine deaminase activity [GO:0004126]; dCTP deaminase activity [GO:0008829]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; base conversion or substitution editing [GO:0016553]; cytidine deamination [GO:0009972]; cytidine to uridine editing [GO:0016554]; defense response to virus [GO:0051607]; DNA cytosine deamination [GO:0070383]; DNA demethylation [GO:0080111]; innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transposition [GO:0010529]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; positive regulation of defense response to virus by host [GO:0002230] GO:0000932; GO:0002230; GO:0003723; GO:0004126; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008829; GO:0009972; GO:0010529; GO:0016553; GO:0016554; GO:0030895; GO:0042802; GO:0045071; GO:0045087; GO:0045869; GO:0047844; GO:0048525; GO:0051607; GO:0070383; GO:0080111; GO:1990904 cytidine deaminase activity [GO:0004126]; dCTP deaminase activity [GO:0008829]; deoxycytidine deaminase activity [GO:0047844]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] FFHWFSK 0.99409 -13.598 0 0 0 0 0 0 0 0 12.5795 0 0 0 0 0 0 0 0 10.37 0 0 0 11.2871 0 0 0 0 11.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2323 13.0986 0 11.1673 13.1443 9.89573 14.1695 0 13.5695 0 0 0 11.7793 0 0 12.6163 0 0 13.4842 0 12.3046 0 0 15.0766 0 0 0 0 0 0 0 0 0 12.6043 0 0 0 0 0 0 0 0 0 0 0 12.4304 0 0 0 0 0 0 0 12.4925 0 0 0 0 10.6403 0 0 0 0 0 0 0 0 0 0 12.6579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCE0 EPG5_HUMAN Ectopic P granules protein 5 homolog EPG5 KIAA1632 Homo sapiens (Human) autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; nucleotide transport [GO:0006862]; toll-like receptor 9 signaling pathway [GO:0034162] GO:0005737; GO:0005764; GO:0006862; GO:0008333; GO:0032456; GO:0034162; GO:0048471; GO:0097352; GO:1990786 AEFMCHMK 0.99409 -31.01 0 0 0 14.9716 0 14.9649 13.4917 0 0 0 0 0 0 0 0 14.479 0 0 0 18.4947 14.8139 14.8814 0 15.2571 0 0 19.0974 0 0 0 0 0 12.7115 0 0 0 0 0 0 16.1978 0 0 0 12.9312 0 18.9047 0 0 0 12.2279 18.9047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9425 0 14.0111 0 0 18.7975 0 0 14.5513 0 0 17.2623 14.9108 0 0 0 0 12.1014 0 0 0 14.2235 11.4974 0 0 13.3625 13.2616 0 13.1232 0 13.6103 15.2496 15.6255 15.9451 19.6392 19.6792 0 14.0923 0 19.725 15.2902 13.7609 0 17.1784 15.6568 0 0 0 13.9577 14.0755 13.8587 14.8394 0 0 0 14.7026 14.243 0 0 12.8325 0 13.5747 0 17.424 0 0 17.2941 17.352 16.3672 13.4472 10.5266 0 14.6094 0 12.9086 13.2747 0 13.6051 0 13.8471 19.5907 13.2487 0 12.4839 19.5215 19.5894 0 13.9071 15.185 0 9.95622 0 11.4078 0 0 10.9604 0 0 14.0087 0 0 0 11.5676 0 0 0 0 19.3816 12.4102 0 12.4458 0 12.5499 0 Q9NY15 STAB1_HUMAN "Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1, FEEL-1) (MS-1 antigen)" STAB1 FEEL1 KIAA0246 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; receptor-mediated endocytosis [GO:0006898] endocytic vesicle membrane [GO:0030666]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endocytic vesicle membrane [GO:0030666]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; receptor-mediated endocytosis [GO:0006898] GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005886; GO:0005887; GO:0006898; GO:0006954; GO:0007155; GO:0007267; GO:0015035; GO:0016525; GO:0030169; GO:0030666; GO:0042742 calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-disulfide reductase activity [GO:0015035]; scavenger receptor activity [GO:0005044] ACCPGYWGSR 0.99409 -15.311 0 11.0934 0 0 0 0 0 0 14.8987 0 15.7449 0 13.1153 0 0 14.5041 0 0 12.995 0 12.5968 0 13.3283 0 0 13.1309 0 0 0 0 12.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5723 0 0 0 0 0 0 0 13.8492 13.9149 0 0 0 0 0 0 0 0 0 0 0 0 10.7011 0 0 0 0 12.1629 0 13.1495 0 0 12.305 0 0 0 12.4055 14.2907 0 0 0 0 12.6281 13.2066 12.1596 0 0 15.0154 0 12.8802 0 13.1345 15.3087 0 0 12.4531 0 13.0622 14.6593 0 0 12.0554 15.0165 13.5451 0 15.1956 0 14.7062 0 15.3063 0 0 0 14.7596 15.0498 0 13.9851 0 14.8673 0 12.8042 0 13.7311 0 0 14.1634 13.8173 14.867 0 0 0 13.5135 0 0 12.7807 0 0 11.3331 0 0 0 13.5571 11.5999 0 0 11.9711 14.778 0 0 12.4447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7669 0 0 0 0 0 13.1894 0 10.1624 14.5512 0 Q9UKL3 C8AP2_HUMAN CASP8-associated protein 2 (FLICE-associated huge protein) CASP8AP2 FLASH KIAA1315 RIP25 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cell cycle [GO:0007049]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor binding [GO:0005123]; peptidase activator activity involved in apoptotic process [GO:0016505]; SUMO polymer binding [GO:0032184]; transcription corepressor activity [GO:0003714]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cell cycle [GO:0007049]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Fas signaling pathway [GO:0036337]; signal transduction [GO:0007165] GO:0003714; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006919; GO:0007049; GO:0007165; GO:0008625; GO:0008656; GO:0016505; GO:0016605; GO:0032184; GO:0036337; GO:0071260; GO:0097190 cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor binding [GO:0005123]; peptidase activator activity involved in apoptotic process [GO:0016505]; SUMO polymer binding [GO:0032184]; transcription corepressor activity [GO:0003714] DASDKMGHSDEVADECFK 0.99409 -28.782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5619 0 0 0 9.61851 0 0 0 9.76899 0 0 11.6834 0 0 0 0 0 0 0 12.3035 0 0 0 0 0 0 0 0 0 13.3098 0 0 0 0 0 0 10.9869 0 16.8149 16.0829 0 0 0 0 0 0 0 0 0 0 13.7769 0 0 0 15.3472 0 13.6469 13.7359 0 12.6938 0 10.9338 0 15.1901 14.7755 14.51 18.9406 0 0 14.1971 0 15.4177 14.9875 0 13.7933 0 0 0 13.5632 14.4163 0 0 12.8434 12.2921 15.1045 14.0545 12.5626 15.0215 0 0 13.8406 0 0 0 0 13.5028 0 0 15.1476 0 9.6175 12.1695 15.2647 13.5784 0 14.7956 0 14.1106 0 12.716 13.1216 0 12.7987 0 0 0 0 0 0 13.5491 13.9654 0 0 13.8501 0 13.6353 0 10.5019 0 11.3709 0 13.5889 10.6903 0 14.1729 0 0 0 0 0 0 0 0 0 12.2668 0 13.2571 0 0 0 12.2276 13.6856 0 0 13.5297 0 0 0 0 10.8992 0 Q9Y6B7 AP4B1_HUMAN AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin) AP4B1 Homo sapiens (Human) protein localization [GO:0008104]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; extrinsic component of membrane [GO:0019898]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein localization [GO:0008104]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] GO:0005802; GO:0005829; GO:0006605; GO:0008104; GO:0016192; GO:0019898; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588; GO:0061938 clathrin binding [GO:0030276] DCSDPNPMVR 0.99409 -15.717 0 0 0 0 0 0 0 0 0 13.5569 0 0 0 0 0 0 0 0 11.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3929 0 0 0 11.4951 0 0 0 0 0 0 0 0 0 0 0 0 15.3745 0 0 0 0 11.2373 0 0 0 0 0 13.2444 14.2447 0 0 13.5709 0 0 14.1096 0 0 13.9673 13.7662 0 13.2436 0 13.3024 12.6676 0 0 0 12.646 0 0 0 0 0 12.9483 0 0 13.7857 0 0 0 0 0 0 0 0 0 0 0 12.0372 0 0 13.7027 0 0 0 13.9601 0 0 0 0 0 13.0114 0 0 0 13.7307 0 0 0 0 0 0 13.7089 0 0 0 0 0 0 0 0 0 12.5173 0 14.8312 0 0 14.4552 0 0 12.0917 14.5661 0 0 16.0959 0 0 0 0 13.8354 0 0 0 0 0 0 0 0 O00592 PODXL_HUMAN "Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1, PC, PCLP-1)" PODXL PCLP PCLP1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell migration [GO:0016477]; epithelial tube formation [GO:0072175]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; podocyte development [GO:0072015]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; regulation of microvillus assembly [GO:0032534] apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; slit diaphragm [GO:0036057] apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; epithelial tube formation [GO:0072175]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; podocyte development [GO:0072015]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; regulation of microvillus assembly [GO:0032534] GO:0001726; GO:0005615; GO:0005730; GO:0005737; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0016324; GO:0016477; GO:0022408; GO:0030027; GO:0030175; GO:0030335; GO:0031528; GO:0032534; GO:0033634; GO:0034451; GO:0036057; GO:0043231; GO:0045121; GO:0070062; GO:0072015; GO:0072175 CGIRLASVPGSQTVVVKEITIHTK 0.9941 -8.7492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RD3 O52E6_HUMAN Olfactory receptor 52E6 (Olfactory receptor OR11-58) OR52E6 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] HIRETVLR 0.9941 -5.2069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6884 0 0 0 0 0 0 0 13.6988 10.0892 0 0 0 0 0 0 12.466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0581 9.95494 0 0 12.2621 0 0 0 0 0 0 0 0 0 12.4864 0 0 0 12.8382 0 0 0 12.6312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4844 0 0 0 0 0 0 13.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8121 0 Q9BXB7 SPT16_HUMAN Spermatogenesis-associated protein 16 (Testis development protein NYD-SP12) SPATA16 Homo sapiens (Human) spermatid development [GO:0007286]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; Golgi apparatus [GO:0005794] acrosomal vesicle [GO:0001669]; Golgi apparatus [GO:0005794]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] GO:0001669; GO:0005794; GO:0007283; GO:0007286 ISSRKLPIFTEHK 0.9941 -8.7402 0 0 0 11.5198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0953 0 0 0 0 0 0 0 11.9395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3822 0 0 0 0 0 0 0 13.7108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6821 0 0 0 0 0 0 0 11.9999 11.9031 13.9916 0 0 0 0 15.1187 0 0 0 14.1308 0 0 0 0 0 0 0 12.2037 0 0 0 0 0 0 0 14.5721 0 0 0 12.4797 14.7836 0 0 0 0 0 0 0 0 11.6755 0 0 0 0 Q9C0D7 ZC12C_HUMAN "Probable ribonuclease ZC3H12C, EC 3.1.-.- (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C)" ZC3H12C KIAA1726 MCPIP3 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]" GO:0003729; GO:0004521; GO:0005634; GO:0036464; GO:0046872; GO:0090502 endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729] CQHMHPHSR 0.9941 -5.1939 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2729 0 0 0 0 0 0 0 15.1208 0 0 0 0 0 10.5877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3126 0 0 0 0 0 10.4077 0 0 13.047 0 0 0 13.2961 0 0 0 0 15.8065 15.8024 0 0 11.9661 0 13.7984 0 0 14.1698 0 0 0 0 12.6662 0 0 0 0 14.7297 0 0 0 0 0 0 0 0 0 0 0 0 15.4025 0 11.6006 0 15.4374 0 0 0 0 0 0 0 0 12.4856 0 0 0 0 0 0 0 0 10.8016 0 0 12.1801 0 13.4691 0 0 0 0 13.2075 0 0 0 0 0 0 0 0 0 10.9798 0 0 0 0 0 0 0 0 0 12.0217 0 13.9703 0 0 0 0 11.1489 0 0 0 0 Q9P2E7 PCD10_HUMAN Protocadherin-10 PCDH10 KIAA1400 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] ALGHSDR 0.9941 -36.567 0 0 0 0 0 0 0 0 0 0 0 0 12.4399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6684 0 0 0 0 0 0 0 13.0459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2131 13.9101 0 0 0 0 0 0 0 0 0 0 0 0 11.3404 0 0 0 11.2653 0 11.5688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1634 10.807 0 12.0611 0 0 0 12.4582 0 0 0 10.7097 0 0 9.78531 0 0 0 0 13.997 13.5505 13.5689 14.1128 12.6861 0 11.873 0 0 0 0 0 0 0 11.7654 0 0 0 0 0 0 0 13.6062 0 12.9607 13.0094 13.5002 0 0 0 0 0 0 0 12.291 0 0 14.2166 0 0 0 0 0 0 0 12.748 12.5039 0 12.6944 0 0 0 0 0 0 0 0 0 11.5285 0 12.6287 0 0 A6NL26 OR5BL_HUMAN Olfactory receptor 5B21 OR5B21 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] MHSAEGQK 0.99411 -8.552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3206 0 12.22 11.9623 0 11.8827 11.6985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75954 TSN9_HUMAN "Tetraspanin-9, Tspan-9 (Tetraspan NET-5)" TSPAN9 NET5 Homo sapiens (Human) focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197] GO:0005886; GO:0005887; GO:0005925; GO:0097197 CCGVTDYTDWYPVLGENTVPDRCCMENSQGCGR 0.99411 -12.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.966 0 0 0 0 0 0 0 12.039 0 0 0 11.8094 0 0 0 0 0 0 0 0 0 0 0 0 10.4797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1344 0 0 0 0 0 0 0 19.2235 19.2525 19.2795 19.3172 0 19.9073 0 19.5525 20.0683 19.9439 19.5022 19.4872 19.484 13.2668 12.971 0 0 0 0 12.1292 19.3753 19.397 19.4149 19.4213 19.3273 19.3249 19.3974 19.3802 19.358 19.3384 19.9174 19.4535 19.366 19.347 0 11.5837 0 11.0861 0 0 0 0 0 0 0 0 19.3225 19.3633 19.3493 19.3976 19.4229 19.38 19.505 19.4978 0 0 0 0 0 0 11.5299 19.4524 19.9462 19.3931 20.3521 0 0 19.3694 19.4166 19.3389 19.3423 0 0 0 10.9009 0 0 0 0 0 0 0 19.5399 12.4983 0 0 16.9215 19.4969 19.5212 0 0 0 16.8856 0 0 0 0 0 0 0 0 0 12.6867 17.2285 0 0 P48643 TCPE_HUMAN "T-complex protein 1 subunit epsilon, TCP-1-epsilon (CCT-epsilon)" CCT5 CCTE KIAA0098 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874] cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998] GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0061077; GO:0070062; GO:0140662; GO:1901998; GO:1904851; GO:1904871; GO:1904874 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] AVANTMRTSLGPNGLDKMMVDK 0.99411 -12.987 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9211 0 0 0 0 0 0 0 0 0 11.1988 12.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4951 0 0 0 0 0 11.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5298 0 0 0 0 0 0 12.3886 0 13.0228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5576 0 0 0 0 14.5712 0 0 0 0 0 0 0 0 0 P51884 LUM_HUMAN "Lumican (Keratan sulfate proteoglycan lumican, KSPG lumican)" LUM LDC SLRR2D Homo sapiens (Human) collagen fibril organization [GO:0030199]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; visual perception [GO:0007601] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; collagen fibril organization [GO:0030199]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; visual perception [GO:0007601] GO:0005201; GO:0005518; GO:0005576; GO:0005583; GO:0005615; GO:0005796; GO:0007601; GO:0030021; GO:0030199; GO:0031012; GO:0032914; GO:0043202; GO:0045944; GO:0062023; GO:0070062 collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021] IKGRVFSK 0.99411 -8.5535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2076 0 0 0 0 0 0 0 0 0 0 0 11.0347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1568 0 0 0 0 0 0 0 0 Q5H9L4 TAF7L_HUMAN "Transcription initiation factor TFIID subunit 7-like (Cancer/testis antigen 40, CT40) (RNA polymerase II TBP-associated factor subunit Q) (TATA box-binding protein-associated factor 50 kDa) (Transcription initiation factor TFIID 50 kDa subunit)" TAF7L TAF2Q Homo sapiens (Human) cell differentiation [GO:0030154]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669] cytoplasm [GO:0005737]; transcription factor TFIID complex [GO:0005669]; cell differentiation [GO:0030154]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermatogenesis [GO:0007283] GO:0005669; GO:0005737; GO:0007283; GO:0030154; GO:0051123 EEEEEDCSEEYLER 0.99411 -10.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8625 0 15.4347 0 0 14.5465 0 0 0 0 14.087 0 0 0 0 0 0 0 0 0 0 0 15.1829 13.4331 13.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8189 0 0 0 0 0 0 0 0 0 0 15.0456 0 0 0 11.9416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7157 0 0 0 0 0 0 0 0 0 0 13.4512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4W9 ZN808_HUMAN Zinc finger protein 808 ZNF808 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CQVCDTAFTWNSQLAR 0.99411 -12.95 0 0 0 0 0 0 0 0 0 0 0 0 12.1127 0 0 0 0 0 11.5938 0 11.8186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.799 0 0 11.4307 0 0 0 0 0 0 11.9026 0 12.7275 0 11.9883 15.1347 0 0 0 0 10.4426 9.87041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4982 14.6619 0 0 11.5328 0 0 14.16 0 0 13.488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.617 0 13.6755 0 0 13.5407 13.8707 0 13.8974 12.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5059 0 0 0 12.7785 0 0 0 0 0 0 0 0 0 12.3975 0 0 0 0 0 0 11.5754 0 0 13.3523 0 0 12.777 0 0 0 0 0 0 0 0 0 10.0338 0 0 10.5945 0 0 Q8N5M4 TTC9C_HUMAN "Tetratricopeptide repeat protein 9C, TPR repeat protein 9C" TTC9C Homo sapiens (Human) HYLLAAVNR 0.99411 -8.0167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TER5 ARH40_HUMAN Rho guanine nucleotide exchange factor 40 (Protein SOLO) ARHGEF40 SOLO Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005829; GO:0005886; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] ALQQPLEQLTRYGRLLEELLR 0.99411 -12.959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6709 14.6584 0 14.2456 0 13.3589 0 0 0 0 0 0 0 0 0 0 11.6851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2948 14.9217 0 0 0 16.4039 15.6132 15.1431 12.1103 0 0 12.7178 0 0 15.5962 14.8773 14.9206 0 0 13.3086 14.3624 0 0 14.592 0 13.6682 14.7913 16.6344 16.0454 15.3644 0 0 13.7723 13.5135 15.4408 14.8527 14.8236 0 0 0 0 0 14.5375 13.4746 14.615 0 0 13.3294 14.551 13.7531 14.6624 14.1679 0 0 0 14.6326 11.499 15.0305 0 15.8078 15.1073 15.2496 0 14.1542 0 0 0 0 0 14.0461 15.0772 0 15.1494 0 0 0 0 13.9372 0 0 0 0 12.3935 12.9172 0 0 0 13.5606 0 0 0 0 0 13.7077 0 0 0 0 14.0357 14.2252 0 0 0 0 14.3761 12.3314 Q96BQ1 FAM3D_HUMAN Protein FAM3D FAM3D UNQ567/PRO1130 Homo sapiens (Human) negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin secretion [GO:0046676] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin secretion [GO:0046676] GO:0005125; GO:0005576; GO:0005615; GO:0046676; GO:0070093 cytokine activity [GO:0005125] MIMSPVK 0.99411 -10.89 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4494 0 0 0 Q96EY5 MB12A_HUMAN Multivesicular body subunit 12A (CIN85/CD2AP family-binding protein) (ESCRT-I complex subunit MVB12A) (Protein FAM125A) MVB12A CFBP FAM125A Homo sapiens (Human) endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; receptor catabolic process [GO:0032801]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; virus maturation [GO:0019075] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; vesicle [GO:0031982] centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; vesicle [GO:0031982]; lipid binding [GO:0008289]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; receptor catabolic process [GO:0032801]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; virus maturation [GO:0019075] GO:0000813; GO:0005634; GO:0005813; GO:0005829; GO:0008289; GO:0010008; GO:0016236; GO:0017124; GO:0019075; GO:0031902; GO:0031982; GO:0032510; GO:0032801; GO:0036258; GO:0039702; GO:0042058; GO:0043130; GO:0043162; GO:0043231; GO:0043328; GO:0046755; GO:0070062; GO:0090148 lipid binding [GO:0008289]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130] AKAPRPVPK 0.99411 -10.89 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SF2 TCPQM_HUMAN T-complex protein 1 subunit theta-like 2 CCT8L2 CESK1 Homo sapiens (Human) protein folding [GO:0006457] chaperonin-containing T-complex [GO:0005832] chaperonin-containing T-complex [GO:0005832]; anion channel activity [GO:0005253]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; calcium-activated potassium channel activity [GO:0015269]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] GO:0005253; GO:0005524; GO:0005832; GO:0006457; GO:0015269; GO:0051082; GO:0140662 anion channel activity [GO:0005253]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; calcium-activated potassium channel activity [GO:0015269]; unfolded protein binding [GO:0051082] LEGPSGPAFLAFAWALK 0.99411 -8.0389 0 0 0 0 0 0 0 12.2713 0 0 0 0 0 0 0 0 10.9511 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5621 0 0 0 0 0 0 0 0 0 0 0 0 0 11.752 0 11.8591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8781 0 13.338 0 0 0 0 13.9215 0 0 0 0 0 14.2225 0 0 0 0 13.9563 0 0 0 13.0814 0 0 0 0 13.3136 0 0 13.122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8334 0 0 13.2102 0 0 0 0 0 0 0 0 0 0 12.7935 0 0 0 0 0 0 12.6842 0 0 0 0 Q9BPX3 CND3_HUMAN "Condensin complex subunit 3 (Chromosome-associated protein G) (Condensin subunit CAP-G, hCAP-G) (Melanoma antigen NY-MEL-3) (Non-SMC condensin I complex subunit G) (XCAP-G homolog)" NCAPG CAPG NYMEL3 Homo sapiens (Human) cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] "condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]" "condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]" GO:0000779; GO:0000793; GO:0000794; GO:0000796; GO:0005634; GO:0005737; GO:0005829; GO:0007076; GO:0016020; GO:0051301; GO:0051984; GO:1905820; GO:1905821 ALEKIKIQLEK 0.99411 -12.951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4793 0 0 10.4344 0 0 0 0 0 0 0 0 13.0254 0 16.8509 0 0 0 0 0 0 13.1762 0 0 0 13.0831 0 0 0 0 0 0 13.6849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0889 0 0 13.73 0 14.4475 11.5274 0 13.4293 10.8685 0 12.3728 13.3346 0 13.2743 15.3496 0 0 14.5701 16.0636 16.2721 13.796 13.4775 0 0 0 0 11.6569 0 0 0 14.1098 0 0 10.0745 0 0 0 0 0 0 0 17.4863 0 0 0 0 13.8033 13.9784 12.7603 13.3929 10.648 0 13.4472 14.2239 0 12.7311 0 13.629 0 0 0 0 0 12.5377 0 13.2034 12.196 0 14.8045 0 0 12.2678 11.5682 0 0 0 0 0 0 0 0 0 0 0 12.2382 0 0 0 0 12.4138 13.3332 12.1984 12.2667 0 0 0 0 0 0 0 0 0 0 0 12.5715 0 13.4057 0 0 11.1062 0 0 0 Q9H2K2 TNKS2_HUMAN "Poly [ADP-ribose] polymerase tankyrase-2, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 6, ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2, EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2, TANK2) (Tankyrase-like protein) (Tankyrase-related protein)" TNKS2 PARP5B TANK2 TNKL Homo sapiens (Human) "multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; protein N-terminus binding [GO:0047485]; multicellular organism growth [GO:0035264]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; regulation of multicellular organism growth [GO:0040014]; Wnt signaling pathway [GO:0016055]" GO:0000139; GO:0000209; GO:0000242; GO:0000781; GO:0003950; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006471; GO:0016055; GO:0019899; GO:0032212; GO:0035264; GO:0040014; GO:0046872; GO:0047485; GO:0048471; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:1904355; GO:1904357; GO:1990404 enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; protein N-terminus binding [GO:0047485] AVLTGEYK 0.99411 -29.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8594 13.0471 10.4045 0 0 0 0 0 0 0 11.5886 0 0 0 0 0 0 0 0 0 0 11.6408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0421 0 0 13.5677 14.128 0 13.0909 0 0 0 0 0 0 0 0 0 0 0 0 11.8728 0 0 12.4092 14.5377 0 13.4039 0 13.6574 0 0 0 0 0 11.8259 11.3461 0 0 0 0 0 13.7011 0 13.7207 13.7807 0 0 0 13.9366 0 12.9412 13.3106 0 11.6576 0 0 0 0 0 0 13.7337 0 0 15.4207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9381 0 0 0 17.4762 17.2077 0 16.6505 16.5459 0 0 15.8745 13.8991 0 15.1355 17.1565 17.7203 17.4291 0 0 0 13.7704 15.7373 0 0 0 0 Q9H6E5 STPAP_HUMAN "Speckle targeted PIP5K1A-regulated poly(A) polymerase, Star-PAP, EC 2.7.7.19 (RNA-binding motif protein 21, RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1, U6-TUTase, EC 2.7.7.52)" TUT1 RBM21 Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; RNA 3'-end processing [GO:0031123]; snRNA processing [GO:0016180]; U6 snRNA 3'-end processing [GO:0034477] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; U6 snRNA binding [GO:0017070]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; RNA 3'-end processing [GO:0031123]; snRNA processing [GO:0016180]; U6 snRNA 3'-end processing [GO:0034477] GO:0003723; GO:0003730; GO:0004652; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0006378; GO:0016180; GO:0016607; GO:0016779; GO:0017070; GO:0019899; GO:0031123; GO:0034477; GO:0046872; GO:0050265; GO:0098789; GO:1990817 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nucleotidyltransferase activity [GO:0016779]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA adenylyltransferase activity [GO:1990817]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; U6 snRNA binding [GO:0017070] AAANYCR 0.99411 -37.078 0 0 0 0 0 0 0 9.5109 0 0 12.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0114 0 0 0 0 0 0 0 0 0 11.559 0 0 0 0 0 0 0 12.9979 0 0 0 10.2921 0 0 0 0 0 0 0 11.8874 12.3355 12.6517 0 0 0 0 0 0 0 0 0 0 13.2917 0 0 0 14.089 14.6329 0 0 0 0 0 0 0 0 13.9243 0 13.3058 0 0 0 0 0 0 0 13.569 11.9917 14.0965 0 0 0 0 0 0 0 10.1898 0 0 14.0996 14.0097 13.8842 13.3767 13.9593 13.4881 0 11.9391 14.2144 13.3385 0 13.6863 10.6392 0 0 0 11.029 0 14.3343 13.9774 0 14.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 13.026 14.1921 14.0405 0 0 0 0 0 0 15.1474 0 0 0 14.0875 12.1834 0 0 0 15.3609 15.0387 14.1699 14.1335 0 0 0 0 0 Q9NRA8 4ET_HUMAN "Eukaryotic translation initiation factor 4E transporter, 4E-T, eIF4E transporter (Eukaryotic translation initiation factor 4E nuclear import factor 1)" EIF4ENIF1 Homo sapiens (Human) miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA stabilization [GO:0048255]; negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106289]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; P-body assembly [GO:0033962]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein import into nucleus [GO:0006606]; stem cell population maintenance [GO:0019827]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605]; kinase binding [GO:0019900]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA stabilization [GO:0048255]; negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106289]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; P-body assembly [GO:0033962]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein import into nucleus [GO:0006606]; stem cell population maintenance [GO:0019827]; translation [GO:0006412] GO:0000932; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006606; GO:0016020; GO:0016605; GO:0016607; GO:0017148; GO:0019827; GO:0019900; GO:0030182; GO:0033962; GO:0035278; GO:0043231; GO:0045665; GO:0048255; GO:0060213; GO:0106289 kinase binding [GO:0019900]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723] DHRLSDK 0.99411 -29.715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4668 0 0 13.4264 0 0 0 12.0823 0 0 0 0 0 0 12.8854 12.4781 0 13.4789 13.6709 12.8624 12.1279 0 0 0 13.2046 13.9255 0 0 0 0 0 11.6356 0 0 0 0 0 0 0 12.3858 0 0 0 0 11.6515 0 12.3855 13.0973 0 14.7069 0 0 0 12.1889 0 0 12.169 0 0 0 0 0 0 0 0 0 12.4623 0 0 12.4046 13.0267 13.2091 0 0 0 0 12.94 0 0 0 0 0 0 13.9778 0 11.314 0 0 0 0 0 0 14.6633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3499 Q9NWF9 RN216_HUMAN "E3 ubiquitin-protein ligase RNF216, EC 2.3.2.27 (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (Ubiquitin-conjugating enzyme 7-interacting protein 1) (Zinc finger protein inhibiting NF-kappa-B)" RNF216 TRIAD3 UBCE7IP1 ZIN Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648] GO:0005634; GO:0005654; GO:0005829; GO:0006915; GO:0032480; GO:0032648; GO:0043161; GO:0046872; GO:0050691; GO:0061630; GO:0070936 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] CGAQMCYLCR 0.99411 -29.775 0 0 0 0 0 10.6324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9814 0 12.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4081 0 0 0 0 0 0 0 0 0 0 0 0 14.3527 13.1232 0 0 0 19.7634 0 0 0 0 0 0 0 0 14.1841 0 0 0 0 0 0 0 0 0 19.4823 0 14.9165 16.5293 0 0 18.909 0 0 0 0 0 0 0 0 12.0849 0 12.2023 0 0 0 0 0 0 0 0 0 0 0 10.6714 0 0 0 0 13.8868 0 0 0 0 0 0 0 0 0 0 0 Q9Y2Y1 RPC10_HUMAN "DNA-directed RNA polymerase III subunit RPC10, RNA polymerase III subunit C10 (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit, RPC12.5) (RNA polymerase III subunit C11, HsC11p, RPC11, hRPC11)" POLR3K RPC11 My010 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779] GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005730; GO:0005829; GO:0006383; GO:0006386; GO:0008270; GO:0042779; GO:0045087; GO:0051607 DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] CCNAQCGHR 0.99411 -8.0358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D2P6 GRD2I_HUMAN "Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)" GRID2IP Homo sapiens (Human) long-term synaptic depression [GO:0060292] anchoring junction [GO:0070161]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; postsynaptic membrane [GO:0045211]; long-term synaptic depression [GO:0060292] GO:0045211; GO:0060292; GO:0070161 AQGAQRLR 0.99412 -11.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9795 0 0 0 0 0 11.4105 0 0 13.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7136 0 O14975 S27A2_HUMAN "Long-chain fatty acid transport protein 2 (Arachidonate--CoA ligase, EC 6.2.1.15) (Fatty acid transport protein 2, FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase, EC 6.2.1.3) (Phytanate--CoA ligase, EC 6.2.1.24) (Solute carrier family 27 member 2) (THCA-CoA ligase, EC 6.2.1.7) (Very long-chain acyl-CoA synthetase, VLACS, VLCS, EC 6.2.1.-) (Very long-chain-fatty-acid-CoA ligase)" SLC27A2 ACSVL1 FACVL1 FATP2 VLACS Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; very long-chain fatty acid catabolic process [GO:0042760] GO:0001561; GO:0001676; GO:0004467; GO:0005324; GO:0005524; GO:0005778; GO:0005779; GO:0005783; GO:0005788; GO:0005789; GO:0005829; GO:0005886; GO:0006635; GO:0006699; GO:0015245; GO:0019899; GO:0030176; GO:0031957; GO:0035579; GO:0042760; GO:0044539; GO:0047676; GO:0047747; GO:0050197; GO:0070062; GO:0070251; GO:0097089 arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; cholate-CoA ligase activity [GO:0047747]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; very long-chain fatty acid-CoA ligase activity [GO:0031957] DEPVRDENGYCVR 0.99412 -11.196 0 0 0 0 0 0 0 11.6933 11.8466 0 0 13.1426 0 0 0 0 0 0 13.1145 0 0 0 12.3645 0 12.6284 12.1119 13.873 13.5708 13.0791 0 13.2434 12.8722 0 0 12.6943 13.6785 12.6488 12.1683 13.1291 13.7191 11.121 11.2326 13.675 12.9549 14.3603 13.3582 0 13.6774 0 12.1704 12.9481 0 0 0 0 0 0 0 13.0684 12.2001 0 0 0 12.1909 12.4265 13.034 12.6961 11.6369 12.6926 0 0 0 0 0 13.3737 0 13.3014 13.18 15.0754 15.6087 11.8275 0 12.2214 12.4614 11.9842 0 11.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3179 0 0 0 0 0 0 0 0 0 11.9854 0 0 0 0 12.475 0 12.5196 0 0 0 0 0 0 0 0 12.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8296 0 0 0 13.0192 13.0534 13.4704 0 0 14.1372 13.6063 13.3394 0 12.4764 10.9945 0 0 0 0 0 0 0 0 O15541 R113A_HUMAN "E3 ubiquitin-protein ligase RNF113A, EC 2.3.2.27 (Cwc24 homolog) (RING finger protein 113A) (Zinc finger protein 183)" RNF113A RNF113 ZNF183 Homo sapiens (Human) "DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]" GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0006281; GO:0016567; GO:0016607; GO:0018276; GO:0034247; GO:0046872; GO:0061630; GO:0070100; GO:0071005 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] CYVCDQQTNGVFNPAK 0.99412 -8.0773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1972 0 13.3663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6061 0 0 0 0 13.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95948 ONEC2_HUMAN "One cut domain family member 2 (Hepatocyte nuclear factor 6-beta, HNF-6-beta) (One cut homeobox 2) (Transcription factor ONECUT-2, OC-2)" ONECUT2 HNF6B Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; mesenchymal stem cell migration [GO:1905319]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; transforming growth factor beta receptor signaling pathway [GO:0007179] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; mesenchymal stem cell migration [GO:1905319]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0005634; GO:0005654; GO:0006357; GO:0007179; GO:0009887; GO:0015629; GO:0030512; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271; GO:1905319; GO:1905322; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ETFRRMWK 0.99412 -11.183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1675 0 0 0 0 13.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4114 0 14.2258 0 P00540 MOS_HUMAN "Proto-oncogene serine/threonine-protein kinase mos, EC 2.7.11.1 (Oocyte maturation factor mos) (Proto-oncogene c-Mos)" MOS Homo sapiens (Human) chromatin organization [GO:0006325]; establishment of meiotic spindle orientation [GO:0051296]; MAPK cascade [GO:0000165]; meiotic spindle organization [GO:0000212]; negative regulation of metaphase/anaphase transition of meiotic cell cycle [GO:1902103]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; regulation of meiotic nuclear division [GO:0040020]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; chromatin organization [GO:0006325]; establishment of meiotic spindle orientation [GO:0051296]; MAPK cascade [GO:0000165]; meiotic spindle organization [GO:0000212]; negative regulation of metaphase/anaphase transition of meiotic cell cycle [GO:1902103]; positive regulation of MAPK cascade [GO:0043410]; protein autophosphorylation [GO:0046777]; regulation of meiotic nuclear division [GO:0040020]; signal transduction [GO:0007165] GO:0000165; GO:0000212; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006325; GO:0007165; GO:0040020; GO:0043410; GO:0046777; GO:0051296; GO:0106310; GO:1902103 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GEGVTPK 0.99412 -12.999 12.2046 0 11.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6548 0 0 0 0 0 0 0 0 11.586 13.0299 13.6089 0 0 0 0 0 0 0 0 0 13.5094 0 0 0 9.64884 0 0 0 0 0 0 0 0 0 11.2728 0 0 0 0 0 0 0 10.0776 0 0 0 0 0 0 13.8103 0 0 0 0 0 0 0 0 0 0 0 12.4175 0 11.7689 0 0 0 0 0 0 0 0 11.7766 0 0 0 0 0 0 0 0 0 0 14.1434 11.0787 0 0 0 11.0171 0 0 11.1752 0 0 11.2759 0 0 0 0 0 0 0 0 0 0 12.287 0 0 0 11.9208 0 0 0 0 0 11.2013 0 0 0 0 0 0 0 12.1485 0 0 0 0 0 11.8865 12.2177 0 0 0 0 10.2288 12.4224 0 0 0 0 15.3007 0 0 0 0 0 0 0 0 0 0 12.3925 0 0 0 0 0 0 0 0 P19429 TNNI3_HUMAN "Troponin I, cardiac muscle (Cardiac troponin I)" TNNI3 TNNC1 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; heart contraction [GO:0060047]; heart development [GO:0007507]; muscle contraction [GO:0006936]; negative regulation of ATP-dependent activity [GO:0032780]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of smooth muscle contraction [GO:0006940]; regulation of systemic arterial blood pressure by ischemic conditions [GO:0001980]; skeletal muscle contraction [GO:0003009]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cardiac myofibril [GO:0097512]; cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; sarcomere [GO:0030017]; troponin complex [GO:0005861] cardiac myofibril [GO:0097512]; cardiac Troponin complex [GO:1990584]; cytosol [GO:0005829]; sarcomere [GO:0030017]; troponin complex [GO:0005861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; troponin C binding [GO:0030172]; troponin T binding [GO:0031014]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; heart contraction [GO:0060047]; heart development [GO:0007507]; muscle contraction [GO:0006936]; negative regulation of ATP-dependent activity [GO:0032780]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of smooth muscle contraction [GO:0006940]; regulation of systemic arterial blood pressure by ischemic conditions [GO:0001980]; skeletal muscle contraction [GO:0003009]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0001570; GO:0001980; GO:0003009; GO:0003779; GO:0005829; GO:0005861; GO:0006874; GO:0006936; GO:0006940; GO:0007507; GO:0010882; GO:0019855; GO:0019901; GO:0019904; GO:0030017; GO:0030172; GO:0031014; GO:0032780; GO:0046872; GO:0048306; GO:0051015; GO:0055010; GO:0060047; GO:0060048; GO:0097512; GO:1990584 actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium channel inhibitor activity [GO:0019855]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; troponin C binding [GO:0030172]; troponin T binding [GO:0031014] AHLKQVKK 0.99412 -13.039 0 11.4263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5827 0 0 0 0 0 0 0 0 0 10.9742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3808 0 0 0 13.1416 14.1747 0 0 13.8269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2499 13.6208 14.4309 12.7655 0 0 0 0 13.4679 0 0 0 13.0113 11.6002 0 0 0 0 0 0 11.0743 14.7961 11.8752 0 0 0 0 0 0 0 10.7371 0 0 0 11.6873 0 13.1613 0 14.2138 0 0 0 0 0 0 0 0 0 13.3201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9911 0 0 0 0 0 0 0 0 12.752 0 0 0 0 0 0 0 0 0 0 13.6731 0 0 12.5765 0 0 0 0 12.5239 0 0 0 0 P40145 ADCY8_HUMAN "Adenylate cyclase type 8, EC 4.6.1.1 (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8, AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase)" ADCY8 Homo sapiens (Human) activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; activation of protein kinase A activity [GO:0034199]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to morphine [GO:0071315]; G protein-coupled opioid receptor signaling pathway [GO:0038003]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; memory [GO:0007613]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synaptic plasticity [GO:0031915]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cellular response to stress [GO:0080135]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; signal transduction [GO:0007165] GO:0003779; GO:0004016; GO:0005516; GO:0005524; GO:0005886; GO:0005887; GO:0005901; GO:0005905; GO:0006171; GO:0007165; GO:0007189; GO:0007204; GO:0007611; GO:0007613; GO:0007616; GO:0007626; GO:0008294; GO:0010255; GO:0014069; GO:0016020; GO:0016323; GO:0016324; GO:0030424; GO:0030425; GO:0030665; GO:0031915; GO:0032793; GO:0032809; GO:0034199; GO:0035556; GO:0035774; GO:0038003; GO:0042593; GO:0042803; GO:0044853; GO:0045121; GO:0046872; GO:0046982; GO:0046983; GO:0048786; GO:0050796; GO:0051259; GO:0051260; GO:0051480; GO:0051721; GO:0060076; GO:0070161; GO:0071277; GO:0071315; GO:0071333; GO:0071377; GO:0080135; GO:0098685; GO:0098686; GO:0098978; GO:0099056; GO:0150076; GO:1900273; GO:1900454; GO:1904322 actin binding [GO:0003779]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721] GILLGFFTGIEVVICALVVVRK 0.99412 -13.044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4082 13.9792 0 0 0 0 11.8391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2838 0 0 0 12.9722 0 0 0 12.3509 11.0847 0 12.4898 0 0 0 0 0 0 12.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5034 0 0 0 0 0 0 0 0 0 12.8407 0 0 0 0 13.3014 12.8964 13.6689 12.7947 0 0 12.1347 0 0 0 0 0 12.4896 0 0 0 0 11.5195 13.0803 0 12.8074 12.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.965 0 0 0 0 12.5744 0 0 10.9247 11.9428 Q01415 GALK2_HUMAN "N-acetylgalactosamine kinase, EC 2.7.1.157 (GalNAc kinase) (Galactokinase 2)" GALK2 GK2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858]; carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012] GO:0004335; GO:0005524; GO:0005829; GO:0005975; GO:0006012; GO:0033858 ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858] LAAKLLAK 0.99412 -8.0687 0 11.1936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8201 0 11.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03924 ZN117_HUMAN "Zinc finger protein 117 (Provirus-linked krueppel, h-PLK) (Zinc finger protein HPF9)" ZNF117 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CDECGKAST 0.99412 -15.563 0 0 0 0 0 0 0 0 0 0 0 11.1795 0 10.8507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2677 0 0 0 0 0 0 0 0 0 0 Q14162 SREC_HUMAN "Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1, SREC-I)" SCARF1 KIAA0149 SREC Homo sapiens (Human) cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898] endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898] GO:0004888; GO:0005044; GO:0005886; GO:0006707; GO:0006898; GO:0007155; GO:0010976; GO:0016021; GO:0016322; GO:0016358; GO:0030169; GO:0030666; GO:0048680 low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888] CACRPGWWGPECQQQCECVRGR 0.99412 -9.2987 0 0 0 0 0 0 0 0 0 10.7512 0 0 0 0 0 0 12.0817 0 0 10.9736 0 12.7342 13.4952 0 0 0 0 0 0 0 0 0 0 0 13.6196 0 0 11.9063 0 0 0 0 0 11.3501 0 0 0 0 0 0 0 0 11.9814 0 0 12.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4093 10.992 0 13.9817 0 0 13.0303 0 13.3467 13.6952 11.9215 0 0 16.2175 13.3397 16.1964 0 11.7356 0 0 0 18.4469 16.4235 0 15.2192 0 12.4532 0 0 11.9164 0 0 0 14.5143 11.5733 13.2938 15.6766 11.7154 13.5693 13.9638 14.8817 13.5889 0 15.5387 0 0 0 0 0 14.0297 0 0 0 0 14.1918 13.734 14.7734 0 0 13.3826 0 12.5646 0 12.7237 0 0 0 0 0 13.6211 0 0 0 0 0 0 10.9831 12.2972 0 0 14.3804 0 0 0 12.6037 0 0 13.5407 14.2007 13.2584 0 0 0 12.4117 0 0 0 0 13.9842 0 0 0 0 14.185 0 0 12.6838 11.6957 0 0 Q5TZA2 CROCC_HUMAN Rootletin (Ciliary rootlet coiled-coil protein) CROCC KIAA0445 Homo sapiens (Human) cellular homeostasis [GO:0019725]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365] 9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219] 9+2 motile cilium [GO:0097729]; actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; subapical part of cell [GO:0120219]; actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cellular homeostasis [GO:0019725]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of localization in cell [GO:0051649]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365] GO:0001917; GO:0003779; GO:0005198; GO:0005200; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019725; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051649; GO:0051656; GO:0070062; GO:0097729; GO:0120219; GO:1903566 actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] AEAALEKQALLQAQLEEQLR 0.99412 -28.481 0 0 0 13.8464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8395 0 0 12.599 0 0 0 0 0 12.3134 0 0 0 0 10.8893 0 0 0 0 0 0 0 0 0 0 0 11.8898 0 0 0 0 0 0 9.28466 0 0 0 11.3635 0 0 11.0333 12.4784 0 0 0 0 15.4559 0 10.1522 0 0 0 0 16.1238 0 0 14.9234 0 13.8439 11.5039 0 0 0 13.9975 0 13.3487 0 0 13.5422 14.7182 12.2368 0 13.44 12.3175 0 0 0 0 0 0 12.1976 0 0 0 12.8832 0 13.8991 0 13.3415 13.0686 0 12.9506 0 0 0 0 14.763 0 0 0 13.493 0 11.1199 0 0 13.7451 0 0 0 0 0 0 0 0 0 0 0 0 12.3214 0 0 0 0 0 0 0 0 11.9062 13.8641 0 0 0 0 0 0 0 0 0 0 0 11.642 12.0024 0 13.182 0 0 0 0 0 10.621 0 Q6IQ21 ZN770_HUMAN Zinc finger protein 770 ZNF770 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEKVFPSISKLK 0.99412 -28.417 0 0 0 0 0 0 9.44386 12.7606 0 0 0 9.96824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7819 0 0 0 0 0 11.4046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.31816 0 0 0 0 0 0 13.8455 0 13.8216 0 0 0 0 0 0 12.707 13.5381 0 14.0961 0 0 13.7905 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8721 13.1163 0 13.8408 0 0 0 0 13.3748 13.9848 0 0 13.3147 0 13.8842 0 0 13.833 0 0 0 0 13.619 12.9094 12.9242 0 0 0 0 13.5419 13.8248 13.0627 13.933 12.6032 12.8512 11.3591 12.9211 12.5094 0 13.4182 0 13.9897 0 0 13.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6IQ22 RAB12_HUMAN Ras-related protein Rab-12 RAB12 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to insulin stimulus [GO:0032869]; endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021] autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagy [GO:0006914]; cellular response to insulin stimulus [GO:0032869]; endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904] GO:0000139; GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005768; GO:0005776; GO:0005794; GO:0005829; GO:0005886; GO:0006904; GO:0006914; GO:0008021; GO:0008333; GO:0009306; GO:0017157; GO:0019003; GO:0030163; GO:0032482; GO:0032593; GO:0032869; GO:0043231; GO:0055037; GO:0055038; GO:0072659 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] AGGGGGLGAGSPALSGGQGR 0.99412 -8.0461 0 0 0 0 0 10.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2997 0 0 0 0 12.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3179 0 0 0 0 0 0 0 11.4245 0 0 0 0 0 12.5907 15.6566 0 0 0 0 0 0 11.4415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7346 0 0 0 13.6028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2672 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWH4 GAK1B_HUMAN Golgi-associated kinase 1B (Expressed in nerve and epithelium during development) (Protein FAM198B) GASK1B C4orf18 ENED FAM198B AD021 UNQ2512/PRO6001 Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] GO:0000139; GO:0005794; GO:0016021 CDDQGSAALAHIIQRK 0.99412 -8.3547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3924 0 0 12.3989 16.4889 13.423 0 0 0 0 0 0 0 0 0 0 12.9957 0 0 0 13.8403 0 0 0 0 0 13.5272 13.4917 0 0 0 0 0 0 0 0 0 0 0 0 13.3177 0 0 0 0 0 12.8828 0 0 0 0 0 0 12.5704 0 16.2985 0 0 0 0 0 12.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3955 0 0 0 0 0 0 0 0 12.1658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8R7 AL14E_HUMAN ARL14 effector protein (ARF7 effector protein) ARL14EP ARF7EP C11orf46 Homo sapiens (Human) cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0005925; GO:0043231 CGAECRCDRK 0.99412 -13.052 0 0 0 0 0 0 0 0 0 0 10.5751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.69 11.4809 0 12.7593 13.9036 0 0 0 0 0 0 0 11.1879 0 0 13.4764 13.3727 0 0 0 12.8068 12.7641 0 0 13.2264 0 0 0 0 0 11.1895 0 0 0 0 0 0 0 0 0 0 0 0 20.2474 0 0 0 0 0 0 13.7262 0 0 0 11.7711 0 12.9732 0 0 0 0 0 0 0 0 13.7662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3385 0 14.2258 0 0 0 0 0 0 Q96M95 CCD42_HUMAN Coiled-coil domain-containing protein 42 CCDC42 CCDC42A Homo sapiens (Human) spermatid development [GO:0007286] spermatid development [GO:0007286] GO:0007286 KEQQRVR 0.99412 -11.193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7559 0 12.7576 0 0 0 13.4201 13.4419 0 0 0 0 0 0 13.1489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6626 0 0 0 0 0 0 0 0 13.3333 0 0 0 0 0 0 0 0 13.5873 0 0 0 0 0 0 0 0 0 0 13.8452 15.8916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1528 0 0 0 0 0 0 0 0 0 0 12.795 0 0 0 0 0 0 0 Q96PQ5 IPP2L_HUMAN "Putative protein phosphatase inhibitor 2-like protein 1 (Protein phosphatase 1, regulatory subunit 2 pseudogene 1)" PPP1R2P1 Homo sapiens (Human) glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966] protein phosphatase inhibitor activity [GO:0004864]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966] GO:0004864; GO:0005977; GO:0009966; GO:0043666 protein phosphatase inhibitor activity [GO:0004864] DLHDDDK 0.99412 -11.184 0 0 0 0 0 0 0 0 0 12.3201 14.9623 12.5575 14.5847 12.3009 0 12.4106 0 0 0 0 0 0 0 0 0 13.4181 0 0 0 0 12.4414 0 0 0 14.3412 0 10.9933 11.8886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0181 0 0 13.1766 17.705 14.3491 14.2146 0 0 0 14.3764 0 12.2972 0 0 0 0 0 0 0 0 0 0 Q9BZL6 KPCD2_HUMAN "Serine/threonine-protein kinase D2, EC 2.7.11.13 (nPKC-D2)" PRKD2 PKD2 HSPC187 Homo sapiens (Human) adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; regulation of T cell apoptotic process [GO:0070232]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; regulation of T cell apoptotic process [GO:0070232]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0001525; GO:0001938; GO:0002250; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007155; GO:0010595; GO:0018105; GO:0018107; GO:0030148; GO:0030949; GO:0032743; GO:0032757; GO:0032793; GO:0033138; GO:0035556; GO:0035924; GO:0038033; GO:0043536; GO:0045743; GO:0045766; GO:0045785; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0050852; GO:0050862; GO:0051091; GO:0051092; GO:0061154; GO:0070232; GO:0070374; GO:0089700; GO:0106310; GO:1901727; GO:1902533; GO:2000573; GO:2001028 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FLITQILVALRHLHFKNIVHCDLK 0.99412 -15.566 0 0 0 0 0 0 0 0 12.106 0 0 0 0 0 12.2428 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1726 0 0 0 0 0 0 0 0 0 0 0 0 10.3691 0 0 0 0 0 0 13.7749 14.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0347 13.7145 13.7881 0 14.0546 13.477 0 0 14.7839 0 13.9057 0 0 13.9826 13.632 0 0 0 0 0 0 0 13.5188 0 0 0 0 0 0 14.1566 13.1798 14.1299 0 0 0 13.8729 14.6344 10.1522 13.7594 9.79667 0 13.4453 0 0 0 13.6468 14.3366 0 13.2577 13.4601 13.0516 13.3518 13.2026 0 12.7361 14.2304 13.635 0 13.9763 13.343 0 14.7957 0 0 0 12.5652 13.3794 0 0 13.0665 13.3682 0 0 0 12.6601 0 0 0 0 0 0 0 12.5716 12.8522 0 0 0 0 0 0 0 0 12.3425 0 0 0 0 0 0 0 0 12.1974 13.2172 0 0 0 11.7537 0 Q9C0B0 UNK_HUMAN RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5) UNK KIAA1753 ZC3H5 ZC3HDC5 Homo sapiens (Human) cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] cytoplasm [GO:0005737]; polysome [GO:0005844] cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764] GO:0001701; GO:0001764; GO:0003723; GO:0005737; GO:0005844; GO:0046872; GO:0048667; GO:1905538; GO:1990715; GO:2000766 metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723] CENGDACQYCHTR 0.99412 -28.494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80879 0 0 0 0 0 10.4486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.655 0 0 0 0 0 0 13.084 0 0 0 0 11.5062 0 11.194 12.4054 0 0 0 13.0878 0 0 0 0 0 0 0 0 0 0 11.5481 0 0 13.963 13.2686 0 0 0 0 0 0 0 0 12.9616 0 0 0 13.0346 0 0 0 12.6571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8932 0 0 0 0 0 12.1745 12.8193 0 12.2117 0 13.1892 0 0 0 0 12.3545 0 0 0 0 0 0 0 0 0 0 0 11.7089 13.1553 0 0 0 0 0 0 10.5403 0 0 0 0 0 0 0 0 0 11.1011 0 0 0 0 0 0 0 0 Q9H488 OFUT1_HUMAN "GDP-fucose protein O-fucosyltransferase 1, EC 2.4.1.221 (Peptide-O-fucosyltransferase 1, O-FucT-1)" POFUT1 FUT12 KIAA0180 Homo sapiens (Human) "angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription, DNA-templated [GO:0006355]; somitogenesis [GO:0001756]" endoplasmic reticulum [GO:0005783]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription, DNA-templated [GO:0006355]; somitogenesis [GO:0001756]" GO:0001525; GO:0001756; GO:0005783; GO:0006004; GO:0006355; GO:0006493; GO:0007219; GO:0007399; GO:0007507; GO:0008417; GO:0008593; GO:0016020; GO:0016266; GO:0036066; GO:0046922 fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922] EIQRAVK 0.99412 -15.564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5831 0 0 0 0 0 0 0 0 15.3905 0 15.1452 17.6177 17.0835 17.0844 0 0 0 0 0 0 0 0 16.315 0 0 0 0 0 0 0 0 0 13.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2159 13.4013 13.7556 0 14.9815 0 0 0 0 0 0 0 0 0 13.432 0 0 0 0 13.1067 0 14.3905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7231 15.6471 0 0 0 0 13.1704 Q9NZ63 TLS1_HUMAN Telomere length and silencing protein 1 homolog (Hepatocellular carcinoma-associated antigen 59) C9orf78 HCA59 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0005654; GO:0005681; GO:0005829 FYHEELNAPIRRNK 0.99412 -15.512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7766 0 0 0 10.807 0 0 0 0 0 0 0 0 0 10.2775 0 0 11.0141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0918 11.2723 13.9302 0 14.129 0 0 0 0 0 0 0 0 0 0 0 0 11.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6078 Q9Y5P8 P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PP2A subunit B isoform PR48) (Protein phosphatase 2A 48 kDa regulatory subunit) PPP2R3B PPP2R3L Homo sapiens (Human) protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726] GO:0000159; GO:0005509; GO:0005634; GO:0005654; GO:0005829; GO:0006470; GO:0019888; GO:0051726 calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888] CMDLDGDGALSMFELEYFYEEQCR 0.99412 -8.0828 0 0 0 0 0 0 0 0 13.423 0 0 0 13.9675 0 13.0316 0 11.6504 0 12.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1027 0 0 0 0 11.6036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.331 13.2105 0 0 0 13.6203 0 0 15.6321 0 13.929 0 0 15.1836 15.1746 15.4605 16.5086 14.9687 13.3065 0 0 15.0576 0 15.1179 15.1665 0 13.2841 0 15.2806 0 15.5582 0 0 0 0 14.7266 13.6367 0 0 0 0 0 12.7201 14.2135 0 0 0 12.7499 0 13.7175 14.0736 14.1396 0 13.9253 13.1357 13.121 0 13.4748 13.4558 15.1702 0 0 0 0 13.6213 12.5905 0 14.2479 0 0 0 0 0 0 0 0 0 0 13.2469 0 13.9806 0 0 0 12.9161 0 0 0 0 11.9146 0 0 0 0 0 0 0 0 0 13.437 0 0 0 0 0 0 0 Q9Y6W5 WASF2_HUMAN "Actin-binding protein WASF2 (Protein WAVE-2) (Verprolin homology domain-containing protein 2) (Wiskott-Aldrich syndrome protein family member 2, WASP family protein member 2)" WASF2 WAVE2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601] actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; synapse [GO:0045202]; actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin filament-based movement [GO:0030048]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; ameboidal-type cell migration [GO:0001667]; angiogenesis [GO:0001525]; endocytosis [GO:0006897]; lamellipodium assembly [GO:0030032]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601] GO:0001525; GO:0001667; GO:0001726; GO:0003779; GO:0005769; GO:0005829; GO:0005911; GO:0006897; GO:0007188; GO:0010592; GO:0015629; GO:0016323; GO:0016601; GO:0017124; GO:0030027; GO:0030032; GO:0030036; GO:0030048; GO:0031209; GO:0032991; GO:0034237; GO:0035855; GO:0045202; GO:0045296; GO:0051018; GO:0051497; GO:0070062; GO:0071933; GO:0072673; GO:0098974; GO:2000601 actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; SH3 domain binding [GO:0017124] EALKFYTDPSYFFDLWKEK 0.99412 -29.915 11.8724 0 0 0 0 9.86549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6897 0 0 0 0 0 0 0 0 0 12.7979 12.6872 0 0 0 0 0 0 0 0 0 0 0 0 14.2114 12.632 0 14.1913 0 14.6436 0 0 0 0 0 0 0 0 0 14.3359 0 0 0 0 0 0 0 0 0 0 0 0 13.7818 0 0 13.5367 0 0 0 0 0 0 0 13.9566 0 0 0 0 13.5773 0 13.9127 13.2583 13.4227 13.6751 0 0 0 0 0 0 0 0 0 13.8298 0 0 0 14.0744 0 13.8515 0 14.3907 0 0 0 0 0 0 0 0 0 0 13.7873 0 0 0 0 0 0 0 0 0 0 12.2449 13.7703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6367 0 0 0 0 0 0 0 A0A075B6I7 LV548_HUMAN Probable non-functional immunoglobulin lambda variable 5-48 IGLV5-48 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 IYWYQQK 0.99413 -10.972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4579 0 0 0 0 0 0 0 11.3901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8209 0 0 0 0 0 0 0 0 0 0 0 14.0127 0 0 0 0 A8MSI8 LYRM9_HUMAN LYR motif-containing protein 9 LYRM9 C17orf108 HSD24 Homo sapiens (Human) GIQQHYKHAVRQSFR 0.99413 -8.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2569 0 0 0 12.3711 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2025 0 0 0 0 0 14.1489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6095 13.5542 0 0 0 0 0 0 11.3577 0 0 0 0 0 0 11.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7932 0 0 0 0 0 0 0 A8MXD5 GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 GRXCR1 DFNB25 Homo sapiens (Human) inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118] kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420] kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420]; glutathione oxidoreductase activity [GO:0097573]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; post-embryonic animal organ morphogenesis [GO:0048563]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118] GO:0005902; GO:0007605; GO:0032420; GO:0042491; GO:0048563; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0097573 glutathione oxidoreductase activity [GO:0097573] ELDERCR 0.99413 -9.3261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2491 13.1252 0 0 0 0 0 0 0 11.3339 12.9876 0 0 16.0431 0 0 0 0 0 0 12.3664 0 0 0 0 0 0 0 0 0 0 0 0 13.0594 0 0 0 0 0 0 0 0 0 0 0 11.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4778 0 0 0 0 0 0 0 14.4587 14.8903 15.2168 14.4656 0 14.2884 0 0 0 0 0 12.0567 0 14.1501 0 0 O00267 SPT5H_HUMAN "Transcription elongation factor SPT5, hSPT5 (DRB sensitivity-inducing factor 160 kDa subunit, DSIF p160) (DRB sensitivity-inducing factor large subunit, DSIF large subunit) (Tat-cotransactivator 1 protein, Tat-CT1 protein)" SUPT5H SPT5 SPT5H Homo sapiens (Human) "negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]" DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000122; GO:0003682; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006368; GO:0016239; GO:0019899; GO:0032044; GO:0032785; GO:0032786; GO:0045944; GO:0046982 chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723] DIVKVIDGPHSGR 0.99413 -30.562 0 0 14.6762 0 0 0 0 0 12.4605 0 0 0 0 0 0 0 0 0 0 12.373 0 0 0 0 0 0 10.7836 0 0 0 0 0 0 0 0 0 11.8737 0 0 0 0 0 0 0 0 0 16.5201 0 0 0 0 0 9.84911 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9034 0 0 13.5503 0 0 0 0 0 0 0 0 0 0 13.0567 0 0 0 0 0 14.3645 16.4213 0 13.6428 11.8852 0 0 0 12.1947 0 0 0 11.64 17.737 0 10.8749 14.0477 13.9139 14.9455 0 0 0 0 13.0123 0 13.2106 0 0 12.9949 11.9734 0 12.7539 0 0 13.1531 13.6419 0 0 0 0 0 0 0 0 14.904 0 13.7053 0 0 0 0 0 0 12.3407 0 0 0 0 14.9198 0 12.2909 13.6619 14.5486 0 0 0 0 0 13.2685 13.9556 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5404 0 0 0 0 0 0 0 0 13.9118 12.6027 O14905 WNT9B_HUMAN Protein Wnt-9b (Protein Wnt-14b) (Protein Wnt-15) WNT9B WNT14B WNT15 UNQ6973/PRO21956 Homo sapiens (Human) "branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to starvation [GO:0009267]; collecting duct development [GO:0072044]; cornea development in camera-type eye [GO:0061303]; embryonic cranial skeleton morphogenesis [GO:0048701]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; in utero embryonic development [GO:0001701]; kidney rudiment formation [GO:0072003]; male genitalia development [GO:0030539]; mesenchymal stem cell maintenance involved in nephron morphogenesis [GO:0072038]; mesonephric duct formation [GO:0072181]; metanephric tubule formation [GO:0072174]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of stem cell population maintenance [GO:1902455]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1905438]; positive regulation of catalytic activity [GO:0043085]; regulation of asymmetric cell division [GO:0009786]; regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003339]; regulation of protein phosphorylation [GO:0001932]; regulation of tube size [GO:0035150]; response to retinoic acid [GO:0032526]; roof of mouth development [GO:0060021]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to starvation [GO:0009267]; collecting duct development [GO:0072044]; cornea development in camera-type eye [GO:0061303]; embryonic cranial skeleton morphogenesis [GO:0048701]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; in utero embryonic development [GO:0001701]; kidney rudiment formation [GO:0072003]; male genitalia development [GO:0030539]; mesenchymal stem cell maintenance involved in nephron morphogenesis [GO:0072038]; mesonephric duct formation [GO:0072181]; metanephric tubule formation [GO:0072174]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of stem cell population maintenance [GO:1902455]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1905438]; positive regulation of catalytic activity [GO:0043085]; regulation of asymmetric cell division [GO:0009786]; regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003339]; regulation of protein phosphorylation [GO:0001932]; regulation of tube size [GO:0035150]; response to retinoic acid [GO:0032526]; roof of mouth development [GO:0060021]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0001658; GO:0001701; GO:0001932; GO:0003339; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0009267; GO:0009786; GO:0030182; GO:0030539; GO:0032526; GO:0035150; GO:0039706; GO:0043085; GO:0045165; GO:0048018; GO:0048701; GO:0060021; GO:0060070; GO:0060071; GO:0061038; GO:0061303; GO:0071300; GO:0072003; GO:0072038; GO:0072044; GO:0072046; GO:0072174; GO:0072181; GO:1902455; GO:1904948; GO:1905438 co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] ACSAGRMERCTCDDSPGLESR 0.99413 -8.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5793 0 13.8731 0 11.1222 0 13.6701 13.9181 14.6164 0 13.7172 13.8641 14.1001 0 0 13.7321 0 14.1478 0 13.6886 0 0 0 0 0 13.895 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5862 0 0 0 0 0 0 0 0 0 13.1718 0 0 0 0 0 0 0 14.0955 0 0 0 0 0 0 0 0 11.6435 O14921 RGS13_HUMAN "Regulator of G-protein signaling 13, RGS13" RGS13 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744] GO:0003924; GO:0005634; GO:0005829; GO:0005886; GO:0007186; GO:0045744 GTPase activity [GO:0003924] IASRWSR 0.99413 -9.3094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.33 0 0 0 0 0 0 0 0 11.8583 11.2997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9276 0 0 0 0 0 0 13.2635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0977 0 0 0 0 13.157 0 0 0 0 0 0 0 0 0 0 0 0 O60496 DOK2_HUMAN Docking protein 2 (Downstream of tyrosine kinase 2) (p56(dok-2)) DOK2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; cell surface receptor signaling pathway [GO:0007166]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005068; GO:0005737; GO:0005829; GO:0007165; GO:0007166; GO:0007169; GO:0007265 transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] CVSGEGNFEFETR 0.99413 -28.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5377 12.2952 12.8248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4472 0 0 0 0 13.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9663 0 0 0 0 0 0 15.1743 0 14.5653 0 0 0 0 0 0 0 14.6609 0 0 0 0 0 0 0 0 0 0 0 0 14.0726 0 0 0 13.286 0 0 0 0 0 12.64 0 0 0 12.535 0 0 0 0 0 0 0 0 0 14.4038 0 0 0 0 0 0 O94830 DDHD2_HUMAN "Phospholipase DDHD2, EC 3.1.1.- (DDHD domain-containing protein 2) (KIAA0725p) (SAM, WWE and DDHD domain-containing protein 1)" DDHD2 KIAA0725 SAMWD1 Homo sapiens (Human) lipid droplet organization [GO:0034389]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; positive regulation of mitochondrial fission [GO:0090141]; triglyceride catabolic process [GO:0019433]; visual learning [GO:0008542] centriolar satellite [GO:0034451]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] centriolar satellite [GO:0034451]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806]; lipid droplet organization [GO:0034389]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; positive regulation of mitochondrial fission [GO:0090141]; triglyceride catabolic process [GO:0019433]; visual learning [GO:0008542] GO:0000266; GO:0004620; GO:0004806; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0007626; GO:0008542; GO:0016020; GO:0019433; GO:0030134; GO:0034389; GO:0034451; GO:0046872; GO:0090141 metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; triglyceride lipase activity [GO:0004806] ILNYFSTR 0.99413 -13.898 0 0 0 0 0 0 0 0 14.7689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4034 0 0 14.7382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4105 0 0 0 0 0 0 0 0 0 0 0 0 14.0185 0 0 0 0 0 0 0 12.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07910 HNRPC_HUMAN "Heterogeneous nuclear ribonucleoproteins C1/C2, hnRNP C1/C2" HNRNPC HNRPC Homo sapiens (Human) "3'-UTR-mediated mRNA stabilization [GO:0070935]; chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of telomere maintenance via telomerase [GO:0032211]; osteoblast differentiation [GO:0001649]; RNA splicing [GO:0008380]" actin cytoskeleton [GO:0015629]; catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697] "actin cytoskeleton [GO:0015629]; catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; nucleosomal DNA binding [GO:0031492]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of telomere maintenance via telomerase [GO:0032211]; osteoblast differentiation [GO:0001649]; RNA splicing [GO:0008380]" GO:0000398; GO:0000785; GO:0001649; GO:0003723; GO:0003730; GO:0005576; GO:0005634; GO:0005654; GO:0005681; GO:0005697; GO:0005829; GO:0006338; GO:0008266; GO:0008380; GO:0015629; GO:0016020; GO:0031492; GO:0032211; GO:0032991; GO:0042802; GO:0070034; GO:0070062; GO:0070935; GO:0071013; GO:1990247 identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA binding [GO:1990247]; nucleosomal DNA binding [GO:0031492]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] DDEKEAEEGEDDR 0.99413 -5.2838 0 0 0 0 0 14.9396 0 0 10.3686 10.9883 0 0 0 0 11.7809 0 0 0 0 12.0746 0 0 0 0 11.8782 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6247 13.5002 0 0 0 14.5744 0 0 0 0 0 15.2115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6791 0 0 0 13.0107 0 14.3412 0 0 0 0 0 13.1821 0 14.0709 0 0 0 0 14.0414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7109 14.0635 0 0 0 0 0 0 0 0 13.8692 0 0 0 0 13.4601 0 11.604 0 0 0 0 0 13.7356 0 0 0 0 0 13.4202 12.9275 0 0 13.6427 0 0 0 0 0 13.5535 0 0 0 0 0 0 0 0 P0C881 R10B1_HUMAN Radial spoke head 10 homolog B RSPH10B Homo sapiens (Human) CSTQPVSYIGHWCNGKRHGK 0.99413 -28.737 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93895 0 0 0 0 10.8474 0 0 0 0 0 0 0 0 0 0 11.0845 0 12.3088 0 0 0 0 0 11.7685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7446 0 0 0 0 0 0 12.6444 0 0 13.1077 0 13.1405 0 0 0 0 0 0 0 12.7319 0 0 0 0 13.9018 0 0 13.1053 0 0 0 0 0 0 0 11.9939 0 11.6463 0 0 0 0 13.3784 0 0 0 14.5707 0 12.5613 0 0 0 0 12.4235 0 0 0 0 12.7638 13.2654 0 0 14.7704 0 10.958 0 12.5596 0 0 11.5295 11.9465 0 0 0 0 12.3072 12.6738 0 0 12.0817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7429 0 0 0 0 P14373 TRI27_HUMAN "Zinc finger protein RFP, EC 2.3.2.27 (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27)" TRIM27 RFP RNF76 Homo sapiens (Human) "Arp2/3 complex-mediated actin nucleation [GO:0034314]; innate immune response [GO:0045087]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of viral transcription [GO:0032897]; positive regulation of actin nucleation [GO:0051127]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; retrograde transport, endosome to Golgi [GO:0042147]; spermatogenesis [GO:0007283]; suppression of viral release by host [GO:0044790]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; innate immune response [GO:0045087]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of viral transcription [GO:0032897]; positive regulation of actin nucleation [GO:0051127]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; retrograde transport, endosome to Golgi [GO:0042147]; spermatogenesis [GO:0007283]; suppression of viral release by host [GO:0044790]" GO:0000122; GO:0000209; GO:0001650; GO:0002820; GO:0003676; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006469; GO:0007283; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0016605; GO:0019789; GO:0019901; GO:0031965; GO:0032703; GO:0032720; GO:0032729; GO:0032880; GO:0032897; GO:0034314; GO:0042147; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0045814; GO:0046596; GO:0046872; GO:0051091; GO:0051092; GO:0051127; GO:0061630; GO:0070534; GO:0090281 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AQGEQAR 0.99413 -9.3108 0 0 0 0 0 0 0 0 0 0 0 0 12.0725 12.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4967 0 0 15.4255 0 0 0 0 0 12.0637 0 0 0 14.4014 0 0 0 0 0 0 0 0 0 11.7888 11.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7321 0 0 0 0 0 0 0 0 0 0 0 0 11.2343 0 0 0 0 11.4661 0 0 0 0 0 0 11.3009 0 0 11.2535 0 0 0 0 0 0 0 0 0 0 0 0 10.4627 0 0 0 0 0 0 0 0 0 0 13.7631 0 0 13.7382 13.6297 0 13.9868 13.7202 0 13.822 0 0 0 0 0 0 13.8001 0 0 0 0 P26927 HGFL_HUMAN "Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (Macrophage-stimulating protein, MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain ]" MST1 D3F15S2 DNF15S2 HGFL Homo sapiens (Human) histone H2A-S139 phosphorylation [GO:0035978]; negative regulation of gluconeogenesis [GO:0045721]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; histone H2A-S139 phosphorylation [GO:0035978]; negative regulation of gluconeogenesis [GO:0045721]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425] GO:0005102; GO:0005576; GO:0005615; GO:0006508; GO:0030971; GO:0035978; GO:0045721; GO:0046425; GO:0062023; GO:2000479 receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102] DLRENFCR 0.99413 -15.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6362 0 0 0 0 0 0 0 12.8936 12.9419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9236 14.8333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8228 0 0 0 0 0 13.0412 12.6733 0 11.5596 0 0 0 0 0 0 0 0 0 0 13.1261 0 0 0 0 P32754 HPPD_HUMAN "4-hydroxyphenylpyruvate dioxygenase, EC 1.13.11.27 (4-hydroxyphenylpyruvic acid oxidase, 4HPPD, HPD, HPPDase)" HPD PPD Homo sapiens (Human) L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572] GO:0000139; GO:0003868; GO:0005789; GO:0005829; GO:0006559; GO:0006572; GO:0042803; GO:0046872; GO:0070062 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803] EVVSHVIKQGKIVFVLSSALNPWNK 0.99413 -9.3113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5028 0 0 0 0 12.7111 12.5985 0 0 12.192 11.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55895 RAG2_HUMAN "V(D)J recombination-activating protein 2, RAG-2" RAG2 Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell homeostatic proliferation [GO:0002358]; B cell lineage commitment [GO:0002326]; chromatin organization [GO:0006325]; defense response to bacterium [GO:0042742]; DN2 thymocyte differentiation [GO:1904155]; mature B cell differentiation involved in immune response [GO:0002313]; negative regulation of T cell differentiation in thymus [GO:0033085]; organ growth [GO:0035265]; positive regulation of organ growth [GO:0046622]; pre-B cell allelic exclusion [GO:0002331]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; V(D)J recombination [GO:0033151] DNA recombinase complex [GO:0097519]; nucleoplasm [GO:0005654] "DNA recombinase complex [GO:0097519]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; B cell differentiation [GO:0030183]; B cell homeostatic proliferation [GO:0002358]; B cell lineage commitment [GO:0002326]; chromatin organization [GO:0006325]; defense response to bacterium [GO:0042742]; DN2 thymocyte differentiation [GO:1904155]; mature B cell differentiation involved in immune response [GO:0002313]; negative regulation of T cell differentiation in thymus [GO:0033085]; organ growth [GO:0035265]; positive regulation of organ growth [GO:0046622]; pre-B cell allelic exclusion [GO:0002331]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; V(D)J recombination [GO:0033151]" GO:0002313; GO:0002326; GO:0002331; GO:0002358; GO:0002360; GO:0003682; GO:0005546; GO:0005547; GO:0005654; GO:0006325; GO:0008270; GO:0030183; GO:0033077; GO:0033085; GO:0033151; GO:0035064; GO:0035091; GO:0035265; GO:0042742; GO:0043325; GO:0043565; GO:0046622; GO:0061630; GO:0080025; GO:0097519; GO:1904155 "chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]" DSCYLPPLRYPATCTFKGSLESEK 0.99413 -8.0939 0 0 0 0 0 0 0 0 0 0 12.8332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4499 0 0 0 0 0 13.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3774 14.6163 14.3411 11.7275 0 13.6012 0 11.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.882 0 0 0 0 13.9456 0 0 0 0 0 0 0 11.0844 0 0 0 0 0 0 0 0 0 14.9417 0 0 0 0 0 15.16 0 0 0 0 0 0 0 0 0 14.737 0 0 0 16.2586 14.1483 15.2789 0 0 0 0 0 0 0 0 0 0 0 13.085 0 0 0 0 0 0 0 0 0 0 0 0 P80192 M3K9_HUMAN "Mitogen-activated protein kinase kinase kinase 9, EC 2.7.11.25 (Mixed lineage kinase 1)" MAP3K9 MLK1 PRKE1 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468] GO:0004674; GO:0004706; GO:0004708; GO:0005524; GO:0006468; GO:0006915; GO:0042803; GO:0043065; GO:0046777; GO:0106310 ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GMNYLHDEAIVPIIHRDLKSSNILILQK 0.99413 -9.3244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1755 0 0 0 0 0 0 0 0 0 0 11.999 0 0 0 0 0 0 0 0 0 0 0 11.1874 0 0 0 0 0 0 16.6217 0 0 0 0 14.5635 13.4319 14.6089 0 0 0 0 0 0 0 0 14.127 14.3085 13.8078 0 0 0 12.8323 0 0 0 15.2394 0 0 12.283 0 12.2771 0 0 0 0 13.9916 0 0 0 0 14.2755 0 0 0 0 0 0 13.6702 0 12.8277 14.8278 0 0 0 0 13.7899 13.7084 0 0 14.7544 0 0 0 0 0 0 13.9022 0 0 13.3849 0 0 0 0 0 0 13.545 13.8498 0 12.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P81274 GPSM2_HUMAN G-protein-signaling modulator 2 (Mosaic protein LGN) GPSM2 LGN Homo sapiens (Human) cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991] cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236] GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0008022; GO:0016328; GO:0019904; GO:0031291; GO:0032991; GO:0042802; GO:0043621; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099738; GO:1904778; GO:1905832 dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621] CCLQEKNCHTASTTTSSTPPK 0.99413 -9.3157 0 0 0 0 0 0 0 0 0 13.0535 13.1651 12.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.68874 10.7058 0 0 0 0 9.93603 0 0 0 0 0 0 10.2657 0 0 0 0 0 0 0 11.1589 0 0 0 0 0 0 0 0 0 0 16.6673 11.0555 0 0 0 0 0 16.2475 0 0 15.0588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2356 13.0305 0 11.1481 12.5001 0 0 0 0 14.3883 0 0 0 0 0 12.6585 0 0 0 0 0 0 0 0 0 13.9453 0 11.8882 0 12.1864 0 11.0618 0 0 0 0 0 11.9934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3483 0 11.7228 13.4385 14.063 13.6222 12.2436 0 13.3945 0 0 13.1218 0 11.8443 0 12.1556 12.2197 0 0 0 12.2344 0 12.6109 0 0 Q01780 EXOSX_HUMAN "Exosome component 10, EC 3.1.13.- (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa, PM/Scl-100) (Polymyositis/scleroderma autoantigen 2)" EXOSC10 PMSCL PMSCL2 RRP6 Homo sapiens (Human) "CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]" cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]" GO:0000166; GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0009048; GO:0016020; GO:0032211; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:0101019; GO:1904872 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034] EMPLLKSEVAAGVKK 0.99413 -28.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03936 ZNF92_HUMAN Zinc finger protein 92 (Zinc finger protein HTF12) ZNF92 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AFKQSSTLTEHK 0.99413 -28.583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0268 0 0 0 0 11.5007 0 0 0 0 0 0 0 0 0 0 0 10.5262 0 0 0 0 0 15.9517 0 0 0 0 0 0 0 0 0 0 0 0 14.8299 0 0 0 0 0 0 0 0 14.4927 14.4776 0 0 0 0 0 13.041 14.0504 0 14.1431 0 0 0 14.6069 0 0 13.0256 0 0 0 13.5549 16.1101 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5623 0 0 13.2823 13.3822 0 0 0 0 0 13.0267 0 0 0 0 0 0 0 0 0 0 0 0 13.561 0 0 0 0 0 0 13.144 0 0 0 0 0 0 0 13.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1013 0 0 0 0 0 0 0 0 0 0 0 Q2WGJ9 FR1L6_HUMAN Fer-1-like protein 6 FER1L6 C8orfK23 Homo sapiens (Human) plasma membrane organization [GO:0007009]; response to bacterium [GO:0009617] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; plasma membrane organization [GO:0007009]; response to bacterium [GO:0009617] GO:0007009; GO:0009617; GO:0016021; GO:0046872 metal ion binding [GO:0046872] ADKTEDGK 0.99413 -30.516 0 0 0 10.2171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2362 0 0 0 0 0 0 0 0 10.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7827 0 0 0 0 0 0 11.9662 0 0 0 14.7712 0 10.3963 0 14.034 11.8336 0 0 15.612 0 15.5756 14.8945 14.866 0 0 15.7849 15.2352 12.5143 0 14.6448 14.678 12.3735 12.099 0 12.5831 14.2273 14.643 14.5035 0 0 16.0763 13.4955 11.5652 0 14.352 14.0893 0 14.1701 15.1413 0 15.5782 0 15.3161 0 0 0 0 0 0 0 16.032 0 14.8336 14.3259 12.9083 0 0 13.7861 14.5492 0 0 10.7624 0 0 13.7014 0 0 0 10.5594 13.1256 15.0029 15.0448 13.0445 14.4506 0 15.2304 0 0 14.4429 11.4153 0 0 14.2117 0 0 0 0 0 0 0 0 13.2767 0 13.7467 14.2686 0 11.8082 0 0 0 0 13.3283 0 0 0 0 16.6704 0 0 Q5C9Z4 NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274] nucleolus [GO:0005730] nucleolus [GO:0005730]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274] GO:0003723; GO:0005730; GO:0042274; GO:0048820 RNA binding [GO:0003723] AKATAATAKTR 0.99413 -15.575 10.7091 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3403 0 0 0 12.4454 0 12.5712 11.0867 12.3009 0 0 0 0 0 12.2681 12.6641 0 0 0 0 0 0 0 0 0 0 0 14.3207 14.8057 0 13.6382 15.083 0 0 12.5726 0 0 0 13.8222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7736 0 0 0 0 0 0 14.6266 0 0 13.9348 13.5105 0 13.6119 0 11.0653 0 11.6097 0 0 0 12.3488 13.6316 0 0 0 0 0 0 0 0 0 0 0 0 14.2745 12.7841 0 13.2224 0 12.5444 14.9727 0 0 0 0 0 15.2268 13.4311 0 0 0 0 0 0 0 0 18.4846 0 15.1167 18.1673 13.2905 0 0 0 0 13.2303 12.3845 0 0 0 14.4423 12.2825 15.223 12.5613 0 0 12.1605 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9029 0 13.122 0 0 0 0 12.9344 0 0 0 0 0 12.27 0 0 0 0 0 0 12.6163 Q6IPU0 CENPP_HUMAN "Centromere protein P, CENP-P" CENPP Homo sapiens (Human) CENP-A containing chromatin assembly [GO:0034080] "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; CENP-A containing chromatin assembly [GO:0034080]" GO:0000775; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0034080 DLFMFFR 0.99413 -13.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4215 14.1458 13.4223 14.3458 14.255 13.8212 0 13.5211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2657 0 0 0 0 0 0 0 0 13.2598 13.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5092 0 0 0 Q6P1L5 F117B_HUMAN Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein) FAM117B ALS2CR13 Homo sapiens (Human) ENGNNSPLPK 0.99413 -13.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8592 0 0 0 0 0 0 0 0 0 15.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.013 15.6295 0 0 0 0 15.5083 0 0 12.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5746 12.905 0 0 0 0 0 0 0 0 11.2057 0 0 14.3786 0 0 12.881 12.9534 0 0 0 12.8474 0 0 0 0 0 0 0 0 13.6639 0 0 0 13.619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5386 0 Q6P2M8 KCC1B_HUMAN "Calcium/calmodulin-dependent protein kinase type 1B, EC 2.7.11.17 (CaM kinase I beta, CaM kinase IB, CaM-KI beta, CaMKI-beta) (Pregnancy up-regulated non-ubiquitously-expressed CaM kinase)" PNCK Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; peptidyl-serine phosphorylation [GO:0018105] GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0106310 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310] DLKPENLLYATPFEDSK 0.99413 -5.2816 0 0 0 0 0 0 0 0 0 0 0 0 12.3753 0 13.2399 11.8158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN28 MACC1_HUMAN Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0005634; GO:0005737; GO:0005739; GO:0008083; GO:0045944; GO:0051781 growth factor activity [GO:0008083] ELTGVLILVNSLEVLR 0.99413 -13.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8781 0 0 0 16.5916 0 0 0 0 0 0 0 0 0 11.4033 0 0 12.5714 0 0 11.8617 0 0 0 0 0 0 0 13.1815 0 0 0 0 0 0 0 0 0 0 9.71824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.954 0 0 0 0 13.0813 12.4787 0 0 12.774 13.4122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1612 12.5705 0 0 0 0 0 Q8NCB2 CAMKV_HUMAN CaM kinase-like vesicle-associated protein CAMKV Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105]; regulation of modification of postsynaptic structure [GO:0099159] cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; peptidyl-serine phosphorylation [GO:0018105]; regulation of modification of postsynaptic structure [GO:0099159] GO:0004683; GO:0005516; GO:0005524; GO:0005886; GO:0018105; GO:0030659; GO:0098978; GO:0099159 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683] AVRVTTLMK 0.99413 -8.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1697 0 0 0 0 0 0 0 0 0 13.6778 0 0 0 0 0 12.6059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3626 0 0 0 0 0 0 0 0 12.9911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9658 0 0 0 0 0 0 0 0 0 15.2202 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDM6 DLG5_HUMAN Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; neuroepithelial cell differentiation [GO:0060563]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186] adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; neuroepithelial cell differentiation [GO:0060563]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186] GO:0001837; GO:0005737; GO:0005886; GO:0005912; GO:0007165; GO:0008013; GO:0008092; GO:0008285; GO:0014069; GO:0030011; GO:0030054; GO:0030159; GO:0030336; GO:0030859; GO:0030901; GO:0035331; GO:0035332; GO:0035556; GO:0036064; GO:0042130; GO:0042981; GO:0045176; GO:0045186; GO:0045197; GO:0045880; GO:0051965; GO:0060441; GO:0060563; GO:0060999; GO:0065003; GO:0071896; GO:0072205; GO:0098609 beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159] AELLLKLLLAK 0.99413 -28.595 0 0 0 0 0 0 0 0 12.7202 12.5157 0 12.2815 15.138 13.4243 0 0 12.8209 12.096 11.9116 0 0 0 11.8352 0 12.282 0 12.3304 12.3262 0 0 0 13.3799 0 0 0 0 0 11.5363 0 11.73 0 13.2458 0 11.9528 0 0 11.153 0 0 0 0 0 0 11.7018 0 0 0 12.5455 12.8755 11.7867 0 0 0 11.0481 0 0 0 0 11.3164 0 0 0 0 0 0 0 0 0 0 11.6538 0 0 13.3527 14.2532 0 0 16.3159 11.5262 13.5247 0 16.597 0 14.1451 0 14.6694 15.206 0 12.8764 0 0 0 0 13.6262 0 13.1232 12.8621 13.0887 13.1181 14.9691 12.8508 0 14.4105 0 0 0 0 0 0 0 13.2354 0 15.4637 0 0 0 0 0 14.0861 12.7949 12.125 0 14.696 0 0 12.7209 14.1146 0 0 11.3985 11.9249 14.8933 13.1506 0 13.8157 10.1053 0 0 13.0447 0 0 0 0 12.5638 12.1853 14.5477 0 15.2739 16.8057 0 13.0395 13.3596 14.5905 14.0055 14.8687 13.687 0 14.716 0 13.7636 14.128 0 0 0 0 0 0 14.1339 0 14.7409 16.3445 Q96A44 SPSB4_HUMAN "SPRY domain-containing SOCS box protein 4, SSB-4" SPSB4 SSB4 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; intracellular signal transduction [GO:0035556]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005829; GO:0006511; GO:0016567; GO:0019005; GO:0035556; GO:0042752; GO:0043161; GO:0048511; GO:1902916; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] GAEPGRPARLDQLLDMPAAGLAVQLR 0.99413 -13.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4138 0 0 12.3488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7637 15.5316 14.5908 14.5724 0 0 14.0057 13.9326 14.2105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MS3 GL1D1_HUMAN "Glycosyltransferase 1 domain-containing protein 1, EC 2.4.-.-" GLT1D1 Homo sapiens (Human) cytosol [GO:0005829]; extracellular region [GO:0005576] cytosol [GO:0005829]; extracellular region [GO:0005576]; glycosyltransferase activity [GO:0016757] GO:0005576; GO:0005829; GO:0016757 glycosyltransferase activity [GO:0016757] LLFLAVLR 0.99413 -8.3629 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4976 0 0 0 0 13.2232 0 0 10.4557 0 0 0 12.5044 0 0 0 0 0 0 0 0 13.2367 0 0 0 0 0 0 0 0 0 0 0 0 13.2558 0 0 0 0 0 0 0 9.68897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.724 0 0 0 0 0 0 0 0 0 13.7321 0 0 0 0 Q9BSD3 RHNO1_HUMAN "RAD9, HUS1, RAD1-interacting nuclear orphan protein 1 (RAD9, RAD1, HUS1-interacting nuclear orphan protein)" RHNO1 C12orf32 RHINO HKMT1188 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; positive regulation of G0 to G1 transition [GO:0070318]; recombinational repair [GO:0000725] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; DNA damage checkpoint signaling [GO:0000077]; positive regulation of G0 to G1 transition [GO:0070318]; recombinational repair [GO:0000725] GO:0000077; GO:0000725; GO:0005634; GO:0005654; GO:0005694; GO:0007049; GO:0034644; GO:0070318; GO:0071479 EELIPQDQK 0.99413 -9.321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2359 14.4367 0 0 0 0 0 0 0 12.3868 12.2655 0 0 0 0 0 0 0 0 0 11.7905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6189 0 0 0 0 0 0 0 0 0 0 Q9BZM1 PG12A_HUMAN "Group XIIA secretory phospholipase A2, GXII sPLA2, sPLA2-XII, EC 3.1.1.4 (Phosphatidylcholine 2-acylhydrolase 12A)" PLA2G12A PLA2G12 FKSG38 UNQ2519/PRO6012 Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644] GO:0004623; GO:0005509; GO:0005576; GO:0005737; GO:0006644; GO:0016042; GO:0047498; GO:0050482 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623] ALLSRPALTLLLLLMAAVVR 0.99413 -15.572 0 0 0 0 0 0 10.9666 0 0 0 0 0 0 0 14.4866 11.6347 12.7998 0 0 0 12.4264 14.7841 13.5343 0 13.0253 12.9653 12.4839 0 11.333 15.0111 0 11.9881 0 14.4892 0 0 14.702 11.8702 10.6405 12.7031 0 14.4022 14.1765 11.9443 10.3207 13.2092 14.147 14.5727 0 13.9512 0 0 0 0 12.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5784 0 0 14.0882 13.9134 0 11.3963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8153 0 0 0 0 0 0 10.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2147 0 0 0 0 0 0 0 13.2443 0 0 0 0 0 0 0 0 0 0 0 14.0829 0 0 0 0 13.6885 0 0 0 15.1688 0 0 0 0 0 0 0 0 0 0 13.0426 0 0 13.9429 0 0 0 0 10.5026 0 13.5366 10.6481 0 Q9H4F1 SIA7D_HUMAN "Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase, EC 2.4.99.7 (NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc-alpha-2,6-sialyltransferase) (ST6GalNAc IV, ST6GalNAcIV) (Sialyltransferase 3C, SIAT3-C) (Sialyltransferase 7D, SIAT7-D)" ST6GALNAC4 SIAT3C SIAT7D Homo sapiens (Human) ganglioside biosynthetic process [GO:0001574]; glycolipid metabolic process [GO:0006664]; O-glycan processing [GO:0016266]; oligosaccharide metabolic process [GO:0009311]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [GO:0047290]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycolipid metabolic process [GO:0006664]; O-glycan processing [GO:0016266]; oligosaccharide metabolic process [GO:0009311]; viral protein processing [GO:0019082]" GO:0000139; GO:0001574; GO:0001665; GO:0006664; GO:0008373; GO:0009311; GO:0016021; GO:0016266; GO:0019082; GO:0047290 "(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [GO:0047290]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]" AVFSRWAK 0.99413 -9.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1916 0 0 0 0 0 13.077 12.8539 13.0714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.292 14.8636 0 0 0 0 0 0 0 15.0919 15.3508 0 0 0 0 0 0 0 0 0 0 0 0 15.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4697 0 0 0 14.6204 14.6441 14.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.837 0 0 0 0 0 0 0 Q9NQG7 HPS4_HUMAN BLOC-3 complex member HPS4 (Hermansky-Pudlak syndrome 4 protein) (Light-ear protein homolog) HPS4 KIAA1667 Homo sapiens (Human) blood coagulation [GO:0007596]; hemostasis [GO:0007599]; intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827] BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; intracellular transport [GO:0046907]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] GO:0005085; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006605; GO:0007040; GO:0007596; GO:0007599; GO:0016020; GO:0016192; GO:0030318; GO:0031085; GO:0031267; GO:0031410; GO:0042470; GO:0042803; GO:0042827; GO:0046907; GO:0046983; GO:0048075; GO:0050821; GO:0060155; GO:1903232; GO:1903955 guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] ADPLPRR 0.99413 -8.0935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXC2 GFOD1_HUMAN "Glucose-fructose oxidoreductase domain-containing protein 1, EC 1.-.-.-" GFOD1 C6orf114 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491] GO:0000166; GO:0005576; GO:0016491 nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491] AVKVHGLLK 0.99413 -8.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1453 0 0 0 0 0 0 0 0 0 0 0 0 11.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5407 0 0 0 0 0 0 0 0 0 0 0 12.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4962 0 0 0 0 0 11.9236 15.5408 0 11.7113 0 14.2333 14.4454 0 0 0 0 14.7405 0 0 15.3647 0 10.3755 0 14.7584 15.0685 0 0 14.805 0 14.3053 0 0 0 14.8654 14.9044 0 0 0 14.8018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9644 0 0 0 13.7877 0 0 Q9UL18 AGO1_HUMAN "Protein argonaute-1, Argonaute1, hAgo1 (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1, eIF-2C 1, eIF2C 1) (Putative RNA-binding protein Q99)" AGO1 EIF2C1 Homo sapiens (Human) miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of angiogenesis [GO:0016525]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578] cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of angiogenesis [GO:0016525]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pre-miRNA processing [GO:0031054]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501] GO:0000932; GO:0000956; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005844; GO:0010501; GO:0016442; GO:0016525; GO:0031054; GO:0035196; GO:0035198; GO:0035278; GO:0036464; GO:0045944; GO:0070578; GO:0070922; GO:1990904 core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727] DAGMPIQGQPCFCKYAQGADSVEPMFR 0.99413 -28.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4621 0 12.2463 0 0 0 0 0 0 12.3085 0 0 0 11.2977 0 0 0 0 12.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4161 15.1032 0 0 13.4051 13.1827 0 0 0 0 0 0 0 0 13.476 11.642 0 0 0 0 14.4075 14.2316 13.9036 0 12.0868 12.6111 0 0 0 0 0 12.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1869 0 0 0 0 0 Q9Y4I5 MTL5_HUMAN "Tesmin (Metallothionein-like 5, testis-specific) (Testis-specific metallothionein-like protein)" TESMIN MTL5 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular metal ion homeostasis [GO:0006875]; male meiotic nuclear division [GO:0007140]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; cellular metal ion homeostasis [GO:0006875]; male meiotic nuclear division [GO:0007140]; regulation of transcription, DNA-templated [GO:0006355]; response to metal ion [GO:0010038]; spermatogenesis [GO:0007283]" GO:0001673; GO:0005634; GO:0005737; GO:0006355; GO:0006875; GO:0007140; GO:0007283; GO:0010038; GO:0030154; GO:0046872 metal ion binding [GO:0046872] AIKACLGR 0.99413 -13.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6715 11.8469 0 13.5958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9953 13.6671 0 0 0 0 0 0 0 0 0 0 0 11.9591 0 12.8473 10.7588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7712 0 0 0 0 0 13.4608 0 0 0 0 0 0 0 11.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T8A7 PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 PPP1R26 KIAA0649 Homo sapiens (Human) negative regulation of phosphatase activity [GO:0010923] nucleolus [GO:0005730] nucleolus [GO:0005730]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923] GO:0004864; GO:0005730; GO:0010923 protein phosphatase inhibitor activity [GO:0004864] AAGGGSR 0.99414 -36.421 0 0 12.4525 12.6596 0 12.9223 18.9891 12.4513 0 0 0 0 0 13.2387 0 0 0 0 0 0 19.2903 12.4547 12.9853 14.2806 0 0 0 12.0063 0 0 0 12.9339 0 13.1737 0 0 0 0 0 0 0 12.4326 12.5494 0 0 0 0 0 0 0 0 12.2551 0 0 0 0 12.067 0 0 0 0 0 0 0 0 0 13.5833 19.5388 13.0102 13.3735 12.9929 19.4937 0 19.5576 19.6145 14.5155 14.5381 16.2088 15.7288 19.8531 15.2639 14.8991 15.0544 15.2319 13.7608 16.1289 14.7376 14.7601 13.8146 15.6873 16.0256 15.5273 14.9254 16.1179 16.1419 15.4419 13.9884 13.8778 15.0652 15.4748 15.164 14.9274 16.21 15.1211 14.6353 15.4303 16.2473 17.2631 15.3347 16.8605 15.6284 0 13.5954 13.8694 14.924 14.7947 14.715 0 14.3342 15.5027 14.7534 19.935 15.7547 14.1203 15.3035 13.6467 14.7841 15.1637 15.0694 16.0497 13.6175 15.7475 16.1363 13.7397 14.865 14.1679 14.0895 16.2863 19.9462 15.5335 0 14.8346 15.3832 16.2746 19.9048 19.9005 15.0126 12.939 19.911 0 19.9337 15.2061 13.7515 14.7721 0 14.1961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9462 0 14.8336 14.1761 0 0 0 0 0 O14626 GP171_HUMAN G-protein coupled receptor 171 (G-protein coupled receptor H963) GPR171 H963 Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of feeding behavior [GO:0060259]; regulation of sensory perception of pain [GO:0051930] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of feeding behavior [GO:0060259]; regulation of sensory perception of pain [GO:0051930] GO:0004930; GO:0005886; GO:0007186; GO:0007188; GO:0008188; GO:0008528; GO:0016021; GO:0042923; GO:0045028; GO:0045638; GO:0051930; GO:0060259 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188] AQKEKLR 0.99414 -5.3044 0 0 0 0 0 0 0 0 13.3368 13.4054 13.189 13.2175 12.992 12.8974 13.3069 13.535 12.8607 13.2892 0 0 0 0 0 0 12.9564 13.0885 13.0497 0 12.5127 0 12.349 13.0266 12.5598 12.2377 12.563 0 0 12.0714 12.5725 11.2979 12.6611 0 0 12.7398 0 0 0 0 12.8259 0 0 0 0 0 0 0 0 0 0 0 13.641 13.3449 0 14.0135 13.5937 0 0 0 14.2594 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5462 15.1347 0 15.2747 0 0 15.0629 0 0 0 15.0446 14.918 0 0 15.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7836 0 0 0 0 0 0 0 0 0 14.7873 0 14.8189 0 15.016 14.6863 11.7684 0 14.869 0 0 0 14.8193 14.9156 0 0 0 0 14.6644 0 14.6695 0 0 O15244 S22A2_HUMAN "Solute carrier family 22 member 2 (Organic cation transporter 2, hOCT2)" SLC22A2 OCT2 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amine transport [GO:0015837]; amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; choline transport [GO:0015871]; dopamine uptake [GO:0090494]; export across plasma membrane [GO:0140115]; histamine uptake [GO:0051615]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic cation transport [GO:0015695]; positive regulation of gene expression [GO:0010628]; purine-containing compound transmembrane transport [GO:0072530]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; amine transmembrane transporter activity [GO:0005275]; choline transmembrane transporter activity [GO:0015220]; efflux transmembrane transporter activity [GO:0015562]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amine transport [GO:0015837]; amino acid import across plasma membrane [GO:0089718]; body fluid secretion [GO:0007589]; choline transport [GO:0015871]; dopamine uptake [GO:0090494]; export across plasma membrane [GO:0140115]; histamine uptake [GO:0051615]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-arginine import across plasma membrane [GO:0097638]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic cation transport [GO:0015695]; positive regulation of gene expression [GO:0010628]; purine-containing compound transmembrane transport [GO:0072530]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] GO:0005275; GO:0005326; GO:0005886; GO:0005887; GO:0006836; GO:0006919; GO:0007589; GO:0008504; GO:0010628; GO:0015101; GO:0015179; GO:0015214; GO:0015220; GO:0015562; GO:0015695; GO:0015837; GO:0015871; GO:0016020; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0061459; GO:0070062; GO:0072530; GO:0089718; GO:0090494; GO:0097638; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1902475; GO:1990962 amine transmembrane transporter activity [GO:0005275]; choline transmembrane transporter activity [GO:0015220]; efflux transmembrane transporter activity [GO:0015562]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; organic cation transmembrane transporter activity [GO:0015101]; pyrimidine nucleoside transmembrane transporter activity [GO:0015214]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910] IIKHIAK 0.99414 -7.878 14.5754 0 0 0 15.3592 0 15.2526 11.2206 14.4441 15.0145 11.9553 12.2278 14.4939 0 11.6818 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4072 11.7096 0 0 0 12.7029 0 14.1937 0 0 0 0 10.9354 14.2882 13.333 11.6264 0 14.4072 0 15.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6161 0 0 0 0 16.7422 0 0 13.5399 0 0 0 0 0 0 0 0 0 11.838 0 0 0 0 0 0 0 0 0 11.8305 12.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0648 0 0 0 0 0 0 12.1864 0 12.3383 0 0 0 0 0 0 12.1395 0 0 0 0 11.4504 0 0 0 0 0 0 0 0 0 0 13.0976 0 12.6299 0 0 14.1962 16.7223 16.704 0 0 14.0526 13.6742 16.4724 12.6071 13.3046 0 0 0 0 0 0 0 0 0 O95741 CPNE6_HUMAN "Copine-6 (Copine VI) (Neuronal-copine, N-copine)" CPNE6 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861] GO:0001786; GO:0005509; GO:0005544; GO:0005768; GO:0005886; GO:0016020; GO:0030136; GO:0030154; GO:0030424; GO:0030425; GO:0043204; GO:0070062; GO:0071277; GO:1903861 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786] AVGGICQDYDSDK 0.99414 -5.3029 0 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7422 0 0 0 0 0 0 12.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0116 0 13.5294 0 0 0 12.2193 0 0 0 13.3603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2435 0 0 13.5347 0 12.2624 0 0 12.9845 0 0 11.2439 0 0 13.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4674 0 0 15.0694 11.2923 0 0 0 0 0 13.0991 0 0 0 0 13.5791 0 0 0 13.4681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95969 SG1D2_HUMAN Secretoglobin family 1D member 2 (Lipophilin-B) SCGB1D2 LIPHB LPNB Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 ILKKCSV 0.99414 -8.132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1801 0 0 13.378 0 0 0 14.9251 0 0 14.7683 10.9936 0 0 0 0 0 0 11.7325 15.0964 0 0 0 13.5833 0 0 0 12.198 0 0 0 0 13.5173 12.4493 0 10.4616 0 0 0 0 14.9448 0 0 0 0 0 0 0 0 0 0 0 0 10.6704 0 0 0 0 0 0 0 0 13.896 0 0 0 0 12.3663 0 0 0 0 0 0 0 0 15.8121 0 0 0 0 0 0 0 14.9372 11.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9464 0 0 P09958 FURIN_HUMAN "Furin, EC 3.4.21.75 (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme, PACE)" FURIN FUR PACE PCSK3 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; blastocyst formation [GO:0001825]; collagen catabolic process [GO:0030574]; dibasic protein processing [GO:0090472]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]; regulation of cholesterol transport [GO:0032374]; regulation of endopeptidase activity [GO:0052548]; regulation of lipoprotein lipase activity [GO:0051004]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral life cycle [GO:0019058]; viral protein processing [GO:0019082]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; endopeptidase activity [GO:0004175]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; amyloid fibril formation [GO:1990000]; blastocyst formation [GO:0001825]; collagen catabolic process [GO:0030574]; dibasic protein processing [GO:0090472]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transforming growth factor beta1 activation [GO:1901394]; protein processing [GO:0016485]; regulation of cholesterol transport [GO:0032374]; regulation of endopeptidase activity [GO:0052548]; regulation of lipoprotein lipase activity [GO:0051004]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral life cycle [GO:0019058]; viral protein processing [GO:0019082]; zymogen activation [GO:0031638]; zymogen inhibition [GO:0097341] GO:0000139; GO:0001825; GO:0002020; GO:0002862; GO:0004175; GO:0004252; GO:0004867; GO:0005576; GO:0005783; GO:0005796; GO:0005802; GO:0005886; GO:0006465; GO:0007179; GO:0008201; GO:0008233; GO:0009966; GO:0009986; GO:0010008; GO:0016020; GO:0016485; GO:0016486; GO:0019058; GO:0019082; GO:0022617; GO:0030140; GO:0030173; GO:0030198; GO:0030574; GO:0031638; GO:0032374; GO:0032804; GO:0032902; GO:0032911; GO:0032940; GO:0042176; GO:0042277; GO:0043043; GO:0045121; GO:0046872; GO:0048406; GO:0051004; GO:0051044; GO:0052548; GO:0070062; GO:0090472; GO:0097341; GO:1901394; GO:1904399; GO:1990000 endopeptidase activity [GO:0004175]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867] LAEEAFFR 0.99414 -10.983 0 0 0 0 0 0 0 0 0 0 0 0 10.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21730 C5AR1_HUMAN "C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor, C5a-R, C5aR) (CD antigen CD88)" C5AR1 C5AR C5R1 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; amyloid-beta clearance [GO:0097242]; astrocyte activation [GO:0048143]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; cognition [GO:0050890]; complement component C5a signaling pathway [GO:0038178]; complement receptor mediated signaling pathway [GO:0002430]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; mRNA transcription by RNA polymerase II [GO:0042789]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynapse organization [GO:0099172]; regulation of tau-protein kinase activity [GO:1902947]; response to peptidoglycan [GO:0032494]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; complement component C5a receptor activity [GO:0004878]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; activation of phospholipase C activity [GO:0007202]; amyloid-beta clearance [GO:0097242]; astrocyte activation [GO:0048143]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; cognition [GO:0050890]; complement component C5a signaling pathway [GO:0038178]; complement receptor mediated signaling pathway [GO:0002430]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; mRNA transcription by RNA polymerase II [GO:0042789]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynapse organization [GO:0099172]; regulation of tau-protein kinase activity [GO:1902947]; response to peptidoglycan [GO:0032494]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] GO:0001774; GO:0002430; GO:0004875; GO:0004878; GO:0004930; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007165; GO:0007200; GO:0007202; GO:0007204; GO:0007606; GO:0010575; GO:0010759; GO:0016323; GO:0030593; GO:0030667; GO:0032494; GO:0038178; GO:0042789; GO:0045177; GO:0045766; GO:0048143; GO:0050679; GO:0050830; GO:0050890; GO:0070374; GO:0090023; GO:0097242; GO:0099172; GO:1902947 complement component C5a receptor activity [GO:0004878]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930] DSFNYTTPDYGHYDDK 0.99414 -10.99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1723 0 0 14.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4635 0 0 0 0 0 0 0 0 0 0 0 12.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3049 13.2409 0 0 0 0 P28161 GSTM2_HUMAN "Glutathione S-transferase Mu 2, EC 2.5.1.18 (GST class-mu 2) (GSTM2-2)" GSTM2 GST4 Homo sapiens (Human) cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; relaxation of cardiac muscle [GO:0055119]; xenobiotic catabolic process [GO:0042178] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; sarcoplasmic reticulum [GO:0016529] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; relaxation of cardiac muscle [GO:0055119]; xenobiotic catabolic process [GO:0042178] GO:0004364; GO:0004602; GO:0005102; GO:0005504; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014809; GO:0016529; GO:0018916; GO:0019899; GO:0042178; GO:0042803; GO:0043295; GO:0043651; GO:0045171; GO:0051122; GO:0055119; GO:0060315; GO:0060316; GO:0070062; GO:0070458; GO:0071313 enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] GLAHSIR 0.99414 -10.749 13.8067 13.996 14.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9881 0 0 0 0 0 13.2685 0 0 0 0 15.5552 13.6701 14.7461 0 14.7047 0 0 0 13.3552 12.7775 0 0 14.7009 14.3757 0 0 0 12.7422 0 0 0 13.358 12.3826 14.3721 0 0 0 0 14.6098 0 0 0 0 12.7713 14.9068 0 0 14.2621 0 13.1239 12.5981 0 0 12.1714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5442 0 0 0 0 P49662 CASP4_HUMAN "Caspase-4, CASP-4, EC 3.4.22.57 (ICE and Ced-3 homolog 2, ICH-2) (ICE(rel)-II) (Mih1) (Protease TX) [Cleaved into: Caspase-4 subunit p10; Caspase-4 subunit p20 ]" CASP4 ICH2 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to amyloid-beta [GO:1904646]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-18-mediated signaling pathway [GO:2000494]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727] AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; IPAF inflammasome complex [GO:0072557]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; cellular response to amyloid-beta [GO:1904646]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-18-mediated signaling pathway [GO:2000494]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727] GO:0004197; GO:0005576; GO:0005737; GO:0005739; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0006954; GO:0016540; GO:0032991; GO:0042981; GO:0045087; GO:0050700; GO:0050727; GO:0050729; GO:0050830; GO:0070059; GO:0070269; GO:0072557; GO:0072559; GO:0097169; GO:0097193; GO:0097199; GO:1903265; GO:1904646; GO:2000494 CARD domain binding [GO:0050700]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199] AEGNHRK 0.99414 -9.0973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5626 0 0 0 0 0 0 0 0 0 0 0 0 13.9221 0 13.7545 0 0 13.2043 0 0 0 0 0 11.3387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0664 0 0 13.2873 0 0 0 0 0 0 0 0 0 0 0 13.1117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5135 0 0 0 0 13.3002 0 0 0 0 0 0 0 0 0 0 0 0 14.2002 0 0 0 P53999 TCP4_HUMAN "Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4, PC4) (SUB1 homolog) (p14)" SUB1 PC4 RPO2TC1 Homo sapiens (Human) negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; promoter clearance from RNA polymerase II promoter [GO:0001111]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395] extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; promoter clearance from RNA polymerase II promoter [GO:0001111]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395] GO:0000978; GO:0001111; GO:0003697; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0042802; GO:0051053; GO:0060261; GO:0060395; GO:0070062 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] GISLNPEQWSQLKEQISDIDDAVRK 0.99414 -9.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4842 0 0 0 0 0 10.96 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.363 13.132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1347 0 0 0 0 0 0 12.5642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4087 0 0 0 0 0 0 0 0 0 Q0WX57 U17LO_HUMAN "Ubiquitin carboxyl-terminal hydrolase 17-like protein 24, EC 3.4.19.12 (Deubiquitinating enzyme 17) (Ubiquitin thioesterase 17) (Ubiquitin-specific-processing protease 17)" USP17L24 USP17 USP17H USP17I USP17J USP17K USP17L USP17M; USP17L25; USP17L26; USP17L27; USP17L28; USP17L29; USP17L30 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; regulation of apoptotic process [GO:0042981] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; hyaluronic acid binding [GO:0005540]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; positive regulation of epithelial cell apoptotic process [GO:1904037]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; regulation of apoptotic process [GO:0042981] GO:0003723; GO:0004197; GO:0004843; GO:0005540; GO:0005634; GO:0005730; GO:0005783; GO:0005829; GO:0006915; GO:0016579; GO:0042981; GO:0071947; GO:1904037 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; hyaluronic acid binding [GO:0005540]; RNA binding [GO:0003723] APASKTLTLHTSAKVLILVLK 0.99414 -8.1241 0 11.2158 0 12.2198 12.8712 0 0 0 0 0 0 12.9633 0 0 0 0 0 0 0 12.8132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5164 0 0 12.5537 0 0 0 0 0 0 0 14.3767 14.4387 14.3915 0 12.5074 0 0 14.2554 0 0 12.6596 0 0 0 0 0 0 0 0 0 13.9962 0 13.0646 13.6451 0 11.5835 0 0 0 0 0 0 0 11.8763 0 14.1373 0 0 13.7363 12.5266 0 0 0 0 11.0907 10.6505 12.1132 0 0 0 10.2475 0 0 0 0 0 0 0 0 0 14.1451 0 13.748 12.6652 0 0 0 0 0 0 0 0 0 0 10.9457 0 0 0 0 0 10.6832 13.1361 0 15.7026 12.5908 0 12.0181 0 0 0 14.2066 0 12.9857 0 14.9218 0 14.4358 15.1099 17.1584 0 0 0 0 0 0 0 13.2591 0 0 13.8481 12.6356 15.8733 0 0 0 0 12.1012 13.1953 0 0 17.3826 14.4082 15.7634 0 0 0 0 0 15.2774 Q14995 NR1D2_HUMAN "Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor, RVR) (Rev-erb-beta) (V-erbA-related protein 1-related, EAR-1R)" NR1D2 Homo sapiens (Human) "cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; circadian behavior [GO:0048512]; energy homeostasis [GO:0097009]; hormone-mediated signaling pathway [GO:0009755]; lipid homeostasis [GO:0055088]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of inflammatory response [GO:0050727]; regulation of lipid metabolic process [GO:0019216]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0008270; GO:0009755; GO:0019216; GO:0030154; GO:0042752; GO:0045892; GO:0045893; GO:0045944; GO:0048512; GO:0050727; GO:0050728; GO:0055088; GO:0097009; GO:1990837; GO:2001014 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" DAVRFGR 0.99414 -8.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.32 13.3867 0 0 0 0 0 0 12.0846 12.7922 0 0 0 11.0513 0 0 0 0 0 0 13.3378 0 0 0 0 0 0 0 0 0 0 13.1968 0 0 12.7425 0 11.5741 12.1619 0 12.0166 0 12.1682 0 0 0 0 0 0 0 0 0 0 13.8979 0 0 14.2043 14.569 0 0 0 0 0 14.694 13.8737 0 0 0 13.0822 0 0 0 0 0 0 0 12.023 0 0 13.6575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1874 12.9931 14.5171 0 0 0 12.6944 13.6975 0 0 0 13.5736 0 0 0 0 0 11.0208 14.8224 14.7042 0 0 0 0 0 14.625 0 13.9672 0 13.5581 0 0 0 14.2091 13.3963 0 0 0 0 0 0 0 0 0 0 13.112 0 0 0 0 0 0 0 0 0 14.997 0 14.6838 0 0 0 0 0 0 Q15650 TRIP4_HUMAN "Activating signal cointegrator 1, ASC-1 (Thyroid receptor-interacting protein 4, TR-interacting protein 4, TRIP-4)" TRIP4 RQT4 Homo sapiens (Human) "intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; toxin transport [GO:1901998]" activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone acetyltransferase binding [GO:0035035]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription, DNA-templated [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116]; toxin transport [GO:1901998]" GO:0002020; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0006355; GO:0008270; GO:0016604; GO:0016922; GO:0019901; GO:0030331; GO:0030520; GO:0031594; GO:0032790; GO:0032991; GO:0035035; GO:0044389; GO:0045661; GO:0045893; GO:0072344; GO:0099053; GO:1901998; GO:1990116 histone acetyltransferase binding [GO:0035035]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270] FPIKGNPKIWK 0.99414 -9.1005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9365 0 0 0 0 0 0 10.3413 0 0 0 0 0 0 0 0 0 0 14.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7362 0 0 0 0 0 13.3734 0 12.0712 0 0 0 0 0 0 0 0 0 12.556 14.2089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3109 0 0 0 0 0 0 0 0 Q17RR3 LIPR3_HUMAN "Pancreatic lipase-related protein 3, PL-RP3, EC 3.1.1.3" PNLIPRP3 Homo sapiens (Human) lipid catabolic process [GO:0016042] extracellular space [GO:0005615] extracellular space [GO:0005615]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042] GO:0004806; GO:0005615; GO:0016042; GO:0016298 lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806] FNFNAYK 0.99414 -9.1 0 0 0 0 11.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4781 0 0 0 0 11.8136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1722 0 0 0 0 0 0 11.7249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7197 11.0957 0 0 10.6329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q502W6 VWA3B_HUMAN "von Willebrand factor A domain-containing protein 3B, VWA domain-containing protein 3B" VWA3B Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 EADTQDSREPR 0.99414 -7.9013 0 0 0 0 0 0 0 0 13.9796 0 0 0 0 0 0 12.779 0 0 0 0 0 0 12.6688 12.5825 0 0 0 0 0 10.6372 0 0 0 0 0 0 0 0 0 0 13.0787 0 10.5192 0 13.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2841 0 0 0 0 0 12.0525 0 14.55 0 0 0 0 0 0 0 0 14.4949 0 0 0 0 12.0512 0 0 0 0 15.164 14.971 14.8245 0 0 13.7604 0 0 14.6997 0 14.1923 13.1535 0 0 0 13.6984 0 0 0 13.9597 0 0 0 0 0 14.1006 14.0168 0 0 0 0 13.8296 15.0903 0 0 0 0 0 0 12.5364 0 13.4834 0 13.1522 13.1477 13.2097 0 0 0 0 0 13.6242 0 0 15.4853 0 0 14.6628 0 0 0 0 0 0 0 0 0 0 0 10.9327 0 0 0 0 13.6217 13.7163 0 15.5393 0 0 0 Q86UT5 NHRF4_HUMAN "Na(+)/H(+) exchange regulatory cofactor NHE-RF4, NHERF-4 (Intestinal and kidney-enriched PDZ protein) (Natrium-phosphate cotransporter IIa C-terminal-associated protein 2, Na/Pi cotransporter C-terminal-associated protein 2, NaPi-Cap2) (PDZ domain-containing protein 2) (PDZ domain-containing protein 3) (Sodium-hydrogen exchanger regulatory factor 4)" PDZD3 IKEPP NHERF4 PDZK2 DLNB27 Homo sapiens (Human) ion transport [GO:0006811]; negative regulation of cGMP-mediated signaling [GO:0010754]; protein localization to plasma membrane [GO:0072659]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to toxic substance [GO:0009636]; water transport [GO:0006833] apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytosol [GO:0005829] apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; cytosol [GO:0005829]; guanylate cyclase inhibitor activity [GO:0030251]; ion channel inhibitor activity [GO:0008200]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-specific protease binding [GO:1990381]; ion transport [GO:0006811]; negative regulation of cGMP-mediated signaling [GO:0010754]; protein localization to plasma membrane [GO:0072659]; receptor guanylyl cyclase signaling pathway [GO:0007168]; response to toxic substance [GO:0009636]; water transport [GO:0006833] GO:0005829; GO:0005903; GO:0006811; GO:0006833; GO:0007168; GO:0008022; GO:0008200; GO:0009636; GO:0010754; GO:0016324; GO:0030251; GO:0043296; GO:0043495; GO:0045177; GO:0072659; GO:1990381 guanylate cyclase inhibitor activity [GO:0030251]; ion channel inhibitor activity [GO:0008200]; protein C-terminus binding [GO:0008022]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-specific protease binding [GO:1990381] AGHVVCRVDPGTSAQR 0.99414 -10.984 0 0 0 0 0 0 0 0 0 12.9266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7998 0 0 0 0 0 11.4764 0 0 0 0 0 0 11.8028 0 0 12.2597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6329 0 0 0 14.0646 0 0 0 0 0 0 0 0 0 0 0 12.6588 0 0 0 0 0 0 0 0 0 0 0 0 13.0027 13.8766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8556 13.1202 0 0 0 0 0 0 0 0 0 0 0 12.1059 0 0 0 0 0 0 0 0 0 0 12.8638 0 0 0 11.1189 0 0 0 0 0 0 0 0 Q8N0T1 RBIS_HUMAN Ribosomal biogenesis factor RBIS C8orf59 Homo sapiens (Human) ribosome biogenesis [GO:0042254] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254] GO:0005654; GO:0005730; GO:0005829; GO:0042254 NKLRGPK 0.99414 -9.3598 0 0 0 0 0 0 0 12.3236 0 10.1204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5909 0 0 0 0 0 0 12.1146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N423 LIRB2_HUMAN "Leukocyte immunoglobulin-like receptor subfamily B member 2, LIR-2, Leukocyte immunoglobulin-like receptor 2 (CD85 antigen-like family member D) (Immunoglobulin-like transcript 4, ILT-4) (Monocyte/macrophage immunoglobulin-like receptor 10, MIR-10) (CD antigen CD85d)" LILRB2 ILT4 LIR2 MIR10 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; interleukin-10-mediated signaling pathway [GO:0140105]; learning or memory [GO:0007611]; negative regulation of antigen processing and presentation [GO:0002578]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of postsynaptic density organization [GO:1905875]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; regulation of dendritic cell differentiation [GO:2001198]; regulation of long-term synaptic potentiation [GO:1900271]; signal transduction [GO:0007165] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; heterotypic cell-cell adhesion [GO:0034113]; immune response [GO:0006955]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; interleukin-10-mediated signaling pathway [GO:0140105]; learning or memory [GO:0007611]; negative regulation of antigen processing and presentation [GO:0002578]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of postsynaptic density organization [GO:1905875]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of T cell costimulation [GO:2000524]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; regulation of dendritic cell differentiation [GO:2001198]; regulation of long-term synaptic potentiation [GO:1900271]; signal transduction [GO:0007165] GO:0001540; GO:0002250; GO:0002578; GO:0002645; GO:0002666; GO:0002767; GO:0002774; GO:0005615; GO:0005737; GO:0005886; GO:0005887; GO:0006955; GO:0006968; GO:0007165; GO:0007166; GO:0007267; GO:0007611; GO:0008157; GO:0009986; GO:0016020; GO:0019221; GO:0023025; GO:0023029; GO:0032396; GO:0032755; GO:0034113; GO:0035307; GO:0042102; GO:0042130; GO:0042288; GO:0042803; GO:0044877; GO:0045591; GO:0050839; GO:0051248; GO:0051926; GO:0070821; GO:0071222; GO:0101003; GO:0140105; GO:1900271; GO:1900454; GO:1905875; GO:2000524; GO:2001198 amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877] ARWSELSDPLVLVMTGAYPK 0.99414 -5.5047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0537 14.9882 14.9084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8703 0 0 0 13.4817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7118 0 0 0 0 0 0 0 0 0 0 13.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEH6 MNS1_HUMAN Meiosis-specific nuclear structural protein 1 MNS1 Homo sapiens (Human) cilium organization [GO:0044782]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; intermediate filament [GO:0005882]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635]; sperm flagellum [GO:0036126] axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; intermediate filament [GO:0005882]; motile cilium [GO:0031514]; nuclear envelope [GO:0005635]; sperm flagellum [GO:0036126]; identical protein binding [GO:0042802]; cilium organization [GO:0044782]; left/right axis specification [GO:0070986]; meiotic cell cycle [GO:0051321]; positive regulation of cilium assembly [GO:0045724]; sperm axoneme assembly [GO:0007288] GO:0005635; GO:0005879; GO:0005882; GO:0005930; GO:0007288; GO:0031514; GO:0036126; GO:0042802; GO:0044782; GO:0045724; GO:0051321; GO:0070986 identical protein binding [GO:0042802] EEMEEENR 0.99414 -30.938 0 0 0 0 0 0 0 0 0 10.551 0 0 0 0 0 0 0 0 0 13.0006 0 0 0 0 10.9544 0 0 0 0 0 0 0 0 13.1439 0 0 0 0 0 0 0 0 0 0 11.9002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9236 0 0 0 0 0 0 0 0 0 12.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0704 0 0 0 0 0 12.2799 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2019 14.0756 14.0452 0 0 13.7324 0 0 14.229 0 0 0 0 0 0 0 0 0 0 0 0 14.0559 Q8TDR2 STK35_HUMAN "Serine/threonine-protein kinase 35, EC 2.7.11.1 (CLP-36-interacting kinase 1, CLIK-1) (PDLIM1-interacting kinase 1) (Serine/threonine-protein kinase 35 L1)" STK35 CLIK1 PDIK1 STK35L1 Homo sapiens (Human) meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; meiotic cell cycle [GO:0051321]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006468; GO:0016604; GO:0051321; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EGNQDNK 0.99414 -9.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7001 0 0 12.4696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WYK2 JDP2_HUMAN Jun dimerization protein 2 JDP2 Homo sapiens (Human) fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; leucine zipper domain binding [GO:0043522]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003682; GO:0005634; GO:0006357; GO:0031065; GO:0035497; GO:0042803; GO:0043522; GO:0045444; GO:0045599; GO:0046982; GO:0090575; GO:1990837 "cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; leucine zipper domain binding [GO:0043522]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" NKVAAAR 0.99414 -9.0949 0 13.6998 0 0 0 0 0 0 10.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6475 0 0 0 0 0 0 0 0 0 0 13.7905 13.044 0 0 13.5203 0 0 0 13.7305 13.4502 0 0 0 11.3414 13.5187 0 0 0 0 0 0 13.9584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6594 0 Q96E52 OMA1_HUMAN "Metalloendopeptidase OMA1, mitochondrial, EC 3.4.24.- (Metalloprotease-related protein 1, MPRP-1) (Overlapping with the m-AAA protease 1 homolog)" OMA1 MPRP1 Homo sapiens (Human) cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638] GO:0002024; GO:0004222; GO:0005743; GO:0006006; GO:0006515; GO:0006629; GO:0008289; GO:0010637; GO:0016020; GO:0016021; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0034982; GO:0042407; GO:0042981; GO:0043065; GO:0046872; GO:0051603; GO:0097009; GO:0120162; GO:0140467; GO:0140468; GO:1903850 lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AIRNFHTSPR 0.99414 -6.5592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4628 13.9845 0 12.2061 0 0 0 0 0 0 0 0 13.4041 0 0 0 0 0 0 0 0 15.3291 0 0 0 0 0 0 0 11.4624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7 0 0 0 0 0 0 0 0 0 0 0 13.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0466 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0482 0 0 16.6572 16.6493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4216 0 0 0 0 0 Q96JX3 SRAC1_HUMAN Protein SERAC1 (Serine active site-containing protein 1) SERAC1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; intracellular cholesterol transport [GO:0032367]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739] endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; extracellular matrix organization [GO:0030198]; intracellular cholesterol transport [GO:0032367]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654] GO:0005739; GO:0005783; GO:0008654; GO:0016021; GO:0030198; GO:0031012; GO:0032367; GO:0036148; GO:0044233 ARCPMER 0.99414 -8.6294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0331 0 0 0 0 0 11.7209 0 0 0 0 0 0 0 12.8894 0 0 0 0 11.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9935 0 12.5191 0 13.4723 0 0 0 0 14.9161 0 12.5332 0 0 0 0 0 0 13.0523 0 0 0 11.4926 0 13.2044 0 0 0 0 0 12.9324 0 0 0 0 0 0 0 0 0 13.4817 0 0 13.1711 0 0 0 12.8549 0 0 0 0 0 0 0 0 0 12.573 13.326 0 0 0 0 11.162 0 13.0266 12.3383 0 0 0 12.1749 0 0 14.6053 15.4582 0 15.6218 14.7603 0 15.1126 12.4665 14.6207 0 0 14.4621 11.1175 0 12.776 0 14.1374 0 12.9674 0 Q9BQC3 DPH2_HUMAN 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2) DPH2 DPH2L2 Homo sapiens (Human) peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183] cytosol [GO:0005829]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; protein-containing complex [GO:0032991]; 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; peptidyl-diphthamide biosynthetic process from peptidyl-histidine [GO:0017183]" GO:0005829; GO:0017183; GO:0032991; GO:0051539; GO:0090560 "2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]" GIAIAYEDEGSG 0.99414 -5.2995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZG1 RAB34_HUMAN Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah) RAB34 RAB39 RAH Homo sapiens (Human) antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosome localization [GO:0032418]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] cilium [GO:0005929]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vesicle [GO:0031982] cilium [GO:0005929]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; small GTPase binding [GO:0031267]; antigen processing and presentation [GO:0019882]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; Golgi to plasma membrane protein transport [GO:0043001]; lysosome localization [GO:0032418]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005794; GO:0005795; GO:0005929; GO:0006897; GO:0016192; GO:0019882; GO:0030030; GO:0030670; GO:0030742; GO:0031267; GO:0031982; GO:0031985; GO:0032418; GO:0043001; GO:0045335; GO:0045880; GO:0048471; GO:0070062; GO:0072659; GO:0090382; GO:0090385 GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; small GTPase binding [GO:0031267] CIASTYYR 0.99414 -9.1003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7582 0 0 0 12.8543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9318 0 0 0 13.0458 0 Q9H5J4 ELOV6_HUMAN "Elongation of very long chain fatty acids protein 6, EC 2.3.1.199 (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6, ELOVL FA elongase 6) (Fatty acid elongase 2, hELO2) (Fatty acyl-CoA elongase) (Long-chain fatty-acyl elongase) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6)" ELOVL6 FACE LCE Homo sapiens (Human) "fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fatty acid elongase complex [GO:0009923]; integral component of endoplasmic reticulum membrane [GO:0030176] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fatty acid elongase complex [GO:0009923]; integral component of endoplasmic reticulum membrane [GO:0030176]; fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]" GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0009923; GO:0019367; GO:0030148; GO:0030176; GO:0034625; GO:0034626; GO:0035338; GO:0042759; GO:0042761; GO:0102756; GO:0120162 fatty acid elongase activity [GO:0009922]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756] AKFELRK 0.99414 -9.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1148 0 0 0 0 0 11.0423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.258 12.0608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1506 0 0 0 0 0 0 12.5743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0859 0 13.1123 0 0 0 0 0 0 0 0 0 0 0 0 Q9P232 CNTN3_HUMAN "Contactin-3 (Brain-derived immunoglobulin superfamily protein 1, BIG-1) (Plasmacytoma-associated neuronal glycoprotein)" CNTN3 KIAA1496 PANG Homo sapiens (Human) cell adhesion [GO:0007155] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155] GO:0005576; GO:0005886; GO:0007155; GO:0031225; GO:0043005 AMENESEVTGYK 0.99414 -13.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9844 12.8626 13.4366 11.9103 0 0 12.1423 11.9228 0 11.8427 0 0 0 0 0 0 0 0 0 0 10.4483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3255 14.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.483 0 0 0 0 0 0 10.7616 0 0 0 0 14.4354 14.5561 0 11.6927 13.9068 0 10.2701 12.2095 0 0 0 0 0 0 0 0 0 Q9P2F8 SI1L2_HUMAN "Signal-induced proliferation-associated 1-like protein 2, SIPA1-like protein 2" SIPA1L2 KIAA1389 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005096; GO:0005737; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096] DVPPFGPPIPKGVTFPK 0.99414 -31.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3529 0 11.6341 0 11.234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1545 0 0 0 0 11.6772 0 0 0 12.8667 14.8095 0 0 0 0 0 0 0 0 0 0 13.1868 0 12.3859 13.5804 13.4907 13.2066 0 13.5929 0 12.9382 0 0 0 11.5755 0 0 13.2832 0 13.1039 15.1949 13.619 0 0 0 0 0 0 13.3053 0 0 0 0 12.5895 0 0 0 0 13.0229 0 11.9281 13.24 0 12.3503 0 0 0 0 0 0 12.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7853 14.1508 0 0 0 0 0 11.8559 13.917 11.9876 14.2828 14.0865 0 13.9879 0 0 14.1448 0 0 13.4248 0 14.5468 0 11.1619 Q9ULW2 FZD10_HUMAN "Frizzled-10, Fz-10, hFz10 (FzE7) (CD antigen CD350)" FZD10 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; negative regulation of GTPase activity [GO:0034260]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956] cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; negative regulation of GTPase activity [GO:0034260]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JUN kinase activity [GO:0043507]; regulation of actin cytoskeleton organization [GO:0032956] GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0009986; GO:0016021; GO:0017147; GO:0030182; GO:0032956; GO:0034260; GO:0038031; GO:0042813; GO:0043507; GO:0043547; GO:0060070; GO:0071300 G protein-coupled receptor activity [GO:0004930]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] CQPIEIPMCK 0.99414 -9.0925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULW3 ABT1_HUMAN "Activator of basal transcription 1, hABT1 (Basal transcriptional activator)" ABT1 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; regulation of transcription by RNA polymerase II [GO:0006357]; small-subunit processome assembly [GO:0034462]; spinal cord motor neuron differentiation [GO:0021522]; transcription by RNA polymerase II [GO:0006366]" nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; regulation of transcription by RNA polymerase II [GO:0006357]; small-subunit processome assembly [GO:0034462]; spinal cord motor neuron differentiation [GO:0021522]; transcription by RNA polymerase II [GO:0006366]" GO:0000447; GO:0000472; GO:0000480; GO:0003677; GO:0003713; GO:0003723; GO:0005634; GO:0005667; GO:0005730; GO:0006357; GO:0006366; GO:0021522; GO:0034462 DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] AARPGGR 0.99414 -8.1275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6997 0 0 0 0 0 0 0 0 18.7427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y259 CHKB_HUMAN "Choline/ethanolamine kinase (Choline kinase beta, CK, CKB, EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase, EK, EC 2.7.1.82) (Ethanolamine kinase beta, EKB) (choline/ethanolamine kinase beta, CKEKB)" CHKB CHETK CHKL Homo sapiens (Human) CDP-choline pathway [GO:0006657]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; CDP-choline pathway [GO:0006657]; muscle organ development [GO:0007517]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphorylation [GO:0016310] GO:0004103; GO:0004305; GO:0005524; GO:0005737; GO:0005829; GO:0006646; GO:0006656; GO:0006657; GO:0007517; GO:0016310 ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305] AYQWCREYLGGAWR 0.99414 -9.0857 0 0 0 0 0 0 0 0 0 0 11.7136 0 0 12.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4802 0 0 0 0 0 0 0 0 0 0 0 11.1506 0 0 11.5245 0 0 0 0 0 0 0 0 0 0 0 10.5322 0 0 0 0 0 12.5099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.419 0 0 0 0 0 12.4187 13.7337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8867 0 0 Q9Y6X9 MORC2_HUMAN "ATPase MORC2, EC 3.6.1.- (MORC family CW-type zinc finger protein 2) (Zinc finger CW-type coiled-coil domain protein 1)" MORC2 KIAA0852 ZCWCC1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; fatty acid metabolic process [GO:0006631]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; fatty acid metabolic process [GO:0006631]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]" GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006631; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042802; GO:0042803; GO:0045814; GO:0045869; GO:0090309 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270] DIQMAETSPEGTKPERR 0.99414 -36.404 0 0 11.853 0 0 0 0 0 13.2406 0 0 0 12.7484 0 0 0 0 0 0 12.7898 0 0 0 13.0098 0 0 0 0 0 0 0 0 0 10.1449 0 0 0 0 0 12.4232 0 0 0 0 0 12.3152 0 0 12.0691 0 0 0 0 0 0 0 0 11.818 0 0 0 0 0 0 0 0 0 0 0 0 15.1577 0 0 0 13.5099 0 15.9839 0 14.253 0 14.9054 0 15.4018 0 12.4754 18.4895 18.5499 18.3511 0 18.3201 0 18.4896 17.6206 0 18.396 0 19.6218 14.9306 14.1305 14.0726 12.6386 14.3759 0 17.2982 14.2568 0 14.3064 14.0403 0 13.2612 14.5828 12.6788 17.3186 0 0 12.7012 14.3808 0 14.3376 14.1853 0 13.7552 0 14.8536 0 0 0 14.4502 0 0 14.722 15.1706 14.0309 17.9699 13.1371 0 0 0 13.1359 12.9806 12.2103 0 12.4507 0 0 14.74 13.9944 0 0 14.5693 12.856 0 12.8726 0 0 16.1602 13.2074 0 12.8464 12.3915 0 0 0 0 0 12.2387 0 0 13.6442 0 0 0 0 0 0 12.6257 0 0 0 0 Q9H582 ZN644_HUMAN "Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2, Zep-2)" ZNF644 KIAA1221 ZEP2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001222; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]" ESGVHKPK 0.99415 -36.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1139 0 0 12.4028 11.0042 12.3532 0 0 0 0 0 0 0 0 0 0 0 10.9079 0 0 0 0 0 0 0 16.9864 0 0 0 0 13.3224 10.6576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7813 0 0 0 11.7306 0 0 0 13.8696 14.6453 14.1625 14.1064 13.9617 14.8901 0 0 0 0 0 0 13.0488 13.5911 0 0 0 0 0 10.4451 17.5116 0 0 0 0 14.725 0 14.757 0 14.8088 11.0819 14.48 12.4421 14.9574 11.5623 0 14.5868 13.7385 0 0 13.527 0 0 0 0 0 14.5699 13.4429 0 0 0 14.7011 0 0 0 14.6188 0 0 14.4213 0 0 0 0 13.3815 0 0 15.025 0 14.4834 0 13.2339 0 0 0 13.3167 17.1137 0 0 0 14.6703 0 0 0 0 0 0 0 0 0 0 0 11.3092 0 0 0 0 0 0 14.607 0 0 0 0 0 O14980 XPO1_HUMAN "Exportin-1, Exp1 (Chromosome region maintenance 1 protein homolog)" XPO1 CRM1 Homo sapiens (Human) mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254] annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein export from nucleus [GO:0046825]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254] GO:0000054; GO:0000055; GO:0000056; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005635; GO:0005642; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006611; GO:0006913; GO:0010824; GO:0015030; GO:0016020; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042254; GO:0043231; GO:0046825; GO:0051028; GO:1990904 nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] AHWKFLK 0.99415 -36.627 0 0 0 0 0 0 0 0 13.4184 0 0 0 0 0 0 0 0 12.6778 0 0 12.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7706 0 0 0 0 0 0 0 0 12.6945 0 0 13.4476 12.1366 16.4253 16.6147 15.2017 13.4014 14.5939 0 0 0 0 13.3082 14.8747 12.8184 0 0 0 17.9525 14.141 15.0651 0 13.2806 13.8657 16.4251 13.9363 0 0 13.1711 0 0 17.7112 0 16.0655 0 15.7465 13.2881 0 0 0 16.2309 0 15.5317 13.2728 13.2958 13.7196 13.9202 14.1547 0 14.465 0 0 15.7871 14.8747 14.7106 13.1573 0 13.1708 0 13.2846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7513 0 0 16.0975 0 0 16.4113 0 0 0 0 0 14.3364 0 0 0 0 0 0 0 14.0773 14.9944 14.8641 16.1762 0 15.5426 0 14.1517 0 O75182 SIN3B_HUMAN Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b) SIN3B KIAA0700 Homo sapiens (Human) histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122] autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806] autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000118; GO:0000122; GO:0000785; GO:0000805; GO:0000806; GO:0001741; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0016575; GO:0016580; GO:0030336; GO:0030849 chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714] AERCMADENCFK 0.99415 -36.546 0 0 0 0 0 0 0 0 13.2583 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7638 12.6082 10.4595 0 0 0 0 0 0 13.4565 0 0 10.0143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.641 12.6546 12.5129 12.3072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1283 0 0 0 12.2649 11.9927 0 0 0 15.2485 13.1349 14.9575 0 0 12.1263 14.8588 15.5071 15.2769 14.4528 14.5914 13.9116 0 0 0 0 0 12.9745 13.2909 14.9836 0 0 0 12.7088 10.3965 12.8002 0 0 0 0 13.5171 0 0 14.1863 0 14.0218 14.3472 14.4412 0 14.0225 0 0 0 0 13.1591 13.0764 14.1655 12.8978 12.8197 0 0 0 0 0 0 13.2437 0 0 0 0 11.1788 0 0 0 0 12.7283 12.7005 0 0 0 0 0 0 0 11.0819 0 0 0 0 12.0147 12.1602 0 0 13.2811 0 0 0 11.4786 11.5189 0 0 0 12.3154 0 10.774 Q13424 SNTA1_HUMAN "Alpha-1-syntrophin (59 kDa dystrophin-associated protein A1 acidic component 1) (Pro-TGF-alpha cytoplasmic domain-interacting protein 1, TACIP1) (Syntrophin-1)" SNTA1 SNT1 Homo sapiens (Human) muscle contraction [GO:0006936]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuromuscular junction development [GO:0007528]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of vasoconstriction by circulating norepinephrine [GO:0003117]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202]; syntrophin complex [GO:0016013]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; sodium channel regulator activity [GO:0017080]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]; muscle contraction [GO:0006936]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuromuscular junction development [GO:0007528]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of vasoconstriction by circulating norepinephrine [GO:0003117]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0002027; GO:0003117; GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0006936; GO:0007528; GO:0016010; GO:0016013; GO:0017080; GO:0030165; GO:0031594; GO:0032991; GO:0042383; GO:0044325; GO:0045202; GO:0045211; GO:0050998; GO:0051117; GO:0060307; GO:0070161; GO:0086005; GO:1902083; GO:1902305 actin binding [GO:0003779]; ATPase binding [GO:0051117]; calmodulin binding [GO:0005516]; nitric-oxide synthase binding [GO:0050998]; PDZ domain binding [GO:0030165]; sodium channel regulator activity [GO:0017080]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] AAEGVQEVSTACTWNGR 0.99415 -13.592 0 0 0 0 0 0 0 0 0 13.3315 0 12.9314 0 0 13.4159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2869 0 0 0 13.3796 13.184 0 13.0583 0 13.6327 0 0 0 13.0308 12.998 12.8394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1225 0 12.4821 0 0 0 13.9817 13.6732 13.6766 0 0 0 13.9207 0 0 0 13.3001 0 13.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4122 0 0 0 0 0 0 0 0 0 13.512 0 13.8016 0 13.1826 13.4192 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3378 12.1861 0 12.7431 0 0 0 0 0 0 0 0 14.0935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1144 13.3425 0 0 0 0 0 0 0 Q5FYB0 ARSJ_HUMAN "Arylsulfatase J, ASJ, EC 3.1.6.-" ARSJ UNQ372/PRO708 Homo sapiens (Human) actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576] actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] AVSGSTCHSGVTCG 0.99415 -15.317 0 0 0 0 0 0 0 0 13.0852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PEW1 ZCH12_HUMAN Zinc finger CCHC domain-containing protein 12 (Smad-interacting zinc finger protein 1) ZCCHC12 SIZN1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0005634; GO:0008270 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] CSYCGEEGHSKETCDNESDK 0.99415 -15.721 0 10.3964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9148 0 0 0 0 0 15.2245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PL24 TMED8_HUMAN Protein TMED8 TMED8 FAM15B L10 Homo sapiens (Human) DATEDLR 0.99415 -15.303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1544 0 11.5446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8174 0 0 0 13.2193 0 0 0 0 0 13.4995 0 0 0 0 0 12.6138 0 14.0345 14.1113 0 12.9582 0 0 0 0 0 0 0 12.4731 0 13.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V24 PAQR2_HUMAN Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II) ADIPOR2 PAQR2 Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cold-induced thermogenesis [GO:0120162]; vascular wound healing [GO:0061042] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023]; adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cold-induced thermogenesis [GO:0120162]; vascular wound healing [GO:0061042] GO:0005886; GO:0009755; GO:0016021; GO:0019395; GO:0031226; GO:0033211; GO:0038023; GO:0042593; GO:0042802; GO:0046872; GO:0055100; GO:0061042; GO:0097003; GO:0120162 adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023] TPEPDIR 0.99415 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XX4 FRAS1_HUMAN Extracellular matrix organizing protein FRAS1 (Fraser syndrome 1 protein) FRAS1 KIAA1500 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; anatomical structure morphogenesis [GO:0009653]; cell communication [GO:0007154]; embryonic limb morphogenesis [GO:0030326]; metanephros morphogenesis [GO:0003338]; morphogenesis of an epithelium [GO:0002009]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skin development [GO:0043588] GO:0002009; GO:0003338; GO:0005201; GO:0005604; GO:0005886; GO:0007154; GO:0009653; GO:0015031; GO:0016021; GO:0030326; GO:0043588; GO:0046872; GO:0060021; GO:0062023 extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872] ACHSSCLACMGPAPSHCTGCKK 0.99415 -37.077 0 0 0 0 0 0 0 0 0 12.7341 0 12.6403 0 0 0 0 12.9655 0 11.9834 0 13.099 0 10.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9993 0 0 12.1241 12.8745 0 0 0 0 0 0 10.4542 0 0 0 10.8401 0 0 0 0 0 0 0 0 13.8825 14.4704 12.2653 0 0 13.1618 13.7354 12.6854 0 0 0 13.3763 0 0 0 0 0 16.8406 14.0611 0 12.3072 0 0 12.6335 10.6494 0 0 12.6877 0 0 0 10.4522 0 11.77 0 13.5631 14.4413 13.9216 14.4728 14.635 14.1948 0 0 12.4771 0 0 14.9542 0 14.4333 14.5267 0 0 11.1679 0 0 13.4332 15.4235 14.2627 13.6969 13.4508 0 12.4965 12.6305 0 12.6187 0 0 12.6205 13.4735 0 13.5536 0 0 0 0 11.6591 12.5792 11.8964 12.0304 0 13.3326 0 10.7173 12.2829 13.7125 0 13.0312 0 13.17 13.6643 13.7942 0 13.5322 10.0289 12.0226 13.1442 11.7068 11.9327 12.0098 0 0 12.1923 14.027 13.1474 13.0301 0 14.3525 0 0 0 0 0 0 Q8N1G0 ZN687_HUMAN Zinc finger protein 687 ZNF687 KIAA1441 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005654; GO:0005829; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AQGPGRK 0.99415 -13.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2772 15.2758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0948 0 0 0 0 0 0 10.493 0 0 0 0 14.3646 0 17.2702 16.0657 0 0 0 0 12.2129 13.5348 0 16.0206 15.5315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9552 0 0 16.899 0 0 0 0 0 0 0 0 0 0 0 0 0 13.274 0 14.8518 0 0 12.4971 14.1112 14.1655 13.8129 0 0 0 13.0258 0 0 14.5838 0 0 0 15.0284 14.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8044 0 0 12.2496 0 Q8N4L2 PP4P2_HUMAN "Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase, Type 2 PtdIns-4,5-P2 4-Ptase, EC 3.1.3.78 (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)" PIP4P2 TMEM55A Homo sapiens (Human) negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856]" GO:0005765; GO:0005886; GO:0016021; GO:0030670; GO:0031902; GO:0034597; GO:0046856; GO:0050765 "phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]" FNTLAKCPHCKK 0.99415 -8.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2859 0 0 10.1208 0 0 0 0 14.4179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2777 0 0 0 0 0 0 0 0 0 13.4594 13.4843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2606 0 0 0 0 0 0 0 0 0 13.0827 0 0 0 10.9526 0 11.3335 0 0 0 0 0 0 0 0 Q9BTW9 TBCD_HUMAN "Tubulin-specific chaperone D (Beta-tubulin cofactor D, tfcD) (SSD-1) (Tubulin-folding cofactor D)" TBCD KIAA0988 SSD1 TFCD PP1096 Homo sapiens (Human) adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] GO:0000226; GO:0000278; GO:0005096; GO:0005737; GO:0005813; GO:0005874; GO:0005912; GO:0005923; GO:0006457; GO:0007021; GO:0007023; GO:0010812; GO:0016328; GO:0031115; GO:0034333; GO:0048487; GO:0048667; GO:0051087; GO:0070830 beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096] DHEAWETR 0.99415 -15.715 0 0 0 0 0 9.60679 0 0 0 0 13.8517 0 0 0 0 0 0 10.6997 0 0 0 0 11.1697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2043 14.4835 14.9496 12.3984 0 0 12.1912 0 12.4534 12.2305 0 0 0 0 0 0 11.5675 9.79123 0 0 11.3638 0 0 11.2584 0 0 0 0 0 11.0562 0 0 0 0 11.1266 0 0 10.082 0 0 0 0 0 0 0 0 0 13.0044 0 0 0 0 0 0 12.476 0 10.5318 0 0 0 0 0 0 0 0 12.226 0 0 12.7761 0 0 0 10.3712 16.8023 0 12.2463 0 0 9.03812 12.8853 0 0 0 0 12.9008 0 0 0 12.0859 12.4917 0 0 0 0 12.894 0 0 0 0 0 11.7277 12.5269 12.1492 0 0 0 11.9975 0 12.4961 11.8639 0 0 9.92435 13.2326 Q9H251 CAD23_HUMAN Cadherin-23 (Otocadherin) CDH23 KIAA1774 KIAA1812 UNQ1894/PRO4340 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426] catenin complex [GO:0016342]; centrosome [GO:0005813]; cochlear hair cell ribbon synapse [GO:0098683]; integral component of membrane [GO:0016021]; kinocilium [GO:0060091]; membrane [GO:0016020]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; equilibrioception [GO:0050957]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; locomotory behavior [GO:0007626]; photoreceptor cell maintenance [GO:0045494]; post-embryonic animal organ morphogenesis [GO:0048563]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] GO:0001917; GO:0005509; GO:0005813; GO:0006816; GO:0007156; GO:0007601; GO:0007605; GO:0007626; GO:0016020; GO:0016021; GO:0016339; GO:0016342; GO:0032420; GO:0032426; GO:0045296; GO:0045494; GO:0048563; GO:0050896; GO:0050953; GO:0050957; GO:0051480; GO:0060088; GO:0060091; GO:0098683; GO:0098684; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] ELVATYEVTLSVIDNASDLPER 0.99415 -8.175 0 0 0 0 0 0 0 0 0 0 0 11.7975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.989 0 0 0 0 0 0 11.8147 0 12.5428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7404 0 0 0 0 0 0 10.933 0 13.0651 0 0 0 13.9452 13.6991 14.5578 0 13.771 0 0 11.373 0 0 0 0 14.1408 0 0 14.1787 0 0 14.1829 14.0551 0 0 0 13.195 0 0 0 0 0 0 0 13.7447 13.838 0 14.3242 13.7684 12.08 0 0 0 0 11.9179 0 0 0 0 14.4809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.459 0 0 0 0 13.2777 0 0 16.0834 0 12.8265 13.5021 13.8787 0 0 0 0 13.9231 13.5228 0 0 0 0 12.9236 12.727 0 13.0534 0 0 13.1867 11.673 0 0 13.25 Q9NSV4 DIAP3_HUMAN "Protein diaphanous homolog 3 (Diaphanous-related formin-3, DRF3) (MDia2)" DIAPH3 DIAP3 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010] GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0007010; GO:0030036; GO:0030041; GO:0031267; GO:0045296 actin binding [GO:0003779]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267] EACNVESNR 0.99415 -8.1685 0 0 0 0 0 0 0 0 0 0 0 11.5987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0024 0 11.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5439 0 0 0 0 0 0 0 0 13.8997 0 0 0 0 0 13.9747 0 0 0 0 0 0 11.4167 0 0 0 0 0 0 0 0 0 0 12.272 0 0 0 0 0 12.6562 0 13.4189 13.8568 0 12.3323 0 0 0 0 0 0 13.5962 0 13.1947 0 0 0 14.3228 0 0 0 12.9108 0 0 0 0 0 0 0 13.4569 0 0 11.6264 0 0 12.8397 0 17.6629 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9921 16.9676 0 0 0 0 0 0 0 Q9UBV7 B4GT7_HUMAN "Beta-1,4-galactosyltransferase 7, Beta-1,4-GalTase 7, Beta4Gal-T7, b4Gal-T7, EC 2.4.1.- (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase, EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)" B4GALT7 XGALT1 UNQ748/PRO1478 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; glycosylation [GO:0070085]; negative regulation of fibroblast proliferation [GO:0048147]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]; carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; glycosylation [GO:0070085]; negative regulation of fibroblast proliferation [GO:0048147]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; proteoglycan biosynthetic process [GO:0030166]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435]" GO:0000139; GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016021; GO:0030145; GO:0030166; GO:0030203; GO:0032580; GO:0036211; GO:0046525; GO:0048147; GO:0070085; GO:0097435 "beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]" EDDEFYR 0.99415 -13.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULL0 K1210_HUMAN Acrosomal protein KIAA1210 KIAA1210 Homo sapiens (Human) acrosomal vesicle [GO:0001669] acrosomal vesicle [GO:0001669] GO:0001669 AGSSPTNK 0.99415 -13.594 0 0 0 0 0 10.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9951 13.5438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9742 14.606 13.8177 0 0 0 0 0 12.7655 0 0 0 0 11.0661 15.6201 0 12.9134 13.3453 0 0 0 0 0 0 0 0 11.5147 0 0 13.4857 0 0 0 0 0 0 0 13.9401 0 0 0 0 0 14.3775 14.3718 0 0 12.6463 13.2939 12.0153 12.6812 0 0 0 0 13.0625 0 13.67 0 11.5637 14.9994 15.0115 0 0 0 0 0 11.3107 0 12.0799 0 0 0 0 0 11.7036 13.4584 0 0 0 0 0 0 0 0 0 0 14.1187 0 0 0 12.7961 0 13.8157 12.3629 13.769 0 12.886 0 12.3187 0 0 A0FGR8 ESYT2_HUMAN "Extended synaptotagmin-2, E-Syt2 (Chr2Syt)" ESYT2 FAM62B KIAA1228 Homo sapiens (Human) endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] GO:0005509; GO:0005544; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0006869; GO:0006897; GO:0008429; GO:0016020; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0042802; GO:0044232; GO:0045296; GO:0061817; GO:0140268 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091] AKTARGLR 0.99416 -29.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0719 0 0 14.2133 17.2184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4421 0 13.9123 0 0 0 0 0 13.9388 12.5822 0 0 0 0 0 0 0 0 0 0 0 0 14.8714 0 0 0 14.9624 0 0 0 13.8323 13.6334 13.3548 0 14.0229 0 0 0 0 0 12.5886 17.1236 0 0 15.1165 15.5477 13.9874 15.1665 0 0 13.6593 13.448 0 0 0 0 12.2203 12.7705 0 0 12.4841 0 0 12.2183 0 13.7967 0 0 13.748 13.8438 15.4591 0 14.2612 0 15.7819 12.5458 0 0 14.3927 13.9645 0 0 0 14.3561 0 16.1277 13.0481 16.2433 0 14.1698 12.4993 12.8684 0 0 14.319 14.7878 15.86 0 0 14.2479 0 0 19.4928 0 0 0 0 13.2392 0 13.9989 0 13.0836 13.5814 0 0 0 0 0 0 0 0 0 14.7065 0 0 0 0 15.28 0 12.1165 13.4988 0 0 0 0 0 P00441 SODC_HUMAN "Superoxide dismutase [Cu-Zn], EC 1.15.1.1 (Superoxide dismutase 1, hSod1)" SOD1 Homo sapiens (Human) aging [GO:0007568]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; auditory receptor cell stereocilium organization [GO:0060088]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of developmental process [GO:0051093]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reproductive process [GO:2000242]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; small GTPase binding [GO:0031267]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; auditory receptor cell stereocilium organization [GO:0060088]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of developmental process [GO:0051093]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reproductive process [GO:2000242]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226] GO:0000303; GO:0001541; GO:0001819; GO:0001890; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005764; GO:0005777; GO:0005829; GO:0006749; GO:0006801; GO:0006879; GO:0006915; GO:0007283; GO:0007566; GO:0007568; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0009410; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031045; GO:0031267; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0032991; GO:0033081; GO:0034465; GO:0035234; GO:0035865; GO:0040014; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043065; GO:0043085; GO:0043087; GO:0043410; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046620; GO:0046677; GO:0046688; GO:0046716; GO:0048538; GO:0048678; GO:0050665; GO:0050728; GO:0050766; GO:0051087; GO:0051093; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115; GO:2000242 chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; small GTPase binding [GO:0031267]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270] TLVVHEK 0.99416 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5573 14.7558 14.6734 0 13.9714 13.8918 0 14.1478 14.4212 14.3125 0 13.6098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9674 0 0 0 12.126 0 0 0 0 0 0 0 0 P56556 NDUA6_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14, CI-B14) (LYR motif-containing protein 6) (NADH-ubiquinone oxidoreductase B14 subunit)" NDUFA6 LYRM6 NADHB14 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]" GO:0005743; GO:0005747; GO:0006120; GO:0006979; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] ELYRAWYR 0.99416 -29.894 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8876 0 0 0 0 0 12.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3337 0 0 0 12.9032 0 0 0 15.5223 0 0 15.2088 0 0 0 0 13.288 0 0 0 0 0 0 0 13.5442 0 0 0 0 0 0 0 14.3525 0 0 0 13.5071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1981 0 0 0 0 0 0 0 13.7852 14.0665 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4832 0 0 0 0 0 0 0 0 0 0 0 P61224 RAP1B_HUMAN "Ras-related protein Rap-1b, EC 3.6.5.2 (GTP-binding protein smg p21B)" RAP1B OK/SW-cl.11 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; establishment of localization in cell [GO:0051649]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of integrin activation [GO:0033625]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of establishment of cell polarity [GO:2000114] azurophil granule membrane [GO:0035577]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886] azurophil granule membrane [GO:0035577]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877]; calcium-ion regulated exocytosis [GO:0017156]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; establishment of localization in cell [GO:0051649]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of integrin activation [GO:0033625]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of establishment of cell polarity [GO:2000114] GO:0003924; GO:0003925; GO:0005525; GO:0005811; GO:0005829; GO:0005886; GO:0005911; GO:0008283; GO:0016020; GO:0017156; GO:0019003; GO:0032486; GO:0033625; GO:0035577; GO:0044877; GO:0045955; GO:0051649; GO:0061028; GO:0070062; GO:0070374; GO:0071320; GO:1901888; GO:2000114; GO:2000301 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877] KTPVPGK 0.99416 -15.82 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2506 11.0384 14.0379 0 0 0 0 12.9752 13.1603 12.6829 0 0 0 0 0 0 0 0 0 0 15.415 0 0 0 0 0 11.6496 0 0 0 10.3718 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74229 0 0 0 10.627 0 0 0 0 0 14.3299 0 12.0781 0 12.9678 0 12.9327 12.3462 0 0 0 0 0 0 0 0 0 12.4541 0 0 0 0 0 14.1771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.282 0 12.5654 13.8651 0 0 0 0 0 Q4G0X9 CCD40_HUMAN Coiled-coil domain-containing protein 40 CCDC40 KIAA1640 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576] axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; regulation of cilium beat frequency [GO:0003356] GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0060287; GO:0070286; GO:0071907; GO:0071910 AEPGGAAGR 0.99416 -29.736 0 0 0 10.332 0 0 0 0 0 0 0 0 0 13.7165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1154 0 15.5687 0 0 0 0 10.9398 15.4131 0 13.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5267 0 0 0 0 Q8NDV7 TNR6A_HUMAN "Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen, Protein GW1) (Glycine-tryptophan protein of 182 kDa)" TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) cellular response to starvation [GO:0009267]; miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442]; RNA binding [GO:0003723]; cellular response to starvation [GO:0009267]; miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213] GO:0000932; GO:0003723; GO:0005654; GO:0005794; GO:0005829; GO:0009267; GO:0016442; GO:0035195; GO:0035278; GO:0043231; GO:0060213 RNA binding [GO:0003723] DLVQEEEQLMEEKKK 0.99416 -15.818 0 0 0 0 0 0 0 0 13.1483 12.2752 13.798 13.2693 13.0624 12.3816 12.3946 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6672 0 0 0 0 0 12.4838 0 13.488 0 0 0 11.9019 0 0 11.6688 0 0 10.938 0 14.2281 13.5709 14.0691 0 0 12.1716 0 0 0 0 0 0 0 12.671 0 10.6017 0 0 0 0 15.2001 0 0 0 0 0 0 14.5537 0 0 0 0 14.4926 0 0 0 0 0 14.7812 15.036 14.2983 13.3081 14.1351 0 15.2454 13.2588 13.1495 15.7131 0 14.7524 0 12.5561 0 0 0 11.18 0 12.6643 15.547 0 15.3827 0 0 0 0 15.093 12.1793 0 10.6778 0 0 0 0 13.6147 0 0 11.1293 0 0 0 0 13.7015 14.8342 0 14.738 0 0 16.0186 0 0 0 13.5054 0 0 0 10.5118 0 0 0 15.1219 0 0 0 0 0 0 0 9.93264 13.9091 14.3273 14.4391 15.4218 15.1115 13.7803 14.5509 16.4439 0 14.0186 14.5639 15.2872 15.3178 15.0809 0 0 0 0 0 15.3348 10.9454 0 0 0 Q9BZE4 GTPB4_HUMAN GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1) GTPBP4 CRFG NOG1 Homo sapiens (Human) "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; ribosomal large subunit biogenesis [GO:0042273]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; ribosomal large subunit biogenesis [GO:0042273]" GO:0000079; GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0033342; GO:0042273; GO:0048471; GO:0050821 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723] AHYNFKKITVVPSAK 0.99416 -29.726 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6721 0 0 0 0 0 11.2904 0 0 0 0 11.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.896 12.2589 0 0 0 0 0 11.2451 16.3493 11.3707 9.94783 0 11.5667 0 0 0 0 0 0 0 0 0 0 0 0 13.5309 0 0 0 0 13.1367 13.0015 13.3849 0 0 19.3381 14.5664 0 0 0 13.2007 13.5874 0 0 0 13.6852 0 0 0 0 0 0 13.8314 0 0 0 0 14.3858 0 11.3071 14.1504 0 0 13.8588 0 12.058 13.9788 0 0 11.8574 15.4649 12.9186 0 0 0 0 13.3215 0 0 0 13.1399 13.7154 0 0 0 0 0 0 0 0 0 0 0 0 12.5554 0 0 0 0 0 0 0 12.8948 0 0 0 0 11.8313 0 0 0 12.2687 0 0 12.5679 0 0 0 0 0 12.5872 0 0 11.9425 0 12.3752 0 0 O15392 BIRC5_HUMAN Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin) BIRC5 API4 IAP4 Homo sapiens (Human) "cell division [GO:0051301]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; protein-containing complex localization [GO:0031503]; regulation of cell cycle [GO:0051726]; regulation of cellular protein metabolic process [GO:0032268]; sensory perception of sound [GO:0007605]" "centriole [GO:0005814]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; survivin complex [GO:1990713]" "centriole [GO:0005814]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; survivin complex [GO:1990713]; chaperone binding [GO:0051087]; cobalt ion binding [GO:0050897]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; protein-containing complex localization [GO:0031503]; regulation of cell cycle [GO:0051726]; regulation of cellular protein metabolic process [GO:0032268]; sensory perception of sound [GO:0007605]" GO:0000086; GO:0000228; GO:0000278; GO:0000281; GO:0000775; GO:0000776; GO:0001934; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005876; GO:0005881; GO:0006468; GO:0007052; GO:0007094; GO:0007605; GO:0008017; GO:0008270; GO:0008284; GO:0015630; GO:0015631; GO:0019899; GO:0030496; GO:0031021; GO:0031267; GO:0031503; GO:0031536; GO:0032133; GO:0032268; GO:0032991; GO:0042802; GO:0042803; GO:0043027; GO:0043066; GO:0043154; GO:0045892; GO:0045931; GO:0046872; GO:0046982; GO:0050897; GO:0051087; GO:0051256; GO:0051301; GO:0051303; GO:0051726; GO:0090267; GO:1901970; GO:1902425; GO:1903490; GO:1990713 chaperone binding [GO:0051087]; cobalt ion binding [GO:0050897]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] DHRISTFK 0.99417 -8.0007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05026 AT1B1_HUMAN Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1) ATP1B1 ATP1B Homo sapiens (Human) ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell adhesion [GO:0007155]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; innate immune response [GO:0045087]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport into plasma membrane raft [GO:0044861]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression [GO:0010468]; relaxation of cardiac muscle [GO:0055119]; response to hypoxia [GO:0001666]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; MHC class II protein complex binding [GO:0023026]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell adhesion [GO:0007155]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; innate immune response [GO:0045087]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport into plasma membrane raft [GO:0044861]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression [GO:0010468]; relaxation of cardiac muscle [GO:0055119]; response to hypoxia [GO:0001666]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725] GO:0001666; GO:0001671; GO:0005391; GO:0005886; GO:0005890; GO:0005901; GO:0006874; GO:0006883; GO:0007155; GO:0008022; GO:0010248; GO:0010468; GO:0010882; GO:0014704; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0023026; GO:0030007; GO:0030315; GO:0030674; GO:0031090; GO:0032781; GO:0035725; GO:0036126; GO:0036376; GO:0042383; GO:0044861; GO:0045087; GO:0046034; GO:0046982; GO:0050821; GO:0051117; GO:0055119; GO:0060048; GO:0070062; GO:0072659; GO:0086009; GO:0086013; GO:0086064; GO:0098655; GO:1901018; GO:1902600; GO:1903278; GO:1903281; GO:1903288; GO:1903408; GO:1903561; GO:1990573 ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; MHC class II protein complex binding [GO:0023026]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674] DDMIFEDCGDVPSEPKERGDFNHER 0.99417 -8.5126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8456 0 0 0 0 13.3811 12.5591 0 12.3631 0 12.27 0 0 0 0 0 0 0 0 13.9461 0 0 0 0 0 0 0 0 0 0 0 13.2316 12.3348 14.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0341 0 0 0 0 0 0 0 0 0 0 0 13.0322 0 13.3269 0 0 0 0 0 13.569 0 13.057 13.2845 13.4718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0029 13.5106 11.7827 0 0 0 0 P06756 ITAV_HUMAN Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain ] ITGAV MSK8 VNRA VTNR Homo sapiens (Human) angiogenesis [GO:0001525]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; endodermal cell differentiation [GO:0035987]; entry into host cell by a symbiont-containing vacuole [GO:0085017]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of entry of bacterium into host cell [GO:2000536]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of phagocytosis [GO:0050764]; regulation of transforming growth factor beta activation [GO:1901388]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta production [GO:0071604]; vasculogenesis [GO:0001570]; viral entry into host cell [GO:0046718] alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin alphav-beta3 complex [GO:0034683]; integrin alphav-beta5 complex [GO:0034684]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579] alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin alphav-beta3 complex [GO:0034683]; integrin alphav-beta5 complex [GO:0034684]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]; coreceptor activity [GO:0015026]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; opsonin binding [GO:0001846]; protease binding [GO:0002020]; protein kinase C binding [GO:0005080]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; voltage-gated calcium channel activity [GO:0005245]; angiogenesis [GO:0001525]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; endodermal cell differentiation [GO:0035987]; entry into host cell by a symbiont-containing vacuole [GO:0085017]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of entry of bacterium into host cell [GO:2000536]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of phagocytosis [GO:0050764]; regulation of transforming growth factor beta activation [GO:1901388]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta production [GO:0071604]; vasculogenesis [GO:0001570]; viral entry into host cell [GO:0046718] GO:0001525; GO:0001570; GO:0001618; GO:0001846; GO:0001968; GO:0002020; GO:0005080; GO:0005178; GO:0005245; GO:0005829; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007160; GO:0007204; GO:0007229; GO:0008284; GO:0008305; GO:0009897; GO:0009986; GO:0010745; GO:0010888; GO:0015026; GO:0016020; GO:0016477; GO:0030335; GO:0031258; GO:0031527; GO:0031528; GO:0031589; GO:0032369; GO:0032587; GO:0033627; GO:0033690; GO:0034113; GO:0034446; GO:0034683; GO:0034684; GO:0034685; GO:0034686; GO:0035579; GO:0035866; GO:0035867; GO:0035868; GO:0035987; GO:0038027; GO:0043277; GO:0045335; GO:0045785; GO:0046718; GO:0046872; GO:0050431; GO:0050748; GO:0050764; GO:0050840; GO:0050919; GO:0051057; GO:0070062; GO:0070371; GO:0070588; GO:0071604; GO:0085017; GO:0097192; GO:0098609; GO:1901388; GO:1902533; GO:1905598; GO:1990430; GO:2000536; GO:2001237 coreceptor activity [GO:0015026]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; opsonin binding [GO:0001846]; protease binding [GO:0002020]; protein kinase C binding [GO:0005080]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; voltage-gated calcium channel activity [GO:0005245] AFPPRRR 0.99417 -28.454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4772 0 0 0 13.3666 15.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6806 0 0 12.5111 0 12.9419 13.711 12.5364 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0864 0 0 0 14.1794 0 0 0 14.2161 0 0 0 0 0 0 0 0 0 14.689 0 0 0 0 0 15.325 0 0 14.8919 0 0 11.6396 15.1716 0 0 15.3817 0 0 0 18.4744 0 0 0 0 0 0 0 0 12.1486 0 0 18.5096 0 0 0 0 0 14.7103 0 0 0 14.216 18.6624 0 0 0 0 13.491 0 0 0 14.8165 0 0 0 0 0 0 0 0 0 12.1835 13.7415 13.3523 0 12.8136 13.3122 0 13.6468 0 14.169 0 0 0 0 0 0 0 0 19.2518 0 13.854 0 0 P08621 RU17_HUMAN "U1 small nuclear ribonucleoprotein 70 kDa, U1 snRNP 70 kDa, U1-70K, snRNP70" SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of protein refolding [GO:0061084]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of ATP-dependent activity [GO:0043462]; regulation of RNA splicing [GO:0043484]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of protein refolding [GO:0061084]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of ATP-dependent activity [GO:0043462]; regulation of RNA splicing [GO:0043484]" GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005685; GO:0016607; GO:0017069; GO:0030619; GO:0043462; GO:0043484; GO:0048026; GO:0061084; GO:0071004; GO:1904715 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619] AETREERMER 0.99417 -28.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3053 0 0 0 0 0 0 0 0 0 0 14.6213 13.2325 13.5902 13.2672 13.4912 0 0 0 0 0 12.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4375 0 0 0 0 0 12.9837 0 0 0 0 0 0 0 12.9554 0 0 0 0 0 0 0 12.5621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8372 0 0 0 0 13.0988 0 12.6168 13.5099 14.2653 0 12.87 0 0 0 0 0 12.6031 0 0 P15085 CBPA1_HUMAN "Carboxypeptidase A1, EC 3.4.17.1" CPA1 CPA Homo sapiens (Human) leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to cadmium ion [GO:0046686] extracellular space [GO:0005615] extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; leukotriene metabolic process [GO:0006691]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to cadmium ion [GO:0046686] GO:0004181; GO:0005615; GO:0006508; GO:0006691; GO:0008270; GO:0046686; GO:0051603 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] FSTGGSK 0.99417 -12.956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4301 0 0 0 0 0 0 0 0 10.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5082 0 0 0 0 10.9326 0 0 0 13.3149 0 0 0 0 0 0 12.5082 0 0 0 0 0 0 12.1949 14.3521 0 0 0 0 0 0 0 0 0 0 14.3492 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3228 0 0 0 12.2442 0 0 0 P24903 CP2F1_HUMAN "Cytochrome P450 2F1, EC 1.14.14.1 (CYPIIF1)" CYP2F1 Homo sapiens (Human) epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; organic acid metabolic process [GO:0006082]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; organic acid metabolic process [GO:0006082]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0006082; GO:0006805; GO:0008392; GO:0008395; GO:0009636; GO:0016712; GO:0019373; GO:0019825; GO:0020037; GO:0043231; GO:0070330; GO:1901170 "arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]" AAMPYTDAVIHEVQR 0.99417 -8.513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7548 0 0 0 0 0 13.3935 0 0 0 0 0 0 P30281 CCND3_HUMAN G1/S-specific cyclin-D3 CCND3 Homo sapiens (Human) cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098] cyclin D3-CDK4 complex [GO:0097130]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin D3-CDK4 complex [GO:0097130]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell population proliferation [GO:0042127]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of insulin receptor signaling pathway [GO:0046626]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098] GO:0000079; GO:0000082; GO:0000122; GO:0000307; GO:0001934; GO:0004693; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016538; GO:0019901; GO:0042098; GO:0042127; GO:0044772; GO:0045737; GO:0046626; GO:0051301; GO:0097130; GO:1900087 cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901] LLGDQRVLQSLLRLEER 0.99417 -7.9875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P38567 HYALP_HUMAN "Hyaluronidase PH-20, Hyal-PH20, EC 3.2.1.35 (Hyaluronoglucosaminidase PH-20) (Sperm adhesion molecule 1) (Sperm surface protein PH-20)" SPAM1 HYAL3 PH20 Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; hyaluronan catabolic process [GO:0030214] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; anchored component of membrane [GO:0031225]; cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; hyalurononglucosaminidase activity [GO:0004415]; binding of sperm to zona pellucida [GO:0007339]; carbohydrate metabolic process [GO:0005975]; cell adhesion [GO:0007155]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; hyaluronan catabolic process [GO:0030214] GO:0001669; GO:0004415; GO:0005886; GO:0005975; GO:0007155; GO:0007339; GO:0007342; GO:0030214; GO:0031225; GO:0031410 hyalurononglucosaminidase activity [GO:0004415] FKHIFFR 0.99417 -11.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8216 0 12.2793 0 0 0 0 0 12.7026 0 13.6609 14.2233 0 0 0 0 0 0 0 0 12.4237 0 0 0 0 11.9673 0 0 0 0 0 0 0 0 0 0 0 0 0 12.971 0 0 0 13.4583 0 13.6935 13.4251 0 12.3141 0 0 0 13.4193 0 0 12.9547 0 0 0 13.4849 0 13.3955 0 11.7019 0 0 0 0 13.0639 0 11.6171 0 0 0 0 13.3034 0 0 13.4713 0 13.6876 0 0 11.559 13.158 0 13.5042 13.1282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6772 0 0 0 0 0 0 0 P45381 ACY2_HUMAN "Aspartoacylase, EC 3.5.1.15 (Aminoacylase-2, ACY-2)" ASPA ACY2 ASP Homo sapiens (Human) aspartate catabolic process [GO:0006533]; central nervous system myelination [GO:0022010]; positive regulation of oligodendrocyte differentiation [GO:0048714] cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; aminoacylase activity [GO:0004046]; aspartoacylase activity [GO:0019807]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; aspartate catabolic process [GO:0006533]; central nervous system myelination [GO:0022010]; positive regulation of oligodendrocyte differentiation [GO:0048714]" GO:0004046; GO:0005634; GO:0005829; GO:0006533; GO:0016788; GO:0016811; GO:0019807; GO:0022010; GO:0042802; GO:0046872; GO:0048714 "aminoacylase activity [GO:0004046]; aspartoacylase activity [GO:0019807]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]" IFDLENLGK 0.99417 -11.147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5668 12.083 12.8796 0 12.7874 12.3882 0 0 0 0 0 0 10.9474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0813 0 0 0 0 0 0 0 0 13.5678 15.0639 15.3005 0 14.6164 15.8276 15.687 0 15.5265 0 0 0 12.2605 15.5424 15.5013 0 12.4522 0 0 13.3062 0 0 16.1681 14.203 0 14.6699 16.2225 14.9638 15.1844 14.1141 0 13.9962 13.7299 14.6897 15.4457 14.2524 0 13.3655 16.657 0 0 0 14.4772 12.6654 14.9452 15.926 15.2614 15.2104 14.1153 0 14.6172 12.6394 0 0 0 13.5993 11.6284 0 0 0 0 0 0 0 14.4619 0 0 14.374 13.8757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2568 0 0 0 0 0 0 0 P51116 FXR2_HUMAN RNA-binding protein FXR2 (FMR1 autosomal homolog 2) FXR2 FMR1L2 Homo sapiens (Human) "negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; negative regulation of translation [GO:0017148]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]" GO:0000381; GO:0001934; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0014069; GO:0016020; GO:0017148; GO:0022625; GO:0030424; GO:0030426; GO:0036464; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043488; GO:0044326; GO:0045182; GO:0045727; GO:0046982; GO:0051489; GO:0098793; GO:1902737; GO:2001022 identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182] ANEQEPCGWWLAR 0.99417 -28.475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9426 0 0 0 0 0 0 0 0 14.0913 0 0 0 0 0 0 14.2519 0 0 0 0 0 0 0 14.9871 0 0 0 0 0 0 14.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.832 0 12.9079 13.4906 12.9743 0 0 16.9624 0 0 14.7111 0 0 0 0 14.0784 0 0 0 0 0 0 0 0 0 0 0 0 Q05925 HME1_HUMAN "Homeobox protein engrailed-1, Homeobox protein en-1, Hu-En-1" EN1 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cerebellum development [GO:0021549]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; drinking behavior [GO:0042756]; embryonic brain development [GO:1990403]; embryonic forelimb morphogenesis [GO:0035115]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; motor learning [GO:0061743]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; skeletal system development [GO:0001501]; social behavior [GO:0035176] chromatin [GO:0000785]; membrane [GO:0016020]; nucleus [GO:0005634] "chromatin [GO:0000785]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anatomical structure morphogenesis [GO:0009653]; cerebellum development [GO:0021549]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; drinking behavior [GO:0042756]; embryonic brain development [GO:1990403]; embryonic forelimb morphogenesis [GO:0035115]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; motor learning [GO:0061743]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; pigmentation [GO:0043473]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; skeletal system development [GO:0001501]; social behavior [GO:0035176]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001501; GO:0005634; GO:0006357; GO:0008344; GO:0009653; GO:0009953; GO:0009954; GO:0016020; GO:0021549; GO:0030182; GO:0030901; GO:0030917; GO:0035115; GO:0035176; GO:0035264; GO:0042220; GO:0042756; GO:0043473; GO:0043524; GO:0045944; GO:0048666; GO:0061743; GO:0071542; GO:1990403; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DPVHPLGTR 0.99417 -12.928 0 0 0 0 0 0 0 0 0 0 0 0 12.9545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8025 Q07890 SOS2_HUMAN "Son of sevenless homolog 2, SOS-2" SOS2 Homo sapiens (Human) B cell homeostasis [GO:0001782]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; B cell homeostasis [GO:0001782]; positive regulation of GTPase activity [GO:0043547]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129] GO:0001782; GO:0003677; GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0033081; GO:0042129; GO:0043547; GO:0046982; GO:0051057; GO:2000973 DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982] EDTCEHK 0.99417 -15.511 11.6104 12.7429 0 0 0 0 0 0 9.82885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5274 0 0 0 0 0 0 13.9044 0 13.7553 0 14.0057 12.7645 14.4171 0 0 0 0 15.105 13.1837 12.5778 0 11.4973 16.1343 12.7594 13.3442 13.4047 13.8881 0 12.1293 12.2431 13.1954 12.4905 0 13.2091 0 0 15.6293 14.4885 0 13.6132 0 14.3765 12.7472 0 0 0 14.1536 12.3725 15.0555 13.3603 0 13.1711 10.6576 0 13.9107 13.4387 0 14.0101 13.3533 0 13.1246 0 0 0 0 0 13.0771 0 0 14.8326 13.8047 0 14.191 13.5356 14.9017 0 13.2454 0 0 0 0 0 12.0336 0 0 13.3309 0 0 0 0 0 0 0 0 0 0 0 0 12.4778 0 11.1717 0 0 0 0 0 13.1067 0 0 0 12.4812 0 Q12959 DLG1_HUMAN "Disks large homolog 1 (Synapse-associated protein 97, SAP-97, SAP97) (hDlg)" DLG1 Homo sapiens (Human) actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098] GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0004385; GO:0004721; GO:0005604; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005911; GO:0005912; GO:0005923; GO:0007015; GO:0007163; GO:0007268; GO:0008022; GO:0008092; GO:0008284; GO:0008360; GO:0009898; GO:0014704; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0019902; GO:0030041; GO:0030054; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031434; GO:0031503; GO:0031579; GO:0031594; GO:0031641; GO:0032147; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042391; GO:0042982; GO:0043005; GO:0043113; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0045197; GO:0045296; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070062; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0097120; GO:0098609; GO:0098839; GO:0098911; GO:0098919; GO:0098978; GO:0099645; GO:1902305; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903760; GO:1903764; GO:2000134 cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325] ALHLLEEYR 0.99417 -7.9844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3553 0 0 0 0 0 0 0 0 0 10.5339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9594 0 12.6883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T2S8 ODAD2_HUMAN Outer dynein arm-docking complex subunit 2 (Armadillo repeat-containing protein 4) ODAD2 ARMC4 Homo sapiens (Human) cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591] axoneme [GO:0005930]; ciliary base [GO:0097546] axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591] GO:0003341; GO:0003356; GO:0005930; GO:0007368; GO:0007507; GO:0021591; GO:0036158; GO:0097546 CGGIQPLVNLLVGINQALLVNVTK 0.99417 -10.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5671 10.4845 0 0 0 0 0 0 0 0 0 0 0 14.4043 0 0 0 13.0525 13.1072 12.918 0 0 0 0 12.0797 0 0 0 14.5518 14.7219 16.7731 0 14.2958 13.7646 12.9345 0 0 15.009 14.9184 15.3041 13.3619 14.8408 15.7173 0 15.3309 0 0 13.4986 13.9104 0 14.2433 0 13.0577 0 13.5303 0 0 12.7868 0 14.5169 0 15.0359 0 0 12.7934 15.3862 0 0 0 12.669 0 13.9415 12.7602 0 0 15.1482 0 13.543 0 0 13.8568 0 0 0 0 0 15.0779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7818 0 0 0 0 0 0 Q86V25 VASH2_HUMAN "Tubulinyl-Tyr carboxypeptidase 2, EC 3.4.17.17 (Vasohibin-2) (Vasohibin-like protein)" VASH2 VASHL Homo sapiens (Human) axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; microtubule binding [GO:0008017]; axon development [GO:0061564]; cell-cell fusion [GO:0140253]; labyrinthine layer blood vessel development [GO:0060716]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; syncytium formation by plasma membrane fusion [GO:0000768] GO:0000768; GO:0001938; GO:0003779; GO:0004181; GO:0005576; GO:0005737; GO:0005856; GO:0006508; GO:0008017; GO:0045765; GO:0045766; GO:0060716; GO:0061564; GO:0140253 actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; microtubule binding [GO:0008017] CPHPKGAKGTR 0.99417 -10.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8207 0 0 0 0 0 0 0 0 0 0 13.0521 0 0 0 0 13.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2095 0 0 0 0 0 0 0 0 0 0 0 0 14.1689 14.6355 0 0 0 0 13.8733 0 0 0 0 0 0 0 0 0 0 13.7374 0 0 0 0 0 13.9601 14.2238 13.7356 0 0 0 0 0 0 0 13.967 0 0 0 0 15.6363 0 12.7383 13.1837 0 0 0 0 0 0 13.9329 0 12.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3571 11.6681 0 0 0 0 0 0 14.0905 14.2741 0 14.0556 0 14.1248 0 0 0 0 14.1743 12.7982 0 0 12.203 0 0 0 0 0 17.5525 0 0 0 0 Q96MI9 CBPC4_HUMAN "Cytosolic carboxypeptidase 4, EC 3.4.17.-, EC 3.4.17.24 (ATP/GTP-binding protein-like 1) (Protein deglutamylase CCP4)" AGBL1 CCP4 Homo sapiens (Human) C-terminal protein deglutamylation [GO:0035609]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] cytosol [GO:0005829] cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; C-terminal protein deglutamylation [GO:0035609]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] GO:0004181; GO:0005829; GO:0006508; GO:0008270; GO:0015631; GO:0035609; GO:0035610 metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270] ADAWDVDAIFCPR 0.99417 -8.7288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9313 0 14.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2444 19.2775 0 0 0 0 0 0 0 14.3261 0 19.3179 19.3798 0 13.5319 19.0625 0 14.4603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4816 0 0 0 0 0 0 0 0 0 0 0 10.7835 0 0 0 0 18.9616 15.2464 0 0 0 0 18.573 0 0 12.7682 0 14.6479 13.8207 0 13.5636 15.0237 0 0 0 0 0 0 14.0035 0 0 0 0 17.9434 0 0 0 0 15.1199 0 0 0 0 0 0 0 0 0 13.0572 0 0 0 0 0 0 0 0 0 0 14.6738 0 0 0 17.8131 Q96NZ1 FOXN4_HUMAN Forkhead box protein N4 FOXN4 Homo sapiens (Human) "amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of transcription, DNA-templated [GO:0006355]; retina layer formation [GO:0010842]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron fate commitment [GO:0060579]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of heart contraction [GO:0008016]; regulation of transcription, DNA-templated [GO:0006355]; retina layer formation [GO:0010842]; ventral spinal cord interneuron differentiation [GO:0021514]; ventral spinal cord interneuron fate commitment [GO:0060579]" GO:0000785; GO:0000981; GO:0000987; GO:0001947; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0021514; GO:0035881; GO:0036302; GO:0045944; GO:0060579 "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" EHFPYFK 0.99417 -10.876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7065 0 10.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3176 13.4648 0 0 0 14.2894 0 0 0 0 13.1894 0 0 13.332 0 12.6505 0 0 14.0592 0 0 14.3723 0 0 14.867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3051 0 0 14.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0398 0 0 0 Q96R47 O2A14_HUMAN Olfactory receptor 2A14 (OST182) (Olfactory receptor 2A6) (Olfactory receptor OR7-12) OR2A14 OR2A14P OR2A6 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AFSTCSSHLCVVGLFFGSAIVTYMAPK 0.99417 -8.7274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4516 12.1473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0377 0 0 0 0 0 0 0 0 0 11.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0207 0 0 0 0 0 0 0 12.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1236 0 13.5926 0 0 0 0 0 0 0 0 11.8184 0 0 0 0 0 0 0 0 0 0 0 11.4266 0 0 0 0 0 0 0 0 0 0 0 Q9UBX1 CATF_HUMAN "Cathepsin F, CATSF, EC 3.4.22.41" CTSF Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; cysteine-type endopeptidase activity [GO:0004197]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603] GO:0004197; GO:0005615; GO:0005764; GO:0005783; GO:0005886; GO:0006508; GO:0019886; GO:0043202; GO:0043231; GO:0051603; GO:0062023; GO:0070062; GO:1903561 cysteine-type endopeptidase activity [GO:0004197] AVLGLVRGRVR 0.99417 -11.147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1657 13.9708 0 12.992 12.7236 0 12.6884 0 13.28 0 0 0 0 0 0 0 0 0 O75475 PSIP1_HUMAN "PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein, DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52)" PSIP1 DFS70 LEDGF PSIP2 Homo sapiens (Human) mRNA 5'-splice site recognition [GO:0000395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979] cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; mRNA 5'-splice site recognition [GO:0000395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979] GO:0000395; GO:0000791; GO:0000792; GO:0003682; GO:0003690; GO:0003712; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006979; GO:0009408; GO:0034399; GO:0045944; GO:0097100; GO:0140297 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] EEDKPRK 0.99418 -13.048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6529 0 0 0 0 0 0 0 0 0 0 0 0 13.7634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75554 WBP4_HUMAN "WW domain-binding protein 4, WBP-4 (Formin-binding protein 21) (WW domain-containing-binding protein 4)" WBP4 FBP21 FNBP21 Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005] "nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0008270; GO:0008380; GO:0016607; GO:0045292; GO:0070064; GO:0071005; GO:0071011 proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DPSKGRWVEGITSEGYHYYYDLISGASQWEK 0.99418 -8.7886 0 0 0 0 0 0 0 13.2262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6246 12.6898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8362 0 0 0 0 14.3616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4969 14.0928 0 0 0 0 14.7671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8777 0 0 0 0 0 0 0 14.142 0 0 0 0 0 0 0 0 O75781 PALM_HUMAN Paralemmin-1 (Paralemmin) PALM KIAA0270 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to electrical stimulus [GO:0071257]; cytoskeleton organization [GO:0007010]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; positive regulation of filopodium assembly [GO:0051491]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; synapse maturation [GO:0060074] anchoring junction [GO:0070161]; apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; filopodium membrane [GO:0031527]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; filopodium membrane [GO:0031527]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; D3 dopamine receptor binding [GO:0031750]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to electrical stimulus [GO:0071257]; cytoskeleton organization [GO:0007010]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of dopamine receptor signaling pathway [GO:0060160]; positive regulation of filopodium assembly [GO:0051491]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; synapse maturation [GO:0060074] GO:0005654; GO:0005886; GO:0007010; GO:0007193; GO:0007194; GO:0008360; GO:0014069; GO:0016323; GO:0016327; GO:0030424; GO:0031235; GO:0031410; GO:0031527; GO:0031750; GO:0043197; GO:0051491; GO:0060074; GO:0060160; GO:0070161; GO:0071257; GO:0072659 D3 dopamine receptor binding [GO:0031750] EVLAAETTSQQER 0.99418 -5.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8687 0 0 0 0 0 0 0 0 0 0 0 14.3953 12.1173 0 0 0 0 0 0 0 0 12.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08913 ADA2A_HUMAN "Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR)" ADRA2A ADRA2R ADRAR Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intestinal absorption [GO:0050892]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; receptor transactivation [GO:0035624]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vasoconstriction [GO:0019229]; Rho protein signal transduction [GO:0007266]; thermoception [GO:0050955]; vasodilation [GO:0042311] axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; dopaminergic synapse [GO:0098691]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; alpha-1B adrenergic receptor binding [GO:0031692]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; heterotrimeric G-protein binding [GO:0032795]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; acute inflammatory response [GO:0002526]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adrenergic receptor signaling pathway [GO:0071875]; cellular response to hormone stimulus [GO:0032870]; DNA replication [GO:0006260]; fear response [GO:0042596]; female pregnancy [GO:0007565]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; intestinal absorption [GO:0050892]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of insulin secretion [GO:0046676]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of norepinephrine secretion [GO:0010700]; negative regulation of uterine smooth muscle contraction [GO:0070473]; phospholipase C-activating adrenergic receptor signaling pathway [GO:0071882]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; receptor transactivation [GO:0035624]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of vasoconstriction [GO:0019229]; Rho protein signal transduction [GO:0007266]; thermoception [GO:0050955]; vasodilation [GO:0042311] GO:0001819; GO:0002526; GO:0004930; GO:0004938; GO:0005737; GO:0005886; GO:0005887; GO:0006260; GO:0007186; GO:0007189; GO:0007193; GO:0007265; GO:0007266; GO:0007565; GO:0008284; GO:0010700; GO:0016323; GO:0019229; GO:0019901; GO:0030036; GO:0030168; GO:0030335; GO:0031692; GO:0031696; GO:0031996; GO:0032147; GO:0032148; GO:0032795; GO:0032811; GO:0032870; GO:0035624; GO:0042311; GO:0042593; GO:0042596; GO:0042803; GO:0043025; GO:0043235; GO:0043268; GO:0043406; GO:0043410; GO:0043679; GO:0045741; GO:0045955; GO:0046676; GO:0046982; GO:0050892; GO:0050955; GO:0050995; GO:0051044; GO:0051379; GO:0051380; GO:0051926; GO:0061179; GO:0070473; GO:0071875; GO:0071880; GO:0071881; GO:0071882; GO:0090303; GO:0098691; GO:0098978; GO:0098982; GO:0099059; GO:0099061; GO:1901020; GO:2000300 alpha-1B adrenergic receptor binding [GO:0031692]; alpha-2C adrenergic receptor binding [GO:0031696]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; heterotrimeric G-protein binding [GO:0032795]; norepinephrine binding [GO:0051380]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996] AFKKILCR 0.99418 -15.562 0 0 0 0 0 0 0 12.9516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6168 11.7096 0 12.5734 12.1563 0 0 12.3696 12.1686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1669 0 12.7682 14.3823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6455 0 0 13.1628 0 0 0 0 13.3489 0 12.9096 0 0 0 13.5908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35240 MERL_HUMAN Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin) NF2 SCH Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010] GO:0000165; GO:0001707; GO:0001953; GO:0003779; GO:0005178; GO:0005634; GO:0005730; GO:0005737; GO:0005769; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0006469; GO:0007398; GO:0008285; GO:0010626; GO:0014010; GO:0014013; GO:0016020; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030336; GO:0030864; GO:0031527; GO:0031647; GO:0032154; GO:0032587; GO:0033687; GO:0033689; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0046426; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177 actin binding [GO:0003779]; integrin binding [GO:0005178] AAEAEQEMQR 0.99418 -13.055 0 0 0 0 0 0 0 12.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9846 0 0 0 0 0 12.484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2925 14.1752 0 0 0 13.3894 13.3204 12.5114 12.5816 12.1999 11.9862 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0768 0 0 0 0 0 0 0 0 13.9778 0 0 0 0 0 0 0 0 0 0 11.284 0 12.4359 12.6222 0 0 0 0 0 0 0 0 0 0 15.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8001 0 14.515 0 13.354 0 0 0 0 0 0 P35606 COPB2_HUMAN "Coatomer subunit beta' (Beta'-coat protein, Beta'-COP) (p102)" COPB2 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]" GO:0000139; GO:0005198; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126; GO:0030133; GO:1901998 structural molecule activity [GO:0005198] CIAVHPTQPFILTSSDDMLIKLWDWDK 0.99418 -13.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1962 0 0 13.0365 0 0 0 0 0 13.9199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9217 0 0 8.6326 0 0 0 12.3495 0 0 12.6277 0 0 12.8888 12.5616 0 0 0 0 0 14.3743 0 13.5468 18.4655 13.8728 13.0298 0 0 15.4295 0 13.0517 0 13.9874 14.9104 15.8997 15.3344 12.5312 0 18.3351 18.4258 13.8931 0 0 0 0 0 0 12.8621 0 0 0 0 0 15.1003 0 0 0 0 14.0885 0 0 12.4369 0 0 13.9789 0 0 12.4402 0 12.6592 0 0 0 13.3389 0 0 0 0 0 10.4017 0 12.3589 0 13.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7312 0 0 0 0 0 0 0 0 0 0 0 0 0 P52292 IMA1_HUMAN Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha) KPNA2 RCH1 SRP1 Homo sapiens (Human) DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of postsynaptic specialization membrane [GO:0098892]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of viral life cycle [GO:1903902]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of DNA recombination [GO:0000018] GO:0000018; GO:0000139; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006259; GO:0006607; GO:0008139; GO:0016020; GO:0042564; GO:0042826; GO:0043657; GO:0061608; GO:0075506; GO:0098892; GO:0098978; GO:0099527; GO:1903902 histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723] DSTEMRRR 0.99418 -13.011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.376 0 0 0 0 0 0 0 0 13.327 0 0 11.7846 0 15.7351 0 0 17.0951 0 12.5996 0 0 0 0 0 0 0 0 0 0 14.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01831 XPC_HUMAN DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125) XPC XPCC Homo sapiens (Human) "DNA repair [GO:0006281]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription, DNA-templated [GO:0045893]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; UV-damage excision repair [GO:0070914]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of DNA damage [GO:0090734]; XPC complex [GO:0071942] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of DNA damage [GO:0090734]; XPC complex [GO:0071942]; bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; heteroduplex DNA loop binding [GO:0000404]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription, DNA-templated [GO:0045893]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; UV-damage excision repair [GO:0070914]" GO:0000109; GO:0000111; GO:0000404; GO:0000405; GO:0000720; GO:0003684; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006289; GO:0006298; GO:0009410; GO:0010224; GO:0010996; GO:0031573; GO:0043231; GO:0044877; GO:0045893; GO:0070914; GO:0071942; GO:0090734; GO:0140612; GO:1901990 bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; heteroduplex DNA loop binding [GO:0000404]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713] ALGNWKLLAK 0.99418 -28.583 0 0 11.2358 0 9.88125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9025 0 0 0 0 0 0 0 10.5401 0 0 0 0 0 0 0 11.4091 0 0 0 0 0 0 0 12.4338 0 0 0 0 0 0 10.4917 0 0 0 0 0 0 0 0 11.512 0 13.7482 0 0 0 14.2453 0 0 0 0 0 0 0 0 12.985 0 10.6496 13.3814 14.8693 12.7228 13.8085 0 13.2496 0 10.3633 12.9077 0 0 18.5381 11.7247 10.6455 0 10.1037 0 0 10.2411 12.9293 0 13.0913 0 0 14.0564 10.1482 12.9656 0 0 16.814 13.1942 0 0 0 0 0 12.6161 0 0 0 11.7104 12.8919 0 0 10.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7775 0 0 0 10.635 0 0 0 0 0 0 12.7556 0 12.852 0 12.8944 0 0 12.3992 0 0 Q14690 RRP5_HUMAN "Protein RRP5 homolog (NF-kappa-B-binding protein, NFBP) (Programmed cell death protein 11)" PDCD11 KIAA0185 Homo sapiens (Human) rRNA processing [GO:0006364] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0032040; GO:0051059 NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723] AFLPLLK 0.99418 -30.559 0 0 0 0 0 15.5154 0 0 0 0 0 0 12.08 0 0 0 0 0 0 15.4017 0 0 11.7351 0 15.3582 0 0 0 12.8435 0 12.8341 0 0 0 0 0 0 0 0 0 0 0 14.6105 0 12.7076 14.7073 0 0 0 0 0 0 0 0 0 0 15.8684 0 0 0 0 0 0 0 0 0 0 15.2652 14.0624 0 13.6536 0 0 0 14.0496 13.18 0 0 0 0 13.172 0 0 0 14.7151 0 0 0 0 0 0 15.8557 0 12.4107 15.3118 15.4017 0 0 15.2049 14.3695 14.1531 13.9475 13.7781 12.6293 14.6309 14.7511 13.6113 0 0 13.389 0 15.5413 12.196 12.3848 16.1106 14.1475 16.2151 0 0 15.1666 0 0 0 14.0049 13.7597 0 0 0 0 10.166 0 0 0 0 0 0 0 0 0 0 0 15.1891 13.3316 0 0 0 0 15.992 0 0 0 13.4205 0 12.5865 0 0 14.9374 14.0759 0 0 14.5299 0 0 0 0 0 0 0 0 0 15.3138 0 12.4499 14.8442 0 0 0 0 0 0 Q15120 PDK3_HUMAN "[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 3)" PDK3 PDHK3 Homo sapiens (Human) cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; peptidyl-serine phosphorylation [GO:0018105]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906]; regulation of reactive oxygen species metabolic process [GO:2000377] GO:0004672; GO:0004674; GO:0004740; GO:0005524; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006468; GO:0010510; GO:0010906; GO:0018105; GO:0035357; GO:0071333; GO:0071398; GO:0097411; GO:2000377 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] DAYETAK 0.99418 -8.0086 11.3778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0427 0 0 0 14.2265 13.6387 14.6285 15.5611 0 14.8927 11.4203 11.621 0 11.4638 0 0 0 0 0 0 0 0 0 0 10.0918 0 0 0 12.7457 13.1992 12.9812 0 0 0 14.2149 14.8911 13.2398 14.687 14.1485 0 0 14.3563 0 0 0 13.2215 0 0 0 0 0 0 0 0 14.0503 13.9286 0 0 0 12.1131 0 14.2986 13.8671 0 0 13.6414 0 14.945 0 14.7764 0 0 13.7599 0 13.2517 0 0 12.6338 13.796 11.7898 0 0 0 0 0 0 0 12.2128 0 0 0 0 13.2877 0 0 0 0 12.2662 0 0 0 0 0 11.9935 12.3906 0 0 0 0 0 0 0 12.8644 12.7314 0 0 0 0 0 0 0 0 0 13.0181 0 0 0 0 0 0 Q16842 SIA4B_HUMAN "CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2, Alpha 2,3-ST 2, Beta-galactoside alpha-2,3-sialyltransferase 2, EC 2.4.99.4 (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase, EC 2.4.99.2) (ST3Gal II, ST3GalII) (ST3GalA.2) (Sialyltransferase 4B, SIAT4-B)" ST3GAL2 SIAT4B Homo sapiens (Human) ganglioside biosynthetic process via lactosylceramide [GO:0010706]; globoside biosynthetic process via lactosylceramide [GO:0010707]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082] extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; globoside biosynthetic process via lactosylceramide [GO:0010707]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]" GO:0000139; GO:0003836; GO:0005576; GO:0006486; GO:0008373; GO:0009101; GO:0009247; GO:0009312; GO:0010706; GO:0010707; GO:0016020; GO:0016021; GO:0016266; GO:0018146; GO:0019082; GO:0030259; GO:0032580; GO:0042803; GO:0047288; GO:0097503; GO:1990743 "beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; monosialoganglioside sialyltransferase activity [GO:0047288]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373]" FTYAPVK 0.99418 -13.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6972 0 11.9963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SRH9 TT39A_HUMAN "Tetratricopeptide repeat protein 39A, TPR repeat protein 39A (Differentially expressed in MCF7 with estradiol protein 6, DEME-6)" TTC39A C1orf34 KIAA0452 Homo sapiens (Human) centrosome [GO:0005813] centrosome [GO:0005813] GO:0005813 ATYIYMK 0.99418 -8.0147 0 0 0 0 0 0 0 0 17.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1069 0 0 0 0 0 0 14.2036 0 0 0 0 0 0 0 0 0 0 0 13.5912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1989 0 0 12.7656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3524 0 0 0 0 0 15.2579 0 0 0 0 11.7424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8042 0 0 0 0 0 0 0 10.4103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9715 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4417 0 0 15.7098 0 0 0 0 9.39566 0 0 0 0 0 0 0 0 0 Q5T5X7 BEND3_HUMAN BEN domain-containing protein 3 BEND3 KIAA1553 Homo sapiens (Human) DNA methylation [GO:0006306]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4 acetylation [GO:0043967]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP metabolic process [GO:1903580]; protein homooligomerization [GO:0051260]; rDNA heterochromatin assembly [GO:0000183] heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA binding [GO:0000182]; DNA methylation [GO:0006306]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4 acetylation [GO:0043967]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP metabolic process [GO:1903580]; protein homooligomerization [GO:0051260]; rDNA heterochromatin assembly [GO:0000183] GO:0000122; GO:0000182; GO:0000183; GO:0000792; GO:0005654; GO:0005730; GO:0006306; GO:0034773; GO:0036124; GO:0043967; GO:0051260; GO:0080182; GO:0098532; GO:1903580 rDNA binding [GO:0000182] IKLIRHYVQLLYPR 0.99418 -5.1878 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9641 0 13.0811 0 0 0 13.4257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5684 0 0 0 14.7145 0 0 0 0 0 0 0 0 0 0 0 14.9314 0 15.1104 0 0 0 14.0063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T619 ZN648_HUMAN Zinc finger protein 648 ZNF648 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AYSHRGTLQQHR 0.99418 -28.731 0 0 0 0 0 0 0 0 0 12.2378 11.2188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0331 0 0 0 0 12.3971 11.7541 0 0 10.7789 0 0 0 0 0 10.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1926 0 0 12.3797 0 0 0 0 0 0 14.0976 0 0 0 0 0 0 0 0 0 0 0 16.0019 0 0 11.7116 0 0 0 0 0 0 0 0 0 0 0 13.8418 0 14.0197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5643 13.5771 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9895 0 0 0 0 0 0 0 0 0 0 12.9761 0 12.0699 0 0 11.5206 16.6219 0 0 0 12.933 0 0 0 12.3758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P2C0 WDR93_HUMAN WD repeat-containing protein 93 WDR93 Homo sapiens (Human) electron transport chain [GO:0022900] mitochondrial respiratory chain complex I [GO:0005747] mitochondrial respiratory chain complex I [GO:0005747]; electron transport chain [GO:0022900] GO:0005747; GO:0022900 EEEHWARLQR 0.99418 -28.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1335 0 0 0 0 0 0 0 0 10.0926 0 0 0 11.1841 0 12.029 0 12.1505 0 0 13.3545 0 0 0 14.413 13.3476 0 14.1958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7364 0 0 0 0 0 0 0 0 13.0326 12.6299 0 0 0 0 0 12.9376 0 0 12.8363 0 0 0 0 0 0 0 12.3772 0 0 0 0 0 0 0 0 0 0 0 13.0772 0 12.5119 0 0 0 12.0372 0 0 0 0 0 0 0 0 0 15.4825 0 0 0 0 0 0 0 0 0 0 0 13.0846 0 0 0 0 0 15.824 Q86UT8 CATAC_HUMAN Centrosomal AT-AC splicing factor (Coiled-coil domain-containing protein 84) CENATAC CCDC84 DLNB14 Homo sapiens (Human) negative regulation of centrosome duplication [GO:0010826]; regulation of protein catabolic process [GO:0042176] centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737]; negative regulation of centrosome duplication [GO:0010826]; regulation of protein catabolic process [GO:0042176] GO:0005737; GO:0005813; GO:0010826; GO:0042176 CCWCLCCGCEVR 0.99418 -11.18 11.9145 0 0 12.2792 0 0 12.2817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9366 0 0 0 10.7686 10.9954 0 0 12.9016 0 0 12.8515 0 0 0 0 0 12.7838 0 0 0 0 0 0 0 0 0 0 11.0156 0 11.2723 0 12.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4426 0 12.4153 0 0 0 0 0 0 0 0 0 0 13.0118 0 0 14.236 0 0 0 0 0 0 13.2411 0 0 0 10.5673 0 0 0 0 0 0 0 0 12.1037 0 12.485 0 0 0 0 0 0 0 0 0 0 0 12.5561 0 0 0 0 0 0 0 0 Q8N6S4 AN13C_HUMAN Ankyrin repeat domain-containing protein 13C ANKRD13C Homo sapiens (Human) protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of signaling receptor activity [GO:0010469] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; signaling receptor binding [GO:0005102]; protein retention in ER lumen [GO:0006621]; regulation of anoikis [GO:2000209]; regulation of signaling receptor activity [GO:0010469] GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006621; GO:0010469; GO:0048471; GO:2000209 signaling receptor binding [GO:0005102] ACHKIFSNHHHR 0.99418 -8.5395 0 0 0 0 9.82942 0 0 0 0 13.7211 0 0 0 0 0 0 0 0 0 11.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.319 0 10.6998 0 0 12.2223 0 0 12.5062 13.2212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3828 0 0 0 0 0 0 0 0 10.991 0 0 0 0 0 0 12.0687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0919 0 0 0 0 0 0 11.0313 0 0 0 0 0 0 0 0 0 0 13.9802 0 0 0 0 0 0 0 11.6578 12.2248 0 0 0 0 0 14.1352 0 12.1784 0 12.2809 0 0 0 0 0 0 10.6247 0 0 0 0 0 0 Q8N8K9 K1958_HUMAN Uncharacterized protein KIAA1958 KIAA1958 Homo sapiens (Human) ILKNAGVGFSITSSTFSSSTKK 0.99418 -15.575 0 0 0 0 10.384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3887 0 10.8567 0 0 0 0 0 14.6452 0 0 10.0583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0039 12.916 13.1145 0 0 0 0 0 0 0 0 11.9803 0 0 0 11.3486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1451 0 0 0 11.408 0 13.8563 0 0 0 12.3851 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHH1 TTL11_HUMAN "Tubulin polyglutamylase TTLL11, EC 6.3.2.- (Tubulin--tyrosine ligase-like protein 11)" TTLL11 C9orf20 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; protein polyglutamylation [GO:0018095] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874] ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; protein polyglutamylation [GO:0018095] GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0036064; GO:0046872; GO:0051013; GO:0070740 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] GSSESELAAR 0.99418 -8.5503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5866 0 0 11.8577 0 0 0 0 0 0 12.9621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1576 0 0 0 0 0 0 0 0 16.4071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92536 YLAT2_HUMAN "Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2, Y+LAT2, y+LAT-2)" SLC7A6 KIAA0245 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; ornithine transport [GO:0015822] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; amino acid transmembrane transport [GO:0003333]; ornithine transport [GO:0015822] GO:0003333; GO:0005886; GO:0005887; GO:0015171; GO:0015174; GO:0015179; GO:0015297; GO:0015822; GO:0016323 amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179] PLFIRNVLAAITR 0.99418 -5.1938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6172 0 0 0 0 0 0 0 0 Q96M60 F227B_HUMAN Protein FAM227B FAM227B C15orf33 Homo sapiens (Human) FLHKLRSEAEIER 0.99418 -8.0084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5008 0 0 0 Q9NY72 SCN3B_HUMAN Sodium channel subunit beta-3 SCN3B KIAA1158 Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; nervous system development [GO:0007399]; positive regulation of heart rate [GO:0010460]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; SA node cell action potential [GO:0086015]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; ventricular cardiac muscle cell action potential [GO:0086005] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; Z disc [GO:0030018]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006]; atrial cardiac muscle cell action potential [GO:0086014]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle contraction [GO:0060048]; membrane depolarization [GO:0051899]; membrane depolarization during action potential [GO:0086010]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; nervous system development [GO:0007399]; positive regulation of heart rate [GO:0010460]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of atrial cardiac muscle cell membrane depolarization [GO:0060371]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; SA node cell action potential [GO:0086015]; sensory perception of pain [GO:0019233]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0001518; GO:0005244; GO:0005886; GO:0006814; GO:0007399; GO:0010460; GO:0010765; GO:0016021; GO:0017080; GO:0019233; GO:0019871; GO:0030018; GO:0035725; GO:0044325; GO:0051899; GO:0060048; GO:0060371; GO:0060373; GO:0072659; GO:0086002; GO:0086005; GO:0086006; GO:0086010; GO:0086012; GO:0086014; GO:0086015; GO:0086091; GO:2000649 sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity involved in cardiac muscle cell action potential [GO:0086006] PFVKTTR 0.99418 -12.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4676 13.476 0 0 0 0 0 0 0 0 0 0 0 0 12.6753 0 0 0 0 0 12.861 0 12.7255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1653 12.5151 0 0 0 0 0 0 0 0 12.1974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UFG5 CS025_HUMAN UPF0449 protein C19orf25 C19orf25 Homo sapiens (Human) AGEDLER 0.99418 -13.017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKA2 FBXL4_HUMAN F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4) (F-box protein FBL4/FBL5) FBXL4 FBL4 FBL5 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; autophagy of mitochondrion [GO:0000422]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000422; GO:0005758; GO:0005829; GO:0006511; GO:0016607; GO:0019005; GO:0031146 LCSLKRLVLYR 0.99418 -8.5519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9166 0 0 0 0 0 12.8209 0 0 0 0 0 0 A0AVK6 E2F8_HUMAN "Transcription factor E2F8, E2F-8" E2F8 Homo sapiens (Human) cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DCIHEHLSGDEFEKSQPSR 0.99419 -30.887 0 0 0 0 0 0 0 0 0 0 0 13.2195 0 0 0 0 0 0 11.8722 0 0 12.4732 13.0227 0 0 0 12.5472 0 0 0 0 0 0 0 0 0 0 0 0 13.097 0 0 0 0 0 0 0 0 0 0 0 13.5046 0 11.9522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5351 0 0 0 0 0 0 0 0 0 0 12.9928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1 0 0 0 0 0 12.2 0 0 0 0 0 0 14.8836 10.8107 12.829 0 0 0 15.2876 0 0 0 0 0 0 0 14.7855 0 0 0 0 0 0 0 11.6815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3761 14.2454 0 0 0 0 0 0 0 0 0 0 0 0 15.5502 0 14.7247 0 0 A6NE01 F186A_HUMAN Protein FAM186A FAM186A Homo sapiens (Human) AKMEEYFQK 0.99419 -30.929 0 0 0 10.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1468 0 0 0 12.5275 13.7523 0 13.8005 0 15.8663 13.1972 0 15.7282 15.9057 14.3572 15.7973 12.3452 13.6055 0 12.2437 0 0 12.3525 13.7873 0 0 0 0 0 0 11.91 0 0 12.4146 12.9863 13.2678 13.4892 0 13.7486 14.2509 0 0 12.9022 12.4928 14.3999 0 0 14.022 0 0 0 0 11.5775 0 0 14.737 0 12.9042 13.4323 13.1892 16.6722 0 0 0 16.4462 0 0 13.6569 13.6497 0 14.1544 13.3464 0 0 0 0 11.129 16.3715 0 14.6196 0 0 16.2924 0 0 12.8123 13.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0372 0 0 0 0 0 0 0 O00411 RPOM_HUMAN "DNA-directed RNA polymerase, mitochondrial, MtRPOL, EC 2.7.7.6" POLRMT Homo sapiens (Human) mitochondrial transcription [GO:0006390]; transcription initiation from mitochondrial promoter [GO:0006391] mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991] mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; mitochondrial transcription [GO:0006390]; transcription initiation from mitochondrial promoter [GO:0006391] GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006390; GO:0006391; GO:0032991; GO:0034245; GO:0042645; GO:0043565 DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] AEALYRLSLAQHLR 0.99419 -36.647 0 0 11.8242 10.2594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5227 0 11.0447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1988 0 0 12.8565 0 0 0 0 13.0318 0 0 14.7053 0 14.7997 0 13.5339 16.162 14.1241 0 13.5664 0 0 14.3193 12.7813 16.011 0 15.6679 10.3366 0 14.6881 14.4286 0 14.2949 15.3844 0 14.2986 0 14.8869 0 15.2269 15.0738 13.3117 14.1758 0 15.3806 15.6073 0 13.4741 15.2401 14.5442 0 0 0 15.254 11.7481 0 0 0 0 13.7183 0 0 0 0 12.2118 0 13.3263 14.9917 0 0 0 0 15.411 14.4238 15.2459 0 15.3568 15.3967 15.2684 0 15.3408 0 0 0 12.7933 15.3192 0 0 0 0 13.9922 0 0 0 12.0815 16.9608 0 0 0 12.1073 0 0 0 0 0 0 15.4525 0 0 0 18.7821 0 0 0 18.8755 O75935 DCTN3_HUMAN "Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit, p22)" DCTN3 DCTN22 Homo sapiens (Human) cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819] centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; structural molecule activity [GO:0005198]; cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000278; GO:0000776; GO:0005198; GO:0005730; GO:0005813; GO:0005819; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0032154; GO:0048471; GO:0061640 structural molecule activity [GO:0005198] ERVKILYK 0.99419 -11.563 0 0 0 0 0 11.329 11.8902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5116 0 0 0 0 0 0 0 0 0 0 0 0 12.6418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76039 CDKL5_HUMAN "Cyclin-dependent kinase-like 5, EC 2.7.11.22 (Serine/threonine-protein kinase 9)" CDKL5 STK9 Homo sapiens (Human) neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; dendrite cytoplasm [GO:0032839]; dendritic growth cone [GO:0044294]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; neuron migration [GO:0001764]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of GTPase activity [GO:0043547]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017]; regulation of dendrite development [GO:0050773]; regulation of postsynapse organization [GO:0099175] GO:0001764; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0006468; GO:0016301; GO:0031267; GO:0032839; GO:0036064; GO:0043547; GO:0044294; GO:0045773; GO:0046777; GO:0050773; GO:0050775; GO:0097542; GO:0098978; GO:0099175; GO:0106310; GO:1902017 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267] DIKPENLLISHNDVLK 0.99419 -11.561 12.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2294 0 0 0 0 0 0 0 0 13.6824 0 13.5628 0 13.6707 0 0 0 0 0 0 0 0 0 0 13.9173 0 0 0 15.2605 14.7488 13.9669 0 0 0 0 0 0 0 0 0 12.9289 0 0 14.0715 0 0 0 0 13.2336 0 13.9507 0 0 0 0 0 0 0 0 0 13.5174 0 13.769 0 0 0 13.6131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9571 0 0 12.3663 0 0 0 0 O96028 NSD2_HUMAN "Histone-lysine N-methyltransferase NSD2, EC 2.1.1.357 (Multiple myeloma SET domain-containing protein, MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein)" NSD2 KIAA1090 MMSET TRX5 WHSC1 Homo sapiens (Human) "atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H3-K36 methylation [GO:0010452]; histone H4-K20 methylation [GO:0034770]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H3-K36 methylation [GO:0010452]; histone H4-K20 methylation [GO:0034770]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006325; GO:0006355; GO:0010452; GO:0018024; GO:0034770; GO:0042799; GO:0043565; GO:0046872; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:2001032 chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565] AKLCSSAETLESHPDIGK 0.99419 -36.54 0 0 0 0 0 0 0 0 0 13.5427 12.602 11.3986 0 0 10.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1617 0 0 0 0 0 0 11.2765 11.5405 0 0 10.6317 11.4713 0 0 0 0 11.4821 9.9335 0 0 0 0 0 0 0 10.9648 10.8688 0 0 0 8.76901 0 0 0 0 14.3961 12.2308 14.1122 0 0 11.1602 14.0407 0 0 0 0 14.7869 0 11.4959 0 14.1223 14.4827 11.6753 0 16.7039 0 0 0 12.2167 13.6496 13.3085 13.93 0 13.063 0 0 0 0 12.2858 13.0363 0 0 10.3184 13.5613 0 12.4071 0 0 0 0 0 0 13.8501 0 0 14.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6596 0 0 13.7331 12.8344 13.3617 0 0 0 0 0 0 0 0 11.011 12.471 0 0 0 0 0 0 0 0 0 13.5122 0 0 12.0008 0 0 0 13.8381 12.2517 13.7649 0 0 0 0 0 0 0 13.2183 0 0 0 11.9737 0 0 0 P14902 I23O1_HUMAN "Indoleamine 2,3-dioxygenase 1, IDO-1, EC 1.13.11.52 (Indoleamine-pyrrole 2,3-dioxygenase)" IDO1 IDO INDO Homo sapiens (Human) 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; kynurenic acid biosynthetic process [GO:0034276]; multicellular organismal response to stress [GO:0033555]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of chronic inflammatory response [GO:0002678]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of type 2 immune response [GO:0002830]; response to lipopolysaccharide [GO:0032496]; swimming behavior [GO:0036269]; T cell proliferation [GO:0042098]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441] cytoplasm [GO:0005737]; cytosol [GO:0005829]; smooth muscle contractile fiber [GO:0030485]; stereocilium bundle [GO:0032421] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; smooth muscle contractile fiber [GO:0030485]; stereocilium bundle [GO:0032421]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; kynurenic acid biosynthetic process [GO:0034276]; multicellular organismal response to stress [GO:0033555]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of chronic inflammatory response [GO:0002678]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of type 2 immune response [GO:0002830]; response to lipopolysaccharide [GO:0032496]; swimming behavior [GO:0036269]; T cell proliferation [GO:0042098]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to kynurenine [GO:0019441]" GO:0002666; GO:0002678; GO:0002830; GO:0004833; GO:0005737; GO:0005829; GO:0006569; GO:0006954; GO:0007565; GO:0009055; GO:0019441; GO:0020037; GO:0030485; GO:0032421; GO:0032496; GO:0032693; GO:0032735; GO:0033555; GO:0033754; GO:0034276; GO:0034354; GO:0036269; GO:0042098; GO:0042130; GO:0046872; GO:0070233; GO:0070234 "electron transfer activity [GO:0009055]; heme binding [GO:0020037]; indoleamine 2,3-dioxygenase activity [GO:0033754]; metal ion binding [GO:0046872]; tryptophan 2,3-dioxygenase activity [GO:0004833]" ALVSLRSYHLQIVTK 0.99419 -13.884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1243 0 0 0 0 0 0 0 12.0094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6594 0 12.5731 0 0 14.78 0 14.8494 12.1961 14.5882 14.8072 0 0 0 0 0 0 0 0 0 0 0 0 P16144 ITB4_HUMAN Integrin beta-4 (GP150) (CD antigen CD104) ITGB4 Homo sapiens (Human) autophagy [GO:0006914]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; nail development [GO:0035878]; peripheral nervous system myelin formation [GO:0032290]; response to wounding [GO:0009611]; skin morphogenesis [GO:0043589]; trophoblast cell migration [GO:0061450] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; nail development [GO:0035878]; peripheral nervous system myelin formation [GO:0032290]; response to wounding [GO:0009611]; skin morphogenesis [GO:0043589]; trophoblast cell migration [GO:0061450] GO:0001664; GO:0005178; GO:0005604; GO:0005730; GO:0005886; GO:0005925; GO:0006914; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009611; GO:0009925; GO:0009986; GO:0016477; GO:0030054; GO:0030056; GO:0031252; GO:0031581; GO:0031965; GO:0032290; GO:0033627; GO:0035878; GO:0043235; GO:0043589; GO:0046847; GO:0048333; GO:0048870; GO:0061450; GO:0070062 G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178] DCAYCTDEMFR 0.99419 -10.97 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6148 0 0 12.4582 13.0935 0 0 0 0 13.0529 0 0 0 0 0 0 0 0 0 0 12.6405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4427 12.3234 0 0 0 0 12.6257 13.5595 13.567 13.6541 12.2277 12.1976 0 0 11.0869 0 13.8163 0 0 0 0 14.2526 14.4565 0 0 0 0 13.5105 0 0 0 12.7409 13.8581 11.8047 0 0 0 0 11.2936 0 12.3835 0 0 14.5769 15.0697 0 12.0941 0 11.9269 0 0 11.8043 16.1603 0 0 14.7329 11.6755 0 12.8249 0 13.7531 0 11.0959 13.5632 0 0 0 0 0 0 14.8762 0 0 0 0 0 14.1581 11.5953 0 13.6025 0 0 0 0 0 0 0 0 13.7282 0 0 0 0 0 0 11.1539 0 0 0 0 0 0 0 0 10.775 0 0 12.1772 0 12.8897 0 11.5236 0 P29474 NOS3_HUMAN "Nitric oxide synthase, endothelial, EC 1.14.13.39 (Constitutive NOS, cNOS) (EC-NOS) (Endothelial NOS, eNOS) (NOS type III, NOSIII)" NOS3 Homo sapiens (Human) angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; calcium ion transport [GO:0006816]; cell redox homeostasis [GO:0045454]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of platelet activation [GO:0010544]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of Notch signaling pathway [GO:0045747]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of blood pressure [GO:0008217]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to fluid shear stress [GO:0034405]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; smooth muscle hyperplasia [GO:0014806]; vasodilation [GO:0042311]; ventricular septum morphogenesis [GO:0060412] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; calcium ion transport [GO:0006816]; cell redox homeostasis [GO:0045454]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of platelet activation [GO:0010544]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of Notch signaling pathway [GO:0045747]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of blood pressure [GO:0008217]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to fluid shear stress [GO:0034405]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; smooth muscle hyperplasia [GO:0014806]; vasodilation [GO:0042311]; ventricular septum morphogenesis [GO:0060412] GO:0000139; GO:0001525; GO:0001542; GO:0001701; GO:0001974; GO:0002028; GO:0003057; GO:0003100; GO:0003180; GO:0003184; GO:0003203; GO:0003785; GO:0004517; GO:0005516; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0006527; GO:0006809; GO:0006813; GO:0006816; GO:0007005; GO:0007263; GO:0008217; GO:0008285; GO:0009408; GO:0009725; GO:0010181; GO:0010544; GO:0010628; GO:0012506; GO:0014740; GO:0014806; GO:0016491; GO:0019430; GO:0020037; GO:0030324; GO:0030666; GO:0031284; GO:0031644; GO:0031663; GO:0032496; GO:0034405; GO:0034617; GO:0034618; GO:0042311; GO:0043267; GO:0043536; GO:0043542; GO:0045454; GO:0045747; GO:0045766; GO:0045776; GO:0046870; GO:0048662; GO:0048873; GO:0050660; GO:0050661; GO:0051346; GO:0051649; GO:0051926; GO:0060412; GO:0070168; GO:0097110; GO:0097746; GO:1902042 actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617] EQQELEALSQDPRR 0.99419 -9.2926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8826 0 0 0 0 0 0 0 0 0 0 0 18.1115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41250 GARS_HUMAN "Glycine--tRNA ligase, EC 6.1.1.14 (Diadenosine tetraphosphate synthetase, Ap4A synthetase, EC 2.7.7.-) (Glycyl-tRNA synthetase, GlyRS) (Glycyl-tRNA synthetase 1)" GARS1 GARS Homo sapiens (Human) diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418] GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0006426; GO:0015966; GO:0016740; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150 ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740] AALLLLLPPRLLAR 0.99419 -11.538 0 0 0 15.6865 0 0 0 0 0 0 12.6887 10.0336 11.4505 0 0 10.8935 0 0 0 12.1543 0 11.9058 0 11.1594 0 0 14.0485 0 0 10.0341 14.0104 0 0 0 12.2351 0 0 0 0 0 0 0 0 0 10.7236 0 0 10.7452 15.7641 0 12.3098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9141 0 0 12.8243 12.0892 13.8584 14.0846 0 0 11.0402 0 0 0 0 0 13.9079 0 15.7155 13.6897 14.8555 11.4294 14.3019 15.1 13.6611 14.9862 0 15.1223 16.1336 15.8644 15.2087 11.2088 11.8759 14.1316 16.3096 13.035 10.932 0 0 14.0513 14.069 14.0206 14.4961 16.5888 10.614 0 14.6523 0 13.8528 14.2527 14.2717 13.31 14.0743 0 14.1698 15.5198 12.9778 0 0 13.655 13.6502 0 0 14.3991 0 13.4457 13.2942 15.9045 0 12.8586 15.3188 0 15.656 0 13.4239 12.8492 0 0 12.7918 0 15.8883 0 0 0 0 15.2838 15.24 15.907 15.3032 14.1263 14.736 10.9032 12.5758 0 11.3472 11.5929 0 0 12.4169 0 0 0 0 0 0 12.2754 14.9754 15.2737 0 0 0 0 0 10.2697 P49366 DHYS_HUMAN "Deoxyhypusine synthase, DHS, EC 2.5.1.46" DHPS DS Homo sapiens (Human) glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; glucose homeostasis [GO:0042593]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell proliferation [GO:0042102]; spermidine catabolic process [GO:0046203]; spermidine metabolic process [GO:0008216]; translation [GO:0006412] GO:0005737; GO:0005829; GO:0006412; GO:0008216; GO:0008284; GO:0008612; GO:0034038; GO:0042102; GO:0042593; GO:0042802; GO:0046203 deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802] EINNPESVYYWAQK 0.99419 -5.2057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2478 0 13.4307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98173 FAM3A_HUMAN Protein FAM3A (Cytokine-like protein 2-19) FAM3A 2-19 2.19 Homo sapiens (Human) antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of gluconeogenesis [GO:0045721]; regulation of lipid biosynthetic process [GO:0046890] extracellular space [GO:0005615] extracellular space [GO:0005615]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of gluconeogenesis [GO:0045721]; regulation of lipid biosynthetic process [GO:0046890] GO:0005615; GO:0019732; GO:0045721; GO:0046890; GO:0061844; GO:1905035 MLMSSVK 0.99419 -9.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13283 G3BP1_HUMAN "Ras GTPase-activating protein-binding protein 1, G3BP-1, EC 3.6.4.12, EC 3.6.4.13 (ATP-dependent DNA helicase VIII, hDH VIII) (GAP SH3 domain-binding protein 1)" G3BP1 G3BP Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of type I interferon production [GO:0032481]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/RNA helicase activity [GO:0033677]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of type I interferon production [GO:0032481]; Ras protein signal transduction [GO:0007265]; stress granule assembly [GO:0034063] GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0004519; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0007265; GO:0010494; GO:0016887; GO:0032481; GO:0033677; GO:0034063; GO:0043204; GO:0045087; GO:0051607; GO:0062029; GO:0090090; GO:1990904 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/RNA helicase activity [GO:0033677]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] EQRINIPPQR 0.99419 -8.0434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.011 12.414 0 0 0 0 0 0 12.2281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7063 12.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1098 0 0 0 0 0 0 0 14.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 12.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14703 MBTP1_HUMAN "Membrane-bound transcription factor site-1 protease, EC 3.4.21.112 (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1, SKI-1)" MBTPS1 KIAA0091 S1P SKI1 Homo sapiens (Human) ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976] GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0007040; GO:0008203; GO:0016021; GO:0016485; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0060627 serine-type endopeptidase activity [GO:0004252] HQKLLSIDLDKVVLPNFR 0.99419 -9.3013 0 11.4978 0 0 0 0 11.7034 0 0 0 12.2913 0 11.4028 14.1459 12.2028 0 14.6624 0 0 0 10.1471 0 13.2331 0 0 12.2916 0 0 0 0 0 0 0 0 0 0 0 14.1817 0 0 0 0 14.1062 10.1458 0 0 0 0 0 12.6655 0 12.2805 0 13.5038 13.7871 12.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5055 0 11.9991 15.2362 14.7266 15.1339 11.9963 13.9335 14.2547 15.7604 14.5111 13.9024 0 16.693 14.7022 0 14.4667 15.2226 14.2782 15.0977 0 15.6505 0 14.8502 13.9408 0 15.3366 0 13.121 14.3887 15.2072 13.3699 0 0 15.2912 0 0 0 0 14.9689 0 0 0 15.8646 15.6079 15.4458 13.7814 13.8209 14.5818 0 15.3505 0 11.9107 0 11.1759 14.2679 0 0 14.6521 15.169 14.5231 14.1854 0 0 0 0 0 13.0153 14.4473 15.206 0 14.279 14.7358 0 0 15.3806 0 13.7598 14.3023 15.3788 0 0 13.3083 0 0 11.5399 0 0 14.3971 0 0 0 13.0748 11.6808 12.4662 0 0 0 15.5677 0 13.738 0 14.7654 11.6724 12.7296 0 Q2M2I3 FA83E_HUMAN Protein FAM83E FAM83E Homo sapiens (Human) signal transduction [GO:0007165] protein kinase binding [GO:0019901]; signal transduction [GO:0007165] GO:0007165; GO:0019901 protein kinase binding [GO:0019901] AGLGGQP 0.99419 -5.1977 0 0 0 11.9195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.231 0 0 0 0 0 0 0 0 0 0 0 14.011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5811 0 0 0 0 0 0 0 11.6064 11.8529 0 0 0 12.2734 12.9688 12.3388 0 0 0 12.7118 12.8155 0 0 0 0 0 0 0 13.1823 0 0 12.6961 14.047 0 0 0 0 0 13.2933 0 0 13.6011 0 0 13.8607 15.1672 13.5775 13.0297 0 0 0 12.9059 0 0 0 0 0 12.6475 0 0 0 0 0 0 0 0 0 12.6738 0 0 12.6187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5FWE3 PRRT3_HUMAN Proline-rich transmembrane protein 3 PRRT3 UNQ5823/PRO19642 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AELDDAGSSLLR 0.99419 -11.576 0 0 0 0 0 0 0 0 0 14.8378 0 0 0 0 0 10.6651 0 0 0 0 0 0 0 15.3109 12.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5057 0 0 12.3055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8942 0 0 0 0 0 14.4083 0 0 0 0 0 0 14.5269 0 0 14.6393 0 0 12.1962 0 0 0 0 0 0 0 0 0 13.2655 0 0 0 0 0 0 0 0 0 0 0 14.7568 0 0 13.8717 0 0 0 0 0 0 0 14.4053 14.1734 14.1251 14.2945 0 0 12.2133 0 0 0 0 0 0 0 14.0656 14.4066 0 0 0 11.7919 0 13.9214 14.6234 0 0 0 11.7773 12.0383 0 0 0 0 0 0 0 0 0 0 13.8665 0 13.9151 0 0 0 0 0 0 12.8782 11.719 0 0 0 0 13.6032 13.3387 0 0 0 0 0 0 0 10.0954 0 0 Q7RTT3 SSX9_HUMAN Putative protein SSX9 SSX9P SSX9 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 AFDDIAKYFSKK 0.99419 -9.2805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.771 0 0 10.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0X4 CLYBL_HUMAN "Citramalyl-CoA lyase, mitochondrial, EC 4.1.3.25 ((3S)-malyl-CoA thioesterase, EC 3.1.2.30) (Beta-methylmalate synthase, EC 2.3.3.-) (Citrate lyase subunit beta-like protein, Citrate lyase beta-like) (Malate synthase, EC 2.3.3.9)" CLYBL CLB Homo sapiens (Human) positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; (S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064] GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121 (S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474] ASLAADIPR 0.99419 -8.7899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3529 0 0 14.3399 14.2683 12.7606 0 0 12.8162 0 15.4537 13.4049 0 13.4156 0 13.175 0 0 0 0 0 0 0 0 13.734 0 0 0 0 0 0 0 0 0 0 13.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2558 0 0 0 0 0 0 0 0 14.3401 0 0 0 14.8057 0 0 0 0 0 13.0372 0 13.4422 0 0 0 0 0 0 0 13.2736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N139 ABCA6_HUMAN "ATP-binding cassette sub-family A member 6, EC 7.6.2.-" ABCA6 Homo sapiens (Human) lipid transport [GO:0006869] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; lipid transport [GO:0006869] GO:0000139; GO:0005319; GO:0005524; GO:0005654; GO:0005886; GO:0006869; GO:0016021; GO:0042626; GO:0043231; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] ALLCKNFLK 0.99419 -36.669 0 12.7411 0 0 0 0 14.0831 0 0 0 0 9.8431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4446 10.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0313 0 13.2852 0 0 0 14.1251 13.4276 0 0 0 0 0 0 0 0 0 0 13.8922 0 0 0 0 0 0 0 0 0 0 11.3911 0 0 0 0 13.1153 0 0 0 0 11.5808 0 0 0 0 0 0 0 0 0 0 0 11.1407 0 0 0 0 0 0 12.4209 0 0 0 0 0 0 0 0 0 0 0 12.879 0 0 13.0711 0 0 0 11.5257 0 0 0 0 0 12.6557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N720 ZN655_HUMAN Zinc finger protein 655 (Vav-interacting Krueppel-like protein) ZNF655 VIK Homo sapiens (Human) negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005730; GO:0005737; GO:0006357; GO:0046872; GO:2000134 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHECNECGK 0.99419 -36.662 0 0 0 0 0 0 0 0 11.4115 0 0 0 0 0 10.5665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3264 0 12.1239 0 0 0 0 0 12.4759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3641 13.276 0 0 0 0 0 0 0 0 14.0636 11.8742 0 0 0 0 0 0 0 0 0 0 0 10.1111 0 11.6414 0 0 0 0 0 0 0 0 0 0 0 11.5475 0 11.6286 0 0 0 11.7911 14.8103 14.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8512 0 0 16.5333 0 0 0 0 0 14.318 0 0 0 0 0 0 0 0 14.3638 0 0 0 0 0 0 0 0 0 0 11.1347 0 0 0 0 Q8N815 CNTD1_HUMAN Cyclin N-terminal domain-containing protein 1 CNTD1 CNTD Homo sapiens (Human) reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; reciprocal meiotic recombination [GO:0007131]; regulation of meiotic cell cycle [GO:0051445]; spermatogenesis [GO:0007283] GO:0005634; GO:0005694; GO:0005737; GO:0007131; GO:0007283; GO:0035861; GO:0051445 DGPMRPR 0.99419 -13.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4109 0 0 0 0 14.4009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7407 14.1376 13.5367 14.2661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6354 13.5571 13.8666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.573 0 0 0 0 0 Q8TB36 GDAP1_HUMAN "Ganglioside-induced differentiation-associated protein 1, GDAP1" GDAP1 Homo sapiens (Human) cellular response to vitamin D [GO:0071305]; glutathione metabolic process [GO:0006749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526] cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778] cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; cellular response to vitamin D [GO:0071305]; glutathione metabolic process [GO:0006749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526] GO:0000266; GO:0005634; GO:0005739; GO:0005778; GO:0005829; GO:0006626; GO:0006749; GO:0008053; GO:0016020; GO:0031307; GO:0032526; GO:0071305 APKVLGTTLVVGLLAGVGYFAFMLFR 0.99419 -8.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8579 0 0 0 0 12.9068 0 0 0 0 0 12.0074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0226 12.8668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8347 0 0 12.963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2968 0 0 0 0 0 0 Q8TBE7 S35G2_HUMAN Solute carrier family 35 member G2 (Transmembrane protein 22) SLC35G2 TMEM22 Homo sapiens (Human) Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] GO:0005794; GO:0005886; GO:0005887; GO:0016021 KMWIVLFGSALAHGCVALITR 0.99419 -11.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4773 0 0 0 0 0 0 0 0 0 14.0082 0 0 0 0 0 0 0 0 15.088 0 0 0 0 0 0 13.0571 10.4472 0 0 0 0 0 0 0 0 10.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93063 EXT2_HUMAN "Exostosin-2, EC 2.4.1.224, EC 2.4.1.225 (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2) (Putative tumor suppressor protein EXT2)" EXT2 Homo sapiens (Human) "cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; chondrocyte differentiation [GO:0002062]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311]" endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; cellular polysaccharide biosynthetic process [GO:0033692]; cellular response to fibroblast growth factor stimulus [GO:0044344]; chondrocyte differentiation [GO:0002062]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal water homeostasis [GO:0050891]; ossification [GO:0001503]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311]" GO:0000139; GO:0001503; GO:0001707; GO:0002062; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006487; GO:0007165; GO:0008217; GO:0010467; GO:0015012; GO:0015014; GO:0015020; GO:0016020; GO:0016021; GO:0016757; GO:0030210; GO:0033692; GO:0042044; GO:0042311; GO:0042328; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0051923; GO:0055078; GO:0060047; GO:0060350; GO:0070062 glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982] AVIKVTPR 0.99419 -30.975 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4686 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2828 12.4655 0 0 0 0 0 0 0 0 0 11.4956 0 0 0 0 0 0 12.124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5753 0 0 0 0 0 13.2942 0 0 13.1491 11.1808 0 12.6153 0 0 11.9416 0 13.8764 13.9966 0 0 0 13.3372 0 0 0 0 0 0 0 0 0 0 0 13.1095 12.7953 12.2375 0 0 0 0 0 13.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6657 0 12.9566 0 0 0 13.4441 0 0 0 0 0 0 0 0 0 0 13.889 0 12.0854 0 0 10.6389 0 0 0 0 0 0 0 9.89957 0 0 11.0963 0 11.866 0 12.8824 12.8014 0 0 0 0 0 0 0 12.1923 12.5298 0 0 0 0 Q96C01 F136A_HUMAN Protein FAM136A FAM136A Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 CTMHCNDK 0.99419 -8.7975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5315 0 0 0 0 0 0 12.8045 0 13.6966 0 0 0 0 0 0 0 0 0 13.209 13.0586 0 0 15.0571 0 13.7966 0 13.0291 0 12.8563 0 0 12.6523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6911 0 0 0 0 0 12.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99569 PKP4_HUMAN Plakophilin-4 (p0071) PKP4 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922] adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155] GO:0000922; GO:0001533; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0005912; GO:0007043; GO:0007267; GO:0009898; GO:0014069; GO:0030054; GO:0030057; GO:0030155; GO:0030496; GO:0032467; GO:0043547; GO:0045296; GO:0048471; GO:0051233; GO:0072686; GO:0098609 cadherin binding [GO:0045296] AAAQVLNTLWQYRDLRSIYK 0.99419 -30.991 0 0 0 0 0 0 0 0 13.6103 0 0 14.3959 0 0 0 0 0 0 0 0 0 13.1711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9764 0 0 0 0 0 0 0 0 0 0 12.0258 0 0 0 0 0 0 0 12.4372 12.6182 0 0 0 0 0 13.0946 14.9741 0 0 0 0 0 0 0 14.1343 0 14.4182 0 0 0 0 0 0 12.6137 0 0 13.5258 13.044 0 13.4466 0 0 0 0 0 0 0 14.1901 0 14.1927 0 0 0 0 12.6699 13.2398 0 0 0 0 0 0 0 0 14.5295 0 0 0 0 0 0 0 0 0 0 9.92837 0 0 0 12.5428 0 0 0 0 0 0 0 12.626 0 0 0 0 0 13.3722 0 12.6149 0 0 0 0 0 0 0 0 0 0 13.6156 0 17.6497 0 0 0 0 0 0 0 0 0 0 0 Q9BQ90 KLDC3_HUMAN Kelch domain-containing protein 3 (Testis intracellular mediator protein) KLHDC3 PEAS Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] chromatin [GO:0000785]; Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0000785; GO:0003682; GO:0005654; GO:0005737; GO:0005829; GO:0007131; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756 chromatin binding [GO:0003682]; ubiquitin ligase-substrate adaptor activity [GO:1990756] DFHSATMLGSHMYVFGGRADR 0.99419 -9.3084 14.4324 0 11.9485 0 0 0 0 0 0 0 0 0 0 0 0 13.3435 15.2648 0 12.087 0 0 11.6667 16.0721 12.1224 11.6808 0 13.6488 0 13.741 0 14.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4512 16.2381 13.7842 16.1813 16.29 15.9954 15.7525 15.7287 15.5798 15.909 15.6951 15.8082 0 0 16.0265 0 16.4645 0 0 0 0 0 0 0 14.6289 0 0 0 0 11.713 0 0 14.5798 0 0 0 14.3573 16.4404 0 0 13.1774 0 16.3679 0 0 0 16.2553 16.6364 0 0 16.4274 0 16.3699 16.3115 0 16.9116 15.8602 15.7457 11.7855 12.9901 13.0289 16.3975 16.3142 16.171 16.1667 14.3511 16.3639 16.2201 0 16.2844 16.4271 11.5361 0 16.3124 0 0 0 16.6587 0 0 16.1661 0 0 0 13.8996 16.4211 0 16.0895 16.4431 13.8531 0 16.389 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0543 16.3349 0 16.258 14.1446 0 0 0 16.3296 0 Q9BQM9 CT144_HUMAN "Uncharacterized protein C20orf144 (Bcl-2-like protein from testis, Bclt)" C20orf144 Homo sapiens (Human) AALSWPRLLSR 0.99419 -8.0665 15.8578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6726 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4883 0 0 10.6715 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5284 0 0 14.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0049 0 0 0 0 15.5691 0 0 0 0 0 0 0 0 0 0 0 0 11.3744 0 0 0 0 0 11.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 14.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQT9 CSTN3_HUMAN "Calsyntenin-3 (Alcadein-beta, Alc-beta)" CLSTN3 CS3 KIAA0726 Homo sapiens (Human) "homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]" anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991] "anchoring junction [GO:0070161]; cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]" GO:0000139; GO:0001540; GO:0001558; GO:0005509; GO:0005789; GO:0007156; GO:0007416; GO:0009986; GO:0019894; GO:0030425; GO:0032991; GO:0035249; GO:0042988; GO:0045211; GO:0050806; GO:0051932; GO:0051965; GO:0070161; GO:0098978; GO:0098982; GO:0099061; GO:1902474; GO:1905606 amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988] AAVTEGK 0.99419 -9.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5647 0 0 0 0 12.5668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7384 0 0 15.3589 0 0 0 0 0 14.6709 0 0 0 0 14.6439 0 0 0 14.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7984 0 0 0 14.782 0 0 0 14.1012 0 0 0 0 0 14.6785 0 0 0 0 14.0275 0 0 0 0 0 11.9197 0 0 0 0 13.5248 0 0 0 14.6849 0 15.6875 14.649 14.1133 0 0 0 0 Q9BZD4 NUF2_HUMAN "Kinetochore protein Nuf2, hNuf2, hNuf2R, hsNuf2 (Cell division cycle-associated protein 1)" NUF2 CDCA1 NUF2R Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052] "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]" "chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]" GO:0000775; GO:0000776; GO:0005654; GO:0005829; GO:0007052; GO:0007059; GO:0007094; GO:0008608; GO:0016020; GO:0031262; GO:0031617; GO:0044877; GO:0045132; GO:0051301; GO:0051315; GO:0051383 protein-containing complex binding [GO:0044877] EKLASILK 0.99419 -36.379 0 0 0 0 0 0 0 0 0 11.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2175 0 12.0851 0 0 0 0 0 0 0 0 12.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.596 0 0 0 13.1916 13.5753 0 0 13.7305 13.3045 0 0 0 13.1736 13.714 0 12.4543 13.3918 0 0 13.8981 0 0 0 0 0 0 0 0 0 0 14.3007 0 0 0 0 0 13.7913 0 13.7374 0 0 0 11.3657 13.8491 0 0 0 0 0 0 13.1302 0 0 0 0 0 0 0 0 0 0 0 12.068 0 0 0 13.3281 0 0 12.5088 0 0 0 0 0 12.9291 0 0 0 0 0 0 0 0 0 0 0 0 15.6147 0 0 0 Q9H0B3 IQCN_HUMAN IQ domain-containing protein N IQCN KIAA1683 Homo sapiens (Human) mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrion [GO:0005739]; nucleus [GO:0005634] GO:0005634; GO:0005739 AAAELPLEAEK 0.99419 -36.679 0 0 0 0 0 0 0 11.2967 0 0 0 0 0 0 0 0 0 0 0 0 9.79212 10.7268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3154 0 0 0 0 0 11.0192 12.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.63 0 12.0709 0 0 0 0 12.4864 0 0 0 0 0 0 0 0 0 11.2555 0 0 0 0 13.8377 15.792 15.7915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5267 0 0 14.639 10.9723 12.9155 0 0 13.5355 0 0 0 0 0 0 17.2665 0 0 14.1727 0 13.5653 0 0 11.6656 0 0 0 0 12.663 0 0 0 0 0 11.7378 0 0 0 0 0 0 15.3737 14.4832 11.73 0 0 0 0 0 11.9039 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8941 0 0 0 Q9H0U9 TSYL1_HUMAN "Testis-specific Y-encoded-like protein 1, TSPY-like protein 1" TSPYL1 TSPYL Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006334; GO:0019899; GO:0042393 chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone binding [GO:0042393] EDLWPNPLQYYLLREGVRR 0.99419 -36.349 0 0 0 0 0 0 11.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4027 17.4705 0 17.5294 17.1124 13.902 19.3802 0 19.0366 0 17.4149 0 17.2413 16.864 0 17.3911 0 14.3558 0 0 13.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6191 12.8621 0 0 13.5486 0 15.9709 0 12.8061 0 0 12.0933 14.2323 0 0 0 0 0 0 0 0 0 0 12.5957 0 0 0 0 0 12.0166 0 0 0 0 0 0 0 0 0 18.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.284 0 0 0 0 0 0 0 0 Q9H3N8 HRH4_HUMAN "Histamine H4 receptor, H4R, HH4R (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144)" HRH4 GPCR105 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of MAPK cascade [GO:0043408]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of MAPK cascade [GO:0043408]" GO:0004969; GO:0004993; GO:0005886; GO:0005887; GO:0006954; GO:0007187; GO:0007197; GO:0007204; GO:0007268; GO:0016907; GO:0030425; GO:0030594; GO:0043408; GO:0045202 G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] AFLKIFCIKK 0.99419 -8.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7475 0 0 0 0 0 0 10.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4567 0 0 0 0 13.0783 0 13.8311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H792 PEAK1_HUMAN Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269) PEAK1 KIAA2002 Homo sapiens (Human) cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0004672; GO:0004715; GO:0005737; GO:0005925; GO:0006468; GO:0015629; GO:0016477; GO:0034446; GO:0042802; GO:0046777; GO:0048041; GO:0051893 identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672] ADLPRIPFR 0.99419 -13.892 0 0 0 0 0 0 0 0 14.4002 15.5217 13.0842 14.424 13.492 0 12.9297 0 0 0 0 0 0 0 0 0 0 0 0 13.0775 12.7018 13.1576 0 0 13.1397 12.7894 0 13.0206 12.6688 12.5822 0 13.0847 0 0 0 12.5798 0 0 0 0 0 14.798 0 13.9177 0 0 0 0 12.0033 12.341 0 0 0 0 0 0 0 0 0 15.325 14.487 0 0 0 0 0 0 12.29 0 12.4814 14.0806 0 14.6675 0 10.5121 0 0 0 0 0 13.6829 14.1769 13.4972 0 0 13.5657 14.1195 0 0 0 15.209 0 0 13.561 18.4455 0 0 15.8013 11.855 14.1047 13.7715 11.4547 0 0 13.3313 0 13.3711 0 15.9979 13.7697 14.1092 0 13.0321 18.3957 0 0 0 13.9928 17.7517 17.5709 17.4219 10.2395 0 0 0 0 0 12.0092 0 17.8988 0 11.3587 15.8295 0 11.1198 0 0 0 0 14.2689 0 0 0 0 0 0 0 0 0 0 12.9616 0 0 0 16.3627 0 0 0 10.954 0 0 13.0633 0 0 13.7282 0 0 0 0 15.2696 0 0 Q9HCZ1 ZN334_HUMAN Zinc finger protein 334 ZNF334 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AILITQKGRQTER 0.99419 -10.967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7867 0 0 0 0 0 0 0 0 11.8571 11.3857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2453 0 0 0 0 13.4501 0 0 0 12.4843 0 0 0 0 0 14.3376 0 0 0 0 0 12.7874 0 0 0 14.4488 0 0 0 0 13.5962 0 13.1346 0 0 14.4394 0 0 13.7692 0 14.0677 0 0 13.4764 0 14.3484 0 14.4381 13.5196 0 11.7409 0 0 0 12.9264 14.4607 0 0 0 0 0 13.2754 0 0 0 0 0 0 13.0822 12.7539 0 0 0 0 0 13.1401 0 0 0 0 0 0 0 0 0 11.3151 0 14.0777 0 0 0 0 0 12.2054 0 11.3233 0 0 0 0 14.3825 14.2111 0 0 0 0 0 0 0 0 0 Q9Y4D2 DGLA_HUMAN "Diacylglycerol lipase-alpha, DAGL-alpha, DGL-alpha, EC 3.1.1.116 (Neural stem cell-derived dendrite regulator) (Sn1-specific diacylglycerol lipase alpha)" DAGLA C11orf11 KIAA0659 NSDDR Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendrite membrane [GO:0032590]; dendritic spine membrane [GO:0032591]; early endosome membrane [GO:0031901]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; varicosity [GO:0043196]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; arachidonic acid metabolic process [GO:0019369]; diacylglycerol catabolic process [GO:0046340]; endocannabinoid signaling pathway [GO:0071926]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; lipid catabolic process [GO:0016042]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neurotransmitter biosynthetic process [GO:0042136]; regulation of neuroinflammatory response [GO:0150077]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921] GO:0004465; GO:0004806; GO:0005737; GO:0005886; GO:0007216; GO:0007405; GO:0016042; GO:0016298; GO:0019369; GO:0022008; GO:0031901; GO:0032590; GO:0032591; GO:0042136; GO:0043196; GO:0045211; GO:0046340; GO:0046872; GO:0047372; GO:0070161; GO:0071926; GO:0098839; GO:0098921; GO:0099055; GO:0150077 acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806] AQFEPNLVPKPPR 0.99419 -13.856 0 0 0 0 0 0 0 0 0 11.6646 0 0 0 0 0 0 0 11.4249 0 0 0 0 0 0 0 0 0 0 0 10.7097 0 0 0 0 0 0 0 0 0 0 11.0105 0 0 0 0 0 0 10.8626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6631 0 0 0 0 12.9135 0 12.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3008 0 0 13.1434 0 0 13.7935 0 13.3285 13.4751 0 0 0 0 0 0 12.6466 0 0 0 12.2028 0 0 0 0 13.4318 11.1038 12.651 0 0 12.965 14.9198 0 0 0 0 0 0 0 0 0 0 0 0 12.5558 0 0 0 0 0 0 0 12.1735 0 0 0 0 0 0 0 0 0 0 0 12.7426 0 0 0 0 0 0 0 A0A0J9YWL9 TX13C_HUMAN Putative testis-expressed protein 13C TEX13C Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] GO:0003723; GO:0003729; GO:0005737; GO:0046872 metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] AIVADPRVPRAIK 0.9942 -10.748 0 0 0 10.9384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0286 0 0 0 0 11.6544 0 0 0 0 0 12.4735 0 14.3659 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4098 0 0 0 0 0 0 0 11.6921 0 0 0 0 11.9624 0 0 0 13.5247 0 0 0 12.1605 0 0 0 0 0 0 0 0 0 0 0 11.4937 0 0 0 0 0 0 11.2283 0 0 11.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5534 0 0 10.4629 A0A5F9ZHS7 NFILZ_HUMAN NFIL3 like protein (NFIL3 like basic leucine zipper) NFILZ Homo sapiens (Human) immune response [GO:0006955]; transcription by RNA polymerase II [GO:0006366] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; immune response [GO:0006955]; transcription by RNA polymerase II [GO:0006366] GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0006955 DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700] ASGRVPR 0.9942 -15.714 0 0 0 0 0 0 0 0 13.2586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NHZ5 LR14B_HUMAN Leucine-rich repeat-containing protein 14B LRRC14B Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 FLGNPLSAR 0.9942 -8.3691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1715 0 0 0 0 0 0 0 14.5039 14.5389 0 0 0 0 0 0 0 0 0 0 0 0 14.8681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B7ZAP0 RBG10_HUMAN "Rab GTPase-activating protein 1-like, isoform 10" RABGAP1L HHL KIAA0471 Homo sapiens (Human) DSLKKQLR 0.9942 -10.749 12.7314 13.1456 0 0 13.8676 0 14.0056 14.1723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9754 0 13.1706 0 0 0 0 13.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2736 0 0 0 0 0 0 0 0 12.4183 0 0 0 0 0 0 11.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14867 BACH1_HUMAN Transcription regulator protein BACH1 (BTB and CNC homolog 1) (HA2303) BACH1 Homo sapiens (Human) "DNA repair [GO:0006281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of metabolic process [GO:0019222]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0000117]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; heme binding [GO:0020037]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; DNA repair [GO:0006281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of metabolic process [GO:0019222]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083]; regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0000117]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000083; GO:0000117; GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006281; GO:0006355; GO:0006357; GO:0019222; GO:0020037; GO:0061418; GO:0090575 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; heme binding [GO:0020037]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASPPLQDSASQTYESMCLEK 0.9942 -9.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6599 0 0 0 0 0 0 0 0 0 0 P0C7V0 CF217_HUMAN Putative uncharacterized protein encoded by LINC00271 (AHI1 divergent transcript) AHI1-DT C6orf217 LINC00271 NCRNA00271 Homo sapiens (Human) ALYHVTFLLRIL 0.9942 -11.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.074 0 17.8645 0 0 0 13.4868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6027 0 0 0 0 0 0 0 13.961 0 0 0 0 0 0 0 0 14.2358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20142 PEPC_HUMAN "Gastricsin, EC 3.4.23.3 (Pepsinogen C)" PGC Homo sapiens (Human) digestion [GO:0007586]; positive regulation of antibacterial peptide production [GO:0002803]; proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; aspartic-type endopeptidase activity [GO:0004190]; digestion [GO:0007586]; positive regulation of antibacterial peptide production [GO:0002803]; proteolysis [GO:0006508] GO:0002803; GO:0004190; GO:0005615; GO:0006508; GO:0007586 aspartic-type endopeptidase activity [GO:0004190] ETMKEKGLLGEFLR 0.9942 -9.3312 0 0 0 12.4279 12.3595 0 13.0287 12.9476 15.2542 14.5822 14.8614 0 13.3665 13.3171 0 14.4614 0 14.6206 0 13.2523 14.2191 0 20.753 0 13.9059 14.6566 0 13.674 14.4488 0 12.95 0 0 14.6764 0 0 0 13.8274 14.3156 13.5482 0 15.1178 0 0 14.5145 14.1997 14.1259 14.0958 13.2224 13.2402 14.8532 14.5196 13.8162 15.4359 14.8696 14.0732 14.7108 9.99053 0 12.4217 0 13.371 0 10.9115 11.5148 12.7817 0 0 0 0 0 0 21.3184 0 0 15.7097 15.7936 15.8141 0 0 0 0 0 0 16.2155 0 21.0807 20.9974 20.9716 20.9589 15.8676 20.9621 10.4164 20.9076 20.8697 20.9305 20.9582 0 20.9757 20.8616 20.9095 0 0 20.8574 20.8801 0 20.8084 20.8008 0 0 0 20.8907 20.7934 17.3159 15.653 16.6338 0 15.5144 0 0 0 20.74 14.8353 14.8437 13.4542 0 0 0 0 0 0 13.6074 0 15.5079 15.5745 0 0 16.0599 0 0 0 15.9345 0 13.1202 0 14.8434 14.8427 15.4088 0 0 0 0 0 0 20.6176 20.6429 15.9972 0 15.1686 14.7797 14.7495 0 0 16.0777 16.0556 14.2569 15.548 14.1029 0 0 14.2505 0 0 0 11.8782 14.9126 0 0 0 0 P34903 GBRA3_HUMAN Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) GABRA3 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synapse [GO:0045202]; benzodiazepine receptor activity [GO:0008503]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0008503; GO:0022851; GO:0030594; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0050877; GO:0051932; GO:0060078; GO:0070161; GO:0098794; GO:0098982; GO:0099060; GO:1902476; GO:1902711; GO:1904315 benzodiazepine receptor activity [GO:0008503]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] ILPLNNLLASK 0.9942 -8.0901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7594 0 0 0 0 0 0 0 0 0 0 0 0 13.26 0 0 0 15.3542 0 0 0 0 0 15.737 0 0 0 0 0 0 0 0 14.7513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1554 0 0 0 0 0 0 0 P43629 KI3L1_HUMAN "Killer cell immunoglobulin-like receptor 3DL1 (CD158 antigen-like family member E) (HLA-BW4-specific inhibitory NK cell receptor) (Natural killer-associated transcript 3, NKAT-3) (p70 natural killer cell receptor clones CL-2/CL-11, p70 NK receptor CL-2/CL-11) (CD antigen CD158e)" KIR3DL1 CD158E NKAT3 NKB1 Homo sapiens (Human) immune response [GO:0006955]; natural killer cell mediated cytotoxicity [GO:0042267] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; HLA-B specific inhibitory MHC class I receptor activity [GO:0030109]; immune response [GO:0006955]; natural killer cell mediated cytotoxicity [GO:0042267] GO:0005886; GO:0005887; GO:0006955; GO:0030109; GO:0042267 HLA-B specific inhibitory MHC class I receptor activity [GO:0030109] CHYRHRFNNFMLYK 0.9942 -15.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60608 EFC2_HUMAN "Endogenous retrovirus group FC1 member 1 Env polyprotein (Envelope polyprotein) (Fc2deltaenv) (HERV-F(c)2_7q36.2 provirus ancestral Env polyprotein) [Includes: Surface protein, SU; Truncated transmembrane protein, TM ]" ERVFC1-1 Homo sapiens (Human) FSWLTLISEGAQLLQSTGVQNLSHCFLCAALRR 0.9942 -8.3582 0 0 0 0 0 0 0 0 0 0 11.6842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8327 0 0 0 0 0 0 0 0 0 0 0 0 11.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8068 0 0 0 0 0 0 0 0 0 0 12.9126 0 0 0 0 12.8726 0 0 0 0 0 13.192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1523 0 0 0 0 11.8868 12.047 0 12.4895 12.6471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61278 SMS_HUMAN "Somatostatin (Growth hormone release-inhibiting factor) [Cleaved into: Somatostatin-28; Somatostatin-14, SST-14; Neuronostatin, NST ]" SST Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; digestion [GO:0007586]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated apoptotic signaling pathway [GO:0008628]; hyperosmotic response [GO:0006972]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell migration [GO:0030334]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410] extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202] extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; digestion [GO:0007586]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated apoptotic signaling pathway [GO:0008628]; hyperosmotic response [GO:0006972]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell migration [GO:0030334]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410] GO:0005179; GO:0005576; GO:0005615; GO:0006972; GO:0007166; GO:0007186; GO:0007267; GO:0007268; GO:0007584; GO:0007586; GO:0008285; GO:0008628; GO:0009408; GO:0009410; GO:0010447; GO:0030334; GO:0042802; GO:0043025; GO:0043200; GO:0045202; GO:0048545 hormone activity [GO:0005179]; identical protein binding [GO:0042802] LRQFLQK 0.9942 -9.0689 0 0 0 0 0 0 0 0 12.9518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.162 0 13.2047 0 13.1753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7046 0 0 0 0 0 12.4877 0 0 0 P62857 RS28_HUMAN 40S ribosomal protein S28 (Small ribosomal subunit protein eS28) RPS28 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0000028; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006364; GO:0006412; GO:0015935; GO:0022627; GO:0030490; GO:0042254; GO:0042274; GO:0042788; GO:0070062; GO:0098556 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] VEFMDDTSR 0.9942 -9.3144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3582 0 0 0 0 14.2026 0 0 0 14.263 0 0 0 0 0 0 0 0 0 11.2065 0 0 13.487 0 0 0 10.1673 0 0 0 0 0 0 0 0 0 0 0 0 11.3433 0 0 0 0 13.1894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4588 0 P68366 TBA4A_HUMAN Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain) TUBA4A TUBA1 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005576; GO:0005737; GO:0005829; GO:0005856; GO:0005874; GO:0007017; GO:0015630; GO:0019901; GO:0070062 GTP binding [GO:0005525]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200] CDPRHGK 0.9942 -8.0769 0 0 0 0 0 0 0 0 12.3502 0 0 0 0 0 0 0 0 11.243 0 0 0 0 0 0 0 0 0 14.2541 0 0 0 0 0 0 11.1415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2876 15.7283 15.37 15.5043 0 0 0 13.252 13.3669 0 0 0 0 0 11.7928 0 0 12.4049 13.2347 12.3113 0 0 0 0 0 0 0 12.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05086 UBE3A_HUMAN "Ubiquitin-protein ligase E3A, EC 2.3.2.26 (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)" UBE3A E6AP EPVE6AP HPVE6A Homo sapiens (Human) androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502] cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0014068; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0035641; GO:0042220; GO:0042542; GO:0042752; GO:0045944; GO:0046872; GO:0048511; GO:0050847; GO:0051865; GO:0060736; GO:0061002; GO:0061630; GO:0061743; GO:0070936; GO:1905528; GO:1990416; GO:2000058 metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ALELYKINAKLCDPHPSK 0.9942 -15.316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8181 0 0 11.4619 0 15.3807 0 0 0 11.5242 11.7275 0 0 0 0 0 0 12.2687 0 0 0 10.882 0 0 0 0 11.5321 0 11.4351 0 19.5068 19.5729 15.7915 15.6426 19.0987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9394 0 0 0 0 0 0 0 0 12.3526 0 0 0 0 14.3276 0 13.5467 0 0 0 0 0 0 0 15.9746 0 0 0 0 0 0 0 0 0 0 0 0 0 14.965 0 0 14.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4022 0 0 0 0 0 0 0 0 13.5893 0 0 0 0 0 0 0 0 0 0 0 14.4537 0 13.1958 0 0 13.556 12.1061 0 0 13.3449 12.6122 0 11.9965 0 14.5225 0 18.5992 0 0 0 0 13.65 0 0 0 0 0 0 Q13797 ITA9_HUMAN Integrin alpha-9 (Integrin alpha-RLC) ITGA9 Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; neutrophil chemotaxis [GO:0030593] basal plasma membrane [GO:0009925]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886] basal plasma membrane [GO:0009925]; external side of plasma membrane [GO:0009897]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; neutrophil chemotaxis [GO:0030593] GO:0005178; GO:0005886; GO:0007155; GO:0007160; GO:0007229; GO:0008305; GO:0009897; GO:0009925; GO:0030593; GO:0033627; GO:0046872; GO:0050900; GO:0098609 integrin binding [GO:0005178]; metal ion binding [GO:0046872] ADGRVLACAHR 0.9942 -13.591 0 0 0 0 0 0 0 0 0 11.1396 0 11.6121 0 0 0 0 0 0 11.2288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2122 0 0 0 0 0 0 0 0 0 11.81 0 0 0 0 12.4346 0 0 0 0 0 0 12.4248 0 0 0 0 0 0 0 0 0 0 0 11.0681 0 0 0 0 0 0 0 0 0 0 0 14.2111 0 0 13.013 0 13.8733 0 0 0 13.6126 0 13.9088 0 0 0 14.4997 12.6729 0 0 0 0 0 14.8968 13.9279 15.0774 0 13.5606 0 0 0 0 0 0 13.4308 13.8049 0 12.7304 0 0 0 0 13.2543 0 0 0 0 13.2134 12.5141 0 0 0 12.7553 0 0 0 0 0 0 0 0 0 0 11.3341 0 0 0 0 0 14.352 0 0 12.9706 0 0 12.8523 0 14.472 13.4802 0 0 0 14.0492 0 0 13.5874 0 0 13.4549 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15334 L2GL1_HUMAN "Lethal(2) giant larvae protein homolog 1, LLGL (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein)" LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] adherens junction [GO:0005912]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] adherens junction [GO:0005912]; axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein-containing complex assembly [GO:0065003]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] GO:0000137; GO:0000139; GO:0005096; GO:0005198; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0007409; GO:0008593; GO:0019901; GO:0030424; GO:0030864; GO:0030866; GO:0031901; GO:0032588; GO:0032878; GO:0045159; GO:0045197; GO:0050708; GO:0051294; GO:0065003 GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198] AINKILWR 0.9942 -8.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q29RF7 PDS5A_HUMAN "Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112, SCC-112)" PDS5A KIAA0648 PDS5 PIG54 Homo sapiens (Human) cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell division [GO:0051301]; DNA repair [GO:0006281]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156]" GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0005886; GO:0006281; GO:0007064; GO:0008156; GO:0051301 AHARQCLLK 0.9942 -37.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7237 0 0 0 0 0 0 0 0 0 0 0 0 11.4765 0 0 0 0 0 0 12.5112 0 12.1904 12.2291 12.4206 0 0 0 0 0 0 0 0 11.8506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6753 0 0 0 0 0 0 0 15.4292 0 0 14.1728 13.8925 14.0588 14.6907 13.1731 12.6745 15.8881 0 14.5792 13.5319 0 0 0 15.0582 13.8976 0 14.1528 0 0 0 0 0 14.4973 13.9387 0 0 0 13.7109 0 0 14.009 0 0 14.8782 0 0 0 13.7265 14.7602 12.7537 0 0 0 0 0 14.7104 14.6124 11.5393 11.7635 0 0 0 0 12.4383 0 0 0 12.7776 0 0 0 0 0 0 0 0 13.3093 0 0 14.4661 0 0 13.2337 0 0 0 0 0 0 0 0 0 12.4266 0 0 0 0 0 13.7805 Q2TAL6 VWC2_HUMAN Brorin (Brain-specific chordin-like protein) (von Willebrand factor C domain-containing protein 2) VWC2 UNQ739/PRO1434 Homo sapiens (Human) negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron differentiation [GO:0045666] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; basement membrane [GO:0005604]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; synapse [GO:0045202] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; basement membrane [GO:0005604]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron differentiation [GO:0045666] GO:0005604; GO:0005614; GO:0005615; GO:0010811; GO:0030514; GO:0032281; GO:0045202; GO:0045666; GO:0070161 CEANGEVLCTVSACPQTECVDPVYEPDQCCPICK 0.9942 -8.3539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2467 0 0 0 0 12.9286 0 0 0 12.9493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8756 0 0 0 0 0 0 14.3056 0 0 0 0 13.5832 13.6298 0 12.1046 13.5225 13.2047 0 12.5308 0 0 0 0 12.9151 0 0 0 0 0 0 0 0 0 13.9858 0 13.2975 0 0 0 14.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8287 0 13.1296 0 0 0 0 0 12.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6021 0 13.2202 0 0 0 0 Q5JTZ9 SYAM_HUMAN "Alanine--tRNA ligase, mitochondrial, EC 6.1.1.7 (Alanyl-tRNA synthetase, AlaRS)" AARS2 AARSL KIAA1270 Homo sapiens (Human) alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; mitochondrial alanyl-tRNA aminoacylation [GO:0070143]; tRNA modification [GO:0006400] GO:0000049; GO:0002161; GO:0004813; GO:0005524; GO:0005739; GO:0006400; GO:0006419; GO:0008270; GO:0016597; GO:0070143 alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] ANTAIRK 0.9942 -10.982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8107 0 0 10.9825 0 0 0 0 0 0 0 0 0 0 0 0 15.5553 15.7216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4031 0 0 0 0 0 0 0 0 16.4105 0 0 12.4105 0 0 0 0 0 0 0 0 0 0 0 11.9695 0 0 0 13.6204 0 0 0 14.2745 0 0 11.7002 0 0 13.4218 0 0 0 0 0 0 0 0 0 11.5052 0 0 0 0 15.7629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGD1 OR4N2_HUMAN Olfactory receptor 4N2 (Olfactory receptor OR14-13) (Olfactory receptor OR14-8) OR4N2 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AFPADKVVSLFHTVIFPLLNPVIYTLR 0.9942 -9.0839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3663 0 0 0 0 0 0 0 11.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF71 MOT10_HUMAN "Monocarboxylate transporter 10, MCT 10 (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1)" SLC16A10 MCT10 TAT1 Homo sapiens (Human) amino acid transport [GO:0006865]; aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460] basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid transport [GO:0006865]; aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460] GO:0005886; GO:0005887; GO:0006590; GO:0006865; GO:0015171; GO:0015173; GO:0015349; GO:0015801; GO:0016021; GO:0016323; GO:0030054; GO:0043231; GO:0070327; GO:0070460 amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; thyroid hormone transmembrane transporter activity [GO:0015349] IFNFAIFK 0.9942 -10.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1391 0 0 0 0 0 0 0 0 0 0 13.4654 12.9458 14.1446 0 14.2885 13.3696 0 0 13.7497 0 0 0 12.7955 0 0 0 0 12.5125 12.4986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5225 0 0 0 0 0 0 0 0 0 0 0 11.7312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1149 0 0 0 0 0 0 0 0 0 0 0 0 11.7639 0 0 0 0 0 0 11.6214 0 0 0 0 12.1507 0 0 12.2035 0 0 Q9C098 DCLK3_HUMAN "Serine/threonine-protein kinase DCLK3, EC 2.7.11.1 (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3)" DCLK3 DCAMKL3 DCDC3C KIAA1765 Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; peptidyl-serine phosphorylation [GO:0018105] GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0018105; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALKGDHRCGETETPK 0.9942 -37.062 0 11.5835 0 0 0 0 14.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.726 0 0 11.1336 0 14.4967 0 0 0 13.233 0 0 0 0 0 13.2386 0 15.1521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.731 13.676 0 0 0 0 0 0 0 0 14.2672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77895 0 0 0 0 14.2051 0 0 0 0 13.4149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6T3 RPAP3_HUMAN RNA polymerase II-associated protein 3 RPAP3 Homo sapiens (Human) protein stabilization [GO:0050821] chaperone complex [GO:0101031]; cytosol [GO:0005829]; R2TP complex [GO:0097255]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytosol [GO:0005829]; R2TP complex [GO:0097255]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; protein stabilization [GO:0050821] GO:0005829; GO:0050821; GO:0097255; GO:0101031; GO:1990062 ASAYFRLK 0.9942 -10.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5169 0 0 11.9369 0 0 0 0 0 0 0 0 12.1559 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0904 0 12.9259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4079 0 0 0 0 0 11.931 12.0207 0 0 0 0 0 12.2344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPD5 SO1B3_HUMAN "Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2, LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8, OATP-8) (Solute carrier family 21 member 8)" SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; heme catabolic process [GO:0042167]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] GO:0005886; GO:0005887; GO:0008514; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0016323; GO:0042167; GO:0043252 bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] DQHQHLNK 0.9942 -8.1032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8723 0 0 0 0 0 0 0 11.6481 11.6948 0 0 0 0 0 0 0 0 13.4022 0 0 12.7195 0 0 0 0 13.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7937 0 0 0 0 0 0 0 0 13.3757 0 12.1073 0 0 0 0 0 0 12.7443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6104 0 0 11.2787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXR7 BABA2_HUMAN BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) BABAM2 BRCC45 BRE Homo sapiens (Human) apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome targeting sequence binding [GO:0000268]; polyubiquitin modification-dependent protein binding [GO:0031593]; tumor necrosis factor receptor binding [GO:0005164]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA repair [GO:0045739]; protein autoubiquitination [GO:0051865]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165] GO:0000152; GO:0000268; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006302; GO:0006325; GO:0006915; GO:0006974; GO:0007095; GO:0007165; GO:0010212; GO:0031593; GO:0035518; GO:0043066; GO:0044818; GO:0045739; GO:0051301; GO:0051865; GO:0070531; GO:0070536; GO:0070537; GO:0070552; GO:0071479; GO:2000001 peroxisome targeting sequence binding [GO:0000268]; polyubiquitin modification-dependent protein binding [GO:0031593]; tumor necrosis factor receptor binding [GO:0005164] ISPMLSPFISSVVRNGK 0.9942 -15.715 0 0 0 0 0 10.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3939 0 0 0 0 0 0 0 0 14.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3245 0 0 0 0 0 0 0 0 13.1119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9703 0 0 0 0 13.7151 0 0 0 0 0 0 13.1644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8435 0 0 0 0 0 Q9UJQ1 LAMP5_HUMAN "Lysosome-associated membrane glycoprotein 5 (Brain and dendritic cell-associated LAMP) (Brain-associated LAMP-like protein, BAD-LAMP) (Lysosome-associated membrane protein 5, LAMP-5)" LAMP5 C20orf103 Homo sapiens (Human) establishment of protein localization to organelle [GO:0072594] anchoring junction [GO:0070161]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; growth cone membrane [GO:0032584]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; growth cone membrane [GO:0032584]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle membrane [GO:0030672]; establishment of protein localization to organelle [GO:0072594] GO:0005765; GO:0005886; GO:0010008; GO:0016021; GO:0030659; GO:0030672; GO:0031901; GO:0031902; GO:0032584; GO:0032590; GO:0033116; GO:0055038; GO:0070161; GO:0072594 AYALKMLFVK 0.9942 -10.975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.834 0 0 0 0 0 11.6906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1034 12.1177 0 0 14.9728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKX3 MYH13_HUMAN "Myosin-13 (Myosin heavy chain 13) (Myosin heavy chain, skeletal muscle, extraocular, MyHC-EO) (Myosin heavy chain, skeletal muscle, laryngeal, MyHC-IIL) (Superfast myosin)" MYH13 Homo sapiens (Human) cellular response to starvation [GO:0009267]; muscle contraction [GO:0006936] extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460] extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular response to starvation [GO:0009267]; muscle contraction [GO:0006936] GO:0000146; GO:0005516; GO:0005524; GO:0005859; GO:0006936; GO:0009267; GO:0016460; GO:0030016; GO:0032982; GO:0051015; GO:0070062 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AKIEKQR 0.9942 -36.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7112 0 0 0 0 0 0 0 0 0 12.3178 0 0 11.7829 0 0 0 11.3587 0 0 12.3516 0 0 10.5881 0 0 0 0 0 0 0 0 0 0 13.9228 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8567 15.1104 0 0 0 12.8083 0 13.4745 0 0 12.7433 0 0 0 13.661 0 0 0 0 0 0 0 13.8435 0 0 0 17.0454 0 0 0 0 0 0 0 0 15.8353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0741 0 0 0 0 0 13.6835 0 14.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4781 0 0 0 0 0 0 0 0 13.0571 13.1903 0 0 0 0 0 0 14.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3R0 GRIP1_HUMAN "Glutamate receptor-interacting protein 1, GRIP-1" GRIP1 Homo sapiens (Human) "dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection arborization [GO:0150012]" anchoring junction [GO:0070161]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] "anchoring junction [GO:0070161]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; beta-catenin binding [GO:0008013]; nuclear glucocorticoid receptor binding [GO:0035259]; protein C-terminus binding [GO:0008022]; signaling receptor complex adaptor activity [GO:0030159]; dendrite development [GO:0016358]; intracellular signal transduction [GO:0035556]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of neuron projection arborization [GO:0150012]" GO:0005789; GO:0005829; GO:0005886; GO:0008013; GO:0008022; GO:0014069; GO:0016358; GO:0030159; GO:0030425; GO:0031410; GO:0035259; GO:0035556; GO:0043005; GO:0043204; GO:0045211; GO:0070161; GO:0098887; GO:0150012 beta-catenin binding [GO:0008013]; nuclear glucocorticoid receptor binding [GO:0035259]; protein C-terminus binding [GO:0008022]; signaling receptor complex adaptor activity [GO:0030159] AVNGINLAK 0.9942 -15.705 0 0 0 14.5429 0 0 0 0 13.3476 0 10.8174 13.3748 13.1242 0 13.0537 13.1231 13.4693 13.4668 0 0 0 0 0 0 13.5914 13.3259 13.3526 13.1785 0 13.4027 13.4001 13.3867 13.2836 0 0 0 13.2361 13.0889 13.3266 0 13.3035 0 0 0 0 0 0 0 0 0 0 13.699 0 0 0 11.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8795 12.4409 11.8975 0 0 0 0 13.2574 0 0 0 0 11.2883 0 0 0 0 13.0171 0 0 0 0 0 0 0 0 0 0 0 0 12.0667 14.7354 0 0 0 13.5579 0 0 0 0 12.6257 11.5836 0 0 0 0 13.2098 0 16.2975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0785 13.6666 14.627 16.6118 0 0 0 0 0 14.4394 0 0 0 0 0 15.0197 15.1761 14.5274 0 14.5246 14.5752 0 0 0 14.2398 0 0 0 0 15.9424 12.1934 0 15.1831 0 0 O60347 TBC12_HUMAN TBC1 domain family member 12 TBC1D12 KIAA0608 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of autophagosome assembly [GO:2000785] autophagosome [GO:0005776]; recycling endosome [GO:0055037] autophagosome [GO:0005776]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of autophagosome assembly [GO:2000785] GO:0005096; GO:0005776; GO:0055037; GO:0090630; GO:2000785 GTPase activator activity [GO:0005096] EGDKNSSPALKS 0.99421 -7.9002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6657 0 0 0 0 0 0 0 0 0 0 14.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3121 0 0 13.3476 14.1298 0 0 0 0 0 0 0 0 0 0 0 0 16.0247 0 0 0 0 0 0 17.3022 0 0 0 0 0 0 12.1803 0 0 0 0 0 0 0 0 0 0 O75417 DPOLQ_HUMAN "DNA polymerase theta, EC 2.7.7.7 (DNA polymerase eta)" POLQ POLH Homo sapiens (Human) base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446] chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446] GO:0003682; GO:0003684; GO:0003887; GO:0005524; GO:0005654; GO:0005694; GO:0005794; GO:0005829; GO:0006261; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0017116; GO:0042802; GO:0051260; GO:0051575; GO:0097681; GO:2000042 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA helicase activity [GO:0017116] AAAAGECK 0.99421 -29.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4032 0 11.3228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.687 0 0 0 0 0 0 0 0 0 0 0 11.6771 0 0 12.7598 10.9346 11.2084 14.59 16.0253 0 0 14.38 0 0 0 0 0 12.4208 0 0 0 0 0 10.6451 0 0 0 0 0 0 0 0 13.8935 13.0807 0 12.2911 0 0 11.9391 12.187 0 13.3494 0 0 0 0 0 12.0075 0 0 13.4471 11.6267 12.3081 11.3506 0 0 10.9902 0 0 0 0 12.9177 0 0 0 0 0 0 0 0 0 0 0 0 12.6372 0 0 12.6249 0 0 0 0 0 0 0 0 0 0 0 0 10.2696 0 0 0 0 0 0 0 0 0 0 12.1329 0 O95803 NDST3_HUMAN "Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (Glucosaminyl N-deacetylase/N-sulfotransferase 3, NDST-3, hNDST-3) (N-heparan sulfate sulfotransferase 3, N-HSST 3) [Includes: Heparan sulfate N-deacetylase NDST3, EC 3.-.-.-; [heparan sulfate]-glucosamine N-sulfotransferase NDST3, EC 2.8.2.8 ]" NDST3 HSST3 UNQ2544/PRO4998 Homo sapiens (Human) "heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]" GO:0000139; GO:0005794; GO:0015012; GO:0015014; GO:0015016; GO:0016021; GO:0019213; GO:0030210; GO:0102140 [heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140] AASLVPK 0.99421 -7.8774 0 0 0 0 0 0 0 0 0 15.6911 0 0 0 0 0 17.1854 17.3304 0 16.2402 0 0 0 16.2195 0 0 16.0111 0 0 0 0 0 0 0 0 0 0 0 0 14.9626 0 0 0 0 0 0 0 17.2915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9981 0 0 0 0 0 0 0 19.799 0 0 0 0 0 0 0 0 0 13.0121 0 0 0 0 14.5136 0 0 0 0 20.6453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9182 0 0 0 0 0 20.2225 13.3025 0 0 17.9216 0 20.0817 20.2289 20.3318 20.1259 0 19.3873 14.8754 18.0675 17.6662 0 0 0 0 0 19.4707 0 19.7084 18.9144 P02545 LMNA_HUMAN Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32) ] LMNA LMN1 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cellular senescence [GO:0090398]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; heterochromatin assembly [GO:0031507]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015] cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of double-strand break [GO:0035861] cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of double-strand break [GO:0035861]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cellular response to hypoxia [GO:0071456]; cellular senescence [GO:0090398]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; heterochromatin assembly [GO:0031507]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K9 trimethylation [GO:1900114]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015] GO:0005198; GO:0005200; GO:0005634; GO:0005635; GO:0005638; GO:0005652; GO:0005654; GO:0005829; GO:0005882; GO:0006606; GO:0006998; GO:0007097; GO:0007517; GO:0008104; GO:0008285; GO:0010628; GO:0016363; GO:0016607; GO:0030334; GO:0030951; GO:0031507; GO:0031647; GO:0031965; GO:0032204; GO:0034504; GO:0035861; GO:0042802; GO:0048471; GO:0051664; GO:0055015; GO:0071456; GO:0072201; GO:0090201; GO:0090398; GO:0090435; GO:1900114; GO:1900180; GO:1903243; GO:1990683; GO:2001237 identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] AQHEDQVEQYK 0.99421 -29.723 0 0 0 0 0 0 0 0 0 0 0 0 12.433 13.4919 0 0 13.9177 0 0 0 0 0 15.095 0 0 0 15.6669 0 14.3966 0 0 0 0 0 0 0 0 0 13.3171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9448 12.7754 0 0 0 0 11.541 0 0 0 0 0 0 0 0 0 0 0 0 12.556 0 0 0 0 0 0 0 0 0 17.9715 18.2757 19.1329 17.803 18.0508 18.7015 0 18.6244 0 0 16.5258 14.872 14.394 0 0 0 0 0 12.4138 0 0 12.963 14.8348 0 0 0 15.1016 0 13.6936 0 0 13.9338 0 16.7141 0 0 0 0 0 0 0 12.3477 0 0 11.366 0 0 0 0 0 13.2738 0 0 14.672 0 14.7133 0 0 0 0 0 0 0 0 14.178 0 0 0 0 0 0 14.3694 0 0 0 12.3394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7067 0 0 0 0 0 0 P11172 UMPS_HUMAN "Uridine 5'-monophosphate synthase, UMP synthase [Includes: Orotate phosphoribosyltransferase, OPRT, OPRTase, EC 2.4.2.10; Orotidine 5'-phosphate decarboxylase, ODC, OMPD, EC 4.1.1.23 (OMPdecase) ]" UMPS OK/SW-cl.21 Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UDP biosynthetic process [GO:0006225]; UMP biosynthetic process [GO:0006222] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; lactation [GO:0007595]; pyrimidine nucleobase biosynthetic process [GO:0019856]; UDP biosynthetic process [GO:0006225]; UMP biosynthetic process [GO:0006222] GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006222; GO:0006225; GO:0007565; GO:0007595; GO:0019856; GO:0042802; GO:0044205; GO:0071466 identical protein binding [GO:0042802]; orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590] CHEFLIFEDRKFADIGNTVK 0.99421 -15.817 0 0 0 0 0 0 0 0 0 11.7508 0 0 11.3215 10.8712 0 0 12.5918 0 0 0 0 0 0 0 0 0 10.8403 0 0 0 0 0 0 0 0 0 11.1482 0 0 0 0 0 0 0 0 10.6094 0 0 0 0 0 0 14.5672 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5499 0 0 0 0 0 0 0 0 0 0 11.6123 0 0 0 0 0 0 0 0 0 12.3513 0 0 0 0 0 0 0 0 0 0 0 18.088 0 0 0 0 0 0 0 0 0 14.2226 18.4881 0 17.4215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4391 12.6385 13.3776 0 12.5505 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3757 0 13.4049 0 0 P16870 CBPE_HUMAN "Carboxypeptidase E, CPE, EC 3.4.17.10 (Carboxypeptidase H, CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase)" CPE Homo sapiens (Human) cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; neuropeptide signaling pathway [GO:0007218]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein modification process [GO:0036211]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; carboxypeptidase activity [GO:0004180]; cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270]; cardiac left ventricle morphogenesis [GO:0003214]; insulin processing [GO:0030070]; neuropeptide signaling pathway [GO:0007218]; peptide hormone secretion [GO:0030072]; peptide metabolic process [GO:0006518]; protein localization to membrane [GO:0072657]; protein localization to secretory granule [GO:0033366]; protein modification process [GO:0036211]; protein processing [GO:0016485]; Wnt signaling pathway [GO:0016055] GO:0003214; GO:0004180; GO:0004181; GO:0005615; GO:0005794; GO:0005886; GO:0006518; GO:0007218; GO:0008270; GO:0016055; GO:0016485; GO:0030070; GO:0030072; GO:0030658; GO:0030667; GO:0033366; GO:0036211; GO:0042043; GO:0050839; GO:0070062; GO:0072657 carboxypeptidase activity [GO:0004180]; cell adhesion molecule binding [GO:0050839]; metallocarboxypeptidase activity [GO:0004181]; neurexin family protein binding [GO:0042043]; zinc ion binding [GO:0008270] EELMEWWK 0.99421 -8.3846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2133 0 0 0 0 0 13.5885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4985 0 0 0 16.9199 13.0569 0 0 0 0 0 0 0 15.3107 0 0 0 0 0 15.0566 0 0 0 0 P27987 IP3KB_HUMAN "Inositol-trisphosphate 3-kinase B, EC 2.7.1.127 (Inositol 1,4,5-trisphosphate 3-kinase B, IP3 3-kinase B, IP3K B, InsP 3-kinase B)" ITPKB Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165]" GO:0000165; GO:0000828; GO:0001932; GO:0002262; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005856; GO:0007165; GO:0007166; GO:0008440; GO:0016020; GO:0016301; GO:0016310; GO:0032957; GO:0032958; GO:0033030; GO:0035726; GO:0045059; GO:0045638; GO:0046579; GO:0046638; GO:0046854; GO:0071277 "ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]; kinase activity [GO:0016301]" DGEPPGK 0.99421 -8.6194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4109 0 0 0 0 0 0 0 0 0 13.5365 0 0 0 0 0 0 0 12.8318 0 0 0 0 13.1141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31944 CASPE_HUMAN "Caspase-14, CASP-14, EC 3.4.22.- [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form ]" CASP14 Homo sapiens (Human) cornification [GO:0070268]; epidermis development [GO:0008544]; keratinization [GO:0031424]; proteolysis [GO:0006508] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cornification [GO:0070268]; epidermis development [GO:0008544]; keratinization [GO:0031424]; proteolysis [GO:0006508] GO:0001533; GO:0004197; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0008544; GO:0031424; GO:0045095; GO:0070268; GO:0097200 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200] DSPQTIPTYTDALHVYSTVEGYIAYRHDQK 0.99421 -9.0999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.03389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4249 0 0 0 0 12.5595 0 0 0 13.1992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34896 GLYC_HUMAN "Serine hydroxymethyltransferase, cytosolic, SHMT, EC 2.1.2.1 (Glycine hydroxymethyltransferase) (Serine methylase)" SHMT1 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653] GO:0000900; GO:0004372; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006231; GO:0006544; GO:0006563; GO:0006565; GO:0006730; GO:0008270; GO:0009113; GO:0017148; GO:0019264; GO:0030170; GO:0035999; GO:0036094; GO:0042802; GO:0042803; GO:0046653; GO:0046655; GO:0048027; GO:0051289; GO:0070062; GO:0070905; GO:1904482; GO:1990830 glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094]; zinc ion binding [GO:0008270] AGMIFYRK 0.99421 -7.8738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.74 14.0294 14.2739 13.9903 0 14.2551 0 0 0 0 0 13.2406 0 0 0 13.2386 0 0 0 13.4964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1211 0 0 0 0 0 P46721 SO1A2_HUMAN "Solute carrier organic anion transporter family member 1A2 (OATP-A) (Organic anion-transporting polypeptide 1, OATP-1) (Sodium-independent organic anion transporter) (Solute carrier family 21 member 3)" SLCO1A2 OATP OATP1 OATP1A2 SLC21A3 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; bile acid and bile salt transport [GO:0015721]; organic anion transport [GO:0015711]; sodium-independent organic anion transport [GO:0043252] GO:0005886; GO:0005887; GO:0008514; GO:0015125; GO:0015347; GO:0015711; GO:0015721; GO:0043252 bile acid transmembrane transporter activity [GO:0015125]; organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347] CGESGACRIYDSTTFR 0.99421 -13.609 0 0 0 0 11.2123 0 0 0 0 0 0 11.8826 0 12.9021 0 0 0 0 10.3302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2971 0 0 0 0 0 0 0 0 0 14.9346 0 9.91758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3282 0 0 11.5016 10.997 0 12.4549 0 13.3507 13.3654 0 0 12.4103 0 10.2923 0 0 0 11.6096 0 0 0 11.889 14.3713 14.5509 0 9.85921 0 0 0 0 0 13.2587 0 0 0 0 0 0 0 11.9177 0 0 14.9854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1634 0 0 0 0 0 0 0 0 0 0 12.2664 0 0 14.2124 0 0 0 0 0 0 0 11.0023 0 0 11.2799 0 0 15.0311 0 12.8151 0 0 12.6248 0 10.5413 10.9349 0 0 0 10.9413 0 0 14.6149 0 0 10.1986 0 0 0 0 11.6145 P47901 V1BR_HUMAN "Vasopressin V1b receptor, V1bR (AVPR V1b) (AVPR V3) (Antidiuretic hormone receptor 1b) (Vasopressin V3 receptor)" AVPR1B AVPR3 VPR3 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; hyperosmotic salinity response [GO:0042538]; multicellular organism aging [GO:0010259]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718] axon terminus [GO:0043679]; dendrite [GO:0030425]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] axon terminus [GO:0043679]; dendrite [GO:0030425]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; vasopressin receptor activity [GO:0005000]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; hyperosmotic salinity response [GO:0042538]; multicellular organism aging [GO:0010259]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; transport across blood-brain barrier [GO:0150104]; viral entry into host cell [GO:0046718] GO:0001992; GO:0004930; GO:0005000; GO:0005080; GO:0005768; GO:0005794; GO:0005886; GO:0005887; GO:0007186; GO:0007188; GO:0007202; GO:0007204; GO:0010259; GO:0014049; GO:0017046; GO:0030425; GO:0032430; GO:0032849; GO:0042127; GO:0042277; GO:0042538; GO:0042802; GO:0043204; GO:0043410; GO:0043679; GO:0045907; GO:0046718; GO:0060732; GO:0090238; GO:0150104 G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; peptide hormone binding [GO:0017046]; protein kinase C binding [GO:0005080]; vasopressin receptor activity [GO:0005000] NLKVKTQAWR 0.99421 -8.1302 0 0 0 0 12.1295 0 0 0 0 13.0981 0 0 0 0 0 12.8643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3954 11.5662 0 0 0 0 0 11.7141 0 0 0 0 0 0 0 0 11.7187 0 0 0 0 0 0 0 0 0 0 0 13.0697 0 0 0 0 0 11.9412 0 0 0 0 0 0 12.7036 12.9072 0 0 0 0 13.6086 0 0 0 0 12.6294 12.8105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0112 0 0 0 0 0 0 0 0 0 0 0 12.6113 0 0 0 0 0 0 0 11.9173 0 0 0 0 0 0 11.0358 0 0 0 0 0 13.9177 0 11.5463 0 0 0 P63267 ACTH_HUMAN "Actin, gamma-enteric smooth muscle (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin) [Cleaved into: Actin, gamma-enteric smooth muscle, intermediate form ]" ACTG2 ACTA3 ACTL3 ACTSG Homo sapiens (Human) mesenchyme migration [GO:0090131]; positive regulation of gene expression [GO:0010628] blood microparticle [GO:0072562]; cell body [GO:0044297]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; myosin filament [GO:0032982] blood microparticle [GO:0072562]; cell body [GO:0044297]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; myosin filament [GO:0032982]; ATP binding [GO:0005524]; mesenchyme migration [GO:0090131]; positive regulation of gene expression [GO:0010628] GO:0005524; GO:0005615; GO:0005737; GO:0005829; GO:0005869; GO:0010628; GO:0030027; GO:0030175; GO:0032982; GO:0044297; GO:0070062; GO:0071944; GO:0072562; GO:0090131 ATP binding [GO:0005524] EIVRDIK 0.99421 -11.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0131 0 0 0 0 0 0 0 0 0 0 0 0 15.429 0 0 0 0 0 11.7433 0 0 11.8781 0 0 0 9.83332 0 0 0 9.87938 0 0 0 0 0 0 0 0 0 13.4814 0 12.0344 0 0 0 0 10.0373 0 0 13.3093 13.2962 0 0 0 0 0 0 0 0 0 0 0 0 10.6672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15005 SPCS2_HUMAN "Signal peptidase complex subunit 2 (Microsomal signal peptidase 25 kDa subunit, SPase 25 kDa subunit)" SPCS2 KIAA0102 SPC25 Homo sapiens (Human) protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465] GO:0005787; GO:0005789; GO:0006465; GO:0016021; GO:0045047 EKSIFLVAHRK 0.99421 -7.8733 0 13.1027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.65 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q33E94 RFX4_HUMAN Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10) RFX4 Homo sapiens (Human) cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021914]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021914]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021537; GO:0021914; GO:0045944; GO:0060271; GO:0070613; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ENNRASK 0.99421 -9.3581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5468 0 12.8069 0 0 0 13.018 0 12.5141 0 0 12.8751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9604 0 0 0 14.0823 0 0 0 0 0 0 0 0 0 0 0 0 14.716 0 0 0 0 0 0 0 12.505 0 0 0 0 0 0 16.0918 0 0 0 0 11.9652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4W1 DCXR_HUMAN "L-xylulose reductase, XR, EC 1.1.1.10 (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase, kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H)" DCXR SDR20C1 Homo sapiens (Human) D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xylulose metabolic process [GO:0005997] brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xylulose metabolic process [GO:0005997]" GO:0004090; GO:0005634; GO:0005881; GO:0005886; GO:0005902; GO:0005903; GO:0005997; GO:0006006; GO:0006739; GO:0016655; GO:0042732; GO:0042802; GO:0050038; GO:0070062; GO:2000379 "carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]" AKTMLNR 0.99421 -7.8982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1058 0 0 0 13.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6552 0 0 0 0 0 0 0 0 0 12.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7139 Q96EQ8 RN125_HUMAN "E3 ubiquitin-protein ligase RNF125, EC 2.3.2.27 (RING finger protein 125) (T-cell RING activation protein 1, TRAC-1)" RNF125 Homo sapiens (Human) adaptive immune response [GO:0002250]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098] Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; p53 binding [GO:0002039]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000139; GO:0000209; GO:0002039; GO:0002250; GO:0006511; GO:0008270; GO:0031624; GO:0032480; GO:0034098; GO:0039536; GO:0043231; GO:0061630; GO:1990830 p53 binding [GO:0002039]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ELYEDSLLDHCITHHR 0.99421 -8.6198 0 0 0 0 0 0 0 0 11.5419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BU02 THTPA_HUMAN "Thiamine-triphosphatase, ThTPase, EC 3.6.1.28" THTPA Homo sapiens (Human) dephosphorylation [GO:0016311]; generation of precursor metabolites and energy [GO:0006091]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772] cytosol [GO:0005829] cytosol [GO:0005829]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; generation of precursor metabolites and energy [GO:0006091]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772] GO:0000287; GO:0005829; GO:0006091; GO:0006772; GO:0016311; GO:0016787; GO:0042357; GO:0050333 hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333] ERPQETEDPDHCLG 0.99421 -11.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0503 0 0 0 12.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6169 0 0 0 0 0 0 0 12.0884 0 0 0 0 0 12.6739 0 0 15.2224 0 0 15.7467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3052 0 0 0 0 0 0 15.2403 Q9NYZ3 GTSE1_HUMAN "G2 and S phase-expressed protein 1, GTSE-1 (Protein B99 homolog)" GTSE1 Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]" cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654] "cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; microtubule binding [GO:0008017]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; microtubule-based process [GO:0007017]" GO:0005654; GO:0005829; GO:0005881; GO:0006977; GO:0007017; GO:0008017; GO:0015630; GO:0016020 microtubule binding [GO:0008017] AIPVPNK 0.99421 -8.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3125 0 0 0 9.48878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1949 0 13.4329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0047 0 0 0 12.7156 0 0 0 0 0 9.34804 0 0 13.8651 13.6981 13.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1319 0 0 0 0 14.2597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15652 JHD2C_HUMAN "Probable JmjC domain-containing histone demethylation protein 2C, EC 1.14.11.- (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8, TR-interacting protein 8, TRIP-8)" JMJD1C JHDM2C KIAA1380 TRIP8 Homo sapiens (Human) "blood coagulation [GO:0007596]; chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; blood coagulation [GO:0007596]; chromatin organization [GO:0006325]; histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000118; GO:0000785; GO:0003712; GO:0005654; GO:0006325; GO:0006355; GO:0006357; GO:0007596; GO:0031490; GO:0032454; GO:0033169; GO:0046872; GO:0046966; GO:0051213 chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712] AGVIRAVSHRDSR 0.99422 -28.557 0 10.5796 0 0 0 0 0 10.8146 0 0 0 11.4017 0 0 0 0 17.6969 13.1506 13.5622 17.0419 16.8422 0 12.0212 0 15.5177 15.2719 15.5227 0 11.5454 0 0 0 0 0 0 12.623 0 0 0 0 0 0 16.5601 16.5804 11.2312 0 11.1719 0 0 14.6359 0 17.2088 18.8031 18.88 17.642 17.4353 0 0 10.8907 0 0 14.5674 15.7839 10.9545 0 0 10.9138 0 11.1979 0 0 10.4927 11.7879 0 11.2177 13.2355 13.131 13.9175 12.7684 14.6817 0 0 0 12.6309 13.7639 12.4062 18.2073 0 11.1978 0 20.8693 0 20.8869 20.7061 19.7433 19.7822 0 22.1818 20.2847 0 14.4789 0 11.5455 13.8929 16.3675 18.0103 0 18.035 15.054 13.8882 13.7066 0 19.7549 12.1073 19.7709 19.0515 12.5565 16.9817 13.7727 15.4819 11.7357 12.8216 13.1231 12.4445 0 21.0096 20.826 14.925 13.7886 11.0929 0 11.9363 13.094 14.0571 19.4249 20.3842 12.7945 13.395 0 13.3742 13.5613 19.9458 19.5146 13.1449 19.4525 15.5549 18.5628 18.7518 18.4113 18.4126 13.4217 12.6845 0 13.9406 0 12.9306 19.6789 17.3335 12.0082 0 0 13.5755 0 12.3934 0 13.2698 0 15.5912 0 17.7195 17.4782 20.5853 20.5084 20.5879 0 13.4942 0 13.423 0 17.2746 Q6ZTR6 ZNFDT_HUMAN Putative uncharacterized protein ZNF516-DT (ZNF516 divergent transcript) ZNF516-DT C18orf65 Homo sapiens (Human) AGDQTGGAFCMCDVSGGGGECVSGSGGGGESGR 0.99422 -5.2797 0 11.7191 0 0 0 0 0 0 0 0 0 0 0 13.63 0 0 0 0 0 0 0 14.3034 0 13.4866 0 0 10.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8968 18.7789 0 0 0 0 0 0 0 18.9623 19.9671 19.8993 0 18.3667 0 0 15.4747 14.2418 14.6741 0 14.2566 0 0 0 13.8532 0 0 0 0 0 0 0 0 0 13.6262 0 0 0 0 0 0 15.319 15.0709 0 0 0 13.1906 15.0266 13.8242 0 0 0 15.8686 18.4302 14.0616 14.8404 0 13.7535 13.9557 18.614 0 14.2884 0 16.3328 18.7016 18.0054 12.0543 16.1197 0 0 14.8932 0 0 14.4341 0 0 13.7314 15.4788 15.1096 13.747 14.4781 0 0 0 0 0 14.3745 0 0 0 0 0 0 0 0 0 0 0 13.7665 0 0 0 0 0 0 13.0625 0 0 0 15.1843 0 14.4497 0 O60716 CTND1_HUMAN "Catenin delta-1 (Cadherin-associated Src substrate, CAS) (p120 catenin, p120(ctn)) (p120(cas))" CTNND1 KIAA0384 Homo sapiens (Human) brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein stabilization [GO:0050821]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt signaling pathway [GO:0016055] "adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; Schaffer collateral - CA1 synapse [GO:0098685]; zonula adherens [GO:0005915]" "adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; Schaffer collateral - CA1 synapse [GO:0098685]; zonula adherens [GO:0005915]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102]; brain development [GO:0007420]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein stabilization [GO:0050821]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt signaling pathway [GO:0016055]" GO:0005102; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005915; GO:0007043; GO:0007420; GO:0008013; GO:0016055; GO:0016342; GO:0030027; GO:0030426; GO:0030496; GO:0043197; GO:0044331; GO:0045296; GO:0050821; GO:0070062; GO:0090090; GO:0098609; GO:0098685; GO:0098686; GO:0098831; GO:0098978; GO:0099072; GO:0099092; GO:1990782 beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102] AASGALRNLAVDAR 0.99422 -8.1799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.672 0 0 0 14.0889 0 12.832 0 0 12.8415 0 13.0749 14.8654 14.6593 14.1054 13.8037 0 0 0 0 0 0 0 0 0 11.396 0 0 10.0983 0 0 0 0 0 12.7514 0 0 0 0 13.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6666 12.1295 12.8263 0 0 0 0 0 0 15.0968 0 0 0 0 0 11.9926 0 16.838 0 12.5275 0 0 11.4132 0 0 0 0 0 12.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7627 0 0 0 0 0 0 P0C7I6 CC159_HUMAN Coiled-coil domain-containing protein 159 CCDC159 Homo sapiens (Human) ARTTRCLQLLAQEIR 0.99422 -8.1793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1335 0 0 0 0 0 0 0 0 0 0 12.1357 0 0 0 0 0 0 0 0 P16066 ANPRA_HUMAN "Atrial natriuretic peptide receptor 1, EC 4.6.1.2 (Atrial natriuretic peptide receptor type A, ANP-A, ANPR-A, NPR-A) (Guanylate cyclase A, GC-A)" NPR1 ANPRA Homo sapiens (Human) blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165] ANPR-A receptor complex [GO:1990620]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] ANPR-A receptor complex [GO:1990620]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165] GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0006468; GO:0007165; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016021; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620 ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672] FNRENSSNILDNLLSR 0.99422 -5.2791 0 11.0626 11.1186 0 11.6307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8989 12.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5594 13.1101 13.6304 14.1677 14.8667 0 0 12.7115 12.106 0 0 0 13.8846 14.8087 14.5099 0 0 13.8282 0 0 0 13.9771 15.9506 14.9646 0 0 0 0 0 0 0 0 14.0841 0 0 13.4531 15.2074 13.4672 0 0 16.2351 0 0 0 14.1735 15.3877 0 0 12.875 0 0 16.1375 15.739 14.0218 13.6522 15.3472 0 0 14.8691 13.6472 11.0829 13.7417 15.0953 14.6141 13.9421 0 15.6044 13.6661 0 14.2577 0 0 14.2716 13.4493 0 0 13.458 0 0 0 0 12.7978 13.8349 0 0 0 0 12.5755 0 14.2204 0 0 0 0 0 0 0 16.246 14.211 13.0739 0 0 0 0 13.8182 0 P19419 ELK1_HUMAN ETS domain-containing protein Elk-1 ELK1 Homo sapiens (Human) "cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416]" axon terminus [GO:0043679]; chromatin [GO:0000785]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "axon terminus [GO:0043679]; chromatin [GO:0000785]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to testosterone stimulus [GO:0071394]; gene expression [GO:0010467]; liver development [GO:0001889]; lung development [GO:0030324]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fibroblast growth factor [GO:0071774]; response to light stimulus [GO:0009416]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0009416; GO:0010467; GO:0030154; GO:0030324; GO:0030374; GO:0030425; GO:0043025; GO:0043679; GO:0045893; GO:0045944; GO:0061629; GO:0071394; GO:0071480; GO:0071774; GO:1901216; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ALPPEVK 0.99422 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9696 0 0 0 0 0 12.905 0 13.601 0 13.6448 0 0 13.7206 0 13.2973 0 13.0883 13.4362 13.169 0 0 0 0 13.7079 0 13.1508 0 0 15.4121 15.2739 0 13.2013 0 0 12.819 0 0 0 0 0 0 13.1285 0 0 0 0 13.9882 0 14.3239 13.1857 0 13.1095 13.1261 0 0 0 13.0801 0 0 0 0 0 0 0 0 13.1049 0 0 0 12.8521 0 13.1309 0 0 0 0 14.845 0 13.782 14.0931 13.9284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34932 HSP74_HUMAN Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2) HSPA4 APG2 Homo sapiens (Human) chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986] GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0045040; GO:0051131; GO:0070062; GO:0140662 ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662] ALLRLSQECEK 0.99422 -28.582 0 0 0 0 0 11.1863 0 0 0 0 0 0 0 13.7017 13.8859 14.5638 14.1069 0 14.791 14.1626 0 0 14.7302 0 13.4298 0 14.8084 14.6504 13.7797 0 10.9824 13.7895 13.933 0 0 0 13.5928 0 13.7327 10.8238 0 13.7234 0 0 14.0333 0 12.2534 13.884 0 0 11.5608 11.1206 0 0 0 0 0 13.744 0 0 0 0 0 0 0 0 12.2939 0 0 12.0114 0 0 11.4282 0 0 0 0 0 0 0 0 0 0 13.2469 15.2198 0 15.6048 0 11.9226 0 0 11.506 12.3865 0 0 0 13.5191 0 14.2493 10.6119 0 11.8128 0 11.0274 0 0 0 0 10.5473 11.2386 0 13.4051 14.2085 0 0 0 0 12.9429 0 11.3574 0 0 13.5234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3351 0 0 0 0 0 12.8658 0 0 15.1932 0 0 13.5277 0 0 0 0 0 11.2574 15.9907 16.488 15.8752 14.2658 14.5557 11.9785 16.0987 15.9297 0 16.1711 16.5523 13.9817 14.61 14.7606 0 0 0 0 0 0 13.6437 12.6342 0 P43353 AL3B1_HUMAN "Aldehyde dehydrogenase family 3 member B1, EC 1.2.1.28, EC 1.2.1.5, EC 1.2.1.7 (Aldehyde dehydrogenase 7)" ALDH3B1 ALDH7 Homo sapiens (Human) alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid biosynthetic process [GO:0030148] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid biosynthetic process [GO:0030148] GO:0004028; GO:0004029; GO:0004030; GO:0005737; GO:0005829; GO:0005886; GO:0006066; GO:0006068; GO:0006081; GO:0006629; GO:0006979; GO:0018477; GO:0018479; GO:0030148; GO:0030667; GO:0031982; GO:0034599; GO:0035579; GO:0046185; GO:0070062 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477] FDYIFFTGSPR 0.99422 -5.2718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.611 15.4627 13.1588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3708 12.5174 0 0 0 0 0 12.7907 12.052 12.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0126 0 0 0 P62140 PP1B_HUMAN "Serine/threonine-protein phosphatase PP1-beta catalytic subunit, PP-1B, PPP1CD, EC 3.1.3.16, EC 3.1.3.53" PPP1CB Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752] GO:0000165; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005977; GO:0006470; GO:0007049; GO:0016791; GO:0017018; GO:0019901; GO:0030155; GO:0032922; GO:0042752; GO:0043153; GO:0046872; GO:0050115; GO:0051301; GO:0070062; GO:0072357 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722] AHQVVEDGYEFFAKR 0.99422 -8.1626 0 0 0 0 0 0 0 0 13.6959 0 0 0 0 15.0727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.233 0 14.5779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1833 0 0 0 0 0 12.4722 0 0 11.8591 12.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2545 13.3993 0 0 12.6304 0 0 0 14.5111 11.8312 0 12.4646 0 11.743 0 0 0 0 0 0 13.2714 13.1619 0 0 0 0 0 0 10.7037 0 0 0 0 0 0 0 0 0 0 0 12.5545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6579 0 0 0 0 0 0 0 Q5T2R2 DPS1_HUMAN "All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1, EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1, TPT 1)" PDSS1 DPS1 TPRT Homo sapiens (Human) isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234] mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] GO:0000010; GO:0004659; GO:0005759; GO:0006744; GO:0008299; GO:0046872; GO:0046982; GO:0050347; GO:0097269; GO:1990234 all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347] AGPLGPSAAAEVRAQVHRR 0.99422 -6.5568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5152 0 12.323 0 11.847 0 12.2028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6193 0 0 13.1968 0 0 0 0 12.8652 12.9384 0 0 0 0 13.5823 0 12.9088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.786 0 0 0 0 0 0 0 0 Q5TIE3 VW5B1_HUMAN von Willebrand factor A domain-containing protein 5B1 VWA5B1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 ADMGGTNILSPLKWVIRQPVHR 0.99422 -28.464 0 0 0 0 0 0 0 0 0 0 0 0 13.4914 0 0 0 0 0 0 0 11.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1192 12.8511 0 0 13.4751 12.5704 12.6825 0 0 14.7556 0 0 0 0 0 0 0 0 0 0 0 14.6102 0 0 12.8101 0 13.6893 0 0 0 0 0 0 0 0 13.0564 0 0 0 0 15.3694 0 0 15.3043 0 0 12.6688 0 13.2968 0 0 0 0 0 0 0 0 0 0 15.6436 13.0703 0 0 0 0 13.8273 0 0 0 0 0 0 0 0 0 0 0 12.7137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0445 0 0 0 10.447 0 0 0 12.8477 Q6NUK1 SCMC1_HUMAN Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) SLC25A24 APC1 MCSC1 SCAMC1 Homo sapiens (Human) ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial transport [GO:0006839]; regulation of cell death [GO:0010941] GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0006839; GO:0010941; GO:0015867; GO:0016021; GO:0034599; GO:0071277 ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] GNGTNVIKIAPETAVK 0.99422 -8.1767 0 0 0 0 0 11.5971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0741 13.9904 13.2267 11.2317 12.4254 0 0 0 0 0 0 0 0 0 0 0 12.6519 0 0 0 0 0 10.8145 0 0 0 0 0 0 0 0 10.4669 0 0 0 0 11.8655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6465 0 0 0 0 17.1338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UYE1 LEU7_HUMAN Leukemia-associated protein 7 (Deleted in lymphocytic leukemia 7) DLEU7 LEU7 Homo sapiens (Human) SFPIHLK 0.99422 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6828 0 0 0 0 0 0 13.3962 0 0 0 0 0 0 0 0 0 0 0 Q86XE0 SNX32_HUMAN Sorting nexin-32 (Sorting nexin-6B) SNX32 SNX6B Homo sapiens (Human) "protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endosome [GO:0005768] "cytosol [GO:0005829]; endosome [GO:0005768]; phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005768; GO:0005829; GO:0015031; GO:0016241; GO:0035091; GO:0042147 phosphatidylinositol binding [GO:0035091] ADRVMRAHK 0.99422 -7.9009 0 0 0 0 0 0 0 0 11.1136 0 0 0 0 0 0 13.8642 12.5964 0 0 13.8983 13.6558 0 14.8305 0 12.9358 14.8061 0 14.4045 14.2158 13.0246 0 11.109 0 0 0 0 0 0 0 0 0 10.9604 12.7009 11.1323 0 0 0 13.4051 14.0047 13.3763 13.4058 0 13.3109 11.6402 0 0 13.2401 13.1792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9917 0 0 0 0 0 13.3446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4338 0 0 0 0 13.2292 0 12.1793 0 11.8776 0 14.583 0 0 0 14.5597 0 0 0 0 0 0 0 0 0 0 0 13.5701 0 13.0972 0 0 0 0 0 0 0 0 0 0 0 0 11.1846 0 0 12.6105 0 13.8837 0 15.1497 0 0 0 0 0 0 0 0 0 0 13.9996 0 0 0 15.6393 0 14.1634 0 13.438 13.4329 0 0 0 0 0 0 0 12.7738 0 0 Q8IY63 AMOL1_HUMAN Angiomotin-like protein 1 AMOTL1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055] bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055] GO:0001525; GO:0003365; GO:0005829; GO:0005886; GO:0005923; GO:0016055; GO:0030036; GO:0030334; GO:0031410; GO:0042802 identical protein binding [GO:0042802] GPPPEYPFK 0.99422 -8.1736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7012 0 0 0 0 0 0 0 0 0 0 0 0 15.3878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HJ9 FMC1_HUMAN "Protein FMC1 homolog (ATP synthase assembly factor FMC1, mitochondrial) (Formation of mitochondrial complex V assembly factor 1 homolog)" FMC1 C7orf55 HSPC268 Homo sapiens (Human) mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; negative regulation of lipid catabolic process [GO:0050995]; regulation of type B pancreatic cell proliferation [GO:0061469] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; negative regulation of lipid catabolic process [GO:0050995]; regulation of type B pancreatic cell proliferation [GO:0061469] GO:0005739; GO:0033615; GO:0050995; GO:0061469 AHRVTSEK 0.99422 -5.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.549 0 14.2009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6373 0 0 0 0 0 0 0 0 0 0 10.8939 0 0 0 0 0 11.5851 0 0 0 0 0 0 0 0 0 0 0 14.7318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1009 0 0 0 0 0 14.4759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKG1 DP13A_HUMAN "DCC-interacting protein 13-alpha, Dip13-alpha (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)" APPL1 APPL DIP13A KIAA1428 Homo sapiens (Human) adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; adiponectin-activated signaling pathway [GO:0033211]; cell cycle [GO:0007049]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; insulin receptor signaling pathway [GO:0008286]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001726; GO:0001786; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0006606; GO:0007049; GO:0007165; GO:0007179; GO:0008286; GO:0010008; GO:0010762; GO:0012506; GO:0016020; GO:0023052; GO:0031410; GO:0031901; GO:0032009; GO:0033211; GO:0034143; GO:0035091; GO:0035729; GO:0042802; GO:0042803; GO:0043422; GO:0044354; GO:0044877; GO:0045088; GO:0046324; GO:0046326; GO:0048023; GO:0048487; GO:0070062; GO:0097708; GO:1900017; GO:1903076; GO:1905303; GO:1905450; GO:2000045 beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877] AFGQGGR 0.99422 -5.2781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1265 13.5834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43502 RA51C_HUMAN "DNA repair protein RAD51 homolog 3, R51H3 (RAD51 homolog C) (RAD51-like protein 2)" RAD51C RAD51L2 Homo sapiens (Human) DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722] GO:0000707; GO:0000722; GO:0000724; GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007062; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0043231; GO:0048471; GO:0140664 ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA binding [GO:0003677] ECLTNKPR 0.99423 -15.561 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77808 0 0 11.9293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4319 0 13.5902 0 0 11.5736 0 0 11.1324 0 0 0 0 0 0 0 0 0 11.4851 0 0 0 0 0 0 0 0 0 12.3651 0 0 O75437 ZN254_HUMAN "Zinc finger protein 254 (Bone marrow zinc finger 5, BMZF-5) (Hematopoietic cell-derived zinc finger protein 1, HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like)" ZNF254 BMZF5 ZNF539 ZNF91L Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFNWSSTLTK 0.99423 -28.717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7819 0 0 0 0 0 0 0 0 0 0 0 0 14.6627 0 0 0 0 0 0 0 0 0 0 13.0398 13.7358 0 0 0 12.9404 0 14.1688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6067 0 12.3559 0 0 0 0 0 13.4533 0 0 0 0 0 0 12.3806 0 12.6683 0 13.1428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05154 IPSP_HUMAN "Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3, PAI-3, PAI3) (Protein C inhibitor, PCI) (Serpin A5)" SERPINA5 PCI PLANH3 PROCI Homo sapiens (Human) fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; lipid transport [GO:0006869]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of hydrolase activity [GO:0051346]; spermatogenesis [GO:0007283] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule [GO:0031091]; platelet dense tubular network [GO:0031094]; protein C inhibitor-coagulation factor V complex [GO:0097181]; protein C inhibitor-coagulation factor Xa complex [GO:0097182]; protein C inhibitor-coagulation factor XI complex [GO:0097183]; protein C inhibitor-KLK3 complex [GO:0036029]; protein C inhibitor-plasma kallikrein complex [GO:0036030]; protein C inhibitor-PLAT complex [GO:0036026]; protein C inhibitor-PLAU complex [GO:0036027]; protein C inhibitor-thrombin complex [GO:0036028]; protein C inhibitor-TMPRSS11E complex [GO:0036025]; protein C inhibitor-TMPRSS7 complex [GO:0036024]; protein-containing complex [GO:0032991] acrosomal membrane [GO:0002080]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule [GO:0031091]; platelet dense tubular network [GO:0031094]; protein C inhibitor-coagulation factor V complex [GO:0097181]; protein C inhibitor-coagulation factor Xa complex [GO:0097182]; protein C inhibitor-coagulation factor XI complex [GO:0097183]; protein C inhibitor-KLK3 complex [GO:0036029]; protein C inhibitor-plasma kallikrein complex [GO:0036030]; protein C inhibitor-PLAT complex [GO:0036026]; protein C inhibitor-PLAU complex [GO:0036027]; protein C inhibitor-thrombin complex [GO:0036028]; protein C inhibitor-TMPRSS11E complex [GO:0036025]; protein C inhibitor-TMPRSS7 complex [GO:0036024]; protein-containing complex [GO:0032991]; acrosin binding [GO:0032190]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; phosphatidylcholine binding [GO:0031210]; protease binding [GO:0002020]; retinoic acid binding [GO:0001972]; serine-type endopeptidase inhibitor activity [GO:0004867]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; lipid transport [GO:0006869]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of hydrolase activity [GO:0051346]; spermatogenesis [GO:0007283] GO:0001972; GO:0002020; GO:0002080; GO:0004867; GO:0005539; GO:0005576; GO:0005615; GO:0006869; GO:0007283; GO:0007342; GO:0008201; GO:0009897; GO:0010951; GO:0016020; GO:0031091; GO:0031094; GO:0031210; GO:0032190; GO:0032991; GO:0036024; GO:0036025; GO:0036026; GO:0036027; GO:0036028; GO:0036029; GO:0036030; GO:0051346; GO:0070062; GO:0097181; GO:0097182; GO:0097183 acrosin binding [GO:0032190]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; phosphatidylcholine binding [GO:0031210]; protease binding [GO:0002020]; retinoic acid binding [GO:0001972]; serine-type endopeptidase inhibitor activity [GO:0004867] KRQLELYLPK 0.99423 -5.2989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25490 TYY1_HUMAN "Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1, YY-1)" YY1 INO80S Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cell development [GO:0048468]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]" chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667] "chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cell development [GO:0048468]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723]" GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0005737; GO:0006275; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0046872; GO:0048468; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837 "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]" KFAQSTNLK 0.99423 -10.872 0 0 0 0 0 0 0 0 0 0 0 9.71562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5612 0 0 11.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5334 0 0 0 0 0 0 0 0 0 0 18.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2208 0 0 0 0 0 0 0 0 0 0 0 17.7904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0953 0 17.7006 0 0 0 0 0 P29322 EPHA8_HUMAN "Ephrin type-A receptor 8, EC 2.7.10.1 (EPH- and ELK-related kinase) (EPH-like kinase 3, EK3, hEK3) (Tyrosine-protein kinase receptor EEK)" EPHA8 EEK HEK3 KIAA1459 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; ephrin receptor signaling pathway [GO:0048013]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; substrate-dependent cell migration [GO:0006929]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] early endosome membrane [GO:0031901]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; ephrin receptor signaling pathway [GO:0048013]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; substrate-dependent cell migration [GO:0006929]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0006929; GO:0007155; GO:0007169; GO:0007411; GO:0016322; GO:0019838; GO:0030155; GO:0031175; GO:0031901; GO:0033628; GO:0033674; GO:0043005; GO:0043235; GO:0043410; GO:0043552; GO:0046777; GO:0048013; GO:0071372 ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] AFQDSDEEK 0.99423 -30.851 12.4143 12.2878 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0375 0 0 0 0 0 0 0 12.9772 0 0 0 0 14.997 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5906 13.7737 0 0 0 0 0 14.5462 0 0 0 0 11.0769 0 0 0 0 0 0 0 0 0 0 0 0 19.0729 12.501 0 0 0 0 0 0 14.8952 0 0 0 0 16.8861 15.0486 0 0 0 13.6179 15.2795 13.456 0 0 13.1086 0 12.9991 0 13.5727 13.2988 0 0 0 0 12.5274 0 14.1989 0 0 0 10.6068 0 0 0 0 0 0 0 12.4272 0 0 0 0 0 14.4346 15.0214 12.5108 0 0 0 0 12.941 14.7478 0 0 0 0 0 0 14.4684 0 0 0 0 15.0229 0 0 12.0314 0 0 14.9536 12.7297 12.8156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5035 0 0 0 0 0 0 0 15.0103 0 0 0 0 0 0 11.9049 0 P41567 EIF1_HUMAN "Eukaryotic translation initiation factor 1, eIF1 (A121) (Protein translation factor SUI1 homolog) (Sui1iso1)" EIF1 SUI1 Homo sapiens (Human) regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; eukaryotic 43S preinitiation complex [GO:0016282]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; eukaryotic 43S preinitiation complex [GO:0016282]; nucleus [GO:0005634]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]" GO:0003723; GO:0003743; GO:0005634; GO:0005737; GO:0006446; GO:0008135; GO:0016282; GO:0043024 "ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" GDDLLPAGTEDYIHIRIQQRNGR 0.99423 -11.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1407 Q12809 KCNH2_HUMAN "Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1, ERG-1, Eag-related protein 1, Ether-a-go-go-related protein 1, H-ERG, hERG-1, hERG1) (Voltage-gated potassium channel subunit Kv11.1)" KCNH2 ERG ERG1 HERG Homo sapiens (Human) "cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]" cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] "cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; inward rectifier potassium channel complex [GO:1902937]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282]; cardiac muscle contraction [GO:0060048]; cellular response to xenobiotic stimulus [GO:0071466]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of potassium ion export across plasma membrane [GO:1903765]; negative regulation of potassium ion transmembrane transport [GO:1901380]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; ventricular cardiac muscle cell action potential [GO:0086005]" GO:0000976; GO:0003064; GO:0005242; GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0008076; GO:0009986; GO:0031625; GO:0042391; GO:0042802; GO:0042803; GO:0045893; GO:0048471; GO:0055075; GO:0055131; GO:0060048; GO:0060306; GO:0060307; GO:0071466; GO:0071805; GO:0086005; GO:0086008; GO:0086009; GO:0086010; GO:0086011; GO:0086013; GO:0086091; GO:0097110; GO:0097623; GO:0098915; GO:1901379; GO:1901380; GO:1901381; GO:1902282; GO:1902937; GO:1903765; GO:1990573 C3HC4-type RING finger domain binding [GO:0055131]; delayed rectifier potassium channel activity [GO:0005251]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]; voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1902282] CPAPTPSLLNIPLSSPGR 0.99423 -11.147 0 0 11.5087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9077 0 0 0 0 0 11.6264 0 0 11.664 0 0 0 0 0 0 0 0 12.6255 0 0 0 0 10.8678 0 0 10.5647 0 0 0 10.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6473 14.1863 15.3599 14.4614 15.2404 13.9633 0 0 0 14.071 13.7139 14.5972 14.295 15.7554 0 0 0 0 0 0 15.2092 0 0 0 15.2643 0 16.0389 0 13.1501 12.865 0 0 14.202 13.3462 0 14.614 14.0629 0 0 15.8906 0 13.4111 0 0 14.2303 0 12.5126 13.4021 13.8316 13.8041 0 0 13.4665 13.5122 13.119 0 13.9642 13.6712 12.8728 0 0 12.3421 0 13.1139 13.31 15.1996 0 0 0 13.1153 0 0 0 0 0 0 0 0 0 12.616 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0194 0 0 0 0 15.2109 0 0 0 0 0 0 0 Q14183 DOC2A_HUMAN "Double C2-like domain-containing protein alpha, Doc2, Doc2-alpha" DOC2A Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; nervous system development [GO:0007399]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle exocytosis [GO:0016079] anchoring junction [GO:0070161]; cell junction [GO:0030054]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202] anchoring junction [GO:0070161]; cell junction [GO:0030054]; extrinsic component of synaptic vesicle membrane [GO:0098850]; lysosome [GO:0005764]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; nervous system development [GO:0007399]; regulation of calcium ion-dependent exocytosis [GO:0017158]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle exocytosis [GO:0016079] GO:0005509; GO:0005544; GO:0005654; GO:0005730; GO:0005764; GO:0006887; GO:0007268; GO:0007399; GO:0016079; GO:0017158; GO:0030054; GO:0043005; GO:0045202; GO:0061669; GO:0070161; GO:0098850 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] LKTKTQR 0.99423 -10.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.68 0 0 0 0 0 10.3914 0 0 0 9.85403 14.1345 0 13.7996 11.126 0 0 0 0 0 0 0 15.2324 0 14.6092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6315 11.3099 0 0 0 0 0 0 0 0 0 0 0 0 0 14.062 0 0 0 0 0 12.72 0 14.819 0 0 0 15.1838 0 0 15.1019 0 0 0 0 0 0 15.0676 0 0 0 0 0 0 0 0 0 0 0 0 Q7L7X3 TAOK1_HUMAN "Serine/threonine-protein kinase TAO1, EC 2.7.11.1 (Kinase from chicken homolog B, hKFC-B) (MARK Kinase, MARKK) (Prostate-derived sterile 20-like kinase 2, PSK-2, PSK2, Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1, TAOK1, hTAOK1)" TAOK1 KIAA1361 MAP3K16 MARKK Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of MAPK cascade [GO:0043408]; regulation of microtubule cytoskeleton organization [GO:0070507] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]; cellular response to DNA damage stimulus [GO:0006974]; central nervous system neuron development [GO:0021954]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of MAPK cascade [GO:0043408]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0000165; GO:0000226; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006281; GO:0006468; GO:0006974; GO:0007026; GO:0007095; GO:0015630; GO:0016301; GO:0016310; GO:0016740; GO:0021954; GO:0032874; GO:0032956; GO:0035556; GO:0043014; GO:0043408; GO:0043539; GO:0046330; GO:0046777; GO:0048156; GO:0048471; GO:0048487; GO:0048812; GO:0050321; GO:0051493; GO:0070050; GO:0070062; GO:0070507; GO:0097194; GO:0106310; GO:1901985 alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740] AEMDEHR 0.99423 -30.884 0 0 0 0 10.2247 0 9.62699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5158 0 0 0 0 0 0 0 0 0 0 11.2802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4144 0 12.2599 0 0 0 0 0 0 0 0 0 0 Q86TB3 ALPK2_HUMAN "Alpha-protein kinase 2, EC 2.7.11.1 (Heart alpha-protein kinase)" ALPK2 HAK Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; establishment of cell polarity [GO:0030010]; heart morphogenesis [GO:0003007]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468] basolateral plasma membrane [GO:0016323] basolateral plasma membrane [GO:0016323]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; establishment of cell polarity [GO:0030010]; heart morphogenesis [GO:0003007]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468] GO:0003007; GO:0003308; GO:0004674; GO:0005524; GO:0006468; GO:0010468; GO:0016323; GO:0030010; GO:0042981; GO:0055013; GO:0106310; GO:1905223 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EAVCAMECFEAGDQGTCFDTIDSLVGR 0.99423 -30.856 0 0 0 0 0 0 0 0 12.7579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5997 0 0 0 0 0 0 0 0 0 11.8237 0 0 0 0 0 0 0 12.3879 0 0 0 0 12.837 0 0 0 0 0 0 0 24.6537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4656 0 0 0 0 0 0 0 15.115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6528 0 0 0 0 0 11.8594 0 0 0 0 0 0 0 13.9001 0 0 0 0 0 0 0 0 0 0 0 13.7447 0 13.9265 13.6593 14.8845 13.7855 13.6346 0 13.8242 13.5387 0 0 0 0 0 0 0 0 14.2065 0 0 Q8NC56 LEMD2_HUMAN "LEM domain-containing protein 2, hLEM2" LEMD2 Homo sapiens (Human) heart formation [GO:0060914]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; neurogenesis [GO:0022008]; nuclear envelope organization [GO:0006998]; protein localization to chromatin [GO:0071168]; skeletal muscle cell differentiation [GO:0035914] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; spindle [GO:0005819] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; spindle [GO:0005819]; chromatin DNA binding [GO:0031490]; heart formation [GO:0060914]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; neurogenesis [GO:0022008]; nuclear envelope organization [GO:0006998]; protein localization to chromatin [GO:0071168]; skeletal muscle cell differentiation [GO:0035914] GO:0005635; GO:0005637; GO:0005639; GO:0005737; GO:0005819; GO:0006998; GO:0016020; GO:0016021; GO:0022008; GO:0030514; GO:0031490; GO:0031965; GO:0035914; GO:0043409; GO:0051898; GO:0060914; GO:0071168 chromatin DNA binding [GO:0031490] ASVRGSSEEDEDAR 0.99423 -10.867 0 0 0 0 13.5463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.026 0 0 0 0 12.0675 11.9671 0 9.92877 0 0 0 0 0 0 13.2254 14.089 0 11.9913 0 10.9959 0 12.5491 10.8333 0 0 0 12.8098 13.8589 0 12.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8919 0 0 0 0 0 0 0 11.6102 0 0 0 0 14.7749 14.8335 16.4857 0 0 0 0 16.8235 0 11.5648 0 0 0 0 12.2023 0 0 11.0767 16.1035 16.2187 15.5219 0 0 0 0 0 11.111 12.5618 0 0 0 0 15.7805 12.8976 16.0354 0 16.6298 0 13.5704 0 16.9645 16.4761 16.4594 12.3446 13.3369 0 0 0 12.3317 0 16.056 14.1943 11.2933 15.4242 16.2878 10.5486 0 13.251 15.9955 0 12.2339 0 0 14.845 16.1586 15.9187 0 13.525 15.1327 0 0 0 0 12.142 0 14.7651 14.3851 13.7918 0 12.4203 0 0 0 14.3661 0 0 14.9505 0 14.3269 14.7944 0 0 0 0 0 0 0 14.9889 0 0 0 12.5585 Q8WXS8 ATS14_HUMAN "A disintegrin and metalloproteinase with thrombospondin motifs 14, ADAM-TS 14, ADAM-TS14, ADAMTS-14, EC 3.4.24.-" ADAMTS14 Homo sapiens (Human) collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; proteolysis [GO:0006508] GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] ADDKCGVCGGDNSHCR 0.99423 -10.873 9.64115 11.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3207 0 0 0 0 0 0 0 0 14.3182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3794 10.4961 0 0 0 0 0 0 0 0 0 0 0 15.3669 0 0 0 0 0 0 0 0 0 0 0 12.4708 0 0 0 0 0 13.2481 0 0 10.9735 0 0 0 0 0 0 0 0 0 0 0 13.4197 0 0 0 12.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6364 0 0 0 0 0 0 0 0 0 0 0 12.3024 0 0 11.7784 12.7052 0 0 0 0 0 0 0 0 0 11.2061 0 0 13.0756 0 0 0 0 0 0 0 0 0 0 0 13.6432 0 Q93033 IGSF2_HUMAN "Immunoglobulin superfamily member 2, IgSF2 (Cell surface glycoprotein V7) (Glu-Trp-Ile EWI motif-containing protein 101, EWI-101) (CD antigen CD101)" CD101 EWI101 IGSF2 V7 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; positive regulation of myeloid leukocyte differentiation [GO:0002763] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of myeloid leukocyte differentiation [GO:0002763]" GO:0002763; GO:0005886; GO:0007166; GO:0016021; GO:0016812; GO:0070062 "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]" AGISYVASFFLLLTKLSIGQREVTVQK 0.99423 -10.876 12.6912 0 0 0 0 11.1884 0 0 0 0 0 0 0 0 0 0 11.9609 0 14.8169 0 0 13.3991 0 0 0 0 0 0 0 0 0 0 0 11.8423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.157 0 0 0 0 0 0 0 0 14.5256 13.2847 14.0578 18.6285 13.9149 0 13.6255 0 0 0 0 0 0 0 13.5596 11.8016 0 0 0 0 0 0 14.3678 0 13.121 14.4156 13.8397 14.9293 0 0 13.6233 14.6001 18.4233 0 0 13.4658 13.7767 0 0 13.3904 18.417 0 14.6113 0 14.3973 0 10.2204 0 14.5489 0 0 13.2005 14.4889 13.8274 0 13.0493 13.1847 13.4202 0 0 12.1614 13.7466 0 13.4861 17.1723 0 0 13.6678 0 0 0 0 0 0 13.8743 0 0 0 0 0 0 0 12.6255 14.9035 13.6773 0 0 0 0 0 0 0 0 Q969M2 CXA10_HUMAN "Gap junction alpha-10 protein (Connexin-62, Cx62)" GJA10 CX62 Homo sapiens (Human) cell-cell signaling [GO:0007267]; detection of light stimulus involved in visual perception [GO:0050908]; gamete generation [GO:0007276]; synapse assembly [GO:0007416] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; detection of light stimulus involved in visual perception [GO:0050908]; gamete generation [GO:0007276]; synapse assembly [GO:0007416] GO:0005243; GO:0005886; GO:0005922; GO:0007267; GO:0007276; GO:0007416; GO:0016021; GO:0050908 gap junction channel activity [GO:0005243] IWLTILFIFRMLVLR 0.99423 -5.2949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LD4 TRI47_HUMAN "E3 ubiquitin-protein ligase TRIM47, EC 2.3.2.27 (Gene overexpressed in astrocytoma protein) (RING finger protein 100) (Tripartite motif-containing protein 47)" TRIM47 GOA RNF100 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005634; GO:0005829; GO:0008270; GO:0016567 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] FLQLFGTKGVK 0.99423 -12.965 0 0 0 0 12.7902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1441 0 13.4786 0 0 0 0 0 11.2217 0 0 0 0 0 0 0 0 0 0 13.6164 0 17.0792 0 0 0 0 0 0 0 0 0 0 0 0 13.7996 0 0 16.8879 0 0 0 15.7442 0 0 0 13.8753 13.1323 0 0 12.2791 13.4053 16.3098 15.4183 12.7043 12.9727 17.2903 0 17.6381 17.1283 0 0 17.4196 15.5263 15.5461 15.4711 15.5321 0 0 0 17.1706 0 15.7405 0 12.2252 14.7225 0 14.8745 0 0 0 0 0 0 0 0 12.3356 0 0 12.7557 0 0 0 17.2609 0 17.524 0 0 16.0757 0 0 0 Q99538 LGMN_HUMAN "Legumain, EC 3.4.22.34 (Asparaginyl endopeptidase) (Protease, cysteine 1)" LGMN PRSC1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471] apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156]; activation of cysteine-type endopeptidase activity [GO:0097202]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; self proteolysis [GO:0097264]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359] GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0019886; GO:0032801; GO:0035729; GO:0036021; GO:0040015; GO:0042359; GO:0043202; GO:0043524; GO:0045177; GO:0045931; GO:0048156; GO:0048471; GO:0051603; GO:0070062; GO:0071277; GO:0090026; GO:0097061; GO:0097202; GO:0097264; GO:1900273; GO:1901185; GO:1904646; GO:2001028 cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156] ESSYACYYDEK 0.99423 -15.511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5594 0 0 0 0 0 0 13.8114 0 0 0 0 0 0 0 0 14.0212 13.9923 13.7065 0 13.4418 0 13.5725 0 0 0 0 13.0119 14.5957 14.4668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1856 12.8829 0 0 0 0 0 11.036 14.4925 0 14.6325 0 0 14.8592 0 0 0 0 0 0 0 0 0 0 13.2151 13.9545 0 0 0 0 0 0 0 0 0 13.5163 0 0 0 0 0 0 0 14.2415 0 0 0 12.3782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H444 CHM4B_HUMAN "Charged multivesicular body protein 4b (Chromatin-modifying protein 4b, CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2, hSnf7-2) (Vacuolar protein sorting-associated protein 32-2, Vps32-2, hVps32-2)" CHMP4B C20orf178 SHAX1 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding [GO:0046755]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding [GO:0046755]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000281; GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005765; GO:0005768; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006620; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0009898; GO:0010458; GO:0010824; GO:0016236; GO:0030117; GO:0030496; GO:0031468; GO:0031982; GO:0032511; GO:0032585; GO:0036258; GO:0036438; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0045296; GO:0046755; GO:0046761; GO:0051258; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090611; GO:0097352; GO:1901215; GO:1901673; GO:1902774; GO:1902902; GO:1904930 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] AALQALKR 0.99423 -30.886 0 0 0 0 0 0 0 0 0 0 11.0066 0 0 0 0 11.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2593 0 10.7658 0 0 0 0 10.7551 0 0 0 10.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8687 0 0 0 0 0 0 0 0 0 0 12.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0701 0 13.3418 0 13.1004 13.6911 0 0 13.4485 0 0 0 0 0 0 0 13.093 0 12.8424 0 0 Q9Y5K3 PCY1B_HUMAN "Choline-phosphate cytidylyltransferase B, EC 2.7.7.15 (CCT-beta) (CTP:phosphocholine cytidylyltransferase B, CCT B, CT B) (Phosphorylcholine transferase B)" PCYT1B CCTB Homo sapiens (Human) CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; CDP-choline pathway [GO:0006657]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283] GO:0001541; GO:0004105; GO:0005737; GO:0005783; GO:0005789; GO:0006656; GO:0006657; GO:0007283; GO:0031210; GO:0042802 choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210] DYDVYAR 0.99423 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2973 0 0 0 0 0 0 0 0 0 13.8464 0 0 0 0 0 0 0 0 0 0 0 0 O00161 SNP23_HUMAN "Synaptosomal-associated protein 23, SNAP-23 (Vesicle-membrane fusion protein SNAP-23)" SNAP23 Homo sapiens (Human) exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903] GO:0002553; GO:0005484; GO:0005654; GO:0005737; GO:0005739; GO:0005886; GO:0005912; GO:0005925; GO:0006887; GO:0006892; GO:0006903; GO:0006906; GO:0015031; GO:0016082; GO:0019905; GO:0030670; GO:0031201; GO:0031629; GO:0035579; GO:0042581; GO:0042582; GO:0043005; GO:0061025; GO:0070062; GO:0070821; GO:0098793 SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905] AKKLIDS 0.99424 -10.883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.893 17.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00522 KRIT1_HUMAN "Krev interaction trapped protein 1, Krev interaction trapped 1 (Cerebral cavernous malformations 1 protein)" KRIT1 CCM1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; endothelium development [GO:0003158]; integrin activation [GO:0033622]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of establishment of cell polarity [GO:2000114]; small GTPase mediated signal transduction [GO:0007264] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; angiogenesis [GO:0001525]; cell redox homeostasis [GO:0045454]; endothelium development [GO:0003158]; integrin activation [GO:0033622]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of protein binding [GO:0032092]; regulation of angiogenesis [GO:0045765]; regulation of establishment of cell polarity [GO:2000114]; small GTPase mediated signal transduction [GO:0007264]" GO:0001525; GO:0001937; GO:0003158; GO:0005546; GO:0005615; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0007264; GO:0008017; GO:0010596; GO:0016525; GO:0030695; GO:0032092; GO:0032991; GO:0033622; GO:0045454; GO:0045765; GO:2000114; GO:2000352 "GTPase regulator activity [GO:0030695]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" DNTKYTYTPGCPIFYCLQDIMR 0.99424 -13.024 0 0 0 14.9221 0 0 0 11.1534 0 0 0 0 0 0 0 14.1709 13.5282 15.8243 15.586 15.4984 15.8171 0 15.8953 14.9524 14.1202 0 12.1349 13.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2167 15.2232 0 0 0 0 0 14.7813 0 14.3154 0 0 0 0 0 14.1529 13.6388 0 0 0 0 11.3344 0 0 18.5325 0 0 0 0 14.1246 0 0 0 0 0 0 15.7915 0 15.8143 0 15.7616 0 9.87946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7487 0 19.3096 0 12.7255 0 0 13.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2716 0 0 0 0 0 0 0 0 15.4054 0 0 0 0 0 0 0 16.4138 0 14.1386 0 14.1828 0 0 0 0 0 0 0 0 14.0581 0 0 0 0 14.5153 0 0 0 0 0 0 0 16.3027 0 O14974 MYPT1_HUMAN "Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1, Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit)" PPP1R12A MBS MYPT1 Homo sapiens (Human) cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018] A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to xenobiotic stimulus [GO:0071466]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165] GO:0000278; GO:0000776; GO:0004857; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0006470; GO:0007098; GO:0007165; GO:0015629; GO:0019208; GO:0019901; GO:0030018; GO:0030155; GO:0031672; GO:0035507; GO:0035508; GO:0043086; GO:0043292; GO:0045944; GO:0046822; GO:0071466; GO:0071889; GO:0072357 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901] ADNQRLKDENGALIR 0.99424 -30.974 0 0 0 0 0 0 10.6309 0 0 0 0 12.3867 0 0 10.3501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0277 0 11.2808 0 0 0 0 0 10.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9958 0 0 0 0 11.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0495 14.5807 0 0 11.8365 14.8019 0 0 13.4037 0 11.7017 0 12.6706 0 0 0 0 13.3682 0 0 0 0 0 11.5669 0 0 0 0 14.5602 11.4593 14.2155 13.8924 13.5857 13.8581 0 14.4424 0 13.2798 0 14.1829 13.9732 0 0 0 13.5191 14.3755 14.1968 0 0 0 13.9442 13.1476 0 0 0 0 13.0139 0 0 11.7764 0 14.2753 0 0 14.1025 0 14.0532 0 0 0 0 13.3361 0 0 0 13.0293 13.8529 0 0 0 0 0 13.5254 0 0 0 13.144 0 0 14.4142 0 O15075 DCLK1_HUMAN "Serine/threonine-protein kinase DCLK1, EC 2.7.11.1 (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1)" DCLK1 DCAMKL1 DCDC3A KIAA0369 Homo sapiens (Human) axon extension [GO:0048675]; central nervous system development [GO:0007417]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; response to virus [GO:0009615] integral component of plasma membrane [GO:0005887]; postsynaptic density [GO:0014069] integral component of plasma membrane [GO:0005887]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; axon extension [GO:0048675]; central nervous system development [GO:0007417]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; peptidyl-serine phosphorylation [GO:0018105]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; response to virus [GO:0009615] GO:0001764; GO:0004672; GO:0004674; GO:0005524; GO:0005887; GO:0006468; GO:0007399; GO:0007417; GO:0009615; GO:0014069; GO:0016197; GO:0018105; GO:0021952; GO:0030900; GO:0034504; GO:0035556; GO:0048675; GO:0048812; GO:0048813; GO:0106310; GO:1900181 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DFIRPKLVTIIR 0.99424 -10.892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.34359 0 0 0 0 0 0 0 0 0 0 0 0 13.9182 0 14.1787 14.198 0 0 11.226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1993 15.4582 0 11.5147 0 0 0 0 12.1226 0 0 0 0 0 0 0 0 0 0 0 12.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0629 0 O95166 GBRAP_HUMAN Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein) (MM46) GABARAP FLC3B HT004 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; chemical synaptic transmission [GO:0007268]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein targeting [GO:0006605]; regulation of Rac protein signal transduction [GO:0035020] actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; synapse [GO:0045202] actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; synapse [GO:0045202]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; chemical synaptic transmission [GO:0007268]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macroautophagy [GO:0016236]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein targeting [GO:0006605]; regulation of Rac protein signal transduction [GO:0035020] GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006605; GO:0006995; GO:0007268; GO:0008017; GO:0008625; GO:0015629; GO:0016236; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0045202; GO:0048487; GO:0050811; GO:0097225; GO:1902524 beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625] ARIGDLDK 0.99424 -8.7254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9726 0 17.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30038 AL4A1_HUMAN "Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial, P5C dehydrogenase, EC 1.2.1.88 (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)" ALDH4A1 ALDH4 P5CDH Homo sapiens (Human) 4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; 4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560] GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802] AIEAALAAR 0.99424 -13.048 0 0 0 0 0 0 11.5741 0 0 0 0 0 0 0 0 14.425 13.3652 13.09 0 13.3467 13.3042 0 0 0 13.6292 0 0 9.78562 0 0 0 0 0 0 0 0 0 0 0 13.5121 0 0 0 0 13.2943 0 0 0 0 0 0 14.0795 0 11.0736 12.7641 0 13.0225 0 10.1449 12.8676 0 0 0 10.3682 0 0 11.1169 0 13.0272 0 0 0 0 10.2685 18.5399 0 0 0 10.3386 0 0 0 13.541 13.4242 13.2684 13.2773 13.3346 18.9532 12.669 17.6479 0 18.6336 18.6766 13.3933 18.6084 0 13.3538 0 0 18.1504 0 0 0 0 0 12.3499 0 0 17.1867 17.3859 17.0505 16.5338 18.224 18.3638 0 0 0 0 0 17.1793 0 17.5094 10.7543 17.7439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9766 16.9431 0 12.6258 12.7134 0 0 0 0 0 0 12.5197 12.5058 0 0 0 16.8918 0 16.1773 0 0 10.6739 12.48 0 0 P50851 LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein) LRBA BGL CDC4L LBA Homo sapiens (Human) mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497] GO:0000423; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0016021; GO:0019901; GO:0034497 protein kinase binding [GO:0019901] ATDEDILAK 0.99424 -36.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6122 0 0 11.589 0 0 0 0 0 13.9424 11.629 0 0 0 0 0 0 0 0 0 0 0 11.4028 0 0 0 11.9174 11.929 13.6637 0 13.7443 9.46759 0 0 0 0 0 0 11.5621 0 0 0 0 0 0 0 0 0 0 0 11.279 0 11.0578 0 0 15.2671 15.0501 0 0 13.3886 0 0 0 0 0 0 16.1842 0 0 11.0025 0 0 0 0 0 0 0 14.5013 0 0 13.5218 0 0 0 0 0 0 14.6337 17.2585 12.9818 12.8379 0 0 0 0 11.9934 12.1963 12.8696 0 13.3933 0 0 12.2959 0 11.4668 0 0 0 12.0827 12.7994 0 17.022 0 0 0 0 12.5434 0 0 13.0473 0 12.384 0 0 0 0 15.1919 0 14.319 0 11.713 0 0 10.3865 0 0 0 0 13.0317 0 12.8515 0 13.1804 0 11.5361 0 0 0 0 12.8108 0 0 0 17.1045 0 0 0 11.7958 0 0 0 P78318 IGBP1_HUMAN "Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4, Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16)" IGBP1 IBP1 Homo sapiens (Human) B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165] GO:0000122; GO:0005737; GO:0005829; GO:0007165; GO:0019888; GO:0032873; GO:0034612; GO:0035303; GO:0042113; GO:0043154; GO:0051721; GO:0060632; GO:0070555 protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888] AREHFINYLTQCHCYHVAEFELPK 0.99424 -10.907 0 0 0 0 0 0 0 0 0 0 0 0 0 10.83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3134 0 0 0 0 0 0 0 0 0 0 0 12.9594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3987 16.1219 0 0 0 0 0 0 0 0 0 0 11.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.051 0 0 0 0 15.5586 0 0 0 0 0 0 0 12.295 0 0 0 0 0 0 0 0 0 0 12.6969 0 0 0 0 0 0 0 0 11.0409 0 0 0 0 0 Q07343 PDE4B_HUMAN "cAMP-specific 3',5'-cyclic phosphodiesterase 4B, EC 3.1.4.53 (DPDE4) (PDE32)" PDE4B DPDE4 Homo sapiens (Human) cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852] centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018] "centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of high voltage-gated calcium channel activity [GO:1901841]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]" GO:0000930; GO:0001780; GO:0004114; GO:0004115; GO:0005634; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0007165; GO:0008021; GO:0014069; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0048471; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071466; GO:0071872; GO:0086004; GO:0140199; GO:1901841; GO:1901898 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]" HMSLLADLK 0.99424 -7.987 10.4074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6753 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1684 0 0 0 0 0 0 0 0 0 0 0 11.5709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4737 0 0 0 0 0 0 0 0 0 12.8359 12.8013 0 0 0 12.2198 0 12.9014 0 0 0 0 0 0 0 0 0 Q14457 BECN1_HUMAN Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa ] BECN1 GT197 Homo sapiens (Human) aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell division [GO:0051301]; cellular defense response [GO:0006968]; cellular response to aluminum ion [GO:0071275]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; engulfment of apoptotic cell [GO:0043652]; late endosome to vacuole transport [GO:0045324]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron development [GO:0048666]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of catalytic activity [GO:0050790]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to mitochondrial depolarisation [GO:0098780]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410] "autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; mitochondrial membrane [GO:0031966]; nuclear body [GO:0016604]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; trans-Golgi network [GO:0005802]" "autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extrinsic component of membrane [GO:0019898]; mitochondrial membrane [GO:0031966]; nuclear body [GO:0016604]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cell division [GO:0051301]; cellular defense response [GO:0006968]; cellular response to aluminum ion [GO:0071275]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; engulfment of apoptotic cell [GO:0043652]; late endosome to vacuole transport [GO:0045324]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron development [GO:0048666]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of catalytic activity [GO:0050790]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to mitochondrial depolarisation [GO:0098780]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]" GO:0000045; GO:0000407; GO:0000422; GO:0000423; GO:0001666; GO:0005737; GO:0005768; GO:0005776; GO:0005783; GO:0005789; GO:0005802; GO:0005829; GO:0006468; GO:0006622; GO:0006914; GO:0006915; GO:0006968; GO:0006995; GO:0007040; GO:0007080; GO:0007568; GO:0008285; GO:0009410; GO:0010008; GO:0010040; GO:0010288; GO:0010506; GO:0010508; GO:0010613; GO:0014068; GO:0016236; GO:0016241; GO:0016604; GO:0019898; GO:0019901; GO:0030425; GO:0031625; GO:0031966; GO:0032465; GO:0032801; GO:0033197; GO:0034198; GO:0034271; GO:0034272; GO:0035032; GO:0036092; GO:0042149; GO:0042802; GO:0043066; GO:0043548; GO:0043652; GO:0045022; GO:0045324; GO:0045335; GO:0048666; GO:0050435; GO:0050790; GO:0051020; GO:0051301; GO:0051607; GO:0060548; GO:0070301; GO:0071275; GO:0071280; GO:0071364; GO:0097352; GO:0098780; GO:1902425; GO:1902902; GO:1905672; GO:2000378; GO:2000786; GO:2001244 GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625] FCLPYRMDVEK 0.99424 -7.9824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5906 0 0 11.0588 12.1864 0 0 0 0 14.6409 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8359 0 0 0 0 0 0 0 0 12.0547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T6M2 CF122_HUMAN Putative uncharacterized protein encoded by LINC00242 LINC00242 C6orf122 NCRNA00242 Homo sapiens (Human) HLLPHSGITSLRR 0.99424 -36.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2139 0 0 0 0 0 0 0 0 0 0 14.0505 0 0 13.8983 0 0 0 0 0 0 14.8807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9687 0 0 0 0 14.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5THK1 PR14L_HUMAN Protein PRR14L (Proline rich 14-like protein) PRR14L C22orf30 Homo sapiens (Human) ADEVLDCQSNQNR 0.99424 -13.014 11.4749 0 0 0 0 0 0 13.2854 0 0 0 13.6408 0 12.138 0 0 12.8681 0 0 12.7747 14.9697 12.6489 0 0 0 13.9895 0 0 0 0 0 0 0 0 0 0 14.0215 0 0 0 0 0 14.9774 0 0 14.4248 0 13.8989 0 0 0 0 0 0 0 0 0 0 15.3569 15.0607 0 0 0 15.4915 12.8736 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9755 0 0 0 0 0 12.5142 0 17.2364 0 0 0 0 0 0 13.9855 0 0 15.5316 0 0 14.6196 0 14.2024 0 0 15.1528 12.5324 0 0 0 0 14.6008 0 0 0 0 0 0 0 13.7658 13.7602 0 0 13.8882 14.5333 0 0 0 13.8091 0 0 0 0 12.8187 0 0 0 0 0 12.2809 14.553 0 0 0 0 0 0 0 0 12.3993 0 0 0 12.6609 0 0 0 0 0 0 0 0 0 0 0 0 15.9493 0 13.9233 0 0 0 0 0 13.007 0 13.3319 0 0 0 0 Q6P3V2 Z585A_HUMAN Zinc finger protein 585A ZNF585A Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGKAFTQRSDLITHQR 0.99424 -13.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4394 0 0 0 0 0 0 0 0 11.9356 0 0 0 0 11.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1311 0 0 0 0 0 12.0216 0 0 0 0 0 0 0 0 0 0 0 13.1416 12.8455 0 0 0 0 0 0 0 0 13.8533 14.8867 0 14.3746 0 14.9121 14.8173 0 0 13.5294 0 0 13.0327 0 0 0 12.9567 13.7104 13.3458 0 12.0212 0 0 12.7905 13.687 0 0 15.5023 14.9097 0 0 13.4838 0 12.2083 14.6171 0 0 0 0 13.8667 15.0468 14.8342 0 0 0 13.6977 0 15.1066 15.4362 0 13.8901 0 0 14.8995 0 0 13.3904 14.0051 12.8442 12.7338 13.6776 14.2504 0 0 0 0 12.7299 0 13.2979 13.1219 0 0 0 0 0 13.7823 0 0 0 13.1111 0 15.6335 0 0 0 0 13.53 0 0 11.0235 0 0 0 13.854 0 0 0 0 0 0 0 14.435 0 0 Q7LFL8 CXXC5_HUMAN "CXXC-type zinc finger protein 5, CF5 (Putative MAPK-activating protein PM08) (Putative NF-kappa-B-activating protein 102) (Retinoid-inducible nuclear factor, RINF)" CXXC5 HSPC195 TCCCIA00297 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; methyl-CpG binding [GO:0008327]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0000122; GO:0005634; GO:0005654; GO:0005829; GO:0008270; GO:0008327; GO:0043123; GO:0043565; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; methyl-CpG binding [GO:0008327]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] CGMCAPCR 0.99424 -8.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71514 0 0 0 0 0 0 0 0 0 0 14.2925 0 0 15.0361 0 0 0 0 0 0 15.0015 15.2253 0 0 0 0 0 0 11.7348 0 0 0 0 0 0 0 0 0 0 13.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5409 0 11.2398 0 0 0 11.7151 0 0 0 0 0 13.0301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTU1 TCF23_HUMAN "Transcription factor 23, TCF-23 (Class A basic helix-loop-helix protein 24, bHLHa24)" TCF23 BHLHA24 Homo sapiens (Human) cell differentiation [GO:0030154]; decidualization [GO:0046697]; developmental process [GO:0032502]; muscle organ development [GO:0007517]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleus [GO:0005634] "chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; cell differentiation [GO:0030154]; decidualization [GO:0046697]; developmental process [GO:0032502]; muscle organ development [GO:0007517]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000791; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007517; GO:0010628; GO:0030154; GO:0032502; GO:0046697; GO:0046983; GO:0051148; GO:0061629; GO:0140416 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]" GLRYLHPLKK 0.99424 -10.905 0 0 0 0 0 0 0 0 0 0 0 0 13.7597 13.9983 0 0 13.4535 15.1651 14.9131 14.6989 0 15.2135 15.3068 14.6094 13.0514 15.0757 15.0194 13.8829 12.5976 13.429 0 0 12.4504 14.4328 14.6899 14.5548 0 0 14.4155 0 14.3222 0 12.975 0 15.024 14.1534 0 0 14.5686 13.1074 0 0 0 0 0 0 0 13.278 0 0 0 0 0 0 0 0 16.9069 16.8729 16.9204 16.8275 16.7528 16.7655 16.6936 0 16.9689 0 16.6874 0 16.7047 16.0896 0 16.6087 0 14.773 13.7798 13.9322 14.6679 16.7753 0 13.5977 16.6246 0 13.2085 13.6184 0 0 0 16.5147 0 16.4812 0 16.4432 0 0 0 0 0 16.2517 16.4426 14.2143 0 0 13.0431 12.8249 0 0 0 0 0 0 0 0 16.1989 0 0 0 0 0 16.4382 0 0 0 0 0 0 0 15.9581 0 16.6028 0 0 0 16.2943 16.0569 0 0 16.9271 15.0653 0 0 0 0 0 0 0 0 0 15.1058 0 0 0 0 15.2312 13.6892 15.079 15.7398 15.243 14.243 0 15.7155 15.0373 15.8972 0 16.0271 0 0 0 15.6541 16.6736 0 Q8NFB2 T185A_HUMAN Transmembrane protein 185A (Protein FAM11A) TMEM185A CXorf13 FAM11A Homo sapiens (Human) dendrite [GO:0030425]; integral component of membrane [GO:0016021] dendrite [GO:0030425]; integral component of membrane [GO:0016021] GO:0016021; GO:0030425 AEGETCVEFK 0.99424 -8.7227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5821 0 0 0 0 0 0 0 0 0 0 0 13.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96C10 DHX58_HUMAN "ATP-dependent RNA helicase DHX58, EC 3.6.4.13 (ATP-dependent helicase LGP2) (Protein D11Lgp2 homolog) (RIG-I-like receptor 3, RLR-3) (RIG-I-like receptor LGP2, RLR)" DHX58 D11LGP2E LGP2 Homo sapiens (Human) cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; response to virus [GO:0009615] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; regulation of innate immune response [GO:0045088]; response to bacterium [GO:0009617]; response to virus [GO:0009615] GO:0003677; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0008270; GO:0009615; GO:0009617; GO:0016887; GO:0032480; GO:0032481; GO:0032728; GO:0039528; GO:0039534; GO:0039536; GO:0045087; GO:0045088; GO:0045824; GO:1900245; GO:1900246 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270] AAQAAQR 0.99424 -36.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7723 0 14.5655 0 0 12.7128 0 0 0 12.9009 11.152 0 0 0 0 0 0 0 0 12.9084 13.0526 0 0 0 0 0 0 0 0 0 0 13.5228 0 0 0 13.1298 12.8945 0 0 15.3396 21.5205 21.5449 16.6354 12.1589 17.2341 13.6913 0 15.7553 16.8488 16.0586 15.4689 0 14.6442 0 16.1493 16.2222 0 0 16.8046 16.6884 13.3987 0 17.5045 0 17.2356 16.7479 15.4902 13.0096 0 0 0 0 13.0841 0 0 0 0 0 13.9372 16.7207 0 16.6521 16.8428 13.9846 14.1263 15.502 13.9325 12.5565 13.5207 12.4374 0 0 0 0 12.9877 0 12.4402 12.012 0 11.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9617 0 0 0 12.3314 0 0 0 0 0 0 0 0 0 0 11.6589 0 0 0 0 0 0 0 Q96EI5 TCAL4_HUMAN "Transcription elongation factor A protein-like 4, TCEA-like protein 4 (Transcription elongation factor S-II protein-like 4)" TCEAL4 NPD017 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] GO:0005634; GO:0050699 WW domain binding [GO:0050699] EGKPEIEGKPESEGEPGSETR 0.99424 -7.9835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0937 0 13.1999 0 0 0 0 0 0 0 0 0 13.7991 0 0 0 0 0 13.7209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRX8 PXL2A_HUMAN "Peroxiredoxin-like 2A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes, Protein PAMM) (Redox-regulatory protein FAM213A)" PRXL2A C10orf58 FAM213A PAMM PRO2290 PSEC0139 UNQ611/PRO1198 Homo sapiens (Human) regulation of osteoclast differentiation [GO:0045670] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; antioxidant activity [GO:0016209]; regulation of osteoclast differentiation [GO:0045670] GO:0005576; GO:0005737; GO:0016209; GO:0045670 antioxidant activity [GO:0016209] AALEYLEDIDLKTLEKEPR 0.99424 -11.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3337 0 0 0 0 0 11.4596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7285 0 0 0 Q9BZE7 EVG1_HUMAN UPF0193 protein EVG1 C22orf23 Homo sapiens (Human) APPARQK 0.99424 -13.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UDY2 ZO2_HUMAN Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2) TJP2 X104 ZO2 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; homotypic cell-cell adhesion [GO:0034109]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]; regulation of membrane permeability [GO:0090559] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; establishment of endothelial intestinal barrier [GO:0090557]; homotypic cell-cell adhesion [GO:0034109]; intestinal absorption [GO:0050892]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of blood-brain barrier permeability [GO:1905605]; protein localization to cell-cell junction [GO:0150105]; regulation of membrane permeability [GO:0090559] GO:0004385; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0019904; GO:0030674; GO:0034109; GO:0035633; GO:0044291; GO:0045216; GO:0045296; GO:0050839; GO:0050892; GO:0090557; GO:0090559; GO:0098609; GO:0150105; GO:1905605; GO:1990782 cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; guanylate kinase activity [GO:0004385]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674] AYSPEYR 0.99424 -36.535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1836 0 0 10.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0567 0 0 0 0 0 0 13.2365 14.1286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1031 0 0 0 0 0 14.0396 0 15.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9071 0 0 0 0 10.2538 0 0 0 0 0 0 0 12.3278 0 0 0 14.4689 0 0 0 0 0 0 11.7657 0 12.2126 0 0 0 14.1608 0 0 14.1896 0 13.955 0 14.269 0 0 12.7603 Q9UKL4 CXD2_HUMAN "Gap junction delta-2 protein (Connexin-36, Cx36) (Gap junction alpha-9 protein)" GJD2 GJA9 Homo sapiens (Human) cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; neuronal action potential [GO:0019228]; visual perception [GO:0007601] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202] connexin complex [GO:0005922]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; gap junction channel activity [GO:0005243]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; neuronal action potential [GO:0019228]; visual perception [GO:0007601] GO:0005243; GO:0005886; GO:0005922; GO:0007267; GO:0007268; GO:0007601; GO:0016021; GO:0019228; GO:0045202 gap junction channel activity [GO:0005243] KIKLAVR 0.99424 -8.5104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y283 INVS_HUMAN Inversin (Inversion of embryo turning homolog) (Nephrocystin-2) INVS INV NPHP2 Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055] cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819] cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055] GO:0005516; GO:0005634; GO:0005737; GO:0005819; GO:0005874; GO:0005929; GO:0016020; GO:0016055; GO:0090090 calmodulin binding [GO:0005516] ANWMQKDLEEMTPLHLTTR 0.99424 -13.036 0 0 0 0 0 0 0 11.8211 12.7687 12.6448 13.0239 12.842 12.6198 13.0147 12.8219 13.4499 0 0 0 0 0 0 0 0 0 12.8054 0 13.0395 0 0 0 0 0 0 0 11.6293 0 0 11.7673 0 11.6293 12.6242 12.1636 13.2436 12.9176 0 12.788 0 12.7268 0 12.6579 0 0 13.0798 13.1054 10.5999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3347 0 0 0 14.1524 12.7564 0 0 0 0 0 0 14.851 11.4944 0 0 14.7874 12.0641 15.8018 15.1487 12.9186 13.3151 16.2895 0 0 15.0159 0 13.6036 0 13.57 0 14.0037 0 0 0 11.7662 0 10.3176 14.0156 15.5279 14.338 15.3976 0 14.7524 16.0911 16.8406 13.1965 13.8135 14.0077 14.7703 13.661 13.5099 0 14.1089 14.8362 12.2101 12.3699 0 14.9882 0 12.4517 16.3109 13.14 13.3346 13.4603 16.441 15.7594 14.0961 0 0 0 0 0 12.0427 0 0 0 0 13.6217 0 12.523 13.4099 0 0 0 0 0 14.8917 0 15.321 0 0 14.814 14.6886 0 14.7445 0 0 14.344 13.4043 0 14.6973 0 14.8284 0 0 Q9Y399 RT02_HUMAN "28S ribosomal protein S2, mitochondrial, MRP-S2, S2mt (Mitochondrial small ribosomal subunit protein uS2m)" MRPS2 CGI-91 Homo sapiens (Human) mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0032543; GO:0061668 structural constituent of ribosome [GO:0003735] ATPRPAR 0.99424 -8.7384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2366 0 0 0 0 0 0 0 0 0 0 0 0 10.5592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9889 0 10.8269 14.8273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8723 12.0012 0 14.0395 0 13.8125 13.6389 0 13.7867 0 0 0 0 0 0 0 0 14.0487 0 10.8289 0 0 Q9Y692 GMEB1_HUMAN "Glucocorticoid modulatory element-binding protein 1, GMEB-1 (DNA-binding protein p96PIF) (Parvovirus initiation factor p96, PIF p96)" GMEB1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp27 protein binding [GO:0051008]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0042802; GO:0046872; GO:0051008; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; Hsp27 protein binding [GO:0051008]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AIRLGGIMLR 0.99424 -15.609 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1197 0 0 0 0 11.537 0 0 0 0 0 12.4209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2753 0 0 0 0 11.301 0 0 0 0 0 0 0 13.9025 0 0 0 11.5944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1272 O15063 GRRE1_HUMAN "Granule associated Rac and RHOG effector protein 1, GARRE1" GARRE1 KIAA0355 Homo sapiens (Human) Rac protein signal transduction [GO:0016601] cytosol [GO:0005829]; P-body [GO:0000932] cytosol [GO:0005829]; P-body [GO:0000932]; CCR4-NOT complex binding [GO:1905762]; small GTPase binding [GO:0031267]; Rac protein signal transduction [GO:0016601] GO:0000932; GO:0005829; GO:0016601; GO:0031267; GO:1905762 CCR4-NOT complex binding [GO:1905762]; small GTPase binding [GO:0031267] AGFHLNPKAIEASLQGCCSEAEAQQTGR 0.99425 -15.696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8517 0 12.6706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.508 0 0 0 0 0 0 0 14.3725 0 16.4184 0 0 0 0 0 10.6008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3956 0 0 13.2614 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1083 P09110 THIK_HUMAN "3-ketoacyl-CoA thiolase, peroxisomal, EC 2.3.1.16 (Acetyl-CoA C-myristoyltransferase, EC 2.3.1.155) (Acetyl-CoA acyltransferase, EC 2.3.1.9) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase)" ACAA1 ACAA PTHIO Homo sapiens (Human) alpha-linolenic acid metabolic process [GO:0036109]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; phenylacetate catabolic process [GO:0010124]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; specific granule lumen [GO:0035580] cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; specific granule lumen [GO:0035580]; acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; palmitoyl-CoA oxidase activity [GO:0016401]; alpha-linolenic acid metabolic process [GO:0036109]; bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; phenylacetate catabolic process [GO:0010124]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0003985; GO:0003988; GO:0005576; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0008206; GO:0008775; GO:0010124; GO:0016020; GO:0016401; GO:0033540; GO:0035580; GO:0036109; GO:0050633 acetate CoA-transferase activity [GO:0008775]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; palmitoyl-CoA oxidase activity [GO:0016401] LKPAFKK 0.99425 -11.578 11.5976 0 0 0 0 0 10.1757 13.4018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8406 14.5441 0 0 0 13.8059 0 0 0 0 0 0 11.6947 0 0 0 0 0 0 0 0 0 0 0 0 14.1291 15.4552 11.9904 0 11.7175 0 13.2333 0 15.5021 13.9638 0 0 0 0 0 14.322 0 0 0 0 0 13.8096 0 14.7974 13.0809 13.5845 0 0 0 14.423 0 12.2048 13.0201 13.4045 0 12.8587 12.8608 0 14.2178 14.2392 0 0 0 14.4516 0 0 14.2177 0 0 0 13.8335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.901 0 0 0 10.9177 0 0 13.976 0 0 0 0 0 14.1677 0 P15976 GATA1_HUMAN "Erythroid transcription factor (Eryf1) (GATA-binding factor 1, GATA-1, GF-1) (NF-E1 DNA-binding protein)" GATA1 ERYF1 GF1 Homo sapiens (Human) "animal organ regeneration [GO:0031100]; basophil differentiation [GO:0030221]; bone mineralization [GO:0030282]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; dendritic cell differentiation [GO:0097028]; eosinophil differentiation [GO:0030222]; eosinophil fate commitment [GO:0035854]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; myeloid cell apoptotic process [GO:0033028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; osteoblast proliferation [GO:0033687]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive erythrocyte differentiation [GO:0060319]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of primitive erythrocyte differentiation [GO:0010725]; Sertoli cell development [GO:0060009]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; C2H2 zinc finger domain binding [GO:0070742]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; animal organ regeneration [GO:0031100]; basophil differentiation [GO:0030221]; bone mineralization [GO:0030282]; cell fate commitment [GO:0045165]; cell-cell signaling [GO:0007267]; cellular response to cAMP [GO:0071320]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to thyroid hormone stimulus [GO:0097067]; dendritic cell differentiation [GO:0097028]; eosinophil differentiation [GO:0030222]; eosinophil fate commitment [GO:0035854]; erythrocyte development [GO:0048821]; erythrocyte differentiation [GO:0030218]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; megakaryocyte differentiation [GO:0030219]; myeloid cell apoptotic process [GO:0033028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of myeloid cell apoptotic process [GO:0033033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; osteoblast proliferation [GO:0033687]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; primitive erythrocyte differentiation [GO:0060319]; regulation of definitive erythrocyte differentiation [GO:0010724]; regulation of glycoprotein biosynthetic process [GO:0010559]; regulation of primitive erythrocyte differentiation [GO:0010725]; Sertoli cell development [GO:0060009]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001223; GO:0001228; GO:0001701; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006366; GO:0007204; GO:0007267; GO:0008270; GO:0008285; GO:0008584; GO:0010559; GO:0010724; GO:0010725; GO:0017053; GO:0030218; GO:0030219; GO:0030220; GO:0030221; GO:0030222; GO:0030282; GO:0030502; GO:0031100; GO:0031490; GO:0032993; GO:0033028; GO:0033033; GO:0033687; GO:0033690; GO:0035854; GO:0043066; GO:0043306; GO:0043565; GO:0045165; GO:0045648; GO:0045893; GO:0045944; GO:0048821; GO:0048873; GO:0050731; GO:0060009; GO:0060319; GO:0061629; GO:0070527; GO:0070742; GO:0071222; GO:0071320; GO:0071372; GO:0097028; GO:0097067; GO:1990837; GO:2000678; GO:2001240 "C2H2 zinc finger domain binding [GO:0070742]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" KDGIQTRNR 0.99425 -15.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43250 GRK6_HUMAN "G protein-coupled receptor kinase 6, EC 2.7.11.16 (G protein-coupled receptor kinase GRK6)" GRK6 GPRK6 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of signal transduction [GO:0009966]; Wnt signaling pathway [GO:0016055] GO:0004672; GO:0004703; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007186; GO:0008277; GO:0009966; GO:0016020; GO:0016055; GO:0047696 ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672] DVLDIEQFSTVK 0.99425 -11.529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9531 10.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13214 SEM3B_HUMAN "Semaphorin-3B (Sema A(V)) (Semaphorin-V, Sema V)" SEMA3B SEMA5 SEMAA Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005783; GO:0005887; GO:0007267; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0061643; GO:0062023; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] DFTIFRSLGQRPSLR 0.99425 -36.99 0 0 0 0 0 0 11.2048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5432 0 12.3343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6693 0 0 0 15.06 0 15.6956 0 13.5525 13.1657 0 0 13.4497 0 0 0 0 13.3986 0 0 0 0 0 0 0 0 0 0 0 12.9021 0 13.4226 0 0 0 0 0 0 0 13.4714 0 0 0 0 13.8599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9214 0 0 0 14.4587 0 0 0 13.6562 0 Q400G9 AMZ1_HUMAN "Archaemetzincin-1, EC 3.4.-.- (Archeobacterial metalloproteinase-like protein 1)" AMZ1 KIAA1950 Homo sapiens (Human) proteolysis [GO:0006508] metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508] GO:0006508; GO:0008237; GO:0046872 metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] KLQHVLGFR 0.99425 -15.703 0 13.2074 0 0 0 0 0 0 0 0 0 13.4087 0 0 0 0 14.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5742 0 0 11.068 12.9413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9863 0 0 0 0 0 11.9546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7747 0 Q8IX05 CD302_HUMAN CD302 antigen (C-type lectin BIMLEC) (C-type lectin domain family 13 member A) (DEC205-associated C-type lectin 1) (Type I transmembrane C-type lectin receptor DCL-1) (CD antigen CD302) CD302 CLEC13A DCL1 KIAA0022 Homo sapiens (Human) phagocytosis [GO:0006909] cell cortex [GO:0005938]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902] cell cortex [GO:0005938]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus [GO:0005902]; carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023]; phagocytosis [GO:0006909] GO:0005902; GO:0005938; GO:0006909; GO:0009897; GO:0016020; GO:0016021; GO:0030175; GO:0030246; GO:0038023 carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023] KYLSDNHILISALVIASTVILTVLGAIIWFLYK 0.99425 -8.0144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N1G4 LRC47_HUMAN Leucine-rich repeat-containing protein 47 LRRC47 KIAA1185 Homo sapiens (Human) phenylalanyl-tRNA aminoacylation [GO:0006432] phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432] GO:0003723; GO:0004826; GO:0006432 phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723] AAAAVSESWPELELAER 0.99425 -8.5424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0581 0 0 0 0 0 0 0 11.9583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.089 0 0 0 0 0 10.9878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7057 14.848 0 0 0 0 0 12.3375 0 0 0 0 0 12.7886 0 0 0 0 0 13.5476 0 0 Q8N3T1 GLT15_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 15, EC 2.4.1.41 (Polypeptide GalNAc transferase-like protein 2, GalNAc-T-like protein 2, pp-GaNTase-like protein 2) (Polypeptide N-acetylgalactosaminyltransferase-like protein 2) (Protein-UDP acetylgalactosaminyltransferase-like protein 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2)" GALNT15 GALNTL2 UNQ770/PRO1564 Homo sapiens (Human) O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transport vesicle [GO:0030133]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016021; GO:0016266; GO:0030133; GO:0030246; GO:0046872 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] ARMLGATR 0.99425 -8.0081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9074 0 0 0 0 0 0 0 0 11.1032 0 0 0 10.6438 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1897 0 0 0 0 0 0 0 0 0 0 12.0869 0 0 0 0 0 0 0 13.8256 0 0 0 0 12.6531 0 0 13.5631 0 0 0 0 0 0 0 0 0 0 13.2116 13.049 0 0 12.0029 0 13.0767 0 0 0 0 0 0 12.767 13.1792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9425 0 0 0 0 12.1264 0 0 0 0 0 0 15.5737 0 0 0 0 12.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.987 Q8N6T0 TO6BL_HUMAN "Type 2 DNA topoisomerase 6 subunit B-like (Type 2 DNA topoisomerase VI subunit B-like, TOPOVIBL)" TOP6BL C11orf80 Homo sapiens (Human) meiotic DNA double-strand break formation [GO:0042138]; reciprocal meiotic recombination [GO:0007131] chromosome [GO:0005694] chromosome [GO:0005694]; meiotic DNA double-strand break formation [GO:0042138]; reciprocal meiotic recombination [GO:0007131] GO:0005694; GO:0007131; GO:0042138 ALAPGRASLGSR 0.99425 -8.5492 0 0 0 0 13.5189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1443 0 0 0 0 0 0 0 0 0 0 0 13.6195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2509 0 0 0 0 0 12.8164 12.399 0 0 14.1236 0 14.8689 14.4649 14.2104 0 0 0 0 0 0 15.9785 13.7018 0 0 0 0 0 0 0 0 13.1852 0 0 0 0 0 0 0 0 13.6001 0 0 0 0 0 12.5805 0 0 0 0 0 0 0 12.543 0 0 12.086 12.2349 0 0 0 0 0 0 12.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHS9 SPT22_HUMAN Spermatogenesis-associated protein 22 (Testis development protein NYD-SP20) SPATA22 Homo sapiens (Human) fertilization [GO:0009566]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA repair synthesis [GO:0000711]; regulation of meiotic cell cycle [GO:0051445]; reproductive system development [GO:0061458] chromosome [GO:0005694] chromosome [GO:0005694]; fertilization [GO:0009566]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA repair synthesis [GO:0000711]; regulation of meiotic cell cycle [GO:0051445]; reproductive system development [GO:0061458] GO:0000711; GO:0005694; GO:0007129; GO:0007276; GO:0009566; GO:0051445; GO:0061458 ELPRLIRGR 0.99425 -8.0007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5327 0 0 0 0 14.2906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96MX3 ZNF48_HUMAN Zinc finger protein 48 (Zinc finger protein 553) ZNF48 ZNF553 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AATAATQGPKAQDK 0.99425 -11.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.984 0 12.1668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7868 0 0 14.9514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3142 0 0 0 0 0 0 0 0 0 15.3926 0 0 0 0 11.4479 0 0 0 0 0 0 0 0 0 0 11.2181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S65 CSRN1_HUMAN "Cysteine/serine-rich nuclear protein 1, CSRNP-1 (Axin-1 up-regulated gene 1 protein) (Protein URAX1) (TGF-beta-induced apoptosis protein 3, TAIP-3)" CSRNP1 AXUD1 TAIP3 Homo sapiens (Human) apoptotic process [GO:0006915]; face morphogenesis [GO:0060325]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; face morphogenesis [GO:0060325]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]" GO:0000785; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006915; GO:0009791; GO:0043565; GO:0045944; GO:0048008; GO:0048705; GO:0060021; GO:0060325 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]" CQMDHTAFPCGCCR 0.99425 -11.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6577 0 10.3949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8855 0 0 0 13.6584 0 0 0 11.1725 11.3123 0 0 0 13.0793 0 10.8079 0 11.8593 0 0 10.3904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9121 11.2277 0 0 11.3123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4608 0 0 0 0 0 0 11.8986 12.6255 0 0 0 0 0 12.8409 0 13.0521 0 10.7547 0 0 12.5358 0 0 12.9636 12.531 0 0 0 10.38 0 0 0 0 11.7527 0 0 0 0 0 0 0 Q99633 PRP18_HUMAN "Pre-mRNA-splicing factor 18 (PRP18 homolog, hPRP18)" PRPF18 HPRP18 Homo sapiens (Human) generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0000350; GO:0005634; GO:0005681; GO:0005682; GO:0006397; GO:0008380; GO:0016607; GO:0046540; GO:0071021 HFPTDPSK 0.99425 -13.88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2232 16.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTD1 SHAS3_HUMAN Putative uncharacterized protein SHANK2-AS3 SHANK2-AS3 C11orf76 Homo sapiens (Human) KPGQTGR 0.99425 -15.654 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1292 0 0 11.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4863 14.4612 14.4406 14.4302 13.4658 0 12.2321 12.2573 12.7728 11.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVI4 NOC4L_HUMAN "Nucleolar complex protein 4 homolog, NOC4 protein homolog (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein)" NOC4L Homo sapiens (Human) rRNA processing [GO:0006364] integral component of membrane [GO:0016021]; Noc4p-Nop14p complex [GO:0030692]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] integral component of membrane [GO:0016021]; Noc4p-Nop14p complex [GO:0030692]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; rRNA processing [GO:0006364] GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0016021; GO:0030692; GO:0031965; GO:0032040 RNA binding [GO:0003723] EPGAAGVRRALGR 0.99425 -7.9998 0 0 11.1023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1233 11.5225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8862 0 0 0 0 0 0 0 0 0 13.4337 0 0 0 0 0 12.5472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4083 0 12.9624 14.2127 12.6414 0 13.245 0 0 0 0 0 13.2764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.071 0 0 0 0 0 12.3483 0 0 0 0 0 Q9BWW8 APOL6_HUMAN "Apolipoprotein L6 (Apolipoprotein L-VI, ApoL-VI)" APOL6 UNQ3095/PRO21341 Homo sapiens (Human) lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] GO:0005576; GO:0005737; GO:0006869; GO:0008289; GO:0042157 lipid binding [GO:0008289] AKALELER 0.99425 -8.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3856 0 0 16.839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4964 0 0 0 0 0 0 0 0 0 12.5824 0 0 0 0 0 0 0 12.3251 0 0 0 0 13.0454 0 0 0 0 0 0 0 0 0 0 0 0 11.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXF3 CECR2_HUMAN Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2) CECR2 KIAA1740 Homo sapiens (Human) apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192] CERF complex [GO:0090537]; euchromatin [GO:0000791]; nucleus [GO:0005634] CERF complex [GO:0090537]; euchromatin [GO:0000791]; nucleus [GO:0005634]; ATP-dependent chromatin remodeler activity [GO:0140658]; apoptotic DNA fragmentation [GO:0006309]; chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; single fertilization [GO:0007338]; vesicle-mediated transport [GO:0016192] GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006309; GO:0006338; GO:0007010; GO:0007338; GO:0016192; GO:0060122; GO:0061640; GO:0090102; GO:0090537; GO:0097194; GO:0140658 ATP-dependent chromatin remodeler activity [GO:0140658] CQEEGLGHFQAVMMEQIGTRSGIRGPFQEMYR 0.99425 -8.0126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2251 0 0 0 0 0 0 0 0 0 13.8278 12.2125 0 0 0 0 0 0 0 0 0 13.2938 13.4676 13.0887 13.776 14.166 13.3151 0 0 12.8829 13.052 0 0 0 0 0 0 0 0 0 0 0 14.9143 13.3407 0 0 15.645 13.8494 0 0 13.8888 14.3196 14.4888 14.3878 0 14.2094 13.981 12.3249 0 0 0 0 12.6667 12.745 0 14.1419 0 0 0 0 0 15.1882 0 0 0 0 0 0 13.7841 0 0 0 0 0 0 13.1256 14.355 0 0 0 0 0 0 12.0073 12.0506 0 0 0 0 0 0 0 12.5408 0 15.0948 0 0 0 0 0 0 Q9BXT8 RNF17_HUMAN RING finger protein 17 (Tudor domain-containing protein 4) RNF17 TDRD4 Homo sapiens (Human) spermatid development [GO:0007286] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; spermatid development [GO:0007286] GO:0005634; GO:0005737; GO:0007286; GO:0042802; GO:0046872 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] AIKVLLAGFK 0.99425 -36.942 0 0 0 0 0 0 0 0 0 13.9405 0 0 9.59451 13.8676 0 0 0 0 10.9025 0 0 0 12.8898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.51231 14.0668 0 0 0 0 0 0 0 12.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.807 0 0 13.2052 15.5856 0 0 12.6148 0 0 12.3163 0 0 0 0 0 0 0 0 13.4607 0 0 14.5302 0 0 0 12.7607 0 0 0 12.903 0 12.5574 0 0 0 13.0071 0 13.0618 0 0 0 14.4554 0 0 0 0 0 14.2381 0 0 14.3035 0 0 0 11.5394 13.2735 0 0 0 0 0 0 0 0 0 14.1118 0 0 0 0 0 0 0 0 0 0 0 10.9152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6533 0 0 0 0 0 11.4045 0 0 0 14.442 Q9BY31 ZN717_HUMAN Zinc finger protein 717 (Krueppel-like factor X17) ZNF717 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGKTFCQK 0.99425 -12.652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5474 0 14.4579 0 0 12.0227 0 0 14.1473 0 0 13.0083 0 0 0 0 0 0 0 0 0 0 0 0 15.5996 13.0729 0 13.6612 0 0 13.7647 0 12.9686 0 15.0279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4722 0 0 0 0 0 0 0 0 14.4066 0 0 0 0 11.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1282 0 0 0 0 0 0 0 0 Q9H3U5 MFSD1_HUMAN "Major facilitator superfamily domain-containing protein 1 (Smooth muscle cell-associated protein 4, SMAP-4)" MFSD1 SMAP4 UG0581B09 Homo sapiens (Human) protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821] GO:0005764; GO:0005765; GO:0016021; GO:0022857; GO:0042803; GO:0050821; GO:0061462 protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857] AERILHK 0.99425 -11.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.688 0 0 0 0 0 0 0 0 0 0 0 Q9NQS7 INCE_HUMAN Inner centromere protein INCENP Homo sapiens (Human) chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein phosphorylation [GO:0006468] "central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]" "central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; protein serine/threonine kinase activator activity [GO:0043539]; chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein phosphorylation [GO:0006468]" GO:0000278; GO:0000281; GO:0000775; GO:0000776; GO:0000800; GO:0000801; GO:0001934; GO:0005634; GO:0005654; GO:0005721; GO:0005819; GO:0005829; GO:0005874; GO:0006468; GO:0007052; GO:0007059; GO:0010369; GO:0015630; GO:0016572; GO:0016604; GO:0030496; GO:0032133; GO:0032991; GO:0043539; GO:0051256; GO:0051257; GO:0051310; GO:0071902; GO:0090267; GO:1901970; GO:1902425; GO:1903490; GO:1990385 protein serine/threonine kinase activator activity [GO:0043539] ASRRLAK 0.99425 -37.051 0 0 0 0 0 0 0 0 0 13.7409 0 0 0 11.2566 13.2195 0 0 9.55109 10.6317 15.4119 11.2323 0 10.9401 0 0 0 0 0 0 0 0 0 0 0 12.4217 13.6461 0 0 0 0 0 0 0 0 0 0 0 0 12.2501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.822 0 0 0 0 0 0 13.7876 12.7609 11.893 12.2876 13.3837 15.2485 13.657 13.1705 12.7639 12.5037 0 0 14.6089 12.9987 0 0 13.3588 15.0895 15.2324 0 0 13.9959 18.076 13.2734 13.2834 14.1786 13.2075 10.8711 14.6855 0 0 0 0 0 0 17.0657 14.0197 0 12.5841 0 15.4146 0 0 16.2945 0 0 13.3334 12.7619 0 0 0 15.246 0 14.4148 0 13.1557 17.3105 13.5432 12.3248 0 11.6819 0 0 0 13.8266 14.6032 0 11.157 0 0 0 0 16.1592 0 0 0 0 14.1557 0 11.8841 15.0244 13.587 13.5847 0 0 0 0 0 13.2519 0 14.0186 13.9612 0 0 0 0 0 0 0 0 0 13.5305 0 0 0 0 Q9NSI8 SAMN1_HUMAN "SAM domain-containing protein SAMSN-1 (Hematopoietic adaptor containing SH3 and SAM domains 1) (Nash1) (SAM domain, SH3 domain and nuclear localization signals protein 1) (SH3-SAM adaptor protein)" SAMSN1 HACS1 Homo sapiens (Human) negative regulation of adaptive immune response [GO:0002820]; negative regulation of B cell activation [GO:0050869]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ruffle [GO:0001726]; phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of B cell activation [GO:0050869]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732] GO:0001726; GO:0001784; GO:0002820; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0050732; GO:0050869 phosphotyrosine residue binding [GO:0001784]; RNA binding [GO:0003723] ASDSMDSLYSGQSSSSGITSCSDGTSNRDSFR 0.99425 -8.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8746 0 0 0 0 15.602 0 0 0 0 0 0 0 0 14.3081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5214 13.7913 0 0 0 0 13.1283 12.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHB6 LIMA1_HUMAN LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm) LIMA1 EPLIN SREBP3 PP624 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529] actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529] GO:0001725; GO:0001726; GO:0003785; GO:0005829; GO:0005886; GO:0005925; GO:0008203; GO:0015629; GO:0016477; GO:0030299; GO:0030835; GO:0031526; GO:0031529; GO:0032154; GO:0042632; GO:0045296; GO:0046872; GO:0051015; GO:0051017 actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872] AMKKFQAPAR 0.99425 -37 0 0 0 0 0 0 0 0 13.4558 0 0 12.1507 0 0 0 0 0 0 0 0 12.8037 0 0 0 0 0 0 0 0 0 0 13.7989 0 0 14.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6261 0 12.6747 13.9766 0 0 13.7539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5293 0 0 13.6357 0 0 0 0 0 12.8601 0 0 0 12.6909 0 0 14.75 0 0 0 0 0 13.3383 0 0 12.5384 0 0 0 0 0 0 0 0 0 0 0 0 12.4721 13.6095 0 0 0 0 0 0 0 0 12.456 0 13.7923 0 0 0 0 0 0 0 0 0 0 0 0 13.9904 0 0 14.1783 0 0 0 12.9112 0 0 0 0 0 12.1723 0 11.4385 13.9452 0 0 0 0 0 Q9ULS6 KCNS2_HUMAN Potassium voltage-gated channel subfamily S member 2 (Delayed-rectifier K(+) channel alpha subunit 2) (Voltage-gated potassium channel subunit Kv9.2) KCNS2 KIAA1144 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259] integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of delayed rectifier potassium channel activity [GO:1902259] GO:0005249; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0048471; GO:0051260; GO:0071805; GO:1902259 voltage-gated potassium channel activity [GO:0005249] DYYAHKVK 0.99425 -11.219 0 0 0 0 0 0 12.5904 0 12.6982 0 0 11.7635 0 11.8271 0 0 0 0 0 0 10.9609 0 0 0 0 0 0 10.8474 0 0 0 0 12.0024 12.6345 0 0 0 0 0 0 12.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9111 0 0 0 12.503 0 0 13.1136 0 0 0 0 0 14.0564 12.0485 0 0 0 0 0 12.8051 0 0 0 0 0 0 0 0 0 0 12.8394 0 12.065 0 0 0 0 12.7308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.539 0 0 0 0 0 0 0 10.4232 12.8518 12.8318 0 0 12.5041 0 0 0 0 0 13.009 0 0 0 0 12.8378 0 12.7674 0 0 0 0 0 Q9Y4R7 TTLL3_HUMAN "Tubulin monoglycylase TTLL3, EC 6.3.2.- (HOTTL) (Tubulin--tyrosine ligase-like protein 3)" TTLL3 PRO0207 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094] axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126] "axoneme [GO:0005930]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; protein polyglycylation [GO:0018094]" GO:0003341; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0030317; GO:0035082; GO:0036126; GO:0046872; GO:0060271; GO:0070735; GO:0070736 "ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, initiating [GO:0070736]" ALRTLPTAKVFISLPPNLDFK 0.99425 -11.573 0 0 0 0 0 0 0 0 13.7966 0 13.4242 0 14.0983 0 0 0 0 0 0 0 0 13.366 13.5528 0 0 0 0 0 13.9557 0 0 0 14.3012 13.0687 0 0 0 0 14.2211 10.9169 0 0 0 0 13.434 0 0 0 0 0 0 12.4034 0 0 10.498 0 0 13.8466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0011 0 13.4169 14.7506 0 0 12.5714 0 0 13.4656 12.5303 14.5174 0 12.896 11.9729 0 12.7045 12.8856 0 11.4448 13.0934 13.8163 17.7529 14.5706 0 0 11.929 0 12.6022 15.1332 0 12.8027 12.0492 0 14.225 0 0 0 0 0 0 0 0 0 0 0 0 12.7924 0 14.462 0 14.772 0 0 0 12.2975 13.7578 0 15.4596 0 0 0 12.939 0 0 0 0 0 0 0 13.0029 0 15.0501 0 0 0 0 0 0 0 0 0 15.5825 0 14.3953 13.5069 0 0 0 0 0 12.8767 0 14.7802 0 11.9503 0 11.9003 0 0 0 0 0 0 0 Q8NF50 DOCK8_HUMAN Dedicator of cytokinesis protein 8 DOCK8 Homo sapiens (Human) cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; cellular response to chemokine [GO:1990869]; dendritic cell migration [GO:0036336]; immunological synapse formation [GO:0001771]; memory T cell proliferation [GO:0061485]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0001771; GO:0005085; GO:0005737; GO:0005829; GO:0007264; GO:0016020; GO:0031252; GO:0031256; GO:0031258; GO:0036336; GO:0043547; GO:0051056; GO:0061485; GO:0070233; GO:1903905; GO:1990869; GO:2000406 guanyl-nucleotide exchange factor activity [GO:0005085] EHLGNRILVKLLTLK 0.99426 -9.0595 13.1226 17.7614 17.3666 13.1062 17.1929 15.5632 17.1873 15.3041 0 11.4622 0 0 9.79216 0 0 16.6099 16.3629 16.1051 16.7452 17.1267 16.8274 17.376 16.7848 16.4088 16.4555 16.5852 16.6751 16.3411 0 0 0 0 0 0 12.0181 0 0 12.9057 0 0 11.3834 0 16.0134 0 0 14.1745 0 10.7415 0 14.1412 0 16.1911 12.719 16.1591 0 0 0 0 0 0 0 0 0 0 0 0 18.4255 18.4204 18.4821 18.3209 18.3203 18.3604 18.2501 18.2071 18.3499 18.4182 18.3556 18.2452 18.022 13.9186 13.8729 17.5053 17.3421 17.3993 17.6176 17.8851 17.3669 18.036 17.5822 17.8495 17.3462 17.8042 13.1897 17.1493 17.5342 17.3592 17.3818 17.4177 17.3592 17.2493 13.9611 17.3614 16.7776 16.5473 16.4801 13.8614 12.9136 17.3815 17.2372 17.046 17.9625 16.7939 17.5365 17.0739 17.4419 17.2917 17.5185 17.5024 13.9842 17.4668 17.3953 17.2735 16.0151 17.4391 17.6132 17.5908 17.1399 17.9436 17.279 17.3001 17.3432 17.2039 17.138 17.249 17.7231 14.4468 17.4112 17.3477 17.9062 17.5015 17.3422 17.5454 17.6114 17.5042 17.3058 17.3637 17.4294 13.0104 0 0 17.5561 17.3887 17.42 17.0293 17.6686 17.1342 17.4596 0 0 0 0 0 0 0 13.8989 14.4875 0 13.5111 0 13.8815 0 16.904 17.3465 17.2538 13.0063 0 16.0156 12.4183 14.3882 0 O43422 P52K_HUMAN "52 kDa repressor of the inhibitor of the protein kinase, p52rIPK (58 kDa interferon-induced protein kinase-interacting protein, p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12)" THAP12 DAP4 P52RIPK PRKRIR THAP0 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; negative regulation of cell population proliferation [GO:0008285]; signal transduction [GO:0007165] GO:0003677; GO:0005634; GO:0007165; GO:0008285; GO:0046872; GO:0046983 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983] AYLRNTLTDQRSSNLALLNINFDIK 0.99426 -8.7972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9486 0 0 0 13.8144 0 0 0 0 0 0 10.0946 0 0 11.9015 0 0 0 0 0 0 0 12.1771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.434 0 0 0 0 0 0 0 0 0 0 0 12.3813 13.3795 0 0 0 0 0 12.5135 12.0841 12.4544 12.8243 0 0 0 0 0 0 13.4294 0 0 11.7247 0 0 0 0 12.0039 0 13.309 0 11.2538 11.8125 0 0 12.1527 0 0 13.058 12.4337 12.6423 0 0 0 14.0879 0 0 0 12.8073 0 12.3217 0 0 0 0 0 0 12.9155 0 0 0 10.4769 0 0 0 0 0 0 0 0 0 0 0 0 13.9391 13.7244 13.8945 0 0 0 0 0 0 O75528 TADA3_HUMAN "Transcriptional adapter 3 (ADA3 homolog, hADA3) (STAF54) (Transcriptional adapter 3-like, ADA3-like protein)" TADA3 ADA3 TADA3L Homo sapiens (Human) "histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitotic cell cycle [GO:0000278]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; regulation of tubulin deacetylation [GO:0090043]" GO:0000124; GO:0000278; GO:0001932; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006355; GO:0006357; GO:0010628; GO:0016573; GO:0016922; GO:0019904; GO:0030374; GO:0030520; GO:0031063; GO:0031647; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0044154; GO:0045893; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0090043; GO:0140672 nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713] ALSAHNR 0.99426 -15.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6432 0 0 14.2095 0 14.0643 14.4925 13.9801 0 0 14.3168 0 0 0 0 13.7074 0 0 0 13.4453 0 13.5247 13.9528 14.0192 0 0 0 13.7382 14.002 13.6923 0 0 0 0 13.7217 0 0 14.9187 13.6656 0 0 0 0 13.5344 0 0 0 0 14.5214 0 13.428 16.1736 0 15.232 0 13.76 13.6334 0 0 0 13.6718 13.2681 14.1528 0 13.3029 0 16.0398 15.2308 0 0 13.4671 0 0 0 0 18.2601 0 0 0 0 0 13.7995 0 13.1181 0 0 0 0 0 0 0 0 0 0 0 16.0883 0 0 0 18.863 0 0 0 0 0 0 0 0 P05160 F13B_HUMAN Coagulation factor XIII B chain (Fibrin-stabilizing factor B subunit) (Protein-glutamine gamma-glutamyltransferase B chain) (Transglutaminase B chain) F13B Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; transferase complex [GO:1990234] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; transferase complex [GO:1990234]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]" GO:0005576; GO:0005615; GO:0007596; GO:0018149; GO:0072378; GO:1990234 LKNLTFIIILIISGELYAEEK 0.99426 -13.589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8467 0 0 0 0 0 0 0 0 13.9604 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 12.2801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4188 0 0 0 12.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0966 0 0 0 0 0 0 0 P28360 MSX1_HUMAN Homeobox protein MSX-1 (Homeobox protein Hox-7) (Msh homeobox 1-like protein) MSX1 HOX7 Homo sapiens (Human) "activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway involved in heart development [GO:0061312]; bone morphogenesis [GO:0060349]; cardiac conduction system development [GO:0003161]; cartilage morphogenesis [GO:0060536]; cell morphogenesis [GO:0000902]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic morphogenesis [GO:0048598]; embryonic nail plate morphogenesis [GO:0035880]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; mammary gland epithelium development [GO:0061180]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway involved in heart development [GO:0061312]; bone morphogenesis [GO:0060349]; cardiac conduction system development [GO:0003161]; cartilage morphogenesis [GO:0060536]; cell morphogenesis [GO:0000902]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic morphogenesis [GO:0048598]; embryonic nail plate morphogenesis [GO:0035880]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; in utero embryonic development [GO:0001701]; mammary gland epithelium development [GO:0061180]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of odontogenesis [GO:0042481]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000902; GO:0000977; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001701; GO:0002039; GO:0003161; GO:0003198; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006366; GO:0007517; GO:0008285; GO:0009952; GO:0010463; GO:0023019; GO:0030308; GO:0030513; GO:0030900; GO:0030901; GO:0034504; GO:0035115; GO:0035116; GO:0035880; GO:0042474; GO:0042475; GO:0042481; GO:0043066; GO:0043517; GO:0048598; GO:0048863; GO:0050821; GO:0051154; GO:0060021; GO:0060325; GO:0060349; GO:0060536; GO:0061180; GO:0061312; GO:0090427; GO:0097152; GO:1902255; GO:1990837; GO:2000678; GO:2001055 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" AEFSSSLSLTETQVKIWFQNRR 0.99426 -9.0573 0 0 0 0 0 0 0 0 0 11.6947 13.0531 11.1327 0 0 0 0 0 0 0 11.1195 0 0 0 0 0 0 11.1333 10.3338 0 0 0 0 0 0 0 0 0 0 0 0 11.4255 0 0 0 0 0 0 0 0 12.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9308 14.3928 0 0 0 0 0 0 14.5785 0 14.208 12.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1046 0 0 0 0 0 0 P36542 ATPG_HUMAN "ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)" ATP5F1C ATP5C ATP5C1 ATP5CL1 Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; oxidative phosphorylation [GO:0006119]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776] "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]" "membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]; ATP biosynthetic process [GO:0006754]; oxidative phosphorylation [GO:0006119]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0000275; GO:0003723; GO:0005739; GO:0005743; GO:0005753; GO:0005759; GO:0006119; GO:0006754; GO:0015986; GO:0016020; GO:0042776; GO:0046933 "proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]" ELIEIISGAAALD 0.99426 -8.8006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8077 0 0 13.6039 0 0 13.2184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1928 0 0 0 0 0 0 0 P49763 PLGF_HUMAN "Placenta growth factor, PlGF" PGF PGFL PLGF Homo sapiens (Human) animal organ regeneration [GO:0031100]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172]; animal organ regeneration [GO:0031100]; cell differentiation [GO:0030154]; cell-cell signaling [GO:0007267]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] GO:0001666; GO:0001934; GO:0001938; GO:0002040; GO:0005172; GO:0005576; GO:0005615; GO:0007165; GO:0007267; GO:0007565; GO:0008083; GO:0008201; GO:0008284; GO:0009410; GO:0016020; GO:0030154; GO:0031100; GO:0032870; GO:0038084; GO:0042056; GO:0042802; GO:0044877; GO:0045766; GO:0048010; GO:0050930; GO:0051781; GO:0060754 chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172] PLREKMK 0.99426 -11.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60201 MYPR_HUMAN "Myelin proteolipid protein, PLP (Lipophilin)" PLP1 PLP Homo sapiens (Human) AMPA selective glutamate receptor signaling pathway [GO:0098990]; astrocyte development [GO:0014002]; axon development [GO:0061564]; axon ensheathment [GO:0008366]; central nervous system myelination [GO:0022010]; chemical synaptic transmission [GO:0007268]; inflammatory response [GO:0006954]; long-chain fatty acid biosynthetic process [GO:0042759]; neuron projection development [GO:0031175]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; substantia nigra development [GO:0021762] integrin alphav-beta3 complex [GO:0034683]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; synapse [GO:0045202] integrin alphav-beta3 complex [GO:0034683]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of myelin sheath [GO:0019911]; structural molecule activity [GO:0005198]; AMPA selective glutamate receptor signaling pathway [GO:0098990]; astrocyte development [GO:0014002]; axon development [GO:0061564]; axon ensheathment [GO:0008366]; central nervous system myelination [GO:0022010]; chemical synaptic transmission [GO:0007268]; inflammatory response [GO:0006954]; long-chain fatty acid biosynthetic process [GO:0042759]; neuron projection development [GO:0031175]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; substantia nigra development [GO:0021762] GO:0005198; GO:0005886; GO:0006954; GO:0007268; GO:0008366; GO:0010628; GO:0014002; GO:0019911; GO:0021762; GO:0022010; GO:0030335; GO:0031175; GO:0034683; GO:0042759; GO:0042802; GO:0043209; GO:0044877; GO:0045202; GO:0061564; GO:0098990; GO:1904427 identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; structural constituent of myelin sheath [GO:0019911]; structural molecule activity [GO:0005198] GSRGQHQAHSLER 0.99426 -8.8056 0 0 0 0 0 0 0 0 0 0 0 0 12.8986 0 0 0 13.1742 0 0 12.9567 0 0 12.855 0 0 0 13.1366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7976 0 0 0 0 0 0 0 0 13.5118 0 13.3106 0 0 0 0 0 0 12.7036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7927 0 0 0 0 0 0 0 0 0 0 0 14.8171 0 0 0 0 14.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4252 0 0 0 0 0 0 0 14.1917 0 0 14.5495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6879 0 0 0 0 0 0 0 0 0 14.91 0 0 0 0 P61296 HAND2_HUMAN "Heart- and neural crest derivatives-expressed protein 2 (Class A basic helix-loop-helix protein 26, bHLHa26) (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2, dHAND)" HAND2 BHLHA26 DHAND Homo sapiens (Human) adult heart development [GO:0007512]; angiogenesis [GO:0001525]; apoptotic process involved in heart morphogenesis [GO:0003278]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cardiac right ventricle formation [GO:0003219]; cartilage morphogenesis [GO:0060536]; cell proliferation involved in outflow tract morphogenesis [GO:0061325]; cellular response to organic cyclic compound [GO:0071407]; cellular response to retinoic acid [GO:0071300]; coronary artery morphogenesis [GO:0060982]; developmental process [GO:0032502]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell apoptotic process [GO:1904019]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mesenchymal cell proliferation [GO:0010463]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; noradrenergic neuron differentiation [GO:0003357]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [GO:2000764]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [GO:2000763]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; primary palate development [GO:1903929]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967]; sympathetic nervous system development [GO:0048485]; thymus development [GO:0048538]; tongue development [GO:0043586]; visceral serous pericardium development [GO:0061032] chromatin [GO:0000785]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; adult heart development [GO:0007512]; angiogenesis [GO:0001525]; apoptotic process involved in heart morphogenesis [GO:0003278]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cardiac right ventricle formation [GO:0003219]; cartilage morphogenesis [GO:0060536]; cell proliferation involved in outflow tract morphogenesis [GO:0061325]; cellular response to organic cyclic compound [GO:0071407]; cellular response to retinoic acid [GO:0071300]; coronary artery morphogenesis [GO:0060982]; developmental process [GO:0032502]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell apoptotic process [GO:1904019]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mesenchymal cell proliferation [GO:0010463]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; noradrenergic neuron differentiation [GO:0003357]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [GO:2000764]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [GO:2000763]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; primary palate development [GO:1903929]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; suckling behavior [GO:0001967]; sympathetic nervous system development [GO:0048485]; thymus development [GO:0048538]; tongue development [GO:0043586]; visceral serous pericardium development [GO:0061032]" GO:0000785; GO:0000977; GO:0000981; GO:0001223; GO:0001228; GO:0001525; GO:0001649; GO:0001701; GO:0001947; GO:0001967; GO:0003219; GO:0003253; GO:0003266; GO:0003278; GO:0003357; GO:0003680; GO:0005634; GO:0005667; GO:0006357; GO:0007507; GO:0007512; GO:0010463; GO:0010613; GO:0010628; GO:0010629; GO:0010667; GO:0032502; GO:0032991; GO:0034103; GO:0042475; GO:0042733; GO:0042803; GO:0043392; GO:0043433; GO:0043586; GO:0045668; GO:0045944; GO:0048485; GO:0048538; GO:0048706; GO:0048935; GO:0060536; GO:0060982; GO:0061032; GO:0061309; GO:0061325; GO:0061629; GO:0070374; GO:0070888; GO:0071300; GO:0071407; GO:1900745; GO:1903929; GO:1904019; GO:1904036; GO:1990837; GO:2000679; GO:2000763; GO:2000764 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]" DDQNGEAEAFKAEIKK 0.99426 -11.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7325 0 Q16698 DECR_HUMAN "2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial, EC 1.3.1.124 (2,4-dienoyl-CoA reductase [NADPH], 4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)" DECR1 DECR SDR18C1 Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]" GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494 "2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; identical protein binding [GO:0042802]; NADPH binding [GO:0070402]" FFSPLQK 0.99426 -9.3005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5048 0 13.5008 0 0 0 13.0736 0 0 13.6195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MIT2 PUS10_HUMAN "tRNA pseudouridine synthase Pus10, Hup10, EC 5.4.99.25 (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase, Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase)" PUS10 CCDC139 DOBI Homo sapiens (Human) primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119] GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029 metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029] DELILEVMNPPPKKIR 0.99426 -10.967 0 0 0 0 0 0 0 10.5936 0 0 0 0 0 11.6971 0 12.3207 0 0 11.2218 0 0 0 0 0 0 0 11.4346 0 0 0 12.2285 0 0 11.5939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2313 0 0 0 12.2063 0 0 13.0319 0 0 11.5925 0 0 0 0 0 0 0 13.2237 0 0 12.5824 0 0 0 0 0 0 0 0 11.9634 14.4247 0 0 0 0 0 0 0 0 0 13.3632 0 0 0 0 12.5458 0 0 0 0 13.9964 12.9394 13.0068 13.4206 0 0 12.3213 13.0204 0 12.1275 0 0 13.1332 11.6977 13.3955 11.7827 0 0 0 13.1699 0 0 0 0 0 0 0 12.8119 0 0 0 13.3462 13.3008 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4774 0 0 0 0 12.4843 13.1974 0 0 Q3MJ16 PA24E_HUMAN "Cytosolic phospholipase A2 epsilon, cPLA2-epsilon, EC 3.1.1.4 (Calcium-dependent N-acyltransferase) (Phospholipase A2 group IVE)" PLA2G4E Homo sapiens (Human) glycerophospholipid catabolic process [GO:0046475]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; positive regulation of endocytic recycling [GO:2001137] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; N-acyltransferase activity [GO:0016410]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; glycerophospholipid catabolic process [GO:0046475]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; positive regulation of endocytic recycling [GO:2001137]" GO:0004623; GO:0005509; GO:0005544; GO:0005546; GO:0005547; GO:0005765; GO:0005829; GO:0005886; GO:0008970; GO:0010314; GO:0016410; GO:0031901; GO:0032266; GO:0036149; GO:0043325; GO:0046475; GO:0047498; GO:0070273; GO:0070292; GO:0080025; GO:2001137 "calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; N-acyltransferase activity [GO:0016410]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]" ICYMLGLWSSIFSLNLLDAWNLSHTSEEFFHRWTREK 0.99426 -9.3077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T230 UTF1_HUMAN Undifferentiated embryonic cell transcription factor 1 UTF1 Homo sapiens (Human) male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; male gonad development [GO:0008584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003713; GO:0005634; GO:0006357; GO:0008584; GO:0045944 transcription coactivator activity [GO:0003713] ALLLDRRQALPTYR 0.99426 -9.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5955 0 0 0 0 0 0 0 14.4174 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3919 0 0 0 0 0 0 0 0 0 0 0 0 12.8411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UP6 CUZD1_HUMAN "CUB and zona pellucida-like domain-containing protein 1, CUB and ZP domain-containing protein 1 (Transmembrane protein UO-44)" CUZD1 UNQ224/PRO257 Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; trypsinogen activation [GO:0032023] integral component of membrane [GO:0016021]; membrane [GO:0016020]; zymogen granule membrane [GO:0042589] integral component of membrane [GO:0016021]; membrane [GO:0016020]; zymogen granule membrane [GO:0042589]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; trypsinogen activation [GO:0032023] GO:0007049; GO:0007155; GO:0016020; GO:0016021; GO:0032023; GO:0042589; GO:0051301 ASPTSDFASPTYDLIKSGCSR 0.99426 -10.979 0 0 16.2335 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6353 0 0 0 0 0 0 0 0 0 0 0 15.2934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7X2 STPG3_HUMAN Protein STPG3 (Sperm-tail PG-rich repeat-containing protein 3) STPG3 C9orf173 Homo sapiens (Human) cytoskeleton [GO:0005856] cytoskeleton [GO:0005856] GO:0005856 EIPVGLRLQTGTPQESLPTYTQTLRELLLEQR 0.99426 -9.0624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1376 0 0 0 0 0 0 0 12.6025 0 11.8912 0 0 0 0 0 0 0 11.6591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2119 0 0 0 0 0 0 0 0 0 0 0 11.1354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7309 0 0 0 0 0 12.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF50 ZN526_HUMAN Zinc finger protein 526 ZNF526 KIAA1951 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ARTLTLQPPR 0.99426 -9.0462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0875 0 0 0 0 0 0 0 0 0 0 0 13.7889 0 12.9106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1359 0 0 12.3246 0 13.221 0 15.9854 0 0 0 14.5044 12.3962 0 0 0 0 12.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6573 0 0 0 13.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5736 0 0 12.9021 0 0 0 14.9346 0 0 0 0 0 0 0 0 11.8147 0 0 13.7145 0 0 0 0 0 0 0 0 0 Q92854 SEM4D_HUMAN Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100) SEMA4D C9orf164 CD100 SEMAJ Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; immune response [GO:0006955]; leukocyte aggregation [GO:0070486]; negative chemotaxis [GO:0050919]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; ossification involved in bone maturation [GO:0043931]; positive regulation of cell migration [GO:0030335]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inhibitory synapse assembly [GO:1905704]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell projection organization [GO:0031344]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; identical protein binding [GO:0042802]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; immune response [GO:0006955]; leukocyte aggregation [GO:0070486]; negative chemotaxis [GO:0050919]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; ossification involved in bone maturation [GO:0043931]; positive regulation of cell migration [GO:0030335]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inhibitory synapse assembly [GO:1905704]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell projection organization [GO:0031344]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220] GO:0000122; GO:0001755; GO:0001934; GO:0004888; GO:0005102; GO:0005615; GO:0005886; GO:0005887; GO:0006955; GO:0007155; GO:0007162; GO:0007411; GO:0008360; GO:0010693; GO:0014068; GO:0030215; GO:0030335; GO:0031344; GO:0038023; GO:0042802; GO:0043066; GO:0043547; GO:0043931; GO:0045499; GO:0045668; GO:0048672; GO:0048814; GO:0048843; GO:0050731; GO:0050732; GO:0050919; GO:0070486; GO:0071526; GO:1900220; GO:1905704 chemorepellent activity [GO:0045499]; identical protein binding [GO:0042802]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888] FADSDADGD 0.99426 -13.608 0 0 0 0 0 0 0 0 0 0 13.2836 0 0 0 0 0 0 0 0 0 0 0 14.0129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3663 0 0 0 0 0 0 0 14.9002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7346 12.695 0 0 0 0 0 0 0 0 0 10.6743 0 10.0423 0 0 0 11.3507 0 0 Q96KG7 MEG10_HUMAN "Multiple epidermal growth factor-like domains protein 10, Multiple EGF-like domains protein 10" MEGF10 KIAA1780 Homo sapiens (Human) apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841] cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886] cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841] GO:0001849; GO:0001891; GO:0005044; GO:0005112; GO:0005886; GO:0014719; GO:0014816; GO:0014841; GO:0016021; GO:0022409; GO:0033002; GO:0034109; GO:0042995; GO:0043277; GO:0043652; GO:0043654; GO:0048627; GO:0048641; GO:0051147; GO:0051451; GO:0055001; GO:1902742; GO:2000288 complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044] CDCSHADGCHPTTGHCR 0.99426 -9.2972 0 0 0 0 0 0 0 12.0252 13.5757 0 0 0 0 12.7828 0 0 0 0 0 0 0 0 0 0 0 12.8133 0 0 0 13.3983 0 0 0 0 0 0 10.9432 0 0 9.98684 0 0 13.8154 11.7712 11.4063 0 13.1939 0 0 0 0 0 0 0 12.6247 0 10.6483 0 0 0 0 0 0 0 0 0 13.3879 0 0 0 0 0 12.2422 14.3937 13.7663 13.0926 13.9894 12.8686 0 12.2306 0 0 12.0265 16.4507 0 0 0 0 16.8385 16.8144 0 16.7909 0 16.7157 0 13.5051 12.7402 0 0 16.133 0 11.1147 0 14.0635 12.8625 0 0 16.1014 0 13.4342 0 0 16.0637 0 0 14.556 0 13.1805 14.2916 13.751 13.7309 0 9.93279 0 13.8357 0 0 0 0 13.5607 12.4682 0 0 0 14.0812 12.981 12.641 0 0 0 13.5881 0 0 0 12.168 13.9634 12.4875 0 12.7374 0 12.1883 12.6457 0 12.1164 0 15.1689 15.8177 0 0 13.8941 0 0 0 0 11.2571 0 0 12.9016 0 0 0 0 12.5067 0 0 0 0 14.1361 0 0 Q96NG8 ZN582_HUMAN Zinc finger protein 582 ZNF582 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CKECGKAFK 0.99426 -9.0536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXC9 BBS2_HUMAN Bardet-Biedl syndrome 2 protein BBS2 Homo sapiens (Human) adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601] BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420] BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; melanosome transport [GO:0032402]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601] GO:0005829; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032402; GO:0032420; GO:0033365; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515 RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] AQRVVVWLGQNFLLPEDTHIQNAPFQVCFTSLR 0.99426 -15.316 0 0 0 0 0 0 0 0 13.1112 12.5028 12.1053 12.5809 0 0 12.7047 0 0 0 0 0 0 0 14.2943 0 0 0 12.9315 0 0 0 0 12.1448 13.492 10.28 12.1477 10.4132 14.3461 0 0 11.8464 10.5592 12.0485 11.1302 0 0 13.1001 12.177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7488 0 13.645 12.75 0 12.6613 13.0506 0 15.2635 0 0 0 0 0 0 0 0 0 0 0 0 14.7443 0 0 0 0 14.8214 14.3063 0 12.5827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0089 0 0 0 13.5182 0 0 0 0 0 0 0 0 0 0 12.6648 13.3149 0 0 11.0037 0 0 Q9P2R7 SUCB1_HUMAN "Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial, EC 6.2.1.5 (ATP-specific succinyl-CoA synthetase subunit beta, A-SCS) (Succinyl-CoA synthetase beta-A chain, SCS-betaA)" SUCLA2 Homo sapiens (Human) succinate metabolic process [GO:0006105]; succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; succinyl-CoA pathway [GO:0006781]; tricarboxylic acid cycle [GO:0006099] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (ADP-forming) [GO:0009361] extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate metabolic process [GO:0006105]; succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; succinyl-CoA pathway [GO:0006781]; tricarboxylic acid cycle [GO:0006099] GO:0000287; GO:0004775; GO:0005524; GO:0005739; GO:0005759; GO:0006099; GO:0006104; GO:0006105; GO:0006781; GO:0009361; GO:0042709; GO:0070062; GO:1901289 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775] ALIADSGLK 0.99426 -9.0507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2456 11.1239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9732 14.2739 0 0 0 13.1097 0 0 18.0314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5266 0 0 0 13.808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5922 0 0 0 0 0 0 0 0 0 0 0 0 14.701 0 0 0 0 Q9Y6N8 CAD10_HUMAN Cadherin-10 (T2-cadherin) CDH10 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic specialization membrane [GO:0099060]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098609; GO:0098742; GO:0098978; GO:0098982; GO:0099059; GO:0099060 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] IDREEKAFYTLR 0.99426 -13.603 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3574 0 0 0 0 0 10.9435 0 0 10.8691 0 0 0 0 0 0 0 12.9722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5536 0 0 0 0 0 13.8719 0 0 0 12.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7413 14.1922 0 0 0 0 0 0 0 11.2724 0 0 0 0 0 16.6477 0 0 0 0 0 0 0 12.5747 0 0 0 0 0 0 0 0 0 0 0 0 14.7774 0 0 0 0 0 0 0 0 0 13.6151 0 0 0 0 0 0 0 0 0 0 0 0 0 13.679 13.6238 0 13.6648 10.6448 0 0 0 0 0 13.9223 0 0 0 0 0 0 0 0 0 0 0 A4D1E9 GTPBA_HUMAN "GTP-binding protein 10 (Protein obg homolog 2, ObgH2)" GTPBP10 OBGH2 UG0751c10 Homo sapiens (Human) ribosome biogenesis [GO:0042254] chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254] GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723] DFLHLFEK 0.99427 -9.3295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0946 0 0 0 0 13.4533 0 15.7851 12.4448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6389 0 0 0 13.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9019 0 0 O76094 SRP72_HUMAN "Signal recognition particle subunit SRP72, SRP72 (Signal recognition particle 72 kDa protein)" SRP72 Homo sapiens (Human) SRP-dependent cotranslational protein targeting to membrane [GO:0006614] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]" "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]" GO:0003723; GO:0005047; GO:0005783; GO:0005786; GO:0005829; GO:0006614; GO:0008312; GO:0030911; GO:0048500 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911] AEDLCRR 0.99427 -11.34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3599 0 0 12.1759 0 12.7829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0614 0 14.5213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5894 11.0358 0 0 0 0 12.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4647 13.1872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02760 AMBP_HUMAN "Protein AMBP (Protein HC) [Cleaved into: Alpha-1-microglobulin, EC 1.6.2.- (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain, ITI-LC (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin ]" AMBP HCP ITIL Homo sapiens (Human) cell adhesion [GO:0007155]; cellular oxidant detoxification [GO:0098869]; cellular response to reactive oxygen species [GO:0034614]; cytochrome c metabolic process [GO:1903606]; female pregnancy [GO:0007565]; heme catabolic process [GO:0042167]; hemoglobin metabolic process [GO:0020027]; negative regulation of immune response [GO:0050777]; negative regulation of JNK cascade [GO:0046329]; protein catabolic process [GO:0030163] blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; antioxidant activity [GO:0016209]; calcium channel inhibitor activity [GO:0019855]; calcium oxalate binding [GO:0046904]; chondroitin sulfate binding [GO:0035374]; collagen fibril binding [GO:0098633]; heme binding [GO:0020037]; IgA binding [GO:0019862]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; cellular oxidant detoxification [GO:0098869]; cellular response to reactive oxygen species [GO:0034614]; cytochrome c metabolic process [GO:1903606]; female pregnancy [GO:0007565]; heme catabolic process [GO:0042167]; hemoglobin metabolic process [GO:0020027]; negative regulation of immune response [GO:0050777]; negative regulation of JNK cascade [GO:0046329]; protein catabolic process [GO:0030163]" GO:0004867; GO:0005576; GO:0005615; GO:0005743; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007565; GO:0009986; GO:0016209; GO:0016491; GO:0016653; GO:0019855; GO:0019862; GO:0020027; GO:0020037; GO:0030163; GO:0031314; GO:0031965; GO:0034614; GO:0035374; GO:0042167; GO:0042803; GO:0046329; GO:0046904; GO:0050777; GO:0062023; GO:0070062; GO:0072562; GO:0098633; GO:0098869; GO:1903606 "antioxidant activity [GO:0016209]; calcium channel inhibitor activity [GO:0019855]; calcium oxalate binding [GO:0046904]; chondroitin sulfate binding [GO:0035374]; collagen fibril binding [GO:0098633]; heme binding [GO:0020037]; IgA binding [GO:0019862]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase inhibitor activity [GO:0004867]" ETLLQDFR 0.99427 -8.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3731 13.056 0 0 0 0 0 0 0 0 0 0 13.9382 0 0 14.411 13.9116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27797 CALR_HUMAN "Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60, ERp60) (HACBP) (grp60)" CALR CRTC Homo sapiens (Human) "cardiac muscle cell differentiation [GO:0055007]; cellular calcium ion homeostasis [GO:0006874]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; glucocorticoid receptor signaling pathway [GO:0042921]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein localization to nucleus [GO:0034504]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of meiotic nuclear division [GO:0040020]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; sequestering of calcium ion [GO:0051208]; spermatogenesis [GO:0007283]; ubiquitin-dependent ERAD pathway [GO:0030433]" acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; polysome [GO:0005844]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790] "acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; polysome [GO:0005844]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; chaperone binding [GO:0051087]; complement component C1q complex binding [GO:0001849]; DNA binding [GO:0003677]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; cardiac muscle cell differentiation [GO:0055007]; cellular calcium ion homeostasis [GO:0006874]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; glucocorticoid receptor signaling pathway [GO:0042921]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein localization to nucleus [GO:0034504]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of meiotic nuclear division [GO:0040020]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; sequestering of calcium ion [GO:0051208]; spermatogenesis [GO:0007283]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003677; GO:0003723; GO:0003729; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005635; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005794; GO:0005829; GO:0005844; GO:0005925; GO:0006355; GO:0006457; GO:0006611; GO:0006874; GO:0007283; GO:0008270; GO:0008284; GO:0009410; GO:0009897; GO:0009986; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0022417; GO:0030246; GO:0030433; GO:0030670; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033116; GO:0033144; GO:0033574; GO:0034504; GO:0034975; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0042921; GO:0042981; GO:0044183; GO:0044194; GO:0044322; GO:0045665; GO:0045787; GO:0045892; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0051087; GO:0051208; GO:0055007; GO:0060473; GO:0062023; GO:0070062; GO:0071257; GO:0071285; GO:0071556; GO:0071682; GO:0090398; GO:0098586; GO:1900026; GO:1901164; GO:1901224; GO:1903416; GO:2000510 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; chaperone binding [GO:0051087]; complement component C1q complex binding [GO:0001849]; DNA binding [GO:0003677]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] AKIDDPTDSK 0.99427 -11.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92561 0 13.3256 0 0 0 0 0 0 0 13.3855 0 0 12.5433 13.0117 14.595 10.8963 0 0 0 0 0 12.9412 0 0 0 0 0 0 12.8853 0 12.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9045 0 12.7966 0 0 0 0 0 0 0 0 0 11.277 0 0 0 0 0 0 0 0 12.921 0 0 0 0 0 12.6063 0 0 0 0 0 0 0 0 11.9179 0 0 0 0 0 0 0 0 0 0 0 0 11.4757 0 10.6206 0 0 12.307 13.0954 0 0 11.1047 0 0 P35367 HRH1_HUMAN "Histamine H1 receptor, H1R, HH1R" HRH1 Homo sapiens (Human) "cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; inositol phosphate-mediated signaling [GO:0048016]; memory [GO:0007613]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; regulation of vascular permeability [GO:0043114]; visual learning [GO:0008542]" cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594]; cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; inflammatory response [GO:0006954]; inositol phosphate-mediated signaling [GO:0048016]; memory [GO:0007613]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; regulation of vascular permeability [GO:0043114]; visual learning [GO:0008542]" GO:0004930; GO:0004969; GO:0004993; GO:0005829; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007187; GO:0007200; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0032962; GO:0043114; GO:0045202; GO:0045907; GO:0048016; GO:0048167; GO:0048245; GO:0071420 G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594] FTWKRLR 0.99427 -9.3435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.298 0 0 0 0 0 0 0 0 13.4358 0 0 0 0 0 0 0 0 0 0 0 14.5413 0 16.48 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0719 15.2393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9412 0 0 14.6279 0 0 0 0 0 P48067 SC6A9_HUMAN "Sodium- and chloride-dependent glycine transporter 1, GlyT-1, GlyT1 (Solute carrier family 6 member 9)" SLC6A9 Homo sapiens (Human) "glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter transport [GO:0006836]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]" apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter transport [GO:0006836]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725]; transport across blood-brain barrier [GO:0150104]" GO:0005768; GO:0005886; GO:0005887; GO:0006836; GO:0009925; GO:0014069; GO:0015187; GO:0015375; GO:0015816; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030285; GO:0031045; GO:0035725; GO:0046985; GO:0060092; GO:0070455; GO:0098686; GO:0098688; GO:0099055; GO:0099056; GO:0150104; GO:1903804; GO:1904782 glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375] DWGPALLEHRTGR 0.99427 -10.747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01130 SRSF2_HUMAN "Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35, SC-35) (Splicing factor, arginine/serine-rich 2)" SRSF2 SFRS2 Homo sapiens (Human) "mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]" GO:0000381; GO:0000398; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008380; GO:0016607 RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714] SPPPVSK 0.99427 -15.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81097 0 0 0 0 0 0 0 0 9.37138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.07978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13563 PKD2_HUMAN "Polycystin-2, PC2 (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2)" PKD2 TRPP2 Homo sapiens (Human) "aorta development [GO:0035904]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell-cell signaling by wnt [GO:0198738]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to osmotic stress [GO:0071470]; cellular response to reactive oxygen species [GO:0034614]; centrosome duplication [GO:0051298]; cilium organization [GO:0044782]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; embryonic placenta development [GO:0001892]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; liver development [GO:0001889]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric cortex development [GO:0072214]; metanephric cortical collecting duct development [GO:0072219]; metanephric distal tubule development [GO:0072235]; metanephric mesenchyme development [GO:0072075]; metanephric part of ureteric bud development [GO:0035502]; metanephric S-shaped body morphogenesis [GO:0072284]; metanephric smooth muscle tissue development [GO:0072208]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neural tube development [GO:0021915]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of calcium ion import [GO:0090279]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; release of sequestered calcium ion into cytosol [GO:0051209]; renal artery morphogenesis [GO:0061441]; renal tubule morphogenesis [GO:0061333]; sodium ion transmembrane transport [GO:0035725]; spinal cord development [GO:0021510]; Wnt signaling pathway [GO:0016055]" basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133] "basal cortex [GO:0045180]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; phosphoprotein binding [GO:0051219]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248]; aorta development [GO:0035904]; branching involved in ureteric bud morphogenesis [GO:0001658]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell-cell signaling by wnt [GO:0198738]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to osmotic stress [GO:0071470]; cellular response to reactive oxygen species [GO:0034614]; centrosome duplication [GO:0051298]; cilium organization [GO:0044782]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; determination of liver left/right asymmetry [GO:0071910]; embryonic placenta development [GO:0001892]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; liver development [GO:0001889]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric cortex development [GO:0072214]; metanephric cortical collecting duct development [GO:0072219]; metanephric distal tubule development [GO:0072235]; metanephric mesenchyme development [GO:0072075]; metanephric part of ureteric bud development [GO:0035502]; metanephric S-shaped body morphogenesis [GO:0072284]; metanephric smooth muscle tissue development [GO:0072208]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neural tube development [GO:0021915]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of calcium ion import [GO:0090279]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; release of sequestered calcium ion into cytosol [GO:0051209]; renal artery morphogenesis [GO:0061441]; renal tubule morphogenesis [GO:0061333]; sodium ion transmembrane transport [GO:0035725]; spinal cord development [GO:0021510]; Wnt signaling pathway [GO:0016055]" GO:0001658; GO:0001889; GO:0001892; GO:0001947; GO:0002133; GO:0003127; GO:0005102; GO:0005244; GO:0005245; GO:0005248; GO:0005249; GO:0005261; GO:0005267; GO:0005509; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005929; GO:0006816; GO:0006874; GO:0007204; GO:0007259; GO:0007368; GO:0007507; GO:0008092; GO:0008285; GO:0009925; GO:0010628; GO:0015271; GO:0016020; GO:0016055; GO:0016323; GO:0021510; GO:0021915; GO:0022843; GO:0030027; GO:0030659; GO:0031514; GO:0031587; GO:0034614; GO:0034703; GO:0035502; GO:0035725; GO:0035904; GO:0036064; GO:0042127; GO:0042802; GO:0042803; GO:0042805; GO:0042994; GO:0043398; GO:0044325; GO:0044782; GO:0045180; GO:0045429; GO:0045737; GO:0045944; GO:0048763; GO:0050982; GO:0051117; GO:0051209; GO:0051219; GO:0051262; GO:0051289; GO:0051290; GO:0051298; GO:0051371; GO:0051649; GO:0051726; GO:0060170; GO:0060315; GO:0060674; GO:0061333; GO:0061441; GO:0070062; GO:0070588; GO:0071277; GO:0071320; GO:0071458; GO:0071464; GO:0071470; GO:0071498; GO:0071556; GO:0071805; GO:0071910; GO:0072075; GO:0072164; GO:0072177; GO:0072208; GO:0072214; GO:0072218; GO:0072219; GO:0072235; GO:0072284; GO:0072686; GO:0090279; GO:0097730; GO:0098662; GO:0198738; GO:2000134 actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; cation channel activity [GO:0005261]; cytoskeletal protein binding [GO:0008092]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; phosphoprotein binding [GO:0051219]; potassium channel activity [GO:0005267]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated cation channel activity [GO:0022843]; voltage-gated ion channel activity [GO:0005244]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248] DDLEKER 0.99427 -11.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6779 0 0 0 0 0 0 0 0 12.3614 0 0 0 0 0 0 11.8134 10.8093 0 0 0 0 0 11.5394 0 10.8843 0 0 0 0 0 12.8697 0 0 12.3224 13.1055 12.9633 12.9935 11.8331 0 0 0 12.6366 0 0 0 0 0 0 0 0 10.7351 0 0 0 13.9654 13.165 13.7731 14.0209 13.2558 14.0784 0 0 0 0 0 13.1318 0 0 13.2416 0 0 10.9559 0 0 12.1948 0 13.7264 13.5064 0 12.443 0 0 0 0 11.7286 0 0 0 0 0 0 0 0 12.97 0 0 0 0 0 0 0 0 0 13.81 0 0 0 14.2637 13.8068 0 14.1056 0 0 0 0 14.5757 0 0 0 0 Q14232 EI2BA_HUMAN Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha) EIF2B1 EIF2BA Homo sapiens (Human) oligodendrocyte development [GO:0014003]; regulation of catalytic activity [GO:0050790]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743]; oligodendrocyte development [GO:0014003]; regulation of catalytic activity [GO:0050790]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413] GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0005886; GO:0006413; GO:0009408; GO:0009749; GO:0014003; GO:0016020; GO:0042802; GO:0043434; GO:0050790; GO:0050852 identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743] CKKIMIER 0.99427 -28.555 0 0 0 0 10.965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2608 0 0 0 0 0 0 0 12.332 0 0 20.5572 0 0 0 0 0 0 0 0 0 0 0 12.6296 0 13.4552 0 0 0 0 0 13.2175 0 10.9636 0 0 0 0 0 0 0 13.5109 0 0 0 0 0 13.0037 0 0 0 0 0 0 12.9443 12.4783 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5791 0 0 13.7563 0 16.0656 0 0 13.3034 13.5442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RW2 COOA1_HUMAN Collagen alpha-1(XXIV) chain COL24A1 Homo sapiens (Human) extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198] GO:0005201; GO:0005576; GO:0005581; GO:0005615; GO:0005788; GO:0030198; GO:0031012; GO:0062023 extracellular matrix structural constituent [GO:0005201] DLLNCEQK 0.99427 -8.0891 0 0 12 0 0 12.5162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3592 0 0 0 0 0 0 0 0 9.69378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9234 0 0 0 0 0 0 12.3799 0 0 13.2356 0 0 0 0 0 11.9067 0 12.9519 0 14.6568 0 0 0 11.8935 0 13.312 0 13.7181 0 0 0 13.1398 0 0 0 0 13.3603 12.8299 13.3625 12.6121 0 0 0 0 0 0 0 0 0 0 13.7575 0 0 12.7346 0 0 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KP44 ANR55_HUMAN Ankyrin repeat domain-containing protein 55 ANKRD55 Homo sapiens (Human) EDPSILECCDSEGCTPLMHAVSGR 0.99427 -8.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6288 13.8023 0 11.9237 0 0 0 0 0 0 0 0 0 0 0 0 15.85 0 0 0 0 0 0 0 0 0 0 16.0672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5282 0 0 0 0 0 0 0 0 0 0 12.1861 0 0 0 0 0 0 0 0 0 10.7802 15.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6M0 OTU6B_HUMAN "Deubiquitinase OTUD6B, EC 3.4.19.12 (DUBA-5) (OTU domain-containing protein 6B)" OTUD6B DUBA5 CGI-77 Homo sapiens (Human) cell population proliferation [GO:0008283]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]; proteasome assembly [GO:0043248]; protein deubiquitination [GO:0016579] cysteine-type deubiquitinase activity [GO:0004843]; cell population proliferation [GO:0008283]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]; proteasome assembly [GO:0043248]; protein deubiquitination [GO:0016579] GO:0004843; GO:0008283; GO:0016579; GO:0017148; GO:0043248; GO:0045727 cysteine-type deubiquitinase activity [GO:0004843] EKKAALEK 0.99427 -8.0681 0 0 0 0 0 0 0 0 0 0 12.733 11.1804 0 0 0 0 0 0 0 0 0 10.3947 0 0 12.8949 11.2107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4693 0 0 0 0 0 0 13.176 0 0 0 0 10.8921 0 0 0 0 0 0 0 15.5811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.39 12.0452 0 0 0 0 0 0 0 0 0 12.3194 0 0 0 0 0 0 0 0 11.5721 0 0 0 0 12.5166 0 0 0 0 0 13.3041 0 0 11.763 0 0 0 10.9652 0 0 0 0 14.8054 0 0 10.556 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9515 0 13.7477 12.5899 0 13.4962 0 13.5228 12.3952 0 12.8208 0 0 0 0 Q8NHU6 TDRD7_HUMAN "Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2, Trap)" TDRD7 PCTAIRE2BP Homo sapiens (Human) lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; post-transcriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770] chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; P granule [GO:0043186]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; post-transcriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283] GO:0002089; GO:0003729; GO:0005737; GO:0005759; GO:0007283; GO:0010608; GO:0030719; GO:0033391; GO:0034587; GO:0035770; GO:0043186; GO:0047485; GO:0070306 mRNA binding [GO:0003729]; protein N-terminus binding [GO:0047485] AILYAKLPLPTDKIQK 0.99427 -28.516 0 0 0 0 0 9.66315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0249 0 11.8273 0 0 0 16.4216 0 0 0 0 0 0 11.9782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4593 0 13.6636 0 0 0 13.2577 0 11.1056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3967 0 0 0 0 0 13.3645 0 0 11.2549 0 0 0 12.4262 0 0 0 0 10.4932 0 0 0 0 13.1988 13.6945 0 0 12.995 0 13.7347 0 0 0 0 0 0 12.5326 11.1055 0 11.1474 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7017 0 0 0 0 12.022 12.2942 0 0 0 0 0 0 0 12.5984 0 0 0 0 0 0 0 0 0 0 0 Q96QD9 UIF_HUMAN "UAP56-interacting factor (Forty-two-three domain-containing protein 1, Protein 40-2-3)" FYTTD1 UIF Homo sapiens (Human) mRNA export from nucleus [GO:0006406] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406] GO:0003723; GO:0003729; GO:0005654; GO:0006406; GO:0016607 mRNA binding [GO:0003729]; RNA binding [GO:0003723] FGILKEQR 0.99427 -11.343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.462 0 0 0 0 0 0 12.5398 0 0 0 0 0 0 0 0 12.1955 0 0 0 0 0 0 0 12.2579 0 0 0 0 0 0 0 13.3024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5643 0 13.1564 0 13.958 14.3799 0 0 0 0 0 0 13.0031 12.858 0 0 12.5455 0 0 0 0 0 0 0 0 12.7695 12.8893 0 0 0 0 0 0 0 15.1408 14.2368 13.8878 11.0899 0 0 13.1887 15.1273 0 15.1507 13.7306 0 0 0 12.5664 13.0919 13.1346 13.1202 0 0 0 13.9299 0 0 0 0 14.748 15.2365 14.3326 0 15.5546 15.2431 14.0961 15.0409 0 0 0 0 0 14.4427 0 0 13.8098 13.8526 0 0 0 0 0 0 0 0 0 0 13.1748 12.2365 12.7119 0 0 0 0 0 0 0 15.2074 0 0 0 0 0 0 0 Q96RI9 TAAR9_HUMAN "Trace amine-associated receptor 9, TaR-9, Trace amine receptor 9 (Trace amine receptor 3, TaR-3)" TAAR9 TA3 TAR3 TRAR3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0001594; GO:0004930; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594] AIKLIVSGK 0.99427 -5.1923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSJ1 TRI51_HUMAN Tripartite motif-containing protein 51 (SPRY domain-containing protein 5) TRIM51 SPRYD5 Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] KMFCEVDK 0.99427 -9.0835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7425 11.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7958 0 0 0 0 11.8236 0 0 0 0 0 14.3591 0 0 0 0 0 0 0 0 13.4882 0 0 11.5538 0 0 0 0 0 15.9765 0 0 0 14.7974 14.9578 0 0 15.4306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9263 0 0 13.7894 0 14.7585 14.9897 0 0 0 0 0 13.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8079 13.5687 0 12.6521 0 0 12.1323 0 0 0 0 0 0 0 13.6466 0 0 0 12.6104 0 0 0 0 Q9HD67 MYO10_HUMAN Unconventional myosin-X (Unconventional myosin-10) MYO10 KIAA0799 Homo sapiens (Human) cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726] "cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]; cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]" GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002 "actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]" AAQEFLESLNFDEIDECVRNIER 0.99427 -28.546 10.208 0 0 0 0 0 0 0 10.1636 0 10.9396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.73642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0321 0 13.5237 0 0 13.5529 0 16.673 0 0 0 0 0 0 12.5778 14.3418 0 0 17.4055 0 0 10.3712 0 0 0 0 0 0 0 0 0 0 0 12.3462 0 0 0 14.179 0 12.6323 0 12.7215 0 0 0 0 0 0 0 0 0 16.3318 0 12.3602 0 0 0 0 0 0 0 0 15.0325 0 14.1765 0 0 12.5551 13.9072 0 12.7995 0 0 0 0 0 0 10.1917 0 13.4982 0 0 0 12.5067 11.7615 0 11.5958 14.0895 13.8795 0 0 13.9132 0 0 0 0 0 0 0 0 0 0 12.2616 0 0 0 0 0 0 0 0 0 0 0 Q9UKZ1 CNO11_HUMAN CCR4-NOT transcription complex subunit 11 CNOT11 C2orf29 C40 Homo sapiens (Human) gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289] GO:0000289; GO:0005634; GO:0005829; GO:0006402; GO:0017148; GO:0030014; GO:0031047 EAAGLFRLLK 0.99427 -8.0733 0 0 0 0 0 0 0 0 0 0 14.517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3368 0 0 0 0 13.1619 0 0 0 0 0 0 0 0 13.6937 0 13.2002 0 0 0 0 0 0 0 0 0 12.5833 0 0 0 0 0 0 0 0 0 0 0 11.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1833 0 0 0 0 0 0 0 0 15.0756 15.1757 0 13.5413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1046 0 0 0 15.3284 0 15.3968 0 0 0 0 0 0 0 0 15.3579 15.5239 0 0 14.9251 0 0 0 0 0 0 0 0 0 12.0842 0 0 0 0 0 0 0 0 0 0 0 14.2845 0 0 0 0 0 0 0 0 0 14.5195 0 11.8068 0 0 0 0 Q9Y2I6 NINL_HUMAN Ninein-like protein NINL KIAA0980 NLP Homo sapiens (Human) microtubule anchoring at centrosome [GO:0034454] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630] centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; calcium ion binding [GO:0005509]; microtubule anchoring at centrosome [GO:0034454] GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0015630; GO:0034454; GO:0045171 calcium ion binding [GO:0005509] ALEKHVDLRENDR 0.99427 -8.1024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1553 0 12.8438 0 0 0 0 0 0 0 0 0 0 11.6775 11.5367 12.3486 11.9823 11.765 0 0 0 0 0 0 11.7292 0 0 0 0 0 0 12.9173 0 0 0 0 0 0 0 0 0 0 12.002 0 12.5319 13.501 13.4876 0 0 0 0 0 0 0 0 0 0 14.656 0 0 13.6715 13.2091 13.9978 0 16.1577 0 0 0 0 0 0 0 0 11.955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y421 FA32A_HUMAN "Protein FAM32A (Ovarian tumor-associated gene 12, OTAG-12)" FAM32A OTAG12 CGI-144 Homo sapiens (Human) apoptotic process [GO:0006915]; cell cycle [GO:0007049] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; cell cycle [GO:0007049] GO:0003723; GO:0005654; GO:0005730; GO:0006915; GO:0007049 RNA binding [GO:0003723] ASKTHKQR 0.99427 -8.58 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3319 13.8198 13.831 0 0 0 0 0 0 0 0 0 0 0 12.3414 0 0 0 12.6001 0 12.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9362 0 0 0 13.7812 0 0 13.7091 0 0 13.6019 0 0 0 12.5798 0 0 0 0 12.79 0 0 0 14.0788 0 0 0 0 14.6358 13.755 0 13.4486 0 0 0 0 0 14.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0993 14.3563 0 0 0 0 0 0 0 A6NKX4 S22AV_HUMAN Putative solute carrier family 22 member 31 SLC22A31 Homo sapiens (Human) ion transport [GO:0006811] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811] GO:0006811; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] AAGGFGR 0.99428 -8.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9539 0 0 0 0 0 13.6703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2557 0 0 0 0 0 0 0 0 15.0713 0 13.6975 0 0 0 0 0 0 0 0 0 0 0 12.4589 0 0 0 0 0 0 0 0 0 0 0 0 13.5748 0 0 0 15.8348 0 0 0 14.0135 0 0 11.8315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60678 ANM3_HUMAN "Protein arginine N-methyltransferase 3, EC 2.1.1.319 (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3)" PRMT3 HRMT1L3 Homo sapiens (Human) "dendritic spine morphogenesis [GO:0060997]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]" cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; modified amino acid binding [GO:0072341]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; ribosome binding [GO:0043022]; dendritic spine morphogenesis [GO:0060997]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]" GO:0005737; GO:0005829; GO:0006479; GO:0008168; GO:0016274; GO:0019919; GO:0031397; GO:0035241; GO:0035242; GO:0043022; GO:0046872; GO:0060997; GO:0072341; GO:1900053 metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; modified amino acid binding [GO:0072341]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; ribosome binding [GO:0043022] ITRTSMCTAIAGYFDIYFEKNCHNR 0.99428 -8.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4437 11.3678 0 0 0 0 12.399 0 0 0 0 13.1065 0 0 0 0 10.441 0 0 0 0 0 0 13.9433 0 0 0 0 0 12.3197 15.5566 0 0 0 0 0 0 0 12.0709 0 0 14.8033 0 0 0 0 0 0 0 0 0 14.4546 14.3372 0 0 0 0 13.7723 14.2457 13.0216 12.3159 0 0 0 0 0 14.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.583 15.2747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1659 0 0 13.522 0 0 O75192 PX11A_HUMAN "Peroxisomal membrane protein 11A, HsPEX11p (28 kDa peroxisomal integral membrane protein, PMP28) (Peroxin-11A) (Peroxisomal biogenesis factor 11A) (Protein PEX11 homolog alpha, PEX11-alpha)" PEX11A PEX11 Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; regulation of peroxisome size [GO:0044375]; signal transduction [GO:0007165] integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991] integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein homodimerization activity [GO:0042803]; brown fat cell differentiation [GO:0050873]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; regulation of peroxisome size [GO:0044375]; signal transduction [GO:0007165] GO:0005777; GO:0005778; GO:0005779; GO:0007031; GO:0007165; GO:0016557; GO:0016559; GO:0032991; GO:0042803; GO:0044375; GO:0050873 protein homodimerization activity [GO:0042803] AAHHYYYSLLLSLVRDLYEISLQMK 0.99428 -9.3834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8696 0 0 0 0 0 0 0 12.1856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1887 0 0 0 O75534 CSDE1_HUMAN Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) "CRD-mediated mRNA stabilization [GO:0070934]; IRES-dependent viral translational initiation [GO:0075522]; male gonad development [GO:0008584]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; stress granule assembly [GO:0034063]" CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mCRD-mediated mRNA stability complex [GO:0106002]; P-body [GO:0000932]; plasma membrane [GO:0005886] "CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mCRD-mediated mRNA stability complex [GO:0106002]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; CRD-mediated mRNA stabilization [GO:0070934]; IRES-dependent viral translational initiation [GO:0075522]; male gonad development [GO:0008584]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; stress granule assembly [GO:0034063]" GO:0000932; GO:0003723; GO:0005794; GO:0005829; GO:0005886; GO:0006446; GO:0008584; GO:0010494; GO:0034063; GO:0035613; GO:0070934; GO:0070937; GO:0070966; GO:0075522; GO:0106002; GO:1900152; GO:2000767 RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613] EAEDGIIAYDDCGVK 0.99428 -30.971 0 0 0 0 0 0 11.8746 10.2259 0 0 0 13.6004 0 0 0 0 0 0 0 13.7819 0 0 0 0 0 0 14.9995 0 11.2846 0 0 0 0 0 0 11.5474 0 0 0 0 0 0 0 0 12.0931 0 0 0 0 0 0 0 0 0 0 0 0 13.6014 0 0 0 0 0 0 0 0 11.2966 0 0 0 0 0 0 0 12.7389 0 0 0 13.3168 0 11.743 0 0 0 12.7099 13.727 11.7195 13.184 0 13.5339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.241 0 12.4668 0 0 0 0 0 0 0 0 0 11.2517 0 0 0 0 0 0 12.5541 0 0 0 12.3554 0 0 0 0 14.9052 11.0927 12.5342 0 0 0 0 0 0 12.2267 0 0 0 0 0 0 0 0 13.0216 0 0 0 0 0 10.8147 0 0 0 0 0 0 0 0 0 0 0 0 11.0676 0 0 0 0 0 13.2243 0 P59051 BRAS2_HUMAN Putative uncharacterized protein encoded by BRWD1-AS2 (ATP1A1 antisense RNA 1) (ATP1A1 antisense gene protein 1) (BRWD1 intronic transcript 2) BRWD1-AS2 BRWD1-IT2 C21orf87 NCRNA00257 Homo sapiens (Human) ATLPNPR 0.99428 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6735 0 0 0 0 0 0 0 0 13.9371 13.7505 0 13.8966 13.7962 0 0 0 0 13.9325 0 13.7139 0 0 Q14766 LTBP1_HUMAN "Latent-transforming growth factor beta-binding protein 1, LTBP-1 (Transforming growth factor beta-1-binding protein 1, TGF-beta1-BP-1)" LTBP1 Homo sapiens (Human) regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991] collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; regulation of transforming growth factor beta activation [GO:1901388]; sequestering of TGFbeta in extracellular matrix [GO:0035583] GO:0001527; GO:0005024; GO:0005509; GO:0005576; GO:0005788; GO:0031012; GO:0032991; GO:0035583; GO:0050431; GO:0050436; GO:0062023; GO:1901388 calcium ion binding [GO:0005509]; microfibril binding [GO:0050436]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024] ALGTHVIHSTHTLPLTVTSQQGVKVKFPPNIVNIHVK 0.99428 -30.864 0 0 0 0 0 0 0 0 0 12.779 10.2366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3641 0 12.3418 12.1401 0 0 0 10.4821 0 0 0 0 0 10.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6717 0 12.5936 0 0 13.113 0 0 10.2582 11.9362 0 13.6371 14.2122 12.5168 16.8556 16.9012 11.1532 10.8373 0 11.1194 0 0 21.0026 11.7692 0 12.7615 0 0 0 14.2967 11.0075 13.9499 0 13.4045 0 13.29 0 0 0 0 12.1465 0 12.1229 12.0017 0 13.2284 11.9511 0 0 10.7077 0 0 11.3761 0 0 13.3791 11.8534 12.8099 0 0 12.1744 12.9773 13.1756 12.3993 0 13.3233 13.6833 0 0 13.6344 14.0223 0 0 11.1696 0 0 0 0 0 0 0 12.0952 0 0 0 0 0 13.2567 0 17.668 18.252 0 14.6997 18.4626 18.9591 19.7665 0 0 13.4649 11.5163 0 0 0 0 0 0 13.719 18.6174 0 0 0 Q16513 PKN2_HUMAN "Serine/threonine-protein kinase N2, EC 2.7.11.13 (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2)" PKN2 PRK2 PRKCL2 Homo sapiens (Human) apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165] apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium-dependent protein kinase C activity [GO:0004698]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165] GO:0003723; GO:0004672; GO:0004674; GO:0004698; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0010631; GO:0016301; GO:0016604; GO:0018105; GO:0030027; GO:0030030; GO:0030496; GO:0031267; GO:0032154; GO:0032467; GO:0032991; GO:0035556; GO:0042826; GO:0043296; GO:0043297; GO:0045070; GO:0045111; GO:0045296; GO:0045931; GO:0048471; GO:0051301; GO:0070063; GO:0106310; GO:2000145 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium-dependent protein kinase C activity [GO:0004698]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; small GTPase binding [GO:0031267] DLKLDNLLLDTEGFVKIADFGLCK 0.99428 -36.499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6275 0 0 13.9971 14.5634 0 0 0 13.9053 0 13.4728 11.7377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1773 10.578 0 0 0 0 0 0 10.8174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4227 12.9645 16.6376 16.3405 16.2577 16.2332 16.747 0 0 0 0 16.5361 16.5239 17.6963 16.4348 16.4227 16.1887 16.3274 14.1497 12.4521 0 13.9461 0 15.5269 16.3487 0 14.5868 14.3487 14.8877 0 13.2481 0 16.4408 0 0 0 13.4268 0 0 0 13.787 15.6959 15.1951 12.7319 0 14.7521 14.8325 13.1207 0 13.4712 0 13.9871 0 12.9836 11.1302 0 0 0 0 0 12.2316 0 13.1309 0 0 0 0 0 0 0 12.5886 0 0 0 0 16.5157 0 0 0 0 0 0 0 12.1896 11.5518 0 0 0 0 0 0 0 13.6445 13.186 0 0 0 0 12.4674 0 Q5JRA6 TGO1_HUMAN "Transport and Golgi organization protein 1 homolog, TANGO1 (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3)" MIA3 KIAA0268 TANGO UNQ6077/PRO20088 Homo sapiens (Human) cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; cargo receptor activity [GO:0038024]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060] GO:0002042; GO:0002687; GO:0005788; GO:0005789; GO:0006887; GO:0006888; GO:0007029; GO:0007162; GO:0009306; GO:0015031; GO:0016020; GO:0016021; GO:0030336; GO:0035459; GO:0038024; GO:0042060; GO:0042953; GO:0043231; GO:0070971; GO:0070973; GO:0090110; GO:0140052; GO:1903038; GO:2000402 cargo receptor activity [GO:0038024] AAAPGLLVWLLVLR 0.99428 -36.298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1814 0 0 10.6006 0 0 0 0 0 0 0 0 0 0 10.0945 0 0 13.852 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1217 0 0 0 14.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9942 13.1505 0 13.5823 0 0 0 0 0 11.2169 0 0 0 14.5436 0 0 0 0 0 0 0 0 0 0 0 12.3091 13.2146 0 0 0 15.6873 13.7068 0 11.421 11.7843 0 0 0 0 0 0 11.538 11.5578 0 0 0 0 0 10.7337 0 17.9505 11.9889 0 0 14.6793 12.375 0 0 0 0 14.3108 0 13.1169 0 0 0 0 0 0 0 13.9676 0 0 11.5208 0 0 0 0 0 0 0 11.1772 0 0 0 0 0 13.7011 0 0 0 0 13.7159 0 12.4097 0 0 0 0 0 0 0 0 0 0 0 10.7929 0 0 0 0 0 0 Q5SY16 NOL9_HUMAN "Polynucleotide 5'-hydroxyl-kinase NOL9, EC 2.7.1.- (Nucleolar protein 9)" NOL9 Homo sapiens (Human) "cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; phosphorylation [GO:0016310]; RNA processing [GO:0006396]" intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]; phosphorylation [GO:0016310]; RNA processing [GO:0006396]" GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006396; GO:0016020; GO:0016310; GO:0045111; GO:0051731 ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723] ADSGLLLK 0.99428 -8.6319 0 0 0 0 0 0 0 0 13.6004 0 13.2295 13.393 0 12.9067 0 13.6917 0 0 0 0 0 0 12.3418 0 0 12.8726 13.4358 12.1173 13.0465 0 0 0 0 13.4821 0 13.4105 0 0 0 0 0 14.5888 0 0 0 0 0 0 13.4277 0 0 12.9594 12.8455 0 0 0 11.606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2286 0 11.6866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8546 0 0 0 11.8831 0 0 0 13.3302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0465 0 0 0 0 14.1951 0 0 0 0 0 15.3436 0 0 0 0 14.009 0 14.4538 13.9753 14.1626 15.0494 0 0 0 0 0 14.5559 0 0 0 0 0 14.8892 0 14.4573 0 0 Q7RTM1 OTOP1_HUMAN "Proton channel OTOP1 (Otopetrin-1, hOtop1)" OTOP1 Homo sapiens (Human) biomineral tissue development [GO:0031214]; cellular response to insulin stimulus [GO:0032869]; detection of gravity [GO:0009590]; inner ear morphogenesis [GO:0042472]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; proton transmembrane transport [GO:1902600] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; proton channel activity [GO:0015252]; biomineral tissue development [GO:0031214]; cellular response to insulin stimulus [GO:0032869]; detection of gravity [GO:0009590]; inner ear morphogenesis [GO:0042472]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; proton transmembrane transport [GO:1902600] GO:0005887; GO:0009590; GO:0015252; GO:0016021; GO:0031214; GO:0032869; GO:0042472; GO:0060336; GO:1902600 proton channel activity [GO:0015252] ESHDKEEEK 0.99428 -9.3755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0504 0 13.2435 11.5205 0 0 0 0 0 0 0 0 12.4439 0 0 0 0 0 0 0 0 0 0 0 0 12.6358 0 0 0 0 0 0 0 12.572 0 0 0 0 0 0 0 0 0 11.5065 0 0 0 0 0 0 0 13.7859 13.2669 12.5936 11.1549 0 0 0 0 0 0 0 0 0 0 0 0 13.2935 0 0 11.9314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6877 13.7461 0 0 0 0 0 0 Q7Z3E1 PARPT_HUMAN "Protein mono-ADP-ribosyltransferase TIPARP, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 14, ARTD14) (Poly [ADP-ribose] polymerase 7, PARP-7) (TCDD-inducible poly [ADP-ribose] polymerase)" TIPARP PARP7 Homo sapiens (Human) androgen metabolic process [GO:0008209]; cellular response to organic cyclic compound [GO:0071407]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570] nucleus [GO:0005634] nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; androgen metabolic process [GO:0008209]; cellular response to organic cyclic compound [GO:0071407]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570] GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0006471; GO:0008209; GO:0008210; GO:0008585; GO:0009791; GO:0010629; GO:0030097; GO:0045732; GO:0046872; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0070213; GO:0071407; GO:0140289; GO:1990404 cis-regulatory region sequence-specific DNA binding [GO:0000987]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404] EYMNRKMFGR 0.99428 -8.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9174 0 0 0 0 0 0 12.0213 0 0 0 0 0 0 0 0 0 0 0 0 13.0809 13.2892 0 0 0 0 0 0 0 0 0 0 0 11.432 0 0 0 0 0 0 0 0 0 0 0 12.677 0 0 12.4935 0 0 0 0 0 0 12.3628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7925 0 0 0 0 0 0 0 12.2081 0 0 0 0 0 0 0 0 0 12.2902 0 0 0 0 0 0 0 0 0 0 0 12.7415 0 15.0418 Q7Z4T9 CFA91_HUMAN "Cilia- and flagella-associated protein 91, CFAP91 (AMY-1-associating protein expressed in testis 1, AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1)" CFAP91 AAT1 C3orf15 MAATS1 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; cell differentiation [GO:0030154]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283] axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514] axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; cell differentiation [GO:0030154]; cilium movement [GO:0003341]; spermatogenesis [GO:0007283] GO:0003341; GO:0005739; GO:0005930; GO:0007283; GO:0030154; GO:0031514; GO:1904158 AEKQVTLALQRQR 0.99428 -31.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4396 10.5425 12.3619 0 0 0 0 0 14.6878 12.9757 14.0768 0 0 0 0 0 0 14.738 0 0 0 0 0 14.4387 11.5852 0 0 0 0 0 11.225 12.9819 0 0 0 0 0 0 0 13.1172 0 13.5369 13.8314 11.8658 12.4503 11.9401 0 0 12.0226 14.1293 13.9827 12.3553 0 0 12.3903 0 0 0 0 12.3408 0 12.1894 12.304 0 14.5075 0 13.9819 0 0 0 13.6524 0 12.9605 12.3845 0 0 13.5662 13.3595 0 13.1999 0 0 0 0 0 13.0026 0 0 0 0 14.5112 0 10.9915 0 0 0 0 0 0 0 11.4038 0 0 0 0 0 0 13.7483 14.5035 13.5016 0 0 0 0 0 Q8IXW0 LMTD2_HUMAN Lamin tail domain-containing protein 2 LMNTD2 C11orf35 Homo sapiens (Human) regulation of chromatin assembly [GO:0010847] lamin filament [GO:0005638] lamin filament [GO:0005638]; structural constituent of chromatin [GO:0030527]; regulation of chromatin assembly [GO:0010847] GO:0005638; GO:0010847; GO:0030527 structural constituent of chromatin [GO:0030527] EPRVSRR 0.99428 -36.267 0 0 0 0 0 0 0 0 0 0 15.0326 0 14.8227 0 0 0 0 0 0 0 0 0 0 0 0 13.886 0 0 13.8878 13.4503 0 0 0 0 0 0 0 0 0 0 12.1879 0 0 10.9094 10.2604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8187 16.3612 0 0 0 11.7476 12.9997 0 0 0 0 0 14.0252 14.8119 14.07 13.5927 14.0175 14.2608 0 0 0 0 0 14.0467 0 0 0 0 12.2687 0 0 12.8187 13.5765 0 0 11.8762 0 15.1846 0 0 14.9282 0 0 11.9127 12.8427 16.57 0 14.3085 0 0 0 14.118 15.1822 0 14.0592 0 0 0 0 19.632 0 12.4189 0 0 12.4609 0 15.4263 0 0 13.0628 0 10.7306 0 14.7415 13.0397 0 15.4105 0 11.9596 15.6689 0 16.539 11.7091 12.335 0 0 0 0 0 0 16.024 0 0 13.5612 0 0 0 0 0 0 0 0 14.2609 Q8N6Q3 CD177_HUMAN "CD177 antigen (Human neutrophil alloantigen 2a, HNA-2a) (NB1 glycoprotein, NB1 GP) (Polycythemia rubra vera protein 1, PRV-1) (CD antigen CD177)" CD177 NB1 PRV1 UNQ595/PRO1181 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction maintenance [GO:0045217]; innate immune response [GO:0045087]; leukocyte cell-cell adhesion [GO:0007159]; neutrophil extravasation [GO:0072672]; neutrophil migration [GO:1990266]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of superoxide anion generation [GO:0032930]; protein localization to cell surface [GO:0034394]; regulation of endocytosis [GO:0030100]; regulation of integrin-mediated signaling pathway [GO:2001044] anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; protease binding [GO:0002020]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction maintenance [GO:0045217]; innate immune response [GO:0045087]; leukocyte cell-cell adhesion [GO:0007159]; neutrophil extravasation [GO:0072672]; neutrophil migration [GO:1990266]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of superoxide anion generation [GO:0032930]; protein localization to cell surface [GO:0034394]; regulation of endocytosis [GO:0030100]; regulation of integrin-mediated signaling pathway [GO:2001044] GO:0002020; GO:0005178; GO:0005886; GO:0007155; GO:0007159; GO:0030027; GO:0030100; GO:0030667; GO:0032930; GO:0034394; GO:0035579; GO:0043315; GO:0044853; GO:0045087; GO:0045217; GO:0046658; GO:0048306; GO:0070062; GO:0070821; GO:0072672; GO:0098742; GO:1990266; GO:2001044 calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; protease binding [GO:0002020] DFLTCHR 0.99428 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9082 0 0 0 0 0 0 0 12.049 0 0 0 0 0 0 0 0 0 Q8N8E3 CE112_HUMAN "Centrosomal protein of 112 kDa, Cep112 (Coiled-coil domain-containing protein 46)" CEP112 CCDC46 Homo sapiens (Human) receptor localization to synapse [GO:0097120] centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120] GO:0005737; GO:0005813; GO:0005886; GO:0060077; GO:0097120 AANMEHENQIQEFKK 0.99428 -15.506 0 0 0 0 0 0 10.9077 0 0 12.7181 0 0 13.061 13.2656 0 0 0 0 0 0 0 0 0 0 0 9.59184 0 0 0 0 0 0 0 0 13.1827 0 0 0 0 12.503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.873 13.8638 14.045 14.4619 13.6564 0 14.5598 13.7653 13.1548 0 0 0 12.7903 0 0 11.6562 0 13.3476 0 13.0114 0 16.4778 16.9115 0 0 17.1431 15.4242 13.056 13.3418 13.1721 0 0 0 13.6668 16.2281 0 0 0 0 0 0 15.1287 0 0 14.8541 0 0 0 0 0 16.3688 0 0 0 0 10.8661 0 0 0 12.2782 15.1675 0 0 0 0 0 0 0 0 0 11.4381 0 0 12.0347 14.6468 0 0 0 0 12.3708 13.8072 0 12.841 0 0 0 16.6697 0 0 0 0 13.963 0 0 0 0 14.0842 13.045 0 0 0 0 0 13.6218 0 12.0123 0 16.4485 9.47897 0 0 0 12.8582 0 Q96BT7 ALKB8_HUMAN "Alkylated DNA repair protein alkB homolog 8 (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8, EC 2.1.1.229)" ALKBH8 ABH8 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098] GO:0000049; GO:0002098; GO:0005506; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006974; GO:0008270; GO:0016300; GO:0016604; GO:0016706; GO:0030488; GO:0106335 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; tRNA (carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] GNRNSQGKK 0.99428 -28.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5093 13.7869 13.1325 0 13.6108 13.0587 0 0 0 0 13.1893 13.9989 0 13.2793 14.0566 0 0 0 0 0 0 0 0 0 0 12.7252 0 14.2415 0 0 0 14.8475 13.3464 0 0 0 10.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2979 0 0 13.1849 15.2597 0 0 0 0 0 0 0 14.9152 0 14.3184 0 0 14.746 0 0 16.1337 0 0 0 0 0 15.0589 0 0 10.6767 10.4493 0 0 15.4429 0 0 0 0 0 0 0 12.6556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.789 0 14.5445 0 0 0 0 0 0 0 9.19704 0 14.5787 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7893 15.1677 0 0 0 0 0 0 0 0 Q96DF8 ESS2_HUMAN "Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H, DGS-H) (Protein ES2)" ESS2 DGCR13 DGCR14 DGSH DGSI ES2 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]" catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]" GO:0000398; GO:0005634; GO:0007399; GO:0071013 AKNSLMYYPEGVPDEEQLFKK 0.99428 -8.3843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0281 0 0 0 11.5763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3179 0 0 0 0 0 0 0 0 0 0 12.8385 0 14.2262 14.3228 0 0 13.1974 12.6159 12.1924 0 0 0 11.9562 0 0 0 0 0 11.9638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6167 0 0 0 0 0 0 Q96PX6 CC85A_HUMAN Coiled-coil domain-containing protein 85A CCDC85A KIAA1912 Homo sapiens (Human) adherens junction [GO:0005912] adherens junction [GO:0005912] GO:0005912 DLCCFLDDDRQK 0.99428 -8.1367 0 0 0 0 0 0 0 11.7582 11.3884 0 0 0 0 0 0 0 0 11.2032 0 0 0 0 11.1082 0 0 10.3992 0 0 9.34589 0 0 0 0 0 0 0 0 0 0 0 0 11.4975 0 0 11.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4815 0 0 0 0 0 0 0 0 0 0 0 0 14.1629 0 0 0 0 0 0 0 0 0 11.3634 11.8403 0 0 0 0 0 14.647 0 0 0 0 0 0 0 0 9.80453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8568 0 0 0 0 12.088 0 0 0 0 11.8974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1894 0 13.2107 12.8759 13.1942 0 0 15.0271 13.5168 0 0 0 0 13.496 0 0 0 0 13.5109 0 12.7053 0 0 Q9BVQ7 SPA5L_HUMAN "Ribosome biogenesis protein SPATA5L1, EC 3.6.4.10 (Spermatogenesis-associated protein 5-like protein 1)" SPATA5L1 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273] cytoplasm [GO:0005737]; spindle [GO:0005819] cytoplasm [GO:0005737]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275]; ribosomal large subunit biogenesis [GO:0042273] GO:0005524; GO:0005737; GO:0005819; GO:0016887; GO:0042273; GO:1990275 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275] ALTALGLAVPRGVLLAGPPGVGK 0.99428 -15.506 0 0 0 13.9686 13.5282 13.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8926 0 16.5269 13.7541 0 0 0 0 13.0749 16.3719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.176 12.2463 0 0 0 0 0 0 0 0 12.1927 14.5065 0 0 0 14.7686 13.0749 13.2184 13.5331 0 13.0343 15.4965 0 12.1332 0 12.8034 13.2085 0 13.8755 10.8281 0 12.852 0 0 13.0349 13.1605 13.8003 13.9887 14.141 13.4189 12.3571 14.0577 14.3545 0 0 0 12.0612 0 0 0 0 0 14.0622 12.2612 0 0 0 13.535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9944 14.3355 0 0 0 0 0 0 Q9H6K5 PRR36_HUMAN Proline-rich protein 36 PRR36 Homo sapiens (Human) AAGTEVGLPR 0.99428 -12.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.299 0 0 0 0 0 0 0 0 0 15.556 0 0 0 0 0 0 0 0 0 0 0 0 12.2097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8044 0 17.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8M5 CNNM2_HUMAN Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2) CNNM2 ACDP2 Homo sapiens (Human) magnesium ion homeostasis [GO:0010960] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857]; magnesium ion homeostasis [GO:0010960] GO:0005524; GO:0005886; GO:0010960; GO:0015095; GO:0016021; GO:0016323; GO:0022857; GO:0043231 ATP binding [GO:0005524]; magnesium ion transmembrane transporter activity [GO:0015095]; transmembrane transporter activity [GO:0022857] ANHSLHNEGAI 0.99428 -36.346 0 0 0 0 0 0 0 0 0 0 0 0 15.0737 0 0 0 0 13.9399 0 0 14.439 0 13.6584 0 14.5067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2109 0 0 0 0 0 0 0 0 0 13.9866 0 13.7057 0 0 0 0 0 0 0 0 13.5968 0 13.8024 0 0 0 0 0 0 0 0 0 0 13.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB19 PKHA2_HUMAN "Pleckstrin homology domain-containing family A member 2, PH domain-containing family A member 2 (Tandem PH domain-containing protein 2, TAPP-2)" PLEKHA2 TAPP2 Homo sapiens (Human) positive regulation of cell-matrix adhesion [GO:0001954] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; positive regulation of cell-matrix adhesion [GO:0001954]" GO:0001954; GO:0001968; GO:0005634; GO:0005737; GO:0005886; GO:0008289; GO:0016020; GO:0030165; GO:0032991; GO:0043236; GO:0043325 "fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]" PPLEEKK 0.99428 -30.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6673 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7515 0 0 13.5694 13.5479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCK0 ZBT26_HUMAN Zinc finger and BTB domain-containing protein 26 (Zinc finger protein 481) (Zinc finger protein Bioref) ZBTB26 KIAA1572 ZNF481 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0042802; GO:0046872; GO:1990837 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DQFLLNDSR 0.99428 -7.8723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3272 0 0 0 0 0 0 0 0 11.9992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2491 0 0 0 0 0 0 0 0 0 0 Q9NYP3 DONS_HUMAN Protein downstream neighbor of Son (B17) DONSON C21orf60 Homo sapiens (Human) DNA damage checkpoint signaling [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478] nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894] nucleus [GO:0005634]; replication fork [GO:0005657]; replisome [GO:0030894]; DNA damage checkpoint signaling [GO:0000077]; DNA replication [GO:0006260]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; nuclear DNA replication [GO:0033260]; replication fork protection [GO:0048478] GO:0000077; GO:0005634; GO:0005657; GO:0006260; GO:0007095; GO:0030894; GO:0033260; GO:0048478 AAGLAGSDLITALISPTTRGLREAMR 0.99428 -7.871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6547 0 0 0 0 0 0 17.7743 17.4414 0 0 0 0 0 0 0 0 0 0 0 10.9475 0 11.1486 0 0 0 0 0 10.9731 0 14.4797 0 13.4679 0 0 0 15.2129 0 12.7364 0 0 13.9704 0 0 0 14.2108 0 12.2562 13.8622 12.2081 0 17.7916 0 0 0 0 0 0 0 0 0 0 0 0 11.6131 0 0 0 0 0 13.1697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0277 0 0 0 0 0 0 0 0 0 19.1648 14.7469 0 0 0 0 0 14.6209 0 0 11.8246 0 0 0 0 0 0 0 0 0 0 0 13.4031 0 0 0 0 0 0 0 20.5686 0 0 0 0 14.0052 0 Q9P2V4 LRIT1_HUMAN "Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 (Leucine-rich repeat-containing protein 21) (Photoreceptor-associated LRR superfamily protein) (Retina-specific protein PAL)" LRIT1 LRRC21 PAL Homo sapiens (Human) integral component of endoplasmic reticulum membrane [GO:0030176] integral component of endoplasmic reticulum membrane [GO:0030176] GO:0030176 AGPSEAR 0.99428 -31.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2077 13.2195 0 0 0 0 0 0 0 0 0 0 0 11.8278 0 0 0 0 0 0 9.87704 0 0 0 0 9.75225 0 12.0594 0 0 0 0 0 0 0 0 0 11.0719 0 0 0 0 0 0 0 0 0 0 0 11.9438 16.9193 12.0373 14.6799 0 0 14.5941 13.5418 0 11.7413 12.2499 12.6261 13.4694 0 0 0 0 18.051 0 0 0 0 0 11.8593 0 0 0 12.0268 13.4905 0 13.6648 0 0 0 0 0 0 0 13.5867 0 0 0 0 15.2434 12.1515 0 0 12.848 12.1446 0 11.9739 0 12.1473 0 12.9421 0 13.088 13.0928 0 17.8054 0 0 0 17.4242 0 0 11.6158 0 0 0 0 0 0 0 0 11.6026 12.2758 0 12.9399 0 0 0 11.201 0 11.1284 0 0 0 0 0 0 0 0 11.4006 0 0 0 0 0 10.9805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UI95 MD2L2_HUMAN "Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2, MAD2-like protein 2) (REV7 homolog, hREV7)" MAD2L2 MAD2B REV7 Homo sapiens (Human) "actin filament organization [GO:0007015]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; error-prone translesion synthesis [GO:0042276]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247]" chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035] "chromatin [GO:0000785]; chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035]; JUN kinase binding [GO:0008432]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; actin filament organization [GO:0007015]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; error-prone translesion synthesis [GO:0042276]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell growth [GO:0001558]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247]" GO:0000122; GO:0000785; GO:0001558; GO:0002208; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005819; GO:0005829; GO:0006302; GO:0007015; GO:0007094; GO:0008432; GO:0010719; GO:0010944; GO:0016035; GO:0033138; GO:0035861; GO:0042177; GO:0042276; GO:0042772; GO:0043247; GO:0043433; GO:0045830; GO:0045893; GO:0051301; GO:0061629; GO:0090090; GO:1904667; GO:2000042; GO:2000048; GO:2000678; GO:2001034 JUN kinase binding [GO:0008432]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] EHRPVEK 0.99428 -8.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8139 0 0 0 12.3285 0 0 0 0 0 0 0 0 0 0 0 11.8192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1185 0 0 0 14.0092 0 0 0 0 11.4554 0 0 0 0 0 0 0 0 0 0 0 0 14.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8627 0 0 0 0 0 0 0 0 13.7496 Q9UL52 TM11E_HUMAN "Transmembrane protease serine 11E, EC 3.4.21.- (Serine protease DESC1) (Transmembrane protease serine 11E2) [Cleaved into: Transmembrane protease serine 11E non-catalytic chain; Transmembrane protease serine 11E catalytic chain ]" TMPRSS11E DESC1 TMPRSS11E2 UNQ742/PRO1461 Homo sapiens (Human) cognition [GO:0050890]; proteolysis [GO:0006508] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cognition [GO:0050890]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005886; GO:0005887; GO:0006508; GO:0008236; GO:0050890 serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] FSQQKHGVLAHMLLICR 0.99428 -9.358 12.0317 0 0 0 11.931 0 0 11.8533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3478 0 0 0 0 15.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3283 0 0 0 0 0 0 0 0 0 0 0 0 11.7235 0 0 0 0 0 15.6329 0 15.2093 14.4781 0 0 0 15.3396 0 0 0 0 0 0 0 0 0 0 0 0 12.4416 0 0 0 0 0 0 0 0 0 0 0 11.3922 0 15.009 15.1679 0 0 0 0 12.4739 14.85 0 0 0 0 11.9086 0 0 0 0 17.6618 0 0 0 0 0 11.9924 11.228 0 12.6858 0 0 0 0 13.025 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NEH6 TM247_HUMAN Transmembrane protein 247 TMEM247 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] GO:0005783; GO:0016021 MVPGDSK 0.99429 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14791 APOL1_HUMAN "Apolipoprotein L1 (Apolipoprotein L, Apo-L, ApoL) (Apolipoprotein L-I, ApoL-I)" APOL1 APOL Homo sapiens (Human) chloride transmembrane transport [GO:1902476]; cholesterol metabolic process [GO:0008203]; cytolysis by host of symbiont cells [GO:0051838]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intrinsic component of membrane [GO:0031224]; very-low-density lipoprotein particle [GO:0034361] blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intrinsic component of membrane [GO:0031224]; very-low-density lipoprotein particle [GO:0034361]; chloride channel activity [GO:0005254]; lipid binding [GO:0008289]; chloride transmembrane transport [GO:1902476]; cholesterol metabolic process [GO:0008203]; cytolysis by host of symbiont cells [GO:0051838]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] GO:0005254; GO:0005576; GO:0005615; GO:0005788; GO:0006869; GO:0008203; GO:0008289; GO:0031224; GO:0034361; GO:0034364; GO:0042157; GO:0045087; GO:0051838; GO:0072562; GO:1902476 chloride channel activity [GO:0005254]; lipid binding [GO:0008289] DIRALRR 0.99429 -11.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.18 13.7524 13.9911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.935 0 14.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2682 0 O95427 PIGN_HUMAN "GPI ethanolamine phosphate transferase 1, EC 2.-.-.- (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein, PIG-N)" PIGN MCD4 Homo sapiens (Human) GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; mannose-ethanolamine phosphotransferase activity [GO:0051377]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0016021; GO:0016254; GO:0051377 mannose-ethanolamine phosphotransferase activity [GO:0051377] AESMFTNAVQILEQFKVK 0.99429 -36.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8423 0 0 0 0 0 14.2144 0 0 0 0 0 0 0 0 0 0 0 15.9263 0 0 0 14.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0005 0 0 0 0 15.3265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10243 MYBA_HUMAN "Myb-related protein A, A-Myb (Myb-like protein 1)" MYBL1 AMYB Homo sapiens (Human) "cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; mitotic cell cycle [GO:0000278]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000278; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0006355; GO:0007141; GO:0007283; GO:0010529; GO:0030154; GO:0045893; GO:0045944; GO:1990511 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FSTPPAILR 0.99429 -13.009 0 14.0223 0 0 0 0 0 0 0 0 0 0 0 0 11.9316 0 0 12.3501 0 0 0 0 0 0 0 0 0 0 0 0 12.7675 0 11.2757 0 0 0 12.7479 0 0 0 0 0 0 0 10.9789 0 0 10.8542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7008 0 0 0 12.561 0 0 10.6175 0 0 13.952 0 0 0 13.4672 13.7807 12.3106 0 0 0 13.628 0 0 0 0 0 14.4487 13.2106 14.3573 0 12.7338 12.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.669 0 0 0 0 0 12.8832 0 0 0 0 0 0 0 13.3782 0 0 0 13.2366 0 0 0 0 0 0 0 0 0 13.8728 0 0 0 0 0 0 0 12.0786 0 0 14.3433 11.7993 0 0 0 16.0483 0 0 16.4314 13.802 0 13.2607 13.4722 12.0967 0 0 0 0 0 0 0 0 P22676 CALB2_HUMAN "Calretinin, CR (29 kDa calbindin)" CALB2 CAB29 Homo sapiens (Human) regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] cytosol [GO:0005829]; dendrite [GO:0030425]; gap junction [GO:0005921]; neuron projection [GO:0043005]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195] cytosol [GO:0005829]; dendrite [GO:0030425]; gap junction [GO:0005921]; neuron projection [GO:0043005]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195]; calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509] GO:0005509; GO:0005634; GO:0005829; GO:0005921; GO:0030425; GO:0043005; GO:0043195; GO:0045202; GO:0051480; GO:0098688; GO:0099509; GO:0099534; GO:1900271 calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534] GSGMMSK 0.99429 -7.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8919 0 14.5201 14.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36955 PEDF_HUMAN "Pigment epithelium-derived factor, PEDF (Cell proliferation-inducing gene 35 protein) (EPC-1) (Serpin F1)" SERPINF1 PEDF PIG35 Homo sapiens (Human) aging [GO:0007568]; cellular response to cobalt ion [GO:0071279]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to retinoic acid [GO:0071300]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron death [GO:1901215]; ovulation cycle [GO:0042698]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron projection development [GO:0010976]; response to acidic pH [GO:0010447]; response to arsenic-containing substance [GO:0046685]; response to peptide [GO:1901652]; retina development in camera-type eye [GO:0060041]; short-term memory [GO:0007614] axon hillock [GO:0043203]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471] axon hillock [GO:0043203]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; serine-type endopeptidase inhibitor activity [GO:0004867]; aging [GO:0007568]; cellular response to cobalt ion [GO:0071279]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to retinoic acid [GO:0071300]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron death [GO:1901215]; ovulation cycle [GO:0042698]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron projection development [GO:0010976]; response to acidic pH [GO:0010447]; response to arsenic-containing substance [GO:0046685]; response to peptide [GO:1901652]; retina development in camera-type eye [GO:0060041]; short-term memory [GO:0007614] GO:0001822; GO:0004867; GO:0005576; GO:0005604; GO:0005615; GO:0007568; GO:0007614; GO:0010447; GO:0010596; GO:0010629; GO:0010951; GO:0010976; GO:0016525; GO:0042470; GO:0042698; GO:0043203; GO:0046685; GO:0048471; GO:0050728; GO:0050769; GO:0060041; GO:0060767; GO:0060770; GO:0062023; GO:0070062; GO:0071279; GO:0071300; GO:0071333; GO:0071549; GO:1901215; GO:1901652 serine-type endopeptidase inhibitor activity [GO:0004867] EIPDEISILLLGVAHFKGQWVTK 0.99429 -10.867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4395 0 10.2469 0 0 0 0 12.7155 0 0 12.2081 0 0 0 0 12.1366 15.947 0 0 12.3168 0 0 0 0 0 0 0 0 0 15.0108 0 0 0 0 0 0 0 0 0 0 0 14.2412 0 10.0795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0004 0 0 0 0 13.426 0 0 0 0 13.2473 0 0 0 0 0 0 0 0 0 0 18.2675 0 0 0 13.7224 0 0 0 0 0 0 16.2342 0 0 0 0 0 0 0 0 16.069 0 17.7725 P56817 BACE1_HUMAN "Beta-secretase 1, EC 3.4.23.46 (Aspartyl protease 2, ASP2, Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1, Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2)" BACE1 BACE KIAA1149 Homo sapiens (Human) amyloid fibril formation [GO:1990000]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; cellular response to amyloid-beta [GO:1904646]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane protein ectodomain proteolysis [GO:0006509]; positive regulation of neuron apoptotic process [GO:0043525]; prepulse inhibition [GO:0060134]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lead ion [GO:0010288]; response to radiation [GO:0009314] axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle lumen [GO:0070931]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle lumen [GO:0070931]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase activity [GO:0004190]; beta-aspartyl-peptidase activity [GO:0008798]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233]; amyloid fibril formation [GO:1990000]; amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; cellular response to amyloid-beta [GO:1904646]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; membrane protein ectodomain proteolysis [GO:0006509]; positive regulation of neuron apoptotic process [GO:0043525]; prepulse inhibition [GO:0060134]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lead ion [GO:0010288]; response to radiation [GO:0009314] GO:0001540; GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005788; GO:0005794; GO:0005802; GO:0005886; GO:0005887; GO:0006508; GO:0006509; GO:0008021; GO:0008233; GO:0008798; GO:0009314; GO:0009986; GO:0010008; GO:0010288; GO:0016021; GO:0016485; GO:0019899; GO:0030424; GO:0030425; GO:0034205; GO:0042987; GO:0043025; GO:0043525; GO:0045121; GO:0050435; GO:0050966; GO:0055037; GO:0060134; GO:0070931; GO:0071280; GO:0071287; GO:0098686; GO:1904646; GO:1990000; GO:2000300 amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase activity [GO:0004190]; beta-aspartyl-peptidase activity [GO:0008798]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; peptidase activity [GO:0008233] EWYYEVIIVRVEINGQDLK 0.99429 -8.1525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.203 0 0 0 0 0 0 0 0 0 9.83278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6661 0 12.5242 0 0 0 0 0 0 0 0 0 0 0 14.433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63279 UBC9_HUMAN "SUMO-conjugating enzyme UBC9, EC 2.3.2.- (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) (p18)" UBE2I UBC9 UBCE9 Homo sapiens (Human) "cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of SUMO transferase activity [GO:1903755]; protein modification process [GO:0036211]; protein sumoylation [GO:0016925]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; SUMO ligase complex [GO:0106068]; sumoylated E2 ligase complex [GO:1990356]; synaptonemal complex [GO:0000795]; transferase complex [GO:1990234] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; SUMO ligase complex [GO:0106068]; sumoylated E2 ligase complex [GO:1990356]; synaptonemal complex [GO:0000795]; transferase complex [GO:1990234]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; HLH domain binding [GO:0043398]; RING-like zinc finger domain binding [GO:0071535]; RNA binding [GO:0003723]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of SUMO transferase activity [GO:1903755]; protein modification process [GO:0036211]; protein sumoylation [GO:0016925]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000122; GO:0000795; GO:0001221; GO:0003723; GO:0005524; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006511; GO:0007059; GO:0007084; GO:0008134; GO:0016605; GO:0016925; GO:0019789; GO:0019899; GO:0036211; GO:0043123; GO:0043398; GO:0044388; GO:0045892; GO:0048471; GO:0051168; GO:0051301; GO:0061656; GO:0071535; GO:0106068; GO:1903755; GO:1990234; GO:1990356 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; HLH domain binding [GO:0043398]; RING-like zinc finger domain binding [GO:0071535]; RNA binding [GO:0003723]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134] RVRAQAK 0.99429 -13.008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.533 0 12.2039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0995 12.1897 12.5979 0 0 0 0 0 14.1554 14.0175 14.2853 0 14.1633 0 0 0 0 0 0 0 13.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8758 13.2986 0 0 0 13.1816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9151 0 0 0 0 0 0 0 0 0 0 0 13.3491 0 0 0 13.3941 0 0 0 0 13.8739 0 0 0 0 0 0 0 13.5813 13.5992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5M7Z0 RNFT1_HUMAN "E3 ubiquitin-protein ligase RNFT1, EC 2.3.2.27 (Protein PTD016) (RING finger and transmembrane domain-containing protein 1)" RNFT1 PTD016 Homo sapiens (Human) positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of ERAD pathway [GO:1904294]; protein autoubiquitination [GO:0051865] GO:0005783; GO:0005789; GO:0016021; GO:0043130; GO:0046872; GO:0051865; GO:0061630; GO:1904294 metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630] GYWYMLLEELCQYYR 0.99429 -13.005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0708 11.9351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0383 13.6703 0 0 14.297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3871 14.2089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5RHP9 ERIC3_HUMAN Glutamate-rich protein 3 ERICH3 C1orf173 Homo sapiens (Human) DAVGLSKDEAPEK 0.99429 -37.04 0 0 0 0 0 0 0 0 10.9215 0 0 0 0 0 0 12.5933 12.2305 0 0 0 0 0 0 0 0 0 0 0 10.3335 0 13.3676 0 12.2831 0 12.2189 12.6335 0 10.4437 0 0 14.2456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5602 0 0 0 0 0 0 0 0 0 0 0 11.633 0 13.5228 0 0 0 0 0 0 0 0 13.4705 12.6502 0 0 0 0 0 0 0 0 0 14.9883 0 0 0 13.0734 0 0 0 12.9155 12.3887 0 0 0 0 0 14.7383 0 0 0 0 13.2353 0 11.9579 0 14.8624 0 9.91864 0 0 0 0 0 0 14.4999 0 0 16.0213 11.9084 0 0 0 12.8271 0 14.6982 10.4894 0 10.9005 0 0 0 15.0364 0 0 12.9081 0 0 0 0 0 0 0 11.1034 11.1997 0 12.6662 0 0 12.9027 0 0 0 0 14.4935 0 14.1909 12.8849 0 12.5735 0 0 0 0 0 13.8024 9.9026 0 0 0 Q6IQ16 SPOPL_HUMAN Speckle-type POZ protein-like (HIB homolog 2) (Roadkill homolog 2) SPOPL Homo sapiens (Human) negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of proteolysis [GO:0030162] GO:0005634; GO:0005737; GO:0016567; GO:0030162; GO:0031397; GO:0031463; GO:0031625; GO:0043161 ubiquitin protein ligase binding [GO:0031625] AQAIDFINR 0.99429 -11.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1935 0 0 0 0 0 0 0 0 0 13.9886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6RFH8 DUX4C_HUMAN "Double homeobox protein 4C (Double homeobox protein 4, centromeric, DUX4c) (Double homeobox protein 4-like protein 9)" DUX4L9 DUX4C Homo sapiens (Human) cell population proliferation [GO:0008283]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; cell population proliferation [GO:0008283]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000976; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0008283; GO:0010468; GO:0045944 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" ERLAQAIGIPEPRVQIWFQNER 0.99429 -36.989 0 0 0 0 0 0 0 0 11.746 0 0 0 0 0 0 0 0 0 0 13.891 0 0 12.1091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9937 13.397 0 13.6822 0 17.7064 0 0 0 17.5052 12.982 0 0 13.7873 14.6433 0 0 12.6089 0 0 0 0 0 13.6632 13.6805 15.0564 0 13.3689 0 0 0 0 13.8001 0 15.2239 0 0 13.8907 13.7337 14.2015 0 0 13.521 13.4301 0 0 15.3929 15.7122 0 15.2225 0 0 0 0 13.3852 0 17.5617 13.4905 15.0374 0 0 0 0 0 0 0 15.4371 0 0 0 0 0 17.1912 12.8714 0 0 12.5563 0 0 0 0 0 12.6802 0 0 0 0 13.174 0 11.9836 0 0 15.5722 0 0 15.0126 Q7RTX9 MOT14_HUMAN "Monocarboxylate transporter 14, MCT 14 (Solute carrier family 16 member 14)" SLC16A14 MCT14 Homo sapiens (Human) monocarboxylic acid transport [GO:0015718] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718] GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016021 monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] ILKTVSWLTMR 0.99429 -15.558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2884 0 0 0 0 0 0 0 0 0 14.1192 0 0 0 12.4153 0 0 0 0 0 0 0 0 0 0 13.989 0 0 13.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0054 0 0 0 11.0787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2276 0 0 0 0 0 0 0 12.0008 0 0 13.0944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UQ0 ZN589_HUMAN Zinc finger protein 589 (Stem cell zinc finger protein 1) ZNF589 SZF1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GFIVESVLR 0.99429 -11.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1529 0 0 0 0 0 0 0 13.8481 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8278 0 0 0 0 0 0 0 0 0 0 0 10.9282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5743 0 0 0 0 0 0 0 0 0 12.3721 0 0 0 0 0 0 0 0 11.8983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6827 0 0 0 0 0 0 0 0 0 Q86YA3 ZGRF1_HUMAN Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1) ZGRF1 C4orf21 Homo sapiens (Human) replication fork reversal [GO:0071932] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; 5'-flap endonuclease activity [GO:0017108]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; replication fork reversal [GO:0071932] GO:0003723; GO:0004386; GO:0005737; GO:0008270; GO:0016021; GO:0017108; GO:0071932 5'-flap endonuclease activity [GO:0017108]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] ALSKVDISFYTSLK 0.99429 -11.151 0 0 0 0 0 0 0 0 0 0 11.8044 14.9946 11.91 13.3819 0 0 0 0 0 0 0 11.8221 0 10.7881 0 13.043 0 0 0 0 11.397 0 10.7363 14.7338 0 0 0 0 0 13.4639 0 0 11.1306 0 0 0 0 10.6062 0 0 0 0 0 0 0 0 0 10.7361 16.0883 0 0 0 0 0 0 0 0 0 0 10.4084 0 0 0 0 0 13.1548 13.208 13.1392 13.808 0 0 15.0588 13.4765 0 0 16.8215 17.0054 16.5273 16.8809 13.2811 0 12.7319 13.2711 14.0755 13.2178 0 0 0 17.2468 0 20.0251 0 0 0 0 14.8282 13.8068 0 12.9008 14.2323 14.6857 0 0 0 13.5386 0 0 0 0 0 13.5195 0 0 13.628 12.6667 0 13.896 0 0 0 0 0 11.8408 0 0 12.6884 0 12.5996 0 0 13.2028 13.7312 12.9876 11.3299 0 0 0 0 0 0 12.9475 13.9742 0 14.0165 0 0 11.3916 0 0 0 12.734 0 12.9605 0 0 13.4148 0 0 0 0 0 0 12.215 0 0 0 0 14.5513 0 0 Q8WVS4 DC2I1_HUMAN Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60) DYNC2I1 WDR60 Homo sapiens (Human) cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242] centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary plasm [GO:0097014]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018] GO:0000242; GO:0005615; GO:0005813; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0042073; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097014; GO:0097542; GO:0097546 dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503] DPDQDARSRDR 0.99429 -11.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.793 0 0 0 0 14.5955 0 0 0 0 0 0 14.0292 0 0 14.4806 13.8462 0 0 13.7331 0 0 0 0 0 0 0 12.9256 0 0 0 14.2101 0 0 0 0 0 0 0 12.4735 0 13.5676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969P0 IGSF8_HUMAN "Immunoglobulin superfamily member 8, IgSF8 (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2, EWI-2) (Keratinocytes-associated transmembrane protein 4, KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein, PGRL) (CD antigen CD316)" IGSF8 CD81P3 EWI2 KCT4 Homo sapiens (Human) cell motility [GO:0048870]; nervous system development [GO:0007399]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell motility [GO:0048870]; nervous system development [GO:0007399]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519] GO:0005886; GO:0007338; GO:0007399; GO:0007519; GO:0016020; GO:0016021; GO:0043231; GO:0048870; GO:0070062 PLPVHVR 0.99429 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96K30 RITA1_HUMAN RBPJ-interacting and tubulin-associated protein 1 (RBPJ-interacting and tubulin-associated protein) RITA1 C12orf52 RITA PSEC0043 Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; nuclear export [GO:0051168] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tubulin binding [GO:0015631]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; nuclear export [GO:0051168] GO:0000122; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0007219; GO:0015631; GO:0022008; GO:0045746; GO:0051168 tubulin binding [GO:0015631] GSTPTLTPRK 0.99429 -10.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1353 0 0 0 0 0 0 0 0 0 12.5401 12.9969 0 0 0 0 0 0 0 0 0 0 0 14.3886 14.8475 0 0 0 0 0 0 0 0 0 11.1452 0 0 0 0 0 0 12.3069 0 0 0 0 0 0 10.3873 0 0 12.495 0 0 0 0 13.2175 0 0 0 0 0 0 0 0 0 0 12.8225 0 13.329 12.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LR9 APLD1_HUMAN Apolipoprotein L domain-containing protein 1 (Vascular early response gene protein) APOLD1 VERGE Homo sapiens (Human) angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; regulation of endothelial cell differentiation [GO:0045601] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; regulation of endothelial cell differentiation [GO:0045601] GO:0001525; GO:0005576; GO:0005886; GO:0006869; GO:0008289; GO:0016021; GO:0030154; GO:0042157; GO:0045601 lipid binding [GO:0008289] FRAPCHR 0.99429 -36.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1867 0 0 0 0 12.6551 17.7552 0 0 0 0 0 12.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUU2 MET22_HUMAN "Methyltransferase-like protein 22, EC 2.1.1.-" METTL22 C16orf68 LP8272 Homo sapiens (Human) protein methylation [GO:0006479] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; protein methylation [GO:0006479] GO:0005634; GO:0005654; GO:0005730; GO:0006479; GO:0008276; GO:0016279; GO:0031072; GO:0032991 heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] DDLCTDPK 0.99429 -8.677 14.6011 13.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2778 0 0 0 0 0 0 0 0 0 0 13.1024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.95 0 0 0 0 0 0 0 0 0 0 0 0 13.1495 0 0 0 0 0 12.8246 14.2496 14.2366 0 0 15.0518 0 0 0 0 0 0 15.0833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H116 GZF1_HUMAN GDNF-inducible zinc finger protein 1 (Zinc finger and BTB domain-containing protein 23) (Zinc finger protein 336) GZF1 ZBTB23 ZNF336 Homo sapiens (Human) "branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001658; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0043565; GO:0045892; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" AGPEEEEEEEEEDEEGEK 0.99429 -8.1601 13.7017 0 0 0 0 0 0 0 0 15.0298 0 0 0 0 0 0 0 0 0 0 0 11.9742 0 11.5527 0 15.4745 0 0 0 0 0 0 16.6128 0 0 0 14.6083 0 0 0 16.3519 0 0 0 16.6626 0 0 17.1535 0 0 0 14.1753 0 0 0 0 0 0 17.4375 0 16.1005 15.9648 16.4615 0 16.02 0 0 0 0 0 12.5703 13.4743 0 0 0 0 0 0 0 0 0 13.5674 0 0 0 0 0 0 0 14.0369 0 17.1653 11.7127 0 0 0 0 15.4755 13.5688 14.74 0 0 0 0 0 0 0 0 0 16.4801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1915 0 11.6541 12.5699 0 0 0 0 0 13.9085 0 0 14.9494 0 0 0 0 14.4494 0 0 14.1614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVH6 TMLH_HUMAN "Trimethyllysine dioxygenase, mitochondrial, EC 1.14.11.8 (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase, TML dioxygenase, TMLD)" TMLHE TMLH Homo sapiens (Human) carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329]; negative regulation of oxidoreductase activity [GO:0051354] GO:0005506; GO:0005739; GO:0005759; GO:0045329; GO:0050353; GO:0051354 iron ion binding [GO:0005506]; trimethyllysine dioxygenase activity [GO:0050353] APEEFELLSKVPLK 0.99429 -8.161 0 0 0 0 0 0 0 0 0 12.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5736 0 0 0 0 0 0 0 0 0 0 0 12.041 12.6197 0 0 0 0 0 11.1024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3188 0 0 13.6287 0 14.0461 0 0 0 0 0 0 0 0 13.7276 0 0 0 0 0 0 0 0 0 14.3143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7093 0 0 0 0 0 0 0 0 13.3308 0 12.9074 0 0 0 0 0 0 0 0 0 0 0 0 0 12.424 0 0 0 0 0 0 0 0 0 0 Q9NZM3 ITSN2_HUMAN Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein) ITSN2 KIAA1256 SH3D1B SWAP Homo sapiens (Human) cell differentiation [GO:0030154]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; positive regulation of dendrite extension [GO:1903861] centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; presynapse [GO:0098793] centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; positive regulation of dendrite extension [GO:1903861] GO:0005085; GO:0005509; GO:0005813; GO:0005829; GO:0005905; GO:0006897; GO:0016197; GO:0030154; GO:0060090; GO:0070062; GO:0098793; GO:0150007; GO:1903861 calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular adaptor activity [GO:0060090] IIPGSEVK 0.99429 -7.8923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2725 14.4568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3075 0 0 0 0 0 0 13.0805 0 13.536 12.6854 14.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0149 0 0 14.6033 0 0 0 0 0 0 0 0 0 0 12.4405 0 13.2859 0 0 0 13.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7591 14.7888 0 0 0 14.87 0 0 0 0 0 0 0 0 0 0 0 0 15.372 0 0 0 0 0 15.1808 14.9015 0 14.461 14.0898 0 0 0 0 A0FGR9 ESYT3_HUMAN "Extended synaptotagmin-3, E-Syt3 (Chr3Syt)" ESYT3 FAM62C Homo sapiens (Human) endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869] GO:0005509; GO:0005544; GO:0005789; GO:0005887; GO:0006869; GO:0008429; GO:0031210; GO:0031227; GO:0031234; GO:0035091; GO:0044232; GO:0061817; GO:0140268 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091] DNFLGLRGKSDPYAK 0.9943 -15.607 0 0 0 0 0 0 0 13.4834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1417 0 0 0 0 0 0 0 0 0 13.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1324 11.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7435 0 15.7341 0 0 0 0 0 0 13.076 0 0 0 0 0 0 0 0 0 0 12.2514 0 0 12.8603 0 0 12.9516 0 0 0 13.5038 0 20.9018 0 0 0 0 0 0 0 0 10.3528 0 0 0 12.1193 0 11.0739 0 0 0 0 0 0 10.8151 0 0 0 0 0 0 0 0 0 0 11.852 0 0 16.5057 12.3146 0 12.6119 0 0 0 0 0 0 0 12.5333 0 0 C9J6K1 CS081_HUMAN Putative uncharacterized protein C19orf81 C19orf81 Homo sapiens (Human) ELPCIRK 0.9943 -15.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.891 13.3983 12.7604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.577 0 0 0 0 0 0 13.0241 0 0 0 0 0 0 12.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1086 O60637 TSN3_HUMAN "Tetraspanin-3, Tspan-3 (Tetraspanin TM4-A) (Transmembrane 4 superfamily member 8)" TSPAN3 TM4SF8 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] GO:0005887; GO:0070062 VENEVDR 0.9943 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75635 SPB7_HUMAN Serpin B7 (Megsin) (TP55) SERPINB7 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of transforming growth factor beta1 production [GO:0032914] cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of platelet-derived growth factor production [GO:0090362]; positive regulation of transforming growth factor beta1 production [GO:0032914] GO:0004867; GO:0005615; GO:0005737; GO:0010951; GO:0032914; GO:0032967; GO:0072126; GO:0090362 serine-type endopeptidase inhibitor activity [GO:0004867] AVAMMHQERKFNLSVIEDPSMK 0.9943 -9.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7799 13.021 0 0 0 0 12.6847 0 0 0 0 0 0 0 0 0 0 13.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9869 0 0 0 0 0 0 12.9618 0 0 0 0 0 0 0 0 12.4878 0 0 0 0 0 0 0 0 0 11.9714 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7144 0 0 0 0 0 0 0 0 0 12.1946 0 0 0 0 0 0 0 0 0 0 0 0 O95232 LC7L3_HUMAN "Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1, CRE-associated protein 1, CREAP-1)" LUC7L3 CREAP1 CROP O48 Homo sapiens (Human) mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380] GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005685; GO:0006376; GO:0008380; GO:0016607; GO:0071004 DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] IKATVEELKEK 0.9943 -15.635 0 0 0 0 0 0 0 0 0 0 0 0 0 11.021 0 0 0 0 0 0 10.6659 10.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2544 11.4488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0442 0 0 0 12.0236 0 0 0 0 0 0 0 0 0 0 0 13.9845 0 12.856 0 0 0 0 0 13.6131 10.4295 13.9533 0 0 0 14.3961 0 0 13.7942 0 0 0 0 0 12.8455 0 0 0 0 0 0 0 14.62 0 0 0 0 14.121 14.2231 0 0 12.0512 0 0 0 0 0 0 0 0 0 12.9998 0 0 0 0 0 0 0 0 0 11.2456 0 0 0 0 13.6432 0 0 0 0 0 11.8338 0 0 0 0 0 0 0 12.6749 0 0 0 0 12.8193 0 0 0 0 0 P04424 ARLY_HUMAN "Argininosuccinate lyase, ASAL, EC 4.3.2.1 (Arginosuccinase)" ASL Homo sapiens (Human) ammonia assimilation cycle [GO:0019676]; arginine biosynthetic process [GO:0006526]; arginine biosynthetic process via ornithine [GO:0042450]; arginine metabolic process [GO:0006525]; locomotory behavior [GO:0007626]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; post-embryonic development [GO:0009791]; urea cycle [GO:0000050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; argininosuccinate lyase activity [GO:0004056]; identical protein binding [GO:0042802]; ammonia assimilation cycle [GO:0019676]; arginine biosynthetic process [GO:0006526]; arginine biosynthetic process via ornithine [GO:0042450]; arginine metabolic process [GO:0006525]; locomotory behavior [GO:0007626]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; post-embryonic development [GO:0009791]; urea cycle [GO:0000050] GO:0000050; GO:0004056; GO:0005737; GO:0005829; GO:0006525; GO:0006526; GO:0007626; GO:0009791; GO:0019676; GO:0042450; GO:0042802; GO:0045429; GO:0070062 argininosuccinate lyase activity [GO:0004056]; identical protein binding [GO:0042802] AGRVFGR 0.9943 -13.815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9419 10.1034 13.1728 12.9974 0 0 0 0 0 0 0 12.6247 0 0 0 0 0 0 0 0 0 0 0 14.345 0 14.7686 14.6896 13.2777 13.0564 13.0079 18.7106 18.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4993 13.8141 0 0 9.39551 0 0 0 0 0 0 0 0 10.5903 0 0 0 0 0 0 0 0 0 10.7248 0 0 0 0 0 0 0 0 0 0 0 0 P05109 S10A8_HUMAN "Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen, CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8, MRP-8, p8) (S100 calcium-binding protein A8) (Urinary stone protein band A)" S100A8 CAGA CFAG MRP8 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptide secretion [GO:0002790]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptide secretion [GO:0002793]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to zinc ion [GO:0010043]; sequestering of zinc ion [GO:0032119]; wound healing [GO:0042060] collagen-containing extracellular matrix [GO:0062023]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] collagen-containing extracellular matrix [GO:0062023]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; arachidonic acid binding [GO:0050544]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptide secretion [GO:0002790]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptide secretion [GO:0002793]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to zinc ion [GO:0010043]; sequestering of zinc ion [GO:0032119]; wound healing [GO:0042060] GO:0002523; GO:0002526; GO:0002544; GO:0002790; GO:0002793; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0006915; GO:0006919; GO:0006954; GO:0008017; GO:0008270; GO:0010043; GO:0014002; GO:0018119; GO:0030307; GO:0030593; GO:0032119; GO:0032496; GO:0034774; GO:0035425; GO:0035662; GO:0042060; GO:0042742; GO:0045087; GO:0045111; GO:0045471; GO:0048306; GO:0050544; GO:0050729; GO:0050786; GO:0050832; GO:0051092; GO:0051493; GO:0062023; GO:0070062; GO:0070488; GO:2001244 arachidonic acid binding [GO:0050544]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270] LLETECPQYIRK 0.9943 -13.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.85 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7581 0 0 0 0 0 0 14.5639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4736 0 0 0 0 0 0 0 0 0 0 0 0 0 P11712 CP2C9_HUMAN "Cytochrome P450 2C9, EC 1.14.14.1 ((R)-limonene 6-monooxygenase, EC 1.14.14.53) ((S)-limonene 6-monooxygenase, EC 1.14.14.51) ((S)-limonene 7-monooxygenase, EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase)" CYP2C9 CYP2C10 Homo sapiens (Human) cellular amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; (R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; cellular amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005737; GO:0005789; GO:0005886; GO:0006082; GO:0006805; GO:0008202; GO:0008203; GO:0008210; GO:0008392; GO:0008395; GO:0008404; GO:0008405; GO:0016098; GO:0016491; GO:0016712; GO:0018675; GO:0018676; GO:0019373; GO:0019627; GO:0020037; GO:0032787; GO:0034875; GO:0042178; GO:0042759; GO:0043231; GO:0043603; GO:0046456; GO:0052741; GO:0070330; GO:0070989; GO:0097267 "(R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]" DQQFLNLMEK 0.9943 -11.174 0 0 0 0 14.3216 13.8776 0 0 0 0 0 0 0 0 0 13.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9307 13.0029 0 0 0 13.9643 15.9219 0 0 13.2096 0 0 0 0 14.3354 0 0 10.8809 0 12.2005 0 0 0 0 0 12.3419 11.3064 0 0 10.8526 0 0 0 0 13.8083 0 0 0 0 0 0 0 0 14.8498 0 0 11.6501 12.7002 0 0 0 0 12.5948 0 0 0 11.3032 15.1919 14.3319 0 0 13.7662 0 0 0 0 0 0 14.1943 13.8901 0 0 0 0 0 0 12.1602 0 13.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7698 0 0 0 0 0 13.165 0 0 0 0 0 0 13.4455 13.2105 0 0 0 0 0 13.1992 0 P48730 KC1D_HUMAN "Casein kinase I isoform delta, CKI-delta, CKId, EC 2.7.11.1 (Tau-protein kinase CSNK1D, EC 2.7.11.26)" CSNK1D HCKID Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; signal transduction [GO:0007165]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; COPII vesicle coating [GO:0048208]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation [GO:1905426]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; signal transduction [GO:0007165]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055] GO:0001934; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0006468; GO:0007020; GO:0007030; GO:0007165; GO:0016055; GO:0018105; GO:0032436; GO:0032922; GO:0033116; GO:0034067; GO:0036064; GO:0042752; GO:0043005; GO:0045296; GO:0048208; GO:0048471; GO:0050321; GO:0051225; GO:0061512; GO:0071539; GO:0090263; GO:0106310; GO:1905426; GO:1905515; GO:1990090; GO:2000052 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321] DDLESLGYVLMYFNLGSLPWQGLKAATK 0.9943 -10.87 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0017 0 0 0 0 0 0 0 0 0 0 13.3012 0 0 0 11.4252 13.4573 0 11.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7689 0 13.5372 13.823 0 0 0 0 0 0 0 0 0 0 12.5742 0 0 0 0 0 0 0 13.23 0 0 0 0 0 0 0 0 12.9874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6594 0 0 0 0 0 0 Q13203 MYBPH_HUMAN "Myosin-binding protein H, MyBP-H (H-protein)" MYBPH Homo sapiens (Human) cell adhesion [GO:0007155]; regulation of striated muscle contraction [GO:0006942] myosin filament [GO:0032982] myosin filament [GO:0032982]; structural constituent of muscle [GO:0008307]; cell adhesion [GO:0007155]; regulation of striated muscle contraction [GO:0006942] GO:0006942; GO:0007155; GO:0008307; GO:0032982 structural constituent of muscle [GO:0008307] ASPKPKIIWMK 0.9943 -9.4239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7562 13.5018 0 0 0 0 0 0 0 0 13.196 0 0 0 13.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3038 0 0 0 0 0 0 0 0 0 0 0 0 Q15849 UT2_HUMAN "Urea transporter 2 (Solute carrier family 14 member 2) (Urea transporter, kidney)" SLC14A2 HUT2 UT2 Homo sapiens (Human) transmembrane transport [GO:0055085]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; urea transmembrane transporter activity [GO:0015204]; transmembrane transport [GO:0055085]; urea transmembrane transport [GO:0071918]; urea transport [GO:0015840] GO:0005886; GO:0015204; GO:0015840; GO:0016020; GO:0016021; GO:0016324; GO:0050839; GO:0055085; GO:0071918 cell adhesion molecule binding [GO:0050839]; urea transmembrane transporter activity [GO:0015204] DDGVAHR 0.9943 -15.66 0 0 0 0 0 0 0 0 0 0 0 0 12.7743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4727 0 0 11.4746 16.6273 0 0 0 0 14.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0177 0 14.56 0 0 0 0 13.6674 0 0 12.6775 0 0 0 15.6888 0 0 0 0 0 0 0 11.6745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.394 0 0 0 0 0 0 0 0 0 0 0 11.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2NKQ1 SGSM1_HUMAN Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2) SGSM1 KIAA1941 RUTBC2 Homo sapiens (Human) activation of GTPase activity [GO:0090630] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0005737; GO:0005794; GO:0005829; GO:0030659; GO:0031267; GO:0090630 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] AAGFLRSNK 0.9943 -15.606 0 0 0 0 0 0 0 0 13.0514 0 0 0 0 0 0 0 0 0 0 0 10.3627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7246 0 0 0 13.9058 0 0 0 0 0 0 0 0 0 0 12.788 0 0 12.2887 12.9028 13.7152 13.4086 0 0 11.9511 0 14.5914 0 0 0 11.394 0 0 0 0 0 0 0 12.1114 13.1738 11.2693 13.5276 0 12.5007 12.9417 15.9447 0 0 0 15.3298 0 0 13.4013 0 11.6107 0 0 10.8874 0 0 0 10.9564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6977 0 0 0 12.6821 0 0 0 0 13.0913 0 0 0 0 0 0 0 0 0 0 11.2636 9.85784 15.3653 0 12.4558 0 0 0 Q3MJ40 C144B_HUMAN Coiled-coil domain-containing protein 144B CCDC144B Homo sapiens (Human) EVEEEMEKHR 0.9943 -13.033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9717 13.4555 13.9239 0 0 0 0 14.0243 0 0 12.4537 0 0 0 0 0 0 0 0 0 0 12.4408 0 0 0 0 0 0 0 0 0 12.9618 12.9129 13.0883 0 0 0 0 0 13.8749 0 0 0 0 0 0 0 0 12.6745 0 0 0 0 0 0 0 0 13.2492 0 0 0 12.9111 12.8614 13.6575 0 0 0 12.6703 0 0 0 0 14.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3YEC7 RABL6_HUMAN "Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1, RBEL1)" RABL6 C9orf86 PARF Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005829 GTP binding [GO:0005525]; GTPase activity [GO:0003924] DKEEGKEER 0.9943 -5.2749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9124 0 0 0 11.1068 0 0 0 0 12.2694 0 0 0 0 0 0 0 0 0 0 11.9796 0 0 0 0 0 0 12.1571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5219 0 0 0 0 0 0 0 0 13.119 0 0 0 0 0 0 12.8141 0 0 13.475 0 0 0 0 0 13.5187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3957 0 13.2095 0 0 0 0 0 0 15.5982 0 13.7632 0 0 0 0 0 14.1407 14.1387 0 0 0 0 14.2557 14.1252 15.0454 14.0097 14.0758 0 13.9677 0 13.6937 0 13.4946 0 0 0 13.8109 0 0 13.7287 0 13.7965 0 13.9035 0 0 0 0 0 0 0 0 0 0 12.343 0 0 0 0 0 0 0 0 0 0 14.3993 0 0 0 0 0 13.4302 0 0 0 0 0 0 0 0 Q5T5S1 CC183_HUMAN Coiled-coil domain-containing protein 183 CCDC183 KIAA1984 Homo sapiens (Human) ALQIQGVK 0.9943 -15.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7069 0 0 0 0 0 13.146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4821 0 0 0 0 0 0 0 0 12.1234 0 0 0 0 14.6766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7373 0 0 0 15.073 14.983 0 13.9309 12.9263 13.2938 0 11.8548 14.1827 14.2678 14.1301 15.5334 14.5563 12.8699 12.9335 0 0 13.9234 13.6049 13.4428 0 13.3482 0 0 0 14.2837 12.5285 0 0 0 11.7972 13.3595 14.966 0 13.4043 0 13.0231 14.993 0 14.7448 0 0 0 0 14.5773 0 13.5845 11.9482 0 0 14.9964 14.138 0 14.1626 0 0 0 0 14.366 0 0 0 0 0 14.6944 0 0 0 0 16.4403 0 0 0 0 0 0 14.6806 0 0 14.4924 14.6359 15.1296 14.6148 0 0 0 13.0094 0 0 0 0 0 0 0 0 0 0 13.5872 0 0 0 0 0 0 0 0 Q6Y288 B3GLT_HUMAN "Beta-1,3-glucosyltransferase, Beta3Glc-T, EC 2.4.1.- (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)" B3GLCT B3GALTL B3GTL Homo sapiens (Human) fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; fucose metabolic process [GO:0006004]; protein O-linked fucosylation [GO:0036066] GO:0005789; GO:0006004; GO:0008375; GO:0016021; GO:0016757; GO:0036066 acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757] EAVRRLLASK 0.9943 -11.167 0 0 0 12.781 0 0 0 0 0 0 0 0 0 12.0522 0 0 0 0 0 0 10.5573 11.3565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5891 0 0 0 0 0 0 0 12.9599 0 0 0 0 0 11.4497 0 0 0 0 0 0 0 0 11.7148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8257 0 0 0 0 12.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q75NE6 MIRH1_HUMAN Putative microRNA 17 host gene protein (Putative microRNA host gene 1 protein) MIR17HG C13orf25 MIRH1 MIRHG1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FCHVDVK 0.9943 -11.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0731 16.9056 0 0 0 12.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1851 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5626 0 0 0 0 0 0 13.0119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L4P6 BEND5_HUMAN BEN domain-containing protein 5 BEND5 C1orf165 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" Golgi apparatus [GO:0005794] "Golgi apparatus [GO:0005794]; DNA binding [GO:0003677]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003677; GO:0005794; GO:0045892 DNA binding [GO:0003677] ALYEELLR 0.9943 -12.652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0207 0 0 10.5837 0 0 0 0 0 0 0 0 0 0 0 0 12.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8846 11.3041 13.7559 13.7739 0 0 0 13.1191 0 12.6582 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8053 13.7056 0 0 12.5528 0 0 12.8577 0 0 0 0 0 0 0 0 0 0 0 15.4281 0 16.2824 13.0793 15.5343 0 0 0 0 0 0 13.4319 0 15.8278 10.7883 0 0 0 12.9048 0 14.4482 0 15.0141 0 0 0 0 0 0 0 14.6329 14.5536 0 14.1448 0 12.7336 0 12.9709 0 0 11.6269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8527 0 0 0 0 Q96D53 COQ8B_HUMAN "Atypical kinase COQ8B, mitochondrial, EC 2.7.-.- (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B)" COQ8B ADCK4 Homo sapiens (Human) cerebellar Purkinje cell layer morphogenesis [GO:0021692]; phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744] cytosol [GO:0005829]; extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744] GO:0005524; GO:0005739; GO:0005829; GO:0005886; GO:0006744; GO:0008289; GO:0016021; GO:0016301; GO:0016310; GO:0016887; GO:0021692; GO:0031314 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301]; lipid binding [GO:0008289] AREARPR 0.9943 -10.894 0 0 0 0 0 0 0 0 14.5199 14.4464 14.7686 14.4404 14.8333 15.0032 0 13.0643 0 0 0 0 0 0 0 0 0 0 13.2447 0 13.2811 14.3518 13.11 15.1497 13.776 14.8198 15.6904 13.3284 15.0997 13.5223 14.9633 14.3564 14.0477 12.904 12.6121 0 12.974 0 12.719 0 12.6151 14.0586 0 11.1378 0 12.8225 14.0357 14.1587 14.0792 11.3411 0 0 11.6239 0 11.2224 0 0 12.5298 0 0 0 10.4546 12.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4639 0 0 0 0 0 0 0 12.9005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3573 0 0 0 13.0198 0 0 0 0 0 0 0 0 13.4857 0 0 0 0 0 0 11.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2175 0 16.2718 0 0 0 13.7639 0 0 19.5463 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXJ7 AMNLS_HUMAN Protein amnionless [Cleaved into: Soluble protein amnionless ] AMN UNQ513/PRO1028 Homo sapiens (Human) cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; Golgi to plasma membrane protein transport [GO:0043001]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]; renal protein absorption [GO:0097017] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cargo receptor activity [GO:0038024]; signaling receptor binding [GO:0005102]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; Golgi to plasma membrane protein transport [GO:0043001]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898]; renal protein absorption [GO:0097017] GO:0005102; GO:0005615; GO:0005886; GO:0005905; GO:0006898; GO:0008104; GO:0009235; GO:0010008; GO:0015889; GO:0016020; GO:0016021; GO:0016324; GO:0030139; GO:0031526; GO:0031528; GO:0038024; GO:0043001; GO:0043235; GO:0070062; GO:0097017 cargo receptor activity [GO:0038024]; signaling receptor binding [GO:0005102] DSDRFSWHDPHLWR 0.9943 -5.2777 0 0 0 0 0 0 0 0 0 0 13.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8963 0 0 0 0 0 0 0 0 12.7094 0 0 12.1951 0 0 0 12.8334 0 0 14.1047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9011 0 0 0 14.4621 0 0 0 0 0 11.9518 0 0 0 0 12.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1558 0 0 13.768 0 0 0 0 0 0 0 Q9BXL7 CAR11_HUMAN "Caspase recruitment domain-containing protein 11 (CARD-containing MAGUK protein 1, Carma 1)" CARD11 CARMA1 Homo sapiens (Human) "B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; homeostasis of number of cells [GO:0048872]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein homooligomerization [GO:0051260]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of T cell differentiation [GO:0045580]; T cell costimulation [GO:0031295]; thymic T cell selection [GO:0045061]; TORC1 signaling [GO:0038202]" CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] "CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; CARD domain binding [GO:0050700]; guanylate kinase activity [GO:0004385]; protein self-association [GO:0043621]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; homeostasis of number of cells [GO:0048872]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein homooligomerization [GO:0051260]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of T cell differentiation [GO:0045580]; T cell costimulation [GO:0031295]; thymic T cell selection [GO:0045061]; TORC1 signaling [GO:0038202]" GO:0001772; GO:0004385; GO:0005737; GO:0005829; GO:0005886; GO:0007249; GO:0030183; GO:0030890; GO:0031295; GO:0032449; GO:0032743; GO:0035739; GO:0038202; GO:0042100; GO:0042981; GO:0043123; GO:0043621; GO:0045061; GO:0045121; GO:0045577; GO:0045580; GO:0048872; GO:0050700; GO:0050862; GO:0051092; GO:0051260; GO:0070062; GO:2000563 CARD domain binding [GO:0050700]; guanylate kinase activity [GO:0004385]; protein self-association [GO:0043621] AGRLLDILHTK 0.9943 -10.886 0 0 10.8338 0 0 0 0 0 0 0 0 14.2706 0 0 10.9887 0 0 0 0 0 0 0 10.3581 0 0 10.3427 11.0722 12.9369 15.1832 13.8793 12.8928 13.582 14.0098 0 0 13.4569 0 12.0144 0 0 0 0 0 0 0 0 11.2063 0 0 0 0 0 0 0 0 10.7664 0 0 0 0 0 0 0 10.7302 0 0 12.0801 12.0761 11.531 0 0 12.3745 15.6285 15.5551 0 0 0 0 0 0 0 0 0 13.3981 13.014 0 0 0 0 0 12.855 0 15.2223 14.4567 0 0 0 0 11.1208 0 0 0 0 0 0 12.6131 0 0 12.3388 0 0 0 0 12.5781 0 0 12.3438 13.6074 12.3055 0 0 0 0 0 0 0 0 0 0 13.4361 13.2929 0 0 0 12.2784 0 0 14.649 0 0 0 0 0 0 0 0 0 12.6171 0 0 0 0 0 11.421 0 0 0 14.7533 0 0 14.9642 15.1688 0 0 0 13.1923 0 13.9805 12.5282 0 15.2658 12.3214 0 10.5794 0 0 11.3296 0 0 0 Q9GZS1 RPA49_HUMAN "DNA-directed RNA polymerase I subunit RPA49, RNA polymerase I subunit A49 (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53)" POLR1E PAF53 PRAF1 Homo sapiens (Human) nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation from RNA polymerase I promoter [GO:0006362] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; RNA polymerase I general transcription initiation factor binding [GO:0001179]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation from RNA polymerase I promoter [GO:0006362] GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0005654; GO:0005730; GO:0005736; GO:0006362; GO:0042790 DNA binding [GO:0003677]; RNA polymerase I general transcription initiation factor binding [GO:0001179] AMRLKISK 0.9943 -5.2708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2508 16.1183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H892 TTC12_HUMAN "Tetratricopeptide repeat protein 12, TPR repeat protein 12" TTC12 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288] centrosome [GO:0005813]; cytoplasm [GO:0005737] centrosome [GO:0005813]; cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; sperm axoneme assembly [GO:0007288] GO:0005737; GO:0005813; GO:0007288; GO:0070286 AQAYMKLEDYEKALVDCEWALK 0.9943 -12.649 15.0585 0 14.6218 0 0 15.2726 0 0 0 13.8173 11.2653 0 0 0 0 0 11.9193 0 0 0 0 0 11.8769 14.4143 0 0 0 0 0 0 0 0 0 0 12.4656 0 11.0661 0 0 0 0 0 12.8369 0 12.814 0 0 0 0 0 0 0 0 11.7448 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9342 0 14.6404 0 0 0 12.269 14.0487 0 0 13.5422 0 0 0 16.5819 15.5981 0 0 0 0 0 0 0 11.0713 0 14.3992 15.0154 15.0197 11.809 15.2952 16.3826 14.468 13.9534 0 12.6793 13.5771 0 0 15.3554 14.8154 14.3911 0 15.6379 0 0 15.9394 0 0 12.8728 15.4545 0 15.5296 13.563 0 0 13.4823 15.4595 15.7881 10.7328 0 0 9.95622 0 13.4211 15.4715 15.411 12.7772 0 0 0 0 15.3576 15.3739 0 15.3902 0 0 14.2366 0 0 0 15.5316 0 0 0 0 0 0 13.0895 0 0 0 0 12.6499 0 0 13.153 0 12.7677 0 10.6132 0 0 0 0 0 12.9103 13.621 0 15.2855 0 0 0 Q9UDY4 DNJB4_HUMAN "DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog, HSP40 homolog, Heat shock protein 40 homolog) (Human liver DnaJ-like protein)" DNAJB4 DNAJW HLJ1 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986] GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0051082; GO:0051085; GO:0051087 ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] KREIYDQFGEEGLK 0.9943 -11.178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7908 0 0 0 0 0 0 0 0 0 0 12.3889 0 11.0651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKU6 TRHDE_HUMAN "Thyrotropin-releasing hormone-degrading ectoenzyme, TRH-DE, TRH-degrading ectoenzyme, EC 3.4.19.6 (Pyroglutamyl-peptidase II, PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase)" TRHDE UNQ2507/PRO5995 Homo sapiens (Human) cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cell-cell signaling [GO:0007267]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] GO:0004177; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0007165; GO:0007267; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062 aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] ATFKISIK 0.9943 -13.819 0 0 0 0 0 11.7495 0 0 11.3157 0 0 0 0 0 0 0 0 0 0 10.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1628 0 0 0 0 0 0 0 0 0 10.1313 0 0 0 0 11.6439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7358 0 0 0 0 0 0 0 0 11.639 0 0 0 0 0 10.8281 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 13.7151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3708 0 0 0 0 0 0 12.7285 12.7833 0 0 0 0 0 0 0 0 0 12.0573 0 0 0 0 0 0 0 0 0 0 12.2694 0 0 0 0 12.3546 0 0 0 0 0 0 0 0 0 13.0641 0 12.7705 0 0 0 11.846 0 0 12.1672 0 0 0 0 0 0 Q9Y4P8 WIPI2_HUMAN "WD repeat domain phosphoinositide-interacting protein 2, WIPI-2 (WIPI49-like protein 2)" WIPI2 CGI-50 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792]" GO:0000045; GO:0000407; GO:0000422; GO:0005654; GO:0005829; GO:0006497; GO:0009267; GO:0010314; GO:0019898; GO:0032266; GO:0032991; GO:0034045; GO:0034497; GO:0044804; GO:0061739; GO:0080025; GO:0098792 "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]" GTEICNYSYSNTILAVKLNRQR 0.9943 -10.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0466 0 0 14.3846 0 0 0 0 0 0 0 0 0 0 0 0 12.8805 0 0 0 0 0 0 0 0 0 0 13.0759 0 12.4972 0 0 0 12.5371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4263 0 0 0 0 0 0 0 0 0 0 Q7LBR1 CHM1B_HUMAN "Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b, CHMP1b) (Vacuolar protein sorting-associated protein 46-2, Vps46-2, hVps46-2)" CHMP1B C18orf2 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005654; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0010008; GO:0010824; GO:0015031; GO:0019904; GO:0030117; GO:0030496; GO:0031468; GO:0032509; GO:0032585; GO:0036258; GO:0039702; GO:0042802; GO:0043162; GO:0045184; GO:0045324; GO:0046761; GO:0051301; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090541; GO:0097352; GO:1901673; GO:1902774; GO:1904903; GO:1904930 identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904] LARLRDQV 0.99431 -10.923 0 0 0 0 0 0 0 0 16.1645 13.7344 0 16.2393 16.0572 16.1947 16.0879 0 12.7303 0 0 0 0 0 0 0 0 13.6074 0 12.1357 12.7608 0 0 16.5886 0 13.0366 0 13.2386 0 0 0 16.3748 13.2582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3653 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7211 16.7411 0 18.3725 16.7817 16.7784 17.9662 0 0 0 16.7033 0 0 0 0 0 18.5446 0 18.7476 18.4207 18.8289 A8MYV0 DCD2C_HUMAN Doublecortin domain-containing protein 2C DCDC2C Homo sapiens (Human) intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; sperm flagellum [GO:0036126] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; sperm flagellum [GO:0036126]; intracellular signal transduction [GO:0035556] GO:0005737; GO:0005815; GO:0005874; GO:0035556; GO:0036126 DKEDARLCEDVER 0.99431 -11.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7032 0 0 0 13.2744 0 0 0 0 0 12.4204 0 0 0 0 0 0 0 0 0 0 0 0 13.6826 0 0 12.5354 0 12.076 12.6051 12.3718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.738 0 0 0 0 0 0 0 0 0 13.3473 0 13.9783 0 0 0 0 0 0 0 0 0 0 0 0 13.479 0 0 0 0 0 0 0 13.4761 0 0 0 0 0 0 14.73 0 0 0 0 0 0 0 0 0 0 13.0352 0 0 0 0 0 14.3653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4807 13.9192 0 0 0 0 0 15.0421 0 O60513 B4GT4_HUMAN "Beta-1,4-galactosyltransferase 4, Beta-1,4-GalTase 4, Beta4Gal-T4, b4Gal-T4, EC 2.4.1.- (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.275) (N-acetyllactosamine synthase, EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4)" B4GALT4 UNQ552/PRO1109 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glycosylation [GO:0070085]; keratan sulfate biosynthetic process [GO:0018146]; lactosylceramide biosynthetic process [GO:0001572]; membrane lipid metabolic process [GO:0006643]; protein glycosylation [GO:0006486] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250]; carbohydrate metabolic process [GO:0005975]; glycosylation [GO:0070085]; keratan sulfate biosynthetic process [GO:0018146]; lactosylceramide biosynthetic process [GO:0001572]; membrane lipid metabolic process [GO:0006643]; protein glycosylation [GO:0006486] GO:0000139; GO:0001572; GO:0003945; GO:0005576; GO:0005794; GO:0005975; GO:0006486; GO:0006643; GO:0008378; GO:0016021; GO:0018146; GO:0035250; GO:0046872; GO:0070085 galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250] AKLLNVGYLEALK 0.99431 -11.558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1739 11.6425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5993 0 0 0 0 0 14.4886 14.6956 0 0 0 14.711 0 0 0 0 13.7424 13.5603 0 0 13.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7036 0 0 0 0 0 12.345 0 0 0 13.1542 0 0 13.4642 13.0725 0 0 0 0 12.987 13.012 0 0 14.93 13.0347 10.5152 0 0 0 0 0 0 0 13.6036 0 0 0 0 13.1622 0 0 0 0 13.2279 13.0991 0 0 13.0025 12.8523 0 13.3552 0 0 0 0 0 0 O95389 CCN6_HUMAN "Cellular communication network factor 6 (CCN family member 6) (WNT1-inducible-signaling pathway protein 3, WISP-3)" CCN6 WISP3 UNQ462/PRO790/PRO956 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; signal transduction [GO:0007165] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; signal transduction [GO:0007165] GO:0005178; GO:0005615; GO:0005739; GO:0007155; GO:0007165; GO:0007267; GO:0008083; GO:0008201; GO:0008285; GO:0016525; GO:0031012; GO:0051881; GO:0060548; GO:1903426 growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178] DGCGCCK 0.99431 -11.556 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5332 0 0 0 0 0 0 0 12.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6471 15.1543 0 0 0 12.9837 13.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1193 13.2879 0 13.3149 0 12.5769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8656 0 0 0 0 0 0 12.9641 0 0 0 0 0 0 0 12.9988 0 0 0 0 0 0 0 0 0 0 0 O95672 ECEL1_HUMAN "Endothelin-converting enzyme-like 1, EC 3.4.24.- (Xce protein)" ECEL1 XCE UNQ2431/PRO4991 Homo sapiens (Human) neuropeptide signaling pathway [GO:0007218]; protein processing [GO:0016485]; respiratory system process [GO:0003016] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; neuropeptide signaling pathway [GO:0007218]; protein processing [GO:0016485]; respiratory system process [GO:0003016] GO:0003016; GO:0004222; GO:0005886; GO:0005887; GO:0007218; GO:0008237; GO:0016485; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] AKVQQLVEDIKYILGQR 0.99431 -11.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5135 13.7135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3132 0 0 0 0 0 P01036 CYTS_HUMAN Cystatin-S (Cystatin-4) (Cystatin-SA-III) (Salivary acidic protein 1) CST4 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of proteolysis [GO:0045861]; retina homeostasis [GO:0001895] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; vesicle [GO:0031982] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; vesicle [GO:0031982]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of proteolysis [GO:0045861]; retina homeostasis [GO:0001895] GO:0001580; GO:0001895; GO:0004869; GO:0005615; GO:0005737; GO:0031982; GO:0045861; GO:0070062; GO:2000117 cysteine-type endopeptidase inhibitor activity [GO:0004869] MSLVNSRCQEA 0.99431 -11.218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4701 0 0 0 17.0769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11226 MBL2_HUMAN "Mannose-binding protein C, MBP-C (Collectin-1) (MBP1) (Mannan-binding protein) (Mannose-binding lectin)" MBL2 COLEC1 MBL Homo sapiens (Human) "acute-phase response [GO:0006953]; antiviral innate immune response [GO:0140374]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing by host of symbiont cells [GO:0051873]; negative regulation of viral process [GO:0048525]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; response to oxidative stress [GO:0006979]" cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370] "cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; antiviral innate immune response [GO:0140374]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, classical pathway [GO:0006958]; complement activation, lectin pathway [GO:0001867]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; killing by host of symbiont cells [GO:0051873]; negative regulation of viral process [GO:0048525]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; response to oxidative stress [GO:0006979]" GO:0001867; GO:0002752; GO:0005102; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0006953; GO:0006958; GO:0006979; GO:0008228; GO:0009897; GO:0009986; GO:0042742; GO:0042802; GO:0045087; GO:0048306; GO:0048525; GO:0050830; GO:0051873; GO:0062023; GO:0140374; GO:1903028; GO:1905370 calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; signaling receptor binding [GO:0005102] ALQTEMARIKK 0.99431 -7.9821 0 10.2779 0 0 0 0 0 0 0 0 0 11.7255 0 0 0 0 0 0 0 11.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6851 0 0 0 0 15.0145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35813 PPM1A_HUMAN "Protein phosphatase 1A, EC 3.1.3.16 (Protein phosphatase 2C isoform alpha, PP2C-alpha) (Protein phosphatase IA)" PPM1A PPPM1A Homo sapiens (Human) "cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; regulation of cell cycle [GO:0051726]" cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of SMAD protein complex assembly [GO:0010991]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of transcription, DNA-templated [GO:0045893]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; regulation of cell cycle [GO:0051726]" GO:0000122; GO:0000287; GO:0004722; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006470; GO:0006499; GO:0006611; GO:0010991; GO:0016020; GO:0016311; GO:0017018; GO:0030145; GO:0030512; GO:0030514; GO:0033192; GO:0035970; GO:0043123; GO:0043124; GO:0045893; GO:0046827; GO:0051726; GO:0070412; GO:0071560; GO:0090263; GO:1901223 calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412] EAELDKYLECR 0.99431 -11.555 0 0 0 0 0 0 0 0 0 0 0 0 11.7734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0208 0 0 0 11.026 0 0 0 0 0 0 0 0 0 9.68794 0 0 0 11.1744 11.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3832 0 10.4691 0 0 9.52158 0 10.8335 14.7513 0 13.5926 0 18.8058 11.7267 19.2355 18.6256 20.9557 20.7716 20.9481 20.8149 20.8022 0 0 19.9455 0 0 0 20.5747 20.2326 20.3686 20.9543 21.3069 20.8029 18.5359 19.2831 19.0454 19.0399 18.2393 19.3434 19.5125 18.955 0 18.8917 18.8137 18.3277 0 18.2414 20.4206 20.0185 0 18.4582 19.3581 18.891 19.0995 18.7292 19.6336 19.7884 18.887 18.9201 19.6038 19.5218 19.7129 19.1311 20.1584 18.2703 19.6526 19.4177 18.5341 17.1428 19.3547 0 18.817 19.2533 12.8113 18.565 0 16.5761 18.2462 17.9204 18.5241 18.5943 0 14.7055 0 18.3326 17.9813 17.2006 18.4263 18.6074 18.4827 0 0 0 0 0 0 0 0 11.7645 0 0 0 11.3235 16.491 10.4643 10.3606 18.5441 0 0 0 0 11.8416 0 0 P43351 RAD52_HUMAN DNA repair protein RAD52 homolog RAD52 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; regulation of nucleotide-excision repair [GO:2000819] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to oxidative stress [GO:0034599]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via single-strand annealing [GO:0045002]; mitotic recombination [GO:0006312]; regulation of nucleotide-excision repair [GO:2000819] GO:0000724; GO:0000730; GO:0003677; GO:0003697; GO:0005634; GO:0005654; GO:0006302; GO:0006310; GO:0006312; GO:0006974; GO:0010792; GO:0032991; GO:0032993; GO:0034599; GO:0042802; GO:0045002; GO:2000819 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697] QLPLEVDLTKAK 0.99431 -11.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59817 Z280A_HUMAN Zinc finger protein 280A (3'OY11.1) (Suppressor of hairy wing homolog 1) (Zinc finger protein 636) ZNF280A SUHW1 ZNF280 ZNF636 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DHQTFKK 0.99431 -8.722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3713 0 0 0 0 0 0 10.3481 0 0 0 0 0 0 0 0 0 0 0 0 11.3524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2484 11.3327 0 0 0 0 0 14.7377 0 0 0 10.116 0 0 0 11.1282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7565 0 0 0 0 0 0 0 12.25 10.5733 12.9627 0 0 0 0 0 0 15.7281 0 0 0 0 11.1027 0 0 0 0 11.8071 0 0 10.1697 0 0 13.567 0 13.9273 11.1409 0 0 0 0 10.5492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03188 CENPC_HUMAN "Centromere protein C, CENP-C (Centromere autoantigen C) (Centromere protein C 1, CENP-C 1) (Interphase centromere complex protein 7)" CENPC CENPC1 ICEN7 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; monopolar spindle attachment to meiosis I kinetochore [GO:0051455] "condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]" "condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; monopolar spindle attachment to meiosis I kinetochore [GO:0051455]" GO:0000278; GO:0000776; GO:0000779; GO:0003677; GO:0005654; GO:0005721; GO:0005829; GO:0007059; GO:0016604; GO:0019237; GO:0030496; GO:0042802; GO:0051301; GO:0051315; GO:0051382; GO:0051455 centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802] KIEIDNKVSDEEDK 0.99431 -11.534 0 0 0 0 0 0 0 0 0 0 0 0 11.3911 0 0 0 0 0 0 0 0 0 0 9.58477 0 0 12.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0124 0 0 0 0 11.0974 0 0 0 0 12.2945 0 0 0 10.9173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3905 0 0 12.5015 0 0 0 0 0 0 0 0 0 11.5812 13.9628 0 0 0 11.023 12.0325 0 11.5898 0 11.4008 0 0 0 0 0 11.2309 0 13.8882 12.6135 0 0 0 0 0 0 0 0 0 11.9981 0 15.6463 0 14.5578 14.7234 14.2883 0 0 0 0 14.5958 12.9762 11.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2866 0 0 11.9452 0 0 0 0 0 0 0 11.7565 0 0 11.9743 0 0 0 0 0 0 0 0 0 0 Q05D32 CTSL2_HUMAN "CTD small phosphatase-like protein 2, CTDSP-like 2, EC 3.1.3.-" CTDSPL2 HSPC058 HSPC129 Homo sapiens (Human) negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein export from nucleus [GO:0046827]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of protein export from nucleus [GO:0046827]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611] GO:0004721; GO:0005654; GO:0006470; GO:0006611; GO:0008420; GO:0030514; GO:0046827 phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420] EERENPSK 0.99431 -15.741 0 0 13.1403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2952 0 0 0 0 0 0 0 0 0 0 12.7309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6295 13.4037 0 0 0 0 13.7297 0 0 0 0 0 0 0 0 0 0 0 0 13.6854 0 0 0 0 14.3116 13.5476 13.6175 0 0 0 0 13.5311 0 0 0 0 0 0 0 0 14.1124 0 0 14.0107 0 0 12.3092 0 15.0259 0 13.6936 0 0 0 0 0 0 0 0 0 15.0694 0 0 0 0 0 0 0 0 13.6657 0 0 0 0 0 0 0 0 0 0 0 0 13.3253 0 0 0 0 13.987 0 0 0 0 0 0 0 0 0 0 0 0 14.5129 0 0 0 12.2927 0 0 0 Q14586 ZN267_HUMAN Zinc finger protein 267 (Zinc finger protein HZF2) ZNF267 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ECGKAFR 0.99431 -11.532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7525 0 0 0 0 0 0 0 0 0 13.0724 13.4727 0 0 0 0 12.3422 0 0 0 0 0 12.3859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1241 0 0 0 0 0 14.0464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2691 13.4196 0 0 13.6324 0 0 0 0 0 0 0 0 11.6494 0 0 Q719I0 AHSA2_HUMAN Putative activator of 90 kDa heat shock protein ATPase homolog 2 (Activator of HSP90 ATPase homolog 2 pseudogene) AHSA2P AHSA2 Homo sapiens (Human) positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457] cytosol [GO:0005829] cytosol [GO:0005829]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457] GO:0001671; GO:0005829; GO:0006457; GO:0032781; GO:0051087; GO:0051879 ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879] ESGVKHK 0.99431 -15.701 0 0 0 0 0 0 0 0 0 0 12.8451 12.853 0 0 0 0 0 0 0 0 0 0 11.0978 0 0 0 0 0 10.9127 0 0 0 0 0 10.9725 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9057 0 0 0 0 0 11.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2245 0 0 0 0 0 0 0 0 11.3624 12.8526 0 0 0 0 0 11.4258 0 0 0 0 13.8441 0 10.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4144 13.7567 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1584 13.6672 0 0 12.8153 0 0 13.3558 13.6722 13.6793 0 0 13.2913 0 0 13.0223 0 0 0 0 0 0 0 0 0 0 0 0 14.0218 13.4482 0 13.6151 0 0 0 0 0 0 0 9.8352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYT2 CMTR2_HUMAN "Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2, EC 2.1.1.296 (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2, HMTr2, MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog)" CMTR2 AFT FTSJD1 Homo sapiens (Human) 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; cap2 mRNA methylation [GO:0097310] GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097309; GO:0097310 mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483] AEQEKLNNLRDCAIQYFMQK 0.99431 -8.5103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2544 0 0 0 0 10.9335 0 0 0 0 0 0 0 0 10.9104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5881 0 0 0 0 0 12.3737 12.8308 0 11.7241 0 15.3334 0 0 0 0 10.4912 0 0 0 11.7102 0 0 0 0 0 0 0 0 0 12.8972 15.4768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9466 0 0 0 0 0 0 0 0 0 0 0 0 11.0475 0 0 15.1193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0822 0 0 0 0 0 0 0 11.1755 0 0 Q8NCP5 ZBT44_HUMAN Zinc finger and BTB domain-containing protein 44 (BTB/POZ domain-containing protein 15) (Zinc finger protein 851) ZBTB44 BTBD15 ZNF851 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0005634; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AYSLKMHR 0.99431 -15.711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9091 0 0 0 12.9465 12.9734 0 0 0 0 0 12.7841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4923 0 0 0 0 12.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGS6 O13C3_HUMAN Olfactory receptor 13C3 (Olfactory receptor OR9-8) OR13C3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] SQDLIGEEK 0.99431 -11.544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.244 0 0 0 Q8TD55 PKHO2_HUMAN "Pleckstrin homology domain-containing family O member 2, PH domain-containing family O member 2 (Pleckstrin homology domain-containing family Q member 1, PH domain-containing family Q member 1)" PLEKHO2 PLEKHQ1 PP9099 Homo sapiens (Human) macrophage apoptotic process [GO:0071888] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813] extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; macrophage apoptotic process [GO:0071888] GO:0005576; GO:0071888; GO:1904813 FILLRSPGNK 0.99431 -10.949 0 0 0 0 0 0 0 0 15.9097 0 16.3326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0138 0 0 0 13.0389 13.6315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8132 0 18.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7046 Q92988 DLX4_HUMAN Homeobox protein DLX-4 (Beta protein 1) (Homeobox protein DLX-7) (Homeobox protein DLX-8) DLX4 BP1 DLX7 DLX8 DLX9 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0030154; GO:0043565; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" PQAPAKK 0.99431 -8.7333 0 0 0 0 0 0 11.8216 0 0 0 0 0 0 14.2707 0 13.6572 13.7369 13.8808 14.5234 16.6815 13.0778 14.591 15.4399 12.5993 13.8327 14.1633 13.1769 0 0 11.2366 0 14.5606 0 0 0 0 10.2008 0 16.0935 0 14.7891 0 0 14.9435 13.8843 0 0 13.2311 11.7163 0 12.572 15.9745 11.819 13.8524 13.1456 11.5163 0 0 0 0 0 0 0 0 0 0 13.6047 13.5381 0 13.644 14.1084 14.6864 0 0 14.4928 15.572 15.1752 14.8874 13.3151 15.1875 14.8074 15.3174 14.6554 14.9676 14.3534 14.9167 13.1486 14.378 14.4578 0 13.5986 13.4605 0 14.4134 0 14.4752 17.5405 0 16.2521 17.3154 16.5592 14.0345 15.2012 15.2831 16.6399 16.6521 17.9006 16.9894 13.9449 15.6603 0 14.1289 14.0548 15.2425 0 0 16.3442 18.927 15.7459 0 16.1078 16.8757 17.1332 16.1568 14.3377 0 15.8751 15.087 15.7575 17.0247 0 0 16.6766 16.1792 18.4226 15.2568 15.1588 0 0 0 16.1256 15.4021 16.235 15.0113 14.5737 16.2307 14.9645 15.1234 0 0 15.5421 14.112 15.3261 0 14.514 0 16.2385 13.6454 0 0 14.7659 13.7882 14.8362 13.92 13.4103 18.419 16.1653 13.9399 14.4615 14.6343 16.3588 15.0955 18.4371 15.5676 13.8884 15.2807 0 13.44 17.8179 0 Q96D46 NMD3_HUMAN "60S ribosomal export protein NMD3, hNMD3" NMD3 CGI-07 Homo sapiens (Human) positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; protein transport [GO:0015031]; ribosomal large subunit export from nucleus [GO:0000055] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; protein transport [GO:0015031]; ribosomal large subunit export from nucleus [GO:0000055] GO:0000055; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0015031; GO:0016020; GO:0030674; GO:0032092; GO:0043023; GO:1902680; GO:1904751 protein-macromolecule adaptor activity [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723] ELLALCLKKIK 0.99431 -15.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2512 0 0 0 0 0 0 0 0 13.1415 0 0 0 0 0 13.699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4951 0 0 0 0 13.3685 0 0 0 0 0 0 11.508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6888 0 0 0 0 0 0 0 12.1212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4673 0 0 0 0 0 0 0 0 0 0 13.3999 0 0 0 0 0 9.91864 0 0 0 0 0 0 0 0 13.5094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99650 OSMR_HUMAN "Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta, IL-31 receptor subunit beta, IL-31R subunit beta, IL-31R-beta, IL-31RB)" OSMR OSMRB Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]; cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097] GO:0002675; GO:0004896; GO:0004923; GO:0005127; GO:0005886; GO:0005900; GO:0008284; GO:0009897; GO:0016324; GO:0019221; GO:0019838; GO:0019955; GO:0034097; GO:0038165; GO:0043235 ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923] ARQCHPRFEK 0.99431 -11.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5194 0 13.3142 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53978 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.769 13.479 0 0 0 0 11.7996 13.4037 12.5689 12.861 12.9748 11.6065 13.6739 13.592 13.7216 0 0 0 0 13.4812 0 0 0 0 0 11.8722 0 0 13.3044 14.2169 0 0 14.252 13.3761 15.1341 0 0 14.4773 0 14.7291 13.5399 13.7835 0 14.6833 0 0 13.6174 0 0 0 0 0 0 14.0359 0 14.3615 0 13.8172 15.486 14.0292 0 0 13.8202 13.3311 0 14.6549 13.4194 13.7177 14.0607 13.7534 0 14.0802 0 0 14.6903 0 14.7259 13.6708 14.3442 0 0 0 13.3204 15.5527 0 0 0 0 0 11.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0895 13.5376 0 0 0 0 0 0 0 Q9HC44 GPBL1_HUMAN Vasculin-like protein 1 (GC-rich promoter-binding protein 1-like 1) GPBP1L1 SP192 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0003723; GO:0005634; GO:0006351; GO:0006355; GO:0045893 DNA binding [GO:0003677]; RNA binding [GO:0003723] AEFEDSDTETSSSETSDDDAWK 0.99431 -10.932 0 0 0 0 0 0 0 0 13.9577 0 0 0 0 0 0 0 12.221 0 0 0 0 0 11.7989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2156 0 0 0 0 0 0 0 0 12.7426 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0859 0 Q9UBS4 DJB11_HUMAN "DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2, ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3, ER-resident protein ERdj3, ERdj3, ERj3p) (HEDJ) (Human DnaJ protein 9, hDj-9) (PWP1-interacting protein 4)" DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 Homo sapiens (Human) mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; misfolded protein binding [GO:0051787]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604] GO:0005102; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0006457; GO:0016020; GO:0016556; GO:0032781; GO:0034663; GO:0050768; GO:0051082; GO:0051604; GO:0051787; GO:0101031 misfolded protein binding [GO:0051787]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082] AYRKLALQLHPDR 0.99431 -15.694 0 0 0 0 0 0 0 0 0 11.3512 0 0 0 0 0 0 0 0 0 0 0 9.97327 13.0077 0 0 12.2303 10.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5218 0 12.4668 0 0 0 0 0 0 10.1874 14.6565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1625 0 0 0 0 0 11.785 0 0 0 0 0 0 0 0 0 0 15.3353 15.7657 12.1889 0 0 0 0 11.4617 0 0 0 0 0 0 0 0 0 0 0 10.8336 0 0 0 0 0 0 11.7388 0 17.7985 17.4215 0 0 0 11.9583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3718 11.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.61 14.4464 0 0 Q9UEE9 CFDP1_HUMAN Craniofacial development protein 1 (Bucentaur) CFDP1 BCNT CENP-29 Homo sapiens (Human) cell adhesion [GO:0007155]; chromatin remodeling [GO:0006338]; fibroblast apoptotic process [GO:0044346]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360] kinetochore [GO:0000776]; nucleus [GO:0005634]; Swr1 complex [GO:0000812] kinetochore [GO:0000776]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; cell adhesion [GO:0007155]; chromatin remodeling [GO:0006338]; fibroblast apoptotic process [GO:0044346]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360] GO:0000776; GO:0000812; GO:0005634; GO:0006338; GO:0007155; GO:0008360; GO:0042127; GO:0044346; GO:2000270 AEELEKPK 0.99431 -11.529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.74 0 0 0 0 0 0 0 16.3399 0 0 0 0 0 0 0 16.1978 0 16.2178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9937 0 0 0 16.038 15.8965 0 15.1271 15.3994 11.2601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5 0 10.9779 0 0 0 0 0 0 0 0 0 0 0 0 14.7364 0 0 0 0 12.1167 0 16.3324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8105 0 0 19.3904 16.2583 13.1337 0 0 11.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULV3 CIZ1_HUMAN Cip1-interacting zinc finger protein (CDKN1A-interacting zinc finger protein 1) (Nuclear protein NP94) (Zinc finger protein 356) CIZ1 LSFR1 NP94 ZNF356 Homo sapiens (Human) maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-templated DNA replication initiation [GO:0032298] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cyclin binding [GO:0030332]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of DNA-templated DNA replication initiation [GO:0032298] GO:0003676; GO:0005634; GO:0005654; GO:0005886; GO:0008270; GO:0030332; GO:0032298; GO:0051457 cyclin binding [GO:0030332]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] ASCSSQQEFQDHMSEPQHQQR 0.99431 -5.5029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1147 0 11.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7443 0 0 0 0 0 0 0 0 0 0 0 13.8606 0 0 0 0 0 0 0 12.4345 16.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4395 0 15.3906 0 0 0 0 0 0 0 0 0 0 11.5926 0 14.623 0 14.324 0 0 0 0 0 0 0 0 0 0 0 0 14.1811 0 0 0 0 13.6455 0 0 0 0 0 0 12.5746 13.8307 0 0 0 0 0 0 0 0 0 0 0 0 11.6941 0 0 0 0 0 0 13.5607 0 0 0 0 0 14.9933 0 13.861 14.0998 13.9454 0 0 0 0 Q9Y466 NR2E1_HUMAN "Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog, Tll, hTll)" NR2E1 TLX Homo sapiens (Human) aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; anterior commissure morphogenesis [GO:0021960]; apoptotic process [GO:0006915]; astrocyte cell migration [GO:0043615]; astrocyte differentiation [GO:0048708]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; aggressive behavior [GO:0002118]; amygdala development [GO:0021764]; anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; anterior commissure morphogenesis [GO:0021960]; apoptotic process [GO:0006915]; astrocyte cell migration [GO:0043615]; astrocyte differentiation [GO:0048708]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cerebral cortex neuron differentiation [GO:0021895]; dentate gyrus development [GO:0021542]; extracellular matrix organization [GO:0030198]; forebrain generation of neurons [GO:0021872]; layer formation in cerebral cortex [GO:0021819]; long-term synaptic potentiation [GO:0060291]; negative regulation of apoptotic process [GO:0043066]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; olfactory bulb development [GO:0021772]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of stem cell proliferation [GO:2000648]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of dendrite morphogenesis [GO:0048814]; regulation of timing of neuron differentiation [GO:0060164]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041]; social behavior [GO:0035176]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; visual perception [GO:0007601]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001662; GO:0002052; GO:0002118; GO:0003707; GO:0004879; GO:0005654; GO:0006357; GO:0006915; GO:0007399; GO:0007405; GO:0007601; GO:0008270; GO:0021542; GO:0021764; GO:0021772; GO:0021819; GO:0021872; GO:0021895; GO:0021960; GO:0030154; GO:0030198; GO:0035019; GO:0035176; GO:0042826; GO:0043066; GO:0043615; GO:0045165; GO:0045665; GO:0045766; GO:0045787; GO:0048708; GO:0048712; GO:0048814; GO:0048856; GO:0060041; GO:0060164; GO:0060291; GO:0072089; GO:0090049; GO:1990837; GO:2000178; GO:2000647; GO:2000648 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" AVPTHSGSELR 0.99431 -10.919 0 0 0 0 0 0 0 0 13.7973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6824 0 13.4888 0 0 0 0 0 0 0 0 0 9.88293 0 0 10.0353 14.3816 0 0 0 0 0 10.0513 0 0 0 9.60281 0 0 0 0 0 0 0 0 0 0 0 0 10.2018 0 0 0 0 0 0 0 0 0 0 0 0 14.986 0 0 0 0 0 0 0 0 0 0 0 0 12.7953 0 0 0 0 0 0 0 0 0 0 0 15.3004 0 0 0 0 0 15.3648 0 0 0 0 0 0 0 12.4357 0 0 0 0 0 14.6028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7881 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8158 0 15.4925 O60486 PLXC1_HUMAN Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232) PLXNC1 VESPR Homo sapiens (Human) cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] GO:0002116; GO:0005102; GO:0005886; GO:0005887; GO:0007155; GO:0007162; GO:0008360; GO:0016020; GO:0017154; GO:0030334; GO:0043087; GO:0050772; GO:1902287 semaphorin receptor activity [GO:0017154]; signaling receptor binding [GO:0005102] APPRPPRPAAPLPLLAYLLALAAPGR 0.99432 -11.591 0 0 0 0 0 0 14.5195 0 0 0 0 0 0 0 0 12.3552 0 12.2096 11.9907 0 0 0 0 13.3809 0 0 0 12.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3526 15.8742 15.0142 15.0246 0 0 14.968 0 0 15.0004 0 15.3882 16.2504 15.1748 16.0973 15.1435 15.85 11.3699 13.5507 14.3968 0 16.1932 0 0 0 14.5967 14.0006 17.1254 15.792 17.3692 16.8421 17.3821 15.1799 15.4694 17.4725 16.8703 16.8682 13.8396 16.7593 0 15.9784 13.2938 15.2698 17.4283 16.4209 14.5857 19.0324 16.903 15.7899 16.4999 18.4065 14.7265 15.6701 15.7526 15.2296 17.1832 15.6643 15.6438 14.3986 13.3424 16.156 13.6931 15.5973 16.8599 16.219 17.1732 16.0295 17.059 0 16.4977 16.5051 16.358 14.668 16.7488 17.4501 0 0 11.1457 16.6429 15.7928 0 15.9941 19.2308 16.1257 0 0 0 0 0 11.3199 0 10.2577 0 0 0 0 0 0 0 14.7339 15.7458 16.9586 15.9056 0 0 0 16.6641 0 O15217 GSTA4_HUMAN "Glutathione S-transferase A4, EC 2.5.1.18 (GST class-alpha member 4) (Glutathione S-transferase A4-4)" GSTA4 Homo sapiens (Human) glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829] cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805] GO:0004364; GO:0005829; GO:0006749; GO:0006805; GO:0042802; GO:0042803 glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] IPNILSAFPFLQEYTVKLSNIPTIK 0.99432 -10.965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.727 12.2397 0 0 0 0 0 15.0693 0 0 0 0 0 0 0 0 0 0 9.82944 0 0 0 0 0 0 12.6061 12.1858 0 0 0 0 0 0 0 0 12.5033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43526 KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2) KCNQ2 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] axon initial segment [GO:0043194]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; nervous system development [GO:0007399]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0005887; GO:0007268; GO:0007399; GO:0008076; GO:0016021; GO:0030506; GO:0033268; GO:0034765; GO:0043194; GO:0045202; GO:0071805 ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249] DPPPEPSPSK 0.99432 -7.9908 0 0 0 0 0 0 0 0 0 0 11.6148 0 0 0 0 0 15.502 0 0 0 0 0 0 14.3632 12.1524 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2002 11.0637 0 0 0 0 0 14.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7411 0 13.4708 0 0 14.349 0 13.8417 0 0 0 13.7408 15.4853 13.7118 16.4586 14.7726 0 0 0 10.5158 0 0 0 0 0 0 0 0 14.3332 0 11.0513 12.8649 0 0 0 0 14.4415 0 13.7468 0 13.7576 0 0 0 0 0 0 0 0 0 0 0 13.7797 11.8029 0 0 0 0 0 0 12.7771 10.7396 0 0 12.6693 10.9852 0 0 0 0 0 0 0 0 0 0 14.6853 0 0 0 0 0 0 0 0 0 13.3791 0 0 12.7286 0 12.7707 0 0 0 0 0 0 0 0 11.8559 14.3016 0 0 0 0 0 P08686 CP21A_HUMAN "Steroid 21-hydroxylase, EC 1.14.14.16 (21-OHase) (Cytochrome P-450c21) (Cytochrome P450 21) (Cytochrome P450 XXI) (Cytochrome P450-C21) (Cytochrome P450-C21B)" CYP21A2 CYP21 CYP21B Homo sapiens (Human) glucocorticoid biosynthetic process [GO:0006704]; mineralocorticoid biosynthetic process [GO:0006705]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; 17-hydroxyprogesterone 21-hydroxylase activity [GO:0103069]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; progesterone 21-hydroxylase activity [GO:0106309]; steroid 21-monooxygenase activity [GO:0004509]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; glucocorticoid biosynthetic process [GO:0006704]; mineralocorticoid biosynthetic process [GO:0006705]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125] GO:0004509; GO:0005496; GO:0005506; GO:0005789; GO:0006694; GO:0006704; GO:0006705; GO:0008202; GO:0008395; GO:0016125; GO:0020037; GO:0103069; GO:0106309 17-hydroxyprogesterone 21-hydroxylase activity [GO:0103069]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; progesterone 21-hydroxylase activity [GO:0106309]; steroid 21-monooxygenase activity [GO:0004509]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395] ARLPLLNATIAEVLR 0.99432 -7.9997 0 11.4447 0 0 0 0 0 0 0 11.0171 0 0 0 0 0 0 12.0154 11.3102 0 11.734 0 11.8904 0 0 0 0 0 0 0 0 0 0 15.6258 0 0 0 15.2811 0 0 16.3937 0 0 0 0 0 0 0 0 9.58646 0 0 0 0 13.6063 0 0 13.7889 0 0 15.9717 0 14.8846 15.4732 0 15.3395 15.9155 15.4556 11.4368 0 0 14.067 0 11.2882 0 0 14.1102 14.212 0 0 0 0 0 14.587 0 0 15.2126 13.2325 15.9738 14.9661 14.8281 15.0686 16.6575 0 17.9604 14.9655 15.2513 14.4341 14.7332 0 0 0 14.7666 14.7289 0 14.2707 15.3742 14.3096 0 0 0 15.006 12.6756 0 14.4764 14.4767 14.9165 13.0271 15.3342 14.7035 0 12.4628 0 14.6444 0 11.4865 0 0 0 15.4607 14.7479 14.0575 0 14.9419 0 14.0542 13.2955 14.5432 0 15.0826 13.6883 14.5118 14.1632 14.9626 13.8248 0 13.5901 0 13.1834 0 0 14.4467 0 0 12.7725 14.7297 0 0 0 0 0 14.4186 0 0 0 14.107 11.8124 0 11.407 0 0 0 12.7492 10.9199 0 13.0305 0 11.3918 0 13.7212 11.9336 P26639 SYTC_HUMAN "Threonine--tRNA ligase 1, cytoplasmic, EC 6.1.1.3 (Threonyl-tRNA synthetase, ThrRS) (Threonyl-tRNA synthetase 1)" TARS1 TARS Homo sapiens (Human) threonyl-tRNA aminoacylation [GO:0006435] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; threonyl-tRNA aminoacylation [GO:0006435] GO:0000049; GO:0004829; GO:0005524; GO:0005829; GO:0006435; GO:0008270; GO:0042802; GO:0070062 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] AILGSVER 0.99432 -9.0177 0 11.3775 0 0 0 0 11.6124 10.7567 0 0 0 14.2161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.305 0 0 12.6962 14.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1453 12.9652 13.4671 12.5898 0 0 0 11.9639 12.2697 0 0 0 0 0 0 0 0 0 0 0 0 11.6199 11.5105 0 0 0 16.5472 0 0 0 0 0 15.824 0 0 11.5468 0 11.7054 0 0 0 0 0 0 12.1388 0 0 12.9891 0 0 0 0 0 15.8298 0 13.5946 12.7616 0 14.5656 0 0 12.2105 12.5219 0 0 0 0 0 0 0 0 0 0 15.8031 13.2416 0 14.4095 0 0 0 0 0 0 13.6909 0 0 13.7085 0 0 0 0 0 0 0 0 0 0 0 13.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7314 18.0706 14.0314 0 Q08752 PPID_HUMAN "Peptidyl-prolyl cis-trans isomerase D, PPIase D, EC 5.2.1.8 (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40, CYP-40) (Cyclophilin-related protein) (Rotamase D)" PPID CYP40 CYPD Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear estrogen receptor binding [GO:0030331]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076] GO:0000122; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006457; GO:0006915; GO:0008134; GO:0015031; GO:0016018; GO:0019076; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0045070; GO:0050714; GO:0051879; GO:0061077; GO:0065003; GO:0071492 cyclosporin A binding [GO:0016018]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear estrogen receptor binding [GO:0030331]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134] AKLQPIALSCVLNIGACK 0.99432 -15.765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2441 0 0 0 13.3703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7139 0 13.2653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9975 0 0 0 0 0 0 0 14.9016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4881 0 0 0 0 0 0 0 13.1002 0 0 0 0 0 0 0 0 0 0 0 14.0366 0 0 0 0 0 0 0 0 0 0 0 0 12.9166 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9717 0 0 0 0 0 0 14.1514 0 0 0 0 0 0 0 0 0 0 Q14CW9 AT7L3_HUMAN Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog) ATXN7L3 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone monoubiquitination [GO:0010390]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "DUBm complex [GO:0071819]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; histone monoubiquitination [GO:0010390]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000124; GO:0003713; GO:0005634; GO:0006282; GO:0006325; GO:0006357; GO:0008270; GO:0010390; GO:0016578; GO:0030374; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0071819 nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270] SESDQEDNDDINDNDWSYGSEKK 0.99432 -8.5373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4695 0 0 0 0 0 0 0 0 0 0 0 12.9844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3408 0 0 0 0 0 0 13.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2036 0 0 0 11.7707 0 0 0 0 0 Q32M84 BTBDG_HUMAN BTB/POZ domain-containing protein 16 BTBD16 C10orf87 Homo sapiens (Human) AQSPKKTK 0.99432 -11.595 0 0 0 0 0 0 0 0 0 0 0 13.1577 0 0 0 0 0 0 13.7881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3123 12.5771 13.3857 10.406 0 0 0 0 0 0 0 0 0 9.1274 0 0 0 0 14.0791 0 13.3782 0 0 0 14.1208 14.4003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1355 0 0 0 0 0 0 11.7676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5153 0 0 0 0 0 13.5492 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2265 13.1277 0 0 0 0 11.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6AZW8 ZN660_HUMAN Zinc finger protein 660 ZNF660 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] AFTSNRNLVDHQR 0.99432 -7.9898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5436 0 0 12.8248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8103 0 0 13.7815 0 0 0 0 0 0 13.5967 0 0 0 0 0 0 13.223 0 0 0 0 0 13.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5211 0 0 0 0 0 0 0 0 Q6ZSR3 YO027_HUMAN "Putative uncharacterized protein FLJ45275, mitochondrial" Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 ATLPHFR 0.99432 -8.5284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3802 0 0 0 0 0 0 0 0 0 13.0745 0 0 0 0 0 0 14.1148 0 0 0 0 14.0045 0 0 0 0 0 0 14.6653 15.4047 0 0 0 0 0 0 0 14.7502 0 0 0 0 0 0 0 0 0 0 0 12.7495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2456 0 0 0 0 0 0 0 0 0 0 0 0 13.2173 0 0 0 0 0 0 0 0 0 0 12.7174 0 0 0 0 0 0 0 0 0 0 0 0 Q8NC38 CA213_HUMAN Putative uncharacterized protein ZNF436-AS1 (ZNF436 antisense RNA 1) (ZNF436 antisense gene protein 1) ZNF436-AS1 C1orf213 Homo sapiens (Human) LAVPVRLKVGSR 0.99432 -15.812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4975 13.9977 12.5022 12.5439 0 12.7495 15.6913 13.3983 0 0 0 0 0 0 0 13.4676 0 0 0 0 0 0 12.7416 0 0 12.958 13.6091 13.2244 13.1715 11.8366 0 0 12.2554 0 12.0692 0 12.7269 0 13.166 13.2096 13.0318 0 0 0 12.5596 0 0 0 12.9976 0 0 0 0 12.7158 0 0 13.0093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6557 0 Q92769 HDAC2_HUMAN "Histone deacetylase 2, HD2, EC 3.5.1.98 (Protein deacylase HDAC2, EC 3.5.1.-)" HDAC2 Homo sapiens (Human) "behavioral response to ethanol [GO:0048149]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin organization [GO:0070828]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein lysine deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; behavioral response to ethanol [GO:0048149]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin organization [GO:0070828]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410]" GO:0000118; GO:0000122; GO:0000781; GO:0000785; GO:0001975; GO:0003300; GO:0003682; GO:0003723; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006357; GO:0008284; GO:0009410; GO:0009913; GO:0010718; GO:0010977; GO:0016358; GO:0016575; GO:0016580; GO:0016581; GO:0019213; GO:0019899; GO:0030336; GO:0030512; GO:0031000; GO:0031072; GO:0032496; GO:0032732; GO:0032760; GO:0032922; GO:0032967; GO:0032991; GO:0033558; GO:0034605; GO:0035094; GO:0035098; GO:0042220; GO:0042475; GO:0042531; GO:0042659; GO:0042733; GO:0042826; GO:0043066; GO:0043392; GO:0043433; GO:0043565; GO:0045347; GO:0045862; GO:0045892; GO:0045893; GO:0045944; GO:0048149; GO:0048714; GO:0051059; GO:0055093; GO:0060789; GO:0061000; GO:0061029; GO:0061198; GO:0061629; GO:0070301; GO:0070828; GO:0070932; GO:0070933; GO:0071300; GO:0071560; GO:0160009; GO:0160010; GO:1902437; GO:1902455; GO:1902459; GO:1903351; GO:1990841; GO:2000273; GO:2000736; GO:2000757 chromatin binding [GO:0003682]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein lysine deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565] CVEVVKTFNLPLLMLGGGGYTIRNVAR 0.99432 -8.5451 0 0 0 0 0 0 0 0 13.1395 0 0 0 0 13.0368 0 0 0 0 0 0 0 12.2257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2734 0 0 0 12.6423 0 0 0 10.7979 0 0 0 0 0 0 0 0 14.8169 0 12.6356 0 0 0 0 0 0 12.3572 0 0 0 0 0 10.8775 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9086 0 11.764 0 0 0 0 0 0 0 0 0 0 0 0 12.833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8729 0 0 0 0 13.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92954 PRG4_HUMAN Proteoglycan 4 (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Cleaved into: Proteoglycan 4 C-terminal part ] PRG4 MSF SZP Homo sapiens (Human) immune response [GO:0006955] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955] GO:0005044; GO:0005615; GO:0006955; GO:0030247; GO:0062023 polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044] CFESFERGRECDCDAQCK 0.99432 -28.538 0 0 0 0 0 0 11.7414 0 0 11.9092 12.4931 0 0 0 0 0 0 0 0 12.1157 0 0 11.4298 11.5279 0 0 0 12.1544 11.571 12.224 0 0 0 0 0 0 11.9092 0 0 0 0 10.8611 12.3287 0 0 13.9526 0 0 0 12.3348 0 0 0 0 0 10.9032 0 0 11.8457 0 0 0 0 0 10.6767 0 0 0 0 0 11.4993 0 0 0 0 13.3734 12.313 0 12.3 11.559 0 0 13.5298 13.8405 0 0 0 18.9744 0 17.146 13.7931 14.8035 15.6566 14.0183 14.4479 12.0086 17.2704 0 0 15.046 13.7104 12.5007 13.9847 14.2216 0 14.1491 0 13.288 12.5114 13.9044 12.8735 14.8671 12.0472 14.0552 13.0582 13.9135 0 12.9353 14.4655 14.2 13.0069 12.0519 13.9083 0 14.1418 0 13.3855 0 14.0193 0 14.9885 12.8568 11.7102 11.911 0 0 13.9771 0 14.5917 13.6733 0 13.7881 13.4277 13.2736 0 10.6472 13.7882 0 0 14.922 12.6879 14.8924 13.7083 0 15.1825 0 0 14.0403 0 13.1656 13.3022 13.4942 0 0 14.6924 13.226 13.3615 0 13.2362 14.3215 13.7877 13.2353 0 13.4238 11.8854 14.0117 0 0 0 0 Q96L93 KI16B_HUMAN Kinesin-like protein KIF16B (Sorting nexin-23) KIF16B C20orf23 KIAA1590 SNX23 Homo sapiens (Human) early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]" GO:0001704; GO:0001919; GO:0003777; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007018; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0080025 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]" ASVKVAVRVR 0.99432 -28.507 0 0 0 13.7815 13.324 0 0 11.8838 0 0 0 0 0 0 0 13.5058 14.4529 14.1232 13.9609 13.3877 13.9392 0 13.9964 0 14.3867 14.5762 0 14.186 14.2147 13.6986 0 0 14.19 0 0 0 0 13.0613 0 0 13.9303 0 0 13.7212 12.4354 0 0 13.5432 13.937 13.994 14.0043 14.7046 14.6486 14.8303 18.9222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7547 0 0 0 14.2402 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4498 15.3337 16.455 0 14.6303 14.7919 13.0414 14.6 0 0 15.2027 0 0 15.5745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9139 0 0 0 0 0 0 0 0 0 0 0 15.2047 0 0 0 0 15.2618 0 0 0 0 0 0 0 0 0 15.4929 15.7115 0 15.5318 15.6818 12.6454 0 0 0 15.2024 0 15.1985 15.4691 15.4806 15.6824 13.3173 0 0 0 0 15.2618 0 0 Q9C0E4 GRIP2_HUMAN "Glutamate receptor-interacting protein 2, GRIP-2" GRIP2 KIAA1719 Homo sapiens (Human) "artery smooth muscle contraction [GO:0014824]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; Notch signaling pathway [GO:0007219]; positive regulation of blood pressure [GO:0045777]; vesicle-mediated transport in synapse [GO:0099003]" cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] "cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; glutamate receptor binding [GO:0035254]; signaling receptor complex adaptor activity [GO:0030159]; artery smooth muscle contraction [GO:0014824]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; Notch signaling pathway [GO:0007219]; positive regulation of blood pressure [GO:0045777]; vesicle-mediated transport in synapse [GO:0099003]" GO:0005829; GO:0005886; GO:0007219; GO:0014069; GO:0014824; GO:0030159; GO:0030425; GO:0035254; GO:0045211; GO:0045777; GO:0098887; GO:0098978; GO:0099003 glutamate receptor binding [GO:0035254]; signaling receptor complex adaptor activity [GO:0030159] DAGGADVSLACR 0.99432 -28.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.271 0 13.0983 0 9.95053 0 0 0 12.7115 0 0 0 11.4657 0 0 0 0 12.7395 0 0 11.923 12.3249 0 12.0156 0 0 0 0 0 0 0 13.7131 14.0876 12.1727 0 12.1747 0 0 0 12.4138 0 11.621 0 0 0 0 12.7507 0 0 0 0 0 0 0 14.2513 11.3463 0 12.8455 0 0 0 13.9013 0 0 0 0 0 0 0 0 0 0 0 16.2382 0 11.7424 0 0 0 0 0 0 0 13.4126 0 11.7748 0 12.5448 0 0 0 0 0 0 0 0 0 11.8573 0 0 0 0 0 0 0 0 11.4261 0 0 0 0 0 0 0 Q9HC62 SENP2_HUMAN "Sentrin-specific protease 2, EC 3.4.22.- (Axam2) (SMT3-specific isopeptidase 2, Smt3ip2) (Sentrin/SUMO-specific protease SENP2)" SENP2 KIAA1331 Homo sapiens (Human) fat cell differentiation [GO:0045444]; mRNA transport [GO:0051028]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein desumoylation [GO:0016926]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139]; fat cell differentiation [GO:0045444]; mRNA transport [GO:0051028]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein desumoylation [GO:0016926]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111]; Wnt signaling pathway [GO:0016055] GO:0005634; GO:0005643; GO:0005654; GO:0005829; GO:0015031; GO:0016055; GO:0016926; GO:0016929; GO:0030111; GO:0031397; GO:0031398; GO:0031648; GO:0031965; GO:0045444; GO:0051028; GO:0070139 deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139] GVNLFEQEIILVPIHRK 0.99432 -10.966 0 0 0 0 9.98328 0 11.3429 13.4769 10.7704 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2995 13.4218 0 0 0 0 0 0 13.1902 11.8607 0 13.3116 0 12.9453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.155 14.2025 16.5417 0 0 12.1205 0 14.154 13.9636 0 0 0 0 0 0 0 15.0771 0 12.9868 13.6744 0 0 0 13.762 0 0 0 0 13.4002 0 0 0 12.7818 0 0 12.4865 0 0 0 0 14.4306 0 0 0 0 0 12.967 0 0 0 11.0562 0 0 12.8611 13.1261 0 0 12.099 11.5084 0 0 0 0 0 13.7547 12.9893 13.109 0 0 0 0 11.9815 0 13.0625 0 0 0 0 0 11.925 0 0 0 0 0 0 0 0 0 0 0 10.7746 11.1448 0 0 0 0 0 15.2184 14.088 12.5358 14.0611 13.0883 9.66754 0 0 0 14.5857 14.8894 Q9NRZ7 PLCC_HUMAN "1-acyl-sn-glycerol-3-phosphate acyltransferase gamma, EC 2.3.1.51 (1-acylglycerol-3-phosphate O-acyltransferase 3, 1-AGP acyltransferase 3, 1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma, LPAAT-gamma)" AGPAT3 LPAAT3 UNQ759/PRO1490 Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654] GO:0000139; GO:0003841; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006654; GO:0008654; GO:0012505; GO:0016020; GO:0016021; GO:0016024; GO:0016746 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746] DTVVEGLRR 0.99432 -13.602 11.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.626 0 0 0 0 12.2264 0 12.7887 0 0 12.7732 13.1889 0 0 0 0 0 0 0 0 0 11.2702 0 11.8014 0 0 13.4066 0 11.4323 0 13.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5222 0 0 0 0 0 0 0 0 13.2022 13.0059 13.9302 13.9994 14.1402 13.1114 0 0 0 14.4077 0 0 0 0 0 0 14.0487 0 11.0401 0 0 0 0 13.7285 0 14.9263 0 0 0 0 0 0 0 0 0 11.8438 0 0 0 0 0 15.1583 13.0868 0 14.0185 0 0 0 11.426 0 0 0 0 0 0 13.5665 0 0 0 0 0 14.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS00 C1GLT_HUMAN "Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, EC 2.4.1.122 (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1, Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1, C1GalT1, Core 1 beta3-Gal-T1)" C1GALT1 Homo sapiens (Human) "angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]" Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; O-glycan processing, core 1 [GO:0016267]" GO:0000139; GO:0001525; GO:0001822; GO:0016021; GO:0016263; GO:0016267; GO:0046872; GO:0060576 glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872] DFPAVGLKTK 0.99432 -8.518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.508 13.7769 0 13.8447 0 14.4754 13.9288 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8821 12.8605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5245 0 0 0 0 13.3446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0841 0 0 0 0 0 12.8511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6157 0 0 0 0 0 14.952 0 0 0 0 14.8126 15.2228 0 0 0 15.5684 0 0 0 13.2356 0 0 Q9NU63 ZFP57_HUMAN "Zinc finger protein 57 homolog, Zfp-57 (Zinc finger protein 698)" ZFP57 C6orf40 ZNF698 Homo sapiens (Human) DNA methylation involved in embryo development [GO:0043045]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; DNA methylation involved in embryo development [GO:0043045]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0003682; GO:0005634; GO:0006349; GO:0006357; GO:0043045; GO:0046872 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AHLTEPPNYCFHCSKSFSSFSR 0.99432 -28.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1865 12.9244 0 0 0 0 0 0 10.9977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7538 0 0 0 12.8355 14.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.316 0 0 0 0 0 0 0 0 0 0 0 13.0571 12.7526 0 0 12.1845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5636 0 0 0 0 0 0 12.3249 13.2281 0 0 0 0 0 0 0 17.4195 12.965 0 0 0 0 12.7454 0 0 0 13.6497 0 0 0 0 0 0 0 18.1432 14.0847 Q9NY46 SCN3A_HUMAN Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3) SCN3A KIAA1356 NAC3 Homo sapiens (Human) membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] axon [GO:0030424]; sarcoplasm [GO:0016528]; voltage-gated sodium channel complex [GO:0001518] axon [GO:0030424]; sarcoplasm [GO:0016528]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001518; GO:0005244; GO:0005248; GO:0006814; GO:0016528; GO:0019228; GO:0030424; GO:0034765; GO:0035725; GO:0086010 voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] ALKTISVIPGLK 0.99432 -28.542 0 0 0 0 0 0 0 0 0 0 11.2961 0 0 0 0 12.182 0 0 0 0 12.3382 0 0 0 0 0 0 0 0 0 0 0 0 10.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76296 0 0 13.1494 0 0 12.3045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0014 0 0 0 12.0739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1812 0 0 0 0 0 0 0 0 0 0 12.4517 0 0 0 0 0 0 0 11.452 0 0 12.142 0 0 0 0 0 10.4163 0 0 0 11.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2064 0 0 0 11.5741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A087X0M5 TVB18_HUMAN T cell receptor beta variable 18 TRBV18 Homo sapiens (Human) adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166] GO:0002250; GO:0005886; GO:0007166; GO:0042101 EGPSILRIQQVVR 0.99433 -9.0535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7538 0 0 12.4406 0 0 11.1718 0 0 0 13.4448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96304 0 0 0 0 0 A0A1B0GVM6 CK097_HUMAN Uncharacterized protein C11orf97 C11orf97 Homo sapiens (Human) ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737] ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737] GO:0005737; GO:0036064; GO:0097546 NLPVGGLKPGLPSRNSLLPQAK 0.99433 -9.0439 0 0 0 10.2192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MU93 CQ100_HUMAN Uncharacterized protein C17orf100 C17orf100 Homo sapiens (Human) HVESSSQRTETTSR 0.99433 -8.5748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.686 0 0 0 0 0 0 12.9341 0 0 0 0 0 0 11.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0755 13.5889 12.9451 12.8533 0 13.4733 13.4392 0 0 0 0 0 0 0 0 0 0 0 0 13.854 13.3978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00294 TULP1_HUMAN Tubby-related protein 1 (Tubby-like protein 1) TULP1 TUBL1 Homo sapiens (Human) "dendrite development [GO:0016358]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" anchoring junction [GO:0070161]; axon terminus [GO:0043679]; cell projection [GO:0042995]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchoring junction [GO:0070161]; axon terminus [GO:0043679]; cell projection [GO:0042995]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; dendrite development [GO:0016358]; detection of light stimulus involved in visual perception [GO:0050908]; eye photoreceptor cell development [GO:0042462]; phagocytosis, recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; retina development in camera-type eye [GO:0060041]; retina homeostasis [GO:0001895]; visual perception [GO:0007601]" GO:0001750; GO:0001895; GO:0001917; GO:0005546; GO:0005576; GO:0005829; GO:0005886; GO:0005929; GO:0006910; GO:0007601; GO:0016358; GO:0042462; GO:0042995; GO:0043679; GO:0045202; GO:0045494; GO:0050766; GO:0050908; GO:0051015; GO:0060041; GO:0061512; GO:0070161; GO:1903546 "actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AKAQGPR 0.99433 -36.207 0 0 10.9789 0 0 0 0 11.5668 10.9166 0 14.1506 10.9349 0 0 13.3757 14.8605 13.8259 0 14.2832 0 14.0712 0 0 0 0 12.5389 13.8887 12.1494 12.5982 11.9667 13.6393 13.7745 13.3641 14.5885 0 13.1444 0 0 0 0 0 12.4181 13.3012 13.9401 14.333 14.4153 14.097 0 0 0 0 0 0 12.7107 11.8147 0 0 0 0 0 0 10.7228 0 0 0 0 0 10.7371 0 0 0 0 0 11.3881 0 0 0 11.581 12.4933 13.4173 12.1943 0 0 14.0314 0 14.2446 0 0 12.7957 0 0 0 12.0549 0 0 12.2237 13.5218 11.0288 0 14.5882 12.7828 12.7946 14.1426 15.0145 0 12.2133 11.1125 13.5059 11.6018 0 14.0483 14.9926 0 0 0 0 14.2277 0 0 0 0 10.8096 0 0 0 0 14.0928 13.2389 14.1923 13.3232 12.8223 0 0 14.7318 0 12.2774 12.7389 0 13.3689 13.6476 0 13.4285 0 13.8552 12.4779 0 10.9501 13.8363 0 0 0 11.7234 0 0 12.6969 0 0 14.3498 12.8785 11.9785 13.453 14.5895 13.6083 18.4729 0 12.5408 14.4985 0 12.0349 13.3421 13.3443 14.0637 0 13.5594 0 14.8645 13.5436 11.5425 0 13.3015 O15055 PER2_HUMAN "Period circadian protein homolog 2, hPER2 (Circadian clock protein PERIOD 2)" PER2 KIAA0347 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; glycogen biosynthetic process [GO:0005978]; histone H3 deacetylation [GO:0070932]; lactate biosynthetic process [GO:0019249]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of vasoconstriction [GO:0019229]; response to ischemia [GO:0002931]; white fat cell differentiation [GO:0050872]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; fatty acid metabolic process [GO:0006631]; gluconeogenesis [GO:0006094]; glycogen biosynthetic process [GO:0005978]; histone H3 deacetylation [GO:0070932]; lactate biosynthetic process [GO:0019249]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of vasoconstriction [GO:0019229]; response to ischemia [GO:0002931]; white fat cell differentiation [GO:0050872]" GO:0000122; GO:0000976; GO:0001222; GO:0002931; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005978; GO:0006094; GO:0006631; GO:0007623; GO:0019229; GO:0019249; GO:0031397; GO:0032922; GO:0042752; GO:0042754; GO:0043153; GO:0045892; GO:0048471; GO:0050767; GO:0050796; GO:0050872; GO:0051726; GO:0051946; GO:0070345; GO:0070932; GO:0097167; GO:0120162; GO:2000678 transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor binding [GO:0001222] DSQGSDCDDSGK 0.99433 -9.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4974 10.6992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8954 0 0 0 0 0 13.325 11.9188 0 0 0 0 0 0 0 0 0 13.8705 0 13.7449 0 0 12.8742 0 0 0 0 0 0 13.5098 0 0 0 0 0 0 16.2039 0 0 0 12.6845 0 0 16.1441 0 0 0 0 13.7574 0 0 0 0 0 12.8923 0 0 0 12.541 0 0 0 0 12.7825 0 11.581 0 0 0 0 13.0637 0 0 0 0 0 0 13.3139 0 0 9.95587 0 0 0 0 13.9266 0 0 0 0 0 0 0 0 0 0 13.2068 11.9918 0 0 0 O94900 TOX_HUMAN Thymocyte selection-associated high mobility group box protein TOX (Thymus high mobility group box protein TOX) TOX KIAA0808 Homo sapiens (Human) "CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment [GO:0002362]; CD8-positive, alpha-beta T cell lineage commitment [GO:0043375]; cerebral cortex neuron differentiation [GO:0021895]; chromatin organization [GO:0006325]; leukocyte differentiation [GO:0002521]; lymph node development [GO:0048535]; natural killer cell differentiation [GO:0001779]; NK T cell lineage commitment [GO:0002364]; Peyer's patch development [GO:0048541]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron projection development [GO:0010976]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; CD4-positive, alpha-beta T cell lineage commitment [GO:0043373]; CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment [GO:0002362]; CD8-positive, alpha-beta T cell lineage commitment [GO:0043375]; cerebral cortex neuron differentiation [GO:0021895]; chromatin organization [GO:0006325]; leukocyte differentiation [GO:0002521]; lymph node development [GO:0048535]; natural killer cell differentiation [GO:0001779]; NK T cell lineage commitment [GO:0002364]; Peyer's patch development [GO:0048541]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron projection development [GO:0010976]; regulation of positive thymic T cell selection [GO:1902232]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0001779; GO:0002362; GO:0002364; GO:0002521; GO:0005634; GO:0006325; GO:0006357; GO:0010976; GO:0021895; GO:0031490; GO:0032825; GO:0043373; GO:0043375; GO:0048535; GO:0048541; GO:1901537; GO:1902232; GO:2000179 chromatin DNA binding [GO:0031490] PASDMGK 0.99433 -9.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.78996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4618 0 0 0 13.0413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9865 0 0 11.1801 10.7793 0 0 0 0 0 0 10.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2434 0 0 0 0 0 0 O95154 ARK73_HUMAN "Aflatoxin B1 aldehyde reductase member 3, EC 1.-.-.- (AFB1 aldehyde reductase 2, AFB1-AR 2)" AKR7A3 AFAR2 Homo sapiens (Human) aflatoxin catabolic process [GO:0046223]; cellular aldehyde metabolic process [GO:0006081] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; aldo-keto reductase (NADP) activity [GO:0004033]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; aflatoxin catabolic process [GO:0046223]; cellular aldehyde metabolic process [GO:0006081] GO:0004033; GO:0005737; GO:0005794; GO:0005829; GO:0006081; GO:0009055; GO:0042802; GO:0046223; GO:0070062 aldo-keto reductase (NADP) activity [GO:0004033]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802] MSRQLSR 0.99433 -9.0506 0 0 0 0 0 0 0 0 0 0 0 0 13.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6896 0 12.567 0 0 0 0 0 0 0 0 0 0 0 0 13.4653 0 0 0 0 13.1496 0 0 0 0 12.7859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10398 ARAF_HUMAN "Serine/threonine-protein kinase A-Raf, EC 2.7.11.1 (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks)" ARAF ARAF1 PKS PKS2 Homo sapiens (Human) MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006] cytosol [GO:0005829]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006] GO:0000165; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005739; GO:0005829; GO:0006468; GO:0032006; GO:0032434; GO:0033138; GO:0036211; GO:0043066; GO:0046872; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AMRRLLSDCLK 0.99433 -11.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1926 0 0 0 0 0 0 0 0 0 0 0 10.4534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5551 0 0 0 0 0 12.1682 0 0 13.3334 0 0 0 0 0 13.5188 0 0 0 0 0 0 0 0 12.8197 0 0 0 0 0 0 0 11.8461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9078 0 0 0 0 12.546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20273 CD22_HUMAN "B-cell receptor CD22 (B-lymphocyte cell adhesion molecule, BL-CAM) (Sialic acid-binding Ig-like lectin 2, Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)" CD22 SIGLEC2 Homo sapiens (Human) B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin production [GO:0002638]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin production [GO:0002638]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776] GO:0001791; GO:0002638; GO:0005102; GO:0005737; GO:0005769; GO:0005886; GO:0005887; GO:0007155; GO:0009897; GO:0009986; GO:0016021; GO:0019903; GO:0030100; GO:0030246; GO:0030888; GO:0032809; GO:0033691; GO:0042113; GO:0042609; GO:0050776; GO:0050849; GO:0050859; GO:0055037; GO:0070062 carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] HTPKLEIKVTPSDAIVR 0.99433 -8.5753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3161 15.3923 0 0 0 0 0 0 0 0 0 0 0 12.3313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43243 MATR3_HUMAN Matrin-3 MATR3 KIAA0723 Homo sapiens (Human) activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; post-transcriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281] membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleus [GO:0005634] membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; post-transcriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281] GO:0001825; GO:0002218; GO:0003170; GO:0003281; GO:0003723; GO:0005198; GO:0005634; GO:0005637; GO:0008270; GO:0010608; GO:0016020; GO:0016363; GO:0035198; GO:0042802; GO:0045087 identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] DSFDDRGPSLNPVLDYDHGSRSQESGYYDR 0.99433 -13.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8036 0 0 0 0 0 0 12.8453 13.753 0 0 0 0 14.2392 0 0 0 0 0 0 13.2889 0 15.1302 11.6497 0 0 0 0 0 0 0 0 0 0 14.4615 0 0 11.5624 0 13.9415 0 0 0 12.0766 0 0 0 0 0 0 0 13.3727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7781 15.0286 0 0 0 0 0 11.8686 0 0 0 12.7395 13.2863 0 11.3665 0 0 0 0 0 0 0 0 0 13.0957 0 0 0 0 0 0 0 0 12.2173 0 0 14.5245 0 0 0 0 0 0 0 P62269 RS18_HUMAN "40S ribosomal protein S18 (Ke-3, Ke3) (Small ribosomal subunit protein uS13)" RPS18 D6S218E Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0014069; GO:0015935; GO:0016020; GO:0019843; GO:0022626; GO:0022627; GO:0070062 RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] EDLERLKK 0.99433 -36.315 0 0 0 0 0 0 0 0 12.6422 11.8455 12.3752 12.3126 0 0 12.0829 12.8149 12.9696 12.618 0 0 0 0 0 0 13.5415 0 13.0949 11.8121 0 0 11.431 13.3508 12.2041 0 0 0 0 0 0 0 0 12.1828 11.8157 0 0 11.8669 12.9412 0 14.0929 13.7997 14.5581 0 12.187 16.2966 0 0 0 0 12.8643 12.362 0 11.4934 9.82169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7234 12.4619 13.6327 0 0 0 0 0 0 0 0 0 14.5203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2827 13.7386 0 0 0 0 0 0 0 0 0 14.3887 0 0 14.0014 14.2896 13.9753 13.5549 14.2835 0 13.2719 14.1204 0 14.2012 14.0336 0 0 0 0 13.2306 0 14.2263 0 0 Q15831 STK11_HUMAN "Serine/threonine-protein kinase STK11, EC 2.7.11.1 (Liver kinase B1, LKB1, hLKB1) (Renal carcinoma antigen NY-REN-19)" STK11 LKB1 PJS Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; establishment of cell polarity [GO:0030010]; G1 to G0 transition [GO:0070314]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vesicle transport along microtubule [GO:1901610]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of Wnt signaling pathway [GO:0030111]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to ionizing radiation [GO:0010212]; response to lipid [GO:0033993]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular protein-containing complex [GO:0140535]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular protein-containing complex [GO:0140535]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; serine/threonine protein kinase complex [GO:1902554]; Z disc [GO:0030018]; ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; activation of protein kinase activity [GO:0032147]; anoikis [GO:0043276]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV-B [GO:0071493]; dendrite extension [GO:0097484]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; establishment of cell polarity [GO:0030010]; G1 to G0 transition [GO:0070314]; glucose homeostasis [GO:0042593]; Golgi localization [GO:0051645]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vesicle transport along microtubule [GO:1901610]; positive thymic T cell selection [GO:0045059]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of dendrite morphogenesis [GO:0048814]; regulation of protein kinase B signaling [GO:0051896]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of Wnt signaling pathway [GO:0030111]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to ionizing radiation [GO:0010212]; response to lipid [GO:0033993]; response to thyroid hormone [GO:0097066]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; tissue homeostasis [GO:0001894]; vasculature development [GO:0001944] GO:0000287; GO:0001558; GO:0001894; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006914; GO:0006974; GO:0007165; GO:0007283; GO:0007409; GO:0008285; GO:0010212; GO:0010508; GO:0014823; GO:0016020; GO:0018107; GO:0030010; GO:0030018; GO:0030111; GO:0030275; GO:0030295; GO:0030308; GO:0030511; GO:0032147; GO:0033762; GO:0033993; GO:0034504; GO:0042593; GO:0043276; GO:0044877; GO:0045059; GO:0045722; GO:0046777; GO:0048814; GO:0050772; GO:0050852; GO:0051645; GO:0051726; GO:0051896; GO:0060767; GO:0060770; GO:0070062; GO:0070314; GO:0071493; GO:0072332; GO:0090090; GO:0097066; GO:0097484; GO:0106310; GO:0120163; GO:0140535; GO:1900182; GO:1901610; GO:1901796; GO:1902554; GO:1904262 ATP binding [GO:0005524]; LRR domain binding [GO:0030275]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] APNPARK 0.99433 -9.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4112 0 0 0 0 0 0 0 0 13.3973 0 0 12.4018 0 0 13.1832 0 0 0 0 0 0 0 0 Q38SD2 LRRK1_HUMAN "Leucine-rich repeat serine/threonine-protein kinase 1, EC 2.7.11.1" LRRK1 KIAA1790 Homo sapiens (Human) bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722]; bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165] GO:0004674; GO:0004722; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0007165; GO:0018108; GO:0035556; GO:0036035; GO:0042802; GO:0043231; GO:0045453; GO:0046872; GO:0050731; GO:0050732; GO:0090263; GO:0106310; GO:1902533 ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722] AQLRKAEK 0.99433 -36.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5489 0 0 0 11.4892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8817 17.482 0 11.9919 0 0 0 15.2942 18.7906 0 0 12.4207 0 0 0 0 13.4297 0 0 0 0 0 0 11.8327 11.7438 0 0 11.6511 14.451 12.1094 0 12.5126 12.3736 11.4406 0 0 0 0 0 0 0 0 0 13.5817 0 0 0 0 0 13.4584 11.5071 12.7185 14.5313 0 0 11.8746 0 0 0 0 0 12.6012 0 11.5056 0 0 10.9828 11.6876 12.6581 0 0 11.9392 0 0 13.9372 0 0 10.4767 11.6148 0 0 12.0425 0 0 0 0 11.8499 0 0 0 0 0 11.3474 11.7705 0 18.329 0 0 0 0 11.0948 0 0 0 Q56NI9 ESCO2_HUMAN "N-acetyltransferase ESCO2, EC 2.3.1.- (Establishment factor-like protein 2, EFO2, EFO2p, hEFO2) (Establishment of cohesion 1 homolog 2, ECO1 homolog 2)" ESCO2 Homo sapiens (Human) double-strand break repair [GO:0006302]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic sister chromatid cohesion [GO:0007064]; post-translational protein acetylation [GO:0034421]; protein localization to chromatin [GO:0071168]; regulation of DNA replication [GO:0006275] cell junction [GO:0030054]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]; XY body [GO:0001741] "cell junction [GO:0030054]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]; XY body [GO:0001741]; acetyltransferase activity [GO:0016407]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; double-strand break repair [GO:0006302]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic sister chromatid cohesion [GO:0007064]; post-translational protein acetylation [GO:0034421]; protein localization to chromatin [GO:0071168]; regulation of DNA replication [GO:0006275]" GO:0000785; GO:0001741; GO:0002244; GO:0004468; GO:0005634; GO:0005654; GO:0005694; GO:0005721; GO:0005794; GO:0006275; GO:0006302; GO:0007064; GO:0008080; GO:0010369; GO:0016407; GO:0030054; GO:0034421; GO:0035861; GO:0046872; GO:0061733; GO:0071168 "acetyltransferase activity [GO:0016407]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; metal ion binding [GO:0046872]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]" ENNCHSAENNSNAPR 0.99433 -9.0619 12.0195 0 0 0 0 0 0 0 11.6577 12.0275 11.6485 11.225 0 0 17.0252 0 0 0 0 11.0965 0 0 11.4513 0 0 0 0 0 0 0 0 12.0781 11.9715 11.5613 10.7912 0 0 0 0 10.842 0 11.5505 0 0 0 0 12.2931 11.5967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2859 0 0 0 0 0 0 13.2894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3715 13.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.533 0 0 0 0 0 0 Q5VT25 MRCKA_HUMAN "Serine/threonine-protein kinase MRCK alpha, EC 2.7.11.1 (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha, MRCK alpha, Myotonic dystrophy protein kinase-like alpha)" CDC42BPA KIAA0451 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027] actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005911; GO:0006468; GO:0016477; GO:0018107; GO:0030027; GO:0031032; GO:0031252; GO:0031532; GO:0042641; GO:0042802; GO:0070062; GO:0106310 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ATDMPWKMRR 0.99433 -8.8053 0 0 0 0 0 0 0 0 0 0 0 13.217 0 0 0 11.3917 0 0 0 0 0 0 0 0 13.9734 0 13.3533 0 0 0 0 0 0 0 0 0 0 0 13.511 11.7765 10.2291 0 13.1175 0 0 13.0294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1137 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9535 13.6126 0 17.3117 0 14.925 14.874 0 11.8041 14.8613 0 0 0 0 0 0 0 12.6312 0 0 0 0 12.9855 0 16.986 0 0 0 0 12.9322 0 0 0 13.3577 15.2054 0 0 11.593 0 0 10.1458 0 0 0 14.022 14.275 10.6651 0 0 13.0903 0 11.4946 0 0 13.0936 0 12.4913 0 0 0 0 0 14.1824 0 0 14.6039 0 12.2565 11.8193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2351 0 12.6883 0 0 0 0 14.3025 14.9863 0 0 0 12.1579 0 0 13.2446 Q68D10 SPT2_HUMAN Protein SPT2 homolog (Protein KU002155) (SPT2 domain-containing protein 1) SPTY2D1 Homo sapiens (Human) "heterochromatin assembly [GO:0031507]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; RNA polymerase I core binding [GO:0001042]; heterochromatin assembly [GO:0031507]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; regulation of chromatin assembly [GO:0010847]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001042; GO:0003677; GO:0005654; GO:0005730; GO:0006334; GO:0006355; GO:0010847; GO:0031507; GO:0042393; GO:0043486; GO:0140713 DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; RNA polymerase I core binding [GO:0001042] AAQGPQRLPFPTGYKR 0.99433 -36.17 0 0 0 0 0 0 10.2938 0 0 13.9243 13.4564 12.2311 0 13.5846 13.5084 12.3268 0 0 0 0 0 0 12.1487 0 12.4933 0 12.7792 0 0 0 12.1724 0 0 13.5156 0 0 0 13.8681 0 0 0 0 0 13.8525 11.7974 0 0 0 0 13.4371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3394 0 0 0 0 0 0 0 0 13.9709 0 12.864 0 0 0 0 0 14.6291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5956 0 0 0 0 0 13.896 14.4465 0 14.3458 0 13.8259 13.8763 14.4867 0 0 0 0 0 0 0 14.7429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0587 0 0 15.1398 14.4705 12.329 14.2602 16.2061 14.4149 14.3332 14.0539 0 0 0 0 14.3545 14.3337 0 0 0 0 12.8587 0 0 0 0 Q6F5E7 TR3N_HUMAN "Putative uncharacterized protein TXNRD3NB (Thioredoxin reductase 2 intronic transcript 1) (Thioredoxin reductase 3 intronic transcript 1) (Thioredoxin reductase 3 neighbor gene protein, TXNRD3 neighbor gene protein) (Thioredoxin reductase 3 new transcript 1)" TXNRD3NB TR2IT1 TXNRD3IT1 TXNRD3NT1 Homo sapiens (Human) LLKISRALQAR 0.99433 -9.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7705 0 0 0 0 0 0 13.6383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6S8J7 POTEA_HUMAN "POTE ankyrin domain family member A (ANKRD26-like family A member 1) (Prostate, ovary, testis-expressed protein on chromosome 8, POTE-8)" POTEA A26A1 POTE8 Homo sapiens (Human) DHDDSAFTEPR 0.99433 -8.7971 0 0 0 0 0 0 0 12.9043 0 0 0 0 0 13.739 0 11.6472 0 0 0 0 13.5785 0 0 0 0 13.462 0 12.9411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6441 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6862 0 0 10.8688 0 0 0 0 0 0 12.7368 0 0 0 0 0 0 0 0 12.1005 13.092 12.965 0 0 13.5209 0 12.0643 0 0 0 13.0784 14.7815 0 12.9545 14.0521 14.0281 13.8367 0 0 14.1459 12.3081 0 0 11.9996 0 0 0 0 0 0 13.4081 0 0 0 12.9518 11.9319 13.9764 13.0991 0 0 12.6879 12.5253 13.2021 0 0 0 12.8883 0 0 0 0 0 0 0 0 11.7982 15.9636 0 15.4653 12.5088 0 13.5494 10.8876 0 10.7765 12.6171 0 0 0 0 13.1134 0 0 0 0 15.2137 14.6221 13.085 11.7004 11.0333 0 12.7683 0 0 0 0 13.0254 12.6931 0 0 0 Q6T4R5 NHS_HUMAN Actin remodeling regulator NHS (Congenital cataracts and dental anomalies protein) (Nance-Horan syndrome protein) NHS Homo sapiens (Human) cell differentiation [GO:0030154]; lens development in camera-type eye [GO:0002088] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear body [GO:0016604] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; cell differentiation [GO:0030154]; lens development in camera-type eye [GO:0002088] GO:0002088; GO:0005794; GO:0005923; GO:0005925; GO:0016324; GO:0016604; GO:0030027; GO:0030054; GO:0030154 DSGDMSVR 0.99433 -36.251 0 0 0 0 12.4526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7375 0 0 0 0 0 0 0 0 0 0 11.5181 0 0 0 0 9.86578 10.1883 0 0 0 0 0 11.4242 0 0 0 0 0 0 0 0 13.8805 13.1433 14.0875 0 13.3372 14.1698 0 0 13.0097 12.9585 0 0 12.9334 0 0 0 0 0 0 0 0 0 13.2238 13.8666 0 12.7659 15.0145 14.0175 14.8862 0 12.9056 12.4874 0 12.0684 11.3161 18.8667 18.8077 0 0 18.9895 12.4754 0 14.5566 0 0 12.6554 0 12.7104 0 0 13.7293 0 17.4168 0 0 0 0 0 0 15.7179 0 0 0 0 12.6841 14.2316 0 0 14.1309 13.6585 18.3838 14.7848 0 0 14.7405 0 0 11.3321 12.4286 0 14.1958 12.8978 13.5078 14.8895 11.3694 0 13.4336 11.8057 13.4998 12.0654 0 0 0 0 0 0 0 0 0 0 0 0 12.3794 13.6224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3697 0 13.3022 0 0 0 0 0 0 Q7Z442 PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2) PKD1L2 KIAA1879 PC1L2 Homo sapiens (Human) detection of mechanical stimulus [GO:0050982] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; detection of mechanical stimulus [GO:0050982] GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0030246; GO:0050982 calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246] ARPEDQRR 0.99433 -9.0623 0 0 0 0 11.5766 13.1841 0 0 13.1573 13.1837 0 0 0 0 0 0 0 12.7798 0 0 0 0 0 0 13.2785 0 0 0 0 0 0 0 0 0 0 13.5338 0 10.371 0 0 0 0 0 0 0 0 0 0 0 9.8117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7648 0 0 0 14.3834 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6235 0 14.6536 0 0 0 11.39 0 0 0 0 0 0 0 0 0 11.2617 0 0 0 0 0 12.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8281 0 0 0 0 0 0 11.971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5676 0 0 0 0 0 0 0 0 0 0 11.9722 0 0 0 11.5864 10.5728 0 0 0 0 0 0 0 0 0 0 0 0 13.9971 0 13.0118 13.0384 0 10.4401 0 0 0 Q96RE7 NACC1_HUMAN "Nucleus accumbens-associated protein 1, NAC-1 (BTB/POZ domain-containing protein 14B)" NACC1 BTBD14B NAC1 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]" cell junction [GO:0030054]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell junction [GO:0030054]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0008284; GO:0030054; GO:0042826; GO:0043231; GO:0045892 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LWDSGQK 0.99433 -8.7918 0 0 0 0 0 0 0 0 0 0 0 11.2115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.445 0 0 0 12.8793 0 0 0 0 0 0 0 11.931 0 0 11.8392 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRH9 ZN251_HUMAN Zinc finger protein 251 ZNF251 Homo sapiens (Human) hematopoietic stem cell homeostasis [GO:0061484]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic stem cell homeostasis [GO:0061484]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:0061484 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DNAQAAEFR 0.99433 -11.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5689 0 0 0 0 0 0 0 13.0528 0 0 12.3264 0 0 14.6393 0 0 0 0 14.4075 0 0 15.5708 0 0 0 0 13.7513 0 0 0 0 0 0 0 0 0 0 0 0 14.9096 11.5652 0 0 0 0 0 0 0 14.0476 13.9813 0 0 0 0 0 0 0 0 14.2978 0 12.3742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYC5 FUT8_HUMAN "Alpha-(1,6)-fucosyltransferase, Alpha1-6FucT, EC 2.4.1.68 (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)" FUT8 Homo sapiens (Human) fibroblast migration [GO:0010761]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral protein processing [GO:0019082] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; fibroblast migration [GO:0010761]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral protein processing [GO:0019082] GO:0000139; GO:0001701; GO:0005794; GO:0006487; GO:0006491; GO:0007179; GO:0007229; GO:0007585; GO:0008424; GO:0009312; GO:0010468; GO:0010761; GO:0016020; GO:0016021; GO:0017124; GO:0018279; GO:0019082; GO:0032580; GO:0036071; GO:0042355; GO:0043112; GO:0046368; GO:0046921; GO:0070062; GO:1900407 alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124] DLTELVQRRITYLQNPK 0.99433 -9.0402 0 0 0 0 0 0 0 0 0 0 0 12.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9584 12.4265 0 0 0 0 0 12.7104 0 0 0 0 0 0 11.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4494 13.388 13.3669 0 13.5254 13.8184 0 0 0 0 0 13.9586 0 0 0 0 0 0 0 0 0 0 0 Q9GIP4 LAT1L_HUMAN "Putative L-type amino acid transporter 1-like protein IMAA (hLAT1 3-transmembrane protein IMAA, hLAT1 3TM IMAA) (hLAT1 3-transmembrane protein MMAA, hLAT1 3TM MMAA)" SLC7A5P2 IMAA MMAA Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; L-amino acid transmembrane transporter activity [GO:0015179] GO:0015179; GO:0016021 L-amino acid transmembrane transporter activity [GO:0015179] AGAGPKRR 0.99433 -10.743 9.92257 0 0 0 0 0 0 0 11.3987 12.2217 0 0 0 0 0 13.8225 0 13.7629 14.389 14.0807 11.6061 0 13.2793 0 13.9775 10.5305 0 14.4607 0 0 0 11.85 0 11.7493 0 0 14.4571 0 0 0 13.7588 14.1523 0 0 12.0153 13.9936 0 0 0 0 11.6548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.637 0 14.0268 12.8655 0 0 0 0 0 14.5233 12.4575 14.6018 14.9492 14.7104 13.3791 14.3341 0 0 0 0 0 0 0 0 0 13.0735 12.8074 0 0 0 14.0712 12.5332 13.1575 0 14.3584 0 13.4112 0 13.8061 14.6187 0 13.5974 11.683 0 13.0885 13.4548 0 0 0 14.8727 15.0478 0 0 14.7599 13.403 0 13.3886 12.8496 0 14.0464 0 0 12.8066 14.7486 0 12.8723 15.1879 14.8896 13.0946 0 14.6973 14.8969 0 0 0 0 15.2121 0 0 0 0 0 0 0 14.4612 0 0 0 0 12.9103 13.2143 13.7886 0 0 13.6025 13.7205 13.2487 0 0 12.7055 13.8259 0 14.5297 0 14.5627 14.5616 13.5529 11.3075 14.5243 14.786 0 14.1057 0 0 Q9H0I3 CC113_HUMAN Coiled-coil domain-containing protein 113 CCDC113 HSPC065 Homo sapiens (Human) cilium assembly [GO:0060271] axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; protein-containing complex [GO:0032991] axoneme [GO:0005930]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271] GO:0005930; GO:0032991; GO:0034451; GO:0036064; GO:0060271 EILLRKELLEK 0.99433 -11.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4012 0 0 0 0 0 0 15.3908 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3983 0 0 0 0 14.4637 0 13.2385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4D5 NXF3_HUMAN "Nuclear RNA export factor 3 (TAP-like protein 3, TAPL-3)" NXF3 TAPL3 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973] cytoplasm [GO:0005737]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006406; GO:0016973; GO:0042272 mRNA binding [GO:0003729]; RNA binding [GO:0003723] GELLKHTK 0.99433 -13.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0599 0 0 0 0 0 0 0 15.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.702 0 0 14.9646 0 0 14.8464 0 0 14.9529 0 0 0 0 18.2868 0 14.6291 0 14.7591 0 0 0 0 0 0 0 0 0 0 0 0 0 14.329 0 0 0 0 0 0 0 0 0 14.1846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9317 0 0 0 14.6833 0 0 Q9NX57 RAB20_HUMAN Ras-related protein Rab-20 RAB20 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385] GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0030670; GO:0043231; GO:0045335; GO:0071346; GO:0090383; GO:0090385 GTP binding [GO:0005525]; GTPase activity [GO:0003924] EECSPNMDAGDR 0.99433 -10.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0466 0 0 14.1152 0 0 0 0 0 0 0 0 0 14.3947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0925 0 0 0 0 0 0 12.3898 0 0 0 0 0 0 10.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0638 0 0 0 0 0 0 0 0 0 13.8081 0 0 0 0 0 0 Q9Y2P4 S27A6_HUMAN "Long-chain fatty acid transport protein 6, FATP-6, Fatty acid transport protein 6 (Arachidonate--CoA ligase, EC 6.2.1.15) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Long-chain-fatty-acid--CoA ligase, EC 6.2.1.3) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1, VLCSH1, hVLCS-H1, EC 6.2.1.-)" SLC27A6 ACSVL2 FACVL2 FATP6 Homo sapiens (Human) long-chain fatty acid transport [GO:0015909]; very long-chain fatty acid metabolic process [GO:0000038] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; long-chain fatty acid transport [GO:0015909]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0000166; GO:0004467; GO:0005324; GO:0005886; GO:0015245; GO:0015909; GO:0016021; GO:0031957; GO:0042383; GO:0047676; GO:1901480 arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; very long-chain fatty acid-CoA ligase activity [GO:0031957] AGMASIILK 0.99433 -9.3051 0 0 0 0 0 0 0 0 14.1019 10.2681 12.823 0 11.9688 0 0 0 12.9953 11.4863 0 0 0 0 13.6948 0 0 0 0 11.9663 0 0 0 0 0 0 0 14.8224 0 0 0 0 0 0 0 0 13.2652 0 0 0 0 0 14.3434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1279 14.5752 12.0644 0 14.0708 14.6198 16.792 15.3764 14.1396 0 12.7636 12.3966 12.8656 0 0 12.3376 0 12.9007 0 0 0 0 0 0 0 0 0 12.3233 0 0 0 12.5701 0 0 0 14.2983 13.6753 0 12.567 0 12.5157 0 0 14.2889 0 14.4142 0 0 0 0 0 0 0 0 0 13.08 11.4019 0 13.2875 0 0 0 0 13.3109 11.7204 12.6535 0 12.9256 0 11.5628 0 0 0 0 10.5511 0 0 0 0 0 0 0 0 11.5756 0 11.6121 0 0 0 0 0 0 0 0 0 0 0 0 11.7173 0 0 0 0 0 0 13.6399 12.4615 0 10.9965 0 0 0 0 A0A1B0GUA9 CM046_HUMAN Uncharacterized protein C13orf46 C13orf46 Homo sapiens (Human) PSQMDVEDLSEDEMQTSWVCCIPYSTRKR 0.99434 -9.0812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7505 0 0 0 0 0 0 0 0 12.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75486 SUPT3_HUMAN Transcription initiation protein SPT3 homolog (SPT3-like protein) SUPT3H SPT3 Homo sapiens (Human) "histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0000124; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006355; GO:0006357; GO:0006366; GO:0016573; GO:0016578; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0045893; GO:0046982 protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713] IMDSAQYAEFCESR 0.99434 -8.3738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2383 0 0 0 0 0 14.1923 0 0 0 0 13.1756 0 12.7924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05177 CP1A2_HUMAN "Cytochrome P450 1A2, EC 1.14.14.1 (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase, EC 4.2.1.152)" CYP1A2 Homo sapiens (Human) aflatoxin metabolic process [GO:0046222]; alkaloid metabolic process [GO:0009820]; cellular respiration [GO:0045333]; cellular response to cadmium ion [GO:0071276]; cholesterol metabolic process [GO:0008203]; dibenzo-p-dioxin metabolic process [GO:0018894]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; long-chain fatty acid biosynthetic process [GO:0042759]; lung development [GO:0030324]; methylation [GO:0032259]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidative demethylation [GO:0070989]; porphyrin-containing compound metabolic process [GO:0006778]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; toxin biosynthetic process [GO:0009403]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231] "endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; aflatoxin metabolic process [GO:0046222]; alkaloid metabolic process [GO:0009820]; cellular respiration [GO:0045333]; cellular response to cadmium ion [GO:0071276]; cholesterol metabolic process [GO:0008203]; dibenzo-p-dioxin metabolic process [GO:0018894]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; long-chain fatty acid biosynthetic process [GO:0042759]; lung development [GO:0030324]; methylation [GO:0032259]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidative demethylation [GO:0070989]; porphyrin-containing compound metabolic process [GO:0006778]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; toxin biosynthetic process [GO:0009403]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0005506; GO:0005789; GO:0006706; GO:0006778; GO:0006805; GO:0008203; GO:0008210; GO:0009055; GO:0009403; GO:0009791; GO:0009820; GO:0010468; GO:0016098; GO:0016491; GO:0016712; GO:0018894; GO:0019373; GO:0019899; GO:0020037; GO:0030324; GO:0032259; GO:0032451; GO:0032787; GO:0034875; GO:0042178; GO:0042572; GO:0042759; GO:0043231; GO:0045333; GO:0046222; GO:0046483; GO:0050665; GO:0070330; GO:0070989; GO:0071276; GO:0097267; GO:0101020; GO:0101021; GO:0106256 "aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]" AFNQRFLWFLQK 0.99434 -12.925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8621 0 12.547 12.4811 12.9832 0 12.3977 0 12.734 0 12.8691 0 12.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5388 12.7543 0 12.7134 13.528 11.8395 12.7186 12.3427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7832 0 0 12.112 0 0 0 0 11.6227 0 0 0 0 14.9575 0 0 0 0 0 10.952 0 14.6058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4763 0 14.2206 0 11.1885 0 0 0 0 0 0 14.3754 0 0 0 0 12.4671 0 0 0 0 0 0 0 0 0 P21926 CD9_HUMAN "CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein, MRP-1) (Tetraspanin-29, Tspan-29) (p24) (CD antigen CD9)" CD9 MIC3 TSPAN29 GIG2 Homo sapiens (Human) cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; platelet activation [GO:0030168]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; sperm-egg recognition [GO:0035036] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein-containing complex [GO:0032991] clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein-containing complex [GO:0032991]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; platelet activation [GO:0030168]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; sperm-egg recognition [GO:0035036] GO:0005178; GO:0005615; GO:0005886; GO:0005887; GO:0005925; GO:0007155; GO:0007342; GO:0008283; GO:0008285; GO:0008347; GO:0009897; GO:0014905; GO:0016020; GO:0030168; GO:0030666; GO:0030669; GO:0030913; GO:0031092; GO:0031623; GO:0032991; GO:0035036; GO:0070062; GO:0071404; GO:0090331; GO:1903561; GO:1905521 integrin binding [GO:0005178] DVLETFTVK 0.99434 -15.505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4063 0 0 0 0 0 0 0 12.4351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9837 0 0 0 0 0 0 0 0 0 11.9712 0 0 0 11.6397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2963 0 13.7989 0 0 0 0 0 0 0 11.5471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34913 HYES_HUMAN "Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2, CEH, EC 3.3.2.10 (Epoxide hydratase) (Soluble epoxide hydrolase, SEH); Lipid-phosphate phosphatase, EC 3.1.3.76 ]" EPHX2 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272] GO:0000287; GO:0004301; GO:0005777; GO:0005782; GO:0005829; GO:0009636; GO:0010628; GO:0015643; GO:0016311; GO:0016787; GO:0016791; GO:0033885; GO:0042577; GO:0042632; GO:0042803; GO:0046272; GO:0046839; GO:0052642; GO:0070062; GO:0090181; GO:0097176 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643] GHIEDCGHWTQMDK 0.99434 -8.088 10.7943 0 0 0 0 0 0 0 0 14.2053 13.5527 0 0 0 0 0 0 0 0 0 0 0 0 13.2193 0 0 0 0 0 0 0 0 0 13.553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0385 0 0 0 0 12.3949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4554 0 0 0 0 0 0 0 0 0 0 12.1173 0 0 0 0 0 0 0 17.3114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43361 MAGA8_HUMAN "Melanoma-associated antigen 8 (Cancer/testis antigen 1.8, CT1.8) (MAGE-8 antigen)" MAGEA8 MAGE8 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0042826 histone deacetylase binding [GO:0042826] AEMLESVIK 0.99434 -9.3434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0528 0 10.8482 11.1689 0 15.1505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5465 0 11.912 0 12.5273 11.7114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43365 MAGAC_HUMAN "Melanoma-associated antigen 12 (Cancer/testis antigen 1.12, CT1.12) (MAGE-12 antigen) (MAGE12F antigen)" MAGEA12 MAGE12 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; histone deacetylase binding [GO:0042826]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0042826 histone deacetylase binding [GO:0042826] EGDCAPEEK 0.99434 -9.3392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57087 JAM2_HUMAN "Junctional adhesion molecule B, JAM-B (Junctional adhesion molecule 2, JAM-2) (Vascular endothelial junction-associated molecule, VE-JAM) (CD antigen CD322)" JAM2 C21orf43 VEJAM UNQ219/PRO245 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cellular extravasation [GO:0045123]; hematopoietic stem cell migration to bone marrow [GO:0097241]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; lymphocyte aggregation [GO:0071593]; maintenance of blood-brain barrier [GO:0035633]; myoblast fusion [GO:0007520]; negative regulation of myelination [GO:0031642]; positive regulation of lymphocyte migration [GO:2000403]; spermatid development [GO:0007286] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160] bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell contact zone [GO:0044291]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; somatodendritic compartment [GO:0036477]; tight junction [GO:0070160]; integrin binding [GO:0005178]; cell-cell adhesion [GO:0098609]; cellular extravasation [GO:0045123]; hematopoietic stem cell migration to bone marrow [GO:0097241]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; lymphocyte aggregation [GO:0071593]; maintenance of blood-brain barrier [GO:0035633]; myoblast fusion [GO:0007520]; negative regulation of myelination [GO:0031642]; positive regulation of lymphocyte migration [GO:2000403]; spermatid development [GO:0007286] GO:0005178; GO:0005886; GO:0005887; GO:0005923; GO:0007159; GO:0007286; GO:0007520; GO:0009986; GO:0031642; GO:0035633; GO:0036477; GO:0044291; GO:0045123; GO:0050901; GO:0070160; GO:0071593; GO:0097241; GO:0098609; GO:0098636; GO:2000403 integrin binding [GO:0005178] HRLLLLLLR 0.99434 -8.5796 0 11.4402 0 0 0 0 0 0 0 0 0 0 14.2561 13.8459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2043 14.8723 11.7761 0 0 0 0 14.3113 0 0 0 0 0 0 13.7382 14.4886 0 14.178 13.6001 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6521 0 14.3822 0 0 13.5818 0 14.6992 14.5491 0 0 0 0 0 0 13.5863 0 14.6649 0 0 13.2511 0 14.1825 0 0 0 15.3857 0 12.533 0 15.0733 10.392 15.0925 13.8235 13.5099 13.0685 13.4463 14.523 13.2866 9.90109 15.1179 13.2509 14.4946 13.4126 0 14.4474 0 14.4529 0 14.7756 15.6263 0 0 0 0 0 0 0 0 0 12.7234 0 0 0 13.6114 0 0 0 0 0 0 15.0532 0 0 0 0 0 14.3476 0 P78310 CXAR_HUMAN "Coxsackievirus and adenovirus receptor, CAR, hCAR (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR)" CXADR CAR Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell proliferation [GO:0060038]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]; actin cytoskeleton reorganization [GO:0031532]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell proliferation [GO:0060038]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633] GO:0001618; GO:0001669; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005886; GO:0005887; GO:0005911; GO:0005912; GO:0005923; GO:0007005; GO:0007157; GO:0007507; GO:0008013; GO:0008354; GO:0010669; GO:0014704; GO:0016323; GO:0016327; GO:0030054; GO:0030165; GO:0030175; GO:0030426; GO:0030593; GO:0031532; GO:0031594; GO:0032991; GO:0034109; GO:0042802; GO:0043005; GO:0044297; GO:0045121; GO:0045216; GO:0046629; GO:0050839; GO:0051607; GO:0055013; GO:0060038; GO:0060044; GO:0070633; GO:0071253; GO:0086067; GO:0086072; GO:0086082; GO:0098904 beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618] AGLIAGAIIGTLLALALIGLIIFCCRK 0.99434 -8.3522 0 0 0 14.8526 0 0 13.9459 13.3894 0 0 0 0 0 0 0 0 11.9221 0 0 13.6265 13.5168 0 0 0 0 13.3212 0 0 14.3949 0 0 0 0 12.7314 13.1413 0 10.9846 0 13.8652 0 13.8771 0 0 13.7877 13.6545 0 11.3645 0 0 0 0 12.845 13.4498 11.4008 0 13.4295 13.3514 12.5622 0 13.1636 11.8342 13.2151 12.7369 0 0 12.3867 0 12.3161 0 0 0 0 10.581 0 11.8729 0 0 0 11.8568 0 0 11.0205 0 0 0 0 0 0 13.973 0 0 0 0 11.7631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6041 0 0 0 0 0 11.6523 0 0 0 0 11.9499 0 0 0 0 14.5264 0 12.3259 0 0 0 0 12.4478 0 0 13.0913 10.0696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9149 15.5551 0 13.6527 0 0 0 13.9283 13.5634 0 0 0 11.5086 0 0 Q02040 AK17A_HUMAN "A-kinase anchor protein 17A, AKAP-17A (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A, PRKA17A) (Splicing factor, arginine/serine-rich 17A)" AKAP17A CXYorf3 DXYS155E SFRS17A XE7 Homo sapiens (Human) "B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723]; B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]" GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018 protein kinase A binding [GO:0051018]; RNA binding [GO:0003723] DDSPRRR 0.99434 -15.557 0 13.6989 0 0 0 11.2673 0 0 0 13.1129 14.698 0 11.8776 0 0 0 0 0 10.2692 0 0 0 0 0 0 0 0 0 0 0 0 10.8776 12.8748 0 0 0 0 0 0 12.0492 0 12.1214 0 0 14.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2945 0 13.2789 0 0 0 10.8398 0 14.5578 10.9236 0 0 0 0 13.9447 0 0 12.6021 0 13.0687 0 12.8647 0 12.8006 10.5454 0 0 0 0 0 0 0 12.0103 12.2836 0 0 0 0 0 0 0 0 12.3283 0 0 0 13.0129 0 0 11.8799 14.9442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5038 0 0 0 0 0 12.7179 11.9594 0 0 0 0 0 0 0 0 0 0 0 11.2331 0 0 12.9996 0 0 0 12.523 12.0386 0 0 10.9061 0 0 0 0 0 0 0 13.1148 0 Q06830 PRDX1_HUMAN "Peroxiredoxin-1, EC 1.11.1.24 (Natural killer cell-enhancing factor A, NKEF-A) (Proliferation-associated gene protein, PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1)" PRDX1 PAGA PAGB TDPX2 Homo sapiens (Human) cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; fibroblast proliferation [GO:0048144]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; retina homeostasis [GO:0001895]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; RNA binding [GO:0003723]; thioredoxin peroxidase activity [GO:0008379]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; fibroblast proliferation [GO:0048144]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; retina homeostasis [GO:0001895]; skeletal system development [GO:0001501] GO:0001501; GO:0001895; GO:0003723; GO:0004601; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0008283; GO:0008379; GO:0019430; GO:0030101; GO:0032872; GO:0034101; GO:0042267; GO:0042470; GO:0042744; GO:0042802; GO:0045296; GO:0045321; GO:0045454; GO:0048144; GO:0070062; GO:1901222 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; RNA binding [GO:0003723]; thioredoxin peroxidase activity [GO:0008379] EYFSKQK 0.99434 -9.0687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0666 0 0 0 0 0 0 0 11.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14168 MPP2_HUMAN MAGUK p55 subfamily member 2 (Discs large homolog 2) (Protein MPP2) MPP2 DLG2 Homo sapiens (Human) excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260] GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0014069; GO:0032590; GO:0043197; GO:0043198; GO:0051260; GO:0060079; GO:0060291 DLELTPNSGTLCGSLSGKKK 0.99434 -15.5 0 0 0 0 0 13.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.089 0 0 13.6123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7088 0 0 0 13.9227 0 14.8051 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1512 0 0 0 0 14.694 0 0 0 0 0 Q5VWK5 IL23R_HUMAN "Interleukin-23 receptor, IL-23 receptor, IL-23R" IL23R Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-23-mediated signaling pathway [GO:0038155]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496] external side of plasma membrane [GO:0009897]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; interleukin-23 receptor complex [GO:0072536]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-23-mediated signaling pathway [GO:0038155]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to interferon-gamma [GO:0034341]; response to lipopolysaccharide [GO:0032496] GO:0001916; GO:0002230; GO:0002827; GO:0004896; GO:0005886; GO:0006954; GO:0006955; GO:0009897; GO:0010536; GO:0019221; GO:0019955; GO:0032496; GO:0032693; GO:0032725; GO:0032729; GO:0032735; GO:0032740; GO:0032819; GO:0034341; GO:0038155; GO:0042102; GO:0042104; GO:0042509; GO:0042531; GO:0043235; GO:0043382; GO:0045672; GO:0046427; GO:0050829; GO:0051135; GO:0051142; GO:0072536; GO:2000318; GO:2000330 cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896] DYPQNSLFDNTTVVYIPDLNTGYK 0.99434 -8.5863 11.8676 0 13.0982 12.3581 14.2359 12.0893 12.4523 0 16.6918 14.613 14.1315 14.8924 16.3614 15.0257 16.0266 12.1278 15.4788 15.8438 13.0518 14.9862 14.3426 12.598 14.4548 13.2968 14.2491 16.1293 15.3332 15.4821 15.2197 11.957 13.4841 14.1197 14.9608 14.1324 0 13.8966 14.6192 0 15.069 14.8444 15.4937 14.4275 14.8289 14.0772 13.1196 13.6962 13.8433 13.4061 12.7735 14.8593 13.3202 13.3899 10.5035 13.1973 9.81404 0 12.4589 10.7209 0 9.91311 0 0 0 0 9.85242 11.8733 0 0 12.8088 11.7591 13.4099 0 0 13.1132 14.2263 15.9734 16.2859 14.0764 15.0323 15.4469 0 15.3027 16.1938 15.3496 14.9536 15.9643 14.2832 16.346 0 0 0 0 14.2259 0 0 14.8059 16.367 16.569 13.395 12.6182 13.5044 0 0 0 15.4176 15.9906 14.6227 14.8654 16.1025 15.4951 14.2675 0 0 0 15.9638 0 14.7225 14.4264 15.8384 16.4348 15.6488 13.0114 14.4333 0 0 0 13.4693 0 13.8287 16.4704 10.9976 15.4186 13.778 15.3542 15.1234 14.7094 13.8738 15.2759 15.8702 16.4535 15.3334 15.5581 14.5854 15.8885 15.4437 15.0553 13.8094 15.1426 0 0 15.6661 13.4082 15.7499 0 0 14.5792 15.4146 15.5601 15.8332 14.6016 14.6233 16.1504 15.2538 16.0463 14.2251 14.2696 13.6208 13.3348 15.9082 16.3301 16.3039 14.5988 0 0 13.8837 15.2797 0 16.2366 0 0 Q6IQ23 PKHA7_HUMAN "Pleckstrin homology domain-containing family A member 7, PH domain-containing family A member 7" PLEKHA7 Homo sapiens (Human) cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell-cell adhesion [GO:0090136]; pore complex assembly [GO:0046931]; zonula adherens maintenance [GO:0045218] cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; pore complex [GO:0046930]; zonula adherens [GO:0005915] cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; pore complex [GO:0046930]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell-cell adhesion [GO:0090136]; pore complex assembly [GO:0046931]; zonula adherens maintenance [GO:0045218] GO:0005654; GO:0005813; GO:0005829; GO:0005915; GO:0030054; GO:0044331; GO:0045218; GO:0046930; GO:0046931; GO:0070062; GO:0070097; GO:0090136 delta-catenin binding [GO:0070097] AHRDGTVWQLYEWQQR 0.99434 -36.859 0 0 0 0 0 0 0 0 0 0 0 13.0786 0 0 0 12.9613 0 0 0 0 13.065 0 0 0 0 0 0 0 12.3449 0 10.2928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8248 0 10.0207 11.9455 11.3744 0 0 10.787 0 0 0 0 14.1433 14.2652 0 0 0 0 0 0 0 0 0 0 0 0 11.3487 0 0 0 0 0 0 0 12.7636 17.6325 11.6719 0 12.3534 0 0 0 0 0 10.6824 0 0 0 0 0 0 0 11.9494 0 0 0 10.7704 0 0 0 10.6555 11.9022 14.6511 0 0 0 11.4822 12.0051 0 0 0 13.8372 14.1938 12.081 0 0 12.3237 17.3342 0 0 14.3968 0 11.4155 12.9062 0 12.0503 0 0 0 0 0 0 0 0 17.3853 0 0 14.6337 14.15 0 0 0 0 0 0 13.5516 0 13.3418 13.3689 14.4061 13.9548 0 0 0 0 13.6668 0 0 0 0 0 13.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUT3 MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 MFSD12 C19orf28 Homo sapiens (Human) carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021] integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162] integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293]; carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; organic substance transport [GO:0071702]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021] GO:0005764; GO:0005765; GO:0005770; GO:0005887; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:0071702; GO:1903712 cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293] AASCCAR 0.99434 -8.353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2588 0 0 0 0 0 0 0 0 0 0 14.6657 0 0 0 0 0 0 0 0 0 13.5239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V97 KBTB6_HUMAN Kelch repeat and BTB domain-containing protein 6 KBTBD6 Homo sapiens (Human) negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020]; response to unfolded protein [GO:0006986] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of Rac protein signal transduction [GO:0035020]; response to unfolded protein [GO:0006986] GO:0005634; GO:0005737; GO:0005829; GO:0006986; GO:0009968; GO:0031463; GO:0035020; GO:0043161; GO:0070936 DPFLCCDPYSGDLYK 0.99434 -9.0832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8318 0 0 0 0 11.4768 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1848 11.3139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2017 0 0 0 0 0 0 0 0 0 0 10.434 0 0 0 0 0 Q8IYD9 LAS2_HUMAN Lung adenoma susceptibility protein 2 LAS2 C18orf54 Homo sapiens (Human) negative regulation of cell population proliferation [GO:0008285] extracellular region [GO:0005576] extracellular region [GO:0005576]; negative regulation of cell population proliferation [GO:0008285] GO:0005576; GO:0008285 IELLILKAK 0.99434 -12.889 0 0 0 0 0 0 0 0 0 0 0 0 10.5897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3453 0 0 0 0 0 0 0 0 0 11.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1258 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ74 CTTB2_HUMAN "Cortactin-binding protein 2, CortBP2" CTTNBP2 C7orf8 CORTBP2 KIAA1758 Homo sapiens (Human) brain development [GO:0007420]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synapse organization [GO:0050807] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic actin cytoskeleton [GO:0098871]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; cell cortex [GO:0005938]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic actin cytoskeleton [GO:0098871]; synaptic vesicle [GO:0008021]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of synapse organization [GO:0050807] GO:0005938; GO:0007420; GO:0008021; GO:0017124; GO:0043197; GO:0050807; GO:0070161; GO:0098871; GO:0098978; GO:1905274 SH3 domain binding [GO:0017124] ASNTGAK 0.99434 -9.0675 0 0 0 0 0 0 0 0 14.2886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7808 11.0063 0 0 0 0 0 0 0 0 13.9698 0 0 0 13.6347 0 0 0 0 0 0 0 11.5784 0 0 0 0 0 10.9619 0 0 10.9404 0 0 0 0 8.80826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76898 12.3152 14.0104 0 0 0 0 0 0 0 0 13.5612 0 0 0 12.3143 0 0 0 0 0 0 0 0 0 0 0 0 10.6345 0 0 0 0 13.5626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3648 0 0 0 0 10.8138 0 0 0 0 0 0 0 0 0 10.3755 0 0 15.7842 11.5481 0 0 0 0 17.7602 0 11.4473 0 0 0 0 0 0 10.9221 14.3216 0 0 0 0 0 0 13.4922 0 0 0 0 0 0 0 0 Q9BXJ2 C1QT7_HUMAN Complement C1q tumor necrosis factor-related protein 7 C1QTNF7 CTRP7 Homo sapiens (Human) collagen trimer [GO:0005581]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; extracellular region [GO:0005576] GO:0005576; GO:0005581 GTAGLRGK 0.99434 -8.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5299 12.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5194 0 0 13.6484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2337 0 0 0 0 0 0 0 0 12.8723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZD7 TMG3_HUMAN "Transmembrane gamma-carboxyglutamic acid protein 3 (Proline-rich gamma-carboxyglutamic acid protein 3, Proline-rich Gla protein 3)" PRRG3 PRGP3 TMG3 Homo sapiens (Human) extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0005886; GO:0016021 calcium ion binding [GO:0005509] AGHTLPR 0.99434 -9.0786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2376 0 11.8236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4558 13.9212 0 0 0 0 0 0 0 0 0 0 0 14.5969 13.5411 14.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3999 0 0 0 0 0 0 0 13.4666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9706 0 0 0 0 0 0 0 12.7663 0 0 0 0 0 0 0 0 0 0 0 0 0 12.634 0 0 0 0 0 0 0 0 0 0 Q9UHA3 RLP24_HUMAN Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like) RSL24D1 C15orf15 RPL24L My024 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit biogenesis [GO:0042273]; translation [GO:0006412] GO:0003735; GO:0005654; GO:0005730; GO:0005840; GO:0006412; GO:0042273 structural constituent of ribosome [GO:0003735] CHKNFKK 0.99434 -15.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4414 0 15.5234 Q9UNE7 CHIP_HUMAN "E3 ubiquitin-protein ligase CHIP, EC 2.3.2.27 (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1)" STUB1 CHIP PP1131 Homo sapiens (Human) cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERBB2 signaling pathway [GO:0038128]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579] GO:0000151; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006515; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030433; GO:0030512; GO:0030544; GO:0030579; GO:0030674; GO:0030911; GO:0030968; GO:0031072; GO:0031371; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032091; GO:0032436; GO:0034450; GO:0034605; GO:0038128; GO:0042405; GO:0042803; GO:0043161; GO:0045862; GO:0046332; GO:0048156; GO:0051087; GO:0051443; GO:0051604; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031 chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450] AITRNPLVAVYYTNR 0.99434 -15.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7367 0 17.1044 0 0 17.817 0 0 0 0 0 0 0 0 14.8106 15.0347 16.4535 0 0 12.32 0 11.5924 0 0 0 0 0 0 12.9764 0 0 0 0 12.0326 0 0 0 0 12.9269 13.2724 0 13.9905 10.539 12.5731 0 0 14.1787 13.0708 0 0 12.846 0 0 0 0 0 0 0 0 0 13.1381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4299 0 0 0 0 0 0 Q9Y5K6 CD2AP_HUMAN CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains) CD2AP Homo sapiens (Human) "actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; transforming growth factor beta1 production [GO:0032905]; vesicle organization [GO:0016050]" actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle [GO:0031982] "actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; vesicle [GO:0031982]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]; transforming growth factor beta1 production [GO:0032905]; vesicle organization [GO:0016050]" GO:0001650; GO:0001726; GO:0005172; GO:0005200; GO:0005737; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007049; GO:0007165; GO:0008013; GO:0008022; GO:0015629; GO:0016050; GO:0016477; GO:0017124; GO:0030139; GO:0030424; GO:0030425; GO:0031252; GO:0031941; GO:0031982; GO:0032905; GO:0032911; GO:0034451; GO:0042802; GO:0043161; GO:0044877; GO:0045296; GO:0048259; GO:0048471; GO:0050714; GO:0051058; GO:0051301; GO:0065003; GO:0070062; GO:0098609; GO:1900182; GO:2000249 beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200]; vascular endothelial growth factor receptor binding [GO:0005172] AQIIELLCIVEALKK 0.99434 -15.504 0 0 0 0 0 0 0 0 12.1908 0 0 0 0 0 0 0 12.8131 0 0 0 0 0 0 0 12.1236 0 0 0 0 0 0 0 0 0 0 11.0835 0 0 0 0 0 11.4269 0 12.4085 0 0 0 0 12.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0721 13.8924 0 0 15.1084 13.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9308 0 0 0 0 0 13.6864 0 0 0 0 0 0 0 0 0 12.2007 0 0 0 13.7727 0 0 11.5591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1599 0 0 0 0 11.9416 0 0 0 0 0 0 0 0 0 13.5263 0 0 0 0 0 0 0 12.9031 0 0 0 0 0 0 11.3432 0 0 0 0 0 11.4583 0 0 O14579 COPE_HUMAN "Coatomer subunit epsilon (Epsilon-coat protein, Epsilon-COP)" COPE Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133] "COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005198; GO:0005654; GO:0005789; GO:0005794; GO:0005829; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0030133; GO:0099612 structural molecule activity [GO:0005198] FGVVLDEIK 0.99435 -11.135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7964 O43281 EFS_HUMAN "Embryonal Fyn-associated substrate, hEFS (Cas scaffolding protein family member 3)" EFS CASS3 Homo sapiens (Human) actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; focal adhesion [GO:0005925] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; protein domain specific binding [GO:0019904]; SH3 domain binding [GO:0017124]; actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0005925; GO:0007155; GO:0007169; GO:0016477; GO:0017124; GO:0019904; GO:0035556; GO:0090527 protein domain specific binding [GO:0019904]; SH3 domain binding [GO:0017124] ATVLAVK 0.99435 -8.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8134 0 0 0 12.115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4414 0 0 0 0 0 0 0 14.9894 0 0 0 0 14.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0737 15.5749 14.8647 0 0 15.1327 0 15.5503 0 13.108 15.1271 0 15.2288 15.4074 15.3652 0 0 0 0 14.6272 0 0 0 14.5603 0 14.2122 13.2556 0 0 0 0 0 13.735 0 13.5487 12.8468 13.9305 0 0 14.1179 13.6093 13.5785 13.4466 0 12.3641 0 14.3253 0 0 0 0 12.5141 0 0 0 0 0 0 0 0 0 0 11.9915 12.8658 0 0 0 18.3274 13.4264 0 0 14.3726 14.088 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0297 0 0 20.5646 12.5748 0 0 0 0 0 0 0 O95072 REC8_HUMAN Meiotic recombination protein REC8 homolog (Cohesin Rec8p) REC8 REC8L1 Homo sapiens (Human) double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177]; oocyte maturation [GO:0001556]; reciprocal meiotic recombination [GO:0007131]; seminiferous tubule development [GO:0072520]; sister chromatid cohesion [GO:0007062]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] cohesin complex [GO:0008278]; kinetochore [GO:0000776]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nuclear meiotic cohesin complex [GO:0034991]; nucleus [GO:0005634] cohesin complex [GO:0008278]; kinetochore [GO:0000776]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nuclear meiotic cohesin complex [GO:0034991]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177]; oocyte maturation [GO:0001556]; reciprocal meiotic recombination [GO:0007131]; seminiferous tubule development [GO:0072520]; sister chromatid cohesion [GO:0007062]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] GO:0000724; GO:0000776; GO:0000800; GO:0001556; GO:0001673; GO:0003682; GO:0005634; GO:0006302; GO:0007062; GO:0007130; GO:0007131; GO:0007141; GO:0007283; GO:0007286; GO:0008278; GO:0009566; GO:0034991; GO:0051177; GO:0051321; GO:0072520 chromatin binding [GO:0003682] EYLRVNVVKTCEEILNYVLVR 0.99435 -11.146 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5539 0 16.1508 10.9349 0 0 11.523 0 0 0 0 0 0 0 0 13.5785 0 0 0 0 0 0 0 0 13.6701 11.89 0 0 0 0 0 0 0 0 12.6572 0 0 12.0146 11.9648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2491 13.191 16.9327 0 14.736 12.5324 0 0 0 13.8583 0 0 0 0 13.2004 13.2739 13.087 0 0 0 13.1564 0 16.5508 0 15.1284 13.6098 13.5394 13.0354 13.2753 0 0 16.2996 14.3653 15.2428 0 0 0 0 11.2261 0 11.9805 13.4269 12.5905 13.4107 0 12.1943 0 15.252 15.3178 13.8991 15.094 13.9176 15.8105 0 14.8542 0 14.4964 0 0 0 0 15.9287 0 0 14.2716 14.6979 0 0 0 14.1693 0 14.0653 14.3089 13.2463 14.7264 13.1313 0 11.5056 0 0 0 0 0 0 0 0 0 13.4282 0 0 0 0 14.7634 13.9447 0 0 16.4836 11.3191 0 13.0967 0 P05455 LA_HUMAN "Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen, SS-B)" SSB Homo sapiens (Human) histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033]" GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0042780; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904 mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049] GAKEGIILFK 0.99435 -9.3793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2876 0 0 0 0 0 0 0 0 0 0 12.12 12.5982 0 12.5233 0 0 0 13.0107 0 0 0 0 0 0 0 0 0 0 0 15.9254 0 11.8464 0 0 12.5421 0 0 0 0 0 0 0 12.3758 0 16.5987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08908 5HT1A_HUMAN "5-hydroxytryptamine receptor 1A, 5-HT-1A, 5-HT1A (G-21) (Serotonin receptor 1A)" HTR1A ADRB2RL1 ADRBRL1 Homo sapiens (Human) "adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; positive regulation of cell population proliferation [GO:0008284]; regulation of behavior [GO:0050795]; regulation of dopamine metabolic process [GO:0042053]; regulation of hormone secretion [GO:0046883]; regulation of serotonin secretion [GO:0014062]; regulation of vasoconstriction [GO:0019229]; serotonin metabolic process [GO:0042428]; serotonin receptor signaling pathway [GO:0007210]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; receptor-receptor interaction [GO:0090722]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; exploration behavior [GO:0035640]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gamma-aminobutyric acid signaling pathway [GO:0007214]; positive regulation of cell population proliferation [GO:0008284]; regulation of behavior [GO:0050795]; regulation of dopamine metabolic process [GO:0042053]; regulation of hormone secretion [GO:0046883]; regulation of serotonin secretion [GO:0014062]; regulation of vasoconstriction [GO:0019229]; serotonin metabolic process [GO:0042428]; serotonin receptor signaling pathway [GO:0007210]" GO:0001662; GO:0004993; GO:0005886; GO:0005887; GO:0007186; GO:0007187; GO:0007198; GO:0007210; GO:0007214; GO:0007268; GO:0008284; GO:0014062; GO:0019229; GO:0030425; GO:0030594; GO:0035640; GO:0042053; GO:0042428; GO:0045202; GO:0046883; GO:0050795; GO:0051378; GO:0090722 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; receptor-receptor interaction [GO:0090722]; serotonin binding [GO:0051378] AARFRIR 0.99435 -13.827 0 0 0 0 0 0 0 0 0 13.0061 0 0 12.3526 13.8957 0 0 12.7784 12.9084 0 13.1974 13.4581 0 10.1192 0 13.2071 14.9689 13.2624 12.8464 0 0 12.6422 0 0 0 0 0 0 0 0 0 0 0 11.7163 0 0 0 0 0 12.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1952 0 16.5025 0 0 0 0 15.0954 0 0 0 13.1267 16.0366 0 0 0 0 0 0 0 15.143 0 0 0 0 0 0 0 0 0 13.729 0 0 0 0 0 15.2437 0 0 0 0 0 15.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1232 13.9771 0 15.4209 0 0 0 0 0 12.8392 0 0 13.8702 14.3131 14.1894 13.3576 13.8329 14.3195 14.2263 14.4001 15.0574 15.0047 13.8033 0 13.6974 13.5935 15.3617 14.0593 0 0 0 14.9778 0 13.9781 0 0 P63128 POK9_HUMAN "Endogenous retrovirus group K member 9 Pol protein (HERV-K(C6) Gag-Pol protein) (HERV-K109 Gag-Pol protein) (HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein) [Includes: Protease, EC 3.4.23.50 (PR) (Retropepsin); Reverse transcriptase/ribonuclease H, EC 2.7.7.49, EC 2.7.7.7, EC 3.1.26.4 (p66 RT) ]" ERVK-9 Homo sapiens (Human) proteolysis [GO:0006508]; viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508]; viral process [GO:0016032] GO:0003723; GO:0003887; GO:0003964; GO:0004190; GO:0004523; GO:0005198; GO:0005886; GO:0006508; GO:0008270; GO:0016032 aspartic-type endopeptidase activity [GO:0004190]; DNA-directed DNA polymerase activity [GO:0003887]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] FQWKVLPQGMLNSPTICQTFVGR 0.99435 -11.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.841 0 0 0 0 12.3516 0 0 0 0 0 0 12.0517 0 0 0 12.1331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1092 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05215 EGR4_HUMAN "Early growth response protein 4, EGR-4 (AT133)" EGR4 Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005654; GO:0006357; GO:0008284; GO:0043565; GO:0045944; GO:0046872; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AFACPVESCVRSFAR 0.99435 -8.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3472 0 0 0 0 0 0 11.1281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0981 0 0 0 0 0 0 14.7097 14.0444 12.5824 0 0 12.2334 12.6632 12.2006 0 0 0 0 0 0 12.6666 12.3323 0 0 11.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9976 12.3932 0 0 0 0 14.2055 0 0 0 0 0 12.7755 0 0 0 0 0 0 0 0 0 12.4329 0 0 12.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3211 12.2111 12.3356 12.1799 0 0 0 0 Q05469 LIPS_HUMAN "Hormone-sensitive lipase, HSL, EC 3.1.1.79 (Monoacylglycerol lipase LIPE, EC 3.1.1.23) (Retinyl ester hydrolase, REH)" LIPE Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; protein phosphorylation [GO:0006468]; triglyceride catabolic process [GO:0019433] caveola [GO:0005901]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020] "caveola [GO:0005901]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; 1,2-diacylglycerol acylhydrolase activity [GO:0102259]; 1,3-diacylglycerol acylhydrolase activity [GO:0102258]; acylglycerol lipase activity [GO:0047372]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; hormone-sensitive lipase activity [GO:0033878]; retinyl-palmitate esterase activity [GO:0050253]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; protein phosphorylation [GO:0006468]; triglyceride catabolic process [GO:0019433]" GO:0004771; GO:0004806; GO:0005811; GO:0005829; GO:0005901; GO:0006468; GO:0008203; GO:0016020; GO:0016042; GO:0019433; GO:0033878; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0102258; GO:0102259 "1,2-diacylglycerol acylhydrolase activity [GO:0102259]; 1,3-diacylglycerol acylhydrolase activity [GO:0102258]; acylglycerol lipase activity [GO:0047372]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; hormone-sensitive lipase activity [GO:0033878]; retinyl-palmitate esterase activity [GO:0050253]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]" CCLAHLLHKSR 0.99435 -13.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.936 0 0 0 0 12.8616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6909 0 0 0 0 0 0 0 0 Q3V5L5 MGT5B_HUMAN "Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B, EC 2.4.1.-, EC 2.4.1.155 (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase B) (GlcNAc-T Vb, GNT-Vb, hGnTVb) (Mannoside acetylglucosaminyltransferase 5B) (N-acetylglucosaminyl-transferase Vb) (N-acetylglucosaminyltransferase IX, GNT-IX)" MGAT5B KIAA2008 Homo sapiens (Human) protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation via serine [GO:0018242] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation via serine [GO:0018242]" GO:0000139; GO:0005794; GO:0006487; GO:0016021; GO:0018242; GO:0030144; GO:0030145 "alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]" EKFLGILNK 0.99435 -9.3731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2815 0 0 0 0 12.0416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUX7 AEBP1_HUMAN "Adipocyte enhancer-binding protein 1, AE-binding protein 1 (Aortic carboxypeptidase-like protein)" AEBP1 ACLP Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; proteolysis [GO:0006508]; regulation of collagen fibril organization [GO:1904026] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] "collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteolysis [GO:0006508]; regulation of collagen fibril organization [GO:1904026]" GO:0000122; GO:0000977; GO:0001227; GO:0004180; GO:0005516; GO:0005518; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0008270; GO:0062023; GO:0070062; GO:1904026 "calmodulin binding [GO:0005516]; carboxypeptidase activity [GO:0004180]; collagen binding [GO:0005518]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" APAPAPEER 0.99435 -11.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6946 0 0 0 13.5707 13.894 0 0 15.4667 13.7361 12.0242 0 0 0 0 0 12.8418 0 14.9809 0 0 0 0 0 0 0 15.1068 13.8786 0 0 0 0 0 0 0 0 0 12.674 12.6987 12.3232 10.7126 0 0 0 0 0 0 0 0 0 10.2738 0 0 0 0 0 0 0 0 0 0 0 0 12.4438 0 0 0 12.2526 0 0 0 13.4691 0 0 0 12.6228 0 0 0 0 0 0 0 0 0 0 0 11.2861 0 0 0 0 0 0 0 0 15.7285 0 0 0 12.2164 0 Q8IZW8 TENS4_HUMAN Tensin-4 (C-terminal tensin-like protein) TNS4 CTEN PP14434 Homo sapiens (Human) apoptotic process [GO:0006915]; protein localization [GO:0008104] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; apoptotic process [GO:0006915]; protein localization [GO:0008104] GO:0003779; GO:0005829; GO:0005856; GO:0005925; GO:0006915; GO:0008104 actin binding [GO:0003779] DVPRETR 0.99435 -9.3868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.578 0 0 0 0 0 0 14.0608 0 0 0 0 0 0 11.9507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6338 Q8NB50 ZFP62_HUMAN "Zinc finger protein 62 homolog, Zfp-62" ZFP62 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDECEKSFNYSSLLIQHK 0.99435 -15.592 0 0 0 0 0 0 0 0 12.0293 0 0 0 0 0 0 0 0 0 0 11.9811 0 10.4241 0 0 0 0 9.50772 0 13.8291 0 0 0 10.3839 0 0 0 0 0 0 0 0 0 0 0 10.5816 0 0 0 0 0 0 0 0 0 0 0 0 10.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8616 13.0364 12.664 0 0 0 11.565 11.4745 10.7301 0 14.0606 0 0 14.9136 0 9.90186 0 14.7657 0 15.5811 0 0 13.2444 0 13.4742 0 14.852 0 0 0 0 14.5672 0 0 12.2029 0 0 11.8331 11.6903 14.1351 0 13.2879 0 0 0 0 0 0 0 12.3104 0 0 0 0 13.0289 0 11.7034 0 0 0 0 11.8682 0 0 14.8061 0 0 13.366 0 0 0 14.3669 0 0 0 14.4195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.282 0 0 0 0 0 0 0 Q8NGF4 O5AP2_HUMAN Olfactory receptor 5AP2 OR5AP2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] DVKKALK 0.99435 -15.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5415 0 0 0 0 0 12.6911 13.292 13.3967 0 0 0 0 0 0 0 0 0 13.054 0 0 0 0 0 12.904 0 0 0 0 13.3382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5107 0 0 0 0 0 16.5828 0 0 0 0 0 0 0 0 12.5818 14.1758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8162 0 0 13.6309 Q96PV4 PNMA5_HUMAN Paraneoplastic antigen-like protein 5 (Tumor antigen BJ-HCC-25) PNMA5 KIAA1934 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] identical protein binding [GO:0042802]; positive regulation of apoptotic process [GO:0043065] GO:0042802; GO:0043065 identical protein binding [GO:0042802] AEASVSAPQATVQARSFSDSSPQTIQGGLPPLVKR 0.99435 -15.634 0 0 0 0 0 0 0 0 10.8745 0 0 0 0 0 0 0 0 13.5203 0 0 0 0 0 0 11.6006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9811 0 0 0 0 0 0 14.7206 14.1664 12.6426 0 13.401 13.3697 13.7196 13.3308 0 14.0562 14.0155 12.0985 12.8289 0 13.2242 0 15.2856 0 0 0 0 0 13.0722 13.5238 0 0 0 0 0 11.9562 11.3311 0 0 0 12.8091 0 0 12.9718 0 0 0 0 15.5042 12.6705 0 0 12.9579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4807 0 0 0 0 0 0 0 0 0 12.3632 12.2875 0 0 0 0 0 13.635 11.6096 Q99766 ATP5S_HUMAN "ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B, FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B)" DMAC2L ATP5S ATPW Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600] "cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]" "cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; metal ion binding [GO:0046872]; proton transmembrane transporter activity [GO:0015078]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600]" GO:0005737; GO:0005743; GO:0006754; GO:0015078; GO:0045263; GO:0046872; GO:1902600 metal ion binding [GO:0046872]; proton transmembrane transporter activity [GO:0015078] GIIALRHLR 0.99435 -9.3831 0 0 0 0 0 0 0 12.3403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5151 0 0 0 0 0 0 0 0 0 0 0 12.3098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6356 0 0 0 0 13.1358 0 0 0 0 0 0 0 0 12.6113 0 0 12.7558 12.5157 0 0 0 0 0 0 0 0 0 0 0 0 13.4756 0 0 0 12.5918 0 0 12.5673 12.0398 0 0 0 0 0 12.4236 0 0 0 0 12.5229 0 12.6639 0 0 13.5445 0 0 0 0 0 0 0 0 0 12.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1025 14.0728 0 0 0 0 13.7823 0 14.4585 0 0 0 0 0 12.9281 0 0 0 12.8755 0 0 0 0 0 Q9BST9 RTKN_HUMAN Rhotekin RTKN RTKN1 Homo sapiens (Human) actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; regulation of apoptotic process [GO:0042981]; Rho protein signal transduction [GO:0007266]; septin ring organization [GO:0031106]; signal transduction [GO:0007165] actomyosin contractile ring [GO:0005826]; cytosol [GO:0005829] actomyosin contractile ring [GO:0005826]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; regulation of apoptotic process [GO:0042981]; Rho protein signal transduction [GO:0007266]; septin ring organization [GO:0031106]; signal transduction [GO:0007165] GO:0000281; GO:0000915; GO:0005095; GO:0005525; GO:0005826; GO:0005829; GO:0006915; GO:0007165; GO:0007266; GO:0031106; GO:0031267; GO:0042981 GTP binding [GO:0005525]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267] ARSVAPLPPQR 0.99435 -8.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7534 0 0 0 0 0 0 0 0 12.8166 11.8586 0 0 0 0 0 0 0 0 12.6726 13.4726 0 0 0 0 0 0 0 0 10.9958 0 0 0 13.7334 0 0 0 0 0 0 0 13.5996 0 0 0 0 0 0 0 12.6143 0 0 0 0 0 0 0 0 0 0 0 0 17.9729 0 0 0 0 0 0 0 0 0 0 14.5748 0 0 0 0 0 13.2388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C029 TRIM7_HUMAN "E3 ubiquitin-protein ligase TRIM7, EC 2.3.2.27 (Glycogenin-interacting protein) (RING finger protein 90) (Tripartite motif-containing protein 7)" TRIM7 GNIP RNF90 Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005737; GO:0005794; GO:0008270; GO:0016567; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DGWAFGVARESVRR 0.99435 -13.022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8817 0 0 0 0 0 0 0 0 0 13.5212 0 0 0 Q9H2U6 CO005_HUMAN Putative uncharacterized protein encoded by LINC00597 LINC00597 C15orf5 Homo sapiens (Human) PPEQTRR 0.99435 -13.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4I2 ZHX3_HUMAN Zinc fingers and homeoboxes protein 3 (Triple homeobox protein 1) (Zinc finger and homeodomain protein 3) ZHX3 KIAA0395 TIX1 Homo sapiens (Human) "cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell differentiation [GO:0030154]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030154; GO:0042803; GO:0045669; GO:0045892; GO:0046872; GO:0046982 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]" DPTFVCSGCSFLAK 0.99435 -15.605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3977 0 12.1614 0 0 0 0 0 0 0 0 0 0 17.2173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1943 0 0 0 0 0 0 0 0 0 0 0 0 13.5049 0 0 13.59 0 11.0222 0 0 0 0 0 0 0 0 0 0 13.971 0 0 0 0 0 0 0 0 0 13.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3069 0 0 0 0 0 13.2702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6785 0 13.0446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4363 13.6064 0 0 0 0 0 Q9UBC1 IKBL1_HUMAN "NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein, I-kappa-B-like protein, IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1)" NFKBIL1 IKBL Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720] GO:0005634; GO:0005654; GO:0005829; GO:0007249; GO:0031665; GO:0032088; GO:0032720; GO:0034122; GO:0071222 CPSAMGIKNK 0.99435 -8.6188 0 0 0 0 0 0 0 0 12.914 11.7309 0 11.9176 13.0252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9954 0 12.1095 11.9449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7365 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9534 0 0 11.6582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5779 0 0 0 0 0 18.2053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3576 0 0 0 0 0 0 0 0 0 0 0 0 13.9639 0 0 0 18.8769 0 0 0 0 0 0 12.3176 12.4459 14.5729 0 0 0 18.6801 0 0 18.1898 0 11.8602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7174 0 17.6546 0 0 0 0 0 Q9UBD9 CLCF1_HUMAN "Cardiotrophin-like cytokine factor 1 (B-cell-stimulating factor 3, BSF-3) (Novel neurotrophin-1, NNT-1)" CLCF1 BSF3 CLC NNT1 Homo sapiens (Human) B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259] CNTFR-CLCF1 complex [GO:0097059]; CRLF-CLCF1 complex [GO:0097058]; extracellular region [GO:0005576] CNTFR-CLCF1 complex [GO:0097059]; CRLF-CLCF1 complex [GO:0097058]; extracellular region [GO:0005576]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259] GO:0002639; GO:0005102; GO:0005125; GO:0005127; GO:0005576; GO:0007166; GO:0007259; GO:0008083; GO:0008284; GO:0019221; GO:0030183; GO:0030890; GO:0042531; GO:0043524; GO:0048295; GO:0048711; GO:0097058; GO:0097059 ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102] DLRAGDSWGMLACLCTVLWHLPAVPALNR 0.99435 -8.3969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.176 0 11.2565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8589 16.0219 0 0 0 0 0 0 0 0 15.8205 0 0 0 0 0 0 15.5421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0444 13.7846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGC7 RF1ML_HUMAN "Peptide chain release factor 1-like, mitochondrial (Mitochondrial translational release factor 1-like) (mtRF1a)" MTRF1L MTRF1A Homo sapiens (Human) mitochondrial translational termination [GO:0070126] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; translation release factor activity [GO:0003747]; mitochondrial translational termination [GO:0070126] GO:0003747; GO:0005739; GO:0005759; GO:0070126 translation release factor activity [GO:0003747] ERELRETEHLLHDENEDLR 0.99435 -15.598 0 0 0 0 0 0 0 0 0 11.4181 0 11.2673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5649 0 0 0 0 0 0 12.5646 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9977 0 0 0 0 0 0 0 0 0 0 0 12.829 0 0 0 12.3266 0 0 0 0 A0A087WXM9 MEIKN_HUMAN Meiosis-specific kinetochore protein MEIKIN Homo sapiens (Human) "female meiosis chromosome segregation [GO:0016321]; homologous chromosome segregation [GO:0045143]; male meiosis chromosome segregation [GO:0007060]; meiotic sister chromatid cohesion involved in meiosis I [GO:0010789]; meiotic sister chromatid cohesion, centromeric [GO:0051754]" "condensed chromosome, centromeric region [GO:0000779]; kinetochore [GO:0000776]" "condensed chromosome, centromeric region [GO:0000779]; kinetochore [GO:0000776]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome segregation [GO:0045143]; male meiosis chromosome segregation [GO:0007060]; meiotic sister chromatid cohesion involved in meiosis I [GO:0010789]; meiotic sister chromatid cohesion, centromeric [GO:0051754]" GO:0000776; GO:0000779; GO:0007060; GO:0010789; GO:0016321; GO:0045143; GO:0051754 AEAPPGSK 0.99436 -7.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.086 0 0 0 0 0 0 0 0 0 0 12.9307 0 0 0 0 0 0 0 0 0 0 0 14.4938 0 0 0 0 0 12.9239 0 12.2366 0 0 0 0 0 0 0 0 0 13.7147 0 0 0 0 0 0 0 0 0 14.4433 0 0 0 0 0 0 0 0 0 14.3526 0 0 0 0 0 0 13.7367 0 0 0 0 0 0 0 0 9.87172 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6785 0 0 0 0 0 0 0 0 12.3061 0 0 A0A1W2PPK0 CPHL2_HUMAN Cytoplasmic polyadenylated homeobox-like protein 2 CPHXL2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CSSFRLR 0.99436 -11.498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MU46 SMTL1_HUMAN Smoothelin-like protein 1 SMTNL1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]" contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634] "contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310]" GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0005815; GO:0008157; GO:0009410; GO:0014823; GO:0018105; GO:0030036; GO:0031430; GO:0031674; GO:0031941; GO:0042310; GO:0043292; GO:0043621; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718 calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; protein self-association [GO:0043621]; tropomyosin binding [GO:0005523] ECSTEPK 0.99436 -7.8964 0 0 0 0 0 0 0 0 0 0 0 12.0859 0 12.0728 11.0577 0 0 0 12.5286 12.0985 0 0 0 0 11.4451 11.6043 0 0 0 0 0 0 0 0 0 11.4086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8984 0 0 14.2593 0 0 0 0 0 16.1956 0 0 0 0 0 0 0 0 11.2425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4504 0 0 0 0 0 14.2844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15083 ERC2_HUMAN ERC protein 2 ERC2 KIAA0378 Homo sapiens (Human) maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; regulation of synaptic plasticity [GO:0048167]; synaptic vesicle priming [GO:0016082] anchoring junction [GO:0070161]; cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; cytoskeleton of presynaptic active zone [GO:0048788]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; structural constituent of presynaptic active zone [GO:0098882]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; regulation of synaptic plasticity [GO:0048167]; synaptic vesicle priming [GO:0016082] GO:0007274; GO:0016082; GO:0030426; GO:0042734; GO:0048167; GO:0048786; GO:0048788; GO:0048790; GO:0070161; GO:0098882; GO:0098978; GO:0098982 structural constituent of presynaptic active zone [GO:0098882] AHNIEDDSR 0.99436 -11.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0308 0 0 0 0 13.1787 0 0 0 0 0 0 12.8432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0577 0 0 14.5297 0 14.2966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4846 13.6927 0 0 0 13.4631 13.7631 0 0 0 0 0 0 0 12.4269 0 0 0 0 0 14.0141 13.2305 14.7118 14.5462 0 0 0 0 14.1169 0 0 13.849 14.4416 0 15.2089 14.3558 13.889 14.5263 14.5377 0 0 12.3329 0 0 0 0 0 0 0 14.5289 0 0 0 0 0 15.8155 0 0 15.1932 0 0 11.0492 0 0 12.5962 0 0 0 0 0 0 0 0 0 0 0 13.1391 0 0 0 13.5281 13.1483 0 0 0 O43709 BUD23_HUMAN "Probable 18S rRNA (guanine-N(7))-methyltransferase, EC 2.1.1.- (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein) (rRNA methyltransferase and ribosome maturation factor)" BUD23 MERM1 WBSCR22 HUSSY-03 PP3381 Homo sapiens (Human) chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476] GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0016435; GO:0046982; GO:0048471; GO:0070476; GO:2000234 methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435] AWVLEKK 0.99436 -15.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04792 HSPB1_HUMAN "Heat shock protein beta-1, HspB1 (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein, HSP 27) (Stress-responsive protein 27, SRP27)" HSPB1 HSP27 HSP28 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein refolding [GO:0042026]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895] axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018] axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; unfolded protein binding [GO:0051082]; anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein refolding [GO:0042026]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895] GO:0000502; GO:0001533; GO:0001895; GO:0001932; GO:0003723; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005925; GO:0006446; GO:0006469; GO:0006986; GO:0008426; GO:0009408; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0032731; GO:0032760; GO:0035556; GO:0035924; GO:0038033; GO:0042026; GO:0042802; GO:0042803; GO:0043066; GO:0043122; GO:0043130; GO:0043536; GO:0044183; GO:0045766; GO:0051082; GO:0061077; GO:0061629; GO:0070062; GO:0070527; GO:0099641; GO:1902176; GO:1904115; GO:2001028 identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; unfolded protein binding [GO:0051082] HTADRWR 0.99436 -5.2045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C604 OR4A8_HUMAN Olfactory receptor 4A8 (Olfactory receptor OR11-110) OR4A8 OR4A8P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] PVSNFPIDK 0.99436 -11.496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3651 14.3031 13.4433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8658 13.6666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18754 RCC1_HUMAN Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032] chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032] GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0031965; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301 chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199] AEYGRLGLGEGAEEKSIPTLISR 0.99436 -9.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2244 0 17.0384 0 0 0 0 0 0 17.8107 0 0 0 12.2536 0 0 16.6835 0 0 0 16.8534 0 0 0 0 0 0 0 0 0 0 17.5953 0 0 0 0 0 0 0 0 16.4741 11.5511 0 0 0 0 0 0 17.4507 0 0 0 0 0 0 0 0 16.1994 0 0 0 16.2574 0 0 0 16.3085 0 0 0 0 0 0 16.1715 0 0 0 0 0 0 0 0 16.2072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0813 0 0 0 0 0 0 0 P43116 PE2R2_HUMAN "Prostaglandin E2 receptor EP2 subtype, PGE receptor EP2 subtype, PGE2 receptor EP2 subtype (Prostanoid EP2 receptor)" PTGER2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to progesterone [GO:0032570] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; prostaglandin E receptor activity [GO:0004957]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of cell population proliferation [GO:0042127]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to progesterone [GO:0032570] GO:0004957; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007189; GO:0007204; GO:0009624; GO:0032496; GO:0032570; GO:0042127; GO:0071380 prostaglandin E receptor activity [GO:0004957] FLSINSIIDPWVFAILRPPVLR 0.99436 -12.649 0 0 0 0 0 0 13.2151 0 0 0 13.7318 0 14.3399 15.8985 16.318 0 0 0 0 13.8798 0 0 0 0 0 14.6119 0 0 0 0 13.8874 14.9741 13.2601 15.0899 15.69 15.2385 14.5643 13.3379 14.6418 0 14.6528 0 14.1934 0 0 15.5465 0 0 12.8298 0 0 0 0 11.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5983 0 0 0 0 0 0 0 0 12.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7479 0 0 0 0 0 0 0 0 14.2978 0 0 0 0 0 0 0 0 0 0 0 12.9103 0 0 0 0 0 0 0 13.5833 0 0 0 14.4863 0 11.1234 0 0 14.2936 14.7112 0 0 15.0782 14.925 13.8564 0 0 0 11.8666 0 0 0 0 0 0 14.6556 P48775 T23O_HUMAN "Tryptophan 2,3-dioxygenase, TDO, EC 1.13.11.11 (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase, TO, TRPO) (Tryptophan pyrrolase) (Tryptophanase)" TDO2 TDO Homo sapiens (Human) protein homotetramerization [GO:0051289]; response to nitroglycerin [GO:1904842]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441] cytosol [GO:0005829] "cytosol [GO:0005829]; amino acid binding [GO:0016597]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; tryptophan 2,3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; response to nitroglycerin [GO:1904842]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441]" GO:0004833; GO:0005829; GO:0016597; GO:0019441; GO:0019442; GO:0019825; GO:0020037; GO:0042802; GO:0046872; GO:0051289; GO:1904842 "amino acid binding [GO:0016597]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; tryptophan 2,3-dioxygenase activity [GO:0004833]" AGTGGSSGYHYLRSTVSDRYK 0.99436 -12.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2859 0 13.1934 0 0 0 0 13.7827 14.3422 0 14.1451 16.0134 14.2558 13.8817 14.0521 14.1127 13.9817 14.1378 16.3211 0 14.0476 14.2004 14.2404 13.5748 0 15.2737 0 0 0 12.7881 0 12.3589 13.4565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4904 0 0 0 12.8005 0 0 0 15.0254 0 0 0 0 0 0 0 0 0 0 0 0 0 12.935 0 0 0 0 15.0946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1826 P55017 S12A3_HUMAN "Solute carrier family 12 member 3 (Na-Cl cotransporter, NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter)" SLC12A3 NCC TSC Homo sapiens (Human) cell volume homeostasis [GO:0006884]; cellular response to inorganic substance [GO:0071241]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; protein phosphorylation [GO:0006468]; response to aldosterone [GO:1904044]; response to dietary excess [GO:0002021]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511]; cell volume homeostasis [GO:0006884]; cellular response to inorganic substance [GO:0071241]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; protein phosphorylation [GO:0006468]; response to aldosterone [GO:1904044]; response to dietary excess [GO:0002021]; signal transduction [GO:0007165]; sodium ion homeostasis [GO:0055078]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0002021; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0006811; GO:0006814; GO:0006884; GO:0007165; GO:0008511; GO:0015081; GO:0015378; GO:0015379; GO:0016020; GO:0016324; GO:0035725; GO:0055064; GO:0055075; GO:0055078; GO:0070062; GO:0071241; GO:1902476; GO:1904044; GO:1990573 potassium:chloride symporter activity [GO:0015379]; sodium ion transmembrane transporter activity [GO:0015081]; sodium:chloride symporter activity [GO:0015378]; sodium:potassium:chloride symporter activity [GO:0008511] AIISLLSKFR 0.99436 -11.172 0 0 0 0 0 13.1494 12.427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8371 0 11.2077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6361 14.4431 14.5266 13.7352 0 15.8851 0 0 0 0 15.2855 0 0 0 0 13.1995 0 0 19.661 0 0 0 0 0 0 0 0 13.4694 0 0 0 14.2786 0 0 0 0 0 0 0 19.0657 0 11.8503 0 0 0 0 0 0 15.0287 0 12.4164 13.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9603 0 0 0 15.9784 12.271 0 0 0 0 0 18.7871 0 15.0679 0 0 0 0 0 0 0 0 14.037 0 0 0 0 0 0 0 0 0 0 0 0 15.9836 0 0 0 0 0 0 0 11.8292 0 Q16829 DUS7_HUMAN "Dual specificity protein phosphatase 7, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PYST2)" DUSP7 PYST2 Homo sapiens (Human) ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; peptidyl-tyrosine dephosphorylation [GO:0035335] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; peptidyl-tyrosine dephosphorylation [GO:0035335] GO:0000165; GO:0004721; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0008330; GO:0017017; GO:0017018; GO:0035335; GO:0043407; GO:0043409; GO:0070371 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] KGNLPIR 0.99436 -15.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4551 0 0 0 0 0 13.556 0 0 0 0 0 0 0 0 0 0 0 13.4053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7514 0 0 0 0 0 0 0 0 13.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5861 0 0 0 0 0 0 13.3967 13.2693 13.4397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8701 0 0 0 0 0 0 Q2M5E4 RGS21_HUMAN "Regulator of G-protein signaling 21, RGS21" RGS21 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]; transmission of nerve impulse [GO:0019226] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of umami taste [GO:0050917]; transmission of nerve impulse [GO:0019226] GO:0003924; GO:0005886; GO:0007186; GO:0009968; GO:0019226; GO:0050913; GO:0050916; GO:0050917 GTPase activity [GO:0003924] DLISKNIAEPTLK 0.99436 -11.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2332 0 0 0 13.3867 0 0 0 0 13.1661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4129 Q3B8N5 PROX2_HUMAN "Prospero homeobox protein 2 (Homeobox prospero-like protein PROX2, PROX-2)" PROX2 Homo sapiens (Human) cell development [GO:0048468]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell development [GO:0048468]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007399; GO:0048468 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ARVETIVR 0.99436 -7.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0032 11.9477 0 13.8157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3618 0 0 0 0 0 0 0 0 12.3457 12.5624 12.818 13.1105 0 0 12.3601 0 0 12.3077 0 12.6604 0 0 0 12.1664 0 14.255 0 0 0 0 0 10.683 0 13.7506 0 13.4682 11.3341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2203 0 14.0988 0 0 0 13.2783 0 0 12.5833 0 12.2886 0 12.8914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3293 0 12.1848 0 0 0 0 0 0 0 11.4193 0 0 0 0 12.4328 0 0 0 0 0 0 0 0 0 0 0 11.8058 0 0 0 0 0 0 11.8128 0 0 9.91546 0 Q5SV97 PERM1_HUMAN PGC-1 and ERR-induced regulator in muscle protein 1 (PPARGC1 and ESRR-induced regulator in muscle 1) (Peroxisome proliferator-activated receptor gamma coactivator 1 and estrogen-related receptor-induced regulator in muscle 1) PERM1 C1orf170 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]; response to muscle activity [GO:0014850]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]; response to muscle activity [GO:0014850]" GO:0005634; GO:0005737; GO:0006355; GO:0014850 ILKHLPRPPPSAVTR 0.99436 -11.507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6332 0 0 0 0 0 0 0 0 0 0 0 0 0 14.162 0 15.6215 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2628 0 0 0 0 0 0 0 0 0 0 12.76 0 0 0 0 0 0 0 0 0 0 15.0511 0 0 0 0 0 0 0 0 12.8449 0 0 0 0 13.332 13.9835 0 0 0 0 0 0 0 13.2202 0 0 0 0 0 0 0 0 0 15.239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68EA5 ZNF57_HUMAN Zinc finger protein 57 (Zinc finger protein 424) ZNF57 ZNF424 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFTYPQAFQRHEKTHTGEK 0.99436 -15.657 0 0 0 11.4217 0 0 0 0 0 0 10.1041 0 0 0 0 0 10.8774 0 0 0 0 0 10.5505 0 0 0 0 0 0 0 0 11.2688 0 0 0 0 0 0 0 0 0 11.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.67983 0 0 0 0 0 0 0 0 10.3826 0 0 0 0 0 0 0 0 0 0 15.0187 0 0 0 0 0 0 0 0 0 0 0 0 11.526 0 0 0 0 15.3599 15.491 0 0 10.6918 0 0 0 11.3993 0 0 14.481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8381 0 0 0 0 0 0 0 0 14.1085 0 0 0 0 0 0 0 0 14.8854 0 0 0 0 0 0 0 0 0 0 11.3942 0 0 0 0 0 0 Q6IPT4 NB5R5_HUMAN "NADH-cytochrome b5 reductase-like, EC 1.6.2.2" CYB5RL Homo sapiens (Human) bicarbonate transport [GO:0015701] endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654] "endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; bicarbonate transport [GO:0015701]" GO:0004128; GO:0005654; GO:0005789; GO:0015701 "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]" DLARWEAAQASK 0.99436 -11.488 0 0 0 0 0 0 0 0 12.5802 12.5887 12.2291 0 12.8325 0 12.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7255 12.3853 12.3767 0 0 12.7632 0 12.3987 12.3859 0 0 12.412 0 12.2793 0 12.278 12.5268 12.2708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8884 12.8361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2475 0 0 0 0 0 0 0 0 0 0 0 12.6641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4322 0 12.8509 0 0 12.3657 0 0 0 0 0 0 0 12.0457 12.68 13.2246 0 0 0 0 0 0 0 0 13.5758 0 13.9513 0 0 Q6P1K2 PMF1_HUMAN "Polyamine-modulated factor 1, PMF-1" PMF1 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; transcription by RNA polymerase II [GO:0006366] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear MIS12/MIND complex [GO:0000818]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; MIS12/MIND type complex [GO:0000444]; NMS complex [GO:0031617]; nuclear MIS12/MIND complex [GO:0000818]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; transcription by RNA polymerase II [GO:0006366] GO:0000444; GO:0000776; GO:0000818; GO:0003713; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006366; GO:0007049; GO:0007059; GO:0031617; GO:0043231; GO:0043522; GO:0051301 leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713] PSGIPEK 0.99436 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5428 12.199 11.9404 11.9325 0 12.1618 0 11.5946 0 0 0 0 11.8345 0 0 12.3407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UW01 CBLN3_HUMAN Cerebellin-3 CBLN3 UNQ755/PRO1486 Homo sapiens (Human) maintenance of synapse structure [GO:0099558] anchoring junction [GO:0070161]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202] anchoring junction [GO:0070161]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]; maintenance of synapse structure [GO:0099558] GO:0005615; GO:0005783; GO:0005794; GO:0045202; GO:0070161; GO:0099558 FHVVKVYNR 0.99436 -15.693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWZ7 ABRX1_HUMAN BRCA1-A complex subunit Abraxas 1 (Coiled-coil domain-containing protein 98) (Protein FAM175A) ABRAXAS1 ABRA1 CCDC98 FAM175A UNQ496/PRO1013 Homo sapiens (Human) attachment of spindle microtubules to kinetochore [GO:0008608]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic spindle assembly [GO:0090307]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212] BRCA1-A complex [GO:0070531]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] BRCA1-A complex [GO:0070531]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593]; attachment of spindle microtubules to kinetochore [GO:0008608]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic spindle assembly [GO:0090307]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212] GO:0005634; GO:0005654; GO:0006282; GO:0006302; GO:0006325; GO:0007095; GO:0008017; GO:0008608; GO:0010212; GO:0016604; GO:0031593; GO:0044818; GO:0045739; GO:0070531; GO:0070536; GO:0070537; GO:0090307 microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593] DVNRLKR 0.99436 -9.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2527 0 0 0 0 0 13.5957 14.0555 0 0 14.1415 0 14.1873 14.3713 13.3482 14.5596 13.5983 13.4751 0 0 0 0 0 0 0 12.8279 12.7591 0 0 14.0154 0 16.1849 0 0 0 0 14.0967 0 0 12.1124 0 0 0 0 0 0 0 0 0 0 0 14.382 0 0 0 13.8941 0 0 0 0 0 0 14.4219 0 0 0 13.6266 14.2654 14.3876 0 0 0 0 0 0 0 13.7375 0 0 0 0 0 13.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V21 AACS_HUMAN "Acetoacetyl-CoA synthetase, EC 6.2.1.16 (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog)" AACS ACSF1 Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; ketone body biosynthetic process [GO:0046951]; positive regulation of insulin secretion [GO:0032024] cytosol [GO:0005829] cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631]; ketone body biosynthetic process [GO:0046951]; positive regulation of insulin secretion [GO:0032024] GO:0005524; GO:0005829; GO:0006631; GO:0030729; GO:0032024; GO:0046951 acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524] AMKPVETHSLQMLHTILSTGSPLK 0.99436 -11.166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2623 0 0 0 0 0 0 0 0 13.2444 10.9911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8538 0 0 0 0 0 0 0 11.74 0 0 0 11.5609 0 0 0 12.0323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1204 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WS4 CL040_HUMAN Uncharacterized protein C12orf40 C12orf40 Homo sapiens (Human) CDYDSMGDTCVVTSSDK 0.99436 -13.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2608 0 0 0 0 0 0 0 15.2806 0 0 0 0 0 0 0 0 14.0563 0 0 0 0 0 0 0 0 0 13.7938 0 0 0 13.416 13.3814 0 0 0 0 0 15.0798 12.6869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5786 13.5928 0 0 0 0 Q8N5S9 KKCC1_HUMAN "Calcium/calmodulin-dependent protein kinase kinase 1, CaM-KK 1, CaM-kinase kinase 1, CaMKK 1, EC 2.7.11.17 (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha, CaM-KK alpha, CaM-kinase kinase alpha, CaMKK alpha)" CAMKK1 CAMKKA Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468] GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0035556; GO:0045860; GO:0106310 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] KLDHVNVVK 0.99436 -8.677 0 0 0 0 0 14.9794 0 0 0 0 0 0 13.5074 0 0 0 0 0 0 0 0 0 0 0 0 0 10.248 0 0 0 14.446 0 0 0 13.8241 0 0 0 0 0 0 0 0 9.55947 0 0 13.3869 0 0 0 13.5554 0 0 0 0 0 11.9452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDV1 SIA7C_HUMAN "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3, EC 2.4.99.7 (GalNAc alpha-2,6-sialyltransferase III) (ST6GalNAc III, ST6GalNAcIII) (STY) (Sialyltransferase 7C, SIAT7-C)" ST6GALNAC3 SIAT7C UNQ2787/PRO7177 Homo sapiens (Human) ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; viral protein processing [GO:0019082] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; (alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [GO:0047290]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; viral protein processing [GO:0019082]" GO:0000139; GO:0001574; GO:0001665; GO:0005654; GO:0006486; GO:0006677; GO:0006687; GO:0008373; GO:0009100; GO:0009311; GO:0016021; GO:0019082; GO:0047290 "(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity [GO:0047290]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]" FITEKKVFAK 0.99436 -11.507 0 14.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1003 0 0 0 0 0 13.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.222 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGW6 OR6K6_HUMAN Olfactory receptor 6K6 (Olfactory receptor OR1-21) OR6K6 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] DMKEAIGRLFHYQK 0.99436 -9.4237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9688 0 0 0 13.2538 0 12.9761 0 0 12.2204 12.9952 0 0 0 0 13.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXT5 FX4L4_HUMAN "Forkhead box protein D4-like 4, FOXD4-like 4 (Forkhead box protein D4-like 2) (Forkhead box protein D4B) (Myeloid factor-gamma)" FOXD4L4 FOXD4B FOXD4L2 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0030154 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CWAGTCR 0.99436 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92952 KCNN1_HUMAN "Small conductance calcium-activated potassium channel protein 1, SK1, SKCa 1, SKCa1 (KCa2.1)" KCNN1 SK Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813] neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286]; chemical synaptic transmission [GO:0007268]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813] GO:0005242; GO:0005516; GO:0005886; GO:0006811; GO:0006813; GO:0007268; GO:0008076; GO:0015269; GO:0016286; GO:0043005; GO:0043025; GO:0045202; GO:0071805 calcium-activated potassium channel activity [GO:0015269]; calmodulin binding [GO:0005516]; inward rectifier potassium channel activity [GO:0005242]; small conductance calcium-activated potassium channel activity [GO:0016286] ALFEKRK 0.99436 -13.023 0 0 0 0 0 0 0 0 0 0 0 0 13.6539 0 0 0 0 0 0 0 0 0 0 0 0 12.6894 0 0 0 13.7221 13.0888 0 0 0 0 0 0 0 0 0 0 0 12.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.68385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4418 0 0 0 0 0 0 0 0 0 10.5024 0 0 0 0 0 0 0 0 0 0 0 14.6486 0 0 13.31 0 0 0 0 14.1025 14.2823 0 0 0 14.3961 0 0 0 0 0 0 0 0 0 11.3401 0 0 15.166 14.4112 0 0 0 0 0 0 0 0 0 12.2461 0 0 0 13.9486 0 0 0 0 0 0 13.0495 0 0 13.2783 0 0 0 13.592 0 Q96K62 ZBT45_HUMAN Zinc finger and BTB domain-containing protein 45 (Zinc finger protein 499) ZBTB45 ZNF499 Homo sapiens (Human) nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0007399; GO:0046872; GO:1990837 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EASLRAHR 0.99436 -11.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N11 INT15_HUMAN Integrator complex subunit 15 INTS15 C7orf26 Homo sapiens (Human) integrator complex [GO:0032039] integrator complex [GO:0032039] GO:0032039 APLAYKR 0.99436 -8.1544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.909 0 13.3271 0 14.248 0 0 0 0 0 0 0 0 13.2052 0 0 0 0 0 0 0 0 0 13.8694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2809 0 0 0 Q99442 SEC62_HUMAN "Translocation protein SEC62 (Translocation protein 1, TP-1, hTP-1)" SEC62 TLOC1 Homo sapiens (Human) "cotranslational protein targeting to membrane [GO:0006613]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]" endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791] "endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; signaling receptor activity [GO:0038023]; cotranslational protein targeting to membrane [GO:0006613]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]" GO:0005783; GO:0005791; GO:0006613; GO:0006620; GO:0016020; GO:0016021; GO:0030176; GO:0031204; GO:0038023 signaling receptor activity [GO:0038023] ADLKKDEK 0.99436 -10.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1675 0 0 0 0 11.8748 0 0 0 0 0 0 0 0 0 0 0 0 12.6148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1582 0 0 0 0 0 0 0 0 0 14.7952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2159 0 0 0 0 0 0 0 0 0 0 0 Q9BPU9 B9D2_HUMAN B9 domain-containing protein 2 (MKS1-related protein 2) B9D2 MKSR2 Homo sapiens (Human) cilium assembly [GO:0060271] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; gamma-tubulin binding [GO:0043015]; cilium assembly [GO:0060271] GO:0005634; GO:0005813; GO:0005829; GO:0016020; GO:0036038; GO:0036064; GO:0043015; GO:0060271 gamma-tubulin binding [GO:0043015] GLQGWPR 0.99436 -10.899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5168 13.3746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BS26 ERP44_HUMAN "Endoplasmic reticulum resident protein 44, ER protein 44, ERp44 (Thioredoxin domain-containing protein 4)" ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580] cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986] GO:0003756; GO:0005576; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976; GO:0035580; GO:0045454; GO:0070062 protein disulfide isomerase activity [GO:0003756] DVLIPGK 0.99436 -15.701 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3523 11.9644 0 0 13.1602 0 0 0 0 0 0 0 0 0 0 0 0 13.2246 0 12.9477 0 0 13.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2517 0 0 0 13.2755 0 0 0 13.4865 0 13.0421 0 0 0 0 0 0 0 0 0 Q9NQ32 CK016_HUMAN Uncharacterized protein C11orf16 C11orf16 Homo sapiens (Human) APGWDGAAPPWDLSFTYPFALQAPWLTGHKPLAR 0.99436 -11.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2923 0 0 0 0 0 10.9852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4985 11.9137 10.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7098 0 0 0 0 0 11.7447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y672 ALG6_HUMAN "Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase, EC 2.4.1.267 (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)" ALG6 My046 Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487]" GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0006490; GO:0016020; GO:0016021; GO:0042281; GO:0046527 "dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]" GFVLLVK 0.99436 -8.1524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9474 0 0 0 0 0 0 12.3187 0 0 0 0 0 0 0 0 13.6259 0 0 0 13.7856 0 0 0 0 15.1337 14.1825 11.7566 13.9384 13.9791 13.7864 0 0 0 0 0 0 14.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3086 14.1617 0 13.4441 0 15.6217 14.0476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6M7 S4A7_HUMAN "Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b, Bicarbonate transporter) (Solute carrier family 4 member 7)" SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6 Homo sapiens (Human) auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857]; auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] GO:0005452; GO:0005886; GO:0008510; GO:0015701; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0032420; GO:0050801; GO:0051453; GO:0055085; GO:0060117 inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; transmembrane transporter activity [GO:0022857] AVYIGVHVPFSKESR 0.99436 -10.894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7864 0 0 11.6738 0 0 0 0 0 0 0 0 14.9474 13.7091 14.744 14.5878 0 0 0 13.5259 0 13.5228 13.6572 0 0 16.1975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6453 0 0 0 0 14.0098 0 14.078 13.787 0 12.2569 12.7823 0 0 0 0 0 0 0 0 0 0 14.7395 0 0 0 0 Q9Y6R7 FCGBP_HUMAN "IgGFc-binding protein (Fcgamma-binding protein antigen, FcgammaBP)" FCGBP Homo sapiens (Human) extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] GO:0005615; GO:0031012; GO:0070062 CECGPGGHVTCQEGAACGPHEECR 0.99436 -11.491 0 0 0 0 0 0 0 0 0 0 11.4585 0 0 0 0 0 11.5651 0 0 12.5467 0 0 0 13.9868 0 0 0 0 0 0 0 11.8681 0 9.39086 0 0 0 11.6631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1228 0 0 0 0 0 0 0 0 12.1032 0 0 0 10.5299 0 12.2265 0 15.3856 0 0 0 0 15.0991 13.0445 0 10.3869 0 15.2045 0 11.6706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7873 0 0 0 0 0 0 12.7049 0 0 0 0 0 13.6806 0 11.1048 0 0 0 0 0 13.9557 0 0 0 0 0 0 0 0 0 12.7775 14.7745 0 0 0 0 0 0 12.2705 0 0 14.7511 0 0 0 0 0 0 0 0 0 16.1886 0 0 0 0 0 0 13.7397 0 0 0 0 0 0 0 A6NEL2 SWAHB_HUMAN Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B) SOWAHB ANKRD56 Homo sapiens (Human) AGTAPSPR 0.99437 -36.097 0 0 10.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8927 0 11.2939 11.8258 14.0363 11.4903 11.5825 0 12.7018 0 0 0 0 0 0 0 0 0 0 0 12.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1185 14.6033 0 0 17.8025 15.3175 0 0 14.0444 0 14.106 14.0357 13.9692 14.4526 13.6047 15.1025 13.5237 13.8349 0 13.8973 0 13.5808 14.6303 0 13.5343 0 0 13.5204 13.8873 13.5316 0 0 14.5025 0 15.7593 13.5807 0 0 0 15.2319 13.5676 13.6406 13.2601 15.3143 0 0 13.8659 15.2639 14.9337 0 14.771 14.6971 14.4147 0 14.5801 14.5427 14.5909 13.5254 13.561 0 13.1738 0 12.8915 14.9157 15.689 14.6127 13.2464 0 13.5387 15.2846 12.9485 13.13 14.6279 14.2516 0 13.0414 14.0387 15.1159 14.7388 12.9427 13.5232 0 0 14.2524 14.0933 13.0945 0 14.4613 12.9751 13.2064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9339 13.5942 14.5507 0 0 0 0 0 A6NKC9 SH2D7_HUMAN SH2 domain-containing protein 7 SH2D7 Homo sapiens (Human) HFVINQLRNR 0.99437 -10.659 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3098 12.0624 0 11.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4522 11.4319 0 0 0 0 0 0 0 0 10.6612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6 14.2399 0 0 0 0 0 0 0 0 0 11.4327 0 0 0 0 0 0 0 0 0 9.96467 0 0 0 0 0 0 0 0 0 0 0 0 11.9179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0808 0 0 0 13.2185 0 0 0 0 0 0 0 0 0 0 O15067 PUR4_HUMAN "Phosphoribosylformylglycinamidine synthase, FGAM synthase, FGAMS, EC 6.3.5.3 (Formylglycinamide ribonucleotide amidotransferase, FGAR amidotransferase, FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase)" PFAS KIAA0361 Homo sapiens (Human) 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to xenobiotic stimulus [GO:0009410] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to xenobiotic stimulus [GO:0009410] GO:0004642; GO:0005524; GO:0005829; GO:0006177; GO:0006189; GO:0006541; GO:0009168; GO:0009410; GO:0044208; GO:0046872; GO:0070062; GO:0097065; GO:0097294 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642] ACVEAPKGNPICSLHDQGAGGNGNVLK 0.99437 -10.924 0 0 0 0 0 0 0 0 0 0 0 0 9.83297 14.9288 0 0 0 0 0 0 0 0 0 0 0 0 15.8935 0 0 0 16.4467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5231 11.5551 12.7312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2554 13.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43663 PRC1_HUMAN Protein regulator of cytokinesis 1 PRC1 Homo sapiens (Human) cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465] chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922] chromosome [GO:0005694]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cell population proliferation [GO:0008284]; regulation of cytokinesis [GO:0032465] GO:0000022; GO:0000226; GO:0000922; GO:0001578; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0005829; GO:0005876; GO:0005886; GO:0008017; GO:0008284; GO:0015630; GO:0019894; GO:0019901; GO:0030496; GO:0032465; GO:0042802; GO:0045171; GO:0051256; GO:0051301; GO:0070938; GO:1990023 identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901] ELSKASKSDATSGILNSTNIQS 0.99437 -8.2132 0 0 0 0 0 0 0 12.9954 0 0 0 0 11.8151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5948 0 0 0 11.6757 0 0 0 0 0 0 0 0 0 0 0 0 13.0162 12.6441 15.0225 14.1927 14.1352 12.8174 0 0 0 13.8005 0 0 0 0 14.5013 13.8098 12.0298 0 0 14.1869 0 13.8114 0 0 13.9034 13.3817 13.6473 13.8005 0 0 14.0611 11.8606 0 13.8604 0 0 12.3647 0 13.5746 0 0 13.8151 11.2291 0 0 13.7205 0 0 0 0 0 0 14.8745 0 0 0 0 0 0 0 14.261 0 11.9784 0 13.8266 0 0 0 0 0 0 0 0 0 11.9183 0 0 11.1159 0 0 13.9292 0 0 14.0023 0 0 0 11.5309 0 O60381 HBP1_HUMAN HMG box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1) HBP1 Homo sapiens (Human) regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000978; GO:0000981; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0016055; GO:0016607; GO:0051726 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AISVILGDR 0.99437 -10.912 0 0 0 0 14.4105 0 0 0 0 0 0 0 0 0 0 11.725 12.4508 0 11.9217 0 12.1171 0 12.0896 14.2515 12.3731 0 0 0 13.4977 0 0 0 0 0 11.3746 0 0 0 0 0 0 0 0 0 0 12.1588 0 11.6093 0 0 13.7418 0 0 0 0 0 0 0 0 0 0 13.6014 0 0 0 0 0 0 15.8791 0 15.742 0 0 0 16.0273 0 11.9406 0 0 16.9438 16.9796 17.3382 17.4153 0 0 17.7388 0 14.492 0 14.7596 0 0 0 0 15.1584 0 0 0 0 0 0 12.3391 0 0 16.6505 16.8748 0 12.7638 0 0 12.8172 0 14.0928 14.4842 0 0 13.8733 0 13.4488 0 16.68 0 0 10.6788 0 17.4686 0 0 17.1159 0 13.4182 0 0 0 0 0 0 0 0 0 0 12.6882 13.4385 12.8245 0 16.8448 0 13.2884 0 0 16.7889 16.9047 0 17.7603 17.728 0 14.3784 0 0 0 0 0 13.7124 0 0 14.1578 0 0 0 14.3188 14.2516 0 17.4871 0 0 14.3482 0 0 0 0 P0DSO1 F246C_HUMAN Protein FAM246C FAM246C Homo sapiens (Human) APGRMAR 0.99437 -11.224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7376 0 0 0 0 0 0 0 13.8157 0 0 0 0 0 0 0 0 0 0 14.1516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17040 ZSC20_HUMAN Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29) ZSCAN20 KOX29 ZNF31 ZNF360 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AMGTVREAAGLPR 0.99437 -10.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8816 0 0 0 0 12.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1166 0 0 10.9947 0 0 0 11.1107 0 0 15.1211 14.9986 0 0 0 0 0 0 0 0 0 0 0 0 12.7572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6448 0 14.835 13.0609 0 14.4053 0 0 0 0 13.8572 0 0 14.1763 0 0 0 11.0401 0 10.6964 0 0 0 0 0 0 0 0 0 11.4328 0 0 11.6025 0 0 14.241 0 0 0 14.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1834 0 14.7051 14.5874 0 0 0 0 0 13.712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0674 P31323 KAP3_HUMAN cAMP-dependent protein kinase type II-beta regulatory subunit PRKAR2B Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; response to antipsychotic drug [GO:0097332]; response to clozapine [GO:0097338] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; response to antipsychotic drug [GO:0097332]; response to clozapine [GO:0097338] GO:0004862; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006631; GO:0007612; GO:0008603; GO:0019904; GO:0030552; GO:0031625; GO:0034236; GO:0035556; GO:0043025; GO:0043197; GO:0043198; GO:0045121; GO:0048471; GO:0050804; GO:0070062; GO:0097332; GO:0097338; GO:0097546; GO:0098978; GO:2000480 cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625] GQYFGELALVTNKPR 0.99437 -11.526 0 0 0 0 0 0 0 10.9456 0 0 11.2329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.956 0 0 0 0 0 0 0 0 0 0 12.8125 0 0 0 0 0 13.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2994 0 0 13.1379 0 0 0 0 0 0 11.8097 0 0 0 0 0 0 0 11.4391 12.3241 0 12.4351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8335 0 0 0 0 0 0 0 0 P33527 MRP1_HUMAN "Multidrug resistance-associated protein 1, EC 7.6.2.2 (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1, EC 7.6.2.3) (Leukotriene C(4) transporter, LTC4 transporter)" ABCC1 MRP MRP1 Homo sapiens (Human) carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; heme catabolic process [GO:0042167]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; hydrolase activity [GO:0016787]; xenobiotic transmembrane transporter activity [GO:0042910]; carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; cobalamin metabolic process [GO:0009235]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; heme catabolic process [GO:0042167]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to xenobiotic stimulus [GO:0009410]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962] GO:0005524; GO:0005886; GO:0005887; GO:0006691; GO:0006805; GO:0008559; GO:0009235; GO:0009410; GO:0009925; GO:0015420; GO:0015431; GO:0015562; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0016787; GO:0034040; GO:0034599; GO:0034634; GO:0034775; GO:0042167; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0045332; GO:0046943; GO:0050729; GO:0055085; GO:0060326; GO:0070062; GO:0070633; GO:0071716; GO:0099039; GO:0140115; GO:0140359; GO:0150104; GO:1904646; GO:1905039; GO:1990962 ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; hydrolase activity [GO:0016787]; xenobiotic transmembrane transporter activity [GO:0042910] AYYPSIVANR 0.99437 -11.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4832 11.2432 0 0 0 0 0 12.2591 0 0 0 0 16.4846 11.8666 0 0 0 0 11.0235 0 12.7265 0 0 0 0 12.8076 0 13.1121 0 0 14.6549 11.1459 13.5986 0 0 0 13.7761 12.6499 0 13.1543 0 0 0 0 0 0 0 0 0 0 13.0527 13.5573 11.6561 12.1782 0 0 14.319 0 11.926 0 12.677 12.5379 0 0 14.7648 12.4235 0 0 0 10.9883 11.6829 0 12.1647 0 0 13.6229 0 0 0 0 0 13.0669 0 0 0 0 0 12.8555 0 0 13.5461 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7651 0 0 0 P35913 PDE6B_HUMAN "Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta, GMP-PDE beta, EC 3.1.4.35" PDE6B PDEB Homo sapiens (Human) "entrainment of circadian clock by photoperiod [GO:0043153]; phototransduction, visible light [GO:0007603]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; signal transduction [GO:0007165]; visual perception [GO:0007601]" photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] "photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; entrainment of circadian clock by photoperiod [GO:0043153]; phototransduction, visible light [GO:0007603]; retina development in camera-type eye [GO:0060041]; retinal cell apoptotic process [GO:1990009]; signal transduction [GO:0007165]; visual perception [GO:0007601]" GO:0004114; GO:0005886; GO:0007165; GO:0007601; GO:0007603; GO:0042622; GO:0043153; GO:0046872; GO:0047555; GO:0060041; GO:0097381; GO:1990009 "3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" DEIQLILPTRAR 0.99437 -11.541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6567 0 0 11.533 0 0 0 0 0 15.4468 0 0 0 13.7722 13.7485 0 14.1916 0 11.5336 0 0 0 0 0 0 0 0 11.449 11.3725 0 0 0 0 0 12.0943 11.7875 0 0 12.7488 0 0 0 0 0 0 12.1426 0 0 14.168 0 12.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52951 GBX2_HUMAN Homeobox protein GBX-2 (Gastrulation and brain-specific homeobox protein 2) GBX2 Homo sapiens (Human) autonomic nervous system development [GO:0048483]; axon guidance [GO:0007411]; branching involved in blood vessel morphogenesis [GO:0001569]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellum development [GO:0021549]; forebrain neuron development [GO:0021884]; inner ear morphogenesis [GO:0042472]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; regulation of nervous system development [GO:0051960]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 2 development [GO:0021568]; thalamus development [GO:0021794] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; autonomic nervous system development [GO:0048483]; axon guidance [GO:0007411]; branching involved in blood vessel morphogenesis [GO:0001569]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellum development [GO:0021549]; forebrain neuron development [GO:0021884]; inner ear morphogenesis [GO:0042472]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; regulation of nervous system development [GO:0051960]; regulation of transcription by RNA polymerase II [GO:0006357]; rhombomere 2 development [GO:0021568]; thalamus development [GO:0021794]" GO:0000785; GO:0000977; GO:0000979; GO:0000981; GO:0001228; GO:0001569; GO:0001755; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007411; GO:0021549; GO:0021555; GO:0021568; GO:0021794; GO:0021884; GO:0021930; GO:0042472; GO:0048483; GO:0051960; GO:0061629; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" AGNANSK 0.99437 -10.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2316 0 0 0 0 0 0 0 0 0 11.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0227 14.5829 0 0 14.4186 10.8565 0 0 0 13.8886 13.8738 0 0 13.4045 13.7978 14.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2718 0 0 0 0 0 12.5891 0 12.1433 0 0 P82909 KGD4_HUMAN Alpha-ketoglutarate dehydrogenase component 4 MRPS36 KGD4 DC47 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; tricarboxylic acid cycle [GO:0006099] mitochondrial inner membrane [GO:0005743]; mitochondrial oxoglutarate dehydrogenase complex [GO:0009353]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial oxoglutarate dehydrogenase complex [GO:0009353]; mitochondrion [GO:0005739]; 2-oxoglutarate metabolic process [GO:0006103]; tricarboxylic acid cycle [GO:0006099] GO:0005739; GO:0005743; GO:0006099; GO:0006103; GO:0009353 PHTPLIR 0.99437 -10.928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5557 0 17.4713 17.5312 0 0 14.4735 0 0 0 13.2958 0 0 0 12.4391 0 0 15.6255 16.0733 0 0 0 0 0 0 0 0 0 0 14.9266 0 0 18.0457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8614 0 0 0 0 13.7848 0 0 0 0 0 0 0 0 0 0 0 0 19.072 18.8875 16.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q69YN2 C19L1_HUMAN "CWF19-like protein 1, C19L1" CWF19L1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" post-mRNA release spliceosomal complex [GO:0071014] "post-mRNA release spliceosomal complex [GO:0071014]; RNA lariat debranching enzyme activator activity [GO:0061632]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0061632; GO:0071014 RNA lariat debranching enzyme activator activity [GO:0061632] MMLCTTSQFK 0.99437 -10.919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9845 0 0 16.5986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTS9 DYM_HUMAN Dymeclin (Dyggve-Melchior-Clausen syndrome protein) DYM Homo sapiens (Human) bone development [GO:0060348]; Golgi organization [GO:0007030] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; enzyme binding [GO:0019899]; bone development [GO:0060348]; Golgi organization [GO:0007030] GO:0005737; GO:0005794; GO:0007030; GO:0016020; GO:0019899; GO:0060348 enzyme binding [GO:0019899] EVLRQSISHKYLMR 0.99437 -10.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4764 0 0 0 0 0 0 0 0 0 0 0 0 13.6409 0 13.6726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9W4 GG6L2_HUMAN Golgin subfamily A member 6-like protein 2 GOLGA6L2 Homo sapiens (Human) ARGAVLRALPPSLQSSL 0.99437 -15.764 0 0 0 0 0 0 0 0 0 0 10.6635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6929 0 13.9581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6194 0 0 0 0 0 0 0 13.5916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1186 0 0 0 14.0677 0 0 0 0 0 0 0 0 12.708 0 0 0 0 0 0 0 0 0 14.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1295 0 0 0 0 0 0 Q8TD10 MIPO1_HUMAN Mirror-image polydactyly gene 1 protein MIPOL1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; identical protein binding [GO:0042802] GO:0005634; GO:0042802 identical protein binding [GO:0042802] EKTIAFLLKELDILR 0.99437 -15.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6898 0 0 0 14.2988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92764 KRT35_HUMAN "Keratin, type I cuticular Ha5 (Hair keratin, type I Ha5) (Keratin-35, K35)" KRT35 HHA5 HKA5 KRTHA5 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; anatomical structure morphogenesis [GO:0009653]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005615; GO:0005829; GO:0005856; GO:0005882; GO:0009653; GO:0030855; GO:0045109; GO:0070062 structural molecule activity [GO:0005198] EELLCLK 0.99437 -15.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2315 0 0 0 0 0 0 0 0 0 0 0 14.2715 0 0 0 0 12.3213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JM2 ZN462_HUMAN "Zinc finger protein 462 (Zinc finger PBX1-interacting protein, ZFPIP)" ZNF462 KIAA1803 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] GO:0003677; GO:0005634; GO:0006325; GO:0010468; GO:0043392; GO:0045944; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] ARIIKHQK 0.99437 -36.144 0 0 0 13.9601 0 0 0 0 17.0001 13.3252 13.773 15.8855 17.2779 15.3677 16.0606 17.6059 13.0298 15.4886 14.4707 13.4946 14.5837 13.0389 15.7595 11.6058 16.7563 17.4487 13.3734 16.4702 16.0267 17.4237 16.5893 16.2256 12.8135 0 16.5654 13.5047 16.053 16.1338 0 13.4014 16.1028 17.4188 15.9681 16.1106 16.0357 16.3896 16.3566 12.2143 16.3003 15.1882 0 15.9443 16.3139 16.2248 16.3695 15.6461 11.7791 12.2754 0 0 0 0 10.9824 0 0 0 12.3709 0 0 0 0 0 0 0 0 13.2814 0 0 13.0004 0 0 11.92 0 12.5848 0 14.1402 19.2231 0 0 18.2011 18.3096 13.7577 12.9969 0 0 13.2756 0 0 12.5158 14.9028 11.2609 0 0 0 0 0 0 0 14.4002 0 0 0 12.1453 12.3937 18.1084 0 18.1247 18.096 0 0 0 0 0 0 0 12.1548 13.9773 0 0 15.1539 0 12.9592 0 0 17.9957 0 18.1199 0 0 18.8308 19.4697 11.7674 19.1397 0 0 0 17.8471 16.3171 0 0 15.4736 0 0 12.3371 12.9095 11.6273 19.0588 18.3761 0 0 0 19.1387 12.9608 18.3745 19.1089 16.918 18.4005 0 17.7941 17.7809 17.7615 0 18.36 0 0 18.553 18.0413 18.5077 17.7985 0 Q9BRK4 LZTS2_HUMAN "Leucine zipper putative tumor suppressor 2, hLZTS2 (Protein LAPSER1)" LZTS2 KIAA1813 LAPSER1 Homo sapiens (Human) microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; midbody [GO:0030496]; plasma membrane [GO:0005886]; vesicle [GO:0031982] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; midbody [GO:0030496]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; microtubule severing [GO:0051013]; mitotic cytokinesis [GO:0000281]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; nuclear export [GO:0051168]; spindle midzone assembly [GO:0051255]; Wnt signaling pathway [GO:0016055] GO:0000281; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0016055; GO:0030496; GO:0031982; GO:0051013; GO:0051168; GO:0051255; GO:0090090 AHNAHLR 0.99437 -36.161 0 0 0 0 11.0238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3901 0 0 13.0917 0 12.4389 0 0 0 0 0 0 0 0 0 12.9769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8311 12.1215 0 0 0 14.0339 0 0 0 13.9094 0 0 0 0 12.4526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9026 0 13.9462 12.3499 0 0 0 0 12.9883 0 12.6621 0 0 0 0 0 12.4959 0 0 0 12.1611 0 0 0 0 0 0 0 0 12.7622 0 0 10.9809 0 0 0 0 13.1743 0 0 0 0 12.6027 0 14.6142 0 0 0 0 0 0 0 0 0 0 12.0527 0 0 0 0 0 0 12.2559 0 0 0 0 0 13.2773 0 0 13.6573 0 0 0 0 Q9BSH5 HDHD3_HUMAN Haloacid dehalogenase-like hydrolase domain-containing protein 3 HDHD3 C9orf158 Homo sapiens (Human) intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634] intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634] GO:0005634; GO:0005730; GO:0043231 AHRLQIRLLTWDVK 0.99437 -10.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7962 13.2051 0 0 0 0 0 0 0 14.1113 14.1465 0 0 0 0 0 0 0 0 0 0 0 0 14.5631 0 0 13.2068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7889 0 0 0 0 0 0 0 0 0 0 0 14.102 14.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H598 VIAAT_HUMAN "Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter, hVIAAT)" SLC32A1 VGAT VIAAT Homo sapiens (Human) aging [GO:0007568]; amino acid transmembrane transport [GO:0003333]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; hippocampus development [GO:0021766]; ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269] cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; dendrite terminus [GO:0044292]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; dendrite terminus [GO:0044292]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; integral component of synaptic vesicle membrane [GO:0030285]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; glycine transmembrane transporter activity [GO:0015187]; aging [GO:0007568]; amino acid transmembrane transport [GO:0003333]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; hippocampus development [GO:0021766]; ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269] GO:0003333; GO:0005886; GO:0006811; GO:0007269; GO:0007568; GO:0008021; GO:0009986; GO:0015171; GO:0015185; GO:0015187; GO:0015495; GO:0015812; GO:0015816; GO:0016020; GO:0021766; GO:0030285; GO:0030425; GO:0030672; GO:0043005; GO:0044292; GO:0044306; GO:0044316; GO:0048786; GO:0051286; GO:0051939; GO:0060077; GO:0061202; GO:0098700; GO:0098793; GO:0098982 amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; glycine transmembrane transporter activity [GO:0015187] ARDWAWEK 0.99437 -11.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2H0 CE126_HUMAN Centrosomal protein of 126 kDa CEP126 KIAA1377 Homo sapiens (Human) cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515] centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; midbody [GO:0030496] centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; midbody [GO:0030496]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; mitotic spindle organization [GO:0007052]; non-motile cilium assembly [GO:1905515] GO:0005737; GO:0005813; GO:0007052; GO:0030496; GO:0031122; GO:0060271; GO:0097546; GO:1905515 ATLATSK 0.99437 -36.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7113 0 0 0 0 0 11.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.956 12.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1155 0 0 0 11.9797 0 13.5788 0 13.2794 0 0 0 0 13.2945 0 13.2346 13.6378 0 0 0 13.6599 0 0 0 0 0 15.1486 0 0 0 0 0 0 0 0 12.0214 12.9368 0 0 0 0 0 0 0 0 0 0 0 13.3845 13.2719 13.3163 15.2775 12.3241 0 0 0 0 0 14.1917 0 13.3407 12.757 0 0 0 0 0 0 0 0 0 0 12.6858 0 0 0 0 13.0976 14.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8998 0 0 0 0 Q9P2H3 IFT80_HUMAN Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56) IFT80 KIAA1374 WDR56 Homo sapiens (Human) articular cartilage development [GO:0061975]; bone mineralization involved in bone maturation [GO:0035630]; cilium assembly [GO:0060271]; endochondral ossification [GO:0001958]; growth plate cartilage chondrocyte differentiation [GO:0003418]; intraciliary anterograde transport [GO:0035720]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992] 9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; articular cartilage development [GO:0061975]; bone mineralization involved in bone maturation [GO:0035630]; cilium assembly [GO:0060271]; endochondral ossification [GO:0001958]; growth plate cartilage chondrocyte differentiation [GO:0003418]; intraciliary anterograde transport [GO:0035720]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224] GO:0001649; GO:0001958; GO:0003418; GO:0005737; GO:0005813; GO:0005929; GO:0007224; GO:0010839; GO:0030992; GO:0033687; GO:0035567; GO:0035630; GO:0035720; GO:0036064; GO:0043616; GO:0060173; GO:0060271; GO:0061975; GO:0097500; GO:0097542; GO:0097731; GO:1905515; GO:2000051 ALELAVKYK 0.99437 -10.904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4524 0 0 0 0 0 0 0 0 0 0 0 11.2416 0 0 14.723 0 15.0486 0 14.6864 14.1625 0 0 0 14.3327 14.0634 14.0466 0 14.0431 0 0 0 0 0 0 0 0 0 0 13.7674 0 0 0 0 0 0 0 0 0 0 14.4928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3939 0 0 12.2822 0 Q9UL01 DSE_HUMAN "Dermatan-sulfate epimerase, DS epimerase, EC 5.1.3.19 (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2, SART-2)" DSE SART2 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate metabolic process [GO:0030205]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; chondroitin-glucuronate 5-epimerase activity [GO:0047757]; metal ion binding [GO:0046872]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate metabolic process [GO:0030204]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate metabolic process [GO:0030205]; heparan sulfate proteoglycan biosynthetic process [GO:0015012] GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0015012; GO:0016021; GO:0030204; GO:0030205; GO:0030206; GO:0030208; GO:0030659; GO:0046872; GO:0047757 chondroitin-glucuronate 5-epimerase activity [GO:0047757]; metal ion binding [GO:0046872] DMAKDYMER 0.99437 -15.738 0 0 0 0 0 0 0 0 0 0 0 13.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8193 12.7412 0 0 0 0 12.3897 13.9241 0 0 11.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9397 0 0 0 0 0 14.7274 14.4283 13.5139 0 0 13.4244 0 0 0 13.3001 0 13.1251 12.9149 0 14.033 0 0 0 0 14.1025 0 0 Q9Y5R8 TPPC1_HUMAN "Trafficking protein particle complex subunit 1 (BET5 homolog) (Multiple myeloma protein 2, MUM-2)" TRAPPC1 BET5 MUM2 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005576; GO:0005737; GO:0005783; GO:0005829; GO:0006888; GO:0006901; GO:0030008; GO:0035578; GO:0048208; GO:0099022; GO:1990071; GO:1990072 EEEYKLMYGMLFSIRSFVSK 0.99437 -11.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4988 0 0 13.0439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94818 NOL4_HUMAN Nucleolar protein 4 (Nucleolar-localized protein) NOL4 NOLP HRIHFB2255 Homo sapiens (Human) nucleolus [GO:0005730] nucleolus [GO:0005730]; RNA binding [GO:0003723] GO:0003723; GO:0005730 RNA binding [GO:0003723] DMYRQFQDWCLR 0.99438 -11.588 0 0 0 0 0 0 0 0 0 11.8928 0 0 0 0 0 16.8263 0 0 0 0 11.7458 0 0 0 0 0 0 12.4713 10.813 0 0 0 11.9757 0 0 0 0 0 0 0 0 16.4595 0 0 0 12.3548 0 0 0 0 0 0 0 16.7631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1979 12.1647 0 0 0 0 0 10.1608 0 0 0 12.6448 0 0 12.3323 0 14.1293 0 0 0 11.6839 12.5164 0 0 0 0 0 0 12.2642 0 0 0 10.7884 0 0 0 0 15.2688 11.6808 0 0 12.6691 0 13.7343 0 0 0 0 12.6348 11.4001 0 0 11.2541 0 13.8927 0 14.5717 0 0 0 0 0 0 0 13.2939 13.9271 0 0 14.951 17.8522 0 0 0 0 0 0 10.6718 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2765 0 0 0 0 0 0 0 0 10.7043 0 0 0 14.0291 0 0 0 0 0 0 12.2053 0 P31153 METK2_HUMAN "S-adenosylmethionine synthase isoform type-2, AdoMet synthase 2, EC 2.5.1.6 (Methionine adenosyltransferase 2, MAT 2) (Methionine adenosyltransferase II, MAT-II)" MAT2A AMS2 MATA2 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556] cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269] cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; cellular response to leukemia inhibitory factor [GO:1990830]; one-carbon metabolic process [GO:0006730]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556] GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:1990830 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478] ELLEIVKK 0.99438 -8.2281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.365 0 13.4168 0 0 13.9819 13.1876 0 0 0 0 13.6371 13.5554 12.9001 0 16.3221 0 0 0 0 13.7941 0 0 0 0 0 13.5203 14.399 14.5194 13.127 13.4767 0 0 14.5071 0 13.4435 14.9093 0 13.0118 0 0 12.4364 13.5278 13.6003 15.0883 0 0 0 0 0 12.4497 0 0 13.2437 0 0 12.5876 12.7356 0 12.7504 0 0 0 14.0866 0 13.5881 16.3502 0 0 0 0 0 0 14.7805 0 0 0 0 0 0 0 0 0 0 0 0 13.5821 12.9977 0 0 0 13.2253 0 P61647 SIA8F_HUMAN "Alpha-2,8-sialyltransferase 8F, EC 2.4.99.- (Sialyltransferase 8F, SIAT8-F) (Sialyltransferase St8Sia VI, ST8SiaVI)" ST8SIA6 SIAT8F Homo sapiens (Human) blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]; blastocyst hatching [GO:0001835]; carbohydrate biosynthetic process [GO:0016051]; ganglioside biosynthetic process [GO:0001574]; glycolipid biosynthetic process [GO:0009247]; glycoprotein metabolic process [GO:0009100]; N-glycan processing [GO:0006491]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]" GO:0000139; GO:0001574; GO:0001835; GO:0003828; GO:0006486; GO:0006491; GO:0006493; GO:0008373; GO:0009100; GO:0009247; GO:0009311; GO:0016021; GO:0016051 "alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity [GO:0003828]; sialyltransferase activity [GO:0008373]" ARILVEESR 0.99438 -13.618 0 0 0 0 0 0 0 0 15.6373 0 0 14.4905 0 0 0 0 0 0 14.8357 0 13.7197 14.4114 14.1991 13.2193 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8555 0 0 0 0 15.5606 13.3673 12.3218 0 12.6399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8801 0 0 14.6328 13.8884 15.3754 15.2876 14.8454 14.6565 16.4042 15.887 13.8803 14.9633 0 0 0 0 14.3819 0 0 0 0 12.0503 0 0 15.115 0 0 0 14.5154 15.3715 14.3341 0 18.4151 0 0 0 0 0 0 0 15.7974 0 14.0863 0 14.7219 14.682 14.8796 0 0 0 0 12.6776 11.871 0 12.2843 14.1246 13.5276 11.4024 0 0 0 15.1346 0 14.5078 0 0 0 0 13.7118 0 0 0 0 0 13.6482 0 0 0 0 0 0 0 14.8395 0 16.4976 0 0 0 0 0 0 0 0 14.6802 0 0 0 0 0 13.8098 0 14.1483 0 13.0172 14.4032 0 0 0 0 0 Q2TBF2 WSCD2_HUMAN WSC domain-containing protein 2 WSCD2 KIAA0789 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GERDHWRSGR 0.99438 -11.589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9736 0 0 0 0 0 0 0 0 0 11.0675 0 0 0 0 0 0 0 0 0 13.3354 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5239 0 0 0 0 0 0 0 0 0 10.6306 0 0 0 0 0 0 0 0 0 14.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5117 0 0 0 0 0 0 14.1901 0 0 0 0 0 0 0 Q56UN5 M3K19_HUMAN "Mitogen-activated protein kinase kinase kinase 19, EC 2.7.11.1 (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)" MAP3K19 RCK YSK4 Homo sapiens (Human) protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007165; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DENTYYREICSAPSGRR 0.99438 -36.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7097 0 17.1756 0 0 10.9848 0 0 0 0 0 0 0 0 0 0 0 11.6876 12.5954 0 0 0 0 0 14.4308 0 0 0 13.8835 0 0 0 0 0 14.3975 14.0442 0 0 0 0 13.0786 0 0 0 0 0 11.8333 0 0 0 0 14.1657 0 0 0 0 0 14.7436 0 14.2511 14.1232 0 0 0 0 14.2128 0 0 0 0 0 0 14.5373 14.2845 0 0 0 0 14.1603 0 0 0 14.5021 0 11.0901 0 14.8572 0 14.1781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7858 0 0 0 0 14.1218 0 Q658Y4 F91A1_HUMAN Protein FAM91A1 FAM91A1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802] cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041] GO:0005802; GO:0006886; GO:0031410; GO:0099041 DERRYYEELLK 0.99438 -8.7219 0 0 0 0 0 0 0 11.0575 0 0 0 0 13.0559 0 0 0 0 0 0 0 12.816 0 0 0 0 11.6354 0 0 0 0 0 0 0 0 11.0957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1012 0 0 0 0 0 0 0 0 0 0 0 10.3471 10.8176 0 0 0 0 0 10.9466 11.4054 0 0 0 0 0 0 0 0 13.5916 0 0 0 0 0 12.3138 0 0 12.1044 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5431 0 12.1555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7723 0 0 0 0 0 0 14.5417 0 0 14.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 13.646 0 0 0 0 0 0 Q6PIV2 FOXR1_HUMAN Forkhead box protein R1 (Forkhead box protein N5) FOXR1 FOXN5 DLNB13 Homo sapiens (Human) chromatin [GO:0000785]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] "chromatin [GO:0000785]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GO:0000785; GO:0000981; GO:0005634; GO:0048471; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" IVKPPKLPLEK 0.99438 -15.812 0 0 0 0 0 0 0 0 0 0 12.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0985 0 0 0 Q7Z408 CSMD2_HUMAN CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2) CSMD2 KIAA1884 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ATFENPMYDR 0.99438 -10.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4157 0 0 0 0 0 0 0 0 0 0 14.2044 0 0 0 0 0 0 0 0 0 0 0 13.7247 0 0 0 0 0 14.4259 0 0 11.9629 13.1642 13.4118 0 0 13.311 0 0 0 11.2512 0 13.3424 12.4836 0 0 0 12.33 0 12.7845 0 0 0 0 0 0 0 12.2385 0 0 0 0 0 0 14.311 11.8709 0 0 0 0 0 0 0 0 0 0 14.111 0 0 0 0 12.9353 0 0 0 0 0 0 0 Q8NE31 FA13C_HUMAN Protein FAM13C FAM13C FAM13C1 Homo sapiens (Human) ALLPDEK 0.99438 -10.948 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6826 0 0 0 0 0 12.7374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1368 0 0 0 11.3481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3587 0 0 13.1181 0 0 11.4258 0 12.4825 0 0 0 0 0 0 11.7201 0 0 0 0 0 11.6494 0 0 0 0 0 0 0 11.9224 0 0 0 0 0 0 0 0 0 0 0 14.7739 0 0 0 12.6437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0027 0 0 Q8WV60 PTCD2_HUMAN "Pentatricopeptide repeat-containing protein 2, mitochondrial" PTCD2 Homo sapiens (Human) kidney development [GO:0001822]; liver development [GO:0001889]; mitochondrion organization [GO:0007005]; mRNA processing [GO:0006397]; muscle cell development [GO:0055001]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; RNA binding [GO:0003723]; kidney development [GO:0001822]; liver development [GO:0001889]; mitochondrion organization [GO:0007005]; mRNA processing [GO:0006397]; muscle cell development [GO:0055001]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0001822; GO:0001889; GO:0003723; GO:0005739; GO:0006397; GO:0007005; GO:0010468; GO:0050684; GO:0055001; GO:0055010 RNA binding [GO:0003723] CPLGAKRYLLTDNVVK 0.99438 -6.5553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5651 0 0 0 0 10.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JP0 FEM1C_HUMAN "Protein fem-1 homolog C, FEM1c (FEM1-gamma)" FEM1C KIAA1785 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0000151; GO:0005654; GO:0005829; GO:0006511; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] DGKLRLLTK 0.99438 -8.7314 0 0 0 0 12.9496 0 14.1173 0 14.1198 0 14.0729 0 13.731 0 0 0 0 0 0 0 13.4093 0 0 14.4333 13.6104 13.5113 0 0 14.8419 13.247 0 0 0 14.7426 14.2673 0 0 0 0 0 0 0 0 0 0 0 0 11.1501 0 0 12.1597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2548 0 0 10.9236 0 0 11.188 0 0 15.0664 0 13.2693 0 0 0 0 0 0 0 0 0 0 0 12.635 0 0 0 0 0 0 0 0 0 0 0 12.3034 14.3757 0 15.2119 0 12.1046 13.5748 0 0 0 12.1644 0 0 13.03 0 0 0 0 0 0 0 0 0 16.487 0 0 0 0 0 11.6914 0 0 0 0 12.909 16.3251 0 0 0 0 0 0 0 0 14.9409 14.5867 14.9097 12.5025 0 14.7044 0 0 16.1533 14.4907 0 0 14.579 14.0879 0 0 15.8077 13.8897 0 0 13.8715 0 0 0 13.9697 14.0026 0 14.1285 0 14.5026 13.9543 0 0 0 0 Q9HDB9 GAK5_HUMAN "Endogenous retrovirus group K member 5 Gag polyprotein (HERV-K(II) Gag protein) (HERV-K_3q12.3 provirus ancestral Gag polyprotein, Gag polyprotein)" ERVK-5 ERVK5 Homo sapiens (Human) viral process [GO:0016032] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; viral process [GO:0016032] GO:0003676; GO:0005198; GO:0005886; GO:0008270; GO:0016032 nucleic acid binding [GO:0003676]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] AICLRAWGK 0.99438 -11.567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8044 0 0 0 0 0 11.789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3845 0 0 0 0 0 0 0 0 13.4291 0 0 15.0378 15.2915 15.155 14.7068 14.8537 14.9403 13.6077 0 0 0 0 0 0 0 0 10.9551 0 13.2191 0 0 0 0 0 0 0 12.5337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8205 0 0 Q9UHX3 AGRE2_HUMAN Adhesion G protein-coupled receptor E2 (EGF-like module receptor 2) (EGF-like module-containing mucin-like hormone receptor-like 2) (CD antigen CD312) ADGRE2 EMR2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; regulation of mast cell degranulation [GO:0043304] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; regulation of mast cell degranulation [GO:0043304] GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0016477; GO:0031256; GO:0032587; GO:0035374; GO:0043304; GO:0071621 calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; G protein-coupled receptor activity [GO:0004930] CRPGWKPR 0.99438 -10.964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NY9 MUS81_HUMAN "Crossover junction endonuclease MUS81, EC 3.1.22.-" MUS81 Homo sapiens (Human) "DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via break-induced replication [GO:0000727]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; osteoblast proliferation [GO:0033687]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]" endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-flap endonuclease activity [GO:0048257]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via break-induced replication [GO:0000727]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; osteoblast proliferation [GO:0033687]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]" GO:0000712; GO:0000727; GO:0000737; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006302; GO:0008821; GO:0031297; GO:0031573; GO:0033687; GO:0043596; GO:0046872; GO:0048257; GO:0048476; GO:0072429; GO:1905347 3'-flap endonuclease activity [GO:0048257]; crossover junction endodeoxyribonuclease activity [GO:0008821]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] AAPVRLGRK 0.99439 -5.5027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1864 0 0 0 0 13.55 0 0 13.4886 13.4312 0 13.4147 13.4095 0 0 0 0 13.085 13.7841 0 0 13.2839 0 15.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3817 0 0 14.7639 0 13.3392 0 13.3276 0 13.0331 0 13.8449 0 0 0 0 0 0 0 0 13.0452 0 14.761 0 0 0 13.7737 0 0 0 0 0 0 13.8943 0 13.272 10.9779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2PYH4 HFM1_HUMAN "Probable ATP-dependent DNA helicase HFM1, EC 3.6.4.12 (SEC63 domain-containing protein 1)" HFM1 SEC3D1 Homo sapiens (Human) resolution of meiotic recombination intermediates [GO:0000712] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000712; GO:0003676; GO:0003678; GO:0005524; GO:0005634; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; nucleic acid binding [GO:0003676] ELELILNRHPPFGTQIK 0.99439 -10.74 0 0 0 0 0 0 0 0 0 0 0 12.0443 0 0 0 0 0 9.87038 0 0 0 0 0 0 0 12.9856 0 0 0 0 0 14.0089 0 9.90724 0 10.4477 0 0 0 0 0 0 0 0 0 0 0 11.2329 0 0 0 0 0 10.5825 0 0 0 13.0152 0 12.3633 0 0 13.2336 12.6292 12.6234 0 0 0 0 0 0 0 0 0 0 11.799 0 0 0 0 15.0091 0 0 0 0 0 0 12.8966 12.9249 0 0 0 0 15.8149 0 0 16.979 0 13.2114 0 0 0 0 0 0 0 0 0 0 0 13.5757 0 0 0 12.9318 0 12.2141 0 0 0 0 0 15.1762 0 12.609 0 0 0 0 0 0 12.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5148 0 0 0 0 0 0 0 A6NGU5 GGT3_HUMAN "Putative glutathione hydrolase 3 proenzyme, EC 3.4.19.13 (Gamma-glutamyltransferase 3) (Putative gamma-glutamyltranspeptidase 3, GGT 3, EC 2.3.2.2) [Cleaved into: Putative glutathione hydrolase 3 heavy chain; Putative glutathione hydrolase 3 light chain ]" GGT3P GGT3 Homo sapiens (Human) glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727] GO:0002682; GO:0005886; GO:0006508; GO:0006750; GO:0006751; GO:0016021; GO:0031179; GO:0036374; GO:0050727; GO:0070062; GO:0102953; GO:0103068; GO:1901750 glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068] GGEPAGY 0.99439 -5.2772 0 0 0 0 0 0 12.9409 0 0 0 11.6338 0 0 0 0 0 14.001 0 0 0 0 0 0 14.5937 14.5009 15.173 0 14.657 0 0 0 0 11.1972 0 10.3755 0 0 0 0 0 0 12.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.548 14.1755 13.8122 13.7858 0 12.3975 0 0 0 0 0 0 0 0 0 0 0 0 12.6839 0 14.4651 12.3497 0 12.0728 0 0 0 0 0 0 0 0 13.3607 0 0 0 0 0 0 13.0452 0 0 0 0 0 0 12.7402 14.3502 0 0 0 0 0 11.5929 0 0 0 0 0 11.4139 0 0 0 12.585 0 0 0 0 0 0 0 0 13.2748 13.3821 0 11.2987 0 0 0 0 0 10.6449 0 0 0 0 0 13.1012 0 0 0 0 0 0 12.8518 0 0 0 0 12.7739 0 0 0 0 0 0 0 0 0 0 A6NIK2 LR10B_HUMAN Leucine-rich repeat-containing protein 10B LRRC10B Homo sapiens (Human) ELRILALDFNK 0.99439 -9.0186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7993 0 0 0 0 0 0 0 0 11.8636 14.0885 0 13.1309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43822 CF410_HUMAN Cilia- and flagella-associated protein 410 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2) CFAP410 C21orf2 LRRC76 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224] GO:0001750; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006974; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0043231; GO:0060271 LCCTLSSLSSAAETGR 0.99439 -8.5263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0131 13.7974 0 0 0 0 0 0 14.3378 0 0 11.312 0 0 0 0 9.63229 0 0 12.1041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.201 0 0 0 0 0 0 11.3594 0 0 0 0 0 0 0 11.4297 9.87123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60921 HUS1_HUMAN "Checkpoint protein HUS1, hHUS1" HUS1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; response to UV [GO:0009411]; telomere maintenance [GO:0000723] checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; response to UV [GO:0009411]; telomere maintenance [GO:0000723] GO:0000077; GO:0000723; GO:0000724; GO:0001932; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006289; GO:0006468; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479 IKLTNKHFPCLTVSVELLSMSSSSR 0.99439 -5.2748 0 0 0 0 0 0 0 0 0 0 0 13.0115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0629 0 0 0 0 0 0 11.6146 0 12.6451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7216 12.7519 0 0 0 12.1056 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0165 0 0 0 0 0 0 0 0 0 0 0 0 12.3169 0 0 0 0 0 0 0 0 13.0004 0 0 0 0 0 0 0 0 O75385 ULK1_HUMAN "Serine/threonine-protein kinase ULK1, EC 2.7.11.1 (Autophagy-related protein 1 homolog, ATG1, hATG1) (Unc-51-like kinase 1)" ULK1 KIAA0722 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of protein lipidation [GO:1903059]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037] Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of autophagosome membrane [GO:0097635]; extrinsic component of omegasome membrane [GO:0097629]; extrinsic component of phagophore assembly site membrane [GO:0097632]; mitochondrial outer membrane [GO:0005741]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axon extension [GO:0048675]; cellular response to nutrient levels [GO:0031669]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection development [GO:0031175]; neuron projection regeneration [GO:0031102]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; regulation of protein lipidation [GO:1903059]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165] GO:0000045; GO:0000407; GO:0000422; GO:0004674; GO:0005524; GO:0005737; GO:0005741; GO:0005776; GO:0005789; GO:0005829; GO:0006468; GO:0006914; GO:0007165; GO:0008104; GO:0008285; GO:0010508; GO:0016236; GO:0016241; GO:0018105; GO:0018107; GO:0030424; GO:0031102; GO:0031175; GO:0031267; GO:0031333; GO:0031669; GO:0034045; GO:0034727; GO:0042594; GO:0042802; GO:0044805; GO:0044877; GO:0046777; GO:0048671; GO:0048675; GO:0051020; GO:0055037; GO:0061709; GO:0097629; GO:0097632; GO:0097635; GO:0106310; GO:1903059; GO:1990316; GO:2000786 ATP binding [GO:0005524]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267] AVPSFDFPK 0.99439 -10.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2963 0 0 0 0 13.1348 0 0 0 11.4383 0 0 0 0 0 0 11.8998 0 12.0729 0 0 0 0 12.097 0 0 0 0 10.8781 12.8648 0 0 0 13.1611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.079 0 0 0 0 0 0 0 0 0 0 12.9824 0 0 14.5969 15.9699 0 11.5435 0 0 0 0 0 12.3177 0 14.0504 0 0 0 0 0 12.8595 12.3198 0 0 0 0 0 11.7599 0 0 0 0 0 0 0 0 0 0 12.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9297 0 0 0 13.9461 0 13.1945 13.5816 0 13.7067 13.7571 0 13.8791 0 0 15.3142 12.7161 14.4356 13.9876 0 0 0 11.5549 15 0 15.2272 0 0 P07948 LYN_HUMAN "Tyrosine-protein kinase Lyn, EC 2.7.10.2 (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)" LYN JTK8 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; C-X-C chemokine receptor CXCR4 signaling pathway [GO:0038159]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; dendritic cell differentiation [GO:0097028]; ephrin receptor signaling pathway [GO:0048013]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; hematopoietic progenitor cell differentiation [GO:0002244]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of immune response [GO:0050777]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cytokine production [GO:0001817]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of protein phosphorylation [GO:0001932]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]" "adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization, intracellular component [GO:0099091]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; C-X-C chemokine receptor CXCR4 signaling pathway [GO:0038159]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; dendritic cell differentiation [GO:0097028]; ephrin receptor signaling pathway [GO:0048013]; erythrocyte differentiation [GO:0030218]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; hematopoietic progenitor cell differentiation [GO:0002244]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; leukocyte migration [GO:0050900]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of immune response [GO:0050777]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress-activated protein kinase signaling cascade [GO:0070304]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cytokine production [GO:0001817]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of protein phosphorylation [GO:0001932]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001782; GO:0001817; GO:0001932; GO:0001933; GO:0001934; GO:0002223; GO:0002244; GO:0002250; GO:0002431; GO:0002513; GO:0002553; GO:0002576; GO:0002762; GO:0002768; GO:0002774; GO:0002862; GO:0002902; GO:0004713; GO:0004715; GO:0005102; GO:0005161; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005758; GO:0005765; GO:0005794; GO:0005829; GO:0005886; GO:0005912; GO:0006468; GO:0006974; GO:0006991; GO:0007165; GO:0007169; GO:0008284; GO:0008285; GO:0009410; GO:0009636; GO:0009725; GO:0009743; GO:0010976; GO:0014003; GO:0014069; GO:0014070; GO:0016301; GO:0017124; GO:0018108; GO:0019899; GO:0030061; GO:0030154; GO:0030218; GO:0030335; GO:0030666; GO:0030889; GO:0031175; GO:0031234; GO:0031295; GO:0031625; GO:0031663; GO:0031668; GO:0032868; GO:0033003; GO:0033628; GO:0034136; GO:0034142; GO:0034144; GO:0034605; GO:0034666; GO:0035556; GO:0038095; GO:0038096; GO:0038159; GO:0042531; GO:0043015; GO:0043200; GO:0043208; GO:0043231; GO:0043304; GO:0043407; GO:0043552; GO:0044325; GO:0045087; GO:0045121; GO:0045646; GO:0046777; GO:0046875; GO:0048013; GO:0048471; GO:0048678; GO:0050777; GO:0050853; GO:0050855; GO:0050900; GO:0051219; GO:0051279; GO:0060252; GO:0060369; GO:0060397; GO:0070062; GO:0070304; GO:0070372; GO:0070373; GO:0070447; GO:0070667; GO:0070668; GO:0071300; GO:0090025; GO:0090330; GO:0097028; GO:0097110; GO:0098978; GO:0099091; GO:0140031; GO:1902532; GO:1902961; GO:2000670 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625] AKSLLTKK 0.99439 -8.5206 0 0 0 0 0 0 12.3594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6413 0 0 0 0 13.2326 0 13.8658 0 0 0 0 0 0 0 0 15.2375 0 0 0 0 0 0 15.805 0 0 0 0 0 13.9875 0 0 0 0 10.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9586 0 0 0 13.2989 0 0 13.0587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DTE0 T2R36_HUMAN "Putative taste receptor type 2 member 36, T2R36, hGR36" TAS2R36 Homo sapiens (Human) sensory perception of taste [GO:0050909] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; sensory perception of taste [GO:0050909] GO:0004930; GO:0005886; GO:0016021; GO:0050909 G protein-coupled receptor activity [GO:0004930] AKSVVLVIVLGPLVFLVCHLVMK 0.99439 -9.0177 0 0 0 0 0 0 0 0 0 0 11.3905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9648 0 0 0 0 0 0 9.71022 0 0 0 0 0 0 11.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6599 0 13.7154 0 0 0 0 0 0 0 0 0 0 0 12.9178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7839 0 0 13.7101 0 13.5577 0 0 0 0 0 0 0 0 0 12.7043 0 0 0 0 0 0 0 0 0 12.8153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6196 0 0 0 0 0 0 0 0 12.8015 0 0 10.2349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2505 0 0 P13196 HEM1_HUMAN "5-aminolevulinate synthase, non-specific, mitochondrial, ALAS-H, EC 2.3.1.37 (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)" ALAS1 ALAS3 ALASH OK/SW-cl.121 Homo sapiens (Human) erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412] GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0030170; GO:0042541; GO:0042802; GO:0048821; GO:1903412 5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170] GGGIGDR 0.99439 -15.5 0 0 0 0 0 0 0 0 0 0 14.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8232 0 0 0 13.9812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7128 0 0 0 0 13.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6138 0 0 0 0 0 0 0 0 0 13.5577 0 0 0 0 0 0 P22897 MRC1_HUMAN "Macrophage mannose receptor 1, MMR (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor, hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)" MRC1 CLEC13D CLEC13DL MRC1L1 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898] cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898] GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0005887; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353 cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618] CFKIFGFMEEER 0.99439 -12.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1181 0 0 0 0 0 0 0 0 16.6835 0 0 0 0 0 17.4844 0 12.6802 13.5682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8296 0 0 0 0 0 0 10.9852 0 0 0 0 0 0 0 16.8248 0 0 0 0 0 0 0 0 0 0 0 15.5762 0 0 0 0 0 0 0 12.1098 0 0 12.6792 0 0 10.9705 0 0 0 13.1042 0 12.7515 0 0 P35590 TIE1_HUMAN "Tyrosine-protein kinase receptor Tie-1, EC 2.7.10.1" TIE1 TIE Homo sapiens (Human) angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570] integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235] integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; branching involved in lymph vessel morphogenesis [GO:0060854]; in utero embryonic development [GO:0001701]; lymphatic endothelial cell differentiation [GO:0060836]; mesoderm development [GO:0007498]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; plasma membrane fusion [GO:0045026]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; regulation of endothelial cell proliferation [GO:0001936]; regulation of extracellular matrix assembly [GO:1901201]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; tissue remodeling [GO:0048771]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0001701; GO:0001936; GO:0003180; GO:0004714; GO:0005524; GO:0005887; GO:0007165; GO:0007169; GO:0007498; GO:0016525; GO:0030336; GO:0032526; GO:0033674; GO:0043235; GO:0045026; GO:0045766; GO:0048771; GO:0060836; GO:0060854; GO:1901201 ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] ECPGCLHGGVCHDHDGECVCPPGFTGTRCEQACR 0.99439 -7.9992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5915 11.9601 12.9454 12.9696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4499 0 0 0 0 15.2984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5694 0 0 0 0 0 0 0 14.8553 0 0 0 0 0 13.3914 0 0 0 14.4893 0 0 0 0 0 14.0305 0 0 0 0 0 12.7658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.948 0 0 0 0 0 0 0 0 0 0 12.1041 0 0 0 0 12.0689 0 0 0 0 0 0 0 0 0 0 0 0 0 P68543 UBX2A_HUMAN UBX domain-containing protein 2A (UBX domain-containing protein 4) UBXN2A UBXD4 Homo sapiens (Human) autophagosome assembly [GO:0000045]; cellular response to leukemia inhibitory factor [GO:1990830]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; nuclear membrane reassembly [GO:0031468]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; regulation of protein ubiquitination [GO:0031396] cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; acetylcholine receptor binding [GO:0033130]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; cellular response to leukemia inhibitory factor [GO:1990830]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; nuclear membrane reassembly [GO:0031468]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; regulation of protein ubiquitination [GO:0031396] GO:0000045; GO:0005634; GO:0005783; GO:0005801; GO:0005829; GO:0007030; GO:0031396; GO:0031468; GO:0033130; GO:0042176; GO:0043130; GO:0043161; GO:0061025; GO:1990830 acetylcholine receptor binding [GO:0033130]; ubiquitin binding [GO:0043130] EEWVCETGSDNQPLGNNQQSNCEYFVDSLFEEAQK 0.99439 -8.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1165 0 0 11.6678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7324 0 0 0 0 0 0 0 13.4833 0 0 0 18.3665 0 0 0 11.7819 0 14.9955 13.9039 14.1511 0 0 0 12.419 0 0 0 0 0 11.4056 0 0 0 0 0 0 0 13.0706 14.0686 13.8316 0 0 0 0 12.333 11.9843 12.0709 0 0 0 12.0321 0 13.0019 0 0 0 0 0 0 0 0 0 11.9177 13.1654 0 13.9935 0 11.757 12.5504 0 0 0 0 0 0 0 18.1215 0 0 12.2362 13.5371 13.8338 0 12.6062 0 0 13.5207 14.3118 14.1106 14.0452 12.8329 14.1693 0 13.317 0 0 13.1476 0 0 15.662 0 0 0 0 Q1ZZU3 SWI5_HUMAN DNA repair protein SWI5 homolog (HBV DNAPTP1-transactivated protein A) (Protein SAE3 homolog) SWI5 C9orf119 SAE3 Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724] nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798]; Swi5-Swi2 complex [GO:0034974] nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798]; Swi5-Swi2 complex [GO:0034974]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724] GO:0000724; GO:0005634; GO:0032798; GO:0034974; GO:0071479 GGAGFPWVR 0.99439 -10.737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4565 0 0 0 0 0 0 0 Q8N5I2 ARRD1_HUMAN Arrestin domain-containing protein 1 (Alpha-arrestin 1) ARRDC1 Homo sapiens (Human) extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; plasma membrane [GO:0005886]; arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625]; extracellular transport [GO:0006858]; extracellular vesicle biogenesis [GO:0140112]; negative regulation of Notch signaling pathway [GO:0045746]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005737; GO:0005886; GO:0006511; GO:0006858; GO:0015031; GO:0016567; GO:0031410; GO:0031625; GO:0042802; GO:0045746; GO:0070062; GO:0140112; GO:1903561; GO:1990756; GO:1990763 arrestin family protein binding [GO:1990763]; identical protein binding [GO:0042802]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; ubiquitin protein ligase binding [GO:0031625] IVHQVRAAIHTPR 0.99439 -9.0274 0 0 11.0407 0 13.5025 0 0 14.1679 0 0 0 0 0 0 0 0 13.4435 0 0 0 0 0 13.2586 0 12.9997 15.2719 0 0 13.2739 0 16.8216 16.3399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4414 0 17.0804 0 0 16.8113 0 0 14.9894 16.2934 0 15.3994 0 0 0 0 0 0 0 0 13.3068 0 0 0 12.1645 0 0 0 15.218 0 13.6278 13.2737 0 0 12.6323 0 13.292 13.0666 0 13.6381 13.3011 0 0 0 12.8598 0 0 0 0 0 0 0 0 12.5693 0 0 0 0 0 0 0 11.2171 0 0 0 13.5949 0 0 12.3399 13.1974 0 0 13.3115 13.5793 0 0 0 0 0 0 0 13.8043 14.0521 13.7778 0 0 0 0 12.424 0 0 0 0 12.3469 0 0 0 0 0 0 0 0 0 0 18.7557 0 0 0 0 0 0 0 0 0 14.0518 0 0 14.3125 0 0 0 0 0 0 0 17.8962 Q8N6K7 SAMD3_HUMAN "Sterile alpha motif domain-containing protein 3, SAM domain-containing protein 3" SAMD3 Homo sapiens (Human) DILKLFPFLKCPYQMFR 0.99439 -8.5177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.28438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2871 0 0 13.5434 0 0 0 17.5705 0 0 14.5982 13.0992 14.688 0 0 0 0 0 12.3983 14.0331 0 0 0 0 0 11.9731 0 0 0 0 0 14.88 14.8069 0 0 0 0 0 0 14.6317 0 14.7881 13.1214 0 12.8218 0 0 0 0 0 12.1861 0 0 14.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2427 0 0 0 0 0 0 0 0 Q8TB52 FBX30_HUMAN F-box only protein 30 FBXO30 FBX30 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GO:0005829; GO:0008270; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] GMVILQWGKRK 0.99439 -8.5358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.684 0 0 0 0 0 0 0 0 0 0 0 0 14.4229 0 13.619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDW0 LRC8C_HUMAN Volume-regulated anion channel subunit LRRC8C (Factor for adipocyte differentiation 158) (Leucine-rich repeat-containing protein 8C) LRRC8C AD158 FAD158 Homo sapiens (Human) anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; fat cell differentiation [GO:0045444]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; ion channel complex [GO:0034702]; membrane [GO:0016020]; plasma membrane [GO:0005886]; volume-sensitive anion channel activity [GO:0005225]; anion transmembrane transport [GO:0098656]; aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; fat cell differentiation [GO:0045444]; protein hexamerization [GO:0034214]; taurine transport [GO:0015734] GO:0005225; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0015734; GO:0015810; GO:0016020; GO:0034214; GO:0034702; GO:0045444; GO:0071470; GO:0098656; GO:0140361 volume-sensitive anion channel activity [GO:0005225] ALSEVSGEDSEEKDNR 0.99439 -10.737 15.0497 15.1404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6885 0 13.9298 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0788 0 0 0 0 0 0 0 0 0 0 10.8877 0 0 0 0 12.1665 0 0 0 0 0 0 0 0 9.50964 0 0 0 0 18.365 12.0867 0 0 0 11.5822 0 11.879 0 0 14.2194 13.9495 0 14.5155 14.4083 19.1585 0 0 0 0 19.047 11.8303 0 15.7358 0 14.1812 0 0 14.0172 0 0 0 0 0 14.5777 0 14.6615 14.3864 14.213 14.1241 14.4621 0 14.6957 14.6809 13.7858 0 12.7342 19.2677 0 0 0 0 14.4773 0 0 0 0 14.6359 10.6805 0 14.7007 14.2683 14.5169 10.0464 0 0 14.6196 14.0699 14.6194 14.829 0 14.5151 19.3346 19.262 0 0 0 13.9117 0 0 0 14.3076 0 14.4488 14.4982 12.5279 0 0 0 0 0 11.1479 0 14.6746 0 0 0 13.4061 0 0 0 0 0 0 0 0 0 14.3807 0 14.9151 0 13.256 0 Q96SD1 DCR1C_HUMAN "Protein artemis, EC 3.1.-.- (DNA cross-link repair 1C protein) (Protein A-SCID) (SNM1 homolog C, hSNM1C) (SNM1-like protein)" DCLRE1C ARTEMIS ASCID SCIDA SNM1C Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]; response to ionizing radiation [GO:0010212]; V(D)J recombination [GO:0033151] Golgi apparatus [GO:0005794]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654] Golgi apparatus [GO:0005794]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]; response to ionizing radiation [GO:0010212]; V(D)J recombination [GO:0033151] GO:0000014; GO:0002250; GO:0003684; GO:0004519; GO:0005654; GO:0005794; GO:0006303; GO:0008409; GO:0010212; GO:0030183; GO:0031848; GO:0033151; GO:0035312; GO:0036297; GO:0070419 5'-3' exodeoxyribonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014] IPLHIISIK 0.99439 -11.328 0 12.4137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.363 14.0335 0 13.6843 0 0 0 0 0 0 0 0 0 13.0002 13.53 0 0 0 14.3961 13.6786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0809 0 12.7931 0 0 0 0 0 0 0 0 11.7693 13.3188 0 0 0 0 0 0 0 0 0 0 14.0473 14.6138 0 0 0 0 0 0 12.5529 0 0 0 13.3604 0 0 0 0 0 0 14.4696 0 0 0 0 0 0 14.247 0 0 0 13.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRQ6 MIC25_HUMAN MICOS complex subunit MIC25 (Coiled-coil-helix cristae morphology protein 1) (Coiled-coil-helix-coiled-coil-helix domain-containing protein 6) CHCHD6 CHCM1 MIC25 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] cytosol [GO:0005829]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401] cytosol [GO:0005829]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; cellular response to DNA damage stimulus [GO:0006974]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] GO:0001401; GO:0005739; GO:0005743; GO:0005829; GO:0006974; GO:0007007; GO:0042407; GO:0044284; GO:0061617; GO:0140275 DTFYKEQLER 0.99439 -9.0328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP50 SHCAF_HUMAN SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein homolog) SINHCAF C12orf14 FAM60A L4 Homo sapiens (Human) negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459] nucleus [GO:0005634]; Sin3 complex [GO:0016580] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459] GO:0000122; GO:0005634; GO:0008284; GO:0016580; GO:0030336; GO:0030512; GO:0045596; GO:1902455; GO:1902459 FGFHKPK 0.99439 -9.0267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ71 RTEL1_HUMAN "Regulator of telomere elongation helicase 1, EC 3.6.4.12 (Novel helicase-like)" RTEL1 C20orf41 KIAA1088 NHL Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657] "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657]" GO:0000723; GO:0000732; GO:0000781; GO:0003677; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0010569; GO:0016887; GO:0031297; GO:0032206; GO:0032508; GO:0043247; GO:0045910; GO:0046872; GO:0051539; GO:0070182; GO:0090657; GO:1902990; GO:1904355; GO:1904358; GO:1904430; GO:1904506; GO:1904535 "4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]" DGISARK 0.99439 -9.2869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3657 0 0 12.8498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4025 12.426 12.991 0 0 0 0 0 0 0 0 13.0192 0 0 0 0 O14965 AURKA_HUMAN "Aurora kinase A, EC 2.7.11.1 (Aurora 2) (Aurora/IPL1-related kinase 1, ARK-1, Aurora-related kinase 1, hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)" AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; apoptotic process [GO:0006915]; cell division [GO:0051301]; centrosome localization [GO:0051642]; cilium disassembly [GO:0061523]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051] axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616] axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]; ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625]; anterior/posterior axis specification [GO:0009948]; apoptotic process [GO:0006915]; cell division [GO:0051301]; centrosome localization [GO:0051642]; cilium disassembly [GO:0061523]; G2/M transition of mitotic cell cycle [GO:0000086]; liver regeneration [GO:0097421]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of centrosome cycle [GO:0046605]; regulation of cytokinesis [GO:0032465]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051] GO:0000086; GO:0000278; GO:0004672; GO:0004674; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0006468; GO:0006915; GO:0007051; GO:0007052; GO:0007057; GO:0007100; GO:0009611; GO:0009948; GO:0010389; GO:0010629; GO:0015630; GO:0018105; GO:0019901; GO:0030496; GO:0031616; GO:0031625; GO:0031647; GO:0032091; GO:0032133; GO:0032436; GO:0032465; GO:0035174; GO:0036064; GO:0042585; GO:0043066; GO:0043161; GO:0043203; GO:0045120; GO:0045840; GO:0046605; GO:0046777; GO:0046982; GO:0048471; GO:0051233; GO:0051301; GO:0051642; GO:0061523; GO:0071539; GO:0072686; GO:0072687; GO:0090141; GO:0097421; GO:0097431; GO:0106310; GO:1900195; GO:1901796; GO:1990138 ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ubiquitin protein ligase binding [GO:0031625] PSNCQNK 0.9944 -9.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5244 0 0 0 0 0 0 13.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1039 0 0 13.9698 0 0 0 0 0 12.8237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60503 ADCY9_HUMAN "Adenylate cyclase type 9, EC 4.6.1.1 (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX, ACIX) (Adenylyl cyclase 9, AC9)" ADCY9 KIAA0520 Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] axon [GO:0030424]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165] GO:0001701; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007165; GO:0007189; GO:0016021; GO:0030424; GO:0030425; GO:0035556; GO:0046872; GO:0071880 adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872] CEKISTLGDCYYCVAGCPEPRADHAYCCIEMGLGMIK 0.9944 -8.8172 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3245 0 0 0 0 0 0 0 0 0 0 0 0 12.2536 0 11.0219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3894 0 0 15.3208 13.1104 0 0 0 0 0 0 0 0 0 0 0 11.0007 0 0 13.5068 0 0 13.3496 0 0 0 0 13.4737 0 0 0 12.5775 12.2332 0 0 14.0224 0 0 0 0 13.4476 0 13.5063 0 12.1225 0 0 12.9936 0 0 0 0 0 0 0 0 13.3578 0 13.649 0 0 0 0 0 12.9728 0 0 0 0 11.6665 0 0 0 0 13.7471 0 0 0 0 0 0 0 12.0725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95568 MET18_HUMAN "Histidine protein methyltransferase 1 homolog, EC 2.1.1.85 (Arsenic-transactivated protein 2, AsTP2) (Methyltransferase-like protein 18)" METTL18 ASTP2 C1orf156 Homo sapiens (Human) "peptidyl-histidine methylation, to form tele-methylhistidine [GO:0042038]; peptidyl-lysine monomethylation [GO:0018026]; regulation of ribosome biogenesis [GO:0090069]; regulation of rRNA processing [GO:2000232]; regulation of translation [GO:0006417]" cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064]; peptidyl-histidine methylation, to form tele-methylhistidine [GO:0042038]; peptidyl-lysine monomethylation [GO:0018026]; regulation of ribosome biogenesis [GO:0090069]; regulation of rRNA processing [GO:2000232]; regulation of translation [GO:0006417]" GO:0005634; GO:0005730; GO:0005829; GO:0006417; GO:0018026; GO:0018064; GO:0031072; GO:0032991; GO:0042038; GO:0090069; GO:2000232 heat shock protein binding [GO:0031072]; protein-L-histidine N-tele-methyltransferase activity [GO:0018064] IIDEGLKR 0.9944 -12.907 0 0 0 0 0 0 0 0 13.736 0 0 0 0 0 0 0 0 0 0 0 0 13.1256 13.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1089 0 0 9.66205 0 0 0 0 0 0 17.9937 0 11.9346 0 0 16.762 0 12.5556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5889 0 0 0 0 0 0 0 11.3907 0 0 0 0 0 0 0 0 13.344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1214 0 0 18.4605 0 0 0 0 0 0 0 0 13.6843 0 0 0 0 0 0 0 0 0 0 0 10.0293 0 0 0 0 0 0 10.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2404 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3623 0 0 11.7716 9.20313 18.261 0 Q04609 FOLH1_HUMAN "Glutamate carboxypeptidase 2, EC 3.4.17.21 (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase, FGCP) (Glutamate carboxypeptidase II, GCPII) (Membrane glutamate carboxypeptidase, mGCP) (N-acetylated-alpha-linked acidic dipeptidase I, NAALADase I) (Prostate-specific membrane antigen, PSM, PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)" FOLH1 FOLH NAALAD1 PSM PSMA GIG27 Homo sapiens (Human) C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493]; C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508] GO:0004180; GO:0004181; GO:0005737; GO:0005886; GO:0005887; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0035609; GO:0046872; GO:0070062; GO:1904492; GO:1904493 Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493] GAVEPDR 0.9944 -8.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4814 0 0 0 11.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1824 0 0 0 0 0 0 0 0 0 0 10.8403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12906 ILF3_HUMAN "Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76, DRBP76) (M-phase phosphoprotein 4, MPP4) (Nuclear factor associated with dsRNA, NFAR) (Nuclear factor of activated T-cells 90 kDa, NF-AT-90) (Translational control protein 80, TCP80)" ILF3 DRBF MPHOSPH4 NF90 Homo sapiens (Human) "defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]" cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]" GO:0003677; GO:0003723; GO:0003725; GO:0003727; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0006468; GO:0016020; GO:0017148; GO:0035925; GO:0045071; GO:0045892; GO:0045893; GO:0051607; GO:1990904 DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727] FQGAGSNK 0.9944 -15.556 0 0 0 12.3689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1469 0 11.0535 0 0 0 0 0 13.4497 0 0 0 0 0 0 11.5823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7632 0 0 0 0 0 0 14.5748 14.5144 15.3631 0 0 0 0 0 0 0 0 15.5266 14.7509 14.9617 0 14.461 0 0 0 0 14.3841 14.7453 0 14.9683 0 0 14.2553 0 0 0 13.6862 14.3086 0 0 14.3392 13.9456 14.0535 13.9654 0 0 0 13.8209 14.0018 13.9651 0 13.4842 0 0 12.3607 0 0 0 0 0 0 12.6669 0 0 0 0 0 0 11.2999 0 0 11.4209 0 0 0 14.1037 0 13.8593 0 0 10.5057 0 0 11.2709 Q16629 SRSF7_HUMAN "Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)" SRSF7 SFRS7 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; RNA splicing [GO:0008380]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0008270; GO:0008380; GO:0016607; GO:0019904; GO:0048025; GO:0051028; GO:0070062; GO:1990830 protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] CYECGEKGHYAYDCHRYSR 0.9944 -8.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2M329 CCD96_HUMAN Coiled-coil domain-containing protein 96 CCDC96 Homo sapiens (Human) cilium assembly [GO:0060271] axoneme [GO:0005930]; ciliary basal body [GO:0036064] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium assembly [GO:0060271] GO:0005930; GO:0036064; GO:0060271 DILTKTK 0.9944 -12.924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3285 0 0 0 0 0 14.9767 0 14.2753 0 0 0 0 0 0 14.9292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4V328 GRAP1_HUMAN "GRIP1-associated protein 1, GRASP-1 [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form) ]" GRIPAP1 KIAA1167 Homo sapiens (Human) "neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]" anchoring junction [GO:0070161]; axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038] "anchoring junction [GO:0070161]; axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]" GO:0005654; GO:0005829; GO:0030424; GO:0030425; GO:0042802; GO:0043231; GO:0055038; GO:0070161; GO:0072562; GO:0098837; GO:0098887; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1905244 identical protein binding [GO:0042802] AQKALSKSK 0.9944 -9.0634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8689 0 0 0 0 0 0 0 0 0 0 11.9897 0 0 0 0 11.2608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5646 0 0 0 0 0 0 0 0 0 0 0 14.8638 13.602 0 0 0 0 0 0 0 11.7902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7627 0 0 0 0 0 0 Q58HT5 AWAT1_HUMAN "Acyl-CoA wax alcohol acyltransferase 1, EC 2.3.1.75 (Diacylglycerol O-acyltransferase 2-like protein 3) (Diacylglycerol acyltransferase 2) (Long-chain-alcohol O-fatty-acyltransferase 1)" AWAT1 DGA2 DGAT2L3 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; lipid metabolic process [GO:0006629]; wax biosynthetic process [GO:0010025] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; arachidonic acid metabolic process [GO:0019369]; lipid metabolic process [GO:0006629]; wax biosynthetic process [GO:0010025] GO:0005789; GO:0006629; GO:0010025; GO:0016021; GO:0019369; GO:0047196; GO:0102966 arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196] NWCVWTHIRDYFPITILKTK 0.9944 -9.0668 0 0 0 0 0 11.6511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.189 0 0 0 0 0 0 11.4221 0 0 0 0 0 0 0 13.2111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.818 0 0 0 0 0 0 0 0 0 0 0 11.2431 12.2885 0 0 0 0 0 0 13.7065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6025 0 0 0 13.5355 0 0 0 0 12.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92753 RORB_HUMAN Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta) RORB NR1F2 RZRB Homo sapiens (Human) "amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; amacrine cell differentiation [GO:0035881]; cellular response to retinoic acid [GO:0071300]; eye photoreceptor cell development [GO:0042462]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; rhythmic process [GO:0048511]; visual perception [GO:0007601]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007601; GO:0008270; GO:0008502; GO:0035881; GO:0042462; GO:0042752; GO:0045668; GO:0045892; GO:0045893; GO:0045944; GO:0046548; GO:0046549; GO:0048511; GO:0060041; GO:0071300; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; melatonin receptor activity [GO:0008502]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" DSLYAEVQKHQQRLQEQR 0.9944 -15.595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1944 15.9278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9118 0 0 13.985 16.0405 0 14.3582 0 0 0 0 14.175 0 13.8248 0 0 0 0 0 0 0 0 0 0 0 11.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3492 0 0 0 Q96DA2 RB39B_HUMAN Ras-related protein Rab-39B RAB39B Homo sapiens (Human) autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0031982; GO:0032482; GO:0043005; GO:0050808 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] CDLDTQR 0.9944 -15.542 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7451 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8254 0 0 0 0 0 0 12.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1502 0 0 0 0 0 0 0 0 11.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0104 13.2334 13.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9705 0 0 0 0 0 0 0 0 0 0 14.9466 0 0 0 0 0 0 0 0 0 Q96H15 TIMD4_HUMAN "T-cell immunoglobulin and mucin domain-containing protein 4, TIMD-4 (T-cell immunoglobulin mucin receptor 4, TIM-4) (T-cell membrane protein 4)" TIMD4 TIM4 Homo sapiens (Human) "apoptotic cell clearance [GO:0043277]; cytoskeletal rearrangement involved in phagocytosis, engulfment [GO:0060097]" extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cytoskeletal rearrangement involved in phagocytosis, engulfment [GO:0060097]" GO:0001786; GO:0005576; GO:0005886; GO:0016021; GO:0043277; GO:0060097 phosphatidylserine binding [GO:0001786] ASTTTHR 0.9944 -15.555 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7341 0 0 0 0 0 0 0 13.1689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6226 0 15.6826 0 15.5951 0 14.6525 15.8852 0 14.8603 0 13.7295 0 14.3647 13.5984 12.8545 13.8857 15.4277 15.3823 15.5404 0 0 0 0 0 0 0 0 0 13.8559 0 0 0 15.4478 0 0 15.2156 0 0 0 0 0 0 15.3501 0 0 0 0 0 0 0 0 0 13.268 0 0 0 0 0 0 0 0 0 0 0 13.6535 0 0 0 0 0 0 0 0 0 14.9549 0 15.5026 0 0 13.7861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KN8 PLAT5_HUMAN "Phospholipase A and acyltransferase 5 (Ca(2+)-independent N-acyltransferase, iNAT, EC 2.3.1.-, EC 3.1.1.32, EC 3.1.1.4) (H-rev107-like protein 5) (HRAS-like suppressor 5, HRSL5)" PLAAT5 HRASLS5 HRLP5 Homo sapiens (Human) N-acylphosphatidylethanolamine metabolic process [GO:0070292] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; N-acylphosphatidylethanolamine metabolic process [GO:0070292] GO:0004623; GO:0005737; GO:0005829; GO:0008970; GO:0016410; GO:0052739; GO:0052740; GO:0070292 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; N-acyltransferase activity [GO:0016410]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] IIQRTKK 0.9944 -9.0432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6282 0 0 0 0 0 14.1042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3763 0 0 0 0 0 0 0 0 0 0 0 0 12.9684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4983 0 0 0 0 0 13.7184 13.513 0 0 0 0 0 0 0 0 0 0 0 0 13.3273 0 0 0 0 0 14.6447 0 14.5036 0 14.3943 14.39 14.3773 13.9072 13.8341 0 0 0 0 0 0 0 0 13.9136 0 0 0 0 0 0 13.0006 0 0 Q9NZH6 IL37_HUMAN "Interleukin-37, IL-37 (FIL1 zeta) (IL-1X) (Interleukin-1 family member 7, IL-1F7) (Interleukin-1 homolog 4, IL-1H, IL-1H4) (Interleukin-1 zeta, IL-1 zeta) (Interleukin-1-related protein, IL-1RP1)" IL37 FIL1Z IL1F7 IL1H4 IL1RP1 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of gene expression [GO:0010628]; regulation of inflammatory response [GO:0050727] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of gene expression [GO:0010628]; regulation of inflammatory response [GO:0050727] GO:0002437; GO:0005125; GO:0005149; GO:0005576; GO:0005615; GO:0005654; GO:0005829; GO:0006954; GO:0006955; GO:0010628; GO:0019221; GO:0032715; GO:0032720; GO:0043231; GO:0050727; GO:0071222 cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149] GSPILLGVSKGEFCLYCDKDK 0.9944 -9.0642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.733 0 14.3046 0 0 0 0 0 0 0 0 14.5763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6I7 WSB1_HUMAN "WD repeat and SOCS box-containing protein 1, WSB-1 (SOCS box-containing WD protein SWiP-1)" WSB1 SWIP1 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]; protein polyubiquitination [GO:0000209] cytosol [GO:0005829] cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; intracellular signal transduction [GO:0035556]; protein aggregate center assembly [GO:0140454]; protein K27-linked ubiquitination [GO:0044314]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005829; GO:0035556; GO:0044314; GO:0061630; GO:0140454 ubiquitin protein ligase activity [GO:0061630] ASFPPRVNEKEIVR 0.9944 -15.591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6021 0 0 0 0 0 13.438 0 0 0 0 0 13.5781 0 0 0 0 0 0 13.2577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3796 0 0 0 0 14.2218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8171 0 0 0 0 0 0 Q96L58 B3GT6_HUMAN "Beta-1,3-galactosyltransferase 6, Beta-1,3-GalTase 6, Beta3Gal-T6, Beta3GalT6, EC 2.4.1.134 (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)" B3GALT6 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; UDP-glycosyltransferase activity [GO:0008194]; chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein glycosylation [GO:0006486]; proteoglycan biosynthetic process [GO:0030166]" GO:0000139; GO:0005794; GO:0005797; GO:0006024; GO:0006486; GO:0008194; GO:0008499; GO:0015012; GO:0016020; GO:0016021; GO:0016757; GO:0030166; GO:0030203; GO:0030206; GO:0032580; GO:0035250; GO:0047220 "galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-galactosyltransferase activity [GO:0035250]; UDP-glycosyltransferase activity [GO:0008194]" ALEREQARHGDLLLLPALR 0.99441 -15.605 0 0 0 0 16.9511 16.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4534 0 12.5521 0 16.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.887 17.8944 0 0 17.7597 0 0 0 13.4106 0 11.9224 17.9671 0 19.5968 0 20.1678 19.1851 15.1717 0 13.8904 0 13.1257 0 0 13.4967 14.4031 11.6445 15.0152 18.7535 13.3247 14.4199 12.539 14.3591 14.0143 12.1624 18.3998 18.4188 18.3471 18.2148 0 13.3025 14.1177 14.3887 0 15.3629 14.5876 14.1918 0 15.4985 13.6766 14.198 15.3636 14.258 13.801 14.3019 15.2462 14.8763 18.786 14.818 14.4322 0 15.5828 13.4276 12.8491 0 18.4061 0 0 14.5395 18.4237 14.2648 14.8883 14.0631 0 14.0958 13.2454 0 16.7428 0 0 0 0 0 16.7667 18.3584 18.6959 17.0584 18.6744 0 0 13.4272 0 0 0 0 0 0 0 0 0 0 0 0 16.8122 13.9817 0 0 0 0 0 0 0 A8MVJ9 HPF1L_HUMAN Putative histone PARylation factor 1-like Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835] nucleus [GO:0005634] nucleus [GO:0005634]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; cellular response to DNA damage stimulus [GO:0006974]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of protein ADP-ribosylation [GO:0010835] GO:0005634; GO:0006974; GO:0010835; GO:0018312; GO:0042393; GO:0072572 histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572] DHLANRRK 0.99441 -9.3364 0 0 0 0 0 0 0 0 12.5893 12.4531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0448 0 0 0 13.9537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0238 0 0 0 0 0 0 0 0 0 B3EWG6 FM25G_HUMAN Protein FAM25G FAM25G Homo sapiens (Human) MLGGLGK 0.99441 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00203 AP3B1_HUMAN AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain) AP3B1 ADTB3A Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; synapse [GO:0045202]; GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; cellular zinc ion homeostasis [GO:0006882]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; regulation of catalytic activity [GO:0050790]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; synaptic vesicle budding from endosome [GO:0016182]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]" GO:0000902; GO:0002224; GO:0002244; GO:0003016; GO:0005739; GO:0005765; GO:0005769; GO:0005794; GO:0006622; GO:0006882; GO:0006886; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0008089; GO:0016020; GO:0016182; GO:0016192; GO:0019903; GO:0030123; GO:0030131; GO:0030665; GO:0030742; GO:0030851; GO:0032438; GO:0034394; GO:0035654; GO:0036211; GO:0042789; GO:0045202; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048872; GO:0050790; GO:0051138; GO:0060155; GO:0060425; GO:0090152; GO:0098773; GO:1903232; GO:1904115 GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903] CATNILEVTDTCLNGLVCLLSNRDEIVVAESVVVIKK 0.99441 -13.84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.05056 0 0 0 0 0 0 0 0 0 0 13.4868 0 11.6363 0 0 0 12.2216 0 0 0 0 12.1605 14.9443 0 0 14.1353 0 0 0 14.7636 0 0 0 14.693 0 15.228 0 0 0 14.2049 0 0 12.5234 0 0 12.4538 0 0 0 0 17.5774 12.2508 0 12.4339 10.7056 0 0 0 0 0 0 0 11.6242 17.0892 0 0 12.7596 14.0777 15.2429 0 0 0 14.912 0 14.0835 0 0 12.0036 0 0 12.8081 14.0751 0 12.5299 0 0 0 13.5806 0 0 16.9834 0 0 0 0 0 0 0 0 0 0 0 13.3344 0 0 0 0 14.3592 0 0 0 0 0 0 13.4201 0 O15535 ZSC9_HUMAN Zinc finger and SCAN domain-containing protein 9 (Cell proliferation-inducing gene 12 protein) (PRD51) (Zinc finger protein 193) ZSCAN9 ZNF193 PIG12 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GIHNIQKR 0.99441 -9.3554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.476 0 0 0 0 0 0 O77932 DXO_HUMAN "Decapping and exoribonuclease protein, DXO, EC 3.6.1.- (5'-3' exoribonuclease DXO, EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO, DeNADding enzyme DXO, EC 3.6.1.-)" DXO DOM3L DOM3Z NG6 Homo sapiens (Human) mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; RNA destabilization [GO:0050779] GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090305; GO:0110152; GO:0110155 5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD-cap (NAD-forming) hydrolase activity [GO:0110152]; RNA pyrophosphohydrolase activity [GO:0034353] AQRLARPPLLR 0.99441 -15.634 0 0 0 0 0 0 0 0 12.9506 0 0 0 0 0 0 0 14.0368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0592 O94829 IPO13_HUMAN "Importin-13, Imp13 (Karyopherin-13, Kap13) (Ran-binding protein 13, RanBP13)" IPO13 KIAA0724 RANBP13 Homo sapiens (Human) protein import into nucleus [GO:0006606] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606] GO:0005634; GO:0005737; GO:0006606; GO:0031267 small GTPase binding [GO:0031267] DTFSQQILRERVNK 0.99441 -8.5848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9926 0 0 10.8939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07332 FES_HUMAN "Tyrosine-protein kinase Fes/Fps, EC 2.7.10.2 (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes)" FES FPS Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cellular response to vitamin D [GO:0071305]; centrosome cycle [GO:0007098]; chemotaxis [GO:0006935]; innate immune response [GO:0045087]; microtubule bundle formation [GO:0001578]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of mast cell degranulation [GO:0043304]; regulation of vesicle-mediated transport [GO:0060627]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; immunoglobulin receptor binding [GO:0034987]; microtubule binding [GO:0008017]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol binding [GO:0035091]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cellular response to vitamin D [GO:0071305]; centrosome cycle [GO:0007098]; chemotaxis [GO:0006935]; innate immune response [GO:0045087]; microtubule bundle formation [GO:0001578]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of neuron projection development [GO:0010976]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of mast cell degranulation [GO:0043304]; regulation of vesicle-mediated transport [GO:0060627]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001578; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0006935; GO:0007098; GO:0007155; GO:0007169; GO:0008017; GO:0008360; GO:0010976; GO:0015630; GO:0018108; GO:0030154; GO:0030155; GO:0031116; GO:0031234; GO:0031410; GO:0034987; GO:0035091; GO:0042127; GO:0043304; GO:0045087; GO:0045595; GO:0045639; GO:0045657; GO:0046777; GO:0060627; GO:0071305; GO:2000145; GO:2000251 ATP binding [GO:0005524]; immunoglobulin receptor binding [GO:0034987]; microtubule binding [GO:0008017]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol binding [GO:0035091]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] FLQEARILK 0.99441 -15.662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4768 0 0 10.3699 0 0 0 0 0 0 0 10.3844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1024 0 14.7067 0 0 0 0 0 0 13.2623 0 14.7983 0 13.9637 13.4779 13.595 0 0 14.1926 13.6203 13.1204 0 12.9451 13.7757 13.7946 12.7107 0 0 0 0 13.7083 14.2974 0 12.9303 0 0 0 13.0377 0 0 0 0 13.7356 0 0 0 0 0 0 0 0 0 13.3009 0 12.9479 0 0 0 13.2291 0 0 0 12.05 0 0 0 0 0 0 12.6339 0 0 13.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3381 0 0 0 0 0 0 0 0 0 P07942 LAMB1_HUMAN Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta) LAMB1 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888] GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005788; GO:0007155; GO:0009887; GO:0009888; GO:0016477; GO:0021812; GO:0030335; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0050679; GO:0051149; GO:0062023; GO:0070062; GO:0070831; GO:0098637; GO:0110011; GO:2001046 extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198] ACDCDPRGIETPQCDQSTGQCVCVEGVEGPR 0.99441 -11.133 0 0 0 0 0 0 0 0 12.0834 0 10.893 12.4239 13.3882 13.3552 0 0 0 0 0 0 13.3845 0 0 0 0 0 14.1134 11.1655 0 0 0 0 0 0 0 12.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9614 0 13.7738 0 0 0 0 0 0 0 13.6 0 12.794 14.6676 0 0 0 12.0815 0 0 0 13.3552 0 15.6088 14.634 12.1084 12.3535 13.6032 0 14.7249 14.4191 15.8802 0 14.232 13.6387 15.6712 16.0346 0 15.4014 12.4962 15.6934 0 15.7545 12.0364 15.2122 0 0 0 12.1742 0 13.6648 0 0 13.3813 10.7405 12.095 13.165 0 0 0 0 11.5562 11.5249 15.8866 17.5214 0 0 0 0 0 0 0 10.0729 11.3314 0 0 0 0 0 11.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1956 0 0 0 0 15.1708 0 15.5766 0 0 0 0 0 P0C264 SBK3_HUMAN "Uncharacterized serine/threonine-protein kinase SBK3, EC 2.7.11.1 (SH3-binding domain kinase family member 3) (Sugen kinase 110)" SBK3 SGK110 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0004674; GO:0005524; GO:0006468; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DLVLRSTFLR 0.99441 -9.0759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4629 0 0 0 0 0 0 10.8186 10.5418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8879 0 0 0 11.3265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5873 0 0 0 14.5238 0 0 0 14.6064 0 0 0 0 13.8789 0 0 0 0 0 14.0695 0 0 0 0 14.2792 13.2327 0 13.5882 0 0 14.705 14.4025 0 0 0 0 14.453 0 0 0 0 0 0 14.2501 0 0 0 14.6111 0 0 0 0 0 0 0 12.7346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.943 0 0 13.8139 0 0 0 0 0 P30876 RPB2_HUMAN "DNA-directed RNA polymerase II subunit RPB2, EC 2.7.7.6 (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)" POLR2B Homo sapiens (Human) transcription by RNA polymerase II [GO:0006366] "membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]" "membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; transcription by RNA polymerase II [GO:0006366]" GO:0003677; GO:0003682; GO:0003723; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0006366; GO:0016020; GO:0032549; GO:0046872 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723] EGEEQLQTQHQKTFIGK 0.99441 -13.836 0 0 0 0 0 0 0 13.9419 0 12.6589 0 0 0 0 0 0 0 0 0 13.1072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0546 0 0 0 0 13.2155 0 0 0 0 10.637 12.1133 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0895 12.8472 0 0 0 0 0 0 0 0 0 15.8809 0 15.4135 13.2629 12.7564 0 0 14.596 0 0 0 13.3386 11.9869 16.1308 0 0 14.8651 0 13.5132 15.4821 0 0 0 0 0 13.9874 13.0236 0 14.0537 0 0 0 0 14.15 0 0 13.5159 0 16.421 0 14.7419 0 0 0 12.7287 0 13.5314 0 0 0 0 13.2354 0 0 0 0 0 0 0 0 13.9958 0 12.5993 13.3493 0 0 13.5986 0 0 0 0 0 14.8842 0 0 16.0657 0 10.8221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14451 GRB7_HUMAN Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein) GRB7 Homo sapiens (Human) epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of translation [GO:0017148]; positive regulation of cell migration [GO:0030335]; stress granule assembly [GO:0034063] cell projection [GO:0042995]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] cell projection [GO:0042995]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of translation [GO:0017148]; positive regulation of cell migration [GO:0030335]; stress granule assembly [GO:0034063] GO:0003723; GO:0005829; GO:0005886; GO:0005925; GO:0007173; GO:0010494; GO:0017148; GO:0019901; GO:0030335; GO:0034063; GO:0035091; GO:0042802; GO:0042995 identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] FFCFLRR 0.99441 -9.0778 0 0 0 0 0 0 0 0 13.3264 0 0 0 0 0 0 14.3613 0 0 0 0 0 0 0 14.663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9701 0 0 0 0 0 0 0 0 0 0 14.7108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4365 0 0 Q17RD7 SYT16_HUMAN Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein) SYT16 STREP14 SYT14L SYT14R Homo sapiens (Human) exocytosis [GO:0006887] identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; exocytosis [GO:0006887] GO:0005543; GO:0006887; GO:0042802 identical protein binding [GO:0042802]; phospholipid binding [GO:0005543] APDTYGKLFLLNSVGQEMSRCK 0.99441 -8.3507 0 0 0 0 10.594 0 0 0 0 0 0 0 0 0 0 0 13.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9906 0 12.7335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5882 9.81986 0 13.9441 0 0 0 0 0 0 0 0 0 13.6192 13.9761 0 0 0 12.7508 0 0 0 0 0 0 0 0 16.345 0 0 0 0 14.1612 0 0 13.4818 0 0 0 0 0 0 0 0 13.5565 10.6971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8934 0 0 0 0 0 0 13.495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68D06 SLN13_HUMAN "Schlafen family member 13, EC 3.1.-.- (Schlafen-13, hSLFN13)" SLFN13 Homo sapiens (Human) defense response to virus [GO:0051607]; rRNA catabolic process [GO:0016075]; tRNA catabolic process [GO:0016078] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; rRNA catabolic process [GO:0016075]; tRNA catabolic process [GO:0016078] GO:0000049; GO:0004521; GO:0005524; GO:0005737; GO:0008270; GO:0016075; GO:0016078; GO:0051607 ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] DVAVLVSTVTEVEQYQSKLLK 0.99441 -15.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2126 0 0 0 0 0 0 0 10.8693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0474 0 14.2933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0005 0 0 0 0 0 15.4441 0 0 11.9775 14.9919 0 0 0 10.7434 0 0 0 0 0 0 14.3792 0 0 0 0 0 0 0 0 11.4256 0 0 0 0 13.0856 0 0 14.0255 0 0 0 0 14.1286 0 0 0 0 0 0 0 0 12.486 0 0 0 0 0 15.9275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3I7 ZN572_HUMAN Zinc finger protein 572 ZNF572 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CFCNSSHLIQHLRMHTGEK 0.99441 -9.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3531 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9097 0 13.9709 0 12.7172 11.673 14.7492 14.9256 14.1521 12.923 14.7895 13.9327 0 0 0 13.6331 13.2281 0 0 12.9303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8067 15.2874 0 0 0 0 12.5249 0 0 10.9794 11.7323 0 0 0 0 0 11.8506 0 0 0 0 0 0 15.1978 15.0532 0 0 0 0 12.0242 0 0 0 12.2798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5382 11.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VE9 SERC5_HUMAN Serine incorporator 5 SERINC5 C5orf12 Homo sapiens (Human) defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; myelination [GO:0042552]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; L-serine transmembrane transporter activity [GO:0015194]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; myelination [GO:0042552]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222]; sphingolipid metabolic process [GO:0006665] GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0006564; GO:0006658; GO:0006665; GO:0008654; GO:0009597; GO:0015194; GO:0016020; GO:0016021; GO:0042552; GO:0043209; GO:0043231; GO:0045087; GO:0048471; GO:0051607; GO:0070062; GO:1904219; GO:1904222 L-serine transmembrane transporter activity [GO:0015194] DSCMENK 0.99441 -8.5792 0 0 0 0 0 0 0 0 0 0 0 0 12.6973 0 12.4413 0 0 0 11.5412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9096 0 0 11.3703 0 0 0 0 0 0 11.8817 0 0 0 0 0 10.5294 0 0 0 0 0 0 0 0 0 0 0 15.2974 13.814 13.7558 0 13.4357 14.7367 0 0 0 14.2164 0 0 0 13.5747 14.7838 0 0 14.8809 0 14.4076 15.4534 14.5436 15.0406 14.7427 14.6954 14.7493 14.729 15.0484 0 14.0178 15.615 0 0 11.9612 13.6155 0 14.4935 0 0 0 13.7496 0 0 0 15.1561 15.5735 0 0 15.4141 0 0 0 0 0 12.1042 0 0 0 0 0 13.8072 14.0295 0 0 12.726 12.6086 12.3186 13.5583 14.7827 15.0532 11.2867 13.2266 0 15.0264 15.8663 0 14.0003 0 15.7841 0 0 0 0 0 0 14.3482 14.6252 15.0205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4217 0 13.6907 0 0 0 0 0 0 Q8IX29 FBX16_HUMAN F-box only protein 16 FBXO16 FBX16 Homo sapiens (Human) CAQVCWHWK 0.99441 -13.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2699 14.3591 14.3663 0 0 0 0 0 11.6361 0 0 0 0 0 0 0 0 14.5806 0 11.3567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6027 0 0 0 0 0 0 0 0 0 0 0 Q8IYS0 ASTRC_HUMAN Protein Aster-C (GRAM domain-containing protein 1C) GRAMD1C UNQ2543/PRO6095 Homo sapiens (Human) cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366] GO:0005789; GO:0005886; GO:0015485; GO:0016021; GO:0032366; GO:0032934; GO:0071397; GO:0120015; GO:0120020; GO:0140268 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015] DILLQGRLYLSENWLCFYSNIFR 0.99441 -15.62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6057 0 0 0 0 0 0 0 0 0 0 0 0 13.5791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6R1 SERP2_HUMAN Stress-associated endoplasmic reticulum protein 2 (Ribosome-associated membrane protein RAMP4-2) SERP2 C13orf21 Homo sapiens (Human) endoplasmic reticulum unfolded protein response [GO:0030968]; protein glycosylation [GO:0006486]; protein transport [GO:0015031] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein glycosylation [GO:0006486]; protein transport [GO:0015031] GO:0005789; GO:0006486; GO:0015031; GO:0016021; GO:0030968 IRMANEKHSK 0.99441 -9.3486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1404 14.3356 14.4811 0 0 0 0 0 0 0 0 0 14.1437 0 14.1737 0 0 0 0 0 11.1156 0 0 0 0 0 0 0 0 0 0 14.4699 0 0 14.1922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4572 0 0 0 0 0 12.9966 14.9728 14.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAQ9 SUN3_HUMAN SUN domain-containing protein 3 (Sad1/unc-84 domain-containing protein 1) SUN3 SUNC1 Homo sapiens (Human) nuclear envelope organization [GO:0006998] integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635] integral component of nuclear inner membrane [GO:0005639]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; protein-membrane adaptor activity [GO:0043495]; nuclear envelope organization [GO:0006998] GO:0005635; GO:0005639; GO:0006998; GO:0034993; GO:0043495 protein-membrane adaptor activity [GO:0043495] ALLRDMK 0.99441 -15.641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2688 0 0 0 0 0 0 0 13.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0853 0 14.5947 0 0 0 0 13.0691 0 0 0 0 0 0 0 0 0 15.8741 0 0 0 0 0 0 0 0 13.3719 0 0 0 13.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.593 0 12.9684 0 0 0 0 12.8366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EL2 RT24_HUMAN "28S ribosomal protein S24, mitochondrial, MRP-S24, S24mt (Mitochondrial small ribosomal subunit protein uS3m) (bMRP-47, bMRP47)" MRPS24 HSPC335 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] NRAARVR 0.99441 -15.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVV2 FND11_HUMAN Fibronectin type III domain-containing protein 11 FNDC11 C20orf195 Homo sapiens (Human) HLALGDQNPLVLPSALFQLIDPWK 0.99441 -8.5923 13.1573 0 0 0 0 0 0 0 0 0 0 0 10.8396 0 0 0 0 0 0 0 0 10.7726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6634 0 0 0 0 0 0 0 0 0 11.6373 0 0 0 0 0 13.1918 0 0 0 0 0 0 0 0 0 11.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5748 0 17.2484 0 12.7438 0 14.1463 0 14.6657 14.7191 13.6481 14.7997 0 0 14.4433 13.708 0 0 0 14.2785 0 0 14.4232 15.2214 0 0 0 13.1701 14.3954 0 0 0 0 0 0 0 0 13.4602 0 0 0 0 0 0 0 0 13.5271 12.1923 0 12.9063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4076 0 0 0 13.5234 0 13.1078 0 13.1753 0 15.5042 0 0 0 0 0 0 13.1759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXU7 UBP26_HUMAN "Ubiquitin carboxyl-terminal hydrolase 26, EC 3.4.19.12 (Deubiquitinating enzyme 26) (Ubiquitin thioesterase 26) (Ubiquitin-specific-processing protease 26)" USP26 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G1/S transition of mitotic cell cycle [GO:0000082]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] EMLLLNLK 0.99441 -15.598 0 0 0 0 0 0 0 0 0 0 0 0 12.8468 11.9794 0 0 0 0 0 0 0 0 0 11.5955 0 0 0 0 0 0 0 11.4552 0 0 0 0 0 11.3506 0 0 0 0 15.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 10.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0372 0 0 0 13.3582 0 0 0 0 13.5287 0 11.4603 14.1528 13.2149 12.9625 0 0 14.699 0 15.0404 0 0 0 0 0 12.8848 0 0 0 13.2662 0 0 0 0 12.7716 0 13.7465 0 0 13.5243 0 0 0 12.6939 13.0465 0 0 0 0 12.8048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.663 0 0 12.548 13.1592 12.2846 15.0644 0 12.579 0 0 Q9H158 PCDC1_HUMAN "Protocadherin alpha-C1, PCDH-alpha-C1" PCDHAC1 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] ATHLLVLTAR 0.99441 -13.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2044 0 0 0 0 0 13.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9247 13.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0859 0 0 13.2628 13.6295 0 0 0 0 0 0 14.356 0 0 14.6621 0 0 0 0 0 0 0 0 0 0 0 10.6582 0 13.2624 13.4318 12.3814 0 0 0 0 0 0 0 0 0 0 0 13.8946 0 12.7591 0 0 0 0 0 0 0 0 0 0 10.7396 0 0 0 0 0 0 14.0111 15.5133 0 0 0 0 0 0 Q9H1J5 WNT8A_HUMAN Protein Wnt-8a (Protein Wnt-8d) WNT8A WNT8D Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; cell fate commitment [GO:0045165]; neural crest cell fate commitment [GO:0014034]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to retinoic acid [GO:0032526]; secondary palate development [GO:0062009] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; anterior/posterior axis specification [GO:0009948]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; cell fate commitment [GO:0045165]; neural crest cell fate commitment [GO:0014034]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to retinoic acid [GO:0032526]; secondary palate development [GO:0062009] GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0009948; GO:0014034; GO:0030182; GO:0032526; GO:0044335; GO:0045165; GO:0045944; GO:0048018; GO:0060070; GO:0061317; GO:0062009; GO:0062023 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] FQFAWER 0.99441 -15.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6115 0 0 0 0 0 0 0 0 0 11.4389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4282 0 0 0 0 0 0 0 0 0 0 13.3879 0 0 0 14.4781 0 0 0 0 0 0 0 0 0 0 0 0 14.0971 0 0 0 0 0 0 0 0 13.7841 0 12.7112 0 0 0 0 14.4232 0 0 0 0 0 0 0 0 0 0 0 11.3801 0 0 0 0 12.3204 0 0 0 0 0 0 0 0 0 0 14.4084 12.5139 0 0 0 0 0 0 0 0 0 0 0 10.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZU5 LMCD1_HUMAN LIM and cysteine-rich domains protein 1 (Dyxin) LMCD1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; regulation of cardiac muscle hypertrophy [GO:0010611] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; regulation of cardiac muscle hypertrophy [GO:0010611] GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0010611; GO:0070886 transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270] CSGCDEIIFAEDYQR 0.99441 -8.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPQ7 PZRN3_HUMAN "E3 ubiquitin-protein ligase PDZRN3, EC 2.3.2.27 (Ligand of Numb protein X 3) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3, Protein SEMACAP3)" PDZRN3 KIAA1095 LNX3 SEMCAP3 Homo sapiens (Human) neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005737; GO:0007528; GO:0008270; GO:0016567; GO:0031594; GO:0061630; GO:0070161 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] EERSGMTTDDDAVSEMK 0.99441 -9.3413 0 0 0 0 0 0 0 0 0 0 0 0 14.4619 0 11.054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7841 0 0 0 0 0 0 0 0 0 0 0 14.6773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4613 0 0 0 0 12.9049 0 0 12.8451 0 0 0 0 0 0 0 0 12.2644 0 0 12.7171 0 0 0 0 0 0 0 0 0 0 15.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2M0 FAN1_HUMAN "Fanconi-associated nuclease 1, EC 3.1.21.-, EC 3.1.4.1 (FANCD2/FANCI-associated nuclease 1, hFAN1) (Myotubularin-related protein 15)" FAN1 KIAA1018 MTMR15 Homo sapiens (Human) DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; magnesium ion binding [GO:0000287]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289] GO:0000287; GO:0000724; GO:0004528; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006289; GO:0008409; GO:0017108; GO:0036297; GO:0045171; GO:0070336; GO:0140036 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; magnesium ion binding [GO:0000287]; phosphodiesterase I activity [GO:0004528]; ubiquitin-dependent protein binding [GO:0140036] AKALAGQSVR 0.99441 -11.132 0 0 0 0 0 0 0 0 0 10.7874 0 0 0 0 0 10.3329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5292 11.0127 0 0 0 0 0 0 0 0 0 0 0 11.5091 13.6554 0 13.6373 13.4029 12.8082 11.4107 0 0 20.7368 0 0 0 14.2945 14.5937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.569 0 13.7816 0 14.5529 0 0 0 0 14.4946 0 0 0 14.1364 0 0 0 11.1469 0 0 0 12.1921 0 12.7094 0 0 0 0 0 13.9987 10.4187 0 12.8133 13.8812 12.6879 13.3941 0 9.48832 13.0205 0 14.2773 0 0 10.4027 0 0 0 0 0 0 0 0 0 0 0 14.3299 0 0 0 0 0 0 0 11.1168 14.757 0 14.1578 0 0 0 0 0 0 10.772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5F8 PCDGJ_HUMAN "Protocadherin gamma-B7, PCDH-gamma-B7" PCDHGB7 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] CELQLEAVVENPLNIFHVIVVIEDVNDHAPQFR 0.99441 -9.3391 0 0 0 12.1266 0 11.3423 0 0 0 0 0 0 0 13.2539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.403 0 0 0 12.3228 0 0 0 0 0 0 0 13.166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9723 0 0 0 14.0048 12.6174 0 13.0451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6H8 CXA3_HUMAN "Gap junction alpha-3 protein (Connexin-46, Cx46)" GJA3 Homo sapiens (Human) cell-cell signaling [GO:0007267]; gap junction-mediated intercellular transport [GO:1990349]; visual perception [GO:0007601] connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887] connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; cell-cell signaling [GO:0007267]; gap junction-mediated intercellular transport [GO:1990349]; visual perception [GO:0007601] GO:0005243; GO:0005887; GO:0005922; GO:0007267; GO:0007601; GO:0055077; GO:1990349 gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077] EEEEQLK 0.99441 -9.3465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9567 12.8679 0 13.2405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4242 0 0 0 0 0 0 0 15.5135 13.7162 0 15.8347 13.7444 0 0 13.2963 0 0 13.4616 0 0 12.5817 0 0 0 0 0 0 0 0 13.2319 14.7573 14.0078 0 0 0 0 12.8656 12.6589 13.7248 12.9856 14.287 0 0 0 0 13.2291 0 0 0 0 13.5269 0 12.6847 0 13.5274 0 0 12.9022 14.4187 0 0 13.8769 14.6504 14.6197 14.6199 14.3516 0 0 13.9403 12.8652 0 0 14.5612 0 0 0 14.3414 12.8657 0 0 0 0 0 15.365 13.9225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6R9 CCD61_HUMAN Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog) CCDC61 Homo sapiens (Human) cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815] centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307] GO:0005737; GO:0005813; GO:0005815; GO:0008017; GO:0030030; GO:0034451; GO:0036064; GO:0042802; GO:0090307; GO:0098534; GO:0120103 identical protein binding [GO:0042802]; microtubule binding [GO:0008017] GVEHAVR 0.99441 -9.3385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1026 0 0 0 0 0 10.9581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7031 0 0 0 11.0015 0 0 0 0 0 11.751 0 14.3323 0 0 0 0 0 0 0 0 0 0 0 11.979 0 0 0 15.2121 0 0 0 0 0 0 0 0 11.9299 0 0 0 0 11.0226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8786 13.8386 Q00987 MDM2_HUMAN "E3 ubiquitin-protein ligase Mdm2, EC 2.3.2.27 (Double minute 2 protein, Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2)" MDM2 Homo sapiens (Human) "amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; cellular response to actinomycin D [GO:0072717]; cellular response to gamma radiation [GO:0071480]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endocardial cushion morphogenesis [GO:0003203]; establishment of protein localization [GO:0045184]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein localization to nucleus [GO:0034504]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of protein catabolic process [GO:0042176]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; transcription factor catabolic process [GO:0036369]; traversing start control point of mitotic cell cycle [GO:0007089]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; 5S rRNA binding [GO:0008097]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ligase activity [GO:0016874]; NEDD8 ligase activity [GO:0061663]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; ribonucleoprotein complex binding [GO:0043021]; SUMO transferase activity [GO:0019789]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; cellular response to actinomycin D [GO:0072717]; cellular response to gamma radiation [GO:0071480]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endocardial cushion morphogenesis [GO:0003203]; establishment of protein localization [GO:0045184]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein localization to nucleus [GO:0034504]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of heart rate [GO:0002027]; regulation of protein catabolic process [GO:0042176]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; transcription factor catabolic process [GO:0036369]; traversing start control point of mitotic cell cycle [GO:0007089]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281]" GO:0000122; GO:0000209; GO:0001568; GO:0001974; GO:0002027; GO:0002039; GO:0003181; GO:0003203; GO:0003281; GO:0003283; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0006511; GO:0006915; GO:0006977; GO:0007089; GO:0008097; GO:0008270; GO:0008284; GO:0016567; GO:0016874; GO:0017053; GO:0019789; GO:0019899; GO:0019904; GO:0030666; GO:0031625; GO:0031648; GO:0032436; GO:0032991; GO:0034504; GO:0036369; GO:0042176; GO:0042802; GO:0043021; GO:0043130; GO:0043161; GO:0043518; GO:0045184; GO:0045892; GO:0045931; GO:0046677; GO:0047485; GO:0051149; GO:0051603; GO:0051726; GO:0051865; GO:0060411; GO:0061630; GO:0061663; GO:0065003; GO:0071456; GO:0071480; GO:0072717; GO:0097718; GO:1901797; GO:1902254; GO:1990000 5S rRNA binding [GO:0008097]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ligase activity [GO:0016874]; NEDD8 ligase activity [GO:0061663]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; protein N-terminus binding [GO:0047485]; ribonucleoprotein complex binding [GO:0043021]; SUMO transferase activity [GO:0019789]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CTSCNEMNPPLPSHCNRCWALR 0.99442 -11.504 16.4131 16.411 15.966 11.7034 13.9149 13.094 17.1064 17.388 13.5458 14.0201 12.3022 15.1047 12.5971 15.8798 14.4761 12.2884 13.4625 0 12.5827 13.0542 11.5333 16.2872 11.4129 16.7755 0 12.3101 11.4943 14.3565 14.1825 14.3967 15.0273 13.6745 15.2668 11.4755 12.8937 15.4868 12.9255 12.4085 12.7982 13.8232 14.0011 12.8915 14.0513 0 0 12.4737 13.9758 12.9215 13.8424 13.8432 14.5485 13.8819 14.9963 14.1367 13.7028 12.4468 13.1716 12.7865 0 0 0 13.2711 0 11.861 12.7967 14.3793 13.4957 17.02 17.3119 0 17.3058 14.5043 14.3676 17.2219 17.987 17.9042 18.0562 18.313 18.0667 17.6523 17.5767 14.3749 16.8149 17.0607 18.3467 18.3325 17.8118 18.9081 17.4685 18.6933 18.1504 18.8221 18.2823 18.4166 19.4463 18.0115 18.531 17.5789 18.2018 19.1478 18.4798 19.052 18.7261 18.8916 18.5586 18.57 19.228 18.3788 18.8648 18.439 17.8265 18.1138 18.4767 18.2971 18.2911 15.7868 17.4472 17.7407 17.6274 18.3608 17.7718 18.0806 17.8637 18.5706 18.3819 17.5321 17.6329 18.2109 17.7978 18.3925 17.8231 18.1937 17.728 17.7694 18.2738 17.5659 17.452 17.5292 18.0634 18.6198 18.2201 18.0759 18.2252 17.5649 18.1106 17.7521 18.0369 15.7134 14.2149 0 16.9886 15.7589 15.4692 17.5724 17.5973 17.7881 18.0549 16.3468 15.7789 15.9965 13.5315 15.9741 15.0117 15.6048 15.8286 16.6493 15.6107 15.0405 15.3695 15.7934 16.1147 16.8776 17.5726 18.2951 17.939 16.5193 0 16.7236 16.7407 0 Q6PD62 CTR9_HUMAN RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1) CTR9 KIAA0155 SH2BP1 Homo sapiens (Human) "blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]" Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] "Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169]; blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone H3-K4 trimethylation [GO:0080182]; histone monoubiquitination [GO:0010390]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of genetic imprinting [GO:2000653]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription, DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]" GO:0000122; GO:0000791; GO:0000993; GO:0001711; GO:0001826; GO:0001829; GO:0001832; GO:0001835; GO:0005654; GO:0006355; GO:0006368; GO:0007259; GO:0010390; GO:0016055; GO:0016593; GO:0016607; GO:0019827; GO:0033523; GO:0042169; GO:0045638; GO:0051569; GO:0051571; GO:0070102; GO:0071222; GO:0080182; GO:2000653; GO:2001162 RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169] CASSESDSDENQNKSGSEAGSPR 0.99442 -8.6104 0 0 0 0 12.1271 0 0 0 0 0 0 11.3342 0 10.5118 0 13.1382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6607 0 0 0 0 0 0 0 0 0 12.7765 0 12.4345 0 0 0 0 0 0 0 0 0 0 0 0 12.997 0 0 0 0 0 0 0 0 11.9242 12.5578 0 0 13.0792 15.3732 0 0 13.4221 13.2909 13.6719 0 11.1821 0 0 13.9064 11.091 0 0 0 0 0 0 0 0 12.9662 0 0 13.9225 0 0 10.0222 0 0 0 13.9756 12.414 11.8331 12.9437 15.1962 0 13.9524 14.3744 14.2543 14.3865 14.0823 13.5475 13.9643 13.9929 13.6502 0 0 0 13.8573 0 15.7154 11.7792 0 13.3188 13.7332 14.7318 0 0 14.9521 15.463 14.4028 13.2396 14.2688 13.1355 14.9357 0 0 0 0 0 0 13.9825 0 12.9558 12.3889 0 12.5157 0 0 0 0 15.6397 0 0 0 0 0 16.4482 0 0 0 0 13.8916 0 13.2808 0 0 0 0 0 O15439 MRP4_HUMAN "ATP-binding cassette sub-family C member 4, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B, MOAT-B) (Multidrug resistance-associated protein 4)" ABCC4 MOATB MRP4 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855] GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016404; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910] ALRLSNMAMGK 0.99442 -9.3882 0 0 0 0 0 0 0 0 14.087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3526 0 0 0 0 0 0 0 0 0 0 0 12.2577 0 0 0 0 0 0 0 0 0 0 13.979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5007 0 0 0 0 0 0 0 11.6147 0 0 0 0 0 0 0 0 0 14.0539 16.2354 16.7878 0 0 15.8156 15.623 0 0 0 16.3133 0 0 0 11.6269 0 12.1349 0 13.2969 0 0 0 0 0 0 15.6067 0 15.4276 15.2085 14.5663 0 0 14.9149 14.5154 0 0 0 0 15.1716 15.2621 14.5424 0 0 13.9312 0 14.0185 14.2673 0 0 0 0 0 15.7817 0 0 0 14.1493 0 0 0 0 0 0 0 0 0 0 13.1469 0 14.9211 13.2013 0 0 11.9702 12.859 0 O43149 ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 ZZEF1 KIAA0399 Homo sapiens (Human) calcium ion binding [GO:0005509]; histone reader activity [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] GO:0005509; GO:0008270; GO:0035064; GO:0070577; GO:0140566 calcium ion binding [GO:0005509]; histone reader activity [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] AHGFEEIRATFLQTDLLKLLVK 0.99442 -8.6141 11.5741 0 0 0 0 0 12.5226 0 11.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1681 0 0 0 0 0 0 0 0 0 12.0638 0 0 0 0 0 0 0 11.4229 0 0 0 0 0 0 0 0 0 0 0 0 13.5141 11.8375 0 0 0 0 0 0 0 11.7202 0 0 0 10.9405 0 0 0 0 0 11.5673 11.5699 0 0 11.075 14.184 15.3979 13.8508 15.3223 15.0638 16.9227 0 13.0978 0 0 0 14.8945 15.5159 0 15.2838 0 12.5686 15.3892 14.5008 15.3689 0 0 0 14.0294 13.9835 14.9541 13.8805 15.0211 14.3462 13.7501 14.2838 0 13.6355 13.8904 12.7669 15.0723 14.6213 14.8969 0 15.2861 13.7851 14.3325 15.687 15.6713 14.7481 15.1174 14.7242 0 11.3736 0 0 13.1097 11.3218 13.9049 0 0 0 0 10.8941 13.7223 0 14.4214 13.8505 0 0 0 11.3082 0 0 0 0 14.0206 16.3761 13.3358 14.5077 13.7992 0 13.2729 15.8094 0 13.9858 0 0 13.9877 12.2474 12.1946 0 0 0 0 0 0 0 13.107 0 0 0 14.629 0 10.9495 0 13.1986 10.6997 O43679 LDB2_HUMAN "LIM domain-binding protein 2, LDB-2 (Carboxyl-terminal LIM domain-binding protein 1, CLIM-1) (LIM domain-binding factor CLIM1)" LDB2 CLIM1 Homo sapiens (Human) cellular component biogenesis [GO:0044085]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019] cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; transcription coregulator activity [GO:0003712]; cellular component biogenesis [GO:0044085]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019] GO:0000122; GO:0001942; GO:0003712; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005886; GO:0007399; GO:0010669; GO:0019899; GO:0030274; GO:0030334; GO:0031252; GO:0035019; GO:0043549; GO:0044085; GO:0044089; GO:0045944 enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; transcription coregulator activity [GO:0003712] DCLKTCLFQK 0.99442 -8.6338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.301 0 0 0 11.301 0 13.2032 0 0 0 0 0 0 0 0 0 12.7406 0 0 0 0 0 10.8622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5861 0 0 0 0 0 0 0 0 0 0 14.5341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6086 0 0 0 0 12.6277 0 12.2724 0 0 0 0 0 0 13.1426 0 0 0 0 0 0 0 0 0 0 0 12.5567 0 0 0 0 0 0 0 12.5293 0 13.1829 0 0 12.0207 11.7422 0 0 0 0 14.4962 0 0 12.667 0 12.9683 0 0 15.2703 14.2184 0 0 0 10.8563 0 0 0 0 0 13.528 0 14.5014 11.7827 0 P03951 FA11_HUMAN "Coagulation factor XI, FXI, EC 3.4.21.27 (Plasma thromboplastin antecedent, PTA) [Cleaved into: Coagulation factor XIa heavy chain; Coagulation factor XIa light chain ]" F11 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370] "extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; serine-type aminopeptidase activity [GO:0070009]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0008201; GO:0016020; GO:0031638; GO:0031639; GO:0042802; GO:0051919; GO:0070009; GO:0070062; GO:1905370 heparin binding [GO:0008201]; identical protein binding [GO:0042802]; serine-type aminopeptidase activity [GO:0070009]; serine-type endopeptidase activity [GO:0004252] DACKGDSGGPLSCK 0.99442 -11.501 0 0 0 11.4503 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6065 0 0 0 0 0 13.6041 0 0 0 0 0 0 13.0984 0 0 0 0 0 0 0 0 0 0 0 13.1508 0 13.3209 12.9721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3224 0 0 0 13.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.086 0 0 0 0 13.2416 0 12.4149 0 0 0 0 0 0 0 12.3619 13.2396 13.2407 0 0 0 13.033 13.0426 0 0 0 0 0 13.4891 13.2418 13.8152 0 0 0 0 0 0 0 0 0 0 0 13.9344 0 0 0 0 0 0 13.6308 0 12.4441 0 0 0 0 0 0 0 0 0 13.2352 0 0 0 0 12.5489 14.066 0 0 0 0 0 0 0 13.0033 0 0 P07305 H10_HUMAN "Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed ]" H1-0 H1F0 H1FV Homo sapiens (Human) chromosome condensation [GO:0030261]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; positive regulation of transcription regulatory region DNA binding [GO:2000679] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; positive regulation of transcription regulatory region DNA binding [GO:2000679] GO:0000785; GO:0000786; GO:0000791; GO:0003680; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0006334; GO:0015629; GO:0016604; GO:0017053; GO:0030261; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0045910; GO:2000679 chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] LSIKRLVTTGVLK 0.99442 -8.405 0 0 0 0 0 0 0 0 13.6054 0 0 0 0 13.0825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.695 0 12.8536 0 12.399 0 13.7926 13.4516 0 13.4546 12.2985 12.1105 13.9335 0 0 0 13.933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5167 0 0 0 0 13.4766 0 14.2216 0 14.6125 13.7245 13.8254 10.6618 13.5017 0 0 0 0 0 13.6897 0 13.459 0 0 P16860 ANFB_HUMAN "Natriuretic peptides B (Brain natriuretic factor prohormone, preproBNP, proBNP) (Gamma-brain natriuretic peptide) (Iso-ANP) [Cleaved into: NT-proBNP (NT-pro-BNP) (NT-proBNP(1-76)); proBNP(3-108); Brain natriuretic peptide 32, BNP(1-32), BNP-32 (Brain natriuretic peptide, BNP); BNP(1-30); BNP(1-29); BNP(1-28); BNP(2-31); BNP(3-32) (des-SerPro-BNP) (proBNP(79-108)); BNP(3-30); BNP(3-29); Brain natriuretic peptide 29, BNP(4-32); BNP(4-31); BNP(4-30); BNP(4-29); BNP(4-27); BNP(5-32); BNP(5-31); BNP(5-29) ]" NPPB Homo sapiens (Human) antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cardiac conduction system development [GO:0003161]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; killing of cells of another organism [GO:0031640]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; vasodilation [GO:0042311] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; diuretic hormone activity [GO:0008613]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cardiac conduction system development [GO:0003161]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; killing of cells of another organism [GO:0031640]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; vasodilation [GO:0042311] GO:0003085; GO:0003161; GO:0005102; GO:0005179; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0006182; GO:0006457; GO:0007166; GO:0007168; GO:0007218; GO:0007589; GO:0008217; GO:0008613; GO:0016525; GO:0019934; GO:0030308; GO:0031640; GO:0032991; GO:0035810; GO:0035815; GO:0042311; GO:0043114; GO:0051427; GO:0061844; GO:0097746 diuretic hormone activity [GO:0008613]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102] DPQTAPSRALLLLLFLHLAFLGGR 0.99442 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8387 0 0 0 0 0 0 0 0 0 0 0 13.1261 0 0 14.1458 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0321 0 0 13.3614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43121 MUC18_HUMAN Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146) MCAM MUC18 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; positive regulation of cell migration [GO:0030335]; vascular wound healing [GO:0061042] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; glomerular filtration [GO:0003094]; positive regulation of cell migration [GO:0030335]; vascular wound healing [GO:0061042] GO:0001525; GO:0003094; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0005925; GO:0007155; GO:0009653; GO:0009897; GO:0016021; GO:0030335; GO:0061042 CVASVPSIPGLNR 0.99442 -8.3779 0 0 0 0 0 0 0 0 0 0 10.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9081 0 0 0 0 0 0 0 12.6513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4628 0 0 0 0 0 0 0 0 10.6033 0 0 0 0 0 0 0 0 12.7601 0 0 0 0 13.1609 0 0 0 0 0 0 0 0 0 14.8515 15.0326 0 0 0 0 0 0 0 0 0 0 0 0 12.4417 0 0 0 0 11.1481 0 0 0 0 0 0 0 0 0 0 13.9113 0 0 0 0 0 0 0 14.5757 0 14.4785 0 0 0 0 14.9148 0 0 14.837 0 0 0 14.3211 0 0 0 0 14.4383 0 0 0 14.8624 0 0 0 0 0 14.8846 14.1422 0 14.2824 0 0 12.7142 0 14.8095 0 13.8569 0 0 P57073 SOX8_HUMAN Transcription factor SOX-8 SOX8 Homo sapiens (Human) "adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hormone levels [GO:0010817]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of hormone levels [GO:0010817]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LLSESEK 0.99442 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98179 RBM3_HUMAN RNA-binding protein 3 (RNA-binding motif protein 3) (RNPL) RBM3 RNPL Homo sapiens (Human) "positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of translation [GO:0006417]; RNA processing [GO:0006396]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of translation [GO:0006417]; RNA processing [GO:0006396]" GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006396; GO:0006417; GO:0030425; GO:0043023; GO:0045727; GO:0048026 ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723] NQGGYDR 0.99442 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06455 MTG8_HUMAN Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2) RUNX1T1 AML1T1 CBFA2T1 CDR ETO MTG8 ZMYND2 Homo sapiens (Human) "negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]" nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0016363; GO:0045599; GO:0045892; GO:0046872; GO:0140297 DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] ALSLVIGDCR 0.99442 -11.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4479 0 0 0 0 12.6166 0 12.5565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4238 13.3943 0 0 0 0 0 0 14.3723 0 0 0 0 0 0 0 0 0 0 0 Q12901 ZN155_HUMAN Zinc finger protein 155 ZNF155 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASSILNHKRLHCQK 0.99442 -8.0871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6709 0 0 0 0 0 0 0 0 0 0 12.8477 0 14.164 0 0 0 0 13.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3139 0 0 0 0 12.0692 0 0 0 0 0 0 14.3001 0 0 0 0 0 0 0 0 12.5655 0 0 0 0 0 12.7351 0 0 0 0 0 0 0 0 0 0 13.2652 0 0 0 0 0 14.0357 0 0 12.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3699 0 0 0 0 0 0 0 0 0 0 0 Q15813 TBCE_HUMAN Tubulin-specific chaperone E (Tubulin-folding cofactor E) TBCE Homo sapiens (Human) adult locomotory behavior [GO:0008344]; developmental growth [GO:0048589]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; muscle atrophy [GO:0014889]; peripheral nervous system neuron axonogenesis [GO:0048936]; post-chaperonin tubulin folding pathway [GO:0007023]; post-embryonic development [GO:0009791]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874]; alpha-tubulin binding [GO:0043014]; chaperone binding [GO:0051087]; adult locomotory behavior [GO:0008344]; developmental growth [GO:0048589]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; muscle atrophy [GO:0014889]; peripheral nervous system neuron axonogenesis [GO:0048936]; post-chaperonin tubulin folding pathway [GO:0007023]; post-embryonic development [GO:0009791]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021] GO:0000226; GO:0005737; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0007052; GO:0008344; GO:0009791; GO:0014889; GO:0043014; GO:0048589; GO:0048936; GO:0051087 alpha-tubulin binding [GO:0043014]; chaperone binding [GO:0051087] GLLSRLLK 0.99442 -9.3793 0 0 0 14.4434 0 0 0 0 0 0 0 0 0 0 0 0 12.1173 13.1819 0 10.5321 0 16.0606 0 15.5102 11.7994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7855 0 19.6584 19.8359 16.7553 0 23.0092 12.0298 23.0822 23.0312 14.9095 0 13.8438 14.4383 13.1983 0 0 15.2184 13.8201 0 12.7352 0 12.7088 0 14.3915 0 0 22.1136 0 0 0 0 12.282 0 15.5522 15.6327 0 0 0 0 0 14.205 15.8358 14.67 0 15.196 15.474 15.4207 0 13.0917 0 0 0 0 15.5435 15.2883 14.7666 21.4058 0 0 0 0 14.4721 15.6631 0 0 0 0 14.5179 0 0 0 14.6446 0 0 0 21.6103 0 11.9384 22.3724 0 13.6775 0 0 12.8272 0 0 0 0 0 0 0 12.4625 0 0 0 0 0 0 0 0 0 21.4533 0 14.249 11.0188 Q52M93 Z585B_HUMAN Zinc finger protein 585B (zinc finger protein 41-like protein) ZNF585B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGKAFTQRSDLITHQR 0.99442 -15.688 0 0 0 0 0 0 0 0 0 0 0 12.6219 0 0 9.3433 0 0 11.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4905 0 0 0 0 0 0 0 15.4906 0 0 0 0 0 0 0 0 0 0 15.1332 0 0 0 0 0 0 0 0 0 0 0 Q8IVW4 CDKL3_HUMAN "Cyclin-dependent kinase-like 3, EC 2.7.11.22 (Serine/threonine-protein kinase NKIAMRE)" CDKL3 NKIAMRE Homo sapiens (Human) dendrite extension [GO:0097484]; negative regulation of axon extension [GO:0030517]; positive regulation of dendrite morphogenesis [GO:0050775]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; dendrite extension [GO:0097484]; negative regulation of axon extension [GO:0030517]; positive regulation of dendrite morphogenesis [GO:0050775]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030517; GO:0036211; GO:0050775; GO:0097484; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] EFHFPELPVTIQSK 0.99442 -11.172 0 0 0 0 0 0 0 0 0 11.8807 12.0195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5911 0 0 0 0 14.9233 0 0 0 16.9157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.488 13.2832 14.4306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8691 13.6962 13.3872 0 13.117 0 0 0 0 0 0 13.2291 0 0 0 0 0 0 0 12.9073 0 0 0 0 0 14.5927 13.1572 0 11.805 14.2762 0 13.2787 0 0 0 0 0 0 0 0 11.7804 0 0 0 0 13.975 0 0 0 0 0 0 0 Q8WWR8 NEUR4_HUMAN "Sialidase-4, EC 3.2.1.18 (N-acetyl-alpha-neuraminidase 4)" NEU4 LP5125 Homo sapiens (Human) ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; negative regulation of neuron projection development [GO:0010977]; oligosaccharide catabolic process [GO:0009313] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; organelle inner membrane [GO:0019866]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; organelle inner membrane [GO:0019866]; plasma membrane [GO:0005886]; exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; negative regulation of neuron projection development [GO:0010977]; oligosaccharide catabolic process [GO:0009313] GO:0004308; GO:0005737; GO:0005741; GO:0005743; GO:0005764; GO:0005789; GO:0005886; GO:0006516; GO:0006689; GO:0009313; GO:0010977; GO:0016020; GO:0019866; GO:0043005; GO:0043202; GO:0043231; GO:0052794; GO:0052795; GO:0052796 exo-alpha-(2->3)-sialidase activity [GO:0052794]; exo-alpha-(2->6)-sialidase activity [GO:0052795]; exo-alpha-(2->8)-sialidase activity [GO:0052796]; exo-alpha-sialidase activity [GO:0004308] ARLHMGIR 0.99442 -11.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6299 0 13.6168 13.3645 13.5638 13.5826 14.037 0 12.7534 0 13.5051 0 0 0 0 0 0 0 13.3341 0 0 0 0 0 13.4733 12.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2604 0 13.8004 0 0 12.5624 0 0 0 0 12.8313 13.0864 0 12.5783 0 0 0 13.0882 0 13.22 13.183 0 0 0 13.9912 0 0 0 0 13.5626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5739 0 0 0 0 0 0 Q96J86 CYYR1_HUMAN Cysteine and tyrosine-rich protein 1 (Proline-rich domain-containing protein) CYYR1 C21orf95 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DAPRLPVR 0.99442 -9.378 0 0 0 0 0 0 0 0 0 0 0 12.7307 12.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2423 0 0 13.6593 0 0 0 0 0 0 12.4975 0 0 13.0097 0 0 11.4669 0 0 0 0 0 0 0 12.1369 0 0 0 0 0 13.2583 0 0 0 0 0 0 0 0 13.0587 0 0 0 0 0 0 13.8581 11.9442 0 0 11.7819 0 0 0 0 0 0 0 14.4619 13.3319 14.2961 0 0 13.6768 0 0 0 0 0 12.6176 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7713 0 0 0 0 0 0 0 13.9388 0 11.0477 0 0 0 0 12.3216 0 0 0 0 0 0 0 Q99626 CDX2_HUMAN Homeobox protein CDX-2 (CDX-3) (Caudal-type homeobox protein 2) CDX2 CDX3 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; endosome to lysosome transport [GO:0008333]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intestinal epithelial cell differentiation [GO:0060575]; labyrinthine layer development [GO:0060711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; stem cell differentiation [GO:0048863]; trophectodermal cell differentiation [GO:0001829] chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification [GO:0009948]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; endosome to lysosome transport [GO:0008333]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intestinal epithelial cell differentiation [GO:0060575]; labyrinthine layer development [GO:0060711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019]; stem cell differentiation [GO:0048863]; trophectodermal cell differentiation [GO:0001829]" GO:0000122; GO:0000785; GO:0000794; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001568; GO:0001829; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008284; GO:0008327; GO:0008333; GO:0009887; GO:0009948; GO:0014807; GO:0017053; GO:0030154; GO:0035019; GO:0045197; GO:0045597; GO:0045944; GO:0048863; GO:0060575; GO:0060711; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" KPAQQSLGSQVKTR 0.99442 -8.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXU1 STK31_HUMAN "Serine/threonine-protein kinase 31, EC 2.7.11.1 (Serine/threonine-protein kinase NYD-SPK) (Sugen kinase 396, SgK396)" STK31 SGK396 Homo sapiens (Human) protein phosphorylation [GO:0006468] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DENDAGNLITFPK 0.99442 -36.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5825 0 0 14.4204 0 0 12.294 0 0 0 0 13.1811 0 12.855 0 0 13.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6148 0 0 0 15.1044 0 0 14.6349 0 14.2226 0 0 0 0 0 0 14.9519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7218 13.7481 0 0 0 0 0 0 0 0 0 12.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPA8 ENY2_HUMAN Transcription and mRNA export factor ENY2 (Enhancer of yellow 2 transcription factor homolog) ENY2 DC6 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription, DNA-templated [GO:0045893]; protein transport [GO:0015031]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]" DUBm complex [GO:0071819]; mitochondrion [GO:0005739]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; transcription factor TFTC complex [GO:0033276] "DUBm complex [GO:0071819]; mitochondrion [GO:0005739]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; transcription factor TFTC complex [GO:0033276]; chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription, DNA-templated [GO:0045893]; protein transport [GO:0015031]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000124; GO:0003682; GO:0003713; GO:0005654; GO:0005739; GO:0006282; GO:0006325; GO:0006357; GO:0006368; GO:0015031; GO:0016578; GO:0016973; GO:0030374; GO:0033276; GO:0035521; GO:0035522; GO:0043484; GO:0043966; GO:0044615; GO:0045893; GO:0070390; GO:0071819 chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713] ALVPDSVKKELLQR 0.99442 -12.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.538 0 0 0 15.9188 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6548 0 0 0 0 0 0 0 0 0 15.4751 0 0 11.019 11.1193 0 0 9.62733 0 0 0 0 0 0 0 13.2883 15.7987 0 0 0 0 0 0 0 0 0 0 0 0 11.3941 0 11.8849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQV8 PRDM8_HUMAN "PR domain zinc finger protein 8, EC 2.1.1.- (PR domain-containing protein 8)" PRDM8 PFM5 Homo sapiens (Human) "methylation [GO:0032259]; oligodendrocyte development [GO:0014003]; regulation of transcription, DNA-templated [GO:0006355]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; oligodendrocyte development [GO:0014003]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0008168; GO:0014003; GO:0016604; GO:0032259; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168] KEYAMEPLVKR 0.99442 -8.4034 0 11.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4405 0 0 0 0 0 13.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6922 13.3055 13.8766 13.087 12.1446 0 0 0 0 11.3421 0 9.63316 0 0 0 11.0291 0 0 0 0 0 0 0 0 0 0 0 0 13.4454 0 0 0 0 0 0 0 0 0 12.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4986 0 0 0 0 0 0 9.89303 0 0 0 0 0 0 13.9239 0 0 0 0 0 12.728 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKX2 MYH2_HUMAN "Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a, MyHC-2a) (Myosin heavy chain IIa, MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2)" MYH2 MYHSA2 Homo sapiens (Human) muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017] cell-cell junction [GO:0005911]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049] GO:0000146; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0005911; GO:0006936; GO:0016460; GO:0030016; GO:0030017; GO:0030049; GO:0032982; GO:0032991; GO:0051015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AVYEKMFLWMVARINQQLDTK 0.99442 -15.691 0 0 0 0 0 0 0 0 0 0 0 12.9625 0 0 12.5163 0 0 0 12.0303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.93 0 14.0465 13.4524 14.1403 13.6356 13.4805 0 12.9418 0 12.5957 0 0 11.8572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7675 0 0 12.3753 0 0 0 0 0 12.9728 12.9025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4655 0 11.9349 12.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6479 0 0 0 12.5888 12.8649 0 0 13.3048 13.0486 0 0 0 12.0657 12.5483 12.6101 0 12.9738 0 0 0 0 Q9Y2G3 AT11B_HUMAN "Phospholipid-transporting ATPase IF, EC 7.6.2.1 (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B)" ATP11B ATPIF ATPIR KIAA0956 Homo sapiens (Human) aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine floppase activity [GO:0090556]; aminophospholipid transport [GO:0015917]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; phospholipid translocation [GO:0045332] GO:0000287; GO:0005524; GO:0005637; GO:0005783; GO:0005802; GO:0005886; GO:0006811; GO:0015075; GO:0015917; GO:0016020; GO:0016021; GO:0016887; GO:0031901; GO:0034220; GO:0035577; GO:0045332; GO:0055037; GO:0055038; GO:0090555; GO:0090556; GO:0140326; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; ion transmembrane transporter activity [GO:0015075]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine floppase activity [GO:0090556] ECSINGMKYQEINGR 0.99442 -11.166 0 0 0 0 12.9225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.405 0 0 14.3007 11.7025 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3782 0 0 0 0 0 0 0 0 12.1491 0 0 0 0 0 0 0 0 0 0 0 16.0861 0 0 0 15.5504 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5341 0 0 12.7016 0 0 0 13.0327 0 0 0 0 15.9861 0 0 15.0367 0 0 0 0 0 0 0 0 0 0 13.4467 0 0 0 13.5986 0 0 0 0 0 0 0 0 0 0 12.2809 0 0 0 12.4452 13.8041 0 0 0 0 0 0 0 0 0 0 13.8375 0 0 0 Q9Y6X0 SETBP_HUMAN "SET-binding protein, SEB" SETBP1 KIAA0437 Homo sapiens (Human) "histone H3-K36 dimethylation [GO:0097676]; histone H3-K4 methylation [GO:0051568]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K4 methylation [GO:0051568]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003677; GO:0005654; GO:0005829; GO:0006355; GO:0016604; GO:0042800; GO:0051568; GO:0097676 DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800] EEERSHSKK 0.99442 -11.488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6815 0 13.4494 0 0 0 0 0 0 0 0 0 0 0 0 12.5101 0 0 11.9069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3894 10.8925 0 0 12.6884 0 0 14.4107 13.8976 15.7541 15.1602 0 0 0 14.5793 14.4516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4637 0 0 0 0 0 14.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7197 0 0 13.0866 0 14.8629 0 0 0 0 0 0 0 12.5968 13.6008 0 0 0 0 0 0 0 0 0 0 13.3863 0 0 0 0 13.0879 0 0 0 0 0 0 0 0 12.2836 12.7571 0 0 13.3977 0 0 0 0 A6NC98 CC88B_HUMAN "Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3, HkRP3)" CCDC88B BRLZ Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; defense response to protozoan [GO:0042832]; positive regulation of cytokine production [GO:0001819]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; defense response to protozoan [GO:0042832]; positive regulation of cytokine production [GO:0001819]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell proliferation [GO:0042102] GO:0001819; GO:0005654; GO:0005737; GO:0005783; GO:0005794; GO:0005813; GO:0005829; GO:0008017; GO:0016020; GO:0030705; GO:0031122; GO:0042102; GO:0042832; GO:0050870; GO:0051959 dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017] AQLEMQSQQLRESNQQLDLSACR 0.99443 -7.8871 0 13.7367 0 0 0 0 0 0 0 0 0 10.8881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0875 0 0 0 0 0 0 0 12.5565 0 12.4602 13.1878 11.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1297 14.9521 0 13.053 0 0 0 0 0 14.4457 0 0 0 0 0 0 13.5616 0 16.6527 0 14.2189 0 0 0 0 13.6726 0 0 0 0 0 0 0 0 0 13.6633 12.9129 0 14.2602 0 0 0 0 13.6267 0 0 0 12.2795 0 0 0 0 0 0 0 13.2294 0 0 12.7669 0 13.0267 12.3761 12.7919 0 14.0444 13.0515 14.6766 11.6543 0 0 13.3969 0 0 10.1042 0 0 0 0 0 0 0 0 0 0 0 0 12.2051 0 0 0 0 0 12.9576 13.7715 14.6532 0 0 0 0 0 A6NHQ2 FBLL1_HUMAN "rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1, EC 2.1.1.- (Protein-glutamine methyltransferase)" FBLL1 Homo sapiens (Human) blastocyst hatching [GO:0001835]; box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; blastocyst hatching [GO:0001835]; box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167] GO:0000494; GO:0001650; GO:0001835; GO:0003723; GO:0005654; GO:0005730; GO:0008649; GO:0015030; GO:0031167; GO:0031428; GO:0032040; GO:1990258; GO:1990259 histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649] GFGGGGR 0.99443 -15.81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0533 0 0 0 0 10.4229 0 13.6312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0919 0 0 0 0 0 0 11.2674 0 13.985 14.3938 11.9179 0 0 17.369 17.1838 17.3748 17.3845 17.3473 12.9208 0 0 17.2522 0 17.2333 17.2349 17.2399 17.1889 17.1554 0 0 0 13.3983 0 17.18 0 0 16.5786 0 16.6074 0 16.5245 0 0 0 0 0 0 0 12.6358 0 0 17.1925 0 0 0 0 0 0 0 0 0 14.9866 0 0 0 0 16.1595 0 0 0 0 0 13.6738 0 0 0 0 0 0 0 13.6899 0 0 0 15.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.906 0 0 0 0 0 0 0 P04844 RPN2_HUMAN "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II, RPN-II) (Ribophorin-2)" RPN2 Homo sapiens (Human) aging [GO:0007568]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to xenobiotic stimulus [GO:0009410] autophagosome membrane [GO:0000421]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791] autophagosome membrane [GO:0000421]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; ribosome binding [GO:0043022]; aging [GO:0007568]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to xenobiotic stimulus [GO:0009410] GO:0000421; GO:0005783; GO:0005789; GO:0005791; GO:0006487; GO:0007568; GO:0008250; GO:0009410; GO:0016020; GO:0016021; GO:0016604; GO:0018279; GO:0036211; GO:0043022 ribosome binding [GO:0043022] MLAQQAVKR 0.99443 -5.3992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43004 EAA2_HUMAN Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2) SLC1A2 EAAT2 GLT1 Homo sapiens (Human) adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632] astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; vesicle [GO:0031982] astrocyte projection [GO:0097449]; axolemma [GO:0030673]; cell body [GO:0044297]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; membrane raft [GO:0045121]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; adult behavior [GO:0030534]; cellular response to cocaine [GO:0071314]; cellular response to extracellular stimulus [GO:0031668]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; glutathione biosynthetic process [GO:0006750]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-aspartate transmembrane transport [GO:0070778]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; telencephalon development [GO:0021537]; transepithelial transport [GO:0070633]; transport across blood-brain barrier [GO:0150104]; visual behavior [GO:0007632] GO:0005313; GO:0005314; GO:0005886; GO:0005887; GO:0006750; GO:0006811; GO:0006836; GO:0007268; GO:0007632; GO:0009410; GO:0009611; GO:0009986; GO:0010259; GO:0015175; GO:0015501; GO:0015813; GO:0016020; GO:0021537; GO:0030534; GO:0030673; GO:0031668; GO:0031982; GO:0033229; GO:0035264; GO:0043200; GO:0044297; GO:0044306; GO:0045121; GO:0046326; GO:0046872; GO:0070207; GO:0070633; GO:0070778; GO:0070779; GO:0071314; GO:0097449; GO:0098712; GO:0098796; GO:0098810; GO:0098978; GO:0099056; GO:0140009; GO:0150104 cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175] KQLGPGK 0.99443 -9.4194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2175 0 12.879 0 0 0 0 0 0 0 0 0 0 11.6888 0 0 13.4238 0 0 14.7789 0 11.5157 0 0 0 0 0 0 14.63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1085 0 0 15.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7402 13.1145 0 0 0 0 0 0 0 0 0 14.679 0 0 0 0 0 0 0 13.3851 0 0 0 0 13.4534 0 0 0 0 0 14.2892 0 0 0 0 0 0 0 0 0 12.2707 0 0 0 13.0092 0 0 0 0 13.9004 0 0 0 0 0 0 0 0 0 0 11.8068 0 0 0 0 0 0 12.132 0 0 13.4075 0 0 0 0 13.1448 0 0 0 P51684 CCR6_HUMAN "C-C chemokine receptor type 6, C-C CKR-6, CC-CKR-6, CCR-6 (Chemokine receptor-like 3, CKR-L3) (DRY6) (G-protein coupled receptor 29) (GPR-CY4, GPRCY4) (LARC receptor) (CD antigen CD196)" CCR6 CKRL3 CMKBR6 GPR29 STRL22 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; DN2 thymocyte differentiation [GO:1904155]; DN3 thymocyte differentiation [GO:1904156]; humoral immune response [GO:0006959]; immune response [GO:0006955]; isotype switching to IgA isotypes [GO:0048290]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration [GO:0072676]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]; regulation of T cell migration [GO:2000404]; signal transduction [GO:0007165]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524]; sperm principal piece [GO:0097228] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524]; sperm principal piece [GO:0097228]; C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; signaling receptor activity [GO:0038023]; calcium-mediated signaling [GO:0019722]; cell chemotaxis [GO:0060326]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; DN2 thymocyte differentiation [GO:1904155]; DN3 thymocyte differentiation [GO:1904156]; humoral immune response [GO:0006959]; immune response [GO:0006955]; isotype switching to IgA isotypes [GO:0048290]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration [GO:0072676]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]; regulation of T cell migration [GO:2000404]; signal transduction [GO:0007165]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679] GO:0002407; GO:0002523; GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006955; GO:0006959; GO:0006968; GO:0007165; GO:0007204; GO:0009897; GO:0009986; GO:0016493; GO:0019722; GO:0019957; GO:0036126; GO:0038023; GO:0048290; GO:0060326; GO:0060474; GO:0072676; GO:0072678; GO:0072679; GO:0097225; GO:0097228; GO:0097524; GO:1904155; GO:1904156; GO:2000404; GO:2000510 C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; chemokine receptor activity [GO:0004950]; signaling receptor activity [GO:0038023] QTSETADNDNASSFTM 0.99443 -8.6726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3376 0 0 0 0 0 0 0 12.6431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51970 NDUA8_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD, CI-19kD) (Complex I-PGIV, CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit)" NDUFA8 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005739; GO:0005743; GO:0005747; GO:0005758; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0044877 NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein-containing complex binding [GO:0044877] AAAHHYGAQCDK 0.99443 -10.651 0 0 0 12.6488 12.531 0 12.8584 13.6375 0 0 0 0 0 0 13.1306 18.328 18.2799 18.4462 13.7586 18.6465 0 0 14.061 14.9669 13.7555 13.95 14.1013 0 0 13.3415 0 0 0 0 10.1732 0 0 0 0 0 0 0 0 0 13.8628 0 13.1954 13.5531 13.9593 14.6521 14.994 18.8616 13.6191 14.4841 14.919 13.7806 14.5233 12.3727 0 0 13.54 13.1331 12.5026 13.57 13.0198 0 14.5907 14.4087 13.7257 0 0 14.4553 18.8369 0 0 0 11.165 0 0 0 0 0 0 15.1931 0 0 0 15.1532 14.8515 16.4588 15.5135 15.9668 0 14.7364 0 0 0 15.1566 13.4504 0 0 19.6042 0 15.7364 15.7999 0 0 0 0 0 0 15.9282 0 0 0 12.9243 0 15.5196 0 0 12.9686 13.255 0 0 19.1508 0 0 0 0 0 0 0 0 15.2239 0 0 15.1153 0 0 15.2249 0 0 15.3149 12.9235 0 0 0 19.2768 11.6233 0 0 0 0 0 14.8623 0 0 15.1869 15.389 15.3656 15.2903 0 0 15.0422 15.095 0 14.8532 0 14.829 15.0613 15.2052 0 0 0 16.3689 0 0 15.0195 15.2901 0 Q15139 KPCD1_HUMAN "Serine/threonine-protein kinase D1, EC 2.7.11.13 (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu)" PRKD1 PKD PKD1 PRKCM Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; negative regulation of endocytosis [GO:0045806]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] autophagosome membrane [GO:0000421]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydroperoxide [GO:0071447]; cellular response to oxidative stress [GO:0034599]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; defense response to Gram-negative bacterium [GO:0050829]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; negative regulation of cell death [GO:0060548]; negative regulation of endocytosis [GO:0045806]; nervous system development [GO:0007399]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; regulation of integrin-mediated signaling pathway [GO:2001044]; regulation of keratinocyte proliferation [GO:0010837]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0000421; GO:0001525; GO:0001938; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005634; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0006468; GO:0006915; GO:0006954; GO:0007030; GO:0007165; GO:0007229; GO:0007265; GO:0007399; GO:0010508; GO:0010595; GO:0010837; GO:0010976; GO:0016301; GO:0018105; GO:0018107; GO:0030148; GO:0030154; GO:0031647; GO:0032793; GO:0033138; GO:0034198; GO:0034599; GO:0035556; GO:0035924; GO:0038033; GO:0042307; GO:0042802; GO:0043123; GO:0043536; GO:0043552; GO:0045087; GO:0045669; GO:0045766; GO:0045806; GO:0045944; GO:0046777; GO:0046872; GO:0048010; GO:0048193; GO:0050829; GO:0051092; GO:0051279; GO:0060548; GO:0071447; GO:0089700; GO:0106310; GO:1901727; GO:2001028; GO:2001044 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DCRFNCHK 0.99443 -9.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8761 0 0 0 0 12.4767 0 0 10.2696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7517 0 0 13.8238 0 14.9257 0 0 0 0 0 0 0 15.3945 14.2028 0 14.1648 13.5217 13.7616 14.8928 15.0676 13.003 0 0 0 13.0589 12.7852 0 0 0 0 0 11.0398 0 11.0091 0 0 0 0 0 0 0 0 0 0 0 0 13.919 0 0 0 0 0 0 0 14.0671 13.5863 0 0 0 0 0 0 0 14.5121 0 0 0 0 0 15.2778 0 0 12.5476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15526 SURF1_HUMAN Surfeit locus protein 1 SURF1 SURF-1 Homo sapiens (Human) aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; respiratory chain complex IV assembly [GO:0008535] integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; cytochrome-c oxidase activity [GO:0004129]; aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; respiratory chain complex IV assembly [GO:0008535] GO:0004129; GO:0005739; GO:0005746; GO:0008535; GO:0009060; GO:0016021; GO:0033617 cytochrome-c oxidase activity [GO:0004129] APASAAWR 0.99443 -36.806 0 0 0 0 0 0 0 0 0 0 0 11.8055 0 0 12.3168 0 0 11.982 0 11.7974 12.2602 0 0 0 11.758 0 0 0 11.9136 0 12.8363 0 0 0 0 13.0193 0 0 0 0 0 12.525 14.1026 13.1142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0316 0 0 11.6401 0 0 0 0 0 0 10.6528 0 0 0 0 0 0 0 12.8965 0 0 0 0 0 0 0 12.6184 0 0 0 0 0 0 12.6581 11.0017 0 0 12.4184 0 0 0 0 0 12.1806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2925 12.2706 0 0 0 0 0 0 0 0 0 0 0 0 12.638 13.1095 0 0 12.7671 0 0 0 13.9622 12.9043 13.426 0 0 0 12.9758 0 0 0 0 0 13.029 0 0 Q3KNV8 PCGF3_HUMAN Polycomb group RING finger protein 3 (RING finger protein 3A) PCGF3 RNF3 RNF3A Homo sapiens (Human) histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]; metal ion binding [GO:0046872]; histone H2A-K119 monoubiquitination [GO:0036353]; inactivation of X chromosome by genomic imprinting [GO:0060819]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000805; GO:0005634; GO:0005654; GO:0006357; GO:0031519; GO:0035102; GO:0036353; GO:0046872; GO:0060819 metal ion binding [GO:0046872] APLLLHYR 0.99443 -10.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1931 0 0 0 0 0 14.368 0 0 0 0 0 0 0 0 0 14.2592 14.54 0 14.8421 14.26 14.3446 0 0 0 0 0 0 13.073 0 0 0 0 0 0 0 0 0 13.3686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.894 0 0 0 0 14.7475 0 0 0 0 16.8334 0 0 0 0 0 0 0 0 0 13.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4911 0 0 0 0 16.4272 0 0 0 0 0 0 15.1649 0 Q5JSL3 DOC11_HUMAN "Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor, ACG) (Zizimin-2)" DOCK11 ZIZ2 Homo sapiens (Human) B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829] cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; B cell homeostasis [GO:0001782]; marginal zone B cell differentiation [GO:0002315]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264] GO:0001782; GO:0002315; GO:0005085; GO:0005829; GO:0007264; GO:0031267; GO:0043547; GO:0051491 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] AQSLFVKECIKTYSTDWHVVNYK 0.99443 -36.78 0 0 0 0 0 0 0 0 0 0 12.4988 0 13.2705 11.9156 12.7667 11.5025 0 0 0 0 0 0 0 0 0 0 0 12.4031 0 0 0 13.2622 11.1852 0 0 0 0 0 0 0 13.0013 0 0 0 0 0 0 0 0 0 0 15.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7127 0 0 0 10.9857 13.0161 14.213 14.07 14.2532 0 13.2798 11.6217 0 14.5621 14.777 14.3858 0 14.7729 12.9931 12.1058 11.6939 0 0 12.8551 0 0 0 12.6465 13.4861 12.5111 12.6416 0 0 13.7151 14.4549 13.2839 13.6225 16.0102 13.7773 12.4664 0 12.2003 13.9633 12.6761 13.1741 0 0 13.9311 0 0 0 16.3638 14.4909 15.5904 13.6714 13.5817 14.7055 14.1559 12.6892 0 0 0 0 0 0 13.031 12.4438 0 11.1988 14.1166 0 0 13.7751 0 14.5393 12.9404 0 14.3115 0 0 14.1954 0 0 13.3482 0 0 0 14.2346 14.0477 0 14.0407 12.9112 0 0 0 0 14.6154 0 0 10.9419 0 14.926 0 0 12.2926 0 0 14.2869 12.9066 0 0 0 0 14.5847 Q5T953 IER5L_HUMAN Immediate early response gene 5-like protein IER5L Homo sapiens (Human) GGIKLHKNLLVSYVLR 0.99443 -7.8962 0 0 0 0 0 0 0 0 0 0 13.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9428 13.8566 16.4847 0 0 0 0 0 14.0777 0 0 0 0 0 0 0 0 0 0 16.6509 0 12.3121 12.4341 12.65 0 0 13.4103 13.941 13.5701 16.1805 10.1912 0 12.8109 12.1708 0 0 0 0 0 0 0 0 0 0 0 16.8184 0 0 0 0 13.8988 0 0 0 14.333 14.367 0 0 0 0 0 0 0 0 0 11.8106 0 0 0 0 11.2553 0 0 16.4041 0 0 0 0 0 0 0 Q5VV52 ZN691_HUMAN Zinc finger protein 691 ZNF691 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ARELGDPIAHPRHEADEK 0.99443 -15.754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.048 0 0 0 0 12.5146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5265 11.7703 11.5151 0 0 0 0 0 0 0 0 0 0 0 0 11.4515 0 11.1994 0 0 0 0 0 0 0 0 11.367 0 11.3193 0 0 0 0 0 11.4686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6MZP7 LIN54_HUMAN Protein lin-54 homolog (CXC domain-containing protein 1) LIN54 CXCDC1 KIAA2037 Homo sapiens (Human) "cell cycle [GO:0007049]; nucleosome organization [GO:0034728]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067]; cell cycle [GO:0007049]; nucleosome organization [GO:0034728]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001067; GO:0003680; GO:0005634; GO:0005654; GO:0006355; GO:0007049; GO:0034728; GO:0046872; GO:0090571 metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067] AKSDPCAMNC 0.99443 -10.654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0831 0 0 0 0 0 0 0 0 0 0 12.0084 0 0 0 0 0 0 0 0 0 0 0 0 10.9633 0 0 0 0 13.35 12.7549 13.1353 0 0 0 0 0 0 0 0 0 12.4891 0 0 0 0 0 0 0 0 0 0 0 13.6659 11.982 0 0 0 12.4975 0 0 0 0 0 0 0 11.6733 0 0 0 0 0 0 0 9.77109 0 0 11.8344 0 0 0 0 0 0 0 13.7443 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2569 0 10.4843 0 0 10.4692 0 0 13.4693 0 0 10.7596 11.2892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4011 0 0 0 0 0 0 0 0 0 0 0 0 13.3817 Q6UB35 C1TM_HUMAN "Monofunctional C1-tetrahydrofolate synthase, mitochondrial, EC 6.3.4.3 (Formyltetrahydrofolate synthetase)" MTHFD1L FTHFSDC1 Homo sapiens (Human) 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999] GO:0001843; GO:0004329; GO:0004488; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006760; GO:0009257; GO:0015942; GO:0016020; GO:0035999; GO:0042803; GO:0048702; GO:0048703 ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803] AKVRLSVLER 0.99443 -7.8804 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8419 14.3406 14.8207 0 0 14.2473 0 0 0 0 0 0 0 0 0 13.3309 0 0 0 0 0 0 0 0 0 0 13.6051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYR6 TEFF1_HUMAN "Tomoregulin-1, TR-1 (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain)" TMEFF1 C9orf2 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888] GO:0005102; GO:0005604; GO:0005886; GO:0008045; GO:0009887; GO:0009888; GO:0016021; GO:0016358 signaling receptor binding [GO:0005102] ASCRCESGYTGQHCEK 0.99443 -8.1494 0 0 0 0 0 0 0 0 0 0 0 12.1825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1924 0 0 0 0 0 0 11.1401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4033 0 0 0 0 12.3933 0 0 0 0 13.4218 12.3353 0 0 0 0 0 0 0 0 0 0 13.7782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZF0 NALCN_HUMAN Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1) NALCN VGCNL1 Homo sapiens (Human) "calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]" integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; calcium ion transmembrane transport [GO:0070588]; ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]" GO:0005244; GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0016021; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034765; GO:0035725; GO:0060075; GO:0070588; GO:0071805 cation channel activity [GO:0005261]; leak channel activity [GO:0022840]; sodium channel activity [GO:0005272]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] AKMYDITQHPFFK 0.99443 -31.173 0 0 0 0 0 0 0 0 0 9.75012 0 0 0 11.1767 0 0 0 0 0 0 0 10.3431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6084 12.1002 0 0 0 0 12.6652 0 0 11.67 0 0 0 0 13.581 12.5988 12.4009 12.8674 0 12.3832 12.4995 12.118 0 0 12.9543 16.5198 15.1934 15.058 11.724 0 0 0 12.6027 0 14.2009 12.779 0 0 10.5514 0 0 0 11.7533 11.5702 0 12.1173 0 14.7844 0 13.9142 0 11.1914 0 12.6582 0 12.6392 0 0 16.5999 12.5762 0 0 0 0 0 0 0 0 11.5019 0 0 13.7228 0 0 14.8315 0 17.8042 13.0122 0 0 0 14.5196 0 0 0 0 0 0 13.3319 0 0 11.6268 10.8424 0 0 0 0 13.393 0 0 0 0 0 0 12.8599 0 13.1016 11.6583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6415 0 0 0 0 0 0 0 Q8N3Z3 GTPB8_HUMAN GTP-binding protein 8 GTPBP8 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739]; GTP binding [GO:0005525]; metal ion binding [GO:0046872] GO:0005525; GO:0005739; GO:0046872 GTP binding [GO:0005525]; metal ion binding [GO:0046872] FLAPYGRQDLHLR 0.99443 -11.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6725 0 0 0 14.188 0 0 0 0 14.3224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDQ6 ZN540_HUMAN Zinc finger protein 540 ZNF540 Nbla10512 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000900; GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0017148; GO:0043231; GO:0045892; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSYSGDLRVHSR 0.99443 -15.812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.602 0 0 0 13.6714 13.1834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8924 0 15.9013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5122 0 0 0 0 0 0 0 Q8TBK6 ZCH10_HUMAN Zinc finger CCHC domain-containing protein 10 ZCCHC10 Homo sapiens (Human) nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] GO:0003676; GO:0008270 nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] ATPMHRLIARR 0.99443 -7.897 0 0 0 0 0 0 0 0 0 0 0 10.2656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6225 0 11.5964 0 12.5154 0 0 11.887 0 0 0 0 11.9736 0 0 0 0 0 0 0 0 0 0 11.9878 0 11.2643 0 0 0 0 0 12.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4107 0 0 12.0614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.363 0 0 0 0 0 0 0 12.1168 0 0 0 0 0 0 0 0 0 10.7712 11.2656 0 0 0 0 0 0 11.8381 0 0 0 0 0 0 0 12.6166 0 0 0 10.5767 0 0 0 0 0 Q8WXG6 MADD_HUMAN "MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor, RabGEF) (Rab3 GDP/GTP exchange protein, Rab3GEP)" MADD DENN IG20 KIAA0358 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase activator activity [GO:0030295]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483] GO:0005085; GO:0005123; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0016021; GO:0030295; GO:0030424; GO:0032483; GO:0042981; GO:0043410; GO:0051726; GO:0097194; GO:1902041; GO:2001236 death receptor binding [GO:0005123]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase activator activity [GO:0030295] AHSLKPSIKEK 0.99443 -11.225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8941 12.0782 0 0 13.2263 0 12.4148 0 0 12.7779 0 13.7464 14.1175 0 0 0 0 14.7111 0 0 0 11.6688 0 0 0 0 0 13.5379 10.342 11.6355 0 12.7273 0 0 0 0 0 13.3824 13.3369 12.3019 11.9028 0 0 0 0 0 11.1318 0 0 0 0 0 0 0 0 0 0 0 13.6126 13.9534 0 0 13.8201 0 0 0 0 0 0 0 14.7209 11.6109 0 13.1669 0 11.2801 0 12.0383 11.1367 0 15.3837 0 12.3311 0 0 0 0 15.3993 0 0 0 0 13.3776 14.418 0 15.96 0 0 0 0 0 0 14.7349 0 14.9088 13.8054 14.6914 15.1689 0 14.2578 0 0 12.2009 13.5094 13.5119 14.7598 0 0 14.3392 14.6997 0 0 15.0438 14.9579 14.7023 0 0 12.4829 0 14.1254 0 0 0 0 16.2983 12.9139 11.7603 13.8578 0 0 0 0 11.1903 0 12.8231 11.4995 0 15.3939 13.2143 11.2734 0 0 13.5459 0 12.6703 0 0 0 0 0 0 0 0 0 Q92520 FAM3C_HUMAN Protein FAM3C (Interleukin-like EMT inducer) FAM3C ILEI GS3786 Homo sapiens (Human) negative regulation of gluconeogenesis [GO:0045721] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089]; cytokine activity [GO:0005125]; negative regulation of gluconeogenesis [GO:0045721] GO:0005125; GO:0005576; GO:0005615; GO:0005794; GO:0031089; GO:0045721; GO:0070062 cytokine activity [GO:0005125] RVAGAAK 0.99443 -9.4205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1954 0 0 0 0 0 11.8529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1419 0 0 0 0 0 0 0 13.5007 0 0 12.9108 0 12.8495 12.8575 13.4517 13.1069 0 0 0 0 0 0 0 0 0 0 0 0 15.1443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92685 ALG3_HUMAN "Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase, EC 2.4.1.258 (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)" ALG3 NOT NOT56L Homo sapiens (Human) dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]" GO:0000033; GO:0005783; GO:0005789; GO:0006486; GO:0006488; GO:0016021; GO:0052925 "alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]" AWQERRLLLR 0.99443 -11.222 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3467 14.1532 0 0 12.898 0 0 0 0 0 0 0 0 0 0 0 12.4174 0 0 12.1666 0 0 0 0 0 0 0 0 0 0 13.0606 0 12.7299 0 0 0 0 0 0 0 0 0 0 11.803 0 0 0 0 0 0 0 9.58013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3016 0 0 0 0 14.0954 0 0 0 0 0 0 12.6073 0 0 13.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4314 0 16.6648 0 0 14.3779 12.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0771 12.6275 0 Q92839 HYAS1_HUMAN "Hyaluronan synthase 1, EC 2.4.1.212 (Hyaluronate synthase 1) (Hyaluronic acid synthase 1, HA synthase 1, HuHAS1)" HAS1 HAS Homo sapiens (Human) cell adhesion [GO:0007155]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; glycosaminoglycan biosynthetic process [GO:0006024]; hyaluronan biosynthetic process [GO:0030213]; negative regulation of fibroblast migration [GO:0010764] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; extracellular matrix assembly [GO:0085029]; extracellular polysaccharide biosynthetic process [GO:0045226]; glycosaminoglycan biosynthetic process [GO:0006024]; hyaluronan biosynthetic process [GO:0030213]; negative regulation of fibroblast migration [GO:0010764] GO:0005794; GO:0005886; GO:0005887; GO:0006024; GO:0007155; GO:0010764; GO:0030213; GO:0036120; GO:0042802; GO:0045226; GO:0050501; GO:0085029 hyaluronan synthase activity [GO:0050501]; identical protein binding [GO:0042802] ALLYPRAR 0.99443 -36.853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0395 0 0 0 0 0 0 11.3694 12.5827 0 0 0 0 0 0 0 0 12.7668 0 13.7242 0 0 11.6479 0 0 0 0 0 0 0 0 0 0 11.8591 0 0 0 12.1011 0 0 14.187 15.1375 0 11.6923 12.3547 0 14.5098 0 0 0 0 14.5206 14.4451 0 0 13.9316 0 0 14.0331 14.3865 14.2704 0 12.3112 13.2748 0 0 13.0801 13.5094 0 0 0 0 0 0 0 14.6897 0 0 0 0 0 0 0 0 14.4014 0 0 0 12.7847 0 14.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUL5 PHF23_HUMAN PHD finger protein 23 (PDH-containing protein JUNE-1) PHF23 Homo sapiens (Human) autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]; positive regulation of protein ubiquitination [GO:0031398] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagosome maturation [GO:1901097]; positive regulation of protein ubiquitination [GO:0031398] GO:0005634; GO:0005654; GO:0005737; GO:0006914; GO:0031398; GO:0046872; GO:1901097; GO:1902902 metal ion binding [GO:0046872] LQAPDSATLLEKMKLK 0.99443 -8.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5292 0 0 0 0 0 0 0 0 14.5999 0 13.0841 0 0 0 0 0 0 15.4799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXS9 S26A6_HUMAN "Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1, Pendrin-L1)" SLC26A6 Homo sapiens (Human) angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; establishment of localization in cell [GO:0051649]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transmembrane transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to interferon-gamma [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; establishment of localization in cell [GO:0051649]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; ion transport [GO:0006811]; mannitol transmembrane transport [GO:0015797]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633] GO:0005254; GO:0005452; GO:0005783; GO:0005886; GO:0005887; GO:0006811; GO:0006821; GO:0008271; GO:0008272; GO:0012506; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0015499; GO:0015562; GO:0015660; GO:0015701; GO:0015724; GO:0015797; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0019531; GO:0019532; GO:0030165; GO:0030321; GO:0030659; GO:0031526; GO:0031982; GO:0034707; GO:0038166; GO:0042045; GO:0042802; GO:0046724; GO:0048240; GO:0050892; GO:0051453; GO:0051454; GO:0051649; GO:0070528; GO:0070633; GO:0071320; GO:0071332; GO:0071346; GO:0097225; GO:2001150 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; efflux transmembrane transporter activity [GO:0015562]; formate efflux transmembrane transporter activity [GO:0015660]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] AVLAAIIIVNLKGMLR 0.99443 -7.8899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4384 0 0 0 0 0 0 0 0 0 0 0 0 0 12.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0976 0 0 0 0 0 14.895 0 0 0 0 0 0 0 0 0 12.2083 0 14.3161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5977 0 0 0 0 0 0 0 0 13.9743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2731 0 11.8924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1B5 XYLT2_HUMAN "Xylosyltransferase 2, EC 2.4.2.26 (Peptide O-xylosyltransferase 1) (Xylosyltransferase II, XT-II, XylT-II)" XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210] extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158]; chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210] GO:0000139; GO:0000287; GO:0005615; GO:0006024; GO:0015012; GO:0016021; GO:0030145; GO:0030158; GO:0030203; GO:0030206; GO:0030210; GO:0050650 magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158] GRAESPGVPVAK 0.99443 -10.902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9563 0 0 0 0 12.941 0 0 0 13.1484 0 0 0 0 0 15.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8077 0 0 11.1422 0 0 0 0 0 0 0 13.0922 0 0 0 Q9H1Z8 AUGN_HUMAN "Augurin (Esophageal cancer-related gene 4 protein, ECRG4)" ECRG4 C2orf40 UNQ761/PRO1508 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; G1 to G0 transition [GO:0070314]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of corticosterone secretion [GO:2000854]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; regulation of cell population proliferation [GO:0042127]; response to wounding [GO:0009611]; vasopressin secretion [GO:0030103] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; extracellular space [GO:0005615] apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dense core granule [GO:0031045]; extracellular space [GO:0005615]; neuropeptide hormone activity [GO:0005184]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; G1 to G0 transition [GO:0070314]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]; positive regulation of corticosterone secretion [GO:2000854]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; regulation of cell population proliferation [GO:0042127]; response to wounding [GO:0009611]; vasopressin secretion [GO:0030103] GO:0005184; GO:0005615; GO:0005737; GO:0007218; GO:0007417; GO:0008285; GO:0009611; GO:0016324; GO:0030103; GO:0031045; GO:0031145; GO:0042127; GO:0051461; GO:0051466; GO:0070314; GO:0090398; GO:2000854 neuropeptide hormone activity [GO:0005184] AASPARPAVLALTGLALLLLLCWGPGGISGNK 0.99443 -11.526 0 0 0 0 0 0 0 0 0 0 14.3969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.876 0 0 13.426 11.6981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9256 0 0 0 0 0 12.1844 0 0 0 0 12.4477 12.5526 0 0 0 0 11.8345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1795 0 0 0 0 0 0 0 0 0 13.0973 0 13.4575 0 14.5892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.713 0 12.4951 0 0 13.4852 0 13.8821 0 0 0 0 0 12.1502 0 14.1066 Q9UJD0 RIMS3_HUMAN "Regulating synaptic membrane exocytosis protein 3, Nim3 (RIM3 gamma) (Rab-3-interacting molecule 3, RIM 3)" RIMS3 KIAA0237 Homo sapiens (Human) calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; positive regulation of synaptic transmission [GO:0050806]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300] anchoring junction [GO:0070161]; cytoskeleton of presynaptic active zone [GO:0048788]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; cytoskeleton of presynaptic active zone [GO:0048788]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; positive regulation of synaptic transmission [GO:0050806]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300] GO:0017156; GO:0031267; GO:0042391; GO:0042734; GO:0044325; GO:0048167; GO:0048786; GO:0048788; GO:0048791; GO:0050806; GO:0070161; GO:2000300 small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325] GLTPKPGSK 0.99443 -9.4196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8006 0 0 0 0 0 0 0 0 12.2578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y276 BCS1_HUMAN "Mitochondrial chaperone BCS1, h-BCS1 (BCS1-like protein)" BCS1L BCS1 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979] mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979] GO:0005524; GO:0005739; GO:0005743; GO:0005750; GO:0007005; GO:0016887; GO:0032979; GO:0032981; GO:0033617; GO:0034551 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] DVQEFIDNPKWYTDR 0.99443 -10.917 0 9.89692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0517 0 0 0 0 0 11.7361 12.0495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2603 0 0 15.7794 0 0 0 0 0 0 0 0 0 0 0 10.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6099 0 0 0 0 0 0 0 0 0 16.5463 Q9Y570 PPME1_HUMAN "Protein phosphatase methylesterase 1, PME-1, EC 3.1.1.89" PPME1 PME1 PP2593 PRO0750 Homo sapiens (Human) G2/M transition of mitotic cell cycle [GO:0000086]; protein demethylation [GO:0006482]; protein phosphorylation [GO:0006468] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; lncRNA binding [GO:0106222]; protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; G2/M transition of mitotic cell cycle [GO:0000086]; protein demethylation [GO:0006482]; protein phosphorylation [GO:0006468] GO:0000086; GO:0004864; GO:0005654; GO:0006468; GO:0006482; GO:0019888; GO:0019901; GO:0019903; GO:0045296; GO:0051721; GO:0051722; GO:0051723; GO:0106222 cadherin binding [GO:0045296]; lncRNA binding [GO:0106222]; protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888] DLTIGQMQGK 0.99443 -36.744 0 0 0 0 0 0 0 0 0 0 0 11.2926 10.6013 0 0 0 0 9.76698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.32672 0 0 0 10.6472 0 0 0 0 0 0 12.9364 11.0442 12.1556 0 0 0 0 0 0 11.4497 13.3171 0 0 0 0 11.9194 0 0 0 0 0 0 0 0 12.1854 0 0 0 0 0 0 0 0 0 0 0 0 15.8674 0 0 0 0 0 11.7155 11.1973 0 0 0 0 0 0 0 0 0 0 11.7134 0 0 0 0 0 0 0 0 9.93745 0 11.7986 11.9286 12.3382 12.1835 0 0 0 0 0 0 12.5362 0 12.5729 12.0768 0 0 0 0 0 0 12.0487 0 0 0 12.4517 12.9806 0 0 0 0 0 0 10.9093 0 0 0 0 0 0 0 0 0 14.6974 14.3355 0 0 13.6349 0 0 13.1439 10.4971 0 0 0 0 0 0 0 10.1054 12.6424 0 0 11.6488 0 0 P11021 BIP_HUMAN "Endoplasmic reticulum chaperone BiP, EC 3.6.4.10 (78 kDa glucose-regulated protein, GRP-78) (Binding-immunoglobulin protein, BiP) (Heat shock protein 70 family protein 5, HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)" HSPA5 GRP78 Homo sapiens (Human) "cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to antibiotic [GO:0071236]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; luteolysis [GO:0001554]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026]; regulation of ATF6-mediated unfolded protein response [GO:1903891]; regulation of IRE1-mediated unfolded protein response [GO:1903894]; regulation of PERK-mediated unfolded protein response [GO:1903897]; regulation of protein folding in endoplasmic reticulum [GO:0060904]; response to cocaine [GO:0042220]; response to methamphetamine hydrochloride [GO:1904313]; stress response to metal ion [GO:0097501]; substantia nigra development [GO:0021762]; toxin transport [GO:1901998]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0001554; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005788; GO:0005789; GO:0005790; GO:0005793; GO:0005829; GO:0005886; GO:0005925; GO:0006983; GO:0009986; GO:0010976; GO:0016020; GO:0016887; GO:0019899; GO:0019904; GO:0021589; GO:0021680; GO:0021762; GO:0030176; GO:0030182; GO:0030335; GO:0030433; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0032991; GO:0034620; GO:0034663; GO:0034975; GO:0035437; GO:0042026; GO:0042149; GO:0042220; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0045296; GO:0051082; GO:0051085; GO:0051087; GO:0051402; GO:0051787; GO:0060904; GO:0070062; GO:0071236; GO:0071277; GO:0071287; GO:0071320; GO:0071353; GO:0071466; GO:0071480; GO:0097501; GO:0140662; GO:1901998; GO:1903891; GO:1903894; GO:1903895; GO:1903897; GO:1904313; GO:1990090; GO:1990440 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; chaperone binding [GO:0051087]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] IPKIQQLVK 0.99444 -11.589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2835 0 0 0 0 0 0 0 0 0 12.1539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6788 0 0 0 0 0 14.0553 15.2058 0 0 0 0 12.8197 0 15.8716 0 0 11.1814 0 0 0 0 0 0 0 0 12.6177 0 0 0 0 14.6357 0 13.5194 0 11.6048 13.4122 0 0 0 13.3978 0 0 0 0 13.1586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49419 AL7A1_HUMAN "Alpha-aminoadipic semialdehyde dehydrogenase, Alpha-AASA dehydrogenase, EC 1.2.1.31 (Aldehyde dehydrogenase family 7 member A1, EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase, EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase, P6c dehydrogenase)" ALDH7A1 ATQ1 Homo sapiens (Human) cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605] GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006081; GO:0007605; GO:0008802; GO:0019285; GO:0042426; GO:0042802; GO:0043878; GO:0070062 aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043] DLGRIFR 0.99444 -10.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5013 13.4019 0 0 0 0 13.8099 0 0 0 0 0 0 12.6571 14.4055 15.8441 14.6198 14.827 0 12.9498 0 0 0 0 0 12.8801 13.0839 0 0 0 14.6711 11.8686 0 0 0 0 0 15.0219 0 0 0 12.1071 14.0245 12.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5517 0 0 0 0 14.2868 13.8568 14.3901 0 0 0 0 0 0 0 0 0 0 0 0 9.57314 0 0 0 12.9813 0 0 0 0 0 0 0 Q13363 CTBP1_HUMAN "C-terminal-binding protein 1, CtBP1, EC 1.1.1.-" CTBP1 CTBP Homo sapiens (Human) "heterochromatin assembly [GO:0031507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]" GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053] "GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; heterochromatin assembly [GO:0031507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone deacetylation [GO:0031065]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872]" GO:0000122; GO:0001221; GO:0001222; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0006468; GO:0008022; GO:0008285; GO:0016616; GO:0017053; GO:0019079; GO:0019904; GO:0031065; GO:0031507; GO:0035067; GO:0042802; GO:0045892; GO:0050872; GO:0051287; GO:0051726; GO:0061629; GO:0090241; GO:0098831; GO:0098978; GO:0098982; GO:0140297 "chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]" AITGRIPDSLKNCVNK 0.99444 -10.962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.27891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0333 0 0 13.1959 13.7359 14.9474 12.9461 12.5979 0 0 14.2207 0 0 0 0 0 0 0 0 0 0 14.7206 0 0 0 0 0 0 0 0 0 14.547 0 0 0 0 0 0 0 0 0 10.5424 0 0 11.4783 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JUK9 PAGE3_HUMAN "P antigen family member 3, PAGE-3 (G antigen family D member 1) (Prostate-associated gene 3 protein)" PAGE3 GAGED1 Homo sapiens (Human) GDGPNVK 0.99444 -10.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.606 0 17.5448 16.8375 0 17.4864 0 0 0 0 14.1931 0 0 0 0 16.7383 14.0759 0 14.392 0 0 0 0 16.3524 0 0 0 0 0 0 0 0 15.5939 0 0 0 13.452 0 0 0 0 11.4585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0769 0 0 0 0 14.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VSY0 GKAP1_HUMAN G kinase-anchoring protein 1 (cGMP-dependent protein kinase-anchoring protein of 42 kDa) GKAP1 GKAP42 FKSG21 Homo sapiens (Human) positive regulation of insulin receptor signaling pathway [GO:0046628]; signal transduction [GO:0007165] Golgi apparatus [GO:0005794] Golgi apparatus [GO:0005794]; identical protein binding [GO:0042802]; positive regulation of insulin receptor signaling pathway [GO:0046628]; signal transduction [GO:0007165] GO:0005794; GO:0007165; GO:0042802; GO:0046628 identical protein binding [GO:0042802] DSREENWQEWR 0.99444 -10.963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7867 0 0 0 0 0 0 0 0 0 0 0 0 13.454 13.0186 0 13.518 0 0 0 0 11.6749 12.4567 0 0 0 0 0 11.7805 13.9157 0 0 0 0 0 0 11.8834 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4294 0 0 0 0 0 0 12.3373 11.1872 0 0 0 0 0 13.2396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1687 0 0 0 0 0 0 10.919 Q6ZXV5 TMTC3_HUMAN "Protein O-mannosyl-transferase TMTC3, EC 2.4.1.109 (Protein SMILE) (Transmembrane and TPR repeat-containing protein 3)" TMTC3 Homo sapiens (Human) positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976] GO:0000030; GO:0004169; GO:0005783; GO:0016021; GO:0034976; GO:0035269; GO:1901800 dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030] AIKLQADFR 0.99444 -10.943 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8533 13.581 0 13.4046 13.0625 0 12.6326 13.7979 0 13.8325 13.7909 12.6681 0 0 13.2066 14.3504 13.6185 12.9711 0 0 0 10.2322 0 0 0 12.8591 0 12.4519 13.6146 0 12.4048 12.9276 13.015 0 0 0 10.9221 0 10.4883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3383 0 14.4778 14.774 0 14.4503 14.5579 11.3181 0 13.8037 0 0 0 14.9755 0 0 0 12.0258 13.5832 13.859 0 0 0 0 15.9361 0 15.1481 0 0 0 0 0 0 0 17.5787 0 0 0 18.0912 13.1722 0 0 14.0291 0 15.6671 0 12.526 0 0 0 14.5575 13.594 12.2538 13.2677 0 0 0 0 0 0 14.02 0 14.7443 0 0 0 0 0 0 0 0 10.0908 0 0 0 12.8766 0 0 0 0 0 0 0 13.7599 13.5742 14.9669 0 0 0 0 0 16.4519 12.2013 0 0 Q8N3X1 FNBP4_HUMAN Formin-binding protein 4 (Formin-binding protein 30) FNBP4 FBP30 KIAA1014 Homo sapiens (Human) nuclear speck [GO:0016607] nuclear speck [GO:0016607] GO:0016607 ELDEEDNSSSSEEDR 0.99444 -8.214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3926 0 0 0 0 0 0 15.3791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4414 17.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3194 0 0 18.7955 0 0 0 0 Q8NA66 CNBD1_HUMAN Cyclic nucleotide-binding domain-containing protein 1 CNBD1 Homo sapiens (Human) FEEFLAILKK 0.99444 -11.588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4738 0 0 0 0 0 0 0 12.3688 12.6719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8378 0 0 0 0 0 0 0 0 18.1505 0 0 0 0 0 10.8321 0 0 0 12.0573 0 0 0 0 0 12.0189 0 0 0 12.1645 0 13.8751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2559 0 0 0 0 0 12.8441 0 0 12.1928 0 0 0 0 0 0 0 12.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8434 0 0 0 0 0 0 Q8TB05 UBAD1_HUMAN UBA-like domain-containing protein 1 UBALD1 FAM100A PP11303 Homo sapiens (Human) MSVNMDELK 0.99444 -13.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969F2 NKD2_HUMAN "Protein naked cuticle homolog 2, Naked-2, hNkd2" NKD2 Homo sapiens (Human) exocytosis [GO:0006887]; Golgi vesicle fusion to target membrane [GO:0048210]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein processing [GO:0010954]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055] basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; exocytic vesicle [GO:0070382]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625]; exocytosis [GO:0006887]; Golgi vesicle fusion to target membrane [GO:0048210]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein processing [GO:0010954]; protein localization to plasma membrane [GO:0072659]; Wnt signaling pathway [GO:0016055] GO:0005509; GO:0005737; GO:0005886; GO:0006887; GO:0010954; GO:0016055; GO:0016323; GO:0016328; GO:0019838; GO:0030178; GO:0031410; GO:0031625; GO:0032036; GO:0032436; GO:0048210; GO:0051117; GO:0070382; GO:0071944; GO:0072659; GO:0090090; GO:1903078 ATPase binding [GO:0051117]; calcium ion binding [GO:0005509]; growth factor binding [GO:0019838]; myosin heavy chain binding [GO:0032036]; ubiquitin protein ligase binding [GO:0031625] ASHLQAR 0.99444 -8.7143 0 0 0 0 0 9.92775 9.40841 0 0 0 0 0 0 0 0 0 14.3478 14.333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2331 0 0 0 0 0 12.7202 11.9612 0 11.1857 0 12.0465 0 12.7686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3577 15.326 0 0 0 0 0 0 0 15.731 0 0 0 12.6695 0 0 0 13.1381 13.6862 0 0 0 14.3475 13.2788 14.194 0 0 0 0 0 0 0 0 0 0 0 0 13.0222 0 0 11.9596 14.4255 0 14.3799 14.9327 0 0 11.9472 0 13.5103 14.5644 0 0 13.329 0 0 0 0 0 0 0 0 0 0 12.1517 11.067 13.8893 12.4077 0 0 0 0 0 0 0 0 0 0 13.8574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6574 0 0 0 0 0 Q9Y232 CDYL_HUMAN "Chromodomain Y-like protein, CDY-like (Crotonyl-CoA hydratase, EC 4.2.1.-)" CDYL CDYL1 Homo sapiens (Human) negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor activity [GO:0003714]; negative regulation of peptidyl-lysine crotonylation [GO:0120094]; random inactivation of X chromosome [GO:0060816]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0005737; GO:0007283; GO:0007286; GO:0016607; GO:0030674; GO:0035064; GO:0042802; GO:0060816; GO:0120092; GO:0120094 chromatin binding [GO:0003682]; crotonyl-CoA hydratase activity [GO:0120092]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor activity [GO:0003714] LTAQEACGKGLVSQVFWPGTFTQEVMVR 0.99444 -11.585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.057 0 12.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0101 0 0 0 0 0 0 14.4651 12.3148 0 0 0 0 0 0 0 0 0 0 0 0 0 P28562 DUS1_HUMAN "Dual specificity protein phosphatase 1, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase hVH1) (Mitogen-activated protein kinase phosphatase 1, MAP kinase phosphatase 1, MKP-1) (Protein-tyrosine phosphatase CL100)" DUSP1 CL100 MKP1 PTPN10 VH1 Homo sapiens (Human) cell cycle [GO:0007049]; cellular response to chemokine [GO:1990869]; endoderm formation [GO:0001706]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of p38MAPK cascade [GO:1903753]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; cell cycle [GO:0007049]; cellular response to chemokine [GO:1990869]; endoderm formation [GO:0001706]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of p38MAPK cascade [GO:1903753]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] GO:0001706; GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0007049; GO:0007162; GO:0008138; GO:0008285; GO:0008330; GO:0017017; GO:0017018; GO:0035335; GO:0035970; GO:0043407; GO:0043409; GO:0051019; GO:0051447; GO:0070262; GO:0090027; GO:0090266; GO:1903753; GO:1990869 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase binding [GO:0051019]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] EARAAQVFFLK 0.99445 -10.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9829 12.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4357 9.97513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1125 0 0 0 0 0 0 0 P49756 RBM25_HUMAN "RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa, RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7)" RBM25 RNPC7 Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]" GO:0000381; GO:0003723; GO:0003729; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0042981 mRNA binding [GO:0003729]; RNA binding [GO:0003723] ASNGNAR 0.99445 -9.0123 10.8097 0 0 0 0 0 0 0 14.2422 0 0 0 0 0 0 0 0 0 0 0 0 14.0713 0 13.9971 0 10.212 0 0 0 0 0 0 0 0 13.0011 0 13.2199 0 0 12.3367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.31599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2682 0 0 13.1857 0 13.8034 0 0 0 13.0683 15.3154 0 0 14.4615 16.153 14.3964 0 15.2355 12.0119 16.3263 13.4512 0 13.2041 13.0535 14.2842 0 0 0 0 0 0 0 0 14.9836 0 0 0 0 0 0 0 0 15.793 14.3859 0 14.8103 0 13.3731 0 0 0 14.3431 0 0 0 0 0 0 0 0 0 0 12.3936 0 0 0 0 11.4977 0 0 14.1901 15.3095 0 0 0 0 0 12.1037 0 0 0 0 0 0 0 0 14.5444 0 0 0 10.9145 0 0 0 0 0 0 0 0 0 14.5523 11.6512 0 P51648 AL3A2_HUMAN "Aldehyde dehydrogenase family 3 member A2, EC 1.2.1.3, EC 1.2.1.94 (Aldehyde dehydrogenase 10) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase)" ALDH3A2 ALDH10 FALDH Homo sapiens (Human) cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]; cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714] GO:0004029; GO:0005737; GO:0005777; GO:0005778; GO:0005789; GO:0005829; GO:0006081; GO:0006631; GO:0006714; GO:0007417; GO:0007422; GO:0008544; GO:0016021; GO:0033306; GO:0042803; GO:0043231; GO:0043878; GO:0046458; GO:0046577; GO:0050061; GO:0052814 aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803] EKLGLLLLTFLGIVAAVLVK 0.99445 -9.0106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8359 0 0 0 0 0 0 13.4069 0 0 0 0 0 0 0 0 15.5324 0 13.6753 0 0 0 0 14.1314 14.122 0 0 0 0 0 0 0 0 12.8844 0 0 0 0 0 0 0 0 0 0 10.7155 0 0 0 0 0 11.9502 0 12.0101 0 0 0 0 0 0 0 12.648 0 0 0 0 13.6258 12.3497 0 0 13.2099 0 0 13.8409 12.833 0 12.648 0 0 0 0 12.6493 0 0 0 0 0 0 0 0 0 0 0 0 13.1693 0 0 12.4356 0 0 0 0 0 0 11.7505 12.0739 0 12.3987 0 0 0 0 0 0 Q13442 HAP28_HUMAN "28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein, PAP) (PDGFA-associated protein 1, PAP1)" PDAP1 HASPP28 Homo sapiens (Human) signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; signal transduction [GO:0007165] GO:0003723; GO:0005576; GO:0005829; GO:0005886; GO:0007165; GO:1904813 RNA binding [GO:0003723] AREEEEQK 0.99445 -12.883 0 0 0 0 0 0 0 0 0 0 0 13.8184 0 0 13.8063 0 13.8474 0 0 13.874 0 13.7383 13.6741 0 14.3957 0 0 12.0791 0 0 0 0 0 0 0 0 0 0 0 11.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5626 0 0 0 11.9082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9481 0 10.6965 13.7062 16.6895 0 0 0 0 16.6758 0 0 0 0 16.6573 0 16.5765 0 16.7509 0 0 0 13.279 0 0 12.5898 0 0 12.6997 11.9415 0 11.7328 0 0 0 0 0 0 14.857 14.1497 0 0 0 0 0 0 0 0 0 0 0 11.5101 12.2137 0 0 0 0 0 0 10.9367 0 0 12.725 0 0 0 0 0 0 0 0 14.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1146 0 0 0 0 0 0 0 0 0 0 0 0 Q5EBM0 CMPK2_HUMAN "UMP-CMP kinase 2, mitochondrial, EC 2.7.4.14 (Nucleoside-diphosphate kinase, EC 2.7.4.6)" CMPK2 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; cytidylate kinase activity [GO:0004127]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] GO:0004127; GO:0004550; GO:0004798; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0006165; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0009142; GO:0033862; GO:0036430; GO:0036431; GO:0071222 ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; cytidylate kinase activity [GO:0004127]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041] GKFQVVAIEGLDATGK 0.99445 -8.2279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9476 0 0 16.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9028 0 0 0 0 0 0 0 0 0 0 0 17.4414 0 17.0804 0 0 0 14.9921 17.8581 16.5131 0 0 15.3994 0 0 0 0 0 0 0 0 0 13.4507 12.9255 0 12.7639 14.5185 12.5383 13.3822 0 13.6964 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2211 20.2763 0 15.3837 12.8978 0 0 0 14.07 0 18.035 12.4003 0 12.2842 0 0 0 12.4564 19.0503 12.5309 14.8118 0 13.6306 0 0 12.9705 12.6699 13.8621 0 14.2223 13.5853 13.8598 13.0534 14.6739 14.1366 0 0 0 14.1845 0 13.9469 0 13.8586 0 0 11.5637 0 0 13.6231 0 0 18.4113 0 0 0 0 13.2657 0 14.3231 12.9124 0 0 0 13.6875 0 0 0 0 0 0 0 0 0 0 20.5788 14.1326 0 0 0 0 0 0 0 Q86X60 FA72B_HUMAN Protein FAM72B FAM72B Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] GO:0005829; GO:0043231 MSTNICSFKDRCVSILCCK 0.99445 -5.2033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3058 0 0 0 0 0 10.8224 0 0 12.3716 0 0 0 0 0 0 0 0 0 0 0 12.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYJ0 PIANP_HUMAN PILR alpha-associated neural protein (PILR-associating neural protein) (Paired immunoglobin-like type 2 receptor-associating neural protein) PIANP C12orf53 PANP UNQ828/PRO1755 Homo sapiens (Human) regulation of immune response [GO:0050776] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; regulation of immune response [GO:0050776] GO:0005886; GO:0016020; GO:0016021; GO:0016323; GO:0050776 GGPSAPR 0.99445 -8.7219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1589 0 0 0 0 0 11.8859 0 12.4165 0 0 0 0 0 0 0 0 12.0692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5705 0 0 0 0 0 0 0 0 0 12.6269 0 0 0 13.2098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0025 0 0 0 0 12.6612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9542 0 13.3536 0 0 0 0 12.6464 12.9613 12.8104 0 0 0 0 0 0 0 0 0 Q8N726 ARF_HUMAN "Tumor suppressor ARF (Alternative reading frame, ARF) (Cyclin-dependent kinase inhibitor 2A) (p14ARF)" CDKN2A CDKN2 MLM Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; apoptotic mitochondrial changes [GO:0008637]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; mitochondrial depolarization [GO:0051882]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein neddylation [GO:2000435]; negative regulation of proteolysis involved in protein catabolic process [GO:1903051]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein export from nucleus [GO:0046825]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; rRNA processing [GO:0006364]; somatic stem cell division [GO:0048103]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; apoptotic mitochondrial changes [GO:0008637]; autophagy of mitochondrion [GO:0000422]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; mitochondrial depolarization [GO:0051882]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein neddylation [GO:2000435]; negative regulation of proteolysis involved in protein catabolic process [GO:1903051]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of apoptotic DNA fragmentation [GO:1902510]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein export from nucleus [GO:0046825]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; rRNA processing [GO:0006364]; somatic stem cell division [GO:0048103]" GO:0000209; GO:0000422; GO:0002039; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005759; GO:0005829; GO:0006364; GO:0006469; GO:0006919; GO:0007049; GO:0008285; GO:0008637; GO:0010389; GO:0010628; GO:0019789; GO:0030889; GO:0031647; GO:0031648; GO:0032991; GO:0033088; GO:0033235; GO:0043065; GO:0043517; GO:0045893; GO:0045944; GO:0046825; GO:0048103; GO:0050821; GO:0051444; GO:0051726; GO:0051882; GO:0055105; GO:0061629; GO:0070534; GO:0090398; GO:0097371; GO:0097718; GO:1900182; GO:1901798; GO:1902510; GO:1903051; GO:1903214; GO:1904667; GO:1990000; GO:1990948; GO:2000059; GO:2000435 disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin-protein transferase inhibitor activity [GO:0055105] GAAGRAR 0.99445 -11.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0857 0 0 0 0 0 0 0 0 0 0 0 0 11.1593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7184 0 0 0 0 0 11.5621 0 0 0 10.5531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6018 0 0 0 0 0 0 0 0 0 0 0 0 11.0863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4673 0 0 0 0 0 Q8TC56 GAR3_HUMAN Golgi associated RAB2 interactor protein 3 GARIN3 FAM71B HSD-51 HSD51 Homo sapiens (Human) Cajal body [GO:0015030]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] Cajal body [GO:0015030]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634] GO:0005634; GO:0005794; GO:0015030 EDLFCYWEK 0.99445 -8.2368 0 0 0 12.1304 0 0 0 0 0 0 0 0 12.9555 0 0 0 12.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3754 0 0 13.5316 0 13.0117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3019 0 0 0 0 0 0 12.0134 0 0 0 0 0 0 0 0 0 12.9249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5223 12.627 0 14.0807 0 0 0 0 0 14.7162 0 0 0 0 0 0 0 0 0 0 0 12.2938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BZ9 TBC20_HUMAN TBC1 domain family member 20 TBC1D20 C20orf140 Homo sapiens (Human) acrosome assembly [GO:0001675]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of GTPase activity [GO:0043547]; seminiferous tubule development [GO:0072520]; virion assembly [GO:0019068] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; acrosome assembly [GO:0001675]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of GTPase activity [GO:0043547]; seminiferous tubule development [GO:0072520]; virion assembly [GO:0019068] GO:0001675; GO:0005096; GO:0005783; GO:0005789; GO:0006888; GO:0007030; GO:0019068; GO:0030173; GO:0031267; GO:0031965; GO:0033116; GO:0034389; GO:0043547; GO:0044829; GO:0046726; GO:0070309; GO:0072520; GO:0090110; GO:1902953 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] ALRSAQGDGPTSGHWDGGAEK 0.99445 -10.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93099 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1636 0 13.1199 12.3379 0 0 0 11.7388 0 11.659 0 12.4677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0341 0 0 0 0 0 0 0 12.0749 0 0 11.571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.676 0 0 0 11.6346 0 0 0 0 0 0 0 0 0 11.4858 0 0 0 0 0 0 0 0 12.4205 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6248 0 10.7555 0 0 11.8428 10.9246 0 0 0 0 0 0 Q96DN2 VWCE_HUMAN von Willebrand factor C and EGF domain-containing protein (HBV X protein up-regulated gene 11 protein) (HBxAg up-regulated gene 11 protein) VWCE URG11 Homo sapiens (Human) cellular response to virus [GO:0098586] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cellular response to virus [GO:0098586] GO:0005509; GO:0005576; GO:0005737; GO:0098586 calcium ion binding [GO:0005509] CTDIDECVTSSCEGHCVNTEGGFVCECGPGMQLSADR 0.99445 -15.496 0 0 11.2285 0 0 0 0 0 11.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8876 0 0 0 13.0412 0 10.2248 12.0306 0 0 0 0 0 0 0 9.96996 0 10.6965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5168 11.8796 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2219 0 0 0 0 0 0 0 0 0 0 10.5946 0 12.8589 0 0 14.8819 0 13.5923 0 0 0 0 0 0 0 0 0 0 0 0 13.2053 0 0 0 0 0 0 0 0 0 0 13.6949 0 0 0 0 13.8785 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JA1 LRIG1_HUMAN "Leucine-rich repeats and immunoglobulin-like domains protein 1, LIG-1" LRIG1 LIG1 Homo sapiens (Human) hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605] GO:0005615; GO:0005886; GO:0007605; GO:0016021; GO:0022405; GO:0031012; GO:0032474; GO:0060384 APCAAACTCAGDSLDCGGR 0.99445 -8.2402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4614 0 0 0 0 0 0 0 0 0 0 0 0 14.0568 15.1036 0 0 0 0 0 0 0 10.7122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5489 0 0 0 0 0 0 0 0 0 0 0 14.2519 0 0 11.9066 0 11.6973 13.5936 14.1116 13.4411 14.2484 0 14.057 0 0 0 0 13.9216 0 12.2298 13.2653 0 0 0 0 0 0 0 0 0 0 16.2314 0 12.3391 0 0 15.3888 0 0 0 0 0 0 0 13.8243 0 12.401 0 0 0 0 10.6502 0 0 0 0 0 0 16.0698 14.297 0 13.0819 0 0 0 0 0 0 13.8948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4098 11.5307 0 0 0 0 0 0 13.5085 0 14.1801 13.018 0 0 0 11.6343 0 Q96KV7 WDR90_HUMAN WD repeat-containing protein 90 WDR90 C16orf15 C16orf16 C16orf17 C16orf18 C16orf19 KIAA1924 Homo sapiens (Human) cilium assembly [GO:0060271] centriole [GO:0005814]; cytoplasm [GO:0005737] centriole [GO:0005814]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271] GO:0005737; GO:0005814; GO:0060271 AFTPARVSCSPHSAK 0.99445 -9.0131 0 0 0 0 0 0 0 0 0 0 0 9.38163 0 0 0 0 0 0 0 11.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1722 0 0 0 0 0 0 0 11.7851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2256 0 12.2909 0 14.1918 0 0 0 0 0 0 12.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0014 0 0 0 0 0 0 0 0 0 0 0 0 Q96S15 WDR24_HUMAN GATOR complex protein WDR24 (WD repeat-containing protein 24) WDR24 C16orf21 JFP7 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774] cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506] GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0010506; GO:0016239; GO:0032008; GO:0034198; GO:0043231; GO:0061700; GO:1904262; GO:1904263 DSSLCQHLFR 0.99445 -12.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4527 0 0 0 0 0 0 0 0 15.1037 0 0 0 0 0 0 0 0 0 14.4126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2706 0 0 0 0 0 0 Q9NQ75 CASS4_HUMAN "Cas scaffolding protein family member 4 (HEF-like protein) (HEF1-EFS-p130Cas-like protein, HEPL)" CASS4 C20orf32 HEFL Homo sapiens (Human) actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; protein tyrosine kinase binding [GO:1990782]; actin filament reorganization [GO:0090527]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0005856; GO:0005925; GO:0007155; GO:0007169; GO:0016477; GO:0030335; GO:0051897; GO:0061098; GO:0090527; GO:1900026; GO:1990782 protein tyrosine kinase binding [GO:1990782] FASIVIANGRLLFK 0.99445 -15.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5369 0 0 0 0 0 0 0 13.5232 0 14.9571 0 0 0 15.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4689 12.9322 0 0 0 0 0 0 0 15.1557 0 0 0 0 0 0 0 0 0 0 0 14.206 0 14.8286 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3064 0 0 0 0 0 0 0 0 0 14.0598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUX0 VAFNB_HUMAN Protein ATP6V1FNB (ATP6V1F neighbor gene protein) ATP6V1FNB Homo sapiens (Human) AAARLPLKLPTLHPK 0.99446 -7.9956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7094 11.1319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 J3KSC0 CR064_HUMAN Putative uncharacterized protein encoded by LINC01387 LINC01387 C18orf64 Homo sapiens (Human) LLVKRNVSLELSCR 0.99446 -8.5173 0 9.57283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3346 11.6914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0771 13.3483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43741 AAKB2_HUMAN "5'-AMP-activated protein kinase subunit beta-2, AMPK subunit beta-2" PRKAB2 Homo sapiens (Human) cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of catalytic activity [GO:0050790]; signal transduction [GO:0007165] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006633; GO:0007165; GO:0019901; GO:0031588; GO:0031669; GO:0050790; GO:0120162 protein kinase binding [GO:0019901] EFVSWQQDLEDSVKPTQQARPTVIR 0.99446 -9.0392 10.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4358 0 0 0 0 0 12.4218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.716 0 15.3186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7387 0 0 0 0 14.6664 0 0 0 13.0854 0 0 0 0 0 0 0 0 0 0 0 14.7066 0 0 14.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.454 0 0 0 0 0 0 0 0 12.8361 0 0 0 P06730 IF4E_HUMAN "Eukaryotic translation initiation factor 4E, eIF-4E, eIF4E (eIF-4F 25 kDa subunit) (mRNA cap-binding protein)" EIF4E EIF4EL1 EIF4F Homo sapiens (Human) "behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; stem cell population maintenance [GO:0019827]; translational initiation [GO:0006413]" chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; RISC complex [GO:0016442] "chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; RISC complex [GO:0016442]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; behavioral fear response [GO:0001662]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; lung development [GO:0030324]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; stem cell population maintenance [GO:0019827]; translational initiation [GO:0006413]" GO:0000082; GO:0000339; GO:0000340; GO:0000932; GO:0001662; GO:0003723; GO:0003743; GO:0005634; GO:0005737; GO:0005829; GO:0005845; GO:0006413; GO:0006417; GO:0010494; GO:0016281; GO:0016442; GO:0017148; GO:0019827; GO:0019899; GO:0030182; GO:0030324; GO:0031370; GO:0033391; GO:0036464; GO:0045665; GO:0045931; GO:0048471; GO:0070062; GO:0071549; GO:0098978; GO:0099524; GO:0099578; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; eukaryotic initiation factor 4G binding [GO:0031370]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743] HPLQNRWALWFFKNDK 0.99446 -7.9992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1789 0 0 0 0 13.8812 0 0 0 0 0 0 0 0 10.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2329 11.2035 0 0 0 0 0 0 0 0 0 0 0 0 P13591 NCAM1_HUMAN "Neural cell adhesion molecule 1, N-CAM-1, NCAM-1 (CD antigen CD56)" NCAM1 NCAM Homo sapiens (Human) cell adhesion [GO:0007155]; commissural neuron axon guidance [GO:0071679]; regulation of semaphorin-plexin signaling pathway [GO:2001260] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; virus receptor activity [GO:0001618]; cell adhesion [GO:0007155]; commissural neuron axon guidance [GO:0071679]; regulation of semaphorin-plexin signaling pathway [GO:2001260] GO:0000139; GO:0001618; GO:0005576; GO:0005829; GO:0005886; GO:0007155; GO:0009897; GO:0009986; GO:0016020; GO:0016021; GO:0031225; GO:0043005; GO:0062023; GO:0071679; GO:2001260 virus receptor activity [GO:0001618] EASMEGIVTIVGLKPETTYAVRLAALNGK 0.99446 -15.591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0012 0 0 0 0 12.2957 11.776 0 0 0 0 0 14.0193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2679 12.5562 12.1081 0 12.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8765 0 0 0 0 0 0 0 0 12.2329 0 0 12.4156 0 0 0 0 0 0 0 0 0 0 0 0 0 P48147 PPCE_HUMAN "Prolyl endopeptidase, PE, EC 3.4.21.26 (Post-proline cleaving enzyme)" PREP PEP Homo sapiens (Human) proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008236; GO:0016020; GO:0070012 oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] EGYTSPKR 0.99446 -8.5088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1352 0 0 0 0 0 0 0 0 0 10.6012 0 0 0 0 10.1325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3882 12.0956 0 14.8692 0 15.0287 0 0 0 0 0 14.1453 13.241 0 0 0 0 0 12.7657 0 0 0 0 0 0 13.4033 13.9348 0 15.1593 0 0 0 0 0 14.3258 14.7064 0 0 0 0 0 0 0 0 13.7196 14.0335 0 0 0 0 15.5655 0 0 0 15.6889 0 0 14.4772 0 0 0 14.387 0 13.9073 11.8329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4358 0 14.4977 14.4866 14.3819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4733 0 0 0 0 0 P51805 PLXA3_HUMAN Plexin-A3 (Plexin-4) (Semaphorin receptor SEX) PLXNA3 PLXN4 SEX Homo sapiens (Human) axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection guidance [GO:0097485]; olfactory nerve formation [GO:0021628]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection guidance [GO:0097485]; olfactory nerve formation [GO:0021628]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; trigeminal nerve structural organization [GO:0021637] GO:0002116; GO:0005886; GO:0005887; GO:0007162; GO:0007411; GO:0008360; GO:0017154; GO:0021612; GO:0021628; GO:0021637; GO:0021766; GO:0021785; GO:0021828; GO:0021860; GO:0030334; GO:0043087; GO:0048843; GO:0048846; GO:0050772; GO:0050919; GO:0051495; GO:0071526; GO:0097485; GO:1902287 semaphorin receptor activity [GO:0017154] ALTLPAMMGLAAGGGLLLLAITAVLVAYKRK 0.99446 -12.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5494 0 0 10.5855 0 0 0 0 0 0 0 0 0 12.116 0 0 0 0 0 0 0 0 0 0 12.962 13.8284 0 0 0 0 0 0 0 0 0 0 13.3334 0 0 0 0 0 0 0 0 0 0 0 14.2476 13.0626 0 0 0 12.2805 0 14.2694 13.3706 0 13.0955 0 0 0 0 0 0 12.7949 0 13.8038 0 0 0 12.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1123 0 0 P59665 DEF1_HUMAN "Neutrophil defensin 1 (Defensin, alpha 1) (HNP-1, HP-1, HP1) [Cleaved into: HP 1-56; Neutrophil defensin 2 (HNP-2, HP-2, HP2) ]" DEFA1 DEF1 DEFA2 MRS; DEFA1B Homo sapiens (Human) antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemotaxis [GO:0006935]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; innate immune response in mucosa [GO:0002227]; intracellular estrogen receptor signaling pathway [GO:0030520]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; modification by host of symbiont membrane [GO:0052337]; T cell chemotaxis [GO:0010818] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796] azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemotaxis [GO:0006935]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; innate immune response in mucosa [GO:0002227]; intracellular estrogen receptor signaling pathway [GO:0030520]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; membrane disruption in another organism [GO:0051673]; modification by host of symbiont membrane [GO:0052337]; T cell chemotaxis [GO:0010818] GO:0002227; GO:0005576; GO:0005615; GO:0005796; GO:0006935; GO:0006955; GO:0010818; GO:0019731; GO:0030520; GO:0031640; GO:0035578; GO:0042832; GO:0050829; GO:0050830; GO:0050832; GO:0051607; GO:0051673; GO:0051873; GO:0052337; GO:0061844; GO:0062023; GO:0070062; GO:0071222 NMACYCR 0.99446 -9.0233 0 0 0 10.44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7401 14.5684 14.3864 14.4792 14.593 14.3105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3241 0 0 0 0 0 0 Q04759 KPCT_HUMAN "Protein kinase C theta type, EC 2.7.11.13 (nPKC-theta)" PRKCQ PRKCT Homo sapiens (Human) "axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]" aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886] "aggresome [GO:0016235]; centriolar satellite [GO:0034451]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; axon guidance [GO:0007411]; CD4-positive, alpha-beta T cell proliferation [GO:0035739]; cell chemotaxis [GO:0060326]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of T cell apoptotic process [GO:0070233]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell activation [GO:0050870]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 2 cell activation [GO:2000570]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of platelet aggregation [GO:0090330]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001558; GO:0001772; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005524; GO:0005829; GO:0005886; GO:0006355; GO:0006468; GO:0006509; GO:0006954; GO:0007411; GO:0016235; GO:0018105; GO:0032212; GO:0032740; GO:0032743; GO:0032753; GO:0034451; GO:0035556; GO:0035739; GO:0038095; GO:0046627; GO:0046872; GO:0050870; GO:0051092; GO:0051973; GO:0060326; GO:0070233; GO:0090330; GO:0106310; GO:1904355; GO:2000318; GO:2000563; GO:2000570 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ATFYAAEIILGLQFLHSKGIVYR 0.99446 -15.619 0 0 0 0 0 0 0 0 0 0 0 0 13.5148 0 0 0 0 0 0 13.5986 11.9734 0 0 0 0 0 0 0 13.0579 0 0 0 12.3767 0 0 0 0 0 0 12.2035 12.3896 0 0 0 0 0 0 0 12.2212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0077 13.3254 12.9038 0 0 0 0 11.5032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1499 0 12.5424 0 0 0 0 0 14.0765 0 11.3278 0 0 0 0 13.3738 0 16.9283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4786 12.9729 0 0 0 0 0 13.7447 0 0 0 0 0 0 12.7765 0 0 0 0 0 0 0 14.3534 0 12.5157 12.6794 0 13.3372 0 0 0 0 0 0 0 0 0 0 0 0 Q13796 SHRM2_HUMAN Protein Shroom2 (Apical-like protein) (Protein APXL) SHROOM2 APXL Homo sapiens (Human) actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280]; actin filament organization [GO:0007015]; apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438] GO:0002089; GO:0003779; GO:0005737; GO:0005856; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0007015; GO:0007420; GO:0008013; GO:0008057; GO:0015280; GO:0016324; GO:0016477; GO:0032401; GO:0032438; GO:0043010; GO:0043296; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015; GO:0070062 actin binding [GO:0003779]; actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; ligand-gated sodium channel activity [GO:0015280] DRCTSPPGLSYMKAK 0.99446 -15.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0283 12.8554 14.9212 0 11.5225 13.0198 0 0 0 14.5994 0 14.6133 0 0 0 13.2218 13.2163 0 0 0 0 11.4987 13.1254 0 0 0 0 0 12.0355 0 0 0 0 14.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9679 0 14.0236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8352 0 0 0 0 0 0 11.823 0 0 0 0 10.9913 14.9023 0 0 0 0 0 0 0 13.5152 0 0 13.6795 0 0 0 0 0 Q14019 COTL1_HUMAN Coactosin-like protein COTL1 CLP Homo sapiens (Human) defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833] cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774] cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832]; regulation of actin filament polymerization [GO:0030833] GO:0003779; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0019899; GO:0030833; GO:0030864; GO:0034774; GO:0050832; GO:0051015; GO:0070062; GO:1904813 actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899] ELEEDFIKSELK 0.99446 -8.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6046 0 0 0 0 0 0 13.1395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16828 DUS6_HUMAN "Dual specificity protein phosphatase 6, EC 3.1.3.16, EC 3.1.3.48 (Dual specificity protein phosphatase PYST1) (Mitogen-activated protein kinase phosphatase 3, MAP kinase phosphatase 3, MKP-3)" DUSP6 MKP3 PYST1 Homo sapiens (Human) cell differentiation [GO:0030154]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; regulation of heart growth [GO:0060420]; response to growth factor [GO:0070848]; response to nitrosative stress [GO:0051409]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330]; cell differentiation [GO:0030154]; ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of apoptotic process [GO:0043065]; regulation of heart growth [GO:0060420]; response to growth factor [GO:0070848]; response to nitrosative stress [GO:0051409]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410] GO:0000165; GO:0001933; GO:0004721; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0008330; GO:0009410; GO:0014070; GO:0017017; GO:0017018; GO:0030154; GO:0035335; GO:0043065; GO:0043409; GO:0051409; GO:0060420; GO:0070371; GO:0070373; GO:0070848 MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330] ALFTRGEDRDR 0.99446 -9.0222 0 0 0 0 0 0 0 0 0 0 0 10.3563 0 0 0 0 0 0 10.9046 0 0 0 10.6998 0 0 0 0 0 0 10.7903 0 0 0 0 0 0 10.6362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0972 0 0 0 0 0 0 0 0 0 14.7142 0 0 0 0 0 0 0 0 0 0 0 0 14.1184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3613 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TV6 TTC7B_HUMAN "Tetratricopeptide repeat protein 7B, TPR repeat protein 7B (Tetratricopeptide repeat protein 7-like-1, TPR repeat protein 7-like-1)" TTC7B TTC7L1 Homo sapiens (Human) phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659] GO:0005829; GO:0005886; GO:0046854; GO:0072659 AHVLYFK 0.99446 -9.0159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9816 0 0 0 0 0 0 0 13.7123 14.3119 0 0 16.1281 0 0 14.3445 0 14.0409 0 0 0 13.7907 0 0 13.493 0 0 0 0 0 13.6508 13.3929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9927 0 0 0 0 15.2094 0 0 0 0 0 0 14.9555 0 0 0 15.0342 12.3701 0 0 0 0 12.0869 0 0 0 15.1541 0 0 0 0 0 0 12.0192 0 13.9465 0 0 0 0 0 0 0 12.2478 0 0 0 0 0 0 0 10.7031 0 0 0 Q8IUE0 TF2LY_HUMAN "Homeobox protein TGIF2LY (TGF-beta-induced transcription factor 2-like protein) (TGFB-induced factor 2-like protein, Y-linked) (TGIF-like on the Y)" TGIF2LY TGIFLY Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ACPCGPCQR 0.99446 -9.031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYB7 DI3L2_HUMAN "DIS3-like exonuclease 2, hDIS3L2, EC 3.1.13.-" DIS3L2 FAM6A Homo sapiens (Human) "cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; mRNA catabolic process [GO:0006402]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; polysome [GO:0005844] "cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; polysome [GO:0005844]; 3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; ribonuclease activity [GO:0004540]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; mRNA catabolic process [GO:0006402]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process, exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827]" GO:0000175; GO:0000178; GO:0000278; GO:0000287; GO:0000291; GO:0000932; GO:0004540; GO:0005737; GO:0005844; GO:0006402; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0034427; GO:0051301; GO:0051306; GO:1990074 3'-5'-exoribonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; ribonuclease activity [GO:0004540] AFPEQALLR 0.99446 -8.5232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9324 12.7065 0 11.3859 12.7538 12.3321 12.5856 0 11.978 11.3363 13.5651 12.4635 14.2616 0 0 13.059 0 0 0 0 0 0 0 0 0 11.9671 11.8049 13.1798 0 12.9514 0 13.0888 0 13.0547 0 0 0 12.3486 13.3895 10.9476 0 0 0 0 0 0 0 0 0 0 0 0 15.6378 15.3286 15.8792 15.7976 16.1563 18.1866 0 18.6609 18.6282 0 0 14.775 13.8025 0 14.2666 15.6557 15.4779 14.8276 13.4813 0 14.3812 15.6627 0 0 14.055 14.453 13.4089 15.3977 0 14.7442 0 13.0121 0 15.1778 13.6864 15.365 13.5355 0 0 11.9998 0 14.7979 13.9319 13.2595 19.8117 0 0 13.1884 15.209 0 12.9164 0 0 0 14.3063 0 18.9181 0 14.9767 0 12.6872 15.4421 0 0 19.1421 13.1886 0 0 0 0 19.2337 14.3567 0 13.1693 14.3139 15.2846 0 0 16.3691 0 0 12.5013 0 0 13.9484 14.5732 0 0 0 12.0319 15.0868 0 0 0 0 12.9573 12.6145 0 0 12.7176 13.1536 0 0 12.5675 12.4585 16.1821 0 0 0 0 0 12.8 0 0 Q96I59 SYNM_HUMAN "Probable asparagine--tRNA ligase, mitochondrial, EC 6.1.1.22 (Asparaginyl-tRNA synthetase, AsnRS)" NARS2 Homo sapiens (Human) asparaginyl-tRNA aminoacylation [GO:0006421] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421] GO:0003676; GO:0004816; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006421 asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676] CPEDVELCHKFIAPGQKDR 0.99446 -8.5229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7137 0 0 0 11.8337 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2701 0 0 0 0 0 13.3372 0 0 0 0 0 0 0 0 0 0 0 0 18.2954 0 0 17.3952 17.2928 0 0 0 17.6856 0 0 0 17.7663 0 0 0 16.6913 0 0 0 16.4879 0 0 0 0 0 0 0 0 16.979 16.7348 13.8284 0 0 0 0 0 0 0 0 0 17.5992 0 0 0 0 0 0 0 0 0 13.7296 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8687 0 0 0 0 0 0 0 0 0 13.2494 0 0 0 14.2085 0 14.2016 0 0 17.1222 12.2366 0 0 0 0 14.7979 0 0 0 0 Q96LZ7 RMD2_HUMAN "Regulator of microtubule dynamics protein 2, RMD-2, hRMD-2 (Protein FAM82A1)" RMDN2 FAM82A FAM82A1 BLOCK18 UNQ9371/PRO34163 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017] GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005876; GO:0008017; GO:0016021; GO:0072686; GO:0097431 microtubule binding [GO:0008017] ELILGIMVGTAGISLLLLWYHK 0.99446 -9.0176 0 0 0 0 0 0 0 0 12.6653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9559 0 15.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8529 0 0 0 0 0 0 0 0 0 0 Q9H2Y9 SO5A1_HUMAN "Solute carrier organic anion transporter family member 5A1 (Organic anion transporter polypeptide-related protein 4, OATP-RP4, OATPRP4) (Solute carrier family 21 member 15)" SLCO5A1 OATP5A1 SLC21A15 Homo sapiens (Human) sodium-independent organic anion transport [GO:0043252] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; sodium-independent organic anion transport [GO:0043252] GO:0005886; GO:0005887; GO:0015347; GO:0043231; GO:0043252 sodium-independent organic anion transmembrane transporter activity [GO:0015347] CEPETLR 0.99446 -7.9967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8106 12.2756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZ94 NLGN3_HUMAN Neuroligin-3 (Gliotactin homolog) NLGN3 KIAA1480 NL3 Homo sapiens (Human) "adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]" "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]" "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; excitatory synapse [GO:0060076]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; inhibitory postsynaptic potential [GO:0060080]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; receptor-mediated endocytosis [GO:0006898]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625]" GO:0002087; GO:0005886; GO:0005887; GO:0006898; GO:0007158; GO:0007268; GO:0007416; GO:0007612; GO:0009986; GO:0030139; GO:0030534; GO:0035176; GO:0038023; GO:0042043; GO:0045202; GO:0048488; GO:0048675; GO:0050804; GO:0050808; GO:0050839; GO:0051965; GO:0051968; GO:0060024; GO:0060076; GO:0060080; GO:0070161; GO:0071625; GO:0089717; GO:0097104; GO:0097105; GO:0097110; GO:0098793; GO:0098983; GO:0098985; GO:0099054; GO:0099055; GO:0099060; GO:2000463; GO:2000969 cell adhesion molecule binding [GO:0050839]; neurexin family protein binding [GO:0042043]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] ANRFEEVAWSKYNPR 0.99446 -12.904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.791 0 0 12.7245 0 0 0 0 0 0 0 Q9UK28 TM59L_HUMAN Transmembrane protein 59-like (Brain-specific membrane-anchored protein) TMEM59L BSMAP C19orf4 Homo sapiens (Human) branching involved in ureteric bud morphogenesis [GO:0001658] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; branching involved in ureteric bud morphogenesis [GO:0001658] GO:0000139; GO:0001658; GO:0016020; GO:0016021 LKLDLTKL 0.99446 -8.5295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1835 0 0 16.4387 14.3542 0 15.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0195 0 13.8569 0 14.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7767 20.8709 0 0 0 17.085 0 0 0 18.8455 0 0 0 0 19.6664 13.4116 0 0 0 0 0 0 0 19.568 0 19.5456 13.2267 12.0221 0 0 19.5122 19.4371 0 13.084 0 13.3682 17.7269 0 0 14.0797 0 19.4685 0 0 18.0913 0 0 0 19.5414 0 19.5227 0 0 0 0 18.6919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2381 0 0 0 0 0 0 0 0 Q9UK76 JUPI1_HUMAN "Jupiter microtubule associated homolog 1 (Androgen-regulated protein 2) (Hematological and neurological expressed 1 protein) [Cleaved into: Jupiter microtubule associated homolog 1, N-terminally processed ]" JPT1 ARM2 HN1 Homo sapiens (Human) cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0031965 RNPPGGK 0.99446 -9.0342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4306 14.5563 0 15.0572 14.8097 11.2041 12.642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y233 PDE10_HUMAN "cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A, EC 3.1.4.17" PDE10A Homo sapiens (Human) cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165] cytosol [GO:0005829] "cytosol [GO:0005829]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; signal transduction [GO:0007165]" GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0007165; GO:0010754; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]" CALFQVDHK 0.99446 -13.762 0 0 13.2136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1747 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.739 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0526 0 0 0 0 0 0 0 0 0 0 12.6046 13.0322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.283 0 0 0 0 0 0 0 13.9598 0 0 0 0 0 0 0 0 0 0 0 12.7335 0 0 0 0 10.854 0 0 0 0 0 14.1087 12.9109 0 0 13.2556 0 Q9Y644 RFNG_HUMAN "Beta-1,3-N-acetylglucosaminyltransferase radical fringe, EC 2.4.1.222 (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)" RFNG Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; regulation of Notch signaling pathway [GO:0008593] extracellular region [GO:0005576]; integral component of Golgi membrane [GO:0030173] extracellular region [GO:0005576]; integral component of Golgi membrane [GO:0030173]; acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein binding [GO:0032092]; regulation of Notch signaling pathway [GO:0008593] GO:0005576; GO:0007389; GO:0007399; GO:0008375; GO:0008593; GO:0009887; GO:0030154; GO:0030173; GO:0032092; GO:0033829; GO:0045747; GO:0046872 acetylglucosaminyltransferase activity [GO:0008375]; metal ion binding [GO:0046872]; O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity [GO:0033829] ACLALAAALAALLLLPLPLPR 0.99446 -8.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5758 0 0 0 0 0 0 0 0 0 14.2329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4C4 MFHA1_HUMAN Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1) MFHAS1 MASL1 Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte differentiation [GO:0030218]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; regulation of macrophage activation [GO:0043030] GO:0005525; GO:0005737; GO:0006954; GO:0030218; GO:0031625; GO:0034136; GO:0034137; GO:0034144; GO:0035308; GO:0043030; GO:0045087; GO:0046330; GO:0050728; GO:0051721; GO:0051897; GO:0070374; GO:1900181; GO:1900745 GTP binding [GO:0005525]; protein phosphatase 2A binding [GO:0051721]; ubiquitin protein ligase binding [GO:0031625] DNPLIQPPYEVCMKGIPYIAAYQK 0.99447 -13.812 11.9032 0 11.7187 13.391 14.377 15.4451 14.1532 14.8378 0 0 0 0 0 0 0 0 0 0 0 15.4506 12.9135 16.5392 12.8928 16.3596 13.0541 15.57 0 0 0 0 0 0 0 0 0 10.7485 0 11.8788 0 0 0 0 0 0 12.602 0 0 0 0 0 0 0 17.1207 0 0 0 0 15.1359 0 0 0 9.78377 0 0 0 0 18.4545 18.506 18.4163 19.0418 18.3893 18.947 0 17.6057 18.6967 17.9209 15.2063 17.8564 14.6638 0 19.0515 17.9748 18.7418 19.8477 16.4939 0 18.2924 17.7286 14.9836 19.7253 19.7827 19.7871 14.8999 19.2551 17.6151 19.7994 19.2382 17.7039 17.7363 19.4304 17.6686 19.6915 19.6846 15.5137 19.6254 19.5475 16.5382 19.0858 19.7522 20.1311 15.7123 19.2401 19.5397 19.0835 19.6634 14.5802 14.6025 15.2481 19.7213 19.6812 15.6341 19.3988 17.9221 17.8597 15.3416 17.6708 19.0643 19.5032 19.5614 19.5727 11.4738 19.6442 19.367 19.3981 14.5084 19.2588 19.4065 14.0707 15.1044 19.9271 0 19.4718 17.984 18.9323 0 17.7685 19.3486 0 0 19.2453 15.1662 19.4609 17.8189 19.5663 19.9246 17.7604 15.4859 0 0 0 0 0 0 14.5611 11.5287 12.7014 0 13.9281 0 11.8189 0 19.0824 14.3761 19.1686 0 0 0 13.1561 15.3594 0 A0PJY2 FEZF1_HUMAN Fez family zinc finger protein 1 (Zinc finger protein 312B) FEZF1 FEZ ZNF312B Homo sapiens (Human) "axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; interneuron migration [GO:1904936]; negative regulation of cell population proliferation [GO:0008285]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; axon guidance [GO:0007411]; cell dedifferentiation [GO:0043697]; forebrain anterior/posterior pattern specification [GO:0021797]; interneuron migration [GO:1904936]; negative regulation of cell population proliferation [GO:0008285]; olfactory bulb development [GO:0021772]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0003700; GO:0005654; GO:0005829; GO:0006357; GO:0007411; GO:0008285; GO:0021772; GO:0021797; GO:0043697; GO:0045666; GO:0045893; GO:0046872; GO:0050767; GO:1904936 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DALPLQQYKLVRPR 0.99447 -8.5686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6505 0 0 0 0 11.9549 0 0 0 0 0 0 0 0 11.9902 0 12.1842 0 0 11.7703 0 0 11.5988 0 0 0 0 0 11.2979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8024 0 0 0 0 0 12.4206 0 0 0 0 0 0 0 0 0 14.4331 0 14.8652 0 0 0 0 0 0 0 0 0 0 0 13.8469 0 0 0 14.7212 11.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8066 14.818 0 0 0 0 O43427 FIBP_HUMAN "Acidic fibroblast growth factor intracellular-binding protein, aFGF intracellular-binding protein (FGF-1 intracellular-binding protein)" FIBP Homo sapiens (Human) fibroblast growth factor receptor signaling pathway [GO:0008543]; platelet aggregation [GO:0070527] endomembrane system [GO:0012505]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634] endomembrane system [GO:0012505]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor signaling pathway [GO:0008543]; platelet aggregation [GO:0070527] GO:0005634; GO:0005739; GO:0008543; GO:0012505; GO:0016020; GO:0016607; GO:0017134; GO:0070527 fibroblast growth factor binding [GO:0017134] LLHAPPK 0.99447 -13.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6163 0 0 14.9155 0 9.39221 0 14.5996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5561 0 0 0 0 0 0 0 O60658 PDE8A_HUMAN "High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A, EC 3.1.4.53" PDE8A Homo sapiens (Human) "cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell death [GO:0060548]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of cell death [GO:0060548]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" GO:0001934; GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0006355; GO:0007165; GO:0019900; GO:0046872; GO:0047555; GO:0060548; GO:0070062; GO:0070374; GO:0071364; GO:1903206 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]" CNIFKNMER 0.99447 -8.5678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3731 0 0 0 0 0 0 0 0 11.0755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1708 0 0 0 0 0 0 11.5473 0 0 0 0 0 0 0 0 0 0 11.7714 0 0 0 0 0 0 0 12.8835 0 0 0 0 0 O75175 CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2) CNOT3 KIAA0691 LENG2 NOT3 Homo sapiens (Human) "gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829]" CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] "CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription, DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829]" GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036 KQSWRFHTK 0.99447 -13.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4639 0 0 0 0 0 0 15.2194 0 0 0 0 14.1734 13.7306 0 14.0185 0 16.583 13.4872 15.4107 15.7556 13.5998 14.4935 14.5473 13.9195 14.7605 0 0 0 0 0 15.5701 0 0 0 0 0 0 0 0 0 0 0 12.8912 12.6422 0 11.3154 0 0 0 0 0 0 0 0 0 0 11.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7935 0 0 0 0 0 0 11.8969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6813 16.9561 15.0127 14.205 0 14.2759 0 0 13.6739 0 0 0 0 0 0 13.1366 0 0 O94906 PRP6_HUMAN "Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1, ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein, U5-102 kDa protein)" PRPF6 C20orf14 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]" catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000244; GO:0000245; GO:0000375; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0006403; GO:0008380; GO:0016020; GO:0016607; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013 identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] AILEKSRLK 0.99447 -11.095 0 0 0 0 0 0 13.4105 0 0 0 0 0 13.8411 0 0 13.3127 12.8645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2739 0 0 0 0 0 0 0 0 13.8572 0 0 0 0 0 0 0 0 13.9685 0 13.4992 11.9484 0 13.4267 13.5898 0 0 14.1213 0 0 0 13.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0637 0 0 12.5754 0 0 0 0 0 0 0 0 0 0 0 O95834 EMAL2_HUMAN "Echinoderm microtubule-associated protein-like 2, EMAP-2, HuEMAP-2" EML2 EMAP2 EMAPL2 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; spindle [GO:0005819]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule polymerization [GO:0031115]; regulation of microtubule nucleation [GO:0010968]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601] GO:0000226; GO:0005102; GO:0005737; GO:0005819; GO:0005874; GO:0005875; GO:0007601; GO:0007605; GO:0008017; GO:0008022; GO:0010968; GO:0015631; GO:0031115; GO:0043621 microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; signaling receptor binding [GO:0005102]; tubulin binding [GO:0015631] ETKVVDVK 0.99447 -13.839 0 0 0 0 0 0 0 0 12.4469 0 0 0 0 0 12.4419 0 0 11.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6554 0 0 0 0 0 0 0 0 0 12.6788 0 0 9.54189 0 12.8084 11.443 11.6947 0 0 0 9.94639 10.1616 0 0 0 0 0 0 0 12.0783 0 0 0 0 0 12.4925 0 0 0 0 0 0 0 0 0 0 15.7555 0 0 0 13.6838 0 0 0 13.5077 18.3972 0 18.6879 18.6426 0 0 0 0 0 0 0 14.9824 0 16.0517 0 0 14.8006 0 0 0 0 17.1627 0 15.0791 0 14.8103 0 14.9613 0 16.2916 0 15.3088 0 0 0 14.9695 13.6862 0 0 0 0 0 0 0 0 14.582 0 13.3813 0 0 0 0 0 0 12.1343 0 0 12.5191 0 0 0 0 0 0 14.9407 14.798 0 0 14.9313 14.4244 0 14.7306 15.4036 9.74836 0 0 15.0858 0 12.7268 14.4865 14.3601 0 15.3401 0 0 0 0 P17483 HXB4_HUMAN Homeobox protein Hox-B4 (Homeobox protein Hox-2.6) (Homeobox protein Hox-2F) HOXB4 HOX2F Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; spleen development [GO:0048536] centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; definitive hemopoiesis [GO:0060216]; embryonic skeletal system morphogenesis [GO:0048704]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]; spleen development [GO:0048536]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0002011; GO:0005634; GO:0005654; GO:0005813; GO:0006357; GO:0009952; GO:0045944; GO:0048103; GO:0048536; GO:0048539; GO:0048704; GO:0060216; GO:0060218; GO:0071425; GO:1990837; GO:2000738 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AACTVQR 0.99447 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49746 TSP3_HUMAN Thrombospondin-3 THBS3 TSP3 Homo sapiens (Human) bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931] GO:0003417; GO:0005509; GO:0005576; GO:0007160; GO:0008201; GO:0043931; GO:0048471; GO:0060346; GO:0062023 calcium ion binding [GO:0005509]; heparin binding [GO:0008201] CNDTVPEDFEPFR 0.99447 -8.0074 0 0 0 0 0 0 0 0 0 15.4874 0 0 0 0 0 0 0 0 0 0 0 0 16.0498 0 12.2272 0 0 0 0 12.31 0 13.3508 0 0 0 0 11.6166 0 0 0 0 0 0 0 0 0 0 11.9943 0 0 11.5154 0 17.9206 0 0 0 11.2512 16.2254 0 0 15.556 16.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8081 0 0 0 0 0 0 13.3302 13.107 0 13.2731 0 0 0 0 0 0 0 0 0 0 0 0 12.2704 12.2922 0 0 0 0 0 0 0 0 0 0 12.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7121 0 12.9361 0 0 0 0 0 0 0 0 12.6139 18.3274 0 0 0 0 0 0 0 0 0 13.2038 13.1252 0 13.5854 0 0 0 14.694 0 0 12.731 12.6927 0 20.496 20.5686 0 0 0 0 0 0 Q12979 ABR_HUMAN Active breakpoint cluster region-related protein ABR Homo sapiens (Human) activation of GTPase activity [GO:0090630]; modulation of chemical synaptic transmission [GO:0050804]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of GTPase activity [GO:0090630]; modulation of chemical synaptic transmission [GO:0050804]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005096; GO:0005829; GO:0007264; GO:0016020; GO:0030424; GO:0043197; GO:0050804; GO:0051056; GO:0070161; GO:0090630; GO:0098685; GO:0098978 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] DNNEIVDKIMGK 0.99447 -8.5641 0 0 0 0 0 0 0 9.97771 0 0 13.339 0 0 0 0 14.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.782 0 0 0 0 0 0 0 0 12.9725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9681 0 0 0 0 0 0 0 0 0 0 14.8974 0 14.441 0 0 0 0 0 0 13.9041 0 13.0479 0 0 12.7372 0 0 18.4938 15.5242 16.5885 0 0 13.1837 13.9358 15.8673 0 0 0 13.7358 0 0 0 0 0 12.5407 0 0 0 0 0 0 15.2512 0 0 0 0 0 0 0 0 15.5914 0 0 0 15.1251 14.9865 0 15.1221 0 0 0 0 13.7678 0 15.4145 0 0 0 0 12.1057 0 0 0 16.1351 14.9735 0 14.3294 12.264 0 0 0 0 11.9124 0 0 0 13.7994 0 0 0 0 0 0 15.0308 0 0 0 0 0 14.464 0 Q14CN2 CLCA4_HUMAN "Calcium-activated chloride channel regulator 4, EC 3.4.-.- (Calcium-activated chloride channel family member 4, hCLCA4) (Calcium-activated chloride channel protein 2, CaCC-2, hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form ]" CLCA4 CaCC2 UNQ562/PRO1124 Homo sapiens (Human) ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] GO:0004222; GO:0005229; GO:0005254; GO:0005576; GO:0005886; GO:0005887; GO:0006508; GO:0016324; GO:0034220; GO:0046872 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AHGGANTARLKLR 0.99447 -11.125 0 0 0 0 0 9.59751 0 10.2267 0 0 0 0 0 12.7622 0 0 0 18.0027 0 0 0 0 9.46909 0 9.11982 14.4067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7462 0 0 15.8423 14.5441 0 0 11.3388 11.3832 0 0 0 0 0 0 0 0 0 0 0 15.0478 14.6699 0 0 0 10.8002 0 0 11.4514 10.991 0 11.8971 15.6701 0 12.5012 0 12.0565 0 15.6801 15.4233 11.9573 16.0864 0 13.3211 0 12.3681 0 0 14.5477 14.3529 12.0956 0 11.4184 12.0814 16.9545 0 0 0 0 0 0 0 0 13.5996 0 0 0 0 12.2582 0 0 0 0 0 0 11.8598 0 0 0 0 0 11.9955 14.2408 0 0 0 10.1674 0 0 0 0 0 19.4191 0 10.9567 18.9513 0 0 13.4436 0 18.1565 0 0 13.8053 0 17.2978 0 19.0206 12.5854 0 11.6437 0 13.2184 0 0 0 0 0 12.2054 0 0 0 0 0 0 10.8049 0 0 11.9601 11.0613 0 Q2WGN9 GAB4_HUMAN "GRB2-associated-binding protein 4 (GRB2-associated binder 2-like, GAB2-like) (GRB2-associated binder 4) (GRB2-associated-binding protein 2-like) (Growth factor receptor bound protein 2-associated protein 4)" GAB4 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; signal transduction [GO:0007165] GO:0005068; GO:0005737; GO:0007165; GO:0035591 signaling adaptor activity [GO:0035591]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] KLRLFAWR 0.99447 -15.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8681 0 13.0498 14.3726 0 12.5709 0 12.4177 0 0 0 0 0 0 10.5307 0 0 0 0 0 11.0431 0 0 0 13.2528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9654 0 0 0 0 Q8NBI5 S43A3_HUMAN Equilibrative nucleobase transporter 1 (Protein FOAP-13) (Solute carrier family 43 member 3) SLC43A3 ENBT1 PSEC0252 Homo sapiens (Human) hypoxanthine transport [GO:0035344] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910]; hypoxanthine transport [GO:0035344] GO:0015207; GO:0015208; GO:0015245; GO:0016021; GO:0016323; GO:0035344; GO:0042910 adenine transmembrane transporter activity [GO:0015207]; fatty acid transmembrane transporter activity [GO:0015245]; guanine transmembrane transporter activity [GO:0015208]; xenobiotic transmembrane transporter activity [GO:0042910] EEKETAEHENR 0.99447 -15.685 0 0 9.64557 0 0 0 0 0 0 0 13.0678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8637 0 0 0 0 0 0 0 18.2458 0 12.7426 0 0 12.2222 0 0 0 11.8064 0 0 15.7814 0 0 0 0 0 12.2936 0 0 0 0 0 0 0 0 0 12.92 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1949 0 0 0 0 0 0 0 11.454 14.8445 0 0 0 0 15.1819 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9598 14.1217 0 13.3898 0 0 13.5503 0 12.7362 0 0 0 0 0 0 0 15.6201 0 0 0 0 0 Q8NGN7 O10D4_HUMAN Putative olfactory receptor 10D4 OR10D4P OR10D4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DVKSDQP 0.99447 -15.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5949 0 0 0 0 0 11.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHB8 OR5K2_HUMAN Olfactory receptor 5K2 (Olfactory receptor OR3-9) OR5K2 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] EVISVLRKILLK 0.99447 -8.8155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.38027 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7632 0 0 0 0 0 0 0 0 0 0 10.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8675 0 0 0 0 0 0 0 0 0 12.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969M7 UBE2F_HUMAN "NEDD8-conjugating enzyme UBE2F, EC 2.3.2.32 (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F)" UBE2F NCE2 Homo sapiens (Human) post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116] GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0043687; GO:0045116; GO:0061654 ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788] LTLASKLKR 0.99447 -9.0653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QT4 TRPM7_HUMAN "Transient receptor potential cation channel subfamily M member 7, EC 2.7.11.1 (Channel-kinase 1) (Long transient receptor potential channel 7, LTrpC-7, LTrpC7)" TRPM7 CHAK1 LTRPC7 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; cation transmembrane transport [GO:0098655]; cellular magnesium ion homeostasis [GO:0010961]; divalent inorganic cation homeostasis [GO:0072507]; necroptotic process [GO:0070266]; protein autophosphorylation [GO:0046777]; protein tetramerization [GO:0051262] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle [GO:0001726] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; cation transmembrane transport [GO:0098655]; cellular magnesium ion homeostasis [GO:0010961]; divalent inorganic cation homeostasis [GO:0072507]; necroptotic process [GO:0070266]; protein autophosphorylation [GO:0046777]; protein tetramerization [GO:0051262] GO:0001726; GO:0003779; GO:0004674; GO:0005261; GO:0005262; GO:0005524; GO:0005886; GO:0005887; GO:0006816; GO:0010961; GO:0016340; GO:0017022; GO:0031032; GO:0046777; GO:0046872; GO:0051262; GO:0070266; GO:0070588; GO:0072507; GO:0098655; GO:0106310 actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DEIVDIDDPETK 0.99447 -8.8166 0 0 0 0 0 0 0 0 0 0 0 12.9151 11.718 0 12.1065 0 11.808 0 0 10.4308 12.6425 0 0 0 0 12.768 12.1955 12.6945 0 12.1334 11.6547 12.1655 11.2897 0 12.0466 0 0 12.6293 0 0 0 11.6784 11.8571 0 0 0 0 0 0 0 12.7326 0 0 0 0 0 0 0 0 0 0 11.3917 0 0 0 0 12.4806 12.1909 0 0 0 11.9968 0 12.7961 0 0 0 0 0 0 0 12.3729 13.593 16.0701 0 14.3627 13.9649 14.3713 14.9719 0 14.7639 0 16.5409 0 13.3923 13.2175 16.5686 13.6201 14.4593 13.3323 11.3116 0 0 0 0 0 0 0 13.1955 12.0395 13.9465 13.6206 0 13.3369 14.0578 0 0 14.2428 13.7426 0 11.9254 0 13.7847 11.3914 14.9371 12.8427 0 13.0883 12.6719 13.0256 14.0153 0 13.4802 12.4797 13.6032 14.2106 14.0233 0 12.23 13.1185 13.6258 0 0 0 12.5295 0 0 0 9.6414 13.171 11.811 13.8388 0 0 12.4531 11.901 0 0 0 0 0 12.8521 0 12.3919 0 0 16.3994 12.9027 0 11.6819 0 0 13.172 0 12.5304 0 0 12.723 12.1165 0 Q96RP9 EFGM_HUMAN "Elongation factor G, mitochondrial, EF-Gmt (Elongation factor G 1, mitochondrial, mEF-G 1) (Elongation factor G1, hEFG1)" GFM1 EFG EFG1 GFM Homo sapiens (Human) mitochondrial translational elongation [GO:0070125] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125] GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0005759; GO:0070125 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] EDPTFKVYFDTENK 0.99447 -13.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4281 0 0 0 0 12.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9951 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVG9 PTSS2_HUMAN "Phosphatidylserine synthase 2, PSS-2, PtdSer synthase 2, EC 2.7.8.29 (Serine-exchange enzyme II)" PTDSS2 PSS2 Homo sapiens (Human) phosphatidylserine biosynthetic process [GO:0006659] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740]; phosphatidylserine biosynthetic process [GO:0006659] GO:0003882; GO:0005789; GO:0006659; GO:0016020; GO:0016021; GO:0016740; GO:0106245 CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740] FFLRDITLRYK 0.99447 -8.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4725 0 0 0 0 9.78834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0422 0 0 0 0 0 0 13.1376 13.2846 13.2032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5063 0 0 12.6371 0 0 12.3703 12.2537 0 0 0 0 0 0 0 0 10.7599 0 0 11.5572 0 0 0 0 0 0 0 0 0 0 0 0 12.4578 0 0 0 0 0 0 0 11.8934 0 0 0 12.8946 0 0 0 Q9H0C3 TM117_HUMAN Transmembrane protein 117 TMEM117 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059] GO:0005783; GO:0005886; GO:0016021; GO:0070059 FIGASLDVK 0.99447 -8.5665 0 11.5417 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7127 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4234 0 0 0 0 0 0 10.1307 13.0347 0 0 0 0 0 0 0 0 11.4168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2736 0 0 14.6954 11.415 0 0 0 0 0 0 0 0 0 0 0 14.3063 14.566 14.7405 0 0 15.1718 0 14.3329 0 0 0 0 13.5848 13.6407 0 13.7262 0 0 13.9464 13.0722 0 0 15.6612 14.8326 0 0 0 0 0 13.4549 14.6466 14.4376 15.0026 0 12.9885 0 0 0 0 13.4272 13.4023 0 13.6692 0 0 0 10.9415 0 10.6493 0 12.3356 0 0 0 13.9946 0 0 0 0 0 10.417 0 0 0 11.6672 0 0 0 0 0 0 0 0 0 11.728 0 0 0 0 0 0 0 0 11.8929 0 0 0 0 0 0 12.2129 11.8481 0 0 0 0 0 10.7255 Q9NS40 KCNH7_HUMAN "Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3, ERG-3, Eag-related protein 3, Ether-a-go-go-related protein 3, hERG-3) (Voltage-gated potassium channel subunit Kv11.3)" KCNH7 ERG3 Homo sapiens (Human) circadian rhythm [GO:0007623]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; circadian rhythm [GO:0007623]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] GO:0005242; GO:0005249; GO:0005886; GO:0005887; GO:0007623; GO:0034765; GO:0042391; GO:0044877; GO:0071805; GO:0086011 inward rectifier potassium channel activity [GO:0005242]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249] DITDMRSWER 0.99447 -36.047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1536 17.8312 17.6969 0 0 0 16.8422 0 0 0 0 0 0 0 0 0 0 0 12.626 0 0 0 0 0 0 0 0 0 16.5601 0 0 0 0 0 0 0 0 0 0 17.7743 0 11.4923 12.2596 0 0 0 0 15.5309 0 0 0 0 0 0 13.2273 0 0 0 0 0 0 0 0 0 0 0 0 13.1829 0 0 0 0 0 14.7459 0 10.8016 0 0 13.0644 0 0 0 0 14.5605 0 0 0 0 0 14.8436 0 0 0 0 0 0 0 0 0 0 13.3614 0 0 0 0 0 0 0 13.2688 0 0 0 0 0 0 0 13.1824 0 0 0 0 0 0 14.2605 17.3868 0 0 13.4703 0 13.254 14.392 0 0 0 0 0 0 0 0 0 0 13.8876 14.0435 0 0 17.7528 0 17.1667 0 0 0 0 13.4975 0 0 0 0 0 9.85212 0 0 0 0 0 0 13.7595 Q9UNM6 PSD13_HUMAN 26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5) PSMD13 Homo sapiens (Human) meiosis I [GO:0007127]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000502; GO:0005198; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0006511; GO:0007127; GO:0008541; GO:0016020; GO:0022624; GO:0034774; GO:0043161; GO:1904813 structural molecule activity [GO:0005198] FYDLSSK 0.99447 -11.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7156 0 11.152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4FU69 EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 EFCAB5 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] AEKKLPR 0.99448 -15.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0312 0 0 0 0 0 0 0 0 0 13.268 0 0 0 0 14.989 11.2804 0 0 0 0 11.8455 0 0 0 0 0 0 0 17.0881 0 16.5876 0 15.8639 15.3363 0 0 0 0 15.1871 0 0 10.2653 0 0 0 0 0 19.9567 15.2612 12.3293 0 0 0 0 0 0 0 14.7302 18.7061 0 0 0 0 0 0 0 0 0 0 0 11.5401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1972 0 0 13.2604 19.5619 0 14.1801 0 0 13.341 0 0 11.7872 0 0 0 19.8475 0 0 0 0 0 0 0 12.0293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0044 0 0 0 10.9714 0 0 14.1768 0 14.6656 0 0 10.5904 0 0 O43314 VIP2_HUMAN "Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2, EC 2.7.4.24 (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2, hsVIP2)" PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; phosphorylation [GO:0016310]; sensory perception of sound [GO:0007605] cytosol [GO:0005829] "cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; phosphorylation [GO:0016310]; sensory perception of sound [GO:0007605]" GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0007605; GO:0016310; GO:0032958; GO:0033857; GO:0043647; GO:0052723; GO:0052724; GO:0102092 "5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]" ARLHEILQK 0.99448 -11.481 0 15.0738 0 0 0 0 10.9212 0 12.3971 12.1719 0 0 0 0 0 0 0 0 10.9268 0 0 0 0 0 0 0 0 0 0 0 11.7069 0 0 0 10.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.148 0 0 0 11.8847 0 0 0 0 0 0 0 0 0 12.9816 0 0 0 0 0 0 0 0 0 0 0 12.971 0 0 0 0 0 12.8231 0 13.1294 0 0 0 0 0 0 0 0 14.3362 13.8107 0 0 0 13.4451 0 0 0 0 13.3048 0 11.6407 0 0 0 0 13.1116 0 0 14.2544 0 13.357 0 0 11.3952 0 12.7025 0 0 0 0 0 13.5438 0 0 0 14.0723 0 0 0 0 12.7559 0 0 0 0 0 0 0 0 13.3981 0 0 0 0 0 12.5621 0 13.8754 14.6633 0 O95793 STAU1_HUMAN Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; modification of postsynaptic structure [GO:0099010]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of viral genome replication [GO:0045070]; protein localization to synapse [GO:0035418] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791] cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; modification of postsynaptic structure [GO:0099010]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of viral genome replication [GO:0045070]; protein localization to synapse [GO:0035418] GO:0003723; GO:0003725; GO:0003729; GO:0005737; GO:0005783; GO:0005791; GO:0005829; GO:0005875; GO:0005886; GO:0007281; GO:0008157; GO:0008298; GO:0010494; GO:0016020; GO:0030425; GO:0034599; GO:0035418; GO:0036464; GO:0043005; GO:0043025; GO:0044297; GO:0045070; GO:0046726; GO:0070062; GO:0098964; GO:0098978; GO:0099010; GO:1900273; GO:1990124 double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723] LAQIQQAK 0.99448 -9.3464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95864 FADS2_HUMAN "Acyl-CoA 6-desaturase, EC 1.14.19.3 (Delta(6) fatty acid desaturase, D6D, Delta(6) desaturase, Delta-6 desaturase) (Fatty acid desaturase 2)" FADS2 Homo sapiens (Human) alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; linoleoyl-CoA desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; stearoyl-CoA 9-desaturase activity [GO:0004768]; alpha-linolenic acid metabolic process [GO:0036109]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; unsaturated fatty acid biosynthetic process [GO:0006636]" GO:0004768; GO:0005789; GO:0005887; GO:0006629; GO:0006636; GO:0016020; GO:0016213; GO:0016717; GO:0036109; GO:0043651 "linoleoyl-CoA desaturase activity [GO:0016213]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; stearoyl-CoA 9-desaturase activity [GO:0004768]" ALLDIIRSLK 0.99448 -11.165 0 0 0 0 0 0 0 0 0 0 0 13.0901 0 11.1215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.905 0 15.9399 0 13.8486 13.3426 0 0 0 0 12.1617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4722 10.803 0 0 0 0 0 0 0 13.8312 0 0 13.9765 0 12.9366 0 0 0 13.1311 12.2105 0 13.1807 12.6034 0 12.9835 0 0 0 13.5457 11.8665 13.2512 0 13.2866 0 0 0 0 12.581 0 0 0 13.4427 0 0 13.1958 0 0 0 0 12.5335 0 0 0 0 13.5005 0 0 0 0 0 0 0 0 0 12.3715 0 0 0 0 0 0 0 0 0 0 0 0 0 P00751 CFAB_HUMAN "Complement factor B, EC 3.4.21.47 (C3/C5 convertase) (Glycine-rich beta glycoprotein, GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment ]" CFB BF BFD Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]" blood microparticle [GO:0072562]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; complement binding [GO:0001848]; serine-type endopeptidase activity [GO:0004252]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; positive regulation of immune response [GO:0050778]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]" GO:0001848; GO:0004252; GO:0005576; GO:0005601; GO:0005615; GO:0005886; GO:0006508; GO:0006956; GO:0006957; GO:0009617; GO:0050778; GO:0070062; GO:0072562; GO:1903028 complement binding [GO:0001848]; serine-type endopeptidase activity [GO:0004252] EKLQDEDLGFL 0.99448 -11.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9889 0 0 0 0 0 11.7659 0 11.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0523 0 0 0 0 0 0 20.3941 13.6104 0 0 0 0 0 0 0 0 0 13.7946 0 0 0 0 0 0 12.9722 0 0 0 0 0 0 0 13.7118 0 0 0 0 0 0 0 0 0 13.1604 0 0 0 0 0 12.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1155 0 0 0 0 0 0 0 0 0 12.1508 0 0 0 0 0 0 0 0 0 0 13.0063 0 0 P08246 ELNE_HUMAN "Neutrophil elastase, EC 3.4.21.37 (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase, HLE) (Medullasin) (PMN elastase)" ELANE ELA2 Homo sapiens (Human) acute inflammatory response to antigenic stimulus [GO:0002438]; biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0002812]; cellular calcium ion homeostasis [GO:0006874]; defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of chemokine production [GO:0032682]; negative regulation of chemotaxis [GO:0050922]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neutrophil-mediated killing of fungus [GO:0070947]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of immune response [GO:0050778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; response to lipopolysaccharide [GO:0032496]; response to UV [GO:0009411]; response to yeast [GO:0001878] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle [GO:0045335]; secretory granule [GO:0030141]; specific granule lumen [GO:0035580]; transcription repressor complex [GO:0017053] azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle [GO:0045335]; secretory granule [GO:0030141]; specific granule lumen [GO:0035580]; transcription repressor complex [GO:0017053]; cytokine binding [GO:0019955]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; transcription corepressor activity [GO:0003714]; acute inflammatory response to antigenic stimulus [GO:0002438]; biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0002812]; cellular calcium ion homeostasis [GO:0006874]; defense response to bacterium [GO:0042742]; extracellular matrix disassembly [GO:0022617]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of chemokine production [GO:0032682]; negative regulation of chemotaxis [GO:0050922]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neutrophil-mediated killing of fungus [GO:0070947]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of immune response [GO:0050778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; pyroptosis [GO:0070269]; response to lipopolysaccharide [GO:0032496]; response to UV [GO:0009411]; response to yeast [GO:0001878] GO:0000122; GO:0001878; GO:0002020; GO:0002438; GO:0002523; GO:0002812; GO:0003714; GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005737; GO:0005829; GO:0006508; GO:0006874; GO:0006909; GO:0008201; GO:0008233; GO:0009411; GO:0009986; GO:0017053; GO:0019955; GO:0022617; GO:0030141; GO:0030163; GO:0032496; GO:0032682; GO:0032717; GO:0032757; GO:0035578; GO:0035580; GO:0042742; GO:0043406; GO:0045335; GO:0048661; GO:0050728; GO:0050778; GO:0050922; GO:0062023; GO:0070062; GO:0070269; GO:0070945; GO:0070947; GO:1903238 cytokine binding [GO:0019955]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; transcription corepressor activity [GO:0003714] DPDPASRTH 0.99448 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36952 SPB5_HUMAN "Serpin B5 (Maspin) (Peptidase inhibitor 5, PI-5)" SERPINB5 PI5 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; morphogenesis of an epithelium [GO:0002009]; negative regulation of endopeptidase activity [GO:0010951]; prostate gland morphogenesis [GO:0060512]; regulation of epithelial cell proliferation [GO:0050678] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; sarcoplasm [GO:0016528] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; sarcoplasm [GO:0016528]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; morphogenesis of an epithelium [GO:0002009]; negative regulation of endopeptidase activity [GO:0010951]; prostate gland morphogenesis [GO:0060512]; regulation of epithelial cell proliferation [GO:0050678] GO:0001533; GO:0002009; GO:0004867; GO:0005615; GO:0005737; GO:0010951; GO:0016528; GO:0030198; GO:0050678; GO:0060512 serine-type endopeptidase inhibitor activity [GO:0004867] IIELPFQNK 0.99448 -11.476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2056 12.492 12.7962 0 0 0 0 0 0 0 0 0 0 12.7998 0 0 0 0 14.6106 0 0 0 14.3562 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4957 16.5338 0 0 0 0 0 0 0 0 13.0491 0 0 0 0 0 11.2306 0 0 0 9.62779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4079 0 0 0 0 0 0 0 0 0 0 11.6049 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9431 P51812 KS6A3_HUMAN "Ribosomal protein S6 kinase alpha-3, S6K-alpha-3, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 3, p90-RSK 3, p90RSK3) (Insulin-stimulated protein kinase 1, ISPK-1) (MAP kinase-activated protein kinase 1b, MAPK-activated protein kinase 1b, MAPKAP kinase 1b, MAPKAPK-1b) (Ribosomal S6 kinase 2, RSK-2) (pp90RSK2)" RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) cell cycle [GO:0007049]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224] GO:0000287; GO:0001501; GO:0002224; GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007049; GO:0007165; GO:0007268; GO:0007417; GO:0018105; GO:0019901; GO:0030307; GO:0032496; GO:0035556; GO:0043027; GO:0043066; GO:0043154; GO:0043555; GO:0043620; GO:0045202; GO:0045597; GO:0045944; GO:0106310 ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711] GGDLFTR 0.99448 -9.0776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9599 0 0 0 P98161 PKD1_HUMAN "Polycystin-1, PC1 (Autosomal dominant polycystic kidney disease 1 protein)" PKD1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell-cell signaling by wnt [GO:0198738]; cell-matrix adhesion [GO:0007160]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of epithelial cell polarity [GO:0090162]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; neural tube development [GO:0021915]; peptidyl-serine phosphorylation [GO:0018105]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133]; calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; Wnt receptor activity [GO:0042813]; anatomical structure morphogenesis [GO:0009653]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-independent cell-matrix adhesion [GO:0007161]; cartilage condensation [GO:0001502]; cartilage development [GO:0051216]; cell-cell signaling by wnt [GO:0198738]; cell-matrix adhesion [GO:0007160]; cytoplasmic sequestering of transcription factor [GO:0042994]; detection of mechanical stimulus [GO:0050982]; digestive tract development [GO:0048565]; embryonic placenta development [GO:0001892]; establishment of epithelial cell polarity [GO:0090162]; genitalia development [GO:0048806]; heart development [GO:0007507]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; liver development [GO:0001889]; lung epithelium development [GO:0060428]; lymph vessel morphogenesis [GO:0036303]; mesonephric duct development [GO:0072177]; mesonephric tubule development [GO:0072164]; metanephric ascending thin limb development [GO:0072218]; metanephric collecting duct development [GO:0072205]; metanephric distal tubule morphogenesis [GO:0072287]; metanephric proximal tubule development [GO:0072237]; neural tube development [GO:0021915]; peptidyl-serine phosphorylation [GO:0018105]; placenta blood vessel development [GO:0060674]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein export from nucleus [GO:0006611]; protein heterotetramerization [GO:0051290]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic spindle organization [GO:0060236]; regulation of proteasomal protein catabolic process [GO:0061136]; response to fluid shear stress [GO:0034405]; skin development [GO:0043588]; spinal cord development [GO:0021510] GO:0000139; GO:0001502; GO:0001701; GO:0001822; GO:0001889; GO:0001892; GO:0002133; GO:0005262; GO:0005634; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005929; GO:0006611; GO:0006816; GO:0007156; GO:0007160; GO:0007161; GO:0007204; GO:0007259; GO:0007507; GO:0009653; GO:0009986; GO:0016020; GO:0016021; GO:0016323; GO:0016328; GO:0018105; GO:0019901; GO:0019904; GO:0021510; GO:0021915; GO:0030155; GO:0030246; GO:0030660; GO:0031514; GO:0032092; GO:0034405; GO:0034703; GO:0034704; GO:0036303; GO:0042813; GO:0042994; GO:0043588; GO:0044325; GO:0045737; GO:0045944; GO:0048565; GO:0048754; GO:0048806; GO:0050982; GO:0051216; GO:0051290; GO:0051726; GO:0060170; GO:0060236; GO:0060428; GO:0060674; GO:0061136; GO:0070062; GO:0070588; GO:0072164; GO:0072177; GO:0072205; GO:0072218; GO:0072237; GO:0072287; GO:0090162; GO:0198738; GO:2000045 calcium channel activity [GO:0005262]; carbohydrate binding [GO:0030246]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; Wnt receptor activity [GO:0042813] ALAALSVRPFALRR 0.99448 -36.773 0 0 0 0 13.4719 0 0 0 15.8884 10.3818 13.9443 0 9.94748 0 14.4661 16.0926 0 13.5274 15.3172 0 0 13.3253 13.0988 0 0 15.9109 15.9608 14.8508 14.7904 0 0 0 0 15.6565 0 0 0 16.3466 16.4277 0 0 0 0 13.8383 12.7668 0 0 15.0747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92438 10.7122 13.8774 0 0 0 0 0 10.8153 0 0 13.7327 16.5534 16.6074 14.9371 0 0 17.9682 13.9718 14.0004 10.9682 13.0185 14.9514 12.3403 0 13.5225 12.9456 13.4699 11.8738 0 13.3015 14.4809 0 14.5331 12.3372 0 16.764 0 0 16.6499 12.5012 0 10.5912 10.251 11.668 14.6466 13.9504 13.9579 14.4467 0 0 13.7347 14.4372 0 12.4725 13.0812 12.6147 14.2177 15.8504 0 14.1036 0 12.2055 12.4576 11.6604 14.0353 0 0 16.4942 11.2678 13.6938 14.017 13.0894 12.9994 15.2394 13.3343 16.8412 0 14.0267 10.7426 12.2688 14.2214 0 14.361 13.3292 15.2799 0 12.6196 12.8467 14.3186 0 14.129 18.2939 12.3336 10.8431 17.7907 0 17.2348 17.2875 17.2376 18.3479 18.2311 18.3927 13.9555 0 16.4371 13.1387 14.2821 0 12.5459 14.2408 13.8321 17.6707 12.4819 14.8478 Q13637 RAB32_HUMAN Ras-related protein Rab-32 RAB32 Homo sapiens (Human) antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192] GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005769; GO:0005783; GO:0005802; GO:0005829; GO:0006886; GO:0007005; GO:0016020; GO:0016192; GO:0019882; GO:0030670; GO:0030742; GO:0032438; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0045335; GO:0072657; GO:0090382; GO:1903232 AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924] CDQNKDSSQSPSQVDQFCK 0.99448 -8.5919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5875 0 0 0 0 0 12.2824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.418 0 0 0 0 0 0 12.1402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2885 13.0606 0 0 0 0 0 0 0 0 13.3979 12.7618 0 0 12.0943 0 0 12.4298 12.7583 0 0 0 0 0 0 0 0 0 0 0 12.2157 0 0 0 0 12.9711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9089 0 0 0 0 0 0 0 0 0 0 0 0 13.5588 0 0 12.4118 0 0 0 0 0 0 0 13.7157 0 Q2KJY2 KI26B_HUMAN Kinesin-like protein KIF26B KIF26B Homo sapiens (Human) establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874] cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; establishment of cell polarity [GO:0030010]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092] GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0008017; GO:0022409; GO:0030010; GO:0072092 ATP binding [GO:0005524]; microtubule binding [GO:0008017] AGQSKISAVSRLLLASPR 0.99448 -36.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3468 0 0 0 0 10.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1398 12.207 0 10.7957 0 0 12.0926 0 0 0 0 14.0647 0 0 0 0 0 0 0 0 0 13.313 14.4374 0 0 0 0 0 14.5408 12.8127 0 0 0 0 13.4261 0 0 0 0 0 12.6723 12.8192 0 14.6231 0 13.7792 12.7025 13.1828 0 0 0 0 0 0 0 0 0 0 12.9607 0 0 11.477 0 0 0 0 15.2275 0 12.9322 11.7402 0 0 0 0 12.7387 0 0 0 0 11.6761 0 0 14.3202 0 11.6735 12.066 0 0 0 0 0 0 0 0 0 0 0 11.6751 0 0 0 0 0 14.9442 0 0 0 12.4466 0 0 11.7144 0 11.1849 0 0 0 0 0 0 12.3723 0 11.2706 0 0 12.3276 0 0 0 0 0 0 13.5332 0 13.8567 Q52WX2 SBK1_HUMAN "Serine/threonine-protein kinase SBK1, EC 2.7.11.1 (SH3-binding kinase 1)" SBK1 Homo sapiens (Human) brain development [GO:0007420]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; brain development [GO:0007420]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107] GO:0004674; GO:0005524; GO:0005737; GO:0007420; GO:0018105; GO:0018107; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FTEPALR 0.99448 -15.753 0 0 0 0 0 0 0 0 0 11.8684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6029 0 11.3967 0 0 0 0 0 0 0 0 0 12.6371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6812 0 0 12.772 0 0 0 10.9736 0 13.0952 0 0 12.97 0 0 0 18.4518 0 18.1663 0 14.3545 0 0 0 0 0 16.2337 0 0 0 0 0 12.1825 16.8801 0 0 0 0 0 11.8056 0 17.6789 0 0 0 0 0 12.8027 16.6109 17.4143 0 0 0 0 0 14.2031 0 0 0 0 0 17.9724 0 0 0 0 0 0 12.1562 0 17.7833 0 0 0 0 0 0 11.6625 0 0 11.5611 0 0 0 0 0 0 0 0 0 0 0 12.0105 0 0 0 0 0 0 0 13.1142 0 11.8005 0 0 0 0 Q587I9 SFT2C_HUMAN Vesicle transport protein SFT2C (SFT2 domain-containing protein 3) SFT2D3 Homo sapiens (Human) protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0015031; GO:0016021; GO:0016192 AEEPGDR 0.99448 -12.659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.959 0 0 0 0 0 0 0 0 0 12.9169 0 0 0 0 0 0 0 0 0 12.489 0 0 0 0 0 0 0 12.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5222 0 0 0 0 0 0 0 0 0 0 0 0 10.9612 0 0 0 0 0 11.8991 0 0 0 0 0 12.4574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ISB3 GRHL2_HUMAN Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3) GRHL2 BOM TFCP2L3 Homo sapiens (Human) anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357] cell-cell junction [GO:0005911]; chromatin [GO:0000785]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell-cell junction [GO:0005911]; chromatin [GO:0000785]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; cell population proliferation [GO:0008283]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte differentiation [GO:0045617]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001161; GO:0001228; GO:0001843; GO:0003208; GO:0003382; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006357; GO:0007155; GO:0007420; GO:0008283; GO:0008544; GO:0016020; GO:0021915; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0043010; GO:0043565; GO:0044030; GO:0045617; GO:0045944; GO:0048701; GO:0051973; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132 "chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" ASDSQEDQEK 0.99448 -8.3498 0 0 0 0 0 0 0 0 12.4757 14.1536 0 0 11.4248 15.1034 11.8122 0 0 13.9053 0 11.5757 0 0 0 0 0 0 0 0 0 11.0572 0 0 0 0 0 13.1137 0 13.9942 0 0 0 0 0 0 0 0 11.5334 0 0 0 0 11.6178 0 0 0 0 0 0 10.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1753 0 0 0 0 0 0 0 0 12.7786 0 0 0 0 0 0 0 12.4803 0 11.3496 13.6136 0 12.6719 0 0 0 14.4196 0 13.8321 0 13.438 13.35 0 0 13.5132 0 0 0 12.7911 0 0 12.4157 0 0 0 13.4626 0 14.5663 0 0 12.3188 0 0 14.4202 13.8114 0 0 13.9225 14.4035 11.8632 12.9643 13.8896 0 0 0 0 0 0 0 0 0 0 0 17.0374 12.8781 13.3554 0 0 0 0 0 0 16.5966 0 0 0 0 0 0 13.1268 0 0 0 0 0 0 0 0 0 0 0 0 16.5999 15.3014 0 0 0 Q8IVL6 P3H3_HUMAN "Prolyl 3-hydroxylase 3, EC 1.14.11.7 (Leprecan-like protein 2) (Protein B)" P3H3 LEPREL2 Homo sapiens (Human) collagen biosynthetic process [GO:0032964]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-lysine hydroxylation [GO:0017185] catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783] catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797]; collagen biosynthetic process [GO:0032964]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; peptidyl-lysine hydroxylation [GO:0017185] GO:0005506; GO:0005783; GO:0008285; GO:0017185; GO:0019797; GO:0031418; GO:0032963; GO:0032964; GO:1902494 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797] ADCLTQCAAR 0.99448 -8.579 11.6535 11.4885 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9753 12.5942 12.0565 0 11.7492 0 0 0 0 0 0 0 0 0 12.0493 0 0 0 12.1799 12.1633 0 0 0 0 12.1204 0 11.9856 11.7199 12.8007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1494 0 14.421 12.7066 14.0001 0 14.2225 0 0 0 14.6321 14.0379 16.2137 14.2233 13.7956 14.8183 13.8661 0 0 14.5112 0 13.8536 11.0007 0 12.3328 0 0 0 12.2662 0 13.2118 0 0 0 0 15.4133 14.9223 13.5988 13.3979 13.5315 0 13.4333 0 13.1483 12.8919 0 13.9011 13.2835 0 0 11.9558 13.4756 14.4939 0 0 13.099 13.1189 0 14.255 0 0 0 12.1789 12.1819 13.1664 0 0 0 0 0 0 0 0 0 0 14.4763 0 0 0 0 12.9591 0 0 0 0 0 0 13.5971 0 0 0 12.3417 0 0 0 0 0 0 0 0 12.882 Q8NFU1 BEST2_HUMAN Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1) BEST2 VMD2L1 Homo sapiens (Human) membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608] chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; cilium [GO:0005929]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; membrane depolarization [GO:0051899]; sensory perception of smell [GO:0007608] GO:0005254; GO:0005886; GO:0005929; GO:0007608; GO:0034707; GO:0051899 chloride channel activity [GO:0005254] FVLTEGQK 0.99448 -11.488 0 0 0 0 0 0 13.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6743 0 0 0 0 0 11.8696 0 0 0 0 0 0 11.3514 12.6173 0 0 0 0 0 0 0 0 0 10.846 11.1337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1395 0 0 0 12.8846 0 0 0 0 13.9301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.888 0 13.2056 13.6935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5225 0 0 0 0 12.9621 0 0 12.867 0 0 12.7368 0 12.916 0 13.2496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92618 ZN516_HUMAN Zinc finger protein 516 ZNF516 KIAA0222 Homo sapiens (Human) "adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]" nucleus [GO:0005634] "nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; adipose tissue development [GO:0060612]; brown fat cell differentiation [GO:0050873]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; response to cold [GO:0009409]" GO:0000978; GO:0000981; GO:0000987; GO:0005634; GO:0006355; GO:0009409; GO:0045893; GO:0046872; GO:0050873; GO:0060612; GO:0120162; GO:0140297 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAATTGQGKSSECFECGK 0.99448 -11.172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1499 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6255 0 0 0 0 14.902 13.9085 0 0 0 13.6322 0 0 0 14.6354 0 14.3121 0 0 13.1239 0 13.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3068 0 0 0 0 0 0 0 0 0 0 14.2143 0 0 0 0 13.216 0 13.1408 0 0 0 0 0 0 0 12.9307 13.456 13.1739 13.0738 0 0 0 12.8957 0 0 0 0 0 13.2883 0 13.1195 0 0 Q92796 DLG3_HUMAN "Disks large homolog 3 (Neuroendocrine-DLG) (Synapse-associated protein 102, SAP-102, SAP102) (XLMR)" DLG3 KIAA1232 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; ubiquitin protein ligase binding [GO:0031625]; cell-cell adhesion [GO:0098609]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of protein tyrosine kinase activity [GO:0061098]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] GO:0001736; GO:0005615; GO:0005829; GO:0005886; GO:0005912; GO:0005923; GO:0008285; GO:0016323; GO:0019900; GO:0019902; GO:0030054; GO:0031625; GO:0032281; GO:0043113; GO:0045197; GO:0061098; GO:0097120; GO:0098609; GO:0098978; GO:0099072 kinase binding [GO:0019900]; phosphatase binding [GO:0019902]; ubiquitin protein ligase binding [GO:0031625] CPECYEVTRLAALRR 0.99448 -8.5923 0 0 0 0 0 0 0 0 13.3264 15.565 16.2077 0 15.7363 15.7858 0 0 0 15.5134 0 0 0 0 0 0 0 0 16.7231 0 0 16.0202 0 14.5575 13.7049 0 0 0 12.1461 0 15.4143 15.7426 13.6306 17.9487 18.3479 0 18.0428 0 0 14.6651 0 0 0 15.7618 15.8423 15.8517 15.8144 15.9365 17.1446 16.3234 16.9563 17.3745 13.7938 14.8846 16.9541 16.3528 17.5535 16.982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.977 17.5343 0 17.4604 17.8936 17.7039 17.5664 0 0 14.1446 0 0 17.7388 0 0 0 0 0 0 17.5173 0 0 16.7784 16.3236 0 0 16.163 17.5002 17.1521 10.7041 0 11.0441 0 14.7346 17.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6028 0 0 0 16.489 15.342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.214 0 0 0 17.0581 16.7528 17.773 16.429 18.5297 18.5482 18.9294 18.0184 16.6863 0 0 19.6588 0 0 15.6036 0 0 18.1286 17.893 18.0607 Q96J65 MRP9_HUMAN ATP-binding cassette sub-family C member 12 (Multidrug resistance-associated protein 9) ABCC12 MRP9 Homo sapiens (Human) transmembrane transport [GO:0055085] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; transmembrane transport [GO:0055085] GO:0005524; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0042626; GO:0055085; GO:0140359 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626] ASLSHVVWKFQRTR 0.99448 -12.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.27954 0 0 0 0 10.6254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9999 0 0 0 0 0 0 0 0 0 12.2654 0 0 0 0 11.1433 0 11.8222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JB8 MPP4_HUMAN MAGUK p55 subfamily member 4 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 5 protein) (Discs large homolog 6) MPP4 ALS2CR5 DLG6 Homo sapiens (Human) protein localization to synapse [GO:0035418] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein localization to synapse [GO:0035418] GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0015629; GO:0032991; GO:0035418 CMKQSRK 0.99448 -15.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8118 12.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KR4 LMLN_HUMAN "Leishmanolysin-like peptidase, EC 3.4.24.- (Invadolysin)" LMLN Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lipid droplet [GO:0005811]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lipid droplet [GO:0005811]; membrane [GO:0016020]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; proteolysis [GO:0006508] GO:0004222; GO:0005737; GO:0005811; GO:0005829; GO:0005925; GO:0006508; GO:0007049; GO:0007155; GO:0008233; GO:0016020; GO:0046872; GO:0051301 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233] CSHENIISYAAYCQQEANMDR 0.99448 -15.808 0 0 0 0 0 0 0 0 0 16.8065 17.5296 17.02 16.687 15.9815 15.999 17.419 18.2859 18.4649 15.774 16.8715 17.2262 12.2111 0 0 17.5118 17.8855 16.7231 16.6365 15.5168 15.8641 18.2114 18.2267 17.2911 16.2134 17.1578 16.1276 16.7068 16.2095 16.8413 18.7938 19.826 18.7231 19.3906 18.8381 19.1655 19.8447 18.922 19.7906 15.5389 17.2541 16.5336 17.4909 15.8423 17.4897 18.103 17.8152 17.9297 16.7511 17.5959 17.9913 16.9386 16.4234 17.3165 16.8715 17.7921 17.754 0 0 0 0 0 0 0 0 0 0 0 0 0 12.775 0 0 0 0 14.0375 14.5144 0 0 0 0 0 0 0 0 0 0 14.3815 0 0 0 12.9953 0 0 0 0 0 0 0 0 0 0 14.5065 0 0 0 18.3752 0 0 0 0 0 0 0 0 0 0 0 12.4876 12.8968 0 12.4833 0 0 13.1194 0 0 0 0 0 0 0 0 0 0 12.5164 0 0 18.2843 18.2749 18.1565 0 0 0 0 12.9238 0 19.0206 19.0699 18.8 17.1591 17.0581 16.7528 18.0933 17.0875 18.7797 18.6917 19.088 18.4255 16.6863 16.6019 16.388 0 12.5276 0 0 17.9557 18.946 18.1893 17.893 18.0607 Q9BXW9 FACD2_HUMAN "Fanconi anemia group D2 protein, Protein FACD2" FANCD2 FACD Homo sapiens (Human) brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA polymerase binding [GO:0070182]; brain morphogenesis [GO:0048854]; cellular response to oxidative stress [GO:0034599]; double-strand break repair involved in meiotic recombination [GO:1990918]; gamete generation [GO:0007276]; homologous chromosome pairing at meiosis [GO:0007129]; interstrand cross-link repair [GO:0036297]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; neuronal stem cell population maintenance [GO:0097150]; regulation of CD40 signaling pathway [GO:2000348]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589]; response to gamma radiation [GO:0010332] GO:0000785; GO:0000793; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007129; GO:0007276; GO:0010332; GO:0016604; GO:0031573; GO:0034599; GO:0036297; GO:0045589; GO:0048854; GO:0050727; GO:0051090; GO:0070182; GO:0097150; GO:1990391; GO:1990918; GO:2000348 DNA polymerase binding [GO:0070182] ATEDGEEDEVSAGEKEQDSDESYDDSD 0.99448 -9.378 0 0 0 0 0 0 0 0 13.1661 13.8876 0 0 13.7788 11.2627 0 0 14.3757 13.2545 0 0 0 0 0 12.1335 10.1867 11.1321 12.2896 11.5025 11.233 0 10.7596 11.3915 11.8029 10.8919 13.9129 0 11.2377 0 10.9566 12.206 14.7204 11.4709 14.0404 15.0117 0 0 12.443 0 0 0 0 0 0 0 0 0 16.7074 16.3234 0 0 0 0 0 0 15.3395 11.7311 0 0 0 0 0 0 11.6037 10.9276 0 0 12.5481 0 0 11.2739 0 0 0 0 13.6469 13.9115 13.7788 0 0 0 10.5869 12.1398 0 13.769 11.4407 0 0 0 0 13.8559 11.9803 12.7196 14.4337 0 0 0 0 0 0 13.5239 0 0 0 12.9407 14.3609 0 15.0458 0 14.3095 0 14.8061 13.2378 0 0 13.1447 0 0 0 10.8978 0 0 0 0 11.9469 0 0 0 13.2449 0 0 0 0 0 0 11.7563 0 0 14.3304 0 12.5941 0 0 14.6303 12.8904 0 0 12.8406 12.8118 13.5043 0 13.499 14.0376 13.1235 13.1595 10.2174 12.967 13.1934 12.5741 13.0032 13.2455 10.4792 12.2302 0 0 0 12.6588 0 0 13.9051 0 Q9H1P6 CT085_HUMAN Uncharacterized protein C20orf85 C20orf85 Homo sapiens (Human) PVTPVEK 0.99448 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H788 SH24A_HUMAN SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38) SH2D4A PPP1R38 SH2A Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatase binding [GO:0019902] GO:0005737; GO:0005829; GO:0019902 phosphatase binding [GO:0019902] ESLPVKPR 0.99448 -5.5016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5978 0 0 0 13.7743 0 15.2719 0 0 0 0 0 0 0 0 0 0 0 0 13.6454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6137 0 0 0 0 0 0 0 13.8682 0 0 12.1513 0 0 0 0 0 0 0 0 0 0 12.6701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HAV4 XPO5_HUMAN "Exportin-5, Exp5 (Ran-binding protein 21)" XPO5 KIAA1291 RANBP21 Homo sapiens (Human) miRNA metabolic process [GO:0010586]; positive regulation of post-transcriptional gene silencing by RNA [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of post-transcriptional gene silencing by RNA [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405] GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1900370; GO:1905172 mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049] ASMTNLVKMGFPSK 0.99448 -15.785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.296 12.8778 13.2303 0 0 0 0 0 0 0 12.7725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3138 16.2411 16.3966 0 0 15.1596 0 0 0 13.6247 0 0 0 0 0 0 0 0 0 0 12.0461 0 0 0 11.3206 0 0 13.9032 10.6813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0313 0 0 13.0567 0 0 0 14.4964 0 19.2718 13.2513 0 0 20.0566 0 12.1981 0 0 0 0 0 19.9234 19.6407 0 11.1339 0 0 18.7911 0 0 0 0 14.9553 0 0 0 0 13.8285 0 0 0 0 12.3863 0 11.8415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7998 0 Q9NTG1 PKDRE_HUMAN Polycystin family receptor for egg jelly (PKD and REJ homolog) (Polycystic kidney disease and receptor for egg jelly-related protein) PKDREJ Homo sapiens (Human) acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982] GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0016021; GO:0050982 calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509] ALLFLSYILTHFIFLALLLILIVLLR 0.99448 -36.756 0 0 0 11.7991 0 0 0 10.2419 0 9.90357 12.8069 0 0 0 14.2339 0 0 0 10.2674 14.5456 0 13.2871 14.2235 15.8443 12.047 13.6687 14.1101 13.2029 0 0 13.4484 0 0 0 0 12.4544 0 11.09 11.5812 0 0 0 0 0 0 12.146 13.1574 0 12.2622 0 0 17.1976 12.0116 0 11.3625 11.2799 0 0 0 0 0 0 0 0 0 0 10.7904 0 13.6085 10.3704 0 12.1404 12.8757 12.251 12.2261 11.1473 12.4207 0 13.0924 17.6244 17.7896 15.1669 17.737 17.2914 14.7132 12.5933 19.1285 14.4246 14.9062 0 0 12.1155 11.5322 13.3791 0 14.0683 12.7175 18.3886 18.0999 13.8774 12.7506 0 14.1794 16.3388 0 0 13.1296 14.5389 13.5759 14.3224 14.9018 0 17.2944 0 16.316 14.6776 13.5104 0 15.3537 18.9641 0 16.2871 0 16.4999 20.1145 13.1057 18.5824 14.9147 0 14.2584 17.5371 16.8979 12.9175 14.3369 12.931 13.9814 0 15.4523 13.4783 13.3967 15.1939 13.3399 9.85554 15.5002 14.3651 18.8811 13.8183 12.6177 12.7418 0 15.0394 0 18.4987 16.8681 14.5114 13.6453 14.2966 13.5025 0 0 0 14.2198 11.3625 12.0996 13.7705 0 12.3081 14.6352 14.293 11.011 14.709 18.0831 13.7614 14.7237 19.3108 0 12.6315 0 0 14.1737 Q9NYW5 TA2R4_HUMAN "Taste receptor type 2 member 4, T2R4" TAS2R4 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; respiratory gaseous exchange by respiratory system [GO:0007585] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; respiratory gaseous exchange by respiratory system [GO:0007585] GO:0001580; GO:0004930; GO:0005886; GO:0007585; GO:0008527; GO:0016021; GO:0033038; GO:0060170 bitter taste receptor activity [GO:0033038]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] ITNFQHSVFLLLKR 0.99448 -9.0742 0 0 0 0 0 0 0 0 0 0 11.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5115 14.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9091 0 0 0 0 0 0 0 0 0 0 14.1595 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P016 THYN1_HUMAN Thymocyte nuclear protein 1 (Thymocyte protein Thy28) THYN1 THY28 HSPC144 MDS012 My0054 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 EAYPDHTQFEK 0.99448 -11.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8172 0 0 0 0 0 18.2587 16.2148 0 0 0 0 0 13.5462 0 0 0 0 0 0 0 0 0 0 0 0 11.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4372 0 0 0 0 0 0 0 0 0 0 0 12.7004 0 0 0 Q9UM19 HPCL4_HUMAN "Hippocalcin-like protein 4, HLP4" HPCAL4 Homo sapiens (Human) central nervous system development [GO:0007417]; signal transduction [GO:0007165] calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; central nervous system development [GO:0007417]; signal transduction [GO:0007165] GO:0005246; GO:0005509; GO:0007165; GO:0007417; GO:0008022; GO:0019904 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904] MVGTVIMMR 0.99448 -9.3543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1378 0 0 0 0 0 0 0 0 0 0 0 12.5898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8418 0 0 12.6364 0 0 10.9325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y616 IRAK3_HUMAN "Interleukin-1 receptor-associated kinase 3, IRAK-3 (IL-1 receptor-associated kinase M, IRAK-M) (Inactive IL-1 receptor-associated kinase 3)" IRAK3 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cytokine production [GO:0001819]; positive regulation of macrophage tolerance induction [GO:0010933]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex disassembly [GO:0043244]; response to exogenous dsRNA [GO:0043330]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to peptidoglycan [GO:0032494]; response to virus [GO:0009615] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cytokine-mediated signaling pathway [GO:0019221]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cytokine production [GO:0001819]; positive regulation of macrophage tolerance induction [GO:0010933]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein-containing complex disassembly [GO:0043244]; response to exogenous dsRNA [GO:0043330]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to peptidoglycan [GO:0032494]; response to virus [GO:0009615] GO:0000287; GO:0001819; GO:0001960; GO:0002755; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0009615; GO:0010933; GO:0010936; GO:0019221; GO:0019901; GO:0032088; GO:0032494; GO:0032496; GO:0032695; GO:0032715; GO:0032720; GO:0034122; GO:0035556; GO:0042177; GO:0042803; GO:0043242; GO:0043244; GO:0043330; GO:0043407; GO:0045824; GO:0046777; GO:0046982; GO:0051092; GO:0070498; GO:0070555 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674] AGNCGAR 0.99448 -8.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3302 0 15.2867 0 0 14.9645 0 13.9294 0 0 13.7726 16.5561 0 0 0 0 0 0 15.4922 15.5683 15.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.388 0 0 15.1891 0 0 0 0 0 0 0 0 0 14.0852 0 0 13.6723 0 0 0 0 0 0 0 13.4067 0 0 0 14.512 0 0 0 0 0 0 10.4092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGD5 ZSA5C_HUMAN Zinc finger and SCAN domain-containing protein 5C (Zinc finger and SCAN domain-containing protein 5C pseudogene) ZSCAN5C ZSCAN5CP Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FMQRIGLQFHQR 0.99449 -15.81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8876 14.3513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4437 0 14.1371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.024 15.6703 0 0 0 0 14.7287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95968 SG1D1_HUMAN Secretoglobin family 1D member 1 (Lipophilin-A) SCGB1D1 LIPHA LPNA Homo sapiens (Human) extracellular space [GO:0005615] extracellular space [GO:0005615] GO:0005615 APLEAVAAKMEVKK 0.99449 -5.3328 0 0 0 0 0 0 0 0 0 0 11.4601 0 11.1836 0 0 0 11.7272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1075 0 0 0 0 0 0 9.89922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2207 0 0 0 0 0 0 0 0 0 12.1463 0 0 11.6233 0 0 0 0 0 11.6656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1115 9.85874 0 0 0 0 0 0 0 0 0 0 0 0 9.72744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3772 0 0 0 10.0861 0 0 10.6304 0 0 0 0 0 0 0 0 0 0 0 0 P11055 MYH3_HUMAN "Myosin-3 (Muscle embryonic myosin heavy chain) (Myosin heavy chain 3) (Myosin heavy chain, fast skeletal muscle, embryonic) (SMHCE)" MYH3 Homo sapiens (Human) actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle myosin complex [GO:0005859]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; actin filament-based movement [GO:0030048]; ATP metabolic process [GO:0046034]; embryonic limb morphogenesis [GO:0030326]; face morphogenesis [GO:0060325]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; muscle organ development [GO:0007517]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009] GO:0000146; GO:0003009; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006936; GO:0007517; GO:0016460; GO:0016887; GO:0017018; GO:0030017; GO:0030048; GO:0030049; GO:0030326; GO:0032982; GO:0045214; GO:0046034; GO:0051015; GO:0060325; GO:0070062 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018] ANLEKICR 0.99449 -5.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6659 0 0 11.7722 0 0 13.6623 14.3547 12.8044 0 14.6482 0 0 0 0 0 0 0 0 0 0 18.5834 14.2026 0 0 0 0 0 0 10.2987 0 12.3875 0 0 0 0 0 0 16.5197 0 0 0 13.1869 0 0 11.1951 0 13.0267 0 10.4243 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2995 0 12.75 0 13.7305 0 0 0 10.5771 11.9169 0 12.1425 0 0 0 0 0 0 0 0 11.3856 0 12.4369 12.6717 0 12.5197 0 0 0 10.6212 0 0 13.495 11.6493 0 0 9.36829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7507 0 0 0 0 10.1208 0 13.79 0 0 12.1004 0 0 0 P21506 ZNF10_HUMAN Zinc finger protein 10 (Zinc finger protein KOX1) ZNF10 KOX1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032991; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" IHVGEETYK 0.99449 -5.315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4583 0 0 12.9187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5085 0 0 0 0 0 0 0 0 0 0 0 12.1381 0 11.9549 11.3946 12.1219 0 12.0671 0 0 0 0 0 0 0 13.1014 0 12.5113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9555 0 0 0 13.4318 0 12.7017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1492 0 0 0 0 0 0 0 P36639 8ODP_HUMAN "Oxidized purine nucleoside triphosphate hydrolase, EC 3.6.1.56 (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase, EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 1, Nudix motif 1)" NUDT1 MTH1 Homo sapiens (Human) aging [GO:0007568]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleoside catabolic process [GO:0006152]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979] acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 2-hydroxy-ATP hydrolase activity [GO:0106377]; 2-hydroxy-dATP hydrolase activity [GO:0106378]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; dATP pyrophosphohydrolase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleoside catabolic process [GO:0006152]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]" GO:0001669; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005886; GO:0006152; GO:0006281; GO:0006979; GO:0007568; GO:0008413; GO:0008584; GO:0008828; GO:0016818; GO:0030515; GO:0031965; GO:0035539; GO:0042262; GO:0046686; GO:0046872; GO:0047693; GO:0106377; GO:0106378 "2-hydroxy-ATP hydrolase activity [GO:0106377]; 2-hydroxy-dATP hydrolase activity [GO:0106378]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; dATP pyrophosphohydrolase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]" GASRLYTLVLVLQPQRVLLGMK 0.99449 -9.4133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3055 0 0 0 12.3594 0 12.3074 0 0 0 0 0 0 0 14.1076 14.6872 0 0 0 13.8246 0 0 14.4533 0 0 12.1208 13.375 0 0 0 0 13.4404 0 0 0 0 0 0 0 0 0 0 14.3211 0 12.9188 13.602 0 0 0 0 0 14.2284 0 0 11.153 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3626 0 0 0 0 0 0 0 0 0 0 12.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8589 0 0 0 P48751 B3A3_HUMAN "Anion exchange protein 3, AE 3, Anion exchanger 3 (CAE3/BAE3) (Cardiac/brain band 3-like protein) (Neuronal band 3-like protein) (Solute carrier family 4 member 3)" SLC4A3 AE3 Homo sapiens (Human) bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential [GO:0086001]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; cardiac conduction [GO:0061337]; cardiac muscle cell action potential [GO:0086001]; ion homeostasis [GO:0050801]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0005452; GO:0005886; GO:0005887; GO:0009897; GO:0015106; GO:0015301; GO:0015701; GO:0016020; GO:0022857; GO:0050801; GO:0051453; GO:0055085; GO:0061337; GO:0086001; GO:0150104 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; inorganic anion exchanger activity [GO:0005452]; transmembrane transporter activity [GO:0022857] ASVLRTLLLK 0.99449 -11.525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6145 0 0 0 0 0 0 0 0 0 0 0 11.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9195 14.9257 0 11.3996 0 0 0 0 14.9767 0 0 0 0 0 0 13.8684 11.3769 0 14.6883 12.7443 0 0 19.3379 0 14.3503 14.1298 11.0392 14.7069 0 0 0 0 0 0 0 0 0 11.8546 0 0 0 0 0 14.3273 0 13.4877 0 0 0 0 0 12.5058 0 0 0 0 0 0 12.7478 0 0 13.928 0 0 0 0 0 0 14.9948 13.886 0 0 0 0 0 0 10.6508 0 0 0 0 0 0 0 0 0 0 13.2647 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4256 0 0 0 0 0 0 0 0 0 0 P61221 ABCE1_HUMAN "ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor, RNS4I)" ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 Homo sapiens (Human) negative regulation of endoribonuclease activity [GO:0060702]; regulation of translation [GO:0006417]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; regulation of translation [GO:0006417]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415]" GO:0000054; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0006417; GO:0016020; GO:0043024; GO:0051539; GO:0060698; GO:0060702 "4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]" DPNNYRPR 0.99449 -5.3359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0488 0 0 0 0 0 0 12.3309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.097 0 0 0 11.0221 0 13.3096 0 0 13.143 0 0 0 0 0 13.4342 14.5056 0 0 0 14.4268 0 14.8294 0 0 0 0 0 0 0 0 13.5684 13.4628 15.7676 0 0 0 0 0 0 0 13.8434 0 0 0 14.1725 0 0 0 0 14.2133 0 0 13.9923 14.8388 14.0518 0 0 0 13.7859 14.0458 0 0 0 0 0 0 0 0 14.9707 0 14.1176 0 13.0454 0 0 0 0 0 0 13.7484 0 0 0 0 0 0 14.1612 11.0862 17.1903 0 0 14.1317 0 0 0 17.0939 12.7217 14.1871 0 0 0 0 13.6211 0 0 0 0 0 0 12.4051 Q14997 PSME4_HUMAN Proteasome activator complex subunit 4 (Proteasome activator PA200) PSME4 KIAA0077 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111] "cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis, exchange of chromosomal proteins [GO:0035093]" GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0010499; GO:0016504; GO:0016607; GO:0035093; GO:0070577; GO:0070628; GO:1990111 lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628] AITYFEIFLPTSLPPELHHKGFK 0.99449 -11.515 0 0 0 0 9.68273 0 0 0 0 0 0 0 10.9984 0 0 0 0 0 0 0 0 0 0 0 0 10.7695 0 0 0 10.2432 0 9.76461 14.392 11.2314 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7553 0 0 12.3619 0 0 0 0 0 0 0 10.4299 0 0 0 0 0 0 0 0 11.3411 0 11.5986 13.9867 0 0 0 0 13.2074 0 0 0 13.9184 13.462 0 0 14.3066 0 12.6494 0 0 0 0 0 0 13.5746 0 14.1982 13.5471 11.7259 0 0 10.9583 12.4559 0 0 15.8204 16.478 0 0 0 10.7255 0 0 0 0 0 0 0 0 17.2336 0 0 0 0 0 13.6325 0 0 0 0 0 0 13.2562 0 0 0 0 0 0 0 12.4027 0 14.1731 0 0 0 0 0 12.8929 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0659 0 16.3627 0 0 12.0851 0 0 0 0 0 0 12.607 0 9.88264 11.1496 0 0 11.8821 0 Q2M3A8 MRAS1_HUMAN Putative uncharacterized protein MRGPRG-AS1 (MRGPRG antisense RNA 1) (MRGPRG antisense gene protein 1) MRGPRG-AS1 C11orf36 HSD-40 HSD40 Homo sapiens (Human) GSTSSSR 0.99449 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4U2R6 RM51_HUMAN "39S ribosomal protein L51, mitochondrial, L51mt, MRP-L51 (Mitochondrial large ribosomal subunit protein mL51) (bMRP-64, bMRP64)" MRPL51 MRP64 CDA09 HSPC241 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543 structural constituent of ribosome [GO:0003735] ELIRGPIWLR 0.99449 -10.609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6594 0 0 0 14.4155 0 0 0 0 0 14.9922 0 13.9138 0 0 0 0 0 0 0 14.0806 0 0 0 0 13.5158 0 0 0 0 0 0 0 13.5304 0 0 0 0 0 0 0 0 0 0 14.6917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0187 0 0 0 0 0 13.4349 0 0 13.5195 0 13.311 0 0 12.5631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZQQ2 S31D1_HUMAN Spermatogenesis-associated protein 31D1 (Protein FAM75D1) SPATA31D1 FAM75D1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 ALLPSPLFLIRICGVCFHRPQNEAR 0.99449 -11.552 0 0 0 11.5825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9213 0 0 0 0 0 0 0 11.2987 0 0 0 0 0 13.5226 0 12.1336 0 13.211 12.2292 12.2026 0 0 10.947 0 10.5086 0 0 0 0 0 0 14.7773 0 0 0 0 0 0 13.6566 13.3851 16.3513 13.8151 0 0 0 13.1066 13.2845 0 13.8324 14.2901 16.0345 0 0 14.5599 0 14.8236 13.6556 15.0852 14.8937 0 13.7414 0 0 0 15.9456 14.36 13.4431 13.8359 12.2607 13.3979 0 13.8641 0 0 0 0 14.4735 12.7918 14.0122 13.0664 0 0 0 0 12.5123 0 16.7004 13.7378 13.7081 0 13.2858 13.1088 0 0 12.8742 0 0 13.1415 13.6395 0 0 0 0 13.1218 0 12.7282 11.9047 14.0026 14.8831 16.4993 0 0 0 0 11.7072 0 0 12.4132 0 13.1376 0 0 0 0 0 0 0 12.0143 0 0 0 0 16.7876 0 0 0 12.3437 0 14.5596 0 0 0 0 Q8NH60 O52J3_HUMAN Olfactory receptor 52J3 (Olfactory receptor OR11-32) OR52J3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] VLYVFTK 0.99449 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDY4 ASAP3_HUMAN "Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 (Development and differentiation-enhancing factor-like 1) (Protein up-regulated in liver cancer 1)" ASAP3 DDEFL1 UPLC1 Homo sapiens (Human) cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; regulation of stress fiber assembly [GO:0051492] cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ruffle [GO:0001726] cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cell migration [GO:0016477]; positive regulation of GTPase activity [GO:0043547]; regulation of stress fiber assembly [GO:0051492] GO:0001726; GO:0005096; GO:0005654; GO:0005829; GO:0005925; GO:0016477; GO:0043231; GO:0043547; GO:0046872; GO:0051492 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] DYEAKMAK 0.99449 -11.518 0 0 0 0 0 0 0 0 0 13.2593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9019 0 0 12.9773 0 0 0 15.1141 0 0 13.7415 14.9168 0 15.5161 13.8436 15.054 15.3741 0 15.0805 0 0 13.4138 12.8398 0 0 0 0 15.4299 13.8774 14.505 0 0 0 0 0 12.8277 13.7576 0 12.9191 0 14.0289 0 0 12.4874 13.2296 0 0 12.8409 14.0838 0 0 0 0 0 0 0 0 0 0 0 13.1904 0 12.1148 0 0 0 0 0 0 0 0 0 0 11.7422 14.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5414 0 0 0 0 0 0 0 Q92526 TCPW_HUMAN "T-complex protein 1 subunit zeta-2, TCP-1-zeta-2 (CCT-zeta-2) (CCT-zeta-like) (TCP-1-zeta-like) (Testis-specific Tcp20) (Testis-specific protein TSA303)" CCT6B Homo sapiens (Human) protein folding [GO:0006457]; toxin transport [GO:1901998] chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829] chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; toxin transport [GO:1901998] GO:0005524; GO:0005829; GO:0005832; GO:0006457; GO:0016887; GO:0044183; GO:0051082; GO:0140662; GO:1901998 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] AERKFIEDR 0.99449 -8.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3043 0 0 0 14.2661 0 13.8732 0 0 0 12.5794 14.1054 0 0 0 0 14.8264 0 0 0 0 0 0 0 0 0 0 0 0 14.148 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6941 0 0 12.7012 0 14.011 14.2498 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1846 0 12.6796 0 0 0 0 0 0 0 10.9262 0 0 0 0 0 0 0 0 0 0 0 14.378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4684 Q96CX2 KCD12_HUMAN BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain) KCTD12 C13orf2 KIAA1778 PFET1 Homo sapiens (Human) protein homooligomerization [GO:0051260] anchoring junction [GO:0070161]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; protein homooligomerization [GO:0051260] GO:0003723; GO:0042734; GO:0042802; GO:0042995; GO:0045211; GO:0051260; GO:0070161 identical protein binding [GO:0042802]; RNA binding [GO:0003723] VARITVCGK 0.99449 -12.69 0 0 0 0 0 0 0 0 0 0 14.1418 0 0 0 0 0 0 13.6176 0 0 0 0 13.5407 0 0 0 13.6994 13.3319 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7091 15.04 0 0 0 0 0 0 0 0 0 13.1433 0 0 0 0 0 0 0 0 0 0 0 14.9868 0 13.0939 0 0 15.5692 0 0 0 0 0 14.9071 15.3657 0 0 0 0 0 13.5588 14.5325 0 13.4441 0 0 0 0 15.1341 0 14.968 0 13.5354 14.2017 14.9594 14.6503 14.3487 0 15.0881 0 0 0 0 0 0 0 0 0 0 14.7139 0 0 0 0 0 0 0 0 0 14.1785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99788 CML1_HUMAN Chemerin-like receptor 1 (Chemokine-like receptor 1) (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ) CMKLR1 CHEMR23 DEZ Homo sapiens (Human) chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; regulation of calcium-mediated signaling [GO:0050848]; skeletal system development [GO:0001501] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; chemokine receptor activity [GO:0004950]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023]; chemotaxis [GO:0006935]; complement receptor mediated signaling pathway [GO:0002430]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; regulation of calcium-mediated signaling [GO:0050848]; skeletal system development [GO:0001501] GO:0001501; GO:0002430; GO:0004875; GO:0004930; GO:0004950; GO:0005886; GO:0005887; GO:0006935; GO:0006954; GO:0006955; GO:0007186; GO:0007200; GO:0007204; GO:0010759; GO:0016021; GO:0032088; GO:0032695; GO:0038023; GO:0045600; GO:0050848; GO:0097003; GO:0097004; GO:0120162 adipokinetic hormone binding [GO:0097004]; adipokinetic hormone receptor activity [GO:0097003]; chemokine receptor activity [GO:0004950]; complement receptor activity [GO:0004875]; G protein-coupled receptor activity [GO:0004930]; signaling receptor activity [GO:0038023] IFLVVVYSIVCFLGILGNGLVIIIATFKMK 0.99449 -8.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.43702 0 0 0 0 12.2092 0 0 0 0 15.5138 0 15.2119 0 0 0 0 0 15.0473 13.1255 0 15.6369 15.7518 0 0 0 15.6884 0 0 0 14.5132 14.188 0 0 0 0 0 13.7796 0 0 0 0 16.7138 0 0 13.8338 13.4265 12.5345 0 14.3231 0 0 0 0 0 0 13.1955 14.4309 0 0 0 0 0 13.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.953 0 12.595 0 0 0 12.435 12.8447 Q99795 GPA33_HUMAN Cell surface A33 antigen (Glycoprotein A33) GPA33 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023] GO:0005886; GO:0005887; GO:0038023; GO:0070062 signaling receptor activity [GO:0038023] EGLIQWDKLLLTHTER 0.99449 -8.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1571 0 0 0 0 11.7886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0448 14.649 0 0 0 0 0 0 0 0 12.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6303 0 10.8917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9658 10.183 0 0 0 0 0 0 0 14.8426 0 0 0 0 13.2332 0 0 0 13.284 0 0 0 14.1311 0 0 0 13.8735 0 0 9.47802 0 13.3577 0 0 0 0 0 12.395 0 10.3795 0 0 0 9.95174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPH2 INO1_HUMAN "Inositol-3-phosphate synthase 1, IPS 1, EC 5.5.1.4 (Myo-inositol 1-phosphate synthase, MI-1-P synthase, MIP synthase, hIPS) (Myo-inositol 1-phosphate synthase A1, hINO1)" ISYNA1 INO1 Homo sapiens (Human) inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654] GO:0004512; GO:0005737; GO:0005829; GO:0006021; GO:0008654 inositol-3-phosphate synthase activity [GO:0004512] DFRSSAGLDK 0.99449 -9.4146 0 0 0 0 0 0 0 0 0 10.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75799 0 0 0 0 0 0 12.7397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3413 0 0 0 0 0 0 0 13.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPH6 OBP2B_HUMAN "Odorant-binding protein 2b (Odorant-binding protein IIb, OBPIIb)" OBP2B UNQ653/PRO1283 Homo sapiens (Human) chemosensory behavior [GO:0007635]; sensory perception of smell [GO:0007608] extracellular space [GO:0005615] extracellular space [GO:0005615]; odorant binding [GO:0005549]; small molecule binding [GO:0036094]; chemosensory behavior [GO:0007635]; sensory perception of smell [GO:0007608] GO:0005549; GO:0005615; GO:0007608; GO:0007635; GO:0036094 odorant binding [GO:0005549]; small molecule binding [GO:0036094] DFPEDRRPR 0.99449 -11.517 0 0 0 0 0 0 0 0 0 13.9513 0 0 11.9563 0 0 0 0 0 11.0906 0 0 0 0 0 0 0 0 0 12.0533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1163 0 0 0 0 0 0 12.0693 0 0 0 13.5965 0 0 0 0 0 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 12.8713 0 0 0 0 0 13.9046 13.5141 0 0 13.527 0 13.5525 0 0 0 12.3971 0 0 0 0 13.0436 13.0279 0 0 0 13.5216 0 0 0 0 13.1118 0 0 0 0 0 0 0 0 0 0 0 11.6927 0 0 0 0 0 0 0 0 0 12.5511 0 12.7949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8151 0 0 0 0 Q9NQL9 DMRT3_HUMAN Doublesex- and mab-3-related transcription factor 3 DMRT3 DMRTA3 Homo sapiens (Human) adult walking behavior [GO:0007628]; male sex differentiation [GO:0046661]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; transmission of nerve impulse [GO:0019226]; ventral spinal cord interneuron specification [GO:0021521] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adult walking behavior [GO:0007628]; male sex differentiation [GO:0046661]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; transmission of nerve impulse [GO:0019226]; ventral spinal cord interneuron specification [GO:0021521]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0007628; GO:0019226; GO:0021521; GO:0042487; GO:0046661; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CRNHGVLSWLKGHK 0.99449 -10.917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6554 0 0 0 12.4051 0 13.0682 0 10.5823 0 0 0 0 0 0 16.1919 0 0 0 0 0 0 0 0 0 0 0 12.2288 14.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4148 0 0 0 0 0 0 0 0 0 0 0 11.3637 0 0 0 0 11.3698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX40 OCAD1_HUMAN OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen) OCIAD1 ASRIJ OCIA Homo sapiens (Human) endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020] endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736] GO:0005764; GO:0005768; GO:0005794; GO:0006897; GO:0016020; GO:0046427; GO:0061484; GO:2000736 ESYEVSLTQK 0.99449 -12.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9579 11.9322 13.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GTR0 EDD13_HUMAN Epididymal protein 13 EDDM13 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 DDPCCSF 0.9945 -10.963 0 0 0 9.80313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2245 0 0 0 0 0 0 0 0 0 10.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7948 0 0 0 0 0 0 0 0 0 11.3929 0 0 0 0 0 0 0 0 0 0 12.0708 0 0 10.8996 11.0537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2695 0 0 0 0 0 0 P0C869 PA24B_HUMAN "Cytosolic phospholipase A2 beta, cPLA2-beta, EC 3.1.1.4 (Lysophospholipase A1 group IVB, EC 3.1.1.5) (Phospholipase A2 group IVB)" PLA2G4B Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; calcium-mediated signaling [GO:0019722]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; parturition [GO:0007567]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; mitochondrial inner membrane [GO:0005743] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623]; arachidonic acid metabolic process [GO:0019369]; calcium-mediated signaling [GO:0019722]; glycerophospholipid catabolic process [GO:0046475]; inflammatory response [GO:0006954]; parturition [GO:0007567]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148] GO:0004622; GO:0004623; GO:0005509; GO:0005544; GO:0005576; GO:0005743; GO:0005829; GO:0006954; GO:0007567; GO:0008970; GO:0019369; GO:0019722; GO:0031901; GO:0036148; GO:0036151; GO:0036152; GO:0046475; GO:0047498; GO:0102545 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623] DYFQHPHFSTWK 0.9945 -9.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5206 0 0 0 0 13.1861 0 0 0 12.8588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.338 9.71682 0 0 0 0 0 0 0 0 0 11.0276 14.5843 0 0 0 0 0 0 0 0 0 0 14.2035 0 0 0 0 0 0 0 0 0 0 14.0159 0 0 0 0 P12259 FA5_HUMAN "Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain ]" F5 Homo sapiens (Human) "blood circulation [GO:0008015]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, extrinsic pathway [GO:0007598]; proteolysis [GO:0006508]; response to vitamin K [GO:0032571]; zymogen activation [GO:0031638]" COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370] "COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; copper ion binding [GO:0005507]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; blood coagulation, extrinsic pathway [GO:0007598]; proteolysis [GO:0006508]; response to vitamin K [GO:0032571]; zymogen activation [GO:0031638]" GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005794; GO:0005886; GO:0006508; GO:0007596; GO:0007598; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0031638; GO:0032571; GO:0032991; GO:0033116; GO:0072377; GO:1903561; GO:1905370 copper ion binding [GO:0005507] DCRMPMGLSTGIISDSQIKASEFLGYWEPR 0.9945 -15.495 0 0 0 0 0 0 0 0 0 0 0 0 12.6551 0 0 0 0 0 15.0305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5682 12.9949 0 0 13.178 0 0 12.3715 0 12.2928 0 12.3568 0 0 0 0 0 0 0 12.2109 13.6243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9466 0 0 0 0 0 0 0 0 0 0 0 13.6224 0 0 13.7334 13.5488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4531 0 0 0 0 0 0 0 0 0 0 13.9261 0 0 0 11.8579 0 0 0 12.5418 0 0 0 0 0 12.0659 0 0 0 0 0 0 0 0 0 0 0 0 13.2751 0 0 0 0 0 0 0 0 0 0 14.3755 13.0778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19320 VCAM1_HUMAN "Vascular cell adhesion protein 1, V-CAM 1, VCAM-1 (INCAM-100) (CD antigen CD106)" VCAM1 Homo sapiens (Human) acute inflammatory response [GO:0002526]; aging [GO:0007568]; amine metabolic process [GO:0009308]; B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac neuron differentiation [GO:0060945]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chronic inflammatory response [GO:0002544]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; innervation [GO:0060384]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; positive regulation of T cell proliferation [GO:0042102]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043] alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex [GO:0071065]; apical part of cell [GO:0045177]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcolemma [GO:0042383] alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex [GO:0071065]; apical part of cell [GO:0045177]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcolemma [GO:0042383]; cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; primary amine oxidase activity [GO:0008131]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; amine metabolic process [GO:0009308]; B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac neuron differentiation [GO:0060945]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chronic inflammatory response [GO:0002544]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; innervation [GO:0060384]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; positive regulation of T cell proliferation [GO:0042102]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043] GO:0001666; GO:0002102; GO:0002526; GO:0002544; GO:0005178; GO:0005615; GO:0005769; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0005902; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007568; GO:0007584; GO:0008131; GO:0009308; GO:0009897; GO:0009986; GO:0010043; GO:0010212; GO:0022614; GO:0030175; GO:0030183; GO:0032496; GO:0034113; GO:0035094; GO:0035584; GO:0035924; GO:0042102; GO:0042383; GO:0045177; GO:0045471; GO:0050839; GO:0050901; GO:0060326; GO:0060384; GO:0060945; GO:0070062; GO:0071065; GO:0071356; GO:0140039; GO:1904646 cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; primary amine oxidase activity [GO:0008131] AKLHIDEMDSVPTVR 0.9945 -8.4077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79933 0 0 0 10.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4872 0 0 0 0 0 13.395 0 12.6513 0 0 0 0 0 0 0 0 15.6967 0 0 0 0 0 0 0 10.2355 0 0 0 0 0 0 0 0 0 0 0 0 13.9566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P25391 LAMA1_HUMAN "Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha, S-LAM alpha)" LAMA1 LAMA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888] GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0007411; GO:0008022; GO:0009887; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0043010; GO:0043208; GO:0045198; GO:0045785; GO:0045995; GO:0048514; GO:0051149; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046 extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102] ACECHVK 0.9945 -10.941 0 0 0 0 0 0 0 0 0 0 17.6805 0 0 0 0 0 10.5903 0 0 0 0 0 0 0 11.8638 0 0 0 12.0621 0 0 12.2153 10.6457 18.6178 0 0 0 0 10.5713 0 0 0 0 0 0 0 0 0 0 0 0 0 12.272 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3012 0 0 0 0 0 0 0 0 0 0 11.7245 13.2616 0 10.1845 0 0 0 0 0 13.7323 0 13.8221 0 13.4685 12.6263 0 12.2978 11.2732 0 12.9182 11.4542 0 0 12.7316 0 11.3339 0 0 0 12.342 0 0 13.1018 0 0 13.0104 0 0 0 15.054 0 0 0 0 12.5876 0 0 13.724 0 0 0 12.7293 12.8186 0 14.3209 15.1075 0 0 0 12.2879 0 0 13.705 0 12.8516 0 15.5966 15.9872 0 12.5603 0 13.5194 0 0 11.8866 0 0 14.3163 0 13.8779 16.1303 0 0 19.153 0 12.337 0 0 0 0 0 0 11.9342 0 14.9474 12.2898 17.064 0 0 0 0 0 0 P51828 ADCY7_HUMAN "Adenylate cyclase type 7, EC 4.6.1.1 (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7)" ADCY7 KIAA0037 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to lithium ion [GO:0071285]; intracellular signal transduction [GO:0035556]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to ethanol [GO:0071361]; cellular response to lithium ion [GO:0071285]; intracellular signal transduction [GO:0035556]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; regulation of adaptive immune response [GO:0002819] GO:0002819; GO:0004016; GO:0005524; GO:0005886; GO:0005887; GO:0006171; GO:0007189; GO:0016021; GO:0035556; GO:0046872; GO:0060135; GO:0071285; GO:0071361; GO:1900016 adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872] CIQIRRK 0.9945 -10.962 0 0 0 0 0 0 10.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1588 0 0 0 0 0 0 0 12.1566 0 0 0 0 0 0 0 0 19.2493 12.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7329 0 0 0 0 0 11.1814 0 0 0 0 0 0 0 11.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51956 NEK3_HUMAN "Serine/threonine-protein kinase Nek3, EC 2.7.11.1 (HSPK 36) (Never in mitosis A-related kinase 3, NimA-related protein kinase 3)" NEK3 Homo sapiens (Human) cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; mitotic cell cycle [GO:0000278]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of tubulin deacetylation [GO:0090043] axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634] axon [GO:0030424]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; mitotic cell cycle [GO:0000278]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of tubulin deacetylation [GO:0090043] GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0030010; GO:0030424; GO:0046872; GO:0048812; GO:0051301; GO:0090043; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] HPFQANSWK 0.9945 -8.6723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.819 0 0 0 0 0 0 0 0 13.0579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5245 0 0 0 0 13.8326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1775 0 0 0 0 0 0 0 0 P57057 G6PT2_HUMAN "Glucose-6-phosphate exchanger SLC37A1 (Glycerol-3-phosphate permease, G-3-P permease) (Solute carrier family 37 member 1)" SLC37A1 G3PP Homo sapiens (Human) carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513]; carbohydrate transport [GO:0008643]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435] GO:0005789; GO:0008643; GO:0015760; GO:0016020; GO:0030176; GO:0035435; GO:0061513 glucose 6-phosphate:inorganic phosphate antiporter activity [GO:0061513] AFIFILTFLLYASFHLSRKPISIVK 0.9945 -10.672 0 0 0 0 0 0 11.3124 0 0 0 0 0 0 0 0 0 11.4231 0 0 0 0 11.468 0 0 12.672 0 0 0 0 0 14.7445 0 0 0 0 0 0 0 0 13.5125 0 12.8533 0 0 0 0 0 0 0 0 0 0 12.3281 0 0 11.6078 0 0 0 0 0 0 9.89098 0 0 0 0 0 0 0 0 0 0 0 11.6244 9.72231 13.8887 12.7833 0 13.2767 0 0 0 0 0 0 11.2973 0 0 0 0 0 0 0 0 0 0 0 0 10.952 0 0 0 0 11.4371 11.2541 0 0 0 0 0 15.382 0 0 0 0 0 0 0 0 0 0 0 12.708 0 0 10.4575 0 0 0 0 0 0 0 0 0 14.0496 0 0 0 0 0 0 0 0 0 0 13.646 0 0 0 0 0 0 0 0 0 0 14.1258 0 13.9639 0 13.9001 14.0104 13.7831 0 0 0 0 0 14.4681 0 0 0 0 13.9238 0 13.6366 0 0 Q14161 GIT2_HUMAN "ARF GTPase-activating protein GIT2, ARF GAP GIT2 (Cool-interacting tyrosine-phosphorylated protein 2, CAT-2, CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2)" GIT2 KIAA0148 Homo sapiens (Human) brain development [GO:0007420]; regulation of ARF protein signal transduction [GO:0032012]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; synaptic vesicle recycling [GO:0036465] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; synapse [GO:0045202] focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; brain development [GO:0007420]; regulation of ARF protein signal transduction [GO:0032012]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; synaptic vesicle recycling [GO:0036465] GO:0005096; GO:0005654; GO:0005925; GO:0007420; GO:0008277; GO:0031267; GO:0032012; GO:0036465; GO:0045202; GO:0046872 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] GTFLCDECCSVHR 0.9945 -15.487 0 0 0 0 0 0 9.96824 0 0 0 0 0 0 0 0 0 12.5388 0 0 0 0 0 0 0 10.8289 0 0 0 0 0 0 0 10.6351 0 0 9.77304 0 0 0 0 10.9279 0 0 0 0 0 11.9236 11.929 0 0 0 0 10.669 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8114 0 0 10.2087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8758 0 12.8621 0 12.4441 12.7567 15.1076 11.6015 0 12.772 13.1702 0 0 12.8308 0 0 0 11.9425 0 11.4242 0 0 0 0 0 0 0 0 12.1778 13.2769 12.8812 0 0 13.3497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5106 0 0 13.1234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1005 0 11.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2657 0 0 0 0 Q14576 ELAV3_HUMAN "ELAV-like protein 3 (Hu-antigen C, HuC) (Paraneoplastic cerebellar degeneration-associated antigen) (Paraneoplastic limbic encephalitis antigen 21)" ELAVL3 HUC PLE21 Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399] ribonucleoprotein complex [GO:1990904] ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] GO:0007399; GO:0030154; GO:0035925; GO:1990904 mRNA 3'-UTR AU-rich region binding [GO:0035925] AINTLNGLKLQTKTIK 0.9945 -15.488 0 0 0 0 0 0 0 0 13.3253 16.3855 0 16.3326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8899 14.0416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4002 0 0 12.0849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5442 0 0 0 0 14.0803 11.3303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5GJ75 TP8L3_HUMAN "Tumor necrosis factor alpha-induced protein 8-like protein 3, TNF alpha-induced protein 8-like protein 3, TNFAIP8-like protein 3" TNFAIP8L3 TIPE3 Homo sapiens (Human) inositol lipid-mediated signaling [GO:0048017]; phospholipid metabolic process [GO:0006644]; phospholipid transport [GO:0015914]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of apoptotic process [GO:0042981]; regulation of lipid metabolic process [GO:0019216] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; inositol lipid-mediated signaling [GO:0048017]; phospholipid metabolic process [GO:0006644]; phospholipid transport [GO:0015914]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of apoptotic process [GO:0042981]; regulation of lipid metabolic process [GO:0019216] GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006644; GO:0008526; GO:0015914; GO:0019216; GO:0035091; GO:0042981; GO:0043552; GO:0048017; GO:0051897; GO:0070374 phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526] DLIKVAIKIGILYR 0.9945 -13.643 0 0 0 0 0 0 0 0 0 0 11.8503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1507 0 0 0 0 0 0 0 11.709 0 0 0 13.7718 14.8596 13.5682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3573 10.3124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4842 0 0 14.2911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VV41 ARHGG_HUMAN Rho guanine nucleotide exchange factor 16 (Ephexin-4) ARHGEF16 EPHEXIN4 NBR Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078] cytosol [GO:0005829] cytosol [GO:0005829]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; positive regulation of protein localization to plasma membrane [GO:1903078] GO:0005085; GO:0005829; GO:0030165; GO:0030971; GO:0031267; GO:0045296; GO:0060326; GO:0090630; GO:1903078 cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267] DPGGMLR 0.9945 -13.654 13.2874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1108 0 0 0 0 0 0 14.4126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2355 0 14.3914 0 0 0 0 0 0 14.2089 0 0 14.4004 12.931 0 0 0 0 0 11.9354 14.5274 0 0 0 13.8412 0 0 13.8575 11.8865 0 0 12.7693 14.9224 14.4744 0 0 0 0 15.0731 14.5497 0 0 0 0 0 0 0 0 0 13.7193 0 0 0 13.6404 0 15.2658 0 10.9198 0 0 0 12.5145 0 12.7474 0 0 14.3861 12.6048 0 0 0 13.9585 0 0 0 12.7202 0 13.8046 0 0 0 0 0 0 0 0 0 15.4132 0 13.8707 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0288 0 12.6002 0 0 0 0 10.649 0 0 0 Q6Q0C1 S2547_HUMAN Solute carrier family 25 member 47 (Hepatocellular carcinoma down-regulated mitochondrial carrier protein) SLC25A47 C14orf68 HDMCP HMFN1655 Homo sapiens (Human) integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; transmembrane transporter activity [GO:0022857] GO:0005739; GO:0005743; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] AFPVNMVVFVAYEAVLRLARGLLT 0.9945 -13.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8311 0 0 0 0 0 0 0 14.9818 15.0934 0 13.1211 0 14.9499 14.1633 0 0 0 0 0 14.8953 0 0 0 0 0 0 13.7016 14.2011 0 0 0 0 14.383 0 12.9323 0 0 0 0 0 0 0 14.9172 0 0 14.9969 0 14.3733 13.7995 13.5114 0 0 0 0 0 0 13.4733 0 0 13.6763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2209 0 0 0 0 0 0 0 0 12.8579 0 0 0 0 0 0 0 11.3388 0 0 0 0 0 0 0 0 Q6ZRI6 CO039_HUMAN Uncharacterized protein C15orf39 C15orf39 FP6578 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 AEKRPLR 0.9945 -11.588 17.0097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0643 11.3365 0 0 0 0 0 15.9936 17.8644 14.1227 15.3535 0 12.9409 13.6842 14.3859 13.7151 13.4743 15.9966 16.6798 13.6405 15.4935 0 11.638 0 0 0 0 11.315 0 11.0057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6576 0 0 0 0 0 0 0 0 0 0 0 13.8887 0 0 0 0 14.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86Y56 DAAF5_HUMAN Dynein axonemal assembly factor 5 (HEAT repeat-containing protein 2) DNAAF5 HEATR2 Homo sapiens (Human) cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293] cytoplasm [GO:0005737]; dynein axonemal particle [GO:0120293]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0005737; GO:0036158; GO:0036159; GO:0045505; GO:0120293 dynein intermediate chain binding [GO:0045505] AIQDAILEVLK 0.9945 -13.659 12.4607 0 0 0 0 0 10.6461 0 17.2392 11.4991 0 11.2061 13.592 0 0 15.9583 16.321 15.9294 16.2684 16.3502 16.2569 0 16.9005 0 15.7954 15.7624 17.3966 15.2165 0 11.0997 0 11.8 16.4325 14.39 0 0 11.4045 0 11.2271 0 14.712 16.4325 12.9296 0 0 0 15.0272 17.0089 14.8025 0 0 0 0 0 0 0 0 0 14.5117 16.3792 0 0 0 14.5783 0 14.5065 12.1357 12.2199 12.7083 0 0 11.854 0 0 0 0 0 0 13.6001 0 0 0 0 0 15.5878 0 14.907 0 0 0 0 13.1738 0 0 0 0 12.8796 0 14.0982 0 16.217 0 0 0 0 13.9804 0 0 13.5491 0 13.8841 12.4743 0 0 13.7308 0 0 10.8347 0 0 0 0 0 0 0 0 0 13.7616 0 11.0676 11.7455 0 11.2983 0 0 13.5321 0 0 0 0 0 0 0 0 0 0 0 12.0709 13.1491 17.032 0 0 0 14.1423 0 14.091 11.8776 0 17.7469 16.1988 0 0 15.6322 14.0988 0 0 0 0 0 0 0 10.6147 0 0 0 0 13.4332 0 0 0 Q8NGJ1 OR4D6_HUMAN Olfactory receptor 4D6 (Olfactory receptor OR11-250) OR4D6 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NKALSTCTSHMLVVTLHFVPCVYIYCR 0.9945 -9.4227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8723 0 0 0 12.9534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8727 0 0 0 0 0 0 Q8TAB3 PCD19_HUMAN Protocadherin-19 PCDH19 KIAA1313 Homo sapiens (Human) brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007420 calcium ion binding [GO:0005509] AEDYDEGENGR 0.9945 -13.615 0 0 11.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6189 0 0 0 0 0 0 0 0 0 0 0 13.1518 0 12.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2811 0 0 0 0 0 12.7846 0 0 0 0 0 0 0 0 0 13.8264 0 0 0 0 0 0 0 0 0 0 0 12.9965 0 0 12.4372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92844 TANK_HUMAN "TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein, I-TRAF)" TANK ITRAF TRAF2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337] cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554] cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]; deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337] GO:0005829; GO:0006974; GO:0007165; GO:0007249; GO:0031625; GO:0032991; GO:0035800; GO:0043124; GO:0046872; GO:0051607; GO:0060337; GO:0071347; GO:0071356; GO:0071479; GO:1902554; GO:1903003; GO:2000158 deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625] GAPSITSVTPRGLCR 0.9945 -8.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.02176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4536 0 0 0 0 0 0 0 0 0 13.4329 0 0 0 0 0 16.3051 0 0 0 15.7403 15.8032 11.2031 0 0 0 0 0 0 0 0 10.4826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5445 0 0 0 0 0 0 0 0 10.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0547 0 0 0 0 0 0 0 0 13.4392 0 0 0 0 0 0 0 0 0 0 0 Q96IY4 CBPB2_HUMAN "Carboxypeptidase B2, EC 3.4.17.20 (Carboxypeptidase U, CPU) (Plasma carboxypeptidase B, pCPB) (Thrombin-activable fibrinolysis inhibitor, TAFI)" CPB2 Homo sapiens (Human) blood coagulation [GO:0007596]; cellular response to glucose stimulus [GO:0071333]; fibrinolysis [GO:0042730]; liver regeneration [GO:0097421]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to heat [GO:0009408]; response to xenobiotic stimulus [GO:0009410] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; blood coagulation [GO:0007596]; cellular response to glucose stimulus [GO:0071333]; fibrinolysis [GO:0042730]; liver regeneration [GO:0097421]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of plasminogen activation [GO:0010757]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to heat [GO:0009408]; response to xenobiotic stimulus [GO:0009410] GO:0003331; GO:0004181; GO:0005576; GO:0005615; GO:0006508; GO:0007596; GO:0008270; GO:0009408; GO:0009410; GO:0010757; GO:0030163; GO:0042730; GO:0051918; GO:0070062; GO:0071333; GO:0097421; GO:2000346 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] IAWHVIRNV 0.9945 -7.8867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7199 0 0 0 0 12.3394 0 0 0 0 0 0 0 0 0 0 0 0 13.245 0 0 0 0 0 0 0 12.7394 0 0 0 12.6743 0 0 0 0 0 0 12.531 0 12.0647 0 0 0 0 0 0 0 0 0 0 0 0 12.586 10.8875 0 0 0 0 0 0 0 13.9817 0 0 0 0 14.1891 0 0 0 0 0 0 0 0 0 12.2352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.979 0 0 0 13.1323 0 0 0 0 0 0 13.4515 0 0 0 0 0 13.1659 12.8959 0 11.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4071 0 0 10.5171 0 0 0 0 0 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JC9 EAF1_HUMAN ELL-associated factor 1 EAF1 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" Cajal body [GO:0015030]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] "Cajal body [GO:0015030]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; transcription elongation regulator activity [GO:0003711]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]" GO:0003711; GO:0005654; GO:0008023; GO:0015030; GO:0016604; GO:0016607; GO:0032783; GO:0034243; GO:0043231; GO:0045171; GO:0045893 transcription elongation regulator activity [GO:0003711] APTKPPVGPK 0.9945 -8.4291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5126 12.2823 12.3582 0 0 0 0 0 0 0 0 9.72508 0 0 0 0 0 0 0 0 0 0 0 0 12.9674 0 0 0 13.0119 13.2534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5766 0 0 9.5792 0 0 13.8508 13.7242 0 0 0 0 0 0 0 0 0 0 14.4215 0 0 14.1282 13.8051 14.1163 15.0619 0 0 13.9168 14.4903 0 0 0 0 0 11.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2816 Q96P88 GNRR2_HUMAN "Putative gonadotropin-releasing hormone II receptor, GnRH II receptor, GnRH-II-R (Type II GnRH receptor)" GNRHR2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0004968; GO:0005886; GO:0005887; GO:0007186; GO:0042277 G protein-coupled receptor activity [GO:0004930]; gonadotropin-releasing hormone receptor activity [GO:0004968]; peptide binding [GO:0042277] GISITSI 0.9945 -8.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3429 0 0 0 0 0 0 9.38896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5297 0 0 0 0 13.0202 0 0 0 0 0 0 13.9135 0 13.6384 13.3525 0 0 0 0 0 0 0 0 0 14.6588 0 0 0 13.7945 0 11.5234 0 13.9605 0 13.8965 0 0 13.3852 0 0 0 13.6313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3019 0 0 0 0 0 Q96SA4 SERC2_HUMAN Serine incorporator 2 (Tumor differentially expressed protein 2-like) SERINC2 TDE2L FKSG84 UNQ263/PRO300 Homo sapiens (Human) phosphatidylserine metabolic process [GO:0006658]; sphingolipid metabolic process [GO:0006665] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylserine metabolic process [GO:0006658]; sphingolipid metabolic process [GO:0006665] GO:0006658; GO:0006665; GO:0016020; GO:0016021; GO:0070062 AEECDSR 0.9945 -8.1459 0 0 0 0 0 0 0 0 0 0 0 13.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9127 0 0 0 0 0 14.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7121 0 0 0 0 13.7776 0 0 0 0 13.5912 0 13.5778 0 0 0 0 0 0 0 0 0 0 0 0 13.9224 0 0 0 0 0 0 13.4302 0 0 0 11.1292 0 14.0679 0 0 0 0 0 0 0 0 0 0 0 12.3384 0 0 0 0 0 0 11.2007 0 0 0 0 0 0 0 0 0 0 10.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99986 VRK1_HUMAN "Serine/threonine-protein kinase VRK1, EC 2.7.11.1 (Vaccinia-related kinase 1)" VRK1 Homo sapiens (Human) cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; Golgi disassembly [GO:0090166]; histone phosphorylation [GO:0016572]; mitotic nuclear membrane disassembly [GO:0007077]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; Golgi disassembly [GO:0090166]; histone phosphorylation [GO:0016572]; mitotic nuclear membrane disassembly [GO:0007077]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006468; GO:0006974; GO:0007077; GO:0007165; GO:0016572; GO:0018105; GO:0019901; GO:0035175; GO:0042393; GO:0046777; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187 ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AKTITKK 0.9945 -10.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.517 0 14.6772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPI8 FANCF_HUMAN "Fanconi anemia group F protein, Protein FACF" FANCF Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; cellular response to DNA damage stimulus [GO:0006974]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513] GO:0000785; GO:0005654; GO:0006513; GO:0006974; GO:0036297; GO:0043240 LPQNNFLK 0.9945 -13.67 0 0 0 0 0 0 0 0 13.7814 0 0 12.7872 0 0 0 0 0 0 0 10.6822 0 10.2063 0 0 0 0 0 0 0 0 0 12.7491 0 0 12.2366 0 0 0 0 12.543 12.5207 0 0 0 0 13.0932 0 0 0 0 0 0 0 0 0 0 13.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9692 0 0 0 0 0 0 0 0 13.9032 13.491 13.6373 0 14.7427 0 13.8909 0 0 13.2101 13.2264 0 0 13.5409 0 0 0 0 0 0 13.3986 0 0 13.9204 13.7999 13.7287 13.1515 0 12.3434 0 0 0 0 0 13.6818 0 0 13.2808 0 0 0 0 0 0 0 0 0 0 12.7995 0 0 0 13.3432 0 0 12.765 0 0 0 0 13.7028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9101 0 0 0 17.0437 0 0 0 0 0 0 0 0 12.2527 0 0 12.0756 0 0 0 0 0 0 Q9P2G1 AKIB1_HUMAN "Ankyrin repeat and IBR domain-containing protein 1, EC 2.3.2.31" ANKIB1 KIAA1386 Homo sapiens (Human) positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0000209; GO:0005737; GO:0006511; GO:0031624; GO:0032436; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] ACVELLVK 0.9945 -10.943 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1594 0 0 13.4524 12.4919 0 0 0 0 0 0 11.1616 0 0 0 0 0 0 10.1401 0 0 0 0 10.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9083 11.0831 0 11.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3826 0 0 0 0 0 0 12.6557 0 0 0 0 12.3852 14.6398 0 0 0 0 0 0 0 0 0 13.2343 0 0 0 0 12.2361 0 0 0 14.7185 12.3123 0 0 0 0 0 0 0 15.1526 0 0 0 0 0 0 0 0 0 0 0 12.9554 0 0 0 11.3872 0 0 0 0 0 13.664 0 13.5595 0 0 0 0 0 0 0 0 14.1502 12.2105 14.7081 0 O95342 ABCBB_HUMAN "Bile salt export pump, EC 7.6.2.- (ATP-binding cassette sub-family B member 11)" ABCB11 BSEP Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic export from cell [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; intracellular canaliculus [GO:0046691]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; carbohydrate transmembrane transporter activity [GO:0015144]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; bile acid signaling pathway [GO:0038183]; canalicular bile acid transport [GO:0015722]; cholesterol homeostasis [GO:0042632]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; phospholipid homeostasis [GO:0055091]; positive regulation of bile acid secretion [GO:0120189]; protein ubiquitination [GO:0016567]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of gene expression [GO:0010468]; response to 17alpha-ethynylestradiol [GO:1904486]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic export from cell [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855] GO:0000139; GO:0005524; GO:0005768; GO:0005886; GO:0006631; GO:0006699; GO:0006805; GO:0006855; GO:0006979; GO:0008206; GO:0008559; GO:0009986; GO:0010468; GO:0015125; GO:0015126; GO:0015144; GO:0015432; GO:0015721; GO:0015722; GO:0016021; GO:0016324; GO:0016567; GO:0031998; GO:0038183; GO:0042626; GO:0042632; GO:0043627; GO:0045471; GO:0046581; GO:0046618; GO:0046691; GO:0055037; GO:0055038; GO:0055085; GO:0055088; GO:0055091; GO:0070062; GO:0120189; GO:1904251; GO:1904486 ABC-type bile acid transporter activity [GO:0015432]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bile acid transmembrane transporter activity [GO:0015125]; canalicular bile acid transmembrane transporter activity [GO:0015126]; carbohydrate transmembrane transporter activity [GO:0015144] FGEENDGFESDKSYNNDK 0.99451 -12.879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1212 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8153 0 0 0 0 0 0 0 0 0 0 14.6837 14.2245 0 11.8213 0 0 0 11.6918 0 10.9079 0 11.4303 0 12.5968 0 0 0 0 0 11.4268 0 0 0 0 0 0 0 0 0 0 13.4797 0 0 0 0 12.0992 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6187 0 0 0 0 0 0 0 0 0 0 0 13.442 0 0 13.8198 0 0 0 11.5969 0 11.5295 0 14.3508 0 0 0 0 0 0 12.2841 0 0 0 11.3779 0 0 P23471 PTPRZ_HUMAN "Receptor-type tyrosine-protein phosphatase zeta, R-PTP-zeta, EC 3.1.3.48 (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2)" PTPRZ1 HTPZP2 PTPRZ PTPRZ2 PTPZ Homo sapiens (Human) axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445] GO:0002244; GO:0004725; GO:0005001; GO:0005178; GO:0005576; GO:0005886; GO:0005887; GO:0006470; GO:0007409; GO:0007417; GO:0007611; GO:0031226; GO:0031641; GO:0035335; GO:0043524; GO:0045202; GO:0048709; GO:0048714; GO:0070445; GO:0072534 integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] ATSELSHSAKSDAGLVGGGEDGDTDDDGDDDDDDR 0.99451 -15.539 10.9182 0 0 0 0 0 0 0 0 0 0 14.9121 0 0 0 0 0 0 11.4077 0 0 12.5543 0 0 0 12.4737 12.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.266 0 0 0 11.5198 14.6921 0 13.9554 0 0 0 0 0 0 0 11.5367 0 0 0 0 0 0 0 0 0 11.0843 0 0 0 0 0 0 13.6062 10.7374 0 12.9706 0 0 12.4686 0 0 11.754 0 17.9915 15.4204 16.5772 0 13.7415 0 15.5544 14.8387 14.775 15.2123 15.5978 0 0 16.0617 17.7647 14.1144 15.8652 16.9527 0 0 0 12.946 12.9912 13.6039 11.1838 0 13.8239 0 0 15.2845 0 13.7022 0 14.2015 13.7021 0 0 15.9115 0 13.3106 12.8949 16.5209 0 0 0 16.3304 11.7111 0 0 14.2661 13.4911 0 0 0 0 11.3123 12.9419 0 11.0676 0 0 0 0 13.8107 13.2197 13.0528 0 0 12.5973 0 0 0 14.6608 0 0 0 0 0 0 0 0 0 13.188 0 12.1668 0 0 12.3574 0 0 0 0 0 11.7726 13.1593 0 P23786 CPT2_HUMAN "Carnitine O-palmitoyltransferase 2, mitochondrial, EC 2.3.1.21 (Carnitine palmitoyltransferase II, CPT II)" CPT2 CPT1 Homo sapiens (Human) carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; in utero embryonic development [GO:0001701]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of cold-induced thermogenesis [GO:0120162] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; acyltransferase activity [GO:0016746]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; in utero embryonic development [GO:0001701]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of cold-induced thermogenesis [GO:0120162] GO:0001676; GO:0001701; GO:0004095; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0006635; GO:0006853; GO:0008458; GO:0009437; GO:0016746; GO:0120162 acyltransferase activity [GO:0016746]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095] ARHLLVLR 0.99451 -10.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5368 17.1403 12.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6423 12.4792 0 0 0 13.2971 11.1793 13.3411 0 0 0 0 0 0 0 0 0 12.4587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7546 0 0 0 0 0 12.6616 0 11.8355 0 15.3552 0 0 0 P35626 ARBK2_HUMAN "Beta-adrenergic receptor kinase 2, Beta-ARK-2, EC 2.7.11.15 (G-protein-coupled receptor kinase 3)" GRK3 ADRBK2 BARK2 Homo sapiens (Human) desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor signaling pathway [GO:0007186]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of signal transduction [GO:0009966]; signal transduction [GO:0007165] GO:0001664; GO:0002029; GO:0004672; GO:0004703; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007186; GO:0009966; GO:0031623; GO:0042995; GO:0047696; GO:0070161; GO:0098793; GO:0098794 ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672] APKFLNK 0.99451 -36.04 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0583 0 0 14.3923 0 0 13.7412 0 0 0 0 14.1852 0 0 0 0 0 0 0 0 0 0 0 0 11.6741 14.1963 13.0544 0 0 0 15.0338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4642 0 0 0 13.4359 0 0 14.9724 14.0997 0 0 0 0 0 0 0 0 13.4822 0 0 0 0 0 0 14.2049 0 13.3607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9476 0 0 0 0 0 P43088 PF2R_HUMAN "Prostaglandin F2-alpha receptor, PGF receptor, PGF2-alpha receptor (Prostanoid FP receptor)" PTGFR Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to prostaglandin D stimulus [GO:0071799]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; parturition [GO:0007567]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; prostaglandin F receptor activity [GO:0004958]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to prostaglandin D stimulus [GO:0071799]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; parturition [GO:0007567]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496] GO:0004958; GO:0005576; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0007186; GO:0007189; GO:0007204; GO:0007567; GO:0008284; GO:0010628; GO:0032355; GO:0032496; GO:0035584; GO:0043066; GO:0071799 prostaglandin F receptor activity [GO:0004958] FKSQQHRQGR 0.99451 -10.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13562 NDF1_HUMAN "Neurogenic differentiation factor 1, NeuroD, NeuroD1 (Class A basic helix-loop-helix protein 3, bHLHa3)" NEUROD1 BHLHA3 NEUROD Homo sapiens (Human) "amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; cellular response to glucose stimulus [GO:0071333]; cerebellum development [GO:0021549]; dentate gyrus development [GO:0021542]; embryonic organ morphogenesis [GO:0048562]; endocrine pancreas development [GO:0031018]; enteroendocrine cell differentiation [GO:0035883]; glucose homeostasis [GO:0042593]; inner ear development [GO:0048839]; insulin secretion [GO:0030073]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; nitric oxide mediated signal transduction [GO:0007263]; nucleocytoplasmic transport [GO:0006913]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of insulin secretion [GO:0050796]; regulation of intestinal epithelial structure maintenance [GO:0060730]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; amacrine cell differentiation [GO:0035881]; anterior/posterior pattern specification [GO:0009952]; cellular response to glucose stimulus [GO:0071333]; cerebellum development [GO:0021549]; dentate gyrus development [GO:0021542]; embryonic organ morphogenesis [GO:0048562]; endocrine pancreas development [GO:0031018]; enteroendocrine cell differentiation [GO:0035883]; glucose homeostasis [GO:0042593]; inner ear development [GO:0048839]; insulin secretion [GO:0030073]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; nitric oxide mediated signal transduction [GO:0007263]; nucleocytoplasmic transport [GO:0006913]; pancreatic A cell fate commitment [GO:0003326]; pancreatic PP cell fate commitment [GO:0003329]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of transcription, DNA-templated [GO:0045893]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of insulin secretion [GO:0050796]; regulation of intestinal epithelial structure maintenance [GO:0060730]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucose [GO:0009749]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003326; GO:0003329; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0006913; GO:0007259; GO:0007263; GO:0009410; GO:0009749; GO:0009952; GO:0021542; GO:0021549; GO:0022008; GO:0023019; GO:0030073; GO:0030182; GO:0031018; GO:0035881; GO:0035883; GO:0042593; GO:0043065; GO:0045597; GO:0045666; GO:0045893; GO:0045944; GO:0046426; GO:0046982; GO:0048562; GO:0048666; GO:0048839; GO:0050796; GO:0051091; GO:0060730; GO:0061629; GO:0070888; GO:0071333; GO:0090575; GO:1990837; GO:2000675; GO:2000679 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" EDDLETMNAEEDSLR 0.99451 -8.1819 0 0 0 0 0 0 11.9831 0 0 0 0 0 0 0 0 0 0 12.7652 0 0 0 0 0 12.1726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.599 0 0 0 0 0 0 0 0 0 13.8174 0 0 0 0 0 14.0843 0 0 0 0 0 0 0 0 0 0 13.6316 0 0 0 0 0 0 0 0 0 14.3713 13.031 12.8497 0 0 12.5888 0 0 14.3453 0 0 15.0668 0 0 0 0 0 0 0 14.1 0 0 0 0 0 0 0 0 14.0303 0 0 0 0 0 0 0 0 0 0 0 14.7436 0 0 0 0 12.5346 0 0 12.7908 0 0 0 0 12.8069 0 0 0 0 0 0 0 0 0 12.6453 0 0 0 0 0 0 0 0 0 0 Q6UY18 LIGO4_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D) LINGO4 LRRN6D UNQ9248/PRO34002 Homo sapiens (Human) positive regulation of synapse assembly [GO:0051965] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; positive regulation of synapse assembly [GO:0051965] GO:0005615; GO:0016021; GO:0031012; GO:0051965 GVAMVLAVGFLPFLTSVTLCFGLIALWSKGKGR 0.99451 -8.7141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4416 0 10.0771 0 0 0 0 0 0 0 0 0 0 0 11.9137 12.7457 0 0 0 0 0 0 0 0 0 0 0 12.0587 0 0 0 13.0127 0 0 0 14.5479 13.9303 14.8786 15.5838 12.4527 14.0717 13.2421 13.6102 13.7475 0 14.268 0 11.8716 0 12.6454 0 0 0 12.4829 0 0 0 0 0 0 0 11.157 0 0 11.9789 15.3509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1311 0 0 0 14.7067 13.3457 14.7542 0 0 0 12.3275 0 0 0 0 0 0 0 0 13.1615 0 0 0 0 0 0 0 11.3354 0 0 0 12.2408 0 0 0 12.345 0 0 0 0 10.5007 11.5764 0 12.0309 0 0 0 Q6ZMW2 ZN782_HUMAN Zinc finger protein 782 ZNF782 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDIAGSACQGLSLMAPHCQYSKEKAHER 0.99451 -12.899 0 0 0 0 0 0 0 0 0 10.5733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4408 0 0 0 0 0 0 0 12.1986 0 0 0 0 0 0 13.214 0 0 0 0 0 0 0 0 0 16.5745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1466 0 0 0 0 0 0 0 0 0 0 0 12.722 0 0 12.5159 0 17.6908 0 11.9468 0 13.8877 0 13.132 0 11.7598 0 0 0 0 0 0 0 0 0 0 Q7RTU0 TCF24_HUMAN "Transcription factor 24, TCF-24" TCF24 Homo sapiens (Human) developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; developmental process [GO:0032502]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0032502; GO:0046983 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" HAFLELQRTLPSVPPDTKLSK 0.99451 -5.3981 0 0 0 0 0 0 13.0566 0 0 13.7586 0 0 0 0 0 0 0 0 0 12.7301 12.3753 0 0 0 0 0 0 0 0 13.4625 0 0 0 0 0 0 0 0 0 12.8815 0 0 0 0 0 0 0 0 13.0105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.28 0 0 13.5785 0 0 0 0 0 0 13.3008 0 0 0 0 0 0 0 12.8812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9587 0 0 0 0 14.0192 0 0 0 0 0 0 14.4871 0 0 13.3093 0 0 0 0 0 0 0 0 0 0 0 14.5444 13.5761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4544 0 Q8IUR7 ARMC8_HUMAN Armadillo repeat-containing protein 8 ARMC8 S863-2 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GID complex [GO:0034657]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GID complex [GO:0034657]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0000151; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0034657; GO:0035580; GO:0043161; GO:0043231; GO:1904724 CLTYMCR 0.99451 -8.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6323 0 0 0 0 14.2176 0 0 0 14.9347 0 14.5301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90112 0 0 0 0 0 0 0 0 0 14.2723 0 0 10.3831 0 11.2535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAX0 OSR1_HUMAN Protein odd-skipped-related 1 OSR1 ODD Homo sapiens (Human) cell differentiation [GO:0030154]; cell proliferation involved in kidney development [GO:0072111]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; gonad development [GO:0008406]; heart development [GO:0007507]; intermediate mesoderm development [GO:0048389]; mesangial cell development [GO:0072143]; mesonephric duct morphogenesis [GO:0072180]; mesonephros development [GO:0001823]; metanephric cap mesenchymal cell proliferation involved in metanephros development [GO:0090094]; metanephric epithelium development [GO:0072207]; metanephric glomerulus vasculature development [GO:0072239]; metanephric interstitial fibroblast development [GO:0072259]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric mesenchyme morphogenesis [GO:0072133]; metanephric nephron tubule development [GO:0072234]; metanephric smooth muscle tissue development [GO:0072208]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of nephron tubule epithelial cell differentiation [GO:0072183]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; pattern specification involved in metanephros development [GO:0072268]; positive regulation of bone mineralization [GO:0030501]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior mesonephric tubule development [GO:0072166]; pronephros development [GO:0048793]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle progenitor cell differentiation [GO:0072184]; roof of mouth development [GO:0060021]; sodium ion transmembrane transport [GO:0035725]; specification of anterior mesonephric tubule identity [GO:0072168]; specification of posterior mesonephric tubule identity [GO:0072169]; stem cell differentiation [GO:0048863]; ureter urothelium development [GO:0072190]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655] chromatin [GO:0000785]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; cell proliferation involved in kidney development [GO:0072111]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint development [GO:0072498]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal limb joint morphogenesis [GO:0036023]; gonad development [GO:0008406]; heart development [GO:0007507]; intermediate mesoderm development [GO:0048389]; mesangial cell development [GO:0072143]; mesonephric duct morphogenesis [GO:0072180]; mesonephros development [GO:0001823]; metanephric cap mesenchymal cell proliferation involved in metanephros development [GO:0090094]; metanephric epithelium development [GO:0072207]; metanephric glomerulus vasculature development [GO:0072239]; metanephric interstitial fibroblast development [GO:0072259]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric mesenchyme morphogenesis [GO:0072133]; metanephric nephron tubule development [GO:0072234]; metanephric smooth muscle tissue development [GO:0072208]; middle ear morphogenesis [GO:0042474]; negative regulation of apoptotic process [GO:0043066]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of nephron tubule epithelial cell differentiation [GO:0072183]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; pattern specification involved in metanephros development [GO:0072268]; positive regulation of bone mineralization [GO:0030501]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior mesonephric tubule development [GO:0072166]; pronephros development [GO:0048793]; regulation of transcription by RNA polymerase II [GO:0006357]; renal vesicle progenitor cell differentiation [GO:0072184]; roof of mouth development [GO:0060021]; sodium ion transmembrane transport [GO:0035725]; specification of anterior mesonephric tubule identity [GO:0072168]; specification of posterior mesonephric tubule identity [GO:0072169]; stem cell differentiation [GO:0048863]; ureter urothelium development [GO:0072190]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001655; GO:0001657; GO:0001823; GO:0002062; GO:0005634; GO:0005829; GO:0006357; GO:0007507; GO:0008406; GO:0010628; GO:0019898; GO:0030154; GO:0030501; GO:0030857; GO:0035115; GO:0035116; GO:0035725; GO:0036023; GO:0042474; GO:0042476; GO:0042733; GO:0043066; GO:0045944; GO:0046872; GO:0048389; GO:0048793; GO:0048863; GO:0050679; GO:0060021; GO:0060272; GO:0071300; GO:0072075; GO:0072111; GO:0072133; GO:0072143; GO:0072162; GO:0072166; GO:0072168; GO:0072169; GO:0072180; GO:0072183; GO:0072184; GO:0072190; GO:0072207; GO:0072208; GO:0072234; GO:0072239; GO:0072259; GO:0072268; GO:0072498; GO:0090094; GO:1905408; GO:1990837; GO:2000543; GO:2000650 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" CQECGKGFCQSR 0.99451 -5.4031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3942 0 0 0 0 12.8918 12.8222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5661 0 0 0 0 0 0 0 0 0 0 0 0 12.3109 0 0 12.631 12.5318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7842 0 0 0 0 0 0 12.5695 Q8WWH5 TRUB1_HUMAN "Pseudouridylate synthase TRUB1, EC 5.4.99.- (TruB pseudouridine synthase homolog 1) (tRNA pseudouridine 55 synthase TRUB1, Psi55 synthase TRUB1, EC 5.4.99.25)" TRUB1 PUS4 Homo sapiens (Human) mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of pre-miRNA processing [GO:2000633]; tRNA modification [GO:0006400] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pre-miRNA binding [GO:0070883]; pseudouridine synthase activity [GO:0009982]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of pre-miRNA processing [GO:2000633]; tRNA modification [GO:0006400] GO:0005634; GO:0005739; GO:0005829; GO:0006397; GO:0006400; GO:0009982; GO:0070883; GO:1990481; GO:2000633 pre-miRNA binding [GO:0070883]; pseudouridine synthase activity [GO:0009982] AAAAVVAAAAR 0.99451 -5.3822 0 0 0 0 0 0 0 0 11.8238 0 12.7221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2054 0 0 0 11.629 0 0 0 0 0 0 0 0 12.8713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5536 0 0 0 0 0 0 0 0 0 0 12.8625 0 0 11.1931 0 0 0 0 0 0 0 0 10.7508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1066 0 0 0 0 0 0 0 0 0 0 0 0 13.6006 0 14.4631 13.4444 0 13.8395 13.6795 0 0 0 0 0 0 13.2252 0 0 0 0 13.395 0 0 0 0 Q96M66 YP010_HUMAN Putative uncharacterized protein FLJ32790 Homo sapiens (Human) AYCRGGSSSTSR 0.99451 -11.326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9234 13.1615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NI8 ZN570_HUMAN Zinc finger protein 570 ZNF570 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ACFKEEIITHEEPLFDER 0.99451 -8.7171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8003 0 0 12.9057 0 13.5778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2614 0 0 0 12.2046 0 0 14.2633 0 0 14.1648 0 13.7093 0 0 0 0 0 0 15.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.966 0 14.9067 14.8134 0 0 0 0 0 0 0 13.328 0 0 0 0 0 0 0 0 0 0 14.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99489 OXDD_HUMAN "D-aspartate oxidase, DASOX, DDO, EC 1.4.3.1" DDO Homo sapiens (Human) aspartate catabolic process [GO:0006533]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; aspartate catabolic process [GO:0006533]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320] GO:0003884; GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006533; GO:0007320; GO:0007625; GO:0008445; GO:0019478; GO:0042445; GO:0071949 D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949] CCALEPSLHGACNIREKVGLR 0.99451 -5.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7172 0 0 11.3241 0 12.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0938 0 0 0 0 0 0 0 0 14.4923 0 0 0 0 18.1004 0 0 0 13.7277 0 10.6982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1684 0 18.0856 0 0 18.4433 0 0 0 0 0 0 0 0 13.3453 13.5095 13.9724 13.7932 14.0268 0 14.2109 0 14.0534 0 0 0 0 13.2369 0 0 0 0 0 0 0 0 0 0 Q9BRT6 LLPH_HUMAN Protein LLP homolog (Protein LAPS18-like) LLPH C12orf31 cPERP-G Homo sapiens (Human) dendrite extension [GO:0097484]; positive regulation of dendritic spine development [GO:0060999] chromosome [GO:0005694]; nucleolus [GO:0005730] chromosome [GO:0005694]; nucleolus [GO:0005730]; basal RNA polymerase II transcription machinery binding [GO:0001099]; RNA binding [GO:0003723]; dendrite extension [GO:0097484]; positive regulation of dendritic spine development [GO:0060999] GO:0001099; GO:0003723; GO:0005694; GO:0005730; GO:0060999; GO:0097484 basal RNA polymerase II transcription machinery binding [GO:0001099]; RNA binding [GO:0003723] EASRLKSILK 0.99451 -8.712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0252 0 0 0 0 0 0 14.3707 0 0 0 15.7602 14.8076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4433 0 0 0 0 0 0 0 0 0 0 0 13.4548 0 0 0 13.5474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.101 0 0 0 0 0 0 12.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX20 RM16_HUMAN "39S ribosomal protein L16, mitochondrial, L16mt, MRP-L16 (Mitochondrial large ribosomal subunit protein uL16m)" MRPL16 PNAS-111 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019843; GO:0032543 rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] APLVPKVR 0.99451 -11.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9136 0 0 0 0 0 0 0 0 11.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8316 0 0 0 0 0 0 0 0 0 0 0 0 12.2874 14.0496 0 0 0 0 13.8367 0 0 0 0 Q9UHV9 PFD2_HUMAN Prefoldin subunit 2 PFDN2 PFD2 HSPC231 Homo sapiens (Human) negative regulation of amyloid fibril formation [GO:1905907]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; amyloid-beta binding [GO:0001540]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; negative regulation of amyloid fibril formation [GO:1905907]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0044183; GO:0050821; GO:0051082; GO:0051495; GO:0101031; GO:1905907; GO:1990062 amyloid-beta binding [GO:0001540]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] AENSGRAGK 0.99451 -8.7158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2174 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0076 15.0644 15.0889 14.1557 10.1964 0 0 11.7225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.621 0 0 0 14.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UIB8 SLAF5_HUMAN SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84) CD84 SLAMF5 Homo sapiens (Human) adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response [GO:0006952]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innate immune response [GO:0045087]; negative regulation of granulocyte macrophage colony-stimulating factor production [GO:0032685]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of macrophage activation [GO:0043030]; regulation of store-operated calcium entry [GO:2001256]; T cell activation [GO:0042110] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; adaptive immune response [GO:0002250]; autophagy [GO:0006914]; defense response [GO:0006952]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innate immune response [GO:0045087]; negative regulation of granulocyte macrophage colony-stimulating factor production [GO:0032685]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell degranulation [GO:0043305]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of macrophage activation [GO:0043030]; regulation of store-operated calcium entry [GO:2001256]; T cell activation [GO:0042110] GO:0002250; GO:0005886; GO:0005887; GO:0006914; GO:0006952; GO:0007156; GO:0009897; GO:0032685; GO:0032701; GO:0032715; GO:0032760; GO:0033004; GO:0042110; GO:0042802; GO:0043030; GO:0043231; GO:0043305; GO:0045087; GO:0071639; GO:2001256 identical protein binding [GO:0042802] MEDAGDYK 0.99451 -12.897 0 0 0 0 0 0 0 0 12.6548 0 0 0 0 0 0 0 0 0 0 10.9971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6648 0 0 0 13.4513 0 0 13.3243 0 0 0 0 0 0 0 0 0 0 0 0 16.9719 0 0 0 0 15.7241 0 0 14.7642 0 17.1526 0 14.8131 0 15.5491 0 0 16.2057 16.5859 0 0 0 0 0 0 0 0 16.316 14.366 15.2062 0 15.0394 0 15.1636 13.8831 0 0 13.0449 12.6643 14.2777 13.2553 0 15.3481 0 0 14.5112 0 0 13.0338 0 0 0 0 0 11.2852 0 11.8445 0 0 0 0 15.8068 0 0 10.463 0 0 0 0 0 0 0 0 13.613 0 0 0 0 13.5533 0 0 0 0 0 0 0 A6NCV1 O6C74_HUMAN Olfactory receptor 6C74 OR6C74 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IPSSQQRKK 0.99452 -8.239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2532 13.521 13.0867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8225 0 0 0 0 0 0 0 O15481 MAGB4_HUMAN Melanoma-associated antigen B4 (MAGE-B4 antigen) MAGEB4 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005737 AHAETSK 0.99452 -8.2101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8376 0 13.4338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6723 13.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4011 0 0 0 0 0 12.8994 0 0 0 0 0 0 0 0 0 0 0 12.9833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4612 0 0 0 0 0 14.4074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7513 P15311 EZRI_HUMAN Ezrin (Cytovillin) (Villin-2) (p81) EZR VIL2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell periphery [GO:0071944]; cell projection [GO:0042995]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell periphery [GO:0071944]; cell projection [GO:0042995]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; vesicle [GO:0031982]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896] GO:0000122; GO:0001650; GO:0001726; GO:0001772; GO:0001931; GO:0001951; GO:0003376; GO:0003723; GO:0003779; GO:0005615; GO:0005737; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0005925; GO:0007159; GO:0008017; GO:0008022; GO:0008360; GO:0010628; GO:0010737; GO:0015629; GO:0016020; GO:0016323; GO:0016324; GO:0019898; GO:0019904; GO:0022614; GO:0030033; GO:0030175; GO:0030863; GO:0030953; GO:0031503; GO:0031528; GO:0031532; GO:0031623; GO:0031982; GO:0032532; GO:0032587; GO:0032703; GO:0032991; GO:0034236; GO:0034237; GO:0035088; GO:0036064; GO:0040018; GO:0042802; GO:0042995; GO:0043622; GO:0044548; GO:0044853; GO:0045177; GO:0045296; GO:0045732; GO:0046847; GO:0048015; GO:0048471; GO:0050714; GO:0050839; GO:0050860; GO:0051015; GO:0051017; GO:0051018; GO:0051117; GO:0051660; GO:0061028; GO:0070062; GO:0070373; GO:0071320; GO:0071944; GO:0072659; GO:0072697; GO:0097718; GO:0098592; GO:1902115; GO:1902896; GO:1902966; GO:1903078; GO:1903753; GO:2000643 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548] EQMMREKEELMLR 0.99452 -9.0158 0 0 0 0 0 0 0 0 12.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9389 0 0 12.2814 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1921 0 0 12.194 0 0 12.9298 0 0 0 0 0 0 0 0 0 0 12.7296 14.6963 0 14.3107 0 0 0 0 0 0 12.7942 0 0 0 0 0 12.0008 0 12.8981 12.5862 12.7081 0 0 0 0 0 0 0 0 12.7204 12.9771 0 0 0 0 0 0 0 0 0 0 12.0309 0 0 0 P17600 SYN1_HUMAN Synapsin-1 (Brain protein 4.1) (Synapsin I) SYN1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091] anchored component of synaptic vesicle membrane [GO:0098993]; anchoring junction [GO:0070161]; axon [GO:0030424]; cell body [GO:0044297]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of synaptic vesicle membrane [GO:0098850]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptonemal complex [GO:0000795] anchored component of synaptic vesicle membrane [GO:0098993]; anchoring junction [GO:0070161]; axon [GO:0030424]; cell body [GO:0044297]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of synaptic vesicle membrane [GO:0098850]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; synaptonemal complex [GO:0000795]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein-membrane anchor activity [GO:0106006]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; chemical synaptic transmission [GO:0007268]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of synaptic vesicle exocytosis [GO:2000300]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091] GO:0000795; GO:0003779; GO:0005524; GO:0005794; GO:0005829; GO:0005856; GO:0007268; GO:0007269; GO:0008021; GO:0014069; GO:0019901; GO:0030424; GO:0030425; GO:0030672; GO:0042802; GO:0044297; GO:0046928; GO:0048306; GO:0048666; GO:0048786; GO:0050808; GO:0070161; GO:0097091; GO:0098685; GO:0098693; GO:0098850; GO:0098993; GO:0106006; GO:2000300 actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein-membrane anchor activity [GO:0106006]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901] GKKIHGEIDIK 0.99452 -13.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0489 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0126 0 15.908 11.4561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6803 0 0 0 0 0 0 0 0 P35236 PTN7_HUMAN "Tyrosine-protein phosphatase non-receptor type 7, EC 3.1.3.48 (Hematopoietic protein-tyrosine phosphatase, HEPTP) (Protein-tyrosine phosphatase LC-PTP)" PTPN7 Homo sapiens (Human) MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470] GO:0000165; GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0009898; GO:0015630; GO:0072686 non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725] DRYKTILPNPQSR 0.99452 -13.757 0 0 0 0 14.3266 0 13.4828 0 0 12.3679 0 0 0 0 0 14.0266 13.9685 0 0 0 0 0 14.6254 0 13.4381 12.9263 14.5683 0 13.6953 12.5223 12.6229 0 0 0 0 0 0 0 18.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.8232 0 0 0 0 0 0 12.9682 13.0393 14.3385 0 0 21.1198 0 19.4246 13.4511 0 0 0 13.6437 19.2927 0 19.2804 0 0 0 19.2794 19.2157 0 0 0 0 0 0 0 0 0 0 0 0 12.9809 0 0 0 0 19.1224 0 0 0 0 0 0 12.8946 0 12.8066 0 0 0 0 0 0 12.8884 0 0 0 0 0 0 0 0 19.1179 0 0 0 0 13.9163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7776 0 0 15.7454 15.8013 0 0 15.6663 15.5773 0 0 0 0 15.9442 0 15.6352 0 0 P51397 DAP1_HUMAN "Death-associated protein 1, DAP-1" DAP DAP1 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]" "death domain binding [GO:0070513]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0006914; GO:0006915; GO:0006919; GO:0010507; GO:0032088; GO:0034198; GO:0045892; GO:0070513; GO:0097190 death domain binding [GO:0070513] PHASMDK 0.99452 -8.7192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52788 SPSY_HUMAN "Spermine synthase, SPMSY, EC 2.5.1.22 (Spermidine aminopropyltransferase)" SMS Homo sapiens (Human) methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; spermine synthase activity [GO:0016768]; methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597] GO:0005829; GO:0006555; GO:0006595; GO:0006597; GO:0016768; GO:0070062 spermine synthase activity [GO:0016768] AIMGSGK 0.99452 -15.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1777 0 0 0 11.4104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.59721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5777 0 0 0 0 0 0 0 14.7104 0 0 0 0 0 0 0 0 0 0 0 13.2314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7411 0 0 0 0 0 0 0 11.8831 12.8604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12800 TFCP2_HUMAN Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008022; GO:0008134; GO:0032991; GO:0042789; GO:0045944; GO:1990837 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]" KLGELPEINGKLVK 0.99452 -8.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7367 0 0 0 0 0 0 0 0 0 0 0 0 13.4656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4707 0 0 0 0 0 18.2605 0 0 0 0 0 0 0 0 0 0 0 13.2376 0 0 0 0 14.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0274 0 0 0 0 0 Q14332 FZD2_HUMAN "Frizzled-2, Fz-2, hFz2 (FzE2)" FZD2 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; endothelial cell differentiation [GO:0045446]; hard palate development [GO:0060022]; inner ear receptor cell development [GO:0060119]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neuron differentiation [GO:0030182]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory perception of smell [GO:0007608]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; endothelial cell differentiation [GO:0045446]; hard palate development [GO:0060022]; inner ear receptor cell development [GO:0060119]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neuron differentiation [GO:0030182]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; sensory perception of smell [GO:0007608]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0003149; GO:0003150; GO:0003151; GO:0004930; GO:0005737; GO:0005886; GO:0005925; GO:0007608; GO:0016021; GO:0016055; GO:0017147; GO:0030165; GO:0030182; GO:0030669; GO:0042813; GO:0045446; GO:0045893; GO:0051091; GO:0060022; GO:0060070; GO:0060071; GO:0060119; GO:0090103; GO:0090179 G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] LERLMVR 0.99452 -9.0075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2982 12.0168 0 13.6238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3829 0 0 0 0 0 0 12.818 0 12.3163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5492 0 0 0 0 0 0 0 13.1867 12.5808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PD74 AAGAB_HUMAN Alpha- and gamma-adaptin-binding protein p34 AAGAB Homo sapiens (Human) protein transport [GO:0015031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; protein transport [GO:0015031] GO:0005737; GO:0005829; GO:0015031; GO:0016607 LFSKLKEMK 0.99452 -8.7218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9004 0 0 0 14.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6URK8 TEPP_HUMAN "Testis, prostate and placenta-expressed protein" TEPP Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 ARPPPFLFCPLSSQRTESPYK 0.99452 -8.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4713 0 0 11.2883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1268 0 0 0 12.5506 11.6368 0 0 0 0 0 0 0 0 0 11.3951 0 0 0 0 0 0 0 0 13.4691 13.0514 13.1313 0 0 13.547 0 12.9921 0 13.3733 0 14.0387 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2531 0 0 0 0 0 0 0 0 0 0 0 14.1436 0 14.2566 0 0 0 0 0 0 Q6ZV50 RFX8_HUMAN DNA-binding protein RFX8 (Regulatory factor X 8) RFX8 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EVTLFVKR 0.99452 -12.92 0 0 0 0 0 0 0 0 0 0 0 0 12.413 10.8134 0 0 0 0 0 0 0 12.8099 0 13.2658 0 0 0 0 11.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6774 0 0 0 9.86904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9888 12.0145 0 0 0 12.9744 11.7528 0 0 0 0 14.637 0 0 0 0 0 0 0 0 0 13.9703 12.0586 15.0511 0 13.6519 11.8617 0 0 0 0 0 14.0841 0 10.7317 0 0 0 0 10.4913 0 0 0 0 11.708 0 13.9548 0 0 13.8139 0 12.6871 0 10.8952 0 10.7742 14.6175 0 0 0 0 12.8388 0 0 0 0 0 0 0 0 12.7681 0 14.5715 0 13.6191 0 0 0 0 0 0 0 0 11.8598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6457 0 0 0 0 12.6762 Q6ZWI9 RFPLB_HUMAN Ret finger protein-like 4B (RING finger protein 211) RFPL4B RNF211 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] AMCPLCR 0.99452 -12.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2842 0 0 0 0 0 0 0 0 0 0 0 12.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0441 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6301 12.4243 0 0 0 0 11.6999 14.5812 14.5821 0 0 13.2084 0 0 0 14.6723 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5772 0 0 0 0 13.877 0 0 0 0 0 0 11.9901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z553 MDGA2_HUMAN MAM domain-containing glycosylphosphatidylinositol anchor protein 2 (MAM domain-containing protein 1) MDGA2 MAMDC1 UNQ8188/PRO23197 Homo sapiens (Human) nervous system development [GO:0007399]; spinal cord motor neuron differentiation [GO:0021522] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; nervous system development [GO:0007399]; spinal cord motor neuron differentiation [GO:0021522] GO:0005576; GO:0005886; GO:0007399; GO:0021522; GO:0031225 ADKEVAMPDGSMQMESYDGTLR 0.99452 -13.812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6027 0 0 0 0 0 Q8N1W2 ZN710_HUMAN Zinc finger protein 710 ZNF710 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] EFKCEVCGR 0.99452 -31.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7109 0 0 0 0 13.8088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.403 0 0 0 11.5263 13.4794 0 0 0 0 0 0 0 0 14.0777 16.3555 0 0 0 0 0 0 14.8762 11.0813 0 0 0 14.7944 0 0 0 0 0 0 0 0 12.9123 0 12.1936 0 12.105 13.6686 0 0 0 0 0 0 0 0 12.2276 0 14.3964 0 0 0 0 0 13.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5366 0 0 Q8TEA7 TBCK_HUMAN TBC domain-containing protein kinase-like protein TBCK TBCKL HSPC302 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; regulation of TOR signaling [GO:0032006] cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell population proliferation [GO:0008283]; regulation of TOR signaling [GO:0032006] GO:0004672; GO:0005096; GO:0005524; GO:0005737; GO:0008283; GO:0030036; GO:0030496; GO:0032006; GO:0072686; GO:0090630 ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; protein kinase activity [GO:0004672] FQILKTITHPRLCQYVDISR 0.99452 -12.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9237 0 0 0 11.7462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3192 0 13.1279 0 14.1629 0 16.1105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7684 0 0 0 0 0 0 0 12.9387 0 0 0 0 14.5464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4066 0 13.1357 16.244 0 0 0 0 0 0 0 0 0 0 14.9335 0 11.9141 0 0 0 12.9693 0 0 0 0 12.4407 0 Q9BYF1 ACE2_HUMAN "Angiotensin-converting enzyme 2, EC 3.4.17.23 (Angiotensin-converting enzyme homolog, ACEH) (Angiotensin-converting enzyme-related carboxypeptidase, ACE-related carboxypeptidase, EC 3.4.17.-) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2 ]" ACE2 UNQ868/PRO1885 Homo sapiens (Human) angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; blood vessel diameter maintenance [GO:0097746]; maternal process involved in female pregnancy [GO:0060135]; membrane fusion [GO:0061025]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of transmembrane transporter activity [GO:0022898]; regulation of vasoconstriction [GO:0019229]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]; viral life cycle [GO:0019058] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cilium [GO:0005929]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cilium [GO:0005929]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; blood vessel diameter maintenance [GO:0097746]; maternal process involved in female pregnancy [GO:0060135]; membrane fusion [GO:0061025]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of transmembrane transporter activity [GO:0022898]; regulation of vasoconstriction [GO:0019229]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]; viral life cycle [GO:0019058] GO:0001618; GO:0001817; GO:0002003; GO:0003051; GO:0003081; GO:0004175; GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0005929; GO:0008237; GO:0008241; GO:0008270; GO:0009986; GO:0015827; GO:0016020; GO:0016021; GO:0016324; GO:0019058; GO:0019065; GO:0019229; GO:0022898; GO:0030666; GO:0031526; GO:0042127; GO:0042802; GO:0045121; GO:0046718; GO:0046813; GO:0048662; GO:0050727; GO:0051957; GO:0060135; GO:0060452; GO:0061025; GO:0070062; GO:0070373; GO:0097746; GO:1903598; GO:1903779; GO:1905737; GO:2000272; GO:2000379 carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] ANHYEDYGDYWR 0.99452 -13.761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2175 0 13.3822 0 0 0 0 0 0 13.3511 0 0 0 0 0 0 13.1887 0 0 0 0 0 0 0 0 0 0 13.9354 0 0 0 13.5371 0 0 0 0 0 0 13.6714 0 0 0 13.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1564 0 0 0 0 0 12.9554 0 0 0 0 13.388 0 0 13.187 0 0 0 0 13.7221 0 13.9164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4362 0 0 0 0 0 O15327 INP4B_HUMAN "Inositol polyphosphate 4-phosphatase type II (Type II inositol 3,4-bisphosphate 4-phosphatase, EC 3.1.3.66)" INPP4B Homo sapiens (Human) inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165]" GO:0005737; GO:0005829; GO:0006661; GO:0007165; GO:0016316; GO:0017161; GO:0034597; GO:0043647; GO:0046855; GO:0046856; GO:0052828 "inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]; phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]" DGGSEGSGGNNDGEK 0.99453 -13.848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4005 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7984 0 9.89895 12.4925 0 0 0 0 0 0 0 12.9174 0 0 0 0 0 13.8332 0 0 0 15.827 0 13.6919 0 0 0 0 13.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7195 0 0 0 0 0 O15498 YKT6_HUMAN "Synaptobrevin homolog YKT6, EC 2.3.1.-" YKT6 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]" apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133] "apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]" GO:0000139; GO:0005484; GO:0005737; GO:0005739; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005887; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030133; GO:0030659; GO:0031201; GO:0033116; GO:0042147; GO:0043025; GO:0045296; GO:0097440; GO:0097441 cadherin binding [GO:0045296]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484] GEAKVVLLK 0.99453 -11.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8379 0 0 0 0 0 0 0 0 0 0 9.97785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75616 ERAL1_HUMAN "GTPase Era, mitochondrial, H-ERA, hERA (Conserved ERA-like GTPase, CEGA) (ERA-W) (ERA-like protein 1)" ERAL1 HERA Homo sapiens (Human) ribosomal small subunit assembly [GO:0000028] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal small subunit assembly [GO:0000028] GO:0000028; GO:0003723; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0019843; GO:0043024 GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] ERVIPFSSLLGFQR 0.99453 -8.5088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4429 0 0 0 0 17.7697 12.4918 0 0 0 0 13.6708 0 11.3387 0 0 0 0 14.1357 0 0 12.7065 0 0 0 0 0 0 13.4954 13.1805 12.8927 0 13.5059 12.9921 0 0 0 0 0 0 0 12.9938 0 0 0 13.326 13.1048 13.0773 0 13.4014 13.2511 0 13.0339 0 0 0 0 0 0 0 0 12.3104 0 0 13.283 0 13.4281 0 0 0 13.5428 13.1932 0 0 14.3518 12.9458 13.3371 0 13.2086 0 0 0 13.0127 0 0 13.1842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3562 0 0 0 0 0 0 0 0 O95789 ZMYM6_HUMAN Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258) ZMYM6 Buster2 KIAA1353 ZNF258 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604] GO:0003677; GO:0005634; GO:0007010; GO:0008270; GO:0022604 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] CSMCQKNADTR 0.99453 -11.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.089 0 0 0 0 0 0 0 0 0 0 0 0 0 9.85773 0 0 12.1192 0 0 0 0 0 0 12.2035 0 0 0 0 0 0 0 0 11.2062 0 0 0 9.83703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.332 0 0 11.7911 0 0 0 0 0 12.9748 0 0 0 0 15.4384 10.8855 0 15.0768 14.5723 0 0 0 14.7598 0 0 0 0 0 0 0 12.7832 9.8177 0 12.3311 0 12.7587 0 0 0 0 0 0 0 13.0806 0 13.2319 0 0 12.5947 12.6766 0 16.2746 0 11.7112 0 13.7422 0 0 12.3766 0 0 0 12.4783 13.3855 0 0 16.1226 0 13.276 0 11.1762 0 0 0 0 0 11.6325 0 0 0 0 0 14.6317 11.6039 0 0 0 0 0 0 0 0 0 0 0 10.9831 0 0 0 0 0 0 12.656 0 12.6321 13.1275 0 0 P14635 CCNB1_HUMAN G2/mitotic-specific cyclin-B1 CCNB1 CCNB Homo sapiens (Human) cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922] centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266] GO:0000079; GO:0000086; GO:0000307; GO:0000922; GO:0000940; GO:0001701; GO:0005113; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005813; GO:0005829; GO:0006468; GO:0007052; GO:0007080; GO:0010971; GO:0016020; GO:0016538; GO:0019901; GO:0044389; GO:0044772; GO:0045931; GO:0048146; GO:0051301; GO:0051987; GO:0061575; GO:0090266; GO:0097125; GO:1905448 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389] FMQNNCVPKK 0.99453 -11.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96578 0 0 0 0 0 0 0 0 0 0 0 0 13.7788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.958 0 14.5614 14.5125 12.8042 12.1137 14.4037 11.3377 13.0841 0 11.4826 12.1027 11.4347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9403 0 0 0 0 0 0 0 0 14.1384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.206 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6522 0 0 0 0 14.7798 0 0 0 11.4698 0 0 0 0 0 0 0 13.6647 0 0 0 0 0 0 0 0 0 12.8649 0 0 0 0 0 0 0 0 P20701 ITAL_HUMAN "Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a)" ITGAL CD11A Homo sapiens (Human) cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory T cell extravasation [GO:0035683]; phagocytosis [GO:0006909]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integrin alphaL-beta2 complex [GO:0034687]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integrin alphaL-beta2 complex [GO:0034687]; integrin complex [GO:0008305]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; cell adhesion molecule binding [GO:0050839]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory T cell extravasation [GO:0035683]; phagocytosis [GO:0006909]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:0002291] GO:0002291; GO:0005178; GO:0005886; GO:0006909; GO:0006954; GO:0007155; GO:0007157; GO:0007159; GO:0007160; GO:0007165; GO:0007229; GO:0008305; GO:0009897; GO:0009986; GO:0016020; GO:0030369; GO:0033627; GO:0034687; GO:0035579; GO:0035683; GO:0043113; GO:0046872; GO:0050839; GO:0070062; GO:0098609 cell adhesion molecule binding [GO:0050839]; ICAM-3 receptor activity [GO:0030369]; integrin binding [GO:0005178]; metal ion binding [GO:0046872] ALRLTAFASLSVELSLSNLEEDAYWVQLDLHFPPGLSFRK 0.99453 -11.097 0 0 0 0 0 0 0 0 13.0163 13.4305 0 13.0039 12.7307 13.4367 13.0937 0 0 0 0 0 0 0 0 0 0 0 10.6959 0 12.8296 12.6629 0 12.7283 12.7292 0 12.5518 13.1266 12.6755 13.0646 12.9487 12.6847 12.6463 0 0 0 12.1167 0 0 0 0 12.2494 0 0 13.1539 12.2167 0 0 12.098 0 0 0 0 0 0 0 0 0 0 11.1788 15.1356 0 0 0 16.116 0 0 0 0 0 0 0 0 10.7076 0 0 12.6552 0 0 0 0 0 0 0 0 0 0 0 0 11.0273 0 0 0 0 0 10.5123 0 0 14.0227 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0531 0 0 12.6629 0 14.3279 0 0 0 0 9.47029 0 0 0 12.1494 0 0 0 0 0 0 0 0 14.3967 0 0 0 15.3568 0 0 0 0 0 0 0 0 0 18.5415 14.4543 0 14.7238 0 18.5722 14.5506 0 0 0 0 0 0 14.4149 0 0 0 0 0 12.1088 14.3624 0 0 P41162 ETV3_HUMAN "ETS translocation variant 3 (ETS domain transcriptional repressor PE1, PE-1) (Mitogenic Ets transcriptional suppressor)" ETV3 METS PE1 Homo sapiens (Human) cell differentiation [GO:0030154]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; negative regulation of cell population proliferation [GO:0008285]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0008285; GO:0017151; GO:0030154; GO:0043231; GO:0090571; GO:0097011; GO:1990837 "DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" CKPQMNYDK 0.99453 -11.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2062 12.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3749 0 13.9064 13.2233 0 0 0 0 0 0 0 14.7908 0 0 15.3974 0 0 0 12.7837 0 0 0 13.9631 0 0 0 12.4424 0 0 0 0 0 0 0 0 0 0 0 0 13.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6283 0 0 0 0 13.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1264 0 0 0 0 0 15.1171 0 P41220 RGS2_HUMAN "Regulator of G-protein signaling 2, RGS2 (Cell growth-inhibiting gene 31 protein) (G0/G1 switch regulatory protein 8)" RGS2 G0S8 GIG31 Homo sapiens (Human) brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenylate cyclase inhibitor activity [GO:0010855]; beta-tubulin binding [GO:0048487]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; brain development [GO:0007420]; brown fat cell differentiation [GO:0050873]; cell cycle [GO:0007049]; G protein-coupled receptor signaling pathway [GO:0007186]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process [GO:0140194]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glycine import across plasma membrane [GO:1900924]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phospholipase activity [GO:0010519]; negative regulation of translation [GO:0017148]; ovulation [GO:0030728]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of neuron projection development [GO:0010976]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; relaxation of cardiac muscle [GO:0055119]; relaxation of vascular associated smooth muscle [GO:0060087]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; spermatogenesis [GO:0007283] GO:0001965; GO:0001975; GO:0003924; GO:0005096; GO:0005516; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0007049; GO:0007186; GO:0007283; GO:0007420; GO:0008277; GO:0009898; GO:0010519; GO:0010614; GO:0010855; GO:0010976; GO:0017148; GO:0030728; GO:0043005; GO:0043407; GO:0045471; GO:0045744; GO:0048487; GO:0050873; GO:0055119; GO:0060087; GO:0060135; GO:0060452; GO:0061052; GO:0140194; GO:1900924 adenylate cyclase inhibitor activity [GO:0010855]; beta-tubulin binding [GO:0048487]; calmodulin binding [GO:0005516]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] KIYTDFIEK 0.99453 -8.5316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8914 11.8523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5055 14.5338 14.5352 0 14.7056 14.5757 0 0 14.3977 14.2488 14.3807 14.1205 13.9575 0 13.7353 17.4255 0 0 0 0 0 0 13.5339 13.8444 14.673 17.3312 0 0 0 13.7264 0 0 16.7675 13.5605 13.8899 13.7088 0 0 0 13.5996 13.6958 13.569 14.6463 13.8448 13.7247 0 0 0 15.0872 0 13.5467 13.6714 13.3969 0 0 13.5085 14.7073 0 13.7448 14.5498 13.5488 0 13.4307 13.6815 13.7618 0 0 13.238 13.3339 14.4308 0 0 14.5608 0 13.6188 14.1159 14.7614 13.3867 14.6099 13.3496 15.1796 0 0 14.1302 0 14.3794 13.3401 0 13.2068 13.4757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7743 14.9227 13.193 0 0 0 14.8397 0 Q2M3W8 ZN181_HUMAN Zinc finger protein 181 (HHZ181) ZNF181 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GMIPDWESRWENK 0.99453 -10.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75012 0 0 0 12.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4664 0 0 0 0 0 0 0 13.0862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6135 0 0 0 0 0 0 0 0 12.4844 0 0 0 0 0 0 0 11.0366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PF18 MORN3_HUMAN MORN repeat-containing protein 3 MORN3 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 EYYEGDWCGSQRSGWGR 0.99453 -9.0219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8767 0 0 0 0 0 0 0 0 0 0 0 11.2848 12.1157 0 0 0 0 12.3207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVD8 PHLP2_HUMAN "PH domain leucine-rich repeat-containing protein phosphatase 2, EC 3.1.3.16 (PH domain leucine-rich repeat-containing protein phosphatase-like, PHLPP-like)" PHLPP2 KIAA0931 PHLPPL Homo sapiens (Human) hippocampus development [GO:0021766]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment membrane [GO:0042622] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment membrane [GO:0042622]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; hippocampus development [GO:0021766]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] GO:0001917; GO:0004722; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0007165; GO:0017018; GO:0021766; GO:0042622; GO:0043231; GO:0045171; GO:0046872; GO:0072686 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] GKTQLHK 0.99453 -9.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.605 0 0 0 0 0 0 0 15.0026 0 9.48014 0 10.8826 14.994 0 11.5659 0 0 0 0 0 0 0 13.4397 11.7578 0 13.2506 0 0 0 0 0 0 0 0 0 0 0 10.9798 11.6719 0 0 0 0 11.4212 12.4781 12.7073 10.4359 0 0 0 0 0 0 0 0 12.8037 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6108 0 0 0 0 0 0 11.52 0 0 0 0 0 0 0 0 0 0 0 12.2423 0 11.9088 0 0 0 0 0 10.2473 0 0 0 0 11.5384 0 0 0 0 0 0 13.5293 0 0 0 0 12.0979 0 0 0 0 0 0 0 0 0 0 11.3655 0 13.7659 11.3535 13.1758 0 11.5479 11.932 0 0 0 0 0 11.4111 11.3527 0 0 0 0 0 0 0 11.96 0 0 0 0 0 0 0 0 0 19.0707 12.0084 0 0 0 11.8357 0 Q8NGY6 OR6N2_HUMAN Olfactory receptor 6N2 (Olfactory receptor OR1-23) OR6N2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IIGAVLK 0.99453 -10.608 0 0 0 0 0 0 0 10.797 14.8308 0 14.3321 0 0 0 14.4244 15.9957 14.2792 0 0 0 14.6447 0 0 0 0 0 15.0372 0 0 15.938 15.0801 0 14.5275 15.6384 14.2742 15.6074 14.2328 0 0 15.9186 14.6798 15.2581 0 0 15.4744 0 0 0 0 0 0 11.4359 0 0 10.9278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3841 14.3856 0 14.8886 14.5618 0 0 0 0 14.6907 0 0 0 0 0 0 0 0 15.8106 0 14.3853 0 0 Q96SU4 OSBL9_HUMAN "Oxysterol-binding protein-related protein 9, ORP-9, OSBP-related protein 9" OSBPL9 ORP9 OSBP4 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699] GO:0005794; GO:0005829; GO:0006699; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231 sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] EIQWETRLFHEDGECWVYDEPLLKR 0.99453 -11.094 0 0 11.3164 0 0 0 0 12.4272 0 0 15.6803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9379 0 15.4599 0 19.168 14.3701 0 0 14.0943 0 15.8539 15.2443 16.6611 16.3865 0 15.334 15.0767 0 14.4137 0 0 14.4734 0 0 15.4947 0 0 0 0 0 15.4741 0 0 0 0 13.6917 0 13.1412 0 0 14.6253 0 0 0 0 12.8488 0 0 0 0 14.9404 16.2021 0 0 16.6919 0 0 0 12.4746 0 0 0 0 13.3385 0 0 0 0 0 0 0 0 11.6611 0 0 0 0 10.8572 0 0 0 14.6332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7418 0 0 0 0 0 0 0 13.861 0 Q9H2K0 IF3M_HUMAN "Translation initiation factor IF-3, mitochondrial, IF-3(Mt), IF-3Mt, IF3(mt), IF3mt" MTIF3 DC38 Homo sapiens (Human) mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790] mitochondrion [GO:0005739] "mitochondrion [GO:0005739]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790]" GO:0003743; GO:0005739; GO:0008135; GO:0032790; GO:0043022; GO:0043024; GO:0070124 "ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" AALFLKRLTLQTVK 0.99453 -11.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.477 0 12.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7855 0 0 11.157 11.7124 0 0 0 0 0 0 14.7434 0 0 14.9253 0 0 0 0 0 0 0 0 0 0 0 0 14.3899 0 0 0 0 0 14.4689 0 0 0 0 0 0 0 0 0 0 0 13.0329 0 14.7628 0 0 15.8438 0 0 0 0 0 11.7701 0 0 13.05 0 0 13.2163 0 0 0 0 0 0 13.9013 0 0 0 15.4676 0 0 0 0 0 0 0 15.206 0 14.0846 0 0 0 0 0 14.9593 0 0 0 0 12.8378 0 0 12.7138 0 0 0 0 0 0 0 0 12.7392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0761 Q9NS93 TM7S3_HUMAN Transmembrane 7 superfamily member 3 (Seven span transmembrane protein) TM7SF3 Homo sapiens (Human) cellular response to unfolded protein [GO:0034620]; negative regulation of programmed cell death [GO:0043069]; positive regulation of insulin secretion [GO:0032024] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellular response to unfolded protein [GO:0034620]; negative regulation of programmed cell death [GO:0043069]; positive regulation of insulin secretion [GO:0032024] GO:0005886; GO:0016021; GO:0032024; GO:0034620; GO:0043069; GO:0070062 ALNKDFHR 0.99453 -8.5304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2681 0 0 0 0 0 0 12.905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUQ6 SPS2L_HUMAN "SPATS2-like protein (DNA polymerase-transactivated protein 6) (Stress granule and nucleolar protein, SGNP)" SPATS2L DNAPTP6 SP1224 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0032991 RNA binding [GO:0003723] AELNTHVNVKEKIYAVR 0.99453 -9.0213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2127 0 0 0 0 0 0 0 0 0 16.5187 0 0 0 17.6536 0 15.4797 16.0513 0 0 0 0 0 13.4776 0 18.8578 0 0 0 0 0 0 0 12.0783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8943 14.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.00194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJT0 TBE_HUMAN Tubulin epsilon chain (Epsilon-tubulin) TUBE1 TUBE Homo sapiens (Human) centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; microtubule [GO:0005874]; pericentriolar material [GO:0000242] cytoplasm [GO:0005737]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278] GO:0000226; GO:0000242; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007098 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200] FMRLYKK 0.99453 -11.104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8553 0 0 0 0 0 0 0 13.001 0 0 0 0 0 0 0 0 0 0 0 14.9673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3606 0 13.4524 0 O95626 AN32D_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member D (Phosphoprotein 32-related protein 2) (Tumorigenic protein pp32r2) ANP32D PP32R2 Homo sapiens (Human) LELSSNR 0.99454 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17693 HLAG_HUMAN "HLA class I histocompatibility antigen, alpha chain G (HLA G antigen) (MHC class I antigen G) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain G, sHLA-G ]" HLA-G HLA-6.0 HLAG Homo sapiens (Human) antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cellular defense response [GO:0006968]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; negative regulation of angiogenesis [GO:0016525]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of immune response [GO:0050777]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell proliferation [GO:0042130]; peripheral B cell tolerance induction [GO:0002451]; positive regulation of cellular senescence [GO:2000774]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein homotrimerization [GO:0070207] cis-Golgi network membrane [GO:0033106]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium membrane [GO:0031527]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] cis-Golgi network membrane [GO:0033106]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium membrane [GO:0031527]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; peptide antigen binding [GO:0042605]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cellular defense response [GO:0006968]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; negative regulation of angiogenesis [GO:0016525]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of immune response [GO:0050777]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell proliferation [GO:0042130]; peripheral B cell tolerance induction [GO:0002451]; positive regulation of cellular senescence [GO:2000774]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein homotrimerization [GO:0070207] GO:0000139; GO:0001915; GO:0002451; GO:0002474; GO:0002476; GO:0002645; GO:0002666; GO:0002729; GO:0002767; GO:0005102; GO:0005615; GO:0005769; GO:0005886; GO:0006968; GO:0009897; GO:0012507; GO:0016020; GO:0016525; GO:0030670; GO:0031527; GO:0031901; GO:0032735; GO:0033106; GO:0042130; GO:0042270; GO:0042605; GO:0042610; GO:0042612; GO:0042802; GO:0042803; GO:0045591; GO:0045953; GO:0050777; GO:0051898; GO:0055038; GO:0060907; GO:0070207; GO:0070317; GO:0071556; GO:2000353; GO:2000774; GO:2001199 CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; peptide antigen binding [GO:0042605]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102] MNLQTLR 0.99454 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19838 NFKB1_HUMAN Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit ] NFKB1 Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to angiotensin [GO:1904385]; cellular response to dsRNA [GO:0071359]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; mammary gland involution [GO:0060056]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; I-kappaB/NF-kappaB complex [GO:0033256]; mitochondrion [GO:0005739]; NF-kappaB complex [GO:0071159]; NF-kappaB p50/p65 complex [GO:0035525]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; I-kappaB/NF-kappaB complex [GO:0033256]; mitochondrion [GO:0005739]; NF-kappaB complex [GO:0071159]; NF-kappaB p50/p65 complex [GO:0035525]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; actinin binding [GO:0042805]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; apoptotic process [GO:0006915]; cellular response to angiotensin [GO:1904385]; cellular response to dsRNA [GO:0071359]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; mammary gland involution [GO:0060056]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; response to muscle stretch [GO:0035994]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001223; GO:0001227; GO:0001228; GO:0003682; GO:0003700; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006366; GO:0006915; GO:0006954; GO:0007254; GO:0010629; GO:0010744; GO:0010884; GO:0010956; GO:0010957; GO:0019899; GO:0032375; GO:0032695; GO:0033256; GO:0034774; GO:0035525; GO:0035580; GO:0035994; GO:0042802; GO:0042805; GO:0043066; GO:0045893; GO:0045944; GO:0050728; GO:0051248; GO:0060056; GO:0071159; GO:0071222; GO:0071260; GO:0071316; GO:0071347; GO:0071354; GO:0071356; GO:0071359; GO:0090263; GO:0098586; GO:1900127; GO:1904385; GO:2000630 "actinin binding [GO:0042805]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]" ICNYVGPAK 0.99454 -15.803 0 0 0 0 0 0 0 0 13.3048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2106 0 0 0 12.4351 0 0 12.535 0 0 12.9456 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7003 0 0 0 0 0 0 0 11.1173 0 13.1352 0 0 14.1435 0 13.8117 0 13.0365 0 0 0 0 11.4032 0 0 14.0616 13.1823 0 0 0 0 0 0 0 0 0 12.6084 0 0 0 0 0 0 0 10.5101 0 0 0 0 0 0 0 0 13.5696 0 0 0 0 0 0 0 0 0 0 12.8998 14.8983 0 0 10.7545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0865 0 0 0 0 0 0 13.3864 0 0 0 0 0 0 0 0 0 0 0 0 P29536 LMOD1_HUMAN "Leiomodin-1 (64 kDa autoantigen 1D) (64 kDa autoantigen 1D3) (64 kDa autoantigen D1) (Leiomodin, muscle form) (Smooth muscle leiomodin, SM-Lmod) (Thyroid-associated ophthalmopathy autoantigen)" LMOD1 Homo sapiens (Human) actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838] actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865] actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; actin nucleation [GO:0045010]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694]; positive regulation of actin filament polymerization [GO:0030838] GO:0003779; GO:0005523; GO:0005829; GO:0005856; GO:0005865; GO:0005884; GO:0006936; GO:0007015; GO:0016020; GO:0030016; GO:0030017; GO:0030239; GO:0030838; GO:0045010; GO:0051694 actin binding [GO:0003779]; tropomyosin binding [GO:0005523] AGGNTDMK 0.99454 -12.641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5563 0 0 0 11.8841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4972 0 0 0 0 0 0 0 0 0 0 13.5446 0 0 0 13.3184 0 0 0 0 0 0 12.9854 0 0 0 14.7207 0 0 0 0 0 0 11.9184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3297 12.8776 0 0 0 0 0 P48052 CBPA2_HUMAN "Carboxypeptidase A2, EC 3.4.17.15" CPA2 Homo sapiens (Human) protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773] extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508] GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270 carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] AIMEHVR 0.99454 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61758 PFD3_HUMAN "Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1, VBP-1, VHL-binding protein 1)" VBP1 PFDN3 Homo sapiens (Human) microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; tubulin complex assembly [GO:0007021] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; polysome [GO:0005844]; prefoldin complex [GO:0016272]; amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082]; microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; tubulin complex assembly [GO:0007021] GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231; GO:0050821; GO:0051082; GO:1905907 amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082] KLDEQYQKYK 0.99454 -11.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6006 0 0 0 0 0 0 0 0 11.4952 0 0 0 0 0 0 0 0 0 0 10.4263 0 0 0 0 0 0 0 0 0 13.7582 13.9158 0 12.9286 14.0726 0 14.7106 13.8111 0 13.6669 0 10.7005 13.5216 0 0 0 0 0 0 14.2879 13.1556 0 0 11.6497 11.3753 0 13.5001 15.4031 0 0 13.5048 0 13.1495 13.2946 0 13.2331 0 0 0 0 0 0 0 0 13.1967 14.4443 0 0 0 14.53 13.5303 0 12.4929 13.327 12.9301 0 0 13.2005 0 0 13.5474 0 10.0349 0 0 13.7202 0 14.0859 0 13.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61960 UFM1_HUMAN Ubiquitin-fold modifier 1 UFM1 C13orf20 BM-002 Homo sapiens (Human) brain development [GO:0007420]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein import into nucleus [GO:0042308]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; brain development [GO:0007420]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein import into nucleus [GO:0042308]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] GO:0005634; GO:0005737; GO:0005783; GO:0007420; GO:0033146; GO:0034976; GO:0042308; GO:0043066; GO:0061709; GO:0071569; GO:1990592 FAAEEFK 0.99454 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14839 CHD4_HUMAN "Chromodomain-helicase-DNA-binding protein 4, CHD-4, EC 3.6.4.12 (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)" CHD4 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; terminal button organization [GO:0072553]" "centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]" "centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; terminal button organization [GO:0072553]" GO:0000122; GO:0000781; GO:0000785; GO:0001221; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006338; GO:0008270; GO:0010629; GO:0016020; GO:0016575; GO:0016581; GO:0016887; GO:0032991; GO:0042393; GO:0042659; GO:0042826; GO:0045892; GO:0045893; GO:0061629; GO:0072553; GO:0090575; GO:0140658; GO:2000736 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270] AHRIGQNKK 0.99454 -8.8206 0 0 0 0 0 0 0 0 0 0 11.5899 0 0 0 0 12.0226 0 0 12.5965 0 0 0 0 0 0 0 0 0 11.6675 0 0 12.3397 0 11.3387 0 0 0 11.1555 0 0 0 0 0 0 0 10.9029 0 10.1586 0 0 10.0885 0 11.8825 0 0 0 0 0 0 0 0 11.1127 0 0 0 0 14.0912 0 14.5549 16.4288 13.8321 0 0 12.5959 0 13.1727 11.979 0 0 0 12.9175 0 13.1536 15.1068 14.8279 14.718 15.1626 14.0762 13.5272 13.7123 13.5681 0 10.014 0 10.8838 12.9134 15.2346 0 14.1208 13.2718 0 0 13.3239 13.3137 13.2247 14.3188 0 0 9.9421 0 0 0 10.7658 11.7941 13.8256 13.157 14.6863 0 14.9664 12.0467 0 0 13.6941 0 0 13.7519 0 0 15.3134 14.1486 0 12.9325 11.8747 13.0109 13.4708 12.5315 14.5927 0 0 0 13.5941 0 14.0756 0 12.935 12.4758 0 12.6068 0 0 13.5458 13.6568 12.8261 0 0 0 0 12.5389 0 12.214 0 0 13.0912 0 0 0 14.6944 0 0 12.613 0 10.4164 12.8211 0 0 12.3259 0 0 0 0 Q5R3F8 PPR29_HUMAN Protein phosphatase 1 regulatory subunit 29 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2) (Leucine-rich repeat and fibronectin type-III domain-containing protein 6) (Leucine-rich repeat-containing protein 62) ELFN2 KIAA1904 LRRC62 PPP1R29 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; protein phosphatase inhibitor activity [GO:0004864] GO:0004864; GO:0005615; GO:0016021; GO:0031012 protein phosphatase inhibitor activity [GO:0004864] KEIVTLDKLR 0.99454 -11.474 0 0 0 0 0 0 0 0 13.5486 0 0 11.1933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6035 0 14.51 0 0 0 0 15.6677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5U4N7 GDAS1_HUMAN "Protein GDF5-AS1, mitochondrial (GDF5 antisense RNA 1) (Growth/differentiation factor 5 opposite strand transcript protein)" GDF5-AS1 GDF5OS Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739] GO:0005739 ALISLKNRSR 0.99454 -11.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3255 0 10.2176 0 0 0 11.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5003 15.5287 0 0 0 0 0 0 14.1126 0 14.2511 0 0 14.2803 0 14.0713 14.1808 14.3375 14.6365 14.6515 14.7159 14.5501 0 14.5486 14.6634 14.5614 13.1518 14.3898 0 0 0 14.1892 14.5988 14.8935 0 0 12.7945 0 0 0 0 0 0 14.1423 0 0 0 14.9008 0 0 0 14.1159 13.0626 0 0 13.3253 13.1628 0 13.9936 0 0 12.1418 0 0 0 0 0 0 13.882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6109 0 0 0 13.6149 0 0 0 0 0 0 Q5VT79 AXA81_HUMAN Annexin A8-like protein 1 ANXA8L1 ANXA8L2 Homo sapiens (Human) endosomal transport [GO:0016197]; endosome organization [GO:0007032]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of serine-type endopeptidase activity [GO:1900004] calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of serine-type endopeptidase activity [GO:1900004] GO:0005509; GO:0005544; GO:0007032; GO:0016197; GO:1900004; GO:1900138 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] GLGTKEGVIIEILASRTK 0.99454 -8.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6706 14.6589 14.7685 0 16.6646 0 0 15.1792 0 0 0 14.6912 14.6033 0 0 0 0 0 0 0 0 0 0 0 0 14.0604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5615 0 0 0 0 0 14.6445 0 0 0 0 0 0 0 0 0 0 0 14.9742 0 0 0 0 0 0 0 0 0 0 12.3791 0 0 0 0 0 0 0 0 14.4127 0 0 0 0 0 0 0 0 0 0 15.0994 0 0 0 15.221 0 0 0 0 0 0 0 0 0 Q5VWQ0 RSBN1_HUMAN "Lysine-specific demethylase 9, KDM9, EC 1.14.11.- (Round spermatid basic protein 1)" RSBN1 Homo sapiens (Human) chromatin organization [GO:0006325] nucleus [GO:0005634] nucleus [GO:0005634]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325] GO:0005634; GO:0006325; GO:0035575; GO:0046872 histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; metal ion binding [GO:0046872] EGIRYAR 0.99454 -11.125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8899 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7 0 0 0 0 0 0 0 0 14.5297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVD7 STOX1_HUMAN Storkhead-box protein 1 (Winged-helix domain-containing protein) STOX1 C10orf24 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418]" GO:0000977; GO:0001228; GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007049; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0045944; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0061418; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904031; GO:1904120 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ALRPPRGFR 0.99454 -15.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0684 0 0 0 0 0 0 0 0 0 0 10.3378 0 0 0 0 0 0 0 0 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2267 0 0 0 0 0 0 0 11.7297 0 0 0 0 12.5417 0 0 0 0 16.5868 0 0 0 0 0 0 13.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8328 0 11.8428 0 12.686 12.0259 0 11.1359 0 0 0 0 0 0 0 0 14.7872 0 0 0 11.7993 0 0 0 14.4041 0 0 0 0 0 0 0 0 0 14.3983 11.638 0 0 0 0 0 14.4589 0 0 0 0 0 0 11.5778 11.8628 0 0 0 0 0 0 0 0 0 11.577 0 0 0 0 0 14.0056 0 0 0 0 0 0 0 Q8IU68 TMC8_HUMAN Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2) TMC8 EVER2 EVIN2 Homo sapiens (Human) negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; regulation of cell growth [GO:0001558]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; zinc ion homeostasis [GO:0055069] GO:0001558; GO:0005615; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005887; GO:0008381; GO:0031333; GO:0031965; GO:0032091; GO:0043120; GO:0055069; GO:0070062; GO:0140311; GO:1902041 mechanosensitive ion channel activity [GO:0008381]; protein sequestering activity [GO:0140311]; tumor necrosis factor binding [GO:0043120] DKSSCESYGYNVCDYQCWENSVGEELYK 0.99454 -8.5675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0907 0 0 12.8176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4773 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0871 0 0 0 0 0 10.6456 0 0 0 0 13.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9624 0 0 0 0 16.7545 0 0 14.8285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE62 CHDH_HUMAN "Choline dehydrogenase, mitochondrial, CDH, CHD, EC 1.1.99.1" CHDH Homo sapiens (Human) choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285] mitochondrial inner membrane [GO:0005743] mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285] GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0042426; GO:0050660 choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491] GWDYAHCLPYFRK 0.99454 -12.663 11.8011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3281 0 0 0 0 12.2837 0 0 0 0 0 0 0 0 11.5932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3296 12.6544 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6647 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.56 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.056 0 0 Q8TEW6 DOK4_HUMAN "Docking protein 4 (Downstream of tyrosine kinase 4) (Insulin receptor substrate 5, IRS-5, IRS5)" DOK4 Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nervous system development [GO:0007399]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0005829; GO:0007169; GO:0007399; GO:0043410 FTFEAGR 0.99454 -12.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8245 0 0 0 0 0 0 0 0 0 0 0 0 12.9518 0 0 0 0 0 0 0 0 0 13.0192 0 0 0 0 0 12.9875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.735 0 0 0 0 0 0 0 0 12.4122 0 0 0 13.6087 0 0 0 0 0 Q96DU9 PABP5_HUMAN "Polyadenylate-binding protein 5, PABP-5, Poly(A)-binding protein 5" PABPC5 PABP5 Homo sapiens (Human) cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] GO:0003723; GO:0003730; GO:0005634; GO:0005759; GO:0005829; GO:0008143; GO:0008266; GO:0010494; GO:1990904 mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] AQKKIER 0.99454 -11.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.621 0 0 0 0 0 0 15.0758 16.5367 0 0 0 13.1984 0 0 0 0 0 16.0285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N68 CR015_HUMAN Putative uncharacterized protein C18orf15 C18orf15 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 QGQGALK 0.99454 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXW7 HDHD5_HUMAN Haloacid dehalogenase-like hydrolase domain-containing 5 (Cat eye syndrome critical region protein 5) HDHD5 CECR5 Homo sapiens (Human) glycerophospholipid biosynthetic process [GO:0046474] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474] GO:0005739; GO:0046474 GWAAPIR 0.99454 -8.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2132 0 0 0 0 0 0 0 0 0 0 0 14.5271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9798 0 0 0 0 0 0 0 0 0 0 0 0 10.663 0 0 0 0 0 0 0 15.7588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZ23 PANK2_HUMAN "Pantothenate kinase 2, mitochondrial, hPanK2, EC 2.7.1.33 (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form, iPanK2; Pantothenate kinase 2, mitochondrial mature form, mPanK2 ]" PANK2 C20orf48 Homo sapiens (Human) aerobic respiration [GO:0009060]; angiogenesis [GO:0001525]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion morphogenesis [GO:0070584]; pantothenate metabolic process [GO:0015939]; phosphorylation [GO:0016310]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; aerobic respiration [GO:0009060]; angiogenesis [GO:0001525]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion morphogenesis [GO:0070584]; pantothenate metabolic process [GO:0015939]; phosphorylation [GO:0016310]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286] GO:0001525; GO:0004594; GO:0005524; GO:0005634; GO:0005739; GO:0005758; GO:0005829; GO:0007286; GO:0009060; GO:0015937; GO:0015939; GO:0016310; GO:0019217; GO:0051881; GO:0070584; GO:0090207; GO:1904251 ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594] ARLCSGWTAAEEAR 0.99454 -15.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3745 0 0 0 0 0 13.5095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8V3 ECT2_HUMAN Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) ECT2 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]" bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]" GO:0000281; GO:0000902; GO:0005085; GO:0005096; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005911; GO:0005923; GO:0005938; GO:0007399; GO:0015031; GO:0016604; GO:0030154; GO:0030496; GO:0031267; GO:0032147; GO:0032154; GO:0032467; GO:0035556; GO:0042307; GO:0042803; GO:0043065; GO:0043123; GO:0043547; GO:0045666; GO:0045859; GO:0051056; GO:0051260; GO:0051988; GO:0070301; GO:0070830; GO:0071277; GO:0071479; GO:0072686; GO:0090630; GO:0097149; GO:2000431 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] AIKKTSK 0.99454 -11.16 0 0 0 0 0 0 0 9.62671 0 0 0 0 0 0 0 10.4838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6056 13.0045 0 0 13.3318 0 14.4571 15.5464 15.4326 15.7364 0 15.7809 15.1692 0 15.5766 0 0 0 15.0245 14.8585 14.7613 0 0 0 0 13.7593 0 14.507 11.8428 14.7383 0 0 13.6157 13.4111 0 12.8508 0 12.8589 13.8418 15.6693 15.3014 0 0 14.121 0 13.6246 0 0 0 13.618 0 0 13.6475 0 0 0 0 0 13.9322 13.0234 9.96292 0 0 14.4803 13.3038 14.3722 13.0542 14.0861 0 0 0 12.9804 0 0 0 0 0 13.9511 12.6707 13.2274 13.0063 0 0 0 0 0 0 0 0 0 0 0 10.6045 0 0 0 15.0274 14.6656 0 13.6895 0 14.036 0 0 0 Q9UL15 BAG5_HUMAN "BAG family molecular chaperone regulator 5, BAG-5 (Bcl-2-associated athanogene 5)" BAG5 KIAA0873 Homo sapiens (Human) Golgi organization [GO:0007030]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein refolding [GO:0061084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neuron death [GO:0070997]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of inclusion body assembly [GO:0090083]; regulation of ubiquitin-protein transferase activity [GO:0051438] cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein refolding [GO:0061084]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neuron death [GO:0070997]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of inclusion body assembly [GO:0090083]; regulation of ubiquitin-protein transferase activity [GO:0051438] GO:0000774; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0007030; GO:0010977; GO:0016020; GO:0016234; GO:0019901; GO:0031397; GO:0031625; GO:0032435; GO:0048471; GO:0050821; GO:0051087; GO:0051438; GO:0051444; GO:0061084; GO:0070997; GO:0090083; GO:1902176 adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625] LEELLTKQLLALDAVDPQGEEKCK 0.99454 -15.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3989 0 12.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6527 0 0 0 0 0 15.2433 0 0 0 0 13.2963 13.7624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9749 0 0 13.2205 14.9986 0 0 0 Q9Y4W6 AFG32_HUMAN "AFG3-like protein 2, EC 3.4.24.- (Paraplegin-like protein)" AFG3L2 Homo sapiens (Human) axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013] m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; protein-containing complex assembly [GO:0065003]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013] GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0055001; GO:0060013; GO:0065003 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270] ATAGEANVPFITVSGSEFLEMFVGVGPARVRDLFALAR 0.99454 -11.124 0 0 0 0 0 0 0 0 0 10.5584 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7029 0 0 12.699 0 0 0 0 0 10.6361 0 0 0 0 0 10.6556 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2783 11.27 0 14.1287 13.5425 0 0 0 0 0 0 0 0 0 0 0 11.2137 0 0 0 0 0 11.668 14.2458 0 0 12.6119 11.8193 0 0 15.2089 0 12.7881 15.3921 16.5681 0 14.6019 15.3362 0 15.2091 14.6204 14.3861 15.7289 12.415 15.1836 0 15.942 0 0 0 13.0341 14.6809 12.793 0 10.4896 0 13.1966 0 13.1778 0 0 10.4896 15.6572 0 13.1615 0 0 0 0 15.1974 14.5288 15.4245 12.9986 0 0 0 17.6492 0 0 0 0 0 0 0 0 14.6183 0 0 0 0 14.2876 0 14.5448 14.5588 0 11.6798 14.2679 0 0 0 11.4504 11.9628 0 0 0 0 12.6854 12.2197 13.0848 0 0 0 0 0 13.1986 0 0 0 12.2439 0 0 0 0 0 14.6867 0 0 0 Q9Y625 GPC6_HUMAN Glypican-6 [Cleaved into: Secreted glypican-6 ] GPC6 UNQ369/PRO705 Homo sapiens (Human) cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]" GO:0005615; GO:0005634; GO:0005796; GO:0005886; GO:0009966; GO:0009986; GO:0016477; GO:0043202; GO:0045202; GO:0046658; GO:0062023; GO:0098696; GO:0099560; GO:1904929; GO:1905475; GO:1905606 "coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]" EVANRVSK 0.99454 -11.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7282 12.2469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NMY6 AXA2L_HUMAN Putative annexin A2-like protein (Annexin A2 pseudogene 2) (Lipocortin II pseudogene) ANXA2P2 ANX2L2 ANX2P2 LPC2B Homo sapiens (Human) basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982] "basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cytoskeletal protein binding [GO:0008092]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; virion binding [GO:0046790]" GO:0001786; GO:0002020; GO:0005262; GO:0005509; GO:0005544; GO:0005546; GO:0005604; GO:0005615; GO:0005634; GO:0005886; GO:0008092; GO:0019834; GO:0031982; GO:0042470; GO:0046790; GO:0070062 "calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cytoskeletal protein binding [GO:0008092]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; virion binding [GO:0046790]" KEVKGDLENAFLNLVQR 0.99455 -11.172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3473 13.1683 14.2715 0 0 14.2636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7979 14.0533 0 15.3273 14.595 0 0 0 0 0 0 0 0 0 14.4009 13.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0672 12.2281 0 13.7356 0 0 0 0 0 0 0 0 13.5051 14.1835 0 0 13.1408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8569 0 0 0 0 0 0 14.2627 0 0 0 0 0 0 0 0 0 0 0 0 0 13.317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MUV8 ZN727_HUMAN Putative zinc finger protein 727 (Zinc finger protein 727 pseudogene) ZNF727 ZNF727P Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKACK 0.99455 -8.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0833 11.5194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2742 14.0818 13.8345 13.7794 13.5088 13.3591 12.2226 0 12.0677 0 0 11.0395 0 0 0 12.4499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5579 0 0 0 12.7528 0 0 0 0 0 13.039 0 0 0 0 0 0 0 0 0 14.5289 0 0 0 13.1342 0 0 0 0 0 0 0 0 0 11.6169 0 0 0 0 0 0 16.2402 0 0 0 0 16.2601 0 0 0 0 13.6265 0 0 0 0 0 0 0 0 0 0 0 12.373 0 0 0 0 0 0 0 0 0 0 0 0 O43435 TBX1_HUMAN "T-box transcription factor TBX1, T-box protein 1 (Testis-specific T-box protein)" TBX1 Homo sapiens (Human) "angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644]" GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" ADPATPGRVHYHPDSPAKGAQWMK 0.99455 -8.3487 0 0 0 0 0 0 0 0 0 0 0 15.1443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3941 0 0 0 12.3666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0394 15.0618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.56 0 15.4526 0 0 0 0 0 0 O60225 SSX5_HUMAN Protein SSX5 SSX5 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 EWEKMKASEK 0.99455 -8.5913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0603 0 0 0 0 0 13.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2122 14.6089 0 13.5893 13.559 0 0 0 0 0 13.3022 13.1902 12.4799 0 12.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6393 0 0 0 P48307 TFPI2_HUMAN "Tissue factor pathway inhibitor 2, TFPI-2 (Placental protein 5, PP5)" TFPI2 Homo sapiens (Human) blood coagulation [GO:0007596]; cellular response to fluid shear stress [GO:0071498] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; cellular response to fluid shear stress [GO:0071498] GO:0004867; GO:0005201; GO:0005615; GO:0007596; GO:0031012; GO:0071498 extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867] ACAKALK 0.99455 -11.512 0 0 0 0 0 0 0 0 14.5796 13.7179 13.5441 12.7496 13.6695 0 13.5663 12.4197 0 0 0 0 0 0 0 0 0 0 0 0 13.2245 13.4433 0 0 0 13.2092 13.3024 0 13.0458 0 0 13.1582 12.5345 0 13.5229 13.1162 12.7562 13.098 13.8681 0 0 0 0 0 0 13.077 0 10.9034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6815 0 0 0 0 13.1137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5689 0 0 13.7387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7569 0 0 0 14.5707 12.8858 0 0 0 0 0 0 0 12.6679 0 0 0 15.3807 0 0 0 0 Q15796 SMAD2_HUMAN "Mothers against decapentaplegic homolog 2, MAD homolog 2, Mothers against DPP homolog 2 (JV18-1) (Mad-related protein 2, hMAD-2) (SMAD family member 2, SMAD 2, Smad2, hSMAD2)" SMAD2 MADH2 MADR2 Homo sapiens (Human) "activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]" activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667] "activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; common-partner SMAD protein phosphorylation [GO:0007182]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nodal signaling pathway [GO:0038092]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; regulation of binding [GO:0051098]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to glucose [GO:0009749]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transcription, DNA-templated [GO:0006351]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]; zygotic specification of dorsal/ventral axis [GO:0007352]" GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001657; GO:0001701; GO:0001706; GO:0001707; GO:0003682; GO:0003690; GO:0003700; GO:0005160; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006351; GO:0007179; GO:0007182; GO:0007183; GO:0007352; GO:0007369; GO:0008285; GO:0009653; GO:0009749; GO:0009791; GO:0009952; GO:0010628; GO:0010718; GO:0017015; GO:0019902; GO:0023019; GO:0030073; GO:0030154; GO:0030324; GO:0030325; GO:0030509; GO:0030513; GO:0031016; GO:0031053; GO:0031625; GO:0032444; GO:0032924; GO:0032991; GO:0034713; GO:0035265; GO:0035556; GO:0038092; GO:0042060; GO:0042802; GO:0045165; GO:0045892; GO:0045893; GO:0045944; GO:0046332; GO:0046872; GO:0048156; GO:0048340; GO:0048617; GO:0048701; GO:0051098; GO:0060039; GO:0060395; GO:0061629; GO:0062009; GO:0070410; GO:0070411; GO:0070412; GO:0070723; GO:0071141; GO:0071142; GO:0071144; GO:0097718; GO:0140297; GO:1900224 "chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]" FCLGLLSNVNRNATVEMTR 0.99455 -9.0769 0 0 0 0 0 12.436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWZ5 TRI42_HUMAN Tripartite motif-containing protein 42 TRIM42 Homo sapiens (Human) cellular anatomical entity [GO:0110165] cellular anatomical entity [GO:0110165]; zinc ion binding [GO:0008270] GO:0008270; GO:0110165 zinc ion binding [GO:0008270] CCCTASSNLNCYYYESR 0.99455 -11.516 0 0 0 0 0 0 13.4359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.691 11.7791 13.2776 0 0 0 0 12.8326 12.2641 0 14.1484 13.9394 0 0 0 0 16.1052 17.268 0 0 0 0 0 14.3533 0 0 14.0642 0 0 15.8141 12.797 12.9108 0 13.3318 15.7785 0 14.4626 0 11.9376 10.6077 15.1386 0 0 0 0 13.2138 12.8632 12.8847 0 12.6905 16.6516 0 12.7385 0 0 0 0 15.0902 12.5991 0 12.2569 0 0 0 0 0 0 17.1016 0 16.6953 12.5038 0 0 13.8877 13.2491 14.0692 0 10.865 0 0 0 0 12.3917 12.8366 0 0 0 0 0 11.5845 0 0 0 13.1456 0 0 0 0 0 0 0 0 12.0756 0 0 14.3887 11.7443 0 0 0 0 0 Q9P2E8 MARH4_HUMAN "E3 ubiquitin-protein ligase MARCHF4, EC 2.3.2.27 (Membrane-associated RING finger protein 4) (Membrane-associated RING-CH protein IV, MARCH-IV) (RING finger protein 174) (RING-type E3 ubiquitin transferase MARCHF4)" MARCHF4 KIAA1399 MARCH4 RNF174 Homo sapiens (Human) Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0000139; GO:0004842; GO:0005795; GO:0005802; GO:0008270; GO:0016021 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CRCRMLFNDLK 0.99455 -8.5926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2163 0 0 0 0 0 0 0 0 0 0 0 0 10.597 0 0 9.86683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4762 0 0 0 0 0 12.5817 0 0 0 0 14.9069 0 13.1526 0 11.9755 0 0 10.4249 0 0 0 0 0 0 0 0 0 13.5221 0 0 0 0 0 0 0 13.0295 0 12.731 0 0 0 0 0 0 0 0 0 0 0 11.257 0 11.094 11.0372 0 0 15.578 0 10.7915 0 0 0 0 0 0 0 12.77 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6256 0 0 0 0 0 0 0 0 10.3335 0 0 0 0 0 0 0 0 0 0 0 0 11.6319 0 0 0 0 0 0 Q8WWI1 LMO7_HUMAN "LIM domain only protein 7, LMO-7 (F-box only protein 20) (LOMP)" LMO7 FBX20 FBXO20 KIAA0858 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051] GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] AQETGHLVMDVRR 0.99456 -36.034 0 10.64 0 0 0 0 0 0 13.4556 0 11.8206 12.1584 13.3764 0 13.4127 13.2411 13.5786 13.3509 13.344 13.4684 13.5985 0 0 0 13.2823 13.6262 0 0 13.2935 0 14.2442 0 13.8804 12.4638 0 0 12.5362 12.4676 0 12.5122 11.5882 0 10.7394 13.2132 13.0189 0 0 11.7549 11.9875 0 0 0 0 12.0358 12.4956 14.8742 15.2175 13.6108 12.9106 12.7835 13.3566 0 11.9604 11.9931 12.3545 12.6054 0 13.8413 0 0 0 11.2054 0 0 0 14.0543 12.2283 12.2183 0 11.7627 0 0 0 18.9671 13.3613 0 13.9491 0 0 19.0835 13.3516 0 13.7872 0 13.1839 0 14.6169 12.719 0 0 0 0 0 0 0 0 0 0 0 11.5215 12.1724 14.3939 0 12.31 0 14.9767 0 0 13.4528 0 14.8156 0 0 0 15.5284 0 0 0 0 13.7867 0 0 0 14.5662 12.8069 12.0382 12.6655 0 12.9556 0 12.8761 0 0 0 0 12.6126 0 0 0 0 0 0 0 0 12.9347 14.136 15.1504 18.7709 0 14.4841 13.017 10.533 14.9457 16.4163 14.5327 15.7213 16.5071 14.8085 0 18.2142 16.0564 14.8752 14.3641 13.0703 10.2673 14.7258 0 15.7238 0 0 O75487 GPC4_HUMAN Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4 ] GPC4 UNQ474/PRO937 Homo sapiens (Human) cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202] "anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055]" GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0046658; GO:0062023; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1904929; GO:1905475; GO:1905606 "coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway [GO:1904929]" ARFGLPALLCTLAVLSAALLAAELKSK 0.99456 -10.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2182 0 0 0 0 0 0 0 0 0 0 0 0 13.3892 0 12.7729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2544 0 0 0 14.1815 13.0571 13.1781 0 0 0 0 0 12.9681 0 0 0 0 0 0 0 0 13.168 0 0 0 12.8145 0 13.8873 13.7331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3247 0 0 0 0 0 0 0 0 11.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00973 OAS1_HUMAN "2'-5'-oligoadenylate synthase 1, (2-5')oligo(A) synthase 1, 2-5A synthase 1, EC 2.7.7.84 (E18/E16) (p46/p42 OAS)" OAS1 OIAS Homo sapiens (Human) antiviral innate immune response [GO:0140374]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; antiviral innate immune response [GO:0140374]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon signaling pathway [GO:0060337] GO:0001730; GO:0003725; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0060700; GO:0070106; GO:0071639; GO:0071659; GO:0098586; GO:0140374; GO:1901857; GO:2000342 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] EGEFSTCFTELQR 0.99456 -10.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3662 0 0 0 0 0 0 0 0 0 0 0 14.4562 0 0 14.3834 0 12.3633 0 0 0 0 0 0 0 0 0 0 12.0739 0 0 0 0 0 0 0 11.4514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9936 0 0 0 0 13.1649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22695 QCR2_HUMAN "Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)" UQCRC2 Homo sapiens (Human) "aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; proteolysis [GO:0006508]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; proteolysis [GO:0006508]" GO:0004222; GO:0005654; GO:0005739; GO:0005743; GO:0005750; GO:0005751; GO:0006119; GO:0006122; GO:0006508; GO:0009060; GO:0045333; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AAYNQVK 0.99456 -9.4108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2663 0 0 0 0 15.1401 0 0 0 12.1526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P85037 FOXK1_HUMAN "Forkhead box protein K1 (Myocyte nuclear factor, MNF)" FOXK1 MNF Homo sapiens (Human) "canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007517; GO:0010507; GO:0010906; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837 "14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" EFEFLMR 0.99456 -10.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03154 ACY1_HUMAN "Aminoacylase-1, ACY-1, EC 3.5.1.14 (N-acyl-L-amino-acid amidohydrolase)" ACY1 Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520] GO:0004046; GO:0005829; GO:0006520; GO:0042802; GO:0046872; GO:0070062 aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] EKEWQRLQSNPHLK 0.99456 -8.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05084 ICA69_HUMAN "Islet cell autoantigen 1 (69 kDa islet cell autoantigen, ICA69) (Islet cell autoantigen p69, ICAp69, p69)" ICA1 Homo sapiens (Human) neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of transport [GO:0051049] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; membrane curvature sensor activity [GO:0140090]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of transport [GO:0051049] GO:0000139; GO:0005737; GO:0005794; GO:0005829; GO:0006836; GO:0019904; GO:0030667; GO:0030672; GO:0043231; GO:0050796; GO:0051049; GO:0070161; GO:0140090 membrane curvature sensor activity [GO:0140090]; protein domain specific binding [GO:0019904] ALCFSSQQR 0.99456 -10.668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9677 16.0332 0 0 0 15.9595 14.7397 15.0506 0 15.6948 15.5353 0 0 0 16.4969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0696 0 13.5097 0 0 0 0 0 0 0 0 0 9.55584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2457 0 0 0 0 0 0 0 0 0 14.2496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15111 PLCL1_HUMAN "Inactive phospholipase C-like protein 1, PLC-L1 (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein, PRIP)" PLCL1 Homo sapiens (Human) "gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of synaptic transmission, GABAergic [GO:0032228]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor binding [GO:1900122]; regulation of synaptic transmission, GABAergic [GO:0032228]" GO:0004435; GO:0004629; GO:0005737; GO:0006629; GO:0007214; GO:0032228; GO:0035556; GO:0048015; GO:0050811; GO:0070679; GO:0120163; GO:1900122 "GABA receptor binding [GO:0050811]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]" AEGAAGR 0.99456 -13.658 10.5528 0 0 0 0 0 0 0 0 0 12.1582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8805 11.6037 0 0 14.1004 0 12.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1616 0 0 10.4606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.442 0 0 0 0 0 0 0 0 0 0 0 0 11.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0476 10.2593 0 0 0 0 0 0 0 0 13.4916 0 0 0 0 0 0 0 0 Q5TAX3 TUT4_HUMAN "Terminal uridylyltransferase 4, TUTase 4, EC 2.7.7.52 (Zinc finger CCHC domain-containing protein 11)" TUT4 KIAA0191 ZCCHC11 Homo sapiens (Human) "miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730] "cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition, RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]" GO:0000289; GO:0001556; GO:0003723; GO:0005615; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010526; GO:0010586; GO:0010587; GO:0016779; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0071076; GO:1990074 miRNA binding [GO:0035198]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270] ARLCLFGSSKNGFGFR 0.99456 -10.94 0 0 13.0858 0 0 0 0 0 10.8199 0 0 11.3116 0 0 12.4405 12.1206 11.3339 0 12.5152 11.9862 0 0 0 0 10.4405 0 0 10.7951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4355 0 0 0 11.9353 0 0 0 0 0 0 0 0 10.6516 0 14.2332 13.4975 15.0804 16.1013 14.58 12.2232 15.0659 13.8566 15.4482 0 14.6353 13.2905 14.7865 0 0 13.4617 12.9095 12.649 14.9664 12.814 0 0 0 0 13.1929 14.671 0 15.5329 12.1068 14.8453 10.3201 14.4499 0 14.6908 15.4047 16.0648 0 0 0 15.479 13.5534 0 14.82 0 15.5276 0 14.9902 0 14.7525 11.4961 0 0 14.9979 13.9458 14.9052 16.5205 0 15.2986 15.2539 0 14.142 13.9173 14.8351 13.8597 12.1496 0 15.7355 0 13.6905 15.3022 13.6534 18.2478 15.9189 0 13.2653 10.7172 15.2878 0 0 14.6053 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2793 0 10.4191 0 14.9106 0 13.7955 14.96 0 0 0 13.1932 0 Q86UB2 BIVM_HUMAN Basic immunoglobulin-like variable motif-containing protein BIVM Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] GO:0005615; GO:0005634; GO:0005737 ANKAFSR 0.99456 -8.3825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2622 0 0 0 0 0 0 0 0 0 0 0 11.5937 0 0 0 0 0 0 0 0 0 0 10.607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZC7 ZN101_HUMAN Zinc finger protein 101 (Zinc finger protein HZF12) ZNF101 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CPTSLQAHERAHTGERPYECNK 0.99456 -13.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1177 12.0088 0 11.0343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5817 0 0 0 0 0 14.6538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5474 0 0 0 0 12.4254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N883 ZN614_HUMAN Zinc finger protein 614 ZNF614 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GFTMKRYLIAHQR 0.99456 -10.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0323 0 0 0 0 13.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9928 0 0 0 0 0 0 0 11.6856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2398 0 0 0 0 0 0 0 0 0 Q8N9U0 TAC2N_HUMAN "Tandem C2 domains nuclear protein (Membrane targeting tandem C2 domain-containing protein 1) (Tandem C2 protein in nucleus, Tac2-N)" TC2N C14orf47 MTAC2D1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 ATEFIKSCCGGCFYGETEK 0.99456 -13.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8546 0 0 11.4901 11.7194 13.3051 0 12.0219 0 0 0 11.4853 0 0 0 0 0 0 0 11.5748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3053 0 13.7945 0 0 0 0 0 0 14.0469 12.5743 0 11.6444 0 11.3172 0 0 0 12.4055 0 0 0 0 0 0 13.0536 13.2334 12.8209 0 0 0 13.7097 0 0 0 13.2955 14.1858 0 0 13.2249 0 0 12.8147 12.0967 0 11.4398 0 0 13.4626 0 0 0 0 0 0 0 13.2826 0 13.0686 0 13.8039 11.2825 12.6946 0 0 0 13.8408 14.0397 13.7912 0 13.8912 0 13.5541 0 0 0 0 0 0 11.6081 0 13.8548 0 0 11.9915 12.7981 0 0 0 0 0 0 0 0 0 0 0 0 10.8354 0 14.1551 0 0 0 0 0 Q8NFY4 SEM6D_HUMAN Semaphorin-6D SEMA6D KIAA1479 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of smooth muscle cell migration [GO:0014911]; semaphorin-plexin signaling pathway [GO:0071526]; smooth muscle cell migration [GO:0014909]; ventricular system development [GO:0021591] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; positive regulation of smooth muscle cell migration [GO:0014911]; semaphorin-plexin signaling pathway [GO:0071526]; smooth muscle cell migration [GO:0014909]; ventricular system development [GO:0021591] GO:0001755; GO:0005615; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0007411; GO:0009986; GO:0014909; GO:0014911; GO:0014912; GO:0021591; GO:0030215; GO:0030335; GO:0030517; GO:0045499; GO:0048843; GO:0050919; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] DHRRSVDSR 0.99456 -10.961 0 0 0 0 0 0 12.0133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3336 0 0 0 0 0 0 12.9243 Q8TD90 MAGE2_HUMAN Melanoma-associated antigen E2 (Hepatocellular carcinoma-associated protein 3) (MAGE-E2 antigen) MAGEE2 HCA3 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 ASLLALVLGHILLNGNRAR 0.99456 -11.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92625 ANS1A_HUMAN Ankyrin repeat and SAM domain-containing protein 1A (Odin) ANKS1A ANKS1 KIAA0229 ODIN Homo sapiens (Human) ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929] cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ephrin receptor binding [GO:0046875]; ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929] GO:0005654; GO:0005829; GO:0006929; GO:0016322; GO:0043005; GO:0046875; GO:0048013; GO:1901187 ephrin receptor binding [GO:0046875] IIASLADR 0.99456 -13.659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.2475 0 0 0 0 0 0 0 0 0 12.422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7552 12.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0308 12.4341 0 0 0 15.3943 0 0 0 0 0 0 12.6312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4662 0 0 0 0 0 0 14.0054 0 0 0 0 0 0 0 0 0 0 0 0 12.5371 0 14.8449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CW6 S7A6O_HUMAN Probable RNA polymerase II nuclear localization protein SLC7A6OS (ADAMS proteinase-related protein) (Solute carrier family 7 member 6 opposite strand transcript) SLC7A6OS Homo sapiens (Human) developmental process [GO:0032502]; hematopoietic progenitor cell differentiation [GO:0002244]; protein transport [GO:0015031] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; developmental process [GO:0032502]; hematopoietic progenitor cell differentiation [GO:0002244]; protein transport [GO:0015031] GO:0002244; GO:0005634; GO:0005737; GO:0015031; GO:0032502 AAENNVFHLVATVCSQEEPVQPLLREVLR 0.99456 -9.413 0 0 0 0 0 0 0 0 0 0 0 11.4682 12.0616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1652 12.7566 0 0 11.6532 0 0 0 0 11.9656 0 0 12.1192 0 0 0 0 0 0 0 0 0 0 0 12.6077 11.6199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5104 0 0 0 13.6873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.765 0 0 0 0 0 10.7201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9817 13.9818 13.7537 0 14.0836 12.8633 14.7976 0 0 13.5718 14.225 0 0 0 0 0 14.8675 0 13.6549 0 0 Q96PZ0 PUS7_HUMAN "Pseudouridylate synthase 7 homolog, EC 5.4.99.-" PUS7 KIAA1897 Homo sapiens (Human) mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] nucleus [GO:0005634] nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119] GO:0001522; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:1902036; GO:1990481; GO:2000380 enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] EEWAKTK 0.99456 -15.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8104 0 0 0 0 0 14.6467 0 0 13.3355 13.9718 13.6359 12.6783 12.4216 0 12.53 12.5082 0 0 11.509 0 0 0 0 0 0 0 13.248 13.5599 0 0 0 13.1816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9678 0 0 0 13.6185 0 0 11.7497 0 12.3762 14.4209 0 0 0 0 0 13.0303 0 0 0 0 13.3695 12.8252 0 0 0 0 0 14.5805 0 0 0 0 12.9084 0 0 0 13.9688 12.6131 12.94 13.4488 0 0 0 0 0 0 0 0 0 13.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96S94 CCNL2_HUMAN Cyclin-L2 (Paneth cell-enhanced expression protein) CCNL2 SB138 Homo sapiens (Human) regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000307; GO:0005634; GO:0005654; GO:0006357; GO:0016538; GO:0016607; GO:0042981; GO:0043231; GO:0043484; GO:0046605; GO:0051726 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] IIVMYLQVLECER 0.99456 -15.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6773 0 0 0 0 0 12.2948 0 0 0 0 0 0 0 0 0 0 0 0 11.828 12.1735 11.7395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7107 0 0 0 0 0 0 13.9519 0 0 0 15.3597 12.8817 15.5573 0 0 0 0 0 0 0 0 0 0 0 15.9852 15.4125 0 12.7976 0 0 0 12.2223 0 0 0 15.4271 0 12.4019 0 0 14.9571 0 0 14.8238 0 0 0 14.7523 14.9646 0 0 0 0 14.1111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2947 0 0 0 0 0 0 Q9BY43 CHM4A_HUMAN "Charged multivesicular body protein 4a (Chromatin-modifying protein 4a, CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1, hSnf-1) (Vacuolar protein sorting-associated protein 32-1, Vps32-1, hVps32-1)" CHMP4A C14orf123 SHAX2 CDA04 HSPC134 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; plasma membrane tubulation [GO:0097320]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; plasma membrane tubulation [GO:0097320]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005634; GO:0005643; GO:0005737; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006620; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0008289; GO:0009898; GO:0010324; GO:0016236; GO:0030117; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0046761; GO:0051117; GO:0051258; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0097320; GO:0097352; GO:1901215; GO:1901673; GO:1902774; GO:1902902; GO:1904930 ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803] ETEKILIK 0.99456 -9.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6742 0 0 0 0 0 0 0 0 0 0 0 0 16.3467 0 16.2265 0 0 0 0 0 16.5557 0 0 12.5996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5815 0 0 0 0 0 0 0 0 13.1521 0 0 0 0 0 0 0 0 0 0 13.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H497 TOR3A_HUMAN Torsin-3A (ATP-dependent interferon-responsive protein) (Torsin family 3 member A) TOR3A ADIR Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] GO:0005524; GO:0005635; GO:0005783; GO:0005788; GO:0016887; GO:0070062 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887] AAGALSK 0.99456 -13.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1051 0 0 0 0 14.8552 0 16.8329 0 12.3861 14.4589 0 0 0 0 0 0 0 0 0 0 15.4292 13.8592 14.3861 15.4327 0 0 16.023 14.5178 0 0 0 0 0 0 14.193 0 0 15.5337 0 0 0 14.895 0 14.1028 14.4681 0 0 13.5141 0 15.3056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5747 0 0 0 0 0 Q9UM22 EPDR1_HUMAN "Mammalian ependymin-related protein 1, MERP-1 (Upregulated in colorectal cancer gene 1 protein)" EPDR1 MERP1 UCC1 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; myofibroblast contraction [GO:1990764] extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; ganglioside GM1 binding [GO:1905573]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; cell-matrix adhesion [GO:0007160]; myofibroblast contraction [GO:1990764] GO:0005509; GO:0005543; GO:0005576; GO:0005764; GO:0007160; GO:0042802; GO:0043202; GO:1905573; GO:1990764 calcium ion binding [GO:0005509]; ganglioside GM1 binding [GO:1905573]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543] ALIPCKR 0.99456 -13.643 0 0 0 0 0 0 0 0 0 0 13.8195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3081 0 12.9176 11.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6903 15.1337 0 0 0 11.9237 0 0 0 17.2161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0371 0 14.1992 0 0 0 0 13.8117 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1898 0 0 0 0 0 0 0 0 0 0 10.8086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60304 ZN500_HUMAN Zinc finger protein 500 (Zinc finger protein with KRAB and SCAN domains 18) ZNF500 KIAA0557 ZKSCAN18 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005654; GO:0005829; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASHGADK 0.99457 -11.312 0 0 11.1083 0 0 0 0 0 0 0 0 0 0 0 12.6835 0 0 0 10.5277 0 0 11.7667 0 15.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7793 0 0 13.2378 0 11.7165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2204 13.0008 16.1321 13.1107 13.4102 0 0 0 0 15.7472 0 0 16.2171 0 16.4318 0 16.8175 16.6108 16.6633 16.844 16.7939 16.6297 0 13.2094 0 16.4346 13.0552 16.8482 16.6335 16.5219 0 13.1594 16.7406 0 0 16.6217 16.4363 16.4366 16.4957 16.2824 16.4204 16.402 0 0 0 0 16.4359 0 0 0 0 0 0 0 16.3312 16.6044 12.0321 16.3809 0 13.3703 13.338 16.43 0 0 0 16.3838 0 13.4273 16.4733 0 0 0 13.3868 0 16.4562 16.4657 16.5345 16.2847 16.5308 0 16.4081 0 0 0 0 16.2686 16.4422 16.6006 0 16.3625 13.9119 0 0 0 0 0 14.9622 0 0 0 11.5466 0 11.4162 0 0 16.1741 0 0 0 0 16.2286 12.7791 0 0 O94776 MTA2_HUMAN "Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1, MTA1-L1 protein) (p53 target protein in deacetylase complex)" MTA2 MTA1L1 PID Homo sapiens (Human) "chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of fibroblast migration [GO:0010762]; regulation of stem cell differentiation [GO:2000736]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of fibroblast migration [GO:0010762]; regulation of stem cell differentiation [GO:2000736]" GO:0000118; GO:0000122; GO:0000781; GO:0000785; GO:0003682; GO:0003713; GO:0003714; GO:0004407; GO:0005654; GO:0005667; GO:0006306; GO:0006325; GO:0006338; GO:0010762; GO:0016020; GO:0016575; GO:0016581; GO:0032991; GO:0042659; GO:0042826; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0061629; GO:2000736 chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] AECSIRLPKAAK 0.99457 -12.875 0 0 0 0 0 0 0 11.5748 0 0 0 0 0 0 0 0 0 0 0 0 15.5524 0 0 0 12.4237 11.7359 0 0 0 0 0 0 0 0 0 0 13.2633 0 0 11.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.384 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7741 13.1591 0 12.7938 0 0 0 0 13.0249 12.6636 12.9248 12.4341 0 0 0 14.3332 13.6316 0 14.3265 13.4305 0 0 0 0 0 14.2458 0 0 13.9234 12.4918 0 0 11.6007 13.0391 13.437 0 14.0339 0 0 0 12.1016 19.2766 0 0 15.2421 0 0 14.4177 0 0 0 0 0 0 0 0 12.3111 0 0 0 0 0 0 0 0 13.9979 0 13.2265 0 0 13.4265 14.5613 13.1664 0 11.4008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8716 0 0 0 11.305 0 0 0 0 12.0597 12.4995 0 P08133 ANXA6_HUMAN "Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II, CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70)" ANXA6 ANX6 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; apoptotic signaling pathway [GO:0097190]; growth plate cartilage chondrocyte differentiation [GO:0003418]; ion transmembrane transport [GO:0034220]; mitochondrial calcium ion homeostasis [GO:0051560]; negative regulation of sequestering of calcium ion [GO:0051283]; neural crest cell migration [GO:0001755]; plasma membrane repair [GO:0001778]; regulation of muscle contraction [GO:0006937] GO:0001755; GO:0001778; GO:0001786; GO:0003418; GO:0005262; GO:0005509; GO:0005525; GO:0005544; GO:0005739; GO:0005765; GO:0005925; GO:0006937; GO:0008289; GO:0015276; GO:0015485; GO:0016020; GO:0031902; GO:0034220; GO:0035374; GO:0042470; GO:0042802; GO:0048306; GO:0048471; GO:0051015; GO:0051283; GO:0051560; GO:0062023; GO:0070062; GO:0097190 actin filament binding [GO:0051015]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; chondroitin sulfate binding [GO:0035374]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated ion channel activity [GO:0015276]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786] ALRKAMK 0.99457 -13.698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3532 0 11.8036 0 0 0 0 0 0 0 0 0 11.3251 0 10.8522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4654 11.7867 11.9878 0 0 0 0 0 12.5195 0 0 0 0 0 11.4224 0 0 0 0 0 0 0 0 14.6535 0 15.0111 14.0685 13.985 15.085 0 0 0 15.5515 0 0 0 0 0 0 0 0 0 12.9372 0 0 0 0 0 0 0 0 12.025 0 0 12.0567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0042 0 0 0 12.5735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9927 0 0 0 0 15.5854 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2497 12.3154 0 0 0 0 P21283 VATC1_HUMAN "V-type proton ATPase subunit C 1, V-ATPase subunit C 1 (Vacuolar proton pump subunit C 1)" ATP6V1C1 ATP6C ATP6D VATC Homo sapiens (Human) proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241] "anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]" GO:0000221; GO:0005765; GO:0005829; GO:0005886; GO:0016241; GO:0016469; GO:0030665; GO:0030672; GO:0045177; GO:0046961; GO:0070062; GO:0070161; GO:1902600 "proton-transporting ATPase activity, rotational mechanism [GO:0046961]" DFQYNEEEMK 0.99457 -13.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8803 0 0 10.0971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0897 0 0 0 0 0 0 13.1102 0 0 12.7741 15.2916 0 0 0 0 0 0 0 13.9539 0 0 0 0 0 13.6328 15.2353 13.9992 16.108 0 0 0 13.8688 0 13.6591 14.0522 11.5336 0 13.6279 14.1819 0 0 0 0 0 0 0 0 0 0 0 13.8087 0 0 0 11.8337 0 0 0 0 0 13.577 0 0 0 0 0 0 0 0 0 13.8177 13.4119 14.3027 0 0 0 13.1127 0 0 0 13.8815 0 0 0 12.6576 0 0 0 0 0 0 0 0 0 0 0 13.1011 0 0 12.2307 0 0 0 0 0 0 0 12.6062 0 11.6217 P23246 SFPQ_HUMAN "Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein, hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor, PSF, PTB-associated-splicing factor)" SFPQ PSF Homo sapiens (Human) "activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]" chromatin [GO:0000785]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]" GO:0000122; GO:0000380; GO:0000724; GO:0000785; GO:0000976; GO:0002218; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006397; GO:0008380; GO:0016363; GO:0016607; GO:0032839; GO:0042382; GO:0042752; GO:0042754; GO:0042803; GO:0042826; GO:0045087; GO:0045876; GO:0045892; GO:0045944; GO:0048511; GO:0051276; GO:0070932; GO:0090575; GO:0098963; GO:1902177 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976] EMEEQMRRQR 0.99457 -12.878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7922 11.6789 0 0 0 0 0 0 0 0 14.2258 0 0 0 0 14.2111 0 0 0 12.1375 0 0 0 12.7917 0 0 0 0 0 0 0 0 0 0 0 0 12.1687 0 0 0 0 0 0 0 0 13.8838 0 0 0 0 0 0 0 0 13.5352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.75 13.1177 11.9132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1356 Q0VDG4 SCRN3_HUMAN Secernin-3 SCRN3 Homo sapiens (Human) proteolysis [GO:0006508] cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508] GO:0006508; GO:0016805; GO:0070004 cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805] IAREHPDMR 0.99457 -13.701 0 0 0 0 0 0 0 0 0 0 12.2828 12.9861 0 0 0 0 0 0 0 0 11.9352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3022 0 0 0 0 0 0 0 0 0 0 0 0 10.0708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.976 0 0 0 0 0 0 0 0 12.5238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7613 0 0 0 0 0 0 0 0 12.8785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5523 11.4955 0 0 0 0 0 0 0 0 12.2849 0 0 0 Q15049 MLC1_HUMAN Membrane protein MLC1 MLC1 KIAA0027 WKL1 Homo sapiens (Human) caveolin-mediated endocytosis [GO:0072584]; cellular response to cholesterol [GO:0071397]; ion transport [GO:0006811]; positive regulation of intracellular transport [GO:0032388]; protein transport [GO:0015031]; regulation of response to osmotic stress [GO:0047484]; vesicle-mediated transport [GO:0016192] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037] basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; caveolin-mediated endocytosis [GO:0072584]; cellular response to cholesterol [GO:0071397]; ion transport [GO:0006811]; positive regulation of intracellular transport [GO:0032388]; protein transport [GO:0015031]; regulation of response to osmotic stress [GO:0047484]; vesicle-mediated transport [GO:0016192] GO:0005737; GO:0005764; GO:0005768; GO:0005769; GO:0005783; GO:0005829; GO:0005886; GO:0005901; GO:0006811; GO:0015031; GO:0016021; GO:0016192; GO:0016323; GO:0031410; GO:0032388; GO:0042802; GO:0044877; GO:0045121; GO:0047484; GO:0048471; GO:0055037; GO:0071397; GO:0072584 identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] PSYDVLLLLLLLVLLLQAGLNTGTAIQCVRFK 0.99457 -9.4333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6341 0 0 0 11.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3343 0 0 0 0 11.3867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15417 CNN3_HUMAN "Calponin-3 (Calponin, acidic isoform)" CNN3 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calmodulin binding [GO:0005516]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855] GO:0003779; GO:0005516; GO:0005829; GO:0005856; GO:0005912; GO:0005925; GO:0015629; GO:0030855; GO:0031032; GO:0098641 actin binding [GO:0003779]; cadherin binding involved in cell-cell adhesion [GO:0098641]; calmodulin binding [GO:0005516] FDEGKLK 0.99457 -11.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8111 13.3962 16.8329 0 0 14.2975 12.3971 0 0 0 0 11.3599 0 0 0 0 0 0 0 15.8387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3MIS6 ZN528_HUMAN Zinc finger protein 528 ZNF528 KIAA1827 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFSVRSSLITHQLIHTGR 0.99457 -8.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1462 0 12.1641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2158 0 0 0 0 14.8741 0 0 0 0 0 0 0 0 12.443 0 0 11.5553 0 0 0 0 0 0 0 0 0 12.7912 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2043 0 15.2385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96SE7 ZN347_HUMAN Zinc finger protein 347 (Zinc finger protein 1111) ZNF347 ZNF1111 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" NSQLSQHQK 0.99457 -8.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1092 0 0 14.2761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUK0 CHCH7_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 CHCHD7 Homo sapiens (Human) mitochondrial respiratory chain complex assembly [GO:0033108] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; mitochondrial respiratory chain complex assembly [GO:0033108] GO:0005739; GO:0005758; GO:0033108 CLDENNYDR 0.99457 -8.6706 0 0 0 0 0 0 0 0 0 11.4976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0913 0 0 0 0 0 0 0 15.4816 0 0 0 0 0 0 0 15.3533 11.3415 0 0 0 0 0 13.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4418 13.4491 12.91 0 13.9114 0 0 0 12.1298 0 0 0 0 0 0 0 0 0 Q9BUM1 G6PC3_HUMAN "Glucose-6-phosphatase 3, G-6-Pase 3, G6Pase 3, EC 3.1.3.9 (Glucose-6-phosphatase beta, G6Pase-beta) (Ubiquitous glucose-6-phosphatase catalytic subunit-related protein)" G6PC3 UGRP Homo sapiens (Human) gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucose-6-phosphatase activity [GO:0004346]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose-6-phosphate transport [GO:0015760] GO:0004346; GO:0005783; GO:0005789; GO:0006094; GO:0015760; GO:0016020; GO:0016021; GO:0051156 glucose-6-phosphatase activity [GO:0004346] ARSRWVR 0.99457 -9.4297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BXS6 NUSAP_HUMAN "Nucleolar and spindle-associated protein 1, NuSAP" NUSAP1 ANKT BM-037 PRO0310 Homo sapiens (Human) establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of mitotic nuclear division [GO:0045840] chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730] chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of mitotic nuclear division [GO:0045840] GO:0000070; GO:0000281; GO:0003677; GO:0003723; GO:0005694; GO:0005730; GO:0005737; GO:0005874; GO:0007076; GO:0008017; GO:0040001; GO:0045840; GO:0072686 DNA binding [GO:0003677]; microtubule binding [GO:0008017]; RNA binding [GO:0003723] ANLRATK 0.99457 -8.4074 0 0 0 0 0 0 0 0 13.3836 15.1816 0 0 0 0 0 0 0 0 0 0 10.3552 0 0 0 0 0 0 0 13.5155 0 0 14.308 13.5313 0 0 13.5109 13.2805 13.2351 13.4997 13.7738 13.5819 0 0 14.0321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7813 0 0 0 0 12.3054 0 0 0 0 0 0 0 0 0 12.1125 0 0 0 0 0 0 11.5992 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8697 0 0 0 0 13.8346 15.2359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1045 13.859 0 0 0 14.1265 0 0 0 0 0 0 11.3848 0 0 0 0 0 0 0 0 0 0 Q9BZQ8 NIBA1_HUMAN Protein Niban 1 (Cell growth-inhibiting gene 39 protein) (Protein FAM129A) NIBAN1 C1orf24 FAM129A NIBAN GIG39 Homo sapiens (Human) negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; response to endoplasmic reticulum stress [GO:0034976] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; response to endoplasmic reticulum stress [GO:0034976] GO:0001933; GO:0001934; GO:0005737; GO:0005829; GO:0005886; GO:0016020; GO:0034976; GO:0045727; GO:0070062 DLTSQFLKTK 0.99457 -13.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0095 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3959 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3402 0 12.2664 0 0 0 0 13.3716 0 0 0 0 0 0 0 0 0 0 0 0 12.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1409 0 0 0 0 0 0 12.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2392 0 0 0 0 0 0 12.5822 0 0 0 0 0 13.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2009 0 0 0 0 0 0 0 0 0 0 Q9NX36 DJC28_HUMAN DnaJ homolog subfamily C member 28 DNAJC28 C21orf55 C21orf78 Homo sapiens (Human) "Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" Golgi transport complex [GO:0017119] "Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0006890; GO:0007030; GO:0017119; GO:0048213 EIVRAQKIYETLIK 0.99457 -8.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7338 0 0 11.9593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0477 0 0 0 0 0 0 0 0 0 0 0 12.14 0 14.7817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63428 0 12.7269 12.0418 0 0 0 0 15.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4145 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P255 ZN492_HUMAN Zinc finger protein 492 (Zinc finger protein 115) ZNF492 KIAA1473 ZNF115 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CKECEKSFCMLSHLAQHK 0.99457 -11.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9019 0 0 15.272 14.3877 0 0 0 0 0 0 0 0 0 0 14.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1699 14.7122 0 0 0 0 0 0 0 0 0 13.4656 0 0 0 13.3757 0 12.2003 0 0 0 0 0 0 0 0 0 0 13.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2E2 KIF17_HUMAN Kinesin-like protein KIF17 (KIF3-related motor protein) KIF17 KIAA1405 KIF3X Homo sapiens (Human) anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0015031; GO:0016192; GO:0016887; GO:0030030; GO:0032391; GO:0032839; GO:0036064; GO:0043005; GO:0098971; GO:1990075 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] CRPMNQRER 0.99457 -11.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6256 0 0 0 0 0 0 0 0 0 16.6034 16.5006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9394 0 0 0 0 0 0 0 0 0 0 0 0 11.8452 0 0 0 12.2318 12.0298 0 0 0 0 0 14.2925 0 0 13.7343 11.7988 14.1655 0 11.9107 0 0 0 0 0 16.6464 0 0 15.0674 0 0 15.0352 0 0 0 0 14.6535 14.6328 0 0 0 15.0689 0 14.0883 0 14.3335 0 14.7201 0 0 0 15.1273 0 0 0 0 15.3824 15.2143 0 0 0 13.0999 0 14.8332 0 0 0 13.8572 0 0 0 0 0 0 12.5781 0 0 17.4879 0 0 0 0 0 0 0 12.5046 0 0 0 0 0 0 0 14.3732 0 14.3585 0 0 0 13.5787 0 Q9UJK0 TSR3_HUMAN "18S rRNA aminocarboxypropyltransferase, EC 2.5.1.- (20S S rRNA accumulation protein 3 homolog, HsTsr3)" TSR3 C16orf42 UND313L Homo sapiens (Human) enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]; rRNA modification [GO:0000154] cytosol [GO:0005829] cytosol [GO:0005829]; 18S rRNA aminocarboxypropyltransferase activity [GO:0106388]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; maturation of SSU-rRNA [GO:0030490]; rRNA modification [GO:0000154] GO:0000154; GO:0000455; GO:0005829; GO:0016740; GO:0030490; GO:0106388; GO:1904047 18S rRNA aminocarboxypropyltransferase activity [GO:0106388]; S-adenosyl-L-methionine binding [GO:1904047]; transferase activity [GO:0016740] FGGLVLSPVGK 0.99457 -8.4092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7047 12.4844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1301 0 0 0 0 0 0 12.3802 0 0 0 0 0 0 0 0 11.794 0 0 0 0 A0A075B6K6 LV403_HUMAN Immunoglobulin lambda variable 4-3 IGLV4-3 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 SDGSHSKGDGIPDR 0.99458 -10.731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B9EJG8 T150C_HUMAN Transmembrane protein 150C TMEM150C Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; proprioception [GO:0019230] integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765] integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; mechanosensitive ion channel activity [GO:0008381]; cellular response to mechanical stimulus [GO:0071260]; proprioception [GO:0019230] GO:0005765; GO:0005887; GO:0008381; GO:0019230; GO:0071260 mechanosensitive ion channel activity [GO:0008381] ILPLNSAER 0.99458 -5.3359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1963 10.2668 12.0958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00443 P3C2A_HUMAN "Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, PI3K-C2-alpha, PtdIns-3-kinase C2 subunit alpha, EC 2.7.1.137, EC 2.7.1.153, EC 2.7.1.154 (Phosphoinositide 3-kinase-C2-alpha)" PIK3C2A Homo sapiens (Human) cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829] clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] "clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; clathrin binding [GO:0030276]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; cell migration [GO:0016477]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; exocytosis [GO:0006887]; insulin receptor signaling pathway [GO:0008286]; membrane organization [GO:0061024]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of autophagy [GO:0010508]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; vascular associated smooth muscle contraction [GO:0014829]" GO:0005524; GO:0005654; GO:0005737; GO:0005802; GO:0005829; GO:0005886; GO:0005942; GO:0006661; GO:0006887; GO:0006897; GO:0007173; GO:0008286; GO:0010508; GO:0014065; GO:0014829; GO:0016020; GO:0016303; GO:0016310; GO:0016477; GO:0030136; GO:0030276; GO:0031982; GO:0035004; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0046854; GO:0046934; GO:0048008; GO:0048015; GO:0048268; GO:0052742; GO:0052812; GO:0061024; GO:0070062; GO:0090050 "1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; clathrin binding [GO:0030276]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol kinase activity [GO:0052742]; phosphatidylinositol-3,4-bisphosphate 5-kinase activity [GO:0052812]; phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]" AEGIARSADAGSFSPTPGQIGGAVKLSISYR 0.99458 -8.4359 0 11.4729 0 0 0 0 0 0 0 0 11.7709 0 0 0 0 0 0 14.6159 0 11.1364 0 11.3523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4089 0 0 0 0 0 0 0 0 0 17.4615 0 0 0 0 0 12.264 0 0 0 12.0088 0 0 0 0 0 0 0 14.7289 0 11.5107 0 0 0 0 0 0 13.0327 0 0 14.2226 13.7766 13.8907 0 0 14.1374 11.737 0 0 0 13.128 13.3108 14.2089 14.1171 0 13.673 12.6497 0 10.7935 0 0 13.3102 0 0 0 0 0 0 0 0 0 14.5057 0 12.9356 0 0 0 0 0 12.6119 14.8853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.977 0 0 0 13.6818 13.6787 0 0 11.3749 0 12.0592 0 O00591 GBRP_HUMAN Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) GABRP Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] GO:0004890; GO:0005231; GO:0005254; GO:0005887; GO:0007165; GO:0007268; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:1902476; GO:1902711; GO:1904315 chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] LVLQFELR 0.99458 -12.919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3588 0 0 12.9595 0 0 0 0 0 13.8518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43164 PJA2_HUMAN "E3 ubiquitin-protein ligase Praja-2, Praja2, EC 2.3.2.27 (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2)" PJA2 KIAA0438 RNF131 Homo sapiens (Human) hippo signaling [GO:0035329]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; protein ubiquitination [GO:0016567]; regulation of macrophage activation [GO:0043030]; regulation of protein kinase A signaling [GO:0010738] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin-protein transferase activity [GO:0004842]; hippo signaling [GO:0035329]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; long-term memory [GO:0007616]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; protein ubiquitination [GO:0016567]; regulation of macrophage activation [GO:0043030]; regulation of protein kinase A signaling [GO:0010738] GO:0000139; GO:0004842; GO:0005737; GO:0005789; GO:0005886; GO:0006954; GO:0007616; GO:0010738; GO:0014069; GO:0016567; GO:0034137; GO:0034236; GO:0034237; GO:0035329; GO:0043030; GO:0045087; GO:0045111; GO:0046330; GO:0046872; GO:0070161; GO:1900745 metal ion binding [GO:0046872]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; ubiquitin-protein transferase activity [GO:0004842] CEEYDGEHDCMFLDPPYSRVITQR 0.99458 -5.3312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3931 0 0 0 0 0 0 0 0 0 0 0 12.4866 0 0 0 0 0 0 0 0 0 0 0 13.5427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3399 0 O43448 KCAB3_HUMAN Voltage-gated potassium channel subunit beta-3 (K(+) channel subunit beta-3) (Kv-beta-3) KCNAB3 KCNA3B Homo sapiens (Human) potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transport [GO:0006813]; regulation of potassium ion transmembrane transport [GO:1901379] GO:0004033; GO:0005249; GO:0005737; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0044325; GO:1901379 aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] EKVEMQLPELYHKIGVGSVTWYPLACGLITSK 0.99458 -13.804 0 0 0 8.8864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3244 0 0 0 0 0 0 10.6146 0 16.9447 0 13.1176 0 12.9924 0 0 0 0 14.4637 0 0 12.4156 10.1857 0 0 0 0 10.0593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93877 0 0 0 0 14.6586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60337 MARH6_HUMAN "E3 ubiquitin-protein ligase MARCHF6, EC 2.3.2.27 (Doa10 homolog) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI, MARCH-VI) (Protein TEB-4) (RING finger protein 176) (RING-type E3 ubiquitin transferase MARCHF6)" MARCHF6 KIAA0597 MARCH6 RNF176 TEB4 Homo sapiens (Human) endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; ER ubiquitin ligase complex [GO:0000835]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; ER ubiquitin ligase complex [GO:0000835]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270]; endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000835; GO:0004842; GO:0005783; GO:0005789; GO:0008270; GO:0010498; GO:0016020; GO:0016021; GO:0016567; GO:0019899; GO:0030176; GO:0030433; GO:0031624; GO:0036503; GO:0043161; GO:0044322; GO:0061630; GO:0070936; GO:1904380; GO:1990381 enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270] EYCELCKHR 0.99458 -5.3381 10.3486 0 0 0 0 0 0 0 13.5935 0 14.4386 11.3856 11.1337 0 13.3346 0 0 14.3252 0 0 0 0 11.213 0 0 0 0 0 0 14.6409 0 0 0 0 0 0 0 11.24 0 11.0523 0 13.7541 0 13.4691 0 14.5445 0 13.0901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8189 0 0 10.3757 11.7534 0 12.6933 0 0 0 0 0 0 0 0 10.3285 0 0 0 0 0 0 0 0 0 0 0 0 13.8741 0 13.6094 0 0 0 0 12.105 0 0 0 0 0 13.5191 0 0 0 0 14.6744 0 0 0 0 0 0 0 11.2032 0 0 0 0 0 12.3248 14.7197 12.4572 0 0 0 0 0 0 0 0 0 0 0 0 11.7653 0 0 0 0 0 12.1548 0 11.3413 0 0 0 0 0 0 14.0979 13.7445 0 0 0 0 0 0 0 12.117 0 0 0 12.0819 0 13.0093 14.0566 13.2684 11.1288 O60341 KDM1A_HUMAN "Lysine-specific histone demethylase 1A, EC 1.14.99.66 (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A)" KDM1A AOF2 KDM1 KIAA0601 LSD1 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; chromatin organization [GO:0006325]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric repeat-containing RNA binding [GO:0061752]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; chromatin organization [GO:0006325]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]" GO:0000122; GO:0000380; GO:0000781; GO:0000785; GO:0002039; GO:0002052; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0006357; GO:0006482; GO:0010569; GO:0010976; GO:0016491; GO:0019899; GO:0021987; GO:0030374; GO:0032091; GO:0032451; GO:0032452; GO:0032453; GO:0032454; GO:0032880; GO:0032991; GO:0033169; GO:0033184; GO:0034644; GO:0034720; GO:0035563; GO:0042551; GO:0043392; GO:0043426; GO:0043433; GO:0043518; GO:0045793; GO:0045892; GO:0045944; GO:0046098; GO:0050660; GO:0050681; GO:0051091; GO:0051572; GO:0051573; GO:0055001; GO:0060765; GO:0060992; GO:0061629; GO:0061752; GO:0071320; GO:0071480; GO:0090308; GO:0120162; GO:0140297; GO:0140682; GO:1902166; GO:1990391; GO:1990841; GO:2000179; GO:2000648 chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-4 FAD-dependent demethylase activity [GO:0140682]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric repeat-containing RNA binding [GO:0061752] DITAEFLVKSK 0.99458 -8.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9373 0 0 0 0 0 13.051 0 0 0 0 0 0 11.9489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.548 0 14.8397 0 0 0 0 0 0 0 0 0 13.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.038 0 0 0 0 0 0 0 0 13.2018 0 0 0 0 0 0 0 0 0 0 0 12.9324 0 0 0 0 13.0921 0 0 0 0 0 0 0 0 O75886 STAM2_HUMAN "Signal transducing adapter molecule 2, STAM-2 (Hrs-binding protein)" STAM2 HBP Homo sapiens (Human) macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; signal transduction [GO:0007165] GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016236; GO:0030139; GO:0031901; GO:0033565; GO:0035091; GO:0036258; GO:0043130; GO:0043231; GO:0043328; GO:0090148 phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130] AHPKVCEKLK 0.99458 -11.007 0 0 0 0 0 0 0 0 0 0 9.86683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6231 0 0 13.0151 0 0 0 0 0 0 0 0 0 0 12.1778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7949 0 13.3677 0 0 0 11.1492 0 0 0 0 0 0 0 0 19.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2317 0 0 0 0 13.1502 0 0 0 0 0 0 0 0 13.5436 0 12.0878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42167 LAP2B_HUMAN "Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma, TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma, TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin, TP (Splenin); Thymopentin (TP5) ]" TMPO LAP2 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; DNA binding [GO:0003677]; lamin binding [GO:0005521] GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005737; GO:0016020; GO:0016021; GO:0031965 DNA binding [GO:0003677]; lamin binding [GO:0005521] AKTPVTLKQR 0.99458 -10.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2167 0 0 0 0 19.4495 0 0 0 0 0 0 0 0 0 14.1335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3758 0 0 0 12.6029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50895 BCAM_HUMAN Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239) BCAM LU MSK19 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; signal transduction [GO:0007165] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; protein C-terminus binding [GO:0008022]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; signal transduction [GO:0007165] GO:0004888; GO:0005055; GO:0005576; GO:0005886; GO:0005887; GO:0007155; GO:0007160; GO:0007165; GO:0008022; GO:0009897; GO:0043236; GO:0062023; GO:0070062 laminin binding [GO:0043236]; laminin receptor activity [GO:0005055]; protein C-terminus binding [GO:0008022]; transmembrane signaling receptor activity [GO:0004888] GGSGGFGDEC 0.99458 -8.4356 0 10.5227 0 11.394 11.949 0 0 0 0 0 0 0 13.5303 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5246 0 0 13.747 0 0 0 0 0 10.5225 12.1012 0 0 0 0 0 0 14.345 0 0 0 0 11.2342 0 11.7573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3989 0 0 12.1025 0 12.5329 0 0 0 0 0 15.5511 0 0 0 0 0 12.2305 0 12.5275 0 10.6061 0 0 13.5134 0 0 13.7515 0 0 0 0 14.0336 0 0 0 9.81133 0 0 12.8098 0 0 0 0 12.8321 0 0 12.7485 0 0 0 13.0824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1368 0 0 12.395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4962 0 Q13309 SKP2_HUMAN S-phase kinase-associated protein 2 (Cyclin-A/CDK2-associated protein p45) (F-box protein Skp2) (F-box/LRR-repeat protein 1) (p45skp2) SKP2 FBXL1 Homo sapiens (Human) defense response to virus [GO:0051607]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; innate immune response [GO:0045087]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; identical protein binding [GO:0042802]; defense response to virus [GO:0051607]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; innate immune response [GO:0045087]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein polyubiquitination [GO:1902916]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000082; GO:0000086; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0019005; GO:0031146; GO:0033148; GO:0042802; GO:0042981; GO:0043161; GO:0045087; GO:0051607; GO:0051726; GO:0070936; GO:1902916 identical protein binding [GO:0042802] CYDIIPETLLELGEIPTLK 0.99458 -5.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6029 0 0 13.3215 0 0 0 0 0 0 0 0 10.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14141 SEPT6_HUMAN Septin-6 SEPTIN6 KIAA0128 SEP2 SEPT6 Homo sapiens (Human) cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; spermatogenesis [GO:0007283] axon terminus [GO:0043679]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin collar [GO:0032173]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021] axon terminus [GO:0043679]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin collar [GO:0032173]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; mitotic cytokinesis [GO:0000281]; protein localization [GO:0008104]; spermatogenesis [GO:0007283] GO:0000281; GO:0000776; GO:0003924; GO:0005525; GO:0005819; GO:0005940; GO:0007283; GO:0008021; GO:0008104; GO:0015630; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0032173; GO:0043679; GO:0060090; GO:0060271; GO:0061640; GO:0097227 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090] DTDPDSKPFSLQETYEAK 0.99458 -11.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5193 14.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4066 0 0 0 0 0 12.6287 0 0 0 0 0 0 0 0 0 14.1169 0 0 13.9749 0 13.9841 0 0 12.8741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5784 0 0 0 0 0 0 11.3681 10.976 0 0 0 0 0 0 11.5115 0 0 0 0 0 0 0 0 0 Q15646 OASL_HUMAN "2'-5'-oligoadenylate synthase-like protein (2'-5'-OAS-related protein, 2'-5'-OAS-RP) (59 kDa 2'-5'-oligoadenylate synthase-like protein) (Thyroid receptor-interacting protein 14, TR-interacting protein 14, TRIP-14) (p59 OASL, p59OASL)" OASL TRIP14 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nuclear thyroid hormone receptor binding [GO:0046966]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615] GO:0003677; GO:0003723; GO:0003725; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0009615; GO:0016020; GO:0016779; GO:0045071; GO:0045087; GO:0046966; GO:0051607; GO:0060700; GO:0070106; GO:1900246 DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nuclear thyroid hormone receptor binding [GO:0046966]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723] ACGGPGNFCPSFSELQR 0.99458 -7.8856 0 0 0 0 0 0 0 0 11.6546 0 0 0 0 0 14.1624 13.9722 0 0 0 0 0 11.1492 0 0 0 0 0 0 14.6314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3974 0 0 0 0 0 0 0 0 9.98513 0 0 0 0 0 0 0 13.3429 0 0 0 0 0 0 0 0 0 10.8315 0 0 0 0 0 0 0 0 0 13.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7379 0 0 0 11.8688 0 0 11.726 0 13.603 13.6458 0 0 0 0 0 0 0 0 0 0 12.0109 0 0 0 0 0 0 12.7142 0 0 0 15.0111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TAP0 GOG7B_HUMAN Golgin subfamily A member 7B GOLGA7B C10orf132 C10orf133 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]; plasma membrane [GO:0005886] Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] GO:0000139; GO:0002178; GO:0005886; GO:0006612; GO:0018230; GO:0019899 enzyme binding [GO:0019899] CSSGSSSSGSSSGSGSSSGGGGGAGAR 0.99458 -8.7111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3056 0 0 0 0 0 0 14.306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9115 13.7718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86YS3 RFIP4_HUMAN "Rab11 family-interacting protein 4, FIP4-Rab11, Rab11-FIP4 (Arfophilin-2)" RAB11FIP4 ARFO2 KIAA1821 Homo sapiens (Human) endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819] cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; spindle [GO:0005819]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; endocytic recycling [GO:0032456]; regulation of cytokinesis [GO:0032465] GO:0005509; GO:0005615; GO:0005768; GO:0005815; GO:0005819; GO:0030139; GO:0030496; GO:0031267; GO:0032154; GO:0032456; GO:0032465; GO:0042803; GO:0055038 calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] AREVELEHEVK 0.99458 -13.755 0 10.4469 0 0 0 0 0 0 11.5723 11.292 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9714 0 0 11.4542 0 0 0 0 11.4512 0 0 10.8843 0 0 0 11.3517 0 0 0 0 0 0 0 0 0 0 0 0 0 10.442 0 0 0 0 0 0 10.2549 0 0 0 0 0 0 11.1544 0 0 11.4708 0 0 0 0 0 0 0 12.9432 0 0 0 12.877 0 0 0 0 0 0 0 0 0 0 12.4763 14.1958 14.0134 14.133 14.3433 0 0 12.3905 0 14.543 0 13.4867 13.4799 13.3383 0 0 0 12.0218 0 0 0 0 0 0 0 0 12.7936 0 0 0 12.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8316 15.1909 0 0 0 0 14.3235 0 0 0 0 0 0 0 0 0 0 12.3131 0 0 0 0 0 0 0 12.4438 0 0 11.2054 0 0 14.9873 Q8TCE9 PPL13_HUMAN "Placental protein 13-like (Charcot-Leyden crystal protein 2, CLC2) (Galectin-14, Gal-14)" LGALS14 PPL13 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of T cell apoptotic process [GO:0070234] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; carbohydrate binding [GO:0030246]; apoptotic process [GO:0006915]; positive regulation of T cell apoptotic process [GO:0070234] GO:0005654; GO:0006915; GO:0030246; GO:0070234 carbohydrate binding [GO:0030246] DISLTRVLISD 0.99458 -8.1481 0 0 0 10.0388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5823 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2688 0 0 0 0 0 0 14.2553 14.4951 0 13.3478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8757 0 0 11.8952 12.5981 0 0 11.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6231 0 0 0 0 0 Q96I99 SUCB2_HUMAN "Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial, EC 6.2.1.4 (GTP-specific succinyl-CoA synthetase subunit beta, G-SCS, GTPSCS) (Succinyl-CoA synthetase beta-G chain, SCS-betaG)" SUCLG2 Homo sapiens (Human) succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099] GO:0000287; GO:0004775; GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0005759; GO:0005886; GO:0006099; GO:0006104; GO:0042709; GO:0045244; GO:1901289 ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776] ASPVAAQAGKLLR 0.99458 -9.4542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.35911 0 0 12.6057 0 0 0 0 0 0 0 0 0 13.3375 0 0 0 0 0 0 13.2693 0 0 0 0 0 0 0 0 15.3052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7852 0 Q96M63 ODAD1_HUMAN Outer dynein arm-docking complex subunit 1 (Coiled-coil domain-containing protein 114) ODAD1 CCDC114 Homo sapiens (Human) cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158] axoneme [GO:0005930]; cilium [GO:0005929]; outer dynein arm [GO:0036157]; outer dynein arm docking complex [GO:0120228] axoneme [GO:0005930]; cilium [GO:0005929]; outer dynein arm [GO:0036157]; outer dynein arm docking complex [GO:0120228]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0005929; GO:0005930; GO:0036157; GO:0036158; GO:0120228 EIHHLHHLVSTLILSSTSAYAVR 0.99458 -10.727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PY5 FMNL2_HUMAN Formin-like protein 2 (Formin homology 2 domain-containing protein 2) FMNL2 FHOD2 KIAA1902 Homo sapiens (Human) cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360] cytosol [GO:0005829] cytosol [GO:0005829]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360] GO:0005829; GO:0007010; GO:0008360; GO:0016477; GO:0022604; GO:0030866; GO:0031267; GO:0045296; GO:0051015 actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267] EKYHQVSLFYNELHYVEK 0.99458 -7.8858 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9671 0 0 14.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1429 0 0 0 0 0 0 13.2402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6898 10.719 0 0 11.3975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7466 0 13.5801 0 0 0 0 0 0 0 0 0 0 0 0 13.7228 0 0 0 0 0 0 0 0 13.2385 0 0 0 0 13.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QD5 DEPD7_HUMAN DEP domain-containing protein 7 (Protein TR2/D15) DEPDC7 Homo sapiens (Human) intracellular signal transduction [GO:0035556] intracellular signal transduction [GO:0035556] GO:0035556 DAGYIYCQRIDQR 0.99458 -8.4331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.521 0 0 0 0 0 0 0 0 10.6447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2494 12.6993 14.9088 12.4507 14.3554 13.0096 13.2079 13.3127 0 13.2261 0 12.6978 12.7453 0 0 0 12.9578 0 0 12.294 0 0 14.4486 14.5839 0 13.3159 14.1478 0 12.2383 12.46 0 0 15.0378 12.933 0 15.4275 14.0379 14.4187 12.3387 15.706 0 15.0074 12.897 14.2608 14.1567 0 0 0 0 0 0 14.3512 13.2417 0 0 0 14.2668 0 12.6557 0 0 0 0 0 0 0 0 0 0 13.909 15.0502 0 0 0 13.6225 0 0 13.2455 0 0 0 0 0 12.5285 0 0 14.3341 0 0 0 0 12.7249 0 0 0 0 0 0 0 12.8086 0 0 12.6391 0 0 0 0 0 0 12.0118 0 0 0 0 0 11.8789 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0A8 COMD4_HUMAN COMM domain-containing protein 4 COMMD4 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0043231 FESGDVK 0.99458 -15.68 12.589 0 0 0 0 0 12.2223 14.1105 0 0 0 0 0 0 0 13.8506 12.7408 14.4332 13.1183 12.8952 0 0 12.9343 13.0327 0 0 13.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4235 0 0 0 0 0 0 0 0 12.3577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7971 0 0 0 0 0 0 15.5424 0 15.4845 0 15.846 14.9566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4872 0 13.7766 12.8946 0 0 0 0 13.4936 0 13.4525 0 0 14.185 0 12.9079 0 0 0 0 0 0 0 0 0 0 0 0 0 13.314 13.848 0 0 0 13.3232 0 0 0 13.7771 0 13.3529 0 13.288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4549 0 0 0 0 0 0 Q9NQR1 KMT5A_HUMAN "N-lysine methyltransferase KMT5A, EC 2.1.1.- (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A, EC 2.1.1.361) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07, PR-Set7, PR/SET07) (SET domain-containing protein 8)" KMT5A PRSET7 SET07 SET8 SETD8 Homo sapiens (Human) "cell division [GO:0051301]; chromatin organization [GO:0006325]; histone H4-K20 monomethylation [GO:0034771]; mitotic chromosome condensation [GO:0007076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714]; cell division [GO:0051301]; chromatin organization [GO:0006325]; histone H4-K20 monomethylation [GO:0034771]; mitotic chromosome condensation [GO:0007076]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005700; GO:0005829; GO:0006325; GO:0006357; GO:0007076; GO:0016278; GO:0016279; GO:0018024; GO:0018026; GO:0034771; GO:0042799; GO:0043516; GO:0045892; GO:0051301; GO:1901796 histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; transcription corepressor activity [GO:0003714] GKQAPRK 0.99458 -8.4305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9834 11.1932 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8583 0 0 0 0 12.1421 0 0 0 0 0 0 0 0 17.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 0 0 0 11.5903 0 0 0 0 0 0 0 0 0 0 0 0 0 13.111 0 0 0 0 Q9UNN4 TF2AY_HUMAN "TFIIA-alpha and beta-like factor (General transcription factor II A, 1-like factor)" GTF2A1L ALF GTF2A1LF Homo sapiens (Human) cognition [GO:0050890]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; transcription factor TFIIA complex [GO:0005672] cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; transcription factor TFIIA complex [GO:0005672]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; cognition [GO:0050890]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0001673; GO:0003677; GO:0003713; GO:0005672; GO:0005737; GO:0006366; GO:0006367; GO:0050890 DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] ATEDFFR 0.99458 -8.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9413 13.0839 0 0 12.6668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPM8 AP4E1_HUMAN AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin) AP4E1 Homo sapiens (Human) protein localization [GO:0008104]; protein targeting [GO:0006605]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; cargo adaptor activity [GO:0140312]; protein localization [GO:0008104]; protein targeting [GO:0006605]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] GO:0005802; GO:0006605; GO:0006898; GO:0008104; GO:0016192; GO:0030124; GO:0031904; GO:0032588; GO:0140312 cargo adaptor activity [GO:0140312] ATVSAPTTTLK 0.99458 -8.4367 0 0 9.81566 0 0 0 0 0 16.1676 14.7074 0 12.1895 0 0 0 12.8023 12.4155 0 0 0 11.6399 0 0 0 0 0 0 15.5422 0 0 0 0 0 15.2449 0 0 0 14.8584 0 0 0 14.2833 14.7514 0 0 17.5484 0 0 15.1784 14.2152 0 0 0 0 0 0 12.8214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.585 0 12.8499 12.301 12.0629 0 0 0 13.6951 13.1456 0 0 0 14.3257 0 0 15.0628 14.0796 13.6925 0 13.5837 0 0 0 13.1712 13.1995 0 0 0 0 13.4336 13.0504 0 0 12.8673 13.1664 13.3648 0 14.3268 15.8126 14.1553 0 0 13.1667 0 0 14.5564 0 14.6689 0 0 0 0 0 13.662 0 13.9281 13.2063 13.2369 0 13.7722 15.4593 15.3887 15.4401 14.1252 14.2801 16.715 12.0594 14.4865 0 14.1936 0 13.92 0 0 0 13.855 11.8285 0 0 0 0 0 0 14.9523 0 0 0 0 0 0 0 0 0 0 0 0 14.8406 14.103 0 14.7127 0 11.8691 0 0 0 Q92953 KCNB2_HUMAN Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2) KCNB2 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; regulation of ion transmembrane transport [GO:0034765]; regulation of smooth muscle contraction [GO:0006940] GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0006940; GO:0008076; GO:0016021; GO:0030425; GO:0032809; GO:0034765; GO:0043025; GO:0043204; GO:0046982; GO:0051260; GO:0071805; GO:0072659 delayed rectifier potassium channel activity [GO:0005251]; protein heterodimerization activity [GO:0046982]; voltage-gated potassium channel activity [GO:0005249] AGESANTK 0.99459 -11.078 0 0 0 0 0 0 0 0 13.5557 15.0298 13.8008 15.5133 13.3869 15.5135 13.5659 17.8884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3294 16.3399 16.6128 14.381 12.5513 12.6607 14.6083 12.508 0 16.1978 12.4842 0 12.5354 17.4049 0 0 0 17.1535 14.6831 0 12.2045 0 0 0 13.2433 17.0199 18.19 17.9937 18.0925 17.3485 17.0539 17.9503 17.393 16.2778 15.0511 15.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.814 0 0 0 0 0 0 15.2607 14.542 0 0 13.8975 0 0 0 0 13.7063 0 0 14.4545 14.7134 0 0 0 0 0 13.1904 0 0 0 0 13.7463 0 0 14.3945 0 0 0 0 0 12.2321 14.3176 0 0 0 0 0 0 13.3192 0 0 0 14.6928 0 0 0 0 0 0 15.3627 0 18.3343 0 0 0 0 0 14.2245 19.6945 19.4665 18.8627 17.7528 17.3094 17.1667 15.2079 0 0 15.2447 0 13.2726 18.1299 17.7195 17.4782 0 0 0 0 0 0 0 14.826 16.8848 O15243 OBRG_HUMAN "Leptin receptor gene-related protein (Endospanin-1) (Leptin receptor overlapping transcript protein) (OB-R gene-related protein, OB-RGRP)" LEPROT LEPR OBR Homo sapiens (Human) late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of protein targeting to mitochondrion [GO:1903955] endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; signaling receptor binding [GO:0005102]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of protein targeting to mitochondrion [GO:1903955] GO:0000139; GO:0005102; GO:0005768; GO:0005794; GO:0010008; GO:0016021; GO:0032511; GO:0046426; GO:0060400; GO:1903955; GO:2000009 signaling receptor binding [GO:0005102] GDDFSWEQW 0.99459 -5.3602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60443 GSDME_HUMAN "Gasdermin-E (Inversely correlated with estrogen receptor expression 1, ICERE-1) (Non-syndromic hearing impairment protein 5) [Cleaved into: Gasdermin-E, N-terminal, GSDME-NT; Gasdermin-E, C-terminal, GSDME-CT ]" GSDME DFNA5 ICERE1 Homo sapiens (Human) cell death [GO:0008219]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; inner ear auditory receptor cell differentiation [GO:0042491]; necrotic cell death [GO:0070265]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of immune response to tumor cell [GO:0002839]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of MAPK cascade [GO:0043410]; pyroptosis [GO:0070269]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cardiolipin binding [GO:1901612]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; wide pore channel activity [GO:0022829]; cell death [GO:0008219]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; inner ear auditory receptor cell differentiation [GO:0042491]; necrotic cell death [GO:0070265]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of immune response to tumor cell [GO:0002839]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of MAPK cascade [GO:0043410]; pyroptosis [GO:0070269]; sensory perception of sound [GO:0007605]" GO:0002839; GO:0005546; GO:0005737; GO:0005829; GO:0005886; GO:0007605; GO:0008219; GO:0008285; GO:0016020; GO:0016021; GO:0022829; GO:0042491; GO:0043410; GO:0070265; GO:0070269; GO:0071356; GO:0098586; GO:0140507; GO:1901612; GO:2001244 "cardiolipin binding [GO:1901612]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; wide pore channel activity [GO:0022829]" AVILKDSK 0.99459 -5.3811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5405 0 0 0 0 0 13.0313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0494 0 12.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.194 0 0 0 0 0 0 14.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0334 0 0 0 0 0 0 0 0 0 14.1923 13.8769 0 0 14.3873 0 0 0 0 0 14.1934 0 0 0 0 0 0 0 0 0 0 13.8338 0 0 0 0 0 13.8763 0 14.1126 0 0 14.134 0 0 0 O60884 DNJA2_HUMAN "DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3, Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14)" DNAJA2 CPR3 HIRIP4 Homo sapiens (Human) positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; positive regulation of cell population proliferation [GO:0008284]; protein refolding [GO:0042026]; response to heat [GO:0009408] GO:0001671; GO:0005524; GO:0005737; GO:0005829; GO:0008284; GO:0009408; GO:0016020; GO:0030544; GO:0042026; GO:0046872; GO:0051082; GO:0051087; GO:0070062 ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] EAYNDSSDEESSSHHGPGVQCAHQ 0.99459 -11.416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6325 0 11.6957 0 11.2656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2965 0 0 0 12.5127 0 0 0 14.5976 0 0 0 0 0 0 0 0 13.6131 0 12.9881 0 0 0 0 0 0 0 0 0 0 0 0 10.9562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4769 0 0 0 0 0 0 0 0 0 0 10.346 0 0 0 0 0 12.9717 0 0 0 0 0 0 11.5078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2776 O75063 XYLK_HUMAN "Glycosaminoglycan xylosylkinase, EC 2.7.1.- (Xylose kinase)" FAM20B KIAA0475 Homo sapiens (Human) phosphorylation [GO:0016310]; proteoglycan biosynthetic process [GO:0030166] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; phosphorylation [GO:0016310]; proteoglycan biosynthetic process [GO:0030166]" GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016021; GO:0016301; GO:0016310; GO:0016773; GO:0030166; GO:0046872 "ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]" ALLILEGGQKVVFKPK 0.99459 -10.608 11.6424 12.1037 0 11.457 0 0 0 11.3202 11.0238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6203 12.3953 0 0 0 0 11.2994 0 0 0 13.265 0 11.4481 0 0 12.6036 0 0 0 13.493 0 11.6882 10.916 0 0 0 0 0 0 0 0 10.6316 0 0 0 0 11.7063 0 0 0 0 0 0 11.3665 0 0 0 0 0 0 0 0 0 14.2827 12.3207 12.2114 0 0 13.0446 12.3618 0 0 0 10.4065 10.4362 0 0 0 14.809 0 0 0 0 0 11.1826 14.3537 12.875 0 0 0 14.6351 14.3656 12.7319 14.6063 12.6304 0 0 0 0 0 0 14.4693 12.5228 14.0781 0 14.1987 0 14.0724 0 0 0 12.1283 13.9801 13.9255 14.6875 0 0 11.1741 12.5819 0 14.1212 0 0 0 0 0 0 11.8609 0 11.8612 13.4915 0 0 0 0 13.5955 11.9372 0 13.5404 0 0 0 0 11.6845 0 0 0 0 0 0 0 0 0 10.0676 13.3126 0 0 13.3852 0 0 0 0 0 13.1025 15.5237 13.9885 P05787 K2C8_HUMAN "Keratin, type II cytoskeletal 8 (Cytokeratin-8, CK-8) (Keratin-8, K8) (Type-II keratin Kb8)" KRT8 CYK8 Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; scaffold protein binding [GO:0097110]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005882; GO:0016363; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0045111; GO:0070062; GO:0097110 scaffold protein binding [GO:0097110]; structural constituent of skin epidermis [GO:0030280] AQYEDIANR 0.99459 -8.2083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9267 0 0 0 0 0 0 0 0 0 11.2479 0 0 0 0 0 0 0 13.0129 0 0 11.9246 0 13.126 0 0 13.0682 0 0 0 0 12.3353 0 0 0 12.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6336 14.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5289 13.7288 13.0207 13.317 0 0 0 0 13.2838 13.6739 0 0 0 0 0 0 0 13.2135 0 0 0 0 P0DPD5 ZN723_HUMAN Zinc finger protein 723 ZNF723 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFSQSSHITTHKR 0.99459 -11.102 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6797 0 0 0 0 0 0 0 0 0 13.9767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23435 CBLN1_HUMAN "Cerebellin-1 (Precerebellin) [Cleaved into: Cerebellin, CER; [des-Ser1]-cerebellin ]" CBLN1 Homo sapiens (Human) cerebellar granule cell differentiation [GO:0021707]; chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; maintenance of synapse structure [GO:0099558]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of inhibitory synapse assembly [GO:1905703]; nervous system development [GO:0007399]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] anchoring junction [GO:0070161]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083] anchoring junction [GO:0070161]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; identical protein binding [GO:0042802]; cerebellar granule cell differentiation [GO:0021707]; chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; maintenance of synapse structure [GO:0099558]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of inhibitory synapse assembly [GO:1905703]; nervous system development [GO:0007399]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] GO:0005576; GO:0005615; GO:0007157; GO:0007268; GO:0007399; GO:0007416; GO:0009306; GO:0021707; GO:0042802; GO:0043083; GO:0045202; GO:0045211; GO:0050808; GO:0051649; GO:0051965; GO:0062023; GO:0070161; GO:0090394; GO:0098688; GO:0098978; GO:0099151; GO:0099558; GO:1900454; GO:1905606; GO:1905703 identical protein binding [GO:0042802] AYLKLER 0.99459 -11.417 0 0 0 0 0 0 0 0 0 0 0 12.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2126 0 0 0 0 0 0 0 0 0 0 0 13.1009 0 0 0 0 0 12.7757 0 0 0 0 0 0 0 0 0 0 0 12.6891 12.4263 0 0 0 P38435 VKGC_HUMAN "Vitamin K-dependent gamma-carboxylase, EC 4.1.1.90 (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase)" GGCX GC Homo sapiens (Human) blood coagulation [GO:0007596]; peptidyl-glutamic acid carboxylation [GO:0017187]; protein modification process [GO:0036211] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; gamma-glutamyl carboxylase activity [GO:0008488]; vitamin binding [GO:0019842]; blood coagulation [GO:0007596]; peptidyl-glutamic acid carboxylation [GO:0017187]; protein modification process [GO:0036211] GO:0005789; GO:0007596; GO:0008488; GO:0016020; GO:0016021; GO:0017187; GO:0019842; GO:0036211 gamma-glutamyl carboxylase activity [GO:0008488]; vitamin binding [GO:0019842] DKAELISGPRQDSR 0.99459 -11.42 0 0 0 0 0 0 0 0 0 0 13.8278 0 0 0 12.8839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7485 11.8315 0 0 0 0 11.9867 0 0 0 0 13.0645 0 0 0 9.98385 0 0 0 0 0 0 0 0 0 12.4217 0 0 0 0 0 0 0 0 12.1587 0 0 0 0 13.9443 0 13.535 13.1855 12.01 0 0 0 0 0 0 12.8924 15.5851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0447 0 0 0 0 0 0 0 12.9226 0 0 0 0 0 0 0 11.207 0 0 0 0 13.0458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3081 0 0 0 0 0 0 0 13.7741 0 0 0 0 13.7121 0 P43354 NR4A2_HUMAN Nuclear receptor subfamily 4 group A member 2 (Immediate-early response protein NOT) (Orphan nuclear receptor NURR1) (Transcriptionally-inducible nuclear receptor) NR4A2 NOT NURR1 TINUR Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; canonical Wnt signaling pathway [GO:0060070]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to extracellular stimulus [GO:0031668]; cellular response to oxidative stress [GO:0034599]; central nervous system neuron differentiation [GO:0021953]; central nervous system projection neuron axonogenesis [GO:0021952]; dopamine biosynthetic process [GO:0042416]; dopaminergic neuron differentiation [GO:0071542]; fat cell differentiation [GO:0045444]; general adaptation syndrome [GO:0051866]; habenula development [GO:0021986]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of catalytic activity [GO:0043085]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of dopamine metabolic process [GO:0042053]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; adult locomotory behavior [GO:0008344]; canonical Wnt signaling pathway [GO:0060070]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to extracellular stimulus [GO:0031668]; cellular response to oxidative stress [GO:0034599]; central nervous system neuron differentiation [GO:0021953]; central nervous system projection neuron axonogenesis [GO:0021952]; dopamine biosynthetic process [GO:0042416]; dopaminergic neuron differentiation [GO:0071542]; fat cell differentiation [GO:0045444]; general adaptation syndrome [GO:0051866]; habenula development [GO:0021986]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron migration [GO:0001764]; positive regulation of catalytic activity [GO:0043085]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of dopamine metabolic process [GO:0042053]; regulation of respiratory gaseous exchange [GO:0043576]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001666; GO:0001764; GO:0001975; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006351; GO:0006357; GO:0006366; GO:0007165; GO:0008013; GO:0008270; GO:0008344; GO:0009791; GO:0016607; GO:0021952; GO:0021953; GO:0021986; GO:0031668; GO:0032991; GO:0034599; GO:0035259; GO:0042053; GO:0042416; GO:0042551; GO:0043085; GO:0043524; GO:0043576; GO:0045444; GO:0045944; GO:0046965; GO:0046982; GO:0051402; GO:0051866; GO:0060070; GO:0071376; GO:0071542; GO:1904948; GO:1990837; GO:2001234 "beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" HGLKEPKR 0.99459 -9.0061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14145 KEAP1_HUMAN "Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2, INrf2) (Kelch-like protein 19)" KEAP1 INRF2 KIAA0132 KLHL19 Homo sapiens (Human) cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511] actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654] actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; cytoplasmic sequestering of transcription factor [GO:0042994]; in utero embryonic development [GO:0001701]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0032436; GO:0034451; GO:0034599; GO:0042802; GO:0042994; GO:0043433; GO:0045604; GO:0061629; GO:0071353; GO:0097718 disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] CKDYLVK 0.99459 -8.2471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0985 0 0 0 0 0 0 0 0 0 0 14.8999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14807 KIF22_HUMAN Kinesin-like protein KIF22 (Kinesin-like DNA-binding protein) (Kinesin-like protein 4) KIF22 KID KNSL4 Homo sapiens (Human) DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; sister chromatid cohesion [GO:0007062] chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634] chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; sister chromatid cohesion [GO:0007062] GO:0000278; GO:0000776; GO:0000785; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005829; GO:0005871; GO:0005874; GO:0006281; GO:0007018; GO:0007062; GO:0007080; GO:0008017; GO:0016607; GO:0016887; GO:0051310; GO:0072686 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] DLEIERLKTK 0.99459 -8.7216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3986 0 0 0 0 0 14.7685 0 0 0 0 0 0 13.627 0 18.0881 13.4238 0 0 0 0 13.909 13.0686 0 13.753 0 0 0 0 0 0 0 13.6807 0 0 0 0 0 0 0 0 0 13.0484 0 0 0 0 0 0 0 0 0 0 0 12.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1517 16.0939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4KMZ1 IQCC_HUMAN IQ domain-containing protein C IQCC Homo sapiens (Human) KLDHKEPDCR 0.99459 -11.092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T1N1 AKND1_HUMAN Protein AKNAD1 AKNAD1 C1orf62 Homo sapiens (Human) IAPKVKIPK 0.99459 -15.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3636 0 0 0 0 0 0 0 Q5T7N3 KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 (Ankyrin repeat domain-containing protein 38) KANK4 ANKRD38 Homo sapiens (Human) negative regulation of actin filament polymerization [GO:0030837] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; negative regulation of actin filament polymerization [GO:0030837] GO:0005737; GO:0005829; GO:0005856; GO:0015630; GO:0030837 AERYKPSEEFLNACR 0.99459 -8.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5896 12.9588 0 0 0 0 0 0 10.9236 10.539 11.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2739 0 0 16.0744 0 0 0 0 13.218 0 0 0 0 0 0 0 0 0 17.0333 0 0 0 0 16.0566 0 14.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3848 10.0531 0 0 10.754 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z309 PBIR2_HUMAN PABIR family member 2 PABIR2 FAM122B Homo sapiens (Human) protein serine/threonine phosphatase inhibitor activity [GO:0004865] GO:0004865 protein serine/threonine phosphatase inhibitor activity [GO:0004865] NSTTIMSR 0.99459 -8.7191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N3V7 SYNPO_HUMAN Synaptopodin SYNPO KIAA1029 Homo sapiens (Human) modification of dendritic spine [GO:0098886]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of stress fiber assembly [GO:0051492]; spine apparatus assembly [GO:1905355] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spine apparatus [GO:0097444]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spine apparatus [GO:0097444]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; modification of dendritic spine [GO:0098886]; positive regulation of actin filament bundle assembly [GO:0032233]; regulation of stress fiber assembly [GO:0051492]; spine apparatus assembly [GO:1905355] GO:0001725; GO:0003779; GO:0005634; GO:0005829; GO:0005886; GO:0005923; GO:0014069; GO:0015629; GO:0030018; GO:0032233; GO:0043197; GO:0043204; GO:0051492; GO:0097444; GO:0098886; GO:1905355 actin binding [GO:0003779] KSMFTFVEKPK 0.99459 -8.2269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.146 0 0 0 0 0 13.9111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.117 0 0 0 0 0 12.6089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N616 TM148_HUMAN Putative uncharacterized protein encoded by LINC00311 LINC00311 NCRNA00311 TMEM148 Homo sapiens (Human) TLFWSEWARESR 0.99459 -10.584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N03 VTM2L_HUMAN V-set and transmembrane domain-containing protein 2-like protein VSTM2L C20orf102 Homo sapiens (Human) axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524] axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524] GO:0005576; GO:0005737; GO:0005886; GO:0007156; GO:0007411; GO:0030424; GO:0043524; GO:0070593; GO:0098632 cell-cell adhesion mediator activity [GO:0098632] ARHHKVK 0.99459 -8.1933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4214 0 0 0 0 0 0 0 0 0 0 Q99518 FMO2_HUMAN "Flavin-containing monooxygenase 2, EC 1.14.13.- (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2, FMO 2)" FMO2 Homo sapiens (Human) energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]" GO:0004497; GO:0004499; GO:0005789; GO:0006082; GO:0006739; GO:0006805; GO:0009404; GO:0016020; GO:0016021; GO:0046322; GO:0050660; GO:0050661; GO:0070995; GO:0072592; GO:0097009 "flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]" AKKVAVIGAGVSGLISLK 0.99459 -8.216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8792 0 0 0 0 0 0 0 0 0 14.4895 0 0 0 0 0 0 0 0 0 14.4043 0 0 14.3347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3848 13.114 0 0 0 0 0 0 0 14.3325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7498 0 0 0 0 0 0 0 Q9BT49 THAP7_HUMAN THAP domain-containing protein 7 THAP7 Homo sapiens (Human) "negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; general transcription initiation factor binding [GO:0140296]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphorylated histone binding [GO:0106153]; protein N-terminus binding [GO:0047485]; transcription corepressor binding [GO:0001222]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000785; GO:0001222; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0016607; GO:0031965; GO:0035064; GO:0035067; GO:0042393; GO:0042802; GO:0042826; GO:0043231; GO:0045892; GO:0046872; GO:0047485; GO:0070577; GO:0070742; GO:0106153; GO:0140296 C2H2 zinc finger domain binding [GO:0070742]; DNA binding [GO:0003677]; general transcription initiation factor binding [GO:0140296]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphorylated histone binding [GO:0106153]; protein N-terminus binding [GO:0047485]; transcription corepressor binding [GO:0001222] HCSAAGCCTRDTR 0.99459 -8.2028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5905 0 0 0 0 0 12.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2C2 ARV1_HUMAN "Protein ARV1, hARV1" ARV1 HT035 Homo sapiens (Human) bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular sterol transport [GO:0032366]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; sterol transporter activity [GO:0015248]; bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular sterol transport [GO:0032366]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125] GO:0005789; GO:0005794; GO:0006665; GO:0006695; GO:0008206; GO:0015248; GO:0016021; GO:0016125; GO:0030301; GO:0032366; GO:0032383; GO:0032541; GO:0090181; GO:0097036 sterol transporter activity [GO:0015248] KKPNFILLLK 0.99459 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6942 14.2723 0 0 13.8054 0 0 0 0 0 0 0 0 0 0 13.3955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6407 0 0 0 0 0 13.9066 0 0 0 0 0 0 0 0 0 13.8938 0 0 0 0 0 0 0 0 0 0 0 0 13.5018 0 0 0 0 0 0 0 13.8512 0 0 0 0 0 0 0 0 0 13.8954 0 0 0 0 0 0 0 0 0 0 12.8678 0 0 0 0 0 0 0 0 Q9NZU0 FLRT3_HUMAN Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3) FLRT3 KIAA1469 UNQ856/PRO1865 Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560] axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060] axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560] GO:0003345; GO:0005104; GO:0005615; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007411; GO:0007416; GO:0007507; GO:0008543; GO:0014069; GO:0030054; GO:0030674; GO:0031012; GO:0031175; GO:0032584; GO:0042803; GO:0043679; GO:0044295; GO:0045499; GO:0048598; GO:0048678; GO:0051965; GO:0060322; GO:0097060; GO:0098742; GO:0098978; GO:0099055; GO:0099560; GO:1990138 chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674] DHQTTGSPSRKTITITVK 0.99459 -11.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7592 0 0 0 0 0 0 0 0 0 0 10.4903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6017 12.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6907 0 0 0 0 0 12.721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.141 0 0 16.6013 0 13.2637 0 0 0 0 0 0 0 0 13.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8384 0 0 0 13.684 0 13.1057 0 0 0 0 0 0 0 0 15.0484 0 14.6959 0 0 0 12.4909 14.2712 14.0891 0 0 0 0 0 0 0 0 0 0 14.8202 0 0 Q9Y5M8 SRPRB_HUMAN "Signal recognition particle receptor subunit beta, SR-beta (Protein APMCF1)" SRPRB PSEC0230 Homo sapiens (Human) "protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785] "cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]" GO:0005525; GO:0005737; GO:0005785; GO:0005789; GO:0005881; GO:0006617; GO:0016020; GO:0016021; GO:0045047 GTP binding [GO:0005525] MASADSR 0.99459 -8.225 0 0 11.2875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3292 0 14.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9778 0 0 0 0 0 0 0 0 0 0 0 0 0 O43681 GET3_HUMAN "ATPase GET3, EC 3.6.-.- (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I)" GET3 ARSA ASNA1 TRC40 Homo sapiens (Human) post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816] GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0006620; GO:0015105; GO:0016887; GO:0043529; GO:0045048; GO:0046872; GO:0070062; GO:0071816 arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872] MCEARHK 0.9946 -5.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DJD9 PEPA5_HUMAN "Pepsin A-5, EC 3.4.23.1 (Pepsinogen-5)" PGA5 Homo sapiens (Human) digestion [GO:0007586]; proteolysis [GO:0006508] extracellular exosome [GO:0070062]; multivesicular body lumen [GO:0097486] extracellular exosome [GO:0070062]; multivesicular body lumen [GO:0097486]; aspartic-type endopeptidase activity [GO:0004190]; digestion [GO:0007586]; proteolysis [GO:0006508] GO:0004190; GO:0006508; GO:0007586; GO:0070062; GO:0097486 aspartic-type endopeptidase activity [GO:0004190] GLLKDFLK 0.9946 -5.4055 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6325 0 0 0 0 0 0 0 13.4003 13.8983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2679 0 0 0 0 0 14.1447 15.3209 14.5904 14.0827 0 0 0 0 0 0 14.7101 0 0 0 0 16.2704 15.5937 15.9978 0 14.0307 14.7796 0 16.0685 0 16.2766 0 0 14.2944 0 14.3969 0 0 15.0589 15.1176 0 14.8101 15.9115 0 0 14.3933 16.4163 0 15.8004 10.9119 0 15.0097 15.0947 0 0 0 0 14.3385 14.8557 14.7245 0 0 14.5611 14.9637 0 0 0 0 14.7715 14.3654 14.8809 14.3691 0 0 0 0 14.3293 0 0 0 14.3365 0 0 0 14.3896 0 0 14.4331 0 0 0 0 13.9569 0 0 14.2024 0 0 0 12.0976 P13807 GYS1_HUMAN "Glycogen [starch] synthase, muscle, EC 2.4.1.11" GYS1 GYS Homo sapiens (Human) glycogen biosynthetic process [GO:0005978]; heart development [GO:0007507] cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; glucose binding [GO:0005536]; glycogen (starch) synthase activity [GO:0004373]; glycogen synthase activity, transferring glucose-1-phosphate [GO:0061547]; protein kinase binding [GO:0019901]; glycogen biosynthetic process [GO:0005978]; heart development [GO:0007507]" GO:0004373; GO:0005536; GO:0005737; GO:0005829; GO:0005978; GO:0007507; GO:0016020; GO:0016234; GO:0019901; GO:0061547 "glucose binding [GO:0005536]; glycogen (starch) synthase activity [GO:0004373]; glycogen synthase activity, transferring glucose-1-phosphate [GO:0061547]; protein kinase binding [GO:0019901]" ARIQEFVR 0.9946 -9.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2546 0 0 0 0 0 0 0 0 0 0 0 13.6712 11.6701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0528 0 0 14.227 0 0 0 14.2397 0 0 0 0 0 0 0 0 0 14.2369 0 0 12.3164 14.5043 0 0 0 0 0 15.4065 0 11.4888 0 0 0 0 14.1003 11.5431 0 0 0 15.1817 14.5959 14.8456 14.7088 0 14.6031 0 0 14.6033 0 15.0456 15.9903 0 12.3492 0 14.1399 0 15.215 0 0 0 0 0 14.7025 14.8956 0 15.1113 11.2829 0 12.7575 0 0 0 0 0 13.6422 0 0 14.9184 0 0 0 10.7759 11.8846 0 0 0 12.0418 12.2498 12.9339 0 0 0 0 0 0 11.635 0 0 0 0 0 P20160 CAP7_HUMAN "Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein, HBP, hHBP)" AZU1 Homo sapiens (Human) antimicrobial humoral response [GO:0019730]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell chemotaxis [GO:0060326]; cellular extravasation [GO:0045123]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; glial cell migration [GO:0008347]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; macrophage chemotaxis [GO:0048246]; microglial cell activation [GO:0001774]; monocyte activation [GO:0042117]; negative regulation of apoptotic process [GO:0043066]; neutrophil-mediated killing of bacterium [GO:0070944]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fractalkine production [GO:0032724]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of tumor necrosis factor production [GO:0032760]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; proteolysis [GO:0006508]; regulation of vascular permeability [GO:0043114] azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231] azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; toxic substance binding [GO:0015643]; antimicrobial humoral response [GO:0019730]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell chemotaxis [GO:0060326]; cellular extravasation [GO:0045123]; defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; glial cell migration [GO:0008347]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; macrophage chemotaxis [GO:0048246]; microglial cell activation [GO:0001774]; monocyte activation [GO:0042117]; negative regulation of apoptotic process [GO:0043066]; neutrophil-mediated killing of bacterium [GO:0070944]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fractalkine production [GO:0032724]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of tumor necrosis factor production [GO:0032760]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; proteolysis [GO:0006508]; regulation of vascular permeability [GO:0043114] GO:0001774; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0006954; GO:0007205; GO:0008201; GO:0008233; GO:0008347; GO:0010628; GO:0010800; GO:0015643; GO:0019730; GO:0019898; GO:0032724; GO:0032731; GO:0032760; GO:0035577; GO:0035578; GO:0035584; GO:0042117; GO:0042582; GO:0043066; GO:0043114; GO:0043231; GO:0043395; GO:0045123; GO:0045348; GO:0045785; GO:0045860; GO:0048246; GO:0050766; GO:0050829; GO:0050930; GO:0051607; GO:0060326; GO:0070062; GO:0070528; GO:0070944 heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; toxic substance binding [GO:0015643] GPDFFTR 0.9946 -11.124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P38646 GRP75_HUMAN "Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein, GRP-75) (Heat shock 70 kDa protein 9) (Mortalin, MOT) (Peptide-binding protein 74, PBP74)" HSPA9 GRP75 HSPA9B mt-HSP70 Homo sapiens (Human) cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; intracellular protein transport [GO:0006886]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; MIB complex [GO:0140275]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; inner mitochondrial membrane organization [GO:0007007]; intracellular protein transport [GO:0006886]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646] GO:0001401; GO:0003723; GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0005925; GO:0006611; GO:0006886; GO:0007007; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0043066; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:0070062; GO:0140275; GO:0140662; GO:1902037; GO:1903707 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] DAGQISGLNVLRVINEPTAAALAYGLDKSEDK 0.9946 -11.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4594 0 0 15.4925 0 0 0 0 0 0 0 0 0 13.2628 0 0 0 0 0 0 13.4482 0 0 0 0 0 13.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5735 0 0 0 0 12.4391 0 0 0 12.2011 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3935 0 0 0 0 0 0 0 0 0 0 0 12.2562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50452 SPB8_HUMAN "Serpin B8 (Cytoplasmic antiproteinase 2, CAP-2, CAP2) (Peptidase inhibitor 8, PI-8)" SERPINB8 PI8 Homo sapiens (Human) epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0005737; GO:0005829; GO:0010951; GO:0062023; GO:0070062; GO:0090136 serine-type endopeptidase inhibitor activity [GO:0004867] CFVEVNEEGTEAAAATAVVR 0.9946 -8.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5015 0 0 0 12.4925 0 12.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4934 0 12.6192 0 0 0 11.8632 13.9388 13.8589 0 0 14.2198 13.8091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 11.6648 0 0 0 0 0 10.3622 0 0 0 14.0876 0 0 0 0 0 0 0 0 0 0 0 0 10.8728 0 0 0 0 0 0 13.3875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1003 0 0 10.4342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55064 AQP5_HUMAN "Aquaporin-5, AQP-5" AQP5 Homo sapiens (Human) camera-type eye morphogenesis [GO:0048593]; carbon dioxide transport [GO:0015670]; cellular hypotonic response [GO:0071476]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; protein homotetramerization [GO:0051289]; saliva secretion [GO:0046541]; water transport [GO:0006833] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; water channel activity [GO:0015250]; camera-type eye morphogenesis [GO:0048593]; carbon dioxide transport [GO:0015670]; cellular hypotonic response [GO:0071476]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; protein homotetramerization [GO:0051289]; saliva secretion [GO:0046541]; water transport [GO:0006833] GO:0005783; GO:0005886; GO:0005887; GO:0005902; GO:0006833; GO:0009925; GO:0015250; GO:0015670; GO:0016021; GO:0016324; GO:0030157; GO:0030659; GO:0042476; GO:0042802; GO:0046541; GO:0048593; GO:0051289; GO:0070062; GO:0071476 identical protein binding [GO:0042802]; water channel activity [GO:0015250] TMELTTR 0.9946 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56749 CLD12_HUMAN Claudin-12 CLDN12 Homo sapiens (Human) calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; maintenance of blood-brain barrier [GO:0035633] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; maintenance of blood-brain barrier [GO:0035633] GO:0005886; GO:0005923; GO:0016021; GO:0016328; GO:0016338; GO:0035633; GO:0042802 identical protein binding [GO:0042802] SSVPNIK 0.9946 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.447 0 0 0 0 0 0 0 0 0 0 19.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4278 0 0 0 0 0 12.3261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5195 0 0 0 0 0 0 0 Q03989 ARI5A_HUMAN "AT-rich interactive domain-containing protein 5A, ARID domain-containing protein 5A (Modulator recognition factor 1, MRF-1)" ARID5A MRF1 Homo sapiens (Human) "cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; chondrocyte differentiation [GO:0002062]; innate immune response [GO:0045087]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000976; GO:0002062; GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006357; GO:0008134; GO:0030331; GO:0032729; GO:0032740; GO:0032755; GO:0032760; GO:0035066; GO:0035613; GO:0042802; GO:0043565; GO:0045087; GO:0045892; GO:0045944; GO:0046965; GO:0046966; GO:0050681; GO:0071222; GO:0071391; GO:2000318; GO:2000556 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA stem-loop binding [GO:0035613]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134] EEEQEREEEQAFLVSLYKFMK 0.9946 -12.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7196 11.8255 0 0 0 0 11.5322 10.5071 0 0 0 0 0 0 0 0 12.4429 0 0 12.3605 0 0 0 0 0 0 13.8628 17.8932 14.0081 14.8575 0 0 0 0 0 0 0 0 0 11.8258 0 0 0 12.4408 13.6697 14.6207 15.8602 12.3174 12.2842 12.9043 0 13.7552 15.2167 14.166 0 12.1841 12.4351 0 0 12.5899 0 13.2088 14.0473 12.8241 13.7629 13.6608 0 14.2608 14.1738 15.3498 14.7868 15.8236 0 13.9651 16.6499 0 0 10.9169 16.7001 0 14.0515 16.6505 16.7599 15.5772 13.4057 11.7507 0 0 12.6685 0 0 11.4245 14.943 0 13.6578 0 14.3955 0 13.4818 0 0 0 14.8184 15.7939 14.9224 0 11.9696 0 0 0 0 0 0 15.4829 15.7013 13.0301 14.2693 0 0 0 0 12.0688 13.7498 13.4232 14.9795 0 13.0827 0 0 Q13303 KCAB2_HUMAN "Voltage-gated potassium channel subunit beta-2, EC 1.1.1.- (K(+) channel subunit beta-2) (Kv-beta-2, hKvbeta2)" KCNAB2 KCNA2B KCNK2 Homo sapiens (Human) NADPH oxidation [GO:0070995]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008] anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; pinceau fiber [GO:1990031]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; pinceau fiber [GO:1990031]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; synapse [GO:0045202]; tertiary granule membrane [GO:0070821]; voltage-gated potassium channel complex [GO:0008076]; aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; NADPH oxidation [GO:0070995]; regulation of action potential [GO:0098900]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of protein localization to cell surface [GO:2000008] GO:0004033; GO:0005249; GO:0005829; GO:0005856; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0031234; GO:0035579; GO:0044224; GO:0044325; GO:0045202; GO:0070161; GO:0070821; GO:0070995; GO:0098900; GO:1901379; GO:1990031; GO:2000008 aldo-keto reductase (NADP) activity [GO:0004033]; potassium channel regulator activity [GO:0015459]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] AETERGLSR 0.9946 -9.0209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13634 CAD18_HUMAN Cadherin-18 (Cadherin-14) CDH18 CDH14 Homo sapiens (Human) adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; catenin complex [GO:0016342]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis [GO:0000902]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction assembly [GO:0007043]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0000902; GO:0005509; GO:0005886; GO:0005912; GO:0007043; GO:0007156; GO:0016021; GO:0016339; GO:0016342; GO:0034332; GO:0045296; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] DNEDNTASILTR 0.9946 -5.3866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9261 0 0 0 0 0 0 0 0 13.6324 12.8237 13.2858 0 13.1728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.102 0 0 14.0203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15386 UBE3C_HUMAN "Ubiquitin-protein ligase E3C, EC 2.3.2.26 (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2, HectH2) (RTA-associated ubiquitin ligase, RAUL)" UBE3C KIAA0010 KIAA10 Homo sapiens (Human) protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] proteasome complex [GO:0000502] proteasome complex [GO:0000502]; ubiquitin protein ligase activity [GO:0061630]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0000502; GO:0006511; GO:0035519; GO:0061630; GO:0070936 ubiquitin protein ligase activity [GO:0061630] FSFEGDFK 0.9946 -11.443 0 0 0 0 0 0 0 0 0 0 0 0 10.7124 0 0 0 0 0 0 11.931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8715 13.2206 0 0 15.3477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7502 0 0 0 0 0 0 0 0 0 0 0 0 0 13.198 0 0 0 13.7619 13.8312 0 14.6438 12.7433 0 0 0 0 12.4863 12.5605 0 0 0 0 10.9562 0 0 0 0 13.4511 0 0 0 0 0 0 0 0 0 0 0 13.0904 0 13.3659 0 0 0 0 0 12.3321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7762 0 Q494R4 CC153_HUMAN Coiled-coil domain-containing protein 153 CCDC153 Homo sapiens (Human) identical protein binding [GO:0042802] GO:0042802 identical protein binding [GO:0042802] AIYAEMSR 0.9946 -9.0377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9913 0 0 0 0 0 0 0 12.9056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9302 0 0 0 0 0 0 0 14.4701 0 0 0 13.2464 12.483 0 0 0 0 0 0 0 0 12.9116 0 0 0 13.4301 0 0 0 0 13.3375 0 0 0 12.6825 0 0 12.3126 13.1307 12.4702 0 0 0 0 11.4406 0 0 0 0 0 0 0 0 12.5026 0 0 11.2464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7197 0 0 0 0 0 13.8947 12.6448 13.3619 0 0 0 0 14.0355 0 0 0 0 0 14.5231 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HYI7 MTX3_HUMAN Metaxin-3 MTX3 Homo sapiens (Human) inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]; protein transport [GO:0015031] cytoplasm [GO:0005737]; MIB complex [GO:0140275]; SAM complex [GO:0001401] cytoplasm [GO:0005737]; MIB complex [GO:0140275]; SAM complex [GO:0001401]; inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]; protein transport [GO:0015031] GO:0001401; GO:0005737; GO:0007005; GO:0007007; GO:0015031; GO:0140275 EVEAQIYR 0.9946 -12.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6421 0 0 0 0 0 0 13.4626 0 14.3378 12.3038 0 0 0 14.4004 12.4934 13.4942 0 11.2962 0 0 0 0 0 0 0 14.3958 13.5143 0 13.5417 0 13.3371 0 14.8853 0 0 0 0 0 0 0 0 0 0 0 14.0942 14.7951 0 0 13.3842 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4722 0 0 0 10.4936 13.8511 14.8701 0 14.5506 15.3051 13.3341 12.6762 0 13.5783 13.6755 0 0 0 0 14.7023 0 0 0 0 10.8243 0 0 0 13.9451 0 14.1801 0 0 0 0 0 0 0 0 0 13.2827 0 13.7766 0 12.925 0 0 0 0 Q5SZJ8 BEND6_HUMAN BEN domain-containing protein 6 BEND6 C6orf65 Homo sapiens (Human) negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] nucleus [GO:0005634] nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666] GO:0003677; GO:0003682; GO:0003714; GO:0005634; GO:0007399; GO:0045666; GO:0045746 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714] CNKSKPQK 0.9946 -5.3814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.47713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8813 0 0 0 0 0 0 0 0 11.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8822 11.4999 0 11.0156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1533 0 0 0 0 0 12.3589 0 11.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T440 CAF17_HUMAN "Putative transferase CAF17, mitochondrial, EC 2.1.-.- (Iron-sulfur cluster assembly factor homolog)" IBA57 C1orf69 Homo sapiens (Human) heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; heme biosynthetic process [GO:0006783]; iron-sulfur cluster assembly [GO:0016226] GO:0003723; GO:0005739; GO:0005759; GO:0006783; GO:0016226; GO:0016740 RNA binding [GO:0003723]; transferase activity [GO:0016740] AGQGNVGLALLWSEKIKGPLHIR 0.9946 -11.115 0 0 11.5753 0 0 0 11.4237 0 0 0 0 0 0 0 0 11.3914 0 0 0 0 10.5379 0 0 0 0 0 0 0 0 0 11.5438 0 10.834 0 0 0 0 0 0 0 0 0 0 0 11.6547 0 0 0 0 0 0 10.4678 12.0585 11.9731 0 0 0 0 0 0 0 0 0 0 0 0 16.4652 15.871 17.1297 16.0829 17.0504 17.5207 16.1994 17.333 18.054 14.7103 15.8274 14.3912 0 17.308 0 15.0797 0 0 0 17.455 0 0 14.2186 0 0 0 0 0 0 0 0 0 13.3437 0 14.8652 14.4737 13.4246 0 0 13.6246 0 13.6486 0 12.3219 13.6816 0 0 0 15.1173 0 0 14.7115 0 13.6051 0 13.5089 0 15.3585 14.8569 13.7928 14.4251 13.9242 16.7338 0 14.5442 13.4612 14.259 0 14.933 0 0 13.5934 13.9028 14.6784 15.4792 14.5233 14.5028 13.3644 14.0109 13.1005 14.212 0 0 0 13.1336 14.0577 14.7371 13.3945 0 14.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7071 0 13.4489 13.5016 0 0 0 14.1896 0 Q5VV43 K0319_HUMAN Dyslexia-associated protein KIAA0319 KIAA0319 Homo sapiens (Human) multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; multicellular organismal response to stress [GO:0033555]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in regeneration [GO:0048692]; negative regulation of dendrite development [GO:2000171]; neuron migration [GO:0001764]; positive regulation of SMAD protein signal transduction [GO:0060391]; response to auditory stimulus [GO:0010996] GO:0001764; GO:0005769; GO:0005886; GO:0010996; GO:0016020; GO:0016021; GO:0030517; GO:0030669; GO:0031410; GO:0031901; GO:0033555; GO:0043231; GO:0048692; GO:0060391; GO:2000171 CICSHLWMENLIQR 0.9946 -12.685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6324 0 0 0 0 0 0 10.7808 0 0 0 0 0 0 0 0 0 0 11.2852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3754 0 0 0 0 0 0 0 0 0 0 15.1063 0 0 14.0007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VW36 FOCAD_HUMAN Focadhesin FOCAD KIAA1797 Homo sapiens (Human) regulation of post-transcriptional gene silencing [GO:0060147] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021] focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; regulation of post-transcriptional gene silencing [GO:0060147] GO:0005925; GO:0016021; GO:0060147 AASPLGSPELCPSALHGLSQAMKLPSPAHHLWSLLSEATGK 0.9946 -15.374 0 0 0 0 0 0 0 0 0 11.2713 0 0 0 0 12.7095 0 0 0 10.2269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1879 0 0 0 0 0 0 0 0 0 0 13.4311 0 0 0 10.4932 0 10.5822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3827 0 12.7041 0 0 12.5349 12.7269 0 0 0 0 13.2474 0 14.4317 11.2176 14.7903 13.6247 14.1324 12.9235 17.0112 0 0 0 0 12.5864 0 13.701 11.2835 0 16.0219 0 0 11.4734 0 13.926 0 0 0 0 14.6782 0 0 0 0 0 13.8638 0 15.4679 0 14.088 0 0 0 11.4099 14.775 0 12.9964 0 12.6506 14.3073 0 12.7695 13.5469 0 0 0 13.4885 0 0 0 0 12.3742 12.8931 0 0 0 11.032 0 0 0 0 11.5002 15.3938 0 0 0 10.0189 0 13.2629 16.9636 0 12.4658 0 0 0 0 0 0 15.4606 0 14.2072 0 0 0 0 11.377 0 0 0 0 0 13.6255 10.9952 Q7RTT5 SSX7_HUMAN Protein SSX7 SSX7 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 HAWTHRLRER 0.9946 -11.473 0 0 0 0 0 0 0 0 0 13.2111 0 0 0 0 0 0 0 12.4997 0 0 0 0 0 0 0 0 0 12.401 0 0 12.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1132 0 0 0 0 0 0 0 0 0 0 0 13.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WU2 LDHD_HUMAN "Probable D-lactate dehydrogenase, mitochondrial, DLD, Lactate dehydrogenase D, EC 1.1.2.4" LDHD Homo sapiens (Human) lactate catabolic process [GO:1903457] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457] GO:0004458; GO:0005739; GO:0005743; GO:0008720; GO:0050660; GO:0071949; GO:1903457 D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660] AVVGGSHVSTAAVVR 0.9946 -11.47 0 0 0 11.7229 0 0 0 0 0 0 0 0 0 0 0 0 0 12.209 0 0 0 0 0 0 0 11.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9842 0 12.1007 15.1555 0 0 10.3621 14.185 19.6106 0 16.2403 0 11.2251 11.621 0 18.6452 0 0 15.5676 15.5747 15.392 18.9149 0 18.8185 16.2231 0 0 0 0 18.1666 0 0 0 15.5144 18.4303 18.4036 19.3508 19.4467 0 0 0 0 0 0 0 18.8519 18.7974 18.7706 0 0 0 0 0 0 0 0 11.9793 0 0 0 0 0 0 17.9634 0 0 0 13.9987 0 0 18.4569 0 0 0 0 0 0 0 18.3264 10.7711 0 0 0 0 14.3399 0 0 13.7311 0 0 0 0 14.2881 18.3335 0 18.2923 0 0 0 0 0 0 Q8IU81 I2BP1_HUMAN "Interferon regulatory factor 2-binding protein 1, IRF-2-binding protein 1, IRF-2BP1 (Probable E3 ubiquitin-protein ligase IRF2BP1, EC 2.3.2.27) (Probable RING-type E3 ubiquitin transferase IRF2BP1)" IRF2BP1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0000209; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630] AEEWHGR 0.9946 -11.442 0 0 10.7489 0 0 0 0 0 0 13.478 13.7701 0 0 0 14.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2483 11.4491 0 0 0 0 0 0 0 10.7541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5965 0 0 0 0 0 0 0 13.1563 0 12.7646 0 0 0 0 0 0 11.5238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4612 Q8TB96 TIP_HUMAN "T-cell immunomodulatory protein, Protein TIP (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin)" ITFG1 LNKN-1 TIP CDA08 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021; GO:0070062 STIYLVR 0.9946 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DR5 BPIA2_HUMAN "BPI fold-containing family A member 2 (Parotid secretory protein, PSP) (Short palate, lung and nasal epithelium carcinoma-associated protein 2)" BPIFA2 C20orf70 SPLUNC2 UNQ510/PRO1025 Homo sapiens (Human) defense response to bacterium [GO:0042742] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; lipopolysaccharide binding [GO:0001530]; defense response to bacterium [GO:0042742] GO:0001530; GO:0005576; GO:0005615; GO:0030141; GO:0042742; GO:0070062 lipopolysaccharide binding [GO:0001530] EICPLIR 0.9946 -8.5086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRN9 TM2D3_HUMAN "TM2 domain-containing protein 3 (Beta-amyloid-binding protein-like protein 2, BBP-like protein 2)" TM2D3 BLP2 Homo sapiens (Human) lateral inhibition [GO:0046331]; positive regulation of Notch signaling pathway [GO:0045747] spanning component of plasma membrane [GO:0044214] spanning component of plasma membrane [GO:0044214]; lateral inhibition [GO:0046331]; positive regulation of Notch signaling pathway [GO:0045747] GO:0044214; GO:0045747; GO:0046331 MAGGVLPLR 0.9946 -5.3954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0641 0 0 0 0 0 0 0 0 Q9BY42 RTF2_HUMAN "Replication termination factor 2, RTF2 (Replication termination factor 2 domain-containing protein 1)" RTF2 C20orf43 RTFDC1 AD-007 CDA05 HSPC164 HSPC169 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752] nucleus [GO:0005634]; replication fork [GO:0005657] nucleus [GO:0005634]; replication fork [GO:0005657]; DNA binding [GO:0003677]; cellular response to hydroxyurea [GO:0072711]; mitotic DNA replication termination [GO:1902979]; regulation of DNA stability [GO:0097752] GO:0003677; GO:0005634; GO:0005657; GO:0072711; GO:0097752; GO:1902979 DNA binding [GO:0003677] PDVSEEAPGPSK 0.9946 -9.0204 0 0 0 0 0 0 0 0 0 0 0 11.9837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7465 0 0 0 0 0 0 0 0 10.5852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6067 10.0025 0 0 11.168 0 0 0 0 0 0 0 0 0 11.8554 0 0 0 12.1977 0 0 0 0 0 12.6805 0 0 0 0 0 12.4947 13.1065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9537 0 0 0 0 0 0 12.7689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1018 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6043 0 0 0 11.5676 0 0 Q9Y375 CIA30_HUMAN "Complex I intermediate-associated protein 30, mitochondrial (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1)" NDUFAF1 CIA30 CGI-65 Homo sapiens (Human) "chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; NADH dehydrogenase complex assembly [GO:0010257]; protein-containing complex assembly [GO:0065003]" cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; NADH dehydrogenase complex assembly [GO:0010257]; protein-containing complex assembly [GO:0065003]" GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0005829; GO:0006120; GO:0010257; GO:0032981; GO:0051082; GO:0051131; GO:0065003 unfolded protein binding [GO:0051082] AIRDEAIYHFRLLK 0.9946 -15.332 0 0 0 0 0 0 0 10.9813 0 0 0 13.6157 0 0 0 12.9309 15.9805 15.758 15.9055 0 15.9694 0 16.11 0 16.0589 0 16.2902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2326 0 0 0 0 0 0 15.9563 15.9414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6259 0 0 0 12.1616 13.3902 14.3332 0 13.4324 0 0 0 0 0 0 0 0 18.0491 12.2963 0 0 0 18.2093 18.3059 0 0 0 0 13.8448 0 15.9652 0 0 0 17.7792 17.7807 0 13.3461 13.0009 17.8804 0 0 0 0 17.5979 0 0 0 0 0 0 17.466 0 0 0 13.6317 13.2195 0 0 13.716 0 12.7994 17.1424 17.0258 0 0 0 0 0 0 12.6473 0 0 0 0 0 0 0 0 0 0 0 13.5919 12.3106 12.5604 0 12.3353 13.4531 0 0 0 0 13.9223 12.7237 0 0 11.7348 0 0 0 0 0 12.7329 0 0 0 0 Q9Y5S1 TRPV2_HUMAN "Transient receptor potential cation channel subfamily V member 2, TrpV2 (Osm-9-like TRP channel 2, OTRPC2) (Vanilloid receptor-like protein 1, VRL-1)" TRPV2 VRL Homo sapiens (Human) calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; positive regulation of axon extension [GO:0045773]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to heat [GO:0009408]; response to temperature stimulus [GO:0009266]; sensory perception [GO:0007600] axonal growth cone [GO:0044295]; cell body [GO:0044297]; cell surface [GO:0009986]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; plasma membrane [GO:0005886] axonal growth cone [GO:0044295]; cell body [GO:0044297]; cell surface [GO:0009986]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ion transmembrane transporter activity [GO:0015075]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; positive regulation of axon extension [GO:0045773]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to heat [GO:0009408]; response to temperature stimulus [GO:0009266]; sensory perception [GO:0007600] GO:0005216; GO:0005261; GO:0005262; GO:0005886; GO:0005887; GO:0007600; GO:0009266; GO:0009408; GO:0009986; GO:0015075; GO:0032584; GO:0042470; GO:0044295; GO:0044297; GO:0045773; GO:0070588; GO:0090280; GO:0098703; GO:0120162 calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; ion channel activity [GO:0005216]; ion transmembrane transporter activity [GO:0015075] DRLFNAVSR 0.9946 -12.681 0 0 0 0 0 0 0 0 0 0 0 13.0012 0 0 0 0 10.8418 0 0 0 0 12.6694 0 10.715 0 0 0 0 0 0 13.1542 0 0 12.861 0 0 0 13.8793 0 13.7217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2115 0 14.0192 0 14.7951 0 0 0 9.71086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4638 0 0 0 14.8365 13.6094 13.4631 0 15.0782 0 0 0 0 0 14.4387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8033 0 0 10.5529 12.0684 0 0 0 0 0 0 0 13.9201 14.2399 0 0 0 0 0 0 0 0 0 14.0388 13.2562 0 14.8876 0 0 13.5908 0 0 0 0 0 0 0 10.4042 0 0 0 12.7501 0 A8MZA4 GG6L6_HUMAN Golgin subfamily A member 6-like protein 6 GOLGA6L6 Homo sapiens (Human) EEEKMHEQEK 0.99461 -36.033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2995 0 0 0 0 0 0 0 14.2303 13.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6639 0 0 0 16.1016 0 0 0 0 0 0 13.009 0 0 0 0 0 0 0 0 0 0 12.8922 0 0 0 0 0 0 12.6046 12.8978 0 0 0 0 9.96557 12.6118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.38 0 0 17.6958 16.1599 0 0 0 0 0 0 0 0 0 0 0 0 12.3429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P38606 VATA_HUMAN "V-type proton ATPase catalytic subunit A, V-ATPase subunit A, EC 7.1.2.2 (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha)" ATP6V1A ATP6A1 ATP6V1A1 VPP2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]" "apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule [GO:0030141]; transport vesicle [GO:0030133]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; Golgi lumen acidification [GO:0061795]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" GO:0000139; GO:0000221; GO:0005524; GO:0005654; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0006879; GO:0007035; GO:0007042; GO:0010008; GO:0016020; GO:0016241; GO:0016324; GO:0016469; GO:0030133; GO:0030141; GO:0030665; GO:0033176; GO:0036295; GO:0043231; GO:0046933; GO:0046961; GO:0048388; GO:0051452; GO:0061795; GO:0070062; GO:1902600 "ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" ASLAETDKITLEVAKLIK 0.99461 -8.5611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8395 0 14.3686 13.764 0 16.0835 16.6318 0 0 13.4227 12.8952 0 0 0 0 0 0 0 12.6768 0 14.7893 0 0 Q70JA7 CHSS3_HUMAN "Chondroitin sulfate synthase 3, EC 2.4.1.175, EC 2.4.1.226 (Carbohydrate synthase 2) (Chondroitin glucuronyltransferase 3) (Chondroitin synthase 2, ChSy-2) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3) (N-acetylgalactosaminyltransferase 3)" CHSY3 CHSY2 CSS3 Homo sapiens (Human) chondroitin sulfate biosynthetic process [GO:0030206] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; chondroitin sulfate biosynthetic process [GO:0030206] GO:0000139; GO:0008376; GO:0016021; GO:0030206; GO:0032580; GO:0046872; GO:0047238; GO:0050510 acetylgalactosaminyltransferase activity [GO:0008376]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510] EIQYGYR 0.99461 -15.482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5059 0 0 0 0 0 0 0 0 0 0 0 9.99251 0 0 0 0 0 0 10.7618 0 0 0 0 13.4547 0 0 0 12.7321 0 0 0 0 0 14.8959 0 13.222 0 0 14.3446 0 0 0 0 0 0 0 0 0 0 0 0 11.3385 0 0 0 12.8854 0 0 0 0 13.0798 0 0 0 0 0 14.8441 0 0 10.3492 0 0 0 0 0 13.2915 0 0 0 0 0 0 0 0 10.9975 0 0 0 0 0 14.0521 0 11.9267 0 0 0 0 0 0 0 11.0526 0 0 0 0 0 0 0 0 0 0 0 0 13.3589 13.0104 0 0 13.5439 0 0 0 0 0 10.7474 0 0 0 0 10.7587 0 Q8NEG5 ZSWM2_HUMAN "E3 ubiquitin-protein ligase ZSWIM2, EC 2.3.2.27 (MEKK1-related protein X, MEX) (RING-type E3 ubiquitin transferase ZSWIM2) (ZZ-type zinc finger-containing protein 2) (Zinc finger SWIM domain-containing protein 2)" ZSWIM2 ZZZ2 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; protein polyubiquitination [GO:0000209] protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0006915; GO:0008270; GO:0043621; GO:0061630; GO:1902043 protein self-association [GO:0043621]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CSHLSRQPVSHSVNTKSTELSLIIEGVQL 0.99461 -15.482 0 0 0 0 0 0 0 0 0 0 0 12.7751 11.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3086 10.9693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4014 0 0 0 0 0 0 0 0 0 0 13.2275 0 0 0 0 0 0 0 13.0753 0 13.2747 0 0 0 0 0 0 0 0 0 13.3219 0 0 0 13.2313 0 0 0 12.4795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9095 Q8WW18 CQ050_HUMAN Uncharacterized protein C17orf50 C17orf50 Homo sapiens (Human) AGAAGNS 0.99461 -8.8235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93038 TNR25_HUMAN "Tumor necrosis factor receptor superfamily member 25 (Apo-3) (Apoptosis-inducing receptor AIR) (Apoptosis-mediating receptor DR3) (Apoptosis-mediating receptor TRAMP) (Death receptor 3) (Lymphocyte-associated receptor of death, LARD) (Protein WSL) (Protein WSL-1)" TNFRSF25 APO3 DDR3 DR3 TNFRSF12 WSL WSL1 UNQ455/PRO779 Homo sapiens (Human) apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165] GO:0005031; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0006915; GO:0007165; GO:0007166; GO:0038023; GO:0042981; GO:0097190 signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031] AQGGTRSPR 0.99461 -8.5633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2214 0 13.015 0 0 0 0 0 0 0 14.0527 14.3094 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4729 14.123 16.3002 15.2488 0 0 0 0 0 13.8401 0 0 14.0883 0 0 0 0 14.3358 13.9091 0 14.2072 14.384 0 0 0 14.5509 14.3144 0 14.3082 13.8733 14.0887 14.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6383 0 0 0 0 0 0 0 0 Q9NPG3 UBN1_HUMAN Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein) UBN1 Homo sapiens (Human) DNA replication-independent chromatin assembly [GO:0006336] bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605] bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; DNA replication-independent chromatin assembly [GO:0006336] GO:0003677; GO:0005634; GO:0005654; GO:0005923; GO:0006336; GO:0016604; GO:0016605; GO:0034451 DNA binding [GO:0003677] FQWNDEIRELLCQVVKIK 0.99461 -8.8228 12.7451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2524 11.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3867 0 0 0 0 0 0 0 0 0 0 0 13.8401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0802 0 0 0 0 0 0 11.8683 0 0 0 0 0 0 11.879 0 0 13.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2953 13.0481 0 0 13.3123 0 19.876 0 13.4285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9828 11.0849 0 0 0 0 0 A0A1W2PR82 PERC1_HUMAN Protein PERCC1 (Proline and glutamage-rich protein with a coiled coil domain) PERCC1 Homo sapiens (Human) digestive tract morphogenesis [GO:0048546]; enteroendocrine cell differentiation [GO:0035883] digestive tract morphogenesis [GO:0048546]; enteroendocrine cell differentiation [GO:0035883] GO:0035883; GO:0048546 GQDPDACDVYADSR 0.99462 -10.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.02 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6621 A6NI79 CCD69_HUMAN Coiled-coil domain-containing protein 69 CCDC69 Homo sapiens (Human) spindle midzone assembly [GO:0051255] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233] cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; microtubule binding [GO:0008017]; spindle midzone assembly [GO:0051255] GO:0005634; GO:0005737; GO:0008017; GO:0030496; GO:0051233; GO:0051255 microtubule binding [GO:0008017] EKNLILEEK 0.99462 -13.695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4492 0 16.2797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15146 MUSK_HUMAN "Muscle, skeletal receptor tyrosine-protein kinase, EC 2.7.10.1 (Muscle-specific tyrosine-protein kinase receptor, MuSK, Muscle-specific kinase receptor)" MUSK Homo sapiens (Human) cell differentiation [GO:0030154]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235] anchoring junction [GO:0070161]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell differentiation [GO:0030154]; memory [GO:0007613]; neuromuscular junction development [GO:0007528]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein geranylgeranylation [GO:2000541]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001934; GO:0004713; GO:0004714; GO:0005518; GO:0005524; GO:0005887; GO:0007169; GO:0007528; GO:0007613; GO:0008582; GO:0010628; GO:0030154; GO:0031594; GO:0033674; GO:0038062; GO:0043235; GO:0045211; GO:0046777; GO:0046872; GO:0070161; GO:0071340; GO:2000541 ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] AEGTVSV 0.99462 -10.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.365 0 10.9873 0 0 0 15.0154 0 13.4127 14.5605 13.4531 0 0 0 15.3799 0 0 0 0 15.1129 0 0 0 0 10.2632 0 0 15.3404 0 13.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1251 0 12.2705 0 0 15.45 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43699 SIGL6_HUMAN "Sialic acid-binding Ig-like lectin 6, Siglec-6 (CD33 antigen-like 1) (CDw327) (Obesity-binding protein 1, OB-BP1) (CD antigen CD327)" SIGLEC6 CD33L CD33L1 OBBP1 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267] GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007267; GO:0016020; GO:0030246; GO:0033691 carbohydrate binding [GO:0030246]; sialic acid binding [GO:0033691] DNAAYFFRLKSK 0.99462 -13.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75074 LRP3_HUMAN "Low-density lipoprotein receptor-related protein 3, LRP-3 (105 kDa low-density lipoprotein receptor-related protein, hLRp105)" LRP3 Homo sapiens (Human) negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898]; transport across blood-brain barrier [GO:0150104] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898]; transport across blood-brain barrier [GO:0150104] GO:0005886; GO:0005905; GO:0006898; GO:0010628; GO:0010629; GO:0016021; GO:0045599; GO:0045669; GO:0150104 ARSAGHGFNATYQVK 0.99462 -8.5983 0 0 0 0 0 0 0 0 0 0 0 10.8677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2539 0 0 0 13.2174 12.8909 0 13.0729 0 13.173 0 0 0 0 0 12.1903 11.7743 0 0 14.5877 15.3888 0 0 0 13.3994 0 0 0 0 14.9665 0 0 0 0 0 0 14.5448 11.6325 0 0 10.9955 0 0 0 0 0 0 14.9055 0 0 13.9663 14.0902 14.5736 0 0 0 14.3546 13.2988 0 0 0 14.9232 0 13.9395 0 0 12.9212 0 0 14.8278 0 14.7646 0 0 0 17.5208 0 0 13.6026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5253 0 0 13.5948 0 13.1727 12.9076 0 0 15.1623 0 10.2167 0 0 0 0 0 O75155 CAND2_HUMAN "Cullin-associated NEDD8-dissociated protein 2 (Cullin-associated and neddylation-dissociated protein 2) (Epididymis tissue protein Li 169) (TBP-interacting protein of 120 kDa B, TBP-interacting protein 120B) (p120 CAND2)" CAND2 KIAA0667 TIP120B Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]" cytosol [GO:0005829]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleus [GO:0005634]; TBP-class protein binding [GO:0017025]; positive regulation of transcription, DNA-templated [GO:0045893]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]" GO:0005634; GO:0005829; GO:0010265; GO:0016567; GO:0017025; GO:0045893 TBP-class protein binding [GO:0017025] ATDLDQEVK 0.99462 -13.64 0 0 0 0 0 10.7074 0 0 0 0 0 0 0 0 0 11.5492 0 0 0 0 10.67 0 0 0 0 0 0 0 0 0 0 0 15.923 0 0 0 0 11.1964 0 0 0 0 0 0 0 0 0 0 0 0 14.3851 0 0 0 0 0 0 0 0 0 0 0 0 10.5679 0 0 0 0 0 0 0 0 0 0 0 0 13.5867 0 13.1355 0 0 0 0 0 0 13.471 0 0 0 0 12.6672 0 14.0433 0 12.5987 12.807 12.2978 0 0 0 0 13.734 11.983 0 0 12.6831 0 0 0 0 0 13.2661 13.5184 13.9633 0 13.8165 0 0 0 0 0 10.6794 14.2532 0 0 14.1799 0 0 0 0 0 0 13.7553 13.7838 0 16.5409 0 0 0 0 0 0 0 0 0 12.262 13.9988 0 0 0 11.7507 11.0829 12.4331 0 0 14.843 0 0 0 0 0 0 0 0 0 0 0 0 11.6771 0 0 0 0 13.1481 13.8113 0 0 0 0 11.7449 P11182 ODB2_HUMAN "Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial, EC 2.3.1.168 (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2, BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2, BCKAD-E2, BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)" DBT BCATE2 Homo sapiens (Human) branched-chain amino acid catabolic process [GO:0009083] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]; branched-chain amino acid catabolic process [GO:0009083] GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0005947; GO:0009083; GO:0015630; GO:0016407; GO:0031405; GO:0031625; GO:0042645; GO:0043754 acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625] AIPRFNQK 0.99462 -13.674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2415 0 0 0 0 0 0 13.5836 13.2257 13.5053 14.1913 0 13.5804 0 0 0 0 0 0 0 0 0 0 0 0 P17936 IBP3_HUMAN "Insulin-like growth factor-binding protein 3, IBP-3, IGF-binding protein 3, IGFBP-3" IGFBP3 IBP3 Homo sapiens (Human) apoptotic process [GO:0006915]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast differentiation [GO:0045663]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; type B pancreatic cell proliferation [GO:0044342] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; nucleus [GO:0005634] endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; nucleus [GO:0005634]; fibronectin binding [GO:0001968]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activator activity [GO:0008160]; apoptotic process [GO:0006915]; MAPK cascade [GO:0000165]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of signal transduction [GO:0009968]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of smooth muscle cell proliferation [GO:0048662]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast differentiation [GO:0045663]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of glucose metabolic process [GO:0010906]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; type B pancreatic cell proliferation [GO:0044342] GO:0000165; GO:0001558; GO:0001649; GO:0001933; GO:0001968; GO:0005520; GO:0005576; GO:0005615; GO:0005634; GO:0005788; GO:0006468; GO:0006915; GO:0008160; GO:0008285; GO:0009968; GO:0010906; GO:0014912; GO:0016942; GO:0031994; GO:0031995; GO:0042567; GO:0043065; GO:0043410; GO:0043567; GO:0043568; GO:0044342; GO:0045663; GO:0046872; GO:0048662 fibronectin binding [GO:0001968]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activator activity [GO:0008160] ARPTLWAAALTLLVLLR 0.99462 -8.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4884 0 0 0 13.0735 0 0 0 0 0 11.5452 0 0 0 0 0 0 0 0 10.9603 0 13.4721 0 0 0 13.7364 0 0 0 0 0 12.505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.47952 0 0 0 0 0 12.9732 0 0 0 0 0 0 0 0 0 0 0 0 0 12.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21399 ACOHC_HUMAN "Cytoplasmic aconitate hydratase, Aconitase, EC 4.2.1.3 (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1, IRP1) (Iron-responsive element-binding protein 1, IRE-BP 1)" ACO1 IREB1 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099]" GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006879; GO:0009791; GO:0010040; GO:0030350; GO:0046872; GO:0047780; GO:0050892; GO:0051538; GO:0051539; GO:0070062 "3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; citrate dehydratase activity [GO:0047780]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]" AVLAESYERIHR 0.99462 -10.916 0 0 13.2186 0 0 0 0 0 0 0 0 11.9268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9648 0 0 0 0 0 0 0 0 0 0 0 0 14.5559 0 0 11.6717 0 0 0 0 0 0 0 11.3411 0 0 0 13.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4296 0 0 0 0 0 0 0 0 0 16.1559 0 0 13.7745 0 0 0 0 14.1851 0 0 0 0 0 0 0 0 0 0 0 0 17.3268 0 0 0 0 0 P51826 AFF3_HUMAN "AF4/FMR2 family member 3 (Lymphoid nuclear protein related to AF4, Protein LAF-4)" AFF3 LAF4 Homo sapiens (Human) embryonic hindlimb morphogenesis [GO:0035116]; regulation of gene expression [GO:0010468]; response to tumor necrosis factor [GO:0034612] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; super elongation complex [GO:0032783] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; super elongation complex [GO:0032783]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; embryonic hindlimb morphogenesis [GO:0035116]; regulation of gene expression [GO:0010468]; response to tumor necrosis factor [GO:0034612] GO:0003690; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0010468; GO:0016604; GO:0032783; GO:0034612; GO:0035116 DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690] CDNEDDYR 0.99462 -13.652 0 0 0 0 0 0 0 0 0 14.4493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9831 0 0 0 0 0 0 12.312 0 0 14.7138 0 0 0 15.4509 11.3245 0 0 0 0 13.0114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.278 0 0 0 0 0 0 0 0 0 0 13.4819 0 0 17.9193 0 0 0 0 0 0 0 0 0 0 13.7646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3425 0 0 0 0 0 0 0 13.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2383 0 0 0 0 0 0 0 0 0 0 14.1652 0 P55040 GEM_HUMAN GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR) GEM KIR Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165] cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233] cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165] GO:0000278; GO:0000287; GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005634; GO:0005886; GO:0006955; GO:0007165; GO:0007166; GO:0009898; GO:0019003; GO:0030496; GO:0051233; GO:0051276; GO:0051310; GO:0072686; GO:1901842 calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287] EPHQYSHRNRHSATPEDHCR 0.99462 -8.5785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0206 13.1877 0 13.1171 13.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5556 14.2728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16543 CDC37_HUMAN "Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed ]" CDC37 CDC37A Homo sapiens (Human) positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; post-transcriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of type I interferon-mediated signaling pathway [GO:0060338] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; HSP90-CDC37 chaperone complex [GO:1990565] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; HSP90-CDC37 chaperone complex [GO:1990565]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; post-transcriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of interferon-gamma-mediated signaling pathway [GO:0060334]; regulation of type I interferon-mediated signaling pathway [GO:0060338] GO:0000079; GO:0005737; GO:0005829; GO:0006457; GO:0006605; GO:0010608; GO:0019887; GO:0019900; GO:0019901; GO:0031072; GO:0050821; GO:0051082; GO:0051087; GO:0051879; GO:0060334; GO:0060338; GO:0070062; GO:0097110; GO:0098779; GO:0101031; GO:1990565 chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082] ASEAKEGEEAGPGDPLLEAVPK 0.99462 -13.638 18.6045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0746 0 0 0 0 0 0 0 0 0 0 0 14.864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JT25 RAB41_HUMAN Ras-related protein Rab-41 RAB41 Homo sapiens (Human) "intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0003924; GO:0005525; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0042147; GO:0043231 GTP binding [GO:0005525]; GTPase activity [GO:0003924] QVTAEQGEEKSR 0.99462 -10.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1157 0 0 0 0 0 0 0 0 0 0 0 15.4269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6046 0 0 0 0 0 0 12.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NE01 CNNM3_HUMAN Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3) CNNM3 ACDP3 Homo sapiens (Human) ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811]; magnesium ion homeostasis [GO:0010960] GO:0005886; GO:0006811; GO:0010960; GO:0016020; GO:0016021; GO:0022857; GO:0043231 transmembrane transporter activity [GO:0022857] ALGLSRLAVLLTLPVALPVGQLLELAAR 0.99462 -8.3446 0 0 0 0 0 0 11.465 0 0 0 0 0 0 0 0 0 11.0088 0 12.1456 0 0 13.0202 0 13.0674 0 0 0 0 0 0 0 0 12.7018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8682 0 0 0 0 12.71 12.7613 0 0 0 0 14.232 0 0 0 0 0 0 12.5647 13.1807 0 0 11.6091 0 0 0 0 0 0 14.3659 16.4553 0 0 0 0 0 0 12.1705 0 0 0 0 0 0 0 13.48 13.7948 12.3855 0 11.6401 16.4773 0 0 0 0 14.6318 0 12.9057 0 0 0 0 0 11.5899 0 13.4236 0 0 0 11.6731 13.5964 12.3009 0 0 0 0 0 0 0 0 0 16.2144 0 0 0 14.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5934 12.8259 0 0 0 0 14.112 Q8NGN1 OR6T1_HUMAN Olfactory receptor 6T1 (Olfactory receptor OR11-277) OR6T1 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004984; GO:0004993; GO:0005887; GO:0007187; GO:0007268; GO:0030425; GO:0030594; GO:0045202 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; olfactory receptor activity [GO:0004984] EALGWPR 0.99462 -8.3486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8759 0 0 0 0 13.492 13.5978 0 0 0 0 0 0 13.6214 0 0 0 14.4721 0 0 0 15.2907 0 0 0 0 10.6667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9948 0 0 0 0 0 0 0 0 0 13.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PU4 UHRF2_HUMAN "E3 ubiquitin-protein ligase UHRF2, EC 2.3.2.27 (Np95/ICBP90-like RING finger protein, Np95-like RING finger protein) (Nuclear protein 97) (Nuclear zinc finger protein Np97) (RING finger protein 107) (RING-type E3 ubiquitin transferase UHRF2) (Ubiquitin-like PHD and RING finger domain-containing protein 2) (Ubiquitin-like-containing PHD and RING finger domains protein 2)" UHRF2 NIRF RNF107 Homo sapiens (Human) cell cycle [GO:0007049]; cell differentiation [GO:0030154]; maintenance of DNA methylation [GO:0010216]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726] heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721] heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; maintenance of DNA methylation [GO:0010216]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726] GO:0000792; GO:0003677; GO:0004842; GO:0005634; GO:0005654; GO:0005721; GO:0007049; GO:0010216; GO:0016567; GO:0019789; GO:0030154; GO:0042393; GO:0046872; GO:0051726; GO:0051865; GO:0061629; GO:0061630 DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AGKPVRVIR 0.99462 -10.937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6611 0 0 12.8551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4077 0 0 0 0 0 0 0 11.9139 0 0 0 0 0 0 11.1803 0 0 0 0 14.4091 0 13.9605 0 0 0 15.9322 0 14.1856 0 0 0 0 0 0 0 0 0 0 0 0 15.3556 0 13.6253 0 14.6132 0 12.6229 0 14.008 0 14.4408 0 0 0 0 0 12.976 0 0 0 14.3943 13.2773 14.4776 14.0087 13.9992 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5355 0 0 0 0 0 0 14.3264 0 0 0 0 0 0 0 0 0 0 13.9978 0 0 0 0 0 0 0 0 0 0 0 13.728 0 0 0 14.5277 0 0 11.7469 0 0 0 0 0 Q9BYH1 SE6L1_HUMAN Seizure 6-like protein SEZ6L KIAA0927 UNQ2542/PRO6094 Homo sapiens (Human) regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074] GO:0005783; GO:0005789; GO:0016021; GO:0043025; GO:0060074; GO:0090036 IHVGEEK 0.99462 -13.636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3579 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCL2 GPAT1_HUMAN "Glycerol-3-phosphate acyltransferase 1, mitochondrial, GPAT-1, EC 2.3.1.15" GPAM GPAT1 KIAA1560 Homo sapiens (Human) activated T cell proliferation [GO:0050798]; activation-induced cell death of T cells [GO:0006924]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cytokine production [GO:0001817]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; activated T cell proliferation [GO:0050798]; activation-induced cell death of T cells [GO:0006924]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cytokine production [GO:0001817]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432] GO:0001817; GO:0004366; GO:0005741; GO:0005886; GO:0006072; GO:0006631; GO:0006637; GO:0006651; GO:0006654; GO:0006655; GO:0006924; GO:0008654; GO:0009749; GO:0016021; GO:0016024; GO:0019432; GO:0031966; GO:0040018; GO:0042104; GO:0050798; GO:0051607; GO:0055089; GO:0055091; GO:0070236; GO:0102420 glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420] EYLESQSQK 0.99462 -10.648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.568 0 0 0 0 0 0 0 11.9484 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1168 13.7276 0 0 0 0 0 0 10.8032 0 14.0037 0 0 0 12.9949 0 12.7141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4152 0 0 13.8118 0 0 0 0 13.9153 0 0 0 0 13.9766 0 0 13.3613 0 0 0 17.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.32 0 0 0 0 0 0 0 16.3213 0 0 0 0 0 0 F2Z333 FND10_HUMAN Fibronectin type III domain-containing protein 10 FNDC10 C1orf233 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ASVLRNRSVLLQWR 0.99463 -9.4007 0 0 0 0 9.96824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8657 0 0 14.6209 0 0 0 0 14.9302 0 0 0 12.207 13.3805 0 13.1302 0 0 15.0076 15.4472 13.9626 0 0 0 0 14.2109 0 15.9376 0 15.3222 15.3936 0 0 0 14.7676 0 0 14.5055 15.4038 15.082 0 13.8588 13.581 0 0 0 0 0 13.6956 15.5733 0 0 0 0 0 0 0 13.1976 0 10.9543 14.9173 0 13.9374 13.208 0 16.405 0 0 0 0 0 0 0 0 0 0 0 0 15.1176 15.1776 0 0 0 0 0 0 0 0 9.25394 0 0 0 0 0 0 0 13.0626 13.8245 0 0 0 0 0 14.2681 0 P16219 ACADS_HUMAN "Short-chain specific acyl-CoA dehydrogenase, mitochondrial, SCAD, EC 1.3.8.1 (Butyryl-CoA dehydrogenase)" ACADS Homo sapiens (Human) butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centrosome [GO:0005813]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539] GO:0003995; GO:0004085; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005813; GO:0006635; GO:0033539; GO:0046359; GO:0050660 acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; flavin adenine dinucleotide binding [GO:0050660] AWRQLHTIYQSVELPETHQMLLQTCRDFAEK 0.99463 -11.312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50440 GATM_HUMAN "Glycine amidinotransferase, mitochondrial, EC 2.1.4.1 (L-arginine:glycine amidinotransferase) (Transamidinase)" GATM AGAT Homo sapiens (Human) creatine biosynthetic process [GO:0006601]; creatine metabolic process [GO:0006600]; learning or memory [GO:0007611]; muscle atrophy [GO:0014889]; positive regulation of cold-induced thermogenesis [GO:0120162] extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; amidinotransferase activity [GO:0015067]; glycine amidinotransferase activity [GO:0015068]; creatine biosynthetic process [GO:0006601]; creatine metabolic process [GO:0006600]; learning or memory [GO:0007611]; muscle atrophy [GO:0014889]; positive regulation of cold-induced thermogenesis [GO:0120162] GO:0005739; GO:0005743; GO:0005758; GO:0006600; GO:0006601; GO:0007611; GO:0014889; GO:0015067; GO:0015068; GO:0070062; GO:0120162 amidinotransferase activity [GO:0015067]; glycine amidinotransferase activity [GO:0015068] TEGVTVR 0.99463 -11.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0946 0 0 0 0 0 0 0 0 18.69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5005 0 0 0 0 0 0 0 0 15.375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15527 SURF2_HUMAN "Surfeit locus protein 2, Surf-2" SURF2 Homo sapiens (Human) nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005730; GO:0005886; GO:0016607 ASPAFDYAEFEPHIVPSTKNPHQLFCKLTLR 0.99463 -8.905 0 0 0 0 10.8882 0 0 0 10.2085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.322 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9073 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8751 0 13.2243 13.4209 12.8257 12.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9036 0 0 0 0 0 0 0 0 0 11.8275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1275 0 0 12.5031 12.4341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3U7 MON2_HUMAN Protein MON2 homolog (Protein SF21) MON2 KIAA1040 SF21 Homo sapiens (Human) Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031] GO:0005829; GO:0006895; GO:0015031; GO:0031901; GO:0070062 ALSLECKKK 0.99463 -13.753 0 0 0 0 0 0 0 10.9405 0 0 0 13.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5895 12.9093 0 0 0 12.8441 0 0 0 0 13.0466 15.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2965 0 0 0 0 0 0 0 0 10.5325 0 0 14.9963 0 0 0 15.1585 17.4935 0 0 19.4459 18.7884 18.7758 18.762 12.8012 13.8389 10.0958 14.6497 12.0899 0 18.7043 13.712 18.6503 12.0655 0 0 12.6526 13.8371 13.5794 0 0 0 0 0 0 0 0 0 19.097 19.0991 19.0644 0 0 0 13.2579 12.9875 0 18.8841 0 0 11.6394 0 12.8554 12.8355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5437 9.56136 13.3994 0 0 0 12.6948 0 0 0 18.1839 0 0 0 0 0 0 0 12.9113 0 18.2061 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5L9 I2BP2_HUMAN "Interferon regulatory factor 2-binding protein 2, IRF-2-binding protein 2, IRF-2BP2" IRF2BP2 Homo sapiens (Human) immature B cell differentiation [GO:0002327]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; immature B cell differentiation [GO:0002327]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0002327; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0046872 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] AVARTARK 0.99463 -11.324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDQ1 CLM1_HUMAN "CMRF35-like molecule 1, CLM-1 (CD300 antigen-like family member F) (Immune receptor expressed on myeloid cells 1, IREM-1) (Immunoglobulin superfamily member 13, IgSF13) (NK inhibitory receptor) (CD antigen CD300f)" CD300LF CD300F CLM1 IGSF13 IREM1 NKIR UNQ3105/PRO10111 Homo sapiens (Human) immune system process [GO:0002376]; interleukin-13-mediated signaling pathway [GO:0035772]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of mast cell activation [GO:0033004]; negative regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034125]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ceramide binding [GO:0097001]; identical protein binding [GO:0042802]; interleukin-4 receptor binding [GO:0005136]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888]; immune system process [GO:0002376]; interleukin-13-mediated signaling pathway [GO:0035772]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of mast cell activation [GO:0033004]; negative regulation of MyD88-dependent toll-like receptor signaling pathway [GO:0034125]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666] GO:0001786; GO:0002376; GO:0004888; GO:0005136; GO:0005886; GO:0016021; GO:0033004; GO:0034125; GO:0035666; GO:0035772; GO:0042802; GO:0097001; GO:1902216; GO:2000426; GO:2000427 ceramide binding [GO:0097001]; identical protein binding [GO:0042802]; interleukin-4 receptor binding [GO:0005136]; phosphatidylserine binding [GO:0001786]; transmembrane signaling receptor activity [GO:0004888] HKLLKLSVLLPLIFTILLLLLVAASLLAWR 0.99463 -12.866 0 0 0 0 0 0 0 0 0 0 0 0 12.9527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.646 12.1221 0 0 0 0 0 0 0 0 0 0 0 12.0561 0 0 0 12.966 13.0458 0 0 13.4017 12.3621 12.2963 0 0 0 0 0 0 0 0 0 0 0 0 15.9384 15.5656 14.1755 0 11.1689 0 0 12.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 13.576 0 0 0 0 0 0 0 0 0 0 0 15.2302 0 13.7424 11.6694 12.7768 0 12.0316 0 12.9104 0 0 0 13.4733 0 0 0 0 0 0 0 0 0 0 0 12.1493 0 0 0 12.5087 0 0 0 10.247 0 0 12.2504 0 0 0 0 0 0 0 0 0 0 0 0 13.4093 0 13.2758 0 11.3754 0 0 0 12.5389 11.8096 0 16.0396 0 10.4874 0 0 17.4432 13.2248 0 15.0697 16.9197 0 0 0 0 0 0 16.2268 14.312 0 11.215 15.6627 0 Q92542 NICA_HUMAN Nicastrin NCSTN KIAA0253 UNQ1874/PRO4317 Homo sapiens (Human) adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; dopamine receptor signaling pathway [GO:0007212]; epithelial cell proliferation [GO:0050673]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098] azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021] "azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674]; adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; dopamine receptor signaling pathway [GO:0007212]; epithelial cell proliferation [GO:0050673]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098]" GO:0000139; GO:0002262; GO:0005739; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0010950; GO:0016020; GO:0016021; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0043085; GO:0050673; GO:0051117; GO:0051402; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:0099056; GO:1900271; GO:1990926 "aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674]" GLLRLLSFCVLLAGLCR 0.99463 -9.4098 13.5002 13.3995 0 0 13.696 11.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5357 11.2909 0 0 0 0 0 0 0 0 0 0 0 14.5799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0262 0 0 0 0 0 0 13.826 0 14.1638 0 0 13.1835 0 0 0 0 0 0 0 11.6612 0 0 0 0 0 0 0 0 0 0 0 13.0419 13.1857 0 13.9902 0 0 0 0 0 0 14.7686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9905 0 13.348 0 0 14.5818 0 15.0759 14.6392 0 12.5322 0 0 0 0 0 13.5922 12.0072 0 12.0463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2818 0 0 0 0 0 0 0 0 14.1749 0 13.4851 0 0 0 0 0 0 Q96CT2 KLH29_HUMAN Kelch-like protein 29 (Kelch repeat and BTB domain-containing protein 9) KLHL29 KBTBD9 KIAA1921 Homo sapiens (Human) AEELVYETVIKWIK 0.99463 -8.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96H79 ZCCHL_HUMAN Zinc finger CCCH-type antiviral protein 1-like ZC3HAV1L C7orf39 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829] GO:0005829 FHVCKSFVK 0.99463 -11.319 0 0 0 0 11.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2368 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4556 0 0 0 0 0 0 0 11.8507 0 0 0 13.349 0 0 0 0 0 0 0 12.8628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2344 0 0 0 0 0 0 12.4034 0 0 0 0 0 13.5677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3862 0 0 0 0 0 0 0 0 Q9BTE0 NAT9_HUMAN "Alpha/beta-tubulin-N-acetyltransferase 9, EC 2.3.1.- (Embryo brain-specific protein)" NAT9 EBS Homo sapiens (Human) protein acetylation [GO:0006473] protein-containing complex [GO:0032991] protein-containing complex [GO:0032991]; N-acetyltransferase activity [GO:0008080]; protein acetylation [GO:0006473] GO:0006473; GO:0008080; GO:0032991 N-acetyltransferase activity [GO:0008080] CTFIVLDAEK 0.99463 -11.315 0 0 0 0 0 0 0 0 12.7974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6678 0 0 0 0 0 0 0 0 0 0 0 0 12.9168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6437 0 13.3536 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7768 0 0 0 0 Q9HBX9 RXFP1_HUMAN Relaxin receptor 1 (Leucine-rich repeat-containing G-protein coupled receptor 7) (Relaxin family peptide receptor 1) RXFP1 LGR7 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; extracellular matrix organization [GO:0030198]; hormone-mediated signaling pathway [GO:0009755]; lung connective tissue development [GO:0060427]; myofibroblast differentiation [GO:0036446]; nipple morphogenesis [GO:0060658]; parturition [GO:0007567] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; extracellular matrix organization [GO:0030198]; hormone-mediated signaling pathway [GO:0009755]; lung connective tissue development [GO:0060427]; myofibroblast differentiation [GO:0036446]; nipple morphogenesis [GO:0060658]; parturition [GO:0007567] GO:0004930; GO:0005886; GO:0005887; GO:0007189; GO:0007190; GO:0007567; GO:0008528; GO:0009755; GO:0030198; GO:0036446; GO:0042562; GO:0046872; GO:0060427; GO:0060658 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; metal ion binding [GO:0046872] CLPQLLHCNGVDDCGNQADEDNCGDNNGWSLQFDK 0.99463 -8.9026 0 0 0 0 0 0 0 0 0 12.7971 0 0 0 0 0 0 0 0 0 12.857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5662 0 11.3316 0 12.2714 0 0 0 0 0 0 0 0 10.7556 11.6387 12.1112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2797 0 0 0 0 0 0 0 0 0 12.1123 11.4666 0 0 11.0523 0 15.2557 0 0 0 0 14.1301 0 0 13.4011 0 0 0 0 0 0 13.084 0 0 0 0 0 14.0809 15.2699 0 0 0 0 0 0 0 0 10.4364 10.4243 0 0 11.6804 13.1141 0 11.8351 0 0 0 0 0 0 0 0 14.1312 12.4518 11.7889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.141 0 0 0 0 0 12.6447 0 0 0 11.9902 0 11.0325 0 0 0 0 0 0 0 0 11.1812 12.0365 0 Q9HDC9 APMAP_HUMAN Adipocyte plasma membrane-associated protein (Protein BSCv) APMAP C20orf3 UNQ1869/PRO4305 Homo sapiens (Human) biosynthetic process [GO:0009058] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cell surface [GO:0009986]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; arylesterase activity [GO:0004064]; strictosidine synthase activity [GO:0016844]; biosynthetic process [GO:0009058] GO:0004064; GO:0009058; GO:0009986; GO:0016020; GO:0016021; GO:0016844 arylesterase activity [GO:0004064]; strictosidine synthase activity [GO:0016844] EPPLLLGVLHPNTK 0.99463 -12.874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8473 0 0 0 0 0 0 0 14.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5891 0 0 12.0018 0 0 0 0 0 0 0 0 0 0 0 0 13.6766 0 0 0 0 12.4323 0 0 0 0 0 0 0 0 0 0 0 A0A1B0GUJ8 PNM8C_HUMAN Paraneoplastic antigen-like protein 8C PNMA8C Homo sapiens (Human) GGVWRVVYMPR 0.99464 -15.679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96838 0 0 13.2976 0 12.8487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4845 0 0 13.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.8275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.502 0 0 0 0 0 0 0 0 0 0 A0A1B0GWH4 HSFX3_HUMAN "Heat shock transcription factor, X-linked member 3" HSFX3 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LLENIQRK 0.99464 -10.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NCI8 CB078_HUMAN Uncharacterized protein C2orf78 C2orf78 Homo sapiens (Human) EPVSTAVTSLRSLPKPQNQFLIQDFSLQPR 0.99464 -8.6465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.57 0 0 0 0 0 0 11.1935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1153 0 0 0 10.4925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.631 0 0 0 0 0 0 12.4542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.099 0 11.9804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7484 12.1936 12.7459 0 0 0 A6NNS2 DRS7C_HUMAN "Dehydrogenase/reductase SDR family member 7C, EC 1.1.1.105 (Sarcoplasmic reticulum protein of 35 kDa, Protein SRP-35) (Short-chain dehydrogenase/reductase family 32C member 2, Protein SDR32C2)" DHRS7C SDR32C2 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; glucose import [GO:0046323]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880] longitudinal sarcoplasmic reticulum [GO:0014801]; sarcoplasmic reticulum membrane [GO:0033017] "longitudinal sarcoplasmic reticulum [GO:0014801]; sarcoplasmic reticulum membrane [GO:0033017]; NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; cellular calcium ion homeostasis [GO:0006874]; glucose import [GO:0046323]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]" GO:0004745; GO:0006874; GO:0010880; GO:0014801; GO:0016616; GO:0033017; GO:0046323 "NAD-retinol dehydrogenase activity [GO:0004745]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]" ALLPNMISRRTGQIVLVNNIQGK 0.99464 -8.4225 0 0 0 0 0 0 0 0 0 0 13.97 0 0 0 0 0 0 0 14.051 10.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.404 0 14.6667 0 0 0 0 0 0 0 13.8399 0 11.0205 0 13.8171 0 0 0 0 0 0 0 0 0 0 0 0 11.3766 0 0 0 0 0 0 0 11.2301 0 14.2223 0 16.1925 13.5551 14.798 14.9553 0 0 0 13.8873 0 13.9097 0 12.7846 0 0 0 14.7641 15.4129 0 14.7778 13.9659 0 0 12.8365 0 0 11.4628 0 0 0 0 0 0 0 0 0 0 13.2528 0 0 0 0 0 0 10.8845 0 0 0 0 0 0 11.4823 0 13.4584 0 14.4434 14.3816 0 13.2521 0 0 0 14.776 0 O60832 DKC1_HUMAN "H/ACA ribonucleoprotein complex subunit DKC1, EC 5.4.99.- (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1)" DKC1 NOLA4 Homo sapiens (Human) box H/ACA RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004] box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697] box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004] GO:0000455; GO:0000495; GO:0001650; GO:0003720; GO:0003723; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0005737; GO:0006364; GO:0006396; GO:0007004; GO:0009982; GO:0031118; GO:0031120; GO:0031429; GO:0032212; GO:0034513; GO:0051973; GO:0070034; GO:0072589; GO:0090661; GO:0090666; GO:0090669; GO:1904851; GO:1904871; GO:1904872; GO:1904874; GO:1990481 box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034] ADAEVIILPKK 0.99464 -8.4233 12.1015 0 11.6337 13.6046 0 0 0 15.2093 0 0 0 0 0 0 0 0 0 0 12.2803 0 0 10.5254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1249 0 0 0 14.0893 0 14.3121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9293 13.9643 0 0 0 0 0 0 11.0199 0 0 0 0 0 0 0 13.426 0 11.8665 0 0 0 0 13.7385 13.4482 0 12.9996 13.1566 13.2195 11.9847 0 0 12.7407 0 0 12.9685 0 11.4019 0 0 0 0 0 11.1707 13.3108 0 0 0 12.8741 13.1971 0 0 0 11.0306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1314 0 0 0 0 0 0 0 0 12.7308 0 0 0 0 0 O95980 RECK_HUMAN "Reversion-inducing cysteine-rich protein with Kazal motifs, hRECK (Suppressor of tumorigenicity 15 protein)" RECK ST15 Homo sapiens (Human) blood vessel maturation [GO:0001955]; embryo implantation [GO:0007566]; embryonic forelimb morphogenesis [GO:0035115]; extracellular matrix organization [GO:0030198]; negative regulation of cell migration [GO:0030336]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; Wnt-protein binding [GO:0017147]; blood vessel maturation [GO:0001955]; embryo implantation [GO:0007566]; embryonic forelimb morphogenesis [GO:0035115]; extracellular matrix organization [GO:0030198]; negative regulation of cell migration [GO:0030336]; negative regulation of metalloendopeptidase activity [GO:1904684]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of angiogenesis [GO:0045765]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040] GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005576; GO:0005886; GO:0007566; GO:0008191; GO:0016020; GO:0017147; GO:0030198; GO:0030336; GO:0031225; GO:0035115; GO:0045765; GO:0090210; GO:0090263; GO:1904684; GO:1904928; GO:1990909 coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; Wnt-protein binding [GO:0017147] EPCQLGCR 0.99464 -8.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2291 0 0 0 11.503 0 11.9043 0 0 0 0 0 0 0 0 12.4291 0 0 0 0 0 0 0 11.2195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0815 0 0 0 0 13.8295 0 0 0 0 0 0 11.3179 12.597 0 13.8506 0 0 14.1129 0 12.8395 0 0 0 0 0 0 0 0 0 0 14.3048 0 0 0 0 0 0 0 0 10.025 0 12.4928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0843 0 0 0 0 0 10.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1887 0 0 0 0 0 0 0 0 Q13554 KCC2B_HUMAN "Calcium/calmodulin-dependent protein kinase type II subunit beta, CaM kinase II subunit beta, CaMK-II subunit beta, EC 2.7.11.17" CAMK2B CAM2 CAMK2 CAMKB Homo sapiens (Human) cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neuron projection development [GO:0010976]; positive regulation of synapse maturation [GO:0090129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transport [GO:0051924]; regulation of dendritic spine development [GO:0060998]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuron migration [GO:2001222]; regulation of skeletal muscle adaptation [GO:0014733]; regulation of synapse structural plasticity [GO:0051823]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202] anchoring junction [GO:0070161]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of neuron projection development [GO:0010976]; positive regulation of synapse maturation [GO:0090129]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transport [GO:0051924]; regulation of dendritic spine development [GO:0060998]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neuron migration [GO:2001222]; regulation of skeletal muscle adaptation [GO:0014733]; regulation of synapse structural plasticity [GO:0051823]; signal transduction [GO:0007165] GO:0003779; GO:0004683; GO:0005516; GO:0005524; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005954; GO:0006468; GO:0007165; GO:0007399; GO:0010976; GO:0014733; GO:0030154; GO:0030666; GO:0033017; GO:0042802; GO:0042803; GO:0043005; GO:0045202; GO:0046777; GO:0048169; GO:0051823; GO:0051924; GO:0060998; GO:0061003; GO:0070161; GO:0090129; GO:0106310; GO:2001222 actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310] APRVPDILSSVRR 0.99464 -9.4321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13619 CUL4A_HUMAN "Cullin-4A, CUL-4A" CUL4A Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of granulocyte differentiation [GO:0030853]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; rhythmic process [GO:0048511]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019] GO:0000082; GO:0001701; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0008283; GO:0008284; GO:0016567; GO:0030097; GO:0030674; GO:0030853; GO:0031146; GO:0031461; GO:0031464; GO:0031625; GO:0034644; GO:0035019; GO:0042254; GO:0043161; GO:0048511; GO:0051246; GO:0080008; GO:0097193; GO:1900087; GO:2000001; GO:2000819 protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] AEFKEGKK 0.99464 -32.021 0 0 0 0 0 0 0 0 0 0 0 9.7839 11.0449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0111 0 0 17.8813 0 0 0 0 0 0 0 0 0 0 0 0 11.8435 0 0 0 0 0 0 14.1944 0 0 0 16.4593 0 0 13.3669 0 0 0 0 0 0 0 16.3671 0 0 13.8477 0 15.0177 13.5991 0 13.8263 0 0 0 0 13.9986 0 0 0 0 0 0 16.8444 0 0 13.4993 13.1423 0 0 13.5194 13.5626 13.5977 0 0 13.4754 0 0 13.3156 0 0 0 0 13.3965 0 13.5136 13.4345 13.3479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8398 0 0 13.6376 0 0 0 0 0 Q1HG43 DOXA1_HUMAN Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein) DUOXA1 NIP NUMBIP Homo sapiens (Human) hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609] GO:0005783; GO:0005789; GO:0005886; GO:0008104; GO:0010729; GO:0015031; GO:0016020; GO:0016021; GO:0019899; GO:0031252; GO:0042743; GO:0045666; GO:0050727; GO:2000609 enzyme binding [GO:0019899] AYCKEAHPKDPDCAL 0.99464 -9.4496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JSP0 FGD3_HUMAN "FYVE, RhoGEF and PH domain-containing protein 3 (Zinc finger FYVE domain-containing protein 5)" FGD3 ZFYVE5 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0001726; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0005856; GO:0007010; GO:0008360; GO:0030027; GO:0030036; GO:0031267; GO:0043087; GO:0046847; GO:0046872; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267] DVVHSIQK 0.99464 -8.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6966 0 14.6462 0 0 0 0 0 0 16.5623 0 0 0 0 0 0 0 0 0 0 13.174 0 0 0 0 0 0 0 0 0 0 0 0 14.7514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4528 14.4181 0 0 0 0 0 0 0 10.8415 0 14.3937 0 0 0 0 0 0 0 0 0 0 13.3769 0 0 0 0 0 0 13.7381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0859 0 0 0 13.7687 Q5NUL3 FFAR4_HUMAN Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1) FFAR4 GPR120 GPR129 O3FAR1 PGR4 Homo sapiens (Human) brown fat cell differentiation [GO:0050873]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production [GO:0001818]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of somatostatin secretion [GO:0090275]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of glucose transmembrane transport [GO:0010827]; white fat cell differentiation [GO:0050872] ciliary membrane [GO:0060170]; cilium [GO:0005929]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; cilium [GO:0005929]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; arrestin family protein binding [GO:1990763]; fatty acid binding [GO:0005504]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527]; brown fat cell differentiation [GO:0050873]; G protein-coupled receptor signaling pathway [GO:0007186]; ghrelin secretion [GO:0036321]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production [GO:0001818]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of somatostatin secretion [GO:0090275]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of glucose transmembrane transport [GO:0010827]; white fat cell differentiation [GO:0050872] GO:0001818; GO:0004930; GO:0005504; GO:0005765; GO:0005886; GO:0005887; GO:0005929; GO:0006954; GO:0007186; GO:0007200; GO:0007204; GO:0008527; GO:0010008; GO:0010827; GO:0030139; GO:0032691; GO:0036321; GO:0043066; GO:0043950; GO:0045669; GO:0046879; GO:0050728; GO:0050872; GO:0050873; GO:0060170; GO:0070094; GO:0070374; GO:0090275; GO:0090336; GO:0120162; GO:1990763 arrestin family protein binding [GO:1990763]; fatty acid binding [GO:0005504]; G protein-coupled receptor activity [GO:0004930]; taste receptor activity [GO:0008527] LVLAAVETTVLVLIFAVSLLGNVCALVLVAR 0.99464 -8.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0289 12.1518 0 13.2899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1826 0 12.1898 0 11.784 0 0 0 12.0486 0 0 0 12.2612 0 0 0 0 14.5003 0 0 0 0 0 0 14.6805 Q68CJ6 SLIP_HUMAN "Nuclear GTPase SLIP-GC, EC 3.6.1.- (Speckled-like pattern in the germinal center)" NUGGC C8orf80 HMFN0672 Homo sapiens (Human) cellular response to lipopolysaccharide [GO:0071222]; negative regulation of apoptotic process [GO:0043066]; regulation of nuclear cell cycle DNA replication [GO:0033262] nuclear speck [GO:0016607] nuclear speck [GO:0016607]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of apoptotic process [GO:0043066]; regulation of nuclear cell cycle DNA replication [GO:0033262] GO:0003924; GO:0005525; GO:0016607; GO:0033262; GO:0043066; GO:0071222 GTP binding [GO:0005525]; GTPase activity [GO:0003924] ACQRGFCR 0.99464 -8.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7778 0 0 0 0 11.2588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1134 0 0 0 12.0112 0 12.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2538 14.0968 0 0 0 0 0 0 0 0 12.2147 0 0 12.9933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6188 0 0 0 0 12.5133 0 0 0 12.0562 0 0 0 0 11.5745 0 0 0 0 0 0 0 0 0 0 13.4305 0 0 0 Q69YH5 CDCA2_HUMAN "Cell division cycle-associated protein 2 (Recruits PP1 onto mitotic chromatin at anaphase protein, Repo-Man)" CDCA2 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088] GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007049; GO:0007059; GO:0007088; GO:0035307; GO:0051301; GO:0051983 DLENEGLVWISLPLPSTSQKAKR 0.99464 -13.795 0 0 0 0 0 0 0 12.6983 0 0 0 0 0 11.7613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.172 13.0339 0 12.704 0 0 0 0 0 0 0 13.9164 0 0 10.8258 0 0 0 0 18.7691 0 0 0 0 0 12.7947 0 14.5608 14.8317 14.6367 12.6925 0 0 0 0 0 0 0 0 0 0 13.8694 0 0 0 14.1262 0 0 0 0 0 0 0 0 13.0699 12.1772 0 12.9182 0 13.4198 13.4298 0 0 0 0 0 13.6446 13.152 0 0 0 0 13.8326 0 0 0 0 0 0 11.7789 0 12.9893 0 0 0 0 0 0 0 13.8848 13.8512 0 13.663 0 0 0 13.794 0 0 0 13.7838 0 13.4665 0 0 Q6K0P9 IFIX_HUMAN Pyrin and HIN domain-containing protein 1 (Interferon-inducible protein X) PYHIN1 IFIX Homo sapiens (Human) "activation of innate immune response [GO:0002218]; cell cycle [GO:0007049]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]" nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] "nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; cell cycle [GO:0007049]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]" GO:0002218; GO:0003690; GO:0005654; GO:0005730; GO:0007049; GO:0016607; GO:0031625; GO:0031648; GO:0032731; GO:0032991; GO:0035457; GO:0035458; GO:0043388; GO:0045893; GO:0050821; GO:1900182; GO:1902164; GO:2000060 double-stranded DNA binding [GO:0003690]; ubiquitin protein ligase binding [GO:0031625] ANNYKKIVLLK 0.99464 -13.8 0 0 0 0 0 0 0 0 13.525 0 0 0 0 0 0 0 0 0 0 10.9212 0 0 0 13.1114 0 0 0 11.502 0 0 0 0 0 0 0 13.5378 12.6059 0 0 0 0 0 0 11.1015 11.4642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8003 0 0 0 0 0 12.3938 12.3737 0 0 0 0 0 12.8552 0 13.2965 0 0 0 12.692 0 12.4122 0 12.9471 0 12.2396 13.813 0 0 13.8315 15.0005 0 13.9533 15.324 0 0 14.222 0 13.7113 13.719 14.6456 0 13.6302 0 0 0 0 14.9428 13.3082 0 0 0 14.6213 11.1577 13.2226 0 0 12.6869 0 13.3958 0 12.3516 13.2168 12.7557 0 0 13.983 14.1573 14.7458 14.7325 0 14.2136 13.7537 0 0 14.0295 13.3333 0 13.5097 15.2589 0 0 0 0 0 0 15.1087 15.1783 0 0 0 0 0 0 12.423 0 0 0 0 0 0 0 0 0 0 14.7573 0 14.5828 0 0 0 0 0 0 Q6P996 PDXD1_HUMAN "Pyridoxal-dependent decarboxylase domain-containing protein 1, EC 4.1.1.-" PDXDC1 KIAA0251 Homo sapiens (Human) carboxylic acid metabolic process [GO:0019752] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; cadherin binding [GO:0045296]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; carboxylic acid metabolic process [GO:0019752] GO:0005794; GO:0016831; GO:0019752; GO:0030170; GO:0043231; GO:0045296 cadherin binding [GO:0045296]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170] ALPLWLSLQYLGLDGFVERIK 0.99464 -11.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0164 0 0 0 0 0 0 0 0 12.4646 0 0 0 0 0 12.1685 0 0 0 0 0 0 0 0 0 13.2089 11.3767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.314 0 0 0 0 0 Q6UWM9 UD2A3_HUMAN "UDP-glucuronosyltransferase 2A3, UDPGT 2A3, EC 2.4.1.17" UGT2A3 UNQ2559/PRO6239 Homo sapiens (Human) cellular glucuronidation [GO:0052695] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695] GO:0015020; GO:0016021; GO:0052695 glucuronosyltransferase activity [GO:0015020] AEIWLIR 0.99464 -10.722 0 13.1566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.454 0 0 0 0 0 0 0 0 0 0 16.626 0 0 0 0 0 0 0 0 0 0 0 0 16.5213 0 0 0 0 0 0 0 0 0 0 13.9441 14.0947 13.8356 0 0 0 0 0 0 0 0 0 0 13.8152 0 0 0 0 15.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6XYB7 LBX2_HUMAN Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2) LBX2 LP3727 Homo sapiens (Human) muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:1904105; GO:1990837; GO:2000052 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" NSGREPR 0.99464 -8.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0075 10.9256 0 0 13.4247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0464 0 0 0 0 0 0 0 0 0 12.7895 0 0 0 10.7674 12.7575 0 12.3505 0 0 13.7105 13.2109 0 0 0 0 0 0 0 0 0 0 14.8365 0 0 13.6425 0 0 0 0 0 0 0 11.5171 0 0 0 0 0 0 0 0 0 0 0 0 13.1595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2798 0 0 0 0 0 0 Q6ZW05 PTHD4_HUMAN Patched domain-containing protein 4 (p53-regulated patched protein) PTCHD4 C6orf138 PTCH53 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020] GO:0016020; GO:0016021 DCLRSKPFLGLLGVLTVCISIITAAGIFFITDGK 0.99464 -13.802 0 0 0 0 0 0 0 0 0 0 0 11.8757 0 0 0 13.7746 0 0 11.6865 0 0 0 0 0 0 0 0 13.703 0 0 0 0 0 0 0 0 12.1502 0 0 0 0 0 0 0 0 0 0 16.8598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0922 0 0 0 0 13.1981 0 13.9551 13.7174 0 13.8324 0 0 0 0 0 0 0 0 15.2992 0 0 11.8605 0 0 12.2786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4803 13.9792 0 0 14.1035 0 0 12.9843 13.1189 0 0 14.8826 13.0602 0 0 0 0 0 0 0 0 0 0 0 0 14.2803 0 0 0 0 0 0 0 0 13.5749 0 14.382 0 0 13.8146 13.9128 13.7451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1127 0 0 14.8361 0 0 0 0 0 0 0 0 Q8NFW5 DMBX1_HUMAN Diencephalon/mesencephalon homeobox protein 1 (Orthodenticle homolog 3) (Paired-like homeobox protein DMBX1) DMBX1 MBX OTX3 PAXB Homo sapiens (Human) "adult feeding behavior [GO:0008343]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; central nervous system development [GO:0007417]; developmental growth [GO:0048589]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; adult feeding behavior [GO:0008343]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; central nervous system development [GO:0007417]; developmental growth [GO:0048589]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007417; GO:0007420; GO:0008343; GO:0008344; GO:0042802; GO:0043565; GO:0045892; GO:0048589; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AGAEDPK 0.99464 -11.354 0 0 0 0 0 0 0 0 0 9.56535 0 0 0 0 0 0 0 0 0 0 0 0 12.2303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1032 0 0 0 0 0 0 0 0 0 0 0 0 11.2857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BT56 SPXN_HUMAN Spexin (NPQ) (Neuropeptide Q) (Spexin hormone) [Cleaved into: Spexin-1; Spexin-2 (NPQ 53-70) ] SPX C12orf39 Homo sapiens (Human) long-chain fatty acid import into cell [GO:0044539]; negative regulation of appetite [GO:0032099]; negative regulation of heart rate [GO:0010459]; negative regulation of renal sodium excretion [GO:0035814]; positive regulation of gastro-intestinal system smooth muscle contraction [GO:1904306]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of sensory perception of pain [GO:0051930] cytoplasm [GO:0005737]; dense core granule [GO:0031045]; extracellular space [GO:0005615]; transport vesicle [GO:0030133] cytoplasm [GO:0005737]; dense core granule [GO:0031045]; extracellular space [GO:0005615]; transport vesicle [GO:0030133]; neuropeptide hormone activity [GO:0005184]; type 2 galanin receptor binding [GO:0031765]; type 3 galanin receptor binding [GO:0031766]; long-chain fatty acid import into cell [GO:0044539]; negative regulation of appetite [GO:0032099]; negative regulation of heart rate [GO:0010459]; negative regulation of renal sodium excretion [GO:0035814]; positive regulation of gastro-intestinal system smooth muscle contraction [GO:1904306]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of sensory perception of pain [GO:0051930] GO:0003084; GO:0005184; GO:0005615; GO:0005737; GO:0010459; GO:0030133; GO:0031045; GO:0031765; GO:0031766; GO:0032099; GO:0035814; GO:0044539; GO:0045944; GO:0051930; GO:1904306 neuropeptide hormone activity [GO:0005184]; type 2 galanin receptor binding [GO:0031765]; type 3 galanin receptor binding [GO:0031766] SPEDEEK 0.99464 -10.724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYZ2 LDH6B_HUMAN "L-lactate dehydrogenase A-like 6B, EC 1.1.1.27" LDHAL6B LDHAL6 LDHL Homo sapiens (Human) lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; L-lactate dehydrogenase activity [GO:0004459]; lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090] GO:0004459; GO:0005634; GO:0005737; GO:0005759; GO:0006089; GO:0006090; GO:1990204 L-lactate dehydrogenase activity [GO:0004459] IIGSGCNLDTARFR 0.99464 -8.659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87971 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5321 0 0 0 0 9.34999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0323 0 0 0 0 0 0 0 12.4688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8651 0 0 0 0 0 0 0 0 0 0 0 0 12.1363 0 11.7907 12.4356 0 0 0 0 0 0 0 0 0 0 0 0 0 8.89057 0 0 0 0 0 0 0 11.7771 0 0 0 0 0 0 0 0 0 0 0 0 13.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW38 FANCL_HUMAN "E3 ubiquitin-protein ligase FANCL, EC 2.3.2.27 (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa, FAAP43) (RING-type E3 ubiquitin transferase FANCL)" FANCL PHF9 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytoplasm [GO:0005737]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127] GO:0000785; GO:0004842; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] DFHLRIVLPEDLQLK 0.99464 -8.6652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0384 0 0 0 12.282 0 0 0 0 0 0 0 0 0 0 0 12.2316 0 0 0 0 0 0 12.7168 0 0 0 0 0 0 12.4148 11.4666 0 0 0 0 0 0 0 0 0 0 10.3833 0 0 0 0 0 0 0 0 0 0 0 0 10.8635 11.1861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3283 0 0 13.7944 18.8983 0 0 0 0 0 0 0 13.352 0 0 12.509 0 0 0 13.1605 12.4902 12.5932 0 0 12.9429 0 12.9076 0 0 12.7348 13.3396 0 0 0 0 0 12.7879 12.1767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.649 0 11.6894 0 0 0 0 12.1398 0 0 0 0 0 0 0 0 0 0 0 0 13.3817 0 0 12.2125 13.1812 0 11.9817 0 0 0 0 0 0 11.5766 0 O60911 CATL2_HUMAN "Cathepsin L2, EC 3.4.22.43 (Cathepsin U) (Cathepsin V)" CTSV CATL2 CTSL2 CTSU UNQ268/PRO305 Homo sapiens (Human) antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; proteolysis involved in protein catabolic process [GO:0051603] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; serine-type endopeptidase activity [GO:0004252]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; proteolysis involved in protein catabolic process [GO:0051603] GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005764; GO:0006955; GO:0008234; GO:0019886; GO:0022617; GO:0043202; GO:0051603 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; serine-type endopeptidase activity [GO:0004252] FDQNLDTKWYQWK 0.99465 -8.4419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1276 0 0 0 0 0 0 10.874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1079 14.1257 0 0 0 0 0 15.0145 0 0 0 0 0 0 0 0 0 0 0 0 12.2554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7273 0 0 14.2766 0 O75764 TCEA3_HUMAN Transcription elongation factor A protein 3 (Transcription elongation factor S-II protein 3) (Transcription elongation factor TFIIS.h) TCEA3 TFIISH Homo sapiens (Human) "transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription, DNA-templated [GO:0006351]" GO:0003677; GO:0005634; GO:0006351; GO:0006368; GO:0008270 DNA binding [GO:0003677]; zinc ion binding [GO:0008270] DYGVNCDKMASEIEDHIYQELK 0.99465 -8.4356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0113 0 0 0 0 0 0 0 0 0 0 10.735 0 0 0 0 0 0 0 0 0 0 0 0 12.7471 0 0 0 0 0 0 0 0 0 12.1378 0 0 0 0 0 0 0 0 15.6578 9.38819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8503 12.5159 13.1964 13.2092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.434 0 14.1392 0 0 13.4303 0 0 0 0 0 0 0 0 0 0 0 12.9343 0 0 11.5378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07954 FUMH_HUMAN "Fumarate hydratase, mitochondrial, Fumarase, HsFH, EC 4.2.1.2" FH Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; negative regulation of histone H3-K36 methylation [GO:0000415]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050] GO:0000050; GO:0000415; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006974; GO:0035861; GO:0042393; GO:0045239; GO:0048873; GO:0070062; GO:0120162; GO:2001034 fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393] IAKTAHK 0.99465 -10.583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17858 PFKAL_HUMAN "ATP-dependent 6-phosphofructokinase, liver type, ATP-PFK, PFK-L, EC 2.7.1.11 (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B, PFK-B) (Phosphohexokinase)" PFKL Homo sapiens (Human) "canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; response to glucose [GO:0009749]" 6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774] "6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; response to glucose [GO:0009749]" GO:0003872; GO:0005524; GO:0005576; GO:0005829; GO:0005945; GO:0006002; GO:0006096; GO:0009749; GO:0016020; GO:0016208; GO:0019900; GO:0030388; GO:0034774; GO:0042802; GO:0046676; GO:0046872; GO:0048029; GO:0061621; GO:0070061; GO:0070062; GO:0070095; GO:1904813 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029] AMLWLSEK 0.99465 -15.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0895 0 0 0 0 0 0 0 0 0 0 0 11.3903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4007 0 0 0 0 0 0 0 0 0 0 13.0044 12.7076 0 0 0 13.2791 0 0 15.3491 0 0 0 0 0 0 0 0 0 0 0 12.5541 0 0 0 0 0 0 0 11.4058 0 12.3827 0 0 0 0 0 0 0 0 0 0 11.8512 0 12.5475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0079 0 0 0 0 0 0 0 0 0 14.5911 0 0 P49448 DHE4_HUMAN "Glutamate dehydrogenase 2, mitochondrial, GDH 2, EC 1.4.1.3" GLUD2 GLUDP1 Homo sapiens (Human) glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; leucine binding [GO:0070728]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamate metabolic process [GO:0006536] GO:0004352; GO:0004353; GO:0004354; GO:0005525; GO:0005739; GO:0005759; GO:0006536; GO:0006537; GO:0006538; GO:0043531; GO:0070728 ADP binding [GO:0043531]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; leucine binding [GO:0070728] FTMELAK 0.99465 -8.4443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4101 0 9.6249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9951 10.5218 0 0 0 0 0 0 13.1221 0 0 0 0 0 0 0 0 14.5332 0 11.1735 14.5853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2572 0 0 0 12.2632 0 0 0 0 0 0 P61024 CKS1_HUMAN "Cyclin-dependent kinases regulatory subunit 1, CKS-1" CKS1B CKS1 PNAS-143 PNAS-16 Homo sapiens (Human) "cell division [GO:0051301]; fibroblast proliferation [GO:0048144]; mitotic cell cycle phase transition [GO:0044772]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]" cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005] "cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell division [GO:0051301]; fibroblast proliferation [GO:0048144]; mitotic cell cycle phase transition [GO:0044772]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000307; GO:0005654; GO:0006355; GO:0007346; GO:0019005; GO:0019901; GO:0042393; GO:0043130; GO:0044772; GO:0048144; GO:0051301; GO:0061575 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130] HVMLPKDIAKLVPK 0.99465 -11.06 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62314 SMD1_HUMAN "Small nuclear ribonucleoprotein Sm D1, Sm-D1 (Sm-D autoantigen) (snRNP core protein D1)" SNRPD1 Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" GO:0000243; GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526; GO:1903241; GO:1990446 RNA binding [GO:0003723]; U1 snRNP binding [GO:1990446] GRGGPRR 0.99465 -8.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3339 12.6991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q03692 COAA1_HUMAN Collagen alpha-1(X) chain COL10A1 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] collagen trimer [GO:0005581]; collagen type X trimer [GO:0005599]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; collagen type X trimer [GO:0005599]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] GO:0001501; GO:0005201; GO:0005576; GO:0005581; GO:0005599; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0046872; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872] GFPGEMGPIGPPGPQGPPGERGPEGIGK 0.99465 -12.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1237 0 0 0 0 0 0 0 0 14.5691 0 14.5344 0 0 0 0 0 0 15.8169 0 0 0 0 0 0 14.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0837 0 0 0 0 13.5581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4844 0 0 0 0 0 0 12.2227 0 0 0 0 0 0 0 12.6112 0 0 0 0 0 0 0 0 0 0 0 11.1047 0 0 0 0 0 0 0 0 0 0 9.87938 0 0 0 14.6915 14.3832 0 0 0 0 14.6328 0 0 0 0 0 0 14.6756 0 0 0 0 Q147U7 SMCO1_HUMAN Single-pass membrane and coiled-coil domain-containing protein 1 (Single-pass membrane protein with coiled-coil domains 1) SMCO1 C3orf43 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AEHYTAK 0.99465 -11.09 0 0 0 0 0 0 0 0 0 0 11.9983 0 0 12.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8136 0 0 0 0 12.6519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1898 0 0 0 0 0 11.7389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.79 0 0 0 14.0107 0 0 0 0 0 0 0 0 0 0 0 14.4267 0 0 0 0 0 13.8525 0 0 0 Q2M3R5 S35G1_HUMAN Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20) SLC35G1 C10orf60 POST TMEM20 Homo sapiens (Human) calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480] GO:0005789; GO:0005886; GO:0016021; GO:0051480; GO:1990034 KTGFIGPK 0.99465 -8.7108 0 0 0 12.0095 0 0 13.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8336 0 0 0 14.4947 0 0 0 14.739 14.3087 13.1573 13.2354 0 14.1123 12.2952 12.8069 0 12.4646 0 0 0 0 0 0 13.3531 0 13.1765 0 0 0 0 13.2877 0 0 0 13.0625 0 0 0 0 0 11.8918 0 12.1862 12.4497 11.5679 0 13.7218 0 12.6229 0 0 0 12.5111 0 0 0 0 0 0 12.6709 0 0 12.4201 0 0 13.6631 13.7021 12.8692 0 13.0066 13.1478 0 0 0 13.1132 12.6622 12.2842 13.3461 13.0744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1423 0 0 12.4922 0 0 0 0 0 Q8N3A8 PARP8_HUMAN "Protein mono-ADP-ribosyltransferase PARP8, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 16, ARTD16) (Poly [ADP-ribose] polymerase 8, PARP-8)" PARP8 Homo sapiens (Human) protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289] GO:0003950; GO:0006471; GO:0070213; GO:0140289; GO:1990404 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404] FGLGHQLKK 0.99465 -36.033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7763 0 0 0 0 0 0 13.7093 0 0 0 14.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5491 0 0 0 0 0 0 0 12.7907 0 0 0 0 0 0 0 0 0 0 12.9804 0 0 0 0 0 0 0 0 0 0 0 0 10.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8175 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9898 Q96CN5 LRC45_HUMAN Leucine-rich repeat-containing protein 45 LRRC45 Homo sapiens (Human) centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytosol [GO:0005829]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0030426 ALGKLLPR 0.99465 -8.4366 0 0 0 0 0 0 0 0 0 12.2316 0 0 12.3756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1108 0 0 0 0 0 0 0 0 0 13.4705 0 0 0 0 0 0 0 0 13.0949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0246 0 0 0 0 0 0 0 0 13.508 0 0 0 0 0 0 0 0 0 0 13.5028 0 0 0 0 0 0 0 0 0 0 13.2343 0 0 0 12.7433 0 0 0 0 0 0 0 13.2074 13.5271 0 12.7827 0 0 0 0 0 0 0 13.3108 0 0 13.0954 0 0 0 0 13.5819 0 0 0 0 Q96R67 OR4CC_HUMAN Olfactory receptor 4C12 (Olfactory receptor OR11-259) OR4C12 Homo sapiens (Human) integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NAEVKSAIR 0.99465 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBG7 RBPJL_HUMAN Recombining binding protein suppressor of hairless-like protein (Transcription factor RBP-L) RBPJL RBPL RBPSUHL Homo sapiens (Human) signal transduction [GO:0007165] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; signal transduction [GO:0007165]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0007165 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CLQQQCEQTVRILHAKVAQK 0.99465 -11.077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4612 0 0 0 12.8269 0 0 0 0 0 0 11.9877 0 0 0 0 0 13.9872 0 0 13.8984 14.1611 13.6731 0 0 0 0 14.2262 0 0 0 0 0 13.4209 0 0 0 0 0 0 0 13.9036 0 13.2314 13.1535 13.7451 0 0 13.6954 13.23 13.0525 0 0 11.4865 0 0 0 11.8167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3033 0 0 0 0 0 12.5619 0 0 0 0 0 0 0 0 0 12.2319 0 0 0 0 0 0 0 11.9812 0 0 0 12.5957 0 0 Q9ULZ3 ASC_HUMAN "Apoptosis-associated speck-like protein containing a CARD, hASC (Caspase recruitment domain-containing protein 5) (PYD and CARD domain-containing protein) (Target of methylation-induced silencing 1)" PYCARD ASC CARD5 TMS1 Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; macropinocytosis [GO:0044351]; myeloid dendritic cell activation [GO:0001773]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002588]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phagocytosis [GO:0050766]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell migration [GO:2000406]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of autophagy [GO:0010506]; regulation of GTPase activity [GO:0043087]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of protein stability [GO:0031647]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] AIM2 inflammasome complex [GO:0097169]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; inflammasome complex [GO:0061702]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; NLRP1 inflammasome complex [GO:0072558]; NLRP3 inflammasome complex [GO:0072559]; NLRP6 inflammasome complex [GO:0140738]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774] AIM2 inflammasome complex [GO:0097169]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; inflammasome complex [GO:0061702]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; NLRP1 inflammasome complex [GO:0072558]; NLRP3 inflammasome complex [GO:0072559]; NLRP6 inflammasome complex [GO:0140738]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; BMP receptor binding [GO:0070700]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; interleukin-6 receptor binding [GO:0005138]; myosin I binding [GO:0017024]; protease binding [GO:0002020]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Pyrin domain binding [GO:0032090]; transmembrane transporter binding [GO:0044325]; tropomyosin binding [GO:0005523]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; icosanoid biosynthetic process [GO:0046456]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; macropinocytosis [GO:0044351]; myeloid dendritic cell activation [GO:0001773]; myeloid dendritic cell activation involved in immune response [GO:0002277]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osmosensory signaling pathway [GO:0007231]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002588]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phagocytosis [GO:0050766]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell migration [GO:2000406]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; pyroptosis [GO:0070269]; regulation of autophagy [GO:0010506]; regulation of GTPase activity [GO:0043087]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of protein stability [GO:0031647]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0000139; GO:0001773; GO:0002020; GO:0002218; GO:0002221; GO:0002230; GO:0002277; GO:0002588; GO:0002821; GO:0005138; GO:0005523; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005874; GO:0006915; GO:0006919; GO:0006954; GO:0007165; GO:0007231; GO:0008385; GO:0008656; GO:0010506; GO:0010803; GO:0017024; GO:0019899; GO:0030838; GO:0031647; GO:0032088; GO:0032090; GO:0032688; GO:0032722; GO:0032729; GO:0032731; GO:0032733; GO:0032755; GO:0032757; GO:0032760; GO:0032991; GO:0033209; GO:0034774; GO:0035578; GO:0042104; GO:0042771; GO:0042802; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043124; GO:0043280; GO:0044325; GO:0044351; GO:0045087; GO:0046330; GO:0046456; GO:0046983; GO:0050729; GO:0050766; GO:0050829; GO:0050830; GO:0050870; GO:0051091; GO:0051092; GO:0051260; GO:0051607; GO:0060907; GO:0061702; GO:0070269; GO:0070374; GO:0070700; GO:0071222; GO:0071347; GO:0071356; GO:0071901; GO:0072332; GO:0072558; GO:0072559; GO:0090200; GO:0097153; GO:0097169; GO:0097202; GO:0140738; GO:1900016; GO:2000406; GO:2001056; GO:2001238; GO:2001242 BMP receptor binding [GO:0070700]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; interleukin-6 receptor binding [GO:0005138]; myosin I binding [GO:0017024]; protease binding [GO:0002020]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Pyrin domain binding [GO:0032090]; transmembrane transporter binding [GO:0044325]; tropomyosin binding [GO:0005523] LKLLSVPLREGYGR 0.99465 -11.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CJ78 ZN865_HUMAN Zinc finger protein 865 ZNF865 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AEVPSSSSSSSSSSSSSSSSSSSSSSSSSQAK 0.99466 -8.1883 0 0 0 0 0 0 0 0 0 0 0 13.8142 0 0 0 12.6254 0 14.1105 0 0 0 0 13.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.96 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9462 0 0 0 14.3532 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3449 0 0 0 0 13.2479 0 0 0 0 0 0 12.6936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.909 0 12.8872 0 0 0 0 0 0 0 0 0 0 12.6279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1307 0 0 0 0 0 0 0 P11086 PNMT_HUMAN "Phenylethanolamine N-methyltransferase, PNMTase, EC 2.1.1.28 (Noradrenaline N-methyltransferase)" PNMT PENT Homo sapiens (Human) catecholamine biosynthetic process [GO:0042423]; epinephrine biosynthetic process [GO:0042418]; methylation [GO:0032259] cytosol [GO:0005829] cytosol [GO:0005829]; N-methyltransferase activity [GO:0008170]; phenylethanolamine N-methyltransferase activity [GO:0004603]; catecholamine biosynthetic process [GO:0042423]; epinephrine biosynthetic process [GO:0042418]; methylation [GO:0032259] GO:0004603; GO:0005829; GO:0008170; GO:0032259; GO:0042418; GO:0042423 N-methyltransferase activity [GO:0008170]; phenylethanolamine N-methyltransferase activity [GO:0004603] FEPRAYLR 0.99466 -11.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11308 ERG_HUMAN Transcriptional regulator ERG (Transforming protein ERG) ERG Homo sapiens (Human) cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0007165; GO:0030154; GO:0045944; GO:1990837; GO:1990904 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ALQNSPR 0.99466 -10.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1955 0 0 0 0 0 0 0 0 0 12.2257 0 0 0 0 0 0 13.0896 0 0 P11831 SRF_HUMAN "Serum response factor, SRF" SRF Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; angiogenesis involved in wound healing [GO:0060055]; associative learning [GO:0008306]; axon extension [GO:0048675]; bicellular tight junction assembly [GO:0070830]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus cartilage development [GO:0060532]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac myofibril assembly [GO:0055003]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-matrix adhesion [GO:0007160]; cellular response to glucose stimulus [GO:0071333]; cellular senescence [GO:0090398]; dorsal aorta morphogenesis [GO:0035912]; epithelial cell-cell adhesion [GO:0090136]; epithelial structure maintenance [GO:0010669]; erythrocyte development [GO:0048821]; eyelid development in camera-type eye [GO:0061029]; face development [GO:0060324]; filopodium assembly [GO:0046847]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hematopoietic stem cell differentiation [GO:0060218]; hippocampus development [GO:0021766]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; lung morphogenesis [GO:0060425]; lung smooth muscle development [GO:0061145]; megakaryocyte development [GO:0035855]; mesoderm formation [GO:0001707]; morphogenesis of an epithelial sheet [GO:0002011]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of miRNA transcription [GO:1902894]; neuron development [GO:0048666]; neuron migration [GO:0001764]; platelet activation [GO:0030168]; platelet formation [GO:0030220]; positive regulation of axon extension [GO:0045773]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by glucose [GO:0046016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription via serum response element binding [GO:0010735]; positive thymic T cell selection [GO:0045059]; primitive streak formation [GO:0090009]; regulation of cell adhesion [GO:0030155]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of water loss via skin [GO:0033561]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; sarcomere organization [GO:0045214]; skin morphogenesis [GO:0043589]; stress fiber assembly [GO:0043149]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea cartilage development [GO:0060534]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; serum response element binding [GO:0010736]; actin cytoskeleton organization [GO:0030036]; angiogenesis involved in wound healing [GO:0060055]; associative learning [GO:0008306]; axon extension [GO:0048675]; bicellular tight junction assembly [GO:0070830]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus cartilage development [GO:0060532]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac myofibril assembly [GO:0055003]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-matrix adhesion [GO:0007160]; cellular response to glucose stimulus [GO:0071333]; cellular senescence [GO:0090398]; dorsal aorta morphogenesis [GO:0035912]; epithelial cell-cell adhesion [GO:0090136]; epithelial structure maintenance [GO:0010669]; erythrocyte development [GO:0048821]; eyelid development in camera-type eye [GO:0061029]; face development [GO:0060324]; filopodium assembly [GO:0046847]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hematopoietic stem cell differentiation [GO:0060218]; hippocampus development [GO:0021766]; long-term memory [GO:0007616]; long-term synaptic depression [GO:0060292]; lung morphogenesis [GO:0060425]; lung smooth muscle development [GO:0061145]; megakaryocyte development [GO:0035855]; mesoderm formation [GO:0001707]; morphogenesis of an epithelial sheet [GO:0002011]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of miRNA transcription [GO:1902894]; neuron development [GO:0048666]; neuron migration [GO:0001764]; platelet activation [GO:0030168]; platelet formation [GO:0030220]; positive regulation of axon extension [GO:0045773]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by glucose [GO:0046016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription via serum response element binding [GO:0010735]; positive thymic T cell selection [GO:0045059]; primitive streak formation [GO:0090009]; regulation of cell adhesion [GO:0030155]; regulation of smooth muscle cell differentiation [GO:0051150]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of water loss via skin [GO:0033561]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; sarcomere organization [GO:0045214]; skin morphogenesis [GO:0043589]; stress fiber assembly [GO:0043149]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea cartilage development [GO:0060534]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001569; GO:0001666; GO:0001707; GO:0001764; GO:0001829; GO:0001947; GO:0002011; GO:0002042; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007160; GO:0007507; GO:0007616; GO:0008285; GO:0008306; GO:0009636; GO:0009725; GO:0010669; GO:0010735; GO:0010736; GO:0021766; GO:0022028; GO:0030036; GO:0030155; GO:0030168; GO:0030220; GO:0030336; GO:0030878; GO:0031490; GO:0033561; GO:0034097; GO:0035855; GO:0035912; GO:0042803; GO:0042826; GO:0043149; GO:0043589; GO:0045059; GO:0045214; GO:0045597; GO:0045773; GO:0045944; GO:0045987; GO:0046016; GO:0046716; GO:0046847; GO:0048538; GO:0048666; GO:0048675; GO:0048821; GO:0051091; GO:0051150; GO:0051491; GO:0055003; GO:0060055; GO:0060218; GO:0060261; GO:0060292; GO:0060324; GO:0060347; GO:0060379; GO:0060425; GO:0060532; GO:0060534; GO:0060947; GO:0061029; GO:0061145; GO:0061629; GO:0070830; GO:0070878; GO:0071333; GO:0090009; GO:0090136; GO:0090398; GO:0140297; GO:1900222; GO:1902894; GO:1902895; GO:1990837 "chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; serum response element binding [GO:0010736]" LRRYTTFSK 0.99466 -15.375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3718 0 0 0 0 0 0 0 0 13.8902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19474 RO52_HUMAN "E3 ubiquitin-protein ligase TRIM21, EC 2.3.2.27 (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (RING-type E3 ubiquitin transferase TRIM21) (Ro(SS-A)) (Sjoegren syndrome type A antigen, SS-A) (Tripartite motif-containing protein 21)" TRIM21 RNF81 RO52 SSA1 Homo sapiens (Human) cell cycle [GO:0007049]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein deubiquitination [GO:0090086]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of viral entry into host cell [GO:0046598]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of type I interferon production [GO:0032479]; regulation of viral entry into host cell [GO:0046596]; response to interferon-gamma [GO:0034341]; suppression of viral release by host [GO:0044790] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein deubiquitination [GO:0090086]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein binding [GO:0032092]; positive regulation of viral entry into host cell [GO:0046598]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of protein localization [GO:0032880]; regulation of type I interferon production [GO:0032479]; regulation of viral entry into host cell [GO:0046596]; response to interferon-gamma [GO:0034341]; suppression of viral release by host [GO:0044790] GO:0000209; GO:0000932; GO:0003677; GO:0003713; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005829; GO:0006513; GO:0007049; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0019901; GO:0031410; GO:0031648; GO:0032088; GO:0032092; GO:0032479; GO:0032880; GO:0032897; GO:0034341; GO:0042802; GO:0042803; GO:0043123; GO:0044790; GO:0045087; GO:0045787; GO:0045824; GO:0046596; GO:0046598; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070534; GO:0090086; GO:1990904 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] ALCWVCAQSRK 0.99466 -8.2072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6275 0 0 0 0 0 0 0 0 0 0 0 12.5165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7857 0 0 0 0 0 0 0 0 0 0 0 0 11.1685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6517 0 15.6091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30530 UFO_HUMAN "Tyrosine-protein kinase receptor UFO, EC 2.7.10.1 (AXL oncogene)" AXL UFO Homo sapiens (Human) animal organ regeneration [GO:0031100]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral entry into host cell [GO:0046718] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; host cell surface [GO:0044228]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618]; animal organ regeneration [GO:0031100]; blood vessel remodeling [GO:0001974]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interferon-alpha [GO:0035457]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; neutrophil clearance [GO:0097350]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; platelet activation [GO:0030168]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of kinase activity [GO:0033674]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein kinase B signaling [GO:0043491]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vagina development [GO:0060068]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; viral entry into host cell [GO:0046718] GO:0001618; GO:0001764; GO:0001779; GO:0001786; GO:0001961; GO:0001974; GO:0004713; GO:0004714; GO:0005524; GO:0005615; GO:0005886; GO:0005887; GO:0006909; GO:0006954; GO:0007165; GO:0007169; GO:0007283; GO:0007399; GO:0009986; GO:0010936; GO:0015629; GO:0016477; GO:0021885; GO:0030168; GO:0031100; GO:0031668; GO:0032036; GO:0032689; GO:0032720; GO:0032825; GO:0032940; GO:0033674; GO:0034101; GO:0034446; GO:0035457; GO:0042698; GO:0043066; GO:0043231; GO:0043235; GO:0043491; GO:0043524; GO:0043548; GO:0044228; GO:0045087; GO:0046718; GO:0048010; GO:0048469; GO:0048549; GO:0051250; GO:0051402; GO:0051649; GO:0051897; GO:0060068; GO:0070062; GO:0070301; GO:0071222; GO:0097028; GO:0097350; GO:1903902; GO:2000669 ATP binding [GO:0005524]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylserine binding [GO:0001786]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618] AWRCPRMGR 0.99466 -8.4952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8314 0 0 0 0 18.47 0 0 0 14.9771 15.6124 11.5314 0 0 12.5926 13.1686 0 16.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.08762 0 0 0 0 0 0 0 0 0 0 0 0 0 P33991 MCM4_HUMAN "DNA replication licensing factor MCM4, EC 3.6.4.12 (CDC21 homolog) (P1-CDC21)" MCM4 CDC21 Homo sapiens (Human) DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-templated DNA replication initiation [GO:0030174] "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-templated DNA replication initiation [GO:0030174]" GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0006260; GO:0006268; GO:0006271; GO:0016020; GO:0016887; GO:0030174; GO:0042555; GO:0071162; GO:1902975 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697] AVPIRVNPR 0.99466 -12.635 11.3001 0 0 0 0 0 0 0 0 0 0 0 0 12.9411 0 13.1637 0 0 12.9116 0 0 0 0 0 0 0 0 0 0 13.1457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0398 0 0 0 0 0 0 0 0 0 13.3471 0 0 0 12.6105 0 12.4725 0 0 12.5026 0 12.7574 0 0 0 0 0 12.4376 13.4871 0 0 0 0 0 0 0 0 0 0 0 13.0629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2133 0 0 0 0 0 0 0 0 13.72 0 0 0 0 0 0 0 0 0 P48200 IREB2_HUMAN "Iron-responsive element-binding protein 2, IRE-BP 2 (Iron regulatory protein 2, IRP2)" IREB2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; intestinal absorption [GO:0050892]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; tricarboxylic acid cycle [GO:0006099] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; intestinal absorption [GO:0050892]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; tricarboxylic acid cycle [GO:0006099]" GO:0003723; GO:0003994; GO:0005737; GO:0005739; GO:0005829; GO:0006099; GO:0006101; GO:0006782; GO:0006826; GO:0006879; GO:0009791; GO:0030316; GO:0030350; GO:0030371; GO:0034101; GO:0046872; GO:0050892; GO:0051539; GO:0051649; GO:0055072 "4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371]" EDVMNILDWK 0.99466 -11.463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7733 0 0 0 0 0 0 13.8448 0 0 0 0 0 13.6325 0 0 14.1582 0 14.0318 13.7844 0 0 0 0 0 0 0 0 13.3065 13.2553 12.5864 0 0 0 14.1933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49767 VEGFC_HUMAN "Vascular endothelial growth factor C, VEGF-C (Flt4 ligand, Flt4-L) (Vascular endothelial growth factor-related protein, VRP)" VEGFC Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cellular response to leukemia inhibitory factor [GO:1990830]; glial cell proliferation [GO:0014009]; induction of positive chemotaxis [GO:0050930]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of blood pressure [GO:0045776]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate-dependent cell migration [GO:0006929]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093] extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172]; animal organ morphogenesis [GO:0009887]; cellular response to leukemia inhibitory factor [GO:1990830]; glial cell proliferation [GO:0014009]; induction of positive chemotaxis [GO:0050930]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of blood pressure [GO:0045776]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate-dependent cell migration [GO:0006929]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084] GO:0001666; GO:0001934; GO:0001938; GO:0002040; GO:0002052; GO:0005172; GO:0005576; GO:0005615; GO:0006929; GO:0007165; GO:0008083; GO:0008284; GO:0009410; GO:0009887; GO:0014009; GO:0016020; GO:0016331; GO:0030947; GO:0031093; GO:0031954; GO:0038084; GO:0042056; GO:0043185; GO:0043536; GO:0045668; GO:0045766; GO:0045776; GO:0045860; GO:0048010; GO:0050714; GO:0050930; GO:0051781; GO:0060252; GO:0060754; GO:1901492; GO:1902462; GO:1990830 chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172] ACEPGFSYSEEVCR 0.99466 -9.0061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0487 0 0 0 13.6124 14.2391 0 0 0 0 14.537 0 0 0 0 0 0 15.4342 0 0 0 0 0 0 14.84 0 0 0 0 0 0 13.2205 0 0 14.0104 0 0 0 0 12.218 0 0 0 14.387 11.0549 0 0 0 13.3556 0 13.9352 13.6886 0 0 0 0 0 0 0 0 0 0 12.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0841 0 13.641 0 0 0 0 0 0 0 13.3585 0 0 14.8804 0 0 0 P62241 RS8_HUMAN 40S ribosomal protein S8 (Small ribosomal subunit protein eS8) RPS8 OK/SW-cl.83 Homo sapiens (Human) "cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]" GO:0000462; GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022626; GO:0022627; GO:0070062; GO:1990904 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GISRDNWHKR 0.99466 -8.9944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P81172 HEPC_HUMAN "Hepcidin (Liver-expressed antimicrobial peptide 1, LEAP-1) (Putative liver tumor regressor, PLTR) [Cleaved into: Hepcidin-25, Hepc25; Hepcidin-20, Hepc20 ]" HAMP HEPC LEAP1 UNQ487/PRO1003 Homo sapiens (Human) acute-phase response [GO:0006953]; aging [GO:0007568]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular iron ion homeostasis [GO:0006879]; cellular response to bile acid [GO:1903413]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to X-ray [GO:0071481]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; establishment of localization in cell [GO:0051649]; immune response [GO:0006955]; iron ion transmembrane transport [GO:0034755]; killing of cells of another organism [GO:0031640]; liver regeneration [GO:0097421]; macrophage activation [GO:0042116]; multicellular organismal iron ion homeostasis [GO:0060586]; myeloid cell homeostasis [GO:0002262]; negative regulation of bone resorption [GO:0045779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intestinal absorption [GO:1904479]; negative regulation of ion transmembrane transporter activity [GO:0032413]; negative regulation of iron export across plasma membrane [GO:1904039]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of iron ion transmembrane transporter activity [GO:1904255]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of macrophage activation [GO:0043032]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to erythropoietin [GO:0036017]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to iron ion starvation [GO:1990641]; response to vitamin A [GO:0033189]; response to zinc ion [GO:0010043]; transcription by RNA polymerase II [GO:0006366] apical cortex [GO:0045179]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercalated disc [GO:0014704]; nucleus [GO:0005634] apical cortex [GO:0045179]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercalated disc [GO:0014704]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; hormone activity [GO:0005179]; iron ion transmembrane transporter inhibitor activity [GO:0097690]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; aging [GO:0007568]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular iron ion homeostasis [GO:0006879]; cellular response to bile acid [GO:1903413]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to X-ray [GO:0071481]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; establishment of localization in cell [GO:0051649]; immune response [GO:0006955]; iron ion transmembrane transport [GO:0034755]; killing of cells of another organism [GO:0031640]; liver regeneration [GO:0097421]; macrophage activation [GO:0042116]; multicellular organismal iron ion homeostasis [GO:0060586]; myeloid cell homeostasis [GO:0002262]; negative regulation of bone resorption [GO:0045779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intestinal absorption [GO:1904479]; negative regulation of ion transmembrane transporter activity [GO:0032413]; negative regulation of iron export across plasma membrane [GO:1904039]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of iron ion transmembrane transporter activity [GO:1904255]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of macrophage activation [GO:0043032]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to erythropoietin [GO:0036017]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to iron ion starvation [GO:1990641]; response to vitamin A [GO:0033189]; response to zinc ion [GO:0010043]; transcription by RNA polymerase II [GO:0006366] GO:0000122; GO:0002092; GO:0002262; GO:0005102; GO:0005179; GO:0005507; GO:0005576; GO:0005615; GO:0005634; GO:0006366; GO:0006879; GO:0006953; GO:0006955; GO:0007259; GO:0007568; GO:0010039; GO:0010043; GO:0014704; GO:0030163; GO:0031640; GO:0032413; GO:0033189; GO:0034755; GO:0034760; GO:0036017; GO:0042116; GO:0042742; GO:0043032; GO:0045179; GO:0045471; GO:0045732; GO:0045779; GO:0045944; GO:0050728; GO:0050829; GO:0050830; GO:0050832; GO:0051649; GO:0060586; GO:0061051; GO:0061844; GO:0071222; GO:0071354; GO:0071356; GO:0071481; GO:0097421; GO:0097690; GO:1902916; GO:1903413; GO:1904039; GO:1904255; GO:1904479; GO:1990641; GO:2000646 copper ion binding [GO:0005507]; hormone activity [GO:0005179]; iron ion transmembrane transporter inhibitor activity [GO:0097690]; signaling receptor binding [GO:0005102] ASWMPMFQRR 0.99466 -5.329 0 0 0 0 0 0 0 0 0 0 0 0 11.0145 0 13.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0651 0 0 11.3893 0 10.3588 12.4816 0 10.3844 0 0 0 0 0 0 0 0 0 0 0 0 12.2957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1778 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8834 13.4547 13.6757 13.5833 13.1411 13.1171 0 12.9845 0 11.5159 0 0 0 0 0 0 0 13.2747 0 0 0 0 12.4025 0 13.15 0 11.6088 0 0 0 12.3716 12.8292 0 0 11.7378 0 0 0 0 0 12.6554 0 0 11.877 0 0 0 0 0 0 0 0 0 0 0 14.1905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7458 0 0 0 0 0 0 11.4918 0 0 11.4345 0 0 0 0 0 0 0 0 0 0 Q00688 FKBP3_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP3, PPIase FKBP3, EC 5.2.1.8 (25 kDa FK506-binding protein, 25 kDa FKBP, FKBP-25) (FK506-binding protein 3, FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase)" FKBP3 FKBP25 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023] GO:0003723; GO:0003755; GO:0005528; GO:0005634; GO:0038023 FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023] ARLEIEPEWAYGK 0.99466 -8.2011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.253 0 0 12.9124 13.5099 14.3684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0504 0 13.2929 0 0 0 0 16.1304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7992 0 0 0 0 0 0 0 0 0 0 0 13.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6608 0 0 0 0 0 0 0 0 0 12.7974 0 0 0 0 Q05048 CSTF1_HUMAN "Cleavage stimulation factor subunit 1 (CF-1 50 kDa subunit) (Cleavage stimulation factor 50 kDa subunit, CSTF 50 kDa subunit, CstF-50)" CSTF1 Homo sapiens (Human) mRNA 3'-end processing [GO:0031124] mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654] mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124] GO:0003723; GO:0005654; GO:0005848; GO:0031124 RNA binding [GO:0003723] TISLCCWDSR 0.99466 -5.3212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXM1 LRIG3_HUMAN "Leucine-rich repeats and immunoglobulin-like domains protein 3, LIG-3" LRIG3 LIG3 UNQ287/PRO326/PRO335 Homo sapiens (Human) otolith morphogenesis [GO:0032474] cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasmic vesicle membrane [GO:0030659]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474] GO:0005615; GO:0005886; GO:0016021; GO:0030659; GO:0031012; GO:0032474 ECYPCSHPSEESCER 0.99466 -11.122 0 0 0 0 12.8482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8145 0 0 12.8541 0 0 0 0 0 0 0 0 0 0 0 12.7877 0 0 0 0 0 0 12.5851 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4885 13.857 0 0 0 0 0 0 0 13.3433 0 0 12.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9221 0 0 11.7819 0 11.4868 0 0 0 11.6516 14.4136 0 0 0 0 0 0 0 0 0 0 0 0 11.8141 15.0896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2936 14.5713 0 0 0 0 0 12.7756 0 0 0 0 0 0 0 0 0 13.2205 12.7461 0 0 0 0 0 11.8805 11.407 Q8NDY3 ARHL1_HUMAN Inactive ADP-ribosyltransferase ARH2 (ADP-ribosylhydrolase-like protein 1) ([Protein ADP-ribosylarginine] hydrolase-like protein 1) ADPRHL1 ARH2 Homo sapiens (Human) cardiac chamber ballooning [GO:0003242]; cardiac myofibril assembly [GO:0055003]; protein de-ADP-ribosylation [GO:0051725] sarcomere [GO:0030017] sarcomere [GO:0030017]; ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; cardiac chamber ballooning [GO:0003242]; cardiac myofibril assembly [GO:0055003]; protein de-ADP-ribosylation [GO:0051725] GO:0000287; GO:0003242; GO:0003875; GO:0030017; GO:0051725; GO:0055003 ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287] CYVEIVEKLPERR 0.99466 -12.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3233 0 13.3746 0 12.8362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.505 12.5264 0 0 0 0 0 0 12.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9019 0 0 0 11.1577 Q8WTQ1 D104A_HUMAN "Beta-defensin 104 (Beta-defensin 4, BD-4, DEFB-4, hBD-4) (Defensin, beta 104)" DEFB104A DEFB104 DEFB4; DEFB104B Homo sapiens (Human) cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; monocyte chemotaxis [GO:0002548]; positive chemotaxis [GO:0050918] extracellular region [GO:0005576] extracellular region [GO:0005576]; chemoattractant activity [GO:0042056]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; monocyte chemotaxis [GO:0002548]; positive chemotaxis [GO:0050918] GO:0002548; GO:0005576; GO:0042056; GO:0045087; GO:0050829; GO:0050830; GO:0050918; GO:1904628 chemoattractant activity [GO:0042056] CRSQEYR 0.99466 -11.468 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1214 0 0 0 0 0 0 12.1536 0 0 0 12.2116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4366 0 0 0 0 0 0 0 0 0 Q8WWZ7 ABCA5_HUMAN "Cholesterol transporter ABCA5, EC 7.6.2.- (ATP-binding cassette sub-family A member 5)" ABCA5 KIAA1888 Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691] GO:0000139; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005794; GO:0005886; GO:0006869; GO:0008203; GO:0010745; GO:0010874; GO:0016021; GO:0031902; GO:0033344; GO:0034375; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0140359; GO:1903064 ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319] DFLLSRKVK 0.99466 -8.9975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3856 0 0 0 0 0 0 0 0 0 0 12.7407 0 11.9866 0 0 0 0 0 0 13.3884 12.5211 11.6691 0 0 0 0 0 0 0 0 0 0 13.2387 0 10.3078 0 13.4946 0 0 0 12.9115 0 0 0 0 0 0 19.0686 0 0 0 13.3337 14.2789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.962 0 14.6734 0 0 0 0 19.3905 0 0 0 13.9455 17.6956 0 0 0 0 0 14.586 18.417 0 0 0 13.7376 0 0 0 13.453 12.416 13.5567 12.1532 0 14.6676 0 13.7074 0 0 0 11.8868 0 0 0 0 0 0 0 0 19.257 0 0 0 11.4602 0 0 0 0 0 0 0 0 0 0 0 13.6965 0 0 0 0 0 0 0 0 Q96JP9 CDHR1_HUMAN "Cadherin-related family member 1 (Photoreceptor cadherin, prCAD) (Protocadherin-21)" CDHR1 KIAA1775 PCDH21 PRCAD Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845] integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622] integral component of plasma membrane [GO:0005887]; photoreceptor outer segment membrane [GO:0042622]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; photoreceptor cell outer segment organization [GO:0035845] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0008594; GO:0035845; GO:0042622; GO:0045494 calcium ion binding [GO:0005509] FNLQLVGPRGIFR 0.99466 -5.3223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3676 15.095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.509 0 0 0 Q99536 VAT1_HUMAN "Synaptic vesicle membrane protein VAT-1 homolog, EC 1.-.-.-" VAT1 Homo sapiens (Human) negative regulation of mitochondrial fusion [GO:0010637] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; negative regulation of mitochondrial fusion [GO:0010637] GO:0005576; GO:0005741; GO:0008270; GO:0010637; GO:0016021; GO:0016491; GO:0035578; GO:0070062 oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] KNVGKVLLVPGPEK 0.99466 -5.3297 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4066 0 0 Q9BXJ9 NAA15_HUMAN "N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100)" NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) "angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NatA complex [GO:0031415]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]" GO:0001525; GO:0003723; GO:0005634; GO:0005667; GO:0005737; GO:0005829; GO:0006474; GO:0016020; GO:0016604; GO:0017196; GO:0030154; GO:0031415; GO:0043022; GO:0043066; GO:0043231; GO:0045893; GO:0050821 ribosome binding [GO:0043022]; RNA binding [GO:0003723] EAEEMCSK 0.99466 -11.124 0 0 0 0 0 0 0 0 0 0 12.1099 0 0 0 0 12.0195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4351 0 13.1498 0 0 0 13.0452 0 0 13.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9665 0 0 0 0 0 0 0 0 0 13.0192 0 0 0 0 0 0 0 0 0 0 0 0 13.1734 0 0 0 0 0 0 0 0 0 0 0 12.8466 0 0 13.4729 0 0 0 12.6756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZB8 CPEB1_HUMAN "Cytoplasmic polyadenylation element-binding protein 1, CPE-BP1, CPE-binding protein 1, h-CPEB, hCPEB-1" CPEB1 CPEB Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; synapse [GO:0045202] "anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; positive regulation of mRNA polyadenylation [GO:1900365]" GO:0000900; GO:0000932; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0032869; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0046872; GO:0070161; GO:0071230; GO:0071456; GO:1900365; GO:1990124; GO:2000766 "metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]" MSSRRMR 0.99466 -15.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1D0 TRPV6_HUMAN "Transient receptor potential cation channel subfamily V member 6, TrpV6 (CaT-like, CaT-L) (Calcium transport protein 1, CaT1) (Epithelial calcium channel 2, ECaC2)" TRPV6 ECAC2 Homo sapiens (Human) calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592] calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] calcium channel complex [GO:0034704]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592] GO:0005216; GO:0005262; GO:0005516; GO:0005886; GO:0005887; GO:0006816; GO:0017158; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703 calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872] ALLARRASVSAR 0.99466 -8.224 0 0 0 0 0 0 0 0 9.85773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9081 0 0 0 0 0 0 0 0 0 0 0 0 0 11.643 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1472 0 0 11.6332 0 0 0 13.972 0 14.1941 12.6563 0 0 0 0 0 0 0 11.9424 0 0 13.1492 0 0 13.4718 0 0 0 0 0 13.5786 15.7238 0 0 0 0 0 0 0 0 0 0 0 11.8324 12.3864 0 0 13.1504 0 11.3523 13.4896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8369 0 11.9998 0 0 0 12.2348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6275 0 0 0 0 0 0 0 0 13.0749 0 0 11.7761 0 0 0 0 0 0 0 0 0 Q9NR83 S2A4R_HUMAN "SLC2A4 regulator (GLUT4 enhancer factor, GEF) (Huntington disease gene regulatory region-binding protein 1, HDBP-1)" SLC2A4RG HDBP1 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0016607; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AEAPWLR 0.99466 -8.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8283 Q9Y3A2 UTP11_HUMAN "Probable U3 small nucleolar RNA-associated protein 11, U3 snoRNA-associated protein 11 (UTP11-like protein)" UTP11 UTP11L CGI-94 HDCMB12P Homo sapiens (Human) nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; rRNA processing [GO:0006364] GO:0003723; GO:0005615; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0007399; GO:0032040; GO:0043065 RNA binding [GO:0003723] EKVKGVTNQTGLK 0.99466 -8.1924 0 0 0 0 0 0 0 0 0 0 0 14.2608 13.9509 13.7295 12.9038 0 0 0 0 0 0 10.8794 0 0 0 0 0 0 0 12.673 0 12.8782 14.5074 0 0 12.5274 12.0631 0 0 0 12.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0343 0 0 0 0 0 0 0 0 0 14.5118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7138 0 0 0 0 0 14.8292 0 0 0 15.0105 0 0 0 0 0 0 14.4824 0 0 Q2TB90 HKDC1_HUMAN "Hexokinase HKDC1, EC 2.7.1.1 (Hexokinase domain-containing protein 1)" HKDC1 Homo sapiens (Human) carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096] GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005737; GO:0005739; GO:0005829; GO:0006006; GO:0006096; GO:0008865; GO:0031966; GO:0046835; GO:0051156 ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536] AELEYGLK 0.99467 -31.244 0 0 10.7134 12.0109 13.634 0 0 11.2668 0 14.6766 14.3644 14.3294 13.4047 15.1008 13.5741 17.5811 17.1489 17.6655 15.7131 0 15.0983 0 16.3546 0 17.7538 17.6426 18.2767 18.2063 17.7714 18.0637 0 14.3142 17.9061 17.9466 0 0 17.9462 17.9487 18.054 18.0191 18.2786 0 18.3138 18.266 18.2852 18.1075 18.2668 0 18.0422 18.3635 18.1259 0 18.0203 17.6117 17.9818 15.0883 14.8046 18.5644 18.4267 18.1694 13.1908 17.0102 13.5948 0 0 0 12.6026 12.6807 13.7691 0 13.1826 0 0 0 0 0 0 0 11.9717 12.9536 11.9442 10.9353 15.2141 13.4817 0 0 13.7081 15.027 0 0 14.089 0 12.4651 0 0 0 0 15.6688 0 12.1876 11.8507 0 0 0 0 13.9854 11.9276 14.1613 0 0 13.0122 14.4767 13.2165 0 13.1065 18.8238 12.8539 17.6457 12.6066 14.0579 0 13.3767 13.9481 12.8382 0 14.1209 0 12.9015 14.4635 14.1229 14.4297 0 13.2454 14.1566 14.7931 0 0 13.7135 0 14.5325 0 13.5211 13.836 0 0 13.3277 0 17.2691 17.2662 0 0 0 0 0 0 0 0 17.6729 16.0215 16.1902 17.7305 17.7525 16.6141 17.8763 17.8162 17.843 16.2378 10.139 16.8028 16.224 16.2815 12.2159 0 0 17.6601 13.6624 13.3334 16.67 18.4105 17.1365 A8K7I4 CLCA1_HUMAN "Calcium-activated chloride channel regulator 1, EC 3.4.-.- (Calcium-activated chloride channel family member 1, hCLCA1) (Calcium-activated chloride channel protein 1, CaCC-1, hCaCC-1)" CLCA1 CACC1 Homo sapiens (Human) calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; zymogen granule membrane [GO:0042589]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; calcium ion transport [GO:0006816]; cellular response to hypoxia [GO:0071456]; ion transmembrane transport [GO:0034220]; proteolysis [GO:0006508] GO:0004222; GO:0005229; GO:0005254; GO:0005615; GO:0005886; GO:0005887; GO:0005902; GO:0006508; GO:0006816; GO:0034220; GO:0042589; GO:0046872; GO:0071456 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] NVAILIPETWKTKADYVR 0.99467 -8.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4992 0 0 15.6938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2111 0 0 O75095 MEGF6_HUMAN "Multiple epidermal growth factor-like domains protein 6, Multiple EGF-like domains protein 6 (Epidermal growth factor-like protein 3, EGF-like protein 3)" MEGF6 EGFL3 KIAA0815 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509] GO:0005509; GO:0005576 calcium ion binding [GO:0005509] AAGRAVVLALVLLLLPAVPVGASVPPR 0.99467 -31.373 11.5428 0 0 0 0 0 0 0 12.2538 14.1335 0 13.5126 12.9052 12.0247 0 0 10.7964 12.2223 0 0 0 0 11.5035 0 0 0 0 11.8754 0 0 11.3344 0 14.6376 0 0 15.7334 0 0 0 0 15.46 0 11.0881 14.993 14.4856 0 0 0 0 0 0 0 0 0 10.9256 0 0 0 10.9468 0 0 0 0 0 10.9846 0 11.5081 12.0579 0 0 12.3163 0 11.0336 0 0 0 12.1843 0 0 0 16.7685 13.3153 11.8636 0 0 0 0 12.8067 13.2067 12.4307 11.3321 11.2132 0 12.8115 0 0 0 0 0 0 0 0 14.807 0 0 12.646 0 0 0 0 0 13.3619 0 0 0 12.2625 0 11.4872 0 0 0 0 0 0 0 0 12.197 0 0 14.64 0 0 0 13.2377 0 0 12.6293 0 11.9471 12.7282 0 0 0 11.3065 0 0 11.1908 0 0 12.7364 0 0 0 0 0 13.5436 0 0 14.6749 15.6515 10.6033 0 0 0 0 0 0 0 17.6772 17.6862 11.66 0 0 13.0965 0 10.5573 11.5778 14.0652 0 16.9466 O94772 LY6H_HUMAN "Lymphocyte antigen 6H, Ly-6H" LY6H Homo sapiens (Human) acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; nervous system development [GO:0007399] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]; acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; nervous system development [GO:0007399] GO:0005576; GO:0005886; GO:0007399; GO:0009887; GO:0030550; GO:0031225; GO:0033130; GO:0045202; GO:0095500 acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550] DHSVNKMCASSCDFVK 0.99467 -8.2707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1097 0 0 0 0 0 0 0 0 0 10.8988 0 0 0 0 0 0 0 0 0 0 0 12.1744 0 0 0 11.1703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95388 CCN4_HUMAN "CCN family member 4 (WNT1-inducible-signaling pathway protein 1, WISP-1) (Wnt-1-induced secreted protein)" CCN4 WISP1 Homo sapiens (Human) bone development [GO:0060348]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; negative regulation of cell death [GO:0060548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of fat cell differentiation [GO:0045599]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; positive regulation of inflammatory response [GO:0050729]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of cytokine production [GO:0001817]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; bone development [GO:0060348]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; negative regulation of cell death [GO:0060548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of fat cell differentiation [GO:0045599]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; positive regulation of inflammatory response [GO:0050729]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of cytokine production [GO:0001817]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0001649; GO:0001817; GO:0005178; GO:0005615; GO:0005829; GO:0007155; GO:0007165; GO:0007267; GO:0008201; GO:0014911; GO:0016055; GO:0030177; GO:0030316; GO:0031012; GO:0032331; GO:0042593; GO:0045599; GO:0045669; GO:0048661; GO:0050729; GO:0060348; GO:0060548; GO:0090303 heparin binding [GO:0008201]; integrin binding [GO:0005178] LWCPHPRR 0.99467 -5.3601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0159 0 0 15.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29034 S10A2_HUMAN Protein S100-A2 (CAN19) (Protein S-100L) (S100 calcium-binding protein A2) S100A2 S100L Homo sapiens (Human) endothelial cell migration [GO:0043542] calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]; endothelial cell migration [GO:0043542] GO:0005509; GO:0042802; GO:0043542; GO:0046914; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914] VDEEGLK 0.99467 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15459 SF3A1_HUMAN "Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114, SAP 114)" SF3A1 SAP114 Homo sapiens (Human) "mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]" GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0016607; GO:0045292; GO:0071004; GO:0071005; GO:0071013; GO:1903241 RNA binding [GO:0003723] AEEPPSQLDQDTQVQDMDEGSDDEEEGQK 0.99467 -8.2793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0318 0 0 0 0 13.2852 0 0 0 0 0 13.4285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0619 0 12.2187 0 0 0 0 0 0 0 12.4808 14.9473 0 13.0387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2214 0 0 0 0 0 0 0 0 0 0 0 11.741 0 0 0 0 0 0 0 0 10.0531 0 0 0 0 0 0 13.001 0 0 0 0 0 14.575 0 0 0 0 0 0 0 0 0 Q5GH77 XKR3_HUMAN XK-related protein 3 (X Kell blood group-related 3) (XTES) XKR3 XRG3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 FLEVISRVVTLAFFIASLKLK 0.99467 -8.2726 0 0 0 0 0 0 0 0 17.4818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0206 0 0 0 0 0 0 0 0 0 13.356 0 0 0 0 0 0 0 0 0 0 0 12.661 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0098 0 0 0 0 0 0 0 13.2101 0 0 0 12.2346 0 0 0 0 0 0 0 0 0 0 11.9917 0 0 0 11.3737 0 14.7073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.749 12.1184 0 0 0 0 0 0 0 0 0 0 0 0 14.7571 0 0 0 9.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86TA1 MOB3B_HUMAN "MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B, MOB kinase activator-like 2B)" MOB3B C9orf35 MOBKL2B Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; regulation of hippo signaling [GO:0035330]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; regulation of hippo signaling [GO:0035330]; signal transduction [GO:0007165] GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0030295; GO:0035330; GO:0046872 metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] TCPVMSGGPK 0.99467 -5.3546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2618 0 0 0 0 0 11.1635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBJ9 SIDT2_HUMAN SID1 transmembrane family member 2 SIDT2 CGI-40 PSEC0072 UNQ685/PRO1325 Homo sapiens (Human) cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033]; cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342] GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0016021; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0051033; GO:0061178 AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033] GAPLLFVVRQKEAVVSFQVPLILR 0.99467 -8.5058 0 0 0 0 0 0 11.3188 0 0 0 0 0 9.57143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3175 0 0 10.9586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0981 0 16.6112 0 10.2622 0 0 11.9381 0 0 11.1665 0 11.8033 10.2977 17.3103 0 0 9.67552 0 0 0 0 0 0 14.9381 0 0 0 10.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3992 0 0 0 11.1415 0 0 0 0 0 10.4418 0 0 0 14.9204 0 0 0 14.978 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXU2 DAAF4_HUMAN Dynein axonemal assembly factor 4 (Dyslexia susceptibility 1 candidate gene 1 protein) DNAAF4 DYX1C1 EKN1 Homo sapiens (Human) cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; learning or memory [GO:0007611]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nuclear estrogen receptor binding [GO:0030331]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; learning or memory [GO:0007611]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136] GO:0001764; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0007611; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0043005; GO:0051649; GO:0061136; GO:0097730; GO:0120293 nuclear estrogen receptor binding [GO:0030331] ALEAWKEYQR 0.99467 -12.737 0 0 0 0 0 0 0 0 0 0 0 0 11.0299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3518 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6399 0 0 0 0 12.8638 0 0 0 0 0 0 0 0 0 12.6219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9927 0 0 0 0 0 0 0 0 0 0 Q92759 TF2H4_HUMAN "General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit, BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit)" GTF2H4 Homo sapiens (Human) DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675] core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; double-stranded DNA binding [GO:0003690]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366] GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006366; GO:0016251; GO:0016607; GO:0070816 ATPase activator activity [GO:0001671]; double-stranded DNA binding [GO:0003690]; RNA polymerase II general transcription initiation factor activity [GO:0016251] AHPVMLK 0.99467 -8.4957 0 0 0 0 0 0 0 0 0 0 0 9.51777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.076 0 0 0 0 0 0 11.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4027 0 0 0 0 0 0 0 0 0 14.0506 0 0 0 0 13.0909 0 0 0 0 0 0 15.8271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7138 0 0 0 13.1553 0 10.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IS3 RAX2_HUMAN Retina and anterior neural fold homeobox protein 2 (Q50-type retinal homeobox protein) (Retina and anterior neural fold homeobox-like protein 1) RAX2 QRX RAXL1 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007601; GO:0045944; GO:0050896 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" VHLPEVR 0.99467 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2668 12.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6653 14.2136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.495 0 0 0 0 0 0 Q9NQC1 JADE2_HUMAN "E3 ubiquitin-protein ligase Jade-2, EC 2.3.2.27 (Jade family PHD finger protein 2) (PHD finger protein 15)" JADE2 KIAA0239 PHF15 Homo sapiens (Human) histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular exosome [GO:0070062]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654] extracellular exosome [GO:0070062]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; histone modification [GO:0016570]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000123; GO:0005654; GO:0006275; GO:0006357; GO:0016567; GO:0016570; GO:0016740; GO:0043966; GO:0043981; GO:0043982; GO:0043983; GO:0046872; GO:0051726; GO:0070062; GO:2000278 metal ion binding [GO:0046872]; transferase activity [GO:0016740] LFTHLRQDLERVR 0.99467 -15.481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.995 0 13.7693 13.4915 13.1451 13.4637 0 0 0 11.1848 0 0 0 12.5753 13.5955 0 0 0 9.64519 0 0 11.3187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.133 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3048 0 0 10.0974 0 0 0 0 0 Q9P2Y4 ZN219_HUMAN Zinc finger protein 219 ZNF219 Homo sapiens (Human) "limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]" integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; limb bud formation [GO:0060174]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurotransmitter levels [GO:0001505]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001505; GO:0003677; GO:0003700; GO:0004969; GO:0005634; GO:0005654; GO:0006355; GO:0016021; GO:0032332; GO:0045892; GO:0045944; GO:0046872; GO:0060174 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histamine receptor activity [GO:0004969]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ALLREAR 0.99467 -12.735 11.5571 0 0 0 0 0 0 0 0 10.9364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0067 12.3787 0 0 12.0932 0 0 18.4258 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8544 0 10.839 0 12.2146 0 0 0 0 0 0 0 0 12.5331 0 0 0 0 Q9UNX3 RL26L_HUMAN 60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1) RPL26L1 RPL26P1 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273] cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062] cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273] GO:0002181; GO:0003723; GO:0003735; GO:0022625; GO:0042273; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ANGTTVHVGIHPSK 0.99467 -8.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MWV9 SM34A_HUMAN Small integral membrane protein 34 SMIM34 SMIM34A Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LASNILRKNDK 0.99468 -8.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5054 12.0871 0 0 9.81657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7629 0 12.2859 0 0 0 0 0 13.3183 0 0 0 0 13.0943 12.3571 0 13.3469 0 0 0 12.625 0 0 14.2505 12.1696 0 0 0 0 0 0 0 13.682 12.2689 13.4951 0 0 0 0 0 0 13.8234 0 0 14.5601 0 0 0 12.6613 0 0 0 0 0 0 0 0 12.3593 0 0 0 0 12.5013 0 11.1996 0 0 11.5296 12.5237 0 13.3045 0 0 0 0 0 0 0 0 0 0 12.3491 0 0 0 0 0 0 0 11.8485 13.7713 0 12.4217 0 12.0428 0 0 0 0 0 0 0 0 P56696 KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4) KCNQ4 Homo sapiens (Human) inner ear morphogenesis [GO:0042472]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of sound [GO:0007605] basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] basal plasma membrane [GO:0009925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; inner ear morphogenesis [GO:0042472]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sensory perception of sound [GO:0007605] GO:0005249; GO:0005251; GO:0005267; GO:0005516; GO:0005886; GO:0006813; GO:0007605; GO:0008076; GO:0009925; GO:0016021; GO:0034765; GO:0042472; GO:0071805 calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249] ILKFLVAK 0.99468 -32.013 0 0 0 0 0 0 0 0 15.2839 0 14.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3737 0 14.0426 0 0 0 0 0 0 13.0494 0 0 16.096 0 0 14.7062 0 13.0896 0 0 0 14.5941 11.6177 13.9483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6139 0 0 0 0 0 0 13.09 0 0 0 0 0 14.8344 14.6208 0 0 15.5681 0 0 14.6868 0 0 0 0 0 0 13.8374 0 0 0 0 0 0 0 0 14.9504 0 0 0 0 0 0 0 0 0 17.3173 0 0 12.5413 0 13.8548 12.7342 12.0172 0 0 12.1542 0 0 13.6792 13.3316 0 0 12.4658 0 0 13.4724 13.6347 12.6059 12.4066 0 0 0 13.5608 0 14.3033 0 0 0 0 14.3869 0 0 14.6933 12.4703 0 0 0 12.2699 13.8186 14.0755 0 13.6797 0 13.3224 0 9.84227 0 0 0 14.3511 0 0 0 14.5317 0 14.1238 0 0 0 0 0 0 P61009 SPCS3_HUMAN "Signal peptidase complex subunit 3 (Microsomal signal peptidase 22/23 kDa subunit, SPC22/23, SPase 22/23 kDa subunit)" SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) protein targeting to ER [GO:0045047]; proteolysis [GO:0006508]; signal peptide processing [GO:0006465]; viral protein processing [GO:0019082] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; signal peptidase complex [GO:0005787]; protein targeting to ER [GO:0045047]; proteolysis [GO:0006508]; signal peptide processing [GO:0006465]; viral protein processing [GO:0019082] GO:0005783; GO:0005787; GO:0005789; GO:0006465; GO:0006508; GO:0016021; GO:0019082; GO:0045047 LLLKDMK 0.99468 -10.636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9604 0 0 12.1057 0 0 0 0 11.1834 0 0 0 0 0 0 17.2263 0 0 0 0 0 0 0 0 0 15.3976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2338 12.1864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12840 KIF5A_HUMAN "Kinesin heavy chain isoform 5A (Kinesin heavy chain neuron-specific 1) (Neuronal kinesin heavy chain, NKHC)" KIF5A NKHC1 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192] axon cytoplasm [GO:1904115]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202] axon cytoplasm [GO:1904115]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; retrograde neuronal dense core vesicle transport [GO:1990049]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192] GO:0003774; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007268; GO:0007411; GO:0008017; GO:0008574; GO:0016020; GO:0016192; GO:0016887; GO:0019894; GO:0030705; GO:0032839; GO:0035253; GO:0043204; GO:0045202; GO:0048471; GO:0048489; GO:0098971; GO:0099641; GO:1904115; GO:1990049 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574] DIFNHIYSMDENLEFHIK 0.99468 -5.3811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8173 0 16.5974 0 0 12.7383 0 0 0 0 0 0 0 0 0 0 0 0 0 15.125 0 0 0 12.2656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13404 UB2V1_HUMAN "Ubiquitin-conjugating enzyme E2 variant 1, UEV-1 (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)" UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19 Homo sapiens (Human) "cell differentiation [GO:0030154]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of transcription, DNA-templated [GO:0045893]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of DNA repair [GO:0006282]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-UEV1A complex [GO:0035370]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-UEV1A complex [GO:0035370]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; cell differentiation [GO:0030154]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of transcription, DNA-templated [GO:0045893]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of DNA repair [GO:0006282]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000151; GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006282; GO:0006301; GO:0006355; GO:0030154; GO:0031371; GO:0032991; GO:0035370; GO:0043123; GO:0045893; GO:0051092; GO:0070062; GO:0070534; GO:1902523; GO:1902533 AISVLAKWQNSYSIKVVLQELR 0.99468 -10.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13526 PIN1_HUMAN "Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, EC 5.2.1.8 (Peptidyl-prolyl cis-trans isomerase Pin1, PPIase Pin1) (Rotamase Pin1)" PIN1 Homo sapiens (Human) cell cycle [GO:0007049]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cytokinesis [GO:0032465]; regulation of gene expression [GO:0010468]; regulation of mitotic nuclear division [GO:0007088]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; synapse organization [GO:0050808] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; cytoskeletal motor activity [GO:0003774]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; tau protein binding [GO:0048156]; cell cycle [GO:0007049]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein binding [GO:0032092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; regulation of cytokinesis [GO:0032465]; regulation of gene expression [GO:0010468]; regulation of mitotic nuclear division [GO:0007088]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein phosphorylation [GO:0001932]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; synapse organization [GO:0050808] GO:0000413; GO:0001666; GO:0001932; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007049; GO:0007088; GO:0008013; GO:0010468; GO:0016607; GO:0016859; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0031647; GO:0032091; GO:0032092; GO:0032465; GO:0032794; GO:0035307; GO:0036064; GO:0042177; GO:0043547; GO:0045944; GO:0048156; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0051443; GO:0060393; GO:0070373; GO:0090263; GO:0098978; GO:0099524; GO:1900180; GO:1902430; GO:2000146 beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; cytoskeletal motor activity [GO:0003774]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; tau protein binding [GO:0048156] EEALELINGYIQK 0.99468 -8.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2KHT4 GSG1_HUMAN Germ cell-specific gene 1 protein GSG1 UNQ709/PRO1360 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005789; GO:0005886; GO:0016021 ALRSSGTAAAK 0.99468 -5.3693 0 0 0 0 0 0 0 0 0 11.8153 0 12.9067 0 12.57 11.9364 12.4351 12.2175 12.5684 13.0703 12.6446 11.9717 0 0 0 0 0 12.5631 12.6446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1791 0 0 0 12.3114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0986 0 0 0 0 0 0 0 0 0 13.3759 0 0 0 0 0 13.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4842 14.4383 0 0 0 0 0 0 13.7376 0 0 0 11.9783 0 0 0 12.9625 0 0 14.6937 12.7889 0 0 0 0 0 14.0478 0 0 14.6141 14.4024 0 0 14.3292 13.1276 0 0 0 0 0 0 0 0 0 12.0894 14.5249 0 0 0 0 13.766 0 0 14.1917 14.6876 14.6564 0 0 0 0 14.5807 0 0 13.7727 0 0 0 0 0 Q5TCX8 M3K21_HUMAN "Mitogen-activated protein kinase kinase kinase 21, EC 2.7.11.25 (Mitogen-activated protein kinase kinase kinase MLK4) (Mixed lineage kinase 4)" MAP3K21 KIAA1804 MLK4 Homo sapiens (Human) protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0004672; GO:0004706; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0042803; GO:0046777; GO:0106310 ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] DYTVPLCRMR 0.99468 -5.3709 0 0 0 0 0 0 0 0 0 14.1692 0 0 0 0 13.5666 0 0 0 0 0 13.3471 0 0 0 0 0 0 13.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2494 0 0 0 0 13.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8722 0 11.6229 0 13.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7355 0 Q7L3T8 SYPM_HUMAN "Probable proline--tRNA ligase, mitochondrial, EC 6.1.1.15 (Prolyl-tRNA synthetase, ProRS)" PARS2 Homo sapiens (Human) prolyl-tRNA aminoacylation [GO:0006433] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; prolyl-tRNA aminoacylation [GO:0006433] GO:0004827; GO:0005524; GO:0005739; GO:0005759; GO:0006433; GO:0042802 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827] GRRLLLSR 0.99468 -13.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9523 0 0 0 13.9515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5728 0 0 Q86YS7 C2CD5_HUMAN C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa) C2CD5 CDP138 KIAA0528 Homo sapiens (Human) cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659] GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0032869; GO:0034451; GO:0038028; GO:0065002; GO:0072659; GO:0090314 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544] AMTVEKASPVGDGNFR 0.99468 -5.3939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7017 0 0 0 0 0 10.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5466 0 14.8786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N145 LGI3_HUMAN Leucine-rich repeat LGI family member 3 (LGI1-like protein 4) (Leucine-rich glioma-inactivated protein 3) LGI3 LGIL4 UNQ8190/PRO23199 Homo sapiens (Human) exocytosis [GO:0006887]; regulation of exocytosis [GO:0017157] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]; exocytosis [GO:0006887]; regulation of exocytosis [GO:0017157] GO:0005576; GO:0006887; GO:0008021; GO:0017157; GO:0043005; GO:0070161 GQTLVYRHIVVDLSA 0.99468 -10.622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96BQ5 CC127_HUMAN Coiled-coil domain-containing protein 127 CCDC127 Homo sapiens (Human) ADGGDGSRWNYALLVPMLGLAAFRWIWSR 0.99468 -13.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0498 0 0 0 0 0 0 0 0 0 0 0 0 12.8568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSC5 HOME3_HUMAN "Homer protein homolog 3, Homer-3" HOMER3 Homo sapiens (Human) G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of store-operated calcium entry [GO:2001256] anchoring junction [GO:0070161]; basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; G protein-coupled glutamate receptor binding [GO:0035256]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; protein targeting [GO:0006605]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]; regulation of store-operated calcium entry [GO:2001256] GO:0005737; GO:0005829; GO:0005886; GO:0006605; GO:0007216; GO:0008022; GO:0014069; GO:0019904; GO:0030425; GO:0032703; GO:0035256; GO:0042802; GO:0045178; GO:0070161; GO:0070885; GO:0098962; GO:0098978; GO:2001256 G protein-coupled glutamate receptor binding [GO:0035256]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904] NAELEHQLR 0.99468 -10.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8638 0 0 0 0 0 0 0 0 0 0 0 0 13.7553 13.8693 0 0 0 0 0 0 0 15.1716 14.1226 0 0 0 0 0 0 0 0 0 Q9Y5F6 PCDGM_HUMAN "Protocadherin gamma-C5, PCDH-gamma-C5" PCDHGC5 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; synapse organization [GO:0050808] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; synapse organization [GO:0050808] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399; GO:0043524; GO:0050808 calcium ion binding [GO:0005509] CLQGNADGDGGGGQCCR 0.99468 -13.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6452 12.8024 0 0 0 0 0 0 11.0632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2196 0 0 0 0 0 14.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.85 0 0 0 12.3527 0 13.4747 13.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4888 11.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5658 0 0 0 0 0 0 13.6006 12.5422 0 0 0 0 0 0 O15254 ACOX3_HUMAN "Peroxisomal acyl-coenzyme A oxidase 3, EC 1.3.3.6 (Branched-chain acyl-CoA oxidase, BRCACox) (Pristanoyl-CoA oxidase)" ACOX3 BRCOX PRCOX Homo sapiens (Human) fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088] GO:0003997; GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0055088; GO:0071949 acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402] EACGGHGYLAMNR 0.99469 -11.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8882 11.8484 0 11.7155 0 0 11.7237 0 0 0 0 0 0 0 0 12.3551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.164 0 13.3249 0 0 0 12.4432 12.8165 0 0 0 0 0 0 0 0 0 0 0 11.9929 0 0 12.4174 0 14.1883 0 0 0 0 0 0 11.6099 0 0 0 0 12.8739 0 0 0 0 0 12.1282 14.018 0 12.7451 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4787 0 12.7047 0 13.7444 0 0 0 12.7007 0 0 0 0 0 12.9394 0 0 0 0 0 0 0 0 0 12.4233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8296 0 0 0 0 0 0 0 O60312 AT10A_HUMAN "Phospholipid-transporting ATPase VA, EC 7.6.2.1 (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A)" ATP10A ATP10C ATPVA ATPVC KIAA0566 Homo sapiens (Human) ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of membrane tubulation [GO:1903527]; regulation of cell shape [GO:0008360] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332]; positive regulation of membrane tubulation [GO:1903527]; regulation of cell shape [GO:0008360] GO:0000287; GO:0005524; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0008360; GO:0016021; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:0140351; GO:1903527; GO:1990531 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554] DLWEDYSR 0.99469 -10.676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53666 0 0 11.9129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7929 0 0 0 0 0 0 0 0 0 16.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4768 11.4315 0 0 O94880 PHF14_HUMAN PHD finger protein 14 PHF14 KIAA0783 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] MOZ/MORF histone acetyltransferase complex [GO:0070776] MOZ/MORF histone acetyltransferase complex [GO:0070776]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0006357; GO:0046872; GO:0070776 metal ion binding [GO:0046872] EEEENGER 0.99469 -5.4078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4222 0 0 0 0 0 0 0 11.1972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.99803 0 0 0 0 0 0 0 0 14.1427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2899 0 0 0 15.1792 0 0 0 12.8091 14.0314 14.854 0 0 0 0 0 0 13.2274 0 0 0 12.555 0 15.8276 14.4688 15.187 0 17.5864 14.5751 0 14.1764 0 0 0 0 0 15.6294 0 15.4755 12.0707 0 0 0 11.1277 0 12.8349 12.9368 14.1408 0 0 0 12.8545 0 13.5542 0 13.8833 0 12.7902 12.6371 14.3031 13.8744 12.0107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0581 14.8529 0 0 0 12.6023 0 P07477 TRY1_HUMAN "Serine protease 1, EC 3.4.21.4 (Anionic trypsin I) (Anionic trypsin-I) (Beta-trypsin) (Cationic trypsinogen) (Pretrypsinogen I) (Trypsin I) (Trypsin-1) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2 ]" PRSS1 TRP1 TRY1 TRYP1 Homo sapiens (Human) digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0007586; GO:0022617; GO:0046872; GO:0062023; GO:0072562 metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252] IIRHPQYDR 0.99469 -10.664 0 0 0 0 0 0 9.43981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.55961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2418 0 0 0 0 0 0 0 11.4759 0 0 0 0 0 0 0 0 11.3513 0 0 0 0 0 0 0 12.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4699 0 0 0 0 0 13.0202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14324 FPPS_HUMAN "Farnesyl pyrophosphate synthase, FPP synthase, FPS, EC 2.5.1.10 ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase, EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)" FDPS FPS KIAA1293 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384] GO:0003723; GO:0004161; GO:0004337; GO:0005654; GO:0005737; GO:0005829; GO:0006695; GO:0033384; GO:0045337; GO:0046872 dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] CWCQAWTEEPR 0.99469 -12.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1751 0 0 0 0 0 0 0 13.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7705 14.3405 0 0 0 0 13.8068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3967 12.0812 0 0 17.1622 0 0 0 0 0 0 0 0 0 12.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3588 0 0 0 0 0 Q13077 TRAF1_HUMAN TNF receptor-associated factor 1 (Epstein-Barr virus-induced protein 6) TRAF1 EBI6 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; positive regulation of JNK cascade [GO:0046330]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0005164; GO:0005737; GO:0005829; GO:0006915; GO:0008270; GO:0009898; GO:0031625; GO:0031996; GO:0033209; GO:0042802; GO:0043122; GO:0046330; GO:0051092; GO:0065003; GO:0070534; GO:2001236 identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] ALCCAGCLSENPR 0.99469 -13.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7162 0 0 0 0 0 0 0 0 0 0 12.1927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6837 0 0 0 0 11.7062 11.7203 0 12.5566 0 0 0 0 0 0 0 0 0 0 0 11.9103 0 0 0 0 0 13.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7097 0 0 0 0 0 0 0 0 0 0 0 12.2507 11.3681 0 0 15.2571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86T75 NBPFB_HUMAN Neuroblastoma breakpoint family member 11 (Neuroblastoma breakpoint family member 24) NBPF11 NBPF24 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DQEEEEDQGPPCPR 0.99469 -5.4097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6253 0 0 0 0 0 0 10.9194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQ70 TCF25_HUMAN "Transcription factor 25, TCF-25 (Nuclear localized protein 1)" TCF25 KIAA1049 NULP1 FKSG26 Homo sapiens (Human) heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634]; RQC complex [GO:1990112] nucleus [GO:0005634]; RQC complex [GO:1990112]; DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714]; heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003677; GO:0003714; GO:0005634; GO:0007507; GO:1990112 DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714] DDDDAEEEGPKR 0.99469 -11.307 11.4138 0 0 10.9987 10.2958 9.65607 11.1051 0 16.2799 17.74 16.0879 17.5277 18.2224 17.5296 17.6171 14.0024 13.8763 0 13.9425 0 14.5419 0 13.3062 0 15.0376 15.8046 0 14.3925 15.8813 14.9758 15.7922 15.6512 16.1318 16.02 10.6877 16.5356 15.7315 16.028 15.8027 0 15.7555 0 16.2732 16.329 15.5203 16.0911 15.3533 15.7375 15.9348 15.9051 0 0 0 0 0 0 0 0 0 0 0 0 9.73737 0 0 0 12.096 11.4035 0 0 0 0 0 0 0 0 0 0 0 12.3613 0 12.5906 12.4435 0 0 0 0 14.2038 13.4082 0 0 14.0202 12.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6107 0 0 0 0 0 0 0 0 0 12.6113 12.5662 0 12.6507 0 0 0 0 0 0 0 0 0 13.1847 14.356 12.1953 0 0 0 0 0 0 0 14.7611 0 13.6241 0 0 16.879 16.796 17.4402 0 0 0 0 0 0 13.6104 15.9645 13.7344 0 15.6923 16.1605 0 16.1629 16.6051 15.8923 16.4935 16.9323 15.1118 0 0 0 0 11.9717 0 15.9006 0 0 0 0 Q9NTZ6 RBM12_HUMAN "RNA-binding protein 12 (RNA-binding motif protein 12) (SH3/WW domain anchor protein in the nucleus, SWAN)" RBM12 KIAA0765 HRIHFB2091 Homo sapiens (Human) regulation of RNA splicing [GO:0043484] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; regulation of RNA splicing [GO:0043484] GO:0003723; GO:0005654; GO:0043484; GO:1990904 RNA binding [GO:0003723] DFFHGLRVDAVHLLK 0.99469 -10.676 0 0 0 0 0 0 13.5196 0 0 0 0 0 0 10.006 10.471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8473 0 0 0 0 0 0 0 0 0 0 0 0 14.0226 17.8743 0 13.1249 0 0 0 0 13.9483 0 0 13.6666 13.2071 0 0 13.6878 0 13.0245 13.7462 13.5652 0 0 0 13.6598 0 13.3305 13.0424 0 12.2921 17.5803 17.6298 0 0 0 17.9382 0 0 0 0 0 13.3611 0 0 0 0 0 14.26 0 13.744 17.2713 0 0 0 0 0 0 13.9002 0 10.3993 0 0 13.7119 0 0 0 18.05 15.0603 15.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 11.416 0 17.9048 13.5169 0 0 12.7141 0 0 11.062 Q9Y2Q1 ZN257_HUMAN "Zinc finger protein 257 (Bone marrow zinc finger 4, BMZF-4)" ZNF257 BMZF4 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ACNHSSNLTKHNS 0.99469 -11.319 9.85033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.352 0 0 0 0 0 14.6 0 0 0 0 11.3591 10.8978 0 0 0 17.9226 11.5679 0 13.629 12.8359 13.215 0 0 0 0 0 0 0 0 13.4038 11.5213 0 0 0 0 0 0 13.8861 0 11.6239 0 16.1404 0 0 0 0 0 0 0 0 0 10.83 0 0 0 0 0 0 10.7674 0 0 0 0 0 10.613 0 0 0 0 0 0 0 0 10.9865 13.0132 0 0 0 0 0 0 Q9Y5I1 PCDAB_HUMAN "Protocadherin alpha-11, PCDH-alpha-11" PCDHA11 CNRS7 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] AVGSWSYSQQRRQR 0.99469 -11.3 0 0 0 0 13.5797 0 0 0 0 0 0 0 0 0 0 0 0 10.1595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8727 14.4679 12.5563 12.9808 12.5616 0 14.5046 0 13.607 14.6322 0 13.8193 14.0929 0 14.4296 13.0626 15.5401 12.9846 14.6863 14.1826 13.7604 14.4057 0 13.9742 14.1386 13.8917 14.257 14.556 12.2952 0 14.9657 0 13.329 14.3156 0 0 0 0 12.3023 12.645 14.1152 12.3312 14.0832 0 12.5663 0 12.1591 12.6 12.6919 12.6163 0 13.5726 14.2169 0 12.7554 12.6385 0 13.9796 13.0285 14.0779 0 0 12.7864 0 12.4992 13.5227 0 13.0429 12.893 13.0425 12.9425 0 0 12.2952 0 0 13.3686 13.464 0 13.2379 0 12.6277 0 0 12.0289 0 0 0 12.5936 0 0 0 13.5328 0 0 0 0 0 13.8516 0 0 0 0 0 12.3451 0 O94953 KDM4B_HUMAN "Lysine-specific demethylase 4B, EC 1.14.11.66 (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B) ([histone H3]-trimethyl-L-lysine(9) demethylase 4B)" KDM4B JHDM3B JMJD2B KIAA0876 Homo sapiens (Human) brain development [GO:0007420]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872]; brain development [GO:0007420]; chromatin remodeling [GO:0006338]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169] GO:0005634; GO:0005654; GO:0006338; GO:0007420; GO:0032452; GO:0032454; GO:0033169; GO:0046872; GO:0051864; GO:0070544; GO:0140684 histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/dimethyl-lysine-9 demethylase activity [GO:0140684]; metal ion binding [GO:0046872] AASFQAERK 0.9947 -10.715 0 0 0 0 0 0 0 0 0 0 0 0 15.4535 11.6935 0 0 0 0 0 0 0 0 0 14.1198 12.6348 0 0 0 0 0 0 13.9882 11.3181 12.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3219 12.5933 13.0475 12.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81689 0 14.6855 0 0 0 11.2216 0 0 0 0 15.424 0 0 0 0 12.4115 0 0 0 13.5534 0 13.4376 12.8231 0 13.0693 0 0 14.6602 15.1558 0 17.4499 15.1987 14.2519 12.7383 0 14.2288 12.664 0 16.1681 14.1689 0 0 12.453 0 0 0 14.1748 0 14.1996 0 13.6969 0 13.6193 0 0 0 0 15.5608 0 14.3897 0 0 12.6748 14.8768 0 0 0 0 0 0 0 0 0 0 15.0354 13.7089 13.3674 0 14.3502 0 0 0 14.8254 0 0 0 11.5295 0 0 0 0 0 13.6466 0 0 13.9726 0 0 0 0 0 13.8734 0 0 14.0609 0 0 14.031 0 0 13.7548 0 0 0 0 P45973 CBX5_HUMAN "Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha, HP1 alpha)" CBX5 HP1A Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]" "chromocenter [GO:0010369]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]" "chromocenter [GO:0010369]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0000118; GO:0000122; GO:0000776; GO:0000781; GO:0000792; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005721; GO:0005730; GO:0006325; GO:0006974; GO:0010369; GO:0017053; GO:0030674; GO:0032991; GO:0035064; GO:0035097; GO:0042802; GO:0042826; GO:0043021; GO:0044877; GO:0045892; GO:0090734; GO:0140297; GO:1990904 chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021] DTDEADLVLAK 0.9947 -8.9023 0 0 0 0 0 0 0 0 0 0 0 11.1849 0 0 0 0 13.9058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9492 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1282 0 0 0 0 0 0 0 0 11.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.77 0 0 0 0 0 0 13.1236 0 0 0 0 0 0 0 0 11.3652 0 13.7565 0 0 12.2925 0 0 0 12.7669 0 0 0 0 0 0 0 12.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53634 CATC_HUMAN "Dipeptidyl peptidase 1, EC 3.4.14.1 (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I, DPP-I, DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain) ]" CTSC CPPI Homo sapiens (Human) aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654] azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252]; aging [GO:0007568]; immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; response to organic substance [GO:0010033]; T cell mediated cytotoxicity [GO:0001913] GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005794; GO:0005813; GO:0006508; GO:0006955; GO:0007568; GO:0008234; GO:0008239; GO:0010033; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0043621; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235 chaperone binding [GO:0051087]; chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein self-association [GO:0043621]; serine-type endopeptidase activity [GO:0004252] EDCFRYYSSEYHYVGGFYGGCNEALMK 0.9947 -9.4091 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3651 0 0 0 0 0 12.5106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6AI14 SL9A4_HUMAN "Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4, NHE-4) (Solute carrier family 9 member 4)" SLC9A4 NHE4 Homo sapiens (Human) gastric acid secretion [GO:0001696]; glandular epithelial cell development [GO:0002068]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; gastric acid secretion [GO:0001696]; glandular epithelial cell development [GO:0002068]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; response to salt stress [GO:0009651]; sodium ion import across plasma membrane [GO:0098719] GO:0001696; GO:0002068; GO:0005774; GO:0005886; GO:0006811; GO:0009651; GO:0015385; GO:0015386; GO:0016021; GO:0016323; GO:0016324; GO:0031410; GO:0051453; GO:0055075; GO:0071805; GO:0098719 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] DILTSNMYQVRQRTLSYNK 0.9947 -36.031 0 0 0 0 0 0 0 10.522 12.9311 0 0 0 0 0 0 0 11.7965 0 0 0 0 0 0 0 0 0 12.3306 12.1476 0 0 0 0 0 0 0 12.2017 0 0 0 0 11.8607 0 0 0 0 0 0 0 0 0 0 0 10.0825 0 13.225 0 13.1328 0 12.7475 0 0 11.57 0 0 0 0 0 0 0 0 0 0 0 10.7134 12.8218 0 0 12.8469 0 13.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4413 0 0 0 0 12.9317 0 0 0 0 0 0 0 0 0 0 12.5159 0 0 0 13.7778 0 0 0 0 0 0 0 12.575 12.6177 12.5919 0 0 0 0 0 0 0 0 0 0 0 0 14.0758 0 0 0 12.4104 0 14.8924 0 0 0 14.5234 0 0 0 14.1803 0 14.1941 12.6638 14.4222 14.5509 14.1989 14.0545 10.1916 0 12.9953 0 0 0 14.0578 0 14.1161 0 0 Q6P4A8 PLBL1_HUMAN "Phospholipase B-like 1, EC 3.1.1.- (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C ]" PLBD1 Homo sapiens (Human) phospholipid catabolic process [GO:0009395] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764] cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; phospholipase activity [GO:0004620]; phospholipid catabolic process [GO:0009395] GO:0004620; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0009395 phospholipase activity [GO:0004620] GGPGGRPGLPQPPPLLLLLLLLPLLLVTAEPPK 0.9947 -13.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7417 0 0 0 0 0 12.8795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2314 0 0 0 13.2445 11.0222 0 0 0 11.5817 0 0 0 0 0 0 0 0 0 0 0 0 18.9464 18.5331 0 0 0 0 0 0 0 0 0 13.2147 0 13.5294 0 0 12.3814 12.8681 12.6659 12.9622 0 0 13.9075 0 0 14.3136 13.7956 13.9618 16.1527 0 0 13.525 0 13.6383 14.0705 0 0 12.9337 0 0 0 0 12.6894 0 0 0 0 0 0 0 0 13.0661 0 14.4787 0 0 0 0 0 12.7669 14.2792 0 0 0 0 0 13.6037 0 0 0 0 0 0 0 12.2232 0 13.1942 15.0921 0 0 0 14.9542 0 0 0 0 0 0 14.1892 12.0276 0 0 0 15.2597 0 0 14.6437 13.8222 0 0 0 0 0 0 0 0 0 12.5035 0 13.0698 12.3256 0 0 0 0 0 0 0 0 0 0 0 11.8044 Q9BTT4 MED10_HUMAN "Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10) (Transformation-related gene 17 protein, TRG-17) (Transformation-related gene 20 protein, TRG-20)" MED10 L6 TRG17 TRG20 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] chromatin [GO:0000785]; core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] chromatin [GO:0000785]; core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0000151; GO:0000785; GO:0003712; GO:0005634; GO:0005654; GO:0016592; GO:0032968; GO:0045944; GO:0051123; GO:0060261; GO:0061630; GO:0070847 transcription coregulator activity [GO:0003712]; ubiquitin protein ligase activity [GO:0061630] ALAKNEQVK 0.9947 -11.357 0 0 0 0 0 0 0 0 12.1733 11.9075 13.3658 11.3499 13.6739 12.2153 11.6223 0 0 0 0 0 0 0 0 0 0 12.5517 0 0 0 11.348 0 11.4018 11.6781 12.9473 11.0141 12.618 0 11.4177 14.072 0 0 0 0 0 0 12.8701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1591 11.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6846 0 16.1726 0 12.327 0 13.5779 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4658 0 0 Q9H3Y6 SRMS_HUMAN "Tyrosine-protein kinase Srms, EC 2.7.10.2" SRMS C20orf148 Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0007169; GO:0009968; GO:0018108; GO:0030154; GO:0031234; GO:0038083; GO:0045087 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] DDIYSPSSSSK 0.9947 -8.6083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9451 14.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4B4 PLK3_HUMAN "Serine/threonine-protein kinase PLK3, EC 2.7.11.21 (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3, PLK-3) (Proliferation-related kinase)" PLK3 CNK FNK PRK Homo sapiens (Human) "apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endomitotic cell cycle [GO:0007113]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle [GO:0000278]; mitotic G1/S transition checkpoint signaling [GO:0044819]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chaperone-mediated autophagy [GO:1904716]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of cell division [GO:0051302]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to osmotic stress [GO:0006970]; response to radiation [GO:0009314]; response to reactive oxygen species [GO:0000302]" GO:0000082; GO:0000086; GO:0000122; GO:0000278; GO:0000302; GO:0000922; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005813; GO:0006468; GO:0006915; GO:0006970; GO:0006974; GO:0006977; GO:0007113; GO:0009314; GO:0030425; GO:0031122; GO:0032465; GO:0043025; GO:0043066; GO:0043491; GO:0044819; GO:0051302; GO:0090166; GO:0090316; GO:0106310; GO:1901796; GO:1904716; GO:2000777 ATP binding [GO:0005524]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ALQPQLGILR 0.9947 -10.717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2719 0 0 12.2877 12.0188 13.5069 0 0 0 0 0 0 0 0 15.3607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7016 0 12.5064 13.9472 0 14.4149 13.5023 15.9918 13.3815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1799 0 0 0 0 Q9UP83 COG5_HUMAN "Conserved oligomeric Golgi complex subunit 5, COG complex subunit 5 (13S Golgi transport complex 90 kDa subunit, GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1)" COG5 GOLTC1 GTC90 Homo sapiens (Human) "glycosylation [GO:0070085]; Golgi organization [GO:0007030]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; glycosylation [GO:0070085]; Golgi organization [GO:0007030]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]" GO:0000139; GO:0000301; GO:0005654; GO:0005794; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0048219; GO:0070085 AEWSHTRFSQWLDDHPSEKDR 0.9947 -10.72 0 0 0 0 0 0 0 0 0 0 13.5278 0 0 0 13.0424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7166 0 0 0 0 0 0 12.9455 0 0 0 0 0 0 0 0 9.45442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0386 14.8394 0 0 0 0 0 0 0 13.8358 0 13.7014 0 0 13.1464 14.4126 0 14.1511 0 12.9588 0 0 0 0 0 0 13.9928 0 14.0946 0 0 0 0 0 14.1784 14.3887 0 0 0 11.6455 0 0 0 0 0 0 0 0 0 0 13.8916 0 0 0 0 0 0 0 0 13.9632 0 0 0 0 0 10.4309 0 0 0 12.7277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2906 0 0 0 0 0 0 0 0 O95140 MFN2_HUMAN "Mitofusin-2, EC 3.6.5.- (Transmembrane GTPase MFN2)" MFN2 CPRP1 KIAA0214 Homo sapiens (Human) apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986] GO:0001825; GO:0003924; GO:0005525; GO:0005739; GO:0005741; GO:0005829; GO:0006626; GO:0006915; GO:0006986; GO:0007006; GO:0008053; GO:0015630; GO:0016021; GO:0031306; GO:0031625; GO:0034497; GO:0046580; GO:0048593; GO:0048662; GO:0051646; GO:0061734; GO:0120162; GO:1904707; GO:1905461 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625] CTSFLVDELGVVDRSQAGDR 0.99471 -8.4211 0 0 0 0 0 0 0 0 14.8813 12.5052 12.8281 16.7654 0 0 12.6126 16.6966 0 0 16.9789 0 0 0 0 0 0 0 0 12.4905 0 12.0702 0 14.6 12.4205 14.6403 14.5075 15.6564 14.9167 16.8407 12.4703 14.5875 16.1925 14.4149 0 16.1318 0 0 0 12.3005 16.3941 0 14.958 0 0 0 12.7449 0 12.4002 12.7642 0 11.5446 0 0 0 11.3582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0011 0 0 0 16.931 0 0 0 13.5529 0 0 0 0 0 15.6563 0 0 13.6782 13.333 14.827 0 13.732 0 0 0 13.3795 0 11.4157 12.82 0 12.4412 0 14.383 13.4679 12.3885 0 0 12.3145 0 0 0 0 0 0 0 0 0 0 12.8694 0 0 0 0 0 12.5637 0 0 19.2337 0 0 0 13.6789 12.2386 0 0 0 0 12.2653 0 0 0 0 0 0 0 0 0 18.9631 17.8981 14.7721 18.8523 18.8577 18.8846 18.7959 0 18.7885 19.0614 19.0517 19.5441 18.4884 0 17.8012 0 11.7818 0 0 19.4319 19.4772 0 0 0 O43657 TSN6_HUMAN "Tetraspanin-6, Tspan-6 (A15 homolog) (Putative NF-kappa-B-activating protein 321) (T245 protein) (Tetraspanin TM4-D) (Transmembrane 4 superfamily member 6)" TSPAN6 TM4SF6 UNQ767/PRO1560 Homo sapiens (Human) negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123] GO:0005887; GO:0039532; GO:0043123; GO:0070062; GO:1901223 ALKQYNSTGDYR 0.99471 -8.6668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0117 0 0 0 0 0 0 0 0 0 0 13.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.648 0 0 10.7606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43688 PLPP2_HUMAN "Phospholipid phosphatase 2, EC 3.1.3.-, EC 3.1.3.4 (Lipid phosphate phosphohydrolase 2) (PAP2-gamma, PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c, PAP-2c, PAP2c)" PLPP2 LPP2 PPAP2C Homo sapiens (Human) ceramide metabolic process [GO:0006672]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670] caveola [GO:0005901]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] caveola [GO:0005901]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ceramide-1-phosphate phosphatase activity [GO:0106235]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392]; ceramide metabolic process [GO:0006672]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; signal transduction [GO:0007165]; sphingolipid biosynthetic process [GO:0030148]; sphingosine metabolic process [GO:0006670] GO:0005769; GO:0005783; GO:0005789; GO:0005886; GO:0005887; GO:0005901; GO:0006644; GO:0006670; GO:0006672; GO:0007165; GO:0008195; GO:0016021; GO:0030148; GO:0031901; GO:0042392; GO:0042577; GO:0046839; GO:0106235 ceramide-1-phosphate phosphatase activity [GO:0106235]; lipid phosphatase activity [GO:0042577]; phosphatidate phosphatase activity [GO:0008195]; sphingosine-1-phosphate phosphatase activity [GO:0042392] GFYCGDDSIR 0.99471 -12.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.846 0 0 0 0 0 0 0 O75330 HMMR_HUMAN Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168) HMMR IHABP RHAMM Homo sapiens (Human) cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819] cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819]; hyaluronic acid binding [GO:0005540] GO:0005540; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0009986; GO:0015630; GO:0016020 hyaluronic acid binding [GO:0005540] CQLLEKEKEDHVNR 0.99471 -15.353 0 0 0 0 11.6865 13.1638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5968 0 11.6305 0 13.6427 0 0 0 0 0 0 0 0 0 0 0 13.4227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9755 0 12.2793 0 0 0 0 0 0 0 0 0 0 0 14.7779 0 0 0 14.9759 0 0 0 0 13.7461 0 0 0 13.751 0 0 0 0 0 0 13.3301 0 0 0 15.7509 14.5498 0 12.2693 0 0 0 0 0 13.214 0 0 0 0 0 0 15.0798 14.0561 0 0 0 14.9062 0 13.4181 0 13.2942 0 0 0 11.9986 0 13.3185 0 0 13.3375 0 0 0 0 14.0419 0 0 0 0 0 0 0 0 13.8996 0 0 0 0 0 13.9639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75600 KBL_HUMAN "2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial, AKB ligase, EC 2.3.1.29 (Aminoacetone synthase) (Glycine acetyltransferase)" GCAT KBL Homo sapiens (Human) biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; threonine catabolic process [GO:0006567] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; threonine catabolic process [GO:0006567] GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006520; GO:0006567; GO:0008890; GO:0009058; GO:0016607; GO:0030170 glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170] ARIRVQISAVHSEEDIDR 0.99471 -12.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1174 0 0 0 0 0 0 0 0 0 0 0 0 11.3912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7431 0 0 0 0 0 0 13.5818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94967 WDR47_HUMAN "WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein, Nemitin)" WDR47 KIAA0893 Homo sapiens (Human) cytoplasm [GO:0005737]; microtubule [GO:0005874] cytoplasm [GO:0005737]; microtubule [GO:0005874] GO:0005737; GO:0005874 GLLYECCVEFCQSK 0.99471 -8.4174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG37 CFC1_HUMAN Cryptic protein (Cryptic family protein 1) CFC1 Homo sapiens (Human) anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; activin receptor binding [GO:0070697]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092] GO:0001568; GO:0005102; GO:0005576; GO:0005886; GO:0007368; GO:0007369; GO:0007507; GO:0009952; GO:0009986; GO:0031225; GO:0038092; GO:0038100; GO:0048856; GO:0070697 activin receptor binding [GO:0070697]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102] LLRPDAPAHPRSLVPSVLQR 0.99471 -12.579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4289 0 12.2176 11.9145 11.6289 0 11.3766 0 0 0 11.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1622 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4382 0 0 0 0 0 0 13.2518 13.8111 13.5266 0 12.4538 0 0 0 0 14.2897 0 0 0 0 0 0 0 0 0 0 0 0 11.7774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16444 DPEP1_HUMAN "Dipeptidase 1, EC 3.4.13.19 (Beta-lactamase, EC 3.5.2.6) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase, hRDP)" DPEP1 MDP RDP Homo sapiens (Human) antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene D4 catabolic process [GO:1901749]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; proteolysis [GO:0006508] anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to nitric oxide [GO:0071732]; cellular response to xenobiotic stimulus [GO:0071466]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene D4 catabolic process [GO:1901749]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; proteolysis [GO:0006508] GO:0005615; GO:0005654; GO:0005886; GO:0006508; GO:0006629; GO:0006749; GO:0006751; GO:0008235; GO:0008270; GO:0008800; GO:0016324; GO:0016805; GO:0016999; GO:0030054; GO:0030336; GO:0031225; GO:0031528; GO:0034235; GO:0043027; GO:0043066; GO:0043154; GO:0045177; GO:0050667; GO:0070062; GO:0070573; GO:0071277; GO:0071466; GO:0071732; GO:0072340; GO:0072341; GO:1901749 beta-lactamase activity [GO:0008800]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270] ALYQLGMR 0.99471 -11.415 0 0 0 0 0 12.0511 0 0 0 0 0 0 13.2232 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8344 12.5825 0 0 0 0 0 0 0 0 12.3444 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5646 0 13.6621 12.4616 0 0 0 0 0 0 0 0 0 0 14.8362 15.9465 13.8259 0 0 14.0372 14.4182 14.0391 0 14.267 0 0 0 0 0 0 0 0 14.278 0 0 0 0 0 0 0 14.185 14.2961 0 0 13.9024 14.0892 0 0 14.1376 0 12.9621 0 0 0 0 14.4497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6902 0 P23759 PAX7_HUMAN Paired box protein Pax-7 (HuP1) PAX7 HUP1 Homo sapiens (Human) anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0007517; GO:0009653; GO:0043066; GO:0048856; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AALPGTVPR 0.99471 -15.345 0 0 0 14.8268 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5998 0 0 0 0 0 0 13.5941 0 13.7671 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6544 0 0 13.6196 10.8257 10.5354 0 0 0 0 13.9074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6769 13.2037 13.5675 12.2848 0 0 0 14.3164 13.6101 13.0615 0 0 15.1761 0 14.1995 15.3735 14.3884 0 14.9237 0 14.68 14.452 11.5468 0 0 0 14.1279 10.6881 0 16.8794 0 14.6391 12.8023 12.7354 0 13.996 0 0 0 0 0 0 0 12.7873 0 13.2932 0 14.4767 11.7523 14.7022 13.8242 0 0 0 13.4881 13.1819 15.1185 14.5629 0 0 15.6996 14.4093 13.8781 12.4345 12.6341 10.3464 14.7247 0 14.2895 12.9466 15.0435 14.6925 12.1889 0 0 12.9621 0 12.7115 0 0 0 0 0 0 0 0 0 0 0 0 14.3251 0 0 0 13.4631 0 0 14.8963 0 12.9577 0 13.4081 0 0 0 P41002 CCNF_HUMAN Cyclin-F (F-box only protein 1) CCNF FBX1 FBXO1 Homo sapiens (Human) cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of centrosome duplication [GO:0010826]; placenta development [GO:0001890]; protein ubiquitination [GO:0016567]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005] cell junction [GO:0030054]; centriole [GO:0005814]; centrosome [GO:0005813]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005]; anaphase-promoting complex binding [GO:0010997]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; cell division [GO:0051301]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of centrosome duplication [GO:0010826]; placenta development [GO:0001890]; protein ubiquitination [GO:0016567]; re-entry into mitotic cell cycle [GO:0000320]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000079; GO:0000307; GO:0000320; GO:0001890; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0010826; GO:0010997; GO:0016538; GO:0016567; GO:0019005; GO:0030054; GO:0031146; GO:0044772; GO:0048471; GO:0051301; GO:0051726 anaphase-promoting complex binding [GO:0010997]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] AECQLQR 0.99471 -9.4483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3925 0 0 0 0 0 0 0 0 11.2787 0 16.7184 0 0 0 0 0 0 18.9512 0 0 0 0 18.8126 0 0 0 0 0 0 0 11.1051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8826 0 0 9.93859 0 0 0 0 13.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89692 0 0 0 P47224 MSS4_HUMAN Guanine nucleotide exchange factor MSS4 (Rab-interacting factor) RABIF MSS4 RASGRF3 Homo sapiens (Human) membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; membrane [GO:0016020] cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264] GO:0005085; GO:0005829; GO:0006892; GO:0007264; GO:0008270; GO:0015031; GO:0016020; GO:0061025 guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270] KAVLCQR 0.99471 -15.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2723 0 0 0 0 0 0 0 0 0 0 P54753 EPHB3_HUMAN "Ephrin type-B receptor 3, EC 2.7.10.1 (EPH-like tyrosine kinase 2, EPH-like kinase 2) (Embryonic kinase 2, EK2, hEK2) (Tyrosine-protein kinase TYRO6)" EPHB3 ETK2 HEK2 TYRO6 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655] cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; central nervous system projection neuron axonogenesis [GO:0021952]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; digestive tract morphogenesis [GO:0048546]; ephrin receptor signaling pathway [GO:0048013]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of axonogenesis [GO:0050770]; regulation of cell-cell adhesion [GO:0022407]; regulation of GTPase activity [GO:0043087]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; substrate adhesion-dependent cell spreading [GO:0034446]; thymus development [GO:0048538]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655] GO:0001525; GO:0001655; GO:0004714; GO:0005003; GO:0005005; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0007413; GO:0008046; GO:0016477; GO:0021952; GO:0022038; GO:0022407; GO:0030425; GO:0031290; GO:0033674; GO:0034446; GO:0043005; GO:0043087; GO:0043235; GO:0046777; GO:0048013; GO:0048538; GO:0048546; GO:0050770; GO:0051965; GO:0060021; GO:0060996; GO:0060997 ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] ARPPPPPSPPPGLLPLLPPLLLLPLLLLPAGCR 0.99471 -12.62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7527 0 12.1224 0 0 0 0 0 0 0 0 0 0 0 0 12.7527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2099 12.8507 0 12.9631 0 12.9175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3979 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6751 0 0 0 13.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4038 13.2861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P63135 POK7_HUMAN "Endogenous retrovirus group K member 7 Pol protein (HERV-K(III) Pol protein) (HERV-K102 Pol protein) (HERV-K_1q22 provirus ancestral Pol protein) [Includes: Reverse transcriptase, RT, EC 2.7.7.49; Ribonuclease H, RNase H, EC 3.1.26.4; Integrase, IN ]" ERVK-7 Homo sapiens (Human) DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; DNA repair [GO:0006281] GO:0003677; GO:0003964; GO:0004523; GO:0005198; GO:0006281; GO:0006310; GO:0008270; GO:0015074; GO:0035613 DNA binding [GO:0003677]; RNA stem-loop binding [GO:0035613]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270] AAYTGPK 0.99471 -15.326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.769 0 0 0 0 11.7027 12.396 12.8975 12.3479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0824 0 0 13.3139 0 0 0 0 0 0 0 15.2738 15.3148 13.6091 15.4682 15.462 12.3001 13.2824 15.5939 14.1959 0 13.5603 0 0 0 0 0 0 0 14.4357 0 0 13.2617 0 0 0 0 0 0 13.9104 12.4623 13.2375 0 11.7285 0 0 0 0 0 0 0 0 11.5371 0 0 0 15.164 12.3671 13.689 0 14.4004 0 0 17.9631 0 0 0 0 0 0 12.5495 0 0 0 0 0 0 11.1492 0 0 0 14.9325 0 0 0 13.3308 0 0 0 14.4259 0 0 0 0 14.8331 0 0 0 0 9.89536 0 0 0 0 0 13.3784 0 0 0 0 0 12.9688 0 0 0 0 0 0 0 Q13829 BACD2_HUMAN "BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2, hBACURD2 (BTB/POZ domain-containing protein TNFAIP1) (Protein B12) (Tumor necrosis factor, alpha-induced protein 1, endothelial)" TNFAIP1 BACURD2 EDP1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell migration [GO:0016477]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; immune response [GO:0006955]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149] GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0006915; GO:0006955; GO:0016477; GO:0016567; GO:0030332; GO:0031267; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0051260 cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] LIESSTK 0.99471 -15.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6508 12.6832 0 0 12.4286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13873 BMPR2_HUMAN "Bone morphogenetic protein receptor type-2, BMP type-2 receptor, BMPR-2, EC 2.7.11.30 (Bone morphogenetic protein receptor type II, BMP type II receptor, BMPR-II)" BMPR2 PPH1 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412] adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214] "adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]; spanning component of plasma membrane [GO:0044214]; activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activator activity [GO:0030546]; transforming growth factor beta receptor activity [GO:0005024]; anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0007178]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412]" GO:0001568; GO:0001649; GO:0001707; GO:0001893; GO:0001935; GO:0001938; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003148; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0004674; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005887; GO:0005905; GO:0005912; GO:0006468; GO:0007178; GO:0009267; GO:0009952; GO:0009986; GO:0010595; GO:0010634; GO:0010862; GO:0014069; GO:0014916; GO:0016362; GO:0019211; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0030513; GO:0030546; GO:0036122; GO:0042127; GO:0043235; GO:0043539; GO:0044214; GO:0044297; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0061626; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782; GO:2000279 "activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activator activity [GO:0030546]; transforming growth factor beta receptor activity [GO:0005024]" FIVGDER 0.99471 -8.6483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9287 0 0 0 0 0 0 11.0957 0 0 0 0 0 0 0 0 0 0 13.1174 0 0 0 0 0 0 0 0 0 0 0 12.1992 0 0 0 0 0 0 0 0 0 0 0 0 12.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5751 12.1415 0 13.1922 0 0 0 0 0 0 12.3432 0 0 0 0 0 0 0 0 0 0 0 10.6985 12.3054 0 0 0 0 0 0 0 0 0 0 0 13.1498 0 0 0 0 0 0 0 0 0 0 0 11.837 0 0 Q8N5C6 SRBD1_HUMAN S1 RNA-binding domain-containing protein 1 SRBD1 Homo sapiens (Human) nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412] mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; nucleobase-containing compound metabolic process [GO:0006139]; translation [GO:0006412] GO:0003729; GO:0003735; GO:0006139; GO:0006412 mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735] ELINNLDADSLREVQQTLEELR 0.99471 -8.6586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4023 12.5128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6818 0 13.87 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4271 0 0 0 14.0866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0575 0 0 0 0 0 0 0 0 0 0 0 13.4263 0 0 0 Q8NDX6 ZN740_HUMAN Zinc finger protein 740 (OriLyt TD-element-binding protein 7) ZNF740 TB7 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CHQCFSRTDRLLR 0.99471 -11.072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2718 12.9072 0 0 13.0211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGC2 OR4E2_HUMAN Olfactory receptor 4E2 (Olfactory receptor OR14-42) OR4E2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] MDSLNQTR 0.99471 -8.655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3368 0 0 14.1688 13.8395 0 0 0 0 0 16.6288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1186 0 0 0 14.2802 0 0 13.0437 16.1065 0 0 0 0 15.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4065 0 0 0 0 0 0 0 13.5979 15.0486 0 0 0 0 0 0 0 15.4214 15.277 0 0 0 0 0 0 0 13.5799 0 13.7425 0 0 15.3828 0 0 0 0 0 13.3645 0 0 0 0 0 0 0 0 0 13.1637 0 13.9067 13.3933 0 0 0 0 0 0 0 0 0 0 Q8NI37 PPTC7_HUMAN "Protein phosphatase PTC7 homolog, EC 3.1.3.16 (T-cell activation protein phosphatase 2C, TA-PP2C) (T-cell activation protein phosphatase 2C-like)" PPTC7 TAPP2C Homo sapiens (Human) peptidyl-serine dephosphorylation [GO:0070262]; regulation of ubiquinone biosynthetic process [GO:0010795] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; peptidyl-serine dephosphorylation [GO:0070262]; regulation of ubiquinone biosynthetic process [GO:0010795] GO:0004722; GO:0005739; GO:0005759; GO:0010795; GO:0017018; GO:0046872; GO:0070262 metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722] DYGVDPSQFSGTLMR 0.99471 -8.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBX8 PI42C_HUMAN "Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma, EC 2.7.1.149 (Phosphatidylinositol 5-phosphate 4-kinase type II gamma, PI(5)P 4-kinase type II gamma, PIP4KII-gamma)" PIP4K2C PIP5K2C Homo sapiens (Human) "1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]" autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular organelle [GO:0043229]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular organelle [GO:0043229]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]" GO:0005524; GO:0005654; GO:0005776; GO:0005783; GO:0005829; GO:0005886; GO:0010506; GO:0016308; GO:0016309; GO:0016310; GO:0042802; GO:0043229; GO:0046627; GO:0046854; GO:0070062; GO:0090217; GO:1902635; GO:2000786 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; identical protein binding [GO:0042802] EYCPQVFRNLRDR 0.99471 -8.6461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7872 15.3635 0 0 15.6424 14.6513 0 0 0 14.632 0 13.8781 0 0 0 12.3953 0 0 0 0 0 0 0 0 0 0 0 9.64212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.67239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.004 0 0 0 0 0 0 Q8TDZ2 MICA1_HUMAN "[F-actin]-monooxygenase MICAL1, EC 1.14.13.225, EC 1.6.3.1 (Molecule interacting with CasL protein 1, MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains)" MICAL1 MICAL NICAL Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; hippocampal mossy fiber expansion [GO:1990026]; intercellular bridge [GO:0045171]; intermediate filament [GO:0005882]; midbody [GO:0030496]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH oxidase H202-forming activity [GO:0106294]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin filament bundle assembly [GO:0051017]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of protein phosphorylation [GO:0001933]; regulation of regulated secretory pathway [GO:1903305]; signal transduction [GO:0007165]; sulfur oxidation [GO:0019417]" GO:0001933; GO:0003779; GO:0005737; GO:0005829; GO:0005882; GO:0005886; GO:0007010; GO:0007165; GO:0015629; GO:0016174; GO:0016709; GO:0017124; GO:0019417; GO:0019901; GO:0030042; GO:0030496; GO:0031267; GO:0043154; GO:0045171; GO:0046872; GO:0051015; GO:0051017; GO:0071949; GO:0106294; GO:1903305; GO:1990026 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH oxidase H202-forming activity [GO:0106294]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]" FSRHNVLHLWPFTIHDLRALGAK 0.99471 -11.416 0 0 0 0 0 0 0 0 10.4237 0 0 14.9986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8833 0 0 0 0 15.1596 0 0 0 14.4034 0 12.397 0 0 0 0 15.5206 0 0 0 0 0 13.1795 0 0 0 0 0 0 15.1738 0 0 0 0 14.4924 0 0 0 14.5103 0 0 0 0 0 0 0 0 0 0 14.1934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6389 0 0 0 0 0 13.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2312 0 0 0 0 0 0 0 0 0 0 0 0 12.2983 0 0 0 0 0 13.7636 0 0 14.4451 0 0 0 0 0 Q96AQ9 F131C_HUMAN Protein FAM131C FAM131C C1orf117 Homo sapiens (Human) MGSCVSR 0.99471 -8.6569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96I25 SPF45_HUMAN Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17) RBM17 SPF45 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681] "nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000380; GO:0000398; GO:0003723; GO:0005654; GO:0005681; GO:0045292 RNA binding [GO:0003723] CPTKVVLLR 0.99471 -15.338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.557 0 0 0 0 0 13.3587 14.0138 0 14.7401 14.1285 0 0 0 0 0 0 0 0 0 0 11.6725 0 0 0 14.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7872 0 13.3287 14.6185 15.0563 0 0 0 0 14.7828 11.2673 0 0 0 0 13.4379 0 0 0 0 0 0 0 0 0 0 0 0 13.7914 0 0 0 14.0861 12.7511 0 12.7149 0 0 0 0 0 14.8226 0 0 0 14.9248 0 12.6261 0 0 0 0 0 0 Q9BVP2 GNL3_HUMAN "Guanine nucleotide-binding protein-like 3 (E2-induced gene 3 protein) (Novel nucleolar protein 47, NNP47) (Nucleolar GTP-binding protein 3) (Nucleostemin)" GNL3 E2IG3 NS Homo sapiens (Human) "cell population proliferation [GO:0008283]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell population proliferation [GO:0042127]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]" chromosome [GO:0005694]; extracellular space [GO:0005615]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634] "chromosome [GO:0005694]; extracellular space [GO:0005615]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell population proliferation [GO:0042127]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]" GO:0003723; GO:0005525; GO:0005615; GO:0005634; GO:0005694; GO:0005730; GO:0008283; GO:0016020; GO:0016604; GO:0017145; GO:0019827; GO:0030496; GO:0032206; GO:0033235; GO:0042127; GO:0048027; GO:1902895; GO:1904816 GTP binding [GO:0005525]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723] AIRVGVIGFPNVGKSSIINSLK 0.99471 -8.6545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9586 0 0 0 0 0 0 0 0 14.5264 0 0 0 0 0 0 13.0941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6813 0 0 0 0 0 0 0 0 14.5424 16.7303 0 0 0 13.0948 17.0613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6574 0 0 0 0 0 0 0 0 0 0 0 14.1818 13.3752 12.8077 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0277 0 12.7031 0 12.3622 Q9BW71 HIRP3_HUMAN HIRA-interacting protein 3 HIRIP3 Homo sapiens (Human) chromatin organization [GO:0006325] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin organization [GO:0006325] GO:0005634; GO:0005654; GO:0005730; GO:0006325 AREKEMQEFTR 0.99471 -12.618 0 0 0 11.0452 0 0 0 0 13.7146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7612 0 0 0 0 11.7071 0 0 13.6961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2084 0 0 0 0 0 0 0 0 0 0 0 13.2996 17.5835 0 17.5349 0 0 0 0 0 0 15.2053 13.5708 13.3983 0 0 0 0 0 0 0 0 13.1046 0 0 0 0 0 0 0 0 14.7615 0 10.8011 0 0 12.1361 0 12.3393 0 0 0 0 0 0 0 0 0 0 0 0 13.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9644 0 0 12.5996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3669 0 0 0 13.6331 0 12.0935 0 Q9BZM5 ULBP2_HUMAN "UL16-binding protein 2 (ALCAN-alpha) (NKG2D ligand 2, N2DL-2, NKG2DL2) (Retinoic acid early transcript 1H)" ULBP2 N2DL2 RAET1H UNQ463/PRO791 Homo sapiens (Human) natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; natural killer cell lectin-like receptor binding [GO:0046703]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267] GO:0005576; GO:0005615; GO:0005783; GO:0005886; GO:0009897; GO:0009986; GO:0030101; GO:0042267; GO:0043231; GO:0046658; GO:0046703 natural killer cell lectin-like receptor binding [GO:0046703] AAAAATK 0.99471 -9.4507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8882 12.7109 12.3436 0 13.5387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H8H2 DDX31_HUMAN "Probable ATP-dependent RNA helicase DDX31, EC 3.6.4.13 (DEAD box protein 31) (Helicain)" DDX31 Homo sapiens (Human) ribosome biogenesis [GO:0042254] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ribosome biogenesis [GO:0042254] GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0005794; GO:0016887; GO:0042254; GO:0043231 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ELKHIFHVRSLHLGHVAK 0.99471 -11.058 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7746 0 0 0 0 0 11.531 0 0 0 0 10.4114 0 0 0 0 0 14.4172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8437 0 17.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8539 0 0 0 0 0 0 0 0 0 13.3116 0 14.4647 0 0 0 0 0 0 0 15.3856 0 0 0 0 0 0 0 0 0 0 0 12.318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9638 0 0 0 0 0 0 Q9NPR2 SEM4B_HUMAN Semaphorin-4B (Semaphorin-C) SEMA4B KIAA1745 SEMAC UNQ749/PRO1480 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0030215; GO:0030335; GO:0045202; GO:0045499; GO:0048843; GO:0050919; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] DPYCAWSGSSCK 0.99471 -11.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8009 0 0 0 0 12.9528 0 0 0 0 13.0834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1445 11.5713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0405 0 12.7219 0 0 0 14.2674 0 0 0 0 14.6566 0 0 12.1941 15.4388 12.6195 0 0 12.2926 0 0 14.4532 0 15.3385 0 14.4651 0 0 14.9015 0 0 0 0 0 0 0 0 14.2374 0 0 0 15.4222 0 0 0 0 14.0357 0 11.1332 0 0 0 15.1407 0 0 13.8073 0 13.4362 0 0 0 0 0 11.6803 0 12.8282 0 0 11.5536 0 0 0 14.1763 0 0 0 0 0 0 0 0 0 0 0 0 11.6726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ35 NRIP3_HUMAN Nuclear receptor-interacting protein 3 (Sarcoma antigen NY-SAR-105) NRIP3 C11orf14 Homo sapiens (Human) proteolysis [GO:0006508] aspartic-type endopeptidase activity [GO:0004190]; proteolysis [GO:0006508] GO:0004190; GO:0006508 aspartic-type endopeptidase activity [GO:0004190] ALVDTGCLYNLISLACVDRLGLKEHVK 0.99471 -12.586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8582 0 0 0 0 0 0 0 0 0 0 0 0 15.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3574 0 0 0 0 0 0 0 0 14.74 0 14.397 0 0 0 0 0 0 0 0 0 13.6546 0 0 0 13.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR34 MA1C1_HUMAN "Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC, EC 3.2.1.113 (HMIC) (Mannosidase alpha class 1C member 1) (Processing alpha-1,2-mannosidase IC, Alpha-1,2-mannosidase IC)" MAN1C1 MAN1A3 MAN1C Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487] endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173] "endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]; carbohydrate metabolic process [GO:0005975]; Golgi apparatus mannose trimming [GO:1904381]; N-glycan processing [GO:0006491]; protein N-linked glycosylation [GO:0006487]" GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005975; GO:0006487; GO:0006491; GO:0030173; GO:0070062; GO:1904381 "calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]" AIRLGEK 0.99471 -15.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8803 0 0 0 0 0 14.3586 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1221 0 0 0 0 0 0 12.3243 15.047 19.1789 0 0 0 0 0 0 0 15.4554 0 0 0 12.2304 0 0 15.0013 14.977 15.0292 0 0 0 14.6482 14.7887 0 0 15.3813 0 0 0 12.9782 0 12.4696 0 0 15.2684 12.4775 13.1775 12.6769 0 12.6384 0 0 0 0 0 0 0 0 0 0 0 0 14.6997 0 0 15.8786 0 15.6195 13.2907 15.2246 14.7478 0 0 0 0 0 0 0 0 12.3717 0 0 12.3175 0 0 0 0 0 0 0 0 0 14.6021 12.9587 Q9NUG6 PDRG1_HUMAN p53 and DNA damage-regulated protein 1 PDRG1 C20orf126 PDRG Homo sapiens (Human) protein folding [GO:0006457]; protein stabilization [GO:0050821] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821] GO:0005737; GO:0006457; GO:0016272; GO:0050821; GO:0051082; GO:0101031; GO:1990062 unfolded protein binding [GO:0051082] ALKVILKG 0.99471 -11.071 0 0 0 0 0 0 0 0 12.5176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2833 0 0 0 0 0 0 0 12.649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3L5 RAP2C_HUMAN "Ras-related protein Rap-2c, EC 3.6.5.2" RAP2C Homo sapiens (Human) establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097] bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; tertiary granule membrane [GO:0070821] bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; tertiary granule membrane [GO:0070821]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transcription coactivator activity [GO:0003713]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097] GO:0003713; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0005923; GO:0019003; GO:0030336; GO:0031954; GO:0032486; GO:0044291; GO:0055038; GO:0061097; GO:0070062; GO:0070821; GO:0090557 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transcription coactivator activity [GO:0003713] RYEKVPLILVGNK 0.99471 -11.076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00476 NPT4_HUMAN Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3) SLC17A3 NPT4 Homo sapiens (Human) anion transport [GO:0006820]; glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910]; anion transport [GO:0006820]; glucose-6-phosphate transport [GO:0015760]; ion transmembrane transport [GO:0034220]; organic anion transport [GO:0015711]; phosphate ion transport [GO:0006817]; sialic acid transport [GO:0015739]; sodium ion transport [GO:0006814]; urate metabolic process [GO:0046415]; urate transport [GO:0015747]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961] GO:0005436; GO:0005737; GO:0005764; GO:0005789; GO:0005886; GO:0005887; GO:0006814; GO:0006817; GO:0006820; GO:0008308; GO:0008514; GO:0015136; GO:0015143; GO:0015562; GO:0015711; GO:0015739; GO:0015747; GO:0015760; GO:0016021; GO:0016324; GO:0019534; GO:0022857; GO:0031526; GO:0034220; GO:0042910; GO:0046415; GO:0048471; GO:1990961 efflux transmembrane transporter activity [GO:0015562]; organic anion transmembrane transporter activity [GO:0008514]; sialic acid transmembrane transporter activity [GO:0015136]; sodium:phosphate symporter activity [GO:0005436]; toxin transmembrane transporter activity [GO:0019534]; transmembrane transporter activity [GO:0022857]; urate transmembrane transporter activity [GO:0015143]; voltage-gated anion channel activity [GO:0008308]; xenobiotic transmembrane transporter activity [GO:0042910] FRLITVR 0.99472 -15.439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14521 DHSD_HUMAN "Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial, CybS (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit)" SDHD SDH4 Homo sapiens (Human) "cellular response to hypoxia [GO:0071456]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; regulation of catecholamine secretion [GO:0050433]; tricarboxylic acid cycle [GO:0006099]" "integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]" "integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; cellular response to hypoxia [GO:0071456]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; regulation of catecholamine secretion [GO:0050433]; tricarboxylic acid cycle [GO:0006099]" GO:0005739; GO:0005740; GO:0005743; GO:0005749; GO:0006099; GO:0006121; GO:0008177; GO:0009055; GO:0016021; GO:0020037; GO:0042776; GO:0046872; GO:0048039; GO:0050433; GO:0071456 electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039] ALLLRTPVVR 0.99472 -11.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6116 14.8418 14.477 0 0 0 12.0149 0 0 0 0 0 0 0 0 0 13.4564 0 0 0 0 13.7415 0 0 13.4429 13.5267 13.7906 0 0 0 0 0 0 0 12.8123 0 0 0 0 14.4985 0 0 0 0 0 0 15.7754 0 11.5569 0 0 13.8516 13.9206 11.8883 13.8066 0 0 11.9961 12.3213 0 13.1606 0 0 0 0 0 0 13.2549 0 0 0 0 11.8967 0 0 0 12.7177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.092 0 15.2189 14.8354 0 0 0 0 0 O43175 SERA_HUMAN "D-3-phosphoglycerate dehydrogenase, 3-PGDH, EC 1.1.1.95 (2-oxoglutarate reductase, EC 1.1.1.399) (Malate dehydrogenase, EC 1.1.1.37)" PHGDH PGDH3 Homo sapiens (Human) brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566] GO:0004617; GO:0005829; GO:0006541; GO:0006544; GO:0006564; GO:0006566; GO:0007420; GO:0009055; GO:0009448; GO:0010468; GO:0019530; GO:0021510; GO:0021782; GO:0021915; GO:0030060; GO:0031175; GO:0051287; GO:0070062; GO:0070314 electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617] MAFANLR 0.99472 -10.604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60242 AGRB3_HUMAN Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3) ADGRB3 BAI3 KIAA0550 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic cleft [GO:0043083]; G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; neuron remodeling [GO:0016322]; positive regulation of synapse assembly [GO:0051965]; regulation of dendrite morphogenesis [GO:0048814] GO:0004930; GO:0005096; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007520; GO:0016021; GO:0016322; GO:0016525; GO:0043083; GO:0048814; GO:0051965; GO:0061743; GO:0098794; GO:0099558 G protein-coupled receptor activity [GO:0004930]; GTPase activator activity [GO:0005096] CLNLPLDVQEGDFQTEV 0.99472 -11.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3926 0 0 0 0 0 0 11.2453 0 0 0 0 0 0 11.8503 0 0 0 0 0 0 0 0 0 0 0 11.1436 0 0 0 0 0 0 11.8546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3951 0 0 11.9251 0 0 12.4885 0 0 0 0 0 0 0 0 0 14.0837 0 0 0 0 0 14.4736 0 0 0 0 12.3565 0 14.7107 0 0 13.0276 0 0 0 0 0 0 0 0 0 0 0 0 12.9185 0 0 0 0 0 0 0 0 0 0 0 0 13.5237 16.6747 0 0 0 0 0 0 0 0 0 0 13.0013 0 0 11.4006 0 0 0 0 0 0 0 0 0 10.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2951 0 9.88163 0 0 O76075 DFFB_HUMAN "DNA fragmentation factor subunit beta, EC 3.-.-.- (Caspase-activated deoxyribonuclease, CAD, Caspase-activated DNase) (Caspase-activated nuclease, CPAN) (DNA fragmentation factor 40 kDa subunit, DFF-40)" DFFB CAD DFF2 DFF40 Homo sapiens (Human) apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; negative regulation of apoptotic DNA fragmentation [GO:1902511] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; apoptotic chromosome condensation [GO:0030263]; apoptotic DNA fragmentation [GO:0006309]; DNA catabolic process [GO:0006308]; negative regulation of apoptotic DNA fragmentation [GO:1902511] GO:0000785; GO:0003677; GO:0004520; GO:0004536; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006308; GO:0006309; GO:0019899; GO:0019904; GO:0030263; GO:0032991; GO:0042802; GO:0097718; GO:1902511 deoxyribonuclease activity [GO:0004536]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904] GAKGGSR 0.99472 -8.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8057 0 0 14.4642 0 0 0 0 0 0 0 0 14.7651 0 0 14.1451 13.5827 0 0 0 0 0 0 12.3033 0 0 0 0 0 0 0 0 14.837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C025 NUD17_HUMAN "Nucleoside diphosphate-linked moiety X motif 17, Nudix motif 17, EC 3.6.1.-" NUDT17 Homo sapiens (Human) NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742] peroxisome [GO:0005777] peroxisome [GO:0005777]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742] GO:0005777; GO:0006734; GO:0006742; GO:0019677; GO:0035529; GO:0046872 metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529] ARPLVLHMSTLLRMIPTMAEDK 0.99472 -8.9674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5157 0 0 0 0 0 0 0 0 0 0 11.3437 0 0 0 0 0 0 0 0 0 0 12.5105 0 0 0 0 10.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22004 BMP6_HUMAN "Bone morphogenetic protein 6, BMP-6 (VG-1-related protein, VG-1-R, VGR-1)" BMP6 VGR Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; cellular response to iron ion [GO:0071281]; cellular response to mechanical stimulus [GO:0071260]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; immune response [GO:0006955]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular permeability [GO:0043117]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; vesicle [GO:0031982] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; vesicle [GO:0031982]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein heterodimerization activity [GO:0046982]; BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; cellular response to iron ion [GO:0071281]; cellular response to mechanical stimulus [GO:0071260]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; immune response [GO:0006955]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular permeability [GO:0043117]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323] GO:0000122; GO:0001501; GO:0001649; GO:0001654; GO:0001822; GO:0001938; GO:0001958; GO:0003323; GO:0005125; GO:0005615; GO:0005737; GO:0006879; GO:0006954; GO:0006955; GO:0008083; GO:0008284; GO:0010628; GO:0010862; GO:0014823; GO:0030182; GO:0030501; GO:0030509; GO:0030539; GO:0031666; GO:0031982; GO:0032026; GO:0032332; GO:0032349; GO:0032526; GO:0043117; GO:0045603; GO:0045666; GO:0045669; GO:0045944; GO:0046982; GO:0050679; GO:0050714; GO:0050731; GO:0051216; GO:0051384; GO:0060391; GO:0060395; GO:0060586; GO:0070700; GO:0071260; GO:0071281; GO:0071773; GO:1903392; GO:2000048; GO:2000860 BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein heterodimerization activity [GO:0046982] DGVHVHPR 0.99472 -11.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6763 12.7859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28039 AOAH_HUMAN "Acyloxyacyl hydrolase, EC 3.1.1.77 [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit ]" AOAH Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231] cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728] GO:0005509; GO:0005576; GO:0006631; GO:0009104; GO:0031410; GO:0043231; GO:0050528; GO:0050728 acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509] ETWKFTLQK 0.99472 -10.587 14.5438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0964 12.3459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0568 0 0 15.3106 0 0 0 14.8789 0 0 0 0 0 0 0 0 16.3211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43304 GPDM_HUMAN "Glycerol-3-phosphate dehydrogenase, mitochondrial, GPD-M, GPDH-M, EC 1.1.5.3 (mitohondrial glycerophosphate dehydrogenase gene, mGDH) (mtGPD)" GPD2 Homo sapiens (Human) glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerophosphate shuttle [GO:0006127] glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerophosphate shuttle [GO:0006127] GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006127; GO:0009331; GO:0019563; GO:0052591 calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591] DDFSSGTSSR 0.99472 -10.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55011 S12A2_HUMAN Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) SLC12A2 NKCC1 Homo sapiens (Human) aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; ion transport [GO:0006811]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511]; aging [GO:0007568]; ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular chloride ion homeostasis [GO:0030644]; cellular potassium ion homeostasis [GO:0030007]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; cellular sodium ion homeostasis [GO:0006883]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; ion transport [GO:0006811]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104] GO:0005829; GO:0005886; GO:0005887; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0007568; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0015379; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869 ammonium transmembrane transporter activity [GO:0008519]; cation:chloride symporter activity [GO:0015377]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; sodium:potassium:chloride symporter activity [GO:0008511] AQIVLLVILLLAIGDFVIGTFIPLESKK 0.99472 -10.598 0 0 0 0 0 0 0 0 11.3737 11.2209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4465 10.1768 0 0 0 0 0 0 0 0 0 0 12.1643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0204 0 0 0 0 0 0 0 13.8523 16.7647 16.7033 0 16.9931 0 16.5934 16.2405 0 16.1418 16.1506 0 15.5392 0 0 16.4405 0 0 0 0 0 0 0 0 0 13.9881 15.5592 0 14.509 0 0 0 15.6668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5819 13.0912 0 0 0 13.6319 0 12.9737 0 13.445 0 0 0 0 0 0 0 0 0 12.8144 0 0 0 0 0 0 0 12.5003 13.3346 0 13.2276 0 0 0 0 0 12.8507 0 0 13.0901 0 0 0 P59923 ZN445_HUMAN "Zinc finger protein 445, ZFP445 (Zinc finger protein 168) (Zinc finger protein with KRAB and SCAN domains 15)" ZNF445 ZFP445 ZKSCAN15 ZNF168 Homo sapiens (Human) maintenance of DNA methylation [GO:0010216]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; maintenance of DNA methylation [GO:0010216]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0003682; GO:0005634; GO:0006357; GO:0010216; GO:0010385; GO:0046872; GO:2000653 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRWSSNCAR 0.99472 -12.634 0 0 0 0 0 0 0 0 0 12.4499 0 0 0 0 0 0 0 0 0 0 10.8568 0 0 0 0 9.69413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1552 0 0 0 0 12.1122 0 0 0 0 0 0 0 16.3055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5626 9.77271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5442 0 0 0 14.9597 0 0 0 0 0 0 0 0 0 13.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2722 0 0 0 0 0 0 0 0 0 0 0 15.7869 Q5XG87 PAPD7_HUMAN "Terminal nucleotidyltransferase 4A (DNA polymerase sigma) (LAK-1) (Non-canonical poly(A) RNA polymerase PAPD7, EC 2.7.7.19) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal guanylyltransferase, EC 2.7.7.-) (Terminal uridylyltransferase 5, TUTase 5) (Topoisomerase-related function protein 4-1, TRF4-1)" TENT4A PAPD7 POLS TRF4 Homo sapiens (Human) double-strand break repair [GO:0006302]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to xenobiotic stimulus [GO:0009410]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation [GO:0043631]; sister chromatid cohesion [GO:0007062] Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499] Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221]; double-strand break repair [GO:0006302]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; response to xenobiotic stimulus [GO:0009410]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; RNA polyadenylation [GO:0043631]; sister chromatid cohesion [GO:0007062] GO:0004652; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0006302; GO:0006397; GO:0007062; GO:0007076; GO:0009410; GO:0031123; GO:0031499; GO:0031965; GO:0043221; GO:0043631; GO:0046872; GO:0060212; GO:0070568; GO:0071076; GO:1905870 ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; SMC family protein binding [GO:0043221] AHPSPGMDSR 0.99472 -11.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4303 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2294 0 14.1546 0 0 0 0 0 0 0 17.2235 13.5047 13.8154 15.0519 14.5801 15.1484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.978 0 13.9033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.781 0 0 0 0 0 0 0 0 10.372 0 13.719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PCE3 PGM2L_HUMAN "Glucose 1,6-bisphosphate synthase, EC 2.7.1.106 (PMMLP) (Phosphoglucomutase-2-like 1)" PGM2L1 BM32A Homo sapiens (Human) glucose metabolic process [GO:0006006] cytosol [GO:0005829] "cytosol [GO:0005829]; glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]; glucose metabolic process [GO:0006006]" GO:0005829; GO:0006006; GO:0016868; GO:0046872; GO:0047933 "glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular transferase activity, phosphotransferases [GO:0016868]; metal ion binding [GO:0046872]" CFSDFKQRGFVVGYDTR 0.99472 -8.4418 0 0 0 0 0 12.6441 0 12.4428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5139 0 0 0 10.7189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1343 14.4935 0 0 0 0 0 14.952 14.3735 0 0 0 16.0308 0 0 0 0 13.2357 0 0 14.5168 0 0 0 0 0 0 0 13.6996 13.4159 0 0 0 0 12.6087 0 14.8489 0 0 0 13.0399 0 0 0 0 0 0 0 13.2242 0 0 14.0455 0 0 0 14.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0063 13.9893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2965 0 0 Q6X4U4 SOSD1_HUMAN "Sclerostin domain-containing protein 1 (Ectodermal BMP inhibitor, Ectodin) (Uterine sensitization-associated gene 1 protein, USAG-1)" SOSTDC1 USAG1 CDA019 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; epithelial cell fate commitment [GO:0072148]; hair follicle morphogenesis [GO:0031069]; mammary gland bud morphogenesis [GO:0060648]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of Wnt signaling pathway [GO:0030178]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389] extracellular space [GO:0005615] extracellular space [GO:0005615]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; canonical Wnt signaling pathway [GO:0060070]; epithelial cell fate commitment [GO:0072148]; hair follicle morphogenesis [GO:0031069]; mammary gland bud morphogenesis [GO:0060648]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of Wnt signaling pathway [GO:0030178]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389] GO:0005615; GO:0007389; GO:0010454; GO:0030178; GO:0030514; GO:0031069; GO:0036122; GO:0042475; GO:0045662; GO:0060070; GO:0060648; GO:0072148; GO:0090090; GO:0098821; GO:2000016 BMP binding [GO:0036122]; BMP receptor activity [GO:0098821] RASKSSK 0.99472 -8.4408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1037 0 0 0 0 0 0 12.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5596 0 12.2869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZQR2 CFA77_HUMAN Cilia- and flagella-associated protein 77 CFAP77 C9orf171 Homo sapiens (Human) cilium [GO:0005929] cilium [GO:0005929] GO:0005929 AGLVTAR 0.99472 -8.4279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.393 0 0 0 0 0 0 0 0 0 0 0 0 13.2061 0 0 0 12.3259 0 0 13.1426 0 12.718 0 0 0 0 0 0 0 0 0 0 0 0 12.6263 0 0 13.2476 0 0 12.8372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9632 13.4915 0 12.626 0 12.4093 0 11.8162 0 0 0 0 12.0528 0 0 Q86YV5 PRAG1_HUMAN "Inactive tyrosine-protein kinase PRAG1 (PEAK1-related kinase-activating pseudokinase 1) (Pragmin) (Sugen kinase 223, SgK223)" PRAG1 SGK223 Homo sapiens (Human) cell migration [GO:0016477]; negative regulation of neuron projection development [GO:0010977]; positive regulation of Rho protein signal transduction [GO:0035025]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; cell migration [GO:0016477]; negative regulation of neuron projection development [GO:0010977]; positive regulation of Rho protein signal transduction [GO:0035025]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593] GO:0004672; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006468; GO:0008360; GO:0008593; GO:0010977; GO:0016477; GO:0035025; GO:0042802; GO:2000145 identical protein binding [GO:0042802]; protein kinase activity [GO:0004672] AAPVPSK 0.99472 -31.371 11.7852 0 11.6631 0 0 11.4694 0 0 11.7017 0 0 12.8324 0 0 0 0 14.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.829 0 0 10.9814 14.2308 14.6517 0 12.169 0 0 0 0 0 0 0 0 10.7251 0 0 0 0 0 0 9.69101 0 0 9.72247 0 0 0 0 0 0 0 13.4721 0 0 0 0 0 0 0 14.048 0 0 0 14.0327 0 0 0 16.128 12.8502 0 16.38 11.5135 0 0 0 0 0 0 13.0021 12.1255 12.743 12.752 0 0 0 13.4263 13.8186 0 0 0 11.7373 0 0 0 0 10.6452 0 13.7972 0 0 11.8249 0 0 0 0 0 0 0 10.7222 0 10.2771 0 0 0 13.3422 0 0 12.7499 10.9927 0 0 10.6086 11.9483 10.4659 0 0 0 0 0 12.4721 0 14.9025 0 13.1436 0 0 0 0 10.2966 0 0 14.9988 12.1636 11.7175 0 11.5287 0 0 13.6829 0 14.8209 14.7973 14.5284 13.8286 13.5845 13.5142 0 0 0 15.3407 0 13.8947 0 14.145 Q8NGE8 OR4D9_HUMAN Olfactory receptor 4D9 (Olfactory receptor OR11-253) OR4D9 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] MDQRNYTR 0.99472 -11.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.115 0 0 0 0 10.8791 0 0 0 0 12.316 12.7424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5924 0 0 0 0 0 0 0 Q8NH90 O5AK2_HUMAN Olfactory receptor 5AK2 OR5AK2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] PLHYTVIMSRTVCIR 0.99472 -8.9667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2811 0 0 0 0 0 10.8152 0 0 0 0 0 11.3352 0 0 0 0 Q96MD7 CI085_HUMAN Uncharacterized protein C9orf85 C9orf85 Homo sapiens (Human) FDKSVQTKK 0.99472 -15.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6449 0 0 0 0 0 0 0 12.0717 0 0 0 0 0 0 0 0 0 0 12.8057 0 17.9977 0 0 0 0 0 0 0 0 0 14.2763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.618 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1965 0 0 17.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H461 FZD8_HUMAN "Frizzled-8, Fz-8, hFz8" FZD8 Homo sapiens (Human) angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; neuron differentiation [GO:0030182]; positive regulation of JUN kinase activity [GO:0043507]; T cell differentiation in thymus [GO:0033077] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; neuron differentiation [GO:0030182]; positive regulation of JUN kinase activity [GO:0043507]; T cell differentiation in thymus [GO:0033077] GO:0001525; GO:0004930; GO:0005102; GO:0005794; GO:0005886; GO:0016021; GO:0017147; GO:0030165; GO:0030182; GO:0031625; GO:0033077; GO:0042813; GO:0043507; GO:0060070; GO:1990851 G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147] ARPPGGGAAPCEPGCQCR 0.99472 -15.48 0 11.0855 0 0 0 0 0 0 0 0 0 10.1692 0 10.8088 10.7784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.401 0 0 0 0 0 0 0 0 0 0 0 10.4762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1579 14.0687 0 0 0 12.6442 11.5216 0 0 15.6172 12.8008 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5046 0 0 0 0 15.5289 11.197 15.3348 0 0 0 0 0 0 11.9034 0 0 0 0 0 0 0 0 11.8006 0 0 0 0 12.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9994 0 0 14.0243 13.2435 0 0 0 0 12.5847 0 0 0 0 0 0 0 0 0 0 0 0 10.8521 12.1434 13.1043 0 11.8759 0 0 0 0 0 Q9NRH2 SNRK_HUMAN "SNF-related serine/threonine-protein kinase, EC 2.7.11.1 (SNF1-related kinase)" SNRK KIAA0096 SNFRK Homo sapiens (Human) intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468] nucleus [GO:0005634] nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468] GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0006468; GO:0030099; GO:0035556; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CAGPSNSMQLASRSAGELVESLKLMSLCLGSQLHGSTK 0.99472 -10.599 0 0 0 0 0 0 0 0 0 0 10.8631 12.0823 0 0 13.0092 0 0 0 0 12.6604 0 0 0 0 0 0 0 12.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3664 0 0 0 0 11.5051 0 12.549 0 0 12.9231 14.9495 0 0 0 13.7476 0 0 12.8243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0678 0 0 0 0 0 0 11.5522 0 0 12.7167 0 0 0 0 0 0 0 0 0 0 0 0 12.138 0 0 0 0 0 13.0469 0 13.3787 0 0 0 0 12.4427 0 0 0 0 14.4247 0 0 15.5721 12.7067 0 11.2112 12.6762 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6779 Q9NZC7 WWOX_HUMAN "WW domain-containing oxidoreductase, EC 1.1.1.- (Fragile site FRA16D oxidoreductase) (Short chain dehydrogenase/reductase family 41C member 1)" WWOX FOR SDR41C1 WOX1 Homo sapiens (Human) cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491]; transcription coactivator activity [GO:0003713]; cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055] GO:0001649; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0042802; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001238; GO:2001241 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491]; transcription coactivator activity [GO:0003713] CMPSPEAQSEETAR 0.99472 -8.7063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.44876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3028 0 11.582 12.2022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8049 0 0 0 0 0 0 0 Q9P2P5 HECW2_HUMAN "E3 ubiquitin-protein ligase HECW2, EC 2.3.2.26 (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)" HECW2 KIAA1301 NEDL2 Homo sapiens (Human) negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686] cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071] GO:0000209; GO:0005737; GO:0016567; GO:0030071; GO:0043161; GO:0048814; GO:0061630; GO:0072686; GO:2000650 ubiquitin protein ligase activity [GO:0061630] DHLLEDAFNQIMGYSR 0.99472 -8.427 0 0 0 0 0 0 0 0 0 0 14.1536 0 0 0 0 9.67101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2827 0 0 12.8601 0 0 0 0 0 0 0 0 11.6039 0 0 0 0 0 10.6082 0 0 0 14.5196 0 0 0 0 13.8892 0 11.9187 0 0 0 0 0 15.2522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.595 0 0 0 0 18.1494 0 0 0 Q9UQE7 SMC3_HUMAN "Structural maintenance of chromosomes protein 3, SMC protein 3, SMC-3 (Basement membrane-associated chondroitin proteoglycan, Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide, hCAP)" SMC3 BAM BMH CSPG6 SMC3L1 Homo sapiens (Human) cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cohesin loading activity [GO:0061775]; double-stranded DNA binding [GO:0003690]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]" GO:0000278; GO:0000775; GO:0000785; GO:0000800; GO:0003682; GO:0003690; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006275; GO:0006281; GO:0007062; GO:0007064; GO:0008278; GO:0016363; GO:0016887; GO:0019827; GO:0030893; GO:0034089; GO:0034990; GO:0034991; GO:0036033; GO:0046982; GO:0048487; GO:0051301; GO:0051321; GO:0061775; GO:0070840; GO:0090307; GO:0097431 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cohesin loading activity [GO:0061775]; double-stranded DNA binding [GO:0003690]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982] AFKHVFGK 0.99472 -31.345 0 0 0 0 0 0 0 0 0 12.6623 15.1251 0 0 0 0 0 0 0 0 13.7027 0 0 0 0 0 0 0 0 0 0 0 0 13.2141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0804 0 0 0 0 0 0 0 12.4939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0535 0 0 0 0 0 0 18.3422 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4067 0 13.1173 13.4906 16.2481 0 14.9685 17.2146 0 0 0 0 0 0 0 0 0 13.2315 0 0 0 0 Q9Y2D8 ADIP_HUMAN "Afadin- and alpha-actinin-binding protein, ADIP (Afadin DIL domain-interacting protein) (SSX2-interacting protein)" SSX2IP KIAA0923 Homo sapiens (Human) cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020] adherens junction [GO:0005912]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] adherens junction [GO:0005912]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein domain specific binding [GO:0019904]; cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020] GO:0005634; GO:0005737; GO:0005912; GO:0007098; GO:0007155; GO:0019904; GO:0031252; GO:0032991; GO:0034451; GO:0035020; GO:0035735; GO:0036064; GO:0060271; GO:2000145 protein domain specific binding [GO:0019904] DEVQKLQNIIASRATQYNHDMK 0.99472 -8.7099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0041 0 0 0 0 0 0 0 0 10.9363 0 0 0 0 0 0 13.1347 0 0 0 0 0 13.5877 0 0 0 0 0 0 0 0 0 12.9237 0 15.5203 0 0 0 0 12.4952 13.2543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4B6 DCAF1_HUMAN "DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein, VprBP) (Serine/threonine-protein kinase VPRBP, EC 2.7.11.1) (Vpr-interacting protein)" DCAF1 KIAA0800 RIP VPRBP Homo sapiens (Human) B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; histone kinase activity (H2A-T120 specific) [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; chromatin organization [GO:0006325]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151] GO:0000122; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043687; GO:0080008; GO:0106310; GO:1990244; GO:1990245 ATP binding [GO:0005524]; histone kinase activity (H2A-T120 specific) [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310] DENSQLVAIVLRRLR 0.99472 -11.09 0 0 0 0 0 0 0 0 13.9843 13.4089 0 0 0 0 13.671 0 0 0 0 0 0 10.1283 0 0 0 13.6393 0 0 0 0 13.2685 0 0 14.4878 12.6119 0 0 0 0 0 0 0 0 12.4745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.067 0 0 0 0 0 0 0 0 0 0 12.3488 0 13.3171 0 15.1893 12.0066 0 0 0 14.3526 0 0 0 0 0 0 0 0 15.0565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7416 0 14.6583 0 0 0 0 0 0 0 0 18.2247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2203 0 0 0 0 0 0 0 0 13.151 0 0 0 0 13.8513 12.8429 0 0 14.1426 13.674 14.5103 13.4955 13.7626 0 0 10.5728 15.0278 0 12.0165 0 0 0 0 B4DYI2 S31C2_HUMAN Putative spermatogenesis-associated protein 31C2 (Protein FAM75C2) SPATA31C2 FAM75C2 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0007283; GO:0016021; GO:0030154 ECPRGLEETWDLLSQLQSLLGPHLEK 0.99473 -8.9938 0 0 0 11.1782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4574 0 11.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14958 CASQ2_HUMAN "Calsequestrin-2 (Calsequestrin, cardiac muscle isoform)" CASQ2 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; detection of calcium ion [GO:0005513]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; protein polymerization [GO:0051258]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of heart rate [GO:0002027]; regulation of membrane repolarization [GO:0060306]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; sequestering of calcium ion [GO:0051208]; striated muscle contraction [GO:0006941] calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; junctional sarcoplasmic reticulum membrane [GO:0014701]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018] calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; junctional sarcoplasmic reticulum membrane [GO:0014701]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium ion sequestering activity [GO:0140314]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; cardiac muscle contraction [GO:0060048]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; detection of calcium ion [GO:0005513]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; protein polymerization [GO:0051258]; Purkinje myocyte to ventricular cardiac muscle cell signaling [GO:0086029]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of heart rate [GO:0002027]; regulation of membrane repolarization [GO:0060306]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; sequestering of calcium ion [GO:0051208]; striated muscle contraction [GO:0006941] GO:0002027; GO:0005509; GO:0005513; GO:0005737; GO:0006874; GO:0006941; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016529; GO:0030018; GO:0033017; GO:0033018; GO:0034704; GO:0042803; GO:0043267; GO:0048306; GO:0051208; GO:0051258; GO:0051279; GO:0060048; GO:0060306; GO:0060315; GO:0071313; GO:0086029; GO:0140314; GO:1901017 calcium ion binding [GO:0005509]; calcium ion sequestering activity [GO:0140314]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803] GVAKKLSLK 0.99473 -8.2217 14.2795 0 0 0 18.322 18.0234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1941 0 0 0 0 0 0 0 0 0 0 0 12.0177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.57 0 0 0 0 11.7205 0 0 0 14.4815 0 13.4892 13.8167 0 0 14.8661 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9089 15.4544 0 0 0 14.4214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1639 0 0 0 0 12.8155 0 0 0 13.2496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2697 0 0 13.6144 0 0 0 14.1745 0 0 0 13.3798 12.8957 0 0 13.7694 0 13.1852 13.7193 0 0 0 O60687 SRPX2_HUMAN Sushi repeat-containing protein SRPX2 (Sushi-repeat protein upregulated in leukemia) SRPX2 SRPUL Homo sapiens (Human) angiogenesis [GO:0001525]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]; vocalization behavior [GO:0071625] anchoring junction [GO:0070161]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; synaptic membrane [GO:0097060] anchoring junction [GO:0070161]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; synaptic membrane [GO:0097060]; hepatocyte growth factor binding [GO:0036458]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; angiogenesis [GO:0001525]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of synapse assembly [GO:0051965]; regulation of phosphorylation [GO:0042325]; vocalization behavior [GO:0071625] GO:0001525; GO:0005102; GO:0005615; GO:0005737; GO:0009986; GO:0036458; GO:0042325; GO:0042802; GO:0048870; GO:0051965; GO:0060076; GO:0062023; GO:0070161; GO:0071625; GO:0090050; GO:0097060; GO:0098609 hepatocyte growth factor binding [GO:0036458]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102] CDYSCSSGYHLEGDR 0.99473 -12.74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8423 0 0 0 0 9.90856 8.90078 0 0 12.2372 0 0 14.087 0 11.9006 0 0 0 0 0 0 0 0 0 0 0 0 0 12.682 0 0 0 0 0 0 0 0 0 0 0 0 10.808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.846 0 0 0 0 0 0 0 0 0 0 12.2901 0 0 10.7109 0 0 0 0 10.2782 0 0 0 0 0 0 0 0 0 0 0 0 O75521 ECI2_HUMAN "Enoyl-CoA delta isomerase 2, EC 5.3.3.8 (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase, D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1, DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase, pECI) (Renal carcinoma antigen NY-REN-1)" ECI2 DRS1 HCA88 PECI Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631] GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006631; GO:0006635; GO:0009062; GO:0016020; GO:0043231 delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062] EVWTRLK 0.99473 -8.4847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10073 ZSC22_HUMAN Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50) ZSCAN22 HKR2 ZNF50 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" IHITVLQ 0.99473 -9.006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2624 0 0 0 0 0 13.8186 0 0 0 0 0 0 0 0 0 0 0 12.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08554 DSC1_HUMAN "Desmocollin-1 (Cadherin family member 1) (Desmosomal glycoprotein 2/3, DG2/DG3)" DSC1 CDHF1 Homo sapiens (Human) cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell-cell adhesion [GO:0098609]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0001533; GO:0005509; GO:0005886; GO:0005911; GO:0005921; GO:0007156; GO:0016020; GO:0016021; GO:0030057; GO:0070062; GO:0098609; GO:0101003 calcium ion binding [GO:0005509] DVRPNVILGR 0.99473 -12.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3419 14.3841 0 13.1098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4234 14.9411 0 0 0 0 0 13.7474 0 0 11.3551 0 0 0 0 14.0946 0 0 0 0 0 12.9438 0 0 0 0 0 0 0 13.7107 0 0 0 0 0 14.7515 0 12.0166 0 0 0 13.9177 0 0 0 14.7122 14.6786 0 13.5239 13.4681 14.1238 14.037 0 13.779 0 0 0 0 14.0458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14435 GALT3_HUMAN "Polypeptide N-acetylgalactosaminyltransferase 3, EC 2.4.1.41 (Polypeptide GalNAc transferase 3, GalNAc-T3, pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3)" GALNT3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; carbohydrate metabolic process [GO:0005975]; fibroblast growth factor receptor signaling pathway [GO:0008543]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; spermatogenesis [GO:0007283] GO:0000139; GO:0004653; GO:0005509; GO:0005794; GO:0005975; GO:0006493; GO:0007283; GO:0008543; GO:0016020; GO:0016021; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0070062 calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] ACTYKGHK 0.99473 -12.741 0 0 0 0 0 0 10.2396 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7181 0 0 12.1576 0 0 0 0 11.9527 0 0 0 0 0 12.2906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2471 0 0 14.9213 13.6458 0 0 0 0 15.9942 0 16.7782 0 0 0 0 0 0 0 16.1739 16.0459 0 0 0 0 13.1962 0 0 13.0107 0 0 0 0 0 0 0 0 14.6235 0 0 0 14.2502 0 0 12.6769 16.0411 0 0 0 11.8279 0 0 10.6136 15.9325 0 0 0 0 12.4398 0 0 0 12.5648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3725 0 12.903 0 0 0 0 0 0 0 0 0 0 0 11.2149 0 0 0 15.9718 0 0 0 9.80494 0 0 0 0 Q16585 SGCB_HUMAN "Beta-sarcoglycan, Beta-SG (43 kDa dystrophin-associated glycoprotein, 43DAG) (A3b)" SGCB Homo sapiens (Human) cardiac muscle cell development [GO:0055013]; muscle organ development [GO:0007517]; vascular associated smooth muscle cell development [GO:0097084] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of plasma membrane [GO:0005887]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of plasma membrane [GO:0005887]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; cardiac muscle cell development [GO:0055013]; muscle organ development [GO:0007517]; vascular associated smooth muscle cell development [GO:0097084] GO:0005737; GO:0005856; GO:0005887; GO:0007517; GO:0016010; GO:0016012; GO:0042383; GO:0055013; GO:0097084 GNLAICVIILLFILAVINLIITLVIWAVIR 0.99473 -12.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7808 0 0 0 0 0 0 0 0 0 0 0 0 11.8075 0 0 0 0 0 0 0 0 0 0 0 0 0 11.263 0 0 0 0 12.9876 0 0 0 0 13.648 13.3902 0 0 0 0 0 12.739 0 0 0 0 0 13.9656 0 0 0 0 13.3888 0 11.8022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1443 0 0 0 0 0 13.9522 0 0 0 0 0 0 0 0 0 0 0 0 14.0527 0 0 0 0 0 0 14.5985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4925 0 0 0 0 0 0 0 0 Q86V48 LUZP1_HUMAN Leucine zipper protein 1 LUZP1 Homo sapiens (Human) artery development [GO:0060840]; neural fold bending [GO:0021503]; ventricular septum development [GO:0003281] extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; artery development [GO:0060840]; neural fold bending [GO:0021503]; ventricular septum development [GO:0003281] GO:0003281; GO:0005634; GO:0016020; GO:0021503; GO:0060840; GO:0070062 ADKASDTSSETVFGKR 0.99473 -32.066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8802 0 0 0 0 0 0 0 0 0 0 0 0 12.7657 0 10.6662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9595 15.1927 15.4197 15.1209 15.4609 0 14.6635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0527 15.2256 14.5913 12.0872 12.6794 11.5197 0 13.5742 14.1226 16.0929 14.3801 15.2228 13.2343 0 0 0 13.5675 13.5161 13.9159 14.5687 14.0095 14.0625 13.2969 14.0515 15.6294 13.8076 15.3267 15.1918 15.6465 0 14.5028 15.4225 15.903 14.4405 14.9844 14.6039 15.6669 14.9145 15.7116 14.4681 12.8813 14.5362 0 15.2144 15.2804 15.2312 14.9399 14.3545 0 14.4939 0 14.8237 0 14.6719 0 9.94147 0 0 0 0 0 0 0 0 11.7606 0 0 0 0 0 0 0 15.7007 16.199 15.8643 12.8752 0 0 0 14.7863 0 Q8TDF6 GRP4_HUMAN RAS guanyl-releasing protein 4 RASGRP4 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; cell population proliferation [GO:0008283]; myeloid cell differentiation [GO:0030099]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to extracellular stimulus [GO:0009991]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; activation of phospholipase C activity [GO:0007202]; cell population proliferation [GO:0008283]; myeloid cell differentiation [GO:0030099]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to extracellular stimulus [GO:0009991]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005085; GO:0005509; GO:0005654; GO:0005829; GO:0005886; GO:0007169; GO:0007202; GO:0007265; GO:0008277; GO:0008283; GO:0009991; GO:0016020; GO:0019992; GO:0030099; GO:0030742; GO:0043547; GO:0046579 calcium ion binding [GO:0005509]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085] ASAICSKLGLAFLHTFHEVTFR 0.99473 -8.2008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5059 0 13.4153 0 0 13.1488 0 0 0 12.9904 12.8851 0 11.5965 0 12.5918 0 0 0 0 0 0 11.287 13.4667 0 0 16.1685 12.444 14.9066 14.6054 0 0 0 0 0 0 0 17.8039 0 0 0 0 12.776 0 13.423 13.0228 15.0902 14.4741 0 14.1007 0 14.1132 15.2669 0 0 12.3123 11.4354 14.2237 15.1966 15.0121 14.4599 14.3748 13.3294 0 0 0 15.0884 0 0 0 0 12.1875 0 0 0 12.9519 11.4824 0 13.5447 12.2984 12.7488 0 0 12.1993 0 12.8739 0 0 0 12.2011 0 0 0 0 0 0 0 0 0 0 13.1852 0 14.3122 0 0 0 0 0 Q96N95 ZN396_HUMAN Zinc finger protein 396 (Zinc finger and SCAN domain-containing protein 14) ZNF396 ZSCAN14 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0042803; GO:0045892; GO:0046872; GO:0046982; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CHDCGKAFSQSSNLFR 0.99473 -8.9974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4982 14.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1646 12.7662 0 0 0 0 0 0 0 0 0 13.6227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.372 0 0 Q96P48 ARAP1_HUMAN "Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2, Cnt-d2)" ARAP1 CENTD2 KIAA0782 Homo sapiens (Human) actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] "cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; actin filament reorganization involved in cell cycle [GO:0030037]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]" GO:0005096; GO:0005547; GO:0005654; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007165; GO:0008360; GO:0030037; GO:0031410; GO:0032580; GO:0043231; GO:0043547; GO:0046872; GO:0051056; GO:0051491; GO:0051497 "GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" AFVPPLAEDLLAR 0.99473 -32.071 0 0 0 0 0 0 0 0 0 0 14.1933 0 0 0 0 0 0 0 0 0 0 14.7497 0 13.2932 14.4325 10.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8424 11.6423 0 0 0 0 14.8255 0 14.4634 0 0 0 10.5462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2038 0 0 12.4997 14.5107 0 12.435 15.3522 15.6248 15.3162 0 0 14.7014 13.5715 0 0 15.3095 14.608 0 0 0 14.9857 14.9558 0 14.6367 0 0 0 0 0 16.5754 13.9652 16.1655 14.9314 0 15.0255 15.0984 0 0 15.884 0 14.638 15.5166 14.6196 0 0 16.0561 15.4193 15.0393 16.0294 13.1968 0 16.3765 0 0 13.0063 0 12.7935 0 0 0 15.696 15.2371 0 16.4842 15.1635 15.548 0 15.1723 0 15.5759 14.7561 16.0542 0 0 15.2593 0 0 0 15.1857 14.7295 0 14.4578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3415 0 15.4557 0 0 0 0 14.531 12.1466 Q99683 M3K5_HUMAN "Mitogen-activated protein kinase kinase kinase 5, EC 2.7.11.25 (Apoptosis signal-regulating kinase 1, ASK-1) (MAPK/ERK kinase kinase 5, MEK kinase 5, MEKK 5)" MAP3K5 ASK1 MAPKKK5 MEKK5 Homo sapiens (Human) "apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; wound healing [GO:0042060]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; IRE1-TRAF2-ASK1 complex [GO:1990604]; protein kinase complex [GO:1902911]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic signaling pathway [GO:0097190]; cellular response to amino acid starvation [GO:0034198]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive nitrogen species [GO:1902170]; cellular response to tumor necrosis factor [GO:0071356]; cellular senescence [GO:0090398]; endothelial cell apoptotic process [GO:0072577]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron death [GO:1901216]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; programmed necrotic cell death [GO:0097300]; protein phosphorylation [GO:0006468]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]; stress-activated MAPK cascade [GO:0051403]; wound healing [GO:0042060]" GO:0000165; GO:0000287; GO:0002931; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0007254; GO:0008631; GO:0009897; GO:0010666; GO:0019901; GO:0019903; GO:0019904; GO:0032991; GO:0034198; GO:0034976; GO:0038066; GO:0042060; GO:0042802; GO:0042803; GO:0043065; GO:0043280; GO:0043507; GO:0045087; GO:0045663; GO:0045860; GO:0045893; GO:0046330; GO:0051403; GO:0070059; GO:0070301; GO:0071356; GO:0072577; GO:0090398; GO:0097190; GO:0097300; GO:0106310; GO:1900745; GO:1901216; GO:1902170; GO:1902911; GO:1904707; GO:1990604 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DDLKCLR 0.99473 -32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2886 0 0 0 0 0 0 0 10.8763 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4793 11.2278 0 11.6535 0 0 0 0 0 0 0 12.2814 13.6287 0 12.5473 12.5787 0 0 14.145 0 0 13.1085 15.5745 12.3627 14.1544 12.9467 15.6514 0 0 13.213 11.0502 16.1015 12.4266 0 0 0 0 12.026 0 14.8994 0 11.4641 0 0 0 0 0 0 0 14.965 17.1036 16.7559 13.9508 19.2015 0 14.3902 0 13.3061 12.7992 12.5546 14.371 0 0 0 0 0 0 15.5065 0 0 13.8581 13.62 0 0 0 14.4547 0 0 0 0 0 0 0 15.9969 0 0 14.4209 0 0 0 0 0 0 0 0 0 0 0 11.4863 0 0 0 0 12.7922 0 0 0 0 13.847 0 0 0 Q9NVN3 RIC8B_HUMAN "Synembryn-B (Brain synembryn, hSyn) (Protein Ric-8B)" RIC8B Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0001965; GO:0005085; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005938; GO:0007186; GO:0008277 G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085] DKKVLVPVTTK 0.99473 -9.0037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5798 0 0 0 0 14.9018 15.2343 0 0 0 0 0 0 12.5846 0 0 0 0 0 0 0 0 0 14.1702 0 0 0 0 0 0 0 0 0 11.3097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0085 0 0 0 0 0 0 13.6801 0 15.2194 0 0 11.229 14.7008 0 0 0 0 0 0 0 0 11.8283 0 13.3744 0 13.7939 13.9032 0 0 13.0043 0 0 0 13.812 0 0 0 0 13.4742 0 14.4803 0 0 13.2307 0 0 0 14.315 15.0675 14.9872 0 0 0 0 0 14.2275 14.65 0 0 0 0 14.4324 15.4106 0 0 15.265 13.7847 0 0 0 0 0 0 0 0 15.1255 0 0 13.6025 0 0 0 14.6888 0 0 13.6832 0 13.6505 0 0 0 0 0 0 0 0 0 0 0 0 14.2473 13.3805 0 0 13.8704 13.7145 0 0 0 14.6821 0 Q9NXR8 ING3_HUMAN Inhibitor of growth protein 3 (p47ING3) ING3 HSPC301 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]" NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812] "NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; Swr1 complex [GO:0000812]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of apoptotic process [GO:0043065]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000786; GO:0000812; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016573; GO:0032777; GO:0035064; GO:0035267; GO:0040008; GO:0042981; GO:0043065; GO:0043967; GO:0043968; GO:0045893; GO:0046872; GO:0051726; GO:1905168; GO:2000779 metal ion binding [GO:0046872]; methylated histone binding [GO:0035064] ASYEAFK 0.99473 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14715 RGPD8_HUMAN "RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3, RanBP2-like 3, RanBP2L3)" RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 Homo sapiens (Human) NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] cytoplasm [GO:0005737]; nuclear pore [GO:0005643] cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; small GTPase binding [GO:0031267]; NLS-bearing protein import into nucleus [GO:0006607]; regulation of catalytic activity [GO:0050790] GO:0005643; GO:0005737; GO:0006607; GO:0031267; GO:0050790 small GTPase binding [GO:0031267] AAKLFPGSPAIYKLK 0.99474 -10.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0517 0 0 0 0 0 0 11.8886 11.0854 0 0 14.4334 13.5686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4523 0 0 0 0 0 0 0 0 0 0 0 0 15.9638 12.1852 0 0 14.1941 0 0 0 0 0 0 0 15.2237 0 0 14.0172 0 11.0959 0 16.1484 0 0 0 0 0 12.4272 0 0 0 0 0 0 15.2959 14.044 0 0 13.6842 0 0 0 0 0 0 0 14.7111 0 0 0 0 0 0 0 0 15.5791 0 15.0571 0 0 0 0 0 0 0 0 0 0 0 0 10.8407 0 0 16.1089 0 16.2337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15033 AREL1_HUMAN "Apoptosis-resistant E3 ubiquitin protein ligase 1, EC 2.3.2.26 (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1)" AREL1 KIAA0317 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0043161; GO:0050727; GO:0061630; GO:0070979; GO:1990390 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] IIPWRLYTFR 0.99474 -10.624 0 0 0 0 0 0 0 0 0 11.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9726 0 0 12.1617 0 0 0 0 0 0 0 0 0 0 14.6551 0 0 15.7146 0 0 0 13.4981 0 0 0 0 0 0 14.5754 13.6313 0 0 12.4295 0 0 0 12.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43506 ADA20_HUMAN "Disintegrin and metalloproteinase domain-containing protein 20, ADAM 20, EC 3.4.24.-" ADAM20 Homo sapiens (Human) male gonad development [GO:0008584]; proteolysis [GO:0006508]; single fertilization [GO:0007338] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; proteolysis [GO:0006508]; single fertilization [GO:0007338] GO:0004222; GO:0005886; GO:0006508; GO:0007338; GO:0008237; GO:0008584; GO:0009897; GO:0016021; GO:0046872; GO:1990913 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] CASMVHLSQACQPKTCNMRGICNNK 0.99474 -8.504 0 0 0 0 0 0 0 0 12.6107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.811 0 0 0 0 12.4806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2673 0 0 0 0 0 0 0 0 0 0 0 0 13.3351 0 0 0 0 0 0 0 0 14.4919 0 12.9148 0 0 0 0 0 12.7555 0 13.4537 0 0 0 13.3058 0 12.4261 0 0 0 0 0 0 0 13.4888 0 0 0 0 0 13.4047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58294 PROK1_HUMAN "Prokineticin-1 (Endocrine-gland-derived vascular endothelial growth factor, EG-VEGF) (Mambakine)" PROK1 UNQ600/PRO1186 Homo sapiens (Human) angiogenesis [GO:0001525]; positive regulation of cell division [GO:0051781]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of angiogenesis [GO:0045765]; vascular endothelial cell proliferation [GO:0101023] extracellular region [GO:0005576] extracellular region [GO:0005576]; growth factor activity [GO:0008083]; angiogenesis [GO:0001525]; positive regulation of cell division [GO:0051781]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of angiogenesis [GO:0045765]; vascular endothelial cell proliferation [GO:0101023] GO:0001525; GO:0005576; GO:0008083; GO:0043410; GO:0045765; GO:0051781; GO:0101023; GO:1905564 growth factor activity [GO:0008083] FPDGRYR 0.99474 -8.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T124 UBX11_HUMAN UBX domain-containing protein 11 (Colorectal tumor-associated antigen COA-1) (Socius) (UBX domain-containing protein 5) UBXN11 SOC UBXD5 PP2243 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cytoskeleton [GO:0005856]; cytosol [GO:0005829] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ubiquitin binding [GO:0043130]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0005829; GO:0005856; GO:0043130; GO:0043161 ubiquitin binding [GO:0043130] ALDRVEEHPGSR 0.99474 -8.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1299 0 14.3702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.64 13.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7532 0 0 0 0 0 0 0 Q5VZ19 TDR10_HUMAN Tudor domain-containing protein 10 TDRD10 UNQ9380/PRO34205 Homo sapiens (Human) P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] P granule [GO:0043186] P granule [GO:0043186]; RNA binding [GO:0003723]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587] GO:0003723; GO:0030719; GO:0034587; GO:0043186 RNA binding [GO:0003723] APLVLEK 0.99474 -13.716 12.4478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5376 14.1947 0 13.8321 0 0 14.0726 0 0 0 0 14.456 0 0 0 0 0 0 14.0964 0 0 0 13.9832 13.3714 0 0 13.3769 0 0 0 0 0 0 13.4656 0 0 0 0 0 12.597 0 0 0 0 0 0 0 0 0 0 0 0 11.3359 0 0 0 0 0 0 0 0 0 0 12.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 13.181 0 0 13.6008 13.5157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2862 0 0 0 0 Q6P050 FXL22_HUMAN F-box and leucine-rich protein 22 FBXL22 Homo sapiens (Human) entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; Z disc [GO:0030018]; ubiquitin protein ligase activity [GO:0061630]; entrainment of circadian clock by photoperiod [GO:0043153]; G2/M transition of mitotic cell cycle [GO:0000086]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000086; GO:0005634; GO:0005730; GO:0005829; GO:0019005; GO:0030018; GO:0031146; GO:0043153; GO:0043161; GO:0051726; GO:0061630 ubiquitin protein ligase activity [GO:0061630] LSAVRSPR 0.99474 -10.62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1146 0 11.6998 0 0 0 10.607 0 0 0 0 0 0 0 0 0 0 15.3787 0 0 0 0 0 0 13.9913 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4686 0 0 0 13.2644 13.7078 0 0 0 0 14.6179 0 0 14.011 13.4652 0 13.2659 0 13.3123 0 0 0 0 13.3056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8969 0 0 0 Q7Z7K6 CENPV_HUMAN "Centromere protein V, CENP-V (Nuclear protein p30) (Proline-rich protein 6)" CENPV PRR6 Homo sapiens (Human) ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044] cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233] cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044] GO:0000776; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0007049; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0031965; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301 carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872] ERWETFQKR 0.99474 -10.631 0 0 0 0 0 0 0 0 0 0 0 13.4567 13.3734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2158 0 0 0 0 0 0 13.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6118 0 0 0 0 0 0 0 0 0 0 0 13.7314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7908 0 14.2677 0 0 0 0 0 13.7055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3073 0 0 0 0 0 0 0 11.3285 0 0 0 0 0 Q8NH72 OR4C6_HUMAN Olfactory receptor 4C6 (Olfactory receptor OR11-138) OR4C6 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] STTISLK 0.99474 -10.622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8589 0 0 0 0 0 0 0 0 13.2558 0 0 0 0 0 0 0 0 0 0 0 0 13.1138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7234 0 0 0 0 14.5693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4571 0 14.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1229 0 0 0 0 0 0 0 0 15.945 0 0 0 0 0 0 0 0 0 16.1116 0 0 0 0 0 0 0 0 14.2179 0 0 0 Q8WXB4 ZN606_HUMAN Zinc finger protein 606 (Zinc finger protein 328) ZNF606 KIAA1852 ZNF328 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CGKVFRNR 0.99474 -13.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7482 0 0 0 0 0 0 0 11.4131 12.9608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.839 0 0 0 0 0 13.9546 0 11.3375 0 13.0148 12.7922 0 0 0 0 0 0 12.8792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2899 0 12.9103 0 0 0 11.5512 0 0 Q9H706 GARE1_HUMAN GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1) GAREM1 C18orf11 FAM59A GAREM Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; proline-rich region binding [GO:0070064]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374] GO:0005886; GO:0007173; GO:0008284; GO:0051781; GO:0070064; GO:0070374; GO:0071364 proline-rich region binding [GO:0070064] IDGAEEDPK 0.99474 -8.495 0 0 18.2633 0 18.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6872 0 0 0 0 0 12.4957 0 0 0 0 15.3049 0 0 0 0 14.5278 0 0 0 0 0 14.3359 0 0 0 0 0 12.884 0 17.4702 14.5215 0 0 0 0 0 13.4001 13.449 0 12.02 0 0 0 0 0 0 17.208 0 0 12.9724 0 0 0 0 0 0 0 0 0 0 0 0 12.9765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1449 0 13.5845 15.1964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC96 CAN10_HUMAN "Calpain-10, EC 3.4.22.- (Calcium-activated neutral proteinase 10, CANP 10)" CAPN10 KIAA1845 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149]; actin cytoskeleton reorganization [GO:0031532]; cellular component disassembly involved in execution phase of apoptosis [GO:0006921]; cellular response to insulin stimulus [GO:0032869]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin secretion [GO:0032024]; positive regulation of intracellular transport [GO:0032388]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; proteolysis [GO:0006508]; type B pancreatic cell apoptotic process [GO:0097050] GO:0000149; GO:0004198; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006921; GO:0008092; GO:0031532; GO:0032024; GO:0032388; GO:0032869; GO:0046326; GO:0097050; GO:2000676 calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cytoskeletal protein binding [GO:0008092]; SNARE binding [GO:0000149] ALPGAWVK 0.99474 -12.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0521 0 13.0302 0 0 0 0 0 0 0 0 0 0 11.0814 0 13.0189 0 0 0 0 13.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9692 0 0 0 11.4695 0 0 0 0 0 0 0 0 0 14.1857 0 0 0 0 12.0033 0 0 0 0 0 0 13.6126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8842 0 0 0 11.4316 0 0 0 Q9Y5L0 TNPO3_HUMAN "Transportin-3 (Importin-12, Imp12) (Transportin-SR, TRN-SR)" TNPO3 IPO12 Homo sapiens (Human) protein import into nucleus [GO:0006606] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635] annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606] GO:0005635; GO:0005642; GO:0005737; GO:0006606; GO:0031267; GO:0042802; GO:0043231; GO:0061608 identical protein binding [GO:0042802]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] ASFWLGELQR 0.99474 -10.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2971 0 13.7005 0 0 0 0 0 11.5531 0 0 0 14.4387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6491 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8802 0 12.2786 0 10.0615 0 0 14.6571 12.9398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.515 0 0 0 A1KZ92 PXDNL_HUMAN "Probable oxidoreductase PXDNL, EC 1.-.-.- (Cardiac peroxidase) (Inactive peroxidasin-like protein) (Polysomal ribonuclease 1, PRM1) (Vascular peroxidase 2)" PXDNL VPO2 Homo sapiens (Human) hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979] GO:0004519; GO:0004601; GO:0005615; GO:0005783; GO:0005886; GO:0006979; GO:0020037; GO:0042744; GO:0046872 endonuclease activity [GO:0004519]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601] AEERWMK 0.99475 -15.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7577 0 0 12.5188 0 0 0 0 12.4842 0 0 0 0 0 0 0 0 0 12.3828 0 0 0 0 0 0 0 12.7801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.708 12.251 14.1961 14.1056 0 14.3071 0 13.8291 0 13.886 0 13.955 15.2075 0 0 13.7051 15.26 0 19.8053 0 0 0 0 0 13.9693 14.8543 0 9.78926 0 0 0 14.2501 0 0 0 13.9612 14.0598 14.3601 14.5602 0 0 0 0 15.8732 0 14.2586 0 0 14.4832 14.1636 0 0 14.3351 0 0 0 0 14.2268 0 0 14.3422 0 0 14.3894 13.9718 14.2668 0 14.1897 0 0 0 0 0 0 14.2811 0 0 0 0 0 14.7424 0 0 13.8017 0 0 0 0 12.6053 0 0 0 0 0 0 11.1828 0 0 0 13.7142 0 13.837 10.9895 0 0 0 11.7556 0 A8MVW0 F1712_HUMAN Protein FAM171A2 FAM171A2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 KLLELGVKPHPR 0.99475 -8.3047 0 0 11.3353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5886 0 0 0 12.9011 0 0 0 0 0 0 0 0 0 11.588 12.7289 0 0 0 0 13.829 0 0 0 13.4592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8866 0 0 0 0 0 11.1931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9245 0 0 0 0 0 0 0 0 P12273 PIP_HUMAN "Prolactin-inducible protein (Gross cystic disease fluid protein 15, GCDFP-15) (Prolactin-induced protein) (Secretory actin-binding protein, SABP) (gp17)" PIP GCDFP15 GPIP4 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of gene expression [GO:0010628]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; retina homeostasis [GO:0001895] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; actin binding [GO:0003779]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; IgG binding [GO:0019864]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of gene expression [GO:0010628]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; retina homeostasis [GO:0001895] GO:0001580; GO:0001895; GO:0002682; GO:0003779; GO:0004190; GO:0005576; GO:0005615; GO:0005634; GO:0006508; GO:0010628; GO:0019864; GO:0042802; GO:0070062; GO:0070233 actin binding [GO:0003779]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; IgG binding [GO:0019864] AQDNTRKIIIK 0.99475 -8.3051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8553 0 0 0 P20591 MX1_HUMAN "Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78, IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed ]" MX1 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; defense response [GO:0006952]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of viral genome replication [GO:0045071]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; signal transduction [GO:0007165] GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005874; GO:0006915; GO:0006952; GO:0007165; GO:0008017; GO:0009615; GO:0016020; GO:0031965; GO:0034340; GO:0042802; GO:0045071; GO:0045087; GO:0048471; GO:0051607; GO:0070106; GO:0140374 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017] GALQKVR 0.99475 -12.864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5473 0 0 0 12.4459 17.4414 12.6148 17.2919 17.9937 17.5041 12.5787 16.7684 16.9289 16.7235 12.611 0 15.3438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0043 0 16.0558 0 14.6384 14.1661 0 0 0 0 0 0 15.3439 0 14.2692 0 0 13.7915 0 14.5131 0 14.7269 14.8347 0 14.418 14.2158 14.2107 0 0 0 0 13.3867 13.2991 0 0 0 0 13.9353 0 0 0 13.4405 0 0 0 0 0 0 0 0 0 13.79 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8558 0 0 0 0 15.4033 0 0 P33316 DUT_HUMAN "Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial, dUTPase, EC 3.6.1.23 (dUTP pyrophosphatase)" DUT Homo sapiens (Human) DNA replication [GO:0006260]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139] GO:0000287; GO:0003723; GO:0004170; GO:0005634; GO:0005654; GO:0005739; GO:0006139; GO:0006226; GO:0006231; GO:0006260; GO:0046081; GO:0070062 dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723] MTPLCPR 0.99475 -10.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q08722 CD47_HUMAN "Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein, IAP) (Protein MER6) (CD antigen CD47)" CD47 MER6 Homo sapiens (Human) ATP export [GO:1904669]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-12 [GO:0071349]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phagocytosis [GO:0050766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of tumor necrosis factor production [GO:0032680] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; thrombospondin receptor activity [GO:0070053]; ATP export [GO:1904669]; cell migration [GO:0016477]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-12 [GO:0071349]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phagocytosis [GO:0050766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; regulation of interferon-gamma production [GO:0032649]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of tumor necrosis factor production [GO:0032680] GO:0005886; GO:0005887; GO:0007229; GO:0008284; GO:0009986; GO:0016477; GO:0022409; GO:0032649; GO:0032653; GO:0032655; GO:0032675; GO:0032680; GO:0035579; GO:0045428; GO:0050729; GO:0050766; GO:0050870; GO:0051496; GO:0070053; GO:0070062; GO:0070821; GO:0071346; GO:0071347; GO:0071349; GO:0086080; GO:0098632; GO:1904669; GO:1905450; GO:2000439 cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; thrombospondin receptor activity [GO:0070053] ESKGMMNDE 0.99475 -5.3408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.81 13.7288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13508 NAR3_HUMAN "Ecto-ADP-ribosyltransferase 3, EC 2.4.2.31 (ADP-ribosyltransferase C2 and C3 toxin-like 3, ARTC3) (Mono(ADP-ribosyl)transferase 3) (NAD(P)(+)--arginine ADP-ribosyltransferase 3)" ART3 TMART Homo sapiens (Human) peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; peptidyl-arginine ADP-ribosylation [GO:0018120]; protein ADP-ribosylation [GO:0006471] GO:0003950; GO:0005576; GO:0005886; GO:0006471; GO:0018120; GO:0031225; GO:0031226; GO:0070062; GO:0106274 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274] LEDHGVK 0.99475 -10.632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1915 0 0 0 0 0 0 0 11.9317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3578 0 0 0 0 0 11.2524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14159 SPIDR_HUMAN DNA repair-scaffolding protein (Scaffolding protein involved in DNA repair) SPIDR KIAA0146 Homo sapiens (Human) cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202] nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654] nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of establishment of protein localization to chromosome [GO:0070202] GO:0000228; GO:0000724; GO:0005654; GO:0006974; GO:0010569; GO:0031334; GO:0070202; GO:0071479; GO:0072711; GO:0072757; GO:2000781 CSFYATVIYQKPQLKSLLLLEQR 0.99475 -13.751 0 0 0 16.3129 0 0 0 0 0 0 0 12.8445 0 0 0 12.7645 0 0 12.4497 12.5028 0 0 11.8698 0 12.8759 13.015 13.649 0 0 13.1831 13.4468 0 0 0 0 0 0 0 0 0 12.8753 13.4003 13.2638 0 11.9884 0 0 0 0 0 0 0 0 0 12.8463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4446 0 0 0 0 0 0 0 0 10.4946 15.0634 0 13.7874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2665 0 13.923 0 11.1127 0 0 0 0 0 0 0 0 0 0 12.0414 0 0 0 10.8798 0 0 0 0 0 0 0 0 0 12.1194 0 0 0 12.2411 0 0 0 0 0 0 0 0 0 0 0 0 10.7737 0 0 0 0 0 0 0 0 0 12.2344 14.2749 0 0 0 0 0 0 14.1013 0 0 0 0 Q15700 DLG2_HUMAN "Disks large homolog 2 (Channel-associated protein of synapse-110, Chapsyn-110) (Postsynaptic density protein PSD-93)" DLG2 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642] adherens junction [GO:0005912]; axon cytoplasm [GO:1904115]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839] adherens junction [GO:0005912]; axon cytoplasm [GO:1904115]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytosol [GO:0005829]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; guanylate kinase activity [GO:0004385]; kinase binding [GO:0019900]; anterograde axonal protein transport [GO:0099641]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; retrograde axonal protein transport [GO:0099642] GO:0004385; GO:0005829; GO:0005886; GO:0005912; GO:0007268; GO:0014069; GO:0016020; GO:0016323; GO:0019900; GO:0030054; GO:0031594; GO:0035865; GO:0043005; GO:0043113; GO:0043204; GO:0044224; GO:0045197; GO:0097120; GO:0098609; GO:0098839; GO:0099641; GO:0099642; GO:1904115 guanylate kinase activity [GO:0004385]; kinase binding [GO:0019900] AVSLEGEPRKVVLHK 0.99475 -10.644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1762 0 0 0 0 0 0 0 13.5688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8674 0 0 0 0 0 0 0 12.9015 13.1321 0 0 15.3392 0 0 0 16.0285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7595 10.0841 0 0 0 0 0 14.8455 0 0 14.2035 0 0 0 0 14.4856 0 0 15.1489 0 0 13.8746 0 0 13.1407 0 10.2938 12.8432 0 0 0 0 0 0 0 11.4339 0 13.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8914 13.9747 0 0 0 0 0 0 0 Q16773 KAT1_HUMAN "Kynurenine--oxoglutarate transaminase 1, EC 2.6.1.7 (Cysteine-S-conjugate beta-lyase, EC 4.4.1.13) (Glutamine transaminase K, GTK) (Glutamine--phenylpyruvate transaminase, EC 2.6.1.64) (Kynurenine aminotransferase 1) (Kynurenine aminotransferase I, KATI) (Kynurenine--oxoglutarate transaminase I)" KYAT1 CCBL1 Homo sapiens (Human) biosynthetic process [GO:0009058]; cellular modified amino acid metabolic process [GO:0006575]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; glutamine-phenylpyruvate transaminase activity [GO:0047316]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular modified amino acid metabolic process [GO:0006575]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053]; response to bacterium [GO:0009617] GO:0005737; GO:0005739; GO:0005829; GO:0006575; GO:0009058; GO:0009617; GO:0016212; GO:0030170; GO:0042803; GO:0047316; GO:0047804; GO:0070189; GO:0097053 cysteine-S-conjugate beta-lyase activity [GO:0047804]; glutamine-phenylpyruvate transaminase activity [GO:0047316]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170] FVKWMIKNK 0.99475 -8.8277 0 0 0 0 0 0 0 0 11.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8593 0 12.9458 0 15.3106 15.2938 0 0 0 0 0 0 0 0 0 0 0 0 13.252 0 0 0 0 0 0 0 0 0 0 12.5437 14.1 13.4751 13.7717 0 0 0 0 0 0 0 0 0 0 12.3911 0 0 0 0 0 0 0 0 0 12.9933 0 0 0 0 0 0 0 0 0 0 12.0323 0 0 0 0 0 0 0 13.2514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6744 0 0 0 Q3MJ62 ZSC23_HUMAN Zinc finger and SCAN domain-containing protein 23 (Zinc finger protein 390) (Zinc finger protein 453) ZSCAN23 ZNF390 ZNF453 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EEEEEHSCGPESGLSRNNPHTR 0.99475 -8.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7848 0 0 0 0 0 0 0 0 0 0 0 0 13.3708 0 0 0 0 0 Q7L576 CYFP1_HUMAN "Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1, Sra-1) (p140sra-1)" CYFIP1 KIAA0068 Homo sapiens (Human) "axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]" axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724] "axonal growth cone [GO:0044295]; central region of growth cone [GO:0090724]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mRNA cap binding complex [GO:0005845]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; peripheral region of growth cone [GO:0090725]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; synapse [GO:0045202]; terminal bouton [GO:0043195]; tertiary granule lumen [GO:1904724]; actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation regulator activity [GO:0045182]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cellular response to insulin stimulus [GO:0032869]; cognition [GO:0050890]; dendrite extension [GO:0097484]; lamellipodium assembly [GO:0030032]; modification of synaptic structure [GO:0099563]; negative regulation of synaptic vesicle recycling [GO:1903422]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite development [GO:1900006]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of myelination [GO:0031641]; regulation of translation [GO:0006417]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; response to electrical stimulus [GO:0051602]; ruffle organization [GO:0031529]" GO:0000340; GO:0000902; GO:0001726; GO:0005576; GO:0005829; GO:0005845; GO:0005925; GO:0006417; GO:0007411; GO:0008360; GO:0010592; GO:0016601; GO:0030027; GO:0030031; GO:0030032; GO:0030833; GO:0031209; GO:0031267; GO:0031529; GO:0031641; GO:0032433; GO:0032869; GO:0034774; GO:0035580; GO:0043005; GO:0043025; GO:0043195; GO:0043197; GO:0044294; GO:0044295; GO:0045182; GO:0045202; GO:0045773; GO:0048471; GO:0048675; GO:0050890; GO:0051015; GO:0051388; GO:0051602; GO:0060076; GO:0070062; GO:0090724; GO:0090725; GO:0097484; GO:0099563; GO:0099578; GO:1900006; GO:1900029; GO:1903422; GO:1904724; GO:1905274; GO:2000601 actin filament binding [GO:0051015]; RNA 7-methylguanosine cap binding [GO:0000340]; small GTPase binding [GO:0031267]; translation regulator activity [GO:0045182] DCPDSAEEYER 0.99475 -5.3182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5925 15.555 0 0 12.6033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4612 13.2689 0 0 0 0 0 0 0 11.0814 0 0 0 12.6753 0 0 0 12.9984 0 0 13.0693 15.3308 13.0503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3801 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2Y5 NRK_HUMAN "Nik-related protein kinase, EC 2.7.11.1" NRK Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; neuron projection morphogenesis [GO:0048812]; protein phosphorylation [GO:0006468]; regulation of MAPK cascade [GO:0043408] GO:0000165; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0031532; GO:0035556; GO:0043408; GO:0048812; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AIDKLTGCEHFSVLQHEETTYIAIALK 0.99475 -36.006 13.9792 0 13.8558 0 0 11.4596 0 0 0 10.6373 0 0 0 0 0 0 0 0 13.604 14.9146 0 10.7707 0 0 10.857 0 11.0254 11.0446 0 0 0 0 0 0 0 0 0 0 11.7289 0 0 0 0 0 0 0 0 10.0325 0 11.3973 0 0 0 12.2329 10.8569 0 13.2021 11.8299 0 0 0 0 0 0 0 0 0 0 0 11.9671 0 0 17.6863 0 0 13.2436 13.9284 14.2284 13.163 0 0 17.0117 0 0 0 18.3447 13.653 15.177 0 13.9921 0 0 13.3562 13.8678 14.0847 14.5832 0 11.3508 13.3555 15.2493 15.2302 16.9339 15.5187 0 15.3823 14.1659 13.461 12.5793 0 14.9709 14.0289 0 15.1239 11.714 12.9365 0 0 0 17.5831 0 14.2288 13.7642 14.2017 10.516 9.25955 0 0 17.6695 11.2783 16.6441 0 14.5818 14.2912 13.9822 0 0 15.1566 18.2024 17.7051 17.4191 17.4561 0 0 0 0 0 0 11.8522 0 13.8288 14.0642 0 0 15.4556 14.0103 14.6425 0 0 0 12.6496 0 14.3601 0 0 0 0 0 0 11.0825 0 0 0 17.9657 18.0362 0 16.0314 0 0 0 0 Q86X67 NUD13_HUMAN "NAD(P)H pyrophosphatase NUDT13, mitochondrial, EC 3.6.1.22 (Nucleoside diphosphate-linked moiety X motif 13, Nudix motif 13) (Protein KiSS-16)" NUDT13 Homo sapiens (Human) NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742]; nucleobase-containing small molecule interconversion [GO:0015949] GO:0000210; GO:0005739; GO:0005759; GO:0006734; GO:0006742; GO:0015949; GO:0016462; GO:0035529; GO:0046872 metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; pyrophosphatase activity [GO:0016462] MSLYCGIACRRK 0.99475 -8.2954 0 0 0 0 0 0 11.8823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2415 0 0 0 0 13.4868 0 0 0 0 0 13.9917 0 0 0 0 0 0 10.6026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0435 0 0 0 15.3012 0 14.7588 0 0 0 0 0 0 14.5525 0 0 0 14.2057 12.8412 12.2085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.947 0 0 0 0 0 15.9918 0 0 0 15.0762 0 0 15.4089 0 15.4734 10.8166 0 14.5656 14.936 0 0 0 0 14.0882 0 0 11.4463 15.0111 0 15.6892 14.6604 11.2706 14.8404 13.7218 13.0899 14.2143 0 14.9649 0 11.8897 0 15.246 0 0 0 0 0 0 0 0 13.9648 0 0 0 0 11.936 0 0 11.528 0 15.2117 15.5919 14.0328 0 0 15.1187 0 14.9816 12.0917 Q8N336 ELMD1_HUMAN ELMO domain-containing protein 1 ELMOD1 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547] GTPase activator activity [GO:0005096]; positive regulation of GTPase activity [GO:0043547] GO:0005096; GO:0043547 GTPase activator activity [GO:0005096] AEWEKKR 0.99475 -13.793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2687 0 0 0 13.119 12.8072 12.81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9936 0 0 0 0 0 0 0 0 0 10.8402 0 0 0 0 0 0 0 0 0 0 0 0 12.7794 0 0 0 0 11.6597 0 0 0 0 0 0 0 0 0 12.7693 0 0 0 0 12.8658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96F46 I17RA_HUMAN "Interleukin-17 receptor A, IL-17 receptor A, IL-17RA (CDw217) (CD antigen CD217)" IL17RA IL17R Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; defense response to fungus [GO:0050832]; fibroblast activation [GO:0072537]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; protein catabolic process [GO:0030163]; response to virus [GO:0009615]; T-helper 17 type immune response [GO:0072538] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; interleukin-17 receptor activity [GO:0030368]; signaling receptor binding [GO:0005102]; cell surface receptor signaling pathway [GO:0007166]; defense response to fungus [GO:0050832]; fibroblast activation [GO:0072537]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; protein catabolic process [GO:0030163]; response to virus [GO:0009615]; T-helper 17 type immune response [GO:0072538] GO:0005102; GO:0005576; GO:0005886; GO:0005887; GO:0006954; GO:0007166; GO:0009615; GO:0030163; GO:0030368; GO:0032736; GO:0032747; GO:0032754; GO:0032755; GO:0045087; GO:0050729; GO:0050832; GO:0071621; GO:0072537; GO:0072538; GO:0097400; GO:1900017; GO:2000340 interleukin-17 receptor activity [GO:0030368]; signaling receptor binding [GO:0005102] FEFLSKLR 0.99475 -12.862 0 0 0 0 0 0 0 0 12.8852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8486 0 0 0 0 0 0 0 0 0 11.3933 0 0 0 0 0 0 0 0 0 10.7515 0 0 0 0 0 15.5007 0 0 0 0 0 11.1397 0 0 0 0 0 0 0 0 0 13.2806 12.4311 0 0 0 0 0 13.2166 0 0 0 0 12.0598 0 0 0 0 0 0 0 0 0 0 0 14.2371 0 13.39 0 15.9938 0 0 0 14.5323 0 11.5734 0 0 0 0 0 0 12.6285 0 0 9.87883 0 0 0 0 0 0 0 0 0 13.5977 0 0 0 0 0 12.1747 0 0 0 12.6664 0 11.7432 0 0 0 0 0 0 0 0 0 0 0 0 0 11.192 0 0 0 12.7409 0 0 0 0 0 0 0 0 0 0 0 11.2172 Q9NPI1 BRD7_HUMAN Bromodomain-containing protein 7 (75 kDa bromodomain protein) (Protein CELTIX-1) BRD7 BP75 CELTIX1 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of histone acetylation [GO:0035066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of histone acetylation [GO:0035066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]" GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006357; GO:0007049; GO:0008285; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0035066; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0070577; GO:2000045; GO:2000134; GO:2000781; GO:2000819 histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] DGTDTSQSGEDGGCWQR 0.99475 -11.306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.961 0 0 0 0 0 0 12.4025 0 0 0 0 0 14.1719 13.4892 0 0 0 0 0 13.0572 13.6524 13.7885 14.7277 0 0 0 0 0 0 0 0 0 13.7136 0 0 0 0 11.9222 0 0 0 13.1486 13.6117 13.7832 0 0 0 0 13.1518 0 0 0 13.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1132 0 0 0 0 13.3201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5896 0 0 0 0 0 0 0 0 0 0 0 12.6694 0 0 0 0 0 0 0 Q9NZR1 TMOD2_HUMAN "Tropomodulin-2 (Neuronal tropomodulin, N-Tmod)" TMOD2 NTMOD Homo sapiens (Human) actin filament organization [GO:0007015]; learning or memory [GO:0007611]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; pointed-end actin filament capping [GO:0051694]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745] cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; synapse [GO:0045202] cytoskeleton [GO:0005856]; myofibril [GO:0030016]; striated muscle thin filament [GO:0005865]; synapse [GO:0045202]; actin binding [GO:0003779]; tropomyosin binding [GO:0005523]; actin filament organization [GO:0007015]; learning or memory [GO:0007611]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; nervous system development [GO:0007399]; neuron-neuron synaptic transmission [GO:0007270]; pointed-end actin filament capping [GO:0051694]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745] GO:0003779; GO:0005523; GO:0005856; GO:0005865; GO:0006936; GO:0007015; GO:0007270; GO:0007399; GO:0007611; GO:0030016; GO:0030239; GO:0045202; GO:0045745; GO:0051694 actin binding [GO:0003779]; tropomyosin binding [GO:0005523] EDFVPFTGEK 0.99475 -11.299 13.4719 13.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2899 0 0 10.6834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0855 0 0 0 11.4803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P1Y5 CAMP3_HUMAN Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha) CAMSAP3 KIAA1543 Homo sapiens (Human) cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell-cell adhesion [GO:0090136]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; in utero embryonic development [GO:0001701]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; protein transport along microtubule [GO:0098840]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of Golgi organization [GO:1903358]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]; zonula adherens maintenance [GO:0045218] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule minus-end [GO:0036449]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; zonula adherens [GO:0005915] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule minus-end [GO:0036449]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; zonula adherens [GO:0005915]; actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cilium movement [GO:0003341]; cytoplasmic microtubule organization [GO:0031122]; embryo development ending in birth or egg hatching [GO:0009792]; epithelial cell-cell adhesion [GO:0090136]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; in utero embryonic development [GO:0001701]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; protein transport along microtubule [GO:0098840]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893]; regulation of Golgi organization [GO:1903358]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle organization [GO:0033043]; zonula adherens maintenance [GO:0045218] GO:0000226; GO:0001701; GO:0003341; GO:0005516; GO:0005654; GO:0005737; GO:0005813; GO:0005915; GO:0005930; GO:0007026; GO:0009792; GO:0030334; GO:0030507; GO:0030951; GO:0031113; GO:0031122; GO:0031175; GO:0031514; GO:0033043; GO:0034453; GO:0036064; GO:0036449; GO:0045198; GO:0045218; GO:0051011; GO:0051015; GO:0051893; GO:0070507; GO:0090136; GO:0098840; GO:1903358 actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507] ASLLERQQRR 0.99475 -13.779 0 0 0 0 0 0 0 0 0 11.0595 14.3702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.8737 0 0 0 0 0 0 0 19.1719 19.1672 13.765 11.7895 0 0 0 0 0 0 0 14.0956 14.2292 14.4103 14.2485 13.8474 13.0857 14.1846 15.1666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2217 13.2298 12.9277 0 0 0 0 0 0 0 0 13.1002 0 0 0 0 0 0 15.6657 0 0 0 11.5646 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3818 0 0 0 0 0 0 0 0 11.9518 11.3841 0 13.5477 12.8728 13.7273 13.1021 11.5245 0 0 15.1915 14.6847 0 0 0 0 0 0 0 11.5363 13.6528 0 0 0 Q9UBX8 B4GT6_HUMAN "Beta-1,4-galactosyltransferase 6, Beta-1,4-GalTase 6, Beta4Gal-T6, b4Gal-T6, EC 2.4.1.- (Glucosylceramide beta-1,4-galactosyltransferase, EC 2.4.1.274) (Lactosylceramide synthase, LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6)" B4GALT6 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; glycosphingolipid biosynthetic process [GO:0006688]; glycosylation [GO:0070085]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551]; protein glycosylation [GO:0006486] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]; carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; glycosphingolipid biosynthetic process [GO:0006688]; glycosylation [GO:0070085]; lactosylceramide biosynthetic process [GO:0001572]; neuron maturation [GO:0042551]; protein glycosylation [GO:0006486]" GO:0000139; GO:0001572; GO:0005794; GO:0005975; GO:0006486; GO:0006688; GO:0008378; GO:0008489; GO:0010706; GO:0016021; GO:0021955; GO:0022010; GO:0032580; GO:0042551; GO:0046872; GO:0070085 "galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]" GEVQFLGRYKLLR 0.99475 -10.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1186 0 0 0 0 0 0 0 11.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6X2 PIAS3_HUMAN "E3 SUMO-protein ligase PIAS3, EC 2.3.2.- (E3 SUMO-protein transferase PIAS3) (Protein inhibitor of activated STAT protein 3)" PIAS3 Homo sapiens (Human) negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847] cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; synapse [GO:0045202] cytoplasm [GO:0005737]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hormone [GO:0009725]; TNFSF11-mediated signaling pathway [GO:0071847] GO:0000122; GO:0003712; GO:0005654; GO:0005737; GO:0006357; GO:0008022; GO:0008270; GO:0009725; GO:0010628; GO:0010629; GO:0015459; GO:0016607; GO:0016925; GO:0019789; GO:0019899; GO:0030425; GO:0033234; GO:0033235; GO:0045202; GO:0045671; GO:0045838; GO:0047485; GO:0061665; GO:0071847 enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] FCLCETSCPQEDYFPPNLFVKVNGKLCPLPGYLPPTK 0.99475 -8.2785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8491 0 0 12.6614 0 0 13.3981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3449 0 14.5355 13.5072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4764 0 0 0 0 0 0 12.1836 0 17.0879 0 11.562 0 0 12.1087 0 12.2754 0 0 0 0 16.2455 0 0 17.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8972 13.6571 0 0 0 16.5631 0 16.9787 0 16.9265 0 15.1088 15.6528 16.4465 9.98485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.71431 0 0 0 0 0 0 0 0 0 13.0594 O00541 PESC_HUMAN Pescadillo homolog PES1 Homo sapiens (Human) "cell population proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]" "chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]" "chromosome [GO:0005694]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]" GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006364; GO:0008283; GO:0016020; GO:0030687; GO:0042273; GO:0043021; GO:0051726; GO:0070545 ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] AGEGTYALDSESCMEK 0.99476 -31.304 12.3875 0 0 0 12.5867 0 12.5662 0 0 0 0 0 0 0 0 0 0 11.692 0 0 0 0 11.5413 12.6912 12.0368 0 0 0 0 0 0 0 12.2516 0 0 0 0 0 12.3399 0 0 0 0 12.2122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0603 0 13.0601 0 0 0 14.8016 14.1566 14.981 0 14.2166 0 0 0 0 0 0 0 0 0 0 14.1833 14.1727 0 0 0 0 0 13.7778 11.0471 0 0 0 0 14.4488 0 0 14.7989 0 0 0 14.8765 0 13.6663 13.5332 14.0683 0 0 12.9919 14.8866 0 0 13.2499 14.698 12.9528 0 0 0 14.637 0 14.4823 0 0 12.9463 13.5583 0 0 0 14.3545 0 13.3826 0 14.5134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6299 0 0 0 0 0 0 0 0 15.1495 0 0 0 0 0 O60573 IF4E2_HUMAN "Eukaryotic translation initiation factor 4E type 2, eIF-4E type 2, eIF4E type 2 (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP, h4EHP) (mRNA cap-binding protein type 3)" EIF4E2 EIF4EL3 Homo sapiens (Human) miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; P-body [GO:0000932]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]" GO:0000339; GO:0000340; GO:0000932; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005845; GO:0008135; GO:0016281; GO:0017148; GO:0031625; GO:0035278 "RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]" FDALKDDDSGDHDQNEENSTQK 0.99476 -9.4067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7722 11.5961 0 0 0 0 0 0 0 0 0 0 0 12.2235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.884 0 0 11.4111 12.6939 0 0 0 0 18.222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.532 0 0 0 0 0 0 O75052 CAPON_HUMAN Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein) NOS1AP CAPON KIAA0464 Homo sapiens (Human) positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] anchoring junction [GO:0070161]; caveola [GO:0005901]; cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome [GO:0002102]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018] anchoring junction [GO:0070161]; caveola [GO:0005901]; cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome [GO:0002102]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]; nitric-oxide synthase binding [GO:0050998]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate by chemical signal [GO:0003062]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] GO:0002102; GO:0003062; GO:0005634; GO:0005739; GO:0005829; GO:0005901; GO:0010628; GO:0010750; GO:0030018; GO:0030175; GO:0030315; GO:0033017; GO:0042383; GO:0045428; GO:0045429; GO:0048471; GO:0050998; GO:0050999; GO:0051000; GO:0060307; GO:0070161; GO:0098901; GO:0098974; GO:0098978; GO:1901381; GO:1901841; GO:1902261; GO:1902514; GO:1903762; GO:2000170 nitric-oxide synthase binding [GO:0050998] CNVFKSK 0.99476 -31.269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3965 15.2086 0 0 0 0 0 18.5509 0 0 0 12.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3873 0 13.6371 0 0 0 0 0 0 0 0 0 15.0408 0 0 0 0 0 0 0 12.7741 0 0 0 0 0 13.9126 0 0 0 0 13.374 12.5579 0 0 0 0 0 0 0 0 14.3324 0 0 0 0 13.3315 0 0 0 0 0 0 0 0 P36021 MOT8_HUMAN "Monocarboxylate transporter 8, MCT 8 (Monocarboxylate transporter 7, MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter)" SLC16A2 MCT8 XPCT Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; cellular amino acid metabolic process [GO:0006520]; monocarboxylic acid transport [GO:0015718]; negative regulation of neural precursor cell proliferation [GO:2000178]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; thyroid hormone transmembrane transporter activity [GO:0015349]; amino acid import across plasma membrane [GO:0089718]; cellular amino acid metabolic process [GO:0006520]; monocarboxylic acid transport [GO:0015718]; negative regulation of neural precursor cell proliferation [GO:2000178]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]; transport across blood-brain barrier [GO:0150104] GO:0005886; GO:0005887; GO:0006520; GO:0006590; GO:0008028; GO:0015171; GO:0015293; GO:0015349; GO:0015718; GO:0016021; GO:0016324; GO:0042403; GO:0070327; GO:0070460; GO:0089718; GO:0150104; GO:2000178 amino acid transmembrane transporter activity [GO:0015171]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; thyroid hormone transmembrane transporter activity [GO:0015349] KYFNMRVFR 0.99476 -5.3649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8901 0 0 0 0 0 13.5628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1338 0 P47884 OR1D4_HUMAN "Olfactory receptor 1D4 (Olfactory receptor 17-30, OR17-30)" OR1D4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0005887; GO:0007165; GO:0007186; GO:0007606 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] MLVNFQSQNK 0.99476 -5.3545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1721 0 16.4708 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6167 0 14.1707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48058 GRIA4_HUMAN "Glutamate receptor 4, GluR-4, GluR4 (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4, GluA4)" GRIA4 GLUR4 Homo sapiens (Human) glutamate receptor signaling pathway [GO:0007215]; negative regulation of smooth muscle cell apoptotic process [GO:0034392] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] AMPA glutamate receptor complex [GO:0032281]; anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of smooth muscle cell apoptotic process [GO:0034392] GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0007215; GO:0015276; GO:0030666; GO:0032281; GO:0034392; GO:0038023; GO:0043025; GO:0043197; GO:0045211; GO:0070161; GO:1903561 AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; signaling receptor activity [GO:0038023] AEAKRMK 0.99476 -31.355 0 0 0 0 9.27062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7506 0 0 0 0 12.3716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7956 0 0 0 0 0 13.0368 12.8838 0 12.9908 0 13.9157 14.6952 14.873 14.6139 13.3022 0 0 0 0 0 0 0 0 0 0 0 13.8762 13.9595 12.3085 0 0 0 0 0 13.1703 0 0 0 14.0622 0 0 13.8768 0 0 0 0 0 14.0982 0 0 0 0 14.3576 0 0 0 0 0 0 0 0 0 12.6039 0 0 0 12.6229 0 13.0427 0 13.1159 0 0 12.6406 0 0 0 0 0 0 0 0 0 0 13.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12894 IFRD2_HUMAN Interferon-related developmental regulator 2 (Protein SKMC15) IFRD2 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 DIFGLGPVLLLDATALK 0.99476 -10.715 0 0 0 0 0 0 0 0 0 11.4168 11.3711 0 0 0 0 0 0 14.265 0 0 15.4761 0 0 0 0 11.9741 0 0 14.6008 14.1133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2538 13.8838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9186 0 13.9578 0 0 0 14.3186 0 0 0 0 13.315 0 0 12.8285 0 0 14.7687 0 0 11.8576 14.3482 14.3242 14.414 13.5229 0 0 14.6724 0 14.3107 0 14.5005 0 0 0 0 0 14.6352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15468 STIL_HUMAN SCL-interrupting locus protein (TAL-1-interrupting locus protein) STIL SIL Homo sapiens (Human) centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099]; identical protein binding [GO:0042802]; centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224] GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0033504; GO:0035264; GO:0042802; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905832 identical protein binding [GO:0042802] AKQQLTEKPAFLVK 0.99476 -31.368 12.8047 0 11.703 0 0 0 0 13.2532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3222 0 0 0 13.225 0 0 0 0 0 13.1909 0 0 0 0 0 0 0 14.5703 14.8961 0 0 0 0 0 0 0 0 13.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3595 0 0 0 0 11.5433 0 11.0459 0 12.9032 0 0 13.2091 0 0 0 0 13.6589 0 11.8325 0 0 0 0 0 0 13.9211 12.1315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.362 0 0 0 0 0 0 0 0 15.2439 0 0 11.2484 0 0 14.4041 0 0 12.0207 0 0 0 Q5T9C2 F102A_HUMAN Protein FAM102A (Early estrogen-induced gene 1 protein) FAM102A C9orf132 EEIG1 Homo sapiens (Human) AFLMKKK 0.99476 -9.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1719 0 0 0 0 13.1206 0 0 0 0 0 0 13.3228 0 0 0 12.9636 0 0 0 0 0 0 0 0 0 0 13.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8035 0 0 0 0 0 0 0 0 Q5VZV1 MT21C_HUMAN "Protein-lysine methyltransferase METTL21C, EC 2.1.1.- (Methyltransferase-like protein 21C)" METTL21C C13orf39 Homo sapiens (Human) cellular response to dexamethasone stimulus [GO:0071549]; hormone-mediated apoptotic signaling pathway [GO:0008628]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; skeletal muscle tissue development [GO:0007519] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; protein-lysine N-methyltransferase activity [GO:0016279]; cellular response to dexamethasone stimulus [GO:0071549]; hormone-mediated apoptotic signaling pathway [GO:0008628]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; skeletal muscle tissue development [GO:0007519] GO:0005634; GO:0005737; GO:0005829; GO:0006479; GO:0007519; GO:0008628; GO:0010880; GO:0016279; GO:0018022; GO:0018023; GO:0031072; GO:0032991; GO:0071549 heat shock protein binding [GO:0031072]; protein-lysine N-methyltransferase activity [GO:0016279] IEPSLHSLQK 0.99476 -5.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5827 0 13.1086 0 0 0 0 10.6452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4311 0 0 12.9733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1194 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9111 0 0 0 0 0 0 0 0 0 0 Q86TL2 STIMA_HUMAN Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110) STIMATE TMEM110 Homo sapiens (Human) activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel regulator activity [GO:0005246]; activation of store-operated calcium channel activity [GO:0032237]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886] GO:0005246; GO:0005789; GO:0016020; GO:0016021; GO:0032237; GO:0032541; GO:0035584; GO:0070886; GO:0140268 calcium channel regulator activity [GO:0005246] AVSVLVEWQQWESLR 0.99476 -9.4084 0 0 0 0 0 0 0 0 0 0 0 0 12.629 0 0 13.4067 14.0741 0 0 0 0 0 0 0 12.3969 0 0 0 0 0 0 0 0 0 0 12.2655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.497 0 12.0545 0 14.2248 12.4131 10.719 0 13.434 0 0 0 0 10.72 0 0 0 0 0 0 0 12.0784 0 0 0 12.0849 0 0 12.8625 0 0 13.2464 0 13.7552 13.8118 0 0 0 13.196 0 0 0 0 13.9423 0 0 0 0 0 0 0 13.6941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5492 12.8544 0 0 0 0 0 0 12.8605 0 0 0 0 0 12.8636 0 0 12.9591 13.5277 13.6093 0 0 0 0 0 0 13.1594 12.5038 0 0 0 0 0 0 0 0 0 0 0 15.2064 13.9953 0 0 0 14.9959 0 0 0 0 0 12.2305 0 0 0 0 0 0 Q8IYA2 C144C_HUMAN Putative coiled-coil domain-containing protein 144C (Coiled-coil domain-containing protein 144C pseudogene) CCDC144CP CCDC144C Homo sapiens (Human) CPSVSPSMPENQSATK 0.99476 -15.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6604 12.945 10.398 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5465 0 0 0 0 0 0 0 12.2262 0 0 13.1233 0 0 0 11.7419 0 0 12.8131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.645 13.4106 12.8854 13.9936 13.5838 13.6577 14.0062 0 0 17.5961 0 0 0 14.0967 12.7981 0 14.7559 0 14.9454 0 13.6432 0 0 0 0 12.8253 14.9002 13.8517 0 0 0 13.8424 13.3761 0 0 0 13.9177 0 15.1076 0 15.2939 0 0 0 13.4511 0 13.2193 15.029 14.2196 0 0 14.258 12.6709 13.9859 0 0 13.4757 0 0 14.4695 13.9407 0 14.1664 0 0 16.4954 0 13.3918 12.832 0 13.7434 0 14.0366 0 0 0 0 0 0 0 12.9826 14.2603 0 13.025 0 0 0 0 0 0 0 13.6766 0 0 13.8003 0 0 0 14.1246 0 0 0 0 0 11.0092 0 Q8IYL2 TRM44_HUMAN "Probable tRNA (uracil-O(2)-)-methyltransferase, EC 2.1.1.211 (Methyltransferase-like protein 19)" TRMT44 C4orf23 METTL19 Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA (uracil-2'-O-)-methyltransferase activity [GO:0052665]; tRNA methylation [GO:0030488] GO:0005737; GO:0016300; GO:0030488; GO:0046872; GO:0052665 metal ion binding [GO:0046872]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA (uracil-2'-O-)-methyltransferase activity [GO:0052665] DFIDQVVLQVANLLLGGKQLNTR 0.99476 -31.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6664 0 0 0 0 16.8274 0 0 0 0 17.0089 0 0 0 0 0 0 0 0 0 0 0 15.3651 0 0 0 0 12.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4101 14.2168 11.5378 14.5856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7098 0 18.0903 0 0 0 0 0 0 0 0 0 0 15.0345 0 0 0 13.5773 0 0 0 0 0 0 0 Q8N6T3 ARFG1_HUMAN "ADP-ribosylation factor GTPase-activating protein 1, ARF GAP 1 (ADP-ribosylation factor 1 GTPase-activating protein, ARF1 GAP) (ARF1-directed GTPase-activating protein)" ARFGAP1 ARF1GAP Homo sapiens (Human) protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; synapse [GO:0045202] cytosol [GO:0005829]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005096; GO:0005829; GO:0015031; GO:0016192; GO:0030100; GO:0032012; GO:0045202; GO:0046872 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] AFEDWLNDDLGSYQGAQGNRYVGFGNTPPPQKK 0.99476 -8.3397 0 0 0 0 11.1186 0 0 0 11.4915 0 0 0 12.795 0 0 12.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7221 0 0 0 0 14.8516 0 0 14.4664 15.1009 0 0 0 0 0 12.6905 0 0 0 0 0 0 0 0 0 0 10.3919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0035 12.3944 0 0 0 14.9631 0 0 0 14.9125 14.2708 0 0 0 0 0 13.7773 0 0 0 0 0 0 0 0 0 13.259 14.6785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ71 TM158_HUMAN "Transmembrane protein 158 (40 kDa BINP-binding protein, p40BBP) (Ras-induced senescence protein 1)" TMEM158 HBBP RIS1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; peptide binding [GO:0042277] GO:0016021; GO:0042277 peptide binding [GO:0042277] AFFAAAFHR 0.99476 -5.3685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3588 13.4055 13.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5281 13.6155 13.5018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IV6 FXDC2_HUMAN Fatty acid hydroxylase domain-containing protein 2 FAXDC2 C5orf4 Homo sapiens (Human) positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein phosphorylation [GO:0001934]; sterol biosynthetic process [GO:0016126] GO:0000254; GO:0001934; GO:0005506; GO:0005737; GO:0005789; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0045654 C-4 methylsterol oxidase activity [GO:0000254]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491] LLHHPTFYKKIHK 0.99476 -8.3364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.659 0 0 0 0 12.3241 0 0 0 11.7246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1954 0 0 14.0662 0 0 0 0 0 0 13.9519 12.6391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2739 12.7706 0 0 0 0 0 0 0 0 0 14.6627 Q96LJ8 UBX10_HUMAN UBX domain-containing protein 10 (UBX domain-containing protein 3) UBXN10 UBXD3 Homo sapiens (Human) cilium assembly [GO:0060271]; ubiquitin-dependent ERAD pathway [GO:0030433] cilium [GO:0005929]; endoplasmic reticulum [GO:0005783] cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; ubiquitin binding [GO:0043130]; cilium assembly [GO:0060271]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005783; GO:0005929; GO:0030433; GO:0043130; GO:0060271 ubiquitin binding [GO:0043130] FIVRTKK 0.99476 -31.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0096 0 0 0 0 0 0 0 0 0 11.3504 0 13.1312 0 0 0 0 0 0 0 0 0 0 11.5778 0 0 0 0 0 0 0 0 0 0 0 0 13.5708 0 0 0 Q96T51 RUFY1_HUMAN RUN and FYVE domain-containing protein 1 (FYVE-finger protein EIP1) (La-binding protein 1) (Rab4-interacting protein) (Zinc finger FYVE domain-containing protein 12) RUFY1 RABIP4 ZFYVE12 Homo sapiens (Human) endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100]; small GTPase mediated signal transduction [GO:0007264] GO:0005737; GO:0005768; GO:0005829; GO:0006897; GO:0007264; GO:0008289; GO:0015031; GO:0016607; GO:0017124; GO:0030100; GO:0031901; GO:0042169; GO:0042802; GO:0043231; GO:0046872 identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124] DDEATHCR 0.99476 -5.3583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3872 0 0 11.9297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7207 0 13.6566 0 0 0 0 0 0 0 0 0 12.3877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1991 0 0 0 0 0 14.2472 0 0 13.457 0 0 0 0 0 13.2413 0 14.1976 0 0 0 14.1854 0 0 0 0 0 0 0 0 13.4248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0731 0 0 0 0 Q9BXB4 OSB11_HUMAN "Oxysterol-binding protein-related protein 11, ORP-11, OSBP-related protein 11" OSBPL11 ORP11 OSBP12 Homo sapiens (Human) fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890] GO:0005654; GO:0005794; GO:0005829; GO:0010890; GO:0015248; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0045444 sterol binding [GO:0032934]; sterol transporter activity [GO:0015248] LAVTKKR 0.99476 -10.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9883 0 0 14.4573 10.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4567 0 12.8156 0 0 0 0 13.9507 0 0 13.7828 0 13.1106 0 0 0 0 0 0 0 0 0 0 0 0 0 12.109 0 0 0 13.2838 0 0 0 0 13.5683 0 0 14.6137 0 0 12.8251 0 0 0 13.203 0 0 0 13.248 0 0 0 0 0 0 0 0 12.7316 12.7257 12.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NR16 C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b) CD163L1 CD163B M160 UNQ6434/PRO23202 Homo sapiens (Human) external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044] GO:0005044; GO:0005576; GO:0009897; GO:0016021 scavenger receptor activity [GO:0005044] GWGQHDCR 0.99476 -15.345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2398 0 0 0 0 0 0 0 0 13.2667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.417 0 0 0 0 0 0 11.5 0 0 0 0 0 0 0 0 13.015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5217 0 0 0 0 0 0 0 0 A5LHX3 PSB11_HUMAN "Proteasome subunit beta type-11, EC 3.4.25.1 (Proteasome subunit beta-5t)" PSMB11 Homo sapiens (Human) "CD8-positive, alpha-beta T cell differentiation [GO:0043374]; proteasomal protein catabolic process [GO:0010498]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]" "cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]" "cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298]; CD8-positive, alpha-beta T cell differentiation [GO:0043374]; proteasomal protein catabolic process [GO:0010498]; proteolysis [GO:0006508]; T cell differentiation in thymus [GO:0033077]" GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0006508; GO:0008233; GO:0010498; GO:0019774; GO:0033077; GO:0043374 endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298] LAHGTTTLAFRFRHGVIAAADTR 0.99477 -5.4096 0 0 0 0 0 0 0 0 0 0 0 10.5838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.51436 0 0 0 0 0 0 0 0 12.1488 9.95018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8155 0 11.6097 0 0 0 11.8173 0 11.8994 11.1193 0 0 0 0 0 0 0 16.3614 15.7888 16.0375 17.2826 0 0 0 0 0 0 0 0 11.0127 10.3753 0 0 0 0 0 0 10.6503 11.6664 0 0 0 0 0 0 0 10.5663 0 11.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43674 NDUB5_HUMAN "NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH, CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)" NDUFB5 Homo sapiens (Human) "aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] "mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]" GO:0005654; GO:0005739; GO:0005743; GO:0005747; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776 NADH dehydrogenase (ubiquinone) activity [GO:0008137] HSGDHGK 0.99477 -15.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.51602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0584 0 0 10.9989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1762 0 0 0 O75695 XRP2_HUMAN Protein XRP2 RP2 Homo sapiens (Human) cilium assembly [GO:0060271]; post-Golgi vesicle-mediated transport [GO:0006892]; protein folding [GO:0006457]; protein transport [GO:0015031]; visual perception [GO:0007601] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; unfolded protein binding [GO:0051082]; cilium assembly [GO:0060271]; post-Golgi vesicle-mediated transport [GO:0006892]; protein folding [GO:0006457]; protein transport [GO:0015031]; visual perception [GO:0007601] GO:0000287; GO:0005096; GO:0005525; GO:0005654; GO:0005737; GO:0005794; GO:0005814; GO:0005886; GO:0005929; GO:0006457; GO:0006892; GO:0007601; GO:0015031; GO:0016604; GO:0031410; GO:0036064; GO:0051082; GO:0060271; GO:0070062; GO:1990075 GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; unfolded protein binding [GO:0051082] GCFFSKR 0.99477 -5.4072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7159 0 0 P23434 GCSH_HUMAN "Glycine cleavage system H protein, mitochondrial (Lipoic acid-containing protein)" GCSH Homo sapiens (Human) glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249] cytoplasm [GO:0005737]; glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249] GO:0004047; GO:0005737; GO:0005739; GO:0005759; GO:0005960; GO:0006546; GO:0009249; GO:0019464 aminomethyltransferase activity [GO:0004047] MALRVVR 0.99477 -11.069 0 0 0 0 0 0 0 0 0 13.1987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51817 PRKX_HUMAN "cAMP-dependent protein kinase catalytic subunit PRKX, PrKX, Protein kinase X, Protein kinase X-linked, Serine/threonine-protein kinase PRKX, EC 2.7.11.1 (Protein kinase PKX1)" PRKX PKX1 Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial tube morphogenesis [GO:0060562]; kidney morphogenesis [GO:0060993]; myeloid cell differentiation [GO:0030099]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of epithelial cell differentiation involved in kidney development [GO:2000696]; signal transduction [GO:0007165] GO:0001525; GO:0001935; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005952; GO:0007155; GO:0007165; GO:0018105; GO:0030099; GO:0030155; GO:0030334; GO:0031589; GO:0043542; GO:0046777; GO:0060562; GO:0060993; GO:0106310; GO:2000696 ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310] DLIKKLLVVDR 0.99477 -8.6068 0 0 13.6025 0 12.4119 0 0 0 0 0 0 0 14.188 10.5565 0 0 0 13.3745 12.8964 0 0 0 13.223 12.0778 0 0 0 0 12.5038 0 0 14.7389 0 0 0 14.4475 13.7038 0 0 0 0 14.793 0 13.976 0 0 0 12.3122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8967 0 0 0 0 13.7585 0 0 0 0 0 0 0 13.6297 0 0 0 0 0 0 10.849 0 0 0 0 12.8108 0 13.688 0 0 0 0 0 14.9474 0 0 0 0 0 0 11.3531 0 0 0 13.8237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0253 12.85 0 12.4818 0 12.5792 0 0 0 0 0 0 12.7972 0 0 0 0 0 10.2369 16.653 0 0 0 0 0 0 0 0 0 0 0 13.4941 0 0 0 0 0 0 0 0 0 0 0 0 14.9557 0 13.0934 14.2293 0 15.5024 Q02241 KIF23_HUMAN Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819] centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467] GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] EDKNHNMYVAGCTEVEVKSTEEAFEVFWR 0.99477 -12.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7799 12.3651 13.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0476 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4056 0 0 0 0 13.7116 0 0 0 0 0 0 0 0 0 0 0 10.9977 0 14.8665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q07001 ACHD_HUMAN Acetylcholine receptor subunit delta CHRND ACHRD Homo sapiens (Human) acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle contraction [GO:0006936]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630] GO:0003009; GO:0004888; GO:0005231; GO:0005654; GO:0005829; GO:0005886; GO:0005887; GO:0005892; GO:0006936; GO:0007165; GO:0007268; GO:0022848; GO:0030594; GO:0031594; GO:0034220; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0048630; GO:0050877; GO:0050881; GO:0050905; GO:0070161; GO:0095500; GO:0099060; GO:1904315 acetylcholine binding [GO:0042166]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; neurotransmitter receptor activity [GO:0030594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] DSWNRVAR 0.99477 -8.6077 0 0 0 0 0 0 0 0 13.1901 0 0 0 0 0 12.5024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8017 12.8519 0 0 0 11.8683 0 0 13.4579 0 0 0 0 16.1124 15.0333 0 0 0 0 0 0 0 12.0477 0 0 0 0 0 0 0 14.267 0 10.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 0 0 0 0 0 0 13.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5DID0 UROL1_HUMAN Uromodulin-like 1 (Olfactorin) UMODL1 Homo sapiens (Human) adipose tissue development [GO:0060612]; cellular response to gonadotropin-releasing hormone [GO:0097211]; multicellular organismal reproductive process [GO:0048609]; neutrophil migration [GO:1990266]; regulation of gene expression [GO:0010468]; regulation of granulosa cell apoptotic process [GO:1904708]; regulation of ovarian follicle development [GO:2000354]; single fertilization [GO:0007338] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414]; adipose tissue development [GO:0060612]; cellular response to gonadotropin-releasing hormone [GO:0097211]; multicellular organismal reproductive process [GO:0048609]; neutrophil migration [GO:1990266]; regulation of gene expression [GO:0010468]; regulation of granulosa cell apoptotic process [GO:1904708]; regulation of ovarian follicle development [GO:2000354]; single fertilization [GO:0007338] GO:0005201; GO:0005509; GO:0005615; GO:0005737; GO:0007338; GO:0009897; GO:0009986; GO:0010468; GO:0016021; GO:0016324; GO:0030414; GO:0048609; GO:0060612; GO:0097211; GO:1904708; GO:1990266; GO:2000354 calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; peptidase inhibitor activity [GO:0030414] AHLKVRTAAR 0.99477 -11.055 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6271 0 0 0 11.015 0 0 0 0 0 0 0 10.5835 10.7571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6744 0 12.6485 0 0 12.5985 0 0 0 0 0 0 0 0 0 0 0 0 14.8776 14.8093 0 14.9832 0 0 0 0 12.1532 17.0335 0 0 14.9647 0 13.759 0 13.5435 0 0 0 0 14.6681 0 14.2973 0 0 0 0 0 0 0 0 0 14.1628 13.0402 12.5168 12.0377 0 0 0 0 0 0 0 0 0 0 12.3652 0 0 0 0 0 0 15.7889 0 0 0 0 0 0 11.721 0 0 14.8071 0 0 0 0 0 12.1775 0 12.0696 0 0 11.0163 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0L3 SPT46_HUMAN Spermatogenesis-associated protein 46 SPATA46 C1orf111 HSD20 Homo sapiens (Human) cell differentiation [GO:0030154]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; spermatogenesis [GO:0007283] nuclear membrane [GO:0031965] nuclear membrane [GO:0031965]; cell differentiation [GO:0030154]; fertilization [GO:0009566]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; spermatogenesis [GO:0007283] GO:0007283; GO:0007342; GO:0009566; GO:0030154; GO:0031965 ARLGDRLSSGSCQAFNSPAEHLR 0.99477 -12.598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6541 0 0 0 0 0 10.9523 0 0 0 0 0 0 0 0 12.2569 0 0 0 0 0 0 0 12.7627 0 0 0 0 0 0 0 0 0 0 0 13.0551 0 0 12.9828 0 0 0 0 0 10.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5951 15.3867 15.2031 0 14.9388 0 0 0 0 0 0 13.4789 0 0 0 0 10.5332 0 0 0 0 14.1159 0 0 0 0 0 0 0 14.3589 15.1796 0 0 14.0792 0 0 0 10.677 0 0 0 13.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.159 0 0 0 0 0 0 0 0 0 0 13.0305 0 0 0 0 0 0 0 0 0 0 0 12.5269 0 13.2854 0 0 12.4177 11.1281 0 0 12.2914 0 0 Q5VVW2 GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 GARNL3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005096; GO:0005737; GO:0051056; GO:0090630 GTPase activator activity [GO:0005096] FGVLFAK 0.99477 -8.601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3751 13.6657 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7191 0 0 15.4201 14.0666 0 0 0 0 0 0 0 0 0 0 0 0 12.5964 0 12.1563 0 0 0 0 13.9077 13.7443 0 0 14.0626 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2634 0 0 0 14.984 0 0 0 0 0 10.9354 0 0 0 0 10.6412 0 0 0 0 0 0 13.6415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5373 0 0 0 0 0 0 0 0 Q5XKK7 F219B_HUMAN Protein FAM219B FAM219B C15orf17 Homo sapiens (Human) ALRLSTPGPR 0.99477 -12.592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.545 0 0 0 0 0 0 0 0 0 0 11.0208 0 10.213 0 0 0 0 11.3424 0 10.8828 10.9075 0 0 0 0 0 0 0 0 0 12.4229 12.2663 0 0 0 13.4901 13.7153 12.3838 14.3551 13.9633 14.0634 0 12.8246 0 0 13.2926 12.2599 11.8981 0 0 0 11.7012 0 0 0 0 0 0 0 0 0 0 12.3427 17.1367 0 0 0 0 0 0 13.1799 12.9586 0 12.8359 13.5072 12.6964 0 0 16.1536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2818 0 0 0 0 0 0 0 0 Q6ZVQ6 YS045_HUMAN Putative uncharacterized protein FLJ42213 Homo sapiens (Human) EMESSPRPHR 0.99477 -12.576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6P3 RAB44_HUMAN Ras-related protein Rab-44 RAB44 Homo sapiens (Human) histamine secretion by mast cell [GO:0002553]; histamine secretion mediated by IgE immunoglobulin [GO:0097279]; vesicle-mediated transport [GO:0016192] azurophil granule membrane [GO:0035577]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histamine secretion by mast cell [GO:0002553]; histamine secretion mediated by IgE immunoglobulin [GO:0097279]; vesicle-mediated transport [GO:0016192] GO:0002553; GO:0003924; GO:0005509; GO:0005525; GO:0005886; GO:0016192; GO:0035577; GO:0035579; GO:0097279 calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] DALQQDLHATGSEPRLGTQR 0.99477 -5.3907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7085 0 0 0 0 0 14.8346 0 0 14.6102 0 13.9576 0 13.3857 0 0 15.1984 14.1058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BVG8 KIFC3_HUMAN Kinesin-like protein KIFC3 KIFC3 Homo sapiens (Human) epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218] centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; zonula adherens [GO:0005915] centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218] GO:0003777; GO:0005524; GO:0005794; GO:0005813; GO:0005871; GO:0005874; GO:0005915; GO:0007017; GO:0007018; GO:0007030; GO:0007601; GO:0008017; GO:0008569; GO:0015630; GO:0030659; GO:0042802; GO:0045218; GO:0070062; GO:0090136 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] AQEEERLSR 0.99477 -15.436 0 0 0 0 0 0 0 0 0 0 0 0 14.2187 0 0 0 0 11.6482 0 12.7465 0 0 0 0 0 0 0 0 0 0 12.8798 0 0 0 0 0 0 13.1225 0 0 0 14.7205 0 0 13.4649 0 0 0 0 0 0 0 0 11.819 12.447 11.9314 12.6567 13.4022 0 12.3295 0 11.6954 0 0 10.5709 12.3552 0 0 0 0 0 0 12.2678 0 0 0 0 0 14.0212 14.3761 0 12.2417 0 0 0 11.937 0 0 0 0 0 0 0 0 0 0 0 11.0506 0 13.786 0 0 14.3523 0 0 0 14.0888 0 0 0 0 14.1939 0 12.9428 12.5678 13.508 13.6118 0 13.6216 13.114 0 0 14.7084 0 0 0 12.7275 0 0 12.7436 12.958 13.4079 0 0 0 13.7104 14.6645 0 14.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2106 0 0 0 0 13.2953 13.2237 0 0 0 0 13.468 0 0 0 0 0 0 0 Q9BYC2 SCOT2_HUMAN "Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial, EC 2.8.3.5 (3-oxoacid CoA-transferase 2A) (Testis-specific succinyl-CoA:3-oxoacid CoA-transferase, SCOT-t)" OXCT2 FKSG25 Homo sapiens (Human) cellular ketone body metabolic process [GO:0046950]; ketone body catabolic process [GO:0046952] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410]; cellular ketone body metabolic process [GO:0046950]; ketone body catabolic process [GO:0046952] GO:0005739; GO:0005759; GO:0008260; GO:0008410; GO:0031514; GO:0046950; GO:0046952 3-oxoacid CoA-transferase activity [GO:0008260]; CoA-transferase activity [GO:0008410] ADFALVK 0.99477 -11.053 0 0 0 0 0 0 0 0 12.0154 12.7134 13.4269 0 13.8861 12.3826 12.5919 0 0 0 0 10.7496 0 0 0 0 0 0 12.1112 0 0 12.1542 0 0 0 0 0 12.3024 0 13.3362 0 0 0 0 12.4319 0 0 0 13.7397 13.114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0215 0 12.498 0 0 0 0 0 0 0 0 13.0571 13.7495 13.5968 13.9992 0 0 0 0 0 0 0 0 13.7467 0 12.7063 14.0271 0 0 0 0 13.5147 13.1961 0 0 0 0 0 0 0 0 13.578 0 14.5845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0809 14.0849 0 0 14.9265 0 15.0801 14.4652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5N1 RABE2_HUMAN Rab GTPase-binding effector protein 2 (Rabaptin-5beta) RABEP2 RABPT5B Homo sapiens (Human) cell projection organization [GO:0030030]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of cilium assembly [GO:1902017] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231] centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; cell projection organization [GO:0030030]; endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of cilium assembly [GO:1902017] GO:0005096; GO:0005769; GO:0005813; GO:0005829; GO:0006897; GO:0008083; GO:0015031; GO:0030030; GO:0036064; GO:0043231; GO:1902017 growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096] AEELIQEIQRR 0.99477 -12.594 0 0 0 0 0 11.0399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77442 0 0 0 0 0 0 0 0 0 0 0 12.1335 0 0 0 14.1524 0 0 0 0 0 0 13.6735 0 0 0 0 0 0 0 0 0 0 0 13.2499 12.5968 12.9922 0 0 0 13.7538 13.6535 14.4226 0 0 0 0 12.8788 13.1679 13.8459 0 0 0 0 13.4976 0 0 0 14.7205 0 0 12.9769 0 13.1594 0 13.9328 13.8476 0 13.6098 0 0 0 0 0 0 13.9644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9751 13.6984 14.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4132 0 0 0 0 0 0 0 Q9HBK9 AS3MT_HUMAN "Arsenite methyltransferase, EC 2.1.1.137 (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase)" AS3MT CYT19 Homo sapiens (Human) arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404] cytosol [GO:0005829] cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; methyltransferase activity [GO:0008168]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404] GO:0005829; GO:0008168; GO:0009404; GO:0018872; GO:0030791; GO:0030792; GO:0032259 arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; methyltransferase activity [GO:0008168] LVTANLITIQNK 0.99477 -8.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1243 12.4967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3736 0 0 15.4581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8966 0 0 14.5093 0 0 0 0 0 0 Q9NP56 PDE7B_HUMAN "cAMP-specific 3',5'-cyclic phosphodiesterase 7B, EC 3.1.4.53" PDE7B Homo sapiens (Human) cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; signal transduction [GO:0007165] cytosol [GO:0005829]; synapse [GO:0045202] "cytosol [GO:0005829]; synapse [GO:0045202]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; chemical synaptic transmission [GO:0007268]; signal transduction [GO:0007165]" GO:0004114; GO:0004115; GO:0005829; GO:0006198; GO:0007165; GO:0007268; GO:0019933; GO:0045202; GO:0046872 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; metal ion binding [GO:0046872]" ESRLLAHLPK 0.99477 -15.433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1246 0 0 0 0 0 13.6602 0 0 0 0 0 0 0 14.5441 14.6039 14.8134 13.5986 13.9606 14.1555 14.1404 0 0 14.5413 0 13.9002 0 0 0 0 0 0 13.9433 0 13.2982 14.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8657 13.8819 0 0 0 0 0 0 0 14.6001 0 14.1714 0 0 0 0 0 0 0 0 14.2839 0 0 0 0 0 0 0 13.5885 15.4448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2899 0 Q9P2J5 SYLC_HUMAN "Leucine--tRNA ligase, cytoplasmic, EC 6.1.1.4 (Leucyl-tRNA synthetase, LeuRS)" LARS1 KIAA1352 LARS Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604] aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418] GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005737; GO:0005764; GO:0005783; GO:0005829; GO:0006418; GO:0006425; GO:0006429; GO:0008361; GO:0012505; GO:0016604; GO:0017101; GO:0032008; GO:0034198; GO:0043547; GO:0071230; GO:0071233; GO:1904263; GO:1990253 aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823] EDCCPGK 0.99477 -11.062 0 0 0 0 0 0 0 0 15.0096 14.14 14.6607 13.8264 14.5177 14.2374 14.2004 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3529 12.4472 12.3192 15.0073 12.7829 14.6151 15.3724 14.7312 13.3829 0 12.7158 0 12.4623 13.5378 12.6447 0 12.9308 12.4738 12.3988 12.6848 13.6086 0 11.7936 0 0 0 0 0 0 13.86 19.0185 0 14.926 15.0119 15.9767 14.9239 0 0 0 0 0 0 0 0 0 0 0 0 0 13.442 0 0 0 0 0 0 0 0 12.1268 0 0 0 0 0 12.5162 14.341 0 0 0 0 0 0 0 0 0 0 12.3094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6602 12.8902 0 12.9627 16.0109 0 13.2805 0 12.9073 16.4175 12.9165 12.9145 13.0585 13.5965 13.1666 14.0948 0 13.723 0 0 0 0 15.3172 0 15.6052 0 0 Q9ULA0 DNPEP_HUMAN "Aspartyl aminopeptidase, EC 3.4.11.21" DNPEP ASPEP DAP Homo sapiens (Human) peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508] GO:0004177; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006518; GO:0008237; GO:0008270; GO:0042802; GO:0072562 aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] SGHSPTR 0.99477 -8.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.999 0 0 14.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4887 11.9216 0 0 0 0 0 0 0 0 0 0 15.0235 0 13.6098 0 0 0 0 0 0 0 0 14.023 11.6086 0 0 0 11.9802 11.9233 0 13.9092 13.9634 0 0 0 0 0 0 0 11.9729 0 12.2985 0 0 0 0 0 11.1167 0 0 0 0 0 0 0 0 0 0 14.3558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y490 TLN1_HUMAN Talin-1 TLN1 KIAA1027 TLN Homo sapiens (Human) cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587] adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893] GO:0001726; GO:0001786; GO:0005178; GO:0005200; GO:0005576; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0007043; GO:0007044; GO:0007229; GO:0009986; GO:0017166; GO:0030274; GO:0030866; GO:0032587; GO:0033622; GO:0035091; GO:0045296; GO:0051015; GO:0051893; GO:0070062; GO:0070527; GO:0098609 actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166] ADQDSEAMKR 0.99477 -15.441 0 0 0 0 0 0 0 0 12.6371 0 0 0 0 0 0 0 0 0 0 0 12.4664 14.8175 0 0 0 0 0 0 12.7762 0 12.1461 0 0 12.4612 0 0 0 0 11.5357 0 12.5422 0 12.0677 0 0 12.4768 0 12.5709 0 12.8285 0 0 0 0 10.9845 0 0 0 0 14.0092 0 0 0 0 13.8201 0 0 0 0 0 0 15.8163 0 0 12.543 0 0 0 0 0 12.0679 0 0 0 0 0 14.3083 0 0 0 0 13.8755 0 13.4937 14.5071 0 0 14.0736 0 0 0 12.8746 0 0 0 14.3158 14.5996 0 0 14.9715 0 0 13.5871 0 0 0 0 0 0 12.8504 0 0 0 0 0 0 13.4965 0 0 0 17.437 0 13.3647 13.9441 0 0 0 0 15.5248 14.9826 0 14.0121 0 14.0751 14.9075 0 0 0 0 17.4041 13.3327 0 0 17.84 0 0 14.6601 17.2331 17.2183 12.867 12.4574 12.7366 0 0 0 0 0 12.8824 0 14.3469 12.0076 0 0 0 0 17.7842 0 13.4746 0 0 Q92508 PIEZ1_HUMAN "Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment, Mib) (Protein FAM38A)" PIEZO1 FAM38A KIAA0233 Homo sapiens (Human) cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381]; cation transport [GO:0006812]; cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391] GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0016020; GO:0016021; GO:0031258; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260 cation channel activity [GO:0005261]; mechanosensitive ion channel activity [GO:0008381] ARLVLWDCLILYNVTVIISK 0.99478 -10.577 0 13.9851 0 0 0 13.8341 13.8564 13.0921 0 0 16.4314 0 0 0 0 0 13.6958 0 0 0 0 0 0 14.0997 0 0 10.1374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5314 0 0 0 0 14.7042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0798 0 0 0 0 0 0 12.9564 16.0052 15.8213 15.0888 0 15.6567 0 0 0 0 15.0372 0 11.9969 14.9466 0 16.4591 0 13.7325 15.1837 15.1109 14.624 14.3582 14.6217 12.428 14.0593 15.2605 0 14.664 15.864 10.9712 15.4502 15.0769 14.9496 0 15.2165 15.3516 0 14.9858 0 0 14.4656 15.0001 0 0 15.1176 0 0 14.9259 0 15.4656 13.528 15.9805 14.3849 0 0 0 14.8595 15.4135 14.9453 13.9595 0 0 0 12.6934 0 14.5592 0 16.4949 15.7889 0 14.7054 14.413 0 15.1936 13.039 14.5331 0 13.3147 0 0 15.3416 0 0 0 0 0 0 0 0 0 0 0 0 0 10.498 0 14.4293 0 14.8541 0 0 0 0 14.8646 0 H7C350 CC188_HUMAN Coiled-coil domain-containing protein 188 CCDC188 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALLDPFLRLK 0.99478 -15.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4107 12.7275 13.0078 13.159 0 0 0 0 0 0 0 0 13.3236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4683 0 0 13.6606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1526 0 0 0 0 0 0 0 13.5116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9694 13.2061 0 0 0 0 0 13.8648 0 14.1364 0 0 O43272 PROD_HUMAN "Proline dehydrogenase 1, mitochondrial, EC 1.5.5.2 (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)" PRODH PIG6 POX2 PRODH2 Homo sapiens (Human) 4-hydroxyproline catabolic process [GO:0019470]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of cell death [GO:0010942]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; 4-hydroxyproline catabolic process [GO:0019470]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of cell death [GO:0010942]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560] GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0010942; GO:0019470; GO:0043231; GO:0071949 FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657] EGWCFGAKLVRGAYLAQER 0.99478 -12.711 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4709 0 0 12.2633 13.8336 13.9278 0 0 0 0 0 14.147 13.1353 0 12.6567 0 0 0 0 0 0 0 12.4577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0725 0 0 11.6082 0 0 0 0 0 0 0 0 0 0 0 0 13.4157 12.7757 12.4302 0 0 0 0 0 0 0 12.8255 0 0 13.1002 0 14.4418 0 0 15.0179 0 0 13.9572 0 0 0 0 0 0 0 0 13.31 0 13.9708 0 0 0 0 0 0 0 0 13.5067 13.7748 14.7137 0 0 0 0 0 0 14.3993 0 13.7125 0 0 0 0 13.6666 0 13.8312 0 0 0 0 0 0 0 14.5388 0 0 0 0 14.064 0 0 13.7175 0 13.5657 0 0 0 14.6463 0 0 0 0 13.9964 0 0 15.3854 14.1124 0 0 13.451 0 0 0 12.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3656 O43299 AP5Z1_HUMAN "AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit, Zeta5)" AP5Z1 KIAA0415 SPG48 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0000724; GO:0005634; GO:0005654; GO:0005737; GO:0005770; GO:0015031; GO:0016192; GO:0016197; GO:0016607; GO:0030119; GO:0044599 APSCLEAFR 0.99478 -31.969 0 12.4382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7802 0 0 0 0 15.0569 17.2448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.498 0 0 0 0 0 0 0 0 0 12.0891 0 0 0 0 0 11.2549 0 0 0 0 11.7442 0 0 0 0 14.9619 0 0 11.7046 0 0 0 0 0 10.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4069 11.0513 0 11.636 0 11.4303 0 11.5852 0 0 0 0 O95813 CER1_HUMAN Cerberus (Cerberus-related protein) (DAN domain family member 4) CER1 DAND4 Homo sapiens (Human) anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; bone mineralization [GO:0030282]; cell migration involved in gastrulation [GO:0042074]; cellular response to BMP stimulus [GO:0071773]; cellular response to cadmium ion [GO:0071276]; determination of dorsal identity [GO:0048263]; determination of heart left/right asymmetry [GO:0061371]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte proliferation [GO:0003419]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesoderm development [GO:2000381]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; nervous system development [GO:0007399]; sequestering of BMP in extracellular matrix [GO:0035582]; signal transduction involved in regulation of gene expression [GO:0023019]; ureteric bud development [GO:0001657] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; BMP binding [GO:0036122]; cytokine activity [GO:0005125]; morphogen activity [GO:0016015]; protein homodimerization activity [GO:0042803]; anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; bone mineralization [GO:0030282]; cell migration involved in gastrulation [GO:0042074]; cellular response to BMP stimulus [GO:0071773]; cellular response to cadmium ion [GO:0071276]; determination of dorsal identity [GO:0048263]; determination of heart left/right asymmetry [GO:0061371]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte proliferation [GO:0003419]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesoderm development [GO:2000381]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; nervous system development [GO:0007399]; sequestering of BMP in extracellular matrix [GO:0035582]; signal transduction involved in regulation of gene expression [GO:0023019]; ureteric bud development [GO:0001657] GO:0001657; GO:0003419; GO:0005125; GO:0005576; GO:0005615; GO:0007369; GO:0007399; GO:0008285; GO:0009948; GO:0009952; GO:0016015; GO:0023019; GO:0030282; GO:0030514; GO:0032926; GO:0035582; GO:0036122; GO:0042074; GO:0042803; GO:0048263; GO:0061371; GO:0071276; GO:0071773; GO:1900176; GO:2000381 BMP binding [GO:0036122]; cytokine activity [GO:0005125]; morphogen activity [GO:0016015]; protein homodimerization activity [GO:0042803] EEAKKFWHHFMFR 0.99478 -11.432 0 0 0 0 0 0 0 0 0 0 11.4712 0 12.0256 11.0056 11.578 0 0 0 0 0 0 0 0 0 0 0 0 9.66019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5983 14.1101 15.0851 0 19.3688 11.2153 0 12.5905 17.7407 0 0 16.619 16.1139 16.7694 15.296 14.847 0 0 0 0 0 0 0 0 0 12.7412 13.4205 0 0 16.1224 13.7441 0 0 15.8777 15.0837 17.0605 16.0355 15.9635 0 0 14.17 14.9098 15.6616 16.8711 16.5362 12.7102 0 0 13.5688 0 15.0093 0 15.466 16.5227 0 0 0 13.9644 0 0 15.7887 15.4867 14.7938 16.0873 0 0 16.9754 0 15.6062 15.6484 16.6787 0 14.9957 16.1129 15.2958 0 15.857 14.5363 14.4872 14.7858 15.2356 0 0 0 14.8766 14.6807 9.82498 14.704 0 0 0 14.2078 10.1028 0 0 11.6699 0 0 0 0 0 0 0 0 0 12.9089 13.8302 0 10.4534 13.7475 0 0 14.493 0 P02708 ACHA_HUMAN Acetylcholine receptor subunit alpha CHRNA1 ACHRA CHNRA Homo sapiens (Human) acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] acetylcholine-gated channel complex [GO:0005892]; anchoring junction [GO:0070161]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ion channel activity [GO:0005216]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; acetylcholine receptor signaling pathway [GO:0095500]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; muscle cell cellular homeostasis [GO:0046716]; musculoskeletal movement [GO:0050881]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neuronal action potential [GO:0019228]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue growth [GO:0048630] GO:0003009; GO:0005216; GO:0005231; GO:0005886; GO:0005887; GO:0005892; GO:0007165; GO:0007268; GO:0007274; GO:0007528; GO:0009986; GO:0015464; GO:0019228; GO:0022848; GO:0030594; GO:0031594; GO:0034220; GO:0042166; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046716; GO:0048630; GO:0050877; GO:0050881; GO:0050905; GO:0070050; GO:0070161; GO:0095500; GO:0099060; GO:1904315 acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; ion channel activity [GO:0005216]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] FTKVLLQYTGHITWTPPAIFK 0.99478 -9.4468 0 0 0 0 0 0 0 0 11.8521 0 0 0 0 0 0 0 0 11.9507 0 0 0 0 0 0 0 10.8948 0 0 0 0 0 0 0 0 13.9129 13.1444 13.4607 13.5589 0 0 0 0 0 0 0 0 13.8447 0 0 0 0 0 0 0 0 12.3744 14.2211 0 0 0 0 0 13.0349 12.0605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0026 0 0 0 0 0 0 0 0 11.4422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2852 0 0 0 11.9574 0 14.7567 0 0 0 0 12.603 0 0 0 0 0 0 0 0 0 0 0 0 11.0018 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0883 0 0 13.3591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10109 ADX_HUMAN "Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1) (Hepatoredoxin)" FDX1 ADX Homo sapiens (Human) cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; electron transport chain [GO:0022900]; hormone biosynthetic process [GO:0042446]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]; steroid biosynthetic process [GO:0006694] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cholesterol metabolic process [GO:0008203]; electron transport chain [GO:0022900]; hormone biosynthetic process [GO:0042446]; P450-containing electron transport chain [GO:0140647]; positive regulation of oxidoreductase activity [GO:0051353]; steroid biosynthetic process [GO:0006694]" GO:0005506; GO:0005739; GO:0005759; GO:0006694; GO:0008203; GO:0009055; GO:0022900; GO:0042446; GO:0051353; GO:0051537; GO:0071320; GO:0140647; GO:1904322 "2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]" AAAGGAR 0.99478 -12.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28072 PSB6_HUMAN "Proteasome subunit beta type-6, EC 3.4.25.1 (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y)" PSMB6 LMPY Y Homo sapiens (Human) proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]" "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; cadherin binding [GO:0045296]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]" GO:0000502; GO:0004175; GO:0004298; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0010498; GO:0019774; GO:0043161; GO:0045296; GO:0070062 cadherin binding [GO:0045296]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298] EMCYRYR 0.99478 -11.439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51784 UBP11_HUMAN "Ubiquitin carboxyl-terminal hydrolase 11, EC 3.4.19.12 (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11)" USP11 UHX1 Homo sapiens (Human) protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; transcription corepressor binding [GO:0001222]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0001222; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006511; GO:0016579 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; transcription corepressor binding [GO:0001222] EDDEEDK 0.99478 -15.475 0 0 0 0 0 0 0 0 0 0 13.247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2214 0 0 0 0 0 0 0 12.1952 0 11.6906 13.5745 0 11.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8551 0 0 0 12.3848 0 0 0 0 0 0 0 0 10.8773 0 0 0 0 11.3336 0 0 0 0 0 0 0 0 0 0 0 11.3486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2491 0 0 0 0 0 0 0 12.2005 0 0 0 0 0 0 0 0 11.1519 0 0 0 0 0 15.2326 0 0 0 0 13.9427 10.4986 0 0 0 0 0 12.2727 0 0 0 0 0 0 0 0 0 0 0 12.0739 0 0 0 13.9399 0 0 0 0 0 0 0 0 0 0 0 0 P53674 CRBB1_HUMAN Beta-crystallin B1 (Beta-B1 crystallin) CRYBB1 Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] GO:0002088; GO:0005212; GO:0007601 structural constituent of eye lens [GO:0005212] GEYPRWNTWSSSYR 0.99478 -10.597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5033 0 0 0 0 0 0 0 0 0 0 0 0 14.0605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55318 FOXA3_HUMAN "Hepatocyte nuclear factor 3-gamma, HNF-3-gamma, HNF-3G (Fork head-related protein FKH H3) (Forkhead box protein A3) (Transcription factor 3G, TCF-3G)" FOXA3 HNF3G TCF3G Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chromatin organization [GO:0006325]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0006325; GO:0006357; GO:0006366; GO:0007283; GO:0009267; GO:0009653; GO:0015629; GO:0019904; GO:0030154; GO:0045944; GO:0061484; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" GYRRPLAHAK 0.99478 -11.46 0 0 0 0 0 0 0 0 0 0 0 11.4378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2046 0 0 0 14.0076 0 0 0 13.8299 0 0 0 0 0 13.0942 12.7271 0 13.7408 0 13.3485 12.7345 0 0 0 0 0 0 0 0 0 13.138 0 0 Q13219 PAPP1_HUMAN "Pappalysin-1, EC 3.4.24.79 (Insulin-like growth factor-dependent IGF-binding protein 4 protease, IGF-dependent IGFBP-4 protease, IGFBP-4ase) (Pregnancy-associated plasma protein A, PAPP-A)" PAPPA Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354] GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0008237; GO:0008270; GO:0030163; GO:0032354; GO:0071548 metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270] AFCNYDGGDCCTSTVK 0.99478 -10.603 0 0 0 0 0 0 0 0 0 11.956 0 0 0 0 0 0 12.5037 0 0 0 0 0 0 0 0 0 0 11.5787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1186 11.6422 0 0 11.6355 0 0 12.9917 12.3181 0 13.1106 0 0 0 0 14.36 0 0 0 0 0 0 0 14.782 12.052 13.8725 18.3296 11.75 0 18.1343 12.4219 11.8327 0 0 0 0 0 0 0 0 0 0 12.0957 0 0 12.0053 11.4359 0 0 0 14.616 0 0 0 0 0 12.8542 0 12.5582 0 0 0 14.2788 0 0 0 14.5908 0 0 0 0 10.2227 14.4132 0 0 0 0 0 0 0 0 12.8817 10.7745 0 0 0 0 19.1822 0 0 15.0904 0 0 0 0 14.5125 14.3604 14.502 14.9741 14.6116 15.0159 0 0 0 0 0 0 14.4708 0 0 13.4771 0 0 Q15036 SNX17_HUMAN Sorting nexin-17 SNX17 KIAA0064 Homo sapiens (Human) aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cholesterol catabolic process [GO:0006707]; coronary vasculature development [GO:0060976]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; receptor-mediated endocytosis [GO:0006898]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165] GO:0001822; GO:0003279; GO:0005102; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0006707; GO:0006886; GO:0006898; GO:0007165; GO:0008022; GO:0010008; GO:0016020; GO:0016197; GO:0030100; GO:0031410; GO:0032456; GO:0032991; GO:0035091; GO:0035904; GO:0043231; GO:0050750; GO:0060976 low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102] LPGQQLR 0.99478 -11.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6946 0 0 0 0 0 0 0 0 12.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3241 0 0 0 0 0 0 0 18.3061 0 0 0 11.7342 0 0 0 0 0 Q2KHN1 RN151_HUMAN RING finger protein 151 RNF151 Homo sapiens (Human) cell differentiation [GO:0030154]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0007283; GO:0008270; GO:0016567; GO:0030154; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ELHNAWSVRQERR 0.99478 -10.601 0 0 0 0 0 0 0 0 13.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7149 12.7657 0 0 12.8473 13.2059 13.188 0 0 0 12.9303 0 13.0416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6065 0 0 0 0 0 0 0 13.4535 14.215 13.084 0 13.2972 0 0 0 12.792 14.2646 0 0 0 13.6695 13.6284 0 13.7273 13.9539 13.1759 0 0 0 0 0 0 0 12.8117 13.2601 0 14.586 0 0 0 0 0 14.0982 0 0 0 0 0 13.3198 14.0023 13.554 0 11.1115 14.8914 13.255 14.2952 13.0266 13.6592 0 0 0 14.6191 13.196 14.2961 14.1301 13.18 0 0 13.0537 0 0 0 0 13.1546 0 0 0 0 0 0 0 0 0 13.243 13.098 0 0 13.0081 0 0 0 0 0 0 0 13.2655 14.1702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9421 0 0 0 19.4731 0 0 Q53HC0 CCD92_HUMAN Coiled-coil domain-containing protein 92 (Limkain beta-2) CCDC92 Homo sapiens (Human) innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688] GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0042802; GO:0043231; GO:0045087; GO:0050688 identical protein binding [GO:0042802] ASTIAYLTSQLHAAKKK 0.99478 -11.075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7923 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0N1 CFA70_HUMAN "Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18, TPR repeat protein 18)" CFAP70 TTC18 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement [GO:0003341] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular exosome [GO:0070062]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; extracellular exosome [GO:0070062]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement [GO:0003341] GO:0003341; GO:0005930; GO:0031514; GO:0036064; GO:0036126; GO:0036157; GO:0060271; GO:0070062 CQLSYELNCSGKYFAFKEQLK 0.99478 -31.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3328 0 0 0 0 0 0 0 0 0 0 0 0 13.5719 0 0 0 0 0 13.171 0 0 12.1262 0 0 0 0 0 0 0 0 0 0 12.4616 15.1544 0 0 0 0 0 0 12.3022 0 0 0 0 0 0 0 0 0 0 0 16.9206 0 0 0 0 0 0 14.3038 0 12.0734 0 0 0 11.8564 13.8179 0 0 0 13.9135 0 0 0 0 0 0 0 0 15.1518 0 0 14.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SE5 RALYL_HUMAN "RNA-binding Raly-like protein, hRALYL (Heterogeneous nuclear ribonucleoprotein C-like 3, hnRNP core protein C-like 3)" RALYL HNRPCL3 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005654; GO:0042802 identical protein binding [GO:0042802]; RNA binding [GO:0003723] ELTQIKTK 0.99478 -10.589 0 0 0 10.7757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5831 0 0 0 13.0299 0 13.6699 12.6228 0 0 0 13.9243 0 0 0 14.9035 0 13.4085 0 13.5545 0 0 0 0 13.6028 0 0 0 0 0 13.105 14.9513 14.0809 0 0 0 13.8658 0 13.9617 13.7242 0 0 0 0 13.9582 13.2323 0 0 0 0 13.7493 13.7201 12.1098 0 0 13.747 0 0 0 0 13.4263 14.8103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5249 13.2243 12.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6151 0 0 0 0 0 11.7855 0 0 Q8TB72 PUM2_HUMAN "Pumilio homolog 2, Pumilio-2" PUM2 KIAA0235 PUMH2 Homo sapiens (Human) adipose tissue development [GO:0060612]; chromosome organization [GO:0051276]; hair follicle development [GO:0001942]; miRNA processing [GO:0035196]; mitochondrion organization [GO:0007005]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of chromosome segregation [GO:0051983]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; respiratory electron transport chain [GO:0022904]; skeletal system development [GO:0001501]; stress granule assembly [GO:0034063] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pumilio-response element binding [GO:0062104]; RNA binding [GO:0003723]; adipose tissue development [GO:0060612]; chromosome organization [GO:0051276]; hair follicle development [GO:0001942]; miRNA processing [GO:0035196]; mitochondrion organization [GO:0007005]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of chromosome segregation [GO:0051983]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; respiratory electron transport chain [GO:0022904]; skeletal system development [GO:0001501]; stress granule assembly [GO:0034063] GO:0001501; GO:0001942; GO:0003723; GO:0003729; GO:0003730; GO:0005737; GO:0005829; GO:0006417; GO:0007005; GO:0010494; GO:0010608; GO:0022904; GO:0031965; GO:0034063; GO:0035196; GO:0035198; GO:0043488; GO:0048471; GO:0051276; GO:0051983; GO:0060612; GO:0060964; GO:0062104; GO:0106222; GO:1900246; GO:2000637 lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pumilio-response element binding [GO:0062104]; RNA binding [GO:0003723] DFNRTPGSR 0.99478 -8.6568 0 0 0 0 0 0 0 0 0 0 0 0 11.9605 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7079 0 0 0 0 0 0 0 12.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.711 0 0 0 0 0 0 13.6769 0 0 0 0 13.6159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0925 0 12.3145 0 0 12.8455 0 13.1385 0 0 0 0 0 0 0 0 0 0 12.6296 0 0 Q8TE85 GRHL3_HUMAN Grainyhead-like protein 3 homolog (Sister of mammalian grainyhead) (Transcription factor CP2-like 4) GRHL3 SOM TFCP2L4 Homo sapiens (Human) central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; eyelid development in camera-type eye [GO:0061029]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; wound healing [GO:0042060] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; central nervous system development [GO:0007417]; cochlea morphogenesis [GO:0090103]; ectoderm development [GO:0007398]; epidermis development [GO:0008544]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; eyelid development in camera-type eye [GO:0061029]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; wound healing [GO:0042060]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001736; GO:0001843; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0007389; GO:0007398; GO:0007417; GO:0008544; GO:0010628; GO:0031490; GO:0032956; GO:0042060; GO:0043547; GO:0043565; GO:0045944; GO:0061029; GO:0061436; GO:0090103; GO:0090179 "chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" GETSLLHPR 0.99478 -11.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2396 0 0 0 14.7867 0 0 12.4641 0 0 0 11.353 12.0081 0 0 0 0 12.9474 0 12.5806 0 0 0 0 0 0 0 0 0 0 11.434 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5514 0 0 0 0 0 0 0 0 18.4865 0 0 0 15.5091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.014 0 0 0 0 13.1638 0 0 0 0 0 0 0 0 Q969N2 PIGT_HUMAN GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein) PIGT CGI-06 PSEC0163 UNQ716/PRO1379 Homo sapiens (Human) attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; attachment of GPI anchor to protein [GO:0016255]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182] GO:0005789; GO:0016020; GO:0016255; GO:0030176; GO:0030182; GO:0031410; GO:0042765; GO:0051402 ARGVPPL 0.99478 -5.4157 0 0 0 0 0 0 0 0 0 0 0 0 14.2563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8605 0 0 0 0 0 0 0 13.936 0 15.2399 0 14.7038 15.907 0 16.7453 14.9707 16.572 16.6283 0 16.6403 12.5638 0 0 0 15.1341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1323 0 0 0 0 0 0 0 0 12.9172 0 0 0 0 0 0 0 0 0 0 0 12.2627 0 0 0 0 0 0 13.0576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2378 0 0 0 0 0 0 0 0 0 Q96EZ8 MCRS1_HUMAN Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2) MCRS1 INO80Q MSP58 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844] "cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; polysome [GO:0005844]; G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]" GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005844; GO:0006275; GO:0006281; GO:0006310; GO:0006338; GO:0008266; GO:0010521; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0036211; GO:0043204; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051571; GO:0051726; GO:0051974; GO:0060382; GO:0071339; GO:1900095; GO:1904357; GO:1904507; GO:1904751 G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521] HPDAFYLAR 0.99478 -11.454 0 0 0 0 0 0 0 0 0 13.0355 0 0 0 12.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96J66 MRP8_HUMAN "ATP-binding cassette sub-family C member 11, EC 7.6.2.2, EC 7.6.2.3 (Multidrug resistance-associated protein 8)" ABCC11 MRP8 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; organic anion transport [GO:0015711]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; organic anion transport [GO:0015711]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908] GO:0005524; GO:0005774; GO:0005886; GO:0005887; GO:0008514; GO:0008559; GO:0015216; GO:0015431; GO:0015432; GO:0015711; GO:0015721; GO:0015865; GO:0016020; GO:0016324; GO:0030659; GO:0042626; GO:0042908; GO:0043225; GO:0055085; GO:0070062; GO:0071716 ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216] FKKFFLQESPVFYVQTLQDPSK 0.99478 -11.43 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6842 0 0 0 0 13.0689 0 0 12.3561 0 0 0 0 0 0 0 0 0 0 0 0 13.8583 14.3497 0 0 0 0 0 0 0 0 0 0 0 11.4692 0 0 0 0 0 0 0 0 0 0 12.4742 10.9829 0 0 0 0 11.6958 0 0 12.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96L12 CALR3_HUMAN Calreticulin-3 (Calreticulin-2) (Calsperin) CALR3 CRT2 Homo sapiens (Human) cell differentiation [GO:0030154]; protein folding [GO:0006457]; spermatogenesis [GO:0007283]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; cell differentiation [GO:0030154]; protein folding [GO:0006457]; spermatogenesis [GO:0007283]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0005635; GO:0005788; GO:0005789; GO:0006457; GO:0007283; GO:0030154; GO:0030246; GO:0030433; GO:0044183; GO:0046872; GO:0051082 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] ARALVQLWAICMLR 0.99478 -11.083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8848 0 0 0 0 0 0 0 0 14.1392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSJ5 CQ080_HUMAN "Uncharacterized protein C17orf80 (Cell migration-inducing gene 3 protein) (Human lung cancer oncogene 8 protein, HLC-8)" C17orf80 HLC8 MIG3 Homo sapiens (Human) extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021] GO:0016021; GO:0070062 AQFYASEKTSPK 0.99478 -9.4505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2174 0 0 0 0 11.6646 0 0 0 0 0 0 16.6004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2091 0 15.7109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0431 0 0 0 0 0 0 0 0 0 Q9H3C7 GGNB2_HUMAN Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; spermatogenesis [GO:0007283] GO:0005634; GO:0005737; GO:0007283; GO:0008285; GO:0010629; GO:0030154; GO:0031410; GO:0033140; GO:0042532; GO:0060716; GO:0061099 CDEHIQKLGSCITDPGNR 0.99478 -11.44 0 0 0 0 0 0 0 0 0 0 12.0318 0 0 10.0792 0 0 0 0 0 10.1562 0 14.3371 0 0 0 0 0 0 0 11.1981 12.2329 0 0 10.4345 0 0 12.9053 0 0 0 0 0 0 0 11.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.925 10.5336 10.0841 0 0 0 10.8882 0 0 12.2141 0 0 0 0 0 0 0 0 0 0 10.7171 14.0048 0 0 11.9102 0 14.1339 11.0075 0 0 0 0 14.5559 13.6317 0 0 0 0 11.2215 0 0 13.4061 0 0 12.1082 10.936 0 0 11.4412 0 0 0 0 0 0 0 12.0372 0 12.0974 0 12.1765 13.8708 0 10.856 11.5614 0 0 0 0 0 0 0 14.04 11.747 0 0 0 0 0 0 0 0 12.5507 0 0 0 0 0 0 0 0 0 0 0 13.5406 13.2134 0 11.5172 0 0 0 13.2946 15.1688 0 0 13.9933 0 11.2831 0 0 0 0 0 Q9H7T3 CJ095_HUMAN Uncharacterized protein C10orf95 C10orf95 Homo sapiens (Human) PCMCTAGR 0.99478 -12.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2835 14.4477 13.8575 12.8216 0 0 0 0 0 0 0 0 14.6565 0 0 0 14.5413 0 0 0 0 0 13.4468 0 0 0 0 0 12.8773 0 0 0 0 0 0 0 0 0 0 0 13.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2787 0 0 0 0 Q9NQX5 NPDC1_HUMAN "Neural proliferation differentiation and control protein 1, NPDC-1" NPDC1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ATPLPPPSPR 0.99478 -8.6448 0 0 11.4448 0 0 0 0 0 0 10.9256 11.0737 0 0 0 0 0 0 0 0 0 0 0 0 12.5014 0 9.81578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3435 0 0 0 0 0 0 0 0 0 10.9332 0 0 0 0 0 0 0 0 0 0 0 12.3993 0 0 0 0 0 0 11.0256 10.1343 0 0 12.0176 0 13.9569 13.6695 0 0 0 12.7351 0 0 0 0 0 0 0 14.2774 0 13.1084 0 12.7683 12.314 13.4925 15.0214 13.6762 0 15.3441 0 0 15.2267 0 0 15.0309 13.4303 0 14.7354 14.6152 14.1193 13.7728 0 0 0 0 0 0 0 13.2228 12.7174 13.7263 15.0708 14.3485 13.6141 13.5846 15.2396 0 14.6228 0 0 0 0 14.0037 13.4625 13.9231 0 0 0 0 12.8215 12.3419 0 12.4428 0 0 0 0 0 0 0 0 12.0525 0 12.8361 0 0 0 0 0 11.6523 12.8839 0 0 10.979 0 0 0 0 0 0 0 12.814 10.9852 12.0613 0 0 0 0 0 0 Q9NWH9 SLTM_HUMAN SAFB-like transcription modulator (Modulator of estrogen-induced transcription) SLTM MET Homo sapiens (Human) apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0006915; GO:0016604; GO:0043565; GO:0050684 RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] AMELRRR 0.99478 -32.057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9607 0 11.528 0 0 0 0 0 0 12.8665 0 0 0 0 0 0 0 0 0 0 0 0 16.3519 0 0 0 0 0 0 0 13.7335 0 13.7652 0 18.7757 17.5456 17.4624 17.0199 0 17.9937 0 0 14.9688 0 15.1113 13.9155 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3028 0 12.8019 12.9966 12.1381 0 13.7567 0 0 0 0 0 0 0 0 0 0 0 12.9947 0 22.1765 20.2763 0 12.9152 13.0703 0 0 0 0 13.0868 0 0 0 0 14.8544 0 0 0 19.0421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4493 19.4206 0 0 0 0 0 0 0 0 0 19.4181 0 0 18.5645 18.4113 0 0 14.135 0 0 0 0 12.0256 0 0 0 0 0 0 0 0 0 0 0 11.2019 0 0 20.5757 20.5078 20.5779 15.1777 0 0 0 0 0 Q9NY47 CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2 ] CACNA2D2 KIAA0558 Homo sapiens (Human) regulation of ion transmembrane transport [GO:0034765] plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891] plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765] GO:0005245; GO:0005886; GO:0005891; GO:0034765; GO:0046872 metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] AHRWQDNIKEEDIVYYDAK 0.99478 -8.648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1101 10.5069 0 11.5169 0 0 0 11.5153 0 13.741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6139 0 0 0 0 0 0 0 0 0 11.0115 0 0 0 0 0 10.3947 11.9212 0 0 11.1417 11.4487 0 0 0 0 0 15.1062 0 13.0973 0 0 18.9815 19.2319 18.047 0 18.7968 0 0 0 0 20.1909 0 14.4084 0 12.5532 14.2868 17.0828 0 0 12.0916 15.436 15.1925 12.2694 14.662 0 12.3987 0 0 0 0 11.1707 12.6759 0 0 0 0 0 0 14.0689 0 15.2059 0 0 0 0 0 0 0 11.5568 0 0 0 0 0 0 0 0 0 0 0 13.7987 13.9891 0 0 0 12.2822 0 0 16.2001 0 11.7345 13.4909 11.7817 13.5887 0 15.0134 0 0 0 0 0 0 15.5342 13.5627 0 0 0 16.4042 14.5774 15.0065 0 12.2486 0 Q9UHB7 AFF4_HUMAN "AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein, Protein AF-5q31) (Major CDK9 elongation factor-associated protein)" AFF4 AF5Q31 MCEF HSPC092 Homo sapiens (Human) regulation of gene expression [GO:0010468]; spermatid development [GO:0007286] euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023] euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]; regulation of gene expression [GO:0010468]; spermatid development [GO:0007286] GO:0000791; GO:0001650; GO:0005654; GO:0007286; GO:0008023; GO:0010468; GO:0032783 AAAEEPR 0.99478 -32.064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9489 0 0 12.0118 0 0 0 0 0 0 10.802 0 0 0 0 0 0 0 11.5887 0 0 0 0 10.9326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3602 0 0 0 0 0 0 0 0 0 10.5089 0 0 0 0 0 0 0 0 0 11.8443 0 0 0 15.612 0 0 0 9.9373 14.3908 14.741 11.3432 0 0 0 0 14.6384 0 13.6001 0 0 11.5734 0 14.3957 11.2851 0 14.4714 0 0 0 0 0 14.3957 0 14.2223 0 0 14.2729 13.9555 0 0 0 11.0274 13.8789 0 0 14.7153 0 12.7041 0 0 0 12.9447 0 0 0 12.8158 0 13.2361 0 0 12.1322 0 0 0 0 0 0 12.9648 13.6415 12.4635 12.5836 0 13.1074 12.9729 13.0484 0 0 13.1288 12.7481 0 0 0 0 0 0 0 12.4934 13.0763 0 0 Q9UJW0 DCTN4_HUMAN "Dynactin subunit 4, Dyn4 (Dynactin subunit p62)" DCTN4 Homo sapiens (Human) cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725] cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485] GO:0000776; GO:0000922; GO:0001725; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005868; GO:0005869; GO:0005925; GO:0005938; GO:0030017; GO:0047485 protein N-terminus binding [GO:0047485] ANKVGIFIK 0.99478 -8.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3802 12.3752 0 0 13.2404 13.1103 0 0 0 15.3205 0 0 0 0 0 0 0 11.6738 0 0 0 0 0 0 0 0 0 12.9008 0 13.2873 0 0 0 0 13.2613 12.6093 0 13.8285 0 0 0 0 0 14.4261 12.6572 0 13.3116 0 0 0 13.1316 0 0 0 0 0 0 0 0 0 11.6776 0 0 0 0 0 0 0 0 0 0 13.2235 0 13.3574 0 0 0 14.0781 0 0 13.2922 0 0 0 0 0 0 0 0 0 0 Q9UPZ9 CILK1_HUMAN "Serine/threonine-protein kinase ICK, EC 2.7.11.1 (Ciliogenesis associated kinase 1) (Intestinal cell kinase, hICK) (Laryngeal cancer kinase 2, LCK2) (MAK-related kinase, MRK)" CILK1 ICK KIAA0936 Homo sapiens (Human) cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634] ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0000287; GO:0001650; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005929; GO:0006468; GO:0007165; GO:0035556; GO:0035720; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0097542; GO:0097546; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DTPTLRSAAK 0.99478 -12.634 0 0 0 0 0 0 0 0 0 13.378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7405 0 0 0 0 0 0 0 0 0 0 12.3222 0 0 0 0 0 0 0 0 0 0 0 0 10.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9566 0 0 0 0 0 0 0 0 0 12.6592 12.7989 0 0 0 0 15.5432 15.1993 0 0 0 0 0 0 0 0 14.9684 0 0 0 0 0 0 12.9491 0 11.3131 0 0 0 14.9867 0 0 0 0 0 0 0 0 0 0 0 0 12.8844 13.357 14.0529 0 12.469 0 0 0 13.9825 0 12.5371 0 0 0 0 12.5582 13.6683 0 0 0 0 0 14.038 0 13.3973 0 0 0 0 0 0 0 0 13.1629 0 12.9145 0 0 0 0 0 0 0 13.7389 0 0 13.1378 0 0 0 0 0 O15438 MRP3_HUMAN "ATP-binding cassette sub-family C member 3, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D, MOAT-D) (Multidrug resistance-associated protein 3)" ABCC3 CMOAT2 MLP2 MRP3 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908] GO:0005524; GO:0005886; GO:0005887; GO:0006805; GO:0006855; GO:0008559; GO:0015164; GO:0015431; GO:0015432; GO:0015721; GO:0016020; GO:0016323; GO:0042626; GO:0042908; GO:0042910; GO:0043225; GO:0055085; GO:0071714; GO:0071716; GO:0140359; GO:0150104 ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910] ALVITNSVKR 0.99479 -12.732 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.125 14.0675 0 14.3364 0 0 0 0 0 0 0 13.9723 0 0 0 14.4831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9309 0 0 14.0537 0 0 0 0 12.9852 12.9739 14.9464 12.1792 0 12.7924 0 0 0 0 12.4269 0 0 0 0 0 12.611 11.637 0 0 12.4288 0 0 12.2174 0 12.2594 0 0 0 0 0 0 0 0 14.2222 0 0 0 12.2643 12.9531 15.1153 0 14.6657 0 12.3362 0 0 0 14.5047 0 11.904 0 0 0 0 0 0 10.6606 0 0 0 12.0151 0 0 0 0 0 0 0 11.3882 0 14.322 0 0 0 0 14.3796 0 0 0 14.0809 0 0 0 0 0 0 0 0 14.5231 0 0 0 0 0 0 0 0 P0C623 OR4Q2_HUMAN Olfactory receptor 4Q2 (olfactory receptor OR14-21) OR4Q2 OR4Q2P Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NQTEVMR 0.99479 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10600 TGFB3_HUMAN "Transforming growth factor beta-3 proprotein [Cleaved into: Latency-associated peptide, LAP; Transforming growth factor beta-3, TGF-beta-3 ]" TGFB3 Homo sapiens (Human) "aging [GO:0007568]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; detection of hypoxia [GO:0070483]; digestive tract development [GO:0048565]; embryonic neurocranium morphogenesis [GO:0048702]; face morphogenesis [GO:0060325]; female pregnancy [GO:0007565]; frontal suture morphogenesis [GO:0060364]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; lung alveolus development [GO:0048286]; mammary gland development [GO:0030879]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; odontogenesis [GO:0042476]; ossification involved in bone remodeling [GO:0043932]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to progesterone [GO:0032570]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; wound healing [GO:0042060]" cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; T-tubule [GO:0030315]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021] "cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; T-tubule [GO:0030315]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; transforming growth factor beta binding [GO:0050431]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714]; aging [GO:0007568]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; detection of hypoxia [GO:0070483]; digestive tract development [GO:0048565]; embryonic neurocranium morphogenesis [GO:0048702]; face morphogenesis [GO:0060325]; female pregnancy [GO:0007565]; frontal suture morphogenesis [GO:0060364]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; lung alveolus development [GO:0048286]; mammary gland development [GO:0030879]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; odontogenesis [GO:0042476]; ossification involved in bone remodeling [GO:0043932]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to progesterone [GO:0032570]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; wound healing [GO:0042060]" GO:0001666; GO:0001701; GO:0005114; GO:0005125; GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0007179; GO:0007435; GO:0007565; GO:0007568; GO:0008083; GO:0008284; GO:0008285; GO:0009986; GO:0010718; GO:0010862; GO:0010936; GO:0030315; GO:0030501; GO:0030509; GO:0030512; GO:0030879; GO:0031093; GO:0032570; GO:0032967; GO:0034616; GO:0034713; GO:0034714; GO:0042060; GO:0042127; GO:0042476; GO:0042704; GO:0042802; GO:0043025; GO:0043065; GO:0043231; GO:0043410; GO:0043524; GO:0043627; GO:0043932; GO:0044877; GO:0045216; GO:0045893; GO:0045944; GO:0048286; GO:0048565; GO:0048702; GO:0048839; GO:0050431; GO:0050714; GO:0051491; GO:0051496; GO:0051781; GO:0060325; GO:0060364; GO:0060391; GO:0060395; GO:0062009; GO:0062023; GO:0070021; GO:0070483; GO:0099126; GO:1904706; GO:1905075 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; transforming growth factor beta binding [GO:0050431]; type I transforming growth factor beta receptor binding [GO:0034713]; type II transforming growth factor beta receptor binding [GO:0005114]; type III transforming growth factor beta receptor binding [GO:0034714] ALDTNYCFR 0.99479 -8.9933 0 12.744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1327 0 0 0 0 0 0 0 10.8732 0 0 0 0 12.8131 0 0 0 0 0 0 0 0 0 0 13.2834 0 0 0 0 0 0 0 0 0 0 11.9769 0 11.3553 0 0 0 0 0 0 0 0 0 0 11.6706 0 0 12.9083 0 14.2853 0 11.5031 0 11.9541 0 12.3768 0 13.0658 0 15.1518 0 0 0 0 13.8813 0 0 0 0 11.9783 0 12.9531 0 14.4351 0 0 0 0 0 0 0 0 13.4663 0 13.6299 0 0 0 0 0 0 0 0 12.3219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13586 STIM1_HUMAN Stromal interaction molecule 1 STIM1 GOK Homo sapiens (Human) activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; sarcoplasmic reticulum membrane [GO:0033017] cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115] GO:0002020; GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005874; GO:0005886; GO:0005887; GO:0006874; GO:0030176; GO:0032237; GO:0032541; GO:0033017; GO:0042802; GO:0044853; GO:0045762; GO:0045766; GO:0051010; GO:0051924; GO:0070166; GO:2001256 calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020] DLTHSDSESSLHMSDRQR 0.99479 -8.9652 0 0 0 0 0 11.9338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1838 0 0 0 0 0 0 0 0 0 0 14.584 0 0 0 0 0 0 0 12.2509 0 0 0 0 0 13.6735 0 0 0 0 0 0 13.9656 12.1701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14541 HNF4G_HUMAN "Hepatocyte nuclear factor 4-gamma, HNF-4-gamma (Nuclear receptor subfamily 2 group A member 2)" HNF4G NR2A2 Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0004879; GO:0005654; GO:0005829; GO:0006357; GO:0008270; GO:0030154; GO:0045171; GO:0045944; GO:0048856; GO:0072686 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" FQVQIGLEDYINDRQYDSRGR 0.99479 -8.9858 0 0 0 0 0 0 0 0 0 0 0 12.9889 0 0 13.6463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9855 0 0 0 0 0 0 0 0 0 0 13.0518 0 0 0 0 0 0 13.882 0 0 0 0 0 0 13.7749 0 0 0 14.2263 0 0 0 0 0 0 0 0 12.4345 0 0 0 0 0 0 0 12.1718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15651 HMGN3_HUMAN "High mobility group nucleosome-binding domain-containing protein 3 (Thyroid receptor-interacting protein 7, TR-interacting protein 7, TRIP-7)" HMGN3 TRIP7 PNAS-24 Homo sapiens (Human) chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966]; nucleosomal DNA binding [GO:0031492]; chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178] GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0031492; GO:0045944; GO:0046966; GO:0061178 chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966]; nucleosomal DNA binding [GO:0031492] SARLSAK 0.99479 -8.4402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.204 14.8634 15.1642 0 0 15.0265 14.8043 0 14.9876 11.7495 0 0 14.1524 14.6786 0 0 0 0 0 0 0 0 14.0956 0 12.8027 0 11.387 0 0 0 0 0 14.398 0 0 0 0 12.744 0 0 13.2546 14.0447 0 0 0 0 13.4996 0 0 0 0 0 0 12.3989 0 0 0 0 0 0 12.9586 0 0 0 0 0 0 0 13.3582 0 0 0 0 14.3127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1507 0 0 0 0 0 0 0 Q6ZSR6 YP007_HUMAN Putative uncharacterized protein FLJ45256 Homo sapiens (Human) HIFPLPLLFSHFLWSKLK 0.99479 -8.9737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7389 0 0 0 0 0 0 0 0 0 0 0 13.9107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9966 0 0 0 13.3341 0 Q92901 RL3L_HUMAN 60S ribosomal protein L3-like (Large ribosomal subunit protein uL3-like) RPL3L Homo sapiens (Human) translation [GO:0006412] cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; ribosome [GO:0005840] cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005840; GO:0006412; GO:0016020; GO:0022625 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EEVEAVTIVETPPLVVVGVVGYVATPRGLR 0.99479 -36.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0945 0 11.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3889 0 15.5041 0 0 0 0 0 0 12.0647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96G30 MRAP2_HUMAN "Melanocortin-2 receptor accessory protein 2, MC2R accessory protein 2" MRAP2 C6orf117 Homo sapiens (Human) energy homeostasis [GO:0097009]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; protein localization to plasma membrane [GO:0072659]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; corticotropin hormone receptor binding [GO:0031780]; identical protein binding [GO:0042802]; signaling receptor regulator activity [GO:0030545]; type 1 melanocortin receptor binding [GO:0070996]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782]; type 5 melanocortin receptor binding [GO:0031783]; energy homeostasis [GO:0097009]; energy reserve metabolic process [GO:0006112]; feeding behavior [GO:0007631]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; protein localization to plasma membrane [GO:0072659]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070] GO:0005783; GO:0005789; GO:0005886; GO:0006112; GO:0007631; GO:0016021; GO:0030545; GO:0031780; GO:0031781; GO:0031782; GO:0031783; GO:0042802; GO:0070996; GO:0072659; GO:0097009; GO:0106070; GO:0106071; GO:0106072; GO:1903077 corticotropin hormone receptor binding [GO:0031780]; identical protein binding [GO:0042802]; signaling receptor regulator activity [GO:0030545]; type 1 melanocortin receptor binding [GO:0070996]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782]; type 5 melanocortin receptor binding [GO:0031783] QGNEESR 0.99479 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0552 0 0 0 0 0 0 Q9UNK4 PA2GD_HUMAN "Group IID secretory phospholipase A2, GIID sPLA2, sPLA2-IID, EC 3.1.1.4 (PLA2IID) (Phosphatidylcholine 2-acylhydrolase 2D) (Secretory-type PLA, stroma-associated homolog)" PLA2G2D SPLASH Homo sapiens (Human) "arachidonic acid secretion [GO:0050482]; CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid metabolic process [GO:0006644]; regulation of acute inflammatory response to antigenic stimulus [GO:0002864]" extracellular region [GO:0005576] "extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]; arachidonic acid secretion [GO:0050482]; CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; negative regulation of T cell proliferation [GO:0042130]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid metabolic process [GO:0006644]; regulation of acute inflammatory response to antigenic stimulus [GO:0002864]" GO:0002361; GO:0002864; GO:0004623; GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0006954; GO:0008201; GO:0016042; GO:0042130; GO:0043395; GO:0046337; GO:0046470; GO:0046471; GO:0047498; GO:0050482 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543] DATDWCCQTHDCCYDHLK 0.99479 -8.4198 0 0 0 11.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0076 0 0 0 0 11.4655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2121 0 0 0 11.3186 0 0 0 0 0 0 0 0 0 10.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6329 0 0 0 0 0 0 11.5954 0 0 0 0 0 0 0 0 12.2532 0 0 0 0 0 0 0 0 0 0 11.8 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3392 0 0 0 0 0 0 11.95 0 0 0 0 Q9Y5Z6 B3GT1_HUMAN "Beta-1,3-galactosyltransferase 1, Beta-1,3-GalTase 1, Beta3Gal-T1, Beta3GalT1, EC 2.4.1.86 (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)" B3GALT1 Homo sapiens (Human) galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; galactosylceramide biosynthetic process [GO:0006682]; lipid glycosylation [GO:0030259]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]" GO:0000139; GO:0006486; GO:0006682; GO:0008194; GO:0008499; GO:0009312; GO:0016021; GO:0016757; GO:0030259; GO:0047275 "glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; glycosyltransferase activity [GO:0016757]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" CEKNIPFLVILISTTHK 0.99479 -8.9666 0 0 0 0 0 10.8893 0 0 12.4165 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6985 10.3574 0 11.2587 14.8612 13.0998 14.6031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3955 0 0 0 0 0 0 0 0 13.4182 13.3015 0 0 12.9566 0 12.5342 14.5494 0 16.3092 0 0 12.9595 12.9413 0 14.012 0 0 0 0 13.0303 0 0 13.9839 13.1695 0 0 0 0 0 13.2193 0 0 0 0 0 0 0 0 12.5798 0 12.8442 12.9902 0 13.1846 0 0 13.7674 0 12.2966 14.288 0 13.0319 12.7455 14.312 0 0 12.3086 11.5954 0 13.2084 0 12.5475 11.0861 0 0 12.3252 12.7725 0 0 0 0 0 0 0 12.3203 12.4878 0 0 12.6309 11.9287 0 0 0 0 0 0 12.6189 0 0 0 13.1463 0 16.8307 11.3759 A0A3B3IS91 PLGRF_HUMAN "POLG alternative reading frame, POLGARF (ORF-Y) [Cleaved into: POLGARF C-terminal fragment, POLGARFin ]" POLG Homo sapiens (Human) extracellular space [GO:0005615]; nucleolus [GO:0005730] extracellular space [GO:0005615]; nucleolus [GO:0005730] GO:0005615; GO:0005730 GAGPGVR 0.9948 -8.4714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.93 0 0 0 0 0 0 13.4038 0 0 0 0 0 0 13.9076 0 0 13.7882 0 0 0 0 14.5053 0 0 13.4057 0 0 0 0 0 0 14.3333 0 13.118 0 12.5574 0 0 12.3554 0 0 0 0 0 13.8544 12.8406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P03950 ANGI_HUMAN "Angiogenin, EC 3.1.27.- (Ribonuclease 5, RNase 5)" ANG RNASE5 Homo sapiens (Human) actin filament polymerization [GO:0030041]; activation of phospholipase A2 activity [GO:0032431]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase B activity [GO:0032148]; angiogenesis [GO:0001525]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell migration [GO:0016477]; defense response to Gram-positive bacterium [GO:0050830]; diacylglycerol biosynthetic process [GO:0006651]; homeostatic process [GO:0042592]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; placenta development [GO:0001890]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein secretion [GO:0050714]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to yeast [GO:0001878]; rRNA transcription [GO:0009303]; tRNA catabolic process [GO:0016078] actin cytoskeleton [GO:0015629]; angiogenin-PRI complex [GO:0032311]; basement membrane [GO:0005604]; chromosome [GO:0005694]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; angiogenin-PRI complex [GO:0032311]; basement membrane [GO:0005604]; chromosome [GO:0005694]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; actin binding [GO:0003779]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; heparin binding [GO:0008201]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ribonuclease activity [GO:0004540]; rRNA binding [GO:0019843]; signaling receptor binding [GO:0005102]; actin filament polymerization [GO:0030041]; activation of phospholipase A2 activity [GO:0032431]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase B activity [GO:0032148]; angiogenesis [GO:0001525]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell migration [GO:0016477]; defense response to Gram-positive bacterium [GO:0050830]; diacylglycerol biosynthetic process [GO:0006651]; homeostatic process [GO:0042592]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; placenta development [GO:0001890]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein secretion [GO:0050714]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to yeast [GO:0001878]; rRNA transcription [GO:0009303]; tRNA catabolic process [GO:0016078] GO:0001525; GO:0001541; GO:0001556; GO:0001666; GO:0001878; GO:0001890; GO:0001938; GO:0003677; GO:0003779; GO:0004519; GO:0004521; GO:0004540; GO:0005102; GO:0005507; GO:0005576; GO:0005604; GO:0005615; GO:0005634; GO:0005694; GO:0005730; GO:0005829; GO:0006651; GO:0007154; GO:0007202; GO:0008201; GO:0009303; GO:0009725; GO:0015629; GO:0016078; GO:0016477; GO:0017148; GO:0019731; GO:0019732; GO:0019843; GO:0030041; GO:0030426; GO:0031410; GO:0032148; GO:0032311; GO:0032431; GO:0042277; GO:0042327; GO:0042592; GO:0042803; GO:0043025; GO:0045087; GO:0048662; GO:0050714; GO:0050830; GO:0061844 actin binding [GO:0003779]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; heparin binding [GO:0008201]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ribonuclease activity [GO:0004540]; rRNA binding [GO:0019843]; signaling receptor binding [GO:0005102] PQGRDDRYCESIMR 0.9948 -13.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8386 0 0 0 0 0 0 0 P18509 PACA_HUMAN "Pituitary adenylate cyclase-activating polypeptide, PACAP [Cleaved into: PACAP-related peptide (PRP-48); Pituitary adenylate cyclase-activating polypeptide 27, PACAP-27, PACAP27; Pituitary adenylate cyclase-activating polypeptide 38, PACAP-38, PACAP38 ]" ADCYAP1 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; insulin secretion [GO:0030073]; negative regulation of cell cycle [GO:0045786]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein localization [GO:0032880] extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204] extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]; pituitary adenylate cyclase activating polypeptide activity [GO:0016521]; pituitary adenylate cyclase-activating polypeptide receptor binding [GO:0031858]; signaling receptor binding [GO:0005102]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; insulin secretion [GO:0030073]; negative regulation of cell cycle [GO:0045786]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein localization [GO:0032880] GO:0005102; GO:0005184; GO:0005576; GO:0007189; GO:0007190; GO:0007204; GO:0007218; GO:0007267; GO:0007565; GO:0008277; GO:0016521; GO:0019933; GO:0030073; GO:0031175; GO:0031858; GO:0032880; GO:0043005; GO:0043204; GO:0043547; GO:0045786; GO:0045860; GO:0045944; GO:0051428; GO:0060124; GO:0070374; GO:0071651; GO:0120162 neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]; pituitary adenylate cyclase activating polypeptide activity [GO:0016521]; pituitary adenylate cyclase-activating polypeptide receptor binding [GO:0031858]; signaling receptor binding [GO:0005102] AAAAWYR 0.9948 -10.4 0 0 0 0 10.7605 0 0 0 13.8468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81404 0 0 0 0 0 0 0 0 0 0 0 10.4061 0 0 0 11.2109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3439 0 0 13.8113 0 0 0 0 11.4881 0 0 0 0 0 0 16.2233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6757 0 0 0 0 0 0 0 10.3268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20774 MIME_HUMAN "Mimecan (Osteoglycin) (Osteoinductive factor, OIF)" OGN OIF SLRR3A Homo sapiens (Human) articular cartilage development [GO:0061975]; bone development [GO:0060348]; negative regulation of smooth muscle cell proliferation [GO:0048662] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; growth factor activity [GO:0008083]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; negative regulation of smooth muscle cell proliferation [GO:0048662] GO:0005576; GO:0005615; GO:0005796; GO:0008083; GO:0031012; GO:0043202; GO:0048662; GO:0060348; GO:0061975; GO:0062023; GO:0070062; GO:1903561 growth factor activity [GO:0008083] ETVIIPNEK 0.9948 -9.0058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5904 14.4097 15.391 14.3024 0 0 11.4693 0 0 0 12.0641 13.8762 0 0 0 0 0 0 0 12.8765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4293 12.6769 13.5267 0 13.4654 14.7605 0 14.2763 0 0 0 0 12.0501 0 13.0549 12.7418 0 11.1703 0 0 0 12.4503 0 0 13.9951 11.478 0 0 13.4974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49711 CTCF_HUMAN Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) CTCF Homo sapiens (Human) "chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; genomic imprinting [GO:0071514]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of transcription by RNA polymerase II [GO:0006357]" "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; genomic imprinting [GO:0071514]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of gene expression, epigenetic [GO:0040029]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000775; GO:0000793; GO:0000976; GO:0000978; GO:0001221; GO:0001227; GO:0001673; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006306; GO:0006349; GO:0006357; GO:0007059; GO:0008270; GO:0008285; GO:0010216; GO:0010628; GO:0031060; GO:0035065; GO:0040029; GO:0043035; GO:0043565; GO:0045892; GO:0045893; GO:0070602; GO:0071459; GO:0071514; GO:0140588 "chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" AFRTVTLLR 0.9948 -13.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6302 0 0 0 0 11.2889 0 0 0 0 0 0 0 0 0 0 0 0 15.2657 0 0 0 0 14.4395 0 0 0 0 0 0 14.1825 0 0 0 0 0 0 0 0 0 0 11.7962 0 0 10.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8577 16.1541 0 0 0 0 0 0 0 0 12.7624 0 0 0 0 0 0 0 0 0 13.2938 14.389 0 0 0 0 0 0 13.6763 0 13.2653 0 13.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 P56705 WNT4_HUMAN Protein Wnt-4 WNT4 UNQ426/PRO864 Homo sapiens (Human) "adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via MAPK cascade [GO:0038030]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]" cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714]; adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via MAPK cascade [GO:0038030]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]" GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0038030; GO:0040037; GO:0042445; GO:0043547; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714] AIDGCELLCCGR 0.9948 -13.682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5979 0 0 0 0 0 0 0 0 13.3309 13.2006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.302 0 0 0 0 0 0 0 19.7768 0 0 0 0 0 0 0 0 0 0 0 14.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5248 0 0 0 11.4491 0 0 12.9323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2656 0 0 0 0 0 0 0 0 0 0 0 0 Q13451 FKBP5_HUMAN "Peptidyl-prolyl cis-trans isomerase FKBP5, PPIase FKBP5, EC 5.2.1.8 (51 kDa FK506-binding protein, 51 kDa FKBP, FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5, FKBP-5) (FKBP54, p54) (HSP90-binding immunophilin) (Rotamase)" FKBP5 AIG6 FKBP51 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; response to bacterium [GO:0009617] GO:0000413; GO:0003755; GO:0005528; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0009617; GO:0016020; GO:0031072; GO:0061077; GO:0070062 FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755] AARLQISMCQK 0.9948 -10.617 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16515 ASIC2_HUMAN "Acid-sensing ion channel 2, ASIC2 (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1, BNC1, BNaC1) (Mammalian degenerin homolog, MDEG)" ASIC2 ACCN ACCN1 BNAC1 MDEG Homo sapiens (Human) central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; inorganic cation transmembrane transport [GO:0098662]; negative regulation of apoptotic process [GO:0043066]; peripheral nervous system development [GO:0007422]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; synapse assembly [GO:0007416] dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886] dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; establishment of localization in cell [GO:0051649]; inorganic cation transmembrane transport [GO:0098662]; negative regulation of apoptotic process [GO:0043066]; peripheral nervous system development [GO:0007422]; phototransduction [GO:0007602]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback [GO:0003026]; regulation of vasoconstriction [GO:0019229]; response to acidic pH [GO:0010447]; sensory perception of sound [GO:0007605]; sensory perception of sour taste [GO:0050915]; sodium ion transmembrane transport [GO:0035725]; synapse assembly [GO:0007416] GO:0003026; GO:0005886; GO:0005887; GO:0007268; GO:0007416; GO:0007417; GO:0007422; GO:0007602; GO:0007605; GO:0010447; GO:0015280; GO:0019229; GO:0022839; GO:0034765; GO:0035418; GO:0035725; GO:0042391; GO:0043025; GO:0043066; GO:0043197; GO:0050915; GO:0050974; GO:0051649; GO:0051965; GO:0098662 ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280] GQECGHQDFTTVFTKYGK 0.9948 -13.749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9471 0 0 0 0 15.2225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6393 0 0 0 13.4798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.332 0 13.2417 0 0 0 0 0 0 0 0 0 0 0 12.5576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VZ46 K1614_HUMAN Uncharacterized protein KIAA1614 KIAA1614 Homo sapiens (Human) centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; nucleus [GO:0005634] apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein kinase C binding [GO:0005080]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341] GO:0005080; GO:0005634; GO:0005938; GO:0007098; GO:0007163; GO:0016324; GO:0060341 protein kinase C binding [GO:0005080] APSLQSLHPVSPSHQRR 0.9948 -13.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6287 0 0 0 0 0 0 0 0 0 0 0 10.8998 12.9933 0 0 0 0 0 0 0 0 11.899 0 0 0 0 10.9633 0 0 0 11.0482 0 0 0 11.09 12.3019 0 0 0 0 0 11.1778 0 10.3087 0 0 0 0 0 0 0 0 14.41 0 0 0 0 12.3812 0 0 0 12.4212 0 0 0 15.2552 0 0 15.3657 0 0 0 0 13.8034 13.0681 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 0 0 13.2982 0 0 14.0579 0 0 0 13.6824 0 0 0 0 13.5179 0 0 0 13.6506 0 12.1665 0 0 0 0 13.8263 14.3 0 13.0664 0 13.3041 11.0188 0 12.4686 0 0 0 0 0 0 0 13.5095 0 0 0 14.3239 0 0 0 15.5681 14.0137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2449 14.0493 13.964 14.521 0 0 0 0 0 0 Q7L3S4 ZN771_HUMAN Zinc finger protein 771 (Mesenchymal stem cell protein DSC43) ZNF771 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" CPECEGS 0.9948 -11.232 0 0 10.3923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5234 0 13.8303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1993 10.2038 0 0 0 0 0 0 0 0 0 14.0545 0 0 0 Q8N4L8 CCD24_HUMAN Coiled-coil domain-containing protein 24 CCDC24 Homo sapiens (Human) blastocyst hatching [GO:0001835] blastocyst hatching [GO:0001835] GO:0001835 HSPSLWELVEEHVPLRERR 0.9948 -10.404 0 0 0 0 0 11.5424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3324 0 0 0 13.0333 13.3563 0 10.7975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGJ2 O52H1_HUMAN Olfactory receptor 52H1 (Olfactory receptor OR11-45) OR52H1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] VILLFSK 0.9948 -10.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3607 11.6135 12.182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6014 0 0 0 0 0 0 0 12.3389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7127 0 0 0 0 0 0 0 0 0 0 0 12.7227 0 14.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGP8 OR5M1_HUMAN Olfactory receptor 5M1 (OST050) (Olfactory receptor OR11-208) OR5M1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] NTDVILAMQQMIR 0.9948 -8.4705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2677 13.1834 0 12.9431 13.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3807 14.0476 15.6391 0 15.7175 0 14.7667 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0441 11.791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2997 0 0 0 0 0 0 0 0 0 0 0 14.1019 12.5471 11.8492 14.7783 0 14.164 0 11.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8975 0 13.9474 0 0 0 0 0 0 Q8TF46 DI3L1_HUMAN "DIS3-like exonuclease 1, EC 3.1.13.-" DIS3L DIS3L1 KIAA1955 Homo sapiens (Human) RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075] centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; plasma membrane [GO:0005886] centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; plasma membrane [GO:0005886]; 3'-5'-exoribonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075] GO:0000175; GO:0000177; GO:0000178; GO:0003723; GO:0005813; GO:0005829; GO:0005886; GO:0006396; GO:0006401; GO:0016075; GO:0019899 3'-5'-exoribonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; RNA binding [GO:0003723] DARHDCILFANEFQQCCYLPR 0.9948 -10.407 0 0 0 14.5358 0 0 15.9413 0 0 12.4556 0 0 10.8148 0 0 0 11.156 12.4083 0 0 16.9886 0 0 0 0 0 10.4654 0 11.8378 12.0945 0 0 0 0 0 0 0 11.3078 0 0 0 11.3841 0 0 0 0 0 0 0 0 0 0 13.7461 0 0 12.5607 12.938 0 0 0 0 0 0 0 0 0 0 0 0 0 14.515 0 0 0 0 0 12.6086 14.8056 0 13.1976 12.6974 0 13.1525 13.5116 0 0 14.8299 0 0 0 0 0 0 14.4515 0 0 14.1128 13.6821 0 0 0 12.6374 13.9297 0 0 0 18.1682 0 18.2457 0 12.8449 0 12.6272 0 0 12.0463 12.0112 13.2287 0 0 10.3318 0 0 0 11.2764 0 15.6451 0 18.1133 0 18.1354 0 13.0035 11.2625 0 0 0 12.8259 0 0 10.0873 0 18.1673 0 11.5457 18.1705 0 0 0 0 12.9816 0 0 11.3371 18.1157 0 0 13.9101 12.8068 12.913 0 13.4685 12.2646 11.3512 13.4051 0 12.8181 13.9131 0 12.3676 0 0 0 17.9108 0 0 0 11.93 0 0 Q8WVT3 TPC12_HUMAN "Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15, TPR repeat protein 15, TTC-15) (Trafficking of membranes and mitosis)" TRAPPC12 TRAMM TTC15 CGI-87 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle tethering [GO:0099022] GO:0000776; GO:0005634; GO:0005654; GO:0005737; GO:0005793; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0048208; GO:0051310; GO:0090234; GO:0099022; GO:1905342; GO:1990072 DYVLAVEAYHSVIK 0.9948 -8.4684 0 0 0 0 0 0 11.5635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.35665 0 0 0 0 0 0 0 0 10.3296 13.3549 0 0 0 0 0 0 10.7291 0 15.7755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.76497 11.3296 0 0 10.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7426 9.71144 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8651 Q99466 NOTC4_HUMAN "Neurogenic locus notch homolog protein 4, Notch 4, hNotch4 [Cleaved into: Notch 4 extracellular truncation; Notch 4 intracellular domain ]" NOTCH4 INT3 Homo sapiens (Human) "branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; endothelial cell morphogenesis [GO:0001886]; epithelial to mesenchymal transition [GO:0001837]; hemopoiesis [GO:0030097]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; vasculature development [GO:0001944]; wound healing [GO:0042060]" cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; endothelial cell morphogenesis [GO:0001886]; epithelial to mesenchymal transition [GO:0001837]; hemopoiesis [GO:0030097]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription, DNA-templated [GO:0045893]; vasculature development [GO:0001944]; wound healing [GO:0042060]" GO:0000122; GO:0000139; GO:0001569; GO:0001709; GO:0001763; GO:0001837; GO:0001886; GO:0001944; GO:0005112; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0005887; GO:0007221; GO:0009986; GO:0030097; GO:0030154; GO:0030879; GO:0038023; GO:0042060; GO:0045596; GO:0045602; GO:0045893; GO:0060354; GO:2000048 calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; signaling receptor activity [GO:0038023] CACLSGYGGPDCLTPPAPK 0.9948 -12.86 0 9.78419 0 0 0 13.7538 0 0 0 0 12.6488 0 12.1653 11.1699 12.0119 0 0 12.59 0 0 0 0 0 0 0 0 0 0 0 11.5479 0 0 0 0 0 0 0 0 0 11.5479 13.4446 0 0 10.3847 0 0 0 0 0 9.9297 0 0 10.7618 0 0 0 11.9197 0 0 0 0 0 0 0 0 0 10.8905 0 13.875 0 0 0 0 0 0 11.7166 0 0 0 13.1176 11.6276 0 14.6331 0 0 0 14.9793 0 14.6694 0 14.5148 14.2614 0 16.6759 12.676 0 0 11.4899 15.7073 0 0 0 12.7612 0 0 0 14.2301 0 0 15.0245 0 0 0 0 0 11.613 14.6991 0 0 0 0 13.1248 0 0 11.7178 0 0 11.3269 0 11.9477 10.4756 14.2395 0 0 0 0 0 0 0 12.0415 0 0 11.1241 12.1634 10.3182 0 11.4525 0 11.3317 13.1811 0 0 0 0 0 12.9813 0 0 0 0 13.9516 11.5243 11.9869 0 14.8417 14.1578 14.1167 0 0 12.147 0 12.7697 0 0 12.3318 13.7994 13.7724 14.8731 12.5125 0 Q9Y2W7 CSEN_HUMAN "Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator, DREAM) (Kv channel-interacting protein 3, KChIP3)" KCNIP3 CSEN DREAM KCHIP3 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; signal transduction [GO:0007165] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; calcium ion binding [GO:0005509]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; voltage-gated ion channel activity [GO:0005244]; apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transmembrane transport [GO:1901379]; signal transduction [GO:0007165]" GO:0000122; GO:0000978; GO:0001227; GO:0005244; GO:0005267; GO:0005509; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006915; GO:0007165; GO:0008076; GO:0015459; GO:0072659; GO:1901379 "calcium ion binding [GO:0005509]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; potassium channel activity [GO:0005267]; potassium channel regulator activity [GO:0015459]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; voltage-gated ion channel activity [GO:0005244]" KEGIKWQR 0.9948 -8.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 M5A8F1 SUPYN_HUMAN Suppressyn (Endogenous retrovirus group 48 member 1) (NDUFV3 antisense RNA 1) (endogenous retrovirus group Fb member 1) ERVH48-1 C21orf105 HERV-Fb1 NDUFV3-AS1 Homo sapiens (Human) syncytium formation [GO:0006949] extracellular space [GO:0005615] extracellular space [GO:0005615]; syncytium formation [GO:0006949] GO:0005615; GO:0006949 NLGVCGSRNGAICPR 0.99481 -13.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4711 0 0 0 0 13.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11362 FGFR1_HUMAN "Fibroblast growth factor receptor 1, FGFR-1, EC 2.7.10.1 (Basic fibroblast growth factor receptor 1, BFGFR, bFGF-R-1) (Fms-like tyrosine kinase 2, FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331)" FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR Homo sapiens (Human) cell migration [GO:0016477]; chordate embryonic development [GO:0043009]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; chordate embryonic development [GO:0043009]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0000165; GO:0001501; GO:0001764; GO:0001837; GO:0004713; GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010518; GO:0010863; GO:0014068; GO:0016021; GO:0016477; GO:0017134; GO:0018108; GO:0031410; GO:0033674; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048705; GO:0051897; GO:0090722; GO:1905564; GO:2000546; GO:2001239 ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] DKPNRVTK 0.99481 -13.751 0 0 0 0 0 0 0 0 0 0 14.6258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4746 0 0 0 0 0 14.6482 0 0 11.7829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2769 0 0 13.1982 0 12.0512 0 0 0 0 0 0 0 0 0 13.5269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6757 0 0 0 0 0 14.8668 0 0 14.4217 0 0 0 0 0 0 0 0 0 0 P17812 PYRG1_HUMAN "CTP synthase 1, EC 6.3.4.2 (CTP synthetase 1) (UTP--ammonia ligase 1)" CTPS1 CTPS Homo sapiens (Human) 'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing compound metabolic process [GO:0006139]; pyrimidine nucleobase biosynthetic process [GO:0019856]; response to xenobiotic stimulus [GO:0009410]; T cell proliferation [GO:0042098] cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing compound metabolic process [GO:0006139]; pyrimidine nucleobase biosynthetic process [GO:0019856]; response to xenobiotic stimulus [GO:0009410]; T cell proliferation [GO:0042098] GO:0003883; GO:0005524; GO:0005737; GO:0005829; GO:0006139; GO:0006241; GO:0006541; GO:0009410; GO:0016020; GO:0019856; GO:0042098; GO:0042100; GO:0042802; GO:0044210; GO:0097268 ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802] GCRLSPR 0.99481 -31.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7252 12.7797 0 11.5815 11.6621 0 11.1842 0 0 0 10.7746 0 0 0 10.3454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2677 12.8471 0 0 0 13.4759 0 0 0 0 0 12.7673 13.4388 0 12.5275 12.7935 0 12.934 0 0 0 0 13.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7108 0 0 0 0 0 0 0 0 0 12.9931 0 11.9622 0 0 0 0 0 0 0 0 11.3098 12.7472 0 0 0 0 0 0 13.2093 12.5654 0 0 13.9707 0 0 0 0 0 14.1285 0 0 0 0 0 0 0 0 0 0 0 0 13.2916 0 0 0 0 0 12.1992 Q02127 PYRD_HUMAN "Dihydroorotate dehydrogenase (quinone), mitochondrial, DHOdehase, EC 1.3.5.2 (Dihydroorotate oxidase)" DHODH Homo sapiens (Human) 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; dihydroorotase activity [GO:0004151]; dihydroorotate dehydrogenase activity [GO:0004152]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225] GO:0004151; GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0006225; GO:0009220; GO:0016021; GO:0044205 dihydroorotase activity [GO:0004151]; dihydroorotate dehydrogenase activity [GO:0004152] FTSLGLLPR 0.99481 -10.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2129 14.3311 15.6901 0 0 0 0 0 0 0 0 0 0 0 0 13.4328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2317 0 14.2199 0 12.8486 0 0 0 0 0 0 0 14.7289 0 0 0 15.0247 0 0 0 0 13.9882 14.6497 0 15.1852 0 0 0 0 14.4028 0 0 14.3401 14.9951 14.3831 14.7638 0 0 0 14.8214 0 0 0 13.6059 13.5294 0 0 0 13.9097 0 0 0 14.5364 13.6304 14.5787 14.8757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.715 0 0 13.5486 0 0 0 0 0 Q14978 NOLC1_HUMAN "Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein, Nopp140) (Hepatitis C virus NS5A-transactivated protein 13, HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130)" NOLC1 KIAA0035 NS5ATP13 Homo sapiens (Human) "box H/ACA RNA metabolic process [GO:0033979]; mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]; rRNA processing [GO:0006364]" box C/D RNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "box C/D RNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D RNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; TFIIB-class transcription factor binding [GO:0001093]; box H/ACA RNA metabolic process [GO:0033979]; mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]; rRNA processing [GO:0006364]" GO:0000278; GO:0001093; GO:0001650; GO:0003723; GO:0005524; GO:0005525; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0006970; GO:0007000; GO:0008139; GO:0008284; GO:0014029; GO:0014032; GO:0015030; GO:0019904; GO:0030674; GO:0031428; GO:0031429; GO:0033979; GO:0034512; GO:0034513; GO:0042306; GO:0045893; GO:0046982; GO:0062064; GO:0062065 ATP binding [GO:0005524]; box C/D RNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; TFIIB-class transcription factor binding [GO:0001093] AAKAPPK 0.99481 -31.332 0 0 0 13.5225 0 10.987 0 0 11.5289 13.1529 0 0 13.7709 13.0638 11.5788 0 13.3741 0 0 0 0 0 0 0 0 0 0 0 0 11.8606 9.91069 11.702 11.6106 0 0 0 0 0 0 11.3735 0 13.73 0 0 0 13.4446 0 0 0 12.3249 0 0 0 13.114 0 0 0 0 0 0 0 0 0 16.8605 0 0 12.6139 0 0 13.7989 0 0 9.64519 14.8256 11.0976 11.6992 12.7401 12.6133 12.8563 14.2339 0 13.7899 13.4433 13.9439 13.2499 11.923 14.1021 0 14.3134 12.6807 14.2379 11.2377 0 14.3891 14.8178 14.883 14.5999 10.6387 0 0 14.079 0 13.4574 14.7122 14.0585 0 11.8866 0 0 12.9599 13.9376 0 0 0 14.1799 15.1255 13.8207 15.2821 13.4935 14.6738 0 0 13.4061 11.4453 14.2278 15.9821 13.9102 0 14.7223 11.4512 14.2498 12.1206 14.522 13.0547 0 13.6842 12.0097 14.0444 13.6028 13.9032 11.2366 12.7699 13.4533 0 13.5302 13.7886 0 0 0 0 14.0765 12.8815 0 12.6376 11.3704 0 14.0669 0 0 15.0314 0 0 12.44 11.3412 10.8532 13.9221 12.4049 0 13.0934 0 12.1962 13.5785 12.6106 0 0 0 15.0084 11.5282 0 11.1228 Q6P1M3 L2GL2_HUMAN LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2) LLGL2 Homo sapiens (Human) cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; leucine transport [GO:0015820]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; leucine transport [GO:0015820]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593]; regulation of protein secretion [GO:0050708] GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0008593; GO:0015820; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0043231; GO:0045159; GO:0045197; GO:0050708; GO:0051294; GO:0051301 GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165] AITRILWLTTR 0.99481 -8.2499 0 0 13.2064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4325 0 0 0 0 0 0 0 0 0 0 10.6644 0 0 10.6546 16.4675 11.6056 0 16.4457 0 0 0 14.6623 14.5723 14.5166 0 0 0 0 0 0 0 0 14.9944 0 0 13.195 14.0325 0 0 0 0 0 0 0 0 0 14.681 14.2861 0 12.7986 13.9163 13.2251 0 0 0 14.5419 14.57 0 0 0 14.2857 15.2068 0 0 0 0 0 11.9179 13.0239 0 17.9753 0 15.8488 15.5075 0 14.298 14.614 12.3329 0 0 0 15.1339 0 0 0 0 14.3636 0 0 0 0 10.4187 13.6653 0 0 0 0 0 0 0 13.8627 13.8852 0 0 0 0 0 17.032 13.0537 0 0 0 0 17.4939 15.0803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1943 0 0 0 12.1497 0 16.8656 Q86TI2 DPP9_HUMAN "Dipeptidyl peptidase 9, DP9, EC 3.4.14.5 (Dipeptidyl peptidase IV-related protein 2, DPRP-2) (Dipeptidyl peptidase IX, DPP IX) (Dipeptidyl peptidase-like protein 9, DPLP9)" DPP9 DPRP2 Homo sapiens (Human) proteolysis [GO:0006508]; pyroptosis [GO:0070269] cell leading edge [GO:0031252]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634] cell leading edge [GO:0031252]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508]; pyroptosis [GO:0070269] GO:0004177; GO:0005634; GO:0005829; GO:0005874; GO:0006508; GO:0008236; GO:0008239; GO:0031252; GO:0042802; GO:0070269 aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; serine-type peptidase activity [GO:0008236] ELVQPFSSLFPKVEYIAR 0.99481 -10.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4651 0 0 0 0 0 0 10.8939 0 0 0 0 12.4921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.328 0 0 0 0 0 0 0 0 0 0 11.4801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9205 13.0357 0 0 0 0 13.0109 0 0 Q8IXF9 AQ12A_HUMAN "Aquaporin-12A, AQP-12" AQP12A AQP12 AQPX2 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; channel activity [GO:0015267] GO:0005737; GO:0015267; GO:0016021 channel activity [GO:0015267] LPHLFQR 0.99481 -10.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1207 0 0 0 0 0 0 0 0 0 12.5108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4432 0 0 0 0 0 0 0 Q8IXS0 F217A_HUMAN Protein FAM217A FAM217A C6orf146 Homo sapiens (Human) ATPKVRQPK 0.99481 -8.5029 0 0 0 0 0 0 0 0 12.188 0 0 19.1828 0 0 0 0 12.0863 0 0 0 0 0 0 0 0 0 0 0 12.3404 0 0 0 0 0 0 0 0 12.0633 0 12.1202 0 0 0 12.0232 19.3144 12.1189 12.2718 19.305 0 0 12.0929 0 0 0 11.9673 0 12.2424 0 0 0 0 0 13.3775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0891 0 0 0 15.1088 11.9151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.401 13.4413 13.5665 0 0 0 0 0 13.669 13.4709 0 0 13.3489 0 0 0 0 13.6659 0 13.3547 13.2202 0 Q8NHQ1 CEP70_HUMAN "Centrosomal protein of 70 kDa, Cep70 (p10-binding protein)" CEP70 BITE Homo sapiens (Human) cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507] centrosome [GO:0005813]; cytosol [GO:0005829] centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0005813; GO:0005829; GO:0042802; GO:0043015; GO:0060271; GO:0070507 gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802] DLQKEQKTLQVK 0.99481 -11.298 0 0 0 0 0 0 0 0 0 0 0 0 14.6087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1662 0 0 0 0 0 0 0 0 0 0 0 11.2704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6242 0 0 0 0 16.3484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5636 0 0 0 0 0 15.2175 0 0 0 0 0 0 0 0 0 16.0316 0 0 0 0 15.3453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8001 0 12.025 14.3159 0 12.0113 12.4069 0 0 0 0 0 0 12.8212 0 0 0 0 0 0 0 12.7314 0 0 Q8NHY3 GA2L2_HUMAN GAS2-like protein 2 (GAS2-related protein on chromosome 17) (Growth arrest-specific protein 2-like 2) GAS2L2 GAR17 Homo sapiens (Human) actin crosslink formation [GO:0051764]; microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of microtubule polymerization or depolymerization [GO:0031110] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017]; actin crosslink formation [GO:0051764]; microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0001578; GO:0001965; GO:0005737; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0031110; GO:0036064; GO:0045745; GO:0051015; GO:0051764; GO:0060296; GO:1904825 actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017] AIEATTK 0.99481 -8.5022 0 0 0 0 0 0 0 0 11.1515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0401 0 0 0 0 0 0 0 0 0 11.558 0 0 0 0 0 0 0 0 0 0 0 0 14.2808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3629 0 0 13.6476 14.6217 14.2555 14.7254 13.3997 13.866 0 0 13.8406 14.7799 0 0 0 0 0 0 0 12.842 0 0 0 0 0 0 12.5996 0 0 0 0 13.2218 0 0 13.6781 0 14.716 0 0 13.1203 0 0 0 0 13.4888 0 0 0 0 0 13.1132 0 12.8332 0 0 0 0 15.2199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1028 0 0 13.6116 14.3049 14.3247 0 18.2414 17.6073 0 12.6858 18.7427 0 13.1267 0 0 12.6319 0 0 0 0 0 0 0 0 0 Q96LQ0 PPR36_HUMAN Protein phosphatase 1 regulatory subunit 36 PPP1R36 C14orf50 Homo sapiens (Human) negative regulation of phosphatase activity [GO:0010923] phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923] GO:0004864; GO:0010923; GO:0019902 phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864] AINMRSPVMSTLLPSLR 0.99481 -13.788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3919 0 0 0 0 0 0 0 14.4958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4809 14.2758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3421 0 0 0 0 0 0 0 0 0 0 0 14.3931 15.503 0 0 0 0 0 0 0 0 0 15.779 0 0 0 14.824 0 0 0 0 14.4793 0 0 0 0 0 14.8738 0 0 0 0 0 15.3664 14.6693 0 0 0 0 14.1262 0 0 0 0 0 11.5611 0 0 0 13.5433 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5088 14.2393 0 0 0 12.8753 0 0 0 Q9NPH3 IL1AP_HUMAN "Interleukin-1 receptor accessory protein, IL-1 receptor accessory protein, IL-1RAcP, EC 3.2.2.6 (Interleukin-1 receptor 3, IL-1R-3, IL-1R3)" IL1RAP C3orf13 IL1R3 Homo sapiens (Human) immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545] extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] "extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]" GO:0002114; GO:0004908; GO:0005149; GO:0005576; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0016020; GO:0032736; GO:0032753; GO:0032754; GO:0032755; GO:0045087; GO:0050135; GO:0051092; GO:0051965; GO:0061809; GO:0065003; GO:0098978; GO:0099151; GO:0099545; GO:0099560; GO:1905606 "interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]" AKTVLTVIKWK 0.99481 -8.2636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.28 Q9UBQ0 VPS29_HUMAN "Vacuolar protein sorting-associated protein 29, hVPS29 (PEP11 homolog) (Vesicle protein sorting 29)" VPS29 DC15 DC7 MDS007 Homo sapiens (Human) "endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; metal ion binding [GO:0046872]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0010008; GO:0030904; GO:0030906; GO:0032456; GO:0042147; GO:0043231; GO:0046872 metal ion binding [GO:0046872] CNSLPAK 0.99481 -8.4931 10.97 0 0 0 0 0 0 0 0 13.3112 0 0 13.495 0 13.0852 14.7199 14.7371 0 13.1904 0 13.7707 13.4473 0 0 0 0 0 0 0 0 13.4059 0 0 0 0 0 0 0 0 0 14.1568 13.9609 13.2769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8626 0 0 0 0 0 0 0 0 0 13.3222 13.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0302 0 0 0 0 13.5773 0 13.088 0 0 0 0 0 0 0 0 11.9142 11.7076 13.372 13.2726 0 0 0 0 13.2596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2F5 ICE1_HUMAN Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1) ICE1 KIAA0947 Homo sapiens (Human) positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] Cajal body [GO:0015030]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023] Cajal body [GO:0015030]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]; protein-macromolecule adaptor activity [GO:0030674]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796] GO:0000791; GO:0005654; GO:0008023; GO:0015030; GO:0016604; GO:0030674; GO:0031334; GO:0035363; GO:0042795; GO:0042796; GO:0045945; GO:0090316 protein-macromolecule adaptor activity [GO:0030674] AMQLVARQRAK 0.99481 -13.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4766 0 0 0 0 0 0 0 0 0 0 10.708 0 0 0 0 0 0 0 13.5997 0 0 0 0 0 0 0 0 11.7746 13.0911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0464 0 0 0 0 0 11.7498 0 12.6915 0 0 0 13.8446 0 13.0956 0 13.1854 0 0 0 0 0 0 12.7809 0 13.2986 0 11.136 0 14.232 13.7889 12.7719 0 14.2567 12.4421 0 0 0 0 0 0 14.7983 14.0497 0 0 0 0 0 0 0 12.4563 0 0 0 0 0 0 13.5666 0 0 0 0 14.5864 0 0 11.735 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7317 0 0 13.9826 A8K554 ZN815_HUMAN Putative protein ZNF815 ZNF815P ZNF815 Homo sapiens (Human) NLKLHLQER 0.99482 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09960 LKHA4_HUMAN "Leukotriene A-4 hydrolase, LTA-4 hydrolase, EC 3.3.2.6 (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H, EC 3.4.11.4)" LTA4H LTA4 Homo sapiens (Human) leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509] GO:0003723; GO:0004177; GO:0004301; GO:0004463; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0008270; GO:0010043; GO:0019370; GO:0019538; GO:0043171; GO:0043434; GO:0045148; GO:0060509; GO:0070006; GO:0070062; GO:1904724; GO:1904813 aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270] AILPCQDTPSVKLTYTAEVSVPKELVALMSAIR 0.99482 -8.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0797 0 13.4914 0 12.8518 0 0 0 0 10.9427 13.4564 13.5768 0 12.5512 13.5221 13.4975 11.6305 0 0 0 0 12.972 0 0 0 10.7363 12.9259 0 0 12.3565 0 0 12.6505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5721 0 0 0 0 13.1197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DMS9 TMIG3_HUMAN Transmembrane domain-containing protein TMIGD3 TMIGD3 UNQ1931/PRO4406 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; inflammatory response [GO:0006954]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; regulation of heart contraction [GO:0008016]; response to wounding [GO:0009611]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; inflammatory response [GO:0006954]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; regulation of heart contraction [GO:0008016]; response to wounding [GO:0009611]; signal transduction [GO:0007165] GO:0004888; GO:0005886; GO:0005887; GO:0006954; GO:0007165; GO:0007190; GO:0008016; GO:0008285; GO:0009611; GO:0016020; GO:0030336; GO:0032088 transmembrane signaling receptor activity [GO:0004888] SRTSILIICILITGLGIISVISHLTK 0.99482 -8.2767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.263 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11912 CD79A_HUMAN B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a) CD79A IGA MB1 Homo sapiens (Human) adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853] B cell receptor complex [GO:0019815]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886] B cell receptor complex [GO:0019815]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853] GO:0002250; GO:0004888; GO:0005771; GO:0005886; GO:0009897; GO:0016021; GO:0019815; GO:0030183; GO:0042100; GO:0042113; GO:0042802; GO:0045121; GO:0050853 identical protein binding [GO:0042802]; transmembrane signaling receptor activity [GO:0004888] IITAEGIILLFCAVVPGTLLLFR 0.99482 -8.2929 0 0 0 0 0 0 0 0 0 0 0 0 0 12.013 0 0 0 0 0 0 12.1658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6688 12.1626 12.3029 13.3117 0 0 0 0 0 0 12.3043 0 0 0 0 0 12.9915 0 0 12.7911 0 0 0 0 0 0 0 0 12.6924 12.2736 12.1721 11.8704 0 0 0 0 12.3473 0 11.733 0 0 0 0 0 0 0 0 0 0 0 11.542 0 0 0 0 13.2668 0 0 0 12.6524 0 0 0 12.7031 0 0 0 12.3155 0 12.4132 0 0 11.2363 0 0 0 0 0 0 0 11.3075 12.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8726 P23109 AMPD1_HUMAN "AMP deaminase 1, EC 3.5.4.6 (AMP deaminase isoform M) (Myoadenylate deaminase)" AMPD1 Homo sapiens (Human) AMP metabolic process [GO:0046033]; GMP salvage [GO:0032263]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] cytosol [GO:0005829] cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; AMP metabolic process [GO:0046033]; GMP salvage [GO:0032263]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] GO:0003876; GO:0005829; GO:0006188; GO:0032263; GO:0032264; GO:0042802; GO:0046033; GO:0046872 AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] ALCIREKYMQK 0.99482 -10.711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6803 0 0 0 0 0 13.0681 0 0 0 13.1565 0 0 0 0 0 13.0563 0 11.2337 11.7365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.16 0 0 0 0 10.1731 0 12.1216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59046 NAL12_HUMAN "NACHT, LRR and PYD domains-containing protein 12 (Monarch-1) (PYRIN-containing APAF1-like protein 7) (Regulated by nitric oxide)" NLRP12 NALP12 PYPAF7 RNO Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell migration [GO:0036336]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of signal transduction [GO:0009968]; negative regulation of Toll signaling pathway [GO:0045751]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-18 production [GO:0032661]; signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to cytokine stimulus [GO:0071345]; dendritic cell migration [GO:0036336]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of signal transduction [GO:0009968]; negative regulation of Toll signaling pathway [GO:0045751]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-18 production [GO:0032661]; signal transduction [GO:0007165] GO:0001818; GO:0005524; GO:0005737; GO:0006919; GO:0007165; GO:0008656; GO:0009968; GO:0031953; GO:0032088; GO:0032661; GO:0032692; GO:0032715; GO:0032731; GO:0036336; GO:0038061; GO:0043122; GO:0043124; GO:0043281; GO:0045345; GO:0045751; GO:0050727; GO:0050728; GO:0050729; GO:0070371; GO:0070373; GO:0071345; GO:1901223; GO:1901224 ATP binding [GO:0005524]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656] HPQCRLQMIQLR 0.99482 -8.2691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5848 0 0 0 0 0 0 12.0229 0 0 10.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6779 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0216 0 12.77 12.7769 0 Q3C1V9 YK041_HUMAN Putative uncharacterized protein ENSP00000334305 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] ubiquitin ligase complex [GO:0000151] ubiquitin ligase complex [GO:0000151]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0006511 ACQVMLLVSTKQLQR 0.99482 -10.678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.319 0 0 0 0 0 0 14.0308 11.3053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53SZ7 PRR30_HUMAN Proline-rich protein 30 PRR30 C2orf53 Homo sapiens (Human) APKQVTTSLKPR 0.99482 -8.295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5879 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.03 0 0 0 12.8794 0 0 0 0 13.3618 0 12.8503 0 0 14.0902 0 0 0 0 0 0 14.8184 0 0 0 12.2377 0 0 13.6763 0 0 15.093 0 14.4018 12.3618 0 0 0 14.1454 15.8953 0 0 0 0 12.1807 0 0 0 15.7319 0 0 0 13.2138 0 0 0 0 12.77 13.7642 0 0 0 0 0 15.505 0 0 0 14.2491 0 0 0 0 0 0 0 0 0 0 12.4491 0 0 0 0 0 0 0 13.3941 0 0 0 0 14.5851 0 0 0 0 0 0 0 0 0 16.462 0 0 0 0 12.0213 0 0 0 0 0 Q6PK04 CC137_HUMAN Coiled-coil domain-containing protein 137 CCDC137 cPERP-B Homo sapiens (Human) chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634] chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723] GO:0001650; GO:0003723; GO:0005634; GO:0005694; GO:0005730 RNA binding [GO:0003723] IVEEERER 0.99482 -10.68 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z406 MYH14_HUMAN "Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc, NMHC II-C)" MYH14 KIAA2034 FP17425 Homo sapiens (Human) actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625] actomyosin [GO:0042641]; brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725] actomyosin [GO:0042641]; brush border [GO:0005903]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion morphogenesis [GO:0070584]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625] GO:0000146; GO:0001725; GO:0003009; GO:0005516; GO:0005524; GO:0005829; GO:0005903; GO:0007519; GO:0007605; GO:0008360; GO:0016020; GO:0016460; GO:0019228; GO:0030048; GO:0030426; GO:0031032; GO:0032982; GO:0042641; GO:0051015; GO:0070062; GO:0070584; GO:0071625; GO:0097513 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AAILEEKRQLEGR 0.99482 -15.386 0 0 0 0 0 0 0 0 10.8242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.768 11.9888 14.2472 0 0 13.7381 0 11.0579 0 0 13.7786 0 0 0 0 0 0 0 0 0 0 0 14.8955 0 0 0 0 0 0 0 0 0 0 13.9593 13.4828 0 0 11.0036 0 0 0 0 15.7543 14.3935 0 13.6151 0 0 0 0 0 13.2263 0 0 0 0 0 0 0 0 0 0 0 14.2889 0 0 0 0 0 14.0767 0 14.0415 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3417 0 0 0 0 0 14.0535 0 0 0 13.3144 0 0 0 0 0 13.3278 14.0257 0 0 0 0 0 13.2969 Q96M02 CJ090_HUMAN "(E2-independent) E3 ubiquitin-conjugating enzyme FATS, EC 2.3.2.- (Centrosomal protein C10orf90) (E2/E3 hybrid ubiquitin-protein ligase FATS) (Fragile-site associated tumor suppressor homolog, FATS)" C10orf90 FATS Homo sapiens (Human) protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of centriole replication [GO:0046599] actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of centriole replication [GO:0046599] GO:0000209; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0008017; GO:0015629; GO:0016567; GO:0046599; GO:0050821; GO:0061630 microtubule binding [GO:0008017]; ubiquitin protein ligase activity [GO:0061630] EDLRQKQSLLPIR 0.99482 -15.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.61 0 0 0 0 0 13.66 12.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5597 0 17.3452 0 13.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6494 0 0 15.218 0 0 0 0 0 0 0 0 14.3364 0 15.4047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96QR8 PURB_HUMAN Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B) PURB Homo sapiens (Human) cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of myeloid cell differentiation [GO:0045637]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; regulation of myeloid cell differentiation [GO:0045637]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0001227; GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006357; GO:0008283; GO:0030154; GO:0032422; GO:0045637; GO:0046332; GO:0140297 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]" ADGDSGSER 0.99482 -10.679 0 0 0 0 10.6264 0 0 0 11.2671 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9253 0 0 0 10.0799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9701 0 0 0 0 10.9127 0 0 0 13.4648 0 0 0 0 0 0 0 0 0 0 12.7506 11.6729 0 0 0 0 0 0 14.0863 14.2827 0 0 0 0 13.6048 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.032 0 Q99848 EBP2_HUMAN Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40) EBNA1BP2 EBP2 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364] "chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]" "chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]" GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:0030687; GO:0034399; GO:0042273 RNA binding [GO:0003723] DLEWVER 0.99482 -15.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2943 0 0 0 0 0 0 15.2619 0 0 13.9893 0 0 0 0 0 0 0 13.1097 0 0 0 0 0 0 0 0 12.8949 15.2218 0 0 0 0 0 0 0 0 0 0 12.3807 0 12.5381 15.0933 0 0 12.4964 0 0 13.3075 0 0 0 14.4829 0 0 0 0 0 0 0 0 12.1628 13.4974 0 0 0 0 0 0 0 11.5407 0 0 0 0 0 0 0 0 0 0 0 14.291 0 12.9048 14.7256 14.6777 0 13.1549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9283 0 0 0 13.8789 0 0 Q9H322 VCX2_HUMAN "Variable charge X-linked protein 2 (Variable charge protein on X with two repeats, VCX-2r) (Variably charged protein X-B, VCX-B)" VCX2 VCX2R VCXB Homo sapiens (Human) brain development [GO:0007420] brain development [GO:0007420] GO:0007420 ASGPPAK 0.99482 -15.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8557 0 13.955 0 0 0 0 0 14.6954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBA0 TRPV4_HUMAN "Transient receptor potential cation channel subfamily V member 4, TrpV4 (Osm-9-like TRP channel 4, OTRPC4) (Transient receptor potential protein 12, TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2, VRL-2) (Vanilloid receptor-related osmotically-activated channel, VR-OAC)" TRPV4 VRL2 VROAC Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion import into cytosol [GO:1902656]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell volume homeostasis [GO:0006884]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of striated muscle contraction [GO:0045989]; positive regulation of vascular permeability [GO:0043117]; regulation of aerobic respiration [GO:1903715]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; vasopressin secretion [GO:0030103] adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]; actin cytoskeleton reorganization [GO:0031532]; actin filament organization [GO:0007015]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion import into cytosol [GO:1902656]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell volume homeostasis [GO:0006884]; cell-cell junction assembly [GO:0007043]; cellular calcium ion homeostasis [GO:0006874]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; microtubule polymerization [GO:0046785]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of striated muscle contraction [GO:0045989]; positive regulation of vascular permeability [GO:0043117]; regulation of aerobic respiration [GO:1903715]; regulation of response to osmotic stress [GO:0047484]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]; vasopressin secretion [GO:0030103]" GO:0000122; GO:0002024; GO:0003779; GO:0005034; GO:0005080; GO:0005216; GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005783; GO:0005881; GO:0005886; GO:0005887; GO:0005912; GO:0005925; GO:0005929; GO:0006816; GO:0006874; GO:0006884; GO:0007015; GO:0007043; GO:0007204; GO:0007231; GO:0008017; GO:0008289; GO:0009612; GO:0009986; GO:0010759; GO:0010977; GO:0015275; GO:0016021; GO:0016324; GO:0019901; GO:0030027; GO:0030103; GO:0030175; GO:0030426; GO:0030864; GO:0031117; GO:0031410; GO:0031532; GO:0032587; GO:0032755; GO:0032868; GO:0034605; GO:0042169; GO:0042538; GO:0042593; GO:0042802; GO:0043014; GO:0043117; GO:0043622; GO:0045989; GO:0046330; GO:0046785; GO:0046872; GO:0047484; GO:0048487; GO:0050729; GO:0050891; GO:0051015; GO:0060351; GO:0070374; GO:0070509; GO:0070588; GO:0071470; GO:0071476; GO:0071477; GO:0071639; GO:0071642; GO:0071651; GO:0097009; GO:0097497; GO:0098703; GO:1902656; GO:1903444; GO:1903715; GO:2000340 "actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cation channel activity [GO:0005261]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, cation-selective, calcium channel activity [GO:0015275]" APAPQPPPILKVFNRPILFDIVSR 0.99482 -31.953 0 0 0 0 0 0 0 0 0 0 0 0 13.4188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2724 0 0 0 0 0 0 0 0 0 0 0 12.9851 0 0 13.5215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBJ7 UBP29_HUMAN "Ubiquitin carboxyl-terminal hydrolase 29, EC 3.4.19.12 (Deubiquitinating enzyme 29) (Ubiquitin thioesterase 29) (Ubiquitin-specific-processing protease 29)" USP29 Homo sapiens (Human) defense response to virus [GO:0051607]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; defense response to virus [GO:0051607]; G1/S transition of mitotic cell cycle [GO:0000082]; innate immune response [GO:0045087]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006511; GO:0016579; GO:0045087; GO:0048471; GO:0050821; GO:0051607; GO:0060340; GO:0071108 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197] DAKQLNMFLDIIHQNKSQQPMK 0.99482 -8.8302 0 0 0 0 0 0 0 0 11.7655 0 0 12.5445 13.6049 0 0 12.2085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3402 0 0 0 0 0 12.275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4359 10.3296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9822 0 0 0 0 11.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1379 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1813 0 0 0 0 0 0 0 0 14.6259 0 0 0 12.2577 0 0 0 15.0695 0 0 11.6462 14.7003 0 0 0 0 0 11.8753 0 0 0 0 0 0 0 0 16.1018 0 0 0 Q9HC97 GPR35_HUMAN "G-protein coupled receptor 35 (Kynurenic acid receptor, KYNA receptor)" GPR35 Homo sapiens (Human) chemokine-mediated signaling pathway [GO:0070098]; cytoskeleton organization [GO:0007010]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuronal action potential [GO:1904456]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; chemokine-mediated signaling pathway [GO:0070098]; cytoskeleton organization [GO:0007010]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of neuronal action potential [GO:1904456]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0004930; GO:0005886; GO:0005887; GO:0007010; GO:0007186; GO:0007204; GO:0016494; GO:0035025; GO:0051482; GO:0070098; GO:1901386; GO:1904456 C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930] ALYITSK 0.99482 -10.698 0 0 0 0 0 0 0 0 0 10.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2511 0 0 14.3153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5872 0 0 0 Q9NPI7 KRCC1_HUMAN Lysine-rich coiled-coil protein 1 (Cryptogenic hepatitis-binding protein 2) KRCC1 CHBP2 BM-003 BM-044 Homo sapiens (Human) QIHQKRK 0.99482 -15.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5658 0 0 0 0 0 0 0 13.8794 0 0 0 Q9NV88 INT9_HUMAN "Integrator complex subunit 9, Int9 (Protein related to CPSF subunits of 74 kDa, RC-74)" INTS9 RC74 Homo sapiens (Human) regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180] GO:0005634; GO:0005654; GO:0005829; GO:0016180; GO:0032039; GO:0034243; GO:0034472 AEVLALPFK 0.99482 -8.298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4214 0 0 0 0 0 0 0 0 0 0 0 11.6694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.72 0 0 0 0 0 0 A6NDV4 TMM8B_HUMAN Transmembrane protein 8B (Nasopharyngeal carcinoma-associated gene 6 protein) (Protein NAG-5) (Protein NGX6) TMEM8B C9orf127 NGX6 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell-matrix adhesion [GO:0007160]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346] GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0007160; GO:0007346; GO:0009986; GO:0016021; GO:0040008 RHCYPPTWR 0.99483 -12.611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0174 11.4307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4875 0 0 13.3464 13.9441 13.5226 13.7659 12.9282 14.0881 0 0 0 0 12.943 13.0605 12.5011 0 13.2786 0 11.9424 0 0 0 0 0 0 0 0 0 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 13.6683 0 0 0 12.5171 15.3016 0 0 0 0 13.2741 0 13.3603 0 0 0 0 0 0 0 13.2254 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4154 12.4958 0 0 0 0 12.3358 0 12.9659 12.7408 0 12.3399 0 12.6002 0 0 0 11.7384 0 0 0 0 0 0 13.1688 12.0503 0 0 0 0 12.7713 11.077 0 0 0 0 0 12.3258 0 12.5166 0 12.8269 0 0 0 0 0 0 0 0 12.9904 0 0 0 0 O00602 FCN1_HUMAN Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin) FCN1 FCNM Homo sapiens (Human) "cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370] "collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]; antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]" GO:0001664; GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0007186; GO:0009897; GO:0030246; GO:0031232; GO:0032757; GO:0033691; GO:0034394; GO:0034774; GO:0038187; GO:0043654; GO:0046597; GO:0046872; GO:0062023; GO:0097367; GO:1903028; GO:1904813; GO:1905370 antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102] DQDNDVSSSNCAEK 0.99483 -12.575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1138 0 0 0 13.2556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3632 0 0 0 0 0 11.6511 0 0 0 0 12.8487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43745 CHP2_HUMAN Calcineurin B homologous protein 2 (Hepatocellular carcinoma-associated antigen 520) CHP2 HCA520 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cellular response to calcium ion [GO:0071277]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sodium:proton antiporter activity [GO:0032417]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031] GO:0005509; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0008284; GO:0010922; GO:0015031; GO:0032417; GO:0042307; GO:0045944; GO:0070886; GO:0071277 calcium ion binding [GO:0005509] HEMLQVLR 0.99483 -8.3317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5035 0 0 0 0 0 0 0 0 0 15.8801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75106 AOC2_HUMAN "Retina-specific copper amine oxidase, RAO, EC 1.4.3.21 (Amine oxidase [copper-containing]) (Semicarbazide-sensitive amine oxidase, SSAO)" AOC2 Homo sapiens (Human) amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805] GO:0005507; GO:0005737; GO:0005886; GO:0006584; GO:0006805; GO:0007601; GO:0008131; GO:0009055; GO:0009308; GO:0048038; GO:0052593; GO:0052594; GO:0052595; GO:0052596 aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593] DVTVERHGGPLPYHR 0.99483 -11.393 0 0 11.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2277 15.9016 0 0 0 0 0 0 0 0 0 0 13.5772 0 0 11.6969 0 0 0 0 0 13.9843 0 0 0 0 0 0 0 0 11.0259 0 0 0 0 0 0 0 0 13.4284 0 0 0 0 0 0 0 0 0 13.547 0 0 0 0 0 0 13.0794 0 0 0 0 0 0 0 P40205 NCYM_HUMAN N-cym protein (N-myc opposite strand) MYCNOS CYMN NCYM Homo sapiens (Human) negative regulation of kinase activity [GO:0033673]; regulation of protein stability [GO:0031647] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of kinase activity [GO:0033673]; regulation of protein stability [GO:0031647] GO:0005634; GO:0005737; GO:0031647; GO:0033673 LLLCNYER 0.99483 -11.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5981 0 0 0 0 0 0 0 0 12.2884 0 0 0 0 0 0 0 12.3623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54368 OAZ1_HUMAN "Ornithine decarboxylase antizyme 1, AZ1, ODC-Az" OAZ1 OAZ Homo sapiens (Human) negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ornithine decarboxylase inhibitor activity [GO:0008073]; negative regulation of polyamine transmembrane transport [GO:1902268]; polyamine biosynthetic process [GO:0006596]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein catabolic process [GO:0045732] GO:0005634; GO:0005737; GO:0005829; GO:0006596; GO:0008073; GO:0045732; GO:0090316; GO:1902268 ornithine decarboxylase inhibitor activity [GO:0008073] ADHVFICFHK 0.99483 -12.601 0 0 0 0 0 0 0 0 0 10.3414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0537 0 0 0 0 0 0 0 13.1463 0 0 0 0 0 0 0 0 0 0 11.0476 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4794 15.4398 0 0 0 13.4793 0 0 0 0 0 16.4989 0 0 11.3489 0 0 0 0 0 0 0 0 11.026 0 0 0 0 0 14.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56915 GSC_HUMAN Homeobox protein goosecoid GSC Homo sapiens (Human) dorsal/ventral neural tube patterning [GO:0021904]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; gastrulation [GO:0007369]; middle ear morphogenesis [GO:0042474]; muscle organ morphogenesis [GO:0048644]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell fate specification [GO:0014036]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in regulation of gene expression [GO:0023019]; Wnt signaling pathway [GO:0016055] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic skeletal system morphogenesis [GO:0048704]; forebrain development [GO:0030900]; gastrulation [GO:0007369]; middle ear morphogenesis [GO:0042474]; muscle organ morphogenesis [GO:0048644]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell fate specification [GO:0014036]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in regulation of gene expression [GO:0023019]; Wnt signaling pathway [GO:0016055]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005667; GO:0006357; GO:0007369; GO:0014036; GO:0016055; GO:0021904; GO:0023019; GO:0030178; GO:0030900; GO:0042474; GO:0048644; GO:0048704; GO:0061629; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" SDLDSDS 0.99483 -10.497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.65853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3787 0 0 0 10.7995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6392 P57772 SELB_HUMAN "Selenocysteine-specific elongation factor (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific)" EEFSEC SELB Homo sapiens (Human) selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414] GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0006414; GO:0035368; GO:0043021; GO:1990904 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049] FRGAPIIPVAAK 0.99483 -15.453 0 0 0 0 0 0 0 0 0 0 14.1474 0 0 0 0 0 0 10.6775 12.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9082 16.9949 16.8089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5253 0 0 14.7514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2348 0 11.4266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3018 14.5939 13.9486 0 0 0 0 0 Q2M1V0 ISX_HUMAN Intestine-specific homeobox (RAX-like homeobox) ISX RAXLX Homo sapiens (Human) enteric nervous system development [GO:0048484]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; enteric nervous system development [GO:0048484]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0048484; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" DQPQEGR 0.99483 -9.3979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2053 0 0 14.6023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5EBM4 ZN542_HUMAN Putative zinc finger protein 542 (Zinc finger protein 542 pseudogene) ZNF542P ZNF542 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AKTRTLFGK 0.99483 -15.433 0 13.8163 0 0 0 0 0 0 0 11.6791 0 13.3643 13.1907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.179 0 0 0 0 0 0 0 0 0 0 0 14.4916 0 0 0 0 0 10.8745 0 10.8461 0 0 0 0 0 0 0 0 9.82413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7033 0 0 0 0 11.0238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6817 0 0 0 10.1385 0 0 0 0 0 0 0 0 0 0 0 14.1009 0 0 0 0 0 0 0 0 Q5VZM2 RRAGB_HUMAN "Ras-related GTP-binding protein B, Rag B, RagB, EC 3.6.5.-" RRAGB Homo sapiens (Human) cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; regulation of TOR signaling [GO:0032006] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; guanyl ribonucleotide binding [GO:0032561]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine starvation [GO:1990253]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; regulation of TOR signaling [GO:0032006] GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0008104; GO:0009267; GO:0010506; GO:0032006; GO:0032008; GO:0032561; GO:0034198; GO:0051020; GO:0071230; GO:1904263; GO:1990131; GO:1990253 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; guanyl ribonucleotide binding [GO:0032561] HFEKLER 0.99483 -11.401 0 0 0 0 0 10.8615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4479 0 0 0 0 0 0 0 0 0 0 0 14.0235 0 0 0 0 0 13.6707 0 0 11.5287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2755 0 0 0 0 0 0 0 0 0 0 0 0 0 13.028 0 0 0 0 0 0 0 0 0 0 0 0 16.0757 0 0 0 0 0 0 12.5764 0 0 0 12.4272 12.3988 0 0 11.7954 0 0 0 0 12.6748 0 0 0 0 0 0 0 0 0 0 Q6IQ32 ADNP2_HUMAN "Activity-dependent neuroprotector homeobox protein 2, ADNP homeobox protein 2 (Zinc finger protein 508)" ADNP2 KIAA0863 ZNF508 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; regulation of gene expression [GO:0010468]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0010468; GO:0030182; GO:0030307; GO:0034599; GO:0046872; GO:0060548; GO:0071300 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]" CNFSNTLYYSMK 0.99483 -12.609 0 0 0 0 0 13.4284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1163 0 0 0 0 0 14.4251 14.5029 14.6083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5169 0 0 0 0 0 0 0 0 0 0 0 0 14.2846 0 11.867 0 0 0 0 0 0 14.4008 0 0 0 0 12.7635 0 0 0 0 0 12.149 0 13.6783 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6054 12.8828 0 0 0 11.3003 0 0 13.6348 0 0 0 0 0 0 12.5393 12.0469 0 12.1226 0 12.9115 0 12.2954 11.8977 0 0 13.9516 13.1038 12.2235 13.5633 0 0 0 0 13.7361 14.2519 13.2511 0 0 13.5059 0 0 0 0 0 0 0 0 0 12.0465 0 0 0 0 0 0 0 0 0 0 0 0 12.0347 12.5982 0 0 0 0 0 13.6356 Q86X45 DAA11_HUMAN "Dynein axonemal assembly factor 11, DNAAF11 (Leucine-rich repeat-containing protein 6) (Leucine-rich testis-specific protein) (Protein tilB homolog) (Testis-specific leucine-rich repeat protein)" DNAAF11 LRRC6 LRTP TSLRP Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; male gonad development [GO:0008584]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; protein localization to cilium [GO:0061512]; protein localization to motile cilium [GO:0120229]; regulation of protein binding [GO:0043393]; reproductive system development [GO:0061458] apical cytoplasm [GO:0090651]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; motile cilium [GO:0031514] apical cytoplasm [GO:0090651]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; male gonad development [GO:0008584]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; protein localization to cilium [GO:0061512]; protein localization to motile cilium [GO:0120229]; regulation of protein binding [GO:0043393]; reproductive system development [GO:0061458] GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005829; GO:0005929; GO:0008584; GO:0030317; GO:0031514; GO:0036158; GO:0036159; GO:0043393; GO:0044458; GO:0051649; GO:0060287; GO:0061458; GO:0061512; GO:0070286; GO:0090651; GO:0090660; GO:0120229; GO:0120293 DHLQAPDTEEHNTK 0.99483 -15.475 0 0 0 0 0 0 0 10.8825 0 0 0 9.32299 0 0 0 10.5534 0 0 0 0 0 0 0 0 0 0 0 12.4149 0 0 0 0 0 0 11.2128 0 0 0 0 0 0 0 0 0 0 0 10.4274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0931 0 0 12.0382 14.6359 15.0311 0 0 15.1163 0 0 14.7047 14.9567 0 12.7212 14.2849 0 0 14.253 0 14.5972 13.0687 0 0 0 0 0 0 0 0 12.76 11.6363 0 0 0 0 0 0 0 0 12.8324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9864 0 0 0 0 0 0 0 0 0 13.129 0 11.7449 0 14.8124 0 0 12.8311 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9417 13.016 0 0 11.7106 11.3647 0 0 0 0 0 0 0 0 0 Q8N7G0 PO5F2_HUMAN "POU domain, class 5, transcription factor 2 (Sperm 1 POU domain transcription factor, SPRM-1)" POU5F2 SPRM1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ELQQLAK 0.99483 -9.4084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7299 0 0 0 0 0 0 0 0 13.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3221 0 0 0 12.0051 11.7458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3876 15.0143 0 0 0 0 0 0 0 0 0 0 Q8WUU5 GATD1_HUMAN GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein) GATAD1 ODAG Homo sapiens (Human) "chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0005654; GO:0006325; GO:0006338; GO:0006355; GO:0008270; GO:0043565 sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] ESVANHL 0.99483 -12.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1683 0 0 0 0 0 0 0 0 0 0 0 0 13.4098 12.6273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5362 0 0 0 12.149 0 0 0 0 12.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0365 0 0 0 0 0 12.9406 0 0 0 0 13.5523 Q8WUX1 S38A5_HUMAN Sodium-coupled neutral amino acid transporter 5 (Solute carrier family 38 member 5) (System N transporter 2) SLC38A5 JM24 SN2 SNAT5 PP7194 Homo sapiens (Human) amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transmembrane transport [GO:1903713]; glutamine transport [GO:0006868]; glycine transport [GO:0015816]; L-alanine transmembrane transport [GO:1904557]; L-histidine transmembrane transport [GO:0089709]; L-serine transport [GO:0015825]; serine transport [GO:0032329]; transport across blood-brain barrier [GO:0150104] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; asparagine transmembrane transport [GO:1903713]; glutamine transport [GO:0006868]; glycine transport [GO:0015816]; L-alanine transmembrane transport [GO:1904557]; L-histidine transmembrane transport [GO:0089709]; L-serine transport [GO:0015825]; serine transport [GO:0032329]; transport across blood-brain barrier [GO:0150104] GO:0003333; GO:0005290; GO:0005886; GO:0005887; GO:0006865; GO:0006868; GO:0015171; GO:0015179; GO:0015182; GO:0015186; GO:0015187; GO:0015194; GO:0015816; GO:0015825; GO:0022858; GO:0022889; GO:0032329; GO:0089709; GO:0150104; GO:1903713; GO:1904557 alanine transmembrane transporter activity [GO:0022858]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-amino acid transmembrane transporter activity [GO:0015179]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-histidine transmembrane transporter activity [GO:0005290]; L-serine transmembrane transporter activity [GO:0015194]; serine transmembrane transporter activity [GO:0022889] AFGPAGK 0.99483 -9.4064 10.8478 0 0 0 0 0 0 0 0 0 0 0 0 11.3376 0 11.6635 12.4139 0 12.8906 14.2634 12.6705 13.125 0 11.5762 13.6175 13.8426 0 13.9026 0 13.7935 12.6084 12.6226 12.887 0 12.8513 0 12.1725 13.4115 0 12.6356 12.0671 0 14.5338 11.8723 13.9055 13.3677 0 13.7798 13.4877 0 0 12.8922 12.8031 0 13.2122 13.9073 0 13.9212 0 11.8788 0 0 12.1086 0 11.785 0 0 15.0189 0 0 0 0 0 0 0 0 0 0 14.5069 13.0393 15.6107 0 0 0 13.5296 0 0 0 0 0 10.9874 0 0 13.943 0 0 12.9458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2396 0 0 0 0 0 14.7972 0 14.2075 14.2587 0 0 0 12.5637 0 0 12.3059 0 12.1031 0 0 0 12.9717 0 0 0 0 0 13.6233 0 15.4023 0 0 0 14.8494 0 0 0 0 0 0 0 15.0141 0 14.5081 13.1362 12.8641 13.2653 14.0147 13.4967 11.9414 12.7771 14.3753 0 12.9593 14.1427 13.3308 12.0093 0 12.7122 0 12.6385 0 15.7498 11.9176 0 13.3334 0 0 Q96ST3 SIN3A_HUMAN Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) SIN3A Homo sapiens (Human) "activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]" chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; transcription repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]" GO:0000118; GO:0000122; GO:0000776; GO:0000785; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006476; GO:0007568; GO:0008104; GO:0010817; GO:0010971; GO:0016575; GO:0016580; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031453; GO:0042754; GO:0043066; GO:0043619; GO:0044877; GO:0045666; GO:0045892; GO:0045944; GO:0048511; GO:0051595; GO:0061629; GO:0071333; GO:0140416; GO:1900181; GO:1901675; GO:1902455; GO:1902459; GO:1903351; GO:2000678 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416] AELVQLVSPFLGKFPELFNWFK 0.99483 -15.462 0 0 0 0 0 0 0 0 0 0 0 0 13.5827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5471 0 0 16.8985 11.8207 0 0 0 10.5241 0 0 0 0 0 0 0 0 0 0 0 0 12.8272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1625 0 0 0 0 0 15.1177 0 0 0 0 0 0 0 0 13.9 0 13.4975 14.3102 0 15.1256 0 0 0 11.1685 0 0 0 0 0 0 0 0 13.6199 0 0 0 0 0 0 0 0 0 0 0 0 12.4838 11.7088 15.6747 0 0 0 0 0 0 0 0 0 12.2893 0 11.9484 0 0 0 0 0 0 0 12.792 0 12.0127 0 0 0 13.467 0 0 0 13.7187 14.4142 0 0 0 0 0 0 0 12.1843 0 0 0 0 0 13.1034 0 0 0 12.796 0 14.0795 13.1547 13.1635 0 13.2275 14.6296 14.1562 0 0 14.0308 0 0 0 0 Q9BRU9 UTP23_HUMAN rRNA-processing protein UTP23 homolog UTP23 C8orf53 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]" nucleolus [GO:0005730]; small-subunit processome [GO:0032040] "nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]" GO:0000480; GO:0003723; GO:0003730; GO:0005730; GO:0032040; GO:0048027; GO:0070181 mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181] GRIQLREQLPR 0.99483 -10.493 0 9.78611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3E2 SNX25_HUMAN Sorting nexin-25 SNX25 MSTP043 Homo sapiens (Human) negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801] endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231] endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; phosphatidylinositol binding [GO:0035091]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801] GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0035091; GO:0043231; GO:0060394 phosphatidylinositol binding [GO:0035091] EHFGMYMER 0.99483 -10.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1156 0 0 0 0 0 12.0778 0 0 0 11.3058 0 0 0 0 0 0 15.1893 12.4504 0 19.3488 0 0 14.7895 0 0 0 14.2761 0 11.9803 0 0 0 0 0 0 0 0 0 0 0 0 15.1233 0 0 0 0 0 12.4893 0 0 0 10.0704 0 0 12.6246 0 13.6487 0 0 0 13.9936 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0114 0 13.4091 0 0 0 0 0 0 Q9P1W9 PIM2_HUMAN "Serine/threonine-protein kinase pim-2, EC 2.7.11.1 (Pim-2h)" PIM2 Homo sapiens (Human) "apoptotic process [GO:0006915]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of mitotic cell cycle [GO:0007346]; response to virus [GO:0009615]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of mitotic cell cycle [GO:0007346]; response to virus [GO:0009615]" GO:0000082; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0006915; GO:0007346; GO:0008285; GO:0009615; GO:0010508; GO:0043066; GO:0043123; GO:0045893; GO:0046777; GO:0050821; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] CFFGQVVAAIQHCHSR 0.99483 -9.3938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9711 0 0 0 13.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7769 13.0521 Q9UPU3 SORC3_HUMAN VPS10 domain-containing receptor SorCS3 SORCS3 KIAA1059 Homo sapiens (Human) learning [GO:0007612]; memory [GO:0007613]; neuropeptide signaling pathway [GO:0007218]; regulation of long-term synaptic depression [GO:1900452] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; membrane [GO:0016020]; neuropeptide receptor activity [GO:0008188]; learning [GO:0007612]; memory [GO:0007613]; neuropeptide signaling pathway [GO:0007218]; regulation of long-term synaptic depression [GO:1900452] GO:0007218; GO:0007612; GO:0007613; GO:0008188; GO:0016020; GO:0016021; GO:0098978; GO:0099061; GO:1900452 neuropeptide receptor activity [GO:0008188] ASYYVSYRR 0.99483 -15.457 0 0 0 10.5892 0 0 0 0 0 0 0 0 13.315 0 11.8575 0 13.1498 0 0 0 0 0 0 0 12.5333 0 0 0 0 12.3717 0 0 12.6464 11.3782 13.5847 0 0 13.6088 13.0899 12.5919 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1184 0 0 0 0 0 0 0 0 0 0 13.2297 0 14.1577 0 13.3927 0 0 0 0 0 15.058 15.3409 0 13.4185 16.1541 16.6091 16.1194 15.6982 14.1455 15.5397 16.9878 11.9247 0 17.8191 17.8069 17.8963 18.1093 18.0309 18.4314 18.3587 18.8126 18.5443 13.0334 13.3648 15.7843 17.2027 15.6946 15.6974 17.8986 17.3903 17.0934 15.6096 0 15.0924 15.7383 17.008 14.7225 13.2696 18.8118 18.7385 14.6546 15.0199 14.0797 16.127 16.5206 17.2728 17.714 17.7902 17.8522 18.6976 16.6249 15.6977 14.1809 15.9907 17.0458 16.4463 16.2232 16.8316 14.8965 16.0662 13.7472 14.3108 13.9529 13.5719 17.1787 17.6012 14.492 13.0846 14.3836 14.9336 13.7996 15.1515 0 14.5012 0 0 17.1756 16.4591 15.6863 18.1485 18.6696 18.4978 0 15.3207 14.1584 0 11.6793 12.2462 15.1466 0 0 0 14.262 12.3665 12.4714 13.0566 0 13.4214 16.8025 15.4259 15.857 12.9596 16.3435 0 14.2321 0 Q9Y546 LRC42_HUMAN Leucine-rich repeat-containing protein 42 LRRC42 Homo sapiens (Human) EFDHSNCK 0.99483 -11.387 0 0 0 0 0 10.3822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2025 0 14.4426 0 0 0 0 12.3 0 0 0 0 0 11.329 0 0 0 0 13.2551 0 12.4553 0 0 0 0 11.1156 0 0 0 0 0 9.9737 0 0 0 0 0 0 0 0 0 0 0 11.5042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y666 S12A7_HUMAN Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4) SLC12A7 KCC4 Homo sapiens (Human) ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573] GO:0005886; GO:0005887; GO:0006811; GO:0006884; GO:0007268; GO:0008519; GO:0015379; GO:0019901; GO:0032991; GO:0045202; GO:0055064; GO:0055075; GO:0071333; GO:0140157; GO:1902476; GO:1990573 ammonium transmembrane transporter activity [GO:0008519]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901] HNTVLMAWPASWK 0.99483 -12.63 0 0 0 0 0 0 15.7759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7124 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2073 0 0 0 0 0 0 0 0 0 12.4496 0 0 0 12.3685 0 11.7986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5542 0 11.8869 12.5008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1574 A9UHW6 MI4GD_HUMAN "MIF4G domain-containing protein (SLBP-interacting protein 1, hSLIP1)" MIF4GD SLIP1 Homo sapiens (Human) cap-dependent translational initiation [GO:0002191]; regulation of translational initiation [GO:0006446] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone mRNA stem-loop binding complex [GO:0062073]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone mRNA stem-loop binding complex [GO:0062073]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; cap-dependent translational initiation [GO:0002191]; regulation of translational initiation [GO:0006446] GO:0002191; GO:0003723; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006446; GO:0008022; GO:0008494; GO:0042802; GO:0062073 identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; translation activator activity [GO:0008494] DGFLLPTGLSSLAQLLLLEIIEFRAAGWK 0.99484 -10.576 0 0 0 0 0 0 0 0 0 0 12.4531 0 0 0 0 0 0 0 0 0 0 11.0995 0 0 0 0 0 0 0 0 0 0 0 0 10.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5724 0 0 0 0 0 0 0 0 0 0 0 13.134 0 11.1226 0 0 0 0 12.7448 0 0 0 13.0883 0 0 0 0 0 12.8382 0 12.9656 0 12.5666 0 0 0 0 0 0 0 0 0 0 0 12.1848 0 0 0 13.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4167 0 0 0 0 0 0 11.6711 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0232 0 11.9715 0 0 0 0 0 0 0 0 0 0 0 0 0 O43399 TPD54_HUMAN "Tumor protein D54, hD54 (Tumor protein D52-like 2)" TPD52L2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; regulation of cell population proliferation [GO:0042127] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; regulation of cell population proliferation [GO:0042127] GO:0003723; GO:0005737; GO:0005975; GO:0042127; GO:0042803; GO:0048471 protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] KTQETLSQAGQK 0.99484 -8.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6511 0 0 0 0 0 0 0 0 0 0 0 0 12.1148 0 12.7955 12.5023 0 0 13.3366 0 0 0 0 0 0 0 12.7995 0 12.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76061 STC2_HUMAN "Stanniocalcin-2, STC-2 (Stanniocalcin-related protein, STC-related protein, STCRP)" STC2 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; regulation of hormone biosynthetic process [GO:0046885]; regulation of store-operated calcium entry [GO:2001256]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; hormone activity [GO:0005179]; protein homodimerization activity [GO:0042803]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; regulation of hormone biosynthetic process [GO:0046885]; regulation of store-operated calcium entry [GO:2001256]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280] GO:0005179; GO:0005615; GO:0005783; GO:0005788; GO:0005794; GO:0006874; GO:0006979; GO:0007566; GO:0010629; GO:0019899; GO:0020037; GO:0030968; GO:0033280; GO:0040015; GO:0042803; GO:0043434; GO:0046697; GO:0046885; GO:0048471; GO:0071456; GO:2001256 enzyme binding [GO:0019899]; heme binding [GO:0020037]; hormone activity [GO:0005179]; protein homodimerization activity [GO:0042803] CKAHALR 0.99484 -9.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0751 0 0 0 0 0 0 0 0 12.8537 0 0 0 0 0 0 0 10.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14317 HCLS1_HUMAN Hematopoietic lineage cell-specific protein (Hematopoietic cell-specific LYN substrate 1) (LckBP1) (p75) HCLS1 HS1 Homo sapiens (Human) "actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]" cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667] "cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; transcription regulator complex [GO:0005667]; actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SH3 domain binding [GO:0017124]; actin filament polymerization [GO:0030041]; cellular response to cytokine stimulus [GO:0071345]; erythrocyte differentiation [GO:0030218]; intracellular signal transduction [GO:0035556]; negative regulation of leukocyte apoptotic process [GO:2000107]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription, DNA-templated [GO:0006355]; response to hormone [GO:0009725]" GO:0000122; GO:0005634; GO:0005667; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0008284; GO:0009725; GO:0014068; GO:0017124; GO:0019901; GO:0030041; GO:0030218; GO:0030427; GO:0030833; GO:0030854; GO:0030864; GO:0033138; GO:0035556; GO:0042307; GO:0042531; GO:0045651; GO:0045944; GO:0050731; GO:0051015; GO:0051091; GO:0051897; GO:0061629; GO:0071345; GO:2000107; GO:2000251 actin filament binding [GO:0051015]; protein kinase binding [GO:0019901]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SH3 domain binding [GO:0017124] DYAKGFGGQYGIQK 0.99484 -9.4403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P83731 RL24_HUMAN 60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24) RPL24 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; exit from mitosis [GO:0010458]; optic nerve development [GO:0021554]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; exit from mitosis [GO:0010458]; optic nerve development [GO:0021554]; retina development in camera-type eye [GO:0060041]; retinal ganglion cell axon guidance [GO:0031290]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412] GO:0000027; GO:0002181; GO:0003723; GO:0003729; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0006412; GO:0010458; GO:0016020; GO:0021554; GO:0022625; GO:0022626; GO:0031290; GO:0042788; GO:0045202; GO:0045296; GO:0060041; GO:0070062 cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] IVKPVKVSAPR 0.99484 -8.902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8113 16.5862 0 0 0 0 0 0 0 0 0 0 14.9412 0 0 0 12.5266 0 0 0 0 0 0 0 0 0 12.91 0 0 0 0 0 13.4103 0 0 0 0 0 0 0 0 0 12.8483 0 0 0 13.1388 0 12.4731 12.8695 0 0 0 0 0 0 0 12.9429 13.2398 0 0 12.7124 0 12.7841 14.5842 12.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.368 12.9674 0 0 13.2375 0 0 0 0 15.3584 0 0 0 0 0 0 18.7557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9467 0 0 0 0 0 Q12884 SEPR_HUMAN "Prolyl endopeptidase FAP, EC 3.4.21.26 (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP, EC 3.4.14.5) (Fibroblast activation protein alpha, FAPalpha) (Gelatine degradation protease FAP, EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease, SIMP) (Surface-expressed protease, Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form, APCE, EC 3.4.14.5, EC 3.4.21.-, EC 3.4.21.26 ]" FAP Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of fibrinolysis [GO:0051917] apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; peptidase complex [GO:1905368]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; peptidase complex [GO:1905368]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of fibrinolysis [GO:0051917] GO:0001525; GO:0002020; GO:0004175; GO:0004252; GO:0005178; GO:0005615; GO:0005737; GO:0005886; GO:0005925; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0016021; GO:0030027; GO:0031258; GO:0032587; GO:0042802; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0051726; GO:0051917; GO:0060244; GO:0097325; GO:1900119; GO:1902362; GO:1903054; GO:1905368 dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] DDNLEHYK 0.99484 -12.709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7744 0 0 0 0 0 0 0 0 0 0 0 0 13.767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9021 0 0 0 0 11.5361 13.6124 0 14.0726 0 13.3651 13.5136 13.1812 0 0 12.5876 9.99774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6239 0 14.7515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4ZHG4 FNDC1_HUMAN Fibronectin type III domain-containing protein 1 (Activation-associated cDNA protein) (Expressed in synovial lining protein) FNDC1 FNDC2 KIAA1866 MEL4B3 Homo sapiens (Human) extracellular region [GO:0005576]; nuclear speck [GO:0016607] extracellular region [GO:0005576]; nuclear speck [GO:0016607] GO:0005576; GO:0016607 AFIVAMPTTSK 0.99484 -35.989 0 10.7525 0 0 0 0 0 0 11.613 0 10.7574 0 11.6151 0 0 0 0 0 0 0 11.7169 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9648 11.4229 0 0 0 0 0 0 0 0 10.4776 0 0 0 0 0 0 0 0 0 12.5582 12.2671 0 0 0 13.6628 0 0 0 0 15.1544 12.1637 0 0 12.635 12.26 0 0 0 12.5575 12.3219 12.5833 0 13.6381 0 0 0 0 16.9991 0 0 13.2431 0 0 0 14.3911 14.217 0 0 17.6972 12.6105 0 13.6772 14.651 14.3904 13.2287 14.1094 13.7773 14.2365 13.54 14.9886 14.4196 13.6279 11.4974 14.0117 0 15.2022 0 0 13.3826 14.6903 14.5633 18.6923 14.6139 13.6513 0 14.0244 13.3754 14.1013 15.5747 13.854 0 12.7077 0 13.7731 0 14.2479 0 0 0 0 13.6259 0 16.7133 14.1505 0 13.0037 0 11.1261 13.1532 11.8942 0 0 12.016 0 0 0 0 0 0 0 0 0 13.1193 0 0 13.7343 0 12.4001 13.0153 0 0 14.1654 0 13.8566 0 0 12.9355 12.597 14.6379 0 0 0 0 0 0 Q5HYJ1 TECRL_HUMAN "Trans-2,3-enoyl-CoA reductase-like, EC 1.3.1.- (Steroid 5-alpha-reductase 2-like 2 protein)" TECRL SRD5A2L2 Homo sapiens (Human) very long-chain fatty acid biosynthetic process [GO:0042761] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] "endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; very long-chain fatty acid biosynthetic process [GO:0042761]" GO:0005783; GO:0016021; GO:0016491; GO:0016627; GO:0042761 "oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]" ALLSQRATRFILK 0.99484 -35.946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.82847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.30895 0 0 0 0 0 0 13.3783 0 0 0 0 14.309 12.5064 0 0 0 0 12.4334 0 0 0 14.3672 0 0 0 0 0 0 0 0 0 0 13.0601 14.8557 15.4454 14.3045 15.4473 15.2063 0 0 14.6313 0 0 0 15.0299 0 0 0 13.3783 0 0 13.0402 14.5795 13.9137 13.4458 14.709 14.4894 15.0058 14.6447 0 0 0 14.6014 14.8508 0 13.2509 0 12.9155 14.545 0 12.4616 13.9726 0 12.3872 0 0 0 12.4713 0 12.3067 0 0 0 12.1437 0 0 0 14.1941 0 0 11.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6951 14.397 Q86SZ2 TPC6B_HUMAN "Trafficking protein particle complex subunit 6B, TRAPP complex subunit 6B" TRAPPC6B Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071] cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; trans-Golgi network [GO:0005802]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nervous system development [GO:0007399]; regulation of GTPase activity [GO:0043087]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022] GO:0005737; GO:0005783; GO:0005801; GO:0005802; GO:0005829; GO:0006888; GO:0006901; GO:0007399; GO:0030008; GO:0043087; GO:0099022; GO:1990071 DELDIMKFICK 0.99484 -10.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.283 0 0 12.8725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2809 0 0 0 0 0 0 12.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UD4 ZN329_HUMAN Zinc finger protein 329 ZNF329 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DGSYLTQHERTHTGEKPFECAECGK 0.99484 -5.3499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3902 0 0 0 0 0 0 13.8809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXM6 NRM_HUMAN Nurim (Nuclear envelope membrane protein) (Nuclear rim protein) NRM NRM29 UNQ555/PRO1112 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965] GO:0005635; GO:0005637; GO:0016020; GO:0016021; GO:0031965 APALLLIPAALASFILAFGTGVEFVRFTSLR 0.99484 -9.4411 0 0 0 0 0 0 0 0 12.6671 0 0 12.0268 12.6756 14.5214 12.8989 12.8246 0 11.9294 0 11.8686 13.4282 0 15.1651 0 0 14.4844 15.1263 0 14.7286 12.9181 0 13.495 0 13.8038 0 13.6945 13.5474 13.6164 14.8032 13.7333 0 0 0 14.3564 0 12.0025 0 13.7014 12.5471 0 11.8525 13.0485 0 13.6568 13.6752 12.8623 14.1484 13.8431 14.324 14.1185 0 0 13.3946 13.1659 12.2425 12.9892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8444 0 0 11.6737 0 0 0 13.8082 10.8548 12.5621 0 0 0 0 0 0 0 0 0 0 0 0 11.4587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3093 0 0 0 14.9456 0 11.2802 0 0 0 0 0 0 0 15.2169 0 14.0194 13.2177 0 15.3538 14.7811 13.9147 14.6332 15.3029 0 0 14.8772 0 0 0 0 0 13.7353 0 14.8295 0 0 Q8N565 MREG_HUMAN Melanoregulin (Dilute suppressor protein homolog) MREG DSU HDCGA21P Homo sapiens (Human) melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; minus-end-directed organelle transport along microtubule [GO:0072385]; phagosome maturation [GO:0090382] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; intrinsic component of organelle membrane [GO:0031300]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; protein-containing complex [GO:0032991] apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; intrinsic component of organelle membrane [GO:0031300]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; protein-containing complex [GO:0032991]; phosphatidylinositol binding [GO:0035091]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; minus-end-directed organelle transport along microtubule [GO:0072385]; phagosome maturation [GO:0090382] GO:0005765; GO:0016324; GO:0030318; GO:0030659; GO:0031300; GO:0031902; GO:0032400; GO:0032402; GO:0032991; GO:0033162; GO:0035091; GO:0042470; GO:0072385; GO:0090382 phosphatidylinositol binding [GO:0035091] KPGVPCLADGQK 0.99484 -11.414 0 0 0 0 0 0 0 0 0 13.2127 0 0 13.238 0 0 0 0 0 0 0 0 0 10.9577 0 0 0 0 0 0 0 0 12.8489 0 0 0 13.4035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7657 0 0 0 0 0 0 0 0 10.8966 13.8909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7329 0 0 0 0 0 0 0 0 11.2503 Q8NA75 DC4L2_HUMAN DDB1- and CUL4-associated factor 4-like protein 2 (WD repeat-containing protein 21C) DCAF4L2 WDR21C Homo sapiens (Human) Cul4-RING E3 ubiquitin ligase complex [GO:0080008] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] GO:0080008 VGLNAPSMLR 0.99484 -11.439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4609 0 0 0 0 0 0 0 11.56 0 0 0 0 0 0 0 0 0 0 11.8543 9.45088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8776 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8224 0 0 0 0 0 0 12.6776 0 0 0 0 0 11.9361 0 0 0 0 0 0 0 0 0 0 0 0 12.5593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96ST2 IWS1_HUMAN Protein IWS1 homolog (IWS1-like protein) IWS1 IWS1L Homo sapiens (Human) mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380] GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0010793; GO:0016973; GO:0050684; GO:0090239; GO:2001253 DLEQMPQRRR 0.99484 -11.431 0 0 0 0 0 0 0 0 0 0 11.4268 0 0 12.8889 0 0 0 0 0 12.216 0 0 0 0 0 0 0 0 0 0 0 14.102 0 0 0 0 0 12.9726 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3419 0 0 0 10.9301 0 0 0 0 0 0 0 0 0 0 14.4544 12.6152 0 13.5182 15.1973 0 14.8813 0 14.742 0 14.2062 0 0 13.5134 0 12.5595 0 11.5074 11.2909 0 0 0 0 12.5042 0 0 0 15.1999 14.9212 10.1302 0 0 0 13.975 0 14.5378 0 0 0 13.6014 12.7855 0 14.3072 0 14.4133 0 14.5882 11.44 0 0 15.1691 13.6477 14.139 12.792 14.3973 10.8579 0 0 0 0 0 13.9758 0 0 13.3362 13.2549 0 0 14.3276 0 0 0 0 13.1481 0 0 0 0 14.6529 0 13.4798 0 14.872 0 0 0 0 0 12.6594 13.9898 0 10.7781 0 0 0 0 0 0 0 0 0 0 0 0 11.7376 0 0 0 0 12.1043 0 0 0 14.5982 Q9H063 MAF1_HUMAN Repressor of RNA polymerase III transcription MAF1 homolog MAF1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480] GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0016479; GO:0016480; GO:0043231 RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006] PDYDFSTAR 0.99484 -5.3486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0018 10.7596 0 0 0 0 0 0 0 0 0 0 0 0 10.9047 0 0 0 9.88978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H5K3 SG196_HUMAN "Protein O-mannose kinase, POMK, EC 2.7.1.183 (Protein kinase-like protein SgK196) (Sugen kinase 196)" POMK SGK196 Homo sapiens (Human) brain development [GO:0007420]; carbohydrate phosphorylation [GO:0046835]; learning or memory [GO:0007611]; neuromuscular process [GO:0050905]; protein O-linked glycosylation [GO:0006493]; protein phosphorylation [GO:0006468]; sensory perception of pain [GO:0019233] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]; brain development [GO:0007420]; carbohydrate phosphorylation [GO:0046835]; learning or memory [GO:0007611]; neuromuscular process [GO:0050905]; protein O-linked glycosylation [GO:0006493]; protein phosphorylation [GO:0006468]; sensory perception of pain [GO:0019233]" GO:0004672; GO:0005524; GO:0005789; GO:0006468; GO:0006493; GO:0007420; GO:0007611; GO:0016021; GO:0016773; GO:0019200; GO:0019233; GO:0046835; GO:0050905 "ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]" EKQPQNSRR 0.99484 -5.3542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7786 11.7356 11.2607 0 0 0 0 0 0 0 0 12.0235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7C9 AAMDC_HUMAN Mth938 domain-containing protein (Adipogenesis associated Mth938 domain-containing protein) AAMDC C11orf67 PTD015 Homo sapiens (Human) positive regulation of fat cell differentiation [GO:0045600] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; positive regulation of fat cell differentiation [GO:0045600] GO:0005737; GO:0045600 GSNTTYK 0.99484 -8.3345 0 0 0 0 0 0 0 0 0 9.6749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1549 0 0 0 0 0 0 0 0 0 14.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5043 13.0116 0 0 0 0 13.434 13.4276 0 0 0 0 0 13.0984 0 0 0 0 0 0 13.2413 0 0 0 0 0 0 0 0 0 0 0 0 13.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4888 0 0 13.578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.141 Q9NP81 SYSM_HUMAN "Serine--tRNA ligase, mitochondrial, EC 6.1.1.11 (SerRSmt) (Seryl-tRNA synthetase, SerRS) (Seryl-tRNA(Ser/Sec) synthetase)" SARS2 SARSM Homo sapiens (Human) mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]; mitochondrial seryl-tRNA aminoacylation [GO:0070158]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434] GO:0000049; GO:0003723; GO:0004828; GO:0005524; GO:0005739; GO:0005759; GO:0006434; GO:0070158; GO:0097056 ATP binding [GO:0005524]; RNA binding [GO:0003723]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049] AETNTGQEPRGLYR 0.99484 -8.6009 0 0 0 0 0 0 11.4238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8597 12.2499 0 0 0 0 0 0 0 0 0 0 13.3814 0 0 0 0 0 0 0 0 12.1158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZC9 SMAL1_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1, EC 3.6.4.- (HepA-related protein, hHARP) (Sucrose nonfermenting protein 2-like 1)" SMARCAL1 HARP Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; t-circle formation [GO:0090656] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; t-circle formation [GO:0090656] GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006303; GO:0006357; GO:0006974; GO:0016787; GO:0031297; GO:0035861; GO:0036310; GO:0043596; GO:0048478; GO:0090656; GO:0140658 ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787] CVRNGDR 0.99484 -5.3419 0 0 0 0 0 0 0 0 14.3536 13.8075 13.4808 13.3711 0 13.3989 0 0 13.0045 0 13.7394 0 0 0 0 0 13.5353 0 13.163 13.3247 0 13.3024 0 0 0 0 0 11.2045 0 0 13.4359 0 14.126 13.4756 12.7844 14.0283 0 0 13.5068 13.3115 12.956 0 13.5041 0 0 0 12.8372 0 14.5393 0 0 0 0 0 0 0 0 0 0 12.1334 0 0 0 10.715 0 0 0 0 0 15.3107 0 14.3828 0 0 13.0373 0 0 0 13.4502 13.1143 0 0 12.6078 13.638 12.4744 0 0 0 0 15.5492 0 0 12.959 12.8092 0 0 0 0 0 0 0 0 14.4252 0 11.9863 0 0 0 12.544 15.6717 0 0 0 0 0 0 0 0 0 11.7969 13.1814 0 0 0 0 0 0 0 0 12.5989 0 0 0 0 0 0 0 0 0 14.6008 0 0 0 0 0 0 12.0199 0 11.855 0 0 14.121 14.5057 14.5151 0 0 15.2704 0 14.5954 15.9166 15.4177 15.5248 0 0 0 0 0 0 0 14.5091 0 0 Q9UKT9 IKZF3_HUMAN Zinc finger protein Aiolos (Ikaros family zinc finger protein 3) IKZF3 ZNFN1A3 Homo sapiens (Human) B cell differentiation [GO:0030183]; mesoderm development [GO:0007498]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of B cell proliferation [GO:0030888]; regulation of lymphocyte differentiation [GO:0045619]; regulation of transcription by RNA polymerase II [GO:0006357]; response to bacterium [GO:0009617]; T cell differentiation [GO:0030217] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; B cell differentiation [GO:0030183]; mesoderm development [GO:0007498]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of B cell proliferation [GO:0030888]; regulation of lymphocyte differentiation [GO:0045619]; regulation of transcription by RNA polymerase II [GO:0006357]; response to bacterium [GO:0009617]; T cell differentiation [GO:0030217]" GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007498; GO:0009617; GO:0030183; GO:0030217; GO:0030888; GO:0042802; GO:0042803; GO:0042826; GO:0042981; GO:0043565; GO:0045577; GO:0045619; GO:0046872; GO:0046982; GO:1990841 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" CDHCRVLFLDYVMFTIHMGCHGFRDPFECNMCGYR 0.99484 -11.454 0 0 0 0 0 0 0 11.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5626 0 0 0 0 12.5064 14.1815 14.6813 0 13.567 0 0 0 0 0 0 0 0 0 0 0 11.7503 0 0 0 0 0 0 14.7384 15.7425 15.9805 0 0 0 0 14.9292 14.5179 14.5987 14.7849 13.4981 14.3916 0 0 0 0 13.8132 13.8617 0 13.7849 14.2306 0 0 0 14.5268 0 0 0 13.3985 15.7312 0 0 0 0 0 13.9519 0 14.4573 14.9904 0 0 0 0 0 12.9182 0 0 0 0 0 14.1898 0 11.8216 0 14.201 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1722 0 0 0 0 0 0 0 0 0 0 0 Q4KMQ1 TPRN_HUMAN Taperin TPRN C9orf75 Homo sapiens (Human) auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] stereocilium [GO:0032420]; stereocilium base [GO:0120044] stereocilium [GO:0032420]; stereocilium base [GO:0120044]; phosphatase binding [GO:0019902]; auditory receptor cell stereocilium organization [GO:0060088]; sensory perception of sound [GO:0007605]; stereocilium maintenance [GO:0120045] GO:0007605; GO:0019902; GO:0032420; GO:0060088; GO:0120044; GO:0120045 phosphatase binding [GO:0019902] GGGAAGAR 0.99485 -5.3783 0 0 0 0 0 0 0 0 0 14.1846 0 0 13.2088 0 13.515 14.118 0 0 0 13.1407 0 0 0 12.0763 0 13.435 14.188 13.3376 0 13.2217 0 13.3983 13.4054 0 0 0 0 13.2768 13.1559 0 0 13.3737 0 13.3621 0 0 13.2622 0 0 12.4353 13.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9498 14.5764 13.6108 12.4646 0 0 11.9592 0 0 0 0 0 0 13.6458 0 14.0498 0 17.4833 17.4181 0 0 16.0417 16.6014 0 13.7345 19.3316 19.4142 15.1016 15.2009 0 16.4226 15.4354 16.5051 0 0 0 13.9079 0 0 13.8916 0 16.4123 16.0099 0 0 0 0 0 16.1966 0 0 16.0319 0 0 0 15.8642 0 15.6714 0 0 0 14.0276 16.5002 13.6932 0 0 13.5342 0 0 0 15.969 15.9481 0 0 0 0 0 0 18.7142 0 0 14.8406 0 0 0 0 0 0 0 14.0535 0 14.6101 0 14.6486 14.4931 0 0 0 0 0 14.7333 0 0 15.1625 0 13.0123 15.359 0 0 14.5969 0 14.6402 15.5902 0 D6RGH6 MCIN_HUMAN "Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein, McIdas protein) (Protein Idas)" MCIDAS IDAS MCI MCIN Homo sapiens (Human) cell cycle [GO:0007049]; centriole assembly [GO:0098534]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cilium assembly [GO:1902017]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346] nuclear body [GO:0016604]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; centriole assembly [GO:0098534]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cilium assembly [GO:1902017]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of mitotic cell cycle [GO:0007346] GO:0003713; GO:0005634; GO:0007049; GO:0007346; GO:0008156; GO:0016604; GO:0030174; GO:0042802; GO:0044458; GO:0045786; GO:0045944; GO:0060271; GO:0098534; GO:1902017; GO:1903251 identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713] PGKPERK 0.99485 -10.6 0 0 0 13.8497 0 0 0 0 12.4177 12.3122 12.7181 0 12.3842 0 0 0 12.8912 0 0 0 17.0034 12.4894 0 12.7773 0 12.6652 12.6472 0 12.6152 12.7242 0 12.863 12.8525 0 12.7803 12.6249 0 12.2482 0 12.1153 12.6284 0 0 0 12.9448 0 0 0 0 0 0 0 0 12.632 12.3925 11.9926 11.9106 0 0 0 0 0 0 0 0 0 0 10.6876 0 0 0 12.7207 0 0 14.4792 14.3393 0 0 0 0 0 13.0058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9447 0 0 0 14.8534 0 0 0 0 19.6141 19.2263 0 0 0 0 0 0 0 19.2898 0 0 0 0 0 0 0 0 18.8317 19.1938 15.1329 0 0 0 0 0 0 0 0 0 0 14.7663 0 19.2393 0 0 0 14.9066 0 0 0 14.319 0 14.3924 12.5476 0 14.4199 0 14.1539 0 0 0 0 14.2998 14.2028 0 0 0 19.4721 0 0 0 0 0 Q04912 RON_HUMAN "Macrophage-stimulating protein receptor, MSP receptor, EC 2.7.10.1 (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain ]" MST1R PTK8 RON Homo sapiens (Human) cell migration [GO:0016477]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773] basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein kinase B signaling [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0005887; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009925; GO:0009986; GO:0016477; GO:0019899; GO:0033674; GO:0043235; GO:0043406; GO:0045087; GO:0051897 ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] AWHFMGCGWCGNMCGQQK 0.99485 -5.3771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5564 0 0 12.7432 0 0 0 0 0 0 0 10.4813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.60058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8282 0 0 0 0 0 0 0 0 0 0 0 13.4662 0 0 0 0 0 Q14188 TFDP2_HUMAN Transcription factor Dp-2 (E2F dimerization partner 2) TFDP2 DP2 Homo sapiens (Human) "cell cycle [GO:0007049]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; heart development [GO:0007507]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007049; GO:0007507; GO:0008134; GO:0019904; GO:0045892; GO:0045944; GO:0051726; GO:0072686; GO:0090575 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]" AQLQELLLQQIAFKNLVQR 0.99485 -5.368 0 0 0 0 0 0 0 0 0 13.4599 0 0 13.2589 0 12.9952 0 0 0 13.2922 0 0 0 12.6326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1807 0 0 12.9641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7525 13.5071 0 0 0 0 13.3613 11.6882 0 0 0 12.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7401 12.2213 0 0 0 0 0 0 0 0 0 12.8303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4206 A6NC05 YD286_HUMAN Glutaredoxin-like protein C5orf63 C5orf63 Homo sapiens (Human) DPCPLCDEAK 0.99486 -12.859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NMK7 CPS4L_HUMAN Putative cleavage and polyadenylation specificity factor subunit 4-like protein CPSF4L Homo sapiens (Human) pre-mRNA cleavage required for polyadenylation [GO:0098789] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; pre-mRNA cleavage required for polyadenylation [GO:0098789] GO:0003723; GO:0005847; GO:0046872; GO:0098789 metal ion binding [GO:0046872]; RNA binding [GO:0003723] EFKLLPGSK 0.99486 -10.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8113 0 0 0 0 0 0 12.985 12.6085 0 0 0 0 14.5018 0 0 0 0 0 0 12.5974 0 0 13.0516 0 0 0 14.6719 0 0 0 0 0 0 0 0 14.1236 12.6796 13.7819 0 0 11.1374 0 0 0 0 0 0 12.5083 13.1828 13.7597 0 13.2849 0 13.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00482 NR5A2_HUMAN "Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor, hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1, LRH-1)" NR5A2 B1F CPF FTF Homo sapiens (Human) "acinar cell differentiation [GO:0090425]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; embryo development ending in birth or egg hatching [GO:0009792]; homeostatic process [GO:0042592]; hormone-mediated signaling pathway [GO:0009755]; pancreas morphogenesis [GO:0061113]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; tissue development [GO:0009888]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]; acinar cell differentiation [GO:0090425]; bile acid metabolic process [GO:0008206]; calcineurin-mediated signaling [GO:0097720]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol homeostasis [GO:0042632]; embryo development ending in birth or egg hatching [GO:0009792]; homeostatic process [GO:0042592]; hormone-mediated signaling pathway [GO:0009755]; pancreas morphogenesis [GO:0061113]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; tissue development [GO:0009888]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005543; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0008206; GO:0008270; GO:0009755; GO:0009792; GO:0009888; GO:0042127; GO:0042592; GO:0042632; GO:0043565; GO:0045070; GO:0045893; GO:0045944; GO:0061113; GO:0090425; GO:0090575; GO:0097720; GO:1990830; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; phospholipid binding [GO:0005543]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]" ALIRANGLK 0.99486 -10.374 0 0 0 0 0 0 0 0 0 0 0 0 12.891 0 0 0 0 0 0 0 0 0 12.8947 0 0 0 0 0 0 0 12.2144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7962 0 0 0 0 0 0 0 0 11.4069 0 0 0 13.7909 0 0 0 0 0 0 0 14.8607 0 0 0 0 0 0 10.0243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15523 DDX3Y_HUMAN "ATP-dependent RNA helicase DDX3Y, EC 3.6.4.13 (DEAD box protein 3, Y-chromosomal)" DDX3Y DBY Homo sapiens (Human) cell differentiation [GO:0030154]; gamete generation [GO:0007276] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186] cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cell differentiation [GO:0030154]; gamete generation [GO:0007276] GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0007276; GO:0016020; GO:0016887; GO:0030154; GO:0043186 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] EEALHQFRSGK 0.99486 -15.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0763 0 0 0 13.4741 0 0 0 13.5406 13.2373 0 0 0 14.0722 0 14.0735 14.2617 0 0 14.1562 0 0 0 0 12.9929 0 0 0 0 0 0 15.1662 10.47 0 0 0 0 0 0 12.8646 0 0 0 0 11.6464 0 0 0 0 0 10.2538 12.943 13.4503 0 12.7833 0 0 0 0 0 12.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2599 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75410 TACC1_HUMAN Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1) TACC1 KIAA1103 Homo sapiens (Human) cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] GO:0000226; GO:0005634; GO:0005737; GO:0005815; GO:0005829; GO:0007052; GO:0008283; GO:0016020; GO:0016922; GO:0021987; GO:0030331; GO:0030374; GO:0030496; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301 nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975] ALPRKLGR 0.99486 -12.855 11.6695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5164 19.4703 19.3448 19.584 0 19.5359 18.149 18.9542 13.1015 0 0 15.2526 14.634 0 19.3317 0 0 0 0 0 0 0 13.5969 13.5521 0 11.8517 0 0 0 0 0 13.5517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1756 0 0 12.0898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2759 0 0 0 0 12.7942 13.0922 0 0 11.9929 0 12.5615 0 0 16.2608 12.193 12.5943 0 0 0 0 0 0 0 0 0 0 0 O75694 NU155_HUMAN Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155) NUP155 KIAA0791 Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611] cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972] GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0035196; GO:0036228; GO:0044611; GO:0086014 structural constituent of nuclear pore [GO:0017056] DPFWNRMK 0.99486 -10.37 0 0 0 0 0 9.71215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9107 12.951 19.1002 0 0 14.0444 13.5845 13.8465 14.8861 0 0 0 14.0312 0 18.2679 11.3627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7685 0 11.9308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2003 0 0 0 0 0 0 0 0 0 15.65 13.0017 13.0548 0 0 0 0 0 0 16.2394 0 0 0 0 0 0 0 0 0 0 0 0 13.2607 0 0 19.1188 0 0 0 0 0 0 13.453 0 O75884 RBBP9_HUMAN "Serine hydrolase RBBP9, EC 3.-.-.- (B5T-overexpressed gene protein, Protein BOG) (Retinoblastoma-binding protein 10, RBBP-10) (Retinoblastoma-binding protein 9, RBBP-9)" RBBP9 BOG RBBP10 Homo sapiens (Human) positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; response to nematode [GO:0009624]; type II pneumocyte differentiation [GO:0060510] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; response to nematode [GO:0009624]; type II pneumocyte differentiation [GO:0060510] GO:0005654; GO:0009624; GO:0010628; GO:0016787; GO:0042127; GO:0060510 hydrolase activity [GO:0016787] LETKLHK 0.99486 -8.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2261 0 15.9942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95861 BPNT1_HUMAN "3'(2'),5'-bisphosphate nucleotidase 1, EC 3.1.3.7 (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase, PIP)" BPNT1 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854] cytosol [GO:0005829] "cytosol [GO:0005829]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; inositol phosphate dephosphorylation [GO:0046855]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]" GO:0005829; GO:0006139; GO:0007399; GO:0008441; GO:0046854; GO:0046855; GO:0046872; GO:0050427 "3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]" HIITTTR 0.99486 -13.708 0 0 10.3358 10.3199 0 0 0 0 0 0 0 16.2725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4081 15.6492 12.3388 0 0 11.5651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16109 LYAM3_HUMAN "P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140, GMP-140) (Leukocyte-endothelial cell adhesion molecule 3, LECAM3) (Platelet activation dependent granule-external membrane protein, PADGEM) (CD antigen CD62P)" SELP GMRP GRMP Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell adhesion [GO:0007155]; defense response to Gram-negative bacterium [GO:0050829]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet activation [GO:0010572]; regulation of integrin activation [GO:0033623]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; platelet dense granule membrane [GO:0031088] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; platelet dense granule membrane [GO:0031088]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; fucose binding [GO:0042806]; glycosphingolipid binding [GO:0043208]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; oligosaccharide binding [GO:0070492]; sialic acid binding [GO:0033691]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell adhesion [GO:0007155]; defense response to Gram-negative bacterium [GO:0050829]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of platelet activation [GO:0010572]; regulation of integrin activation [GO:0033623]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496] GO:0001530; GO:0002687; GO:0005509; GO:0005615; GO:0005886; GO:0005887; GO:0006954; GO:0007155; GO:0007157; GO:0007159; GO:0008201; GO:0009897; GO:0010572; GO:0014068; GO:0016339; GO:0031088; GO:0031092; GO:0032496; GO:0033623; GO:0033691; GO:0034097; GO:0035584; GO:0042806; GO:0043208; GO:0048306; GO:0050829; GO:0050901; GO:0070492; GO:1903238 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; fucose binding [GO:0042806]; glycosphingolipid binding [GO:0043208]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; oligosaccharide binding [GO:0070492]; sialic acid binding [GO:0033691] FECQPGYR 0.99486 -13.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.661 0 0 0 0 0 0 0 0 0 0 0 11.0613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8404 17.1059 13.097 12.6584 0 0 0 12.7826 0 0 0 0 0 0 0 15.3008 0 0 15.0595 0 0 0 0 0 13.5824 0 16.2273 0 0 0 12.0203 0 11.3076 0 0 11.4386 0 0 0 0 0 0 11.79 0 0 0 0 12.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2596 0 0 14.8256 0 0 10.4428 0 0 0 0 0 0 13.1923 0 0 0 0 0 0 0 0 13.145 0 0 0 0 P19224 UD16_HUMAN "UDP-glucuronosyltransferase 1-6, UDPGT 1-6, UGT1*6, UGT1-06, UGT1.6, EC 2.4.1.17 (Phenol-metabolizing UDP-glucuronosyltransferase) (UDP-glucuronosyltransferase 1-F, UGT-1F, UGT1F) (UDP-glucuronosyltransferase 1A6)" UGT1A6 GNT1 UGT1 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic metabolic process [GO:0006805] GO:0001889; GO:0005783; GO:0005789; GO:0006805; GO:0015020; GO:0016021; GO:0019899; GO:0042803; GO:0043231; GO:0045922; GO:0046982; GO:0052695; GO:1904224; GO:2001030 enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] CYTKFSDHMTFSQRVANFLVNLLEPYLFYCLFSK 0.99486 -8.9736 0 0 0 0 0 0 0 11.3953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9228 13.4357 11.6331 0 0 0 0 0 10.5844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9981 0 0 0 11.6614 14.8532 0 11.6453 0 0 0 0 0 0 0 0 0 14.5996 0 0 15.4325 0 0 0 0 16.8984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0027 0 0 0 0 0 0 0 0 0 12.1358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.365 0 0 0 14.87 0 0 0 0 0 0 15.1218 Q15257 PTPA_HUMAN "Serine/threonine-protein phosphatase 2A activator, EC 5.2.1.8 (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator, PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')" PTPA PPP2R4 Homo sapiens (Human) mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666] ATPase complex [GO:1904949]; calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159] ATPase complex [GO:1904949]; calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666] GO:0000159; GO:0003755; GO:0005102; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0008160; GO:0019888; GO:0032515; GO:0032516; GO:0034704; GO:0035307; GO:0035308; GO:0042803; GO:0043065; GO:0043666; GO:0051721; GO:0070062; GO:1904949 ATP binding [GO:0005524]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102] VNQGLIR 0.99486 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16531 DDB1_HUMAN "DNA damage-binding protein 1 (DDB p127 subunit) (DNA damage-binding protein a, DDBa) (Damage-specific DNA-binding protein 1) (HBV X-associated protein 1, XAP-1) (UV-damaged DNA-binding factor) (UV-damaged DNA-binding protein 1, UV-DDB 1) (XPE-binding factor, XPE-BF) (Xeroderma pigmentosum group E-complementing protein, XPCe)" DDB1 XAP1 Homo sapiens (Human) apoptotic process [GO:0006915]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; histone H2A monoubiquitination [GO:0035518]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055] "chromosome, telomeric region [GO:0000781]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]" "chromosome, telomeric region [GO:0000781]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]; apoptotic process [GO:0006915]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; histone H2A monoubiquitination [GO:0035518]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; nucleotide-excision repair [GO:0006289]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; viral release from host cell [GO:0019076]; Wnt signaling pathway [GO:0016055]" GO:0000781; GO:0003677; GO:0003684; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006511; GO:0006915; GO:0006974; GO:0010498; GO:0016055; GO:0016567; GO:0019076; GO:0030674; GO:0031464; GO:0031465; GO:0032991; GO:0034644; GO:0035234; GO:0035518; GO:0035861; GO:0042752; GO:0043066; GO:0043161; GO:0044877; GO:0045070; GO:0045722; GO:0045732; GO:0046726; GO:0048511; GO:0051093; GO:0051702; GO:0070062; GO:0070914; GO:0071987; GO:0080008; GO:0097602; GO:1901990; GO:2000242 cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987] EKEFNKGPWK 0.99486 -13.747 11.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4391 0 0 12.2827 0 0 0 0 12.5585 0 0 0 0 13.9197 0 0 12.6888 14.298 0 10.5981 0 0 0 0 0 0 0 10.6094 0 0 12.2541 0 11.0598 10.3567 0 12.1165 0 0 11.7396 0 11.3101 13.8894 0 0 12.7406 12.4765 12.0116 12.8156 0 0 0 0 0 0 11.7171 0 0 0 0 0 11.9501 14.7807 0 14.6844 11.8165 12.6895 0 12.323 11.5184 0 0 0 0 0 0 0 0 12.5744 0 0 0 0 0 0 0 0 14.9412 0 0 0 0 10.1799 0 0 0 0 0 0 0 13.4463 0 0 0 0 0 0 Q16568 CART_HUMAN Cocaine- and amphetamine-regulated transcript protein [Cleaved into: CART(1-39); CART(42-89) ] CARTPT CART Homo sapiens (Human) adult feeding behavior [GO:0008343]; cell-cell signaling [GO:0007267]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; circadian regulation of gene expression [GO:0032922]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of appetite [GO:0032099]; negative regulation of bone resorption [GO:0045779]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of osteoclast differentiation [GO:0045671]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; positive regulation of epinephrine secretion [GO:0032812]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; signal transduction [GO:0007165]; somatostatin secretion [GO:0070253] extracellular space [GO:0005615]; secretory granule [GO:0030141]; synapse [GO:0045202] extracellular space [GO:0005615]; secretory granule [GO:0030141]; synapse [GO:0045202]; neuropeptide hormone activity [GO:0005184]; adult feeding behavior [GO:0008343]; cell-cell signaling [GO:0007267]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; circadian regulation of gene expression [GO:0032922]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of appetite [GO:0032099]; negative regulation of bone resorption [GO:0045779]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of osteoclast differentiation [GO:0045671]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; positive regulation of epinephrine secretion [GO:0032812]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; signal transduction [GO:0007165]; somatostatin secretion [GO:0070253] GO:0001678; GO:0005184; GO:0005615; GO:0007165; GO:0007186; GO:0007218; GO:0007267; GO:0007268; GO:0008343; GO:0009267; GO:0030141; GO:0032099; GO:0032812; GO:0032922; GO:0043410; GO:0045202; GO:0045671; GO:0045777; GO:0045779; GO:0045860; GO:0050796; GO:0051971; GO:0070093; GO:0070253 neuropeptide hormone activity [GO:0005184] ELIEALQEVLKKLK 0.99486 -5.4153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69699 0 0 0 0 0 0 0 0 0 0 0 0 11.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3413 0 0 0 11.3011 0 0 0 12.2992 11.8895 0 11.4475 0 0 0 0 0 15.1793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4837 0 0 0 0 0 0 0 12.7342 0 0 0 0 12.0527 0 0 0 0 0 0 0 0 11.0361 0 0 0 0 0 0 0 0 0 0 0 14.6357 0 0 0 0 0 0 0 0 0 12.4807 0 0 0 11.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VTD9 GFI1B_HUMAN Zinc finger protein Gfi-1b (Growth factor independent protein 1B) (Potential regulator of CDKN1A translocated in CML) GFI1B Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667] "nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; chromatin organization [GO:0006325]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005667; GO:0005886; GO:0006325; GO:0006357; GO:0016363; GO:0046872; GO:0061629; GO:1903706; GO:1990837; GO:2000134 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" ESQHNLK 0.99486 -8.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3747 0 0 0 0 0 0 0 0 0 0 15.2383 0 0 0 0 15.4998 0 0 0 0 0 0 14.5057 13.1115 0 0 0 0 0 0 0 0 0 15.5224 0 14.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9623 0 0 0 0 0 12.1711 0 0 0 0 0 0 0 0 0 0 10.8084 0 0 0 0 0 0 11.954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0377 0 0 0 0 0 0 Q6ZU80 CE128_HUMAN "Centrosomal protein of 128 kDa, Cep128" CEP128 C14orf145 C14orf61 Homo sapiens (Human) protein localization [GO:0008104] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922] centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922]; protein localization [GO:0008104] GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0008104; GO:0120103 ALEELTEKLNEAQKQEVVSDR 0.99486 -8.7011 0 0 0 0 0 0 0 11.4105 0 0 0 0 12.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5088 0 13.7433 12.5992 0 14.2745 0 10.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6004 0 0 0 0 0 0 0 0 0 13.1619 15.184 0 13.9762 12.5507 0 0 0 14.5715 0 0 13.0847 0 0 0 0 0 0 18.2957 0 0 0 0 14.0537 0 0 0 0 14.3145 0 0 0 14.2332 13.4344 0 0 11.985 14.969 0 0 0 0 0 0 0 0 14.7229 0 0 11.2757 0 0 0 0 0 0 0 0 0 13.3127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8529 0 13.2936 0 0 11.9374 0 12.9923 0 0 0 0 0 0 0 0 0 11.2515 0 0 0 0 0 0 0 0 Q92917 GPKOW_HUMAN G-patch domain and KOW motifs-containing protein (G-patch domain-containing protein 5) (Protein MOS2 homolog) (Protein T54) GPKOW GPATC5 GPATCH5 T54 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681 RNA binding [GO:0003723] ARSRALVQLPR 0.99486 -8.9923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9558 0 12.846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0918 0 0 0 0 0 11.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8167 0 0 Q96B26 EXOS8_HUMAN "Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2, OIP-2) (Ribosomal RNA-processing protein 43) (p9)" EXOSC8 OIP2 RRP43 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]" GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0016075; GO:0034427; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0043928; GO:0071028; GO:0071035; GO:0071038; GO:0071042; GO:0101019 identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925] AVTRHKEVK 0.99486 -8.9697 11.2573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6342 0 0 12.1437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8601 0 0 0 0 0 0 0 0 12.3726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96C28 ZN707_HUMAN Zinc finger protein 707 ZNF707 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] DMAQEPVTFRDVAIYFSREEWACLEPSQR 0.99486 -8.9931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.043 0 0 12.5965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7986 0 0 0 0 0 10.1038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JM7 LMBL3_HUMAN "Lethal(3)malignant brain tumor-like protein 3, H-l(3)mbt-like protein 3, L(3)mbt-like protein 3, L3mbt-like 3 (MBT-1)" L3MBTL3 KIAA1798 MBT1 Homo sapiens (Human) "chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]" GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008270; GO:0030225; GO:0030851; GO:0042393; GO:0042802; GO:0043249; GO:0045892; GO:0090308 chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270] DQHADDVKEDFEER 0.99486 -13.711 0 0 0 0 0 0 0 0 12.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0883 0 0 0 11.0347 0 0 0 11.7404 0 0 0 0 0 12.0196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2771 12.7404 14.8131 0 0 0 12.3818 13.7737 0 13.3177 12.7376 0 13.513 13.3194 12.6245 0 12.6453 0 12.8259 0 0 0 13.6855 0 13.645 0 12.0926 12.8365 12.8144 0 0 0 0 15.2134 12.6638 0 0 0 0 0 0 12.7576 0 0 0 0 12.8782 13.9004 0 13.2893 13.7608 13.7156 11.979 15.6464 0 0 0 0 0 0 0 0 12.3364 0 0 0 12.9923 13.1004 0 13.5693 13.4168 0 12.0378 0 13.8672 0 0 12.9556 0 0 13.241 0 0 11.7435 12.0175 0 12.7583 0 0 0 0 0 0 0 0 12.1997 0 0 0 0 0 0 0 0 0 14.6984 14.2744 0 0 0 13.2325 0 0 0 Q9BQB6 VKOR1_HUMAN "Vitamin K epoxide reductase complex subunit 1, EC 1.17.4.4 (Vitamin K1 2,3-epoxide reductase subunit 1)" VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351 Homo sapiens (Human) blood coagulation [GO:0007596]; bone development [GO:0060348]; peptidyl-glutamic acid carboxylation [GO:0017187]; positive regulation of coagulation [GO:0050820]; regulation of blood coagulation [GO:0030193]; response to antibiotic [GO:0046677]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-insensitive) activity [GO:0047058]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057]; blood coagulation [GO:0007596]; bone development [GO:0060348]; peptidyl-glutamic acid carboxylation [GO:0017187]; positive regulation of coagulation [GO:0050820]; regulation of blood coagulation [GO:0030193]; response to antibiotic [GO:0046677]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805] GO:0005783; GO:0005789; GO:0006805; GO:0007596; GO:0010243; GO:0014070; GO:0016021; GO:0017187; GO:0030193; GO:0042373; GO:0046677; GO:0047057; GO:0047058; GO:0048038; GO:0050820; GO:0060348 quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-insensitive) activity [GO:0047058]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057] GSTWGSPGWVR 0.99486 -8.9649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2639 12.436 0 0 0 0 0 0 0 0 12.0463 0 0 0 0 0 0 0 0 0 0 0 13.2821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.603 0 0 0 0 Q9BXC0 HCAR1_HUMAN Hydroxycarboxylic acid receptor 1 (G-protein coupled receptor 104) (G-protein coupled receptor 81) HCAR1 GPR104 GPR81 HCA1 FKSG80 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of lipid catabolic process [GO:0050995] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of lipid catabolic process [GO:0050995] GO:0004930; GO:0005886; GO:0007186; GO:0016021; GO:0050995 G protein-coupled receptor activity [GO:0004930] AGSIVFLTVVAADRYFKVVHPHHAVNTISTR 0.99486 -12.857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.394 0 0 0 11.3352 0 10.1034 11.6217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.623 0 0 0 0 12.4657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93583 0 0 0 0 12.2859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7245 0 0 0 0 0 0 0 0 0 0 0 0 12.6542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZM5 YIPF3_HUMAN "Protein YIPF3 (Killer lineage protein 1) (Natural killer cell-specific antigen KLIP1) (YIP1 family member 3) [Cleaved into: Protein YIPF3, 36 kDa form III ]" YIPF3 C6orf109 KLIP1 Homo sapiens (Human) cell differentiation [GO:0030154] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; cell differentiation [GO:0030154] GO:0005794; GO:0005886; GO:0016021; GO:0030133; GO:0030154; GO:0043231 TSDTIIR 0.99486 -10.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX00 TM160_HUMAN Transmembrane protein 160 TMEM160 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FRRSLLPPQR 0.99486 -10.37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9022 0 0 0 0 0 0 0 0 0 0 0 12.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8617 12.6261 0 13.0629 0 0 0 12.9761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0755 0 12.1906 0 0 0 0 0 0 0 0 13.714 0 0 0 Q9NXX6 NSE4A_HUMAN "Non-structural maintenance of chromosomes element 4 homolog A, NS4EA, Non-SMC element 4 homolog A" NSMCE4A C10orf86 PP4762 Homo sapiens (Human) DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204] "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of response to DNA damage stimulus [GO:2001022]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]" GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0006281; GO:0016604; GO:0016925; GO:0030915; GO:0032204; GO:2001022 MSGDSSGR 0.99486 -8.9706 0 0 0 0 0 0 0 0 0 9.96106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJX2 CDC23_HUMAN "Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8, APC8) (Cyclosome subunit 8)" CDC23 ANAPC8 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic cell cycle [GO:0000278]; mitotic metaphase plate congression [GO:0007080]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of exit from mitosis [GO:0007096]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000278; GO:0004842; GO:0005654; GO:0005680; GO:0005737; GO:0005829; GO:0006511; GO:0007080; GO:0007091; GO:0007096; GO:0007346; GO:0016567; GO:0030071; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979 ubiquitin-protein transferase activity [GO:0004842] AYFLYMYSR 0.99486 -8.9845 0 0 0 0 0 0 0 0 0 0 0 13.8533 0 0 12.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7748 0 0 0 0 0 0 0 0 0 0 0 0 14.1066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8298 0 0 0 0 0 0 0 0 0 0 0 0 13.2748 0 0 14.2305 0 0 0 0 0 0 0 0 0 0 0 13.3046 0 0 0 0 0 0 0 0 0 0 0 11.9719 14.002 0 0 0 0 0 0 0 13.9251 0 0 12.7848 0 0 0 0 14.0843 13.5008 0 0 13.3298 0 0 0 0 0 0 0 0 0 0 0 Q9Y3P9 RBGP1_HUMAN Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA) RABGAP1 HSPC094 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; regulation of GTPase activity [GO:0043087] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875] centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; regulation of GTPase activity [GO:0043087] GO:0005096; GO:0005813; GO:0005829; GO:0005875; GO:0007049; GO:0015631; GO:0031267; GO:0043087; GO:0090630 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631] CREFFNK 0.99486 -13.721 0 12.428 0 0 0 0 0 0 0 12.0236 0 0 0 0 0 0 0 0 0 0 0 0 13.3892 0 0 13.6409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7767 10.9946 0 11.3712 0 11.5382 0 0 12.448 14.5704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7005 0 0 0 0 0 11.9206 0 0 14.2966 12.4404 0 13.6708 0 0 0 0 0 0 0 14.1851 0 0 0 0 0 0 0 0 12.1496 0 0 0 0 0 0 0 0 0 0 12.2138 0 0 11.0608 12.685 14.1929 0 12.0748 0 0 0 0 13.3867 0 0 11.6973 0 0 0 12.5729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2554 0 0 0 0 A1L167 U2QL1_HUMAN "Ubiquitin-conjugating enzyme E2Q-like protein 1, EC 2.3.2.23 (E2Q-like ubiquitin-conjugating enzyme 1)" UBE2QL1 Homo sapiens (Human) protein polyubiquitination [GO:0000209] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209] GO:0000209; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0061631 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631] DSVLWQDMK 0.99487 -8.4646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4534 0 11.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8141 12.6628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6098 0 0 0 0 0 0 0 0 0 0 0 0 14.1623 0 11.8357 0 13.4247 0 0 0 0 12.8589 0 0 0 11.7794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08727 K1C19_HUMAN "Keratin, type I cytoskeletal 19 (Cytokeratin-19, CK-19) (Keratin-19, K19)" KRT19 Homo sapiens (Human) cell differentiation involved in embryonic placenta development [GO:0060706]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; Notch signaling pathway [GO:0007219]; response to estrogen [GO:0043627]; sarcomere organization [GO:0045214] apicolateral plasma membrane [GO:0016327]; cell periphery [GO:0071944]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; terminal web [GO:1990357]; Z disc [GO:0030018] apicolateral plasma membrane [GO:0016327]; cell periphery [GO:0071944]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; terminal web [GO:1990357]; Z disc [GO:0030018]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; cell differentiation involved in embryonic placenta development [GO:0060706]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109]; Notch signaling pathway [GO:0007219]; response to estrogen [GO:0043627]; sarcomere organization [GO:0045214] GO:0005200; GO:0005829; GO:0005856; GO:0005882; GO:0005886; GO:0007219; GO:0008307; GO:0016327; GO:0030018; GO:0030855; GO:0042383; GO:0043034; GO:0043627; GO:0045109; GO:0045214; GO:0060706; GO:0070062; GO:0071944; GO:1990357 structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307] DYSHYYTTIQDLR 0.99487 -13.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20472 PRVA_HUMAN Parvalbumin alpha PVALB Homo sapiens (Human) cochlea development [GO:0090102]; excitatory chemical synaptic transmission [GO:0098976]; gene expression [GO:0010467]; inhibitory chemical synaptic transmission [GO:0098977] axon [GO:0030424]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; synapse [GO:0045202] axon [GO:0030424]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; stereocilium [GO:0032420]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; cochlea development [GO:0090102]; excitatory chemical synaptic transmission [GO:0098976]; gene expression [GO:0010467]; inhibitory chemical synaptic transmission [GO:0098977] GO:0005509; GO:0005634; GO:0005737; GO:0010467; GO:0030424; GO:0032420; GO:0032437; GO:0032991; GO:0042802; GO:0043025; GO:0044877; GO:0045202; GO:0090102; GO:0098976; GO:0098977 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877] AVGAFSATDSFDHKK 0.99487 -10.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P98066 TSG6_HUMAN "Tumor necrosis factor-inducible gene 6 protein, EC 3.1.1.- (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein, TSG-6) (Tumor necrosis factor alpha-induced protein 6, TNF alpha-induced protein 6)" TNFAIP6 TSG6 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; fibronectin fibril organization [GO:1905590]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoclast differentiation [GO:0045671]; ovarian cumulus expansion [GO:0001550]; ovulation [GO:0030728]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor clustering [GO:1903911]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724] extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; calcium ion binding [GO:0005509]; carboxylic ester hydrolase activity [GO:0052689]; fibronectin binding [GO:0001968]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; fibronectin fibril organization [GO:1905590]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoclast differentiation [GO:0045671]; ovarian cumulus expansion [GO:0001550]; ovulation [GO:0030728]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor clustering [GO:1903911]; signal transduction [GO:0007165] GO:0001550; GO:0001968; GO:0005509; GO:0005540; GO:0005576; GO:0005615; GO:0006954; GO:0007155; GO:0007165; GO:0007267; GO:0030212; GO:0030335; GO:0030514; GO:0030728; GO:0045668; GO:0045671; GO:0050728; GO:0052689; GO:0090024; GO:1903911; GO:1904724; GO:1904813; GO:1905590 calcium ion binding [GO:0005509]; carboxylic ester hydrolase activity [GO:0052689]; fibronectin binding [GO:0001968]; hyaluronic acid binding [GO:0005540] LTYAEAK 0.99487 -8.4554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8141 13.7363 0 0 0 0 0 14.4031 0 0 0 0 0 0 0 0 0 0 0 0 12.9926 0 0 0 0 14.0276 0 0 0 0 0 0 0 0 13.1094 0 0 13.0749 0 0 0 0 0 0 0 0 0 13.985 0 0 0 14.927 0 13.8052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7629 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1571 0 0 0 0 0 0 16.011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13617 CUL2_HUMAN "Cullin-2, CUL-2" CUL2 Homo sapiens (Human) G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891] Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146] GO:0000082; GO:0005654; GO:0005730; GO:0005829; GO:0016567; GO:0019005; GO:0030674; GO:0030891; GO:0031146; GO:0031461; GO:0031462; GO:0031625; GO:0044877; GO:0097193 protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625] ALTSVVNYR 0.99487 -13.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.445 0 0 0 0 0 0 0 11.2509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1539 0 0 0 0 0 0 0 13.7365 0 0 13.4932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3472 0 0 0 0 0 0 0 12.095 14.5973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W5X9 TTC23_HUMAN "Tetratricopeptide repeat protein 23, TPR repeat protein 23 (Cervical cancer proto-oncogene 8 protein, HCC-8)" TTC23 HCC8 Homo sapiens (Human) positive regulation of smoothened signaling pathway [GO:0045880] cilium [GO:0005929] cilium [GO:0005929]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0005929; GO:0045880 ALLSLQKFKEAAENLTK 0.99487 -9.0053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3213 0 0 0 0 0 0 0 0 10.8871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4869 0 0 11.1692 0 0 0 0 0 0 11.7881 11.8643 0 0 0 13.1767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3851 0 0 0 0 0 0 10.7505 0 0 0 0 0 0 0 0 0 0 0 0 11.7074 0 0 0 0 0 0 0 0 11.6357 0 12.4512 10.2548 0 0 0 0 0 0 12.2429 13.4003 0 0 0 0 0 0 11.265 0 0 11.6372 12.8154 12.2873 0 0 0 0 0 0 0 0 0 0 0 0 12.0915 0 0 0 0 0 0 12.4277 Q7L2Z9 CENPQ_HUMAN "Centromere protein Q, CENP-Q" CENPQ C6orf139 Homo sapiens (Human) metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; Mis6-Sim4 complex [GO:0031511]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; Mis6-Sim4 complex [GO:0031511]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342] GO:0005634; GO:0005654; GO:0005829; GO:0015629; GO:0031511; GO:0051310; GO:1905342 ANEEGLALLQEEIDKMVETTELMTGNIQSLK 0.99487 -13.777 0 0 0 0 0 0 0 0 0 11.1689 0 0 0 11.4184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1611 0 10.1775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3071 0 0 0 0 0 0 0 0 0 16.4789 0 0 0 0 0 0 0 0 10.7642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0341 12.7526 0 0 0 0 0 0 15.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4575 13.8759 0 13.5239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5668 0 0 Q8IZU0 FAM9B_HUMAN Protein FAM9B FAM9B Homo sapiens (Human) meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795] nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] GO:0000795; GO:0005654; GO:0007286; GO:0051321 IFQEQQKKWQQYR 0.99487 -10.436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9696 13.1929 14.4436 0 0 0 12.3765 0 15.6087 12.8328 0 0 0 0 0 13.9827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9432 12.9351 0 0 14.513 14.3181 0 0 13.009 0 0 0 0 0 0 0 12.0944 0 0 0 0 0 0 0 0 0 13.3887 0 0 12.5181 0 0 0 0 0 0 11.4404 0 15.0232 0 0 0 12.5138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6354 14.4695 0 0 0 0 0 0 Q8N5Y2 MS3L1_HUMAN "Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1, MSL3-like 1)" MSL3 MSL3L1 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription, DNA-templated [GO:0006355]" histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone acetyltransferase complex [GO:0000123]; MSL complex [GO:0072487]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064]; chromatin organization [GO:0006325]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; histone H4-K16 acetylation [GO:0043984]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016573; GO:0016575; GO:0035064; GO:0035267; GO:0043967; GO:0043968; GO:0043984; GO:0045893; GO:0046972; GO:0072487; GO:1900095 DNA binding [GO:0003677]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; methylated histone binding [GO:0035064] ARVLYDAK 0.99487 -8.4796 0 0 0 0 0 0 0 0 0 0 0 11.6495 0 0 0 0 0 0 0 0 12.3099 0 11.7732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4371 0 16.8371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3463 0 11.0557 0 0 14.5505 0 0 14.9622 16.8472 0 0 0 0 0 13.3079 12.7669 0 0 0 0 13.2256 14.1228 0 12.8982 0 11.5476 0 13.1841 12.6942 12.2737 0 10.6523 10.3348 0 0 0 11.0122 0 0 0 0 0 0 0 12.9517 0 0 0 13.8714 0 12.5809 13.926 0 0 0 0 14.5099 0 12.5981 0 0 0 13.0717 0 0 0 0 0 0 0 0 0 0 9.49613 0 0 14.5619 0 12.6134 0 14.4703 13.5857 0 0 12.5345 0 12.8118 0 0 0 12.9728 0 0 0 12.7102 10.5632 12.3437 12.354 0 13.767 0 0 0 0 0 13.6102 Q92570 NR4A3_HUMAN Nuclear receptor subfamily 4 group A member 3 (Mitogen-induced nuclear orphan receptor) (Neuron-derived orphan receptor 1) (Nuclear hormone receptor NOR-1) NR4A3 CHN CSMF MINOR NOR1 TEC Homo sapiens (Human) animal organ regeneration [GO:0031100]; cellular respiration [GO:0045333]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to leptin stimulus [GO:0044320]; common myeloid progenitor cell proliferation [GO:0035726]; energy homeostasis [GO:0097009]; fat cell differentiation [GO:0045444]; gastrulation [GO:0007369]; mast cell degranulation [GO:0043303]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of feeding behavior [GO:2000253]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway [GO:0038097]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; pyruvate oxidation [GO:0009444]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; animal organ regeneration [GO:0031100]; cellular respiration [GO:0045333]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to leptin stimulus [GO:0044320]; common myeloid progenitor cell proliferation [GO:0035726]; energy homeostasis [GO:0097009]; fat cell differentiation [GO:0045444]; gastrulation [GO:0007369]; mast cell degranulation [GO:0043303]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of feeding behavior [GO:2000253]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway [GO:0038097]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; pyruvate oxidation [GO:0009444]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0007369; GO:0008270; GO:0009444; GO:0010613; GO:0010828; GO:0019901; GO:0031100; GO:0032765; GO:0035259; GO:0035497; GO:0035726; GO:0038097; GO:0042803; GO:0043303; GO:0044320; GO:0045333; GO:0045444; GO:0045944; GO:0046321; GO:0048008; GO:0048660; GO:0048661; GO:0050679; GO:0061469; GO:0071376; GO:0071870; GO:0097009; GO:1900625; GO:1903208; GO:1904707; GO:1904754; GO:2000253 "cAMP response element binding [GO:0035497]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" CLSVGMVK 0.99487 -10.41 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4736 0 0 0 0 0 0 0 0 0 0 0 0 11.0461 14.7921 0 15.1915 0 0 0 0 0 0 0 0 15.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9524 Q9UGJ0 AAKG2_HUMAN "5'-AMP-activated protein kinase subunit gamma-2, AMPK gamma2, AMPK subunit gamma-2 (H91620p)" PRKAG2 Homo sapiens (Human) ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ATP biosynthetic process [GO:0006754]; cellular response to glucose starvation [GO:0042149]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126] GO:0004679; GO:0004862; GO:0005524; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005977; GO:0006110; GO:0006468; GO:0006469; GO:0006633; GO:0006754; GO:0008603; GO:0008607; GO:0010800; GO:0016126; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0035556; GO:0042149; GO:0043531; GO:0045860; GO:0046320; GO:0046324; GO:0050790 ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887] AAPLWESK 0.99487 -10.629 0 0 0 0 0 0 0 0 0 0 0 0 12.1521 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9544 10.2957 13.5941 13.4379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8591 0 11.4413 0 0 0 0 10.8169 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3724 0 0 10.5366 0 0 0 0 10.57 0 0 0 12.5579 0 0 0 0 0 0 0 0 13.8003 0 0 0 0 11.2376 0 0 0 0 0 0 0 0 14.046 0 0 0 0 0 0 0 0 0 15.5004 0 0 0 0 0 11.9942 0 0 0 0 0 0 0 0 0 0 0 12.0531 0 11.8949 0 13.5263 0 0 0 0 0 0 0 0 0 0 0 0 0 13.32 12.7947 0 0 0 0 13.4128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2772 0 0 0 0 0 0 0 0 Q9UKW6 ELF5_HUMAN "ETS-related transcription factor Elf-5 (E74-like factor 5) (Epithelium-restricted ESE-1-related Ets factor) (Epithelium-specific Ets transcription factor 2, ESE-2)" ELF5 ESE2 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0005634; GO:0006357; GO:0030154; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" MTYEKLSR 0.99487 -8.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2027 0 12.8733 13.2143 0 12.9482 12.5446 0 0 12.221 12.5657 12.8568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8198 0 0 0 0 0 0 0 0 0 Q9Y2P0 ZN835_HUMAN Zinc finger protein 835 ZNF835 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] FSNRSHLLQHR 0.99487 -31.953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84081 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7499 0 0 0 0 0 0 13.9625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2357 0 14.7951 13.1204 13.6964 0 0 0 0 13.9132 0 0 13.9291 13.2896 14.2685 0 0 15.7723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6649 0 12.5887 0 0 0 0 0 0 13.2221 0 0 0 0 0 0 10.6855 0 0 12.5428 0 0 0 0 0 0 0 0 13.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NJ46 NKX63_HUMAN Homeobox protein Nkx-6.3 NKX6-3 Homo sapiens (Human) cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; enteroendocrine cell differentiation [GO:0035883]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; enteroendocrine cell differentiation [GO:0035883]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001709; GO:0005634; GO:0006357; GO:0030154; GO:0030857; GO:0035883; GO:0043565; GO:0045944; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AGNEYPTR 0.99488 -15.381 0 0 0 0 0 0 0 0 15.1119 15.1941 0 15.0654 0 13.4274 14.8855 0 12.4886 0 0 0 0 0 0 0 0 0 13.2185 0 0 0 0 0 0 14.8373 0 0 0 0 0 14.8991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0987 13.8837 0 13.4093 0 0 13.5417 0 13.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.414 0 0 0 12.222 0 0 0 0 0 11.9611 0 0 0 0 13.9657 14.0027 16.925 0 0 13.8157 0 0 0 13.9706 0 0 0 0 0 0 0 0 0 0 0 0 12.0514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9006 0 0 0 0 0 0 0 0 0 16.125 13.5634 16.1547 16.1861 11.9945 0 16.5041 13.459 0 0 13.4579 15.9509 0 0 12.0794 0 0 0 0 0 16.1648 0 0 O15287 FANCG_HUMAN "Fanconi anemia group G protein, Protein FACG (DNA repair protein XRCC9)" FANCG XRCC9 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; protein monoubiquitination [GO:0006513]; response to radiation [GO:0009314]; spermatid development [GO:0007286] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; damaged DNA binding [GO:0003684]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; protein monoubiquitination [GO:0006513]; response to radiation [GO:0009314]; spermatid development [GO:0007286] GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006513; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0036297; GO:0043240 damaged DNA binding [GO:0003684] AQDALTLCEELLSRTSSLLPK 0.99488 -8.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.036 13.1427 0 0 0 0 0 0 0 0 0 0 0 15.5666 0 14.855 0 0 0 0 13.6687 0 0 0 0 0 11.9943 0 0 0 0 0 0 13.6408 0 14.5601 0 0 0 0 0 0 13.6115 0 0 0 0 0 0 14.2928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1191 13.4156 0 0 0 0 11.6047 0 0 0 0 0 11.58 0 0 9.36564 0 0 0 0 13.1894 0 0 0 13.2199 11.7947 0 0 0 0 0 0 0 0 0 0 0 0 0 O60765 Z354A_HUMAN "Zinc finger protein 354A (Transcription factor 17, TCF-17) (Zinc finger protein eZNF)" ZNF354A EZNF HKL1 TCF17 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0007605; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASSCSTSLSGCQR 0.99488 -10.442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9775 0 0 0 0 11.9917 14.5564 13.0937 0 0 12.5473 0 13.7436 13.6467 14.5043 14.9644 0 13.8601 15.2408 0 0 0 0 0 0 0 0 0 0 0 0 11.6762 0 0 0 0 16.909 14.44 14.617 0 15.5625 12.8855 0 0 0 0 14.5878 0 14.5121 14.3098 0 0 0 0 0 0 0 0 14.5335 14.4243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4824 13.4975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95136 S1PR2_HUMAN "Sphingosine 1-phosphate receptor 2, S1P receptor 2, S1P2 (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor Edg-5, S1P receptor Edg-5)" S1PR2 EDG5 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; excitatory postsynaptic potential [GO:0060079]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; excitatory postsynaptic potential [GO:0060079]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376] GO:0001664; GO:0003376; GO:0004930; GO:0005178; GO:0005737; GO:0005886; GO:0007186; GO:0007189; GO:0008284; GO:0008289; GO:0008528; GO:0010800; GO:0014912; GO:0016021; GO:0019222; GO:0031532; GO:0038036; GO:0046847; GO:0060079; GO:0090394; GO:0098794; GO:1903142; GO:1904706 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036] GSLYSEYLNPNKVQEHYNYTKETLETQETTSR 0.99488 -10.698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48165 CXA8_HUMAN "Gap junction alpha-8 protein (Connexin-50, Cx50) (Lens fiber protein MP70)" GJA8 Homo sapiens (Human) cell-cell signaling [GO:0007267]; gap junction-mediated intercellular transport [GO:1990349]; lens development in camera-type eye [GO:0002088]; regulation of catalase activity [GO:1902551]; regulation of glutathione peroxidase activity [GO:1903282]; regulation of granulocyte macrophage colony-stimulating factor production [GO:0032645] connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] connexin complex [GO:0005922]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; cell-cell signaling [GO:0007267]; gap junction-mediated intercellular transport [GO:1990349]; lens development in camera-type eye [GO:0002088]; regulation of catalase activity [GO:1902551]; regulation of glutathione peroxidase activity [GO:1903282]; regulation of granulocyte macrophage colony-stimulating factor production [GO:0032645] GO:0002088; GO:0005243; GO:0005886; GO:0005887; GO:0005922; GO:0007267; GO:0032645; GO:0042802; GO:1902551; GO:1903282; GO:1990349 gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802] AKGYQLLEEEK 0.99488 -10.44 0 0 0 10.8798 0 0 11.3073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9358 0 11.3898 0 0 0 11.6438 0 0 0 0 0 11.3665 0 0 0 10.6896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1365 0 0 0 0 0 0 12.0686 0 0 0 0 0 0 0 0 0 0 12.0692 0 0 15.4609 0 0 15.2959 0 15.3862 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8281 P61163 ACTZ_HUMAN "Alpha-centractin, Centractin (ARP1) (Actin-RPV) (Centrosome-associated actin homolog)" ACTR1A CTRN1 Homo sapiens (Human) vesicle-mediated transport [GO:0016192] cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630] cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; ATP binding [GO:0005524]; vesicle-mediated transport [GO:0016192] GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0005875; GO:0015630; GO:0016192; GO:0070062; GO:0099738 ATP binding [GO:0005524] ACYLSINPQKDETLETEK 0.99488 -10.696 0 0 0 0 0 9.93469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.31759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0694 0 0 0 0 0 12.8883 0 13.5614 0 0 0 13.7071 0 0 13.4581 0 0 0 0 12.422 0 0 0 0 0 0 0 0 0 12.0936 13.8465 0 0 0 10.4791 0 0 0 0 13.1798 0 0 0 0 0 0 0 0 0 11.8137 0 0 0 13.6387 0 0 0 13.5595 13.7132 0 0 0 13.6868 12.1321 0 13.6123 0 0 0 0 0 0 0 0 0 0 0 11.6463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0037 0 11.8646 14.1718 0 0 0 0 12.8286 Q09019 DMWD_HUMAN Dystrophia myotonica WD repeat-containing protein (Dystrophia myotonica-containing WD repeat motif protein) (Protein 59) (Protein DMR-N9) DMWD DM9 Homo sapiens (Human) dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204] dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204] GO:0005634; GO:0030425; GO:0043204 FATLTLQER 0.99488 -10.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1471 0 0 0 0 0 0 0 0 0 Q7Z5D8 NANGN_HUMAN NANOG neighbor homeobox (Homeobox protein C14) NANOGNB Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] ARWLTPVIPALWEAEAGR 0.99488 -15.427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8469 0 0 0 0 0 0 0 0 13.6457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0831 0 0 0 0 0 0 0 0 0 0 12.3494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9185 0 0 0 0 0 0 0 12.5279 0 0 0 0 0 0 0 0 14.0239 0 0 0 0 0 Q96GN5 CDA7L_HUMAN Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2) CDCA7L HR1 JPO2 R1 Homo sapiens (Human) "positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001650; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0008284 ATPRRSR 0.99488 -12.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8989 0 0 0 0 11.626 0 0 12.4206 0 0 0 0 12.2038 0 0 0 0 0 0 12.4727 0 0 13.2499 0 0 0 0 0 0 14.4683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6056 0 14.3229 14.797 0 0 0 0 0 0 0 13.6179 0 13.8198 0 0 13.267 0 0 0 0 0 0 0 13.4926 14.0566 16.0523 14.7323 16.2373 0 0 0 13.0082 0 13.08 14.6472 0 0 0 0 0 0 0 0 14.327 0 0 0 0 15.1313 13.043 0 12.9735 0 0 0 0 0 0 13.0586 0 0 12.9249 0 0 9.68278 0 0 0 0 0 0 0 0 0 13.4094 0 0 0 0 0 0 0 12.7894 0 12.1426 13.4911 13.1359 12.7695 13.3801 0 12.8952 13.3207 0 0 0 0 13.7205 0 0 0 0 0 0 Q96RD0 OR8B2_HUMAN Olfactory receptor 8B2 (Olfactory receptor OR11-309) OR8B2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] KALIKIQR 0.99488 -8.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3298 0 0 0 13.8875 13.5469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2917 0 0 0 0 0 0 0 0 0 12.8576 0 0 13.3628 0 0 0 0 0 0 0 0 0 0 0 0 12.8938 13.8083 0 0 0 0 0 13.2481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0959 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0275 13.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0426 0 0 0 13.2317 0 Q9BZ76 CNTP3_HUMAN Contactin-associated protein-like 3 (Cell recognition molecule Caspr3) CNTNAP3 CASPR3 KIAA1714 Homo sapiens (Human) cell adhesion [GO:0007155]; cell recognition [GO:0008037] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell recognition [GO:0008037] GO:0005576; GO:0005886; GO:0007155; GO:0008037; GO:0016021 CEQRLALR 0.99488 -11.297 12.7945 0 0 0 0 0 0 0 0 0 0 0 0 13.5008 0 0 11.943 0 0 0 11.4216 13.1023 0 0 0 0 16.7346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1382 0 0 0 0 0 0 0 0 0 0 15.728 0 0 0 14.7153 0 16.2507 0 0 14.8821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8149 0 0 0 0 0 13.1505 14.4997 0 11.7425 0 0 0 0 14.6095 12.5756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3629 0 11.7859 0 0 0 0 0 0 0 0 0 0 16.2242 0 0 13.0868 0 0 0 0 13.3086 0 0 0 0 0 0 13.1793 0 0 0 0 11.981 0 0 0 0 0 0 Q9UK08 GBG8_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 (Gamma-9) GNG8 GNG9 GNGT9 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0003924; GO:0005834; GO:0005886; GO:0007186; GO:0031681 G-protein beta-subunit binding [GO:0031681]; GTPase activity [GO:0003924] DKRLFCVLL 0.99488 -11.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0JNW5 UH1BL_HUMAN UHRF1-binding protein 1-like (Syntaxin-6 Habc-interacting protein of 164 kDa) UHRF1BP1L KIAA0701 SHIP164 Homo sapiens (Human) cytosol [GO:0005829]; early endosome [GO:0005769] cytosol [GO:0005829]; early endosome [GO:0005769]; GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803] GO:0005769; GO:0005829; GO:0042803; GO:0062069 GARP complex binding [GO:0062069]; protein homodimerization activity [GO:0042803] AGDSCNHWMYFSDATK 0.99489 -8.2629 0 11.2007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2108 0 0 0 0 0 13.4727 0 0 0 0 0 0 0 0 0 0 13.0809 0 0 0 0 0 0 0 0 0 0 11.855 0 14.5035 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7966 0 0 0 0 0 0 0 0 0 0 0 14.0606 14.9788 O60244 MED14_HUMAN "Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component, ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2, CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog, hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component, Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component, DRIP150)" MED14 ARC150 CRSP2 CXorf4 DRIP150 EXLM1 RGR1 TRAP170 Homo sapiens (Human) "positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]" core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear receptor coactivator activity [GO:0030374]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019]" GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0030374; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847 nuclear receptor coactivator activity [GO:0030374]; nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] AHQKLQELK 0.99489 -35.942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7344 13.5361 0 0 0 10.9094 0 0 0 12.1777 0 0 0 0 0 0 0 0 0 0 12.9407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9774 0 13.7561 12.6937 0 11.5528 0 0 0 12.6089 13.391 12.9211 14.5259 15.0366 15.235 14.0127 13.4696 13.1633 17.4302 0 0 12.9626 14.1989 0 13.0518 15.6984 15.2649 13.5148 14.6788 14.9402 0 0 0 13.2398 0 16.5438 0 0 0 12.5735 0 11.7447 13.6711 12.6334 14.1184 0 14.8216 14.5436 0 12.7536 0 0 14.7981 0 0 14.8016 11.9772 13.4476 0 0 0 11.89 17.0846 13.5738 12.3249 0 14.5392 12.8305 13.8844 0 13.8805 14.598 13.8469 14.2661 13.7921 0 0 11.8393 14.5021 0 0 12.9498 0 0 12.7741 13.5237 0 0 13.6823 0 0 0 0 13.0824 0 0 0 0 12.7385 13.9607 0 0 0 12.7529 0 14.3695 11.4422 0 0 0 0 12.3275 0 12.408 P0DPQ3 PR20G_HUMAN Proline-rich protein 20G PRR20G Homo sapiens (Human) GSGAGLLR 0.99489 -12.61 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6204 0 14.5618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P12272 PTHR_HUMAN "Parathyroid hormone-related protein, PTH-rP, PTHrP (Parathyroid hormone-like protein, PLP) [Cleaved into: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139]) ]" PTHLH PTHRP Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte development [GO:0061182]; negative regulation of chondrocyte differentiation [GO:0032331]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; regulation of chondrocyte differentiation [GO:0032330]; regulation of gene expression [GO:0010468]; skeletal system development [GO:0001501] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; hormone activity [GO:0005179]; peptide hormone receptor binding [GO:0051428]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte development [GO:0061182]; negative regulation of chondrocyte differentiation [GO:0032331]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; regulation of chondrocyte differentiation [GO:0032330]; regulation of gene expression [GO:0010468]; skeletal system development [GO:0001501] GO:0001501; GO:0002076; GO:0005179; GO:0005576; GO:0005615; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0007189; GO:0007267; GO:0007565; GO:0008284; GO:0008285; GO:0008544; GO:0010468; GO:0030282; GO:0032330; GO:0032331; GO:0046058; GO:0051428; GO:0061182 hormone activity [GO:0005179]; peptide hormone receptor binding [GO:0051428] EQPLKTPGK 0.99489 -11.381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23743 DGKA_HUMAN "Diacylglycerol kinase alpha, DAG kinase alpha, EC 2.7.1.107 (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha, DGK-alpha)" DGKA DAGK DAGK1 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205] GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005543; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543] ANLPVLPPVAVLPLGTGNDLARCLR 0.99489 -15.461 0 0 0 0 0 0 0 0 0 0 0 9.49502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.764 0 0 0 0 0 0 0 0 15.5157 0 0 0 0 0 12.2458 0 0 11.48 0 0 0 0 0 0 12.5505 0 0 0 0 0 0 0 0 0 0 0 12.3077 0 0 0 0 0 13.3994 0 12.6898 0 0 0 0 0 0 10.3929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9015 0 0 0 0 0 11.6931 0 0 0 0 14.3061 0 14.6298 0 0 0 0 0 0 11.0993 0 0 11.8403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42224 STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) STAT1 Homo sapiens (Human) "blood circulation [GO:0008015]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-27-mediated signaling pathway [GO:0070106]; macrophage derived foam cell differentiation [GO:0010742]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; renal tubule development [GO:0061326]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to hydrogen peroxide [GO:0042542]; response to interferon-beta [GO:0035456]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337]" axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; ISGF3 complex [GO:0070721]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575] "axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; ISGF3 complex [GO:0070721]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; cadherin binding [GO:0045296]; CCR5 chemokine receptor binding [GO:0031730]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-like protein ligase binding [GO:0044389]; blood circulation [GO:0008015]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-beta [GO:0035458]; cellular response to interferon-gamma [GO:0071346]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-27-mediated signaling pathway [GO:0070106]; macrophage derived foam cell differentiation [GO:0010742]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; renal tubule development [GO:0061326]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to hydrogen peroxide [GO:0042542]; response to interferon-beta [GO:0035456]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon signaling pathway [GO:0060337]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001222; GO:0001223; GO:0001937; GO:0002053; GO:0002230; GO:0003340; GO:0003690; GO:0003700; GO:0005164; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006952; GO:0007259; GO:0007584; GO:0008015; GO:0009410; GO:0009612; GO:0010742; GO:0016525; GO:0016922; GO:0019221; GO:0019899; GO:0030424; GO:0030425; GO:0031730; GO:0032727; GO:0032869; GO:0032991; GO:0033209; GO:0034097; GO:0035035; GO:0035456; GO:0035458; GO:0042127; GO:0042393; GO:0042542; GO:0042802; GO:0042803; GO:0042981; GO:0043124; GO:0043434; GO:0044389; GO:0045296; GO:0045648; GO:0045893; GO:0045944; GO:0046725; GO:0048471; GO:0048661; GO:0051591; GO:0051607; GO:0051721; GO:0051770; GO:0060333; GO:0060337; GO:0061326; GO:0070106; GO:0070721; GO:0071346; GO:0071407; GO:0072136; GO:0072162; GO:0072308; GO:0090575; GO:1990841 "cadherin binding [GO:0045296]; CCR5 chemokine receptor binding [GO:0031730]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-like protein ligase binding [GO:0044389]" ALLKDQQPGTFLLR 0.99489 -11.387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8843 0 0 0 0 0 0 0 0 13.117 0 0 0 0 0 0 0 0 0 0 0 0 13.7313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4866 12.7861 13.2629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1894 0 0 11.5736 0 0 0 13.4476 0 0 0 12.0801 15.1277 0 0 0 0 11.9845 16.4825 17.0289 0 0 13.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3922 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2098 0 0 0 14.9813 0 0 0 14.9618 12.0718 0 0 0 0 0 0 12.2224 0 0 0 0 0 0 11.9215 0 0 0 0 14.8592 0 0 0 0 0 0 0 P43235 CATK_HUMAN "Cathepsin K, EC 3.4.22.38 (Cathepsin O) (Cathepsin O2) (Cathepsin X)" CTSK CTSO CTSO2 Homo sapiens (Human) autophagy of mitochondrion [GO:0000422]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; thyroid hormone generation [GO:0006590] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654] apical plasma membrane [GO:0016324]; endolysosome lumen [GO:0036021]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; serine-type endopeptidase activity [GO:0004252]; autophagy of mitochondrion [GO:0000422]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response [GO:0006955]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; thyroid hormone generation [GO:0006590] GO:0000422; GO:0001957; GO:0001968; GO:0004197; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0006508; GO:0006590; GO:0006955; GO:0008234; GO:0009897; GO:0016324; GO:0022617; GO:0030574; GO:0036021; GO:0043202; GO:0043231; GO:0043394; GO:0045453; GO:0051603; GO:0061037 collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; serine-type endopeptidase activity [GO:0004252] GYVTPVK 0.99489 -11.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49759 CLK1_HUMAN "Dual specificity protein kinase CLK1, EC 2.7.12.1 (CDC-like kinase 1)" CLK1 CLK Homo sapiens (Human) peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484] GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0018105; GO:0018107; GO:0018108; GO:0043484; GO:0046777; GO:0106310 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] EHLAMMERILGPLPKHMIQK 0.99489 -8.2927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2367 0 0 0 0 0 12.714 0 0 13.9699 0 0 0 0 0 0 12.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3555 0 0 0 0 0 0 11.161 11.5502 0 0 0 0 0 0 0 0 11.9651 0 0 0 0 0 0 0 0 0 12.778 0 Q12888 TP53B_HUMAN "TP53-binding protein 1, 53BP1, p53-binding protein 1, p53BP1" TP53BP1 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin modification-dependent histone binding [GO:0061649]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]" GO:0000077; GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006303; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0042393; GO:0045830; GO:0045893; GO:0045944; GO:0051091; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:1990391; GO:2000042 damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin modification-dependent histone binding [GO:0061649] DPVSPASQK 0.99489 -15.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89692 0 12.5095 0 0 0 0 0 0 15.8237 0 0 14.3414 0 0 13.6289 0 0 0 0 0 0 12.9051 0 14.3995 15.0877 11.8195 0 0 0 0 0 12.7759 17.4765 0 0 0 0 0 0 13.5846 14.6496 0 0 0 0 13.5311 15.2493 0 0 0 0 0 0 0 0 0 0 0 13.1804 0 0 0 0 0 0 0 0 0 12.2762 0 0 0 0 13.0998 0 0 0 0 0 12.3687 0 0 12.1768 14.6694 0 0 12.1343 12.6683 0 12.4564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2619 13.1292 12.4026 13.2386 0 0 0 0 0 0 Q13522 PPR1A_HUMAN "Protein phosphatase 1 regulatory subunit 1A (Protein phosphatase inhibitor 1, I-1, IPP-1)" PPP1R1A IPP1 Homo sapiens (Human) glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556] GO:0004865; GO:0005737; GO:0005977; GO:0035556 protein serine/threonine phosphatase inhibitor activity [GO:0004865] EQDNSPR 0.99489 -12.629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1465 0 0 0 0 0 Q2T9J0 TYSD1_HUMAN "Peroxisomal leader peptide-processing protease, EC 3.4.21.- (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form ]" TYSND1 Homo sapiens (Human) protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998] GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0016020; GO:0016485; GO:0031998; GO:0042802 identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252] DALHRLPHSTAALAALLPPEVGVPWGLPLR 0.99489 -10.491 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9685 0 0 0 0 0 0 0 0 0 0 11.2351 0 10.535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5763 0 0 0 0 0 11.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0428 0 0 0 0 0 11.7213 0 0 0 0 0 0 Q2TBA0 KLH40_HUMAN Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5) (Sarcosynapsin) KLHL40 KBTBD5 SRYP Homo sapiens (Human) negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528] A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674] A band [GO:0031672]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; I band [GO:0031674]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; skeletal muscle fiber development [GO:0048741]; skeletal muscle fiber differentiation [GO:0098528] GO:0005737; GO:0031397; GO:0031398; GO:0031463; GO:0031672; GO:0031674; GO:0032435; GO:0032436; GO:0048741; GO:0098528 CLDSVMCYDR 0.99489 -12.631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1992 0 0 0 14.4854 13.834 14.8141 0 0 0 14.4988 0 0 0 14.5992 0 0 12.9015 12.8631 0 0 0 0 11.168 0 0 0 0 0 0 0 0 0 10.2776 0 0 0 0 0 9.90127 9.39941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6207 0 0 0 0 0 0 14.2311 0 0 0 0 0 0 12.2006 0 0 0 12.0366 0 0 0 0 0 0 0 0 0 0 0 0 Q3SYG4 PTHB1_HUMAN Protein PTHB1 (Bardet-Biedl syndrome 9 protein) (Parathyroid hormone-responsive B1 gene protein) BBS9 PTHB1 Homo sapiens (Human) cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; pericentriolar material [GO:0000242] BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; pericentriolar material [GO:0000242]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0000242; GO:0005829; GO:0005929; GO:0007601; GO:0015031; GO:0016020; GO:0034451; GO:0034464; GO:0035869; GO:0045444; GO:0050896; GO:0060170; GO:0060271; GO:0061512 ELNYDELDVEMKELQK 0.99489 -11.379 10.4567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1703 0 0 14.7861 0 0 0 0 0 0 0 13.4571 0 0 0 0 0 0 0 0 0 0 0 12.3038 12.8401 0 0 0 0 0 0 0 0 15.6692 0 0 0 15.8236 0 15.8663 0 0 0 13.092 0 0 12.6261 0 0 12.9225 13.0692 0 14.2883 0 0 12.561 0 0 10.5228 0 0 0 0 0 0 14.7218 14.7692 16.7386 0 0 16.3808 16.452 13.0803 0 0 12.641 12.7303 0 0 0 15.1315 0 0 0 12.8128 13.3803 0 0 15.965 0 0 0 12.9261 0 17.3022 16.069 0 0 0 0 12.4923 0 0 16.6509 0 0 0 0 0 0 10.2518 0 Q5H9U9 DDX6L_HUMAN "Probable ATP-dependent RNA helicase DDX60-like, EC 3.6.4.13 (DEAD box protein 60-like)" DDX60L Homo sapiens (Human) defense response to virus [GO:0051607] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; defense response to virus [GO:0051607] GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0016887; GO:0051607 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727] AEYINFLENLK 0.99489 -8.2614 0 0 0 0 0 0 0 0 0 12.6806 0 12.6447 12.6737 0 13.131 12.1382 12.3729 0 0 10.834 0 0 0 11.3905 0 0 0 0 0 0 0 0 0 14.6732 13.3426 13.2961 13.6551 14.8348 0 0 13.97 0 12.5286 0 0 0 0 0 0 0 0 0 9.49526 0 0 0 0 0 0 11.3406 0 0 0 0 0 0 0 0 0 14.0712 11.0443 0 0 14.1595 0 11.2025 12.1212 12.6467 11.7587 13.4493 0 11.7009 0 11.752 12.1447 0 0 14.3551 11.3274 0 12.9715 0 12.1951 13.971 13.0638 0 0 15.1175 0 14.4458 12.043 14.0332 0 0 0 0 0 0 12.8777 0 0 13.2726 0 0 0 11.9642 11.0108 0 0 13.6534 0 0 0 0 11.2833 0 0 0 0 0 14.1197 0 0 0 11.5306 0 0 0 0 0 0 0 0 0 12.9636 0 0 0 14.0125 0 10.9655 0 0 10.6591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0046 0 0 0 0 0 0 13.3779 10.0812 0 0 13.3667 Q6ZUG5 YC006_HUMAN Uncharacterized protein FLJ43738 Homo sapiens (Human) PVTVRKK 0.99489 -11.361 0 0 0 0 0 0 12.1995 0 0 0 0 0 0 12.9989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6974 0 17.2025 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7613 0 0 0 0 0 16.7688 0 0 0 13.0877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2Y8 GVIN1_HUMAN Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1) GVINP1 GVIN1 VLIG1 Homo sapiens (Human) cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525] GO:0005525; GO:0005634; GO:0005829 GTP binding [GO:0005525] EHEQQLSFLK 0.99489 -35.938 0 0 0 0 0 0 0 0 0 0 0 0 11.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4173 0 0 0 12.6532 0 13.2348 0 12.6188 0 0 0 13.3226 0 0 0 0 0 12.7266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5892 12.8085 14.5175 0 0 0 0 11.1379 14.4028 0 0 10.8619 16.7598 16.4265 20.8299 0 16.3528 13.7312 13.5274 15.7409 0 15.5513 13.8586 15.8677 14.3326 0 13.3574 14.3564 0 16.0065 0 16.1964 0 13.1712 13.3549 0 12.8127 12.6703 0 14.5195 10.1571 14.6953 0 0 0 13.3864 0 0 11.7841 12.5789 0 14.0674 12.0165 0 0 0 14.8266 12.6083 12.7717 0 0 0 13.5177 11.2197 12.3249 12.0976 13.452 0 0 10.9963 14.2435 13.7581 0 9.90666 0 0 0 12.0558 0 0 0 12.3029 14.2734 12.6933 0 0 0 0 0 14.6103 0 0 0 14.2102 0 0 0 12.4687 0 12.0817 0 0 0 0 0 0 12.2285 Q7Z6J0 SH3R1_HUMAN "E3 ubiquitin-protein ligase SH3RF1, EC 2.3.2.27 (Plenty of SH3s, Protein POSH) (RING finger protein 142) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2)" SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]" GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043154; GO:0043370; GO:0046330; GO:0046872; GO:0048471; GO:0051865; GO:0061630; GO:2000564; GO:2001237 MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] EKKGLLK 0.99489 -12.624 0 0 0 0 0 0 0 0 12.7538 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7397 0 0 12.5871 0 0 0 11.9352 12.1784 0 0 0 0 12.6544 0 0 0 0 0 0 12.7684 0 12.5658 0 0 0 9.8107 0 0 0 0 11.1089 0 0 0 0 0 0 0 0 0 0 0 0 11.2291 11.9479 10.7484 0 0 0 0 0 12.5418 0 12.5541 12.3868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2201 0 0 0 0 0 0 0 12.4245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3472 0 0 0 0 0 0 0 0 11.5418 0 0 0 0 11.7091 0 0 0 0 0 12.1812 0 0 12.0808 0 0 0 11.4286 0 0 0 0 0 0 0 0 0 Q8N5G2 MACOI_HUMAN Macoilin (Macoilin-1) (Transmembrane protein 57) MACO1 TMEM57 Homo sapiens (Human) brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202] axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]; microtubule binding [GO:0008017]; brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041] GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0016021; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0044306; GO:0045202 microtubule binding [GO:0008017] ADLQASRQVEQELR 0.99489 -11.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6575 0 0 0 0 0 0 0 0 0 0 Q8NA72 POC5_HUMAN "Centrosomal protein POC5 (Protein of centriole 5, hPOC5)" POC5 C5orf37 Homo sapiens (Human) cell cycle [GO:0007049] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cell cycle [GO:0007049] GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007049 CDFASKNR 0.99489 -15.472 0 0 0 0 0 0 0 0 0 0 0 13.7184 0 0 0 0 0 0 0 0 12.6781 0 0 12.6903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6081 0 14.3857 0 14.0033 0 0 0 0 14.4797 11.9125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4677 0 12.4882 0 0 0 0 0 0 0 14.9156 12.4213 0 0 0 0 0 17.4667 0 0 14.891 17.3134 0 0 17.3027 0 0 0 0 0 0 0 15.742 0 0 0 14.607 15.8942 0 14.5317 0 0 16.6125 14.6258 16.6748 0 0 15.4063 0 0 12.8732 12.7186 0 0 13.1681 0 15.0694 0 0 13.5322 0 14.2558 14.6018 0 0 0 0 0 0 0 0 0 0 14.3767 13.6497 0 0 0 0 0 0 14.7339 0 0 0 0 13.6912 0 0 0 0 0 0 13.7896 0 0 0 0 0 0 15.1608 13.9843 0 0 0 0 0 0 14.6974 0 Q8NFR7 CC148_HUMAN Coiled-coil domain-containing protein 148 CCDC148 Homo sapiens (Human) AKVRQWR 0.99489 -10.492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4763 12.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3285 0 0 0 0 0 11.5679 0 0 0 0 0 0 0 0 0 13.7942 0 0 0 13.9722 13.7808 0 13.1072 0 0 13.276 0 0 0 0 0 13.789 0 0 0 0 0 0 0 0 0 11.6181 0 0 0 0 0 0 0 0 13.0612 0 0 13.6068 18.4685 0 0 0 0 0 0 0 13.3764 0 12.0307 0 0 0 0 0 0 0 13.5135 0 0 0 0 0 0 0 0 0 0 0 11.7649 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAW3 ZN671_HUMAN Zinc finger protein 671 ZNF671 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] ARQKPYLCGACGK 0.99489 -10.713 0 0 0 0 0 0 0 0 0 12.3166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7791 0 0 0 0 0 0 0 12.1203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5259 0 0 13.9524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWV3 RT4I1_HUMAN "Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein)" RTN4IP1 NIMP Homo sapiens (Human) nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773] GO:0005739; GO:0005741; GO:0007399; GO:0008270; GO:0016491; GO:0050773 oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] DPLHVKIK 0.99489 -15.457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7065 0 0 0 0 0 0 0 0 0 0 12.9178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969V3 NCLN_HUMAN Nicalin (Nicastrin-like protein) NCLN Homo sapiens (Human) protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; ribosome binding [GO:0043022]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966] GO:0005789; GO:0009966; GO:0016020; GO:0016021; GO:0032991; GO:0043022; GO:0043254; GO:0050821; GO:0061635 ribosome binding [GO:0043022] TLTRNTR 0.99489 -8.2915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3107 13.1365 0 0 0 0 12.82 0 0 12.9343 0 10.9824 13.0066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.426 0 0 0 0 0 Q96RS0 TGS1_HUMAN "Trimethylguanosine synthase, EC 2.1.1.- (CLL-associated antigen KW-2) (Cap-specific guanine-N2 methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif, PIMT, PIPMT)" TGS1 HCA137 NCOA6IP PIMT Homo sapiens (Human) 7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]; ribonucleoprotein complex biogenesis [GO:0022613]; spliceosomal snRNP assembly [GO:0000387] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; RNA methyltransferase activity [GO:0008173]; RNA trimethylguanosine synthase activity [GO:0071164]; 7-methylguanosine cap hypermethylation [GO:0036261]; 7-methylguanosine RNA capping [GO:0009452]; ribonucleoprotein complex biogenesis [GO:0022613]; spliceosomal snRNP assembly [GO:0000387] GO:0000387; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008173; GO:0009452; GO:0015030; GO:0022613; GO:0030532; GO:0036261; GO:0071164 RNA methyltransferase activity [GO:0008173]; RNA trimethylguanosine synthase activity [GO:0071164] DSGNNSGDQATEEEEGGYSCGTAESHDSK 0.99489 -11.379 0 0 0 18.4275 0 0 0 0 12.2148 0 0 0 0 18.4201 13.9538 0 14.0233 12.6558 0 0 0 0 0 0 0 15.3927 0 0 0 15.3423 19.3458 19.3556 0 0 0 0 0 0 19.4751 0 13.7053 15.6139 0 0 13.4481 0 0 0 0 0 0 0 12.6966 0 0 10.385 0 19.6269 0 0 0 0 0 18.3862 18.4077 0 0 0 0 0 0 14.5213 0 12.0507 0 0 12.2544 0 0 0 0 0 0 0 0 0 0 12.7668 0 0 0 0 0 0 14.4681 0 0 0 0 0 0 0 0 12.9319 0 15.3062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1454 0 0 0 0 11.683 0 0 15.2289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0796 0 0 0 0 0 0 0 0 0 0 12.7529 18.557 0 0 13.4945 13.903 0 0 0 0 0 18.4515 0 0 0 Q9BPZ2 SPI2B_HUMAN "Spindlin-2B (Spindlin-like protein 2B, SPIN-2, SPIN-2B)" SPIN2B SPIN2 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell cycle [GO:0007049]; gamete generation [GO:0007276]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; methylated histone binding [GO:0035064]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; gamete generation [GO:0007276]; regulation of cell cycle [GO:0051726]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005654; GO:0005829; GO:0006355; GO:0006915; GO:0007049; GO:0007276; GO:0035064; GO:0051726 methylated histone binding [GO:0035064] AWFYITYEK 0.99489 -11.384 0 0 0 0 0 0 0 0 0 12.3682 0 0 0 0 0 0 0 0 0 0 0 0 12.2183 0 0 0 12.8173 0 0 12.8298 0 0 0 0 0 0 0 0 0 0 0 13.0295 0 0 0 12.2013 12.4623 12.2641 11.7271 0 12.8792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9818 0 0 0 0 0 0 0 0 0 0 0 13.7166 0 0 0 0 0 0 14.2966 0 0 0 0 0 0 0 0 14.1961 0 0 0 0 Q9BS34 ZN670_HUMAN Zinc finger protein 670 ZNF670 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cellular lipid metabolic process [GO:0044255]; lipid metabolic process [GO:0006629]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0006629; GO:0044255; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KVSTGVK 0.99489 -10.495 0 0 0 0 0 0 0 0 14.4878 11.9335 0 12.7296 0 13.327 13.7533 0 0 0 0 0 0 0 0 0 0 0 0 12.6999 0 12.4983 0 12.7181 0 12.7013 13.7738 0 0 0 13.7353 0 0 0 0 12.055 0 0 0 0 0 0 12.7922 0 0 0 0 13.5358 13.6063 13.2571 0 0 13.1471 12.9571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1913 14.1522 15.772 0 0 14.15 14.6321 0 0 0 13.6385 13.7294 0 0 0 0 0 0 0 0 13.7614 0 0 Q9GZR7 DDX24_HUMAN "ATP-dependent RNA helicase DDX24, EC 3.6.4.13 (DEAD box protein 24)" DDX24 Homo sapiens (Human) RNA metabolic process [GO:0016070] membrane [GO:0016020]; nucleolus [GO:0005730] membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070] GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016020; GO:0016070; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AKTWIPEVHDQK 0.99489 -8.2689 0 0 0 0 0 0 10.0811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5945 0 0 0 0 0 13.2402 0 0 0 0 0 11.6845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2223 0 0 0 0 0 0 12.7058 12.5854 0 0 0 20.6424 14.2798 13.403 0 0 0 0 0 0 13.2943 0 12.3963 13.8218 0 0 0 0 0 0 0 0 0 0 0 10.3601 0 0 0 13.3418 0 0 0 0 0 0 14.0557 10.7323 0 0 0 0 0 0 11.2127 0 0 0 11.5869 0 0 10.9832 0 0 12.2046 14.8932 0 0 0 0 0 0 0 0 0 0 15.5413 0 0 0 13.4436 0 0 0 0 0 11.4109 0 0 11.419 0 0 0 0 0 0 0 0 0 0 0 13.779 0 13.7141 0 0 0 11.0037 0 0 Q9H252 KCNH6_HUMAN "Potassium voltage-gated channel subfamily H member 6 (Ether-a-go-go-related gene potassium channel 2, ERG-2, Eag-related protein 2, Ether-a-go-go-related protein 2, hERG-2, hERG2) (Voltage-gated potassium channel subunit Kv11.2)" KCNH6 ERG2 Homo sapiens (Human) membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity [GO:0005249]; membrane repolarization during action potential [GO:0086011]; potassium ion transmembrane transport [GO:0071805]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307] GO:0005242; GO:0005249; GO:0005886; GO:0005887; GO:0034765; GO:0042391; GO:0060307; GO:0071805; GO:0086011; GO:0086091 inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity [GO:0005249] HSPQSPQEDPDCWPLK 0.99489 -8.8337 0 0 0 0 0 0 0 0 0 0 0 10.0807 0 0 0 0 0 0 0 0 0 11.4876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0118 11.5071 0 0 0 0 0 12.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6S0 YTDC2_HUMAN "3'-5' RNA helicase YTHDC2, EC 3.6.4.13 (YTH domain-containing protein 2, hYTHDC2)" YTHDC2 Homo sapiens (Human) "germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]" endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770] "endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]" GO:0003723; GO:0005524; GO:0005634; GO:0005783; GO:0007286; GO:0008186; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247 "3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]" AFIHRLSQSLGLVSKSK 0.99489 -12.633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5662 0 0 0 0 0 0 0 0 11.8803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7711 0 10.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1006 0 0 0 0 14.505 13.4628 0 0 0 14.053 0 16.1353 0 0 13.1808 0 0 0 0 10.8695 0 0 0 0 0 15.3868 15.7556 0 0 0 0 0 0 0 0 0 13.5038 0 0 10.9157 0 0 0 0 0 13.8771 0 0 0 0 0 0 12.1677 0 0 0 0 0 0 0 0 0 13.9973 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1227 12.6158 0 0 0 0 0 0 0 0 0 0 12.4202 0 0 0 0 0 0 14.0822 0 0 0 12.7777 0 0 0 0 0 0 0 10.5926 Q9HBE1 PATZ1_HUMAN "POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)" PATZ1 PATZ RIAZ ZBTB19 ZNF278 ZSG Homo sapiens (Human) "male gonad development [GO:0008584]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]" male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; male gonad development [GO:0008584]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217]" GO:0000978; GO:0001227; GO:0001673; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0008584; GO:0010596; GO:0030217; GO:0031625; GO:0045892; GO:0045893; GO:0046872 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]" CQTCNASFATR 0.99489 -10.711 0 0 0 0 0 0 0 0 0 11.2938 0 0 10.3811 0 10.5135 10.908 10.3074 0 0 0 0 0 0 0 0 0 0 0 0 11.3368 12.5681 0 12.2467 0 0 0 0 0 0 11.1656 0 12.1259 12.9327 0 0 0 0 12.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1434 0 0 0 0 10.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8844 0 0 0 0 0 0 0 0 0 0 0 10.5914 11.4356 0 0 0 0 0 0 12.6834 12.3952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBE8 NLK_HUMAN "Serine/threonine-protein kinase NLK, EC 2.7.11.24 (Nemo-like kinase) (Protein LAK1)" NLK LAK1 Homo sapiens (Human) "intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of transcription, DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]" GO:0000287; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006468; GO:0007179; GO:0007223; GO:0018107; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0042501; GO:0046777; GO:0050821; GO:0106310; GO:0140297 ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625] CCFSTSTGR 0.99489 -8.2626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5M1 F215A_HUMAN "Uncharacterized protein FAM215A (Apoptosis-related protein 2, APR-2)" FAM215A APR2 C17orf88 Homo sapiens (Human) CFFSHGPK 0.99489 -12.629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NJG2 SWAHD_HUMAN Ankyrin repeat domain-containing protein SOWAHD (Ankyrin repeat domain-containing protein 58) (Protein sosondowah homolog D) SOWAHD ANKRD58 Homo sapiens (Human) AQLGGAANR 0.9949 -9.3969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5366 0 0 0 0 0 0 0 0 0 0 14.6766 0 0 0 0 0 0 0 0 12.826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9483 0 0 0 12.095 0 0 11.9381 12.2456 0 0 0 0 0 12.301 12.3899 0 0 0 12.35 0 12.149 12.2017 12.7501 0 0 0 0 10.8742 0 0 13.2958 0 12.3505 12.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2896 0 0 13.0505 0 0 0 P21918 DRD5_HUMAN D(1B) dopamine receptor (D(5) dopamine receptor) (D1beta dopamine receptor) (Dopamine D5 receptor) DRD5 DRD1B DRD1L2 Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular calcium ion homeostasis [GO:0006874]; cellular response to catecholamine stimulus [GO:0071870]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; negative regulation of blood pressure [GO:0045776]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of adenylate cyclase activity [GO:0045762]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; synaptic transmission, dopaminergic [GO:0001963]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060]" brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; synapse [GO:0045202] "brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; integral component of plasma membrane [GO:0005887]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; synapse [GO:0045202]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; associative learning [GO:0008306]; cellular calcium ion homeostasis [GO:0006874]; cellular response to catecholamine stimulus [GO:0071870]; chemical synaptic transmission [GO:0007268]; dopamine receptor signaling pathway [GO:0007212]; long-term synaptic depression [GO:0060292]; negative regulation of blood pressure [GO:0045776]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of adenylate cyclase activity [GO:0045762]; reactive oxygen species metabolic process [GO:0072593]; regulation of female receptivity [GO:0045924]; regulation of systemic arterial blood pressure by vasopressin [GO:0001992]; response to amphetamine [GO:0001975]; response to cocaine [GO:0042220]; sensitization [GO:0046960]; synaptic transmission, dopaminergic [GO:0001963]; transmission of nerve impulse [GO:0019226]; wound healing [GO:0042060]" GO:0001588; GO:0001963; GO:0001975; GO:0001992; GO:0001994; GO:0004930; GO:0004952; GO:0005886; GO:0005887; GO:0005929; GO:0006874; GO:0007189; GO:0007190; GO:0007191; GO:0007212; GO:0007268; GO:0008306; GO:0019226; GO:0031526; GO:0033861; GO:0035240; GO:0042060; GO:0042220; GO:0045202; GO:0045762; GO:0045776; GO:0045924; GO:0046960; GO:0060158; GO:0060170; GO:0060292; GO:0071870; GO:0071880; GO:0072593; GO:0097730 "dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]" IYRIAQVQIR 0.9949 -11.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22748 CAH4_HUMAN "Carbonic anhydrase 4, EC 4.2.1.1 (Carbonate dehydratase IV) (Carbonic anhydrase IV, CA-IV)" CA4 Homo sapiens (Human) bicarbonate transport [GO:0015701]; one-carbon metabolic process [GO:0006730] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658] anchored component of external side of plasma membrane [GO:0031362]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701]; one-carbon metabolic process [GO:0006730] GO:0004089; GO:0005791; GO:0005793; GO:0005794; GO:0005802; GO:0005886; GO:0006730; GO:0008270; GO:0009986; GO:0015701; GO:0016020; GO:0016324; GO:0016836; GO:0030658; GO:0030667; GO:0031362; GO:0031526; GO:0048471; GO:0070062 carbonate dehydratase activity [GO:0004089]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] EEKLRHYFR 0.9949 -8.3101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0333 0 0 0 0 0 14.8586 0 0 0 0 0 0 0 13.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50461 CSRP3_HUMAN "Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3, CRP3) (LIM domain protein, cardiac) (Muscle LIM protein)" CSRP3 CLP MLP Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac myofibril assembly [GO:0055003]; cellular calcium ion homeostasis [GO:0006874]; detection of muscle stretch [GO:0035995]; glucose homeostasis [GO:0042593]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; muscle cell cellular homeostasis [GO:0046716]; muscle tissue development [GO:0060537]; negative regulation of actin filament severing [GO:1903919]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of actin filament severing [GO:1903920]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase C signaling [GO:0070528]; protein localization to organelle [GO:0033365]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; T-tubule organization [GO:0033292] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; actin cytoskeleton organization [GO:0030036]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue development [GO:0048738]; cardiac myofibril assembly [GO:0055003]; cellular calcium ion homeostasis [GO:0006874]; detection of muscle stretch [GO:0035995]; glucose homeostasis [GO:0042593]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; muscle cell cellular homeostasis [GO:0046716]; muscle tissue development [GO:0060537]; negative regulation of actin filament severing [GO:1903919]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of actin filament severing [GO:1903920]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase C signaling [GO:0070528]; protein localization to organelle [GO:0033365]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; skeletal muscle tissue development [GO:0007519]; T-tubule organization [GO:0033292] GO:0002026; GO:0003300; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006874; GO:0006954; GO:0007519; GO:0008286; GO:0008307; GO:0030018; GO:0030036; GO:0031433; GO:0033292; GO:0033365; GO:0035995; GO:0042593; GO:0042802; GO:0042805; GO:0045214; GO:0045662; GO:0045663; GO:0045944; GO:0046716; GO:0046872; GO:0048738; GO:0055003; GO:0060048; GO:0060537; GO:0070528; GO:1903076; GO:1903919; GO:1903920 actin binding [GO:0003779]; actinin binding [GO:0042805]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433] FGESEKCPR 0.9949 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3473 0 14.7879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01432 AMPD3_HUMAN "AMP deaminase 3, EC 3.5.4.6 (AMP deaminase isoform E) (Erythrocyte AMP deaminase)" AMPD3 Homo sapiens (Human) AMP catabolic process [GO:0006196]; AMP metabolic process [GO:0046033]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; AMP catabolic process [GO:0006196]; AMP metabolic process [GO:0046033]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264] GO:0003876; GO:0005576; GO:0005829; GO:0006188; GO:0006196; GO:0032264; GO:0034774; GO:0046033; GO:0046872; GO:1904813 AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872] ELHLFLK 0.9949 -11.438 0 0 0 0 0 0 0 12.1424 0 0 0 0 0 0 0 0 0 0 0 0 16.115 0 0 12.612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5684 0 0 0 0 0 0 0 0 0 0 0 14.8105 0 0 0 14.04 0 0 13.7008 14.0736 13.7155 13.9832 14.0436 13.9425 12.9918 0 0 0 0 0 0 0 0 0 0 0 18.8612 13.9163 0 14.3857 0 0 0 19.1115 14.4406 0 14.8831 14.762 0 14.2555 18.9205 14.8823 14.3746 14.4622 14.3486 0 0 0 14.6742 0 14.4119 0 14.5479 14.6627 0 14.6119 16.1401 0 0 19.1234 14.7132 14.7731 14.4471 14.4402 0 0 0 14.4261 0 14.5488 0 11.1134 0 0 14.4564 14.4418 14.3271 0 0 14.571 0 0 0 0 0 0 0 0 14.9705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6777 0 14.6382 0 0 0 0 0 0 Q5GH70 XKR9_HUMAN "XK-related protein 9, hXKR9 [Cleaved into: XK-related protein 9, processed form ]" XKR9 XRG9 Homo sapiens (Human) apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782] GO:0005886; GO:0016020; GO:0016021; GO:0017128; GO:0043652; GO:0070782; GO:1902742 phospholipid scramblase activity [GO:0017128] IALFLLLFLWLLGIIWAFK 0.9949 -9.4083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.904 0 0 0 13.3061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0674 0 0 0 0 0 0 0 13.3819 0 0 0 0 0 0 14.0232 14.0609 0 13.9986 0 0 12.6943 0 13.7179 0 0 0 0 12.9115 13.9711 0 0 0 0 0 0 0 0 0 0 13.2535 0 0 0 0 0 0 10.8124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0218 0 14.1395 Q6ZN01 MASTR_HUMAN MEF2-activating motif and SAP domain-containing transcriptional regulator (MEF2-activating SAP transcriptional regulatory protein) MAMSTR MASTR Homo sapiens (Human) positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003712; GO:0005634; GO:0006357; GO:0010831; GO:0045944 transcription coregulator activity [GO:0003712] AQLLPNR 0.9949 -10.576 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9558 0 0 0 0 0 0 0 0 0 0 14.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6799 0 0 0 0 0 17.621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1035 0 0 0 0 0 Q6ZSC3 RBM43_HUMAN RNA-binding protein 43 (RNA-binding motif protein 43) RBM43 C2orf38 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] ETFILEGKENREK 0.9949 -11.053 0 0 0 0 0 0 0 0 12.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.506 0 0 0 0 0 14.1136 0 0 0 0 16.8027 0 0 0 0 0 0 0 Q8IZU1 FAM9A_HUMAN Protein FAM9A FAM9A Homo sapiens (Human) meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] nucleolus [GO:0005730]; synaptonemal complex [GO:0000795] nucleolus [GO:0005730]; synaptonemal complex [GO:0000795]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] GO:0000795; GO:0005730; GO:0007286; GO:0051321 AQLEAQVRAAPAKK 0.9949 -8.302 0 0 0 0 0 0 0 0 11.9001 0 0 0 0 0 0 0 0 0 13.671 0 0 0 0 0 11.3692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.387 0 0 0 13.6035 0 0 0 0 0 0 0 14.6736 0 0 0 12.3928 0 0 0 13.2884 0 0 0 0 0 0 0 0 0 0 0 0 0 12.214 0 0 0 0 0 0 0 12.5897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4T8 CBR4_HUMAN "3-oxoacyl-[acyl-carrier-protein] reductase, EC 1.1.1.100 (3-ketoacyl-[acyl-carrier-protein] reductase beta subunit, KAR beta subunit) (Carbonyl reductase family member 4, CBR4) (Quinone reductase CBR4, EC 1.6.5.10) (Short chain dehydrogenase/reductase family 45C member 1)" CBR4 SDR45C1 Homo sapiens (Human) daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289] mitochondrial matrix [GO:0005759]; oxidoreductase complex [GO:1990204] "mitochondrial matrix [GO:0005759]; oxidoreductase complex [GO:1990204]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]; protein homotetramerization [GO:0051289]" GO:0003955; GO:0004316; GO:0005759; GO:0006633; GO:0008753; GO:0016616; GO:0044597; GO:0044598; GO:0048038; GO:0051289; GO:0051290; GO:0070402; GO:1990204 "3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; quinone binding [GO:0048038]" ALAKEVAR 0.9949 -12.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92503 S14L1_HUMAN SEC14-like protein 1 SEC14L1 SEC14L Homo sapiens (Human) choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; RIG-I binding [GO:0039552]; choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of RIG-I signaling pathway [GO:0039536] GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039536; GO:0039552; GO:0045087 RIG-I binding [GO:0039552] DEHILRFLRAR 0.9949 -8.3106 0 13.6206 0 0 0 0 12.3364 0 0 0 0 0 0 0 0 0 12.7579 0 0 0 0 0 0 0 0 0 0 0 11.5664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4045 15.6833 15.5363 0 0 0 0 13.5612 0 0 0 0 13.0169 0 0 0 0 0 0 0 16.0131 0 12.1267 0 0 0 0 12.0013 0 15.7569 15.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1953 0 0 0 0 0 0 0 0 0 13.9109 0 0 0 15.4073 0 0 0 11.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9461 0 13.4372 0 Q9BZE0 GLIS2_HUMAN Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) GLIS2 NKL Homo sapiens (Human) "cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; cell differentiation involved in kidney development [GO:0061005]; central nervous system development [GO:0007417]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007417; GO:0016607; GO:0043433; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0061005; GO:0061484; GO:0097730; GO:1900182; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" CPTCSKSFSR 0.9949 -8.3023 0 0 0 0 11.7271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6148 0 0 0 0 0 11.9453 11.9235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4678 0 11.6528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6671 0 0 0 0 13.5847 0 0 0 0 0 0 0 12.6831 0 0 0 14.1908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6337 0 0 0 0 0 0 13.1552 0 0 0 0 0 0 0 Q9H981 ARP8_HUMAN "Actin-related protein 8, hArp8 (INO80 complex subunit N)" ACTR8 ARP8 INO80N Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]" centrosome [GO:0005813]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centrosome [GO:0005813]; Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription, DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]" GO:0000723; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0006275; GO:0006302; GO:0006310; GO:0006338; GO:0006355; GO:0007049; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051301; GO:0051726; GO:0060382; GO:1904507 ATP binding [GO:0005524] ECQLTNK 0.9949 -11.409 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7048 0 0 0 0 0 0 0 0 0 0 0 0 11.3898 0 0 0 0 0 0 0 0 0 0 14.2672 0 13.1923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.949 0 0 0 0 0 0 0 0 0 0 13.3703 0 0 0 0 0 0 0 0 0 0 12.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBI4 STML1_HUMAN "Stomatin-like protein 1, SLP-1 (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein, STORP)" STOML1 SLP1 UNC24 MSTP019 Homo sapiens (Human) lipid transport [GO:0006869] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; lipid transport [GO:0006869] GO:0005886; GO:0006869; GO:0016021; GO:0031902; GO:0045121 AFNVPPCKLASK 0.9949 -11.449 0 0 0 0 10.6881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5121 15.5401 14.7272 14.7465 0 14.5161 0 0 14.5398 0 14.4871 0 0 14.077 14.3786 14.2181 0 0 0 0 0 0 0 13.8066 13.6559 0 0 0 0 0 13.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7763 0 0 0 0 0 14.0723 0 0 0 13.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3622 0 0 0 0 0 15.3273 13.3133 13.6925 0 0 13.6714 0 0 0 0 0 0 0 13.8659 0 0 0 0 Q9ULR3 PPM1H_HUMAN "Protein phosphatase 1H, EC 3.1.3.16" PPM1H ARHCL1 KIAA1157 URCC2 Homo sapiens (Human) protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein dephosphorylation [GO:0006470] GO:0004721; GO:0005634; GO:0005654; GO:0005737; GO:0006470; GO:0017018; GO:0042802; GO:0098978 identical protein binding [GO:0042802]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721] PILILKETR 0.9949 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0723 0 0 0 13.0396 13.3026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3958 0 0 0 0 0 0 0 0 12.1234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6R1 S4A4_HUMAN "Electrogenic sodium bicarbonate cotransporter 1, Sodium bicarbonate cotransporter (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1)" SLC4A4 NBC NBC1 NBCE1 Homo sapiens (Human) bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; positive regulation of glycolytic process [GO:0045821]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857]; bicarbonate transport [GO:0015701]; ion homeostasis [GO:0050801]; positive regulation of glycolytic process [GO:0045821]; regulation of intracellular pH [GO:0051453]; regulation of membrane potential [GO:0042391]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104] GO:0005452; GO:0005886; GO:0005887; GO:0006814; GO:0008510; GO:0009986; GO:0015293; GO:0015701; GO:0016020; GO:0016323; GO:0022857; GO:0035725; GO:0036376; GO:0042391; GO:0042802; GO:0045821; GO:0050801; GO:0051453; GO:0055085; GO:0070062; GO:0150104 identical protein binding [GO:0042802]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857] AKSYHEIGR 0.9949 -11.452 0 0 0 10.3502 0 11.9912 0 0 12.4434 0 0 0 0 0 12.2209 0 0 0 10.8806 0 0 0 0 12.2803 11.2815 0 0 0 0 13.0968 0 0 0 0 0 0 0 12.1819 10.65 0 0 0 0 0 13.4463 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0114 0 0 0 0 0 0 0 14.0668 0 0 14.8548 0 0 15.171 14.6892 0 14.6789 0 14.4085 0 13.9758 0 15.5816 0 13.3635 14.3589 15.5161 15.0942 0 0 0 0 0 13.2077 0 12.5783 0 12.1764 0 0 0 0 0 0 0 0 13.3405 0 11.9419 0 14.8936 13.4467 14.382 0 0 0 0 12.6747 14.3895 0 13.6378 12.9944 0 11.7235 17.9081 0 12.2915 0 0 0 0 0 0 0 0 0 0 0 0 15.004 14.8946 0 0 0 0 0 13.7424 11.3587 13.9124 0 0 0 11.6824 13.8219 0 13.6946 0 12.4471 0 0 0 12.0247 0 12.0488 0 P01599 KV117_HUMAN Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA) IGKV1-17 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; antigen binding [GO:0003823]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0003823; GO:0005576; GO:0005615; GO:0005886; GO:0006955; GO:0019814; GO:0070062; GO:0072562 antigen binding [GO:0003823] LIYAASSLQSGVPSR 0.99491 -8.9002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1871 0 0 0 0 0 0 0 12.5538 0 0 0 0 0 0 0 15.2444 0 0 11.8846 14.9923 0 0 0 0 0 18.0908 0 0 0 0 0 0 0 0 10.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0636 0 0 0 0 0 0 0 9.72535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49326 FMO5_HUMAN "Flavin-containing monooxygenase 5, FMO 5 (Baeyer-Villiger monooxygenase 1, hBVMO1, EC 1.14.13.-) (Dimethylaniline monooxygenase [N-oxide-forming] 5, EC 1.14.13.8) (Dimethylaniline oxidase 5) (NADPH oxidase, EC 1.6.3.1)" FMO5 Homo sapiens (Human) lipid metabolic process [GO:0006629]; NADPH oxidation [GO:0070995]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; lipid metabolic process [GO:0006629]; NADPH oxidation [GO:0070995]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805]" GO:0004031; GO:0004497; GO:0004499; GO:0005783; GO:0005789; GO:0005829; GO:0006629; GO:0006805; GO:0016021; GO:0050660; GO:0050661; GO:0070995; GO:0090181; GO:0106294 "aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]" GAWILNRVGDYGYPADVLFSSRLTHFIWK 0.99491 -9.4403 12.7448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.171 0 0 0 13.2013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5693 0 0 14.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0503 0 0 11.5954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57727 TMPS3_HUMAN "Transmembrane protease serine 3, EC 3.4.21.- (Serine protease TADG-12) (Tumor-associated differentially-expressed gene 12 protein)" TMPRSS3 ECHOS1 TADG12 UNQ323/PRO382 Homo sapiens (Human) cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; cellular sodium ion homeostasis [GO:0006883]; proteolysis [GO:0006508]; sensory perception of sound [GO:0007605] GO:0004252; GO:0005044; GO:0005783; GO:0005789; GO:0006508; GO:0006883; GO:0007605; GO:0016021; GO:0017080; GO:0043025 scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080] DGEDEYRCVR 0.99491 -8.6062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5094 0 12.8429 0 0 0 0 0 0 11.9281 15.3295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13875 MOBP_HUMAN Myelin-associated oligodendrocyte basic protein MOBP Homo sapiens (Human) nervous system development [GO:0007399] cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471] cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; myosin binding [GO:0017022]; nervous system development [GO:0007399] GO:0003779; GO:0007399; GO:0017022; GO:0030864; GO:0048471 actin binding [GO:0003779]; myosin binding [GO:0017022] EEDWICCACQK 0.99491 -9.4466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9222 0 16.0659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7174 0 0 0 0 0 11.6615 0 0 10.7735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17R89 RHG44_HUMAN "Rho GTPase-activating protein 44 (NPC-A-10) (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2, RICH-2)" ARHGAP44 KIAA0672 RICH2 Homo sapiens (Human) "exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of Rac protein signal transduction [GO:0035020]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]" anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037] "anchoring junction [GO:0070161]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; modification of dendritic spine [GO:0098886]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of Rac protein signal transduction [GO:0035020]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]" GO:0005096; GO:0005543; GO:0005829; GO:0006887; GO:0007165; GO:0014069; GO:0030425; GO:0031256; GO:0031267; GO:0032956; GO:0035020; GO:0035021; GO:0043087; GO:0043197; GO:0048786; GO:0051056; GO:0051490; GO:0055037; GO:0061001; GO:0070161; GO:0098886; GO:0098887; GO:0098978; GO:0099152 GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267] EEMEEAANR 0.99491 -10.595 0 0 0 13.2946 0 0 10.9682 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3531 0 0 0 0 0 0 0 0 0 0 0 15.2186 14.3969 0 0 0 0 0 0 0 0 0 13.4426 14.8805 0 0 14.9399 0 14.7777 13.2277 12.6487 0 15.5479 0 13.6014 0 13.4959 0 0 13.4694 13.4728 14.2414 0 13.6545 0 0 15.4334 0 0 13.8602 13.5497 13.2409 0 0 0 13.5064 0 0 0 0 13.77 13.4463 0 13.2291 14.2009 14.8659 0 13.4371 0 13.8166 14.8503 13.224 13.9191 0 13.1827 0 0 0 0 0 13.4135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q494R0 FBAS1_HUMAN Putative uncharacterized protein FBXL19-AS1 (FBXL19 antisense RNA 1) (FBXL19 antisense gene protein 1) FBXL19-AS1 NCRNA00095 Homo sapiens (Human) GDCDMGCVVQASGLFPAEMRER 0.99491 -8.8992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5997 0 0 0 0 0 0 11.6138 0 0 0 0 0 0 10.6857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2223 0 0 0 0 12.6604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2502 0 0 0 0 0 0 0 0 0 0 13.0592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWF7 NXPE4_HUMAN NXPE family member 4 (Protein FAM55D) NXPE4 C11orf33 FAM55D UNQ3018/PRO9799 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 AIQHLLLR 0.99491 -9.4415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.61611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5606 0 0 0 0 0 0 0 12.2854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2625 0 0 0 0 0 0 0 0 0 11.4827 0 0 0 0 0 0 0 0 0 10.359 0 0 0 13.1456 0 0 0 13.0682 0 0 0 0 0 13.6562 0 0 0 0 0 0 0 0 0 0 13.5223 13.4903 0 0 0 0 0 0 0 0 0 0 13.4159 0 14.5658 0 0 0 10.8817 0 0 0 0 0 0 13.232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPC3 CIP1_HUMAN "E3 ubiquitin-protein ligase CCNB1IP1, EC 2.3.2.27 (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1)" CCNB1IP1 C14orf18 HEI10 Homo sapiens (Human) blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286] synaptonemal complex [GO:0000795] synaptonemal complex [GO:0000795]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286] GO:0000795; GO:0001825; GO:0007131; GO:0007286; GO:0042802; GO:0046872; GO:0051026; GO:0061630 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] ALAFWTYQVHQERLYQEYNFSK 0.99491 -8.3291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7547 0 0 0 17.4055 0 0 12.5807 0 0 0 16.6009 0 0 0 0 16.2038 0 0 0 0 0 0 0 14.5272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4662 0 0 0 0 12.0013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NW61 PKHJ1_HUMAN "Pleckstrin homology domain-containing family J member 1, PH domain-containing family J member 1 (Guanine nucleotide-releasing protein x)" PLEKHJ1 GNRPX Homo sapiens (Human) "endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0042147; GO:0055037 ASYEFMR 0.99491 -8.3342 0 0 0 0 0 0 0 0 0 0 11.0568 0 0 0 0 0 0 0 0 14.2664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.722 0 0 0 15.8891 0 0 0 0 0 0 0 13.0024 0 0 0 0 0 0 0 15.1262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1294 12.2975 0 0 0 11.4107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNX9 KCJ14_HUMAN "ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K(+) channel Kir2.4, IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14)" KCNJ14 IRK4 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005886; GO:0008076; GO:0030425; GO:0034765; GO:0043025; GO:1990573 inward rectifier potassium channel activity [GO:0005242] AQLLQPR 0.99491 -12.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8693 14.3497 0 0 0 0 0 0 11.0132 16.7757 0 0 0 9.82389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A183 LCE6A_HUMAN Late cornified envelope protein 6A LCE6A C1orf44 Homo sapiens (Human) keratinization [GO:0031424] keratinization [GO:0031424] GO:0031424 EEECEGD 0.99492 -13.73 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8202 0 0 0 0 0 0 0 0 0 0 0 0 14.2491 0 13.4779 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6081 12.1177 0 0 12.8291 0 0 0 0 0 0 0 0 0 0 0 0 0 13.344 0 0 0 0 12.1357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2487 0 0 0 0 0 0 0 0 0 0 0 11.33 0 0 0 0 0 0 0 0 0 0 0 0 0 B2RV13 CF97D_HUMAN Sperm axonemal maintenance protein CFAP97D1 (CFAP97 domain-containing protein 1) CFAP97D1 C17orf105 Homo sapiens (Human) sperm axoneme assembly [GO:0007288] sperm axoneme assembly [GO:0007288] GO:0007288 ELVRITMENQGILK 0.99492 -13.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6561 0 0 0 16.0859 0 0 0 0 0 0 0 0 0 0 13.371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2694 0 0 0 0 0 0 0 0 O15357 SHIP2_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2, EC 3.1.3.86 (Inositol polyphosphate phosphatase-like protein 1, INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2, SH2 domain-containing inositol phosphatase 2, SHIP-2)" INPPL1 SHIP2 Homo sapiens (Human) actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of immune response [GO:0050776]; regulation of signal transduction [GO:0009966]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178]" GO:0001958; GO:0002376; GO:0003779; GO:0004445; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006006; GO:0006661; GO:0006897; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0009966; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0034485; GO:0042169; GO:0043569; GO:0046856; GO:0050776; GO:0097178 "actin binding [GO:0003779]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]" APVPSATKNKVAITVPAPQLGHHR 0.99492 -12.851 0 0 0 0 0 0 0 0 0 12.81 0 0 0 14.2912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4195 0 10.5764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7806 15.1231 0 0 0 0 0 0 0 0 0 0 0 10.913 0 0 15.256 0 0 0 0 0 0 19.2702 14.0712 0 13.3819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7038 0 14.4594 0 0 0 0 0 15.8258 0 13.3322 0 0 0 0 0 0 0 0 0 0 10.6187 0 0 0 0 0 0 0 0 14.688 15.1213 0 0 0 0 0 0 0 0 0 0 0 14.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13061 TRDN_HUMAN Triadin TRDN Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum membrane organization [GO:0090158]; establishment of localization in cell [GO:0051649]; heart contraction [GO:0060047]; muscle contraction [GO:0006936]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to bacterium [GO:0009617] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; cellular calcium ion homeostasis [GO:0006874]; cytoplasmic microtubule organization [GO:0031122]; endoplasmic reticulum membrane organization [GO:0090158]; establishment of localization in cell [GO:0051649]; heart contraction [GO:0060047]; muscle contraction [GO:0006936]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901846]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to bacterium [GO:0009617] GO:0005102; GO:0005783; GO:0005829; GO:0005886; GO:0006874; GO:0006936; GO:0009617; GO:0010649; GO:0010880; GO:0014701; GO:0014808; GO:0016021; GO:0016529; GO:0030314; GO:0030674; GO:0031122; GO:0033017; GO:0033018; GO:0044325; GO:0051279; GO:0051649; GO:0060047; GO:0060315; GO:0060316; GO:0086036; GO:0090158; GO:1901846 protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325] AGKEVKPK 0.99492 -8.9648 0 0 0 0 14.088 0 0 14.3346 0 11.8251 11.662 11.6167 0 0 0 0 0 13.579 0 11.8129 0 0 0 15.7128 13.6632 13.6089 14.5616 0 0 0 0 11.8119 0 0 0 0 0 0 0 11.8627 11.5429 0 0 0 0 14.1842 13.3375 13.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4211 0 15.1105 0 0 13.6472 0 0 0 19.8607 0 0 0 0 14.4385 0 0 0 0 0 0 0 13.3472 0 14.5156 0 0 0 0 0 13.7215 14.0093 13.3667 0 13.5456 0 0 0 0 0 13.9324 14.6795 0 13.6225 0 0 15.0931 0 0 20.5944 13.5158 18.2608 0 13.59 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5765 13.1933 0 0 15.2881 15.7766 0 16.3072 16.1587 0 14.0369 0 0 14.1047 14.0767 0 0 0 0 0 0 0 0 0 14.0282 0 0 Q14055 CO9A2_HUMAN Collagen alpha-2(IX) chain COL9A2 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] collagen type IX trimer [GO:0005594]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501] GO:0001501; GO:0005201; GO:0005576; GO:0005594; GO:0005615; GO:0005788; GO:0030020; GO:0030198; GO:0031012; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] AAATASPRSLLVLLQVVVLALAQIR 0.99492 -13.74 0 0 0 0 0 0 0 0 10.1989 0 0 0 0 0 0 0 0 0 12.3941 0 0 0 0 0 0 0 0 0 0 0 12.6914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9195 0 0 0 0 0 0 0 0 0 11.3766 0 0 0 0 0 0 12.6845 0 15.5598 0 0 0 12.7568 0 0 0 0 0 11.9578 0 0 12.9682 12.6662 0 12.6558 0 13.9335 0 0 0 0 0 0 0 0 0 0 0 12.4949 12.7577 0 0 12.5655 0 0 0 0 13.7305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0684 0 0 0 11.1619 13.9246 13.0341 0 0 0 0 0 0 0 0 0 0 0 0 13.2759 Q15477 SKIV2_HUMAN "Helicase SKI2W, Ski2, EC 3.6.4.- (Helicase-like protein, HLP)" SKIV2L DDX13 SKI2W SKIV2 W Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]" cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087] "cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401]" GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005829; GO:0006401; GO:0016787; GO:0055087; GO:0070478 ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AQLPVVVFTFSR 0.99492 -31.939 0 10.674 0 0 0 0 0 0 0 0 11.109 0 0 0 0 0 0 0 14.7873 0 0 0 0 0 0 0 0 12.0221 0 11.3452 10.7192 0 0 0 0 0 0 0 0 0 0 0 11.1903 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4166 0 0 0 0 0 11.7549 0 0 11.7318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8567 15.6764 0 15.2103 0 15.4236 0 10.3713 0 15.4772 0 0 0 0 0 0 0 15.2306 0 15.2604 14.9357 14.877 0 0 0 15.2123 14.6681 0 0 0 0 0 0 0 0 15.1776 0 0 0 0 0 0 0 0 0 0 0 14.5401 0 0 0 0 0 0 0 13.4677 13.7357 0 13.3938 13.8398 0 13.2054 0 0 0 0 0 0 0 0 0 0 0 0 13.5018 0 0 Q5D0E6 DALD3_HUMAN DALR anticodon-binding domain-containing protein 3 DALRD3 Homo sapiens (Human) arginyl-tRNA aminoacylation [GO:0006420]; tRNA C3-cytosine methylation [GO:0106217] arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; arginyl-tRNA aminoacylation [GO:0006420]; tRNA C3-cytosine methylation [GO:0106217] GO:0000049; GO:0004814; GO:0005524; GO:0006420; GO:0106217 arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; tRNA binding [GO:0000049] AHGVCVR 0.99492 -9.9559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9633 13.4624 0 0 0 0 0 0 12.3571 0 0 0 0 13.0477 0 0 0 13.1066 0 0 0 13.0013 0 0 0 0 Q8N8M0 NAT16_HUMAN "Probable N-acetyltransferase 16, EC 2.3.1.-" NAT16 C7orf52 Homo sapiens (Human) "acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; N-acetyltransferase activity [GO:0008080]" GO:0008080; GO:0016747 "acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; N-acetyltransferase activity [GO:0008080]" FCSQLVK 0.99492 -12.852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3419 0 0 0 0 0 0 0 0 0 0 0 11.7002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5746 0 0 0 0 0 Q8NCU7 C2C4A_HUMAN C2 calcium-dependent domain-containing protein 4A (Nuclear-localized factor 1) (Protein FAM148A) C2CD4A FAM148A NLF1 Homo sapiens (Human) positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; positive regulation of acute inflammatory response [GO:0002675]; regulation of cell adhesion [GO:0030155]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528] GO:0002528; GO:0002675; GO:0005634; GO:0005654; GO:0005730; GO:0030155 ESLLLGGPPAPRPR 0.99492 -10.369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.727 14.0131 0 15.7602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7264 0 11.7601 0 0 0 0 0 0 11.4175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DY2 DRC10_HUMAN Dynein regulatory complex protein 10 (IQ domain-containing protein D) IQCD DRC10 Homo sapiens (Human) ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514] GO:0005737; GO:0031514; GO:0036064 EDMEGMLGEDVMR 0.99492 -13.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4737 12.2389 0 0 0 12.0699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0768 12.8513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96G46 DUS3L_HUMAN "tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like, EC 1.3.1.89 (mRNA-dihydrouridine synthase DUS3L, EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)" DUS3L Homo sapiens (Human) mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943] flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943] GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0017150; GO:0046872; GO:0050660; GO:0106414 flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150] CPYGVTCRFAGAHLR 0.99492 -13.735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4263 0 0 0 0 0 0 0 0 0 12.9668 0 0 15.9096 0 0 0 0 0 0 0 0 16.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0527 0 0 16.421 0 0 0 0 0 15.1599 13.975 0 0 16.2855 0 0 0 0 0 0 0 0 0 15.8218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5F2 PCDBB_HUMAN "Protocadherin beta-11, PCDH-beta-11" PCDHB11 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] FLKPVIPNIQAKGLGK 0.99492 -10.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02730 B3AT_HUMAN "Band 3 anion transport protein (Anion exchange protein 1, AE 1, Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233)" SLC4A1 AE1 DI EPB3 Homo sapiens (Human) anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018] basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857]; anion transport [GO:0006820]; bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; cellular ion homeostasis [GO:0006873]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; ion homeostasis [GO:0050801]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085] GO:0005452; GO:0005886; GO:0005887; GO:0006820; GO:0006821; GO:0006873; GO:0007596; GO:0008509; GO:0009898; GO:0015106; GO:0015108; GO:0015301; GO:0015701; GO:0016021; GO:0016323; GO:0017121; GO:0022857; GO:0030018; GO:0030492; GO:0030506; GO:0030863; GO:0035811; GO:0042803; GO:0043495; GO:0045852; GO:0048821; GO:0050801; GO:0051354; GO:0051453; GO:0055085; GO:0070062; GO:0072562; GO:0072659; GO:1904539 anion transmembrane transporter activity [GO:0008509]; anion:anion antiporter activity [GO:0015301]; ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; hemoglobin binding [GO:0030492]; inorganic anion exchanger activity [GO:0005452]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; transmembrane transporter activity [GO:0022857] EELLRALLLKHSHAGELEALGGVK 0.99493 -8.9835 0 0 0 0 0 11.7886 0 0 0 0 0 0 0 0 11.097 0 15.1644 0 0 0 18.799 0 0 0 0 16.5467 0 0 0 0 10.6831 0 0 11.4854 0 0 11.6186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0637 0 15.3297 0 20.2219 0 0 15.2292 0 15.6938 14.7991 11.3713 13.3039 12.1166 14.9867 11.8129 0 12.8629 0 15.117 0 0 0 0 0 13.5156 0 12.7947 0 0 22.9997 0 0 0 12.8762 19.6738 0 0 14.0869 0 0 19.7416 12.0651 0 14.3596 22.7434 0 20.5171 22.8339 13.7919 18.9438 0 16.7898 19.878 13.2174 18.698 0 0 0 16.9402 14.121 0 0 0 21.729 21.2937 0 0 0 21.6149 0 21.3428 21.7036 0 19.089 18.9422 0 12.2842 20.87 0 0 0 14.3762 15.6919 0 0 0 13.2457 13.3953 0 0 0 14.3455 14.9922 15.0488 0 13.2906 0 0 15.5635 0 0 12.7959 0 0 18.764 19.1716 0 19.5934 0 15.5411 0 P14735 IDE_HUMAN "Insulin-degrading enzyme, EC 3.4.24.56 (Abeta-degrading protease) (Insulin protease, Insulinase) (Insulysin)" IDE Homo sapiens (Human) amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992] GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0008340; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0019885; GO:0030163; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0045732; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0140036; GO:0150094; GO:1901142; GO:1901143; GO:1903715 ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] IVPIKDIRNLYVTFPIPDLQK 0.99493 -13.791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0068 0 0 0 0 0 0 0 0 0 0 0 0 11.4568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.859 0 0 0 0 0 0 0 0 15.7011 0 0 0 0 0 13.0817 0 0 0 0 15.3305 13.8905 14.2493 0 14.2613 14.6595 14.4946 13.6171 0 0 14.1158 14.34 0 14.1107 12.944 0 0 0 15.2538 14.1952 15.1518 14.3567 0 13.6981 0 12.1015 0 14.842 0 13.8142 0 0 0 13.1711 13.2507 15.6958 14.5697 13.4231 14.0928 12.9343 10.8032 15.6148 0 0 0 0 0 0 0 0 13.0868 0 12.968 0 0 14.535 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4205 0 0 0 0 0 0 0 0 0 0 0 Q6UVM3 KCNT2_HUMAN Potassium channel subfamily T member 2 (Sequence like an intermediate conductance potassium channel subunit) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1) KCNT2 SLICK Homo sapiens (Human) potassium ion export across plasma membrane [GO:0097623] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chloride-activated potassium channel activity [GO:0070089]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]; potassium ion export across plasma membrane [GO:0097623] GO:0005228; GO:0005524; GO:0005886; GO:0015271; GO:0016021; GO:0070089; GO:0097623 ATP binding [GO:0005524]; chloride-activated potassium channel activity [GO:0070089]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271] ERERGSNLAFMFR 0.99493 -35.938 0 0 0 0 0 0 0 0 0 0 0 0 0 13.161 0 0 13.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0997 0 0 0 11.7647 10.8053 0 0 0 0 0 0 11.9534 0 0 0 0 0 0 0 0 0 12.0088 0 0 0 0 0 0 0 0 0 0 14.7578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7316 0 0 12.6592 0 0 0 0 0 0 13.671 0 0 0 0 0 0 0 0 13.7396 0 0 0 13.1007 0 0 0 0 0 0 13.7329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6224 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0816 0 0 0 0 0 0 0 11.4638 0 0 0 0 0 0 0 0 0 Q8N4P6 LRC71_HUMAN Leucine-rich repeat-containing protein 71 LRRC71 C1orf92 Homo sapiens (Human) AFELTHTEVVERR 0.99493 -11.263 0 0 0 11.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6783 0 0 0 0 0 0 0 0 0 10.5396 0 0 0 0 0 0 0 0 0 0 0 Q8NGN0 OR4D5_HUMAN Olfactory receptor 4D5 (Olfactory receptor OR11-276) OR4D5 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ALSTCASHIAVVTLIFVPCIYVYTRPFR 0.99493 -5.3482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8806 0 0 0 0 0 0 0 0 0 0 0 0 12.6056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TAI1 TYMOS_HUMAN TYMS opposite strand protein TYMSOS C18orf56 Homo sapiens (Human) CPCGRPS 0.99493 -11.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0454 0 0 0 0 0 0 0 Q96F24 NRBF2_HUMAN "Nuclear receptor-binding factor 2, NRBF-2 (Comodulator of PPAR and RXR)" NRBF2 COPR Homo sapiens (Human) autophagy [GO:0006914]; regulation of lipid kinase activity [GO:0043550]; response to endoplasmic reticulum stress [GO:0034976] "autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]" "autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleoplasm [GO:0005654]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; autophagy [GO:0006914]; regulation of lipid kinase activity [GO:0043550]; response to endoplasmic reticulum stress [GO:0034976]" GO:0005654; GO:0005737; GO:0005776; GO:0006914; GO:0031410; GO:0034976; GO:0035032; GO:0043550 AAAYLSEAMKLTQSEQAHLSLELQR 0.99493 -8.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2598 0 0 12.9563 0 0 0 0 14.4727 0 0 0 0 0 0 0 15.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LU7 MRFL_HUMAN Myelin regulatory factor-like protein MYRFL C12orf15 C12orf28 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]" endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autoprocessing [GO:0016540]" GO:0003700; GO:0005634; GO:0005789; GO:0016021; GO:0016540; GO:0043565; GO:0045893 DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565] GACYPTLRPTAGR 0.99493 -8.6904 0 0 0 0 0 0 0 0 14.9341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3863 13.246 0 0 12.3881 12.6304 11.3635 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4406 0 0 0 0 0 12.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4146 13.3192 13.1228 0 0 17.2824 0 0 13.495 13.1496 0 0 0 13.3281 0 15.1549 16.0127 11.4146 0 0 0 0 13.5274 0 0 0 0 0 0 0 0 0 13.0613 0 0 14.2155 14.6715 13.7164 0 0 0 0 13.0021 0 13.4177 0 0 0 0 0 0 0 0 0 13.1739 0 0 13.3225 0 0 0 10.4048 0 9.97571 0 0 0 13.2213 13.3544 0 14.9496 0 0 0 0 0 0 0 0 13.6908 0 0 0 0 0 0 0 0 0 0 0 13.5643 0 14.5054 10.4156 13.068 0 13.3887 0 0 15.2825 0 0 Q96MG7 NSE3_HUMAN "Non-structural maintenance of chromosomes element 3 homolog, Non-SMC element 3 homolog (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2)" NSMCE3 HCA4 MAGEG1 NDNL2 Homo sapiens (Human) cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein sumoylation [GO:0016925]; regulation of growth [GO:0040008]; regulation of telomere maintenance [GO:0032204] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; protein dimerization activity [GO:0046983]; cellular response to hydroxyurea [GO:0072711]; cellular response to radiation [GO:0071478]; cellular response to UV [GO:0034644]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; protein sumoylation [GO:0016925]; regulation of growth [GO:0040008]; regulation of telomere maintenance [GO:0032204]" GO:0000122; GO:0000724; GO:0000781; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0016925; GO:0030915; GO:0031398; GO:0032204; GO:0034644; GO:0040008; GO:0046983; GO:0071478; GO:0072711 protein dimerization activity [GO:0046983] DRDWSHSGNPGASR 0.99493 -11.26 0 0 0 0 0 0 0 0 13.4118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1302 0 0 Q99963 SH3G3_HUMAN Endophilin-A3 (EEN-B2) (Endophilin-3) (SH3 domain protein 2C) (SH3 domain-containing GRB2-like protein 3) SH3GL3 CNSA3 SH3D2C Homo sapiens (Human) central nervous system development [GO:0007417]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; positive regulation of neuron differentiation [GO:0045666]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191] "acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endosome [GO:0098845]; presynapse [GO:0098793]" "acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic endosome [GO:0098845]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022]; central nervous system development [GO:0007417]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; positive regulation of neuron differentiation [GO:0045666]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191]" GO:0001669; GO:0005737; GO:0007165; GO:0007417; GO:0008022; GO:0008289; GO:0016191; GO:0031901; GO:0042802; GO:0045666; GO:0098793; GO:0098845; GO:0098978; GO:0099092; GO:1900186 identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein C-terminus binding [GO:0008022] AKLGMLNTVSKIR 0.99493 -10.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5363 0 0 0 15.4947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.342 0 0 0 0 0 14.1075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2423 0 0 0 Q9BTE6 AASD1_HUMAN Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1) AARSD1 Homo sapiens (Human) alanyl-tRNA aminoacylation [GO:0006419]; regulation of translational fidelity [GO:0006450] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; alanyl-tRNA aminoacylation [GO:0006419]; regulation of translational fidelity [GO:0006450] GO:0002196; GO:0003676; GO:0004813; GO:0005524; GO:0005634; GO:0005737; GO:0006419; GO:0006450; GO:0046872 alanine-tRNA ligase activity [GO:0004813]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; Ser-tRNA(Ala) hydrolase activity [GO:0002196] GAGKKGR 0.99493 -8.6941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8691 13.9622 0 0 0 0 0 0 14.7789 0 15.2476 0 0 0 0 0 0 0 14.3062 11.4589 0 0 0 0 0 0 0 0 0 12.9403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2166 0 0 0 0 0 0 14.2628 0 0 0 0 0 12.7949 0 14.8043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2A2 AL8A1_HUMAN "2-aminomuconic semialdehyde dehydrogenase, EC 1.2.1.32 (Aldehyde dehydrogenase 12) (Aldehyde dehydrogenase family 8 member A1)" ALDH8A1 ALDH12 Homo sapiens (Human) 9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; retinal dehydrogenase activity [GO:0001758]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573]" GO:0001758; GO:0005829; GO:0016620; GO:0042573; GO:0042574; GO:0042904; GO:0047102; GO:0070062; GO:0097053 "aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; retinal dehydrogenase activity [GO:0001758]" FLPCSSYIDSYDPSTGEVYCR 0.99493 -8.6931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1397 0 0 0 0 0 0 0 0 0 0 0 Q9H6X5 CS044_HUMAN Uncharacterized protein C19orf44 C19orf44 Homo sapiens (Human) IAPGHSR 0.99493 -11.236 0 0 0 0 0 0 0 0 0 0 0 0 11.9177 0 0 0 0 0 0 0 0 0 0 13.0162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4421 0 0 0 0 0 0 0 14.5096 0 0 0 0 0 0 0 18.1737 0 0 0 0 0 14.1716 0 0 0 0 0 0 0 0 0 0 0 0 12.7183 13.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ88 TIGAR_HUMAN "Fructose-2,6-bisphosphatase TIGAR, EC 3.1.3.46 (TP53-induced glycolysis and apoptosis regulator) (TP53-induced glycolysis regulatory phosphatase)" TIGAR C12orf5 Homo sapiens (Human) "cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; glucose catabolic process to lactate via pyruvate [GO:0019661]; glycolytic process [GO:0006096]; intestinal epithelial cell development [GO:0060576]; mitophagy [GO:0000423]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron death [GO:1901215]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA repair [GO:0045739]; positive regulation of hexokinase activity [GO:1903301]; reactive oxygen species metabolic process [GO:0072593]; regulation of pentose-phosphate shunt [GO:0043456]; regulation of response to DNA damage checkpoint signaling [GO:1902153]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; bisphosphoglycerate 2-phosphatase activity [GO:0004083]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; glucose catabolic process to lactate via pyruvate [GO:0019661]; glycolytic process [GO:0006096]; intestinal epithelial cell development [GO:0060576]; mitophagy [GO:0000423]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuron death [GO:1901215]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA repair [GO:0045739]; positive regulation of hexokinase activity [GO:1903301]; reactive oxygen species metabolic process [GO:0072593]; regulation of pentose-phosphate shunt [GO:0043456]; regulation of response to DNA damage checkpoint signaling [GO:1902153]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]" GO:0000423; GO:0002931; GO:0004083; GO:0004331; GO:0005634; GO:0005737; GO:0005741; GO:0005829; GO:0006003; GO:0006096; GO:0006974; GO:0009410; GO:0010332; GO:0010659; GO:0010666; GO:0019661; GO:0030388; GO:0043069; GO:0043456; GO:0045739; GO:0045820; GO:0060576; GO:0071279; GO:0071456; GO:0072593; GO:1901215; GO:1901525; GO:1902153; GO:1903301; GO:1904024; GO:2000378 "bisphosphoglycerate 2-phosphatase activity [GO:0004083]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]" ARFALTVVR 0.99493 -5.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8269 0 0 0 14.4634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9896 0 0 0 0 0 0 14.5656 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGR2 Z3H7B_HUMAN "Zinc finger CCCH domain-containing protein 7B (Rotavirus 'X'-associated non-structural protein, RoXaN)" ZC3H7B KIAA1031 Homo sapiens (Human) miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608] nucleus [GO:0005634] nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608] GO:0003723; GO:0005634; GO:0010608; GO:0035196; GO:0035198; GO:0046872 metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] ACPDGDKCRCAHGQEELNEWLDR 0.99493 -35.924 0 0 0 0 0 0 0 0 0 0 10.8645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6673 0 0 0 0 0 0 0 0 0 0 0 11.4164 9.67751 0 0 0 0 0 0 0 0 0 11.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7673 12.1761 13.418 0 0 0 0 0 0 0 12.6178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2599 13.2804 0 12.4015 0 13.6839 0 15.0794 0 0 0 12.4962 13.1003 12.0452 13.7945 0 0 0 0 0 0 0 11.6521 13.645 Q9Y3D9 RT23_HUMAN "28S ribosomal protein S23, mitochondrial, MRP-S23, S23mt (Mitochondrial small ribosomal subunit protein mS23)" MRPS23 CGI-138 HSPC329 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005763; GO:0031965; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] AGVLKEKPLWFDVYDAFPPLR 0.99493 -9.976 0 0 0 0 0 13.0393 11.0805 0 0 0 0 0 0 0 0 0 0 0 12.4922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2225 12.2378 0 0 0 12.4833 0 15.3458 12.4567 12.6065 12.5355 15.2459 15.1996 12.8072 0 0 0 0 0 0 0 0 14.1524 0 13.4767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5214 12.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6199 0 0 0 0 0 0 0 0 0 13.6013 0 Q9Y603 ETV7_HUMAN Transcription factor ETV7 (ETS translocation variant 7) (ETS-related protein Tel2) (Tel-related Ets factor) (Transcription factor Tel-2) ETV7 TEL2 TELB TREF Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0006357; GO:0006366; GO:0009887; GO:0030154; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ALRHYYKLNIIK 0.99493 -5.3425 0 0 0 0 0 0 0 0 0 0 0 0 11.2272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5064 12.5592 0 11.5351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2274 0 0 11.829 0 0 0 0 0 13.0585 0 0 0 0 0 15.0809 14.1777 0 0 0 0 0 0 0 0 14.4812 0 0 0 0 13.1523 0 0 0 0 0 0 12.6385 0 0 0 0 0 12.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9196 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1819 14.702 12.7712 13.9903 0 0 0 0 13.564 0 0 0 0 0 0 0 12.0789 0 0 0 0 0 0 0 0 0 Q9Y6X3 SCC4_HUMAN "MAU2 chromatid cohesion factor homolog, MAU-2 (Cohesin loading complex subunit SCC4 homolog)" MAU2 KIAA0892 SCC4 Homo sapiens (Human) cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; double-stranded DNA binding [GO:0003690]; protein N-terminus binding [GO:0047485]; cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088] GO:0000785; GO:0003690; GO:0005634; GO:0005654; GO:0016604; GO:0032116; GO:0034088; GO:0047485; GO:0051301; GO:0071921; GO:0090694 double-stranded DNA binding [GO:0003690]; protein N-terminus binding [GO:0047485] AWLISQQIPQFEDVK 0.99493 -5.3496 0 0 0 0 0 0 0 0 10.8965 0 0 0 0 0 0 0 0 0 0 0 12.2525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7066 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4268 0 0 0 0 0 0 0 13.1189 0 13.5136 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05823 RN5A_HUMAN "2-5A-dependent ribonuclease, 2-5A-dependent RNase, EC 3.1.26.- (Ribonuclease 4) (Ribonuclease L, RNase L)" RNASEL RNS4 Homo sapiens (Human) defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; defense response to virus [GO:0051607]; fat cell differentiation [GO:0045444]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; RNA processing [GO:0006396]; rRNA processing [GO:0006364] GO:0003723; GO:0004521; GO:0004540; GO:0004672; GO:0005524; GO:0005759; GO:0005829; GO:0006364; GO:0006396; GO:0006397; GO:0006468; GO:0016363; GO:0019843; GO:0042802; GO:0043021; GO:0043488; GO:0045071; GO:0045444; GO:0045944; GO:0046326; GO:0046872; GO:0051607 ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] FLYKRGANVNLR 0.99494 -10.441 10.8111 0 0 13.8897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2642 0 0 0 16.0534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.832 0 0 12.8403 0 12.4746 0 0 13.784 0 0 0 0 0 12.6229 0 0 0 0 0 0 0 0 0 0 0 10.1042 12.0143 12.7228 12.234 14.2837 13.7536 13.6363 0 0 0 17.5268 0 17.5489 0 15.3787 15.8187 0 14.8996 14.8615 14.0257 15.3815 12.7033 14.6496 15.4699 11.5367 14.8157 16.0645 15.3894 17.1134 0 14.2229 15.1127 0 16.016 14.6498 12.9518 0 13.682 16.9064 13.9683 13.1837 15.5947 13.4795 17.1057 16.9186 15.6374 16.2211 15.8019 13.0981 13.5071 14.8888 0 15.4679 14.4767 14.7379 17.8001 12.4929 12.4932 15.8705 17.4445 0 14.7114 18.8461 12.1535 14.0634 13.4741 12.7528 14.1108 0 15.3629 0 14.1661 15.1278 17.3444 15.4959 15.2514 14.5631 15.3128 0 13.4231 14.196 15.1149 11.9965 0 13.8578 16.1747 15.2152 12.5313 14.4406 14.352 13.1734 0 0 0 0 0 0 0 0 0 9.44603 0 0 0 13.116 12.8706 0 13.192 14.0745 12.8953 0 14.1612 0 0 0 A6NMZ2 SNTAN_HUMAN Sentan (Protein S100-A1-like) (S100 calcium-binding protein A1-like) SNTN S100A1L Homo sapiens (Human) cilium [GO:0005929] cilium [GO:0005929]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914] GO:0005509; GO:0005929; GO:0046914; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; transition metal ion binding [GO:0046914] ALRKCSDLEK 0.99494 -8.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B5MCN3 S14L6_HUMAN Putative SEC14-like protein 6 SEC14L6 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 DLWKPGIELLQEFFSALEANYPEILKSLIVVR 0.99494 -10.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5741 0 0 0 0 0 11.3856 0 0 0 13.5175 10.6748 0 0 0 12.0652 0 0 0 0 0 0 0 0 0 0 0 0 11.3579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2275 12.6333 0 0 13.4932 0 0 0 0 0 0 0 0 13.3496 0 0 0 13.118 0 12.4918 0 0 13.0013 13.1896 0 0 12.8256 0 0 0 12.0795 0 14.7039 0 0 0 0 0 0 0 12.9838 0 0 0 0 0 0 0 0 0 13.1924 12.9535 0 0 13.4175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3853 0 13.8093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5165 0 0 0 0 O43313 ATMIN_HUMAN "ATM interactor (ATM/ATR-substrate CHK2-interacting zinc finger protein, ASCIZ) (Zinc finger protein 822)" ATMIN KIAA0431 ZNF822 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; motile cilium assembly [GO:0044458]; positive regulation of gene expression [GO:0010628]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear body [GO:0016604]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; dynein complex binding [GO:0070840]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]; cellular response to DNA damage stimulus [GO:0006974]; motile cilium assembly [GO:0044458]; positive regulation of gene expression [GO:0010628]; positive regulation of non-motile cilium assembly [GO:1902857]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000976; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006974; GO:0010628; GO:0016604; GO:0044458; GO:0045893; GO:0045944; GO:0046872; GO:0070840; GO:1902857 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; dynein complex binding [GO:0070840]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976]" AASEAAAAAGSAALAAGAR 0.99494 -15.471 10.6327 0 0 11.6544 0 0 10.5183 0 15.0327 14.2455 15.6785 14.6923 15.1702 15.1315 14.7265 13.1166 12.6769 10.3633 12.38 0 0 0 0 0 11.5212 11.1575 13.7395 12.2368 14.4297 13.7579 14.9743 15.5956 15.431 15.5416 14.9783 0 14.7313 15.5024 14.6491 14.6018 14.7115 15.3346 14.8281 15.791 13.3174 14.415 14.0366 12.8833 11.8627 13.692 14.1793 0 0 14.6376 14.9247 13.6149 12.2417 12.9483 12.3566 0 11.8152 9.40841 12.4831 12.7251 13.4921 13.7097 0 0 0 0 0 12.8948 0 13.8159 0 0 0 0 0 15.5926 13.9452 0 0 0 0 11.1002 11.3751 0 0 0 0 0 0 0 0 0 0 15.6111 13.0128 0 0 0 0 0 0 0 0 0 13.4745 12.9863 0 14.2691 0 0 0 0 0 0 0 0 0 0 0 0 11.0572 11.3357 0 0 0 0 11.829 13.7265 11.4143 11.6355 0 13.5971 10.868 0 0 0 0 0 0 0 0 11.6335 0 16.1419 0 0 0 11.3709 0 0 0 13.4531 12.0903 16.0621 15.8945 15.7612 15.9807 16.5044 16.9017 16.8858 15.8336 14.6206 16.1424 15.728 15.8772 15.8408 15.579 0 0 11.0593 0 15.6003 0 17.0066 0 0 O75153 CLU_HUMAN Clustered mitochondria protein homolog CLUH KIAA0664 Homo sapiens (Human) intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; mRNA binding [GO:0003729]; intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005] GO:0003729; GO:0005737; GO:0007005; GO:0048312 mRNA binding [GO:0003729] DEEVELCSSVECK 0.99494 -12.573 0 0 0 0 0 0 0 0 13.1201 11.4118 12.8782 13.1421 0 13.11 0 13.1067 13.4767 13.4023 0 13.261 0 16.478 10.481 0 0 0 0 13.1738 0 0 13.2323 13.2253 12.5544 0 0 13.3617 0 13.0603 0 0 12.5089 10.1454 10.7574 0 0 0 0 0 0 12.6833 12.5523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7407 0 15.2633 0 13.4882 0 0 0 0 0 0 15.0426 14.9554 0 0 0 0 0 0 0 14.2111 0 0 0 0 0 0 0 0 0 0 0 0 14.6063 0 0 0 0 14.2074 0 0 14.9286 14.6531 15.9747 14.0812 0 13.4175 0 0 0 0 0 14.16 0 0 18.0311 0 0 0 0 0 0 0 0 15.9472 0 0 12.8498 0 14.8826 14.7634 0 10.3888 14.7531 0 0 0 14.695 0 0 11.6141 14.4908 0 0 0 0 0 10.7446 0 16.1404 0 14.5048 14.6697 0 0 14.8041 14.6829 0 14.8121 14.7438 14.4596 0 14.6728 0 15.0099 0 14.2301 0 0 14.6421 0 0 0 0 O75817 POP7_HUMAN "Ribonuclease P protein subunit p20, RNaseP protein p20 (Ribonucleases P/MRP protein subunit POP7 homolog, hPOP7)" POP7 RPP20 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]" cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172] "cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]" GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0005730; GO:0005737; GO:0006364; GO:0008033; GO:0030681; GO:0033204; GO:0043231; GO:0090502 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] EPLTRIR 0.99494 -15.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3487 0 0 0 0 0 13.3476 0 0 14.1388 0 14.719 0 0 0 0 0 13.6636 0 0 0 15.7862 15.5923 0 0 13.0299 13.6434 0 0 15.1152 15.6527 0 0 13.717 13.2255 0 13.1297 0 14.5828 0 13.3476 0 0 0 0 0 0 0 15.0854 15.2045 0 0 15.3741 0 0 0 0 0 0 14.8746 12.8689 13.7349 13.2645 0 0 0 13.4026 15.1402 0 0 13.8259 15.8179 14.2944 0 14.768 14.9208 0 0 0 0 0 0 0 0 0 0 0 14.8913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0167 13.5986 0 0 0 0 0 0 O94923 GLCE_HUMAN "D-glucuronyl C5-epimerase, EC 5.1.3.17 (Heparan sulfate C5-epimerase, Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)" GLCE KIAA0836 Homo sapiens (Human) heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]" GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016021; GO:0016857; GO:0030210; GO:0042803; GO:0047464 "calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]" AAASESNNYMNHVAK 0.99494 -10.455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53877 0 0 0 13.7633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1921 0 14.8956 0 0 0 12.861 0 0 0 0 12.8274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1028 0 14.9397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5976 0 11.5289 10.9047 0 0 0 O94992 HEXI1_HUMAN Protein HEXIM1 (Cardiac lineage protein 1) (Estrogen down-regulated gene 1 protein) (Hexamethylene bis-acetamide-inducible protein 1) (Menage a quatre protein 1) HEXIM1 CLP1 EDG1 HIS1 MAQ1 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; heart development [GO:0007507]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of signal transduction by p53 class mediator [GO:1901798]" 7SK snRNP [GO:0120259]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "7SK snRNP [GO:0120259]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; P-TEFb complex binding [GO:0106140]; protein kinase inhibitor activity [GO:0004860]; snRNA binding [GO:0017069]; activation of innate immune response [GO:0002218]; heart development [GO:0007507]; innate immune response [GO:0045087]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of signal transduction by p53 class mediator [GO:1901798]" GO:0000122; GO:0002218; GO:0004860; GO:0004861; GO:0005634; GO:0005654; GO:0005737; GO:0007507; GO:0017069; GO:0032897; GO:0034244; GO:0042802; GO:0043231; GO:0045087; GO:0045736; GO:0045892; GO:0097322; GO:0106140; GO:0120259; GO:1901798 7SK snRNA binding [GO:0097322]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; identical protein binding [GO:0042802]; P-TEFb complex binding [GO:0106140]; protein kinase inhibitor activity [GO:0004860]; snRNA binding [GO:0017069] AAAKSDDTSDDDFMEEGGEEDGGSDGMGGDGSEFLQR 0.99494 -5.3765 0 0 0 0 0 0 0 0 0 0 0 0 11.6664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0804 0 14.0279 0 0 11.8445 0 0 0 11.7813 0 0 0 0 0 12.162 0 0 0 0 0 0 13.3298 12.6213 0 0 0 0 0 0 0 10.9564 0 0 0 11.8173 0 0 0 0 0 0 0 0 0 13.5411 12.8128 0 0 0 0 12.5837 0 0 14.4912 0 0 0 0 0 0 0 0 0 0 0 12.6784 0 0 0 0 0 0 12.66 0 0 0 0 11.1226 0 0 12.2874 0 0 0 0 0 0 0 0 12.7344 11.66 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6055 O95754 SEM4F_HUMAN "Semaphorin-4F (Semaphorin-M, Sema M) (Semaphorin-W, Sema W)" SEMA4F SEMAM SEMAW Homo sapiens (Human) axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; retinal ganglion cell axon guidance [GO:0031290]; semaphorin-plexin signaling pathway [GO:0071526] anchoring junction [GO:0070161]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; retinal ganglion cell axon guidance [GO:0031290]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005783; GO:0005886; GO:0005887; GO:0007267; GO:0007399; GO:0007411; GO:0014069; GO:0016020; GO:0030215; GO:0030335; GO:0030425; GO:0031290; GO:0043204; GO:0045211; GO:0045499; GO:0048843; GO:0050919; GO:0070161; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] AHTVGAGLAGFFLGILAASLTLILIGRRQQR 0.99494 -8.4604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8368 0 0 0 0 0 0 0 0 0 0 14.3058 0 P13805 TNNT1_HUMAN "Troponin T, slow skeletal muscle, TnTs (Slow skeletal muscle troponin T, sTnT)" TNNT1 TNT Homo sapiens (Human) muscle contraction [GO:0006936]; negative regulation of muscle contraction [GO:0045932]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009]; slow-twitch skeletal muscle fiber contraction [GO:0031444]; transition between fast and slow fiber [GO:0014883] cytosol [GO:0005829]; troponin complex [GO:0005861] cytosol [GO:0005829]; troponin complex [GO:0005861]; tropomyosin binding [GO:0005523]; troponin T binding [GO:0031014]; muscle contraction [GO:0006936]; negative regulation of muscle contraction [GO:0045932]; sarcomere organization [GO:0045214]; skeletal muscle contraction [GO:0003009]; slow-twitch skeletal muscle fiber contraction [GO:0031444]; transition between fast and slow fiber [GO:0014883] GO:0003009; GO:0005523; GO:0005829; GO:0005861; GO:0006936; GO:0014883; GO:0031014; GO:0031444; GO:0045214; GO:0045932 tropomyosin binding [GO:0005523]; troponin T binding [GO:0031014] AQELSDWIHQLESEKFDLMAK 0.99494 -10.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5613 0 0 14.3058 0 0 0 0 14.462 0 14.3185 14.0363 14.1521 0 0 14.1839 0 0 0 14.3652 0 13.7631 13.6139 14.5158 0 14.6713 0 13.9388 0 15.2239 14.0283 15.9748 14.2541 14.5373 13.6227 14.6291 0 0 13.3288 14.1658 13.1742 0 0 0 0 0 0 0 0 14.2145 0 11.9874 0 0 0 0 0 12.1647 0 0 0 0 13.9727 0 13.5198 0 0 0 0 0 0 0 11.4263 0 0 0 0 0 0 18.4969 0 0 0 13.7328 0 0 0 0 18.4679 P28288 ABCD3_HUMAN "ATP-binding cassette sub-family D member 3, EC 3.1.2.-, EC 7.6.2.- (70 kDa peroxisomal membrane protein, PMP70)" ABCD3 PMP70 PXMP1 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038] GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0014070; GO:0015721; GO:0015910; GO:0016020; GO:0016021; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0043621; GO:0047617; GO:0140359; GO:1903512 ABC-type transporter activity [GO:0140359]; acyl-CoA hydrolase activity [GO:0047617]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; long-chain fatty acid transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621] ALGLHGK 0.99494 -15.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.414 0 12.3031 13.8504 12.3564 13.1116 13.7787 0 0 0 0 13.5083 11.9003 14.0997 0 0 0 0 0 12.526 0 0 0 0 0 0 0 0 0 0 0 0 13.2165 0 0 11.537 0 0 0 0 0 0 0 0 11.7669 0 12.5705 0 12.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5635 0 12.7214 0 12.2401 0 0 0 0 11.8542 0 12.572 13.2384 12.2942 0 0 0 0 0 0 0 0 0 0 12.0116 0 0 0 0 0 0 0 12.4841 0 0 0 0 0 0 P32942 ICAM3_HUMAN "Intercellular adhesion molecule 3, ICAM-3 (CDw50) (ICAM-R) (CD antigen CD50)" ICAM3 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; phagocytosis [GO:0006909] GO:0005102; GO:0005178; GO:0005886; GO:0005887; GO:0006909; GO:0007155; GO:0070062; GO:0098609 integrin binding [GO:0005178]; signaling receptor binding [GO:0005102] NSSVQLR 0.99494 -10.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2136 0 0 0 0 0 0 0 0 0 0 13.5524 12.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46976 GLYG_HUMAN "Glycogenin-1, GN-1, GN1, EC 2.4.1.186" GYG1 GYG Homo sapiens (Human) glycogen biosynthetic process [GO:0005978] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774] cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; glycogenin glucosyltransferase activity [GO:0008466]; glycosyltransferase activity [GO:0016757]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978] GO:0005576; GO:0005829; GO:0005978; GO:0008466; GO:0016020; GO:0016757; GO:0030145; GO:0034774; GO:0042803; GO:0043202; GO:0102751; GO:1904813 glycogenin glucosyltransferase activity [GO:0008466]; glycosyltransferase activity [GO:0016757]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751] KLDTYLQ 0.99494 -11.297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1089 0 0 14.4818 0 0 0 12.5486 0 0 0 15.9372 0 0 0 0 15.1332 0 0 0 13.5309 0 14.9393 0 0 0 0 0 0 13.9227 14.6357 14.9089 0 0 0 0 0 0 13.8038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7742 0 0 0 0 0 0 0 0 P56704 WNT3A_HUMAN Protein Wnt-3a WNT3A Homo sapiens (Human) "axis elongation involved in somitogenesis [GO:0090245]; axon guidance [GO:0007411]; B cell proliferation [GO:0042100]; calcium ion transmembrane transport via low voltage-gated calcium channel [GO:0090676]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; cell proliferation in midbrain [GO:0033278]; cellular response to retinoic acid [GO:0071300]; COP9 signalosome assembly [GO:0010387]; dorsal/ventral neural tube patterning [GO:0021904]; extracellular matrix organization [GO:0030198]; fat cell differentiation [GO:0045444]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; modulation of chemical synaptic transmission [GO:0050804]; myoblast differentiation [GO:0045445]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of heart induction by canonical Wnt signaling pathway [GO:0003136]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; paraxial mesodermal cell fate commitment [GO:0048343]; platelet aggregation [GO:0070527]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000081]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production [GO:0001819]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor internalization [GO:0002092]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; postsynapse to nucleus signaling pathway [GO:0099527]; presynapse assembly [GO:0099054]; protein localization [GO:0008104]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]; secondary palate development [GO:0062009]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spinal cord association neuron differentiation [GO:0021527]; synaptic vesicle recycling [GO:0036465]; transcription by RNA polymerase II [GO:0006366]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Wnt-Frizzled-LRP5/6 complex [GO:1990851] "cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; axis elongation involved in somitogenesis [GO:0090245]; axon guidance [GO:0007411]; B cell proliferation [GO:0042100]; calcium ion transmembrane transport via low voltage-gated calcium channel [GO:0090676]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; cell proliferation in midbrain [GO:0033278]; cellular response to retinoic acid [GO:0071300]; COP9 signalosome assembly [GO:0010387]; dorsal/ventral neural tube patterning [GO:0021904]; extracellular matrix organization [GO:0030198]; fat cell differentiation [GO:0045444]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; modulation of chemical synaptic transmission [GO:0050804]; myoblast differentiation [GO:0045445]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of heart induction by canonical Wnt signaling pathway [GO:0003136]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; paraxial mesodermal cell fate commitment [GO:0048343]; platelet aggregation [GO:0070527]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000081]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production [GO:0001819]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor internalization [GO:0002092]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; postsynapse to nucleus signaling pathway [GO:0099527]; presynapse assembly [GO:0099054]; protein localization [GO:0008104]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]; secondary palate development [GO:0062009]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spinal cord association neuron differentiation [GO:0021527]; synaptic vesicle recycling [GO:0036465]; transcription by RNA polymerase II [GO:0006366]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]" GO:0001649; GO:0001701; GO:0001819; GO:0001934; GO:0001947; GO:0002092; GO:0003136; GO:0003713; GO:0005102; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006366; GO:0007411; GO:0008104; GO:0008283; GO:0008284; GO:0009986; GO:0010387; GO:0010628; GO:0010977; GO:0019904; GO:0021527; GO:0021766; GO:0021846; GO:0021874; GO:0021904; GO:0030097; GO:0030182; GO:0030198; GO:0030666; GO:0030879; GO:0030890; GO:0031901; GO:0032092; GO:0033138; GO:0033278; GO:0035914; GO:0036342; GO:0036465; GO:0039706; GO:0042100; GO:0042472; GO:0043280; GO:0045165; GO:0045444; GO:0045445; GO:0045599; GO:0045893; GO:0045944; GO:0048018; GO:0048103; GO:0048337; GO:0048343; GO:0048643; GO:0048697; GO:0048843; GO:0050768; GO:0050804; GO:0050807; GO:0051091; GO:0060070; GO:0061098; GO:0061184; GO:0061317; GO:0062009; GO:0070062; GO:0070507; GO:0070527; GO:0071300; GO:0090245; GO:0090263; GO:0090676; GO:0098793; GO:0098978; GO:0099054; GO:0099527; GO:1901215; GO:1903078; GO:1904339; GO:1904953; GO:1905606; GO:1990851; GO:2000049; GO:2000081; GO:2000179; GO:2000347; GO:2000727 co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713] AIGDFLKDK 0.99494 -10.429 0 0 0 0 0 0 0 0 0 13.0474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8711 0 0 0 0 0 0 0 10.906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3116 14.1234 0 14.5777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62937 PPIA_HUMAN "Peptidyl-prolyl cis-trans isomerase A, PPIase A, EC 5.2.1.8 (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed ]" PPIA CYPA Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; lipid droplet organization [GO:0034389]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of viral life cycle [GO:1903901]; neuron differentiation [GO:0030182]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790]; activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; lipid droplet organization [GO:0034389]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of viral life cycle [GO:1903901]; neuron differentiation [GO:0030182]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]; viral release from host cell [GO:0019076] GO:0000413; GO:0001933; GO:0001934; GO:0003723; GO:0003755; GO:0005178; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0006457; GO:0006469; GO:0006915; GO:0016018; GO:0016020; GO:0019076; GO:0030168; GO:0030182; GO:0030593; GO:0030595; GO:0031982; GO:0032148; GO:0032873; GO:0032991; GO:0034389; GO:0034599; GO:0034774; GO:0035307; GO:0042118; GO:0043231; GO:0043410; GO:0045069; GO:0045070; GO:0046790; GO:0050714; GO:0051082; GO:0051092; GO:0060352; GO:0061944; GO:0070062; GO:0070527; GO:1902176; GO:1903901; GO:1904399; GO:1904813; GO:2001233 cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790] FGSRNGK 0.99494 -10.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8503 14.2565 13.9637 0 0 13.8054 14.6099 15.7785 0 15.7423 0 14.1016 15.6081 0 15.5989 13.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01726 MSHR_HUMAN "Melanocyte-stimulating hormone receptor, MSH-R (Melanocortin receptor 1, MC1-R)" MC1R MSHR Homo sapiens (Human) "adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; negative regulation of tumor necrosis factor production [GO:0032720]; pigmentation [GO:0043473]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of metabolic process [GO:0019222]; sensory perception of pain [GO:0019233]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; negative regulation of tumor necrosis factor production [GO:0032720]; pigmentation [GO:0043473]; positive regulation of feeding behavior [GO:2000253]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of metabolic process [GO:0019222]; sensory perception of pain [GO:0019233]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" GO:0004930; GO:0004977; GO:0004980; GO:0005737; GO:0005886; GO:0005887; GO:0007187; GO:0007189; GO:0008528; GO:0009650; GO:0010739; GO:0019222; GO:0019233; GO:0031625; GO:0032720; GO:0035556; GO:0042438; GO:0042562; GO:0043473; GO:0045944; GO:0051897; GO:0070914; GO:0090037; GO:2000253 G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625] PVHQGFGLK 0.99494 -8.464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q04743 EMX2_HUMAN Homeobox protein EMX2 (Empty spiracles homolog 2) (Empty spiracles-like protein 2) EMX2 Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; central nervous system development [GO:0007417]; cerebral cortex regionalization [GO:0021796]; dentate gyrus development [GO:0021542]; forebrain cell migration [GO:0021885]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; ureter morphogenesis [GO:0072197] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cell proliferation in forebrain [GO:0021846]; central nervous system development [GO:0007417]; cerebral cortex regionalization [GO:0021796]; dentate gyrus development [GO:0021542]; forebrain cell migration [GO:0021885]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; ureter morphogenesis [GO:0072197]" GO:0000785; GO:0000978; GO:0000981; GO:0001764; GO:0005634; GO:0006357; GO:0007417; GO:0007420; GO:0009410; GO:0009952; GO:0021542; GO:0021796; GO:0021846; GO:0021885; GO:0030182; GO:0072197; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" FQGNDTSPESFLLHNALARK 0.99494 -10.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12996 CSTF3_HUMAN "Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit, CSTF 77 kDa subunit, CstF-77)" CSTF3 Homo sapiens (Human) mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; RNA 3'-end processing [GO:0031123] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006378; GO:0006379; GO:0031123 mRNA binding [GO:0003729]; RNA binding [GO:0003723] AKLAAIIPDPVVAPSIVPVLK 0.99494 -10.442 0 0 0 0 0 12.2431 0 0 0 0 0 0 14.6009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9246 0 0 0 0 11.7286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3482 0 0 12.0571 14.0387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.007 0 0 0 0 0 0 14.0926 0 13.8125 15.4462 0 0 0 0 0 0 13.4294 0 16.9918 0 0 0 0 0 0 0 0 0 0 0 12.0916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13489 BIRC3_HUMAN "Baculoviral IAP repeat-containing protein 3, EC 2.3.2.27 (Apoptosis inhibitor 2, API2) (Cellular inhibitor of apoptosis 2, C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1, hIAP-1, hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1)" BIRC3 API2 MIHC RNF49 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell surface receptor signaling pathway [GO:0007166]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of nucleotide-binding oligomerization domain containing signaling pathway [GO:0070424]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; spermatogenesis [GO:0007283]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007166; GO:0007249; GO:0007283; GO:0016740; GO:0031398; GO:0032991; GO:0033209; GO:0034121; GO:0038061; GO:0039535; GO:0042981; GO:0043027; GO:0043066; GO:0043123; GO:0044877; GO:0045088; GO:0045121; GO:0046872; GO:0050727; GO:0051726; GO:0060544; GO:0060546; GO:0061630; GO:0070424; GO:2000116 cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transferase activity [GO:0016740]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] CFCCDGGLR 0.99494 -10.437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8618 0 0 13.4682 0 0 14.4856 0 0 0 14.5818 14.206 14.1951 10.949 15.44 0 13.0321 0 0 0 0 0 0 12.8948 0 0 0 0 10.6304 0 0 0 0 0 0 0 15.1431 0 0 0 0 0 0 0 0 0 12.9975 0 0 0 0 0 0 0 0 14.0889 0 0 0 0 0 0 0 0 0 0 0 10.2211 0 0 0 0 0 0 0 0 0 12.8166 0 0 0 0 0 0 0 0 0 0 0 10.4229 0 0 0 0 0 0 0 0 Q494U1 PKHN1_HUMAN "Pleckstrin homology domain-containing family N member 1, PH domain-containing family N member 1 (Cardiolipin and phosphatidic acid-binding protein)" PLEKHN1 CLPABP Homo sapiens (Human) 3'-UTR-mediated mRNA destabilization [GO:0061158]; positive regulation of apoptotic process [GO:0043065]; response to hypoxia [GO:0001666] cytoskeleton [GO:0005856]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cardiolipin binding [GO:1901612]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; positive regulation of apoptotic process [GO:0043065]; response to hypoxia [GO:0001666] GO:0001666; GO:0001786; GO:0005739; GO:0005856; GO:0005886; GO:0031966; GO:0043065; GO:0061158; GO:0070300; GO:1901612; GO:1901981 cardiolipin binding [GO:1901612]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylserine binding [GO:0001786] GNREDSAR 0.99494 -8.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5459 0 12.8211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.137 0 0 0 0 0 0 0 0 0 0 0 14.9156 14.8282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7811 14.7014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6275 0 Q4KMP7 TB10B_HUMAN TBC1 domain family member 10B (Rab27A-GAP-beta) TBC1D10B FP2461 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; regulation of GTPase activity [GO:0043087]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005096; GO:0005829; GO:0005886; GO:0042147; GO:0043087; GO:0090630 GTPase activator activity [GO:0005096] ELKWLDMFSNWDK 0.99494 -10.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3982 16.9171 13.4896 13.3353 0 0 13.5591 0 0 0 0 0 12.2989 13.0545 0 0 0 0 0 0 0 0 0 0 0 13.2862 0 0 0 0 0 14.1621 13.8008 0 0 0 0 0 0 0 0 14.1426 0 0 0 0 0 0 0 0 0 14.1795 0 13.4802 0 13.5 0 0 13.8012 13.6515 13.9698 0 13.4779 13.6426 0 0 0 0 0 0 13.7463 0 0 0 0 0 13.6245 0 0 0 13.4612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4353 0 14.0186 0 0 0 0 0 0 0 0 Q5T197 DCST1_HUMAN "E3 ubiquitin-protein ligase DCST1, EC 2.3.2.27 (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase)" DCST1 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; ubiquitin-dependent protein catabolic process [GO:0006511] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005886; GO:0006511; GO:0016021; GO:0045087; GO:0046872; GO:0060339; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AAVPIGLLVCLCLLQAFGYRLR 0.99494 -15.402 0 0 0 0 0 0 0 0 0 0 0 13.4942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.034 0 12.4326 0 14.1562 14.2327 15.3392 14.8333 11.8245 12.8077 14.6072 0 14.8943 0 0 0 0 0 14.1619 14.2827 0 0 0 14.8569 13.0145 12.5929 0 0 0 0 0 12.0636 11.958 14.7892 0 0 0 12.3559 0 0 0 0 0 0 14.5114 0 0 0 0 0 11.6154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8696 0 13.7801 0 0 0 0 0 0 14.2001 0 14.0576 0 12.4072 0 13.0173 0 0 0 0 11.77 0 12.118 13.089 0 0 0 0 0 0 0 0 10.5454 0 0 0 Q6NUS8 UD3A1_HUMAN "UDP-glucuronosyltransferase 3A1, UDPGT 3A1, EC 2.4.1.17" UGT3A1 Homo sapiens (Human) integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541] integral component of membrane [GO:0016021]; UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194] GO:0008194; GO:0015020; GO:0016021; GO:0043541 glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194] FLIPDIKEEEK 0.99494 -8.4595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1848 14.2452 14.0022 0 0 0 0 12.8455 12.7015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1246 0 0 11.1056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ULP2 AFTIN_HUMAN Aftiphilin AFTPH AFTH Homo sapiens (Human) intracellular transport [GO:0046907]; protein transport [GO:0015031] AP-1 adaptor complex [GO:0030121]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; intracellular transport [GO:0046907]; protein transport [GO:0015031] GO:0005654; GO:0005794; GO:0005829; GO:0015031; GO:0030121; GO:0030276; GO:0032588; GO:0043231; GO:0046907; GO:0048471 clathrin binding [GO:0030276] DITAELSAPVK 0.99494 -11.294 0 0 0 0 12.1999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7198 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4419 0 0 0 0 13.7955 0 12.9878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5545 14.8361 0 0 0 0 0 0 0 0 0 12.8534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2323 0 0 0 0 0 0 0 0 0 0 0 14.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2959 0 0 0 0 0 0 0 0 0 0 Q86TH1 ATL2_HUMAN "ADAMTS-like protein 2, ADAMTSL-2" ADAMTSL2 KIAA0605 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] extracellular matrix [GO:0031012]; extracellular region [GO:0005576] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril binding [GO:0050436]; extracellular matrix organization [GO:0030198]; lobar bronchus epithelium development [GO:0060481]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512] GO:0005576; GO:0030198; GO:0030512; GO:0031012; GO:0050436; GO:0060481 microfibril binding [GO:0050436] DIRCSEDEKLCDPNTR 0.99494 -11.281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1999 0 0 0 0 0 0 0 0 0 0 0 13.691 0 0 0 13.9502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.279 0 0 0 0 0 11.1895 0 0 0 9.88397 11.1849 0 0 11.6714 0 13.6072 0 0 0 0 0 0 0 0 0 0 0 12.9729 0 0 13.2962 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8456 14.1474 0 0 0 14.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7749 0 0 0 13.7522 0 0 0 13.9243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0385 0 0 0 0 0 0 12.3482 0 0 0 0 0 0 0 0 0 Q8TEL6 TP4AP_HUMAN "Short transient receptor potential channel 4-associated protein, Trp4-associated protein, Trpc4-associated protein (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein, Protein TRUSS)" TRPC4AP C20orf188 TRRP4AP Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0005262; GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0070588; GO:0080008; GO:0140627; GO:1990756 calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin ligase-substrate adaptor activity [GO:1990756] GLLTRLLQVMKK 0.99494 -8.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8236 0 13.373 13.0502 0 0 0 12.9135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9205 0 0 0 0 0 0 0 12.6882 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3049 0 0 13.7445 0 0 0 15.1312 14.5157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8808 0 0 0 12.4946 0 12.3724 0 0 0 0 0 0 0 0 0 0 Q99456 K1C12_HUMAN "Keratin, type I cytoskeletal 12 (Cytokeratin-12, CK-12) (Keratin-12, K12)" KRT12 Homo sapiens (Human) cornea development in camera-type eye [GO:0061303]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; cornea development in camera-type eye [GO:0061303]; epidermis development [GO:0008544]; epithelial cell differentiation [GO:0030855]; morphogenesis of an epithelium [GO:0002009]; visual perception [GO:0007601] GO:0002009; GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0007601; GO:0008544; GO:0030855; GO:0061303; GO:0070062 structural molecule activity [GO:0005198] ARLELEIETYR 0.99494 -8.4619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.424 0 11.0937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9763 0 0 0 11.6726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7052 0 18.0153 0 0 13.8978 0 0 15.3641 0 13.9258 0 0 0 0 0 15.927 0 0 0 0 0 17.5642 14.1244 17.2861 13.501 0 0 10.3208 14.4011 0 15.3853 14.2508 16.3718 0 0 0 13.8289 0 0 0 0 0 0 0 13.8407 0 0 0 14.3006 12.9063 13.493 0 0 0 0 13.4722 0 0 0 12.8809 0 13.0453 0 0 0 16.6607 0 0 0 14.8571 0 0 0 0 0 0 0 16.5548 14.1688 16.5081 0 0 0 0 14.4798 0 14.4984 0 0 Q9BXD5 NPL_HUMAN "N-acetylneuraminate lyase, NALase, EC 4.1.3.3 (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase)" NPL C1orf13 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262] cytosol [GO:0005829] cytosol [GO:0005829]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262] GO:0005829; GO:0005975; GO:0008747; GO:0019262; GO:0042802 identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747] AIMTLVSGIPMGPPR 0.99494 -8.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9945 0 0 0 14.0622 0 0 0 0 0 0 0 0 0 0 0 14.5205 16.4904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0586 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9A7 RMI1_HUMAN "RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa, BLAP75) (FAAP75)" RMI1 C9orf76 Homo sapiens (Human) DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of meiotic recombination intermediates [GO:0000712]; resolution of recombination intermediates [GO:0071139]; response to glucose [GO:0009749] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of meiotic recombination intermediates [GO:0000712]; resolution of recombination intermediates [GO:0071139]; response to glucose [GO:0009749] GO:0000166; GO:0000712; GO:0000724; GO:0002023; GO:0005634; GO:0005654; GO:0006260; GO:0009749; GO:0016604; GO:0031422; GO:0035264; GO:0042593; GO:0071139 nucleotide binding [GO:0000166] FLEGLQKCQR 0.99494 -15.392 0 0 0 0 0 0 0 0 12.6462 0 0 13.5444 0 0 0 0 0 0 12.5189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9751 0 0 0 0 13.0785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6354 0 13.8736 0 0 14.9978 0 0 0 0 0 0 0 0 14.9464 14.5496 13.4843 14.4059 0 0 0 0 13.6626 0 13.3945 0 0 0 0 0 14.6841 0 0 0 0 0 14.4493 0 0 12.6451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8104 0 13.6826 0 0 0 14.8939 0 0 0 0 Q9NQV7 PRDM9_HUMAN "Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9, EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9, EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9, EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9, EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9, EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9, EC 2.1.1.361)" PRDM9 PFM6 Homo sapiens (Human) "chromatin organization [GO:0006325]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; transcription cis-regulatory region binding [GO:0000976]; chromatin organization [GO:0006325]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of reciprocal meiotic recombination [GO:0010845]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000976; GO:0005634; GO:0005654; GO:0005694; GO:0006311; GO:0006325; GO:0006355; GO:0007129; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0018024; GO:0042800; GO:0042803; GO:0043066; GO:0044648; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:1905437; GO:1905516; GO:1990918; GO:2001255 histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; transcription cis-regulatory region binding [GO:0000976] EEWAEMGDWEKTRYR 0.99494 -8.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.899 0 0 12.2987 0 14.1185 0 0 0 0 0 15.9481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4758 12.3222 0 0 0 0 0 0 0 0 0 0 0 0 11.8953 0 0 0 0 0 0 0 0 0 11.1529 0 10.5117 0 0 0 0 0 0 12.528 0 0 0 0 0 0 0 0 0 0 0 0 11.9832 0 0 0 0 0 0 0 0 0 0 0 10.8942 0 0 0 0 0 0 0 0 0 0 0 0 12.9104 0 0 15.3063 Q9UBN4 TRPC4_HUMAN "Short transient receptor potential channel 4, TrpC4 (Trp-related protein 4, hTrp-4, hTrp4)" TRPC4 Homo sapiens (Human) calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480] basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cortical cytoskeleton [GO:0030863]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; manganese ion transport [GO:0006828]; oligodendrocyte differentiation [GO:0048709]; regulation of cytosolic calcium ion concentration [GO:0051480]" GO:0005262; GO:0005886; GO:0005887; GO:0005901; GO:0006816; GO:0006828; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0034703; GO:0034704; GO:0045296; GO:0048709; GO:0051480; GO:0070509; GO:0070588; GO:0070679 "beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" CNCVECVSSSDVDSLR 0.99494 -8.4795 0 0 0 0 0 0 0 0 13.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0905 0 0 0 0 0 0 12.9576 0 0 12.8581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86039 0 14.8962 0 0 0 0 0 13.6654 0 0 11.1475 0 0 0 13.4267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6682 16.4472 14.8493 0 0 12.6453 0 17.2055 14.5603 0 0 0 0 15.9932 10.8876 0 0 0 0 0 0 0 12.0345 0 0 0 0 0 13.0407 11.4212 0 0 0 0 0 14.5055 11.586 0 0 0 0 0 0 0 11.2007 0 0 0 0 0 11.5427 0 10.6306 0 0 14.0643 0 0 14.9675 0 0 0 0 13.9873 0 0 0 15.2617 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8208 O43900 PRIC3_HUMAN "Prickle planar cell polarity protein 3 (LIM domain only protein 6, LMO-6) (Prickle-like protein 3, Pk3) (Triple LIM domain protein 6)" PRICKLE3 LMO6 Homo sapiens (Human) cell projection organization [GO:0030030] mitochondrion [GO:0005739]; plasma membrane [GO:0005886] mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; zinc ion binding [GO:0008270]; cell projection organization [GO:0030030] GO:0005739; GO:0005886; GO:0008270; GO:0030030 zinc ion binding [GO:0008270] GQPCNSCREQCPGFLLHGWRK 0.99495 -10.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7196 0 0 0 0 0 13.9508 0 0 10.8091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1629 0 0 0 0 0 0 0 0 0 12.4077 0 0 0 0 0 0 0 0 0 0 0 0 10.6633 0 0 0 13.5683 0 13.632 0 O60879 DIAP2_HUMAN "Protein diaphanous homolog 2 (Diaphanous-related formin-2, DRF2)" DIAPH2 DIA Homo sapiens (Human) actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477] actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730] actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477] GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477 actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267] AIDPKQPNMMTEIVK 0.99495 -11.378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1445 14.5126 0 0 13.202 0 0 0 12.3307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0954 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2393 0 0 0 0 0 15.3797 0 15.1843 0 15.3936 14.9175 0 15.3672 0 0 0 0 13.5744 0 0 15.0656 0 0 0 0 15.5096 0 0 14.3153 0 0 0 14.1193 13.4647 16.1294 0 13.5003 0 0 0 0 0 14.0585 0 0 0 0 12.3259 0 0 0 0 0 0 0 0 0 0 0 14.3054 0 0 0 0 0 0 0 0 0 11.8183 0 13.5639 10.1374 0 0 14.8653 0 14.5317 0 0 13.0695 0 0 0 0 12.2055 13.1909 0 0 13.0492 13.0864 0 13.9257 14.4867 0 0 11.8935 10.0443 O75541 ZN821_HUMAN Zinc finger protein 821 ZNF821 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872; GO:1990837 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837] DNETPEER 0.99495 -11.362 0 0 13.1977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2665 0 0 0 0 0 0 0 14.4747 0 0 12.5003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04075 ALDOA_HUMAN "Fructose-bisphosphate aldolase A, EC 4.1.2.13 (Lung cancer antigen NY-LU-1) (Muscle-type aldolase)" ALDOA ALDA Homo sapiens (Human) "actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]" actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724] "actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]; actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]" GO:0003723; GO:0003779; GO:0004332; GO:0005576; GO:0005615; GO:0005634; GO:0005829; GO:0006000; GO:0006096; GO:0006754; GO:0006941; GO:0007015; GO:0007339; GO:0008092; GO:0008360; GO:0015629; GO:0015631; GO:0016020; GO:0030388; GO:0031093; GO:0031430; GO:0031674; GO:0034774; GO:0042802; GO:0045296; GO:0046716; GO:0051289; GO:0061827; GO:0070061; GO:0070062; GO:1904724; GO:1904813 actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631] GGVVGIK 0.99495 -10.695 12.5736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7303 0 0 0 P21246 PTN_HUMAN "Pleiotrophin, PTN (Heparin-binding brain mitogen, HBBM) (Heparin-binding growth factor 8, HBGF-8) (Heparin-binding growth-associated molecule, HB-GAM) (Heparin-binding neurite outgrowth-promoting factor, HBNF) (Heparin-binding neurite outgrowth-promoting factor 1, HBNF-1) (Osteoblast-specific factor 1, OSF-1)" PTN HBNF1 NEGF1 Homo sapiens (Human) bone mineralization [GO:0030282]; decidualization [GO:0046697]; dendrite arborization [GO:0140059]; dendrite regeneration [GO:0031104]; estrous cycle [GO:0044849]; integrin-mediated signaling pathway [GO:0007229]; learning [GO:0007612]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; memory [GO:0007613]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuroblast proliferation [GO:0007406]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; ossification involved in bone remodeling [GO:0043932]; positive regulation of axon regeneration [GO:0048680]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell differentiation [GO:2000738]; receptor clustering [GO:0043113]; regulation of endothelial cell migration [GO:0010594]; regulation of hemopoiesis [GO:1903706]; regulation of myelination [GO:0031641]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; response to auditory stimulus [GO:0010996]; tissue regeneration [GO:0042246]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864]; bone mineralization [GO:0030282]; decidualization [GO:0046697]; dendrite arborization [GO:0140059]; dendrite regeneration [GO:0031104]; estrous cycle [GO:0044849]; integrin-mediated signaling pathway [GO:0007229]; learning [GO:0007612]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; memory [GO:0007613]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuroblast proliferation [GO:0007406]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; ossification involved in bone remodeling [GO:0043932]; positive regulation of axon regeneration [GO:0048680]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell differentiation [GO:2000738]; receptor clustering [GO:0043113]; regulation of endothelial cell migration [GO:0010594]; regulation of hemopoiesis [GO:1903706]; regulation of myelination [GO:0031641]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; response to auditory stimulus [GO:0010996]; tissue regeneration [GO:0042246]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185] GO:0002232; GO:0002690; GO:0004864; GO:0005178; GO:0005576; GO:0005615; GO:0005783; GO:0005886; GO:0007185; GO:0007229; GO:0007399; GO:0007406; GO:0007612; GO:0007613; GO:0008083; GO:0008201; GO:0008284; GO:0010594; GO:0010976; GO:0010996; GO:0019901; GO:0030282; GO:0030501; GO:0031104; GO:0031641; GO:0032991; GO:0035374; GO:0042246; GO:0043113; GO:0043932; GO:0044849; GO:0045778; GO:0046697; GO:0048167; GO:0048477; GO:0048680; GO:0048714; GO:0051781; GO:0140059; GO:1900006; GO:1900272; GO:1903706; GO:2000036; GO:2000347; GO:2000738 chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864] CKIPCNWK 0.99495 -8.491 0 0 0 0 0 0 0 0 0 0 0 0 13.8226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7383 0 13.8803 0 12.5302 0 0 0 0 0 14.3543 14.2345 13.8952 0 0 0 0 0 12.5748 0 0 0 0 0 0 0 0 0 0 0 13.2881 0 0 0 0 0 0 12.6879 12.8777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7421 0 13.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24394 IL4RA_HUMAN "Interleukin-4 receptor subunit alpha, IL-4 receptor subunit alpha, IL-4R subunit alpha, IL-4R-alpha, IL-4RA (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha, Soluble IL-4 receptor subunit alpha, Soluble IL-4R-alpha, sIL4Ralpha/prot (IL-4-binding protein, IL4-BP) ]" IL4R IL4RA 582J2.1 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064] centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine receptor activity [GO:0004896]; interleukin-4 receptor activity [GO:0004913]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064] GO:0002532; GO:0002639; GO:0004896; GO:0004913; GO:0005615; GO:0005654; GO:0005886; GO:0005887; GO:0006955; GO:0007165; GO:0009897; GO:0016064; GO:0019221; GO:0030728; GO:0032722; GO:0034451; GO:0042127; GO:0042832; GO:0043032; GO:0043235; GO:0043306; GO:0043627; GO:0045063; GO:0045064; GO:0045626; GO:0045630; GO:0120162; GO:1901741; GO:1990834 cytokine receptor activity [GO:0004896]; interleukin-4 receptor activity [GO:0004913] EAPPWGK 0.99495 -8.4918 0 0 0 0 0 0 0 0 0 0 12.4556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6994 0 0 0 0 0 0 0 0 0 0 0 14.6271 0 0 12.3032 0 0 0 11.8402 0 0 0 10.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6714 0 0 0 0 0 0 0 12.7139 0 12.3813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P27544 CERS1_HUMAN "Ceramide synthase 1, CerS1 (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1, EC 2.3.1.299)" CERS1 LAG1 LASS1 UOG1 Homo sapiens (Human) cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of telomerase activity [GO:0051974]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of telomerase activity [GO:0051974]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148] GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0016410; GO:0030148; GO:0036146; GO:0043231; GO:0046513; GO:0050291; GO:0051974; GO:0071466; GO:0071492; GO:0072721; GO:1901526 N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] AEKPLRNGLVK 0.99495 -5.4219 0 0 0 0 0 0 13.2839 0 0 0 0 0 0 0 0 0 0 0 0 12.2505 0 0 12.3505 0 13.1428 0 0 0 0 0 0 0 0 0 11.6997 0 0 0 0 12.3417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1688 12.6352 0 0 0 0 0 0 0 0 0 0 0 0 13.017 0 0 0 0 0 0 0 0 0 13.3536 0 0 0 0 0 0 0 0 0 0 13.3426 0 0 0 0 14.5847 0 0 0 0 0 0 12.3887 0 13.594 0 0 0 14.4516 0 0 0 0 0 0 12.306 12.9001 0 0 0 0 0 0 13.7488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0318 0 13.5658 0 0 P29972 AQP1_HUMAN "Aquaporin-1, AQP-1 (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule)" AQP1 CHIP28 Homo sapiens (Human) ammonium transmembrane transport [GO:0072488]; camera-type eye morphogenesis [GO:0048593]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cell volume homeostasis [GO:0006884]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid secretion [GO:0033326]; cGMP-mediated signaling [GO:0019934]; corticotropin secretion [GO:0051458]; defense response to Gram-negative bacterium [GO:0050829]; establishment of localization in cell [GO:0051649]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; fibroblast migration [GO:0010761]; glomerular filtration [GO:0003094]; glycerol transmembrane transport [GO:0015793]; hyperosmotic response [GO:0006972]; lateral ventricle development [GO:0021670]; lipid digestion [GO:0044241]; metanephric descending thin limb development [GO:0072220]; metanephric glomerulus vasculature development [GO:0072239]; metanephric proximal convoluted tubule segment 2 development [GO:0072232]; metanephric proximal straight tubule development [GO:0072230]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; secretory granule organization [GO:0033363]; sensory perception of pain [GO:0019233]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]; wound healing [GO:0042060] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; ammonium transmembrane transporter activity [GO:0008519]; carbon dioxide transmembrane transporter activity [GO:0035379]; ephrin receptor binding [GO:0046875]; glycerol transmembrane transporter activity [GO:0015168]; identical protein binding [GO:0042802]; intracellular cGMP-activated cation channel activity [GO:0005223]; nitric oxide transmembrane transporter activity [GO:0030184]; potassium channel activity [GO:0005267]; potassium ion transmembrane transporter activity [GO:0015079]; transmembrane transporter activity [GO:0022857]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372]; ammonium transmembrane transport [GO:0072488]; camera-type eye morphogenesis [GO:0048593]; carbon dioxide transmembrane transport [GO:0035378]; carbon dioxide transport [GO:0015670]; cell volume homeostasis [GO:0006884]; cellular homeostasis [GO:0019725]; cellular hyperosmotic response [GO:0071474]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to inorganic substance [GO:0071241]; cellular response to mechanical stimulus [GO:0071260]; cellular response to mercury ion [GO:0071288]; cellular response to nitric oxide [GO:0071732]; cellular response to retinoic acid [GO:0071300]; cellular response to salt stress [GO:0071472]; cellular response to UV [GO:0034644]; cellular water homeostasis [GO:0009992]; cerebrospinal fluid secretion [GO:0033326]; cGMP-mediated signaling [GO:0019934]; corticotropin secretion [GO:0051458]; defense response to Gram-negative bacterium [GO:0050829]; establishment of localization in cell [GO:0051649]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; fibroblast migration [GO:0010761]; glomerular filtration [GO:0003094]; glycerol transmembrane transport [GO:0015793]; hyperosmotic response [GO:0006972]; lateral ventricle development [GO:0021670]; lipid digestion [GO:0044241]; metanephric descending thin limb development [GO:0072220]; metanephric glomerulus vasculature development [GO:0072239]; metanephric proximal convoluted tubule segment 2 development [GO:0072232]; metanephric proximal straight tubule development [GO:0072230]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; nitric oxide transport [GO:0030185]; odontogenesis [GO:0042476]; pancreatic juice secretion [GO:0030157]; positive regulation of angiogenesis [GO:0045766]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of saliva secretion [GO:0046878]; potassium ion transport [GO:0006813]; renal water absorption [GO:0070295]; renal water homeostasis [GO:0003091]; renal water transport [GO:0003097]; secretory granule organization [GO:0033363]; sensory perception of pain [GO:0019233]; transepithelial water transport [GO:0035377]; water transport [GO:0006833]; wound healing [GO:0042060] GO:0003091; GO:0003094; GO:0003097; GO:0005223; GO:0005267; GO:0005372; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005903; GO:0006813; GO:0006833; GO:0006884; GO:0006972; GO:0008519; GO:0009925; GO:0009992; GO:0010761; GO:0010763; GO:0015079; GO:0015168; GO:0015250; GO:0015670; GO:0015793; GO:0016021; GO:0016323; GO:0016324; GO:0019233; GO:0019725; GO:0019934; GO:0021670; GO:0022857; GO:0030157; GO:0030184; GO:0030185; GO:0030424; GO:0030950; GO:0031526; GO:0031965; GO:0033326; GO:0033363; GO:0034644; GO:0035377; GO:0035378; GO:0035379; GO:0042060; GO:0042383; GO:0042476; GO:0042802; GO:0043066; GO:0043154; GO:0044241; GO:0045177; GO:0045766; GO:0046875; GO:0046878; GO:0048146; GO:0048593; GO:0050829; GO:0050891; GO:0051458; GO:0051649; GO:0070062; GO:0070295; GO:0070301; GO:0071241; GO:0071260; GO:0071280; GO:0071288; GO:0071300; GO:0071320; GO:0071456; GO:0071472; GO:0071474; GO:0071549; GO:0071732; GO:0072220; GO:0072230; GO:0072232; GO:0072239; GO:0072488 ammonium transmembrane transporter activity [GO:0008519]; carbon dioxide transmembrane transporter activity [GO:0035379]; ephrin receptor binding [GO:0046875]; glycerol transmembrane transporter activity [GO:0015168]; identical protein binding [GO:0042802]; intracellular cGMP-activated cation channel activity [GO:0005223]; nitric oxide transmembrane transporter activity [GO:0030184]; potassium channel activity [GO:0005267]; potassium ion transmembrane transporter activity [GO:0015079]; transmembrane transporter activity [GO:0022857]; water channel activity [GO:0015250]; water transmembrane transporter activity [GO:0005372] SSDLTDRVK 0.99495 -5.4192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3376 0 0 0 0 0 11.7212 0 0 0 0 0 15.2472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35557 HXK4_HUMAN "Hexokinase-4, HK4, EC 2.7.1.1 (Glucokinase) (Hexokinase type IV, HK IV) (Hexokinase-D)" GCK Homo sapiens (Human) calcium ion import [GO:0070509]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; NADP metabolic process [GO:0006739]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; regulation of glycolytic process [GO:0006110]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158]; calcium ion import [GO:0070509]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; NADP metabolic process [GO:0006739]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; regulation of glycolytic process [GO:0006110]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266] GO:0001678; GO:0004340; GO:0005524; GO:0005536; GO:0005654; GO:0005739; GO:0005829; GO:0006006; GO:0006096; GO:0006110; GO:0006739; GO:0008865; GO:0019158; GO:0032024; GO:0032869; GO:0042593; GO:0043266; GO:0044320; GO:0045721; GO:0045725; GO:0046835; GO:0050796; GO:0051156; GO:0051594; GO:0061621; GO:0070509 ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; mannokinase activity [GO:0019158] GLRLETHEEASVKMLPTYVR 0.99495 -5.4144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4895 0 0 0 0 0 0 0 13.6015 0 0 0 0 14.5965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43146 DCC_HUMAN Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC) DCC IGDCC1 Homo sapiens (Human) anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell-cell adhesion [GO:0098609]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron projection development [GO:0010977]; neuron migration [GO:0001764]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of neuron death [GO:1901214]; spinal cord ventral commissure morphogenesis [GO:0021965] axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytosol [GO:0005829]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; netrin receptor activity [GO:0005042]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell-cell adhesion [GO:0098609]; dorsal/ventral axon guidance [GO:0033563]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendrite development [GO:2000171]; negative regulation of neuron projection development [GO:0010977]; neuron migration [GO:0001764]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of neuron death [GO:1901214]; spinal cord ventral commissure morphogenesis [GO:0021965] GO:0001764; GO:0004888; GO:0005042; GO:0005829; GO:0005886; GO:0006915; GO:0007409; GO:0007411; GO:0009986; GO:0010977; GO:0021965; GO:0033563; GO:0033564; GO:0044295; GO:0048671; GO:0098609; GO:0098685; GO:0099061; GO:0099170; GO:1901214; GO:2000171 netrin receptor activity [GO:0005042]; transmembrane signaling receptor activity [GO:0004888] FVRLSWRPPAEAK 0.99495 -11.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5336 0 0 0 0 0 0 0 0 0 0 0 0 13.8049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6J9G0 STYK1_HUMAN "Tyrosine-protein kinase STYK1, EC 2.7.10.2 (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1)" STYK1 NOK Homo sapiens (Human) cell differentiation [GO:0030154]; innate immune response [GO:0045087]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005886; GO:0007169; GO:0016021; GO:0030154; GO:0031234; GO:0045087 ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102] EPAGLHEVQDFLGRIQFHQYLGKHK 0.99495 -10.687 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5663 0 0 0 0 11.1589 0 0 0 0 0 0 0 0 11.0195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3383 0 0 0 0 0 0 0 0 0 0 12.6868 0 0 0 15.0889 15.2685 0 14.9297 15.2487 0 0 15.8717 0 0 0 14.9593 14.456 0 0 13.8555 0 11.998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7852 13.2257 0 0 0 0 12.9707 0 0 0 0 0 0 10.5929 0 0 0 14.219 0 0 0 0 0 0 0 0 0 0 0 13.1558 0 0 0 13.8862 0 0 13.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4766 0 0 12.0989 0 13.9096 0 Q6ZV77 CI139_HUMAN Putative uncharacterized protein LINC02908 (Long intergenic non-protein coding RNA 2908) LINC02908 C9orf139 Homo sapiens (Human) EAVLPRLRVTR 0.99495 -8.4889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVT6 CF20D_HUMAN Protein CFAP20DC (Uncharacterized protein C3orf67) CFAP20DC C3orf67 Homo sapiens (Human) LRLKSTSR 0.99495 -11.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4011 0 0 0 0 0 0 0 0 17.0447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XD8 ZFAN4_HUMAN AN1-type zinc finger protein 4 (AN1-type zinc finger and ubiquitin domain-containing protein-like 1) ZFAND4 ANUBL1 Homo sapiens (Human) zinc ion binding [GO:0008270] GO:0008270 zinc ion binding [GO:0008270] CGNNFCASHRYAETHGCTYDYK 0.99495 -10.489 0 16.3236 0 0 0 13.5085 12.8884 12.8978 0 15.1419 14.9334 15.9646 0 0 13.7413 0 0 0 0 0 0 14.417 0 0 12.9279 0 0 0 14.0817 0 14.8879 0 0 0 14.9427 0 0 13.0933 0 13.5298 0 13.4468 0 0 0 14.8019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5838 11.7051 0 0 0 0 13.4883 12.7855 0 0 0 0 0 0 0 0 13.8057 10.5651 0 0 0 13.6928 0 0 0 14.723 0 0 0 11.1534 0 0 0 0 13.6283 0 0 0 0 0 0 0 13.44 0 11.3473 0 13.6749 13.2231 13.6015 13.5632 0 12.9334 0 0 12.6966 0 0 0 0 13.2961 0 0 0 13.8748 0 0 0 13.078 0 0 12.9914 0 13.4018 14.4715 0 15.2876 0 0 0 0 0 0 13.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 13.574 0 0 0 0 0 0 0 0 13.165 13.2723 Q8N823 ZN611_HUMAN Zinc finger protein 611 ZNF611 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFACHSYLAK 0.99495 -11.382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8136 0 14.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7411 0 13.4616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0B7 TNG6_HUMAN Transport and Golgi organization protein 6 homolog (Transmembrane and coiled-coil domain-containing protein 7) TANGO6 KIAA1746 TMCO7 Homo sapiens (Human) protein secretion [GO:0009306] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein secretion [GO:0009306] GO:0009306; GO:0016021 AAIHVVVLLLR 0.99495 -10.689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9328 0 0 0 0 0 0 0 0 14.1133 13.3181 0 10.4654 0 12.3863 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2392 0 0 0 0 0 0 0 14.0741 0 0 0 14.708 0 15.2737 11.6106 14.5053 0 0 13.9634 14.5612 14.7147 13.163 13.8134 0 14.2803 16.0036 0 0 0 13.3353 10.8066 0 0 0 14.7521 0 12.088 0 13.8922 0 0 12.7807 12.1524 0 0 0 0 0 0 0 14.887 13.734 0 15.7508 0 0 0 0 0 0 13.4124 0 0 0 12.1361 12.0159 0 0 0 0 0 14.1716 0 0 0 0 13.5884 11.9299 0 15.7746 0 0 0 0 0 12.6066 0 0 0 0 0 11.8233 13.4878 0 0 0 0 13.0048 0 0 0 0 11.6793 0 0 0 13.2412 0 13.0946 0 Q9NR80 ARHG4_HUMAN "Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1, Asef, Asef1)" ARHGEF4 KIAA1112 Homo sapiens (Human) filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; ruffle membrane [GO:0032587] cytosol [GO:0005829]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904]; filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005829; GO:0019904; GO:0030032; GO:0032587; GO:0035556; GO:0046847; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904] ALEQRFNRER 0.99495 -12.624 0 0 0 0 0 0 0 0 12.5242 12.5765 12.6519 13.1986 12.6226 0 0 12.3686 12.4454 12.6905 0 0 0 0 11.2425 0 0 0 12.8875 0 0 0 12.6904 0 12.7153 12.8612 12.1674 12.7513 0 12.8036 12.7129 13.0885 12.7062 12.8882 16.2803 0 12.9283 0 0 0 0 0 0 0 12.225 0 12.9232 11.9354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1196 13.4375 0 13.9023 0 0 15.3434 13.6703 0 14.6151 0 0 0 13.6005 14.0712 13.8599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9207 11.5719 0 0 0 0 12.8035 0 0 0 0 0 12.512 0 0 0 0 0 0 0 0 0 0 14.3313 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3625 0 12.1769 0 0 12.6052 0 14.3188 14.1338 14.072 14.0421 0 14.1821 14.456 0 19.0614 0 0 14.04 13.8366 0 10.1698 0 0 0 14.4266 0 0 0 0 Q9NZB2 F120A_HUMAN Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A) FAM120A C9orf10 KIAA0183 OSSA Homo sapiens (Human) cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA binding [GO:0003723] GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0016020 RNA binding [GO:0003723] DLPPAALLYRPVR 0.99495 -10.71 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3499 0 0 0 0 0 0 0 0 0 0 0 0 14.5314 0 0 0 0 0 13.5577 0 0 0 0 0 0 0 0 0 0 0 0 14.5464 0 14.321 0 0 0 0 0 0 0 0 0 0 13.5409 0 0 0 0 0 0 0 0 11.6242 0 0 11.7133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9688 0 0 0 0 0 0 11.629 0 0 0 12.3226 13.7456 0 0 0 0 0 0 10.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0357 0 0 Q9UBS5 GABR1_HUMAN "Gamma-aminobutyric acid type B receptor subunit 1, GABA-B receptor 1, GABA-B-R1, GABA-BR1, GABABR1, Gb1" GABBR1 GPRC3A Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021] "anchoring junction [GO:0070161]; axolemma [GO:0030673]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]" GO:0001649; GO:0004888; GO:0004965; GO:0005615; GO:0005789; GO:0005886; GO:0005887; GO:0007193; GO:0007194; GO:0007214; GO:0008021; GO:0008285; GO:0014049; GO:0014053; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038039; GO:0043025; GO:0043197; GO:0043198; GO:0045121; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0070161; GO:0098685; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099579; GO:0150099; GO:1902712; GO:1990430 extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888] CLANGSWTDMDTPSR 0.99495 -12.609 0 0 0 0 0 0 0 0 14.6882 0 14.2507 0 0 14.1771 0 0 12.5587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5205 10.7161 0 0 0 0 11.1255 0 0 0 14.988 12.9862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2643 0 0 0 0 0 12.0477 0 0 0 0 11.504 0 0 14.6183 13.9148 15.7874 13.6787 0 15.7425 13.9277 15.9576 15.0902 13.877 16.1763 15.6345 15.9307 15.2219 15.9813 15.4488 14.1614 0 0 0 0 13.6642 13.576 12.8686 0 13.7642 0 0 0 13.1312 13.4737 13.6015 0 13.2358 11.0637 0 0 13.0592 12.5738 0 0 12.7874 0 0 0 0 0 0 13.0373 0 0 0 0 0 0 0 0 0 0 0 0 12.978 0 0 9.91228 0 0 0 0 0 0 0 10.9547 0 0 0 0 0 0 0 0 0 0 11.099 0 0 0 0 0 0 0 0 0 12.0767 0 0 0 Q9UIE0 ZN230_HUMAN Zinc finger protein 230 (Zinc finger protein FDZF2) ZNF230 FDZF2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEDCGKRYK 0.99495 -11.387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75258 0 9.15312 0 0 0 0 0 11.7747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1924 0 0 0 12.547 0 12.1932 0 0 0 0 15.5095 0 0 0 12.3082 0 0 0 0 0 12.238 0 0 0 0 13.0355 0 12.4099 0 0 0 0 0 0 12.2075 0 0 0 12.3287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9451 0 0 0 13.0349 0 0 0 0 0 0 0 0 0 0 12.7056 0 0 0 0 0 0 0 0 0 0 11.8541 0 0 0 0 0 0 P13647 K2C5_HUMAN "Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5, CK-5) (Keratin-5, K5) (Type-II keratin Kb5)" KRT5 Homo sapiens (Human) epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; intermediate filament polymerization [GO:0045107]; keratinization [GO:0031424]; regulation of cell migration [GO:0030334]; regulation of protein localization [GO:0032880]; response to mechanical stimulus [GO:0009612] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; membrane [GO:0016020]; nucleus [GO:0005634]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280]; epidermis development [GO:0008544]; intermediate filament organization [GO:0045109]; intermediate filament polymerization [GO:0045107]; keratinization [GO:0031424]; regulation of cell migration [GO:0030334]; regulation of protein localization [GO:0032880]; response to mechanical stimulus [GO:0009612] GO:0005200; GO:0005634; GO:0005737; GO:0005829; GO:0005882; GO:0008544; GO:0009612; GO:0016020; GO:0030280; GO:0030334; GO:0031424; GO:0032880; GO:0045095; GO:0045107; GO:0045109; GO:0070062; GO:0097110 scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of skin epidermis [GO:0030280] AQYEEIANR 0.99496 -8.2576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.841 0 0 10.2973 0 0 0 0 0 0 0 0 0 0 0 13.9612 10.366 11.7717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4626 0 11.608 12.9528 13.1498 11.3017 14.7358 0 14.6791 17.9011 17.7375 17.9496 16.4877 16.2437 17.2068 16.1577 16.0204 15.7376 16.6408 16.2563 16.0648 16.1789 15.3179 15.2248 16.3145 17.6682 17.514 16.7482 16.1089 15.6802 0 0 0 12.395 0 0 13.0331 0 11.4202 0 14.4029 14.7269 12.611 13.6599 0 12.6474 13.6232 15.1727 14.1478 12.7229 14.6114 16.0718 16.1316 13.4511 14.968 14.2995 14.1217 0 11.9432 12.3057 15.2911 0 13.6744 0 12.946 10.9251 17.4958 16.88 15.7939 14.3628 11.967 13.3102 14.5422 0 0 0 0 13.8385 0 13.4193 0 0 13.7331 0 0 0 11.1475 0 0 0 0 0 11.5698 10.79 12.1211 0 0 0 0 12.1426 14.4383 12.7114 0 0 10.4349 0 11.6946 12.5177 P00568 KAD1_HUMAN "Adenylate kinase isoenzyme 1, AK 1, EC 2.7.4.3, EC 2.7.4.6 (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase)" AK1 Homo sapiens (Human) ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; outer dense fiber [GO:0001520] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; outer dense fiber [GO:0001520]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142] GO:0001520; GO:0004017; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0006165; GO:0006172; GO:0009142; GO:0015949; GO:0046033; GO:0046034; GO:0070062 adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550] MEEKLKK 0.99496 -9.3967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0681 0 0 0 0 0 0 0 0 0 0 0 11.1715 0 11.1116 0 0 0 13.2027 0 0 0 11.1277 0 0 0 0 0 0 0 0 10.4798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0131 0 0 0 9.76612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11229 ACM1_HUMAN Muscarinic acetylcholine receptor M1 CHRM1 Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of ion transport [GO:0043270]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of glial cell proliferation [GO:0060251]; regulation of locomotion [GO:0040012]; saliva secretion [GO:0046541]; signal transduction [GO:0007165]" anchoring junction [GO:0070161]; axon terminus [GO:0043679]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202] "anchoring junction [GO:0070161]; axon terminus [GO:0043679]; cholinergic synapse [GO:0098981]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099529]; phosphatidylinositol phospholipase C activity [GO:0004435]; adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of ion transport [GO:0043270]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of glial cell proliferation [GO:0060251]; regulation of locomotion [GO:0040012]; saliva secretion [GO:0046541]; signal transduction [GO:0007165]" GO:0004435; GO:0004993; GO:0005886; GO:0005887; GO:0007165; GO:0007186; GO:0007187; GO:0007197; GO:0007205; GO:0007207; GO:0007213; GO:0007268; GO:0007274; GO:0007399; GO:0016020; GO:0016907; GO:0030425; GO:0030594; GO:0040012; GO:0043270; GO:0043679; GO:0045202; GO:0046541; GO:0050890; GO:0060251; GO:0070161; GO:0090316; GO:0098685; GO:0098978; GO:0098981; GO:0099056; GO:0099061; GO:0099529 G protein-coupled acetylcholine receptor activity [GO:0016907]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099529]; phosphatidylinositol phospholipase C activity [GO:0004435] CCRCCRAPR 0.99496 -11.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6594 0 0 0 0 0 12.0293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.343 0 0 0 0 0 12.4509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.992 0 0 0 0 13.571 0 13.8725 0 0 0 0 0 0 0 12.2455 0 0 0 0 0 0 0 0 0 13.6551 0 0 0 0 12.7872 12.8097 0 0 11.4766 0 0 12.5557 0 0 0 12.7924 12.5929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8518 12.3402 0 0 0 P12980 LYL1_HUMAN "Protein lyl-1 (Class A basic helix-loop-helix protein 18, bHLHa18) (Lymphoblastic leukemia-derived sequence 1)" LYL1 BHLHA18 Homo sapiens (Human) "B cell differentiation [GO:0030183]; blood vessel maturation [GO:0001955]; definitive hemopoiesis [GO:0060216]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; B cell differentiation [GO:0030183]; blood vessel maturation [GO:0001955]; definitive hemopoiesis [GO:0060216]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0001955; GO:0003677; GO:0005654; GO:0006355; GO:0006357; GO:0030183; GO:0045893; GO:0046983; GO:0060216 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" LAMKYIGFLVRLLR 0.99496 -11.409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5796 0 0 0 0 0 0 0 0 0 0 0 12.4668 12.5045 14.0514 14.1025 13.5818 0 0 0 0 0 11.2483 13.8493 0 0 11.7662 11.1363 0 0 0 15.0122 0 0 0 0 0 14.4438 0 0 0 11.4525 0 0 0 0 0 0 11.1439 0 0 11.6977 0 0 13.1191 0 0 0 0 0 0 0 0 12.909 0 0 0 0 0 12.9507 0 0 0 0 0 0 0 13.6979 0 0 0 0 15.8079 0 0 0 10.9059 0 0 0 0 0 11.2409 0 0 0 9.81785 0 0 0 0 0 0 14.3168 0 14.8867 0 0 0 0 9.94626 0 P55316 FOXG1_HUMAN "Forkhead box protein G1 (Brain factor 1, BF-1, BF1) (Brain factor 2, BF-2, BF2, hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1, HFK1) (Forkhead-related protein FKHL2, HFK2) (Forkhead-related protein FKHL3, HFK3)" FOXG1 FKH2 FKHL1 FKHL2 FKHL3 FKHL4 FOXG1A FOXG1B FOXG1C Homo sapiens (Human) "aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; aging [GO:0007568]; axon midline choice point recognition [GO:0016199]; brain development [GO:0007420]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000981; GO:0002052; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0007346; GO:0007405; GO:0007420; GO:0007568; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0045892; GO:0048664; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" GAGAGGEEK 0.99496 -8.2654 0 0 0 0 0 0 0 0 13.2262 13.1811 13.0406 13.7483 0 11.9153 12.1847 12.1932 0 0 0 0 0 0 0 0 0 19.2712 0 12.3586 12.3995 13.3021 0 13.2791 13.2371 12.1394 0 12.3059 19.2978 13.3129 12.4853 0 13.2261 0 12.2279 0 13.2758 0 11.8933 13.1082 13.5041 19.3481 0 0 0 0 0 14.0593 0 14.0336 13.1945 0 14.3875 0 0 0 0 13.158 0 0 0 0 0 0 0 0 0 13.4969 0 0 12.6866 0 0 0 0 0 0 0 0 12.6637 0 13.9571 13.0628 13.6597 13.9037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5151 0 0 0 0 13.0186 0 0 0 0 0 0 0 13.4147 0 0 0 12.9564 13.4305 13.7169 0 0 14.3891 14.6997 14.6535 0 13.7597 13.4453 19.8997 19.8831 19.8494 19.8834 19.8547 0 12.6653 0 0 0 0 0 0 0 P61026 RAB10_HUMAN "Ras-related protein Rab-10, EC 3.6.5.2" RAB10 Homo sapiens (Human) antigen processing and presentation [GO:0019882]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; establishment of protein localization to membrane [GO:0090150]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] adherens junction [GO:0005912]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802] adherens junction [GO:0005912]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cadherin binding involved in cell-cell adhesion [GO:0098641]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; antigen processing and presentation [GO:0019882]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; establishment of protein localization to membrane [GO:0090150]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0005929; GO:0006893; GO:0006904; GO:0007409; GO:0008021; GO:0009306; GO:0016192; GO:0016197; GO:0017157; GO:0019003; GO:0019882; GO:0030659; GO:0030667; GO:0030670; GO:0030859; GO:0031489; GO:0032593; GO:0032869; GO:0043001; GO:0043231; GO:0045055; GO:0045200; GO:0048471; GO:0055037; GO:0055038; GO:0070062; GO:0070382; GO:0071782; GO:0071786; GO:0072659; GO:0090150; GO:0097051; GO:0098641; GO:1903361 cadherin binding involved in cell-cell adhesion [GO:0098641]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489] EPNSENVDISSGGGVTGWKSKCC 0.99496 -11.052 0 10.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.702 0 0 0 0 0 0 0 0 0 11.5241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8316 0 0 0 0 0 0 0 0 11.984 0 0 0 0 0 0 13.2777 13.9733 0 0 0 0 0 13.5442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0887 0 0 0 0 0 0 0 0 13.2662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3613 0 0 0 13.4516 0 Q12797 ASPH_HUMAN "Aspartyl/asparaginyl beta-hydroxylase, EC 1.14.11.16 (Aspartate beta-hydroxylase, ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase)" ASPH BAH Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane transport [GO:0070588]; cell population proliferation [GO:0008283]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]" calcium channel complex [GO:0034704]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017] "calcium channel complex [GO:0034704]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane transport [GO:0070588]; cell population proliferation [GO:0008283]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]" GO:0005198; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006936; GO:0007389; GO:0008283; GO:0008285; GO:0008307; GO:0009055; GO:0010524; GO:0010649; GO:0010880; GO:0010881; GO:0014701; GO:0016021; GO:0030176; GO:0031585; GO:0031647; GO:0032237; GO:0032541; GO:0033017; GO:0033018; GO:0033198; GO:0034704; GO:0035108; GO:0042264; GO:0044325; GO:0045862; GO:0045893; GO:0055074; GO:0060021; GO:0060314; GO:0060316; GO:0060325; GO:0062101; GO:0070588; GO:0071277; GO:0090316; GO:0097202; GO:1901879 calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325] AQNKIAESIPYLKEGIESGDPGTDDGR 0.99496 -8.2913 0 0 0 0 0 0 0 0 0 0 0 0 12.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2755 0 0 12.6871 0 0 0 0 0 0 13.774 0 0 0 0 0 0 11.6808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4484 13.6947 14.2167 0 13.864 0 0 11.4812 0 0 0 0 0 0 12.9184 12.5202 0 0 14.1436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.651 13.4159 0 0 13.0992 0 0 0 0 0 0 0 0 0 0 0 12.1515 0 0 0 0 0 Q13227 GPS2_HUMAN "G protein pathway suppressor 2, GPS-2" GPS2 Homo sapiens (Human) B cell differentiation [GO:0030183]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]; cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; B cell differentiation [GO:0030183]; JNK cascade [GO:0007254]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of JNK cascade [GO:0046329]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fat cell differentiation [GO:0045598]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription by RNA polymerase II [GO:0006357]; response to mitochondrial depolarisation [GO:0098780] GO:0000122; GO:0003712; GO:0003713; GO:0003714; GO:0005095; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0005829; GO:0006357; GO:0007254; GO:0010804; GO:0010875; GO:0017053; GO:0019216; GO:0030183; GO:0030332; GO:0034122; GO:0035360; GO:0045598; GO:0045599; GO:0045944; GO:0046329; GO:0050728; GO:0050859; GO:0098780; GO:1900045 cyclin binding [GO:0030332]; GTPase inhibitor activity [GO:0005095]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] EQILKLEEK 0.99496 -12.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7551 12.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMN8 CCNI2_HUMAN Cyclin-I2 CCNI2 Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; mitotic cell cycle phase transition [GO:0044772]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000307; GO:0005634; GO:0005737; GO:0016538; GO:0044772 cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538] GSTLALVIITLELER 0.99496 -12.203 13.5814 15.9876 14.4076 15.4718 14.8345 15.0993 13.7836 11.1119 0 0 0 0 0 0 0 0 0 0 0 13.432 0 0 0 0 0 10.9228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2304 0 0 0 11.5787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2529 0 0 0 14.7783 14.5084 0 14.9344 0 14.4736 14.5981 14.0213 0 0 14.0899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96C03 MID49_HUMAN Mitochondrial dynamics protein MID49 (Mitochondrial dynamics protein of 49 kDa) (Mitochondrial elongation factor 2) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein) MIEF2 MID49 SMCR7 Homo sapiens (Human) dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of mitochondrion organization [GO:0010821] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; mitochondrion organization [GO:0007005]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of mitochondrion organization [GO:0010821] GO:0003374; GO:0005739; GO:0005741; GO:0007005; GO:0010821; GO:0016021; GO:0090141; GO:0090314 AEFSQKRGK 0.99496 -12.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.446 0 0 0 0 0 0 0 0 12.9069 12.1892 0 0 0 0 0 0 0 0 0 12.258 0 0 0 0 0 0 13.9283 0 0 11.5378 0 0 12.6331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1308 0 12.3489 0 0 0 0 0 13.6609 0 0 0 0 15.4193 0 0 0 0 0 13.4815 0 0 0 0 0 0 0 0 0 0 0 0 12.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7287 0 12.8486 14.5664 0 0 0 0 0 11.3008 11.7433 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP72 RAB18_HUMAN Ras-related protein Rab-18 RAB18 Homo sapiens (Human) brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; small GTPase mediated signal transduction [GO:0007264] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; small GTPase mediated signal transduction [GO:0007264] GO:0001654; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0005886; GO:0006886; GO:0007264; GO:0007420; GO:0016324; GO:0019003; GO:0030667; GO:0034389; GO:0071782; GO:0071786 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] EEGQGGGACGGYCSVL 0.99496 -8.2612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6339 0 0 0 12.5942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9404 0 0 0 0 0 0 0 0 0 15.015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6776 0 10.4089 10.6773 0 0 12.6636 0 0 0 0 0 0 0 0 0 0 9.6725 0 10.8334 0 0 0 0 0 0 0 0 0 11.8278 0 0 0 11.1396 0 0 0 12.1826 11.5935 0 10.8555 13.0571 0 0 0 10.5285 0 0 0 0 A0AVT1 UBA6_HUMAN "Ubiquitin-like modifier-activating enzyme 6, Ubiquitin-activating enzyme 6, EC 6.2.1.45 (Monocyte protein 4, MOP-4) (Ubiquitin-activating enzyme E1-like protein 2, E1-L2)" UBA6 MOP4 UBE1L2 Homo sapiens (Human) amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; cellular response to DNA damage stimulus [GO:0006974]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006974; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0032446; GO:0060996 ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839] ACIGDTLCQK 0.99497 -8.3248 0 0 0 0 0 0 0 0 13.1097 0 13.3585 13.0281 0 0 0 0 0 0 0 0 0 0 0 0 15.3951 0 12.6588 0 0 0 0 0 0 11.986 0 0 0 0 0 0 16.3519 0 0 0 0 0 0 0 10.1764 0 0 13.09 0 0 17.4414 0 0 0 0 0 0 15.4206 15.9994 0 0 15.3438 10.6878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6399 0 0 12.7696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7964 0 0 0 0 0 0 0 0 0 0 0 0 0 O00408 PDE2A_HUMAN "cGMP-dependent 3',5'-cyclic phosphodiesterase, EC 3.1.4.17 (Cyclic GMP-stimulated phosphodiesterase, CGS-PDE, cGSPDE)" PDE2A Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]" GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004114; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0043949; GO:0043951; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:1904613 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]" DRKILQLCGELYDLDASSLQLK 0.99497 -32.27 0 0 0 0 0 0 0 0 0 0 0 15.137 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6573 12.4099 0 0 0 0 16.3399 0 0 0 0 0 0 0 16.1978 0 11.4496 0 0 0 0 0 0 0 0 0 0 12.3828 0 0 0 0 0 0 0 0 15.9107 16.0194 15.1743 0 0 0 0 0 10.1695 0 0 0 0 14.1902 15.0783 12.0654 14.3272 14.7747 13.4546 14.788 0 14.8681 14.9375 0 0 0 11.0486 0 0 0 0 0 0 14.491 13.7448 0 0 13.7222 12.5831 0 16.2111 0 0 0 14.535 0 0 0 12.2849 13.1021 0 14.7144 0 13.6879 0 0 14.0296 0 13.9017 14.6031 14.6656 0 0 14.912 13.8564 0 15.4967 14.6908 0 13.8832 14.1634 13.7984 14.9665 12.4646 0 0 0 0 15.1003 0 0 0 14.5511 0 0 0 0 13.9008 13.9922 0 0 0 0 0 0 0 19.4012 0 17.7528 0 0 0 0 0 0 0 13.9326 17.9448 0 0 0 0 0 0 0 0 0 0 0 O43432 IF4G3_HUMAN "Eukaryotic translation initiation factor 4 gamma 3, eIF-4-gamma 3, eIF-4G 3, eIF4G 3 (eIF-4-gamma II, eIF4GII)" EIF4G3 Homo sapiens (Human) regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413] cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281] "cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]" GO:0000339; GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0006413; GO:0006446; GO:0008135; GO:0016281 "mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" DPNQGGKDITEEIMSGGGSR 0.99497 -31.925 0 0 0 14.2494 13.0317 13.2656 13.8856 13.3934 0 14.3178 13.5002 14.7539 14.375 13.2209 13.2268 13.0412 10.4269 0 0 0 0 13.7313 0 0 11.1426 0 0 0 0 0 13.6299 13.1764 0 15.1969 0 0 12.8313 0 0 13.1462 14.04 12.476 12.1206 0 0 10.1236 13.0109 11.7016 0 0 0 11.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 10.234 0 14.8032 0 0 0 11.5475 0 0 0 0 10.9965 0 10.9221 0 0 0 13.6488 14.7453 11.7245 0 0 13.3394 13.2087 12.1201 15.2002 13.5077 13.8094 13.8879 0 0 13.6633 13.8561 0 12.8826 12.3212 0 0 14.7528 0 12.1668 12.4564 11.6802 0 13.4745 13.7229 0 13.8551 0 11.0473 0 15.1575 0 13.4602 12.3201 0 0 0 0 14.1346 13.247 0 0 0 0 10.6864 0 13.5042 12.3161 0 13.3735 14.8475 0 16.0067 11.9277 0 0 14.1863 0 0 0 0 0 0 0 13.368 0 14.3373 0 0 11.9805 0 12.9423 0 11.8313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2459 0 0 0 0 O95104 SCAF4_HUMAN "SR-related and CTD-associated factor 4 (CTD-binding SR-like protein RA4) (Splicing factor, arginine/serine-rich 15)" SCAF4 KIAA1172 SFRS15 Homo sapiens (Human) "mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; mRNA processing [GO:0006397]; negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]" GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008022; GO:1990269; GO:2000805 protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269] AIKLYKHVVQIVEK 0.99497 -32.295 0 0 0 0 0 0 0 0 13.8738 0 0 0 0 0 11.8614 11.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4187 0 0 0 13.3297 12.8863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.823 0 0 15.5593 0 0 12.711 0 12.6314 0 0 0 0 0 0 0 14.7049 0 14.5419 14.0296 14.6598 13.4691 15.2782 15.2935 15.8762 0 13.1268 15.0703 0 0 13.0369 13.9446 0 0 0 0 0 0 0 0 13.8064 0 0 0 0 0 0 0 0 0 0 0 0 14.6024 0 0 0 0 0 0 0 11.8975 0 0 0 13.4503 14.2381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8503 16.0259 0 12.4119 0 0 0 0 0 0 Q03938 ZNF90_HUMAN Zinc finger protein 90 (Zinc finger protein HTF9) ZNF90 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0008270 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AFNRSSHLTSHKR 0.99497 -32.409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7751 0 0 0 0 0 0 0 0 0 0 0 0 11.2297 0 0 0 0 0 0 0 0 0 13.875 0 0 0 13.1793 0 0 0 16.474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12796 PNRC1_HUMAN Proline-rich nuclear receptor coactivator 1 (Proline-rich protein 2) (Protein B4-2) PNRC1 PROL2 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 APAALPNRSLAVAGGTPRAAPK 0.99497 -13.725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1068 0 12.4025 0 0 0 0 12.4006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7507 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5446 14.8978 0 0 0 0 0 0 13.4781 0 0 0 15.1031 0 15.2836 13.902 14.4198 15.0599 15.1844 15.1306 0 14.8537 14.9312 14.4972 0 0 0 0 0 12.5236 0 0 13.2538 13.7591 0 14.5938 0 14.7739 15.0286 15.6676 14.923 0 0 0 14.5599 0 14.4989 14.8259 0 0 0 0 0 14.6704 0 15.0881 12.4525 14.8406 14.6099 14.8781 0 12.0727 0 0 0 14.5106 11.5797 0 0 0 15.6938 14.0842 0 0 0 0 11.9021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2524 0 0 0 Q5R387 PA2GC_HUMAN Putative inactive group IIC secretory phospholipase A2 (Phosphatidylcholine 2-acylhydrolase-like protein GIIC) PLA2G2C Homo sapiens (Human) arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644] extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid metabolic process [GO:0006644] GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0046470; GO:0047498; GO:0050482 calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543] HITGRSAFFSYYGYGCYCGLGDK 0.99497 -10.574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.972 0 0 0 0 0 0 0 14.5872 0 13.0351 0 0 0 13.0486 0 0 0 13.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5SNV9 CA167_HUMAN Uncharacterized protein C1orf167 C1orf167 Homo sapiens (Human) AHSSPEPRACK 0.99497 -32.106 0 0 0 0 0 0 0 0 12.1475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.566 0 0 9.19997 0 0 0 0 0 0 0 0 0 10.8906 0 0 0 0 0 0 0 0 0 0 11.8158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1275 0 0 0 0 0 0 0 0 12.0473 0 12.3203 13.8942 12.886 0 11.6559 0 0 12.4607 13.7215 0 13.7247 14.6023 12.5104 10.6419 0 0 12.0284 11.7022 11.9471 0 0 0 0 0 0 13.5627 11.8725 0 0 0 0 0 0 0 13.7618 0 0 0 0 14.3454 13.4659 13.6128 0 0 14.0305 0 14.4926 14.7522 0 13.1691 12.062 0 13.9407 0 0 0 0 0 12.305 0 13.8099 13.4691 0 0 0 0 0 0 0 12.5806 12.0701 0 15.5314 0 0 0 0 0 0 0 15.1617 14.6771 0 0 0 0 11.7593 12.4406 0 13.3814 11.6043 0 13.3161 0 11.4342 12.7429 0 0 13.5948 0 0 0 0 13.9696 0 Q5SVZ6 ZMYM1_HUMAN Zinc finger MYM-type protein 1 ZMYM1 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270] GO:0005634; GO:0008270; GO:0046983 protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270] CTSKVQKVK 0.99497 -8.3232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8481 13.6428 0 12.0283 0 0 0 0 0 0 0 0 0 0 0 0 13.9901 0 0 0 0 0 0 0 0 0 0 0 14.1975 0 0 0 0 0 0 11.9552 13.4193 0 0 13.244 13.5853 0 0 0 0 0 13.0898 0 15.4141 0 0 0 0 0 0 0 0 0 12.8442 0 13.4676 12.4916 0 12.7008 0 0 13.1251 15.5557 14.4049 0 0 13.4955 13.1686 0 13.1352 14.0643 0 0 0 13.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0095 13.7456 0 0 0 0 0 0 0 0 0 0 0 0 12.4991 0 0 0 0 0 0 0 0 0 0 0 9.82918 Q6NUP7 PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 PPP4R4 KIAA1622 PP4R4 Homo sapiens (Human) blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287] cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein serine/threonine phosphatase complex [GO:0008287]; protein phosphatase regulator activity [GO:0019888]; blastocyst hatching [GO:0001835]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; regulation of protein serine/threonine phosphatase activity [GO:0080163] GO:0001835; GO:0005737; GO:0005829; GO:0008287; GO:0019888; GO:0032515; GO:0080163 protein phosphatase regulator activity [GO:0019888] AASRTLCIFLRYNR 0.99497 -32.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.7764 0 0 0 0 0 0 12.1804 12.1024 0 0 0 13.4972 0 0 12.6782 12.0096 14.7158 14.5205 17.6417 0 0 0 0 14.7096 0 0 0 0 14.3973 14.7089 0 15.074 0 0 0 13.0879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4996 11.2773 0 14.1037 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8912 12.6613 0 0 12.0205 13.8732 0 0 0 0 12.5676 0 10.5765 12.7592 0 0 0 0 0 0 16.855 0 0 0 0 0 0 10.4117 0 0 0 0 0 0 16.7334 0 0 0 0 0 0 0 13.5807 0 Q8IWA6 CCD60_HUMAN Coiled-coil domain-containing protein 60 CCDC60 Homo sapiens (Human) EHIIHMPQEDYISWLQSR 0.99497 -8.3193 0 0 0 0 0 0 0 0 0 10.3375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.654 0 0 0 0 0 0 11.9258 14.7732 14.8908 14.4545 14.0503 17.872 0 0 12.9618 14.372 0 11.9777 0 0 0 13.9431 14.3202 0 14.0616 0 14.6279 15.1019 14.2594 0 0 0 0 15.5041 15.4327 0 15.1241 14.5109 0 15.2483 15.5862 0 0 14.8042 17.793 0 0 14.5145 0 15.0918 15.339 14.8178 14.8912 0 15.2121 14.5322 0 0 14.9438 15.8243 14.0251 11.6206 0 0 0 14.4548 0 14.0662 14.7047 0 0 13.5254 0 0 0 14.0821 0 0 0 13.9798 0 0 0 0 0 0 0 13.0797 0 14.4023 0 0 0 0 0 0 0 12.7547 0 0 0 0 0 0 0 0 13.806 0 0 0 0 0 0 Q8IWQ3 BRSK2_HUMAN "Serine/threonine-protein kinase BRSK2, EC 2.7.11.1 (Brain-selective kinase 2, EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2, BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A)" BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; actin cytoskeleton reorganization [GO:0031532]; axonogenesis [GO:0007409]; cell division [GO:0051301]; cellular response to glucose starvation [GO:0042149]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]" GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030182; GO:0031532; GO:0035556; GO:0036503; GO:0042149; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807 ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] AIEMAQHGQR 0.99497 -8.3019 0 0 0 0 0 0 0 0 0 0 11.8912 10.4926 0 0 0 0 0 13.1078 0 0 13.0427 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2713 0 0 0 0 0 0 13.807 0 0 0 0 0 0 0 12.0428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3538 0 0 0 13.9661 0 0 0 0 0 0 14.7469 0 11.9858 13.7669 0 0 0 0 0 0 0 12.686 0 12.7975 0 13.1042 0 0 11.3801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7449 0 11.7679 12.8743 12.9408 12.2616 0 13.1107 13.2615 0 0 0 13.5313 13.7378 0 0 0 0 0 13.7567 0 0 0 0 0 0 0 0 14.2672 0 0 0 0 0 0 0 0 0 0 0 14.4421 0 0 0 0 0 0 14.3639 13.8655 0 0 0 0 11.6991 13.7466 0 0 0 13.638 0 0 Q8IWX7 UN45B_HUMAN "Protein unc-45 homolog B, Unc-45B (SMUNC45)" UNC45B CMYA4 UNC45 Homo sapiens (Human) cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517] A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018] A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517] GO:0002088; GO:0005737; GO:0005829; GO:0007517; GO:0030018; GO:0030154; GO:0031672; GO:0048471; GO:0051879; GO:0061077 Hsp90 protein binding [GO:0051879] AAHALAK 0.99497 -11.446 0 0 0 0 11.0043 0 0 0 13.4229 0 0 0 11.3594 12.1655 13.3056 0 12.2764 12.5925 14.3114 11.9303 12.3 0 12.7366 0 0 12.9919 0 11.4275 0 13.2086 13.3166 0 0 11.2467 0 0 0 12.3897 13.5928 12.6005 12.0258 13.8258 12.9325 13.3993 0 0 0 12.3232 10.9301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7209 0 0 0 0 0 15.76 15.6461 16.6424 0 0 13.2538 17.0245 13.69 0 15.744 15.768 15.8578 0 0 16.1399 0 15.7576 16.1228 0 16.5901 16.1361 16.8296 11.819 0 0 0 0 15.5173 13.2101 14.0715 0 12.8043 13.5409 0 0 0 0 0 0 17.6236 15.9049 14.894 15.9823 0 14.0287 0 0 0 0 13.9049 0 0 14.15 15.933 13.0891 0 0 18.2341 0 0 14.267 0 0 0 0 0 0 0 12.6454 0 0 0 12.6947 0 12.2481 0 15.995 15.9999 14.3283 0 0 0 0 13.0862 0 0 0 0 13.4188 0 0 0 0 15.9718 0 0 0 0 0 0 0 0 Q96GD3 SCMH1_HUMAN Polycomb protein SCMH1 (Sex comb on midleg homolog 1) SCMH1 Homo sapiens (Human) "heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; heterochromatin assembly [GO:0031507]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003682; GO:0005634; GO:0005654; GO:0031507; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; histone binding [GO:0042393] DMESFWKLNR 0.99497 -10.594 0 0 0 0 0 12.1549 0 0 0 0 0 0 0 0 0 13.3372 0 12.8921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6317 0 0 0 0 0 0 0 0 0 0 15.3512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.641 0 0 Q9GZR2 REXO4_HUMAN "RNA exonuclease 4, EC 3.1.-.- (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog, hPMC2)" REXO4 PMC2 XPMC2H Homo sapiens (Human) "DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]" nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; DNA repair [GO:0006281]; regulation of transcription, DNA-templated [GO:0006355]; rRNA processing [GO:0006364]" GO:0000737; GO:0000738; GO:0003690; GO:0003697; GO:0003723; GO:0004519; GO:0004527; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0006364; GO:0008408; GO:0016607 3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697] ERTNGDIVPERGDIEHK 0.99497 -32.316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7308 0 0 0 0 0 0 0 0 13.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1916 0 0 0 0 0 12.5563 13.1379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8625 0 0 14.4444 0 11.6829 14.8487 0 0 13.6571 14.4546 0 14.356 0 12.1245 0 0 0 0 0 0 0 0 0 14.557 14.1033 0 11.833 0 13.4512 0 0 0 0 0 0 11.3877 13.2574 14.4727 0 11.8168 13.8528 0 0 12.7197 14.3722 0 13.8953 0 0 0 0 13.7328 13.8191 13.5585 0 0 0 0 0 0 0 0 0 13.9183 0 0 13.8982 0 0 0 0 0 0 0 0 13.1842 0 14.3245 0 0 0 13.8748 0 0 0 14.0806 13.7898 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1788 0 0 0 0 0 0 0 0 0 0 Q9P2F5 STOX2_HUMAN Storkhead-box protein 2 STOX2 KIAA1392 Homo sapiens (Human) embryo development ending in birth or egg hatching [GO:0009792]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; embryo development ending in birth or egg hatching [GO:0009792]; maternal placenta development [GO:0001893]; positive regulation of transcription by RNA polymerase II [GO:0045944]" GO:0000977; GO:0001228; GO:0001893; GO:0005634; GO:0005737; GO:0009792; GO:0045944 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DEDTPATIPR 0.99497 -32.192 0 0 0 0 0 0 0 0 14.1023 0 0 0 0 10.8348 0 0 12.8365 0 0 13.1465 0 0 0 0 12.7908 0 13.2208 12.1454 0 0 0 10.5287 0 0 0 0 10.4792 0 0 0 9.78233 0 11.1834 0 12.6397 0 0 0 0 0 9.92166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6626 0 0 0 0 0 0 0 0 0 12.5423 0 0 0 0 0 12.1229 0 12.2814 0 0 0 0 0 15.1691 0 0 0 0 0 0 0 0 0 0 0 0 13.1784 12.4456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3635 0 0 0 0 0 0 13.1298 0 0 13.2264 0 0 14.3431 0 0 0 0 0 0 0 0 0 0 11.1059 0 13.0018 0 0 0 0 0 0 0 0 0 11.2029 0 0 12.025 14.2981 O00409 FOXN3_HUMAN Forkhead box protein N3 (Checkpoint suppressor 1) FOXN3 C14orf116 CHES1 Homo sapiens (Human) "craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0008022; GO:0045892; GO:0097094 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]" NGITSCR 0.99498 -8.3255 0 0 0 0 0 0 0 0 0 0 11.2823 0 0 0 0 0 0 0 0 0 0 12.7437 0 0 0 0 0 0 0 0 10.8328 0 12.0199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4941 0 0 0 0 0 0 0 0 0 0 11.9589 0 12.7758 0 0 0 11.0581 0 0 0 0 0 0 0 0 12.4508 0 0 0 0 12.7373 0 14.0646 13.6891 0 13.8133 0 0 13.8535 0 13.6428 0 0 0 12.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8622 0 0 0 11.8855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94966 UBP19_HUMAN "Ubiquitin carboxyl-terminal hydrolase 19, EC 3.4.19.12 (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9)" USP19 KIAA0891 ZMYND9 Homo sapiens (Human) negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cysteine-type deubiquitinase activity [GO:0004843]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0004843; GO:0005789; GO:0005829; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380 cysteine-type deubiquitinase activity [GO:0004843]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625] EASKQLLLWRLPNVLIVQLK 0.99498 -12.851 0 0 12.1822 0 0 0 0 0 0 0 0 13.4374 0 0 13.3983 0 0 0 13.3095 0 12.2518 12.6151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0005 0 0 0 0 0 0 14.2639 0 13.3667 11.325 14.9044 0 14.1199 0 0 0 12.1615 0 0 0 0 0 0 0 0 12.0276 17.5545 17.6533 0 12.992 13.0154 15.3034 14.4637 13.6296 14.0318 0 0 13.9179 13.3276 13.1196 15.8879 15.187 0 0 0 14.5582 13.9192 0 0 14.3455 17.597 16.0223 15.0541 0 15.9239 17.9587 0 0 0 17.9706 15.5696 0 0 14.837 16.2446 13.6094 0 0 13.8446 18.039 13.1071 0 0 13.5503 14.7068 14.4689 14.6141 14.9817 0 0 0 14.144 13.8135 0 13.6783 0 17.7424 13.0321 0 0 14.1491 13.1095 14.746 0 0 0 13.0298 0 0 0 0 13.3555 0 0 0 0 12.4021 0 0 0 0 P49917 DNLI4_HUMAN "DNA ligase 4, EC 6.5.1.1 (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4)" LIG4 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DN2 thymocyte differentiation [GO:1904155]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; fibroblast proliferation [GO:0048144]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]" "chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DN2 thymocyte differentiation [GO:1904155]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; fibroblast proliferation [GO:0048144]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair, DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; stem cell proliferation [GO:0072089]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151]" GO:0000012; GO:0000781; GO:0000793; GO:0001701; GO:0002328; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005958; GO:0006260; GO:0006266; GO:0006297; GO:0006302; GO:0006303; GO:0007049; GO:0007417; GO:0008022; GO:0008283; GO:0010165; GO:0010332; GO:0016874; GO:0022008; GO:0032807; GO:0033077; GO:0033151; GO:0033152; GO:0033153; GO:0035019; GO:0036464; GO:0043524; GO:0045190; GO:0046872; GO:0048144; GO:0048146; GO:0050769; GO:0051102; GO:0051103; GO:0051276; GO:0051301; GO:0051402; GO:0070419; GO:0071285; GO:0071479; GO:0071897; GO:0072089; GO:0075713; GO:0097680; GO:1904155; GO:2001252 ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022] AAPKMKK 0.99498 -35.918 0 0 0 0 0 0 0 0 0 0 0 0 17.0022 0 0 0 0 14.7599 0 0 0 0 0 14.8432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4007 0 0 0 0 0 0 0 0 0 0 0 0 11.3407 0 0 0 14.6231 0 12.5042 0 0 0 0 12.956 0 11.5026 0 0 0 0 0 14.125 0 0 0 0 0 0 0 0 16.1297 0 0 0 14.4407 15.131 12.5431 0 0 0 0 0 0 0 14.0876 0 0 0 0 0 13.925 14.57 0 0 0 13.6159 0 0 13.1077 14.7962 0 0 0 0 0 11.0763 14.0961 0 0 0 0 14.4001 13.8807 0 0 0 0 0 0 0 11.9862 0 0 14.5233 13.9568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2703 0 0 0 0 0 0 0 12.6668 0 Q6UXG2 ELAP1_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator 1 (Estrogen-induced gene 121 protein) ELAPOR1 EIG121 KIAA1324 UNQ2426/PRO4985 Homo sapiens (Human) autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of vacuole organization [GO:0044090] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of vacuole organization [GO:0044090] GO:0000045; GO:0003723; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0005887; GO:0009267; GO:0016021; GO:0031902; GO:0044090; GO:0070062; GO:2000786 RNA binding [GO:0003723] ESEYHYEYTACDSTGSR 0.99498 -8.8974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.919 0 11.5133 0 0 0 0 0 0 0 12.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5174 0 0 0 0 0 0 0 0 0 12.0024 0 0 0 12.3134 0 0 0 0 0 12.5158 0 0 0 0 0 0 0 0 0 0 0 13.441 0 0 0 0 11.1359 0 0 0 0 0 0 11.0889 0 0 12.3062 0 0 0 0 0 0 0 0 12.1582 0 0 0 12.8191 0 0 0 Q8N539 FBCD1_HUMAN Fibrinogen C domain-containing protein 1 FIBCD1 UNQ701/PRO1346 Homo sapiens (Human) cell adhesion [GO:0007155] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; cell adhesion [GO:0007155] GO:0005102; GO:0005615; GO:0007155; GO:0008061; GO:0016020; GO:0016021; GO:0046872; GO:0062023 chitin binding [GO:0008061]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102] APARGTR 0.99498 -9.4453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG78 OR8G5_HUMAN Olfactory receptor 8G5 (Olfactory receptor 8G6) (Olfactory receptor OR11-298) OR8G5 OR8G5P OR8G6 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] NKDVHVALK 0.99498 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBB0 THAP6_HUMAN THAP domain-containing protein 6 THAP6 Homo sapiens (Human) microtubule cytoskeleton [GO:0015630] microtubule cytoskeleton [GO:0015630]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0015630; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] CCSAIGCASR 0.99498 -13.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7886 0 0 0 0 11.9885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3893 12.6743 0 0 0 0 0 0 0 0 0 12.5996 0 0 0 0 0 0 0 0 0 13.6126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6053 0 0 12.954 12.6634 0 13.5422 13.0472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93098 WNT8B_HUMAN Protein Wnt-8b WNT8B Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; determination of dorsal identity [GO:0048263]; gastrulation [GO:0007369]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; determination of dorsal identity [GO:0048263]; gastrulation [GO:0007369]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165] GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0007165; GO:0007369; GO:0007399; GO:0030182; GO:0032355; GO:0032526; GO:0045165; GO:0048018; GO:0048263; GO:0060070; GO:0071300 cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018] AETVSSCNCK 0.99498 -8.8988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1553 0 0 0 0 0 0 0 0 0 12.2305 0 0 0 0 0 16.6691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3844 0 0 0 Q96M34 TEX55_HUMAN "Testis-specific expressed protein 55 (Testis-specific conserved, cAMP-dependent type II PK-anchoring protein)" TEX55 C3orf30 TSCPA Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 EADYRVQPCK 0.99498 -13.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9744 0 12.8649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1862 0 14.2004 0 0 0 0 11.9126 14.093 14.1106 13.3253 13.4511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1877 0 12.6871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.816 0 0 0 0 0 11.4895 0 0 0 0 0 0 0 0 13.1445 0 0 0 0 0 0 Q9NRY4 RHG35_HUMAN "Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1, GRF-1) (Rho GAP p190A, p190-A)" ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP Homo sapiens (Human) "axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319]" actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319]" GO:0001843; GO:0003677; GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005634; GO:0005829; GO:0005886; GO:0007266; GO:0007411; GO:0007413; GO:0008064; GO:0008360; GO:0008361; GO:0010976; GO:0015629; GO:0016477; GO:0021955; GO:0030879; GO:0030900; GO:0030950; GO:0031668; GO:0032794; GO:0032956; GO:0035024; GO:0036064; GO:0043010; GO:0043116; GO:0043547; GO:0044319; GO:0044877; GO:0045724; GO:0050770; GO:0051056; GO:0097485 DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877] AFKENLETSPFITPGK 0.99498 -13.79 0 0 0 0 0 0 11.4434 13.7847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9961 0 0 0 0 13.3688 0 10.7837 10.3786 0 0 0 14.1205 0 0 0 0 0 0 0 0 0 0 13.735 0 0 0 0 0 10.5136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9373 0 11.0871 0 0 12.3071 13.3957 0 0 0 0 11.3705 0 0 13.1903 0 13.4437 10.6325 13.925 0 13.3811 0 0 10.5197 13.3802 13.6928 0 14.3424 13.0276 13.7717 0 0 14.9278 0 11.7196 0 11.0744 0 0 0 10.6775 0 11.18 0 0 0 0 11.0296 0 0 0 0 0 12.82 0 12.7827 10.8235 0 11.7225 11.6915 12.3491 0 0 0 0 0 0 0 0 0 12.2639 0 0 0 0 0 0 0 0 0 0 0 14.6695 0 0 0 0 0 0 0 15.042 16.5534 0 0 15.0159 0 12.2028 0 10.4364 0 0 0 0 15.1979 0 0 0 0 14.9091 0 12.4466 0 0 Q9NVI7 ATD3A_HUMAN ATPase family AAA domain-containing protein 3A ATAD3A Homo sapiens (Human) antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; antiviral innate immune response [GO:0140374]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558] GO:0001558; GO:0005524; GO:0005739; GO:0005743; GO:0007005; GO:0016021; GO:0016887; GO:0042645; GO:0042802; GO:0043066; GO:0140374 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802] AEGPGRGDEPSPS 0.99498 -9.4401 0 0 0 0 0 0 0 0 15.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6561 0 11.526 15.1007 0 10.8111 0 0 0 0 0 0 0 0 0 0 14.5886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2381 0 0 0 0 13.9714 0 0 0 13.6769 0 0 0 0 0 13.1541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.106 0 14.6323 0 0 0 0 0 12.4814 0 0 0 14.2723 0 0 0 13.2376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7673 11.1311 0 0 0 0 0 0 0 0 0 13.3337 13.2939 0 0 12.4463 13.4268 0 12.0339 0 12.1505 Q9NZP8 C1RL_HUMAN "Complement C1r subcomponent-like protein, C1r-LP, C1r-like protein, EC 3.4.21.- (C1r-like serine protease analog protein, CLSPa)" C1RL C1RL1 C1RLP CLSPA Homo sapiens (Human) "complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]" blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615] "blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; zymogen activation [GO:0031638]" GO:0004252; GO:0005615; GO:0006958; GO:0031638; GO:0045087; GO:0070062; GO:0072562 serine-type endopeptidase activity [GO:0004252] LGNFPWQAFTSIHGR 0.99498 -8.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5036 0 0 0 0 0 0 0 13.3319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7306 14.5819 14.1236 0 0 0 13.7286 13.6945 13.6039 0 13.6011 13.2406 13.0928 10.8369 0 0 13.8824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8209 0 0 0 0 0 0 0 0 0 0 0 13.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95865 DDAH2_HUMAN "N(G),N(G)-dimethylarginine dimethylaminohydrolase 2, DDAH-2, Dimethylarginine dimethylaminohydrolase 2, EC 3.5.3.18 (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein)" DDAH2 DDAH G6A NG30 Homo sapiens (Human) arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of apoptotic process [GO:0043066]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of apoptotic process [GO:0043066]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999] GO:0000052; GO:0003824; GO:0005739; GO:0005829; GO:0006525; GO:0006527; GO:0006809; GO:0007263; GO:0016403; GO:0016597; GO:0043066; GO:0045429; GO:0050999; GO:0070062 amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403] ALQDLGLR 0.99499 -11.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6232 0 0 0 0 0 0 0 0 0 P01730 CD4_HUMAN T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4) CD4 Homo sapiens (Human) "adaptive immune response [GO:0002250]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; enzyme-linked receptor protein signaling pathway [GO:0007167]; helper T cell enhancement of adaptive immune response [GO:0035397]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] "clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; defense response to Gram-negative bacterium [GO:0050829]; enzyme-linked receptor protein signaling pathway [GO:0007167]; helper T cell enhancement of adaptive immune response [GO:0035397]; immune response [GO:0006955]; interleukin-15-mediated signaling pathway [GO:0035723]; macrophage differentiation [GO:0030225]; maintenance of protein location in cell [GO:0032507]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of viral entry into host cell [GO:0046598]; regulation of calcium ion transport [GO:0051924]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell selection [GO:0045058]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001618; GO:0001934; GO:0002250; GO:0004888; GO:0005201; GO:0005769; GO:0005788; GO:0005789; GO:0005886; GO:0005887; GO:0006955; GO:0007155; GO:0007165; GO:0007166; GO:0007167; GO:0007169; GO:0008270; GO:0009897; GO:0015026; GO:0018108; GO:0019722; GO:0019899; GO:0019901; GO:0023026; GO:0030217; GO:0030225; GO:0030669; GO:0032507; GO:0032743; GO:0033674; GO:0035397; GO:0035723; GO:0038023; GO:0042011; GO:0042012; GO:0042101; GO:0042110; GO:0042289; GO:0042802; GO:0042803; GO:0043123; GO:0043410; GO:0045058; GO:0045121; GO:0045657; GO:0045860; GO:0045893; GO:0046598; GO:0050731; GO:0050829; GO:0050850; GO:0050863; GO:0050870; GO:0051924; GO:0070374; GO:0097011; GO:1990782 coreceptor activity [GO:0015026]; enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; interleukin-16 binding [GO:0042011]; interleukin-16 receptor activity [GO:0042012]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270] ASSSKSWITFDLKNK 0.99499 -8.9635 0 0 11.7233 0 0 0 0 0 0 10.7678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8247 0 10.1783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5462 0 0 0 0 0 0 0 0 0 12.1705 0 0 0 14.3388 0 12.0924 0 0 0 0 0 0 0 12.2224 0 0 14.7681 0 0 0 0 0 11.3647 0 13.791 0 0 0 0 0 0 13.1378 0 0 0 0 11.3304 12.4814 0 14.7873 13.1536 0 10.7201 15.8688 0 11.066 14.5966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4854 0 12.9823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7963 0 0 15.0283 0 13.4914 0 0 11.833 0 11.8851 0 16.1362 0 0 0 0 0 0 0 14.9659 12.0938 0 0 P54709 AT1B3_HUMAN "Sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3, ATPB-3) (CD antigen CD298)" ATP1B3 Homo sapiens (Human) cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein-macromolecule adaptor activity [GO:0030674]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725] GO:0001671; GO:0005886; GO:0005890; GO:0006883; GO:0016323; GO:0016324; GO:0030007; GO:0030674; GO:0032781; GO:0035725; GO:0036126; GO:0036376; GO:0042470; GO:0050821; GO:0051117; GO:0070062; GO:0071805; GO:0072659; GO:0086009; GO:1901018; GO:1903278; GO:1903288; GO:1990573 ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein-macromolecule adaptor activity [GO:0030674] NLTVCPDGALFEQK 0.99499 -9.9599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NUN9 ZN746_HUMAN "Zinc finger protein 746 (Parkin-interacting substrate, PARIS)" ZNF746 PARIS Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0031625; GO:0045892; GO:0045944; GO:0046872; GO:0051260; GO:0051291; GO:1901216 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]" GFGHKPGLKK 0.99499 -11.617 0 0 0 13.3738 14.7433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2848 14.0088 0 0 0 0 0 0 0 11.6243 0 0 13.7133 0 0 0 0 0 0 0 12.5156 0 11.3404 0 0 0 0 11.928 0 0 0 0 0 14.0026 0 0 0 12.9014 14.318 13.6742 0 0 12.3909 0 0 12.6593 0 15.5753 0 0 0 0 0 0 0 0 0 11.9441 0 11.7944 14.3443 0 0 11.3757 0 0 0 0 14.7044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1356 0 0 0 0 0 12.4949 10.6587 0 0 0 15.7824 0 0 0 0 0 Q6P4Q7 CNNM4_HUMAN Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4) CNNM4 ACDP4 KIAA1592 Homo sapiens (Human) enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857]; enamel mineralization [GO:0070166]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; metal ion homeostasis [GO:0055065]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016021; GO:0016323; GO:0022857; GO:0032991; GO:0043231; GO:0050896; GO:0055065; GO:0070166 magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081]; transmembrane transporter activity [GO:0022857] ASHENAI 0.99499 -9.9605 11.9732 0 0 0 0 0 0 0 13.3486 0 0 0 0 12.8271 0 10.484 0 0 0 11.941 0 0 12.4111 0 0 0 11.7543 0 0 0 0 12.5288 0 0 0 0 0 0 0 0 13.0647 0 0 0 0 0 0 0 0 0 0 13.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2597 0 0 14.0301 0 0 0 0 11.8531 0 13.588 12.2226 15.9178 0 11.2738 0 14.0627 11.7936 14.4342 16.0659 11.3936 0 13.6272 13.2873 13.5675 13.9242 13.188 13.2562 13.9797 13.7991 13.2448 15.9953 0 0 13.9806 13.7278 13.8039 0 0 0 0 0 0 0 0 0 14.0626 12.6302 0 0 0 0 0 13.9824 14.5041 0 15.6493 14.2551 11.735 10.9742 13.5907 13.4746 0 13.8097 13.4272 11.7199 14.557 0 0 13.356 0 0 0 14.2159 12.8348 0 0 0 13.9732 0 0 0 0 0 0 0 13.7437 0 15.7286 14.4153 0 12.9028 0 11.109 0 0 0 10.4202 0 0 0 12.5532 0 0 0 13.8172 13.2484 0 0 0 13.171 0 0 0 Q6PJ69 TRI65_HUMAN Tripartite motif-containing protein 65 TRIM65 Homo sapiens (Human) positive regulation of autophagy [GO:0010508] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; positive regulation of autophagy [GO:0010508] GO:0005654; GO:0005829; GO:0008270; GO:0010508 zinc ion binding [GO:0008270] CGKACPECR 0.99499 -15.398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1761 0 0 0 0 0 0 0 0 0 0 0 0 13.5221 0 0 0 0 Q6XZF7 DNMBP_HUMAN Dynamin-binding protein (Scaffold protein Tuba) DNMBP ARHGEF36 KIAA1010 TUBA Homo sapiens (Human) aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202] cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]; guanyl-nucleotide exchange factor activity [GO:0005085]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005794; GO:0005795; GO:0005829; GO:0005856; GO:0005911; GO:0007568; GO:0008360; GO:0035556; GO:0045202; GO:0051056; GO:0098793 guanyl-nucleotide exchange factor activity [GO:0005085] DKKTLEELQSAR 0.99499 -10.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5013 0 12.0878 0 13.2044 0 0 0 0 10.0759 0 0 0 0 0 0 0 0 0 0 0 0 11.9387 10.6581 0 11.4485 12.7038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9374 0 0 0 0 12.7459 0 0 0 14.3308 0 0 0 0 0 0 0 12.1602 0 0 12.8006 0 13.709 0 14.4149 0 0 0 0 0 12.1956 12.7915 0 0 0 0 14.5987 0 0 0 0 0 0 13.9163 0 13.7496 0 0 13.6996 0 0 15.1463 12.2808 0 0 13.5928 12.4913 14.3134 15.0242 0 15.141 0 0 0 0 0 0 14.3825 0 0 12.8671 0 14.8356 0 0 0 0 0 0 0 10.6116 0 0 0 13.4459 0 12.8464 13.0639 0 0 0 0 0 15.1329 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0905 0 13.4944 14.3645 0 0 0 0 13.3025 0 0 13.1795 0 10.9207 0 Q86VY4 TSYL5_HUMAN "Testis-specific Y-encoded-like protein 5, TSPY-like protein 5" TSPYL5 KIAA1750 Homo sapiens (Human) cellular response to gamma radiation [GO:0071480]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; cellular response to gamma radiation [GO:0071480]; nucleosome assembly [GO:0006334]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; regulation of growth [GO:0040008] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0008284; GO:0031398; GO:0040008; GO:0042393; GO:0051897; GO:0071480 chromatin binding [GO:0003682]; histone binding [GO:0042393] AYLRLSRK 0.99499 -9.9653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8833 0 0 0 0 13.9851 0 0 0 0 15.6193 14.135 15.5858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRR9 RHG09_HUMAN Rho GTPase-activating protein 9 (Rho-type GTPase-activating protein 9) ARHGAP9 Homo sapiens (Human) regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; secretory granule lumen [GO:0034774]; GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]" GO:0005096; GO:0005547; GO:0005576; GO:0005737; GO:0005829; GO:0007165; GO:0034774; GO:0043087; GO:0051056 "GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]" AWHRALRTVIER 0.99499 -11.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7194 0 0 15.3131 0 0 13.3143 0 0 0 0 0 0 13.8745 0 12.8761 0 0 0 0 12.6592 0 0 0 0 14.3668 0 0 0 13.3935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3112 0 0 0 0 0 14.0025 0 13.2422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5602 0 0 0 0 13.4418 11.5748 Q9GZP7 VN1R1_HUMAN "Vomeronasal type-1 receptor 1 (G-protein coupled receptor GPCR24, hGPCR24) (V1r-like receptor 1) (V3r-related gene protein) (Vomeronasal olfactory receptor chromosome 19 subtype I member 1)" VN1R1 V1RL1 VNR19I1 Homo sapiens (Human) response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pheromone receptor activity [GO:0016503]; response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] GO:0005886; GO:0007606; GO:0016021; GO:0016503; GO:0019236 pheromone receptor activity [GO:0016503] MVGDTLK 0.99499 -9.9644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5738 0 0 0 0 0 0 0 0 9.64645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H3M0 KCNF1_HUMAN Potassium voltage-gated channel subfamily F member 1 (Voltage-gated potassium channel subunit Kv5.1) (kH1) KCNF1 Homo sapiens (Human) non-motile cilium assembly [GO:1905515]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] ciliary base [GO:0097546]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] ciliary base [GO:0097546]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; non-motile cilium assembly [GO:1905515]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0008076; GO:0016021; GO:0034765; GO:0051260; GO:0071805; GO:0097546; GO:1905515 potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249] KGICPICFK 0.99499 -9.966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NS37 ZHANG_HUMAN "CREB/ATF bZIP transcription factor (Host cell factor-binding transcription factor Zhangfei, HCF-binding transcription factor Zhangfei)" CREBZF ZF Homo sapiens (Human) "ATF6-mediated unfolded protein response [GO:0036500]; integrated stress response signaling [GO:0140467]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]" chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]; ATF6-mediated unfolded protein response [GO:0036500]; integrated stress response signaling [GO:0140467]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615]" GO:0000785; GO:0000976; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0009615; GO:0036500; GO:0042802; GO:0045814; GO:0045892; GO:0045944; GO:0051090; GO:0090575; GO:0140467 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976]" AAAAAAR 0.99499 -10.367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7612 13.8361 13.4081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUJ3 T11L1_HUMAN T-complex protein 11-like protein 1 TCP11L1 Homo sapiens (Human) signal transduction [GO:0007165] microtubule [GO:0005874] microtubule [GO:0005874]; signal transduction [GO:0007165] GO:0005874; GO:0007165 EIVPLFR 0.99499 -10.354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7746 0 0 0 0 0 0 0 0 10.9476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6089 0 0 12.4683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8752 0 14.4219 0 0 0 0 0 0 12.3897 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9038 0 0 0 12.9406 0 13.2416 0 15.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1195 0 0 0 0 0 0 0 0 0 0 14.0853 0 0 0 14.3843 0 0 0 0 0 14.1918 0 0 0 0 Q9UHV8 PP13_HUMAN "Galactoside-binding soluble lectin 13 (Galectin-13, Gal-13) (Placental tissue protein 13, PP13, Placental protein 13)" LGALS13 PLAC8 Homo sapiens (Human) apoptotic process [GO:0006915]; phospholipid metabolic process [GO:0006644]; positive regulation of T cell apoptotic process [GO:0070234] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; carbohydrate binding [GO:0030246]; lysophospholipase activity [GO:0004622]; apoptotic process [GO:0006915]; phospholipid metabolic process [GO:0006644]; positive regulation of T cell apoptotic process [GO:0070234] GO:0004622; GO:0005654; GO:0005737; GO:0006644; GO:0006915; GO:0016363; GO:0016604; GO:0030246; GO:0070234 carbohydrate binding [GO:0030246]; lysophospholipase activity [GO:0004622] IPPSFVK 0.99499 -9.9546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3872 0 0 0 0 0 0 0 0 13.02 0 0 0 0 0 0 0 0 0 0 14.1415 0 0 12.5526 0 13.3648 0 0 13.8074 0 0 0 0 0 0 0 0 13.4685 0 0 0 0 0 0 0 0 0 0 0 12.727 0 0 0 0 0 0 0 0 0 0 0 0 12.4831 12.521 0 12.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.582 0 0 0 0 13.1461 Q9Y3E0 GOT1B_HUMAN Vesicle transport protein GOT1B (Germ cell tumor 2) (Golgi transport 1 homolog B) (Putative NF-kappa-B-activating protein 470) (hGOT1a) GOLT1B GCT2 GOT1A CGI-141 HDCMA39P UNQ432/PRO793 Homo sapiens (Human) "endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0000139; GO:0005783; GO:0005829; GO:0006888; GO:0015031; GO:0016020; GO:0016021; GO:0032991; GO:0042147; GO:0043123 FFFQKHK 0.99499 -9.9758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4738 15.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00469 PLOD2_HUMAN "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2, EC 1.14.11.4 (Lysyl hydroxylase 2, LH2)" PLOD2 Homo sapiens (Human) hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]; protein modification process [GO:0036211]; response to hypoxia [GO:0001666] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; rough endoplasmic reticulum membrane [GO:0030867]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; hydroxylysine biosynthetic process [GO:0046947]; peptidyl-lysine hydroxylation [GO:0017185]; protein modification process [GO:0036211]; response to hypoxia [GO:0001666] GO:0001666; GO:0005506; GO:0005783; GO:0005789; GO:0008475; GO:0017185; GO:0030867; GO:0031418; GO:0036211; GO:0046947; GO:0070062 iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-lysine 5-dioxygenase activity [GO:0008475] DKLDPDMALCR 0.995 -11.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2054 0 0 0 0 0 0 0 11.94 0 0 0 0 11.5052 0 0 14.2583 0 0 0 0 0 0 0 0 0 0 0 10.781 0 13.7644 9.26948 11.8727 0 0 0 0 11.4749 0 12.9759 13.378 13.4058 11.3794 0 15.0482 12.3658 12.1133 0 0 0 11.5555 13.8952 0 0 0 0 0 0 0 0 0 0 0 0 13.5965 0 10.8919 0 13.7572 0 0 11.3041 0 0 0 0 0 0 13.5863 0 0 13.7139 0 0 13.3726 0 0 10.5653 0 0 0 0 0 0 0 0 13.5823 0 0 0 0 0 0 0 0 0 0 0 0 12.5245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2095 13.2403 11.8327 0 0 0 0 0 0 O14777 NDC80_HUMAN "Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1, HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC)" NDC80 HEC HEC1 KNTC2 Homo sapiens (Human) attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057] "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]" "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; NMS complex [GO:0031617]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]" GO:0000070; GO:0000132; GO:0000278; GO:0000775; GO:0000776; GO:0000940; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0007094; GO:0008315; GO:0008608; GO:0016020; GO:0030332; GO:0031262; GO:0031617; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483; GO:1905342 cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483] AQVYVPLK 0.995 -31.407 0 0 0 0 0 0 13.4645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.989 0 0 0 12.7058 0 0 0 0 0 0 0 0 0 0 0 0 12.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6461 11.8537 14.5465 0 0 0 0 0 0 12.7199 0 0 0 0 13.5516 13.016 13.8163 15.4022 0 14.4979 10.0208 0 13.5406 16.2287 15.3596 0 0 0 14.5943 0 0 0 0 12.7113 15.7223 0 9.87223 0 14.0429 0 0 0 15.79 14.9681 14.6615 0 12.8942 15.1237 14.8037 14.2209 0 13.6886 13.6644 13.9697 0 0 14.6197 15.1141 0 0 0 0 0 14.6954 14.8948 14.735 13.2132 0 0 0 0 0 0 0 0 0 14.9616 15.5436 15.0361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0844 0 0 14.8896 15.066 0 O60829 PAGE4_HUMAN "P antigen family member 4, PAGE-4 (G antigen family C member 1) (PAGE-1)" PAGE4 GAGEC1 JM27 Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; regulation of stress-activated MAPK cascade [GO:0032872]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; regulation of stress-activated MAPK cascade [GO:0032872]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594] GO:0003677; GO:0003713; GO:0005634; GO:0005737; GO:0005739; GO:0006979; GO:0032872; GO:0042594; GO:0043066; GO:1903202; GO:1903427 DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713] EAGDGQP 0.995 -10.414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7392 12.6391 11.7848 0 12.5537 0 12.212 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6579 0 0 12.977 0 0 0 9.16224 0 0 0 0 0 0 0 0 0 0 11.1946 0 0 0 0 0 0 0 0 0 0 0 0 10.8641 0 10.2431 0 0 0 0 0 0 0 0 0 13.3032 0 0 0 0 0 0 0 0 10.6277 0 17.5495 0 0 0 0 11.1917 0 0 0 0 0 0 12.1508 11.7926 0 11.7443 0 0 0 12.4928 12.4075 0 0 0 0 0 0 0 13.0953 0 0 0 0 0 0 0 12.2635 0 0 0 11.8724 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0151 0 0 0 0 0 14.4671 0 0 0 0 11.3948 0 0 0 0 0 0 0 0 0 11.3234 0 0 0 13.0449 13.5013 0 0 0 0 0 0 0 10.6755 0 0 P01040 CYTA_HUMAN "Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed ]" CSTA STF1 STFA Homo sapiens (Human) cell-cell adhesion [GO:0098609]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; peptidase inhibitor complex [GO:1904090] cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; peptidase inhibitor complex [GO:1904090]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; cell-cell adhesion [GO:0098609]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149] GO:0001533; GO:0002020; GO:0004869; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0010466; GO:0018149; GO:0030216; GO:0045861; GO:0098609; GO:1904090 cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020] DDELTGF 0.995 -12.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.136 0 0 0 0 0 0 0 0 0 0 0 0 11.5123 0 11.7971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29323 EPHB2_HUMAN "Ephrin type-B receptor 2, EC 2.7.10.1 (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5, EK5, hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2 ]" EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 Homo sapiens (Human) "angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]" axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235] "axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of kinase activity [GO:0033674]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]" GO:0001525; GO:0001540; GO:0001655; GO:0001933; GO:0002639; GO:0004713; GO:0004714; GO:0005005; GO:0005102; GO:0005524; GO:0005576; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0005887; GO:0006469; GO:0007162; GO:0007169; GO:0007399; GO:0007411; GO:0007413; GO:0007611; GO:0007612; GO:0008046; GO:0009986; GO:0010628; GO:0016310; GO:0018108; GO:0021631; GO:0021934; GO:0021952; GO:0022038; GO:0030193; GO:0030335; GO:0030424; GO:0030425; GO:0030890; GO:0031290; GO:0031915; GO:0032760; GO:0033674; GO:0042113; GO:0042472; GO:0042802; GO:0043005; GO:0043025; GO:0043197; GO:0043235; GO:0044877; GO:0046425; GO:0046580; GO:0048013; GO:0048168; GO:0048170; GO:0048593; GO:0050771; GO:0050878; GO:0051489; GO:0051965; GO:0060021; GO:0060996; GO:0060997; GO:0061003; GO:0070373; GO:0071222; GO:0071679; GO:0097104; GO:0098794; GO:0098978; GO:0099055; GO:0099056; GO:0099557; GO:0106028; GO:0110077; GO:0120192; GO:1900016; GO:1900273; GO:1903078; GO:1904646; GO:1904782; GO:1904783; GO:2000316; GO:2000822 amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] ANQGDEACTHCPINSRTTSEGATNCVCR 0.995 -12.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7704 0 0 0 0 0 12.4643 0 0 0 12.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4511 0 9.79212 13.9798 13.4784 0 11.3662 0 14.1368 0 9.87041 0 0 0 0 0 13.1547 0 15.0101 0 0 0 0 0 0 0 18.5512 0 13.7075 12.7105 0 0 0 0 0 12.1999 0 14.2359 0 0 0 12.0315 13.5222 0 0 0 14.1805 14.5045 0 0 0 13.1456 0 0 0 0 0 0 0 0 0 0 0 14.257 0 14.5549 0 0 11.7369 0 10.1435 0 0 13.6364 0 12.7683 0 0 0 14.9719 13.9366 12.4857 13.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8556 0 0 0 0 15.1067 0 0 0 0 0 0 P40937 RFC5_HUMAN "Replication factor C subunit 5 (Activator 1 36 kDa subunit, A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit, RF-C 36 kDa subunit, RFC36)" RFC5 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264] GO:0003677; GO:0005524; GO:0005634; GO:0005654; GO:0005663; GO:0006260; GO:0006261; GO:0006281; GO:0016887; GO:0019899; GO:0031390; GO:0032508; GO:1900264 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme binding [GO:0019899] LPHLLLYGPPGTGKTSTILACAKQLYK 0.995 -11.294 0 0 0 0 0 0 0 10.5927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7249 0 0 0 0 0 0 0 13.0898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P47871 GLR_HUMAN "Glucagon receptor, GL-R" GCGR Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucagon stimulus [GO:0071377]; cellular response to starvation [GO:0009267]; exocytosis [GO:0006887]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of glycogen metabolic process [GO:0070873]; response to nutrient [GO:0007584]; response to starvation [GO:0042594] endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] endosome [GO:0005768]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucagon stimulus [GO:0071377]; cellular response to starvation [GO:0009267]; exocytosis [GO:0006887]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of gene expression [GO:0010628]; regulation of blood pressure [GO:0008217]; regulation of glycogen metabolic process [GO:0070873]; response to nutrient [GO:0007584]; response to starvation [GO:0042594] GO:0004967; GO:0005768; GO:0005886; GO:0005887; GO:0006091; GO:0006887; GO:0007166; GO:0007188; GO:0007189; GO:0007584; GO:0008217; GO:0008528; GO:0009267; GO:0009755; GO:0010628; GO:0016021; GO:0017046; GO:0042593; GO:0042594; GO:0070873; GO:0071377 G protein-coupled peptide receptor activity [GO:0008528]; glucagon receptor activity [GO:0004967]; peptide hormone binding [GO:0017046] EVQSELRR 0.995 -11.28 0 0 12.8893 0 0 0 0 0 0 0 0 0 0 0 0 14.8108 0 0 0 15.2972 0 0 0 13.4099 0 0 14.6712 0 0 15.4259 0 0 0 11.3253 0 0 13.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3644 0 0 0 0 0 0 13.7329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5319 0 0 13.1024 0 0 0 0 0 0 14.3089 0 0 0 0 0 0 0 0 0 0 0 0 10.462 0 0 0 0 0 0 0 0 0 0 0 11.3131 0 0 0 0 0 10.5385 0 0 12.1029 0 13.0632 0 0 15.4055 0 0 0 0 13.7618 12.7874 0 0 P56182 RRP1_HUMAN "Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1, NNP-1) (Nucleolar protein Nop52) (RRP1-like protein)" RRP1 D21S2056E NNP1 NOP52 RRP1A Homo sapiens (Human) rRNA processing [GO:0006364] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]" "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; rRNA processing [GO:0006364]" GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0006364; GO:0030687; GO:0030688 RNA binding [GO:0003723] AEPEAGEEQAGDDR 0.995 -8.6991 0 0 0 0 10.5978 0 0 0 0 0 12.0933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6866 13.313 13.2949 0 0 0 0 0 0 0 13.6029 0 0 0 0 0 0 0 0 0 0 0 14.0211 0 0 0 0 13.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8351 0 0 0 0 0 0 0 0 0 0 12.5448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3229 0 Q53ET0 CRTC2_HUMAN "CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2, TORC-2, Transducer of CREB protein 2)" CRTC2 TORC2 Homo sapiens (Human) gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; histone H3-K9 acetylation [GO:0043970]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; histone H3-K9 acetylation [GO:0043970]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; toxin transport [GO:1901998] GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006094; GO:0008140; GO:0032793; GO:0042593; GO:0043970; GO:0045944; GO:0051289; GO:0070062; GO:1901998 cAMP response element binding protein binding [GO:0008140]; chromatin binding [GO:0003682] HLLKPWDAK 0.995 -10.442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0Y5 OR8I2_HUMAN Olfactory receptor 8I2 (Olfactory receptor OR11-170) OR8I2 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] ALVNFQSNR 0.995 -8.7001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1331 0 12.0317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRA0 LSMD1_HUMAN "N-alpha-acetyltransferase 38, NatC auxiliary subunit (LSM domain-containing protein 1) (Phosphonoformate immuno-associated protein 2)" NAA38 LSMD1 MAK31 PFAAP2 Homo sapiens (Human) N-terminal peptidyl-methionine acetylation [GO:0017196]; negative regulation of apoptotic process [GO:0043066] cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N-terminal peptidyl-methionine acetylation [GO:0017196]; negative regulation of apoptotic process [GO:0043066] GO:0005634; GO:0005654; GO:0005737; GO:0017196; GO:0031417; GO:0043066 EDSAAER 0.995 -8.6923 0 0 0 11.3847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7337 0 0 0 0 0 0 11.5518 0 0 13.0304 0 0 0 0 0 12.7176 12.4125 0 0 0 0 0 0 0 12.9452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0532 0 0 0 0 0 0 0 0 11.9105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H213 MAGH1_HUMAN "Melanoma-associated antigen H1 (Apoptosis-related protein 1, APR-1) (MAGE-H1 antigen) (Restin)" MAGEH1 APR1 Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0006915 DWPCNYDWDSDDDAEVEAILNSGAR 0.995 -10.425 0 0 0 9.84057 0 0 0 0 0 0 0 0 0 0 0 0 10.5211 0 10.1997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5844 0 0 0 11.6327 0 12.0836 0 11.798 11.7686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7553 16.9529 0 12.3535 12.5503 0 0 13.3157 0 0 12.6072 12.7383 0 0 0 0 0 0 0 13.2737 12.3613 12.925 0 12.5627 0 11.2637 0 11.7144 0 0 0 0 0 13.3817 0 0 0 0 14.1547 0 0 0 0 0 0 0 16.0217 0 0 0 0 0 0 0 0 0 12.1568 0 14.8538 14.2915 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9617 0 0 0 0 0 0 0 0 Q9NW15 ANO10_HUMAN Anoctamin-10 (Transmembrane protein 16K) ANO10 TMEM16K Homo sapiens (Human) cation transport [GO:0006812]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229]; cation transport [GO:0006812]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005227; GO:0005229; GO:0005886; GO:0006812; GO:0006821; GO:0016020; GO:0016021; GO:0034220; GO:0043231; GO:0055085 calcium activated cation channel activity [GO:0005227]; intracellular calcium activated chloride channel activity [GO:0005229] HELENLR 0.995 -15.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7999 0 0 0 0 0 0 11.6928 0 0 0 0 0 0 0 0 0 11.114 0 0 0 10.9297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5054 0 0 0 0 0 0 12.8597 0 13.6935 13.2034 0 0 12.0097 0 0 0 14.9289 12.7609 0 0 0 0 0 13.1221 0 0 0 0 0 0 0 0 13.2221 0 0 0 0 0 11.9865 12.673 13.1235 0 12.9462 0 0 0 0 0 0 0 0 0 12.4657 12.1987 0 0 11.8923 0 0 0 0 11.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9736 0 0 0 0 0 0 0 Q9UPG8 PLAL2_HUMAN Zinc finger protein PLAGL2 (Pleiomorphic adenoma-like protein 2) PLAGL2 KIAA0198 Homo sapiens (Human) "chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; chylomicron assembly [GO:0034378]; lipid metabolic process [GO:0006629]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]" GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006351; GO:0006357; GO:0006629; GO:0009791; GO:0034378; GO:0043565; GO:0046872; GO:2001244 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" DFLCQYCAQR 0.995 -8.9827 0 0 0 0 0 0 0 0 0 0 12.9553 0 0 0 0 0 0 12.3227 0 0 12.1784 0 0 0 0 0 0 0 0 0 9.7624 0 9.58193 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2021 0 10.0378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7069 0 0 13.5992 0 10.4077 0 11.6053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3501 0 0 0 0 0 0 0 0 0 12.7572 0 0 0 0 13.1083 0 11.5589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8866 0 0 0 0 0 0 0 0 0 0 0 0 12.3039 0 0 12.8286 0 0 0 0 P05423 RPC4_HUMAN "DNA-directed RNA polymerase III subunit RPC4, RNA polymerase III subunit C4 (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog)" POLR3D BN51 BN51T Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383] GO:0003677; GO:0003682; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607 chromatin binding [GO:0003682]; DNA binding [GO:0003677] APPKAAR 0.99501 -10.694 15.8323 13.7954 0 0 0 0 0 0 0 0 0 0 0 0 10.0753 0 0 0 0 13.3841 0 0 11.6784 12.4978 12.1222 13.4069 0 0 0 0 0 0 0 0 0 0 14.1217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8653 13.8847 16.911 0 0 0 0 11.3855 0 12.5268 0 0 14.7022 17.2419 13.0908 18.259 0 15.175 16.1647 14.0239 13.6989 14.8034 0 0 0 0 0 0 17.8501 14.3161 0 13.7314 17.853 13.7728 13.5392 0 17.7634 17.7441 12.9498 15.4337 13.1084 14.1846 18.5946 0 15.1062 17.4965 17.3671 0 0 0 0 14.3247 13.5836 17.7148 17.1959 15.8762 0 0 14.4231 0 14.0626 14.35 0 13.7515 0 14.5357 17.0003 15.0473 0 0 0 17.5845 18.3982 0 0 0 0 0 11.2325 0 0 16.2575 0 0 18.0824 11.2939 17.8709 0 14.3435 15.2753 14.899 0 13.5767 10.0285 0 0 0 0 0 0 0 0 0 0 14.614 17.0379 0 17.0679 0 0 0 13.5101 0 0 A5PL33 KRBA1_HUMAN Protein KRBA1 KRBA1 KIAA1862 Homo sapiens (Human) GLELGHGR 0.99501 -12.608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6369 0 0 0 0 0 0 0 9.76461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9597 0 14.4511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6822 0 0 0 12.6259 0 0 0 0 0 0 0 0 0 14.1479 0 0 0 0 0 12.1051 0 0 A8K979 ERI2_HUMAN "ERI1 exoribonuclease 2, EC 3.1.-.- (Exonuclease domain-containing protein 1)" ERI2 EXOD1 KIAA1504 Homo sapiens (Human) "exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]" "3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]" GO:0000175; GO:0000467; GO:0003676; GO:0008270 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] KCCGYFKWEQTLQK 0.99501 -11.374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2986 0 0 0 0 0 0 0 0 0 0 0 0 0 13.665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4797 0 0 14.5619 14.8827 0 0 0 0 0 0 12.1988 0 0 O43247 TEX33_HUMAN Testis-expressed protein 33 TEX33 C22orf33 EAN57 Homo sapiens (Human) DLEHWHGRK 0.99501 -10.707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6722 0 0 0 O75746 S2512_HUMAN "Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial (Araceli hiperlarga, Aralar, Aralar1) (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12)" SLC25A12 AGC1 ARALAR1 Homo sapiens (Human) aspartate family amino acid metabolic process [GO:0009066]; aspartate transmembrane transport [GO:0015810]; gluconeogenesis [GO:0006094]; glutamate biosynthetic process [GO:0006537]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of myelination [GO:0031643]; response to calcium ion [GO:0051592] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] "integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate family amino acid metabolic process [GO:0009066]; aspartate transmembrane transport [GO:0015810]; gluconeogenesis [GO:0006094]; glutamate biosynthetic process [GO:0006537]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of myelination [GO:0031643]; response to calcium ion [GO:0051592]" GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006537; GO:0009066; GO:0010907; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0031643; GO:0042802; GO:0043490; GO:0051592; GO:1904024; GO:2001171 "3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]" AAVAATQ 0.99501 -11.025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4038 0 13.8076 0 0 0 0 0 0 0 0 0 11.581 0 0 0 0 0 0 0 0 12.4216 0 0 0 0 0 0 0 13.6669 0 0 0 0 0 0 0 0 0 10.5162 0 0 0 0 14.1505 13.3276 0 0 0 0 0 10.1383 14.3359 16.0946 16.0449 15.9971 16.2393 15.1399 14.5462 15.5017 15.8497 15.8717 15.6049 15.3847 0 15.5142 15.0472 14.5491 0 15.9 14.5231 13.3476 0 15.1825 15.539 14.0647 0 15.6512 14.845 16.488 15.8825 15.461 0 14.5302 15.0083 16.1152 16.5306 15.0159 13.2873 0 0 14.5624 14.3595 14.243 15.8108 16.1947 15.7026 14.4598 14.0458 15.8328 16.1912 14.8234 14.6551 15.0233 0 16.5908 16.0486 15.9615 0 0 14.4737 14.7801 15.1693 15.2469 16.4719 14.1069 15.3759 14.7969 14.0316 15.5534 15.6652 15.6034 17.0623 15.8011 15.89 0 0 0 16.1091 15.2594 0 13.5362 0 0 15.3334 0 0 0 0 0 0 15.0809 0 14.975 14.1843 0 0 13.0636 0 15.2709 15.2851 15.2639 14.9752 16.51 14.483 0 0 13.7272 P11166 GTR1_HUMAN "Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain, GLUT-1) (HepG2 glucose transporter)" SLC2A1 GLUT1 Homo sapiens (Human) cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; long-chain fatty acid import across plasma membrane [GO:0015911]; monosaccharide transmembrane transport [GO:0015749]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female germ cell nucleus [GO:0001674]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; caveola [GO:0005901]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; female germ cell nucleus [GO:0001674]; female pronucleus [GO:0001939]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; glucose import [GO:0046323]; glucose import across plasma membrane [GO:0098708]; glucose transmembrane transport [GO:1904659]; L-ascorbic acid metabolic process [GO:0019852]; long-chain fatty acid import across plasma membrane [GO:0015911]; monosaccharide transmembrane transport [GO:0015749]; photoreceptor cell maintenance [GO:0045494]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to Thyroglobulin triiodothyronine [GO:1904016]; transport across blood-brain barrier [GO:0150104] GO:0000139; GO:0001666; GO:0001674; GO:0001917; GO:0001939; GO:0005324; GO:0005355; GO:0005829; GO:0005886; GO:0005887; GO:0005901; GO:0007417; GO:0007565; GO:0014704; GO:0015149; GO:0015749; GO:0015911; GO:0016020; GO:0016323; GO:0016324; GO:0019852; GO:0019900; GO:0021987; GO:0030018; GO:0030496; GO:0030864; GO:0032868; GO:0033300; GO:0042149; GO:0042383; GO:0042470; GO:0042802; GO:0042910; GO:0043621; GO:0045494; GO:0046323; GO:0055056; GO:0065003; GO:0070062; GO:0070837; GO:0071260; GO:0071474; GO:0072562; GO:0098708; GO:0098793; GO:0150104; GO:1904016; GO:1904659 D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; hexose transmembrane transporter activity [GO:0015149]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; long-chain fatty acid transporter activity [GO:0005324]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910] EKKVTILELFR 0.99501 -5.3438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8589 0 12.5948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11766 ADHX_HUMAN "Alcohol dehydrogenase class-3, EC 1.1.1.1 (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase, FALDH, FDH, GSH-FDH, EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase, EC 1.1.1.284)" ADH5 ADHX FDH Homo sapiens (Human) ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; S-(hydroxymethyl)glutathione dehydrogenase NAD activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase NADP activity [GO:0106321]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523]" GO:0001523; GO:0003016; GO:0004024; GO:0005504; GO:0005739; GO:0005829; GO:0006069; GO:0008270; GO:0009055; GO:0010430; GO:0018119; GO:0018467; GO:0032496; GO:0042802; GO:0045777; GO:0046294; GO:0051409; GO:0051775; GO:0051903; GO:0070062; GO:0106321; GO:0106322 "alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; S-(hydroxymethyl)glutathione dehydrogenase NAD activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase NADP activity [GO:0106321]; zinc ion binding [GO:0008270]" LVSEYMSKK 0.99501 -10.707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P35790 CHKA_HUMAN "Choline kinase alpha, CK, EC 2.7.1.32 (CHETK-alpha) (Ethanolamine kinase, EK, EC 2.7.1.82)" CHKA CHK CKI Homo sapiens (Human) CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646] GO:0004103; GO:0004104; GO:0004305; GO:0004713; GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0006657; GO:0006869; GO:0042149; GO:0042803; GO:1905691 ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713] FDAYFHQKR 0.99501 -11.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3382 11.0658 0 0 0 0 14.6854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q09028 RBBP4_HUMAN "Histone-binding protein RBBP4 (Chromatin assembly factor 1 subunit C, CAF-1 subunit C) (Chromatin assembly factor I p48 subunit, CAF-I 48 kDa subunit, CAF-I p48) (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4, RBBP-4) (Retinoblastoma-binding protein p48)" RBBP4 RBAP48 Homo sapiens (Human) "brain development [GO:0007420]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]" "ATPase complex [GO:1904949]; CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]" "ATPase complex [GO:1904949]; CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; brain development [GO:0007420]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; DNA replication-independent chromatin assembly [GO:0006336]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000118; GO:0000122; GO:0000781; GO:0000785; GO:0000978; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006335; GO:0006336; GO:0006338; GO:0006355; GO:0007049; GO:0007420; GO:0008285; GO:0016575; GO:0016580; GO:0016581; GO:0016589; GO:0030336; GO:0030512; GO:0031497; GO:0032991; GO:0033186; GO:0035098; GO:0042393; GO:0042659; GO:0042826; GO:0045892; GO:0045893; GO:1902455; GO:1902459; GO:1904949; GO:2000736 histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] EAAFDDAVEER 0.99501 -5.3468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3593 0 0 0 0 0 0 0 0 10.8962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16795 NDUA9_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD, CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)" NDUFA9 NDUFS2L Homo sapiens (Human) "aerobic respiration [GO:0009060]; circadian rhythm [GO:0007623]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]" mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; circadian rhythm [GO:0007623]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; sodium ion transport [GO:0006814]; ubiquinone-6 biosynthetic process [GO:1901006]" GO:0003954; GO:0005634; GO:0005739; GO:0005743; GO:0005747; GO:0005759; GO:0006120; GO:0006814; GO:0007623; GO:0008137; GO:0009060; GO:0031966; GO:0032981; GO:0042776; GO:0044877; GO:1901006 NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877] FGPIPLGSLGWK 0.99501 -10.458 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6826 0 10.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8303 11.1856 12.098 0 0 0 0 0 12.5666 0 0 0 0 0 0 0 13.2737 0 0 0 0 0 12.28 0 0 12.0896 0 0 0 0 0 0 0 0 0 0 13.9786 0 0 0 0 0 0 0 0 12.594 0 0 0 0 12.2184 0 0 0 0 0 0 0 0 12.379 12.6138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3477 0 0 0 0 0 0 11.9004 0 0 0 0 0 12.498 0 0 12.5259 12.1759 0 0 0 0 0 0 0 0 0 Q5TFG8 ZC21B_HUMAN Zinc finger C2HC domain-containing protein 1B ZC2HC1B C6orf94 FAM164B Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] FAADVLERHGPICKK 0.99501 -5.3473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5446 0 0 0 0 0 0 13.9527 0 0 0 0 0 0 0 0 0 0 0 0 12.4064 13.1859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5283 0 0 0 0 0 0 0 0 0 0 10.4916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q63HQ2 EGFLA_HUMAN "Pikachurin (Agrin-like protein) (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)" EGFLAM AGRINL AGRNL PIKA Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; tissue development [GO:0009888] anchoring junction [GO:0070161]; basement membrane [GO:0005604]; cell projection [GO:0042995]; interstitial matrix [GO:0005614]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083] anchoring junction [GO:0070161]; basement membrane [GO:0005604]; cell projection [GO:0042995]; interstitial matrix [GO:0005614]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; animal organ morphogenesis [GO:0009887]; extracellular matrix organization [GO:0030198]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of cell-substrate adhesion [GO:0010811]; tissue development [GO:0009888] GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0009887; GO:0009888; GO:0010811; GO:0019800; GO:0030198; GO:0042995; GO:0043083; GO:0048786; GO:0070161 calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539] APCAHGGSCR 0.99501 -10.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1473 0 0 0 0 0 0 0 0 0 0 11.5263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7856 0 14.1539 15.8236 0 15.8912 13.2091 0 0 0 15.1661 13.413 14.8704 0 14.309 13.993 14.157 14.0194 14.094 14.5761 0 0 14.4676 0 0 0 0 13.6614 13.6257 0 0 0 14.6724 15.2589 0 15.2332 0 0 0 0 0 0 13.7592 0 0 13.8341 12.4375 13.6119 0 13.2318 13.0765 0 0 0 0 0 0 0 0 12.7604 0 0 0 0 0 0 0 0 0 0 0 12.3081 0 0 0 0 11.8842 0 0 11.4247 0 0 0 0 0 11.4803 0 0 0 0 0 13.1966 0 0 0 0 0 0 11.6552 0 Q8IYK8 REM2_HUMAN GTP-binding protein REM 2 (Rad and Gem-like GTP-binding protein 2) REM2 Homo sapiens (Human) plasma membrane [GO:0005886] plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GO:0003924; GO:0005246; GO:0005525; GO:0005886 calcium channel regulator activity [GO:0005246]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] FLANLVPR 0.99501 -10.467 0 0 9.15358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0195 13.173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8784 0 0 0 0 0 0 0 0 0 0 0 14.3115 0 0 0 0 0 0 11.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7169 0 0 0 0 Q8WV24 PHLA1_HUMAN "Pleckstrin homology-like domain family A member 1 (Apoptosis-associated nuclear protein) (Proline- and glutamine-rich protein, PQ-rich protein, PQR protein) (Proline- and histidine-rich protein) (T-cell death-associated gene 51 protein)" PHLDA1 PHRIP TDAG51 Homo sapiens (Human) apoptotic process [GO:0006915]; FasL biosynthetic process [GO:0045210]; positive regulation of apoptotic process [GO:0043065] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phosphatidylinositol phosphate binding [GO:1901981]; apoptotic process [GO:0006915]; FasL biosynthetic process [GO:0045210]; positive regulation of apoptotic process [GO:0043065] GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006915; GO:0031410; GO:0043065; GO:0045210; GO:1901981 phosphatidylinositol phosphate binding [GO:1901981] GSRWGEDGAR 0.99501 -10.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5236 0 0 0 0 0 10.6443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DM3 RMC1_HUMAN "Regulator of MON1-CCZ1 complex (Colon cancer-associated protein Mic1, Mic-1) (WD repeat-containing protein 98)" RMC1 C18orf8 MIC1 WDR98 Homo sapiens (Human) autophagy [GO:0006914]; regulation of autophagy [GO:0010506] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658] late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; Mon1-Ccz1 complex [GO:0035658]; autophagy [GO:0006914]; regulation of autophagy [GO:0010506] GO:0005765; GO:0006914; GO:0010506; GO:0031902; GO:0035658 FVIAVLMEYIR 0.99501 -8.4755 0 11.4368 0 0 0 0 0 0 11.3086 0 0 0 0 0 0 10.8966 0 0 12.511 0 0 0 0 0 0 0 0 0 0 0 0 10.6964 0 0 0 12.3047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3676 12.3516 12.8167 11.9019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7673 0 0 0 0 10.7959 0 0 0 0 17.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4963 0 0 0 0 0 0 0 12.8535 0 12.9684 14.5681 0 0 0 0 0 13.456 0 0 0 12.773 0 0 0 0 12.6881 0 0 0 0 0 13.0286 0 0 13.3072 0 0 0 0 0 0 12.7164 13.2552 0 0 0 0 12.4364 11.9157 0 0 0 0 0 0 13.0835 0 0 0 0 Q96K58 ZN668_HUMAN Zinc finger protein 668 ZNF668 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASLTKHSR 0.99501 -31.849 0 0 0 0 0 0 0 0 0 0 0 0 10.3625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4305 0 0 12.4559 0 11.7002 0 0 17.0279 0 0 13.1137 0 0 0 0 14.5784 0 17.1912 0 12.8579 0 0 0 13.2057 13.3611 0 12.529 0 0 0 0 0 0 0 0 0 0 12.3089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2445 0 0 0 0 0 12.7498 0 0 0 13.6425 11.886 0 0 0 10.6037 0 0 0 0 0 0 0 0 12.6285 13.9147 0 0 0 Q96T92 INSM2_HUMAN Insulinoma-associated protein 2 (Zinc finger protein IA-6) INSM2 IA6 Nbla106 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of cell cycle process [GO:0010564] cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of cell cycle process [GO:0010564]" GO:0000122; GO:0000978; GO:0001227; GO:0005634; GO:0005737; GO:0010564; GO:0017053; GO:0030182; GO:0046872 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAGGERRGK 0.99501 -10.453 0 0 0 0 0 0 0 11.2679 0 0 0 0 0 0 0 0 0 12.0861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.644 0 0 0 0 0 0 0 0 13.3133 14.1312 0 16.8506 17.718 0 0 13.284 12.831 0 0 0 0 14.8242 12.4548 0 0 0 0 0 0 0 15.017 0 0 0 0 0 0 0 0 0 12.7496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7739 0 0 0 0 0 0 0 0 0 0 0 13.045 Q9NRG4 SMYD2_HUMAN "N-lysine methyltransferase SMYD2, EC 2.1.1.- (HSKM-B) (Histone methyltransferase SMYD2, EC 2.1.1.354) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2)" SMYD2 KMT3C Homo sapiens (Human) "chromatin organization [GO:0006325]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993]; chromatin organization [GO:0006325]; heart development [GO:0007507]; histone lysine methylation [GO:0034968]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]" GO:0000122; GO:0000993; GO:0002039; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006325; GO:0007507; GO:0008285; GO:0016278; GO:0016279; GO:0018024; GO:0018026; GO:0018027; GO:0034968; GO:0043516; GO:0046872; GO:0046975; GO:1901796 histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993] AEGLGGLER 0.99501 -10.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1821 0 12.6718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7942 11.0043 13.0475 11.3934 0 0 0 0 0 0 0 0 0 17.8802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2492 0 12.5681 0 0 0 0 0 0 0 0 0 14.3507 0 0 0 0 0 18.4612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y678 COPG1_HUMAN "Coatomer subunit gamma-1 (Gamma-1-coat protein, Gamma-1-COP)" COPG1 COPG Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306] GO:0000139; GO:0005198; GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0009306; GO:0030126; GO:0030133; GO:0051683; GO:0072384 structural molecule activity [GO:0005198] AGAVSALAKFGAQNEEMLPSILVLLKR 0.99501 -11.366 0 0 0 0 0 0 0 0 0 0 0 0 12.6281 0 0 0 0 0 0 10.6684 0 0 0 0 0 12.2307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0101 0 0 0 15.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8133 13.4341 13.4319 0 12.1837 0 0 0 0 0 0 0 0 0 0 0 14.9361 0 0 0 0 0 0 0 0 13.3815 0 0 0 0 0 0 0 0 0 14.9852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6821 0 0 0 13.5678 0 0 0 0 0 0 0 0 12.3224 13.7586 0 0 0 0 0 0 0 0 0 0 0 0 0 O43889 CREB3_HUMAN "Cyclic AMP-responsive element-binding protein 3, CREB-3, cAMP-responsive element-binding protein 3 (Leucine zipper protein) (Luman) (Transcription factor LZIP-alpha) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3, N-terminal Luman, Transcriptionally active form ]" CREB3 LZIP Homo sapiens (Human) "chemotaxis [GO:0006935]; cytoplasmic sequestering of transcription factor [GO:0042994]; establishment of viral latency [GO:0019043]; induction of positive chemotaxis [GO:0050930]; integrated stress response signaling [GO:0140467]; negative regulation of cell cycle [GO:0045786]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; release from viral latency [GO:0019046]; response to endoplasmic reticulum stress [GO:0034976]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; CCR1 chemokine receptor binding [GO:0031726]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator binding [GO:0001221]; chemotaxis [GO:0006935]; cytoplasmic sequestering of transcription factor [GO:0042994]; establishment of viral latency [GO:0019043]; induction of positive chemotaxis [GO:0050930]; integrated stress response signaling [GO:0140467]; negative regulation of cell cycle [GO:0045786]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [GO:0006990]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; release from viral latency [GO:0019046]; response to endoplasmic reticulum stress [GO:0034976]; transcription, DNA-templated [GO:0006351]" GO:0000139; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0001558; GO:0002230; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006351; GO:0006357; GO:0006935; GO:0006990; GO:0008140; GO:0016020; GO:0016021; GO:0016604; GO:0019043; GO:0019046; GO:0030176; GO:0030335; GO:0031726; GO:0034976; GO:0035497; GO:0042127; GO:0042802; GO:0042803; GO:0042981; GO:0042994; GO:0043025; GO:0045786; GO:0045893; GO:0045944; GO:0046983; GO:0050930; GO:0051928; GO:0090026; GO:0090045; GO:0090575; GO:0140467; GO:1902236; GO:1990837 "cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; CCR1 chemokine receptor binding [GO:0031726]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator binding [GO:0001221]" LVLTDEEK 0.99502 -10.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1737 0 0 0 13.7596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6788 0 0 0 0 13.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6984 P10644 KAP0_HUMAN "cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1, TSE1)" PRKAR1A PKR1 PRKAR1 TSE1 Homo sapiens (Human) cardiac muscle cell proliferation [GO:0060038]; intracellular signal transduction [GO:0035556]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of gene expression [GO:0010629]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm connecting piece [GO:0097224] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm connecting piece [GO:0097224]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625]; cardiac muscle cell proliferation [GO:0060038]; intracellular signal transduction [GO:0035556]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of gene expression [GO:0010629]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214] GO:0001707; GO:0004862; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005952; GO:0006357; GO:0008603; GO:0010629; GO:0016020; GO:0019904; GO:0030552; GO:0031588; GO:0031594; GO:0031625; GO:0032991; GO:0034236; GO:0035556; GO:0044853; GO:0045214; GO:0046007; GO:0060038; GO:0097224; GO:0097546; GO:0098978; GO:2000480 cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625] AGTRTDSR 0.99502 -12.219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8826 16.4634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0768 0 12.9098 0 0 16.1475 0 0 0 0 0 12.9204 0 0 12.9978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4836 0 0 0 0 0 0 12.5866 0 12.4905 0 12.4857 0 0 0 12.8122 0 0 0 11.8952 0 0 0 0 0 0 12.4415 13.738 0 0 Q15572 TAF1C_HUMAN "TATA box-binding protein-associated factor RNA polymerase I subunit C (RNA polymerase I-specific TBP-associated factor 110 kDa, TAFI110) (TATA box-binding protein-associated factor 1C, TBP-associated factor 1C) (Transcription initiation factor SL1/TIF-IB subunit C)" TAF1C Homo sapiens (Human) transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668] fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase transcription factor SL1 complex [GO:0005668]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase I promoter [GO:0006361] GO:0001164; GO:0001181; GO:0001650; GO:0005654; GO:0005668; GO:0005730; GO:0006360; GO:0006361; GO:0006366 RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181] GAAWWER 0.99502 -10.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4112 0 0 13.9737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.452 0 0 0 0 0 17.0376 0 0 0 0 0 0 12.142 0 12.013 0 0 12.4677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88596 0 0 0 0 12.8572 0 0 0 12.8968 0 0 0 0 0 0 0 0 0 0 0 12.544 0 0 0 11.853 11.9837 0 0 0 0 0 0 0 0 0 0 0 0 9.59505 0 0 0 0 0 0 0 0 0 0 0 0 0 9.00175 0 12.3194 0 12.9904 0 0 0 0 0 0 0 0 Q5T6C5 AT7L2_HUMAN Ataxin-7-like protein 2 ATXN7L2 Homo sapiens (Human) AAAAMAALER 0.99502 -32.407 10.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4862 0 0 13.3814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1368 0 0 0 0 0 0 0 0 0 0 15.6656 0 0 13.4051 0 0 0 0 0 12.8466 0 14.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2843 0 13.7945 0 0 0 0 13.2694 0 0 0 13.5612 0 0 13.5912 0 0 0 12.9506 0 0 0 0 0 13.3761 0 0 0 0 0 0 0 0 0 0 0 11.3788 0 13.21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N2Q7 NLGN1_HUMAN Neuroligin-1 NLGN1 KIAA1070 Homo sapiens (Human) "AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion involved in synapse maturation [GO:0090125]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; maintenance of synapse structure [GO:0099558]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal signal transduction [GO:0023041]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]" "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; filopodium tip [GO:0032433]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron to neuron synapse [GO:0098984]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein complex involved in cell-cell adhesion [GO:0098635]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]" "anchoring junction [GO:0070161]; asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; filopodium tip [GO:0032433]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; neuromuscular junction [GO:0031594]; neuron to neuron synapse [GO:0098984]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein complex involved in cell-cell adhesion [GO:0098635]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion involved in synapse maturation [GO:0090125]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; maintenance of synapse structure [GO:0099558]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal signal transduction [GO:0023041]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of neuromuscular synaptic transmission [GO:1900075]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]" GO:0001540; GO:0005794; GO:0005886; GO:0005887; GO:0006605; GO:0007157; GO:0007158; GO:0007268; GO:0007399; GO:0007416; GO:0009986; GO:0010841; GO:0010976; GO:0014069; GO:0016080; GO:0016339; GO:0023041; GO:0030165; GO:0030425; GO:0031175; GO:0031594; GO:0032230; GO:0032433; GO:0035418; GO:0038023; GO:0042043; GO:0042802; GO:0043083; GO:0043197; GO:0043235; GO:0045184; GO:0045202; GO:0045664; GO:0048488; GO:0048511; GO:0048789; GO:0048812; GO:0050804; GO:0050839; GO:0051491; GO:0051965; GO:0051968; GO:0060074; GO:0060076; GO:0060077; GO:0060999; GO:0061002; GO:0070161; GO:0071277; GO:0072553; GO:0089717; GO:0090125; GO:0097091; GO:0097104; GO:0097105; GO:0097110; GO:0097113; GO:0097114; GO:0097115; GO:0097119; GO:0097120; GO:0098635; GO:0098793; GO:0098794; GO:0098978; GO:0098982; GO:0098984; GO:0098985; GO:0099054; GO:0099055; GO:0099060; GO:0099558; GO:0140058; GO:1900029; GO:1900075; GO:1900244; GO:1902533; GO:1904861; GO:2000302; GO:2000310; GO:2000311; GO:2000463 amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023] ALPRCTWPNYVWR 0.99502 -11.052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1176 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0237 13.578 0 0 0 17.2046 0 0 0 0 13.9689 0 0 0 0 12.1936 0 0 12.6207 19.7174 0 0 0 0 0 0 0 0 10.2582 0 12.6739 0 0 11.9474 0 0 13.9311 0 0 12.6007 0 0 0 18.6291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0473 0 0 0 0 0 0 13.1881 0 15.1093 0 15.3904 13.0993 0 0 0 0 12.4266 0 12.1576 0 12.8464 12.9404 0 0 11.3427 0 0 0 0 12.5001 0 0 0 11.9237 Q8N393 ZN786_HUMAN Zinc finger protein 786 ZNF786 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EHLRVHSGERPFQCLK 0.99502 -11.045 0 0 0 0 0 0 0 0 0 14.7884 0 0 0 0 0 0 0 0 0 0 13.4046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1949 0 0 0 0 0 0 0 0 0 14.4073 0 0 0 0 0 0 0 0 12.4635 0 0 0 0 0 0 0 0 0 0 16.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0333 0 0 12.669 0 0 0 0 0 0 14.6569 0 0 0 15.8469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8278 0 15.0524 11.9026 Q8N7Q3 ZN676_HUMAN Zinc finger protein 676 ZNF676 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFTWSSSFTK 0.99502 -12.217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9879 0 0 0 13.3965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEG4 FA83F_HUMAN Protein FAM83F FAM83F Homo sapiens (Human) signal transduction [GO:0007165] protein kinase binding [GO:0019901]; signal transduction [GO:0007165] GO:0007165; GO:0019901 protein kinase binding [GO:0019901] DLVTVEQVLPPVEPIPLGELSQK 0.99502 -12.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9936 12.8084 0 0 0 0 0 12.1428 0 0 0 0 12.5195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0726 0 0 0 0 0 0 0 0 0 0 0 11.4511 0 0 0 13.2082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6582 0 0 0 Q8NGR6 OR1B1_HUMAN "Olfactory receptor 1B1 (Olfactory receptor 9-B, OR9-B) (Olfactory receptor OR9-26)" OR1B1 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] IGAAILRLPSAAGR 0.99502 -11.408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1219 0 0 0 0 0 0 0 12.4966 13.2962 0 0 0 0 0 12.0848 0 0 0 0 0 0 0 0 0 11.9713 0 0 12.5255 0 13.673 0 0 13.409 0 12.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2221 0 0 0 0 0 0 0 0 0 13.1714 0 0 0 0 12.3345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2143 0 0 0 0 0 0 0 14.2047 14.3755 14.5432 0 0 14.5509 14.314 0 0 13.5482 0 0 0 12.5515 0 0 0 0 0 0 11.9131 0 0 Q8TCW9 PKR1_HUMAN "Prokineticin receptor 1, PK-R1 (G-protein coupled receptor 73) (G-protein coupled receptor ZAQ) (GPR73a)" PROKR1 GPR73 PKR1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0007186 G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983] ASYNGGK 0.99502 -12.211 0 0 0 0 0 0 0 0 13.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7861 0 14.2275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2359 0 0 0 0 0 0 0 0 0 0 0 12.9145 0 0 0 0 0 0 11.5881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WU76 SCFD2_HUMAN Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1) SCFD2 STXBP1L1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] plasma membrane [GO:0005886]; secretory granule [GO:0030141] plasma membrane [GO:0005886]; secretory granule [GO:0030141]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192] GO:0005886; GO:0006886; GO:0006904; GO:0016192; GO:0019905; GO:0030141 syntaxin binding [GO:0019905] DLVASLKPGTQVIVLSTRLLK 0.99502 -5.3538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9224 0 0 0 0 14.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5274 0 13.4152 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXW3 PIBF1_HUMAN "Progesterone-induced-blocking factor 1, PIBF (Centrosomal protein of 90 kDa, CEP90)" PIBF1 C13orf24 PIBF Homo sapiens (Human) activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634] centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; interleukin-4 receptor binding [GO:0005136]; activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539] GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515 interleukin-4 receptor binding [GO:0005136] CAHEEDR 0.99502 -32.38 0 0 0 0 0 0 0 0 0 13.4267 0 0 0 0 0 0 0 0 0 0 0 13.4285 0 11.7102 0 0 0 0 0 0 0 9.92855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4724 0 0 0 10.0743 0 10.4508 0 0 0 0 0 11.0595 0 0 0 0 0 0 13.6061 0 0 0 13.5407 0 0 13.9286 0 0 15.5765 0 0 0 0 0 11.7976 0 0 0 0 0 0 14.5958 14.4856 0 13.0967 0 0 0 13.6639 0 0 0 0 0 12.0129 0 14.1132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3049 9.55599 0 0 0 11.6234 0 0 0 0 0 0 12.301 14.4638 0 0 0 0 0 0 9.66908 0 13.1466 0 0 0 12.795 0 0 0 12.7197 0 0 0 0 0 0 Q96BR5 COA7_HUMAN Cytochrome c oxidase assembly factor 7 (Beta-lactamase hcp-like protein) (Respiratory chain assembly factor 1) (Sel1 repeat-containing protein 1) COA7 C1orf163 RESA1 SELRC1 Homo sapiens (Human) mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] GO:0005654; GO:0005739; GO:0005758 AEVLKNR 0.99502 -10.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96D59 RN183_HUMAN "E3 ubiquitin-protein ligase RNF183, EC 2.3.2.27" RNF183 Homo sapiens (Human) apoptotic process [GO:0006915]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976] cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lysosomal membrane [GO:0005765] cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976] GO:0000209; GO:0005765; GO:0005783; GO:0005789; GO:0006915; GO:0016567; GO:0030176; GO:0033106; GO:0034976; GO:0046872; GO:0051865; GO:0061630; GO:1902237 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] MAEQQGR 0.99502 -11.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1942 0 0 0 0 0 9.94575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96GJ1 TRM2B_HUMAN "tRNA (uracil-5-)-methyltransferase homolog B, EC 2.1.1.35 (TRM2 homolog B) (rRNA (uracil-5-)-methyltransferase TRMT2B, EC 2.1.1.-)" TRMT2B CXorf34 Homo sapiens (Human) mitochondrion [GO:0005739] mitochondrion [GO:0005739]; rRNA (uridine-C5-)-methyltransferase activity [GO:0070041]; S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697] GO:0005739; GO:0030697; GO:0070041 rRNA (uridine-C5-)-methyltransferase activity [GO:0070041]; S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697] DGNVVCVQSNHLK 0.99502 -12.202 0 0 0 0 0 0 0 0 14.6028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8725 0 0 14.5362 0 0 0 0 0 0 14.8866 0 0 0 0 0 0 0 0 0 0 13.7577 0 0 0 14.8499 0 0 0 0 0 11.0415 0 0 0 0 0 0 0 0 0 0 0 11.6059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.041 19.0908 18.6344 18.5641 18.797 0 15.2728 0 0 0 15.2308 0 13.0658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3524 0 0 0 0 0 0 0 0 0 10.5626 0 0 0 0 0 0 0 12.1849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2796 0 0 0 0 0 15.6257 0 15.5639 0 13.4185 13.1141 0 0 0 0 0 0 0 12.4172 0 0 0 0 Q96M83 CCDC7_HUMAN Coiled-coil domain-containing protein 7 (Protein BIOT2) CCDC7 BIOT2 C10orf68 Homo sapiens (Human) DIIKGPISAQLK 0.99502 -32.309 0 0 0 0 0 0 13.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6533 11.2396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9676 0 0 12.1787 0 0 0 0 0 15.725 0 0 15.819 17.9217 0 0 0 14.435 0 0 0 0 0 0 13.5632 19.0464 13.6311 13.1702 14.1696 0 0 18.1584 0 0 12.3035 0 13.3544 0 13.2161 13.2845 0 0 11.9127 0 0 13.5209 0 0 14.4308 0 13.7223 0 0 0 0 0 0 14.8496 0 0 0 0 0 18.7847 14.4401 0 0 0 0 0 14.5377 0 0 14.6008 14.5953 15.2014 15.3368 0 0 0 0 0 0 0 0 14.1838 0 14.2682 0 0 Q9BXH1 BBC3_HUMAN "Bcl-2-binding component 3, isoforms 1/2 (JFY-1) (p53 up-regulated modulator of apoptosis)" BBC3 PUMA Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; T cell apoptotic process [GO:0070231]; toxin transport [GO:1901998] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; PUMA-BCL-xl complex [GO:0097143] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; PUMA-BCL-xl complex [GO:0097143]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic signaling pathway [GO:0097190]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; determination of adult lifespan [GO:0008340]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of growth [GO:0045926]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein homooligomerization [GO:0032464]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of thymocyte apoptotic process [GO:0070245]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; release of cytochrome c from mitochondria [GO:0001836]; release of sequestered calcium ion into cytosol [GO:0051209]; response to endoplasmic reticulum stress [GO:0034976]; T cell apoptotic process [GO:0070231]; toxin transport [GO:1901998] GO:0001836; GO:0001844; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0006919; GO:0006974; GO:0008340; GO:0031334; GO:0032464; GO:0032471; GO:0034976; GO:0042771; GO:0043525; GO:0044346; GO:0045926; GO:0051209; GO:0070059; GO:0070231; GO:0070245; GO:0071456; GO:0071479; GO:0090200; GO:0097143; GO:0097190; GO:0097194; GO:1900740; GO:1901998; GO:1902237; GO:1903896; GO:2000271; GO:2001056; GO:2001244 APEMEPN 0.99502 -11.047 0 0 0 10.45 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2488 12.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9703 0 0 0 0 0 0 0 10.6745 0 10.5625 10.055 0 0 0 12.03 0 11.0771 17.1265 0 11.9586 0 10.879 0 0 0 12.3362 0 10.9981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8107 0 0 0 0 0 0 0 11.9395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9372 0 0 0 0 0 0 0 0 0 0 10.8107 10.5285 0 0 0 0 0 9.74712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H1X3 DJC25_HUMAN DnaJ homolog subfamily C member 25 DNAJC25 Homo sapiens (Human) protein folding [GO:0006457] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein folding [GO:0006457] GO:0005789; GO:0006457; GO:0016021 AISYLATVPK 0.99502 -32.368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2336 0 0 0 0 0 0 0 12.4211 0 0 0 0 0 15.6785 0 0 0 13.2598 0 13.994 0 0 0 0 0 0 0 0 0 12.3081 0 0 0 0 0 0 13.671 0 0 0 0 0 13.1323 0 0 0 0 12.8872 0 0 12.415 0 0 0 0 12.498 0 0 0 0 0 0 0 0 0 12.3835 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2088 0 Q9NP80 PLPL8_HUMAN "Calcium-independent phospholipase A2-gamma, EC 3.1.1.-, EC 3.1.1.5 (Intracellular membrane-associated calcium-independent phospholipase A2 gamma, iPLA2-gamma) (PNPLA-gamma) (Patatin-like phospholipase domain-containing protein 8) (iPLA2-2)" PNPLA8 IPLA22 IPLA2G BM-043 Homo sapiens (Human) arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cardiolipin metabolic process [GO:0032048]; cell death [GO:0008219]; fatty acid metabolic process [GO:0006631]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; regulation of cellular response to oxidative stress [GO:1900407]; triglyceride homeostasis [GO:0070328] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cardiolipin metabolic process [GO:0032048]; cell death [GO:0008219]; fatty acid metabolic process [GO:0006631]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; regulation of cellular response to oxidative stress [GO:1900407]; triglyceride homeostasis [GO:0070328] GO:0001516; GO:0004620; GO:0004622; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0006631; GO:0008219; GO:0008970; GO:0016020; GO:0016021; GO:0019369; GO:0031966; GO:0032048; GO:0034638; GO:0043651; GO:0046338; GO:0047499; GO:0050482; GO:0055088; GO:0070328; GO:0102545; GO:1900407 ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620] AVFGNQNEMISR 0.99502 -32.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3124 0 0 0 0 0 13.5079 0 0 13.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.752 12.554 0 0 14.338 0 14.3421 0 14.4429 13.4861 0 0 0 0 0 0 0 0 13.1336 0 0 0 0 0 0 15.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 14.16 0 12.1039 0 12.7891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9763 0 0 0 Q9UPT6 JIP3_HUMAN "C-Jun-amino-terminal kinase-interacting protein 3, JIP-3, JNK-interacting protein 3 (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3)" MAPK8IP3 JIP3 KIAA1066 Homo sapiens (Human) anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; protein stabilization [GO:0050821]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471] axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; anterograde axonal protein transport [GO:0099641]; axon development [GO:0061564]; axon regeneration [GO:0031103]; negative regulation of apoptotic process [GO:0043066]; positive regulation of JNK cascade [GO:0046330]; protein stabilization [GO:0050821]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005078; GO:0005737; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030424; GO:0030425; GO:0030426; GO:0031103; GO:0031410; GO:0043066; GO:0044297; GO:0046328; GO:0046330; GO:0048471; GO:0050821; GO:0061564; GO:0099641; GO:1904115 JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] DDFFGMGK 0.99502 -32.183 0 0 0 0 0 0 0 0 0 13.471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5825 13.8276 0 13.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1385 13.2166 0 13.2857 0 0 0 0 0 13.4059 0 0 0 0 12.5819 0 13.5691 0 0 0 0 14.0182 0 0 0 0 0 0 0 11.7276 0 0 0 0 12.6008 0 0 13.7306 14.5118 0 13.3526 0 0 12.7087 0 0 13.7846 0 0 0 0 0 0 14.4712 12.6484 0 0 0 14.2078 0 12.8929 13.1353 12.2747 0 12.2188 0 0 13.0147 13.2583 0 0 0 0 0 0 0 12.3548 0 0 0 10.084 0 12.5499 0 0 0 0 0 0 0 0 12.9923 0 0 13.5733 0 0 0 13.5362 0 0 0 0 0 13.0781 12.5441 0 12.5937 0 0 0 0 12.8919 0 0 Q9Y2T6 GPR55_HUMAN G-protein coupled receptor 55 GPR55 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; bone resorption [GO:0045453]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Rho protein signal transduction [GO:0035025] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930]; activation of phospholipase C activity [GO:0007202]; bone resorption [GO:0045453]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0004930; GO:0004949; GO:0005887; GO:0007186; GO:0007202; GO:0035025; GO:0045453; GO:0045671; GO:0051482; GO:0070374 cannabinoid receptor activity [GO:0004949]; G protein-coupled receptor activity [GO:0004930] AHRPSRVQLVLQDTTISR 0.99502 -10.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1665 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0492 0 0 0 11.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9446 0 0 0 0 0 0 P13667 PDIA4_HUMAN "Protein disulfide-isomerase A4, EC 5.3.4.1 (Endoplasmic reticulum resident protein 70, ER protein 70, ERp70) (Endoplasmic reticulum resident protein 72, ER protein 72, ERp-72, ERp72)" PDIA4 ERP70 ERP72 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976] GO:0003723; GO:0003756; GO:0005615; GO:0005783; GO:0005788; GO:0006457; GO:0009306; GO:0009986; GO:0015035; GO:0034976; GO:0042470; GO:0061077 protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723] EFVTAFKKGK 0.99503 -13.738 0 0 0 0 0 0 0 0 13.1446 12.7163 0 12.6756 0 13.1839 12.1607 0 0 0 0 0 13.1504 0 0 0 0 12.7997 12.4675 0 12.7275 0 0 13.054 0 12.0933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8115 0 0 0 0 0 0 0 0 14.107 0 0 0 14.8969 0 13.3574 0 0 0 0 0 0 0 0 0 0 13.6298 0 0 0 0 0 0 14.1012 0 0 0 0 14.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1564 0 0 0 0 0 15.4439 14.1898 0 0 0 14.0931 14.2914 0 0 0 0 0 12.5109 0 0 0 0 0 P35453 HXD13_HUMAN Homeobox protein Hox-D13 (Homeobox protein Hox-4I) HOXD13 HOX4I Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; branch elongation of an epithelium [GO:0060602]; embryonic digit morphogenesis [GO:0042733]; embryonic hindgut morphogenesis [GO:0048619]; male genitalia development [GO:0030539]; morphogenesis of an epithelial fold [GO:0060571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anterior/posterior pattern specification [GO:0009952]; branch elongation of an epithelium [GO:0060602]; embryonic digit morphogenesis [GO:0042733]; embryonic hindgut morphogenesis [GO:0048619]; male genitalia development [GO:0030539]; morphogenesis of an epithelial fold [GO:0060571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to testosterone [GO:0033574]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001501; GO:0003677; GO:0003682; GO:0003700; GO:0005654; GO:0006355; GO:0006357; GO:0006366; GO:0009952; GO:0030539; GO:0033574; GO:0042127; GO:0042733; GO:0045944; GO:0048619; GO:0060527; GO:0060571; GO:0060602; GO:0060687; GO:1990837 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DQPQGSHFWK 0.99503 -10.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.882 0 0 0 14.2742 0 0 0 0 0 12.004 0 0 14.9999 0 0 0 0 0 0 0 0 11.356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14684 RRP1B_HUMAN Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B) RRP1B KIAA0179 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364] "chromosome [GO:0005694]; cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]" "chromosome [GO:0005694]; cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]" GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0030687; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586 RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713] DHTLVQTIAR 0.99503 -35.915 0 0 0 0 0 0 0 0 0 0 0 14.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8207 0 0 0 0 0 0 0 0 11.1374 0 0 0 12.6116 11.738 0 0 17.1713 11.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3734 0 0 0 0 0 0 0 0 0 0 13.8413 12.2508 13.2959 0 14.1712 0 0 0 0 13.1712 13.4871 0 0 11.8585 0 15.6727 0 0 0 0 0 0 0 0 0 0 0 0 0 12.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TF39 ZN483_HUMAN Zinc finger protein 483 (Zinc finger protein with KRAB and SCAN domains 16) ZNF483 KIAA1962 ZKSCAN16 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CLRDDDHGLMEESQQYCGSSEEDHGNQGNSKGR 0.99503 -12.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.007 0 0 0 0 0 12.9978 0 0 0 12.4588 0 0 12.3467 0 0 0 0 0 0 0 0 0 0 0 11.1935 12.6433 0 0 0 0 0 0 0 0 0 11.2236 0 0 10.6304 0 0 0 0 0 0 12.2495 0 0 0 0 0 0 0 0 0 0 0 0 14.3379 0 0 0 11.1163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9077 0 0 0 0 12.2577 Q96BR1 SGK3_HUMAN "Serine/threonine-protein kinase Sgk3, EC 2.7.11.1 (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like)" SGK3 CISK SGKL Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090] cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037] cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080]; intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090] GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0017081; GO:0018105; GO:0030334; GO:0035091; GO:0035556; GO:0042127; GO:0051090; GO:0055037; GO:0106310; GO:2001240 ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080] ESCPSVSIPSSDEHREK 0.99503 -13.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8872 0 0 0 0 0 0 0 0 11.0061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3192 0 0 0 0 0 0 0 0 0 10.7103 0 0 0 0 0 0 0 0 0 0 0 11.3961 0 0 14.5366 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4337 13.3933 13.8189 0 13.5831 0 14.8522 0 15.3051 0 15.5666 0 14.8962 15.0826 14.9473 0 0 0 13.2523 0 0 0 0 0 0 0 0 0 0 12.945 0 15.7999 0 0 0 0 0 0 12.5374 0 13.2455 0 0 0 11.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 9.15591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3365 0 0 0 0 0 0 10.2355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1437 Q9H773 DCTP1_HUMAN "dCTP pyrophosphatase 1, EC 3.6.1.12 (Deoxycytidine-triphosphatase 1, dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein)" DCTPP1 XTP3TPA CDA03 Homo sapiens (Human) dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143] GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840 dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556] TDGEPGPQGWSPRER 0.99503 -10.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3814 0 0 0 0 0 0 0 0 0 0 0 11.4324 0 0 0 0 11.9036 0 0 0 0 0 0 0 0 0 12.2197 0 0 0 0 0 0 0 0 11.4827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJT1 TBD_HUMAN Tubulin delta chain (Delta-tubulin) TUBD1 TUBD Homo sapiens (Human) cell projection organization [GO:0030030]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; positive regulation of smoothened signaling pathway [GO:0045880] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; cell projection organization [GO:0030030]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; positive regulation of smoothened signaling pathway [GO:0045880] GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005874; GO:0005929; GO:0007017; GO:0030030; GO:0045880 GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200] AVLVDMEPK 0.99503 -12.762 0 0 0 0 0 0 0 0 0 0 12.5304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9658 0 0 12.209 0 10.9083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.723 0 0 0 0 0 0 0 0 0 0 12.3365 0 0 0 12.1885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1756 0 12.0652 0 0 O15403 MOT7_HUMAN "Monocarboxylate transporter 7, MCT 7 (Monocarboxylate transporter 6, MCT 6) (Solute carrier family 16 member 6)" SLC16A6 MCT6 MCT7 Homo sapiens (Human) monocarboxylic acid transport [GO:0015718] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718] GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020; GO:0016021 monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] ERIGWRYSLLFVGLLQLNIVIFGALLR 0.99504 -8.3175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1685 0 0 0 0 0 12.3564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8636 0 0 0 0 0 0 0 13.1961 0 0 12.9437 0 0 0 0 12.9372 0 0 0 0 0 0 0 0 12.6988 0 0 0 0 0 12.9099 0 0 0 0 0 0 0 13.3677 0 0 0 0 0 0 12.8969 0 0 12.3713 12.8288 0 12.3057 0 0 12.4286 12.5689 12.4829 0 12.779 13.1685 12.3179 13.5838 0 0 13.4143 12.8214 0 0 0 0 0 0 12.615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1438 0 0 0 0 0 0 0 0 0 0 0 0 O60733 PLPL9_HUMAN "85/88 kDa calcium-independent phospholipase A2, CaI-PLA2, EC 3.1.1.4 (2-lysophosphatidylcholine acylhydrolase, EC 3.1.1.5) (Group VI phospholipase A2, GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta, iPLA2-beta) (Palmitoyl-CoA hydrolase, EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9, PNPLA9)" PLA2G6 PLPLA9 Homo sapiens (Human) "antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311]" centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143] "centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832]; vasodilation [GO:0042311]" GO:0001934; GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0007204; GO:0007613; GO:0014832; GO:0016021; GO:0016290; GO:0016787; GO:0017171; GO:0019731; GO:0019901; GO:0031143; GO:0032049; GO:0034451; GO:0034638; GO:0034976; GO:0035774; GO:0035965; GO:0038096; GO:0042311; GO:0042802; GO:0043008; GO:0045921; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0051967; GO:0060135; GO:0090037; GO:0090200; GO:0090238; GO:0102545; GO:0102991; GO:1901339; GO:2000304 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; lysophospholipase activity [GO:0004622]; myristoyl-CoA hydrolase activity [GO:0102991]; palmitoyl-CoA hydrolase activity [GO:0016290]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A2 activity [GO:0004623]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171] ECFHHSR 0.99504 -8.3211 0 0 0 0 0 0 0 0 0 0 0 11.7463 0 0 0 0 0 11.1024 0 0 0 0 0 0 0 0 0 9.94683 0 0 0 0 11.0281 0 0 0 0 0 0 10.3465 0 0 0 11.1817 0 0 0 0 0 0 0 0 0 9.63276 0 0 14.2102 0 0 0 0 0 0 0 0 14.9618 0 0 0 0 0 0 0 0 14.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4336 0 0 0 14.9923 0 0 0 0 0 13.7814 0 0 0 0 16.0189 0 0 0 0 0 0 0 0 0 0 14.7836 0 0 0 0 0 12.5875 0 0 15.3994 0 0 10.9661 0 0 15.9941 0 0 0 11.9795 0 11.4699 14.0534 0 0 0 0 15.7786 12.9809 0 0 14.2271 0 0 0 13.6305 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6317 12.8329 0 0 13.0135 0 0 12.5154 14.3693 0 0 0 P00915 CAH1_HUMAN "Carbonic anhydrase 1, EC 4.2.1.1 (Carbonate dehydratase I) (Carbonic anhydrase B, CAB) (Carbonic anhydrase I, CA-I) (Cyanamide hydratase CA1, EC 4.2.1.69)" CA1 Homo sapiens (Human) one-carbon metabolic process [GO:0006730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270]; one-carbon metabolic process [GO:0006730] GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0006730; GO:0008270; GO:0016836; GO:0018820; GO:0070062 arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; hydro-lyase activity [GO:0016836]; zinc ion binding [GO:0008270] GGPFSDSYR 0.99504 -12.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7541 11.6288 0 0 0 0 0 11.8723 0 0 0 11.1341 0 0 9.77816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5792 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5889 0 0 0 0 0 0 0 0 0 12.3563 0 0 0 0 12.1806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7608 0 14.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.639 0 0 12.3569 12.952 0 12.7935 0 0 12.9658 0 0 0 12.3417 0 0 0 0 0 12.9773 0 0 Q05516 ZBT16_HUMAN Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF) ZBTB16 PLZF ZNF145 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification involved in bone maturation [GO:0043931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053] "cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification involved in bone maturation [GO:0043931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0001222; GO:0001227; GO:0001228; GO:0001673; GO:0001823; GO:0003677; GO:0005634; GO:0005829; GO:0005886; GO:0006357; GO:0006915; GO:0007417; GO:0008022; GO:0008283; GO:0008285; GO:0009880; GO:0009952; GO:0016567; GO:0016604; GO:0016605; GO:0016607; GO:0017053; GO:0019904; GO:0030097; GO:0030099; GO:0032332; GO:0032991; GO:0034504; GO:0035116; GO:0035136; GO:0042733; GO:0042802; GO:0042803; GO:0043065; GO:0043931; GO:0045600; GO:0045638; GO:0045778; GO:0045892; GO:0045893; GO:0046872; GO:0048133; GO:0051138; GO:0051216; GO:0061036 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]" RFQAQSALQQHMEVHAGVR 0.99504 -5.4282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1223 0 0 12.5325 13.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PH81 CP087_HUMAN UPF0547 protein C16orf87 C16orf87 Homo sapiens (Human) IINQRLIL 0.99504 -12.85 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4888 0 0 12.1066 0 0 0 0 0 0 0 0 0 0 15.4704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3458 13.5243 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2157 0 13.6517 0 0 Q9H489 TSY26_HUMAN "Putative testis-specific Y-encoded-like protein 3, TSPY-like protein 3 (Testis-specific Y-encoded protein 26 pseudogene)" TSPY26P TSPYL3 Homo sapiens (Human) nucleosome assembly [GO:0006334] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0005634; GO:0006334; GO:0042393 chromatin binding [GO:0003682]; histone binding [GO:0042393] SFFSWFSQHSLPEADR 0.99504 -8.2913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7318 11.6423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1235 12.7975 0 12.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7684 15.4535 14.2786 12.5094 0 0 12.6396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3044 12.7445 0 0 12.8795 12.9523 0 0 12.6852 0 0 13.0135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5207 0 0 0 0 12.7425 0 0 0 0 0 0 0 0 13.0654 0 0 0 0 0 13.1028 12.8379 13.3734 0 0 0 0 0 0 Q9P0S2 COX16_HUMAN "Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial, hCOX16" COX16 C14orf112 HSPC203 PTD019 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617] integral component of mitochondrial inner membrane [GO:0031305] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial cytochrome c oxidase assembly [GO:0033617] GO:0031305; GO:0033617 FDDWKNIR 0.99504 -8.2899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5709 0 0 0 0 0 0 0 0 0 13.0911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MXV6 CD15L_HUMAN CMT1A duplicated region transcript 15 protein-like protein CDRT15L2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 LIPHPRRLWPFVR 0.99505 -8.329 0 0 0 13.0465 12.7461 12.6912 14.0062 0 0 0 0 0 0 12.1412 0 0 0 12.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0244 0 12.9196 0 15.0923 12.3779 13.1134 12.3093 14.1204 0 0 13.4372 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8031 0 0 17.8556 13.3986 0 13.2496 0 0 0 0 13.909 13.7669 14.0732 0 0 0 0 0 0 0 12.9495 0 0 14.7305 0 0 0 0 15.1559 0 12.5797 0 0 13.7818 0 13.0342 0 0 0 0 0 0 0 0 0 13.3209 0 0 13.7654 0 0 0 0 0 0 0 0 14.8951 13.5676 0 13.2497 0 0 0 11.4353 0 0 12.4948 0 0 0 0 0 0 0 0 0 0 13.6043 0 11.845 0 0 0 O14744 ANM5_HUMAN "Protein arginine N-methyltransferase 5, PRMT5, EC 2.1.1.320 (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog, SKB1 homolog, SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed ]" PRMT5 HRMT1L5 IBP72 JBP1 SKB1 Homo sapiens (Human) "chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription, termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription, DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0000785; GO:0002039; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006325; GO:0006353; GO:0006355; GO:0007088; GO:0008168; GO:0008327; GO:0008469; GO:0016274; GO:0018216; GO:0032922; GO:0034709; GO:0034969; GO:0035097; GO:0035243; GO:0035246; GO:0042118; GO:0042802; GO:0043021; GO:0043985; GO:0044020; GO:0044030; GO:0045596; GO:0046982; GO:0048026; GO:0048714; GO:0070372; GO:0070888; GO:0090161; GO:0097421; GO:1901796; GO:1904992 E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714] DWNTLIVGKLSPWIRPDSK 0.99505 -11.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60216 RAD21_HUMAN "Double-strand-break repair protein rad21 homolog, hHR21 (Nuclear matrix protein 1, NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product) ]" RAD21 HR21 KIAA0078 NXP1 SCC1 Homo sapiens (Human) apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; establishment of meiotic sister chromatid cohesion [GO:0034089]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; reciprocal meiotic recombination [GO:0007131]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sister chromatid cohesion [GO:0007062] "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]" "chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; establishment of meiotic sister chromatid cohesion [GO:0034089]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; reciprocal meiotic recombination [GO:0007131]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sister chromatid cohesion [GO:0007062]" GO:0000775; GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006302; GO:0006310; GO:0006357; GO:0006915; GO:0007062; GO:0007131; GO:0008278; GO:0010972; GO:0016020; GO:0016363; GO:0030496; GO:0034089; GO:0034991; GO:0045841; GO:0045876; GO:0051301; GO:0071168; GO:1990414 chromatin binding [GO:0003682]; DNA binding [GO:0003677] AKYLLADCNEAFIKIK 0.99505 -11.618 0 0 0 0 0 11.1549 0 13.1297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0382 11.7571 11.4755 0 0 0 12.9016 0 0 0 0 13.3834 0 0 0 0 13.1379 0 0 0 0 0 0 0 0 0 0 0 10.5372 0 0 0 0 0 0 10.6177 0 0 11.0625 0 0 0 0 0 12.403 0 0 0 0 13.0353 0 0 0 0 15.1024 14.2004 0 0 14.1947 0 14.3811 0 0 0 0 14.0853 0 0 0 0 0 0 0 0 14.8886 0 15.289 0 0 0 0 0 0 13.7792 15.9311 13.1955 0 0 14.227 11.9441 0 0 14.2381 13.9781 0 14.0914 13.6201 0 0 0 13.6875 0 0 0 14.1573 0 14.6875 13.1468 0 0 0 11.6915 0 14.0295 14.9562 0 0 0 0 13.8922 12.0882 0 15.7349 0 14.1823 14.8007 0 0 14.7031 13.4581 0 13.7684 13.5964 0 0 0 0 0 0 0 17.4407 13.1191 0 13.7781 0 0 0 13.407 0 0 P01303 NPY_HUMAN "Pro-neuropeptide Y [Cleaved into: Neuropeptide Y (Neuropeptide tyrosine, NPY); C-flanking peptide of NPY, CPON ]" NPY Homo sapiens (Human) "adult feeding behavior [GO:0008343]; aging [GO:0007568]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; monocyte activation [GO:0042117]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of blood pressure [GO:0045776]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of appetite [GO:0032100]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of eating behavior [GO:1904000]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nitric oxide metabolic process [GO:1904407]; regulation of nerve growth factor production [GO:0032903]; response to yeast [GO:0001878]; sensory perception of taste [GO:0050909]; short-day photoperiodism [GO:0048572]" extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal dense core vesicle [GO:0098992]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; terminal bouton [GO:0043195] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal dense core vesicle [GO:0098992]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; terminal bouton [GO:0043195]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]; signaling receptor binding [GO:0005102]; adult feeding behavior [GO:0008343]; aging [GO:0007568]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; monocyte activation [GO:0042117]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of blood pressure [GO:0045776]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of appetite [GO:0032100]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of eating behavior [GO:1904000]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nitric oxide metabolic process [GO:1904407]; regulation of nerve growth factor production [GO:0032903]; response to yeast [GO:0001878]; sensory perception of taste [GO:0050909]; short-day photoperiodism [GO:0048572]" GO:0001664; GO:0001878; GO:0002865; GO:0004930; GO:0005102; GO:0005179; GO:0005184; GO:0005246; GO:0005576; GO:0005615; GO:0005794; GO:0007187; GO:0007218; GO:0007268; GO:0007568; GO:0007631; GO:0008284; GO:0008343; GO:0010811; GO:0019731; GO:0019732; GO:0021954; GO:0021987; GO:0031175; GO:0031841; GO:0032100; GO:0032903; GO:0042117; GO:0043195; GO:0043204; GO:0045087; GO:0045776; GO:0045964; GO:0048471; GO:0048572; GO:0050829; GO:0050830; GO:0050909; GO:0060575; GO:0061844; GO:0070374; GO:0098992; GO:1901215; GO:1904000; GO:1904407 calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]; signaling receptor binding [GO:0005102] HYINLITRQR 0.99505 -10.38 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3772 0 0 P07205 PGK2_HUMAN "Phosphoglycerate kinase 2, EC 2.7.2.3 (Phosphoglycerate kinase, testis specific)" PGK2 PGKB Homo sapiens (Human) flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310] GO:0004618; GO:0005524; GO:0005634; GO:0005829; GO:0006094; GO:0006096; GO:0016310; GO:0030317; GO:0035686; GO:0043531; GO:0070062 ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618] GQDPSGK 0.99505 -10.353 14.2928 11.5305 0 0 0 0 9.51061 0 0 0 13.1433 13.3185 12.952 0 0 13.5026 13.0175 0 11.0898 0 13.4676 0 0 0 0 0 13.5563 13.4031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4534 0 0 0 12.5529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.592 0 0 14.6833 0 0 0 0 0 0 0 0 13.9216 13.6701 0 0 0 0 0 0 0 12.1165 0 0 14.3588 0 0 0 0 0 0 0 0 14.4911 0 0 P51687 SUOX_HUMAN "Sulfite oxidase, mitochondrial, EC 1.8.3.1" SUOX Homo sapiens (Human) sulfur compound metabolic process [GO:0006790] mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; sulfur compound metabolic process [GO:0006790] GO:0005739; GO:0005758; GO:0005759; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546 heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482] HVKWLGR 0.99505 -11.242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5396 0 0 0 0 0 0 10.3164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02818 NUCB1_HUMAN Nucleobindin-1 (CALNUC) NUCB1 NUC Homo sapiens (Human) small GTPase mediated signal transduction [GO:0007264] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020] endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase mediated signal transduction [GO:0007264] GO:0001965; GO:0003677; GO:0005085; GO:0005509; GO:0005615; GO:0005788; GO:0005793; GO:0005794; GO:0007264; GO:0016020; GO:0070062 calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085] AVLAVPLER 0.99505 -15.405 10.744 0 0 11.073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9583 11.368 0 0 0 11.6027 0 0 0 0 0 0 0 0 10.5693 0 0 0 0 10.5531 0 0 0 0 11.9621 0 0 0 0 0 0 0 11.7454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7921 0 14.1232 11.6132 11.921 0 13.1307 0 0 0 0 0 0 0 0 12.0324 0 0 0 13.1692 12.3135 0 13.3469 0 0 0 12.3922 13.1818 0 0 14.3525 0 0 0 0 0 13.4444 0 14.0496 14.7412 0 12.7562 13.6736 14.1869 13.0381 0 11.2091 12.8692 11.2338 0 12.0901 0 0 14.7844 0 0 15.315 0 0 14.2211 0 11.4879 11.6099 0 13.7367 0 0 10.7944 11.7616 0 0 14.7562 11.4877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8047 0 0 0 0 0 0 0 0 0 0 12.2049 9.82039 13.4477 11.691 15.3434 0 0 12.4676 0 0 0 Q13093 PAFA_HUMAN "Platelet-activating factor acetylhydrolase, PAF acetylhydrolase, EC 3.1.1.47 (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2, gVIIA-PLA2) (LDL-associated phospholipase A2, LDL-PLA(2)) (PAF 2-acylhydrolase)" PLA2G7 PAFAH Homo sapiens (Human) lipid oxidation [GO:0034440]; low-density lipoprotein particle remodeling [GO:0034374]; peptide hormone processing [GO:0016486]; phosphatidylcholine catabolic process [GO:0034638]; plasma lipoprotein particle oxidation [GO:0034441]; platelet activating factor catabolic process [GO:0062234]; platelet activating factor metabolic process [GO:0046469]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte chemotaxis [GO:0090026] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362] "cytoplasm [GO:0005737]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; hydrolase activity, acting on ester bonds [GO:0016788]; phospholipid binding [GO:0005543]; lipid oxidation [GO:0034440]; low-density lipoprotein particle remodeling [GO:0034374]; peptide hormone processing [GO:0016486]; phosphatidylcholine catabolic process [GO:0034638]; plasma lipoprotein particle oxidation [GO:0034441]; platelet activating factor catabolic process [GO:0062234]; platelet activating factor metabolic process [GO:0046469]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte chemotaxis [GO:0090026]" GO:0003847; GO:0005543; GO:0005576; GO:0005737; GO:0016486; GO:0016788; GO:0034362; GO:0034364; GO:0034374; GO:0034440; GO:0034441; GO:0034638; GO:0046469; GO:0047499; GO:0050729; GO:0062234; GO:0090026 "1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; hydrolase activity, acting on ester bonds [GO:0016788]; phospholipid binding [GO:0005543]" FLGTHWLMGNILRLLFGSMTTPANWNSPLR 0.99505 -9.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.9285 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0094 0 0 15.2711 13.1377 0 0 0 0 13.284 0 0 0 0 0 0 12.6104 0 0 0 0 0 0 0 0 15.3975 0 0 0 13.0476 0 19.1421 0 0 0 0 0 12.4807 0 0 0 0 0 14.5038 0 0 0 14.2842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4LDG9 DNAL1_HUMAN "Dynein axonemal light chain 1, LC1" DNAL1 C14orf168 Homo sapiens (Human) outer dynein arm assembly [GO:0036158] cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157] cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; outer dynein arm assembly [GO:0036158] GO:0005737; GO:0005874; GO:0036157; GO:0036158; GO:0043014; GO:0045504 alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504] DWAEFVK 0.99505 -15.413 0 0 0 0 0 10.6051 11.2554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1613 0 0 0 0 0 0 0 0 0 0 0 12.0398 10.9809 0 0 0 0 0 0 0 0 0 0 10.9522 0 0 0 0 0 0 0 0 0 0 0 0 13.3516 0 0 0 0 0 0 13.0183 0 14.7789 0 13.4197 10.7692 0 13.2511 11.7729 15.0701 10.9344 0 0 0 0 13.0888 0 0 0 13.2095 0 0 0 12.8132 0 0 13.6581 0 12.9883 14.8222 12.737 0 0 0 12.5689 0 0 13.0453 0 14.8296 0 13.5082 12.5139 0 0 0 16.1342 13.1894 0 0 0 12.4087 0 12.9367 0 0 0 0 0 15.906 0 11.9057 0 11.9366 0 0 11.1402 0 0 0 0 11.9726 13.3059 10.4798 0 0 0 0 11.9721 12.5112 0 0 11.8998 0 0 0 0 0 0 13.236 12.6598 0 0 12.8211 11.5762 11.3587 14.6035 0 13.9775 0 12.303 0 0 0 14.5561 Q5TAP6 UT14C_HUMAN U3 small nucleolar RNA-associated protein 14 homolog C UTP14C KIAA0266 Homo sapiens (Human) cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040] cytosol [GO:0005829]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; rRNA processing [GO:0006364]; spermatogenesis [GO:0007283] GO:0005730; GO:0005829; GO:0006364; GO:0007283; GO:0030154; GO:0032040; GO:0051321 AFQKLTTPK 0.99505 -9.9394 0 0 0 0 9.81105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3083 12.4994 0 0 0 0 0 0 0 11.1418 0 12.8181 0 13.012 12.6829 0 0 0 0 0 0 13.1428 0 12.5943 0 0 0 11.2857 0 0 12.4216 0 0 13.9524 0 0 11.6057 14.5292 0 14.3231 0 13.3461 0 0 0 0 0 0 13.8237 0 0 13.1262 13.5007 0 0 0 0 0 12.7046 12.5356 0 12.945 14.1227 14.9255 0 0 0 0 0 13.3329 0 0 0 13.8086 0 15.0538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.167 13.3706 14.5163 0 0 0 0 0 Q6UN15 FIP1_HUMAN "Pre-mRNA 3'-end-processing factor FIP1, hFip1 (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia)" FIP1L1 FIP1 RHE Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] GO:0003723; GO:0005654; GO:0005829; GO:0005847; GO:0006378; GO:0098789 RNA binding [GO:0003723] DHSPTPSVFNSDEERYR 0.99505 -10.381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1015 0 0 0 12.2306 0 0 0 0 0 0 0 0 0 0 0 16.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMS7 ZN783_HUMAN Zinc finger protein 783 ZNF783 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0042802; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] GQTECRIPR 0.99505 -9.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9456 0 0 0 11.4325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN16 M3K15_HUMAN "Mitogen-activated protein kinase kinase kinase 15, EC 2.7.11.25 (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15, MEK kinase 15, MEKK 15)" MAP3K15 ASK3 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004709; GO:0005524; GO:0006468; GO:0046872; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] ALRAVYVR 0.99505 -10.362 0 13.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2654 0 11.2535 12.0015 13.1562 0 12.1456 13.607 12.0284 0 13.4393 13.5872 15.0562 0 0 15.7549 12.8066 0 0 13.8266 13.5727 0 17.5015 0 0 0 14.0219 13.0623 12.0853 0 15.903 0 11.8221 0 11.6786 12.4863 0 0 11.5445 0 13.7061 12.4411 0 0 14.9675 16.5586 11.9747 0 0 13.4011 0 0 15.149 0 0 0 0 11.6554 0 0 0 0 0 13.032 10.9772 0 0 0 0 11.8458 0 0 0 0 0 0 0 0 0 0 12.4129 0 0 12.3138 14.0603 0 0 0 10.7717 0 14.0191 0 0 0 0 0 0 0 12.3446 0 12.7689 0 0 0 13.2068 0 Q86T90 K1328_HUMAN Protein hinderin KIAA1328 Homo sapiens (Human) ADVKLKTSR 0.99505 -11.24 0 0 0 0 0 13.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.942 0 0 0 0 0 0 0 0 0 0 0 13.7499 10.746 0 0 0 0 0 0 0 0 0 0 14.0617 0 0 0 14.202 0 0 0 13.5527 0 13.0508 0 0 0 0 0 14.3754 14.1114 0 0 13.6879 0 0 0 0 0 0 0 0 14.2453 0 0 0 0 0 0 0 0 0 0 13.9531 0 0 0 0 0 0 0 0 0 0 0 18.1931 0 0 0 0 0 0 0 0 0 0 0 10.3352 12.2295 0 0 0 0 0 13.1455 0 14.8621 0 0 11.8841 0 0 Q86VS3 IQCH_HUMAN IQ domain-containing protein H (Testis development protein NYD-SP5) IQCH Homo sapiens (Human) FLRNYAIPEVKIK 0.99505 -15.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6069 10.5347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3188 0 0 0 0 0 0 0 0 0 11.7548 0 0 0 0 0 13.694 0 11.5579 0 0 0 0 0 0 0 14.1235 13.7655 13.7843 0 0 0 0 0 0 0 0 0 12.0547 0 0 0 0 0 0 0 0 11.4718 0 0 15.0702 0 0 14.9989 0 11.8855 13.0709 18.2247 0 0 0 0 0 0 0 0 0 0 12.1285 0 0 0 0 11.5274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0963 13.5943 0 0 0 0 0 0 0 11.1583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W34 AMZ2_HUMAN "Archaemetzincin-2, EC 3.4.-.- (Archeobacterial metalloproteinase-like protein 2)" AMZ2 BM-014 Homo sapiens (Human) proteolysis [GO:0006508] metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508] GO:0006508; GO:0008237; GO:0046872 metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237] QIIRHSEQTLKTALISK 0.99505 -8.8974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1716 0 0 0 0 0 0 0 0 13.2667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1609 0 0 13.3757 13.997 13.102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9662 13.9974 0 0 12.953 0 0 0 0 0 0 0 0 0 0 0 14.93 12.3705 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUA0 WFDC8_HUMAN WAP four-disulfide core domain protein 8 (Putative protease inhibitor WAP8) WFDC8 C20orf170 WAP8 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867] GO:0004867; GO:0005576 serine-type endopeptidase inhibitor activity [GO:0004867] CCSHCGLKCMDPR 0.99505 -8.3248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2723 0 0 0 0 0 0 0 0 0 11.8228 0 0 11.7036 0 0 13.8194 0 12.9754 0 14.1611 0 0 0 0 13.9648 0 0 0 12.4375 0 0 0 0 0 0 0 0 10.0851 0 12.2349 0 0 0 11.6845 0 0 0 0 0 0 0 0 13.8511 0 0 0 13.0399 0 0 0 0 0 0 0 0 0 12.9322 14.3769 0 0 0 0 0 14.3716 0 13.7305 13.3309 0 0 0 0 0 0 0 12.1927 12.577 0 0 12.2262 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUG1 KRA13_HUMAN Keratin-associated protein 1-3 (Keratin-associated protein 1.8) (Keratin-associated protein 1.9) KRTAP1-3 B2B KAP1.2 KAP1.3 KAP1.8 KAP1.9 KRATP1.9 KRTAP1.8 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280] GO:0005829; GO:0030280; GO:0045095 structural constituent of skin epidermis [GO:0030280] PSYCGQSCCR 0.99505 -8.9285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4247 0 0 0 13.4628 0 0 0 0 0 0 0 0 0 12.61 0 0 0 0 11.0974 0 0 0 0 0 0 0 13.2959 0 0 0 0 0 0 0 0 14.2966 0 0 13.653 11.5447 11.3866 0 0 0 0 0 13.1265 0 0 0 0 0 12.8035 0 0 0 0 0 12.9106 0 0 0 0 13.3693 0 13.8752 0 0 0 0 12.1289 0 0 0 0 0 14.5251 0 0 0 0 0 0 0 0 0 0 0 0 12.3843 0 0 0 0 0 14.4917 0 0 0 0 0 0 0 0 14.5882 0 0 13.6272 0 12.8061 0 13.2443 0 0 0 13.8215 0 0 0 0 0 0 14.6861 0 0 Q8IZ41 RASEF_HUMAN Ras and EF-hand domain-containing protein (Ras-related protein Rab-45) RASEF RAB45 Homo sapiens (Human) cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] GO:0003924; GO:0005509; GO:0005525; GO:0005737; GO:0005829; GO:0019003; GO:0042802; GO:0048471 calcium ion binding [GO:0005509]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802] ALCTELR 0.99505 -8.3263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8828 13.3024 0 0 0 0 13.7364 0 0 0 0 0 0 0 12.5535 0 0 14.5417 0 14.2474 0 0 0 0 0 13.4915 0 0 0 12.8907 13.1201 0 0 0 0 0 13.4338 13.7527 0 0 0 0 0 0 0 13.2441 0 0 0 14.155 13.4654 13.3136 0 0 0 0 0 0 13.6508 0 0 0 0 0 0 0 0 0 0 13.3556 13.9367 0 0 0 0 0 0 0 0 0 12.7404 0 0 0 0 0 0 0 0 0 0 0 0 15.0575 0 0 0 0 0 0 0 0 0 0 Q8NGS5 O13C4_HUMAN Olfactory receptor 13C4 (Olfactory receptor OR9-7) OR13C4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAIKYLLSR 0.99505 -11.614 0 0 0 0 0 0 0 0 0 0 0 0 11.78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7122 0 11.3566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3501 0 0 0 0 0 0 11.9393 0 0 0 0 0 0 0 0 0 12.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1516 0 0 0 0 0 0 0 0 0 0 0 12.1805 0 0 0 0 0 0 0 0 0 12.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3654 0 0 0 0 0 0 Q8TCX1 DC2L1_HUMAN "Cytoplasmic dynein 2 light intermediate chain 1, Dynein 2 light intermediate chain" DYNC2LI1 D2LIC LIC3 CGI-60 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017] apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514] apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; dynein heavy chain binding [GO:0045504]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017] GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005868; GO:0005874; GO:0005929; GO:0005930; GO:0007368; GO:0031514; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045177; GO:0045504; GO:0097542; GO:1902017 dynein heavy chain binding [GO:0045504] KVICKTLR 0.99505 -10.367 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4977 0 14.9269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3828 0 13.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92820 GGH_HUMAN "Gamma-glutamyl hydrolase, EC 3.4.19.9 (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)" GGH Homo sapiens (Human) tetrahydrofolylpolyglutamate metabolic process [GO:0046900] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773]; exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900] GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724 exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242] DYEILFK 0.99505 -15.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.994 17.2658 15.3036 15.4307 0 12.7425 14.4543 0 0 0 0 0 13.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8032 0 0 0 0 0 0 0 0 0 0 0 13.5961 0 0 Q96AY2 EME1_HUMAN "Crossover junction endonuclease EME1, EC 3.1.22.- (MMS4 homolog, hMMS4)" EME1 MMS4 Homo sapiens (Human) double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429] endodeoxyribonuclease complex [GO:1905347]; heterochromatin [GO:0000792]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] endodeoxyribonuclease complex [GO:1905347]; heterochromatin [GO:0000792]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; double-strand break repair [GO:0006302]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429] GO:0000712; GO:0000792; GO:0003677; GO:0004519; GO:0005654; GO:0005730; GO:0006302; GO:0031297; GO:0031573; GO:0043596; GO:0046872; GO:0048476; GO:0072429; GO:1905347 DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872] GKETLQGFVTDITAKTAGK 0.99505 -15.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.985 0 12.4179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8764 0 0 11.4311 0 0 0 0 0 12.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1725 0 0 0 0 0 0 0 0 0 0 0 12.3715 0 0 0 0 0 0 0 0 0 11.8094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7M6 ZSWM4_HUMAN Zinc finger SWIM domain-containing protein 4 ZSWIM4 Homo sapiens (Human) Cul2-RING ubiquitin ligase complex [GO:0031462] Cul2-RING ubiquitin ligase complex [GO:0031462]; zinc ion binding [GO:0008270] GO:0008270; GO:0031462 zinc ion binding [GO:0008270] DLFYCAHVVALSLYRIR 0.99505 -5.455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7953 13.7099 13.8897 13.7911 13.7092 14.379 0 13.6018 0 13.1221 0 14.1293 13.7439 13.8757 0 0 0 0 0 0 0 0 0 0 0 0 14.7112 14.8476 13.8013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2541 0 0 0 0 0 0 15.1255 0 0 0 12.2879 0 0 0 0 0 0 0 0 0 0 0 0 0 11.56 0 0 0 0 0 0 0 0 0 13.078 0 0 0 0 0 0 0 0 10.9976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9332 0 0 0 0 0 0 13.3912 0 0 0 0 0 Q9NZ72 STMN3_HUMAN Stathmin-3 (SCG10-like protein) STMN3 SCLIP Homo sapiens (Human) blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]; blastocyst hatching [GO:0001835]; cytoplasmic microtubule organization [GO:0031122]; microtubule depolymerization [GO:0007019]; negative regulation of Rac protein signal transduction [GO:0035021]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0001835; GO:0005737; GO:0005794; GO:0005829; GO:0007019; GO:0007399; GO:0015631; GO:0019904; GO:0030426; GO:0031110; GO:0031122; GO:0031175; GO:0035021; GO:0043005; GO:0043087; GO:0051493 protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631] ASTISAYK 0.99505 -8.3216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULW8 PADI3_HUMAN "Protein-arginine deiminase type-3, EC 3.5.3.15 (Peptidylarginine deiminase III) (Protein-arginine deiminase type III)" PADI3 PAD3 PDI3 Homo sapiens (Human) histone citrullination [GO:0036414] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668]; histone citrullination [GO:0036414] GO:0004668; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0036414; GO:0042802 calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein-arginine deiminase activity [GO:0004668] ALLFQGVVDDEQVKTISINQVLSNKDLINYNK 0.99505 -8.8986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9518 0 0 0 0 0 0 0 0 0 0 0 0 10.0494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3257 0 0 0 0 0 0 0 0 0 0 0 0 0 14.049 13.0575 0 16.5376 0 0 0 14.7281 0 0 0 0 0 14.8381 14.4502 0 14.5879 0 0 0 15.909 15.491 14.7563 0 0 0 0 0 0 0 0 0 15.5486 0 14.8394 0 0 0 0 0 0 0 14.277 0 0 0 0 0 0 0 0 0 14.1699 0 0 14.6116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1015 Q9UPV7 PHF24_HUMAN PHD finger protein 24 PHF24 KIAA1045 Homo sapiens (Human) "detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]" "metal ion binding [GO:0046872]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]" GO:0007214; GO:0008277; GO:0032228; GO:0046872; GO:0050966 metal ion binding [GO:0046872] AQHSWFCK 0.99505 -11.252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7312 0 0 0 0 0 12.4735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y6N5 SQOR_HUMAN "Sulfide:quinone oxidoreductase, mitochondrial, SQOR, EC 1.8.5.8 (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)" SQOR SQRDL CGI-44 Homo sapiens (Human) "hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]" mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] "mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]" GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0070813; GO:0071949 FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224] CAGAPQK 0.99505 -15.425 12.8276 0 12.4913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5179 0 0 0 12.9242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3913 0 0 0 13.9279 0 0 Q9Y4F4 TGRM1_HUMAN TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B) TOGARAM1 FAM179B KIAA0423 Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116] GO:0000226; GO:0005815; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0008017; GO:0031116; GO:0035082; GO:0036064; GO:0060271; GO:0072686; GO:0090307; GO:1905515 microtubule binding [GO:0008017] AAAPSALLLLPPFPVLSTYRLQSRSR 0.99506 -31.902 0 0 0 13.5056 0 11.024 0 0 11.5204 0 14.583 12.315 0 14.1949 0 17.2748 17.4057 17.5204 16.3505 11.637 16.8734 16.5397 16.2195 0 15.895 16.1143 16.1559 15.027 14.3997 15.5233 0 13.6184 12.5968 0 0 14.6594 0 0 0 0 0 9.38137 16.8239 16.6795 16.8094 17.2791 17.2915 16.9548 15.5391 12.9684 14.4236 16.5035 17.6895 16.5279 14.8825 15.7067 0 0 15.454 15.2319 12.0922 16.2793 15.0918 14.4897 14.5305 11.0175 17.2384 16.7726 0 0 14.813 12.2163 15.5969 16.9953 0 0 13.7688 15.0252 15.5171 14.4629 13.2716 13.9506 13.7325 16.2691 13.9817 0 22.5954 0 21.1008 20.5315 13.7075 15.3208 20.6434 20.6485 18.7031 20.3942 23.0914 14.8845 23.1898 14.9705 0 0 0 19.9985 14.7418 16.4306 19.5571 18.8932 15.9594 18.6137 18.5281 12.6959 19.9425 19.8651 20.3032 19.8138 14.7589 19.5084 15.0714 19.888 19.8317 19.367 14.5105 20.451 0 14.336 0 0 0 15.0039 14.9045 0 13.6724 14.6122 20.0111 20.6764 15.321 20.2047 19.376 15.2353 19.3089 0 20.136 0 20.0139 0 19.2877 19.0934 19.0268 19.899 14.0699 13.9475 18.2661 14.0856 20.657 19.4084 13.9117 13.5387 13.8763 0 0 0 14.9955 0 14.292 14.7421 0 18.9982 18.1922 18.0675 17.6662 20.8146 20.7679 20.8469 20.1711 12.8978 20.9201 0 19.7084 18.932 O60240 PLIN1_HUMAN Perilipin-1 (Lipid droplet-associated protein) PLIN1 PERI PLIN Homo sapiens (Human) cellular response to cold [GO:0070417]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; lipid binding [GO:0008289]; cellular response to cold [GO:0070417]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629] GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0008289; GO:0016042; GO:0070417 lipid binding [GO:0008289] GLLGGVAHTLQK 0.99506 -12.557 0 0 0 0 0 0 0 12.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60894 RAMP1_HUMAN "Receptor activity-modifying protein 1 (Calcitonin-receptor-like receptor activity-modifying protein 1, CRLR activity-modifying protein 1)" RAMP1 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular protein transport [GO:0006886]; positive regulation of protein glycosylation [GO:0060050]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] amylin receptor complex 1 [GO:0150056]; cell surface [GO:0009986]; CGRP receptor complex [GO:1990406]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] amylin receptor complex 1 [GO:0150056]; cell surface [GO:0009986]; CGRP receptor complex [GO:1990406]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; amylin receptor activity [GO:0097643]; calcitonin gene-related peptide binding [GO:1990407]; calcitonin gene-related peptide receptor activity [GO:0001635]; coreceptor activity [GO:0015026]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; angiogenesis [GO:0001525]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; calcium ion transport [GO:0006816]; cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular protein transport [GO:0006886]; positive regulation of protein glycosylation [GO:0060050]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0001525; GO:0001635; GO:0005886; GO:0005887; GO:0006816; GO:0006886; GO:0007186; GO:0007189; GO:0008277; GO:0009986; GO:0015026; GO:0015031; GO:0031623; GO:0032870; GO:0043235; GO:0060050; GO:0072659; GO:0097643; GO:0097647; GO:0150056; GO:1990406; GO:1990407; GO:1990408 amylin receptor activity [GO:0097643]; calcitonin gene-related peptide binding [GO:1990407]; calcitonin gene-related peptide receptor activity [GO:0001635]; coreceptor activity [GO:0015026] ALCRLPR 0.99506 -8.9629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5735 12.3187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8499 12.0485 0 0 0 0 0 0 0 0 13.8272 0 0 0 0 0 0 0 0 0 0 0 0 0 P02675 FIBB_HUMAN Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain ] FGB Homo sapiens (Human) "adaptive immune response [GO:0002250]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; synapse [GO:0045202] "blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; fibrinogen complex [GO:0005577]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; synapse [GO:0045202]; chaperone binding [GO:0051087]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation, fibrin clot formation [GO:0072378]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592]" GO:0002250; GO:0005102; GO:0005198; GO:0005201; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005886; GO:0005938; GO:0007155; GO:0007160; GO:0009897; GO:0009986; GO:0031091; GO:0031093; GO:0031639; GO:0034116; GO:0042730; GO:0043152; GO:0044320; GO:0045087; GO:0045202; GO:0045907; GO:0045921; GO:0050714; GO:0051087; GO:0051258; GO:0051592; GO:0062023; GO:0065003; GO:0070062; GO:0070374; GO:0070527; GO:0071347; GO:0072378; GO:0072562; GO:0090277; GO:1900026; GO:1902042; GO:1903561; GO:2000352 chaperone binding [GO:0051087]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198] GHRPLDK 0.99506 -12.553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4484 0 0 0 0 0 0 0 10.4911 0 0 0 0 10.5418 0 0 0 0 0 0 0 14.2707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4469 0 0 0 0 0 0 10.2433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9176 0 0 0 0 0 0 0 0 11.9304 0 0 11.4205 12.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14867 GBRA1_HUMAN Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) GABRA1 Homo sapiens (Human) "chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202] "anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendrite membrane [GO:0032590]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; synaptic transmission, GABAergic [GO:0051932]" GO:0004890; GO:0005231; GO:0005237; GO:0005886; GO:0005887; GO:0007165; GO:0007214; GO:0007268; GO:0022851; GO:0030594; GO:0030659; GO:0032590; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0050877; GO:0051932; GO:0060078; GO:0070161; GO:0098794; GO:0098982; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862 excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; inhibitory extracellular ligand-gated ion channel activity [GO:0005237]; neurotransmitter receptor activity [GO:0030594]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] FKGPMTVLR 0.99506 -10.389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.133 0 0 15.3321 0 0 0 0 0 13.8754 0 13.933 0 13.3188 0 0 0 0 13.314 0 13.4743 0 0 0 0 0 0 0 0 0 0 12.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31512 FMO4_HUMAN "Dimethylaniline monooxygenase [N-oxide-forming] 4, EC 1.14.13.8 (Dimethylaniline oxidase 4) (Hepatic flavin-containing monooxygenase 4, FMO 4)" FMO4 FMO2 Homo sapiens (Human) energy homeostasis [GO:0097009]; negative regulation of fatty acid oxidation [GO:0046322]; xenobiotic catabolic process [GO:0042178] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; energy homeostasis [GO:0097009]; negative regulation of fatty acid oxidation [GO:0046322]; xenobiotic catabolic process [GO:0042178]" GO:0004497; GO:0004499; GO:0005789; GO:0016021; GO:0042178; GO:0046322; GO:0050660; GO:0050661; GO:0097009 "flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]" ATLAIIGLIGLKGSILSGTELQAR 0.99506 -5.5003 0 0 0 0 0 0 0 0 11.6234 0 0 0 0 0 0 0 0 0 0 0 10.4387 0 0 0 0 0 0 0 0 0 0 0 0 13.1062 13.2856 13.3157 13.5889 13.8595 13.5068 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6069 0 0 0 0 0 0 0 0 0 0 0 0 10.5342 0 0 0 0 0 0 0 0 11.0142 0 0 0 0 0 0 0 0 15.5451 15.1402 13.6124 0 0 0 0 0 12.5552 0 0 0 0 0 15.184 13.4934 0 0 11.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2961 0 0 0 0 0 0 14.371 0 0 0 0 0 12.5107 0 0 12.2515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7358 0 0 0 0 0 0 0 0 15.35 0 0 0 0 0 P35613 BASI_HUMAN "Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer, EMMPRIN) (Hepatoma-associated antigen, HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor, TCSF) (CD antigen CD147)" BSG UNQ6505/PRO21383 Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434] acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383] acrosomal membrane [GO:0002080]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434] GO:0000139; GO:0001525; GO:0001618; GO:0001750; GO:0001917; GO:0002080; GO:0003407; GO:0005537; GO:0005739; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0007156; GO:0007166; GO:0007411; GO:0007566; GO:0010575; GO:0010595; GO:0016020; GO:0016323; GO:0030424; GO:0030593; GO:0032755; GO:0038023; GO:0042383; GO:0042470; GO:0042475; GO:0043231; GO:0043434; GO:0045121; GO:0045296; GO:0045494; GO:0046598; GO:0046689; GO:0046697; GO:0051591; GO:0061154; GO:0070062; GO:0070593; GO:0072659; GO:0098632; GO:1904466 cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] ALMNGSESR 0.99506 -12.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1601 13.5418 0 14.7162 0 0 0 0 11.4089 10.9812 11.3959 0 0 0 0 0 0 12.7823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8569 0 14.965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P40394 ADH7_HUMAN "All-trans-retinol dehydrogenase [NAD(+)] ADH7, EC 1.1.1.105 (Alcohol dehydrogenase class 4 mu/sigma chain, EC 1.1.1.1) (Alcohol dehydrogenase class IV mu/sigma chain) (Gastric alcohol dehydrogenase) (Omega-hydroxydecanoate dehydrogenase ADH7, EC 1.1.1.66) (Retinol dehydrogenase)" ADH7 Homo sapiens (Human) ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572] cytosol [GO:0005829]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; plasma membrane [GO:0005886]; alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; aldehyde oxidase activity [GO:0004031]; ethanol binding [GO:0035276]; NAD-retinol dehydrogenase activity [GO:0004745]; omega-hydroxydecanoate dehydrogenase activity [GO:0050153]; receptor antagonist activity [GO:0048019]; retinol binding [GO:0019841]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069]; fatty acid omega-oxidation [GO:0010430]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; retinoic acid metabolic process [GO:0042573]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]" GO:0001523; GO:0004022; GO:0004024; GO:0004031; GO:0004745; GO:0005829; GO:0005886; GO:0006069; GO:0008270; GO:0009617; GO:0010430; GO:0019841; GO:0035276; GO:0042572; GO:0042573; GO:0045471; GO:0048019; GO:0050153 "alcohol dehydrogenase (NAD+) activity [GO:0004022]; alcohol dehydrogenase activity, zinc-dependent [GO:0004024]; aldehyde oxidase activity [GO:0004031]; ethanol binding [GO:0035276]; NAD-retinol dehydrogenase activity [GO:0004745]; omega-hydroxydecanoate dehydrogenase activity [GO:0050153]; receptor antagonist activity [GO:0048019]; retinol binding [GO:0019841]; zinc ion binding [GO:0008270]" IKILATGICR 0.99506 -11.277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0828 13.5707 13.6802 0 0 0 0 13.6995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7519 0 0 0 0 0 0 0 P45954 ACDSB_HUMAN "Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial, SBCAD, EC 1.3.8.5 (2-methyl branched chain acyl-CoA dehydrogenase, 2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase, 2-methylbutyryl-CoA dehydrogenase)" ACADSB Homo sapiens (Human) fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2-methyl-branched-chain-enoyl-CoA reductase activity [GO:0047119]; 2-methylacyl-CoA dehydrogenase activity [GO:0003853]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]; short-branched-chain-acyl-CoA dehydrogenase activity [GO:0016937]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550] GO:0003853; GO:0003995; GO:0005739; GO:0005759; GO:0006550; GO:0006631; GO:0016937; GO:0042802; GO:0047119; GO:0050660; GO:0102035 2-methyl-branched-chain-enoyl-CoA reductase activity [GO:0047119]; 2-methylacyl-CoA dehydrogenase activity [GO:0003853]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isobutyryl-CoA:FAD oxidoreductase activity [GO:0102035]; short-branched-chain-acyl-CoA dehydrogenase activity [GO:0016937] DTPGLHIGKPENKLGLR 0.99506 -10.391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9081 0 0 0 14.5074 0 0 0 0 0 15.2715 0 0 0 0 0 0 0 0 0 0 0 13.2369 14.1737 0 0 0 14.2627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4163 0 0 0 0 13.5639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2046 0 0 0 0 0 P61006 RAB8A_HUMAN "Ras-related protein Rab-8A, EC 3.6.5.2 (Oncogene c-mel)" RAB8A MEL RAB8 Homo sapiens (Human) "autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]" centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140] "centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein tyrosine kinase binding [GO:1990782]; small GTPase binding [GO:0031267]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]" GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0009306; GO:0010506; GO:0014069; GO:0017157; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031267; GO:0031489; GO:0032456; GO:0032588; GO:0032869; GO:0036064; GO:0043025; GO:0043197; GO:0043231; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0070062; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098969; GO:0098978; GO:0099003; GO:1990782 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein tyrosine kinase binding [GO:1990782]; small GTPase binding [GO:0031267] FMETSAK 0.99506 -11.288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05D60 DEUP1_HUMAN Deuterosome assembly protein 1 (Coiled-coil domain-containing protein 67) DEUP1 CCDC67 Homo sapiens (Human) cell projection organization [GO:0030030]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; multi-ciliated epithelial cell differentiation [GO:1903251] centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536] centriole [GO:0005814]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; identical protein binding [GO:0042802]; cell projection organization [GO:0030030]; centriole replication [GO:0007099]; de novo centriole assembly involved in multi-ciliated epithelial cell differentiation [GO:0098535]; multi-ciliated epithelial cell differentiation [GO:1903251] GO:0005737; GO:0005814; GO:0007099; GO:0030030; GO:0042802; GO:0098535; GO:0098536; GO:1903251 identical protein binding [GO:0042802] DEFIIEK 0.99506 -10.416 0 0 0 0 0 0 0 0 0 9.95096 0 0 10.7154 0 0 0 0 0 0 0 0 11.0042 17.1915 0 0 0 0 0 0 0 9.96417 0 0 0 0 9.75896 0 0 10.3137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7196 0 12.6199 0 0 0 0 0 0 0 0 0 0 0 0 0 10.219 0 0 11.3653 13.4728 0 0 14.0346 0 13.7882 0 14.1129 0 0 0 0 0 0 13.7413 0 0 0 0 0 0 0 15.3701 14.2101 0 0 0 13.7116 13.8054 0 13.8582 0 0 11.4805 0 0 0 0 0 13.964 0 11.4274 0 13.9698 0 13.5558 0 0 0 13.454 0 0 10.933 0 0 13.9173 0 0 0 0 0 0 0 0 13.581 13.5638 0 0 0 0 0 0 0 0 11.9317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q10570 CPSF1_HUMAN "Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit, CPSF 160 kDa subunit)" CPSF1 CPSF160 Homo sapiens (Human) mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789] GO:0005634; GO:0005654; GO:0005847; GO:0006378; GO:0019899; GO:0035925; GO:0098789 enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925] CAAMLVYGTR 0.99506 -9.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1719 0 0 0 0 0 0 12.4227 0 0 0 0 0 0 0 0 0 0 15.885 13.5051 0 0 0 0 0 0 0 0 0 0 0 13.5879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4969 0 0 12.6125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.23 0 0 0 0 0 11.3532 0 0 0 0 0 11.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15375 EPHA7_HUMAN "Ephrin type-A receptor 7, EC 2.7.10.1 (EPH homology kinase 3, EHK-3) (EPH-like kinase 11, EK11, hEK11)" EPHA7 EHK3 HEK11 Homo sapiens (Human) axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; neuron apoptotic process [GO:0051402]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685] dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; brain development [GO:0007420]; branching morphogenesis of a nerve [GO:0048755]; ephrin receptor signaling pathway [GO:0048013]; negative chemotaxis [GO:0050919]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of synapse assembly [GO:0051964]; nephric duct morphogenesis [GO:0072178]; neuron apoptotic process [GO:0051402]; phosphorylation [GO:0016310]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell-cell adhesion [GO:0022407]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of postsynapse organization [GO:0099175]; regulation of protein autophosphorylation [GO:0031952]; retinal ganglion cell axon guidance [GO:0031290]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001934; GO:0004713; GO:0004714; GO:0005004; GO:0005005; GO:0005524; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0007420; GO:0008046; GO:0016310; GO:0019838; GO:0022407; GO:0030425; GO:0031290; GO:0031594; GO:0031952; GO:0033674; GO:0043005; GO:0043025; GO:0043235; GO:0043281; GO:0043525; GO:0045499; GO:0046875; GO:0048013; GO:0048671; GO:0048755; GO:0050730; GO:0050919; GO:0051402; GO:0051964; GO:0070372; GO:0072178; GO:0098685; GO:0098686; GO:0098978; GO:0099061; GO:0099175 ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; chemorepellent activity [GO:0045499]; ephrin receptor binding [GO:0046875]; GPI-linked ephrin receptor activity [GO:0005004]; growth factor binding [GO:0019838]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] CECEDGYYR 0.99506 -12.572 0 0 0 0 0 0 0 0 11.6624 0 0 0 10.2917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.918 0 0 0 0 0 10.6722 0 0 0 11.2303 0 0 0 0 0 0 0 0 0 0 13.5944 0 0 0 0 14.9511 0 0 0 0 0 0 0 12.789 11.9375 0 0 0 0 12.3931 0 0 0 11.7036 0 0 0 0 0 14.718 0 0 0 0 0 0 0 13.2207 0 12.8698 0 13.4497 13.4426 0 0 0 0 10.8205 12.3957 0 11.767 0 0 12.3495 0 0 0 11.6422 0 0 11.0974 0 0 13.7168 12.3457 13.5543 0 13.6875 0 0 0 12.9488 0 0 0 0 13.3667 12.834 13.2962 12.5561 0 0 0 10.6668 13.7703 0 0 0 0 0 0 0 0 0 0 0 13.8474 11.9933 0 12.7188 0 0 0 13.6868 0 Q6PI78 TMM65_HUMAN Transmembrane protein 65 TMEM65 Homo sapiens (Human) cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779] integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779] GO:0003231; GO:0005739; GO:0005743; GO:0005886; GO:0014704; GO:0016021; GO:1903779 LLPLLRSRTAR 0.99506 -10.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6358 11.2207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6571 0 0 0 Q7Z3B3 KANL1_HUMAN "KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1, hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog)" KANSL1 CENP-36 KIAA1267 MSL1V1 NSL1 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]" histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000123; GO:0000776; GO:0005634; GO:0005654; GO:0006325; GO:0035035; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0051571; GO:0071339 histone acetyltransferase binding [GO:0035035] ANKGLIVLGEVPPPEHTTDLFLPLSSEVKTDHGTDK 0.99506 -31.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3627 0 0 0 0 12.5307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8627 13.4348 0 0 0 0 0 0 14.0928 0 13.0782 0 0 0 0 0 0 0 0 14.761 11.1143 0 14.6254 14.3931 0 17.6345 0 16.0562 0 15.6337 14.9832 13.8284 16.0651 14.0532 14.3594 0 10.7401 13.8408 0 0 0 0 0 15.2414 0 0 14.4772 12.3669 0 0 0 0 11.8807 13.7506 0 0 0 0 0 14.6874 0 13.5275 13.242 13.7386 0 16.5407 13.4418 0 0 0 0 14.7365 0 0 0 0 0 0 13.4493 0 15.4545 0 0 0 0 13.0539 12.4839 0 0 13.3708 14.0331 0 0 0 0 0 13.7094 0 13.0753 0 12.6922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3253 0 0 0 0 0 0 0 Q8IZS5 OFCC1_HUMAN Orofacial cleft 1 candidate gene 1 protein (Orofacial clefting chromosomal breakpoint region candidate 1 protein) OFCC1 MRDS1 Homo sapiens (Human) perinuclear region of cytoplasm [GO:0048471] perinuclear region of cytoplasm [GO:0048471] GO:0048471 EATEGTGNPAFNMSSPDLSACQTAEKKVIR 0.99506 -9.9753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8808 0 0 0 11.7383 0 0 0 12.0502 0 0 0 0 0 0 0 12.0173 0 0 0 0 0 0 0 13.2093 12.4675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0984 0 0 0 12.6999 0 0 0 0 12.8447 0 0 0 0 0 0 0 0 0 0 13.0371 0 13.7901 0 0 0 0 0 0 0 0 12.6916 0 0 0 14.1482 0 0 13.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0695 0 0 0 0 0 0 0 0 0 0 13.5369 13.8416 0 0 0 0 0 0 0 0 0 0 14.6635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1935 0 0 Q8N3L3 TXLNB_HUMAN "Beta-taxilin (Muscle-derived protein 77, hMDP77)" TXLNB C6orf198 MDP77 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; syntaxin binding [GO:0019905] GO:0005737; GO:0019905 syntaxin binding [GO:0019905] ALRAKEYECFVMK 0.99506 -32.164 0 0 0 0 0 0 0 0 0 0 11.4013 0 0 0 0 0 0 0 0 12.4394 0 0 0 0 0 11.4014 0 0 0 0 0 0 0 0 0 0 11.2308 13.1141 0 0 0 13.0797 0 0 0 0 0 0 0 0 0 0 11.6549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7667 14.1411 13.0166 0 0 0 0 0 0 11.9204 0 0 11.7535 0 0 13.7769 14.4805 14.279 11.5561 0 0 11.8894 0 0 0 0 12.0557 0 0 0 11.9169 0 14.9359 15.3955 0 0 0 14.3782 14.5476 12.9549 15.0832 13.8294 14.592 0 14.0972 0 14.2953 11.787 0 13.0617 0 0 12.9844 13.034 13.3238 13.1297 13.4009 12.5587 14.2101 14.2912 15.1947 14.5031 0 14.7152 13.9909 0 0 11.3315 14.559 0 0 12.6478 0 13.8519 0 13.8909 0 0 0 0 0 0 0 0 0 0 12.8297 0 0 0 12.5364 0 0 13.3098 0 0 11.3275 0 0 0 0 15.3729 Q8N7L0 F216B_HUMAN Protein FAM216B FAM216B C13orf30 Homo sapiens (Human) RCPSVLPVSVVLPRAQSK 0.99506 -8.9612 0 0 0 0 0 0 0 0 0 0 0 13.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4517 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9953 0 0 0 0 13.1052 0 0 0 0 0 0 0 0 0 10.6475 0 0 0 0 0 0 0 0 0 0 13.1974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5616 0 0 12.4712 0 0 0 0 0 0 0 0 0 0 0 0 12.9167 0 0 Q8NDV2 GPR26_HUMAN G-protein coupled receptor 26 GPR26 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] EILNRLLHR 0.99506 -9.9785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9825 0 0 0 0 14.6674 13.5214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0456 0 0 0 0 0 0 0 13.1964 0 0 0 0 0 0 0 0 0 13.0613 12.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0149 0 0 0 12.4517 12.5812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4P4 RNF41_HUMAN "E3 ubiquitin-protein ligase NRDP1, EC 2.3.2.27 (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1)" RNF41 FLRF NRDP1 SBBI03 Homo sapiens (Human) autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377] cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; identical protein binding [GO:0042802]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377] GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0005829; GO:0006914; GO:0008270; GO:0008285; GO:0010498; GO:0016567; GO:0019904; GO:0030336; GO:0030971; GO:0031267; GO:0042802; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000377; GO:2000379 erythropoietin receptor binding [GO:0005128]; identical protein binding [GO:0042802]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] PVPRIMR 0.99506 -9.9811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0103 0 0 0 16.0518 0 0 0 13.3982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZI6 TF2L1_HUMAN "Transcription factor CP2-like protein 1 (CP2-related transcriptional repressor 1, CRTR-1) (Transcription factor LBP-9)" TFCP2L1 CRTR1 LBP9 Homo sapiens (Human) cell morphogenesis [GO:0000902]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; epithelial cell maturation [GO:0002070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of growth [GO:0045927]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431] chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell morphogenesis [GO:0000902]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; epithelial cell maturation [GO:0002070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of growth [GO:0045927]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]" GO:0000122; GO:0000785; GO:0000902; GO:0000978; GO:0000981; GO:0001228; GO:0002070; GO:0005634; GO:0005737; GO:0006357; GO:0007028; GO:0007431; GO:0008340; GO:0016020; GO:0045927; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" GRNVRPK 0.99506 -11.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4375 12.4084 0 0 0 13.7491 0 0 0 0 12.1163 0 0 13.6733 0 0 0 0 11.5428 0 0 0 0 0 11.9823 0 13.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 12.409 0 0 0 0 0 0 0 0 0 0 12.764 0 0 0 0 0 0 12.7007 0 0 0 0 14.0104 0 15.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2D5 AKAP2_HUMAN "A-kinase anchor protein 2, AKAP-2 (AKAP-KL) (Protein kinase A-anchoring protein 2, PRKA2)" AKAP2 KIAA0920 PRKA2 Homo sapiens (Human) DGEFTLTTLKK 0.99506 -12.556 0 0 0 0 0 0 0 0 0 0 0 0 0 12.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1253 0 0 0 0 0 0 0 13.2975 13.2975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1917 14.3756 0 0 0 13.428 13.3271 0 0 0 0 9.00927 0 0 0 0 0 0 0 0 0 0 0 0 14.6599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95456 Q9Y4F1 FARP1_HUMAN "FERM, ARHGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (FERM, RhoGEF and pleckstrin domain-containing protein 1) (Pleckstrin homology domain-containing family C member 2, PH domain-containing family C member 2)" FARP1 CDEP PLEKHC2 Homo sapiens (Human) dendrite morphogenesis [GO:0048813]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416] anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978] anchoring junction [GO:0070161]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; dendrite morphogenesis [GO:0048813]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of presynapse assembly [GO:1905606]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; synapse assembly [GO:0007416] GO:0005085; GO:0005829; GO:0005856; GO:0007416; GO:0008092; GO:0030175; GO:0030425; GO:0031234; GO:0031267; GO:0043197; GO:0048813; GO:0070161; GO:0098890; GO:0098942; GO:0098974; GO:0098978; GO:1905606 cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] DYVFKLHFK 0.99506 -10.382 0 0 0 0 0 0 11.2374 0 0 0 0 0 0 0 0 0 0 0 14.2055 0 0 0 0 0 0 0 0 0 0 0 0 0 8.58676 12.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3708 12.4876 0 0 0 0 0 0 11.4119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4541 13.3941 0 0 0 0 0 0 11.8346 0 12.8529 0 0 0 0 0 0 0 0 0 0 0 9.65172 0 0 0 0 0 0 0 11.0288 11.1199 0 0 0 12.9882 0 0 0 0 0 0 0 13.099 0 0 0 0 0 0 0 0 0 0 0 0 12.4064 0 0 14.4234 0 0 0 0 0 0 0 0 0 0 0 0 11.1339 0 11.5595 0 11.3602 0 0 0 0 0 15.4844 0 0 12.606 13.1004 13.3654 13.4998 0 0 0 11.6996 0 0 0 0 0 0 0 0 Q9Y5E5 PCDB4_HUMAN "Protocadherin beta-4, PCDH-beta-4" PCDHB4 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] LQLDRQTGDLLLREK 0.99506 -11.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4878 0 0 12.7124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7918 0 0 0 0 0 0 0 14.939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2131 0 0 0 0 0 0 0 0 A8MYU2 KCNU1_HUMAN "Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)" KCNU1 KCNMA3 KCNMC1 SLO3 Homo sapiens (Human) regulation of ion transmembrane transport [GO:0034765]; reproductive process [GO:0022414] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765]; reproductive process [GO:0022414] GO:0005244; GO:0005267; GO:0005886; GO:0016021; GO:0022414; GO:0034765 potassium channel activity [GO:0005267]; voltage-gated ion channel activity [GO:0005244] AIKTSNSVKFSK 0.99507 -8.9816 0 0 12.8162 0 0 0 0 0 10.8123 0 0 15.9953 17.6143 0 0 0 0 0 0 0 0 0 13.4501 0 13.8598 11.1993 0 0 13.8076 0 14.5135 17.0025 0 0 0 14.8898 0 16.6448 0 0 12.981 14.0718 16.8999 0 0 0 17.3753 0 16.0718 15.5293 15.3645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2371 10.5769 0 0 11.213 0 9.96052 0 0 0 0 0 0 0 9.97728 0 0 14.6462 0 0 0 0 0 0 0 0 0 13.0807 12.3224 0 0 0 0 0 13.4602 0 12.8733 10.1303 0 0 0 0 14.0211 0 13.381 0 0 0 13.4805 0 0 0 0 13.613 0 0 0 0 0 0 0 0 0 0 0 10.423 14.7079 0 12.9256 0 0 12.9397 0 10.5728 0 0 0 0 13.1752 0 0 0 0 0 12.2173 0 0 0 0 13.4407 13.22 0 0 0 0 0 12.0778 14.5945 0 0 12.7484 0 12.5416 0 9.62905 0 0 0 0 13.1115 0 0 P04196 HRG_HUMAN "Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein, HPRG)" HRG Homo sapiens (Human) angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; chemotaxis [GO:0006935]; cytolysis by host of symbiont cells [GO:0051838]; defense response to fungus [GO:0050832]; fibrinolysis [GO:0042730]; heme transport [GO:0015886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel remodeling [GO:2000504]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of immune response to tumor cell [GO:0002839]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of blood coagulation [GO:0030193]; regulation of gene expression [GO:0010468]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of platelet activation [GO:0010543]; regulation of protein-containing complex assembly [GO:0043254] blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endolysosome [GO:0036019]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093] blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endolysosome [GO:0036019]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; heme binding [GO:0020037]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; immunoglobulin binding [GO:0019865]; metal ion binding [GO:0046872]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; chemotaxis [GO:0006935]; cytolysis by host of symbiont cells [GO:0051838]; defense response to fungus [GO:0050832]; fibrinolysis [GO:0042730]; heme transport [GO:0015886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel remodeling [GO:2000504]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of immune response to tumor cell [GO:0002839]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of blood coagulation [GO:0030193]; regulation of gene expression [GO:0010468]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of platelet activation [GO:0010543]; regulation of protein-containing complex assembly [GO:0043254] GO:0001525; GO:0002839; GO:0004866; GO:0004867; GO:0004869; GO:0005102; GO:0005576; GO:0005886; GO:0006935; GO:0007162; GO:0008201; GO:0008270; GO:0008285; GO:0009986; GO:0010468; GO:0010543; GO:0010593; GO:0010951; GO:0015886; GO:0016525; GO:0019865; GO:0020037; GO:0030168; GO:0030193; GO:0030308; GO:0031093; GO:0032956; GO:0033629; GO:0036019; GO:0042730; GO:0043065; GO:0043254; GO:0043395; GO:0043537; GO:0046872; GO:0050730; GO:0050832; GO:0051838; GO:0051894; GO:0051918; GO:0061844; GO:0062023; GO:0070062; GO:0072562; GO:1900747; GO:2000504; GO:2001027 cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; heme binding [GO:0020037]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; immunoglobulin binding [GO:0019865]; metal ion binding [GO:0046872]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270] GPGKGPR 0.99507 -8.6988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.902 0 0 0 0 0 0 0 0 0 17.3728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0269 0 0 0 0 0 0 0 0 0 15.8935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06710 PAX8_HUMAN Paired box protein Pax-8 PAX8 Homo sapiens (Human) "anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to gonadotropin stimulus [GO:0071371]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric nephron tubule formation [GO:0072289]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; otic vesicle development [GO:0071599]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of thyroid-stimulating hormone secretion [GO:2000612]; regulation of transcription by RNA polymerase II [GO:0006357]; sulfur compound metabolic process [GO:0006790]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventricular septum development [GO:0003281]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid-stimulating hormone receptor activity [GO:0004996]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular response to gonadotropin stimulus [GO:0071371]; central nervous system development [GO:0007417]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesonephros development [GO:0001823]; metanephric comma-shaped body morphogenesis [GO:0072278]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric nephron tubule formation [GO:0072289]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; otic vesicle development [GO:0071599]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of thyroid hormone generation [GO:2000611]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; regulation of apoptotic process [GO:0042981]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of thyroid-stimulating hormone secretion [GO:2000612]; regulation of transcription by RNA polymerase II [GO:0006357]; sulfur compound metabolic process [GO:0006790]; thyroid gland development [GO:0030878]; transcription, DNA-templated [GO:0006351]; urogenital system development [GO:0001655]; ventricular septum development [GO:0003281]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001655; GO:0001658; GO:0001822; GO:0001823; GO:0003281; GO:0003337; GO:0003677; GO:0003700; GO:0004996; GO:0005634; GO:0005654; GO:0006351; GO:0006357; GO:0006790; GO:0007417; GO:0009653; GO:0010667; GO:0030878; GO:0039003; GO:0042472; GO:0042981; GO:0045893; GO:0045944; GO:0048793; GO:0048856; GO:0071371; GO:0071599; GO:0072108; GO:0072207; GO:0072221; GO:0072278; GO:0072284; GO:0072289; GO:0072305; GO:0072307; GO:0090190; GO:1900212; GO:1900215; GO:1900218; GO:1990837; GO:2000594; GO:2000611; GO:2000612 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; thyroid-stimulating hormone receptor activity [GO:0004996]; transcription cis-regulatory region binding [GO:0000976]" KHLRTDAFSQHHLEPLECPFER 0.99507 -10.453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0414 13.8984 13.9647 14.4266 15.2262 17.7588 0 14.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7625 0 0 0 0 0 0 0 13.4961 0 0 12.9895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13487 SNPC2_HUMAN "snRNA-activating protein complex subunit 2, SNAPc subunit 2 (Proximal sequence element-binding transcription factor subunit delta, PSE-binding factor subunit delta, PTF subunit delta) (Small nuclear RNA-activating complex polypeptide 2) (snRNA-activating protein complex 45 kDa subunit, SNAPc 45 kDa subunit)" SNAPC2 SNAP45 Homo sapiens (Human) snRNA transcription [GO:0009301]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; snRNA transcription [GO:0009301]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] GO:0005634; GO:0005654; GO:0005829; GO:0006366; GO:0006383; GO:0009301; GO:0016251; GO:0016604 RNA polymerase II general transcription initiation factor activity [GO:0016251] PPKPTQARGK 0.99507 -10.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8083 0 0 13.8151 0 14.5745 14.4847 14.3932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0284 0 0 14.8472 12.6778 0 0 0 0 12.6615 13.2039 0 0 0 0 0 0 0 0 0 0 12.951 0 13.2149 0 0 0 0 0 0 0 0 0 13.9419 0 12.4828 0 0 0 12.6001 0 12.791 0 0 0 13.1358 0 0 11.9714 14.4807 12.3375 13.1287 0 0 14.1898 12.9197 0 11.3608 0 0 0 12.7664 13.0136 0 0 13.8423 0 0 0 0 0 0 0 0 0 14.2101 0 0 0 0 15.1033 0 0 0 0 0 0 0 0 0 11.254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q17RS7 GEN_HUMAN "Flap endonuclease GEN homolog 1, EC 3.1.-.-" GEN1 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139] centrosome [GO:0005813]; nucleoplasm [GO:0005654] centrosome [GO:0005813]; nucleoplasm [GO:0005654]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; resolution of recombination intermediates [GO:0071139] GO:0000287; GO:0000400; GO:0000724; GO:0005654; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0042803; GO:0071139; GO:0071140; GO:0090267 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803] ACCCEGFPFHEVIQEFLLNK 0.99507 -32.23 0 0 0 0 0 0 0 0 12.0029 12.0666 0 0 11.7524 0 11.0539 0 0 0 0 0 0 0 0 0 0 0 0 10.4497 0 0 11.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8119 11.9404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9877 0 12.856 0 0 0 0 0 0 14.4138 11.8082 13.6867 15.7251 0 0 14.9441 13.5264 0 0 0 14.1071 12.3256 13.8049 12.5392 14.5079 12.8738 0 0 0 0 0 0 0 16.1638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7221 0 0 14.8204 0 12.7158 0 0 0 13.0577 0 0 13.1955 0 0 0 0 0 0 0 0 10.2088 0 0 13.2406 0 0 0 11.7004 0 0 0 0 0 0 0 0 0 0 12.6994 14.3829 13.3336 12.6828 0 0 0 12.7782 15.1909 0 12.4981 0 0 0 0 0 0 0 0 15.1183 Q53S58 TM177_HUMAN Transmembrane protein 177 TMEM177 Homo sapiens (Human) integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305] integral component of membrane [GO:0016021]; integral component of mitochondrial inner membrane [GO:0031305] GO:0016021; GO:0031305 EAQKFALAR 0.99507 -8.9784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.514 0 0 0 0 0 0 13.066 0 0 0 0 0 0 13.4847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2975 0 0 0 0 0 0 12.108 0 11.5817 0 0 0 0 0 0 0 0 13.2881 0 0 0 0 0 0 0 0 0 0 0 0 12.515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q56P03 EAPP_HUMAN "E2F-associated phosphoprotein, EAPP" EAPP C14orf11 BM-036 Homo sapiens (Human) negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968] GO:0005634; GO:0005737; GO:0008284; GO:0032968; GO:0034244 AVQVTKK 0.99507 -10.463 17.9596 0 0 0 0 12.4148 0 14.6587 18.2458 18.5515 17.2633 18.4661 16.3313 0 0 19.9647 19.9008 19.9488 20.01 20.0091 20.2393 17.5984 19.4533 18.5758 19.657 19.8297 18.1539 18.3905 18.979 16.9613 0 14.0811 0 0 0 0 14.6169 0 0 0 18.3583 16.7365 16.3502 19.0564 19.7549 18.616 0 0 0 13.932 17.7866 15.5844 15.8317 0 16.1088 16.0993 0 12.9004 12.4354 0 14.8397 14.6315 15.1975 0 12.6803 12.5695 0 0 0 0 0 11.5041 0 0 0 19.3846 19.4114 19.6471 18.8885 19.8515 20.0387 21.3308 16.6953 16.4557 16.5152 16.4336 16.4836 16.6064 16.4385 15.928 16.6234 16.6995 16.3157 0 15.9769 16.1861 16.3028 16.8002 0 18.153 17.4911 17.8342 18.138 18.4328 0 16.6806 17.2432 17.4923 17.9678 18.3005 18.8645 10.234 19.0006 0 17.4022 17.2094 18.3435 18.288 18.3987 18.3474 18.5311 17.2069 17.3764 17.1376 0 17.498 17.0421 18.1161 17.9155 19.5168 16.1348 18.5842 19.7471 19.5129 18.8749 19.5757 19.2564 17.7796 19.4722 19.3796 20.0207 17.8314 17.8841 19.2622 19.085 18.5629 19.7538 19.8219 19.8168 20.3179 19.0289 19.0077 0 17.3614 19.9263 19.9448 17.2306 0 0 0 0 0 0 0 14.1897 16.1682 0 18.7527 0 0 0 17.0096 17.6254 17.7711 18.1024 16.5509 15.4847 0 16.6887 0 Q5TAB7 RIPP2_HUMAN Protein ripply2 RIPPLY2 C6orf159 Homo sapiens (Human) bone morphogenesis [GO:0060349]; determination of left/right symmetry [GO:0007368]; embryonic pattern specification [GO:0009880]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; ossification [GO:0001503]; post-anal tail morphogenesis [GO:0036342]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756] nucleus [GO:0005634] nucleus [GO:0005634]; bone morphogenesis [GO:0060349]; determination of left/right symmetry [GO:0007368]; embryonic pattern specification [GO:0009880]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; ossification [GO:0001503]; post-anal tail morphogenesis [GO:0036342]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756] GO:0000122; GO:0001503; GO:0001756; GO:0005634; GO:0007219; GO:0007368; GO:0009880; GO:0032525; GO:0036342; GO:0060349 HPVRLFWPK 0.99507 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6YP21 KAT3_HUMAN "Kynurenine--oxoglutarate transaminase 3, EC 2.6.1.7 (Cysteine-S-conjugate beta-lyase 2, EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III, KATIII) (Kynurenine--glyoxylate transaminase, EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III)" KYAT3 CCBL2 KAT3 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053] cytoplasm [GO:0005737]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053] GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053 cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723] AWSVQKS 0.99507 -10.466 0 0 0 0 0 0 0 0 0 0 12.733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4234 0 0 0 0 0 0 12.6143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9129 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WZ6 ZN227_HUMAN Zinc finger protein 227 ZNF227 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDICDKDFR 0.99507 -11.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1263 0 0 0 0 0 0 0 0 12.0935 12.9815 0 0 14.0958 0 14.1189 0 14.077 14.1057 0 12.6577 0 0 0 0 13.2212 13.27 0 10.6804 11.5415 0 12.8008 0 0 12.7171 0 10.2097 0 0 0 9.8276 0 0 0 0 0 0 12.352 12.6358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.321 0 0 0 0 0 12.1047 0 0 0 0 0 0 13.4163 0 0 0 0 14.4473 0 12.5271 0 13.2786 0 0 0 0 0 0 0 0 0 Q8NET4 RTL9_HUMAN Retrotransposon Gag-like protein 9 (Retrotransposon gag domain-containing protein 1) (Tumor antigen BJ-HCC-23) RTL9 KIAA1318 RGAG1 Homo sapiens (Human) ATASGCGMGMSMPQMTATDSR 0.99507 -12.608 0 0 0 0 0 0 0 0 0 0 13.7141 0 0 0 0 0 0 0 0 0 11.8895 0 0 0 0 11.1351 0 0 0 0 0 0 0 12.1204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8618 0 0 0 13.4875 12.4386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0735 0 0 0 0 12.3194 11.2741 0 11.2329 0 0 0 0 0 0 0 0 0 0 0 0 11.5355 0 0 0 0 0 0 11.5459 0 0 0 0 13.3868 0 0 0 0 0 0 0 Q8NG80 OR2L5_HUMAN Olfactory receptor 2L5 (Olfactory receptor 2L11) (Olfactory receptor OR1-53) OR2L5 OR2L11 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] SLRSLTEDK 0.99507 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q93045 STMN2_HUMAN "Stathmin-2 (Superior cervical ganglion-10 protein, Protein SCG10)" STMN2 SCG10 SCGN10 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; microtubule depolymerization [GO:0007019]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; calcium-dependent protein binding [GO:0048306]; tubulin binding [GO:0015631]; cellular response to nerve growth factor stimulus [GO:1990090]; microtubule depolymerization [GO:0007019]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0005737; GO:0005768; GO:0005794; GO:0005829; GO:0007019; GO:0007026; GO:0010976; GO:0010977; GO:0015631; GO:0016020; GO:0030027; GO:0030426; GO:0031110; GO:0031115; GO:0031117; GO:0031175; GO:0043005; GO:0043025; GO:0048306; GO:0048471; GO:1990090 calcium-dependent protein binding [GO:0048306]; tubulin binding [GO:0015631] KDLSLEEIQKK 0.99507 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96CQ1 S2536_HUMAN Solute carrier family 25 member 36 SLC25A36 Homo sapiens (Human) mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; pyrimidine nucleotide transmembrane transporter activity [GO:0015218]; mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881] GO:0000002; GO:0005739; GO:0005743; GO:0006864; GO:0007005; GO:0015218; GO:0016021; GO:0051881; GO:1990519 pyrimidine nucleotide transmembrane transporter activity [GO:0015218] GLGPNLVGVAPSRAIYFAAYSNCK 0.99507 -8.6997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9708 0 0 0 0 0 0 10.6502 0 0 16.8819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96Q04 LMTK3_HUMAN "Serine/threonine-protein kinase LMTK3, EC 2.7.11.1 (Lemur tyrosine kinase 3)" LMTK3 KIAA1883 TYKLM3 Homo sapiens (Human) protein phosphorylation [GO:0006468] axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0016021; GO:0030424; GO:0030425; GO:0046872; GO:0106310 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DLRTLQR 0.99507 -32.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4965 0 12.6582 0 0 0 0 0 0 0 0 13.0286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0321 0 0 0 0 0 0 0 0 0 15.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9813 0 0 0 0 0 0 0 0 13.2922 0 0 0 0 0 0 0 13.3856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96Q27 ASB2_HUMAN "Ankyrin repeat and SOCS box protein 2, ASB-2" ASB2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; dendritic cell migration [GO:0036336]; heart looping [GO:0001947]; intracellular signal transduction [GO:0035556]; podosome assembly [GO:0071800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle cell differentiation [GO:0035914]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; cullin family protein binding [GO:0097602]; actin cytoskeleton reorganization [GO:0031532]; cardiac muscle cell development [GO:0055013]; cardiac muscle cell differentiation [GO:0055007]; dendritic cell migration [GO:0036336]; heart looping [GO:0001947]; intracellular signal transduction [GO:0035556]; podosome assembly [GO:0071800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle cell differentiation [GO:0035914]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0001947; GO:0005829; GO:0005856; GO:0006511; GO:0007165; GO:0014732; GO:0016567; GO:0030018; GO:0031532; GO:0035556; GO:0035914; GO:0036336; GO:0043161; GO:0055007; GO:0055013; GO:0071800; GO:0097602 cullin family protein binding [GO:0097602] APMGLFQGVMQKYSSSLFK 0.99507 -10.447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2246 0 0 0 0 0 0 14.1072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6442 0 0 0 0 0 17.6415 0 0 0 0 12.314 11.0995 14.3004 10.8012 0 0 0 0 0 15.7958 0 0 13.5746 13.1645 0 0 0 0 0 0 13.6468 0 12.2311 0 0 0 0 0 0 0 0 14.8463 13.1438 0 0 0 0 0 0 9.52576 0 0 0 0 0 0 10.1404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9708 0 0 0 0 0 0 14.0347 0 0 0 12.126 0 Q9H0A0 NAT10_HUMAN "RNA cytidine acetyltransferase, EC 2.3.1.- (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein, hALP)" NAT10 ALP KIAA1709 Homo sapiens (Human) negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391] "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391]" GO:0000049; GO:0000154; GO:0000781; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006473; GO:0008080; GO:0010824; GO:0016020; GO:0030496; GO:0032211; GO:0045727; GO:0051391; GO:0070182; GO:0106162; GO:1904812; GO:1990883 ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049] ELKESLQDTQPVGVLVDCCKTLDQAK 0.99507 -10.465 0 0 0 0 0 11.551 0 0 0 0 0 9.75797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0584 0 0 0 0 0 0 13.0421 0 0 0 0 13.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7676 0 0 0 0 0 0 0 0 0 11.6556 0 0 0 0 0 0 14.5584 0 0 0 0 0 0 0 12.9785 12.144 0 0 0 0 0 0 14.5018 0 13.7309 0 14.2562 12.0652 13.4539 12.0059 0 0 0 13.3496 12.2181 0 0 0 0 0 0 0 0 0 0 0 0 12.4322 0 14.5444 Q9HCE5 MET14_HUMAN "N6-adenosine-methyltransferase non-catalytic subunit (Methyltransferase-like protein 14, hMETTL14)" METTL14 KIAA1627 Homo sapiens (Human) "forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]" GO:0000398; GO:0003729; GO:0005634; GO:0005654; GO:0006402; GO:0007283; GO:0016422; GO:0019827; GO:0021861; GO:0036396; GO:0042063; GO:0045727; GO:0061157; GO:0080009; GO:1901533 mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA binding [GO:0003729] DVGLADR 0.99507 -10.706 0 0 0 0 14.5846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4807 12.4974 13.3759 0 11.0173 0 0 0 0 0 0 14.0509 0 0 13.066 0 0 0 0 0 13.633 0 0 14.0571 0 0 0 0 0 0 0 0 0 0 0 13.6273 Q9ULQ1 TPC1_HUMAN Two pore channel protein 1 (Two pore calcium channel protein 1) (Voltage-dependent calcium channel protein TPC1) TPCN1 KIAA1169 TPC1 Homo sapiens (Human) endocytosis involved in viral entry into host cell [GO:0075509]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765] early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; recycling endosome membrane [GO:0055038] "early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; recycling endosome membrane [GO:0055038]; identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; endocytosis involved in viral entry into host cell [GO:0075509]; ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508]; regulation of ion transmembrane transport [GO:0034765]" GO:0005244; GO:0005248; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0010508; GO:0015280; GO:0016021; GO:0019905; GO:0031901; GO:0034220; GO:0034765; GO:0036019; GO:0042802; GO:0042803; GO:0055038; GO:0072345; GO:0075509; GO:0080025; GO:0097682 "identical protein binding [GO:0042802]; intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]" FKSLLLHK 0.99507 -12.195 0 0 0 0 0 0 0 0 17.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.428 0 16.3278 0 0 0 0 0 0 0 0 0 0 0 0 16.3054 0 13.7841 0 0 16.2328 0 0 0 0 0 16.1528 16.0047 0 0 0 0 0 0 0 0 0 0 0 14.9142 0 14.7182 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2352 0 0 0 0 13.515 0 0 14.3576 0 0 0 0 0 0 0 13.3098 0 10.6045 0 0 0 0 13.8405 0 0 0 13.8706 0 0 0 0 13.7025 0 0 0 0 0 0 0 0 15.0182 0 0 0 0 0 0 13.2373 0 13.6798 0 13.3911 0 11.9995 0 13.5442 0 13.7987 0 0 0 0 13.4441 0 0 0 0 0 0 0 14.2335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3031 0 0 11.6719 0 0 0 0 0 0 0 0 Q9Y5P0 O51B4_HUMAN Olfactory receptor 51B4 (Odorant receptor HOR5'beta1) OR51B4 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LFSGQSR 0.99507 -11.371 0 0 0 0 0 0 0 0 0 0 0 12.3111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5909 0 0 0 0 13.4193 0 12.939 0 0 0 0 0 0 0 0 0 0 0 0 13.2254 0 0 12.6116 0 0 0 0 0 13.0637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7518 0 0 0 0 0 0 0 0 O14617 AP3D1_HUMAN AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin) AP3D1 PRO0039 Homo sapiens (Human) "anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195] "AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]" GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0006623; GO:0006886; GO:0006896; GO:0008089; GO:0010008; GO:0016020; GO:0016182; GO:0016183; GO:0016192; GO:0030123; GO:0032438; GO:0035646; GO:0035654; GO:0036465; GO:0043195; GO:0045944; GO:0046907; GO:0048007; GO:0048490; GO:0048499; GO:0051138; GO:0060155; GO:0061088; GO:0072657; GO:0098794; GO:0098830; GO:0098943; GO:0098978; GO:1903232; GO:1904115 AEGTTYR 0.99508 -12.222 0 0 0 0 0 0 0 0 0 16.3193 0 0 0 0 0 0 0 0 0 0 0 15.5974 0 0 0 0 0 0 0 0 0 0 0 0 16.9711 0 0 0 0 0 12.9385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1233 13.3464 13.3333 0 0 18.7579 0 0 0 0 18.921 0 0 0 0 0 17.1851 0 0 18.8397 12.243 0 0 0 18.3667 0 0 12.6566 19.1556 0 0 0 0 0 0 14.6946 0 18.7894 18.2222 18.2631 18.3111 0 0 0 18.4797 0 0 18.4644 0 0 0 0 0 0 0 0 18.8998 18.9284 0 0 0 0 0 0 0 0 0 0 0 0 18.5928 0 0 0 0 0 0 17.5708 17.5724 17.54 0 17.6331 0 17.6186 0 0 0 17.4963 0 0 0 0 0 0 0 14.1568 0 17.6697 P17096 HMGA1_HUMAN "High mobility group protein HMG-I/HMG-Y, HMG-I(Y) (High mobility group AT-hook protein 1, High mobility group protein A1) (High mobility group protein R)" HMGA1 HMGIY Homo sapiens (Human) "base-excision repair [GO:0006284]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; oncogene-induced cell senescence [GO:0090402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; transcription regulator complex [GO:0005667]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; enzyme binding [GO:0019899]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; structural constituent of chromatin [GO:0030527]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221]; base-excision repair [GO:0006284]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome disassembly [GO:0006337]; oncogene-induced cell senescence [GO:0090402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000987; GO:0001221; GO:0003677; GO:0003680; GO:0003682; GO:0003712; GO:0003713; GO:0003906; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0005925; GO:0006268; GO:0006284; GO:0006337; GO:0006355; GO:0008285; GO:0019899; GO:0030374; GO:0030527; GO:0035985; GO:0042974; GO:0042975; GO:0045892; GO:0045893; GO:0045944; GO:0046965; GO:0051575; GO:0090402; GO:0090575 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; enzyme binding [GO:0019899]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; peroxisome proliferator activated receptor binding [GO:0042975]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; structural constituent of chromatin [GO:0030527]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription coregulator binding [GO:0001221] NKGAAKTR 0.99508 -12.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7168 0 0 0 14.1206 14.5119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.921 0 0 0 0 0 0 0 0 0 13.0275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1321 0 0 0 0 0 0 0 0 P50443 S26A2_HUMAN Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2) SLC26A2 DTD DTDST Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; ion transport [GO:0006811]; ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; ion transport [GO:0006811]; ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358] GO:0001503; GO:0005886; GO:0005887; GO:0006811; GO:0008271; GO:0015106; GO:0015108; GO:0015116; GO:0015301; GO:0016020; GO:0016324; GO:0019531; GO:0031528; GO:0050428; GO:0070062; GO:1902358 anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116] APIPIELVVVVAATLASHFGK 0.99508 -10.474 0 0 0 0 0 0 0 0 0 0 0 0 14.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7868 0 0 0 0 0 0 12.7841 0 0 0 12.6748 0 0 0 0 0 0 0 0 0 12.7582 0 0 0 0 0 0 0 0 11.3619 0 0 0 0 13.7429 0 0 0 0 0 14.416 0 0 0 0 0 0 13.0605 12.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4201 0 0 0 0 0 0 0 12.5459 0 0 0 0 0 12.4463 0 0 0 0 0 13.5358 0 0 0 13.4265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8434 0 0 0 12.2043 0 0 P83105 HTRA4_HUMAN "Serine protease HTRA4, EC 3.4.21.- (High-temperature requirement factor A4)" HTRA4 Homo sapiens (Human) negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] extracellular region [GO:0005576] extracellular region [GO:0005576]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508] GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0012501; GO:0030512; GO:0042802; GO:0043065 endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252] AARRLGK 0.99508 -10.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.661 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4W4Y0 CN028_HUMAN Uncharacterized protein C14orf28 (Dopamine receptor-interacting protein 1) C14orf28 DRIP1 Homo sapiens (Human) LLWIWDKMEK 0.99508 -11.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2213 13.5827 13.7753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4842 0 0 0 0 0 0 0 0 13.4286 15.6276 0 0 0 0 0 13.5608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8044 0 0 0 0 13.6029 0 0 0 0 14.6371 0 0 0 0 13.719 0 14.0447 13.1922 0 0 14.0115 0 14.3715 0 0 13.3295 0 0 13.5155 0 0 13.6503 0 0 0 0 0 0 14.7137 15.3633 0 0 0 0 0 15.1808 0 0 0 0 0 0 0 0 0 Q5JPH6 SYEM_HUMAN "Probable glutamate--tRNA ligase, mitochondrial, EC 6.1.1.17 (Glutamyl-tRNA synthetase, GluRS)" EARS2 KIAA1970 Homo sapiens (Human) glutamyl-tRNA aminoacylation [GO:0006424]; tRNA aminoacylation for mitochondrial protein translation [GO:0070127] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamate-tRNA(Gln) ligase activity [GO:0050561]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; glutamyl-tRNA aminoacylation [GO:0006424]; tRNA aminoacylation for mitochondrial protein translation [GO:0070127] GO:0000049; GO:0004818; GO:0005524; GO:0005739; GO:0005759; GO:0006424; GO:0008270; GO:0050561; GO:0070127 ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; glutamate-tRNA(Gln) ligase activity [GO:0050561]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270] AALLRRLLQR 0.99508 -11.041 11.4657 0 14.5623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7041 0 0 13.4852 0 0 12.4202 0 0 0 0 0 0 0 12.565 0 12.8906 13.1927 0 12.9537 13.7686 14.035 0 0 13.193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1449 0 12.1127 0 0 0 0 14.2174 12.5659 10.0531 0 0 11.4057 0 0 0 10.8269 11.8995 11.3812 0 0 0 0 0 0 0 14.1005 0 0 0 0 0 0 14.2943 0 0 0 0 0 0 0 0 0 0 14.1142 0 0 10.9812 0 13.7614 0 0 0 12.0306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3911 0 0 0 0 0 0 0 0 0 0 13.3502 14.3457 0 13.6542 14.0456 12.2142 14.4254 15.1368 13.4485 0 10.9385 0 12.7099 0 0 0 0 0 0 0 0 0 0 Q86SQ7 SDCG8_HUMAN "Serologically defined colon cancer antigen 8 (Antigen NY-CO-8) (Centrosomal colon cancer autoantigen protein, hCCCAP)" SDCCAG8 CCCAP NPHP10 HSPC085 Homo sapiens (Human) cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; regulation of cilium assembly [GO:1902017]; tube formation [GO:0035148] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; photoreceptor cell cilium [GO:0097733] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; photoreceptor cell cilium [GO:0097733]; cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; regulation of cilium assembly [GO:1902017]; tube formation [GO:0035148] GO:0001764; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0007098; GO:0030010; GO:0030030; GO:0031023; GO:0034451; GO:0035148; GO:0036064; GO:0097733; GO:1902017 EELSGMK 0.99508 -11.044 0 0 0 0 0 0 0 0 0 10.1668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4245 13.4385 16.3202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0291 0 12.6871 0 0 0 0 0 0 0 0 0 0 0 0 12.6316 13.4019 13.2883 13.356 0 13.4481 0 0 15.5794 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4705 0 0 13.4046 0 0 0 0 0 0 0 0 0 0 0 0 13.2684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92541 RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog RTF1 KIAA0252 Homo sapiens (Human) blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055] GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0051571; GO:0080182; GO:1990269 RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697] ARLEQMTEKER 0.99508 -10.489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2788 13.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0336 0 0 11.3983 0 0 0 0 0 0 0 11.8805 0 0 0 0 0 0 0 13.9425 0 0 0 0 0 0 12.1612 0 0 0 0 0 14.1513 0 14.8657 0 0 14.3395 0 0 0 0 0 0 0 0 0 14.3447 13.409 0 0 0 0 0 0 0 11.6029 0 0 15.2005 0 13.6565 0 13.5103 0 0 13.3855 13.6516 0 13.5919 0 0 13.5744 14.144 0 11.7439 0 0 0 14.0493 0 12.6326 0 13.3548 0 0 0 0 0 0 0 0 0 13.6672 0 0 0 0 0 12.8894 0 0 0 0 0 0 0 0 0 0 0 0 12.4939 0 13.1505 13.941 0 0 0 0 0 0 0 0 Q9BVR0 HRC23_HUMAN Putative HERC2-like protein 3 HERC2P3 Homo sapiens (Human) metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] GO:0004842; GO:0046872 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] CQQLKLYILKAGR 0.99508 -12.211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4676 0 0 0 0 0 0 0 0 0 0 0 0 11.9765 0 12.116 13.5092 0 0 0 12.6131 12.5947 0 12.5699 0 0 12.9099 12.2964 0 0 0 0 14.5576 0 11.8731 12.3488 0 0 0 0 12.0079 0 13.5784 13.0022 0 0 0 0 0 0 0 13.5779 0 0 0 0 0 0 13.2432 0 0 0 0 13.6464 0 0 0 0 13.6782 0 11.6801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5588 0 0 0 0 0 0 15.3607 0 0 0 0 0 11.9401 Q9P2T1 GMPR2_HUMAN "GMP reductase 2, GMPR 2, EC 1.7.1.7 (Guanosine 5'-monophosphate oxidoreductase 2, Guanosine monophosphate reductase 2)" GMPR2 Homo sapiens (Human) GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144] cytosol [GO:0005829]; GMP reductase complex [GO:1902560] cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144] GO:0003920; GO:0005829; GO:0006144; GO:0046037; GO:0046872; GO:1902560 GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872] DILGGIR 0.99508 -12.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8957 0 0 0 0 0 0 0 0 11.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2344 12.9026 0 13.2812 17.3248 0 0 0 0 0 0 11.083 0 13.1532 0 0 13.3556 0 0 14.0326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2533 0 0 0 0 0 10.9497 0 0 0 0 0 0 11.8772 0 0 0 0 10.9725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHV5 RPGFL_HUMAN "Rap guanine nucleotide exchange factor-like 1 (Link guanine nucleotide exchange factor II, Link GEFII)" RAPGEFL1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] membrane [GO:0016020]; plasma membrane [GO:0005886] membrane [GO:0016020]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186]; nervous system development [GO:0007399]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] GO:0005085; GO:0005886; GO:0007186; GO:0007265; GO:0007399; GO:0016020; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] AQLLKKFIK 0.99508 -12.762 0 0 0 13.0059 0 0 0 0 0 0 0 0 0 0 13.1326 11.4495 0 0 10.8963 0 0 0 0 0 0 0 0 0 0 0 12.0415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1243 0 13.1638 13.3198 0 0 0 12.6618 0 16.1782 14.1996 0 0 0 0 0 12.4466 0 0 0 0 0 15.3007 12.9401 0 0 0 0 0 0 0 0 0 13.0558 0 0 0 16.4326 0 0 0 0 0 0 0 0 0 15.6447 0 0 0 15.7672 0 15.6555 0 0 0 0 0 0 0 0 0 12.8986 0 12.4405 0 0 14.9935 0 0 0 0 15.2988 0 15.0714 0 0 0 0 0 11.7494 0 15.0243 0 0 13.6258 13.3647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8301 13.1942 0 0 0 0 0 0 0 Q9UN88 GBRT_HUMAN Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) GABRQ Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202] anchoring junction [GO:0070161]; chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; synapse [GO:0045202]; chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; neurotransmitter transmembrane transporter activity [GO:0005326]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165] GO:0004888; GO:0004890; GO:0005231; GO:0005254; GO:0005326; GO:0005886; GO:0005887; GO:0007165; GO:0007268; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0043005; GO:0043235; GO:0045202; GO:0045211; GO:0050877; GO:0070161; GO:1902476; GO:1902711; GO:1904315 chloride channel activity [GO:0005254]; excitatory extracellular ligand-gated ion channel activity [GO:0005231]; GABA-A receptor activity [GO:0004890]; neurotransmitter receptor activity [GO:0030594]; neurotransmitter transmembrane transporter activity [GO:0005326]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315] AAVILLLIR 0.99508 -10.476 0 0 0 0 0 0 0 0 0 12.3336 15.6269 12.4317 12.1834 13.9569 12.6828 0 12.6557 0 0 0 0 0 0 0 12.1967 0 0 12.338 0 0 12.8188 0 12.4352 12.0881 12.4102 12.5583 0 12.6051 12.5612 0 0 12.5555 0 0 0 0 0 0 0 11.3683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2985 0 0 0 0 0 0 0 11.5277 0 0 0 0 0 13.345 0 0 0 0 0 0 0 14.6198 0 9.93491 0 0 0 0 13.7979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4564 0 12.0711 0 0 0 0 0 0 0 13.5355 0 0 0 13.3819 14.0214 13.594 0 0 0 13.5602 0 0 13.1974 9.77571 0 0 0 13.6163 0 0 0 0 A0A1B0GU33 TEX53_HUMAN Testis-expressed protein 53 TEX53 Homo sapiens (Human) ACILRRP 0.99509 -10.561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05556 ITB1_HUMAN "Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa, GPIIA) (VLA-4 subunit beta) (CD antigen CD29)" ITGB1 FNRB MDF2 MSK12 Homo sapiens (Human) "axon extension [GO:0048675]; B cell differentiation [GO:0030183]; basement membrane organization [GO:0071711]; calcium-independent cell-matrix adhesion [GO:0007161]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular defense response [GO:0006968]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; dendrite morphogenesis [GO:0048813]; establishment of mitotic spindle orientation [GO:0000132]; formation of radial glial scaffolds [GO:0021943]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell migration [GO:0008354]; heterotypic cell-cell adhesion [GO:0034113]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; maintenance of blood-brain barrier [GO:0035633]; mesodermal cell differentiation [GO:0048333]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fate specification [GO:0048626]; myoblast fusion [GO:0007520]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Rho protein signal transduction [GO:0035024]; neuroblast proliferation [GO:0007405]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of wound healing [GO:0090303]; reactive gliosis [GO:0150103]; receptor internalization [GO:0031623]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of inward rectifier potassium channel activity [GO:1901979]; regulation of spontaneous synaptic transmission [GO:0150003]; sarcomere organization [GO:0045214]; visual learning [GO:0008542]; wound healing, spreading of epidermal cells [GO:0035313]" cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha1-beta1 complex [GO:0034665]; integrin alpha10-beta1 complex [GO:0034680]; integrin alpha11-beta1 complex [GO:0034681]; integrin alpha2-beta1 complex [GO:0034666]; integrin alpha3-beta1 complex [GO:0034667]; integrin alpha4-beta1 complex [GO:0034668]; integrin alpha5-beta1 complex [GO:0034674]; integrin alpha7-beta1 complex [GO:0034677]; integrin alpha8-beta1 complex [GO:0034678]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685] "cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha1-beta1 complex [GO:0034665]; integrin alpha10-beta1 complex [GO:0034680]; integrin alpha11-beta1 complex [GO:0034681]; integrin alpha2-beta1 complex [GO:0034666]; integrin alpha3-beta1 complex [GO:0034667]; integrin alpha4-beta1 complex [GO:0034668]; integrin alpha5-beta1 complex [GO:0034674]; integrin alpha7-beta1 complex [GO:0034677]; integrin alpha8-beta1 complex [GO:0034678]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; collagen binding involved in cell-matrix adhesion [GO:0098639]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; axon extension [GO:0048675]; B cell differentiation [GO:0030183]; basement membrane organization [GO:0071711]; calcium-independent cell-matrix adhesion [GO:0007161]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular defense response [GO:0006968]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; dendrite morphogenesis [GO:0048813]; establishment of mitotic spindle orientation [GO:0000132]; formation of radial glial scaffolds [GO:0021943]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell migration [GO:0008354]; heterotypic cell-cell adhesion [GO:0034113]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; maintenance of blood-brain barrier [GO:0035633]; mesodermal cell differentiation [GO:0048333]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fate specification [GO:0048626]; myoblast fusion [GO:0007520]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Rho protein signal transduction [GO:0035024]; neuroblast proliferation [GO:0007405]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of wound healing [GO:0090303]; reactive gliosis [GO:0150103]; receptor internalization [GO:0031623]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of inward rectifier potassium channel activity [GO:1901979]; regulation of spontaneous synaptic transmission [GO:0150003]; sarcomere organization [GO:0045214]; visual learning [GO:0008542]; wound healing, spreading of epidermal cells [GO:0035313]" GO:0000082; GO:0000132; GO:0001618; GO:0001701; GO:0001726; GO:0001968; GO:0002020; GO:0002042; GO:0002052; GO:0003779; GO:0005178; GO:0005737; GO:0005886; GO:0005925; GO:0006909; GO:0006968; GO:0007155; GO:0007156; GO:0007159; GO:0007160; GO:0007161; GO:0007229; GO:0007405; GO:0007517; GO:0007520; GO:0008354; GO:0008542; GO:0009897; GO:0009986; GO:0010008; GO:0010710; GO:0010763; GO:0014704; GO:0015026; GO:0016020; GO:0016477; GO:0021943; GO:0023035; GO:0030027; GO:0030030; GO:0030032; GO:0030175; GO:0030183; GO:0030335; GO:0031589; GO:0031594; GO:0031623; GO:0032154; GO:0032587; GO:0033627; GO:0033631; GO:0034113; GO:0034665; GO:0034666; GO:0034667; GO:0034668; GO:0034674; GO:0034677; GO:0034678; GO:0034680; GO:0034681; GO:0035024; GO:0035313; GO:0035633; GO:0035748; GO:0042383; GO:0042470; GO:0043065; GO:0043197; GO:0043235; GO:0043236; GO:0043547; GO:0044877; GO:0045121; GO:0045214; GO:0045296; GO:0045445; GO:0045665; GO:0045766; GO:0046872; GO:0046982; GO:0048333; GO:0048471; GO:0048626; GO:0048675; GO:0048813; GO:0050839; GO:0050901; GO:0051726; GO:0051897; GO:0051951; GO:0055007; GO:0055037; GO:0060379; GO:0060912; GO:0070062; GO:0071404; GO:0071711; GO:0090303; GO:0097386; GO:0098639; GO:0098685; GO:0098978; GO:0099699; GO:0150003; GO:0150103; GO:1901979; GO:1903078; GO:1990782; GO:2000273; GO:2000811 actin binding [GO:0003779]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; collagen binding involved in cell-matrix adhesion [GO:0098639]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618] CHEGNGTFECGACRCNEGR 0.99509 -10.538 0 0 0 0 10.6206 0 0 0 12.076 14.1624 0 0 0 12.0088 0 10.6911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9541 0 0 0 0 0 12.673 0 0 0 0 0 0 0 0 0 0 0 9.98982 0 0 0 14.9563 0 0 0 0 15.0897 0 0 0 0 12.6447 0 0 0 0 10.7437 12.8747 0 0 0 0 13.2793 0 0 0 12.1996 12.8758 0 0 0 0 0 0 0 13.3798 0 0 13.5411 12.6481 11.325 0 0 0 13.8888 0 0 0 0 0 0 0 0 0 9.72443 0 0 0 0 0 0 0 12.3782 0 0 0 0 0 0 0 0 12.4721 0 0 0 0 0 0 0 0 0 0 0 10.3338 0 0 0 0 0 0 14.1245 12.0054 0 0 0 0 0 0 0 0 0 0 17.9122 0 15.5758 15.2832 0 15.0678 10.7173 0 13.5332 13.0543 0 9.86228 0 0 0 0 0 12.6548 0 0 Q6PGP7 TTC37_HUMAN "Tetratricopeptide repeat protein 37, TPR repeat protein 37 (SKI3 homolog, Ski3) (Tricho-hepatic-enteric syndrome protein, Thespin)" TTC37 KIAA0372 Homo sapiens (Human) "nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]" GO:0000791; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0034427; GO:0055087 AALNELLKHIK 0.99509 -12.839 0 0 0 0 0 0 0 10.7048 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2922 0 13.5889 13.7932 0 0 0 0 0 0 0 0 0 0 11.4157 0 0 0 0 0 0 11.8546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7972 10.9641 0 14.8675 0 0 0 0 14.9575 0 12.6133 0 0 0 0 0 0 0 0 0 0 0 14.3766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2544 0 0 0 0 0 0 0 0 14.2166 0 0 14.2362 12.1076 0 13.4922 0 0 0 0 0 0 0 12.972 0 12.7238 0 13.7648 0 13.6237 14.0883 0 0 0 0 0 0 12.8232 13.8592 0 14.5613 0 0 0 0 0 0 Q7RTU7 SCX_HUMAN "Basic helix-loop-helix transcription factor scleraxis (Class A basic helix-loop-helix protein 41, bHLHa41) (Class A basic helix-loop-helix protein 48, bHLHa48)" SCX BHLHA41 BHLHA48 SCXA SCXB Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; deltoid tuberosity development [GO:0035993]; developmental process [GO:0032502]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; face morphogenesis [GO:0060325]; heart valve formation [GO:0003188]; heart valve morphogenesis [GO:0003179]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cartilage development [GO:0061035]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; Sertoli cell differentiation [GO:0060008]; skeletal muscle cell differentiation [GO:0035914]; tendon cell differentiation [GO:0035990]; tendon development [GO:0035989]; tendon formation [GO:0035992]; tissue homeostasis [GO:0001894]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; deltoid tuberosity development [GO:0035993]; developmental process [GO:0032502]; embryonic skeletal system development [GO:0048706]; endochondral ossification [GO:0001958]; face morphogenesis [GO:0060325]; heart valve formation [GO:0003188]; heart valve morphogenesis [GO:0003179]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gastrulation [GO:2000543]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cartilage development [GO:0061035]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; Sertoli cell differentiation [GO:0060008]; skeletal muscle cell differentiation [GO:0035914]; tendon cell differentiation [GO:0035990]; tendon development [GO:0035989]; tendon formation [GO:0035992]; tissue homeostasis [GO:0001894]; transcription, DNA-templated [GO:0006351]" GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001707; GO:0001894; GO:0001958; GO:0002062; GO:0003179; GO:0003188; GO:0003677; GO:0005634; GO:0005667; GO:0006351; GO:0006357; GO:0008284; GO:0010628; GO:0030154; GO:0030199; GO:0030509; GO:0032502; GO:0032967; GO:0035914; GO:0035989; GO:0035990; GO:0035992; GO:0035993; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0048706; GO:0060008; GO:0060325; GO:0061035; GO:0061036; GO:0061056; GO:0070888; GO:0071260; GO:0071560; GO:2000543 "bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]" AGGGGPGGR 0.99509 -10.572 11.5217 12.3602 0 0 0 0 0 15.8678 0 0 0 0 0 0 0 0 0 11.8209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3026 0 0 0 0 0 13.9294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.885 0 0 0 0 0 0 0 0 0 0 0 12.658 12.5086 0 0 0 0 0 0 13.0102 0 0 Q8TBE9 NANP_HUMAN "N-acylneuraminate-9-phosphatase, EC 3.1.3.29 (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase)" NANP C20orf147 HDHD4 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; dephosphorylation [GO:0016311]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380] cytosol [GO:0005829] cytosol [GO:0005829]; N-acylneuraminate-9-phosphatase activity [GO:0050124]; phosphatase activity [GO:0016791]; carbohydrate metabolic process [GO:0005975]; dephosphorylation [GO:0016311]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380] GO:0005829; GO:0005975; GO:0006045; GO:0016311; GO:0016791; GO:0046380; GO:0050124 N-acylneuraminate-9-phosphatase activity [GO:0050124]; phosphatase activity [GO:0016791] AMLTELR 0.99509 -10.573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9748 0 0 0 0 0 0 0 0 12.2132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4262 0 0 0 14.4651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0055 0 13.1367 0 0 13.9959 0 0 0 0 0 0 0 12.1945 0 0 0 0 0 13.0015 12.0917 0 0 18.2448 14.4522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7794 0 0 0 12.6387 0 0 0 0 0 0 0 0 0 0 12.5101 0 11.4482 0 0 0 0 0 0 0 0 0 0 0 11.3799 0 0 0 0 0 0 0 0 11.8466 11.8978 0 0 14.749 0 12.0178 12.6486 0 0 0 12.1133 0 0 0 0 12.3126 12.9212 12.3249 0 0 0 0 0 Q9BUH8 BEGIN_HUMAN Brain-enriched guanylate kinase-associated protein BEGAIN KIAA1446 Homo sapiens (Human) regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202] cytoplasm [GO:0005737]; membrane [GO:0016020]; synapse [GO:0045202]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] GO:0005737; GO:0016020; GO:0045202; GO:0098962 ASPLYASYKADSFSEGDDLSQGHLAEPCFLR 0.99509 -12.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9178 0 0 0 0 0 0 0 0 12.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.722 0 0 0 10.3599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4072 14.7973 0 0 0 0 0 0 0 0 0 0 0 0 13.862 0 0 13.364 0 17.3023 0 0 0 13.8893 0 0 0 0 0 0 0 0 0 0 0 13.8582 0 0 11.9265 0 12.5728 11.921 0 12.5434 0 13.1991 0 0 0 0 0 0 12.3944 0 0 0 0 12.5954 0 0 0 14.4984 14.1233 0 10.5139 0 0 0 12.2612 0 13.9715 0 0 0 14.4811 0 0 0 0 0 0 0 0 0 0 0 12.0036 0 0 0 0 0 0 0 0 0 15.5919 0 0 0 0 0 Q9H1J1 REN3A_HUMAN "Regulator of nonsense transcripts 3A (Nonsense mRNA reducing factor 3A) (Up-frameshift suppressor 3 homolog A, hUpf3)" UPF3A RENT3A UPF3 Homo sapiens (Human) "mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]" GO:0000184; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0017056; GO:0035145; GO:0042162; GO:0043231; GO:0045727; GO:0051028 RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162] EHRDVER 0.99509 -12.824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HD40 SPCS_HUMAN "O-phosphoseryl-tRNA(Sec) selenium transferase, EC 2.9.1.2 (Liver-pancreas antigen, LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase, Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase, SepSecS) (Soluble liver antigen, SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein)" SEPSECS TRNP48 Homo sapiens (Human) selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phosphoseryl-selenocysteinyl-tRNA selenium transferase activity [GO:0098621]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056] GO:0000049; GO:0001514; GO:0005634; GO:0005737; GO:0005829; GO:0097056; GO:0098621 phosphoseryl-selenocysteinyl-tRNA selenium transferase activity [GO:0098621]; tRNA binding [GO:0000049] AVTQLGSMLFTR 0.99509 -12.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5298 0 14.125 0 0 0 0 13.8866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTJ4 MA2C1_HUMAN "Alpha-mannosidase 2C1, EC 3.2.1.24 (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)" MAN2C1 MANA MANA1 Homo sapiens (Human) mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313] GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872 alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872] ETVRKCAR 0.99509 -10.532 10.2556 0 0 0 0 0 11.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0254 0 0 0 0 0 0 0 0 11.1228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9508 0 0 0 12.694 12.2406 12.163 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9424 0 0 0 13.8455 0 0 0 0 0 0 0 0 13.7613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1782 0 0 0 0 0 10.6156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6774 Q9UJA5 TRM6_HUMAN "tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6, tRNA(m1A58)MTase subunit TRM6)" TRMT6 KIAA1153 TRM6 CGI-09 Homo sapiens (Human) mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; RNA binding [GO:0003723]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488] GO:0003723; GO:0005634; GO:0005654; GO:0030488; GO:0031515; GO:0080009 RNA binding [GO:0003723] AVQVQRR 0.99509 -12.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0504 13.5699 0 0 0 0 0 0 0 0 0 0 0 0 12.1836 0 0 12.0708 0 0 0 0 0 0 0 15.0416 0 0 0 0 14.9465 14.944 0 0 0 0 0 0 0 14.6851 15.1711 0 14.6056 0 0 0 15.6331 0 0 15.5593 15.2187 0 0 14.3154 0 0 0 0 0 0 15.1249 0 0 0 0 0 0 0 0 0 0 0 0 13.7967 0 0 13.68 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5234 14.1719 0 0 0 0 0 0 O43323 DHH_HUMAN "Desert hedgehog protein, DHH, EC 3.1.-.- (HHG-3) [Cleaved into: Desert hedgehog protein N-product, DHH-N ]" DHH Homo sapiens (Human) cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286] extracellular space [GO:0005615]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286] GO:0001649; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005886; GO:0007224; GO:0007267; GO:0007286; GO:0008233; GO:0008270; GO:0010468; GO:0016540; GO:0030238; GO:0032355; GO:0033327; GO:0042552; GO:0043627; GO:0045880; GO:0050810 calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270] GDWVLAADASGR 0.9951 -8.8374 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0503 0 0 12.1425 0 0 0 11.802 0 0 0 0 0 11.8032 0 0 11.9683 0 17.3153 0 0 0 0 17.359 0 17.4153 0 0 11.4977 0 0 11.0462 0 11.9925 0 14.1795 17.5471 12.3017 14.4261 17.6753 17.5918 0 0 17.5948 17.6813 14.3834 14.261 0 0 13.8165 13.7858 0 16.9721 0 0 0 0 0 0 13.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0785 14.0787 0 0 0 0 0 0 0 13.1999 0 0 0 12.3292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9606 0 16.7573 0 0 0 0 0 0 14.4187 13.8105 14.7077 14.4966 13.4136 13.4006 19.2656 14.9769 19.2639 13.7459 14.9756 14.4165 0 13.0754 14.8078 0 0 0 0 14.0674 0 19.315 0 0 P28290 ITPI2_HUMAN "Protein ITPRID2 (Cleavage signal-1 protein, CS-1) (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2)" ITPRID2 CS1 KIAA1927 KRAP SSFA2 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102] GO:0005102; GO:0005654; GO:0005829; GO:0005886; GO:0051015 actin filament binding [GO:0051015]; signaling receptor binding [GO:0005102] LLGLEEQLRAVRMPSPFR 0.9951 -12.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5174 0 0 10.8386 10.703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4255 0 0 14.7056 0 0 13.3283 14.2582 0 0 0 0 0 0 11.6409 11.1956 0 0 0 0 0 0 0 0 0 0 13.801 0 0 0 0 13.6265 12.6881 0 0 0 0 14.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3985 13.119 0 0 0 0 0 0 0 0 11.2417 0 0 0 0 0 0 0 0 10.828 0 0 0 Q07955 SRSF1_HUMAN "Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1, ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)" SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 Homo sapiens (Human) "alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; regulation of RNA splicing [GO:0043484]" catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA topoisomerase binding [GO:0044547]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; regulation of RNA splicing [GO:0043484]" GO:0000380; GO:0000395; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0016607; GO:0043484; GO:0044547; GO:0051028; GO:0071013 DNA topoisomerase binding [GO:0044547]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] DGYDYDGYR 0.9951 -12.848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5655 0 0 0 0 0 0 0 0 0 0 0 0 0 15.131 0 0 0 0 0 0 0 0 10.6402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L8C5 SYT13_HUMAN "Synaptotagmin-13 (Synaptotagmin XIII, SytXIII)" SYT13 KIAA1427 Homo sapiens (Human) calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] axon [GO:0030424]; exocytic vesicle [GO:0070382]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synapse [GO:0045202]; transport vesicle [GO:0030133] axon [GO:0030424]; exocytic vesicle [GO:0070382]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synapse [GO:0045202]; transport vesicle [GO:0030133]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005886; GO:0005887; GO:0006906; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0030133; GO:0030276; GO:0030424; GO:0043231; GO:0045202; GO:0070382; GO:0071277 calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149] DVSVKVTLK 0.9951 -12.844 14.8531 0 0 0 14.2372 0 0 0 0 16.2795 0 12.7029 0 0 0 12.2231 0 0 0 0 0 0 0 0 0 0 0 0 10.6449 0 0 0 0 0 0 0 0 15.936 0 0 0 0 0 0 0 0 0 0 16.0101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.126 18.0245 0 0 0 15.6164 15.6832 15.5009 0 0 15.3289 0 15.3385 15.0872 15.1515 15.7166 15.6431 0 0 0 14.3659 15.7735 0 15.366 13.4996 0 0 0 14.4499 0 0 0 0 13.3813 0 0 14.1338 12.8547 0 0 15.1503 0 0 13.7632 0 14.2656 0 14.481 14.6263 13.6963 15.0863 0 0 14.5975 13.663 0 14.5112 0 0 14.6771 15.1487 12.4861 0 15.1147 15.1482 12.8643 0 0 0 15.0429 15.1601 0 12.0976 0 15.1362 0 0 11.7401 12.4415 11.691 15.2558 15.0565 0 12.2758 0 0 0 0 14.875 0 0 0 0 11.9794 0 0 14.7137 0 11.024 0 0 13.6856 0 15.0158 0 0 0 0 0 0 0 Q8N5Q1 GAR5B_HUMAN Golgi associated RAB2 interactor protein 5B GARIN5B C19orf16 FAM71E2 Homo sapiens (Human) AEEIQEESGVLNLLPSLQHSQHSEWPDAGA 0.9951 -10.315 0 0 0 0 13.7099 0 0 0 0 0 0 14.0169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8611 0 0 0 16.026 0 0 0 0 0 11.3415 12.8726 0 0 0 0 14.7423 0 0 0 0 0 0 0 0 0 0 0 0 14.6003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4658 0 0 10.6931 0 0 11.2735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4296 11.2713 12.4634 0 0 0 0 0 Q96M29 TEKT5_HUMAN Tektin-5 TEKT5 Homo sapiens (Human) cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126] microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294] GO:0005634; GO:0015630; GO:0036126; GO:0060271; GO:0060294 CCQEQMR 0.9951 -10.317 0 0 0 0 0 0 0 0 0 14.3578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1465 12.4956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.728 0 0 15.5395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75044 SRGP2_HUMAN "SLIT-ROBO Rho GTPase-activating protein 2, srGAP2 (Formin-binding protein 2) (Rho GTPase-activating protein 34)" SRGAP2 ARHGAP34 FNBP2 KIAA0456 SRGAP2A Homo sapiens (Human) actin filament severing [GO:0051014]; dendritic spine development [GO:0060996]; excitatory synapse assembly [GO:1904861]; extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration [GO:0021816]; filopodium assembly [GO:0046847]; inhibitory synapse assembly [GO:1904862]; lamellipodium assembly involved in ameboidal cell migration [GO:0003363]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron migration [GO:2001223]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine head [GO:0044327]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine head [GO:0044327]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; actin filament severing [GO:0051014]; dendritic spine development [GO:0060996]; excitatory synapse assembly [GO:1904861]; extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration [GO:0021816]; filopodium assembly [GO:0046847]; inhibitory synapse assembly [GO:1904862]; lamellipodium assembly involved in ameboidal cell migration [GO:0003363]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron migration [GO:2001223]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0003363; GO:0005096; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0014069; GO:0021816; GO:0030027; GO:0030336; GO:0031267; GO:0034446; GO:0042802; GO:0042803; GO:0043547; GO:0044327; GO:0045211; GO:0045335; GO:0046847; GO:0048812; GO:0051014; GO:0051056; GO:0060996; GO:0070161; GO:1904861; GO:1904862; GO:2001223 GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267] AGASCPSGGHVADIYLANINKQR 0.99511 -31.834 0 8.58033 0 0 0 0 0 0 15.0111 11.6758 12.6074 0 0 14.6632 0 0 0 13.6531 13.9871 0 0 0 0 0 13.8395 11.6046 0 0 13.4557 0 12.9414 14.0985 11.203 0 0 0 14.8173 11.3137 13.3256 0 0 0 0 14.4157 0 14.5788 0 0 0 0 14.224 0 11.2071 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4935 0 0 0 13.944 0 0 0 0 12.7666 0 0 12.4436 0 10.4247 0 0 14.5169 13.4402 14.8126 0 10.9473 0 14.3376 0 13.5719 13.4662 12.5226 0 12.7008 0 0 0 0 16.479 13.1427 14.6906 0 13.593 0 0 0 0 0 13.139 0 13.5614 0 0 0 0 10.8563 0 0 0 15.8969 12.7583 12.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4395 12.9214 18.2398 0 0 12.9864 0 14.7044 15.6096 14.5906 0 0 0 0 0 0 0 0 0 0 14.0812 11.799 15.4886 0 0 14.5036 0 0 11.5626 0 12.8474 0 14.1847 11.8441 0 0 0 13.5028 0 0 0 0 O95347 SMC2_HUMAN "Structural maintenance of chromosomes protein 2, SMC protein 2, SMC-2 (Chromosome-associated protein E, hCAP-E) (XCAP-E homolog)" SMC2 CAPE SMC2L1 PRO0324 Homo sapiens (Human) cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820] GO:0000228; GO:0000785; GO:0000793; GO:0000794; GO:0000796; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007076; GO:0010032; GO:0016887; GO:0045132; GO:0051301; GO:0051383; GO:0051984; GO:0070062; GO:1905820; GO:1905821 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697] AMNVLTEAEER 0.99511 -32.161 0 0 0 0 0 0 12.0024 0 0 12.6562 12.5346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0045 0 11.06 0 11.1763 0 0 0 12.9276 0 0 0 0 0 0 0 0 0 13.3856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5908 0 0 0 0 0 0 13.5189 0 0 12.8823 12.9835 13.2603 0 0 0 0 14.722 14.1864 0 0 13.2382 0 13.9775 0 13.8783 13.1869 13.3753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1307 0 0 0 0 0 0 0 0 0 0 0 0 12.3028 0 0 0 0 0 0 0 0 0 0 0 0 12.1141 0 0 14.2399 0 0 0 0 0 0 14.2704 0 0 0 0 0 0 0 13.2855 0 14.3218 0 13.9732 13.4383 13.6314 0 0 14.4598 14.1298 13.661 14.2986 0 0 13.4877 0 0 0 0 0 0 0 0 0 P11413 G6PD_HUMAN "Glucose-6-phosphate 1-dehydrogenase, G6PD, EC 1.1.1.49" G6PD Homo sapiens (Human) "cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]" centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634] "centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]" GO:0004345; GO:0005536; GO:0005634; GO:0005737; GO:0005829; GO:0006006; GO:0006098; GO:0006629; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0016020; GO:0019322; GO:0021762; GO:0032094; GO:0034451; GO:0034599; GO:0042802; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378 glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803] ATPEEKLK 0.99511 -10.361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5424 0 0 0 0 18.9567 0 0 0 0 0 0 0 0 0 0 0 13.384 0 0 0 0 0 0 0 0 0 0 15.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0553 0 0 0 0 14.273 0 0 0 0 0 0 14.369 0 0 0 13.1735 0 0 0 0 13.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0653 0 0 0 0 0 0 0 0 0 0 0 13.4508 0 0 0 0 13.0653 Q5T7P8 SYT6_HUMAN "Synaptotagmin-6 (Synaptotagmin VI, SytVI)" SYT6 Homo sapiens (Human) acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; acrosomal vesicle exocytosis [GO:0060478]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001786; GO:0005509; GO:0005829; GO:0005886; GO:0014059; GO:0016021; GO:0016192; GO:0017156; GO:0017158; GO:0019898; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0060478; GO:0070161; GO:0070382; GO:0071277; GO:0097038 calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] IYLLPDRKCK 0.99511 -15.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7204 12.5516 0 0 0 0 0 0 0 0 0 0 0 0 16.0766 0 0 0 0 0 14.0649 0 15.3721 0 0 15.8589 0 0 0 13.3212 0 0 12.7239 0 0 15.5253 0 0 0 0 12.653 0 0 13.8452 0 0 14.2484 13.8367 15.0586 0 12.6273 0 12.719 12.9753 0 0 0 13.1141 0 14.2871 13.2275 0 0 13.2972 13.8283 0 0 0 0 0 0 0 0 0 15.5608 0 0 0 13.8612 0 0 0 0 12.5398 0 0 0 0 0 0 0 0 0 0 12.8126 0 0 0 0 0 0 Q8WVZ1 ZDH19_HUMAN "Palmitoyltransferase ZDHHC19, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 19, DHHC-19)" ZDHHC19 Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] GO:0000139; GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706; GO:0048471; GO:0097356 protein-cysteine S-palmitoyltransferase activity [GO:0019706] AIAIVVAVSAAGLLVPLSLLLLIQALSVSSADR 0.99511 -9.9418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9763 0 0 0 0 12.3691 11.8533 0 0 0 0 0 0 0 0 11.5167 0 12.7205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7841 0 0 0 0 0 12.7474 0 0 0 0 0 0 0 0 0 0 0 12.3057 0 0 0 0 0 0 0 11.9273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7746 0 0 0 0 0 0 0 0 0 0 0 11.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0835 Q9HCM7 FBSL_HUMAN Fibrosin-1-like protein (AUTS2-like protein) (HBV X-transactivated gene 9 protein) (HBV XAg-transactivated protein 9) FBRSL1 AUTS2L KIAA1545 XTP9 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] AAPGDVK 0.99511 -31.882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6966 0 0 0 0 0 0 14.0042 0 0 0 12.1481 0 0 0 0 0 0 13.7303 0 0 0 0 0 0 13.279 13.4019 0 0 16.2006 15.6014 0 11.7802 0 0 0 0 0 0 13.3573 10.0246 13.3167 0 0 0 0 14.7556 0 0 0 0 13.5061 0 13.6921 0 0 0 0 0 0 13.1693 0 0 0 9.29698 13.0094 0 0 10.8292 0 0 13.7636 0 0 0 0 0 0 0 0 0 14.0521 13.0055 0 11.6163 0 0 0 0 0 11.95 0 0 0 0 0 0 13.1691 0 0 0 0 0 13.0522 0 0 0 0 0 0 0 0 Q9NS28 RGS18_HUMAN "Regulator of G-protein signaling 18, RGS18" RGS18 RGS13 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0003924; GO:0005096; GO:0005737; GO:0005886; GO:0007186; GO:0008277; GO:0009968 GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924] GPQQIHLKAKAIYEK 0.99511 -9.9391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.432 0 0 0 0 0 0 0 0 0 12.8338 0 0 0 0 13.3421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4987 0 0 13.8575 0 0 12.9358 0 0 13.1551 0 0 0 0 0 0 0 12.6705 0 0 0 0 0 0 0 0 0 0 0 12.3685 12.7092 12.5364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P291 ARMX1_HUMAN "Armadillo repeat-containing X-linked protein 1 (ARM protein lost in epithelial cancers on chromosome X 1, Protein ALEX1)" ARMCX1 ALEX1 AD032 Homo sapiens (Human) hematopoietic stem cell homeostasis [GO:0061484] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; hematopoietic stem cell homeostasis [GO:0061484] GO:0005739; GO:0005741; GO:0016021; GO:0061484 AHSGSHSGGGLEAK 0.99511 -31.888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0082 0 0 0 0 0 0 0 0 0 16.1929 10.7577 0 14.4762 13.5309 11.2288 0 0 0 0 0 0 10.9314 0 0 0 0 0 0 13.2523 0 0 0 14.4407 0 0 13.9699 0 0 0 13.4472 0 0 0 0 0 0 0 13.7898 0 0 15.0045 0 0 12.8573 0 0 0 13.0636 14.2483 14.631 0 10.1053 0 0 13.2836 0 0 0 12.7196 11.8729 14.3388 13.4219 10.8211 14.7395 0 0 0 11.0487 14.7038 11.6146 0 13.9368 12.7086 0 12.2819 14.0172 0 0 0 0 10.1408 11.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3622 0 0 12.1315 0 13.1818 0 12.2551 0 14.3037 0 0 0 0 0 0 Q9ULG3 CFA92_HUMAN Uncharacterized protein CFAP92 (Putative cilia and flagella associated protein 92) CFAP92 KIAA1257 Homo sapiens (Human) AQESDSDR 0.99511 -32.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.805 0 0 0 12.5715 0 0 0 11.4391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8211 0 0 12.4128 12.2978 0 0 0 0 0 0 11.5475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4808 0 14.4138 0 0 14.108 0 0 0 14.4963 0 0 0 0 14.1742 0 0 0 0 0 0 0 0 14.0424 14.3944 0 0 0 0 0 0 0 13.6992 13.541 14.2104 0 0 0 0 14.707 0 0 0 15.09 14.4069 0 0 0 0 14.2933 0 14.3029 0 0 0 12.2027 0 13.3436 0 13.6535 14.0111 0 0 0 14.4812 0 14.8916 14.2418 14.1354 13.9415 0 0 14.0043 0 0 0 0 0 0 0 0 14.4533 15.2314 0 0 0 0 0 0 12.5316 0 0 0 0 0 0 0 11.4875 0 0 0 0 0 11.5958 0 0 A6NMS3 OR5K4_HUMAN Olfactory receptor 5K4 OR5K4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] AGNLHSMIHVGLLLRLTFCR 0.99512 -9.4624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0783 0 0 0 0 0 12.0068 0 0 0 17.276 16.6359 0 0 0 0 0 0 0 0 0 0 0 0 13.3164 0 0 13.4066 0 0 0 0 0 0 13.3012 0 0 0 0 0 0 0 0 0 0 0 13.6316 0 0 0 0 0 0 16.5729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3908 0 0 0 0 0 0 O14737 PDCD5_HUMAN "Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19, Protein TFAR19)" PDCD5 TFAR19 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200] GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008201; GO:0008285; GO:0010628; GO:0010698; GO:0043065; GO:0043280; GO:0048487; GO:0070062; GO:0071560; GO:0090200; GO:1903638; GO:1903645 acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201] ARLSNLALVK 0.99512 -9.9741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7609 0 0 13.8899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5318 0 0 0 0 0 0 0 12.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0064 0 0 0 0 0 11.8679 0 0 0 0 0 0 12.9493 0 0 0 0 0 0 11.3069 0 14.6773 0 0 0 0 0 0 0 0 0 0 0 13.9977 15.2671 0 0 0 0 0 0 0 0 0 0 0 14.1248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4242 9.65422 0 11.2611 O60500 NPHN_HUMAN Nephrin (Renal glomerulus-specific cell adhesion receptor) NPHS1 NPHN Homo sapiens (Human) cell-cell adhesion [GO:0098609]; glomerular basement membrane development [GO:0032836]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; podocyte development [GO:0072015]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; skeletal muscle tissue development [GO:0007519]; slit diaphragm assembly [GO:0036060] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057] cell projection [GO:0042995]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022]; cell-cell adhesion [GO:0098609]; glomerular basement membrane development [GO:0032836]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; podocyte development [GO:0072015]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; skeletal muscle tissue development [GO:0007519]; slit diaphragm assembly [GO:0036060] GO:0005886; GO:0005887; GO:0005911; GO:0005925; GO:0007254; GO:0007519; GO:0007520; GO:0017022; GO:0030838; GO:0032836; GO:0035418; GO:0036057; GO:0036060; GO:0042995; GO:0050839; GO:0070062; GO:0072015; GO:0098609 cell adhesion molecule binding [GO:0050839]; myosin binding [GO:0017022] DGLLLGPDPRIPGFPR 0.99512 -35.666 0 0 0 0 0 0 0 0 0 0 0 8.87581 0 0 0 0 0 0 0 0 0 14.6412 0 12.7848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.454 0 0 0 0 0 0 0 0 0 0 0 0 14.1749 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1976 0 0 0 0 0 0 0 0 0 12.0933 0 0 0 0 0 0 0 0 16.3709 0 0 0 0 0 0 0 0 0 0 0 0 13.5486 0 0 0 0 0 0 0 0 0 0 0 0 12.8418 0 0 13.8747 13.0153 13.442 0 12.5435 0 0 0 9.71514 0 0 13.6582 0 0 13.3882 0 16.6803 13.3029 14.7757 0 0 O75494 SRS10_HUMAN "Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein, SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats, TASR, TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein, TLS-associated SR protein)" SRSF10 FUSIP1 FUSIP2 SFRS13A TASR Homo sapiens (Human) "cytosolic transport [GO:0016482]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; cytosolic transport [GO:0016482]; mRNA splice site selection [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]" GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006376; GO:0016482; GO:0016607; GO:0030425; GO:0043025; GO:0043679; GO:0048024; GO:0048025; GO:0050733; GO:0051082 RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082] NVYSSSR 0.99512 -9.9503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2853 0 0 0 0 0 0 0 0 0 10.4409 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.08505 0 0 9.48148 0 0 0 0 0 0 0 0 0 0 12.6685 0 0 0 0 0 0 O94808 GFPT2_HUMAN "Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2, EC 2.6.1.16 (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2, GFAT 2, GFAT2) (Hexosephosphate aminotransferase 2)" GFPT2 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829] cytosol [GO:0005829]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to leukemia inhibitory factor [GO:1990830]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0097367; GO:1990830 carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360] CGIFAYMNYRVPRTR 0.99512 -9.9531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7267 0 0 0 O95025 SEM3D_HUMAN Semaphorin-3D SEMA3D UNQ760/PRO1491 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] AEHEEGK 0.99512 -35.907 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4251 0 0 0 0 0 0 0 0 0 0 0 0 0 10.566 0 0 0 0 0 0 0 0 0 0 11.3249 0 10.4898 0 0 0 0 0 0 9.97154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1277 0 0 0 0 0 0 0 0 0 0 11.7224 0 0 0 0 0 0 0 9.56037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00749 UROK_HUMAN "Urokinase-type plasminogen activator, U-plasminogen activator, uPA, EC 3.4.21.73 [Cleaved into: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B ]" PLAU Homo sapiens (Human) blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; fibrinolysis [GO:0042730]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of fibrinolysis [GO:0051917]; regulation of plasminogen activation [GO:0010755]; regulation of signaling receptor activity [GO:0010469]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; regulation of wound healing [GO:0061041]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; urokinase plasminogen activator signaling pathway [GO:0038195] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase complex [GO:1905370]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine protease inhibitor complex [GO:0097180]; serine-type endopeptidase complex [GO:1905370]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; fibrinolysis [GO:0042730]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of plasminogen activation [GO:0010757]; plasminogen activation [GO:0031639]; positive regulation of cell migration [GO:0030335]; proteolysis [GO:0006508]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of fibrinolysis [GO:0051917]; regulation of plasminogen activation [GO:0010755]; regulation of signaling receptor activity [GO:0010469]; regulation of smooth muscle cell migration [GO:0014910]; regulation of smooth muscle cell-matrix adhesion [GO:2000097]; regulation of wound healing [GO:0061041]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; urokinase plasminogen activator signaling pathway [GO:0038195] GO:0001666; GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0005925; GO:0006508; GO:0006935; GO:0007165; GO:0007596; GO:0009986; GO:0010469; GO:0010755; GO:0010757; GO:0014909; GO:0014910; GO:0030155; GO:0030335; GO:0031639; GO:0033628; GO:0035579; GO:0038195; GO:0042127; GO:0042730; GO:0051917; GO:0051918; GO:0061041; GO:0070062; GO:0070821; GO:0097180; GO:0098637; GO:1905370; GO:2000097 serine-type endopeptidase activity [GO:0004252] ALLARLLLCVLVVSDSK 0.99512 -8.927 0 0 0 0 0 0 0 0 11.092 0 0 0 0 0 0 0 0 0 0 0 12.4521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8352 13.2223 0 0 0 0 0 14.5558 0 0 0 0 0 0 0 12.3993 0 0 0 0 13.2303 0 0 14.2413 0 0 13.7358 0 0 0 0 0 0 0 0 0 0 0 0 14.1277 0 0 0 10.8489 0 0 0 0 0 0 0 0 0 0 0 10.8462 0 0 0 0 0 14.1277 0 0 0 13.9432 0 0 0 13.9386 10.9845 0 0 0 0 13.5669 13.2576 0 0 0 10.5936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8026 0 0 0 0 0 13.1964 0 0 0 0 0 0 0 0 P04554 PRM2_HUMAN "Protamine-2 (Sperm histone P2) (Sperm protamine P2) [Cleaved into: Basic nuclear protein HPI1; Basic nuclear protein HPI2; Basic nuclear protein HPS1; Basic nuclear protein HPS2; Sperm histone HP4 (Sperm protamine P4); Sperm histone HP2 (Sperm protamine P2, P2'); Sperm histone HP3 (P2'') (Sperm protamine P3) ]" PRM2 Homo sapiens (Human) chromosome condensation [GO:0030261]; chromosome organization [GO:0051276]; nucleus organization [GO:0006997]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; cadmium ion binding [GO:0046870]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; chromosome condensation [GO:0030261]; chromosome organization [GO:0051276]; nucleus organization [GO:0006997]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] GO:0000786; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0006997; GO:0007283; GO:0007286; GO:0008270; GO:0030261; GO:0046870; GO:0051276 cadmium ion binding [GO:0046870]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270] LHRIHRR 0.99512 -5.4368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C2Y1 NBPF7_HUMAN Putative neuroblastoma breakpoint family member 7 NBPF7P NBPF7 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 EEKLAEQLKQAEELR 0.99512 -9.9751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1984 14.0942 14.7598 11.5078 0 0 0 0 0 13.6139 13.6051 0 0 0 0 0 0 13.0711 13.5459 0 13.4324 0 0 14.7178 0 0 0 13.7654 0 0 0 0 0 0 0 12.8063 0 0 0 13.1815 0 0 13.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10412 H14_HUMAN Histone H1.4 (Histone H1b) (Histone H1s-4) H1-4 H1F4 HIST1H1E Homo sapiens (Human) chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334] heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634] heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334] GO:0000122; GO:0000786; GO:0000792; GO:0003690; GO:0003723; GO:0005634; GO:0006334; GO:0030261; GO:0030527; GO:0031490; GO:0031492; GO:0045910; GO:0080182; GO:0098532 chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] AASGEAK 0.99512 -10.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8859 13.0605 0 0 0 0 0 0 13.4875 0 13.5347 0 13.3354 0 13.4701 0 0 0 0 0 0 0 0 0 0 0 13.3337 0 0 0 0 0 13.2737 0 0 0 0 0 0 0 0 0 0 12.5528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42025 ACTY_HUMAN "Beta-centractin (Actin-related protein 1B, ARP1B)" ACTR1B CTRN2 Homo sapiens (Human) centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524] GO:0005524; GO:0005576; GO:0005737; GO:0005813; GO:0005829; GO:0005869; GO:0015630; GO:0016020; GO:0034774; GO:0070062; GO:1904813 ATP binding [GO:0005524] DQLQTFSEEHPVLLTEAPLNPSK 0.99512 -12.552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.548 0 0 0 0 0 0 17.4224 0 0 0 17.4332 0 0 18.2354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9855 0 0 0 0 0 0 0 11.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49336 CDK8_HUMAN "Cyclin-dependent kinase 8, EC 2.7.11.22, EC 2.7.11.23 (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35)" CDK8 Homo sapiens (Human) protein phosphorylation [GO:0006468] mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0008353; GO:0016592; GO:0032991; GO:0106310 ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353] AFHLLQK 0.99512 -12.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P49916 DNLI3_HUMAN "DNA ligase 3, EC 6.5.1.1 (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3)" LIG3 Homo sapiens (Human) "base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]" cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair, DNA ligation [GO:0006288]; base-excision repair, gap-filling [GO:0006287]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]" GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006266; GO:0006273; GO:0006287; GO:0006288; GO:0006302; GO:0007005; GO:0007049; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681 ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270] AAGTPKK 0.99512 -35.901 0 0 0 0 14.2897 0 0 0 0 10.8878 0 14.3078 0 0 0 0 0 10.0723 0 11.2905 0 14.5787 12.229 0 0 13.0274 0 0 0 12.7313 10.7795 11.7044 11.0298 12.2165 0 0 11.14 0 0 0 0 13.0001 12.4175 0 0 0 0 0 0 0 0 11.3339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4291 0 11.6033 0 0 0 0 0 0 0 0 0 14.8344 14.7692 15.3241 0 0 12.7984 0 13.649 0 15.9208 15.6011 0 10.3261 0 0 0 14.7777 15.5238 0 0 0 0 0 0 14.1729 16.0719 14.4412 11.9738 12.5837 0 13.5078 12.8566 0 13.9828 15.9278 13.6203 0 0 0 15.5542 15.4439 0 0 12.3968 0 0 15.3759 15.2784 17.0725 0 0 15.0033 14.1681 14.3315 13.2488 13.6364 13.9085 10.6757 0 0 0 0 0 0 0 0 0 15.1981 0 14.2879 13.0784 0 11.5586 14.8222 11.8299 0 15.3762 0 0 11.1646 0 0 13.7754 10.4429 14.1353 0 13.822 0 0 0 0 13.744 13.1234 0 0 0 0 0 0 0 0 0 P51512 MMP16_HUMAN "Matrix metalloproteinase-16, MMP-16, EC 3.4.24.- (MMP-X2) (Membrane-type matrix metalloproteinase 3, MT-MMP 3, MTMMP3) (Membrane-type-3 matrix metalloproteinase, MT3-MMP, MT3MMP)" MMP16 C8orf57 MMPX2 Homo sapiens (Human) chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501] GO:0001501; GO:0001958; GO:0004222; GO:0005576; GO:0005796; GO:0005886; GO:0005887; GO:0006508; GO:0008047; GO:0008270; GO:0009986; GO:0016485; GO:0030198; GO:0030574; GO:0031012; GO:0035988; GO:0048701; GO:0070006; GO:0097094 enzyme activator activity [GO:0008047]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270] AIAIVIPCILALCLLVLVYTVFQFKRK 0.99512 -9.9578 0 0 0 13.2086 0 0 13.0174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5622 0 0 0 0 0 0 0 0 0 13.2725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5475 0 0 0 0 0 0 0 0 0 11.948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6571 0 0 0 0 13.1984 0 0 0 0 0 0 12.4219 13.1201 0 0 0 0 0 0 Q14511 CASL_HUMAN "Enhancer of filamentation 1, hEF1 (CRK-associated substrate-related protein, CAS-L, CasL) (Cas scaffolding protein family member 2) (Neural precursor cell expressed developmentally down-regulated protein 9, NEDD-9) (Renal carcinoma antigen NY-REN-12) (p105) [Cleaved into: Enhancer of filamentation 1 p55 ]" NEDD9 CASL CASS2 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; actin filament reorganization [GO:0090527]; activation of GTPase activity [GO:0090630]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cilium disassembly [GO:0061523]; cytoskeleton organization [GO:0007010]; integrin-mediated signaling pathway [GO:0007229]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922] cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; spindle pole [GO:0000922]; protein tyrosine kinase binding [GO:1990782]; actin filament bundle assembly [GO:0051017]; actin filament reorganization [GO:0090527]; activation of GTPase activity [GO:0090630]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cilium disassembly [GO:0061523]; cytoskeleton organization [GO:0007010]; integrin-mediated signaling pathway [GO:0007229]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0000922; GO:0001772; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005819; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007010; GO:0007049; GO:0007155; GO:0007165; GO:0007169; GO:0007229; GO:0007611; GO:0016477; GO:0030027; GO:0030335; GO:0030336; GO:0032956; GO:0036064; GO:0040008; GO:0045672; GO:0051017; GO:0051301; GO:0061098; GO:0061523; GO:0072686; GO:0090527; GO:0090630; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522 protein tyrosine kinase binding [GO:1990782] EQAPDCSSSDGSER 0.99512 -10.362 0 0 0 0 0 0 0 0 13.2107 0 10.8782 0 0 0 0 10.476 0 0 0 0 0 0 0 0 12.7459 0 0 0 0 0 0 0 12.9307 0 0 0 11.7805 0 0 13.5643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5557 0 0 0 0 0 0 0 12.2272 0 11.1504 0 12.7045 0 11.8752 0 12.6274 0 0 0 0 0 0 0 0 0 13.4679 0 0 10.7255 12.8687 0 0 0 0 0 0 0 0 0 0 0 0 12.6736 12.588 0 0 0 0 0 0 11.2152 0 13.3566 0 0 0 0 0 0 0 10.7576 0 0 0 12.6986 10.8456 0 11.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4833 0 0 0 13.1428 10.8273 0 0 0 0 0 10.1468 0 0 0 0 0 14.0505 0 0 10.642 0 0 11.7821 0 0 0 Q15118 PDK1_HUMAN "[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial, EC 2.7.11.2 (Pyruvate dehydrogenase kinase isoform 1, PDH kinase 1)" PDK1 PDHK1 Homo sapiens (Human) cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; protein phosphorylation [GO:0006468]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906] GO:0004672; GO:0004740; GO:0005524; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006468; GO:0008283; GO:0008631; GO:0010510; GO:0010906; GO:0097411 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740] AIYDFTDTVIRIR 0.99512 -5.4344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3301 0 0 0 0 13.2959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7268 12.4633 11.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16762 THTR_HUMAN "Thiosulfate sulfurtransferase, EC 2.8.1.1 (Rhodanese)" TST Homo sapiens (Human) cyanate catabolic process [GO:0009440]; epithelial cell differentiation [GO:0030855]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; thiosulfate sulfurtransferase activity [GO:0004792]; cyanate catabolic process [GO:0009440]; epithelial cell differentiation [GO:0030855]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346] GO:0000098; GO:0004792; GO:0005615; GO:0005739; GO:0005759; GO:0008097; GO:0009440; GO:0019346; GO:0030855; GO:0035928; GO:0051029 5S rRNA binding [GO:0008097]; thiosulfate sulfurtransferase activity [GO:0004792] ALFQTKK 0.99512 -5.4349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6409 0 0 0 0 0 13.1261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4595 0 12.937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4553 0 0 0 0 0 13.253 0 0 0 0 0 0 0 0 0 0 0 12.1821 0 0 0 Q494X3 ZN404_HUMAN Zinc finger protein 404 ZNF404 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFRSISGLSQHKR 0.99512 -10.388 0 0 0 0 0 0 0 0 13.7737 0 14.7807 14.7992 14.2569 0 14.2641 0 0 0 0 0 0 0 0 0 0 0 0 14.2668 0 0 0 0 0 0 0 0 13.5139 13.4961 13.446 13.2982 0 13.5418 14.0461 0 13.1187 0 0 0 11.6779 0 0 0 10.3478 0 10.9279 0 10.1944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7315 0 0 11.655 0 0 0 14.1087 12.3596 0 0 0 0 0 0 0 12.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3311 11.6865 0 0 10.7388 0 0 11.6202 0 12.5874 0 0 0 0 0 0 0 0 0 0 13.0806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.923 0 16.0378 0 0 0 0 10.5268 0 0 0 0 0 0 0 0 0 0 Q5BJD5 TM41B_HUMAN Transmembrane protein 41B (Protein stasimon) TMEM41B KIAA0033 Homo sapiens (Human) autophagosome assembly [GO:0000045]; intracellular lipid transport [GO:0032365]; modulation by host of viral RNA genome replication [GO:0044830]; nervous system development [GO:0007399] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phospholipid scramblase activity [GO:0017128]; autophagosome assembly [GO:0000045]; intracellular lipid transport [GO:0032365]; modulation by host of viral RNA genome replication [GO:0044830]; nervous system development [GO:0007399] GO:0000045; GO:0005789; GO:0007399; GO:0016021; GO:0017128; GO:0032365; GO:0044233; GO:0044830 phospholipid scramblase activity [GO:0017128] VNMKVPR 0.99512 -10.387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8006 14.1182 13.9927 13.2284 13.2687 12.5561 0 0 0 0 12.7094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2075 0 0 0 0 0 0 0 0 0 0 0 14.6999 13.9427 14.251 0 0 14.6989 0 0 0 0 0 0 0 0 0 0 0 0 Q5SQI0 ATAT_HUMAN "Alpha-tubulin N-acetyltransferase 1, Alpha-TAT, Alpha-TAT1, TAT, EC 2.3.1.108 (Acetyltransferase mec-17 homolog)" ATAT1 C6orf134 MEC17 Nbla00487 Homo sapiens (Human) alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283] axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686] "axon [GO:0030424]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule bundle [GO:0097427]; mitotic spindle [GO:0072686]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]; alpha-tubulin acetylation [GO:0071929]; cilium assembly [GO:0060271]; dentate gyrus development [GO:0021542]; neuron development [GO:0048666]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of fat cell differentiation [GO:0045598]; regulation of microtubule cytoskeleton organization [GO:0070507]; spermatogenesis [GO:0007283]" GO:0004468; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0005925; GO:0007283; GO:0019799; GO:0021542; GO:0030424; GO:0044546; GO:0045598; GO:0048666; GO:0060271; GO:0070507; GO:0071929; GO:0072686; GO:0097427; GO:1900227 "lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; tubulin N-acetyltransferase activity [GO:0019799]" GAIIGFIKVGYK 0.99512 -8.8964 11.6093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0487 14.8606 0 0 13.6511 0 0 14.8619 0 0 0 0 0 0 0 15.1801 0 0 0 0 0 0 0 0 0 0 0 12.6072 0 13.3529 14.6996 13.8681 0 13.984 14.7706 14.7952 0 0 0 15.7229 0 0 13.6998 0 0 0 15.0417 0 0 13.8104 14.0167 14.1466 14.4233 14.6303 0 13.5093 14.7365 14.3355 14.4108 12.9534 13.3597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7772 0 0 0 0 0 0 12.2536 0 Q6IMI4 ST6B1_HUMAN "Sulfotransferase 6B1, ST6B1 (Thyroxine sulfotransferase, EC 2.8.2.n2)" SULT6B1 Homo sapiens (Human) sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923] GO:0005737; GO:0005829; GO:0008146; GO:0051923 sulfotransferase activity [GO:0008146] AKILVIFR 0.99512 -32.641 0 0 0 0 0 13.6721 0 0 0 0 13.7446 0 0 9.33269 0 12.6006 0 0 0 0 0 0 11.3848 0 0 0 0 10.7729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0779 0 0 0 0 11.6463 0 0 0 0 9.71352 11.6319 10.9588 0 10.186 0 0 0 0 0 0 0 0 11.0122 0 11.474 0 0 0 0 0 0 0 0 0 12.175 11.7962 12.3092 11.8299 0 0 0 0 0 0 0 0 0 0 0 0 13.1697 0 0 0 11.6103 0 0 0 0 0 0 0 0 0 0 0 0 16.4152 0 0 15.5827 15.4231 0 15.1323 0 13.8886 0 14.3708 13.9181 13.6472 15.1137 0 0 0 0 13.0336 0 0 0 12.6782 17.4483 0 0 12.8996 15.1214 0 0 0 14.818 0 0 14.5987 16.0568 0 0 0 14.9256 0 0 0 0 0 0 11.6334 0 0 0 0 0 0 12.3994 11.7047 0 15.3787 0 0 0 13.6527 0 17.1526 0 11.601 0 0 0 0 Q6PK18 OGFD3_HUMAN "2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3, EC 1.14.11.-" OGFOD3 C17orf101 Homo sapiens (Human) integral component of membrane [GO:0016021]; membrane [GO:0016020] "integral component of membrane [GO:0016021]; membrane [GO:0016020]; dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" GO:0005506; GO:0016020; GO:0016021; GO:0016705; GO:0031418; GO:0051213 "dioxygenase activity [GO:0051213]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" FIEVPCSEDYDSHR 0.99512 -8.3286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.471 0 13.5978 0 0 0 0 0 0 0 0 0 12.7398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7134 0 12.9293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4795 12.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0477 0 0 0 0 0 0 0 0 0 0 12.4427 0 0 0 0 0 0 Q86TW2 ADCK1_HUMAN "AarF domain-containing protein kinase 1, EC 2.7.-.-" ADCK1 Homo sapiens (Human) lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; phosphorylation [GO:0016310]; positive regulation of cristae formation [GO:1903852] extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743] extracellular region [GO:0005576]; integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; phosphorylation [GO:0016310]; positive regulation of cristae formation [GO:1903852] GO:0004674; GO:0005524; GO:0005576; GO:0005743; GO:0007005; GO:0010637; GO:0016310; GO:0032592; GO:0055088; GO:1903852 ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674] AVLHDGR 0.99512 -35.655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.893 0 12.8744 0 13.1312 12.525 13.0157 12.5101 12.3615 13.2036 12.7583 0 0 0 0 0 0 0 0 0 0 0 0 14.6695 0 0 0 0 0 13.922 15.3605 0 0 0 0 0 13.5336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0363 0 0 0 0 0 0 10.5044 0 0 10.8794 0 0 0 0 0 0 0 0 0 0 14.4944 0 0 0 0 0 0 0 0 0 0 12.1014 0 0 0 0 0 0 0 0 0 0 0 15.0301 0 0 0 0 0 0 0 0 0 0 12.5943 12.9867 0 0 12.6402 0 0 12.6473 0 0 0 0 12.6619 0 12.8301 0 0 Q86XN6 ZN761_HUMAN Zinc finger protein 761 ZNF761 KIAA2033 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CDVCGKLFNQK 0.99512 -11.628 0 0 0 0 0 0 0 0 10.8808 0 0 0 14.2202 12.991 0 0 11.0235 11.0914 10.7718 0 0 0 0 0 0 0 12.1449 0 12.1403 0 0 12.0488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.664 0 0 0 0 13.1643 0 0 0 0 0 0 0 0 0 11.8098 11.0682 0 11.3026 0 0 0 0 9.89417 0 0 0 0 0 0 0 0 0 12.9748 10.9949 0 14.7857 0 0 0 0 0 0 0 13.8515 0 14.0852 0 0 11.3419 14.7954 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1618 13.246 0 0 0 0 0 0 0 0 0 0 11.3809 0 0 0 10.8269 0 0 0 13.0921 0 0 12.8216 0 0 13.0378 11.4712 0 0 14.9611 0 0 0 0 12.7085 14.1953 14.5067 0 0 0 0 0 0 0 0 12.7538 0 13.056 0 13.6575 0 0 0 12.9261 0 12.9931 0 0 0 13.2484 0 0 0 0 13.3117 11.6855 0 0 0 Q8IWY8 ZSC29_HUMAN Zinc finger and SCAN domain-containing protein 29 (Zinc finger protein 690) ZSCAN29 ZNF690 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ELPSGSHIGDRR 0.99512 -32.58 0 0 0 0 11.0701 0 0 0 0 0 0 0 0 9.43123 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8558 0 0 0 0 11.7703 0 0 0 0 0 0 0 11.4448 0 0 0 0 0 0 0 0 0 0 11.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.038 13.6076 11.1775 10.9005 0 0 0 13.9991 11.6248 0 0 0 14.9343 14.0199 0 0 0 0 15.953 12.881 0 14.3314 0 0 0 13.776 0 13.5473 0 14.9352 14.2475 13.8379 0 0 13.5141 0 0 0 14.6068 10.3623 0 0 13.8996 0 0 14.0029 13.6491 0 0 13.9417 0 13.8061 0 0 13.5335 13.9896 13.6249 13.8214 0 11.0287 13.7269 0 14.5434 0 13.5751 13.9473 0 13.9092 12.1977 13.5275 0 0 13.4315 0 0 0 0 13.5937 0 13.6433 13.7947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0737 14.072 0 0 0 0 0 0 0 Q8N8B7 TEANC_HUMAN Transcription elongation factor A N-terminal and central domain-containing protein (TFIIS central domain-containing protein 1) TCEANC Homo sapiens (Human) "transcription, DNA-templated [GO:0006351]" nucleus [GO:0005634] "nucleus [GO:0005634]; transcription, DNA-templated [GO:0006351]" GO:0005634; GO:0006351 AKCLLSKWK 0.99512 -11.273 0 0 0 0 0 0 0 0 10.363 0 0 11.8035 0 0 11.6917 0 0 0 0 0 12.5221 0 0 0 0 0 0 0 0 0 0 10.7586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3074 0 0 0 0 0 0 0 13.5468 0 12.5464 0 12.9428 13.2215 0 0 0 13.3088 13.3545 14.0234 13.7775 0 13.4534 0 15.2307 0 13.0387 13.3846 0 0 0 0 0 0 0 0 0 0 0 13.0124 0 0 0 0 13.865 0 0 15.4664 0 0 0 0 13.0278 0 0 0 13.2132 0 13.9353 13.4993 12.9763 13.1156 13.4185 0 0 12.7376 12.8265 0 13.7087 0 15.709 15.847 0 0 16.9919 15.0229 14.7347 0 0 0 0 0 0 0 0 0 0 0 14.1373 13.8266 0 0 0 0 0 0 0 14.8831 0 0 0 0 0 0 0 15.07 0 13.6634 0 0 0 0 0 0 Q96MC2 DRC1_HUMAN Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164) DRC1 C2orf39 CCDC164 Homo sapiens (Human) axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of cilium movement [GO:0003352] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of cilium movement [GO:0003352] GO:0003352; GO:0005829; GO:0005858; GO:0005930; GO:0007368; GO:0007507; GO:0031514; GO:0060285; GO:0070286 AMRHFALIDDEKFWEIWLMNEEEAK 0.99512 -11.268 0 0 0 0 0 0 0 0 0 0 10.441 0 0 0 0 0 0 0 12.5467 0 0 0 0 13.0056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3043 0 0 0 12.7569 0 0 0 12.8018 11.4038 0 0 0 0 13.1719 0 0 0 16.3607 0 0 14.4647 15.8143 16.1152 0 0 12.9637 0 0 0 14.3072 0 0 15.0924 0 0 0 13.6321 0 0 0 0 0 0 15.6083 0 0 0 17.1338 12.5954 0 0 0 14.4184 14.1808 0 14.7825 0 0 0 0 0 14.7282 14.4468 12.0276 0 0 0 0 0 0 0 14.138 15.3536 0 0 0 0 0 12.4348 0 0 0 0 12.2635 14.3873 15.0493 14.3204 0 0 0 11.2908 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3435 12.2706 10.8933 0 12.8661 0 0 Q9BQ83 SLX1_HUMAN "Structure-specific endonuclease subunit SLX1, EC 3.1.-.- (GIY-YIG domain-containing protein 1)" SLX1A GIYD1 SLX1; SLX1B GIYD2 SLX1 Homo sapiens (Human) DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of t-circle formation [GO:1904431]; t-circle formation [GO:0090656]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric D-loop disassembly [GO:0061820] nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557] nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; metal ion binding [GO:0046872]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of t-circle formation [GO:1904431]; t-circle formation [GO:0090656]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric D-loop disassembly [GO:0061820] GO:0000724; GO:0005654; GO:0006281; GO:0008821; GO:0010792; GO:0010833; GO:0017108; GO:0033557; GO:0046872; GO:0061820; GO:0090656; GO:1904357; GO:1904431 5'-flap endonuclease activity [GO:0017108]; crossover junction endodeoxyribonuclease activity [GO:0008821]; metal ion binding [GO:0046872] APPWARLPLTLRWVR 0.99512 -10.386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3366 0 0 0 0 0 0 12.6515 0 0 0 0 0 0 0 0 0 0 0 12.9809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8653 0 0 0 0 0 12.041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0751 0 0 0 0 0 13.3326 13.3451 0 0 0 0 0 0 0 Q9BZV3 IMPG2_HUMAN "Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa, IPM 200) (Sialoprotein associated with cones and rods proteoglycan, Spacrcan)" IMPG2 IPM200 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; retina morphogenesis in camera-type eye [GO:0060042]; visual perception [GO:0007601] cell projection [GO:0042995]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; interphotoreceptor matrix [GO:0033165]; receptor complex [GO:0043235] cell projection [GO:0042995]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; interphotoreceptor matrix [GO:0033165]; receptor complex [GO:0043235]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]; extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; retina morphogenesis in camera-type eye [GO:0060042]; visual perception [GO:0007601] GO:0005201; GO:0005540; GO:0005576; GO:0007601; GO:0008104; GO:0008201; GO:0016021; GO:0030198; GO:0031012; GO:0033165; GO:0042995; GO:0043235; GO:0060042 extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540] EIRVLEFR 0.99512 -10.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4182 0 0 0 0 0 0 0 0 0 0 0 11.4002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.969 0 0 0 13.4698 0 13.0073 0 0 0 0 0 0 13.3029 0 0 0 0 0 0 0 0 0 0 0 0 12.111 0 0 0 0 0 0 14.9847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZV7 HPLN2_HUMAN Hyaluronan and proteoglycan link protein 2 (Brain link protein 1) HAPLN2 BRAL1 Homo sapiens (Human) cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; establishment of blood-nerve barrier [GO:0008065]; extracellular matrix assembly [GO:0085029]; skeletal system development [GO:0001501] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; node of Ranvier [GO:0033268] extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; node of Ranvier [GO:0033268]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; establishment of blood-nerve barrier [GO:0008065]; extracellular matrix assembly [GO:0085029]; skeletal system development [GO:0001501] GO:0001501; GO:0005540; GO:0005576; GO:0007155; GO:0007417; GO:0008065; GO:0031012; GO:0033268; GO:0085029 hyaluronic acid binding [GO:0005540] FPITTPRPR 0.99512 -5.4282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.59289 0 0 12.563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8482 0 0 0 0 0 0 12.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1661 0 0 0 0 0 0 0 0 0 0 Q9H5X1 CIA2A_HUMAN Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A) CIAO2A CIA2A FAM96A Homo sapiens (Human) chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428] CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428] GO:0005654; GO:0005829; GO:0007059; GO:0016226; GO:0046872; GO:0097361; GO:0097428; GO:0106035 metal ion binding [GO:0046872] QPRIMEEK 0.99512 -12.566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0873 0 0 0 0 11.4859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7H0 MET17_HUMAN "Methyltransferase-like protein 17, mitochondrial, EC 2.1.1.- (False p73 target gene protein) (Methyltransferase 11 domain-containing protein 1) (Protein RSM22 homolog, mitochondrial)" METTL17 METT11D1 Homo sapiens (Human) methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412] mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047]; methylation [GO:0032259]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412] GO:0005654; GO:0005759; GO:0006412; GO:0008168; GO:0032259; GO:0042274; GO:1904047 methyltransferase activity [GO:0008168]; S-adenosyl-L-methionine binding [GO:1904047] DLYRCAR 0.99512 -11.248 0 0 0 0 0 0 0 0 0 0 0 14.2712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2563 0 0 13.5314 0 10.778 0 0 0 0 0 0 0 0 11.8172 0 13.1728 13.1179 0 0 0 13.1648 13.5723 14.1851 0 0 13.4387 0 0 0 14.3701 13.5613 14.8996 13.7718 0 0 14.0152 0 0 0 0 0 0 0 0 0 0 0 16.876 0 0 0 0 0 14.6266 0 0 14.6131 0 13.1423 0 16.1102 0 0 0 17.0493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBU9 POPD2_HUMAN "Popeye domain-containing protein 2, Popeye protein 2" POPDC2 POP2 Homo sapiens (Human) heart development [GO:0007507]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146] integral component of membrane [GO:0016021]; sarcolemma [GO:0042383] integral component of membrane [GO:0016021]; sarcolemma [GO:0042383]; cAMP binding [GO:0030552]; heart development [GO:0007507]; regulation of heart rate [GO:0002027]; regulation of membrane potential [GO:0042391]; skeletal muscle tissue development [GO:0007519]; striated muscle cell differentiation [GO:0051146] GO:0002027; GO:0007507; GO:0007519; GO:0016021; GO:0030552; GO:0042383; GO:0042391; GO:0051146 cAMP binding [GO:0030552] FGLRFDIR 0.99512 -12.565 0 0 0 0 13.2393 0 0 0 0 13.5655 0 0 0 0 0 0 0 0 0 10.6386 0 10.0896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5102 0 0 0 0 0 0 0 0 0 0 0 0 9.92438 0 0 0 0 0 0 13.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8894 0 0 0 0 14.4243 13.854 0 0 13.8357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3685 Q9NQV6 PRD10_HUMAN "PR domain zinc finger protein 10, EC 2.1.1.- (PR domain-containing protein 10) (Tristanin)" PRDM10 KIAA1231 PFM7 TRIS Homo sapiens (Human) methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468] GO:0000785; GO:0003677; GO:0005634; GO:0008168; GO:0010468; GO:0017053; GO:0032259; GO:0045944; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168] DFLCSTCGK 0.99512 -35.886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1601 0 0 0 0 13.6342 12.1309 0 0 0 0 0 10.6645 0 0 0 11.3392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0646 15.3785 11.6491 14.9728 17.651 0 15.7195 0 14.3208 0 14.1111 0 10.1343 0 14.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6591 0 0 13.3032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6525 0 13.7042 0 Q9NXH9 TRM1_HUMAN "tRNA (guanine(26)-N(2))-dimethyltransferase, EC 2.1.1.216 (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)" TRMT1 Homo sapiens (Human) tRNA modification [GO:0006400]; tRNA N2-guanine methylation [GO:0002940] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; tRNA modification [GO:0006400]; tRNA N2-guanine methylation [GO:0002940] GO:0000049; GO:0002940; GO:0003723; GO:0004809; GO:0005634; GO:0005654; GO:0006400; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049] DLTCAVITEFARIQLGAKGIQIK 0.99512 -12.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4868 0 11.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2281 0 0 13.3592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UNS1 TIM_HUMAN "Protein timeless homolog, hTIM" TIMELESS TIM TIM1 TIMELESS1 Homo sapiens (Human) "branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]" GO:0000076; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0009582; GO:0030324; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048478; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781 DNA binding [GO:0003677]; identical protein binding [GO:0042802] AFVELLFWKNTAVVR 0.99512 -11.267 0 0 0 0 0 14.623 14.461 0 14.475 0 0 0 0 0 0 13.1437 11.3735 0 11.6357 0 14.3382 11.7917 0 0 0 0 0 0 12.4653 0 11.0206 0 0 0 0 0 0 0 0 0 13.3478 0 0 0 0 0 14.2099 0 0 0 0 0 0 0 11.5256 0 0 9.70032 0 0 0 0 0 0 0 0 14.6792 14.7112 14.6214 13.8243 0 15.3759 14.8146 15.1798 0 0 10.1166 14.015 14.696 13.5666 0 16.5959 12.511 0 0 13.5998 0 0 0 11.4023 12.9606 0 0 0 0 0 13.0672 13.9422 0 0 0 14.8242 18.5086 0 0 13.0541 12.8986 13.4703 0 0 0 0 12.7665 13.972 0 13.2541 0 0 15.6523 13.9818 14.9921 0 0 15.8191 0 0 0 0 13.1772 0 0 12.0672 17.0167 13.6794 0 17.11 0 9.12652 0 14.2083 0 0 16.3521 11.9067 15.5141 0 11.6921 0 0 0 13.1637 0 0 0 14.6523 0 11.9998 0 0 0 0 12.5949 0 0 12.6134 0 0 0 0 0 0 11.7736 0 12.8719 0 15.8855 0 0 0 0 A6NEC2 PSAL_HUMAN "Puromycin-sensitive aminopeptidase-like protein, EC 3.4.11.-" NPEPPSL1 Homo sapiens (Human) peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508] GO:0005737; GO:0006508; GO:0008270; GO:0042277; GO:0043171; GO:0070006; GO:0070062 metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] AIKATFDISLVVPK 0.99513 -5.4414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17020 ZNF16_HUMAN Zinc finger protein 16 (Zinc finger protein KOX9) ZNF16 HZF1 KOX9 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to sodium dodecyl sulfate [GO:0072707]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell cycle phase transition [GO:1901989]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of kinase activity [GO:0033674]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0005730; GO:0006357; GO:0007049; GO:0008284; GO:0033674; GO:0043066; GO:0045648; GO:0045654; GO:0046872; GO:0051301; GO:0051781; GO:0072707; GO:1901989 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFSQRSKLIK 0.99513 -5.4496 10.8195 0 11.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0224 0 0 0 0 0 0 0 0 0 11.9503 0 0 0 0 0 0 12.5388 0 0 0 0 0 0 0 0 9.54214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.917 15.0897 0 15.0505 13.3673 0 15.1518 13.4451 15.0566 0 15.7602 0 0 0 12.5594 0 0 0 10.6584 0 13.0241 0 0 0 0 0 0 0 12.6722 0 0 0 0 0 0 0 0 0 0 12.9855 0 0 0 0 0 12.0643 0 0 0 12.4 0 0 12.0093 14.1291 0 0 0 0 0 0 0 14.9744 0 0 0 13.7524 0 0 0 0 0 0 0 0 0 0 10.1271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1053 0 P23919 KTHY_HUMAN "Thymidylate kinase, EC 2.7.4.9 (dTMP kinase)" DTYMK CDC8 TMPK TYMK Homo sapiens (Human) cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; phosphorylation [GO:0016310]; thymidine biosynthetic process [GO:0046105] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; phosphorylation [GO:0016310]; thymidine biosynthetic process [GO:0046105] GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0016310; GO:0046105; GO:0071363 ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041] LLSSYLQK 0.99513 -5.4519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.335 0 0 0 0 11.7192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2019 0 0 0 0 0 0 0 14.1728 0 0 14.1909 0 0 0 0 0 0 0 0 12.3832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1173 12.7179 0 0 0 0 12.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36954 RPB9_HUMAN "DNA-directed RNA polymerase II subunit RPB9, RNA polymerase II subunit B9 (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit, RPB14.5)" POLR2I Homo sapiens (Human) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]" "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]" GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0006379; GO:0008270 DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270] FCQECNNMLYPK 0.99513 -10.451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46109 CRKL_HUMAN Crk-like protein CRKL Homo sapiens (Human) acetylcholine receptor signaling pathway [GO:0095500]; activation of GTPase activity [GO:0090630]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pharynx development [GO:0060465]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Ras protein signal transduction [GO:0007265]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655] cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591]; acetylcholine receptor signaling pathway [GO:0095500]; activation of GTPase activity [GO:0090630]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pharynx development [GO:0060465]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Ras protein signal transduction [GO:0007265]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; synapse assembly [GO:0007416]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655] GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0001933; GO:0001934; GO:0003151; GO:0003723; GO:0005654; GO:0005829; GO:0006629; GO:0007165; GO:0007254; GO:0007265; GO:0007283; GO:0007338; GO:0007416; GO:0008284; GO:0008543; GO:0008584; GO:0009952; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035556; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0045296; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060465; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0086100; GO:0090630; GO:0095500; GO:0098749; GO:0098761; GO:0098890; GO:1900026; GO:1903977; GO:1904393; GO:1904888; GO:2000404 cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591] AIQKRVPCAYDK 0.99513 -5.4543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5994 13.9456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51864 TDGF3_HUMAN Putative teratocarcinoma-derived growth factor 3 (Cripto-3 growth factor) (Epidermal growth factor-like cripto protein CR3) (Teratocarcinoma-derived growth factor 1 pseudogene 3) TDGF1P3 CRIPTO3 TDGF2 TDGF3 Homo sapiens (Human) anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092]; signal transduction [GO:0007165] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; activin receptor binding [GO:0070697]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092]; signal transduction [GO:0007165] GO:0001568; GO:0005102; GO:0005576; GO:0005886; GO:0007165; GO:0007368; GO:0007507; GO:0008083; GO:0009952; GO:0009986; GO:0038092; GO:0038100; GO:0048856; GO:0070697 activin receptor binding [GO:0070697]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102] DCRKMVR 0.99513 -10.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.038 0 12.1568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53355 DAPK1_HUMAN "Death-associated protein kinase 1, DAP kinase 1, EC 2.7.11.1" DAPK1 DAPK Homo sapiens (Human) apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; DAPK1-calmodulin complex [GO:1990722]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; DAPK1-calmodulin complex [GO:1990722]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834] GO:0002357; GO:0002834; GO:0004672; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010506; GO:0010508; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043280; GO:0046777; GO:0071346; GO:0071447; GO:0097190; GO:0106310; GO:1904094; GO:1990722; GO:2000310 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; syntaxin-1 binding [GO:0017075] CQMEVIK 0.99513 -12.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3493 0 0 0 14.0824 0 0 13.6204 16.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4097 0 0 0 0 0 13.3249 0 0 0 0 12.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1517 0 0 12.5147 0 0 0 0 0 12.7119 0 0 0 12.1864 15.0411 15.5104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78411 IRX5_HUMAN Iroquois-class homeodomain protein IRX-5 (Homeodomain protein IRX-2A) (Homeodomain protein IRXB2) (Iroquois homeobox protein 5) IRX5 IRX2A IRXB2 Homo sapiens (Human) cell development [GO:0048468]; embryonic cranial skeleton morphogenesis [GO:0048701]; gonad development [GO:0008406]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; vitamin D binding [GO:0005499]; cell development [GO:0048468]; embryonic cranial skeleton morphogenesis [GO:0048701]; gonad development [GO:0008406]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" GO:0000785; GO:0000978; GO:0000981; GO:0005499; GO:0005634; GO:0006357; GO:0007601; GO:0008406; GO:0030182; GO:0048468; GO:0048701; GO:0050896; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; vitamin D binding [GO:0005499]" ENKMTWTPR 0.99513 -12.194 0 0 0 0 0 0 11.008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3995 0 0 0 0 0 9.101 0 0 0 0 0 0 0 0 0 0 0 0 11.8892 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7807 0 0 0 0 0 0 0 0 0 0 13.4078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53QZ3 RHG15_HUMAN Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15) ARHGAP15 BM-024 BM-030 BM-046 Homo sapiens (Human) regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005737; GO:0005829; GO:0007165; GO:0008360; GO:0016020; GO:0043087; GO:0051056 GTPase activator activity [GO:0005096] FITRRPSLK 0.99513 -10.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q68CP4 HGNAT_HUMAN "Heparan-alpha-glucosaminide N-acetyltransferase, EC 2.3.1.78 (Transmembrane protein 76)" HGSNAT TMEM76 Homo sapiens (Human) lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259] GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016021; GO:0016746; GO:0035579; GO:0051259; GO:0070821 acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019] DNQSHKEHLTQNIVATALWVLIAYILYRK 0.99513 -10.421 0 0 0 0 0 0 0 0 0 11.8137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6068 13.8754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0005 12.8016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0197 0 0 13.6785 0 0 0 0 13.7507 0 0 14.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86W11 ZSC30_HUMAN Zinc finger and SCAN domain-containing protein 30 (ZNF-WYM) (Zinc finger protein 397 opposite strand) (Zinc finger protein 397OS) ZSCAN30 ZNF397OS Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GNAAGNK 0.99513 -10.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5C7 DTWD1_HUMAN "tRNA-uridine aminocarboxypropyltransferase 1, EC 2.5.1.25 (DTW domain-containing protein 1)" DTWD1 MDS009 Homo sapiens (Human) tRNA modification [GO:0006400] nucleus [GO:0005634] nucleus [GO:0005634]; tRNA-uridine aminocarboxypropyltransferase activity [GO:0016432]; tRNA modification [GO:0006400] GO:0005634; GO:0006400; GO:0016432 tRNA-uridine aminocarboxypropyltransferase activity [GO:0016432] AQQSGRSK 0.99513 -8.9626 0 0 0 10.4119 0 0 0 0 11.9132 12.4753 12.3157 12.4843 11.9027 11.5874 0 0 0 0 0 0 0 0 0 0 0 12.4627 11.7616 0 0 0 0 13.9595 0 0 12.8436 0 0 11.8778 12.3034 11.4286 0 13.8673 13.6168 12.8586 12.2327 0 12.6889 14.0703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9386 0 0 0 0 0 14.1251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1752 0 0 0 0 0 11.3026 0 0 0 0 0 0 0 13.1176 0 0 0 0 15.0643 0 0 0 0 0 0 0 0 0 0 0 0 15.0529 0 0 0 0 0 0 0 0 14.9323 0 0 0 13.7938 0 0 14.6698 10.8005 0 0 0 14.3401 0 0 0 0 0 0 13.4366 11.5546 0 0 0 0 0 0 12.4013 12.923 0 0 0 0 0 0 0 11.3417 0 0 0 0 0 Q8TE82 S3TC1_HUMAN SH3 domain and tetratricopeptide repeat-containing protein 1 SH3TC1 Homo sapiens (Human) AYKSALDYTK 0.99513 -11.367 0 0 0 12.125 0 0 13.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3227 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3574 0 0 0 13.5105 0 0 14.2164 11.1132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9417 0 0 0 12.2923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4475 10.9106 0 12.2479 0 12.4861 0 11.9199 0 0 0 0 13.8408 14.4529 0 0 0 0 0 0 10.2796 0 0 11.863 12.7347 13.6957 0 0 0 0 13.3622 0 10.6426 0 0 0 0 13.6991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCX4 TRPC7_HUMAN "Short transient receptor potential channel 7, TrpC7 (Transient receptor protein 7, TRP-7, hTRP7)" TRPC7 TRP7 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338] cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] "cation channel complex [GO:0034703]; cis-Golgi network [GO:0005801]; integral component of plasma membrane [GO:0005887]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; manganese ion transport [GO:0006828]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]" GO:0005262; GO:0005635; GO:0005801; GO:0005886; GO:0005887; GO:0006828; GO:0007338; GO:0015279; GO:0034703; GO:0048471; GO:0051480; GO:0070588; GO:0070679 "calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]" DDDFYAYDEDGTR 0.99513 -9.4907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77325 0 0 0 0 0 0 0 0 0 10.7771 11.2077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9664 0 0 0 0 0 13.0835 0 0 0 0 0 0 0 0 0 0 14.914 0 0 0 0 0 0 0 0 12.7026 0 0 0 0 12.48 0 0 0 0 0 13.5713 13.034 0 0 0 12.7573 0 0 0 9.99223 0 0 0 11.4449 12.1954 0 12.7668 12.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.621 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8948 0 0 0 0 0 0 0 12.7016 0 0 0 0 0 0 0 0 9.24942 0 Q9Y2F9 BTBD3_HUMAN BTB/POZ domain-containing protein 3 BTBD3 KIAA0952 Homo sapiens (Human) cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008] GO:0005634; GO:0005829; GO:0021987; GO:0022008; GO:0042802; GO:0048813 identical protein binding [GO:0042802] FQSCAYR 0.99513 -5.4536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6292 14.4509 0 14.8845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3575 0 0 0 0 0 13.7501 0 0 0 0 0 14.3527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2U5 M3K2_HUMAN "Mitogen-activated protein kinase kinase kinase 2, EC 2.7.11.25 (MAPK/ERK kinase kinase 2, MEK kinase 2, MEKK 2)" MAP3K2 MAPKKK2 MEKK2 Homo sapiens (Human) "cellular response to mechanical stimulus [GO:0071260]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to mechanical stimulus [GO:0071260]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]" GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0019901; GO:0045893; GO:0046872; GO:0071260; GO:0106310 ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] APTNWRLGK 0.99513 -8.9608 0 0 0 0 0 0 0 0 0 0 11.7791 0 0 0 0 11.7594 0 0 11.7613 0 0 0 0 0 12.0077 0 0 11.6557 0 0 0 0 0 0 0 0 0 0 0 0 11.5546 0 11.9915 0 0 0 0 0 0 0 0 0 0 0 0 11.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0799 12.8098 0 14.1223 0 0 0 0 0 0 0 0 0 13.2284 0 0 0 0 0 13.1981 0 0 13.1544 13.3042 0 0 11.4423 0 0 0 0 0 13.8881 0 0 12.2516 13.4957 0 12.7851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5105 14.8726 0 0 0 0 0 0 0 0 14.4781 0 0 13.217 13.1868 0 14.0732 13.2638 14.6036 14.8996 13.9131 13.7528 0 13.2813 14.8147 0 0 0 12.2245 0 0 14.476 0 0 O43847 NRDC_HUMAN "Nardilysin, EC 3.4.24.61 (N-arginine dibasic convertase, NRD convertase, NRD-C) (Nardilysin convertase)" NRDC NRD1 Homo sapiens (Human) negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; proteolysis [GO:0006508]; regulation of endopeptidase activity [GO:0052548] cell surface [GO:0009986]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cell surface [GO:0009986]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; epidermal growth factor binding [GO:0048408]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; proteolysis [GO:0006508]; regulation of endopeptidase activity [GO:0052548] GO:0004222; GO:0005739; GO:0005829; GO:0006508; GO:0009986; GO:0046872; GO:0048408; GO:0051044; GO:0052548; GO:0120163 epidermal growth factor binding [GO:0048408]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] AFTTTLNLLPYHKIVK 0.99514 -12.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9778 0 12.2223 12.7685 13.9663 0 0 0 0 0 13.3113 0 0 0 12.567 0 0 0 13.9876 0 0 0 0 0 0 0 0 0 0 13.6801 0 0 11.0179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0652 0 0 0 0 0 16.8673 0 0 0 14.1689 12.8578 15.9644 15.8888 15.8495 12.7624 0 16.651 0 0 16.946 0 16.0198 16.0984 0 16.4898 0 0 0 10.9003 0 0 0 15.7415 0 15.6692 14.9009 0 0 0 15.811 16.0032 0 0 14.7201 0 0 0 12.3624 14.8071 17.1435 0 16.1621 16.3069 0 16.5259 0 0 17.0518 0 0 0 16.0016 13.8081 0 0 0 0 0 16.7386 16.6948 0 16.3808 16.452 0 0 0 15.4754 15.7412 0 15.3971 0 0 13.5294 0 14.5777 0 16.9959 13.2467 0 15.98 0 0 0 0 0 0 0 0 0 12.238 0 0 0 0 16.6509 16.6186 0 15.8382 0 16.0191 0 15.9283 0 O75880 SCO1_HUMAN "Protein SCO1 homolog, mitochondrial" SCO1 SCOD1 Homo sapiens (Human) cellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; myofibril [GO:0030016]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617] GO:0005507; GO:0005739; GO:0006878; GO:0016531; GO:0030016; GO:0031305; GO:0033617 copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507] AMLVLVPGRVMR 0.99514 -8.9801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4426 0 0 0 0 0 0 0 0 0 0 10.8626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2723 0 0 0 0 0 0 0 9.71392 0 0 0 0 0 12.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5415 0 0 0 0 0 11.6636 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3727 0 13.7474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8919 0 0 0 0 0 0 0 0 0 0 0 0 O95400 CD2B2_HUMAN "CD2 antigen cytoplasmic tail-binding protein 2, CD2 cytoplasmic domain-binding protein 2, CD2 tail-binding protein 2 (U5 snRNP 52K protein, U5-52K)" CD2BP2 KIAA1178 Homo sapiens (Human) spliceosomal tri-snRNP complex assembly [GO:0000244] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682] cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; spliceosomal tri-snRNP complex assembly [GO:0000244] GO:0000244; GO:0001650; GO:0005634; GO:0005654; GO:0005682; GO:0005737; GO:0005829; GO:0016607; GO:0043021 ribonucleoprotein complex binding [GO:0043021] ERPPGQR 0.99514 -12.76 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4236 0 0 0 0 0 0 0 0 0 0 0 0 12.8871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2123 0 0 14.4616 0 0 0 0 0 P20674 COX5A_HUMAN "Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)" COX5A Homo sapiens (Human) "cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751] "mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]" GO:0004129; GO:0005743; GO:0005751; GO:0006123; GO:0009055; GO:0031966; GO:0045333; GO:0046872 cytochrome-c oxidase activity [GO:0004129]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872] CYSHGSQETDEEFDAR 0.99514 -10.465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3467 0 0 0 0 0 0 0 12.6853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2217 0 0 13.3464 14.4662 0 0 0 0 0 0 0 0 14.9871 0 0 14.2451 0 0 0 0 0 0 0 0 14.1844 0 0 0 0 0 0 14.3762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1535 0 0 0 0 0 0 0 P49619 DGKG_HUMAN "Diacylglycerol kinase gamma, DAG kinase gamma, EC 2.7.1.107 (Diglyceride kinase gamma, DGK-gamma)" DGKG DAGK3 Homo sapiens (Human) diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of protein kinase C signaling [GO:0090038]; neuron development [GO:0048666]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of dendrite development [GO:0050773] GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005829; GO:0005856; GO:0005886; GO:0006654; GO:0007205; GO:0008289; GO:0016020; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834; GO:0048666; GO:0050773; GO:0090038 ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; lipid binding [GO:0008289]; NAD+ kinase activity [GO:0003951] DVVCYLSLLETGR 0.99514 -11.027 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4362 0 0 0 0 0 0 0 13.5085 0 0 0 0 0 0 15.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2981 0 0 0 0 0 0 13.05 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4984 0 0 11.9016 0 0 0 0 0 0 0 14.8763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8047 0 0 0 0 0 0 0 0 P51689 ARSD_HUMAN "Arylsulfatase D, ASD, EC 3.1.6.-" ARSD Homo sapiens (Human) endoplasmic reticulum lumen [GO:0005788]; lysosome [GO:0005764] endoplasmic reticulum lumen [GO:0005788]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] GO:0004065; GO:0005764; GO:0005788; GO:0046872 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872] DSLPVLLFLCLLLKTCEPKTANAFK 0.99514 -5.4911 0 0 0 0 0 0 0 0 0 0 0 0 14.6866 0 14.7205 0 0 14.8869 0 0 0 0 14.7474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0568 14.68 0 0 0 0 0 16.3619 15.676 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3658 Q5GAN6 RNS10_HUMAN Inactive ribonuclease-like protein 10 RNASE10 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of flagellated sperm motility [GO:1902093]; regulation of fertilization [GO:0080154]; single fertilization [GO:0007338] extracellular region [GO:0005576] extracellular region [GO:0005576]; nucleic acid binding [GO:0003676]; defense response to Gram-positive bacterium [GO:0050830]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of flagellated sperm motility [GO:1902093]; regulation of fertilization [GO:0080154]; single fertilization [GO:0007338] GO:0003676; GO:0005576; GO:0007338; GO:0022409; GO:0034113; GO:0050830; GO:0080154; GO:1902093 nucleic acid binding [GO:0003676] ECNDMMAHK 0.99514 -10.473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3489 0 0 12.3423 0 0 12.8087 0 0 0 0 0 0 0 0 12.2583 0 0 12.3886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6375 0 12.5172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0043 0 0 0 0 0 0 0 0 0 0 0 0 13.1789 0 0 0 0 0 0 0 0 0 0 0 0 14.6104 15.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z3D4 LYSM3_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 3 LYSMD3 Homo sapiens (Human) Golgi organization [GO:0007030] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Golgi organization [GO:0007030] GO:0005794; GO:0005886; GO:0007030; GO:0016021 DIEQIVKCTDNK 0.99514 -8.6977 0 0 0 0 0 0 10.1011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4997 0 12.9536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8756 15.0191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N8A8 F169B_HUMAN Protein FAM169B FAM169B KIAA0888L Homo sapiens (Human) DDPECGVEEEDAGLAGQPPGK 0.99514 -8.981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4107 13.7878 0 0 14.5927 0 14.2669 14.106 15.1863 0 14.0303 0 14.7444 13.0916 13.6905 13.6946 13.202 14.4322 0 14.1647 0 0 0 0 0 0 0 13.4473 0 0 0 0 0 0 13.1992 0 0 0 0 0 0 0 0 0 0 0 12.7105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NDA8 MROH1_HUMAN Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A) MROH1 HEATR7A KIAA1833 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AAEALGRLVK 0.99514 -11.041 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64097 11.1667 0 0 0 0 0 0 0 0 0 0 0 15.5245 0 0 0 17.0321 0 0 0 13.315 0 0 0 0 0 0 0 0 0 0 0 12.8622 12.3981 0 0 14.4775 0 0 0 0 0 0 12.3529 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5199 0 12.3592 0 0 0 0 0 0 0 0 15.902 0 15.2312 0 0 0 0 0 0 0 0 0 0 0 14.744 14.7383 0 0 0 0 0 0 0 10.203 0 0 0 0 15.1267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTV7 CABL2_HUMAN "CDK5 and ABL1 enzyme substrate 2 (Interactor with CDK3 2, Ik3-2)" CABLES2 C20orf150 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell cycle [GO:0051726] cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell cycle [GO:0051726] GO:0007049; GO:0051301; GO:0051726 APPQALR 0.99514 -10.481 10.4026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6474 0 0 0 0 0 0 0 0 0 0 0 10.5824 12.6496 0 0 0 0 0 0 0 0 0 9.6206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.84317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4175 0 0 0 0 0 15.7058 14.9038 0 13.5077 0 0 0 13.7092 0 16.6364 13.9936 0 0 0 0 0 14.3662 0 12.8131 0 0 0 15.8598 13.5844 0 0 14.469 15.3205 15.6532 0 15.6742 0 0 0 0 0 15.0812 15.5222 15.8774 15.6325 15.8113 14.6868 14.2479 0 0 14.8087 14.9001 0 0 0 13.4155 0 0 15.4688 15.5699 0 15.1972 15.4871 15.1718 15.3122 15.7214 14.9325 0 14.896 15.3837 15.2403 15.3554 0 0 0 0 0 0 15.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2192 14.4893 0 0 0 0 0 0 Q9P2S5 WRP73_HUMAN WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene) WRAP73 WDR8 Homo sapiens (Human) cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; MWP complex [GO:1990811]; cell projection organization [GO:0030030]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization to mitotic spindle pole body [GO:1902440] GO:0000070; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0036064; GO:0072686; GO:0090307; GO:1902440; GO:1902857; GO:1990811 GLVQVWSLEQPEWHCK 0.99514 -10.489 0 0 0 0 0 0 0 0 12.5631 0 0 13.0624 0 12.7983 12.8188 0 0 12.8042 12.9195 0 0 11.4512 12.0912 0 12.2614 0 0 0 0 0 0 12.4139 0 11.7412 11.776 0 0 0 12.2454 0 11.752 0 0 0 12.0618 0 0 11.9728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2099 0 0 14.4815 0 0 12.8194 0 0 0 0 14.9163 0 0 0 0 0 0 0 13.57 0 0 0 0 0 0 0 0 0 14.5256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3697 0 0 0 13.3651 0 0 0 13.6225 0 0 13.4871 13.8483 13.6263 13.8605 13.4484 0 0 13.5921 0 13.7071 0 13.7979 13.1451 0 0 12.6292 0 Q8IYK2 CC105_HUMAN Coiled-coil domain-containing protein 105 CCDC105 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062] GO:0070062 AQHQINGR 0.99515 -31.441 0 0 0 0 13.0126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2726 15.2154 15.7321 14.6601 15.5817 13.6611 0 0 14.7585 15.2067 14.7676 14.6849 15.2365 0 13.6315 14.1271 0 16.589 0 14.4977 14.1409 0 0 0 0 0 0 0 13.4439 0 0 13.5581 0 14.2873 13.4826 0 15.2694 14.7874 14.9305 0 0 0 0 13.6289 13.6095 0 14.1351 0 0 0 13.3034 0 0 0 0 0 13.5845 0 0 0 0 0 13.2771 16.0707 13.8054 13.5058 0 12.2204 0 0 13.7107 12.8454 0 13.4391 0 0 12.7436 0 12.8359 0 0 0 13.1923 0 0 13.2625 14.1126 13.2667 14.5838 0 0 0 0 0 0 0 0 0 0 0 0 15.6945 0 0 0 0 0 15.6659 0 0 15.7491 0 0 0 O00338 ST1C2_HUMAN "Sulfotransferase 1C2, ST1C2, EC 2.8.2.1 (Sulfotransferase 1C1, SULT1C#1) (humSULTC2)" SULT1C2 SULT1C1 Homo sapiens (Human) amine metabolic process [GO:0009308]; sulfation [GO:0051923] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; amine metabolic process [GO:0009308]; sulfation [GO:0051923] GO:0004062; GO:0005737; GO:0005764; GO:0005829; GO:0008146; GO:0009308; GO:0051923 aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146] AMPSPRILK 0.99515 -5.4992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15375 MOT6_HUMAN "Monocarboxylate transporter 6, MCT 6 (Monocarboxylate transporter 5, MCT 5) (Solute carrier family 16 member 5)" SLC16A5 MCT5 MCT6 Homo sapiens (Human) monocarboxylic acid transport [GO:0015718] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; monocarboxylic acid transport [GO:0015718] GO:0005887; GO:0008028; GO:0015293; GO:0015718; GO:0016020; GO:0016021 monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] DLFLEAK 0.99515 -10.524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5566 0 0 0 0 0 13.1263 13.4522 13.2396 0 0 0 0 0 12.9978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1356 0 0 0 0 13.0424 0 0 0 0 12.313 0 0 12.7989 0 0 0 0 0 0 14.0822 0 0 0 0 13.6439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43167 ZBT24_HUMAN Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450) ZBTB24 KIAA0441 ZNF450 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0002244; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] DCHRKFMDVSQLK 0.99515 -10.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1374 0 0 0 0 0 14.2278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6567 0 0 0 0 0 0 0 0 0 12.7404 0 0 13.9034 0 0 0 0 0 0 11.9939 12.4782 12.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8269 0 0 0 0 0 0 0 0 0 0 0 12.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 P05305 EDN1_HUMAN "Endothelin-1 (Preproendothelin-1, PPET1) [Cleaved into: Endothelin-1, ET-1; Big endothelin-1 ]" EDN1 Homo sapiens (Human) adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; inositol phosphate-mediated signaling [GO:0048016]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C deactivation [GO:0042313]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093] basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093]; cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; inositol phosphate-mediated signaling [GO:0048016]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C deactivation [GO:0042313]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826] GO:0000122; GO:0001516; GO:0001569; GO:0001701; GO:0001821; GO:0001975; GO:0003100; GO:0003253; GO:0003357; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0006366; GO:0006468; GO:0006874; GO:0006885; GO:0007005; GO:0007166; GO:0007186; GO:0007193; GO:0007204; GO:0007205; GO:0007249; GO:0007267; GO:0007585; GO:0007589; GO:0008284; GO:0009953; GO:0010193; GO:0010259; GO:0010460; GO:0010595; GO:0010613; GO:0010629; GO:0010737; GO:0010827; GO:0014034; GO:0014065; GO:0014823; GO:0014824; GO:0014826; GO:0019229; GO:0019233; GO:0019722; GO:0030072; GO:0030133; GO:0030185; GO:0030195; GO:0030335; GO:0030878; GO:0031583; GO:0031707; GO:0031708; GO:0032308; GO:0032496; GO:0033093; GO:0033574; GO:0034392; GO:0034696; GO:0035050; GO:0035094; GO:0035810; GO:0035815; GO:0035994; GO:0042045; GO:0042310; GO:0042313; GO:0042474; GO:0042482; GO:0042554; GO:0043179; GO:0043200; GO:0043406; GO:0043507; GO:0044321; GO:0044751; GO:0045178; GO:0045321; GO:0045429; GO:0045793; GO:0045840; GO:0045944; GO:0045987; GO:0046887; GO:0046888; GO:0048016; GO:0048237; GO:0048661; GO:0048675; GO:0051091; GO:0051216; GO:0051248; GO:0051482; GO:0051771; GO:0051899; GO:0051930; GO:0060070; GO:0060137; GO:0060298; GO:0060385; GO:0060585; GO:0061051; GO:0061626; GO:0070101; GO:0070294; GO:0070301; GO:0070371; GO:0070588; GO:0071277; GO:0071310; GO:0071346; GO:0071347; GO:0071356; GO:0071372; GO:0071373; GO:0071385; GO:0071389; GO:0071398; GO:0071456; GO:0071466; GO:0071548; GO:0071560; GO:0086100; GO:0086101; GO:0090023; GO:0097492; GO:1901224; GO:1902074; GO:1902287; GO:1903537; GO:1904707; GO:2000273; GO:2001259 cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179] CQCASQK 0.99515 -10.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7081 0 0 0 0 0 0 0 0 14.0415 14.1138 17.0442 0 14.7206 0 0 0 12.5074 0 0 13.1269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3779 12.7902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19237 TNNI1_HUMAN "Troponin I, slow skeletal muscle (Troponin I, slow-twitch isoform)" TNNI1 Homo sapiens (Human) cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; regulation of striated muscle contraction [GO:0006942]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] cytosol [GO:0005829]; troponin complex [GO:0005861] cytosol [GO:0005829]; troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; cardiac muscle contraction [GO:0060048]; muscle contraction [GO:0006936]; regulation of striated muscle contraction [GO:0006942]; skeletal muscle contraction [GO:0003009]; transition between fast and slow fiber [GO:0014883]; ventricular cardiac muscle tissue morphogenesis [GO:0055010] GO:0003009; GO:0003779; GO:0005829; GO:0005861; GO:0006936; GO:0006942; GO:0014883; GO:0046872; GO:0055010; GO:0060048 actin binding [GO:0003779]; metal ion binding [GO:0046872] EAEKVRYLAER 0.99515 -10.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.42962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0243 0 0 0 0 12.2846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0555 0 0 0 0 0 0 0 0 0 12.316 0 13.0277 13.4732 14.4995 13.334 13.1697 13.8735 14.204 0 0 0 13.875 0 0 13.9258 12.8796 14.4013 0 13.6473 14.0744 0 0 0 0 12.0883 0 0 12.0218 0 0 11.8778 0 12.7659 13.2154 13.1699 0 0 14.7085 0 0 11.9475 13.2708 0 0 0 0 11.859 0 0 0 13.3277 13.3252 0 0 0 0 12.3598 0 11.8815 0 0 0 14.0188 13.8194 12.8906 12.7168 12.915 0 0 0 0 0 0 0 0 0 0 0 0 0 13.577 0 0 0 0 0 0 0 0 0 13.0724 0 Q10587 TEF_HUMAN Thyrotroph embryonic factor TEF KIAA1655 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0042802; GO:0044877; GO:0048511; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DEKYWTR 0.99515 -31.459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0221 0 0 18.9799 0 18.4641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.067 0 0 0 0 0 0 0 0 0 14.8341 0 0 0 0 0 0 0 0 0 0 13.0808 0 0 0 Q59GN2 R39L5_HUMAN Putative 60S ribosomal protein L39-like 5 (60S ribosomal protein L39 pseudogene 5) RPL39P5 Homo sapiens (Human) translation [GO:0006412] cytosolic large ribosomal subunit [GO:0022625] cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412] GO:0003735; GO:0006412; GO:0022625 structural constituent of ribosome [GO:0003735] IKQFLAK 0.99515 -12.833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3258 0 0 0 0 0 11.8147 13.9312 0 0 11.9763 0 0 0 0 16.8861 14.7257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9727 0 0 0 0 0 0 0 0 0 0 0 11.3035 0 0 0 0 0 0 0 0 0 0 0 Q5JRC9 FA47A_HUMAN Protein FAM47A FAM47A Homo sapiens (Human) EGMDDFR 0.99515 -31.831 12.4957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2916 0 0 12.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1011 0 0 0 0 11.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81791 0 0 0 0 0 15.9837 15.9721 14.864 14.7466 13.1605 15.1222 14.824 14.5796 15.1267 14.9229 15.1425 13.5001 12.6208 13.0291 0 15.2242 10.7532 15.2445 14.8187 14.8288 14.9812 11.7779 14.3233 0 0 15.0935 15.3766 12.3202 0 14.2875 0 14.4486 15.5688 15.01 0 13.6555 0 14.368 0 0 0 0 14.5303 14.7711 13.2625 0 0 14.9168 0 13.3147 12.055 0 13.2368 15.4681 0 14.1557 13.4222 11.366 12.5755 0 14.7936 0 14.5968 11.6676 0 13.9237 14.4095 15.7365 0 14.7355 0 14.4546 14.9004 0 12.7227 0 0 0 13.1282 12.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4721 14.0517 0 0 0 14.4268 0 Q5JU67 CF157_HUMAN Cilia- and flagella-associated protein 157 CFAP157 C9orf117 Homo sapiens (Human) sperm axoneme assembly [GO:0007288] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288] GO:0005829; GO:0005886; GO:0007288; GO:0008017; GO:0036064; GO:0043231 microtubule binding [GO:0008017] EMKEFYHIQIR 0.99515 -10.542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2725 11.8048 0 11.8061 0 0 0 0 12.4516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3403 13.9525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3962 0 0 0 13.6905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5898 0 12.1974 0 0 0 0 0 0 0 0 0 11.4106 11.5507 0 0 0 0 0 0 0 11.3611 0 0 0 0 14.2891 0 12.7891 11.9326 0 16.5861 0 0 0 0 0 0 0 0 0 13.3953 0 0 13.162 0 0 0 0 0 0 15.7463 0 0 13.5891 0 13.5166 13.0787 0 0 10.8647 0 0 0 14.2835 14.7001 0 0 0 0 0 0 0 0 11.6652 0 0 0 0 0 13.7145 13.603 0 0 0 0 0 0 0 Q5TGY3 AHDC1_HUMAN AT-hook DNA-binding motif-containing protein 1 AHDC1 Homo sapiens (Human) DNA binding [GO:0003677] GO:0003677 DNA binding [GO:0003677] AGGFGGR 0.99515 -12.844 0 0 0 0 0 9.48468 0 0 10.5181 0 0 0 0 0 0 0 0 0 0 9.92261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5149 0 0 0 0 0 0 10.067 0 0 0 10.9902 0 11.9716 0 0 0 0 0 10.73 13.1203 0 0 0 0 0 0 11.4318 10.9966 0 0 12.0805 0 0 0 0 0 0 0 0 0 15.1381 16.1995 0 14.3736 13.8751 14.2883 0 0 0 0 11.9575 0 13.4946 13.5445 16.4664 0 0 0 0 14.0193 0 0 12.6533 14.1598 11.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.117 0 0 0 0 0 0 0 0 13.0999 0 0 0 0 0 0 0 13.0714 0 0 12.7807 0 0 0 0 12.4272 0 0 0 13.7429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4855 0 0 0 11.0796 12.7797 11.6443 0 0 0 0 0 Q86UP2 KTN1_HUMAN Kinectin (CG-1 antigen) (Kinesin receptor) KTN1 CG1 KIAA0004 Homo sapiens (Human) microtubule-based movement [GO:0007018]; protein transport [GO:0015031] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723]; microtubule-based movement [GO:0007018]; protein transport [GO:0015031] GO:0003723; GO:0005783; GO:0005788; GO:0005789; GO:0005887; GO:0007018; GO:0015031; GO:0016020; GO:0016021; GO:0019894; GO:0030176; GO:0045296 cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723] DKLLAAVK 0.99515 -31.504 13.2948 0 11.2078 0 0 0 13.8871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1509 0 0 0 0 0 0 0 0 12.3076 0 0 0 15.3993 0 0 0 0 17.8028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0209 0 13.7889 0 0 15.9717 0 0 15.949 16.293 15.805 0 0 0 0 0 0 0 0 0 0 11.4532 0 12.1004 0 11.6527 0 0 0 0 0 12.9777 0 13.3633 0 0 0 0 0 16.2733 0 0 13.8929 13.859 0 13.3826 13.0248 13.1341 0 13.0792 11.6194 13.2838 0 0 0 10.6342 0 0 0 0 11.2175 17.4641 0 11.7953 0 17.1588 0 13.7486 0 15.955 0 0 0 11.6119 0 12.7963 0 0 12.2794 11.8812 0 17.7066 0 17.7361 13.2789 13.0757 0 0 14.948 0 0 0 12.3022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.429 16.7547 0 17.8351 0 0 0 0 0 0 0 11.9402 0 0 0 0 0 Q8ND71 GIMA8_HUMAN "GTPase IMAP family member 8 (Immune-associated nucleotide-binding protein 9, IAN-9) (Protein IanT)" GIMAP8 IAN9 IANT Homo sapiens (Human) regulation of T cell apoptotic process [GO:0070232] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; regulation of T cell apoptotic process [GO:0070232] GO:0005525; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0070232 GTP binding [GO:0005525] ALLTKVNDLRK 0.99515 -10.523 0 0 0 0 10.5145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.026 0 0 13.4134 0 0 0 0 0 0 0 14.0052 0 0 0 12.9705 0 0 0 0 0 0 0 13.0629 13.4712 0 0 0 13.1062 0 0 13.8143 0 0 0 0 0 0 0 0 12.3186 14.1803 13.9333 13.0645 0 13.6552 0 0 0 0 0 0 12.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2892 12.9445 0 0 0 0 0 0 0 0 0 0 0 16.9959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2152 0 0 0 0 0 0 Q92636 FAN_HUMAN "Protein FAN (Factor associated with neutral sphingomyelinase activation, Factor associated with N-SMase activation)" NSMAF FAN Homo sapiens (Human) ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; signal transduction [GO:0007165] GO:0005737; GO:0005829; GO:0006672; GO:0007165; GO:0016230; GO:0043065 sphingomyelin phosphodiesterase activator activity [GO:0016230] GSHHERK 0.99515 -12.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0589 18.0639 0 12.1487 12.3653 0 14.9945 0 12.4814 15.306 0 0 16.225 0 16.0303 16.2096 0 0 13.6309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7126 0 0 0 0 0 0 14.3151 0 0 0 15.3701 15.4157 0 0 14.5504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.61 0 0 0 0 0 14.25 0 0 0 0 0 13.2292 0 0 0 0 0 0 0 0 0 0 0 13.7688 14.0956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9222 0 13.3168 Q96EU6 RRP36_HUMAN Ribosomal RNA processing protein 36 homolog RRP36 C6orf153 HSPC253 Homo sapiens (Human) "cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]" 90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]" GO:0000462; GO:0000469; GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030686; GO:0042274 RNA binding [GO:0003723] AKEKELVK 0.99515 -31.45 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8618 0 0 0 0 0 13.2068 0 0 0 0 0 0 0 13.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6286 0 0 15.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EY4 TMA16_HUMAN Translation machinery-associated protein 16 TMA16 C4orf43 Homo sapiens (Human) nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654; GO:0005730 LKNEKALR 0.99515 -10.53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8101 0 12.9249 0 0 0 0 0 0 0 0 0 0 0 0 14.1298 0 13.9762 0 0 0 0 0 0 0 12.1222 0 13.5881 13.539 0 0 0 0 0 0 0 0 0 13.8049 14.1483 0 0 14.0682 0 0 13.3458 14.5924 0 0 0 14.1492 0 12.3129 13.1476 13.1794 0 0 0 0 13.5286 0 13.6059 0 0 12.5171 0 0 0 0 0 0 0 0 0 0 13.9385 0 0 0 12.0974 0 0 13.6479 0 12.6478 0 0 0 14.0969 11.719 15.0962 0 13.9883 0 13.9429 13.944 0 0 0 0 13.65 0 0 0 0 13.5375 0 0 0 0 0 0 0 11.2435 0 0 0 0 0 11.9622 13.6354 0 0 0 0 0 0 0 0 Q99941 ATF6B_HUMAN "Cyclic AMP-dependent transcription factor ATF-6 beta, cAMP-dependent transcription factor ATF-6 beta (Activating transcription factor 6 beta, ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein, Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta ]" ATF6B CREBL1 G13 Homo sapiens (Human) ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165] chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]" GO:0000785; GO:0000976; GO:0000981; GO:0003700; GO:0005634; GO:0005789; GO:0005794; GO:0006357; GO:0007165; GO:0030176; GO:0030968; GO:0032993; GO:0035497; GO:0036500; GO:0045944; GO:0090575; GO:1903892; GO:1990440; GO:1990837 "cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" ALPTRKPPLQPK 0.99515 -12.831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7647 0 0 0 0 0 0 0 0 0 0 0 12.8571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4587 0 0 0 0 0 0 13.2275 0 0 0 0 0 0 0 0 0 10.6567 0 0 0 0 0 0 0 0 0 0 0 13.8334 0 0 0 0 0 0 0 12.1368 0 13.3525 0 0 0 0 0 0 0 13.8315 12.8477 0 0 0 0 0 12.0642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9087 0 0 0 Q9NY93 DDX56_HUMAN "Probable ATP-dependent RNA helicase DDX56, EC 3.6.4.13 (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56)" DDX56 DDX21 NOH61 Homo sapiens (Human) positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364] membrane [GO:0016020]; nucleolus [GO:0005730] membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364] GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0006364; GO:0010976; GO:0016020; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] ATGPVVEQAVRGLVLVPTK 0.99515 -12.822 0 0 0 0 11.6171 11.0496 0 0 13.2994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8842 15.3672 15.3157 0 0 0 0 0 0 0 0 0 10.9733 0 0 0 0 0 0 0 0 0 0 0 10.2603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5342 16.5981 16.4364 0 14.9966 14.5821 15.0738 15.2144 10.5728 0 0 0 0 10.7262 12.6079 0 0 0 0 0 0 12.3018 12.8171 13.0616 11.0061 12.8965 0 0 0 0 0 11.1419 0 0 0 12.6167 0 0 0 0 0 15.5491 12.2563 0 0 0 0 15.1791 0 0 0 15.4158 15.0032 0 0 15.3854 10.7837 10.0879 0 12.2556 0 0 0 14.2461 0 0 11.931 12.0141 0 0 8.98496 0 0 15.2338 15.6826 11.5867 0 13.7898 0 14.2412 0 0 0 0 0 11.7811 14.3322 12.4466 0 0 0 13.161 0 9.82725 12.194 0 0 0 0 0 0 0 0 0 12.8296 0 0 0 0 0 12.4495 0 0 0 Q9P299 COPZ2_HUMAN "Coatomer subunit zeta-2 (Zeta-2-coat protein, Zeta-2 COP)" COPZ2 Homo sapiens (Human) "intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133] "cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005789; GO:0005801; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0030126; GO:0030133; GO:0033116 MQRPEAWPR 0.99515 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75762 TRPA1_HUMAN "Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120, p120) (Wasabi receptor)" TRPA1 ANKTM1 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421]; calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic substance [GO:0071310]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ion transport [GO:0006811]; protein homotetramerization [GO:0051289]; response to cold [GO:0009409]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955] GO:0005262; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0010033; GO:0014070; GO:0015267; GO:0015278; GO:0019233; GO:0032421; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070588; GO:0071310; GO:0097604 calcium channel activity [GO:0005262]; calcium-release channel activity [GO:0015278]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; temperature-gated cation channel activity [GO:0097604] AVALLLSHNADIVLNK 0.99516 -35.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5823 0 0 0 0 0 0 9.75632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.166 0 0 0 0 0 0 0 0 0 0 0 0 12.9618 0 0 0 12.2242 0 0 0 0 0 0 0 0 0 0 0 12.649 14.1523 12.121 0 0 0 15.1329 0 0 0 0 0 0 0 0 12.0327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5332 0 0 0 0 0 0 14.0375 0 0 0 0 0 0 0 0 0 0 0 0 12.9348 0 12.6405 0 0 0 0 13.0717 0 0 0 12.6922 13.4593 0 12.7913 0 0 0 0 0 13.1166 0 0 13.7765 0 0 0 14.6417 0 0 0 0 Q8N1H7 S6OS1_HUMAN Protein SIX6OS1 (Six6 opposite strand transcript 1) SIX6OS1 C14orf39 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; oogenesis [GO:0048477]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283] central element [GO:0000801]; chromosome [GO:0005694] central element [GO:0000801]; chromosome [GO:0005694]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; oogenesis [GO:0048477]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283] GO:0000801; GO:0005694; GO:0007129; GO:0007283; GO:0010705; GO:0048477; GO:0051090 DKEMYHDYICQYK 0.99516 -35.655 0 0 0 0 12.7774 0 0 0 0 10.692 0 0 0 0 0 0 0 0 13.2423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6196 0 0 0 13.627 13.4827 0 0 0 0 11.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3112 16.9778 0 17.1658 17.1148 17.6752 0 0 0 14.0251 13.5651 13.9286 0 16.8952 17.3737 14.1109 11.9314 14.7295 0 0 0 12.9236 12.4438 15.3368 15.1555 0 0 13.7715 17.2308 17.4432 0 16.1976 15.6607 14.6606 14.6027 0 0 16.503 0 14.0244 10.2874 0 0 16.1793 0 0 0 0 0 0 0 15.6052 0 0 0 0 0 13.1108 0 15.4634 11.1693 12.525 0 0 0 0 0 0 0 0 0 17.5211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9625 Q8NAP8 ZBT8B_HUMAN Zinc finger and BTB domain-containing protein 8B ZBTB8B Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" CPFCPYTAKQKGILK 0.99516 -10.559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8848 0 0 0 0 0 0 0 0 0 0 0 0 0 13.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7574 15.8784 0 0 0 0 0 0 0 0 13.6179 13.7497 12.7668 0 0 0 0 0 0 0 0 0 0 0 10.4323 0 0 0 12.7304 10.5577 12.0155 0 0 0 0 0 0 0 0 0 0 0 12.8209 11.5772 0 0 0 0 0 0 0 0 0 0 10.2495 0 0 0 0 0 0 0 0 Q9NYU2 UGGG1_HUMAN "UDP-glucose:glycoprotein glucosyltransferase 1, UGT1, hUGT1, EC 2.4.1.- (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1)" UGGT1 GT UGCGL1 UGGT UGT1 UGTR Homo sapiens (Human) 'de novo' post-translational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; protein-containing complex [GO:0032991]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' post-translational protein folding [GO:0051084]; endoplasmic reticulum mannose trimming [GO:1904380]; ER-associated misfolded protein catabolic process [GO:0071712]; protein N-linked glycosylation via asparagine [GO:0018279] GO:0003980; GO:0005783; GO:0005788; GO:0005793; GO:0018279; GO:0032991; GO:0044322; GO:0051082; GO:0051084; GO:0070062; GO:0071712; GO:1904380 UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082] ADMVNEDLLSDGTSENESGFWDSFKWGFTGQKTEEVK 0.99516 -15.422 0 0 0 0 0 0 0 0 0 13.3536 0 0 0 0 15.2279 0 0 0 0 12.1533 0 0 0 0 11.6093 13.2185 11.0707 14.683 0 11.5279 0 0 0 0 0 0 0 0 0 11.3368 0 11.4358 0 13.0718 0 13.4872 13.5575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8245 13.6569 0 0 0 17.8326 0 12.768 0 0 11.4238 19.3333 0 0 0 0 0 0 0 0 0 0 0 15.8067 16.0159 13.3537 0 0 0 0 0 0 0 17.4888 0 17.1635 12.1129 0 0 0 0 17.5992 10.7662 0 0 0 0 0 0 0 0 0 18.0599 0 0 0 17.948 0 0 0 0 0 13.1899 13.1871 0 12.8059 0 13.474 0 0 0 0 11.0922 0 0 0 0 0 12.6768 13.1488 14.2942 0 0 0 13.3599 13.6307 0 0 0 0 0 13.2602 0 0 0 P48634 PRC2A_HUMAN Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2) PRRC2A BAT2 G2 Homo sapiens (Human) cell differentiation [GO:0030154] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell differentiation [GO:0030154] GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016020; GO:0030154; GO:0070062 RNA binding [GO:0003723] AELHPVELKPFQDYQKLSSNLGGPGSSR 0.99517 -32.571 0 0 0 0 0 0 0 10.6127 16.5919 15.0564 14.7808 14.4621 14.9041 15.9791 16.0112 12.5229 0 0 13.9244 12.4643 0 0 0 0 11.7138 15.9221 16.3914 13.7563 15.7305 14.5332 12.4724 15.8104 0 15.1199 12.6906 0 0 15.5118 15.8715 10.7573 13.7008 16.2574 13.724 15.9723 16.2719 13.8763 0 14.7963 10.6343 12.2919 0 0 0 14.6138 15.2638 15.1014 15.5324 15.2048 13.0867 14.4697 0 12.49 12.2821 13.8162 12.9953 0 0 0 0 0 0 0 0 0 13.4301 0 0 0 15.24 0 10.7042 0 13.9517 14.0159 13.442 19.2653 0 0 0 15.7304 15.2523 0 0 13.9905 0 12.7787 0 15.4749 12.3641 11.3227 12.7169 12.7402 0 0 0 13.8568 0 15.4341 0 14.5882 14.5744 0 14.3374 13.3869 15.121 14.1815 0 16.0364 14.8263 16.3939 0 0 15.8815 0 15.3072 13.2269 13.8585 13.1294 14.2494 14.1383 0 0 13.9887 13.937 13.2567 0 0 13.5796 13.3907 14.4077 0 0 12.9185 12.9711 0 0 0 13.2195 0 0 15.4037 12.5851 12.9388 0 0 15.8411 11.8253 16.0368 13.63 16.3488 0 14.9452 12.8467 12.6508 0 16.1874 15.8207 16.5509 0 14.648 14.6297 14.5166 0 13.4378 16.1016 12.3573 0 12.397 0 12.4408 A1X283 SPD2B_HUMAN SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains) SH3PXD2B FAD49 KIAA1295 TKS4 Homo sapiens (Human) adipose tissue development [GO:0060612]; bone development [GO:0060348]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; podosome assembly [GO:0071800]; protein localization to membrane [GO:0072657]; skeletal system development [GO:0001501]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102] "anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; adipose tissue development [GO:0060612]; bone development [GO:0060348]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; podosome assembly [GO:0071800]; protein localization to membrane [GO:0072657]; skeletal system development [GO:0001501]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]" GO:0001501; GO:0001654; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0016176; GO:0022617; GO:0030154; GO:0032266; GO:0042169; GO:0042554; GO:0042995; GO:0060348; GO:0060612; GO:0070161; GO:0071800; GO:0072657; GO:0080025 "phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]" ALLVPPKAK 0.99517 -32.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5313 0 0 0 0 0 0 0 0 0 0 0 12.4479 0 0 12.4884 0 0 0 13.0724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5294 13.7346 14.6752 0 0 0 0 0 0 0 0 0 0 13.14 12.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3238 0 0 0 0 0 0 0 12.4421 0 0 0 0 0 0 0 0 10.9623 0 0 0 0 0 0 0 0 0 0 13.101 0 0 0 0 0 0 0 0 14.5074 0 0 0 0 0 14.2224 0 13.2986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.477 0 0 0 0 12.0603 0 0 0 0 0 13.2557 0 O75150 BRE1B_HUMAN "E3 ubiquitin-protein ligase BRE1B, BRE1-B, EC 2.3.2.27 (95 kDa retinoblastoma-associated protein, RBP95) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B)" RNF40 BRE1B KIAA0661 Homo sapiens (Human) chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] axon terminus [GO:0043679]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; HULC complex [GO:0033503]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] axon terminus [GO:0043679]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; HULC complex [GO:0033503]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; chromatin organization [GO:0006325]; histone H2B conserved C-terminal lysine ubiquitination [GO:0071894]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein polyubiquitination [GO:1902916]; response to peptide hormone [GO:0043434]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0003730; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006511; GO:0010390; GO:0016020; GO:0017075; GO:0019898; GO:0031624; GO:0031625; GO:0033503; GO:0033523; GO:0042803; GO:0043005; GO:0043434; GO:0043679; GO:0044877; GO:0046872; GO:0061630; GO:0071894; GO:1901800; GO:1902916 metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; syntaxin-1 binding [GO:0017075]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625] AEVDELR 0.99517 -35.871 0 11.8772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0951 0 0 0 0 0 11.6104 0 0 0 0 0 0 0 0 0 0 0 0 16.9011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.471 0 0 0 0 0 0 0 0 0 0 0 0 13.7001 0 0 0 0 0 0 16.014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0831 0 0 0 0 0 0 0 0 0 0 0 0 13.1891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29590 PML_HUMAN "Protein PML (E3 SUMO-protein ligase PML, EC 2.3.2.-) (Promyelocytic leukemia protein) (RING finger protein 71) (RING-type E3 SUMO transferase PML) (Tripartite motif-containing protein 19, TRIM19)" PML MYL PP8675 RNF71 TRIM19 Homo sapiens (Human) "activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; oncogene-induced cell senescence [GO:0090402]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; suppression of viral release by host [GO:0044790]; transforming growth factor beta receptor signaling pathway [GO:0007179]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; SUMO binding [GO:0032183]; SUMO transferase activity [GO:0019789]; sumo-dependent protein binding [GO:0140037]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; oncogene-induced cell senescence [GO:0090402]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein-containing complex assembly [GO:0065003]; protein-containing complex localization [GO:0031503]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; suppression of viral release by host [GO:0044790]; transforming growth factor beta receptor signaling pathway [GO:0007179]" GO:0000781; GO:0000785; GO:0000792; GO:0001666; GO:0002230; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0006605; GO:0006606; GO:0006915; GO:0006919; GO:0006977; GO:0007179; GO:0007182; GO:0008270; GO:0008285; GO:0008630; GO:0008631; GO:0009411; GO:0010332; GO:0010522; GO:0010761; GO:0016363; GO:0016525; GO:0016605; GO:0019789; GO:0030099; GO:0030155; GO:0030308; GO:0030578; GO:0031065; GO:0031503; GO:0031625; GO:0031901; GO:0031965; GO:0032183; GO:0032206; GO:0032211; GO:0032469; GO:0032691; GO:0032922; GO:0032938; GO:0034097; GO:0042406; GO:0042752; GO:0042771; GO:0042802; GO:0042803; GO:0043153; GO:0043161; GO:0044790; GO:0045087; GO:0045165; GO:0045892; GO:0045893; GO:0045930; GO:0046332; GO:0046982; GO:0048146; GO:0048384; GO:0050821; GO:0050897; GO:0051457; GO:0051726; GO:0051974; GO:0060058; GO:0060444; GO:0065003; GO:0070059; GO:0071353; GO:0090398; GO:0090402; GO:0097191; GO:0140037; GO:1901798; GO:1904816; GO:1990830; GO:2000059; GO:2000758; GO:2000779; GO:2001238 cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; SUMO binding [GO:0032183]; SUMO transferase activity [GO:0019789]; sumo-dependent protein binding [GO:0140037]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AEGVSTPLAGRGLAER 0.99517 -10.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4784 0 0 0 0 0 0 0 0 0 0 0 11.0633 0 0 0 0 0 0 0 0 0 0 0 0 9.73183 0 0 0 0 13.4476 0 0 0 0 0 11.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9253 0 13.8816 0 0 0 0 0 0 0 0 0 0 0 0 13.0971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1333 0 0 11.3954 0 0 0 0 13.6659 13.4809 0 0 0 0 0 0 13.287 0 11.2943 0 0 0 0 0 0 0 0 0 Q9H607 OCEL1_HUMAN Occludin/ELL domain-containing protein 1 OCEL1 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; bicellular tight junction assembly [GO:0070830] GO:0005923; GO:0016324; GO:0031410; GO:0070830 GKLRHLK 0.99517 -8.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0816 0 0 0 0 13.6374 13.0291 0 14.0771 0 0 0 0 0 0 0 0 16.2075 0 0 0 0 15.7297 0 0 0 13.706 0 0 0 0 0 0 0 0 12.9743 0 0 0 12.8321 0 11.5143 13.8042 0 0 0 12.5567 0 12.066 12.9489 0 12.8974 13.1536 0 12.3137 0 0 0 0 0 0 0 14.2412 13.0362 15.8096 0 0 15.9924 16.1524 13.5336 13.3566 0 0 16.1917 0 0 0 0 0 0 0 15.168 15.5109 12.8049 14.809 10.5509 15.12 14.804 0 0 0 0 0 0 12.6843 0 12.0336 0 0 0 0 0 0 11.5631 11.6876 13.007 13.0864 0 0 0 0 0 15.5343 O15111 IKKA_HUMAN "Inhibitor of nuclear factor kappa-B kinase subunit alpha, I-kappa-B kinase alpha, IKK-A, IKK-alpha, IkBKA, IkappaB kinase, EC 2.7.11.10 (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1, IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha, NFKBIKA) (Transcription factor 16, TCF-16)" CHUK IKKA TCF16 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; NIK/NF-kappaB signaling [GO:0038061]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; response to virus [GO:0009615]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleoplasm [GO:0005654] "CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459]; anatomical structure morphogenesis [GO:0009653]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; NIK/NF-kappaB signaling [GO:0038061]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; response to virus [GO:0009615]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0006955; GO:0007249; GO:0007252; GO:0008384; GO:0008385; GO:0009615; GO:0009653; GO:0009898; GO:0018105; GO:0032088; GO:0032727; GO:0033209; GO:0034614; GO:0035631; GO:0038061; GO:0042803; GO:0043123; GO:0045087; GO:0045893; GO:0045944; GO:0046982; GO:0051092; GO:0071276; GO:0071356; GO:0097110; GO:0098586; GO:1990459 ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459] EADNTVMFMQGK 0.99518 -9.9417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9543 0 0 0 13.513 0 0 0 12.6733 0 14.4888 14.2646 0 0 0 0 0 0 0 0 0 0 0 9.99619 0 0 0 0 0 0 0 0 0 0 0 10.8446 0 0 0 0 0 0 14.4587 0 0 0 0 0 0 0 0 0 0 10.9318 0 0 13.7193 0 0 11.0434 13.5302 0 14.1435 0 14.1169 0 0 0 0 0 0 12.0309 13.7565 0 10.4105 0 0 0 0 0 0 12.7259 0 0 14.7099 12.9212 15.5716 0 0 0 14.946 13.5321 14.116 13.1161 0 0 0 0 0 13.965 15.1038 0 12.1265 0 0 13.9412 0 0 14.4533 14.136 0 0 0 13.4633 0 13.2046 13.3432 0 0 0 13.6758 0 14.1175 13.9054 0 0 13.0528 0 0 0 12.8286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2339 12.9038 0 0 14.8198 0 0 0 12.5305 0 0 0 0 P05546 HEP2_HUMAN "Heparin cofactor 2 (Heparin cofactor II, HC-II) (Protease inhibitor leuserpin-2, HLS2) (Serpin D1)" SERPIND1 HCF2 Homo sapiens (Human) blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; negative regulation of endopeptidase activity [GO:0010951] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; negative regulation of endopeptidase activity [GO:0010951] GO:0004866; GO:0004867; GO:0005576; GO:0005615; GO:0005788; GO:0006935; GO:0007596; GO:0008201; GO:0010951; GO:0070062 endopeptidase inhibitor activity [GO:0004866]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867] EVVKVSMMQTK 0.99518 -10.35 0 0 0 0 0 0 0 0 0 0 0 0 12.2267 0 0 0 0 0 0 0 0 0 13.2521 0 0 0 0 0 0 12.2229 0 0 0 11.2647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7262 0 11.0293 0 0 12.1575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0445 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4902 0 14.8278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5968 0 0 0 0 13.9996 14.6458 0 0 0 13.3346 0 0 12.7002 0 12.6605 13.8462 13.2989 14.251 12.84 0 0 0 0 0 0 0 13.1837 0 0 0 0 0 0 0 0 14.3303 0 0 0 0 0 0 0 13.8801 0 12.944 12.2461 13.5132 0 11.8005 14.5986 10.992 0 0 0 0 0 0 13.5226 13.9086 0 P28340 DPOD1_HUMAN "DNA polymerase delta catalytic subunit, EC 2.7.7.7 (3'-5' exodeoxyribonuclease, EC 3.1.11.-) (DNA polymerase subunit delta p125)" POLD1 POLD Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]; response to UV [GO:0009411]" aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634] "aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]; response to UV [GO:0009411]" GO:0000109; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006261; GO:0006281; GO:0006287; GO:0006297; GO:0008296; GO:0009411; GO:0016020; GO:0016235; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0046872; GO:0051539; GO:0055089; GO:0070987; GO:0071897 "3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]" DLEDQEQLLR 0.99518 -12.551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3832 0 17.3897 0 16.4027 0 0 0 0 0 0 0 0 0 0 0 0 14.7313 0 0 0 0 0 16.0471 0 0 0 0 0 0 0 0 0 0 14.1793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6405 0 0 0 0 0 0 0 0 0 0 0 13.312 0 13.5668 0 0 0 0 0 12.9674 13.0696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0976 0 0 0 0 0 P62829 RL23_HUMAN 60S ribosomal protein L23 (60S ribosomal protein L17) (Large ribosomal subunit protein uL14) RPL23 Homo sapiens (Human) cellular response to actinomycin D [GO:0072717]; cytoplasmic translation [GO:0002181]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; ribosomal protein import into nucleus [GO:0006610]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribosome [GO:0005840] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cellular response to actinomycin D [GO:0072717]; cytoplasmic translation [GO:0002181]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; ribosomal protein import into nucleus [GO:0006610]; translation [GO:0006412] GO:0000122; GO:0001223; GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005840; GO:0005925; GO:0006412; GO:0006610; GO:0008284; GO:0010628; GO:0016020; GO:0022625; GO:0022626; GO:0031625; GO:0032986; GO:0032991; GO:0050821; GO:0070062; GO:0070180; GO:0070314; GO:0072717; GO:1901798; GO:1903450; GO:1904667; GO:1990948; GO:2000059 large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] GGSSGAK 0.99518 -10.352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7233 0 0 13.7125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0741 14.1513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZV60 YL023_HUMAN Putative uncharacterized protein encoded by LINC00173 LINC00173 NCRNA00173 Homo sapiens (Human) ALFMVLR 0.99518 -9.9388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4597 0 0 0 0 13.3525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JH8 RADIL_HUMAN Ras-associating and dilute domain-containing protein RADIL KIAA1849 Homo sapiens (Human) neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] microtubule [GO:0005874]; protein-containing complex [GO:0032991] microtubule [GO:0005874]; protein-containing complex [GO:0032991]; GTPase binding [GO:0051020]; neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0001755; GO:0005874; GO:0007165; GO:0032991; GO:0034446; GO:0051020 GTPase binding [GO:0051020] AVDLIRHGGKK 0.99518 -12.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1085 0 0 0 0 0 0 0 12.2804 0 13.9157 11.9627 14.6021 0 0 12.9812 12.5836 0 0 12.2267 0 0 0 0 13.3357 0 13.4406 0 0 0 0 12.587 0 0 0 12.4291 0 0 0 11.4754 0 0 13.8971 0 0 11.9699 0 14.6719 0 13.6974 0 0 0 0 0 0 0 12.5388 0 0 0 12.6116 0 0 0 0 0 0 0 0 0 0 0 12.5871 13.2551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.701 13.5084 0 0 0 0 0 0 Q96PB8 LRC3B_HUMAN Leucine-rich repeat-containing protein 3B (Leucine-rich repeat protein 15) LRRC3B LRP15 UNQ195/PRO221 Homo sapiens (Human) extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] GO:0005615; GO:0016021; GO:0031012 DLHQLRVLNLSK 0.99518 -11.628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4Z3 CAPAM_HUMAN "mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase, EC 2.1.1.62 (Cap-specific adenosine methyltransferase, CAPAM, hCAPAM) (Phosphorylated CTD-interacting factor 1, hPCIF1) (Protein phosphatase 1 regulatory subunit 121)" PCIF1 C20orf67 CAPAM PPP1R121 Homo sapiens (Human) mRNA methylation [GO:0080009]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727] intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; S-adenosyl-L-methionine binding [GO:1904047]; mRNA methylation [GO:0080009]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727] GO:0005634; GO:0005654; GO:0015630; GO:0016422; GO:0017148; GO:0045171; GO:0045727; GO:0080009; GO:0099122; GO:1904047; GO:1990269 mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; S-adenosyl-L-methionine binding [GO:1904047] CWSRRENR 0.99518 -9.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6025 0 0 0 0 0 0 14.6796 0 14.0507 0 0 0 0 0 15.5579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC38 GLOD4_HUMAN Glyoxalase domain-containing protein 4 GLOD4 C17orf25 CGI-150 My027 Homo sapiens (Human) extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; cadherin binding [GO:0045296] GO:0005739; GO:0045296; GO:0070062 cadherin binding [GO:0045296] DVLGMKVESCSVARLECSGAISAHCSDYTR 0.99518 -9.9497 0 11.6501 0 0 0 0 0 0 0 0 0 0 0 11.0542 0 0 0 0 0 0 0 0 0 0 11.3223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8866 0 0 0 0 0 0 0 0 0 0 0 11.3829 0 0 0 0 12.2143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4097 0 0 14.7397 0 0 0 0 0 14.8136 0 0 0 0 12.537 0 0 0 0 0 15.8947 15.6426 16.9539 10.594 0 0 0 0 0 17.3452 0 0 0 17.6296 18.1937 0 0 0 0 13.2184 0 13.2073 0 0 0 15.3794 17.9391 0 0 13.5746 0 0 16.6352 16.5479 0 16.5676 0 0 0 0 0 10.2849 0 0 0 0 0 0 14.2195 0 15.4958 0 0 0 0 0 0 0 14.554 0 15.0612 12.4607 18.0906 13.7616 18.0746 0 0 0 13.1584 0 0 Q9NR21 PAR11_HUMAN "Protein mono-ADP-ribosyltransferase PARP11, EC 2.4.2.- (ADP-ribosyltransferase diphtheria toxin-like 11, ARTD11) (Poly [ADP-ribose] polymerase 11, PARP-11)" PARP11 C12orf6 Homo sapiens (Human) cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein transport [GO:0015031]; spermatogenesis [GO:0007283] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein auto-ADP-ribosylation [GO:0070213]; protein mono-ADP-ribosylation [GO:0140289]; protein transport [GO:0015031]; spermatogenesis [GO:0007283] GO:0003950; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006998; GO:0007283; GO:0015031; GO:0016604; GO:0030154; GO:0051028; GO:0070213; GO:0140289; GO:1990404 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404] DAAYSSRFCK 0.99518 -9.9429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4445 0 0 13.0136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4359 0 0 12.5078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43852 CALU_HUMAN Calumenin (Crocalbin) (IEF SSP 9302) CALU Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509] GO:0005509; GO:0005576; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0016020; GO:0033018; GO:0042470 calcium ion binding [GO:0005509] DWIKFAQKR 0.99519 -9.9738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6908 0 15.3558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2711 0 0 0 0 0 0 0 12.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7993 0 12.1568 0 0 0 0 0 0 0 0 0 0 0 13.7148 0 0 0 0 0 0 0 0 11.5516 0 0 0 0 0 P0C7U3 ZH11B_HUMAN "Probable palmitoyltransferase ZDHHC11B, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 11B, DHHC-11B)" ZDHHC11B Homo sapiens (Human) peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612] GO:0005783; GO:0005794; GO:0006612; GO:0016021; GO:0018230; GO:0019706 protein-cysteine S-palmitoyltransferase activity [GO:0019706] HAHVIQNQFCHLCK 0.99519 -8.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.52988 0 0 0 0 0 0 15.3232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.529 0 0 0 0 0 0 0 0 0 0 0 12.2317 0 0 11.8645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6389 0 0 0 12.0158 0 0 0 0 0 0 0 0 14.1509 0 0 0 0 0 0 0 13.4182 0 0 0 0 0 0 0 0 0 P40200 TACT_HUMAN T-cell surface protein tactile (Cell surface antigen CD96) (T cell-activated increased late expression protein) (CD antigen CD96) CD96 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell cytokine production [GO:0002728]; response to lipopolysaccharide [GO:0032496] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell cytokine production [GO:0002728]; response to lipopolysaccharide [GO:0032496] GO:0002728; GO:0005737; GO:0005886; GO:0005887; GO:0006954; GO:0006955; GO:0007155; GO:0007160; GO:0032496; GO:0032689 EDNGTQETLISQNHLISNSTLLK 0.99519 -10.424 0 0 0 0 0 0 0 0 13.7074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4167 0 P49069 CAMLG_HUMAN Guided entry of tail-anchored proteins factor CAMLG (Calcium signal-modulating cyclophilin ligand) CAMLG CAML GET2 Homo sapiens (Human) B cell homeostasis [GO:0001782]; defense response [GO:0006952]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; receptor recycling [GO:0001881]; signal transduction [GO:0007165]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; vesicle-mediated transport [GO:0016192] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; ubiquitin protein ligase binding [GO:0031625]; B cell homeostasis [GO:0001782]; defense response [GO:0006952]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; receptor recycling [GO:0001881]; signal transduction [GO:0007165]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; vesicle-mediated transport [GO:0016192] GO:0001782; GO:0001881; GO:0005737; GO:0005783; GO:0005789; GO:0006952; GO:0007165; GO:0007173; GO:0016020; GO:0016192; GO:0030176; GO:0031397; GO:0031625; GO:0032435; GO:0043529; GO:0045048; GO:0050821; GO:0071816 ubiquitin protein ligase binding [GO:0031625] IKTTVLTAALLLSGIPAEVINR 0.99519 -8.9177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4961 0 13.9705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62330 ARF6_HUMAN "ADP-ribosylation factor 6, EC 3.6.5.2" ARF6 Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; erythrocyte apoptotic process [GO:1902217]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726] cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; erythrocyte apoptotic process [GO:1902217]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor-mediated endocytosis [GO:0048261]; nervous system development [GO:0007399]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein secretion [GO:0050714]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192] GO:0001726; GO:0001889; GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006886; GO:0007049; GO:0007155; GO:0007399; GO:0016020; GO:0016192; GO:0019003; GO:0030139; GO:0030154; GO:0030838; GO:0030866; GO:0031527; GO:0031901; GO:0031996; GO:0032154; GO:0032456; GO:0034394; GO:0035020; GO:0036010; GO:0047485; GO:0048261; GO:0048488; GO:0050714; GO:0051301; GO:0051489; GO:0051549; GO:0055038; GO:0060998; GO:0070062; GO:0090162; GO:0090543; GO:0097178; GO:0097284; GO:0098793; GO:0098978; GO:0099562; GO:0120183; GO:1902217; GO:1903078; GO:1905606; GO:1990090; GO:2000009; GO:2000171 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996] IDEARQELHR 0.99519 -8.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1252 0 12.3008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.358 0 0 0 10.6389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6034 13.6273 0 0 0 0 0 0 0 0 13.2555 15.9493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14542 S29A2_HUMAN "Equilibrative nucleoside transporter 2 (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter, Equilibrative NBMPR-insensitive nucleoside transporter) (Hydrophobic nucleolar protein, 36 kDa) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2)" SLC29A2 DER12 ENT2 HNP36 Homo sapiens (Human) adenine transport [GO:0015853]; adenosine transport [GO:0032238]; cellular response to insulin stimulus [GO:0032869]; guanine transport [GO:0015854]; hypoxanthine transport [GO:0035344]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; thymine transport [GO:0035364]; transport across blood-brain barrier [GO:0150104]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynapse [GO:0098793] basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213]; adenine transport [GO:0015853]; adenosine transport [GO:0032238]; cellular response to insulin stimulus [GO:0032869]; guanine transport [GO:0015854]; hypoxanthine transport [GO:0035344]; lactation [GO:0007595]; neurotransmitter reuptake [GO:0098810]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine-containing compound transmembrane transport [GO:0072531]; thymine transport [GO:0035364]; transport across blood-brain barrier [GO:0150104]; uridine transport [GO:0015862]; xenobiotic transmembrane transport [GO:0006855] GO:0001504; GO:0005326; GO:0005337; GO:0005730; GO:0005886; GO:0005887; GO:0006836; GO:0006855; GO:0007595; GO:0015211; GO:0015213; GO:0015853; GO:0015854; GO:0015858; GO:0015860; GO:0015862; GO:0016323; GO:0031965; GO:0032238; GO:0032869; GO:0035344; GO:0035364; GO:0072531; GO:0098793; GO:0098810; GO:0150104; GO:1901642 neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; purine nucleoside transmembrane transporter activity [GO:0015211]; uridine transmembrane transporter activity [GO:0015213] ILGSLLAILLLFALTAALVK 0.99519 -8.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9282 0 0 0 13.4996 0 0 0 0 14.9857 0 0 0 12.4034 0 0 12.732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5595 0 0 13.6143 0 0 0 10.6667 0 0 0 12.4421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7276 0 0 0 0 0 13.2841 0 15.4187 0 0 0 0 0 0 0 13.3706 0 0 0 0 0 0 12.956 13.748 0 0 14.8506 0 0 Q14DG7 T132B_HUMAN Transmembrane protein 132B TMEM132B KIAA1786 KIAA1906 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ESDDEDDEEK 0.99519 -8.3284 0 0 0 0 0 0 0 0 0 0 10.5966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.782 0 0 0 0 0 0 0 0 0 0 11.0859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4605 0 0 0 11.8442 0 0 0 13.5229 0 0 14.7295 0 0 0 0 0 0 0 0 0 0 12.6685 0 0 0 0 0 0 13.1905 0 13.4103 0 0 0 11.1951 0 0 10.5911 0 0 0 14.6987 13.5314 0 11.6043 0 12.5187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6544 0 0 0 10.774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7701 11.8755 0 0 0 13.0498 0 0 0 0 10.238 0 0 0 Q5UAW9 GP157_HUMAN G-protein coupled receptor 157 GPR157 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] ciliary membrane [GO:0060170]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; radial glial cell differentiation [GO:0060019] GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0048512; GO:0051482; GO:0060019; GO:0060170 G protein-coupled receptor activity [GO:0004930] HSSMADK 0.99519 -12.187 0 0 0 0 0 0 0 0 13.3187 12.8337 11.7255 11.065 12.0372 13.1571 13.6789 11.159 0 0 0 0 0 0 0 0 12.3781 0 0 13.1095 13.5327 12.7972 12.9323 13.9506 12.3289 15.0521 14.073 14.6032 13.7007 14.0406 13.2248 13.8883 13.8099 0 10.4768 12.5139 12.7139 0 0 13.8767 11.4647 0 0 13.4649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1595 0 0 0 0 0 0 0 0 0 0 13.8508 0 0 0 12.7832 0 0 0 0 0 0 0 0 0 0 11.7508 0 0 14.6934 0 0 0 0 0 0 11.4985 0 0 0 14.0965 0 0 0 0 12.6973 0 0 0 0 0 0 11.7842 0 13.0829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4997 12.4662 13.2537 12.2626 12.5709 13.2517 12.7863 0 14.9462 13.0537 13.4189 0 11.9134 15.4673 12.4587 0 0 0 0 13.3228 11.5894 14.8503 11.7057 0 Q7Z5H5 VN1R4_HUMAN "Vomeronasal type-1 receptor 4 (G-protein coupled receptor GPCR27, hGPCR27) (V1r-like receptor 4)" VN1R4 V1RL4 Homo sapiens (Human) response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pheromone receptor activity [GO:0016503]; response to pheromone [GO:0019236]; sensory perception of chemical stimulus [GO:0007606] GO:0005886; GO:0007606; GO:0016021; GO:0016503; GO:0019236 pheromone receptor activity [GO:0016503] HLIVANFLALR 0.99519 -8.8963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7071 0 0 0 0 0 0 13.704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N944 AMER3_HUMAN "APC membrane recruitment protein 3, Amer3 (Protein FAM123C)" AMER3 FAM123C Homo sapiens (Human) regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055] plasma membrane [GO:0005886] "plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; regulation of canonical Wnt signaling pathway [GO:0060828]; Wnt signaling pathway [GO:0016055]" GO:0005546; GO:0005886; GO:0008013; GO:0016055; GO:0060828 "beta-catenin binding [GO:0008013]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" NLFHIRR 0.99519 -9.4797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9L1 ZIC4_HUMAN Zinc finger protein ZIC 4 (Zinc finger protein of the cerebellum 4) ZIC4 Homo sapiens (Human) central nervous system development [GO:0007417]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; central nervous system development [GO:0007417]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0007417; GO:0046872; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" HMKVHGR 0.99519 -9.9725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.679 14.6793 0 0 15.3355 0 0 13.5421 0 12.1293 0 0 0 0 0 14.1727 13.6221 0 0 0 0 0 0 13.8076 13.6114 0 0 13.1542 0 0 0 0 0 0 0 12.2549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH80 O10D3_HUMAN Putative olfactory receptor 10D3 (HTPCRX09) (Olfactory receptor OR11-293) OR10D3 OR10D3P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] LISYKDCVCQLFFFHFLGSIECFLFTVMAYDR 0.99519 -9.4729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHS2 AATC2_HUMAN "Putative aspartate aminotransferase, cytoplasmic 2, EC 2.6.1.1 (Glutamate oxaloacetate transaminase 1-like protein 1) (Transaminase A-like protein 1)" GOT1L1 Homo sapiens (Human) aspartate biosynthetic process [GO:0006532] cytosol [GO:0005829] cytosol [GO:0005829]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; aspartate biosynthetic process [GO:0006532] GO:0004069; GO:0005829; GO:0006532; GO:0030170 L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170] ILQYFVSQGFEFFCSQSLSK 0.99519 -9.4781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDX7 NEK7_HUMAN "Serine/threonine-protein kinase Nek7, EC 2.7.11.1 (Never in mitosis A-related kinase 7, NimA-related protein kinase 7)" NEK7 Homo sapiens (Human) cellular response to potassium ion [GO:0035865]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to potassium ion [GO:0035865]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225] GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0018105; GO:0032212; GO:0035865; GO:0046872; GO:0051225; GO:0051973; GO:0106310; GO:1900227; GO:1904355 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] GQFSEVYR 0.99519 -9.4901 0 0 0 0 0 0 0 0 0 0 0 0 11.958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1046 0 0 13.2782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A05 VATE2_HUMAN "V-type proton ATPase subunit E 2, V-ATPase subunit E 2 (Vacuolar proton pump subunit E 2)" ATP6V1E2 ATP6E1 ATP6EL2 ATP6V1EL2 Homo sapiens (Human) regulation of macroautophagy [GO:0016241] "acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]" "acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; proton-transporting two-sector ATPase complex, catalytic domain [GO:0033178]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]" GO:0001669; GO:0005829; GO:0016241; GO:0033178; GO:0046961 "proton-transporting ATPase activity, rotational mechanism [GO:0046961]" HVEVQIDK 0.99519 -9.4644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6783 0 14.6727 0 0 0 0 0 0 0 0 0 0 14.5198 0 0 0 0 0 0 14.8353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5548 15.7371 0 0 0 0 0 0 0 0 0 0 0 0 11.8697 0 0 0 15.1568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6496 0 0 13.3979 Q96MF4 CC140_HUMAN Coiled-coil domain-containing protein 140 CCDC140 Homo sapiens (Human) AARPRTR 0.99519 -10.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7688 0 13.8976 0 15.0989 0 0 0 0 0 0 0 0 0 0 0 13.1892 0 0 0 0 0 0 0 0 13.4418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5944 0 0 12.5105 12.7499 0 0 0 0 15.4608 0 0 0 0 0 0 0 0 14.4451 13.3085 13.4657 0 0 15.1978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8382 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0I3 CCSE1_HUMAN Serine-rich coiled-coil domain-containing protein 1 (Coiled-coil serine-rich protein 1) CCSER1 FAM190A KIAA1680 Homo sapiens (Human) AIAEHVK 0.99519 -12.181 0 0 0 0 0 0 0 0 0 0 0 0 13.6579 0 0 0 0 0 0 0 0 12.5994 0 0 0 11.8129 12.3207 0 0 0 0 0 12.9641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9135 0 0 0 0 0 0 0 13.3312 0 0 13.6464 0 0 14.582 0 11.734 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5755 0 13.7479 0 12.8168 15.1344 14.5125 0 14.7998 0 0 0 13.6239 0 0 0 0 13.7306 0 14.7601 0 0 0 0 0 0 0 0 14.1411 0 0 0 0 0 0 0 0 0 13.5044 0 0 0 0 0 0 0 0 0 0 0 13.1636 0 0 0 13.8903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0W8 SPAT7_HUMAN Spermatogenesis-associated protein 7 (HSD-3.1) (Spermatogenesis-associated protein HSD3) SPATA7 HSD3 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; rod photoreceptor outer segment [GO:0120200] axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; rod photoreceptor outer segment [GO:0120200]; microtubule cytoskeleton organization [GO:0000226]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601] GO:0000226; GO:0005654; GO:0005739; GO:0005829; GO:0005930; GO:0007601; GO:0015630; GO:0032391; GO:0036064; GO:0045494; GO:0050896; GO:0120200; GO:0120206; GO:1903546; GO:1903621 APSGDLLDKHSELFSNK 0.99519 -31.459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5192 0 0 0 12.4972 13.1399 14.7829 12.6436 0 13.2366 0 0 0 0 0 0 0 0 0 12.3929 0 0 0 0 0 0 0 0 14.048 0 0 0 11.9061 0 0 0 13.3166 12.4225 0 0 12.2523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7131 0 0 0 0 0 Q9UBE0 SAE1_HUMAN "SUMO-activating enzyme subunit 1 (Ubiquitin-like 1-activating enzyme E1A) [Cleaved into: SUMO-activating enzyme subunit 1, N-terminally processed ]" SAE1 AOS1 SUA1 UBLE1A Homo sapiens (Human) positive regulation of protein sumoylation [GO:0033235]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO activating enzyme complex [GO:0031510] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SUMO activating enzyme complex [GO:0031510]; ATP-dependent protein binding [GO:0043008]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; ubiquitin activating enzyme activity [GO:0004839]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925] GO:0004839; GO:0005634; GO:0005654; GO:0005737; GO:0008022; GO:0008047; GO:0016925; GO:0031510; GO:0032446; GO:0033235; GO:0043008; GO:0044388; GO:0046982; GO:1903955 ATP-dependent protein binding [GO:0043008]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; small protein activating enzyme binding [GO:0044388]; ubiquitin activating enzyme activity [GO:0004839] KVVFCPVK 0.99519 -9.9705 0 0 0 0 12.3595 0 0 12.3845 0 0 0 13.9093 0 0 0 0 15.007 0 0 0 14.0226 0 14.4087 13.3278 15.0952 15.417 0 15.1301 0 0 0 13.2774 0 0 0 0 0 0 13.684 10.6079 15.0968 14.6921 14.1242 15.378 0 0 0 0 0 10.9538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3082 15.4606 16.2181 15.4084 15.8282 15.8667 14.1163 10.957 0 0 0 15.5499 0 0 0 0 0 0 0 0 0 10.5494 11.5614 0 0 0 0 0 0 11.7518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8058 0 0 0 0 0 0 0 11.7707 0 0 0 0 0 0 14.8421 0 15.1742 0 0 0 0 15.829 0 10.5227 0 0 14.7609 0 11.8773 0 0 0 0 0 0 0 0 0 0 0 0 12.809 0 0 0 0 0 0 0 13.8584 15.0527 0 0 0 0 10.302 0 0 0 0 0 0 0 0 0 11.215 0 0 Q9UFP1 GAK1A_HUMAN Golgi-associated kinase 1A (Protein FAM198A) GASK1A C3orf41 FAM198A Homo sapiens (Human) caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] caveola [GO:0005901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231] GO:0005576; GO:0005783; GO:0005794; GO:0005901; GO:0043231 ARNMGFWR 0.99519 -31.488 0 0 0 0 0 0 0 0 0 13.3824 0 0 14.6205 0 11.5355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8514 0 0 0 15.0679 0 0 0 0 0 0 0 0 0 0 0 0 0 12.728 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0269 0 0 0 0 0 0 0 14.2102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1232 0 0 0 0 12.6159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NJI1 CK086_HUMAN Uncharacterized protein C11orf86 C11orf86 Homo sapiens (Human) PQEGQLR 0.9952 -11.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8965 0 0 0 0 0 0 0 0 0 0 12.7031 0 0 0 15.0769 15.0995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75367 H2AY_HUMAN "Core histone macro-H2A.1, Histone macroH2A1, mH2A1 (Histone H2A.y, H2A/y) (Medulloblastoma antigen MU-MB-50.205)" MACROH2A1 H2AFY Homo sapiens (Human) "dosage compensation [GO:0007549]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976]; dosage compensation [GO:0007549]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]" GO:0000122; GO:0000182; GO:0000228; GO:0000781; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0000979; GO:0001739; GO:0001740; GO:0003677; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0051572; GO:0061086; GO:0070062; GO:0071169; GO:0071901; GO:1901837; GO:1902750; GO:1902882; GO:1902883; GO:1902884; GO:1903226; GO:1904815; GO:1990841 chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976] GVTIASGGVLPNIHPELLAKKR 0.9952 -10.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95382 M3K6_HUMAN "Mitogen-activated protein kinase kinase kinase 6, EC 2.7.11.25 (Apoptosis signal-regulating kinase 2)" MAP3K6 ASK2 MAPKKK6 MEKK6 Homo sapiens (Human) protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165] GO:0000287; GO:0004672; GO:0004709; GO:0005524; GO:0006468; GO:0007165; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] EYQALVQRALQR 0.9952 -10.007 0 0 0 0 0 0 0 0 0 0 11.9779 12.17 12.2284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8623 0 0 0 0 0 0 11.1468 0 0 0 0 12.7488 0 0 0 0 0 0 0 0 11.4168 0 12.1742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5183 0 0 0 0 0 0 0 13.7914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7447 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2581 0 0 0 0 0 0 13.7014 13.7659 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4411 13.1981 0 0 13.7003 0 13.5874 13.4481 13.3249 0 0 0 0 0 0 0 0 13.0441 0 0 P13473 LAMP2_HUMAN "Lysosome-associated membrane glycoprotein 2, LAMP-2, Lysosome-associated membrane protein 2 (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)" LAMP2 Homo sapiens (Human) autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; establishment of protein localization to organelle [GO:0072594]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647] autolysosome [GO:0044754]; azurophil granule membrane [GO:0035577]; chaperone-mediated autophagy translocation complex [GO:0061742]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of autophagosome membrane [GO:0097637]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; trans-Golgi network [GO:0005802] autolysosome [GO:0044754]; azurophil granule membrane [GO:0035577]; chaperone-mediated autophagy translocation complex [GO:0061742]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; integral component of autophagosome membrane [GO:0097637]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; trans-Golgi network [GO:0005802]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; establishment of protein localization to organelle [GO:0072594]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of protein-containing complex assembly [GO:0031333]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647] GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005802; GO:0005886; GO:0006605; GO:0009267; GO:0016020; GO:0017038; GO:0019899; GO:0019904; GO:0030670; GO:0031088; GO:0031333; GO:0031647; GO:0031902; GO:0035577; GO:0043202; GO:0043231; GO:0044754; GO:0046716; GO:0048471; GO:0050821; GO:0061684; GO:0061740; GO:0061742; GO:0070062; GO:0072594; GO:0097352; GO:0097637; GO:0101003; GO:1905146 enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904] HHHAGYEQF 0.9952 -11.034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6912 0 0 0 0 0 0 15.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62899 RL31_HUMAN 60S ribosomal protein L31 (Large ribosomal subunit protein eL31) RPL31 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0070062 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] APRALKEIR 0.9952 -10.469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9511 0 0 11.7215 0 0 0 0 0 0 0 0 0 0 0 12.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1108 0 0 0 13.9833 0 0 0 0 13.4925 0 0 0 14.1529 0 12.1874 13.4435 0 14.1339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6258 0 0 0 0 0 0 0 12.9583 0 0 0 0 0 12.255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1359 12.3294 0 0 Q04726 TLE3_HUMAN "Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3, ESG3)" TLE3 KIAA1547 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cold-induced thermogenesis [GO:0120163]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0007165; GO:0009887; GO:0016055; GO:0090090; GO:0120163; GO:1990907 transcription corepressor activity [GO:0003714] AEEKDSLSRYDSDGDK 0.9952 -10.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8906 14.0354 0 0 13.9819 14.9309 14.4373 14.6164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5534 13.403 0 0 0 10.0088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1542 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5175 9.99647 0 0 0 0 0 10.9999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q05481 ZNF91_HUMAN Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10) ZNF91 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transposon integration [GO:0070895]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0008270; GO:0045892; GO:0070895 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AFKHSSALAKHK 0.9952 -11.036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8254 0 0 12.484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1981 0 0 0 0 0 0 15.3455 14.8391 0 0 0 0 0 0 11.6254 0 0 0 0 12.9933 0 0 0 0 0 0 0 13.0244 16.1198 13.6317 13.6305 13.3691 13.6638 0 0 0 0 0 0 0 0 11.8282 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0058 0 0 0 0 0 0 0 0 0 0 0 0 13.2946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W0Q7 USPL1_HUMAN "SUMO-specific isopeptidase USPL1, EC 3.4.22.- (Ubiquitin-specific peptidase-like protein 1, USP-like 1)" USPL1 C13orf22 D13S106 Homo sapiens (Human) Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; snRNA transcription [GO:0009301] Cajal body [GO:0015030]; extracellular space [GO:0005615] Cajal body [GO:0015030]; extracellular space [GO:0005615]; deSUMOylase activity [GO:0016929]; SUMO binding [GO:0032183]; Cajal body organization [GO:0030576]; cell population proliferation [GO:0008283]; protein desumoylation [GO:0016926]; snRNA transcription [GO:0009301] GO:0005615; GO:0008283; GO:0009301; GO:0015030; GO:0016926; GO:0016929; GO:0030576; GO:0032183 deSUMOylase activity [GO:0016929]; SUMO binding [GO:0032183] ENQKKPFVGSWVK 0.9952 -10.471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.18 0 12.2365 0 12.394 11.6924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4997 0 0 12.8186 0 0 0 0 0 0 0 0 0 0 0 0 13.1535 0 0 0 0 11.3753 0 0 0 14.1188 13.1374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8127 0 0 0 0 10.9416 0 0 Q6PI97 HOATZ_HUMAN Cilia- and flagella-associated protein HOATZ HOATZ C11orf88 HOATZIN Homo sapiens (Human) axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737] cilium [GO:0005929]; cytoplasm [GO:0005737]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283] GO:0005737; GO:0005929; GO:0007283; GO:0030317; GO:0035082; GO:0060271 AKEHKAK 0.9952 -12.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5541 13.4091 13.9974 0 0 0 0 0 0 13.8311 13.6479 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1641 0 0 0 0 0 0 15.9452 0 0 14.9829 0 0 0 0 0 0 0 13.7351 0 14.3739 0 0 13.2268 16.8284 13.2208 0 0 0 0 0 0 0 15.058 0 0 0 16.1023 12.7391 0 0 0 13.0019 0 0 0 13.0694 0 0 0 14.9882 0 12.7675 12.672 12.5817 13.0614 0 0 0 0 0 0 0 14.6688 0 0 15.0561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9371 0 0 0 0 0 0 Q86VW2 ARHGP_HUMAN Rho guanine nucleotide exchange factor 25 (Guanine nucleotide exchange factor GEFT) (Rac/Cdc42/Rho exchange factor GEFT) (RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT) (p63RhoGEF) ARHGEF25 GEFT Homo sapiens (Human) axon guidance [GO:0007411]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; guanyl-nucleotide exchange factor activity [GO:0005085]; axon guidance [GO:0007411]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0030016; GO:0030017; GO:0035023; GO:0051056 guanyl-nucleotide exchange factor activity [GO:0005085] DFLNALQSPIEYQRR 0.9952 -10.45 0 0 0 0 0 0 0 0 0 0 14.5883 0 0 0 0 0 0 0 0 0 0 0 0 10.2862 0 10.37 0 0 0 0 0 0 0 0 0 0 13.6551 16.2095 15.0557 0 0 0 12.6504 0 0 0 0 0 0 0 0 0 0 0 16.0131 0 16.4873 16.7511 0 16.2707 0 0 0 15.3971 15.3395 15.5938 0 11.9881 0 12.8211 0 0 0 0 0 10.9259 0 0 0 0 0 0 0 0 13.0089 15.4388 15.084 0 13.259 0 0 0 0 12.4457 0 0 12.7024 0 0 0 12.4165 12.0632 0 0 0 0 12.5397 0 15.3362 0 0 0 11.7463 0 12.3157 0 12.4136 0 0 11.5473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3243 0 0 0 0 12.0456 10.9394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.773 0 0 18.1337 17.8351 0 0 0 0 0 0 0 12.9037 0 0 0 0 18.0607 Q86XS8 GOLI_HUMAN "E3 ubiquitin-protein ligase RNF130, EC 2.3.2.27 (Goliath homolog, H-Goliath) (RING finger protein 130) (RING-type E3 ubiquitin transferase RNF130)" RNF130 Homo sapiens (Human) apoptotic process [GO:0006915]; programmed cell death [GO:0012501]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; programmed cell death [GO:0012501]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005737; GO:0006511; GO:0006915; GO:0012501; GO:0016021; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] AISKLTTR 0.9952 -8.9492 0 0 0 0 0 0 0 0 13.0273 0 12.7371 0 12.3947 0 0 0 14.2869 13.4031 0 0 0 0 13.0775 0 13.508 0 0 12.9363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0426 0 12.5663 0 0 12.0128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7906 0 0 0 0 0 0 0 13.3139 0 0 0 13.7296 13.5893 12.9768 0 12.7745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5678 0 0 0 0 0 0 0 0 0 0 0 12.4229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0819 0 12.6347 0 0 0 13.7297 0 0 0 14.392 0 0 14.2944 0 0 0 13.891 0 0 11.5583 0 14.2202 0 0 0 14.2733 Q8N402 YV020_HUMAN Putative uncharacterized protein LOC388882 Homo sapiens (Human) HHGFWRK 0.9952 -10.017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N7W2 BEND7_HUMAN BEN domain-containing protein 7 BEND7 C10orf30 Homo sapiens (Human) extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; DNA binding [GO:0003677] GO:0003677; GO:0070062 DNA binding [GO:0003677] DWVQILQDQIKLAR 0.9952 -10.477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NEZ5 FBX22_HUMAN F-box only protein 22 (F-box protein FBX22p44) FBXO22 FBX22 Homo sapiens (Human) cellular response to starvation [GO:0009267]; nucleocytoplasmic transport [GO:0006913]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; regulation of skeletal muscle fiber development [GO:0048742]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; nucleus [GO:0005634]; Z disc [GO:0030018] cytosol [GO:0005829]; nucleus [GO:0005634]; Z disc [GO:0030018]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to starvation [GO:0009267]; nucleocytoplasmic transport [GO:0006913]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; regulation of skeletal muscle fiber development [GO:0048742]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000209; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0006913; GO:0009267; GO:0030018; GO:0032436; GO:0036211; GO:0043161; GO:0048742 ubiquitin-protein transferase activity [GO:0004842] MEPVGCCGECR 0.9952 -8.9501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4939 0 0 0 0 0 0 0 0 0 0 12.9081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0181 0 0 12.9336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A33 CCD47_HUMAN PAT complex subunit CCDC47 (Calumin) (Coiled-coil domain-containing protein 47) CCDC47 GK001 MSTP041 PSEC0077 Homo sapiens (Human) endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; osteoblast differentiation [GO:0001649]; post-embryonic development [GO:0009791]; protein insertion into ER membrane [GO:0045048]; ubiquitin-dependent ERAD pathway [GO:0030433] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; rough endoplasmic reticulum membrane [GO:0030867] chaperone complex [GO:0101031]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; rough endoplasmic reticulum membrane [GO:0030867]; calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; osteoblast differentiation [GO:0001649]; post-embryonic development [GO:0009791]; protein insertion into ER membrane [GO:0045048]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0001649; GO:0003723; GO:0005509; GO:0005783; GO:0005789; GO:0006983; GO:0009791; GO:0016020; GO:0030176; GO:0030433; GO:0030867; GO:0032469; GO:0036503; GO:0043022; GO:0044183; GO:0045048; GO:0101031 calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; RNA binding [GO:0003723] ALVRLQK 0.9952 -8.9588 0 10.5679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6414 0 0 0 0 0 0 0 0 0 13.1485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9592 0 12.8672 0 0 12.7655 0 0 13.2145 0 0 0 0 12.9283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HA4 CA159_HUMAN Uncharacterized protein C1orf159 C1orf159 UNQ2998/PRO9739 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ACYRRNK 0.9952 -31.499 12.1278 0 0 0 0 0 0 10.1217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5132 13.3574 13.1863 0 0 0 0 0 0 0 0 0 0 0 0 15.1889 0 0 0 0 10.1829 0 0 13.6985 0 0 0 0 0 15.6016 0 14.8699 0 0 14.5816 15.9274 14.3969 0 14.1273 13.791 14.0452 13.9424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4186 0 13.2796 10.715 0 0 13.769 0 11.6965 0 12.8094 13.5321 0 0 0 0 0 0 0 14.3014 0 13.7841 0 13.6555 13.046 14.1198 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0159 0 0 0 0 0 0 0 15.168 11.3098 0 0 0 12.74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99932 SPAG8_HUMAN "Sperm-associated antigen 8 (HSD-1) (Sperm membrane protein 1, SMP-1) (Sperm membrane protein BS-84)" SPAG8 Homo sapiens (Human) cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819] acrosomal vesicle [GO:0001669]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283] GO:0001669; GO:0001673; GO:0005634; GO:0005737; GO:0005819; GO:0005879; GO:0007049; GO:0007283; GO:0007338; GO:0008017; GO:0016020; GO:0030154; GO:0032092; GO:0045944 microtubule binding [GO:0008017] LGGGGGR 0.9952 -10.016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.019 0 0 0 0 9.99138 0 13.4853 0 0 15.7096 14.2659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.72344 0 0 0 0 0 0 0 0 0 0 Q9BW62 KATL1_HUMAN "Katanin p60 ATPase-containing subunit A-like 1, Katanin p60 subunit A-like 1, EC 5.6.1.1 (p60 katanin-like 1)" KATNAL1 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283] centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568]; cytoplasmic microtubule organization [GO:0031122]; microtubule severing [GO:0051013]; spermatogenesis [GO:0007283] GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008352; GO:0008568; GO:0015630; GO:0016853; GO:0016887; GO:0031122; GO:0042802; GO:0051013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568] AELLKINLR 0.9952 -10.481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H257 CARD9_HUMAN "Caspase recruitment domain-containing protein 9, hCARD9" CARD9 Homo sapiens (Human) antifungal innate immune response [GO:0061760]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; JNK cascade [GO:0007254]; neutrophil mediated immunity [GO:0002446]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; regulation of apoptotic process [GO:0042981]; regulation of interleukin-2 production [GO:0032663]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]; response to xenobiotic stimulus [GO:0009410] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; CARD domain binding [GO:0050700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; antifungal innate immune response [GO:0061760]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immunoglobulin mediated immune response [GO:0016064]; JNK cascade [GO:0007254]; neutrophil mediated immunity [GO:0002446]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; regulation of apoptotic process [GO:0042981]; regulation of interleukin-2 production [GO:0032663]; response to exogenous dsRNA [GO:0043330]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]; response to xenobiotic stimulus [GO:0009410] GO:0001819; GO:0002446; GO:0005737; GO:0005829; GO:0005886; GO:0007249; GO:0007254; GO:0009410; GO:0016064; GO:0032449; GO:0032494; GO:0032495; GO:0032663; GO:0032722; GO:0032725; GO:0032740; GO:0032755; GO:0032760; GO:0032874; GO:0032991; GO:0042802; GO:0042803; GO:0042981; GO:0043123; GO:0043280; GO:0043330; GO:0043621; GO:0045089; GO:0046330; GO:0046872; GO:0048874; GO:0050700; GO:0050830; GO:0051092; GO:0051260; GO:0051607; GO:0060907; GO:0061760; GO:0070374; GO:1900017; GO:2000318 CARD domain binding [GO:0050700]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621] ALRKMQK 0.9952 -31.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4639 0 0 0 0 12.2486 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2532 0 0 0 12.9023 0 0 0 14.6854 12.8981 0 0 12.359 0 0 12.5555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6167 0 0 12.8494 0 0 0 0 0 15.6225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9198 14.4178 0 0 0 0 0 0 0 Q9Y5R5 DMRT2_HUMAN "Doublesex- and mab-3-related transcription factor 2 (Doublesex-like 2 protein, DSXL-2)" DMRT2 DSXL2 Homo sapiens (Human) embryonic skeletal system development [GO:0048706]; myotome development [GO:0061055]; positive regulation of myotome development [GO:2000287]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; embryonic skeletal system development [GO:0048706]; myotome development [GO:0061055]; positive regulation of myotome development [GO:2000287]; regulation of somitogenesis [GO:0014807]; regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007548; GO:0014807; GO:0042802; GO:0046872; GO:0048706; GO:0061055; GO:2000287 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CRNHGVVSCLKGHK 0.99521 -5.4278 0 0 0 14.3887 0 0 0 12.3845 0 0 0 0 0 0 0 0 0 11.7214 0 11.0443 16.7055 15.8125 17.0734 17.8387 0 0 0 0 0 0 0 12.7507 0 0 11.0156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4556 15.4847 15.401 0 0 16.1422 13.2436 15.2457 16.0979 0 0 13.4491 17.5897 16.8911 18.0922 13.4844 15.2861 14.2013 21.6682 21.6035 0 17.1946 18.7006 18.5096 17.5252 18.1531 18.8285 18.4411 18.256 18.7069 0 15.3658 15.977 19.0349 18.0056 18.0464 17.7838 16.8984 17.5075 0 18.366 0 18.5151 18.9813 18.2966 18.5219 0 18.0802 0 0 18.3526 0 19.0812 18.8987 18.3753 18.2067 19.1801 19.6976 18.6189 18.694 19.436 19.1609 18.9302 18.02 0 19.2219 18.6917 0 18.3756 19.3127 15.7346 18.9622 18.2237 17.6259 18.8438 0 19.0304 18.7401 18.9513 0 18.0912 0 0 0 17.732 17.9591 0 14.5895 18.4608 16.9914 0 0 0 12.2849 0 0 0 0 0 0 0 0 14.3763 0 0 19.6588 19.4809 0 0 0 16.9187 0 0 0 A2VEC9 SSPO_HUMAN SCO-spondin (SCO-spondin pseudogene) SSPOP KIAA2036 SSPO Homo sapiens (Human) cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane protein complex [GO:0098797] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane protein complex [GO:0098797]; peptidase inhibitor activity [GO:0030414]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399] GO:0005615; GO:0005887; GO:0007155; GO:0007399; GO:0030154; GO:0030414; GO:0031012; GO:0098797 peptidase inhibitor activity [GO:0030414] ADCQLCICQDGR 0.99521 -35.787 0 11.5174 10.8882 0 0 0 0 0 12.9101 12.5271 12.4439 11.6151 0 0 13.0086 0 11.9957 0 0 0 0 0 0 0 0 0 0 11.6686 0 12.5301 11.325 11.1586 0 0 0 0 14.0092 12.9259 0 0 11.3176 0 12.3044 10.7641 0 0 11.3635 0 0 0 12.6125 0 0 12.221 0 0 0 0 0 0 0 0 0 0 0 0 13.8668 0 0 12.2073 11.348 0 0 10.2241 12.8944 0 0 0 0 0 0 0 12.3973 0 13.1007 13.562 0 13.5062 0 12.92 11.9246 13.9789 0 14.6404 15.1508 14.6638 13.2168 13.882 0 12.8777 0 13.4709 0 13.2599 0 12.927 0 10.8612 12.3299 14.2606 12.1767 0 11.7748 10.8833 13.2825 0 0 0 0 14.1018 0 14.6106 0 0 12.388 14.007 13.0516 13.8053 0 0 0 12.6275 14.3611 0 0 12.6381 13.5199 0 12.3694 13.2849 12.1889 14.486 17.1283 0 13.2609 0 13.9135 11.0137 0 14.5788 12.252 13.7139 13.8111 13.923 11.1248 18.9105 0 0 12.5688 14.2951 0 14.2874 12.4699 13.9293 14.445 0 13.6892 11.7042 13.9205 0 13.7098 13.2494 0 13.2258 13.3231 13.2714 12.5723 12.7248 12.6993 13.3813 A8MXQ7 IQAK1_HUMAN IQ motif and ankyrin repeat domain-containing protein 1 IQANK1 Homo sapiens (Human) regulation of barbed-end actin filament capping [GO:2000812] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; regulation of barbed-end actin filament capping [GO:2000812] GO:0005634; GO:0005737; GO:2000812 AAAGKPGENR 0.99521 -5.4406 0 0 0 0 0 0 11.2306 0 14.3211 0 0 13.7337 0 0 0 0 0 12.2768 0 11.8655 10.7686 0 0 0 0 0 0 0 0 11.3853 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2828 0 12.5032 0 15.2806 15.3435 15.6444 15.5267 0 0 0 0 0 0 0 0 0 0 0 14.9023 0 14.1908 0 0 12.7426 0 0 0 14.741 0 0 0 0 0 0 0 0 0 14.0636 0 0 0 0 0 0 0 13.4937 0 0 0 0 0 0 0 12.4358 0 0 0 13.0806 0 18.93 0 0 13.189 0 10.8931 0 15.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9555 0 0 0 0 0 0 16.0893 16.1255 0 0 0 0 11.9118 13.986 15.5997 0 15.4697 0 0 14.4292 0 0 0 15.2956 0 0 O94822 LTN1_HUMAN "E3 ubiquitin-protein ligase listerin, EC 2.3.2.27 (RING finger protein 160) (RING-type E3 ubiquitin transferase listerin) (Zinc finger protein 294)" LTN1 C21orf10 C21orf98 KIAA0714 RNF160 ZNF294 HSPC087 Homo sapiens (Human) protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] cytosol [GO:0005829]; RQC complex [GO:1990112] cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116] GO:0005829; GO:0008270; GO:0043023; GO:0051865; GO:0061630; GO:0072344; GO:1990112; GO:1990116 ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] CCDNDMER 0.99521 -35.838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9454 12.0133 11.8091 0 12.8168 0 0 0 0 11.7865 11.7221 0 11.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1727 0 0 15.2243 8.8314 14.551 0 0 0 0 0 0 0 0 0 0 13.5614 0 13.5961 0 0 0 0 0 13.2679 13.5572 13.3446 13.5939 13.2236 0 14.1532 14.1423 0 0 12.8298 12.963 13.1289 0 12.7503 0 0 13.1094 0 0 0 13.2737 0 0 12.9352 0 13.0793 15.2684 0 0 0 14.1167 0 0 13.9525 0 0 0 15.6733 14.3826 12.9617 18.1279 14.498 14.2383 13.3229 0 14.5074 0 0 13.5823 12.9315 13.3316 17.7194 17.7019 14.1961 0 14.3435 13.8266 13.4246 14.4331 13.613 19.5102 13.2658 13.6413 10.2838 13.0247 0 13.2764 13.1245 0 14.3055 13.2793 0 0 0 0 0 13.2849 0 14.0902 13.7681 14.9556 0 0 0 0 0 0 12.308 0 0 0 0 0 0 0 0 18.2052 13.2165 0 12.9692 0 0 0 10.7658 0 O94887 FARP2_HUMAN "FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain-including RhoGEF, FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2) (Pleckstrin homology domain-containing family C member 3, PH domain-containing family C member 3)" FARP2 KIAA0793 PLEKHC3 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; semaphorin-plexin signaling pathway [GO:0071526] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; semaphorin-plexin signaling pathway [GO:0071526] GO:0005085; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0008092; GO:0016322; GO:0016601; GO:0022405; GO:0030316; GO:0031532; GO:0033623; GO:0071526; GO:0071800 cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085] AITEVTTTLQHILIRLENLQKLTELQR 0.99521 -35.696 0 0 0 11.1396 0 0 0 0 0 0 0 0 12.448 0 0 0 0 0 10.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3022 0 0 0 0 11.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6764 0 0 0 0 0 12.662 13.7572 11.6391 14.2015 0 0 10.9422 14.4069 0 12.6806 0 0 12.4041 16.2984 15.9961 15.9056 15.888 14.0582 15.8775 15.2893 0 15.1413 14.894 0 0 0 0 0 0 15.2337 0 0 0 0 13.9376 13.3493 0 0 0 15.7749 0 0 0 14.6157 12.969 0 0 0 0 13.1795 0 0 11.7513 0 0 0 13.535 0 13.1108 0 0 13.9343 0 0 13.2945 12.8568 14.495 0 0 0 12.768 0 11.5119 0 0 0 0 13.7376 12.5824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3953 0 11.759 0 0 0 0 14.3851 0 12.3074 0 0 O95487 SC24B_HUMAN Protein transport protein Sec24B (SEC24-related protein B) SEC24B Homo sapiens (Human) aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178] GO:0000149; GO:0001843; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0021747; GO:0030127; GO:0035909; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301 SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] ARSFITWLR 0.99521 -5.4366 0 0 0 0 0 0 0 0 0 0 11.3108 0 0 0 0 0 0 0 0 0 0 0 11.0289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7238 0 0 12.5434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.957 0 0 0 0 0 0 13.1739 0 0 0 0 0 0 0 0 11.377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8525 0 15.087 0 0 0 0 0 0 0 0 0 0 P08069 IGF1R_HUMAN "Insulin-like growth factor 1 receptor, EC 2.7.10.1 (Insulin-like growth factor I receptor, IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain ]" IGF1R Homo sapiens (Human) aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315] alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor activity [GO:0005009]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; aging [GO:0007568]; amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; glucose homeostasis [GO:0042593]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001965; GO:0003230; GO:0004713; GO:0004714; GO:0005009; GO:0005010; GO:0005158; GO:0005198; GO:0005520; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005899; GO:0005901; GO:0006955; GO:0007165; GO:0007169; GO:0007409; GO:0007568; GO:0008284; GO:0008286; GO:0010656; GO:0014065; GO:0014068; GO:0016020; GO:0021549; GO:0021766; GO:0030010; GO:0030315; GO:0030335; GO:0030424; GO:0031994; GO:0032467; GO:0033197; GO:0033674; GO:0033690; GO:0035094; GO:0035867; GO:0038083; GO:0042593; GO:0042802; GO:0043025; GO:0043066; GO:0043231; GO:0043235; GO:0043243; GO:0043409; GO:0043410; GO:0043548; GO:0043559; GO:0043560; GO:0044849; GO:0045056; GO:0045471; GO:0046328; GO:0046777; GO:0048009; GO:0048015; GO:0048661; GO:0048680; GO:0051054; GO:0051897; GO:0071260; GO:0071333; GO:0071392; GO:0071393; GO:0071394; GO:0071549; GO:0071560; GO:0090031; GO:0090398; GO:0097062; GO:0097242; GO:0120162; GO:0140318; GO:1902065; GO:1902911; GO:1903944; GO:1904045; GO:1904193; GO:1904385; GO:1904646; GO:1990314 ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor activity [GO:0005009]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] ACTENNECCHPECLGSCSAPDNDTACVACR 0.99521 -10.489 0 10.621 0 0 0 0 0 0 12.686 0 0 12.7893 0 0 0 0 0 0 0 0 0 11.8752 0 0 0 0 0 0 0 0 11.6302 0 0 0 0 0 0 0 0 11.437 0 0 0 11.5058 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0428 0 0 0 0 0 11.0783 0 0 13.8063 14.7868 13.707 13.8351 0 0 13.6102 0 13.2554 14.3563 13.0153 13.7463 0 0 0 0 14.0743 0 13.8907 0 0 0 0 0 13.8172 13.1298 12.9493 0 0 0 0 0 0 0 0 0 0 14.148 12.1981 12.8256 0 13.471 0 0 0 0 13.9081 13.5727 0 0 0 0 0 0 0 14.0358 0 0 0 0 14.6504 0 13.9396 13.7692 13.8101 15.0218 0 0 13.3622 14.1001 13.5156 13.8752 14.5509 0 15.1754 0 0 13.1175 13.4597 0 0 0 0 0 0 0 13.6638 0 0 0 0 0 0 0 0 0 0 12.6674 13.8627 0 0 0 0 12.7561 11.7572 0 0 0 14.6679 0 0 10.958 0 0 P35555 FBN1_HUMAN Fibrillin-1 [Cleaved into: Asprosin ] FBN1 FBN Homo sapiens (Human) activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527] basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501] GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205 calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877] CDEGYESGFMMMK 0.99521 -5.4335 0 0 0 0 0 0 0 0 12.2132 0 11.5157 15.4176 0 0 14.6177 11.6286 11.9792 0 0 10.8777 0 12.5762 0 0 12.1028 0 11.1468 0 0 0 0 11.9769 0 0 10.9865 11.674 13.5803 0 0 12.6493 11.3987 12.418 12.974 0 10.7956 15.0033 0 0 13.7549 11.3279 0 0 10.6378 0 0 0 0 0 0 0 0 0 0 10.2059 0 0 0 13.8273 0 15.347 10.586 0 13.4391 0 14.5293 13.5489 14.6164 12.3604 13.6032 12.6836 13.2234 0 15.3617 12.1944 13.4988 11.9198 14.0682 15.0808 15.6673 15.1908 15.8356 15.2742 15.6449 0 15.3347 14.7914 14.5443 14.0601 12.4444 12.75 13.5398 0 0 11.2393 15.046 0 12.7032 15.2856 14.8558 13.0754 0 11.8809 14.9612 13.1283 11.791 13.1388 0 14.3299 11.9273 13.8615 13.4381 15.5953 0 14.0586 14.297 0 15.0233 11.1211 15.3039 12.9061 0 12.822 0 0 0 13.7372 0 10.1722 14.4678 12.0332 0 0 0 0 13.0946 0 0 13.3512 11.3212 13.7934 0 12.2832 12.3476 12.5177 13.4574 0 11.8664 13.8033 0 12.5087 14.3873 0 0 14.6681 11.542 0 0 0 14.6786 12.2429 13.3417 11.9407 0 0 0 0 14.8144 0 0 13.136 P58181 O10A3_HUMAN Olfactory receptor 10A3 (HTPCRX12) (Olfactory receptor OR11-97) OR10A3 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KLISLAYTLLTPLLNPLIYSLR 0.99521 -12.827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2112 0 0 0 0 0 0 19.0418 13.8562 13.9214 12.8541 0 13.1804 0 11.2303 0 10.0119 0 0 0 0 0 0 0 0 0 0 0 9.88023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4137 13.0803 0 0 13.7161 13.4468 0 13.3414 0 0 0 0 11.0486 0 0 0 14.6715 0 0 0 0 0 0 0 0 0 0 14.4958 0 0 14.3585 0 13.9342 0 14.9263 0 0 0 13.607 14.0107 14.4166 13.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9928 14.2317 0 0 0 0 0 0 P82279 CRUM1_HUMAN Protein crumbs homolog 1 CRB1 Homo sapiens (Human) blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842] GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016021; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386 calcium ion binding [GO:0005509] CLSNSCQNNSTCK 0.99521 -5.4398 0 0 0 13.0629 0 0 13.3184 0 0 11.0598 0 0 0 0 0 0 0 12.0988 0 0 0 0 12.6692 0 12.9142 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6684 0 0 0 0 14.7819 0 0 0 14.7024 0 14.7864 14.4593 0 0 0 0 0 12.3883 0 0 0 0 0 15.8904 0 0 0 0 0 0 0 0 0 0 14.1245 0 0 14.6127 0 0 0 0 15.2843 0 14.9708 0 0 14.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7004 0 0 0 13.6573 0 10.4872 0 0 0 0 0 0 0 0 0 13.5684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2011 Q13813 SPTN1_HUMAN "Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)" SPTAN1 NEAS SPTA2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724] cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; spectrin [GO:0008091]; tertiary granule lumen [GO:1904724]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] GO:0003779; GO:0005200; GO:0005509; GO:0005516; GO:0005576; GO:0005829; GO:0005886; GO:0008091; GO:0015630; GO:0016020; GO:0030036; GO:0030054; GO:0030864; GO:0035580; GO:0042995; GO:0043231; GO:0045296; GO:0051015; GO:0051693; GO:0070062; GO:1903561; GO:1904724 actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200] AKLGDSHDLQRFLSDFR 0.99521 -32.626 0 0 0 0 0 0 0 0 13.5166 0 11.529 0 0 0 0 0 0 0 0 0 11.6386 0 0 0 0 0 0 0 0 0 0 0 0 9.61396 0 0 0 11.5626 0 0 0 11.8689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5333 0 0 11.5154 14.1156 0 14.1274 17.4436 0 0 11.8702 0 0 0 0 0 0 11.9006 0 0 0 17.4871 0 17.1899 0 0 0 0 11.7148 0 0 0 13.6855 10.3606 0 0 12.4552 14.9175 0 0 13.2259 0 11.6903 0 0 0 0 11.3859 0 11.7127 12.8221 0 0 11.8385 12.2974 0 0 11.0404 0 0 0 0 12.945 0 0 0 0 0 0 14.062 0 0 0 13.4151 0 0 0 13.4111 12.1796 0 0 0 13.1989 0 13.0396 13.4307 14.9064 0 13.8661 13.253 12.8107 14.1306 12.8793 12.5875 13.441 0 0 0 0 0 0 0 0 0 0 Q14865 ARI5B_HUMAN "AT-rich interactive domain-containing protein 5B, ARID domain-containing protein 5B (MRF1-like protein) (Modulator recognition factor 2, MRF-2)" ARID5B DESRT MRF2 Homo sapiens (Human) "adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]" GO:0000122; GO:0000976; GO:0001822; GO:0001889; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006807; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0045892; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0051091; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830 DNA binding [GO:0003677]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] DNETDQGSNSEKVAEEAGEK 0.99521 -32.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8072 0 13.4717 13.2265 13.3643 0 0 0 0 0 0 12.9161 0 0 11.6321 0 0 0 12.6218 0 0 0 0 12.3411 0 0 0 0 0 0 0 0 0 0 0 13.2625 12.9691 0 0 0 0 0 12.9071 0 14.1886 0 12.8305 12.7926 12.322 0 0 0 0 13.339 13.213 0 0 13.8239 13.0305 0 0 0 13.9414 0 0 0 0 14.1497 12.4112 0 0 0 13.9434 0 11.231 0 0 0 0 0 0 0 0 0 11.7669 0 0 0 0 0 0 0 13.1651 14.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5703 0 0 0 0 0 Q14CZ7 FAKD3_HUMAN "FAST kinase domain-containing protein 3, mitochondrial" FASTKD3 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial RNA processing [GO:0000963]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial RNA processing [GO:0000963]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528] GO:0000963; GO:0003723; GO:0005654; GO:0005739; GO:0005759; GO:0033617; GO:0035770; GO:0044528; GO:0070131 RNA binding [GO:0003723] ESHLDTLSR 0.99521 -12.822 0 15.2314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7868 13.1407 10.9171 0 0 0 12.0409 0 14.7273 14.5518 0 0 15.2246 0 10.8911 0 0 14.5203 0 14.5863 0 0 0 0 0 0 0 0 12.6823 0 0 0 0 0 13.5494 0 0 14.8457 15.2069 0 0 0 0 0 0 0 0 0 14.2313 0 14.0793 0 15.6125 0 0 0 0 15.3024 11.0973 0 0 0 0 15.3558 0 15.8287 0 0 0 0 0 0 14.4185 9.7376 0 0 0 0 13.2379 0 0 12.6081 0 0 0 0 0 0 14.8745 0 0 12.9348 0 0 13.7498 0 0 0 0 0 0 0 0 0 0 0 15.2474 0 0 0 0 0 0 0 Q5JPF3 AN36C_HUMAN Ankyrin repeat domain-containing protein 36C (Protein immuno-reactive with anti-PTH polyclonal antibodies) ANKRD36C Homo sapiens (Human) ion channel inhibitor activity [GO:0008200] GO:0008200 ion channel inhibitor activity [GO:0008200] AEREVAVR 0.99521 -35.645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5432 0 0 0 0 0 11.5867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0641 0 0 0 0 13.0308 10.9592 0 0 14.2444 14.6183 0 0 0 0 0 0 0 14.3007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5023 0 0 0 0 10.7439 0 0 0 0 0 0 0 0 0 0 0 0 14.0903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3827 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0465 0 10.2129 0 0 Q5T0J7 TEX35_HUMAN Testis-expressed protein 35 TEX35 C1orf49 Homo sapiens (Human) microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634] GO:0005634; GO:0015630 CLLCALK 0.99521 -10.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9567 0 0 0 0 0 0 0 0 12.396 0 0 0 0 0 0 0 Q5TCZ1 SPD2A_HUMAN SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains) SH3PXD2A FISH KIAA0418 SH3MD1 TKS5 Homo sapiens (Human) in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; podosome [GO:0002102] "anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; podosome [GO:0002102]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]" GO:0001701; GO:0002020; GO:0002102; GO:0005546; GO:0005737; GO:0005829; GO:0006801; GO:0010314; GO:0016176; GO:0032266; GO:0042554; GO:0042995; GO:0043325; GO:0070161; GO:0070273; GO:0072675 "phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]" EDYGSSK 0.99521 -35.624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8312 0 0 0 0 0 0 16.0498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9181 0 13.3943 0 0 0 0 0 17.6147 0 0 0 17.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.379 10.8061 0 0 0 0 15.5862 15.1498 0 0 13.8079 14.277 0 0 14.205 15.8913 13.0876 14.0035 14.9458 13.0848 0 15.226 15.8157 13.1347 0 0 0 0 12.0935 0 13.4285 0 0 12.627 0 0 0 14.3534 14.6727 19.018 19.3423 0 0 0 0 0 0 13.7928 13.3522 0 12.8099 13.2811 0 0 0 0 0 0 0 0 0 0 0 12.8032 0 13.8028 0 0 0 0 18.5628 18.5894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.618 0 0 0 0 0 0 20.496 0 0 0 0 0 0 13.4875 Q68EM7 RHG17_HUMAN "Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1, RICH-1)" ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0005886; GO:0005923; GO:0007015; GO:0007165; GO:0017124; GO:0017156; GO:0032956; GO:0035020 GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124] ALAVLEK 0.99521 -32.476 0 0 0 0 0 0 11.3186 0 12.3732 11.1474 0 0 14.1084 13.5141 0 14.1794 0 0 0 0 0 0 10.8904 0 0 0 0 0 0 0 0 0 0 0 13.4449 0 0 0 12.7933 0 0 0 0 0 13.4942 11.2173 0 0 0 0 0 0 0 0 0 12.8634 11.5244 0 12.1531 0 0 0 0 11.4071 11.4217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.893 0 0 0 14.5791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8737 0 0 0 0 0 13.6451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4902 0 0 0 12.2381 0 0 0 12.6848 0 0 0 0 0 0 0 0 0 0 0 0 13.3164 12.4404 0 0 Q6ZU52 K0408_HUMAN Uncharacterized protein KIAA0408 KIAA0408 Homo sapiens (Human) EKMELLDQFDNER 0.99521 -32.49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7445 0 0 0 12.0985 0 0 0 14.1901 0 0 0 0 0 0 0 13.6229 0 14.2365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2973 0 0 0 0 16.1528 0 14.23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.785 0 0 14.2698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1942 0 0 0 0 0 0 0 0 0 0 14.0141 0 Q7Z4S6 KI21A_HUMAN Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62) KIF21A KIAA1708 KIF2 Homo sapiens (Human) microtubule-based movement [GO:0007018] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018] GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005886; GO:0007018; GO:0008017; GO:0016887; GO:0030424; GO:0030425; GO:0071532 ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] EIEDLRAK 0.99521 -32.534 0 0 0 9.83393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1887 14.0415 0 0 0 0 0 16.0843 0 0 0 0 0 0 0 0 0 15.2393 0 0 0 0 0 13.8533 0 0 0 0 0 0 0 0 0 0 0 13.8848 14.1647 0 0 12.0382 15.1299 19.4385 0 0 0 0 0 0 0 13.4644 0 11.7893 0 0 0 0 12.6417 13.7549 0 0 14.9191 14.854 14.7164 0 0 0 0 0 0 0 0 0 0 13.1585 0 12.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UN3 R4RL2_HUMAN "Reticulon-4 receptor-like 2 (Nogo receptor-like 3) (Nogo-66 receptor homolog 1) (Nogo-66 receptor-related protein 2, NgR2)" RTN4RL2 NGRH1 NGRL3 Homo sapiens (Human) axon regeneration [GO:0031103]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of neuron projection development [GO:0010977] anchored component of plasma membrane [GO:0046658]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886] anchored component of plasma membrane [GO:0046658]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; axon regeneration [GO:0031103]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of neuron projection development [GO:0010977] GO:0005576; GO:0005615; GO:0005886; GO:0007166; GO:0009986; GO:0010977; GO:0030424; GO:0030425; GO:0031012; GO:0031103; GO:0038023; GO:0043005; GO:0043204; GO:0045121; GO:0046658; GO:0070062 signaling receptor activity [GO:0038023] DLPAEDSRGR 0.99521 -12.835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7973 0 12.3889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9714 0 0 0 0 0 0 0 0 0 0 0 12.5465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5933 0 0 0 12.0064 0 0 0 0 0 0 0 0 Q86VD1 MORC1_HUMAN "MORC family CW-type zinc finger protein 1 (Cancer/testis antigen 33, CT33)" MORC1 MORC Homo sapiens (Human) "behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; DNA hypermethylation [GO:0044026]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of transposition [GO:0010529]; regulation of gene expression, epigenetic [GO:0040029]; spermatogenesis [GO:0007283]; transposition [GO:0032196]" male germ cell nucleus [GO:0001673]; nucleus [GO:0005634] "male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; DNA hypermethylation [GO:0044026]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; negative regulation of transposition [GO:0010529]; regulation of gene expression, epigenetic [GO:0040029]; spermatogenesis [GO:0007283]; transposition [GO:0032196]" GO:0001662; GO:0001673; GO:0005634; GO:0007283; GO:0008270; GO:0010529; GO:0030154; GO:0031047; GO:0032196; GO:0040029; GO:0043046; GO:0044026; GO:2000143 zinc ion binding [GO:0008270] EFFDIWICANNPNR 0.99521 -32.569 0 0 0 0 11.53 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5105 12.0668 0 12.8689 0 0 0 0 11.6404 0 0 0 0 0 0 0 11.3811 13.1849 0 0 0 0 0 0 12.2946 0 12.3475 0 0 0 0 13.3292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.013 0 13.345 13.3392 13.9572 14.9666 0 13.9011 14.7099 12.8979 15.4627 14.2303 14.0128 0 12.7819 14.6448 14.1259 13.5042 0 14.5017 13.0441 13.2248 12.4384 13.3735 13.8931 13.4217 14.0402 15.2332 13.5503 13.9336 0 13.2045 14.5727 12.3743 15.0956 13.3857 0 0 13.12 14.9438 15.2533 14.8543 14.6964 14.816 13.3696 0 13.6059 13.5492 16.306 17.6258 14.3769 15.0775 14.0895 15.5012 15.119 13.6959 15.025 12.729 0 14.0766 14.6577 14.2921 0 14.9558 12.9113 12.9813 14.7134 13.6145 14.3443 0 15.3032 12.8222 15.348 14.5206 14.1496 13.714 14.2959 15.4605 12.9638 12.5409 14.1298 0 0 0 13.9247 13.6659 13.3805 13.9052 0 13.5131 13.7363 0 0 0 0 0 12.1815 0 12.9449 12.7426 0 0 0 0 0 12.4803 12.7337 0 0 0 0 0 0 0 Q8IX04 UEVLD_HUMAN "Ubiquitin-conjugating enzyme E2 variant 3, UEV-3 (EV and lactate/malate dehydrogenase domain-containing protein)" UEVLD UEV3 Homo sapiens (Human) carboxylic acid metabolic process [GO:0019752]; endosome to lysosome transport [GO:0008333]; protein transport [GO:0015031] ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062] "ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; ubiquitin binding [GO:0043130]; carboxylic acid metabolic process [GO:0019752]; endosome to lysosome transport [GO:0008333]; protein transport [GO:0015031]" GO:0000813; GO:0008333; GO:0015031; GO:0016616; GO:0019752; GO:0043130; GO:0070062 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; ubiquitin binding [GO:0043130]" AMELLRVKGQR 0.99521 -12.83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6507 0 0 0 0 0 12.5681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96TA2 YMEL1_HUMAN "ATP-dependent zinc metalloprotease YME1L1, EC 3.4.24.- (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease, PAMP) (YME1-like protein 1)" YME1L1 FTSH1 YME1L UNQ1868/PRO4304 Homo sapiens (Human) cell population proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; cell population proliferation [GO:0008283]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508] GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0006508; GO:0006515; GO:0007005; GO:0008283; GO:0016020; GO:0016021; GO:0016604; GO:0016887; GO:0034214; GO:0034982; GO:0035694; GO:0043066; GO:0046872 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] DKILMGPER 0.99521 -32.479 0 0 0 0 0 0 0 0 0 0 10.3921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5306 0 0 0 0 0 0 0 11.0679 0 12.861 0 13.7185 11.5432 0 0 0 13.6511 0 0 0 0 0 0 10.118 0 0 0 0 0 0 0 0 0 13.2608 13.9432 0 0 0 12.2819 0 0 0 0 0 0 12.3492 0 12.3673 0 0 13.1139 0 0 11.4353 0 0 13.1869 13.9562 13.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8185 11.6109 13.1786 0 0 0 0 0 11.7444 0 0 0 0 0 0 0 0 0 12.8645 0 0 12.4379 11.0925 0 10.739 0 0 0 0 12.0543 12.7041 0 0 0 15.3296 12.1317 14.092 0 0 0 12.9311 0 0 0 0 0 14.5033 0 0 0 0 0 12.6489 0 0 0 15.5947 0 0 0 0 0 0 0 0 0 0 0 0 10.5785 0 0 Q9BQI7 PSD2_HUMAN "PH and SEC7 domain-containing protein 2 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 C, Exchange factor for ARF6 C) (Pleckstrin homology and SEC7 domain-containing protein 2)" PSD2 EFA6C Homo sapiens (Human) regulation of ARF protein signal transduction [GO:0032012] cleavage furrow [GO:0032154]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587] cleavage furrow [GO:0032154]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; ruffle membrane [GO:0032587]; guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543]; regulation of ARF protein signal transduction [GO:0032012] GO:0005085; GO:0005543; GO:0016021; GO:0030425; GO:0032012; GO:0032154; GO:0032587; GO:0043025; GO:0098794; GO:0098978 guanyl-nucleotide exchange factor activity [GO:0005085]; phospholipid binding [GO:0005543] EHYLTFEKSR 0.99521 -35.826 0 0 0 0 0 0 0 0 0 12.0903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0933 0 15.1577 0 0 0 0 0 15.5243 0 0 0 0 0 0 0 0 0 0 0 0 11.1021 12.8816 14.773 0 0 0 0 0 13.5997 0 0 0 0 0 0 13.5595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7966 0 0 0 0 0 0 0 0 0 0 0 12.8165 0 0 0 0 0 0 0 0 13.5826 0 0 0 0 0 0 0 0 0 0 0 11.7317 0 0 0 0 0 0 Q9BWE0 REPI1_HUMAN Replication initiator 1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464) REPIN1 RIP60 ZNF464 Homo sapiens (Human) DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357] chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654] chromosome [GO:0005694]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003677; GO:0003723; GO:0005654; GO:0005664; GO:0005694; GO:0006260; GO:0006357; GO:0043035; GO:0046872 chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] AHRCAHCR 0.99521 -35.72 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2233 9.75389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8876 0 13.995 0 0 12.5139 0 0 14.5188 0 13.6231 0 0 0 0 0 0 0 0 0 0 0 0 0 14.424 11.0288 0 0 0 0 0 0 14.3864 0 0 0 15.5468 14.8925 0 0 12.8742 0 0 0 13.7081 0 0 0 0 14.3771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8825 0 0 0 0 0 0 0 0 0 0 0 0 11.7752 0 0 0 0 0 0 12.2732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9196 0 0 0 0 0 Q9NWS9 ZN446_HUMAN Zinc finger protein 446 (Zinc finger protein with KRAB and SCAN domains 20) ZNF446 ZKSCAN20 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; extracellular space [GO:0005615]; nucleus [GO:0005634] "chromatin [GO:0000785]; extracellular space [GO:0005615]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005615; GO:0005634; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FRGFCYQEVAGPR 0.99521 -10.519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5173 0 0 0 0 0 0 12.5958 0 0 0 0 0 0 10.1404 0 0 0 0 0 0 0 0 0 0 11.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0598 13.3256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5137 0 0 0 0 0 0 12.6122 0 0 0 0 0 10.7273 0 0 0 0 11.7134 0 0 0 11.3681 0 0 0 0 0 0 0 0 10.8204 0 0 0 0 0 0 0 11.4633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGP5 DPOLL_HUMAN "DNA polymerase lambda, Pol Lambda, EC 2.7.7.7, EC 4.2.99.- (DNA polymerase beta-2, Pol beta2) (DNA polymerase kappa)" POLL Homo sapiens (Human) "base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; nucleotide-excision repair [GO:0006289]; somatic hypermutation of immunoglobulin genes [GO:0016446]" GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006260; GO:0006287; GO:0006289; GO:0006303; GO:0016446; GO:0035861; GO:0046872; GO:0051575; GO:0071897 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872] AFPKRQK 0.99521 -32.516 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4994 14.4439 0 0 0 0 0 0 12.1809 0 0 0 0 0 0 11.8938 12.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8914 0 0 0 0 0 0 0 11.1207 0 0 0 12.1949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.38003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1879 0 0 0 0 13.7652 0 0 0 0 0 12.8359 0 0 11.8406 0 13.2365 13.8506 13.0298 0 0 0 0 12.3178 12.6771 14.8122 0 0 0 0 0 0 0 0 0 0 14.527 13.8622 0 15.2161 14.4214 13.0476 0 9.62985 13.2071 0 0 13.3467 13.0297 12.7143 0 0 13.5448 11.9344 0 0 15.9041 0 0 0 O14832 PAHX_HUMAN "Phytanoyl-CoA dioxygenase, peroxisomal, EC 1.14.11.18 (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase, PhyH)" PHYH PAHX Homo sapiens (Human) 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089] 9+0 non-motile cilium [GO:0097731]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] 9+0 non-motile cilium [GO:0097731]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089] GO:0001561; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731 carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244] AAARLQIVLGHLGR 0.99522 -10.55 0 10.8897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3141 0 0 0 0 0 0 0 0 0 14.2494 0 0 0 13.1141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0191 0 0 0 13.225 0 0 0 13.1069 0 0 0 0 0 0 0 0 0 0 0 0 13.9387 0 0 0 0 0 0 0 0 0 12.9285 0 0 0 0 0 0 0 0 0 0 0 14.0359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4391 0 0 0 0 0 13.809 0 O14841 OPLA_HUMAN "5-oxoprolinase, EC 3.5.2.9 (5-oxo-L-prolinase, 5-OPase) (Pyroglutamase)" OPLAH Homo sapiens (Human) glutathione metabolic process [GO:0006749] cytosol [GO:0005829] cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749] GO:0005524; GO:0005829; GO:0006749; GO:0017168; GO:0042802 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; identical protein binding [GO:0042802] CLVGRDIPLNQGCLAPVRVVIPR 0.99522 -10.557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.707 0 13.261 0 0 0 0 0 0 0 0 0 0 0 0 10.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.402 0 0 0 0 0 0 0 0 0 0 13.5517 0 0 0 0 0 0 0 0 0 0 14.0502 14.0833 14.0633 16.9493 0 0 0 11.2892 0 13.511 0 0 0 0 0 0 0 14.4076 0 0 12.3718 13.8021 10.6312 0 0 0 0 0 0 0 15.1329 0 0 14.5877 0 0 14.6781 0 14.5494 11.7463 0 0 0 0 0 12.8799 0 0 0 15.0578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9236 14.1446 0 0 0 11.283 0 O76050 NEUL1_HUMAN "E3 ubiquitin-protein ligase NEURL1, EC 2.3.2.27 (Neuralized-like protein 1A, h-neu, h-neuralized 1) (RING finger protein 67) (RING-type E3 ubiquitin transferase NEURL1)" NEURL1 NEURL NEURL1A RNF67 Homo sapiens (Human) brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288] anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] "anchoring junction [GO:0070161]; apical dendrite [GO:0097440]; dendritic spine [GO:0043197]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; cellular response to amino acid stimulus [GO:0071230]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of Notch signaling pathway [GO:0045746]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of synapse maturation [GO:0090129]; protein monoubiquitination [GO:0006513]; skeletal muscle tissue development [GO:0007519]; sperm axoneme assembly [GO:0007288]" GO:0004842; GO:0005886; GO:0006513; GO:0007219; GO:0007288; GO:0007399; GO:0007420; GO:0007519; GO:0007595; GO:0008285; GO:0014069; GO:0043065; GO:0043197; GO:0043204; GO:0045183; GO:0045741; GO:0045746; GO:0046872; GO:0048170; GO:0048471; GO:0051491; GO:0060999; GO:0061630; GO:0070161; GO:0071230; GO:0090129; GO:0097440 "metal ion binding [GO:0046872]; translation factor activity, non-nucleic acid binding [GO:0045183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]" ALVFTSRPVRVAETIFVK 0.99522 -10.553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9567 0 11.0737 0 0 0 10.7964 0 0 0 0 0 13.5584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6061 13.8035 0 0 0 0 0 12.7563 0 0 0 13.8087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7745 13.7673 0 0 0 0 0 0 12.6707 P11177 ODPB_HUMAN "Pyruvate dehydrogenase E1 component subunit beta, mitochondrial, PDHE1-B, EC 1.2.4.1" PDHB PHE1B Homo sapiens (Human) acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254] mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732]; tricarboxylic acid cycle [GO:0006099] GO:0004739; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005967; GO:0006006; GO:0006086; GO:0006099; GO:0045254; GO:0061732 pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739] DFLIPIGK 0.99522 -15.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.301 0 0 0 0 0 0 0 0 0 14.6671 0 0 0 0 0 0 0 0 0 0 0 0 12.9246 0 0 0 10.2595 0 0 11.5364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5993 0 0 11.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7852 0 0 0 0 0 0 0 11.3849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23025 XPA_HUMAN DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein) XPA XPAC Homo sapiens (Human) "base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; protein localization to nucleus [GO:0034504]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634] "intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleotide-excision repair factor 1 complex [GO:0000110]; nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair involved in interstrand cross-link repair [GO:1901255]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; nucleotide-excision repair, DNA incision [GO:0033683]; protein localization to nucleus [GO:0034504]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" GO:0000110; GO:0000715; GO:0003684; GO:0005634; GO:0005654; GO:0006281; GO:0006284; GO:0009650; GO:0019904; GO:0033683; GO:0034504; GO:0042803; GO:0045171; GO:0046872; GO:0070914; GO:1901255; GO:1990837 damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837] ALMLRQARLAAR 0.99522 -10.558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9329 0 0 0 0 0 0 0 0 12.0708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.868 13.8559 0 0 0 0 0 13.7461 13.4598 0 0 0 0 13.977 0 0 0 0 0 0 0 0 13.6982 13.363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7588 12.6723 0 0 0 13.08 0 13.9219 0 0 0 0 0 0 0 0 0 14.0546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2128 12.9472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43487 RANG_HUMAN "Ran-specific GTPase-activating protein (Ran-binding protein 1, RanBP1)" RANBP1 Homo sapiens (Human) nucleocytoplasmic transport [GO:0006913]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165] GO:0005092; GO:0005096; GO:0005634; GO:0005635; GO:0005643; GO:0005737; GO:0005813; GO:0005829; GO:0006913; GO:0007165; GO:0031267; GO:0045296; GO:0046604 cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] FASENDLPEWK 0.99522 -10.569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9807 0 0 0 0 0 0 11.599 13.5113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6299 0 0 0 0 0 0 13.179 0 0 0 0 0 0 0 0 0 0 16.0104 0 0 0 14.7148 14.3119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.605 0 0 0 0 0 15.5233 0 0 0 Q70IA6 MOB2_HUMAN MOB kinase activator 2 (HCCA2) (Mob2 homolog) (Mps one binder kinase activator-like 2) MOB2 HCCA2 Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] GO:0001934; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007165; GO:0030295; GO:0046872; GO:0048471 metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] ITDFQFK 0.99522 -5.4608 0 0 0 0 0 0 0 0 12.9704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.684 0 0 0 0 0 0 13.1257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCV5 WFDC5_HUMAN WAP four-disulfide core domain protein 5 (Putative protease inhibitor WAP1) (p53-responsive gene 5 protein) WFDC5 PRG5 WAP1 UNQ3036/PRO9842 Homo sapiens (Human) antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; antibacterial humoral response [GO:0019731]; innate immune response [GO:0045087] GO:0004867; GO:0005615; GO:0019731; GO:0045087 serine-type endopeptidase inhibitor activity [GO:0004867] ACFRQCVPRVSVK 0.99522 -10.546 0 0 0 0 11.8509 0 0 0 0 0 0 0 0 0 0 12.0856 0 0 0 11.4268 0 0 0 14.2394 0 0 0 11.1909 11.2168 0 0 12.0584 13.9408 0 0 0 12.8172 12.504 0 0 0 0 11.0179 0 0 0 0 0 12.6927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9917 10.3475 0 12.8082 0 13.0588 0 0 11.8216 0 14.004 13.3399 0 0 13.1621 0 15.2494 0 15.2466 14.9834 13.3997 12.6626 11.5169 14.3746 0 0 13.3372 13.0625 0 0 0 12.3594 0 12.2779 16.0671 0 0 0 17.5823 0 0 0 0 0 0 14.3733 18.985 14.8122 19.6839 13.6745 13.6091 12.3114 0 0 14.0807 0 0 10.3856 13.2732 0 0 14.7907 0 12.946 0 0 14.0226 0 0 0 13.3242 13.7907 0 0 0 0 11.5152 0 12.7831 0 0 14.4069 13.373 0 0 0 13.5283 12.9195 0 0 0 0 15.6628 11.6594 15.0619 0 0 18.2366 12.197 12.2693 0 0 11.5868 0 14.6493 0 0 O75828 CBR3_HUMAN "Carbonyl reductase [NADPH] 3, EC 1.1.1.184 (NADPH-dependent carbonyl reductase 3) (Quinone reductase CBR3, EC 1.6.5.10) (Short chain dehydrogenase/reductase family 21C member 2)" CBR3 SDR21C2 Homo sapiens (Human) cognition [GO:0050890]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; oxidoreductase activity [GO:0016491]; cognition [GO:0050890]; xenobiotic metabolic process [GO:0006805] GO:0004090; GO:0005615; GO:0005654; GO:0005829; GO:0006805; GO:0008753; GO:0016491; GO:0050890; GO:0070402 carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753]; oxidoreductase activity [GO:0016491] ILARRLDEK 0.99523 -10.313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9421 0 0 14.7732 0 0 0 0 0 14.705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P18283 GPX2_HUMAN "Glutathione peroxidase 2, GPx-2, GSHPx-2, EC 1.11.1.9 (Gastrointestinal glutathione peroxidase) (Glutathione peroxidase-gastrointestinal, GPx-GI, GSHPx-GI) (Glutathione peroxidase-related protein 2, GPRP-2)" GPX2 Homo sapiens (Human) response to oxidative stress [GO:0006979] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; electron transfer activity [GO:0009055]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979] GO:0004601; GO:0004602; GO:0005737; GO:0005829; GO:0006979; GO:0009055 electron transfer activity [GO:0009055]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601] LIIWSPVRR 0.99523 -5.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6891 15.7711 16.3881 16.3281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14416 GRM2_HUMAN "Metabotropic glutamate receptor 2, mGluR2" GRM2 GPRC1B MGLUR2 Homo sapiens (Human) "behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]" anchoring junction [GO:0070161]; astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] "anchoring junction [GO:0070161]; astrocyte projection [GO:0097449]; axon [GO:0030424]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]" GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0005887; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0035095; GO:0042220; GO:0042734; GO:0051896; GO:0051966; GO:0070161; GO:0090461; GO:0097110; GO:0097449; GO:0099055; GO:2001023 adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110] AAFEGVVRALLQK 0.99523 -5.4911 10.9346 0 0 0 11.5371 0 11.4594 0 0 0 0 11.203 0 0 0 11.6695 0 0 0 0 11.3278 0 12.0089 0 0 0 0 0 12.3649 0 0 10.7729 15.4117 0 0 0 0 0 10.4063 15.6687 12.1886 0 0 0 0 0 0 13.032 0 0 0 11.7468 0 0 0 0 0 0 0 11.7425 0 0 0 0 0 0 0 12.9445 0 0 0 0 0 0 0 0 13.6409 14.3337 0 0 0 0 0 13.4422 0 13.1838 11.2959 0 0 12.1815 14.9581 12.5108 14.9228 0 0 13.5266 0 0 0 12.8305 0 11.3577 0 0 0 0 11.7891 13.6927 0 12.1128 0 0 12.8509 14.2167 15.1445 0 14.3327 0 13.8886 12.7721 13.5031 0 13.4172 0 13.3214 11.9286 11.9358 14.2093 11.5095 0 0 0 0 0 0 12.4455 0 13.9715 0 14.073 0 0 12.6652 12.3703 0 12.2031 0 0 0 13.5254 12.6652 0 13.1031 13.8158 0 12.0058 0 0 11.7307 0 0 0 0 0 0 0 0 13.1615 0 0 13.7124 12.1975 0 13.4437 0 17.5024 0 12.4062 13.1165 13.3945 Q68BL7 OLM2A_HUMAN Olfactomedin-like protein 2A (Photomedin-1) OLFML2A UNQ9394/PRO34319 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] extracellular matrix [GO:0031012]; extracellular space [GO:0005615] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165] GO:0005615; GO:0007165; GO:0030198; GO:0031012; GO:0042802; GO:0050840 extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802] AAAALPPRPLLLLPLVLLLSGR 0.99523 -5.4942 0 0 0 0 0 0 0 0 0 0 0 11.8466 0 0 0 0 0 0 0 0 0 0 0 13.1637 0 15.298 0 0 0 13.7976 15.8575 11.2512 0 0 0 0 0 0 0 0 11.0103 0 0 0 10.3915 0 0 0 11.1102 0 11.9336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5904 0 0 11.593 0 13.6735 0 13.5561 14.5658 12.936 0 13.0737 12.6044 0 0 12.804 14.8366 14.4322 0 11.7813 12.4108 0 0 0 14.0234 0 13.6584 12.1203 0 0 13.196 0 12.816 14.241 0 0 0 0 0 0 0 0 0 0 0 13.5427 0 0 12.5362 0 0 0 0 0 0 0 13.1586 11.5281 14.7635 12.0909 0 0 12.3814 0 0 0 0 0 0 0 0 14.2007 0 12.0555 21.0382 14.3478 0 0 13.2991 0 0 0 0 13.8039 0 0 15.4706 0 0 0 0 0 0 0 12.9175 12.2977 17.0808 15.0004 12.4515 13.8382 14.0261 21.4683 0 21.3352 0 18.6343 0 14.6288 19.5453 0 Q6A1A2 PDPK2_HUMAN "Putative 3-phosphoinositide-dependent protein kinase 2, EC 2.7.11.1 (3-phosphoinositide-dependent protein kinase 2 pseudogene)" PDPK2P PDPK2 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105] GO:0004674; GO:0005524; GO:0005737; GO:0016020; GO:0018105; GO:0035556; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DLVEKLLVLDATKR 0.99523 -5.4985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V87 FHI2B_HUMAN "FHF complex subunit HOOK interacting protein 2B, FHIP2B (Retinoic acid-induced protein 16)" FHIP2B FAM160B2 RAI16 FP13191 Homo sapiens (Human) AEYPPGMR 0.99523 -5.4988 0 0 0 0 0 0 0 0 0 0 10.1655 0 0 0 0 0 0 0 0 0 0 12.6994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4297 0 0 14.4967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2726 0 0 0 0 13.37 Q8N201 INT1_HUMAN "Integrator complex subunit 1, Int1" INTS1 KIAA1440 UNQ1821/PRO3434 Homo sapiens (Human) inner cell mass cell proliferation [GO:0001833]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; inner cell mass cell proliferation [GO:0001833]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474] GO:0001833; GO:0005634; GO:0005654; GO:0016020; GO:0016021; GO:0016180; GO:0031965; GO:0032039; GO:0034243; GO:0034474; GO:0043154 ALLREIIKQTK 0.99523 -33.675 0 11.1445 0 0 0 0 0 0 14.7724 0 0 0 12.4292 0 0 0 12.1494 0 0 16.9476 13.0829 13.2189 0 0 13.8105 0 0 12.1192 14.8283 0 9.7528 18.7802 0 14.099 0 0 0 12.7441 0 0 0 0 0 0 0 0 14.8051 15.787 0 0 0 17.1976 17.6147 0 0 0 13.9622 0 0 0 0 0 0 0 0 0 0 11.2543 0 0 0 0 0 0 13.3418 13.7094 0 15.0564 0 13.9285 0 0 0 13.592 0 17.7258 0 0 16.0036 0 13.8018 0 0 0 14.102 0 0 10.4706 13.6223 0 12.9881 0 14.0924 13.8361 0 14.4269 0 11.7423 0 0 14.9687 12.0458 12.7355 0 11.7152 0 10.9405 0 14.7432 14.3943 0 0 0 0 12.8355 14.4677 0 12.0218 14.4353 0 12.6912 13.6017 0 0 0 14.4578 0 15.9533 0 11.0877 12.7871 0 14.3088 14.592 15.1502 0 11.1936 12.5959 0 0 13.0356 14.4901 13.7608 11.9695 0 0 14.3343 0 0 0 0 14.3929 0 0 0 0 0 0 19.2448 0 0 13.5342 13.1739 14.2167 12.7917 0 0 0 13.9871 0 Q9NRX6 KISHB_HUMAN Protein kish-B (Transmembrane protein 167B) TMEM167B C1orf119 AD-020 Homo sapiens (Human) constitutive secretory pathway [GO:0045054] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; constitutive secretory pathway [GO:0045054] GO:0000139; GO:0005794; GO:0016021; GO:0045054 KGVWGVFYK 0.99523 -5.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX76 CKLF6_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 6 (Chemokine-like factor superfamily member 6) CMTM6 CKLFSF6 Homo sapiens (Human) endocytic recycling [GO:0032456]; protein transport [GO:0015031]; regulation of protein stability [GO:0031647] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; endocytic recycling [GO:0032456]; protein transport [GO:0015031]; regulation of protein stability [GO:0031647] GO:0005886; GO:0015031; GO:0016020; GO:0016021; GO:0031647; GO:0031901; GO:0032456; GO:0035577; GO:0035579; GO:0055038 LPLLRRVLK 0.99523 -5.4985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.53827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.6239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MZF0 PRR33_HUMAN Proline-rich protein 33 PRR33 C11orf89 Homo sapiens (Human) AQPLVPVAHIRPLPTTVQAASPLPEEPPVPR 0.99524 -11.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1981 0 13.9134 0 0 17.5312 0 0 0 0 14.2164 0 0 0 0 17.2283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9145 A8TX70 CO6A5_HUMAN Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4) COL6A5 COL29A1 VWA4 Homo sapiens (Human) cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198] GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0062023 extracellular matrix structural constituent conferring tensile strength [GO:0030020] ADIMFLVDSSWSIGNENFRK 0.99524 -31.555 0 0 0 0 0 13.256 0 11.2852 13.3433 0 0 0 0 14.3304 0 0 12.9723 0 0 0 0 0 12.9665 0 0 0 0 12.9461 0 0 0 0 13.7509 0 0 12.5848 0 0 13.4103 0 0 13.2445 0 12.5868 0 0 0 0 0 0 0 0 0 0 0 9.86161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.083 11.4258 13.7134 14.2761 0 0 0 12.9436 0 0 13.9508 18.3848 14.2118 14.697 0 0 0 0 15.6862 0 0 14.2678 0 14.8779 0 0 14.8397 0 0 0 0 13.9073 14.7737 12.0454 0 12.4193 0 13.6936 13.7179 0 13.8436 0 0 0 0 0 12.7841 0 15.5709 15.2529 14.9941 0 16.6145 13.2207 0 13.4887 13.1351 13.5674 10.8191 0 13.5613 13.3849 0 14.8197 13.7502 13.3489 12.0431 13.5507 14.3058 0 0 0 0 0 0 14.0314 0 0 0 13.2364 0 13.5525 12.0371 0 0 0 0 0 0 0 0 0 0 0 13.4546 13.5358 14.1753 13.2367 12.7683 0 0 10.8105 0 11.3551 0 O75145 LIPA3_HUMAN "Liprin-alpha-3 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3, PTPRF-interacting protein alpha-3)" PPFIA3 KIAA0654 Homo sapiens (Human) neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synapse organization [GO:0050808]; synaptic vesicle docking [GO:0016081] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; epididymosome [GO:0098875]; glutamatergic synapse [GO:0098978]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831] acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; epididymosome [GO:0098875]; glutamatergic synapse [GO:0098978]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synapse organization [GO:0050808]; synaptic vesicle docking [GO:0016081] GO:0001669; GO:0005829; GO:0007269; GO:0016081; GO:0048172; GO:0048786; GO:0050808; GO:0098831; GO:0098875; GO:0098978 ADGVSVRTYSC 0.99524 -31.531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8513 0 0 14.3364 14.1255 13.9583 13.0381 0 0 12.6736 14.0234 0 14.3242 14.5531 14.3245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2189 0 0 0 0 0 0 0 0 0 0 0 0 12.5061 0 10.7708 0 0 13.3127 0 0 0 16.5653 0 0 0 0 0 0 0 0 0 0 14.8464 0 0 12.9222 0 0 0 0 0 12.0118 12.9785 11.7652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06400 RB_HUMAN "Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb, Rb) (pp110)" RB1 Homo sapiens (Human) "aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin assembly [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of cohesin loading [GO:0071922]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]" chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin assembly [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071930]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of cohesin loading [GO:0071922]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription, DNA-templated [GO:0006355]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006366; GO:0006469; GO:0007224; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0014009; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043433; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050673; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051301; GO:0051402; GO:0051726; GO:0060253; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0071901; GO:0071922; GO:0071930; GO:0090230; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1902948; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234 disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625] CEHRIMESLAWLSDSPLFDLIKQSK 0.99524 -11.644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7007 0 0 0 0 0 8.9098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.207 0 0 0 0 12.8912 0 10.1749 0 0 0 0 0 0 0 0 13.5804 0 0 0 13.9093 13.3962 13.2381 14.0375 13.5174 13.1397 0 0 0 0 15.1057 0 0 0 0 0 0 10.3765 0 0 0 0 0 0 0 0 10.4315 0 0 0 0 0 0 10.1669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9688 0 0 15.2912 0 0 0 0 0 0 0 Q13085 ACACA_HUMAN "Acetyl-CoA carboxylase 1, ACC1, EC 6.4.1.2 (Acetyl-Coenzyme A carboxylase alpha, ACC-alpha)" ACACA ACAC ACC1 ACCA Homo sapiens (Human) acetyl-CoA metabolic process [GO:0006084]; cellular response to prostaglandin E stimulus [GO:0071380]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid homeostasis [GO:0055088]; malonyl-CoA biosynthetic process [GO:2001295]; protein homotetramerization [GO:0051289]; protein metabolic process [GO:0019538]; tissue homeostasis [GO:0001894] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; acetyl-CoA metabolic process [GO:0006084]; cellular response to prostaglandin E stimulus [GO:0071380]; fatty acid biosynthetic process [GO:0006633]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lipid homeostasis [GO:0055088]; malonyl-CoA biosynthetic process [GO:2001295]; protein homotetramerization [GO:0051289]; protein metabolic process [GO:0019538]; tissue homeostasis [GO:0001894] GO:0001650; GO:0001894; GO:0003989; GO:0005524; GO:0005739; GO:0005829; GO:0006084; GO:0006633; GO:0015629; GO:0019538; GO:0042802; GO:0046872; GO:0046949; GO:0051289; GO:0055088; GO:0071380; GO:2001295 acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872] ARDKFEEDR 0.99524 -31.548 0 0 0 0 0 0 0 0 13.9922 11.3404 0 11.4926 0 0 13.5545 16.4136 16.0787 0 11.4226 11.3127 0 0 14.6246 0 0 16.0081 16.0282 14.8666 14.6377 14.3659 0 0 0 14.2395 0 0 0 0 0 17.0852 0 0 14.8905 0 0 13.2107 0 0 0 0 0 16.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7063 13.4534 0 13.5099 0 0 11.9381 0 0 0 0 0 12.0924 0 0 0 0 0 20.0438 0 19.0623 14.7118 13.0087 19.3092 19.3071 13.3805 19.0984 14.6728 18.9337 0 12.7037 19.4082 13.1699 13.2647 12.8706 19.1252 11.675 0 12.1529 13.1758 0 19.8826 0 13.6604 18.7775 0 0 0 0 13.7393 13.8999 0 13.7342 0 0 14.173 11.1291 19.2069 0 12.3604 13.3161 0 14.0721 0 13.9505 0 0 0 0 15.3234 13.8796 12.8925 14.9491 14.6422 0 0 0 0 0 14.2939 13.3809 18.7799 0 10.8553 0 0 0 13.2032 18.6835 0 0 0 14.9033 13.4819 13.8707 13.5747 13.7151 11.8205 13.8907 18.6984 0 0 0 0 0 18.6734 19.3774 19.3371 19.3501 0 12.4748 0 Q5H9E4 S2553_HUMAN Solute carrier family 25 member 53 (Mitochondrial carrier triple repeat protein 6) SLC25A53 MCART6 Homo sapiens (Human) mitochondrial transmembrane transport [GO:1990542] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NAD transmembrane transporter activity [GO:0051724]; mitochondrial transmembrane transport [GO:1990542] GO:0005739; GO:0005743; GO:0016021; GO:0051724; GO:1990542 NAD transmembrane transporter activity [GO:0051724] ELQHRTR 0.99524 -10.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXH9 PAMR1_HUMAN Inactive serine protease PAMR1 (Peptidase domain-containing protein associated with muscle regeneration 1) (Regeneration-associated muscle protease homolog) PAMR1 RAMP FP938 UNQ699/PRO1344 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; calcium ion binding [GO:0005509] GO:0005509; GO:0005576 calcium ion binding [GO:0005509] AGWYGGDCMRCGQVLR 0.99524 -9.9382 0 0 0 0 0 0 0 0 0 0 0 13.7238 0 0 0 13.243 0 0 0 0 0 0 0 0 0 10.6799 0 0 0 0 0 0 0 12.2946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0751 0 13.2194 0 12.6082 0 0 11.7197 0 0 0 0 0 0 0 0 11.2254 0 0 0 0 0 12.9837 15.6373 12.9146 0 13.9934 0 0 14.8117 17.2721 14.0735 0 16.9404 15.2797 0 0 0 0 15.8041 0 0 0 10.4115 15.1716 0 14.3442 15.2934 16.4552 0 12.2963 0 14.5994 0 14.9457 13.3428 13.4671 0 0 0 0 0 0 0 0 0 0 16.7757 0 0 15.9573 15.9662 0 0 15.1289 0 0 15.1472 0 0 0 15.141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8091 0 15.4098 0 15.2209 14.7375 0 0 0 14.901 0 0 14.9232 15.1401 0 Q6ZRX8 YL004_HUMAN Putative uncharacterized protein FLJ45999 Homo sapiens (Human) AWECHHTTGPQPNPR 0.99524 -9.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6022 0 0 0 0 0 13.7472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZW13 CP086_HUMAN Uncharacterized protein C16orf86 C16orf86 Homo sapiens (Human) LERKAQR 0.99524 -11.635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2141 0 0 0 0 19.686 18.3396 19.1778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4316 18.9821 0 0 18.8932 0 0 0 19.2686 17.6776 0 0 0 0 0 0 0 0 20.0538 20.0546 20.4884 0 0 0 0 0 0 0 19.6803 0 0 0 0 0 0 19.2796 0 0 0 0 0 0 0 0 0 0 0 18.2618 18.9395 18.9523 19.6569 19.1836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZWE6 PKHM3_HUMAN "Pleckstrin homology domain-containing family M member 3, PH domain-containing family M member 3 (Differentiation associated protein)" PLEKHM3 DAPR PLEKHM1L Homo sapiens (Human) myoblast differentiation [GO:0045445] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; myoblast differentiation [GO:0045445] GO:0005737; GO:0005794; GO:0005886; GO:0045445; GO:0046872 metal ion binding [GO:0046872] CESCGAVFHSECK 0.99524 -12.551 0 0 0 0 0 0 0 0 0 0 0 12.3294 0 0 0 11.985 0 0 0 0 0 0 0 12.5975 0 0 0 0 0 0 0 0 12.2382 0 0 0 0 0 0 0 0 0 0 0 11.7397 0 12.5792 0 0 0 12.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2864 0 0 0 0 0 0 0 0 12.9533 0 0 0 0 0 13.6384 0 0 0 0 0 14.4009 0 0 0 0 15.3317 0 0 0 0 0 0 14.891 0 0 0 14.4802 0 11.0511 0 13.4073 0 0 0 15.7768 0 0 0 14.2419 0 0 15.0462 0 0 0 12.7608 0 14.6954 0 0 0 0 13.0438 0 13.9669 0 12.8718 0 0 0 0 0 0 0 14.2204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9177 0 0 0 0 0 0 0 0 0 0 0 0 12.2985 11.5038 0 0 Q8IYM1 SEP12_HUMAN Septin-12 SEPTIN12 SEPT12 Homo sapiens (Human) cell differentiation [GO:0030154]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; spermatogenesis [GO:0007283] cell division site [GO:0032153]; cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725] cell division site [GO:0032153]; cleavage furrow [GO:0032154]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; cell differentiation [GO:0030154]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; spermatogenesis [GO:0007283] GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0019003; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0035091; GO:0042802; GO:0042803; GO:0048471; GO:0060090; GO:0061640; GO:0097227 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803] ADSLTMEEREAFR 0.99524 -9.9332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.736 0 0 0 0 0 0 0 0 0 0 12.8835 0 0 0 0 Q8TD35 LKAM1_HUMAN Protein LKAAEAR1 (LKAAEAR motif-containing protein 1) LKAAEAR1 C20orf201 Homo sapiens (Human) AAIRLELFLPPQLK 0.99524 -11.642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9833 0 0 12.0975 0 13.403 0 11.8969 0 12.8707 0 12.5159 0 10.7738 0 0 0 0 0 11.147 0 0 0 0 0 0 0 12.6065 0 0 12.769 0 11.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0864 0 0 0 0 0 0 15.8516 11.4548 0 16.1912 16.2859 16.1421 0 0 13.8936 0 0 0 0 16.0957 0 0 0 15.4767 12.8808 15.6727 0 12.6279 0 15.0647 0 0 16.5631 16.8321 0 16.425 16.3411 16.29 0 0 0 0 0 13.3965 13.155 12.8328 0 0 12.291 12.4763 0 0 0 0 14.5679 16.2926 0 0 0 0 0 0 14.5195 0 0 11.3796 0 10.3477 0 0 0 0 14.5082 13.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6154 0 0 0 0 12.674 15.1832 0 Q9BUV0 RSRP1_HUMAN Arginine/serine-rich protein 1 RSRP1 C1orf63 HT033 NPD014 Homo sapiens (Human) DSPSTSRSGGSSRLSSR 0.99524 -12.571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5356 11.9995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3729 0 0 0 0 Q9P2J9 PDP2_HUMAN "[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial, PDP 2, EC 3.1.3.43 (Pyruvate dehydrogenase phosphatase catalytic subunit 2, PDPC 2)" PDP2 KIAA1348 Homo sapiens (Human) positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; positive regulation of pyruvate dehydrogenase activity [GO:1904184]; protein dephosphorylation [GO:0006470] GO:0004722; GO:0004741; GO:0005739; GO:0005759; GO:0006470; GO:0046872; GO:1904184 [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722] AGETTHK 0.99524 -12.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74672 0 0 0 0 0 0 0 0 0 0 0 0 11.5854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9803 0 0 0 0 0 0 13.2778 0 0 0 0 0 0 0 10.4718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2661 0 0 13.4672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 17.869 0 0 0 Q9P2M4 TBC14_HUMAN TBC1 domain family member 14 TBC1D14 KIAA1322 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; negative regulation of autophagy [GO:0010507]; recycling endosome to Golgi transport [GO:0071955]; regulation of autophagosome assembly [GO:2000785] autophagosome [GO:0005776]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037] autophagosome [GO:0005776]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; protein kinase binding [GO:0019901]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; negative regulation of autophagy [GO:0010507]; recycling endosome to Golgi transport [GO:0071955]; regulation of autophagosome assembly [GO:2000785] GO:0005096; GO:0005654; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010507; GO:0019901; GO:0043231; GO:0055037; GO:0071955; GO:0090630; GO:2000785 GTPase activator activity [GO:0005096]; protein kinase binding [GO:0019901] DSKRIQK 0.99524 -31.526 0 0 0 0 0 0 0 0 0 0 0 13.2186 0 0 0 0 0 0 0 0 0 11.1702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8208 0 0 0 13.2297 0 0 0 14.4069 0 0 15.0396 13.8989 0 0 0 0 0 13.3022 0 0 0 0 0 0 0 13.2917 0 0 0 0 0 0 11.8521 12.8004 13.418 0 0 0 0 0 14.5688 0 0 0 0 0 12.6474 0 0 0 13.9451 0 0 0 0 12.6943 12.2777 12.9473 0 0 0 0 0 0 0 0 0 0 14.1327 0 0 0 0 0 0 0 0 0 0 0 0 14.9388 0 0 0 13.9017 0 0 0 0 13.8899 0 13.9243 0 13.6256 0 14.0889 0 0 0 0 0 0 0 0 Q9UGU0 TCF20_HUMAN "Transcription factor 20, TCF-20 (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein, SPRE-binding protein)" TCF20 KIAA0292 SPBP Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000976; GO:0003700; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0016604; GO:0045944; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] ADSCTNSEGSSQPEEQLKSPMAESLDGGCSSSSEDQGER 0.99524 -11.646 0 0 0 0 0 0 13.6742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5419 0 0 0 0 0 0 0 11.8683 0 0 0 0 0 0 0 12.0124 0 0 0 13.3305 0 0 12.7532 12.0609 0 0 0 16.4713 0 0 14.3021 0 0 12.6042 12.536 14.0586 0 0 12.9905 0 13.4222 16.9745 13.7191 0 0 0 0 0 0 0 0 11.6386 13.7572 12.917 0 0 0 0 0 0 13.1516 0 14.5171 16.4453 0 0 0 0 0 0 0 12.256 0 0 0 0 0 12.9933 0 0 0 13.6347 13.7447 0 13.2755 0 0 14.1094 0 0 14.1942 14.0386 0 0 0 14.1487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4301 14.4013 0 0 0 0 0 0 A6NM62 LRC53_HUMAN Leucine-rich repeat-containing protein 53 LRRC53 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 ANEHTSENLCCRTFDEPLCAHEARNYHTK 0.99525 -12.184 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3176 0 0 0 0 0 0 0 0 0 0 0 13.1857 12.6357 0 0 0 0 0 13.5859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.085 0 12.8245 0 15.0237 0 0 0 0 0 0 0 0 0 15.4498 0 0 0 0 0 0 0 14.0604 0 12.8199 12.8605 13.5118 0 0 0 0 0 0 13.487 0 0 14.5631 16.3432 14.3397 0 0 0 0 0 13.2971 0 12.8009 12.0345 0 0 11.97 15.7013 0 13.6811 13.2862 0 0 14.1753 14.2513 0 0 13.3647 0 0 13.8084 12.461 0 0 0 0 0 0 0 13.3435 15.1786 0 13.2671 0 0 0 13.5894 0 0 0 13.4276 14.0481 0 0 12.8932 0 0 0 0 0 13.9772 0 0 0 0 0 0 0 0 12.7523 0 0 0 0 0 0 0 0 0 0 O15031 PLXB2_HUMAN Plexin-B2 (MM1) PLXNB2 KIAA0315 Homo sapiens (Human) brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116] cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287] GO:0001843; GO:0001932; GO:0002116; GO:0005887; GO:0007156; GO:0007162; GO:0007405; GO:0007420; GO:0008360; GO:0009986; GO:0010976; GO:0017154; GO:0030334; GO:0043087; GO:0045727; GO:0050772; GO:0070062; GO:0071526; GO:1902287; GO:1904861; GO:2001222 semaphorin receptor activity [GO:0017154] AIKHQVEK 0.99525 -31.813 0 0 0 0 0 0 0 0 0 0 12.341 0 0 0 11.9143 0 0 0 0 0 0 0 14.7784 0 0 0 0 0 0 0 11.2738 0 0 0 0 0 0 0 0 0 0 11.1057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2789 0 0 0 0 0 0 11.5993 0 0 0 14.9358 0 0 11.9185 0 11.4814 0 9.9334 10.1463 15.0258 0 14.7664 0 14.7595 0 13.0218 0 11.2862 0 13.9459 12.2376 0 12.1451 17.4537 0 14.6742 15.1813 0 0 0 0 0 0 0 17.4276 13.0558 0 0 0 13.3765 12.3018 16.7955 0 0 13.8275 0 13.7997 13.9304 0 10.7036 0 16.0032 13.6348 13.6332 11.1821 0 12.0435 0 0 11.2199 12.9961 13.6838 0 14.3389 0 0 0 13.6797 0 13.1556 0 14.1923 0 0 13.7214 9.25363 10.0385 13.7882 0 14.4278 0 13.4827 0 0 0 0 0 15.8315 0 0 10.7122 11.7486 0 0 0 12.625 0 0 0 0 0 12.4485 0 0 12.3814 0 0 0 0 0 O60603 TLR2_HUMAN Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282) TLR2 TIL4 Homo sapiens (Human) apoptotic process [GO:0006915]; cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; central nervous system myelin formation [GO:0032289]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of diacyl bacterial lipopeptide [GO:0042496]; detection of triacyl bacterial lipopeptide [GO:0042495]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; learning [GO:0007612]; leukotriene metabolic process [GO:0006691]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synapse assembly [GO:0051964]; nitric oxide metabolic process [GO:0046209]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of Wnt signaling pathway [GO:0030177]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124] cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory granule membrane [GO:0030667]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355] "cell body [GO:0044297]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory granule membrane [GO:0030667]; Toll-like receptor 1-Toll-like receptor 2 protein complex [GO:0035354]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; Toll-like receptor binding [GO:0035325]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]; apoptotic process [GO:0006915]; cell activation [GO:0001775]; cellular response to bacterial lipopeptide [GO:0071221]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; central nervous system myelin formation [GO:0032289]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; detection of diacyl bacterial lipopeptide [GO:0042496]; detection of triacyl bacterial lipopeptide [GO:0042495]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; learning [GO:0007612]; leukotriene metabolic process [GO:0006691]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of phagocytosis [GO:0050765]; negative regulation of synapse assembly [GO:0051964]; nitric oxide metabolic process [GO:0046209]; positive regulation of cellular response to macrophage colony-stimulating factor stimulus [GO:1903974]; positive regulation of chemokine production [GO:0032722]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of Wnt signaling pathway [GO:0030177]; response to fatty acid [GO:0070542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]" GO:0001530; GO:0001540; GO:0001666; GO:0001774; GO:0001775; GO:0001875; GO:0002224; GO:0002755; GO:0004888; GO:0005737; GO:0005794; GO:0005886; GO:0005887; GO:0006691; GO:0006915; GO:0006954; GO:0006955; GO:0007165; GO:0007252; GO:0007612; GO:0008285; GO:0009636; GO:0009986; GO:0010628; GO:0014005; GO:0030177; GO:0030667; GO:0030670; GO:0031226; GO:0032289; GO:0032570; GO:0032722; GO:0032728; GO:0032733; GO:0032735; GO:0032741; GO:0032755; GO:0032757; GO:0032760; GO:0032868; GO:0034123; GO:0034134; GO:0035325; GO:0035354; GO:0035355; GO:0038023; GO:0038124; GO:0038187; GO:0042495; GO:0042496; GO:0042497; GO:0042802; GO:0042834; GO:0042995; GO:0043235; GO:0044297; GO:0044877; GO:0045087; GO:0045121; GO:0045944; GO:0046209; GO:0048714; GO:0050135; GO:0050729; GO:0050765; GO:0050830; GO:0051092; GO:0051607; GO:0051770; GO:0051964; GO:0061809; GO:0070542; GO:0071221; GO:0071223; GO:0071346; GO:0071726; GO:0071727; GO:1901224; GO:1903974; GO:1904466 "amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; Toll-like receptor binding [GO:0035325]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]" FTFRNVK 0.99525 -8.8661 0 0 0 12.7803 0 0 0 13.5801 0 0 0 0 12.9595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0323 0 18.7556 0 14.6021 0 14.513 0 0 14.2188 0 0 0 0 13.4368 0 0 14.9861 0 0 0 0 0 0 11.2546 0 14.823 0 0 0 13.6793 0 0 0 0 14.4288 0 15.5721 0 17.7994 0 0 0 14.5753 15.3005 12.8347 0 14.3422 0 19.3405 0 13.4463 13.2178 14.2765 15.9167 13.5865 13.3603 13.2262 0 0 14.3103 13.7139 12.6847 14.7139 0 14.5247 0 14.3802 0 0 0 0 14.4654 0 0 14.9318 13.7768 0 13.2413 13.3916 0 0 0 0 0 0 0 0 0 0 0 0 13.4914 0 0 0 0 0 0 0 0 0 0 13.6703 0 P49406 RM19_HUMAN "39S ribosomal protein L19, mitochondrial, L19mt, MRP-L19 (39S ribosomal protein L15, mitochondrial, L15mt, MRP-L15) (Mitochondrial large ribosomal subunit protein bL19m)" MRPL19 KIAA0104 MRPL15 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543] GO:0003735; GO:0005634; GO:0005739; GO:0005743; GO:0005762; GO:0032543 structural constituent of ribosome [GO:0003735] HRPVEPER 0.99525 -12.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3729 0 0 0 0 0 0 0 11.1261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2818 12.9028 0 0 13.7588 0 13.2761 0 0 0 0 13.8178 0 0 0 0 0 12.4597 13.1738 0 0 0 0 14.0155 0 0 0 0 0 11.8568 13.4548 14.3749 13.3818 0 13.7044 14.7848 0 13.9484 0 13.5912 0 0 0 0 0 0 13.5286 15.3364 13.0055 0 0 0 0 0 13.1751 13.7541 0 14.3665 14.458 0 0 14.3655 0 13.8791 0 0 10.3413 0 14.827 13.2916 14.7922 0 11.9562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6722 14.5004 12.9182 0 0 0 0 0 Q5HYJ3 FA76B_HUMAN Protein FAM76B FAM76B Homo sapiens (Human) nuclear speck [GO:0016607] nuclear speck [GO:0016607] GO:0016607 AASALYACTKCTQR 0.99525 -9.9696 0 0 0 0 0 0 10.5249 0 0 0 0 0 0 0 0 0 0 11.2936 0 0 14.1014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2721 0 10.7202 0 0 10.6773 0 0 0 0 11.2226 0 0 0 0 11.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9496 0 11.39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2901 0 Q9H9C1 SPE39_HUMAN "Spermatogenesis-defective protein 39 homolog, hSPE-39 (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction)" VIPAS39 C14orf133 SPE39 VIPAR Homo sapiens (Human) cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023] cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023]; protein-containing complex binding [GO:0044877]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034] GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007034; GO:0007283; GO:0008333; GO:0017185; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0046907; GO:0055037; GO:0090385; GO:0099023 protein-containing complex binding [GO:0044877] DFVDDDDDDDLER 0.99525 -8.8851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5218 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8003 13.2841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3617 0 0 0 0 0 0 0 0 0 0 0 0 14.5212 0 0 0 0 0 13.4815 0 0 0 0 0 0 12.7533 0 0 0 0 0 11.2558 14.735 0 0 0 11.9805 0 0 0 0 10.4513 0 0 0 0 0 0 0 0 0 11.3866 0 0 0 0 0 0 0 0 0 0 13.8776 0 0 0 0 0 0 0 11.7127 12.2328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0815 0 0 0 0 0 0 0 0 0 0 0 15.7697 0 0 0 0 0 15.6744 0 0 0 0 Q9UHD0 IL19_HUMAN "Interleukin-19, IL-19 (Melanoma differentiation-associated protein-like protein) (NG.1)" IL19 ZMDA1 Homo sapiens (Human) apoptotic process [GO:0006915]; immune response [GO:0006955]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; reactive oxygen species metabolic process [GO:0072593]; signal transduction [GO:0007165] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; apoptotic process [GO:0006915]; immune response [GO:0006955]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; reactive oxygen species metabolic process [GO:0072593]; signal transduction [GO:0007165] GO:0005125; GO:0005576; GO:0005615; GO:0006915; GO:0006955; GO:0007165; GO:0010989; GO:0072593; GO:2001237; GO:2001244 cytokine activity [GO:0005125] KLQCVSLWLLGTILILCSVDNHGLR 0.99525 -9.9488 0 0 0 0 0 0 0 0 11.0224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5264 0 0 0 0 0 0 0 0 0 0 0 14.2122 0 0 0 0 0 0 14.0039 0 0 0 0 0 0 0 0 16.7051 0 14.4275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3193 0 12.4367 0 0 0 0 0 0 0 0 0 14.2853 0 0 0 0 0 0 0 0 0 0 15.1024 14.448 0 0 0 15.2295 0 0 14.1449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3218 0 0 0 0 0 0 0 A0A1B0GUU1 CQ113_HUMAN Transmembrane protein C17orf113 C17orf113 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 FNLCQALLGTEHGDYYSPRRVR 0.99526 -32.467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8811 0 0 0 0 0 0 0 0 0 0 0 11.4301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.72 0 0 0 0 0 0 0 0 0 0 11.5295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3814 12.2325 12.2059 0 0 0 0 0 0 0 11.5447 0 11.8204 0 0 12.7345 0 0 0 0 0 12.3234 17.2393 0 0 0 0 0 9.89438 0 11.7206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0851 0 13.1954 0 0 0 0 10.6846 0 0 0 0 0 0 0 0 0 0 0 A6QL64 AN36A_HUMAN Ankyrin repeat domain-containing protein 36A ANKRD36 ANKRD36A KIAA1641 UNQ2430/PRO499 Homo sapiens (Human) AEREVAVR 0.99526 -32.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3307 13.5001 14.6686 0 0 13.0788 0 0 0 14.7554 0 0 0 0 0 0 0 0 0 0 0 16.9011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3975 0 0 0 0 11.6983 0 11.9823 14.5278 0 0 13.6133 0 0 12.483 13.3552 0 12.2502 14.6746 0 0 0 0 0 14.4596 13.5013 0 0 14.3866 0 14.1176 0 17.1533 0 0 13.1933 12.4923 0 0 13.1499 0 14.9634 0 0 0 12.2062 0 14.956 0 14.2473 0 13.6818 0 14.9995 12.9657 0 0 13.4877 16.5018 14.8808 12.0228 0 14.0577 0 14.7058 14.6292 0 0 14.2027 0 0 0 15.8475 15.6861 0 0 0 13.9896 0 0 0 14.5393 0 14.1898 15.8035 13.8822 14.1464 13.8258 0 0 0 0 16.3865 0 0 0 0 0 0 0 0 0 0 0 18.0906 14.0607 13.7234 13.1165 0 0 14.0876 0 0 A8MTQ0 NOTO_HUMAN Homeobox protein notochord NOTO Homo sapiens (Human) central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; regulation of cilium assembly [GO:1902017]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; neuron differentiation [GO:0030182]; notochord development [GO:0030903]; regulation of cilium assembly [GO:1902017]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001947; GO:0005634; GO:0006357; GO:0007417; GO:0009880; GO:0009953; GO:0030182; GO:0030903; GO:0044458; GO:1902017; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AQLAARLK 0.99526 -9.478 0 0 0 0 0 0 0 0 0 0 0 0 12.5037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7924 0 13.8624 0 0 0 0 12.3408 0 12.8786 0 0 0 12.8934 0 0 12.847 0 0 13.5527 0 0 0 0 12.738 0 12.7566 0 12.8532 0 0 0 0 0 0 13.836 0 0 0 0 12.6987 0 0 0 0 0 0 13.5913 13.1894 0 0 0 0 0 0 0 0 12.8472 0 0 0 0 0 0 0 0 0 0 12.2295 0 12.3309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.844 0 0 0 0 0 0 0 O15117 FYB1_HUMAN "FYN-binding protein 1 (Adhesion and degranulation promoting adaptor protein, ADAP) (FYB-120/130, p120/p130) (FYN-T-binding protein) (SLAP-130) (SLP-76-associated phosphoprotein)" FYB1 FYB SLAP130 Homo sapiens (Human) immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852] GO:0005102; GO:0005634; GO:0005829; GO:0005886; GO:0006955; GO:0007229; GO:0008289; GO:0015629; GO:0032991; GO:0044877; GO:0050852; GO:0070161; GO:0072659 lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102] EDRKIDAAK 0.99526 -9.4729 0 0 0 0 0 0 0 0 0 13.3218 0 0 0 0 12.0975 0 0 0 0 0 0 0 0 13.4153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2008 12.6863 0 0 0 0 0 0 0 0 0 0 0 12.2387 0 0 0 0 0 0 0 0 0 0 0 13.7277 0 0 13.5992 0 0 15.9103 12.0737 0 0 0 0 11.7974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3145 0 0 11.5252 9.95494 0 0 0 0 0 0 12.6841 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4103 12.2985 0 0 0 0 0 0 13.3281 0 0 0 14.0647 0 0 0 0 0 0 0 0 0 0 10.5298 0 0 0 14.4221 0 0 0 0 0 0 0 0 0 O75376 NCOR1_HUMAN "Nuclear receptor corepressor 1, N-CoR, N-CoR1" NCOR1 KIAA1047 Homo sapiens (Human) "chromatin organization [GO:0006325]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]" chromatin [GO:0000785]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "chromatin [GO:0000785]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714]; chromatin organization [GO:0006325]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of miRNA maturation [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]" GO:0000118; GO:0000122; GO:0000785; GO:0000976; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006357; GO:0016020; GO:0016922; GO:0017053; GO:0042826; GO:0045475; GO:0045820; GO:0045892; GO:0045922; GO:0046329; GO:0046966; GO:0051225; GO:0060766; GO:0061629; GO:0072686; GO:1903799 histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714] DPAFGGK 0.99526 -35.769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1182 0 0 0 0 0 11.3948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1401 0 0 0 11.6336 0 0 0 0 0 0 0 0 0 9.71922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3899 0 16.778 0 0 0 0 0 0 14.4506 0 11.3696 0 13.9792 0 0 0 0 0 0 0 15.1569 0 0 0 0 15.0249 0 0 11.6177 0 0 0 0 0 0 10.8935 0 16.5662 0 11.5894 0 0 0 11.1975 12.595 0 15.5555 0 0 0 0 0 0 0 0 12.504 0 0 0 0 0 0 0 0 11.3424 12.2752 0 0 11.3625 11.7212 0 0 11.2889 0 0 0 0 0 0 0 11.0233 0 0 0 0 0 0 11.9664 0 0 0 0 0 0 0 0 P05783 K1C18_HUMAN "Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18, CK-18) (Keratin-18, K18)" KRT18 CYK18 PIG46 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; hepatocyte apoptotic process [GO:0097284]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of apoptotic process [GO:0043066]; tumor necrosis factor-mediated signaling pathway [GO:0033209] adherens junction [GO:0005912]; cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471] adherens junction [GO:0005912]; cell periphery [GO:0071944]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; keratin filament [GO:0045095]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding involved in cell-cell adhesion [GO:0098641]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198]; anatomical structure morphogenesis [GO:0009653]; cell cycle [GO:0007049]; extrinsic apoptotic signaling pathway [GO:0097191]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; hepatocyte apoptotic process [GO:0097284]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of apoptotic process [GO:0043066]; tumor necrosis factor-mediated signaling pathway [GO:0033209] GO:0003723; GO:0005198; GO:0005730; GO:0005737; GO:0005815; GO:0005829; GO:0005856; GO:0005882; GO:0005912; GO:0007049; GO:0009653; GO:0033209; GO:0034451; GO:0043000; GO:0043066; GO:0045095; GO:0045104; GO:0048471; GO:0070062; GO:0071944; GO:0097110; GO:0097191; GO:0097284; GO:0098641 cadherin binding involved in cell-cell adhesion [GO:0098641]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; structural molecule activity [GO:0005198] DWSHYFK 0.99526 -9.4836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11274 BCR_HUMAN "Breakpoint cluster region protein, EC 2.7.11.1 (Renal carcinoma antigen NY-REN-26)" BCR BCR1 D22S11 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of nitrogen compound metabolic process [GO:0051171]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264] GO:0002692; GO:0003014; GO:0004674; GO:0004713; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006468; GO:0006909; GO:0007165; GO:0007264; GO:0007420; GO:0014069; GO:0016020; GO:0030036; GO:0030216; GO:0030424; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051056; GO:0051171; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0070062; GO:0070161; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:1905517; GO:1905522; GO:2000378 ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713] ARPGTAR 0.99526 -32.567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.32 0 0 0 0 11.3241 17.0364 0 0 13.3088 12.9617 13.4741 13.6853 17.3766 0 14.5031 0 0 12.3815 0 0 13.5927 13.6046 14.1976 13.0312 0 0 13.6275 0 0 0 0 0 0 12.8209 0 12.1984 0 0 0 0 0 0 0 0 0 0 13.3022 0 0 0 0 0 0 0 0 0 0 0 14.5067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7754 0 0 0 0 0 0 0 0 0 12.6218 0 0 0 0 0 0 0 16.8013 13.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4257 0 0 0 0 19.1186 0 13.3626 12.2069 13.8569 13.8287 0 0 12.7285 0 0 0 0 0 0 0 11.5854 0 0 12.4542 0 0 17.4642 0 14.0952 0 0 P11387 TOP1_HUMAN "DNA topoisomerase 1, EC 5.6.2.1 (DNA topoisomerase I)" TOP1 Homo sapiens (Human) chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to xenobiotic stimulus [GO:0009410] chromosome [GO:0005694]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993] "chromosome [GO:0005694]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to xenobiotic stimulus [GO:0009410]" GO:0000932; GO:0000978; GO:0001650; GO:0001673; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0009410; GO:0012501; GO:0016310; GO:0018105; GO:0019904; GO:0032922; GO:0032993; GO:0040016; GO:0043204; GO:0097100 "ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]" ANRAVAILCNHQRAPPK 0.99526 -35.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15586 GNS_HUMAN "N-acetylglucosamine-6-sulfatase, EC 3.1.6.14 (Glucosamine-6-sulfatase, G6S)" GNS Homo sapiens (Human) glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027]; keratan sulfate catabolic process [GO:0042340] GO:0005539; GO:0005576; GO:0006027; GO:0008449; GO:0008484; GO:0035578; GO:0042340; GO:0043199; GO:0043202; GO:0046872; GO:0070062; GO:1904813 glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484] GPGIKPNQTSK 0.99526 -8.9376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.643 0 0 0 0 0 0 0 0 0 0 0 13.4485 0 14.101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0155 0 15.0638 0 11.2926 0 0 0 13.4769 0 14.0282 0 0 9.69378 14.757 14.9925 14.2875 0 0 0 0 14.4817 0 14.0697 0 0 10.804 0 0 15.4284 0 0 0 0 0 0 14.129 0 14.6749 14.1723 0 14.8537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7133 0 0 0 17.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15884 ITF2_HUMAN "Transcription factor 4, TCF-4 (Class B basic helix-loop-helix protein 19, bHLHb19) (Immunoglobulin transcription factor 2, ITF-2) (SL3-3 enhancer factor 2, SEF-2)" TCF4 BHLHB19 ITF2 SEF2 Homo sapiens (Human) "cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-DNA complex assembly [GO:0065004]; regulation of transcription by RNA polymerase II [GO:0006357]" beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; TFIIB-class transcription factor binding [GO:0001093]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-DNA complex assembly [GO:0065004]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001093; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0006357; GO:0007399; GO:0008013; GO:0008022; GO:0030154; GO:0042802; GO:0045666; GO:0045893; GO:0045944; GO:0046982; GO:0065004; GO:0070369; GO:0070888; GO:1990837; GO:1990907 "beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; TFIIB-class transcription factor binding [GO:0001093]" DINEAFKELGR 0.99526 -9.4961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8466 0 0 12.2136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0515 0 0 0 0 0 12.0867 11.1105 0 0 0 0 0 0 0 12.5282 0 0 0 11.0707 12.0504 0 0 0 0 10.4669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6589 0 0 11.6457 P20020 AT2B1_HUMAN "Plasma membrane calcium-transporting ATPase 1, EC 7.2.2.10 (Plasma membrane calcium ATPase isoform 1, PMCA1) (Plasma membrane calcium pump isoform 1)" ATP2B1 PMCA1 Homo sapiens (Human) aging [GO:0007568]; brain development [GO:0007420]; calcium ion export [GO:1901660]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic spine membrane [GO:0032591]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; integral component of presynaptic membrane [GO:0099056]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body membrane [GO:0032809]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165]; aging [GO:0007568]; brain development [GO:0007420]; calcium ion export [GO:1901660]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to vitamin D [GO:0071305]; ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; neural retina development [GO:0003407]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056]; response to cold [GO:0009409] GO:0001772; GO:0001818; GO:0003056; GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005654; GO:0005886; GO:0005887; GO:0006874; GO:0007420; GO:0007568; GO:0008217; GO:0009409; GO:0009898; GO:0015085; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0019829; GO:0030165; GO:0030285; GO:0030501; GO:0032591; GO:0032809; GO:0034220; GO:0043231; GO:0045121; GO:0046872; GO:0051480; GO:0051481; GO:0051928; GO:0070062; GO:0070161; GO:0071305; GO:0071386; GO:0098978; GO:0098982; GO:0099056; GO:0099059; GO:1900076; GO:1901660; GO:1903779; GO:1905056; GO:1990034 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; PDZ domain binding [GO:0030165] EGGLPRHVGNK 0.99526 -10.014 0 0 0 0 0 0 0 0 0 13.4338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6851 0 0 14.533 0 0 0 0 0 0 0 0 0 0 13.518 0 0 0 11.5871 0 0 0 0 0 13.1148 0 0 0 0 0 13.3703 0 0 13.6927 0 0 0 0 0 0 12.9419 0 0 14.322 13.7365 13.9732 0 0 0 13.9935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.949 0 0 0 0 0 0 0 0 0 12.8692 0 0 0 0 0 0 13.5583 0 0 0 0 0 0 0 0 0 0 12.7617 12 0 0 13.6703 0 0 0 0 0 0 P21359 NF1_HUMAN Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated ] NF1 Homo sapiens (Human) "actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fibroblast proliferation [GO:0048144]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mast cell apoptotic process [GO:0033024]; mast cell proliferation [GO:0070662]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; observational learning [GO:0098597]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein import into nucleus [GO:0006606]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell migration [GO:0036135]; Schwann cell proliferation [GO:0014010]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; vascular associated smooth muscle cell migration [GO:1904738]; vascular associated smooth muscle cell proliferation [GO:1990874]; visual learning [GO:0008542]; wound healing [GO:0042060]" axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793] "axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fibroblast proliferation [GO:0048144]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; mast cell apoptotic process [GO:0033024]; mast cell proliferation [GO:0070662]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; observational learning [GO:0098597]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein import into nucleus [GO:0006606]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell migration [GO:0036135]; Schwann cell proliferation [GO:0014010]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; vascular associated smooth muscle cell migration [GO:1904738]; vascular associated smooth muscle cell proliferation [GO:1990874]; visual learning [GO:0008542]; wound healing [GO:0042060]" GO:0000165; GO:0001525; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001935; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006469; GO:0006606; GO:0007154; GO:0007265; GO:0007405; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0014010; GO:0014044; GO:0014065; GO:0016020; GO:0016525; GO:0016601; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030316; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0033024; GO:0033027; GO:0034605; GO:0035021; GO:0036135; GO:0042060; GO:0042308; GO:0043065; GO:0043087; GO:0043407; GO:0043409; GO:0043473; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045671; GO:0045685; GO:0045762; GO:0045765; GO:0046929; GO:0048144; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048709; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0051402; GO:0061534; GO:0061535; GO:0070662; GO:0070667; GO:0072089; GO:0097192; GO:0097529; GO:0098597; GO:0098793; GO:1900148; GO:1900271; GO:1904707; GO:1904738; GO:1904753; GO:1990874; GO:2000647; GO:2001241 GTPase activator activity [GO:0005096]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429] ALKKVAQLAVINSLEK 0.99526 -35.623 0 0 0 0 0 0 0 14.7935 12.6972 0 0 0 13.8601 0 0 14.167 0 0 0 0 0 13.7693 12.6088 13.9713 0 0 0 14.135 0 0 0 0 11.8564 0 0 0 0 0 0 0 13.6528 0 0 0 11.4659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1126 13.03 0 0 12.878 13.4397 12.3549 0 14.332 14.6011 0 15.8137 16.0016 15.2153 0 14.2581 0 13.3734 13.5899 13.7468 14.5545 14.4561 13.8348 14.4226 15.2012 13.8156 0 15.4007 16.1269 14.8902 0 12.1317 14.2294 15.0307 0 0 0 0 17.1994 0 15.3315 0 16.0421 13.5774 0 13.4155 0 15.6998 14.3039 12.4019 0 12.0648 14.3267 16.7207 13.527 0 0 10.0331 15.0786 15.3537 17.0515 15.1676 15.8987 16.2439 15.2187 15.1723 15.3073 14.7816 0 13.2341 16.2215 0 0 0 13.0101 15.552 15.2672 0 0 0 14.876 15.2929 14.0351 0 15.4907 16.4788 14.0962 0 0 14.2005 0 0 11.7211 0 13.8969 14.5958 0 14.2174 0 0 0 12.3866 11.2401 0 0 12.1999 0 14.9293 14.8695 0 P43657 LPAR6_HUMAN "Lysophosphatidic acid receptor 6, LPA receptor 6, LPA-6 (Oleoyl-L-alpha-lysophosphatidic acid receptor) (P2Y purinoceptor 5, P2Y5) (Purinergic receptor 5) (RB intron encoded G-protein coupled receptor)" LPAR6 P2RY5 Homo sapiens (Human) blastocyst hatching [GO:0001835]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid receptor activity [GO:0070915]; blastocyst hatching [GO:0001835]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0001835; GO:0004930; GO:0005886; GO:0005887; GO:0035025; GO:0051482; GO:0070915 G protein-coupled receptor activity [GO:0004930]; lysophosphatidic acid receptor activity [GO:0070915] INKTKVLK 0.99526 -8.9217 0 0 0 12.3118 13.4194 12.9201 12.2393 12.2126 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6196 0 12.3511 0 0 0 0 0 0 0 0 12.3114 0 0 0 0 0 0 0 0 0 0 11.904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4685 0 0 0 0 14.2161 14.4272 14.4123 0 0 0 0 0 0 0 14.7619 0 0 0 0 0 0 14.419 0 0 13.5877 0 0 0 0 0 0 14.2195 14.4954 0 0 0 0 0 0 11.5013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9377 0 12.5393 13.1917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46939 UTRN_HUMAN "Utrophin (Dystrophin-related protein 1, DRP-1)" UTRN DMDL DRP1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270]; actin cytoskeleton organization [GO:0030036]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649] GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0006936; GO:0007517; GO:0008270; GO:0016010; GO:0016020; GO:0017166; GO:0019901; GO:0030036; GO:0030054; GO:0030175; GO:0030864; GO:0031527; GO:0031594; GO:0032991; GO:0042383; GO:0042995; GO:0045211; GO:0051015; GO:0070062; GO:0070161; GO:2000649 actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270] AMRKQSSEVK 0.99526 -35.779 10.6153 15.1494 0 12.7732 0 13.9783 13.5239 0 0 0 0 0 0 0 0 0 11.8522 12.6515 0 0 15.5448 0 11.4162 0 0 0 0 0 0 0 12.5229 13.918 13.287 10.3075 0 12.5351 0 0 0 0 0 12.147 0 0 0 12.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4171 0 0 0 0 0 13.1003 15.3286 0 0 0 14.0162 13.857 0 13.3955 0 12.3581 13.8066 13.847 14.2306 0 12.7916 0 12.5363 12.3613 12.8008 12.7951 14.5215 13.1539 0 0 13.3288 0 0 12.6887 0 0 0 0 0 15.015 0 13.657 15.9902 0 0 14.0051 0 0 12.3078 12.9328 11.4499 0 13.6715 0 0 0 0 0 0 13.6033 0 13.6745 13.2897 14.7822 11.5376 11.8944 0 0 12.2284 12.9836 0 12.9891 12.4585 0 0 0 0 0 12.5301 0 11.6079 0 0 0 0 0 13.7181 0 15.5866 12.5243 0 0 0 14.8893 0 14.4114 0 12.5624 0 0 0 0 12.5895 0 0 13.7406 0 0 13.9179 0 0 13.209 0 14.7875 0 0 11.7381 0 0 P78423 X3CL1_HUMAN Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine ] CX3CL1 FKN NTT SCYD1 A-152E5.2 Homo sapiens (Human) aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883] cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883] GO:0001774; GO:0001954; GO:0002052; GO:0002523; GO:0002548; GO:0002931; GO:0005102; GO:0005178; GO:0005576; GO:0005615; GO:0005886; GO:0006935; GO:0006952; GO:0006954; GO:0006955; GO:0007155; GO:0007186; GO:0007267; GO:0007568; GO:0008009; GO:0008284; GO:0009986; GO:0010812; GO:0010976; GO:0016020; GO:0016021; GO:0016322; GO:0019221; GO:0030336; GO:0030593; GO:0030595; GO:0031664; GO:0031737; GO:0032233; GO:0032690; GO:0032691; GO:0032715; GO:0032720; GO:0032914; GO:0033622; GO:0035425; GO:0042056; GO:0042995; GO:0043005; GO:0043025; GO:0043066; GO:0043123; GO:0043410; GO:0043547; GO:0045237; GO:0045944; GO:0048020; GO:0048167; GO:0048245; GO:0048247; GO:0048471; GO:0048661; GO:0050729; GO:0050767; GO:0050902; GO:0050918; GO:0051041; GO:0051092; GO:0051281; GO:0051897; GO:0060055; GO:0060326; GO:0061518; GO:0070050; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356; GO:0097192; GO:0098609; GO:0098883; GO:0110091; GO:1900450; GO:1903721; GO:1903979; GO:1904141; GO:2001223; GO:2001234; GO:2001240 CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102] APISLSWLLR 0.99526 -8.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6534 13.5446 0 0 0 0 0 0 0 14.8305 0 0 14.2094 0 0 0 0 0 0 0 0 0 14.0154 0 12.5982 0 0 0 0 0 13.6683 0 13.0399 13.3842 0 0 0 13.018 0 0 0 0 0 0 14.2065 13.5942 0 0 0 0 13.7257 0 0 0 0 0 12.8971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13043 STK4_HUMAN "Serine/threonine-protein kinase 4, EC 2.7.11.1 (Mammalian STE20-like protein kinase 1, MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit, MST1/N; Serine/threonine-protein kinase 4 18kDa subunit, MST1/C ]" STK4 KRS2 MST1 Homo sapiens (Human) "apoptotic process [GO:0006915]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell morphogenesis [GO:0000902]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte apoptotic process [GO:1903945]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; primitive hemopoiesis [GO:0060215]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; apoptotic process [GO:0006915]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell morphogenesis [GO:0000902]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte apoptotic process [GO:1903945]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; primitive hemopoiesis [GO:0060215]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]" GO:0000287; GO:0000902; GO:0001569; GO:0001841; GO:0001934; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006606; GO:0006915; GO:0007165; GO:0007417; GO:0008625; GO:0016604; GO:0018105; GO:0030216; GO:0032092; GO:0032991; GO:0033138; GO:0035265; GO:0035329; GO:0035556; GO:0042802; GO:0042803; GO:0043065; GO:0043408; GO:0043539; GO:0045600; GO:0046621; GO:0046777; GO:0050673; GO:0050680; GO:0050821; GO:0051262; GO:0060070; GO:0060215; GO:0060706; GO:0060800; GO:0061629; GO:0090090; GO:0097284; GO:0106310; GO:1902043; GO:1903945; GO:1904237 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] ETVQLRNPPR 0.99526 -8.8962 0 0 0 0 0 0 0 11.4722 0 0 0 10.3854 0 0 0 0 0 0 0 0 0 0 12.5287 0 0 0 0 12.6905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2157 0 0 13.1641 0 0 0 0 0 0 12.3192 0 0 0 0 0 0 0 13.8508 12.9495 0 0 0 0 0 0 0 13.6062 13.2938 0 0 0 0 13.5398 0 0 11.6168 0 11.9235 0 0 0 0 0 0 0 0 14.6698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0091 0 0 0 0 0 0 0 11.3884 0 0 11.3006 0 0 0 0 11.3271 0 0 0 0 0 11.3228 0 0 0 0 0 0 0 0 0 0 0 0 Q13790 APOF_HUMAN "Apolipoprotein F, Apo-F (Lipid transfer inhibitor protein, LTIP)" APOF Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869] extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362] extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869] GO:0005102; GO:0005319; GO:0005615; GO:0006629; GO:0006869; GO:0008203; GO:0015485; GO:0034362; GO:0034364 cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; signaling receptor binding [GO:0005102] EQQSTGR 0.99526 -9.4901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9729 0 0 13.2083 0 0 0 0 0 0 0 0 0 0 0 0 10.3622 0 0 9.84207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0064 0 0 13.7196 0 0 0 0 0 14.2029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0089 0 Q14151 SAFB2_HUMAN "Scaffold attachment factor B2, SAF-B2" SAFB2 KIAA0138 Homo sapiens (Human) regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0016604; GO:0042802; GO:0043231; GO:0043565; GO:0050684; GO:0060008; GO:0060765; GO:0070062 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565] DGQHYGDDR 0.99526 -35.642 0 12.463 12.2147 12.4836 19.2589 0 12.6758 0 0 0 0 0 12.5071 0 11.7657 19.2516 19.271 19.3852 19.3045 19.4005 19.3023 11.8939 19.5618 12.0507 19.1108 19.3142 18.672 12.4577 0 19.3431 0 0 11.702 0 0 0 0 0 0 0 0 0 0 19.3347 0 13.1332 0 19.2912 0 12.8018 12.8973 13.3737 13.3961 11.5796 0 0 0 10.9492 0 0 0 13.4014 0 0 0 10.2547 15.7936 14.437 14.7193 15.0887 14.2939 16.5245 0 0 14.8216 15.82 16.2476 16.2721 16.1521 15.5998 16.0293 16.3063 15.6593 13.854 14.697 15.9743 20.3412 20.1942 20.1962 20.2288 20.1646 20.2177 20.2205 20.0958 20.078 20.1149 20.2671 15.6039 20.3031 20.1499 20.2043 15.2085 16.347 20.2294 20.2871 14.5983 20.1352 20.1999 16.2973 20.2278 16.1907 20.1351 20.2042 20.1834 20.1299 20.2023 20.1476 20.1641 20.1368 20.2375 20.1341 20.1357 15.7151 14.7066 16.4397 20.2053 15.9127 15.6488 20.2399 15.3821 20.1573 14.3976 15.508 19.6063 17.2539 20.1761 20.1875 15.7214 20.1874 20.2463 0 20.271 20.2407 17.0622 20.2459 20.2537 14.6739 15.3923 0 0 15.8369 12.9591 0 17.1918 20.2335 20.1836 14.9376 0 0 11.8605 0 0 0 10.6971 0 14.2331 0 0 0 0 0 20.1708 20.2368 16.5712 15.2107 0 20.1863 0 20.1284 11.3801 Q15542 TAF5_HUMAN "Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit, TAF(II)100, TAFII-100, TAFII100)" TAF5 TAF2D Homo sapiens (Human) "DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276] "actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; identical protein binding [GO:0042802]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367]" GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0006468; GO:0015629; GO:0016251; GO:0033276; GO:0035521; GO:0035522; GO:0042789; GO:0042802; GO:0043966; GO:0045893; GO:0051123; GO:0060261 identical protein binding [GO:0042802]; RNA polymerase II general transcription initiation factor activity [GO:0016251] QTLLAVLQFLR 0.99526 -9.4689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5752 0 0 0 0 0 0 13.5718 0 0 0 0 0 0 0 0 0 0 0 0 13.1529 0 0 13.4616 0 0 0 0 13.3308 0 0 0 0 0 0 0 0 13.8382 0 0 13.2568 13.0481 0 0 0 0 12.5404 12.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6RW13 ATRAP_HUMAN Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein) AGTRAP ATRAP Homo sapiens (Human) regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; angiotensin type II receptor activity [GO:0004945]; identical protein binding [GO:0042802]; regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666] GO:0000139; GO:0001666; GO:0004945; GO:0005789; GO:0005794; GO:0005886; GO:0005938; GO:0008217; GO:0016021; GO:0030659; GO:0042802; GO:0043231 angiotensin type II receptor activity [GO:0004945]; identical protein binding [GO:0042802] FGVGMAILSLLLK 0.99526 -10.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6SA08 TSSK4_HUMAN "Testis-specific serine/threonine-protein kinase 4, TSK-4, TSSK-4, Testis-specific kinase 4, EC 2.7.11.1 (Serine/threonine-protein kinase 22E)" TSSK4 C14orf20 STK22E TSSK5 Homo sapiens (Human) fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126] acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286] GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0032793; GO:0035556; GO:0036126; GO:0042803; GO:0044877; GO:0106310; GO:1990443 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877] ASDDYLNK 0.99526 -8.9256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6764 0 0 0 0 0 13.9792 0 0 0 0 15.9374 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8665 0 0 0 0 0 12.8674 0 0 0 0 0 0 0 12.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0695 0 0 0 12.484 0 0 0 12.809 0 0 0 0 0 0 0 13.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.56 0 0 0 Q7Z4S9 SH2D6_HUMAN SH2 domain-containing protein 6 SH2D6 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0007169; GO:0035556 ELTCLLFPTKP 0.99526 -10.011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8215 0 0 0 0 0 Q86W24 NAL14_HUMAN "NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)" NLRP14 NALP14 NOD5 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cell differentiation [GO:0030154]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283] GO:0005524; GO:0005737; GO:0007283; GO:0030154; GO:0050727 ATP binding [GO:0005524] AGETQEDQEAVLGDGTEYRNR 0.99526 -35.784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1769 0 0 0 0 0 0 0 0 0 0 0 0 11.0244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0861 0 13.6794 0 0 0 14.1121 13.587 13.8882 0 0 0 14.1897 0 11.6515 0 0 0 13.5726 0 0 13.9201 0 13.6537 14.3518 14.343 14.363 0 0 0 0 0 11.3622 0 0 0 0 14.4648 0 0 0 0 0 12.6631 0 0 14.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0033 0 0 0 14.5448 17.4544 0 0 Q86YR7 MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 (Dbs-related Rho family guanine nucleotide exchange factor) (MCF2-transforming sequence-like protein 2) MCF2L2 DRG KIAA0861 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; guanyl-nucleotide exchange factor activity [GO:0005085] GO:0005085; GO:0005737 guanyl-nucleotide exchange factor activity [GO:0005085] AGASTGR 0.99526 -35.706 10.3863 0 0 12.2285 0 0 12.2337 0 0 0 0 13.2589 0 0 0 13.1793 0 0 0 0 11.392 0 12.5026 0 12.1591 0 0 0 0 0 0 10.4924 0 0 0 9.9435 0 0 0 0 0 0 0 0 12.6703 0 12.3422 9.80313 0 0 0 0 0 0 0 12.7854 0 0 0 0 0 0 0 0 0 0 0 0 13.2772 0 9.92266 0 13.1132 0 13.1765 14.8944 12.8686 15.2765 13.0809 15.093 14.9893 16.1888 14.4912 14.8173 0 11.9863 14.3981 15.5958 0 0 0 0 10.3335 0 15.001 14.0016 13.5066 13.6862 0 13.7684 14.57 0 14.6775 0 0 0 13.6256 13.6899 0 0 0 12.8158 0 0 0 0 13.745 0 0 0 13.3209 13.7875 13.6892 0 0 13.4085 0 0 0 15.2904 0 0 13.5605 13.3599 0 14.3734 0 0 0 0 13.5253 13.3716 0 13.8158 0 15.1046 0 0 11.5189 0 0 13.1788 0 12.9427 13.3864 0 13.4418 0 0 0 0 0 0 0 0 0 13.1916 0 0 0 0 0 14.6011 0 0 0 0 13.7745 0 0 Q8N158 GPC2_HUMAN Glypican-2 [Cleaved into: Secreted glypican-2 ] GPC2 Homo sapiens (Human) cell migration [GO:0016477]; neuron differentiation [GO:0030182]; positive regulation of neuron projection development [GO:0010976]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; smoothened signaling pathway [GO:0007224] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202] anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]; cell migration [GO:0016477]; neuron differentiation [GO:0030182]; positive regulation of neuron projection development [GO:0010976]; regulation of protein localization to membrane [GO:1905475]; regulation of signal transduction [GO:0009966]; smoothened signaling pathway [GO:0007224] GO:0005615; GO:0005783; GO:0005796; GO:0005886; GO:0007224; GO:0009966; GO:0009986; GO:0010976; GO:0016477; GO:0030182; GO:0043202; GO:0045202; GO:0046658; GO:0062023; GO:1905475 ERLARMR 0.99526 -9.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2166 0 15.3736 0 0 0 0 0 15.4462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8823 0 14.4415 0 0 0 0 0 15.1407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.373 0 0 0 15.078 0 15.5672 0 Q8NCT3 K0895_HUMAN Uncharacterized protein KIAA0895 KIAA0895 Homo sapiens (Human) IMEVNELTDR 0.99526 -11.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6862 15.0607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0005 0 0 0 0 0 0 16.0472 0 Q92738 US6NL_HUMAN "USP6 N-terminal-like protein (Related to the N-terminus of tre, RN-tre)" USP6NL KIAA0019 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]" cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]" GO:0005096; GO:0005829; GO:0005886; GO:0007030; GO:0019068; GO:0031267; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:0090630; GO:1903358 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] DHIMFRDR 0.99526 -32.462 0 0 0 0 0 0 0 0 0 0 0 10.8013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0802 11.9763 11.8994 0 0 0 0 0 0 0 16.4105 0 0 0 0 0 0 13.086 0 0 0 0 0 0 0 0 0 13.118 15.6878 0 0 13.712 13.9172 0 0 0 16.5392 14.4501 0 14.5425 0 0 0 13.2649 0 0 14.2394 0 0 0 0 14.53 0 0 0 14.4622 13.1306 14.7851 0 0 14.0276 0 14.6858 0 0 12.9644 0 0 0 0 14.0726 0 0 0 0 14.3224 14.1551 0 14.7172 0 0 14.4118 0 0 0 0 15.4271 0 0 0 0 0 0 0 0 0 0 0 13.6996 0 0 14.5161 0 0 13.0493 0 0 0 0 0 0 Q96PE7 MCEE_HUMAN "Methylmalonyl-CoA epimerase, mitochondrial, EC 5.1.99.1 (DL-methylmalonyl-CoA racemase)" MCEE Homo sapiens (Human) L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626] GO:0004493; GO:0005759; GO:0019626; GO:0046491; GO:0046872 metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493] IGAHGKPVIFLHPK 0.99526 -11.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1768 0 0 0 0 0 14.6052 0 0 0 0 0 11.5684 0 0 11.9916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZW5 SCND2_HUMAN Putative SCAN domain-containing protein SCAND2P (SCAN domain-containing protein 2 pseudogene) SCAND2P SCAND2 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ASETGSTASCAGR 0.99526 -8.9169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2737 0 0 0 0 0 0 0 0 0 0 12.6533 0 12.7257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0097 0 0 0 13.4111 0 0 0 0 0 0 0 0 0 0 13.2546 0 0 0 0 0 0 13.237 13.3652 0 13.1436 0 0 13.0057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1545 0 0 0 0 0 0 0 0 0 14.9694 0 0 0 0 0 0 0 0 13.4964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NTU4 CTSRZ_HUMAN "Cation channel sperm-associated auxiliary subunit zeta, CatSper-zeta, CatSperzeta (Testis-expressed protein 40)" CATSPERZ C11orf20 TEX40 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; male meiotic nuclear division [GO:0007140]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; male meiotic nuclear division [GO:0007140]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] GO:0005737; GO:0007140; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0097228 LPLPLMELMENEALEILTK 0.99526 -9.4793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P104 DOK5_HUMAN "Docking protein 5 (Downstream of tyrosine kinase 5) (Insulin receptor substrate 6, IRS-6, IRS6)" DOK5 C20orf180 Homo sapiens (Human) neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0005829; GO:0007169; GO:0030182; GO:0043410; GO:0051386 FSDERAAYFR 0.99526 -9.488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3091 0 0 0 0 0 12.8376 0 0 0 0 0 0 0 10.4097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5579 0 0 0 0 0 0 0 15.7383 0 0 0 0 0 0 14.2009 17.1234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5547 0 0 0 0 0 0 0 15.0712 0 0 0 0 0 0 0 12.6594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UJX5 APC4_HUMAN "Anaphase-promoting complex subunit 4, APC4 (Cyclosome subunit 4)" ANAPC4 APC4 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071] GO:0004842; GO:0005634; GO:0005654; GO:0005680; GO:0005829; GO:0007049; GO:0007346; GO:0019903; GO:0030071; GO:0031145; GO:0034399; GO:0051301; GO:0051445; GO:0070979 protein phosphatase binding [GO:0019903]; ubiquitin-protein transferase activity [GO:0004842] FGSFTYATTEKVRR 0.99526 -10.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0301 0 0 0 0 14.2794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5242 13.6753 0 0 0 0 0 0 0 0 0 0 13.0516 0 0 0 0 14.9882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2386 0 0 0 0 0 0 10.9518 0 0 0 0 0 0 0 11.3943 0 0 0 0 0 0 0 14.7118 0 0 0 0 0 14.7925 0 14.9813 14.7877 14.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MZH6 OOSP1_HUMAN Putative oocyte-secreted protein 1 homolog OOSP1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 MKTILGFK 0.99527 -10.487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00533 EGFR_HUMAN "Epidermal growth factor receptor, EC 2.7.10.1 (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)" EGFR ERBB ERBB1 HER1 Homo sapiens (Human) "activation of phospholipase C activity [GO:0007202]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; ossification [GO:0001503]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" "basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]; spanning component of plasma membrane [GO:0044214]" "basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]; spanning component of plasma membrane [GO:0044214]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618]; activation of phospholipase C activity [GO:0007202]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; digestive tract morphogenesis [GO:0048546]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein catabolic process [GO:0042177]; ossification [GO:0001503]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of miRNA maturation [GO:1903800]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0000139; GO:0000902; GO:0001503; GO:0001618; GO:0001892; GO:0001934; GO:0001942; GO:0003682; GO:0003690; GO:0004709; GO:0004713; GO:0004714; GO:0004888; GO:0005006; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005768; GO:0005789; GO:0005886; GO:0005887; GO:0005925; GO:0007165; GO:0007166; GO:0007169; GO:0007173; GO:0007202; GO:0007435; GO:0007611; GO:0008284; GO:0009925; GO:0009986; GO:0010008; GO:0010750; GO:0014066; GO:0016020; GO:0016323; GO:0018108; GO:0019899; GO:0019900; GO:0019903; GO:0021795; GO:0030054; GO:0030154; GO:0030296; GO:0030297; GO:0030307; GO:0030335; GO:0030669; GO:0031625; GO:0031901; GO:0031965; GO:0032587; GO:0032991; GO:0033138; GO:0033674; GO:0034614; GO:0038083; GO:0038134; GO:0042059; GO:0042177; GO:0042327; GO:0042802; GO:0043066; GO:0043235; GO:0043406; GO:0044214; GO:0045121; GO:0045296; GO:0045737; GO:0045739; GO:0045740; GO:0045893; GO:0045944; GO:0046328; GO:0046777; GO:0048146; GO:0048408; GO:0048471; GO:0048546; GO:0050673; GO:0050679; GO:0050730; GO:0050999; GO:0051015; GO:0051117; GO:0051205; GO:0051897; GO:0060571; GO:0061029; GO:0070141; GO:0070372; GO:0070374; GO:0070435; GO:0071230; GO:0071276; GO:0071364; GO:0071392; GO:0090263; GO:0097489; GO:0097708; GO:0098609; GO:1900020; GO:1900087; GO:1901224; GO:1903078; GO:1903800; GO:1905208 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618] CDPSCPNGSCWGAGEENCQK 0.99527 -12.826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9304 0 0 0 10.8425 0 0 0 0 0 12.0283 0 0 0 0 0 11.1523 0 0 0 0 0 0 0 11.7812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5256 13.0573 12.7981 0 0 0 0 14.0441 0 0 14.9059 17.296 0 0 14.8474 14.172 14.8168 14.7545 14.7172 14.7855 0 0 0 0 0 14.1322 0 14.2569 14.889 14.2801 13.8888 0 13.0197 13.7697 0 0 0 0 0 14.0522 13.8756 0 0 14.2292 0 0 10.5852 13.0506 13.6247 0 0 0 0 11.2678 0 10.872 0 13.1835 0 0 0 0 0 0 0 10.8979 0 0 0 0 12.5274 0 11.1111 0 0 12.7959 0 12.5493 0 0 0 0 12.7143 0 10.022 12.5905 0 0 0 0 14.2453 0 0 0 0 0 0 0 12.3901 0 14.0631 12.3676 0 13.2444 12.0897 0 P61247 RS3A_HUMAN "40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein, Fte-1)" RPS3A FTE1 MFTL Homo sapiens (Human) cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cell differentiation [GO:0030154]; cytoplasmic translation [GO:0002181]; negative regulation of apoptotic process [GO:0043066]; translation [GO:0006412]; translational initiation [GO:0006413] GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006412; GO:0006413; GO:0022626; GO:0022627; GO:0030154; GO:0043066; GO:0045202; GO:0048027; GO:0070062; GO:1990904 mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] DKMCSMVKK 0.99527 -10.509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P82921 RT21_HUMAN "28S ribosomal protein S21, mitochondrial, MRP-S21, S21mt (Mitochondrial small ribosomal subunit protein bS21m)" MRPS21 RPMS21 MDS016 Homo sapiens (Human) mitochondrial translation [GO:0032543]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412] GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412; GO:0032543 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] INFLMRK 0.99527 -11.038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12816 TROP_HUMAN Trophinin (MAGE-D3 antigen) TRO KIAA1114 MAGED3 Homo sapiens (Human) embryo implantation [GO:0007566]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of transcription by RNA polymerase II [GO:0000122] intrinsic component of plasma membrane [GO:0031226]; nucleus [GO:0005634] intrinsic component of plasma membrane [GO:0031226]; nucleus [GO:0005634]; embryo implantation [GO:0007566]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0007156; GO:0007566; GO:0031226 AQMGIGEEAVAGPWNWDDMDIDCLTR 0.99527 -11.04 0 0 0 0 0 0 0 10.1263 0 0 0 0 0 11.9772 0 0 0 11.2676 0 10.8724 0 11.8256 0 11.3181 0 0 0 0 0 12.0297 0 12.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.224 0 0 0 13.2907 0 0 0 0 0 0 0 0 0 13.9754 0 0 0 0 14.0887 0 0 0 0 0 12.5262 0 0 0 0 14.9901 0 0 14.6134 0 14.3068 0 0 14.5542 15.3193 12.9236 14.0264 0 13.874 0 0 13.3451 0 14.1809 0 14.1397 13.8451 0 0 15.5976 0 13.6337 13.8963 13.959 13.5395 0 0 0 0 0 0 0 0 0 15.1983 15.3459 0 0 0 0 0 0 11.7869 0 0 0 0 0 0 0 0 14.3595 9.43388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8244 0 Q13444 ADA15_HUMAN "Disintegrin and metalloproteinase domain-containing protein 15, ADAM 15, EC 3.4.24.- (Metalloprotease RGD disintegrin protein) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15, MDC-15) (Metargidin)" ADAM15 MDC15 Homo sapiens (Human) angiogenesis [GO:0001525]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell-matrix adhesion [GO:0007160]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response to tumor cell [GO:0002418]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; male gonad development [GO:0008584]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of receptor binding [GO:1900121]; proteolysis [GO:0006508]; response to hypobaric hypoxia [GO:1990910]; tissue regeneration [GO:0042246] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886] acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; SH3 domain binding [GO:0017124]; angiogenesis [GO:0001525]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell-matrix adhesion [GO:0007160]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response to tumor cell [GO:0002418]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; male gonad development [GO:0008584]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of receptor binding [GO:1900121]; proteolysis [GO:0006508]; response to hypobaric hypoxia [GO:1990910]; tissue regeneration [GO:0042246] GO:0001525; GO:0001669; GO:0001953; GO:0002418; GO:0004222; GO:0005178; GO:0005615; GO:0005886; GO:0005912; GO:0006508; GO:0007160; GO:0007229; GO:0008237; GO:0008584; GO:0009986; GO:0016021; GO:0017124; GO:0022617; GO:0030308; GO:0030336; GO:0030574; GO:0031514; GO:0042246; GO:0045087; GO:0046872; GO:0060317; GO:0070062; GO:1900121; GO:1904628; GO:1990910 integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; SH3 domain binding [GO:0017124] ARLHQRLCQLK 0.99527 -10.512 0 0 0 0 0 0 0 0 12.2897 0 0 0 0 12.0834 0 12.8278 12.3 13.0625 0 12.9188 0 11.4613 0 0 12.3911 0 0 13.9297 13.5314 0 0 14.6795 14.796 0 0 13.8314 0 14.3424 0 0 12.1115 0 14.272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.242 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3093 15.7944 14.2097 0 0 0 0 0 0 0 0 18.3205 18.2148 Q8IVC4 ZN584_HUMAN Zinc finger protein 584 ZNF584 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFKHSSTLLQHK 0.99527 -8.9481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5732 0 0 0 0 0 13.1958 14.0736 14.2524 0 0 0 0 0 13.5418 0 12.0798 0 0 0 0 0 11.8851 0 0 0 11.3686 0 0 0 0 12.6867 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5682 0 11.8939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WXF1 PSPC1_HUMAN Paraspeckle component 1 (Paraspeckle protein 1) PSPC1 PSP1 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; innate immune response [GO:0045087]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]" cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382] "cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; innate immune response [GO:0045087]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]" GO:0001650; GO:0002218; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0016363; GO:0016607; GO:0042382; GO:0042752; GO:0045087; GO:0045892; GO:0048511 RNA binding [GO:0003723] GSQGGNFEGPNKR 0.99527 -9.5082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9663 0 0 0 0 0 0 0 0 0 0 0 0 14.8135 0 0 0 0 0 12.5472 0 0 14.519 13.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96KS0 EGLN2_HUMAN "Prolyl hydroxylase EGLN2, EC 1.14.11.- (Egl nine homolog 2, EC 1.14.11.29) (Estrogen-induced tag 6, EIT-6) (HPH-3) (Hypoxia-inducible factor prolyl hydroxylase 1, HIF-PH1, HIF-prolyl hydroxylase 1, HPH-1) (Prolyl hydroxylase domain-containing protein 1, PHD1)" EGLN2 EIT6 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; intracellular estrogen receptor signaling pathway [GO:0030520]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell growth [GO:0001558]; regulation of neuron apoptotic process [GO:0043523]; response to hypoxia [GO:0001666] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; oxygen sensor activity [GO:0019826]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; intracellular estrogen receptor signaling pathway [GO:0030520]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell growth [GO:0001558]; regulation of neuron apoptotic process [GO:0043523]; response to hypoxia [GO:0001666] GO:0001558; GO:0001666; GO:0005634; GO:0005654; GO:0005737; GO:0008198; GO:0016706; GO:0018401; GO:0019826; GO:0030520; GO:0031418; GO:0031543; GO:0031545; GO:0043523; GO:0045454; GO:0045732; GO:0071456 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; oxygen sensor activity [GO:0019826]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; peptidyl-proline dioxygenase activity [GO:0031543] LLIFWSDR 0.99527 -12.822 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.702 13.0529 15.0694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.377 0 0 13.1287 0 13.2546 0 0 12.7355 12.4959 11.4911 0 12.7997 14.2246 0 0 0 0 0 0 0 0 0 13.6777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3001 0 0 0 14.8309 0 13.4786 0 0 0 0 0 0 0 0 0 14.2265 0 0 0 0 12.6097 0 0 0 0 0 0 0 0 11.1066 0 10.5893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4086 0 12.7309 12.9505 0 0 12.4472 0 0 0 0 0 0 11.2036 11.7741 0 0 Q9NP60 IRPL2_HUMAN "X-linked interleukin-1 receptor accessory protein-like 2, IL-1 receptor accessory protein-like 2, IL-1-RAPL-2, IL-1RAPL-2, IL1RAPL-2, EC 3.2.2.6 (IL1RAPL-2-related protein) (Interleukin-1 receptor 9, IL-1R-9, IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1, TIGIRR-1)" IL1RAPL2 IL1R9 Homo sapiens (Human) central nervous system development [GO:0007417]; regulation of presynapse assembly [GO:1905606] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; central nervous system development [GO:0007417]; regulation of presynapse assembly [GO:1905606]" GO:0004908; GO:0004910; GO:0005886; GO:0007417; GO:0016021; GO:0050135; GO:0061809; GO:0098978; GO:1905606 "interleukin-1 receptor activity [GO:0004908]; interleukin-1, type II, blocking receptor activity [GO:0004910]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]" DLIYKIELAGGLGAIFLLLVLLVVIYK 0.99527 -8.9456 0 0 0 0 0 11.0276 0 0 0 11.3019 13.8794 0 0 0 0 12.4405 11.1063 0 11.4473 12.0082 13.5797 0 12.1878 0 0 0 0 11.2129 0 0 10.5302 0 0 0 0 0 11.2568 0 12.928 0 10.2038 0 0 0 10.3898 0 0 0 0 0 0 0 0 0 11.2407 0 0 0 0 0 0 0 0 0 0 0 0 10.5328 10.0429 0 0 14.6559 0 14.053 0 12.4595 13.8344 11.3397 12.4455 0 0 12.3996 0 13.5206 12.853 0 0 0 14.5432 0 14.2161 12.5558 0 0 0 11.4744 0 0 0 14.5124 14.2025 14.6174 14.0202 13.1518 13.6823 0 14.0997 15.2434 14.8675 14.7523 13.7044 15.0649 0 0 0 13.1123 0 13.8363 14.0821 12.6092 13.1876 14.0615 13.9904 14.0654 14.5134 0 13.6481 13.1865 14.3321 0 0 13.3645 13.2766 0 14.5278 13.9485 0 13.3907 12.7356 13.0425 0 14.1755 12.6195 0 14.1278 0 13.8181 15.3798 0 13.0773 11.8252 12.0293 12.7031 12.1955 12.3898 13.7317 13.691 0 0 14.1822 0 0 0 0 13.7424 0 0 0 0 0 0 0 13.553 12.6141 14.5074 0 0 0 13.6177 0 Q9NTM9 CUTC_HUMAN Copper homeostasis protein cutC homolog CUTC CGI-32 Homo sapiens (Human) copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262] GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070 copper ion binding [GO:0005507] QSVQIPVFVMIRPRGGDFLYSDR 0.99527 -10.517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P217 ZSWM5_HUMAN Zinc finger SWIM domain-containing protein 5 ZSWIM5 KIAA1511 Homo sapiens (Human) Cul2-RING ubiquitin ligase complex [GO:0031462]; extracellular space [GO:0005615] Cul2-RING ubiquitin ligase complex [GO:0031462]; extracellular space [GO:0005615]; zinc ion binding [GO:0008270] GO:0005615; GO:0008270; GO:0031462 zinc ion binding [GO:0008270] ETFLLPQDGHLQFAQFIDNLKQIYKGK 0.99527 -8.9448 0 0 0 0 0 0 0 0 0 0 0 0 0 13.066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6948 0 0 0 0 0 13.5683 0 0 0 14.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4384 0 0 0 0 0 0 0 0 0 0 14.4665 11.6199 12.1793 9.89562 13.463 9.75029 0 13.1781 0 0 0 0 0 0 0 0 0 0 0 0 11.0535 0 0 0 0 0 0 0 0 0 18.8513 0 0 19.768 0 0 0 0 0 0 0 0 0 0 0 0 13.1789 12.1723 19.6669 0 0 0 0 0 0 0 13.8779 0 13.3522 0 0 0 13.638 14.0929 18.5833 0 13.989 11.1387 0 0 0 0 16.3065 0 13.3697 0 0 0 0 0 0 0 0 0 13.2812 0 14.0073 13.4598 0 13.0094 0 0 0 0 0 0 0 13.4941 0 0 0 13.8239 12.8381 Q9UJT2 TSKS_HUMAN "Testis-specific serine kinase substrate, Testis-specific kinase substrate (STK22 substrate 1)" TSKS STK22S1 TSKS1 Homo sapiens (Human) centriole [GO:0005814]; cytoplasm [GO:0005737] centriole [GO:0005814]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901] GO:0005737; GO:0005814; GO:0019901 protein kinase binding [GO:0019901] LHKKILELER 0.99527 -8.9492 0 0 0 0 0 11.3494 0 0 0 0 12.0991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5914 0 0 0 0 0 0 0 0 0 0 0 10.4409 0 0 0 0 0 0 0 0 0 0 0 0 9.3082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8441 0 0 0 0 13.5005 13.0416 0 0 0 0 12.6468 0 0 12.684 0 0 0 0 0 13.2101 0 0 0 0 0 0 0 0 0 17.7819 13.6055 0 0 13.1798 0 0 0 0 13.3348 13.2202 12.6622 0 0 14.0431 13.1939 12.997 0 0 0 0 13.3411 12.9636 0 0 12.8593 0 0 0 12.8473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.649 0 0 0 0 0 0 12.0321 0 0 0 0 0 0 0 0 0 0 0 0 11.6867 0 Q00973 B4GN1_HUMAN "Beta-1,4 N-acetylgalactosaminyltransferase 1, EC 2.4.1.92 ((N-acetylneuraminyl)-galactosylglucosylceramide) (GM2/GD2 synthase) (GalNAc-T)" B4GALNT1 GALGT SIAT2 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; spermatogenesis [GO:0007283] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity [GO:0003947]; acetylgalactosaminyltransferase activity [GO:0008376]; carbohydrate metabolic process [GO:0005975]; ganglioside biosynthetic process [GO:0001574]; glycosphingolipid metabolic process [GO:0006687]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; spermatogenesis [GO:0007283] GO:0000139; GO:0001574; GO:0003947; GO:0005794; GO:0005975; GO:0006687; GO:0007283; GO:0008376; GO:0016020; GO:0019915; GO:0030173; GO:0030259 (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity [GO:0003947]; acetylgalactosaminyltransferase activity [GO:0008376] AFDPAELRAASATR 0.99528 -10.55 0 0 0 0 0 0 0 0 0 12.0683 0 0 0 12.126 0 0 0 0 0 0 0 0 0 0 0 0 11.6267 0 0 0 11.7055 0 12.0569 0 0 0 12.147 0 0 0 0 0 0 0 11.7847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8964 0 0 0 0 0 0 0 0 0 12.4709 0 0 0 12.9072 0 0 0 0 0 0 0 0 0 12.7807 11.0653 0 17.7931 0 0 0 0 0 0 0 0 13.326 0 0 0 0 0 0 0 0 0 0 0 0 12.9435 13.2147 13.1881 0 0 0 0 0 14.1207 14.1415 0 0 13.1012 0 0 0 0 0 0 13.0683 0 0 Q86T96 RN180_HUMAN "E3 ubiquitin-protein ligase RNF180, EC 2.3.2.27 (RING finger protein 180) (RING-type E3 ubiquitin transferase RNF180)" RNF180 Homo sapiens (Human) adult behavior [GO:0030534]; norepinephrine metabolic process [GO:0042415]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein polyubiquitination [GO:0000209]; regulation of catalytic activity [GO:0050790]; serotonin metabolic process [GO:0042428] integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear envelope [GO:0005635] integral component of membrane [GO:0016021]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; nuclear envelope [GO:0005635]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; adult behavior [GO:0030534]; norepinephrine metabolic process [GO:0042415]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein polyubiquitination [GO:0000209]; regulation of catalytic activity [GO:0050790]; serotonin metabolic process [GO:0042428] GO:0000209; GO:0005635; GO:0016021; GO:0030534; GO:0031227; GO:0031398; GO:0031624; GO:0032436; GO:0042415; GO:0042428; GO:0046872; GO:0050790; GO:0061630 metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630] AQWTVGK 0.99528 -33.662 0 0 0 0 0 0 0 0 12.2303 14.4752 0 0 0 0 0 0 0 0 12.7719 11.822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0717 0 0 12.1681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9791 0 0 0 0 0 13.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0674 0 0 0 0 0 0 12.0033 0 0 0 0 0 12.7678 0 0 13.4226 0 0 0 0 0 0 14.7065 12.8164 15.3705 0 0 0 0 0 0 0 0 14.383 0 13.3366 13.664 13.3787 0 0 0 0 13.7972 0 0 0 0 0 0 0 0 0 13.7992 0 0 Q86XR2 NIBA3_HUMAN Protein Niban 3 (B-cell novel protein 1) (Niban-like protein 2) (Protein FAM129C) NIBAN3 BCNP1 FAM129C Homo sapiens (Human) EVYSFGEMPWDLALMQTCYR 0.99528 -10.569 0 0 0 0 0 0 0 0 0 0 13.1402 0 0 13.3181 0 0 0 0 0 0 0 0 0 0 12.3839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1739 0 0 0 0 0 0 0 0 16.1251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94696 0 0 0 0 0 11.4909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9843 14.8084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96Q42 ALS2_HUMAN Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein) ALS2 ALS2CR6 KIAA1563 Homo sapiens (Human) "axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]" centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982] "centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]" GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016197; GO:0016601; GO:0030027; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035022; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043087; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267] AARVKTR 0.99528 -10.546 0 0 0 0 0 0 0 0 0 0 0 0 13.5926 0 15.1715 0 0 0 0 0 0 11.223 0 0 0 0 11.0126 0 0 0 0 0 0 13.8761 0 0 0 0 0 13.2577 0 0 0 0 11.8746 0 0 13.1855 0 13.7956 13.8456 12.7302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7707 0 11.8882 0 0 0 13.7065 15.8589 16.2691 0 0 0 13.6306 0 0 0 10.8644 12.948 13.4805 11.9729 12.0691 0 0 13.0411 15.4538 13.2725 0 0 0 13.7694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2572 0 13.0785 0 0 0 13.5015 0 0 13.0717 0 0 13.8483 0 11.8462 0 0 0 0 13.3759 0 0 15.0268 0 0 0 0 0 0 0 0 0 13.4331 0 0 0 0 0 15.0339 0 13.3541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCL3 ZFP14_HUMAN "Zinc finger protein 14 homolog, Zfp-14 (Zinc finger protein 531)" ZFP14 KIAA1559 ZNF531 Homo sapiens (Human) blastocyst hatching [GO:0001835]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; blastocyst hatching [GO:0001835]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001835; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRVHQQLAR 0.99528 -10.545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9791 0 0 0 14.5185 0 0 0 0 0 0 10.8133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4221 0 0 0 0 0 11.9562 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWQ8 PHAG1_HUMAN Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp) PAG1 CBP PAG Homo sapiens (Human) adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165] GO:0002250; GO:0005886; GO:0007165; GO:0016021; GO:0035556; GO:0035591; GO:0042169; GO:0045121; GO:0050863; GO:0050868 SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591] EGGEAEESATDTTSETNK 0.99528 -10.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0266 0 0 0 0 0 0 0 13.4486 0 0 0 0 13.7526 13.3246 14.011 0 14.0886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4112 0 0 0 0 0 13.2936 13.8969 0 0 0 13.6659 0 0 0 0 0 0 15.2542 0 0 0 13.7885 0 0 0 14.0018 13.6187 12.8278 0 0 0 0 0 0 0 0 0 0 13.5378 0 0 0 0 0 0 0 0 14.8975 0 15.0416 0 0 0 0 0 0 0 0 0 0 0 14.5402 0 0 Q9Y250 LZTS1_HUMAN Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1) LZTS1 FEZ1 Homo sapiens (Human) mitotic cell cycle phase transition [GO:0044772]; negative regulation of macroautophagy [GO:0016242]; regulation of dendrite morphogenesis [GO:0048814]; regulation of synaptic plasticity [GO:0048167] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; microtubule binding [GO:0008017]; mitotic cell cycle phase transition [GO:0044772]; negative regulation of macroautophagy [GO:0016242]; regulation of dendrite morphogenesis [GO:0048814]; regulation of synaptic plasticity [GO:0048167] GO:0005737; GO:0005886; GO:0008017; GO:0014069; GO:0016242; GO:0043197; GO:0044772; GO:0048167; GO:0048814; GO:0070161 microtubule binding [GO:0008017] AQQVLHLQVLQLQQEKR 0.99528 -10.556 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2918 0 0 0 0 0 0 0 0 11.3472 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.412 13.2088 13.5069 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8703 12.891 0 0 0 0 0 0 0 0 0 0 0 13.1601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0721 0 0 0 0 0 0 0 14.0329 0 0 0 0 0 0 0 0 0 0 14.131 0 0 0 0 0 0 0 0 11.1521 0 12.1368 13.1317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2998 0 0 0 Q14190 SIM2_HUMAN "Single-minded homolog 2 (Class E basic helix-loop-helix protein 15, bHLHe15)" SIM2 BHLHE15 Homo sapiens (Human) cell differentiation [GO:0030154]; embryonic pattern specification [GO:0009880]; lung development [GO:0030324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; cell differentiation [GO:0030154]; embryonic pattern specification [GO:0009880]; lung development [GO:0030324]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005654; GO:0006357; GO:0007399; GO:0009880; GO:0016604; GO:0030154; GO:0030324; GO:0046982 "DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ASIIRLTTSYLKMR 0.99529 -5.4335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5137 0 0 0 0 0 0 0 0 0 0 0 16.4787 0 0 0 0 0 12.026 0 0 0 11.0396 0 0 0 0 0 0 0 0 0 0 13.6215 0 0 0 0 0 0 15.9533 0 0 0 0 0 0 0 0 0 0 16.0432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2624 0 0 0 0 0 0 0 0 0 11.6303 0 15.2322 0 11.5881 0 0 Q15528 MED22_HUMAN "Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (Surfeit locus protein 5, Surf-5)" MED22 SURF5 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nucleus [GO:0005634] core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0003712; GO:0005634; GO:0005737; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 transcription coregulator activity [GO:0003712] ALPQSKETLLQSYNK 0.99529 -5.4268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.176 13.4413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q1L5Z9 LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192) LONRF2 RNF192 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0005737; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AQLAILGMTSLK 0.99529 -11.999 0 0 0 0 0 0 0 0 0 0 12.1623 0 0 0 0 0 0 0 0 0 12.194 0 0 0 0 12.2105 0 0 0 0 0 12.7442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0691 0 0 10.1534 0 10.6043 0 0 16.134 15.789 0 14.7815 13.7829 14.1062 13.1088 0 0 0 0 13.3273 13.4282 15.5743 0 14.7544 14.6592 0 0 12.748 14.2347 14.7592 0 0 0 0 0 0 0 0 0 14.0782 0 0 13.9319 0 0 0 0 0 13.4871 14.0483 0 0 0 0 0 0 0 0 0 13.3442 0 13.2709 0 0 0 13.7454 0 0 0 13.0856 12.9527 0 0 0 12.708 0 11.7746 0 13.742 15.4575 0 0 0 0 0 14.7989 14.6704 0 0 0 0 0 0 17.6169 11.9119 12.0609 16.1783 0 0 15.9309 15.0131 0 0 0 0 0 0 0 14.8046 0 0 0 Q5JQS5 OR2BB_HUMAN Olfactory receptor 2B11 OR2B11 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AVLRIQSSK 0.99529 -11.973 0 0 0 0 0 0 0 0 0 0 11.406 0 11.5647 0 11.3265 0 0 0 0 0 0 0 0 13.1532 0 0 12.6046 0 0 0 13.18 0 13.0023 0 0 0 11.5765 13.2767 0 0 0 0 13.2161 11.0575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.421 0 0 11.1635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2293 0 0 0 0 0 0 0 0 0 12.6153 14.4039 15.2821 0 13.4202 15.3523 14.7085 15.4406 0 0 13.1805 12.4534 0 0 0 0 0 0 15.5032 0 12.6622 0 0 Q86Y22 CONA1_HUMAN Collagen alpha-1(XXIII) chain COL23A1 Homo sapiens (Human) extracellular matrix organization [GO:0030198] cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell surface [GO:0009986]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; extracellular matrix organization [GO:0030198] GO:0005201; GO:0005581; GO:0005615; GO:0005788; GO:0005886; GO:0008201; GO:0009986; GO:0016021; GO:0030198; GO:0031012; GO:0042802; GO:0062023 extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; identical protein binding [GO:0042802] AGGGGDAGK 0.99529 -11.966 0 0 0 0 10.5039 0 0 0 0 0 0 0 0 0 0 0 13.6862 14.3516 0 12.527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.75699 0 0 0 0 0 0 0 0 0 0 0 14.061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3433 0 0 0 0 0 0 0 0 P16278 BGAL_HUMAN "Beta-galactosidase, EC 3.2.1.23 (Acid beta-galactosidase, Lactase) (Elastin receptor 1)" GLB1 ELNR1 Homo sapiens (Human) cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; perinuclear region of cytoplasm [GO:0048471]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803]; cellular carbohydrate metabolic process [GO:0044262]; galactose catabolic process [GO:0019388]; glycosaminoglycan catabolic process [GO:0006027]; glycosphingolipid metabolic process [GO:0006687]; keratan sulfate catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016] GO:0004565; GO:0005576; GO:0005737; GO:0005773; GO:0005794; GO:0006027; GO:0006687; GO:0016936; GO:0019388; GO:0035578; GO:0042340; GO:0042803; GO:0043202; GO:0043231; GO:0044262; GO:0048471; GO:0051413; GO:0070062; GO:1904016; GO:1904813 beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; protein homodimerization activity [GO:0042803] HHLGDDVVLFTTDGAHK 0.9953 -5.4581 0 0 13.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.823 0 0 0 0 0 0 12.2603 0 0 0 0 0 0 9.50269 0 0 0 0 0 0 0 0 0 0 12.2507 0 0 0 0 11.1359 0 0 0 0 0 0 0 0 0 0 0 0 13.9063 0 0 0 0 0 12.71 0 0 13.5516 13.1583 11.1979 0 0 0 0 11.3801 10.9321 15.1409 0 0 15.8643 15.166 0 16.4303 15.3327 16.056 19.3209 19.3518 0 12.796 0 0 0 0 0 10.8262 0 0 0 0 13.0977 13.1831 0 19.361 19.3844 19.0642 0 13.2952 0 0 14.4039 0 12.8163 13.8047 0 0 0 0 0 0 16.3403 0 12.6711 13.102 0 0 14.9769 0 14.7793 0 0 0 0 11.7214 0 0 0 0 0 13.5608 0 0 0 10.8126 13.3257 0 19.4419 19.5753 0 11.327 0 0 13.0821 0 10.4487 11.5972 0 0 0 13.5651 0 0 0 15.5014 0 0 14.6609 13.1741 0 13.5474 0 0 O14545 TRAD1_HUMAN TRAF-type zinc finger domain-containing protein 1 (Protein FLN29) TRAFD1 FLN29 Homo sapiens (Human) negative regulation of innate immune response [GO:0045824] metal ion binding [GO:0046872]; negative regulation of innate immune response [GO:0045824] GO:0045824; GO:0046872 metal ion binding [GO:0046872] CNKKLEK 0.9953 -11.644 0 0 0 0 0 0 0 0 0 13.4193 0 0 0 10.4457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6884 9.82828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7149 0 13.1077 0 0 0 0 0 0 0 0 0 0 0 10.6404 0 0 0 0 0 0 0 0 12.8934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5058 0 0 12.4146 0 0 0 11.3936 0 0 0 0 0 0 12.4648 0 0 0 11.4411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5491 12.6162 12.541 12.7913 0 12.1527 12.8154 13.0276 0 0 0 0 0 0 0 0 0 0 0 12.3525 0 10.0871 0 0 O60563 CCNT1_HUMAN "Cyclin-T1, CycT1, Cyclin-T" CCNT1 Homo sapiens (Human) "cell cycle [GO:0007049]; cell division [GO:0051301]; phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903655]; phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903654]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]" cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691] "cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphorylation of RNA polymerase II C-terminal domain serine 2 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903655]; phosphorylation of RNA polymerase II C-terminal domain serine 5 residues involved in positive regulation of transcription elongation from RNA polymerase II promoter [GO:1903654]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]" GO:0000079; GO:0000976; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0006468; GO:0007049; GO:0008024; GO:0009410; GO:0016538; GO:0019901; GO:0032786; GO:0032968; GO:0043923; GO:0045944; GO:0051301; GO:0061575; GO:0070063; GO:0070691; GO:0097322; GO:0140297; GO:1903654; GO:1903655 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976] FGVDPDK 0.9953 -12.55 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7197 0 0 0 0 0 0 0 0 13.2933 0 0 12.9503 0 0 0 0 0 0 10.5681 0 0 0 0 0 11.5448 0 0 11.6782 0 11.1551 14.2386 11.1436 0 0 0 0 0 0 0 0 0 0 0 0 17.032 0 0 0 0 14.246 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06241 FYN_HUMAN "Tyrosine-protein kinase Fyn, EC 2.7.10.2 (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase, SLK) (p59-Fyn)" FYN Homo sapiens (Human) activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to glycine [GO:1905430]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamate [GO:1905232]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; heart process [GO:0003015]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; leukocyte migration [GO:0050900]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to ethanol [GO:0045471]; response to singlet oxygen [GO:0000304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685] actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transmembrane transporter binding [GO:0044325]; type 5 metabotropic glutamate receptor binding [GO:0031802]; activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to glycine [GO:1905430]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamate [GO:1905232]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; heart process [GO:0003015]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; leukocyte migration [GO:0050900]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to ethanol [GO:0045471]; response to singlet oxygen [GO:0000304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0000304; GO:0001764; GO:0002223; GO:0002250; GO:0002862; GO:0003015; GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005634; GO:0005739; GO:0005768; GO:0005829; GO:0005884; GO:0005886; GO:0006468; GO:0006816; GO:0007169; GO:0007249; GO:0007411; GO:0007612; GO:0007631; GO:0008360; GO:0010629; GO:0010730; GO:0010976; GO:0014069; GO:0016004; GO:0016567; GO:0018108; GO:0019899; GO:0030154; GO:0030163; GO:0030425; GO:0030900; GO:0031234; GO:0031295; GO:0031397; GO:0031802; GO:0035556; GO:0036120; GO:0038096; GO:0042177; GO:0042531; GO:0042802; GO:0043014; GO:0043123; GO:0043274; GO:0044297; GO:0044325; GO:0045087; GO:0045121; GO:0045471; GO:0046777; GO:0046872; GO:0046875; GO:0048010; GO:0048013; GO:0048156; GO:0048471; GO:0048813; GO:0050321; GO:0050730; GO:0050798; GO:0050804; GO:0050852; GO:0050900; GO:0050966; GO:0070301; GO:0070851; GO:0071560; GO:0090314; GO:0097038; GO:0097062; GO:0097110; GO:0097386; GO:0097718; GO:0098685; GO:1900182; GO:1900449; GO:1901216; GO:1902951; GO:1903202; GO:1904645; GO:1904646; GO:1905232; GO:1905430; GO:1905477; GO:1905664; GO:2001056 alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transmembrane transporter binding [GO:0044325]; type 5 metabotropic glutamate receptor binding [GO:0031802] DGSLNQSSGYR 0.9953 -10.349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0C7P0 CISD3_HUMAN "CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2, Miner2) (Mitochondrial inner NEET protein, MiNT)" CISD3 Homo sapiens (Human) protein maturation by [2Fe-2S] cluster transfer [GO:0106034] mitochondrion [GO:0005739] "mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034]" GO:0005739; GO:0046872; GO:0051537; GO:0106034 "2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]" AEVGSPL 0.9953 -11.637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5057 0 0 0 11.766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2415 13.2863 13.4597 0 0 0 0 0 0 0 13.8753 0 13.206 0 0 0 0 0 12.9504 0 0 0 0 12.4661 13.3769 13.0916 0 0 0 0 0 0 13.409 12.9851 0 0 0 0 0 0 0 0 13.4684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5032 0 0 0 0 12.8541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2061 13.796 0 0 0 0 13.4504 P43652 AFAM_HUMAN "Afamin (Alpha-albumin, Alpha-Alb)" AFM ALB2 ALBA Homo sapiens (Human) protein stabilization [GO:0050821]; protein transport within extracellular region [GO:0071693]; vitamin transport [GO:0051180] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fatty acid binding [GO:0005504]; vitamin E binding [GO:0008431]; zinc ion binding [GO:0008270]; protein stabilization [GO:0050821]; protein transport within extracellular region [GO:0071693]; vitamin transport [GO:0051180] GO:0005504; GO:0005576; GO:0005615; GO:0005737; GO:0008270; GO:0008431; GO:0050821; GO:0051180; GO:0070062; GO:0071693; GO:0072562 fatty acid binding [GO:0005504]; vitamin E binding [GO:0008431]; zinc ion binding [GO:0008270] DLLRNCCNTENPPGCYRYAEDK 0.9953 -35.685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.68568 0 0 0 0 0 9.93208 0 0 0 0 0 0 0 0 10.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7619 0 0 0 0 0 0 0 0 0 11.8797 0 0 0 0 0 0 0 0 0 0 0 0 13.6572 0 0 0 0 11.6554 0 0 0 13.4817 11.203 0 0 0 0 0 0 11.0656 0 0 0 14.3216 0 11.3267 14.4556 13.6923 0 13.0632 0 0 0 13.7322 0 0 13.3143 0 0 13.1996 0 0 0 12.7678 0 12.792 13.8388 0 0 14.5057 12.6079 0 12.9831 13.4499 0 0 0 0 0 13.5125 0 0 0 0 0 12.9785 0 0 0 0 0 0 0 0 0 14.9875 0 0 0 0 0 0 0 11.2897 13.4378 13.5621 0 12.6063 0 11.5618 0 0 12.5129 12.7958 0 0 13.4537 0 0 0 0 P54762 EPHB1_HUMAN "Ephrin type-B receptor 1, EC 2.7.10.1 (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6, EK6, hEK6) (Neuronally-expressed EPH-related tyrosine kinase, NET) (Tyrosine-protein kinase receptor EPH-2)" EPHB1 ELK EPHT2 HEK6 NET Homo sapiens (Human) angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of kinase activity [GO:0033674]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of neuron death [GO:1901214]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001525; GO:0001771; GO:0004714; GO:0005005; GO:0005524; GO:0005576; GO:0005783; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0007411; GO:0008046; GO:0014719; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0033674; GO:0043005; GO:0043235; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070062; GO:0070372; GO:0098978; GO:1901214; GO:1902723; GO:1902725 ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] ACPAGTFK 0.9953 -5.4662 0 0 0 0 0 0 0 0 0 0 0 12.9945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3608 13.2079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3341 0 0 0 0 0 13.7894 0 0 14.552 0 0 0 0 0 0 0 0 0 0 0 0 13.253 0 16.6662 0 0 0 13.3931 14.1062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7828 0 Q8NGF1 O52R1_HUMAN Olfactory receptor 52R1 (Olfactory receptor OR11-22) OR52R1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FGHDVPR 0.9953 -5.4394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2024 12.9951 0 0 12.5825 11.6591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3481 0 0 0 13.4001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2396 0 Q92932 PTPR2_HUMAN "Receptor-type tyrosine-protein phosphatase N2, R-PTP-N2, EC 3.1.3.-, EC 3.1.3.48 (Islet cell autoantigen-related protein, IAR, ICAAR) (Phogrin) [Cleaved into: IA-2beta60 ]" PTPRN2 KIAA0387 Homo sapiens (Human) insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; regulation of secretion [GO:0051046] anchoring junction [GO:0070161]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; ficolin-1-rich granule membrane [GO:0101003]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269]; protein dephosphorylation [GO:0006470]; regulation of secretion [GO:0051046] GO:0005001; GO:0005886; GO:0005887; GO:0006470; GO:0006629; GO:0007269; GO:0030141; GO:0030667; GO:0030672; GO:0035773; GO:0043235; GO:0045202; GO:0051046; GO:0070161; GO:0101003 transmembrane receptor protein tyrosine phosphatase activity [GO:0005001] AENSHSHSDYINASPIMDHDPR 0.9953 -11.664 11.7626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5252 0 0 0 0 0 0 12.7708 0 10.6785 11.5855 0 0 0 0 0 11.7606 0 0 0 0 0 0 0 11.5015 12.3216 0 0 0 12.2759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1263 11.1877 14.2954 0 0 13.1903 0 0 0 0 0 12.4119 13.1924 12.5302 13.2027 0 0 12.2732 0 13.1734 0 12.6243 0 12.0606 11.206 0 0 0 0 12.7057 0 0 0 12.0363 0 0 0 0 12.5412 0 0 0 13.9847 12.5692 0 15.4315 11.2414 0 0 0 0 14.1094 0 0 12.9521 0 0 0 0 0 0 14.6625 0 12.136 12.3156 11.8828 11.2579 11.8898 0 12.3866 0 0 0 14.5593 13.4457 0 11.7458 12.1353 12.7736 0 14.5786 0 0 0 0 0 0 0 0 0 0 0 12.0682 16.6122 0 0 0 0 12.0189 0 0 0 0 12.005 12.4741 0 0 16.0247 0 0 0 0 0 Q96BD5 PF21A_HUMAN PHD finger protein 21A (BHC80a) (BRAF35-HDAC complex protein BHC80) PHF21A BHC80 KIAA1696 BM-006 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654] DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000118; GO:0000122; GO:0003677; GO:0003682; GO:0005654; GO:0006325; GO:0046872; GO:1990391 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] CQDQMLK 0.9953 -31.807 0 10.5888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0396 12.894 0 12.6167 12.8354 14.0503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7133 13.4593 0 13.4676 16.9489 14.2277 0 12.7897 14.5445 14.1672 0 0 0 14.3348 14.348 0 0 0 0 12.2403 0 0 14.3801 0 0 0 14.5583 0 14.2099 0 0 0 14.7186 14.268 14.3229 14.3814 0 16.1923 0 14.8518 0 14.8278 0 0 0 0 15.8505 0 0 0 15.75 14.9284 0 0 0 15.2228 0 0 16.0405 0 15.7656 14.9078 14.3782 14.4779 13.5485 0 0 0 15.2732 15.0954 15.5777 0 14.4272 14.1771 0 14.5578 14.6247 14.0761 0 14.5454 15.2195 0 0 0 14.721 14.7134 0 14.7135 13.4756 14.763 15.3517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5479 15.4052 14.8165 0 0 0 15.2562 0 Q96H96 COQ2_HUMAN "4-hydroxybenzoate polyprenyltransferase, mitochondrial, 4-HB polyprenyltransferase, EC 2.5.1.39 (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog, hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase, PHB:PPT, PHB:polyprenyltransferase)" COQ2 CL640 Homo sapiens (Human) glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743] "integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; 4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744]" GO:0002083; GO:0004659; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0016765; GO:0031305; GO:0047293 "4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]" ALALAWLPGWR 0.9953 -5.4474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4132 13.67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6659 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5162 0 0 0 14.9325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1958 0 0 0 0 12.887 0 0 0 15.7869 0 0 0 13.1697 0 13.2466 0 12.8083 0 0 0 13.6524 13.6575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4754 0 0 0 0 0 0 0 0 0 0 0 Q9P0U4 CXXC1_HUMAN CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1) CXXC1 CFP1 CGBP PCCX1 PHF18 Homo sapiens (Human) "histone H3-K4 methylation [GO:0051568]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188] "cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; methylated histone binding [GO:0035064]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; histone H3-K4 methylation [GO:0051568]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000987; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008270; GO:0016363; GO:0016607; GO:0035064; GO:0035097; GO:0045322; GO:0045893; GO:0048188; GO:0051568 cis-regulatory region sequence-specific DNA binding [GO:0000987]; methylated histone binding [GO:0035064]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] AIREWYCRECR 0.9953 -35.617 0 0 0 0 0 11.9473 0 0 0 10.2575 0 0 0 0 0 0 0 13.4836 13.4643 11.4687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6496 0 0 0 0 0 0 0 0 0 10.8827 0 14.0031 0 0 0 15.234 0 0 0 0 0 0 0 0 11.3819 0 0 0 0 0 0 11.129 0 12.4356 0 0 0 0 0 0 0 0 0 11.7972 0 12.6967 0 0 0 0 13.5106 0 0 12.999 0 0 0 12.4183 0 0 0 0 0 12.971 0 11.9127 0 12.0233 0 13.8229 0 15.4402 0 12.6271 12.3847 0 0 0 0 12.1648 0 0 0 0 0 11.606 12.1104 12.3249 0 11.9772 0 0 0 0 10.8969 0 11.7758 0 14.9053 0 0 0 0 0 0 11.4524 0 12.0142 0 0 0 11.2951 14.4001 0 0 0 10.9546 14.6623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8423 0 10.6196 0 0 11.4334 0 0 11.1859 0 0 14.6062 0 O60447 EVI5_HUMAN "Ecotropic viral integration site 5 protein homolog, EVI-5 (Neuroblastoma stage 4S gene protein)" EVI5 NB4S Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819] "cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005096; GO:0005634; GO:0005815; GO:0005819; GO:0005829; GO:0007049; GO:0031267; GO:0042147; GO:0043547; GO:0051301; GO:0090630 GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267] AEQEVISLQEKVQYLSAQNK 0.99531 -9.9289 0 0 0 0 0 0 0 0 12.8181 0 12.5371 0 0 12.8005 0 0 11.9511 12.5545 0 0 0 0 11.9249 0 12.0705 12.0482 0 12.7634 0 0 0 0 0 0 0 16.4549 11.9181 0 0 0 0 0 0 0 12.0744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9718 11.6407 0 0 0 13.9519 12.2316 0 13.7599 0 0 16.4661 0 0 0 0 0 0 0 0 14.6435 17.9954 0 0 0 0 15.1805 13.6823 0 0 0 0 0 12.8317 0 0 0 0 0 0 12.2457 0 0 0 0 0 0 0 0 0 12.2944 14.0326 0 0 0 0 0 0 12.3299 13.5108 0 13.0086 0 0 12.3687 0 0 13.6407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8517 0 0 0 0 0 0 12.5563 0 0 13.007 0 0 0 13.248 16.4538 13.4062 0 17.0738 Q15546 PAQRB_HUMAN Monocyte to macrophage differentiation factor (Progestin and adipoQ receptor family member 11) (Progestin and adipoQ receptor family member XI) MMD PAQR11 Homo sapiens (Human) cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; regulation of protein localization [GO:0032880] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020] Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023]; cytolysis [GO:0019835]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein kinase activity [GO:0045860]; regulation of protein localization [GO:0032880] GO:0004672; GO:0005765; GO:0005794; GO:0005887; GO:0016020; GO:0019835; GO:0031902; GO:0032880; GO:0038023; GO:0045666; GO:0045860 protein kinase activity [GO:0004672]; signaling receptor activity [GO:0038023] FMNHRAPANGRYK 0.99531 -9.9474 0 0 0 0 0 0 0 0 0 0 11.5056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4142 0 0 0 0 0 12.4122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2912 0 14.9762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.522 0 0 0 0 0 0 13.0142 0 0 0 0 0 0 0 12.3851 0 15.0893 0 0 0 0 0 0 0 0 Q6UWW0 LCN15_HUMAN Lipocalin-15 LCN15 UNQ2541/PRO6093 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576]; small molecule binding [GO:0036094] GO:0005576; GO:0036094 small molecule binding [GO:0036094] KDHLSMSTR 0.99531 -5.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6757 12.7578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92696 PGTA_HUMAN "Geranylgeranyl transferase type-2 subunit alpha, EC 2.5.1.60 (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha, Rab GG transferase alpha, Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha)" RABGGTA Homo sapiens (Human) protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601] GO:0004663; GO:0005737; GO:0005829; GO:0005886; GO:0005968; GO:0007601; GO:0008270; GO:0018344; GO:0031267; GO:0036211 Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270] DLTVLCHLEQLLLVTHLDLSHNRLRTLPPALAALR 0.99531 -9.9318 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9228 0 0 0 0 0 0 13.0503 13.1836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.697 0 0 0 0 13.4468 0 0 12.9191 0 0 13.6971 14.5356 0 0 0 0 0 0 0 0 0 12.1745 13.5873 0 12.8903 0 0 0 0 0 0 0 0 13.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.676 0 0 0 0 0 0 0 0 10.8483 0 0 0 0 0 0 0 0 11.6576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ66 PLCB1_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1, EC 3.1.4.11 (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I, PLC-I) (Phospholipase C-beta-1, PLC-beta-1)" PLCB1 KIAA0581 Homo sapiens (Human) "activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]; activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of monocyte extravasation [GO:2000438]; negative regulation of transcription, DNA-templated [GO:0045892]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription, DNA-templated [GO:0045893]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; signal transduction [GO:0007165]" GO:0000086; GO:0000785; GO:0004435; GO:0004629; GO:0005096; GO:0005509; GO:0005516; GO:0005521; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0007186; GO:0007213; GO:0007215; GO:0007612; GO:0007613; GO:0008277; GO:0016607; GO:0019899; GO:0021987; GO:0031161; GO:0031965; GO:0032735; GO:0032957; GO:0032991; GO:0035722; GO:0035723; GO:0040019; GO:0042802; GO:0045444; GO:0045663; GO:0045892; GO:0045893; GO:0046330; GO:0046488; GO:0048009; GO:0048015; GO:0048639; GO:0060466; GO:0070062; GO:0070498; GO:0080154; GO:0098794; GO:0098978; GO:0098982; GO:0099170; GO:0099178; GO:1900087; GO:1902618; GO:1903140; GO:1904117; GO:1904637; GO:1905631; GO:2000344; GO:2000438; GO:2000560 "calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]" AYTKLKLQVTPEGR 0.99531 -32.455 10.9397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.34143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1024 0 0 0 0 0 0 11.4105 12.4571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9293 14.6908 13.8239 13.8949 13.5354 0 14.3113 0 11.1864 0 13.1857 0 0 0 0 0 0 14.4653 0 12.6598 0 0 0 0 0 0 11.0992 13.8651 10.7389 0 0 14.273 13.0509 11.9929 0 14.9537 0 0 0 0 0 0 0 0 14.5846 0 13.4767 14.4326 0 0 0 0 14.2658 11.2127 0 13.0183 14.4324 0 12.1341 0 12.2298 11.9219 0 0 0 14.1988 13.024 0 15.1764 12.801 13.3174 13.6765 0 0 0 12.9618 0 0 0 13.365 0 0 0 0 0 0 12.559 0 12.0026 0 0 12.9305 0 0 0 0 0 10.9666 0 11.3352 0 0 0 0 0 0 13.749 12.216 0 0 0 0 0 0 Q9UID6 ZN639_HUMAN Zinc finger protein 639 (Zinc finger protein ANC_2H01) (Zinc finger protein ZASC1) ZNF639 ZASC1 Homo sapiens (Human) "negative regulation by host of viral transcription [GO:0043922]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; viral entry into host cell [GO:0046718]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; viral entry into host cell [GO:0046718]" GO:0000976; GO:0000978; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0030307; GO:0043621; GO:0043922; GO:0043923; GO:0045892; GO:0045944; GO:0046718; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" ARNRNQNYLVPSPVLR 0.99531 -5.4908 0 0 0 0 0 0 0 12.8793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9736 0 0 0 0 0 12.1391 0 0 0 0 0 0 0 0 0 0 14.6638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8254 0 0 13.8668 0 14.3536 0 0 11.7786 0 14.4258 0 0 0 16.2141 0 16.5846 0 0 0 0 0 0 0 14.4255 13.3479 0 0 0 0 0 0 0 0 0 0 0 0 14.8474 0 11.9356 0 0 0 0 0 0 0 0 13.5859 0 0 0 0 0 14.7644 0 0 0 0 0 0 0 0 0 0 14.7226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4801 0 0 11.8997 13.0685 0 0 0 0 0 0 0 13.2221 0 0 Q9UJX6 ANC2_HUMAN "Anaphase-promoting complex subunit 2, APC2 (Cyclosome subunit 2)" ANAPC2 APC2 KIAA1406 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0007399; GO:0010629; GO:0030154; GO:0031145; GO:0031625; GO:0031915; GO:0045773; GO:0050775; GO:0051301; GO:0051445; GO:0070979; GO:0090129 ubiquitin protein ligase binding [GO:0031625] AALEAYCK 0.99531 -9.9378 0 0 0 0 0 0 0 0 10.5293 0 0 0 0 11.6615 0 0 0 0 0 0 0 0 0 13.1378 0 10.0399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8116 0 0 0 0 0 10.2662 0 13.629 13.4657 15.011 0 0 14.7673 0 0 0 0 13.1516 13.5011 12.6572 13.4754 12.8947 0 15.8835 0 11.6579 14.4913 14.2336 14.1474 14.2753 17.0552 0 0 14.3537 13.7782 0 0 0 12.8708 13.571 0 0 11.1044 13.0683 0 0 0 12.5437 11.9323 11.7623 13.1175 15.4142 15.8921 0 13.3684 14.0651 14.4558 13.4433 0 0 14.4073 0 0 0 13.9706 0 0 0 14.8519 0 0 13.5025 14.5513 12.9273 10.5242 0 12.3538 12.492 0 15.6519 0 10.2146 0 0 0 0 0 0 12.7141 0 0 0 10.6855 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1697 13.0435 0 0 11.5336 0 0 Q16655 MAR1_HUMAN "Melanoma antigen recognized by T-cells 1, MART-1 (Antigen LB39-AA) (Antigen SK29-AA) (Protein Melan-A)" MLANA MART1 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802] endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; trans-Golgi network [GO:0005802] GO:0005789; GO:0005794; GO:0005802; GO:0005887; GO:0042470 DSKVSLQEK 0.99532 -5.5005 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0172 0 12.9357 0 0 0 0 0 0 0 14.1078 0 0 Q5JSS6 MEIG1_HUMAN Meiosis expressed gene 1 protein homolog MEIG1 Homo sapiens (Human) manchette assembly [GO:1905198]; protein localization [GO:0008104]; sperm axoneme assembly [GO:0007288] cytosol [GO:0005829]; manchette [GO:0002177]; nucleus [GO:0005634] cytosol [GO:0005829]; manchette [GO:0002177]; nucleus [GO:0005634]; manchette assembly [GO:1905198]; protein localization [GO:0008104]; sperm axoneme assembly [GO:0007288] GO:0002177; GO:0005634; GO:0005829; GO:0007288; GO:0008104; GO:1905198 DNTFYYYNKQR 0.99532 -9.9688 0 0 0 0 0 0 0 0 0 0 0 0 11.832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9248 14.1932 0 0 13.1257 0 0 14.052 0 0 0 0 0 0 0 0 15.5134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VU43 MYOME_HUMAN Myomegalin (Cardiomyopathy-associated protein 2) (Phosphodiesterase 4D-interacting protein) PDE4DIP CMYA2 KIAA0454 KIAA0477 MMGL Homo sapiens (Human) astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; positive regulation of microtubule nucleation [GO:0090063]; protein-containing complex assembly [GO:0065003]; regulation of Golgi organization [GO:1903358] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; myofibril [GO:0030016]; nucleus [GO:0005634] centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; myofibril [GO:0030016]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; positive regulation of microtubule nucleation [GO:0090063]; protein-containing complex assembly [GO:0065003]; regulation of Golgi organization [GO:1903358] GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0007098; GO:0019899; GO:0030016; GO:0030953; GO:0060090; GO:0065003; GO:0090063; GO:1903358 enzyme binding [GO:0019899]; molecular adaptor activity [GO:0060090] CAQESSQK 0.99532 -9.9911 0 0 0 0 12.1228 0 0 0 13.6634 0 0 0 0 12.2984 12.8978 0 13.5543 14.0112 13.2299 14.3207 0 13.1956 13.6099 0 14.2427 14.5325 14.8321 11.3534 13.2936 0 12.9822 0 0 0 11.8042 10.2038 0 0 12.0607 0 12.4196 12.7127 14.1044 11.9441 0 13.8851 0 0 0 0 0 12.6436 0 0 0 0 0 0 0 0 11.1113 0 0 0 0 0 0 0 0 11.6644 0 0 0 0 0 14.2701 13.6734 14.1024 15.2262 16.1397 15.4177 14.9297 0 0 15.9265 15.124 16.7702 14.9434 14.3697 0 14.0498 15.5745 15.2237 0 15.0692 0 14.9746 16.0497 16.0327 0 12.1312 15.2484 13.2375 14.3664 14.9336 15.8408 15.3574 13.0682 13.9775 0 15.4166 0 15.4739 14.2696 14.5967 13.1256 15.0731 15.3645 13.741 13.9614 14.4017 15.1458 14.4674 0 0 12.6787 13.3039 18.5616 13.7826 13.3026 0 14.1703 0 13.9012 13.1822 14.7569 13.8323 0 0 0 0 14.0994 0 0 12.8869 0 0 12.5297 13.2621 14.8052 0 13.712 0 15.006 13.9303 14.7925 15.4055 0 0 0 13.5543 13.1026 0 14.9643 13.3191 13.1423 0 13.5156 12.4822 13.943 12.6769 0 13.5858 13.8321 13.7099 12.6895 0 14.187 0 0 Q6ZMT4 KDM7A_HUMAN "Lysine-specific demethylase 7A (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7) ([histone H3]-dimethyl-L-lysine9 demethylase 7A, EC 1.14.11.65)" KDM7A JHDM1D KDM7 KIAA1718 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription, DNA-templated [GO:0045893]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006357; GO:0006482; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0033169; GO:0035064; GO:0035574; GO:0035575; GO:0045893; GO:0051864; GO:0070544; GO:0071557; GO:0071558; GO:0140683 2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3-di/monomethyl-lysine-9 demethylase activity [GO:0140683]; histone H3-methyl-lysine-36 demethylase activity [GO:0051864]; histone H3-methyl-lysine-9 demethylase activity [GO:0032454]; histone H3-tri/di-methyl-lysine-27 demethylase activity [GO:0071558]; histone H4-methyl-lysine-20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270] CYEMEKR 0.99532 -5.497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.08 0 0 0 0 0 0 0 11.5674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6817 0 0 0 0 0 0 0 0 14.308 10.0971 0 0 0 13.2264 0 0 0 0 14.8263 0 0 0 12.9334 0 0 13.7388 0 0 0 0 0 13.3701 17.6474 0 12.5273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.29508 0 0 13.7447 0 0 0 0 12.4818 0 0 0 0 12.7137 0 0 0 0 12.0768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0974 10.2169 0 0 0 0 0 0 0 11.4186 0 0 0 0 12.0161 0 0 0 0 19.1737 19.1698 0 0 17.3965 11.7432 0 0 Q709C8 VP13C_HUMAN Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C) VPS13C KIAA1421 Homo sapiens (Human) Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868] GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0019898; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090 ACNAIEDAQSTRQQQK 0.99532 -33.575 12.2291 0 12.7289 0 0 0 0 0 0 11.8623 0 0 0 0 0 11.8441 0 0 12.4572 0 0 14.2255 0 0 0 0 0 0 11.212 0 12.6191 0 0 0 0 0 0 0 0 10.0638 0 0 0 12.3372 11.0817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6925 0 0 0 11.3449 0 13.4564 14.9507 13.3604 14.9234 0 13.6479 0 18.9512 0 15.9408 0 16.303 0 13.8545 13.3115 0 0 0 16.3846 13.8185 0 12.8718 0 14.4913 0 0 0 13.7296 13.5231 13.5142 13.3163 14.2628 0 0 15.354 12.961 13.882 14.5861 14.4026 12.8466 0 0 14.4047 0 0 0 13.7055 12.6832 13.4376 12.9838 12.7399 14.5895 0 0 12.7061 14.0325 0 14.4159 0 0 0 0 0 12.8279 13.183 0 0 12.4491 0 0 0 14.4805 14.9964 0 0 0 13.9102 0 0 10.4274 0 12.4443 0 0 0 0 0 0 0 0 0 17.37 0 15.1063 0 0 0 13.784 0 0 13.5497 13.4207 0 0 0 13.9353 Q7RTY1 MOT9_HUMAN "Monocarboxylate transporter 9, MCT 9 (Solute carrier family 16 member 9)" SLC16A9 C10orf36 MCT9 Homo sapiens (Human) carnitine transmembrane transport [GO:1902603]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]; urate metabolic process [GO:0046415] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carnitine transmembrane transporter activity [GO:0015226]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293]; carnitine transmembrane transport [GO:1902603]; creatine transmembrane transport [GO:0015881]; monocarboxylic acid transport [GO:0015718]; urate metabolic process [GO:0046415] GO:0005308; GO:0005886; GO:0005887; GO:0008028; GO:0015226; GO:0015293; GO:0015718; GO:0015881; GO:0016021; GO:0046415; GO:1902603 carnitine transmembrane transporter activity [GO:0015226]; creatine transmembrane transporter activity [GO:0005308]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293] ITLANGDWKQDSLLHKNPTVTHTK 0.99532 -8.8652 0 12.4179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2289 0 0 0 0 0 0 0 14.6171 15.0445 0 0 0 0 0 0 0 14.7423 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9449 14.4548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6738 0 0 0 0 0 0 0 0 Q86Y01 DTX1_HUMAN "E3 ubiquitin-protein ligase DTX1, EC 2.3.2.27 (Protein deltex-1, Deltex1, hDTX1) (RING-type E3 ubiquitin transferase DTX1)" DTX1 Homo sapiens (Human) "cell surface receptor signaling pathway [GO:0007166]; negative regulation of neuron differentiation [GO:0045665]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of neuron differentiation [GO:0045665]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; transcription by RNA polymerase II [GO:0006366]; transcription, DNA-templated [GO:0006351]" GO:0003713; GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0006351; GO:0006366; GO:0007166; GO:0007219; GO:0008270; GO:0008593; GO:0016567; GO:0016604; GO:0017124; GO:0031625; GO:0045665; GO:0061630 Notch binding [GO:0005112]; SH3 domain binding [GO:0017124]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270] APPAPPLPPPPPPGGPPGALAVR 0.99532 -9.9685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH51 OR8K3_HUMAN Olfactory receptor 8K3 (Olfactory receptor OR11-181) OR8K3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] AFSTCGAHLTVVIVFYGTLLFMYVQPK 0.99532 -9.4666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWB5 PIHD2_HUMAN PIH1 domain-containing protein 2 PIH1D2 Homo sapiens (Human) box C/D snoRNP assembly [GO:0000492]; protein stabilization [GO:0050821]; rRNA processing [GO:0006364] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; small GTPase binding [GO:0031267]; box C/D snoRNP assembly [GO:0000492]; protein stabilization [GO:0050821]; rRNA processing [GO:0006364] GO:0000492; GO:0005737; GO:0006364; GO:0031267; GO:0050821; GO:0097255; GO:0101031; GO:1990904 small GTPase binding [GO:0031267] FIKEKSTLIITMPLV 0.99532 -8.8601 0 0 0 0 0 0 0 0 11.9732 0 0 0 0 11.9956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9555 0 11.2622 0 0 11.7356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9475 0 0 0 0 0 0 0 0 0 12.164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6876 0 0 0 0 0 0 0 11.3707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0171 0 0 0 0 0 0 0 0 0 0 0 0 11.7713 11.5861 0 0 Q9BT09 CNPY3_HUMAN Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein) CNPY3 CTG4A ERDA5 PRAT4A TNRC5 HSPC084 UNQ1934/PRO4409 Homo sapiens (Human) innate immune response [GO:0045087] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; signaling receptor binding [GO:0005102]; innate immune response [GO:0045087] GO:0005102; GO:0005788; GO:0045087 signaling receptor binding [GO:0005102] AKAAGGR 0.99532 -8.8954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.79586 0 0 0 0 0 0 0 0 0 0 0 0 11.5369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9511 0 0 0 0 12.9796 0 0 14.4762 0 0 0 11.8943 0 0 15.8954 0 0 0 0 0 0 19.7937 12.4957 15.2603 0 0 13.3914 0 0 16.0461 0 13.9655 0 13.4865 0 0 12.138 0 15.575 14.5951 0 0 0 11.9289 0 14.4482 0 0 14.3205 0 13.832 12.6979 0 12.6546 0 0 0 0 0 12.2525 0 11.5853 0 0 0 10.923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0432 0 0 0 0 0 0 0 0 0 0 Q9HAY6 BCDO1_HUMAN "Beta,beta-carotene 15,15'-dioxygenase, EC 1.13.11.63 (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1)" BCO1 BCDO BCDO1 BCMO1 Homo sapiens (Human) beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238] cytosol [GO:0005829] "cytosol [GO:0005829]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238]" GO:0001523; GO:0003834; GO:0005829; GO:0010436; GO:0016121; GO:0035238; GO:0042572; GO:0042574; GO:0046872; GO:1901810 "beta-carotene 15,15'-dioxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]" DGEVYYR 0.99532 -8.8813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HBE4 IL21_HUMAN "Interleukin-21, IL-21 (Za11)" IL21 Homo sapiens (Human) cell maturation [GO:0048469]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; germinal center B cell differentiation [GO:0002314]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165]; T follicular helper cell differentiation [GO:0061470]; tyrosine phosphorylation of STAT protein [GO:0007260] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; interleukin-2 receptor binding [GO:0005134]; cell maturation [GO:0048469]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; germinal center B cell differentiation [GO:0002314]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165]; T follicular helper cell differentiation [GO:0061470]; tyrosine phosphorylation of STAT protein [GO:0007260] GO:0001819; GO:0002314; GO:0002639; GO:0005125; GO:0005126; GO:0005134; GO:0005576; GO:0005615; GO:0007165; GO:0007260; GO:0008284; GO:0030890; GO:0032729; GO:0032740; GO:0034105; GO:0042102; GO:0042531; GO:0045954; GO:0048469; GO:0050729; GO:0051607; GO:0061470; GO:0098586 cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; interleukin-2 receptor binding [GO:0005134] FKSLLQKMIHQHLSSR 0.99532 -8.8838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8248 0 0 0 0 12.7072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2315 12.5735 12.4235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5828 0 0 13.1662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0701 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4756 0 0 0 Q9HBI0 PARVG_HUMAN Gamma-parvin PARVG Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of cell polarity [GO:0007163]; substrate adhesion-dependent cell spreading [GO:0034446] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; cell-matrix adhesion [GO:0007160]; establishment or maintenance of cell polarity [GO:0007163]; substrate adhesion-dependent cell spreading [GO:0034446] GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0007160; GO:0007163; GO:0015629; GO:0030031; GO:0031532; GO:0034446 actin binding [GO:0003779] DEGLLSCPVSPEDIVNK 0.99532 -9.4686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.595 0 0 0 0 0 0 0 0 0 0 0 12.6755 0 0 0 0 14.0432 0 0 0 0 0 0 0 0 0 14.5406 0 13.8994 0 0 12.763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBQ6 EXTL2_HUMAN "Exostosin-like 2, EC 2.4.1.223 (Alpha-1,4-N-acetylhexosaminyltransferase EXTL2) (Alpha-GalNAcT EXTL2) (EXT-related protein 2) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) [Cleaved into: Processed exostosin-like 2 ]" EXTL2 EXTR2 Homo sapiens (Human) heparan sulfate proteoglycan biosynthetic process [GO:0015012]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; UDP-N-acetylgalactosamine metabolic process [GO:0019276] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] "cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; alpha-1,4-N-acetylgalactosaminyltransferase activity [GO:0035248]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; glycosaminoglycan binding [GO:0005539]; manganese ion binding [GO:0030145]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; N-acetylglucosamine metabolic process [GO:0006044]; protein glycosylation [GO:0006486]; UDP-N-acetylgalactosamine metabolic process [GO:0019276]" GO:0001888; GO:0005539; GO:0005576; GO:0005654; GO:0005783; GO:0005789; GO:0005829; GO:0006044; GO:0006486; GO:0015012; GO:0016021; GO:0019276; GO:0030145; GO:0035248; GO:0047237 "alpha-1,4-N-acetylgalactosaminyltransferase activity [GO:0035248]; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047237]; glycosaminoglycan binding [GO:0005539]; manganese ion binding [GO:0030145]" EIKSQGK 0.99532 -9.4707 0 0 0 0 0 0 0 0 0 12.4896 0 0 0 0 0 0 10.0637 0 0 0 0 0 0 0 0 0 12.6332 0 0 0 0 0 12.1326 0 0 0 0 0 0 0 11.5505 0 0 0 0 0 11.1173 0 10.7255 12.0742 0 0 0 0 0 10.7329 0 0 0 0 0 0 0 0 0 0 16.3333 10.5844 15.4746 15.9487 16.3376 15.4547 15.6931 14.9188 14.5594 0 14.2428 0 11.7555 11.838 12.3005 0 0 0 0 0 15.5896 13.194 0 0 12.6877 12.4096 0 0 0 0 0 0 0 0 0 11.9441 0 0 0 0 12.7259 11.6566 11.1995 0 0 0 12.025 11.4581 13.7124 0 13.4944 0 10.0764 12.6374 0 0 11.0752 0 0 0 0 11.8579 0 0 0 13.525 10.2607 0 0 0 0 9.18606 13.3626 11.6041 0 0 13.1175 0 13.172 0 0 0 0 0 12.123 0 0 13.1395 0 0 12.4413 0 0 0 11.516 13.0044 0 0 0 0 0 0 0 12.7761 0 0 0 0 0 0 11.9969 0 12.7808 0 Q9UKR0 KLK12_HUMAN "Kallikrein-12, EC 3.4.21.- (Kallikrein-like protein 5, KLK-L5)" KLK12 KLKL5 UNQ669/PRO1303 Homo sapiens (Human) proteolysis [GO:0006508] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141] extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008236; GO:0030141 peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236] LLRLRLPVR 0.99532 -5.4985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.224 0 0 0 0 0 0 0 0 0 0 9.9156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6433 11.2495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0922 0 0 0 0 0 0 0 0 0 0 0 9.51349 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UQM7 KCC2A_HUMAN "Calcium/calmodulin-dependent protein kinase type II subunit alpha, CaM kinase II subunit alpha, CaMK-II subunit alpha, EC 2.7.11.17" CAMK2A CAMKA KIAA0968 Homo sapiens (Human) angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; response to ischemia [GO:0002931] anchoring junction [GO:0070161]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069] anchoring junction [GO:0070161]; calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; response to ischemia [GO:0002931] GO:0000082; GO:0002931; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005954; GO:0006468; GO:0006816; GO:0010666; GO:0014069; GO:0016301; GO:0018105; GO:0030666; GO:0035254; GO:0038166; GO:0042802; GO:0042803; GO:0043005; GO:0043197; GO:0046777; GO:0046872; GO:0046928; GO:0048168; GO:0051092; GO:0051346; GO:0051928; GO:0060996; GO:0070161; GO:0106310; GO:1902108; GO:1990443; GO:2000124; GO:2001222 ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DLKPENLLLASKLK 0.99532 -8.8702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7935 0 0 0 0 0 0 0 0 0 0 0 13.8294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.906 0 0 0 0 0 0 0 0 0 0 0 14.2868 0 0 0 0 0 0 16.3159 0 14.8798 0 0 0 13.2773 0 0 0 0 0 0 14.5103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5N6 ORC6_HUMAN Origin recognition complex subunit 6 ORC6 ORC6L Homo sapiens (Human) DNA replication initiation [GO:0006270]; negative regulation of cell division [GO:0051782] cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808] cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]; DNA binding [GO:0003677]; DNA replication initiation [GO:0006270]; negative regulation of cell division [GO:0051782] GO:0000808; GO:0001650; GO:0003677; GO:0005654; GO:0005664; GO:0005829; GO:0006270; GO:0016020; GO:0051782 DNA binding [GO:0003677] IGQQVDR 0.99532 -9.4713 0 0 0 0 0 0 0 0 0 0 0 10.523 0 0 0 0 0 0 12.3118 0 0 0 0 11.5279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1913 13.4171 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2016 13.9576 13.192 0 0 13.3848 13.9321 14.3746 12.7948 12.5908 12.2332 16.4744 13.3873 13.4564 0 0 0 0 0 0 12.4447 0 0 0 0 0 0 14.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5543 0 0 0 0 0 0 0 12.7551 0 0 11.9711 0 0 0 0 0 0 11.5173 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1303 0 0 0 0 13.704 0 0 11.9101 0 0 12.2035 0 0 0 0 0 0 0 0 A0AV96 RBM47_HUMAN RNA-binding protein 47 (RNA-binding motif protein 47) RBM47 Homo sapiens (Human) cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244] nucleus [GO:0005634] nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244; GO:0003723; GO:0003729; GO:0005634; GO:0016554 mRNA binding [GO:0003729]; RNA binding [GO:0003723] AVRELNNYEIRPGR 0.99533 -10.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0817 0 0 0 0 13.8548 0 0 0 0 13.8715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00746 NDKM_HUMAN "Nucleoside diphosphate kinase, mitochondrial, NDK, NDP kinase, mitochondrial, EC 2.7.4.6 (Nucleoside diphosphate kinase D, NDPKD) (nm23-H4)" NME4 NM23D Homo sapiens (Human) CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; lipid transport [GO:0006869]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside metabolic process [GO:0009116]; UTP biosynthetic process [GO:0006228] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cardiolipin binding [GO:1901612]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; lipid transport [GO:0006869]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside metabolic process [GO:0009116]; UTP biosynthetic process [GO:0006228] GO:0004550; GO:0005524; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006165; GO:0006183; GO:0006228; GO:0006241; GO:0006869; GO:0009116; GO:0046872; GO:1901612 ATP binding [GO:0005524]; cardiolipin binding [GO:1901612]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550] MGGLFWR 0.99533 -9.5011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4558 0 0 0 11.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4982 0 0 O43823 AKAP8_HUMAN "A-kinase anchor protein 8, AKAP-8 (A-kinase anchor protein 95 kDa, AKAP 95)" AKAP8 AKAP95 Homo sapiens (Human) cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; signal transduction [GO:0007165] condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; signal transduction [GO:0007165] GO:0000278; GO:0000793; GO:0001939; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005794; GO:0007076; GO:0007165; GO:0008270; GO:0015031; GO:0016020; GO:0016363; GO:0031065; GO:0032720; GO:0034237; GO:0042826; GO:0044839; GO:0045087; GO:0051059; GO:0071222; GO:0071380 double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] GQGRFQDR 0.99533 -8.9428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0941 0 12.4124 0 0 0 16.0868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7593 0 0 0 0 0 0 0 0 0 0 0 14.4574 0 0 0 0 0 0 0 0 13.175 0 13.8929 0 0 0 0 0 11.2123 0 0 0 0 0 0 14.3699 12.3494 15.2776 0 0 0 0 14.1016 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7306 O95180 CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2) CACNA1H Homo sapiens (Human) aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518]; low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; aldosterone biosynthetic process [GO:0032342]; calcium ion import [GO:0070509]; cellular response to hormone stimulus [GO:0032870]; cellular response to potassium ion [GO:0035865]; cortisol biosynthetic process [GO:0034651]; inorganic cation transmembrane transport [GO:0098662]; membrane depolarization during action potential [GO:0086010]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; neuronal action potential [GO:0019228]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of heart contraction [GO:0008016]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] GO:0001518; GO:0005244; GO:0005248; GO:0005887; GO:0005891; GO:0006936; GO:0007517; GO:0007520; GO:0008016; GO:0008332; GO:0016021; GO:0019228; GO:0032342; GO:0032870; GO:0034651; GO:0034765; GO:0035865; GO:0042391; GO:0043005; GO:0045956; GO:0046872; GO:0070509; GO:0086010; GO:0097110; GO:0098662; GO:2000344 low voltage-gated calcium channel activity [GO:0008332]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248] AESLDPRPLR 0.99533 -10.009 12.617 12.6854 15.2033 0 0 13.1564 0 0 0 11.6483 0 14.7641 0 14.2709 0 14.2107 13.3201 0 0 0 12.3818 13.2474 12.0925 12.7584 13.9607 11.3427 0 0 0 0 0 0 0 0 0 11.8796 13.5518 0 0 13.0235 14.6883 0 11.5115 0 0 0 0 0 0 10.5151 11.1891 0 0 0 0 0 0 0 0 0 9.37623 0 0 0 0 0 14.124 13.3442 12.4423 14.3733 0 14.6596 0 0 0 0 13.4458 14.7115 11.0193 15.3802 0 14.815 12.7612 13.9532 12.9771 13.4462 13.0749 13.9406 11.8921 14.941 13.0336 13.0109 0 12.9949 0 13.9411 0 0 15.2403 0 13.955 0 0 0 0 0 0 0 12.8429 13.9475 0 0 13.8942 13.8138 14.0233 0 0 13.6057 0 14.1311 13.3339 0 12.7196 15.2072 13.2282 0 0 0 0 0 0 0 0 13.5937 0 0 0 0 14.9926 0 0 0 13.7359 14.6347 0 0 12.6793 11.3145 14.2311 14.1677 13.0318 0 13.7911 0 13.2958 0 13.4926 10.9814 0 12.7722 0 0 0 11.344 13.3676 14.5187 0 0 0 0 10.5142 0 13.0837 0 0 12.3089 13.0225 0 0 0 O95872 GPAN1_HUMAN G patch domain and ankyrin repeat-containing protein 1 (Ankyrin repeat domain-containing protein 59) (G patch domain-containing protein 10) (HLA-B-associated transcript 4) (Protein G5) GPANK1 ANKRD59 BAT4 G5 GPATCH10 Homo sapiens (Human) nucleic acid binding [GO:0003676] GO:0003676 nucleic acid binding [GO:0003676] ANPIPTVLK 0.99533 -10.013 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4937 0 0 11.3096 0 0 0 0 0 0 0 0 11.294 0 0 0 10.9302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2564 0 0 0 0 0 0 0 0 0 0 0 12.4405 0 0 0 0 0 0 0 P25067 CO8A2_HUMAN Collagen alpha-2(VIII) chain (Endothelial collagen) COL8A2 Homo sapiens (Human) angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674]; angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198] GO:0001525; GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0030198; GO:0030674; GO:0031012; GO:0048593; GO:0050673; GO:0062023; GO:0098609 extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674] GEPGAVGPK 0.99533 -8.9376 10.0395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7346 0 0 0 14.6732 0 0 0 0 0 14.5981 0 0 12.9425 0 0 0 0 0 0 0 0 0 0 0 0 16.6629 13.4542 0 0 0 0 0 0 0 0 0 0 10.2417 0 0 0 13.6512 0 0 14.1618 13.659 11.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0304 0 0 13.9387 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1378 0 0 13.4151 0 0 0 0 0 0 0 10.8438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4VNC1 AT134_HUMAN "Probable cation-transporting ATPase 13A4, EC 7.2.2.- (P5-ATPase isoform 4)" ATP13A4 UNQ3052/PRO9871 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038] early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type transmembrane transporter activity [GO:0140358]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085] GO:0005524; GO:0005789; GO:0005886; GO:0006874; GO:0016020; GO:0016021; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0034220; GO:0046872; GO:0055038; GO:0055085; GO:0140358 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type transmembrane transporter activity [GO:0140358] AVVLQTGFNTAKGDLVRSILYPK 0.99533 -9.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3158 0 0 0 14.6178 11.3122 12.1966 0 15.3042 14.8055 0 0 15.512 14.5362 16.2255 0 14.1671 15.2662 15.7469 15.8914 14.3193 0 14.4958 0 0 0 13.6607 0 0 0 14.7148 14.2923 0 0 0 0 0 12.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1232 0 0 0 14.6342 11.7512 0 15.4674 13.5067 0 0 0 13.0351 12.1643 0 0 0 0 0 12.9201 0 0 0 0 13.128 0 0 0 0 0 0 0 0 11.5579 0 0 0 0 0 0 0 0 0 0 11.8635 0 0 0 0 0 Q6DJT9 PLAG1_HUMAN Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein) PLAG1 Homo sapiens (Human) "gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] "centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]" GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005654; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0010628; GO:0010629; GO:0016607; GO:0022612; GO:0035264; GO:0045944; GO:0046872; GO:0060252; GO:0060736 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DFLCQYCAQR 0.99533 -9.5076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88791 0 0 0 0 0 0 0 0 0 0 0 13.2164 0 0 0 0 0 0 13.0375 0 12.289 10.8203 0 13.2586 0 0 13.6521 0 0 0 0 13.495 0 0 13.9193 0 0 0 0 0 0 0 0 0 0 0 0 14.3025 0 16.3619 0 15.2478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P575 BGP11_HUMAN Putative inactive beta-glucuronidase protein GUSBP11 (Beta-glucuronidase pseudogene 11) GUSBP11 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975] "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]" GO:0004553; GO:0005975 "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]" DSGEGFW 0.99533 -9.5004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9725 0 0 14.2771 0 0 0 0 0 0 13.9901 12.3289 13.1276 0 0 0 0 0 14.0663 13.8718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5287 0 0 0 0 0 0 0 0 13.5722 0 0 13.7246 13.8378 0 0 0 0 14.0937 0 0 0 0 13.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZVH7 ESPNL_HUMAN Espin-like protein ESPNL Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605] cytoplasm [GO:0005737]; stereocilium tip [GO:0032426] cytoplasm [GO:0005737]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; actin filament bundle assembly [GO:0051017]; sensory perception of sound [GO:0007605] GO:0005737; GO:0007605; GO:0032426; GO:0051015; GO:0051017 actin filament binding [GO:0051015] ARFFGSSQRPAWDTEPGR 0.99533 -9.486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9272 14.0348 0 15.2542 13.3428 0 0 14.8296 0 0 0 0 0 11.9409 0 0 0 0 0 0 0 0 14.6032 14.6518 0 0 0 0 0 0 13.9235 0 13.1808 14.3749 13.6175 0 0 0 0 14.5811 0 0 0 14.0301 0 0 0 0 13.6451 0 13.8618 0 0 0 0 0 15.0013 0 0 0 0 0 0 0 0 13.5747 0 0 0 0 0 0 0 0 0 0 13.9279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3235 0 Q8IYT1 GAR4_HUMAN "Golgi associated RAB2 interactor protein 4 (Golgi-associated Rab2B interactor-like 4, GARI-L4, GARI-like 4)" GARIN4 FAM71A Homo sapiens (Human) Golgi organization [GO:0007030] Golgi apparatus [GO:0005794]; nucleus [GO:0005634] Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; Golgi organization [GO:0007030] GO:0005634; GO:0005794; GO:0007030 ISVQDHEKQQLRLK 0.99533 -9.4779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3436 0 0 0 0 0 0 0 0 0 0 0 0 11.4991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N335 GPD1L_HUMAN "Glycerol-3-phosphate dehydrogenase 1-like protein, GPD1-L, EC 1.1.1.8" GPD1L KIAA0089 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; NAD metabolic process [GO:0019674]; NADH metabolic process [GO:0006734]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase C signaling [GO:0090038]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; ventricular cardiac muscle cell action potential [GO:0086005] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; NAD metabolic process [GO:0019674]; NADH metabolic process [GO:0006734]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase C signaling [GO:0090038]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; ventricular cardiac muscle cell action potential [GO:0086005]" GO:0002027; GO:0005829; GO:0005886; GO:0005975; GO:0006734; GO:0009331; GO:0010765; GO:0016616; GO:0017080; GO:0019674; GO:0033137; GO:0042803; GO:0044325; GO:0046168; GO:0051287; GO:0060373; GO:0070062; GO:0086005; GO:0090038; GO:2000010; GO:2000649 "NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]" AAVIRLGLMEMIAFARIFCK 0.99533 -9.4879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5909 0 0 0 0 0 0 0 12.7983 0 12.3211 0 0 0 0 0 0 0 0 10.7009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2684 0 0 0 0 13.4374 0 12.9981 0 0 13.1795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ19 BACD1_HUMAN "BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1, hBACURD1 (BTB/POZ domain-containing protein KCTD13) (Polymerase delta-interacting protein 1) (TNFAIP1-like protein)" KCTD13 BACURD1 PDIP1 POLDIP1 FKSG86 PP6832 Homo sapiens (Human) cell migration [GO:0016477]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; positive regulation of synaptic transmission [GO:0050806]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of DNA replication [GO:0045740]; positive regulation of synaptic transmission [GO:0050806]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; stress fiber assembly [GO:0043149] GO:0005654; GO:0005829; GO:0016477; GO:0016567; GO:0016604; GO:0019904; GO:0031267; GO:0031463; GO:0035024; GO:0042802; GO:0043149; GO:0043161; GO:0045740; GO:0050806; GO:0051260 identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267] PVVKLLHNR 0.99533 -10.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5876 0 12.5914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2367 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2K5 R3HD2_HUMAN R3H domain-containing protein 2 R3HDM2 KIAA1002 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723] GO:0003723; GO:0005634 RNA binding [GO:0003723] AVIINKTSNTR 0.99533 -12.821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8147 0 0 0 13.7361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3794 0 0 11.9924 0 0 0 0 12.4845 0 0 0 13.4196 0 0 0 0 0 13.8479 0 0 0 0 0 13.5022 0 0 0 0 0 0 13.9539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.273 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7066 13.1503 0 14.051 0 0 0 0 0 0 0 0 0 0 0 0 Q07666 KHDR1_HUMAN "KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein, Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)" KHDRBS1 SAM68 Homo sapiens (Human) "G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Grb2-Sos complex [GO:0070618]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of translational initiation [GO:0045948]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA export from nucleus [GO:0046831]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]" GO:0000082; GO:0000086; GO:0000122; GO:0000381; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007283; GO:0008143; GO:0008266; GO:0016020; GO:0017124; GO:0019904; GO:0032991; GO:0035591; GO:0042169; GO:0042802; GO:0044877; GO:0045892; GO:0045948; GO:0046831; GO:0046833; GO:0048024; GO:0050852; GO:0070618; GO:1990782 DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591] APPARPVKGAYR 0.99534 -10.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1134 0 0 0 0 0 0 0 11.7317 0 0 0 0 0 0 11.8965 0 0 11.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1949 0 0 0 0 0 0 0 0 Q6VAB6 KSR2_HUMAN "Kinase suppressor of Ras 2, hKSR2, EC 2.7.11.1" KSR2 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165] GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0007265; GO:0019722; GO:0046872; GO:0106310; GO:0120162 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] DNEDQLK 0.99534 -31.797 0 0 0 0 14.0554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5464 0 0 0 0 0 14.5795 0 15.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2038 0 13.8536 0 0 0 0 0 0 0 0 0 0 0 0 13.1482 0 12.8392 13.0553 15.0231 0 0 0 0 0 14.2132 0 0 0 0 0 14.0172 0 0 14.7021 0 0 0 0 0 0 14.6081 12.8186 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4502 0 13.5365 0 0 0 0 0 14.295 0 0 0 12.4588 0 0 0 0 0 14.1047 0 0 0 0 0 10.46 0 Q7Z434 MAVS_HUMAN "Mitochondrial antiviral-signaling protein, MAVS (CARD adapter inducing interferon beta, Cardif) (Interferon beta promoter stimulator protein 1, IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter, VISA)" MAVS IPS1 KIAA1271 VISA Homo sapiens (Human) activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of IP-10 production [GO:0071660]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of peroxisome organization [GO:1900063]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; ubiquitin ligase complex [GO:0000151] integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; ubiquitin ligase complex [GO:0000151]; CARD domain binding [GO:0050700]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; activation of innate immune response [GO:0002218]; cellular response to exogenous dsRNA [GO:0071360]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of IP-10 production [GO:0071660]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of peroxisome organization [GO:1900063]; signal transduction [GO:0007165]; type I interferon signaling pathway [GO:0060337] GO:0000151; GO:0001934; GO:0002218; GO:0002230; GO:0002735; GO:0005739; GO:0005741; GO:0005778; GO:0007165; GO:0016021; GO:0019901; GO:0031966; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0035591; GO:0042307; GO:0042742; GO:0043123; GO:0045071; GO:0045087; GO:0045944; GO:0050700; GO:0051091; GO:0051607; GO:0060337; GO:0060340; GO:0060760; GO:0071360; GO:0071651; GO:0071660; GO:1900063 CARD domain binding [GO:0050700]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591] EVPCHRPSPGALWLQVAVTGVLVVTLLVVLYRR 0.99534 -8.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6257 0 0 0 0 13.219 0 0 0 0 0 0 0 0 0 0 14.9551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7033 0 0 0 0 11.7058 0 0 0 0 0 15.0008 0 0 0 0 0 0 0 13.042 0 0 0 12.0685 0 0 0 12.0908 0 0 0 13.9111 0 0 Q8NGC6 OR4KH_HUMAN Olfactory receptor 4K17 (Olfactory receptor OR14-29) OR4K17 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EMKISMK 0.99534 -8.9444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7174 0 0 0 0 0 0 0 Q969Z4 TR19L_HUMAN Tumor necrosis factor receptor superfamily member 19L (Receptor expressed in lymphoid tissues) RELT TNFRSF19L Homo sapiens (Human) amelogenesis [GO:0097186]; apoptotic process [GO:0006915] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; amelogenesis [GO:0097186]; apoptotic process [GO:0006915] GO:0005654; GO:0005886; GO:0006915; GO:0016021; GO:0048471; GO:0097186 AGAKAGR 0.99534 -8.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1323 0 13.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0581 0 0 0 0 0 0 0 0 0 Q96E39 RMXL1_HUMAN "RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1)" RBMXL1 Homo sapiens (Human) "mRNA processing [GO:0006397]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]" spliceosomal complex [GO:0005681] "spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]" GO:0003723; GO:0005681; GO:0006397; GO:0008380; GO:0048026 RNA binding [GO:0003723] DDGYSTKDSYSSRDYPSSR 0.99534 -8.9545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4807 0 0 0 0 0 0 0 0 0 13.9159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1613 0 0 0 0 0 0 0 0 0 0 0 12.2392 0 0 0 12.7202 0 0 0 0 0 12.2488 0 0 0 0 0 13.9799 12.7349 0 0 Q96JB5 CK5P3_HUMAN CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (LXXLL/leucine-zipper-containing ARF-binding protein) (Protein HSF-27) CDK5RAP3 IC53 LZAP MSTP016 OK/SW-cl.114 PP1553 Homo sapiens (Human) apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976] GO:0000079; GO:0001889; GO:0001933; GO:0005634; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0007095; GO:0007346; GO:0007420; GO:0008283; GO:0010921; GO:0016020; GO:0019901; GO:0030262; GO:0030332; GO:0030968; GO:0031398; GO:0032088; GO:0032991; GO:0034976; GO:0042177; GO:0043231; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0045664; GO:0045944; GO:0051019; GO:0051059; GO:0060318; GO:0071569; GO:0071901; GO:0097371; GO:1900182; GO:1901798 cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389] DWQEIIALYEKDNTYLVELSSLLVR 0.99534 -11.87 0 0 0 0 0 0 0 0 0 0 9.59378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0211 13.36 0 13.432 0 0 0 0 0 0 11.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3351 12.725 0 13.6468 0 0 0 0 0 0 0 0 0 0 0 12.6037 0 0 0 0 0 0 10.5518 0 0 14.3231 0 0 0 0 13.1448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2996 0 0 0 0 0 0 0 13.7984 0 0 0 0 0 0 0 12.2459 12.6943 0 0 0 0 0 0 0 14.1197 0 0 0 0 0 0 0 0 0 0 0 0 12.0219 0 0 Q9Y2B5 VP9D1_HUMAN VPS9 domain-containing protein 1 (Protein ATP-BL) VPS9D1 ATPBL C16orf7 Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; endocytic vesicle [GO:0030139] cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; proton motive force-driven ATP synthesis [GO:0015986]; vesicle-mediated transport [GO:0016192] GO:0005085; GO:0005096; GO:0005829; GO:0015986; GO:0016192; GO:0030139; GO:0031267; GO:0042802 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267] EQRALYAAILEYEQDHDWPK 0.99534 -8.948 0 0 0 0 0 0 0 0 0 0 0 0 11.2276 0 0 0 0 0 0 0 0 12.4512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0391 0 0 0 0 0 0 0 0 0 12.9754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.984 0 12.4654 13.9498 13.9465 0 0 0 0 0 12.9814 0 13.7699 0 12.8236 13.235 13.1855 13.8322 14.0627 0 0 0 0 14.1967 0 13.5302 0 0 0 0 13.7153 0 0 0 0 14.5542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5205 0 0 0 0 0 0 0 0 0 0 13.0808 0 12.2564 0 0 0 0 0 0 0 0 14.1625 0 0 0 0 0 0 0 0 0 0 0 12.6782 0 0 0 O15318 RPC7_HUMAN "DNA-directed RNA polymerase III subunit RPC7, RNA polymerase III subunit C7 (DNA-directed RNA polymerase III subunit G) (RNA polymerase III 32 kDa apha subunit, RPC32-alpha) (RNA polymerase III 32 kDa subunit, RPC32)" POLR3G Homo sapiens (Human) cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; chromatin binding [GO:0003682]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383] GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0008283; GO:0016604; GO:0032728; GO:0045087; GO:0045089; GO:0051607 chromatin binding [GO:0003682]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899] AGPKPKK 0.99535 -32.454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5925 0 13.5361 14.0011 0 0 0 0 14.0256 0 0 0 0 0 0 10.897 10.4539 0 0 0 0 0 0 0 0 0 0 0 13.7985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5158 0 0 0 13.2942 0 0 0 0 0 0 0 0 0 14.7119 0 0 0 0 0 0 0 14.7236 0 0 0 14.5504 0 0 0 0 0 0 0 0 0 0 0 0 13.3387 0 0 0 0 0 0 0 0 0 0 0 11.477 0 0 0 0 0 0 0 P23378 GCSP_HUMAN "Glycine dehydrogenase (decarboxylating), mitochondrial, EC 1.4.4.2 (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))" GLDC GCSP Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255] GO:0004375; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0005960; GO:0006546; GO:0009055; GO:0016594; GO:0016829; GO:0019464; GO:0030170; GO:0036255; GO:0042803; GO:0070280; GO:1903442; GO:1990830 electron transfer activity [GO:0009055]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170] AAQRQINFR 0.99535 -12.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.305 0 0 0 0 0 0 10.5729 0 0 0 0 0 0 0 0 12.4708 0 0 0 0 0 0 0 14.3898 0 0 0 0 0 0 0 14.6535 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6896 0 0 14.1149 14.2875 0 0 0 0 0 13.2418 0 13.9734 0 13.4394 0 0 0 0 0 0 0 14.5201 14.1609 14.5339 12.8387 0 0 0 0 0 0 0 0 0 0 0 11.9561 0 0 0 0 0 0 0 0 0 14.6318 0 0 0 0 0 0 0 0 0 0 14.8652 0 0 0 0 17.3384 0 0 Q14213 IL27B_HUMAN "Interleukin-27 subunit beta, IL-27 subunit beta, IL-27B (Epstein-Barr virus-induced gene 3 protein, EBV-induced gene 3 protein)" EBI3 IL27B Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; humoral immune response [GO:0006959]; leptin-mediated signaling pathway [GO:0033210]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of interferon-gamma production [GO:0032729]; T cell proliferation [GO:0042098]; T-helper 1 type immune response [GO:0042088] endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-27 receptor binding [GO:0045523]; peptide hormone binding [GO:0017046]; cytokine-mediated signaling pathway [GO:0019221]; humoral immune response [GO:0006959]; leptin-mediated signaling pathway [GO:0033210]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of interferon-gamma production [GO:0032729]; T cell proliferation [GO:0042098]; T-helper 1 type immune response [GO:0042088] GO:0004896; GO:0005125; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0006959; GO:0009897; GO:0017046; GO:0019221; GO:0019955; GO:0032729; GO:0033210; GO:0042088; GO:0042098; GO:0043235; GO:0045523; GO:0046641 cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-27 receptor binding [GO:0045523]; peptide hormone binding [GO:0017046] LSPLAER 0.99535 -11.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14667 K0100_HUMAN Protein KIAA0100 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein) KIAA0100 BCOX1 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 AAVLKRNLSTEALK 0.99535 -12.545 0 0 0 0 0 0 0 0 0 0 12.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1232 0 0 10.3513 0 12.0637 0 0 0 0 0 0 12.6023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.574 0 0 0 13.7784 0 0 0 0 0 0 14.4959 0 12.7138 0 15.472 14.516 0 12.7281 0 14.7661 14.5951 15.3447 0 0 14.3695 13.8387 13.8692 12.9166 0 0 0 0 12.4457 0 0 0 13.4855 13.7282 0 0 0 0 0 0 0 0 0 12.0248 0 0 10.3582 0 10.007 12.6332 0 0 15.4287 0 12.9542 0 13.6753 13.6722 0 0 0 12.5965 0 0 0 13.5819 0 0 0 13.1947 0 0 0 0 0 0 0 0 0 12.0015 0 0 13.3757 0 0 13.532 0 0 0 0 0 13.1428 13.4521 12.6902 0 0 0 0 0 0 13.2517 0 0 0 14.4155 0 0 0 Q15051 IQCB1_HUMAN "IQ calmodulin-binding motif-containing protein 1 (Nephrocystin-5) (p53 and DNA damage-regulated IQ motif protein, PIQ)" IQCB1 KIAA0036 NPHP5 OK/SW-cl.85 Homo sapiens (Human) cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750] centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; cilium assembly [GO:0060271]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494] GO:0001750; GO:0005516; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0015630; GO:0019899; GO:0032391; GO:0045171; GO:0045494; GO:0048496; GO:0060271; GO:0070062; GO:0072686 calmodulin binding [GO:0005516]; enzyme binding [GO:0019899] AAVTLQRAALK 0.99535 -11.984 0 0 0 0 0 0 0 0 0 10.7921 0 0 13.2684 0 0 0 0 9.69881 0 0 11.9324 0 0 0 0 10.5568 12.9829 0 0 0 11.8495 0 11.4725 13.3748 12.7105 13.5135 13.6146 0 0 13.3024 13.3369 0 13.5233 0 13.1933 12.9333 12.6707 0 0 0 0 0 0 0 0 0 13.3194 0 0 0 0 0 0 0 0 0 0 10.2881 0 0 0 0 0 0 0 13.2139 0 0 0 14.2672 0 0 0 0 0 0 12.3312 0 0 14.3703 0 0 0 0 0 0 12.1035 14.1889 0 0 0 0 0 0 0 0 0 13.6761 0 14.7537 0 0 0 0 0 0 0 15.3488 0 0 11.08 0 0 0 0 0 12.6394 0 0 0 0 13.9558 0 13.0628 0 12.8691 0 0 0 0 14.9722 0 0 0 0 0 0 0 0 13.1582 0 0 0 0 0 0 12.5735 14.8653 14.1608 12.1493 0 0 0 12.3997 13.4293 13.0191 0 12.2509 0 0 0 0 13.7838 0 0 13.2716 14.6971 0 13.6496 0 Q4VC31 MIX23_HUMAN Protein MIX23 (Coiled-coil domain-containing protein 58) MIX23 CCDC58 Homo sapiens (Human) mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] GO:0005739; GO:0005758 CRIHFKPPK 0.99535 -11.965 0 0 0 0 0 0 0 0 0 0 12.4666 0 0 0 0 0 0 11.5657 0 0 11.2268 0 0 0 0 11.4146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9319 14.3236 0 0 0 0 0 0 0 14.2484 13.2966 0 0 13.9951 0 0 0 13.3451 0 0 0 0 12.9981 0 0 0 0 10.0217 0 13.9992 0 0 0 0 0 0 0 0 0 13.1109 0 0 0 0 13.208 0 12.8709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.919 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53EZ4 CEP55_HUMAN "Centrosomal protein of 55 kDa, Cep55 (Up-regulated in colon cancer 6)" CEP55 C10orf3 URCC6 Homo sapiens (Human) cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; midbody [GO:0030496] centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; midbody [GO:0030496]; identical protein binding [GO:0042802]; cranial skeletal system development [GO:1904888]; establishment of protein localization [GO:0045184]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066] GO:0000281; GO:0005737; GO:0005813; GO:0005814; GO:0014066; GO:0016020; GO:0030496; GO:0032154; GO:0042802; GO:0045171; GO:0045184; GO:0061952; GO:0090543; GO:1904888 identical protein binding [GO:0042802] DALEKNQQWLVYDQQREVYVK 0.99535 -11.96 0 0 0 0 0 0 0 0 0 0 0 0 12.9466 0 0 0 0 0 11.8408 9.05023 0 0 0 0 0 0 0 0 0 0 0 0 12.873 0 0 0 0 0 0 0 0 0 0 10.987 0 0 0 0 0 0 0 0 0 12.7772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4526 0 13.6255 0 0 0 0 0 0 0 18.0822 0 0 0 0 0 0 0 0 14.023 0 13.055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9904 0 0 0 14.7586 0 0 0 12.7884 0 0 0 0 0 12.6534 0 15.2 0 13.8354 0 0 13.5622 0 0 11.7665 11.0661 0 0 0 0 0 0 0 0 0 0 12.521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1434 Q6PF06 TM10B_HUMAN "tRNA methyltransferase 10 homolog B, EC 2.1.1.221 (RNA (guanine-9-)-methyltransferase domain-containing protein 3) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10B)" TRMT10B RG9MTD3 Homo sapiens (Human) protein insertion into mitochondrial inner membrane [GO:0045039]; tRNA N1-guanine methylation [GO:0002939] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721] cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; protein insertion into mitochondrial inner membrane [GO:0045039]; tRNA N1-guanine methylation [GO:0002939] GO:0000049; GO:0002939; GO:0005634; GO:0005654; GO:0005743; GO:0005829; GO:0009019; GO:0042721; GO:0045039; GO:0052905 tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049] DWKLEGSTQK 0.99535 -11.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0261 0 0 0 0 0 13.7726 0 0 0 0 0 0 0 0 14.5929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2254 15.7758 13.2647 0 0 0 0 13.1248 0 0 0 0 13.3076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0684 13.8993 0 0 0 14.2166 13.4881 0 0 0 0 14.7122 0 0 0 0 0 0 0 0 0 12.9376 0 0 Q96S07 PRR25_HUMAN Proline-rich protein 25 PRR25 gs64 Homo sapiens (Human) LGAPVGR 0.99535 -11.98 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BUL8 PDC10_HUMAN Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15) PDCD10 CCM3 TFAR15 Homo sapiens (Human) "angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; endothelium development [GO:0003158]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; regulation of angiogenesis [GO:0045765]; regulation of Golgi organization [GO:1903358]; response to hydrogen peroxide [GO:0042542]; wound healing, spreading of cells [GO:0044319]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; endothelium development [GO:0003158]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; regulation of angiogenesis [GO:0045765]; regulation of Golgi organization [GO:1903358]; response to hydrogen peroxide [GO:0042542]; wound healing, spreading of cells [GO:0044319]" GO:0000139; GO:0001525; GO:0003158; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0033138; GO:0036481; GO:0042542; GO:0042803; GO:0043066; GO:0043406; GO:0044319; GO:0045747; GO:0045765; GO:0047485; GO:0050821; GO:0051683; GO:0070062; GO:0071902; GO:0090051; GO:0090168; GO:0090316; GO:0090443; GO:1903358; GO:1903588; GO:1990830 protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485] DGKAINVFVSANRLIHQTNLILQTFK 0.99535 -12.55 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8556 0 0 10.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7906 0 0 0 13.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7965 0 0 0 10.9041 0 0 0 0 0 0 0 Q9H0T7 RAB17_HUMAN Ras-related protein Rab-17 RAB17 Homo sapiens (Human) cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of melanosome localization [GO:0032401]; filopodium assembly [GO:0046847]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; regulation of dendrite development [GO:0050773]; regulation of endocytosis [GO:0030100]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; transcytosis [GO:0045056] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of melanosome localization [GO:0032401]; filopodium assembly [GO:0046847]; immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor [GO:0002415]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; regulation of dendrite development [GO:0050773]; regulation of endocytosis [GO:0030100]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; transcytosis [GO:0045056] GO:0002415; GO:0003924; GO:0005525; GO:0005768; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0016323; GO:0016324; GO:0019003; GO:0030100; GO:0030139; GO:0030425; GO:0032401; GO:0032402; GO:0032456; GO:0042470; GO:0043025; GO:0045056; GO:0046847; GO:0050773; GO:0051489; GO:0051963; GO:0055037; GO:0055038; GO:0060271; GO:0070062 GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] AAPSQPR 0.99535 -11.969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.794 13.9944 11.7502 13.9504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6745 0 0 0 0 0 0 0 0 0 0 13.489 13.223 0 0 13.886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.971 0 0 0 0 0 0 0 0 0 0 0 15.0335 0 0 0 0 0 0 0 0 0 0 14.2371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.84 14.7878 0 0 0 0 0 0 0 14.4973 Q9H936 GHC1_HUMAN "Mitochondrial glutamate carrier 1, GC-1 (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22)" SLC25A22 GC1 Homo sapiens (Human) aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; regulation of insulin secretion [GO:0050796] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; ion transport [GO:0006811]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; regulation of insulin secretion [GO:0050796] GO:0005280; GO:0005313; GO:0005743; GO:0006811; GO:0015183; GO:0015810; GO:0015813; GO:0016021; GO:0022857; GO:0043490; GO:0050796 amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857] DGQKLTLLK 0.99535 -12.538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2517 0 0 10.5763 0 0 0 0 0 0 14.4803 0 12.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCL0 PCD18_HUMAN Protocadherin-18 PCDH18 KIAA1562 Homo sapiens (Human) brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007420 calcium ion binding [GO:0005509] GDSEAGDSDYDLGRDSPIDR 0.99535 -11.978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6446 0 0 16.9042 17.6672 0 16.9172 0 16.8348 0 0 0 15.8475 0 0 0 0 0 13.7874 0 0 0 0 0 0 14.6952 0 0 0 0 0 13.5161 16.0856 0 0 0 0 0 0 14.3593 0 0 0 0 0 0 0 0 13.5498 12.8385 13.4823 0 12.8781 0 0 12.478 14.8395 0 13.4222 0 0 0 0 0 0 12.9331 17.4868 13.2682 17.5719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1992 14.5252 0 0 0 0 0 0 Q9NUR3 TM74B_HUMAN Transmembrane protein 74B TMEM74B C20orf46 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 GELYRRR 0.99535 -11.972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBB4 ATX10_HUMAN Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein) ATXN10 SCA10 Homo sapiens (Human) cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; neuron projection development [GO:0031175] GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0007399; GO:0016020; GO:0030425; GO:0031175; GO:0043025; GO:0048471; GO:0060271 HPESEWPFLIITDLFLK 0.99535 -11.99 12.4353 17.4496 12.0379 0 14.5216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4318 0 0 12.3827 0 0 0 0 0 13.8483 15.0791 0 16.6524 0 0 0 0 0 0 14.3967 0 0 0 0 0 0 13.9056 13.8082 13.8045 14.1417 0 13.9726 0 0 15.396 12.5583 0 19.3717 0 15.526 14.7077 14.6071 12.5954 14.3702 14.4798 0 0 0 15.0545 0 14.934 0 13.9673 0 0 15.3357 0 15.4945 14.4651 0 0 0 14.3608 14.2333 14.232 13.7481 15.0079 0 0 14.4764 0 14.2125 14.0336 14.3457 0 15.5511 0 11.4135 0 14.4632 14.1283 0 14.2943 0 0 0 14.59 0 0 0 0 0 0 0 0 0 0 13.3096 0 0 0 12.5428 0 0 0 15.4959 14.3554 14.1741 0 0 0 0 15.0126 0 P06858 LIPL_HUMAN "Lipoprotein lipase, LPL, EC 3.1.1.34 (Phospholipase A1, EC 3.1.1.32)" LPL LIPD Homo sapiens (Human) cellular response to fatty acid [GO:0071398]; cellular response to nutrient [GO:0031670]; cholesterol homeostasis [GO:0042632]; chylomicron remodeling [GO:0034371]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cellular response to insulin stimulus [GO:1900077]; phospholipid metabolic process [GO:0006644]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of sequestering of triglyceride [GO:0010890]; positive regulation of tumor necrosis factor production [GO:0032760]; response to bacterium [GO:0009617]; response to cold [GO:0009409]; response to glucose [GO:0009749]; response to xenobiotic stimulus [GO:0009410]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle remodeling [GO:0034372] catalytic complex [GO:1902494]; cell surface [GO:0009986]; chylomicron [GO:0042627]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361] catalytic complex [GO:1902494]; cell surface [GO:0009986]; chylomicron [GO:0042627]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; lipoprotein particle binding [GO:0071813]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; triglyceride binding [GO:0017129]; triglyceride lipase activity [GO:0004806]; cellular response to fatty acid [GO:0071398]; cellular response to nutrient [GO:0031670]; cholesterol homeostasis [GO:0042632]; chylomicron remodeling [GO:0034371]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle mediated signaling [GO:0055096]; negative regulation of cellular response to insulin stimulus [GO:1900077]; phospholipid metabolic process [GO:0006644]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of sequestering of triglyceride [GO:0010890]; positive regulation of tumor necrosis factor production [GO:0032760]; response to bacterium [GO:0009617]; response to cold [GO:0009409]; response to glucose [GO:0009749]; response to xenobiotic stimulus [GO:0009410]; triglyceride biosynthetic process [GO:0019432]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle remodeling [GO:0034372] GO:0004465; GO:0004620; GO:0004806; GO:0005102; GO:0005509; GO:0005576; GO:0005615; GO:0005886; GO:0006631; GO:0006633; GO:0006641; GO:0006644; GO:0008201; GO:0008970; GO:0009409; GO:0009410; GO:0009617; GO:0009749; GO:0009986; GO:0010744; GO:0010884; GO:0010886; GO:0010890; GO:0016042; GO:0016298; GO:0017129; GO:0019432; GO:0019433; GO:0031670; GO:0032722; GO:0032731; GO:0032755; GO:0032760; GO:0034185; GO:0034361; GO:0034371; GO:0034372; GO:0042627; GO:0042632; GO:0042803; GO:0043395; GO:0043495; GO:0045600; GO:0050729; GO:0052739; GO:0052740; GO:0055096; GO:0070328; GO:0071398; GO:0071813; GO:1900077; GO:1902494; GO:2000343 1-acyl-2-lysophosphatidylserine acylhydrolase activity [GO:0052740]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; lipase activity [GO:0016298]; lipoprotein lipase activity [GO:0004465]; lipoprotein particle binding [GO:0071813]; phosphatidylserine 1-acylhydrolase activity [GO:0052739]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; signaling receptor binding [GO:0005102]; triglyceride binding [GO:0017129]; triglyceride lipase activity [GO:0004806] AYRCSSK 0.99536 -11.66 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9792 12.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5891 13.6902 14.1607 13.3691 13.893 13.9739 13.8722 0 0 16.915 0 13.8532 12.9014 12.4769 13.9287 14.0686 13.9847 15.6714 13.8706 0 13.7186 0 0 0 0 0 14.9095 0 14.7838 13.5934 13.7669 0 17.9549 10.5911 13.6034 14.5197 14.4715 0 0 13.8455 13.526 0 0 0 0 14.0853 0 0 13.7426 13.3106 13.7593 0 0 14.8182 13.7391 0 0 0 0 0 0 0 14.7261 12.9599 0 0 11.5635 0 0 0 13.116 0 0 0 0 0 0 9.25567 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0115 0 0 0 0 0 0 0 0 Q13976 KGP1_HUMAN "cGMP-dependent protein kinase 1, cGK 1, cGK1, EC 2.7.11.12 (cGMP-dependent protein kinase I, cGKI)" PRKG1 PRKG1B PRKGR1A PRKGR1B Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; actin cytoskeleton organization [GO:0030036]; cGMP-mediated signaling [GO:0019934]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165] GO:0001764; GO:0004672; GO:0004692; GO:0005246; GO:0005524; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006468; GO:0007165; GO:0016358; GO:0019934; GO:0030036; GO:0030553; GO:0030900; GO:0042802; GO:0043087; GO:0060087; GO:0090331; GO:0106310; GO:1904706; GO:1904753 ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310] EDSPSEDPVFLRTLGK 0.99536 -11.662 0 0 0 0 0 0 0 12.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4419 0 14.9968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0126 12.9997 14.1311 13.9906 13.1847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4125 0 0 0 0 0 17.2739 0 0 14.8496 0 17.7274 0 17.4219 0 0 18.5832 0 0 0 0 0 17.8522 16.2911 15.1122 0 0 0 14.7585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8596 0 0 0 0 Q5XKP0 MIC13_HUMAN MICOS complex subunit MIC13 (Protein P117) MICOS13 C19orf70 MIC13 QIL1 Homo sapiens (Human) cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401] MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007] GO:0001401; GO:0005654; GO:0005739; GO:0005743; GO:0007007; GO:0042407; GO:0044284; GO:0061617; GO:0140275 EGWEYVK 0.99536 -11.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7484 0 0 0 15.5636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BYD9 ACTT3_HUMAN "Actin-related protein T3, ARP-T3 (Actin-related protein M1)" ACTRT3 ARPM1 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; male germ cell nucleus [GO:0001673] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; male germ cell nucleus [GO:0001673] GO:0001673; GO:0005737; GO:0005856 ESFCYVAMNYEEEMAK 0.99536 -10.309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9983 15.8649 15.0006 14.94 0 0 0 0 0 0 0 0 0 0 13.2899 0 0 0 0 0 0 0 0 0 0 0 0 11.1216 0 0 0 0 0 0 0 0 0 0 0 0 12.0803 0 11.4522 0 13.8651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NSJ1 Z355P_HUMAN Putative zinc finger protein 355P (Zinc finger protein ZnFP01) ZNF355P ZNF834 PRED65 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFYWVLSFTK 0.99536 -10.323 10.5738 0 0 0 0 0 0 10.9701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9256 0 0 0 0 0 0 14.0645 13.878 0 13.9007 13.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2459 0 0 0 0 0 10.7055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0371 0 0 0 0 Q9BYX2 TBD2A_HUMAN "TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1, PARIS-1)" TBC1D2 PARIS1 PP8997 TBC1D2A Homo sapiens (Human) activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; positive regulation of GTPase activity [GO:0043547] GO:0005096; GO:0005654; GO:0005829; GO:0005886; GO:0030054; GO:0031410; GO:0043547; GO:0045296; GO:0070161; GO:0090630 cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096] ALEAAQQEKR 0.99537 -33.552 0 12.468 0 13.5132 0 0 0 0 0 0 0 0 0 0 0 10.223 0 12.8995 0 0 0 0 0 0 0 13.9773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5537 0 0 0 0 0 13.1883 0 0 0 0 0 0 0 12.4035 14.5751 0 0 15.009 0 0 0 0 0 10.0922 0 0 0 0 0 0 0 0 0 0 0 0 15.0209 0 0 0 0 0 0 0 14.0643 0 0 13.0553 0 12.663 0 0 12.7139 13.9891 0 13.1106 0 14.4361 11.6379 12.2456 13.6417 0 0 0 0 11.3712 0 12.2854 0 12.6218 0 0 14.2479 13.1857 0 0 0 0 13.9183 0 13.6215 13.1343 13.4866 0 0 12.903 0 0 12.2251 14.1448 0 0 0 12.0867 13.6914 0 0 13.4057 0 0 0 12.2317 0 0 0 13.1402 0 14.1161 12.5752 0 0 0 15.3385 0 12.9311 0 0 0 0 0 0 0 0 0 13.7953 0 0 0 0 0 14.0609 14.6069 13.8544 0 12.0982 0 0 0 0 O60264 SMCA5_HUMAN "SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5, EC 3.6.4.- (Sucrose nonfermenting protein 2 homolog, hSNF2H)" SMARCA5 SNF2H WCRF135 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; DNA-templated transcription, initiation [GO:0006352]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin assembly [GO:0000183]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CHRAC [GO:0008623]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; site of double-strand break [GO:0035861]; WICH complex [GO:0090535] "ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CHRAC [GO:0008623]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; site of double-strand break [GO:0035861]; WICH complex [GO:0090535]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone octamer slider activity [GO:0140751]; nucleosome binding [GO:0031491]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; DNA-templated transcription, initiation [GO:0006352]; histone H2A phosphorylation [GO:1990164]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin assembly [GO:0000183]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000183; GO:0000793; GO:0001650; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005677; GO:0005721; GO:0005730; GO:0006275; GO:0006281; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0006357; GO:0008094; GO:0008623; GO:0016479; GO:0016589; GO:0016590; GO:0016887; GO:0031062; GO:0031065; GO:0031213; GO:0031491; GO:0031497; GO:0035066; GO:0035861; GO:0044030; GO:0045740; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0090536; GO:0110016; GO:0140658; GO:0140751; GO:1905213; GO:1990164; GO:1990830; GO:2001020 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone octamer slider activity [GO:0140751]; nucleosome binding [GO:0031491]" ADVEKSLPPK 0.99537 -12.169 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.723 17.1362 17.112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.681 0 0 13.9457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5302 0 13.0991 0 0 0 0 14.1246 0 13.9925 0 14.3376 14.5764 12.6873 14.3486 14.4265 19.739 13.592 0 15.0855 13.5177 0 0 0 0 12.8141 0 12.8477 14.2261 14.3049 13.643 0 14.0737 0 13.1241 13.6226 0 0 13.985 0 0 0 14.2408 14.2853 0 0 12.981 0 0 0 0 14.2175 14.3593 14.4795 13.087 13.4842 0 13.2638 14.4151 14.7044 0 13.4508 13.1186 12.2455 13.4271 13.1224 13.6847 13.3628 12.1636 0 14.5839 0 13.3442 0 14.2185 14.3067 13.0539 14.5705 13.7148 0 0 0 0 0 0 0 0 14.4703 0 0 0 0 0 0 0 0 0 0 0 15.0467 0 0 0 0 14.9368 13.1884 13.7448 13.1173 0 0 0 0 0 P53804 TTC3_HUMAN "E3 ubiquitin-protein ligase TTC3, EC 2.3.2.27 (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3, TPR repeat protein 3)" TTC3 DCRR1 RNF105 TPRD Homo sapiens (Human) protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006511; GO:0046872; GO:0070936 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] AIEYRPENYLLYGNR 0.99537 -33.568 0 0 0 0 0 10.5209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2644 0 0 0 0 0 0 11.8665 0 0 0 0 0 0 0 12.4066 12.8116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7411 15.6364 0 15.941 13.9396 0 0 0 14.8238 0 13.2794 14.2043 0 0 0 14.2774 0 0 0 0 0 0 0 0 13.8579 0 14.3758 0 15.4995 0 13.4522 0 0 0 0 0 0 0 0 0 0 15.3028 0 0 0 13.7728 0 0 0 0 11.5444 0 11.9335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9562 0 0 0 16.4337 0 0 0 0 0 0 14.7421 0 0 12.2587 0 0 0 10.6722 0 0 Q12905 ILF2_HUMAN Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa) ILF2 NF45 PRO3063 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724] "extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0003677; GO:0003723; GO:0003725; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0035580; GO:0045893; GO:1904724; GO:1904813; GO:1990904 DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723] AYEKPPEK 0.99537 -9.9285 0 0 0 0 0 0 0 0 15.0781 15.024 0 0 0 0 0 0 0 0 10.198 0 0 0 0 0 0 0 0 0 0 0 10.9321 10.9257 11.2121 0 0 0 12.8188 0 0 0 0 10.8839 0 0 0 10.6169 0 0 0 0 0 0 0 0 0 12.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7641 0 0 0 0 0 0 0 0 0 12.6141 13.7945 0 0 0 13.9836 13.2479 14.2827 0 0 0 0 12.1232 0 0 0 0 12.5197 0 0 0 0 13.1404 0 0 0 0 0 0 12.751 0 0 0 0 0 0 0 0 0 12.6098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5558 0 0 0 13.1858 0 14.0856 12.5209 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VVH5 IKBP1_HUMAN "Interleukin-1 receptor-associated kinase 1-binding protein 1, IRAK1-binding protein 1" IRAK1BP1 Homo sapiens (Human) I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955] GO:0005634; GO:0005737; GO:0006955; GO:0007249 EAAAEAK 0.99537 -10.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3913 0 0 0 0 0 0 0 13.3554 0 0 0 0 14.1434 13.7541 0 0 0 0 0 0 12.8056 0 0 0 0 0 13.3004 0 0 0 0 0 12.0336 13.6603 14.1846 12.7116 0 0 0 13.7405 0 0 13.0588 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.836 0 0 0 13.4981 0 0 0 0 0 0 11.3392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q629K1 TRIQK_HUMAN Triple QxxK/R motif-containing protein (Triple repetitive-sequence of QXXK/R protein homolog) TRIQK C8orf83 Homo sapiens (Human) endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] GO:0005789; GO:0016021 KQIGKQDYK 0.99537 -12.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8707 0 14.8582 13.8336 0 0 0 0 0 0 0 0 0 0 0 0 13.4701 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XI8 ZSWM9_HUMAN Uncharacterized protein ZSWIM9 ZSWIM9 C19orf68 Homo sapiens (Human) DWGGAQFEGEK 0.99537 -33.647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.836 0 0 0 11.3699 11.0464 10.7341 0 0 0 0 0 10.9322 0 15.8038 0 0 0 0 0 0 0 0 15.1775 0 10.4594 0 0 0 12.6425 12.8837 0 0 0 0 0 14.1012 11.1331 15.0686 0 15.3103 14.0351 13.4818 13.4846 14.537 14.3233 14.517 13.6041 15.516 13.5778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4886 0 0 0 0 0 0 0 0 11.6575 0 0 16.7662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7694 0 0 0 0 11.5743 0 0 0 11.5049 0 0 0 0 0 0 0 0 0 13.429 0 0 0 0 12.8355 0 0 0 0 0 0 0 16.163 0 0 15.5645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWF2 FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation) FOXRED2 ERFAD Homo sapiens (Human) ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum lumen [GO:0005788]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0004497; GO:0005788; GO:0030433; GO:0050660 flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497] DVFFDDR 0.99537 -10.348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.073 0 13.3727 12.9745 13.0323 0 0 0 13.0511 13.0687 13.1224 0 0 0 0 0 0 0 0 12.9318 0 0 0 0 0 12.5367 0 0 0 12.3724 0 0 12.4051 0 0 0 14.2621 13.002 0 12.4399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.488 0 13.4875 0 0 0 0 0 0 13.8812 0 0 0 0 0 0 0 0 0 0 11.3505 0 13.551 0 0 0 0 13.6291 0 0 13.1847 0 0 0 0 14.5806 0 0 0 0 0 0 0 0 12.8802 0 13.7582 0 11.073 0 0 11.616 0 16.1139 0 12.9185 12.3899 12.9788 0 14.5214 14.1695 14.2087 13.3849 0 12.6545 0 0 0 0 0 0 0 12.5184 0 0 0 0 0 13.6961 0 0 0 0 0 0 0 0 0 0 0 0 13.0744 0 0 0 18.8392 0 0 0 0 0 0 Q9BSN7 TM204_HUMAN Transmembrane protein 204 (Claudin-like protein 24) TMEM204 C16orf30 CLP24 UNQ6509/PRO21434 Homo sapiens (Human) lymph vessel development [GO:0001945]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; smooth muscle cell differentiation [GO:0051145] adherens junction [GO:0005912]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lymph vessel development [GO:0001945]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; smooth muscle cell differentiation [GO:0051145] GO:0001945; GO:0005886; GO:0005912; GO:0016021; GO:0030947; GO:0051145 GLDNDYVESPC 0.99537 -12.18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPN4 CP131_HUMAN Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1) CEP131 AZI1 KIAA1118 Homo sapiens (Human) cell cycle [GO:0007049]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212] acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288] GO:0001669; GO:0002177; GO:0005813; GO:0005814; GO:0005829; GO:0007049; GO:0007288; GO:0008284; GO:0010824; GO:0015630; GO:0034451; GO:0035735; GO:0035869; GO:0036064; GO:0042803; GO:0043231; GO:0044877; GO:0045171; GO:0060271; GO:0071539; GO:0090316; GO:0120212; GO:1905198; GO:1905515; GO:1990953 protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] AELATLQAR 0.99537 -12.177 0 0 0 0 0 0 0 0 0 0 0 14.3729 0 0 14.2868 0 0 0 0 0 0 0 0 0 13.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7932 0 0 0 0 0 0 0 0 0 0 12.9337 0 0 11.3324 0 13.2522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5988 12.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.368 0 0 0 0 0 0 0 0 0 13.9819 0 0 11.5378 14.9679 0 0 0 14.7747 11.7215 13.3022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95279 KCNK5_HUMAN Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2) KCNK5 TASK2 Homo sapiens (Human) potassium ion export across plasma membrane [GO:0097623]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; potassium ion export across plasma membrane [GO:0097623]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; stabilization of membrane potential [GO:0030322] GO:0005267; GO:0005887; GO:0006813; GO:0015271; GO:0022841; GO:0030322; GO:0034765; GO:0060075; GO:0071805; GO:0097623; GO:1990573 outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841] FFGGRAKR 0.99538 -5.4329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2445 0 0 0 0 0 0 0 0 0 0 10.3094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9148 13.3514 0 13.582 0 0 0 0 0 13.8809 0 0 0 0 15.6227 14.1228 0 0 0 13.8619 0 0 13.9028 0 0 0 0 12.4421 0 0 0 13.8954 12.2284 0 0 0 0 0 0 0 13.9577 0 0 0 12.3032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O96005 CLPT1_HUMAN Putative lipid scramblase CLPTM1 (Cleft lip and palate transmembrane protein 1) CLPTM1 Homo sapiens (Human) cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; GABA receptor binding [GO:0050811]; cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081] GO:0005887; GO:0009897; GO:0016020; GO:0030154; GO:0033081; GO:0050811 GABA receptor binding [GO:0050811] GVLFRIFIIWAISSWFR 0.99538 -5.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2683 13.9904 13.4615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2384 12.7471 12.4248 13.4858 0 0 0 0 0 0 0 14.0022 0 0 0 14.4719 0 0 0 0 15.2495 15.2016 15.2058 0 13.4351 12.6095 0 0 0 0 0 0 13.0387 0 0 0 0 0 13.0612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.985 13.5151 0 0 0 0 0 0 0 0 0 0 0 12.7691 0 0 0 0 0 0 11.2622 0 0 0 0 0 0 P27815 PDE4A_HUMAN "cAMP-specific 3',5'-cyclic phosphodiesterase 4A, EC 3.1.4.53 (DPDE2) (PDE46)" PDE4A DPDE2 Homo sapiens (Human) cAMP catabolic process [GO:0006198]; cellular response to xenobiotic stimulus [GO:0071466]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165] cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; cAMP catabolic process [GO:0006198]; cellular response to xenobiotic stimulus [GO:0071466]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of protein kinase A signaling [GO:0010738]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]" GO:0004114; GO:0004115; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006198; GO:0007165; GO:0007186; GO:0007608; GO:0010738; GO:0016020; GO:0019898; GO:0030552; GO:0032587; GO:0046872; GO:0048471; GO:0071466; GO:0106070 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]" ESFLYRSDSDYDMSPKTMSR 0.99538 -5.4267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13951 PEBB_HUMAN "Core-binding factor subunit beta, CBF-beta (Polyomavirus enhancer-binding protein 2 beta subunit, PEA2-beta, PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit)" CBFB Homo sapiens (Human) "cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" core-binding factor complex [GO:0016513]; membrane [GO:0016020]; nucleoplasm [GO:0005654] "core-binding factor complex [GO:0016513]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000209; GO:0001649; GO:0003713; GO:0005654; GO:0006357; GO:0006366; GO:0016020; GO:0016513; GO:0030098; GO:0030099; GO:0043371; GO:0043378; GO:0043565; GO:0045944; GO:0048469; GO:0060216 sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713] ECEIKYTGFR 0.99538 -5.4471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0625 0 0 0 0 0 0 0 0 0 11.9982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.195 0 0 0 0 0 0 0 0 0 0 Q3SXM0 DC4L1_HUMAN DDB1- and CUL4-associated factor 4-like protein 1 (WD repeat-containing protein 21B) DCAF4L1 WDR21B Homo sapiens (Human) Cul4-RING E3 ubiquitin ligase complex [GO:0080008] Cul4-RING E3 ubiquitin ligase complex [GO:0080008] GO:0080008 GKGWRATR 0.99538 -8.8474 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2427 0 0 0 0 0 0 0 0 0 12.0562 0 0 C9JLR9 ZFTA_HUMAN "Zinc finger translocation-associated protein, ZFTA" ZFTA C11orf95 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" "negative regulation of transcription, DNA-templated [GO:0045892]" GO:0045892 AECLMDYDPR 0.99539 -11.865 0 0 0 0 0 0 0 0 11.4932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6917 0 11.0112 0 0 0 0 0 0 0 11.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7142 0 0 0 0 0 0 0 0 0 12.8092 12.2727 12.6222 12.923 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2175 0 11.9713 0 13.3198 0 11.7238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9139 0 0 0 13.1732 13.2427 0 0 0 11.0824 12.6802 13.2384 0 14.4591 12.8365 0 0 0 0 0 0 0 10.8906 0 O15062 ZBTB5_HUMAN Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" EHMRVVVK 0.99539 -10.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1405 0 0 12.6577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5914 0 0 0 0 12.9786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0481 0 0 0 0 13.6324 0 0 0 0 0 14.4552 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4067 0 0 0 0 0 0 0 0 0 0 0 0 12.5692 12.9364 0 0 0 12.9155 0 O60869 EDF1_HUMAN "Endothelial differentiation-related factor 1, EDF-1 (Multiprotein-bridging factor 1, MBF1)" EDF1 Homo sapiens (Human) "endothelial cell differentiation [GO:0045446]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]; endothelial cell differentiation [GO:0045446]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription, DNA-templated [GO:0006355]" GO:0001094; GO:0003677; GO:0003713; GO:0003723; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006355; GO:0019216; GO:0043388; GO:0045446; GO:0045893 calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713] AIGLKLRGK 0.99539 -8.8699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.954 0 0 0 0 0 0 0 0 0 0 0 16.8944 0 0 0 0 16.3519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8507 15.8279 0 16.045 15.1271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2716 0 0 0 16.3554 0 0 0 16.3287 0 0 0 0 14.4121 0 0 0 0 0 14.7055 14.1515 0 14.1747 0 14.2439 13.207 0 0 14.6279 0 0 0 0 0 0 0 0 14.1566 0 14.088 0 0 0 0 0 0 0 0 0 14.0766 0 0 14.2516 0 0 0 11.5562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75185 AT2C2_HUMAN "Calcium-transporting ATPase type 2C member 2, ATPase 2C2, EC 7.2.2.10 (Ca(2+)/Mn(2+)-ATPase 2C2) (Secretory pathway Ca(2+)-transporting ATPase type 2, SPCA2)" ATP2C2 KIAA0703 SPCA2 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; mammary gland epithelium development [GO:0061180]; manganese ion transport [GO:0006828]; positive regulation of calcium ion import [GO:0090280]; protein localization to plasma membrane [GO:0072659] basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588] basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; mammary gland epithelium development [GO:0061180]; manganese ion transport [GO:0006828]; positive regulation of calcium ion import [GO:0090280]; protein localization to plasma membrane [GO:0072659] GO:0000139; GO:0005388; GO:0005524; GO:0005783; GO:0005886; GO:0006828; GO:0006874; GO:0009898; GO:0015662; GO:0016021; GO:0016323; GO:0016887; GO:0031410; GO:0032588; GO:0034220; GO:0046872; GO:0048471; GO:0061180; GO:0070588; GO:0072659; GO:0090280; GO:0140613 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type ion transporter activity [GO:0015662]; P-type manganese transporter activity [GO:0140613] DTILSRALILK 0.99539 -31.713 14.1921 0 0 11.5699 0 0 0 0 13.373 0 14.7442 0 14.4999 0 14.4566 13.7938 12.5295 0 0 0 0 0 0 12.8284 0 0 0 0 0 13.6822 0 0 12.5971 0 0 0 0 0 12.7656 0 0 0 0 13.3802 0 0 0 12.4867 0 11.581 0 10.904 0 0 0 0 0 0 0 0 0 0 0 0 10.6731 0 14.1356 0 0 14.1206 13.329 0 0 10.2635 0 13.4074 0 0 0 14.3474 0 0 0 0 0 0 0 0 0 15.1038 0 0 0 0 14.1167 0 0 0 10.4636 14.416 0 0 14.7955 13.9353 0 0 0 0 0 0 0 0 15.0167 15.3844 0 0 13.8004 12.1828 0 0 0 0 13.8048 0 14.9031 13.6873 0 14.5137 0 13.4078 0 0 0 11.8762 12.8624 13.047 0 0 13.4226 0 0 0 14.1675 14.07 0 14.1269 0 13.8101 10.9698 0 0 0 0 0 0 0 0 13.9987 0 15.3086 0 0 0 0 14.0441 12.5379 0 11.6035 0 0 14.4035 14.4739 0 0 13.1492 0 0 0 0 0 P0DPE3 TMDD1_HUMAN Transmembrane and death domain protein 1 TMDD1 C12orf81 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; signal transduction [GO:0007165] GO:0007165; GO:0016021 ASPGSPGPLATVQGWWETKLLLPKER 0.99539 -8.8594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3843 11.3506 11.0696 11.7102 0 11.3504 10.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5941 0 0 12.7367 0 0 0 0 0 0 0 0 12.6633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0059 0 0 0 0 0 12.0722 0 0 0 12.9349 0 12.7608 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2746 0 0 0 0 0 12.7513 0 0 0 0 0 0 P10826 RARB_HUMAN "Retinoic acid receptor beta, RAR-beta (HBV-activated protein) (Nuclear receptor subfamily 1 group B member 2) (RAR-epsilon)" RARB HAP NR1B2 Homo sapiens (Human) apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; stem cell proliferation [GO:0072089]; striatum development [GO:0021756]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; embryonic eye morphogenesis [GO:0048048]; embryonic hindlimb morphogenesis [GO:0035116]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hormone-mediated signaling pathway [GO:0009755]; multicellular organism growth [GO:0035264]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384]; signal transduction [GO:0007165]; stem cell proliferation [GO:0072089]; striatum development [GO:0021756]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001657; GO:0002068; GO:0003417; GO:0003677; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0006915; GO:0007165; GO:0008270; GO:0009755; GO:0021756; GO:0022008; GO:0030154; GO:0032331; GO:0035116; GO:0035264; GO:0043065; GO:0045944; GO:0048048; GO:0048384; GO:0048566; GO:0055012; GO:0072089; GO:1990837; GO:2000647 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" CFEVGMSKESVR 0.99539 -8.8833 0 0 0 0 0 0 9.55102 0 0 0 0 0 0 9.87758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7255 13.1932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7523 0 0 0 0 0 0 0 14.4656 14.5853 13.0201 12.5994 13.0586 0 0 0 13.1632 0 0 12.9165 0 0 14.8069 0 11.301 0 0 0 0 0 0 14.5588 0 0 0 0 0 0 0 0 0 13.9558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4897 14.3976 0 0 0 13.9636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5647 0 0 0 0 0 0 12.9728 11.7367 P18825 ADA2C_HUMAN "Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor, Alpha-2C adrenoceptor, Alpha-2CAR)" ADRA2C ADRA2L2 ADRA2RL2 Homo sapiens (Human) activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; receptor transactivation [GO:0035624]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229] cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-2A adrenergic receptor binding [GO:0031694]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of protein kinase B activity [GO:0032148]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adrenergic receptor signaling pathway [GO:0071875]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of norepinephrine secretion [GO:0010700]; platelet activation [GO:0030168]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; receptor transactivation [GO:0035624]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229] GO:0004930; GO:0004938; GO:0005737; GO:0005768; GO:0005886; GO:0005887; GO:0006940; GO:0007186; GO:0007267; GO:0010700; GO:0019229; GO:0030168; GO:0031694; GO:0032148; GO:0032811; GO:0035624; GO:0042803; GO:0043410; GO:0045666; GO:0046982; GO:0051379; GO:0071875; GO:0071880 alpha-2A adrenergic receptor binding [GO:0031694]; alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379]; G protein-coupled receptor activity [GO:0004930]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] ATIVAVWLISAVISFPPLVSLYR 0.99539 -8.8623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5416 12.1184 0 13.2774 14.2628 0 0 14.9076 0 0 0 0 0 0 0 0 14.3617 0 0 0 0 0 13.086 0 0 0 14.3509 0 0 0 13.0929 0 0 0 14.2118 0 0 0 0 14.4221 13.8825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7248 0 0 0 0 11.7777 0 0 0 0 0 0 Q7Z6M4 MTEF4_HUMAN "Transcription termination factor 4, mitochondrial (Mitochondrial transcription termination factor 4) (mTERF domain-containing protein 2) [Cleaved into: mTERF domain-containing protein 2 processed ]" MTERF4 MTERFD2 HSPC096 Homo sapiens (Human) "camera-type eye development [GO:0043010]; heart development [GO:0007507]; mitochondrial transcription [GO:0006390]; protein targeting to mitochondrion [GO:0006626]; regulation of transcription, DNA-templated [GO:0006355]; ribosome assembly [GO:0042255]; rRNA processing [GO:0006364]" cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; double-stranded DNA binding [GO:0003690]; rRNA binding [GO:0019843]; camera-type eye development [GO:0043010]; heart development [GO:0007507]; mitochondrial transcription [GO:0006390]; protein targeting to mitochondrion [GO:0006626]; regulation of transcription, DNA-templated [GO:0006355]; ribosome assembly [GO:0042255]; rRNA processing [GO:0006364]" GO:0003690; GO:0005739; GO:0005759; GO:0005762; GO:0005829; GO:0006355; GO:0006364; GO:0006390; GO:0006626; GO:0007507; GO:0019843; GO:0042255; GO:0043010 double-stranded DNA binding [GO:0003690]; rRNA binding [GO:0019843] EEEESESSTSDDK 0.99539 -12.815 0 0 0 0 0 0 0 0 11.9499 12.6592 0 12.0469 0 11.6032 0 11.1236 0 0 0 12.2625 0 0 0 0 11.5383 0 0 0 11.9089 13.2671 0 11.4588 0 0 0 0 0 0 11.9853 14.4335 0 10.4726 0 0 0 14.5579 0 0 0 0 0 0 13.392 0 0 0 0 0 10.708 0 0 0 0 0 0 11.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0684 0 0 13.855 0 0 0 0 0 0 0 0 0 0 13.4526 0 0 0 0 0 12.7401 0 0 0 0 0 0 0 0 0 0 13.0568 0 0 12.4037 0 0 0 0 0 0 0 0 0 0 0 11.3124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5112 0 0 0 13.3076 0 0 0 0 0 0 0 0 0 0 0 13.4476 13.1577 0 0 13.3247 14.3134 13.1979 14.553 13.2068 13.1698 0 0 0 11.8482 0 0 0 0 14.4633 0 0 Q8N6W0 CELF5_HUMAN "CUGBP Elav-like family member 5, CELF-5 (Bruno-like protein 5) (CUG-BP- and ETR-3-like factor 5) (RNA-binding protein BRUNOL-5)" CELF5 BRUNOL5 Homo sapiens (Human) "mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0036002; GO:1990904 mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] GPDGSSK 0.99539 -8.8785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86361 0 0 0 0 0 0 0 0 0 0 11.8945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9142 0 0 0 0 0 0 11.103 0 0 11.601 0 0 0 0 0 0 11.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4922 10.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NFF5 FAD1_HUMAN "FAD synthase, EC 2.7.7.2 (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region ]" FLAD1 PP591 Homo sapiens (Human) FAD biosynthetic process [GO:0006747]; riboflavin metabolic process [GO:0006771] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; identical protein binding [GO:0042802]; FAD biosynthetic process [GO:0006747]; riboflavin metabolic process [GO:0006771] GO:0003919; GO:0005524; GO:0005759; GO:0005829; GO:0005886; GO:0006747; GO:0006771; GO:0042802 ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; identical protein binding [GO:0042802] DIWDFLR 0.99539 -8.8919 0 0 0 0 0 9.90962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.846 0 0 11.2948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1413 0 9.61809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6626 0 0 0 0 12.9322 0 0 0 0 0 0 0 0 0 12.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NR3 PTHD1_HUMAN Patched domain-containing protein 1 PTCHD1 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; excitatory chemical synaptic transmission [GO:0098976]; inhibitory chemical synaptic transmission [GO:0098977]; long-term memory [GO:0007616]; short-term memory [GO:0007614]; smoothened signaling pathway [GO:0007224]; social behavior [GO:0035176]; thalamus development [GO:0021794] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; excitatory chemical synaptic transmission [GO:0098976]; inhibitory chemical synaptic transmission [GO:0098977]; long-term memory [GO:0007616]; short-term memory [GO:0007614]; smoothened signaling pathway [GO:0007224]; social behavior [GO:0035176]; thalamus development [GO:0021794] GO:0005886; GO:0007224; GO:0007268; GO:0007614; GO:0007616; GO:0016020; GO:0016021; GO:0021794; GO:0035176; GO:0045202; GO:0050890; GO:0098976; GO:0098977 APQFSHFQEDIIFSK 0.99539 -12.82 0 0 0 0 0 0 0 0 0 0 0 12.9736 13.7424 0 0 0 0 0 12.5477 0 0 0 0 0 0 0 11.4243 0 0 0 0 11.7435 12.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4693 14.3661 14.4264 14.3367 0 0 0 13.8936 0 0 0 0 0 0 0 0 0 0 0 13.5434 13.885 12.2543 0 13.8825 13.9984 0 14.1844 14.3964 0 13.9021 0 0 0 0 0 0 0 0 0 0 0 0 13.8195 0 0 13.5542 0 0 0 0 0 0 0 0 0 0 13.5278 0 13.3004 0 0 0 0 0 0 13.8013 0 0 13.0893 0 0 0 0 12.5781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1129 0 13.6417 0 Q9BRP7 FDXA1_HUMAN "Ferredoxin-fold anticodon-binding domain-containing protein 1, FDX-ACDB domain-containing protein 1" FDXACB1 Homo sapiens (Human) rRNA base methylation [GO:0070475] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; rRNA base methylation [GO:0070475] GO:0005737; GO:0070042; GO:0070475 rRNA (uridine-N3-)-methyltransferase activity [GO:0070042] AGVAKNR 0.99539 -5.4632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7361 0 0 0 0 0 0 0 0 0 0 13.1575 0 11.4215 0 0 0 0 0 0 0 11.5749 0 0 0 13.3954 0 0 0 0 0 0 10.3605 14.2963 0 0 0 0 0 0 0 0 0 12.8088 15.1446 0 0 0 0 0 0 0 0 0 0 0 11.2622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB29 ILRL2_HUMAN "Interleukin-1 receptor-like 2, EC 3.2.2.6 (IL-36 receptor, IL-36R) (Interleukin-1 receptor-related protein 2, IL-1Rrp2, IL1R-rp2)" IL1RL2 IL1RRP2 Homo sapiens (Human) cellular defense response [GO:0006968]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T cell differentiation [GO:0045582]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; interleukin-1 receptor activity [GO:0004908]; interleukin-1, type I, activating receptor activity [GO:0004909]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; cellular defense response [GO:0006968]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of T cell differentiation [GO:0045582]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]" GO:0004908; GO:0004909; GO:0005886; GO:0005887; GO:0006954; GO:0006968; GO:0007165; GO:0032755; GO:0045087; GO:0045582; GO:0050135; GO:0050727; GO:0061809 "interleukin-1 receptor activity [GO:0004908]; interleukin-1, type I, activating receptor activity [GO:0004909]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]" DNTNLRCWR 0.99539 -31.784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1264 0 0 0 0 0 13.5354 0 0 0 0 12.8741 0 12.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.601 0 11.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2523 0 10.0104 0 0 0 0 10.8456 0 0 0 0 11.9737 0 0 0 0 0 12.4306 0 0 0 0 0 14.4115 0 0 12.9303 0 0 0 0 0 0 0 0 0 13.4192 0 11.6953 0 0 0 0 11.5376 12.5058 12.5003 0 12.7861 0 0 0 14.0351 0 0 0 0 0 11.4991 0 0 0 0 0 0 0 0 11.3914 0 0 12.5726 0 0 0 0 11.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1775 0 0 0 Q9NP73 ALG13_HUMAN "Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13, EC 2.4.1.141, EC 3.4.19.12 (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) (UDP-N-acetylglucosamine transferase subunit ALG13 homolog)" ALG13 CXorf45 GLT28D1 MDS031 Homo sapiens (Human) proteolysis [GO:0006508] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; cysteine-type deubiquitinase activity [GO:0004843]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723]; proteolysis [GO:0006508] GO:0003723; GO:0004577; GO:0004843; GO:0005789; GO:0006508 cysteine-type deubiquitinase activity [GO:0004843]; N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity [GO:0004577]; RNA binding [GO:0003723] ACVSYMRENQQTFESYVEGSFEK 0.99539 -8.8808 0 0 0 0 0 0 0 0 11.5884 0 0 0 0 0 0 0 12.381 0 0 0 0 0 0 0 13.2038 0 0 0 9.79867 0 0 0 0 0 0 0 11.2696 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6883 13.4665 13.4042 0 13.2507 0 0 13.3247 12.5197 14.6174 0 13.6145 0 11.6851 14.648 14.8485 0 12.8191 0 12.5672 0 0 0 0 0 15.374 12.0989 0 0 0 0 0 12.6762 0 0 0 12.4155 0 0 0 0 12.2107 0 0 0 0 0 0 0 0 0 0 12.2775 0 0 11.5935 12.3796 0 0 0 0 0 0 0 0 0 0 15.2197 12.1603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0175 0 0 0 0 0 0 11.7049 0 0 11.3356 10.9139 0 11.623 0 0 0 0 11.1155 0 0 0 0 0 0 0 0 0 A8MW95 BECN2_HUMAN Beclin-2 (Beclin-1 autophagy-related pseudogene 1) (Beclin-1-like protein 1) BECN2 BECN1L1 BECN1P1 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172]; glucose homeostasis [GO:0042593]; late endosome to vacuole transport [GO:0045324] "phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]" "phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; protein-containing complex binding [GO:0044877]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to nitrogen starvation [GO:0006995]; endosome to lysosome transport [GO:0008333]; G protein-coupled receptor catabolic process [GO:1990172]; glucose homeostasis [GO:0042593]; late endosome to vacuole transport [GO:0045324]" GO:0000045; GO:0000407; GO:0006914; GO:0006995; GO:0008333; GO:0034271; GO:0034272; GO:0042593; GO:0044877; GO:0045324; GO:1990172 protein-containing complex binding [GO:0044877] EPGVTTR 0.9954 -9.5069 9.78467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6853 0 0 0 0 0 0 0 12.705 14.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5339 0 0 0 0 0 0 0 0 0 0 0 0 11.7894 11.6976 0 0 0 0 0 0 0 0 C9JC47 F157A_HUMAN Putative protein FAM157A FAM157A Homo sapiens (Human) DPAPTNFPLR 0.9954 -11.87 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2999 0 10.4513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6672 0 12.9017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7265 0 0 0 0 0 0 0 0 0 0 0 13.2704 13.1039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43151 TET3_HUMAN "Methylcytosine dioxygenase TET3, EC 1.14.11.n2" TET3 KIAA0401 Homo sapiens (Human) 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-K4 trimethylation [GO:0080182]; oxidative demethylation [GO:0070989]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] chromosome [GO:0005694]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634] chromosome [GO:0005694]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]; 5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; DNA demethylation [GO:0080111]; DNA demethylation of male pronucleus [GO:0044727]; histone H3-K4 trimethylation [GO:0080182]; oxidative demethylation [GO:0070989]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493] GO:0001939; GO:0001940; GO:0005634; GO:0005694; GO:0005737; GO:0006211; GO:0006325; GO:0006493; GO:0008270; GO:0008327; GO:0044727; GO:0045944; GO:0070579; GO:0070989; GO:0080111; GO:0080182 methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270] AIRIEKVIYTGK 0.9954 -35.601 0 0 0 0 0 0 0 0 14.8169 12.4953 0 0 0 0 12.8881 12.6148 14.919 12.6234 0 0 0 0 0 14.3441 12.8948 12.5788 12.879 0 12.8306 0 0 12.3848 11.1035 0 0 0 0 0 0 10.8166 12.6563 13.4674 0 11.2138 0 0 0 0 11.9112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1952 0 0 0 0 11.8824 13.5725 13.5746 13.3302 14.5186 14.6104 13.9643 15.4563 12.463 0 12.3561 0 0 14.6902 15.0596 13.3157 14.17 12.8624 13.7934 15.6173 15.431 12.7608 0 0 14.0069 13.4015 0 0 13.9122 13.243 0 0 0 0 13.5872 14.4795 13.5199 0 0 14.167 0 12.7828 0 13.1236 12.8335 0 0 13.8149 13.87 0 0 15.0661 0 13.9584 13.6646 0 0 0 9.89052 13.5325 10.3404 0 0 14.7105 11.2849 14.0247 13.1909 13.5937 14.6194 15.2084 0 14.6156 13.5893 0 0 0 14.3981 14.4103 0 0 13.8963 0 0 0 0 0 0 0 0 13.3571 0 0 0 0 11.028 0 0 13.6821 0 0 13.9038 13.2401 0 0 11.2706 0 P19801 AOC1_HUMAN "Amiloride-sensitive amine oxidase [copper-containing], DAO, Diamine oxidase, EC 1.4.3.22 (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase, KAO)" AOC1 ABP1 DAO1 Homo sapiens (Human) amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to heparin [GO:0071504]; cellular response to histamine [GO:0071420]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677] bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580] "bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]; amine metabolic process [GO:0009308]; cellular response to azide [GO:0097185]; cellular response to copper ion [GO:0071280]; cellular response to copper ion starvation [GO:0035874]; cellular response to heparin [GO:0071504]; cellular response to histamine [GO:0071420]; putrescine metabolic process [GO:0009445]; response to antibiotic [GO:0046677]" GO:0005507; GO:0005509; GO:0005576; GO:0005615; GO:0005777; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0008270; GO:0009308; GO:0009445; GO:0035580; GO:0035874; GO:0042803; GO:0044877; GO:0046677; GO:0048038; GO:0052597; GO:0052598; GO:0052599; GO:0052600; GO:0070062; GO:0071280; GO:0071420; GO:0071504; GO:0097185 "calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; methylputrescine oxidase activity [GO:0052599]; primary amine oxidase activity [GO:0008131]; propane-1,3-diamine oxidase activity [GO:0052600]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; quinone binding [GO:0048038]; zinc ion binding [GO:0008270]" ALCLFEMPTGVPLRR 0.9954 -5.4894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2323 0 14.9707 0 0 0 0 0 0 14.1048 0 0 0 12.4703 0 0 0 0 0 15.1413 11.1113 0 0 0 0 0 0 0 0 0 0 0 0 14.4608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6295 0 0 0 0 0 0 0 0 0 11.4961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8272 0 0 0 0 0 0 0 0 0 0 0 0 12.9312 11.2801 0 0 0 0 0 0 0 0 0 0 16.2906 0 0 15.7297 0 0 0 0 0 0 0 0 0 0 0 0 15.8147 0 0 P46695 IEX1_HUMAN "Radiation-inducible immediate-early gene IEX-1 (Differentiation-dependent gene 2 protein, Protein DIF-2) (Immediate early protein GLY96) (Immediate early response 3 protein) (PACAP-responsive gene 1 protein, Protein PRG1)" IER3 DIF2 IEX1 PRG1 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of response to DNA damage stimulus [GO:2001020] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634] cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; regulation of response to DNA damage stimulus [GO:2001020] GO:0005634; GO:0005829; GO:0006915; GO:0009653; GO:0016021; GO:0043066; GO:2001020 VLYPRVVRR 0.9954 -5.4985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2696 0 0 0 0 0 0 0 15.0532 0 0 0 0 0 0 0 0 0 0 14.9184 0 0 0 13.8822 0 0 0 14.4601 14.8158 0 0 0 0 0 0 0 0 0 14.5665 0 0 0 14.6316 0 0 0 14.438 14.1843 14.3718 0 14.6495 0 13.9938 0 14.4549 14.1707 14.2072 0 0 0 0 14.0083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6987 0 13.9926 0 0 0 0 0 Q09328 MGT5A_HUMAN "Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A, EC 2.4.1.155 (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V, GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V, Secreted GNT-V) ]" MGAT5 GGNT5 Homo sapiens (Human) negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] "extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082]" GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0016021; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1903614; GO:1904894 "alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]" ALFTPWK 0.9954 -5.4896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1391 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7302 0 0 0 13.4866 0 0 0 0 0 0 0 13.4644 0 12.5651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5201 0 0 0 0 0 0 0 0 12.2466 11.7111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7299 0 0 0 0 0 0 0 14.2657 14.2046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2122 15.2166 0 0 0 0 0 0 0 0 0 0 0 14.9296 13.3791 13.1274 Q15722 LT4R1_HUMAN "Leukotriene B4 receptor 1, LTB4-R 1, LTB4-R1 (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7, P2Y7)" LTB4R BLT BLT1 BLTR CMKRL1 GPR16 P2RY7 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; muscle contraction [GO:0006936]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; nucleotide binding [GO:0000166]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; muscle contraction [GO:0006936]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] GO:0000166; GO:0001632; GO:0004974; GO:0005886; GO:0005887; GO:0006936; GO:0006954; GO:0006955; GO:0007186; GO:0007200; GO:0007218; GO:0008528 G protein-coupled peptide receptor activity [GO:0008528]; leukotriene B4 receptor activity [GO:0001632]; leukotriene receptor activity [GO:0004974]; nucleotide binding [GO:0000166] ALAGQAAGLGLVGKRLSLAR 0.9954 -8.9358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92879 CELF1_HUMAN "CUGBP Elav-like family member 1, CELF-1 (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1, CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog, EDEN-BP homolog) (RNA-binding protein BRUNOL-2)" CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 Homo sapiens (Human) "embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; post-transcriptional gene silencing [GO:0016441]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of inflammatory response [GO:0050727]; regulation of RNA splicing [GO:0043484]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinucleolar compartment [GO:0097356]; ribonucleoprotein complex [GO:1990904] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinucleolar compartment [GO:0097356]; ribonucleoprotein complex [GO:1990904]; BRE binding [GO:0042835]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splice site selection [GO:0006376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; post-transcriptional gene silencing [GO:0016441]; post-transcriptional gene silencing by RNA [GO:0035194]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of inflammatory response [GO:0050727]; regulation of RNA splicing [GO:0043484]" GO:0000381; GO:0000900; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0006376; GO:0006397; GO:0007281; GO:0008285; GO:0009792; GO:0010494; GO:0010628; GO:0010629; GO:0010942; GO:0016020; GO:0016441; GO:0035194; GO:0036002; GO:0042835; GO:0043484; GO:0050727; GO:0061157; GO:0097356; GO:1990904 BRE binding [GO:0042835]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] GCAFVTFTTR 0.9954 -5.4883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6705 0 0 0 0 0 0 0 0 0 0 0 15.1057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JS3 PGBD1_HUMAN PiggyBac transposable element-derived protein 1 (Cerebral protein 4) PGBD1 hucep-4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] membrane [GO:0016020] "membrane [GO:0016020]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; scavenger receptor activity [GO:0005044]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005044; GO:0006357; GO:0016020; GO:0042802 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; scavenger receptor activity [GO:0005044]" ACNPGASLDPLDFR 0.9954 -10.024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1669 0 0 0 0 0 0 0 0 0 0 0 12.6024 0 12.6241 0 0 0 12.4137 0 0 0 0 11.8598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6589 0 0 0 0 0 0 0 0 0 13.5909 0 11.9401 0 11.9452 0 0 0 0 0 0 0 0 0 14.3551 0 11.5393 0 0 0 0 10.6612 0 0 0 0 13.4924 0 0 0 0 0 0 0 0 0 0 0 12.3288 10.8015 0 0 13.6959 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0945 0 0 13.0676 0 0 0 12.8173 0 0 0 0 0 0 0 0 0 0 13.152 0 0 0 0 0 0 0 0 0 14.4869 Q9BRQ8 FSP1_HUMAN "Ferroptosis suppressor protein 1, FSP1, EC 1.6.5.- (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death, AMID) (p53-responsive gene 3 protein)" AIFM2 AMID PRG3 Homo sapiens (Human) apoptotic mitochondrial changes [GO:0008637]; negative regulation of ferroptosis [GO:0110076]; positive regulation of apoptotic process [GO:0043065]; regulation of cellular response to oxidative stress [GO:1900407]; ubiquinone metabolic process [GO:0006743] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; apoptotic mitochondrial changes [GO:0008637]; negative regulation of ferroptosis [GO:0110076]; positive regulation of apoptotic process [GO:0043065]; regulation of cellular response to oxidative stress [GO:1900407]; ubiquinone metabolic process [GO:0006743]" GO:0003677; GO:0004174; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005811; GO:0005829; GO:0005886; GO:0006743; GO:0008637; GO:0016021; GO:0016655; GO:0043065; GO:0050660; GO:0110076; GO:1900407 "DNA binding [GO:0003677]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]" AFESRLASSGALR 0.9954 -10.023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.745 0 0 0 0 0 0 0 0 0 0 0 0 0 13.007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2052 0 13.5983 0 12.9421 0 0 0 0 14.5987 13.1218 0 0 0 0 0 0 0 0 0 0 11.7972 0 Q9BSH4 TACO1_HUMAN Translational activator of cytochrome c oxidase 1 (Coiled-coil domain-containing protein 44) (Translational activator of mitochondrially-encoded cytochrome c oxidase I) TACO1 CCDC44 PRO0477 Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617]; motor learning [GO:0061743]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of mitochondrial translation [GO:0070129] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; motor learning [GO:0061743]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of mitochondrial translation [GO:0070129] GO:0003729; GO:0005739; GO:0019843; GO:0033617; GO:0061743; GO:0070129; GO:0097177; GO:1904959 mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843] AAPPRDPR 0.9954 -9.5029 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2582 0 0 0 0 0 11.8393 0 0 0 0 13.8298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7115 13.571 13.6373 13.6756 0 14.4744 0 0 0 0 0 13.3061 13.2305 0 0 13.3566 0 0 0 0 0 0 0 0 0 0 14.6461 13.4788 0 0 0 0 0 13.1062 0 0 0 0 13.7799 0 0 14.9403 0 0 0 0 14.697 0 0 0 0 0 0 0 13.043 0 0 0 0 0 13.1664 0 0 0 0 0 0 0 0 12.7136 0 0 0 13.2022 11.9846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0913 0 0 0 0 0 0 0 15.2479 0 0 0 Q9HCY8 S10AE_HUMAN "Protein S100-A14 (S100 calcium-binding protein A14, S114)" S100A14 S100A15 Homo sapiens (Human) apoptotic process [GO:0006915]; calcium ion homeostasis [GO:0055074]; defense response to bacterium [GO:0042742]; positive regulation of granulocyte chemotaxis [GO:0071624]; positive regulation of monocyte chemotaxis [GO:0090026]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; chemokine receptor binding [GO:0042379]; apoptotic process [GO:0006915]; calcium ion homeostasis [GO:0055074]; defense response to bacterium [GO:0042742]; positive regulation of granulocyte chemotaxis [GO:0071624]; positive regulation of monocyte chemotaxis [GO:0090026]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142] GO:0005509; GO:0005615; GO:0006915; GO:0032496; GO:0034142; GO:0042379; GO:0042742; GO:0048306; GO:0048471; GO:0055074; GO:0070062; GO:0071624; GO:0090026 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; chemokine receptor binding [GO:0042379] SVKLERPVR 0.9954 -5.4985 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4G8 RPGF2_HUMAN "Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF, CNrasGEF) (Neural RAP guanine nucleotide exchange protein, nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1, PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1)" RAPGEF2 KIAA0313 NRAPGEP PDZGEF1 Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; WW domain binding [GO:0050699]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; blood vessel development [GO:0001568]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; cAMP-mediated signaling [GO:0019933]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; establishment of endothelial intestinal barrier [GO:0090557]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; microvillus assembly [GO:0030033]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of melanin biosynthetic process [GO:0048022]; nerve growth factor signaling pathway [GO:0038180]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; Ras protein signal transduction [GO:0007265]; regulation of cell junction assembly [GO:1901888]; regulation of synaptic plasticity [GO:0048167]; small GTPase mediated signal transduction [GO:0007264]; ventricular system development [GO:0021591] GO:0000165; GO:0001568; GO:0001764; GO:0005085; GO:0005096; GO:0005509; GO:0005737; GO:0005770; GO:0005829; GO:0005886; GO:0005887; GO:0005911; GO:0005923; GO:0007186; GO:0007218; GO:0007264; GO:0007265; GO:0008285; GO:0010976; GO:0016020; GO:0016324; GO:0019933; GO:0019992; GO:0021591; GO:0021884; GO:0030033; GO:0030139; GO:0030165; GO:0030552; GO:0031175; GO:0031547; GO:0031697; GO:0032092; GO:0032486; GO:0032991; GO:0035556; GO:0038180; GO:0043005; GO:0043025; GO:0043547; GO:0043950; GO:0045202; GO:0045860; GO:0048022; GO:0048167; GO:0048471; GO:0050699; GO:0050774; GO:0061028; GO:0070300; GO:0070374; GO:0071320; GO:0071321; GO:0071880; GO:0072659; GO:0090557; GO:1901888; GO:1990090; GO:2000481; GO:2000670; GO:2001214; GO:2001224 beta-1 adrenergic receptor binding [GO:0031697]; calcium ion binding [GO:0005509]; cAMP binding [GO:0030552]; diacylglycerol binding [GO:0019992]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; phosphatidic acid binding [GO:0070300]; WW domain binding [GO:0050699] ETNQLKRMK 0.9954 -11.869 0 0 0 11.5375 0 0 0 0 0 0 0 0 0 0 13.3371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9834 0 0 0 0 0 0 0 0 10.9979 0 0 0 0 0 13.5848 0 13.8243 14.2334 13.3357 0 0 0 0 0 0 12.6001 14.1071 0 0 12.6272 12.374 0 12.8708 0 0 0 0 0 0 0 0 12.6415 12.3549 0 0 0 0 0 12.2409 12.0514 12.4286 0 0 0 0 0 0 0 12.2392 0 0 0 0 0 0 0 12.7538 0 0 0 0 0 0 0 11.1594 0 13.0564 12.9671 0 13.6282 0 0 0 0 0 0 0 0 11.1587 0 0 0 0 12.6121 0 11.7743 0 0 0 0 0 0 13.6176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02556 IRF8_HUMAN "Interferon regulatory factor 8, IRF-8 (Interferon consensus sequence-binding protein, H-ICSBP, ICSBP)" IRF8 ICSBP1 Homo sapiens (Human) autophagy [GO:0006914]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; dendritic cell differentiation [GO:0097028]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; immune response [GO:0006955]; immune system process [GO:0002376]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phagocytosis [GO:0006909]; plasmacytoid dendritic cell differentiation [GO:0002273]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type I interferon production [GO:0032479] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; autophagy [GO:0006914]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; dendritic cell differentiation [GO:0097028]; follicular B cell differentiation [GO:0002316]; germinal center B cell differentiation [GO:0002314]; immune response [GO:0006955]; immune system process [GO:0002376]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phagocytosis [GO:0006909]; plasmacytoid dendritic cell differentiation [GO:0002273]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type I interferon production [GO:0032479]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0002273; GO:0002314; GO:0002316; GO:0002376; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006909; GO:0006914; GO:0006955; GO:0030099; GO:0032479; GO:0032729; GO:0032735; GO:0042742; GO:0042832; GO:0045944; GO:0071222; GO:0071346; GO:0097028; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" DEVVQVFDTSQFFR 0.99541 -12.549 0 0 0 0 0 0 0 0 0 11.5028 12.42 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7926 0 0 11.6806 0 0 0 0 0 11.22 0 0 0 0 12.158 0 0 0 0 0 0 0 0 0 0 0 11.1214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0784 0 0 14.2222 0 0 0 0 0 0 15.4001 0 13.8447 0 0 0 0 0 0 0 0 0 0 10.9805 0 15.4103 0 0 0 0 0 0 0 14.798 0 0 0 0 0 0 0 0 0 0 0 12.8903 12.8844 12.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96867 0 0 0 0 0 0 0 0 10.8709 0 0 0 0 12.4048 0 0 12.0417 0 0 0 0 0 0 0 0 0 0 10.2087 0 0 0 0 0 12.6719 0 0 Q9UK80 UBP21_HUMAN "Ubiquitin carboxyl-terminal hydrolase 21, EC 3.4.19.12 (Deubiquitinating enzyme 21) (Ubiquitin thioesterase 21) (Ubiquitin-specific-processing protease 21)" USP21 USP23 PP1490 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; deNEDDylase activity [GO:0019784]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0003713; GO:0004843; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006511; GO:0008234; GO:0016578; GO:0016579; GO:0019784; GO:0045893; GO:0046872 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; deNEDDylase activity [GO:0019784]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713] EEELESENAPVCDRCR 0.99541 -8.9567 0 0 14.0872 0 0 0 0 0 11.9129 12.6258 0 13.0876 0 0 12.2029 0 0 0 0 0 0 15.7252 0 13.1088 9.83561 0 12.6953 0 0 12.0705 12.0725 0 12.1677 0 0 0 12.6312 0 0 0 0 0 0 11.5326 0 12.6138 0 0 0 0 0 0 0 0 0 0 0 0 12.2218 0 0 0 0 0 0 0 16.8226 16.8571 0 15.8837 0 0 0 17.741 13.1784 15.6876 0 15.5284 15.5624 16.0254 17.0536 16.5274 16.0003 15.9188 15.9912 17.3736 15.8523 16.0024 16.8214 0 16.0135 15.8837 17.6194 16.3374 17.0982 15.7614 15.774 16.1708 16.2458 16.0076 17.1098 15.8537 15.5986 15.6842 15.6755 15.8407 0 15.6386 14.9001 14.5575 16.3395 15.656 16.4329 14.9734 15.0446 15.9465 13.8612 11.9708 15.6568 0 16.3851 15.9987 16.5623 15.6255 15.5497 15.7126 15.9564 16.1441 16.109 0 15.5543 16.7191 15.7317 15.3514 16.5117 15.7348 19.2397 16.7997 15.6552 0 15.8372 0 0 0 13.7678 0 15.6708 0 0 0 15.4831 14.7811 15.1391 16.9556 16.5118 0 15.199 0 16.9769 0 0 17.2515 12.4 15.8424 0 0 0 0 0 0 15.622 15.9573 16.4219 15.6304 0 0 16.4753 0 15.0296 0 A6NEQ2 F181B_HUMAN Protein FAM181B FAM181B Homo sapiens (Human) KSPLTAPR 0.99541 -8.9467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5505 0 12.9898 13.2788 13.7922 13.5448 12.1051 11.2371 0 0 11.3706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4936 14.682 0 13.7051 14.8103 0 0 0 0 0 0 0 0 14.7261 0 14.0697 0 0 A6NJZ3 O6C65_HUMAN Olfactory receptor 6C65 OR6C65 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KILSLNKQ 0.99541 -11.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60602 TLR5_HUMAN Toll-like receptor 5 (Toll/interleukin-1 receptor-like protein 3) TLR5 TIL3 Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; toll-like receptor 5 signaling pathway [GO:0034146]; toll-like receptor signaling pathway [GO:0002224] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; interleukin-1 receptor binding [GO:0005149]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; cellular response to mechanical stimulus [GO:0071260]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of toll-like receptor signaling pathway [GO:0034123]; toll-like receptor 5 signaling pathway [GO:0034146]; toll-like receptor signaling pathway [GO:0002224] GO:0002224; GO:0002755; GO:0004888; GO:0005149; GO:0005886; GO:0005887; GO:0006954; GO:0032757; GO:0034123; GO:0034146; GO:0038023; GO:0042742; GO:0045087; GO:0071260 interleukin-1 receptor binding [GO:0005149]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] FRGFCFICYK 0.99541 -11.996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8335 0 0 0 0 0 14.5313 0 0 0 0 0 0 13.9566 0 0 0 0 0 0 0 0 0 10.7329 0 0 0 0 0 0 0 0 12.5441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9704 0 12.7469 0 13.4668 0 0 0 0 0 0 0 12.4673 0 0 12.7846 0 0 0 12.4868 0 12.4935 0 0 0 0 0 11.4447 0 0 0 0 0 0 0 0 0 0 0 12.6353 0 0 0 0 0 0 0 0 0 0 0 O76021 RL1D1_HUMAN Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1) RSL1D1 CATX11 CSIG PBK1 L12 Homo sapiens (Human) maturation of LSU-rRNA [GO:0000470]; osteoblast differentiation [GO:0001649]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880] 90S preribosome [GO:0030686]; chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730] 90S preribosome [GO:0030686]; chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; osteoblast differentiation [GO:0001649]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880] GO:0000470; GO:0001649; GO:0003723; GO:0003730; GO:0005694; GO:0005730; GO:0016020; GO:0030686; GO:0032880; GO:0042981; GO:0045296; GO:0048027; GO:2000772 cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723] ELRVRLTLPHSIR 0.99541 -12.538 0 11.6086 0 0 0 0 13.0131 0 0 0 0 0 0 13.0797 0 0 11.3288 11.7465 11.1878 13.3963 0 0 0 13.2581 11.2895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1907 12.904 0 0 0 12.7459 0 0 12.8754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.893 12.5202 0 0 0 0 0 0 0 0 0 0 12.8373 12.724 12.8763 0 15.0085 0 0 0 0 15.8812 0 13.2083 0 0 0 0 0 0 12.2485 13.0229 12.9215 0 14.6849 0 0 0 14.2809 15.6376 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7902 0 0 0 13.0636 12.9428 0 12.0107 0 14.2048 0 0 0 0 0 0 0 12.8268 0 0 0 0 0 0 0 0 0 14.1601 0 0 12.9109 0 0 0 0 0 0 0 0 0 0 0 12.6354 0 0 12.7007 12.9296 13.2061 0 0 12.4025 0 0 0 0 12.8121 0 12.6312 0 0 P29144 TPP2_HUMAN "Tripeptidyl-peptidase 2, TPP-2, EC 3.4.14.10 (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II, TPP-II)" TPP2 Homo sapiens (Human) amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508] GO:0000209; GO:0004175; GO:0004177; GO:0004252; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0008240; GO:0016604; GO:0042802; GO:0080144 aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240] ETGAASFLCR 0.99541 -12.538 0 0 0 0 0 0 0 0 0 0 11.2457 0 0 0 0 0 0 0 0 12.0913 0 0 10.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0331 0 0 10.4471 0 0 0 0 0 0 0 0 0 0 0 10.9201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2883 0 0 13.7851 0 0 10.7773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1685 Q13042 CDC16_HUMAN "Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6, APC6) (CDC16 homolog, CDC16Hs) (Cyclosome subunit 6)" CDC16 ANAPC6 Homo sapiens (Human) anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654] anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346] GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0051445; GO:0070979; GO:0072686 FLFENKLKK 0.99541 -11.99 0 0 0 0 0 0 0 0 0 0 13.4964 0 0 0 0 0 0 0 0 0 0 0 0 12.8859 0 0 0 0 0 14.3632 0 0 0 13.063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5772 12.456 0 0 0 0 0 0 14.4477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4271 0 0 0 0 10.7139 0 0 9.99577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0835 0 0 0 0 0 0 0 0 0 0 13.6794 0 0 13.8681 0 0 0 0 0 0 13.3042 0 0 0 0 0 0 13.5254 0 0 0 0 0 0 13.8365 0 0 Q5BKZ1 ZN326_HUMAN DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs and DBC1) ZNF326 ZIRD Homo sapiens (Human) "mRNA processing [GO:0006397]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" GO:0000993; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016363; GO:0032784; GO:0043231; GO:0043484; GO:0044609; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993] DFEDDYTHSACR 0.99541 -11.977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4341 0 0 0 0 12.9891 0 0 0 0 11.8782 0 0 12.112 0 0 12.2836 0 0 0 0 0 0 0 0 0 13.4427 0 0 0 0 0 14.48 0 0 0 10.2457 14.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.93 0 0 0 0 13.4585 0 0 0 13.0625 0 14.412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0759 0 0 0 0 0 0 0 0 0 0 0 0 Q6DT37 MRCKG_HUMAN "Serine/threonine-protein kinase MRCK gamma, EC 2.7.11.1 (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma, MRCK gamma, MRCKG, Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha)" CDC42BPG DMPK2 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829] cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0018107; GO:0031032; GO:0031252; GO:0031532; GO:0034451; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AEWVQTVPLKK 0.99541 -11.957 0 0 10.8476 0 0 0 0 11.022 0 12.2247 12.1479 10.5681 0 0 0 0 0 0 0 0 0 0 14.0089 0 0 0 0 10.7819 0 0 11.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2873 10.3648 0 12.0891 0 0 14.4865 0 0 0 0 0 0 12.7996 0 0 0 13.5223 0 13.1125 0 0 10.6486 0 0 0 0 11.9785 0 0 0 0 0 0 0 0 0 0 0 0 13.0357 0 0 0 0 0 0 0 0 12.3964 12.9391 13.4457 11.5145 0 0 0 0 0 0 0 12.902 0 10.5126 12.4549 0 0 12.6138 13.1878 0 0 0 0 12.9547 12.3055 0 0 12.7828 10.9523 0 0 0 0 0 0 11.7317 0 0 13.3982 0 0 0 0 0 0 12.8168 0 0 13.3276 0 11.8544 0 0 12.1531 0 13.1327 0 11.6905 12.5254 0 0 0 0 12.6509 0 0 0 0 0 0 0 Q9NP64 ZCC17_HUMAN "Zinc finger CCHC domain-containing protein 17 (Nucleolar protein of 40 kDa, pNO40) (Pnn-interacting nucleolar protein) (Putative S1 RNA-binding domain protein, PS1D protein)" ZCCHC17 PS1D HSPC243 HSPC251 LDC4 Homo sapiens (Human) RNA stabilization [GO:0043489] cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730] cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; RNA stabilization [GO:0043489] GO:0003723; GO:0005730; GO:0008270; GO:0022625; GO:0042802; GO:0043489 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270] DLDPNNVIIEQEERRR 0.99541 -11.986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.039 0 0 0 12.8318 0 0 12.6942 0 0 0 0 0 0 12.6249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MV72 YH009_HUMAN Putative UPF0607 protein ENSP00000382826 Homo sapiens (Human) cytoplasm [GO:0005737]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] GO:0005509; GO:0005615; GO:0005737; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306] AAGHRSR 0.99542 -9.8382 0 13.1777 0 0 0 0 0 0 0 0 0 0 0 11.5011 13.858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2817 0 13.393 0 0 0 0 0 0 13.3749 13.7239 0 0 12.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.573 0 0 0 0 0 13.4379 0 0 0 0 0 0 12.122 12.1737 0 0 0 0 0 0 0 0 0 0 11.701 0 11.7026 0 0 0 0 0 0 0 10.6787 0 0 0 0 0 0 0 P35659 DEK_HUMAN Protein DEK DEK Homo sapiens (Human) chromatin remodeling [GO:0006338]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079] B-WICH complex [GO:0110016]; contractile fiber [GO:0043292]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] B-WICH complex [GO:0110016]; contractile fiber [GO:0043292]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723]; chromatin remodeling [GO:0006338]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; transcription by RNA polymerase II [GO:0006366]; viral genome replication [GO:0019079] GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006357; GO:0006366; GO:0007165; GO:0019079; GO:0035066; GO:0042393; GO:0043292; GO:0045943; GO:0045944; GO:0045945; GO:0110016; GO:2000779; GO:2001032 DNA binding [GO:0003677]; histone binding [GO:0042393]; RNA binding [GO:0003723] ATSKSKK 0.99542 -33.542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.142 0 10.3748 13.8794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7468 0 13.425 0 0 10.1835 0 12.0079 0 13.565 0 0 13.0512 0 0 0 13.6545 13.1042 0 0 0 0 0 0 0 0 0 0 12.9089 0 0 0 0 0 9.96809 9.88985 0 0 12.0472 12.5073 12.3685 13.6587 0 13.4108 0 0 0 0 0 17.211 0 0 0 0 0 10.7399 0 0 0 0 0 0 13.719 17.261 12.2521 0 13.0869 0 0 13.0507 0 0 0 11.0107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6295 11.4955 0 0 0 0 0 0 0 0 Q14678 KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein) KANK1 ANKRD15 KANK KIAA0172 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell population proliferation [GO:0008283]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; podocyte cell migration [GO:0090521]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023] GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0008013; GO:0008283; GO:0010977; GO:0030036; GO:0030177; GO:0030336; GO:0030837; GO:0032587; GO:0035023; GO:0035024; GO:0046627; GO:0090263; GO:0090303; GO:0090521; GO:1900025; GO:1900028; GO:2000114; GO:2000393 beta-catenin binding [GO:0008013] ALTSKDMRFCLNTLQHEWFR 0.99542 -11.655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0966 0 0 0 14.2513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2358 13.4566 0 0 0 0 0 0 0 13.57 0 0 0 0 0 0 12.7118 0 0 0 14.4363 0 13.7557 0 0 0 0 13.9148 0 13.9354 0 13.9796 14.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JTW2 CEP78_HUMAN "Centrosomal protein of 78 kDa, Cep78" CEP78 C9orf81 Homo sapiens (Human) cilium organization [GO:0044782] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; cilium organization [GO:0044782] GO:0005813; GO:0005814; GO:0005829; GO:0036064; GO:0044782 ALKGCLSISSVLK 0.99542 -33.644 12.3981 13.1342 0 0 0 0 0 15.6023 16.5434 15.4517 15.9052 16.1563 16.1365 0 16.3706 16.4276 0 0 0 0 0 0 0 0 0 0 13.4848 16.0531 0 15.8318 0 0 15.2596 15.7183 0 0 0 16.1716 0 13.7368 16.3097 14.954 14.5278 0 15.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7905 13.8628 0 0 0 0 14.5606 15.5186 15.5573 15.3536 0 14.2684 0 14.7654 14.525 0 0 0 13.2441 14.9205 14.9891 0 14.2562 0 0 14.5967 0 0 0 13.1536 0 11.1081 0 0 0 14.4651 0 0 0 0 0 0 0 0 0 0 0 0 14.4334 0 14.7115 0 12.8273 11.3814 0 13.8705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2958 0 0 0 0 0 13.4715 14.3801 0 17.6634 0 0 0 0 0 0 11.066 11.4872 0 0 0 13.0901 14.6972 0 0 0 0 0 15.9127 Q7Z4H4 ADM2_HUMAN "Protein ADM2 (Intermedin) [Cleaved into: Adrenomedullin-2, AM2 (Intermedin-long, IMDL); Intermedin-short, IMDS ]" ADM2 AM2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; digestion [GO:0007586]; feeding behavior [GO:0007631]; negative regulation of blood pressure [GO:0045776]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate [GO:0010460]; protein phosphorylation [GO:0006468]; regulation of systemic arterial blood pressure [GO:0003073] extracellular region [GO:0005576] extracellular region [GO:0005576]; hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; digestion [GO:0007586]; feeding behavior [GO:0007631]; negative regulation of blood pressure [GO:0045776]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of heart rate [GO:0010460]; protein phosphorylation [GO:0006468]; regulation of systemic arterial blood pressure [GO:0003073] GO:0001525; GO:0003073; GO:0005179; GO:0005576; GO:0006468; GO:0007189; GO:0007586; GO:0007631; GO:0010460; GO:0010628; GO:0044877; GO:0045766; GO:0045776 hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877] PVVWKLHR 0.99542 -10.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H9E1 ANRA2_HUMAN Ankyrin repeat family A protein 2 (RFXANK-like protein 2) ANKRA2 ANKRA Homo sapiens (Human) regulation of gene expression [GO:0010468]; regulation of protein-containing complex assembly [GO:0043254] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625]; regulation of gene expression [GO:0010468]; regulation of protein-containing complex assembly [GO:0043254] GO:0005634; GO:0005829; GO:0005856; GO:0010468; GO:0016020; GO:0019901; GO:0031625; GO:0032991; GO:0042826; GO:0043254; GO:0050750 histone deacetylase binding [GO:0042826]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; ubiquitin protein ligase binding [GO:0031625] GYTDIVK 0.99542 -10.307 0 0 0 0 0 0 0 0 0 12.078 0 0 0 12.7166 17.3638 17.5814 17.4651 17.6531 0 13.4059 0 0 12.5593 0 13.1549 14.4748 14.8672 13.1897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5345 13.3494 13.0323 0 17.705 14.1757 17.6453 0 0 0 0 0 14.3078 0 0 15.6363 14.025 13.9286 12.8187 17.2864 0 12.7907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6499 16.6538 0 0 16.0152 0 0 0 16.2181 16.5805 16.5141 0 0 0 0 16.1438 0 0 0 16.6505 0 0 0 0 0 0 0 0 15.253 0 0 0 0 0 0 0 0 0 16.1943 0 14.0796 0 0 0 0 16.5919 0 0 0 0 0 0 0 0 0 14.2718 0 14.1629 14.1223 13.9814 0 0 0 0 0 19.5045 19.5235 14.1364 0 0 Q9UL16 CFA45_HUMAN Cilia- and flagella-associated protein 45 (Coiled-coil domain-containing protein 19) (Nasopharyngeal epithelium-specific protein 1) CFAP45 CCDC19 NESG1 Homo sapiens (Human) cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] 9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AMP binding [GO:0016208]; cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] GO:0005576; GO:0005634; GO:0005654; GO:0005879; GO:0005930; GO:0016208; GO:0030317; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0097729 AMP binding [GO:0016208] AQDYQAEQDALRAK 0.99542 -9.8534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.77781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2903 0 0 0 10.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0023 0 0 0 0 0 0 0 0 0 0 0 Q5VYK3 ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog) ECPAS ECM29 KIAA0368 Homo sapiens (Human) proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502] centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0030433; GO:0031410; GO:0043248; GO:0060090; GO:0070628 molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628] ALSINTLVKISKSAGAMLK 0.99543 -10.32 0 14.8141 0 0 13.4388 13.7862 15.1062 13.3424 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3129 0 0 0 0 0 0 0 0 9.38009 0 0 0 0 13.6345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0289 0 0 0 0 12.091 0 0 0 10.2531 0 0 0 0 0 15.2526 15.6829 15.4434 0 16.3448 12.5449 15.7054 15.8929 0 16.0482 16.0628 16.0231 16.2422 16.1611 16.3774 13.5868 15.5518 15.9783 13.8815 11.757 15.3155 15.296 13.4974 15.4129 16.2888 0 15.3903 12.4111 12.7895 16.5769 10.1294 13.7895 12.0373 13.5672 16.2246 16.2129 16.6345 16.6785 16.4326 16.2805 16.0307 0 0 16.0726 0 0 0 16.8243 0 14.1609 0 0 13.1789 16.2833 0 13.5663 15.4954 15.8351 0 15.809 13.2505 0 15.3132 15.3144 0 15.3341 15.2614 15.1615 0 13.5767 0 0 15.1772 0 14.2567 0 0 12.1843 14.8346 0 0 0 15.0428 0 0 0 0 0 15.9752 0 9.956 0 0 0 0 0 0 0 0 11.0703 0 0 0 0 0 0 14.4861 12.1139 14.6076 0 0 0 15.2846 0 P30040 ERP29_HUMAN "Endoplasmic reticulum resident protein 29, ERp29 (Endoplasmic reticulum resident protein 28, ERp28) (Endoplasmic reticulum resident protein 31, ERp31)" ERP29 C12orf8 ERP28 Homo sapiens (Human) intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein secretion [GO:0009306]; protein unfolding [GO:0043335]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein secretion [GO:0009306]; protein unfolding [GO:0043335]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235] GO:0001934; GO:0005783; GO:0005788; GO:0005790; GO:0006457; GO:0006886; GO:0009306; GO:0009986; GO:0010628; GO:0010629; GO:0016020; GO:0030133; GO:0042470; GO:0042803; GO:0043335; GO:0043406; GO:0050709; GO:0051087; GO:1902235 chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803] AAAVPRAAFLSPLLPLLLGFLLLSAPHGGSGLHTK 0.99543 -11.661 0 0 0 0 0 0 0 0 0 0 14.1369 10.4873 13.9411 12.1227 0 12.4915 0 0 11.7523 0 0 0 0 0 11.6866 0 0 0 12.5107 0 14.0741 12.6629 0 0 0 0 0 0 0 0 0 13.6026 0 0 0 13.1643 0 14.0607 0 0 12.6443 12.104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1826 0 0 14.2493 12.5282 0 0 0 13.2254 0 0 0 0 14.1181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1752 0 0 0 0 12.9166 0 0 0 0 0 0 0 11.9482 0 14.6193 14.4036 13.7378 0 0 0 0 0 0 0 13.044 0 0 0 0 P38398 BRCA1_HUMAN "Breast cancer type 1 susceptibility protein, EC 2.3.2.27 (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)" BRCA1 RNF53 Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cell cycle [GO:0045786]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA methylation [GO:0044030]; regulation of DNA repair [GO:0006282]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]" BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; gamma-tubulin large complex [GO:0000931]; lateral element [GO:0000800]; nuclear body [GO:0016604]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151] "BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; gamma-tubulin large complex [GO:0000931]; lateral element [GO:0000800]; nuclear body [GO:0016604]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; histone H2A K63-linked deubiquitination [GO:0070537]; histone H2A monoubiquitination [GO:0035518]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cell cycle [GO:0045786]; negative regulation of centriole replication [GO:0046600]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA methylation [GO:0044030]; regulation of DNA repair [GO:0006282]; regulation of gene expression by genomic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]" GO:0000151; GO:0000152; GO:0000209; GO:0000724; GO:0000800; GO:0000931; GO:0000976; GO:0003677; GO:0003684; GO:0003713; GO:0003723; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005886; GO:0006281; GO:0006282; GO:0006301; GO:0006302; GO:0006349; GO:0006357; GO:0006633; GO:0006974; GO:0007059; GO:0007095; GO:0007098; GO:0008270; GO:0008630; GO:0009048; GO:0010212; GO:0010575; GO:0010628; GO:0015631; GO:0016567; GO:0016604; GO:0019899; GO:0031398; GO:0031436; GO:0031625; GO:0032991; GO:0033147; GO:0035066; GO:0035067; GO:0035518; GO:0035825; GO:0043009; GO:0043627; GO:0044030; GO:0044818; GO:0045717; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045893; GO:0045944; GO:0046600; GO:0051571; GO:0051572; GO:0051573; GO:0051574; GO:0051726; GO:0051865; GO:0070063; GO:0070512; GO:0070531; GO:0070532; GO:0070533; GO:0070537; GO:0071356; GO:0071479; GO:0071681; GO:0085020; GO:0110025; GO:1902042; GO:1990391; GO:1990904; GO:2000001; GO:2000378; GO:2000617; GO:2000620 damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AACEFSETDVTNTEHHQPSNNDLNTTEK 0.99543 -31.601 0 0 0 0 0 0 0 0 10.6798 12.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.452 0 0 0 0 0 15.1023 0 14.4809 0 0 0 0 0 0 11.09 11.5971 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9802 12.7119 0 0 0 12.1093 0 10.3814 0 0 0 0 0 0 14.5169 13.5333 13.8619 0 12.9367 0 0 0 13.0565 0 14.1303 0 0 13.9199 14.1198 13.7674 14.2012 0 11.8724 13.2795 0 0 14.3244 0 0 0 0 0 16.4299 14.5038 0 0 0 13.7839 0 12.2925 0 0 0 0 0 0 0 0 0 0 16.3327 13.2925 0 0 0 0 0 0 0 0 11.9047 0 13.8595 0 14.1393 0 0 0 0 12.7487 0 13.2562 0 0 13.1055 0 0 0 0 0 0 0 0 0 0 18.6212 0 0 0 0 18.7554 0 0 0 0 0 0 0 0 0 0 12.8635 0 P55201 BRPF1_HUMAN Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140) BRPF1 BR140 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000123; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0006357; GO:0010698; GO:0043966; GO:0043972; GO:0044154; GO:0045893; GO:0046872; GO:0050793; GO:0070776; GO:1903706 acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; metal ion binding [GO:0046872] ANCYTAFHVTCAQQAGLYMKMEPVR 0.99543 -34.645 0 0 0 0 0 0 0 0 0 14.4993 0 0 0 0 0 0 0 12.626 0 0 11.5596 0 0 0 0 0 0 11.9811 0 0 0 0 0 0 0 0 11.7967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.038 0 13.9461 0 0 0 0 0 13.9008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2616 12.1784 0 11.751 0 0 12.8732 0 0 0 14.7555 14.7896 13.6908 0 15.2378 14.9433 0 13.4794 0 14.2877 14.5913 0 0 0 12.4842 0 0 12.3273 0 0 14.3511 0 0 10.7087 0 0 0 0 0 0 0 0 0 11.5404 0 13.3918 0 0 0 0 13.8973 12.5128 0 0 10.0243 14.1289 15.6958 0 0 0 0 0 10.7622 0 0 0 0 13.5011 0 0 13.4567 0 13.4405 0 0 P61371 ISL1_HUMAN "Insulin gene enhancer protein ISL-1, Islet-1" ISL1 Homo sapiens (Human) atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; mesenchymal cell differentiation [GO:0048762]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage colony-stimulating factor production [GO:1901258]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524] chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; mesenchymal cell differentiation [GO:0048762]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuron fate specification [GO:0048665]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage colony-stimulating factor production [GO:1901258]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; sinoatrial node cell development [GO:0060931]; spinal cord motor neuron cell fate specification [GO:0021520]; spinal cord motor neuron differentiation [GO:0021522]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001755; GO:0003139; GO:0003148; GO:0003151; GO:0003203; GO:0003215; GO:0003266; GO:0005634; GO:0005737; GO:0006357; GO:0006366; GO:0007409; GO:0007507; GO:0008283; GO:0008284; GO:0010575; GO:0010718; GO:0016922; GO:0021520; GO:0021522; GO:0021524; GO:0021559; GO:0021983; GO:0030331; GO:0031016; GO:0031103; GO:0031290; GO:0031333; GO:0032024; GO:0032725; GO:0032729; GO:0032730; GO:0032731; GO:0032735; GO:0032755; GO:0032760; GO:0033147; GO:0035066; GO:0042531; GO:0043388; GO:0043425; GO:0043524; GO:0045597; GO:0045665; GO:0045766; GO:0045944; GO:0046872; GO:0048665; GO:0048762; GO:0048880; GO:0048936; GO:0050680; GO:0050728; GO:0055010; GO:0060037; GO:0060070; GO:0060379; GO:0060384; GO:0060413; GO:0060913; GO:0060931; GO:0061629; GO:0071385; GO:0071657; GO:0086091; GO:0090090; GO:1901258; GO:1990837; GO:1990841 "bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" GDMGDPPK 0.99543 -12.175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5119 0 0 0 0 0 0 0 0 0 0 0 12.1053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9659 0 14.8141 0 13.5974 0 14.3257 0 0 13.0771 0 14.9809 0 13.5424 0 0 0 0 13.6022 0 0 0 0 0 0 0 13.0793 0 0 0 0 0 0 14.3817 13.7701 0 13.2245 0 0 0 0 0 0 0 13.709 0 0 0 0 0 0 11.977 0 0 0 0 0 13.7868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6299 0 0 0 0 0 0 Q58DX5 NADL2_HUMAN "Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2, NAALADase L2" NAALADL2 Homo sapiens (Human) response to bacterium [GO:0009617] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; response to bacterium [GO:0009617] GO:0005654; GO:0009617; GO:0016021 KVLQKNVVAYISLHSPIR 0.99543 -12.174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.217 0 12.2321 0 0 0 11.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4406 0 0 0 0 0 0 0 0 12.9244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1591 0 15.7477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1425 0 0 0 0 0 11.7892 14.1037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IVE0 CROL2_HUMAN Putative ciliary rootlet coiled-coil protein-like 2 protein (Ciliary rootlet coiled-coil protein pseudogene 3) CROCCP3 CROCCL2 KIAA1922 Homo sapiens (Human) centrosome cycle [GO:0007098] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; centrosome cycle [GO:0007098] GO:0005813; GO:0005814; GO:0007098; GO:0035253 AEVAEALTK 0.99543 -10.321 0 0 0 0 0 0 0 0 0 0 0 12.3839 0 0 0 12.885 0 0 0 0 0 0 0 0 11.9159 0 0 0 0 0 0 0 12.0268 0 0 0 0 12.5912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5422 0 0 0 0 0 0 0 0 0 0 0 0 11.1818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.716 0 0 0 0 13.911 0 0 12.7848 12.1388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6571 0 0 0 0 0 0 13.2593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8616 0 0 0 0 0 0 0 0 Q8NH09 OR8S1_HUMAN Olfactory receptor 8S1 OR8S1 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] AAPTALP 0.99543 -10.331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1535 15.6098 15.6232 15.4413 12.6323 14.4792 0 15.2793 12.3393 0 13.637 0 0 0 0 0 15.1186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5501 0 0 0 14.7177 13.0872 0 0 14.6434 14.4757 15.4031 15.4017 0 0 14.7019 0 0 0 0 12.8907 0 13.1986 0 13.2818 0 0 0 0 14.1195 0 0 0 14.7506 0 13.8011 0 0 0 13.8005 14.2079 0 14.0705 0 10.9926 0 14.9937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.967 0 0 0 0 0 0 0 Q96KW2 P12L2_HUMAN POM121-like protein 2 POM121L2 POM121L Homo sapiens (Human) protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] nuclear pore [GO:0005643] nuclear pore [GO:0005643]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405] GO:0005643; GO:0006405; GO:0006606; GO:0008139; GO:0017056 nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056] AGSSVGFGMPFPPAQGSVGR 0.99543 -10.329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6216 14.6324 0 0 0 0 0 14.0144 0 0 15.1394 0 0 0 13.7948 14.2139 0 15.1104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6637 15.2893 15.305 14.4103 0 13.9704 0 0 0 0 0 0 0 0 13.7813 0 0 0 0 13.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4344 0 0 13.5957 0 0 14.7859 0 0 0 12.4651 0 0 0 0 0 0 0 0 0 0 Q96PR1 KCNC2_HUMAN Potassium voltage-gated channel subfamily C member 2 (Shaw-like potassium channel) (Voltage-gated potassium channel Kv3.2) KCNC2 Homo sapiens (Human) action potential [GO:0001508]; cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; terminal bouton [GO:0043195]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249]; action potential [GO:0001508]; cellular response to ammonium ion [GO:0071242]; cellular response to nitric oxide [GO:0071732]; cellular response to toxic substance [GO:0097237]; globus pallidus development [GO:0021759]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of voltage-gated potassium channel activity [GO:1903818]; potassium ion transmembrane transport [GO:0071805]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to light intensity [GO:0009642]; response to magnesium ion [GO:0032026]; response to nerve growth factor [GO:1990089]; response to organic cyclic compound [GO:0014070] GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0005887; GO:0008076; GO:0009642; GO:0014070; GO:0014075; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0021759; GO:0030424; GO:0030425; GO:0030673; GO:0031982; GO:0032026; GO:0032590; GO:0032809; GO:0038060; GO:0042734; GO:0043195; GO:0043204; GO:0044325; GO:0045202; GO:0045211; GO:0045471; GO:0051260; GO:0051291; GO:0070161; GO:0071242; GO:0071732; GO:0071805; GO:0097237; GO:0099508; GO:1903818; GO:1990089 delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249] AAKDVLGFLRVVR 0.99543 -12.168 0 0 0 0 0 0 0 0 0 14.6385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6714 0 12.4738 0 13.7361 0 0 0 0 13.1236 0 0 0 0 0 0 0 12.1807 0 13.2237 0 0 13.0269 12.8622 0 0 0 0 14.4011 0 0 0 0 0 0 11.2579 0 13.1229 14.8042 0 0 12.5882 0 0 0 0 0 0 0 0 11.6983 0 0 0 0 0 0 15.2436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9437 0 14.3726 0 0 0 0 13.0573 12.2493 12.2842 0 11.1504 0 0 0 0 10.5088 0 0 13.4656 0 0 0 12.8195 0 0 12.3017 0 0 0 0 0 0 0 O95206 PCDH8_HUMAN Protocadherin-8 (Arcadlin) PCDH8 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; regulation of synaptic membrane adhesion [GO:0099179]; somitogenesis [GO:0001756] anchoring junction [GO:0070161]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734] anchoring junction [GO:0070161]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; morphogenesis of embryonic epithelium [GO:0016331]; regulation of synaptic membrane adhesion [GO:0099179]; somitogenesis [GO:0001756] GO:0001756; GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007267; GO:0007268; GO:0016331; GO:0030425; GO:0042734; GO:0070161; GO:0098978; GO:0099055; GO:0099179 calcium ion binding [GO:0005509] DTVVARVQAR 0.99544 -12.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4714 0 0 0 0 0 0 0 0 0 0 0 0 12.6327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4416 0 0 0 0 0 0 14.0341 0 0 0 0 P35663 CYLC1_HUMAN Cylicin-1 (Cylicin I) (Multiple-band polypeptide I) CYLC1 CYL CYL1 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] acrosomal matrix [GO:0043159]; cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634] acrosomal matrix [GO:0043159]; cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005198; GO:0005200; GO:0005634; GO:0007283; GO:0030154; GO:0033150; GO:0043159 structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] DTESTDAESGDSKDER 0.99544 -31.711 0 0 0 0 0 0 0 0 0 0 0 0 0 9.45442 0 12.8255 11.7944 0 0 0 0 0 0 0 0 0 0 10.5136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8151 14.5969 0 0 13.4116 12.207 0 11.8414 0 0 0 0 10.8317 0 0 0 0 0 11.9045 0 0 0 0 0 0 11.2739 0 0 0 0 0 13.3386 0 12.0227 0 14.5075 0 0 0 0 0 13.5634 0 0 0 13.184 0 0 11.1321 0 0 13.4284 0 0 0 13.701 0 11.1751 13.0461 0 12.1309 0 0 0 11.482 10.9717 0 0 0 0 0 0 0 0 0 0 0 12.9368 0 0 0 15.3667 0 0 0 0 0 0 0 0 0 12.1493 0 0 0 0 0 13.7124 0 0 0 0 0 0 13.9475 0 0 11.4811 0 0 0 0 0 0 0 0 10.3226 0 0 12.5425 0 0 0 0 0 0 0 12.3234 0 Q5JTV8 TOIP1_HUMAN "Torsin-1A-interacting protein 1 (Lamin-associated protein 1B, LAP1B)" TOR1AIP1 LAP1 Homo sapiens (Human) membrane organization [GO:0061024]; nuclear membrane organization [GO:0071763]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; lamin binding [GO:0005521]; membrane organization [GO:0061024]; nuclear membrane organization [GO:0071763]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504] GO:0001671; GO:0005521; GO:0005634; GO:0005637; GO:0008092; GO:0016020; GO:0016021; GO:0031965; GO:0032781; GO:0034504; GO:0051117; GO:0061024; GO:0071763; GO:0090435 ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; lamin binding [GO:0005521] DVALVLTVLLEEETLGTSLGLK 0.99544 -12.782 0 0 0 0 0 0 0 0 10.7742 0 12.3525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4373 0 0 10.8675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9962 Q96PC5 MIA2_HUMAN "Melanoma inhibitory activity protein 2, MIA protein 2 (CTAGE family member 5 ER export factor) (Cutaneous T-cell lymphoma-associated antigen 5) (Meningioma-expressed antigen 6/11)" MIA2 CTAGE5 MEA11 MEA6 MGEA11 MGEA6 Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cargo receptor activity [GO:0038024]; enzyme activator activity [GO:0008047]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; vesicle cargo loading [GO:0035459] GO:0005783; GO:0005789; GO:0006888; GO:0008047; GO:0009306; GO:0016020; GO:0016021; GO:0032527; GO:0035459; GO:0038024; GO:0042953; GO:0070971; GO:0070973 cargo receptor activity [GO:0038024]; enzyme activator activity [GO:0008047] DSDENSK 0.99544 -31.777 0 0 0 0 0 0 0 10.0515 0 0 0 11.0649 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.88646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8316 0 0 0 0 0 14.6487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1209 14.5402 0 13.4817 0 0 13.0584 0 0 13.4715 12.7597 0 0 0 14.1108 14.0654 10.6612 14.0694 13.1088 0 0 0 0 0 13.824 0 0 0 15.2957 0 0 12.8615 0 13.3351 0 0 0 0 0 0 0 12.4257 0 0 0 0 0 0 0 0 10.9725 0 0 0 0 14.1475 14.4911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HC10 OTOF_HUMAN Otoferlin (Fer-1-like protein 2) OTOF FER1L2 Homo sapiens (Human) membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082] anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672]; AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509]; membrane fusion [GO:0061025]; plasma membrane organization [GO:0007009]; sensory perception of sound [GO:0007605]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082] GO:0000139; GO:0005509; GO:0005789; GO:0005829; GO:0007009; GO:0007605; GO:0016021; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0042995; GO:0048787; GO:0061025; GO:0070161 AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509] ESMFSWDETEYK 0.99544 -35.598 0 0 0 0 0 0 0 0 0 0 13.0348 14.3529 13.5533 13.5088 12.6336 0 14.1316 0 0 13.2295 0 0 13.3173 14.6899 12.7145 0 0 0 12.8969 0 11.1951 0 0 0 13.3471 0 0 12.0752 0 10.5157 0 0 0 0 0 0 14.087 0 15.1618 0 14.402 0 0 0 0 0 0 0 0 0 10.7006 0 0 0 10.6988 0 0 16.0065 12.9691 0 14.5188 0 12.2115 14.3792 11.4474 13.4517 0 13.9222 0 11.5614 13.9761 0 12.2705 0 11.7049 14.7473 11.5218 13.5411 0 14.75 0 11.0049 0 13.6323 14.5091 12.1567 12.2239 10.8287 14.1275 0 0 11.4643 0 0 12.231 0 0 12.9388 0 0 0 0 14.2323 14.8668 0 15.4701 0 12.7375 11.4646 14.2574 13.324 10.9161 0 14.8989 15.0394 12.5587 0 13.6886 14.1716 0 12.1327 12.214 0 0 0 0 0 13.0077 0 0 0 0 0 0 14.9 13.0741 0 12.8262 0 0 14.3445 13.0974 0 0 0 0 0 14.8019 14.6107 0 0 12.4054 0 14.477 0 14.8193 12.6731 13.041 14.9754 0 15.0486 0 14.2819 0 0 13.1042 0 0 0 0 Q9Y483 MTF2_HUMAN "Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2, hPCl2)" MTF2 PCL2 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]" GO:0000122; GO:0000977; GO:0001222; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0006325; GO:0006355; GO:0007379; GO:0019827; GO:0035064; GO:0035098; GO:0045944; GO:0046872; GO:0048863; GO:0061086; GO:0061087; GO:1990830 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222] ALQVMKQTLPYSVADLEWDAGHK 0.99544 -9.9283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9607 16.9476 16.8422 0 0 0 0 15.2719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2852 0 0 0 0 0 0 0 18.6644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.0566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4113 0 0 12.6731 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20.5686 0 0 0 0 0 0 O00487 PSDE_HUMAN "26S proteasome non-ATPase regulatory subunit 14, EC 3.4.19.- (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1)" PSMD14 POH1 Homo sapiens (Human) double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000502; GO:0000724; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0034774; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0061578; GO:0070122; GO:0070536; GO:0070628; GO:0140492; GO:1904813 endopeptidase activator activity [GO:0061133]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628] HYYSITINYR 0.99545 -8.8509 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4296 12.511 0 0 0 0 11.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2178 0 0 0 0 0 0 0 0 0 0 11.8711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P36222 CH3L1_HUMAN "Chitinase-3-like protein 1 (39 kDa synovial protein) (Cartilage glycoprotein 39, CGP-39, GP-39, hCGP-39) (YKL-40)" CHI3L1 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; extracellular matrix structural constituent [GO:0005201]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to tumor necrosis factor [GO:0071356]; chitin catabolic process [GO:0006032]; inflammatory response [GO:0006954]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase B signaling [GO:0051897]; response to interleukin-1 [GO:0070555]; response to interleukin-6 [GO:0070741]; response to mechanical stimulus [GO:0009612]; response to tumor necrosis factor [GO:0034612] GO:0005201; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0005975; GO:0006032; GO:0006915; GO:0006954; GO:0007250; GO:0008061; GO:0009612; GO:0010800; GO:0030246; GO:0030324; GO:0031012; GO:0032757; GO:0034612; GO:0035580; GO:0045766; GO:0048471; GO:0051216; GO:0051897; GO:0070062; GO:0070374; GO:0070555; GO:0070741; GO:0071356 carbohydrate binding [GO:0030246]; chitin binding [GO:0008061]; extracellular matrix structural constituent [GO:0005201] EGDGSCFPDALDR 0.99545 -8.8471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0224 0 0 0 0 11.6345 0 0 0 0 0 0 0 0 0 0 0 0 13.9228 0 0 0 0 0 14.4819 0 0 0 0 0 0 0 0 0 14.3061 0 0 13.5259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P62273 RS29_HUMAN 40S ribosomal protein S29 (Small ribosomal subunit protein uS14) RPS29 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935] cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0008270; GO:0015935; GO:0022627; GO:0042788; GO:0070062; GO:0098556 structural constituent of ribosome [GO:0003735]; zinc ion binding [GO:0008270] DIGFIKLD 0.99545 -11.863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4695 12.8265 0 0 0 0 0 0 Q06210 GFPT1_HUMAN "Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1, EC 2.6.1.16 (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1, GFAT 1, GFAT1) (Hexosephosphate aminotransferase 1)" GFPT1 GFAT GFPT Homo sapiens (Human) circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; energy reserve metabolic process [GO:0006112]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047] GO:0004360; GO:0005829; GO:0006002; GO:0006047; GO:0006048; GO:0006112; GO:0006487; GO:0006541; GO:0032922; GO:0070062; GO:0097367 carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360] GALTVGITNTVGSSISR 0.99545 -8.852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15031 SYLM_HUMAN "Leucine--tRNA ligase, mitochondrial, EC 6.1.1.4 (Leucyl-tRNA synthetase, LeuRS)" LARS2 KIAA0028 Homo sapiens (Human) leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; leucyl-tRNA aminoacylation [GO:0006429]; mitochondrial translation [GO:0032543]; tRNA aminoacylation for protein translation [GO:0006418] GO:0002161; GO:0004823; GO:0005524; GO:0005739; GO:0005759; GO:0006418; GO:0006429; GO:0032543 aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823] LGFYASLLKR 0.99545 -9.6993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4006 0 0 0 0 0 0 0 0 0 11.0511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8761 0 0 0 13.5114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.08 0 11.6966 12.7382 10.6628 0 11.6281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4443 10.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4397 0 0 0 0 0 14.705 11.3724 0 0 0 0 0 0 0 0 0 0 12.4708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5W0B1 OBI1_HUMAN "ORC ubiquitin ligase 1, OBI1, EC 2.3.2.27 (RING finger protein 219)" OBI1 C13orf7 RNF219 Homo sapiens (Human) protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; regulation of DNA replication [GO:0006275] chromatin [GO:0000785] chromatin [GO:0000785]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; regulation of DNA replication [GO:0006275] GO:0000785; GO:0003682; GO:0004842; GO:0006275; GO:0006513; GO:0046872; GO:0051865 chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] DSSEDDISR 0.99545 -11.803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9608 12.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6462 12.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9398 0 0 0 0 0 0 0 0 14.0374 0 14.0837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5Y6 BMP8A_HUMAN "Bone morphogenetic protein 8A, BMP-8A" BMP8A Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; negative regulation of insulin secretion [GO:0046676]; ossification [GO:0001503]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] extracellular space [GO:0005615] extracellular space [GO:0005615]; BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; negative regulation of insulin secretion [GO:0046676]; ossification [GO:0001503]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395] GO:0001503; GO:0002024; GO:0005125; GO:0005615; GO:0008083; GO:0010862; GO:0030154; GO:0030509; GO:0046676; GO:0051216; GO:0060395; GO:0070700; GO:0097009 BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083] AVRPLRR 0.99545 -11.8 0 0 0 0 0 0 0 13.212 0 0 0 0 0 0 0 13.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8126 0 0 0 0 12.5492 0 0 12.5794 0 0 0 0 0 12.5053 0 0 0 0 0 0 16.0642 15.7651 15.5681 15.0581 0 0 0 0 0 0 0 0 0 0 12.601 12.8772 0 12.5667 0 0 0 0 0 0 0 0 0 0 14.8207 0 0 0 0 0 0 11.3706 0 0 0 0 14.0022 0 0 13.7388 13.2231 10.7019 0 0 0 14.9205 14.6107 0 12.591 0 13.8391 0 12.8954 0 0 13.576 0 13.6582 0 13.581 0 13.633 0 14.0933 14.6229 0 0 0 0 0 0 0 0 12.277 12.975 0 0 0 0 0 0 12.8392 0 0 14.3336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8367 0 0 0 0 0 Q9H209 O10A4_HUMAN Olfactory receptor 10A4 (HP2) (Olfactory receptor-like protein JCG5) OR10A4 OR10A4P Homo sapiens (Human) axon guidance [GO:0007411] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; axon guidance [GO:0007411] GO:0004930; GO:0004984; GO:0005886; GO:0007411; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] ILSTIFR 0.99545 -11.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11161 EGR2_HUMAN "E3 SUMO-protein ligase EGR2, EC 2.3.2.- (AT591) (E3 SUMO-protein transferase ERG2) (Early growth response protein 2, EGR-2) (Zinc finger protein Krox-20)" EGR2 KROX20 Homo sapiens (Human) "aorta development [GO:0035904]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cellular response to organic substance [GO:0071310]; facial nerve structural organization [GO:0021612]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; rhombomere 3 formation [GO:0021660]; rhombomere 3 structural organization [GO:0021659]; rhombomere 5 formation [GO:0021666]; rhombomere 5 structural organization [GO:0021665]; rhythmic behavior [GO:0007622]; Schwann cell differentiation [GO:0014037]; skeletal muscle cell differentiation [GO:0035914]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; aorta development [GO:0035904]; brain development [GO:0007420]; brain segmentation [GO:0035284]; cellular response to organic substance [GO:0071310]; facial nerve structural organization [GO:0021612]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; learning or memory [GO:0007611]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; peripheral nervous system development [GO:0007422]; positive regulation of myelination [GO:0031643]; positive regulation of Schwann cell differentiation [GO:0014040]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein export from nucleus [GO:0006611]; protein sumoylation [GO:0016925]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; rhombomere 3 formation [GO:0021660]; rhombomere 3 structural organization [GO:0021659]; rhombomere 5 formation [GO:0021666]; rhombomere 5 structural organization [GO:0021665]; rhythmic behavior [GO:0007622]; Schwann cell differentiation [GO:0014037]; skeletal muscle cell differentiation [GO:0035914]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006611; GO:0007420; GO:0007422; GO:0007611; GO:0007622; GO:0008045; GO:0010467; GO:0014037; GO:0014040; GO:0016925; GO:0021612; GO:0021659; GO:0021660; GO:0021665; GO:0021666; GO:0030278; GO:0031625; GO:0031643; GO:0032868; GO:0035284; GO:0035904; GO:0035914; GO:0042552; GO:0043231; GO:0043565; GO:0045444; GO:0045893; GO:0045944; GO:0046872; GO:0048168; GO:0061629; GO:0061665; GO:0071310; GO:0071837; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SUMO ligase activity [GO:0061665]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]" DLHGTAGPDR 0.99546 -10.036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3393 0 14.2544 0 0 12.5406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7872 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7471 0 0 0 0 0 0 13.9823 0 0 0 13.2499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.187 0 0 0 0 0 0 0 P20645 MPRD_HUMAN "Cation-dependent mannose-6-phosphate receptor, CD Man-6-P receptor, CD-MPR (46 kDa mannose 6-phosphate receptor, MPR 46)" M6PR MPR46 MPRD Homo sapiens (Human) endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299] clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133] clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888]; endosome to lysosome transport [GO:0008333]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299] GO:0004888; GO:0005765; GO:0005768; GO:0005770; GO:0005802; GO:0005886; GO:0005887; GO:0006622; GO:0006898; GO:0007041; GO:0008333; GO:0016020; GO:0019904; GO:0030133; GO:0030669; GO:0032588; GO:0033299; GO:0048471; GO:1905394 protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888] ELALVKRLK 0.99546 -8.8557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7619 0 0 0 0 0 0 0 0 13.5428 0 0 0 0 13.0834 0 0 0 13.4139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0VF96 CGNL1_HUMAN Cingulin-like protein 1 (Junction-associated coiled-coil protein) (Paracingulin) CGNL1 JACOP KIAA1749 Homo sapiens (Human) actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105] bicellular tight junction [GO:0005923]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991] bicellular tight junction [GO:0005923]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; actin filament organization [GO:0007015]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of stress fiber assembly [GO:0051497]; protein localization to cell-cell junction [GO:0150105] GO:0005923; GO:0007015; GO:0016459; GO:0032991; GO:0051058; GO:0051497; GO:0150105 ANLEELRSQHNEKVEENSTLQQR 0.99546 -11.865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5456 17.4414 17.0199 0 0 0 0 0 15.8091 15.9064 0 0 0 0 0 0 0 0 13.0584 0 0 0 0 0 13.7425 0 12.416 0 0 0 0 0 0 11.1365 0 0 0 0 0 0 0 0 0 14.44 0 0 0 0 0 0 0 0 0 0 0 0 10.7796 0 13.8477 0 0 0 0 0 0 14.4108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7683 0 0 0 0 0 14.7181 0 0 0 0 0 0 0 0 0 0 0 14.6288 14.0101 0 0 0 0 12.9501 13.7199 0 12.9234 0 14.1999 14.5769 0 0 0 0 0 0 11.3768 0 0 0 0 0 Q5J5C9 DB121_HUMAN "Beta-defensin 121 (Beta-defensin 21, DEFB-21) (Defensin, beta 121)" DEFB121 DEFB21 Homo sapiens (Human) defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] extracellular region [GO:0005576] extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087] GO:0005576; GO:0042742; GO:0045087 CRTTCKESEVYYILCK 0.99546 -5.432 12.5426 0 13.3867 0 0 0 0 12.7642 12.4972 14.0543 13.0251 14.2834 14.1226 13.6146 0 0 11.8796 0 0 0 0 0 0 0 0 0 12.6869 13.6796 0 12.6244 12.456 12.7469 0 0 11.9508 13.8614 0 12.3131 0 0 12.2576 0 0 0 12.0834 13.0185 0 0 11.3563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3069 0 0 0 0 14.6866 13.8261 0 0 0 11.068 0 0 0 0 0 0 12.4112 12.938 0 11.8641 0 13.0428 0 0 11.7742 0 13.0784 0 12.769 0 0 0 0 0 0 0 0 14.4259 0 0 0 0 0 0 0 0 0 0 0 11.7278 0 0 0 0 0 13.3869 0 0 0 0 0 0 0 0 0 12.0445 0 0 0 0 0 0 0 0 12.9041 10.9949 0 0 0 0 14.936 0 0 0 0 13.1432 0 0 13.0075 0 16.1035 0 13.7169 15.3796 14.3745 0 14.3326 15.4919 14.0428 0 15.3989 14.2267 14.491 14.6413 0 0 13.6026 14.0287 14.1171 0 0 0 11.3451 Q7Z3V5 ZN571_HUMAN Zinc finger protein 571 ZNF571 HSPC059 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFGRTSDLIQHQK 0.99546 -10.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5949 0 0 0 0 0 10.4135 0 0 0 0 0 0 0 0 0 10.8022 0 0 0 0 0 0 0 0 0 0 0 11.8157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1326 0 15.0395 0 0 0 0 0 0 0 0 0 0 0 0 10.0912 10.5567 0 0 0 0 0 0 0 0 0 0 0 10.7945 0 0 14.0589 0 0 0 0 0 0 0 0 Q8IX90 SKA3_HUMAN Spindle and kinetochore-associated protein 3 SKA3 C13orf3 RAMA1 Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110] centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876] centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0000278; GO:0000776; GO:0000940; GO:0005813; GO:0005829; GO:0005876; GO:0007059; GO:0031110; GO:0051301; GO:0072686 FLKHGQNIR 0.99546 -11.874 0 0 0 0 0 0 0 0 10.0677 0 0 0 11.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8619 0 0 0 12.2793 0 0 12.3722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3419 0 0 0 0 0 0 0 0 17.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80768 0 0 0 0 0 0 0 12.0802 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63359 0 0 0 0 0 0 0 0 10.7189 0 13.4383 0 0 0 11.9604 10.1477 13.3399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY17 PLPL6_HUMAN "Patatin-like phospholipase domain-containing protein 6, EC 3.1.1.5 (Neuropathy target esterase)" PNPLA6 NTE Homo sapiens (Human) glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470] GO:0004622; GO:0005783; GO:0005789; GO:0005829; GO:0016020; GO:0016021; GO:0046470; GO:0046475; GO:0102545 lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545] AGTIIAR 0.99546 -33.541 0 0 0 0 12.5892 0 0 0 0 0 0 0 11.6526 11.2915 12.3266 0 13.2825 0 0 0 0 12.4165 13.4433 13.254 12.8815 0 10.6983 0 0 0 0 11.86 0 0 12.543 0 13.0255 0 0 0 0 0 14.2842 0 0 0 0 12.5635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9565 0 12.7531 0 0 0 0 0 0 0 0 14.3542 0 0 0 0 0 0 11.4972 14.2695 0 13.2433 0 0 0 11.8243 0 0 0 12.5705 13.9022 0 0 12.1732 11.4865 0 0 0 0 13.4925 0 14.9449 0 0 0 14.6812 0 0 0 0 0 0 0 11.6598 0 0 0 0 12.6437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2722 0 13.5736 0 13.3009 0 12.273 0 0 0 12.7577 0 12.5595 0 0 0 12.274 0 0 0 14.3698 12.4692 0 0 13.9223 0 0 0 0 0 13.32 0 Q8IYD8 FANCM_HUMAN "Fanconi anemia group M protein, Protein FACM, EC 3.6.4.13 (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa, FAAP250) (Protein Hef ortholog)" FANCM KIAA1596 Homo sapiens (Human) double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; resolution of meiotic recombination intermediates [GO:0000712] GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:0071932; GO:1902527 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724] ALGNYAYCQVVR 0.99546 -8.8885 0 0 11.8827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2055 12.0255 0 0 0 0 0 12.8427 0 0 0 0 0 0 0 13.1509 0 0 0 0 12.5549 0 0 0 0 0 10.4901 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2102 0 0 0 0 0 0 0 12.8492 0 0 13.6312 0 0 0 0 0 0 0 14.2655 0 0 0 14.292 0 0 0 0 0 0 12.2119 0 0 0 0 0 0 0 0 0 0 0 0 0 15.626 12.8432 0 0 0 0 0 0 0 0 0 0 0 0 13.5801 12.958 0 0 0 0 0 0 0 13.9089 0 13.2143 0 15.4746 12.2264 13.5335 0 12.6769 13.5677 0 0 13.8409 0 14.4769 0 0 0 0 0 0 0 0 0 0 0 13.0947 0 12.9688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZ69 TRM2A_HUMAN "tRNA (uracil-5-)-methyltransferase homolog A, EC 2.1.1.35 (mRNA (uracil-5-)-methyltransferase TRMT2A, EC 2.1.1.-)" TRMT2A Homo sapiens (Human) mRNA processing [GO:0006397] cytosol [GO:0005829] cytosol [GO:0005829]; C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697]; mRNA processing [GO:0006397] GO:0003723; GO:0005829; GO:0006397; GO:0008169; GO:0030697 C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity [GO:0030697] AFQEFIR 0.99546 -10.028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2071 13.7498 0 0 0 0 14.1631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.74771 0 0 0 0 10.6341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4807 0 0 0 0 0 0 0 0 13.477 0 0 14.6486 12.2632 14.1425 0 0 0 0 0 0 0 0 0 0 13.3819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4082 0 0 12.4026 0 10.4748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4272 0 0 0 0 0 0 0 13.5015 0 0 0 0 0 0 0 11.4471 0 0 0 0 10.7894 0 0 0 12.5168 0 0 0 0 0 0 0 0 Q8TDS7 MRGRD_HUMAN Mas-related G-protein coupled receptor member D (Beta-alanine receptor) (G-protein coupled receptor TGR7) MRGPRD MRGD Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005615; GO:0005886; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930] CFRVDMVQAALIMGVLTPVMTLSSLTLFVWVR 0.99546 -8.8587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5087 10.8703 0 0 0 12.6823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1933 0 13.089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWF5 ZNRF4_HUMAN "E3 ubiquitin-protein ligase ZNRF4, EC 2.3.2.27 (Nixin) (RING finger protein 204) (RING-type E3 ubiquitin transferase ZNRF4) (Zinc/RING finger protein 4)" ZNRF4 RNF204 Homo sapiens (Human) ubiquitin-dependent protein catabolic process [GO:0006511] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005783; GO:0005789; GO:0006511; GO:0016021; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] LGNRSLGAIVLIRR 0.99546 -8.8918 11.1254 0 0 0 0 0 0 0 12.5716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.181 0 0 0 0 0 0 0 13.3802 12.6684 0 14.6983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1918 0 0 0 0 13.8514 0 0 0 0 0 0 0 0 13.2972 0 0 0 0 0 0 0 12.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7223 0 0 0 0 0 0 0 0 0 12.4234 0 0 0 0 0 0 0 0 0 0 Q9ULJ8 NEB1_HUMAN Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A) PPP1R9A KIAA1222 Homo sapiens (Human) actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; modulation of chemical synaptic transmission [GO:0050804]; neuron projection development [GO:0031175] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; postsynaptic density [GO:0014069] actin cytoskeleton [GO:0015629]; anchoring junction [GO:0070161]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; filopodium [GO:0030175]; postsynaptic density [GO:0014069]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; calcium-mediated signaling [GO:0019722]; modulation of chemical synaptic transmission [GO:0050804]; neuron projection development [GO:0031175] GO:0005737; GO:0007015; GO:0014069; GO:0015629; GO:0019722; GO:0030175; GO:0030425; GO:0030864; GO:0031175; GO:0043197; GO:0050804; GO:0051015; GO:0070161 actin filament binding [GO:0051015] AHLVEVQGLQVR 0.99546 -10.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.012 0 11.9897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5607 16.5356 0 0 14.7582 13.863 0 14.6984 0 13.1289 14.5662 13.8389 14.2035 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3897 0 12.2133 0 12.9578 12.2174 13.4184 0 0 13.7053 0 0 0 0 0 13.1512 13.0325 13.4862 0 0 12.2632 0 0 12.7946 13.7444 0 0 0 0 13.3711 0 13.1195 0 0 0 0 0 0 0 0 0 11.9798 13.6818 0 14.3587 15.4873 0 0 0 0 0 0 0 10.7729 0 0 11.723 0 0 0 12.4983 0 0 0 0 13.1409 0 0 0 0 12.0197 0 0 0 Q9Y2T4 2ABG_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (IMYPNO1) (PP2A subunit B isoform B55-gamma) (PP2A subunit B isoform PR55-gamma) (PP2A subunit B isoform R2-gamma) (PP2A subunit B isoform gamma) PPP2R2C Homo sapiens (Human) cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159] cytosol [GO:0005829]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888] GO:0000159; GO:0005829; GO:0019888 protein phosphatase regulator activity [GO:0019888] MFDRNTKR 0.99546 -8.8806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1818 0 0 0 0 0 12.2836 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0993 0 0 0 0 0 0 0 0 0 0 0 0 0 11.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4015 0 0 0 0 0 0 Q52LC2 VAS1L_HUMAN V-type proton ATPase subunit S1-like protein (Vacuolar proton pump subunit S1-like protein) ATP6AP1L Homo sapiens (Human) regulation of cellular pH [GO:0030641] integral component of membrane [GO:0016021]; proton-transporting V-type ATPase complex [GO:0033176] integral component of membrane [GO:0016021]; proton-transporting V-type ATPase complex [GO:0033176]; regulation of cellular pH [GO:0030641] GO:0016021; GO:0030641; GO:0033176 ARVLKLVLK 0.99547 -11.977 0 0 0 0 0 0 0 0 0 10.4435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6822 13.4605 10.6274 0 11.7508 0 0 0 0 0 0 0 0 12.0173 11.6686 11.5917 0 0 0 0 0 11.9792 0 0 0 0 10.3813 0 0 0 0 0 0 12.1638 0 13.3803 0 0 0 0 0 0 12.8813 0 12.7937 11.0389 0 0 0 0 0 0 0 0 0 0 0 14.1695 0 0 16.1659 0 11.8315 14.4863 14.9839 14.4855 0 14.9874 0 14.8357 14.4524 13.8843 0 0 14.4303 0 12.6161 0 0 0 0 12.3676 14.7786 13.8718 0 0 14.1766 14.6299 14.6815 0 0 14.2558 0 13.5168 0 0 15.5733 15.614 10.9076 0 15.4074 0 13.9661 0 13.5134 0 13.8656 15.6071 0 10.7493 0 0 0 0 0 13.4815 0 0 0 0 0 10.1594 0 0 0 0 14.0218 0 13.0512 14.5028 0 15.7433 0 0 0 0 0 0 0 13.3082 11.143 0 14.5979 0 0 11.4177 0 0 0 0 0 13.0743 0 0 13.6345 9.80901 O43586 PPIP1_HUMAN "Proline-serine-threonine phosphatase-interacting protein 1, PEST phosphatase-interacting protein 1 (CD2-binding protein 1) (H-PIP)" PSTPIP1 CD2BP1 Homo sapiens (Human) actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165] actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931] actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165] GO:0001931; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0030041; GO:0032154; GO:0042802; GO:0045087; GO:0048471; GO:0051015 actin filament binding [GO:0051015]; identical protein binding [GO:0042802] DADDAEQAFERISANGHQK 0.99547 -33.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2342 0 0 0 0 0 0 0 0 0 14.3947 0 0 13.1829 0 12.1891 12.2707 11.926 0 0 0 0 0 12.4859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3392 0 12.8715 0 0 0 0 12.2091 12.394 0 0 11.3657 12.2048 0 0 11.3909 12.6128 0 12.597 0 0 0 0 0 0 0 0 0 0 12.9344 0 0 0 0 0 0 0 0 0 0 0 0 11.8703 0 0 0 0 12.6607 0 0 0 16.9319 0 0 0 0 0 13.0565 0 14.4795 0 0 0 13.0141 0 0 0 0 0 P35610 SOAT1_HUMAN "Sterol O-acyltransferase 1, EC 2.3.1.26 (Acyl-coenzyme A:cholesterol acyltransferase 1, ACAT-1) (Cholesterol acyltransferase 1)" SOAT1 ACACT ACACT1 ACAT ACAT1 SOAT STAT Homo sapiens (Human) cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; low-density lipoprotein particle clearance [GO:0034383]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772]; cholesterol efflux [GO:0033344]; cholesterol esterification [GO:0034435]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; low-density lipoprotein particle clearance [GO:0034383]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379] GO:0000062; GO:0004772; GO:0005783; GO:0005789; GO:0008203; GO:0008374; GO:0010742; GO:0010878; GO:0015485; GO:0016020; GO:0016021; GO:0033344; GO:0034379; GO:0034383; GO:0034435; GO:0034736; GO:0042632; GO:0042802; GO:0042986 cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; O-acyltransferase activity [GO:0008374]; sterol O-acyltransferase activity [GO:0004772] ENPEEDEDQR 0.99547 -11.988 0 0 0 0 0 0 0 0 0 0 0 0 12.3984 0 0 0 0 13.7863 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0342 0 0 0 0 0 0 0 13.8754 13.7005 0 0 0 0 13.5324 0 0 0 0 13.0526 0 0 12.4803 0 0 0 0 0 0 12.7302 0 12.4948 0 12.9441 0 0 0 0 0 0 0 13.1253 0 0 0 13.4672 0 0 0 0 0 0 0 0 0 0 0 0 12.7892 0 0 12.8945 0 0 0 0 0 13.6111 0 0 0 0 11.1918 0 11.2661 0 0 0 13.9557 12.9151 0 0 0 0 0 11.9553 0 12.8326 0 13.0736 0 0 0 11.6416 0 0 0 0 0 0 P62316 SMD2_HUMAN "Small nuclear ribonucleoprotein Sm D2, Sm-D2 (snRNP core protein D2)" SNRPD2 SNRPD1 Homo sapiens (Human) "7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; 7-methylguanosine cap hypermethylation [GO:0036261]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387]; U2-type prespliceosome assembly [GO:1903241]" GO:0000245; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0008380; GO:0030532; GO:0034709; GO:0034715; GO:0034719; GO:0036261; GO:0046540; GO:0070062; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:1903241 RNA binding [GO:0003723] EMWTEVPK 0.99547 -11.956 0 0 0 0 0 0 0 0 11.7606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6854 0 13.2551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8982 0 0 0 0 0 0 12.3195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0752 0 0 0 0 0 0 0 0 0 Q2M2I8 AAK1_HUMAN "AP2-associated protein kinase 1, EC 2.7.11.1 (Adaptor-associated kinase 1)" AAK1 KIAA1048 Homo sapiens (Human) endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880] anchoring junction [GO:0070161]; cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; terminal bouton [GO:0043195] anchoring junction [GO:0070161]; cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880] GO:0004674; GO:0005112; GO:0005524; GO:0005737; GO:0005829; GO:0005905; GO:0006468; GO:0006897; GO:0019897; GO:0030136; GO:0031252; GO:0032880; GO:0035612; GO:0043195; GO:0045747; GO:0046777; GO:0050821; GO:0061024; GO:0070161; GO:0106310; GO:2000369 AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] LTAEELLNK 0.99547 -11.94 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1638 0 12.5936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9527 0 0 0 0 12.6404 0 0 0 0 0 15.5046 15.831 0 0 16.0281 15.6453 15.4441 15.3315 0 0 0 15.264 15.3326 15.694 0 16.2636 0 14.1971 14.2031 0 0 15.2728 13.599 12.7683 0 12.8786 0 13.7522 0 14.7776 0 0 14.798 0 0 0 0 0 13.4146 0 0 0 12.5473 0 13.5947 0 0 0 0 12.4694 0 0 0 0 0 0 0 0 0 0 12.7354 0 0 0 0 0 0 12.2406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P597 KLC3_HUMAN Kinesin light chain 3 (KLC2-like) (kinesin light chain 2) KLC3 KLC2 KLC2L Homo sapiens (Human) axo-dendritic transport [GO:0008088]; microtubule-based movement [GO:0007018]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuron projection [GO:0043005] ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; axo-dendritic transport [GO:0008088]; microtubule-based movement [GO:0007018]; sperm mitochondrial sheath assembly [GO:0120317]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283] GO:0005737; GO:0005739; GO:0005871; GO:0005874; GO:0007018; GO:0007283; GO:0007286; GO:0008017; GO:0008088; GO:0019894; GO:0031514; GO:0035253; GO:0043005; GO:0120317 kinesin binding [GO:0019894]; microtubule binding [GO:0008017] EILHKEDLPAPLGAPNTGTAGDAEQALR 0.99547 -11.953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1156 0 0 0 0 0 0 0 0 0 0 0 0 16.7212 0 0 0 0 0 0 0 0 0 0 12.6266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XT4 TRI50_HUMAN "E3 ubiquitin-protein ligase TRIM50, EC 2.3.2.27 (RING-type E3 ubiquitin transferase TRIM50) (Tripartite motif-containing protein 50)" TRIM50 TRIM50A Homo sapiens (Human) protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567] GO:0005737; GO:0005829; GO:0008270; GO:0016567; GO:0042802; GO:0061630 identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] KVLPAPEPLKLDPATAHPLLELSK 0.99547 -9.5102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6532 0 0 0 0 12.5928 0 0 0 0 0 12.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6501 0 0 0 0 11.4325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2986 0 0 0 0 0 0 0 11.8576 0 0 0 0 0 0 0 0 12.5494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969X2 SIA7F_HUMAN "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, EC 2.4.99.- (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI, ST6GalNAcVI, hST6GalNAc VI) (Sialyltransferase 7F, SIAT7-F)" ST6GALNAC6 SIAT7F UNQ708/PRO1359 Homo sapiens (Human) cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486] cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; cell-cell recognition [GO:0009988]; ganglioside biosynthetic process [GO:0001574]; glycoprotein metabolic process [GO:0009100]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide metabolic process [GO:0006677]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]" GO:0000139; GO:0001574; GO:0001665; GO:0005737; GO:0005886; GO:0006486; GO:0006677; GO:0006687; GO:0008373; GO:0009100; GO:0009311; GO:0009312; GO:0009988; GO:0016021 "alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]" HLPLSRRR 0.99547 -11.988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5341 0 0 0 0 0 0 0 0 0 0 15.9229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96ND0 F210A_HUMAN Protein FAM210A FAM210A C18orf19 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739] GO:0005737; GO:0005739; GO:0016021 LTEKLQETK 0.99547 -11.941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2119 0 14.6894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BPX5 ARP5L_HUMAN "Actin-related protein 2/3 complex subunit 5-like protein (Arp2/3 complex 16 kDa subunit 2, ARC16-2)" ARPC5L Homo sapiens (Human) Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; regulation of actin filament polymerization [GO:0030833] Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978] Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; regulation of actin filament polymerization [GO:0030833] GO:0005737; GO:0005885; GO:0005925; GO:0016477; GO:0030833; GO:0034314; GO:0051015; GO:0070062; GO:0098978 actin filament binding [GO:0051015] ALAVGGLGSIIRVLTAR 0.99547 -5.463 0 0 0 0 0 0 0 0 0 0 0 0 12.0761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8294 0 0 0 0 0 12.6255 0 0 0 0 0 0 12.4778 0 0 0 16.108 0 16.0195 0 16.0777 0 0 15.8563 0 0 0 15.7471 0 0 0 15.5142 15.6992 0 0 0 0 0 14.9015 0 14.0056 0 0 0 15.5264 15.2731 15.0091 15.1154 14.3682 13.8978 13.8401 0 0 14.7877 14.3443 0 0 14.3012 14.6207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0107 12.8345 0 0 0 0 0 0 12.0965 0 0 0 13.6602 0 0 0 0 0 0 0 0 0 0 11.2473 0 0 0 11.028 0 0 0 0 0 0 0 0 0 Q9GZT8 NIF3L_HUMAN NIF3-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein) NIF3L1 ALS2CR1 MDS015 My018 Homo sapiens (Human) "negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]" cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:0042802; GO:0045893; GO:0061629; GO:1903507 identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629] GFLSDLR 0.99547 -11.957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.6124 0 19.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1236 0 0 0 19.9304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3792 0 0 0 0 14.4831 15.1518 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7472 0 0 0 Q9H3Q1 BORG4_HUMAN Cdc42 effector protein 4 (Binder of Rho GTPases 4) CDC42EP4 BORG4 CEP4 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; cellular response to interferon-gamma [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] GO:0003723; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0007266; GO:0008360; GO:0012505; GO:0015629; GO:0015630; GO:0030838; GO:0031267; GO:0031274; GO:0045335; GO:0071346 RNA binding [GO:0003723]; small GTPase binding [GO:0031267] ARAAVSR 0.99547 -11.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7995 0 0 17.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7916 0 0 11.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7633 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8383 0 0 Q9P2M7 CING_HUMAN Cingulin CGN KIAA1319 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule cytoskeleton organization [GO:0000226] GO:0000226; GO:0003779; GO:0005886; GO:0005923; GO:0008017; GO:0016459; GO:0030054; GO:0045296 actin binding [GO:0003779]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017] ARREVADAQR 0.99547 -33.766 0 0 15.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5347 14.6966 14.5386 14.2503 13.8436 14.0674 12.9889 12.9936 12.2372 12.8024 12.5786 12.7232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0598 0 0 0 0 0 16.6967 13.7277 14.3322 0 0 14.8473 0 0 0 0 0 0 12.9829 0 0 0 0 14.9521 12.6313 0 0 0 0 0 0 0 0 13.1103 0 16.1426 0 0 0 0 0 0 0 0 0 13.2416 0 0 10.4855 0 0 0 0 0 0 13.4387 0 0 0 0 0 0 0 0 0 0 11.477 0 0 0 0 0 0 0 0 11.8057 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5514 0 0 0 0 0 0 0 0 0 0 Q9Y5I4 PCDC2_HUMAN "Protocadherin alpha-C2, PCDH-alpha-C2" PCDHAC2 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] ILPDTQR 0.99547 -12.537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5517 0 0 0 0 11.8978 0 0 11.1765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.763 12.8645 0 0 0 0 0 0 0 0 0 11.9691 0 0 0 0 11.2434 11.9596 0 0 0 0 0 11.9204 12.0935 0 0 0 0 0 0 12.7271 15.5651 0 0 15.7463 15.1853 15.4459 0 15.604 0 14.2413 0 12.9056 0 14.4954 14.2408 13.8062 0 0 12.1566 0 0 0 11.4477 15.787 0 0 14.4278 15.2195 0 0 13.9698 0 0 13.7092 0 0 0 0 13.6792 13.8837 0 0 0 0 0 13.8409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5696 0 0 0 0 0 0 0 0 0 0 0 Q9UFH2 DYH17_HUMAN Dynein axonemal heavy chain 17 (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein axonemal light chain 2) DNAH17 DNAHL1 DNEL2 Homo sapiens (Human) cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126] axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158] GO:0003341; GO:0003777; GO:0005524; GO:0005858; GO:0005874; GO:0005930; GO:0007018; GO:0008569; GO:0030286; GO:0031514; GO:0036126; GO:0036157; GO:0036158; GO:0045505; GO:0051959; GO:0060285 ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569] AAKWILAAVALLLQV 0.99548 -31.703 0 10.305 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5043 10.1494 11.8433 12.0948 9.68506 12.9554 11.3331 12.0775 0 0 12.7383 12.2467 0 10.4708 0 11.3364 0 13.2778 0 0 0 11.2274 0 14.7501 11.0011 0 14.9009 0 0 0 0 0 0 0 12.2223 0 13.733 0 13.7847 0 0 0 0 0 0 0 0 0 0 0 0 12.5925 13.2414 0 0 12.4368 14.8033 14.3355 12.2483 0 12.389 11.9302 0 13.3821 12.4292 16.4577 0 17.7538 0 0 15.7699 12.1695 0 16.6733 0 12.4928 0 0 11.5453 0 14.2023 14.4459 0 0 15.4698 0 0 0 15.0175 0 12.9573 0 0 0 0 10.8405 14.0965 16.5116 0 13.9563 17.9153 13.4603 18.3496 17.5964 14.8092 0 12.3051 10.6544 11.5222 0 14.0529 0 17.0586 14.2117 11.8952 14.7529 14.1362 11.7464 13.5858 12.1807 14.6173 17.6256 13.4601 0 12.9855 11.3394 0 14.9449 0 0 0 0 13.6372 13.1678 0 0 0 0 12.3052 10.5314 17.1002 13.8205 13.4638 0 12.7153 14.9272 0 0 13.5114 14.0215 12.8027 13.5013 0 0 12.5147 12.9374 13.4679 10.9801 17.5058 0 13.627 0 0 0 0 O00410 IPO5_HUMAN "Importin-5, Imp5 (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5, RanBP5)" IPO5 KPNB3 RANBP5 Homo sapiens (Human) cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634] cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005730; GO:0005737; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0016020; GO:0031267; GO:0042307; GO:0045736; GO:0061608; GO:0071230 GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267] FYFHDGVR 0.99548 -31.765 10.8281 0 0 0 0 0 0 0 0 0 0 9.98712 0 0 0 0 0 10.1887 0 0 0 0 0 0 0 11.8377 0 11.3517 0 0 0 0 0 0 12.0532 0 0 0 0 0 0 0 0 9.8412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8115 10.874 0 10.5657 0 0 0 0 0 0 12.1224 13.1616 0 0 0 0 0 0 0 0 0 11.9854 0 0 13.5159 0 0 0 0 0 0 13.4234 0 13.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7073 12.5372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8615 O14926 FSCN2_HUMAN Fascin-2 (Retinal fascin) FSCN2 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; anatomical structure morphogenesis [GO:0009653]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; visual perception [GO:0007601] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; stereocilium [GO:0032420] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; anatomical structure morphogenesis [GO:0009653]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; visual perception [GO:0007601] GO:0003779; GO:0005737; GO:0007163; GO:0007601; GO:0009653; GO:0015629; GO:0016477; GO:0030036; GO:0030674; GO:0032420; GO:0042462; GO:0051015; GO:0051017 actin binding [GO:0003779]; actin filament binding [GO:0051015]; protein-macromolecule adaptor activity [GO:0030674] AEDFVFEFRERGR 0.99548 -5.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4714 0 12.5849 0 0 0 0 0 12.5488 0 13.3161 0 0 0 0 0 0 0 0 13.3846 0 0 0 0 0 13.711 13.6313 0 0 0 0 0 14.3164 0 0 12.8923 13.4794 0 0 0 0 0 0 0 13.4432 0 12.5207 0 0 13.9158 14.0516 0 0 0 0 0 13.2689 13.065 0 0 0 0 0 0 13.5147 0 0 0 0 13.0873 0 0 0 0 0 0 0 0 0 13.289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZQN7 SO4C1_HUMAN "Solute carrier organic anion transporter family member 4C1 (OATP-H) (Organic anion transporter M1, OATP-M1) (Solute carrier family 21 member 20)" SLCO4C1 OATP4C1 OATPX SLC21A20 Homo sapiens (Human) cell differentiation [GO:0030154]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; sodium-independent organic anion transmembrane transporter activity [GO:0015347]; cell differentiation [GO:0030154]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283] GO:0005886; GO:0005887; GO:0007283; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0070062 sodium-independent organic anion transmembrane transporter activity [GO:0015347] DFPAALK 0.99548 -10.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0151 13.9629 14.1455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86VX9 MON1A_HUMAN Vacuolar fusion protein MON1 homolog A MON1A SAND1 Homo sapiens (Human) protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829]; Mon1-Ccz1 complex [GO:0035658] cytosol [GO:0005829]; Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein secretion [GO:0009306]; protein targeting to vacuole [GO:0006623]; vesicle-mediated transport [GO:0016192] GO:0005085; GO:0005829; GO:0006623; GO:0009306; GO:0016192; GO:0035658 guanyl-nucleotide exchange factor activity [GO:0005085] ARSLVFSILLARNQLVALVR 0.99548 -10.294 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1888 14.2195 0 0 0 0 0 0 0 0 0 0 10.706 0 0 0 0 0 0 0 0 0 0 12.9379 12.5702 13.2405 0 12.6097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2587 13.1014 13.061 0 0 9.84951 14.2043 14.4566 0 16.347 0 14.14 16.9405 14.3667 15.2562 15.7512 0 0 0 0 0 15.036 0 0 0 13.9461 0 0 0 13.6292 0 0 0 0 0 0 0 0 13.3204 14.4427 0 0 0 0 0 13.3266 0 11.4256 13.52 0 0 13.47 0 0 0 0 14.3905 14.1281 0 14.1911 0 13.937 12.3677 0 13.5588 0 14.0324 0 14.0846 0 0 0 0 12.4884 0 0 0 0 0 0 0 0 0 12.8285 12.7472 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9325 13.8586 0 0 0 0 0 0 Q86XE5 HOGA1_HUMAN "4-hydroxy-2-oxoglutarate aldolase, mitochondrial, EC 4.1.3.16 (Dihydrodipicolinate synthase-like, DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase, Probable KHG-aldolase) (Protein 569272)" HOGA1 C10orf65 DHDPSL Homo sapiens (Human) 4-hydroxyproline catabolic process [GO:0019470]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; oxalate metabolic process [GO:0033609]; pyruvate biosynthetic process [GO:0042866] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (4S)-4-hydroxy-2-oxoglutarate aldolase activity [GO:0106009]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; protein homodimerization activity [GO:0042803]; 4-hydroxyproline catabolic process [GO:0019470]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; oxalate metabolic process [GO:0033609]; pyruvate biosynthetic process [GO:0042866] GO:0005739; GO:0005759; GO:0008700; GO:0009436; GO:0019470; GO:0033609; GO:0042803; GO:0042866; GO:0046487; GO:0106009 (4S)-4-hydroxy-2-oxoglutarate aldolase activity [GO:0106009]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; protein homodimerization activity [GO:0042803] FGIPGLK 0.99548 -34.631 0 0 0 0 0 0 0 0 0 0 0 0 12.6764 0 0 0 0 0 0 0 0 0 13.5965 0 0 0 0 0 0 0 12.3376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4255 0 0 0 0 0 0 18.7051 0 0 0 13.1263 0 0 0 12.0986 0 0 0 0 0 0 0 0 0 0 0 12.8937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4843 13.5041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9499 0 0 12.4344 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NES8 DB124_HUMAN "Beta-defensin 124 (Beta-defensin 24, DEFB-24) (Defensin, beta 124)" DEFB124 DEFB24 Homo sapiens (Human) cellular response to peptidoglycan [GO:0071224]; defense response to bacterium [GO:0042742]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026] extracellular region [GO:0005576] extracellular region [GO:0005576]; cellular response to peptidoglycan [GO:0071224]; defense response to bacterium [GO:0042742]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; innate immune response [GO:0045087]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026] GO:0005576; GO:0007249; GO:0032722; GO:0032735; GO:0032743; GO:0032755; GO:0042742; GO:0045087; GO:0071224; GO:0071651; GO:0090026; GO:2000343 GQGACQTYCTR 0.99548 -5.4816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5019 0 0 12.4566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9271 0 0 0 0 0 0 0 0 0 0 11.8179 0 0 12.387 0 0 0 0 0 0 0 0 0 0 Q92888 ARHG1_HUMAN "Rho guanine nucleotide exchange factor 1 (115 kDa guanine nucleotide exchange factor, p115-RhoGEF, p115RhoGEF) (Sub1.5)" ARHGEF1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266] GO:0001664; GO:0003723; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0007186; GO:0007266; GO:0051056 G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723] AVEVHVLLLDDLLLLLQRQDER 0.99548 -34.571 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7922 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0831 0 0 0 0 0 0 0 0 0 0 0 13.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5638 0 0 0 0 15.0597 0 0 0 0 0 14.3045 0 0 0 0 14.4647 0 0 0 0 0 0 0 12.892 0 0 0 0 0 0 0 0 0 0 0 15.3968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8798 13.1784 13.7629 13.1631 11.911 0 11.2924 12.4114 14.2243 0 0 12.7447 0 0 0 0 0 0 13.9597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4173 0 13.1279 0 0 0 14.2628 0 0 0 Q96AX2 RAB37_HUMAN Ras-related protein Rab-37 RAB37 Homo sapiens (Human) protein transport [GO:0015031] azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579] azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031] GO:0003924; GO:0005525; GO:0005768; GO:0005793; GO:0005794; GO:0005886; GO:0015031; GO:0035577; GO:0035579 GTP binding [GO:0005525]; GTPase activity [GO:0003924] KRSSCCSFM 0.99548 -5.4838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.202 11.8911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV86 NTM1A_HUMAN "N-terminal Xaa-Pro-Lys N-methyltransferase 1, EC 2.1.1.244 (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (N-terminal RCC1 methyltransferase) (X-Pro-Lys N-terminal protein methyltransferase 1A, NTM1A) [Cleaved into: N-terminal Xaa-Pro-Lys N-methyltransferase 1, N-terminally processed ]" NTMT1 C9orf32 METTL11A NRMT NRMT1 AD-003 Homo sapiens (Human) chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-alanine methylation [GO:0018011]; N-terminal peptidyl-alanine trimethylation [GO:0018012]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-proline methylation [GO:0035568]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine methylation [GO:0035570]; N-terminal peptidyl-serine trimethylation [GO:0035573]; N-terminal protein amino acid methylation [GO:0006480]; spindle organization [GO:0007051] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-alanine methylation [GO:0018011]; N-terminal peptidyl-alanine trimethylation [GO:0018012]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-proline methylation [GO:0035568]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine methylation [GO:0035570]; N-terminal peptidyl-serine trimethylation [GO:0035573]; N-terminal protein amino acid methylation [GO:0006480]; spindle organization [GO:0007051] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006480; GO:0007051; GO:0007059; GO:0008168; GO:0008276; GO:0016571; GO:0018011; GO:0018012; GO:0018013; GO:0018016; GO:0035568; GO:0035570; GO:0035572; GO:0035573; GO:0042054; GO:0071885 histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276] FLQRFLR 0.99548 -5.4879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5027 0 0 0 0 0 0 0 0 0 12.4613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7863 0 0 12.4585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0934 13.4344 0 0 0 0 0 0 0 13.2219 0 0 0 0 0 0 16.9778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1366 0 0 0 0 0 0 0 0 16.6787 0 0 0 0 16.2095 0 Q9GZZ9 UBA5_HUMAN "Ubiquitin-like modifier-activating enzyme 5, Ubiquitin-activating enzyme 5 (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1)" UBA5 UBE1DC1 Homo sapiens (Human) erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270]; erythrocyte differentiation [GO:0030218]; megakaryocyte differentiation [GO:0030219]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709] GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0008270; GO:0030218; GO:0030219; GO:0032446; GO:0033146; GO:0034976; GO:0042803; GO:0043231; GO:0050905; GO:0061709; GO:0071566; GO:0071569; GO:1990592 ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; UFM1 activating enzyme activity [GO:0071566]; zinc ion binding [GO:0008270] PNPQCDDRNCRK 0.99548 -5.4751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NWB6 ARGL1_HUMAN Arginine and glutamate-rich protein 1 ARGLU1 Homo sapiens (Human) cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296] GO:0005654; GO:0005739; GO:0005829; GO:0045296 cadherin binding [GO:0045296] AREEEERAK 0.99548 -31.755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2624 11.6927 0 0 0 11.4971 11.9301 10.0712 13.0894 12.2628 0 0 0 16.0139 11.6911 0 12.9427 12.8478 0 0 11.8103 0 0 0 10.7468 0 0 0 0 11.7298 0 0 0 0 10.0603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2313 0 0 0 10.3187 0 0 0 0 0 0 0 11.4302 0 0 0 0 0 0 0 0 0 0 10.2396 0 10.3085 0 12.6461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8015 13.9036 13.8626 13.7974 13.7907 0 0 0 13.5672 13.8234 0 0 0 14.0645 14.9633 0 0 0 0 0 12.1992 0 0 0 Q9UMD9 COHA1_HUMAN "Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1, LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen, 97 kDa LAD antigen, 97-LAD) (Linear IgA bullous disease antigen of 97 kDa, LABD97) ]" COL17A1 BP180 BPAG2 Homo sapiens (Human) cell-matrix adhesion [GO:0007160]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell-matrix adhesion [GO:0007160]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581] GO:0005201; GO:0005576; GO:0005581; GO:0005604; GO:0005615; GO:0005788; GO:0005886; GO:0005887; GO:0005911; GO:0007160; GO:0008544; GO:0030020; GO:0030056; GO:0030198; GO:0031012; GO:0031581; GO:0062023 extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020] EGPMGPR 0.99548 -12.011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2654 12.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2581 0 0 0 0 0 0 0 13.3022 11.745 0 0 0 0 0 0 0 0 0 12.5846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1356 0 0 0 0 0 0 Q9Y493 ZAN_HUMAN Zonadhesin ZAN Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609] GO:0005615; GO:0005886; GO:0007339; GO:0016021; GO:0031012; GO:0098609 ALPCAESCECQK 0.99548 -34.555 0 0 0 0 0 0 0 0 0 0 13.1266 0 0 0 0 0 0 0 0 12.7142 0 0 0 0 0 0 0 0 12.3879 0 0 10.9533 0 0 0 0 0 0 12.6124 0 0 0 12.8863 0 0 0 0 0 0 12.0457 11.9956 0 0 0 0 0 0 0 0 0 0 13.1715 0 0 14.8522 0 14.0687 11.8455 0 0 0 0 0 11.4118 0 0 11.6269 0 0 11.6123 0 12.6038 0 12.1632 0 11.5797 0 0 0 0 13.5522 12.6648 14.3375 14.1646 0 0 15.1508 0 14.5223 0 0 0 13.852 0 0 0 0 0 0 0 13.6797 13.8744 13.6425 0 0 0 0 0 13.392 14.844 0 0 0 12.9483 0 12.4575 12.8936 0 14.3125 12.4967 0 0 0 0 0 0 11.3552 12.1445 0 0 0 11.6964 13.2996 0 0 0 0 14.8055 0 0 0 0 0 13.5534 0 0 14.0014 14.4378 0 14.6392 12.0076 0 0 12.3856 0 0 0 10.7631 0 0 0 0 0 0 0 11.7118 0 0 0 0 O95183 VAMP5_HUMAN "Vesicle-associated membrane protein 5, VAMP-5 (Myobrevin)" VAMP5 HSPC191 Homo sapiens (Human) cell differentiation [GO:0030154]; Golgi to plasma membrane protein transport [GO:0043001]; muscle organ development [GO:0007517]; skeletal muscle tissue development [GO:0007519] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of organelle membrane [GO:0031301]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cell differentiation [GO:0030154]; Golgi to plasma membrane protein transport [GO:0043001]; muscle organ development [GO:0007517]; skeletal muscle tissue development [GO:0007519] GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0007517; GO:0007519; GO:0009986; GO:0014704; GO:0030154; GO:0030659; GO:0031301; GO:0043001; GO:0048471; GO:0070062 ICVGLVVVGVLLIILIVLLVVFLPQSSDSSSAPR 0.99549 -9.8525 13.0647 0 0 0 0 0 10.1533 0 0 0 0 0 0 14.5268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3602 0 0 0 12.348 0 0 0 0 0 0 0 0 0 0 0 0 0 12.261 0 0 0 0 0 0 0 0 0 11.5156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5779 0 0 0 0 0 P48960 AGRE5_HUMAN Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta ] ADGRE5 CD97 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954] GO:0004888; GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0005925; GO:0006954; GO:0006955; GO:0007155; GO:0007166; GO:0007186; GO:0007189; GO:0007267; GO:0016020; GO:0030667; GO:0070062 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888] CRPGWKPR 0.99549 -9.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1789 0 0 0 0 0 12.4005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6814 0 13.3185 0 0 0 0 12.2515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0482 0 0 0 0 10.3605 0 10.3113 0 10.5416 0 0 0 0 0 P63272 SPT4H_HUMAN "Transcription elongation factor SPT4, hSPT4 (DRB sensitivity-inducing factor 14 kDa subunit, DSIF p14) (DRB sensitivity-inducing factor small subunit, DSIF small subunit)" SUPT4H1 SPT4H SUPT4H Homo sapiens (Human) "chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]" DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243]; regulation of transcription, DNA-templated [GO:0006355]; transcription elongation from RNA polymerase II promoter [GO:0006368]" GO:0000122; GO:0000993; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006368; GO:0006397; GO:0008270; GO:0032044; GO:0032785; GO:0032786; GO:0034243; GO:0034244; GO:0045944; GO:0046982 protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270] ALETVPKDLRHLR 0.99549 -10.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5789 10.1186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3368 0 0 0 0 0 0 0 0 0 0 0 0 13.3238 12.886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1706 0 12.7197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8199 11.3028 0 0 10.7444 0 13.0994 12.1615 0 10.7172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 0 0 0 11.1834 0 0 0 0 0 0 Q8N2U9 S66A2_HUMAN Solute carrier family 66 member 2 (PQ-loop repeat-containing protein 1) SLC66A2 PQLC1 Homo sapiens (Human) "phospholipid translocation [GO:0045332]; retrograde transport, endosome to Golgi [GO:0042147]" cytosol [GO:0005829]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] "cytosol [GO:0005829]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; phospholipid translocation [GO:0045332]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005768; GO:0005802; GO:0005829; GO:0016021; GO:0042147; GO:0045332 FESPLLWQSAIMILTMLLMLKLCTEVR 0.99549 -9.8508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8813 0 0 0 0 0 0 0 0 0 0 13.1778 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4575 0 0 0 0 0 0 0 0 0 0 Q96BY7 ATG2B_HUMAN Autophagy-related protein 2 homolog B ATG2B C14orf103 Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709] endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045] endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; late nucleophagy [GO:0044805]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709] GO:0000045; GO:0000407; GO:0000422; GO:0005789; GO:0005811; GO:0019898; GO:0032266; GO:0034045; GO:0034727; GO:0044805; GO:0061709; GO:0120013 lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266] AAMQEKEEEPVIKIMVDDAIVIR 0.99549 -35.574 0 0 0 0 0 0 14.4132 0 11.7495 0 11.8483 12.2778 0 0 0 11.7481 0 0 12.874 11.3814 0 0 11.5581 0 12.8054 11.8992 12.3861 11.2573 11.9165 0 0 12.5434 0 0 0 11.7097 0 0 0 11.755 0 0 0 10.8484 0 0 0 0 0 12.6759 0 11.7559 0 0 13.2431 0 12.4521 0 0 0 11.3003 0 0 0 0 0 0 15.0676 0 14.8293 0 13.3408 15.556 0 0 0 0 12.5318 0 0 0 0 14.0618 13.5676 0 0 0 0 13.4531 14.2502 0 0 11.5937 0 12.7136 0 0 13.4034 0 14.1559 0 0 0 0 0 14.1159 0 14.2366 0 12.6004 15.0417 15.6099 12.1257 14.7304 0 10.1215 0 12.8162 0 0 0 0 0 0 0 0 14.9961 0 0 0 0 18.1322 14.7512 0 13.7142 0 12.0567 14.5555 0 0 0 14.3221 14.9543 14.8769 0 0 0 15.8509 0 0 12.8004 0 13.0114 0 0 0 14.5315 15.0985 14.7779 15.8806 14.535 14.4699 14.8638 15.6407 15.0169 14.5401 15.3089 15.7687 14.8547 14.4715 14.1988 0 14.0815 0 13.9181 15.5188 0 14.7246 0 0 Q9BR77 CCD77_HUMAN Coiled-coil domain-containing protein 77 CCDC77 Homo sapiens (Human) centrosome [GO:0005813]; membrane [GO:0016020] centrosome [GO:0005813]; membrane [GO:0016020] GO:0005813; GO:0016020 AHKIQGELK 0.99549 -12.168 0 0 0 0 0 0 0 0 0 0 13.734 0 11.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3078 0 0 0 0 0 0 0 13.6029 0 0 0 13.9221 14.3784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0741 0 0 13.4197 0 12.2499 0 0 0 0 0 12.9884 0 0 13.0441 0 0 0 13.3153 0 0 0 0 0 0 17.4066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5336 0 0 0 0 0 0 0 0 10.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5209 0 0 0 0 0 0 0 0 0 13.3364 0 0 0 13.1791 0 0 0 0 0 13.3689 Q9BXS5 AP1M1_HUMAN AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin) AP1M1 CLTNM Homo sapiens (Human) endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; clathrin adaptor activity [GO:0035615]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005765; GO:0005769; GO:0005829; GO:0005886; GO:0006886; GO:0016020; GO:0016192; GO:0030121; GO:0030136; GO:0030659; GO:0031410; GO:0032438; GO:0032588; GO:0035579; GO:0035615; GO:0035646; GO:0060155; GO:0070062; GO:1903232 clathrin adaptor activity [GO:0035615] HSHSRIEYMIKAK 0.99549 -9.8465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8698 0 0 0 0 0 0 0 13.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8706 0 0 Q9H4A5 GLP3L_HUMAN Golgi phosphoprotein 3-like (GPP34-related protein) GOLPH3L GPP34R Homo sapiens (Human) "Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; positive regulation of protein secretion [GO:0050714]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588] "cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; phosphatidylinositol-4-phosphate binding [GO:0070273]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; positive regulation of protein secretion [GO:0050714]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000139; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0031985; GO:0032580; GO:0032588; GO:0043001; GO:0048194; GO:0050714; GO:0070273 phosphatidylinositol-4-phosphate binding [GO:0070273] GILTTEK 0.99549 -9.8381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5669 12.5697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7734 0 0 0 14.4036 0 0 0 0 0 0 15.5233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5351 0 0 0 0 0 0 0 0 0 14.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NXL9 MCM9_HUMAN "DNA helicase MCM9, hMCM9, EC 3.6.4.12 (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9)" MCM9 C6orf61 MCMDC1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634] chromosome [GO:0005694]; MCM complex [GO:0042555]; MCM8-MCM9 complex [GO:0097362]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; double-strand break repair via homologous recombination [GO:0000724]; female gamete generation [GO:0007292]; mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication [GO:0070716]; protein localization to chromatin [GO:0071168]; recombinational interstrand cross-link repair [GO:0036298] GO:0000724; GO:0003678; GO:0003682; GO:0003697; GO:0005524; GO:0005634; GO:0005694; GO:0006974; GO:0007292; GO:0016887; GO:0019899; GO:0032406; GO:0032407; GO:0032408; GO:0032508; GO:0036298; GO:0042555; GO:0044877; GO:0070716; GO:0071168; GO:0097362 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; enzyme binding [GO:0019899]; MutLbeta complex binding [GO:0032406]; MutSalpha complex binding [GO:0032407]; MutSbeta complex binding [GO:0032408]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697] CRDYQEIK 0.99549 -11.655 0 0 0 0 0 0 0 0 0 0 0 12.2643 0 0 0 0 0 0 11.1803 0 11.844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4271 0 0 0 12.0609 0 0 0 9.75909 0 0 0 10.2197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8438 14.0448 0 13.967 14.3556 0 0 0 14.5877 0 14.7169 0 13.5289 14.6782 0 0 14.3337 14.4726 0 14.459 14.3838 13.0729 0 13.5444 0 0 0 0 0 0 13.2055 0 0 0 12.8927 0 0 0 0 0 14.0645 0 15.2381 0 0 13.8668 0 0 0 13.5286 0 0 13.5074 13.2972 14.2347 14.0184 13.7674 13.8334 13.8871 14.071 0 11.0034 14.5298 0 0 0 11.8884 0 0 14.5775 0 13.2541 14.5209 0 0 0 14.04 0 12.3663 14.5372 0 0 13.5141 0 0 0 10.1054 0 0 0 15.4561 0 0 0 12.4891 0 0 0 0 13.4263 0 0 0 0 0 0 Q96DL1 NXPE2_HUMAN NXPE family member 2 (Protein FAM55B) NXPE2 FAM55B Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ARNQGCDR 0.9955 -10.347 11.6915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3093 0 0 0 0 0 0 13.416 0 0 0 0 0 0 0 0 10.5984 0 0 0 0 0 12.4024 0 0 14.3327 0 0 12.1116 0 12.0033 0 0 0 0 0 12.7046 0 0 0 11.3942 0 10.6876 0 0 0 0 0 0 0 0 11.437 11.7892 14.1138 0 13.3483 0 0 0 14.7236 0 0 0 13.042 13.836 10.3162 15.6383 17.8771 18.318 18.3897 19.2141 0 18.019 15.7094 17.7531 16.0535 16.4305 13.499 17.4752 15.4903 17.6559 18.0995 13.9829 16.8008 17.4177 16.4827 14.5787 17.1426 15.4118 16.4951 16.1758 17.6756 15.6232 17.3502 15.0226 14.6 15.4855 15.4729 16.9259 15.0793 16.8545 17.32 14.8575 15.9895 17.3351 13.935 17.3392 16.6006 16.6784 18.0182 17.6387 16.3584 17.5887 17.2991 15.2668 13.8619 14.8379 17.3119 15.5631 15.0044 17.4594 15.5287 14.0892 14.3019 13.4921 14.6814 16.1057 16.7487 16.8365 16.5783 16.0057 16.5326 0 0 0 16.8061 16.5497 0 14.7243 0 15.1423 17.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0789 14.1536 16.4484 16.3919 16.2001 0 12.0554 0 13.8905 0 P05166 PCCB_HUMAN "Propionyl-CoA carboxylase beta chain, mitochondrial, PCCase subunit beta, EC 6.4.1.3 (Propanoyl-CoA:carbon dioxide ligase subunit beta)" PCCB Homo sapiens (Human) branched-chain amino acid metabolic process [GO:0009081]; fatty acid metabolic process [GO:0006631]; short-chain fatty acid catabolic process [GO:0019626] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; branched-chain amino acid metabolic process [GO:0009081]; fatty acid metabolic process [GO:0006631]; short-chain fatty acid catabolic process [GO:0019626] GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006631; GO:0009081; GO:0019626; GO:1902494 ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658] AAALRVAAVGAR 0.9955 -12.814 11.2901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.727 0 0 0 0 12.2907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3926 0 0 0 0 0 0 0 0 0 12.9474 14.0059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.792 0 0 0 0 0 0 0 0 0 0 13.31 12.8877 0 0 11.9921 0 0 0 0 0 0 0 0 0 11.7707 12.1307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6568 13.4602 0 0 13.9001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P16455 MGMT_HUMAN "Methylated-DNA--protein-cysteine methyltransferase, EC 2.1.1.63 (6-O-methylguanine-DNA methyltransferase, MGMT) (O-6-methylguanine-DNA-alkyltransferase)" MGMT Homo sapiens (Human) cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168]; cellular response to ionizing radiation [GO:0071479]; cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA ligation [GO:0006266]; DNA repair [GO:0006281]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; positive regulation of double-strand break repair [GO:2000781]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410] GO:0003677; GO:0003908; GO:0005509; GO:0005634; GO:0005654; GO:0006266; GO:0006281; GO:0006307; GO:0008168; GO:0009008; GO:0009410; GO:0009636; GO:0016020; GO:0034599; GO:0043066; GO:0043281; GO:0045471; GO:0051593; GO:0060644; GO:0071407; GO:0071479; GO:2000781 calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; methyltransferase activity [GO:0008168] DKDCEMK 0.9955 -12.777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53602 MVD1_HUMAN "Diphosphomevalonate decarboxylase, EC 4.1.1.33 (Mevalonate (diphospho)decarboxylase, MDDase) (Mevalonate pyrophosphate decarboxylase)" MVD MPD Homo sapiens (Human) "cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]" cytosol [GO:0005829] "cytosol [GO:0005829]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]" GO:0004163; GO:0005524; GO:0005829; GO:0006695; GO:0008284; GO:0008299; GO:0019287; GO:0030544; GO:0042803 ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803] EEDVGQPRLQACLREIR 0.9955 -12.778 0 11.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7214 0 15.1069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7076 0 0 0 0 0 0 0 0 0 0 14.668 0 0 0 0 Q8NA70 FA47B_HUMAN Protein FAM47B FAM47B Homo sapiens (Human) AFVEEVEAQLMTK 0.9955 -12.782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.865 0 0 0 0 0 0 0 12.6312 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0455 11.8542 12.7891 0 0 0 0 0 0 0 12.0783 0 0 12.9165 0 0 0 0 0 0 13.2583 0 0 0 0 0 0 0 0 0 13.007 0 0 0 0 0 0 13.5209 0 0 0 0 0 0 0 12.6931 0 0 0 0 12.8094 0 0 0 12.8782 0 0 0 12.8245 0 0 13.8336 0 0 13.7023 0 14.7055 0 0 0 0 0 0 0 0 0 0 0 14.6095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99678 GPR20_HUMAN G-protein coupled receptor 20 GPR20 Homo sapiens (Human) positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; G protein-coupled receptor activity [GO:0004930]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025] GO:0004930; GO:0005829; GO:0005886; GO:0005887; GO:0035025; GO:0043235; GO:0051482 G protein-coupled receptor activity [GO:0004930] CRQPACAR 0.9955 -12.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6339 0 13.8097 13.8471 0 0 0 0 0 0 0 0 0 0 0 0 0 13.68 0 0 13.8941 0 0 0 0 0 0 0 13.8192 13.6623 0 0 0 0 13.5751 13.5637 13.9197 15.0976 0 0 0 0 0 0 0 0 0 15.0257 0 13.5296 0 0 0 0 0 0 0 15.0612 0 0 15.0252 15.0847 0 0 0 0 14.9468 0 14.4079 0 13.6405 0 0 0 0 0 0 0 0 0 0 0 0 13.7478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2866 0 0 0 13.6071 0 P22460 KCNA5_HUMAN Potassium voltage-gated channel subfamily A member 5 (HPCN1) (Voltage-gated potassium channel HK2) (Voltage-gated potassium channel subunit Kv1.5) KCNA5 Homo sapiens (Human) atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018] cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; intracellular canaliculus [GO:0046691]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; voltage-gated potassium channel complex [GO:0008076]; Z disc [GO:0030018]; alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090]; atrial cardiac muscle cell action potential [GO:0086014]; membrane hyperpolarization [GO:0060081]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; membrane repolarization during bundle of His cell action potential [GO:0086050]; membrane repolarization during SA node cell action potential [GO:0086052]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; Notch signaling pathway [GO:0007219]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of myoblast proliferation [GO:2000288]; potassium ion export across plasma membrane [GO:0097623]; potassium ion homeostasis [GO:0055075]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of insulin secretion [GO:0050796]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391]; regulation of potassium ion transport [GO:0043266]; regulation of vasoconstriction [GO:0019229]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic substance [GO:0010033] GO:0001666; GO:0005102; GO:0005249; GO:0005251; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0006813; GO:0007219; GO:0008076; GO:0009612; GO:0009986; GO:0010033; GO:0014704; GO:0015271; GO:0016021; GO:0019229; GO:0019901; GO:0030018; GO:0034705; GO:0034765; GO:0042391; GO:0042542; GO:0043266; GO:0045121; GO:0046691; GO:0048471; GO:0050796; GO:0051260; GO:0051393; GO:0051481; GO:0055075; GO:0055093; GO:0060081; GO:0060372; GO:0071805; GO:0086014; GO:0086050; GO:0086052; GO:0086087; GO:0086089; GO:0086090; GO:0086091; GO:0097110; GO:0097623; GO:0098914; GO:1900087; GO:2000288 alpha-actinin binding [GO:0051393]; delayed rectifier potassium channel activity [GO:0005251]; outward rectifier potassium channel activity [GO:0015271]; protein kinase binding [GO:0019901]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization [GO:0086087]; voltage-gated potassium channel activity involved in SA node cell action potential repolarization [GO:0086090] EEEKPLPR 0.99551 -11.799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5102 0 0 12.6354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81009 0 0 0 0 0 0 0 0 P41227 NAA10_HUMAN "N-alpha-acetyltransferase 10, EC 2.3.1.255 (N-terminal acetyltransferase complex ARD1 subunit homolog A, hARD1) (NatA catalytic subunit Naa10)" NAA10 ARD1 ARD1A TE2 Homo sapiens (Human) "chromosome organization [GO:0051276]; internal protein amino acid acetylation [GO:0006475]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]; protein acetylation [GO:0006473]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; chromosome organization [GO:0051276]; internal protein amino acid acetylation [GO:0006475]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]; protein acetylation [GO:0006473]" GO:0004596; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0006473; GO:0006474; GO:0006475; GO:0008080; GO:0016020; GO:0031415; GO:0051276; GO:1990189; GO:1990190; GO:2000719 N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189] DSSEASDSAS 0.99551 -9.927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9631 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q06278 AOXA_HUMAN "Aldehyde oxidase, EC 1.2.3.1 (Aldehyde oxidase 1) (Azaheterocycle hydroxylase, EC 1.17.3.-)" AOX1 AO Homo sapiens (Human) lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805]" GO:0004031; GO:0005506; GO:0005829; GO:0006629; GO:0006805; GO:0016491; GO:0042802; GO:0042803; GO:0043546; GO:0050660; GO:0051287; GO:0051537; GO:0070062; GO:0071949 "2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]" CGLSPEKVR 0.99551 -11.802 0 0 0 0 0 0 0 0 0 0 0 10.8549 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3541 0 0 11.5433 12.0468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4887 0 0 0 0 0 0 14.1531 0 0 0 0 10.4537 0 0 0 0 0 0 13.231 0 0 0 0 13.0982 0 0 13.0191 0 12.4526 13.6695 0 0 0 13.5162 0 0 0 18.8358 13.447 0 14.0957 13.645 13.4735 12.3295 0 0 0 0 0 0 0 0 0 0 0 16.1307 0 0 0 0 17.2151 0 0 12.4355 0 0 0 0 0 0 0 0 0 11.9181 0 0 0 16.588 0 17.0131 12.1729 0 0 12.9621 0 16.5797 16.4262 0 16.7537 12.2398 16.3373 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2354 0 0 12.7714 0 0 12.2003 0 17.6101 0 0 0 0 0 0 0 0 0 0 0 Q5JR12 PPM1J_HUMAN "Protein phosphatase 1J, EC 3.1.3.16 (Protein phosphatase 2C isoform zeta, PP2C-zeta)" PPM1J PPP2CZ Homo sapiens (Human) protein dephosphorylation [GO:0006470] myosin phosphatase activity [GO:0017018]; protein dephosphorylation [GO:0006470] GO:0006470; GO:0017018 myosin phosphatase activity [GO:0017018] LLHRHIR 0.99551 -9.9282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6Q0C0 TRAF7_HUMAN "E3 ubiquitin-protein ligase TRAF7, EC 2.3.2.27 (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)" TRAF7 RFWD1 RNF119 Homo sapiens (Human) apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ribosomal large subunit assembly [GO:0000027] cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ribosomal large subunit assembly [GO:0000027] GO:0000027; GO:0000151; GO:0004842; GO:0005730; GO:0005886; GO:0006915; GO:0007219; GO:0008270; GO:0016567; GO:0031410; GO:0043231; GO:0043410; GO:0070372; GO:2001235 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CPVDNVK 0.99551 -11.861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7424 12.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9863 0 0 0 0 10.8986 0 0 0 0 0 0 0 0 13.4147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.004 0 0 0 0 0 0 14.4033 0 0 0 0 0 13.1839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4099 0 0 0 12.1247 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUX9 CHMP7_HUMAN Charged multivesicular body protein 7 (Chromatin-modifying protein 7) CHMP7 Homo sapiens (Human) autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex disassembly [GO:1904903]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein localization to chromatin [GO:0071168]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex disassembly [GO:1904903]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of cell death [GO:0060548]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein localization to chromatin [GO:0071168]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702] GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005771; GO:0005828; GO:0005829; GO:0005886; GO:0006900; GO:0006914; GO:0006997; GO:0007080; GO:0010458; GO:0015031; GO:0030496; GO:0031468; GO:0032511; GO:0032585; GO:0036258; GO:0039702; GO:0043162; GO:0045324; GO:0046761; GO:0051469; GO:0060548; GO:0061763; GO:0061952; GO:0071168; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904903; GO:1904930 CKEEARR 0.99551 -33.519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5895 0 0 0 0 12.2809 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5935 0 0 0 0 0 17.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7383 13.5087 0 0 13.5394 13.9146 0 0 12.9004 0 0 0 0 13.717 0 13.3426 11.393 10.7075 0 0 0 0 0 12.2922 0 0 13.0879 0 0 13.3824 0 0 0 0 0 13.5974 0 10.2075 0 13.8575 0 0 12.0531 0 11.6188 0 0 0 13.0584 0 12.0813 12.8272 0 0 0 0 12.7083 0 12.2063 0 0 14.4567 0 12.0268 11.777 0 0 0 0 0 18.6061 18.7147 0 0 0 0 0 0 11.9621 0 0 0 0 10.8783 0 0 0 0 0 0 0 0 0 Q9Y5Q8 TF3C5_HUMAN "General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit, TFIIIC 63 kDa subunit, TFIIIC63) (Transcription factor IIIC subunit epsilon)" GTF3C5 CDABP0017 Homo sapiens (Human) 5S class rRNA transcription by RNA polymerase III [GO:0042791]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127] nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]; DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995]; 5S class rRNA transcription by RNA polymerase III [GO:0042791]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384]; tRNA transcription by RNA polymerase III [GO:0042797] GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0006383; GO:0006384; GO:0035914; GO:0042791; GO:0042797 DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995] DGWCLPK 0.99551 -33.758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0096 0 0 0 0 0 0 0 0 0 0 0 9.96258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2445 0 14.343 0 0 0 0 0 0 0 0 0 0 0 0 12.67 12.1101 0 0 11.5053 0 0 12.2894 0 0 0 0 0 10.7082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0391 0 0 0 12.4805 Q13823 NOG2_HUMAN Nucleolar GTP-binding protein 2 (Autoantigen NGP-1) GNL2 NGP1 Homo sapiens (Human) ribosome biogenesis [GO:0042254] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634] membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; ribosome biogenesis [GO:0042254] GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0016020; GO:0042254 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723] ATIRRLNMYR 0.99552 -34.452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87075 0 0 0 0 0 0 0 11.362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5132 0 0 0 0 0 0 0 10.3012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1402 0 0 0 11.8544 12.3483 10.4435 0 13.8285 0 0 0 0 13.5865 0 0 10.8171 0 0 12.9812 0 0 0 0 0 0 0 0 0 0 0 0 0 11.332 0 0 0 0 14.8537 0 13.8016 0 0 0 12.7535 13.2605 0 0 0 0 0 0 10.6375 0 0 0 0 0 0 0 0 12.8011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2765 0 0 0 0 0 0 11.0958 0 0 0 Q7RTY5 PRS48_HUMAN "Serine protease 48, EC 3.4.21.- (Epidermis-specific serine protease-like protein)" PRSS48 ESSPL Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508 serine-type endopeptidase activity [GO:0004252] SLPGVYTNVIYYQK 0.99552 -8.8502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1988 0 0 0 0 13.2309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9H8 MUT7_HUMAN "Exonuclease mut-7 homolog, EC 3.1.-.- (Exonuclease 3'-5' domain-containing protein 3)" EXD3 HBE269 Homo sapiens (Human) 3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676] GO:0003676; GO:0008408; GO:0046872 3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676] AQQQAKAVLK 0.99552 -9.698 12.1908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9794 16.6233 0 0 0 0 0 0 0 16.0787 0 16.7231 0 0 0 0 0 0 0 0 9.88634 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7065 0 0 15.8423 0 0 0 16.4673 16.3234 16.0735 0 9.65843 0 0 15.3971 0 15.5938 0 13.8857 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2207 0 0 0 0 15.6327 0 13.7654 0 0 0 15.0636 14.3153 0 0 17.9053 22.0562 0 0 0 0 0 0 13.1611 0 0 0 0 0 0 15.2526 0 12.8775 12.9958 18.4184 0 0 0 0 0 0 9.92312 0 12.6991 0 12.6535 0 0 0 0 0 0 0 0 0 19.0623 0 0 11.0253 0 0 0 11.0428 11.3292 0 0 18.2634 18.2749 18.1565 11.893 0 0 11.5178 0 15.0926 19.0206 19.0699 18.781 0 0 16.7528 17.773 16.429 18.5297 16.5468 18.9294 18.0184 16.6863 16.6019 16.388 0 0 0 18.0457 17.8826 18.946 18.1286 17.9153 18.0607 Q8N9V7 TOPZ1_HUMAN Protein TOPAZ1 (Testis- and ovary-specific PAZ domain-containing protein 1) TOPAZ1 C3orf77 Homo sapiens (Human) apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; ncRNA transcription [GO:0098781]; spermatid development [GO:0007286]; spermatocyte division [GO:0048137] cytosol [GO:0005829] cytosol [GO:0005829]; apoptotic process [GO:0006915]; ectopic germ cell programmed cell death [GO:0035234]; ncRNA transcription [GO:0098781]; spermatid development [GO:0007286]; spermatocyte division [GO:0048137] GO:0005829; GO:0006915; GO:0007286; GO:0035234; GO:0048137; GO:0098781 CEDNQSR 0.99552 -34.552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8333 12.1096 0 0 0 0 0 0 0 13.1489 0 13.0926 13.0926 14.5491 16.1505 15.032 0 0 0 14.5841 14.419 0 0 12.203 13.0761 0 14.0727 0 14.519 0 0 0 0 13.3042 0 13.755 0 11.9538 0 0 0 12.9232 0 0 0 0 0 0 0 0 12.9044 0 0 0 0 0 0 0 0 11.9228 0 0 13.1179 0 0 13.4102 0 0 0 0 0 0 11.6486 0 0 0 0 0 0 0 0 0 0 10.5459 0 0 0 0 0 0 0 Q96P47 AGAP3_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3, AGAP-3 (CRAM-associated GTPase, CRAG) (Centaurin-gamma-3, Cnt-g3) (MR1-interacting protein, MRIP-1)" AGAP3 CENTG3 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cellular response to reactive oxygen species [GO:0034614]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; nucleus [GO:0005634] cell periphery [GO:0071944]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; activation of GTPase activity [GO:0090630]; cellular response to reactive oxygen species [GO:0034614]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161] GO:0003924; GO:0005096; GO:0005525; GO:0005634; GO:0005737; GO:0031593; GO:0034614; GO:0043161; GO:0046872; GO:0071944; GO:0090630 GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593] AIPIKQGILLK 0.99552 -9.9939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2576 0 13.4525 0 0 0 0 0 0 0 0 0 0 0 0 14.8166 0 14.6081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6035 0 0 0 0 0 14.7389 0 0 0 0 0 0 0 0 13.7153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0M0 WWP1_HUMAN "NEDD4-like E3 ubiquitin-protein ligase WWP1, EC 2.3.2.26 (Atrophin-1-interacting protein 5, AIP5) (HECT-type E3 ubiquitin transferase WWP1) (TGIF-interacting ubiquitin ligase 1, Tiul1) (WW domain-containing protein 1)" WWP1 Homo sapiens (Human) "central nervous system development [GO:0007417]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; central nervous system development [GO:0007417]; ion transmembrane transport [GO:0034220]; negative regulation of transcription, DNA-templated [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]" GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007417; GO:0016567; GO:0034220; GO:0043161; GO:0045892; GO:0046718; GO:0061630; GO:0070062 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] EWFFLLSHEVLNPMYCLFEYAGK 0.99552 -11.886 0 0 0 0 0 0 0 0 0 0 0 0 10.7367 0 0 0 0 0 0 0 0 0 10.8919 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9481 0 0 0 0 0 15.8434 0 0 15.4866 15.7427 0 15.8236 0 0 15.6552 15.412 0 0 15.4995 15.0586 0 0 0 0 13.7418 0 0 15.3946 14.8705 14.3335 0 0 0 0 14.7133 0 14.2323 0 13.8445 0 0 0 0 14.3156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3202 11.3833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5952 0 0 0 0 0 0 0 Q9UHI5 LAT2_HUMAN "Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2, hLAT2) (Solute carrier family 7 member 8)" SLC7A8 LAT2 Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; glycine transport [GO:0015816]; L-alanine import across plasma membrane [GO:1904273]; L-leucine import across plasma membrane [GO:1903801]; leucine import across plasma membrane [GO:0098713]; leucine transport [GO:0015820]; metal ion homeostasis [GO:0055065]; neutral amino acid transport [GO:0015804]; proline transmembrane transport [GO:0035524]; response to toxic substance [GO:0009636]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; valine transport [GO:0015829] GO:0005737; GO:0005886; GO:0005887; GO:0006865; GO:0009636; GO:0009925; GO:0015101; GO:0015171; GO:0015175; GO:0015179; GO:0015180; GO:0015187; GO:0015190; GO:0015349; GO:0015804; GO:0015816; GO:0015820; GO:0015827; GO:0015829; GO:0016323; GO:0016324; GO:0019534; GO:0031528; GO:0035524; GO:0042605; GO:0055065; GO:0070327; GO:0089718; GO:0098713; GO:0150104; GO:1903801; GO:1904273 amino acid transmembrane transporter activity [GO:0015171]; glycine transmembrane transporter activity [GO:0015187]; L-alanine transmembrane transporter activity [GO:0015180]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; neutral amino acid transmembrane transporter activity [GO:0015175]; organic cation transmembrane transporter activity [GO:0015101]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349]; toxin transmembrane transporter activity [GO:0019534] LFFAGAR 0.99552 -10.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKJ8 ADA21_HUMAN "Disintegrin and metalloproteinase domain-containing protein 21, ADAM 21, EC 3.4.24.-" ADAM21 Homo sapiens (Human) male gonad development [GO:0008584]; proteolysis [GO:0006508]; single fertilization [GO:0007338] axon [GO:0030424]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913] axon [GO:0030424]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sperm head plasma membrane [GO:1990913]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; male gonad development [GO:0008584]; proteolysis [GO:0006508]; single fertilization [GO:0007338] GO:0004222; GO:0005886; GO:0006508; GO:0007338; GO:0008237; GO:0008584; GO:0009897; GO:0016021; GO:0030424; GO:0043025; GO:0046872; GO:1990913 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237] CNNHDQHCR 0.99552 -9.6958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8673 0 0 0 0 0 0 12.6711 0 13.3837 0 12.685 0 0 0 0 0 0 13.5943 0 0 0 12.2866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2113 0 0 0 0 13.5356 0 0 13.2849 0 0 13.3515 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8876 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5715 0 14.0306 0 0 0 14.349 0 0 0 0 0 12.9735 0 0 0 0 0 12.5821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14842 FFAR1_HUMAN Free fatty acid receptor 1 (G-protein coupled receptor 40) FFAR1 GPR40 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; negative regulation of interleukin-1 beta production [GO:0032691]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; response to fatty acid [GO:0070542] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; bioactive lipid receptor activity [GO:0045125]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; negative regulation of interleukin-1 beta production [GO:0032691]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of insulin secretion [GO:0032024]; response to fatty acid [GO:0070542] GO:0004930; GO:0005886; GO:0005887; GO:0007186; GO:0007204; GO:0008289; GO:0030073; GO:0032024; GO:0032691; GO:0042593; GO:0045125; GO:0051928; GO:0070542 bioactive lipid receptor activity [GO:0045125]; G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289] ALARSGLTHRR 0.99553 -8.8761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.176 0 0 0 0 0 0 0 11.7354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3411 0 11.4094 0 0 0 0 13.7047 0 0 16.1244 15.9293 0 0 0 0 14.8726 0 0 0 0 0 0 0 0 0 0 0 14.6754 0 0 0 0 13.11 0 0 0 14.6583 0 0 0 0 0 0 0 0 0 0 0 0 10.0028 0 0 0 0 0 0 0 0 0 0 0 0 13.0086 0 0 0 0 12.4092 0 0 0 0 0 0 0 0 0 0 0 0 P0CI01 SPDE6_HUMAN Speedy protein E6 SPDYE6 Homo sapiens (Human) positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] protein kinase binding [GO:0019901]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737] GO:0019901; GO:0045737 protein kinase binding [GO:0019901] EWSDESEEEPEK 0.99553 -10.027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5377 0 0 12.0794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9551 0 15.1575 0 16.4168 14.2385 0 0 0 0 0 0 0 14.8496 0 0 0 0 0 11.2573 0 13.74 0 0 0 0 13.7485 0 13.3464 14.2168 0 0 0 13.3183 0 0 0 0 0 0 0 0 0 13.3588 0 0 13.5728 0 0 0 0 13.6969 14.2101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1376 0 13.5762 0 13.4779 0 0 0 0 0 Q06495 NPT2A_HUMAN "Sodium-dependent phosphate transport protein 2A, Sodium-phosphate transport protein 2A (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A, Na(+)/Pi cotransporter 2A, NaPi-2a) (Solute carrier family 34 member 1)" SLC34A1 NPT2 SLC17A2 Homo sapiens (Human) arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to phosphate starvation [GO:0016036]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium-dependent phosphate transport [GO:0044341]; tricarboxylic acid metabolic process [GO:0072350] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytosol [GO:0005829]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; sodium:phosphate symporter activity [GO:0005436]; arsenate ion transmembrane transport [GO:1901684]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to metal ion [GO:0071248]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to phosphate starvation [GO:0016036]; cellular response to staurosporine [GO:0072734]; dentinogenesis [GO:0097187]; gentamycin metabolic process [GO:1901128]; glycoprotein metabolic process [GO:0009100]; indole metabolic process [GO:0042431]; kidney development [GO:0001822]; ossification [GO:0001503]; phosphate ion homeostasis [GO:0055062]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; positive regulation of membrane potential [GO:0045838]; positive regulation of phosphate transmembrane transport [GO:2000187]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to lead ion [GO:0010288]; response to magnesium ion [GO:0032026]; response to mercury ion [GO:0046689]; response to potassium ion [GO:0035864]; response to thyroid hormone [GO:0097066]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium-dependent phosphate transport [GO:0044341]; tricarboxylic acid metabolic process [GO:0072350] GO:0001503; GO:0001822; GO:0005436; GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0005887; GO:0005903; GO:0006817; GO:0009100; GO:0009410; GO:0009986; GO:0010288; GO:0016036; GO:0016324; GO:0016607; GO:0030165; GO:0030643; GO:0031526; GO:0031982; GO:0032026; GO:0032355; GO:0033189; GO:0035435; GO:0035864; GO:0042431; GO:0042802; GO:0044341; GO:0044877; GO:0045121; GO:0045838; GO:0046686; GO:0046689; GO:0048471; GO:0055062; GO:0060416; GO:0071248; GO:0071374; GO:0072350; GO:0072686; GO:0072734; GO:0097066; GO:0097187; GO:0098719; GO:1901128; GO:1901684; GO:2000120; GO:2000187 identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; sodium:phosphate symporter activity [GO:0005436] CNHIFVDTGLPDLAVGLILLAGSLVLLCTCLILLVK 0.99553 -11.953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2337 0 0 0 14.1812 0 0 0 0 0 0 0 0 Q8TDN4 CABL1_HUMAN "CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1, Ik3-1)" CABLES1 CABLES Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726] GO:0005634; GO:0005829; GO:0007049; GO:0007399; GO:0051301; GO:0051726 FPHIKLTLSKIR 0.99553 -10.036 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9493 0 0 13.0271 0 0 0 13.2047 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9899 0 0 0 0 11.8482 0 0 0 0 0 12.7956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8022 0 0 14.3941 0 0 0 0 0 0 0 0 0 0 0 0 0 14.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4755 0 0 0 0 0 0 0 0 14.2066 0 0 0 0 0 0 0 0 13.6732 0 0 0 0 Q93100 KPBB_HUMAN "Phosphorylase b kinase regulatory subunit beta, Phosphorylase kinase subunit beta" PHKB Homo sapiens (Human) generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886] cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468] GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005977; GO:0006091; GO:0006468 calmodulin binding [GO:0005516] CNTHDER 0.99553 -31.696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7015 0 0 0 0 0 0 0 0 0 0 0 11.545 0 12.9158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64261 0 0 0 0 17.7401 12.993 0 0 0 13.4931 0 0 10.5728 0 0 0 0 12.4261 0 13.8887 0 0 13.8852 0 14.0631 0 14.1007 0 13.617 0 0 0 0 0 12.9444 0 0 12.5342 0 0 0 0 0 0 11.6535 12.8796 0 0 11.4819 0 0 11.1179 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4593 0 0 0 0 0 0 0 0 0 0 0 12.329 0 12.9244 0 0 0 0 0 0 10.4406 0 0 0 0 0 0 12.155 0 0 0 0 0 13.4556 0 0 12.1033 14.4615 0 0 0 11.4889 0 0 0 0 Q96JE9 MAP6_HUMAN "Microtubule-associated protein 6, MAP-6 (Stable tubule-only polypeptide, STOP)" MAP6 KIAA1878 Homo sapiens (Human) cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507] axon [GO:0030424]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle membrane [GO:0030658] axon [GO:0030424]; cis-Golgi network [GO:0005801]; dendrite [GO:0030425]; Golgi-associated vesicle [GO:0005798]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle membrane [GO:0030658]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; cytoskeleton-dependent intracellular transport [GO:0030705]; dendrite morphogenesis [GO:0048813]; lysosome localization [GO:0032418]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of axonogenesis [GO:0050772]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0000226; GO:0005516; GO:0005798; GO:0005801; GO:0005874; GO:0008017; GO:0030424; GO:0030425; GO:0030658; GO:0030705; GO:0032418; GO:0048471; GO:0048813; GO:0050772; GO:0070507 calmodulin binding [GO:0005516]; microtubule binding [GO:0008017] AWPLPRR 0.99553 -12.536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1362 0 0 0 0 0 0 0 0 0 0 12.8893 0 0 0 0 0 0 12.2405 0 0 0 0 0 0 0 0 13.0655 0 12.9417 11.4684 11.5753 0 12.2611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1626 0 0 0 0 0 11.7327 0 0 0 0 0 0 0 0 0 0 0 0 12.2179 0 0 0 0 0 0 0 Q96NN9 AIFM3_HUMAN "Apoptosis-inducing factor 3, EC 1.-.-.- (Apoptosis-inducing factor-like protein)" AIFM3 AIFL Homo sapiens (Human) execution phase of apoptosis [GO:0097194] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; execution phase of apoptosis [GO:0097194]" GO:0005737; GO:0005739; GO:0005743; GO:0005783; GO:0005829; GO:0016651; GO:0046872; GO:0050660; GO:0051537; GO:0097194 "2 iron, 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]" ASKQALQLQRR 0.99553 -31.693 0 0 0 0 0 0 0 0 13.0655 12.489 12.5822 12.8104 12.6311 0 0 11.8865 0 11.3273 13.0841 13.7576 0 0 0 0 0 11.9 0 0 11.9301 11.5812 0 0 0 0 0 11.3772 0 0 14.7116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4618 13.6713 15.3358 0 0 0 0 0 17.131 0 13.5674 0 16.1346 0 0 0 0 0 0 0 12.6295 13.5591 0 0 0 13.4751 14.0979 0 0 0 0 0 13.2231 0 13.7055 0 0 0 12.3259 0 0 0 13.5499 0 0 0 13.7136 0 13.9489 0 0 13.6061 13.9082 13.9784 13.7603 13.9686 0 13.7986 13.9734 0 13.2441 0 0 0 13.6437 0 0 0 0 0 0 Q9BUP0 EFHD1_HUMAN EF-hand domain-containing protein D1 (EF-hand domain-containing protein 1) (Swiprosin-2) EFHD1 SWS2 PP3051 Homo sapiens (Human) neuron projection development [GO:0031175]; regulation of cellular hyperosmotic salinity response [GO:1900069] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; neuron projection development [GO:0031175]; regulation of cellular hyperosmotic salinity response [GO:1900069] GO:0005509; GO:0005739; GO:0005743; GO:0031175; GO:0061891; GO:1900069 calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891] EVDEDFDGKLSFREFLLIFHK 0.99553 -9.5043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8848 0 0 0 0 12.7138 12.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0771 0 0 0 0 0 12.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6981 0 0 0 0 0 0 Q9HBL6 LRTM1_HUMAN Leucine-rich repeat and transmembrane domain-containing protein 1 LRTM1 HT017 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919] GO:0007411; GO:0008201; GO:0016021; GO:0048495; GO:0050919 heparin binding [GO:0008201]; Roundabout binding [GO:0048495] ALLESMPSVR 0.99553 -10.037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.764 0 0 0 0 0 0 0 0 0 0 15.6066 0 0 0 0 0 13.8834 0 0 13.2896 0 12.6735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQ11 AT132_HUMAN "Polyamine-transporting ATPase 13A2, EC 7.6.2.-" ATP13A2 PARK9 Homo sapiens (Human) autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; transmembrane transport [GO:0055085]; zinc ion homeostasis [GO:0055069] autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982] "autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; integral component of lysosomal membrane [GO:1905103]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]; ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; P-type transmembrane transporter activity [GO:0140358]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]; autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular cation homeostasis [GO:0030003]; cellular iron ion homeostasis [GO:0006879]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; cellular zinc ion homeostasis [GO:0006882]; extracellular exosome biogenesis [GO:0097734]; ion transmembrane transport [GO:0034220]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of glucosylceramidase activity [GO:1905123]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; transmembrane transport [GO:0055085]; zinc ion homeostasis [GO:0055069]" GO:0000421; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005776; GO:0006874; GO:0006879; GO:0006882; GO:0006914; GO:0007041; GO:0008270; GO:0010628; GO:0010821; GO:0015417; GO:0016020; GO:0016021; GO:0016241; GO:0016243; GO:0016887; GO:0019829; GO:0030003; GO:0030133; GO:0030145; GO:0031902; GO:0031982; GO:0032585; GO:0033157; GO:0034220; GO:0034599; GO:0043005; GO:0043025; GO:0043202; GO:0046777; GO:0050714; GO:0052548; GO:0055069; GO:0055085; GO:0055088; GO:0061462; GO:0061909; GO:0070300; GO:0071287; GO:0071294; GO:0080025; GO:0097734; GO:0140358; GO:1900180; GO:1901215; GO:1902047; GO:1903135; GO:1903146; GO:1903543; GO:1903710; GO:1904714; GO:1905037; GO:1905103; GO:1905123; GO:1905165; GO:1905166; GO:1990938; GO:2000152 "ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; P-type transmembrane transporter activity [GO:0140358]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; zinc ion binding [GO:0008270]" FKQLERELAEQPWPPLPAGPLR 0.99553 -10.031 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9546 0 0 0 0 10.0434 0 0 0 0 0 0 0 0 0 14.14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6251 0 0 0 10.3315 0 10.388 0 0 0 11.4905 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3125 0 0 0 0 0 0 15.7655 16.1797 15.6843 0 0 0 12.3413 11.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0626 0 0 0 0 0 14.4325 12.1021 12.086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1305 0 11.6502 0 0 0 0 0 Q9P2B2 FPRP_HUMAN "Prostaglandin F2 receptor negative regulator (CD9 partner 1, CD9P-1) (Glu-Trp-Ile EWI motif-containing protein F, EWI-F) (Prostaglandin F2-alpha receptor regulatory protein) (Prostaglandin F2-alpha receptor-associated protein) (CD antigen CD315)" PTGFRN CD9P1 EWIF FPRP KIAA1436 Homo sapiens (Human) lipid droplet organization [GO:0034389]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lipid droplet organization [GO:0034389]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905] GO:0005789; GO:0005794; GO:0009986; GO:0014905; GO:0016021; GO:0034389 EAEIHSK 0.99553 -8.8912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8405 14.7775 0 0 0 0 0 0 0 0 13.5137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8536 0 0 0 0 0 0 0 13.6692 0 0 0 17.2466 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4136 0 14.2053 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y223 GLCNE_HUMAN "Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing), EC 3.2.1.183 (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase, EC 2.7.1.60 (ManAc kinase) ]" GNE GLCNE Homo sapiens (Human) cell adhesion [GO:0007155]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate metabolic process [GO:0006054]; UDP-N-acetylglucosamine metabolic process [GO:0006047] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761]; cell adhesion [GO:0007155]; N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate metabolic process [GO:0006054]; UDP-N-acetylglucosamine metabolic process [GO:0006047]" GO:0004553; GO:0005524; GO:0005737; GO:0005829; GO:0006045; GO:0006047; GO:0006054; GO:0007155; GO:0008761; GO:0009384; GO:0046872 "ATP binding [GO:0005524]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; N-acylmannosamine kinase activity [GO:0009384]; UDP-N-acetylglucosamine 2-epimerase activity [GO:0008761]" EKNGNNR 0.99553 -11.987 0 0 11.6138 0 12.1196 0 0 11.744 0 0 0 0 0 0 0 0 0 12.3769 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2Q9 RT28_HUMAN "28S ribosomal protein S28, mitochondrial, MRP-S28, S28mt (28S ribosomal protein S35, mitochondrial, MRP-S35, S35mt) (Mitochondrial small ribosomal subunit protein bS1m)" MRPS28 MRPS35 HSPC007 Homo sapiens (Human) mitochondrial translation [GO:0032543] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; mitochondrial translation [GO:0032543] GO:0003723; GO:0005739; GO:0005743; GO:0005763; GO:0032543 RNA binding [GO:0003723] GTRVRLR 0.99553 -8.8587 0 0 0 0 0 0 0 0 11.384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.688 0 0 0 0 0 0 10.3884 0 0 11.5077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5956 0 0 0 0 0 0 0 13.2172 13.6702 14.0484 13.7835 0 13.9541 0 13.5697 0 0 0 13.6971 0 0 13.7852 0 0 0 0 13.7287 13.93 0 0 0 Q9Y4G2 PKHM1_HUMAN "Pleckstrin homology domain-containing family M member 1, PH domain-containing family M member 1 (162 kDa adapter protein, AP162)" PLEKHM1 KIAA0356 Homo sapiens (Human) autophagosome-lysosome fusion [GO:0061909]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031] autolysosome [GO:0044754]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleolus [GO:0005730] autolysosome [GO:0044754]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; autophagosome-lysosome fusion [GO:0061909]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029]; protein transport [GO:0015031] GO:0005730; GO:0005764; GO:0005765; GO:0015031; GO:0031902; GO:0032418; GO:0043231; GO:0044754; GO:0045780; GO:0046872; GO:0061909; GO:1900029; GO:1902774 metal ion binding [GO:0046872] EALQKVR 0.99553 -35.467 0 0 0 0 0 0 0 0 10.8179 0 0 0 0 0 0 0 0 0 0 0 10.9305 0 0 0 0 0 0 9.97269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4108 0 0 0 0 0 0 0 13.0445 0 0 0 12.0622 0 0 0 0 0 0 0 11.5163 0 13.6471 0 0 0 0 0 0 0 0 0 13.8229 0 0 13.1945 0 0 0 0 0 0 0 0 0 12.3309 0 0 0 0 0 0 0 0 11.0581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3683 0 10.2419 0 11.7956 11.6871 0 13.8745 0 0 0 0 0 0 0 0 0 0 0 Q5TC63 GRTP1_HUMAN Growth hormone-regulated TBC protein 1 (TBC1 domain family member 6) GRTP1 TBC1D6 Homo sapiens (Human) activation of GTPase activity [GO:0090630] GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630] GO:0005096; GO:0090630 GTPase activator activity [GO:0005096] IIFRVALTLIK 0.99554 -9.5167 0 0 0 0 0 0 0 0 17.021 18.0364 17.1638 17.2312 17.0539 16.9829 14.8803 13.603 14.3997 17.6602 16.4515 13.0174 0 0 13.5365 0 15.9495 13.6758 13.2828 13.4539 14.8356 15.7412 16.6098 14.6711 16.8978 17.5687 16.3938 17.5493 16.9458 15.2423 16.2831 16.7779 14.2739 13.3826 12.585 15.0321 16.3225 16.3617 16.0692 16.2404 13.6308 16.3544 13.2952 0 0 0 0 0 15.3863 14.8185 14.9037 14.716 0 0 14.1503 13.8521 14.2291 0 0 0 0 0 0 0 0 0 15.6127 14.884 0 0 0 11.2291 0 12.4842 11.4946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9452 0 0 15.2756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9459 0 0 14.7418 0 12.6365 0 0 0 0 0 0 0 17.7221 17.9525 0 14.5363 14.6041 0 13.8771 14.836 15.3169 14.143 15.2339 14.6139 18.17 0 0 0 0 0 14.9912 0 17.9397 0 18.2714 O00635 TRI38_HUMAN "E3 ubiquitin-protein ligase TRIM38, EC 2.3.2.27 (RING finger protein 15) (Tripartite motif-containing protein 38) (Zinc finger protein RoRet)" TRIM38 RNF15 RORET Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of defense response to virus [GO:0050687]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of viral entry into host cell [GO:0046598]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of interferon-beta production [GO:0032648]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of defense response to virus [GO:0050687]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of viral entry into host cell [GO:0046598]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468]; regulation of interferon-beta production [GO:0032648]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596] GO:0000209; GO:0003713; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0016925; GO:0019901; GO:0032648; GO:0032880; GO:0042803; GO:0043123; GO:0043161; GO:0045070; GO:0045087; GO:0046596; GO:0046598; GO:0050687; GO:0051091; GO:0051092; GO:0061630; GO:0070936 protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ASTTSTK 0.99554 -35.57 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7248 0 0 0 0 18.4667 11.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7423 0 0 0 0 0 0 0 0 0 12.6215 0 0 0 0 Q0VF49 K2012_HUMAN Uncharacterized protein KIAA2012 KIAA2012 Homo sapiens (Human) AFGHGRIDHSWLPSDK 0.99554 -35.544 0 0 9.24332 0 0 0 0 0 9.96291 0 0 0 0 0 0 0 0 12.1875 0 10.9013 0 12.1381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6004 0 0 0 0 0 0 15.4097 0 0 0 0 0 0 0 0 0 0 0 12.8298 0 0 0 0 0 0 0 0 0 0 0 0 13.0794 0 13.0792 13.7116 0 0 0 0 0 14.3784 13.8192 0 0 13.0207 15.0265 0 0 0 15.9998 0 15.2764 0 13.7779 0 0 0 0 0 0 0 13.9268 0 0 14.2555 0 12.1477 0 13.9508 0 13.7347 13.8965 17.1676 0 0 13.8111 0 0 13.8878 14.0405 0 0 13.7234 13.8846 0 0 0 0 14.4875 0 13.8794 14.1199 0 0 0 0 0 0 14.0018 0 0 0 0 0 14.1384 14.1227 0 0 13.1615 0 0 13.253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.776 12.9524 0 12.6083 0 0 Q15746 MYLK_HUMAN "Myosin light chain kinase, smooth muscle, MLCK, smMLCK, EC 2.7.11.18 (Kinase-related protein, KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form ]" MYLK MLCK MLCK1 MYLK1 Homo sapiens (Human) aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820] actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820] GO:0001725; GO:0003779; GO:0004672; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006939; GO:0014820; GO:0015629; GO:0030027; GO:0030335; GO:0032060; GO:0032154; GO:0046872; GO:0051928; GO:0060414; GO:0071476; GO:0090303 actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; protein kinase activity [GO:0004672] DEVEVSDDDEK 0.99554 -9.5161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7093 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2224 0 0 0 0 0 11.517 0 0 0 0 0 0 0 12.925 0 0 0 0 0 10.5023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8485 0 0 0 10.036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG08 HELB_HUMAN "DNA helicase B, hDHB, EC 3.6.4.12" HELB Homo sapiens (Human) "cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]" GO:0000462; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006260; GO:0006269; GO:0006281; GO:0006974; GO:0016887; GO:0017116; GO:0035861; GO:0043139; GO:0044877; GO:1903775; GO:2000042 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116] ECEVSSDDVNK 0.99554 -12.013 14.6048 0 0 11.9651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8546 12.1627 0 0 0 0 13.4146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8718 13.8226 12.8509 0 0 0 0 0 0 13.2109 0 15.0293 13.3942 13.6659 13.1821 13.1035 0 14.6741 0 0 0 0 13.1329 0 14.8468 15.2904 15.4715 0 13.372 14.0492 0 0 0 0 0 0 0 13.7515 13.5697 0 14.5327 14.7956 0 0 0 17.0809 14.4286 0 0 0 0 0 13.6922 0 0 0 0 12.9114 14.1996 0 13.5098 14.9829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3328 13.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7579 12.5242 13.5272 0 0 0 16.4608 0 Q9NPB6 PAR6A_HUMAN "Partitioning defective 6 homolog alpha, PAR-6, PAR-6 alpha, PAR-6A (PAR6C) (Tax interaction protein 40, TIP-40)" PARD6A PAR6A Homo sapiens (Human) cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; viral process [GO:0016032] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; tight junction [GO:0070160] apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; tight junction [GO:0070160]; GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267]; cell division [GO:0051301]; cell-cell junction maintenance [GO:0045217]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein secretion [GO:0050714]; regulation of cellular localization [GO:0060341]; viral process [GO:0016032] GO:0001726; GO:0001933; GO:0005080; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0005923; GO:0005938; GO:0007098; GO:0007163; GO:0016032; GO:0016324; GO:0030742; GO:0031267; GO:0034451; GO:0045197; GO:0045217; GO:0050714; GO:0051301; GO:0060341; GO:0070160; GO:0120157; GO:1904781 GTP-dependent protein binding [GO:0030742]; protein kinase C binding [GO:0005080]; small GTPase binding [GO:0031267] ALASGPPPLRLLVQK 0.99554 -9.5264 0 0 0 0 0 0 0 0 0 0 0 12.5342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6892 0 0 0 0 0 0 0 0 11.3263 0 0 0 0 0 0 0 0 0 11.6548 0 0 15.3286 0 0 0 0 0 0 14.2739 0 11.9008 12.9276 0 0 0 0 0 10.9128 0 10.523 10.6343 0 0 0 12.0736 0 13.6965 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8389 0 0 14.8433 0 0 0 11.8756 0 0 0 0 0 12.5333 0 0 12.7259 0 0 12.364 0 0 0 0 0 0 0 10.8236 0 0 0 0 0 0 0 0 0 0 11.3337 0 0 0 0 13.0792 0 0 0 0 10.3055 15.0283 0 11.7674 0 Q9UK32 KS6A6_HUMAN "Ribosomal protein S6 kinase alpha-6, S6K-alpha-6, EC 2.7.11.1 (90 kDa ribosomal protein S6 kinase 6, p90-RSK 6, p90RSK6) (Ribosomal S6 kinase 4, RSK-4) (pp90RSK4)" RPS6KA6 RSK4 Homo sapiens (Human) "central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; central nervous system development [GO:0007417]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of embryonic development [GO:0045992]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mesoderm development [GO:2000381]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]" GO:0000287; GO:0001650; GO:0004672; GO:0004674; GO:0004711; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006978; GO:0007165; GO:0007417; GO:0018105; GO:0045992; GO:0070373; GO:0106310; GO:2000381 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711] GGDVFTR 0.99554 -9.5178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2061 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2215 0 0 9.91804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7064 0 0 0 0 0 0 11.691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7223 0 0 0 0 0 0 0 0 0 10.4907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8332 0 0 0 A0A1B0GTH6 CS2IP_HUMAN Casein kinase II subunit alpha'-interacting protein CSNKA2IP Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 ALSSTLLQSKPQKTSSLDYLWTSSLQR 0.99555 -12.155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7985 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5379 0 0 0 0 0 13.7075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2882 P00740 FA9_HUMAN "Coagulation factor IX, EC 3.4.21.22 (Christmas factor) (Plasma thromboplastin component, PTC) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain ]" F9 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370] "collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; serine-type endopeptidase complex [GO:1905370]; calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]" GO:0004175; GO:0004252; GO:0005509; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006508; GO:0007596; GO:0007597; GO:0016020; GO:0031638; GO:0032991; GO:0062023; GO:0070062; GO:1905370 calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252] CSFEEAR 0.99555 -9.8372 11.8905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3089 0 0 0 0 0 0 0 14.0252 0 0 0 13.9516 0 0 0 0 0 0 0 0 0 14.8454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0907 0 0 0 0 0 0 0 0 0 11.8258 0 10.7396 0 13.085 0 0 14.0767 0 0 0 0 0 11.8174 12.746 0 0 0 0 0 0 0 14.4633 0 13.1756 0 0 0 0 0 0 13.7413 0 0 0 12.8274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7948 0 0 0 0 0 P04066 FUCO_HUMAN "Tissue alpha-L-fucosidase, EC 3.2.1.51 (Alpha-L-fucosidase I) (Alpha-L-fucoside fucohydrolase 1, Alpha-L-fucosidase 1)" FUCA1 Nbla10230 Homo sapiens (Human) fucose metabolic process [GO:0006004]; glycolipid catabolic process [GO:0019377]; glycosaminoglycan catabolic process [GO:0006027]; glycoside catabolic process [GO:0016139] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycolipid catabolic process [GO:0019377]; glycosaminoglycan catabolic process [GO:0006027]; glycoside catabolic process [GO:0016139] GO:0004560; GO:0005576; GO:0005737; GO:0005764; GO:0006004; GO:0006027; GO:0016139; GO:0019377; GO:0035578; GO:0043202; GO:0043231; GO:0070062 alpha-L-fucosidase activity [GO:0004560] DEVVVNDRWGQNCSCHHGGYYNCEDK 0.99555 -10.304 0 0 0 0 0 0 0 0 0 0 0 12.0615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1944 0 0 0 0 11.505 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7234 0 0 0 0 0 0 0 0 11.1169 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5695 11.8051 0 12.0687 0 0 0 13.724 0 0 0 0 0 12.6916 11.9697 11.2265 0 0 0 0 12.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6932 0 0 0 0 0 0 0 12.2889 0 14.8289 0 0 11.9781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1966 0 0 0 12.4757 0 0 0 0 0 0 0 0 0 0 13.0033 11.6317 0 12.5803 12.098 0 13.6684 0 0 0 0 0 11.1053 0 12.0751 0 0 0 0 0 0 0 0 12.9098 0 0 0 0 0 0 P17252 KPCA_HUMAN "Protein kinase C alpha type, PKC-A, PKC-alpha, EC 2.7.11.13" PRKCA PKCA PRKACA Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; intracellular signal transduction [GO:0035556]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555] alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; histone kinase activity (H3-T6 specific) [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; intracellular signal transduction [GO:0035556]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555] GO:0001525; GO:0001938; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006468; GO:0007077; GO:0007155; GO:0008270; GO:0010595; GO:0010613; GO:0018105; GO:0018107; GO:0019899; GO:0030335; GO:0031666; GO:0031966; GO:0034351; GO:0035403; GO:0035556; GO:0035866; GO:0043488; GO:0043536; GO:0043687; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045931; GO:0048471; GO:0070062; GO:0070374; GO:0070555; GO:0090330; GO:0097190; GO:0106071; GO:0106310; GO:2000707 ATP binding [GO:0005524]; calcium-dependent protein kinase C activity [GO:0004698]; enzyme binding [GO:0019899]; histone kinase activity (H3-T6 specific) [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270] AKLGPAGNKVISPSEDR 0.99555 -12.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P55283 CADH4_HUMAN "Cadherin-4 (Retinal cadherin, R-CAD, R-cadherin)" CDH4 Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of axon extension [GO:0045773] catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] catenin complex [GO:0016342]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of axon extension [GO:0045773] GO:0005509; GO:0005886; GO:0005887; GO:0007155; GO:0007156; GO:0007157; GO:0007411; GO:0016342; GO:0045296; GO:0045773; GO:0048675; GO:0098742 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] EKERHTK 0.99555 -9.8457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4954 0 12.2151 0 11.4252 0 0 0 0 0 0 0 0 0 0 0 0 12.8223 0 0 0 0 0 14.4217 0 0 0 0 0 0 0 12.6638 10.6753 12.1422 12.3288 0 0 0 0 0 10.969 0 0 0 0 0 0 0 0 0 12.6265 0 0 13.6468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7973 0 0 0 0 0 0 14.8777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q4G176 ACSF3_HUMAN "Malonate--CoA ligase ACSF3, mitochondrial, EC 6.2.1.n3 (Acyl-CoA synthetase family member 3)" ACSF3 PSEC0197 Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; malonate catabolic process [GO:0090410] GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0006631; GO:0006633; GO:0016405; GO:0016878; GO:0031957; GO:0035338; GO:0090409; GO:0090410 acid-thiol ligase activity [GO:0016878]; ATP binding [GO:0005524]; CoA-ligase activity [GO:0016405]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957] ALAFGDRIALVDQHGRHTYR 0.99555 -10.292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9803 0 0 0 0 0 0 0 0 0 0 15.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8512 0 0 0 0 12.6278 0 0 13.3857 0 0 0 0 0 0 0 0 0 0 0 11.0831 0 0 0 0 0 0 0 0 0 0 11.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53G59 KLH12_HUMAN "Kelch-like protein 12 (CUL3-interacting protein 1) (DKIR homolog, hDKIR)" KLHL12 C3IP1 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055] centriolar satellite [GO:0034451]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] centriolar satellite [GO:0034451]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055] GO:0005829; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0034451; GO:0042802; GO:0043231; GO:0048208 identical protein binding [GO:0042802] KFHLRPELR 0.99555 -10.295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6229 12.1821 0 13.0391 0 0 0 0 0 0 0 0 0 12.022 0 0 0 0 Q6ZMG9 CERS6_HUMAN "Ceramide synthase 6, CerS6 (LAG1 longevity assurance homolog 6) (Sphingoid base N-palmitoyltransferase CERS6, EC 2.3.1.291)" CERS6 LASS6 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; inflammatory response [GO:0006954]; sphingolipid biosynthetic process [GO:0030148] GO:0003677; GO:0005783; GO:0005789; GO:0006954; GO:0016020; GO:0016021; GO:0016410; GO:0030148; GO:0046513; GO:0050291 DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] DDRSDIESSSDEEDSEPPGK 0.99555 -10.305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3818 0 0 11.6659 0 0 14.178 0 0 0 14.3075 0 0 0 0 0 0 14.7636 0 0 0 0 0 0 11.7541 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8567 0 13.3298 0 13.992 0 0 0 13.8865 14.3359 13.3273 0 0 0 13.8072 13.7509 0 12.922 13.8355 13.0007 0 0 0 0 0 0 13.7503 0 13.4075 13.3108 13.2267 12.9114 0 12.32 0 12.0868 0 0 0 0 0 0 0 0 0 0 0 13.8997 0 14.0874 14.5538 13.0393 0 13.3587 13.4544 0 0 0 0 0 0 11.5635 0 0 0 0 12.0245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86WK7 AMGO3_HUMAN Amphoterin-induced protein 3 (AMIGO-3) (Alivin-3) AMIGO3 ALI3 KIAA1851 UNQ6084/PRO20089 Homo sapiens (Human) brain development [GO:0007420]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of neuron projection development [GO:0010977]; positive regulation of synapse assembly [GO:0051965] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; protein-containing complex binding [GO:0044877]; brain development [GO:0007420]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; negative regulation of neuron projection development [GO:0010977]; positive regulation of synapse assembly [GO:0051965] GO:0007157; GO:0007420; GO:0010977; GO:0016021; GO:0044877; GO:0051965 protein-containing complex binding [GO:0044877] LLLFNNR 0.99555 -12.153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.072 0 0 0 0 0 0 0 0 0 0 0 17.4406 0 0 0 0 0 0 0 0 0 0 17.4147 0 0 0 13.3906 13.7449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWU4 ZNT8_HUMAN "Zinc transporter 8, ZnT-8 (Solute carrier family 30 member 8)" SLC30A8 ZNT8 Homo sapiens (Human) cellular zinc ion homeostasis [GO:0006882]; insulin processing [GO:0030070]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; regulation of sequestering of zinc ion [GO:0061088]; regulation of vesicle-mediated transport [GO:0060627]; response to glucose [GO:0009749]; response to interferon-gamma [GO:0034341]; response to interleukin-1 [GO:0070555]; response to zinc ion [GO:0010043]; sequestering of zinc ion [GO:0032119]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; insulin processing [GO:0030070]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; regulation of sequestering of zinc ion [GO:0061088]; regulation of vesicle-mediated transport [GO:0060627]; response to glucose [GO:0009749]; response to interferon-gamma [GO:0034341]; response to interleukin-1 [GO:0070555]; response to zinc ion [GO:0010043]; sequestering of zinc ion [GO:0032119]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] GO:0005385; GO:0005886; GO:0006829; GO:0006882; GO:0008270; GO:0009749; GO:0010043; GO:0016021; GO:0030070; GO:0030073; GO:0030141; GO:0030658; GO:0030667; GO:0031410; GO:0032024; GO:0032119; GO:0034341; GO:0042803; GO:0060627; GO:0061088; GO:0070555; GO:0071577 protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; zinc ion transmembrane transporter activity [GO:0005385] AAFVHALGDLFQSISVLISALIIYFKPEYK 0.99555 -9.8442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2637 12.2112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0249 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9604 0 0 0 0 0 0 0 0 0 0 11.8524 0 0 0 0 0 0 0 0 11.7981 0 0 0 0 12.1056 0 0 0 0 0 0 14.0615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDC3 BRSK1_HUMAN "Serine/threonine-protein kinase BRSK1, EC 2.7.11.1 (Brain-selective kinase 1, EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1, BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1, SAD1 homolog, hSAD1)" BRSK1 KIAA1811 SAD1 SADB Homo sapiens (Human) associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle clustering [GO:2000807]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504] anchoring junction [GO:0070161]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021] anchoring junction [GO:0070161]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; centrosome duplication [GO:0051298]; establishment of cell polarity [GO:0030010]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of neuron projection development [GO:0010975]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle clustering [GO:2000807]; response to UV [GO:0009411]; synaptic vesicle cycle [GO:0099504] GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006468; GO:0006974; GO:0007095; GO:0007269; GO:0007409; GO:0008021; GO:0008306; GO:0009411; GO:0010975; GO:0018105; GO:0019901; GO:0030010; GO:0030054; GO:0030182; GO:0035556; GO:0042149; GO:0043015; GO:0048156; GO:0048167; GO:0048786; GO:0050321; GO:0050770; GO:0051298; GO:0070161; GO:0090176; GO:0099504; GO:0106310; GO:0150034; GO:2000807 ATP binding [GO:0005524]; gamma-tubulin binding [GO:0043015]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321] EIAILKLIEHPHVLKLHDVYENK 0.99555 -12.162 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3707 0 13.7031 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8568 0 16.8958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6757 0 0 0 16.2155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5593 Q96JI7 SPTCS_HUMAN Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein) SPG11 KIAA1840 Homo sapiens (Human) autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; walking behavior [GO:0090659] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202] axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein kinase binding [GO:0019901]; autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; walking behavior [GO:0090659] GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256 protein kinase binding [GO:0019901] CRPGDSEK 0.99555 -11.654 0 11.2905 0 0 0 0 0 0 0 0 11.445 13.3045 0 0 0 0 0 0 0 0 0 0 12.0138 0 0 0 0 0 0 0 0 0 0 11.2826 0 0 0 0 0 0 0 0 0 0 11.8754 0 12.5942 0 0 0 0 0 10.6515 9.92181 0 0 0 0 0 0 0 0 11.3782 0 10.9903 0 12.0441 0 0 13.079 0 0 0 0 13.9298 0 13.378 0 0 0 0 0 17.4431 12.2506 11.8135 15.7383 0 13.9431 13.8267 0 14.0754 14.036 0 0 12.7144 14.0894 12.9911 13.9959 13.3276 0 0 0 0 12.5583 0 0 14.1874 0 0 0 0 0 0 0 14.1333 15.2281 15.2153 0 0 0 0 0 0 11.0142 14.5546 15.2387 0 0 14.0144 0 0 0 0 13.4017 11.5806 0 0 0 0 0 0 11.3505 0 14.8209 13.5575 14.4677 0 11.4584 10.6811 0 0 0 0 0 0 0 15.276 10.3591 0 0 0 11.6709 0 0 0 0 0 14.0193 0 0 0 11.0783 0 0 11.6688 0 14.329 0 0 0 Q9H4F8 SMOC1_HUMAN "SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1, SMOC-1)" SMOC1 Homo sapiens (Human) cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667] basement membrane [GO:0005604]; extracellular space [GO:0005615] basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; limb development [GO:0060173]; regulation of osteoblast differentiation [GO:0045667] GO:0001654; GO:0005509; GO:0005604; GO:0005615; GO:0008201; GO:0030154; GO:0030198; GO:0045667; GO:0050840; GO:0060173 calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201] FTDYCDLNK 0.99555 -12.16 10.7317 0 0 0 0 0 0 0 0 14.2663 0 0 0 0 0 0 10.4868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5586 0 0 0 0 0 0 10.6792 0 0 0 13.0144 13.332 12.626 13.3818 13.5207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2239 0 0 0 0 0 0 0 0 13.2089 13.2219 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2461 0 0 0 0 0 0 0 12.0286 0 0 0 13.4665 0 0 0 0 0 0 0 12.6044 0 13.9024 0 0 12.1117 0 0 12.2312 0 0 0 0 0 0 11.8641 0 0 0 11.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43318 M3K7_HUMAN "Mitogen-activated protein kinase kinase kinase 7, EC 2.7.11.25 (Transforming growth factor-beta-activated kinase 1, TGF-beta-activated kinase 1)" MAP3K7 TAK1 Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; anoikis [GO:0043276]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; histone H3 acetylation [GO:0043966]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; p38MAPK cascade [GO:0038066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta receptor signaling pathway [GO:0007179] ATAC complex [GO:0140672]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886] ATAC complex [GO:0140672]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; anoikis [GO:0043276]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; histone H3 acetylation [GO:0043966]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; I-kappaB phosphorylation [GO:0007252]; interleukin-1-mediated signaling pathway [GO:0070498]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; p38MAPK cascade [GO:0038066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0000165; GO:0000287; GO:0002223; GO:0002726; GO:0002753; GO:0002755; GO:0004672; GO:0004674; GO:0004707; GO:0004709; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007179; GO:0007249; GO:0007250; GO:0007252; GO:0007254; GO:0008349; GO:0010008; GO:0016239; GO:0030971; GO:0032743; GO:0038066; GO:0038095; GO:0042802; GO:0043123; GO:0043276; GO:0043507; GO:0043966; GO:0050852; GO:0051092; GO:0051403; GO:0070423; GO:0070498; GO:0097110; GO:0106310; GO:0140672 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110] AFIVELRQLSR 0.99556 -9.8556 12.1878 0 0 0 0 0 0 13.5591 0 0 13.6638 0 0 0 0 0 0 10.4265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4796 0 12.1478 14.0576 0 14.9571 0 0 0 0 0 0 0 0 0 0 0 15.2791 0 0 0 0 11.5748 0 11.0224 0 0 0 0 15.2854 0 0 0 12.5947 13.1639 0 15.1553 0 0 0 12.3231 0 0 14.6223 0 14.1634 0 0 0 0 0 0 14.4821 0 0 0 0 0 0 12.4732 0 0 19.0523 0 0 19.1716 0 0 0 0 12.8492 0 14.4714 0 0 13.9844 0 14.1233 14.1975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4707 0 0 11.5161 0 10.0991 O95684 CEP43_HUMAN Centrosomal protein 43 (FGFR1 oncogene partner) CEP43 FGFR1OP FOP Homo sapiens (Human) cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284] cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292]; cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284] GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0006469; GO:0008284; GO:0019901; GO:0030030; GO:0030292; GO:0030307; GO:0030335; GO:0034453; GO:0042803; GO:0042995; GO:0048471 protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292] AATAAAVVAEEDTELRDLLVQTLENSGVLNRIK 0.99556 -9.8782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5015 14.1612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9336 0 0 0 0 0 0 0 0 0 0 12.9259 0 0 0 0 0 0 0 13.1685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22413 ENPP1_HUMAN "Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, E-NPP 1 (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form ] [Includes: Alkaline phosphodiesterase I, EC 3.1.4.1; Nucleotide pyrophosphatase, NPPase, EC 3.6.1.9 (Nucleotide diphosphatase) ]" ENPP1 M6S1 NPPS PC1 PDNP1 Homo sapiens (Human) 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; bone mineralization [GO:0030282]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]; sequestering of triglyceride [GO:0030730] basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886] "basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; GTP diphosphatase activity [GO:0036219]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphatase activity [GO:0016791]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ATP metabolic process [GO:0046034]; biomineralization [GO:0110148]; bone mineralization [GO:0030282]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to insulin stimulus [GO:0032869]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; immune response [GO:0006955]; inorganic diphosphate transport [GO:0030505]; melanocyte differentiation [GO:0030318]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell growth [GO:0030308]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of hh target transcription factor activity [GO:1990787]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of protein autophosphorylation [GO:0031953]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; nucleoside triphosphate catabolic process [GO:0009143]; phosphate ion homeostasis [GO:0055062]; phosphate-containing compound metabolic process [GO:0006796]; regulation of bone mineralization [GO:0030500]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035]; sequestering of triglyceride [GO:0030730]" GO:0003676; GO:0004115; GO:0004527; GO:0004528; GO:0004551; GO:0005044; GO:0005158; GO:0005509; GO:0005524; GO:0005615; GO:0005765; GO:0005886; GO:0005887; GO:0006091; GO:0006796; GO:0006955; GO:0008270; GO:0009143; GO:0009986; GO:0010035; GO:0010467; GO:0016021; GO:0016323; GO:0016791; GO:0030247; GO:0030282; GO:0030308; GO:0030318; GO:0030500; GO:0030502; GO:0030505; GO:0030643; GO:0030730; GO:0031953; GO:0032869; GO:0033198; GO:0035529; GO:0036218; GO:0036219; GO:0036221; GO:0042803; GO:0045599; GO:0045719; GO:0046034; GO:0046325; GO:0046627; GO:0047429; GO:0047693; GO:0050427; GO:0050656; GO:0055062; GO:0090305; GO:0106177; GO:0110148; GO:1990787 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; calcium ion binding [GO:0005509]; cyclic-GMP-AMP hydrolase activity [GO:0106177]; dTTP diphosphatase activity [GO:0036218]; exonuclease activity [GO:0004527]; GTP diphosphatase activity [GO:0036219]; insulin receptor binding [GO:0005158]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide diphosphatase activity [GO:0004551]; phosphatase activity [GO:0016791]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; protein homodimerization activity [GO:0042803]; scavenger receptor activity [GO:0005044]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270]" FNPEWYKGEPIWVTAK 0.99556 -9.8645 0 0 0 0 0 0 0 0 12.3331 0 0 0 0 0 0 0 11.75 0 0 0 0 10.6104 12.0294 0 0 0 0 0 0 0 0 0 0 13.6238 0 0 0 0 0 0 0 0 10.0733 0 11.6823 0 0 11.7664 0 10.5112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6231 0 16.657 0 16.0269 0 0 12.5594 0 0 0 0 0 0 13.0406 0 0 0 12.0801 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8166 0 15.1052 0 11.9012 0 0 0 10.3854 0 0 0 0 0 0 0 0 0 12.4957 11.0297 0 0 0 0 0 0 0 12.7169 0 0 10.5367 0 0 0 0 0 0 0 17.6822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8747 0 0 0 0 0 12.935 0 0 0 0 0 0 0 0 0 0 0 0 15.7777 0 0 0 0 12.0163 0 Q01954 BNC1_HUMAN Zinc finger protein basonuclin-1 BNC1 BNC Homo sapiens (Human) "cell differentiation [GO:0030154]; epidermis development [GO:0008544]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of transcription by RNA polymerase I [GO:0006356]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity [GO:0001216]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of transcription by RNA polymerase I [GO:0006356]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000182; GO:0001216; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006355; GO:0006356; GO:0007283; GO:0008284; GO:0008544; GO:0030154; GO:0045943; GO:0046872; GO:1900195 DNA-binding transcription activator activity [GO:0001216]; metal ion binding [GO:0046872]; rDNA binding [GO:0000182] AHYKTVHLR 0.99556 -33.514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.914 0 0 0 0 0 0 0 0 0 0 0 0 11.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3284 0 0 0 12.2146 14.3301 0 0 0 0 0 0 14.7705 0 0 0 0 0 14.1793 0 0 14.3238 0 0 0 0 14.171 0 0 0 0 0 0 0 0 0 0 0 0 14.1314 0 0 0 0 0 0 0 0 0 15.4805 0 0 0 0 0 0 0 0 0 0 0 14.515 0 0 14.7232 14.5202 13.2084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5384 14.4715 13.1748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.22 0 Q08462 ADCY2_HUMAN "Adenylate cyclase type 2, EC 4.6.1.1 (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2)" ADCY2 KIAA1060 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to forskolin [GO:1904322] GO:0000287; GO:0004016; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006171; GO:0007188; GO:0007189; GO:0008179; GO:0016020; GO:0019933; GO:0030145; GO:0030425; GO:0045121; GO:1904322 adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145] AGQMENTNNFHNLYVKR 0.99556 -5.4813 0 0 0 0 0 0 0 0 14.7579 0 0 0 0 0 0 0 11.3058 0 0 0 0 0 0 10.7812 0 0 0 0 0 14.9567 0 14.9382 0 0 0 0 0 0 14.379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8655 12.1757 0 0 0 0 15.6926 0 13.3903 0 0 14.103 13.9636 0 0 0 0 0 0 0 14.136 0 0 0 0 0 0 0 0 0 0 0 12.4963 0 0 0 0 0 13.4658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6488 0 0 12.6347 0 12.766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4791 0 0 0 0 0 Q1RN00 YC018_HUMAN Putative uncharacterized protein LOC151760 Homo sapiens (Human) HHKKATR 0.99556 -10.332 0 0 0 0 0 0 0 0 12.9951 12.6763 12.3845 13.1969 12.7863 12.9082 12.7158 0 17.0163 0 0 0 0 12.2859 0 0 0 12.8949 12.976 0 0 0 12.7632 13.0435 0 0 0 0 0 12.5865 0 12.7249 0 12.7297 0 0 0 0 0 0 12.3214 12.7442 13.1064 0 0 0 0 0 12.2654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4887 15.1176 0 15.089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9812 0 0 0 0 0 0 0 14.8448 0 0 13.1481 0 0 18.9328 14.9314 13.2101 0 0 0 0 0 0 0 13.5659 0 0 0 14.8184 0 0 0 0 0 13.5325 0 13.0783 0 0 0 14.697 0 0 0 0 0 0 0 0 0 14.4564 14.3898 0 14.4964 14.3243 18.972 14.8765 14.3549 0 19.0245 14.6141 18.7924 14.4237 14.1951 0 0 0 0 0 0 0 0 18.9179 Q6UXD7 S49A3_HUMAN "Solute carrier family 49 member A3 (Major facilitator superfamily domain-containing protein 7) (Myosin light polypeptide 5 regulatory protein, MYL5)" SLC49A3 MFSD7 LP2561 UNQ385/PRO717 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857] GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] PGRLAGR 0.99556 -10.347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TDL5 BPIB1_HUMAN "BPI fold-containing family B member 1 (Long palate, lung and nasal epithelium carcinoma-associated protein 1) (von Ebner minor salivary gland protein, VEMSGP)" BPIFB1 C20orf114 LPLUNC1 UNQ706/PRO1357 Homo sapiens (Human) innate immune response in mucosa [GO:0002227]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144] extracellular exosome [GO:0070062]; extracellular region [GO:0005576] extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lipid binding [GO:0008289]; innate immune response in mucosa [GO:0002227]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144] GO:0002227; GO:0005576; GO:0008289; GO:0034144; GO:0070062 lipid binding [GO:0008289] HIIWLKVITANILQLQVK 0.99556 -12.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3644 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2926 0 12.4001 0 0 11.0338 0 0 0 11.157 12.1226 0 0 0 0 0 0 11.3786 0 0 0 0 0 0 0 0 0 0 11.8819 0 0 0 0 11.873 16.2835 12.0187 12.8005 0 14.6406 0 0 0 0 0 0 14.9605 0 0 0 0 0 0 0 0 0 0 0 11.7275 0 0 11.0604 0 0 0 0 0 14.3068 0 0 12.3191 0 16.718 0 12.1067 0 0 0 0 0 0 0 0 12.0434 0 0 0 0 0 0 0 10.6658 10.8584 0 0 0 0 13.3411 0 0 0 0 0 0 12.8255 0 0 0 13.5287 0 0 10.6628 0 0 0 Q8TF01 PNISR_HUMAN "Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130, SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)" PNISR C6orf111 SFRS18 SRRP130 HSPC261 HSPC306 Homo sapiens (Human) cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; RNA binding [GO:0003723] GO:0003723; GO:0005654; GO:0005829; GO:0005886; GO:0016607; GO:0048786 RNA binding [GO:0003723] DFKFSSQDDR 0.99556 -12.797 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1745 0 0 0 0 0 0 0 0 0 0 12.9279 0 0 0 10.3761 0 0 0 0 0 0 0 0 0 0 0 0 12.7781 0 0 0 0 12.6446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.9592 0 15.4958 0 0 0 0 14.7888 14.4014 0 13.0199 0 0 0 0 13.3769 0 12.7412 13.4338 0 0 13.4921 0 0 0 0 16.4069 0 0 10.9856 0 13.5636 0 13.5503 16.1977 12.4273 15.8319 0 0 0 13.6149 14.7204 0 0 0 0 0 0 0 15.9227 13.753 0 0 0 12.0559 15.8202 15.5557 0 0 0 0 15.1906 0 15.3943 15.5453 15.7449 0 15.3031 0 15.1282 15.18 0 0 0 0 0 0 0 0 12.5529 0 12.429 0 0 0 10.6844 0 0 0 0 16.3903 0 0 0 0 0 0 0 0 0 0 14.8552 0 0 0 15.188 0 Q96EV2 RBM33_HUMAN RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33) RBM33 PRR8 Homo sapiens (Human) RNA binding [GO:0003723] GO:0003723 RNA binding [GO:0003723] ALKHLRQTR 0.99556 -9.8519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.3785 0 0 12.5497 0 0 0 13.1324 0 0 0 0 0 0 12.7649 12.4596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0575 0 15.7854 12.6209 0 0 12.6704 14.0526 0 0 17.4888 0 0 0 0 0 0 13.3569 0 0 0 13.5619 0 12.6037 0 14.9198 0 0 15.3359 0 0 0 0 0 0 0 0 14.7487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8487 13.8153 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0X6 RN208_HUMAN RING finger protein 208 RNF208 Homo sapiens (Human) protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005654; GO:0005829; GO:0016567; GO:0046872; GO:0051865; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] GPHVILK 0.99556 -5.4733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1077 0 0 0 0 0 0 0 0 0 0 0 Q9ULC8 ZDHC8_HUMAN "Palmitoyltransferase ZDHHC8, EC 2.3.1.225 (Zinc finger DHHC domain-containing protein 8, DHHC-8) (Zinc finger protein 378)" ZDHHC8 KIAA1292 ZDHHCL1 ZNF378 Homo sapiens (Human) high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; mitochondrial membrane [GO:0031966]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; high-density lipoprotein particle assembly [GO:0034380]; locomotory behavior [GO:0007626]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein palmitoylation [GO:0018345] GO:0000139; GO:0005794; GO:0005829; GO:0007626; GO:0010875; GO:0016021; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0031966; GO:0034380; GO:1903078 palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706] CSHCSVCDNCVEDFDHHCPWVNNCIGR 0.99556 -10.328 0 12.1389 0 0 0 0 0 13.1011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5122 10.4743 0 0 0 0 0 0 0 0 0 11.3694 11.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3292 0 0 0 0 0 0 10.1085 0 0 0 0 14.4393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7108 0 0 0 13.5841 0 11.4911 0 0 0 0 0 0 0 0 0 0 0 0 10.5473 0 0 0 0 12.4299 0 0 0 0 0 0 0 A6NDH6 O5H15_HUMAN Olfactory receptor 5H15 OR5H15 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IPLFLAFLVIYLITIMGNLGLIAVIWK 0.99557 -9.9282 0 0 0 0 11.6824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3414 11.483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7359 0 0 0 0 0 0 13.6049 0 0 0 0 0 0 0 0 0 0 12.4648 0 10.0917 13.1742 12.2279 0 0 0 0 13.2582 0 12.0417 0 0 13.9318 11.833 0 11.8484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4453 0 0 0 0 0 11.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4391 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K8V0 ZN785_HUMAN Zinc finger protein 785 ZNF785 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GSLAIHR 0.99557 -11.806 0 0 0 0 0 0 0 0 12.609 0 0 12.248 0 0 0 12.0684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4644 0 0 0 0 0 0 0 0 0 0 0 11.4814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1174 0 0 0 0 0 10.4489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3122 0 0 0 0 0 0 0 13.6718 0 13.0784 0 0 10.9073 12.7697 0 0 0 12.0487 0 12.6776 0 0 13.7915 0 0 0 0 18.4087 0 12.0763 0 12.5208 12.0903 12.6123 0 0 0 0 0 0 0 0 0 0 14.515 0 0 0 0 0 0 0 0 0 0 0 0 11.0906 0 0 0 0 0 12.2957 0 0 0 0 0 0 0 0 0 0 13.2032 0 0 0 15.0152 15.2779 0 0 0 0 17.0718 17.0494 0 0 0 0 P18564 ITB6_HUMAN Integrin beta-6 ITGB6 Homo sapiens (Human) bone development [GO:0060348]; bronchiole development [GO:0060435]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to ionizing radiation [GO:0071479]; enamel mineralization [GO:0070166]; hard palate development [GO:0060022]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; lung alveolus development [GO:0048286]; phospholipid homeostasis [GO:0055091]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; skin development [GO:0043588]; SMAD protein signal transduction [GO:0060395]; surfactant homeostasis [GO:0043129]; transforming growth factor beta production [GO:0071604]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060] cell junction [GO:0030054]; centrosome [GO:0005813]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alphav-beta6 complex [GO:0034685]; integrin complex [GO:0008305]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cell junction [GO:0030054]; centrosome [GO:0005813]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alphav-beta6 complex [GO:0034685]; integrin complex [GO:0008305]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; bone development [GO:0060348]; bronchiole development [GO:0060435]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-matrix adhesion [GO:0007160]; cellular response to ionizing radiation [GO:0071479]; enamel mineralization [GO:0070166]; hard palate development [GO:0060022]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; Langerhans cell differentiation [GO:0061520]; lung alveolus development [GO:0048286]; phospholipid homeostasis [GO:0055091]; regulation of transforming growth factor beta activation [GO:1901388]; response to virus [GO:0009615]; skin development [GO:0043588]; SMAD protein signal transduction [GO:0060395]; surfactant homeostasis [GO:0043129]; transforming growth factor beta production [GO:0071604]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060] GO:0000902; GO:0001618; GO:0005178; GO:0005654; GO:0005813; GO:0005886; GO:0005925; GO:0006954; GO:0006955; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008305; GO:0009615; GO:0009897; GO:0016477; GO:0030054; GO:0033627; GO:0034685; GO:0038023; GO:0042060; GO:0043129; GO:0043235; GO:0043588; GO:0048286; GO:0055091; GO:0060022; GO:0060348; GO:0060395; GO:0060435; GO:0061520; GO:0070166; GO:0071479; GO:0071604; GO:1901388 integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618] CECGEDMLSTDSCK 0.99557 -9.9255 0 0 0 0 0 0 0 0 0 11.3836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4251 0 0 0 0 11.0023 0 0 11.2032 0 0 0 0 11.2455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0339 0 0 0 0 0 0 0 0 0 14.6642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0727 13.6704 14.5363 0 0 12.9973 0 0 12.1359 0 0 0 0 0 0 0 0 0 0 0 0 0 14.921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8321 0 13.0541 0 13.18 0 16.5441 13.2416 13.2981 11.8791 0 0 0 0 0 12.9074 11.1587 12.2131 0 0 0 13.3041 14.4596 11.7205 P29320 EPHA3_HUMAN "Ephrin type-A receptor 3, EC 2.7.10.1 (EPH-like kinase 4, EK4, hEK4) (HEK, Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1, Eph-like tyrosine kinase 1)" EPHA3 ETK ETK1 HEK TYRO4 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; negative regulation of endocytosis [GO:0045806]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; negative regulation of endocytosis [GO:0045806]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005003; GO:0005004; GO:0005005; GO:0005524; GO:0005576; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0005887; GO:0007155; GO:0007169; GO:0007411; GO:0010717; GO:0010976; GO:0015629; GO:0016477; GO:0018108; GO:0031965; GO:0032956; GO:0033674; GO:0043005; GO:0043087; GO:0043235; GO:0045806; GO:0048013; GO:0051893; GO:0070507; GO:0071300; GO:0097155; GO:0097156; GO:1903078 ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane-ephrin receptor activity [GO:0005005] ARGTNVTISSLKPDTIYVFQIR 0.99557 -11.861 0 0 0 0 0 0 0 0 0 0 0 12.4884 0 0 0 0 0 0 10.8049 0 0 0 0 0 11.2636 11.5469 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3419 0 0 0 12.0711 0 0 0 0 0 0 0 0 10.3784 0 0 0 0 0 0 0 0 0 0 0 10.1401 10.3735 0 0 11.0094 0 0 0 0 0 13.8832 13.5939 0 0 0 0 0 11.8944 18.1444 0 11.3038 18.803 19.1178 18.1141 0 17.6478 0 17.9351 17.5048 14.7829 15.9402 13.9699 0 0 13.7065 14.8712 14.2408 12.5005 0 16.8373 16.972 15.4768 14.5597 13.2092 0 0 13.0073 0 12.1528 14.8332 0 0 0 0 0 0 13.092 0 0 0 17.7383 0 0 12.7982 0 13.395 12.993 0 0 0 0 0 14.07 0 14.2647 11.2555 0 0 13.3081 0 0 0 12.432 12.524 0 0 0 11.6443 0 0 0 13.5168 0 0 11.2835 0 0 0 0 0 0 0 12.7048 0 0 0 0 11.9913 12.0057 0 0 0 0 12.8057 0 0 Q5TH74 STPG1_HUMAN "O(6)-methylguanine-induced apoptosis 2, MAPO2 (Sperm-tail PG-rich repeat-containing protein 1)" STPG1 C1orf201 Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110] mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrion [GO:0005739]; nucleus [GO:0005634]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110] GO:0005634; GO:0005739; GO:0043065; GO:1902110 GFNSQAK 0.99557 -11.859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3394 0 0 0 0 0 0 0 12.5847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2259 0 0 13.1019 0 Q5VTL8 PR38B_HUMAN Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27) PRPF38B Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] precatalytic spliceosome [GO:0071011] precatalytic spliceosome [GO:0071011]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0003723; GO:0006397; GO:0008380; GO:0071011 RNA binding [GO:0003723] ALGFMYIR 0.99557 -11.799 0 12.7517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.569 0 0 0 13.1215 0 0 0 16.0587 0 10.9998 0 0 0 0 0 0 15.2164 0 12.8781 13.3098 0 0 0 0 0 0 0 0 0 0 12.3222 0 0 0 0 15.1489 12.3408 0 14.9108 14.0985 0 0 0 0 12.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1068 12.4935 0 0 0 0 0 0 0 0 0 12.3285 0 0 0 0 0 14.5109 12.5591 12.4349 0 0 0 0 14.5328 0 Q96EG3 ZN837_HUMAN Zinc finger protein 837 ZNF837 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0042802; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ADAQGASGAR 0.99557 -12.329 0 0 0 0 0 0 0 0 0 13.1193 0 0 0 0 11.9647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.36584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5026 0 13.3461 0 0 9.69397 0 14.9156 15.0423 0 0 14.0409 13.5515 13.8604 0 14.8377 14.1886 0 0 0 12.6409 0 13.6952 0 13.1153 0 0 0 0 0 14.218 0 0 13.3604 0 11.4997 0 0 0 0 0 0 0 0 0 0 0 13.2505 0 0 12.6881 10.7385 13.3588 0 0 11.5909 0 0 0 0 0 0 0 0 0 12.9676 0 0 0 0 11.3085 0 0 14.5148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6517 Q9P227 RHG23_HUMAN Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23) ARHGAP23 KIAA1501 Homo sapiens (Human) regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005829; GO:0007165; GO:0051056; GO:0070062 GTPase activator activity [GO:0005096] DDSAAAPKTPWGINIIKK 0.99557 -34.452 0 0 0 0 0 0 0 0 0 11.3127 0 10.283 0 0 0 0 0 14.3061 15.0342 10.2678 0 0 13.5701 0 14.32 0 14.4031 13.2894 0 0 0 0 0 0 0 14.2437 10.7284 0 0 0 0 12.2284 0 0 13.1655 0 0 0 0 0 0 0 14.5672 13.8677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.471 13.0218 13.2499 0 13.3677 13.0668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9804 0 0 0 13.7324 0 0 0 0 0 12.1273 0 14.5855 13.0279 13.747 13.444 0 0 13.6341 0 0 13.2877 0 11.6426 13.2813 13.5694 13.7997 10.997 0 14.1454 0 0 13.4898 0 12.9658 0 0 0 11.7605 12.3913 0 0 18.1272 0 0 0 0 14.3694 0 0 0 12.7547 11.2977 11.7304 0 0 0 12.0573 0 0 12.5172 0 0 11.477 12.5414 0 0 13.405 0 0 12.0577 0 0 0 0 0 11.758 0 17.8561 0 0 0 0 0 Q9ULJ3 ZBT21_HUMAN Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295) ZBTB21 KIAA1227 ZNF295 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; POZ domain binding [GO:0031208]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0008327; GO:0031208; GO:0042802; GO:0043565; GO:0045892; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; POZ domain binding [GO:0031208]; sequence-specific DNA binding [GO:0043565]" ALELALK 0.99557 -34.506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3656 0 0 0 0 0 0 0 0 0 0 0 12.4483 11.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4366 0 0 0 0 0 0 13.4967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9672 0 0 0 0 14.31 0 12.0547 0 0 13.3699 14.6504 0 0 0 0 0 0 0 0 0 0 0 0 17.7453 0 0 12.6738 0 0 0 0 0 10.7406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.617 0 0 0 0 0 0 0 0 0 0 0 0 12.3772 0 0 0 0 0 0 11.471 0 0 0 0 0 0 0 0 0 0 0 0 10.8684 0 0 0 0 11.9306 0 0 12.4417 0 Q9Y673 ALG5_HUMAN "Dolichyl-phosphate beta-glucosyltransferase, DolP-glucosyltransferase, EC 2.4.1.117 (Asparagine-linked glycosylation protein 5 homolog)" ALG5 HSPC149 Homo sapiens (Human) determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576]; determination of left/right symmetry [GO:0007368]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279] GO:0004576; GO:0004581; GO:0005789; GO:0006486; GO:0006487; GO:0007368; GO:0016020; GO:0016021; GO:0018279 dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581]; oligosaccharyl transferase activity [GO:0004576] APLLLQLAVLGAALAAAALVLISIVAFTTATK 0.99557 -11.798 0 0 14.7092 0 0 14.504 15.0103 14.0266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1601 12.0993 12.357 12.5422 0 0 0 0 0 0 0 12.5898 0 0 0 0 0 0 11.5924 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1358 0 0 0 0 0 0 0 13.1839 13.2686 0 0 0 0 0 0 13.5516 0 0 13.7123 13.51 0 14.4542 0 0 13.7546 0 0 0 12.7515 0 0 0 0 0 0 13.4107 0 0 0 0 0 0 0 13.65 0 0 0 0 0 0 0 0 14.2033 14.2551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7289 0 0 13.2553 0 0 0 0 0 0 A8MZG2 CP090_HUMAN Uncharacterized protein C16orf90 C16orf90 Homo sapiens (Human) GALPQPSPSR 0.99558 -11.888 0 0 0 0 0 0 0 0 0 0 12.8062 0 0 0 0 0 11.7142 0 0 12.4642 0 0 0 0 0 11.4404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3837 0 0 0 11.3968 0 15.6024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8163 0 0 0 14.5643 0 0 0 0 0 0 0 0 0 12.5168 0 0 0 14.9007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4947 0 0 14.009 0 0 0 0 0 0 0 0 0 0 12.7129 0 11.3936 0 0 0 0 0 0 0 0 0 0 0 12.3814 0 0 0 0 0 0 12.0075 0 0 12.2909 0 0 O75953 DNJB5_HUMAN "DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-2) (Heat shock protein Hsp40-3) (Heat shock protein cognate 40, Hsc40)" DNAJB5 HSC40 Homo sapiens (Human) chaperone cofactor-dependent protein refolding [GO:0051085]; response to unfolded protein [GO:0006986] cytosol [GO:0005829] cytosol [GO:0005829]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; response to unfolded protein [GO:0006986] GO:0005829; GO:0006986; GO:0051082; GO:0051085; GO:0051087 chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] DKPHAHFR 0.99558 -11.884 0 0 0 0 0 0 0 0 13.2282 0 0 0 0 12.541 0 0 0 0 0 0 0 13.5248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63601 0 0 0 0 13.9831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1022 14.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8265 0 0 0 0 0 O95630 STABP_HUMAN "STAM-binding protein, EC 3.4.19.- (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase)" STAMBP AMSH Homo sapiens (Human) hippocampal neuron apoptotic process [GO:0110088]; mitotic cytokinesis [GO:0000281]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of cell population proliferation [GO:0008284]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; receptor signaling pathway via JAK-STAT [GO:0007259] cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; deubiquitinase activity [GO:0101005]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; protein domain specific binding [GO:0019904]; hippocampal neuron apoptotic process [GO:0110088]; mitotic cytokinesis [GO:0000281]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of cell population proliferation [GO:0008284]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; receptor signaling pathway via JAK-STAT [GO:0007259] GO:0000281; GO:0005634; GO:0005654; GO:0005768; GO:0005769; GO:0005829; GO:0005886; GO:0007259; GO:0008284; GO:0014067; GO:0016020; GO:0016579; GO:0019904; GO:0032154; GO:0046580; GO:0046872; GO:0061578; GO:0070062; GO:0070122; GO:0070536; GO:0101005; GO:0110088; GO:0110091; GO:0140492 deubiquitinase activity [GO:0101005]; isopeptidase activity [GO:0070122]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; protein domain specific binding [GO:0019904] AVTITDLR 0.99558 -35.443 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7372 0 0 0 0 0 11.6177 0 0 0 11.5397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2805 0 0 0 0 0 0 0 0 0 0 14.4722 11.5732 14.6122 0 0 0 0 0 12.0722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5486 0 0 0 0 0 0 0 0 12.3445 0 0 0 0 13.079 0 0 0 14.4026 0 15.1624 0 0 13.7191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7025 13.5111 0 0 0 0 14.5085 0 P33176 KINH_HUMAN "Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain, UKHC)" KIF5B KNS KNS1 Homo sapiens (Human) "anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]" axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982] "axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein-containing complex binding [GO:0044877]; anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to interferon-gamma [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; cytoskeleton-dependent intracellular transport [GO:0030705]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]" GO:0003777; GO:0005524; GO:0005765; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007028; GO:0007411; GO:0008017; GO:0008574; GO:0016020; GO:0016887; GO:0030705; GO:0031982; GO:0032230; GO:0032418; GO:0032839; GO:0034451; GO:0035253; GO:0035617; GO:0042267; GO:0042391; GO:0042802; GO:0043268; GO:0044877; GO:0045296; GO:0045335; GO:0047496; GO:0048471; GO:0048489; GO:0051642; GO:0071346; GO:0072383; GO:0098971; GO:0099641; GO:1903078; GO:1904115; GO:1990048; GO:1990049 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein-containing complex binding [GO:0044877] EAKENASRDR 0.99558 -31.631 0 0 0 0 0 0 0 0 0 0 0 12.565 0 0 0 0 0 0 0 9.72681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9976 14.2793 13.6446 14.2564 0 0 12.0575 0 0 0 14.6452 0 0 13.6957 0 0 13.4118 0 0 0 0 0 12.5244 0 0 10.889 0 0 0 0 13.1743 0 0 0 0 0 13.6404 10.3662 13.5308 0 0 0 0 0 13.0447 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9603 14.3824 0 13.7503 0 0 0 14.0918 0 11.4883 0 0 0 0 0 0 0 0 0 0 0 0 12.0925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8682 0 0 0 12.9519 13.2147 P53985 MOT1_HUMAN "Monocarboxylate transporter 1, MCT 1 (Solute carrier family 16 member 1)" SLC16A1 MCT1 Homo sapiens (Human) behavioral response to nutrient [GO:0051780]; carboxylic acid transmembrane transport [GO:1905039]; cellular response to organic cyclic compound [GO:0071407]; centrosome cycle [GO:0007098]; glucose homeostasis [GO:0042593]; lipid metabolic process [GO:0006629]; mevalonate transport [GO:0015728]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; regulation of insulin secretion [GO:0050796]; response to food [GO:0032094]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; carboxylic acid transmembrane transporter activity [GO:0046943]; identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; mevalonate transmembrane transporter activity [GO:0015130]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic cyclic compound binding [GO:0097159]; symporter activity [GO:0015293]; behavioral response to nutrient [GO:0051780]; carboxylic acid transmembrane transport [GO:1905039]; cellular response to organic cyclic compound [GO:0071407]; centrosome cycle [GO:0007098]; glucose homeostasis [GO:0042593]; lipid metabolic process [GO:0006629]; mevalonate transport [GO:0015728]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; regulation of insulin secretion [GO:0050796]; response to food [GO:0032094]; transport across blood-brain barrier [GO:0150104] GO:0005813; GO:0005886; GO:0005887; GO:0006629; GO:0007098; GO:0008028; GO:0009925; GO:0015129; GO:0015130; GO:0015293; GO:0015718; GO:0015728; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0016328; GO:0030054; GO:0032094; GO:0035879; GO:0042593; GO:0042802; GO:0043231; GO:0045202; GO:0046943; GO:0050796; GO:0051780; GO:0070062; GO:0071407; GO:0097159; GO:0150104; GO:1905039 carboxylic acid transmembrane transporter activity [GO:0046943]; identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; mevalonate transmembrane transporter activity [GO:0015130]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic cyclic compound binding [GO:0097159]; symporter activity [GO:0015293] DTDGGPK 0.99558 -11.885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9785 0 12.5291 13.7722 13.8557 13.8428 0 0 0 0 0 14.3809 0 0 13.1396 0 14.0149 0 0 0 0 12.7439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3704 0 0 0 13.0268 0 0 0 0 0 0 13.5188 0 13.603 0 0 14.0229 13.5242 0 0 0 0 0 13.0748 13.3674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4323 0 0 13.0959 0 0 12.9788 0 0 0 0 0 0 0 0 P84098 RL19_HUMAN 60S ribosomal protein L19 (Large ribosomal subunit protein eL19) RPL19 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; synapse [GO:0045202]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0016020; GO:0022625; GO:0022626; GO:0042788; GO:0045202 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] ILMEHIHK 0.99558 -31.692 0 0 0 0 0 0 11.9882 0 0 0 0 0 0 0 0 13.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4153 0 0 0 0 0 0 0 0 0 0 0 0 13.4945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1474 0 0 0 15.6776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00722 PLCB2_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-2) (Phospholipase C-beta-2, PLC-beta-2)" PLCB2 Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipid metabolic process [GO:0006644] cytosol [GO:0005829]; G-protein beta/gamma-subunit complex [GO:0031680]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886] cytosol [GO:0005829]; G-protein beta/gamma-subunit complex [GO:0031680]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543]; activation of phospholipase C activity [GO:0007202]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipid metabolic process [GO:0006644] GO:0001580; GO:0004435; GO:0004629; GO:0005509; GO:0005543; GO:0005794; GO:0005829; GO:0005886; GO:0006644; GO:0007186; GO:0007200; GO:0007202; GO:0016042; GO:0031680; GO:0031683; GO:0046488; GO:0048015 calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phospholipid binding [GO:0005543] AYDLLSK 0.99558 -35.396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2111 0 0 12.2734 0 0 10.8093 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3051 0 0 0 0 0 0 0 0 0 12.1506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0344 0 0 0 0 0 0 0 0 0 0 10.3504 14.6968 0 0 0 0 0 15.3392 14.9373 14.9668 13.9081 13.4202 0 16.6244 0 16.6874 15.8676 15.0701 0 0 0 16.3256 0 14.3053 13.0233 15.3496 14.1618 0 16.5855 15.9207 17.0246 16.1451 13.0097 13.3041 12.9081 13.6582 17.3506 0 15.7946 15.5507 16.2749 15.4399 19.005 15.6583 15.9397 13.4255 15.5661 0 15.5517 15.3103 15.3353 16.6413 14.1997 12.9293 15.7093 17.1341 16.6959 0 15.4809 0 0 15.2333 0 16.0103 15.0352 0 0 16.2824 15.4248 0 15.8261 15.0367 0 15.8827 15.9457 15.6197 14.8902 0 0 0 0 13.6629 0 0 13.1695 16.4645 0 0 13.001 15.0817 0 12.757 0 0 0 0 0 0 0 0 0 15.6012 14.4039 14.4289 14.3523 0 0 12.6311 13.9908 0 Q5VWW1 C1QL3_HUMAN "Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13, C1q/TNF-related protein 13)" C1QL3 CTRP13 Homo sapiens (Human) regulation of synapse organization [GO:0050807] collagen trimer [GO:0005581]; extracellular space [GO:0005615] collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; regulation of synapse organization [GO:0050807] GO:0005581; GO:0005615; GO:0042802; GO:0050807 identical protein binding [GO:0042802] GGDGTSMWADLCK 0.99558 -11.882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6P9F0 CCD62_HUMAN Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa) CCDC62 Homo sapiens (Human) blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; positive regulation of transcription by RNA polymerase II [GO:0045944] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0001835; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0030331; GO:0030374; GO:0045944; GO:0071392 nuclear estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374] DIIEAVNHIADCSGKFKMLEHALR 0.99558 -35.454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7081 0 13.2713 0 0 0 0 0 13.442 10.3901 0 13.6004 0 0 15.4501 0 0 0 0 0 0 13.5608 0 12.989 0 14.1544 0 13.7551 0 13.2277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3805 15.5146 0 15.352 0 0 0 0 0 0 0 13.5845 13.6348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.88 0 0 0 12.1953 12.4703 0 0 0 12.6994 11.8588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6257 13.3109 0 0 0 0 0 0 0 0 0 0 12.962 0 0 12.6941 0 12.5228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8ND23 CARL3_HUMAN "Capping protein, Arp2/3 and myosin-I linker protein 3 (Capping protein regulator and myosin 1 linker protein 3) (Leucine-rich repeat-containing protein 16B)" CARMIL3 C14orf121 LRRC16B Homo sapiens (Human) cell migration [GO:0016477]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315] cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; cell migration [GO:0016477]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315] GO:0005737; GO:0005886; GO:0016477; GO:0030027; GO:0034315; GO:2000249 GLFHFRR 0.99558 -35.367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.91263 0 0 0 0 0 0 12.9856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9937 16.6384 16.8113 0 0 0 15.1792 15.1271 0 0 0 12.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0438 0 15.184 15.3954 0 0 13.9056 0 0 0 0 11.0342 0 0 0 0 13.7436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 C9JRZ8 AK1BF_HUMAN "Aldo-keto reductase family 1 member B15, EC 1.1.1.-, EC 1.1.1.300, EC 1.1.1.54 (Estradiol 17-beta-dehydrogenase AKR1B15) (Farnesol dehydrogenase, EC 1.1.1.216) (Testosterone 17beta-dehydrogenase, EC 1.1.1.64)" AKR1B15 Homo sapiens (Human) estrogen biosynthetic process [GO:0006703] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; farnesol dehydrogenase activity [GO:0047886]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; estrogen biosynthetic process [GO:0006703]" GO:0004032; GO:0004303; GO:0005739; GO:0005759; GO:0005829; GO:0006703; GO:0016616; GO:0047045; GO:0047655; GO:0047886; GO:0052650 "alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; farnesol dehydrogenase activity [GO:0047886]; NADP-retinol dehydrogenase activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]" GNMISGK 0.99559 -9.6968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8817 0 0 12.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6305 0 0 0 0 0 0 14.08 0 16.0007 0 0 14.684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.81 0 0 0 0 0 16.1186 0 0 0 0 0 14.6845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15370 SOX12_HUMAN Transcription factor SOX-12 (Protein SOX-22) SOX12 SOX22 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord development [GO:0021510]" chromatin [GO:0000785]; nucleoplasm [GO:0005654]; protein-DNA complex [GO:0032993] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; spinal cord development [GO:0021510]" GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005654; GO:0006355; GO:0009653; GO:0021510; GO:0030154; GO:0032993; GO:0045165; GO:0045591; GO:0045944; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" HMADYPDYKYR 0.99559 -11.951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8671 0 0 0 12.4032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.695 0 0 0 0 0 13.2804 0 0 0 13.2494 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1407 13.1088 0 0 0 0 0 0 0 0 0 14.4385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.931 0 0 13.1073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94760 DDAH1_HUMAN "N(G),N(G)-dimethylarginine dimethylaminohydrolase 1, DDAH-1, Dimethylarginine dimethylaminohydrolase 1, EC 3.5.3.18 (DDAHI) (Dimethylargininase-1)" DDAH1 DDAH Homo sapiens (Human) arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073] GO:0000052; GO:0003073; GO:0003824; GO:0005829; GO:0006525; GO:0006527; GO:0007263; GO:0008285; GO:0016403; GO:0016597; GO:0043116; GO:0045429; GO:0045766; GO:0046872; GO:0050999; GO:0070062; GO:1900038 amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872] ALPESLGQHALR 0.99559 -9.9965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3293 12.792 12.8082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59910 DJB13_HUMAN DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein) DNAJB13 TSARG3 TSARG6 Homo sapiens (Human) axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085] axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126] axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085] GO:0005829; GO:0005930; GO:0031514; GO:0036126; GO:0051082; GO:0051085; GO:0051087; GO:0097224; GO:1904158 chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] DKILTIDVKPGWR 0.99559 -11.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8319 0 0 0 0 0 0 0 0 12.8991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6798 0 0 0 0 0 0 0 0 Q5CZ79 AN20B_HUMAN Ankyrin repeat domain-containing protein 20B (Ankyrin repeat domain-containing protein 20A pseudogene) ANKRD20A8P ANKRD20B Homo sapiens (Human) CQIDICDKENR 0.99559 -12.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.044 0 13.1112 0 0 0 0 0 0 17.0926 0 0 0 0 0 0 0 0 0 17.6171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4358 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.706 0 0 12.9331 0 12.8208 0 11.7041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5217 0 0 Q8IWB1 IPRI_HUMAN "Inositol 1,4,5-trisphosphate receptor-interacting protein (Protein DANGER)" ITPRIP DANGER KIAA1754 Homo sapiens (Human) extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; protein kinase inhibitor activity [GO:0004860]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042] GO:0004860; GO:0005640; GO:0005886; GO:0008625; GO:0016020; GO:0016021; GO:1902042 protein kinase inhibitor activity [GO:0004860] LTGPSGLSSYHLKTALLHLLLLR 0.99559 -9.9947 0 0 0 0 0 0 0 0 0 0 0 0 13.7227 0 0 0 0 0 0 0 0 14.1856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0674 0 0 0 0 0 0 0 0 14.141 0 12.7511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.457 0 0 0 0 13.6334 13.7784 0 12.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N111 CEND_HUMAN Cell cycle exit and neuronal differentiation protein 1 (BM88 antigen) CEND1 BM88 Homo sapiens (Human) adult walking behavior [GO:0007628]; cerebellar granular layer maturation [GO:0021686]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; radial glia guided migration of cerebellar granule cell [GO:0021933] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; adult walking behavior [GO:0007628]; cerebellar granular layer maturation [GO:0021686]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of cerebellar granule cell precursor proliferation [GO:0021941]; radial glia guided migration of cerebellar granule cell [GO:0021933] GO:0007628; GO:0016021; GO:0021686; GO:0021702; GO:0021933; GO:0021941 APLTKPSK 0.99559 -10.002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7856 12.8877 0 13.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1307 0 0 13.1978 17.5257 0 0 13.1491 13.0977 0 0 12.6223 0 0 0 13.1057 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3251 0 0 0 0 0 0 0 0 13.931 0 0 0 12.6471 13.2283 0 0 0 0 0 Q8N1A0 KT222_HUMAN Keratin-like protein KRT222 (Keratin-222) (Keratin-222 pseudogene) KRT222 KA21 KRT222P Homo sapiens (Human) intermediate filament [GO:0005882] intermediate filament [GO:0005882]; structural molecule activity [GO:0005198] GO:0005198; GO:0005882 structural molecule activity [GO:0005198] DKKPTTSR 0.99559 -12.535 0 0 0 0 13.1049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NBJ4 GOLM1_HUMAN Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2) GOLM1 C9orf155 GOLPH2 PSEC0242 UNQ686/PRO1326 Homo sapiens (Human) nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887] endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216] GO:0005615; GO:0005788; GO:0005794; GO:0005887; GO:0006997; GO:0019216 EQCEERIEEVTKK 0.99559 -10.026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2435 0 13.6469 0 0 0 0 0 0 0 0 0 0 0 0 13.2455 14.4208 0 0 0 0 0 0 0 14.3197 0 0 0 0 0 0 0 0 0 0 0 0 11.8225 0 0 0 11.8284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7094 0 0 0 0 Q9Y2R9 RT07_HUMAN "28S ribosomal protein S7, mitochondrial, MRP-S7, S7mt (Mitochondrial small ribosomal subunit protein uS7m) (bMRP-27a, bMRP27a)" MRPS7 Homo sapiens (Human) mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840] mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412] GO:0000028; GO:0003723; GO:0003729; GO:0003735; GO:0005743; GO:0005763; GO:0005840; GO:0006412; GO:0019843; GO:0032543 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735] AVLQLPGLTQVRWSRYSPEFK 0.99559 -9.695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1893 0 0 0 0 0 0 12.6874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2712 0 0 0 13.1211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4521 0 0 0 0 0 0 0 13.9332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4435 0 0 0 12.1395 0 0 0 0 0 0 0 0 11.6503 Q6NTE8 MRNIP_HUMAN MRN complex-interacting protein (MRN-interacting protein) MRNIP C5orf45 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212] GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032 chromatin binding [GO:0003682] FSQDLPRKR 0.9956 -10.03 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV44 THUM3_HUMAN "tRNA (guanine(6)-N2)-methyltransferase THUMP3, EC 2.1.1.256 (THUMP domain-containing protein 3)" THUMPD3 Homo sapiens (Human) tRNA methylation [GO:0030488]; tRNA N2-guanine methylation [GO:0002940] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049]; tRNA methylation [GO:0030488]; tRNA N2-guanine methylation [GO:0002940] GO:0000049; GO:0002940; GO:0004809; GO:0005730; GO:0005737; GO:0005829; GO:0016423; GO:0030488 tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA (guanine-N2-)-methyltransferase activity [GO:0004809]; tRNA binding [GO:0000049] DETDESSKEETEPQVLK 0.9956 -9.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3632 0 12.4808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZN0 GPR88_HUMAN Probable G-protein coupled receptor 88 (Striatum-specific G-protein coupled receptor) GPR88 STRG Homo sapiens (Human) cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; neuromuscular process controlling balance [GO:0050885]; neuronal action potential [GO:0019228]; phototransduction [GO:0007602] cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cilium [GO:0005929]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cytoskeletal motor activity [GO:0003774]; G protein-coupled photoreceptor activity [GO:0008020]; cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; neuromuscular process controlling balance [GO:0050885]; neuronal action potential [GO:0019228]; phototransduction [GO:0007602] GO:0003774; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0005929; GO:0007186; GO:0007602; GO:0007626; GO:0008020; GO:0019228; GO:0050885; GO:0061743; GO:0071482 cytoskeletal motor activity [GO:0003774]; G protein-coupled photoreceptor activity [GO:0008020] GGLLGLGLTVSLLSHCLVALNR 0.9956 -8.8904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4688 0 0 0 0 0 13.8897 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2625 0 0 0 0 0 0 13.9224 0 0 0 0 0 13.4197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60248 SOX15_HUMAN Protein SOX-15 (Protein SOX-12) (Protein SOX-20) SOX15 SOX12 SOX20 SOX26 SOX27 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; male gonad development [GO:0008584]; myoblast development [GO:0048627]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle tissue regeneration [GO:0043403]; trophoblast giant cell differentiation [GO:0060707]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; male gonad development [GO:0008584]; myoblast development [GO:0048627]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of satellite cell activation involved in skeletal muscle regeneration [GO:0014718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle tissue regeneration [GO:0043403]; trophoblast giant cell differentiation [GO:0060707]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006325; GO:0006355; GO:0006357; GO:0008584; GO:0009653; GO:0014718; GO:0030154; GO:0043403; GO:0045843; GO:0045944; GO:0048627; GO:0060707; GO:0070318; GO:2000288 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" KAKSSGAGPSR 0.99561 -12.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4835 0 0 0 0 0 11.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95352 ATG7_HUMAN "Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7, APG7-like, hAGP7) (Ubiquitin-activating enzyme E1-like protein)" ATG7 APG7L Homo sapiens (Human) autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774] axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; macroautophagy [GO:0016236]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; suppression by virus of host autophagy [GO:0039521] GO:0000045; GO:0000407; GO:0000422; GO:0005576; GO:0005737; GO:0005829; GO:0005930; GO:0006497; GO:0006501; GO:0006914; GO:0006995; GO:0009267; GO:0015031; GO:0016236; GO:0019778; GO:0019779; GO:0031401; GO:0032446; GO:0034727; GO:0034774; GO:0039521; GO:0042752; GO:0042803; GO:0043065; GO:0044805; GO:0045732; GO:0048511; GO:0051607; GO:0071455; GO:1904813 Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803] ALAAADR 0.99561 -9.5257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8709 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7616 0 0 0 0 0 0 12.9679 0 0 14.272 0 0 0 13.7725 0 0 0 0 0 0 0 0 0 14.2875 0 0 0 0 0 0 0 10.8522 0 0 0 0 14.1662 12.5593 0 0 0 0 0 0 0 0 0 0 14.4393 0 0 13.2335 14.9105 13.1291 0 0 0 0 13.7125 0 0 0 12.553 0 12.1131 12.626 12.6384 0 0 0 0 0 0 0 0 0 0 0 0 9.87708 0 0 12.4404 0 12.9635 13.2219 0 0 0 0 0 0 0 0 0 0 12.5718 0 0 0 0 0 0 0 0 0 0 0 0 12.7558 O95760 IL33_HUMAN "Interleukin-33, IL-33 (Interleukin-1 family member 11, IL-1F11) (Nuclear factor from high endothelial venules, NF-HEV) [Cleaved into: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270) ]" IL33 C9orf26 IL1F11 NFHEV Homo sapiens (Human) cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; gene expression [GO:0010467]; interleukin-33-mediated signaling pathway [GO:0038172]; microglial cell activation involved in immune response [GO:0002282]; microglial cell proliferation [GO:0061518]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macrophage proliferation [GO:0120042]; negative regulation of T-helper 1 type immune response [GO:0002826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of CD80 production [GO:0150145]; positive regulation of CD86 production [GO:0150142]; positive regulation of cellular defense response [GO:0010186]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; regulation of sensory perception of pain [GO:0051930]; type 2 immune response [GO:0042092]; wound healing [GO:0042060] chromosome [GO:0005694]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transport vesicle [GO:0030133] chromosome [GO:0005694]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transport vesicle [GO:0030133]; cytokine activity [GO:0005125]; interleukin-33 receptor binding [GO:0002112]; cellular response to mechanical stimulus [GO:0071260]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; gene expression [GO:0010467]; interleukin-33-mediated signaling pathway [GO:0038172]; microglial cell activation involved in immune response [GO:0002282]; microglial cell proliferation [GO:0061518]; negative regulation of immunoglobulin production [GO:0002638]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of macrophage proliferation [GO:0120042]; negative regulation of T-helper 1 type immune response [GO:0002826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of CD80 production [GO:0150145]; positive regulation of CD86 production [GO:0150142]; positive regulation of cellular defense response [GO:0010186]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; regulation of sensory perception of pain [GO:0051930]; type 2 immune response [GO:0042092]; wound healing [GO:0042060] GO:0000122; GO:0001819; GO:0002112; GO:0002282; GO:0002638; GO:0002639; GO:0002686; GO:0002826; GO:0002830; GO:0005125; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0010186; GO:0010467; GO:0010628; GO:0030133; GO:0032436; GO:0032689; GO:0032722; GO:0032736; GO:0032753; GO:0032754; GO:0032755; GO:0032760; GO:0038172; GO:0042060; GO:0042092; GO:0043032; GO:0043231; GO:0045345; GO:0045348; GO:0045944; GO:0048714; GO:0050729; GO:0051607; GO:0051770; GO:0051930; GO:0061518; GO:0071260; GO:0097191; GO:0120042; GO:0150078; GO:0150142; GO:0150145 cytokine activity [GO:0005125]; interleukin-33 receptor binding [GO:0002112] KEACYFR 0.99561 -10.302 0 0 0 12.8582 0 0 12.9069 0 0 0 0 0 0 0 0 0 0 11.2767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6973 12.7661 13.133 0 0 13.1829 13.0738 0 13.5489 0 0 0 13.2427 13.3497 0 0 13.7585 13.6778 13.0571 0 13.3799 13.5424 13.6146 0 0 0 0 0 0 13.632 0 0 13.0699 13.5126 13.1045 0 0 0 12.979 0 0 0 0 0 13.8461 0 13.4607 13.3164 13.6515 0 0 0 13.3867 13.5249 13.5485 0 13.581 13.2418 13.1561 13.3053 14.1261 0 0 13.7897 0 0 0 0 0 0 0 0 0 0 0 0 13.5593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0CG22 DR4L1_HUMAN "Putative dehydrogenase/reductase SDR family member 4-like 1, EC 1.1.-.- (Short chain dehydrogenase/reductase family 25C member 4, Protein SDR25C4)" DHRS4L1 SDR25C4 Homo sapiens (Human) retinal metabolic process [GO:0042574] peroxisome [GO:0005777] peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090]; retinal metabolic process [GO:0042574] GO:0004090; GO:0005777; GO:0042574 carbonyl reductase (NADPH) activity [GO:0004090] ALALMIKAVVPEMEK 0.99561 -9.5175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3445 0 0 0 0 0 0 0 11.437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4222 13.5542 0 13.641 0 0 0 13.2437 17.7138 13.339 13.619 13.4872 14.0766 0 13.9845 13.7999 0 13.789 14.2835 11.6984 14.7445 13.5975 13.2843 0 0 13.6592 0 14.2117 0 0 14.5987 0 0 0 0 0 0 0 0 0 0 13.3935 14.0354 0 0 14.619 0 14.8623 13.711 0 0 14.2091 17.6746 13.5501 15.327 0 14.6035 0 13.9853 0 0 14.3537 13.9426 14.1058 13.8779 13.6991 13.9577 14.8919 13.7677 14.4637 0 13.8863 15.5895 12.0434 17.6831 13.4598 13.3923 0 14.7168 0 14.4159 0 13.7497 14.0731 14.3695 13.9217 14.0292 14.2899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5478 12.259 0 0 0 0 0 0 0 Q13569 TDG_HUMAN "G/T mismatch-specific thymine DNA glycosylase, EC 3.2.2.29 (Thymine-DNA glycosylase, hTDG)" TDG Homo sapiens (Human) "base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression, epigenetic [GO:0040029]" GO:0000122; GO:0000287; GO:0003677; GO:0003684; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0006298; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032091; GO:0032183; GO:0035511; GO:0035562; GO:0040029; GO:0042803; GO:0043621; GO:0043739; GO:0045008; GO:0045995; GO:0080111; GO:0140297; GO:1902544 ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; uracil DNA N-glycosylase activity [GO:0004844] IAVFNGKCIYEIFSK 0.99561 -10.298 0 0 0 0 0 0 0 0 11.8906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16342 PDCD2_HUMAN Programmed cell death protein 2 (Zinc finger MYND domain-containing protein 7) (Zinc finger protein Rp-8) PDCD2 RP8 ZMYND7 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532] GO:0003677; GO:0005634; GO:0005737; GO:0006915; GO:0006919; GO:0019899; GO:0043065; GO:0046872; GO:0070062; GO:1901532; GO:1902035 DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872] MAAAGAR 0.99561 -12.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4979 10.866 0 11.2599 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8193 13.1637 0 0 0 13.1423 13.7366 13.5764 0 0 0 0 0 0 0 0 0 14.6995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3551 0 14.0367 0 0 0 0 0 13.531 0 0 0 0 0 0 12.5076 0 0 0 13.4714 15.2269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6NZY7 BORG3_HUMAN Cdc42 effector protein 5 (Binder of Rho GTPases 3) CDC42EP5 BORG3 CEP5 Homo sapiens (Human) JNK cascade [GO:0007254]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]; small GTPase binding [GO:0031267]; JNK cascade [GO:0007254]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0007254; GO:0007266; GO:0008360; GO:0012505; GO:0016020; GO:0030838; GO:0031267; GO:0031274 small GTPase binding [GO:0031267] CRPNADLELNDVIGL 0.99561 -10.289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.209 0 0 0 0 0 0 0 13.6117 0 0 0 0 0 0 0 0 13.8364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.309 0 0 15.0368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0573 0 14.1573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7878 0 0 0 0 0 0 0 0 Q8IY18 SMC5_HUMAN "Structural maintenance of chromosomes protein 5, SMC protein 5, SMC-5, hSMC5" SMC5 KIAA0594 SMC5L1 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]" "cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]" "cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]" GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0016887; GO:0016925; GO:0018393; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0032204; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0051301; GO:0051984; GO:0071459; GO:0090398 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697] AKLVTELTNLIKICTSLHIQK 0.99561 -10.291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0469 0 0 0 0 0 0 14.2207 0 0 0 0 0 14.0794 0 0 0 0 0 13.1586 0 0 0 0 0 0 0 0 0 0 11.907 0 12.3716 0 0 0 0 0 0 11.6676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7969 0 0 0 11.9965 0 0 0 0 0 0 0 0 0 0 0 Q8IY92 SLX4_HUMAN Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12) SLX4 BTBD12 KIAA1784 KIAA1987 Homo sapiens (Human) DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820] "cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]" "cell junction [GO:0030054]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820]" GO:0000706; GO:0000712; GO:0000724; GO:0000781; GO:0003677; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006289; GO:0008047; GO:0010792; GO:0019899; GO:0030054; GO:0032206; GO:0033557; GO:0036297; GO:0046872; GO:0061820; GO:0072429; GO:0090656; GO:1904357; GO:1904431 DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872] DEAATTWEKMGQCALPPPQGQHSGAR 0.99561 -12.113 0 0 0 0 0 0 0 0 12.1441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2352 0 0 0 0 0 0 0 0 12.1559 0 0 0 0 16.2052 0 0 17.1803 16.3082 16.2707 17.1672 17.0407 15.8651 15.7252 0 16.8007 16.2443 16.307 16.1539 15.4 0 0 0 0 0 16.5483 14.4274 16.1434 0 12.3555 0 0 0 0 12.3418 0 16.1049 0 0 0 0 0 0 0 0 16.1747 11.9646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6912 0 0 0 0 0 0 13.378 0 0 0 13.8467 0 0 0 0 0 0 12.6217 0 Q96JA3 PKHA8_HUMAN "Pleckstrin homology domain-containing family A member 8, PH domain-containing family A member 8 (Phosphatidylinositol-four-phosphate adapter protein 2, FAPP-2, Phosphoinositol 4-phosphate adapter protein 2, hFAPP2) (Serologically defined breast cancer antigen NY-BR-86)" PLEKHA8 FAPP2 Homo sapiens (Human) ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802] cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031] GO:0000139; GO:0005654; GO:0005794; GO:0005802; GO:0005829; GO:0006869; GO:0015031; GO:0017089; GO:0035621; GO:0035627; GO:0051861; GO:0070273; GO:0097001; GO:0120009; GO:1902387; GO:1902388 ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; phosphatidylinositol-4-phosphate binding [GO:0070273] FLKGFLTEVK 0.99561 -10.297 0 0 0 0 0 0 0 0 0 0 14.2056 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5886 0 0 0 0 13.7561 0 0 13.8114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0105 0 0 0 0 0 0 0 0 0 0 12.922 12.7639 14.7007 0 0 0 0 0 0 0 0 0 0 15.2817 0 15.2816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.908 0 0 0 0 0 0 0 0 14.4174 0 0 Q9BZE2 PUS3_HUMAN "tRNA pseudouridine(38/39) synthase, EC 5.4.99.45 (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3)" PUS3 FKSG32 Homo sapiens (Human) mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119] GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0009982; GO:0031119; GO:0106029; GO:1990481 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029] ADLDIVTMDYAAQKYVGTHDFR 0.99561 -11.669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5536 0 0 0 0 0 0 0 11.4028 13.9356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.068 0 0 0 0 0 14.4373 0 0 0 0 0 0 0 0 Q9HC23 PROK2_HUMAN "Prokineticin-2, PK2 (Protein Bv8 homolog)" PROK2 BV8 Homo sapiens (Human) angiogenesis [GO:0001525]; chemotaxis [GO:0006935]; circadian rhythm [GO:0007623]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283] extracellular region [GO:0005576] extracellular region [GO:0005576]; G protein-coupled receptor binding [GO:0001664]; angiogenesis [GO:0001525]; chemotaxis [GO:0006935]; circadian rhythm [GO:0007623]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283] GO:0001525; GO:0001664; GO:0001935; GO:0005576; GO:0006935; GO:0006954; GO:0007186; GO:0007204; GO:0007218; GO:0007283; GO:0007623; GO:0019233; GO:0043066; GO:0045987 G protein-coupled receptor binding [GO:0001664] NNFGNGR 0.99561 -9.523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.407 0 0 0 0 0 0 0 0 0 0 0 11.6321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99708 CTIP_HUMAN "DNA endonuclease RBBP8, EC 3.1.-.- (CtBP-interacting protein, CtIP) (Retinoblastoma-binding protein 8, RBBP-8) (Retinoblastoma-interacting protein and myosin-like, RIM) (Sporulation in the absence of SPO11 protein 2 homolog, SAE2)" RBBP8 CTIP Homo sapiens (Human) blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous recombination [GO:0035825]; meiotic cell cycle [GO:0051321]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357] BRCA1-C complex [GO:0070533]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; transcription repressor complex [GO:0017053] BRCA1-C complex [GO:0070533]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; transcription repressor complex [GO:0017053]; damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403]; blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous recombination [GO:0035825]; meiotic cell cycle [GO:0051321]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000014; GO:0000082; GO:0000403; GO:0000406; GO:0000724; GO:0001835; GO:0003684; GO:0003690; GO:0003697; GO:0003714; GO:0005634; GO:0005654; GO:0006281; GO:0006357; GO:0010792; GO:0017053; GO:0035825; GO:0035861; GO:0042802; GO:0043231; GO:0044818; GO:0051301; GO:0051321; GO:0061629; GO:0070336; GO:0070533; GO:0110025; GO:1905168 damaged DNA binding [GO:0003684]; double-strand/single-strand DNA junction binding [GO:0000406]; double-stranded DNA binding [GO:0003690]; flap-structured DNA binding [GO:0070336]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714]; Y-form DNA binding [GO:0000403] EENAVFKIPLRPR 0.99562 -34.448 0 0 0 0 0 0 0 0 16.5966 14.9622 15.2615 14.5882 17.1026 13.7159 16.712 11.2796 16.7682 16.572 12.025 11.4851 0 0 0 0 16.5365 0 17.0105 16.6033 16.6051 16.5186 16.4813 14.0279 16.8463 0 12.9998 13.8268 14.0555 13.9865 0 14.3513 16.6216 16.7399 16.5651 16.5256 16.5431 0 0 16.481 0 0 0 0 0 0 0 0 0 16.0638 0 15.3732 0 0 0 0 0 15.3224 0 0 14.4051 0 13.3771 0 0 0 0 0 14.1744 0 0 0 0 11.7428 0 0 0 0 0 14.1785 0 15.1181 0 0 0 0 0 13.9149 0 0 11.898 0 0 14.1984 0 0 0 0 14.5631 0 14.5861 0 0 0 13.3853 0 0 0 0 0 0 12.0854 0 0 14.7905 13.9177 0 0 14.4957 0 0 0 0 0 13.2733 0 0 0 14.6874 15.1313 14.5996 11.2041 0 0 14.7973 14.0877 0 0 14.3511 0 0 0 0 0 15.5819 0 0 0 0 13.8252 14.9004 0 13.5155 13.6102 0 17.215 0 0 0 0 0 0 0 11.9634 0 0 0 17.391 0 17.307 14.1653 16.0612 A6NM28 ZFP92_HUMAN "Zinc finger protein 92 homolog, Zfp-92" ZFP92 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AAILLTTRPK 0.99562 -31.639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3115 0 0 0 0 0 0 12.4707 0 0 0 0 0 0 0 0 0 0 12.9963 13.4597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7463 0 0 0 0 0 0 11.6804 0 12.636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60494 CUBN_HUMAN Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor) CUBN IFCR Homo sapiens (Human) cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894] GO:0001894; GO:0005509; GO:0005765; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0010008; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062 calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023] CVHGICEDLMR 0.99562 -9.8622 0 0 0 0 0 0 0 0 13.2278 0 13.4116 13.1285 0 13.3938 0 0 0 0 0 11.9449 0 0 0 13.1092 0 13.8174 14.7539 13.3574 0 13.4148 13.4829 13.3327 13.1902 13.3339 0 0 0 0 0 0 0 0 13.2609 13.1887 0 0 13.0037 0 13.8846 12.8145 0 0 14.3023 0 11.8872 12.1039 0 0 0 0 0 0 0 0 0 0 15.6372 0 0 0 0 11.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3447 15.6303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1897 0 0 0 0 0 0 0 0 15.3224 0 0 0 0 0 14.7321 0 0 0 12.9441 0 0 0 0 0 15.5093 0 14.6763 0 0 14.6945 0 14.5868 14.849 0 0 0 0 14.4359 0 0 0 0 0 0 0 0 0 P51610 HCFC1_HUMAN "Host cell factor 1, HCF, HCF-1 (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6 ]" HCFC1 HCF1 HFC1 Homo sapiens (Human) "cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]" cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188] "cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]" GO:0000122; GO:0000123; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0006355; GO:0007049; GO:0010628; GO:0016020; GO:0019046; GO:0030674; GO:0032991; GO:0035097; GO:0042802; GO:0043025; GO:0043254; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0044665; GO:0045296; GO:0045787; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0051568; GO:0051571; GO:0071339; GO:0140297 cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713] AWNNQVCCKDLWYLETEK 0.99562 -12.812 0 0 0 14.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2471 0 15.2435 13.5902 0 0 13.3726 0 0 0 0 0 0 0 0 17.0553 0 0 12.7585 0 0 0 0 0 0 0 0 0 0 0 0 15.0449 13.7881 14.8912 0 0 0 0 0 0 0 0 0 0 0 14.8506 0 0 0 0 0 0 13.2611 11.5804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7599 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9679 0 0 0 13.6519 0 13.0745 0 0 0 15.3627 0 0 Q02930 CREB5_HUMAN "Cyclic AMP-responsive element-binding protein 5, CREB-5, cAMP-responsive element-binding protein 5 (cAMP-response element-binding protein A, CRE-BPa)" CREB5 CREBPA Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] "chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006357; GO:0035497; GO:0042802; GO:0045893; GO:0046872; GO:0070062; GO:1990837 "cAMP response element binding [GO:0035497]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" NEVAQLKQLLLTHK 0.99562 -10.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4362 15.6494 0 0 0 0 0 0 12.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q0IIM8 TBC8B_HUMAN TBC1 domain family member 8B TBC1D8B Homo sapiens (Human) activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; vesicle-mediated transport [GO:0016192] cytosol [GO:0005829] cytosol [GO:0005829]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; glomerular filtration [GO:0003094]; vesicle-mediated transport [GO:0016192] GO:0003094; GO:0005096; GO:0005509; GO:0005829; GO:0016192; GO:0090630 calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096] EDDPEKFREALLK 0.99562 -9.8366 0 0 11.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3774 0 0 0 0 0 0 9.98214 0 0 0 0 0 0 11.5201 0 0 0 0 10.2504 0 10.6064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2683 0 0 0 0 0 12.6626 0 0 0 12.8683 0 0 12.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1487 0 12.4406 0 13.3556 0 13.4318 0 0 0 0 0 0 0 0 14.336 0 0 0 14.5902 0 12.9331 0 0 0 0 15.038 0 14.9317 0 13.5942 0 0 0 14.4351 13.9282 14.1123 0 0 0 12.6318 0 0 0 0 12.6005 0 0 0 14.0197 0 0 0 12.6077 0 0 12.4095 11.7684 0 0 0 0 0 0 0 0 0 0 0 0 13.0449 12.0789 0 12.8822 0 0 0 0 13.6919 0 0 0 0 12.3964 0 0 Q13585 MTR1L_HUMAN Melatonin-related receptor (G protein-coupled receptor 50) (H9) GPR50 Homo sapiens (Human) cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005654; GO:0005886; GO:0005887; GO:0007186; GO:0007267; GO:0008502 G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502] AASGHLK 0.99562 -12.79 0 0 0 0 0 0 0 0 0 11.6272 0 0 10.9949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0071 0 11.1936 0 0 0 0 0 0 0 0 0 0 0 0 13.5797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0221 13.4571 0 11.295 0 12.9111 0 0 0 11.8815 14.893 13.5734 13.4767 13.9988 12.2936 0 0 12.5188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8488 0 0 12.2161 0 11.0868 0 0 0 0 0 0 0 0 0 0 0 12.3159 0 11.8455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9484 0 0 0 0 0 0 0 Q5VXH5 PRAM7_HUMAN PRAME family member 7 PRAMEF7 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 APPRLLELARQR 0.99562 -34.502 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95949 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3735 0 0 0 0 0 0 0 0 0 14.2948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2165 13.3832 13.9959 0 13.0305 13.7593 13.4817 0 13.2682 13.3695 14.9255 14.7424 15.6456 14.946 14.7585 0 0 14.3509 0 14.3035 13.9513 11.7968 0 13.1175 0 13.6362 13.261 13.2668 13.4455 15.3746 0 0 12.9191 0 13.0994 0 0 0 0 13.9586 12.9916 15.1099 0 13.3252 0 0 14.0521 0 0 0 13.5643 0 14.8757 0 0 13.8886 15.785 0 13.5067 13.5042 14.8681 13.6069 0 0 0 13.4883 12.9353 0 0 0 0 0 0 13.4506 0 0 13.3593 13.3507 13.3896 0 0 13.3252 0 0 0 0 0 0 0 13.2298 14.9814 13.2962 0 0 0 13.412 0 0 0 0 12.7673 0 0 0 0 0 0 0 0 14.0873 14.0181 13.7829 0 0 Q6NT55 CP4FN_HUMAN "Ultra-long-chain fatty acid omega-hydroxylase, EC 1.14.14.177 (Cytochrome P450 4F22)" CYP4F22 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690]" GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0016021; GO:0016705; GO:0020037; GO:0046513 "heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]" IYAVSTLLLFLLFFLFRLLLR 0.99562 -11.713 0 0 0 0 0 0 0 11.4127 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3445 0 0 0 0 13.8018 0 0 0 0 0 0 0 12.1876 0 11.8859 0 0 11.7839 13.8418 0 0 0 0 0 11.2301 0 14.3665 12.8361 0 0 0 12.0769 0 0 0 12.9433 11.047 13.6573 0 0 0 12.7217 0 0 0 13.7767 0 0 0 0 15.5456 0 0 0 0 11.745 0 0 0 0 11.0892 12.0074 0 11.7932 14.6598 0 13.3171 11.9578 0 0 0 11.8721 0 0 0 11.4001 0 0 14.4392 0 11.7516 0 0 11.7949 0 0 0 13.5027 0 13.666 13.012 0 0 12.6531 10.1063 11.16 0 0 0 11.4393 14.8888 0 0 0 0 0 11.0434 0 0 0 0 0 14.5719 0 0 0 0 0 0 0 0 0 0 0 0 14.4766 0 0 0 14.2031 0 0 Q86SQ4 AGRG6_HUMAN "Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment, ADGRG6-NTF; ADGRG6 C-terminal fragment, ADGRG6-CTF ]" ADGRG6 DREG GPR126 VIGR Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; nervous system development [GO:0007399]; Schwann cell differentiation [GO:0014037] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; nervous system development [GO:0007399]; Schwann cell differentiation [GO:0014037] GO:0004175; GO:0004930; GO:0005518; GO:0005737; GO:0005789; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007399; GO:0009986; GO:0014037; GO:0016021; GO:0019933; GO:0022011; GO:0042552; GO:0043236; GO:0050840; GO:0060347 collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236] AQFTFFNKTGLFQDVGPQRK 0.99562 -34.533 0 9.6561 0 0 0 0 0 13.3021 0 0 0 0 0 0 0 0 12.7017 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9108 0 0 0 0 0 0 0 0 0 11.7907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4971 0 12.959 0 0 0 9.99237 0 0 0 0 0 0 0 0 0 0 0 11.7793 0 0 0 0 0 0 0 0 13.4286 0 15.3722 0 10.5201 11.3926 0 0 0 0 0 0 0 14.965 0 13.5851 0 11.936 0 0 0 0 0 0 0 0 15.5564 0 0 10.5291 0 0 0 0 0 0 0 0 0 13.1994 0 0 0 0 0 0 14.5226 0 15.7429 0 0 13.0946 0 0 0 0 0 0 10.6954 0 0 0 0 13.0678 13.6707 0 12.3708 0 0 12.5968 0 0 13.8 0 0 0 14.3792 0 0 12.98 11.3116 0 11.3621 0 Q8NHQ9 DDX55_HUMAN "ATP-dependent RNA helicase DDX55, EC 3.6.4.13 (DEAD box protein 55)" DDX55 KIAA1595 Homo sapiens (Human) cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] AEGLDLASCVR 0.99562 -9.8708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4699 13.536 0 12.1814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9263 0 0 0 0 11.9911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q99784 NOE1_HUMAN Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1) OLFM1 NOE1 NOEL1 Homo sapiens (Human) atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165] anchoring junction [GO:0070161]; axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202] anchoring junction [GO:0070161]; axon [GO:0030424]; axonal growth cone [GO:0044295]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; atrioventricular valve formation [GO:0003190]; cardiac epithelial to mesenchymal transition [GO:0060317]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuronal signal transduction [GO:0023041]; positive regulation of apoptotic process [GO:0043065]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; regulation of axon extension [GO:0030516]; signal transduction [GO:0007165] GO:0003190; GO:0005615; GO:0005783; GO:0007165; GO:0007399; GO:0010628; GO:0010629; GO:0010718; GO:0023041; GO:0030424; GO:0030516; GO:0043025; GO:0043065; GO:0043204; GO:0044295; GO:0045202; GO:0060317; GO:0070161 DARTKQLR 0.99562 -9.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3603 15.2248 15.0107 13.8852 14.2312 13.8739 14.9322 0 0 0 0 0 0 0 0 0 0 13.3754 0 13.6445 14.5507 13.739 0 13.4143 0 0 13.7609 14.6039 0 14.1858 13.6962 13.401 13.2953 13.4171 13.0137 13.2598 0 0 13.8762 0 0 0 14.0873 0 14.5257 14.6192 13.3597 0 14.1435 13.6147 0 0 0 15.6153 13.9038 13.7997 14.3955 13.029 0 0 0 13.5419 14.6249 13.7328 13.3592 0 0 13.3588 0 12.9468 13.3418 13.3825 16.1024 0 0 0 0 16.1828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5793 13.6167 13.0101 0 0 0 0 0 0 Q9H6J7 CSTP1_HUMAN Centriolar satellite-associated tubulin polyglutamylase complex regulator 1 CSTPP1 C11orf49 Homo sapiens (Human) cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815] cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815] GO:0005737; GO:0005815; GO:0005874 AFWRCFR 0.99562 -12.806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2547 0 0 0 0 11.6104 0 0 0 0 0 16.9569 0 0 0 0 0 14.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8935 0 12.756 0 0 12.807 12.644 0 0 0 0 0 0 0 12.4422 0 0 0 0 Q9NUP9 LIN7C_HUMAN "Protein lin-7 homolog C, Lin-7C (Mammalian lin-seven protein 3, MALS-3) (Vertebrate lin-7 homolog 3, Veli-3)" LIN7C MALS3 VELI3 Homo sapiens (Human) exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202] basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031] GO:0002011; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008092; GO:0015031; GO:0016323; GO:0019904; GO:0045199; GO:0045202; GO:0097016; GO:0097025; GO:0098793; GO:0098839; GO:1903361 cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; protein domain specific binding [GO:0019904] AAQGKVK 0.99562 -9.8637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8395 0 13.3542 0 0 0 0 0 14.0996 0 0 0 0 0 0 14.2056 0 0 0 0 12.4941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7247 0 0 0 0 0 0 0 O60391 NMD3B_HUMAN "Glutamate receptor ionotropic, NMDA 3B, GluN3B (N-methyl-D-aspartate receptor subtype 3B, NMDAR3B, NR3B)" GRIN3B Homo sapiens (Human) ionotropic glutamate receptor signaling pathway [GO:0035235]; protein insertion into membrane [GO:0051205]; regulation of calcium ion transport [GO:0051924] anchoring junction [GO:0070161]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211] anchoring junction [GO:0070161]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; glycine binding [GO:0016594]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023]; ionotropic glutamate receptor signaling pathway [GO:0035235]; protein insertion into membrane [GO:0051205]; regulation of calcium ion transport [GO:0051924] GO:0004970; GO:0005261; GO:0005262; GO:0005886; GO:0015276; GO:0016594; GO:0017146; GO:0030594; GO:0035235; GO:0038023; GO:0042165; GO:0043025; GO:0045211; GO:0051205; GO:0051924; GO:0070161 calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; glycine binding [GO:0016594]; ionotropic glutamate receptor activity [GO:0004970]; ligand-gated ion channel activity [GO:0015276]; neurotransmitter binding [GO:0042165]; neurotransmitter receptor activity [GO:0030594]; signaling receptor activity [GO:0038023] APLARARAR 0.99563 -12.328 0 0 0 0 0 0 0 0 0 0 11.1455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7311 12.2725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8918 0 0 13.6069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.453 0 0 0 0 0 0 14.0388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3443 0 0 0 0 0 0 0 0 0 13.7932 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6611 13.5064 0 0 0 0 0 0 0 0 13.734 12.9006 0 0 0 0 0 0 0 0 0 0 O95502 NPTXR_HUMAN Neuronal pentraxin receptor NPTXR Homo sapiens (Human) regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021] glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962] GO:0016021; GO:0046872; GO:0098962; GO:0098978 metal ion binding [GO:0046872] ALPELYAFTACMWLRSR 0.99563 -11.82 0 0 0 0 0 0 0 0 0 0 0 11.6349 0 0 10.7726 13.0009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6876 0 0 0 0 0 0 0 9.52233 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4984 11.4214 0 0 0 0 0 0 0 0 0 0 11.3518 0 0 0 0 10.9736 0 0 0 0 0 0 0 0 0 0 0 14.9395 14.933 13.8375 14.3382 0 13.9558 0 0 0 0 13.6315 0 13.4853 13.5463 0 13.8018 0 14.1311 0 0 14.4914 11.5026 0 0 0 0 0 0 0 0 0 0 12.4201 0 14.535 0 0 0 0 0 0 12.6753 0 12.2402 0 0 12.8766 0 0 12.688 0 0 0 0 0 0 0 0 14.4997 0 0 0 0 0 0 0 0 0 13.7156 0 0 0 15.3174 0 0 15.2033 15.2272 0 14.2152 13.4634 13.4931 0 13.0752 0 0 0 0 0 0 11.5524 0 0 11.5318 0 0 0 0 0 O95996 APCL_HUMAN "Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like, APC-like)" APC2 APCL Homo sapiens (Human) activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055] actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794] actin filament [GO:0005884]; beta-catenin destruction complex [GO:0030877]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; lamellipodium membrane [GO:0031258]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; activation of GTPase activity [GO:0090630]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell differentiation [GO:0045595]; Wnt signaling pathway [GO:0016055] GO:0000226; GO:0001708; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005884; GO:0007026; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0015630; GO:0016055; GO:0016342; GO:0016477; GO:0030496; GO:0030877; GO:0031258; GO:0043161; GO:0045171; GO:0045295; GO:0045595; GO:0045732; GO:0048471; GO:0090090; GO:0090630; GO:0098794 beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017] AHPLLRLK 0.99563 -31.69 13.7895 0 0 0 0 0 0 0 0 0 13.4622 0 0 0 0 0 0 11.1598 12.4052 13.8578 13.856 0 0 0 14.3609 13.8524 0 13.3782 11.9437 13.6337 0 10.0269 0 0 0 0 0 0 0 0 13.6272 0 0 0 0 0 0 0 0 0 0 0 11.8873 0 0 0 0 0 11.427 0 0 0 0 0 0 0 0 0 0 0 0 14.6582 0 0 0 0 0 0 13.4232 0 14.1476 0 14.8436 0 0 0 0 0 0 0 0 0 13.4331 0 0 0 0 0 15.9674 0 0 0 0 0 0 0 0 0 0 0 0 16.3194 0 13.9163 0 0 0 0 0 15.8426 0 14.08 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8117 0 0 0 0 14.7489 14.727 0 0 13.8841 14.3543 11.8863 0 0 13.2161 0 14.0966 13.4507 13.6698 14.0834 0 0 0 0 0 0 0 0 12.8096 13.1911 0 12.727 0 0 0 0 0 12.6194 0 0 0 0 0 0 P51815 ZN75D_HUMAN Zinc finger protein 75D (Zinc finger protein 75) (Zinc finger protein 82) ZNF75D ZNF75 ZNF82 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" EAVLLGGTAVAPGFK 0.99563 -11.81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3569 0 0 0 0 0 0 0 Q13123 RED_HUMAN Protein Red (Cytokine IK) (IK factor) (Protein RER) IK RED RER Homo sapiens (Human) "mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]" GO:0000278; GO:0000398; GO:0000922; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007094; GO:0016607; GO:0034501; GO:0042802; GO:0071005 identical protein binding [GO:0042802] AEIASKEK 0.99563 -35.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7019 0 12.0567 0 0 0 0 0 0 0 10.8994 0 0 0 0 0 0 0 0 0 15.7618 15.8423 0 0 0 17.4824 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2772 0 0 0 0 0 0 0 0 11.6441 0 0 0 0 0 15.4171 13.0391 14.2998 0 0 0 0 12.3518 0 12.3639 0 0 0 0 0 15.7631 0 0 0 0 0 0 0 0 12.3029 13.6477 0 13.8645 0 0 0 0 14.7469 0 0 13.6949 0 0 0 0 0 0 12.6178 12.7162 0 0 12.394 0 0 0 0 0 0 13.7664 0 15.2283 0 0 0 12.8747 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8826 0 0 0 0 Q16831 UPP1_HUMAN "Uridine phosphorylase 1, UPase 1, UrdPase 1, EC 2.4.2.3" UPP1 UP Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; nucleobase-containing compound metabolic process [GO:0006139]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; nucleobase-containing compound metabolic process [GO:0006139]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218] GO:0004850; GO:0005654; GO:0005829; GO:0006139; GO:0006218; GO:0006248; GO:0006249; GO:0009032; GO:0042149; GO:0042802; GO:0044206; GO:0046050; GO:0046074; GO:0046079; GO:0047847 deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850] AEFEQIVLGKRVIR 0.99563 -11.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7205 14.1225 0 0 13.5432 0 0 0 0 0 0 0 0 0 Q496Y0 LONF3_HUMAN LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127) LONRF3 RNF127 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0005737; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] AGQQPPPPLRVNVVLSGLLGKLFPGPAR 0.99563 -9.615 0 0 0 0 0 0 0 0 0 0 0 10.6241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.442 15.7298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5569 13.2104 13.4714 12.2091 13.8612 11.7425 0 11.7909 0 0 10.957 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8099 0 0 12.811 0 0 0 0 0 0 0 0 0 0 16.8818 0 0 0 0 0 0 0 0 0 0 0 15.8656 0 0 0 0 0 0 0 0 15.152 0 0 0 0 0 0 0 0 0 0 11.3292 0 0 0 0 0 0 0 0 0 0 0 0 13.4637 0 13.3574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3285 15.669 14.5612 12.5063 0 14.8269 0 13.8481 0 0 0 0 0 0 0 0 13.6225 0 0 Q6PKG0 LARP1_HUMAN La-related protein 1 (La ribonucleoprotein domain family member 1) LARP1 KIAA0731 LARP Homo sapiens (Human) cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; post-transcriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; cadherin binding [GO:0045296]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; post-transcriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413] GO:0000339; GO:0000340; GO:0003723; GO:0003730; GO:0005737; GO:0005829; GO:0006413; GO:0008190; GO:0008283; GO:0008494; GO:0010494; GO:0010608; GO:0016020; GO:0016239; GO:0017148; GO:0031369; GO:0031929; GO:0038202; GO:0043024; GO:0045070; GO:0045296; GO:0045727; GO:0045947; GO:0045948; GO:0048027; GO:0048255; GO:0072752; GO:1990928 cadherin binding [GO:0045296]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369] AAVPKQR 0.99563 -35.437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2229 0 0 0 13.7999 0 0 0 10.9456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2636 0 0 0 14.0094 0 0 0 0 10.5774 0 0 0 0 0 0 0 0 0 9.20482 0 0 0 0 0 0 0 0 0 10.7542 0 0 0 0 0 14.3983 0 0 0 0 0 0 13.0372 0 13.3329 0 12.1915 14.4542 0 0 0 0 0 0 0 0 13.1331 0 10.6548 0 0 0 15.2168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7773 0 0 0 0 0 0 11.3612 0 0 11.6129 12.1918 0 0 0 0 0 0 0 0 0 0 0 0 10.4069 0 0 0 0 0 12.5373 0 13.1132 12.7378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6749 0 10.9138 0 0 0 0 0 0 Q6ZNA1 ZN836_HUMAN Zinc finger protein 836 ZNF836 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFKQGSLLTRHK 0.99563 -12.307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2234 0 0 0 0 0 13.7062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0283 10.4048 0 12.2313 0 0 0 0 0 0 0 11.9126 0 0 13.4284 14.1708 17.1292 0 0 0 0 17.5704 0 0 0 0 0 0 0 0 0 0 0 13.6937 17.5218 0 0 14.6442 0 0 0 0 0 0 16.9689 0 0 0 0 0 0 18.4279 0 0 10.2983 18.1513 0 0 0 0 0 0 0 0 10.4698 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6679 13.6472 10.7588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2577 0 12.372 0 0 0 0 0 0 0 0 0 13.7701 0 Q86YN6 PRGC2_HUMAN "Peroxisome proliferator-activated receptor gamma coactivator 1-beta, PGC-1-beta, PPAR-gamma coactivator 1-beta, PPARGC-1-beta (PGC-1-related estrogen receptor alpha coactivator)" PPARGC1B PERC PGC1 PGC1B PPARGC1 Homo sapiens (Human) "actin filament organization [GO:0007015]; bone trabecula formation [GO:0060346]; cellular response to reactive oxygen species [GO:0034614]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitochondrial transcription [GO:0006390]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone resorption [GO:0045780]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]" cytosol [GO:0005829]; mediator complex [GO:0016592]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; mediator complex [GO:0016592]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712]; actin filament organization [GO:0007015]; bone trabecula formation [GO:0060346]; cellular response to reactive oxygen species [GO:0034614]; intracellular estrogen receptor signaling pathway [GO:0030520]; mitochondrial transcription [GO:0006390]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone resorption [GO:0045780]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]" GO:0001503; GO:0003712; GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006355; GO:0006390; GO:0007015; GO:0010694; GO:0016592; GO:0030331; GO:0030374; GO:0030520; GO:0034614; GO:0042327; GO:0045672; GO:0045780; GO:0045892; GO:0045944; GO:0050682; GO:0051091; GO:0051384; GO:0051591; GO:0060346; GO:0120162 AF-2 domain binding [GO:0050682]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] DSLALGR 0.99563 -35.361 14.8425 0 0 0 0 0 0 0 12.149 0 0 0 0 0 0 0 11.7868 10.343 12.2251 0 0 0 0 0 0 0 0 0 0 0 0 11.9948 0 0 11.6937 0 0 0 0 0 0 0 0 0 0 0 0 12.0459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9835 16.3622 0 12.1618 15.0994 14.7085 14.3491 11.3919 14.7288 15.2268 14.6798 14.4836 14.5769 14.4061 14.6125 0 14.4554 0 0 0 0 14.4531 15.6623 15.6948 0 0 0 15.1103 14.9689 15.7785 15.9248 0 16.0097 0 0 0 0 0 0 15.6701 0 0 0 0 0 0 14.9355 15.0706 15.4102 15.3837 0 0 0 0 0 0 13.5344 15.8374 15.3062 15.4884 15.5068 15.3446 16.165 15.6033 0 15.3843 15.067 15.344 15.348 15.2652 0 15.2336 0 15.2463 0 0 13.8875 0 0 0 0 0 0 0 12.7071 0 0 0 0 0 0 0 0 13.1144 14.4558 14.6586 0 0 0 0 0 14.9322 0 Q8N7Z5 ANR31_HUMAN Ankyrin repeat domain-containing protein 31 ANKRD31 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343] chromatin [GO:0000785]; nucleus [GO:0005634] chromatin [GO:0000785]; nucleus [GO:0005634]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic DNA double-strand break formation involved in reciprocal meiotic recombination [GO:0010780]; positive regulation of meiotic DNA double-strand break formation [GO:1903343] GO:0000785; GO:0005634; GO:0007129; GO:0010780; GO:1903343 ASILLNGKLK 0.99563 -35.366 0 0 0 0 0 0 0 14.18 0 12.015 0 0 0 0 0 0 0 11.5712 0 0 0 12.6887 0 0 0 0 0 10.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0289 0 0 10.15 0 0 0 0 0 14.423 0 13.1584 0 0 0 0 0 13.3592 17.7077 0 0 10.8655 11.6012 0 0 0 0 0 0 0 12.3791 0 0 0 13.4071 0 0 13.815 0 0 0 0 0 0 0 10.9996 0 11.7923 16.6997 13.3143 12.6455 0 0 0 0 0 0 0 0 0 14.2054 0 0 12.3311 13.9319 0 15.1441 17.8992 11.6666 15.5011 0 0 11.3365 0 0 13.5821 0 0 0 14.9078 14.9051 12.0058 0 0 12.8386 13.0159 12.2793 0 0 14.0242 0 0 0 0 0 0 0 14.983 0 11.4484 0 14.1544 0 9.96622 0 0 0 0 0 13.8791 13.519 0 0 0 0 0 12.0484 11.8777 0 0 14.6892 0 0 0 0 0 0 14.0849 0 Q96BR6 ZN669_HUMAN Zinc finger protein 669 ZNF669 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" AFSCSTSLR 0.99563 -9.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9052 0 13.7732 13.7017 0 13.2633 0 0 0 0 13.3584 0 0 0 0 0 0 15.2396 13.128 13.1322 0 0 0 0 0 0 13.1446 0 0 0 0 0 0 0 13.3898 0 13.4221 0 12.3984 12.0413 0 12.9584 0 0 0 0 0 0 0 12.0037 0 0 0 0 0 0 14.8727 13.7425 0 12.218 0 0 0 0 0 0 0 0 0 0 12.1975 0 11.8818 0 0 0 0 0 12.2027 0 0 12.6604 0 0 0 0 0 0 11.7215 0 11.929 0 0 0 0 0 0 0 Q96QP1 ALPK1_HUMAN "Alpha-protein kinase 1, EC 2.7.11.1 (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase)" ALPK1 KIAA1527 LAK Homo sapiens (Human) cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein phosphorylation [GO:0006468] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922] centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein phosphorylation [GO:0006468] GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310 ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AHSALLLKYSKK 0.99563 -9.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9724 0 0 0 0 0 0 0 13.7527 13.567 0 0 0 0 12.6728 11.0782 0 0 12.2739 0 0 13.4833 12.9039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6069 0 0 0 13.5395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9766 0 0 0 0 0 0 0 13.2933 0 0 0 0 0 0 0 0 0 0 13.4293 0 12.1866 14.7581 0 0 13.8876 0 0 0 14.0758 0 12.8244 0 13.7567 13.4413 14.8521 0 15.7779 0 13.7649 0 0 0 0 0 14.626 0 0 0 0 0 0 0 0 13.5681 14.5195 0 0 0 13.8709 15.7745 0 0 0 0 14.3954 0 0 12.9622 0 14.4753 0 0 13.5619 0 0 0 14.3407 0 0 0 0 14.8602 12.422 14.3648 13.9784 0 0 14.304 0 0 15.0556 0 0 0 0 14.3557 0 13.3276 0 0 13.1477 0 0 0 0 Q9BYV8 CEP41_HUMAN "Centrosomal protein of 41 kDa, Cep41 (Testis-specific gene A14 protein)" CEP41 TSGA14 Homo sapiens (Human) cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031] GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0015031; GO:0016020; GO:0018095; GO:0036064; GO:0060271 AEPHTKDK 0.99563 -12.321 0 0 0 0 0 0 0 0 0 0 11.8647 10.6882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9774 0 0 0 0 0 0 0 12.6889 0 0 0 19.4535 0 15.3882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5677 0 0 0 0 0 14.5539 0 0 15.439 0 0 0 0 15.1556 11.6504 0 0 12.9452 0 0 0 15.2649 0 0 0 12.9432 0 0 0 0 0 0 0 0 0 0 0 12.7955 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5807 0 0 0 0 0 0 0 0 0 12.7421 0 0 0 0 0 0 0 Q9HAU4 SMUF2_HUMAN "E3 ubiquitin-protein ligase SMURF2, hSMURF2, EC 2.3.2.26 (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)" SMURF2 Homo sapiens (Human) "negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]" GO:0000122; GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0016607; GO:0017015; GO:0030512; GO:0030514; GO:0030579; GO:0042802; GO:0043161; GO:0045121; GO:0045892; GO:0046332; GO:0060071; GO:0061630; GO:0090263; GO:1901165 identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] ALQGAAGPR 0.99563 -35.504 0 0 0 0 0 0 0 0 11.9243 0 12.5279 0 0 0 0 11.5241 0 0 12.2316 0 0 0 0 0 0 0 0 12.093 0 0 0 0 0 0 0 0 0 0 0 0 10.8835 0 0 0 0 0 0 0 0 0 0 0 0 11.7497 0 0 0 0 0 0 0 0 0 0 0 0 11.1938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4578 0 13.8795 0 13.224 0 0 0 0 0 0 0 0 0 13.1313 0 0 0 0 0 14.3129 12.7502 0 13.8573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1873 0 0 0 0 0 0 12.521 13.0327 0 12.1863 0 16.403 0 11.1202 0 13.8753 0 0 0 0 13.8142 0 0 0 0 0 0 0 0 0 O60813 PRA11_HUMAN PRAME family member 11 PRAMEF11 Homo sapiens (Human) "negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]" GO:0005737; GO:0008284; GO:0043066; GO:0045596; GO:0045892 EIVTQFTTQFLKLR 0.99564 -11.881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8289 0 0 0 14.1651 0 0 0 0 0 0 12.7459 12.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.47476 0 13.9668 13.0915 11.193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7005 0 11.6195 0 0 0 10.4341 11.811 0 0 0 14.5127 13.619 13.543 13.8461 13.7632 12.5676 0 0 0 0 0 14.0479 0 0 0 13.9371 14.1866 14.0342 0 14.1148 0 0 0 14.1383 0 14.161 16.633 14.7378 0 0 12.4209 0 16.1467 14.2824 14.4215 11.6458 0 14.4501 0 0 0 0 14.6166 0 0 14.2788 0 0 0 14.3778 18.2045 0 0 14.1703 17.2385 17.0389 14.1831 14.2221 0 0 0 0 0 0 0 14.5985 15.2965 14.0194 15.4979 0 0 0 0 0 0 13.8956 0 0 0 0 0 0 0 0 11.5123 0 11.2613 11.5278 0 0 0 0 0 0 0 13.8126 14.1064 0 14.2872 0 0 9.82404 0 0 O94811 TPPP_HUMAN "Tubulin polymerization-promoting protein, TPPP, EC 3.6.5.- (25 kDa brain-specific protein) (TPPP/p25) (p24) (p25-alpha)" TPPP TPPP1 Homo sapiens (Human) astral microtubule organization [GO:0030953]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule nucleation by microtubule organizing center [GO:0051418]; microtubule polymerization [GO:0046785]; myelin assembly [GO:0032288]; negative regulation of tubulin deacetylation [GO:1904428]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of protein polymerization [GO:0032273]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of microtubule cytoskeleton organization [GO:0070507] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic Golgi apparatus [GO:0150051] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic Golgi apparatus [GO:0150051]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule nucleation by microtubule organizing center [GO:0051418]; microtubule polymerization [GO:0046785]; myelin assembly [GO:0032288]; negative regulation of tubulin deacetylation [GO:1904428]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of protein polymerization [GO:0032273]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of microtubule cytoskeleton organization [GO:0070507] GO:0000287; GO:0001578; GO:0003924; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005874; GO:0008017; GO:0014003; GO:0015631; GO:0030953; GO:0031334; GO:0031643; GO:0032273; GO:0032288; GO:0042803; GO:0046785; GO:0048471; GO:0048709; GO:0051301; GO:0051418; GO:0070507; GO:0072686; GO:0150051; GO:1904428 GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631] EVHRLIEGKAPIISGVTK 0.99564 -11.858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1988 0 10.6861 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.91 0 0 0 0 0 0 0 0 0 0 13.7813 0 0 0 12.2074 13.4699 13.6208 14.9179 0 0 0 0 0 0 14.2387 13.5807 0 0 0 0 0 13.644 12.7939 13.0104 13.4423 0 0 14.7337 0 0 0 0 0 13.4295 0 0 13.1273 0 0 0 0 0 11.284 0 0 13.9185 0 0 0 0 0 0 13.0187 0 0 0 0 0 0 0 0 13.1814 10.812 0 0 0 0 0 0 12.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5439 0 12.9743 0 0 11.563 0 0 Q6UWJ8 C16L2_HUMAN CD164 sialomucin-like 2 protein CD164L2 UNQ6122/PRO20044 Homo sapiens (Human) cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021] GO:0016021; GO:0031410 GFGRGALIR 0.99564 -11.877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5788 0 0 13.8073 0 0 0 0 0 0 0 0 0 0 0 Q99611 SPS2_HUMAN "Selenide, water dikinase 2, EC 2.7.9.3 (Selenium donor protein 2) (Selenophosphate synthase 2)" SEPHS2 SPS2 Homo sapiens (Human) phosphorylation [GO:0016310]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]; phosphorylation [GO:0016310]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; selenocysteine metabolic process [GO:0016259]" GO:0001887; GO:0004756; GO:0005524; GO:0005737; GO:0005829; GO:0016259; GO:0016260; GO:0016310; GO:0046872 "ATP binding [GO:0005524]; metal ion binding [GO:0046872]; selenide, water dikinase activity [GO:0004756]" IIDKPRVIEVLPR 0.99564 -11.88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8149 0 0 0 0 0 0 0 0 0 0 0 11.2952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A1W2PPM1 CPHXL_HUMAN Cytoplasmic polyadenylated homeobox-like protein (Cytoplasmic polyadenylated homeobox 1) CPHXL CPHX1 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ARLPPAER 0.99565 -5.4787 0 0 0 0 0 0 0 0 10.6073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4028 0 0 0 0 0 12.4467 0 0 0 0 0 0 0 0 0 0 0 0 13.0612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 H3BV60 TGR3L_HUMAN "Transforming growth factor-beta receptor type 3-like protein (TGF-beta receptor type-3-like protein, TGFR-3L) (Transforming growth factor-beta receptor type III-like protein, TGF-beta receptor type III-like protein)" TGFBR3L Homo sapiens (Human) cell migration [GO:0016477]; epithelial to mesenchymal transition [GO:0001837]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179] cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; glycosaminoglycan binding [GO:0005539]; transforming growth factor beta receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114]; cell migration [GO:0016477]; epithelial to mesenchymal transition [GO:0001837]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001837; GO:0005024; GO:0005114; GO:0005539; GO:0005615; GO:0007179; GO:0009986; GO:0016021; GO:0016477; GO:0017015 glycosaminoglycan binding [GO:0005539]; transforming growth factor beta receptor activity [GO:0005024]; type II transforming growth factor beta receptor binding [GO:0005114] ASPSGPQPRR 0.99565 -11.934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2435 0 15.1861 0 15.0921 0 0 0 0 0 0 0 0 0 0 0 0 13.7002 0 14.6528 0 0 0 12.2022 0 0 13.4225 15.1187 0 13.6648 0 13.7221 0 0 0 19.3751 0 0 0 0 14.3446 0 0 0 0 0 13.8578 0 13.6638 0 0 0 0 0 0 0 0 13.8889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75586 MED6_HUMAN "Mediator of RNA polymerase II transcription subunit 6 (Activator-recruited cofactor 33 kDa component, ARC33) (Mediator complex subunit 6, hMed6) (Renal carcinoma antigen NY-REN-28)" MED6 ARC33 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019] GO:0001223; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0045944; GO:0051123; GO:0060261; GO:0070847 DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223] GPPEKRMR 0.99565 -9.9993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7968 10.8439 11.9512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.669 0 0 0 0 0 0 0 0 0 0 0 13.288 0 0 0 0 0 0 0 12.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1662 0 0 11.2737 0 0 0 0 0 0 P07199 CENPB_HUMAN "Major centromere autoantigen B (Centromere protein B, CENP-B)" CENPB Homo sapiens (Human) "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]" "chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; satellite DNA binding [GO:0003696]; sequence-specific DNA binding [GO:0043565]" GO:0000775; GO:0000779; GO:0003677; GO:0003682; GO:0003696; GO:0005634; GO:0005654; GO:0005694; GO:0005721; GO:0016604; GO:0019237; GO:0043565 centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; satellite DNA binding [GO:0003696]; sequence-specific DNA binding [GO:0043565] AAGLPVK 0.99565 -33.353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6308 0 0 0 0 0 0 12.079 0 0 0 0 0 0 0 0 0 0 0 0 10.6278 0 0 10.9862 0 0 0 0 0 0 0 0 0 16.0055 15.8707 0 0 0 0 0 0 0 0 0 13.1347 13.1236 13.7177 12.769 0 0 0 0 0 11.8577 13.8552 11.8628 0 0 0 0 0 0 0 0 0 0 0 0 0 12.146 0 0 0 0 0 0 0 13.8154 0 12.7545 0 0 0 0 0 0 11.8691 0 0 0 0 0 0 0 0 11.7678 0 0 11.6279 11.6831 0 0 0 0 0 0 0 0 0 0 P54652 HSP72_HUMAN "Heat shock-related 70 kDa protein 2, Heat shock 70 kDa protein 2" HSPA2 Homo sapiens (Human) cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein phosphorylation [GO:0001934]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex disassembly [GO:0070194]; vesicle-mediated transport [GO:0016192] blood microparticle [GO:0072562]; CatSper complex [GO:0036128]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; meiotic spindle [GO:0072687]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptonemal complex [GO:0000795] blood microparticle [GO:0072562]; CatSper complex [GO:0036128]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; meiotic spindle [GO:0072687]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; glycolipid binding [GO:0051861]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tau protein binding [GO:0048156]; unfolded protein binding [GO:0051082]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of inclusion body assembly [GO:0090084]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein phosphorylation [GO:0001934]; protein refolding [GO:0042026]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex disassembly [GO:0070194]; vesicle-mediated transport [GO:0016192] GO:0000795; GO:0001673; GO:0001934; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006986; GO:0007140; GO:0007141; GO:0007283; GO:0007286; GO:0009408; GO:0009409; GO:0009986; GO:0010971; GO:0016020; GO:0016192; GO:0016887; GO:0019899; GO:0031072; GO:0034620; GO:0036128; GO:0042026; GO:0044183; GO:0048156; GO:0051082; GO:0051085; GO:0051087; GO:0051787; GO:0051861; GO:0070062; GO:0070194; GO:0072562; GO:0072687; GO:0090084; GO:0097718; GO:0140662; GO:1901896 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; glycolipid binding [GO:0051861]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein folding chaperone [GO:0044183]; tau protein binding [GO:0048156]; unfolded protein binding [GO:0051082] CQEVINWLDRNQMAEKDEYEHK 0.99565 -33.417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2321 0 0 0 0 0 0 0 13.6419 0 0 0 0 0 0 0 0 10.6497 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3743 0 0 0 14.879 0 0 0 10.9207 0 0 0 0 14.9388 0 0 0 0 0 0 0 0 0 0 13.9475 13.3596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6362 0 0 0 14.018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1555 0 0 10.375 0 10.3883 0 0 0 13.4566 0 12.4767 Q6N022 TEN4_HUMAN "Teneurin-4, Ten-4 (Protein Odd Oz/ten-m homolog 4) (Tenascin-M4, Ten-m4) (Teneurin transmembrane protein 4)" TENM4 KIAA1302 ODZ4 TNM4 Homo sapiens (Human) cardiac cell fate specification [GO:0060912]; cardiac muscle cell proliferation [GO:0060038]; central nervous system myelin formation [GO:0032289]; gastrulation with mouth forming second [GO:0001702]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron development [GO:0048666]; positive regulation of gastrulation [GO:2000543]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell proliferation [GO:0060038]; central nervous system myelin formation [GO:0032289]; gastrulation with mouth forming second [GO:0001702]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; neuron development [GO:0048666]; positive regulation of gastrulation [GO:2000543]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165] GO:0001702; GO:0005634; GO:0005737; GO:0005886; GO:0005887; GO:0007157; GO:0007165; GO:0031641; GO:0031643; GO:0032289; GO:0042803; GO:0043005; GO:0046982; GO:0048666; GO:0048714; GO:0050839; GO:0060038; GO:0060912; GO:2000543 cell adhesion molecule binding [GO:0050839]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803] ACHPRCAEHGTCRDGK 0.99565 -33.301 0 11.419 0 0 0 0 0 0 0 0 14.8833 15.137 12.8131 0 0 13.8858 0 0 12.9286 12.6512 0 10.6472 11.5619 0 12.307 12.3117 12.5102 12.6544 0 0 0 12.1014 0 14.381 12.2269 14.5029 0 15.0306 0 0 0 12.3454 0 0 12.1471 0 0 11.8449 0 0 0 13.6154 11.5934 12.3549 0 0 0 0 0 17.3485 0 0 0 0 0 0 11.5328 0 0 0 0 0 0 12.048 12.9477 11.4564 12.8115 15.0119 14.9317 14.5322 15.1147 14.1811 13.6014 14.5367 14.6604 0 15.8002 13.2039 0 0 0 12.8416 0 11.9176 0 0 12.7302 13.8271 0 13.392 12.6178 13.1781 14.5706 14.3934 15.0515 14.4376 0 13.2215 12.1186 15.7769 12.5318 0 12.764 13.2549 0 0 0 13.7954 14.2769 14.1644 15.9817 14.3571 14.7075 13.1176 14.872 0 0 13.1492 0 13.1642 0 12.3159 0 0 0 0 13.4381 0 14.6174 15.9094 15.0596 12.1234 14.866 0 13.5548 0 0 0 0 0 0 14.142 0 0 13.6832 0 0 0 0 0 11.8754 0 0 0 0 12.2746 12.8133 0 13.2296 0 11.9067 0 14.3554 0 13.6428 0 0 0 0 0 Q96DD0 LRC39_HUMAN "Leucine-rich repeat-containing protein 39 (Myosin-interacting M-band-associated stress-responsive protein, Myomasp)" LRRC39 UNQ6500/PRO21368 Homo sapiens (Human) signal transduction [GO:0007165] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430] cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; M band [GO:0031430]; protein serine/threonine phosphatase activity [GO:0004722]; signal transduction [GO:0007165] GO:0004722; GO:0005737; GO:0007165; GO:0031430; GO:0043231 protein serine/threonine phosphatase activity [GO:0004722] EDGRVILK 0.99565 -12.534 0 0 14.1428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1848 0 0 0 0 0 0 0 0 12.0526 0 11.0055 11.8497 0 0 0 0 0 0 0 0 11.5475 0 0 0 0 0 0 10.6772 11.8515 13.3556 0 0 0 0 0 0 0 0 0 0 0 12.5151 0 0 0 0 0 0 13.0226 0 0 0 11.4294 0 0 0 12.3963 0 0 0 0 0 12.4435 15.8829 0 0 13.6136 16.087 0 0 0 0 0 0 14.1038 0 13.5092 0 0 0 0 13.9279 0 0 0 0 14.3351 0 0 0 0 17.0747 0 0 0 0 12.9804 0 0 0 14.2028 0 0 0 13.8538 0 14.4034 14.071 0 0 0 14.8267 0 0 0 13.7058 0 0 0 0 0 0 0 0 0 0 13.8225 0 13.0452 14.7311 14.9689 13.7678 0 0 12.5531 0 13.8635 12.5049 0 0 0 0 0 0 0 14.3852 0 0 0 0 0 0 0 0 14.6404 0 Q96LI6 HSFY1_HUMAN "Heat shock transcription factor, Y-linked (Heat shock transcription factor 2-like protein, HSF2-like)" HSFY1 HSF2L HSFY; HSFY2 HSF2L HSFY Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" IQQNFQR 0.99565 -9.6947 0 0 11.0492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3112 0 0 0 0 0 0 12.7983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H903 MTD2L_HUMAN "Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2, mitochondrial (NADP-dependent methylenetetrahydrofolate dehydrogenase 2-like protein, MTHFD2-like) [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase, EC 1.5.1.15, EC 1.5.1.5; Methenyltetrahydrofolate cyclohydrolase, EC 3.5.4.9 ]" MTHFD2L Homo sapiens (Human) 10-formyltetrahydrofolate metabolic process [GO:0009256]; folic acid metabolic process [GO:0046655]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; 10-formyltetrahydrofolate metabolic process [GO:0009256]; folic acid metabolic process [GO:0046655]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999] GO:0000105; GO:0004477; GO:0004487; GO:0004488; GO:0005739; GO:0005743; GO:0005759; GO:0006164; GO:0009086; GO:0009256; GO:0035999; GO:0046655 methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488] LCLDQHSLIPATASAVWEIIKR 0.99565 -11.942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8317 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4659 0 Q9HA72 CAHM2_HUMAN Calcium homeostasis modulator protein 2 (Protein FAM26B) CALHM2 FAM26B Homo sapiens (Human) positive regulation of apoptotic process [GO:0043065] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; cation channel activity [GO:0005261]; positive regulation of apoptotic process [GO:0043065] GO:0005261; GO:0005887; GO:0043065 cation channel activity [GO:0005261] QEAYWAQYR 0.99565 -11.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6727 0 0 0 0 12.3778 0 0 11.1639 0 0 0 0 0 0 0 0 0 0 10.6587 0 10.7874 11.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2925 0 0 0 0 0 0 0 0 0 12.8618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2Z0 THA10_HUMAN THAP domain-containing protein 10 THAP10 Homo sapiens (Human) DNA binding [GO:0003677]; metal ion binding [GO:0046872] GO:0003677; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872] AVRLLWDR 0.99565 -12.491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2154 15.2146 0 0 15.1624 0 19.6068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1317 0 0 0 13.1238 19.2743 0 13.1522 13.4449 19.3115 0 19.3104 0 0 0 0 0 0 0 0 0 0 14.4496 0 0 0 0 0 14.5577 0 0 0 0 0 0 0 0 17.9362 0 0 10.3657 0 0 0 0 0 0 0 0 0 18.8892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.468 0 0 0 0 0 0 Q9Y6N6 LAMC3_HUMAN Laminin subunit gamma-3 (Laminin-12 subunit gamma) (Laminin-14 subunit gamma) (Laminin-15 subunit gamma) LAMC3 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; cell migration [GO:0016477]; retina development in camera-type eye [GO:0060041]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020] basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]; structural molecule activity [GO:0005198]; animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; cell migration [GO:0016477]; retina development in camera-type eye [GO:0060041]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] GO:0005198; GO:0005576; GO:0005604; GO:0007601; GO:0009887; GO:0009888; GO:0014002; GO:0016020; GO:0016477; GO:0031012; GO:0034446; GO:0060041 structural molecule activity [GO:0005198] AAAALLLGLALLAPR 0.99565 -33.501 0 14.3291 14.6095 0 0 0 13.3741 0 0 0 0 0 0 0 13.1501 0 0 12.004 0 11.8361 0 0 10.9522 11.8704 0 11.0703 0 12.4489 0 11.8572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5991 20.3347 0 0 12.0518 12.2109 0 11.6893 11.3334 0 0 0 0 0 0 0 14.1398 0 16.4155 0 11.0756 12.4219 0 0 0 0 0 0 0 0 0 0 0 0 15.562 0 12.3387 0 0 0 0 0 0 0 12.132 0 0 0 0 15.8946 0 0 0 0 11.796 0 0 0 0 0 0 0 0 13.5655 0 0 0 0 0 0 0 15.9934 13.1577 0 0 15.5751 0 0 0 15.6353 0 0 0 0 0 0 0 0 14.1764 14.6971 15.1951 15.1425 14.9528 15.9435 15.358 15.1005 13.0646 15.3069 15.4224 0 14.8187 11.7901 11.698 14.554 14.8504 0 16.2364 15.8348 0 15.121 13.2554 13.6595 P01266 THYG_HUMAN "Thyroglobulin, Tg" TG Homo sapiens (Human) hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590] GO:0005179; GO:0005576; GO:0005615; GO:0006590; GO:0007165; GO:0015705; GO:0030878; GO:0031641; GO:0042446; GO:0042802 hormone activity [GO:0005179]; identical protein binding [GO:0042802] ATSFGSLRCQVK 0.99566 -34.446 0 0 0 0 8.90491 0 0 0 0 0 0 0 0 0 0 0 12.9739 0 0 0 0 0 12.9322 0 0 0 12.5079 0 0 0 0 0 0 0 0 0 13.5681 0 0 0 0 0 13.5953 13.4211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4084 0 0 0 12.6615 12.496 12.24 0 0 12.6623 14.1176 0 0 0 0 0 13.1351 0 0 0 0 0 0 12.4127 0 0 0 22.4268 0 22.666 0 0 0 0 0 0 13.4328 0 14.723 18.2393 12.1232 13.9255 14.5716 0 0 13.2894 13.7962 14.6794 14.3994 13.5188 12.8895 0 0 0 0 12.7308 0 0 12.4047 0 12.5378 12.7725 0 14.0566 13.7457 13.4325 10.8105 0 0 12.6758 15.8072 0 0 17.543 16.3066 0 0 13.2502 0 0 14.4012 12.9637 0 0 0 12.5725 0 0 13.6299 0 0 0 0 0 0 0 14.0458 0 0 0 0 0 14.9136 13.1199 16.5792 0 0 0 0 0 0 Q6NZI2 CAVN1_HUMAN Caveolae-associated protein 1 (Cavin-1) (Polymerase I and transcript release factor) CAVIN1 PTRF FKSG13 Homo sapiens (Human) positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134]; positive regulation of cell motility [GO:2000147]; protein secretion [GO:0009306]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361] GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005901; GO:0006361; GO:0006363; GO:0009303; GO:0009306; GO:0032991; GO:0042134; GO:0042802; GO:0043231; GO:0045121; GO:2000147 identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA primary transcript binding [GO:0042134] GEAGDLR 0.99566 -12.018 0 0 0 0 0 0 0 0 11.7215 12.1536 13.5223 0 13.2333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7972 0 0 12.4241 0 0 0 0 11.9925 0 0 0 11.086 11.4911 10.0796 0 0 12.6722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8613 15.7398 13.89 13.3194 0 12.4836 0 0 0 13.1157 13.4971 0 0 0 0 0 0 0 0 0 0 0 0 13.784 12.2852 12.0958 13.3772 0 0 0 0 15.0764 13.0178 0 0 0 0 0 0 0 0 14.1018 14.6705 0 0 0 0 0 13.5726 0 0 0 0 0 11.9008 0 11.7095 0 11.2612 0 0 0 14.7091 14.3028 0 15.39 10.8028 0 0 14.0642 0 13.4055 0 14.462 0 0 0 0 0 0 0 0 0 13.7861 0 0 0 12.4681 14.1062 12.6496 0 14.1243 13.9001 13.0844 0 10.0893 0 0 0 13.4698 10.9398 0 0 0 0 0 0 0 0 Q8IUG5 MY18B_HUMAN Unconventional myosin-XVIIIb MYO18B Homo sapiens (Human) actomyosin structure organization [GO:0031032]; cardiac muscle cell development [GO:0055013]; in utero embryonic development [GO:0001701]; vasculogenesis [GO:0001570] filamentous actin [GO:0031941]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; nucleus [GO:0005634]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018] filamentous actin [GO:0031941]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; nucleus [GO:0005634]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774]; actomyosin structure organization [GO:0031032]; cardiac muscle cell development [GO:0055013]; in utero embryonic development [GO:0001701]; vasculogenesis [GO:0001570] GO:0001570; GO:0001701; GO:0003774; GO:0005524; GO:0005634; GO:0016460; GO:0016461; GO:0030018; GO:0031032; GO:0031941; GO:0032982; GO:0051015; GO:0055013 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cytoskeletal motor activity [GO:0003774] AGVISRLEKQR 0.99566 -34.532 0 0 12.1842 0 0 0 0 0 0 0 0 0 0 12.1236 13.0221 9.85498 0 10.0448 0 0 0 0 0 0 0 0 0 12.3711 0 0 12.4934 0 0 0 0 11.1865 0 0 10.1908 0 0 0 0 0 11.9049 0 0 0 0 0 0 0 0 12.6781 11.6633 0 0 10.9625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5188 0 0 13.9905 0 13.7099 13.277 12.9735 13.4875 14.1884 13.6194 15.0364 10.6622 17.3904 14.5399 0 13.0823 16.9224 11.8978 0 13.2434 14.4113 13.9074 14.3946 16.7607 0 0 14.9794 14.8501 15.2306 12.906 14.6757 0 0 12.5814 14.6164 13.8109 0 0 11.94 13.2202 15.8451 16.3323 14.8345 14.5979 0 15.4316 13.7454 0 15.5378 0 0 11.3693 14.9779 14.9433 0 12.6077 0 0 12.8664 13.5173 0 0 0 0 0 0 13.065 13.1967 0 0 0 14.5444 13.3966 0 0 12.3819 14.2978 14.8338 0 0 17.0441 15.0051 0 12.7959 13.4852 13.7862 14.3266 14.7489 0 14.5659 0 12.7912 12.4991 12.4444 0 12.0112 12.6524 12.6548 0 13.7822 0 12.5334 15.2798 13.7119 13.6102 13.1392 Q8IVL1 NAV2_HUMAN "Neuron navigator 2, EC 3.6.4.12 (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2, unc53H2)" NAV2 HELAD1 KIAA1419 POMFIL2 RAINB1 STEERIN2 Homo sapiens (Human) glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564] interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654] interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564] GO:0003025; GO:0005524; GO:0005614; GO:0005654; GO:0007399; GO:0007605; GO:0007608; GO:0007626; GO:0008201; GO:0016887; GO:0021554; GO:0021563; GO:0021564; GO:0022008; GO:0043138 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; heparin binding [GO:0008201] AGEGPGSRDTSCER 0.99566 -33.86 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9875 11.1857 0 0 0 0 0 0 12.5819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8431 0 0 13.8405 0 0 0 0 0 0 0 0 0 0 0 12.5318 0 0 10.6589 0 0 0 0 10.9782 0 0 0 0 0 0 0 0 0 0 0 12.1842 0 11.505 13.3566 0 0 15.2108 0 14.3385 13.978 14.095 14.8861 14.8386 0 15.3585 14.892 0 0 13.4988 14.7559 14.5681 13.2193 13.6997 0 15.5837 0 0 0 0 0 13.1097 13.5113 0 0 0 13.2471 12.6858 0 0 12.68 0 0 0 0 14.0411 13.7848 0 0 12.7751 0 14.5594 0 0 13.7159 15.3838 0 0 0 0 13.6785 12.3356 0 0 0 13.1652 0 0 0 12.6279 0 13.0309 12.8258 0 12.8382 12.2879 0 0 13.03 0 0 11.9699 0 0 13.2203 13.3989 0 0 14.4039 0 0 0 0 0 0 0 0 0 0 13.6468 11.5565 0 0 0 Q8TD30 ALAT2_HUMAN "Alanine aminotransferase 2, ALT2, EC 2.6.1.2 (Glutamate pyruvate transaminase 2, GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2)" GPT2 AAT2 ALT2 Homo sapiens (Human) 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851] mitochondrial matrix [GO:0005759] mitochondrial matrix [GO:0005759]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851] GO:0004021; GO:0005759; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853 L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170] AVEYAVRGPIVLK 0.99566 -10.045 0 14.7896 0 0 13.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3537 0 0 0 0 0 17.9791 0 0 0 18.4986 19.4124 0 0 0 0 0 0 0 0 0 18.8214 0 0 0 0 0 0 0 0 12.8722 18.306 0 0 0 0 0 0 0 0 18.2073 0 18.1873 0 0 15.3503 12.1689 0 14.6262 0 0 0 12.4674 0 18.664 0 0 0 0 0 0 0 0 0 13.2633 11.8359 0 0 13.6514 18.4548 0 0 11.6566 0 0 0 0 13.367 0 0 0 0 0 0 0 0 0 0 15.1764 0 0 0 0 0 0 0 0 0 15.2036 0 0 13.4649 0 0 13.0457 0 0 13.4079 0 0 Q9BXX0 EMIL2_HUMAN "EMILIN-2 (Elastin microfibril interface-located protein 2, Elastin microfibril interfacer 2) (Protein FOAP-10)" EMILIN2 Homo sapiens (Human) cell adhesion mediated by integrin [GO:0033627]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood coagulation [GO:0030194]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of platelet aggregation [GO:1901731]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576] collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix constituent conferring elasticity [GO:0030023]; cell adhesion mediated by integrin [GO:0033627]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood coagulation [GO:0030194]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of platelet aggregation [GO:1901731]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127] GO:0005576; GO:0005581; GO:0008217; GO:0030023; GO:0030194; GO:0030336; GO:0033627; GO:0042127; GO:0043065; GO:0045766; GO:0062023; GO:1900426; GO:1901731 extracellular matrix constituent conferring elasticity [GO:0030023] DSLHLLK 0.99566 -34.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9907 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8445 0 0 0 0 0 0 0 0 13.4847 0 14.9724 0 12.6809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7013 13.6201 0 0 13.5018 12.7819 13.0733 11.2868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9832 13.3822 0 0 0 0 0 11.9395 0 0 13.6482 14.4455 0 0 0 0 0 0 0 15.1766 0 0 12.1511 0 A0A1W2PPL8 TFKLN_HUMAN TATA-box-binding protein-associated factor 11-like protein 14 TAF11L14 Homo sapiens (Human) RNA polymerase II preinitiation complex assembly [GO:0051123] transcription factor TFIID complex [GO:0005669] transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0003713; GO:0005669; GO:0046982; GO:0051123 protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713] EAVCRLK 0.99567 -12.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NNF4 ZN726_HUMAN Zinc finger protein 726 ZNF726 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNQSSNYTTHK 0.99567 -12.129 0 0 0 0 0 0 10.5326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2476 0 0 13.563 0 0 0 0 0 0 0 0 0 0 0 0 11.2342 0 0 0 0 0 0 0 0 0 0 0 12.4274 0 0 0 0 0 0 0 11.9287 0 0 0 0 0 0 0 0 0 0 0 0 0 11.431 0 0 0 0 13.1115 0 0 0 0 0 0 13.3442 13.2234 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8446 0 0 0 0 11.8542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4542 0 0 0 0 0 0 0 0 0 0 0 0 12.4082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15498 VAV_HUMAN Proto-oncogene vav VAV1 VAV Homo sapiens (Human) cell migration [GO:0016477]; cellular response to xenobiotic stimulus [GO:0071466]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; reactive oxygen species metabolic process [GO:0072593]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; cell migration [GO:0016477]; cellular response to xenobiotic stimulus [GO:0071466]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; reactive oxygen species metabolic process [GO:0072593]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264]; T cell costimulation [GO:0031295]; T cell differentiation [GO:0030217]; vascular endothelial growth factor receptor signaling pathway [GO:0048010] GO:0001784; GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006955; GO:0007186; GO:0007229; GO:0007264; GO:0008361; GO:0016477; GO:0030168; GO:0030217; GO:0030593; GO:0031295; GO:0038095; GO:0038096; GO:0043087; GO:0043547; GO:0045954; GO:0046872; GO:0048010; GO:0051056; GO:0071466; GO:0072593; GO:0140031 guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784] ALLICKR 0.99567 -31.676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1535 0 0 0 0 0 0 0 0 0 0 0 13.0046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48664 EAA4_HUMAN Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6) SLC1A6 EAAT4 Homo sapiens (Human) aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; regulation of membrane potential [GO:0042391] glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; plasma membrane [GO:0005886] glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; membrane protein complex [GO:0098796]; plasma membrane [GO:0005886]; glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; establishment of localization in cell [GO:0051649]; ion transport [GO:0006811]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter transport [GO:0006836]; neurotransmitter uptake [GO:0001504]; regulation of membrane potential [GO:0042391] GO:0001504; GO:0005313; GO:0005314; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0006836; GO:0007268; GO:0015175; GO:0015183; GO:0015501; GO:0015810; GO:0015813; GO:0016020; GO:0042391; GO:0045111; GO:0046872; GO:0051649; GO:0098712; GO:0098796; GO:0098978; GO:0099056; GO:0140009 glutamate:sodium symporter activity [GO:0015501]; high-affinity L-glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; neutral amino acid transmembrane transporter activity [GO:0015175] FLRRNAFILLTVSAVVIGVSLAFALR 0.99567 -12.145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9435 0 0 11.2306 0 0 0 0 0 0 0 0 13.3689 0 13.7551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.327 0 0 P53370 NUDT6_HUMAN "Nucleoside diphosphate-linked moiety X motif 6, Nudix motif 6, EC 3.6.1.- (Antisense basic fibroblast growth factor) (Protein GFG)" NUDT6 FGF2AS Homo sapiens (Human) negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285] GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0051287 ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529] ELPENYK 0.99567 -11.675 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.665 0 0 0 0 0 0 0 0 0 11.7877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.92806 0 0 0 10.4975 0 0 0 0 11.5836 17.9324 0 0 0 16.047 0 0 13.5765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8333 0 13.0537 0 13.7953 0 0 0 13.8829 0 14.9625 15.1651 0 0 0 0 15.2812 0 14.2552 0 0 0 14.7991 0 0 0 0 0 13.8568 0 0 0 0 0 13.7861 14.159 14.8994 15.0305 0 12.3979 0 0 0 0 13.2353 13.9506 0 0 0 13.9446 0 15.1568 0 14.0487 14.0995 0 0 0 0 0 0 13.4925 0 0 0 12.5041 0 0 0 0 0 14.4641 13.1543 0 0 14.4982 0 13.9515 14.6153 0 0 0 0 Q15404 RSU1_HUMAN "Ras suppressor protein 1, RSP-1, Rsu-1" RSU1 RSP1 Homo sapiens (Human) positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165] GO:0005829; GO:0005925; GO:0007165; GO:0010811; GO:0043547; GO:0070062 LTKLQILSLR 0.99567 -12.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2426 0 0 0 0 0 0 0 13.478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2519 14.2884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2027 0 0 0 0 0 0 0 0 0 0 13.9349 0 0 0 0 0 0 0 0 0 0 10.2315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JSH3 WDR44_HUMAN WD repeat-containing protein 44 (Rabphilin-11) WDR44 RPH11 Homo sapiens (Human) cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471] GO:0005794; GO:0005829; GO:0010008; GO:0048471 DSQPSLDLASATSGDK 0.99567 -12.105 0 0 0 0 0 0 12.7976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1207 0 13.4468 0 0 0 0 0 15.4669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2307 0 0 0 13.4454 0 0 0 0 0 0 0 0 0 0 13.6223 13.594 0 0 0 0 0 13.7674 14.5615 0 0 0 0 14.0671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5409 0 0 0 13.5569 13.6138 0 0 0 0 0 0 13.1729 14.605 14.9961 0 0 13.9342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8137 0 0 0 14.4374 0 Q8N5T2 TBC19_HUMAN TBC1 domain family member 19 TBC1D19 Homo sapiens (Human) GTPase activator activity [GO:0005096] GO:0005096 GTPase activator activity [GO:0005096] EPLVYMR 0.99567 -12.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8759 15.4754 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7554 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WWQ0 PHIP_HUMAN "PH-interacting protein, PHIP (DDB1- and CUL4-associated factor 14) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11)" PHIP DCAF14 WDR11 Homo sapiens (Human) "cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleus [GO:0005634] "nucleus [GO:0005634]; insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577]; cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0001932; GO:0005158; GO:0005634; GO:0006357; GO:0007010; GO:0008284; GO:0008286; GO:0008360; GO:0022604; GO:0043066; GO:0043568; GO:0045840; GO:0045893; GO:0045944; GO:0070577; GO:2001237 insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577] AESSSDEEEESEKQK 0.99567 -35.432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6349 0 12.7877 0 11.7518 0 0 0 0 0 12.9043 13.1313 0 0 0 0 0 0 0 0 0 0 0 0 13.3483 0 0 0 0 0 0 0 0 13.55 11.4623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7838 12.5061 0 0 0 12.5554 0 0 0 0 0 0 13.2788 14.1731 0 12.7196 0 0 0 0 0 0 0 0 0 0 13.1699 0 0 0 12.6966 0 0 0 0 0 0 0 0 13.4658 13.1853 0 0 12.8224 0 12.4565 11.7629 12.9785 0 0 14.4755 0 0 0 0 11.4699 14.3965 0 0 14.7286 13.4312 0 0 0 0 0 15.3947 17.0456 0 0 0 13.0157 0 0 0 12.7279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4294 0 0 0 0 0 0 0 Q96EF9 ZHX1R_HUMAN "Zinc fingers and homeoboxes protein 1, isoform 2 (ZHX1-C8orf76 readthrough transcript protein)" ZHX1-C8orf76 C8orf76 Homo sapiens (Human) LWQWFYEETESSDDVEVLTLKK 0.99567 -9.523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96M69 LRGUK_HUMAN Leucine-rich repeat and guanylate kinase domain-containing protein LRGUK Homo sapiens (Human) axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; phosphorylation [GO:0016310]; spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177] acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; phosphorylation [GO:0016310]; spermatogenesis [GO:0007283] GO:0001669; GO:0002177; GO:0004385; GO:0005524; GO:0005829; GO:0007283; GO:0016310; GO:0030154; GO:0035082; GO:0042995 ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385] DSLVSMK 0.99567 -35.347 0 0 0 0 0 0 0 0 12.7161 0 0 0 0 0 0 0 12.9613 0 0 0 0 0 0 0 12.7321 0 0 0 0 0 0 0 0 0 0 12.0131 0 0 0 0 0 0 12.1559 0 0 10.5775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1295 0 0 10.3748 0 0 0 0 0 0 0 12.4725 0 0 0 0 13.2966 0 0 0 13.7058 0 13.1443 0 0 0 0 0 12.6635 0 0 12.6735 0 0 0 0 14.9747 0 0 0 0 0 0 0 0 0 13.0072 0 0 0 0 0 12.2072 0 0 0 0 0 0 0 0 0 0 13.5163 0 0 0 0 0 0 0 0 14.9548 0 13.5501 0 0 0 0 0 0 0 0 12.8062 0 0 0 0 0 0 0 0 12.6165 0 0 14.3893 0 0 0 13.3752 0 0 0 0 12.2512 0 0 0 0 0 0 0 0 0 Q9HBW9 AGRL4_HUMAN "Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein, ETL protein)" ADGRL4 ELTD1 ETL UNQ202/PRO228 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; protein-containing complex assembly [GO:0065003] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; protein-containing complex assembly [GO:0065003] GO:0004930; GO:0005509; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021; GO:0031410; GO:0065003 calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930] IQEEYYRLFKNVPCCFGCLR 0.99567 -12.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5244 0 0 0 12.6963 0 0 13.8681 0 0 0 0 0 11.5684 12.5744 0 0 0 0 0 0 0 0 12.5419 0 13.9665 0 0 0 0 0 0 0 0 0 0 13.1903 0 0 0 12.803 14.7315 0 0 13.5765 12.5324 0 0 12.9555 13.4529 0 0 0 0 0 14.0578 14.216 0 0 12.4086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NPC4 A4GAT_HUMAN "Lactosylceramide 4-alpha-galactosyltransferase, EC 2.4.1.228 (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (CD77 synthase) (Globotriaosylceramide synthase, Gb3 synthase) (P1/Pk synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase)" A4GALT A14GALT A4GALT1 Homo sapiens (Human) globoside biosynthetic process [GO:0001576]; glycosphingolipid biosynthetic process [GO:0006688]; plasma membrane organization [GO:0007009] integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020] integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; galactosyltransferase activity [GO:0008378]; hexosyltransferase activity [GO:0016758]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643]; globoside biosynthetic process [GO:0001576]; glycosphingolipid biosynthetic process [GO:0006688]; plasma membrane organization [GO:0007009] GO:0001576; GO:0006688; GO:0007009; GO:0008378; GO:0015643; GO:0016020; GO:0016758; GO:0030173; GO:0050512 galactosyltransferase activity [GO:0008378]; hexosyltransferase activity [GO:0016758]; lactosylceramide 4-alpha-galactosyltransferase activity [GO:0050512]; toxic substance binding [GO:0015643] ALLAQLHAR 0.99567 -12.108 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2739 0 0 10.7018 0 0 0 11.9006 0 0 0 0 0 0 0 0 0 0 0 0 12.2924 0 0 0 0 0 0 0 0 0 0 0 0 14.1641 0 0 0 12.7979 10.8707 13.203 0 12.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.453 0 0 0 0 0 0 11.1986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y3C1 NOP16_HUMAN Nucleolar protein 16 (HBV pre-S2 trans-regulated protein 3) NOP16 CGI-117 HSPC111 Homo sapiens (Human) ribosomal large subunit biogenesis [GO:0042273] intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273] GO:0003723; GO:0005654; GO:0005730; GO:0042273; GO:0043231 RNA binding [GO:0003723] AMEVDIEERPK 0.99567 -12.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8994 0 0 0 0 12.535 0 0 14.6808 14.1581 0 0 0 0 0 0 13.6329 0 0 13.6006 19.1508 0 0 12.9275 0 0 13.6864 12.7899 0 0 0 12.6516 0 0 0 0 14.0047 0 0 0 0 0 0 0 0 18.5881 0 0 0 0 0 0 0 13.7706 0 12.3003 0 13.0708 0 13.1057 14.4124 13.4885 0 0 0 12.5964 0 0 12.7091 0 0 0 0 0 0 0 0 15.2859 12.7976 0 0 13.594 0 13.3318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5047 13.5238 0 0 0 0 0 A2RUB1 MEIOC_HUMAN Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein) MEIOC C17orf104 Homo sapiens (Human) "chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase plate congression [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]" GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192 AEMFLSQFNRYNENVDYCR 0.99568 -11.712 0 0 0 0 0 0 0 0 13.2016 0 0 0 0 0 0 13.4696 14.3692 0 14.0061 13.5754 14.4381 0 17.9771 14.383 0 0 11.503 13.1201 0 0 0 0 0 0 0 0 0 0 11.6174 0 0 0 0 0 12.6391 0 0 0 0 0 0 11.862 0 12.0701 14.765 14.5564 14.4723 0 0 0 0 12.9604 0 0 0 12.1876 0 0 0 0 0 0 11.7408 14.2387 12.543 14.9681 0 14.1657 0 12.8138 14.5267 14.5791 13.86 0 0 14.8306 0 0 0 13.7474 0 0 0 0 14.1046 0 0 0 13.938 0 15.4693 15.7447 13.3931 0 12.9431 0 15.3167 12.4613 15.1068 0 14.3231 18.068 0 18.0137 11.9078 11.7983 14.3662 13.9226 14.0914 12.6494 13.1835 15.0426 0 15.5187 13.9022 11.3491 0 14.1389 14.5985 13.8866 12.5015 14.8789 14.3569 14.448 19.4387 13.875 15.8658 0 0 15.8466 0 12.8327 14.8742 0 14.1467 13.885 15.0737 0 12.9618 0 14.4871 0 0 14.1015 14.8905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3449 12.5338 15.1679 0 10.7925 0 0 14.3041 0 O00767 SCD_HUMAN "Stearoyl-CoA desaturase, hSCD1, EC 1.14.19.1 (Acyl-CoA desaturase) (Delta(9)-desaturase, Delta-9 desaturase) (Fatty acid desaturase)" SCD FADS5 SCD1 SCDOS Homo sapiens (Human) monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleolus [GO:0005730]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768]; monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636] GO:0004768; GO:0005506; GO:0005730; GO:0005783; GO:0005789; GO:0006636; GO:0016020; GO:0016021; GO:0016491; GO:0030176; GO:0032896; GO:0070542; GO:0120162; GO:1903966 iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768] DDIYDPTYK 0.99568 -9.5488 0 0 0 0 0 0 0 0 11.0472 0 0 0 11.9428 0 0 0 17.5895 0 0 0 0 0 0 0 0 13.8205 0 0 0 17.7298 17.8225 0 0 0 0 17.5935 0 0 0 0 17.6609 13.6374 14.0894 0 12.8529 14.071 13.5535 17.7089 0 0 0 0 0 17.7289 0 0 17.6156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6207 0 0 0 0 0 0 0 0 0 0 12.5664 11.6582 12.6576 13.0717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.5884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.6061 0 0 0 0 10.6582 0 0 0 0 18.6186 12.9762 18.5262 13.3937 0 0 0 0 0 0 0 0 0 O95470 SGPL1_HUMAN "Sphingosine-1-phosphate lyase 1, S1PL, SP-lyase 1, SPL 1, hSPL, EC 4.1.2.27 (Sphingosine-1-phosphate aldolase)" SGPL1 KIAA1252 Homo sapiens (Human) androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570] GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030148; GO:0030149; GO:0030170; GO:0030176; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190 pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117] ESVTQIMKNPKAK 0.99568 -12.787 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9283 0 11.3964 0 12.4247 0 0 12.409 0 0 0 0 0 0 0 0 0 0 0 0 13.0031 0 12.9724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7993 0 0 0 0 0 0 0 0 12.4674 0 0 0 0 0 0 13.4839 0 0 0 0 0 0 0 11.8385 0 0 0 0 0 0 0 0 0 0 0 0 12.935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P06753 TPM3_HUMAN "Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5, hTM5)" TPM3 Homo sapiens (Human) actin filament organization [GO:0007015]; muscle contraction [GO:0006936] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle thin filament tropomyosin [GO:0005862]; stress fiber [GO:0001725] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle thin filament tropomyosin [GO:0005862]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; muscle contraction [GO:0006936] GO:0001725; GO:0005829; GO:0005856; GO:0005862; GO:0005884; GO:0006936; GO:0007015; GO:0015629; GO:0051015; GO:0070062 actin filament binding [GO:0051015] DEEKMELQEIQLK 0.99568 -9.8352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21580 TNAP3_HUMAN "Tumor necrosis factor alpha-induced protein 3, TNF alpha-induced protein 3, EC 2.3.2.-, EC 3.4.19.12 (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50; A20p37 ]" TNFAIP3 OTUD7C Homo sapiens (Human) apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; negative regulation of B cell activation [GO:0050869]; negative regulation of bone resorption [GO:0045779]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of osteoclast proliferation [GO:0090291]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of defense response to virus by host [GO:0050691]; regulation of germinal center formation [GO:0002634]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; regulation of vascular wound healing [GO:0061043]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; tolerance induction to lipopolysaccharide [GO:0072573] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; Lys63-specific deubiquitinase activity [GO:0061578]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; negative regulation of B cell activation [GO:0050869]; negative regulation of bone resorption [GO:0045779]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of osteoclast proliferation [GO:0090291]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of defense response to virus by host [GO:0050691]; regulation of germinal center formation [GO:0002634]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; regulation of vascular wound healing [GO:0061043]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; tolerance induction to lipopolysaccharide [GO:0072573] GO:0001922; GO:0002020; GO:0002237; GO:0002634; GO:0002677; GO:0003677; GO:0004842; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0005829; GO:0006915; GO:0006954; GO:0007010; GO:0008022; GO:0008270; GO:0010803; GO:0016477; GO:0016579; GO:0019900; GO:0030177; GO:0031397; GO:0032088; GO:0032495; GO:0032691; GO:0032703; GO:0032715; GO:0032720; GO:0034136; GO:0034140; GO:0034144; GO:0034148; GO:0035523; GO:0035871; GO:0042802; GO:0043124; GO:0043130; GO:0043621; GO:0045732; GO:0045736; GO:0045779; GO:0045824; GO:0048662; GO:0050691; GO:0050728; GO:0050869; GO:0061043; GO:0061578; GO:0070062; GO:0070301; GO:0070423; GO:0070429; GO:0070433; GO:0070530; GO:0070536; GO:0070936; GO:0071108; GO:0071222; GO:0071947; GO:0072573; GO:0072666; GO:0090291; GO:1902042; GO:1990168; GO:2000347; GO:2000349; GO:2000352 cysteine-type deubiquitinase activity [GO:0004843]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; Lys63-specific deubiquitinase activity [GO:0061578]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] AEQVLPQALYLSNMRKAVK 0.99568 -9.8286 0 11.1628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6106 0 0 11.3473 0 0 0 0 0 0 0 0 0 0 10.4409 0 9.90869 0 0 0 0 0 0 10.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8327 0 0 11.8503 14.8828 0 12.4439 0 13.8873 0 0 0 0 0 0 0 0 14.7579 12.2266 14.3776 0 0 12.6548 15.3044 12.3154 14.5518 14.3586 0 0 10.5621 0 0 0 0 11.9148 15.3161 0 0 0 0 0 0 11.866 16.6403 0 0 11.9005 0 13.1384 15.1866 15.5932 0 0 15.6014 12.1339 0 11.1853 12.2507 0 0 0 17.0166 15.3317 16.7742 0 15.0586 0 15.4913 0 0 14.0758 0 14.1421 10.2037 0 12.0917 0 0 12.4502 0 0 0 0 0 12.484 0 0 0 0 0 12.2117 0 0 12.0899 0 0 0 0 0 0 0 0 0 0 Q13352 CENPR_HUMAN "Centromere protein R, CENP-R (Beta-3-endonexin) (Integrin beta-3-binding protein) (Nuclear receptor-interacting factor 3)" ITGB3BP CENPR NRIF3 Homo sapiens (Human) "apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein C-terminus binding [GO:0008022]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; CENP-A containing chromatin assembly [GO:0034080]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" GO:0000776; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006915; GO:0007049; GO:0007155; GO:0007165; GO:0008022; GO:0016020; GO:0034080; GO:0051301 protein C-terminus binding [GO:0008022] SLKLDGLLEENSFDPSK 0.99568 -10.291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMU5 TRI72_HUMAN "Tripartite motif-containing protein 72 (Mitsugumin-53, Mg53)" TRIM72 MG53 Homo sapiens (Human) exocytosis [GO:0006887]; muscle organ development [GO:0007517]; muscle system process [GO:0003012]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of myotube differentiation [GO:0010832]; plasma membrane repair [GO:0001778]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; sarcolemma [GO:0042383] cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; sarcolemma [GO:0042383]; identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; exocytosis [GO:0006887]; muscle organ development [GO:0007517]; muscle system process [GO:0003012]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of myotube differentiation [GO:0010832]; plasma membrane repair [GO:0001778]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567] GO:0001778; GO:0001786; GO:0003012; GO:0005737; GO:0006887; GO:0007517; GO:0008270; GO:0010832; GO:0016567; GO:0030659; GO:0031624; GO:0042383; GO:0042802; GO:0043161; GO:0043569; GO:0046627; GO:0051260; GO:0061630 identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ALRSPERR 0.99568 -9.5244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0662 0 0 0 0 0 0 15.62 0 0 0 0 0 0 0 0 0 0 14.2032 0 14.3206 0 0 0 0 0 0 0 0 0 13.4847 0 16.2777 0 0 0 0 13.1159 0 0 0 0 0 0 12.817 13.8771 0 0 0 11.9062 13.6084 13.1624 14.9011 12.3126 0 0 0 14.1543 0 0 12.8623 0 0 12.5663 0 0 0 12.5675 0 0 0 0 12.8116 0 0 0 0 0 0 0 0 0 14.2518 13.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9912 13.9186 0 0 0 0 0 0 Q99638 RAD9A_HUMAN "Cell cycle checkpoint control protein RAD9A, hRAD9, EC 3.1.11.2 (DNA repair exonuclease rad9 homolog A)" RAD9A Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231] checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] checkpoint clamp complex [GO:0030896]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5' exonuclease activity [GO:0008408]; enzyme binding [GO:0019899]; exodeoxyribonuclease III activity [GO:0008853]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231] GO:0000076; GO:0000077; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006974; GO:0008408; GO:0008630; GO:0008853; GO:0017124; GO:0019899; GO:0019901; GO:0030896; GO:0031573; GO:0042826; GO:0071479; GO:1902231 3'-5' exonuclease activity [GO:0008408]; enzyme binding [GO:0019899]; exodeoxyribonuclease III activity [GO:0008853]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124] CCISLNGRSSRLVVQLHCK 0.99568 -9.8346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2502 0 0 0 0 0 0 0 0 0 11.7603 0 0 0 12.5546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3314 0 0 0 0 0 0 0 0 0 0 0 14.4542 0 0 0 0 0 0 0 0 0 0 0 15.0487 16.3016 0 0 0 0 0 13.3411 0 0 0 0 0 0 0 0 0 0 0 17.3564 0 0 0 0 0 14.5296 0 0 0 0 0 0 0 0 0 0 0 0 12.242 0 0 0 0 0 0 0 0 0 12.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2884 0 0 0 0 0 0 0 Q9NQ39 RS10L_HUMAN Putative 40S ribosomal protein S10-like RPS10P5 RPS10L Homo sapiens (Human) cytosolic small ribosomal subunit [GO:0022627] cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] GO:0003723; GO:0003735; GO:0022627 RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] EGVMVAK 0.99568 -11.748 0 0 12.193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1028 13.8997 0 0 17.3806 0 0 0 0 0 0 0 17.4994 0 0 0 0 0 13.0032 0 0 0 0 0 0 0 13.9309 0 0 0 14.6579 0 0 0 0 12.9781 0 17.6378 0 0 0 0 0 0 0 0 0 0 0 0 13.814 0 13.8784 0 0 0 0 0 13.8271 0 0 0 0 0 13.452 14.0684 15.5788 15.7088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8515 0 0 0 Q9UK11 ZN223_HUMAN Zinc finger protein 223 ZNF223 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AHTGERPYNCDDCGK 0.99568 -9.8236 0 0 0 0 0 0 0 0 0 10.1385 0 0 0 0 0 0 0 0 0 0 0 0 12.9636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.292 0 0 0 0 15.2146 11.9808 0 13.6658 11.939 0 11.691 0 14.2569 0 0 0 0 13.3967 0 0 10.6813 0 0 0 0 0 0 0 0 0 0 10.7765 0 9.13848 0 12.1352 10.2063 13.7333 0 14.0757 0 12.29 0 0 0 14.0365 13.0011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2822 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4F3 MARF1_HUMAN Meiosis regulator and mRNA stability factor 1 (Limkain-b1) (Meiosis arrest female protein 1) MARF1 KIAA0430 LKAP Homo sapiens (Human) double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; post-transcriptional gene silencing [GO:0016441]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; peroxisome [GO:0005777]; CCR4-NOT complex binding [GO:1905762]; mRNA base-pairing post-transcriptional repressor activity [GO:1903231]; ribonuclease activity [GO:0004540]; double-strand break repair [GO:0006302]; female meiotic nuclear division [GO:0007143]; oogenesis [GO:0048477]; post-transcriptional gene silencing [GO:0016441]; regulation of gene expression [GO:0010468] GO:0004540; GO:0005737; GO:0005777; GO:0005794; GO:0006302; GO:0007143; GO:0010468; GO:0016020; GO:0016441; GO:0043231; GO:0048477; GO:1903231; GO:1905762 CCR4-NOT complex binding [GO:1905762]; mRNA base-pairing post-transcriptional repressor activity [GO:1903231]; ribonuclease activity [GO:0004540] ALAAQFVKLLR 0.99568 -9.5251 0 0 0 0 0 13.8412 13.3362 15.009 0 0 0 0 0 11.0881 0 0 0 0 0 0 0 0 0 0 10.7345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3301 12.328 11.3895 0 0 0 0 0 12.8005 13.2097 13.393 10.6448 0 0 0 0 0 15.169 0 0 0 0 15.4994 13.7117 13.3958 14.011 0 12.4537 0 14.7726 11.7617 0 0 0 0 17.151 0 12.016 14.7005 11.3508 0 0 0 0 0 12.8396 0 0 0 0 0 14.3496 13.5548 0 0 0 12.4195 0 0 13.3325 14.6755 16.6092 0 12.1361 0 0 0 0 0 0 0 0 0 0 0 12.7498 0 0 0 0 0 12.0381 12.518 0 0 15.1966 0 10.1193 0 14.8532 14.4882 12.6881 12.9977 0 0 0 0 0 12.6937 13.5662 0 14.6419 0 0 0 0 0 0 0 12.2338 0 0 0 13.0267 0 12.0863 0 12.4737 0 14.0814 12.7618 11.3747 14.0623 0 0 13.3269 0 0 Q9Y6M5 ZNT1_HUMAN "Zinc transporter 1, ZnT-1 (Solute carrier family 30 member 1)" SLC30A1 ZNT1 Homo sapiens (Human) cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829] GO:0001701; GO:0005385; GO:0005737; GO:0005783; GO:0005794; GO:0005886; GO:0006829; GO:0006874; GO:0006882; GO:0010312; GO:0016021; GO:0019855; GO:0030315; GO:0031965; GO:0046929; GO:0070509; GO:0070574; GO:0071577; GO:0071584; GO:0071585; GO:0090281; GO:0098685; GO:0099061 calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385] ESALILLQTVPKQIDIR 0.99568 -10.297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.547 0 0 0 0 12.4697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7035 0 0 0 0 0 13.9648 0 0 0 0 0 0 0 0 13.3292 0 0 0 0 13.9281 0 0 0 0 0 0 0 0 0 0 0 13.7804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UB98 ANR12_HUMAN Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein) ANKRD12 ANCO2 KIAA0874 Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 CDSDLCEMNAGMPK 0.99569 -12.318 0 0 11.6587 0 0 0 0 0 13.2635 15.0298 13.5335 13.5116 0 13.6853 13.7685 14.079 14.0314 13.2386 13.1639 13.4648 13.2287 0 16.006 14.0652 14.0284 13.0958 0 13.0759 14.2717 13.4612 12.3923 10.7881 13.1426 10.802 0 14.9323 0 11.6904 10.9875 0 0 11.9236 0 12.5815 11.302 12.7874 17.2549 17.1998 0 13.7484 0 12.6384 0 0 12.6782 17.0199 17.9224 16.2254 18.2911 16.8113 15.9574 17.1253 16.0499 15.1743 0 15.2131 10.9746 12.5954 11.6532 0 0 0 0 12.028 0 0 0 0 0 0 11.263 0 0 0 14.2518 0 0 0 0 0 14.7922 0 14.6802 0 0 0 14.1414 0 0 0 0 0 0 18.5862 0 0 0 0 0 0 15.1811 0 0 0 0 0 0 11.5171 0 0 0 0 0 0 0 0 14.3826 0 14.2677 13.5647 0 0 0 0 0 0 19.0466 0 0 0 0 0 0 0 0 0 0 0 0 18.9251 0 0 0 0 0 0 18.8793 19.3904 12.8848 0 0 17.1667 0 14.9582 15.4732 14.5927 0 15.1135 14.8952 0 0 18.863 14.9511 10.268 0 15.0378 18.9092 14.75 14.7998 0 O76027 ANXA9_HUMAN Annexin A9 (Annexin XXXI) (Annexin-31) (Annexin-9) (Pemphaxin) ANXA9 ANX31 Homo sapiens (Human) cell-cell adhesion [GO:0098609] cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle [GO:0031982] "cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]; vesicle [GO:0031982]; acetylcholine receptor activity [GO:0015464]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; virion binding [GO:0046790]; cell-cell adhesion [GO:0098609]" GO:0001786; GO:0002020; GO:0005262; GO:0005509; GO:0005543; GO:0005544; GO:0005546; GO:0005615; GO:0005634; GO:0005829; GO:0005886; GO:0009986; GO:0015464; GO:0019834; GO:0031982; GO:0045202; GO:0046790; GO:0098609 "acetylcholine receptor activity [GO:0015464]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; virion binding [GO:0046790]" EQRQLISRNFQER 0.99569 -11.841 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.518 0 0 0 0 0 0 0 0 0 0 0 0 0 10.825 0 0 0 0 0 0 0 0 0 13.9869 0 13.8152 0 0 13.7125 11.1257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2099 0 0 0 13.2236 0 0 13.5751 12.9717 0 0 0 0 0 0 12.1322 0 0 0 0 0 0 13.1984 0 0 0 0 0 13.5147 14.2405 0 0 0 0 0 0 0 0 12.9517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P24462 CP3A7_HUMAN "Cytochrome P450 3A7, EC 1.14.14.1 (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2)" CYP3A7 Homo sapiens (Human) estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] endoplasmic reticulum membrane [GO:0005789] endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805] GO:0002933; GO:0004497; GO:0005506; GO:0005789; GO:0006694; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0019825; GO:0020037; GO:0042572; GO:0042573; GO:0062183; GO:0070330; GO:0070989; GO:0101020; GO:0101021 all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395] AESRDETVSGA 0.99569 -9.8763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1943 0 0 13.2725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8806 0 14.6776 0 0 0 14.2211 11.6591 0 0 14.4794 0 0 0 0 0 0 0 0 13.6063 0 0 0 15.1537 0 0 0 13.4001 0 0 0 11.2437 0 0 0 0 0 0 0 0 0 0 0 14.0582 0 0 0 10.2745 0 0 0 0 0 0 0 0 13.4672 13.6019 13.9815 0 0 0 0 0 0 0 0 0 13.324 0 17.0495 0 14.0895 0 0 0 0 0 0 0 0 0 15.2164 0 0 0 0 0 0 0 0 0 0 0 0 12.0642 0 0 13.7924 0 0 P48426 PI42A_HUMAN "Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha, EC 2.7.1.149 (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIP5KIII) (Phosphatidylinositol 5-Phosphate 4-Kinase, PI5P4Kalpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha, PI(5)P 4-kinase type II alpha, PIP4KII-alpha) (PtdIns(4)P-5-kinase B isoform) (PtdIns(4)P-5-kinase C isoform) (PtdIns(5)P-4-kinase isoform 2-alpha)" PIP4K2A PI5P4KA PIP5K2 PIP5K2A Homo sapiens (Human) "1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; autophagosome-lysosome fusion [GO:0061909]; megakaryocyte development [GO:0035855]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; vesicle-mediated cholesterol transport [GO:0090119]" autophagosome [GO:0005776]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886] "autophagosome [GO:0005776]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process [GO:1902635]; autophagosome-lysosome fusion [GO:0061909]; megakaryocyte development [GO:0035855]; negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090217]; negative regulation of insulin receptor signaling pathway [GO:0046627]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphorylation [GO:0016310]; positive regulation of autophagosome assembly [GO:2000786]; regulation of autophagy [GO:0010506]; vesicle-mediated cholesterol transport [GO:0090119]" GO:0001750; GO:0001917; GO:0005524; GO:0005654; GO:0005764; GO:0005776; GO:0005829; GO:0005886; GO:0010506; GO:0016308; GO:0016309; GO:0016310; GO:0035855; GO:0042803; GO:0046627; GO:0046854; GO:0061909; GO:0090119; GO:0090217; GO:1902635; GO:2000786 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803] FHTSYDK 0.99569 -9.8781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.064 0 0 13.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50993 AT1A2_HUMAN "Sodium/potassium-transporting ATPase subunit alpha-2, Na(+)/K(+) ATPase alpha-2 subunit, EC 7.2.2.13 (Sodium pump subunit alpha-2)" ATP1A2 KIAA0778 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization [GO:0086009]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium:sodium antiporter activity [GO:1903280]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; positive regulation of heart contraction [GO:0045823]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of muscle contraction [GO:0006937]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of striated muscle contraction [GO:0006942]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; relaxation of cardiac muscle [GO:0055119]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; response to nicotine [GO:0035094]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; visual learning [GO:0008542]" caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315] "caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cardiac muscle contraction [GO:0060048]; cation transmembrane transport [GO:0098655]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular potassium ion homeostasis [GO:0030007]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; cellular sodium ion homeostasis [GO:0006883]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization [GO:0086009]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium:sodium antiporter activity [GO:1903280]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; positive regulation of heart contraction [GO:0045823]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of muscle contraction [GO:0006937]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of striated muscle contraction [GO:0006942]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; relaxation of cardiac muscle [GO:0055119]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; response to nicotine [GO:0035094]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; visual learning [GO:0008542]" GO:0001504; GO:0001662; GO:0002026; GO:0002087; GO:0005391; GO:0005496; GO:0005524; GO:0005737; GO:0005768; GO:0005886; GO:0005890; GO:0005901; GO:0006813; GO:0006814; GO:0006883; GO:0006937; GO:0006940; GO:0006942; GO:0008217; GO:0008344; GO:0008542; GO:0010881; GO:0010996; GO:0014704; GO:0016020; GO:0016791; GO:0016887; GO:0019229; GO:0019829; GO:0021764; GO:0021989; GO:0030007; GO:0030315; GO:0030955; GO:0031090; GO:0031402; GO:0035094; GO:0035641; GO:0035725; GO:0036376; GO:0040011; GO:0042995; GO:0043025; GO:0043197; GO:0045822; GO:0045823; GO:0045988; GO:0046034; GO:0046982; GO:0051087; GO:0051481; GO:0051946; GO:0051966; GO:0055119; GO:0060048; GO:0071260; GO:0071383; GO:0071805; GO:0086004; GO:0086009; GO:0086012; GO:0086064; GO:0098655; GO:0150104; GO:1902600; GO:1903170; GO:1903280; GO:1903416; GO:1903561; GO:1990239; GO:1990573 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled cation transmembrane transporter activity [GO:0019829]; chaperone binding [GO:0051087]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; sodium ion binding [GO:0031402]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239] DGPNALTPPPTTPEWVKFCR 0.99569 -12.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5372 0 0 0 17.0874 0 17.2053 0 0 0 0 0 0 0 11.0657 0 0 0 0 0 0 0 0 15.8855 11.6324 15.3545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5964 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6568 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5159 0 0 0 0 12.3022 0 0 0 0 0 0 0 0 12.4759 Q13573 SNW1_HUMAN SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein) SNW1 SKIIP SKIP Homo sapiens (Human) "cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]" catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; enzyme binding [GO:0019899]; Notch binding [GO:0005112]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear vitamin D receptor binding [GO:0042809]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]" GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0003723; GO:0005112; GO:0005634; GO:0005654; GO:0005681; GO:0006357; GO:0016363; GO:0016604; GO:0016607; GO:0016922; GO:0019899; GO:0030511; GO:0042771; GO:0042809; GO:0042974; GO:0043923; GO:0045892; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050681; GO:0050769; GO:0051571; GO:0070562; GO:0070564; GO:0071007; GO:0071013; GO:0071300 enzyme binding [GO:0019899]; Notch binding [GO:0005112]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear vitamin D receptor binding [GO:0042809]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] AGIKTHVEK 0.99569 -11.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2371 0 10.3935 0 0 0 0 11.007 0 0 0 0 0 12.8846 12.8291 13.9342 17.3645 0 17.6759 0 0 0 0 0 13.3266 14.5061 13.8238 13.6916 13.9205 16.2229 17.4385 0 0 0 0 0 0 0 0 10.7262 14.1227 0 0 0 0 0 14.8341 0 0 11.0843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7184 0 0 0 0 0 0 0 11.8064 0 0 0 0 0 0 0 0 11.3434 0 0 0 0 0 18.9937 0 0 0 12.0907 13.8203 0 13.6332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6AWC8 YK026_HUMAN Putative uncharacterized protein LOC100129027 Homo sapiens (Human) AVLTPFLTK 0.99569 -12.376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6255 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4778 0 0 0 0 0 0 0 0 0 0 0 0 12.8629 0 0 0 0 0 0 13.1027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SH2 ZAR1_HUMAN Zygote arrest protein 1 (Oocyte-specific maternal effect factor) ZAR1 Homo sapiens (Human) post-transcriptional gene silencing by RNA [GO:0035194]; translation [GO:0006412] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; post-transcriptional gene silencing by RNA [GO:0035194]; translation [GO:0006412] GO:0005737; GO:0006412; GO:0035194 ERLMALLAQVGPGLGPRAR 0.99569 -12.328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0753 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8084 0 12.3898 0 0 0 0 0 0 14.2883 0 0 0 11.5283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3462 0 0 0 0 0 11.2054 0 0 15.9337 12.3608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1759 0 0 0 0 0 12.9729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYL9 PSYR_HUMAN Psychosine receptor (G-protein coupled receptor 65) (T-cell death-associated gene 8 protein) GPR65 TDAG8 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic process [GO:0006915]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; response to acidic pH [GO:0010447] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic process [GO:0006915]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; response to acidic pH [GO:0010447] GO:0004930; GO:0005886; GO:0005887; GO:0006915; GO:0006955; GO:0007186; GO:0007189; GO:0010447; GO:0031532; GO:0035025; GO:0051482; GO:0051496; GO:0090630 G protein-coupled receptor activity [GO:0004930] IIKLLVSITVTFVLCFTPFHVMLLIR 0.99569 -12.303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1724 0 13.9713 0 0 0 0 0 13.2479 0 0 0 13.7867 0 13.4703 0 0 13.0395 0 0 0 0 0 0 10.5858 0 0 13.6451 0 0 0 13.1653 0 0 0 0 0 0 0 0 13.3622 0 0 0 0 0 0 0 13.1837 0 0 0 0 0 0 0 0 11.2009 0 0 0 0 0 0 0 0 0 0 12.7361 0 11.1553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5859 0 0 0 0 0 0 0 Q8IZH2 XRN1_HUMAN "5'-3' exoribonuclease 1, EC 3.1.13.- (Strand-exchange protein 1 homolog)" XRN1 SEP1 Homo sapiens (Human) "cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202] "cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis, exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075]" GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0045202; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:0090503; GO:1905795 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034] DAEFCLFDR 0.99569 -11.819 0 0 0 0 10.4434 10.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4045 0 0 0 0 0 0 12.5166 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5166 0 0 0 0 0 0 0 0 15.5938 13.0715 0 0 0 0 11.3449 0 0 0 0 0 0 11.182 0 12.9246 0 13.2415 0 0 0 12.209 0 0 0 0 11.1671 0 0 11.0428 10.7476 0 0 0 13.9623 13.4415 0 0 0 0 0 0 10.8306 13.0366 12.3319 10.7695 0 0 12.702 0 0 0 0 0 0 0 0 0 10.5882 0 0 12.2446 11.2966 0 0 0 0 0 12.1054 0 10.878 0 0 11.4974 0 0 11.7324 0 0 0 14.8082 0 0 10.8643 0 0 0 0 11.8232 0 0 0 0 0 0 0 17.7902 0 0 11.6044 0 0 0 0 0 0 0 13.3086 0 0 0 0 0 0 0 Q8TE76 MORC4_HUMAN MORC family CW-type zinc finger protein 4 (Zinc finger CW-type coiled-coil domain protein 2) (Zinc finger CW-type domain protein 4) MORC4 ZCW4 ZCWCC2 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] GO:0005634; GO:0005654; GO:0008270; GO:0016887; GO:0035064 ATP hydrolysis activity [GO:0016887]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] ALAKLTRLR 0.99569 -12.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.186 0 0 0 0 0 0 0 0 12.5143 0 0 0 0 0 0 11.9273 12.1126 0 0 13.171 0 12.9994 0 0 12.6629 0 14.8624 11.8034 12.0618 13.2427 10.7582 14.7745 14.3782 0 13.7712 0 0 0 0 0 14.5911 13.1065 13.5825 0 0 0 0 0 0 12.6606 12.7983 12.2982 13.6408 13.5841 13.7366 12.3105 12.2941 0 0 0 0 0 0 0 12.8615 12.2707 0 0 0 0 0 0 0 0 13.5327 0 0 0 0 0 12.7106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.468 0 0 0 0 0 0 0 Q8WWY6 MB3L1_HUMAN "Methyl-CpG-binding domain protein 3-like 1, MBD3-like protein 1" MBD3L1 MBD3L Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634] GO:0005634 MSSYTFK 0.99569 -9.8601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7709 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9323 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92886 NGN1_HUMAN "Neurogenin-1, NGN-1 (Class A basic helix-loop-helix protein 6, bHLHa6) (Neurogenic basic-helix-loop-helix protein) (Neurogenic differentiation factor 3, NeuroD3)" NEUROG1 BHLHA6 NEUROD3 NGN NGN1 Homo sapiens (Human) auditory behavior [GO:0031223]; cell fate commitment [GO:0045165]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; craniofacial suture morphogenesis [GO:0097094]; exit from mitosis [GO:0010458]; genitalia development [GO:0048806]; genitalia morphogenesis [GO:0035112]; hard palate morphogenesis [GO:1905748]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; learned vocalization behavior [GO:0098583]; mastication [GO:0071626]; negative regulation of relaxation of muscle [GO:1901078]; negative regulation of saliva secretion [GO:1905747]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; peristalsis [GO:0030432]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle organ development [GO:0048634]; regulation of transcription by RNA polymerase II [GO:0006357]; thorax and anterior abdomen determination [GO:0007356]; trigeminal nerve development [GO:0021559]; vestibulocochlear nerve formation [GO:0021650] chromatin [GO:0000785]; nucleus [GO:0005634]; perikaryon [GO:0043204] "chromatin [GO:0000785]; nucleus [GO:0005634]; perikaryon [GO:0043204]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; auditory behavior [GO:0031223]; cell fate commitment [GO:0045165]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; craniofacial suture morphogenesis [GO:0097094]; exit from mitosis [GO:0010458]; genitalia development [GO:0048806]; genitalia morphogenesis [GO:0035112]; hard palate morphogenesis [GO:1905748]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; learned vocalization behavior [GO:0098583]; mastication [GO:0071626]; negative regulation of relaxation of muscle [GO:1901078]; negative regulation of saliva secretion [GO:1905747]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; peristalsis [GO:0030432]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle organ development [GO:0048634]; regulation of transcription by RNA polymerase II [GO:0006357]; thorax and anterior abdomen determination [GO:0007356]; trigeminal nerve development [GO:0021559]; vestibulocochlear nerve formation [GO:0021650]" GO:0000785; GO:0000978; GO:0000981; GO:0003682; GO:0003700; GO:0005634; GO:0006357; GO:0007356; GO:0007399; GO:0010458; GO:0021559; GO:0021650; GO:0030182; GO:0030432; GO:0031223; GO:0031536; GO:0035112; GO:0042472; GO:0042803; GO:0043204; GO:0045165; GO:0045666; GO:0045944; GO:0048634; GO:0048806; GO:0048839; GO:0050885; GO:0051091; GO:0070888; GO:0071626; GO:0090102; GO:0090103; GO:0097094; GO:0098583; GO:1901078; GO:1905747; GO:1905748; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ASEVPGAQDDEQER 0.99569 -12.373 0 0 0 0 10.6678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4197 0 0 0 0 0 0 0 0 0 0 0 0 Q96LT4 SAMD8_HUMAN "Sphingomyelin synthase-related protein 1, SMSr, EC 2.7.8.- (Ceramide phosphoethanolamine synthase, CPE synthase) (Sterile alpha motif domain-containing protein 8, SAM domain-containing protein 8)" SAMD8 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] GO:0002950; GO:0005783; GO:0005789; GO:0005829; GO:0005887; GO:0006686; GO:0016021; GO:0030148; GO:0030173; GO:0030176; GO:0033188; GO:0046513; GO:0047493; GO:1905373; GO:2000303 ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; sphingomyelin synthase activity [GO:0033188] HRSILLR 0.99569 -10.344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PU5 NED4L_HUMAN "E3 ubiquitin-protein ligase NEDD4-like, EC 2.3.2.26, EC 2.3.2.36 (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2)" NEDD4L KIAA0439 NEDL3 Homo sapiens (Human) cell differentiation [GO:0030154]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell differentiation [GO:0030154]; ion transmembrane transport [GO:0034220]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendrite extension [GO:1903861]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; regulation of membrane repolarization [GO:0060306]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular cardiac muscle cell action potential [GO:0086005] GO:0000209; GO:0003254; GO:0004842; GO:0005654; GO:0005737; GO:0005771; GO:0005794; GO:0005829; GO:0006511; GO:0015459; GO:0016567; GO:0017080; GO:0019870; GO:0019871; GO:0030154; GO:0031647; GO:0034220; GO:0034765; GO:0042391; GO:0043161; GO:0044325; GO:0048814; GO:0060306; GO:0061630; GO:0070062; GO:0070936; GO:0086005; GO:1901016; GO:1901017; GO:1901380; GO:1902305; GO:1902306; GO:1903861; GO:2000009; GO:2000650; GO:2001288 potassium channel inhibitor activity [GO:0019870]; potassium channel regulator activity [GO:0015459]; sodium channel inhibitor activity [GO:0019871]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] DFLLRPR 0.99569 -32.739 0 0 0 0 0 0 0 0 0 0 0 0 11.2755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.158 0 0 0 13.4915 0 0 0 0 0 0 0 0 0 0 0 0 12.445 0 0 0 14.0653 0 0 0 0 0 0 0 0 0 0 0 0 15.1661 0 0 0 0 0 0 0 14.0258 13.6383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2699 0 0 0 0 0 0 13.7969 0 0 0 13.3555 0 0 11.927 0 0 0 13.1877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7791 0 0 11.2997 14.097 0 14.2096 0 0 0 0 0 0 0 0 15.0402 0 0 0 0 0 0 0 0 0 10.3714 0 0 0 0 0 Q96T25 ZIC5_HUMAN Zinc finger protein ZIC 5 (Zinc finger protein of the cerebellum 5) ZIC5 Homo sapiens (Human) cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007417; GO:0030154; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AKYKLINHIR 0.99569 -11.839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2757 0 11.9527 0 0 0 0 0 12.7355 13.5051 0 0 0 0 14.6821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0533 0 0 12.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3571 0 0 12.7611 0 0 13.7232 0 11.5312 0 0 0 0 0 0 0 0 0 12.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95359 TACC2_HUMAN "Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1, AZU-1)" TACC2 Homo sapiens (Human) cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; nuclear receptor binding [GO:0016922]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052] GO:0000226; GO:0005654; GO:0005737; GO:0005815; GO:0005829; GO:0005886; GO:0007052; GO:0008283; GO:0016922; GO:0021987 nuclear receptor binding [GO:0016922] DFSLAGNFSR 0.9957 -33.397 0 0 0 0 0 0 0 0 12.0473 12.3946 0 0 0 0 11.5701 0 0 0 0 0 0 0 12.2314 11.7104 0 0 0 0 11.8588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9755 0 0 0 0 12.8195 11.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8319 0 0 13.554 0 13.8291 13.6239 14.391 13.0199 0 12.2174 12.6478 0 14.8798 0 0 0 10.6463 10.9326 0 13.5158 0 0 12.686 0 10.138 0 0 0 0 0 13.0826 13.1905 12.6614 0 12.0458 10.4712 13.805 0 13.6116 0 0 0 0 12.5635 0 0 12.9458 0 0 12.7973 0 0 0 0 11.8327 0 0 12.8334 0 0 0 0 0 0 0 13.4507 0 0 0 11.6204 14.3106 15.9225 0 0 14.8047 0 0 11.947 0 12.1828 0 0 0 0 0 0 0 12.833 0 0 0 12.4172 0 0 0 0 P20042 IF2B_HUMAN "Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta, eIF-2-beta)" EIF2S2 EIF2B Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584] cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]" GO:0001701; GO:0001731; GO:0001732; GO:0002176; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0008135; GO:0008584; GO:0031369; GO:0046872 "metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]" DEALEDEDNK 0.9957 -9.6136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.041 0 0 0 0 0 0 0 0 0 0 13.0353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9226 0 0 0 0 0 0 0 0 0 13.2822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1539 0 0 0 0 0 0 P22455 FGFR4_HUMAN "Fibroblast growth factor receptor 4, FGFR-4, EC 2.7.10.1 (CD antigen CD334)" FGFR4 JTK2 TKF Homo sapiens (Human) cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133] endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005007; GO:0005524; GO:0005576; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005887; GO:0007169; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010715; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0033674; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0055062; GO:0070374; GO:0070857; GO:2000573 ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] DPSNRHSYPQQAPYWTHPQR 0.9957 -12.488 0 0 0 0 0 0 0 0 0 0 0 12.8379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4793 13.2493 0 0 0 0 0 0 0 15.9243 0 0 0 0 0 0 0 10.4277 12.2547 12.4883 0 12.445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.542 0 0 0 0 0 0 0 0 0 11.5371 0 0 0 13.2157 0 0 0 0 0 13.8758 0 0 0 0 13.0559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7431 0 0 13.1343 0 0 0 0 0 0 13.2388 0 0 0 0 0 0 16.7742 0 12.7672 0 0 0 0 0 0 0 11.8522 0 0 0 0 0 13.161 0 0 0 13.4564 Q3KR37 ASTRB_HUMAN Protein Aster-B (GRAM domain-containing protein 1B) GRAMD1B KIAA1201 UNQ3032/PRO9834 Homo sapiens (Human) cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632]; intracellular sterol transport [GO:0032366] GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0016020; GO:0016021; GO:0032366; GO:0032934; GO:0042632; GO:0070300; GO:0071397; GO:0120015; GO:0120020; GO:0140268 cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015] ASKTTTVRR 0.9957 -33.495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0254 0 0 0 0 0 10.7789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7304 0 0 0 12.2775 15.1379 0 0 0 0 11.8068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0026 12.9711 0 0 0 13.4463 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXD1 HRCT1_HUMAN Histidine-rich carboxyl terminus protein 1 HRCT1 UNQ338/PRO537 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AQPWPFR 0.9957 -11.857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7558 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z7A4 PXK_HUMAN "PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase, MONaKA)" PXK Homo sapiens (Human) inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of ion transport [GO:0043271] GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0008022; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0043271; GO:0050804 actin binding [GO:0003779]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022] DFQCLIK 0.9957 -33.353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3826 13.2024 11.7453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.777 0 0 12.9193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7373 12.5751 13.1948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.734 16.2275 0 0 0 13.1497 0 13.3592 0 0 0 0 0 13.7787 0 0 0 0 0 0 0 12.5263 0 0 0 0 13.3817 0 0 11.7645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWC1 MA7D3_HUMAN MAP7 domain-containing protein 3 MAP7D3 MDP3 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785] cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819] cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785] GO:0000226; GO:0005737; GO:0005819; GO:0008017; GO:0015630; GO:0015631; GO:0016020; GO:0046785 microtubule binding [GO:0008017]; tubulin binding [GO:0015631] ARDAPKK 0.9957 -33.859 0 0 0 0 0 0 10.7089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5023 0 0 0 12.9425 0 14.0975 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0658 0 11.8483 11.9238 0 0 0 0 13.0164 0 0 11.501 0 0 11.5939 0 0 11.2379 11.4154 0 0 0 0 12.6387 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.695 0 0 0 0 0 0 0 13.8328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0998 0 0 0 0 0 0 0 0 12.9539 13.8555 0 0 0 0 0 0 0 0 0 0 0 15.7358 0 0 0 0 0 11.3249 12.4053 0 0 0 0 0 0 0 0 0 0 13.3266 Q8N3S3 PHTF2_HUMAN Protein PHTF2 PHTF2 Homo sapiens (Human) endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021] GO:0005783; GO:0016021 CSSSRQDSESAR 0.9957 -9.9248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5681 0 0 0 0 0 0 0 0 10.8093 0 0 0 0 0 0 0 0 0 0 0 0 9.75669 0 0 0 0 0 11.5549 0 0 0 0 0 0 0 0 10.7661 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0966 0 0 0 14.8373 0 13.0756 13.6692 13.2415 0 12.7564 0 14.8372 0 0 13.0285 12.3668 14.1757 0 0 13.9396 0 0 13.205 15.815 0 0 0 0 13.6899 0 12.7561 0 0 0 0 15.0653 0 15.1969 0 14.1703 0 0 12.1588 0 0 0 0 0 0 10.7223 14.2676 0 0 0 12.8824 0 0 12.8516 0 10.3038 0 0 12.2239 0 0 0 0 0 0 0 12.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 13.987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4105 0 0 0 0 0 0 Q8TDY8 IGDC4_HUMAN "Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36, hDDM36)" IGDCC4 DDM36 KIAA1628 NOPE Homo sapiens (Human) cell-cell adhesion [GO:0098609] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell-cell adhesion [GO:0098609] GO:0005886; GO:0016021; GO:0098609 KSPPACR 0.9957 -11.88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2652 0 0 13.7187 0 0 0 0 0 12.7533 0 0 0 0 12.6802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5674 0 0 0 0 0 0 0 11.9495 11.844 0 0 0 11.9214 0 0 0 0 0 0 0 0 0 0 14.5437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3685 16.1531 14.1545 14.4109 15.896 0 15.2615 0 0 13.4078 0 16.0542 16.3991 15.9196 0 0 0 0 14.371 0 15.4997 0 0 Q9H840 GEMI7_HUMAN "Gem-associated protein 7, Gemin-7 (SIP3)" GEMIN7 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Sm-like protein family complex [GO:0120114]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; Sm-like protein family complex [GO:0120114]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]" GO:0000387; GO:0000398; GO:0005654; GO:0005737; GO:0005829; GO:0016604; GO:0032797; GO:0034719; GO:0097504; GO:0120114 AALRERYLR 0.9957 -33.299 0 0 0 0 0 0 0 0 0 12.8506 0 0 0 0 0 0 0 0 0 0 12.7148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1844 0 0 0 14.5797 13.9636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULI0 ATD2B_HUMAN ATPase family AAA domain-containing protein 2B ATAD2B KIAA1240 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0016887; GO:0042393; GO:0045944; GO:0070577 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577] CVGYCGADIKALCTEAALIALR 0.9957 -33.372 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8844 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9256 0 11.7105 16.1574 13.6878 12.3692 0 14.039 13.3072 14.2105 15.2513 0 0 0 13.5226 0 0 12.5956 0 13.2395 0 0 0 14.2819 13.2154 0 0 11.3583 0 11.6644 0 15.3412 0 0 0 0 13.3726 0 0 0 0 13.4539 0 0 13.3022 13.5487 12.416 15.1113 14.1246 0 0 12.4225 13.4993 14.5814 0 0 13.1274 0 0 0 12.9166 0 0 13.5531 13.7501 12.9562 0 0 0 0 0 0 0 13.0692 0 12.8468 0 0 12.106 13.1675 0 15.3619 0 13.1517 12.9925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.719 15.4828 O75167 PHAR2_HUMAN Phosphatase and actin regulator 2 PHACTR2 C6orf56 KIAA0680 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036] plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092] plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton organization [GO:0030036] GO:0003779; GO:0004864; GO:0005886; GO:0030036; GO:0031092 actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864] EYQANDSDSDGPILYTDDEDEDEDEDGSGESALASK 0.99571 -11.934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4949 15.2871 0 0 0 0 0 13.3453 13.2961 13.6194 0 13.5381 0 0 13.2946 0 0 0 0 0 0 0 13.0759 14.2541 0 0 0 13.7218 0 0 0 0 0 13.0979 0 0 0 0 0 13.5069 0 0 0 0 0 0 0 0 14.6213 14.0132 14.1789 0 14.657 0 0 0 0 16.0776 0 0 0 0 0 0 0 13.6502 0 0 13.5233 14.365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08842 STS_HUMAN "Steryl-sulfatase, EC 3.1.6.2 (Arylsulfatase C, ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase)" STS ARSC1 Homo sapiens (Human) epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706] GO:0004065; GO:0004773; GO:0005764; GO:0005768; GO:0005783; GO:0005788; GO:0005789; GO:0005794; GO:0005886; GO:0006706; GO:0007565; GO:0008484; GO:0008544; GO:0016020; GO:0016021; GO:0043231; GO:0046872 arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484] FYEILKVMQEAADRHTQTLPEVPDQFSWNNFLWK 0.99571 -12.533 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7442 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7521 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3197 0 0 P13533 MYH6_HUMAN "Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform, MyHC-alpha)" MYH6 MYHCA Homo sapiens (Human) adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; regulation of ATP-dependent activity [GO:0043462]; regulation of blood pressure [GO:0008217]; regulation of heart contraction [GO:0008016]; regulation of heart growth [GO:0060420]; regulation of heart rate [GO:0002027]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral muscle development [GO:0007522] cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018] cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin complex [GO:0016459]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; sarcomere [GO:0030017]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; protein kinase binding [GO:0019901]; adult heart development [GO:0007512]; ATP metabolic process [GO:0046034]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy in response to stress [GO:0014898]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; regulation of ATP-dependent activity [GO:0043462]; regulation of blood pressure [GO:0008217]; regulation of heart contraction [GO:0008016]; regulation of heart growth [GO:0060420]; regulation of heart rate [GO:0002027]; regulation of the force of heart contraction [GO:0002026]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral muscle development [GO:0007522] GO:0000146; GO:0001701; GO:0001725; GO:0002026; GO:0002027; GO:0005516; GO:0005524; GO:0005829; GO:0005859; GO:0006936; GO:0006941; GO:0007512; GO:0007522; GO:0008016; GO:0008217; GO:0014898; GO:0016459; GO:0016460; GO:0017018; GO:0019901; GO:0030016; GO:0030017; GO:0030018; GO:0030049; GO:0030239; GO:0032982; GO:0043462; GO:0045214; GO:0046034; GO:0051015; GO:0055009; GO:0055010; GO:0055013; GO:0060048; GO:0060420 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; myosin phosphatase activity [GO:0017018]; protein kinase binding [GO:0019901] EEFVKAK 0.99571 -34.443 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.026 0 0 0 0 0 0 0 0 0 10.5481 0 0 0 0 13.9745 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8251 0 0 0 0 0 0 0 0 0 0 11.3544 0 0 0 13.3725 12.7992 0 13.5338 13.4729 0 0 0 0 13.5092 0 0 0 0 0 0 0 16.651 0 17.0094 0 13.1603 0 0 0 0 0 0 0 0 11.5644 13.8668 15.9813 0 0 0 14.2544 0 13.118 0 0 0 0 0 12.6994 11.4187 0 0 11.4527 0 0 0 0 13.6223 0 0 13.812 0 0 12.7779 0 0 0 0 0 0 12.6173 14.5639 0 0 0 0 0 0 13.006 12.168 0 13.5731 0 0 0 0 0 13.4539 0 13.7016 0 0 13.2536 0 0 0 0 14.1861 14.3216 0 0 0 13.5468 12.6552 12.5559 0 0 10.9981 0 13.6383 0 0 0 0 0 0 0 13.9013 Q6IQ20 NAPEP_HUMAN "N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, N-acyl phosphatidylethanolamine phospholipase D, NAPE-PLD, NAPE-hydrolyzing phospholipase D, EC 3.1.4.54" NAPEPLD C7orf18 Homo sapiens (Human) host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622] cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659] GO:0000139; GO:0001523; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0031901; GO:0032052; GO:0042622; GO:0042802; GO:0043227; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0102200 bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270] FGPFDLAAIPIGAYEPRWFMK 0.99571 -12.502 0 0 0 0 0 0 0 0 0 0 0 13.5707 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.9748 11.4558 0 0 0 0 0 0 0 0 11.885 0 0 0 0 0 0 0 0 9.63604 0 0 0 Q8IZF6 AGRG4_HUMAN Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) ADGRG4 GPR112 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0016021 G protein-coupled receptor activity [GO:0004930] DPYCSSP 0.99571 -34.376 0 0 0 0 0 0 0 0 11.3445 0 16.1687 15.7763 0 0 0 14.0807 0 0 0 0 0 0 12.8452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8629 0 0 0 0 0 0 0 0 0 0 13.5841 0 0 0 0 0 0 0 0 0 13.8121 15.0408 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0981 0 0 0 15.4089 0 16.3098 0 0 0 0 0 0 13.3461 15.4042 0 0 12.0871 0 14.1303 13.8312 0 0 0 0 11.9871 0 11.9152 0 0 0 0 0 0 0 0 0 0 13.4522 0 0 0 0 14.3636 0 0 0 0 0 0 0 0 0 0 0 12.7438 12.702 11.7933 13.3547 0 0 13.7787 16.2991 0 0 0 0 0 0 15.4475 0 0 0 0 0 0 16.5196 0 0 16.8527 0 13.7801 13.9149 0 0 0 14.3465 0 0 12.5923 0 0 0 0 0 0 Q9C0H6 KLHL4_HUMAN Kelch-like protein 4 KLHL4 KIAA1687 Homo sapiens (Human) centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630] centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; actin binding [GO:0003779] GO:0003779; GO:0005737; GO:0015630; GO:0034451 actin binding [GO:0003779] GTPVQGR 0.99571 -11.92 0 0 0 0 0 0 0 0 0 0 0 0 15.4115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7891 0 15.003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O76041 NEBL_HUMAN Nebulette (Actin-binding Z-disk protein) NEBL C10orf113 LNEBL Homo sapiens (Human) cardiac muscle thin filament assembly [GO:0071691] extracellular exosome [GO:0070062]; I band [GO:0031674]; stress fiber [GO:0001725]; Z disc [GO:0030018] extracellular exosome [GO:0070062]; I band [GO:0031674]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; filamin binding [GO:0031005]; structural constituent of muscle [GO:0008307]; tropomyosin binding [GO:0005523]; cardiac muscle thin filament assembly [GO:0071691] GO:0001725; GO:0005523; GO:0008092; GO:0008307; GO:0030018; GO:0031005; GO:0031674; GO:0051015; GO:0070062; GO:0071691 actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; filamin binding [GO:0031005]; structural constituent of muscle [GO:0008307]; tropomyosin binding [GO:0005523] ASHYRRHWSR 0.99572 -35.272 0 0 0 0 0 0 0 0 14.7427 0 0 13.1565 13.8322 0 15.3794 0 0 13.8082 14.4034 0 0 0 14.3778 0 14.7078 13.4617 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1242 0 0 13.148 0 0 0 0 0 0 0 0 0 0 11.1514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4445 0 14.3691 0 0 0 0 0 13.2126 13.1422 0 0 0 0 0 0 0 15.5026 13.6008 0 12.9704 0 0 0 0 0 0 0 13.3949 0 0 13.5278 13.695 0 0 0 0 13.2091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4186 0 0 0 0 0 0 0 0 11.8855 0 0 0 0 0 12.424 10.4476 0 0 0 0 0 0 0 0 0 0 0 0 10.1523 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23497 SP100_HUMAN Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa) SP100 Homo sapiens (Human) "DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; interferon-gamma-mediated signaling pathway [GO:0060333]; maintenance of protein location [GO:0045185]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Fas signaling pathway [GO:1902044]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to retinoic acid [GO:0032526]; response to type I interferon [GO:0034340]; retinoic acid receptor signaling pathway [GO:0048384]; telomere maintenance [GO:0000723]; type I interferon signaling pathway [GO:0060337]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; interferon-gamma-mediated signaling pathway [GO:0060333]; maintenance of protein location [GO:0045185]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral transcription [GO:0032897]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of angiogenesis [GO:0045765]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Fas signaling pathway [GO:1902044]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to retinoic acid [GO:0032526]; response to type I interferon [GO:0034340]; retinoic acid receptor signaling pathway [GO:0048384]; telomere maintenance [GO:0000723]; type I interferon signaling pathway [GO:0060337]" GO:0000122; GO:0000723; GO:0000781; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0006978; GO:0010596; GO:0016604; GO:0016605; GO:0019900; GO:0019904; GO:0032526; GO:0032897; GO:0034097; GO:0034340; GO:0034341; GO:0034399; GO:0042802; GO:0042803; GO:0043392; GO:0043433; GO:0045185; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0046826; GO:0046983; GO:0048384; GO:0051091; GO:0060333; GO:0060337; GO:0061629; GO:0070087; GO:1902041; GO:1902044 "chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" EEEEDEEDEQEEENEEDDDK 0.99572 -31.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7291 0 9.94244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8246 13.8284 10.8203 0 10.4925 0 0 0 0 0 0 13.2076 0 0 0 0 0 0 14.0512 14.4292 0 11.3896 0 0 0 13.9009 15.4945 0 0 0 0 0 14.6118 13.5721 0 0 0 0 12.5526 0 0 14.2844 0 0 0 0 0 13.2401 0 0 0 0 0 13.5445 0 0 14.3126 14.7027 15.1539 14.3512 0 0 0 0 0 0 14.5134 0 0 0 0 0 0 0 12.8283 13.733 0 12.2755 0 0 0 0 0 0 15.5736 11.8362 0 12.0473 0 13.9904 0 0 0 0 0 12.2629 0 0 0 0 0 0 12.4507 0 0 0 14.7426 0 15.1868 0 0 0 0 0 P42704 LPPRC_HUMAN "Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein, LRP 130) (GP130)" LRPPRC LRP130 Homo sapiens (Human) mitochondrial RNA catabolic process [GO:0000957]; mitochondrion transport along microtubule [GO:0047497]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129] condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904] condensed nuclear chromosome [GO:0000794]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion transport along microtubule [GO:0047497]; mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129] GO:0000794; GO:0000957; GO:0000961; GO:0003697; GO:0003723; GO:0003730; GO:0005634; GO:0005637; GO:0005640; GO:0005654; GO:0005739; GO:0005856; GO:0005874; GO:0008017; GO:0016020; GO:0031625; GO:0042645; GO:0047497; GO:0048471; GO:0048487; GO:0051028; GO:0070129; GO:1990904 beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625] AENQPIRDVLKQLILVLCSEENMQK 0.99572 -35.34 0 0 0 0 0 11.2287 0 0 0 0 0 0 0 11.029 0 0 0 0 0 0 0 0 0 0 0 14.8229 12.0094 0 0 0 0 0 0 0 0 0 9.5969 0 0 0 0 0 0 0 0 0 0 12.2878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8069 0 11.3251 0 12.3511 0 0 0 0 0 0 0 0 0 0 0 13.7887 0 0 9.8876 0 10.8229 0 14.1147 0 0 0 0 0 0 0 14.8949 0 0 0 12.149 14.3515 9.86668 0 14.1859 0 0 0 0 0 0 0 19.1609 0 0 12.424 0 12.3007 12.8216 0 13.8221 0 0 12.113 14.0256 0 0 0 12.73 0 0 13.3628 0 0 12.6965 0 0 0 0 0 15.066 0 0 0 0 12.2868 0 15.0291 0 0 14.8671 0 0 0 0 0 0 0 14.0736 12.6731 0 10.5262 13.9056 0 0 Q5UIP0 RIF1_HUMAN Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) "cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; somatic stem cell population maintenance [GO:0035019]; subtelomeric heterochromatin assembly [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]" "chromatin [GO:0000785]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]" "chromatin [GO:0000785]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; somatic stem cell population maintenance [GO:0035019]; subtelomeric heterochromatin assembly [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]" GO:0000122; GO:0000723; GO:0000785; GO:0000793; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006974; GO:0007049; GO:0016604; GO:0031509; GO:0031965; GO:0035019; GO:0035861; GO:0043247; GO:0045814; GO:0045830; GO:0051233; GO:0051574; GO:0140445; GO:1990830; GO:2000042; GO:2001034 AENQSHDYK 0.99572 -35.292 0 0 0 0 0 0 0 0 14.1265 13.0585 12.731 13.924 0 0 13.6296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.235 12.5849 0 13.4337 9.92394 0 0 0 0 13.2446 0 0 9.3149 0 19.4396 0 0 11.3127 11.0159 0 14.2158 0 0 15.8144 15.9671 0 0 0 0 0 0 0 0 0 0 12.8707 13.5137 0 12.7856 0 0 12.4293 12.7859 0 0 0 0 10.5303 13.0525 0 0 0 0 0 0 0 0 0 16.1499 0 0 0 0 0 0 12.118 0 16.4803 0 0 0 0 0 0 0 0 0 10.4021 11.0949 0 15.7265 0 0 0 0 0 14.5803 0 0 0 0 0 15.2424 0 13.7363 10.9261 0 0 0 14.8628 12.9151 0 0 10.4077 0 11.4925 0 0 11.3595 13.5661 0 0 12.0267 0 0 13.6775 14.2858 0 14.1717 10.4138 12.0899 0 0 11.7727 0 13.819 11.8587 0 0 0 0 0 0 14.22 13.7647 14.255 14.249 0 0 0 0 0 0 0 13.8404 0 13.8058 13.2364 0 Q6UXY1 BI2L2_HUMAN "Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2, BAI1-associated protein 2-like protein 2 (Planar intestinal- and kidney-specific BAR domain protein, Pinkbar)" BAIAP2L2 UNQ9336/PRO34007 Homo sapiens (Human) actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838] cell-cell contact zone [GO:0044291]; clathrin complex [GO:0071439]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506] cell-cell contact zone [GO:0044291]; clathrin complex [GO:0071439]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; phospholipid binding [GO:0005543]; actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; membrane organization [GO:0061024]; plasma membrane organization [GO:0007009]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838] GO:0005543; GO:0005654; GO:0005829; GO:0005886; GO:0007009; GO:0012506; GO:0030659; GO:0030838; GO:0044291; GO:0051017; GO:0051764; GO:0061024; GO:0071439; GO:2000251 phospholipid binding [GO:0005543] AAELEEK 0.99572 -12.029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0495 15.4019 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0801 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQW6 ANLN_HUMAN Anillin ANLN Homo sapiens (Human) actomyosin contractile ring assembly [GO:0000915]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; podocyte cell migration [GO:0090521]; positive regulation of bleb assembly [GO:1904172]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106] actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654] actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; actomyosin contractile ring assembly [GO:0000915]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic cytokinesis [GO:0000281]; podocyte cell migration [GO:0090521]; positive regulation of bleb assembly [GO:1904172]; regulation of exit from mitosis [GO:0007096]; septin ring assembly [GO:0000921]; septin ring organization [GO:0031106] GO:0000281; GO:0000915; GO:0000921; GO:0002244; GO:0003779; GO:0005654; GO:0005826; GO:0005829; GO:0005938; GO:0007096; GO:0015629; GO:0030496; GO:0031106; GO:0032059; GO:0045296; GO:0090521; GO:1904172 actin binding [GO:0003779]; cadherin binding [GO:0045296] DPSGLDK 0.99572 -35.327 0 0 0 0 0 11.1719 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3149 0 0 0 0 0 0 0 0 14.1286 0 0 0 0 0 0 0 12.4272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7881 0 0 0 0 0 0 0 0 0 0 0 Q9Y2G7 ZFP30_HUMAN "Zinc finger protein 30 homolog, Zfp-30 (Zinc finger protein 745)" ZFP30 KIAA0961 ZNF745 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFRVRGQLNLHQR 0.99572 -9.6913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5867 13.9908 0 0 0 12.7484 0 0 0 0 0 0 0 0 14.3712 0 0 13.449 0 0 0 0 0 12.1984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6133 0 0 0 0 0 0 0 0 13.1406 0 0 0 13.3102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P33076 C2TA_HUMAN "MHC class II transactivator, CIITA, EC 2.3.1.-, EC 2.7.11.1" CIITA MHC2TA Homo sapiens (Human) "immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral entry into host cell [GO:0046597]; phosphorylation [GO:0016310]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to antibiotic [GO:0046677]; response to interferon-gamma [GO:0034341]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; PML body [GO:0016605] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; acyltransferase activity [GO:0016746]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTP binding [GO:0005525]; protein C-terminus binding [GO:0008022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral entry into host cell [GO:0046597]; phosphorylation [GO:0016310]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; response to antibiotic [GO:0046677]; response to interferon-gamma [GO:0034341]" GO:0000122; GO:0000976; GO:0003713; GO:0004674; GO:0005524; GO:0005525; GO:0005654; GO:0005829; GO:0006954; GO:0006955; GO:0008022; GO:0016310; GO:0016605; GO:0016746; GO:0032966; GO:0034341; GO:0044877; GO:0045345; GO:0045348; GO:0045892; GO:0045893; GO:0045944; GO:0046597; GO:0046677; GO:0106310; GO:0140297 acyltransferase activity [GO:0016746]; ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTP binding [GO:0005525]; protein C-terminus binding [GO:0008022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713] FTIEPFKAK 0.99573 -10.043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7625 0 0 13.2288 0 12.5145 0 12.4476 0 0 0 0 0 0 0 0 0 0 13.1928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1882 0 15.7744 13.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1959 0 0 13.6683 17.8775 15.0345 0 0 14.6664 0 14.3179 14.8194 14.7893 0 14.8447 0 14.3584 18.2151 12.6683 15.1609 0 14.8104 0 13.5706 0 17.1157 15.4557 0 14.7542 0 15.3628 0 0 0 15.5636 15.6623 15.8979 14.7748 15.1121 0 0 0 0 16.104 14.9941 14.9518 14.9714 0 0 0 0 15.0979 0 15.0357 13.9996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8169 14.1001 0 0 0 0 0 0 Q15054 DPOD3_HUMAN DNA polymerase delta subunit 3 (DNA polymerase delta subunit C) (DNA polymerase delta subunit p66) (DNA polymerase delta subunit p68) POLD3 KIAA0039 Homo sapiens (Human) "DNA biosynthetic process [GO:0071897]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]" cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; zeta DNA polymerase complex [GO:0016035] "cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; zeta DNA polymerase complex [GO:0016035]; protein-macromolecule adaptor activity [GO:0030674]; DNA biosynthetic process [GO:0071897]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; DNA synthesis involved in UV-damage excision repair [GO:1904161]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276]; mismatch repair [GO:0006298]; nucleotide-excision repair, DNA gap filling [GO:0006297]" GO:0000731; GO:0005654; GO:0005737; GO:0006261; GO:0006271; GO:0006297; GO:0006298; GO:0016035; GO:0030674; GO:0042276; GO:0043625; GO:0071897; GO:1904161 protein-macromolecule adaptor activity [GO:0030674] AEPVKVLQKEK 0.99573 -12.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8089 0 12.994 0 13.1868 13.7088 0 0 0 0 0 12.8617 14.1545 15.8913 0 13.8701 0 14.4537 16.9734 0 14.1727 0 0 0 0 0 0 0 0 0 13.9938 13.9887 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1432 0 11.6751 0 0 0 0 0 0 0 11.8175 0 0 0 0 0 12.7634 0 0 0 0 0 0 0 0 17.5828 0 0 0 0 13.8119 0 12.5596 0 0 0 0 0 0 0 0 0 16.2924 0 0 13.9832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7205 0 Q96S99 PKHF1_HUMAN "Pleckstrin homology domain-containing family F member 1, PH domain-containing family F member 1 (Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains, Apoptosis-inducing protein) (PH and FYVE domain-containing protein 1) (Phafin-1) (Zinc finger FYVE domain-containing protein 15)" PLEKHF1 APPD LAPF ZFYVE15 Homo sapiens (Human) apoptotic process [GO:0006915]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050] early endosome [GO:0005769]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] early endosome [GO:0005769]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; apoptotic process [GO:0006915]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein localization to plasma membrane [GO:0072659]; vesicle organization [GO:0016050] GO:0005634; GO:0005764; GO:0005765; GO:0005769; GO:0006915; GO:0007032; GO:0008333; GO:0010008; GO:0010314; GO:0010508; GO:0016050; GO:0032266; GO:0035091; GO:0046872; GO:0048471; GO:0070273; GO:0072659; GO:2001244 metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314] ELAAQQR 0.99573 -5.4781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3437 0 0 0 0 0 0 0 0 0 0 0 14.6254 0 0 0 0 0 13.8869 0 0 0 0 0 0 0 10.2498 0 13.1081 0 0 13.8524 0 0 0 0 0 0 0 0 0 0 10.6997 0 14.4402 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7381 0 0 0 13.7282 0 0 0 0 0 14.3358 0 0 12.1451 0 0 14.1442 0 0 0 0 13.8146 0 0 0 0 0 0 12.8201 13.3211 13.0869 13.6971 13.0351 0 10.9089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HB07 MYG1_HUMAN "MYG1 exonuclease, EC 3.1.-.-" MYG1 C12orf10 Homo sapiens (Human) locomotory exploration behavior [GO:0035641] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclease activity [GO:0004518]; locomotory exploration behavior [GO:0035641] GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0035641 nuclease activity [GO:0004518] FLRGLLTLLLPPPPLYTR 0.99573 -12.128 0 0 0 0 0 0 0 0 0 0 0 17.1374 0 0 0 0 12.7341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3284 0 0 13.6602 0 0 0 0 0 0 10.143 0 0 0 0 0 0 13.5583 0 0 0 13.3339 0 0 0 0 0 10.1097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3567 0 13.1685 0 Q9Y3C4 TPRKB_HUMAN EKC/KEOPS complex subunit TPRKB (PRPK-binding protein) (TP53RK-binding protein) TPRKB CGI-121 My019 Homo sapiens (Human) telomere maintenance via recombination [GO:0000722]; tRNA threonylcarbamoyladenosine modification [GO:0002949] cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; telomere maintenance via recombination [GO:0000722]; tRNA threonylcarbamoyladenosine modification [GO:0002949] GO:0000408; GO:0000722; GO:0002949; GO:0005634; GO:0005737; GO:0005829; GO:0019901 protein kinase binding [GO:0019901] AVHLYKLGKMK 0.99573 -12.105 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UPU7 TBD2B_HUMAN TBC1 domain family member 2B TBC1D2B KIAA1055 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897] cytosol [GO:0005829]; early endosome [GO:0005769] cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; endocytosis [GO:0006897] GO:0005096; GO:0005769; GO:0005829; GO:0006897; GO:0090630 GTPase activator activity [GO:0005096] DIIGSYK 0.99574 -32.897 0 0 0 0 15.8833 13.6672 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7068 11.9253 13.0383 0 11.8872 0 11.7426 0 0 10.6363 0 0 10.5011 0 0 14.5266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0515 0 0 10.5969 0 0 0 0 0 0 0 0 0 0 0 19.0501 10.8065 0 0 0 0 0 0 19.0709 14.1386 13.9871 13.9582 0 14.2161 13.784 14.971 15.103 0 15.7646 0 0 0 0 0 0 0 0 0 0 0 14.3839 20.1264 0 14.3889 13.7064 17.1749 0 15.8869 14.8295 0 13.8589 14.7155 14.3228 0 0 12.6104 0 0 0 0 0 14.4145 14.1439 14.2212 14.896 16.417 14.6328 14.8777 16.3087 14.5739 19.5139 16.0195 0 15.1208 0 14.3738 14.0776 15.4876 0 0 0 0 0 14.8528 0 0 0 15.0959 0 0 0 0 0 0 14.5776 0 0 14.4328 14.6017 0 14.4637 12.1378 12.6636 0 12.8291 0 0 12.7364 0 0 0 0 12.5399 0 12.1591 0 13.5986 13.5857 0 12.7169 0 0 0 0 Q9Y238 DLEC1_HUMAN "Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1, DLC-1)" DLEC1 DLC1 Homo sapiens (Human) cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829] cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283] GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487 alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631] CYPDKETAFSIMPR 0.99574 -33.235 0 0 0 0 0 0 0 10.7107 12.4872 0 0 0 0 0 0 0 0 10.7224 0 0 0 0 11.4737 0 12.0457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0212 0 0 0 0 0 0 0 10.1128 0 0 0 0 0 0 15.8237 0 0 0 0 0 0 0 0 0 0 0 13.4987 0 0 0 0 14.7861 14.9113 14.7178 15.6619 0 15.0035 14.1035 13.6314 16.1556 14.5599 0 0 0 14.947 16.503 15.1552 15.8394 16.2629 14.5434 14.8542 14.3281 12.7435 16.3077 0 0 16.3384 12.2203 16.6063 16.6704 15.8147 16.9932 15.2955 16.8855 16.822 15.8273 16.1506 16.9221 0 14.7531 14.367 15.7 0 15.5297 15.718 15.8549 16.8445 16.3973 16.9402 13.0028 16.7221 16.0249 15.208 16.3376 14.0055 16.4126 15.1307 0 11.367 16.3614 15.8825 13.7647 14.9638 16.0359 15.0983 0 16.2594 15.011 15.9448 16.4147 13.2197 0 15.5127 15.648 13.8876 0 16.4927 15.3441 0 0 14.6914 13.8949 14.7407 0 0 0 12.1594 10.6421 0 0 0 0 0 0 0 0 13.8709 0 14.1599 15.6251 14.6017 0 0 0 11.9232 13.6601 0 O14804 TAAR5_HUMAN "Trace amine-associated receptor 5, TaR-5, Trace amine receptor 5, hTaar5 (Putative neurotransmitter receptor)" TAAR5 PNR Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of chemical stimulus [GO:0007606]; signal transduction [GO:0007165] GO:0001594; GO:0004930; GO:0005887; GO:0007165; GO:0007186; GO:0007606; GO:1990081 G protein-coupled receptor activity [GO:0004930]; trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081] FTVRVALR 0.99574 -11.748 0 0 0 0 0 0 0 11.0647 0 12.6237 0 0 0 0 0 0 0 0 0 0 0 12.6285 0 0 0 0 0 0 0 0 9.9691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9175 0 12.6521 0 13.6539 0 0 0 13.4829 13.6735 13.3167 12.9869 0 0 0 13.6738 0 13.576 0 0 0 0 0 0 0 0 12.1194 15.696 15.2116 13.5079 0 0 0 0 0 0 13.5744 0 0 0 0 0 13.3004 13.5058 0 0 0 0 13.7789 12.8833 0 0 0 0 0 0 14.0695 0 13.9376 0 13.6887 0 13.8998 0 0 0 0 0 14.8916 13.0243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9547 0 10.9997 0 0 0 0 0 0 14.8732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75976 CBPD_HUMAN "Carboxypeptidase D, EC 3.4.17.22 (Metallocarboxypeptidase D) (gp180)" CPD Homo sapiens (Human) peptide metabolic process [GO:0006518]; protein processing [GO:0016485] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485] GO:0004181; GO:0004185; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0016020; GO:0016021; GO:0016485; GO:0070062 metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270] ALIEWIR 0.99574 -33.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5199 0 0 0 0 0 0 0 0 15.1644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.121 0 0 0 0 0 0 14.3256 0 13.547 15.8082 13.0638 15.9445 16.2206 15.8328 15.5438 15.7289 0 15.2316 13.6196 16.136 0 0 16.2253 15.2482 0 14.6597 0 0 0 13.2424 14.6545 0 0 0 0 0 0 0 0 15.7966 16.4091 12.6929 0 0 0 12.4631 13.2013 0 12.4857 0 0 0 10.1529 13.5923 0 0 0 12.8104 14.3316 0 0 14.861 0 13.2032 0 0 0 0 0 0 0 0 0 12.991 0 0 0 0 0 0 0 0 14.6246 13.0833 0 0 0 0 0 0 12.9793 0 0 0 0 0 0 14.246 0 0 0 0 0 0 0 0 O95671 ASML_HUMAN "Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase, dTTPase/UTPase, EC 3.6.1.9 (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase, Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein, ASMTL, EC 2.1.1.- ]" ASMTL Homo sapiens (Human) methylation [GO:0032259]; nucleotide metabolic process [GO:0009117] cytosol [GO:0005829] cytosol [GO:0005829]; dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; UTP diphosphatase activity [GO:0036221]; methylation [GO:0032259]; nucleotide metabolic process [GO:0009117] GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0035529; GO:0036218; GO:0036221; GO:0047429 dTTP diphosphatase activity [GO:0036218]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; UTP diphosphatase activity [GO:0036221] AADIASKVDASACGMER 0.99574 -11.75 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3363 0 0 0 0 0 0 0 0 0 0 0 0 14.0649 14.0399 0 0 0 11.2693 0 0 0 0 0 0 14.0776 0 0 0 0 0 0 0 0 0 11.9143 0 0 0 0 18.9637 0 0 0 0 12.6984 0 0 0 0 0 0 0 0 0 0 13.3802 0 0 0 0 0 0 0 0 13.468 0 0 0 14.3197 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0132 0 0 0 0 0 0 10.9334 0 0 0 0 0 0 0 0 0 0 0 10.09 0 0 0 0 0 O95785 WIZ_HUMAN Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803) WIZ ZNF803 Homo sapiens (Human) positive regulation of nuclear cell cycle DNA replication [GO:0010571]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357] extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0001222; GO:0005634; GO:0005654; GO:0006357; GO:0010571; GO:0030496; GO:0044877; GO:0046872; GO:0050821; GO:0070062; GO:1990226 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]" AADGGER 0.99574 -33.199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4987 0 0 0 0 0 0 0 0 0 12.8736 0 0 0 0 0 0 14.5943 0 0 0 0 0 0 0 0 13.843 0 14.4508 0 13.5647 14.5191 0 0 0 0 13.1747 0 10.9723 0 0 12.3599 0 0 0 0 0 12.9234 0 0 0 0 14.6613 0 0 0 11.4849 0 0 13.8028 0 0 0 14.1176 0 0 0 13.6983 10.3963 0 0 13.0911 0 12.1822 14.9662 12.4629 0 0 0 0 0 11.208 0 0 0 13.5632 0 0 11.2689 0 0 0 0 0 0 0 0 0 0 0 10.4975 10.933 0 0 0 0 12.3428 0 0 0 0 14.2699 0 0 0 11.4496 0 0 0 0 10.7572 P01106 MYC_HUMAN "Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39, bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64)" MYC BHLHE39 Homo sapiens (Human) "branching involved in ureteric bud morphogenesis [GO:0001658]; cellular iron ion homeostasis [GO:0006879]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; energy reserve metabolic process [GO:0006112]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell division [GO:0051782]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxygen transport [GO:0015671]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA methylation [GO:1905643]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of metanephric cap mesenchymal cell proliferation [GO:0090096]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-DNA complex disassembly [GO:0032986]; regulation of cell cycle process [GO:0010564]; regulation of gene expression [GO:0010468]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to growth factor [GO:0070848]; response to xenobiotic stimulus [GO:0009410]" chromatin [GO:0000785]; Myc-Max complex [GO:0071943]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571] "chromatin [GO:0000785]; Myc-Max complex [GO:0071943]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator binding [GO:0001221]; branching involved in ureteric bud morphogenesis [GO:0001658]; cellular iron ion homeostasis [GO:0006879]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; energy reserve metabolic process [GO:0006112]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast apoptotic process [GO:0044346]; G1/S transition of mitotic cell cycle [GO:0000082]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell division [GO:0051782]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxygen transport [GO:0015671]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA methylation [GO:1905643]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of metanephric cap mesenchymal cell proliferation [GO:0090096]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein-DNA complex disassembly [GO:0032986]; regulation of cell cycle process [GO:0010564]; regulation of gene expression [GO:0010468]; regulation of somatic stem cell population maintenance [GO:1904672]; regulation of telomere maintenance [GO:0032204]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to growth factor [GO:0070848]; response to xenobiotic stimulus [GO:0009410]" GO:0000082; GO:0000122; GO:0000165; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001221; GO:0001227; GO:0001228; GO:0001658; GO:0002053; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006112; GO:0006338; GO:0006357; GO:0006879; GO:0006974; GO:0008284; GO:0009410; GO:0010332; GO:0010468; GO:0010564; GO:0010628; GO:0015671; GO:0032204; GO:0032873; GO:0032986; GO:0032991; GO:0034644; GO:0043066; GO:0043280; GO:0044346; GO:0044877; GO:0045656; GO:0045893; GO:0045944; GO:0046983; GO:0048146; GO:0048147; GO:0050679; GO:0051276; GO:0051782; GO:0051973; GO:0070371; GO:0070848; GO:0070888; GO:0071456; GO:0071466; GO:0071943; GO:0090096; GO:0090571; GO:0140297; GO:1902255; GO:1902895; GO:1904672; GO:1905643; GO:2000573; GO:2001022 "core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator binding [GO:0001221]" APKVVILKK 0.99574 -12.284 0 0 0 0 0 0 0 0 0 0 14.9523 0 11.8157 0 0 15.3594 0 14.3166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1844 0 0 0 14.027 0 0 0 0 0 0 0 0 0 10.1892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2728 0 0 0 0 0 0 0 0 13.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8932 0 0 14.3195 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0637 0 0 0 0 P22079 PERL_HUMAN "Lactoperoxidase, LPO, EC 1.11.1.7 (Salivary peroxidase, SPO)" LPO SAPX Homo sapiens (Human) defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615] basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393]; defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979] GO:0001580; GO:0004601; GO:0005576; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0046872; GO:0070062 heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393] ASEHILLATSHTLFLR 0.99574 -12.259 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9584 0 14.4581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3156 0 0 0 0 0 0 0 0 0 0 0 0 14.4738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0504 0 0 0 0 0 0 0 0 0 0 0 0 0 P24468 COT2_HUMAN "COUP transcription factor 2, COUP-TF2 (Apolipoprotein A-I regulatory protein 1, ARP-1) (COUP transcription factor II, COUP-TF II) (Nuclear receptor subfamily 2 group F member 2)" NR2F2 ARP1 TFCOUP2 Homo sapiens (Human) "anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; female gonad development [GO:0008585]; fertilization [GO:0009566]; forebrain development [GO:0030900]; interneuron migration [GO:1904936]; lymphatic endothelial cell fate commitment [GO:0060838]; maternal placenta development [GO:0001893]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; placenta blood vessel development [GO:0060674]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; radial pattern formation [GO:0009956]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; skeletal muscle tissue development [GO:0007519]; trophoblast giant cell differentiation [GO:0060707]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel morphogenesis [GO:0048514]; cell differentiation [GO:0030154]; female gonad development [GO:0008585]; fertilization [GO:0009566]; forebrain development [GO:0030900]; interneuron migration [GO:1904936]; lymphatic endothelial cell fate commitment [GO:0060838]; maternal placenta development [GO:0001893]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; placenta blood vessel development [GO:0060674]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; radial pattern formation [GO:0009956]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; skeletal muscle tissue development [GO:0007519]; trophoblast giant cell differentiation [GO:0060707]" GO:0000122; GO:0000978; GO:0001893; GO:0001937; GO:0001972; GO:0003084; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0007519; GO:0008270; GO:0008585; GO:0009566; GO:0009952; GO:0009956; GO:0010596; GO:0030154; GO:0030900; GO:0032355; GO:0042803; GO:0043565; GO:0045736; GO:0045892; GO:0045893; GO:0045944; GO:0048514; GO:0048856; GO:0060674; GO:0060707; GO:0060838; GO:1904936 DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] AEPYPTSR 0.99574 -10.285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5816 0 0 0 0 0 0 0 16.0163 0 0 13.6707 0 0 0 14.7112 0 0 0 0 0 0 0 0 0 13.4886 13.1871 0 0 0 0 0 12.7929 0 13.729 14.9728 12.5847 0 0 0 0 0 0 0 13.0681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8446 0 14.7989 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12965 MYO1E_HUMAN Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E) MYO1E MYO1C Homo sapiens (Human) actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091]; actin filament organization [GO:0007015]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0001570; GO:0001701; GO:0003094; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005903; GO:0005912; GO:0006807; GO:0006897; GO:0007015; GO:0015629; GO:0016459; GO:0016887; GO:0030050; GO:0030136; GO:0032437; GO:0032836; GO:0035091; GO:0035166; GO:0048008; GO:0051015; GO:0070062; GO:0072015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol binding [GO:0035091] CTPHYIRCIKPNETK 0.99574 -33.288 0 0 0 0 0 0 0 0 14.9253 15.3453 0 0 0 0 14.3339 13.9383 0 11.6794 0 14.2847 14.7779 14.6427 0 0 0 0 14.5956 14.3653 13.4114 13.9964 0 0 14.0838 15.409 15.4077 0 0 14.3113 0 0 0 0 0 0 0 0 11.228 14.5528 13.8626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.433 0 0 14.1309 14.4559 0 14.1772 15.8012 13.965 14.3816 16.4116 15.7513 14.0419 0 0 0 13.4712 14.0056 13.951 0 0 0 0 13.1419 0 0 14.0997 15.1958 13.3714 15.5863 0 14.1118 15.8605 14.8126 16.7568 15.9882 0 14.4929 14.1941 16.2605 16.5187 16.4065 16.1152 0 0 0 16.6755 16.6361 16.9572 15.708 16.1615 14.5732 0 15.849 15.0611 15.8627 16.6424 15.9701 16.4589 15.6814 16.5588 16.6015 14.6533 15.6031 16.194 15.747 16.4107 14.412 15.4101 16.448 13.049 15.5965 14.0331 14.1526 16.5372 14.115 16.3105 15.9557 15.2275 0 11.5186 0 0 14.2383 0 13.909 14.9442 14.6982 13.0468 16.3672 15.0125 15.5838 14.8248 13.2408 16.2936 0 13.7694 0 0 13.3201 0 15.2033 15.3322 13.7976 14.7312 15.7408 0 12.7389 0 0 15.4745 0 Q86UL8 MAGI2_HUMAN "Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1, AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2, MAGI-2)" MAGI2 ACVRINP1 AIP1 KIAA0705 Homo sapiens (Human) cellular response to nerve growth factor stimulus [GO:1990090]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; planar cell polarity pathway involved in axis elongation [GO:0003402]; podocyte development [GO:0072015]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202] bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; planar cell polarity pathway involved in axis elongation [GO:0003402]; podocyte development [GO:0072015]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395] GO:0001750; GO:0001917; GO:0002092; GO:0003402; GO:0005634; GO:0005737; GO:0005770; GO:0005814; GO:0005886; GO:0005911; GO:0005923; GO:0007165; GO:0007399; GO:0008285; GO:0010976; GO:0014069; GO:0019902; GO:0030159; GO:0030336; GO:0030425; GO:0031697; GO:0032516; GO:0032926; GO:0032991; GO:0036057; GO:0038180; GO:0043113; GO:0045202; GO:0046332; GO:0048471; GO:0051898; GO:0060395; GO:0070699; GO:0072015; GO:0072583; GO:0097546; GO:1990090 beta-1 adrenergic receptor binding [GO:0031697]; phosphatase binding [GO:0019902]; signaling receptor complex adaptor activity [GO:0030159]; SMAD binding [GO:0046332]; type II activin receptor binding [GO:0070699] AIELIKSGGRR 0.99574 -11.768 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0315 0 0 0 0 0 0 0 0 0 0 0 0 13.7795 0 0 0 0 0 0 0 0 13.1175 0 0 0 16.2384 0 0 13.3355 0 17.2495 13.4422 0 0 0 0 14.0208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4402 0 0 0 0 0 0 0 14.1396 12.4319 0 0 0 0 0 0 0 0 0 0 0 0 13.9072 0 0 0 0 13.676 0 0 0 0 0 10.6694 0 14.7232 0 0 0 12.7624 0 0 0 0 0 0 12.6942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N752 KC1AL_HUMAN "Casein kinase I isoform alpha-like, CKI-alpha-like, EC 2.7.11.1 (CK1)" CSNK1A1L Homo sapiens (Human) negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055] GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0007165; GO:0016055; GO:0018105; GO:0090090; GO:0106310 ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] NKNNVKDN 0.99574 -11.71 0 0 0 0 0 0 0 0 13.7046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9I5 FADS6_HUMAN "Fatty acid desaturase 6, EC 1.14.19.-" FADS6 FP18279 Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; lipid metabolic process [GO:0006629] integral component of membrane [GO:0016021] "integral component of membrane [GO:0016021]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]; fatty acid biosynthetic process [GO:0006633]; lipid metabolic process [GO:0006629]" GO:0006629; GO:0006633; GO:0016021; GO:0016717 "oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]" LRKVELGTALR 0.99574 -9.5226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0415 0 0 0 0 0 0 0 0 0 0 12.7826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9904 12.4556 0 0 0 12.946 0 12.8916 0 0 12.6793 Q8N9Z2 CC71L_HUMAN Coiled-coil domain-containing protein 71L CCDC71L C7orf74 Homo sapiens (Human) cellular lipid metabolic process [GO:0044255]; positive regulation of fat cell differentiation [GO:0045600] cellular lipid metabolic process [GO:0044255]; positive regulation of fat cell differentiation [GO:0045600] GO:0044255; GO:0045600 AAAARRR 0.99574 -33.35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0774 0 0 0 0 0 0 0 0 0 13.4383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5845 0 0 0 0 13.7809 0 0 0 0 13.7545 0 0 0 0 0 0 0 0 0 0 18.5052 0 Q9BUP3 HTAI2_HUMAN "Oxidoreductase HTATIP2, EC 1.1.1.- (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2)" HTATIP2 CC3 TIP30 Homo sapiens (Human) angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; negative regulation of apoptotic process [GO:0043066]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; negative regulation of apoptotic process [GO:0043066]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0001525; GO:0003713; GO:0004674; GO:0005634; GO:0005635; GO:0005737; GO:0005829; GO:0006357; GO:0006915; GO:0016020; GO:0016491; GO:0030154; GO:0043066; GO:0043068; GO:0045765; GO:0045944; GO:0046777; GO:0051170 oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713] AHGSLKP 0.99574 -9.5204 0 0 0 0 0 0 0 0 14.1423 0 0 0 0 0 0 0 14.5967 0 0 0 0 0 14.0997 0 15.6687 0 0 13.4704 0 0 0 0 0 0 0 0 0 0 0 14.5589 0 0 0 0 13.8836 0 0 0 0 0 0 0 9.89209 0 12.4034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5224 Q9H0M4 ZCPW1_HUMAN Zinc finger CW-type PWWP domain protein 1 ZCWPW1 Homo sapiens (Human) cell differentiation [GO:0030154]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; positive regulation of DNA recombination [GO:0045911]; positive regulation of double-strand break repair [GO:2000781]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; nucleus [GO:0005634] chromosome [GO:0005694]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; positive regulation of DNA recombination [GO:0045911]; positive regulation of double-strand break repair [GO:2000781]; spermatogenesis [GO:0007283] GO:0005634; GO:0005694; GO:0007127; GO:0007129; GO:0007283; GO:0008270; GO:0008327; GO:0030154; GO:0035064; GO:0045911; GO:2000781 methyl-CpG binding [GO:0008327]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] EVRTVPKNLGLSACK 0.99574 -32.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5437 0 0 11.4976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.733 14.6593 13.745 0 0 0 0 0 11.8429 0 0 0 0 0 0 12.8288 0 0 10.9301 0 0 10.0098 0 0 12.339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95425 SVIL_HUMAN Supervillin (Archvillin) (p205/p250) SVIL Homo sapiens (Human) actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519] actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102] "actin cytoskeleton [GO:0015629]; cell projection [GO:0042995]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519]" GO:0002102; GO:0005546; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0007519; GO:0008154; GO:0015629; GO:0030496; GO:0032154; GO:0032467; GO:0036449; GO:0042995; GO:0043034; GO:0051014; GO:0051015; GO:0051016 "actin filament binding [GO:0051015]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]" AEEEEGEGEGEEKEEDVCFTEALEQSK 0.99575 -12.397 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8726 0 0 0 0 0 12.4479 0 0 0 0 10.7683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7965 0 14.5313 0 17.1958 0 17.8611 10.8841 0 0 0 0 0 0 0 0 0 0 0 0 13.7448 13.8261 13.706 0 0 0 14.107 0 0 13.1425 0 0 0 14.5716 15.681 11.2922 0 0 0 0 0 11.2066 0 0 0 12.5192 14.3285 0 0 0 0 0 11.778 0 12.4633 0 0 0 0 0 13.5555 12.3289 0 0 12.2869 11.3199 0 0 0 0 0 0 12.5261 0 12.9693 0 0 16.5071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7206 0 0 0 0 0 0 O15018 PDZD2_HUMAN PDZ domain-containing protein 2 (Activated in prostate cancer protein) (PDZ domain-containing protein 3) [Cleaved into: Processed PDZ domain-containing protein 2 ] PDZD2 AIPC KIAA0300 PDZK3 Homo sapiens (Human) cell adhesion [GO:0007155] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155] GO:0005576; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0007155; GO:0034451; GO:0043231 ANDPCDLDSR 0.99575 -33.94 0 0 0 0 0 0 0 10.9294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.516 0 0 0 0 15.7958 0 0 15.5275 0 12.1821 0 0 0 0 0 0 0 0 0 13.7359 13.2795 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1859 12.916 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4468 0 0 0 12.7609 10.916 0 13.4489 0 14.7387 0 0 11.7447 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8495 0 0 0 0 0 0 15.0954 0 13.2281 13.8164 0 11.3523 13.0033 0 14.2438 14.3387 0 0 11.7553 0 0 0 0 0 0 12.6119 0 0 0 0 0 0 0 0 0 11.1765 0 0 11.2664 0 0 11.5539 0 0 0 13.8122 0 0 0 0 0 0 O15061 SYNEM_HUMAN Synemin (Desmuslin) SYNM DMN KIAA0353 SYN Homo sapiens (Human) fast-twitch skeletal muscle fiber contraction [GO:0031443]; intermediate filament cytoskeleton organization [GO:0045104] adherens junction [GO:0005912]; costamere [GO:0043034]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofilament cytoskeleton [GO:0060053]; sarcolemma [GO:0042383] adherens junction [GO:0005912]; costamere [GO:0043034]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; neurofilament cytoskeleton [GO:0060053]; sarcolemma [GO:0042383]; intermediate filament binding [GO:0019215]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166]; fast-twitch skeletal muscle fiber contraction [GO:0031443]; intermediate filament cytoskeleton organization [GO:0045104] GO:0005200; GO:0005882; GO:0005912; GO:0008307; GO:0017166; GO:0019215; GO:0031443; GO:0042383; GO:0043034; GO:0045104; GO:0045111; GO:0060053 intermediate filament binding [GO:0019215]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; vinculin binding [GO:0017166] ATLTLAMADWLR 0.99575 -33.893 0 0 0 0 0 0 0 0 0 14.1294 0 0 0 0 0 9.79048 0 0 0 0 0 0 0 0 12.5943 11.3812 0 0 0 0 12.9759 0 0 10.3208 0 0 0 0 12.9669 0 0 10.9522 12.7275 0 0 0 0 0 0 0 0 0 0 0 0 0 9.7225 0 0 0 0 0 0 0 0 0 14.4633 0 14.1853 0 0 0 0 0 0 0 10.2856 0 10.7683 10.591 0 0 0 12.5378 0 0 0 14.7437 0 0 0 13.4235 14.4821 11.8223 0 15.6933 0 0 0 0 0 0 11.4452 14.0625 0 0 0 0 10.2624 0 0 11.2036 10.7878 10.9441 0 0 0 0 0 0 0 0 12.9363 0 0 12.5388 0 0 0 0 0 0 0 0 0 0 0 0 11.3607 0 0 0 0 0 0 0 0 0 0 0 12.8988 0 0 0 0 0 0 15.3413 14.5373 14.5313 12.572 14.4863 12.6222 14.6917 11.9415 0 14.7494 0 14.2723 11.6204 0 0 0 0 0 0 0 0 0 0 O43820 HYAL3_HUMAN "Hyaluronidase-3, Hyal-3, EC 3.2.1.35 (Hyaluronoglucosaminidase-3) (Lung carcinoma protein 3, LuCa-3)" HYAL3 LUCA3 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; negative regulation of ovarian follicle development [GO:2000355]; ovarian follicle atresia [GO:0001552]; penetration of zona pellucida [GO:0007341]; positive regulation of acrosomal vesicle exocytosis [GO:2000368]; response to antibiotic [GO:0046677]; response to virus [GO:0009615] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225] acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; hyaluronoglucuronidase activity [GO:0033906]; hyalurononglucosaminidase activity [GO:0004415]; carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; negative regulation of ovarian follicle development [GO:2000355]; ovarian follicle atresia [GO:0001552]; penetration of zona pellucida [GO:0007341]; positive regulation of acrosomal vesicle exocytosis [GO:2000368]; response to antibiotic [GO:0046677]; response to virus [GO:0009615] GO:0001552; GO:0001669; GO:0002080; GO:0004415; GO:0005576; GO:0005764; GO:0005769; GO:0005783; GO:0005886; GO:0005975; GO:0006954; GO:0007341; GO:0009615; GO:0030214; GO:0031410; GO:0033906; GO:0046677; GO:0051216; GO:0071347; GO:0071356; GO:0071493; GO:0097225; GO:2000355; GO:2000368 hyaluronoglucuronidase activity [GO:0033906]; hyalurononglucosaminidase activity [GO:0004415] AAMACSHQR 0.99575 -11.837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1767 0 0 15.001 0 0 0 0 0 0 0 14.4459 0 0 0 0 0 0 0 0 0 0 13.2962 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7398 0 0 0 0 0 0 0 0 0 0 12.9329 0 0 0 0 11.9895 0 0 0 0 0 0 0 0 0 13.0397 0 0 0 0 13.3108 0 0 0 0 12.0755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9231 0 0 0 0 0 0 12.4263 0 0 0 0 0 0 0 13.6619 0 0 0 0 0 0 0 0 0 13.656 0 0 0 0 0 0 0 O43933 PEX1_HUMAN Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1) PEX1 Homo sapiens (Human) microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; microtubule-based peroxisome localization [GO:0060152]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625] GO:0005524; GO:0005737; GO:0005777; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0008022; GO:0016558; GO:0016887; GO:0044877; GO:0060152; GO:0070062 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877] GFLPASLRSVNLHKPR 0.99575 -10.342 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3316 0 0 0 0 0 0 0 0 0 0 15.1656 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0522 0 0 0 0 0 0 14.3382 0 13.0584 0 0 0 0 0 0 0 0 0 0 0 12.7457 0 0 0 0 13.0983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0527 14.2076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8535 0 0 0 0 0 0 12.535 0 0 0 0 0 O75439 MPPB_HUMAN "Mitochondrial-processing peptidase subunit beta, EC 3.4.24.64 (Beta-MPP) (P-52)" PMPCB MPPB Homo sapiens (Human) mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627] mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein processing involved in protein targeting to mitochondrion [GO:0006627] GO:0004222; GO:0005739; GO:0005743; GO:0006627; GO:0006851; GO:0017087; GO:0046872 metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222] FHFGDSLCTHKGEIPALPPCK 0.99575 -12.369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1347 0 14.3197 14.9387 0 0 0 0 0 15.2742 0 0 10.4416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94218 0 0 0 0 0 0 14.0352 0 0 13.545 0 0 0 0 0 12.1799 0 12.9245 0 0 13.0903 13.1767 13.3794 0 0 0 12.6075 12.4789 0 0 0 13.199 13.272 0 13.373 0 0 0 0 0 0 0 0 13.341 14.0792 13.6172 0 13.0972 13.2223 13.3446 13.1652 0 12.6566 10.4887 0 0 0 12.5762 13.6846 14.5221 0 0 14.5907 0 11.8882 0 0 0 0 14.1918 12.4382 0 0 0 0 0 0 14.0265 0 13.2337 12.4783 0 0 0 0 0 0 0 11.7959 11.673 0 0 11.9115 0 0 0 10.1401 0 12.6486 0 14 0 0 0 0 0 O75717 WDHD1_HUMAN "WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1, And-1)" WDHD1 AND1 Homo sapiens (Human) DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278] cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; mitotic cell cycle [GO:0000278] GO:0000278; GO:0003677; GO:0003682; GO:0005654; GO:0005737; GO:0006261; GO:0006281; GO:0043596 chromatin binding [GO:0003682]; DNA binding [GO:0003677] AKENLNLSKK 0.99575 -11.796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4166 0 13.837 0 0 0 0 0 0 0 0 17.7037 0 0 17.5815 0 0 0 0 0 0 17.6259 17.7037 0 17.6848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1403 0 0 0 0 0 12.7967 0 15.1105 0 0 13.8908 14.3824 0 0 0 0 0 0 0 0 0 14.4075 0 0 0 0 0 0 0 13.1612 18.5664 14.3469 0 0 14.4161 0 0 0 0 0 0 0 0 0 0 0 0 14.1889 13.9588 13.9232 0 0 0 0 0 0 0 15.3369 0 0 0 0 0 0 0 13.1791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7472 0 0 0 0 13.8361 0 0 0 0 0 18.6231 0 15.4733 0 P01591 IGJ_HUMAN Immunoglobulin J chain (Joining chain of multimeric IgA and IgM) JCHAIN IGCJ IGJ Homo sapiens (Human) adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; glomerular filtration [GO:0003094]; humoral immune response [GO:0006959]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of respiratory burst [GO:0060267]; protein-containing complex assembly [GO:0065003]; retina homeostasis [GO:0001895] blood microparticle [GO:0072562]; dimeric IgA immunoglobulin complex [GO:0071750]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; monomeric IgA immunoglobulin complex [GO:0071748]; pentameric IgM immunoglobulin complex [GO:0071756]; secretory dimeric IgA immunoglobulin complex [GO:0071752]; secretory IgA immunoglobulin complex [GO:0071751] blood microparticle [GO:0072562]; dimeric IgA immunoglobulin complex [GO:0071750]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; monomeric IgA immunoglobulin complex [GO:0071748]; pentameric IgM immunoglobulin complex [GO:0071756]; secretory dimeric IgA immunoglobulin complex [GO:0071752]; secretory IgA immunoglobulin complex [GO:0071751]; antigen binding [GO:0003823]; IgA binding [GO:0019862]; immunoglobulin receptor binding [GO:0034987]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; glomerular filtration [GO:0003094]; humoral immune response [GO:0006959]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of respiratory burst [GO:0060267]; protein-containing complex assembly [GO:0065003]; retina homeostasis [GO:0001895] GO:0001895; GO:0002250; GO:0003094; GO:0003823; GO:0005576; GO:0005615; GO:0006955; GO:0006959; GO:0019731; GO:0019862; GO:0030674; GO:0034987; GO:0042803; GO:0045087; GO:0060267; GO:0065003; GO:0070062; GO:0071748; GO:0071750; GO:0071751; GO:0071752; GO:0071756; GO:0072562 antigen binding [GO:0003823]; IgA binding [GO:0019862]; immunoglobulin receptor binding [GO:0034987]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674] CARITSRIIR 0.99575 -11.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6317 0 0 0 P26436 ASPX_HUMAN Acrosomal protein SP-10 (Acrosomal vesicle protein 1) ACRV1 Homo sapiens (Human) spermatogenesis [GO:0007283] acrosomal vesicle [GO:0001669] acrosomal vesicle [GO:0001669]; spermatogenesis [GO:0007283] GO:0001669; GO:0007283 KIFEGGK 0.99575 -9.8188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5702 0 0 0 0 0 12.9372 0 0 0 0 0 0 0 12.7279 0 0 0 0 0 0 0 13.637 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0992 0 12.889 0 0 0 13.1189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42702 LIFR_HUMAN "Leukemia inhibitory factor receptor, LIF receptor, LIF-R (CD antigen CD118)" LIFR Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]; cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097] GO:0004896; GO:0004923; GO:0005127; GO:0005886; GO:0005887; GO:0007166; GO:0008284; GO:0009897; GO:0019221; GO:0019838; GO:0019955; GO:0034097; GO:0038165; GO:0043235; GO:0048861; GO:0070062; GO:0070120 ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923] APSGTGR 0.99575 -33.918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6028 11.9392 0 0 11.5149 0 0 0 12.2944 12.4271 0 0 0 0 0 0 0 0 0 0 0 14.0987 0 0 13.4286 0 0 13.3177 14.4732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8376 0 0 13.4493 0 0 0 0 0 0 11.8011 0 13.205 0 0 0 0 0 0 0 0 0 0 0 0 13.454 14.365 13.0607 0 0 0 0 0 0 0 0 14.2211 0 0 0 13.6459 0 0 0 0 14.1427 13.8078 10.8222 14.338 13.82 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P43246 MSH2_HUMAN "DNA mismatch repair protein Msh2, hMSH2 (MutS protein homolog 2)" MSH2 Homo sapiens (Human) B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204] "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]" GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008022; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0019899; GO:0019901; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0051096; GO:0071168; GO:0140664 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]" AGNKASK 0.99575 -33.858 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.771 0 13.8681 0 0 0 0 0 0 0 0 0 16.2946 0 0 0 12.8526 0 0 0 0 0 0 17.2149 0 0 0 12.7226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5217 0 0 0 0 0 0 13.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.666 0 0 0 0 0 0 0 15.2571 0 0 0 0 0 0 14.6007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.716 0 0 0 0 Q0VAM2 RGF1B_HUMAN Ras-GEF domain-containing family member 1B (GPI gamma-4) RASGEF1B GPIG4 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] early endosome [GO:0005769]; late endosome [GO:0005770]; midbody [GO:0030496]; plasma membrane [GO:0005886] early endosome [GO:0005769]; late endosome [GO:0005770]; midbody [GO:0030496]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265] GO:0005085; GO:0005769; GO:0005770; GO:0005886; GO:0007265; GO:0030496; GO:0043547 guanyl-nucleotide exchange factor activity [GO:0005085] FWELAKQVSEFMTWKQVECPFER 0.99575 -11.794 0 0 0 0 0 0 0 0 0 13.2955 0 0 0 0 0 0 0 0 0 0 0 12.8887 0 12.7077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.458 0 0 0 0 0 0 0 0 12.4493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0579 0 0 0 13.2928 0 0 0 0 0 0 0 0 14.7333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4877 0 12.9852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13449 LSAMP_HUMAN "Limbic system-associated membrane protein, LSAMP (IgLON family member 3)" LSAMP IGLON3 LAMP Homo sapiens (Human) cell adhesion [GO:0007155]; nervous system development [GO:0007399] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; nervous system development [GO:0007399] GO:0005576; GO:0005829; GO:0005886; GO:0007155; GO:0007399; GO:0031225 KQLPLVLLRLLCLLPTGLPVR 0.99575 -11.819 0 0 0 10.8058 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1821 0 0 12.3779 0 0 0 0 0 0 0 0 0 9.91383 0 0 0 0 0 0 0 0 0 0 13.798 0 10.6079 0 0 0 0 0 0 15.3842 0 0 0 0 0 11.5741 0 0 0 0 0 0 0 0 0 0 0 14.3778 0 0 0 0 10.9259 0 0 0 0 11.3069 14.5702 0 0 13.5765 0 0 12.8513 11.5158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4565 Q15172 2A5A_HUMAN "Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha, PR61alpha) (PP2A B subunit isoform R5-alpha)" PPP2R5A Homo sapiens (Human) negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165] "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]" "centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]" GO:0000159; GO:0000775; GO:0004721; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006470; GO:0007165; GO:0016020; GO:0019888; GO:0019900; GO:0030018; GO:0031430; GO:0035307; GO:0072542; GO:0090219; GO:1903077 kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888] FLGLRAFIR 0.99575 -9.8345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8653 13.7178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0208 0 0 0 0 0 0 0 0 0 0 16.5042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9585 0 0 0 0 16.5417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8758 0 0 0 0 0 0 0 Q15223 NECT1_HUMAN "Nectin-1 (Herpes virus entry mediator C, Herpesvirus entry mediator C, HveC) (Herpesvirus Ig-like receptor, HIgR) (Nectin cell adhesion molecule 1) (Poliovirus receptor-related protein 1) (CD antigen CD111)" NECTIN1 HVEC PRR1 PVRL1 Homo sapiens (Human) axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune response [GO:0006955]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; regulation of synapse assembly [GO:0051963]; retina development in camera-type eye [GO:0060041]; viral entry into host cell [GO:0046718]; virion attachment to host cell [GO:0019062] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone membrane [GO:0032584]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone membrane [GO:0032584]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune response [GO:0006955]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; regulation of synapse assembly [GO:0051963]; retina development in camera-type eye [GO:0060041]; viral entry into host cell [GO:0046718]; virion attachment to host cell [GO:0019062] GO:0001618; GO:0002089; GO:0002934; GO:0005576; GO:0005886; GO:0005912; GO:0006826; GO:0006955; GO:0007155; GO:0007156; GO:0007157; GO:0007411; GO:0015026; GO:0016020; GO:0016021; GO:0019062; GO:0030246; GO:0030425; GO:0032584; GO:0042802; GO:0042803; GO:0043231; GO:0043296; GO:0044291; GO:0044877; GO:0046718; GO:0046790; GO:0050839; GO:0051963; GO:0060041; GO:0070166; GO:0098609; GO:0098686; GO:0099059; GO:1902414 carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virion binding [GO:0046790]; virus receptor activity [GO:0001618] AGPVPTAIIGGVAGSILLVLIVVGGIVVALR 0.99575 -10.344 0 0 0 0 0 0 0 0 0 0 0 11.0707 0 0 0 0 0 0 12.7324 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0694 0 0 0 0 0 0 0 14.7531 0 0 0 0 15.6607 0 13.8468 14.1182 14.0948 0 13.9854 0 13.9594 14.2421 11.6099 13.1932 0 0 0 0 0 0 11.2881 0 0 0 14.5972 13.7744 0 13.4731 0 0 0 0 13.4731 0 13.3993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.044 0 0 12.9908 0 0 0 12.2621 0 0 0 0 0 0 0 0 0 0 0 0 12.6681 0 0 11.3568 0 12.3954 0 12.6877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16384 SSX1_HUMAN "Protein SSX1 (Cancer/testis antigen 5.1, CT5.1) (Synovial sarcoma, X breakpoint 1)" SSX1 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0003714; GO:0005634 transcription corepressor activity [GO:0003714] AMTKLGFK 0.99575 -9.548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6066 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T6F0 DCA12_HUMAN DDB1- and CUL4-associated factor 12 (Centrosome-related protein TCC52) (Testis cancer centrosome-related protein) (WD repeat-containing protein 40A) DCAF12 KIAA1892 TCC52 WDR40A Homo sapiens (Human) protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737] centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0005737; GO:0005813; GO:0010506; GO:0016567; GO:0080008; GO:0140627; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] CNTLFVVDVQTSQITKIPILKDR 0.99575 -12.399 0 0 0 0 0 0 0 0 0 0 0 12.9502 0 14.8801 13.5572 12.5926 13.0806 12.5614 13.7358 13.0911 0 0 0 0 12.7681 13.9085 14.1282 13.1102 0 13.7024 0 13.7443 0 0 12.3828 12.0438 0 0 0 0 0 0 0 13.4071 0 14.0314 0 13.5577 0 0 0 12.1325 0 0 0 13.7794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3006 0 0 0 0 14.2637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8755 0 0 14.2153 0 0 14.548 0 0 0 15.5989 0 0 14.0002 0 14.2447 14.997 0 13.7076 0 0 14.5614 0 0 0 0 Q6ZN17 LN28B_HUMAN "Protein lin-28 homolog B, Lin-28B" LIN28B CSDD2 Homo sapiens (Human) miRNA catabolic process [GO:0010587]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of primary miRNA processing [GO:2000635]; positive regulation of miRNA catabolic process [GO:2000627]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA destabilization [GO:0050779] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; negative regulation of pre-miRNA processing [GO:2000632]; negative regulation of primary miRNA processing [GO:2000635]; positive regulation of miRNA catabolic process [GO:2000627]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; RNA destabilization [GO:0050779] GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010587; GO:0031054; GO:0031123; GO:0050779; GO:1990837; GO:2000627; GO:2000632; GO:2000635 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270] AEGGASK 0.99575 -11.795 0 11.2318 0 10.9446 0 0 0 11.264 0 13.3028 0 0 0 0 0 0 11.7674 11.8322 0 11.4912 0 0 11.6184 0 0 0 12.0526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9227 13.5684 0 13.6241 13.5746 0 0 0 0 0 0 0 0 12.8013 12.7622 19.1737 19.173 0 0 0 0 0 12.799 17.7288 0 0 0 0 0 0 0 0 19.3324 14.3401 0 13.3075 0 0 15.1765 0 0 0 13.2213 0 0 0 0 0 0 14.2012 13.3025 0 0 0 0 0 0 13.3119 19.1299 14.1331 13.3619 19.0719 0 0 13.2092 19.0267 0 13.4086 20.1073 0 0 0 0 0 0 0 13.2569 0 13.1484 13.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0003 0 13.7964 0 0 0 13.5926 0 0 0 0 0 0 0 Q70Z35 PREX2_HUMAN "Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein, P-Rex2, PtdIns(3,4,5)-dependent Rac exchanger 2 (DEP domain-containing protein 2)" PREX2 DEPDC2 Homo sapiens (Human) adult locomotory behavior [GO:0008344]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphatidylinositol 3-kinase signaling [GO:0014065]; regulation of small GTPase mediated signal transduction [GO:0051056] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; adult locomotory behavior [GO:0008344]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; phosphatidylinositol 3-kinase signaling [GO:0014065]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005096; GO:0005829; GO:0005886; GO:0007186; GO:0008344; GO:0014065; GO:0048813; GO:0051056 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085] AQKLLLELNKIR 0.99575 -33.911 0 0 0 0 0 0 0 0 0 0 11.3146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2705 0 0 0 0 0 0 12.2689 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6927 13.6214 0 14.0242 0 0 0 12.8901 12.9305 11.5637 14.1467 0 0 13.2139 14.4472 14.8323 17.1857 15.5719 11.6043 12.148 0 13.5331 14.2685 0 0 14.6733 14.423 0 0 0 0 0 0 13.0049 0 0 0 11.0539 13.762 14.5074 14.2273 0 0 0 14.4031 13.3285 14.2828 0 12.9306 0 0 12.9591 0 0 0 0 13.724 0 0 0 17.457 13.0486 14.2672 13.072 0 13.6611 13.5988 0 14.1552 0 0 13.1531 0 0 0 0 14.9535 0 12.071 0 0 0 0 0 0 0 0 16.7083 13.9539 16.0252 0 0 0 0 0 0 0 0 12.9183 13.2604 0 13.2654 0 0 0 0 12.8628 0 0 0 0 0 0 10.5061 Q86VP6 CAND1_HUMAN "Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A, TBP-interacting protein 120A) (p120 CAND1)" CAND1 KIAA0829 TIP120 TIP120A Homo sapiens (Human) cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265] cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; ubiquitin ligase complex [GO:0000151] cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; ubiquitin ligase complex [GO:0000151]; TBP-class protein binding [GO:0017025]; cell differentiation [GO:0030154]; negative regulation of catalytic activity [GO:0043086]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265] GO:0000151; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0010265; GO:0016020; GO:0016567; GO:0017025; GO:0030154; GO:0031461; GO:0034774; GO:0043086; GO:0045899; GO:0070062; GO:1904813 TBP-class protein binding [GO:0017025] ALHKQMK 0.99575 -9.5469 0 13.0469 0 0 11.8567 0 11.4558 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6265 18.4072 12.9058 0 0 0 0 13.0295 13.7 12.9236 12.6877 13.5126 0 0 0 0 0 0 0 0 0 10.3009 0 0 13.5676 0 11.8845 0 12.9335 0 0 0 11.977 0 0 15.8869 14.3338 14.1301 14.3955 11.3824 15.0013 13.7138 14.0583 15.2374 0 0 0 0 0 0 11.6071 0 0 0 13.4981 0 0 0 11.1847 10.4019 0 0 0 11.9367 0 10.8874 12.7038 0 0 11.719 10.8589 0 14.2991 0 13.2962 9.90796 14.1467 0 14.2417 0 14.4369 0 0 12.1683 13.3981 0 0 12.7118 0 13.1443 0 19.5672 0 0 0 12.6983 0 0 0 0 0 0 0 12.5629 0 0 0 0 13.3034 0 14.1907 0 0 0 Q86XK2 FBX11_HUMAN "F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1, VIT-1)" FBXO11 FBX11 PRMT9 VIT1 UG063H01 Homo sapiens (Human) protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151] chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0016274; GO:0016567; GO:0036211; GO:0042981 protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CHTCNTTDR 0.99575 -9.8232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1242 18.7372 18.6644 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2702 0 0 0 13.6659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.746 0 0 0 0 0 12.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.089 0 0 0 0 0 0 0 0 0 0 0 0 Q8IW41 MAPK5_HUMAN "MAP kinase-activated protein kinase 5, MAPK-activated protein kinase 5, MAPKAP kinase 5, MAPKAP-K5, MAPKAPK-5, MK-5, MK5, EC 2.7.11.1 (p38-regulated/activated protein kinase, PRAK)" MAPKAPK5 PRAK Homo sapiens (Human) cellular senescence [GO:0090398]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; signal transduction [GO:0007165]; stress-induced premature senescence [GO:0090400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular senescence [GO:0090398]; intracellular signal transduction [GO:0035556]; negative regulation of TOR signaling [GO:0032007]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; Ras protein signal transduction [GO:0007265]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; signal transduction [GO:0007165]; stress-induced premature senescence [GO:0090400] GO:0002039; GO:0004674; GO:0004683; GO:0004708; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006417; GO:0007165; GO:0007265; GO:0009931; GO:0018105; GO:0032007; GO:0032156; GO:0032212; GO:0032991; GO:0035556; GO:0046777; GO:0051019; GO:0051973; GO:0060999; GO:0090398; GO:0090400; GO:0106310; GO:1901796; GO:1904355 ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase binding [GO:0051019]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] ECKLLRDTLQSFSWNGR 0.99575 -11.794 0 0 0 0 0 0 13.0596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1453 0 0 0 0 0 0 0 0 0 0 0 11.9992 11.6633 12.5582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4902 0 0 0 0 0 0 0 0 0 0 Q8TEW8 PAR3L_HUMAN "Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein, PAR3-L protein)" PARD3B ALS2CR19 PAR3B PAR3L Homo sapiens (Human) cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; protein localization [GO:0008104] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; endomembrane system [GO:0012505]; protein-containing complex [GO:0032991] adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; endomembrane system [GO:0012505]; protein-containing complex [GO:0032991]; phosphatidylinositol binding [GO:0035091]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; protein localization [GO:0008104] GO:0000226; GO:0005912; GO:0005923; GO:0005938; GO:0007049; GO:0007155; GO:0008104; GO:0012505; GO:0016324; GO:0030010; GO:0030054; GO:0032991; GO:0035091; GO:0043296; GO:0045197; GO:0051301; GO:0051660 phosphatidylinositol binding [GO:0035091] EERERIGAK 0.99575 -33.83 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6059 0 0 0 0 13.9882 13.3799 14.0301 14.3303 0 0 13.916 0 13.3202 0 0 16.3795 12.8468 12.4028 12.6849 0 13.5188 0 0 15.3285 0 0 12.7565 15.6342 18.9603 0 0 13.6939 0 0 13.4368 14.6214 0 0 0 0 0 0 0 0 14.6014 0 0 17.2002 0 0 15.8756 0 13.9705 14.101 14.1364 0 11.8826 0 0 13.5633 13.6886 13.3958 0 0 14.1981 0 13.7334 14.2423 0 0 14.4217 0 0 0 14.7473 0 0 0 0 0 0 0 0 14.1528 12.8138 13.8731 0 0 0 10.6094 0 0 0 0 0 0 0 15.9307 0 11.7548 0 0 14.2694 0 13.8259 13.5723 0 0 0 0 Q96PP9 GBP4_HUMAN "Guanylate-binding protein 4, EC 3.6.5.- (GTP-binding protein 4, GBP-4) (Guanine nucleotide-binding protein 4)" GBP4 Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832] GO:0000139; GO:0003924; GO:0005525; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0031410; GO:0042802; GO:0042803; GO:0042832; GO:0048471; GO:0050830; GO:0071346 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] ALEILDKISQPVVVVAIVGLYRTGK 0.99575 -9.5501 0 0 0 0 0 0 0 0 12.141 0 0 0 0 0 0 0 0 0 0 13.3215 0 0 13.7433 0 11.3931 0 0 13.2817 0 0 0 0 0 0 11.8881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7654 0 0 0 0 0 12.1776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.935 0 0 0 0 0 15.9204 0 0 0 0 0 0 0 0 0 12.9631 14.2021 17.1297 0 0 15.7723 0 14.5014 12.4371 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0397 0 0 0 0 0 0 0 0 0 0 0 13.2522 0 13.6309 0 0 0 0 0 0 0 0 Q9BQE6 LBHD1_HUMAN LBH domain-containing protein 1 LBHD1 C11orf48 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]" nucleus [GO:0005634] "nucleus [GO:0005634]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0005634; GO:0045893 EDSHGSGSPFKASQD 0.99575 -9.8279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0595 0 15.0426 14.8403 14.5331 13.4346 13.6935 13.1721 0 12.7771 12.9432 0 0 0 0 0 0 0 0 0 12.5033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTX1 NDC1_HUMAN "Nucleoporin NDC1, hNDC1 (Transmembrane protein 48)" NDC1 TMEM48 Homo sapiens (Human) homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886]; protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056]; homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283] GO:0005635; GO:0005643; GO:0005737; GO:0005886; GO:0006913; GO:0006999; GO:0007129; GO:0007283; GO:0015031; GO:0015629; GO:0016020; GO:0016021; GO:0017056; GO:0030674; GO:0031965; GO:0051028; GO:0051292; GO:0051664; GO:0070762 protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056] EQIKNFLSK 0.99575 -12.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0529 0 0 0 11.1653 12.7308 0 0 0 0 0 14.4515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0924 0 0 0 14.0474 0 0 0 0 0 14.2867 0 0 13.7483 0 0 0 0 14.1709 14.6441 14.6097 14.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4K1 RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 RIBC2 C22orf11 Homo sapiens (Human) axonemal microtubule [GO:0005879]; nucleus [GO:0005634] axonemal microtubule [GO:0005879]; nucleus [GO:0005634] GO:0005634; GO:0005879 ATLLFERQQWR 0.99575 -33.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1533 0 12.8021 0 0 0 0 0 0 0 0 12.7996 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.833 0 0 15.0385 0 0 0 15.1894 0 0 0 0 0 0 0 0 0 0 14.8117 0 0 0 14.7947 0 0 15.0241 14.2442 14.247 13.6476 12.931 14.6215 0 0 0 0 0 14.9389 0 0 0 0 0 0 15.0295 0 0 14.5448 14.7449 0 15.016 0 0 12.6017 0 0 13.5383 0 0 0 0 12.7765 0 0 0 0 0 0 0 12.1475 0 12.5394 0 0 0 0 0 0 0 0 0 0 11.7328 0 0 0 0 12.1478 0 0 0 0 0 0 0 0 0 0 0 0 14.7018 0 Q9NZM6 PK2L2_HUMAN Polycystic kidney disease 2-like 2 protein (Polycystin-2L2) (Polycystin-L2) PKD2L2 Homo sapiens (Human) detection of mechanical stimulus [GO:0050982] integral component of membrane [GO:0016021]; membrane [GO:0016020] integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; detection of mechanical stimulus [GO:0050982] GO:0005262; GO:0005509; GO:0016020; GO:0016021; GO:0050982 calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509] EGFDENEIQNAEQMK 0.99575 -12.348 0 0 0 0 0 0 0 0 0 0 0 13.1417 0 0 12.0769 0 0 0 0 14.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2632 0 0 13.4357 13.7208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9133 0 0 0 0 0 0 0 0 0 0 0 0 10.3953 15.818 0 0 13.0547 0 0 0 14.2803 13.8149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8767 0 13.4583 12.5218 0 13.3156 11.446 0 0 10.8032 0 13.2647 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NZP2 OR6C2_HUMAN Olfactory receptor 6C2 (HSA3) OR6C2 Homo sapiens (Human) sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005886; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GVSVLTTSVAPLLNPFIYTLRNK 0.99575 -12.372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.444 0 0 0 0 0 0 14.0351 0 0 0 0 0 0 0 12.5956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8688 0 0 0 0 0 0 0 0 0 0 0 0 12.3844 0 0 0 0 13.1371 0 0 0 0 Q9ULJ1 ODF2L_HUMAN Protein BCAP (Basal body centriole-associated protein) (Outer dense fiber protein 2-like) ODF2L BCAP KIAA1229 Homo sapiens (Human) cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of cilium assembly [GO:1902017] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of cilium assembly [GO:1902017] GO:0005737; GO:0005813; GO:0005814; GO:0030030; GO:0034451; GO:0036064; GO:1902017; GO:1902018 CENLQQK 0.99575 -12.303 0 0 0 0 0 0 0 0 0 0 16.0766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.99336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.0435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5473 0 0 0 0 0 0 12.8966 0 0 13.6948 13.1513 12.9161 0 0 0 0 0 0 13.9062 0 0 0 0 12.2086 0 0 0 0 0 0 0 0 0 0 0 0 0 12.526 0 0 0 0 0 0 0 0 19.3277 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.34999 13.9028 Q9Y258 CCL26_HUMAN "C-C motif chemokine 26 (CC chemokine IMAC) (Eotaxin-3) (Macrophage inflammatory protein 4-alpha, MIP-4-alpha) (Small-inducible cytokine A26) (Thymic stroma chemokine-1, TSC-1)" CCL26 SCYA26 UNQ216/PRO242 Homo sapiens (Human) cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818] extracellular space [GO:0005615] extracellular space [GO:0005615]; CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; receptor ligand activity [GO:0048018]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818] GO:0001938; GO:0002548; GO:0005615; GO:0006935; GO:0006954; GO:0007165; GO:0007186; GO:0007267; GO:0008009; GO:0010818; GO:0030335; GO:0030593; GO:0030838; GO:0031728; GO:0031737; GO:0043547; GO:0048018; GO:0048020; GO:0048245; GO:0048247; GO:0050921; GO:0070098; GO:0070374; GO:0071346; GO:0071347; GO:0071356 CCR chemokine receptor binding [GO:0048020]; CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; receptor ligand activity [GO:0048018] AVIFTTKR 0.99575 -12.29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8031 0 0 0 Q9Y4C0 NRX3A_HUMAN Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha) NRXN3 C14orf60 KIAA0743 Homo sapiens (Human) adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625] GO:0005886; GO:0005887; GO:0007158; GO:0007411; GO:0007612; GO:0030534; GO:0035176; GO:0038023; GO:0046872; GO:0050839; GO:0071625; GO:0097109 cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023] ARFGLRNIIADPVTFK 0.99575 -9.5456 0 0 0 0 0 0 0 0 12.3295 0 0 0 12.3474 12.0637 0 0 0 0 0 0 0 0 0 0 14.4013 0 0 0 0 0 11.6854 0 0 0 0 0 0 0 0 0 14.4181 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0157 15.2026 14.9839 14.3643 0 14.1425 0 0 0 0 0 0 0 14.2048 0 0 0 0 12.9166 0 0 0 0 0 0 0 12.5158 0 0 0 12.617 0 12.6886 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7707 0 13.3072 15.2397 0 14.2834 0 12.9635 0 0 0 0 0 0 12.4701 0 0 0 0 0 0 0 0 12.4374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2489 12.2725 0 0 0 0 0 0 O60284 ST18_HUMAN Suppression of tumorigenicity 18 protein (Zinc finger protein 387) ST18 KIAA0535 ZNF387 Homo sapiens (Human) interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tumor necrosis factor-mediated signaling pathway [GO:0033209] chromatin [GO:0000785]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] "chromatin [GO:0000785]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0008285; GO:0032993; GO:0033209; GO:0045944; GO:0070102; GO:0070498; GO:2001269 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" ARKGGVK 0.99576 -34.439 0 0 0 0 0 0 0 0 0 0 0 14.8623 0 13.6855 0 0 0 0 0 12.8537 0 0 0 0 0 0 14.3036 0 0 0 0 13.8453 0 13.99 0 14.1265 0 13.9129 0 13.955 14.0445 0 0 11.626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3453 0 0 14.4753 0 12.487 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7733 0 0 0 14.6696 13.1513 0 0 0 16.3345 0 0 15.1362 0 0 0 0 0 14.5438 0 0 0 14.582 0 0 0 16.0731 0 15.5585 0 0 0 0 13.757 0 0 13.5828 0 12.2405 0 0 0 0 0 13.6889 0 0 0 0 0 0 0 0 0 0 0 12.672 0 0 14.0014 0 12.8852 0 15.4036 15.2285 0 0 15.2804 15.0218 0 15.8152 0 0 15.6477 15.5399 0 0 0 0 0 15.8292 12.5106 0 0 0 P10588 NR2F6_HUMAN "Nuclear receptor subfamily 2 group F member 6 (V-erbA-related protein 2, EAR-2)" NR2F6 EAR2 ERBAL2 Homo sapiens (Human) anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron development [GO:0048666]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0030154; GO:0043153; GO:0043565; GO:0048666; GO:0048856; GO:0050965; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]" AFQEQVDK 0.99576 -34.37 0 0 13.2842 0 0 0 0 0 11.0511 0 0 0 0 0 12.5055 0 0 0 0 0 11.9297 0 0 0 10.7577 0 0 10.9658 0 0 11.1637 0 0 0 0 0 0 0 0 0 0 0 0 0 9.81783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5236 0 15.6887 0 0 16.2336 0 11.1645 0 0 14.3061 15.158 13.15 0 0 0 0 0 0 0 0 0 14.9541 12.7123 15.9979 14.0618 13.0466 0 0 12.1133 0 0 0 0 12.9839 13.2926 13.6514 0 0 0 0 0 13.216 13.1022 0 12.7501 0 0 0 0 0 0 14.2447 12.4385 13.2636 15.0835 0 0 0 0 0 13.7052 12.3692 0 14.3529 0 0 12.4233 12.5118 0 14.1506 0 0 0 0 0 0 0 0 0 12.4049 0 0 0 11.0429 14.3531 0 0 0 0 0 0 0 0 0 0 0 10.8604 0 11.5589 P52741 ZN134_HUMAN Zinc finger protein 134 ZNF134 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001227; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DNLTQHK 0.99576 -11.857 0 0 0 13.4813 13.7649 13.0286 13.7713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7856 0 11.8483 0 0 0 11.8559 0 0 0 11.6722 0 0 0 0 0 12.5459 0 0 0 0 0 16.4885 0 11.6763 0 0 0 13.6388 0 0 0 0 11.522 0 0 0 0 0 15.0566 0 14.5707 0 0 0 0 12.4861 14.386 0 0 14.2438 13.5595 13.8351 13.4181 12.9523 12.8939 12.5893 0 0 11.5662 11.5898 12.2783 12.2406 13.4138 12.514 0 0 12.0194 0 0 10.9574 13.4834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9303 0 0 0 0 0 0 0 Q6VMQ6 MCAF1_HUMAN "Activating transcription factor 7-interacting protein 1 (ATF-interacting protein, ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator, hAM) (MBD1-containing chromatin-associated factor 1) (P621)" ATF7IP MCAF MCAF1 Homo sapiens (Human) "DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATP hydrolysis activity [GO:0016887]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of transcription, DNA-templated [GO:0045893]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647]; regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045898]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006306; GO:0006355; GO:0016604; GO:0016887; GO:0031647; GO:0045892; GO:0045893; GO:0045898; GO:0050821; GO:0090309 ATP hydrolysis activity [GO:0016887]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714] DSLEEPQKK 0.99576 -11.895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0565 0 0 0 0 0 0 0 0 0 14.1645 0 0 0 0 0 0 14.2377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7153 0 15.9461 0 17.9179 17.2375 0 12.0476 12.4061 0 0 0 0 0 0 0 13.3891 0 0 0 0 0 0 0 0 0 0 0 0 11.7841 0 0 0 11.9554 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1358 0 0 0 0 0 0 0 0 0 0 12.8888 0 11.0729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H6D8 FNDC4_HUMAN Fibronectin type III domain-containing protein 4 (Fibronectin type III repeat-containing protein 1) FNDC4 FRCP1 UNQ6389/PRO21134 Homo sapiens (Human) negative regulation of inflammatory response [GO:0050728]; response to transforming growth factor beta [GO:0071559] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation of inflammatory response [GO:0050728]; response to transforming growth factor beta [GO:0071559] GO:0005576; GO:0005615; GO:0005783; GO:0005886; GO:0016021; GO:0050728; GO:0071559 GESPPGPR 0.99576 -12.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7303 0 0 0 0 0 0 0 16.7374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCM9 TRI39_HUMAN "E3 ubiquitin-protein ligase TRIM39, EC 2.3.2.27 (RING finger protein 23) (RING-type E3 ubiquitin transferase TRIM39) (Testis-abundant finger protein) (Tripartite motif-containing protein 39)" TRIM39 RNF23 TFP Homo sapiens (Human) apoptotic process [GO:0006915]; innate immune response [GO:0045087]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; innate immune response [GO:0045087]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of gene expression [GO:0010468] GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007095; GO:0008270; GO:0010468; GO:0016567; GO:0032435; GO:0042802; GO:0043124; GO:0045087; GO:0050821; GO:0061630; GO:1902806; GO:2000059; GO:2001235 identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] DHKALLGLVK 0.99576 -11.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43345 ZN208_HUMAN Zinc finger protein 208 (Zinc finger protein 91-like) ZNF208 ZNF91L Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0008270 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AFNQSAILIKHKR 0.99577 -35.209 0 0 0 10.6402 0 0 0 0 12.4704 0 0 0 12.1194 0 0 0 0 0 0 0 0 0 11.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5344 0 0 14.4131 0 0 0 0 0 0 0 0 11.0773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9559 0 0 0 0 13.1446 0 12.5511 12.5333 13.6088 12.7941 12.8012 0 0 0 0 0 12.7542 13.934 0 0 13.0748 12.0245 0 0 0 0 0 0 0 11.9391 0 12.3239 0 0 13.1244 0 0 0 0 14.188 0 0 0 0 0 0 0 0 0 0 13.3283 0 0 0 14.6081 0 0 0 13.9965 14.6926 12.0158 0 0 10.8476 0 0 0 0 0 0 0 0 11.827 0 14.2907 14.2133 11.6566 0 0 0 0 12.3114 11.1434 0 0 0 0 0 0 0 0 0 0 0 0 0 P10155 RO60_HUMAN "RNA-binding protein RO60 (60 kDa SS-A/Ro ribonucleoprotein, 60 kDa Ro protein, 60 kDa ribonucleoprotein Ro, RoRNP) (Ro 60 kDa autoantigen, Ro60 autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen, SS-A) (TROVE domain family member 2)" RO60 SSA2 TROVE2 Homo sapiens (Human) cellular response to interferon-alpha [GO:0035457]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; regulation of gene expression [GO:0010468]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904] cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cellular response to interferon-alpha [GO:0035457]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; regulation of gene expression [GO:0010468]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383] GO:0002520; GO:0003723; GO:0005654; GO:0005829; GO:0006383; GO:0007224; GO:0009411; GO:0010468; GO:0016604; GO:0030620; GO:0035457; GO:0046872; GO:0060271; GO:1990904 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620] AIADWYNEK 0.99577 -11.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0272 0 0 0 12.3631 0 12.7964 0 0 0 0 12.8243 0 0 0 0 0 0 0 12.5077 0 12.5808 0 0 0 0 0 0 0 0 0 12.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9835 13.0126 0 0 0 0 0 0 0 0 0 0 10.9565 0 0 0 0 0 0 0 0 0 11.8915 0 0 0 0 0 0 11.5846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P15121 ALDR_HUMAN "Aldo-keto reductase family 1 member B1, EC 1.1.1.300, EC 1.1.1.372, EC 1.1.1.54 (Aldehyde reductase) (Aldose reductase, AR, EC 1.1.1.21)" AKR1B1 ALDR1 ALR2 Homo sapiens (Human) C21-steroid hormone biosynthetic process [GO:0006700]; carbohydrate metabolic process [GO:0005975]; cellular hyperosmotic salinity response [GO:0071475]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; fructose biosynthetic process [GO:0046370]; metanephric collecting duct development [GO:0072205]; negative regulation of apoptotic process [GO:0043066]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; retinoid metabolic process [GO:0001523] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glyceraldehyde oxidoreductase activity [GO:0043795]; glycerol dehydrogenase [NADP+] activity [GO:0047956]; NADP-retinol dehydrogenase activity [GO:0052650]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758]; C21-steroid hormone biosynthetic process [GO:0006700]; carbohydrate metabolic process [GO:0005975]; cellular hyperosmotic salinity response [GO:0071475]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; fructose biosynthetic process [GO:0046370]; metanephric collecting duct development [GO:0072205]; negative regulation of apoptotic process [GO:0043066]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; retinoid metabolic process [GO:0001523] GO:0001523; GO:0001758; GO:0002070; GO:0003091; GO:0004032; GO:0005615; GO:0005654; GO:0005829; GO:0005975; GO:0006700; GO:0009055; GO:0035809; GO:0036130; GO:0043066; GO:0043795; GO:0044597; GO:0044598; GO:0046370; GO:0047655; GO:0047956; GO:0052650; GO:0070062; GO:0071475; GO:0072205 alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glyceraldehyde oxidoreductase activity [GO:0043795]; glycerol dehydrogenase [NADP+] activity [GO:0047956]; NADP-retinol dehydrogenase activity [GO:0052650]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758] LIQYCQSK 0.99577 -12.516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2308 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4949 0 0 0 0 0 0 P36888 FLT3_HUMAN "Receptor-type tyrosine-protein kinase FLT3, EC 2.7.10.1 (FL cytokine receptor) (Fetal liver kinase-2, FLK-2) (Fms-like tyrosine kinase 3, FLT-3) (Stem cell tyrosine kinase 1, STK-1) (CD antigen CD135)" FLT3 CD135 FLK2 STK1 Homo sapiens (Human) animal organ regeneration [GO:0031100]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; cellular response to glucocorticoid stimulus [GO:0071385]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; lymphocyte proliferation [GO:0046651]; myeloid progenitor cell differentiation [GO:0002318]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; pro-B cell differentiation [GO:0002328]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; response to organonitrogen compound [GO:0010243]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; nuclear glucocorticoid receptor binding [GO:0035259]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021]; animal organ regeneration [GO:0031100]; B cell differentiation [GO:0030183]; cellular response to cytokine stimulus [GO:0071345]; cellular response to glucocorticoid stimulus [GO:0071385]; common myeloid progenitor cell proliferation [GO:0035726]; cytokine-mediated signaling pathway [GO:0019221]; dendritic cell differentiation [GO:0097028]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; lymphocyte proliferation [GO:0046651]; myeloid progenitor cell differentiation [GO:0002318]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; pro-B cell differentiation [GO:0002328]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; response to organonitrogen compound [GO:0010243]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0001776; GO:0002318; GO:0002328; GO:0004713; GO:0004714; GO:0004896; GO:0005021; GO:0005524; GO:0005634; GO:0005783; GO:0005788; GO:0005829; GO:0005886; GO:0005887; GO:0007169; GO:0008284; GO:0010008; GO:0010243; GO:0014068; GO:0018108; GO:0019221; GO:0019838; GO:0030097; GO:0030183; GO:0031100; GO:0033674; GO:0035259; GO:0035726; GO:0042531; GO:0042981; GO:0043235; GO:0043406; GO:0043410; GO:0043552; GO:0043621; GO:0044877; GO:0046651; GO:0046777; GO:0071345; GO:0071385; GO:0097028 ATP binding [GO:0005524]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; nuclear glucocorticoid receptor binding [GO:0035259]; protein self-association [GO:0043621]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021] AYPQIRCTWTFSRK 0.99577 -11.929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6614 0 0 0 0 0 0 12.4426 0 12.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0248 0 13.2608 0 0 0 0 13.9097 0 0 0 0 0 0 0 13.5222 0 14.9493 0 14.5157 14.5882 0 0 0 0 0 0 0 0 13.7421 0 0 0 0 13.2619 0 0 0 12.3097 0 0 0 0 0 0 0 0 15.3737 0 0 0 0 0 13.1368 0 0 11.7886 0 0 0 0 13.3565 13.6273 13.5473 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13112 CAF1B_HUMAN "Chromatin assembly factor 1 subunit B, CAF-1 subunit B (Chromatin assembly factor I p60 subunit, CAF-I 60 kDa subunit, CAF-I p60) (M-phase phosphoprotein 7)" CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 Homo sapiens (Human) cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334] CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334] GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0007049; GO:0031497; GO:0032991; GO:0033186; GO:0042393; GO:0051082 chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082] AIVEFLSNLARHTKAVNVVR 0.99577 -9.6195 0 0 0 0 0 0 0 0 0 10.9526 10.9977 10.0799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.42794 0 0 0 0 0 0 0 0 0 0 13.4169 0 0 0 0 0 0 0 0 0 0 13.2832 13.6822 13.2203 13.2787 12.7473 0 0 0 0 0 13.2594 0 0 12.8844 0 0 0 0 0 0 0 0 12.6149 12.5096 13.6306 0 0 0 0 0 12.3995 0 0 0 0 0 0 0 12.572 0 0 14.4601 0 0 0 0 12.8227 12.6496 12.8735 0 0 0 0 0 0 0 0 12.6926 0 0 13.314 12.866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.713 0 0 12.832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3929 0 12.0899 Q14118 DAG1_HUMAN "Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan, Alpha-DG; Beta-dystroglycan, Beta-DG ]" DAG1 Homo sapiens (Human) aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403] adherens junction [GO:0005912]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383] adherens junction [GO:0005912]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403] GO:0001618; GO:0001954; GO:0002009; GO:0002011; GO:0002162; GO:0003779; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005654; GO:0005737; GO:0005788; GO:0005796; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006509; GO:0007411; GO:0007568; GO:0008307; GO:0009897; GO:0010470; GO:0010717; GO:0014894; GO:0015631; GO:0016010; GO:0016011; GO:0016021; GO:0016203; GO:0016323; GO:0016340; GO:0016476; GO:0017166; GO:0021675; GO:0021682; GO:0022011; GO:0030027; GO:0030175; GO:0030336; GO:0031103; GO:0031643; GO:0033268; GO:0034399; GO:0034453; GO:0042169; GO:0042383; GO:0043034; GO:0043231; GO:0043236; GO:0043237; GO:0043403; GO:0043409; GO:0043434; GO:0044853; GO:0045211; GO:0045860; GO:0048714; GO:0050807; GO:0051393; GO:0051898; GO:0060055; GO:0060441; GO:0060445; GO:0062023; GO:0070062; GO:0070938; GO:0071260; GO:0071397; GO:0071679; GO:0071711; GO:0098696; GO:0098942; GO:0098978; GO:0098982; GO:0099524; GO:1904261 actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618] FVGDPALVLNDIHKKIALVK 0.99577 -9.612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0394 0 13.6419 0 14.1852 0 0 13.5383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2376 0 0 0 0 0 0 0 0 0 14.5887 17.077 13.9974 0 0 0 14.1953 14.9866 0 0 0 0 0 0 0 0 0 16.1437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2112 0 0 0 0 0 13.5369 0 0 0 11.3001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4192 0 0 0 0 0 Q8IZP9 AGRG2_HUMAN "Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6, He6)" ADGRG2 GPR64 HE6 TM7LN2 Homo sapiens (Human) adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; spermatogenesis [GO:0007283] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; spermatogenesis [GO:0007283] GO:0004930; GO:0005829; GO:0005886; GO:0005887; GO:0007166; GO:0007186; GO:0007189; GO:0007283; GO:0009986; GO:0016021; GO:0016324; GO:0070062 G protein-coupled receptor activity [GO:0004930] ILIQLCAALLLLNLVFLLDSWIALYK 0.99577 -35.193 0 0 0 0 0 0 0 0 0 12.0796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1635 12.2051 0 0 0 0 0 0 0 0 11.575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3247 14.0736 0 0 14.8495 15.0345 14.64 14.5231 11.695 0 0 0 13.4171 0 14.3834 0 0 0 0 0 0 12.5615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1462 13.9443 13.893 14.4194 0 0 12.7336 0 0 0 0 0 0 0 0 0 11.5727 0 0 12.5404 0 0 12.5302 0 0 0 0 0 0 0 0 13.0395 0 14.5958 13.2254 0 14.2725 0 0 0 0 0 0 0 10.2709 0 0 0 0 13.3465 0 0 0 0 0 0 0 Q9BPW4 APOL4_HUMAN "Apolipoprotein L4 (Apolipoprotein L-IV, ApoL-IV)" APOL4 Homo sapiens (Human) lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231] extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lipid binding [GO:0008289]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] GO:0005615; GO:0006629; GO:0006869; GO:0008289; GO:0042157; GO:0043231 lipid binding [GO:0008289] FTEEVIEYFQK 0.99577 -12.53 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.955 11.9863 0 0 0 0 13.5011 0 0 0 12.4059 0 0 0 0 13.654 0 13.8066 0 0 0 12.5288 13.0578 0 12.9153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5851 0 0 0 0 0 0 0 0 0 12.5721 0 0 0 14.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7605 0 Q9NP71 MLXPL_HUMAN "Carbohydrate-responsive element-binding protein, ChREBP (Class D basic helix-loop-helix protein 14, bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein, WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein)" MLXIPL BHLHD14 MIO WBSCR14 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; triglyceride homeostasis [GO:0070328]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; anatomical structure morphogenesis [GO:0009653]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose mediated signaling pathway [GO:0010255]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glycolytic process [GO:0045821]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; triglyceride homeostasis [GO:0070328]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0008284; GO:0009653; GO:0010255; GO:0033137; GO:0035538; GO:0042593; GO:0045723; GO:0045821; GO:0045892; GO:0045893; GO:0045944; GO:0046889; GO:0046982; GO:0055089; GO:0061629; GO:0070328; GO:0090324; GO:0097009 "carbohydrate response element binding [GO:0035538]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]" AVTEGTLGK 0.99577 -35.252 0 0 0 0 0 0 0 0 0 10.5572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9367 0 0 11.8337 10.9572 0 0 0 0 0 0 0 12.3989 11.78 11.958 0 0 0 0 0 11.6411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6947 0 0 0 15.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3842 13.488 0 0 0 0 15.0311 0 0 15.4234 0 0 0 11.635 0 0 0 0 15.753 0 0 13.1463 0 0 0 0 0 0 0 0 0 0 0 14.7972 0 0 0 0 0 0 0 0 0 0 0 0 14.5007 9.64519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7054 12.9675 12.7012 14.7041 13.4767 0 12.7061 13.0413 12.7033 0 13.9979 13.8443 0 11.0988 15.3766 0 0 0 Q9UFF9 CNOT8_HUMAN "CCR4-NOT transcription complex subunit 8, EC 3.1.13.4 (CAF1-like protein, CALIFp) (CAF2) (CCR4-associated factor 8) (Caf1b)" CNOT8 CALIF POP2 Homo sapiens (Human) "exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; miRNA-mediated gene silencing [GO:0035195]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]" CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932] "CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; miRNA-mediated gene silencing [GO:0035195]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; transcription, DNA-templated [GO:0006351]" GO:0000175; GO:0000289; GO:0000932; GO:0003723; GO:0004535; GO:0005634; GO:0005829; GO:0006351; GO:0008284; GO:0030014; GO:0030015; GO:0035195; GO:0043928; GO:0046872; GO:0061014 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723] MKELFFEDSIDDAK 0.99577 -9.9242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2719 0 11.4937 0 0 0 0 0 12.0638 0 0 0 0 0 0 0 0 0 0 11.5174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4L1 HYOU1_HUMAN "Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein, ORP-150) (170 kDa glucose-regulated protein, GRP-170)" HYOU1 GRP170 ORP150 Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931] endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790] endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931] GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0016020; GO:0034663; GO:0034976; GO:0051082; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:0140662; GO:1903298; GO:1903382 ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082] AKVTRVEFEELCADLFER 0.99577 -12.525 0 0 0 0 0 0 11.0641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1384 0 11.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2211 13.9664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7309 13.7831 0 12.792 13.6222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1156 13.6564 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5725 0 0 0 0 0 0 13.0502 0 0 0 0 13.4721 0 0 13.774 0 13.5916 12.8716 0 0 0 0 0 0 0 0 P78371 TCPB_HUMAN "T-complex protein 1 subunit beta, TCP-1-beta (CCT-beta)" CCT2 99D8.1 CCTB Homo sapiens (Human) binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199] azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998] GO:0002199; GO:0005524; GO:0005576; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0035578; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:0140662; GO:1901998; GO:1904851; GO:1904871; GO:1904874 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082] IGVNQPKR 0.99578 -12.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.32 14.1408 0 0 14.253 0 0 0 0 0 0 14.9693 0 13.6872 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6286 0 0 0 0 0 0 12.6281 0 0 0 12.7873 12.7807 0 13.0686 0 0 0 0 13.2486 0 0 0 0 0 0 0 12.3699 0 0 13.6669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2297 15.3648 14.7909 0 0 0 0 0 0 0 0 12.9891 0 13.6042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1404 14.0823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0874 0 0 0 0 0 0 0 0 0 Q16538 GP162_HUMAN Probable G-protein coupled receptor 162 (Gene-rich cluster gene A protein) GPR162 GRCA Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930] GO:0004930; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930] ADVRTVWEQCVAIMSEEDGDDDGGCDDYAEGRVCK 0.99578 -12.024 11.7495 0 0 13.5355 13.3554 0 0 0 0 0 0 0 12.6998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.757 0 0 0 0 0 0 0 0 0 0 0 12.3201 10.6707 0 0 0 11.4217 0 0 0 0 0 0 0 12.3468 0 0 0 0 0 0 0 0 0 0 13.4561 0 12.2957 13.7629 0 0 14.0625 14.1824 13.9215 14.0549 0 13.9075 13.7639 0 13.1477 0 14.4903 14.3933 13.954 0 13.5518 0 0 0 14.955 0 14.0919 0 13.6498 0 0 0 0 0 14.1345 0 0 16.4782 14.2902 0 0 14.0636 13.6048 14.1551 14.1641 14.428 14.4264 13.0729 14.5357 13.2295 15.0703 13.6611 0 0 14.2693 0 0 15.5349 13.733 12.6059 12.5836 14.3997 13.6419 0 0 0 0 0 0 13.7518 0 14.346 13.9703 0 12.7183 13.4942 0 0 0 0 0 0 0 0 14.1069 0 13.8564 0 0 0 0 13.7396 0 0 0 13.6899 0 0 0 14.8776 0 Q17RB8 LONF1_HUMAN LON peptidase N-terminal domain and RING finger protein 1 (RING finger protein 191) LONRF1 RNF191 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] GO:0005829; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] CLDHAPYCPLCK 0.99578 -12.093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5649 0 0 0 0 0 0 0 0 0 0 0 0 12.0665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2673 0 0 13.862 0 0 0 0 0 0 0 0 14.775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6791 0 0 0 0 0 0 0 0 0 Q92851 CASPA_HUMAN "Caspase-10, CASP-10, EC 3.4.22.63 (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2, FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12 ]" CASP10 MCH4 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981] CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342] CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981] GO:0004197; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006919; GO:0031265; GO:0031625; GO:0035877; GO:0042981; GO:0043123; GO:0097153; GO:0097199; GO:0097200; GO:0097342 cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625] DMIFLLK 0.99578 -32.811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0222 0 0 0 9.71467 0 0 0 0 0 0 0 0 0 12.0764 0 0 0 0 0 10.6645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8578 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3791 0 0 0 13.9135 0 14.1236 0 0 14.4439 0 13.5823 0 0 14.3785 0 0 0 0 0 0 0 0 0 0 10.6361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4955 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6294 13.6588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0531 0 0 0 0 0 0 13.9428 0 0 0 A6NCK2 TR43B_HUMAN Tripartite motif-containing protein 43B TRIM43B Homo sapiens (Human) innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468] GO:0005737; GO:0008270; GO:0010468; GO:0016567; GO:0045087; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] KLHPVLHK 0.99579 -10.046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.955 14.3053 0 13.7925 0 0 0 0 12.2879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9098 0 0 0 13.6524 12.5714 0 0 0 0 0 0 0 0 12.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A7E2Y1 MYH7B_HUMAN "Myosin-7B (Antigen MLAA-21) (Myosin cardiac muscle beta chain) (Myosin heavy chain 7B, cardiac muscle beta isoform) (Slow A MYH14)" MYH7B KIAA1512 Homo sapiens (Human) membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460] membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146] GO:0000146; GO:0005524; GO:0016020; GO:0016460; GO:0032982; GO:0051015 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146] ANAEVAQWRSKYEADAIQR 0.99579 -33.192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0168 0 0 0 0 0 0 0 0 10.6447 0 0 0 0 0 0 0 12.8347 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4975 0 13.3845 0 0 0 15.4873 13.3995 0 15.4998 0 0 0 0 13.1054 13.4936 0 0 0 0 0 0 14.0421 0 14.0252 0 0 0 0 0 11.4363 0 0 12.4684 0 0 12.5713 0 0 0 0 0 0 0 0 0 0 0 12.3285 0 0 11.9588 0 0 13.2745 0 0 0 0 0 0 13.3621 0 0 0 0 12.822 13.8797 0 11.0829 10.7167 0 11.7477 10.4436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0029 13.3803 0 0 0 0 0 0 P19447 ERCC3_HUMAN "General transcription and DNA repair factor IIH helicase subunit XPB, TFIIH subunit XPB, EC 3.6.4.12 (Basic transcription factor 2 89 kDa subunit, BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit, TFIIH 89 kDa subunit, TFIIH p89) (Xeroderma pigmentosum group B-complementing protein)" ERCC3 XPB XPBC Homo sapiens (Human) "apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550] "nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]; 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]" GO:0000112; GO:0000439; GO:0000717; GO:0001666; GO:0003677; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006265; GO:0006281; GO:0006283; GO:0006289; GO:0006366; GO:0006367; GO:0006368; GO:0006915; GO:0006979; GO:0008022; GO:0008104; GO:0009411; GO:0009650; GO:0016887; GO:0033683; GO:0035315; GO:0043065; GO:0043138; GO:0047485; GO:0048568; GO:0097550; GO:1901990; GO:1990841 3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485] EYAIRLNKPYIYGPTSQGER 0.99579 -9.6941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1472 0 0 0 0 0 0 10.3661 11.2755 0 11.3266 0 0 0 0 0 0 0 0 0 0 14.5325 0 13.2563 13.8974 11.7876 12.3302 11.8296 0 11.2862 0 0 11.9523 12.3461 14.2982 0 0 0 0 0 0 0 0 0 12.8924 0 0 12.619 0 0 0 0 0 0 0 0 0 12.7688 11.6094 0 0 0 0 0 11.3297 0 0 0 0 13.2386 0 12.2114 0 0 13.6411 0 0 10.6528 0 0 0 0 0 13.5209 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7208 0 13.848 0 0 0 0 0 0 0 0 0 0 0 0 P49961 ENTP1_HUMAN "Ectonucleoside triphosphate diphosphohydrolase 1, NTPDase 1, EC 3.6.1.5 (Ecto-ATP diphosphohydrolase 1, Ecto-ATPDase 1, Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (CD antigen CD39)" ENTPD1 CD39 Homo sapiens (Human) blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; nucleoside diphosphate catabolic process [GO:0009134] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; uridine-diphosphatase activity [GO:0045134]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; nucleoside diphosphate catabolic process [GO:0009134] GO:0004382; GO:0005524; GO:0005886; GO:0005887; GO:0007155; GO:0007596; GO:0009134; GO:0016020; GO:0017110; GO:0045134; GO:0070062; GO:0102485; GO:0102486; GO:0102487; GO:0102488; GO:0102489; GO:0102490; GO:0102491 8-oxo-dGTP phosphohydrolase activity [GO:0102490]; ATP binding [GO:0005524]; dATP phosphohydrolase activity [GO:0102485]; dCTP phosphohydrolase activity [GO:0102486]; dGTP phosphohydrolase activity [GO:0102491]; dTTP phosphohydrolase activity [GO:0102488]; dUTP phosphohydrolase activity [GO:0102487]; GTP phosphohydrolase activity [GO:0102489]; guanosine-diphosphatase activity [GO:0004382]; nucleoside-diphosphatase activity [GO:0017110]; uridine-diphosphatase activity [GO:0045134] AREVIPR 0.99579 -9.6927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9364 0 0 13.334 13.515 0 13.6426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4193 0 0 0 0 0 0 0 14.7943 0 0 0 13.4107 0 0 0 10.3513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P57071 PRD15_HUMAN "PR domain zinc finger protein 15, EC 2.1.1.- (PR domain-containing protein 15) (Zinc finger protein 298)" PRDM15 C21orf83 ZNF298 Homo sapiens (Human) methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0008168; GO:0016604; GO:0032259; GO:0043409; GO:0045944; GO:0046872; GO:0090263; GO:1990841; GO:2000035 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" DFMCELCGKTFSER 0.99579 -33.179 10.5216 12.6017 0 0 0 11.9439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1947 0 0 0 0 12.9722 13.8726 11.4662 0 0 12.3592 0 0 0 0 0 10.9204 0 0 0 0 0 0 0 0 0 0 0 14.4338 15.4695 13.6413 14.068 13.7871 0 0 15.1644 13.5857 14.5292 18.4641 14.8629 15.5011 13.6337 0 15.3243 15.7991 12.4738 0 17.2573 16.0452 15.0994 15.2231 15.6989 13.9198 15.3499 13.2696 0 15.3848 16.0526 18.6888 0 13.041 15.4145 15.6333 15.5705 15.1157 0 0 14.3531 13.4454 13.864 15.2494 14.1807 0 15.9966 0 14.091 13.595 14.6898 14.8614 0 14.1264 16.4214 13.4284 13.4244 16.0253 15.0449 14.8582 15.762 0 0 14.9075 16.1756 0 15.8033 0 14.0728 13.611 13.5603 15.1089 14.5925 0 14.0429 14.9517 0 0 0 15.3774 0 0 14.1159 0 15.0122 14.7745 15.1384 0 0 0 13.5356 0 0 0 10.875 0 0 0 0 0 0 0 13.68 0 0 13.061 14.2659 14.3692 14.1338 0 14.3699 0 15.4109 0 Q03721 KCNC4_HUMAN Potassium voltage-gated channel subfamily C member 4 (KSHIIIC) (Voltage-gated potassium channel subunit Kv3.4) KCNC4 C1orf30 Homo sapiens (Human) chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076] axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005267; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0016021; GO:0030424; GO:0032590; GO:0032809; GO:0034765; GO:0045202; GO:0051260; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; potassium channel activity [GO:0005267]; voltage-gated potassium channel activity [GO:0005249] ALRRSTTR 0.99579 -12.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6966 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZRP7 QSOX2_HUMAN "Sulfhydryl oxidase 2, EC 1.8.3.2 (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1)" QSOX2 QSCN6L1 SOXN Homo sapiens (Human) protein folding [GO:0006457] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of Golgi membrane [GO:0030173]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756]; protein folding [GO:0006457] GO:0003756; GO:0005615; GO:0005654; GO:0005794; GO:0005886; GO:0006457; GO:0016971; GO:0030173; GO:0031965 flavin-linked sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756] AAAGAAVARSPGIGAGPALRAR 0.99579 -33.478 0 0 0 0 0 0 0 0 11.9359 0 11.9286 12.6377 11.9407 0 0 11.3263 0 0 11.642 10.6502 11.7659 0 0 0 0 0 0 0 0 0 0 11.5544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0012 12.6036 12.989 0 0 12.2997 13.1105 15.9383 0 0 0 0 0 0 0 0 12.537 13.1321 14.5621 13.1618 0 0 0 0 0 0 0 0 13.3811 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5651 0 13.4083 10.9545 0 0 13.4886 0 0 0 0 0 0 0 0 0 0 0 13.1468 0 0 13.2241 14.7515 0 11.6959 0 0 0 0 11.4709 0 0 12.8691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9264 0 0 0 0 0 0 0 0 0 14.7131 14.0186 14.2234 14.0933 0 13.7163 0 11.4199 14.2578 14.0806 0 13.6052 0 15.1453 0 0 0 0 14.2628 0 15.5176 0 0 Q7Z2W4 ZCCHV_HUMAN "Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13, ARTD13) (Inactive Poly [ADP-ribose] polymerase 13, PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein, ZAP)" ZC3HAV1 ZC3HDC2 PRO1677 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; response to virus [GO:0009615] GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0009615; GO:0032481; GO:0032727; GO:0032728; GO:0043123; GO:0045071; GO:0045087; GO:0045296; GO:0046872; GO:0051607; GO:0061014; GO:1900246 cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] FPNCLRSHNLMDR 0.99579 -9.7013 0 0 0 0 9.89435 0 0 0 0 0 0 0 0 0 11.0417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.087 0 11.1652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2784 0 12.9935 13.9643 0 0 0 0 13.0284 0 0 0 12.6329 0 19.3579 13.3136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9647 0 0 11.9918 15.1012 0 12.2297 0 0 0 0 0 0 0 11.6652 13.2244 0 0 0 0 0 0 0 0 0 0 15.5881 0 0 0 0 0 11.2426 0 0 0 14.807 0 0 0 0 14.6861 0 0 0 12.0426 0 14.3928 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N67 DOCK7_HUMAN Dedicator of cytokinesis protein 7 DOCK7 KIAA1771 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264] axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005] axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264] GO:0000226; GO:0005085; GO:0005925; GO:0007264; GO:0007409; GO:0022027; GO:0030424; GO:0030426; GO:0031175; GO:0031267; GO:0033138; GO:0043005; GO:0043547; GO:0045178; GO:0045200; GO:0050767; GO:0090630; GO:0120163; GO:1904754 guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] AYIQITYVEPYFDTYEMKDR 0.99579 -32.852 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7497 12.9066 13.6387 0 0 12.2217 0 11.5378 0 0 0 0 0 0 0 0 0 0 0 10.2142 0 0 10.8787 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2865 12.545 12.5204 0 0 0 0 0 0 0 10.4347 0 0 0 0 9.91207 10.8323 0 0 0 0 0 0 0 0 0 0 12.2041 13.5125 14.6247 0 13.6715 0 0 0 0 15.7631 0 14.2838 13.535 13.8177 13.9488 15.8737 14.1938 11.6233 0 0 0 0 13.9635 15.4347 0 0 0 14.2046 0 14.6344 13.9398 0 13.8154 0 13.7778 0 0 0 0 0 0 11.9206 13.2599 14.7081 0 10.1697 15.4799 13.9712 0 12.7275 14.4714 13.959 0 13.2673 13.5333 14.1981 12.4538 15.5601 13.5501 15.2447 12.8006 14.5401 13.9624 0 0 0 0 0 0 14.2588 0 0 13.8411 12.1038 0 0 14.3087 12.0118 14.372 0 14.7003 0 0 0 0 0 11.8252 13.9633 0 13.5172 0 0 12.7408 13.1068 0 0 0 0 0 10.9089 0 0 Q9H0N5 PHS2_HUMAN "Pterin-4-alpha-carbinolamine dehydratase 2, PHS 2, EC 4.2.1.96 (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor)" PCBD2 DCOH2 DCOHM Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]" nucleus [GO:0005634] "nucleus [GO:0005634]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; positive regulation of transcription, DNA-templated [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729]" GO:0004505; GO:0005634; GO:0006729; GO:0008124; GO:0042802; GO:0045893 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505] AAVLGALGATRRLLAALR 0.99579 -10.042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3374 0 0 0 0 0 0 11.5264 0 0 0 0 0 0 0 0 0 0 16.036 0 0 9.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1816 0 11.5982 0 0 15.2824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H2G2 SLK_HUMAN "STE20-like serine/threonine-protein kinase, STE20-like kinase, hSLK, EC 2.7.11.1 (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase, STE20-related kinase) (Serine/threonine-protein kinase 2)" SLK KIAA0204 STK2 Homo sapiens (Human) apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471] cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893] GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0030334; GO:0031122; GO:0031252; GO:0042802; GO:0042803; GO:0042981; GO:0045296; GO:0046777; GO:0048471; GO:0051893; GO:0070062; GO:0106310 ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] APKELRK 0.99579 -32.887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2861 0 0 0 0 0 0 0 20.2923 0 0 0 15.2262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2827 0 0 0 0 0 0 0 0 0 0 0 13.2917 0 0 0 0 0 0 0 0 0 13.5812 13.6445 0 13.5793 0 0 0 0 14.2631 0 0 0 12.8133 13.6108 0 0 0 0 0 12.5771 0 14.6234 0 0 0 13.6232 12.2805 0 0 0 0 0 0 0 0 11.9817 0 16.7703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NRM1 ENAM_HUMAN Enamelin ENAM Homo sapiens (Human) ameloblast differentiation [GO:0036305]; amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; positive regulation of enamel mineralization [GO:0070175] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576] endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; structural constituent of tooth enamel [GO:0030345]; ameloblast differentiation [GO:0036305]; amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; positive regulation of enamel mineralization [GO:0070175] GO:0005576; GO:0005788; GO:0030345; GO:0031012; GO:0031214; GO:0036305; GO:0070175; GO:0097186 structural constituent of tooth enamel [GO:0030345] AYPPTSR 0.99579 -33.232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4389 0 0 0 0 0 0 0 0 0 11.0664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.238 0 0 0 0 0 0 0 17.4003 0 0 0 12.966 0 0 0 0 0 0 13.5723 0 0 0 0 0 0 14.2225 0 13.3401 0 14.6087 0 0 15.2419 0 0 0 0 0 0 14.492 14.1979 0 0 11.6897 0 0 0 13.0079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6804 0 0 0 0 0 Q9NZ56 FMN2_HUMAN Formin-2 FMN2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192] GO:0003779; GO:0005634; GO:0005730; GO:0005737; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0015031; GO:0016192; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781 actin binding [GO:0003779] AKQVVKLLSNK 0.99579 -33.282 9.65871 0 14.2688 0 0 0 0 0 0 0 0 0 10.1636 0 0 0 0 0 0 0 12.1079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8678 0 0 0 0 0 13.4211 12.7206 0 0 0 0 0 0 0 0 0 0 0 0 9.99563 0 0 0 0 0 0 0 0 0 0 10.5949 0 10.1371 14.4884 13.8787 15.5259 15.9032 15.2392 13.3763 15.3654 16.6675 14.7608 15.4971 0 15.871 15.4772 14.7958 13.9669 15.2281 12.8067 15.3384 14.3931 15.3748 0 14.5313 15.3483 15.1801 12.5517 14.5212 0 15.3448 14.4734 15.3872 14.6121 14.1782 15.4146 15.9848 0 16.5707 15.9098 14.4937 15.21 15.1942 16.0412 15.1887 12.307 15.7987 15.3592 15.4521 15.1636 15.2465 15.6455 15.1607 15.3942 15.0111 15.4268 14.0919 15.6152 15.8058 15.2847 15.6693 13.0116 16.162 16.1039 12.9314 0 0 15.9873 14.2492 16.555 15.5809 15.6052 16.1819 0 13.79 14.5156 0 14.3055 0 14.8092 12.5377 14.644 14.9125 15.1288 14.9349 0 0 10.2718 0 10.5657 0 0 0 0 0 0 0 0 11.0088 0 15.7107 14.0157 14.732 15.3585 0 12.2214 0 14.0064 0 Q9UHL4 DPP2_HUMAN "Dipeptidyl peptidase 2, EC 3.4.14.2 (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II, DPP II) (Quiescent cell proline dipeptidase)" DPP7 DPP2 QPP Homo sapiens (Human) lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982] azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982]; aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508] GO:0004177; GO:0005576; GO:0005794; GO:0006508; GO:0008236; GO:0008239; GO:0031982; GO:0035578; GO:0043231; GO:0070062; GO:1905146 aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236] AARREQQPALR 0.99579 -9.6926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1901 0 0 11.4683 0 0 0 0 0 0 0 0 0 0 14.6111 11.3654 12.0003 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y471 CMAH_HUMAN "Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase, CMP-NeuAc hydroxylase-like protein (Cytidine monophosphate-N-acetylneuraminic acid hydroxylase pseudogene)" CMAHP CMAH Homo sapiens (Human) CMP-N-acetylneuraminate metabolic process [GO:0046381]; regulation of Wnt signaling pathway [GO:0030111] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; nucleus [GO:0005634]; CMP-N-acetylneuraminate monooxygenase activity [GO:0030338]; CMP-N-acetylneuraminate metabolic process [GO:0046381]; regulation of Wnt signaling pathway [GO:0030111] GO:0005634; GO:0005737; GO:0005856; GO:0016020; GO:0030111; GO:0030338; GO:0046381 CMP-N-acetylneuraminate monooxygenase activity [GO:0030338] ARLVKNLQPR 0.99579 -11.676 0 0 0 0 0 0 0 0 13.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0625 0 0 0 0 10.7986 0 0 0 0 0 0 0 0 10.5635 0 0 0 0 14.8286 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2779 13.9573 0 13.9505 0 13.7412 0 13.5548 0 0 0 0 0 0 0 0 0 0 11.2492 0 0 0 10.9608 0 0 0 0 0 0 0 11.2512 11.9425 11.2509 0 0 0 0 0 0 0 0 0 0 11.4345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6468 0 0 0 0 12.5354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2AJT9 BCLA3_HUMAN BCLAF1 and THRAP3 family member 3 BCLAF3 CXorf23 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944] mediator complex [GO:0016592]; mitochondrion [GO:0005739] mediator complex [GO:0016592]; mitochondrion [GO:0005739]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; positive regulation of transcription by RNA polymerase II [GO:0045944] GO:0003677; GO:0003712; GO:0005739; GO:0016592; GO:0045944 DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712] CIEKPYMNYTTQR 0.9958 -33.812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5438 13.0698 0 0 14.7466 0 0 0 0 13.5122 0 0 0 0 0 0 13.5256 0 0 13.5893 0 15.1435 0 0 13.5178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8074 13.7765 0 0 0 0 0 13.9464 0 0 0 0 0 0 0 0 0 9.80088 0 0 0 0 0 0 0 0 0 0 0 0 13.185 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NGR9 MROH6_HUMAN Maestro heat-like repeat-containing protein family member 6 MROH6 C8orf73 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AGGVWGRSR 0.9958 -12.236 0 0 0 0 0 0 0 0 13.1141 0 10.3601 10.6471 0 0 0 0 0 12.4284 0 0 0 0 0 11.9878 12.7424 0 0 0 0 0 0 0 0 12.2338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.398 0 0 15.1734 0 0 0 0 0 0 10.5988 0 0 0 0 10.5982 0 0 0 0 0 14.145 0 0 0 0 13.8546 0 13.5056 11.5935 15.9367 0 14.8881 12.6893 15.0593 13.0189 0 0 0 14.8377 0 0 0 0 0 0 0 0 12.2434 0 0 0 0 0 11.3747 0 0 0 0 0 0 0 0 0 18.8449 0 11.1936 0 0 0 0 0 0 0 13.2621 0 0 0 0 0 11.7558 11.9256 0 0 0 0 0 0 0 0 0 0 0 12.724 0 0 0 0 0 0 0 13.4184 0 0 14.0004 13.941 0 13.0422 0 13.8719 13.2774 0 0 13.8 13.5546 0 14.0073 13.5866 14.0205 18.872 13.0319 0 0 0 13.6962 10.5 14.1056 0 0 P35475 IDUA_HUMAN "Alpha-L-iduronidase, EC 3.2.1.76" IDUA Homo sapiens (Human) chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate catabolic process [GO:0030209]; disaccharide metabolic process [GO:0005984]; glycosaminoglycan catabolic process [GO:0006027]; heparin catabolic process [GO:0030211] coated vesicle [GO:0030135]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202] "coated vesicle [GO:0030135]; extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; L-iduronidase activity [GO:0003940]; signaling receptor binding [GO:0005102]; chondroitin sulfate catabolic process [GO:0030207]; dermatan sulfate catabolic process [GO:0030209]; disaccharide metabolic process [GO:0005984]; glycosaminoglycan catabolic process [GO:0006027]; heparin catabolic process [GO:0030211]" GO:0003940; GO:0004553; GO:0005102; GO:0005984; GO:0006027; GO:0030135; GO:0030207; GO:0030209; GO:0030211; GO:0043202; GO:0070062 "hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; L-iduronidase activity [GO:0003940]; signaling receptor binding [GO:0005102]" AHPNRSVAVTLRLR 0.9958 -12.25 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5058 0 12.8835 11.9007 13.0085 12.1695 0 13.0595 0 12.9279 0 0 12.5583 0 0 0 0 0 0 0 0 0 0 0 0 11.8081 13.3304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1026 14.6267 0 13.8951 0 0 0 0 0 0 0 13.5272 0 14.3404 0 11.219 0 0 0 0 13.5317 0 0 0 0 0 0 0 0 13.3962 0 12.9033 0 0 0 0 0 0 0 0 0 0 0 12.9466 0 0 14.2788 0 0 0 0 13.8843 13.2951 0 0 0 13.7714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5026 15.1826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02742 GCNT1_HUMAN "Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase, EC 2.4.1.102 (Core 2 beta-1,6-N-acetylglucosaminyltransferase, C2GlcNAcT) (Core 2-branching enzyme) (Core2-GlcNAc-transferase, C2GNT, Core 2 GNT) (Leukocyte type core 2 beta-1,6-N-acetylglucosaminyltransferase, C2GnT-L)" GCNT1 NACGT2 Homo sapiens (Human) "cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; O-glycan processing [GO:0016266]; O-glycan processing, core 2 [GO:0016268]; positive regulation of leukocyte tethering or rolling [GO:1903238]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]" extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802] "extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; trans-Golgi network [GO:0005802]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]; cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; O-glycan processing [GO:0016266]; O-glycan processing, core 2 [GO:0016268]; positive regulation of leukocyte tethering or rolling [GO:1903238]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]" GO:0000139; GO:0003829; GO:0005615; GO:0005802; GO:0008375; GO:0009101; GO:0016021; GO:0016266; GO:0016268; GO:0031985; GO:0032868; GO:0048729; GO:0050901; GO:0060352; GO:0060993; GO:1903238 "acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]" ALETLKH 0.9958 -11.756 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5251 15.8885 15.9267 15.1859 0 0 11.5441 0 0 0 0 0 0 12.4646 0 15.6311 0 0 0 0 0 0 0 0 0 0 12.4625 0 15.6923 0 15.4471 12.4042 16.1594 16.1912 0 0 0 0 0 0 0 0 0 0 16.4565 0 0 0 0 0 0 10.3466 0 0 0 0 0 0 0 0 0 0 14.2296 13.7582 14.7115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0907 12.9969 0 15.0822 0 0 13.0464 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6059 0 0 0 0 0 0 0 0 0 0 13.0696 0 0 0 0 0 12.913 0 0 0 0 0 0 0 12.9122 14.0235 0 0 0 13.3715 0 0 0 0 0 0 0 0 0 0 18.6999 13.0365 0 17.6814 0 0 0 0 0 0 0 0 0 12.3368 0 0 13.8309 0 Q14940 SL9A5_HUMAN "Sodium/hydrogen exchanger 5 (Na(+)/H(+) exchanger 5, NHE-5) (Solute carrier family 9 member 5)" SLC9A5 NHE5 Homo sapiens (Human) ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719] GO:0005886; GO:0006811; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719 potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385] ESGSGACLDLQVIDTVRSGR 0.9958 -12.245 13.2902 0 0 0 0 0 0 0 0 0 0 0 0 13.5129 0 0 0 0 0 0 0 0 0 11.347 0 0 0 0 0 14.3811 0 11.29 0 0 0 13.2645 0 0 11.3083 0 12.3732 0 0 11.4047 0 0 14.0482 0 0 0 0 13.0005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.121 0 0 0 0 0 0 0 16.4078 16.5132 0 0 15.8502 0 15.247 0 13.5406 13.5162 13.5665 0 15.1452 14.5167 0 0 0 14.3088 12.0528 14.4822 0 0 0 0 0 0 16.3245 16.9251 0 0 0 0 0 15.7859 15.6588 12.8713 16.0586 0 13.6338 13.4911 14.4681 16.0215 14.6434 0 15.5566 13.7206 16.2187 0 0 14.2584 0 15.4391 15.0744 0 15.2721 15.596 0 0 12.355 15.9392 0 15.6023 15.8939 16.1798 15.7063 0 12.5588 0 0 15.429 15.2604 0 0 0 15.4256 0 0 14.7731 0 14.6228 15.4023 12.2639 14.3317 0 0 0 0 0 0 12.7274 12.677 0 0 0 13.9743 0 14.4023 0 15.9124 0 0 10.7874 0 0 14.8732 0 Q16670 ZSC26_HUMAN Zinc finger and SCAN domain-containing protein 26 (Protein SRE-ZBP) (Zinc finger protein 187) ZSCAN26 ZNF187 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" GHQCHECGK 0.9958 -12.258 0 0 0 0 0 0 0 10.2896 0 12.3157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q32MZ4 LRRF1_HUMAN "Leucine-rich repeat flightless-interacting protein 1, LRR FLII-interacting protein 1 (GC-binding factor 2) (TAR RNA-interacting protein)" LRRFIP1 GCF2 TRIP Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003725; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006357; GO:0042803; GO:0045296 "cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded RNA binding [GO:0003725]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AEAREIRMK 0.9958 -11.746 0 0 0 0 0 0 0 0 0 0 0 0 9.86697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6KCM7 SCMC2_HUMAN Calcium-binding mitochondrial carrier protein SCaMC-2 (Mitochondrial ATP-Mg/Pi carrier protein 3) (Mitochondrial Ca(2+)-dependent solute carrier protein 3) (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25) SLC25A25 APC3 KIAA1896 MCSC3 SCAMC2 UNQ549/PRO1106 Homo sapiens (Human) adipose tissue development [GO:0060612]; ATP metabolic process [GO:0046034]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509]; adipose tissue development [GO:0060612]; ATP metabolic process [GO:0046034]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094] GO:0002021; GO:0005347; GO:0005509; GO:0005743; GO:0014823; GO:0016021; GO:0032094; GO:0035264; GO:0043010; GO:0045333; GO:0046034; GO:0060612; GO:0070588 ATP transmembrane transporter activity [GO:0005347]; calcium ion binding [GO:0005509] LKVLMQVHASR 0.9958 -12.254 0 0 0 0 0 0 0 0 11.1783 0 0 0 0 0 0 14.1402 0 0 0 0 0 0 0 15.7626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3792 0 0 0 12.8314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5061 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7849 0 13.8636 0 12.9366 0 13.1803 0 14.6408 13.7718 0 0 13.9314 0 0 0 0 0 0 0 0 0 0 Q6ZNB6 NFXL1_HUMAN "NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein, hOZFP)" NFXL1 OZFP Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634] "chromatin [GO:0000785]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000977; GO:0000981; GO:0005634; GO:0006355; GO:0008270; GO:0016020; GO:0016021 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" AGPECLHCEEGCSK 0.9958 -34.427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7929 0 0 0 0 0 0 0 0 0 0 0 0 11.3383 12.2432 0 12.2497 0 0 0 0 0 0 0 0 0 0 13.5407 0 0 0 0 0 0 0 0 0 0 11.5118 0 0 0 0 0 10.8814 0 0 0 0 0 0 0 14.4084 0 0 0 12.4304 13.8271 0 13.9596 13.5742 12.2383 13.4114 0 0 0 17.2906 0 12.9835 12.5929 13.201 0 13.9292 0 13.4809 13.2923 0 0 15.0591 11.7978 13.1263 0 0 0 0 13.0432 13.7141 0 0 0 0 0 0 11.2508 0 16.0186 15.9328 16.1066 0 0 0 0 0 0 0 0 0 0 0 11.6684 0 12.1887 13.4264 0 0 0 0 0 12.3902 0 0 0 0 0 14.0713 0 0 14.4002 11.6961 0 0 13.2205 0 0 0 11.0819 12.2464 0 0 0 0 0 0 0 0 13.1031 0 13.0143 0 12.4444 0 0 0 0 0 Q86YC2 PALB2_HUMAN Partner and localizer of BRCA2 PALB2 FANCN Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; inner cell mass cell proliferation [GO:0001833]; mesoderm development [GO:0007498]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756] DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; inner cell mass cell proliferation [GO:0001833]; mesoderm development [GO:0007498]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; post-anal tail morphogenesis [GO:0036342]; somitogenesis [GO:0001756] GO:0000724; GO:0001756; GO:0001833; GO:0003677; GO:0005634; GO:0005654; GO:0006915; GO:0007498; GO:0009887; GO:0032991; GO:0035264; GO:0036342; GO:0043066; GO:0048568; GO:1990391 DNA binding [GO:0003677] AVLGLTKRR 0.9958 -33.974 0 0 0 0 0 0 10.8225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3658 14.1802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7091 0 13.6387 0 0 0 13.8634 0 0 0 0 0 0 0 0 0 0 0 0 13.7692 12.677 0 0 0 0 0 0 14.7858 0 0 0 0 0 0 0 0 0 0 0 13.4327 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0293 0 0 0 0 0 0 0 Q86YV0 RASL3_HUMAN RAS protein activator like-3 RASAL3 Homo sapiens (Human) negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020] cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of NK T cell proliferation [GO:0051142]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165] GO:0005096; GO:0005737; GO:0005829; GO:0005938; GO:0007165; GO:0016020; GO:0042802; GO:0043087; GO:0046580; GO:0051142; GO:0070062; GO:0098562 GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802] AIDEYMK 0.9958 -34.355 0 0 0 0 0 10.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7315 12.8184 0 0 0 0 0 0 0 12.5666 0 0 0 0 0 0 0 10.9915 0 0 0 0 0 0 0 0 0 0 14.3852 14.4131 14.2465 0 0 0 0 14.2479 15.1214 0 12.8061 15.3367 13.8666 0 0 14.6176 13.8325 0 0 15.346 13.7886 13.9413 0 0 0 0 0 0 0 0 0 14.1363 13.8063 13.7585 14.2971 0 13.9067 0 0 13.5767 14.0586 14.3508 0 15.9915 0 14.2121 13.8381 14.6857 0 14.029 0 0 13.1075 13.9279 0 14.1196 15.3379 13.8231 13.923 0 0 0 0 13.393 15.6065 0 0 0 0 0 0 0 13.7597 0 0 0 13.756 0 0 13.576 14.4959 0 14.4717 0 0 0 0 0 13.8745 0 0 14.4404 0 0 0 0 0 13.6713 14.2527 0 0 0 0 0 0 0 Q9HA90 EFCC1_HUMAN EF-hand and coiled-coil domain-containing protein 1 (Coiled-coil domain-containing protein 48) EFCC1 C3orf73 CCDC48 Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; calcium ion binding [GO:0005509] GO:0005509; GO:0005829 calcium ion binding [GO:0005509] GQAEVRR 0.9958 -33.858 11.8429 0 0 0 0 0 12.3612 12.8475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5302 0 0 13.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5706 0 0 13.6416 0 0 0 12.6835 0 0 0 0 0 0 0 14.4313 0 0 0 14.4262 14.6483 0 0 15.0604 0 0 0 14.9368 0 0 14.3021 0 0 0 13.8281 0 0 0 0 0 0 0 11.7551 13.5294 0 11.8969 13.8762 0 13.1222 13.1883 0 0 0 15.5414 0 14.422 0 13.7981 15.6281 14.8209 15.3048 0 0 0 0 0 0 0 14.8875 0 13.1372 0 0 0 0 12.0252 0 0 0 0 0 0 0 0 0 0 0 17.5768 0 0 0 0 0 0 0 0 0 14.4396 13.0244 0 14.0601 0 0 0 12.2277 0 0 0 0 0 0 0 Q9HBW1 LRRC4_HUMAN "Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand, NGL-2)" LRRC4 BAG NAG14 UNQ554/PRO1111 Homo sapiens (Human) excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685] anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; excitatory synapse assembly [GO:1904861]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic density protein 95 clustering [GO:0097119]; synaptic membrane adhesion [GO:0099560] GO:0005886; GO:0043197; GO:0050804; GO:0060076; GO:0070161; GO:0097119; GO:0098685; GO:0098978; GO:0099061; GO:0099560; GO:1904861 DLNISEGRMAELK 0.9958 -11.708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8736 13.9605 0 14.3662 14.4507 14.4831 11.6926 11.6801 0 15.6804 15.2129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2881 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQX4 MYO5C_HUMAN Unconventional myosin-Vc MYO5C Homo sapiens (Human) actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459] actin cytoskeleton [GO:0015629]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; actin filament organization [GO:0007015]; vesicle transport along actin filament [GO:0030050] GO:0000146; GO:0005516; GO:0005524; GO:0007015; GO:0015629; GO:0016459; GO:0030050; GO:0051015; GO:0070062 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146] AALIIQQYFR 0.9958 -34.369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3826 11.3742 0 0 0 12.4425 0 0 0 0 0 0 11.8037 0 0 0 0 0 0 0 0 0 11.198 0 0 0 0 0 0 0 12.3066 0 0 0 0 11.653 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2556 0 0 0 15.6761 0 0 13.7144 14.0674 14.1059 0 14.4551 0 0 0 14.0407 0 14.7858 14.5067 0 13.3731 14.5732 0 0 0 11.5081 11.7585 14.8191 0 0 0 0 0 0 0 14.2939 13.1769 0 0 13.6089 13.1283 14.5989 0 15.3772 13.4093 0 13.643 0 13.5519 13.0959 0 13.8778 15.069 0 13.0463 13.5069 0 0 12.6098 13.1896 0 0 13.2986 0 13.9914 0 12.624 0 13.0441 12.847 0 14.3867 13.6536 13.5304 14.2085 0 12.3868 0 0 0 0 13.4041 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8449 0 11.9164 14.2547 14.1401 12.493 0 0 0 0 0 0 Q9ULV0 MYO5B_HUMAN Unconventional myosin-Vb MYO5B KIAA1119 Homo sapiens (Human) actin filament organization [GO:0007015]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192] actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991] actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; protein-containing complex [GO:0032991]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; small GTPase binding [GO:0031267]; actin filament organization [GO:0007015]; endosomal transport [GO:0016197]; protein transport [GO:0015031]; renal water homeostasis [GO:0003091]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192] GO:0000146; GO:0003091; GO:0005516; GO:0005524; GO:0007015; GO:0015031; GO:0015629; GO:0016192; GO:0016197; GO:0016459; GO:0030050; GO:0030659; GO:0031267; GO:0032991; GO:0045179; GO:0051015; GO:0070062 actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; small GTPase binding [GO:0031267] ALRIEAR 0.9958 -34.344 0 0 14.8089 0 0 0 10.2365 0 0 0 0 0 0 0 10.5029 0 0 0 10.7191 10.6904 0 12.1527 16.1168 12.1073 0 12.0274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3138 0 16.4498 16.4606 16.4804 15.1596 14.992 0 18.6755 18.7003 18.6623 0 15.8794 0 0 0 12.3335 0 0 0 0 0 0 0 13.3246 12.4497 0 13.8463 0 14.4703 0 14.7562 0 0 18.8397 0 0 17.1531 0 0 0 0 0 10.8832 0 0 12.9831 0 0 0 0 0 0 0 17.1585 13.4516 12.693 0 0 0 0 16.395 0 0 0 11.2688 0 0 0 0 0 0 0 0 0 0 0 0 15.3138 14.4153 13.4353 11.8785 12.22 0 0 0 0 0 13.3208 14.0549 11.2582 0 13.8299 0 13.9217 0 0 0 12.7606 0 0 0 0 0 0 0 0 0 13.5383 0 0 0 0 Q9Y5T5 UBP16_HUMAN "Ubiquitin carboxyl-terminal hydrolase 16, EC 3.4.19.12 (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-processing protease UBP-M) (Ubiquitin-specific-processing protease 16)" USP16 MSTP039 Homo sapiens (Human) "cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein deubiquitination [GO:0016579]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein deubiquitination [GO:0016579]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000278; GO:0003713; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006325; GO:0006357; GO:0006511; GO:0006974; GO:0008270; GO:0016578; GO:0016579; GO:0035522; GO:0042393; GO:0043130; GO:0045893; GO:0045901; GO:0045944; GO:0051289; GO:0051301; GO:0051726; GO:0070537; GO:0140014 cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270] CGHQGCGR 0.9958 -10.283 0 0 0 0 0 0 0 0 0 0 0 11.1636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4448 13.3775 0 13.2229 12.8352 0 0 12.7011 0 0 0 12.9635 0 0 0 0 0 12.2539 0 12.0928 0 0 0 0 0 0 0 0 0 0 13.1373 13.4002 13.1704 13.9209 12.7314 16.6866 0 0 0 0 0 0 0 0 0 0 0 0 14.4471 0 0 0 0 0 0 0 0 14.2904 0 0 0 0 0 0 12.2421 0 0 11.0743 0 0 0 12.6273 0 12.5871 0 0 0 11.0699 0 0 0 12.294 0 0 0 0 11.8088 0 0 0 0 0 13.6701 0 0 0 0 0 A6NKL6 T200C_HUMAN Transmembrane protein 200C (Transmembrane protein TTMA) (Two transmembrane domain-containing family member A) TMEM200C TTMA Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AKDLAAAAAAAAAAAASSSSSAPAAAPPGAIPLNGFLSYVQSR 0.99581 -9.5405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.319 0 0 11.818 0 0 0 0 0 12.2781 11.4521 0 0 0 0 0 0 0 0 0 0 0 11.1804 0 0 0 0 0 0 0 13.5047 11.6917 12.8615 0 0 0 0 10.5144 0 0 0 13.3588 0 0 0 12.3837 0 0 0 0 12.0107 0 12.9764 13.1921 13.5384 13.1723 0 0 0 0 11.3054 0 0 13.5859 0 0 12.3627 0 0 13.4914 16.2368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4551 0 0 0 11.2205 0 0 0 0 0 0 0 0 10.3017 0 0 0 0 11.0451 0 0 0 0 0 0 0 O43719 HTSF1_HUMAN "HIV Tat-specific factor 1, Tat-SF1" HTATSF1 Homo sapiens (Human) "mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; U2-type prespliceosome assembly [GO:1903241]; viral genome replication [GO:0019079]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing, via spliceosome [GO:0000398]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; U2-type prespliceosome assembly [GO:1903241]; viral genome replication [GO:0019079]" GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006357; GO:0019079; GO:0032784; GO:1903241 RNA binding [GO:0003723] AEEGDADEKLFEESDDKEDEDADGK 0.99581 -9.8212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4772 0 0 0 0 0 0 0 0 0 0 0 0 13.9919 0 14.2158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.32434 11.4726 0 10.0329 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9171 0 0 12.5147 0 0 0 0 0 14.1302 12.9663 13.0561 0 0 12.7126 14.85 0 0 0 13.6258 0 0 13.5362 13.3473 13.6699 12.3283 14.1932 0 0 0 0 0 0 0 15.8228 0 0 0 0 0 0 12.6766 0 0 0 0 0 0 12.0847 0 0 0 0 0 10.8071 0 0 0 0 0 0 12.8517 0 11.9198 11.1233 12.0438 0 0 0 0 0 0 0 0 0 0 0 0 14.0163 0 0 0 0 11.4655 0 0 11.9372 13.2347 0 0 12.1276 0 11.4507 0 12.9957 13.6907 11.3852 0 13.6593 0 0 11.323 0 0 0 0 14.4207 0 0 0 0 O95628 CNOT4_HUMAN "CCR4-NOT transcription complex subunit 4, EC 2.3.2.27 (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4)" CNOT4 NOT4 Homo sapiens (Human) nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634] CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0016567; GO:0030014; GO:0045652; GO:0046872; GO:0051865 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842] LADPEVLK 0.99581 -12.357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2756 0 0 0 0 16.8983 15.8426 0 0 0 0 0 0 0 0 0 0 0 13.7855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1891 0 15.0609 0 15.0442 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7949 0 0 O95817 BAG3_HUMAN "BAG family molecular chaperone regulator 3, BAG-3 (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1)" BAG3 BIS Homo sapiens (Human) aggresome assembly [GO:0070842]; autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein transport along microtubule [GO:0098840]; spinal cord development [GO:0021510]; striated muscle cell apoptotic process [GO:0010658] aggresome [GO:0016235]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018] aggresome [GO:0016235]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; aggresome assembly [GO:0070842]; autophagosome assembly [GO:0000045]; brain development [GO:0007420]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein targeting to mitochondrion [GO:1903215]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter in response to stress [GO:0097201]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein transport along microtubule [GO:0098840]; spinal cord development [GO:0021510]; striated muscle cell apoptotic process [GO:0010658] GO:0000045; GO:0000774; GO:0001725; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0007420; GO:0008625; GO:0010658; GO:0010664; GO:0016020; GO:0016235; GO:0021510; GO:0030018; GO:0034605; GO:0034620; GO:0042307; GO:0043005; GO:0043066; GO:0044877; GO:0045296; GO:0045505; GO:0046716; GO:0046827; GO:0050821; GO:0051087; GO:0061684; GO:0070842; GO:0071260; GO:0097192; GO:0097201; GO:0098840; GO:0101031; GO:0140597; GO:1903215; GO:1905337 adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; dynein intermediate chain binding [GO:0045505]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877] KVQTILEK 0.99581 -12.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7344 0 0 0 11.9905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2482 0 0 0 0 10.3713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6202 0 0 0 0 11.1543 0 0 0 0 0 0 0 0 0 0 0 12.202 0 0 0 0 0 0 13.3742 0 12.2829 0 0 0 0 0 0 0 0 0 0 0 0 11.9691 0 0 0 0 11.9316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P04629 NTRK1_HUMAN "High affinity nerve growth factor receptor, EC 2.7.10.1 (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A, Trk-A) (gp140trk) (p140-TrkA)" NTRK1 MTC TRK TRKA Homo sapiens (Human) "aging [GO:0007568]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; sympathetic nervous system development [GO:0048485]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038] "axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; aging [GO:0007568]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; B cell differentiation [GO:0030183]; behavioral response to formalin induced pain [GO:0061368]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nicotine [GO:0071316]; circadian rhythm [GO:0007623]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; learning or memory [GO:0007611]; mechanoreceptor differentiation [GO:0042490]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; olfactory nerve development [GO:0021553]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; programmed cell death involved in cell development [GO:0010623]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of protein kinase B signaling [GO:0051896]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to hydrostatic pressure [GO:0051599]; response to nutrient levels [GO:0031667]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]; Sertoli cell development [GO:0060009]; sympathetic nervous system development [GO:0048485]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001934; GO:0004713; GO:0004714; GO:0005004; GO:0005030; GO:0005166; GO:0005524; GO:0005769; GO:0005770; GO:0005886; GO:0005887; GO:0006468; GO:0007169; GO:0007411; GO:0007568; GO:0007611; GO:0007623; GO:0008285; GO:0009314; GO:0009410; GO:0009986; GO:0010008; GO:0010465; GO:0010623; GO:0010976; GO:0014068; GO:0018108; GO:0019900; GO:0021553; GO:0030183; GO:0030424; GO:0030425; GO:0031175; GO:0031667; GO:0031901; GO:0031902; GO:0032991; GO:0033674; GO:0038083; GO:0038180; GO:0042490; GO:0042802; GO:0042803; GO:0043025; GO:0043066; GO:0043068; GO:0043121; GO:0043235; GO:0043524; GO:0043547; GO:0045766; GO:0046579; GO:0046777; GO:0048011; GO:0048406; GO:0048485; GO:0048666; GO:0048678; GO:0050965; GO:0050966; GO:0051092; GO:0051402; GO:0051599; GO:0051602; GO:0051896; GO:0051965; GO:0051968; GO:0055038; GO:0060009; GO:0060385; GO:0061368; GO:0070374; GO:0071316; GO:1990090 ATP binding [GO:0005524]; GPI-linked ephrin receptor activity [GO:0005004]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotrophin binding [GO:0043121]; neurotrophin p75 receptor binding [GO:0005166]; neurotrophin receptor activity [GO:0005030]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] ACPPEVYAIMR 0.99581 -9.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3122 13.364 0 0 0 0 0 0 0 0 0 0 0 13.5203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9108 0 13.6111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5765 0 0 0 0 0 0 0 0 0 0 0 P05112 IL4_HUMAN "Interleukin-4, IL-4 (B-cell stimulatory factor 1, BSF-1) (Binetrakin) (Lymphocyte stimulatory factor 1) (Pitrakinra)" IL4 Homo sapiens (Human) "activation of Janus kinase activity [GO:0042976]; B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; cholesterol metabolic process [GO:0008203]; dendritic cell differentiation [GO:0097028]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; immune response [GO:0006955]; innate immune response in mucosa [GO:0002227]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neuroinflammatory response [GO:0150076]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of eosinophil chemotaxis [GO:2000424]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of immune response [GO:0050776]; regulation of isotype switching [GO:0045191]; regulation of phosphorylation [GO:0042325]; T cell activation [GO:0042110]; T-helper 2 cell differentiation [GO:0045064]; type 2 immune response [GO:0042092]" extracellular region [GO:0005576]; extracellular space [GO:0005615] "extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-4 receptor binding [GO:0005136]; activation of Janus kinase activity [GO:0042976]; B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; cholesterol metabolic process [GO:0008203]; dendritic cell differentiation [GO:0097028]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; immune response [GO:0006955]; innate immune response in mucosa [GO:0002227]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor production [GO:0032720]; neuroinflammatory response [GO:0150076]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of eosinophil chemotaxis [GO:2000424]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of immune response [GO:0050776]; regulation of isotype switching [GO:0045191]; regulation of phosphorylation [GO:0042325]; T cell activation [GO:0042110]; T-helper 2 cell differentiation [GO:0045064]; type 2 immune response [GO:0042092]" GO:0000122; GO:0001774; GO:0002227; GO:0002230; GO:0002674; GO:0002677; GO:0005125; GO:0005136; GO:0005576; GO:0005615; GO:0006955; GO:0008083; GO:0008203; GO:0008284; GO:0010628; GO:0010633; GO:0016239; GO:0030183; GO:0030335; GO:0030890; GO:0031296; GO:0032720; GO:0032733; GO:0032736; GO:0042092; GO:0042102; GO:0042110; GO:0042116; GO:0042325; GO:0042531; GO:0042976; GO:0043011; GO:0043031; GO:0043066; GO:0043306; GO:0045064; GO:0045191; GO:0045348; GO:0045582; GO:0045671; GO:0045892; GO:0045893; GO:0045944; GO:0048260; GO:0048295; GO:0048304; GO:0050728; GO:0050776; GO:0071677; GO:0097028; GO:0097192; GO:0120162; GO:0150076; GO:0150079; GO:1900223; GO:1901741; GO:1901857; GO:1903660; GO:1903845; GO:2000320; GO:2000352; GO:2000424; GO:2000553; GO:2001171; GO:2001237 cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-4 receptor binding [GO:0005136] FLKRLDR 0.99581 -35.245 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8431 13.7135 0 0 0 0 0 0 0 0 0 0 0 0 13.5983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29401 TKT_HUMAN "Transketolase, TK, EC 2.2.1.1" TKT Homo sapiens (Human) "glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]" cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; vesicle [GO:0031982] "cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; regulation of growth [GO:0040008]; ribose phosphate biosynthetic process [GO:0046390]" GO:0000287; GO:0004802; GO:0005509; GO:0005654; GO:0005777; GO:0005789; GO:0005829; GO:0006098; GO:0009052; GO:0016604; GO:0030976; GO:0031982; GO:0040008; GO:0042803; GO:0046166; GO:0046390; GO:0070062 calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802] ESYHKPDQQK 0.99581 -11.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.999 0 10.562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.726 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4184 0 0 0 0 0 0 10.6102 0 0 0 0 0 0 10.3388 0 0 0 0 0 0 0 P48051 KCNJ6_HUMAN "G protein-activated inward rectifier potassium channel 2, GIRK-2 (BIR1) (Inward rectifier K(+) channel Kir3.2) (KATP-2) (Potassium channel, inwardly rectifying subfamily J member 6)" KCNJ6 GIRK2 KATP2 KCNJ7 Homo sapiens (Human) potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765] GO:0005242; GO:0005794; GO:0005886; GO:0006813; GO:0008076; GO:0015467; GO:0034765; GO:1990573 G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242] CNVHHGNVR 0.99581 -12.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6452 0 0 0 0 0 0 0 0 0 0 12.0982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54132 BLM_HUMAN "RecQ-like DNA helicase BLM, EC 3.6.4.12 (Bloom syndrome protein) (DNA helicase, RecQ-like type 2, RecQ2) (RecQ protein-like 3)" BLM RECQ2 RECQL3 Homo sapiens (Human) "cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-templated DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]" chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657] "chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-templated DNA replication [GO:0090329]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; resolution of recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]" GO:0000079; GO:0000228; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000729; GO:0000800; GO:0002039; GO:0003677; GO:0003678; GO:0003697; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006260; GO:0006268; GO:0006281; GO:0006310; GO:0006974; GO:0007095; GO:0008094; GO:0008270; GO:0009378; GO:0010165; GO:0016363; GO:0016605; GO:0016887; GO:0031297; GO:0031422; GO:0032201; GO:0032508; GO:0032991; GO:0042802; GO:0042803; GO:0043138; GO:0044806; GO:0045893; GO:0045910; GO:0048478; GO:0051259; GO:0051260; GO:0051782; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0071139; GO:0071479; GO:0072711; GO:0072757; GO:0090329; GO:0090656; GO:1905773; GO:1990814 "3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]" ALVAKVSQR 0.99581 -12.302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7006 10.7779 0 0 10.5288 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0003 0 0 0 13.8265 0 0 0 0 0 0 13.3926 0 0 0 0 0 13.6757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8746 0 0 0 0 17.0981 0 11.1388 0 0 0 0 0 0 0 13.603 13.4485 15.8873 0 0 0 12.5613 12.3525 0 12.6173 12.0474 0 0 0 0 11.4177 14.2411 15.7683 0 12.248 0 0 0 0 12.9768 11.8642 0 0 0 0 12.862 0 0 0 13.1846 0 0 0 0 0 0 11.8804 15.8701 12.1225 13.2136 12.7786 0 0 12.1799 13.3274 0 15.0236 15.1787 0 0 12.5524 0 0 0 0 0 13.3339 12.7129 12.4331 0 0 0 0 0 12.1466 0 0 16.33 16.5819 13.6094 0 10.9705 0 13.9279 0 14.0292 14.2104 0 14.1374 12.5413 0 14.8075 13.4099 14.9456 14.9851 0 0 11.7096 13.6644 0 0 0 0 P54886 P5CS_HUMAN "Delta-1-pyrroline-5-carboxylate synthase, P5CS (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase, GK, EC 2.7.2.11 (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase, GPR, EC 1.2.1.41 (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase) ]" ALDH18A1 GSAS P5CS PYCS Homo sapiens (Human) citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; phosphorylation [GO:0016310]; proline biosynthetic process [GO:0006561] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; phosphorylation [GO:0016310]; proline biosynthetic process [GO:0006561] GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0006536; GO:0006561; GO:0006592; GO:0016310; GO:0019240; GO:0042802; GO:0055129 ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723] CGFQPFNQHLLPWVKCTTVFR 0.99581 -12.352 11.8622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3239 0 0 0 14.8143 14.9209 13.9981 0 0 14.8659 0 0 14.3451 0 0 14.3235 0 14.5087 0 0 0 0 14.8267 0 0 0 0 0 0 15.1713 15.3617 13.5922 15.1003 0 0 0 0 14.721 0 0 14.043 12.8099 12.8781 0 15.0961 15.2386 14.2823 15.601 12.9805 0 0 13.6838 0 13.4069 0 14.0856 0 0 12.8841 0 0 13.7917 0 0 0 14.8551 14.1993 14.9839 14.6923 15.5216 13.889 13.9704 16.0269 15.1028 14.802 11.7217 14.964 0 0 0 0 0 14.1319 0 0 0 0 14.1777 10.7178 0 0 13.6701 0 0 13.0879 0 0 0 0 0 0 0 13.3173 13.1359 0 13.8883 0 0 0 0 0 0 Q05193 DYN1_HUMAN "Dynamin-1, EC 3.6.5.5" DNM1 DNM Homo sapiens (Human) endocytosis [GO:0006897]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; toxin transport [GO:1901998] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; modulation of chemical synaptic transmission [GO:0050804]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle endocytosis [GO:0048488]; toxin transport [GO:1901998] GO:0001917; GO:0003723; GO:0003924; GO:0005525; GO:0005737; GO:0005874; GO:0005886; GO:0006897; GO:0006898; GO:0007032; GO:0008017; GO:0016020; GO:0016185; GO:0019901; GO:0030117; GO:0031623; GO:0042802; GO:0045202; GO:0048488; GO:0050804; GO:0070062; GO:0098684; GO:0098835; GO:0098978; GO:1901998 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] APAVPPAR 0.99581 -9.8217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.336 12.9725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9737 0 0 0 12.4381 15.9328 13.0888 0 0 0 13.8642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5749 14.7052 0 0 0 0 0 0 12.7916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9616 0 0 0 0 0 0 13.293 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6511 12.0727 0 0 Q15042 RB3GP_HUMAN "Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130, Rab3-GAP)" RAB3GAP1 KIAA0066 RAB3GAP Homo sapiens (Human) brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; face morphogenesis [GO:0060325]; hypothalamus development [GO:0021854]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of GTPase activity [GO:0043087]; regulation of short-term neuronal synaptic plasticity [GO:0048172] GO:0005085; GO:0005096; GO:0005789; GO:0005794; GO:0005811; GO:0005829; GO:0007420; GO:0021854; GO:0031267; GO:0032991; GO:0034389; GO:0043010; GO:0043087; GO:0043547; GO:0048172; GO:0060079; GO:0060325; GO:0061646; GO:0070062; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786 GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267] ARSLKAK 0.99581 -12.341 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0552 15.691 0 0 0 13.5386 0 0 0 0 0 0 0 14.834 0 0 0 0 0 14.6916 0 0 0 0 0 0 14.5941 0 0 0 0 0 14.4133 0 0 0 0 0 0 12.1949 0 0 14.4194 0 0 0 0 0 0 0 13.177 0 0 0 11.1643 0 0 0 0 0 0 0 0 0 0 0 10.8833 0 0 0 0 0 0 0 0 0 0 0 Q68J44 DUS29_HUMAN "Dual specificity phosphatase 29 (Dual specificity phosphatase 27) (Dual specificity phosphatase DUPD1, EC 3.1.3.16, EC 3.1.3.48)" DUSP29 DUPD1 DUSP27 Homo sapiens (Human) glucose homeostasis [GO:0042593]; muscle cell differentiation [GO:0042692]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; MAP kinase phosphatase activity [GO:0033549]; myosin phosphatase activity [GO:0017018]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; glucose homeostasis [GO:0042593]; muscle cell differentiation [GO:0042692]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAPK cascade [GO:0043409]; protein dephosphorylation [GO:0006470] GO:0004725; GO:0005634; GO:0005737; GO:0006470; GO:0008138; GO:0017018; GO:0032991; GO:0033549; GO:0042593; GO:0042692; GO:0042803; GO:0043409; GO:0070373 MAP kinase phosphatase activity [GO:0033549]; myosin phosphatase activity [GO:0017018]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] DMTLVDAIQQVAK 0.99581 -12.316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5717 0 0 0 0 0 0 0 0 0 13.24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86U38 NOP9_HUMAN Nucleolar protein 9 NOP9 C14orf21 KIAA2021 Homo sapiens (Human) "endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]" "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]" "90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]" GO:0000056; GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005730; GO:0030686; GO:0030688 RNA binding [GO:0003723] EAPETGEER 0.99581 -35.225 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7659 0 11.4727 0 0 0 0 0 0 11.2932 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3662 0 0 0 0 0 18.7003 18.6623 0 0 0 0 0 13.2202 12.7175 0 0 12.7133 0 0 0 0 0 0 0 0 12.8407 0 0 0 0 13.0905 0 0 0 0 12.1385 0 0 12.7233 0 0 0 0 14.3605 0 0 0 0 0 0 0 0 12.6768 0 0 0 0 0 0 0 12.4852 0 12.25 0 0 0 0 0 0 0 0 0 0 12.9852 0 0 0 0 0 0 0 11.991 12.5088 0 0 0 0 0 11.9029 0 0 0 0 0 12.7073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IX03 KIBRA_HUMAN "Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein, KIBRA) (WW domain-containing protein 1)" WWC1 KIAA0869 Homo sapiens (Human) "cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ruffle membrane [GO:0032587]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0032991; GO:0035330; GO:0035331; GO:0043410; GO:0046621; GO:0048471; GO:0060090 kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; transcription coactivator activity [GO:0003713] AEIATAKSRVNK 0.99581 -11.817 0 0 0 9.56892 0 0 0 0 0 0 0 0 0 10.8978 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6318 0 0 0 0 0 0 0 13.6467 14.0583 14.1689 13.5162 15.3318 0 14.3102 0 0 0 11.1338 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0532 0 0 0 0 0 0 0 0 0 14.0265 0 12.8709 0 0 0 13.275 0 13.5932 12.6182 12.8321 0 12.6494 0 0 0 12.815 0 11.5671 0 14.3061 0 11.1936 0 0 15.4225 0 0 0 0 14.9486 11.475 0 0 0 0 12.6081 0 0 13.1672 0 13.3505 0 0 0 0 0 14.9118 14.1455 12.8477 12.5455 12.5675 0 0 13.3628 0 0 0 13.1277 0 0 0 0 0 0 0 0 11.7686 0 13.0258 0 0 0 12.8205 0 0 0 13.7491 0 13.0385 0 0 13.3876 0 14.757 0 0 0 0 0 13.2879 0 0 12.3047 11.136 0 0 15.3992 0 13.2884 13.1035 Q8NFL0 B3GN7_HUMAN "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7, BGnT-7, Beta-1,3-Gn-T7, Beta-1,3-N-acetylglucosaminyltransferase 7, Beta3Gn-T7, EC 2.4.1.-" B3GNT7 Homo sapiens (Human) keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]" GO:0000139; GO:0008194; GO:0008375; GO:0008499; GO:0008532; GO:0016021; GO:0016266; GO:0016757; GO:0018146; GO:0030311 "acetylglucosaminyltransferase activity [GO:0008375]; glycosyltransferase activity [GO:0016757]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]; UDP-glycosyltransferase activity [GO:0008194]" AMLVVHK 0.99581 -9.5221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2428 0 0 0 0 0 0 0 15.181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.305 0 0 0 0 0 0 0 0 10.7551 13.8476 0 0 0 0 0 0 0 0 15.3562 0 0 0 16.3776 0 0 0 0 13.9063 0 14.0851 0 0 0 0 0 0 0 0 0 13.9451 0 0 0 14.3724 0 0 0 15.4455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0771 0 0 0 0 0 0 0 0 0 0 10.7964 0 0 0 Q96AW1 VOPP1_HUMAN "Vesicular, overexpressed in cancer, prosurvival protein 1 (EGFR-coamplified and overexpressed protein, ECop) (Glioblastoma-amplified secreted protein) (Putative NF-kappa-B-activating protein 055N)" VOPP1 ECOP GASP Homo sapiens (Human) cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; integral component of organelle membrane [GO:0031301] cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; integral component of organelle membrane [GO:0031301] GO:0005768; GO:0030659; GO:0031301 HCWYFEGLYPTYYICRSYEDCCGSR 0.99581 -9.8023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0959 0 0 10.1804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.166 0 0 0 0 0 11.0428 0 11.9271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8456 0 0 0 0 0 0 12.3361 0 0 0 12.1304 0 0 0 0 9.69791 0 0 0 0 0 0 0 0 0 0 0 0 12.8349 12.0997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7477 0 0 0 0 Q99983 OMD_HUMAN "Osteomodulin (Keratan sulfate proteoglycan osteomodulin, KSPG osteomodulin) (Osteoadherin, OSAD)" OMD SLRR2C UNQ190/PRO216 Homo sapiens (Human) cell adhesion [GO:0007155]; regulation of bone mineralization [GO:0030500] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; cell adhesion [GO:0007155]; regulation of bone mineralization [GO:0030500] GO:0005576; GO:0005615; GO:0005796; GO:0007155; GO:0030500; GO:0043202; GO:0062023; GO:0070062 LLLGYNEISK 0.99581 -12.385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9509 0 0 0 0 16.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4691 0 0 0 0 16.1366 0 0 0 0 0 0 0 0 13.4921 0 0 11.3112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4458 0 0 0 0 0 0 0 0 0 0 0 10.5711 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BWW9 APOL5_HUMAN "Apolipoprotein L5 (Apolipoprotein L-V, ApoL-V)" APOL5 Homo sapiens (Human) lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] cytoplasm [GO:0005737]; extracellular region [GO:0005576] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157] GO:0005576; GO:0005737; GO:0006629; GO:0006869; GO:0008035; GO:0008289; GO:0042157 high-density lipoprotein particle binding [GO:0008035]; lipid binding [GO:0008289] AVRGSRVVK 0.99581 -12.369 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1988 10.9471 0 0 0 0 0 14.1755 0 11.6597 0 0 0 0 0 11.2043 0 0 0 0 0 13.5245 0 0 13.7389 13.2591 13.5817 0 11.9209 0 11.7308 0 0 0 0 13.3093 0 0 0 0 0 0 0 0 0 13.2494 13.1865 0 0 0 14.4365 0 0 0 0 0 0 0 0 0 12.0438 0 0 0 0 0 0 0 0 0 0 0 0 11.6691 0 0 0 0 0 0 0 0 0 0 0 0 10.4201 Q9H2S9 IKZF4_HUMAN Zinc finger protein Eos (Ikaros family zinc finger protein 4) IKZF4 KIAA1782 ZNFN1A4 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]" nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0016604; GO:0019904; GO:0032991; GO:0043425; GO:0045892; GO:0045944; GO:0051260 bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270] GPLTDPGASPSNGCQDSTDTESNHEDR 0.99581 -11.818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7468 0 0 0 0 0 0 0 13.4671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2C2 UST_HUMAN "Uronyl 2-sulfotransferase, EC 2.8.2.-" UST DS2ST Homo sapiens (Human) dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; dermatan sulfate biosynthetic process [GO:0030208]; establishment of cell polarity [GO:0030010]; protein sulfation [GO:0006477]; regulation of axonogenesis [GO:0050770] GO:0000139; GO:0006477; GO:0008146; GO:0016021; GO:0030010; GO:0030208; GO:0050770 sulfotransferase activity [GO:0008146] CGSRTVVLLLRILSEK 0.99581 -9.8227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4907 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3069 0 10.7262 0 0 0 0 0 11.577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5118 0 0 0 0 0 0 14.9155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2KHM9 MOONR_HUMAN "Protein moonraker, MNR (OFD1- and FOPNL-interacting protein)" KIAA0753 MNR OFIP Homo sapiens (Human) centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829] centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539] GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0034451; GO:0060271; GO:0061824; GO:0071539 ALERWPSTSPK 0.99582 -11.906 0 0 12.2753 17.1677 0 0 0 0 18.6996 18.9893 18.9693 19.0277 19.0052 19.0664 19.0573 0 0 0 0 0 0 0 15.7915 0 0 0 0 11.1664 9.99223 0 19.1332 19.0409 19.2083 19.0769 19.1194 19.2109 19.0785 19.2351 19.0934 19.1349 19.155 19.1765 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6594 17.792 18.2806 17.6708 16.3841 15.4243 0 0 15.8653 16.257 17.0749 0 0 0 0 0 0 0 0 0 0 0 13.316 0 0 0 0 0 0 0 0 0 0 0 0 14.2269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1506 0 0 0 0 0 0 0 0 11.6624 14.0283 13.5936 0 0 0 16.0793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5413 0 0 0 0 0 0 20.1655 13.0207 20.0577 12.9721 19.9601 13.5567 19.1013 12.8596 19.0233 19.0939 11.9314 19.0194 20.1716 11.8619 0 0 0 0 0 0 0 19.4729 0 19.572 O94763 RMP_HUMAN "Unconventional prefoldin RPB5 interactor 1 (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein, RPB5-mediating protein)" URI1 C19orf2 NNX3 PPP1R19 RMP URI Homo sapiens (Human) cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062] chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615] GO:0000122; GO:0000993; GO:0001558; GO:0003682; GO:0003714; GO:0004864; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0009615; GO:0010923; GO:0019212; GO:0030425; GO:0050821; GO:0051219; GO:0071363; GO:0071383; GO:0101031; GO:1990062; GO:2001243 chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714] AKHRIAHK 0.99582 -11.893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9148 12.357 12.3675 0 11.9518 0 0 0 0 0 0 0 10.6609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.244 0 0 11.3465 0 0 0 0 0 0 0 0 9.80678 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9963 14.0449 14.262 0 14.1382 0 0 0 0 13.683 14.8454 0 13.5228 13.6729 11.2556 0 14.0583 0 0 0 13.701 0 12.7575 14.5188 10.6062 12.9711 0 0 14.5174 0 0 0 0 0 13.6204 13.4534 13.6975 0 0 0 13.8575 0 0 12.3323 12.7892 13.5999 13.7725 17.5699 0 13.9635 13.9984 13.4282 0 13.119 0 13.5651 0 0 14.5734 14.5567 13.7506 0 13.9212 0 15.039 0 0 0 0 0 13.6479 13.7871 0 13.2511 12.9363 0 13.8674 0 12.1352 0 0 0 12.7568 0 0 0 0 0 0 0 0 13.3048 0 0 0 0 0 17.1995 0 13.7549 0 0 0 0 0 0 P42566 EPS15_HUMAN "Epidermal growth factor receptor substrate 15, Protein Eps15 (Protein AF-1p)" EPS15 AF1P Homo sapiens (Human) clathrin coat assembly [GO:0048268]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; vesicle organization [GO:0016050]; viral entry into host cell [GO:0046718] aggresome [GO:0016235]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886] aggresome [GO:0016235]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124]; clathrin coat assembly [GO:0048268]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; vesicle organization [GO:0016050]; viral entry into host cell [GO:0046718] GO:0005509; GO:0005829; GO:0005886; GO:0005905; GO:0006895; GO:0006897; GO:0015031; GO:0016020; GO:0016050; GO:0016197; GO:0016235; GO:0017124; GO:0019065; GO:0030132; GO:0031593; GO:0031901; GO:0032456; GO:0043231; GO:0045296; GO:0046718; GO:0048268 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124] EDTIKQR 0.99582 -11.911 0 0 0 0 0 0 0 0 0 14.705 14.2641 0 0 0 0 0 0 0 0 0 12.2911 0 0 0 13.2261 0 12.5227 0 0 0 0 14.7867 0 0 0 0 0 0 0 0 0 0 0 14.0434 14.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7645 0 0 0 11.0042 0 0 12.728 13.3651 0 14.2545 0 0 12.8504 13.8543 0 0 0 0 0 0 0 13.8761 0 0 0 13.5739 0 0 0 0 0 12.9764 13.7299 0 0 0 11.547 0 0 13.6458 0 0 0 12.0253 12.4248 0 0 0 0 13.8609 0 0 0 0 0 0 13.6174 0 0 0 14.645 0 0 10.3414 0 0 0 0 0 0 0 0 0 0 0 14.0346 0 0 0 0 12.721 0 0 0 0 0 0 0 0 0 0 0 14.6798 0 0 0 0 0 0 14.5681 0 0 0 0 0 Q12879 NMDE1_HUMAN "Glutamate receptor ionotropic, NMDA 2A, GluN2A (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A, NMDAR2A, NR2A, hNR2A)" GRIN2A NMDAR2A Homo sapiens (Human) "activation of cysteine-type endopeptidase activity [GO:0097202]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; directional locomotion [GO:0033058]; dopamine metabolic process [GO:0042417]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein catabolic process [GO:0030163]; protein localization to postsynaptic membrane [GO:1903539]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; serotonin metabolic process [GO:0042428]; sleep [GO:0030431]; startle response [GO:0001964]; visual learning [GO:0008542]" anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021] "anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; amyloid-beta binding [GO:0001540]; glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity [GO:0097202]; brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; cation transmembrane transport [GO:0098655]; chemical synaptic transmission [GO:0007268]; directional locomotion [GO:0033058]; dopamine metabolic process [GO:0042417]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein catabolic process [GO:0030163]; protein localization to postsynaptic membrane [GO:1903539]; regulation of cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to amphetamine [GO:0001975]; response to ethanol [GO:0045471]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; serotonin metabolic process [GO:0042428]; sleep [GO:0030431]; startle response [GO:0001964]; visual learning [GO:0008542]" GO:0001540; GO:0001964; GO:0001975; GO:0004972; GO:0005789; GO:0005886; GO:0005887; GO:0007215; GO:0007268; GO:0007420; GO:0007611; GO:0007613; GO:0008021; GO:0008270; GO:0008542; GO:0009410; GO:0009611; GO:0009986; GO:0014069; GO:0015276; GO:0017146; GO:0019233; GO:0022008; GO:0022849; GO:0030163; GO:0030431; GO:0030659; GO:0033058; GO:0035235; GO:0038023; GO:0042177; GO:0042417; GO:0042428; GO:0042734; GO:0043065; GO:0043197; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0051968; GO:0060079; GO:0060291; GO:0070161; GO:0097060; GO:0097202; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:0099061; GO:1903539; GO:1904062; GO:2000463 amyloid-beta binding [GO:0001540]; glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated ion channel activity [GO:0015276]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023]; zinc ion binding [GO:0008270] DCSEVERTYLKTK 0.99582 -12.46 0 0 0 0 0 0 0 0 10.123 0 0 10.3417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.713 13.2158 0 0 0 0 13.2054 14.5627 0 0 13.4507 0 12.2992 11.7572 12.1294 0 0 0 0 0 0 0 0 11.1341 0 0 0 10.9694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0456 0 0 0 0 0 0 0 0 0 10.9385 0 0 0 10.793 0 0 0 0 0 0 0 0 11.3545 0 14.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3261 0 0 Q13938 CAYP1_HUMAN Calcyphosin (Calcyphosine) CAPS Homo sapiens (Human) intracellular signal transduction [GO:0035556] cytoplasm [GO:0005737]; vesicle [GO:0031982] cytoplasm [GO:0005737]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; intracellular signal transduction [GO:0035556] GO:0005509; GO:0005737; GO:0031982; GO:0035556 calcium ion binding [GO:0005509] FFRQLDR 0.99582 -11.898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T089 MORN1_HUMAN MORN repeat-containing protein 1 MORN1 Homo sapiens (Human) CADGSTYK 0.99582 -9.8331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7758 16.9538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8355 0 0 0 0 13.2167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PJP8 DCR1A_HUMAN "DNA cross-link repair 1A protein (Beta-lactamase DCLRE1A, EC 3.5.2.6) (SNM1 homolog A, hSNM1, hSNM1A)" DCLRE1A KIAA0086 SNM1 SNM1A Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654] fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; 5'-3' exodeoxyribonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848] GO:0001650; GO:0003684; GO:0005654; GO:0006303; GO:0007049; GO:0008800; GO:0031848; GO:0035312; GO:0036297; GO:0046872; GO:0051301 5'-3' exodeoxyribonuclease activity [GO:0035312]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; metal ion binding [GO:0046872] DGSLEEDDDSCGFFK 0.99582 -12.485 0 0 0 0 0 0 0 0 0 0 0 0 13.1986 0 0 0 0 0 16.7086 0 0 13.4348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3902 0 0 0 0 0 0 0 0 0 13.008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2899 0 0 0 0 0 13.703 0 0 12.4829 0 0 0 0 0 0 0 0 0 0 14.6851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0006 0 0 0 0 0 0 0 0 0 0 Q7Z2G1 H2BWT_HUMAN Histone H2B type W-T (H2B histone family member W testis-specific) (H2B.W histone 1) H2BW1 H2BFWT Homo sapiens (Human) nucleosome assembly [GO:0006334] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786] nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527]; nucleosome assembly [GO:0006334] GO:0000786; GO:0003677; GO:0005654; GO:0006334; GO:0030527; GO:0031965; GO:0046982 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AVLRTSLYAIQQQRK 0.99582 -9.8274 0 0 0 0 0 0 0 0 12.1993 0 0 12.4121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1229 0 16.3399 0 0 11.7403 0 0 0 0 0 0 16.2178 0 0 16.6626 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2288 0 0 0 0 0 11.8046 0 11.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6688 0 0 0 0 0 0 0 0 0 12.5432 11.6811 0 0 0 0 0 0 0 0 0 19.3926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2544 14.0141 0 0 14.1655 0 0 0 0 0 17.9448 0 0 0 0 0 0 0 0 0 13.0818 0 Q7Z388 D19L4_HUMAN "Probable C-mannosyltransferase DPY19L4, EC 2.4.1.- (Dpy-19-like protein 4) (Protein dpy-19 homolog 4)" DPY19L4 Homo sapiens (Human) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406] GO:0000030; GO:0005637; GO:0016021; GO:0018406 mannosyltransferase activity [GO:0000030] AEEEGPPVELR 0.99582 -12.442 0 0 0 0 0 0 0 0 0 0 0 14.5353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3877 12.555 12.6246 0 14.3135 0 0 15.2749 0 0 0 0 0 15.3752 0 0 0 0 12.8022 0 0 0 0 14.7325 0 0 0 14.8386 13.8568 13.6854 0 0 0 0 0 0 0 0 0 0 13.6638 15.0588 0 13.7039 0 12.7409 0 0 14.2465 0 13.3966 0 11.6689 0 0 0 0 12.8406 0 13.6961 13.743 0 0 0 15.2361 0 0 12.6618 0 0 0 0 13.464 0 14.4703 0 0 0 0 0 0 0 0 0 14.6668 0 11.234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5428 0 Q8N302 AGGF1_HUMAN "Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q, hVG5Q) (G patch domain-containing protein 7) (Vasculogenesis gene on 5q protein)" AGGF1 GPATC7 GPATCH7 VG5Q Homo sapiens (Human) angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; nucleic acid binding [GO:0003676]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570] GO:0001525; GO:0001570; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0045766; GO:0048471 nucleic acid binding [GO:0003676] AKIGIHHKNSPPK 0.99582 -12.438 0 0 11.0853 0 0 0 0 0 0 0 0 0 16.917 0 0 0 0 0 0 0 10.6177 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.079 14.4213 0 0 0 0 11.8281 0 11.477 0 0 0 0 12.3223 0 0 0 0 0 0 0 0 0 0 13.5728 0 0 0 0 0 0 0 12.6003 0 0 0 0 0 13.6795 0 0 0 0 11.7244 13.411 0 0 0 0 13.6249 0 0 0 0 0 12.4415 0 12.8119 0 0 0 14.1151 0 0 0 0 0 0 0 0 0 0 12.7071 0 0 0 0 0 0 12.4875 13.9871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4286 14.5742 14.522 15.8348 0 0 0 0 0 0 0 0 0 0 0 14.3686 0 15.4654 0 0 0 0 0 0 0 0 0 Q8N4M7 CJ126_HUMAN Putative uncharacterized protein C10orf126 C10orf126 Homo sapiens (Human) AGPGFHR 0.99582 -9.5423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.071 0 0 0 0 0 0 0 0 0 0 12.949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N9N2 ASCC1_HUMAN Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) ASCC1 CGI-18 Homo sapiens (Human) "DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; regulation of transcription, DNA-templated [GO:0006355]" DNA repair complex [GO:1990391]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "DNA repair complex [GO:1990391]; neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; RNA binding [GO:0003723]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508]; regulation of transcription, DNA-templated [GO:0006355]" GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0006307; GO:0006355; GO:0016607; GO:0031594; GO:0032508; GO:1990391 RNA binding [GO:0003723] IDGRNYR 0.99582 -10.342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7647 0 11.7901 0 12.0837 0 0 0 0 11.4079 0 0 0 0 0 0 15.7115 0 0 0 0 16.2446 0 0 0 0 0 0 0 0 0 14.6499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1653 0 0 0 0 0 0 0 0 0 0 0 0 0 11.789 0 11.0747 0 0 0 0 0 0 0 0 0 13.1302 0 0 0 0 0 Q8NCR0 B3GL2_HUMAN "UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2, Beta-1,3-GalNAc-T2, EC 2.4.1.313 (Beta-1,3-N-acetylgalactosaminyltransferase II)" B3GALNT2 Homo sapiens (Human) protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; glycosyltransferase activity [GO:0016757]; UDP-glycosyltransferase activity [GO:0008194]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0005783; GO:0005789; GO:0006486; GO:0006493; GO:0008194; GO:0008376; GO:0016021; GO:0016757 acetylgalactosaminyltransferase activity [GO:0008376]; glycosyltransferase activity [GO:0016757]; UDP-glycosyltransferase activity [GO:0008194] CGDPCRCQAR 0.99582 -12.462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2606 0 0 0 0 0 0 0 0 11.4814 0 0 0 0 0 0 0 0 0 0 0 10.6921 0 0 0 0 0 0 0 10.4344 0 0 0 0 0 0 13.1178 0 0 0 0 0 0 0 0 10.9448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1522 0 0 0 0 0 12.0405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3353 0 0 0 0 0 0 0 0 12.3055 0 13.2163 13.3285 10.8882 0 0 0 0 0 0 0 0 0 0 0 12.184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IZ0 PAWR_HUMAN "PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein, Par-4)" PAWR PAR4 Homo sapiens (Human) actin filament bundle assembly [GO:0051017]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cellular senescence [GO:2000774]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; leucine zipper domain binding [GO:0043522]; transcription corepressor activity [GO:0003714]; actin filament bundle assembly [GO:0051017]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cellular senescence [GO:2000774]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300] GO:0000122; GO:0000785; GO:0003714; GO:0003779; GO:0005634; GO:0005737; GO:0005886; GO:0006915; GO:0010628; GO:0010629; GO:0015629; GO:0019899; GO:0030889; GO:0042130; GO:0042986; GO:0043065; GO:0043522; GO:0048147; GO:0050860; GO:0051017; GO:0097190; GO:1901300; GO:2000774 actin binding [GO:0003779]; enzyme binding [GO:0019899]; leucine zipper domain binding [GO:0043522]; transcription corepressor activity [GO:0003714] DEEEPDGVPEK 0.99582 -9.5759 10.0712 0 0 0 0 9.65428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSE5 SPEB_HUMAN "Agmatinase, mitochondrial, EC 3.5.3.11 (Agmatine ureohydrolase, AUH)" AGMAT Homo sapiens (Human) "agmatine biosynthetic process [GO:0097055]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]" mitochondrion [GO:0005739] "mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; agmatine biosynthetic process [GO:0097055]; putrescine biosynthetic process from arginine, using agmatinase [GO:0033389]; spermidine biosynthetic process [GO:0008295]" GO:0005739; GO:0008295; GO:0008783; GO:0033389; GO:0046872; GO:0097055 agmatinase activity [GO:0008783]; metal ion binding [GO:0046872] FGPRRIR 0.99582 -11.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NU02 ANKE1_HUMAN Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5) ANKEF1 ANKRD5 Homo sapiens (Human) calcium ion binding [GO:0005509] GO:0005509 calcium ion binding [GO:0005509] EKLDNLPKPAENQK 0.99582 -9.5432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4241 0 0 14.2713 0 0 0 14.2244 0 0 15.4762 0 0 0 15.2657 15.4087 15.3258 0 0 0 0 15.0462 0 15.0664 0 0 14.6992 14.4107 15.5398 0 0 14.6822 14.6711 0 14.4529 14.2525 0 0 0 0 14.7417 0 14.3123 0 14.2909 11.3475 0 0 0 0 0 0 0 0 0 14.1296 0 0 0 0 14.4919 0 14.0358 0 15.1306 0 14.0396 14.5633 0 12.7633 0 0 13.4916 0 0 0 13.767 0 0 0 0 14.0164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5E6 PCDB3_HUMAN "Protocadherin beta-3, PCDH-beta-3" PCDHB3 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; synapse assembly [GO:0007416] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007399; GO:0007416; GO:0016021; GO:0016339; GO:0045202 calcium ion binding [GO:0005509] PIIPNFVAQGAERVSEANPSFRK 0.99582 -11.854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9462 0 0 0 0 0 0 0 0 0 14.8293 0 0 0 0 0 0 0 13.3476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.641 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y5K1 SPO11_HUMAN "Meiotic recombination protein SPO11, EC 5.6.2.2 (Cancer/testis antigen 35, CT35)" SPO11 Homo sapiens (Human) double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic DNA double-strand break processing [GO:0000706]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130] "chromosome, telomeric region [GO:0000781]; nuclear chromosome [GO:0000228]" "chromosome, telomeric region [GO:0000781]; nuclear chromosome [GO:0000228]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic DNA double-strand break processing [GO:0000706]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]" GO:0000228; GO:0000706; GO:0000781; GO:0001541; GO:0003677; GO:0003918; GO:0005524; GO:0007130; GO:0007131; GO:0007141; GO:0007283; GO:0007286; GO:0007292; GO:0016787; GO:0034502; GO:0042138; GO:0045141; GO:0046872; GO:0048477; GO:1990918 "ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]" EPPTGGSR 0.99582 -11.9 0 0 0 0 0 0 0 0 0 0 0 9.81758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7241 0 0 11.4406 0 0 0 0 0 0 0 0 0 0 0 13.7561 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3327 0 0 11.1996 0 0 0 12.3665 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9057 0 0 0 0 0 0 11.9131 12.0914 12.1124 0 0 0 0 0 0 0 0 0 0 A0A1B0GVH6 CM042_HUMAN Uncharacterized protein C13orf42 C13orf42 Homo sapiens (Human) ERLWERTVP 0.99583 -12.51 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9207 0 0 0 0 0 13.8731 0 0 0 0 0 0 0 0 13.8005 0 0 0 0 0 0 0 0 0 0 0 13.9649 0 13.8778 0 0 0 0 0 14.6705 13.818 0 0 0 0 12.3794 0 0 13.2547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9324 0 0 0 0 0 0 0 11.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8766 0 0 0 0 0 0 O43854 EDIL3_HUMAN EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1) EDIL3 DEL1 Homo sapiens (Human) cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561] collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811] GO:0005178; GO:0005509; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561 calcium ion binding [GO:0005509]; integrin binding [GO:0005178] IAYSNDGK 0.99583 -12.528 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5142 0 0 0 0 0 0 0 0 13.4539 0 0 0 0 0 0 0 0 0 14.8068 0 0 0 0 0 0 13.8105 0 0 14.2281 0 0 0 0 0 0 0 0 0 0 0 13.3168 13.4546 0 0 13.0816 0 0 0 0 0 0 0 0 13.5971 0 0 0 0 0 0 0 0 14.7727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7968 0 0 0 13.5023 0 0 P07357 CO8A_HUMAN Complement component C8 alpha chain (Complement component 8 subunit alpha) C8A Homo sapiens (Human) "complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]" blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886] "blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane attack complex [GO:0005579]; plasma membrane [GO:0005886]; complement binding [GO:0001848]; protein-containing complex binding [GO:0044877]; complement activation [GO:0006956]; complement activation, alternative pathway [GO:0006957]; complement activation, classical pathway [GO:0006958]; cytolysis [GO:0019835]; immune response [GO:0006955]; positive regulation of immune response [GO:0050778]" GO:0001848; GO:0005576; GO:0005579; GO:0005615; GO:0005886; GO:0006955; GO:0006956; GO:0006957; GO:0006958; GO:0016020; GO:0019835; GO:0044877; GO:0050778; GO:0070062; GO:0072562 complement binding [GO:0001848]; protein-containing complex binding [GO:0044877] ADGSWSCWSSWSVCR 0.99583 -32.85 0 0 9.44541 0 0 0 0 12.4431 0 0 0 0 11.007 0 0 11.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8056 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9187 12.7491 0 0 13.335 0 0 0 0 0 0 16.0934 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2661 0 0 0 0 13.4939 0 0 0 0 0 0 0 0 0 0 13.0717 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9844 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1316 0 0 0 0 0 0 0 0 11.6615 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0077 Q68DU8 KCD16_HUMAN BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16) KCTD16 KIAA1317 Homo sapiens (Human) protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] anchoring junction [GO:0070161]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235] anchoring junction [GO:0070161]; cell projection [GO:0042995]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0008277; GO:0042734; GO:0042995; GO:0043235; GO:0045211; GO:0051260; GO:0070161 CIQDFLKIK 0.99583 -12.525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9601 11.784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2879 0 0 0 0 0 0 11.4287 0 13.2424 0 0 0 0 0 0 12.9344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9872 0 0 0 0 0 0 9.87557 0 0 13.0363 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6DD87 ZN787_HUMAN Zinc finger protein 787 (TTF-I-interacting peptide 20) ZNF787 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AAGPRSR 0.99583 -11.927 9.73605 0 0 0 0 0 0 0 13.9054 0 0 15.8939 0 0 15.0877 15.3519 16.2833 0 0 13.7608 0 0 0 0 11.844 14.7481 13.9343 10.2286 14.7534 0 13.1193 10.7574 0 0 0 0 0 0 0 0 13.1233 10.9589 14.1622 0 13.7368 14.449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3599 0 13.7745 0 0 0 0 0 0 11.8614 0 0 0 13.9822 0 0 0 0 0 0 11.6688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8272 0 0 0 0 0 0 11.4067 0 0 11.1722 0 11.9183 0 0 10.9385 0 0 13.9721 0 0 0 12.248 0 0 0 0 14.1393 0 0 0 0 0 0 0 0 13.8365 0 14.1784 0 0 0 0 0 0 0 0 0 0 0 0 Q8N954 GPT11_HUMAN G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75) GPATCH11 CCDC75 CENP-Y Homo sapiens (Human) kinetochore [GO:0000776] kinetochore [GO:0000776]; nucleic acid binding [GO:0003676] GO:0000776; GO:0003676 nucleic acid binding [GO:0003676] AVRYYSHMK 0.99583 -12.513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5943 0 0 0 12.6988 0 0 0 0 0 0 11.1856 0 0 0 0 0 11.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1419 13.2816 0 0 0 0 0 0 0 0 0 11.4068 0 0 0 0 0 12.1775 0 12.5879 0 15.3624 12.2467 0 0 0 0 0 0 0 0 0 15.758 0 0 0 12.1541 0 0 0 0 0 14.9066 11.826 0 0 12.2258 15.3694 11.5146 0 0 0 14.9306 0 0 0 0 0 11.6459 0 0 0 0 0 15.0416 0 0 0 15.1641 13.722 0 16.1831 0 0 0 12.5521 0 0 0 0 0 0 12.6367 0 0 0 0 0 0 0 15.9662 0 0 0 0 0 11.8719 16.0549 0 14.317 16.217 0 0 12.3831 13.7216 0 0 11.6626 11.2686 Q8N9C0 IGS22_HUMAN "Immunoglobulin superfamily member 22, IgSF22" IGSF22 Homo sapiens (Human) ACLECELTSK 0.99583 -33.045 0 0 0 0 0 0 0 0 0 0 16.5259 0 0 0 0 0 12.9618 0 0 0 0 0 0 0 0 0 11.1859 0 0 0 0 11.1447 11.1329 0 11.1202 0 10.8517 0 0 0 0 0 0 0 0 0 0 0 13.6409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2744 0 0 0 13.4775 11.8612 0 0 0 13.3011 0 0 0 0 13.1993 13.2418 0 13.3122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.75 0 11.1785 0 13.1628 0 0 13.7028 13.6785 13.4167 0 13.6558 0 0 14.3968 12.3624 0 14.8953 12.4701 0 0 0 0 0 0 12.4307 12.227 0 15.1411 12.0836 12.5998 0 0 0 0 0 0 14.7823 0 11.6609 13.4005 0 0 13.4897 0 13.0962 12.0436 12.7866 0 0 12.3379 0 0 0 13.029 0 15.446 0 0 0 0 0 0 0 0 14.6427 0 0 0 0 Q96JY0 MAEL_HUMAN Protein maelstrom homolog MAEL Homo sapiens (Human) "cell morphogenesis [GO:0000902]; DNA methylation involved in gamete generation [GO:0043046]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; gene expression [GO:0010467]; gene silencing by RNA [GO:0031047]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; piRNA metabolic process [GO:0034587]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of organ growth [GO:0046620]; spermatogenesis [GO:0007283]" autosome [GO:0030849]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; piP-body [GO:0071547]; XY body [GO:0001741] "autosome [GO:0030849]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; P granule [GO:0043186]; perinuclear region of cytoplasm [GO:0048471]; piP-body [GO:0071547]; XY body [GO:0001741]; sequence-specific DNA binding [GO:0043565]; cell morphogenesis [GO:0000902]; DNA methylation involved in gamete generation [GO:0043046]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; gene expression [GO:0010467]; gene silencing by RNA [GO:0031047]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; piRNA metabolic process [GO:0034587]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of organ growth [GO:0046620]; spermatogenesis [GO:0007283]" GO:0000122; GO:0000785; GO:0000902; GO:0001673; GO:0001741; GO:0005634; GO:0005737; GO:0007129; GO:0007140; GO:0007283; GO:0008630; GO:0009566; GO:0010467; GO:0030849; GO:0031047; GO:0033391; GO:0034587; GO:0035234; GO:0043046; GO:0043066; GO:0043186; GO:0043565; GO:0045892; GO:0046620; GO:0048471; GO:0051093; GO:0060964; GO:0071547; GO:2000242 sequence-specific DNA binding [GO:0043565] DPGPSEK 0.99583 -33.04 0 0 0 0 0 0 0 0 0 12.0837 0 0 0 0 0 0 0 0 0 0 13.4419 0 0 0 0 0 0 0 14.7434 0 0 0 0 0 0 0 0 0 0 10.6662 0 0 0 0 11.4558 0 0 0 0 0 0 11.8903 0 0 0 0 0 14.6058 0 0 0 0 0 0 0 0 0 0 0 0 11.6796 0 0 0 0 16.8511 11.1977 0 0 0 0 0 14.2586 0 14.0879 0 0 11.9716 0 0 0 13.5361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4868 0 0 0 0 0 0 0 0 0 0 0 12.0604 0 0 0 0 0 0 0 0 0 0 0 0 16.3076 16.2146 0 0 0 0 0 14.0878 0 0 0 0 0 0 0 0 0 10.5806 0 0 0 0 0 0 0 0 0 0 0 0 11.4083 0 0 0 0 0 13.6597 0 0 0 0 0 0 12.9432 10.6212 0 Q96MU6 ZN778_HUMAN Zinc finger protein 778 ZNF778 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" ASSHLHKHGR 0.99583 -12.507 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5141 0 0 0 11.5456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3382 0 0 0 0 0 12.7841 0 0 0 0 0 0 0 0 13.2152 0 0 13.7393 13.567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1897 0 0 0 0 0 12.745 0 0 0 12.2982 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9775 0 0 0 0 0 Q9BR39 JPH2_HUMAN "Junctophilin-2, JP-2 (Junctophilin type 2) [Cleaved into: Junctophilin-2 N-terminal fragment, JP2NT ]" JPH2 JP2 Homo sapiens (Human) "calcium ion homeostasis [GO:0055074]; calcium ion transport into cytosol [GO:0060402]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle tissue development [GO:0055024]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]" endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018] "endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; calcium ion homeostasis [GO:0055074]; calcium ion transport into cytosol [GO:0060402]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle tissue development [GO:0055024]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]" GO:0000122; GO:0001046; GO:0001227; GO:0001786; GO:0003677; GO:0005546; GO:0005547; GO:0005634; GO:0005789; GO:0005886; GO:0010314; GO:0014701; GO:0016021; GO:0016529; GO:0030018; GO:0030314; GO:0032266; GO:0045892; GO:0055024; GO:0055074; GO:0060314; GO:0060316; GO:0060402; GO:0070273; GO:0070300; GO:0080025 "core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]" ETPAKLEPKPIIPK 0.99583 -9.9241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.639 10.2269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6676 0 0 0 0 0 13.208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P0M6 H2AW_HUMAN "Core histone macro-H2A.2, Histone macroH2A2, mH2A2" MACROH2A2 H2AFY2 Homo sapiens (Human) "brain development [GO:0007420]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of keratinocyte differentiation [GO:0045618]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]" "Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976]; brain development [GO:0007420]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of keratinocyte differentiation [GO:0045618]" GO:0000122; GO:0000781; GO:0000785; GO:0000786; GO:0000976; GO:0000977; GO:0001740; GO:0003677; GO:0005654; GO:0006334; GO:0007420; GO:0007549; GO:0030527; GO:0031490; GO:0045618; GO:0045814; GO:0046982; GO:0070062; GO:0071169; GO:1901837 chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976] FVIHCHIPQWGSDK 0.99583 -12.508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8851 0 0 0 0 0 0 0 0 12.894 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1264 0 0 0 0 0 0 0 0 0 0 12.4169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14315 FLNC_HUMAN "Filamin-C, FLN-C, FLNc (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)" FLNC ABPL FLN2 Homo sapiens (Human) sarcomere organization [GO:0045214] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018] costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; sarcomere organization [GO:0045214] GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045214; GO:0051015 actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802] ATIRPVFDPSKVR 0.99584 -33.165 0 0 12.0719 0 0 0 0 0 0 0 11.8482 0 13.5591 12.23 0 12.4476 11.5394 0 0 0 0 0 0 0 12.9309 0 0 13.7208 0 0 0 11.9852 0 0 12.4563 0 0 0 0 0 0 0 13.0677 12.3185 0 0 0 0 12.842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3726 0 13.4284 0 0 13.993 0 0 0 0 0 0 0 16.084 12.5501 15.9058 15.8609 16.4756 15.6866 14.4874 0 12.9388 14.3832 15.735 0 0 16.7146 0 0 13.366 0 0 0 15.6644 0 14.9277 0 0 0 13.0452 0 13.8398 13.9837 0 14.4291 15.2281 0 0 0 13.1311 11.64 0 14.4798 13.7753 14.1617 0 0 12.5853 0 0 13.6886 0 0 0 0 0 0 13.6684 13.3176 0 0 0 11.6665 0 13.3072 0 13.8988 0 0 13.9634 0 0 0 0 0 0 0 13.935 0 0 0 0 13.7535 13.4349 0 0 11.9902 13.0599 0 13.5601 0 13.1369 13.746 13.1861 0 0 0 0 13.6646 14.5494 O00180 KCNK1_HUMAN Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1) KCNK1 HOHO1 KCNO1 TWIK1 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076] anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076]; identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725]; stabilization of membrane potential [GO:0030322] GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0005887; GO:0006813; GO:0008076; GO:0016021; GO:0016324; GO:0022841; GO:0030322; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0055037; GO:0060075; GO:0070161; GO:0071805; GO:0097060; GO:1902937 identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; sodium channel activity [GO:0005272] ITVHVTR 0.99584 -12.083 0 13.5539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15057 ACAP2_HUMAN "Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2, Cnt-b2)" ACAP2 CENTB2 KIAA0041 Homo sapiens (Human) actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456] endosome membrane [GO:0010008]; membrane [GO:0016020]; ruffle [GO:0001726] endosome membrane [GO:0010008]; membrane [GO:0016020]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456] GO:0001726; GO:0005096; GO:0010008; GO:0016020; GO:0030029; GO:0032456; GO:0046872; GO:1990090 GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872] DFSQMASNNPEK 0.99584 -12.09 0 0 0 0 0 0 0 0 0 0 14.583 13.4282 0 0 0 0 12.1062 0 0 0 9.16952 0 0 0 12.451 0 0 0 0 0 0 12.374 0 0 0 0 0 0 0 13.3718 0 0 0 0 13.1116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8831 0 11.3213 0 0 11.8643 0 0 0 0 0 12.0636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4219 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5598 0 10.8379 0 0 0 0 0 11.1999 0 0 0 15.2373 0 0 0 0 0 0 0 0 0 0 0 0 0 Q969F9 HPS3_HUMAN BLOC-2 complex member HPS3 (Hermansky-Pudlak syndrome 3 protein) HPS3 Homo sapiens (Human) intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; early endosome [GO:0005769] BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; organelle organization [GO:0006996]; platelet dense granule organization [GO:0060155] GO:0005737; GO:0005769; GO:0006996; GO:0031084; GO:0046907; GO:0060155; GO:1903232 CAFSTLGR 0.99584 -33.178 0 0 0 0 0 0 0 0 14.1162 0 13.5278 13.8782 13.0626 11.7124 13.5602 0 13.7685 0 0 0 0 0 0 0 0 12.3682 0 13.0918 0 0 0 0 0 13.2905 0 0 13.2193 0 0 13.5564 0 0 0 0 13.926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5399 0 0 0 0 0 0 12.1565 0 13.9525 0 0 13.4602 0 0 11.5177 0 0 0 13.375 0 0 0 14.5236 0 10.5227 0 0 12.6738 0 0 10.0359 0 10.9035 0 0 0 0 0 0 0 0 0 11.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8589 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1995 0 10.9562 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H227 GBA3_HUMAN "Cytosolic beta-glucosidase, EC 3.2.1.21 (Cytosolic beta-glucosidase-like protein 1) (Cytosolic galactosylceramidase, EC 3.2.1.46) (Cytosolic glucosylceramidase, EC 3.2.1.45) (Cytosolic glycosylceramidase, Cytosolic GCase) (Glucosidase beta acid 3) (Glucosylceramidase beta 3) (Klotho-related protein, KLrP)" GBA3 CBG CBGL1 Homo sapiens (Human) beta-glucoside catabolic process [GO:1901805]; cellular oligosaccharide catabolic process [GO:0051692]; galactosylceramide catabolic process [GO:0006683]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; positive regulation of exo-alpha-sialidase activity [GO:1903017]; protein stabilization [GO:0050821] catalytic complex [GO:1902494]; cytosol [GO:0005829] catalytic complex [GO:1902494]; cytosol [GO:0005829]; beta-galactosidase activity [GO:0004565]; beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glycosylceramidase activity [GO:0017042]; scopolin beta-glucosidase activity [GO:0102483]; beta-glucoside catabolic process [GO:1901805]; cellular oligosaccharide catabolic process [GO:0051692]; galactosylceramide catabolic process [GO:0006683]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; positive regulation of exo-alpha-sialidase activity [GO:1903017]; protein stabilization [GO:0050821] GO:0004336; GO:0004348; GO:0004565; GO:0005829; GO:0006680; GO:0006683; GO:0006687; GO:0008422; GO:0016139; GO:0017042; GO:0046477; GO:0050821; GO:0051692; GO:0102483; GO:1901805; GO:1902494; GO:1903017 beta-galactosidase activity [GO:0004565]; beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glycosylceramidase activity [GO:0017042]; scopolin beta-glucosidase activity [GO:0102483] AITFHLDLFAK 0.99584 -12.08 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6047 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6957 0 0 0 0 0 0 0 13.3216 14.5152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8138 0 0 0 0 0 0 12.0786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NQZ5 STAR7_HUMAN "StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7, StARD7)" STARD7 GTT1 Homo sapiens (Human) mitochondrial outer membrane [GO:0005741] mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289] GO:0005741; GO:0008289 lipid binding [GO:0008289] ATSQSSER 0.99584 -12.098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7604 14.4571 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5699 0 0 0 0 Q9NWZ5 UCKL1_HUMAN "Uridine-cytidine kinase-like 1, EC 2.7.1.48" UCKL1 URKL1 F538 Homo sapiens (Human) CTP salvage [GO:0044211]; phosphorylation [GO:0016310]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; phosphorylation [GO:0016310]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206] GO:0004849; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0016310; GO:0043097; GO:0044206; GO:0044211 ATP binding [GO:0005524]; uridine kinase activity [GO:0004849] DTPGRQAEKSETACEDR 0.99584 -9.6228 0 13.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2796 11.1862 0 12.688 0 0 0 0 0 0 0 0 0 11.8265 0 0 15.1716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4437 0 0 0 12.889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8776 14.2433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4624 0 0 0 0 0 0 0 0 0 0 0 0 18.8846 0 0 0 0 0 0 0 14.435 0 0 0 0 0 15.7794 0 0 0 18.8176 O14682 ENC1_HUMAN "Ectoderm-neural cortex protein 1, ENC-1 (Kelch-like protein 37) (Nuclear matrix protein NRP/B) (p53-induced gene 10 protein)" ENC1 KLHL37 NRPB PIG10 Homo sapiens (Human) negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of neuron projection development [GO:0010976]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein ubiquitination [GO:0016567] chromatin [GO:0000785]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromatin [GO:0000785]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; actin binding [GO:0003779]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; positive regulation of neuron projection development [GO:0010976]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein ubiquitination [GO:0016567] GO:0000785; GO:0003779; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005856; GO:0007399; GO:0010499; GO:0010976; GO:0016363; GO:0016567; GO:0017148; GO:0031463; GO:0043025 actin binding [GO:0003779] FGHGSAELK 0.99585 -12.103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8919 0 0 0 0 0 0 0 0 0 13.1147 0 0 13.5132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4664 13.0489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7748 0 15.461 0 0 0 0 0 11.9241 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60384 ZN861_HUMAN Putative zinc finger protein 861 ZNF861P Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] KPCEYQECR 0.99585 -12.099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3078 0 0 0 12.8991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5203 0 0 15.2257 0 0 0 0 14.6195 0 0 13.9269 14.6293 11.3786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75445 USH2A_HUMAN Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein) USH2A Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696] apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; response to stimulus [GO:0050896]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601] GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0009887; GO:0009888; GO:0016021; GO:0016324; GO:0016477; GO:0017022; GO:0032391; GO:0032421; GO:0034446; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050896; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696 collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022] CDHCNFGFK 0.99585 -34.079 0 0 0 0 0 0 0 0 0 0 0 0 10.4909 0 0 0 0 0 12.302 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1492 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3676 0 0 0 0 0 0 10.5686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8524 0 0 0 14.8467 0 12.3916 0 14.6762 0 0 11.3761 12.7461 11.618 14.9983 13.545 15.2329 14.8493 11.7115 0 12.0782 16.2508 0 0 13.1625 0 13.3256 12.6741 15.0881 17.5594 0 14.3333 14.4025 14.4244 0 0 11.4846 0 12.6827 0 0 15.3974 15.2597 0 0 0 12.1345 0 0 14.0069 0 0 13.9555 0 13.4337 14.3731 0 14.2863 0 13.9864 0 13.5022 12.9702 12.0036 0 14.1254 13.4957 0 0 13.6577 0 13.9862 14.4428 0 0 0 0 0 0 0 0 11.9916 11.3625 0 0 14.3435 13.919 13.8279 14.2623 0 0 0 0 0 13.059 11.5841 0 0 0 0 13.2164 11.8494 12.2083 0 13.8267 13.3765 0 0 0 0 15.4086 0 O94851 MICA2_HUMAN "[F-actin]-monooxygenase MICAL2, EC 1.14.13.225 (MICAL C-terminal-like protein, Mical-cL) (Molecule interacting with CasL protein 2, MICAL-2)" MICAL2 KIAA0750 MICAL2PV1 MICAL2PV2 MICALCL Homo sapiens (Human) actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417] cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; positive regulation of transcription via serum response element binding [GO:0010735]; sulfur oxidation [GO:0019417]" GO:0001947; GO:0003779; GO:0005634; GO:0005737; GO:0007010; GO:0007507; GO:0010735; GO:0016174; GO:0016491; GO:0016709; GO:0019417; GO:0030042; GO:0043914; GO:0046872; GO:0051019; GO:0071949 "actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH:sulfur oxidoreductase activity [GO:0043914]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]" AVSPQCPEEPR 0.99585 -34.159 0 0 0 0 0 0 0 0 15.4455 15.5169 0 14.6299 13.2588 13.7929 13.6148 13.5921 0 12.7306 12.7245 12.67 0 11.2702 11.3619 0 13.2475 0 0 13.8566 0 13.0103 13.9016 14.7601 14.6778 15.4767 15.4852 14.7277 13.3271 14.0831 14.3731 13.883 12.3246 14.2912 0 10.6297 13.58 14.557 12.8387 11.8262 14.0579 0 0 0 0 0 0 0 12.2237 0 11.2491 12.6569 0 0 0 0 0 0 14.1455 13.6992 13.7002 0 0 0 11.8245 13.3868 0 0 12.7431 0 13.7644 0 14.0002 0 16.4531 12.6566 16.452 16.0145 16.8645 15.2629 0 15.4158 11.9324 15.1624 0 11.5753 14.7126 15.1927 15.0147 16.1848 0 11.7507 0 0 0 0 0 0 13.904 18.787 0 10.7463 0 12.8114 0 0 13.8599 14.937 14.777 0 0 12.304 0 0 0 0 0 0 18.7692 0 0 11.4736 11.8135 0 0 13.2635 14.0188 0 0 0 13.1029 0 0 0 0 15.0536 13.6247 0 0 14.6712 12.4897 0 0 12.6356 13.8289 0 14.7598 0 0 12.4396 13.8421 0 14.3011 11.7263 11.8115 0 0 0 12.6688 14.4153 0 12.231 0 10.1932 0 0 0 13.9767 0 13.4215 0 11.6976 P30837 AL1B1_HUMAN "Aldehyde dehydrogenase X, mitochondrial, EC 1.2.1.3 (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)" ALDH1B1 ALDH5 ALDHX Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068] GO:0004029; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0005975; GO:0006068; GO:0043878; GO:0051287 aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287] AAGDSNLKR 0.99585 -12.126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4812 12.3184 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4276 0 0 0 0 0 0 0 0 13.4029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5QGS0 NEXMI_HUMAN "Neurite extension and migration factor (XLMR protein related to neurite extension, XPN)" NEXMIF KIAA2022 Homo sapiens (Human) negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron migration [GO:2001223]; nervous system development [GO:0007399] cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron migration [GO:2001223]; nervous system development [GO:0007399] GO:0001953; GO:0005634; GO:0005654; GO:0005829; GO:0007399; GO:0030496; GO:0033629; GO:0072686; GO:2000048; GO:2001223 ALRDEKCK 0.99585 -34.082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0935 0 0 0 0 0 0 0 13.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1779 0 0 13.2713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4771 14.3925 11.9318 0 0 12.8742 13.3501 0 0 11.2518 0 0 12.5429 0 0 14.3567 14.2391 14.5115 15.8249 14.5887 13.3024 17.6759 0 18.6019 18.6525 14.8464 18.4093 0 15.7823 0 15.4417 0 15.2448 15.4866 0 0 0 14.6221 14.5307 0 0 0 13.6399 0 0 14.4091 0 0 0 13.3364 0 0 18.3902 17.8818 13.8725 13.3188 0 0 0 0 0 0 11.5736 0 0 0 0 0 0 12.9189 11.9888 0 0 18.3865 0 0 10.9701 0 0 0 0 18.0223 12.43 0 12.8341 0 0 0 14.9233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.619 0 13.6819 0 0 0 0 0 0 Q86VM9 ZCH18_HUMAN Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1) ZC3H18 NHN1 Homo sapiens (Human) RNA destabilization [GO:0050779] nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904] nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; RNA destabilization [GO:0050779] GO:0003723; GO:0016607; GO:0030674; GO:0032991; GO:0046872; GO:0050779; GO:0140262; GO:1990904 metal ion binding [GO:0046872]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723] ASDLEDEESAARGPSQEEEDNHSDEEDR 0.99585 -34.311 0 0 0 0 0 0 0 0 0 0 0 12.4684 15.8953 15.7676 0 11.9704 0 0 11.2238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4683 0 0 11.2146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5935 14.6405 14.1278 0 0 12.9259 11.307 0 0 11.3601 0 0 0 0 13.4922 14.3514 14.6006 13.3577 0 0 13.4818 14.0025 0 14.8809 0 16.7219 0 13.0682 12.1902 16.67 0 16.4734 11.252 0 0 0 0 0 13.3673 14.8231 0 0 0 0 0 13.0135 14.3524 13.7105 12.9523 12.7263 0 0 0 14.5013 0 0 0 0 0 0 0 0 0 13.2929 0 0 0 0 0 13.1696 14.6248 15.715 15.8963 0 0 0 0 0 0 0 12.873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8553 0 15.629 0 0 11.9513 12.6337 0 0 Q86WG5 MTMRD_HUMAN Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2) SBF2 CMT4B2 KIAA1766 MTMR13 Homo sapiens (Human) autophagy [GO:0006914]; myelination [GO:0042552]; regulation of GTPase activity [GO:0043087] axon [GO:0030424]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774] axon [GO:0030424]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091]; autophagy [GO:0006914]; myelination [GO:0042552]; regulation of GTPase activity [GO:0043087] GO:0005085; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0043087; GO:0048471 guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091] EEPRTDRSQR 0.99585 -34.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8878 0 0 0 0 0 0 12.2118 0 0 0 0 12.4036 0 0 12.1165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97971 0 16.5212 0 15.2594 0 0 15.9512 15.3123 0 0 11.9995 0 0 0 18.2817 0 0 0 14.4318 0 0 0 0 0 0 0 0 0 0 12.9618 12.9542 0 0 0 0 0 13.7562 0 0 0 0 13.4383 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1098 0 0 0 0 0 0 15.0123 0 0 0 12.9626 0 0 0 0 0 0 0 0 0 13.9142 0 0 0 0 0 0 12.4364 0 12.4741 0 0 0 0 0 0 14.169 0 0 0 0 14.5516 0 0 0 Q8IVL0 NAV3_HUMAN "Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3, unc53H3)" NAV3 KIAA0938 POMFIL1 STEERIN3 Homo sapiens (Human) negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116] nuclear outer membrane [GO:0005640] nuclear outer membrane [GO:0005640]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116] GO:0005524; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017] AISHSGSFR 0.99585 -34.112 0 0 0 0 0 0 0 0 0 0 0 0 10.2068 0 0 0 0 0 0 0 13.0213 0 13.082 0 0 12.0989 0 11.2547 12.0895 0 0 10.6202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.923 13.2176 0 12.5252 13.5142 0 0 0 14.2086 0 0 14.2441 0 16.0388 11.4235 0 0 0 14.3943 0 0 15.9061 0 0 17.2588 13.4267 17.0759 17.2768 17.2691 0 0 15.508 0 12.6682 0 0 14.6554 13.0839 13.2336 0 13.4229 15.4549 13.8005 0 0 0 0 12.5241 0 13.1566 0 14.7785 0 14.1496 13.2583 0 13.4387 14.9686 13.9018 13.4522 17.1154 0 14.7349 0 0 13.2034 14.1311 14.5758 0 16.2673 11.749 0 0 13.0301 0 0 0 0 0 15.3685 0 0 0 0 0 12.5264 12.7392 0 0 15.0904 12.874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.698 0 17.2746 0 0 0 0 0 12.5173 Q8IY21 DDX60_HUMAN "Probable ATP-dependent RNA helicase DDX60, EC 3.6.4.13 (DEAD box protein 60)" DDX60 Homo sapiens (Human) defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615] GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727] AKVLSVLKHSLLSFK 0.99585 -34.741 0 0 0 0 0 0 0 0 0 0 12.7266 0 12.5148 0 0 12.1848 0 16.4832 0 0 0 0 0 0 12.4662 12.5435 0 12.1322 12.6493 0 12.6223 11.78 0 0 0 0 0 0 0 0 0 0 12.4235 0 0 13.0346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8778 0 0 0 0 0 0 16.7064 0 0 0 0 0 0 0 14.04 0 0 0 0 14.8842 17.6531 13.379 13.3373 0 13.2393 0 0 14.6353 13.3405 17.5958 0 0 0 13.5184 14.5336 15.0812 0 0 0 0 11.4523 14.3899 0 0 0 0 0 0 0 0 0 0 10.1003 0 0 0 0 0 0 0 0 0 13.9921 0 0 13.332 0 0 0 13.9234 15.0258 10.7901 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3731 0 0 13.9412 0 0 0 0 0 0 0 0 14.2132 0 13.7144 0 0 0 0 11.0957 0 0 0 0 0 0 0 Q96A73 P33MX_HUMAN "Putative monooxygenase p33MONOX, EC 1.-.-.- (Brain-derived rescue factor p60MONOX) (Flavin monooxygenase motif-containing protein of 33 kDa)" KIAA1191 P33MONOX Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491] GO:0005737; GO:0016491 oxidoreductase activity [GO:0016491] DAGYTPHKGLTTEETK 0.99585 -9.6909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3639 0 0 0 0 0 8.98151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4628 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96RY7 IF140_HUMAN Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2) IFT140 KIAA0590 WDTC2 Homo sapiens (Human) cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; intraciliary transport particle A [GO:0030991]; photoreceptor connecting cilium [GO:0032391] axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; intraciliary transport particle A [GO:0030991]; photoreceptor connecting cilium [GO:0032391]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589] GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097542; GO:0120199; GO:1902017; GO:1905515; GO:1990403 AEEVMKVK 0.99585 -34.32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6019 12.8623 0 0 0 0 0 0 12.5358 0 0 15.797 0 0 0 0 13.9094 13.864 12.7651 0 0 12.8919 13.1984 12.9592 15.1433 0 15.1603 0 0 0 0 0 17.0576 12.9811 0 0 0 0 0 0 0 16.085 0 0 12.5375 0 0 0 0 13.5545 0 0 12.2394 0 0 0 0 0 0 0 0 12.7355 0 0 15.1978 0 0 0 0 0 12.2787 14.8209 0 10.4842 0 0 12.6853 12.1973 0 0 0 0 0 0 0 0 0 0 0 0 12.7251 0 11.022 13.7022 0 0 0 0 11.7594 0 0 0 0 0 0 0 0 0 A8MUX0 KR161_HUMAN Keratin-associated protein 16-1 KRTAP16-1 KAP16.1 Homo sapiens (Human) cytosol [GO:0005829]; keratin filament [GO:0045095] cytosol [GO:0005829]; keratin filament [GO:0045095] GO:0005829; GO:0045095 PACVTSYSCR 0.99586 -11.745 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.86773 0 0 12.777 0 0 0 0 0 14.8645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9248 0 0 13.7941 0 0 0 0 0 0 14.6722 0 0 0 0 0 0 0 0 14.4832 0 0 0 0 0 13.3865 0 15.1554 14.3412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3336 0 0 0 0 0 0 0 14.1882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14827 RGRF2_HUMAN "Ras-specific guanine nucleotide-releasing factor 2, Ras-GRF2 (Ras guanine nucleotide exchange factor 2)" RASGRF2 GRF2 Homo sapiens (Human) long-term synaptic potentiation [GO:0060291]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to endoplasmic reticulum stress [GO:0034976] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085]; long-term synaptic potentiation [GO:0060291]; positive regulation of GTPase activity [GO:0043547]; Ras protein signal transduction [GO:0007265]; regulation of NMDA receptor activity [GO:2000310]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; response to endoplasmic reticulum stress [GO:0034976] GO:0005085; GO:0005516; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0007265; GO:0034976; GO:0035023; GO:0043547; GO:0051056; GO:0060291; GO:2000310 calmodulin binding [GO:0005516]; guanyl-nucleotide exchange factor activity [GO:0005085] CEEEQDGK 0.99586 -11.703 0 0 0 0 0 0 0 0 0 12.4442 0 0 0 0 0 13.9345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9348 0 0 0 0 0 0 0 0 0 0 0 11.5096 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9649 0 0 0 0 0 0 0 0 13.3008 0 0 0 0 11.6099 0 13.8489 12.7939 14.4914 0 0 0 13.4742 0 13.1216 0 11.2521 13.0473 0 0 0 0 13.6096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8298 0 0 0 0 0 0 0 0 0 12.8069 0 0 0 0 0 0 0 0 0 0 13.411 13.2127 0 12.7568 0 0 0 0 0 0 0 0 0 0 0 0 13.7457 0 11.8938 0 0 0 0 0 0 13.1158 13.4018 0 0 13.8906 0 0 0 0 0 0 0 12.4569 0 0 13.2684 0 12.4738 0 0 0 O14939 PLD2_HUMAN "Phospholipase D2, PLD 2, hPLD2, EC 3.1.4.4 (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2)" PLD2 Homo sapiens (Human) cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; regulation of vesicle-mediated transport [GO:0060627]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; presynapse [GO:0098793] endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; inositol lipid-mediated signaling [GO:0048017]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; regulation of vesicle-mediated transport [GO:0060627]; small GTPase mediated signal transduction [GO:0007264]; synaptic vesicle recycling [GO:0036465] GO:0004630; GO:0005789; GO:0005886; GO:0006654; GO:0007010; GO:0007264; GO:0009395; GO:0035091; GO:0036465; GO:0038096; GO:0043231; GO:0048017; GO:0060627; GO:0070290; GO:0098793 N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630] AAMGTAWR 0.99586 -35.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.87403 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9947 0 0 0 0 0 13.7015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6016 0 0 0 0 18.4345 0 0 0 14.6589 0 12.9741 0 0 0 0 0 0 0 0 0 10.2366 0 0 0 0 0 0 0 0 0 0 11.0571 0 0 0 0 0 0 0 0 0 12.3345 0 0 0 0 0 0 0 0 0 12.6595 0 0 0 0 0 0 0 0 0 0 0 0 13.6345 0 O95900 TRUB2_HUMAN "Pseudouridylate synthase TRUB2, mitochondrial, EC 5.4.99.- (TruB pseudouridine synthase homolog 2) (tRNA pseudouridine 55 synthase TRUB2, Psi55 synthase TRUB2, EC 5.4.99.25)" TRUB2 Homo sapiens (Human) mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; tRNA processing [GO:0008033] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; tRNA processing [GO:0008033] GO:0003723; GO:0005739; GO:0005759; GO:0006397; GO:0008033; GO:0009982; GO:0035770; GO:0070131; GO:1990481 pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723] GSAGLSR 0.99586 -11.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4354 0 0 0 11.4437 0 12.9136 0 13.2733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9015 0 0 0 12.5874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8329 0 0 0 0 0 0 0 0 0 14.1292 13.0575 0 0 0 0 13.1453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9171 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.711 0 0 0 0 0 0 0 0 P09914 IFIT1_HUMAN "Interferon-induced protein with tetratricopeptide repeats 1, IFIT-1 (Interferon-induced 56 kDa protein, IFI-56K, P56)" IFIT1 G10P1 IFI56 IFNAI1 ISG56 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of helicase activity [GO:0051097]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; regulation of defense response to virus [GO:0050688]; response to virus [GO:0009615] cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657] cytoplasm [GO:0005737]; cytosol [GO:0005829]; host cell [GO:0043657]; RNA binding [GO:0003723]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of helicase activity [GO:0051097]; negative regulation of protein binding [GO:0032091]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; regulation of defense response to virus [GO:0050688]; response to virus [GO:0009615] GO:0003723; GO:0005737; GO:0005829; GO:0009615; GO:0019060; GO:0032091; GO:0043657; GO:0045070; GO:0045071; GO:0050688; GO:0051097; GO:0051607; GO:0071357; GO:0071360; GO:0140374 RNA binding [GO:0003723] ACFEKVLEVDPENPESSAGYAISAYR 0.99586 -11.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5205 0 0 0 0 0 0 0 0 0 0 12.7263 0 0 0 0 0 0 0 10.0891 0 0 0 0 0 0 10.9156 0 0 0 0 0 0 0 0 0 0 0 0 11.7545 0 0 0 0 0 0 10.569 0 0 0 0 0 0 0 0 0 0 0 10.9851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6788 0 0 12.9368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2162 0 0 13.0554 0 0 0 0 12.0921 0 0 18.8178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8007 0 0 0 0 0 0 0 0 0 0 0 P41229 KDM5C_HUMAN "Lysine-specific demethylase 5C, EC 1.14.11.67 (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)" KDM5C DXS1272E JARID1C SMCX XE169 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; zinc ion binding [GO:0008270]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]" GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0008270; GO:0032452; GO:0032453; GO:0034647; GO:0034720; GO:0045892; GO:0048511 DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone H3-methyl-lysine-4 demethylase activity [GO:0032453]; histone H3-tri/di/monomethyl-lysine-4 demethylase activity [GO:0034647]; zinc ion binding [GO:0008270] EGILQLR 0.99586 -9.7052 0 0 0 0 0 0 0 0 0 0 12.7105 13.232 13.025 0 0 0 12.8656 0 0 0 0 0 10.9245 0 0 13.2942 13.1766 0 12.8004 0 13.164 13.4001 12.0552 11.289 0 0 0 11.7677 0 11.1776 0 0 0 0 13.4346 12.5727 12.7853 0 12.3935 0 0 0 0 0 11.2807 0 0 11.6157 0 0 0 11.1107 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6387 0 0 0 0 0 12.5674 14.5097 13.5933 0 0 19.2383 0 12.1868 0 0 0 0 0 0 11.1696 0 10.757 0 14.4866 0 0 0 0 0 12.595 0 0 0 0 0 0 0 0 0 0 0 14.7189 0 0 0 0 0 0 0 0 0 0 12.225 0 0 0 0 0 12.8158 0 0 0 0 0 0 0 0 0 0 0 0 0 9.83411 0 12.4862 0 0 0 0 0 0 0 12.8288 0 14.3382 14.4735 0 14.4987 14.1484 0 0 0 0 14.3877 14.4418 0 0 0 0 14.0264 0 14.0923 0 0 Q6NWY9 PR40B_HUMAN Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C) PRPF40B HYPC Homo sapiens (Human) "mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004] "nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0005685; GO:0016607; GO:0045292; GO:0071004 RNA binding [GO:0003723] AGKESDEK 0.99586 -12.284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5916 0 0 0 0 0 0 0 0 10.1724 0 0 0 0 0 0 0 0 0 0 15.2921 0 15.3699 0 0 0 0 0 0 0 12.5475 12.8607 0 0 0 11.982 13.7014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1366 10.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9748 0 0 0 0 0 11.1809 0 0 11.5028 0 0 0 11.1401 0 0 0 0 11.4288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7895 0 Q7RTS5 OTOP3_HUMAN Proton channel OTOP3 (Otopetrin-3) OTOP3 Homo sapiens (Human) proton transmembrane transport [GO:1902600] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton channel activity [GO:0015252]; proton transmembrane transport [GO:1902600] GO:0005886; GO:0015252; GO:0016021; GO:1902600 proton channel activity [GO:0015252] AAAAQSRWGR 0.99586 -9.7057 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0216 0 0 0 0 14.5125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.472 0 0 10.4481 10.9094 13.1454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9821 12.0727 13.6929 0 0 0 0 0 0 13.0201 13.3837 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6813 0 0 0 0 0 0 0 13.1995 0 12.2658 0 12.7777 0 0 0 0 0 13.1435 0 0 0 0 0 0 0 0 0 Q86VZ6 JAZF1_HUMAN Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802) JAZF1 TIP27 ZNF802 Homo sapiens (Human) lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0017053; GO:0046872 metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714] CGKSYKTAQGLR 0.99586 -9.7238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1069 0 0 0 0 0 0 0 11.3206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4441 0 0 0 0 12.3504 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3933 0 12.2969 0 0 0 12.0484 0 0 0 0 0 0 0 0 0 0 0 0 12.0959 0 0 0 0 0 11.9812 0 0 11.6389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IY67 RAVR1_HUMAN Ribonucleoprotein PTB-binding 1 (Protein raver-1) RAVER1 KIAA1978 Homo sapiens (Human) "regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]" GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005737 mRNA binding [GO:0003729]; RNA binding [GO:0003723] AKSDLLGK 0.99586 -11.755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7406 0 0 0 0 0 0 0 12.3615 0 0 0 0 0 0 0 0 13.0154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4779 12.3956 0 0 0 0 0 0 0 0 0 0 13.4645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92522 H1X_HUMAN Histone H1.10 (Histone H1x) H1-10 H1FX Homo sapiens (Human) chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527]; chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334] GO:0000786; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006334; GO:0030261; GO:0030527; GO:0031492; GO:0045296; GO:0045910 cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527] ADKKPAR 0.99586 -12.245 0 0 11.2203 0 0 0 0 0 0 0 0 0 13.1823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3275 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6089 0 0 0 0 0 0 0 0 0 11.2118 0 0 0 0 0 0 0 0 0 14.8245 0 0 18.4594 0 0 0 0 17.7129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7309 0 0 0 Q9NQG5 RPR1B_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor) RPRD1B C20orf77 CREPT Homo sapiens (Human) dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]" "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, holoenzyme [GO:0016591]; identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]" GO:0000993; GO:0005634; GO:0005654; GO:0008284; GO:0010564; GO:0016591; GO:0031124; GO:0042802; GO:0045944; GO:0070940 identical protein binding [GO:0042802]; RNA polymerase II complex binding [GO:0000993] ATEEKKSLK 0.99586 -11.729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 B5ME19 EIFCL_HUMAN Eukaryotic translation initiation factor 3 subunit C-like protein EIF3CL Homo sapiens (Human) formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852] eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413] GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0031369; GO:0033290 RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369] ALSTLRQK 0.99587 -12.296 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6575 0 0 14.0975 0 0 0 0 0 0 0 0 0 0 11.2473 0 0 13.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0435 0 12.631 12.9676 12.9636 0 0 0 0 0 0 0 0 0 11.1589 13.8863 0 13.424 0 0 0 0 15.5142 0 0 0 0 0 12.3588 0 0 0 0 0 13.8803 0 0 0 14.2936 13.4833 0 0 0 0 12.5536 13.5861 0 14.3457 0 0 13.9374 0 0 0 14.0547 0 0 0 0 0 0 0 0 0 0 0 0 13.5971 0 13.0011 0 0 0 0 0 0 0 0 0 0 13.0797 0 11.9905 0 0 0 0 12.9537 12.0423 0 0 0 0 0 0 0 0 15.1574 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8018 0 C9JH25 PRRT4_HUMAN Proline-rich transmembrane protein 4 PRRT4 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 CPTGLAALLLLGLGLAAAAALGSAAHRPLRPLR 0.99587 -12.362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2555 11.8845 0 0 0 0 0 0 0 0 0 0 0 0 13.7083 0 0 0 0 0 0 0 0 0 0 0 0 0 14.657 0 0 0 0 0 0 0 12.672 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0573 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5288 0 13.4986 0 0 0 0 0 0 0 0 0 0 12.131 0 0 0 0 P07686 HEXB_HUMAN "Beta-hexosaminidase subunit beta, EC 3.2.1.52 (Beta-N-acetylhexosaminidase subunit beta, Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein, HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A ]" HEXB HCC7 Homo sapiens (Human) astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maintenance of location in cell [GO:0051651]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuron cellular homeostasis [GO:0070050]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein metabolic process [GO:0019538]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; skeletal system development [GO:0001501] acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; beta-N-acetylhexosaminidase complex [GO:1905379]; cortical granule [GO:0060473]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020] acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; beta-N-acetylhexosaminidase complex [GO:1905379]; cortical granule [GO:0060473]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; ganglioside catabolic process [GO:0006689]; glycosaminoglycan metabolic process [GO:0030203]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; maintenance of location in cell [GO:0051651]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neuron cellular homeostasis [GO:0070050]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein metabolic process [GO:0019538]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; single fertilization [GO:0007338]; skeletal system development [GO:0001501] GO:0001501; GO:0001669; GO:0004563; GO:0005576; GO:0005764; GO:0006689; GO:0006874; GO:0007040; GO:0007338; GO:0007341; GO:0007605; GO:0007626; GO:0008049; GO:0008360; GO:0008375; GO:0008654; GO:0009313; GO:0016020; GO:0019538; GO:0019915; GO:0030203; GO:0035578; GO:0042552; GO:0042582; GO:0042802; GO:0043202; GO:0043615; GO:0045944; GO:0048477; GO:0050885; GO:0051651; GO:0060473; GO:0070050; GO:0070062; GO:0102148; GO:1905379 acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; identical protein binding [GO:0042802]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148] ANRVWGALR 0.99587 -12.388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9705 0 0 0 0 0 0 0 0 0 14.2164 0 0 13.6765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1602 0 0 0 0 0 0 0 12.197 11.8942 0 0 14.172 0 0 0 0 0 0 0 0 0 0 14.9448 13.2824 12.8716 12.8153 13.2502 14.2555 0 0 0 14.3392 0 0 14.4342 0 14.8979 0 0 0 0 14.6552 12.6079 0 0 0 14.8583 15.1477 0 0 0 0 0 0 15.0366 0 0 14.3555 0 0 0 0 0 0 0 0 0 13.4242 15.1503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20138 CD33_HUMAN "Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3, Siglec-3) (gp67) (CD antigen CD33)" CD33 SIGLEC3 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; immune response-inhibiting signal transduction [GO:0002765]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of monocyte activation [GO:0150102]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of protein secretion [GO:0050714]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; signal transduction [GO:0007165] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; immune response-inhibiting signal transduction [GO:0002765]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of monocyte activation [GO:0150102]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of protein secretion [GO:0050714]; positive regulation of protein tyrosine phosphatase activity [GO:1903615]; signal transduction [GO:0007165] GO:0002765; GO:0005654; GO:0005777; GO:0005794; GO:0005886; GO:0005887; GO:0007155; GO:0007165; GO:0007267; GO:0008285; GO:0009897; GO:0009986; GO:0019903; GO:0030246; GO:0032691; GO:0032717; GO:0032720; GO:0033691; GO:0035579; GO:0038023; GO:0050714; GO:0051926; GO:0070821; GO:0098609; GO:0150102; GO:1903615 carbohydrate binding [GO:0030246]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor activity [GO:0038023] DSPVATNK 0.99587 -12.298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0994 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1501 0 0 0 0 0 0 0 0 12.5803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.089 0 0 0 13.152 0 12.8164 0 0 0 0 0 14.6656 0 0 0 0 0 12.7102 0 0 0 0 0 13.1707 12.5147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6094 0 0 0 0 0 0 0 0 0 9.98257 0 0 10.2376 0 0 0 14.7518 0 0 0 0 0 P40197 GPV_HUMAN "Platelet glycoprotein V, GPV (Glycoprotein 5) (CD antigen CD42d)" GP5 Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glycoprotein Ib-IX-V complex [GO:1990779]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; megakaryocyte development [GO:0035855]; positive regulation of platelet activation [GO:0010572]; release of sequestered calcium ion into cytosol [GO:0051209]" GO:0005615; GO:0005886; GO:0005887; GO:0007155; GO:0007596; GO:0007597; GO:0010572; GO:0035855; GO:0051209; GO:0070062; GO:1990779 ALPRALFR 0.99587 -11.836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z624 CMKMT_HUMAN "Calmodulin-lysine N-methyltransferase, CLNMT, CaM KMT, EC 2.1.1.60" CAMKMT C2orf34 CLNMT Homo sapiens (Human) mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]; regulation of rhodopsin mediated signaling pathway [GO:0022400] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; calmodulin-lysine N-methyltransferase activity [GO:0018025]; heat shock protein binding [GO:0031072]; mitochondrion organization [GO:0007005]; peptidyl-lysine methylation [GO:0018022]; protein methylation [GO:0006479]; regulation of rhodopsin mediated signaling pathway [GO:0022400] GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006479; GO:0007005; GO:0018022; GO:0018025; GO:0022400; GO:0031072; GO:0032991 calmodulin-lysine N-methyltransferase activity [GO:0018025]; heat shock protein binding [GO:0031072] QKHLDDCLR 0.99587 -11.833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86XM0 CTSRD_HUMAN "Cation channel sperm-associated auxiliary subunit delta, CatSper-delta, CatSperdelta (Transmembrane protein 146)" CATSPERD TMEM146 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228] CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283] GO:0005886; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0097228 CKIEFLTGEFIYR 0.99587 -10.282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5234 0 0 0 0 0 0 10.7478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9743 12.1694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4954 0 0 0 0 0 0 0 0 14.1101 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1299 12.0384 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5599 0 0 0 11.8739 0 11.18 0 0 0 0 0 0 0 0 11.5295 13.176 0 0 0 0 0 Q8NBE8 KLH23_HUMAN Kelch-like protein 23 KLHL23 Homo sapiens (Human) FLFILSRKNLSVWK 0.99587 -12.294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.288 0 0 0 14.7973 0 0 0 0 0 0 0 0 0 0 0 0 13.7676 0 0 0 0 0 0 0 0 0 0 13.4651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0054 0 0 0 0 0 12.8066 0 0 0 0 0 12.8066 0 0 13.6198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8078 0 0 Q96A28 SLAF9_HUMAN "SLAM family member 9 (CD2 family member 10, CD2F-10) (CD84 homolog 1, CD84-H1)" SLAMF9 CD2F10 UNQ1938/PRO4421 Homo sapiens (Human) T cell activation [GO:0042110] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021] cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; T cell activation [GO:0042110] GO:0009897; GO:0009986; GO:0016021; GO:0042110 GLLIFLLLVILAMGLWVIR 0.99587 -12.365 0 12.864 0 0 0 0 11.4058 0 0 10.5572 0 0 0 0 13.7634 0 0 11.4776 0 11.9469 0 0 15.5187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8463 0 0 12.4961 0 0 0 14.2274 0 0 10.8127 0 0 0 17.336 14.8528 16.3355 16.3639 17.4951 15.4988 15.9587 16.3898 17.0718 16.9636 17.0193 16.1089 15.3999 15.7406 16.5721 11.1978 0 11.0142 0 0 0 11.1672 0 0 0 0 0 0 0 13.816 14.5866 0 0 12.3331 12.7026 0 0 13.3211 0 12.1876 0 0 13.7716 0 12.8808 0 17.4022 0 0 13.8369 13.8148 13.5037 17.6891 12.953 12.6938 14.3499 0 11.2368 12.3709 0 15.0518 11.9963 0 13.6354 0 0 0 12.2997 13.2635 0 14.7208 13.2538 0 0 0 14.6902 0 0 12.7669 0 0 12.7841 14.1824 12.4422 0 0 11.2609 13.782 0 0 12.3599 0 12.1785 0 0 13.6397 0 0 10.8772 0 12.4928 0 0 0 0 13.1667 14.4537 11.9604 0 11.5269 0 16.0637 15.7044 17.5889 18.117 13.8473 0 13.5335 0 13.749 15.9009 12.4309 0 16.3412 15.1453 0 0 0 16.8397 Q9H0I9 TKTL2_HUMAN "Transketolase-like protein 2, EC 2.2.1.1" TKTL2 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802] GO:0004802; GO:0005737; GO:0030976; GO:0046872 metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; transketolase activity [GO:0004802] LRIHSIR 0.99587 -11.765 0 0 0 0 0 0 0 0 0 12.4781 0 0 0 0 0 0 0 0 11.0662 12.1083 0 0 0 0 0 0 0 11.6155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9624 0 0 12.4731 0 0 0 0 0 0 0 0 0 0 0 0 14.1244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H579 MROH8_HUMAN Protein MROH8 (Maestro heat-like repeat-containing protein family member 8) MROH8 C20orf131 C20orf132 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 AELFSLTIK 0.99587 -11.792 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8114 0 0 0 0 0 0 0 0 0 0 Q9NRW4 DUS22_HUMAN "Dual specificity protein phosphatase 22, EC 3.1.3.16, EC 3.1.3.48 (JNK-stimulatory phosphatase-1, JSP-1) (Low molecular weight dual specificity phosphatase 2, LMW-DSP2) (Mitogen-activated protein kinase phosphatase x, MAP kinase phosphatase x, MKP-x)" DUSP22 JSP1 LMWDSP2 MKPX Homo sapiens (Human) cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; leading edge of lamellipodium [GO:0061851]; plasma membrane [GO:0005886]; myosin phosphatase activity [GO:0017018]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903996]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of JNK cascade [GO:0046330]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0000122; GO:0002710; GO:0004725; GO:0004726; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0007179; GO:0008138; GO:0016311; GO:0017018; GO:0030336; GO:0031941; GO:0035335; GO:0042127; GO:0046330; GO:0050860; GO:0050868; GO:0051895; GO:0061851; GO:0071364; GO:1903996; GO:1990782 myosin phosphatase activity [GO:0017018]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] DAEQLSK 0.99587 -9.802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8489 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4A8 NF2L3_HUMAN "Nuclear factor erythroid 2-related factor 3, NF-E2-related factor 3, NFE2-related factor 3 (Nuclear factor, erythroid derived 2, like 3)" NFE2L3 NRF3 Homo sapiens (Human) integrated stress response signaling [GO:0140467]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366] chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; integrated stress response signaling [GO:0140467]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0090575; GO:0140467 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AARSGPLDAGEEEK 0.99587 -11.786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1549 0 0 0 0 12.8702 0 0 0 0 13.7447 0 0 0 13.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1639 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y561 LRP12_HUMAN "Low-density lipoprotein receptor-related protein 12, LDLR-related protein 12, LRP-12 (Suppressor of tumorigenicity 7 protein)" LRP12 ST7 Homo sapiens (Human) endocytosis [GO:0006897]; locomotion [GO:0040011]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] clathrin-coated pit [GO:0005905]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; low-density lipoprotein particle receptor activity [GO:0005041]; endocytosis [GO:0006897]; locomotion [GO:0040011]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165] GO:0001764; GO:0005041; GO:0005887; GO:0005905; GO:0006897; GO:0007165; GO:0016021; GO:0031175; GO:0040008; GO:0040011 low-density lipoprotein particle receptor activity [GO:0005041] CDGYWHCPNGRDETNCTMCQKEEFPCSR 0.99587 -11.827 0 0 0 0 0 0 0 10.2794 11.2776 12.8869 11.9432 0 13.2996 12.2259 0 0 0 0 0 0 0 0 0 0 0 0 12.48 0 11.6849 12.8048 12.3638 13.7071 13.9266 11.8607 0 12.7045 12.7855 0 0 13.2406 0 12.0807 0 12.2649 0 0 0 14.1092 0 0 0 11.2423 0 0 0 0 12.7641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7947 12.0012 14.0387 0 0 0 11.3669 0 0 0 15.1904 0 0 0 10.5056 0 0 0 0 0 13.9047 0 0 0 0 0 0 0 0 0 0 0 0 12.3877 0 0 11.5721 0 0 0 13.3641 0 0 0 0 0 0 11.8906 0 0 0 0 12.7684 13.1744 0 11.7839 0 14.188 13.8936 0 0 0 0 12.1373 0 0 11.8369 0 11.4732 0 0 0 11.3198 0 13.0648 0 0 0 0 0 14.291 14.0125 0 0 13.0663 0 13.6922 0 0 0 13.1771 0 0 0 0 0 0 0 0 0 0 0 0 Q6PKX4 DOK6_HUMAN Docking protein 6 (Downstream of tyrosine kinase 6) DOK6 DOK5L Homo sapiens (Human) positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0005829; GO:0007169; GO:0043410 FPDEKAAYFRNFHK 0.99588 -33.164 11.2855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9448 0 13.6837 0 13.3991 11.5951 12.7186 13.8187 11.9147 0 11.176 11.9641 12.5685 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.867 18.3108 18.4868 15.5712 19.2159 16.1472 15.6008 18.0111 14.5368 18.2746 16.6198 16.5651 17.8419 15.4721 16.149 16.8911 0 13.9948 13.8309 11.6994 14.9981 14.3726 14.601 14.5322 14.1315 0 13.5434 14.7481 15.1906 13.7623 17.6057 0 0 16.4066 15.6212 16.4582 14.2008 16.9263 14.7578 13.5935 13.9347 14.9597 15.1617 15.4441 14.3211 10.6475 15.9126 14.0423 15.5443 14.2647 14.1248 13.8738 0 15.2647 16.0111 14.0792 0 15.8543 16.5448 13.4442 16.6422 13.5639 16.1826 13.8834 14.35 16.2055 17.2874 15.8368 15.8798 14.8297 14.9251 14.3038 14.112 15.8775 15.6647 14.7454 15.3045 14.9408 15.376 14.727 14.0375 13.8696 0 0 16.9102 14.8858 15.2984 0 14.2356 14.6672 0 0 0 0 0 0 0 0 13.7652 14.0777 0 0 0 0 13.7368 14.2082 14.2864 13.9676 13.1745 0 0 0 14.2095 0 O75677 RFPL1_HUMAN Ret finger protein-like 1 (RING finger protein 78) RFPL1 RFPL1L RNF78 Homo sapiens (Human) "cell cycle [GO:0007049]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; negative regulation of cell division [GO:0051782]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic cell cycle [GO:0045930]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription, DNA-templated [GO:0045893]" GO:0000785; GO:0004842; GO:0005654; GO:0005737; GO:0007049; GO:0008285; GO:0010972; GO:0032436; GO:0043065; GO:0045893; GO:0045930; GO:0046872; GO:0051782; GO:2001272 metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842] FTCGRHYWEVDVGTSTEWDLGVCRESVHR 0.99588 -11.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.23 12.6829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8882 13.7252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9949 0 0 12.9018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8947 0 0 0 0 0 0 0 0 P01270 PTHY_HUMAN "Parathyroid hormone, PTH (Parathormone) (Parathyrin)" PTH Homo sapiens (Human) activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]; transcription by RNA polymerase II [GO:0006366] GO:0001501; GO:0005179; GO:0005576; GO:0005615; GO:0006366; GO:0006874; GO:0007186; GO:0007189; GO:0007202; GO:0007266; GO:0007267; GO:0008628; GO:0009410; GO:0009967; GO:0010288; GO:0010468; GO:0010629; GO:0010960; GO:0030282; GO:0030501; GO:0031856; GO:0031857; GO:0032331; GO:0033280; GO:0034645; GO:0045453; GO:0045471; GO:0045725; GO:0045944; GO:0046058; GO:0046326; GO:0046686; GO:0047485; GO:0048018; GO:0048873; GO:0051428; GO:0055062; GO:0060732; GO:0071107; GO:0071774; GO:0071864; GO:0071866; GO:0090290; GO:1900158 hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857] EDNVLVESHEK 0.99588 -9.5416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2098 0 0 0 0 0 0 0 0 0 0 0 11.8141 0 0 0 0 0 0 0 0 0 0 0 12.7986 0 0 0 0 12.6912 0 12.4625 0 0 0 0 13.3943 0 0 12.181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1033 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17097 ZNF7_HUMAN Zinc finger protein 7 (Zinc finger protein HF.16) (Zinc finger protein KOX4) ZNF7 KOX4 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0046872 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFNRSSRLTQHQK 0.99588 -12.435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2372 0 0 0 0 0 0 0 0 14.7435 11.3178 0 14.4031 0 0 14.3793 0 0 0 14.3103 0 17.3974 10.7328 12.8545 0 0 0 14.2187 0 13.1116 0 13.8516 0 0 0 0 0 13.7454 0 12.4831 0 12.0008 0 0 0 0 14.3061 0 0 14.9049 0 0 0 0 0 0 0 11.8137 0 0 0 14.2426 0 0 0 0 0 0 0 13.5965 0 16.0505 0 0 0 12.7938 0 0 0 13.1328 0 13.149 0 0 0 0 0 0 13.8539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7504 0 13.2962 0 0 0 0 0 12.2268 0 0 P26583 HMGB2_HUMAN "High mobility group protein B2 (High mobility group protein 2, HMG-2)" HMGB2 HMG2 Homo sapiens (Human) "cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin organization [GO:0006325]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to steroid hormone [GO:0048545]; spermatid nucleus differentiation [GO:0007289]; V(D)J recombination [GO:0033151]" chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991] "chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; chemoattractant activity [GO:0042056]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; non-sequence-specific DNA binding, bending [GO:0044378]; protein domain specific binding [GO:0019904]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin organization [GO:0006325]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to steroid hormone [GO:0048545]; spermatid nucleus differentiation [GO:0007289]; V(D)J recombination [GO:0033151]" GO:0000122; GO:0000400; GO:0000785; GO:0000793; GO:0000976; GO:0000987; GO:0001938; GO:0002437; GO:0003677; GO:0003684; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006265; GO:0006303; GO:0006325; GO:0006334; GO:0006357; GO:0007289; GO:0008134; GO:0008301; GO:0008584; GO:0008625; GO:0010629; GO:0019904; GO:0032075; GO:0032392; GO:0032496; GO:0032728; GO:0032991; GO:0033151; GO:0042056; GO:0043388; GO:0044378; GO:0045087; GO:0045089; GO:0045648; GO:0045654; GO:0045892; GO:0045893; GO:0045944; GO:0048471; GO:0048545; GO:0050767; GO:0050786; GO:0050829; GO:0050830; GO:0060326; GO:0071222; GO:0072091; GO:0097100; GO:0140297; GO:1902042 "chemoattractant activity [GO:0042056]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; non-sequence-specific DNA binding, bending [GO:0044378]; protein domain specific binding [GO:0019904]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]" AKGKSEAGK 0.99588 -12.482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8017 0 11.1493 11.8151 0 13.476 0 0 0 0 0 12.4552 13.8546 14.8296 13.7155 0 11.4941 12.298 0 12.2215 12.2488 0 13.4998 13.1923 12.8261 0 0 0 0 11.6672 0 0 0 16.2499 0 0 14.2302 0 0 0 14.5077 0 0 0 0 0 0 0 13.8429 0 0 14.1188 14.8043 14.9314 13.8104 15.2116 14.1585 14.8043 0 14.9815 0 0 0 15.4018 0 14.0481 0 0 0 14.9787 14.4834 0 13.6651 0 0 0 0 11.7606 0 0 0 0 13.7785 0 0 13.9095 0 0 12.8229 14.3491 14.4368 0 0 0 0 0 0 0 0 13.6414 12.0331 12.8773 0 0 0 0 13.7201 0 14.9732 0 0 0 0 0 P30939 5HT1F_HUMAN "5-hydroxytryptamine receptor 1F, 5-HT-1F, 5-HT1F (Serotonin receptor 1F)" HTR1F HTR1EL Homo sapiens (Human) "adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202] "dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; synapse [GO:0045202]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]" GO:0004993; GO:0005886; GO:0005887; GO:0007187; GO:0007193; GO:0007198; GO:0007268; GO:0030425; GO:0030594; GO:0045202; GO:0051378 G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378] AAKTLYHK 0.99588 -12.448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1702 0 0 12.7466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7084 0 12.1611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0371 0 0 0 0 0 0 0 0 14.1407 0 17.0969 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7425 12.2898 0 0 0 0 0 0 14.4527 0 0 0 0 0 Q13217 DNJC3_HUMAN "DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6, ER-resident protein ERdj6, ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa, Protein kinase inhibitor p58)" DNAJC3 P58IPK PRKRI Homo sapiens (Human) cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790] azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986] GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0006986; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0043066; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1903561; GO:1903912 chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860] AQRLLKQSQK 0.99588 -33.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93809 0 0 0 0 14.4259 0 0 0 0 0 0 15.7868 13.1901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3737 0 0 0 12.9683 0 0 13.7762 0 0 0 0 0 13.0059 0 12.9658 0 0 0 0 0 12.8427 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0926 0 0 0 12.2691 12.0103 Q15014 MO4L2_HUMAN Mortality factor 4-like protein 2 (MORF-related gene X protein) (Protein MSL3-2) (Transcription factor-like protein MRGX) MORF4L2 KIAA0026 MRGX Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; plasma membrane [GO:0005886] "histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; plasma membrane [GO:0005886]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779]; regulation of growth [GO:0040008]" GO:0000123; GO:0000786; GO:0005654; GO:0005730; GO:0005886; GO:0006281; GO:0006325; GO:0016573; GO:0016575; GO:0035267; GO:0040008; GO:0042981; GO:0043967; GO:0043968; GO:0045893; GO:0045944; GO:0051155; GO:0051726; GO:1905168; GO:2000779 MEVKVKIPEELK 0.99588 -9.5423 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7939 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8073 12.1603 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2022 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q3KRA9 ALKB6_HUMAN "Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6, EC 1.14.11.- (Alkylated DNA repair protein alkB homolog 6)" ALKBH6 ABH6 Homo sapiens (Human) cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872] GO:0005634; GO:0005654; GO:0005737; GO:0005925; GO:0046872; GO:0051213 dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872] LQNWGGLPHPRGMVPERLPPWLQR 0.99588 -9.5332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8964 0 0 0 0 0 0 0 13.3085 0 14.6332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9365 10.9011 0 0 0 0 0 0 0 0 0 0 12.6995 14.3 0 0 0 0 0 13.1094 0 0 0 0 0 0 0 12.7711 0 0 0 13.7343 0 0 0 0 0 0 12.855 0 0 0 0 13.1937 0 0 0 0 12.218 0 0 0 0 10.9508 0 0 13.0744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UXX5 ITIH6_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H6 (Inter-alpha-trypsin inhibitor heavy chain H5-like protein, Inter-alpha inhibitor H5-like protein)" ITIH6 ITIH5L UNQ6369/PRO21074 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] extracellular region [GO:0005576] extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] GO:0004867; GO:0005576; GO:0030212 serine-type endopeptidase inhibitor activity [GO:0004867] AGLHVSGKLLGAPPR 0.99588 -32.84 0 0 0 0 0 0 0 0 15.9303 0 13.7213 15.796 0 16.1641 13.8236 0 0 0 14.3567 0 0 0 12.9582 0 0 0 0 0 0 0 16.3292 0 16.3863 0 13.9264 15.0733 0 0 0 0 16.4726 11.8686 0 0 0 0 0 0 12.9201 13.0321 0 0 0 0 0 0 0 0 0 0 15.1268 0 0 0 0 0 0 0 13.2482 0 0 0 0 0 0 0 13.0402 0 0 0 0 0 13.243 0 0 0 0 0 0 0 0 0 0 0 13.9345 0 0 0 0 0 0 0 0 0 0 0 13.0635 0 0 0 13.5058 0 0 13.8836 0 14.0658 0 14.5533 0 0 0 0 0 0 0 0 0 16.3406 0 0 14.6846 0 0 0 0 13.8571 0 0 0 13.4778 0 0 0 0 0 0 13.6451 0 13.2857 0 0 0 0 0 16.4868 13.7149 0 0 16.963 0 0 16.1583 0 0 0 17.1133 0 0 0 15.9899 12.4414 0 0 0 0 17.5705 16.2804 13.2803 0 17.2283 Q6ZNE9 RUFY4_HUMAN RUN and FYVE domain-containing protein 4 RUFY4 Homo sapiens (Human) autophagosome assembly [GO:0000045]; cellular response to interleukin-4 [GO:0071353]; positive regulation of macroautophagy [GO:0016239] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410] autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; cellular response to interleukin-4 [GO:0071353]; positive regulation of macroautophagy [GO:0016239] GO:0000045; GO:0005776; GO:0016239; GO:0031410; GO:0032266; GO:0046872; GO:0071353 metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266] AEEGAILKVTKDLR 0.99588 -32.798 12.134 0 0 0 11.7778 12.2505 0 11.6608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2836 0 0 0 0 0 0 0 0 0 0 12.0684 0 0 12.8109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0052 0 0 0 0 0 0 19.1545 0 0 0 0 12.8797 14.2306 0 0 12.5181 0 0 0 0 0 0 0 0 0 0 15.0518 0 12.4002 0 0 12.6227 0 0 0 0 0 13.8701 0 0 0 14.591 0 0 11.7764 0 13.8173 0 12.4482 0 12.5453 0 14.3485 14.3832 12.8618 0 12.6509 0 0 0 13.2275 14.2999 13.53 0 16.5049 0 0 11.7255 0 13.6479 0 0 0 12.1778 0 12.5008 0 0 0 0 0 0 0 0 0 0 12.1884 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTS1 BHA15_HUMAN "Class A basic helix-loop-helix protein 15, bHLHa15 (Class B basic helix-loop-helix protein 8, bHLHb8) (Muscle, intestine and stomach expression 1, MIST-1)" BHLHA15 BHLHB8 MIST1 Homo sapiens (Human) calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cellular response to glucose starvation [GO:0042149]; endoplasmic reticulum unfolded protein response [GO:0030968]; establishment of localization in cell [GO:0051649]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of myotube differentiation [GO:0010832]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell maturation [GO:0072560] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cellular response to glucose starvation [GO:0042149]; endoplasmic reticulum unfolded protein response [GO:0030968]; establishment of localization in cell [GO:0051649]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; Golgi organization [GO:0007030]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of myotube differentiation [GO:0010832]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell maturation [GO:0072560]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006851; GO:0007030; GO:0007186; GO:0007267; GO:0010832; GO:0019722; GO:0030182; GO:0030968; GO:0042149; GO:0042593; GO:0042802; GO:0046983; GO:0048312; GO:0051649; GO:0072560; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" LSKIETLTLAKNYIK 0.99588 -10.337 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.292 0 0 0 0 0 0 0 0 0 0 0 10.9154 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4088 0 0 0 0 0 0 0 0 0 13.4311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.588 0 0 0 0 0 0 0 0 Q9HD34 LYRM4_HUMAN LYR motif-containing protein 4 LYRM4 C6orf149 ISD11 CGI-203 Homo sapiens (Human) iron-sulfur cluster assembly [GO:0016226] iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604] iron-sulfur cluster assembly complex [GO:1990229]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; iron-sulfur cluster assembly [GO:0016226] GO:0005739; GO:0005759; GO:0016226; GO:0016604; GO:1990221; GO:1990229 FSAYNYR 0.99588 -9.5375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0908 0 0 0 0 0 0 0 0 0 0 0 12.3951 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9819 0 12.2054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4482 0 0 0 13.0178 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6296 0 Q9NV79 PCMD2_HUMAN Protein-L-isoaspartate O-methyltransferase domain-containing protein 2 PCMTD2 C20orf36 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719] GO:0004719; GO:0005737 protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719] FDFCEPSFVTGNCLEISPDCSQYDR 0.99588 -10.336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8962 0 0 11.571 0 0 0 0 14.953 0 0 0 15.1563 0 0 0 0 14.5635 14.7526 0 14.0766 14.9657 0 0 0 0 0 0 0 13.4862 0 0 0 11.1598 0 0 13.0114 0 0 0 0 0 0 0 0 11.4848 0 0 11.8158 12.0888 0 15.2821 0 14.3966 0 0 0 0 0 0 0 0 0 0 15.2292 0 0 0 0 11.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.64111 0 0 0 0 0 0 0 0 0 0 0 0 11.1857 0 Q9NZD8 SPG21_HUMAN Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein) (Spastic paraplegia 21 protein) SPG21 ACP33 BM-019 GL010 Homo sapiens (Human) antigen receptor-mediated signaling pathway [GO:0050851] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140] cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609]; antigen receptor-mediated signaling pathway [GO:0050851] GO:0005794; GO:0005829; GO:0010008; GO:0030140; GO:0042609; GO:0043231; GO:0050851 CD4 receptor binding [GO:0042609] AHLKTGGNFPYLCRSAEVNLYVQIHLLQFHGTK 0.99588 -9.5398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2933 0 0 0 0 0 12.3539 0 10.9564 0 12.4665 0 0 12.9057 0 0 0 11.6761 11.8418 15.106 15.4022 15.2218 14.2695 0 0 0 0 0 0 0 0 10.2935 0 0 14.5517 0 0 0 11.6903 0 14.2432 0 15.2175 0 0 0 0 0 0 0 0 14.4971 0 0 0 0 0 0 0 0 13.4134 0 0 0 0 0 0 0 0 0 0 0 11.9209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4098 0 0 0 0 0 12.7709 0 10.4202 13.5111 0 0 0 0 0 0 0 0 0 0 0 11.9834 0 0 0 0 0 0 Q9UK96 FBX10_HUMAN F-box only protein 10 FBXO10 FBX10 PRMT11 Homo sapiens (Human) apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0000151; GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0042981 ubiquitin-protein transferase activity [GO:0004842] CLFRDGK 0.99588 -33.125 0 0 0 0 0 0 0 0 0 0 0 0 13.0536 0 0 0 0 0 11.4427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3311 0 14.7075 0 13.9102 0 12.5345 13.5543 0 17.7246 0 15.0194 11.4792 14.151 13.3678 13.4516 13.9396 14.7272 14.6879 13.365 14.841 13.6786 15.9257 14.1424 0 0 0 14.4863 15.6249 14.5967 15.4972 13.1229 0 13.0213 16.2946 0 0 13.1398 12.939 14.0859 0 0 14.2966 13.2083 0 0 0 14.0764 0 12.1735 15.3361 0 14.1378 14.574 13.3641 13.2807 14.3465 13.1885 0 0 0 0 15.0735 0 0 0 0 0 13.6834 0 12.5693 0 0 13.0963 0 0 0 13.0149 14.3782 14.7976 13.7422 0 0 0 0 0 11.6453 0 0 15.1933 0 14.0107 14.4608 0 0 0 11.8822 0 14.1606 14.3387 0 0 0 0 0 0 Q9Y210 TRPC6_HUMAN "Short transient receptor potential channel 6, TrpC6 (Transient receptor protein 6, TRP-6)" TRPC6 TRP6 Homo sapiens (Human) calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; manganese ion transport [GO:0006828]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338] cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057] "cation channel complex [GO:0034703]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; manganese ion transport [GO:0006828]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of cytosolic calcium ion concentration [GO:0051480]; single fertilization [GO:0007338]" GO:0005261; GO:0005262; GO:0005737; GO:0005886; GO:0005887; GO:0006812; GO:0006828; GO:0007204; GO:0007338; GO:0015279; GO:0016020; GO:0032414; GO:0034703; GO:0036057; GO:0042803; GO:0051480; GO:0051928; GO:0070588; GO:0070679 "calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; inositol 1,4,5 trisphosphate binding [GO:0070679]; protein homodimerization activity [GO:0042803]; store-operated calcium channel activity [GO:0015279]" FLVVLAVAIGLPFLALIYWFAPCSKMGK 0.99588 -9.8174 0 0 0 0 0 13.2149 13.0725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8561 0 0 12.7566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0584 0 0 0 0 11.9379 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3539 0 0 0 0 0 0 0 0 15.6599 14.5714 14.6826 13.045 0 0 16.0435 0 13.1365 15.7654 15.341 11.9838 0 15.6586 0 12.4708 14.0283 13.8014 0 0 0 0 0 14.2602 0 0 0 0 0 0 0 0 12.7897 0 14.1009 0 0 0 0 0 13.9905 0 0 13.9568 14.2409 0 0 0 0 0 0 0 12.7043 12.8319 14.318 0 15.4146 0 0 0 0 0 14.4881 0 14.0944 0 0 0 0 0 0 0 0 11.378 0 0 0 14.2805 13.1379 14.8946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2322 0 0 0 0 0 0 0 Q9Y6K5 OAS3_HUMAN "2'-5'-oligoadenylate synthase 3, (2-5')oligo(A) synthase 3, 2-5A synthase 3, EC 2.7.7.84 (p100 OAS, p100OAS)" OAS3 P/OKcl.4 Homo sapiens (Human) defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of chemokine (C-X-C motif) ligand 9 production [GO:0035395]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529] GO:0001730; GO:0003725; GO:0005524; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006139; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0035395; GO:0039529; GO:0039530; GO:0042742; GO:0043231; GO:0045071; GO:0045087; GO:0046872; GO:0051607; GO:0060339; GO:0060700; GO:0071639; GO:0071650; GO:0071659; GO:2000342 2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872] AQLEACQQER 0.99588 -11.899 0 0 0 0 0 0 0 0 0 0 14.0138 0 0 0 0 0 0 0 13.7066 0 0 12.4002 12.2906 0 0 0 0 11.078 0 0 0 0 0 13.005 0 0 0 10.4396 0 0 0 12.5273 13.9727 0 0 13.9731 0 13.4665 10.9421 0 0 0 13.5651 0 12.5307 0 0 0 0 0 0 14.0207 0 13.8287 0 0 0 0 12.7228 0 0 11.3721 0 0 0 0 0 0 0 0 13.5362 0 14.7617 16.6744 0 0 12.7444 12.6565 0 0 0 13.8296 14.1097 0 0 0 0 0 0 13.898 0 0 0 0 0 0 13.2938 13.6632 0 0 13.1032 14.0359 15.0483 0 0 0 0 0 0 0 0 0 13.0947 0 0 0 13.8574 13.2153 0 0 0 0 14.9623 0 0 0 0 0 0 0 0 0 0 14.1608 0 13.5775 0 14.1072 11.3893 0 0 0 0 0 0 13.5307 13.4219 14.0305 0 13.6527 0 0 11.9187 13.2434 0 13.6241 11.1012 0 13.5755 13.1659 0 0 0 0 14.2447 0 0 0 0 0 O60763 USO1_HUMAN "General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein, TAP) (Vesicle-docking protein)" USO1 VDP Homo sapiens (Human) endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133] cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280] GO:0000139; GO:0001650; GO:0003723; GO:0005783; GO:0005794; GO:0005795; GO:0005815; GO:0005829; GO:0006886; GO:0006888; GO:0007264; GO:0012507; GO:0016020; GO:0030133; GO:0032252; GO:0045056; GO:0045296; GO:0048211; GO:0048280; GO:0048471; GO:0061025; GO:1900076 cadherin binding [GO:0045296]; RNA binding [GO:0003723] DKLELEITDSKK 0.99589 -9.5759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4021 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6904 0 13.2777 0 0 0 11.4726 0 0 0 0 0 15.2671 0 0 0 0 0 13.7675 14.7001 14.5594 0 0 12.0735 0 13.644 13.7877 0 13.8788 0 14.165 14.1426 12.8731 0 0 9.86697 0 0 0 12.1072 0 0 0 0 0 0 0 0 14.5804 0 0 0 0 15.3462 18.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0767 0 0 0 0 0 0 0 12.8399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P20585 MSH3_HUMAN "DNA mismatch repair protein Msh3, hMSH3 (Divergent upstream protein, DUP) (Mismatch repair protein 1, MRP1)" MSH3 DUC1 DUG Homo sapiens (Human) DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; somatic recombination of immunoglobulin gene segments [GO:0016447] membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983]; DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; somatic recombination of immunoglobulin gene segments [GO:0016447] GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0051096; GO:0140664 ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983] ATSVSVQDDRIR 0.99589 -34.071 0 0 0 0 0 0 0 0 11.3817 10.9604 0 0 0 10.4413 0 0 0 0 0 0 0 10.3547 0 0 10.8113 0 0 11.5325 0 0 0 12.6551 0 0 10.4864 16.3901 0 0 0 0 0 0 0 14.1172 0 9.97054 0 0 0 10.1457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0608 0 0 12.7269 0 0 0 10.9452 0 14.1191 12.8601 0 0 0 14.7734 0 13.6359 0 0 0 0 0 0 0 14.2844 0 0 0 12.5629 0 0 11.332 11.1351 14.1373 14.1146 0 0 0 0 0 0 11.3248 0 0 0 0 0 12.4872 0 0 13.0605 0 0 0 0 0 0 0 11.9926 0 0 0 0 0 0 0 0 0 0 12.2358 0 0 0 0 0 0 0 0 0 0 0 0 10.6633 0 0 0 12.3901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8682 0 0 0 0 13.6654 0 P51617 IRAK1_HUMAN "Interleukin-1 receptor-associated kinase 1, IRAK-1, EC 2.7.11.1" IRAK1 IRAK Homo sapiens (Human) activation of NF-kappaB-inducing kinase activity [GO:0007250]; aging [GO:0007568]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cytokine-mediated signaling pathway [GO:0001959]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; NF-kappaB-inducing kinase activity [GO:0004704]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; aging [GO:0007568]; cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of type I interferon production [GO:0032481]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cytokine-mediated signaling pathway [GO:0001959]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337] GO:0001959; GO:0002224; GO:0002755; GO:0004672; GO:0004674; GO:0004704; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0006468; GO:0007250; GO:0007254; GO:0007568; GO:0010008; GO:0016301; GO:0019221; GO:0019901; GO:0031072; GO:0031663; GO:0032088; GO:0032481; GO:0032496; GO:0032991; GO:0034134; GO:0034142; GO:0034162; GO:0034605; GO:0035556; GO:0042802; GO:0042803; GO:0043123; GO:0043406; GO:0045087; GO:0046777; GO:0046982; GO:0048661; GO:0051092; GO:0060337; GO:0070498; GO:0070555; GO:0071222; GO:0071456; GO:0106310; GO:1901224; GO:1904996 ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; NF-kappaB-inducing kinase activity [GO:0004704]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] AVKTHGARTK 0.99589 -9.5574 0 0 0 11.2522 0 0 11.512 11.1075 0 0 0 13.5444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.96152 0 0 0 0 0 0 0 0 0 10.3955 0 0 0 0 0 0 0 0 0 0 11.3041 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8993 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7023 0 0 0 0 0 14.2648 0 11.1731 0 0 0 0 0 0 0 0 0 0 12.0441 0 0 0 0 0 0 12.0522 12.4911 0 10.6749 0 0 0 0 0 10.6253 0 0 0 0 Q86UZ6 ZBT46_HUMAN "Zinc finger and BTB domain-containing protein 46 (BTB-ZF protein expressed in effector lymphocytes, BZEL) (BTB/POZ domain-containing protein 4) (Zinc finger protein 340)" ZBTB46 BTBD4 ZNF340 Homo sapiens (Human) granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of transcription by RNA polymerase II [GO:0000122]; plasmacytoid dendritic cell differentiation [GO:0002273]; positive regulation of dendritic cell differentiation [GO:2001200]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; granulocyte differentiation [GO:0030851]; macrophage differentiation [GO:0030225]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of leukocyte activation [GO:0002695]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of transcription by RNA polymerase II [GO:0000122]; plasmacytoid dendritic cell differentiation [GO:0002273]; positive regulation of dendritic cell differentiation [GO:2001200]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000981; GO:0001227; GO:0002273; GO:0002695; GO:0005634; GO:0006357; GO:0030225; GO:0030851; GO:0030853; GO:0045650; GO:0045656; GO:0046872; GO:2001199; GO:2001200 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]" CPYCSFSAMHQCILKRHMR 0.99589 -11.915 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4501 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2755 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8532 0 0 0 0 0 0 0 0 0 0 0 12.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96NT5 PCFT_HUMAN "Proton-coupled folate transporter, HsPCFT, hPCFT (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1)" SLC46A1 G21 HCP1 PCFT Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; folate import across plasma membrane [GO:1904447]; folate transmembrane transport [GO:0098838]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; heme metabolic process [GO:0042168]; intestinal folate absorption [GO:0098829]; proton transmembrane transport [GO:1902600]; transmembrane transport [GO:0055085] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; folic acid:proton symporter activity [GO:0140211]; heme transmembrane transporter activity [GO:0015232]; methotrexate transmembrane transporter activity [GO:0015350]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; cellular iron ion homeostasis [GO:0006879]; folate import across plasma membrane [GO:1904447]; folate transmembrane transport [GO:0098838]; folic acid metabolic process [GO:0046655]; folic acid transport [GO:0015884]; heme metabolic process [GO:0042168]; intestinal folate absorption [GO:0098829]; proton transmembrane transport [GO:1902600]; transmembrane transport [GO:0055085] GO:0005542; GO:0005737; GO:0005768; GO:0005886; GO:0006879; GO:0008517; GO:0009986; GO:0010008; GO:0015078; GO:0015232; GO:0015350; GO:0015884; GO:0016020; GO:0016021; GO:0016323; GO:0016324; GO:0022857; GO:0031526; GO:0042168; GO:0046655; GO:0055085; GO:0098829; GO:0098838; GO:0140211; GO:1902600; GO:1904447 folic acid binding [GO:0005542]; folic acid transmembrane transporter activity [GO:0008517]; folic acid:proton symporter activity [GO:0140211]; heme transmembrane transporter activity [GO:0015232]; methotrexate transmembrane transporter activity [GO:0015350]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857] LFTFRHHR 0.99589 -9.5553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.85 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0676 13.8338 0 0 0 0 12.5032 0 0 0 14.3348 0 0 0 0 0 0 13.3983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4319 0 0 0 Q9BRP0 OVOL2_HUMAN "Transcription factor Ovo-like 2, hOvo2 (Zinc finger protein 339)" OVOL2 ZNF339 Homo sapiens (Human) angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dorsal/ventral pattern formation [GO:0009953]; embryonic digestive tract morphogenesis [GO:0048557]; endocardium formation [GO:0060214]; epidermal cell differentiation [GO:0009913]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of gene expression [GO:0010629]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural crest cell migration [GO:0001755]; neural fold formation [GO:0001842]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; regulation of cell cycle [GO:0051726]; regulation of keratinocyte proliferation [GO:0010837]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001755; GO:0001842; GO:0001947; GO:0003682; GO:0005634; GO:0006357; GO:0008283; GO:0009913; GO:0009953; GO:0010628; GO:0010629; GO:0010719; GO:0010837; GO:0010944; GO:0045617; GO:0045618; GO:0045746; GO:0046872; GO:0048557; GO:0051726; GO:0060214; GO:0060347; GO:0060390; GO:0060716; GO:0071560; GO:1990837; GO:2000647 "chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" MLNRHLK 0.99589 -34.021 14.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.521 0 0 0 14.6597 0 0 0 13.8008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2187 14.414 14.0319 14.7356 13.4295 15.6259 0 0 13.6681 12.8216 0 12.9757 13.6014 0 0 0 0 0 12.7228 0 0 0 13.958 0 0 0 0 13.066 0 0 0 0 13.119 0 0 0 15.6883 14.2014 0 0 13.9892 14.4539 0 0 0 15.6681 15.6616 0 0 0 16.0688 0 13.8323 0 0 15.9563 0 0 0 0 0 0 0 0 0 0 0 15.9982 0 0 0 0 16.8457 15.9359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4853 14.9848 Q9NTN9 SEM4G_HUMAN Semaphorin-4G SEMA4G KIAA1619 Homo sapiens (Human) axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887] extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001755; GO:0005615; GO:0005887; GO:0007411; GO:0030215; GO:0030335; GO:0045499; GO:0048843; GO:0050919; GO:0071526 chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215] KWTSFLK 0.99589 -9.5729 0 0 0 0 0 0 0 0 0 14.6631 0 0 0 14.9127 0 14.2516 0 0 0 13.9691 0 0 0 0 0 0 0 13.9527 0 0 13.8452 0 0 0 0 0 0 0 0 0 13.5778 0 0 0 0 0 13.1859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60271 JIP4_HUMAN "C-Jun-amino-terminal kinase-interacting protein 4, JIP-4, JNK-interacting protein 4 (Cancer/testis antigen 89, CT89) (Human lung cancer oncogene 6 protein, HLC-6) (JNK-associated leucine-zipper protein, JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis, PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1)" SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 Homo sapiens (Human) "lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]" acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471] "acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159]; lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]" GO:0001669; GO:0001933; GO:0005078; GO:0005737; GO:0005765; GO:0005829; GO:0008432; GO:0016192; GO:0019894; GO:0030159; GO:0030335; GO:0032418; GO:0034451; GO:0042147; GO:0042802; GO:0045665; GO:0045666; GO:0048471; GO:0051146; GO:0070062; GO:1903860 identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159] AHVQKEDGR 0.9959 -9.6078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6837 0 13.7047 0 0 0 0 0 0 0 13.7192 0 11.6745 0 0 0 0 0 0 0 0 0 0 0 12.6167 0 0 0 14.1379 0 0 13.3276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4216 15.1773 13.844 0 13.7954 12.6667 13.7519 14.0783 0 0 0 0 0 0 12.8215 0 0 0 0 0 0 0 0 0 14.245 0 0 0 0 0 0 0 0 0 0 0 0 13.757 12.9352 0 0 0 0 11.7168 0 11.1824 0 10.6907 0 0 0 0 0 11.3737 0 0 0 0 0 0 0 0 0 0 O75420 GGYF1_HUMAN GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1) GIGYF1 CDS2 PERQ1 PP3360 Homo sapiens (Human) insulin-like growth factor receptor signaling pathway [GO:0048009] cytosol [GO:0005829]; protein-containing complex [GO:0032991] cytosol [GO:0005829]; protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009] GO:0005829; GO:0032991; GO:0048009 AAETLNFGPEWLR 0.9959 -12.086 0 0 0 0 0 0 0 0 0 0 0 0 11.0633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.631 0 0 0 0 13.6247 0 0 14.0424 0 0 0 0 0 13.85 0 0 0 14.7848 0 0 0 0 0 13.5656 0 0 14.9923 0 0 0 0 0 0 0 0 0 14.3739 0 14.9231 0 14.9252 13.1214 0 0 0 14.1456 0 14.1475 0 0 16.6928 0 14.3188 14.4517 0 0 14.5722 0 0 0 0 0 0 0 0 0 0 14.9099 0 14.5025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9863 0 0 0 0 0 0 0 0 0 0 0 0 P04150 GCR_HUMAN "Glucocorticoid receptor, GR (Nuclear receptor subfamily 3 group C member 1)" NR3C1 GRL Homo sapiens (Human) "adrenal gland development [GO:0030325]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; glucocorticoid metabolic process [GO:0008211]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; mammary gland duct morphogenesis [GO:0060603]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucocorticoid biosynthetic process [GO:0031946]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor activity [GO:0004883]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]; adrenal gland development [GO:0030325]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; glucocorticoid metabolic process [GO:0008211]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; mammary gland duct morphogenesis [GO:0060603]; maternal behavior [GO:0042711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucocorticoid biosynthetic process [GO:0031946]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; signal transduction [GO:0007165]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001046; GO:0001227; GO:0001228; GO:0003700; GO:0003723; GO:0004879; GO:0004883; GO:0005496; GO:0005634; GO:0005654; GO:0005737; GO:0005759; GO:0005815; GO:0005819; GO:0005829; GO:0006111; GO:0006325; GO:0006355; GO:0006357; GO:0006915; GO:0007049; GO:0007059; GO:0007165; GO:0008211; GO:0008270; GO:0016020; GO:0016607; GO:0019901; GO:0030325; GO:0030518; GO:0031946; GO:0032991; GO:0042711; GO:0042802; GO:0043525; GO:0045892; GO:0045944; GO:0051301; GO:0051879; GO:0060603; GO:0071383; GO:0071385; GO:0071549; GO:0071560; GO:1902895; GO:1990239; GO:1990837 "core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor activity [GO:0004883]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; zinc ion binding [GO:0008270]" AVEGQHNYLCAGRNDCIIDKIR 0.9959 -12.04 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6823 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7584 0 0 0 0 0 0 0 12.8052 0 0 0 0 0 0 0 0 0 0 0 13.241 0 14.1174 0 0 0 0 0 0 0 0 0 0 12.1751 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8831 0 0 0 0 0 0 12.6667 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P48551 INAR2_HUMAN "Interferon alpha/beta receptor 2, IFN-R-2, IFN-alpha binding protein, IFN-alpha/beta receptor 2 (Interferon alpha binding protein) (Type I interferon receptor 2)" IFNAR2 IFNABR IFNARB Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]; cell surface receptor signaling pathway [GO:0007166]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337] GO:0004896; GO:0004905; GO:0005576; GO:0005615; GO:0005886; GO:0005887; GO:0007166; GO:0007259; GO:0009615; GO:0019221; GO:0019901; GO:0019962; GO:0035455; GO:0035456; GO:0051607; GO:0060337; GO:0098586 cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905] GNMSGNFTYIIDK 0.9959 -12.036 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.675 0 0 0 0 0 0 0 0 0 0 0 0 12.8482 0 12.7028 0 0 0 0 0 15.5719 0 13.5436 14.3121 14.2239 14.1829 14.4426 0 0 13.5386 13.9168 0 14.0598 0 0 0 0 12.5612 13.6549 0 0 0 0 13.9715 0 0 0 0 0 13.2268 0 13.8517 0 13.6304 13.7683 13.9766 0 0 14.8183 0 0 0 0 0 0 13.2758 0 0 0 0 13.5298 0 0 0 0 0 13.0384 13.2165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9007 12.954 0 0 0 0 0 0 P49736 MCM2_HUMAN DNA replication licensing factor MCM2 (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28) MCM2 BM28 CCNL1 CDCL1 KIAA0030 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; regulation of DNA-templated DNA replication initiation [GO:0030174] "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]" "chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; regulation of DNA-templated DNA replication initiation [GO:0030174]" GO:0000727; GO:0000781; GO:0000785; GO:0003677; GO:0003678; GO:0003688; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0005737; GO:0006260; GO:0006268; GO:0006270; GO:0006334; GO:0006915; GO:0016787; GO:0019899; GO:0030174; GO:0042393; GO:0042555; GO:0046872; GO:0071162; GO:0071353; GO:0090102; GO:1902975; GO:1905775 ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697] AESSESFTMASSPAQR 0.9959 -9.6032 0 0 0 11.6289 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5073 0 0 0 0 0 0 0 0 0 11.5098 0 0 0 0 0 0 0 0 0 0 0 0 12.3427 0 0 0 0 0 0 8.88728 0 0 0 0 0 0 0 9.21534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8264 12.3729 0 0 10.4527 0 13.3256 0 0 0 0 0 0 0 13.452 0 0 0 13.526 0 0 0 0 0 0 0 0 12.1814 0 0 0 0 0 12.4242 0 0 0 0 13.9284 11.8198 13.0312 12.6571 0 0 0 0 0 0 12.9555 0 0 0 0 0 14.2149 12.9163 0 0 11.9434 0 0 0 0 0 0 0 12.4089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7499 0 0 13.1883 0 0 0 12.7172 12.9865 14.7329 0 13.9984 12.3785 0 15.6166 12.4722 0 0 13.3978 0 0 0 13.2079 0 0 Q14676 MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) MDC1 KIAA0170 NFBD1 Homo sapiens (Human) DNA repair [GO:0006281]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573] chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; protein C-terminus binding [GO:0008022]; DNA repair [GO:0006281]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573] GO:0005634; GO:0005654; GO:0005694; GO:0005925; GO:0006281; GO:0008022; GO:0016604; GO:0031573; GO:0070975 FHA domain binding [GO:0070975]; protein C-terminus binding [GO:0008022] AQPFGFIDSDTDAEEER 0.9959 -34.305 0 0 0 0 0 0 0 0 0 0 10.9746 0 0 0 0 0 0 14.7747 0 0 0 0 12.0376 0 15.3005 0 0 0 0 0 13.2013 0 12.8852 0 0 0 0 11.4168 9.32326 0 0 0 14.599 0 0 0 0 12.5275 0 0 0 0 0 0 13.1223 0 12.906 0 11.1689 0 0 0 13.1416 0 0 11.2902 0 0 0 0 0 0 0 0 11.205 0 0 0 12.8372 0 0 0 14.9198 13.2391 0 0 0 12.5295 0 15.009 0 13.72 12.13 0 0 13.1429 0 14.1215 0 12.8463 0 0 13.5748 0 0 14.9327 0 0 0 0 0 0 14.6435 0 0 0 0 0 0 0 14.2361 14.8225 0 0 14.2674 0 0 0 12.9289 14.112 0 0 0 0 0 0 0 12.4709 0 11.3321 14.2104 14.0653 0 0 12.5461 0 0 0 13.1632 0 0 0 0 0 12.4111 12.8546 14.367 9.88716 0 12.7851 0 0 12.4709 0 0 0 17.2285 12.485 0 13.6922 12.2794 13.7522 11.7471 14.4481 14.4409 0 0 0 0 0 Q5T764 IFT1B_HUMAN Interferon-induced protein with tetratricopeptide repeats 1B (Interferon-induced protein with tetratricopeptide repeats 1-like protein) IFIT1B IFIT1L Homo sapiens (Human) cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688] cytosol [GO:0005829] cytosol [GO:0005829]; RNA binding [GO:0003723]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to type I interferon [GO:0071357]; defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688] GO:0003723; GO:0005829; GO:0050688; GO:0051607; GO:0071357; GO:0071360 RNA binding [GO:0003723] AITHYLK 0.9959 -9.6082 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5656 0 0 13.643 0 0 0 0 0 0 0 0 0 0 10.8163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0632 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1626 0 0 0 13.113 13.7971 0 14.1722 0 0 0 0 0 0 0 0 12.5648 0 15.4844 0 15.4178 15.1319 0 0 11.1663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.446 0 0 11.7702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9801 0 0 0 0 0 13.3245 0 0 0 0 0 0 13.2007 0 0 0 0 12.7823 0 12.4625 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4842 0 0 0 0 Q71UI9 H2AV_HUMAN Histone H2A.V (H2A.F/Z) (H2A.Z variant histone 2) H2AZ2 H2AFV H2AV Homo sapiens (Human) extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634] extracellular exosome [GO:0070062]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982; GO:0070062 DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527] AGLQFPVGR 0.9959 -12.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3284 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5602 0 0 0 0 0 0 0 14.9517 0 0 0 0 0 0 0 14.757 0 0 0 12.9417 0 13.2301 15.1491 14.6963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L1T6 NB5R4_HUMAN "Cytochrome b5 reductase 4, EC 1.6.2.2 (Flavohemoprotein b5/b5R, b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R)" CYB5R4 NCB5OR Homo sapiens (Human) bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801]" GO:0003032; GO:0004128; GO:0005783; GO:0005789; GO:0006091; GO:0006801; GO:0015701; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0072593 "cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]" DYREEEKK 0.9959 -12.073 0 0 12.3615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.0239 18.0428 0 0 0 0 0 0 0 15.8423 16.8877 0 15.6984 16.4673 16.3234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.982 0 0 16.7977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2942 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z591 AKNA_HUMAN Microtubule organization protein AKNA (AT-hook-containing transcription factor) AKNA KIAA1968 Homo sapiens (Human) delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727] GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234 DNA binding [GO:0003677] ARGSLIPR 0.9959 -34.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7618 12.4488 15.4071 0 0 12.3293 0 14.7942 0 11.91 0 0 0 11.9779 0 0 0 0 0 0 0 0 0 0 0 0 12.2911 0 0 14.1409 12.1201 0 12.1257 0 12.7642 11.5793 0 11.7676 0 0 0 0 0 0 0 0 11.2852 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6832 11.5701 0 0 0 13.3544 11.3044 0 0 0 0 16.2132 14.3674 14.4677 0 0 0 0 0 14.2611 0 0 13.3093 0 14.6001 0 13.7622 14.7525 14.4517 14.0938 0 14.2396 0 14.1548 0 13.0949 15.0306 15.2111 0 0 0 0 14.9697 18.2863 13.9598 14.2953 0 14.3438 0 14.1061 13.916 14.2335 13.7983 0 14.3291 0 14.6007 13.2589 14.1631 14.2299 12.4607 0 13.0459 14.7892 0 0 0 0 16.2264 13.7505 0 0 14.2717 0 0 0 0 0 14.1282 14.0416 14.5561 0 0 11.452 12.8735 0 0 0 11.8651 14.1975 0 0 14.0306 13.3093 16.2466 0 0 14.3639 12.6885 14.1844 0 0 13.8051 0 0 Q8IYB8 SUV3_HUMAN "ATP-dependent RNA helicase SUPV3L1, mitochondrial, EC 3.6.4.13 (Suppressor of var1 3-like protein 1, SUV3-like protein 1)" SUPV3L1 SUV3 Homo sapiens (Human) DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401] mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion morphogenesis [GO:0070584]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401] GO:0000958; GO:0000962; GO:0000965; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0016887; GO:0030307; GO:0032508; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0042803; GO:0043066; GO:0045025; GO:0070584; GO:2000827 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] HAKQIFPVLDCK 0.9959 -9.6287 0 0 0 0 0 0 0 0 12.2821 0 0 0 11.6636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9629 12.5605 0 0 0 0 0 0 0 0 0 0 12.5719 0 0 14.7097 0 0 13.8076 0 0 0 0 0 17.6047 0 0 0 17.3902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9342 0 0 0 0 0 0 0 0 12.0354 13.6427 0 0 0 0 0 0 0 0 0 0 15.116 14.0969 14.9467 11.3103 0 13.8095 0 13.3718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H008 LHPP_HUMAN "Phospholysine phosphohistidine inorganic pyrophosphate phosphatase, hLHPP, EC 3.1.3.-, EC 3.6.1.1" LHPP Homo sapiens (Human) dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634] cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796] GO:0004427; GO:0005634; GO:0005829; GO:0006796; GO:0016311; GO:0016607; GO:0016791; GO:0042803; GO:0046872 inorganic diphosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803] ALQVRTGK 0.9959 -9.6071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NVX2 NLE1_HUMAN Notchless protein homolog 1 NLE1 HUSSY-07 Homo sapiens (Human) hematopoietic stem cell homeostasis [GO:0061484]; inner cell mass cell differentiation [GO:0001826]; kidney development [GO:0001822]; mitotic cell cycle [GO:0000278]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of mitotic cell cycle [GO:0045930]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; ribosomal large subunit assembly [GO:0000027]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756] nucleolus [GO:0005730]; nucleoplasm [GO:0005654] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; hematopoietic stem cell homeostasis [GO:0061484]; inner cell mass cell differentiation [GO:0001826]; kidney development [GO:0001822]; mitotic cell cycle [GO:0000278]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of mitotic cell cycle [GO:0045930]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; ribosomal large subunit assembly [GO:0000027]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756] GO:0000027; GO:0000278; GO:0001756; GO:0001822; GO:0001826; GO:0005654; GO:0005730; GO:0007219; GO:0045930; GO:0048705; GO:0061484; GO:0090263; GO:2001268 IWDTTAGR 0.9959 -12.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2885 12.2986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7927 12.6083 0 0 0 0 0 0 0 0 11.7138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1217 0 0 0 0 13.8983 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5997 0 Q9NZQ0 DJC27_HUMAN DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein) DNAJC27 RABJS RBJ Homo sapiens (Human) intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701] nucleus [GO:0005634] nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of MAPK export from nucleus [GO:0071701] GO:0003924; GO:0005525; GO:0005634; GO:0006886; GO:0070374; GO:0071701 GTP binding [GO:0005525]; GTPase activity [GO:0003924] AVVNARTALLKNIK 0.9959 -9.9234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2346 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1123 0 0 0 0 0 12.5526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y574 ASB4_HUMAN "Ankyrin repeat and SOCS box protein 4, ASB-4" ASB4 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; positive regulation of vasculogenesis [GO:2001214]; protein autoubiquitination [GO:0051865] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829] Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; intracellular signal transduction [GO:0035556]; positive regulation of vasculogenesis [GO:2001214]; protein autoubiquitination [GO:0051865] GO:0004842; GO:0005829; GO:0031462; GO:0031466; GO:0031625; GO:0035556; GO:0051865; GO:0061630; GO:2001214 ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842] AIPDDDLEK 0.9959 -12.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8836 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3456 0 0 0 0 0 0 12.0945 0 0 0 0 0 0 0 13.4813 13.5249 13.6401 12.7156 13.2485 12.5007 0 0 0 0 0 0 11.6431 0 0 0 0 12.6027 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7541 0 0 0 0 0 0 0 0 0 11.764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P52630 STAT2_HUMAN Signal transducer and activator of transcription 2 (p113) STAT2 Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337] chromatin [GO:0000785]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; defense response to virus [GO:0051607]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell population proliferation [GO:0042127]; regulation of mitochondrial fission [GO:0090140]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to peptide hormone [GO:0043434]; type I interferon signaling pathway [GO:0060337]" GO:0000785; GO:0000978; GO:0000981; GO:0001932; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006952; GO:0007259; GO:0019221; GO:0042127; GO:0042802; GO:0043434; GO:0044389; GO:0045944; GO:0051607; GO:0060337; GO:0060339; GO:0070721; GO:0090140; GO:0090575 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin-like protein ligase binding [GO:0044389]" ALLGRLTTLIELLLPK 0.99591 -35.179 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4672 0 0 0 0 0 0 0 0 11.9574 0 0 0 0 0 0 0 0 12.2273 10.374 0 0 0 0 11.713 0 0 0 0 0 0 10.5067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2803 0 0 0 0 0 0 0 13.4748 0 12.0707 0 0 0 0 0 0 0 11.6373 0 0 13.8924 0 0 12.862 0 0 0 0 0 0 0 15.3171 0 13.0542 13.3821 13.9696 13.6065 0 0 12.9753 12.7821 16.3057 0 0 0 0 0 0 0 0 0 0 14.9114 0 0 12.44 13.9629 0 0 0 14.7231 0 13.2228 0 11.6113 0 0 0 12.1155 0 13.7907 13.2564 0 12.9621 0 0 0 0 12.1674 0 0 12.4205 0 0 0 13.5412 0 0 0 0 11.6573 0 11.7377 12.8119 0 11.5939 0 0 0 0 0 0 13.2825 11.9552 13.6454 14.4604 0 0 0 0 0 Q8TAQ5 ZN420_HUMAN Zinc finger protein 420 ZNF420 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" ARKLVMFR 0.99591 -9.6451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2767 0 0 0 0 0 0 0 0 0 0 0 11.7426 0 0 0 0 0 0 0 13.2336 0 0 0 11.3783 11.0188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3725 0 0 0 12.6014 12.713 0 13.7183 13.1476 0 0 0 13.8831 0 13.8324 0 0 14.4531 0 0 11.9196 0 0 0 0 13.0681 0 12.7707 0 12.0131 0 12.6048 0 0 0 0 0 11.733 0 12.7227 0 0 11.3798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8149 0 0 0 0 0 0 0 0 15.4009 0 0 14.363 0 0 14.7895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8643 0 O75382 TRIM3_HUMAN Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97) TRIM3 BERP RNF22 RNF97 Homo sapiens (Human) nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794] cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031] GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0007399; GO:0008022; GO:0008270; GO:0015031; GO:0030425; GO:0042802; GO:0043161; GO:0061630 identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] AALQRQLEAVRGR 0.99592 -11.727 0 0 10.5227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7354 0 0 11.9173 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4349 0 0 0 0 0 0 0 0 0 0 0 11.4374 0 0 0 0 0 12.4433 0 0 0 0 0 0 0 0 11.9891 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8944 0 0 0 0 0 0 13.3554 11.4483 0 0 0 0 11.1222 0 0 11.2724 14.1058 0 11.641 0 0 0 0 11.6869 0 0 0 0 0 0 14.8804 0 0 0 0 0 0 0 0 0 0 0 O95810 CAVN2_HUMAN Caveolae-associated protein 2 (Cavin-2) (PS-p68) (Phosphatidylserine-binding protein) (Serum deprivation-response protein) CAVIN2 SDPR Homo sapiens (Human) plasma membrane tubulation [GO:0097320] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein kinase C binding [GO:0005080]; plasma membrane tubulation [GO:0097320] GO:0001786; GO:0005080; GO:0005543; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0045121; GO:0097320 phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein kinase C binding [GO:0005080] IVSVERR 0.99592 -12.244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1664 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P17026 ZNF22_HUMAN Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26) ZNF22 KOX15 KROX26 Homo sapiens (Human) "odontogenesis [GO:0042476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; odontogenesis [GO:0042476]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000977; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0008270; GO:0042476 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]" CDECGESFK 0.99592 -11.706 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0452 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.302 0 0 0 0 0 0 0 0 0 12.6119 0 0 0 0 P51582 P2RY4_HUMAN "P2Y purinoceptor 4, P2Y4 (P2P) (Uridine nucleotide receptor, UNR)" P2RY4 NRU Homo sapiens (Human) cellular response to ATP [GO:0071318]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; transepithelial chloride transport [GO:0030321] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UTP receptor activity [GO:0045030]; signaling receptor activity [GO:0038023]; cellular response to ATP [GO:0071318]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; regulation of synaptic vesicle exocytosis [GO:2000300]; transepithelial chloride transport [GO:0030321] GO:0005524; GO:0005886; GO:0005887; GO:0007186; GO:0007200; GO:0007204; GO:0016323; GO:0016324; GO:0030321; GO:0038023; GO:0045028; GO:0045030; GO:0071318; GO:0071380; GO:0098978; GO:0099059; GO:0099509; GO:2000300 ATP binding [GO:0005524]; G protein-coupled purinergic nucleotide receptor activity [GO:0045028]; G protein-coupled UTP receptor activity [GO:0045030]; signaling receptor activity [GO:0038023] LLEADCR 0.99592 -9.7049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.851 0 0 0 13.5143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6786 0 0 0 14.14 13.5816 14.2075 14.2522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8371 0 Q53GS7 GLE1_HUMAN "mRNA export factor GLE1, hGLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1)" GLE1 GLE1L Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; regulation of translational initiation [GO:0006446]; regulation of translational termination [GO:0006449] GO:0000822; GO:0005543; GO:0005615; GO:0005635; GO:0005643; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0006406; GO:0006446; GO:0006449; GO:0006913; GO:0015031; GO:0016020; GO:0016973; GO:0031369; GO:0031965; GO:0036064; GO:0042802; GO:0044614 identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369] ACEDKRR 0.99592 -11.754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7751 0 0 11.8667 0 0 0 12.9994 0 0 0 0 0 0 0 14.2882 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q658L1 SAXO2_HUMAN Stabilizer of axonemal microtubules 2 SAXO2 FAM154B Homo sapiens (Human) axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126] axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017] GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0036064; GO:0036126 microtubule binding [GO:0008017] DLNSYKVQPVAIVRPLER 0.99592 -11.723 0 0 0 0 0 0 0 0 0 0 0 0 12.5168 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.2232 17.4519 12.2475 0 0 0 0 0 0 0 13.582 0 0 0 0 13.262 0 13.1443 0 0 0 0 0 0 0 0 13.1629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0094 0 Q86UN6 AKA28_HUMAN "A-kinase anchor protein 14, AKAP-14 (A-kinase anchor protein 28 kDa, AKAP 28) (Protein kinase A-anchoring protein 14, PRKA14)" AKAP14 AKAP28 Homo sapiens (Human) axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952] axoneme [GO:0005930]; cAMP-dependent protein kinase complex [GO:0005952]; protein kinase A regulatory subunit binding [GO:0034237] GO:0005930; GO:0005952; GO:0034237 protein kinase A regulatory subunit binding [GO:0034237] FRENWQK 0.99592 -9.6905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3234 0 0 0 0 0 0 0 0 10.437 0 11.8553 0 0 0 0 0 0 0 0 0 0 0 0 12.2169 13.9021 16.0717 15.3777 0 0 15.2833 14.8045 0 14.8945 14.5902 14.2614 0 0 0 15.0539 14.5049 11.8397 0 14.0314 0 0 0 0 0 0 14.9601 0 0 14.271 0 16.5662 0 0 11.5166 0 14.6787 0 0 0 0 0 0 14.0276 14.8435 0 14.3711 14.6656 0 0 0 14.2994 0 14.1083 0 0 0 0 0 0 11.9283 0 0 13.6786 12.9108 10.6852 0 10.638 10.5499 0 0 0 0 0 0 0 10.4981 0 0 0 12.3892 0 0 14.0303 0 0 0 0 0 0 Q8NA23 WDR31_HUMAN WD repeat-containing protein 31 WDR31 Homo sapiens (Human) LLLRCQLK 0.99592 -11.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.89 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4733 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX95 SYBU_HUMAN Syntabulin (Golgi-localized syntaphilin-related protein) (Syntaxin-1-binding protein) SYBU GOLSYN KIAA1472 Homo sapiens (Human) axonal transport of mitochondrion [GO:0019896]; synapse maturation [GO:0060074] axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231] axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; kinesin binding [GO:0019894]; syntaxin-1 binding [GO:0017075]; axonal transport of mitochondrion [GO:0019896]; synapse maturation [GO:0060074] GO:0000139; GO:0005881; GO:0016021; GO:0017075; GO:0019894; GO:0019896; GO:0031410; GO:0043231; GO:0060074; GO:1904115 kinesin binding [GO:0019894]; syntaxin-1 binding [GO:0017075] AVQTDVVPYSPAISELIQSVLQK 0.99592 -11.745 0 0 0 0 0 0 14.7052 0 0 0 0 0 0 0 0 0 0 0 0 0 12.766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6513 0 0 0 0 13.5996 0 11.5931 0 0 0 0 0 13.381 14.3417 0 13.3426 0 0 0 0 0 0 0 12.7812 0 0 12.8697 0 0 0 0 0 14.231 13.5223 0 0 0 14.2093 15.7603 14.2636 13.6296 0 0 13.7199 13.8271 13.0177 13.1969 14.557 0 0 17.84 13.2795 13.09 12.9295 0 0 0 0 0 0 0 13.7815 0 0 0 0 0 11.1073 0 0 13.2565 12.7503 0 0 0 0 0 0 0 0 0 14.1404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6308 0 0 0 0 0 0 Q9NZB8 MOCS1_HUMAN "Molybdenum cofactor biosynthesis protein 1 (Cell migration-inducing gene 11 protein) (Molybdenum cofactor synthesis-step 1 protein A-B) [Includes: GTP 3',8-cyclase, EC 4.1.99.22 (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase, EC 4.6.1.17 (Molybdenum cofactor biosynthesis protein C) ]" MOCS1 MIG11 Homo sapiens (Human) Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324] cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634] "cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]" GO:0005525; GO:0005634; GO:0005829; GO:0006777; GO:0019008; GO:0032324; GO:0046872; GO:0051539; GO:0061798; GO:0061799 "4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]" ADSDANSK 0.99592 -12.283 0 0 0 0 0 0 0 0 0 0 13.2897 12.9547 12.9604 0 0 0 14.2698 12.9767 0 0 0 0 0 0 14.0086 11.3282 0 0 0 0 0 0 13.2884 12.7517 13.3143 0 13.1062 0 0 0 13.2242 0 0 0 0 0 0 9.3015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4955 0 0 10.5595 0 12.6935 0 13.3869 0 0 13.486 0 13.5575 0 12.1777 0 12.5185 0 0 0 15.2847 0 0 0 0 0 0 13.1082 0 0 0 0 0 0 0 10.6534 0 0 13.5106 0 0 0 14.4778 0 0 0 0 14.777 0 12.6539 0 0 0 0 11.042 14.7038 0 0 0 0 15.5729 0 14.929 12.311 0 0 0 15.1605 0 0 0 0 14.2132 0 0 0 0 0 0 0 11.1874 0 0 0 14.6126 0 0 0 14.6422 0 0 0 0 0 0 14.1397 0 0 0 0 0 0 0 0 0 0 18.6702 O43581 SYT7_HUMAN "Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII, SytVII)" SYT7 PCANAP7 Homo sapiens (Human) calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] "anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of presynaptic membrane [GO:0099056]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192]" GO:0000149; GO:0001778; GO:0001786; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006909; GO:0008021; GO:0014059; GO:0016192; GO:0017156; GO:0017158; GO:0019905; GO:0030276; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042995; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0070062; GO:0070092; GO:0070161; GO:0070382; GO:0071277; GO:0090119; GO:0090385; GO:0098686; GO:0099056; GO:1990926; GO:1990927 "calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]" ETTIIITVMDKDKLSR 0.99593 -11.788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6912 0 0 0 0 0 0 0 0 0 0 0 16.9211 0 16.8054 0 0 0 15.7326 0 0 0 0 14.5608 14.2369 0 0 0 0 0 0 0 14.7395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2477 0 0 0 0 0 0 17.3777 11.084 0 0 0 0 13.7683 0 0 0 0 0 0 0 0 0 0 13.7808 0 0 0 0 12.5007 0 14.3413 13.8897 14.2776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8569 0 14.6911 0 0 0 0 0 Q9UPZ6 THS7A_HUMAN "Thrombospondin type-1 domain-containing protein 7A [Cleaved into: Thrombospondin type-1 domain-containing protein 7A, soluble form ]" THSD7A KIAA0960 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154] cell projection [GO:0042995]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cell projection [GO:0042995]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154] GO:0001525; GO:0005576; GO:0005886; GO:0016021; GO:0030154; GO:0031532; GO:0042995 ACEAPQACQSYR 0.99593 -33.123 10.9815 0 0 0 0 0 0 0 13.5564 0 0 0 15.9936 15.1042 0 0 10.3974 0 0 0 0 0 11.7184 0 0 0 0 0 0 0 0 0 0 0 12.9145 12.0379 10.5013 0 0 0 0 11.9061 0 0 0 0 0 0 0 0 13.5607 13.7269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9203 15.3475 16.1597 15.381 15.7197 0 15.0684 0 10.5104 11.6071 0 0 0 0 12.2228 0 0 0 0 13.8505 16.62 0 0 10.6008 0 0 0 0 0 14.1963 0 0 16.2841 0 11.4389 0 11.5152 0 0 0 12.967 0 0 12.0025 0 12.002 0 0 13.7409 0 10.4686 0 0 14.93 0 13.8878 0 0 0 0 0 0 0 11.465 12.1229 0 0 0 0 0 12.9009 0 0 0 0 0 0 0 0 13.9269 0 0 0 10.7419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9604 11.1388 0 0 0 0 0 0 0 0 0 0 B7ZC32 KIF28_HUMAN Kinesin-like protein KIF28P (Kinesin-like protein 6) KIF28P KLP6 Homo sapiens (Human) microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384] kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966] kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384] GO:0003777; GO:0005524; GO:0005871; GO:0005874; GO:0007005; GO:0007018; GO:0008017; GO:0016887; GO:0031966; GO:0072384 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777] AAAEGASADK 0.99593 -12.293 0 0 0 0 0 0 0 0 14.6834 0 0 0 0 0 0 0 0 0 0 12.0514 0 0 0 0 11.7483 0 0 11.4939 0 0 0 0 0 11.6455 0 0 11.9486 0 0 0 0 0 12.9483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4154 0 0 0 0 0 0 0 0 0 13.8292 12.8906 12.1282 0 0 12.4486 0 13.1465 0 0 12.8262 0 15.2146 0 0 14.7642 0 0 11.8031 0 0 0 0 0 0 0 12.0992 0 0 11.7985 0 0 0 12.803 0 0 14.8386 0 0 14.3732 18.1331 0 0 0 0 0 0 12.4652 0 0 11.4024 0 0 11.031 0 0 13.3814 0 0 13.2597 0 13.6704 14.2925 0 0 0 0 13.0255 0 0 0 16.222 0 0 0 0 0 0 0 0 13.2963 0 0 13.8618 0 0 0 16.1776 0 0 0 0 0 0 0 13.0678 0 0 0 0 0 13.3404 0 10.8825 O60941 DTNB_HUMAN "Dystrobrevin beta, DTN-B (Beta-dystrobrevin)" DTNB Homo sapiens (Human) neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] anchoring junction [GO:0070161]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202] anchoring junction [GO:0070161]; basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; zinc ion binding [GO:0008270]; neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536] GO:0005634; GO:0005737; GO:0005886; GO:0008270; GO:0009925; GO:0014069; GO:0030182; GO:0030425; GO:0045202; GO:0060077; GO:0070161; GO:0099536 zinc ion binding [GO:0008270] AQQNPTLLAELRLLR 0.99593 -12.405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0148 0 0 0 0 0 0 12.3361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19367 HXK1_HUMAN "Hexokinase-1, EC 2.7.1.1 (Brain form hexokinase) (Hexokinase type I, HK I) (Hexokinase-A)" HK1 Homo sapiens (Human) canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731] cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739] cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731] GO:0001678; GO:0002720; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005739; GO:0005741; GO:0005829; GO:0006002; GO:0006006; GO:0006013; GO:0006096; GO:0006954; GO:0008865; GO:0019158; GO:0032731; GO:0042834; GO:0045087; GO:0045121; GO:0046835; GO:0047931; GO:0051156; GO:0061621; GO:0072655; GO:0072656 ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834] EGLHNAK 0.99593 -12.292 0 0 0 15.8842 0 0 0 0 16.8697 17.2089 16.9761 16.7177 16.5526 16.2656 16.4757 16.6573 12.5809 13.9683 14.1717 0 0 9.99972 12.5274 0 0 16.8173 16.9124 14.2045 12.2406 12.3541 16.7285 16.9399 17.4979 16.8574 16.6923 16.8012 16.7052 16.7416 16.782 16.9484 16.9448 16.7787 16.7124 16.9559 16.8676 16.8183 12.3323 16.7215 16.7989 16.7357 16.8504 13.5436 16.6796 16.5592 16.6424 12.1016 16.5668 0 16.2024 13.098 15.6506 15.6969 15.653 15.741 15.6523 15.6592 0 0 0 0 0 10.6758 0 0 13.2123 0 13.0427 13.6477 14.6098 15.4077 0 12.926 0 0 0 0 0 0 0 11.5077 0 12.7796 0 13.8561 14.86 0 15.6597 12.6398 0 0 0 0 13.3703 0 13.526 0 0 13.0396 0 0 0 12.8927 0 0 0 0 0 0 12.8949 0 12.3058 0 13.9268 0 0 15.1654 0 13.9917 0 0 14.2989 0 0 14.9719 13.753 0 13.8146 14.4845 0 0 13.9715 0 13.6539 13.1567 13.2541 14.761 0 13.8205 17.6287 17.614 14.658 0 0 0 14.0275 0 14.3258 17.7816 17.8833 18.4864 17.7139 17.6232 17.7134 17.7435 17.7544 17.5384 17.7151 17.7117 17.7248 17.8548 17.8035 13.8305 0 0 0 17.7839 17.5576 18.229 17.527 17.5292 Q14CN4 K2C72_HUMAN "Keratin, type II cytoskeletal 72 (Cytokeratin-72, CK-72) (Keratin-72, K72) (Type II inner root sheath-specific keratin-K6irs2) (Type-II keratin Kb35)" KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 Homo sapiens (Human) intermediate filament organization [GO:0045109]; keratinization [GO:0031424] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; keratin filament [GO:0045095]; structural constituent of skin epidermis [GO:0030280]; intermediate filament organization [GO:0045109]; keratinization [GO:0031424] GO:0005829; GO:0030280; GO:0031424; GO:0045095; GO:0045109; GO:0070062 structural constituent of skin epidermis [GO:0030280] DPLAKTSGSSCATK 0.99593 -12.406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0765 0 0 0 11.0751 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6395 0 0 0 0 0 0 11.5732 12.4924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6223 12.4534 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5224 13.3458 0 0 0 0 0 0 0 0 0 11.1322 0 0 0 0 0 12.253 0 0 0 12.6933 0 0 0 0 0 0 0 0 0 13.2295 0 0 0 0 12.783 0 0 0 0 0 0 0 0 0 12.3136 0 0 0 0 0 14.1066 0 0 12.5676 0 0 0 0 0 Q5T280 CI114_HUMAN "Putative methyltransferase C9orf114, EC 2.1.1.- (Centromere protein 32, CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1)" SPOUT1 C9orf114 Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616] cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616]; methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608] GO:0000776; GO:0003723; GO:0005737; GO:0007049; GO:0008168; GO:0010608; GO:0031616; GO:0032259; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0072686 methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] GQACVQLARILQYLECPQYLR 0.99593 -11.778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8731 0 0 11.9281 0 0 0 16.3644 12.7693 13.5936 0 0 0 0 0 15.2362 0 0 0 0 0 0 0 12.7528 0 0 0 0 0 0 0 12.653 0 0 0 13.1906 0 0 0 0 0 0 14.032 0 0 0 0 0 0 13.986 0 0 0 0 0 13.5548 0 0 0 0 13.9915 14.4856 0 14.072 0 13.8198 0 13.8068 0 0 13.3504 13.7924 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.945 13.3778 0 0 0 0 0 0 0 Q63HR2 TNS2_HUMAN "Tensin-2, EC 3.1.3.48 (C1 domain-containing phosphatase and tensin homolog, C1-TEN) (Tensin-like C1 domain-containing phosphatase)" TNS2 KIAA1075 TENC1 Homo sapiens (Human) cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850] dendrite [GO:0030425]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794] dendrite [GO:0030425]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725]; cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850] GO:0001822; GO:0004725; GO:0005886; GO:0005925; GO:0008285; GO:0014850; GO:0019725; GO:0019900; GO:0030425; GO:0032963; GO:0035264; GO:0035335; GO:0042802; GO:0043025; GO:0046627; GO:0046872; GO:0048871; GO:0098794 identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725] FCEDKVATELQPSQRR 0.99593 -10.051 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9604 0 0 0 9.91807 0 0 0 0 0 0 0 0 0 0 9.6455 0 0 0 0 11.0746 0 0 0 0 0 0 0 0 0 0 9.86115 0 0 13.2507 0 0 0 16.1215 0 0 0 12.6475 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0751 14.2919 0 0 15.0485 0 0 14.6782 0 0 14.6579 0 0 0 0 0 0 0 0 0 Q6ZT12 UBR3_HUMAN "E3 ubiquitin-protein ligase UBR3, EC 2.3.2.27 (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650)" UBR3 KIAA2024 ZNF650 Homo sapiens (Human) embryo development ending in birth or egg hatching [GO:0009792]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596] GO:0000151; GO:0001967; GO:0004842; GO:0005737; GO:0006511; GO:0007608; GO:0008270; GO:0009792; GO:0016021; GO:0016567; GO:0061630; GO:0071596 ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CRTCGISPCMSLCAECFHQGDHTGHDFNMFR 0.99593 -12.404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.957 0 0 0 0 10.886 0 12.6266 0 0 0 0 11.8478 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8919 14.8527 14.0633 14.9962 0 15.66 15.5693 14.7511 15.9165 15.768 13.3009 0 0 0 0 0 16.9061 0 0 0 14.6533 0 14.7883 13.8382 0 14.4925 0 0 0 13.2334 0 12.587 0 0 0 14.0357 0 13.3339 0 13.9851 0 12.9837 0 13.2972 0 0 0 0 15.1008 13.062 0 13.7627 10.7349 14.686 13.0486 0 14.1068 0 0 13.8553 13.4188 14.5411 13.7014 0 0 13.6831 0 14.5984 0 14.3408 14.2443 15.2002 0 0 0 0 0 0 14.4093 12.6502 0 14.5259 14.3335 0 0 12.9964 13.8769 10.065 14.2246 13.2953 0 0 0 0 0 0 0 13.3191 14.0694 13.358 13.4826 0 0 0 Q76KP1 B4GN4_HUMAN "N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1, NGalNAc-T1, EC 2.4.1.244 (Beta-1,4-N-acetylgalactosaminyltransferase IV, Beta4GalNAc-T4, Beta4GalNAcT4)" B4GALNT4 Homo sapiens (Human) Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021] Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842] GO:0008376; GO:0016021; GO:0032580; GO:0033842 acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842] AARPLPLFLGR 0.99593 -11.783 13.664 0 13.3146 0 0 0 12.0818 0 0 0 11.8684 0 12.5773 0 0 0 0 0 0 0 0 0 0 12.4423 12.7854 0 0 0 0 12.0965 0 12.5294 0 0 12.7012 0 0 0 0 0 12.9681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9273 0 0 0 0 0 0 0 0 0 14.263 0 0 16.6691 14.3899 0 14.6632 0 0 15.4168 13.9686 0 0 14.0333 15.285 0 14.1097 0 13.8396 0 0 13.6607 13.3514 13.271 12.9091 0 0 0 14.1613 0 12.7983 0 0 0 0 0 14.1528 0 0 14.6118 0 0 0 0 0 0 0 13.9717 0 15.4618 0 14.3376 0 0 0 0 13.0209 0 0 0 0 0 13.2401 0 0 0 0 0 0 0 0 0 0 0 13.1244 0 10.8319 0 0 0 0 0 0 0 0 0 0 0 14.6592 12.6513 0 13.7264 13.0978 0 15.6727 0 0 0 0 12.5446 0 0 Q8IUC0 KR131_HUMAN Keratin-associated protein 13-1 (High sulfur keratin-associated protein 13.1) KRTAP13-1 KAP13.1 KRTAP13.1 Homo sapiens (Human) cytosol [GO:0005829]; intermediate filament [GO:0005882] cytosol [GO:0005829]; intermediate filament [GO:0005882] GO:0005829; GO:0005882 GCQQTCWEPTSCQTSYVESSPCQTSCYR 0.99593 -11.765 0 0 9.40071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98954 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.40708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3694 0 0 0 0 0 0 0 11.8827 13.281 0 0 0 0 0 12.5613 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3721 0 11.3661 0 0 0 0 0 0 0 0 0 0 0 12.2671 12.6096 0 10.2176 0 0 0 0 12.8767 0 0 0 0 0 0 0 0 13.0743 0 0 0 10.3523 0 0 0 0 0 0 0 10.9994 0 0 0 0 0 0 0 0 0 11.3431 0 0 0 11.492 Q8IX15 HOMEZ_HUMAN Homeobox and leucine zipper protein Homez (Homeodomain leucine zipper-containing factor) HOMEZ KIAA1443 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006357 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" ARVVYRR 0.99593 -11.764 0 0 0 0 0 0 0 0 0 0 17.1652 0 0 0 0 16.3465 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7073 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0291 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5J2 MINY1_HUMAN "Ubiquitin carboxyl-terminal hydrolase MINDY-1, EC 3.4.19.12 (Deubiquitinating enzyme MINDY-1) (Protein FAM63A)" MINDY1 FAM63A KIAA1390 Homo sapiens (Human) protein K48-linked deubiquitination [GO:0071108] nuclear body [GO:0016604]; nucleoplasm [GO:0005654] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380]; protein K48-linked deubiquitination [GO:0071108] GO:0004843; GO:0005654; GO:0016604; GO:0016807; GO:0036435; GO:0071108; GO:1990380 cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; Lys48-specific deubiquitinase activity [GO:1990380] MEYHQPEDPAPGK 0.99593 -9.7248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1494 0 0 0 0 0 0 0 0 0 0 0 11.7092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.237 0 0 15.0713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.551 0 0 0 13.7265 13.4804 0 0 0 0 0 12.5765 12.9177 0 0 0 13.957 0 0 12.812 0 0 13.2134 0 0 12.6946 13.8138 0 13.8986 0 0 0 0 15.6096 13.8597 0 12.9646 0 0 0 0 0 0 0 0 0 0 0 12.8139 13.0616 0 0 0 0 0 0 13.3815 0 0 0 0 0 0 14.7027 0 0 0 0 0 12.1547 0 0 0 0 0 0 12.771 0 0 0 0 11.4699 0 0 0 0 0 0 0 Q8N9N5 BANP_HUMAN Protein BANP (BEN domain-containing protein 1) (Btg3-associated nuclear protein) (Scaffold/matrix-associated region-1-binding protein) BANP BEND1 SMAR1 Homo sapiens (Human) cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504] nuclear body [GO:0016604]; nucleoplasm [GO:0005654] nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; cell cycle [GO:0007049]; chromatin organization [GO:0006325]; negative regulation of protein catabolic process [GO:0042177]; protein localization to nucleus [GO:0034504] GO:0003677; GO:0005654; GO:0006325; GO:0007049; GO:0016604; GO:0034504; GO:0042177; GO:0042802 DNA binding [GO:0003677]; identical protein binding [GO:0042802] CRTAWRR 0.99593 -9.7332 0 0 0 0 0 0 10.6992 0 0 0 0 0 0 0 0 0 0 0 11.513 11.2809 0 0 11.9276 0 0 0 12.4377 12.3517 0 0 0 0 0 0 0 11.6962 0 0 12.7623 0 0 11.6992 0 11.7949 0 0 0 0 0 0 0 0 11.4827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.086 0 0 0 12.8172 0 0 0 0 0 0 12.7199 0 0 0 0 0 0 0 0 0 0 12.9803 13.3294 0 0 0 0 0 0 0 0 0 12.5248 0 12.4291 0 13.7169 0 0 0 0 0 0 12.7963 0 0 0 0 0 0 0 12.5259 0 0 12.7077 0 0 0 12.6937 12.8535 0 12.6882 12.7002 0 13.837 0 0 0 0 0 0 0 0 0 0 0 10.2816 0 12.143 0 0 0 0 0 0 0 0 12.0669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2076 0 0 0 0 Q8WWW8 GAB3_HUMAN GRB2-associated-binding protein 3 (GRB2-associated binder 3) (Growth factor receptor bound protein 2-associated protein 3) GAB3 Homo sapiens (Human) macrophage differentiation [GO:0030225]; signal transduction [GO:0007165] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; signaling adaptor activity [GO:0035591]; macrophage differentiation [GO:0030225]; signal transduction [GO:0007165] GO:0005737; GO:0007165; GO:0030225; GO:0035591 signaling adaptor activity [GO:0035591] DLKPQRK 0.99593 -32.995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1007 0 0 0 0 16.8274 16.6957 16.8647 0 0 17.0089 14.5548 0 0 0 0 0 0 0 0 0 0 15.2207 0 0 0 14.4102 0 0 0 0 0 0 0 0 0 14.0871 0 13.9914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5891 14.2347 0 0 0 0 14.3252 0 0 14.2641 0 0 16.5635 0 14.0073 0 14.658 0 14.711 0 14.6637 13.3294 0 12.3244 14.9347 14.2123 14.1614 0 15.334 15.4338 15.5817 15.5386 13.3453 0 13.2203 0 0 14.3083 14.1773 0 13.2589 13.3527 0 0 0 14.2838 0 0 0 14.2971 0 0 0 0 14.2611 0 13.9919 12.9486 0 0 13.6609 0 11.9595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4511 14.7706 0 0 0 0 0 16.8656 Q92614 MY18A_HUMAN "Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus, MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210, SP-R210)" MYO18A CD245 KIAA0216 MYSPDZ TIAF1 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030] actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; trans-Golgi network [GO:0005802] "actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030]" GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005793; GO:0005802; GO:0006259; GO:0007030; GO:0008094; GO:0009986; GO:0016020; GO:0016460; GO:0016477; GO:0031032; GO:0032982; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028 "actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; RNA binding [GO:0003723]" AMEVEIEDLHLQIDDIAKAKTALEEQLSR 0.99593 -33.039 0 0 0 0 0 0 12.0373 0 0 0 0 12.2506 0 0 0 0 10.5886 0 0 0 0 0 13.0673 0 0 0 12.0155 0 12.2421 12.108 0 0 12.3776 0 0 0 0 0 0 0 0 0 0 12.2451 9.39896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9835 0 11.4524 0 0 13.7999 14.0119 0 13.3269 13.5026 14.6005 0 0 0 12.926 0 0 13.7697 18.3836 14.168 13.4849 14.0238 13.4029 0 0 11.1396 13.6131 13.2306 10.7645 13.2015 15.2612 0 14.8667 0 0 13.6954 0 0 0 0 14.026 0 0 0 0 13.9475 0 13.0192 0 0 11.5901 0 0 11.8562 13.3173 0 0 12.4324 13.344 0 0 13.0611 0 12.7845 0 0 13.1735 0 0 0 12.7339 14.0818 0 0 0 13.8878 0 0 0 0 14.5496 0 0 0 0 14.4044 0 12.9008 14.0947 0 0 11.272 0 0 0 0 10.5945 12.8787 12.6939 10.6903 0 0 0 0 12.8523 0 0 0 0 0 12.8983 13.1605 11.5362 Q92903 CDS1_HUMAN "Phosphatidate cytidylyltransferase 1, EC 2.7.7.41 (CDP-DAG synthase 1) (CDP-DG synthase 1) (CDP-diacylglycerol synthase 1, CDS 1) (CDP-diglyceride pyrophosphorylase 1) (CDP-diglyceride synthase 1) (CTP:phosphatidate cytidylyltransferase 1)" CDS1 CDS Homo sapiens (Human) CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165] GO:0004142; GO:0004605; GO:0005783; GO:0005789; GO:0006661; GO:0007165; GO:0007602; GO:0016021; GO:0016024; GO:0045600; GO:0140042 diacylglycerol cholinephosphotransferase activity [GO:0004142]; phosphatidate cytidylyltransferase activity [GO:0004605] ETDIDDRYGDLDSRTDSDIPEIPPSSDR 0.99593 -9.7231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7104 11.5002 0 0 0 0 0 0 0 0 0 0 13.1426 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6225 0 11.723 12.0079 0 0 0 0 0 0 0 0 10.8962 0 0 0 11.1732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9984 0 0 0 0 0 0 0 0 0 0 0 12.389 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.069 11.8789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9934 0 0 11.0236 0 0 0 0 0 0 0 0 0 0 0 Q99835 SMO_HUMAN "Smoothened homolog, SMO (Protein Gx)" SMO SMOH Homo sapiens (Human) anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell proliferation [GO:0050673]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of heart morphogenesis [GO:2000826]; regulation of somatic stem cell population maintenance [GO:1904672]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; somite development [GO:0061053]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371] 9+0 non-motile cilium [GO:0097731]; centriole [GO:0005814]; ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] 9+0 non-motile cilium [GO:0097731]; centriole [GO:0005814]; ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell proliferation [GO:0050673]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of heart morphogenesis [GO:2000826]; regulation of somatic stem cell population maintenance [GO:1904672]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021910]; somite development [GO:0061053]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371] GO:0000122; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001947; GO:0002052; GO:0002053; GO:0003140; GO:0003323; GO:0004930; GO:0005113; GO:0005814; GO:0005886; GO:0005929; GO:0006606; GO:0006915; GO:0007224; GO:0007228; GO:0007371; GO:0007405; GO:0007417; GO:0007494; GO:0009952; GO:0010628; GO:0010629; GO:0016021; GO:0021542; GO:0021696; GO:0021794; GO:0021904; GO:0021910; GO:0021938; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030666; GO:0030857; GO:0031069; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043066; GO:0043231; GO:0043392; GO:0045880; GO:0045944; GO:0046622; GO:0048143; GO:0048741; GO:0048745; GO:0048853; GO:0048873; GO:0050673; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060242; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070062; GO:0070986; GO:0071397; GO:0071542; GO:0071679; GO:0072285; GO:0090190; GO:0097542; GO:0097731; GO:1904672; GO:2000826 G protein-coupled receptor activity [GO:0004930]; patched binding [GO:0005113] AGFVLAPIGLVLIVGGYFLIR 0.99593 -9.7204 0 0 11.9321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2387 12.5825 12.9875 0 13.0374 0 0 13.176 0 0 0 0 0 0 0 0 0 10.9204 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7677 0 12.601 12.9506 12.806 0 0 12.4191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1439 0 16.7806 0 0 12.4657 0 0 0 15.8553 0 0 0 0 0 0 12.8578 0 0 0 0 0 0 13.49 11.6728 0 0 0 0 0 0 0 0 0 12.4418 10.086 0 0 0 0 0 0 0 0 0 13.4517 0 0 13.6218 0 0 0 0 0 16.2848 0 0 0 0 14.8127 0 12.7962 13.2879 15.0582 0 0 0 15.1523 12.7867 0 0 0 13.6778 0 0 0 13.1284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2799 0 0 0 0 0 0 0 0 Q9NPG4 PCD12_HUMAN "Protocadherin-12 (Vascular cadherin-2) (Vascular endothelial cadherin-2, VE-cad-2, VE-cadherin-2) [Cleaved into: Protocadherin-12, secreted form ]" PCDH12 UNQ395/PRO731 Homo sapiens (Human) calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; glycogen metabolic process [GO:0005977]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; labyrinthine layer development [GO:0060711]; neuron recognition [GO:0008038] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; glycogen metabolic process [GO:0005977]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; labyrinthine layer development [GO:0060711]; neuron recognition [GO:0008038] GO:0005509; GO:0005886; GO:0005887; GO:0005911; GO:0005977; GO:0007155; GO:0007156; GO:0008038; GO:0016339; GO:0060711; GO:0070062 calcium ion binding [GO:0005509] GQAGEPCEVGQSHK 0.99593 -12.364 9.32957 0 0 0 0 0 0 0 0 0 0 0 14.5747 11.9832 10.3388 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7399 0 0 0 0 0 0 10.752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0804 17.9937 0 16.8113 0 0 15.9994 14.8866 0 14.9659 0 0 0 0 0 0 0 0 0 0 12.4912 0 0 0 0 0 0 0 0 14.217 0 0 0 14.2704 13.165 0 0 0 12.3078 0 0 13.1034 0 0 0 0 0 0 0 0 0 0 0 0 13.8127 0 12.2248 11.9362 0 0 0 12.9022 0 0 0 11.3131 0 0 0 0 0 11.5361 0 0 0 0 13.1278 0 0 0 0 13.4929 0 16.7311 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4158 10.8002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0445 0 12.7324 0 0 0 0 0 14.4132 Q9P2L0 WDR35_HUMAN WD repeat-containing protein 35 (Intraflagellar transport protein 121 homolog) WDR35 IFT121 KIAA1336 Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991] axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512] GO:0005813; GO:0005929; GO:0005930; GO:0030991; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0061512; GO:0097542; GO:1990830 DVWDMKWAKDNPDLFAMMEK 0.99593 -33.157 0 0 0 0 0 0 0 0 0 0 0 0 11.4933 0 0 0 0 0 0 12.9063 0 0 0 0 0 0 0 0 0 0 0 12.3908 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6749 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8793 0 0 0 0 0 0 0 0 0 13.9651 0 0 0 0 0 0 0 0 0 0 0 13.4571 15.6218 15.1227 14.7156 0 18.4572 16.5239 13.2497 0 15.9974 0 0 0 0 0 0 15.925 18.0235 0 0 0 0 13.1412 0 0 0 0 11.748 0 0 0 0 0 12.1136 0 0 0 0 0 0 0 0 0 13.8605 0 0 0 10.7725 0 0 0 0 0 0 0 0 12.234 0 0 14.1624 13.0217 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7545 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1021 15.195 0 15.8688 0 0 0 0 0 0 0 Q9Y6J0 CABIN_HUMAN "Calcineurin-binding protein cabin-1 (Calcineurin inhibitor, CAIN)" CABIN1 KIAA0330 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent chromatin assembly [GO:0006336] aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase inhibitor activity [GO:0004864]; cell surface receptor signaling pathway [GO:0007166]; DNA replication-independent chromatin assembly [GO:0006336] GO:0004864; GO:0005634; GO:0005654; GO:0005829; GO:0006336; GO:0007166; GO:0016235 protein phosphatase inhibitor activity [GO:0004864] AAEQGVQKPAAETPASACIPGKPSASTPTLWDGK 0.99593 -33.01 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3867 0 15.4669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2675 12.6262 0 0 0 0 0 0 12.2392 0 0 10.3299 0 0 10.4267 0 0 0 12.5476 12.5785 12.4971 12.5507 12.2326 0 0 0 0 0 0 0 16.0672 16.6622 11.0149 14.9455 15.8086 0 0 0 0 0 0 15.1056 0 0 0 0 15.1472 15.0264 13.6292 13.6787 0 15.0725 14.874 15.28 15.4866 0 0 14.9879 0 0 0 15.6578 15.2741 15.1092 0 14.3279 0 0 15.1002 0 0 15.2391 13.4069 0 0 0 12.0469 14.5656 10.3291 0 0 0 0 0 0 9.657 0 0 12.086 10.8678 0 0 0 13.5687 0 0 0 0 13.4134 0 12.4483 0 13.4934 0 11.116 12.9811 0 0 14.165 0 0 0 12.8377 11.4871 0 13.5331 0 0 13.2246 13.1547 0 14.6756 0 0 0 0 13.0912 0 12.5051 0 11.0742 0 13.6458 0 0 14.4917 0 14.802 0 0 11.2439 0 0 0 O15014 ZN609_HUMAN Zinc finger protein 609 ZNF609 KIAA0295 Homo sapiens (Human) muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0005634; GO:0005654; GO:0006357; GO:0007517; GO:0045944; GO:0046872; GO:1990841; GO:2000291; GO:2001224 metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841] AEEGKSPFRESSGDGMK 0.99594 -34.13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0073 0 0 0 0 0 0 0 10.4581 0 0 12.39 0 0 0 0 0 0 0 0 0 0 18.6341 0 0 0 0 10.6913 0 10.3656 0 0 0 0 0 0 0 12.3039 0 0 11.4972 12.2523 14.0997 12.3282 0 0 0 14.0447 12.6067 0 11.1768 0 0 0 0 0 0 0 0 0 14.1853 0 0 0 0 12.8823 0 0 0 13.7678 0 0 0 0 0 0 0 0 0 10.5222 0 0 0 14.8458 0 0 0 0 14.456 10.968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.3791 0 0 13.8424 0 0 13.8609 0 13.6022 0 0 0 18.1192 0 0 0 0 13.2437 13.2674 0 0 0 0 0 0 0 0 0 0 P13674 P4HA1_HUMAN "Prolyl 4-hydroxylase subunit alpha-1, 4-PH alpha-1, EC 1.14.11.2 (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)" P4HA1 P4HA Homo sapiens (Human) collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401] GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016020; GO:0016222; GO:0018401; GO:0030199; GO:0031418; GO:0042802; GO:0043231 identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656] ALLLTKK 0.99594 -34.21 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8914 0 0 0 0 0 0 0 0 0 0 0 13.0077 0 0 0 0 0 0 13.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2498 0 0 0 0 13.964 0 0 0 0 0 0 12.1974 13.4836 0 0 0 0 13.11 0 0 15.9746 0 0 0 0 0 0 15.7956 0 0 0 0 0 0 0 0 0 13.3177 0 12.7245 0 0 0 0 15.0775 0 0 0 0 0 12.7399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.7917 14.3389 0 0 0 0 0 0 12.4675 0 0 0 0 0 13.1574 0 0 0 0 0 0 0 0 P17098 ZNF8_HUMAN Zinc finger protein 8 (Zinc finger protein HF.18) ZNF8 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]; BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270; GO:0030509 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]" AFNQNSSLGRHKR 0.99594 -9.8005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5507 0 0 0 0 0 0 0 0 0 0 0 10.183 0 0 0 0 0 0 0 0 13.8269 0 0 0 12.0965 0 0 0 0 0 0 0 0 0 0 0 10.6272 0 0 0 0 0 0 0 0 0 0 Q12802 AKP13_HUMAN "A-kinase anchor protein 13, AKAP-13 (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene, LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13, PRKA13) (p47)" AKAP13 BRX HT31 LBC Homo sapiens (Human) adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056] cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of Rho protein signal transduction [GO:0035023]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0004691; GO:0005078; GO:0005085; GO:0005634; GO:0005829; GO:0005938; GO:0007186; GO:0007507; GO:0016020; GO:0031267; GO:0035023; GO:0035025; GO:0043123; GO:0043406; GO:0046872; GO:0048471; GO:0051018; GO:0051056; GO:0051168; GO:0055007; GO:0060090; GO:0060297; GO:0060348; GO:0061049; GO:0071875; GO:0086023 cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein kinase A binding [GO:0051018]; small GTPase binding [GO:0031267] ASSISEEVAVGSIAATLK 0.99594 -34.153 15.5942 16.8875 15.5039 0 0 0 0 16.1472 0 0 0 11.991 0 0 0 0 0 0 0 0 13.2681 12.2297 0 12.2264 0 0 0 0 0 0 0 0 0 0 11.0428 0 0 13.6323 0 0 0 12.2071 0 0 0 0 13.1012 0 0 0 0 12.3006 12.3087 12.2798 10.2639 0 0 0 0 0 0 0 0 0 0 0 0 13.4295 12.0709 15.1908 13.0745 0 0 15.8267 0 0 0 13.6278 0 0 12.8334 0 15.7566 0 0 0 17.1399 0 0 13.397 0 0 0 0 14.4534 11.8151 0 0 0 13.6544 14.938 0 0 14.6147 0 13.18 13.9473 0 0 0 0 0 13.2296 0 13.418 0 0 0 12.6689 0 13.0307 0 0 0 12.5307 0 13.054 12.3794 13.5531 11.8082 15.2491 0 0 15.4352 0 10.5425 0 0 13.2325 13.8647 13.6004 13.6698 0 0 0 12.5025 0 12.1653 0 0 13.9306 0 13.5406 13.0577 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7139 0 0 0 14.2362 10.9419 0 0 0 13.0665 0 14.4223 11.7477 Q13838 DX39B_HUMAN "Spliceosome RNA helicase DDX39B, EC 3.6.4.13 (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein)" DDX39B BAT1 UAP56 Homo sapiens (Human) "mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784]" GO:0000245; GO:0000346; GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005687; GO:0005688; GO:0005737; GO:0006405; GO:0006406; GO:0008186; GO:0008380; GO:0010501; GO:0016607; GO:0016887; GO:0017070; GO:0030621; GO:0032786; GO:0042802; GO:0043008; GO:0046784; GO:2000002 "ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]" AGRFGTK 0.99594 -12.455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.54 0 14.065 0 0 0 13.3437 12.557 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5BKX5 CS054_HUMAN UPF0692 protein C19orf54 C19orf54 Homo sapiens (Human) LIRVATER 0.99594 -12.458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2802 0 0 0 0 0 0 0 14.7661 0 0 0 0 0 0 0 0 0 0 0 12.2741 0 0 0 0 0 0 0 0 0 14.5762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7L591 DOK3_HUMAN Docking protein 3 (Downstream of tyrosine kinase 3) DOK3 Homo sapiens (Human) Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667] cytoplasm [GO:0005737]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0005737; GO:0005886; GO:0007169; GO:0007265; GO:0030667; GO:0101003 AVAGAIARQRER 0.99594 -10.34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2958 0 0 0 0 13.9063 0 0 0 0 0 0 13.4552 13.3794 13.6434 0 0 0 14.7028 13.3655 0 0 0 0 13.716 13.4988 0 0 0 0 13.2075 0 13.7841 13.3126 0 12.5896 0 0 0 14.0256 0 0 13.5266 0 0 12.4617 14.0121 0 12.6377 13.3355 13.8689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4014 0 0 0 0 0 0 0 0 0 0 0 13.1067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N5I9 NOPC1_HUMAN NOP protein chaperone 1 NOPCHAP1 C12orf45 Homo sapiens (Human) box C/D snoRNP assembly [GO:0000492] nucleus [GO:0005634] nucleus [GO:0005634]; box C/D snoRNP complex binding [GO:0062064]; box C/D snoRNP assembly [GO:0000492] GO:0000492; GO:0005634; GO:0062064 box C/D snoRNP complex binding [GO:0062064] ANEKLRK 0.99594 -12.431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9576 14.2086 14.9697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7954 13.7567 0 0 0 0 0 0 13.7381 13.374 14.0016 0 0 0 12.821 0 0 0 0 13.7406 14.1911 13.2442 0 0 0 0 13.4348 13.3243 0 13.4119 13.4642 0 0 0 12.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3284 13.554 0 13.3985 13.4397 0 0 0 0 0 13.6565 0 0 0 0 0 Q8TDN1 KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 (Voltage-gated potassium channel subunit Kv6.4) KCNG4 KCNG3 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076] integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765] GO:0005249; GO:0005251; GO:0005654; GO:0005886; GO:0008076; GO:0016021; GO:0034765; GO:0044325; GO:0051260; GO:0071805 delayed rectifier potassium channel activity [GO:0005251]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] AEEDQGECSR 0.99594 -12.481 0 0 0 0 0 14.309 14.6047 0 13.1208 15.745 0 0 13.4037 13.0619 16.8485 14.4495 0 0 11.6032 14.8439 0 0 15.5393 11.4327 13.2482 13.9854 11.8711 14.2728 0 0 0 0 0 0 0 0 0 13.419 0 13.0787 0 0 14.6742 0 14.7998 0 0 0 0 0 14.412 0 0 0 11.4473 13.3163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1459 0 0 0 12.5152 0 0 0 0 0 0 0 0 12.7162 12.9034 0 0 14.5375 14.2179 14.4585 12.5266 0 12.8806 13.907 12.8842 12.3305 12.4871 14.415 0 12.9944 12.6376 0 0 0 0 0 0 0 0 12.501 15.1366 13.0336 0 0 13.2189 14.5206 0 14.1242 0 0 13.3468 0 0 14.3387 15.4051 15.6396 13.9105 13.6829 0 13.7767 14.4738 0 0 0 13.7669 13.604 0 14.8128 0 13.9372 0 11.1028 0 0 0 0 0 0 13.7573 12.4708 0 0 15.842 15.626 15.7 0 0 0 0 0 0 0 0 13.5302 14.5613 0 13.1372 0 0 0 14.0109 13.1464 0 14.002 0 0 0 0 11.9786 Q9BWW7 SCRT1_HUMAN "Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein, SCRT, Scratch 1, hScrt)" SCRT1 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]" nuclear body [GO:0016604] "nuclear body [GO:0016604]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of neuron migration [GO:2001222]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0016604; GO:0043565; GO:0046872; GO:1990837; GO:2001222 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" HACGECGK 0.99594 -11.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2714 12.6935 0 0 0 0 0 0 0 0 0 0 12.8007 0 12.7846 12.7399 0 0 0 0 0 0 0 11.5218 0 0 0 0 0 0 0 11.1544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2334 0 0 0 0 0 0 0 0 0 0 0 0 12.1897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H7B2 RPF2_HUMAN Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog) RPF2 BXDC1 Homo sapiens (Human) "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]" chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]" GO:0000027; GO:0000463; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0008097; GO:0019843; GO:0042273; GO:1901796; GO:1902570 5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843] KRPNNLVIGR 0.99594 -12.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4627 0 0 0 0 0 14.2881 0 0 0 0 0 15.7674 15.922 0 0 12.6439 0 0 0 0 0 0 0 0 12.324 0 0 0 0 0 0 0 15.3488 0 0 15.0728 0 0 0 0 0 0 0 0 0 0 0 14.0626 0 14.0776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.1048 15.7326 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4622 0 13.0306 Q9HAH1 ZN556_HUMAN Zinc finger protein 556 ZNF556 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" HCGKAFR 0.99594 -34.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0977 0 0 0 0 0 0 0 0 14.3746 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.726 0 0 0 0 0 0 0 13.1642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.706 0 0 0 0 0 0 0 0 0 14.9576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBL6 CPNE7_HUMAN Copine-7 (Copine VII) CPNE7 Homo sapiens (Human) cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cellular response to calcium ion [GO:0071277]; lipid metabolic process [GO:0006629] GO:0005544; GO:0005634; GO:0005737; GO:0005886; GO:0006629; GO:0046872; GO:0070062; GO:0071277 calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] PLLLKFGR 0.99594 -12.425 13.7633 13.4975 14.0549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.231 0 0 0 0 0 0 18.7203 0 0 0 0 18.8068 0 12.484 0 0 0 0 0 0 0 11.1862 0 0 11.3009 0 0 0 0 0 0 0 0 0 0 0 0 18.8015 0 0 0 17.9999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.5873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8468 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8842 0 0 12.7324 0 Q9Y487 VPP2_HUMAN "V-type proton ATPase 116 kDa subunit a 2, V-ATPase 116 kDa subunit a 2 (Lysosomal H(+)-transporting ATPase V0 subunit a 2) (TJ6) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2)" ATP6V0A2 Homo sapiens (Human) cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; Golgi lumen acidification [GO:0061795]; immune response [GO:0006955]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035] "acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]" "acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; Golgi lumen acidification [GO:0061795]; immune response [GO:0006955]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]" GO:0000139; GO:0000220; GO:0001669; GO:0005765; GO:0005886; GO:0005925; GO:0006879; GO:0006955; GO:0007035; GO:0010008; GO:0016021; GO:0016241; GO:0016471; GO:0030670; GO:0033176; GO:0036295; GO:0043231; GO:0046961; GO:0048471; GO:0051117; GO:0061795; GO:1902600 "ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]" ALEEGSR 0.99594 -11.849 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3823 0 0 0 0 0 0 0 13.7448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q2TB18 ASTE1_HUMAN Protein asteroid homolog 1 ASTE1 HT001 Homo sapiens (Human) nuclease activity [GO:0004518] GO:0004518 nuclease activity [GO:0004518] CWYEGNNRFGLLMVENLEEHSEASNIE 0.99595 -9.534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1972 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0046 0 16.2252 0 16.1398 16.0048 0 0 0 15.3162 17.1446 0 0 0 0 15.3907 0 0 13.4896 13.6108 0 12.7366 0 0 0 0 16.7699 16.8394 16.8505 12.8968 15.9489 15.9215 0 0 14.9806 15.7229 0 0 0 15.9314 0 0 12.6149 0 0 0 0 16.4614 16.3799 0 0 0 13.1236 14.1456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6738 0 0 0 0 0 0 0 Q6A162 K1C40_HUMAN "Keratin, type I cytoskeletal 40 (Cytokeratin-40, CK-40) (Keratin-40, K40) (Type I hair keratin Ka36)" KRT40 KA36 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198]; epithelial cell differentiation [GO:0030855]; intermediate filament organization [GO:0045109] GO:0005198; GO:0005829; GO:0005856; GO:0005882; GO:0030855; GO:0045109 structural molecule activity [GO:0005198] CDLERQNQEYQVLLDVKAR 0.99595 -9.817 0 0 0 0 0 0 0 0 0 0 10.3831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7811 0 0 0 0 0 0 0 0 0 14.1076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.329 11.4946 0 0 0 0 0 0 0 0 0 0 0 0 11.8412 0 0 0 0 11.8766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3698 0 0 0 0 Q8IZC4 RTKN2_HUMAN "Rhotekin-2 (Pleckstrin homology domain-containing family K member 1, PH domain-containing family K member 1)" RTKN2 PLEKHK1 Homo sapiens (Human) hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; hemopoiesis [GO:0030097]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; signal transduction [GO:0007165] GO:0005634; GO:0005737; GO:0005886; GO:0007165; GO:0008284; GO:0030097; GO:0051092; GO:1901224; GO:2001243 IDLEIRMR 0.99595 -34.929 0 0 0 0 0 0 0 0 0 11.3704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7095 0 0 0 14.623 0 13.6356 0 0 0 0 0 14.2676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3946 0 0 11.9734 12.56 12.1945 11.8278 12.8239 12.2934 0 0 0 0 0 0 0 0 13.8373 0 0 0 0 13.6935 0 0 0 0 0 11.931 0 0 12.0334 14.7591 16.9904 0 0 14.2074 12.4703 0 0 0 0 0 13.3336 0 0 0 16.9917 0 0 0 0 0 0 0 0 0 0 0 0 14.6133 0 12.2908 0 Q8NCU4 CC191_HUMAN Coiled-coil domain-containing protein 191 CCDC191 KIAA1407 Homo sapiens (Human) AIQRAECR 0.99595 -35.127 11.4421 0 0 0 0 0 0 0 13.5807 14.8161 15.0076 13.4392 14.4134 12.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5645 12.4517 12.4072 12.4108 12.7971 12.8676 12.4409 12.692 12.1571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9717 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9513 0 0 0 0 11.69 0 0 0 0 12.941 0 0 0 13.2528 14.9989 0 0 0 0 0 0 0 0 0 0 0 0 13.178 0 0 0 0 0 13.7963 0 0 13.5783 0 0 12.6491 13.4865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7809 0 0 12.7384 0 0 0 0 15.1001 0 18.1173 0 0 0 0 0 0 14.4708 0 14.3349 0 0 10.0974 0 0 0 0 0 15.0525 11.5807 15.6174 Q8NGQ6 OR9I1_HUMAN Olfactory receptor 9I1 (Olfactory receptor OR11-228) OR9I1 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] RLQVSLSM 0.99595 -11.914 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3702 0 0 0 0 0 0 13.5992 0 13.7423 0 13.067 0 0 0 0 0 0 0 0 15.018 13.1281 11.8455 13.5622 0 14.9114 14.709 0 0 14.3583 13.0151 0 0 15.0307 0 0 0 0 0 0 0 0 0 13.8847 0 15.0531 15.4755 0 0 15.769 0 0 0 0 0 14.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6667 0 0 0 0 0 0 14.1257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7594 0 Q8WXF5 CRGN_HUMAN Gamma-crystallin N (Gamma-N-crystallin) CRYGN Homo sapiens (Human) lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] structural constituent of eye lens [GO:0005212]; lens development in camera-type eye [GO:0002088]; visual perception [GO:0007601] GO:0002088; GO:0005212; GO:0007601 structural constituent of eye lens [GO:0005212] NCVNTIK 0.99595 -9.5314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8024 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.27001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5446 12.9598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9089 0 0 0 0 0 0 0 0 0 0 11.3563 0 0 0 Q9UPQ3 AGAP1_HUMAN "Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1, AGAP-1 (Centaurin-gamma-2, Cnt-g2) (GTP-binding and GTPase-activating protein 1, GGAP1)" AGAP1 CENTG2 KIAA1099 Homo sapiens (Human) activation of GTPase activity [GO:0090630]; protein transport [GO:0015031] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; activation of GTPase activity [GO:0090630]; protein transport [GO:0015031] GO:0003924; GO:0005096; GO:0005525; GO:0005543; GO:0005737; GO:0015031; GO:0046872; GO:0090630 GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543] AIPIKQGMLLK 0.99595 -9.5373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5374 0 0 0 0 0 14.0956 Q9Y4A5 TRRAP_HUMAN "Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor, PAF350/400) (STAF40) (Tra1 homolog)" TRRAP PAF400 Homo sapiens (Human) "chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276] "Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; monoubiquitinated histone deubiquitination [GO:0035521]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006282; GO:0006325; GO:0006355; GO:0006357; GO:0016573; GO:0016578; GO:0033276; GO:0035267; GO:0035521; GO:0035522; GO:0042981; GO:0043484; GO:0043966; GO:0043967; GO:0043968; GO:0045893; GO:0051726; GO:1905168; GO:2000779 transcription coregulator activity [GO:0003712] APGEAQFIPNKQLQPKETQIYIK 0.99595 -35.17 0 0 0 0 11.3266 0 0 0 0 12.9032 0 12.916 0 11.9238 0 12.6755 0 0 0 13.7684 0 0 0 0 11.3324 11.0966 0 0 0 0 0 0 15.5333 0 0 0 0 11.3727 14.0059 12.9316 0 0 12.0857 0 11.2231 0 0 0 11.8815 0 0 0 0 0 0 11.3544 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8209 0 0 14.5914 12.0612 12.5047 0 13.4721 10.0558 0 11.6429 14.5016 0 17.3181 15.6028 15.9685 0 13.7408 10.7288 14.0009 14.8099 0 17.7361 15.5951 14.4111 17.3045 0 0 13.5646 15.0386 14.0051 12.7774 11.8474 16.3923 0 0 12.9332 0 14.5854 12.3315 0 14.2894 12.4592 14.1809 0 13.6224 13.7548 0 13.9085 0 0 0 15.724 0 0 14.2922 0 13.2832 0 15.0866 14.2056 14.5791 0 11.5716 13.0892 12.9547 0 0 0 14.7198 0 13.4738 0 0 0 0 0 14.2521 13.3938 0 0 11.4364 10.6742 15.4785 14.4103 10.7483 12.3844 0 11.0859 0 13.7376 10.632 0 13.9597 13.0025 0 0 0 0 13.6161 12.6224 0 0 0 0 12.3372 0 13.6071 13.2721 O94855 SC24D_HUMAN Protein transport protein Sec24D (SEC24-related protein D) SEC24D KIAA0755 Homo sapiens (Human) COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231] COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; intracellular membrane-bounded organelle [GO:0043231]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886] GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0043231; GO:0070971; GO:0090110 SNARE binding [GO:0000149]; zinc ion binding [GO:0008270] AVLHQPLKVIR 0.99596 -12.073 0 0 0 0 0 0 11.0241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1566 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2694 0 0 0 0 0 0 0 0 0 P54710 ATNG_HUMAN "Sodium/potassium-transporting ATPase subunit gamma, Na(+)/K(+) ATPase subunit gamma (FXYD domain-containing ion transport regulator 2) (Sodium pump gamma chain)" FXYD2 ATP1C ATP1G1 Homo sapiens (Human) establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376]; transmembrane transport [GO:0055085] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; sodium ion export across plasma membrane [GO:0036376]; transmembrane transport [GO:0055085] GO:0001671; GO:0005886; GO:0005890; GO:0010248; GO:0017080; GO:0030674; GO:0036376; GO:0055085; GO:0070062; GO:1902600; GO:1903408; GO:1990573 ATPase activator activity [GO:0001671]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080] CGGNKKR 0.99596 -9.8817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2648 0 0 0 0 15.9471 0 17.3236 0 0 0 0 15.038 0 0 0 13.682 0 13.5428 0 0 0 0 0 0 13.512 0 0 0 0 0 0 0 0 14.8301 0 0 0 0 14.906 0 0 0 0 0 0 14.3254 0 0 0 14.6685 13.9941 0 0 0 0 0 0 12.3811 15.1108 14.0183 0 0 0 14.4405 0 0 0 0 0 13.1819 0 0 14.9028 0 0 0 0 0 13.8577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8223 0 0 0 0 0 13.4788 0 0 0 0 0 0 Q7RTU5 ASCL5_HUMAN "Achaete-scute homolog 5, ASH-5, hASH5 (Class A basic helix-loop-helix protein 47, bHLHa47)" ASCL5 BHLHA47 Homo sapiens (Human) positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0006357; GO:0045944; GO:0046983; GO:0090575 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" GPSKSWYPR 0.99596 -9.5605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7631 0 0 11.1369 10.8457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0253 0 0 0 0 0 0 0 0 Q96T17 MA7D2_HUMAN MAP7 domain-containing protein 2 MAP7D2 Homo sapiens (Human) microtubule cytoskeleton organization [GO:0000226] microtubule cytoskeleton [GO:0015630] microtubule cytoskeleton [GO:0015630]; microtubule cytoskeleton organization [GO:0000226] GO:0000226; GO:0015630 ARLQYEKQMEER 0.99596 -9.8946 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6568 0 0 12.1477 0 0 0 0 0 0 0 0 13.3368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.187 0 0 0 0 0 0 11.6542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6177 0 0 0 0 13.2432 0 0 0 0 0 0 0 13.7719 0 0 14.2617 14.1228 15.793 0 0 13.6983 13.7718 19.6062 0 0 0 15.7943 0 0 16.1461 0 0 0 14.1188 13.8672 14.3635 10.8685 14.4047 14.4013 0 13.8672 0 0 0 0 0 13.6218 0 0 0 0 0 0 0 0 15.9331 0 0 0 0 0 0 0 0 0 0 0 0 12.2625 15.0971 12.6277 12.6927 11.212 0 0 11.2971 0 0 0 0 13.1885 12.6104 0 12.4052 14.5841 10.7589 0 0 0 11.2365 0 0 0 Q9BU68 PR15L_HUMAN Proline-rich protein 15-like protein (Protein ATAD4) PRR15L ATAD4 Homo sapiens (Human) LEKIVDK 0.99596 -9.5727 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0409 0 0 0 0 0 0 11.2249 0 0 0 0 0 0 13.0551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6867 12.261 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UG56 PISD_HUMAN "Phosphatidylserine decarboxylase proenzyme, mitochondrial, EC 4.1.1.65 [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain ]" PISD Homo sapiens (Human) mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634] integral component of mitochondrial inner membrane [GO:0031305]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821] GO:0004609; GO:0005634; GO:0005739; GO:0006646; GO:0010821; GO:0016540; GO:0031305; GO:0035694 phosphatidylserine decarboxylase activity [GO:0004609] DLHTNSPR 0.99596 -9.8974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8556 0 10.5403 11.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95625 ZBT11_HUMAN Zinc finger and BTB domain-containing protein 11 ZBTB11 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleolus [GO:0005730]; nucleoplasm [GO:0005654] "nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005654; GO:0005730; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AILRYLTNER 0.99597 -9.6267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1785 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1647 0 0 0 0 0 0 0 14.1592 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2107 0 0 0 0 0 0 9.37141 0 0 0 0 0 0 0 0 0 11.504 0 0 0 0 11.2682 0 0 0 13.8974 0 0 0 12.6247 0 0 0 11.1341 0 0 0 0 0 0 0 0 0 0 12.8798 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P30825 SL7A1_HUMAN "High affinity cationic amino acid transporter 1, CAT-1, CAT1 (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter)" SLC7A1 ATRC1 ERR REC1L Homo sapiens (Human) amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104] GO:0000064; GO:0005290; GO:0005886; GO:0005887; GO:0006865; GO:0009925; GO:0015171; GO:0015174; GO:0015189; GO:0015807; GO:0015819; GO:0015822; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1903352; GO:1903810; GO:1903826 amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] PIGEFSR 0.99597 -9.6069 0 0 0 0 0 0 0 0 14.8098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.494 0 0 0 0 0 0 0 0 0 12.6534 0 0 0 P48449 LSS_HUMAN "Lanosterol synthase, EC 5.4.99.7 (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase, OSC, hOSC)" LSS OSC Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]; lanosterol synthase activity [GO:0000250]; cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104] GO:0000250; GO:0005789; GO:0005811; GO:0006694; GO:0006695; GO:0016020; GO:0016104; GO:0031647 lanosterol synthase activity [GO:0000250] EEIVRYLR 0.99597 -9.6283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6732 13.1182 0 13.0551 0 0 0 0 0 0 14.2978 0 0 0 0 14.3592 12.6803 0 0 0 0 0 0 0 0 0 14.2194 0 0 0 0 0 0 0 0 0 0 0 0 13.6347 0 13.7599 12.9813 14.1135 0 13.7387 0 13.3353 12.2718 12.0912 12.2208 0 0 0 0 0 12.4937 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1495 0 0 0 0 Q53GI3 ZN394_HUMAN Zinc finger protein 394 (Zinc finger protein with KRAB and SCAN domains 14) ZNF394 ZKSCAN14 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AERPTDSEEHGNK 0.99597 -9.6307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2932 0 0 0 0 10.8046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3102 13.4603 0 0 0 0 0 0 0 0 0 0 0 0 15.6899 0 0 0 0 0 0 13.4276 0 0 0 0 0 0 15.3318 10.5701 0 0 0 0 14.9784 0 0 0 0 12.9333 0 0 0 0 0 0 0 15.0782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1534 0 0 0 0 0 0 0 12.2898 0 0 10.3092 0 0 0 0 0 0 0 0 0 0 0 12.2731 0 0 0 0 0 0 0 0 0 0 Q5VYJ5 MALR1_HUMAN MAM and LDL-receptor class A domain-containing protein 1 MALRD1 C10orf112 DIET1 Homo sapiens (Human) cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021] cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858] GO:0005794; GO:0016021; GO:0030659; GO:0042632; GO:0070858 CDFEANSCDWFEAISGDHFDWIR 0.99597 -9.6338 0 0 0 0 0 0 0 0 0 0 11.6767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2622 12.7655 0 12.3914 0 0 0 0 12.0558 0 11.419 0 0 0 13.1165 0 13.8835 0 0 0 0 0 0 0 0 12.8166 0 0 0 0 11.8268 0 0 0 0 0 11.1231 0 0 11.8728 13.6013 0 13.5765 13.4433 13.3354 12.5177 13.4422 13.2408 0 13.3677 14.0025 13.5646 0 0 0 0 12.9724 0 0 0 0 0 0 0 0 14.4144 0 12.1151 13.6997 10.9557 0 0 12.0773 11.9128 10.7068 0 0 0 0 0 0 0 0 0 0 12.169 0 0 14.0262 0 10.8553 0 0 0 0 0 0 0 11.3972 0 11.8469 0 11.9441 0 0 0 0 10.4676 0 0 Q92914 FGF11_HUMAN "Fibroblast growth factor 11, FGF-11 (Fibroblast growth factor homologous factor 3, FHF-3)" FGF11 FHF3 Homo sapiens (Human) cell-cell signaling [GO:0007267]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; sodium channel regulator activity [GO:0017080]; cell-cell signaling [GO:0007267]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165] GO:0005576; GO:0005634; GO:0005737; GO:0007165; GO:0007267; GO:0007399; GO:0008083; GO:0017080; GO:1905150 growth factor activity [GO:0008083]; sodium channel regulator activity [GO:0017080] AALASSLIRQKR 0.99597 -9.6029 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9385 0 16.9748 0 0 0 0 0 0 17.8259 0 0 0 0 12.0234 13.1119 17.7509 0 0 0 0 13.2865 12.8251 0 0 12.6622 18.1894 0 0 0 0 13.3799 13.7133 0 0 0 0 0 0 0 11.9676 0 0 0 0 0 0 0 0 0 0 0 16.3134 11.5588 0 0 0 12.7917 0 0 12.0546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9545 0 0 0 0 0 17.3078 0 0 17.2615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQP7 MGME1_HUMAN "Mitochondrial genome maintenance exonuclease 1, EC 3.1.-.-" MGME1 C20orf72 DDK1 Homo sapiens (Human) mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002] mitochondrion [GO:0005739] mitochondrion [GO:0005739]; single-stranded DNA exodeoxyribonuclease activity [GO:0008297]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002] GO:0000002; GO:0005739; GO:0006264; GO:0008297; GO:0043504 single-stranded DNA exodeoxyribonuclease activity [GO:0008297] HKLPNQGEDRR 0.99597 -9.6368 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1065 0 0 13.8502 0 0 0 0 0 Q9BUQ8 DDX23_HUMAN "Probable ATP-dependent RNA helicase DDX23, EC 3.6.4.13 (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD)" DDX23 Homo sapiens (Human) "cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682] "catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; R-loop disassembly [GO:0062176]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]" GO:0000354; GO:0000375; GO:0000398; GO:0000785; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005682; GO:0005730; GO:0008380; GO:0016887; GO:0046540; GO:0062176; GO:0070062; GO:0071013 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724] DASPSKEER 0.99598 -33.154 0 0 0 0 0 0 0 0 0 11.2628 0 0 0 0 0 0 0 0 0 0 14.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2259 0 0 0 0 0 0 0 0 0 0 0 12.0334 0 15.0361 0 0 13.3215 0 0 0 13.6204 0 0 13.0742 12.8434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3425 0 0 0 0 16.6376 0 0 12.6027 16.9401 0 0 0 17.025 0 0 0 0 0 0 14.6034 0 0 0 0 0 0 0 0 0 0 11.9088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0988 0 0 14.7745 0 0 0 0 14.5554 0 0 0 17.1599 0 14.7076 13.0297 12.7403 0 0 O15156 ZBT7B_HUMAN "Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox, hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog, Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK)" ZBTB7B ZBTB15 ZFP67 ZNF857B Homo sapiens (Human) "adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; adaptive thermogenesis [GO:1990845]; ectoderm development [GO:0007398]; lactation [GO:0007595]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of gene expression [GO:0010629]; negative regulation of NK T cell proliferation [GO:0051141]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription by RNA polymerase II [GO:0000122]; NK T cell differentiation [GO:0001865]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of SREBP signaling pathway [GO:2000640]; regulation of transcription by RNA polymerase II [GO:0006357]; response to insulin [GO:0032868]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0001865; GO:0005654; GO:0006357; GO:0006366; GO:0007398; GO:0007595; GO:0010628; GO:0010629; GO:0031065; GO:0032740; GO:0032868; GO:0042803; GO:0042826; GO:0043372; GO:0043377; GO:0046628; GO:0046872; GO:0051141; GO:0090336; GO:0120162; GO:1990837; GO:1990845; GO:2000320; GO:2000640 "cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AFLQTKGAR 0.99598 -12.276 0 0 0 0 0 0 0 0 0 0 12.8504 0 0 0 0 0 12.9173 0 10.9583 0 0 0 0 0 12.8359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8846 0 0 0 0 0 13.586 0 15.818 0 0 0 0 0 0 0 13.8164 0 0 13.6418 0 0 0 0 0 13.4897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2988 13.4295 13.9156 14.2043 0 0 0 14.3405 12.4694 13.3219 0 13.6131 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8697 O15457 MSH4_HUMAN "MutS protein homolog 4, hMSH4" MSH4 Homo sapiens (Human) female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283] chromosome [GO:0005694]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795] chromosome [GO:0005694]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283] GO:0000795; GO:0001541; GO:0003677; GO:0003690; GO:0005524; GO:0005634; GO:0005694; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0030983; GO:0140664 ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983] EIYHMTYMIVCKLLSEIYEHIHCLYK 0.99598 -11.702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.673 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.80479 0 0 0 0 0 0 0 0 0 12.1654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1857 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0634 0 0 0 10.7042 0 0 0 0 0 0 0 0 0 0 0 0 13.6495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P11277 SPTB1_HUMAN "Spectrin beta chain, erythrocytic (Beta-I spectrin)" SPTB SPTB1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693] GO:0003779; GO:0005200; GO:0005829; GO:0005886; GO:0008091; GO:0009986; GO:0014731; GO:0015629; GO:0030036; GO:0030054; GO:0030506; GO:0030864; GO:0031235; GO:0032991; GO:0042995; GO:0051015; GO:0051693 actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200] ALEDLAQELEK 0.99598 -12.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7408 0 11.4635 0 11.679 12.9407 0 0 0 0 11.0911 0 0 0 0 11.0843 0 12.0309 0 12.4598 0 0 0 0 12.1392 0 0 11.5097 0 0 0 10.5321 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6301 0 0 0 0 0 0 0 11.4831 0 0 16.6412 16.6982 0 0 0 0 13.2254 0 13.015 0 0 12.8863 0 0 0 0 0 0 13.6978 0 12.7628 0 0 0 0 0 13.5714 0 0 0 0 0 0 0 13.4368 13.7261 13.5723 0 0 0 0 0 13.4882 0 0 0 0 13.2458 0 0 0 0 0 12.3754 10.8685 0 0 12.9676 0 0 0 0 0 0 0 0 0 0 13.3468 0 12.9977 0 0 0 0 0 0 0 0 0 0 0 13.053 0 0 0 0 0 0 0 0 0 12.8373 13.5746 12.2452 13.0504 0 0 12.7737 14.9017 0 0 0 0 14.0165 0 0 0 P53567 CEBPG_HUMAN "CCAAT/enhancer-binding protein gamma, C/EBP gamma" CEBPG Homo sapiens (Human) B cell differentiation [GO:0030183]; enucleate erythrocyte differentiation [GO:0043353]; immune response [GO:0006955]; integrated stress response signaling [GO:0140467]; liver development [GO:0001889]; mRNA metabolic process [GO:0016071]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; B cell differentiation [GO:0030183]; enucleate erythrocyte differentiation [GO:0043353]; immune response [GO:0006955]; integrated stress response signaling [GO:0140467]; liver development [GO:0001889]; mRNA metabolic process [GO:0016071]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0003677; GO:0005634; GO:0005654; GO:0006357; GO:0006955; GO:0016071; GO:0030183; GO:0032729; GO:0042267; GO:0042802; GO:0043353; GO:0043388; GO:0043433; GO:0043565; GO:0045739; GO:0045944; GO:0051091; GO:0090575; GO:0140297; GO:0140467; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" AQDTLQR 0.99598 -12.243 0 0 0 0 0 0 0 0 0 13.0323 0 0 0 0 0 0 0 0 0 0 0 13.4353 0 0 0 0 0 0 0 0 0 0 14.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7546 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.346 0 0 0 0 0 0 0 0 0 0 0 11.8206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5615 0 0 0 0 0 0 0 0 0 0 10.9238 0 0 0 0 0 0 0 0 0 0 0 11.2318 0 0 0 0 0 0 0 0 0 0 0 Q02846 GUC2D_HUMAN "Retinal guanylyl cyclase 1, RETGC-1, EC 4.6.1.2 (CG-E) (Guanylate cyclase 2D, retinal) (Rod outer segment membrane guanylate cyclase, ROS-GC)" GUCY2D CORD6 GUC1A4 GUC2D RETGC RETGC1 Homo sapiens (Human) cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886] endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; nuclear outer membrane [GO:0005640]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of rhodopsin mediated signaling pathway [GO:0022400]; signal transduction [GO:0007165]; visual perception [GO:0007601] GO:0001653; GO:0001750; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005640; GO:0005789; GO:0005886; GO:0005887; GO:0006182; GO:0006468; GO:0007165; GO:0007168; GO:0007601; GO:0019934; GO:0022400; GO:0038023; GO:0042622; GO:0042803; GO:0044877; GO:0097381 ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; peptide receptor activity [GO:0001653]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein-containing complex binding [GO:0044877]; signaling receptor activity [GO:0038023] ARPGQFS 0.99598 -33.004 0 0 0 0 0 0 10.5117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3363 11.8791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9208 0 0 0 0 0 0 0 0 0 0 0 11.3122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3354 0 0 0 0 0 13.0291 0 0 Q15029 U5S1_HUMAN "116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (SNU114 homolog, hSNU114) (U5 snRNP-specific protein, 116 kDa, U5-116 kDa)" EFTUD2 KIAA0031 SNRP116 Homo sapiens (Human) "cellular response to xenobiotic stimulus [GO:0071466]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]" Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540] "Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to xenobiotic stimulus [GO:0071466]; mRNA splicing, via spliceosome [GO:0000398]; response to cocaine [GO:0042220]" GO:0000398; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0015030; GO:0016020; GO:0016607; GO:0030623; GO:0042220; GO:0043231; GO:0046540; GO:0071005; GO:0071007; GO:0071013; GO:0071466; GO:1990904 GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623] EELKLNIRPLLR 0.99598 -12.241 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8796 0 0 0 0 0 0 0 0 0 0 12.4176 0 0 0 0 0 0 10.7756 0 0 0 0 0 11.2993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4833 13.7718 0 0 0 0 0 0 0 15.123 0 0 0 0 13.9243 0 0 0 13.7918 0 0 0 0 13.859 12.1389 0 0 0 13.3818 0 12.3798 0 0 0 0 13.3038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0815 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 0 0 0 0 0 12.9351 0 0 0 0 0 0 0 0 0 0 0 0 12.594 0 13.985 0 0 Q16772 GSTA3_HUMAN "Glutathione S-transferase A3, EC 2.5.1.18 (GST class-alpha member 3) (Glutathione S-transferase A3-3)" GSTA3 Homo sapiens (Human) glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805] cytosol [GO:0005829]; extracellular exosome [GO:0070062] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805] GO:0004364; GO:0005829; GO:0006629; GO:0006749; GO:0006805; GO:0070062 glutathione transferase activity [GO:0004364] AILNYIASKYNLYGKDIK 0.99598 -12.283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9107 13.2791 12.5082 12.9049 11.6869 12.1936 0 0 0 0 0 12.2276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3315 0 0 0 0 0 0 0 0 0 0 0 0 0 12.655 0 0 0 11.2596 0 0 0 0 0 0 0 0 0 0 0 0 11.9592 0 0 0 0 0 0 12.0802 14.7899 0 0 0 0 0 12.5456 0 13.6573 0 0 0 0 0 0 0 0 0 0 0 Q5VZ18 SHE_HUMAN SH2 domain-containing adapter protein E SHE Homo sapiens (Human) phosphotyrosine residue binding [GO:0001784] GO:0001784 phosphotyrosine residue binding [GO:0001784] GSKDPLVK 0.99598 -11.742 11.0188 0 0 0 0 10.3959 0 0 0 11.7751 0 0 0 14.6028 0 0 0 0 0 0 0 10.415 0 0 0 10.6504 0 0 11.032 0 0 0 0 0 0 11.2844 0 0 10.5308 10.9215 0 10.4121 0 0 10.9741 11.5243 0 0 0 12.1593 12.5912 12.2871 0 12.6783 14.8348 13.8967 12.4698 15.9295 13.1625 15.1579 11.3083 0 0 14.3071 13.9785 0 0 0 0 11.2812 0 0 0 0 0 12.7398 0 0 0 0 0 12.5116 0 0 0 0 0 0 12.7322 11.3819 0 0 0 0 0 0 0 12.6736 0 0 0 12.497 0 0 0 0 13.508 0 0 13.1572 0 0 0 0 13.7472 0 0 12.7867 0 12.8624 0 0 0 0 0 13.1265 0 0 12.762 12.9001 0 0 0 0 0 0 12.1943 0 0 12.6339 13.3219 0 12.5517 0 0 0 14.3989 0 0 0 0 0 0 0 12.8493 0 0 0 0 0 0 12.5453 0 0 0 0 0 0 0 0 0 12.8109 0 13.0298 0 14.4178 14.0979 0 0 0 Q96NL6 SCLT1_HUMAN Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1) SCLT1 SAP1 Homo sapiens (Human) cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829] centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; clathrin binding [GO:0030276]; protein C-terminus binding [GO:0008022]; sodium channel regulator activity [GO:0017080]; cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162] GO:0005813; GO:0005814; GO:0005829; GO:0008022; GO:0017080; GO:0030276; GO:0045162; GO:0060271; GO:0071439; GO:0097539 clathrin binding [GO:0030276]; protein C-terminus binding [GO:0008022]; sodium channel regulator activity [GO:0017080] AASLMNLENI 0.99598 -33.148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9554 0 0 0 0 0 0 0 0 0 0 0 14.1307 0 14.1747 14.3924 0 11.5533 0 0 14.1633 0 0 12.6012 14.1035 14.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.304 0 0 0 0 12.6297 0 0 0 0 0 0 0 0 0 0 14.5803 0 13.339 0 0 0 0 14.876 0 14.4833 14.4192 0 0 0 12.8751 12.3068 12.7817 0 0 14.1611 0 0 14.5766 12.7133 15.6912 0 0 0 0 12.1484 13.4583 0 0 0 0 0 0 0 0 0 0 13.5843 0 12.3971 0 0 0 14.9002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3993 0 0 0 13.1943 0 13.6064 0 0 0 0 0 14.6512 14.9136 15.7096 0 0 0 0 0 0 0 14.2322 0 0 0 0 Q9HA65 TBC17_HUMAN TBC1 domain family member 17 TBC1D17 Homo sapiens (Human) "activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" autophagosome [GO:0005776]; cytosol [GO:0005829]; recycling endosome [GO:0055037] "autophagosome [GO:0005776]; cytosol [GO:0005829]; recycling endosome [GO:0055037]; GTPase activator activity [GO:0005096]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005096; GO:0005776; GO:0005829; GO:0006914; GO:0015031; GO:0042147; GO:0055037; GO:0090630 GTPase activator activity [GO:0005096] ALLRVLSR 0.99598 -9.6515 0 0 0 0 0 0 0 0 0 0 0 0 13.1604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5819 0 0 0 0 0 0 0 0 13.9083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0633 0 0 0 12.7494 0 0 0 0 0 0 0 14.1636 0 0 0 0 0 0 0 14.8706 0 0 0 13.9646 16.2477 15.3206 0 15.9211 15.5222 0 0 0 0 0 0 0 0 0 0 0 0 0 15.629 0 0 0 16.0866 0 0 0 15.7298 0 0 0 0 14.4315 0 0 0 0 0 0 0 14.8554 0 0 14.3924 0 0 0 13.9403 0 0 0 0 0 0 0 0 0 0 15.7544 0 0 0 0 0 0 Q9NQX1 PRDM5_HUMAN "PR domain zinc finger protein 5, EC 2.1.1.- (PR domain-containing protein 5)" PRDM5 PFM2 Homo sapiens (Human) "cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extracellular matrix organization [GO:1903053]; regulation of gene expression [GO:0010468]" nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extracellular matrix organization [GO:1903053]; regulation of gene expression [GO:0010468]" GO:0000122; GO:0000278; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0008168; GO:0010468; GO:0016575; GO:0016604; GO:0043565; GO:0045892; GO:0045944; GO:0046872; GO:0051567; GO:0140297; GO:1903053; GO:1990830 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]" CHHCDATFK 0.99598 -33.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8367 0 12.4865 0 0 0 0 9.84609 0 0 16.0868 12.2873 0 0 0 0 0 0 0 12.2386 0 0 9.30882 12.8786 0 0 0 0 0 0 0 0 0 16.0209 0 16.4673 16.3234 16.0735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2382 0 0 0 0 15.2759 0 0 0 0 0 0 14.6511 0 14.4245 14.4861 13.2903 11.5059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0573 0 0 0 0 0 13.6054 0 0 0 0 0 0 0 0 10.3154 0 0 0 0 0 0 0 0 0 13.5599 0 13.5303 0 0 0 0 0 13.3775 0 0 0 0 0 0 0 11.2168 12.9224 0 0 18.781 0 0 12.0182 17.773 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y4K3 TRAF6_HUMAN "TNF receptor-associated factor 6, EC 2.3.2.27 (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6)" TRAF6 RNF85 Homo sapiens (Human) "activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] "CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; bone resorption [GO:0045453]; cell development [GO:0048468]; cellular response to cytokine stimulus [GO:0071345]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; tumor necrosis factor-mediated signaling pathway [GO:0033209]" GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002223; GO:0002637; GO:0002726; GO:0002753; GO:0002755; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006974; GO:0007249; GO:0007250; GO:0008270; GO:0009898; GO:0010008; GO:0019886; GO:0019901; GO:0030316; GO:0031398; GO:0031435; GO:0031624; GO:0031625; GO:0031666; GO:0031996; GO:0032147; GO:0032735; GO:0032743; GO:0032755; GO:0032813; GO:0032991; GO:0033209; GO:0035631; GO:0038095; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0043507; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046330; GO:0047485; GO:0048468; GO:0048471; GO:0050852; GO:0051091; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:1901224; GO:1904996; GO:2000679 histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] CPNEGCLHKMELR 0.99598 -11.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6092 0 13.9428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7372 0 0 0 10.7754 0 0 12.71 0 0 0 11.1912 12.366 0 0 0 0 10.8194 0 0 0 0 0 0 0 0 0 0 0 0 14.2394 14.8399 0 0 0 0 0 0 0 0 12.0371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5496 0 0 0 0 0 0 0 0 0 0 13.6307 Q14008 CKAP5_HUMAN "Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein, Ch-TOG)" CKAP5 KIAA0097 Homo sapiens (Human) cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; microtubule plus-end binding [GO:0051010]; ribonucleoprotein complex binding [GO:0043021]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; positive regulation of microtubule nucleation [GO:0090063]; RNA transport [GO:0050658]; spindle organization [GO:0007051] GO:0000776; GO:0000922; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007019; GO:0007051; GO:0007052; GO:0007098; GO:0008017; GO:0016020; GO:0030951; GO:0032991; GO:0043021; GO:0045296; GO:0046785; GO:0050658; GO:0051010; GO:0051298; GO:0051301; GO:0061863; GO:0090063 cadherin binding [GO:0045296]; microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; microtubule plus-end binding [GO:0051010]; ribonucleoprotein complex binding [GO:0043021] AGGPPKK 0.99599 -34.21 16.1079 16.6782 16.3528 11.7175 15.9527 14.0818 16.0185 16.272 14.854 15.0298 14.3226 13.9443 14.7022 12.5225 13.9969 14.9873 15.0802 15.1087 14.1188 15.7625 15.682 15.6221 14.8581 15.4712 15.4724 15.2991 15.9285 13.7522 16.124 14.2427 15.669 15.3109 15.3347 14.6484 14.5875 13.9503 15.5024 15.2942 12.4525 14.4086 13.4091 15.0355 15.0003 14.2485 15.0426 13.1484 15.0109 15.1638 13.742 15.8073 14.946 12.4995 13.2002 13.1327 0 12.7579 13.9128 11.6389 12.3373 0 0 10.7422 0 10.1949 0 0 15.8945 16.0602 11.7263 15.6577 15.6951 15.6981 15.6484 13.8377 14.4482 16.1723 14.9377 15.6218 15.8411 15.9186 16.5415 15.8772 15.881 17.7469 16.1364 15.8002 15.499 15.6977 15.6437 15.7311 15.7023 16.1422 16.3469 13.8995 16.0962 15.4384 13.9249 15.6893 15.3609 13.8097 15.5917 12.5821 0 15.4728 16.347 14.9628 16.3446 13.2737 13.5836 15.5511 12.9182 12.7829 15.8563 15.3686 15.7763 13.5955 13.7534 16.4136 15.5999 16.4049 16.682 14.7362 13.8037 15.7253 15.6062 15.967 15.5488 0 15.6217 15.7985 16.5723 16.044 16.0855 16.6206 16.1184 15.5643 14.7986 16.2991 15.7928 14.8553 15.0863 14.4169 15.298 11.9231 15.0106 13.8865 13.0326 13.9068 0 0 16.271 0 12.7485 15.4492 15.6681 16.0893 16.0298 15.3943 16.2899 16.331 16.7093 16.1604 17.184 15.3294 15.9862 16.0417 16.3186 16.0514 16.5973 14.515 15.9518 15.9121 16.0715 16.1189 13.7093 17.009 15.5053 16.8476 13.5399 11.6775 O60508 PRP17_HUMAN "Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3, Ehb3) (PRP17 homolog, hPRP17)" CDC40 EHB3 PRP17 PRPF17 Homo sapiens (Human) "embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]" catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007] "catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]" GO:0000398; GO:0003723; GO:0003729; GO:0005654; GO:0016607; GO:0071007; GO:0071013; GO:1990403 mRNA binding [GO:0003729]; RNA binding [GO:0003723] EMYDYQGR 0.99599 -12.411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1755 0 0 0 0 0 0 0 0 0 0 15.0216 0 0 0 0 11.9825 12.7183 0 0 0 0 0 13.061 0 0 0 0 0 0 13.5727 0 15.1673 0 12.5041 11.5493 0 0 14.1767 0 0 0 14.5198 0 13.9377 0 0 0 12.5899 12.7011 14.6587 13.7371 13.689 14.4721 0 0 0 0 0 14.012 0 13.5174 0 0 13.909 12.9761 13.5543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7507 0 0 0 0 0 P17032 ZN37A_HUMAN Zinc finger protein 37A (Zinc finger protein KOX21) ZNF37A KOX21 ZNF37 Homo sapiens (Human) "regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0046872 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" FPSQSHLELINTSRNYSIMKFNEFNK 0.99599 -9.6847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P78348 ASIC1_HUMAN "Acid-sensing ion channel 1, ASIC1 (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2, BNaC2)" ASIC1 ACCN2 BNAC2 Homo sapiens (Human) associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; neurotransmitter secretion [GO:0007269]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793] cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280]; associative learning [GO:0008306]; behavioral fear response [GO:0001662]; calcium ion transmembrane transport [GO:0070588]; cellular response to pH [GO:0071467]; memory [GO:0007613]; negative regulation of neurotransmitter secretion [GO:0046929]; neurotransmitter secretion [GO:0007269]; protein homotrimerization [GO:0070207]; regulation of membrane potential [GO:0042391]; response to acidic pH [GO:0010447]; response to amphetamine [GO:0001975]; response to pH [GO:0009268]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814] GO:0001662; GO:0001975; GO:0005794; GO:0005886; GO:0005887; GO:0006814; GO:0007165; GO:0007269; GO:0007613; GO:0008306; GO:0009268; GO:0009986; GO:0010447; GO:0015280; GO:0022839; GO:0035725; GO:0042391; GO:0044736; GO:0046929; GO:0050915; GO:0070207; GO:0070588; GO:0071467; GO:0098793 acid-sensing ion channel activity [GO:0044736]; ion gated channel activity [GO:0022839]; ligand-gated sodium channel activity [GO:0015280] ASAKYLAKK 0.99599 -9.7322 0 0 0 0 0 10.4169 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9019 13.5529 0 0 0 0 0 0 0 0 0 0 0 0 13.5454 12.8989 14.3332 0 0 0 0 12.3604 0 0 0 0 0 0 0 0 0 0 13.912 0 0 0 0 0 0 0 0 0 0 10.8524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14432 PDE3A_HUMAN "cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A, EC 3.1.4.17 (Cyclic GMP-inhibited phosphodiesterase A, CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase, cGI-PDE)" PDE3A Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165] cytosol [GO:0005829]; integral component of membrane [GO:0016021] "cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]" GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007165; GO:0007186; GO:0009410; GO:0016021; GO:0019933; GO:0019934; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0043951; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130 "3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]" ADPASPR 0.99599 -11.776 0 0 0 0 0 0 0 0 0 0 11.851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4109 0 0 0 0 0 0 0 0 0 12.4923 0 0 12.7708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8042 0 0 0 0 0 0 0 0 0 0 12.7194 0 0 0 12.4745 14.5848 0 0 0 12.6999 14.5715 14.1286 14.3429 0 13.6707 0 0 14.2177 0 0 14.6091 0 0 0 0 0 14.5321 0 0 0 0 0 0 0 0 0 15.0816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2809 0 0 0 0 0 0 17.6999 0 0 0 0 12.7846 0 0 0 0 0 0 0 0 14.0804 0 0 0 0 0 0 0 0 12.5645 0 0 13.9834 12.724 0 0 0 0 11.9452 10.3259 0 12.9077 0 0 0 0 0 0 0 Q86UU0 BCL9L_HUMAN "B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, BCL9-like protein (Protein BCL9-2)" BCL9L DLNB11 Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; myoblast differentiation [GO:0045445]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366] beta-catenin-TCF complex [GO:1990907]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] beta-catenin-TCF complex [GO:1990907]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; myoblast differentiation [GO:0045445]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366] GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0006366; GO:0008013; GO:0010718; GO:0022604; GO:0030512; GO:0035019; GO:0035914; GO:0045445; GO:0045944; GO:0060070; GO:1990907 beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713] LQEEYYEEKRR 0.99599 -9.7183 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A2RRP1 NBAS_HUMAN NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein) (Neuroblastoma-amplified sequence) NBAS NAG Homo sapiens (Human) "negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020] "cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; SNARE binding [GO:0000149]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]" GO:0000149; GO:0000956; GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0015031; GO:0016020; GO:0070939; GO:2000623 SNARE binding [GO:0000149] CQVPKDPK 0.996 -9.7444 0 10.7879 0 0 0 0 11.241 11.9596 0 0 0 13.5965 0 13.475 0 0 0 0 0 0 0 13.0088 0 0 0 0 0 0 0 0 0 0 12.7561 0 13.5545 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8077 0 0 0 0 0 0 0 0 0 13.0879 12.0922 0 0 0 15.121 0 0 0 0 0 0 13.6078 0 0 0 0 0 13.7213 0 0 0 12.1261 11.9862 0 0 0 14.0491 0 0 0 12.7591 0 14.9104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2202 0 9.60093 12.9396 0 0 0 0 0 11.2003 0 12.898 12.591 0 0 0 0 0 0 0 15.1016 15.6092 0 9.86508 0 0 0 11.7761 0 0 0 0 0 0 0 0 13.4479 0 0 0 0 0 0 0 0 0 14.0755 0 0 0 0 0 O00507 USP9Y_HUMAN "Probable ubiquitin carboxyl-terminal hydrolase FAF-Y, EC 3.4.19.12 (Deubiquitinating enzyme FAF-Y) (Fat facets protein-related, Y-linked) (Ubiquitin thioesterase FAF-Y) (Ubiquitin-specific protease 9, Y chromosome) (Ubiquitin-specific-processing protease FAF-Y)" USP9Y DFFRY Homo sapiens (Human) BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; protein deubiquitination [GO:0016579]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; BMP signaling pathway [GO:0030509]; cell migration [GO:0016477]; protein deubiquitination [GO:0016579]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0007179; GO:0007283; GO:0008234; GO:0016477; GO:0016579; GO:0030509; GO:0070410 co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234] AFRGKHLSLIVR 0.996 -35.163 0 12.4936 11.6812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5647 0 14.1392 0 13.3295 12.0277 13.2751 0 10.4552 0 0 0 12.0251 0 0 11.3579 12.4829 0 0 0 0 0 0 0 0 0 0 0 0 11.8391 0 0 0 0 0 0 0 0 10.6791 0 0 0 0 0 0 0 10.7943 0 0 0 20.2876 0 0 0 0 0 0 13.0717 15.5765 0 12.1906 12.3811 12.7553 13.1753 14.2043 14.0496 0 12.1006 0 12.4343 18.7018 0 10.6 13.4342 0 14.2286 0 18.682 13.0125 0 17.0068 0 0 14.0887 0 0 0 0 0 13.115 15.878 0 15.1566 12.9014 15.054 0 0 0 14.324 0 0 13.7082 0 16.7217 0 0 0 11.7102 0 13.6818 16.2536 16.2458 0 0 16.3323 0 0 12.7632 16.3542 0 0 15.1027 15.1949 13.0972 10.9476 11.1778 11.8692 13.7234 0 0 14.3075 13.4079 12.7461 12.987 0 0 15.0911 0 14.879 16.2291 0 0 0 0 0 13.4362 0 0 0 0 0 0 0 0 0 13.8543 0 0 0 0 0 10.5257 11.8883 O14512 SOCS7_HUMAN "Suppressor of cytokine signaling 7, SOCS-7 (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4, NAP-4)" SOCS7 NAP4 SOCS6 Homo sapiens (Human) intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008] GO:0005634; GO:0005829; GO:0005886; GO:0005942; GO:0009968; GO:0016567; GO:0017124; GO:0035556; GO:0040008; GO:0046854; GO:0046935 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; SH3 domain binding [GO:0017124] GEQQQQQQQQPPPPPPPPGPLR 0.996 -11.849 0 0 0 0 0 0 0 12.2149 0 0 12.1157 11.6899 0 12.6778 13.9243 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7196 14.6251 12.0047 13.8353 14.0492 14.3163 14.1913 10.443 14.2177 0 0 0 0 0 0 0 0 0 9.95485 0 0 0 0 0 0 13.2201 14.5943 14.6159 12.9553 13.4857 0 0 13.1041 12.2831 12.3533 0 0 0 0 0 0 0 0 0 0 14.1265 0 0 0 0 0 0 0 14.1466 0 0 13.8144 13.4905 0 0 0 13.5566 0 0 12.3993 0 0 0 0 0 0 0 0 0 12.0152 0 0 0 0 0 0 0 0 0 12.5013 0 0 12.5845 0 0 0 13.9557 0 0 0 12.1947 0 0 0 0 11.4398 0 10.3042 0 0 14.5602 0 0 13.9269 0 0 13.5041 14.454 0 0 14.321 0 0 13.7818 15.8261 14.3849 0 0 0 0 0 0 12.3426 11.3162 0 11.5637 13.3125 0 12.1513 13.2111 0 0 12.6612 0 0 0 0 0 0 0 0 0 0 0 15.425 O15553 MEFV_HUMAN Pyrin (Marenostrin) MEFV MEF TRIM20 Homo sapiens (Human) inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; protein ubiquitination [GO:0016567]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; regulation of gene expression [GO:0010468]; regulation of interleukin-1 beta production [GO:0032651]; response to interferon-gamma [GO:0034341] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726] autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; inflammasome complex [GO:0061702]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of macrophage inflammatory protein 1 alpha production [GO:0071641]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of autophagy [GO:0010508]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of interleukin-1 beta production [GO:0032731]; protein ubiquitination [GO:0016567]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; regulation of gene expression [GO:0010468]; regulation of interleukin-1 beta production [GO:0032651]; response to interferon-gamma [GO:0034341] GO:0001726; GO:0002221; GO:0003779; GO:0005634; GO:0005654; GO:0005737; GO:0005776; GO:0005829; GO:0005874; GO:0005875; GO:0006954; GO:0008270; GO:0010468; GO:0010508; GO:0016567; GO:0030027; GO:0031410; GO:0032651; GO:0032691; GO:0032695; GO:0032731; GO:0034341; GO:0042802; GO:0045087; GO:0050728; GO:0061630; GO:0061702; GO:0070269; GO:0071641; GO:1900016; GO:1900226; GO:1904270; GO:2001056 actin binding [GO:0003779]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] ARPTPDGGASADLK 0.996 -12.434 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3662 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9919 0 0 0 0 0 14.1212 0 12.8271 10.8446 12.3752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5476 0 0 0 0 0 11.9496 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4156 0 13.1984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8512 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5242 0 0 0 0 0 0 0 0 P14410 SUIS_HUMAN "Sucrase-isomaltase, intestinal [Cleaved into: Sucrase, EC 3.2.1.48; Isomaltase, EC 3.2.1.10 ]" SI Homo sapiens (Human) polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] "apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]; polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987]" GO:0004553; GO:0004558; GO:0004574; GO:0004575; GO:0005794; GO:0005886; GO:0005903; GO:0005987; GO:0016021; GO:0016324; GO:0030246; GO:0044245; GO:0070062 "alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]" AHVAFPDFFR 0.996 -12.479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2075 11.2708 0 0 0 0 0 11.8564 0 13.9508 0 0 0 0 0 11.907 12.1275 0 0 0 0 0 0 0 11.373 0 0 0 0 0 0 0 0 0 11.2834 11.6855 0 0 0 0 12.3085 11.9533 11.962 12.2802 13.3537 12.4217 12.6551 12.0458 0 11.7175 0 11.1685 0 12.4019 0 0 0 0 14.9043 0 12.0327 13.1398 15.0866 14.5275 0 12.7425 0 0 14.4697 14.4316 13.192 0 0 13.6376 14.6752 14.6573 0 13.328 13.0675 13.8166 14.1101 17.3208 13.7091 15.1183 13.8996 14.6629 12.8168 0 0 0 0 0 13.4951 13.1768 13.8098 0 13.8291 0 13.5366 15.062 14.0001 0 15.2721 14.3517 0 11.9697 11.3365 14.3099 14.618 0 13.5596 13.9741 13.6925 0 14.2804 14.1988 0 0 0 14.6102 13.1418 14.0045 14.061 16.0734 15.3272 0 12.0823 13.3502 12.4707 0 0 12.2321 0 0 0 0 0 14.2765 0 14.8638 0 0 11.634 0 0 0 0 0 0 11.8731 11.9572 13.3655 0 0 0 0 13.1425 0 0 0 0 0 0 0 P22059 OSBP1_HUMAN Oxysterol-binding protein 1 OSBP OSBP1 Homo sapiens (Human) bile acid biosynthetic process [GO:0006699]; ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802] cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918] GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006686; GO:0006699; GO:0008142; GO:0015248; GO:0015914; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0035627; GO:0035774; GO:0042531; GO:0043231; GO:0048471; GO:0070273; GO:0097038; GO:0120015; GO:1904411 oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015]; sterol transporter activity [GO:0015248] ALWFERKK 0.996 -35.049 10.9913 0 10.7309 14.2301 0 0 0 0 0 0 0 0 0 0 0 13.0837 0 0 14.261 0 0 0 0 0 0 0 0 11.3122 12.7176 0 0 0 0 11.7237 0 0 12.7489 0 0 0 0 0 0 0 0 0 10.1722 13.111 0 11.6619 0 0 0 0 0 0 10.0614 0 0 0 0 0 0 0 0 0 0 0 12.2134 0 0 0 0 0 0 10.2388 13.7464 12.8305 0 0 13.3635 0 12.7112 0 0 0 0 0 13.8271 13.0392 12.4002 0 0 0 0 0 0 0 0 0 0 0 14.0824 0 14.1846 0 0 0 0 0 0 0 9.85554 0 0 13.7295 13.1582 0 0 12.3872 0 0 0 0 0 0 11.856 0 0 0 0 0 0 0 0 12.2598 13.169 0 0 0 0 0 0 11.6106 13.0337 0 0 0 10.0436 0 0 0 0 0 12.5662 0 12.1474 0 0 13.5914 0 0 0 0 0 13.1713 12.1459 0 0 0 0 12.3987 11.8121 14.8231 0 10.2875 0 0 0 0 P61129 ZC3H6_HUMAN Zinc finger CCCH domain-containing protein 6 ZC3H6 KIAA2035 ZC3HDC6 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0000785; GO:0003723; GO:0005634; GO:0045892; GO:0046872 metal ion binding [GO:0046872]; RNA binding [GO:0003723] FDHDAELEKR 0.996 -12.427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8668 11.8598 0 11.1781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0419 13.8912 0 0 0 0 0 10.9483 0 0 0 14.8496 0 0 11.6716 0 0 0 0 0 0 15.4678 0 0 0 0 0 0 0 0 0 0 0 0 11.046 0 0 0 0 0 0 0 0 0 0 15.7549 13.4551 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6194 0 0 0 0 0 0 0 0 0 10.6303 0 13.2913 13.816 0 0 0 0 0 0 0 0 0 11.0898 10.5311 0 0 13.2108 0 0 0 14.434 0 11.3489 0 0 0 0 0 9.84991 0 13.2357 0 Q14191 WRN_HUMAN "Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease, EC 3.1.-.-; ATP-dependent helicase, EC 3.6.4.12 ]" WRN RECQ3 RECQL2 Homo sapiens (Human) aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820] "centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]" "centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; aging [GO:0007568]; base-excision repair [GO:0006284]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; multicellular organism aging [GO:0010259]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of apoptotic process [GO:0042981]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820]" GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0003682; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006268; GO:0006281; GO:0006284; GO:0006302; GO:0006310; GO:0006974; GO:0006979; GO:0007420; GO:0007568; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0010259; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032405; GO:0032508; GO:0040009; GO:0042803; GO:0042981; GO:0043005; GO:0043138; GO:0044806; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773 3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403] AAMLAPLLEVIK 0.996 -35.144 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0039 0 12.6776 0 0 0 0 14.5332 10.6797 13.0729 13.7449 0 0 13.8576 0 0 10.4502 0 0 0 0 0 14.5841 14.3769 13.3439 14.187 13.4726 12.8828 13.4724 0 0 13.1373 15.2899 14.7263 0 14.2912 15.1668 15.2249 0 13.7992 13.7734 15.1989 13.1867 0 0 13.9197 11.9823 13.4039 0 16.001 0 0 11.6244 13.6533 13.8523 0 0 14.1611 0 0 14.0819 0 14.263 13.3957 0 0 12.6592 13.372 0 12.5961 14.5508 0 12.9622 0 13.3188 0 0 13.4037 0 13.7013 0 0 0 0 0 0 13.7416 14.9379 14.8257 0 0 0 0 0 0 0 0 0 0 0 0 10.8962 0 0 14.9124 14.2326 12.194 0 0 0 0 0 0 Q14CX5 MF13A_HUMAN Transmembrane protein 180 (Major facilitator superfamily domain-containing 13A) MFSD13A C10orf77 TMEM180 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 AQRQNLSQAQTLDVKMV 0.996 -10.28 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15147 PLCB4_HUMAN "1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4, EC 3.1.4.11 (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4, PLC-beta-4)" PLCB4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] cytosol [GO:0005829] cytosol [GO:0005829]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol-mediated signaling [GO:0048015] GO:0004435; GO:0004629; GO:0005509; GO:0005829; GO:0007186; GO:0016042; GO:0048015 calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629] AMQIIEMYEPDEDLKK 0.996 -11.85 0 0 0 0 0 0 0 0 11.7625 0 13.0454 0 14.5503 0 14.1127 0 0 0 13.6915 0 16.2993 0 16.7032 0 0 0 0 0 0 0 0 12.7508 12.5511 0 0 0 0 0 0 0 14.8129 10.6109 0 14.383 0 0 0 0 0 0 13.7837 0 0 0 0 10.4697 0 0 0 0 0 0 0 0 0 0 13.07 12.9005 14.412 13.8164 13.3918 13.4001 0 0 17.9181 0 0 15.1472 0 0 0 15.4888 0 0 14.5963 14.5709 13.6543 14.1075 0 0 15.5954 0 0 0 0 0 0 0 0 0 13.7891 0 0 0 0 0 0 0 0 13.6251 0 0 0 0 0 0 0 14.8564 14.6481 19.1789 0 17.4668 0 0 0 0 0 0 0 13.0934 13.4375 19.0519 17.2864 0 0 13.0109 14.4284 13.0907 19.2403 12.812 0 0 0 0 18.7142 0 0 12.9969 12.4603 0 12.9848 0 0 15.6767 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9202 0 0 0 0 0 13.6213 0 0 0 0 0 13.9458 Q4VX76 SYTL3_HUMAN Synaptotagmin-like protein 3 (Exophilin-6) SYTL3 SLP3 Homo sapiens (Human) exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886] exocytic vesicle [GO:0070382]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886] GO:0005544; GO:0005886; GO:0006886; GO:0006887; GO:0019897; GO:0031267; GO:0042043; GO:0070382 calcium-dependent phospholipid binding [GO:0005544]; neurexin family protein binding [GO:0042043]; small GTPase binding [GO:0031267] GCSHRVCAQCR 0.996 -35.122 11.1861 0 9.61666 0 0 0 0 0 0 13.1789 9.85587 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.58474 0 0 10.1782 13.1537 0 12.6407 0 0 0 0 0 0 9.59695 0 0 0 0 0 12.9842 11.1134 0 0 0 14.3693 0 0 0 0 0 0 10.7154 0 11.9129 14.3994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5409 0 0 15.7951 0 0 15.913 0 0 12.9014 0 0 0 0 0 0 13.5298 14.0378 13.2877 0 0 0 0 0 0 16.2328 0 14.0369 14.8504 12.2474 14.1812 0 12.3851 13.3224 0 12.8363 0 0 0 0 0 0 0 10.691 15.1692 0 0 0 0 0 0 0 0 11.3657 0 0 0 0 0 0 0 13.6504 0 13.182 0 0 0 11.8019 0 Q6P4F7 RHGBA_HUMAN Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A) ARHGAP11A KIAA0013 Homo sapiens (Human) positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165] GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056 GTPase activator activity [GO:0005096] AFYGIKVK 0.996 -12.455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9734 0 0 0 13.8299 0 10.5901 0 13.1752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z2K8 GRIN1_HUMAN "G protein-regulated inducer of neurite outgrowth 1, GRIN1" GPRIN1 KIAA1893 Homo sapiens (Human) neuron projection development [GO:0031175] growth cone [GO:0030426]; plasma membrane [GO:0005886] growth cone [GO:0030426]; plasma membrane [GO:0005886]; phosphoprotein binding [GO:0051219]; neuron projection development [GO:0031175] GO:0005886; GO:0030426; GO:0031175; GO:0051219 phosphoprotein binding [GO:0051219] ASGKAQPQSGGK 0.996 -34.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6432 0 0 0 0 0 0 16.0111 15.5752 0 14.3997 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4841 0 0 0 0 0 0 0 0 12.477 0 11.1233 0 0 0 0 0 0 0 0 0 0 0 0 12.5292 0 0 0 0 14.2945 0 0 0 0 10.838 0 12.0954 0 0 0 14.7498 0 13.5854 13.5247 13.2127 12.5111 0 0 12.6528 0 0 0 0 0 0 0 0 0 0 14.5517 0 16.1156 0 0 0 0 0 0 0 0 0 0 0 12.2173 0 0 12.705 0 0 0 0 0 0 0 0 0 10.2987 0 12.7153 11.5805 13.5468 0 0 13.5564 0 0 0 0 0 0 12.8937 0 0 0 0 0 0 0 0 0 0 13.8097 0 16.601 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8948 12.6735 13.3105 0 0 0 0 0 11.5307 15.5608 Q8N8V2 GBP7_HUMAN "Guanylate-binding protein 7, EC 3.6.5.- (GTP-binding protein 7, GBP-7) (Guanine nucleotide-binding protein 7) (Guanylate-binding protein 4-like)" GBP7 GBP4L Homo sapiens (Human) cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; negative regulation of cytokine production [GO:0001818]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type I interferon production [GO:0032480]; negative regulation of type III interferon production [GO:0034345]; positive regulation of viral genome replication [GO:0045070]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122] cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020] cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; negative regulation of cytokine production [GO:0001818]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of type I interferon production [GO:0032480]; negative regulation of type III interferon production [GO:0034345]; positive regulation of viral genome replication [GO:0045070]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122] GO:0001818; GO:0003924; GO:0005525; GO:0016020; GO:0031410; GO:0032480; GO:0034345; GO:0042832; GO:0043122; GO:0045070; GO:0046426; GO:0050830; GO:0051607; GO:0071346 GTP binding [GO:0005525]; GTPase activity [GO:0003924] EDQLDSNFQMQSENFCSYIFTHAK 0.996 -34.803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.691 0 0 0 12.0981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2007 0 0 11.2218 0 0 0 13.4638 13.7224 0 0 0 13.6793 0 0 0 0 0 0 0 13.6367 12.4331 0 0 0 12.8027 0 0 0 14.4769 0 0 0 12.7905 12.9781 14.2466 0 0 0 0 14.5161 0 0 0 0 0 14.9882 14.5222 0 0 0 0 14.5163 0 0 0 14.0851 0 0 12.7828 0 13.7637 0 0 0 0 13.2879 13.3236 0 14.4035 13.9525 0 13.6013 12.7098 0 12.9646 13.9832 14.5103 10.4354 0 0 0 0 14.1511 13.4666 13.5198 0 13.2544 0 0 13.1809 0 0 14.6849 0 14.7641 13.2842 0 0 0 0 0 0 0 12.2245 0 0 10.9645 0 0 0 12.8527 0 13.798 0 0 0 0 0 0 Q8ND07 BBOF1_HUMAN Basal body-orientation factor 1 (Coiled-coil domain-containing protein 176) BBOF1 C14orf45 CCDC176 Homo sapiens (Human) motile cilium assembly [GO:0044458] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium assembly [GO:0044458] GO:0005737; GO:0036064; GO:0044458 EFGDESK 0.996 -35.007 0 0 0 0 0 0 0 0 0 16.2831 16.138 16.0763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5381 0 0 0 0 0 16.0142 0 0 10.7912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6508 0 13.6598 0 14.1924 17.3596 0 14.9289 14.7477 14.4729 0 0 0 0 14.7051 0 0 0 0 0 14.3415 0 0 0 0 0 15.8062 0 13.3072 13.1153 12.6707 13.5853 11.9268 14.0029 0 0 0 12.9335 0 0 0 0 0 13.4964 0 14.0219 14.0715 0 12.8259 0 14.1169 14.7965 0 12.6741 12.2174 0 12.4728 0 0 0 13.7671 0 14.3946 13.2782 0 11.0376 13.1235 0 0 0 0 0 0 0 0 0 0 13.7101 0 0 0 0 0 18.15 0 18.0575 0 14.2238 13.995 0 0 0 0 17.9418 0 0 0 13.4751 0 0 0 0 0 Q8TEQ0 SNX29_HUMAN Sorting nexin-29 (RUN domain-containing protein 2A) SNX29 RUNDC2A Homo sapiens (Human) phosphatidylinositol binding [GO:0035091] GO:0035091 phosphatidylinositol binding [GO:0035091] AASRFPK 0.996 -34.92 0 0 0 0 0 0 0 11.9087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6091 0 0 0 0 0 12.0715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0437 0 0 11.9806 0 0 13.6944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8004 0 0 0 0 0 0 13.3468 0 12.8696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BV79 MECR_HUMAN "Enoyl-[acyl-carrier-protein] reductase, mitochondrial, EC 1.3.1.104 (2-enoyl thioester reductase) (Nuclear receptor-binding factor 1, HsNrbf-1, NRBF-1)" MECR NBRF1 CGI-63 Homo sapiens (Human) fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631] GO:0005634; GO:0005739; GO:0005759; GO:0006631; GO:0006633; GO:0019166 trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166] GFWLSQWK 0.996 -12.429 0 0 0 0 0 0 0 0 0 0 0 0 11.4287 0 12.6077 12.3706 12.2658 0 13.2607 0 13.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3939 0 0 12.0531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4146 12.2491 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0863 0 0 0 0 0 0 0 15.5412 12.8071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7419 0 12.6517 13.0836 0 0 0 0 12.2014 13.9361 12.6879 0 0 0 0 0 0 11.3486 0 0 0 0 0 0 0 0 0 0 0 13.3641 0 13.8179 0 0 0 0 0 0 12.1807 0 0 0 0 0 0 0 Q9BXM0 PRAX_HUMAN Periaxin PRX KIAA1620 Homo sapiens (Human) axon ensheathment [GO:0008366]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of RNA splicing [GO:0043484] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; axon ensheathment [GO:0008366]; peripheral nervous system myelin maintenance [GO:0032287]; regulation of RNA splicing [GO:0043484] GO:0005634; GO:0005737; GO:0005886; GO:0008366; GO:0032287; GO:0043484; GO:0070161 EAEVQGDRASPGEK 0.996 -35.063 0 12.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7976 0 12.9481 0 0 0 0 0 13.0634 12.1228 13.0144 13.1672 0 0 0 0 0 0 0 0 0 11.2595 0 0 0 0 15.9871 0 0 0 0 0 0 0 0 12.6125 0 0 0 0 14.5419 12.9163 12.2586 0 13.8634 0 11.0336 12.472 0 13.1419 13.392 0 12.6539 0 0 12.4671 0 14.8857 0 0 0 12.8098 0 0 14.278 0 0 0 0 0 0 0 14.3536 14.3827 16.9106 0 0 15.3657 0 0 0 0 11.827 0 0 14.2681 14.7495 12.7084 13.7181 0 0 0 0 0 0 13.0017 0 0 0 0 0 0 0 0 0 0 11.8325 14.1679 15.0478 0 0 0 14.2712 13.8187 Q9BXU0 TEX12_HUMAN Testis-expressed protein 12 TEX12 Homo sapiens (Human) meiotic DNA repair synthesis [GO:0000711]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694] central element [GO:0000801]; chromosome [GO:0005694]; meiotic DNA repair synthesis [GO:0000711]; synaptonemal complex assembly [GO:0007130] GO:0000711; GO:0000801; GO:0005694; GO:0007130 MANHLVKPDNR 0.996 -9.7374 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2486 0 0 0 13.0861 0 0 0 13.3514 0 0 0 13.3738 0 0 13.3396 12.9915 12.938 13.1943 0 0 0 0 0 0 12.4201 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2071 Q9H920 RN121_HUMAN RING finger protein 121 RNF121 Homo sapiens (Human) ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-dependent ERAD pathway [GO:0030433] GO:0000139; GO:0005789; GO:0016021; GO:0030433; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630] FLVIWILFSAVTAFVTFRATRK 0.996 -12.424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8776 0 14.2952 0 0 0 0 0 0 0 14.8705 0 0 0 0 0 13.6481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4874 0 0 0 0 0 0 0 14.6452 0 0 0 0 14.5923 0 13.8202 15.2064 0 0 14.4594 0 0 0 0 14.7693 0 0 14.8639 0 0 0 0 0 11.8281 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1587 0 0 0 12.1735 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NP79 VTA1_HUMAN "Vacuolar protein sorting-associated protein VTA1 homolog (Dopamine-responsive gene 1 protein, DRG-1) (LYST-interacting protein 5, LIP5) (SKD1-binding protein 1, SBP1)" VTA1 C6orf55 HSPC228 My012 Homo sapiens (Human) ESCRT III complex disassembly [GO:1904903]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]; viral budding [GO:0046755] cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; protein C-terminus binding [GO:0008022]; ESCRT III complex disassembly [GO:1904903]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031]; viral budding [GO:0046755] GO:0005654; GO:0005771; GO:0005829; GO:0008022; GO:0010008; GO:0015031; GO:0016236; GO:0032511; GO:0036258; GO:0043231; GO:0046755; GO:0070062; GO:0071985; GO:1904903 protein C-terminus binding [GO:0008022] LLTTGRE 0.996 -9.7401 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6092 13.715 0 13.6767 0 13.8546 0 13.1459 0 0 0 0 15.2021 0 0 0 0 0 12.8524 0 0 0 0 0 0 13.6477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7803 13.0145 0 0 15.2712 0 13.4781 14.3474 0 0 14.1056 13.7644 0 0 0 0 0 0 15.4184 0 0 13.4218 0 0 0 0 12.7758 0 14.312 0 0 0 0 13.9236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5323 13.6179 0 0 0 0 0 0 0 Q9NUY8 TBC23_HUMAN TBC1 domain family member 23 (HCV non-structural protein 4A-transactivated protein 1) TBC1D23 NS4ATP1 Homo sapiens (Human) "brain development [GO:0007420]; embryonic brain development [GO:1990403]; neuron projection development [GO:0031175]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle tethering to Golgi [GO:0099041]; vesicle-mediated transport [GO:0016192]" cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802] "cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; trans-Golgi network [GO:0005802]; brain development [GO:0007420]; embryonic brain development [GO:1990403]; neuron projection development [GO:0031175]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle tethering to Golgi [GO:0099041]; vesicle-mediated transport [GO:0016192]" GO:0005794; GO:0005802; GO:0005829; GO:0007420; GO:0016192; GO:0031175; GO:0031410; GO:0042147; GO:0099041; GO:1990403 AIKQQIMK 0.996 -11.848 0 0 0 0 0 0 0 0 0 12.4627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4921 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9199 0 12.355 0 0 0 0 0 0 0 12.534 0 0 0 0 0 0 0 0 0 0 12.726 0 0 0 12.4639 P22304 IDS_HUMAN "Iduronate 2-sulfatase, EC 3.1.6.13 (Alpha-L-iduronate sulfate sulfatase, Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain ]" IDS SIDS Homo sapiens (Human) glycosaminoglycan catabolic process [GO:0006027] cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764] cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484]; glycosaminoglycan catabolic process [GO:0006027] GO:0004423; GO:0005509; GO:0005737; GO:0005764; GO:0006027; GO:0008484; GO:0043202 calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423]; sulfuric ester hydrolase activity [GO:0008484] NLLKHFR 0.99601 -9.7949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.334 0 0 0 0 0 0 0 0 0 0 13.2233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8815 0 0 0 0 0 0 0 0 12.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8429 0 0 0 0 0 0 0 0 0 0 12.3908 0 0 0 0 0 0 0 0 0 0 0 Q8N8Y2 VA0D2_HUMAN "V-type proton ATPase subunit d 2, V-ATPase subunit d 2 (Vacuolar proton pump subunit d 2)" ATP6V0D2 Homo sapiens (Human) regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034] "apical plasma membrane [GO:0016324]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]" "apical plasma membrane [GO:0016324]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034]" GO:0005765; GO:0005769; GO:0007034; GO:0007035; GO:0010008; GO:0016020; GO:0016241; GO:0016324; GO:0016471; GO:0030670; GO:0033179; GO:0033181; GO:0046961; GO:0070062 "proton-transporting ATPase activity, rotational mechanism [GO:0046961]" ETLYPTFGK 0.99601 -9.8138 0 0 0 0 0 0 0 0 0 0 0 0 11.7993 0 10.7266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0576 11.703 0 0 0 0 0 12.963 0 0 0 0 0 14.2812 13.7541 0 15.397 0 14.9493 0 0 0 0 0 0 0 12.1466 13.1856 0 0 0 0 0 0 0 0 0 0 0 12.9641 12.5447 0 0 12.4308 0 0 0 0 12.9664 0 0 12.8415 12.5641 0 11.5717 0 0 0 0 11.6449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7065 0 11.9265 0 Q9ULT6 ZNRF3_HUMAN "E3 ubiquitin-protein ligase ZNRF3, EC 2.3.2.27 (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3)" ZNRF3 KIAA1133 RNF203 Homo sapiens (Human) "limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein ubiquitination [GO:0016567]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]" integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] "integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein ubiquitination [GO:0016567]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]" GO:0004842; GO:0005109; GO:0005886; GO:0005887; GO:0006511; GO:0016055; GO:0016567; GO:0038018; GO:0046872; GO:0060173; GO:0061630; GO:0072089; GO:0090090; GO:2000051; GO:2000095 frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] CSRLPPPPPLPLLLGLLLAAAGPGAARAK 0.99601 -9.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3086 0 0 0 0 11.2109 0 0 0 13.3688 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.4425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0702 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.849 0 0 0 0 0 0 0 0 0 0 0 11.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07204 TRBM_HUMAN "Thrombomodulin, TM (Fetomodulin) (CD antigen CD141)" THBD THRM Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; female pregnancy [GO:0007565]; negative regulation of blood coagulation [GO:0030195]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to lipopolysaccharide [GO:0032496]; response to X-ray [GO:0010165]; zymogen activation [GO:0031638]" apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; vacuolar membrane [GO:0005774] "apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; serine-type endopeptidase complex [GO:1905370]; vacuolar membrane [GO:0005774]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; blood coagulation [GO:0007596]; blood coagulation, common pathway [GO:0072377]; female pregnancy [GO:0007565]; negative regulation of blood coagulation [GO:0030195]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to lipopolysaccharide [GO:0032496]; response to X-ray [GO:0010165]; zymogen activation [GO:0031638]" GO:0004888; GO:0005509; GO:0005615; GO:0005774; GO:0005886; GO:0005887; GO:0006508; GO:0007565; GO:0007596; GO:0009897; GO:0009986; GO:0010165; GO:0010544; GO:0016020; GO:0016327; GO:0030195; GO:0031638; GO:0032496; GO:0038023; GO:0051591; GO:0051918; GO:0072377; GO:1905370 calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888] EVVLQHVR 0.99602 -12.068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4119 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7823 0 0 0 0 14.8949 0 14.0785 0 0 13.3109 0 0 0 0 0 0 0 0 13.2053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2251 0 0 15.2393 0 14.0487 0 P40222 TXLNA_HUMAN Alpha-taxilin TXLNA TXLN Homo sapiens (Human) B cell activation [GO:0042113]; exocytosis [GO:0006887] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887] GO:0005576; GO:0005737; GO:0005829; GO:0006887; GO:0016020; GO:0019905; GO:0042113 syntaxin binding [GO:0019905] ALQTERNDLNK 0.99602 -9.8833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4607 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0922 0 0 0 0 0 0 0 0 0 16.8911 0 0 0 11.9399 0 0 0 15.0326 0 15.576 16.825 19.2408 16.7751 0 0 18.7069 0 0 0 0 0 12.3298 0 16.8984 17.5075 0 0 0 18.5151 17.5612 18.2966 18.3572 18.8649 18.0802 18.8204 0 18.3526 0 0 0 0 18.1859 0 18.781 0 0 0 0 0 0 0 0 0 0 18.3403 0 0 0 0 17.6259 0 0 0 0 0 0 0 0 0 0 15.9569 0 0 0 17.2209 0 0 0 0 0 0 0 0 0 0 0 0 12.9076 0 0 0 19.6588 19.4731 0 0 0 0 0 0 0 P46777 RL5_HUMAN 60S ribosomal protein L5 (Large ribosomal subunit protein uL18) RPL5 MSTP030 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of translation [GO:0045727]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625]; cytoplasmic translation [GO:0002181]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of translation [GO:0045727]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412] GO:0000027; GO:0002181; GO:0003723; GO:0003730; GO:0003735; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005829; GO:0005925; GO:0006364; GO:0006412; GO:0008097; GO:0010628; GO:0016020; GO:0022625; GO:0022626; GO:0031625; GO:0032991; GO:0042273; GO:0045202; GO:0045727; GO:0048027; GO:0050821; GO:0070062; GO:1901796; GO:1904667; GO:1990904; GO:1990948; GO:2000059; GO:2000435 5S rRNA binding [GO:0008097]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625] GFVKVVKNK 0.99602 -33.087 0 0 0 0 0 0 0 0 0 13.5522 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6281 0 0 0 0 0 11.5546 0 0 13.076 0 11.1077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.109 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9213 0 0 0 0 0 0 0 0 12.6555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56524 HDAC4_HUMAN "Histone deacetylase 4, HD4, EC 3.5.1.98" HDAC4 KIAA0288 Homo sapiens (Human) "B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]" GO:0000118; GO:0000122; GO:0000978; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006476; GO:0006954; GO:0007399; GO:0008270; GO:0008284; GO:0010832; GO:0014894; GO:0014898; GO:0016575; GO:0016607; GO:0017053; GO:0019789; GO:0030183; GO:0030955; GO:0033235; GO:0033558; GO:0034983; GO:0040029; GO:0042113; GO:0042802; GO:0042826; GO:0043393; GO:0043433; GO:0045820; GO:0045892; GO:0045893; GO:0045944; GO:0051091; GO:0061629; GO:0070555; GO:0070932; GO:0070933; GO:0140297 DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; potassium ion binding [GO:0030955]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270] DGPVVTALK 0.99602 -12.061 0 0 0 13.3884 0 13.1194 0 0 12.4484 13.6528 13.0498 13.7797 0 13.2025 12.945 0 0 0 0 10.462 0 0 0 0 0 0 0 0 0 12.758 14.6409 12.6528 12.8576 16.9231 12.4542 12.9218 0 0 0 0 0 12.8841 12.9541 12.7652 0 12.587 0 0 0 0 0 0 0 0 0 0 11.9714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3542 0 0 14.4948 0 0 12.6618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4564 0 13.4059 0 12.1212 13.0876 13.4316 0 0 12.967 13.4297 0 0 0 0 0 0 0 0 0 0 0 14.2425 14.5285 14.3144 0 14.3816 0 14.5272 0 0 14.7289 0 0 0 0 13.3708 0 13.2404 0 0 0 14.6074 0 0 Q86WJ1 CHD1L_HUMAN "Chromodomain-helicase-DNA-binding protein 1-like, EC 3.6.4.12 (Amplified in liver cancer protein 1)" CHD1L ALC1 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281] GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006338; GO:0006974; GO:0016887; GO:0140658 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; nucleotide binding [GO:0000166] AEAARVQEQDLR 0.99602 -9.5598 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5497 0 13.0148 0 0 0 0 0 0 0 0 12.6194 0 14.0543 0 0 0 0 0 0 0 0 0 0 10.2985 0 0 0 0 0 0 0 10.344 0 0 0 0 0 0 0 0 0 14.0005 0 0 0 0 0 11.6622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7712 0 0 0 0 0 0 0 0 0 0 Q8IXZ3 SP8_HUMAN Transcription factor Sp8 (Specificity protein 8) SP8 Homo sapiens (Human) dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; dorsal/ventral pattern formation [GO:0009953]; embryonic limb morphogenesis [GO:0030326]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009953; GO:0009954; GO:0030326; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" ATCDCPNCQEAER 0.99602 -9.5373 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5307 0 0 0 12.5608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2331 0 0 0 12.8125 13.3052 0 0 0 0 0 0 0 15.3466 0 0 0 0 0 0 0 0 0 0 0 0 0 14.067 0 0 0 0 11.0004 0 14.8294 0 0 0 0 0 0 0 0 13.9217 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4P3 MESH1_HUMAN "Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1, EC 3.1.7.2 (HD domain-containing protein 3) (Metazoan SpoT homolog 1, MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase, (ppGpp)ase)" HDDC3 MESH1 Homo sapiens (Human) "guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]" GO:0008893; GO:0046872 "guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]" HLFKQRGLTI 0.99602 -12.062 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.9279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.275 0 Q8N9R6 CDRT4_HUMAN CMT1A duplicated region transcript 4 protein CDRT4 Homo sapiens (Human) PMMRMLPTVR 0.99602 -9.8836 0 0 0 13.3512 0 0 0 13.075 0 13.0473 12.5402 12.1774 14.5645 11.9092 12.6927 13.9116 15.6528 14.4829 13.1702 12.9631 19.6839 0 16.6317 0 12.4224 19.7467 17.7414 13.1551 0 12.9226 12.0341 0 14.0749 12.3295 12.9363 12.9522 13.5405 13.314 13.0796 13.1523 13.0013 0 13.727 13.9056 14.7448 19.7998 19.7669 13.2152 13.3365 14.1096 14.0282 0 0 13.1387 12.1693 12.2101 14.0051 0 10.7197 12.0065 10.2864 11.4 0 0 10.1426 0 0 0 0 0 0 0 0 0 12.5252 0 0 0 0 0 0 12.2959 0 0 0 0 0 0 0 0 20.5547 13.2361 13.3072 0 0 0 0 13.4528 0 0 12.6961 0 0 0 0 12.3252 0 0 0 0 0 14.899 0 0 0 0 0 0 0 13.5325 0 0 12.9513 0 0 20.3212 13.0399 0 0 0 0 14.225 0 0 0 0 20.3442 0 0 0 0 0 20.3289 0 20.2836 14.3387 0 13.9159 0 0 0 0 0 0 13.7781 0 14.6237 14.4437 0 14.3392 14.3287 15.9524 14.5681 14.4321 15.0293 14.5342 14.3041 16.0279 14.9942 15.5624 15.4367 20.1515 12.8466 20.1473 0 14.3044 0 13.4853 0 0 Q9C0E8 LNP_HUMAN Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark) LNPK KIAA1715 LNP Homo sapiens (Human) blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; limb development [GO:0060173]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; limb development [GO:0060173]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330] GO:0005654; GO:0005783; GO:0005789; GO:0007029; GO:0007596; GO:0016021; GO:0030176; GO:0032330; GO:0035115; GO:0042733; GO:0042802; GO:0046872; GO:0060173; GO:0071782; GO:0071786; GO:0071788; GO:0098826; GO:1903373 identical protein binding [GO:0042802]; metal ion binding [GO:0046872] LAMTLPFFAFPLIIWSIRTVIIFFFSKR 0.99602 -9.5359 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9217 0 0 0 0 0 0 0 0 0 0 12.3909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NK97 S22AK_HUMAN Solute carrier family 22 member 20 (Organic anion transporter 6) (Solute carrier family 22 member 20 pseudogene) SLC22A20P OAT6 SLC22A20 Homo sapiens (Human) ion transport [GO:0006811] integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; ion transport [GO:0006811] GO:0006811; GO:0016021; GO:0022857 transmembrane transporter activity [GO:0022857] GRTVAGILLGYSFTLGQLILAGVAYLIR 0.99603 -9.9218 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4271 0 0 0 0 0 0 0 0 0 0 12.2971 0 0 12.324 0 0 13.2305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9041 0 0 0 0 0 0 0 0 0 0 12.62 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5022 0 12.8375 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9367 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0181 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31146 COR1A_HUMAN "Coronin-1A (Coronin-like protein A, Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein, TACO)" CORO1A CORO1 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; epithelial cell migration [GO:0010631]; homeostasis of number of cells within a tissue [GO:0048873]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; thymocyte migration [GO:0072679]; uropod organization [GO:0032796]; vesicle fusion [GO:0006906] actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991] actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; membrane [GO:0016020]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cytoskeletal protein binding [GO:0008092]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; calcium ion transport [GO:0006816]; cell migration [GO:0016477]; cell-substrate adhesion [GO:0031589]; cellular response to interleukin-4 [GO:0071353]; early endosome to recycling endosome transport [GO:0061502]; epithelial cell migration [GO:0010631]; homeostasis of number of cells within a tissue [GO:0048873]; innate immune response [GO:0045087]; leukocyte chemotaxis [GO:0030595]; natural killer cell degranulation [GO:0043320]; negative regulation of actin nucleation [GO:0051126]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vesicle fusion [GO:0031339]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; phagocytosis [GO:0006909]; phagolysosome assembly [GO:0001845]; positive chemotaxis [GO:0050918]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; thymocyte migration [GO:0072679]; uropod organization [GO:0032796]; vesicle fusion [GO:0006906] GO:0001772; GO:0001845; GO:0001891; GO:0003723; GO:0003779; GO:0003785; GO:0005737; GO:0005769; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006816; GO:0006906; GO:0006909; GO:0007015; GO:0008022; GO:0008092; GO:0008360; GO:0010631; GO:0016020; GO:0016477; GO:0030027; GO:0030036; GO:0030424; GO:0030595; GO:0030670; GO:0030833; GO:0030864; GO:0031339; GO:0031589; GO:0032036; GO:0032796; GO:0032956; GO:0032991; GO:0038180; GO:0042098; GO:0042102; GO:0042803; GO:0043029; GO:0043320; GO:0043524; GO:0043548; GO:0045087; GO:0045335; GO:0048873; GO:0050918; GO:0051015; GO:0051126; GO:0051279; GO:0051402; GO:0061502; GO:0070062; GO:0071353; GO:0072679; GO:0098978; GO:2000406 actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; cytoskeletal protein binding [GO:0008092]; myosin heavy chain binding [GO:0032036]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723] ADQCYEDVR 0.99603 -9.6061 0 0 0 10.3795 10.4507 0 0 0 0 0 0 0 0 0 9.77698 11.2063 0 0 0 9.641 0 0 0 0 10.8157 0 0 0 0 0 0 0 12.3624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1552 0 0 0 0 10.8495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5418 0 14.7408 0 0 0 12.8113 15.3175 0 0 0 0 0 0 14.7378 0 0 0 0 0 0 0 0 0 14.7166 10.5328 0 0 0 14.8979 0 0 0 0 13.9779 0 0 0 0 0 0 0 0 13.2703 0 0 0 0 0 0 0 0 13.867 0 0 0 11.8609 0 0 0 0 0 0 0 0 0 0 10.8331 12.7641 0 0 0 15.0455 14.3299 13.3778 0 13.8358 0 0 12.8314 13.9172 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5T0U0 CC122_HUMAN Coiled-coil domain-containing protein 122 CCDC122 Homo sapiens (Human) DKIITVKESIIEK 0.99603 -9.8945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3556 0 0 0 0 0 0 0 0 0 13.6342 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7027 0 0 0 0 0 0 0 0 0 0 12.4897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5019 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VUJ6 LRCH2_HUMAN Leucine-rich repeat and calponin homology domain-containing protein 2 LRCH2 KIAA1495 Homo sapiens (Human) EQTSRNDSHIIGSK 0.99603 -9.6025 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9287 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6056 0 0 0 0 0 0 0 0 0 12.7448 0 12.5106 0 0 0 0 0 0 0 0 0 0 0 0 Q96NG5 ZN558_HUMAN Zinc finger protein 558 ZNF558 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DVMLENCR 0.99603 -9.9005 0 0 0 11.7102 0 0 12.0769 0 0 0 0 0 0 0 0 0 0 0 12.7147 0 0 0 0 0 0 0 0 0 0 0 14.3041 0 12.6821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8929 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2712 13.2551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4709 0 13.456 0 0 0 0 0 12.9667 14.265 0 0 12.7166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96Q07 BTBD9_HUMAN BTB/POZ domain-containing protein 9 BTBD9 KIAA1880 Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]" cytoplasm [GO:0005737] "cytoplasm [GO:0005737]; adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]" GO:0005737; GO:0007616; GO:0008344; GO:0042428; GO:0042748; GO:0048512; GO:0050804; GO:0050951; GO:0060586; GO:1900242 HPIDDDCRSGIEIKLGQPSIINHIR 0.99603 -9.5726 0 0 0 0 10.8752 0 0 0 0 0 0 0 12.1289 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4596 0 13.3596 0 11.6935 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5869 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.304 0 0 0 0 0 0 0 0 0 0 12.2449 0 0 11.2443 0 0 0 0 11.898 0 0 0 0 0 12.8313 0 0 13.2144 0 0 11.1727 0 11.676 0 0 0 0 0 14.1212 0 0 0 0 0 13.1706 0 13.6764 0 0 0 0 11.4731 0 0 0 0 0 0 13.1648 0 0 0 0 0 0 12.7532 0 0 0 11.3623 0 0 12.5009 0 0 0 0 0 12.9831 12.122 0 0 0 0 0 0 12.3289 0 0 0 13.4732 11.8242 0 0 0 0 12.083 0 0 0 0 0 0 0 0 0 0 Q9BQQ7 RTP3_HUMAN Receptor-transporting protein 3 (3CxxC-type zinc finger protein 3) (Transmembrane protein 7) RTP3 TMEM7 Z3CXXC3 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; olfactory receptor binding [GO:0031849]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; protein insertion into membrane [GO:0051205]; protein targeting to membrane [GO:0006612] GO:0001580; GO:0005737; GO:0006612; GO:0016021; GO:0031849; GO:0051205 olfactory receptor binding [GO:0031849] CKKCPQPLFEDPEFTQENISR 0.99603 -9.8968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9031 0 0 0 0 0 0 0 0 10.5479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8165 10.3795 13.1446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2564 0 0 0 Q9BT88 SYT11_HUMAN "Synaptotagmin-11 (Synaptotagmin XI, SytXI)" SYT11 KIAA0080 Homo sapiens (Human) autophagy [GO:0006914]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; establishment of vesicle localization [GO:0051650]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of cytokine production [GO:0001818]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of endocytosis [GO:0045806]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of phagocytosis [GO:0050765]; negative regulation of tumor necrosis factor production [GO:0032720]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] anchoring junction [GO:0070161]; axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982] anchoring junction [GO:0070161]; axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early phagosome [GO:0032009]; excitatory synapse [GO:0060076]; exocytic vesicle [GO:0070382]; inhibitory synapse [GO:0060077]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]; beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; calcium ion regulated lysosome exocytosis [GO:1990927]; calcium-ion regulated exocytosis [GO:0017156]; cellular response to calcium ion [GO:0071277]; establishment of vesicle localization [GO:0051650]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of cytokine production [GO:0001818]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of endocytosis [GO:0045806]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of phagocytosis [GO:0050765]; negative regulation of tumor necrosis factor production [GO:0032720]; plasma membrane repair [GO:0001778]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of defense response to bacterium [GO:1900424]; regulation of dopamine secretion [GO:0014059]; regulation of phagosome maturation [GO:1905162]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192] GO:0000149; GO:0001778; GO:0001786; GO:0001818; GO:0001891; GO:0005509; GO:0005544; GO:0005764; GO:0005765; GO:0005802; GO:0005886; GO:0005887; GO:0006906; GO:0006914; GO:0007612; GO:0007613; GO:0008021; GO:0014059; GO:0014069; GO:0016192; GO:0017156; GO:0017158; GO:0030276; GO:0030424; GO:0030425; GO:0030665; GO:0031369; GO:0031625; GO:0031982; GO:0032009; GO:0032715; GO:0032720; GO:0033602; GO:0042802; GO:0043005; GO:0043197; GO:0043204; GO:0045202; GO:0045335; GO:0045806; GO:0046929; GO:0048487; GO:0048787; GO:0050765; GO:0051650; GO:0055037; GO:0055038; GO:0060076; GO:0060077; GO:0070161; GO:0070382; GO:0071277; GO:0098793; GO:1900424; GO:1903979; GO:1905162; GO:1905171; GO:1990927 beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]; translation initiation factor binding [GO:0031369]; ubiquitin protein ligase binding [GO:0031625] EVCESPRKPVAK 0.99603 -9.5725 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2376 0 0 0 0 0 0 0 0 0 0 0 13.4895 13.6169 13.9118 0 0 0 0 0 12.34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.656 0 11.7457 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0I9 LRC27_HUMAN Leucine-rich repeat-containing protein 27 LRRC27 KIAA1674 Homo sapiens (Human) IPSLQQLHLQR 0.99603 -9.903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3417 0 0 0 0 0 0 0 12.6793 12.6648 0 0 12.562 0 0 0 0 0 0 0 0 13.7071 0 0 12.3625 0 0 0 0 0 14.5748 0 0 0 0 14.0724 0 0 0 0 0 0 14.2167 14.6119 13.4255 13.8478 0 11.162 11.367 12.3075 0 0 11.663 12.2806 12.2947 0 0 0 10.5733 0 0 0 13.6503 14.2115 0 0 0 0 0 0 Q9Y240 CLC11_HUMAN C-type lectin domain family 11 member A (C-type lectin superfamily member 3) (Lymphocyte secreted C-type lectin) (Osteolectin) (Stem cell growth factor) (p47) CLEC11A CLECSF3 LSLCL SCGF Homo sapiens (Human) ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615] cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083]; ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284] GO:0001503; GO:0005576; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0030246 carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083] LGHKCFLLSR 0.99603 -9.6027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3368 13.7027 12.791 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HYC2 K2026_HUMAN Uncharacterized protein KIAA2026 KIAA2026 Homo sapiens (Human) GTKPIQALLAKNIGNK 0.99604 -34.867 0 0 0 0 13.8959 0 0 0 0 13.8402 0 0 13.4114 0 0 0 0 0 12.1341 0 12.0148 0 0 10.9703 0 11.8042 0 0 0 0 0 0 11.6833 0 14.3274 14.8708 0 0 14.3575 13.8612 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8704 12.0493 12.0775 0 0 0 0 0 0 0 13.643 0 0 12.3431 15.725 0 14.0168 13.855 14.7719 15.4243 17.933 14.6061 14.0833 13.2583 12.7466 13.9071 0 0 0 0 0 15.1842 15.8524 14.9535 0 15.7089 16.3677 12.9971 15.2271 16.1162 0 0 14.9369 0 14.8379 15.5477 0 0 14.4804 14.6286 16.0733 16.0521 19.9375 15.1442 15.7124 13.4741 11.374 14.9706 14.7051 15.4467 19.6464 15.2516 15.411 14.297 15.2017 0 15.1137 14.2136 19.4847 14.8471 14.8735 13.5788 12.5626 14.9616 12.8504 13.1359 13.5983 13.4822 14.8106 14.9168 12.3885 12.8725 19.1591 19.1572 0 0 14.9804 14.2907 0 14.6755 13.514 12.9779 14.4535 0 13.5946 14.8828 0 19.1269 18.7355 18.5246 0 0 0 0 0 0 0 0 0 12.6731 0 12.4533 0 0 13.8235 14.1533 18.5764 13.4103 15.3642 0 11.3494 13.6297 0 0 O95696 BRD1_HUMAN Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2) BRD1 BRL BRPF2 Homo sapiens (Human) chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902] chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204] chromosome [GO:0005694]; dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; chromatin organization [GO:0006325]; erythrocyte maturation [GO:0043249]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of developmental process [GO:0050793]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902] GO:0005634; GO:0005694; GO:0006325; GO:0006357; GO:0016607; GO:0030425; GO:0035902; GO:0036409; GO:0042393; GO:0043204; GO:0043249; GO:0043966; GO:0044154; GO:0045648; GO:0046872; GO:0050793; GO:0051602; GO:0070776; GO:1903706 histone binding [GO:0042393]; metal ion binding [GO:0046872] ANCYTAFHVTCAQK 0.99604 -34.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7484 0 0 13.1608 0 0 0 0 0 0 0 0 0 14.4862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7984 12.9926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2803 0 0 0 0 0 0 0 0 0 0 12.2011 0 9.68734 0 12.8831 0 0 0 10.0654 0 0 0 0 0 0 0 0 0 0 0 0 11.418 0 0 0 12.2041 0 0 0 12.1327 0 0 0 0 0 0 0 0 0 0 0 0 0 10.743 10.4787 12.5419 0 12.0244 0 0 0 0 0 0 0 0 0 0 12.0051 12.1178 0 0 0 0 12.3234 0 0 0 0 0 0 0 0 0 11.6952 0 0 0 0 0 0 0 11.3409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10163 PRB4_HUMAN "Basic salivary proline-rich protein 4, Salivary proline-rich protein Po (Parotid o protein) (Salivary proline-rich protein II-1) [Cleaved into: Protein N1; Glycosylated protein A; Peptide P-D (Proline-rich peptide IB-5) ]" PRB4 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 PAQGQQPPQ 0.99604 -11.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1186 13.8746 0 0 14.0383 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1792 0 0 12.383 0 0 0 0 0 0 0 12.1695 0 0 0 0 0 0 0 0 0 0 0 13.6933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JXM2 MET24_HUMAN "Probable methyltransferase-like protein 24, EC 2.1.1.-" METTL24 C6orf186 Homo sapiens (Human) methylation [GO:0032259] extracellular region [GO:0005576] extracellular region [GO:0005576]; methyltransferase activity [GO:0008168]; methylation [GO:0032259] GO:0005576; GO:0008168; GO:0032259 methyltransferase activity [GO:0008168] CLLGAVLLFGLR 0.99604 -11.698 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3472 0 0 0 0 0 0 0 0 0 0 12.7635 0 0 0 0 0 0 Q5TZF3 ANR45_HUMAN Ankyrin repeat domain-containing protein 45 ANKRD45 Homo sapiens (Human) cell population proliferation [GO:0008283] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496] cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; cell population proliferation [GO:0008283] GO:0005737; GO:0008283; GO:0030496; GO:0032154; GO:0090543 MTTPCQVK 0.99604 -9.651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.38115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5U5Z8 CBPC2_HUMAN "Cytosolic carboxypeptidase 2, EC 3.4.17.- (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2)" AGBL2 CCP2 Homo sapiens (Human) protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829] centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508] GO:0004181; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0035610; GO:0036064 metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] AVRVDTYEYELTLRTDLYTNK 0.99604 -34.798 0 0 0 0 0 0 0 0 0 13.5171 0 13.655 0 12.7862 13.6562 0 12.5901 0 0 0 0 0 0 0 0 12.9608 13.0592 0 13.6118 12.2251 0 0 0 0 0 13.2616 12.9222 0 0 12.5575 13.8852 0 0 9.94436 0 0 0 0 14.05 0 0 0 0 13.8084 0 0 0 0 13.7782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9536 0 0 0 0 0 0 0 11.8638 0 0 0 0 0 0 0 0 13.2309 0 0 0 0 0 0 0 0 0 0 0 0 13.5593 0 0 0 0 0 14.6582 0 0 12.4367 0 0 0 0 14.5811 0 14.4606 14.0515 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZS46 YF009_HUMAN Putative uncharacterized protein FLJ45840 Homo sapiens (Human) SPPLTLISR 0.99604 -11.74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXF0 NPAS3_HUMAN "Neuronal PAS domain-containing protein 3, Neuronal PAS3 (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12, bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6)" NPAS3 BHLHE12 MOP6 PASD6 Homo sapiens (Human) "positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" APTKPSFQQDPSRR 0.99604 -9.6438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.461 0 0 0 0 11.7576 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5707 15.0264 0 0 0 0 0 0 0 0 0 14.6938 0 15.5254 0 0 0 15.1443 0 0 0 14.0379 0 0 0 0 0 0 0 0 0 0 0 0 14.8527 0 0 0 0 0 0 16.0249 0 0 0 0 0 0 0 15.4678 0 0 13.1879 0 0 14.2876 0 12.5312 14.3496 0 10.2116 0 0 14.0527 0 14.7731 0 0 0 14.6981 15.725 0 0 0 14.5385 0 0 0 0 0 0 0 0 0 14.8482 0 0 14.2486 0 0 0 12.2846 0 14.1323 0 14.9019 14.7746 0 0 0 0 0 13.3718 0 11.6996 0 0 0 0 0 0 14.9015 0 Q8N988 ZN557_HUMAN Zinc finger protein 557 ZNF557 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]" DVMLENCR 0.99604 -12.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0981 0 0 0 0 0 0 0 0 0 0 0 13.1755 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5418 0 0 0 0 0 0 0 0 0 0 0 0 12.5851 12.4429 0 0 0 12.8414 0 0 13.4653 14.4237 0 12.3184 0 12.6234 0 12.2519 12.7411 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9127 0 0 0 0 0 12.0279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGH3 OR2D3_HUMAN Olfactory receptor 2D3 (Olfactory receptor OR11-89) OR2D3 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] KCFSHRQ 0.99604 -11.705 0 0 0 10.3842 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3335 0 0 0 0 0 0 0 0 Q8NHS4 CLHC1_HUMAN Clathrin heavy chain linker domain-containing protein 1 CLHC1 C2orf63 Homo sapiens (Human) DFTTDDLLQLLMSCPQVELIQCLTK 0.99604 -9.6479 0 0 0 0 17.306 15.5904 0 14.4587 0 0 0 0 0 0 10.623 0 15.7249 0 0 0 0 0 0 0 0 0 14.6037 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1359 0 0 0 0 0 0 0 0 14.7644 0 10.985 0 0 0 0 0 0 12.0384 11.2441 0 0 11.4165 13.7552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8014 0 0 0 0 15.0833 0 14.9793 15.2363 15.8606 0 0 14.435 0 0 0 0 0 0 0 13.9186 0 0 0 0 0 0 0 0 0 0 0 14.4696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.927 19.4476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7108 0 0 0 0 0 0 0 0 0 Q96QT6 PHF12_HUMAN "PHD finger protein 12 (PHD factor 1, Pf1)" PHF12 KIAA1523 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0006357; GO:0016580; GO:0017053; GO:0035091; GO:0045892; GO:0046872; GO:0070822 metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222] ILERRASR 0.99604 -11.699 0 0 0 0 0 0 0 13.803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1601 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4899 0 10.8833 0 0 0 12.7175 0 0 0 0 0 0 0 0 0 0 18.2196 18.1903 0 13.5511 18.3117 0 0 14.6554 13.8676 0 0 0 0 0 0 0 18.21 0 12.385 0 0 0 0 0 0 0 0 0 0 10.6862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9172 13.5256 13.478 0 0 13.6686 13.444 0 0 0 0 12.8983 0 0 9.39744 0 0 0 0 12.0693 0 13.6344 0 0 Q9BWD1 THIC_HUMAN "Acetyl-CoA acetyltransferase, cytosolic, EC 2.3.1.9 (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)" ACAT2 ACTL Homo sapiens (Human) fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629] GO:0003985; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006635; GO:0070062 acetyl-CoA C-acetyltransferase activity [GO:0003985] GLTPLAR 0.99604 -9.6354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2483 14.1776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4083 12.7815 0 0 0 0 0 0 0 0 0 0 12.7321 0 0 0 0 13.6668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9C0G6 DYH6_HUMAN Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6) DNAH6 DNAHC6 DNHL1 HL2 KIAA1697 Homo sapiens (Human) cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874] axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018] GO:0005524; GO:0005858; GO:0005874; GO:0007018; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060285 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569] ACRFALRAAGFVPDDCAFGPFEDYHK 0.99604 -34.977 0 0 0 0 0 0 0 0 11.9721 10.9176 0 0 0 0 0 0 12.7336 11.8978 13.818 0 0 0 0 12.3218 13.1414 0 0 0 0 0 0 0 0 0 0 12.6603 12.8605 0 0 0 10.7685 12.452 0 0 0 0 13.9114 0 0 0 0 13.8357 0 0 13.6427 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2537 0 0 0 14.4349 13.1881 0 13.0478 14.1352 13.5327 0 15.3432 13.5902 12.2993 0 0 16.6813 13.6797 12.7273 0 13.1064 0 14.698 0 0 13.1041 0 14.8071 14.5982 11.8541 0 0 0 14.9284 14.3596 0 12.6753 0 0 0 14.8749 0 14.5111 14.9076 14.9439 0 13.5867 16.0993 15.7608 14.7023 0 0 14.2186 15.4868 13.9419 0 0 0 13.4815 0 0 0 14.9934 0 0 15.396 15.9905 12.7882 13.6508 0 13.1973 0 0 0 12.8254 12.4157 14.9916 13.2778 0 0 0 0 14.1099 0 13.5613 13.0094 15.6926 11.6094 0 0 0 0 0 0 13.6884 14.2654 0 0 0 13.5847 0 13.1204 0 12.4923 0 0 0 12.9037 0 12.6273 Q9NXD2 MTMRA_HUMAN Myotubularin-related protein 10 (Inactive phosphatidylinositol 3-phosphatase 10) MTMR10 Homo sapiens (Human) phosphatidylinositol dephosphorylation [GO:0046856] cytoplasm [GO:0005737]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol dephosphorylation [GO:0046856] GO:0004438; GO:0005737; GO:0005829; GO:0046856 phosphatidylinositol-3-phosphatase activity [GO:0004438] CIATDTSQYDLWGK 0.99604 -34.848 0 0 0 0 0 0 0 0 0 0 12.593 0 0 0 0 13.1993 0 0 0 12.108 0 0 0 0 0 12.1486 0 0 12.7623 0 0 0 0 0 0 0 0 0 0 13.234 13.3163 0 0 0 13.3475 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0812 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8771 13.3401 0 0 0 0 0 0 0 12.2708 0 0 0 0 16.3055 0 0 0 0 0 0 0 13.4277 0 0 0 14.9344 0 16.2555 0 0 0 0 13.3699 0 12.8692 13.7163 12.1256 0 13.8349 14.4082 14.6207 14.414 13.4887 11.4609 0 0 0 0 0 0 0 0 12.8592 0 0 0 0 0 0 13.1073 13.9184 0 0 0 14.6121 0 0 0 0 0 13.2538 0 0 0 0 0 0 0 13.0422 11.9599 0 0 0 14.269 13.7332 0 14.8309 0 14.0521 0 0 0 0 0 0 0 0 0 13.5593 0 0 0 0 O94854 K0754_HUMAN "Microtubule-actin cross-linking factor 1, isoforms 6/7 (Uncharacterized protein KIAA0754)" MACF1 KIAA0754 Homo sapiens (Human) cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; metal ion binding [GO:0046872] GO:0005737; GO:0005856; GO:0046872 metal ion binding [GO:0046872] ASSRRGSDASDFDLLETQSACSDTSESSAAGGQGNSR 0.99605 -35.046 0 0 0 0 0 0 0 0 0 15.6602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9209 0 0 0 0 16.6203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7542 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4069 0 13.4934 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8097 13.8464 0 0 18.292 14.1845 0 0 13.9278 0 13.6739 13.6407 13.7698 0 13.3359 0 0 0 0 0 0 13.5098 0 0 P01130 LDLR_HUMAN "Low-density lipoprotein receptor, LDL receptor" LDLR Homo sapiens (Human) amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of receptor recycling [GO:0001920]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443] apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of receptor recycling [GO:0001920]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771] GO:0001540; GO:0001618; GO:0001920; GO:0002020; GO:0005041; GO:0005509; GO:0005764; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0005887; GO:0005905; GO:0006629; GO:0006897; GO:0006898; GO:0006909; GO:0007616; GO:0008203; GO:0009897; GO:0009986; GO:0010008; GO:0010628; GO:0010629; GO:0010867; GO:0010899; GO:0010989; GO:0015914; GO:0016020; GO:0016323; GO:0030169; GO:0030229; GO:0030299; GO:0030301; GO:0030669; GO:0032050; GO:0034362; GO:0034381; GO:0034383; GO:0034384; GO:0036020; GO:0036477; GO:0042159; GO:0042632; GO:0042802; GO:0043235; GO:0045177; GO:0048844; GO:0050729; GO:0051246; GO:0051248; GO:0061771; GO:0061889; GO:0070508; GO:0071398; GO:0071404; GO:0071813; GO:0090118; GO:0090181; GO:0097242; GO:0097443; GO:0150094; GO:1903979; GO:1905167; GO:1905907; GO:1990666 amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618] ALSIVLPIVLLVFLCLGVFLLWK 0.99605 -35.113 0 0 0 0 0 0 0 0 12.0539 13.6631 11.9082 0 12.0408 13.4338 13.6899 0 0 0 0 0 11.9388 0 0 0 0 0 0 12.428 0 0 0 0 12.0689 0 0 13.0044 14.1272 12.0676 12.4956 0 12.9706 0 0 0 12.5054 0 0 0 0 12.2496 11.9651 0 0 0 0 0 0 0 14.2973 0 0 12.7823 0 0 0 0 0 0 0 11.6563 0 0 0 11.0285 0 12.719 0 14.4315 17.1628 14.1245 14.9398 14.4574 13.5255 12.3371 0 0 12.1391 15.8866 0 14.0549 15.1524 11.5665 0 0 0 0 12.9721 0 0 13.6462 0 10.6394 0 13.6106 0 0 12.9096 15.78 14.3435 0 13.2341 0 0 0 0 18.1793 15.7512 0 15.0755 17.9592 15.4122 14.012 0 15.0396 14.1071 0 10.9545 0 15.1084 13.1618 0 13.6259 0 15.7596 15.022 0 14.8335 0 0 0 0 0 0 17.3372 0 13.7064 14.265 11.9403 0 0 0 12.9281 0 12.0099 0 0 0 13.4177 13.4186 13.4431 13.5961 13.2754 0 0 14.8271 0 0 0 12.2007 0 14.2786 0 13.4274 0 0 13.3383 15.6407 13.5818 13.6515 0 P0C7P3 SLN14_HUMAN "Protein SLFN14 [Cleaved into: C-terminally truncated SLFN14 endoribonuclease, EC 3.1.-.- (Schlafen family member 14) ]" SLFN14 Homo sapiens (Human) "cellular response to magnesium ion [GO:0071286]; cellular response to manganese ion [GO:0071287]; mRNA catabolic process [GO:0006402]; platelet maturation [GO:0036345]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA catabolic process [GO:0016075]" cytoplasm [GO:0005737]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; ribosome binding [GO:0043022]; cellular response to magnesium ion [GO:0071286]; cellular response to manganese ion [GO:0071287]; mRNA catabolic process [GO:0006402]; platelet maturation [GO:0036345]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA catabolic process [GO:0016075]" GO:0004521; GO:0005524; GO:0005634; GO:0005737; GO:0006402; GO:0016075; GO:0036345; GO:0043022; GO:0071286; GO:0071287; GO:0090502 ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; ribosome binding [GO:0043022] CIQEEEDMRILASEFFK 0.99605 -35.004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9038 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5386 0 0 0 13.431 13.5754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3961 0 0 0 0 0 11.1808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5479 12.8327 0 0 0 0 0 0 13.1559 0 0 0 12.7254 0 0 11.5959 0 13.581 0 0 13.1538 0 0 0 0 12.8936 0 0 0 12.916 0 0 0 0 0 12.9109 12.8022 0 13.6372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6136 0 P23396 RS3_HUMAN "40S ribosomal protein S3, EC 4.2.99.18 (Small ribosomal subunit protein uS3)" RPS3 OK/SW-cl.26 Homo sapiens (Human) apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]; translational initiation [GO:0006413] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron-sulfur cluster binding [GO:0051536]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; cytoplasmic translation [GO:0002181]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]; translational initiation [GO:0006413] GO:0002181; GO:0003677; GO:0003684; GO:0003723; GO:0003729; GO:0003735; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005743; GO:0005759; GO:0005783; GO:0005829; GO:0005840; GO:0005844; GO:0005886; GO:0005925; GO:0006281; GO:0006412; GO:0006413; GO:0006915; GO:0006974; GO:0007059; GO:0008017; GO:0010628; GO:0014069; GO:0015631; GO:0016020; GO:0017148; GO:0019899; GO:0019900; GO:0019901; GO:0022626; GO:0022627; GO:0030544; GO:0031116; GO:0031334; GO:0031397; GO:0032079; GO:0032357; GO:0032358; GO:0032587; GO:0032743; GO:0034614; GO:0042104; GO:0042981; GO:0043507; GO:0044390; GO:0044877; GO:0045738; GO:0045739; GO:0050862; GO:0051018; GO:0051092; GO:0051225; GO:0051301; GO:0051536; GO:0051879; GO:0061481; GO:0070062; GO:0070181; GO:0070301; GO:0071159; GO:0071356; GO:0072686; GO:0097100; GO:0140078; GO:0140297; GO:1901224; GO:1902231; GO:1902546; GO:1905053; GO:1990904; GO:2001235; GO:2001272 class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron-sulfur cluster binding [GO:0051536]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390] HVLLRQGVLGIKVK 0.99605 -9.6845 0 12.4207 10.8825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3332 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1221 0 0 0 0 0 14.1286 14.0708 14.2126 0 13.8818 14.8717 0 0 0 0 0 13.5101 13.0567 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3325 10.2541 0 0 0 0 0 0 0 0 13.6378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3721 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0949 0 0 0 0 0 0 14.0238 0 0 Q504Y3 ZCPW2_HUMAN Zinc finger CW-type PWWP domain protein 2 ZCWPW2 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] GO:0005634; GO:0008270; GO:0035064 methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270] NNIEKKK 0.99605 -9.6887 0 0 0 0 0 0 0 0 13.9246 0 0 0 0 0 0 13.5708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6257 14.0746 15.5637 14.0766 13.3628 0 0 0 13.1751 0 0 0 0 0 12.9315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3819 0 13.167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9365 0 0 0 0 0 13.0883 0 0 0 0 0 0 0 12.6033 0 0 0 0 O75386 TULP3_HUMAN Tubby-related protein 3 (Tubby-like protein 3) TULP3 TUBL3 Homo sapiens (Human) "anterior/posterior pattern specification [GO:0009952]; bone development [GO:0060348]; brain development [GO:0007420]; bronchus morphogenesis [GO:0060434]; central nervous system neuron differentiation [GO:0021953]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; G protein-coupled receptor signaling pathway [GO:0007186]; ganglion development [GO:0061548]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021914]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of transcription, DNA-templated [GO:0006355]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]" 9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; anterior/posterior pattern specification [GO:0009952]; bone development [GO:0060348]; brain development [GO:0007420]; bronchus morphogenesis [GO:0060434]; central nervous system neuron differentiation [GO:0021953]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; G protein-coupled receptor signaling pathway [GO:0007186]; ganglion development [GO:0061548]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning [GO:0021914]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of transcription, DNA-templated [GO:0006355]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831]" GO:0001664; GO:0001843; GO:0005546; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0005929; GO:0005930; GO:0006355; GO:0007186; GO:0007420; GO:0008277; GO:0009952; GO:0019899; GO:0021914; GO:0021953; GO:0031076; GO:0035091; GO:0042733; GO:0044877; GO:0045879; GO:0048702; GO:0060348; GO:0060434; GO:0060831; GO:0061512; GO:0061548; GO:0097546; GO:0097731; GO:0120160; GO:1901621 "enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]" LEPFMVQPNPEARLRR 0.99606 -10.279 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P22694 KAPCB_HUMAN "cAMP-dependent protein kinase catalytic subunit beta, PKA C-beta, EC 2.7.11.11" PRKACB Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; high-density lipoprotein particle assembly [GO:0034380]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; neural tube closure [GO:0001843]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; regulation of protein processing [GO:0070613]; renal water homeostasis [GO:0003091]; signal transduction [GO:0007165] GO:0000287; GO:0001843; GO:0003091; GO:0004674; GO:0004679; GO:0004691; GO:0005524; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0005952; GO:0006468; GO:0007165; GO:0007188; GO:0010737; GO:0031625; GO:0034380; GO:0070062; GO:0070613; GO:0097546; GO:0106310; GO:1901621 AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625] CAKEFGEF 0.99606 -9.7497 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2689 0 0 0 0 12.2553 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7985 0 0 0 0 0 12.71 0 0 0 0 0 0 0 0 13.1678 0 0 14.265 14.3773 0 14.5316 0 0 14.4917 0 0 0 14.1961 0 0 0 0 14.5544 0 0 0 15.5608 13.8011 14.1245 0 14.0551 0 13.8211 0 14.8673 14.0502 0 13.9163 0 0 0 0 14.2499 0 0 0 14.9349 0 14.7899 0 0 0 0 0 14.0714 0 0 14.3312 13.8271 0 14.0993 0 0 0 13.8564 0 0 13.7527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P56159 GFRA1_HUMAN "GDNF family receptor alpha-1, GDNF receptor alpha-1, GDNFR-alpha-1, GFR-alpha-1 (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1)" GFRA1 GDNFRA RETL1 TRNR1 Homo sapiens (Human) aging [GO:0007568]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; kidney development [GO:0001822]; male gonad development [GO:0008584]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731] anchored component of membrane [GO:0031225]; axon [GO:0030424]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235] anchored component of membrane [GO:0031225]; axon [GO:0030424]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]; glial cell-derived neurotrophic factor receptor activity [GO:0016167]; integrin binding [GO:0005178]; neurotrophin receptor activity [GO:0005030]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; aging [GO:0007568]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; kidney development [GO:0001822]; male gonad development [GO:0008584]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731] GO:0001822; GO:0005030; GO:0005102; GO:0005178; GO:0005771; GO:0005794; GO:0005886; GO:0007166; GO:0007399; GO:0007568; GO:0008584; GO:0009897; GO:0016167; GO:0016477; GO:0019898; GO:0030424; GO:0031175; GO:0031225; GO:0038023; GO:0043025; GO:0043235; GO:0050731; GO:0070062; GO:0098797 glial cell-derived neurotrophic factor receptor activity [GO:0016167]; integrin binding [GO:0005178]; neurotrophin receptor activity [GO:0005030]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102] ACNLDDICK 0.99606 -10.053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9889 12.2701 0 0 15.8337 0 0 0 0 0 0 0 0 11.9796 12.1792 0 0 0 0 0 0 0 0 13.4765 0 0 0 0 0 12.1608 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2062 11.1165 0 0 0 0 12.6303 0 0 0 0 12.6234 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0905 0 0 0 0 0 0 0 Q14254 FLOT2_HUMAN "Flotillin-2 (Epidermal surface antigen, ESA) (Membrane component chromosome 17 surface marker 1)" FLOT2 ESA1 M17S1 Homo sapiens (Human) anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982] acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982]; anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072] GO:0001931; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0051092; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905 AEAERMK 0.99606 -10.054 12.7449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0082 14.009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7781 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3691 0 0 0 11.8125 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2739 13.1816 0 0 0 0 0 0 0 0 0 0 Q70IA8 MOB3C_HUMAN MOB kinase activator 3C (Mob1 homolog 2C) (Mps one binder kinase activator-like 2C) MOB3C MOBKL2C Homo sapiens (Human) positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165] GO:0001934; GO:0005634; GO:0005737; GO:0007165; GO:0030295; GO:0046872 metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295] DKTFRPR 0.99606 -12.429 0 0 0 0 0 0 0 0 0 0 0 11.1886 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9925 0 0 0 12.6628 11.3898 0 0 0 0 0 14.2004 14.4329 0 0 0 0 0 0 0 13.561 13.19 0 0 0 0 0 0 0 14.4026 14.5054 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0752 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9015 0 14.554 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5265 0 0 0 0 0 0 11.7673 0 0 0 Q86UW9 DTX2_HUMAN "Probable E3 ubiquitin-protein ligase DTX2, EC 2.3.2.27 (Protein deltex-2, Deltex2, hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2)" DTX2 KIAA1528 RNF58 Homo sapiens (Human) Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567] GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0031965; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] KVLELLKVAWK 0.99606 -9.7319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8107 0 0 0 0 13.2831 0 0 0 0 0 0 0 0 0 11.234 0 0 0 0 0 0 0 0 0 0 0 13.0102 0 0 0 0 0 0 0 0 0 0 0 12.4802 0 0 0 0 0 0 0 0 12.8959 0 0 0 0 0 0 0 0 0 0 0 12.4899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N0W7 FMR1N_HUMAN "FMR1 neighbor protein (Cancer/testis antigen 37, CT37) (Sarcoma antigen NY-SAR-35)" FMR1NB Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ENQVAKPCNELQDLSESECLR 0.99606 -9.716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TCB7 METL6_HUMAN "tRNA N(3)-methylcytidine methyltransferase METTL6, EC 2.1.1.- (Methyltransferase-like protein 6, hMETTL6)" METTL6 Homo sapiens (Human) tRNA methylation [GO:0030488] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735]; tRNA methylation [GO:0030488] GO:0005634; GO:0005737; GO:0019899; GO:0030488; GO:0052735 enzyme binding [GO:0019899]; tRNA (cytosine-3-)-methyltransferase activity [GO:0052735] NWDLFYKR 0.99606 -9.7295 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1665 0 13.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2037 0 0 0 0 0 0 0 14.5716 0 0 0 0 0 0 0 0 0 0 0 13.5511 0 0 0 13.7013 12.9717 0 0 0 13.2845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4415 0 0 0 0 0 0 0 0 Q92630 DYRK2_HUMAN "Dual specificity tyrosine-phosphorylation-regulated kinase 2, EC 2.7.12.1" DYRK2 Homo sapiens (Human) cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224] GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006468; GO:0006974; GO:0007224; GO:0018105; GO:0018107; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:0106310; GO:1901796; GO:1990904 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713] AYDHKVHQHVALK 0.99606 -9.7345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.673 0 Q96PC3 AP1S3_HUMAN AP-1 complex subunit sigma-3 (Adaptor protein complex AP-1 subunit sigma-1C) (Adaptor-related protein complex 1 subunit sigma-1C) (Clathrin assembly protein complex 1 sigma-1C small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1C subunit) (Sigma 1C subunit of AP-1 clathrin) (Sigma-adaptin 1C) (Sigma1C-adaptin) AP1S3 Homo sapiens (Human) melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] AP-1 adaptor complex [GO:0030121]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588] AP-1 adaptor complex [GO:0030121]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; clathrin adaptor activity [GO:0035615]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192] GO:0000139; GO:0005765; GO:0005769; GO:0005829; GO:0005905; GO:0006605; GO:0016192; GO:0030121; GO:0030659; GO:0032588; GO:0035615; GO:0043231; GO:0060155; GO:1903232 clathrin adaptor activity [GO:0035615] ELKLVYKR 0.99606 -10.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.02459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0387 0 0 0 0 13.135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1866 0 0 0 0 0 0 0 14.6671 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0942 0 0 0 0 15.3027 0 0 0 Q9BZK8 OCR1_HUMAN Ovarian cancer-related protein 1 OCR1 Homo sapiens (Human) AMLFTLK 0.99606 -12.48 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9594 0 0 0 0 0 0 14.5116 0 0 0 0 0 0 0 0 0 0 13.6809 0 14.3433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6407 13.3529 0 0 0 0 0 0 0 0 0 14.3836 12.3782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6895 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3848 0 0 0 0 0 0 0 0 0 Q9C0B9 ZCHC2_HUMAN Zinc finger CCHC domain-containing protein 2 ZCCHC2 C18orf49 KIAA1744 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270] GO:0003676; GO:0005737; GO:0008270; GO:0035091 nucleic acid binding [GO:0003676]; phosphatidylinositol binding [GO:0035091]; zinc ion binding [GO:0008270] ANGLSDPGPLADFREPAVRSR 0.99606 -12.421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9333 0 0 0 0 0 0 14.1496 0 0 12.4032 0 13.7595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7417 0 0 0 0 0 0 0 0 0 11.2897 0 0 11.6552 0 0 0 11.6426 0 12.5794 12.9024 0 14.0591 12.9225 0 0 0 0 0 0 0 0 0 0 11.4558 0 0 11.3648 0 0 0 14.3964 16.5125 0 0 12.6106 0 0 0 15.8644 0 0 15.2968 0 0 12.3986 0 0 0 17.2716 0 13.7536 0 0 0 0 0 0 0 0 0 15.6808 0 12.5583 0 0 0 14.2119 0 14.2682 12.5199 0 0 13.991 0 0 0 0 0 0 0 0 0 0 13.4441 13.5471 0 0 0 0 0 11.0682 0 0 12.5614 0 0 0 0 0 14.7836 0 0 0 11.0647 0 0 0 0 0 12.392 0 0 Q9NXG2 THUM1_HUMAN THUMP domain-containing protein 1 THUMPD1 Homo sapiens (Human) tRNA modification [GO:0006400] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; tRNA modification [GO:0006400] GO:0003723; GO:0005654; GO:0006400 RNA binding [GO:0003723] AQYVLAK 0.99606 -9.7372 0 0 0 0 0 0 0 0 0 0 0 0 12.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0181 0 0 0 12.5892 0 12.3478 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1928 0 0 0 0 0 0 0 0 0 0 0 13.0128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2812 0 13.7678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.584 0 0 0 0 0 0 0 Q9UI26 IPO11_HUMAN "Importin-11, Imp11 (Ran-binding protein 11, RanBP11)" IPO11 RANBP11 Homo sapiens (Human) protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610] GO:0005635; GO:0005654; GO:0005829; GO:0006606; GO:0006610; GO:0031267; GO:0061608 nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267] DCMLMSHLEEPKVTEDEEPPTEQDK 0.99606 -9.7516 0 0 11.9224 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0753 0 0 0 0 0 0 0 0 13.8828 0 0 0 0 0 0 13.9225 0 0 0 13.1097 0 14.4368 0 0 0 0 0 0 0 0 13.4573 11.489 0 0 0 12.3167 0 13.8017 0 14.0301 13.6639 0 0 0 0 0 0 0 0 0 0 11.404 0 0 13.7066 0 0 0 0 14.4696 14.5732 0 0 14.4842 0 0 0 0 0 11.4141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.591 0 0 0 0 0 0 11.8929 0 13.4798 0 0 0 0 0 Q9Y3Q0 NALD2_HUMAN "N-acetylated-alpha-linked acidic dipeptidase 2, EC 3.4.17.21 (Glutamate carboxypeptidase III, GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II, NAALADase II)" NAALAD2 Homo sapiens (Human) proteolysis [GO:0006508] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508] GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016021; GO:0016805; GO:0046872 carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; serine-type peptidase activity [GO:0008236] DPSPENKNLPR 0.99607 -9.7948 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6026 0 0 0 0 0 13.176 0 0 0 13.7283 13.8049 12.1307 13.63 13.0085 12.9837 0 0 0 13.2694 0 0 0 0 0 0 0 0 0 0 0 0 12.6422 11.8802 14.168 0 13.578 13.0802 0 13.3249 0 0 12.957 0 0 0 0 0 0 0 0 0 12.7679 0 0 0 0 0 13.3522 0 12.7735 0 13.0149 13.2669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8262 0 0 9.91313 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3723 0 0 Q00872 MYPC1_HUMAN "Myosin-binding protein C, slow-type, Slow MyBP-C (C-protein, skeletal muscle slow isoform)" MYBPC1 MYBPCS Homo sapiens (Human) cell adhesion [GO:0007155] cytosol [GO:0005829]; myofibril [GO:0030016]; myosin filament [GO:0032982] cytosol [GO:0005829]; myofibril [GO:0030016]; myosin filament [GO:0032982]; actin binding [GO:0003779]; myosin binding [GO:0017022]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432]; cell adhesion [GO:0007155] GO:0003779; GO:0005829; GO:0007155; GO:0008307; GO:0017022; GO:0030016; GO:0031432; GO:0032982 actin binding [GO:0003779]; myosin binding [GO:0017022]; structural constituent of muscle [GO:0008307]; titin binding [GO:0031432] ADAAEYSVMTTGGQSSAK 0.99608 -9.8135 0 0 0 0 0 0 0 0 15.0597 0 11.9243 11.9595 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1477 14.6372 0 0 0 0 0 0 0 0 0 14.8321 0 0 0 14.919 0 0 15.1464 0 0 0 0 0 12.0136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5315 0 0 0 0 0 0 0 14.2347 0 0 0 15.4744 15.538 15.8716 15.6831 0 15.459 15.3622 14.4661 14.9395 16.1547 0 0 0 0 15.235 0 14.9316 0 0 0 0 0 0 0 12.4661 0 0 0 0 0 14.7404 0 0 0 14.7558 0 0 0 0 0 0 0 0 13.5915 0 0 10.2071 0 0 0 0 0 10.9109 0 11.7133 0 0 0 0 13.5093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1459 0 0 13.2282 13.5681 0 0 13.4546 13.1598 0 0 13.871 14.5242 14.0885 11.1719 0 0 11.8438 12.5292 0 0 0 0 0 Q12778 FOXO1_HUMAN Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma) FOXO1 FKHR FOXO1A Homo sapiens (Human) "apoptotic process [GO:0006915]; autophagy [GO:0006914]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cellular glucose homeostasis [GO:0001678]; cellular response to cold [GO:0070417]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hyperoxia [GO:0071455]; cellular response to insulin stimulus [GO:0032869]; cellular response to nitric oxide [GO:0071732]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of insulin secretion [GO:0046676]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fatty acid [GO:0070542]; temperature homeostasis [GO:0001659]" chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; promoter-specific chromatin binding [GO:1990841]; protein phosphatase 2A binding [GO:0051721]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; blood vessel development [GO:0001568]; canonical Wnt signaling pathway [GO:0060070]; cellular glucose homeostasis [GO:0001678]; cellular response to cold [GO:0070417]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hyperoxia [GO:0071455]; cellular response to insulin stimulus [GO:0032869]; cellular response to nitric oxide [GO:0071732]; cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of insulin secretion [GO:0046676]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription, DNA-templated [GO:0045892]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fatty acid [GO:0070542]; temperature homeostasis [GO:0001659]" GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001568; GO:0001659; GO:0001678; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006357; GO:0006473; GO:0006914; GO:0006915; GO:0006974; GO:0008013; GO:0008286; GO:0009267; GO:0010508; GO:0031490; GO:0031625; GO:0032869; GO:0032873; GO:0034599; GO:0043065; GO:0043066; GO:0043565; GO:0045444; GO:0045599; GO:0045722; GO:0045732; GO:0045892; GO:0045893; GO:0045944; GO:0046676; GO:0051721; GO:0060070; GO:0070417; GO:0070542; GO:0071455; GO:0071732; GO:0090090; GO:0097009; GO:0097150; GO:1903243; GO:1990841; GO:2000177; GO:2000377 "beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; promoter-specific chromatin binding [GO:1990841]; protein phosphatase 2A binding [GO:0051721]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]" FAKSRSR 0.99608 -9.813 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5451 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1036 0 0 0 0 0 14.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0286 0 0 0 0 0 Q13907 IDI1_HUMAN "Isopentenyl-diphosphate Delta-isomerase 1, EC 5.3.3.2 (Isopentenyl pyrophosphate isomerase 1, IPP isomerase 1, IPPI1)" IDI1 Homo sapiens (Human) cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]; isoprenoid biosynthetic process [GO:0008299] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777] cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]; isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]; isoprenoid biosynthetic process [GO:0008299] GO:0000287; GO:0004452; GO:0005737; GO:0005777; GO:0005829; GO:0006695; GO:0008299; GO:0009240; GO:0030145; GO:0046872; GO:0050992 isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872] IGAETKK 0.99608 -9.8146 0 0 0 0 11.1471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6973 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9813 0 0 0 0 0 13.7541 0 0 0 0 0 0 0 14.1489 14.097 0 13.5459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4877 0 0 0 0 0 0 0 0 0 0 0 13.8583 0 0 14.1093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5JU85 IQEC2_HUMAN IQ motif and SEC7 domain-containing protein 2 IQSEC2 KIAA0522 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] cytoplasm [GO:0005737]; Schaffer collateral - CA1 synapse [GO:0098685] cytoplasm [GO:0005737]; Schaffer collateral - CA1 synapse [GO:0098685]; guanyl-nucleotide exchange factor activity [GO:0005085]; actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696] GO:0005085; GO:0005737; GO:0030036; GO:0032012; GO:0050804; GO:0098685; GO:0098696 guanyl-nucleotide exchange factor activity [GO:0005085] ARLQPASVALR 0.99608 -12.063 0 0 0 0 0 0 0 0 0 0 0 0 16.9224 0 0 0 0 0 0 0 0 11.2625 0 0 0 0 0 0 0 11.7679 0 0 0 16.9692 16.8801 0 0 16.9869 0 16.9984 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1366 0 0 13.2517 0 12.4885 0 0 0 0 0 13.2692 0 0 0 0 12.748 12.3439 0 0 0 0 0 15.4475 10.8469 0 12.5167 0 0 0 0 0 0 0 0 0 0 12.5545 0 0 0 0 15.3483 0 0 0 0 0 0 0 0 0 12.473 0 0 0 0 0 0 0 0 14.5491 0 0 12.4437 0 14.7836 11.8173 10.6801 0 0 14.4658 0 0 10.7457 0 0 0 0 0 0 0 0 0 13.4558 0 12.6786 0 0 0 13.528 0 0 0 18.0887 0 0 18.0519 10.8435 11.8213 0 0 0 0 0 0 11.1313 0 0 0 0 0 0 0 18.1194 0 11.0503 Q96N16 JKIP1_HUMAN "Janus kinase and microtubule-interacting protein 1 (GABA-B receptor-binding protein) (Multiple alpha-helices and RNA-linker protein 1, Marlin-1)" JAKMIP1 GABABRBP JAMIP1 MARLIN1 Homo sapiens (Human) cognition [GO:0050890]; protein transport [GO:0015031] cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; microtubule [GO:0005874]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; microtubule [GO:0005874]; ribonucleoprotein complex [GO:1990904]; GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; cognition [GO:0050890]; protein transport [GO:0015031] GO:0003723; GO:0005737; GO:0005874; GO:0008017; GO:0015031; GO:0019898; GO:0019900; GO:0050811; GO:0050890; GO:1990904 GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; RNA binding [GO:0003723] DVRRFQLK 0.99608 -9.8107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5563 0 0 0 0 14.0053 0 0 0 0 14.334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3618 11.6742 0 0 0 12.1414 14.2022 12.6761 0 0 14.1419 0 0 18.5557 13.8886 0 0 12.9709 0 11.9518 0 14.2735 0 0 0 0 0 0 14.0654 0 0 0 15.7461 0 0 0 0 0 0 0 0 0 0 0 15.2166 0 0 0 0 0 0 0 14.2935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5293 0 0 0 0 0 0 0 13.0146 0 14.6737 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4147 0 0 0 0 Q99502 EYA1_HUMAN "Eyes absent homolog 1, EC 3.1.3.16, EC 3.1.3.48" EYA1 Homo sapiens (Human) anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; peptidyl-tyrosine dephosphorylation [GO:0035335]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; striated muscle tissue development [GO:0014706] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993] cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; histone tyrosine phosphatase activity (H2-Y142 specific) [GO:0140793]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723]; anatomical structure development [GO:0048856]; anatomical structure morphogenesis [GO:0009653]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; peptidyl-tyrosine dephosphorylation [GO:0035335]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; striated muscle tissue development [GO:0014706] GO:0001656; GO:0001658; GO:0003151; GO:0003723; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0006325; GO:0007389; GO:0007501; GO:0007605; GO:0009653; GO:0010212; GO:0014706; GO:0016604; GO:0016925; GO:0017018; GO:0030154; GO:0032993; GO:0035335; GO:0035909; GO:0042473; GO:0042474; GO:0045664; GO:0045739; GO:0045944; GO:0046872; GO:0048665; GO:0048704; GO:0048752; GO:0048856; GO:0050673; GO:0050679; GO:0060037; GO:0071600; GO:0072513; GO:0090103; GO:0097192; GO:0140793; GO:2001240 histone tyrosine phosphatase activity (H2-Y142 specific) [GO:0140793]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723] ALSLIHSR 0.99608 -9.8138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5047 0 0 0 0 0 0 12.9059 0 12.8726 0 0 0 0 0 0 0 0 0 0 0 0 10.2153 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.547 0 0 0 0 0 0 0 14.9974 0 0 0 0 0 0 0 Q9NSC7 SIA7A_HUMAN "Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1, EC 2.4.99.3 (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I, ST6GalNAc-I, ST6GalNAcI, hST6GalNAc-I) (Sialyltransferase 7A, SIAT7-A)" ST6GALNAC1 SIAT7A UNQ543/PRO848 Homo sapiens (Human) host-mediated regulation of intestinal microbiota composition [GO:0048874]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] "Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; transferase activity [GO:0016740]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486]" GO:0000139; GO:0001665; GO:0006486; GO:0008373; GO:0009312; GO:0016021; GO:0016740; GO:0048874 "alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]; transferase activity [GO:0016740]" AHTTGDR 0.99608 -12.06 0 0 0 0 0 0 0 0 0 0 0 0 14.4455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2427 0 14.5129 14.5169 14.4501 14.6041 0 0 14.9586 0 0 13.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2494 0 0 0 0 13.8345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0365 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4742 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2978 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2707 14.4294 0 13.628 0 0 0 14.4535 13.8102 0 0 0 0 0 0 0 0 0 0 0 A6ND36 FA83G_HUMAN Protein FAM83G (Protein associated with SMAD1) FAM83G PAWS1 Homo sapiens (Human) BMP signaling pathway [GO:0030509]; signal transduction [GO:0007165] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; BMP signaling pathway [GO:0030509]; signal transduction [GO:0007165] GO:0005634; GO:0005829; GO:0007165; GO:0019901; GO:0030509 protein kinase binding [GO:0019901] EHSVPLR 0.99609 -9.8933 10.7385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2421 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0987 13.5319 0 0 0 0 0 0 0 0 0 0 0 12.733 13.4779 0 0 11.3775 0 0 12.3109 0 0 0 0 0 0 13.2193 0 13.4566 13.2263 13.7254 12.9526 13.6692 0 0 13.4215 13.0111 0 0 0 0 13.3051 12.3034 0 0 0 0 0 0 13.1505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3817 0 H0UI37 TSTD3_HUMAN Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 (Rhodanese domain-containing protein 3) TSTD3 Homo sapiens (Human) DVTYKELKNLLNSK 0.99609 -9.5696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.36 0 12.2446 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15520 FGF10_HUMAN "Fibroblast growth factor 10, FGF-10 (Keratinocyte growth factor 2)" FGF10 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060] GO:0000132; GO:0001525; GO:0001656; GO:0001759; GO:0001823; GO:0001934; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007368; GO:0007431; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010628; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030154; GO:0030334; GO:0030538; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0031532; GO:0032355; GO:0032496; GO:0032781; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0042056; GO:0042060; GO:0042246; GO:0042475; GO:0042693; GO:0043410; GO:0043616; GO:0045739; GO:0045747; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048536; GO:0048538; GO:0048557; GO:0048754; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050731; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060054; GO:0060173; GO:0060174; GO:0060428; GO:0060430; GO:0060436; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:2000647; GO:2000648; GO:2001240 chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111] EFNNDCK 0.99609 -9.572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.182 0 0 0 0 0 0 0 0 14.794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6108 0 0 0 0 0 0 0 0 0 0 0 12.2669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1514 0 0 0 0 0 14.1069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.3904 0 0 0 0 0 0 0 0 11.3951 0 0 0 0 11.7375 0 0 11.24 10.5126 0 0 0 0 P52954 LBX1_HUMAN Transcription factor LBX1 (Ladybird homeobox protein homolog 1) LBX1 LBX1H Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; cell population proliferation [GO:0008283]; glutamatergic neuron differentiation [GO:1905962]; heart looping [GO:0001947]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glutamatergic neuron differentiation [GO:0120007]; neuron fate determination [GO:0048664]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron differentiation [GO:0021522] chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell population proliferation [GO:0008283]; glutamatergic neuron differentiation [GO:1905962]; heart looping [GO:0001947]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glutamatergic neuron differentiation [GO:0120007]; neuron fate determination [GO:0048664]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron differentiation [GO:0021522]" GO:0000785; GO:0000981; GO:0001947; GO:0005634; GO:0005667; GO:0006357; GO:0007517; GO:0008283; GO:0008285; GO:0009653; GO:0021522; GO:0048664; GO:0120007; GO:1905962; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]" AAPGEER 0.99609 -9.5591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0232 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2214 0 0 0 0 14.4276 0 0 0 0 0 0 0 0 Q4G0F5 VP26B_HUMAN Vacuolar protein sorting-associated protein 26B (Vesicle protein sorting 26B) VPS26B Homo sapiens (Human) "cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]" "cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]" GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0016241; GO:0030904; GO:0030906; GO:0042147; GO:0045335; GO:0071346 ATISRRLNDVVK 0.99609 -9.9071 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9203 14.5552 0 0 14.6496 0 0 0 0 0 0 15.7857 0 0 0 15.6112 0 0 15.126 0 15.7787 15.4684 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2058 16.0528 15.2622 0 0 0 0 0 0 0 0 13.4881 0 0 0 0 0 0 0 0 0 16.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86V71 ZN429_HUMAN Zinc finger protein 429 ZNF429 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFILSSR 0.99609 -34.99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8556 0 0 0 0 0 0 0 9.88762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3806 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1978 0 0 0 0 0 0 13.0378 0 0 0 0 0 13.2132 12.8474 0 0 0 13.1559 0 0 0 0 0 0 0 13.3031 0 13.9915 0 0 12.364 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5025 0 0 0 0 0 0 0 0 0 12.8732 Q96CW5 GCP3_HUMAN "Gamma-tubulin complex component 3, GCP-3, hGCP3 (Gamma-ring complex protein 104 kDa, h104p, hGrip104) (Spindle pole body protein Spc98 homolog, hSpc98)" TUBGCP3 GCP3 Homo sapiens (Human) cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; single fertilization [GO:0007338]; spindle assembly [GO:0051225] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; polar microtubule [GO:0005827]; spindle [GO:0005819] centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; membrane [GO:0016020]; polar microtubule [GO:0005827]; spindle [GO:0005819]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; single fertilization [GO:0007338]; spindle assembly [GO:0051225] GO:0000278; GO:0000923; GO:0000930; GO:0005198; GO:0005200; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0007020; GO:0007338; GO:0008275; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321 gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198] CLLDSDSRALLNQLR 0.99609 -9.8941 0 14.454 0 0 0 0 0 0 13.6922 0 0 0 0 0 0 14.2734 0 12.3119 13.1195 0 0 0 0 0 0 12.538 0 12.7366 0 0 0 0 0 0 0 0 0 0 0 12.4038 11.6597 0 0 0 0 0 0 0 13.9203 0 12.0209 0 0 0 0 0 0 0 0 11.8488 0 0 0 0 0 0 0 0 0 10.9789 0 0 0 12.2973 0 16.1767 0 11.531 0 0 16.3331 0 13.4666 13.6983 0 15.5398 0 0 13.7876 11.4625 0 0 0 10.9524 0 0 14.607 18.5851 0 12.6089 14.1924 0 0 0 15.262 12.0806 0 0 0 0 0 0 12.8494 13.9121 0 0 0 0 0 0 0 0 0 0 13.2961 0 0 0 0 0 13.3446 13.6585 11.3653 0 12.244 12.3069 0 0 12.554 0 0 0 0 0 0 0 0 0 11.7523 0 0 0 13.1145 0 0 14.2195 0 0 11.5218 11.2932 12.2206 0 0 0 0 0 0 0 0 12.8604 0 0 0 0 0 0 0 0 0 0 Q99853 FOXB1_HUMAN Forkhead box protein B1 (Transcription factor FKH-5) FOXB1 FKH5 Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542]" GO:0000785; GO:0000978; GO:0000981; GO:0001655; GO:0001756; GO:0005634; GO:0006357; GO:0007412; GO:0007595; GO:0008542; GO:0009653; GO:0021510; GO:0021767; GO:0021794; GO:0021855; GO:0022029; GO:0030154; GO:0030901; GO:0033504; GO:0043524; GO:0043565; GO:0061030; GO:0061374; GO:0061377; GO:0061379; GO:0061381; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" FIMDRFPYYRENTQR 0.99609 -9.5586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2304 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8956 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8528 0 0 0 13.2138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D1B5 GSAP_HUMAN "Gamma-secretase-activating protein, GSAP (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form, GSAP-16K ]" GSAP PION Homo sapiens (Human) positive regulation of amyloid-beta formation [GO:1902004]; regulation of proteolysis [GO:0030162] trans-Golgi network [GO:0005802] trans-Golgi network [GO:0005802]; amyloid-beta binding [GO:0001540]; positive regulation of amyloid-beta formation [GO:1902004]; regulation of proteolysis [GO:0030162] GO:0001540; GO:0005802; GO:0030162; GO:1902004 amyloid-beta binding [GO:0001540] DVLPWLRAQR 0.9961 -9.6019 11.0406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1942 0 0 0 0 0 13.9202 0 0 13.1223 14.0978 0 0 0 14.7412 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7626 0 0 13.47 0 0 0 0 0 0 0 0 0 0 0 11.3661 0 0 0 0 0 0 0 0 0 13.7503 13.4493 0 0 0 0 0 0 0 13.5775 12.5507 0 0 0 12.4829 0 0 0 14.4583 13.0913 11.8202 0 15.1594 0 13.1374 14.5643 0 13.2691 0 13.2808 0 0 13.6204 15.5877 0 0 0 0 14.6818 0 0 0 0 13.4168 13.9821 0 0 14.8298 0 13.5575 0 15.3007 11.6347 13.6673 15.1592 14.1532 15.1202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1162 0 0 0 0 0 13.3306 0 A6NNT2 CP096_HUMAN Uncharacterized protein C16orf96 C16orf96 Homo sapiens (Human) AHKDDVPKDR 0.9961 -9.9083 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7555 0 0 0 0 0 15.3643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2633 0 0 0 0 0 0 0 0 0 16.1867 0 15.8517 0 13.4724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0859 0 16.0772 0 0 0 0 0 0 0 0 0 0 13.1674 0 0 0 12.7257 0 0 0 13.6908 13.5203 0 0 0 0 0 0 0 0 0 0 0 12.9542 0 0 0 14.1111 0 0 0 0 13.6461 0 0 0 0 0 0 0 0 0 0 0 12.4747 0 14.2516 12.987 0 12.9323 0 12.3189 0 0 0 0 0 0 0 0 0 13.9856 13.034 14.0168 0 0 0 0 0 0 0 13.1023 0 0 0 0 0 0 0 0 0 0 13.5445 0 0 0 0 0 Q07866 KLC1_HUMAN "Kinesin light chain 1, KLC 1" KLC1 KLC KNS2 Homo sapiens (Human) microtubule-based movement [GO:0007018]; stress granule disassembly [GO:0035617] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; growth cone [GO:0030426]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894]; microtubule-based movement [GO:0007018]; stress granule disassembly [GO:0035617] GO:0003774; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0016020; GO:0019894; GO:0030426; GO:0031410; GO:0035617 cytoskeletal motor activity [GO:0003774]; kinesin binding [GO:0019894] CLKKDDESNLVEEK 0.9961 -11.695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4899 0 0 0 0 0 0 0 0 0 0 11.7701 9.92236 0 12.8888 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0003 0 0 0 0 0 0 0 0 0 0 11.7566 0 0 12.9708 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWL6 KIRR2_HUMAN Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3) KIRREL2 NEPH3 UNQ5827/PRO19646 Homo sapiens (Human) cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933] cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057] cell-cell junction [GO:0005911]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; negative regulation of protein phosphorylation [GO:0001933] GO:0001933; GO:0005886; GO:0005887; GO:0005911; GO:0007155; GO:0016021; GO:0036057; GO:0042802; GO:0050839; GO:0098609 cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802] GGAAEAR 0.9961 -9.9123 0 0 0 0 0 0 0 0 0 0 0 10.7093 0 13.9575 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1197 0 0 0 0 0 0 0 0 0 0 0 13.8244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z392 TPC11_HUMAN Trafficking protein particle complex subunit 11 TRAPPC11 C4orf41 Homo sapiens (Human) constitutive secretory pathway [GO:0045054]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; regulation of protein complex stability [GO:0061635]; vesicle tethering [GO:0099022] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072] cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; constitutive secretory pathway [GO:0045054]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; regulation of protein complex stability [GO:0061635]; vesicle tethering [GO:0099022] GO:0005737; GO:0005794; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0045054; GO:0048208; GO:0061635; GO:0099022; GO:1990072 ALKLLDYVMCDYR 0.9961 -9.9214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0175 0 14.5201 0 0 0 0 13.7457 0 0 13.4351 13.1445 0 0 12.4011 14.3984 0 0 0 0 0 0 12.2641 0 10.1131 0 0 0 0 0 0 0 0 10.9235 0 0 0 0 0 0 0 0 0 0 13.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7268 0 0 0 0 0 0 0 0 0 0 0 12.6415 0 0 0 12.5336 0 0 0 0 0 0 0 0 0 0 11.6007 0 0 0 0 0 12.2983 0 12.1631 Q8NHK3 KI2LB_HUMAN Killer cell immunoglobulin-like receptor 2DL5B (CD158 antigen-like family member F2) (Killer cell immunoglobulin-like receptor 2DLX) (CD antigen CD158f2) KIR2DL5B CD158F CD158F2 KIR2DL5 KIR2DLX Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] GO:0005886; GO:0016021 CRGSHPR 0.9961 -11.74 0 0 11.3862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.69106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6547 0 0 14.5308 11.1957 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96JF6 ZN594_HUMAN Zinc finger protein 594 (Zinc finger protein HZF18) ZNF594 KIAA1871 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0005654; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AYWCNQCGRAFQGSSDLIR 0.9961 -11.687 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6042 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8703 0 0 0 0 0 0 12.1221 0 0 0 14.6714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6855 0 0 0 0 0 0 13.8899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8804 0 0 0 0 Q9NSY2 STAR5_HUMAN "StAR-related lipid transfer protein 5 (START domain-containing protein 5, StARD5)" STARD5 Homo sapiens (Human) cholesterol import [GO:0070508] cytosol [GO:0005829] cytosol [GO:0005829]; bile acid binding [GO:0032052]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; cholesterol import [GO:0070508] GO:0005829; GO:0015485; GO:0032052; GO:0070508; GO:0120020 bile acid binding [GO:0032052]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020] FYANLQK 0.9961 -12.273 0 0 0 0 0 0 0 0 0 0 0 12.4459 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1668 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0247 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0383 0 0 0 Q9P287 BCCIP_HUMAN BRCA2 and CDKN1A-interacting protein (P21- and CDK-associated protein 1) (Protein TOK-1) BCCIP TOK1 Homo sapiens (Human) DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; kinase regulator activity [GO:0019207]; RNA binding [GO:0003723]; tubulin binding [GO:0015631]; DNA repair [GO:0006281]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; neuroendocrine cell differentiation [GO:0061101]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079] GO:0000079; GO:0000132; GO:0000226; GO:0003723; GO:0005634; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0007052; GO:0015631; GO:0019207; GO:0019908; GO:0034453; GO:0061101; GO:0090307; GO:0097431 kinase regulator activity [GO:0019207]; RNA binding [GO:0003723]; tubulin binding [GO:0015631] DEEEEKEVENEDEDDDDSDK 0.9961 -11.697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1587 12.6596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7406 0 12.9813 0 0 13.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0452 0 0 15.6006 16.4149 0 0 0 0 0 13.1244 0 14.7013 0 0 0 0 0 0 0 11.3238 11.9595 0 0 13.9631 0 0 0 0 0 0 0 13.3775 15.3006 11.0142 11.9405 0 10.6325 0 0 0 12.2197 0 0 0 12.0851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6316 0 0 0 0 0 0 0 0 0 0 14.32 14.206 0 14.0589 14.1348 0 0 0 0 0 0 0 0 0 0 13.9176 0 0 0 0 0 0 0 P14616 INSRR_HUMAN "Insulin receptor-related protein, IRR, EC 2.7.10.1 (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain ]" INSRR IRR Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cellular response to alkaline pH [GO:0071469]; male sex determination [GO:0030238]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] axon [GO:0030424]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235] axon [GO:0030424]; insulin receptor complex [GO:0005899]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; insulin receptor activity [GO:0005009]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; actin cytoskeleton reorganization [GO:0031532]; cellular response to alkaline pH [GO:0071469]; male sex determination [GO:0030238]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0004714; GO:0005009; GO:0005524; GO:0005887; GO:0005899; GO:0007169; GO:0030238; GO:0030424; GO:0031532; GO:0033674; GO:0043235; GO:0043548; GO:0043560; GO:0046777; GO:0071469 ATP binding [GO:0005524]; insulin receptor activity [GO:0005009]; insulin receptor substrate binding [GO:0043560]; phosphatidylinositol 3-kinase binding [GO:0043548]; transmembrane receptor protein tyrosine kinase activity [GO:0004714] ASTFGIHQGSCLAQCPSGFTRNSSSIFCHKCEGLCPK 0.99611 -9.6326 0 0 0 0 0 0 0 0 0 13.3041 0 0 0 0 0 0 0 0 0 15.2896 12.6121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7627 0 0 0 0 0 0 0 0 0 0 0 0 18.912 0 0 0 0 0 0 0 0 12.7393 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7925 0 0 0 0 0 0 11.8758 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.5529 0 0 0 0 0 0 0 0 0 10.5237 0 0 0 0 0 0 0 0 0 14.0758 0 0 0 0 0 0 0 0 0 0 0 0 14.2342 14.3971 0 0 17.8659 13.6004 11.8201 0 0 0 P61077 UB2D3_HUMAN "Ubiquitin-conjugating enzyme E2 D3, EC 2.3.2.23 ((E3-independent) E2 ubiquitin-conjugating enzyme D3, EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D3) (Ubiquitin carrier protein D3) (Ubiquitin-conjugating enzyme E2(17)KB 3) (Ubiquitin-conjugating enzyme E2-17 kDa 3) (Ubiquitin-protein ligase D3)" UBE2D3 UBC5C UBCH5C Homo sapiens (Human) apoptotic process [GO:0006915]; DNA repair [GO:0006281]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; DNA repair [GO:0006281]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] GO:0000122; GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006513; GO:0006915; GO:0010008; GO:0016567; GO:0030514; GO:0036211; GO:0043161; GO:0051865; GO:0061630; GO:0061631; GO:0070062; GO:0070936; GO:0070979; GO:1903955 ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842] EWTQKYAM 0.99611 -9.6477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0514 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N6R0 EFNMT_HUMAN "eEF1A lysine and N-terminal methyltransferase, eEF1A-KNMT (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase, EC 2.1.1.-; eEF1A N-terminal methyltransferase, EC 2.1.1.- ]" METTL13 EEF1AKNMT FEAT KIAA0859 CGI-01 Homo sapiens (Human) methylation [GO:0032259]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; methylation [GO:0032259]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0008168; GO:0032259; GO:1902807 methyltransferase activity [GO:0008168] DPTLGMSCPPPAFVEQSFLQK 0.99611 -9.6392 0 0 13.8989 0 0 0 0 0 0 0 0 0 0 0 10.5709 0 0 0 0 0 0 0 0 0 0 10.6339 10.759 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8059 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7377 0 0 0 0 12.0874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3334 13.5221 13.9306 12.7754 14.2007 0 0 0 12.7623 0 0 14.9048 0 0 0 0 0 0 0 0 0 0 0 14.3216 0 13.35 0 15.8616 0 0 0 15.4983 0 14.3753 0 0 0 0 0 0 0 0 0 0 11.457 0 0 0 0 0 0 0 0 0 0 0 0 13.2287 0 0 0 0 0 0 0 Q9NX18 SDHF2_HUMAN "Succinate dehydrogenase assembly factor 2, mitochondrial, SDH assembly factor 2, SDHAF2" SDHAF2 C11orf79 PGL2 SDH5 Homo sapiens (Human) "mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; mitochondrial respiratory chain complex II assembly [GO:0034553]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; protein dephosphorylation [GO:0006470]; protein-FAD linkage [GO:0018293]; tricarboxylic acid cycle [GO:0006099]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; mitochondrial respiratory chain complex II assembly [GO:0034553]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; protein dephosphorylation [GO:0006470]; protein-FAD linkage [GO:0018293]; tricarboxylic acid cycle [GO:0006099]" GO:0005730; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006121; GO:0006470; GO:0010719; GO:0018293; GO:0034553; GO:0090090 ARLLYESRK 0.99611 -9.6506 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.45127 0 0 0 0 0 0 0 0 11.9047 0 0 0 13.0879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1248 0 0 0 0 0 0 0 0 0 15.1459 0 0 0 0 0 0 0 0 0 A0A2Z4LIS9 FXO3B_HUMAN Forkhead box protein O3B FOXO3B Homo sapiens (Human) cytosol [GO:0005829] cytosol [GO:0005829]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565] GO:0003700; GO:0005829; GO:0043565 DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565] GVLSSQDSPHFQEK 0.99612 -10.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4235 0 12.4912 0 0 0 0 0 0 0 0 0 0 12.0179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2775 0 0 0 0 0 0 0 0 0 0 0 0 13.0992 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.89052 0 0 0 0 13.9882 0 0 0 11.0253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2343 0 0 O94907 DKK1_HUMAN "Dickkopf-related protein 1, Dickkopf-1, Dkk-1, hDkk-1 (SK)" DKK1 UNQ492/PRO1008 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] "early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; canonical Wnt signaling pathway [GO:0060070]; cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]" GO:0000122; GO:0000904; GO:0001706; GO:0001707; GO:0001942; GO:0002090; GO:0005576; GO:0005615; GO:0005886; GO:0007611; GO:0008083; GO:0010628; GO:0010942; GO:0010977; GO:0030178; GO:0030279; GO:0030326; GO:0030514; GO:0030900; GO:0031901; GO:0032091; GO:0032526; GO:0033137; GO:0039706; GO:0042662; GO:0042663; GO:0043066; GO:0043507; GO:0045813; GO:0048019; GO:0050750; GO:0051966; GO:0060070; GO:0060173; GO:0060325; GO:0060394; GO:0061743; GO:0090082; GO:0090090; GO:0090244; GO:0098883; GO:1901216; GO:1901296; GO:1902949; GO:1904338; GO:1904723; GO:1904958; GO:1905607; GO:2000096; GO:2000726 co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019] CYCGEGLSCR 0.99612 -9.7082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93264 0 0 0 0 0 0 0 0 0 0 0 0 15.6338 0 0 0 0 0 0 0 12.8085 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6284 0 0 0 0 14.5718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1677 0 0 0 0 10.2847 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3429 0 0 0 0 0 14.7208 0 0 0 0 0 0 0 0 0 0 12.8846 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50150 GBG4_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 GNG4 GNGT4 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell growth [GO:0030308]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; plasma membrane [GO:0005886]; G-protein beta-subunit binding [GO:0031681]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell growth [GO:0030308]; regulation of G protein-coupled receptor signaling pathway [GO:0008277] GO:0005834; GO:0005886; GO:0007186; GO:0008277; GO:0030308; GO:0031681; GO:0070062 G-protein beta-subunit binding [GO:0031681] MEACMDR 0.99612 -10.242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8138 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P86452 ZBED6_HUMAN Zinc finger BED domain-containing protein 6 ZBED6 Homo sapiens (Human) "negative regulation of cell death [GO:0060548]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; regulation of transcription by RNA polymerase II [GO:0006357]" centriolar satellite [GO:0034451]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "centriolar satellite [GO:0034451]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of cell death [GO:0060548]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000785; GO:0000976; GO:0000981; GO:0001227; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006357; GO:0034451; GO:0045787; GO:0045892; GO:0046872; GO:0046983; GO:0051148; GO:0060548 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]" AICNLCEK 0.99612 -12.421 0 0 0 14.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2447 0 13.8483 0 0 0 11.2248 0 13.729 0 0 0 0 15.8024 14.8742 0 0 0 0 0 14.7732 14.7221 0 0 0 0 0 0 0 0 0 0 0 15.037 0 11.9263 14.5183 14.1404 0 15.384 12.1319 0 0 0 0 0 0 14.4446 0 13.1223 0 15.2727 13.9362 0 0 0 0 0 0 0 0 0 0 0 0 12.4967 0 0 0 0 0 0 0 15.8473 12.8078 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6603 0 0 11.6466 0 0 0 12.0197 0 0 0 Q6PCT2 FXL19_HUMAN F-box/LRR-repeat protein 19 (F-box and leucine-rich repeat protein 19) FBXL19 FBL19 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005] cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; histone demethylase activity [GO:0032452]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0003712; GO:0005829; GO:0006357; GO:0006482; GO:0008270; GO:0019005; GO:0032452; GO:0043161; GO:0045322 histone demethylase activity [GO:0032452]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270] ACVRTECGDCHFCR 0.99612 -10.241 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0377 0 12.0187 0 0 0 0 12.814 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5182 0 13.2666 13.7687 13.8801 0 0 0 0 0 11.6998 0 0 0 14.7879 14.6656 14.6059 0 0 0 0 0 0 12.4035 0 0 0 13.4419 0 0 0 0 0 0 9.95622 0 15.6419 0 9.12156 0 0 11.832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.571 0 0 0 0 13.7478 10.8353 0 0 0 0 0 0 0 0 0 11.8825 0 12.0316 0 12.4482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZMK1 CYHR1_HUMAN Cysteine and histidine-rich protein 1 CYHR1 KIAA0496 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; zinc ion binding [GO:0008270] GO:0005634; GO:0005654; GO:0008270; GO:0048471 zinc ion binding [GO:0008270] EEQATCPNCR 0.99612 -10.271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6535 0 0 0 0 0 0 0 11.7285 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4155 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0269 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.499 0 0 0 13.6626 0 0 0 0 0 0 0 0 12.2849 0 12.5276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6758 0 0 0 0 0 0 0 11.8146 0 0 13.5867 0 0 0 13.6472 0 0 0 0 0 14.6644 10.5941 0 0 0 Q7Z5J1 DHI1L_HUMAN "Hydroxysteroid 11-beta-dehydrogenase 1-like protein, EC 1.1.1.- (11-beta-hydroxysteroid dehydrogenase type 3, 11-DH3, 11-beta-HSD3) (Short chain dehydrogenase/reductase family 26C member 2) (Short-chain dehydrogenase/reductase 10)" HSD11B1L HSD3 SCDR10 SDR26C2 Homo sapiens (Human) extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654] extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; oxidoreductase activity [GO:0016491] GO:0005576; GO:0005654; GO:0016491; GO:0043231 oxidoreductase activity [GO:0016491] ALPSLTDSK 0.99612 -9.6834 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1988 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2357 0 0 0 0 0 0 0 0 0 10.8262 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYF3 TEX11_HUMAN "Testis-expressed protein 11 (Protein ZIP4 homolog, ZIP4H)" TEX11 ZIP4 Homo sapiens (Human) apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130] central element [GO:0000801]; chromosome [GO:0005694] central element [GO:0000801]; chromosome [GO:0005694]; apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; ectopic germ cell programmed cell death [GO:0035234]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; negative regulation of developmental process [GO:0051093]; negative regulation of reproductive process [GO:2000242]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130] GO:0000712; GO:0000801; GO:0005694; GO:0006311; GO:0006915; GO:0007060; GO:0007130; GO:0007131; GO:0008584; GO:0009566; GO:0035234; GO:0043066; GO:0051026; GO:0051093; GO:2000242 ALKKALLLYK 0.99612 -10.266 0 0 0 0 0 0 0 0 0 12.2188 0 0 0 0 0 0 0 12.5235 0 0 12.3996 0 13.1244 0 0 0 0 0 0 0 0 0 12.2904 0 0 0 0 0 10.591 0 0 0 0 0 0 13.5286 0 11.1586 0 0 12.0629 0 0 0 0 0 0 0 0 0 0 0 0 9.42402 0 0 0 0 0 0 10.78 0 0 0 0 0 0 11.8392 0 0 0 11.7082 0 0 14.3987 14.0231 14.5572 14.1477 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2491 0 0 0 0 0 0 0 0 10.2502 0 13.3184 0 0 0 0 0 0 0 0 0 0 0 0 0 16.6754 0 0 0 0 0 0 0 0 0 13.4179 15.1897 0 15.3595 11.9313 0 0 12.1438 0 0 0 0 0 0 0 0 0 0 0 12.9341 0 0 0 0 0 0 0 12.9622 0 0 0 0 15.1451 11.0231 14.8848 0 0 0 0 0 0 Q8TBZ8 ZN564_HUMAN Zinc finger protein 564 ZNF564 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000978; GO:0003700; GO:0005634; GO:0006357; GO:0046872 DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978] AFIFPSYVRKHER 0.99612 -10.242 0 0 0 0 0 0 10.8899 0 0 0 0 14.4263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.205 12.0403 11.829 0 0 12.0616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6297 0 11.0144 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7037 0 13.4205 0 15.2912 0 15.5909 12.481 13.1129 13.1365 13.8221 0 0 0 0 0 0 0 0 12.7721 0 0 0 12.9944 0 0 0 11.7385 0 0 0 0 12.803 0 0 0 0 0 0 0 0 0 0 12.9408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2513 0 0 12.0629 0 0 0 11.0068 0 12.0112 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3429 Q14919 NC2A_HUMAN "Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha, NC2-alpha)" DRAP1 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0001046; GO:0001091; GO:0003713; GO:0003714; GO:0005634; GO:0006355; GO:0006366; GO:0016251; GO:0017025; GO:0017054; GO:0042802; GO:0045944; GO:0046982; GO:0090575 core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714] ALELFLESLLKK 0.99613 -10.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3772 0 13.0995 0 0 15.1439 0 11.5962 0 0 0 0 0 0 0 11.2672 0 0 0 0 0 14.868 0 0 12.2896 12.8835 0 0 11.1712 0 0 14.0668 19.1556 0 0 0 12.1697 14.4302 14.5056 13.3632 14.4591 13.8629 13.2021 12.9544 13.2848 0 13.3784 13.328 0 0 11.7374 14.2162 0 14.3232 14.276 14.3914 12.8817 18.5902 12.8701 0 13.314 0 13.8359 0 0 0 0 0 0 0 0 0 0 13.2333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5185 15.0225 15.1546 0 0 0 0 0 0 Q5T481 RBM20_HUMAN RNA-binding protein 20 (RNA-binding motif protein 20) RBM20 Homo sapiens (Human) "heart formation [GO:0060914]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of RNA splicing [GO:0033120]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634] "cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; zinc ion binding [GO:0008270]; heart formation [GO:0060914]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of RNA splicing [GO:0033120]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" GO:0003723; GO:0003729; GO:0005634; GO:0006397; GO:0008270; GO:0008380; GO:0033120; GO:0036464; GO:0043484; GO:0048024; GO:0048025; GO:0060914; GO:0097157; GO:1990935 mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]; zinc ion binding [GO:0008270] DQEGADDRK 0.99613 -10.063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6117 0 0 15.2689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8238 0 0 0 0 0 0 0 0 12.9582 0 0 0 11.4104 0 0 0 13.792 0 0 13.0386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.602 0 14.5132 0 12.9043 0 0 0 12.0986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.753 0 12.5882 0 13.1326 0 0 0 0 0 0 0 0 10.673 0 0 0 0 0 0 0 0 0 0 0 0 10.0268 0 0 0 Q6P9G9 ZN449_HUMAN Zinc finger protein 449 (Zinc finger and SCAN domain-containing protein 19) ZNF449 ZSCAN19 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357]; spermatogonial cell division [GO:0007284] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogonial cell division [GO:0007284]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007284; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" EQILELLVLEQFLTILPTEIETWVREHCPENRER 0.99613 -9.7372 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9283 13.1779 13.1927 0 0 0 0 12.4737 0 0 16.4209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.28 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4V2 SVOP_HUMAN "Synaptic vesicle 2-related protein, SV2-related protein" SVOP Homo sapiens (Human) anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane region [GO:0098590]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672] anchoring junction [GO:0070161]; integral component of membrane [GO:0016021]; plasma membrane region [GO:0098590]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter activity [GO:0022857] GO:0008021; GO:0016021; GO:0022857; GO:0030672; GO:0070161; GO:0098590 transmembrane transporter activity [GO:0022857] GKMRDLFTPHFR 0.99613 -9.7588 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0258 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.847 11.2641 0 0 0 0 0 0 12.3766 0 0 0 12.8507 13.1256 0 13.6111 0 0 0 0 0 0 0 0 12.6953 0 0 0 12.8749 12.8773 0 0 12.9325 0 0 0 0 0 0 0 0 13.5113 14.8636 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8084 0 0 0 0 0 13.6638 0 0 0 0 13.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7675 0 0 0 13.7729 0 0 0 0 11.1515 0 0 0 0 0 0 0 0 0 0 0 13.2717 0 12.054 0 Q8ND61 CC020_HUMAN Uncharacterized protein C3orf20 C3orf20 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] GO:0005737; GO:0016021 LLARISK 0.99613 -10.278 12.2034 11.3789 12.6239 0 0 0 0 0 0 0 0 0 0 12.6476 13.7137 0 0 13.7844 12.7303 0 13.2041 13.494 13.5372 11.7406 0 13.3439 0 0 13.3063 13.2644 0 0 0 0 0 0 0 13.4543 13.4013 13.1918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.664 0 0 0 0 0 0 13.6734 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1602 0 0 0 0 14.218 14.442 0 13.2844 12.6827 0 17.4413 11.6518 0 0 0 0 0 0 0 11.7064 0 0 14.3604 0 0 0 0 0 0 0 0 0 0 16.2456 14.0928 0 16.3896 0 0 0 0 13.5891 0 13.7796 0 10.5227 0 0 0 0 0 0 0 13.1966 0 16.5626 0 0 0 0 0 16.3818 16.6273 16.1586 16.2016 0 0 11.7737 0 0 15.3519 0 16.4219 0 0 0 0 0 0 0 0 0 0 0 0 12.6063 0 0 0 0 0 16.2817 0 0 0 0 0 14.7115 15.8577 10.9267 Q9C0H2 TTYH3_HUMAN "Protein tweety homolog 3, hTTY3" TTYH3 KIAA1691 Homo sapiens (Human) chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220] chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; volume-sensitive chloride channel activity [GO:0072320]; chloride transport [GO:0006821]; ion transmembrane transport [GO:0034220] GO:0005229; GO:0005254; GO:0005886; GO:0006821; GO:0034220; GO:0034707; GO:0070062; GO:0072320 chloride channel activity [GO:0005254]; intracellular calcium activated chloride channel activity [GO:0005229]; volume-sensitive chloride channel activity [GO:0072320] AANPFQQKLSGSHK 0.99613 -9.7291 0 0 0 0 0 0 0 0 14.7707 15.1815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9358 14.8041 0 0 0 14.4947 0 0 0 0 15.0514 0 0 14.9012 0 0 0 0 0 0 0 0 13.6344 13.7018 13.3361 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2351 0 0 0 0 0 11.792 12.078 0 12.9694 0 0 0 0 0 0 11.1868 11.8683 0 14.8036 14.5787 13.9851 13.8408 14.6501 14.6546 14.6318 15.6565 15.5847 0 13.8482 13.0934 0 11.5992 13.4041 0 13.7533 13.2881 0 13.5605 0 0 12.1507 0 15.8047 14.9817 0 0 0 0 12.5122 11.8154 12.3742 0 0 12.8709 13.8206 12.8959 0 0 0 12.7242 13.0192 0 12.2887 12.283 12.2517 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9335 0 11.9931 0 0 14.0421 13.6818 0 0 0 0 0 0 0 0 0 12.0944 0 12.1126 0 12.3509 0 0 0 0 0 10.4913 0 0 12.4403 15.5274 Q9UHG0 DCDC2_HUMAN Doublecortin domain-containing protein 2 (Protein RU2S) DCDC2 KIAA1154 RU2 Homo sapiens (Human) cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605] axoneme [GO:0005930]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686] axoneme [GO:0005930]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; kinesin binding [GO:0019894]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605] GO:0001764; GO:0005737; GO:0005815; GO:0005829; GO:0005874; GO:0005929; GO:0005930; GO:0006968; GO:0007605; GO:0015630; GO:0019894; GO:0030111; GO:0034451; GO:0035556; GO:0045880; GO:0048813; GO:0060091; GO:0060271; GO:0072686; GO:1902017 kinesin binding [GO:0019894] ASSLPPIVGSRK 0.99613 -9.7316 0 0 0 0 0 0 0 0 0 10.8868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7498 0 0 0 0 11.7631 0 11.8984 12.7036 0 12.6071 12.3195 14.3493 0 0 0 0 13.7835 0 0 13.1778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6952 14.3446 0 0 0 0 0 0 O75674 TM1L1_HUMAN TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1) TOM1L1 SRCASM Homo sapiens (Human) activation of protein kinase activity [GO:0032147]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; membrane [GO:0016020] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; membrane [GO:0016020]; clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130]; activation of protein kinase activity [GO:0032147]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162] GO:0005737; GO:0005764; GO:0005768; GO:0005795; GO:0005829; GO:0007165; GO:0010008; GO:0015031; GO:0016020; GO:0017124; GO:0019901; GO:0030276; GO:0030295; GO:0031954; GO:0032147; GO:0035091; GO:0043130; GO:0043162; GO:0045839; GO:0070062 clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130] EVYLDLVKK 0.99614 -9.7887 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5454 0 0 13.5889 13.2307 0 0 0 0 13.5289 0 0 0 13.5788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P82979 SARNP_HUMAN SAP domain-containing ribonucleoprotein (Cytokine-induced protein of 29 kDa) (Nuclear protein Hcc-1) (Proliferation-associated cytokine-inducible protein CIP29) SARNP HCC1 HSPC316 Homo sapiens (Human) mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346] cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417] GO:0000122; GO:0000346; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0006406; GO:0006417; GO:0016607; GO:0016973; GO:0036464 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723] AERFNVPVSLESK 0.99614 -9.8103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8011 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WVK7 SKA2_HUMAN Spindle and kinetochore-associated protein 2 (Protein FAM33A) SKA2 FAM33A Homo sapiens (Human) cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110] cytosol [GO:0005829]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876] cytosol [GO:0005829]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]; microtubule binding [GO:0008017]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; regulation of microtubule polymerization or depolymerization [GO:0031110] GO:0000278; GO:0000776; GO:0000940; GO:0005829; GO:0005876; GO:0007059; GO:0008017; GO:0031110; GO:0051301 microtubule binding [GO:0008017] ICATVKKTMNMIQK 0.99614 -9.7935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6523 0 15.1445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96EK2 PF21B_HUMAN PHD finger protein 21B PHF21B KIAA1661 Homo sapiens (Human) metal ion binding [GO:0046872] GO:0046872 metal ion binding [GO:0046872] ANEDPCWK 0.99614 -12.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.539 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6838 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0327 0 0 0 0 0 0 0 0 0 0 0 0 18.1353 0 0 0 0 0 0 0 0 0 Q9NU53 GINM1_HUMAN Glycoprotein integral membrane protein 1 GINM1 C6orf72 UNQ710/PRO1361 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 DDGDISK 0.99614 -9.8128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8818 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX05 F120C_HUMAN Constitutive coactivator of PPAR-gamma-like protein 2 (Protein FAM120C) (Tumor antigen BJ-HCC-21) FAM120C CXorf17 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; RNA binding [GO:0003723] GO:0003723; GO:0005634 RNA binding [GO:0003723] DPSNLDVVGK 0.99614 -12.051 0 0 0 0 0 0 0 11.6682 0 11.7024 0 13.1176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8687 0 0 0 13.7309 0 0 0 14.1272 14.6708 0 0 13.4837 0 0 0 0 0 0 0 0 10.7208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3294 14.0971 0 13.1321 11.3048 0 14.7958 0 0 0 12.3539 0 10.6276 0 0 0 14.1818 0 12.4537 0 14.2496 0 0 0 0 0 0 14.4844 0 0 0 0 0 12.8598 0 0 14.5525 0 0 0 0 14.3545 14.1159 0 0 0 0 0 0 0 0 0 0 14.4655 14.2628 0 12.2357 0 0 0 0 12.5728 12.8376 14.437 0 0 0 14.1956 0 0 0 0 0 0 0 0 0 12.7757 0 0 0 0 0 14.2236 14.7662 13.9071 0 0 14.4172 14.22 13.9536 0 0 0 0 14.4361 12.3366 0 13.7277 0 0 0 0 13.8972 0 0 O43242 PSMD3_HUMAN 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) PSMD3 Homo sapiens (Human) proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511] "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]" "cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511]" GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0008541; GO:0016020; GO:0022624; GO:0030234; GO:0034774; GO:0042176; GO:0043161; GO:0070062; GO:1904813 enzyme regulator activity [GO:0030234] EMAEDDDDSFP 0.99616 -12.269 0 0 0 0 0 0 0 0 0 0 0 0 0 12.18 0 0 0 0 0 0 0 0 0 0 0 11.3227 0 0 0 11.6014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2328 13.1507 0 0 11.3884 0 0 12.6155 0 13.1681 0 12.592 13.6763 0 13.4165 0 15.0903 11.9478 0 0 0 11.6444 0 0 0 0 0 14.0018 0 0 0 0 13.9288 0 13.8407 0 0 0 0 0 13.8776 0 0 0 0 15.0411 13.8657 15.4612 13.5142 0 13.2802 13.7404 0 0 13.0247 11.8763 0 13.4164 0 11.9811 0 0 13.1954 15.4229 13.1823 13.2103 0 0 0 0 0 0 0 10.5981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4301 14.5278 14.692 0 14.7779 0 0 0 0 0 0 12.1627 0 0 0 0 0 0 O43707 ACTN4_HUMAN Alpha-actinin-4 (Non-muscle alpha-actinin 4) ACTN4 Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; muscle cell development [GO:0055001]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018] actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; integrin binding [GO:0005178]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transmembrane transporter binding [GO:0044325]; actin cytoskeleton organization [GO:0030036]; muscle cell development [GO:0055001]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; response to hypoxia [GO:0001666]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050] GO:0000977; GO:0001666; GO:0001725; GO:0001882; GO:0003713; GO:0003723; GO:0003779; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0015031; GO:0015629; GO:0016604; GO:0016922; GO:0030018; GO:0030036; GO:0030050; GO:0030054; GO:0030335; GO:0030374; GO:0030864; GO:0031093; GO:0031143; GO:0031490; GO:0032417; GO:0032991; GO:0033209; GO:0035357; GO:0042803; GO:0042974; GO:0042981; GO:0042995; GO:0043005; GO:0044325; GO:0047485; GO:0048384; GO:0048471; GO:0051015; GO:0055001; GO:0070062; GO:1900025; GO:1901224; GO:1903506; GO:1990904 actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; integrin binding [GO:0005178]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoic acid receptor binding [GO:0042974]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]; transmembrane transporter binding [GO:0044325] GKMRVHK 0.99616 -12.267 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5581 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7964 0 0 0 0 0 0 0 0 0 0 13.2251 13.8506 0 0 0 0 0 0 13.5713 0 0 0 0 0 13.456 0 0 13.51 0 0 0 0 0 10.3681 0 0 0 0 0 0 17.2424 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94933 SLIK3_HUMAN SLIT and NTRK-like protein 3 SLITRK3 KIAA0848 Homo sapiens (Human) "axonogenesis [GO:0007409]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; synaptic transmission, GABAergic [GO:0051932]; terminal button organization [GO:0072553]" cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886] "cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; integral component of postsynaptic density membrane [GO:0099061]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; axonogenesis [GO:0007409]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; neurotransmitter-gated ion channel clustering [GO:0072578]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; synaptic transmission, GABAergic [GO:0051932]; terminal button organization [GO:0072553]" GO:0005886; GO:0007409; GO:0009986; GO:0051932; GO:0051965; GO:0072553; GO:0072578; GO:0097116; GO:0098982; GO:0099060; GO:0099061; GO:0099560; GO:1905606 AVSLTHLDLRGNRLK 0.99616 -9.9175 0 11.8805 0 0 0 0 10.9571 0 12.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2981 11.6432 0 12.582 0 0 0 0 11.7954 0 11.5404 13.8816 0 13.8609 14.3731 0 13.5697 0 0 0 13.603 0 0 0 11.8349 0 14.6565 12.1605 13.2909 0 0 0 0 0 0 0 0 0 11.0043 0 11.8785 0 0 0 0 13.3604 0 9.43838 12.4567 13.2852 0 0 0 0 0 0 12.0612 0 0 11.4692 0 0 12.2606 0 0 10.7779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3748 0 0 11.2104 0 0 0 0 0 0 0 0 0 11.4199 0 0 0 0 0 0 0 0 0 0 0 O95218 ZRAB2_HUMAN "Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)" ZRANB2 ZIS ZNF265 Homo sapiens (Human) mRNA processing [GO:0006397]; RNA splicing [GO:0008380] nucleoplasm [GO:0005654] nucleoplasm [GO:0005654]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380] GO:0001530; GO:0003723; GO:0005654; GO:0006397; GO:0008380; GO:0046872 lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; RNA binding [GO:0003723] EESDGEYDEFGR 0.99616 -9.5909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1263 12.3746 12.276 0 13.3009 0 12.2233 0 0 12.2018 0 0 0 0 0 0 9.84361 0 0 0 0 0 0 0 0 0 0 12.7994 0 12.6537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2588 13.9805 0 0 0 0 0 14.8577 15.2738 14.6907 0 14.9216 0 13.8909 0 0 0 0 0 0 0 0 15.0182 0 0 0 13.7887 14.503 0 0 0 0 0 0 0 0 0 12.9169 0 0 0 0 0 10.8121 0 0 0 14.2116 0 12.0906 14.701 0 0 0 0 0 0 0 0 0 10.6352 0 0 0 0 0 0 0 0 0 14.1846 11.7635 14.2807 0 0 0 0 0 0 13.9999 0 0 12.6626 13.8696 0 14.7414 0 0 15.0804 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P00488 F13A_HUMAN "Coagulation factor XIII A chain, Coagulation factor XIIIa, EC 2.3.2.13 (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain)" F13A1 F13A Homo sapiens (Human) "blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]" blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; transferase complex [GO:1990234] "blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; transferase complex [GO:1990234]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; blood coagulation [GO:0007596]; blood coagulation, fibrin clot formation [GO:0072378]; peptide cross-linking [GO:0018149]" GO:0003810; GO:0005576; GO:0005615; GO:0007596; GO:0018149; GO:0031093; GO:0046872; GO:0062023; GO:0072378; GO:0072562; GO:1990234 metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810] EEYVLNDIGVIFYGEVNDIK 0.99616 -9.5876 0 0 0 0 10.6233 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2126 0 0 0 9.81706 0 0 0 0 11.721 10.2292 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2226 0 0 14.9754 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9028 0 0 0 0 0 0 17.7809 0 0 0 0 0 0 12.911 0 0 0 0 0 0 0 0 0 13.2649 0 0 0 P56851 EP3B_HUMAN "Epididymal secretory protein E3-beta (Human epididymis-specific protein 3-beta, HE3-beta)" EDDM3B FAM12B HE3B UNQ6412/PRO21187 Homo sapiens (Human) extracellular region [GO:0005576] extracellular region [GO:0005576] GO:0005576 EVSWREFMK 0.99616 -9.9211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7465 0 0 0 0 0 0 11.8505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0328 0 0 0 0 0 14.1647 15.0027 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5944 13.8211 0 0 0 0 0 13.9084 0 0 0 0 13.794 0 0 13.3907 0 0 0 0 0 14.0533 0 13.8628 0 14.61 13.9215 0 14.5534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3028 0 0 13.8977 0 0 0 0 0 13.5085 0 0 0 0 0 12.9713 0 0 0 13.9202 0 0 0 0 0 0 0 0 P98187 CP4F8_HUMAN "Cytochrome P450 4F8, EC 1.14.14.1 (CYPIVF8)" CYP4F8 Homo sapiens (Human) icosanoid metabolic process [GO:0006690]; prostaglandin metabolic process [GO:0006693] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; alkane 1-monooxygenase activity [GO:0018685]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; icosanoid metabolic process [GO:0006690]; prostaglandin metabolic process [GO:0006693] GO:0004497; GO:0005506; GO:0005789; GO:0006690; GO:0006693; GO:0016021; GO:0018685; GO:0020037; GO:0070330 alkane 1-monooxygenase activity [GO:0018685]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497] ACRLVHDFTDAVIQER 0.99616 -9.9109 0 0 0 0 0 0 0 0 12.29 0 12.1135 11.5047 0 11.7832 13.4192 0 0 0 0 0 0 0 0 0 0 0 0 11.5551 0 12.3717 0 11.5445 0 12.63 12.4388 13.3796 12.0445 0 12.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7551 0 0 0 0 0 0 0 0 0 0 0 14.4735 0 12.7617 0 0 0 0 0 0 0 0 0 0 0 12.9874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3498 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5501 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q02817 MUC2_HUMAN "Mucin-2, MUC-2 (Intestinal mucin-2)" MUC2 SMUC Homo sapiens (Human) maintenance of gastrointestinal epithelium [GO:0030277] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; inner mucus layer [GO:0070702]; outer mucus layer [GO:0070703]; plasma membrane [GO:0005886] collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; inner mucus layer [GO:0070702]; outer mucus layer [GO:0070703]; plasma membrane [GO:0005886]; maintenance of gastrointestinal epithelium [GO:0030277] GO:0005615; GO:0005796; GO:0005886; GO:0030277; GO:0031012; GO:0062023; GO:0070702; GO:0070703 AQALDHSCSCCKEEK 0.99616 -9.9117 0 0 0 0 0 0 0 0 0 12.3418 12.0017 11.6738 0 0 12.032 11.6372 11.4658 12.3538 0 0 0 0 15.2322 0 12.168 11.3189 0 11.5084 0 0 0 0 0 0 0 12.0952 0 0 0 10.3291 0 0 0 0 0 0 0 10.7172 12.6937 0 0 0 9.99704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6442 17.7441 17.3079 17.2149 13.0874 0 17.8579 13.5051 20.5037 19.9392 0 0 0 0 17.3071 15.5712 0 0 0 14.4021 0 0 13.721 0 15.9141 0 0 0 0 16.7129 0 0 0 0 0 0 0 0 0 0 0 15.31 0 13.7698 0 0 0 12.3789 0 0 0 0 12.3702 0 0 0 0 17.9959 0 0 0 13.3525 14.226 0 12.3582 0 0 0 0 13.2551 0 0 13.7683 12.198 0 13.0519 0 0 17.4108 0 0 0 0 16.0991 13.1904 0 13.1198 0 0 0 0 0 0 12.9921 0 0 0 0 0 16.5963 0 12.9695 0 12.8645 0 0 0 0 Q03403 TFF2_HUMAN "Trefoil factor 2 (Spasmolysin) (Spasmolytic polypeptide, SP)" TFF2 SML1 Homo sapiens (Human) chemokine-mediated signaling pathway [GO:0070098]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of gastric acid secretion [GO:0060455] extracellular space [GO:0005615] extracellular space [GO:0005615]; CXCR4 chemokine receptor binding [GO:0031723]; chemokine-mediated signaling pathway [GO:0070098]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of gastric acid secretion [GO:0060455] GO:0005615; GO:0030277; GO:0031723; GO:0060455; GO:0070098 CXCR4 chemokine receptor binding [GO:0031723] NCGYPGISPEECASR 0.99616 -9.5715 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2741 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4919 0 11.2175 0 0 0 0 0 0 0 0 0 0 0 0 10.6736 0 0 0 0 0 0 0 0 0 0 0 12.8932 0 0 0 0 0 0 0 0 0 0 0 0 0 Q12913 PTPRJ_HUMAN "Receptor-type tyrosine-protein phosphatase eta, Protein-tyrosine phosphatase eta, R-PTP-eta, EC 3.1.3.48 (Density-enhanced phosphatase 1, DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J, R-PTP-J) (CD antigen CD148)" PTPRJ DEP1 Homo sapiens (Human) B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; contact inhibition [GO:0060242]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579] cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; contact inhibition [GO:0060242]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852] GO:0001772; GO:0004725; GO:0005161; GO:0005886; GO:0005887; GO:0005911; GO:0006470; GO:0008013; GO:0008285; GO:0009986; GO:0010642; GO:0016791; GO:0019221; GO:0019901; GO:0030155; GO:0030183; GO:0030308; GO:0030336; GO:0032587; GO:0032760; GO:0035335; GO:0035579; GO:0035584; GO:0042059; GO:0043116; GO:0043407; GO:0043410; GO:0045295; GO:0045296; GO:0045785; GO:0048008; GO:0050731; GO:0050852; GO:0050860; GO:0050918; GO:0051019; GO:0051894; GO:0051897; GO:0051898; GO:0060242; GO:0070062; GO:0070097; GO:1905451 beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725] EPALVLK 0.99616 -11.694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6589 13.9208 0 0 0 0 0 11.4738 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.547 0 0 0 0 0 0 0 0 0 12.7564 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8282 0 0 13.2371 0 0 0 0 0 13.2862 0 0 0 0 0 0 0 0 17.3363 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4055 0 0 0 0 0 12.7992 13.3899 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3852 0 0 0 0 0 0 13.2819 0 Q14093 CYLC2_HUMAN Cylicin-2 (Cylicin II) (Multiple-band polypeptide II) CYLC2 CYL2 Homo sapiens (Human) cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634] cytoskeletal calyx [GO:0033150]; nucleus [GO:0005634]; structural constituent of cytoskeleton [GO:0005200]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283] GO:0005200; GO:0005634; GO:0007283; GO:0030154; GO:0033150 structural constituent of cytoskeleton [GO:0005200] ADEKKDEDGK 0.99616 -9.9164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1379 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4059 0 0 0 0 0 0 0 0 0 0 0 13.2414 0 0 0 0 12.6943 0 0 0 0 0 0 13.0799 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0876 13.2732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1805 0 0 12.1431 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15034 HERC3_HUMAN "Probable E3 ubiquitin-protein ligase HERC3, EC 2.3.2.26 (HECT domain and RCC1-like domain-containing protein 3) (HECT-type E3 ubiquitin transferase HERC3)" HERC3 KIAA0032 Homo sapiens (Human) protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829] cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511] GO:0005737; GO:0005829; GO:0006511; GO:0016567; GO:0031410; GO:0061630 ubiquitin protein ligase activity [GO:0061630] FKYHIVK 0.99616 -9.5675 0 0 0 0 0 0 0 0 12.6229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.467 0 0 0 13.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3655 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0774 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1468 0 0 0 Q6ZQY2 LR74B_HUMAN Leucine-rich repeat-containing protein 74B LRRC74B Homo sapiens (Human) ELLPVFR 0.99616 -9.5719 0 0 0 0 0 0 0 0 0 0 0 14.2672 0 0 12.6541 0 0 12.7026 12.7202 0 0 0 12.2364 0 12.3318 0 0 0 0 12.0525 0 13.8966 0 0 0 0 0 0 0 0 0 0 13.7409 0 0 0 0 0 0 0 0 0 12.1527 0 12.2571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3848 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6428 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6955 0 0 14.737 0 0 0 0 0 0 0 0 0 0 14.1281 0 0 0 0 0 0 0 0 0 0 0 13.8388 13.9714 14.2166 0 0 0 0 0 0 0 0 0 Q8IZX4 TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like (TAF(II)210) (TBP-associated factor 1-like) (TBP-associated factor 210 kDa) (Transcription initiation factor TFIID 210 kDa subunit) TAF1L Homo sapiens (Human) "male meiotic nuclear division [GO:0007140]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]" nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669] "nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025]; male meiotic nuclear division [GO:0007140]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]" GO:0001091; GO:0003677; GO:0004402; GO:0004674; GO:0005654; GO:0005669; GO:0006357; GO:0007140; GO:0016251; GO:0017025; GO:0045893; GO:0051123; GO:0070577 DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025] DAGYGEK 0.99616 -12.268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2658 0 0 0 0 0 0 0 0 0 0 12.3134 0 11.9893 0 0 0 0 0 0 0 0 0 0 10.8916 0 0 0 0 0 10.9638 0 0 0 0 14.2073 0 0 0 0 0 0 0 0 0 13.1721 0 0 0 14.4964 0 0 0 0 0 0 0 12.6098 0 0 13.2227 0 0 0 0 13.7097 0 0 0 0 0 0 0 11.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3656 0 0 0 0 0 0 0 0 0 0 0 11.7364 0 0 0 0 Q8N841 TTLL6_HUMAN "Tubulin polyglutamylase TTLL6, EC 6.3.2.- (Protein polyglutamylase TTLL6) (Tubulin--tyrosine ligase-like protein 6)" TTLL6 TTL.6 Homo sapiens (Human) microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874] 9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; positive regulation of cilium movement [GO:0003353]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296] GO:0000226; GO:0001578; GO:0003353; GO:0005524; GO:0005829; GO:0005874; GO:0005929; GO:0015631; GO:0018095; GO:0036064; GO:0046872; GO:0051013; GO:0060296; GO:0070739; GO:0070740; GO:0097731 ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740] DPCMQDQEAYSHCLISGQKGCER 0.99616 -9.5681 0 0 0 0 0 0 0 0 0 12.6947 13.5827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9125 0 0 0 0 0 0 0 0 0 0 11.4156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4871 0 0 0 10.9708 0 0 0 0 0 0 0 12.3974 0 0 0 0 0 0 0 0 10.4366 0 0 0 12.3348 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8839 0 0 13.206 0 0 0 0 13.7153 0 0 12.64 13.2715 0 0 11.0641 0 0 0 0 0 0 13.3086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7572 0 12.0934 0 0 0 0 0 0 0 14.3595 0 0 0 0 0 12.5386 0 0 0 0 0 0 Q96KX1 CD036_HUMAN Uncharacterized protein C4orf36 C4orf36 Homo sapiens (Human) KNTVKTILR 0.99616 -9.9072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9Y2X9 ZN281_HUMAN Zinc finger protein 281 (GC-box-binding zinc finger protein 1) (Transcription factor ZBP-99) (Zinc finger DNA-binding protein 99) ZNF281 GZP1 ZBP99 Homo sapiens (Human) "embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]" nucleoplasm [GO:0005654]; nucleus [GO:0005634] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; stem cell differentiation [GO:0048863]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0010172; GO:0010629; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:0048863; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]" CDTCQQYFSR 0.99616 -11.689 0 0 0 0 0 0 0 0 12.6206 0 0 0 0 0 0 0 10.6862 0 12.0204 0 0 0 0 0 0 12.5315 11.5265 0 12.1608 0 0 0 0 12.1728 11.9815 0 12.5644 12.4527 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6185 0 14.8987 13.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.632 0 0 0 14.3338 0 0 14.4244 0 0 0 0 0 0 0 0 0 0 13.6794 0 0 0 0 0 13.2545 0 0 14.314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9945 0 0 14.0918 13.9358 0 14.1273 0 14.1101 14.1311 14.0776 0 0 14.1625 14.113 0 0 0 0 0 0 14.9499 0 0 0 0 0 0 0 12.4431 0 13.8278 0 0 0 0 13.3021 0 0 0 0 0 17.3768 0 0 16.9907 16.9761 0 0 0 13.8822 13.6965 0 0 0 0 0 0 0 0 0 0 Q9Y5H3 PCDGA_HUMAN "Protocadherin gamma-A10, PCDH-gamma-A10" PCDHGA10 Homo sapiens (Human) cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007399 calcium ion binding [GO:0005509] LPDTQLLKFQLNK 0.99616 -9.8931 0 0 0 0 0 0 0 0 0 0 0 14.0189 0 0 0 13.1874 12.1979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4277 0 0 0 12.223 0 0 0 11.735 0 0 0 0 0 0 11.8482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6259 16.0201 14.0626 0 0 0 0 0 0 0 14.0631 0 0 0 0 0 0 15.5951 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0975 0 0 16.562 0 0 0 0 0 0 0 0 0 9.97642 0 13.5362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9816 0 0 0 0 0 0 0 0 0 0 14.2321 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1462 0 0 0 13.5499 0 0 0 0 0 0 A8K010 CF176_HUMAN Putative transcriptional regulator encoded by LINC00473 LINC00473 C6orf176 Homo sapiens (Human) "transcription, DNA-templated [GO:0006351]" "transcription, DNA-templated [GO:0006351]" GO:0006351 APGCAGR 0.99617 -11.739 0 0 0 0 0 0 0 10.9689 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2114 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.016 0 0 0 0 0 11.6971 11.7314 0 0 0 0 0 0 0 0 Q86X76 NIT1_HUMAN "Deaminated glutathione amidase, dGSH amidase, EC 3.5.1.128 (Nitrilase homolog 1)" NIT1 Homo sapiens (Human) cellular amide catabolic process [GO:0043605] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; deaminated glutathione amidase activity [GO:0110050]; cellular amide catabolic process [GO:0043605] GO:0005634; GO:0005737; GO:0005739; GO:0043605; GO:0110050 deaminated glutathione amidase activity [GO:0110050] HLPVFQHR 0.99617 -9.6325 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0885 10.4164 10.9482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H201 EPN3_HUMAN Epsin-3 (EPS-15-interacting protein 3) EPN3 Homo sapiens (Human) endocytosis [GO:0006897] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886] clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; clathrin binding [GO:0030276]; EH domain binding [GO:1990175]; phospholipid binding [GO:0005543]; endocytosis [GO:0006897] GO:0005543; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005905; GO:0006897; GO:0019897; GO:0030125; GO:0030136; GO:0030276; GO:0043231; GO:0048471; GO:0070062; GO:1990175 clathrin binding [GO:0030276]; EH domain binding [GO:1990175]; phospholipid binding [GO:0005543] APQVAKTR 0.99617 -9.6012 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8216 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.086 0 0 0 0 0 12.9191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1574 0 0 12.654 13.35 0 0 0 0 0 0 0 0 0 0 12.3525 0 0 0 0 0 0 0 0 0 12.1852 0 0 0 0 0 0 0 12.3445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00115 DNS2A_HUMAN "Deoxyribonuclease-2-alpha, EC 3.1.22.1 (Acid DNase) (Deoxyribonuclease II alpha, DNase II alpha) (Lysosomal DNase II) (R31240_2)" DNASE2 DNASE2A DNL2 Homo sapiens (Human) apoptotic DNA fragmentation [GO:0006309]; DNA metabolic process [GO:0006259]; enucleate erythrocyte differentiation [GO:0043353]; regulation of immune response [GO:0050776] extracellular exosome [GO:0070062]; lysosome [GO:0005764] extracellular exosome [GO:0070062]; lysosome [GO:0005764]; deoxyribonuclease II activity [GO:0004531]; DNA binding [GO:0003677]; apoptotic DNA fragmentation [GO:0006309]; DNA metabolic process [GO:0006259]; enucleate erythrocyte differentiation [GO:0043353]; regulation of immune response [GO:0050776] GO:0003677; GO:0004531; GO:0005764; GO:0006259; GO:0006309; GO:0043353; GO:0050776; GO:0070062 deoxyribonuclease II activity [GO:0004531]; DNA binding [GO:0003677] GPWTCVGDMNR 0.99618 -10.238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4095 0 0 0 0 0 0 0 0 0 13.634 0 0 0 0 0 0 0 13.9649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4926 0 0 0 0 0 0 Q8IWX8 CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6) CHERP DAN26 SCAF6 Homo sapiens (Human) cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017] cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396] GO:0003723; GO:0005654; GO:0005737; GO:0006396; GO:0006874; GO:0007399; GO:0008285; GO:0016020; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886 RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325] DKWDQYK 0.99618 -10.24 0 11.1777 0 0 12.1112 0 12.7201 13.344 14.4489 0 0 12.8105 0 0 0 0 0 0 14.1156 13.9234 11.8588 12.0559 11.8596 0 0 0 0 0 0 0 0 13.1152 0 0 0 0 0 0 10.1134 0 13.5042 0 0 0 13.9574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8727 0 14.171 12.517 0 14.641 0 13.5293 14.7846 0 12.9163 0 17.0067 0 15.0386 14.081 12.08 15.1371 0 0 14.1842 14.1945 0 0 12.5999 12.6117 11.946 0 15.2884 14.7766 16.0536 0 13.1103 0 13.9017 0 0 12.0559 12.3335 0 12.7865 0 13.5554 0 0 16.1592 0 11.6007 0 17.1414 14.7845 0 13.1781 0 13.4741 0 0 0 15.4111 0 0 16.9243 0 0 0 13.7558 0 0 0 10.9571 0 15.8767 0 0 11.2641 0 0 0 0 0 0 13.6622 0 0 11.5496 0 0 0 0 9.80135 0 0 0 0 0 0 0 14.5633 13.5276 0 0 0 11.8675 0 13.9561 0 Q9BUA3 SPNDC_HUMAN "Spindlin interactor and repressor of chromatin-binding protein (SPIN1-docking protein, SPIN-DOC)" SPINDOC C11orf84 Homo sapiens (Human) "negative regulation of transcription, DNA-templated [GO:0045892]" "negative regulation of transcription, DNA-templated [GO:0045892]" GO:0045892 ALCMVCGAEIR 0.99618 -9.6503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6578 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6229 0 14.0933 0 0 13.7764 0 0 0 14.2513 0 0 0 0 0 0 12.9206 0 0 0 0 0 13.7953 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UKL6 PPCT_HUMAN "Phosphatidylcholine transfer protein, PC-TP (START domain-containing protein 2, StARD2) (StAR-related lipid transfer protein 2)" PCTP STARD2 Homo sapiens (Human) lipid transport [GO:0006869]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid transport [GO:0015914] cytosol [GO:0005829] cytosol [GO:0005829]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; lipid transport [GO:0006869]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid transport [GO:0015914] GO:0005829; GO:0006869; GO:0008525; GO:0015914; GO:0031210; GO:0120163 phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525] ACQNYLKKT 0.99618 -9.682 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3406 0 0 16.4135 12.9756 14.0772 13.6627 0 0 16.158 0 13.4239 0 16.3925 13.7979 0 16.2191 0 16.564 11.1946 0 0 0 0 0 12.4623 0 0 14.1393 12.23 14.7857 13.6202 0 16.4021 0 0 0 0 13.1452 0 15.8924 16.0719 0 0 0 0 0 15.0391 14.9509 0 0 12.1492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6723 13.7634 12.4772 0 0 0 0 0 18.337 0 0 0 18.2215 0 0 0 18.2093 12.8762 0 0 0 0 0 0 18.1934 0 0 0 0 0 0 0 10.888 0 0 0 0 0 17.5979 0 0 0 12.5839 0 0 12.7409 13.2378 0 0 0 0 0 0 0 12.923 17.1157 12.6784 17.1024 14.0966 0 0 0 0 0 0 0 0 0 12.8645 17.0736 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.726 0 0 0 0 0 0 16.646 0 16.7307 0 0 0 16.7829 0 O00399 DCTN6_HUMAN Dynactin subunit 6 (Dynactin subunit p27) (Protein WS-3) DCTN6 WS3 Homo sapiens (Human) mitotic spindle organization [GO:0007052] centrosome [GO:0005813]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776] centrosome [GO:0005813]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]; dynein complex binding [GO:0070840]; mitotic spindle organization [GO:0007052] GO:0000776; GO:0005813; GO:0005829; GO:0005869; GO:0007052; GO:0070840 dynein complex binding [GO:0070840] GSSTPVK 0.99619 -9.714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7534 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1623 0 0 0 12.8824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P10966 CD8B_HUMAN T-cell surface glycoprotein CD8 beta chain (CD antigen CD8b) CD8B CD8B1 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] cell surface [GO:0009986]; early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101] cell surface [GO:0009986]; early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]; coreceptor activity [GO:0015026]; MHC class I protein binding [GO:0042288]; adaptive immune response [GO:0002250]; immune response [GO:0006955]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169] GO:0002250; GO:0005576; GO:0005886; GO:0005887; GO:0006955; GO:0007169; GO:0009986; GO:0015026; GO:0031901; GO:0042101; GO:0042110; GO:0042288; GO:0050852 coreceptor activity [GO:0015026]; MHC class I protein binding [GO:0042288] ARLRFMK 0.99619 -10.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8635 0 0 0 0 0 0 12.7798 0 12.8411 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7445 0 12.0931 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4926 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9757 0 0 16.3456 P36551 HEM6_HUMAN "Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial, COX, Coprogen oxidase, Coproporphyrinogenase, EC 1.3.3.3" CPOX CPO CPX Homo sapiens (Human) heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to arsenic-containing substance [GO:0046685]; response to insecticide [GO:0017085]; response to iron ion [GO:0010039]; response to lead ion [GO:0010288]; response to methylmercury [GO:0051597] GO:0004109; GO:0005212; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006782; GO:0006783; GO:0010039; GO:0010288; GO:0017085; GO:0042803; GO:0046685; GO:0051597 coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212] LWQQLRR 0.99619 -10.246 0 0 0 0 0 0 0 0 0 0 0 12.0755 0 0 11.2207 0 0 0 0 0 0 11.5228 0 11.6709 0 0 0 0 0 0 0 0 0 0 11.7486 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1263 0 0 0 0 0 0 0 0 0 13.2976 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8158 0 13.6678 0 0 0 0 0 0 0 0 0 0 13.4346 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41240 CSK_HUMAN "Tyrosine-protein kinase CSK, EC 2.7.10.2 (C-Src kinase) (Protein-tyrosine kinase CYL)" CSK Homo sapiens (Human) adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852] GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0007420; GO:0008022; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0033673; GO:0034236; GO:0034332; GO:0042802; GO:0042997; GO:0043406; GO:0045121; GO:0045779; GO:0046777; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375; GO:1990782 ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782] DPNWYKAKNK 0.99619 -9.7314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9742 0 0 0 0 0 0 14.3673 11.6085 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7954 0 0 0 0 0 0 0 0 12.7619 0 0 0 0 0 0 15.2309 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3689 0 13.76 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.184 12.0535 0 14.5748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01995 TAGL_HUMAN "Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha, SM22-alpha)" TAGLN SM22 WS3-10 Homo sapiens (Human) epithelial cell differentiation [GO:0030855]; muscle organ development [GO:0007517] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856] cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; epithelial cell differentiation [GO:0030855]; muscle organ development [GO:0007517] GO:0005737; GO:0005856; GO:0007517; GO:0030855; GO:0051015 actin filament binding [GO:0051015] GPSYGMSREVQSKIEK 0.99619 -10.266 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1604 13.8854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7192 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N448 LNX2_HUMAN Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1) LNX2 PDZRN1 Homo sapiens (Human) neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182] plasma membrane [GO:0005886] plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842]; neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182] GO:0004842; GO:0005886; GO:0030165; GO:0030182; GO:0042802; GO:0046872; GO:0061351 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842] CLRNFLQEKDFCPLDR 0.99619 -10.059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.118 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0397 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9181 0 0 14.3054 0 0 0 0 12.9062 0 0 0 0 0 0 13.9007 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5451 0 0 0 0 0 0 0 13.188 0 0 0 0 0 0 0 Q8N6F7 GCSAM_HUMAN "Germinal center-associated signaling and motility protein (Germinal center B-cell-expressed transcript 2 protein) (Germinal center-associated lymphoma protein, hGAL)" GCSAM GAL GCET2 Homo sapiens (Human) negative regulation of lymphocyte migration [GO:2000402]; regulation of B cell receptor signaling pathway [GO:0050855] cytoplasm [GO:0005737]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901]; negative regulation of lymphocyte migration [GO:2000402]; regulation of B cell receptor signaling pathway [GO:0050855] GO:0003779; GO:0005737; GO:0005886; GO:0019901; GO:0045159; GO:0050855; GO:2000402 actin binding [GO:0003779]; myosin II binding [GO:0045159]; protein kinase binding [GO:0019901] ILIFEKR 0.99619 -9.7107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1435 0 0 0 0 0 0 0 0 0 0 0 0 13.3009 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5666 0 0 0 0 0 15.482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WUD4 CCD12_HUMAN Coiled-coil domain-containing protein 12 CCDC12 Homo sapiens (Human) post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684] post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684] GO:0005684; GO:0071014 ALREKTGR 0.99619 -10.278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7773 0 0 0 0 0 0 0 0 0 0 0 0 12.8288 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BQF6 SENP7_HUMAN "Sentrin-specific protease 7, EC 3.4.22.- (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7)" SENP7 KIAA1707 SSP2 SUSP2 Homo sapiens (Human) antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific endopeptidase activity [GO:0070139]; antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926] GO:0005634; GO:0005737; GO:0016926; GO:0070139; GO:0140374 SUMO-specific endopeptidase activity [GO:0070139] DPIVNFELPIHLEKWFPRHVIK 0.99619 -10.06 0 0 0 0 0 0 0 0 0 0 0 0 12.7417 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5223 0 0 0 0 0 0 0 0 0 0 0 12.1459 0 13.0468 0 0 0 0 0 0 0 11.5412 0 0 0 0 0 0 0 0 0 15.1051 0 13.2807 0 15.358 0 15.5265 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9005 0 0 0 13.5204 0 0 0 12.9339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6143 0 0 0 0 0 0 18.8898 0 0 Q9BYE2 TMPSD_HUMAN "Transmembrane protease serine 13, EC 3.4.21.- (Membrane-type mosaic serine protease, Mosaic serine protease)" TMPRSS13 MSP TMPRSS11 Homo sapiens (Human) proteolysis [GO:0006508] blood microparticle [GO:0072562]; integral component of membrane [GO:0016021] blood microparticle [GO:0072562]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005044; GO:0006508; GO:0016021; GO:0072562 scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252] CNDYLVYDSYLTPRMMCAGDLR 0.99619 -10.271 0 0 0 10.6274 0 11.5559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.515 0 0 0 0 0 0 0 0 11.8122 0 0 0 0 0 0 0 0 0 11.6429 0 0 0 0 0 0 0 0 11.2367 0 0 0 0 12.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6787 11.1319 12.856 0 0 0 0 0 0 0 0 0 11.3049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6581 0 0 0 0 0 Q9HC73 CRLF2_HUMAN "Cytokine receptor-like factor 2 (Cytokine receptor-like 2) (IL-XR) (Thymic stromal lymphopoietin protein receptor, TSLP receptor)" CRLF2 CRL2 ILXR TSLPR Homo sapiens (Human) cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235] external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894] GO:0004896; GO:0004923; GO:0005127; GO:0005576; GO:0005886; GO:0008284; GO:0009897; GO:0016021; GO:0019221; GO:0019955; GO:0032754; GO:0033005; GO:0038165; GO:0043235; GO:1904894 ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923] AMEDVYGPDTYPSDWSEVTCWQR 0.99619 -10.276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4996 12.8327 10.8571 0 12.2913 0 0 0 12.4458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6759 0 0 0 10.2889 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3818 0 13.9484 14.3947 0 13.0201 0 13.2803 0 15.1603 13.4543 14.4888 0 0 0 0 0 0 12.763 0 0 0 0 0 0 0 0 11.6009 0 13.0838 0 0 0 0 0 0 11.9883 0 0 0 13.2454 0 0 0 0 0 0 0 0 0 0 0 10.7626 0 0 0 13.4791 0 0 0 0 0 0 0 13.9213 0 0 0 0 0 0 0 0 0 13.2582 0 0 12.6917 0 0 12.9265 12.8056 0 0 0 0 0 0 0 0 13.4362 0 0 0 0 13.3316 13.234 0 0 0 0 0 0 0 P07195 LDHB_HUMAN "L-lactate dehydrogenase B chain, LDH-B, EC 1.1.1.27 (LDH heart subunit, LDH-H) (Renal carcinoma antigen NY-REN-46)" LDHB Homo sapiens (Human) lactate metabolic process [GO:0006089]; NAD metabolic process [GO:0019674]; pyruvate metabolic process [GO:0006090] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; oxidoreductase complex [GO:1990204] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; oxidoreductase complex [GO:1990204]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase activity [GO:0004459]; NAD binding [GO:0051287]; lactate metabolic process [GO:0006089]; NAD metabolic process [GO:0019674]; pyruvate metabolic process [GO:0006090] GO:0004459; GO:0005737; GO:0005743; GO:0005829; GO:0006089; GO:0006090; GO:0016020; GO:0019674; GO:0019900; GO:0042802; GO:0045121; GO:0051287; GO:0070062; GO:1990204 identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase activity [GO:0004459]; NAD binding [GO:0051287] DDEVAQLK 0.9962 -9.757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23528 COF1_HUMAN "Cofilin-1 (18 kDa phosphoprotein, p18) (Cofilin, non-muscle isoform)" CFL1 CFL Homo sapiens (Human) actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; cytoskeleton organization [GO:0007010]; establishment of spindle localization [GO:0051293]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; positive regulation by host of viral process [GO:0044794]; positive regulation of embryonic development [GO:0040019]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to virus [GO:0009615]; Rho protein signal transduction [GO:0007266] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; vesicle [GO:0031982] actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; cytoskeleton organization [GO:0007010]; establishment of spindle localization [GO:0051293]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; positive regulation by host of viral process [GO:0044794]; positive regulation of embryonic development [GO:0040019]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to virus [GO:0009615]; Rho protein signal transduction [GO:0007266] GO:0000281; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005925; GO:0007010; GO:0007266; GO:0009615; GO:0015629; GO:0016020; GO:0016363; GO:0022604; GO:0030027; GO:0030036; GO:0030042; GO:0030043; GO:0030426; GO:0031258; GO:0031982; GO:0032587; GO:0040019; GO:0043066; GO:0044794; GO:0051014; GO:0051015; GO:0051293; GO:0061001; GO:0070062 actin filament binding [GO:0051015] KKLTGIK 0.9962 -9.7371 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.849 0 0 0 0 0 0 0 0 0 0 0 0 10.8729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.814 0 0 0 0 0 0 13.2341 0 0 0 0 0 0 0 0 0 0 0 0 12.3259 0 0 0 0 0 0 0 0 10.8556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6PID8 KLD10_HUMAN Kelch domain-containing protein 10 KLHDC10 KIAA0265 Homo sapiens (Human) positive regulation of stress-activated MAPK cascade [GO:0032874]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654] Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ubiquitin ligase-substrate adaptor activity [GO:1990756]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627] GO:0005654; GO:0005737; GO:0016567; GO:0031462; GO:0032874; GO:0140627; GO:1990756 ubiquitin ligase-substrate adaptor activity [GO:1990756] EWTQLKPNNLSCDLPEERYR 0.9962 -12.059 0 12.0819 0 0 0 0 0 0 15.2086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7707 0 0 0 0 13.5324 0 12.917 0 13.8615 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3339 0 0 0 0 0 0 0 0 0 13.6785 0 0 0 0 0 0 10.8695 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8445 0 0 10.739 0 0 0 0 0 15.008 11.3713 0 0 0 0 0 0 0 13.3361 0 13.4268 15.1912 14.6788 0 0 0 0 12.0444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86U06 RBM23_HUMAN "Probable RNA-binding protein 23 (CAPER beta, CAPERbeta) (RNA-binding motif protein 23) (RNA-binding region-containing protein 4) (Splicing factor SF2)" RBM23 RNPC4 PP239 Homo sapiens (Human) "mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]" membrane [GO:0016020]; nucleus [GO:0005634] "membrane [GO:0016020]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]" GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0016020; GO:0045893; GO:0048024 RNA binding [GO:0003723] DARTVFCMQLAAR 0.9962 -9.7547 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96HA8 NTAQ1_HUMAN "Protein N-terminal glutamine amidohydrolase, EC 3.5.1.122 (Protein NH2-terminal glutamine deamidase, N-terminal Gln amidase, Nt(Q)-amidase) (WDYHV motif-containing protein 1)" NTAQ1 C8orf32 WDYHV1 Homo sapiens (Human) protein modification process [GO:0036211] cytosol [GO:0005829]; nucleus [GO:0005634] cytosol [GO:0005829]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773]; protein modification process [GO:0036211] GO:0005634; GO:0005829; GO:0008418; GO:0036211; GO:0070773 protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773] DACVYSSCYCEENIWK 0.9962 -9.7797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.143 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0885 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6402 10.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96LW2 KS6R_HUMAN "Ribosomal protein S6 kinase-related protein, EC 2.7.11.1 (Sugen kinase 494)" RSKR SGK494 Homo sapiens (Human) protein phosphorylation [GO:0006468] ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468] GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0106310 ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] FPVAAER 0.9962 -9.7557 0 0 0 0 0 0 0 0 11.686 0 0 11.2621 0 0 0 0 0 0 0 10.6242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5789 0 13.2863 0 0 0 0 0 0 10.3939 0 0 0 0 0 0 0 0 0 0 0 0 13.4764 13.0083 12.5522 0 0 0 0 0 0 11.049 0 0 0 0 12.1016 11.35 11.2911 0 0 0 0 12.4064 0 0 0 0 0 0 0 0 13.0537 0 0 0 14.3514 0 0 0 0 15.6739 15.5894 0 0 0 13.3011 0 0 0 0 12.9949 0 0 0 0 12.9742 0 0 0 0 0 0 12.6312 0 0 0 0 14.3001 0 0 0 0 0 0 0 13.2654 0 0 0 0 13.0027 0 0 12.8015 0 12.1825 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2002 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6873 0 Q9H4T2 ZSC16_HUMAN Zinc finger and SCAN domain-containing protein 16 (Zinc finger protein 392) (Zinc finger protein 435) ZSCAN16 ZNF392 ZNF435 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" AEDHYWGQDSSSQKCSPHR 0.9962 -9.7369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2406 0 0 0 0 0 0 13.82 0 0 0 0 0 0 0 0 0 0 12.3765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4094 13.3451 14.0771 0 0 0 13.521 12.992 0 0 0 0 0 0 12.7744 0 13.6237 14.2951 0 0 0 12.5811 0 13.3173 12.0555 13.0341 11.3427 0 0 0 13.7356 13.8117 0 0 0 0 0 0 11.1645 0 0 0 12.4499 0 0 12.776 0 0 0 0 0 12.9035 0 0 10.8994 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUU6 OTULL_HUMAN Inactive ubiquitin thioesterase OTULINL OTULINL FAM105A Homo sapiens (Human) cytoplasm [GO:0005737]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nuclear envelope [GO:0005635] cytoplasm [GO:0005737]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nuclear envelope [GO:0005635] GO:0005635; GO:0005737; GO:0042406 CVRQVRR 0.9962 -12.056 16.6448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1252 0 0 0 0 0 14.4295 0 14.1569 12.8139 0 0 0 0 0 0 0 0 0 0 0 0 12.2091 0 0 0 0 12.5445 12.4311 0 0 0 0 0 0 0 14.1137 0 0 0 0 13.7389 14.5916 0 0 14.8323 0 15.4854 0 14.7071 0 15.0631 15.1285 0 0 14.8296 0 15.1983 0 15.1109 0 14.7732 0 0 0 0 0 13.5894 0 0 0 0 0 0 14.1298 15.1353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43516 WIPF1_HUMAN "WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein, WASP-interacting protein)" WIPF1 WASPIP WIP Homo sapiens (Human) actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; protein-containing complex assembly [GO:0065003]; response to other organism [GO:0051707] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ruffle [GO:0001726] actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; ruffle [GO:0001726]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; protein-containing complex assembly [GO:0065003]; response to other organism [GO:0051707] GO:0001726; GO:0003779; GO:0005522; GO:0005829; GO:0005884; GO:0008154; GO:0015629; GO:0017124; GO:0030048; GO:0031410; GO:0051707; GO:0065003 actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124] ALPATPQLPSRSGVDSPR 0.99621 -9.8102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5531 0 0 0 0 0 0 Q96FX8 PERP_HUMAN "p53 apoptosis effector related to PMP-22 (Keratinocyte-associated protein 1, KCP-1) (P53-induced protein PIGPC1) (Transmembrane protein THW)" PERP KCP1 KRTCAP1 PIGPC1 THW Homo sapiens (Human) activation of cysteine-type endopeptidase activity [GO:0097202]; amelogenesis [GO:0097186]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; heterotypic cell-cell adhesion [GO:0034113]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; Notch signaling pathway [GO:0007219]; positive regulation of proteolysis [GO:0045862] cell-cell junction [GO:0005911]; desmosome [GO:0030057]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886] cell-cell junction [GO:0005911]; desmosome [GO:0030057]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; activation of cysteine-type endopeptidase activity [GO:0097202]; amelogenesis [GO:0097186]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; heterotypic cell-cell adhesion [GO:0034113]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; Notch signaling pathway [GO:0007219]; positive regulation of proteolysis [GO:0045862] GO:0002934; GO:0005739; GO:0005794; GO:0005886; GO:0005887; GO:0005911; GO:0007219; GO:0030057; GO:0034113; GO:0045862; GO:0072332; GO:0097186; GO:0097202; GO:0098609 CGLACER 0.99621 -9.8074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2409 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7591 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7805 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7099 0 0 0 Q9P0Z9 SOX_HUMAN "Peroxisomal sarcosine oxidase, PSO, EC 1.5.3.1, EC 1.5.3.7 (L-pipecolate oxidase) (L-pipecolic acid oxidase)" PIPOX LPIPOX PSO Homo sapiens (Human) L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777] cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115]; L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554] GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660 flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115] GEVGLLDNSGGVIYAYKALRALQDAIR 0.99621 -9.7857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4448 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2458 0 0 0 0 0 0 0 0 0 0 0 12.906 0 0 0 0 0 0 0 13.0372 0 0 0 0 0 0 0 13.3392 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8235 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P34982 OR1D2_HUMAN "Olfactory receptor 1D2 (Olfactory receptor 17-4, OR17-4) (Olfactory receptor OR17-6) (Olfactory receptor-like protein HGMP07E)" OR1D2 OLFR1 Homo sapiens (Human) chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; olfactory receptor activity [GO:0004984]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338] GO:0004930; GO:0004984; GO:0005886; GO:0005887; GO:0006935; GO:0007165; GO:0007186; GO:0007338; GO:0007608; GO:0042802 G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; olfactory receptor activity [GO:0004984] AILRIPSVSK 0.99622 -11.693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9784 12.9524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2279 0 0 Q96A23 CPNE4_HUMAN Copine-4 (Copine IV) (Copine-8) CPNE4 Homo sapiens (Human) cellular response to calcium ion [GO:0071277] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886] extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872]; cellular response to calcium ion [GO:0071277] GO:0005544; GO:0005886; GO:0046872; GO:0070062; GO:0071277 calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872] HDFIGEFTSTFK 0.99622 -9.8927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2839 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2669 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6691 P78364 PHC1_HUMAN "Polyhomeotic-like protein 1, hPH1 (Early development regulatory protein 1)" PHC1 EDR1 PH1 Homo sapiens (Human) "histone ubiquitination [GO:0016574]; negative regulation of transcription, DNA-templated [GO:0045892]" nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102] "nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270]; histone ubiquitination [GO:0016574]; negative regulation of transcription, DNA-templated [GO:0045892]" GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0008270; GO:0016574; GO:0031519; GO:0035102; GO:0042393; GO:0045892 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270] ETESEQNSNSTNGSSSSGGSSR 0.99623 -9.6007 12.9855 12.0393 11.9398 12.5657 0 0 12.6957 0 11.2637 0 0 0 0 0 0 11.5486 0 12.0341 0 0 0 11.7873 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4069 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1489 0 0 12.5434 11.8455 0 11.5031 11.1855 0 0 0 0 0 0 0 0 0 12.9052 0 15.0312 14.4148 0 0 15.0821 13.9495 15.842 15.1707 14.2334 15.2723 12.9932 14.9212 0 0 0 0 13.4877 0 14.9556 15.0512 13.9669 0 13.3311 0 13.318 13.7959 13.5474 16.1822 13.5668 13.7994 13.4833 14.0377 13.1027 13.2251 0 0 0 12.9832 15.2317 14.2158 14.0986 0 13.2507 14.4394 13.1693 14.9851 13.1986 14.8913 13.9951 15.043 13.0258 13.1841 14.2044 14.9352 14.1791 0 15.6411 0 13.6143 14.0527 14.0977 13.5983 13.6488 13.974 15.244 13.1985 14.6088 14.6475 15.3934 15.2132 15.8281 14.0816 15.1981 15.3812 15.3404 13.3886 15.8699 14.4081 15.992 0 0 0 13.4219 13.0027 15.0684 14.7568 0 13.1505 0 0 0 0 0 0 0 0 0 13.565 12.6381 0 0 11.9335 0 15.6666 13.9737 15.2638 14.7114 0 0 0 13.0949 0 Q674X7 KAZRN_HUMAN Kazrin KAZN C1orf196 KAZ KIAA1026 HRIHFB2003 Homo sapiens (Human) keratinization [GO:0031424] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654] cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; keratinization [GO:0031424] GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424 ARCETQNIDPVVWTNQR 0.99623 -12.42 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6DWJ6 GP139_HUMAN Probable G-protein coupled receptor 139 (G(q)-coupled orphan receptor GPRg1) (G-protein-coupled receptor PGR3) GPR139 GPRG1 PGR3 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; neuropeptide receptor activity [GO:0008188]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200] GO:0005886; GO:0007186; GO:0007200; GO:0008188; GO:0016021; GO:0042802 identical protein binding [GO:0042802]; neuropeptide receptor activity [GO:0008188] AFFKCQK 0.99623 -9.5851 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1467 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6927 0 0 0 0 0 0 0 0 13.0282 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6J6 FRMD5_HUMAN FERM domain-containing protein 5 FRMD5 Homo sapiens (Human) actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021] adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; integral component of membrane [GO:0016021]; cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334] GO:0005178; GO:0005856; GO:0005912; GO:0008092; GO:0016021; GO:0019901; GO:0030334; GO:0031032; GO:0045785; GO:2000146 cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901] IILTYFAPTPEACK 0.99623 -9.5873 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.447 12.1901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7681 0 0 10.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N183 NDUF2_HUMAN "NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 (B17.2-like, B17.2L) (Mimitin) (Myc-induced mitochondrial protein, MMTN) (NDUFA12-like protein)" NDUFAF2 NDUFA12L Homo sapiens (Human) mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex binding [GO:0044877]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179] GO:0005739; GO:0005743; GO:0032981; GO:0044877; GO:0061179 protein-containing complex binding [GO:0044877] DGKSHNQ 0.99623 -9.9208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0808 0 0 0 0 13.3222 0 13.0667 13.7208 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7303 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NHU3 SMS2_HUMAN "Phosphatidylcholine:ceramide cholinephosphotransferase 2, EC 2.7.8.27 (Sphingomyelin synthase 2)" SGMS2 SMS2 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; phosphorylation [GO:0016310]; regulation of bone mineralization [GO:0030500]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of Golgi membrane [GO:0030173]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ceramide cholinephosphotransferase activity [GO:0047493]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188]; ceramide biosynthetic process [GO:0046513]; phosphorylation [GO:0016310]; regulation of bone mineralization [GO:0030500]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686] GO:0005794; GO:0005886; GO:0005887; GO:0006686; GO:0016301; GO:0016310; GO:0030148; GO:0030173; GO:0030176; GO:0030500; GO:0033188; GO:0046513; GO:0047493 ceramide cholinephosphotransferase activity [GO:0047493]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188] SLSSGLR 0.99623 -9.9107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7674 0 0 0 0 0 0 0 0 0 0 0 14.4132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6558 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BX63 FANCJ_HUMAN "Fanconi anemia group J protein, Protein FACJ, EC 3.6.4.13 (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1, BRCA1-interacting protein 1)" BRIP1 BACH1 FANCJ Homo sapiens (Human) cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284] BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "BRCA1-B complex [GO:0070532]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to vitamin [GO:0071295]; chiasma assembly [GO:0051026]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous recombination [GO:0035825]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284]" GO:0000077; GO:0003677; GO:0003678; GO:0003682; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006302; GO:0006357; GO:0007284; GO:0007286; GO:0008285; GO:0009636; GO:0010629; GO:0010705; GO:0016887; GO:0031965; GO:0035825; GO:0043139; GO:0046872; GO:0051026; GO:0051539; GO:0070532; GO:0071295; GO:0071456; GO:0072520; GO:1904385; GO:1990918 "4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; RNA helicase activity [GO:0003724]" AEVQLSCCCACHSK 0.99623 -9.9096 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1625 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0002 0 0 0 0 0 0 0 0 12.5954 14.293 0 0 0 13.4131 0 0 13.9373 13.6966 14.1044 0 0 0 0 0 0 0 12.3465 0 0 0 0 12.2512 10.3963 13.1692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9408 0 0 0 0 0 0 0 0 0 14.54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.549 0 0 0 0 0 0 Q14137 BOP1_HUMAN Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein) BOP1 KIAA0124 Homo sapiens (Human) "cell population proliferation [GO:0008283]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]" "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex [GO:1990904]" "chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; cell population proliferation [GO:0008283]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosome biogenesis [GO:0042254]" GO:0000027; GO:0000448; GO:0000463; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0008283; GO:0030687; GO:0042254; GO:0043021; GO:0051726; GO:0070545; GO:1901796; GO:1990904 ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723] CLDLYLCPRQR 0.99624 -10.212 0 0 0 0 0 0 0 0 0 0 0 0 15.2841 0 0 0 0 0 13.1923 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3743 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0008 0 0 10.9738 0 0 11.538 0 0 13.4441 0 0 0 0 0 0 0 0 0 0 0 0 14.815 0 14.397 0 13.793 12.8702 0 0 0 0 0 0 0 12.9195 0 0 0 0 14.1507 12.7852 14.6225 12.0528 0 15.5907 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8707 14.1577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7814 0 12.7736 0 0 0 14.8736 14.0291 0 13.1663 0 13.101 0 14.042 0 0 0 0 0 0 0 0 0 0 14.0829 0 0 13.9853 0 0 0 0 0 0 0 0 Q8WU10 PYRD1_HUMAN "Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1, EC 1.8.1.-" PYROXD1 Homo sapiens (Human) cellular response to oxidative stress [GO:0034599] nucleus [GO:0005634]; sarcomere [GO:0030017] nucleus [GO:0005634]; sarcomere [GO:0030017]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; cellular response to oxidative stress [GO:0034599] GO:0005634; GO:0016491; GO:0030017; GO:0034599; GO:0050660 flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491] DTDSAQEFQK 0.99624 -10.204 0 0 0 0 0 0 0 0 12.91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8759 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0161 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9999 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0265 0 0 0 12.1784 0 12.7763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43304 S14L5_HUMAN SEC14-like protein 5 SEC14L5 KIAA0420 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 HLWRPGVKALLR 0.99625 -9.658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4635 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.03793 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4121 0 0 0 0 0 0 P28698 MZF1_HUMAN "Myeloid zinc finger 1, MZF-1 (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42)" MZF1 MZF ZNF42 ZSCAN6 Homo sapiens (Human) "negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]" nucleoplasm [GO:0005654] "nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000122; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003700; GO:0005654; GO:0006355; GO:0042803; GO:0045944; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]" CAECGQSFR 0.99625 -10.265 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0086 0 0 0 0 0 0 0 0 0 12.3427 0 0 0 0 10.5529 0 0 0 15.9717 0 14.2034 15.949 0 0 0 0 0 0 0 11.3607 0 0 0 0 0 0 0 0 0 0 14.6311 12.5932 0 0 0 0 0 0 0 11.1437 0 0 0 0 0 0 0 0 0 0 0 0 15.3065 0 14.3287 0 13.663 0 0 0 0 0 0 0 0 0 0 0 14.8329 0 0 0 0 0 0 0 0 12.4552 0 0 0 0 0 0 15.0831 0 0 0 0 0 16.1169 0 0 0 0 12.5989 0 0 0 0 0 0 0 0 0 13.8384 0 16.0384 0 0 0 0 0 12.1566 0 17.8351 0 0 0 15.8786 0 13.999 13.9734 12.8059 0 0 0 0 0 P51572 BAP31_HUMAN "B-cell receptor-associated protein 31, BCR-associated protein 31, Bap31 (6C6-AG tumor-associated antigen) (Protein CDM) (p28)" BCAP31 BAP31 DXS1357E Homo sapiens (Human) "apoptotic process [GO:0006915]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein targeting to mitochondrion [GO:0006626]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]" clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum [GO:0097038] "clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; integral component of plasma membrane [GO:0005887]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrion [GO:0005739]; perinuclear endoplasmic reticulum [GO:0097038]; MHC class I protein binding [GO:0042288]; protein-containing complex binding [GO:0044877]; apoptotic process [GO:0006915]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein targeting to mitochondrion [GO:0006626]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]" GO:0000139; GO:0005739; GO:0005783; GO:0005789; GO:0005811; GO:0005829; GO:0005887; GO:0006626; GO:0006888; GO:0006915; GO:0007204; GO:0007283; GO:0016020; GO:0030136; GO:0032471; GO:0032580; GO:0033116; GO:0034976; GO:0035584; GO:0042288; GO:0043280; GO:0044233; GO:0044877; GO:0051561; GO:0070973; GO:0071556; GO:0097038; GO:1903071; GO:1904154; GO:2001244 MHC class I protein binding [GO:0042288]; protein-containing complex binding [GO:0044877] EIRKYDDVTEK 0.99625 -9.6812 0 0 0 0 0 0 0 0 0 0 0 11.0222 0 0 13.4851 0 9.76396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1868 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5094 16.3509 0 13.7771 0 16.6234 0 0 14.1062 0 0 0 16.6132 0 0 0 0 0 0 0 0 0 0 0 13.1555 0 12.4874 0 0 13.7658 13.521 0 0 13.3501 0 13.4701 0 13.514 0 0 0 12.8098 0 0 0 0 0 0 12.2544 0 13.2037 0 13.2034 13.1137 13.2378 0 14.6396 0 0 0 12.9216 12.7982 0 0 0 0 13.1474 0 11.692 0 0 0 0 0 13.4033 0 12.528 0 12.0128 0 0 0 0 0 0 0 0 0 0 0 12.2313 0 0 0 0 0 13.3315 0 0 P78344 IF4G2_HUMAN "Eukaryotic translation initiation factor 4 gamma 2, eIF-4-gamma 2, eIF-4G 2, eIF4G 2 (Death-associated protein 5, DAP-5) (p97)" EIF4G2 DAP5 OK/SW-cl.75 Homo sapiens (Human) cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; regulation of cell cycle [GO:0051726]; regulation of translational initiation [GO:0006446] adherens junction [GO:0005912]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020] "adherens junction [GO:0005912]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cell death [GO:0008219]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of cell growth [GO:0030307]; regulation of cell cycle [GO:0051726]; regulation of translational initiation [GO:0006446]" GO:0003723; GO:0003729; GO:0003743; GO:0005829; GO:0005912; GO:0006446; GO:0008135; GO:0008219; GO:0010507; GO:0016020; GO:0016281; GO:0030307; GO:0034645; GO:0045296; GO:0051726 "cadherin binding [GO:0045296]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]" AIAKIKMLGNIK 0.99625 -10.248 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1696 0 10.5123 0 0 0 0 0 0 0 12.1529 0 0 0 0 10.8177 0 0 0 0 0 0 0 0 11.0717 0 0 0 0 0 0 13.8992 0 0 0 0 11.4738 0 0 13.1145 0 11.8248 11.5832 10.7884 0 0 0 11.9372 0 0 0 0 0 12.8618 13.6395 0 10.2999 0 10.2783 15.2891 0 0 12.3531 12.819 9.92404 0 0 11.5915 15.5313 13.2711 14.9133 0 15.0387 14.9003 11.5294 15.0276 15.191 11.6326 15.4225 15.0629 0 0 10.4861 15.1708 15.4472 14.6238 14.606 0 0 0 13.8728 14.2104 0 14.4085 0 13.089 0 14.307 0 14.1265 0 14.3637 0 13.649 13.1195 14.3637 11.6721 13.9699 0 0 0 12.3493 13.629 11.8078 0 11.5057 11.7529 0 0 0 11.9664 11.6178 0 14.5897 14.275 13.94 0 13.2968 13.2865 0 10.9254 0 0 12.6376 0 18.4777 0 0 13.9947 13.8388 0 0 0 0 14.357 10.0647 0 11.142 0 10.6624 0 11.7288 13.3318 0 14.7447 11.3407 0 0 0 0 0 0 12.2887 0 0 Q6ICG6 K0930_HUMAN Uncharacterized protein KIAA0930 KIAA0930 C22orf9 Homo sapiens (Human) ILTDILEVRQK 0.99625 -9.6798 0 0 0 0 10.913 0 0 0 0 0 0 0 0 0 11.9579 0 0 0 0 0 0 10.4872 11.3818 0 11.6986 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2824 13.5041 11.1609 13.982 0 0 13.4619 0 0 0 0 0 12.7469 0 14.6241 14.2507 13.3236 12.9049 0 14.253 12.9349 12.8982 0 14.3802 13.2827 0 0 0 14.1152 12.3747 13.0942 0 13.7722 12.1836 0 12.9822 0 0 0 12.3253 0 0 0 12.3839 0 13.6987 12.294 15.1218 13.812 12.8308 0 15.3074 13.3691 0 0 13.6544 0 12.6927 12.5036 14.388 13.9288 13.8568 13.8392 14.1072 12.9331 13.4407 14.4724 0 12.1157 0 13.4526 14.1034 0 13.9887 0 0 0 12.7187 0 0 14.53 15.1732 13.8461 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0001 0 13.4375 0 0 0 0 0 0 Q6UWQ5 LYZL1_HUMAN "Lysozyme-like protein 1, EC 3.2.1.17" LYZL1 LYC2 UNQ648/PRO1278 Homo sapiens (Human) metabolic process [GO:0008152] extracellular region [GO:0005576] extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; metabolic process [GO:0008152] GO:0003796; GO:0005576; GO:0008152 lysozyme activity [GO:0003796] DLSEWKK 0.99625 -9.6704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZSS3 ZN621_HUMAN Zinc finger protein 621 ZNF621 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AFKWYGSFVQHQK 0.99625 -10.265 0 0 0 0 12.3257 0 11.951 0 0 0 0 0 0 0 11.7952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4537 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0967 0 0 0 0 13.9693 14.4674 15.0043 0 0 14.0777 0 13.8332 0 15.3135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.868 0 0 0 0 0 0 Q8N0W5 IQCK_HUMAN IQ domain-containing protein K IQCK Homo sapiens (Human) AAPRQIPSHIVRLK 0.99625 -10.264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1126 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7913 12.6292 11.9781 0 0 0 0 0 0 0 12.375 12.5115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9197 0 0 0 0 14.6166 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7104 13.3142 12.6932 0 0 0 0 0 0 0 12.0099 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6616 0 13.4875 0 0 0 0 0 0 0 0 0 0 0 8.74947 0 0 0 0 0 0 0 0 0 0 11.4165 0 Q99572 P2RX7_HUMAN "P2X purinoceptor 7, P2X7 (ATP receptor) (P2Z receptor) (Purinergic receptor)" P2RX7 Homo sapiens (Human) apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cellular response to ATP [GO:0071318]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrial depolarization [GO:0051882]; mitochondrion organization [GO:0007005]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid transfer to membrane [GO:0006649]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; prostaglandin secretion [GO:0032310]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein secretion [GO:0009306]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of another organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell apoptotic process [GO:0070231]; T cell homeostasis [GO:0043029]; T cell mediated cytotoxicity [GO:0001913]; T cell proliferation [GO:0042098]; vesicle budding from membrane [GO:0006900] bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793] bleb [GO:0032059]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integral component of nuclear inner membrane [GO:0005639]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; apoptotic signaling pathway [GO:0097190]; bleb assembly [GO:0032060]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling using extracellular calcium source [GO:0035585]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; cellular response to ATP [GO:0071318]; cellular response to dsRNA [GO:0071359]; cellular response to extracellular stimulus [GO:0031668]; ceramide biosynthetic process [GO:0046513]; collagen metabolic process [GO:0032963]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; gamma-aminobutyric acid secretion [GO:0014051]; glutamate secretion [GO:0014047]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; membrane depolarization [GO:0051899]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrial depolarization [GO:0051882]; mitochondrion organization [GO:0007005]; NAD transport [GO:0043132]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell volume [GO:0045794]; negative regulation of MAPK cascade [GO:0043409]; phagolysosome assembly [GO:0001845]; phospholipid transfer to membrane [GO:0006649]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of bleb assembly [GO:1904172]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of glycolytic process [GO:0045821]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of ion transmembrane transport [GO:0034767]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; prostaglandin secretion [GO:0032310]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; protein secretion [GO:0009306]; purinergic nucleotide receptor signaling pathway [GO:0035590]; reactive oxygen species metabolic process [GO:0072593]; regulation of killing of cells of another organism [GO:0051709]; regulation of sodium ion transport [GO:0002028]; release of sequestered calcium ion into cytosol [GO:0051209]; response to ATP [GO:0033198]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; sensory perception of pain [GO:0019233]; skeletal system morphogenesis [GO:0048705]; synaptic vesicle exocytosis [GO:0016079]; T cell apoptotic process [GO:0070231]; T cell homeostasis [GO:0043029]; T cell mediated cytotoxicity [GO:0001913]; T cell proliferation [GO:0042098]; vesicle budding from membrane [GO:0006900] GO:0000165; GO:0000902; GO:0001530; GO:0001614; GO:0001845; GO:0001913; GO:0001916; GO:0002028; GO:0002931; GO:0004931; GO:0005102; GO:0005524; GO:0005639; GO:0005737; GO:0005739; GO:0005886; GO:0005887; GO:0005911; GO:0006468; GO:0006509; GO:0006649; GO:0006900; GO:0006954; GO:0007005; GO:0007166; GO:0009306; GO:0009410; GO:0009612; GO:0009897; GO:0010043; GO:0010524; GO:0010628; GO:0014047; GO:0014049; GO:0014051; GO:0014054; GO:0016020; GO:0016079; GO:0016485; GO:0017121; GO:0019233; GO:0030163; GO:0030501; GO:0031594; GO:0031668; GO:0032059; GO:0032060; GO:0032308; GO:0032310; GO:0032496; GO:0032730; GO:0032731; GO:0032755; GO:0032963; GO:0033198; GO:0034405; GO:0034767; GO:0035585; GO:0035590; GO:0042098; GO:0042802; GO:0043025; GO:0043029; GO:0043132; GO:0043406; GO:0043409; GO:0045779; GO:0045794; GO:0045821; GO:0046513; GO:0046931; GO:0048705; GO:0048873; GO:0050714; GO:0050830; GO:0051209; GO:0051495; GO:0051592; GO:0051602; GO:0051709; GO:0051882; GO:0051899; GO:0051901; GO:0060907; GO:0070231; GO:0070234; GO:0070588; GO:0071318; GO:0071359; GO:0072593; GO:0097190; GO:0097191; GO:0098793; GO:0098794; GO:1904172; GO:1905114 ATP binding [GO:0005524]; extracellularly ATP-gated cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102] CCQPCVVNEYYYR 0.99625 -10.271 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7749 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4473 0 0 0 0 0 0 0 0 0 0 0 12.8315 0 0 0 14.8305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7925 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9ULW5 RAB26_HUMAN Ras-related protein Rab-26 RAB26 Homo sapiens (Human) "exocrine system development [GO:0035272]; Golgi to plasma membrane protein transport [GO:0043001]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]" anchored component of synaptic vesicle membrane [GO:0098993]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intrinsic component of plasma membrane [GO:0031226]; secretory granule membrane [GO:0030667] "anchored component of synaptic vesicle membrane [GO:0098993]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intrinsic component of plasma membrane [GO:0031226]; secretory granule membrane [GO:0030667]; GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; exocrine system development [GO:0035272]; Golgi to plasma membrane protein transport [GO:0043001]; regulated exocytosis [GO:0045055]; regulation of exocytosis [GO:0017157]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]" GO:0000139; GO:0003924; GO:0005525; GO:0005768; GO:0005794; GO:0017157; GO:0019002; GO:0030667; GO:0031226; GO:0035272; GO:0043001; GO:0045055; GO:0098993; GO:0099575 GMP binding [GO:0019002]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] GASCCRP 0.99625 -10.237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2257 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7RTT6 SSX6_HUMAN Putative protein SSX6 SSX6P SSX6 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 DDAKASEK 0.99626 -9.7538 0 0 0 0 0 0 0 0 0 11.7856 0 12.3633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6999 0 13.111 0 0 0 12.7802 0 0 0 12.4917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6652 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.357 13.172 13.618 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7196 0 0 P12955 PEPD_HUMAN "Xaa-Pro dipeptidase, X-Pro dipeptidase, EC 3.4.13.9 (Imidodipeptidase) (Peptidase D) (Proline dipeptidase, Prolidase)" PEPD PRD Homo sapiens (Human) cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508] extracellular exosome [GO:0070062] extracellular exosome [GO:0070062]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508] GO:0004181; GO:0006508; GO:0006520; GO:0008233; GO:0030145; GO:0030574; GO:0070006; GO:0070062; GO:0102009 manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009] AVKVGMK 0.99627 -9.7843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5548 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53708 ITA8_HUMAN Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain ] ITGA8 Homo sapiens (Human) brain development [GO:0007420]; cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] apical part of cell [GO:0045177]; cell surface [GO:0009986]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha8-beta1 complex [GO:0034678]; integrin complex [GO:0008305]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; brain development [GO:0007420]; cell adhesion mediated by integrin [GO:0033627]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; metanephros development [GO:0001656]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; smooth muscle cell differentiation [GO:0051145]; smooth muscle tissue development [GO:0048745]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179] GO:0001656; GO:0001822; GO:0005178; GO:0005783; GO:0005886; GO:0005925; GO:0007160; GO:0007179; GO:0007229; GO:0007420; GO:0007613; GO:0008305; GO:0009897; GO:0009986; GO:0014069; GO:0030030; GO:0030198; GO:0030511; GO:0032591; GO:0033627; GO:0034446; GO:0034678; GO:0042472; GO:0043204; GO:0045177; GO:0045184; GO:0045944; GO:0046872; GO:0048333; GO:0048745; GO:0051145; GO:0098609 integrin binding [GO:0005178]; metal ion binding [GO:0046872] FAVPRLEK 0.99627 -9.7815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9034 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6854 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4537 0 0 0 0 0 0 0 0 13.6767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P53803 RPAB4_HUMAN "DNA-directed RNA polymerases I, II, and III subunit RPABC4, RNA polymerases I, II, and III subunit ABC4 (ABC10-alpha) (DNA-directed RNA polymerase II subunit K) (RNA polymerase II 7.0 kDa subunit, RPB7.0) (RPB10alpha)" POLR2K Homo sapiens (Human) regulation of transcription by RNA polymerase I [GO:0006356]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]" "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270]; regulation of transcription by RNA polymerase I [GO:0006356]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383]" GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005666; GO:0005736; GO:0005829; GO:0006356; GO:0006366; GO:0006383; GO:0008270 DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; zinc ion binding [GO:0008270] CRECGYR 0.99627 -9.7659 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9253 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2186 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4125 0 0 0 0 0 0 0 0 0 0 0 0 0 11.151 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61962 DCAF7_HUMAN DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog) DCAF7 HAN11 WDR68 Homo sapiens (Human) protein ubiquitination [GO:0016567] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-macromolecule adaptor activity [GO:0030674]; protein ubiquitination [GO:0016567] GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016363; GO:0016567; GO:0016604; GO:0030674; GO:0032991; GO:0080008 protein-macromolecule adaptor activity [GO:0030674] GVYPDLLATSGDYLRVWR 0.99627 -9.7857 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2958 0 0 0 14.0264 13.6919 0 13.9676 0 0 12.0508 0 0 0 0 13.706 0 0 0 13.9081 0 0 0 0 15.4114 0 0 0 0 0 0 0 0 13.0646 0 0 0 0 0 15.5843 0 0 0 0 0 0 16.0932 0 0 14.9448 0 17.0005 0 16.7874 15.3269 15.3386 0 0 0 0 0 14.4697 0 0 0 0 0 0 0 0 0 15.2359 0 0 0 15.2406 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUB1 ACS2L_HUMAN "Acetyl-coenzyme A synthetase 2-like, mitochondrial, EC 6.2.1.1 (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2, AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase, EC 6.2.1.17)" ACSS1 ACAS2L KIAA1846 Homo sapiens (Human) acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; ethanol oxidation [GO:0006069]; propionate biosynthetic process [GO:0019542] GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006069; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218 acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218] CKVVITFNQGLRGGR 0.99627 -9.7795 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6478 13.6763 13.7209 0 0 12.5033 12.3786 0 14.7182 11.9977 0 0 14.3556 0 0 0 0 0 0 0 0 0 15.1209 0 0 0 0 13.758 0 14.0544 0 14.8668 0 0 14.4083 12.2211 14.7612 14.1302 14.0056 0 14.2764 14.939 0 0 0 0 0 0 13.1359 0 0 0 0 0 0 0 14.5349 0 0 14.8919 12.5514 0 0 0 0 0 14.4249 12.9638 0 0 0 0 0 0 0 0 0 0 12.5092 0 0 0 13.8944 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7339 0 16.1096 0 0 0 0 0 Q5JTN6 WDR38_HUMAN WD repeat-containing protein 38 WDR38 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244] hematopoietic progenitor cell differentiation [GO:0002244] GO:0002244 AKCLRVLK 0.99628 -11.692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1028 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4633 0 0 10.762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41225 SOX3_HUMAN Transcription factor SOX-3 SOX3 Homo sapiens (Human) "anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; face development [GO:0060324]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sex determination [GO:0007530]" chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; face development [GO:0060324]; hypothalamus development [GO:0021854]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pituitary gland development [GO:0021983]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; sensory organ development [GO:0007423]; sex determination [GO:0007530]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0003677; GO:0005654; GO:0006355; GO:0007417; GO:0007423; GO:0007530; GO:0009653; GO:0021854; GO:0021983; GO:0030154; GO:0045665; GO:0045944; GO:0060324; GO:1990837 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" KTKTLLK 0.99629 -9.8921 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4362 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1566 0 0 0 0 0 0 0 0 0 11.1498 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2199 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P19827 ITIH1_HUMAN "Inter-alpha-trypsin inhibitor heavy chain H1, ITI heavy chain H1, ITI-HC1, Inter-alpha-inhibitor heavy chain 1 (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein, SHAP)" ITIH1 IGHEP1 Homo sapiens (Human) hyaluronan metabolic process [GO:0030212] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576] blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867]; hyaluronan metabolic process [GO:0030212] GO:0004867; GO:0005509; GO:0005540; GO:0005576; GO:0030212; GO:0062023; GO:0070062; GO:0072562 calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; serine-type endopeptidase inhibitor activity [GO:0004867] ARSPGQHDGTYFGR 0.9963 -9.581 0 0 0 0 0 0 0 0 0 0 0 11.5067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6794 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7338 0 0 0 0 0 0 0 0 12.2095 13.9376 13.791 0 0 11.1075 0 12.8049 12.2375 0 12.8925 0 0 0 0 0 0 0 0 0 12.2478 0 0 0 0 12.6321 0 0 0 0 0 0 0 0 0 14.3435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0967 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1134 P37287 PIGA_HUMAN "Phosphatidylinositol N-acetylglucosaminyltransferase subunit A, EC 2.4.1.198 (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein, PIG-A)" PIGA Homo sapiens (Human) cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254] GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0016020; GO:0016021; GO:0016254; GO:0017176; GO:1990830 phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194] HDSITIVVVSRLVYR 0.9963 -9.5827 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7969 0 0 0 0 13.2003 0 0 0 0 0 0 0 0 12.9464 13.3681 14.0055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZUS6 CC149_HUMAN Coiled-coil domain-containing protein 149 CCDC149 Homo sapiens (Human) ASTPEDGKGIPEGGGMR 0.9963 -10.167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0895 0 0 0 0 0 0 0 15.8662 0 0 0 0 0 13.6561 0 0 0 0 13.8483 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8494 14.4334 0 0 0 0 14.6141 0 0 14.057 0 0 0 0 0 0 0 0 0 0 0 13.9294 14.0933 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z6W7 DNJB7_HUMAN DnaJ homolog subfamily B member 7 DNAJB7 HSC3 Homo sapiens (Human) chaperone-mediated protein folding [GO:0061077] cytoplasm [GO:0005737]; nucleus [GO:0005634] cytoplasm [GO:0005737]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077] GO:0005634; GO:0005737; GO:0044183; GO:0051082; GO:0051087; GO:0061077 chaperone binding [GO:0051087]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082] AYHKVALK 0.9963 -9.595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZS8 CA2D3_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3 ] CACNA2D3 Homo sapiens (Human) regulation of ion transmembrane transport [GO:0034765] voltage-gated calcium channel complex [GO:0005891] voltage-gated calcium channel complex [GO:0005891]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765] GO:0005245; GO:0005891; GO:0034765; GO:0046872 metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245] AGDKENIFNADHFPLWYRR 0.9963 -9.5964 0 0 0 0 0 0 0 0 0 0 0 0 12.721 0 0 0 10.8144 0 0 0 10.4065 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4213 0 0 0 12.5446 0 0 12.0027 0 0 0 0 0 0 0 0 0 0 11.6738 0 9.8292 0 0 0 16.7968 0 0 0 13.632 0 12.1401 13.6783 13.6523 12.6265 0 0 0 0 0 0 0 0 0 0 0 12.705 13.762 14.1874 0 0 0 13.8424 14.3533 13.7329 14.4849 0 0 13.3239 0 14.3544 14.7253 13.9756 0 13.0604 0 0 0 0 12.4162 0 14.7668 0 14.2657 13.8452 0 13.9385 18.2977 0 0 0 0 0 0 0 13.1674 0 0 0 13.8249 0 0 13.5254 0 13.4512 0 0 0 0 0 0 0 0 0 0 0 14.7704 13.9347 0 13.4822 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2571 0 0 0 13.3617 0 0 0 0 0 Q92826 HXB13_HUMAN Homeobox protein Hox-B13 HOXB13 Homo sapiens (Human) angiogenesis [GO:0001525]; epidermis development [GO:0008544]; epithelial cell maturation involved in prostate gland development [GO:0060743]; negative regulation of transcription by RNA polymerase II [GO:0000122]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; response to wounding [GO:0009611] chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; angiogenesis [GO:0001525]; epidermis development [GO:0008544]; epithelial cell maturation involved in prostate gland development [GO:0060743]; negative regulation of transcription by RNA polymerase II [GO:0000122]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; response to testosterone [GO:0033574]; response to wounding [GO:0009611]" GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001525; GO:0005654; GO:0005667; GO:0006357; GO:0008327; GO:0008544; GO:0009611; GO:0033574; GO:0040008; GO:0043565; GO:0060527; GO:0060743; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; methyl-CpG binding [GO:0008327]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]" KRIPYSK 0.9963 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96P65 QRFPR_HUMAN Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155) QRFPR GPR103 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; G protein-coupled receptor signaling pathway [GO:0007186] GO:0004930; GO:0004983; GO:0005886; GO:0005887; GO:0007186; GO:0016021 G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983] EMSKIARK 0.9963 -9.9206 0 0 0 0 0 0 0 11.149 0 0 0 0 0 0 0 0 0 0 0 0 13.9257 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4851 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4704 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7513 0 0 0 0 0 0 0 0 0 0 0 14.6908 0 0 0 0 0 0 0 0 0 0 0 0 14.2175 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4671 0 0 0 0 0 0 0 0 12.6787 13.875 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3312 0 0 0 14.2157 0 13.0752 0 18.1157 0 0 0 13.8727 0 0 17.3905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.4337 0 0 0 0 0 Q9H2A9 CHST8_HUMAN "Carbohydrate sulfotransferase 8, EC 2.8.2.- (GalNAc-4-O-sulfotransferase 1, GalNAc-4-ST1, GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1)" CHST8 Homo sapiens (Human) carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146]; carbohydrate biosynthetic process [GO:0016051]; central nervous system development [GO:0007417]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790] GO:0000139; GO:0001537; GO:0006790; GO:0007417; GO:0008146; GO:0016021; GO:0016051; GO:0030166; GO:0042446 N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146] EPTERVTR 0.9963 -9.5871 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0334 0 0 0 0 0 0 0 0 0 0 0 12.9369 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8741 0 0 0 0 0 0 0 0 0 12.4159 12.8679 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0228 0 0 0 0 0 0 12.9553 0 0 0 0 0 0 Q9NYT6 ZN226_HUMAN Zinc finger protein 226 ZNF226 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKSFGR 0.9963 -9.5927 0 0 0 0 0 0 16.8311 16.6921 0 0 0 0 0 0 0 0 0 0 8.88716 0 0 0 0 0 0 0 0 0 0 13.0707 0 12.887 0 0 0 0 0 0 0 0 0 0 0 0 10.9626 0 0 0 0 0 0 0 0 0 11.4311 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1936 0 0 0 0 0 0 0 0 0 0 0 0 14.9492 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3458 0 0 0 13.5103 0 0 0 0 0 0 13.395 0 0 0 0 0 0 14.0165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9155 0 12.4561 13.3829 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4375 0 0 0 0 0 0 11.6339 0 0 0 0 0 O14497 ARI1A_HUMAN "AT-rich interactive domain-containing protein 1A, ARID domain-containing protein 1A (B120) (BRG1-associated factor 250, BAF250) (BRG1-associated factor 250a, BAF250A) (Osa homolog 1, hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)" ARID1A BAF250 BAF250A C1orf4 OSA1 SMARCF1 Homo sapiens (Human) "androgen receptor signaling pathway [GO:0030521]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular estrogen receptor signaling pathway [GO:0030520]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514] "bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; chromatin remodeling [GO:0006338]; epigenetic maintenance of chromatin in transcription-competent conformation [GO:0045815]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular estrogen receptor signaling pathway [GO:0030520]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0030520; GO:0030521; GO:0035060; GO:0042921; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819 DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713] AAQVAPAAASSLGNPPPPPPSELKK 0.99631 -10.232 12.7211 0 0 0 0 0 0 0 0 0 0 12.0859 12.4216 11.7091 12.6191 0 0 12.2445 0 0 0 0 0 0 9.9486 0 0 0 0 0 0 0 12.3133 13.3582 0 0 0 12.743 0 11.8119 0 0 0 0 0 0 0 0 0 11.3985 0 0 0 0 0 0 0 8.65421 0 0 0 0 0 0 0 0 0 0 0 10.3841 13.2325 0 0 0 12.5703 12.3307 10.8947 14.9838 13.4107 13.0179 13.4896 0 12.6224 0 0 16.0898 13.1371 12.3611 12.5593 0 13.5212 14.5471 14.0777 14.3576 11.9526 0 0 0 0 12.5362 12.8833 12.7139 0 0 0 13.9925 12.9724 12.3493 12.4979 13.9953 12.5368 0 0 0 14.9127 0 13.4407 0 12.8036 13.6986 0 12.7667 12.9163 0 0 0 13.2249 11.8173 0 0 0 12.744 0 0 0 12.6457 13.5467 11.078 13.6657 11.3197 0 0 10.5247 0 0 14.5817 0 12.8935 0 10.4575 12.9696 13.5332 12.2724 0 0 0 0 0 0 0 0 0 0 0 0 13.7217 0 0 13.3825 13.0283 14.0309 13.0609 0 0 12.385 0 13.0656 0 0 12.5353 O75845 SC5D_HUMAN "Lathosterol oxidase, EC 1.14.19.20 (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase)" SC5D SC5DL Homo sapiens (Human) cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; lipid metabolic process [GO:0006629]; sterol biosynthetic process [GO:0016126] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; C-5 sterol desaturase activity [GO:0000248]; delta7-sterol 5(6)-desaturase activity [GO:0050046]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; lipid metabolic process [GO:0006629]; sterol biosynthetic process [GO:0016126] GO:0000248; GO:0005506; GO:0005789; GO:0006629; GO:0016020; GO:0016021; GO:0016126; GO:0016491; GO:0033489; GO:0033490; GO:0050046 C-5 sterol desaturase activity [GO:0000248]; delta7-sterol 5(6)-desaturase activity [GO:0050046]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491] EIKFTVQALPWISILTVALFLLEIR 0.99631 -10.204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3621 0 0 14.4788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P41208 CETN2_HUMAN Centrin-2 (Caltractin isoform 1) CETN2 CALT CEN2 Homo sapiens (Human) cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283] 9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942] 9+2 motile cilium [GO:0097729]; apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; cell division [GO:0051301]; centriole replication [GO:0007099]; mitotic cell cycle [GO:0000278]; mRNA transport [GO:0051028]; nucleotide-excision repair [GO:0006289]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283] GO:0000278; GO:0005509; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006289; GO:0007099; GO:0007283; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0032465; GO:0032795; GO:0036064; GO:0044615; GO:0045177; GO:0051028; GO:0051301; GO:0070390; GO:0071942; GO:0097729 calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017] ALGFEPK 0.99631 -9.6661 0 0 0 0 0 0 0 0 0 12.9443 12.7477 0 0 0 0 10.6705 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0223 0 0 0 0 0 0 0 0 0 0 0 11.594 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2696 13.9977 0 0 0 0 0 0 0 0 14.232 0 0 0 0 0 12.5524 0 13.4177 13.1917 0 0 0 13.5764 0 0 0 0 14.0721 0 0 12.7766 0 0 0 0 13.3707 13.3204 0 13.6468 0 0 Q68D86 C102B_HUMAN Coiled-coil domain-containing protein 102B CCDC102B C18orf14 Homo sapiens (Human) AAQMEKTMR 0.99631 -9.6552 0 0 0 0 0 0 0 0 10.9391 0 0 12.1181 0 13.5713 14.5692 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0361 0 0 0 0 14.1163 0 0 0 11.3042 0 0 0 0 0 0 0 0 0 10.2862 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5629 0 12.2405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.284 0 0 0 0 0 0 0 0 0 12.8194 0 0 0 11.7731 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4947 0 0 0 0 11.7243 0 13.6541 0 0 0 0 0 0 11.9895 0 11.8604 0 0 0 0 0 0 13.3112 0 0 0 0 0 13.9674 0 0 0 Q6P179 ERAP2_HUMAN "Endoplasmic reticulum aminopeptidase 2, EC 3.4.11.- (Leukocyte-derived arginine aminopeptidase, L-RAP)" ERAP2 LRAP Homo sapiens (Human) adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; signal transduction [GO:0007165] GO:0002250; GO:0002474; GO:0004175; GO:0004177; GO:0005737; GO:0005788; GO:0005789; GO:0005886; GO:0006508; GO:0007165; GO:0008217; GO:0008237; GO:0008270; GO:0016021; GO:0019885; GO:0042277; GO:0043171; GO:0070006 aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270] ESRHIALSNMPKVK 0.99631 -9.6583 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5194 0 0 0 0 0 0 0 0 0 0 10.643 0 0 0 0 11.7121 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5095 0 0 0 0 0 0 0 0 0 11.4583 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6347 0 0 0 0 0 0 0 0 0 13.828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.379 0 0 13.7795 0 0 12.2225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7984 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0404 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8059 0 0 0 0 0 0 0 12.7962 0 0 0 0 0 0 0 0 0 15.8633 14.1122 13.2126 0 0 0 0 0 0 0 0 0 Q86SF2 GALT7_HUMAN "N-acetylgalactosaminyltransferase 7, EC 2.4.1.41 (Polypeptide GalNAc transferase 7, GalNAc-T7, pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7)" GALNT7 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020] extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; carbohydrate metabolic process [GO:0005975]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0004653; GO:0005794; GO:0005975; GO:0006493; GO:0016020; GO:0016021; GO:0016266; GO:0030246; GO:0046872; GO:0070062 carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653] DVNDPMPNR 0.99631 -9.6555 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3154 0 12.6384 0 12.5813 0 0 0 0 10.0225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.689 0 0 0 0 0 0 0 0 0 0 0 0 0 15.2531 0 0 0 13.6543 0 0 0 0 0 0 0 14.2943 0 0 0 0 15.2732 0 14.1201 15.2011 14.2164 0 13.9755 13.6102 13.6428 0 14.8888 0 0 0 0 0 14.5765 14.876 0 0 0 14.8225 0 14.2885 0 0 0 14.0855 13.8838 14.363 14.4221 14.2941 13.42 0 0 13.7679 0 0 0 0 0 14.5984 0 13.6253 0 0 0 0 0 0 0 0 0 0 13.7626 12.938 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUW3 SPA2L_HUMAN "Spermatogenesis-associated protein 2-like protein, SPATA2-like protein" SPATA2L C16orf76 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737] GO:0005737 GLARAFELLELAAVHLYLLPWR 0.99631 -10.202 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6352 0 0 0 14.3958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4273 0 0 0 0 0 0 0 0 0 12.7328 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4L4 SPEM1_HUMAN Spermatid maturation protein 1 SPEM1 C17orf83 Homo sapiens (Human) flagellated sperm motility [GO:0030317]; sperm individualization [GO:0007291] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; flagellated sperm motility [GO:0030317]; sperm individualization [GO:0007291] GO:0005737; GO:0007291; GO:0016021; GO:0030317 KQTQPPKK 0.99631 -10.237 0 0 0 0 0 0 0 0 15.2081 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.13 0 0 11.2753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9608 0 0 0 0 11.001 0 9.28519 0 0 0 0 13.9467 14.2258 13.9997 13.8172 14.2864 13.912 13.8152 14.793 13.1445 0 0 0 0 0 0 0 0 11.8626 14.7943 0 14.2655 14.4634 0 14.3173 0 0 14.3686 0 0 0 14.7468 0 0 0 0 0 0 0 0 0 0 0 14.6166 0 0 14.6283 14.5497 0 14.6198 0 11.9603 0 0 0 14.5175 14.486 0 14.1307 14.1219 0 14.5124 14.669 0 14.5214 14.5012 14.5703 14.8068 14.6871 0 14.2063 14.497 0 0 0 0 0 0 14.0134 0 14.3192 0 11.8701 0 0 0 0 0 0 0 0 0 0 11.793 0 0 11.8451 12.4028 0 0 14.7988 0 0 0 0 14.218 0 Q969Q0 RL36L_HUMAN 60S ribosomal protein L36a-like (Large ribosomal subunit protein eL42-like) RPL36AL Homo sapiens (Human) translation [GO:0006412] cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412] GO:0003735; GO:0005634; GO:0005783; GO:0005829; GO:0005886; GO:0006412; GO:0022625 structural constituent of ribosome [GO:0003735] IVLRLECVEPNCR 0.99631 -10.236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5243 0 0 0 0 0 0 0 0 0 0 0 12.0043 0 0 0 0 0 0 12.6593 0 12.7143 0 0 0 0 0 0 0 11.9902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5414 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UHQ7 TCAL9_HUMAN "Transcription elongation factor A protein-like 9, TCEA-like protein 9 (Transcription elongation factor S-II protein-like 9) (WW domain-binding protein 5, WBP-5)" TCEAL9 WBP5 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; WW domain binding [GO:0050699] GO:0005634; GO:0050699 WW domain binding [GO:0050699] LIQSLQEFK 0.99631 -9.6578 10.0765 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.853 0 13.0856 0 0 0 12.833 0 0 0 12.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3268 0 0 0 11.5149 0 12.1822 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8611 10.3006 0 0 0 0 0 0 11.2705 0 0 0 0 0 0 9.75939 0 14.2199 0 0 0 0 0 0 0 0 0 13.7485 0 0 0 0 0 0 0 14.0402 0 12.1238 0 0 12.8192 0 0 13.7482 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1569 13.9385 0 0 14.1863 0 0 0 0 0 0 0 0 0 10.0095 13.9794 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5859 15.4934 13.8556 0 0 12.1831 0 0 0 0 0 Q9Y2T3 GUAD_HUMAN "Guanine deaminase, Guanase, Guanine aminase, EC 3.5.4.3 (Guanine aminohydrolase, GAH) (p51-nedasin)" GDA KIAA1258 Homo sapiens (Human) allantoin metabolic process [GO:0000255]; deoxyguanosine catabolic process [GO:0006161]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; guanine metabolic process [GO:0046098]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139] cytosol [GO:0005829] cytosol [GO:0005829]; deaminase activity [GO:0019239]; guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; allantoin metabolic process [GO:0000255]; deoxyguanosine catabolic process [GO:0006161]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; guanine metabolic process [GO:0046098]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139] GO:0000255; GO:0005829; GO:0006139; GO:0006147; GO:0006161; GO:0007399; GO:0008270; GO:0008892; GO:0019239; GO:0046038; GO:0046055; GO:0046098 deaminase activity [GO:0019239]; guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270] DEVEAVKNLYPSYK 0.99631 -10.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7394 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MTL0 IQCF5_HUMAN IQ domain-containing protein F5 IQCF5 Homo sapiens (Human) calmodulin binding [GO:0005516] GO:0005516 calmodulin binding [GO:0005516] GMLVRRTLLHAALR 0.99632 -9.6697 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6776 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2006 0 0 P46952 3HAO_HUMAN "3-hydroxyanthranilate 3,4-dioxygenase, EC 1.13.11.6 (3-hydroxyanthranilate oxygenase, 3-HAO, h3HAO) (3-hydroxyanthranilic acid dioxygenase, HAD)" HAAO Homo sapiens (Human) 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan catabolic process [GO:0006569] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; electron transfer activity [GO:0009055]; ferrous iron binding [GO:0008198]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan catabolic process [GO:0006569]" GO:0000334; GO:0005737; GO:0005829; GO:0006569; GO:0008198; GO:0009055; GO:0009435; GO:0010043; GO:0019805; GO:0034354; GO:0043420; GO:0046686; GO:0046874; GO:0070050 "3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; electron transfer activity [GO:0009055]; ferrous iron binding [GO:0008198]" LETELDGLR 0.99632 -10.262 0 0 0 10.331 0 0 0 0 0 0 0 12.1992 0 11.4411 12.0531 12.9237 0 0 0 10.1601 0 0 0 0 0 11.9738 12.3894 0 11.6905 12.7166 12.0293 12.0591 0 0 0 0 0 0 0 12.2299 11.108 0 0 0 18.0696 0 0 0 0 0 0 0 0 0 13.4276 0 0 0 0 0 12.5385 14.3466 12.666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.389 0 0 0 0 0 14.6145 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9146 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2634 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4259 0 0 0 0 0 0 0 0 0 0 14.2471 0 12.9545 0 0 Q8WXI8 CLC4D_HUMAN "C-type lectin domain family 4 member D (C-type lectin superfamily member 8) (C-type lectin-like receptor 6, CLEC-6) (Dendritic cell-associated C-type lectin 3, DC-associated C-type lectin 3, Dectin-3) (CD antigen CD368)" CLEC4D CLECSF8 MCL Homo sapiens (Human) adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell activation [GO:0030887]; T cell differentiation involved in immune response [GO:0002292] external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821] external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; carbohydrate binding [GO:0030246]; immunoglobulin receptor binding [GO:0034987]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; immune response [GO:0006955]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell activation [GO:0030887]; T cell differentiation involved in immune response [GO:0002292] GO:0002250; GO:0002292; GO:0005537; GO:0005886; GO:0006955; GO:0009897; GO:0016021; GO:0030246; GO:0030887; GO:0034987; GO:0035579; GO:0038094; GO:0038187; GO:0042742; GO:0043123; GO:0046872; GO:0061760; GO:0070821; GO:0101003 carbohydrate binding [GO:0030246]; immunoglobulin receptor binding [GO:0034987]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187] RGTGVHK 0.99632 -10.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5259 12.6904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3878 0 0 12.0801 0 0 0 0 0 0 0 13.9359 0 13.6789 12.2947 0 0 12.0353 0 12.8998 0 14.3306 0 0 0 14.2683 13.5182 0 0 14.1298 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0PK00 T120B_HUMAN Transmembrane protein 120B TMEM120B Homo sapiens (Human) fat cell differentiation [GO:0045444]; protein heterooligomerization [GO:0051291] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637] integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; fat cell differentiation [GO:0045444]; protein heterooligomerization [GO:0051291] GO:0005637; GO:0016020; GO:0016021; GO:0045444; GO:0051291 FKLYLTIILLLGAVACRFVLHYR 0.99633 -9.7654 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0746 0 0 0 0 0 13.5373 0 0 0 0 0 0 0 0 0 0 0 14.5843 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1699 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9909 0 0 0 0 0 14.0399 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9984 0 0 0 0 13.2643 0 0 0 0 0 0 0 0 0 0 0 0 12.1501 0 0 0 0 0 13.3325 0 0 12.9767 0 0 0 0 A6NNE9 MARHB_HUMAN "E3 ubiquitin-protein ligase MARCHF11, EC 2.3.2.27 (Membrane-associated RING finger protein 11) (Membrane-associated RING-CH protein XI, MARCH-XI) (RING-type E3 ubiquitin transferase MARCHF11)" MARCHF11 MARCH11 Homo sapiens (Human) cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021] cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GO:0004842; GO:0008270; GO:0016021; GO:0030659 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] GSWTCELCCYR 0.99633 -9.7641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.406 0 0 0 0 0 0 0 0 12.9531 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1318 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96B33 CLD23_HUMAN Claudin-23 CLDN23 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; bicellular tight junction assembly [GO:0070830]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155] GO:0005198; GO:0005886; GO:0005923; GO:0007155; GO:0016021; GO:0016338; GO:0042802; GO:0070830 identical protein binding [GO:0042802]; structural molecule activity [GO:0005198] ALMVTSLAATVLGLLLASLGVR 0.99634 -9.7792 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0402 0 0 0 0 0 0 13.2586 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.076 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BZV2 S19A3_HUMAN "Thiamine transporter 2, ThTr-2, ThTr2 (Solute carrier family 19 member 3)" SLC19A3 Homo sapiens (Human) thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; thiamine transmembrane transporter activity [GO:0015234]; thiamine transmembrane transport [GO:0071934]; thiamine transport [GO:0015888]; thiamine-containing compound metabolic process [GO:0042723]; transmembrane transport [GO:0055085] GO:0005886; GO:0015234; GO:0015888; GO:0016021; GO:0042723; GO:0055085; GO:0071934 thiamine transmembrane transporter activity [GO:0015234] PSREIKK 0.99634 -9.7774 0 0 0 0 0 0 0 0 0 0 0 13.179 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5736 0 14.1902 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O00559 RCAS1_HUMAN Receptor-binding cancer antigen expressed on SiSo cells (Cancer-associated surface antigen RCAS1) (Estrogen receptor-binding fragment-associated gene 9 protein) EBAG9 RCAS1 Homo sapiens (Human) regulation of cell growth [GO:0001558] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141] Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; peptidase activator activity involved in apoptotic process [GO:0016505]; regulation of cell growth [GO:0001558] GO:0000139; GO:0001558; GO:0016021; GO:0016505; GO:0030141 peptidase activator activity involved in apoptotic process [GO:0016505] LADREKR 0.99636 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5833 0 0 0 0 0 0 0 0 0 Q5XKL5 BTBD8_HUMAN BTB/POZ domain-containing protein 8 BTBD8 Homo sapiens (Human) nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634] GO:0005634; GO:0005654 FKAHRAILSAR 0.99636 -9.8901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8386 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3865 0 0 0 0 0 0 0 0 0 13.0735 11.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92908 GATA6_HUMAN Transcription factor GATA-6 (GATA-binding factor 6) GATA6 Homo sapiens (Human) "animal organ formation [GO:0048645]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hypoxia [GO:0071456]; club cell differentiation [GO:0060486]; endodermal cell fate determination [GO:0007493]; epithelial cell differentiation [GO:0030855]; G1 to G0 transition involved in cell differentiation [GO:0070315]; gene expression [GO:0010467]; heart contraction [GO:0060047]; in utero embryonic development [GO:0001701]; intestinal epithelial cell differentiation [GO:0060575]; liver development [GO:0001889]; lung saccule development [GO:0060430]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of sebum secreting cell proliferation [GO:1904003]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of transforming growth factor beta2 production [GO:0032912]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract septum morphogenesis [GO:0003148]; pancreatic A cell differentiation [GO:0003310]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta activation [GO:1901390]; regulation of antimicrobial humoral response [GO:0002759]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to growth factor [GO:0070848]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sebaceous gland cell differentiation [GO:0001949]; sinoatrial node development [GO:0003163]; skin epidermis development [GO:0098773]; smooth muscle cell differentiation [GO:0051145]; stem cell differentiation [GO:0048863]; tube morphogenesis [GO:0035239]; type B pancreatic cell differentiation [GO:0003309]; type II pneumocyte differentiation [GO:0060510]" chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]; animal organ formation [GO:0048645]; atrioventricular canal development [GO:0036302]; atrioventricular node development [GO:0003162]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; cellular response to gonadotropin stimulus [GO:0071371]; cellular response to hypoxia [GO:0071456]; club cell differentiation [GO:0060486]; endodermal cell fate determination [GO:0007493]; epithelial cell differentiation [GO:0030855]; G1 to G0 transition involved in cell differentiation [GO:0070315]; gene expression [GO:0010467]; heart contraction [GO:0060047]; in utero embryonic development [GO:0001701]; intestinal epithelial cell differentiation [GO:0060575]; liver development [GO:0001889]; lung saccule development [GO:0060430]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of sebum secreting cell proliferation [GO:1904003]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta1 production [GO:0032911]; negative regulation of transforming growth factor beta2 production [GO:0032912]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract septum morphogenesis [GO:0003148]; pancreatic A cell differentiation [GO:0003310]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta activation [GO:1901390]; regulation of antimicrobial humoral response [GO:0002759]; response to cAMP [GO:0051591]; response to estrogen [GO:0043627]; response to growth factor [GO:0070848]; response to retinoic acid [GO:0032526]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; sebaceous gland cell differentiation [GO:0001949]; sinoatrial node development [GO:0003163]; skin epidermis development [GO:0098773]; smooth muscle cell differentiation [GO:0051145]; stem cell differentiation [GO:0048863]; tube morphogenesis [GO:0035239]; type B pancreatic cell differentiation [GO:0003309]; type II pneumocyte differentiation [GO:0060510]" GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001223; GO:0001701; GO:0001889; GO:0001949; GO:0002759; GO:0003148; GO:0003162; GO:0003163; GO:0003309; GO:0003310; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006644; GO:0007493; GO:0008270; GO:0008584; GO:0009410; GO:0009636; GO:0010467; GO:0010666; GO:0014898; GO:0019901; GO:0030513; GO:0030855; GO:0031965; GO:0032526; GO:0032911; GO:0032912; GO:0035239; GO:0036302; GO:0042475; GO:0043066; GO:0043627; GO:0045165; GO:0045766; GO:0045892; GO:0045893; GO:0045944; GO:0048645; GO:0048863; GO:0051145; GO:0051525; GO:0051591; GO:0051891; GO:0055007; GO:0060038; GO:0060045; GO:0060047; GO:0060430; GO:0060486; GO:0060510; GO:0060575; GO:0060947; GO:0070315; GO:0070848; GO:0071371; GO:0071456; GO:0071773; GO:0098773; GO:0110024; GO:0140297; GO:1901390; GO:1902894; GO:1904003; GO:1990837 "chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; NFAT protein binding [GO:0051525]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]" RVPSSRR 0.99636 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9128 0 0 12.7636 0 13.718 0 0 0 0 13.4765 0 12.6705 12.8073 0 12.1201 13.0905 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5114 0 0 0 0 0 0 0 0 13.7054 0 0 0 13.7771 13.5547 0 0 13.8265 13.5157 13.7821 13.6013 0 13.5791 13.7875 0 0 0 0 13.2703 0 0 0 0 Q96NA8 TSNA1_HUMAN t-SNARE domain-containing protein 1 TSNARE1 Homo sapiens (Human) intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201] endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906] GO:0000149; GO:0005484; GO:0006886; GO:0006906; GO:0012505; GO:0016021; GO:0031201; GO:0048278 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] ALLPMAQR 0.99636 -9.8889 10.6259 0 0 11.0095 0 0 0 0 0 0 0 12.2968 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.694 13.4675 0 0 0 0 0 0 13.8051 0 0 0 0 14.7419 0 0 0 0 0 0 0 0 0 0 0 13.8049 0 13.1621 0 0 0 0 14.066 0 0 0 0 0 0 0 0 0 0 12.8531 0 13.6167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2782 0 0 14.5396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIE6 RN3P2_HUMAN Putative RRN3-like protein RRN3P2 (RNA polymerase I transcription factor homolog pseudogene 2) RRN3P2 Homo sapiens (Human) transcription initiation from RNA polymerase I promoter [GO:0006361] nucleus [GO:0005634] nucleus [GO:0005634]; RNA polymerase I core binding [GO:0001042]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361] GO:0001042; GO:0001181; GO:0005634; GO:0006361 RNA polymerase I core binding [GO:0001042]; RNA polymerase I general transcription initiation factor activity [GO:0001181] ALENDFFNSPPR 0.99637 -10.22 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6439 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95476 CNEP1_HUMAN "CTD nuclear envelope phosphatase 1, EC 3.1.3.16 (Serine/threonine-protein phosphatase dullard)" CTDNEP1 DULLARD Homo sapiens (Human) canonical Wnt signaling pathway [GO:0060070]; gamete generation [GO:0007276]; mesoderm development [GO:0007498]; mitotic nuclear membrane disassembly [GO:0007077]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; canonical Wnt signaling pathway [GO:0060070]; gamete generation [GO:0007276]; mesoderm development [GO:0007498]; mitotic nuclear membrane disassembly [GO:0007077]; nuclear envelope organization [GO:0006998]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein dephosphorylation [GO:0006470]; protein localization to nucleus [GO:0034504] GO:0004721; GO:0004722; GO:0005635; GO:0005737; GO:0005789; GO:0005811; GO:0006470; GO:0006998; GO:0007077; GO:0007276; GO:0007498; GO:0010867; GO:0016021; GO:0017018; GO:0031965; GO:0034504; GO:0060070; GO:0071595; GO:0090263 myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722] HPVRFFVHK 0.99637 -10.166 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1107 0 0 0 0 13.8814 13.1507 0 0 0 0 0 0 0 18.7927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6183 0 0 0 0 0 0 0 0 0 P32418 NAC1_HUMAN Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1) SLC8A1 CNC NCX1 Homo sapiens (Human) calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; metal ion transport [GO:0030001]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular associated smooth muscle contraction [GO:0014829] axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018] axon [GO:0030424]; axon terminus [GO:0043679]; cell periphery [GO:0071944]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intercalated disc [GO:0014704]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; transmembrane transporter binding [GO:0044325]; calcium ion export [GO:1901660]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular calcium ion homeostasis [GO:0006874]; cellular response to caffeine [GO:0071313]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; cellular response to reactive oxygen species [GO:0034614]; cellular sodium ion homeostasis [GO:0006883]; ion transport [GO:0006811]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; metal ion transport [GO:0030001]; muscle contraction [GO:0006936]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of bone mineralization [GO:0030501]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of the force of heart contraction [GO:0098735]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; relaxation of smooth muscle [GO:0044557]; response to ATP [GO:0033198]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537]; vascular associated smooth muscle contraction [GO:0014829] GO:0002026; GO:0002027; GO:0002028; GO:0005432; GO:0005509; GO:0005516; GO:0005654; GO:0005739; GO:0005874; GO:0005886; GO:0005887; GO:0006811; GO:0006874; GO:0006883; GO:0006936; GO:0007584; GO:0008092; GO:0009410; GO:0009749; GO:0010468; GO:0010649; GO:0010763; GO:0010881; GO:0010882; GO:0014069; GO:0014704; GO:0014829; GO:0015491; GO:0016020; GO:0021537; GO:0030001; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030501; GO:0030506; GO:0033198; GO:0034614; GO:0035725; GO:0035902; GO:0035994; GO:0036376; GO:0042383; GO:0042542; GO:0043025; GO:0043197; GO:0043198; GO:0043679; GO:0044325; GO:0044557; GO:0045202; GO:0051481; GO:0055013; GO:0055074; GO:0055119; GO:0060048; GO:0060402; GO:0070509; GO:0070588; GO:0071313; GO:0071320; GO:0071456; GO:0071901; GO:0071944; GO:0086012; GO:0086064; GO:0097553; GO:0098703; GO:0098719; GO:0098735; GO:0098794; GO:0099055; GO:0099580; GO:1901660; GO:1903779; GO:1905060 ankyrin binding [GO:0030506]; calcium ion binding [GO:0005509]; calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; cation:cation antiporter activity [GO:0015491]; cytoskeletal protein binding [GO:0008092]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; transmembrane transporter binding [GO:0044325] RLLFYKYVYK 0.99637 -10.173 0 0 0 8.93023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5053 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1264 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6613 0 10.6208 0 0 0 0 10.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13952 NFYC_HUMAN "Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C, NF-YC) (Transactivator HSM-1/2)" NFYC Homo sapiens (Human) "histone H3-K4 trimethylation [GO:0080182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of histone acetylation [GO:0035065]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" CCAAT-binding factor complex [GO:0016602]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575] "CCAAT-binding factor complex [GO:0016602]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; histone H3-K4 trimethylation [GO:0080182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of histone acetylation [GO:0035065]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0006457; GO:0016602; GO:0032993; GO:0035065; GO:0045944; GO:0046982; GO:0080182; GO:0090575 "DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" AWIHTEDNKR 0.99637 -10.22 0 0 0 0 0 0 0 0 0 0 11.485 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6411 0 0 0 0 0 0 0 0 0 0 13.802 0 13.9269 0 0 0 0 0 0 13.332 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5475 13.8521 0 13.5358 11.469 13.5575 0 0 13.1167 0 13.0094 0 12.8787 13.445 0 0 0 0 0 13.0927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5K130 CLU1O_HUMAN Putative uncharacterized protein CLLU1-AS1 (CLLU1 antisense RNA 1) (Chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein) CLLU1-AS1 CLLU1OS Homo sapiens (Human) GNVTRRR 0.99637 -10.209 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3045 0 0 Q6UXI7 VITRN_HUMAN Vitrin VIT UNQ647/PRO1277 Homo sapiens (Human) extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614] collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614]; glycosaminoglycan binding [GO:0005539]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510] GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198; GO:0062023 glycosaminoglycan binding [GO:0005539] IIQNICTEFNSQPRN 0.99637 -10.182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0624 0 0 0 0 0 0 15.8402 15.3234 15.8681 0 15.4042 0 0 0 0 0 0 0 0 0 15.4154 0 0 0 0 0 11.3414 0 0 0 0 0 0 0 0 0 0 0 15.8268 0 0 0 15.3479 15.2105 15.1891 15.3743 0 0 0 0 0 14.2815 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6746 14.5482 0 0 0 0 0 Q8WV48 CC107_HUMAN Coiled-coil domain-containing protein 107 CCDC107 PSEC0222 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 PPLKDQR 0.99637 -10.199 0 0 0 0 0 0 0 0 0 0 0 0 14.3549 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WZ60 KLHL6_HUMAN Kelch-like protein 6 KLHL6 Homo sapiens (Human) B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617] B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617] GO:0002467; GO:0009617; GO:0050853 ASCGIAPCNNR 0.99637 -10.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1027 0 0 0 0 0 0 14.0381 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2816 14.0183 0 0 0 0 0 0 0 0 0 14.7117 0 14.53 0 14.3959 0 0 0 0 0 0 0 0 0 13.8736 0 13.8616 0 0 0 0 0 0 0 0 14.903 13.6389 0 0 16.3116 0 0 0 0 0 0 0 0 13.8238 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5658 0 0 0 0 0 Q99816 TS101_HUMAN Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101) TSG101 Homo sapiens (Human) autophagosome maturation [GO:0097352]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein monoubiquitination [GO:0006513]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886] cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; autophagosome maturation [GO:0097352]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein monoubiquitination [GO:0006513]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076] GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005815; GO:0005829; GO:0005886; GO:0006513; GO:0006858; GO:0007049; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0016236; GO:0019076; GO:0030216; GO:0030374; GO:0031625; GO:0031901; GO:0031902; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043328; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090148; GO:0090543; GO:0097352; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397 calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; nuclear receptor coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790] AQAELNALK 0.99637 -9.5936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BTN0 LRFN3_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (Synaptic adhesion-like molecule 4) LRFN3 SALM4 UNQ5865/PRO34192 Homo sapiens (Human) regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; synaptic membrane adhesion [GO:0099560] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886] anchoring junction [GO:0070161]; axon [GO:0030424]; cell surface [GO:0009986]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; plasma membrane [GO:0005886]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179]; synaptic membrane adhesion [GO:0099560] GO:0005886; GO:0009986; GO:0030424; GO:0030425; GO:0070161; GO:0098978; GO:0099059; GO:0099061; GO:0099179; GO:0099560; GO:1905606 AILPLLLCLLPLAPASSPPQSATPSPCPRR 0.99637 -10.221 0 0 0 0 0 0 0 0 0 0 0 0 0 12.393 0 0 0 0 0 0 0 11.5307 0 0 0 11.4996 0 0 0 0 0 0 0 0 0 11.5306 0 0 0 0 0 0 0 0 0 0 0 0 12.3289 0 0 13.3855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.88612 0 0 0 11.3489 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6338 0 0 0 12.4702 13.0633 12.7727 13.3372 0 0 0 0 0 10.1443 12.1432 12.9245 10.8975 0 13.7852 0 0 0 0 0 0 0 0 0 12.2467 0 11.2802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.0263 0 0 0 0 17.0983 0 0 0 0 0 0 0 0 0 17.0133 0 0 Q9BYD1 RM13_HUMAN "39S ribosomal protein L13, mitochondrial, L13mt, MRP-L13 (Mitochondrial large ribosomal subunit protein uL13m)" MRPL13 Homo sapiens (Human) mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840] mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412] GO:0003723; GO:0003729; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0005840; GO:0006412; GO:0017148; GO:0032543 mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735] DPVAIVK 0.99637 -9.6 0 0 14.8104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7675 0 13.208 0 0 14.4923 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1914 12.8121 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O60828 PQBP1_HUMAN "Polyglutamine-binding protein 1, PQBP-1 (38 kDa nuclear protein containing a WW domain, Npw38) (Polyglutamine tract-binding protein 1)" PQBP1 NPW38 JM26 Homo sapiens (Human) "activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]" cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713]; activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000380; GO:0002218; GO:0002230; GO:0003677; GO:0003690; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598 DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; transcription coactivator activity [GO:0003713] PLPVALQTRLAK 0.99638 -10.223 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6119 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9302 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P54274 TERF1_HUMAN Telomeric repeat-binding factor 1 (NIMA-interacting protein 2) (TTAGGG repeat-binding factor 1) (Telomeric protein Pin2/TRF1) TERF1 PIN2 TRBF1 TRF TRF1 Homo sapiens (Human) cell division [GO:0051301]; meiotic telomere clustering [GO:0045141]; negative regulation of DNA replication [GO:0008156]; negative regulation of establishment of protein localization to telomere [GO:1904850]; negative regulation of establishment of protein-containing complex localization to telomere [GO:1904914]; negative regulation of establishment of RNA localization to telomere [GO:1904911]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of shelterin complex assembly [GO:1904792]; positive regulation of telomere maintenance [GO:0032206]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820] "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; spindle [GO:0005819]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; spindle [GO:0005819]; ankyrin repeat binding [GO:0071532]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; telomeric DNA binding [GO:0042162]; cell division [GO:0051301]; meiotic telomere clustering [GO:0045141]; negative regulation of DNA replication [GO:0008156]; negative regulation of establishment of protein localization to telomere [GO:1904850]; negative regulation of establishment of protein-containing complex localization to telomere [GO:1904914]; negative regulation of establishment of RNA localization to telomere [GO:1904911]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via semi-conservative replication [GO:0032214]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of shelterin complex assembly [GO:1904792]; positive regulation of telomere maintenance [GO:0032206]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820]" GO:0000723; GO:0000781; GO:0000783; GO:0001650; GO:0003677; GO:0003691; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0007004; GO:0008017; GO:0008022; GO:0008156; GO:0008301; GO:0009410; GO:0016233; GO:0016604; GO:0032206; GO:0032211; GO:0032214; GO:0042162; GO:0042802; GO:0042803; GO:0045141; GO:0051301; GO:0051974; GO:0061820; GO:0070187; GO:0071532; GO:0090656; GO:0098505; GO:1904357; GO:1904792; GO:1904850; GO:1904911; GO:1904914; GO:1905778; GO:1905839 "ankyrin repeat binding [GO:0071532]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded telomeric DNA binding [GO:0003691]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; telomeric DNA binding [GO:0042162]" AEDVSSAAPSPR 0.99638 -9.6574 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7778 0 0 0 0 10.1499 10.9951 0 11.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.677 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8708 0 0 0 0 0 0 0 11.822 11.9643 12.1678 0 13.1946 12.0451 0 0 0 0 0 0 0 0 0 0 0 0 12.7754 0 0 0 0 0 0 0 0 0 12.1405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2919 0 0 0 0 0 11.3055 0 0 0 0 0 0 0 0 0 0 11.3582 11.7729 0 0 0 0 0 0 0 0 Q12815 TROAP_HUMAN Tastin (Trophinin-assisting protein) (Trophinin-associated protein) TROAP Homo sapiens (Human) cell adhesion [GO:0007155] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; cell adhesion [GO:0007155] GO:0005737; GO:0007155 EVVTHSDEGGVASLGLAQRVPLR 0.99638 -10.236 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3833 13.7975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8149 0 0 0 0 0 0 16.9167 0 13.2326 13.8624 13.2413 0 0 0 0 0 0 0 0 13.5898 0 0 0 0 0 0 0 0 0 13.7862 0 0 0 0 0 0 13.803 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2974 0 0 13.1101 0 0 0 0 0 0 0 0 0 11.1501 0 Q5SWA1 PR15B_HUMAN Protein phosphatase 1 regulatory subunit 15B PPP1R15B Homo sapiens (Human) ER overload response [GO:0006983]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542] endoplasmic reticulum [GO:0005783]; protein phosphatase type 1 complex [GO:0000164] endoplasmic reticulum [GO:0005783]; protein phosphatase type 1 complex [GO:0000164]; protein phosphatase regulator activity [GO:0019888]; ER overload response [GO:0006983]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542] GO:0000164; GO:0001933; GO:0005783; GO:0006983; GO:0019888; GO:0032516; GO:0034976; GO:0042542; GO:0070262; GO:1903898; GO:1903912 protein phosphatase regulator activity [GO:0019888] LLSQLLAPLPGLLQK 0.99638 -9.6658 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7211 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z5Q5 DPOLN_HUMAN "DNA polymerase nu, EC 2.7.7.7" POLN Homo sapiens (Human) DNA-templated DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985] nucleoplasm [GO:0005654]; nucleus [GO:0005634] nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-templated DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; translesion synthesis [GO:0019985] GO:0000724; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0006261; GO:0006302; GO:0019985; GO:0030332; GO:0036297 cyclin binding [GO:0030332]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887] AMFVSSK 0.99638 -9.6672 0 0 0 0 11.2712 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3824 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1644 0 0 0 0 0 0 0 0 0 0 0 0 15.544 0 0 0 0 0 0 0 11.3077 0 0 0 0 0 0 0 0 0 0 0 0 13.7945 13.8621 0 0 0 0 0 14.6526 0 0 0 12.0758 11.577 0 0 0 0 0 0 0 0 0 12.0259 0 0 0 0 0 0 12.1232 0 0 0 0 0 0 0 0 12.0119 0 0 0 0 0 0 0 0 0 0 0 0 0 9.61121 14.6171 0 0 0 0 0 0 0 12.5874 12.3468 12.456 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0298 0 Q8NH04 O2T27_HUMAN Olfactory receptor 2T27 (Olfactory receptor OR1-67) OR2T27 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] FPWLLFALILLVFLTSIASNVVK 0.99638 -9.6796 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5805 0 0 11.8629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6454 0 0 0 0 0 11.3821 0 0 0 0 0 0 0 11.7481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4664 0 0 0 0 0 13.2801 11.0662 0 13.7149 0 0 0 0 0 0 0 0 0 0 11.3914 0 0 13.5442 0 0 0 0 13.8631 0 0 0 0 13.9485 0 0 11.4158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7461 0 0 0 14.0576 14.1887 0 0 0 13.4066 0 0 13.9283 0 0 0 11.7284 0 0 0 0 0 0 13.4074 0 0 0 0 0 0 0 0 14.0653 0 0 14.1792 0 0 13.2495 0 0 0 0 0 0 0 0 0 13.3443 0 0 Q9ULI2 RIMKB_HUMAN "Beta-citrylglutamate synthase B, EC 6.3.1.17 (N-acetyl-aspartylglutamate synthetase B, NAAG synthetase B, NAAGS, EC 6.3.2.41) (Ribosomal protein S6 modification-like protein B)" RIMKLB FAM80B KIAA1238 Homo sapiens (Human) glutamine family amino acid metabolic process [GO:0009064] cytoplasm [GO:0005737]; cytosol [GO:0005829] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; citrate-L-glutamate ligase activity [GO:0072591]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]; glutamine family amino acid metabolic process [GO:0009064]" GO:0005524; GO:0005737; GO:0005829; GO:0009064; GO:0016879; GO:0046872; GO:0072590; GO:0072591 "ATP binding [GO:0005524]; citrate-L-glutamate ligase activity [GO:0072591]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; metal ion binding [GO:0046872]; N-acetyl-L-aspartate-L-glutamate ligase activity [GO:0072590]" LPGGLFNMNQLLANEIKLLVD 0.99638 -9.6679 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9356 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2511 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8401 0 0 0 0 0 0 0 0 14.5528 11.7249 0 0 0 0 0 11.6956 0 0 0 0 Q9ULS5 TMCC3_HUMAN Transmembrane and coiled-coil domain protein 3 TMCC3 KIAA1145 Homo sapiens (Human) endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802] GO:0005783; GO:0005789; GO:0012505; GO:0016021; GO:0042802; GO:0071889 14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802] AYGGSATIVNKPK 0.99638 -10.235 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3879 10.842 12.7691 13.1599 12.3416 13.9005 12.6445 13.4355 0 9.88241 0 0 0 0 0 0 0 12.9103 14.525 14.9491 14.4811 0 0 14.5254 0 0 0 0 0 14.5783 0 10.7308 0 0 0 0 0 13.8243 0 0 15.734 13.3006 14.1154 13.62 15.147 13 0 12.6718 12.5919 12.7456 0 0 0 0 12.7 13.9905 0 12.8863 0 0 0 13.9557 14.3843 0 0 14.7838 15.8224 14.6475 0 13.3895 0 13.7591 13.6192 0 0 13.7734 0 0 0 0 16.2503 13.7775 13.8737 0 0 0 11.5548 11.8623 14.913 15.8295 16.5507 16.203 0 0 16.177 13.9979 0 12.8669 16.318 15.287 15.6825 0 0 13.515 14.8321 0 14.0502 14.7274 0 15.9441 0 0 13.7408 0 15.4606 0 14.6008 14.1918 14.6956 0 0 0 0 0 15.2152 0 0 11.4891 0 0 14.9839 12.705 15.4939 15.0684 14.6313 0 0 15.4475 0 0 15.536 15.7376 14.5356 15.5227 0 13.0473 0 0 0 0 0 13.3588 14.1839 14.2157 0 0 0 13.4691 13.1202 0 13.5342 14.409 14.7892 0 13.6254 0 0 P49257 LMAN1_HUMAN Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1) LMAN1 ERGIC53 F5F8D Homo sapiens (Human) blood coagulation [GO:0007596]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017] collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; sarcomere [GO:0030017]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; blood coagulation [GO:0007596]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031] GO:0000139; GO:0005537; GO:0005783; GO:0005789; GO:0005793; GO:0006457; GO:0006888; GO:0007029; GO:0007030; GO:0007596; GO:0010638; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0030017; GO:0030134; GO:0033116; GO:0046872; GO:0051082; GO:0062023; GO:0070062; GO:1903215 mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082] EHLHIVKR 0.9964 -9.7651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6199 0 11.5832 0 11.9907 11.6587 0 0 0 0 0 11.7265 0 0 11.6473 0 0 0 0 0 0 0 0 0 0 0 0 11.2795 0 0 11.5032 11.1351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.1411 0 0 0 0 0 0 0 0 0 0 13.6923 0 0 13.4914 0 0 0 0 0 0 0 12.7091 12.7181 16.8443 0 0 12.6294 0 0 0 0 0 0 0 13.8761 0 0 0 13.791 0 0 0 13.7309 0 0 12.6284 0 0 0 0 17.0149 0 0 0 0 16.1879 0 0 13.9724 0 0 0 16.4348 0 0 0 0 0 15.0505 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.8124 0 0 0 0 0 0 P98175 RBM10_HUMAN "RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1, S1-1)" RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 Homo sapiens (Human) "3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; vascular associated smooth muscle cell apoptotic process [GO:1905288]; vascular associated smooth muscle cell proliferation [GO:1990874]" nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] "nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; vascular associated smooth muscle cell apoptotic process [GO:1905288]; vascular associated smooth muscle cell proliferation [GO:1990874]" GO:0000122; GO:0000381; GO:0000398; GO:0003723; GO:0005634; GO:0016607; GO:0032991; GO:0035198; GO:0042802; GO:0046872; GO:0048025; GO:0070935; GO:1904706; GO:1905288; GO:1905461; GO:1990874 identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723] DGDYRDQDYRTEQGEEEEEEEDEEEEEK 0.9964 -9.7641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2621 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2956 0 0 0 0 0 0 0 0 0 12.8987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1565 0 0 0 12.1929 0 0 15.1591 11.6688 0 0 0 0 0 0 0 0 0 0 0 0 11.9421 0 0 0 11.8614 11.6378 12.1615 12.8391 0 0 14.1565 0 0 0 0 13.6179 0 0 0 0 11.3208 0 0 0 11.9392 0 0 0 14.444 15.1081 0 13.6656 0 11.4969 0 13.8265 0 0 12.0494 0 12.2471 11.7674 0 11.9168 0 15.3307 0 11.5563 0 14.5941 0 0 0 0 0 0 13.8559 0 0 11.157 0 0 0 0 0 0 0 0 0 0 0 12.9344 12.0429 0 0 0 0 12.6451 0 0 0 12.9351 0 0 0 0 0 13.2688 0 10.3868 12.5254 0 Q01844 EWS_HUMAN RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein) EWSR1 EWS Homo sapiens (Human) Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] GO:0003712; GO:0003723; GO:0005516; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0015030; GO:0042802; GO:0046872 calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712] GGFDRGGMSRGGR 0.9964 -9.7771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5716 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6784 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9342 13.9796 13.9543 13.9538 12.7013 0 13.0038 14.6015 0 0 0 12.9876 14.5107 0 0 0 0 14.9558 13.763 0 0 0 13.1368 14.5899 13.8865 0 0 0 0 0 0 14.5557 12.5369 13.635 0 0 0 0 0 0 0 0 0 0 13.8276 0 0 0 0 0 0 13.0824 13.5256 0 0 11.9419 12.8496 0 11.5251 0 11.3222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2611 0 0 10.8697 0 12.9909 0 14.0815 0 A6NMT0 DBX1_HUMAN Homeobox protein DBX1 (Developing brain homeobox protein 1) DBX1 Homo sapiens (Human) cell differentiation in spinal cord [GO:0021515]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral spinal cord interneuron specification [GO:0021521] chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; cell differentiation in spinal cord [GO:0021515]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral spinal cord interneuron specification [GO:0021521]" GO:0000785; GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0021515; GO:0021521 "DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]" PRRGMLR 0.99643 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2681 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6405 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8MV23 SERP3_HUMAN Serpin E3 SERPINE3 Homo sapiens (Human) negative regulation of endopeptidase activity [GO:0010951] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951] GO:0004867; GO:0005615; GO:0010951 serine-type endopeptidase inhibitor activity [GO:0004867] GISGQDGFYVSEAIHKAK 0.99643 -9.5998 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8508 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6139 0 16.2121 0 15.7224 15.454 14.9287 0 0 0 16.2889 0 0 0 0 15.0587 0 0 15.2869 0 15.7714 0 0 0 0 0 0 15.2576 0 0 0 0 0 0 15.2129 0 0 0 14.8213 0 14.8435 14.9454 0 0 0 0 0 0 0 0 0 14.7331 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4216 0 0 0 0 0 0 P04271 S100B_HUMAN Protein S100-B (S-100 protein beta chain) (S-100 protein subunit beta) (S100 calcium-binding protein B) S100B Homo sapiens (Human) axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; learning or memory [GO:0007611]; memory [GO:0007613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of neuronal synaptic plasticity [GO:0048168] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RAGE receptor binding [GO:0050786]; S100 protein binding [GO:0044548]; tau protein binding [GO:0048156]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; learning or memory [GO:0007611]; memory [GO:0007613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of neuronal synaptic plasticity [GO:0048168] GO:0001726; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007409; GO:0007417; GO:0007611; GO:0007613; GO:0008270; GO:0008284; GO:0042802; GO:0042803; GO:0043025; GO:0043123; GO:0043231; GO:0044548; GO:0048156; GO:0048168; GO:0048306; GO:0048471; GO:0050786 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RAGE receptor binding [GO:0050786]; S100 protein binding [GO:0044548]; tau protein binding [GO:0048156]; zinc ion binding [GO:0008270] LKKSELK 0.99643 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P08567 PLEK_HUMAN "Pleckstrin (Platelet 47 kDa protein, p47)" PLEK P47 Homo sapiens (Human) actin cytoskeleton reorganization [GO:0031532]; cell projection organization [GO:0030030]; cortical actin cytoskeleton organization [GO:0030866]; hematopoietic progenitor cell differentiation [GO:0002244]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of inositol-polyphosphate 5-phosphatase activity [GO:0010925]; positive regulation of integrin activation [GO:0033625]; positive regulation of platelet activation [GO:0010572]; protein kinase C signaling [GO:0070528]; protein secretion by platelet [GO:0070560]; regulation of cell diameter [GO:0060305]; ruffle organization [GO:0031529]; thrombin-activated receptor signaling pathway [GO:0070493]; vesicle docking involved in exocytosis [GO:0006904] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; actin cytoskeleton reorganization [GO:0031532]; cell projection organization [GO:0030030]; cortical actin cytoskeleton organization [GO:0030866]; hematopoietic progenitor cell differentiation [GO:0002244]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of inositol-polyphosphate 5-phosphatase activity [GO:0010925]; positive regulation of integrin activation [GO:0033625]; positive regulation of platelet activation [GO:0010572]; protein kinase C signaling [GO:0070528]; protein secretion by platelet [GO:0070560]; regulation of cell diameter [GO:0060305]; ruffle organization [GO:0031529]; thrombin-activated receptor signaling pathway [GO:0070493]; vesicle docking involved in exocytosis [GO:0006904]" GO:0002244; GO:0002576; GO:0005080; GO:0005576; GO:0005737; GO:0005829; GO:0005886; GO:0006904; GO:0007229; GO:0010572; GO:0010920; GO:0010925; GO:0016020; GO:0030030; GO:0030836; GO:0030845; GO:0030866; GO:0031529; GO:0031532; GO:0032233; GO:0032587; GO:0033625; GO:0042803; GO:0043325; GO:0045744; GO:0046488; GO:0050849; GO:0060305; GO:0070493; GO:0070527; GO:0070528; GO:0070560 "phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]" VRKFILR 0.99643 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7646 12.9137 14.3853 0 0 0 0 0 0 0 0 14.2499 13.1234 0 0 0 0 0 0 0 12.3841 0 0 14.0859 0 12.6383 0 0 0 13.4005 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6863 0 0 0 0 0 0 0 13.9254 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P14384 CBPM_HUMAN "Carboxypeptidase M, CPM, EC 3.4.17.12" CPM Homo sapiens (Human) anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; anatomical structure morphogenesis [GO:0009653]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485] GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005886; GO:0006518; GO:0008270; GO:0009653; GO:0009986; GO:0016485; GO:0031225; GO:0070062 carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270] FPKEHRIGIPEFK 0.99643 -10.165 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8692 0 0 0 0 0 0 0 0 0 0 0 11.753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2319 0 0 0 0 0 0 12.4684 0 0 0 0 0 14.7068 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7665 0 0 0 0 0 0 0 0 0 0 12.3713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7998 0 0 0 0 0 0 0 11.8167 0 0 0 0 0 0 11.5979 0 0 0 0 0 0 0 0 12.9408 0 0 0 Q6PUV4 CPLX2_HUMAN "Complexin-2 (Complexin II, CPX II) (Synaphin-1)" CPLX2 Homo sapiens (Human) cell differentiation [GO:0030154]; mast cell degranulation [GO:0043303]; nervous system development [GO:0007399]; positive regulation of synaptic plasticity [GO:0031915]; regulation of exocytosis [GO:0017157]; regulation of neurotransmitter secretion [GO:0046928]; synaptic vesicle exocytosis [GO:0016079]; vesicle docking involved in exocytosis [GO:0006904] anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex [GO:0070554]; terminal bouton [GO:0043195] anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex [GO:0070554]; terminal bouton [GO:0043195]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; cell differentiation [GO:0030154]; mast cell degranulation [GO:0043303]; nervous system development [GO:0007399]; positive regulation of synaptic plasticity [GO:0031915]; regulation of exocytosis [GO:0017157]; regulation of neurotransmitter secretion [GO:0046928]; synaptic vesicle exocytosis [GO:0016079]; vesicle docking involved in exocytosis [GO:0006904] GO:0000149; GO:0005634; GO:0005829; GO:0006904; GO:0007399; GO:0016079; GO:0017157; GO:0019905; GO:0030154; GO:0031201; GO:0031915; GO:0043195; GO:0043204; GO:0043303; GO:0046928; GO:0070161; GO:0070554 SNARE binding [GO:0000149]; syntaxin binding [GO:0019905] DKYGLKK 0.99643 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q92499 DDX1_HUMAN "ATP-dependent RNA helicase DDX1, EC 3.6.4.13 (DEAD box protein 1) (DEAD box protein retinoblastoma, DBP-RB)" DDX1 Homo sapiens (Human) "defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669] "cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]; defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of translational initiation [GO:0006446]; response to exogenous dsRNA [GO:0043330]; spliceosomal complex assembly [GO:0000245]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]" GO:0000245; GO:0002735; GO:0003677; GO:0003682; GO:0003712; GO:0003723; GO:0003724; GO:0003725; GO:0004518; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0006302; GO:0006388; GO:0006446; GO:0008143; GO:0010494; GO:0016020; GO:0016887; GO:0032508; GO:0033677; GO:0043123; GO:0043330; GO:0045087; GO:0051607; GO:0071920; GO:0072669; GO:0090305; GO:1903608; GO:1990904 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712] EHKMDQAIIFCRTK 0.99643 -10.172 0 0 0 0 0 0 0 0 14.5504 0 0 0 0 0 13.4375 0 13.5365 14.2809 12.9431 0 0 0 0 0 0 0 0 0 13.9892 0 0 0 0 0 0 13.4209 0 0 0 0 0 0 13.8091 12.8907 13.9792 13.4398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3975 0 0 0 0 0 0 0 0 0 0 13.5644 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5132 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3419 Q96G23 CERS2_HUMAN "Ceramide synthase 2, CerS2 (LAG1 longevity assurance homolog 2) (SP260) (Sphingosine N-acyltransferase CERS2, EC 2.3.1.24) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2, EC 2.3.1.297)" CERS2 LASS2 TMSG1 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; regulation of lipid metabolic process [GO:0019216]; sphingolipid biosynthetic process [GO:0030148] GO:0003677; GO:0005783; GO:0005789; GO:0016020; GO:0016021; GO:0016410; GO:0019216; GO:0030148; GO:0046513; GO:0048681; GO:0050291; GO:1900148; GO:1905045 DNA binding [GO:0003677]; N-acyltransferase activity [GO:0016410]; sphingosine N-acyltransferase activity [GO:0050291] DGRVYAKASDLYITLPLALLFLIVR 0.99643 -10.166 0 0 0 10.8609 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7838 0 0 0 0 0 0 0 0 0 10.8205 0 0 0 0 0 0 0 12.6784 0 13.6395 0 0 0 0 0 11.478 0 14.0975 14.0712 0 0 0 0 0 0 0 12.4232 0 0 0 0 12.6204 0 0 0 0 0 0 0 12.9573 0 13.8086 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96N20 ZN75A_HUMAN Zinc finger protein 75A ZNF75A Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0046872; GO:1990837 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" ALYNDVMQENYETVISLALFVLPKPK 0.99643 -10.163 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2802 0 0 0 0 0 0 11.6758 0 0 0 0 0 0 11.6253 0 0 0 0 0 0 0 0 0 0 0 0 13.0467 0 0 12.2682 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5413 0 0 0 0 13.0114 0 0 0 0 0 0 0 0 0 0 0 0 11.8477 13.243 0 0 0 0 13.2044 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2507 0 12.885 0 0 0 0 0 0 0 14.4987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.94891 Q9BUE0 MED18_HUMAN Mediator of RNA polymerase II transcription subunit 18 (Mediator complex subunit 18) (p28b) MED18 Homo sapiens (Human) positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; termination of RNA polymerase II transcription [GO:0006369] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; termination of RNA polymerase II transcription [GO:0006369] GO:0003712; GO:0005634; GO:0006357; GO:0006369; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 transcription coregulator activity [GO:0003712] PLVHLEK 0.99643 -9.5979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1466 0 0 0 0 0 0 0 0 0 14.0864 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0447 0 0 0 0 0 0 13.0877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9675 0 0 0 0 0 Q9UKJ5 CHIC2_HUMAN Cysteine-rich hydrophobic domain-containing protein 2 (BrX-like translocated in leukemia) CHIC2 BTL Homo sapiens (Human) Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886] GO:0005794; GO:0005798; GO:0005886; GO:0043231 ASINRVNSCLK 0.99643 -10.182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3284 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4405 0 0 0 0 0 0 0 0 13.0015 0 14.8381 0 14.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2989 0 0 14.257 0 0 0 0 0 0 0 0 0 10.5083 0 0 0 0 0 0 0 0 0 19.2898 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4721 0 0 0 0 0 O75083 WDR1_HUMAN "WD repeat-containing protein 1 (Actin-interacting protein 1, AIP1) (NORI-1)" WDR1 Homo sapiens (Human) actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605] cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podosome [GO:0002102] cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605] GO:0002102; GO:0002446; GO:0005576; GO:0005829; GO:0005886; GO:0005911; GO:0007605; GO:0008360; GO:0030042; GO:0030043; GO:0030054; GO:0030220; GO:0030834; GO:0030836; GO:0030864; GO:0030865; GO:0040011; GO:0042247; GO:0042995; GO:0043297; GO:0045199; GO:0045214; GO:0048713; GO:0051015; GO:0060307; GO:0070062; GO:1990266 actin filament binding [GO:0051015] EHLLKYEYQPFAGKIK 0.99644 -10.209 0 0 0 0 0 0 0 0 12.418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8492 0 10.7357 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3008 11.6615 0 0 12.4249 12.9329 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1608 0 0 0 0 0 12.6664 0 0 0 0 12.8504 0 0 0 0 0 0 0 0 0 0 12.6104 0 12.1385 12.6168 13.0883 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7415 0 0 0 0 0 13.3283 0 12.7315 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.074 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P21728 DRD1_HUMAN D(1A) dopamine receptor (Dopamine D1 receptor) DRD1 Homo sapiens (Human) "activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult walking behavior [GO:0007628]; astrocyte development [GO:0014002]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; cellular calcium ion homeostasis [GO:0006874]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to dopamine [GO:1903351]; cerebral cortex GABAergic interneuron migration [GO:0021853]; conditioned taste aversion [GO:0001661]; dentate gyrus development [GO:0021542]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; dopamine transport [GO:0015872]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose import [GO:0046323]; grooming behavior [GO:0007625]; habituation [GO:0046959]; histone H3-S10 phosphorylation [GO:0043987]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; maternal behavior [GO:0042711]; mating behavior [GO:0007617]; memory [GO:0007613]; neuronal action potential [GO:0019228]; operant conditioning [GO:0035106]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; prepulse inhibition [GO:0060134]; protein import into nucleus [GO:0006606]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249]; temperature homeostasis [GO:0001659]; transmission of nerve impulse [GO:0019226]; vasodilation [GO:0042311]; visual learning [GO:0008542]" anchoring junction [GO:0070161]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886] "anchoring junction [GO:0070161]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult walking behavior [GO:0007628]; astrocyte development [GO:0014002]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; cellular calcium ion homeostasis [GO:0006874]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to dopamine [GO:1903351]; cerebral cortex GABAergic interneuron migration [GO:0021853]; conditioned taste aversion [GO:0001661]; dentate gyrus development [GO:0021542]; dopamine metabolic process [GO:0042417]; dopamine receptor signaling pathway [GO:0007212]; dopamine transport [GO:0015872]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glucose import [GO:0046323]; grooming behavior [GO:0007625]; habituation [GO:0046959]; histone H3-S10 phosphorylation [GO:0043987]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; maternal behavior [GO:0042711]; mating behavior [GO:0007617]; memory [GO:0007613]; neuronal action potential [GO:0019228]; operant conditioning [GO:0035106]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cell migration [GO:0030335]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; prepulse inhibition [GO:0060134]; protein import into nucleus [GO:0006606]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to amphetamine [GO:0001975]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249]; temperature homeostasis [GO:0001659]; transmission of nerve impulse [GO:0019226]; vasodilation [GO:0042311]; visual learning [GO:0008542]" GO:0001588; GO:0001659; GO:0001661; GO:0001662; GO:0001932; GO:0001975; GO:0004930; GO:0004952; GO:0005634; GO:0005789; GO:0005886; GO:0005887; GO:0005929; GO:0006606; GO:0006874; GO:0007187; GO:0007189; GO:0007190; GO:0007191; GO:0007212; GO:0007416; GO:0007613; GO:0007617; GO:0007625; GO:0007628; GO:0008542; GO:0009410; GO:0010628; GO:0014002; GO:0015872; GO:0019226; GO:0019228; GO:0021542; GO:0021756; GO:0021853; GO:0030335; GO:0030432; GO:0035106; GO:0035240; GO:0035249; GO:0042053; GO:0042311; GO:0042417; GO:0042711; GO:0043197; GO:0043268; GO:0043987; GO:0046323; GO:0046959; GO:0046960; GO:0048148; GO:0051281; GO:0051482; GO:0051584; GO:0051968; GO:0060134; GO:0060158; GO:0060170; GO:0060291; GO:0060292; GO:0070161; GO:0071870; GO:0071880; GO:0097730; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:1903351; GO:2000300; GO:2001224 "dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]" DFSVRILTACFLSLLILSTLLGNTLVCAAVIR 0.99644 -10.221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6035 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8381 0 13.4634 0 0 0 0 18.4605 0 0 0 0 18.1941 0 0 0 0 0 13.4647 0 0 0 0 0 0 0 0 0 0 18.6103 0 0 0 0 14.2756 18.0582 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7237 0 0 0 0 0 0 P60866 RS20_HUMAN 40S ribosomal protein S20 (Small ribosomal subunit protein uS10) RPS20 Homo sapiens (Human) cytoplasmic translation [GO:0002181]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202] cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; small ribosomal subunit [GO:0015935]; synapse [GO:0045202]; MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; cytoplasmic translation [GO:0002181]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; translation [GO:0006412] GO:0002181; GO:0003723; GO:0003735; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0016020; GO:0022626; GO:0022627; GO:0045202; GO:0070062; GO:0097371; GO:1901798; GO:1990948 MDM2/MDM4 family protein binding [GO:0097371]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948] IRITLTSR 0.99644 -10.208 0 0 0 0 16.7479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4254 0 0 0 9.96545 0 0 0 0 0 0 0 0 0 0 0 0 0 16.3723 0 16.5504 0 0 16.8219 16.5464 0 0 0 16.4619 0 0 0 0 0 0 0 0 15.0462 16.0131 0 0 0 0 16.0634 0 0 0 0 0 0 0 0 0 0 0 16.7848 0 0 0 0 0 0 16.3419 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.084 0 0 0 0 0 0 0 0 0 Q96C19 EFHD2_HUMAN EF-hand domain-containing protein D2 (Swiprosin-1) EFHD2 SWS1 Homo sapiens (Human) membrane raft [GO:0045121] membrane raft [GO:0045121]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] GO:0005509; GO:0045121; GO:0045296 cadherin binding [GO:0045296]; calcium ion binding [GO:0005509] EFLLIFR 0.99644 -10.231 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2322 0 0 0 0 0 12.3008 0 0 0 0 13.7777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.792 0 0 0 0 0 0 0 0 0 0 0 0 14.7115 0 0 0 0 0 13.909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9458 0 0 0 0 13.1299 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCU5 PREB_HUMAN Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12) PREB SEC12 Homo sapiens (Human) COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634] endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400] GO:0003400; GO:0003677; GO:0005085; GO:0005096; GO:0005634; GO:0005789; GO:0006888; GO:0009306; GO:0016020; GO:0030176; GO:0032527; GO:0048208; GO:0051020; GO:0070971 DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085] FQAHQQQGNK 0.99644 -10.223 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9342 0 0 0 0 0 10.8826 0 0 0 0 11.7817 0 0 0 0 0 0 0 0 0 0 0 10.9471 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2027 12.425 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8882 0 0 0 0 13.9696 0 0 0 0 14.0291 0 0 0 0 0 0 0 11.965 0 0 0 0 0 0 0 0 0 0 10.4221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8176 0 0 0 0 0 0 0 0 0 11.6558 0 0 0 0 0 0 0 0 0 0 0 Q8IXB1 DJC10_HUMAN "DnaJ homolog subfamily C member 10, EC 1.8.4.- (Endoplasmic reticulum DNA J domain-containing protein 5, ER-resident protein ERdj5, ERdj5) (Macrothioredoxin, MTHr)" DNAJC10 ERDJ5 UNQ495/PRO1012 Homo sapiens (Human) intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020] "endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase activity [GO:0015035]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433]" GO:0001671; GO:0001933; GO:0005783; GO:0005788; GO:0015035; GO:0015036; GO:0016020; GO:0016671; GO:0030433; GO:0030544; GO:0032781; GO:0034663; GO:0034975; GO:0034976; GO:0036498; GO:0051087; GO:0051117; GO:0051787; GO:0070059 "ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase activity [GO:0015035]" AIAALISEKLETLR 0.99645 -9.6783 0 0 0 10.0565 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3304 0 0 0 0 10.0539 0 0 0 0 0 0 0 0 0 0 0 0 10.7087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8439 0 0 0 0 0 0 0 0 0 10.4524 0 0 10.7546 0 0 0 0 0 0 11.2675 0 10.8978 0 10.9498 14.9021 0 12.9933 0 0 13.283 0 14.9152 0 0 12.5439 14.1649 13.267 0 13.3907 0 14.4603 0 0 0 0 0 11.8835 0 12.9124 0 0 0 0 0 10.456 0 0 0 0 0 0 0 0 0 14.7962 0 0 0 0 0 11.1413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2942 0 0 0 0 0 0 11.7187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0576 0 0 0 0 Q99685 MGLL_HUMAN "Monoglyceride lipase, MGL, EC 3.1.1.23 (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase, MAGL)" MGLL Homo sapiens (Human) acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886] cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803]; acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433] GO:0004622; GO:0005654; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0016298; GO:0019369; GO:0019433; GO:0019898; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:2000124 acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; protein homodimerization activity [GO:0042803] VERALPK 0.99645 -9.6648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BSU1 PHAF1_HUMAN Phagosome assembly factor 1 PHAF1 C16orf6 C16orf70 Homo sapiens (Human) Golgi to plasma membrane protein transport [GO:0043001] dendrite [GO:0030425]; phagophore assembly site [GO:0000407]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802] dendrite [GO:0030425]; phagophore assembly site [GO:0000407]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; Golgi to plasma membrane protein transport [GO:0043001] GO:0000407; GO:0005802; GO:0030425; GO:0030672; GO:0043001 IPLAIKK 0.99645 -10.067 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7499 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.319 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0242 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P07237 PDIA1_HUMAN "Protein disulfide-isomerase, PDI, EC 5.3.4.1 (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)" P4HB ERBA2L PDI PDIA1 PO4DB Homo sapiens (Human) cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991] cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; thiol oxidase activity [GO:0016972]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976] GO:0003723; GO:0003756; GO:0003779; GO:0004656; GO:0005178; GO:0005576; GO:0005783; GO:0005788; GO:0005793; GO:0005829; GO:0005856; GO:0005925; GO:0006457; GO:0009897; GO:0015035; GO:0016222; GO:0016972; GO:0018401; GO:0019899; GO:0030027; GO:0032991; GO:0034663; GO:0034975; GO:0034976; GO:0035722; GO:0038155; GO:0042470; GO:0045785; GO:0046598; GO:0046982; GO:0070062; GO:0071456; GO:0098761; GO:1900026; GO:1902175 actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; thiol oxidase activity [GO:0016972] AEGSEIR 0.99647 -9.7713 0 0 0 0 0 0 0 0 13.1095 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7151 12.0677 0 0 0 0 12.0237 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63225 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3104 0 11.7477 0 0 0 0 0 0 0 0 0 13.5691 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8036 0 0 0 0 0 0 0 0 13.7254 0 0 0 0 0 12.9098 11.7673 13.2899 0 0 0 0 0 0 14.4981 0 0 0 0 14.5661 0 0 0 0 0 0 0 0 12.7192 0 0 0 0 0 0 0 0 12.0221 0 0 14.4029 0 0 16.5446 0 0 Q8NGA8 O4F17_HUMAN Olfactory receptor 4F17 (Olfactory receptor 4F11) (Olfactory receptor 4F18) (Olfactory receptor 4F19) OR4F17 OR4F11P OR4F18 OR4F19 Homo sapiens (Human) integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] SLDKFLAVFYSVITPLLNPIIYTLR 0.99647 -9.7639 0 0 0 0 0 0 0 0 0 0 13.4905 0 0 0 0 0 0 0 0 0 0 0 13.1221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3974 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.144 0 0 0 0 0 0 0 0 14.3875 13.5206 0 0 13.8311 12.919 13.441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5043 0 Q99453 PHX2B_HUMAN "Paired mesoderm homeobox protein 2B (Neuroblastoma Phox, NBPhox) (PHOX2B homeodomain protein) (Paired-like homeobox 2B)" PHOX2B PMX2B Homo sapiens (Human) autonomic nervous system development [GO:0048483]; brainstem development [GO:0003360]; cell differentiation in hindbrain [GO:0021533]; cellular response to BMP stimulus [GO:0071773]; dopaminergic neuron differentiation [GO:0071542]; efferent axon development in a lateral line nerve [GO:0048894]; enteric nervous system development [GO:0048484]; glial cell differentiation [GO:0010001]; hindbrain tangential cell migration [GO:0021934]; inner ear development [GO:0048839]; medullary reticular formation development [GO:0021723]; motor neuron migration [GO:0097475]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron differentiation [GO:0003357]; parasympathetic nervous system development [GO:0048486]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system development [GO:0060541]; retrotrapezoid nucleus neuron differentiation [GO:0061452]; skeletal muscle cell differentiation [GO:0035914]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; type B pancreatic cell proliferation [GO:0044342] chromatin [GO:0000785]; nucleoplasm [GO:0005654] "chromatin [GO:0000785]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; autonomic nervous system development [GO:0048483]; brainstem development [GO:0003360]; cell differentiation in hindbrain [GO:0021533]; cellular response to BMP stimulus [GO:0071773]; dopaminergic neuron differentiation [GO:0071542]; efferent axon development in a lateral line nerve [GO:0048894]; enteric nervous system development [GO:0048484]; glial cell differentiation [GO:0010001]; hindbrain tangential cell migration [GO:0021934]; inner ear development [GO:0048839]; medullary reticular formation development [GO:0021723]; motor neuron migration [GO:0097475]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron differentiation [GO:0003357]; parasympathetic nervous system development [GO:0048486]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory system development [GO:0060541]; retrotrapezoid nucleus neuron differentiation [GO:0061452]; skeletal muscle cell differentiation [GO:0035914]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; type B pancreatic cell proliferation [GO:0044342]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001764; GO:0002087; GO:0003357; GO:0003358; GO:0003360; GO:0005654; GO:0006357; GO:0010001; GO:0010468; GO:0010971; GO:0021533; GO:0021723; GO:0021934; GO:0035914; GO:0044342; GO:0045665; GO:0045666; GO:0045944; GO:0048483; GO:0048484; GO:0048485; GO:0048486; GO:0048839; GO:0048894; GO:0060541; GO:0061452; GO:0061549; GO:0071542; GO:0071773; GO:0097475; GO:0120162; GO:1901166; GO:1904691; GO:1990837 "DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" IRTTFTSAQLK 0.99647 -9.7763 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.93936 0 0 0 0 0 0 0 12.91 0 0 0 0 12.1644 0 0 0 0 12.1322 12.9595 13.1875 0 13.8091 0 0 13.2352 13.4494 13.5664 13.3829 0 0 0 12.6726 0 0 0 0 0 0 0 0 0 0 13.1272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.759 0 0 12.7321 0 0 0 13.7729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1712 0 0 0 0 0 0 11.3502 0 0 O60844 ZG16_HUMAN "Zymogen granule membrane protein 16, Zymogen granule protein 16, hZG16 (Secretory lectin ZG16)" ZG16 Homo sapiens (Human) defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031]; suppression of symbiont entry into host [GO:0052373] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; zymogen granule membrane [GO:0042589] collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; zymogen granule membrane [GO:0042589]; carbohydrate binding [GO:0030246]; peptidoglycan binding [GO:0042834]; defense response to Gram-positive bacterium [GO:0050830]; protein transport [GO:0015031]; suppression of symbiont entry into host [GO:0052373] GO:0005615; GO:0005796; GO:0015031; GO:0030246; GO:0042589; GO:0042834; GO:0050830; GO:0052373; GO:0062023; GO:0070701 carbohydrate binding [GO:0030246]; peptidoglycan binding [GO:0042834] YKWYLKK 0.99649 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZN18 AEBP2_HUMAN "Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2, AE-binding protein 2)" AEBP2 Homo sapiens (Human) chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] chromatin [GO:0000785]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654] chromatin [GO:0000785]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0000785; GO:0003677; GO:0003712; GO:0005654; GO:0006325; GO:0006357; GO:0035098; GO:0046872 DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712] LKRTLIR 0.99649 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6ZQV5 ZN788_HUMAN "Putative KRAB domain-containing protein ZNF788 (Zinc finger family member 788, pseudogene)" ZNF788P ZNF788 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0005634; GO:0006355 NLYREVMQETLR 0.99649 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H4R4 CT191_HUMAN Putative nuclear receptor corepressor 1-like protein NCOR1P1 (Nuclear receptor corepressor 1 pseudogene 1) NCOR1P1 C20orf191 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] nuclear thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357] GO:0000122; GO:0003714; GO:0006357; GO:0046966 nuclear thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714] KQVKVFV 0.99649 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5149 0 0 0 0 0 0 0 0 0 0 0 0 12.2622 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5083 0 14.2204 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9863 0 11.6228 0 A5YM72 CRNS1_HUMAN "Carnosine synthase 1, EC 6.3.2.11 (ATP-grasp domain-containing protein 1)" CARNS1 ATPGD1 KIAA1394 Homo sapiens (Human) carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548] GO:0005524; GO:0005829; GO:0006548; GO:0016887; GO:0035499; GO:0046872; GO:0047730; GO:0102102 ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; carnosine synthase activity [GO:0047730]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872] DLTCPTGASAELAR 0.9965 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6924 0 0 14.8136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2353 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P05165 PCCA_HUMAN "Propionyl-CoA carboxylase alpha chain, mitochondrial, PCCase subunit alpha, EC 6.4.1.3 (Propanoyl-CoA:carbon dioxide ligase subunit alpha)" PCCA Homo sapiens (Human) branched-chain amino acid metabolic process [GO:0009081]; fatty acid metabolic process [GO:0006631]; short-chain fatty acid catabolic process [GO:0019626] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] catalytic complex [GO:1902494]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; branched-chain amino acid metabolic process [GO:0009081]; fatty acid metabolic process [GO:0006631]; short-chain fatty acid catabolic process [GO:0019626] GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006631; GO:0009081; GO:0009374; GO:0019626; GO:0019899; GO:0046872; GO:1902494 ATP binding [GO:0005524]; biotin binding [GO:0009374]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658] ASAGGGGK 0.9965 -10.171 0 0 0 0 0 0 0 0 0 0 0 12.5847 0 0 0 0 0 0 11.2679 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7949 0 0 0 11.2633 11.1385 13.1994 0 0 0 15.3191 0 0 0 0 0 13.4714 0 0 0 0 0 0 0 0 0 13.0018 0 0 0 0 0 0 0 0 0 0 0 0 12.8141 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8598 0 0 12.9612 0 0 0 0 0 0 0 0 0 0 0 13.7406 0 0 0 0 0 0 0 0 0 0 0 12.3951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.6397 12.3226 0 0 0 0 0 12.7858 0 13.5278 14.2297 0 0 14.4905 13.9763 14.0918 14.8371 14.5527 0 14.677 17.7678 15.1808 12.7323 12.0995 0 0 0 0 14.1966 0 15.4537 14.212 0 P13639 EF2_HUMAN "Elongation factor 2, EF-2" EEF2 EF2 Homo sapiens (Human) hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; synapse [GO:0045202] aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414] GO:0002244; GO:0003723; GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005844; GO:0005886; GO:0006414; GO:0016020; GO:0016235; GO:0019901; GO:0034774; GO:0043022; GO:0045202; GO:0045296; GO:0045727; GO:0070062; GO:1904813; GO:1990904 cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746] EETAKLIEKLDIK 0.9965 -9.5991 0 0 0 0 10.1331 0 0 0 0 0 10.9421 0 11.7408 0 0 0 0 0 0 0 10.2811 0 13.1335 0 0 0 0 0 0 0 0 10.2437 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.52964 0 0 0 16.266 16.2672 16.1648 0 0 17.1144 17.8511 17.8456 13.5665 17.0487 13.486 12.786 0 13.572 14.6296 16.7304 13.1398 16.8157 16.4217 0 16.8089 13.9464 14.3137 12.8004 16.3327 13.8553 16.4232 16.1664 0 14.6686 0 17.654 17.4879 0 13.9144 0 17.4709 0 13.4135 14.4234 16.6582 13.409 15.9883 0 16.5324 16.8998 16.7461 16.9249 16.3401 0 16.3015 0 0 0 0 0 11.4658 13.3014 0 0 17.1118 13.8213 13.7416 0 0 0 0 0 0 0 0 0 13.5023 17.8418 0 13.9908 0 0 15.9855 0 0 0 0 0 11.396 0 0 11.7831 0 0 0 0 0 0 0 13.825 0 0 0 0 16.113 0 P55042 RAD_HUMAN GTP-binding protein RAD (RAD1) (Ras associated with diabetes) RRAD RAD Homo sapiens (Human) negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264] cytosol [GO:0005829]; plasma membrane [GO:0005886] cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; small GTPase mediated signal transduction [GO:0007264] GO:0003924; GO:0005246; GO:0005516; GO:0005525; GO:0005829; GO:0005886; GO:0007264; GO:1901842 calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; GTPase activity [GO:0003924] KMAFRAK 0.9965 -10.194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4816 12.2674 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P60008 HILS1_HUMAN Putative spermatid-specific linker histone H1-like protein (H1.9 linker histone pseudogene) H1-9P H1-9 HILS1 Homo sapiens (Human) "chromatin remodeling [GO:0006338]; chromosome condensation [GO:0030261]; germ cell development [GO:0007281]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" male germ cell nucleus [GO:0001673]; nucleosome [GO:0000786]; nucleus [GO:0005634] "male germ cell nucleus [GO:0001673]; nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; nucleosomal DNA binding [GO:0031492]; chromatin remodeling [GO:0006338]; chromosome condensation [GO:0030261]; germ cell development [GO:0007281]; heterochromatin assembly [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; regulation of transcription, DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]" GO:0000786; GO:0001673; GO:0003676; GO:0003690; GO:0005634; GO:0006334; GO:0006338; GO:0006355; GO:0007281; GO:0007283; GO:0030261; GO:0031492; GO:0031507; GO:0042393; GO:0045910 double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]; nucleosomal DNA binding [GO:0031492] PSTSKVILR 0.9965 -10.18 0 0 0 0 0 0 0 0 12.1521 0 0 0 0 12.0886 12.6746 11.4839 0 0 0 0 0 0 0 0 0 0 0 14.6073 0 0 0 0 0 0 11.614 0 0 11.8098 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2187 0 0 0 0 14.7839 14.0811 12.7915 14.238 0 0 0 0 15.8578 0 0 0 0 Q969Z0 FAKD4_HUMAN "FAST kinase domain-containing protein 4 (Cell cycle progression restoration protein 2, Cell cycle progression protein 2) (Protein TBRG4) (Transforming growth factor beta regulator 4)" TBRG4 CPR2 FASTKD4 KIAA0948 Homo sapiens (Human) mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial mRNA stability [GO:0044528] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]; RNA binding [GO:0003723]; mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial mRNA stability [GO:0044528] GO:0000963; GO:0003723; GO:0005739; GO:0005759; GO:0008284; GO:0016071; GO:0035770; GO:0044528; GO:0051726; GO:0090615 RNA binding [GO:0003723] DLLGRFVLARR 0.9965 -10.197 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.4325 0 14.6561 0 15.032 0 14.8261 16.4451 0 0 0 0 16.8647 17.3728 17.359 0 0 0 0 0 0 0 0 0 0 0 0 15.7977 12.235 13.7678 0 12.8462 14.0414 0 0 10.1342 0 0 0 0 0 0 0 0 0 12.5157 0 0 0 0 0 0 0 0 0 0 16.739 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6526 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0676 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4006 0 0 0 0 0 12.6966 0 0 0 14.6441 0 0 0 0 Q96CB5 CH044_HUMAN Putative uncharacterized protein C8orf44 C8orf44 Homo sapiens (Human) PAWPTWR 0.9965 -10.176 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGN5 PARP2_HUMAN "Poly [ADP-ribose] polymerase 2, PARP-2, hPARP-2, EC 2.4.2.30 (ADP-ribosyltransferase diphtheria toxin-like 2, ARTD2) (DNA ADP-ribosyltransferase PARP2, EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2, ADPRT-2) (Poly[ADP-ribose] synthase 2, pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2, EC 2.4.2.-)" PARP2 ADPRT2 ADPRTL2 Homo sapiens (Human) base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734] nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; nucleosome binding [GO:0031491]; base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212] GO:0003677; GO:0003682; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006284; GO:0006302; GO:0006471; GO:0016570; GO:0018312; GO:0030592; GO:0031491; GO:0061051; GO:0070212; GO:0070213; GO:0090734; GO:0097191; GO:0140294; GO:1901215; GO:1990404 chromatin binding [GO:0003682]; DNA binding [GO:0003677]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; nucleosome binding [GO:0031491] EKFEKVPGK 0.9965 -10.165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7458 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.503 0 0 0 13.0142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3877 0 0 13.7596 0 0 0 12.4948 0 0 0 10.7074 0 12.529 0 0 0 0 13.0123 0 0 0 0 12.6919 0 12.1388 0 0 0 9.71457 0 14.619 12.8724 0 0 0 0 12.5974 0 0 0 0 12.808 0 0 0 14.0415 14.0721 15.565 0 0 0 0 0 11.1788 12.4874 0 0 0 0 0 0 0 0 0 0 13.4502 0 0 0 0 0 0 0 0 0 10.8472 0 12.4333 0 0 0 0 0 0 0 0 0 Q9UMY4 SNX12_HUMAN Sorting nexin-12 SNX12 Homo sapiens (Human) endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; retromer complex [GO:0030904] early endosome [GO:0005769]; early endosome membrane [GO:0031901]; retromer complex [GO:0030904]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100] GO:0005769; GO:0010629; GO:0010955; GO:0015031; GO:0019899; GO:0030100; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0034499; GO:0035091; GO:0042177; GO:0051224; GO:2000642 enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266] IVVPPLPGKALK 0.9965 -10.161 0 0 0 0 0 0 0 10.0351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0899 0 0 0 0 0 0 0 0 0 0 11.5148 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7437 0 0 0 12.4903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6083 0 0 0 0 0 0 0 15.4633 0 0 0 0 0 0 0 0 10.8113 0 0 9.70122 0 0 0 0 0 0 0 0 0 0 13.0649 0 0 0 0 0 0 12.6845 A6NM03 O2AG2_HUMAN Olfactory receptor 2AG2 OR2AG2 OR2AG2P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EVMRALR 0.99651 -10.229 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q01459 DIAC_HUMAN "Di-N-acetylchitobiase, EC 3.2.1.-" CTBS CTB Homo sapiens (Human) chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] extracellular space [GO:0005615]; lysosome [GO:0005764] extracellular space [GO:0005615]; lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313] GO:0004568; GO:0005615; GO:0005764; GO:0006032; GO:0008061; GO:0009313 chitin binding [GO:0008061]; chitinase activity [GO:0004568] DQRAPYYNYK 0.99651 -9.6642 0 0 0 0 0 0 0 0 0 0 0 12.8999 0 13.3926 0 0 0 0 0 0 0 0 12.8475 0 0 0 0 11.7601 0 13.5847 0 0 0 0 11.6284 0 0 13.5371 0 0 0 0 11.582 11.2646 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0412 0 11.3088 0 14.0434 0 14.3545 0 12.4939 14.2518 0 0 0 0 0 14.0887 0 0 0 0 13.6034 14.0752 14.9309 0 0 0 0 0 0 0 0 0 11.3675 13.8876 0 0 0 13.0276 0 0 0 0 13.2906 0 0 0 0 0 11.5287 11.7026 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1935 13.3019 0 0 0 11.6535 0 0 0 0 13.4302 0 0 13.6317 13.1818 0 0 0 0 0 0 12.6975 0 11.8289 0 0 0 0 12.5653 0 0 0 13.3048 12.5536 13.1751 0 12.8249 12.1934 0 0 Q8WUJ1 NEUFC_HUMAN Neuferricin (Cytochrome b5 domain-containing protein 2) CYB5D2 Homo sapiens (Human) neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666] endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020] endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]; heme binding [GO:0020037]; neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666] GO:0005576; GO:0012505; GO:0016020; GO:0020037; GO:0030182; GO:0045666 heme binding [GO:0020037] LFIPEELSR 0.99652 -9.6734 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96IQ7 VSIG2_HUMAN "V-set and immunoglobulin domain-containing protein 2 (Cortical thymocyte-like protein, CT-like protein)" VSIG2 CTH CTXL UNQ2770/PRO7154 Homo sapiens (Human) lipid metabolic process [GO:0006629] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020] integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; lipid metabolic process [GO:0006629] GO:0005887; GO:0006629; GO:0016020 EDAIAPGISEHTCMRADSSK 0.99652 -9.6771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1117 0 0 0 0 0 0 0 Q9NRP4 SDHF3_HUMAN "Succinate dehydrogenase assembly factor 3, mitochondrial, SDH assembly factor 3, SDHAF3" SDHAF3 ACN9 DC11 Homo sapiens (Human) mitochondrial respiratory chain complex II assembly [GO:0034553]; regulation of gluconeogenesis [GO:0006111]; succinate metabolic process [GO:0006105] mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759] mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex II assembly [GO:0034553]; regulation of gluconeogenesis [GO:0006111]; succinate metabolic process [GO:0006105] GO:0005758; GO:0005759; GO:0006105; GO:0006111; GO:0034553 PGRHVSRVR 0.99652 -9.6647 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.897 0 15.2454 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1787 0 0 0 12.6077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6785 0 0 0 0 0 0 0 0 0 0 0 0 Q6UWN5 LYPD5_HUMAN Ly6/PLAUR domain-containing protein 5 LYPD5 UNQ1908/PRO4356 Homo sapiens (Human) anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] GO:0005576; GO:0005886; GO:0031225 ALQVLALLLPVLLLVGLSA 0.99654 -9.7762 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1468 0 0 10.6651 0 0 12.0526 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1315 0 0 0 0 0 0 0 0 0 11.6376 0 0 0 0 0 0 10.526 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.63061 0 0 0 0 0 0 0 0 0 0 0 0 13.5485 0 0 0 0 0 0 0 0 0 0 0 0 0 11.957 0 0 0 0 0 0 15.0169 0 0 0 0 0 Q96NA2 RILP_HUMAN Rab-interacting lysosomal protein RILP PP10141 Homo sapiens (Human) cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; intralumenal vesicle formation [GO:0070676]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; regulation of multivesicular body size [GO:0010796] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991] ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; intralumenal vesicle formation [GO:0070676]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of protein catabolic process [GO:0045732]; protein transport [GO:0015031]; regulation of multivesicular body size [GO:0010796] GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0008333; GO:0010796; GO:0015031; GO:0030670; GO:0031267; GO:0031902; GO:0032509; GO:0032991; GO:0036064; GO:0042177; GO:0045022; GO:0045732; GO:0046983; GO:0051959; GO:0060271; GO:0070676 dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267] AGPQEERALLRQLK 0.99654 -9.77 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2182 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2577 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1569 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6137 0 0 0 0 0 0 11.3453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4532 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6476 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8515 0 12.198 0 0 0 0 0 0 13.4656 O43869 OR2T1_HUMAN "Olfactory receptor 2T1 (Olfactory receptor 1-25, OR1-25) (Olfactory receptor OR1-61)" OR2T1 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] RALGRFK 0.99656 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7638 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8163 0 0 0 0 0 0 0 0 Q9Y3M2 CBY1_HUMAN "Protein chibby homolog 1 (ARPP-binding protein) (Cytosolic leucine-rich protein) (PIGEA-14) (PKD2 interactor, Golgi and endoplasmic reticulum-associated 1)" CBY1 ARB1 C22orf2 CBY PGEA1 HRIHFB2025 Homo sapiens (Human) "canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell differentiation [GO:0055007]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; floor plate development [GO:0033504]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; protein homotetramerization [GO:0051289]; protein localization [GO:0008104]" centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802] "centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell differentiation [GO:0055007]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; floor plate development [GO:0033504]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; protein homotetramerization [GO:0051289]; protein localization [GO:0008104]" GO:0005634; GO:0005654; GO:0005802; GO:0005814; GO:0005829; GO:0008013; GO:0008104; GO:0016607; GO:0030178; GO:0033504; GO:0036064; GO:0042802; GO:0042803; GO:0045444; GO:0045892; GO:0051289; GO:0055007; GO:0060070; GO:0060271; GO:0090090 beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] EVQRLRR 0.99656 -10.193 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2373 10.5828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4929 0 0 0 0 0 0 0 0 0 0 0 0 10.7442 11.007 0 0 0 0 0 0 11.7036 0 0 0 0 0 0 0 0 0 0 12.5351 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NX09 DDIT4_HUMAN "DNA damage-inducible transcript 4 protein (HIF-1 responsive protein RTP801) (Protein regulated in development and DNA damage response 1, REDD-1)" DDIT4 REDD1 RTP801 Homo sapiens (Human) apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of glycolytic process [GO:0045820]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of TOR signaling [GO:0032007]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron death [GO:1901216]; protein-containing complex disassembly [GO:0032984]; reactive oxygen species metabolic process [GO:0072593]; regulation of TOR signaling [GO:0032006]; response to hypoxia [GO:0001666] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; 14-3-3 protein binding [GO:0071889]; apoptotic process [GO:0006915]; brain development [GO:0007420]; cellular response to dexamethasone stimulus [GO:0071549]; defense response to virus [GO:0051607]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of glycolytic process [GO:0045820]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of TOR signaling [GO:0032007]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of neuron death [GO:1901216]; protein-containing complex disassembly [GO:0032984]; reactive oxygen species metabolic process [GO:0072593]; regulation of TOR signaling [GO:0032006]; response to hypoxia [GO:0001666] GO:0001666; GO:0001764; GO:0005737; GO:0005739; GO:0005829; GO:0006915; GO:0007420; GO:0010801; GO:0030182; GO:0032006; GO:0032007; GO:0032984; GO:0033137; GO:0042771; GO:0045820; GO:0048011; GO:0051607; GO:0071549; GO:0071889; GO:0072593; GO:1901216; GO:1902532 14-3-3 protein binding [GO:0071889] GALLDVCVEQGKSCHSVGQLALDPSLVPTFQLTLVLR 0.99657 -10.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O94973 AP2A2_HUMAN "AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9, HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit)" AP2A2 ADTAB CLAPA2 HIP9 HYPJ KIAA0899 Homo sapiens (Human) clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; secretory granule membrane [GO:0030667] AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; secretory granule membrane [GO:0030667]; cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis [GO:0006898]; vesicle-mediated transport [GO:0016192] GO:0005829; GO:0005886; GO:0006886; GO:0006898; GO:0008289; GO:0009898; GO:0016192; GO:0019901; GO:0030122; GO:0030666; GO:0030667; GO:0030669; GO:0031410; GO:0035615; GO:0036020; GO:0045334; GO:0072583; GO:0097718; GO:0098794; GO:0098884; GO:0101003; GO:0140312 cargo adaptor activity [GO:0140312]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901] ALDGYSKK 0.99658 -9.6632 0 0 0 0 0 0 0 15.3466 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9174 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9492 0 10.824 0 0 0 0 0 0 0 12.2432 13.4009 0 0 0 0 0 0 12.5755 0 0 0 0 0 13.7255 14.0026 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0195 0 12.2906 0 10.7669 0 0 0 0 0 11.6727 0 0 0 0 0 0 0 0 0 0 14.8779 0 0 0 0 11.9553 0 0 0 0 0 0 0 0 0 0 12.8376 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q00169 PIPNA_HUMAN "Phosphatidylinositol transfer protein alpha isoform, PI-TP-alpha, PtdIns transfer protein alpha, PtdInsTP alpha" PITPNA PITPN Homo sapiens (Human) lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; stearic acid binding [GO:0070540]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601] GO:0000062; GO:0005634; GO:0005737; GO:0005829; GO:0006629; GO:0007601; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0070062; GO:0070540; GO:0120019; GO:1901611 fatty-acyl-CoA binding [GO:0000062]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; stearic acid binding [GO:0070540] IETWHKPDLGTQENVHK 0.99658 -9.677 0 0 0 0 11.7082 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3911 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.946 0 0 0 0 P26599 PTBP1_HUMAN "Polypyrimidine tract-binding protein 1, PTB (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I, hnRNP I)" PTBP1 PTB Homo sapiens (Human) "IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of RNA splicing [GO:0033119]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]" GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0008187; GO:0008380; GO:0016020; GO:0033119; GO:0035307; GO:0036002; GO:0043484; GO:0045595; GO:0048025; GO:0051148; GO:0070062; GO:0070886; GO:0075522 mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723] DGIVPDIAVGTK 0.9966 -9.7696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P28356 HXD9_HUMAN Homeobox protein Hox-D9 (Homeobox protein Hox-4C) (Homeobox protein Hox-5.2) HOXD9 HOX4C Homo sapiens (Human) "adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; hindlimb morphogenesis [GO:0035137]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]" chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; adult locomotory behavior [GO:0008344]; anterior/posterior pattern specification [GO:0009952]; embryonic forelimb morphogenesis [GO:0035115]; embryonic skeletal system morphogenesis [GO:0048704]; hindlimb morphogenesis [GO:0035137]; mammary gland development [GO:0030879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]" GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006357; GO:0007338; GO:0007519; GO:0008344; GO:0009952; GO:0009954; GO:0030879; GO:0035115; GO:0035137; GO:0045944; GO:0048704; GO:0048935; GO:1990837 "DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]" CPYTKYQTLELEK 0.99662 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4435 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43325 LYRM1_HUMAN LYR motif-containing protein 1 LYRM1 Homo sapiens (Human) midbody [GO:0030496]; nucleoplasm [GO:0005654] midbody [GO:0030496]; nucleoplasm [GO:0005654] GO:0005654; GO:0030496 PVYLRSHDEVS 0.99663 -10.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2786 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5924 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7632 0 0 0 0 0 0 0 0 0 0 0 P78346 RPP30_HUMAN "Ribonuclease P protein subunit p30, RNaseP protein p30 (RNase P subunit 2)" RPP30 RNASEP2 Homo sapiens (Human) "RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]" multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172] "multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonuclease MRP complex [GO:0000172]; ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033]" GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005634; GO:0005654; GO:0005655; GO:0006364; GO:0008033; GO:0030681; GO:0033204; GO:0090502 ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723] AGSDLKALRGLVETAAHLGYSVVAINHIVDFK 0.99665 -9.6767 0 0 0 0 0 0 0 0 10.8556 11.9384 0 13.9714 12.7065 0 0 0 0 13.4735 0 0 0 0 0 0 0 11.844 12.8367 11.1017 12.7183 11.6717 0 0 0 10.3436 0 14.0726 11.8419 0 0 12.6112 14.195 0 10.8567 0 10.301 0 0 11.7497 12.8319 12.8727 0 0 0 11.9832 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6283 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2943 0 14.0167 0 0 14.0295 0 0 0 0 0 0 0 0 0 0 0 0 15.0276 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1813 0 0 Q8WYR4 RSPH1_HUMAN "Radial spoke head 1 homolog (Cancer/testis antigen 79, CT79) (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein)" RSPH1 TSA2 TSGA2 Homo sapiens (Human) axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; nucleus [GO:0005634]; outer dense fiber [GO:0001520] condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286] GO:0000794; GO:0001520; GO:0005634; GO:0005829; GO:0007286; GO:0031514; GO:0035082; GO:0051321; GO:0072687 ARLPNGDTYEGSYEFGK 0.99665 -9.6622 0 0 0 0 0 0 0 10.9946 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5657 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5339 0 0 0 0 0 0 0 14.0144 0 13.0558 0 0 0 0 0 0 0 0 11.0584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5251 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5386 0 0 0 0 0 0 0 13.5703 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5285 0 12.6297 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9NUV9 GIMA4_HUMAN "GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein, IAN-1, hIAN1) (Immunity-associated protein 4)" GIMAP4 IAN1 IMAP4 MSTP062 Homo sapiens (Human) cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231] cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; GTP binding [GO:0005525] GO:0005525; GO:0005829; GO:0043231 GTP binding [GO:0005525] AQLLGLIQRVVRENK 0.99665 -9.6611 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4751 14.8135 15.7079 14.4116 0 0 0 0 0 0 0 0 0 13.4624 0 0 0 10.6422 13.8099 0 12.163 0 0 0 0 14.634 0 0 0 0 0 0 0 0 0 0 16.1726 0 0 0 14.9798 12.7771 0 0 0 13.4761 0 0 0 0 15.5831 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9252 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5175 0 0 0 10.4239 0 15.054 0 0 0 0 0 0 0 P56378 ATP68_HUMAN "ATP synthase subunit ATP5MJ, mitochondrial (6.8 kDa mitochondrial proteolipid protein, MLQ) (ATP synthase membrane subunit 6.8PL)" ATP5MJ ATP5MPL C14orf2 MP68 PRO1574 Homo sapiens (Human) proton motive force-driven ATP synthesis [GO:0015986] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; proton motive force-driven ATP synthesis [GO:0015986] GO:0005743; GO:0005753; GO:0015986; GO:0016021 AADKRSK 0.99669 -10.191 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13007 IL24_HUMAN "Interleukin-24, IL-24 (Melanoma differentiation-associated gene 7 protein, MDA-7) (Suppression of tumorigenicity 16 protein)" IL24 MDA7 ST16 Homo sapiens (Human) apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; serine phosphorylation of STAT protein [GO:0042501]; wound healing [GO:0042060] extracellular region [GO:0005576]; extracellular space [GO:0005615] extracellular region [GO:0005576]; extracellular space [GO:0005615]; cytokine activity [GO:0005125]; apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; serine phosphorylation of STAT protein [GO:0042501]; wound healing [GO:0042060] GO:0005125; GO:0005576; GO:0005615; GO:0006915; GO:0008284; GO:0008285; GO:0030336; GO:0042060; GO:0042501; GO:0042531; GO:0071222; GO:0071353 cytokine activity [GO:0005125] RFLLFRR 0.99669 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.117 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A4D256 CC14C_HUMAN "Dual specificity protein phosphatase CDC14C, EC 3.1.3.16, EC 3.1.3.48 (CDC14 cell division cycle 14 homolog C)" CDC14C CDC14B2 CDC14Bretro Homo sapiens (Human) cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; protein dephosphorylation [GO:0006470]; regulation of exit from mitosis [GO:0007096] centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922] centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; protein dephosphorylation [GO:0006470]; regulation of exit from mitosis [GO:0007096] GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005789; GO:0005813; GO:0006470; GO:0007096; GO:0008138; GO:0016021; GO:0017018; GO:0032467; GO:0060271; GO:0072686 myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138] GQENGQHR 0.99675 -10.15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0952 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0643 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15234 CASC3_HUMAN "Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein, MLN 51) (Protein barentsz, Btz)" CASC3 MLN51 Homo sapiens (Human) "intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]" cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006] "cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; U2-type catalytic step 1 spliceosome [GO:0071006]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; regulation of translation [GO:0006417]" GO:0000184; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005829; GO:0006406; GO:0006417; GO:0008298; GO:0010494; GO:0016607; GO:0019899; GO:0030425; GO:0031625; GO:0031965; GO:0035145; GO:0042802; GO:0048471; GO:0071006; GO:2000622 enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625] DPNWNGER 0.99675 -10.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3493 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2599 12.8269 12.0339 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6789 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.185 0 0 0 0 0 0 0 0 0 18.6026 0 0 0 12.121 0 18.002 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3425 0 0 12.2639 0 0 0 0 0 0 13.6224 0 0 13.8057 0 0 19.0491 0 0 0 0 0 0 0 P47872 SCTR_HUMAN "Secretin receptor, SCT-R" SCTR Homo sapiens (Human) adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; response to nutrient levels [GO:0031667] cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] cytoplasmic microtubule [GO:0005881]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; secretin receptor activity [GO:0015055]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cAMP-mediated signaling [GO:0043950]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; response to nutrient levels [GO:0031667] GO:0002024; GO:0005881; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007420; GO:0008528; GO:0009992; GO:0015055; GO:0016021; GO:0017046; GO:0031667; GO:0032098; GO:0043950; GO:0048167 G protein-coupled peptide receptor activity [GO:0008528]; peptide hormone binding [GO:0017046]; secretin receptor activity [GO:0015055] DAVLFSSDDVTYCDAHRAGCK 0.99675 -10.146 0 0 0 0 0 9.75749 0 0 0 0 11.5978 0 0 13.7027 0 0 0 0 0 0 0 0 0 13.4807 0 0 0 13.6579 0 0 0 0 0 0 17.9048 17.1863 11.0945 0 0 0 0 0 0 10.5151 12.9724 13.6764 12.4792 0 0 12.0809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4508 0 0 0 0 0 0 0 0 0 0 0 0 12.8748 0 0 0 14.403 13.1441 0 0 0 0 12.3276 0 0 12.4043 0 0 0 0 0 0 0 0 0 0 0 0 0 15.0467 0 0 0 0 13.255 0 0 0 0 14.8615 0 14.9459 0 0 12.0806 0 0 0 13.0209 0 0 0 0 0 0 0 0 0 14.0693 0 0 0 0 0 0 0 0 0 0 13.1542 0 0 13.1498 0 0 0 0 0 0 0 0 0 0 0 0 11.2509 0 0 0 0 0 0 0 0 0 Q53GA4 PHLA2_HUMAN "Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C, p17-BWR1C)" PHLDA2 BWR1C HLDA2 IPL TSSC3 Homo sapiens (Human) animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of gene expression [GO:0010468]; regulation of glycogen metabolic process [GO:0070873]; regulation of growth hormone activity [GO:1903547]; regulation of spongiotrophoblast cell proliferation [GO:0060721] cytoplasm [GO:0005737]; membrane [GO:0016020] cytoplasm [GO:0005737]; membrane [GO:0016020]; phosphatidylinositol phosphate binding [GO:1901981]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of gene expression [GO:0010468]; regulation of glycogen metabolic process [GO:0070873]; regulation of growth hormone activity [GO:1903547]; regulation of spongiotrophoblast cell proliferation [GO:0060721] GO:0001890; GO:0005737; GO:0006915; GO:0009887; GO:0010468; GO:0016020; GO:0030334; GO:0043065; GO:0045995; GO:0060721; GO:0070873; GO:1901981; GO:1903547 phosphatidylinositol phosphate binding [GO:1901981] ARPKELR 0.99675 -10.16 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0209 0 12.5226 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4986 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6724 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86UD3 MARH3_HUMAN "E3 ubiquitin-protein ligase MARCHF3, EC 2.3.2.27 (Membrane-associated RING finger protein 3) (Membrane-associated RING-CH protein III, MARCH-III) (RING finger protein 173) (RING-type E3 ubiquitin transferase MARCHF3)" MARCHF3 MARCH3 RNF173 Homo sapiens (Human) endocytosis [GO:0006897]; protein ubiquitination [GO:0016567] early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764] early endosome membrane [GO:0031901]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein ubiquitination [GO:0016567] GO:0004842; GO:0005764; GO:0005768; GO:0006897; GO:0008270; GO:0016021; GO:0016567; GO:0031901; GO:0043231 ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270] KPRPLVEWLR 0.99676 -10.19 0 0 0 0 0 11.67 12.4163 0 13.7985 0 0 13.6028 14.1988 13.6475 0 0 0 0 13.593 0 0 0 12.3244 0 0 10.854 0 0 13.7843 13.9587 0 14.2242 0 0 0 0 0 0 0 10.9082 0 0 0 0 11.5389 0 0 14.9575 0 0 14.1305 0 0 0 0 0 12.9165 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1067 0 0 0 14.4585 0 0 0 0 0 0 0 0 13.438 0 0 11.0783 0 0 0 0 0 0 0 0 0 11.4733 0 0 11.7047 0 0 0 0 0 0 0 0 0 0 13.5372 13.0597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.283 0 10.6869 0 0 0 0 0 0 12.7471 0 0 0 13.0653 0 13.8894 0 14.7389 0 0 11.9106 0 0 0 12.0035 0 0 0 12.7897 0 0 0 0 O75326 SEM7A_HUMAN "Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1, Sema K1) (Semaphorin-L, Sema L) (CD antigen CD108)" SEMA7A CD108 SEMAL Homo sapiens (Human) axon extension [GO:0048675]; axon guidance [GO:0007411]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of inflammatory response [GO:0050727]; semaphorin-plexin signaling pathway [GO:0071526] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886] anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; chemorepellent activity [GO:0045499]; integrin binding [GO:0005178]; semaphorin receptor binding [GO:0030215]; axon extension [GO:0048675]; axon guidance [GO:0007411]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of protein phosphorylation [GO:0001934]; protein phosphorylation [GO:0006468]; regulation of inflammatory response [GO:0050727]; semaphorin-plexin signaling pathway [GO:0071526] GO:0001649; GO:0001755; GO:0001934; GO:0005178; GO:0005615; GO:0005886; GO:0005887; GO:0006468; GO:0006954; GO:0006955; GO:0007229; GO:0007411; GO:0009897; GO:0016020; GO:0021988; GO:0030215; GO:0030335; GO:0031225; GO:0045499; GO:0045773; GO:0048675; GO:0048843; GO:0050727; GO:0050919; GO:0060907; GO:0070374; GO:0071526 chemorepellent activity [GO:0045499]; integrin binding [GO:0005178]; semaphorin receptor binding [GO:0030215] LGLPLRLRLLLLLWAAAASAQGHLR 0.99681 -10.149 0 0 0 0 0 0 10.8384 0 0 11.3306 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7954 0 0 0 0 12.6329 0 0 0 0 0 0 0 0 0 0 0 14.3122 11.3457 0 0 0 0 0 0 13.1619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9552 14.9145 0 0 0 0 0 0 14.9665 15.0524 0 0 14.8942 0 11.9266 0 0 13.9892 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8012 0 0 0 0 0 0 0 0 0 13.431 0 0 0 0 0 14.1739 0 0 0 0 0 0 0 0 0 0 15.3204 0 0 0 0 10.9874 14.5082 14.1975 0 0 0 10.677 13.7967 10.6893 0 0 0 0 0 0 0 0 15.0033 0 14.0816 13.2532 0 0 14.9767 0 0 0 0 0 0 14.9918 0 0 0 0 15.2546 0 0 0 0 14.1655 0 0 0 0 P35222 CTNB1_HUMAN Catenin beta-1 (Beta-catenin) CTNNB1 CTNNB OK/SW-cl.35 PRO2286 Homo sapiens (Human) "acinar cell differentiation [GO:0090425]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; apoptotic signaling pathway [GO:0097190]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; hypothalamus development [GO:0021854]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung epithelial cell differentiation [GO:0060487]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; myoblast proliferation [GO:0051450]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]" "adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]" "adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transmembrane transporter binding [GO:0044325]; acinar cell differentiation [GO:0090425]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; apoptotic signaling pathway [GO:0097190]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; hypothalamus development [GO:0021854]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung epithelial cell differentiation [GO:0060487]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; myoblast proliferation [GO:0051450]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]" GO:0000122; GO:0000165; GO:0000209; GO:0000578; GO:0000791; GO:0000904; GO:0000922; GO:0001221; GO:0001569; GO:0001658; GO:0001701; GO:0001702; GO:0001708; GO:0001711; GO:0001764; GO:0001837; GO:0001840; GO:0002052; GO:0002053; GO:0002062; GO:0002089; GO:0003266; GO:0003338; GO:0003340; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005912; GO:0005916; GO:0005923; GO:0005925; GO:0005938; GO:0006366; GO:0007155; GO:0007160; GO:0007249; GO:0007268; GO:0007398; GO:0007403; GO:0007405; GO:0008013; GO:0008022; GO:0008285; GO:0008543; GO:0009410; GO:0009948; GO:0009950; GO:0009954; GO:0010628; GO:0010629; GO:0010718; GO:0010909; GO:0016020; GO:0016323; GO:0016327; GO:0016328; GO:0016342; GO:0016525; GO:0016600; GO:0016922; GO:0019827; GO:0019899; GO:0019900; GO:0019901; GO:0019903; GO:0021819; GO:0021854; GO:0022009; GO:0030018; GO:0030027; GO:0030054; GO:0030316; GO:0030331; GO:0030539; GO:0030877; GO:0030902; GO:0030997; GO:0031016; GO:0031069; GO:0031528; GO:0031641; GO:0032212; GO:0032331; GO:0032355; GO:0032968; GO:0032991; GO:0032993; GO:0033077; GO:0033234; GO:0034333; GO:0034394; GO:0034750; GO:0035050; GO:0035112; GO:0035115; GO:0035116; GO:0035315; GO:0035995; GO:0036023; GO:0036520; GO:0042129; GO:0042475; GO:0042733; GO:0042734; GO:0043065; GO:0043066; GO:0043123; GO:0043161; GO:0043410; GO:0043525; GO:0044325; GO:0044334; GO:0044336; GO:0044338; GO:0044339; GO:0045177; GO:0045202; GO:0045211; GO:0045294; GO:0045296; GO:0045453; GO:0045597; GO:0045603; GO:0045669; GO:0045671; GO:0045743; GO:0045765; GO:0045892; GO:0045893; GO:0045944; GO:0045976; GO:0046332; GO:0048145; GO:0048469; GO:0048471; GO:0048489; GO:0048538; GO:0048599; GO:0048617; GO:0048643; GO:0048660; GO:0048664; GO:0048709; GO:0048715; GO:0050767; GO:0050808; GO:0051091; GO:0051145; GO:0051450; GO:0051571; GO:0051884; GO:0051973; GO:0060066; GO:0060070; GO:0060440; GO:0060441; GO:0060484; GO:0060487; GO:0060492; GO:0060742; GO:0060767; GO:0060769; GO:0060789; GO:0060916; GO:0061047; GO:0061154; GO:0061198; GO:0061324; GO:0061549; GO:0061550; GO:0061629; GO:0070062; GO:0070369; GO:0070411; GO:0070602; GO:0071363; GO:0071681; GO:0071944; GO:0072033; GO:0072053; GO:0072054; GO:0072079; GO:0072089; GO:0072182; GO:0072497; GO:0090090; GO:0090279; GO:0090425; GO:0097091; GO:0097190; GO:0097718; GO:0098609; GO:0098685; GO:0098831; GO:0099092; GO:0140297; GO:1903204; GO:1904798; GO:1904888; GO:1904948; GO:1904954; GO:1990138; GO:1990226; GO:1990403; GO:1990711; GO:1990791; GO:1990907; GO:1990909; GO:2000008; GO:2000017; GO:2000288; GO:2000648; GO:2001234 alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transmembrane transporter binding [GO:0044325] EGLLAIFKSGGIPALVK 0.99681 -10.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1097 0 0 0 0 0 0 0 11.9748 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5461 0 0 0 0 0 0 0 0 13.4544 0 0 0 9.87369 0 0 0 0 0 0 0 0 0 0 15.4163 0 13.5786 0 0 12.9127 0 0 0 0 0 0 12.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9093 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0305 0 0 0 0 0 0 0 0 0 0 12.7741 0 0 12.4202 0 0 0 0 0 11.9484 0 0 0 0 0 10.8239 0 0 13.9682 0 0 0 0 0 0 0 P52732 KIF11_HUMAN "Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5, TR-interacting protein 5, TRIP-5)" KIF11 EG5 KNSL1 TRIP5 Homo sapiens (Human) cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle elongation [GO:0051231]; spindle organization [GO:0007051] cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922] cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle elongation [GO:0051231]; spindle organization [GO:0007051] GO:0000070; GO:0000278; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007051; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0016020; GO:0019901; GO:0032991; GO:0046602; GO:0051231; GO:0051301; GO:0072686; GO:0090307 ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901] AAHEKQHNIFLDQMTIDEDK 0.99681 -10.143 0 0 0 0 0 0 0 0 0 10.1777 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1438 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0262 0 0 0 0 0 0 0 14.8152 0 0 0 0 0 0 0 11.2559 0 0 0 0 0 0 0 0 0 13.1188 0 0 0 0 0 15.2521 12.9403 0 0 13.356 0 0 0 0 0 0 0 0 12.7406 0 0 0 0 0 0 0 0 0 13.1163 13.0231 0 0 0 0 12.8769 0 0 0 0 0 0 0 12.9241 12.5098 0 0 0 0 12.5785 10.9933 0 0 0 0 0 0 0 12.8776 0 0 13.2226 13.4587 13.567 0 0 0 0 0 0 0 0 12.251 0 0 0 0 0 0 0 0 0 Q5VTE6 ANGE2_HUMAN Protein angel homolog 2 ANGEL2 KIAA0759L Homo sapiens (Human) 3'-UTR-mediated mRNA stabilization [GO:0070935]; negative regulation of mitotic cell cycle [GO:0045930] Cajal body [GO:0015030]; cytoplasm [GO:0005737] Cajal body [GO:0015030]; cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; negative regulation of mitotic cell cycle [GO:0045930] GO:0000175; GO:0003730; GO:0005737; GO:0015030; GO:0045930; GO:0070935 3'-5'-exoribonuclease activity [GO:0000175]; mRNA 3'-UTR binding [GO:0003730] PVLHWSFR 0.99681 -10.149 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7988 0 0 0 0 0 0 0 0 0 0 0 0 14.3308 13.3904 13.3715 0 0 0 0 13.2402 0 11.5646 0 0 0 0 0 0 0 0 0 0 12.1963 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4069 0 0 0 0 Q5VUY0 ADCL3_HUMAN "Arylacetamide deacetylase-like 3, EC 3.1.1.-" AADACL3 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021]; carboxylic ester hydrolase activity [GO:0052689] GO:0016021; GO:0052689 carboxylic ester hydrolase activity [GO:0052689] FPVPVRDCLVATIHFLKSLDAYGVDPAR 0.99681 -10.145 10.788 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1278 12.7896 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.206 0 0 0 0 0 11.3714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NG99 OR7G2_HUMAN "Olfactory receptor 7G2 (OST260) (Olfactory receptor 19-13, OR19-13) (Olfactory receptor OR19-6)" OR7G2 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] MPSASGK 0.99681 -10.142 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8TBY0 RBM46_HUMAN "Probable RNA-binding protein 46 (Cancer/testis antigen 68, CT68) (RNA-binding motif protein 46)" RBM46 Homo sapiens (Human) mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829] nucleus [GO:0005634] nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA stabilization [GO:0048255]; trophectodermal cell differentiation [GO:0001829] GO:0001829; GO:0003723; GO:0003729; GO:0005634; GO:0048255 mRNA binding [GO:0003729]; RNA binding [GO:0003723] LPTLPAR 0.99681 -10.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2487 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5481 0 0 0 0 0 13.955 0 0 0 0 0 13.6469 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5214 0 0 0 13.7946 0 P00390 GSHR_HUMAN "Glutathione reductase, mitochondrial, GR, GRase, EC 1.8.1.7" GSR GLUR GRD1 Homo sapiens (Human) cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase (NADPH) activity [GO:0004362]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749] GO:0004362; GO:0005739; GO:0005759; GO:0005829; GO:0006749; GO:0009055; GO:0009897; GO:0034599; GO:0045454; GO:0050660; GO:0050661; GO:0070062 electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase (NADPH) activity [GO:0004362]; NADP binding [GO:0050661] AARAFRGFLLLLPEPAALTR 0.99682 -10.189 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4525 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1587 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8594 13.0138 13.6985 14.0377 12.608 14.0435 13.5094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5651 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7941 0 0 0 0 13.0136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4995 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6034 0 0 0 0 0 Q9UHC7 MKRN1_HUMAN "E3 ubiquitin-protein ligase makorin-1, EC 2.3.2.27 (RING finger protein 61) (RING-type E3 ubiquitin transferase makorin-1)" MKRN1 RNF61 Homo sapiens (Human) protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] cytosol [GO:0005829] cytosol [GO:0005829]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567] GO:0000209; GO:0003723; GO:0005829; GO:0016567; GO:0046872; GO:0061630 metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630] ACRYFDEGRGSCPFGGNCFYK 0.99682 -10.188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6991 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0704 0 0 0 0 0 0 0 0 0 0 0 12.5329 0 0 0 0 0 0 0 0 0 0 0 11.541 0 0 0 0 0 0 0 0 0 14.1507 0 0 0 0 0 0 12.33 0 0 0 0 0 14.187 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0AUZ9 KAL1L_HUMAN KAT8 regulatory NSL complex subunit 1-like protein (MSL1v2) KANSL1L C2orf67 Homo sapiens (Human) NSL complex [GO:0044545] NSL complex [GO:0044545]; histone acetyltransferase binding [GO:0035035] GO:0035035; GO:0044545 histone acetyltransferase binding [GO:0035035] EILTPSWRMVVLQPLDEYNLGKEEIEDLSDEVFSLR 0.99688 -10.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6791 0 13.0104 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2011 0 12.6724 10.0436 0 0 0 13.8118 0 0 0 10.3723 0 0 0 0 0 13.2305 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0535 0 0 0 0 0 0 13.6187 0 0 0 0 0 11.1445 13.0212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29120 NEC1_HUMAN "Neuroendocrine convertase 1, NEC 1, EC 3.4.21.93 (Prohormone convertase 1) (Proprotein convertase 1, PC1)" PCSK1 NEC1 Homo sapiens (Human) cell-cell signaling [GO:0007267]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133] axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; cell-cell signaling [GO:0007267]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410] GO:0004252; GO:0005615; GO:0005791; GO:0005802; GO:0006508; GO:0007267; GO:0009410; GO:0009749; GO:0010157; GO:0016020; GO:0016485; GO:0016486; GO:0016540; GO:0021983; GO:0022008; GO:0030133; GO:0030425; GO:0031016; GO:0031667; GO:0032496; GO:0034774; GO:0042802; GO:0043005; GO:0043043; GO:0043204; GO:0043278; GO:0043434; GO:0043679; GO:0048471; GO:0048678; GO:0050714; GO:0051384; GO:0051592; GO:0070542; GO:0070555 identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252] LILHGTSSQPEHMK 0.99688 -10.159 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3604 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50336 PPOX_HUMAN "Protoporphyrinogen oxidase, PPO, EC 1.3.3.4" PPOX Homo sapiens (Human) heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782] intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966] intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782] GO:0004729; GO:0005758; GO:0006779; GO:0006782; GO:0006783; GO:0016491; GO:0031304; GO:0031966; GO:0050660 flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729] GRTVVVLGGGISGLAASYHLSRAPCPPK 0.99688 -10.157 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8887 0 0 11.8711 0 0 0 0 0 12.0901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.256 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.719 0 0 0 0 0 0 12.9866 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.646 0 0 0 0 Q96JC4 ZN479_HUMAN "Zinc finger protein 479 (Zinc finger protein Kr19, HKr19)" ZNF479 Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000978; GO:0000981; GO:0005634; GO:0006355; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" CEECGKAFSWSSNLTR 0.99688 -10.139 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6541 0 0 0 0 0 0 0 0 0 0 0 0 11.1884 0 0 0 0 0 0 0 0 0 0 10.4808 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8383 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9286 0 13.4651 13.6522 13.3309 13.5926 12.7512 0 0 0 0 11.5385 0 0 0 0 0 12.141 0 0 0 0 0 0 0 10.5954 0 0 10.9115 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3436 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0K1 SIK2_HUMAN "Serine/threonine-protein kinase SIK2, EC 2.7.11.1 (Qin-induced kinase) (Salt-inducible kinase 2, SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2)" SIK2 KIAA0781 QIK SNF1LK2 Homo sapiens (Human) cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789] cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; cellular response to glucose starvation [GO:0042149]; intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626] GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0042149; GO:0046626; GO:0046777; GO:0106310 ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674] EPPRSLEQQLQEHR 0.99688 -10.138 12.9343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3407 14.6194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4792 11.0387 0 0 13.4485 0 0 0 0 0 0 13.7489 0 13.3228 0 0 0 0 13.9101 0 0 0 0 0 0 0 0 0 0 0 16.6947 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.97197 0 15.0786 0 11.455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.348 15.2079 0 0 0 0 0 0 12.2082 0 12.5454 0 0 12.8932 10.8084 0 0 0 0 0 0 0 0 0 0 0 Q9NTG7 SIR3_HUMAN "NAD-dependent protein deacetylase sirtuin-3, mitochondrial, hSIRT3, EC 2.3.1.286 (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3)" SIRT3 SIR2L3 Homo sapiens (Human) aerobic respiration [GO:0009060]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; aerobic respiration [GO:0009060]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of catalase activity [GO:1902553]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of superoxide dismutase activity [GO:1901671]; protein ADP-ribosylation [GO:0006471]; protein deacetylation [GO:0006476] GO:0003950; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006471; GO:0006476; GO:0008270; GO:0009060; GO:0017136; GO:0032991; GO:0034979; GO:0034983; GO:0043565; GO:0070403; GO:1901671; GO:1902553; GO:2000304 NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent protein deacetylase activity [GO:0034979]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270] DLVQRETGK 0.99688 -10.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.014 16.8124 0 0 0 0 11.6619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.3713 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6656 0 0 0 13.4703 0 0 0 0 0 0 0 15.0427 15.9553 16.2574 15.4117 0 15.475 0 17.3674 0 14.6156 0 0 0 0 17.3877 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8505 0 0 0 0 0 13.6275 0 18.6917 0 0 0 0 0 13.8339 0 0 0 0 0 0 0 18.0912 0 0 0 0 0 0 0 12.09 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IZJ1 UNC5B_HUMAN "Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1, p53RDL1)" UNC5B P53RDL1 UNC5H2 UNQ1883/PRO4326 Homo sapiens (Human) angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; netrin receptor activity [GO:0005042]; angiogenesis [GO:0001525]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068] GO:0001525; GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0014068; GO:0016021; GO:0033564; GO:0043524; GO:0045121; GO:2001240 netrin receptor activity [GO:0005042] AFPATQIYFK 0.99691 -10.072 0 0 0 0 0 0 0 0 0 0 0 14.2594 0 0 0 0 0 13.9044 0 0 13.1668 0 0 0 0 0 13.5636 0 0 13.7748 0 0 0 0 0 0 0 0 0 0 0 13.3904 13.2314 0 0 0 0 14.2564 0 13.3899 13.6695 12.7951 12.8825 12.7097 12.5089 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3856 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.7642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8812 0 0 0 0 0 0 19.6264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3829 0 15.4593 0 0 0 18.9441 0 0 0 0 0 Q6B0B8 TIGD3_HUMAN Tigger transposable element-derived protein 3 TIGD3 Homo sapiens (Human) nucleus [GO:0005634] nucleus [GO:0005634]; DNA binding [GO:0003677] GO:0003677; GO:0005634 DNA binding [GO:0003677] AFKAHYRHR 0.99694 -10.156 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2301 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2806 11.178 0 0 13.6503 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8605 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9BRR0 ZKSC3_HUMAN "Zinc finger protein with KRAB and SCAN domains 3 (Zinc finger and SCAN domain-containing protein 13) (Zinc finger protein 306) (Zinc finger protein 309) (Zinc finger protein 47 homolog, Zf47, Zfp-47)" ZKSCAN3 ZFP47 ZNF306 ZNF309 ZSCAN13 Homo sapiens (Human) "autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; autophagy [GO:0006914]; lysosome organization [GO:0007040]; negative regulation of autophagy [GO:0010507]; negative regulation of cellular senescence [GO:2000773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006914; GO:0007040; GO:0010507; GO:0043565; GO:0045892; GO:0045893; GO:0046872; GO:2000773 "chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]" ERFRGFR 0.99694 -10.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6103 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9HCJ0 TNR6C_HUMAN Trinucleotide repeat-containing gene 6C protein TNRC6C KIAA1582 Homo sapiens (Human) "miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932] "cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; miRNA-mediated gene silencing [GO:0035195]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]" GO:0000932; GO:0003723; GO:0005654; GO:0005829; GO:0035195; GO:0035278; GO:0060213; GO:1900153 RNA binding [GO:0003723] ANPGTNWGETLK 0.99694 -10.137 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5326 0 0 0 0 0 0 0 0 0 0 0 0 12.0268 0 0 0 0 0 0 0 0 0 0 14.1486 0 12.7122 0 0 0 13.6204 0 13.0707 13.401 0 0 13.6263 12.8168 0 12.3595 13.6206 14.1569 0 0 0 12.1821 12.7503 0 12.6218 0 0 13.9063 0 0 13.401 0 0 0 12.8864 0 0 0 11.8637 0 0 0 0 0 12.2472 0 0 0 0 0 0 0 0 12.0317 0 0 0 13.8023 0 0 0 12.476 0 0 0 0 13.3635 0 0 14.1977 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8321 13.4075 0 12.7476 0 0 0 0 0 0 Q9Y6D5 BIG2_HUMAN "Brefeldin A-inhibited guanine nucleotide-exchange protein 2, Brefeldin A-inhibited GEP 2 (ADP-ribosylation factor guanine nucleotide-exchange factor 2)" ARFGEF2 ARFGEP2 BIG2 Homo sapiens (Human) endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012] anchoring junction [GO:0070161]; asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802] anchoring junction [GO:0070161]; asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802]; GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012] GO:0000139; GO:0001881; GO:0005085; GO:0005794; GO:0005802; GO:0005815; GO:0005829; GO:0005879; GO:0006887; GO:0006893; GO:0007032; GO:0010256; GO:0015031; GO:0016020; GO:0017022; GO:0031410; GO:0032012; GO:0032279; GO:0032280; GO:0032760; GO:0034237; GO:0035556; GO:0043197; GO:0043231; GO:0048471; GO:0050811; GO:0055037; GO:0070161 GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237] AFNSNYEQR 0.99701 -10.135 0 0 0 11.2903 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5326 0 0 0 0 0 0 0 0 0 0 0 10.3826 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9827 0 0 16.7694 11.2845 13.5846 13.7062 0 11.7111 12.4874 0 0 0 0 13.9862 0 0 0 0 13.2185 0 14.9078 0 0 14.274 14.8765 0 0 0 13.7961 11.4488 13.0294 0 12.3274 0 12.7676 14.2079 0 0 0 13.6172 12.6218 0 0 0 0 14.1619 0 0 0 12.9276 0 0 0 14.9611 12.4058 13.0338 12.4478 0 0 13.2907 0 12.7047 12.6119 0 13.7092 0 0 0 13.3957 12.4676 0 13.9219 0 13.6757 13.0704 0 0 11.1283 0 0 14.0875 0 14.3962 13.2972 0 13.4489 0 0 0 0 0 0 0 0 0 11.7471 0 0 12.7133 0 0 0 0 0 0 0 0 0 0 0 Q8TBC5 ZSC18_HUMAN Zinc finger and SCAN domain-containing protein 18 (Zinc finger protein 447) ZSCAN18 ZNF447 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]" EAQAGAR 0.99707 -10.135 0 0 0 0 0 0 0 0 0 0 10.1055 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9453 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9975 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.106 0 0 0 0 0 0 0 0 0 0 13.135 0 13.6088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P50747 BPL1_HUMAN "Biotin--protein ligase, EC 6.3.4.- (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase, EC 6.3.4.9; Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase, EC 6.3.4.10 (Holocarboxylase synthetase, HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase, EC 6.3.4.11; Biotin--[acetyl-CoA-carboxylase] ligase, EC 6.3.4.15 ]" HLCS Homo sapiens (Human) biotin metabolic process [GO:0006768]; post-translational protein modification [GO:0043687]; response to biotin [GO:0070781] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363] chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; biotin metabolic process [GO:0006768]; post-translational protein modification [GO:0043687]; response to biotin [GO:0070781] GO:0000785; GO:0004077; GO:0004078; GO:0004079; GO:0004080; GO:0005524; GO:0005652; GO:0005737; GO:0005739; GO:0005829; GO:0006768; GO:0009374; GO:0016363; GO:0018271; GO:0019899; GO:0043687; GO:0070781 ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899] ADYLIARVVTVLEKLIK 0.99714 -10.135 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1222 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8N4Q0 PTGR3_HUMAN "Prostaglandin reductase 3, PRG-3, EC 1.3.1.48 (Zinc-binding alcohol dehydrogenase domain-containing protein 2)" PTGR3 ZADH2 Homo sapiens (Human) negative regulation of fat cell differentiation [GO:0045599] peroxisome [GO:0005777] peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599] GO:0005777; GO:0008270; GO:0016491; GO:0036132; GO:0045599; GO:0047522 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270] AGTLPAK 0.99718 -10.079 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8718 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6205 0 0 0 0 0 0 0 0 13.5429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IWR1 TRI59_HUMAN Tripartite motif-containing protein 59 (RING finger protein 104) (Tumor suppressor TSBF-1) TRIM59 RNF104 TRIM57 TSBF1 Homo sapiens (Human) innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of viral entry into host cell [GO:0046597] GO:0005783; GO:0005789; GO:0008270; GO:0016021; GO:0043124; GO:0045087; GO:0046597; GO:0061630 ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270] EKDTPQK 0.9972 -10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4163 0 0 0 0 0 0 0 0 0 0 0 17.2343 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3186 14.0855 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6188 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGS0 OR1N1_HUMAN "Olfactory receptor 1N1 (Olfactory receptor 1-26, OR1-26) (Olfactory receptor 1N3) (Olfactory receptor OR9-22)" OR1N1 OR1N3 Homo sapiens (Human) signal transduction [GO:0007165] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984]; signal transduction [GO:0007165] GO:0004930; GO:0004984; GO:0005886; GO:0007165; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] TRGGVGK 0.99727 -10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2951 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9697 13.1072 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q86SG5 S1A7A_HUMAN Protein S100-A7A (S100 calcium-binding protein A15) (S100 calcium-binding protein A7-like 1) (S100 calcium-binding protein A7A) S100A7A S100A15 S100A7L1 Homo sapiens (Human) cytosol [GO:0005829]; extracellular space [GO:0005615] cytosol [GO:0005829]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein self-association [GO:0043621]; transition metal ion binding [GO:0046914] GO:0005509; GO:0005615; GO:0005829; GO:0043621; GO:0046914; GO:0048306 calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein self-association [GO:0043621]; transition metal ion binding [GO:0046914] YTGRDGK 0.99746 -10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7077 0 0 0 17.4375 17.3495 17.3645 17.1857 17.6623 14.6472 0 0 0 0 0 17.066 16.6723 0 17.5377 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5PSV4 BRM1L_HUMAN Breast cancer metastasis-suppressor 1-like protein (BRMS1-homolog protein p40) (BRMS1-like protein p40) BRMS1L Homo sapiens (Human) histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of growth [GO:0040008] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822] nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; histone deacetylase binding [GO:0042826]; histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of growth [GO:0040008] GO:0000122; GO:0005634; GO:0016575; GO:0016580; GO:0030336; GO:0030512; GO:0040008; GO:0042826; GO:0070822; GO:1902455; GO:1902459 histone deacetylase binding [GO:0042826] ERLSQVDAK 0.99752 -10.129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.001 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9016 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.7595 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.8764 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2606 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9541 0 0 0 0 0 0 0 0 0 0 0 0 0 P21673 SAT1_HUMAN "Diamine acetyltransferase 1, EC 2.3.1.57 (Polyamine N-acetyltransferase 1) (Putrescine acetyltransferase) (Spermidine/spermine N(1)-acetyltransferase 1, SSAT, SSAT-1)" SAT1 SAT Homo sapiens (Human) angiogenesis [GO:0001525]; polyamine biosynthetic process [GO:0006596]; putrescine catabolic process [GO:0009447]; spermidine acetylation [GO:0032918] cytosol [GO:0005829] cytosol [GO:0005829]; diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809]; angiogenesis [GO:0001525]; polyamine biosynthetic process [GO:0006596]; putrescine catabolic process [GO:0009447]; spermidine acetylation [GO:0032918] GO:0001525; GO:0004145; GO:0005829; GO:0006596; GO:0008080; GO:0009447; GO:0019809; GO:0032918; GO:0042802 diamine N-acetyltransferase activity [GO:0004145]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; spermidine binding [GO:0019809] MAKFVIR 0.99753 -10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6106 0 0 0 0 0 0 0 0 0 0 11.7147 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7965 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGL3 OR5DE_HUMAN Olfactory receptor 5D14 (Olfactory receptor OR11-141) (Olfactory receptor OR11-150) OR5D14 Homo sapiens (Human) G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; G protein-coupled receptor signaling pathway [GO:0007186]; sensory perception of smell [GO:0007608] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0007186; GO:0007608; GO:0016021 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] IRSVSGR 0.99753 -10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1125 13.7391 0 0 12.6899 0 0 13.5459 0 0 0 0 0 0 0 0 0 0 13.5441 13.0006 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8878 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.366 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5911 0 0 0 0 0 0 0 0 14.0324 0 0 0 0 0 0 0 0 13.8547 0 0 0 0 0 0 0 0 0 Q7RTT9 S29A4_HUMAN "Equilibrative nucleoside transporter 4, hENT4 (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4)" SLC29A4 ENT4 PMAT PSEC0113 Homo sapiens (Human) cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793] apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910]; cation transmembrane transport [GO:0098655]; dopamine uptake [GO:0090494]; epinephrine uptake [GO:0051625]; export across plasma membrane [GO:0140115]; histamine metabolic process [GO:0001692]; histamine uptake [GO:0051615]; monoamine transport [GO:0015844]; neurotransmitter transport [GO:0006836]; norepinephrine uptake [GO:0051620]; organic acid transmembrane transport [GO:1903825]; organic cation transport [GO:0015695]; serotonin uptake [GO:0051610]; toxin transport [GO:1901998]; transport across blood-brain barrier [GO:0150104]; xenobiotic transport [GO:0042908] GO:0001692; GO:0005326; GO:0005337; GO:0005342; GO:0005886; GO:0006836; GO:0008324; GO:0008504; GO:0015101; GO:0015562; GO:0015695; GO:0015844; GO:0016021; GO:0016323; GO:0016324; GO:0019534; GO:0042908; GO:0042910; GO:0051610; GO:0051615; GO:0051620; GO:0051625; GO:0090494; GO:0098655; GO:0098793; GO:0140115; GO:0150104; GO:1901998; GO:1903825 cation transmembrane transporter activity [GO:0008324]; efflux transmembrane transporter activity [GO:0015562]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleoside transmembrane transporter activity [GO:0005337]; organic acid transmembrane transporter activity [GO:0005342]; organic cation transmembrane transporter activity [GO:0015101]; toxin transmembrane transporter activity [GO:0019534]; xenobiotic transmembrane transporter activity [GO:0042910] FDVPRPRVQR 0.99757 -10.082 0 0 0 0 0 0 11.4493 0 0 0 0 0 0 0 0 0 0 11.8317 0 0 0 0 10.4449 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.0824 0 0 12.0433 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9211 0 0 11.6892 0 0 0 0 0 0 0 0 0 0 12.8977 13.8069 0 0 0 11.5458 0 0 0 13.3399 12.5094 0 0 11.9469 14.4949 12.4858 0 13.556 0 0 0 0 0 0 0 0 15.7254 0 0 0 0 0 0 0 12.8349 0 0 13.0429 0 0 0 0 0 13.4511 0 15.2036 0 0 12.8809 0 0 0 0 0 11.1094 0 0 0 0 0 9.94407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4368 0 0 0 0 13.1126 0 0 11.1662 0 0 0 0 P07992 ERCC1_HUMAN DNA excision repair protein ERCC-1 ERCC1 Homo sapiens (Human) "cell population proliferation [GO:0008283]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]" "chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]; damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094]; cell population proliferation [GO:0008283]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryonic organ development [GO:0048568]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; meiotic mismatch repair [GO:0000710]; mitotic recombination [GO:0006312]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA incision [GO:0033683]; nucleotide-excision repair, DNA incision, 5'-to lesion [GO:0006296]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to cadmium ion [GO:0046686]; response to immobilization stress [GO:0035902]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to sucrose [GO:0009744]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914]" GO:0000109; GO:0000110; GO:0000710; GO:0000720; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006296; GO:0006303; GO:0006310; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0007584; GO:0008022; GO:0008283; GO:0008584; GO:0009650; GO:0009744; GO:0010165; GO:0010259; GO:0019904; GO:0032205; GO:0033683; GO:0035166; GO:0035264; GO:0035902; GO:0036297; GO:0045190; GO:0046686; GO:0048477; GO:0048568; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090399; GO:0090656; GO:1904431; GO:1905765; GO:1990841 damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094] MDPGKDK 0.99759 -10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18.2272 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P29353 SHC1_HUMAN "SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1, SH2 domain protein C1)" SHC1 SHC SHCA Homo sapiens (Human) "actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435] "cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of growth [GO:0040008]; regulation of superoxide metabolic process [GO:0090322]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]" GO:0001525; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005543; GO:0005759; GO:0005829; GO:0005886; GO:0007169; GO:0007173; GO:0007176; GO:0007507; GO:0008284; GO:0008286; GO:0016525; GO:0019901; GO:0030971; GO:0031532; GO:0035556; GO:0040008; GO:0042742; GO:0043066; GO:0043410; GO:0045892; GO:0045893; GO:0046875; GO:0048408; GO:0070374; GO:0070435; GO:0071363; GO:0071864; GO:0090322; GO:0098609 ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phospholipid binding [GO:0005543]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068] HLLLVDPEGVVRTKDHR 0.99759 -10.128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1491 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0642 0 0 0 0 0 0 0 0 12.0049 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5578 0 0 0 11.7816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0825 0 0 0 0 0 0 0 0 0 0 0 P51948 MAT1_HUMAN CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Cyclin-G1-interacting protein) (Menage a trois) (RING finger protein 66) (RING finger protein MAT1) (p35) (p36) MNAT1 CAP35 MAT1 RNF66 Homo sapiens (Human) adult heart development [GO:0007512]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA helicase activity [GO:1905775]; nucleotide-excision repair [GO:0006289]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein-containing complex assembly [GO:0065003]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; transcription by RNA polymerase II [GO:0006366]; ventricular system development [GO:0021591] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985] CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase activating kinase holoenzyme complex [GO:0019907]; nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein N-terminus binding [GO:0047485]; zinc ion binding [GO:0008270]; adult heart development [GO:0007512]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA helicase activity [GO:1905775]; nucleotide-excision repair [GO:0006289]; positive regulation of smooth muscle cell proliferation [GO:0048661]; protein-containing complex assembly [GO:0065003]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; transcription by RNA polymerase II [GO:0006366]; ventricular system development [GO:0021591] GO:0000079; GO:0000082; GO:0000439; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006357; GO:0006366; GO:0007512; GO:0008270; GO:0019907; GO:0021591; GO:0043066; GO:0047485; GO:0048661; GO:0051592; GO:0061575; GO:0065003; GO:0070516; GO:0070985; GO:1905775; GO:2000045 cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein N-terminus binding [GO:0047485]; zinc ion binding [GO:0008270] DDQGCPR 0.99759 -10.128 0 10.0256 0 10.3091 0 0 0 0 0 0 0 0 13.2942 11.0532 11.413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1133 0 0 0 0 0 0 11.2052 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2297 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9256 0 12.9983 12.3744 12.3067 0 0 0 12.4334 0 12.7785 0 12.1879 0 0 0 0 0 0 0 0 13.6232 0 0 12.6895 0 0 0 0 0 0 0 0 11.4504 0 0 0 0 0 0 0 12.4906 0 0 0 0 0 0 0 0 0 0 0 11.5269 11.3224 0 11.6264 0 0 0 0 0 0 0 0 12.574 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4602 12.5554 0 0 13.9737 11.6071 0 0 14.6088 14.5304 0 0 12.6017 0 0 12.5142 0 0 0 0 0 0 0 0 0 13.4184 Q8WY07 CTR3_HUMAN "Cationic amino acid transporter 3, CAT-3, CAT3 (Cationic amino acid transporter y+) (Solute carrier family 7 member 3)" SLC7A3 ATRC3 CAT3 Homo sapiens (Human) amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine import across plasma membrane [GO:0097640]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; amino acid transport [GO:0006865]; L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine import across plasma membrane [GO:0097640]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104] GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015189; GO:0016021; GO:0061459; GO:0097638; GO:0097639; GO:0097640; GO:0150104; GO:1903352 amino acid transmembrane transporter activity [GO:0015171]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064] PWQAFRR 0.99764 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1335 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5486 O95881 TXD12_HUMAN "Thioredoxin domain-containing protein 12, EC 1.8.4.2 (Endoplasmic reticulum resident protein 18, ER protein 18, ERp18) (Endoplasmic reticulum resident protein 19, ER protein 19, ERp19) (Thioredoxin-like protein p19) (hTLP19)" TXNDC12 TLP19 UNQ713/PRO1376 Homo sapiens (Human) negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; protein-disulfide reductase (glutathione) activity [GO:0019153]; protein-disulfide reductase activity [GO:0015035]; negative regulation of cell death [GO:0060548]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236] GO:0005783; GO:0005788; GO:0015035; GO:0019153; GO:0060548; GO:1902236 protein-disulfide reductase (glutathione) activity [GO:0019153]; protein-disulfide reductase activity [GO:0015035] SWCGACK 0.99765 -10.12 0 0 0 0 0 0 0 0 0 0 0 10.593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P42771 CDN2A_HUMAN "Cyclin-dependent kinase inhibitor 2A (Cyclin-dependent kinase 4 inhibitor A, CDK4I) (Multiple tumor suppressor 1, MTS-1) (p16-INK4a, p16-INK4, p16INK4A)" CDKN2A CDKN2 MTS1 Homo sapiens (Human) "cell cycle [GO:0007049]; cellular senescence [GO:0090398]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; replicative senescence [GO:0090399]" cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985] "cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; senescence-associated heterochromatin focus [GO:0035985]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cellular senescence [GO:0090398]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; replicative senescence [GO:0090399]" GO:0000079; GO:0001953; GO:0003723; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0007049; GO:0007265; GO:0008285; GO:0019901; GO:0030308; GO:0032088; GO:0034393; GO:0035985; GO:0042326; GO:0045736; GO:0045892; GO:0051059; GO:0051726; GO:0090398; GO:0090399; GO:2000045; GO:2000111 cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723] AAAGGTR 0.99765 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.596 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16526 CRY1_HUMAN Cryptochrome-1 CRY1 PHLL1 Homo sapiens (Human) "blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]" cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634] "cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; blue light signaling pathway [GO:0009785]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA damage induced protein phosphorylation [GO:0006975]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein ubiquitination [GO:0031398]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]" GO:0000122; GO:0003677; GO:0003690; GO:0005634; GO:0005737; GO:0005739; GO:0006094; GO:0006975; GO:0007623; GO:0009416; GO:0009785; GO:0009882; GO:0014823; GO:0016922; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0042826; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:0070888; GO:0071949; GO:2000001; GO:2000323; GO:2000850 blue light photoreceptor activity [GO:0009882]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; FAD binding [GO:0071949]; histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901] EFFYTAATNNPR 0.99765 -10.124 0 0 0 0 0 16.0063 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6073 14.41 14.8082 0 15.3408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0008 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4956 0 12.4267 0 15.1627 0 0 0 11.9413 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1092 0 0 0 0 0 0 0 0 0 0 0 A6NDN8 UBIML_HUMAN Putative ubiquitin-like protein FUBI-like protein ENSP00000310146 Homo sapiens (Human) RLGVHNV 0.9977 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1683 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A8K2U0 A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9) A2ML1 CPAMD9 Homo sapiens (Human) regulation of endopeptidase activity [GO:0052548] extracellular exosome [GO:0070062]; extracellular space [GO:0005615] extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of endopeptidase activity [GO:0052548] GO:0002020; GO:0004866; GO:0004867; GO:0005615; GO:0030414; GO:0052548; GO:0070062 endopeptidase inhibitor activity [GO:0004866]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867] ANTYWYREVER 0.9977 -10.088 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3923 0 0 0 0 0 0 0 11.2536 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.4143 19.5518 15.5346 19.9092 15.2592 15.1397 0 11.5455 0 15.1254 15.4779 19.0109 15.6159 19.2101 19.4619 0 16.0107 0 0 15.8896 17.1358 19.213 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.818 0 14.5814 13.8004 17.0677 16.3171 13.219 0 0 15.5589 15.1154 12.444 14.7433 0 12.053 0 11.5781 0 0 0 0 0 0 11.7703 0 11.886 0 0 0 11.0558 0 0 0 0 0 0 18.6909 0 13.2596 0 0 0 0 13.8803 0 0 0 11.0089 0 0 0 0 12.426 0 11.6959 0 0 0 0 0 13.7958 P51153 RAB13_HUMAN Ras-related protein Rab-13 (Cell growth-inhibiting gene 4 protein) RAB13 GIG4 Homo sapiens (Human) bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endothelial cell chemotaxis [GO:0035767]; establishment of Sertoli cell barrier [GO:0097368]; Golgi vesicle fusion to target membrane [GO:0048210]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; trans-Golgi network to recycling endosome transport [GO:0044795]; vesicle docking involved in exocytosis [GO:0006904] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140] bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endothelial cell chemotaxis [GO:0035767]; establishment of Sertoli cell barrier [GO:0097368]; Golgi vesicle fusion to target membrane [GO:0048210]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of exocytosis [GO:0017157]; trans-Golgi network to recycling endosome transport [GO:0044795]; vesicle docking involved in exocytosis [GO:0006904] GO:0003924; GO:0005525; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0005923; GO:0006904; GO:0008021; GO:0009306; GO:0010737; GO:0016197; GO:0016328; GO:0017157; GO:0030027; GO:0030054; GO:0030139; GO:0030140; GO:0030866; GO:0031175; GO:0031410; GO:0032456; GO:0032593; GO:0032869; GO:0035767; GO:0043005; GO:0043231; GO:0044795; GO:0048210; GO:0055037; GO:0055038; GO:0070062; GO:0070830; GO:0072659; GO:0097368; GO:1902463 GTP binding [GO:0005525]; GTPase activity [GO:0003924] CDMEAKR 0.9977 -10.107 0 0 0 0 0 0 0 0 0 13.5783 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5139 0 12.693 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5897 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH02 O2T29_HUMAN Olfactory receptor 2T29 OR2T29 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] DVMGALK 0.9977 -10.084 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.564 0 0 0 0 0 0 0 0 12.1848 0 0 0 0 14.6777 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5865 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4477 0 0 0 0 0 0 0 12.7766 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6352 13.6963 0 0 0 0 0 0 0 13.5534 0 14.2777 0 13.162 0 13.5491 0 0 0 0 0 0 0 0 0 0 12.9593 0 0 0 14.3056 0 0 0 0 0 0 12.1272 0 0 0 0 13.119 0 0 0 0 0 0 0 0 12.2616 0 0 0 0 Q92748 THRSP_HUMAN "Thyroid hormone-inducible hepatic protein (Spot 14 protein, S14, SPOT14)" THRSP Homo sapiens (Human) lipid metabolic process [GO:0006629]; regulation of lipid biosynthetic process [GO:0046890]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617] cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; lipid metabolic process [GO:0006629]; regulation of lipid biosynthetic process [GO:0046890]; regulation of triglyceride biosynthetic process [GO:0010866]; response to bacterium [GO:0009617] GO:0005654; GO:0005829; GO:0006629; GO:0009617; GO:0010866; GO:0042802; GO:0042803; GO:0046890 identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803] MQVLTKR 0.9977 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P46059 S15A1_HUMAN "Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)" SLC15A1 PEPT1 Homo sapiens (Human) dipeptide import across plasma membrane [GO:0140206]; ion transport [GO:0006811]; protein transport [GO:0015031]; tripeptide import across plasma membrane [GO:0140207] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spanning component of membrane [GO:0089717] apical plasma membrane [GO:0016324]; brush border [GO:0005903]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; spanning component of membrane [GO:0089717]; dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; tripeptide transmembrane transporter activity [GO:0042937]; dipeptide import across plasma membrane [GO:0140206]; ion transport [GO:0006811]; protein transport [GO:0015031]; tripeptide import across plasma membrane [GO:0140207] GO:0005427; GO:0005886; GO:0005887; GO:0005903; GO:0006811; GO:0015031; GO:0015333; GO:0016324; GO:0042937; GO:0071916; GO:0089717; GO:0140206; GO:0140207 dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; proton-dependent oligopeptide secondary active transmembrane transporter activity [GO:0005427]; tripeptide transmembrane transporter activity [GO:0042937] FSYYGMR 0.99772 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2619 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8241 13.2639 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7212 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9177 0 0 0 0 0 0 0 0 0 10.5196 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6Q6R5 CRIP3_HUMAN "Cysteine-rich protein 3, CRP-3 (Chromosome 6 LIM domain only protein, h6LIMo)" CRIP3 CRP3 Homo sapiens (Human) cytoplasm [GO:0005737] cytoplasm [GO:0005737]; metal ion binding [GO:0046872] GO:0005737; GO:0046872 metal ion binding [GO:0046872] TGLPQGK 0.99772 -10.12 0 11.3488 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7467 0 0 0 0 0 0 0 13.4257 0 12.3542 0 0 0 0 0 0 0 0 0 0 0 12.4155 0 0 12.4092 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H609 ZN576_HUMAN Zinc finger protein 576 ZNF576 Homo sapiens (Human) regulation of transcription by RNA polymerase II [GO:0006357] nucleus [GO:0005634] "nucleus [GO:0005634]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0000981; GO:0005634; GO:0006357; GO:0043565; GO:0046872 "DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]" SHGPAAK 0.99772 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9596 0 0 13.908 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6909 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2401 0 0 0 0 0 13.3325 0 0 0 0 0 0 0 0 0 0 0 13.0714 0 0 0 13.0479 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7181 12.7023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9P2N6 KANL3_HUMAN KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD) KANSL3 KIAA1310 NSL3 PRTD SI1 Homo sapiens (Human) "chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654] "histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; chromatin organization [GO:0006325]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]" GO:0000123; GO:0005654; GO:0006325; GO:0043231; GO:0043981; GO:0043982; GO:0043984; GO:0044545; GO:0045893; GO:0045944; GO:0051571; GO:1900095 ALQSDRLARLANEGACNEPVLR 0.99772 -10.123 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8217 14.0167 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4045 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.6887 12.6662 0 0 0 0 0 13.6413 16.5904 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6235 0 0 0 0 0 0 0 0 0 0 0 0 12.8628 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7801 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UGF7 O12D3_HUMAN Olfactory receptor 12D3 (Hs6M1-27) (Olfactory receptor OR6-27) OR12D3 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of smell [GO:0050911] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911] GO:0004930; GO:0004984; GO:0005549; GO:0005886; GO:0016021; GO:0050911 G protein-coupled receptor activity [GO:0004930]; odorant binding [GO:0005549]; olfactory receptor activity [GO:0004984] SCRILHK 0.99772 -10.134 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9227 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.332 0 0 0 0 0 13.274 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6158 0 0 0 0 0 0 0 0 12.8743 0 0 0 0 12.5018 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q53FZ2 ACSM3_HUMAN "Acyl-coenzyme A synthetase ACSM3, mitochondrial, EC 6.2.1.2 (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase, EC 6.2.1.17) (Protein SA homolog)" ACSM3 SAH Homo sapiens (Human) acyl-CoA metabolic process [GO:0006637]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; regulation of blood pressure [GO:0008217] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739] mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; methylbutanoate-CoA ligase activity [GO:0043759]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218]; acyl-CoA metabolic process [GO:0006637]; cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; regulation of blood pressure [GO:0008217] GO:0004321; GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0006637; GO:0008217; GO:0015645; GO:0018729; GO:0042632; GO:0043759; GO:0046872; GO:0047760; GO:0050218 ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; methylbutanoate-CoA ligase activity [GO:0043759]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218] GDRVILILPR 0.99777 -10.106 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4522 0 0 11.9666 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3806 0 0 0 0 0 0 12.2867 0 0 11.3032 0 0 0 0 0 0 0 Q9Y239 NOD1_HUMAN Nucleotide-binding oligomerization domain-containing protein 1 (Caspase recruitment domain-containing protein 4) NOD1 CARD4 Homo sapiens (Human) activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to muramyl dipeptide [GO:0071225]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cell death [GO:0010942]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; xenophagy [GO:0098792] anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic vesicle [GO:0045335] anchored component of plasma membrane [GO:0046658]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to muramyl dipeptide [GO:0071225]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; ERK1 and ERK2 cascade [GO:0070371]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cell death [GO:0010942]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of xenophagy [GO:1904417]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; xenophagy [GO:0098792] GO:0002221; GO:0002606; GO:0005524; GO:0005737; GO:0005829; GO:0006915; GO:0006919; GO:0006952; GO:0006954; GO:0007165; GO:0007249; GO:0007254; GO:0008656; GO:0009595; GO:0010942; GO:0016045; GO:0016323; GO:0016324; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0035556; GO:0038187; GO:0042742; GO:0042802; GO:0042803; GO:0042834; GO:0042981; GO:0043123; GO:0043280; GO:0044877; GO:0045087; GO:0045335; GO:0046330; GO:0046658; GO:0050700; GO:0050830; GO:0051000; GO:0051092; GO:0060907; GO:0070371; GO:0070374; GO:0071225; GO:0098792; GO:1901224; GO:1904417 ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877] ALWAHLFSSLRGYLK 0.99777 -10.101 0 0 0 0 0 12.2552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5126 0 0 11.3744 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7889 0 0 0 0 0 0 0 0 0 0 0 0 13.941 0 0 0 0 0 0 0 0 0 0 13.539 0 0 11.9835 0 0 0 12.9361 0 0 13.9091 0 0 11.6587 11.962 12.8655 11.9107 0 0 12.0401 0 13.4005 0 11.2928 0 0 0 14.551 0 0 0 0 0 0 0 12.3968 13.2289 14.1085 13.2089 12.7786 0 12.7917 0 0 12.8904 13.0934 0 0 12.5921 0 0 0 0 0 0 13.4407 0 13.6769 12.1476 12.7947 16.3521 0 12.3014 0 13.386 0 0 0 0 0 0 0 12.3124 12.9195 0 11.8046 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9725 0 0 0 0 13.5049 0 0 12.09 13.105 12.597 A6ND91 ASPDH_HUMAN Aspartate dehydrogenase domain-containing protein ASPDH Homo sapiens (Human) NAD biosynthetic process [GO:0009435] aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]; NAD biosynthetic process [GO:0009435] GO:0009435; GO:0033735; GO:0050661 aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661] SFAVHTR 0.99778 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7146 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15269 SPTC1_HUMAN "Serine palmitoyltransferase 1, EC 2.3.1.50 (Long chain base biosynthesis protein 1, LCB 1) (Serine-palmitoyl-CoA transferase 1, SPT 1, SPT1)" SPTLC1 LCB1 Homo sapiens (Human) ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; regulation of fat cell apoptotic process [GO:1904649]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; SPOTS complex [GO:0035339] endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; serine C-palmitoyltransferase complex [GO:0017059]; SPOTS complex [GO:0035339]; pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; regulation of fat cell apoptotic process [GO:1904649]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512] GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0006686; GO:0016021; GO:0017059; GO:0030148; GO:0030170; GO:0035339; GO:0046511; GO:0046512; GO:0046513; GO:1904504; GO:1904649 pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758] AASTIKEVAQAVLL 0.99778 -10.122 0 0 0 0 0 0 0 0 12.1462 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8552 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2357 0 0 0 0 0 0 0 0 0 0 0 13.1336 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7164 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O43307 ARHG9_HUMAN Rho guanine nucleotide exchange factor 9 (Collybistin) (PEM-2 homolog) (Rac/Cdc42 guanine nucleotide exchange factor 9) ARHGEF9 ARHDH9 KIAA0424 Homo sapiens (Human) regulation of postsynaptic specialization assembly [GO:0099150]; regulation of small GTPase mediated signal transduction [GO:0051056] anchoring junction [GO:0070161]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572] anchoring junction [GO:0070161]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; postsynaptic density [GO:0014069]; postsynaptic specialization [GO:0099572]; guanyl-nucleotide exchange factor activity [GO:0005085]; regulation of postsynaptic specialization assembly [GO:0099150]; regulation of small GTPase mediated signal transduction [GO:0051056] GO:0005085; GO:0005829; GO:0014069; GO:0051056; GO:0070161; GO:0098982; GO:0099150; GO:0099572 guanyl-nucleotide exchange factor activity [GO:0005085] DICEGYLK 0.99778 -10.133 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8976 0 0 0 0 0 0 0 11.9045 0 11.4527 0 0 0 0 0 0 0 0 0 0 16.3146 0 0 0 15.039 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P02649 APOE_HUMAN "Apolipoprotein E, Apo-E" APOE Homo sapiens (Human) "AMPA glutamate receptor clustering [GO:0097113]; amyloid precursor protein metabolic process [GO:0042982]; artery morphogenesis [GO:0048844]; cellular calcium ion homeostasis [GO:0006874]; cGMP-mediated signaling [GO:0019934]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron remnant clearance [GO:0034382]; cytoskeleton organization [GO:0007010]; fatty acid homeostasis [GO:0055089]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intermediate-density lipoprotein particle clearance [GO:0071831]; intracellular transport [GO:0046907]; lipid transport involved in lipid storage [GO:0010877]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; locomotory exploration behavior [GO:0035641]; long-chain fatty acid transport [GO:0015909]; long-term memory [GO:0007616]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of location in cell [GO:0051651]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of blood coagulation [GO:0030195]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of lipid transport across blood-brain barrier [GO:1903001]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of phospholipid efflux [GO:1902999]; negative regulation of platelet activation [GO:0010544]; negative regulation of postsynaptic membrane organization [GO:1901627]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of triglyceride metabolic process [GO:0090209]; neuron projection development [GO:0031175]; nitric oxide mediated signal transduction [GO:0007263]; NMDA glutamate receptor clustering [GO:0097114]; phospholipid efflux [GO:0033700]; positive regulation by host of viral process [GO:0044794]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heparan sulfate binding [GO:1905855]; positive regulation of heparan sulfate proteoglycan binding [GO:1905860]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipid transport across blood-brain barrier [GO:1903002]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neurofibrillary tangle assembly [GO:1902998]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import [GO:0017038]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of amyloid-beta clearance [GO:1900221]; regulation of axon extension [GO:0030516]; regulation of behavioral fear response [GO:2000822]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cellular response to very-low-density lipoprotein particle stimulus [GO:1905890]; regulation of cholesterol metabolic process [GO:0090181]; regulation of innate immune response [GO:0045088]; regulation of neuron death [GO:1901214]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein metabolic process [GO:0051246]; regulation of protein-containing complex assembly [GO:0043254]; regulation of tau-protein kinase activity [GO:1902947]; response to caloric restriction [GO:0061771]; response to dietary excess [GO:0002021]; response to reactive oxygen species [GO:0000302]; reverse cholesterol transport [GO:0043691]; synaptic transmission, cholinergic [GO:0007271]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle clearance [GO:0071830]; vasodilation [GO:0042311]; very-low-density lipoprotein particle clearance [GO:0034447]; very-low-density lipoprotein particle remodeling [GO:0034372]; virion assembly [GO:0019068]" blood microparticle [GO:0072562]; chylomicron [GO:0042627]; clathrin-coated endocytic vesicle membrane [GO:0030669]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; discoidal high-density lipoprotein particle [GO:0034365]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; very-low-density lipoprotein particle [GO:0034361] "blood microparticle [GO:0072562]; chylomicron [GO:0042627]; clathrin-coated endocytic vesicle membrane [GO:0030669]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; discoidal high-density lipoprotein particle [GO:0034365]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; very-low-density lipoprotein particle [GO:0034361]; amyloid-beta binding [GO:0001540]; antioxidant activity [GO:0016209]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle receptor binding [GO:0050750]; metal chelating activity [GO:0046911]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; very-low-density lipoprotein particle receptor binding [GO:0070326]; AMPA glutamate receptor clustering [GO:0097113]; amyloid precursor protein metabolic process [GO:0042982]; artery morphogenesis [GO:0048844]; cellular calcium ion homeostasis [GO:0006874]; cGMP-mediated signaling [GO:0019934]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron remnant clearance [GO:0034382]; cytoskeleton organization [GO:0007010]; fatty acid homeostasis [GO:0055089]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intermediate-density lipoprotein particle clearance [GO:0071831]; intracellular transport [GO:0046907]; lipid transport involved in lipid storage [GO:0010877]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; locomotory exploration behavior [GO:0035641]; long-chain fatty acid transport [GO:0015909]; long-term memory [GO:0007616]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of location in cell [GO:0051651]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of blood coagulation [GO:0030195]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of lipid transport across blood-brain barrier [GO:1903001]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of phospholipid efflux [GO:1902999]; negative regulation of platelet activation [GO:0010544]; negative regulation of postsynaptic membrane organization [GO:1901627]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of triglyceride metabolic process [GO:0090209]; neuron projection development [GO:0031175]; nitric oxide mediated signal transduction [GO:0007263]; NMDA glutamate receptor clustering [GO:0097114]; phospholipid efflux [GO:0033700]; positive regulation by host of viral process [GO:0044794]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heparan sulfate binding [GO:1905855]; positive regulation of heparan sulfate proteoglycan binding [GO:1905860]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipid transport across blood-brain barrier [GO:1903002]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neurofibrillary tangle assembly [GO:1902998]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import [GO:0017038]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of amyloid-beta clearance [GO:1900221]; regulation of axon extension [GO:0030516]; regulation of behavioral fear response [GO:2000822]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cellular response to very-low-density lipoprotein particle stimulus [GO:1905890]; regulation of cholesterol metabolic process [GO:0090181]; regulation of innate immune response [GO:0045088]; regulation of neuron death [GO:1901214]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein metabolic process [GO:0051246]; regulation of protein-containing complex assembly [GO:0043254]; regulation of tau-protein kinase activity [GO:1902947]; response to caloric restriction [GO:0061771]; response to dietary excess [GO:0002021]; response to reactive oxygen species [GO:0000302]; reverse cholesterol transport [GO:0043691]; synaptic transmission, cholinergic [GO:0007271]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle clearance [GO:0071830]; vasodilation [GO:0042311]; very-low-density lipoprotein particle clearance [GO:0034447]; very-low-density lipoprotein particle remodeling [GO:0034372]; virion assembly [GO:0019068]" GO:0000302; GO:0001540; GO:0001937; GO:0002021; GO:0005102; GO:0005198; GO:0005319; GO:0005543; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005788; GO:0005794; GO:0005886; GO:0006641; GO:0006707; GO:0006874; GO:0006898; GO:0007010; GO:0007186; GO:0007263; GO:0007271; GO:0007616; GO:0008201; GO:0008203; GO:0008289; GO:0010467; GO:0010544; GO:0010596; GO:0010629; GO:0010875; GO:0010877; GO:0010976; GO:0010977; GO:0015909; GO:0016020; GO:0016209; GO:0017038; GO:0019068; GO:0019899; GO:0019934; GO:0030195; GO:0030425; GO:0030516; GO:0030669; GO:0031012; GO:0031175; GO:0032489; GO:0032805; GO:0033344; GO:0033700; GO:0034361; GO:0034362; GO:0034363; GO:0034364; GO:0034365; GO:0034372; GO:0034374; GO:0034375; GO:0034380; GO:0034382; GO:0034384; GO:0034447; GO:0035641; GO:0042158; GO:0042159; GO:0042311; GO:0042627; GO:0042632; GO:0042802; GO:0042803; GO:0042982; GO:0043025; GO:0043083; GO:0043254; GO:0043395; GO:0043407; GO:0043524; GO:0043537; GO:0043691; GO:0044794; GO:0044877; GO:0045088; GO:0045541; GO:0045807; GO:0045893; GO:0046889; GO:0046907; GO:0046911; GO:0046983; GO:0048156; GO:0048168; GO:0048662; GO:0048844; GO:0050709; GO:0050728; GO:0050750; GO:0051000; GO:0051044; GO:0051055; GO:0051246; GO:0051248; GO:0051651; GO:0055089; GO:0060228; GO:0060999; GO:0061000; GO:0061136; GO:0061771; GO:0062023; GO:0070062; GO:0070326; GO:0070328; GO:0070374; GO:0071682; GO:0071813; GO:0071830; GO:0071831; GO:0072562; GO:0090090; GO:0090181; GO:0090205; GO:0090209; GO:0090370; GO:0097113; GO:0097114; GO:0098978; GO:0120020; GO:1900221; GO:1900223; GO:1900272; GO:1901214; GO:1901215; GO:1901216; GO:1901627; GO:1901631; GO:1902004; GO:1902430; GO:1902947; GO:1902951; GO:1902952; GO:1902991; GO:1902995; GO:1902998; GO:1902999; GO:1903001; GO:1903002; GO:1903561; GO:1905855; GO:1905860; GO:1905890; GO:1905906; GO:1905907; GO:1905908; GO:1905920; GO:1990777; GO:2000822 amyloid-beta binding [GO:0001540]; antioxidant activity [GO:0016209]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle receptor binding [GO:0050750]; metal chelating activity [GO:0046911]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; very-low-density lipoprotein particle receptor binding [GO:0070326] AKLEEQAQQIR 0.99778 -10.132 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8788 0 0 0 11.7059 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2418 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6301 0 0 0 0 0 12.146 0 0 13.3678 0 0 0 12.3462 0 12.2708 11.4186 0 0 0 0 0 0 0 0 0 0 0 0 12.8889 0 11.9966 0 0 0 0 0 0 11.6969 0 0 0 0 13.1294 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14493 SLBP_HUMAN Histone RNA hairpin-binding protein (Histone stem-loop-binding protein) SLBP HBP Homo sapiens (Human) cap-dependent translational initiation [GO:0002191]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone mRNA stem-loop binding complex [GO:0062073]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone mRNA stem-loop binding complex [GO:0062073]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; histone pre-mRNA DCP binding [GO:0071208]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cap-dependent translational initiation [GO:0002191]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028] GO:0002191; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006398; GO:0042802; GO:0051028; GO:0062073; GO:0071204; GO:0071207; GO:0071208; GO:1990904 histone pre-mRNA DCP binding [GO:0071208]; histone pre-mRNA stem-loop binding [GO:0071207]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723] CSDWASAVEEDEMR 0.99778 -10.122 0 0 0 0 0 0 0 0 0 0 13.3757 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3629 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9122 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8892 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5775 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.1002 0 0 0 0 0 14.5618 0 0 13.4045 0 0 0 Q92887 MRP2_HUMAN "ATP-binding cassette sub-family C member 2, EC 7.6.2.-, EC 7.6.2.2, EC 7.6.2.3 (Canalicular multidrug resistance protein) (Canalicular multispecific organic anion transporter 1) (Multidrug resistance-associated protein 2)" ABCC2 CMOAT CMOAT1 CMRP MRP2 Homo sapiens (Human) bile acid and bile salt transport [GO:0015721]; bilirubin transport [GO:0015723]; heme catabolic process [GO:0042167]; leukotriene transport [GO:0071716]; negative regulation of gene expression [GO:0010629]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic export from cell [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport across blood-brain barrier [GO:1990962] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886] apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910]; bile acid and bile salt transport [GO:0015721]; bilirubin transport [GO:0015723]; heme catabolic process [GO:0042167]; leukotriene transport [GO:0071716]; negative regulation of gene expression [GO:0010629]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic export from cell [GO:0046618]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport across blood-brain barrier [GO:1990962] GO:0005524; GO:0005886; GO:0005887; GO:0006805; GO:0006855; GO:0008514; GO:0008559; GO:0009986; GO:0010629; GO:0015127; GO:0015431; GO:0015721; GO:0015723; GO:0016020; GO:0016324; GO:0042167; GO:0042626; GO:0042910; GO:0043225; GO:0046581; GO:0046618; GO:0055085; GO:0070633; GO:0071716; GO:0140359; GO:0150104; GO:1990962 ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bilirubin transmembrane transporter activity [GO:0015127]; organic anion transmembrane transporter activity [GO:0008514]; xenobiotic transmembrane transporter activity [GO:0042910] ARRALQR 0.99778 -10.123 0 0 0 0 0 0 0 0 0 0 0 0 0 10.7439 0 0 0 0 0 0 0 15.8761 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2589 0 0 12.6828 0 0 0 0 0 0 0 0 19.6079 0 14.027 0 0 12.2398 14.2112 0 0 0 18.8556 12.1476 13.1955 0 11.1887 0 0 0 14.6864 15.6582 12.0307 13.4815 0 0 14.1426 0 13.0343 0 20.0566 0 0 0 0 14.1902 0 0 19.9234 13.1263 0 0 0 0 12.2717 0 0 0 0 19.099 0 18.8811 18.5628 0 12.1624 13.9709 0 13.3009 0 12.819 0 10.9461 0 0 0 0 12.6295 0 0 0 0 15.088 0 0 0 0 0 0 14.1214 0 0 0 0 0 0 0 O14917 PCD17_HUMAN Protocadherin-17 (Protocadherin-68) PCDH17 PCDH68 PCH68 Homo sapiens (Human) adult behavior [GO:0030534]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of synaptic transmission [GO:0050805]; presynaptic active zone assembly [GO:1904071]; regulation of synaptic vesicle clustering [GO:2000807]; synaptic membrane adhesion [GO:0099560] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056] GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; calcium ion binding [GO:0005509]; adult behavior [GO:0030534]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of synaptic transmission [GO:0050805]; presynaptic active zone assembly [GO:1904071]; regulation of synaptic vesicle clustering [GO:2000807]; synaptic membrane adhesion [GO:0099560] GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0030534; GO:0050805; GO:0098978; GO:0098982; GO:0099055; GO:0099056; GO:0099560; GO:1904071; GO:2000807 calcium ion binding [GO:0005509] ACIEPCTSTK 0.99783 -10.098 0 0 0 0 12.9075 0 0 12.5369 0 0 12.0876 0 0 12.8106 0 0 0 0 0 0 0 0 0 0 11.3126 0 0 0 0 0 12.6803 0 11.5812 0 0 0 0 0 0 0 10.5639 0 0 0 0 0 0 0 0 0 0 12.5496 11.7609 12.9091 10.4278 0 0 0 0 0 0 9.76527 10.9234 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4819 0 0 12.855 0 0 0 0 0 0 0 12.6847 0 0 0 0 12.9311 12.6998 0 12.9122 0 0 0 0 0 0 13.581 0 0 0 0 0 0 13.715 0 0 13.0744 12.7497 11.0316 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7533 0 0 14.7915 0 0 0 14.5325 0 0 0 0 12.5069 0 12.9435 0 0 0 0 0 0 12.8568 0 13.5236 0 0 0 0 13.6308 12.915 0 0 0 0 0 O95402 MED26_HUMAN "Mediator of RNA polymerase II transcription subunit 26 (Activator-recruited cofactor 70 kDa component, ARC70) (Cofactor required for Sp1 transcriptional activation subunit 7, CRSP complex subunit 7) (Mediator complex subunit 26) (Transcriptional coactivator CRSP70)" MED26 ARC70 CRSP7 Homo sapiens (Human) positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation from RNA polymerase II promoter [GO:0006367] GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0010628; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847 transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712] AGFSPDSSKADSDAASSGGSDSK 0.99783 -10.096 0 0 0 0 0 0 0 14.8512 0 0 0 0 0 0 0 0 0 11.9756 0 11.9482 0 13.032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1434 12.4966 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4917 0 0 0 0 0 0 0 0 19.043 0 13.4322 0 0 18.9772 13.6005 13.0112 12.634 0 0 13.0301 0 0 12.6208 0 0 13.7915 12.9991 12.7774 0 13.4065 0 0 0 0 13.5185 0 0 0 0 13.5053 0 0 14.2858 13.1513 0 14.9034 0 12.728 0 0 12.9462 0 15.4484 0 13.5614 14.0211 0 0 13.7497 0 13.7185 13.7696 13.6542 0 13.7213 0 13.411 0 13.6494 13.248 13.0462 13.4091 13.5047 13.7012 0 13.6534 0 0 13.3775 13.2477 0 0 0 14.4762 13.6251 0 0 13.2291 0 0 13.3554 0 13.0796 13.2284 0 14.9254 0 0 0 0 0 0 0 13.1579 0 0 0 0 0 0 0 0 0 13.7639 14.6475 13.7153 0 0 0 9.45115 0 0 P0DPB5 RPC22_HUMAN "Protein POLR1D, isoform 2" POLR1D Homo sapiens (Human) cytosol [GO:0005829]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; nucleoplasm [GO:0005654] GO:0005654; GO:0005829 AETMGPMGWMKCPLASTNK 0.99783 -10.101 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98982 0 0 0 0 0 0 0 0 0 0 0 9.48244 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.4623 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5583 0 17.0268 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P59103 DAOA_HUMAN D-amino acid oxidase activator (Protein G72) DAOA G72 Homo sapiens (Human) negative regulation of D-amino-acid oxidase activity [GO:1900758]; positive regulation of catalytic activity [GO:0043085] Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471] Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; negative regulation of D-amino-acid oxidase activity [GO:1900758]; positive regulation of catalytic activity [GO:0043085] GO:0005739; GO:0005794; GO:0008047; GO:0019899; GO:0043085; GO:0048471; GO:1900758 enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899] DQSCNHK 0.99783 -10.106 0 0 0 0 0 0 0 0 0 0 11.3916 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9314 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13950 RUNX2_HUMAN "Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1, CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2, OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit, PEA2-alpha A, PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit)" RUNX2 AML3 CBFA1 OSF2 PEBP2A Homo sapiens (Human) "BMP signaling pathway [GO:0030509]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; endochondral ossification [GO:0001958]; epithelial cell proliferation [GO:0050673]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; ligamentous ossification [GO:0036076]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; osteoblast fate commitment [GO:0002051]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to L-ascorbic acid [GO:0033591]; response to sodium phosphate [GO:1904383]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; T cell differentiation [GO:0030217]" chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667] "chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; BMP signaling pathway [GO:0030509]; cell maturation [GO:0048469]; cellular response to BMP stimulus [GO:0071773]; chondrocyte development [GO:0002063]; chondrocyte differentiation [GO:0002062]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; endochondral ossification [GO:0001958]; epithelial cell proliferation [GO:0050673]; gene expression [GO:0010467]; hemopoiesis [GO:0030097]; ligamentous ossification [GO:0036076]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; osteoblast fate commitment [GO:0002051]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of ossification [GO:0030278]; regulation of transcription by RNA polymerase II [GO:0006357]; response to L-ascorbic acid [GO:0033591]; response to sodium phosphate [GO:1904383]; smoothened signaling pathway [GO:0007224]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; T cell differentiation [GO:0030217]" GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001503; GO:0001649; GO:0001958; GO:0002051; GO:0002062; GO:0002063; GO:0002076; GO:0003700; GO:0005524; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0007224; GO:0010467; GO:0010628; GO:0019904; GO:0030097; GO:0030182; GO:0030217; GO:0030278; GO:0030509; GO:0031490; GO:0032332; GO:0033591; GO:0035115; GO:0036076; GO:0040036; GO:0042475; GO:0042487; GO:0043425; GO:0045595; GO:0045669; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0048469; GO:0048701; GO:0048863; GO:0050673; GO:0050679; GO:0071773; GO:0072089; GO:1901522; GO:1904383; GO:1990837; GO:2000648 "ATP binding [GO:0005524]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]" FNDLRFVGR 0.99783 -10.094 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2649 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1846 0 0 12.0993 0 0 0 0 0 0 0 11.4844 0 0 0 0 9.75906 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.9087 16.8787 0 0 0 0 0 0 0 16.665 0 0 0 0 0 0 10.0958 0 0 0 0 0 0 9.96636 0 0 0 0 0 0 0 12.4422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4616 12.1981 0 0 13.3958 0 0 0 0 0 13.1123 0 14.4987 0 0 0 10.5935 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4936 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9H0I2 ENKD1_HUMAN Enkurin domain-containing protein 1 ENKD1 C16orf48 UNQ6410/PRO21183 Homo sapiens (Human) 9+0 non-motile cilium [GO:0097731]; ciliary base [GO:0097546]; cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630] 9+0 non-motile cilium [GO:0097731]; ciliary base [GO:0097546]; cytoplasmic microtubule [GO:0005881]; microtubule cytoskeleton [GO:0015630] GO:0005881; GO:0015630; GO:0097546; GO:0097731 ALWRSPK 0.99783 -10.097 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3716 0 0 0 0 0 0 0 0 0 0 0 0 0 15.5512 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 W5XKT8 SACA6_HUMAN Sperm acrosome membrane-associated protein 6 (BACHELOR-like protein) SPACA6 SPACA6P UNQ2487/PRO5774 Homo sapiens (Human) fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021] acrosomal membrane [GO:0002080]; integral component of membrane [GO:0016021]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342] GO:0002080; GO:0007342; GO:0016021 FAGGGLR 0.99783 -10.091 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8563 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0927 0 0 0 0 0 0 12.7616 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1385 0 0 12.5036 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P31995 FCG2C_HUMAN "Low affinity immunoglobulin gamma Fc region receptor II-c, IgG Fc receptor II-c (CDw32) (Fc-gamma RII-c, Fc-gamma-RIIc, FcRII-c) (CD antigen CD32)" FCGR2C CD32 FCG2 IGFR2 Homo sapiens (Human) cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; regulation of immune response [GO:0050776] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888]; cell surface receptor signaling pathway [GO:0007166]; immune response [GO:0006955]; regulation of immune response [GO:0050776] GO:0004888; GO:0005737; GO:0005887; GO:0006955; GO:0007166; GO:0016021; GO:0019864; GO:0050776 IgG binding [GO:0019864]; transmembrane signaling receptor activity [GO:0004888] APTDDDK 0.99784 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5731 0 0 9.73023 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q15238 PSG5_HUMAN "Pregnancy-specific beta-1-glycoprotein 5, PS-beta-G-5, PSBG-5, Pregnancy-specific glycoprotein 5 (Fetal liver non-specific cross-reactive antigen 3, FL-NCA-3)" PSG5 Homo sapiens (Human) female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] cell surface [GO:0009986]; extracellular region [GO:0005576] cell surface [GO:0009986]; extracellular region [GO:0005576]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157] GO:0005576; GO:0007157; GO:0007565; GO:0009986 LPLLNPI 0.99784 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1625 12.6643 0 0 0 13.1412 0 13.0893 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.412 0 0 0 0 0 0 13.1983 0 0 0 0 0 0 0 0 0 0 0 13.2899 0 0 0 0 0 0 0 0 0 0 12.7828 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0852 0 0 0 0 0 0 0 0 0 0 0 A0A075B6Y3 TJA3_HUMAN T cell receptor alpha joining 3 TRAJ3 Homo sapiens (Human) adaptive immune response [GO:0002250] T cell receptor complex [GO:0042101] T cell receptor complex [GO:0042101]; adaptive immune response [GO:0002250] GO:0002250; GO:0042101 GYSSASK 0.99785 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7981 0 0 0 0 0 0 0 11.4075 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.90516 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A590UK83 SMI45_HUMAN Protein SMIM45 (Small integral membrane protein 45) SMIM45 LINC00634 Homo sapiens (Human) QVEANPR 0.99785 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5046 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8203 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P69208 MORN_HUMAN "Morphogenetic neuropeptide (Head activator, HA)" Homo sapiens (Human) cell cycle [GO:0007049]; cell division [GO:0051301]; G protein-coupled receptor internalization [GO:0002031]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cell cycle process [GO:0090068]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neural precursor cell proliferation [GO:2000179]; protein localization to cell surface [GO:0034394]; receptor internalization [GO:0031623] cytoplasm [GO:0005737] cytoplasm [GO:0005737]; growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018]; cell cycle [GO:0007049]; cell division [GO:0051301]; G protein-coupled receptor internalization [GO:0002031]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cell cycle process [GO:0090068]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neural precursor cell proliferation [GO:2000179]; protein localization to cell surface [GO:0034394]; receptor internalization [GO:0031623] GO:0002031; GO:0005737; GO:0007049; GO:0007218; GO:0008083; GO:0031623; GO:0034394; GO:0048018; GO:0051044; GO:0051301; GO:0090068; GO:2000179 growth factor activity [GO:0008083]; receptor ligand activity [GO:0048018] QPPGGSK 0.99785 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8014 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5918 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0887 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGE1 OR6C4_HUMAN Olfactory receptor 6C4 (Olfactory receptor OR12-10) OR6C4 Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] EGGAFNK 0.99785 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.5481 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NGF8 OR4B1_HUMAN Olfactory receptor 4B1 (OST208) (Olfactory receptor OR11-106) OR4B1 Homo sapiens (Human) integral component of plasma membrane [GO:0005887] integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005887 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] NHSAEGR 0.99785 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.95261 0 0 0 0 0 0 0 0 0 11.2398 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8WTP9 XAGE3_HUMAN "X antigen family member 3, XAGE-3 (Cancer/testis antigen 12.3, CT12.3) (G antigen family D member 4) (Placenta-specific gene 6 protein)" XAGE3 GAGED4 PLAC6 PP9012 Homo sapiens (Human) MPEGGDR 0.99785 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9415 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0033 12.993 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5753 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P0DKB6 MPC1L_HUMAN Mitochondrial pyruvate carrier 1-like protein MPC1L Homo sapiens (Human) mitochondrial pyruvate transmembrane transport [GO:0006850] integral component of mitochondrial inner membrane [GO:0031305] integral component of mitochondrial inner membrane [GO:0031305]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850] GO:0006850; GO:0031305; GO:0050833 pyruvate transmembrane transporter activity [GO:0050833] MAVLWRK 0.9979 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4663 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q11128 FUT5_HUMAN "4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5, EC 2.4.1.152 (3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT5, EC 2.4.1.65) (Fucosyltransferase 5) (Fucosyltransferase V, Fuc-TV, FucT-V) (Galactoside 3-L-fucosyltransferase)" FUT5 Homo sapiens (Human) carbohydrate metabolic process [GO:0005975]; ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021] Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; carbohydrate metabolic process [GO:0005975]; ceramide metabolic process [GO:0006672]; fucosylation [GO:0036065]; L-fucose catabolic process [GO:0042355]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493] GO:0000139; GO:0005794; GO:0005975; GO:0006486; GO:0006487; GO:0006493; GO:0006672; GO:0008417; GO:0009311; GO:0009312; GO:0016021; GO:0017060; GO:0017083; GO:0032580; GO:0036065; GO:0042355; GO:0046920 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417] DLARYLQELDK 0.9979 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9961 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3484 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7717 0 0 0 0 0 0 0 0 12.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6215 0 0 12.8981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2568 0 0 0 0 0 Q8N9P0 YF006_HUMAN Putative uncharacterized protein FLJ36797 Homo sapiens (Human) PLSLRVGLALPGGR 0.9979 -10.095 0 0 0 0 0 0 0 0 0 11.8181 13.2599 0 11.9914 0 11.5114 0 0 0 0 0 0 0 0 0 0 0 0 0 12.2373 12.7482 0 12.2599 12.4454 0 12.7302 0 12.0985 0 0 0 11.6434 0 0 12.198 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9004 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0U1RRN3 SPTOS_HUMAN Putative transmembrane protein SPTY2D1OS (SPTY2D1 antisense RNA 1) (SPTY2D1 opposite strand) SPTY2D1OS SPTY2D1-AS1 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 WPVQESK 0.99791 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.9732 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NIE9 PRS29_HUMAN "Putative serine protease 29, EC 3.4.21.- (Implantation serine proteinase 2-like protein, ISP2-like protein)" PRSS29P ISP2 Homo sapiens (Human) proteolysis [GO:0006508] extracellular space [GO:0005615] extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508] GO:0004252; GO:0005615; GO:0006508 serine-type endopeptidase activity [GO:0004252] GLLNVSR 0.99791 -10.12 12.6102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7602 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6599 0 0 11.7163 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1442 0 0 0 0 0 0 0 P40123 CAP2_HUMAN "Adenylyl cyclase-associated protein 2, CAP 2" CAP2 Homo sapiens (Human) activation of adenylate cyclase activity [GO:0007190]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069] cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802]; activation of adenylate cyclase activity [GO:0007190]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; establishment or maintenance of cell polarity [GO:0007163]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165] GO:0000902; GO:0003779; GO:0005737; GO:0005886; GO:0007010; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0014069; GO:0019933; GO:0042802; GO:0045761 actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802] EESSPSR 0.99791 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q16586 SGCA_HUMAN "Alpha-sarcoglycan, Alpha-SG (50 kDa dystrophin-associated glycoprotein, 50DAG) (Adhalin) (Dystroglycan-2)" SGCA ADL DAG2 Homo sapiens (Human) muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; skeletal muscle tissue regeneration [GO:0043403] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383] cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; sarcoglycan complex [GO:0016012]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; skeletal muscle tissue regeneration [GO:0043403] GO:0005509; GO:0005737; GO:0005856; GO:0005911; GO:0006936; GO:0007517; GO:0014894; GO:0016010; GO:0016012; GO:0016021; GO:0042383; GO:0043403; GO:0045121 calcium ion binding [GO:0005509] DSFDTTR 0.99791 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.01064 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.6779 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IUK8 CBLN2_HUMAN Cerebellin-2 CBLN2 UNQ1892/PRO4338 Homo sapiens (Human) maintenance of synapse structure [GO:0099558]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; spontaneous synaptic transmission [GO:0098814]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synapse [GO:0045202] extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synapse [GO:0045202]; maintenance of synapse structure [GO:0099558]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; spontaneous synaptic transmission [GO:0098814]; synapse assembly [GO:0007416]; synapse organization [GO:0050808] GO:0005615; GO:0007416; GO:0045202; GO:0050808; GO:0051965; GO:0098814; GO:0098978; GO:0099558; GO:1905606 VAFSATR 0.99791 -10.12 9.17817 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1334 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5731 0 0 0 0 0 0 0 0 0 0 0 0 0 11.8927 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96A32 MYL11_HUMAN "Myosin regulatory light chain 11 (Fast skeletal myosin light chain 2) (MLC2B) (Myosin light chain 11) (Myosin regulatory light chain 2, skeletal muscle isoform)" MYL11 HSRLC MYLPF Homo sapiens (Human) actin-myosin filament sliding [GO:0033275]; immune response [GO:0006955]; muscle contraction [GO:0006936]; muscle tissue morphogenesis [GO:0060415]; skeletal muscle tissue development [GO:0007519] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; muscle myosin complex [GO:0005859] cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; muscle myosin complex [GO:0005859]; calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307]; actin-myosin filament sliding [GO:0033275]; immune response [GO:0006955]; muscle contraction [GO:0006936]; muscle tissue morphogenesis [GO:0060415]; skeletal muscle tissue development [GO:0007519] GO:0005509; GO:0005737; GO:0005765; GO:0005829; GO:0005859; GO:0006936; GO:0006955; GO:0007519; GO:0008307; GO:0033275; GO:0060415 calcium ion binding [GO:0005509]; structural constituent of muscle [GO:0008307] VLDPEGK 0.99791 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.263 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NJJ6 CS067_HUMAN UPF0575 protein C19orf67 C19orf67 Homo sapiens (Human) ASTSSPK 0.99797 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8354 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1781 0 0 0 0 0 0 0 0 0 0 0 12.9417 0 0 0 0 0 0 0 0 0 0 0 13.6585 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5HYR2 DMRTC_HUMAN Doublesex- and mab-3-related transcription factor C1 DMRTC1; DMRTC1B Homo sapiens (Human) "regulation of transcription, DNA-templated [GO:0006355]" chromatin [GO:0000785]; nucleus [GO:0005634] "chromatin [GO:0000785]; nucleus [GO:0005634]; regulation of transcription, DNA-templated [GO:0006355]" GO:0000785; GO:0005634; GO:0006355 AGALTGK 0.99797 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.8807 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7146 14.8111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5064 0 0 0 0 0 0 0 13.6559 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.8931 0 Q9HA64 KT3K_HUMAN "Ketosamine-3-kinase, EC 2.7.1.172 (Fructosamine-3-kinase-related protein, FN3K-RP, FN3K-related protein) (Protein-psicosamine 3-kinase FN3KRP, EC 2.7.1.-)" FN3KRP Homo sapiens (Human) phosphorylation [GO:0016310]; post-translational protein modification [GO:0043687] cytosol [GO:0005829] cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-ribulosamine 3-kinase activity [GO:0102193]; phosphorylation [GO:0016310]; post-translational protein modification [GO:0043687] GO:0005524; GO:0005829; GO:0016301; GO:0016310; GO:0043687; GO:0102193 ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein-ribulosamine 3-kinase activity [GO:0102193] GGGQEER 0.99797 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3809 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5885 0 12.3396 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.0551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q6XE24 RBMS3_HUMAN "RNA-binding motif, single-stranded-interacting protein 3" RBMS3 Homo sapiens (Human) defense response to tumor cell [GO:0002357]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; defense response to tumor cell [GO:0002357]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628] GO:0002357; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0008143; GO:0008266; GO:0010628; GO:0010629; GO:0035925; GO:0090090; GO:1990904 mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] DANGVSR 0.99798 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.2355 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7633 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5782 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.4429 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z4R8 CF120_HUMAN UPF0669 protein C6orf120 C6orf120 Homo sapiens (Human) apoptotic process [GO:0006915] azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576] azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; apoptotic process [GO:0006915] GO:0005576; GO:0006915; GO:0035578 LVLEILF 0.99798 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5543 0 14.8214 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NM43 TCPQL_HUMAN Putative T-complex protein 1 subunit theta-like 1 CCT8L1P CCT8L1 Homo sapiens (Human) protein folding [GO:0006457] chaperonin-containing T-complex [GO:0005832] chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457] GO:0005524; GO:0005832; GO:0006457; GO:0051082; GO:0140662 ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082] KILGMNN 0.99803 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q7Z465 BNIPL_HUMAN Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein BNIPL Homo sapiens (Human) apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; regulation of growth rate [GO:0040009] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; negative regulation of cell population proliferation [GO:0008285]; regulation of growth rate [GO:0040009] GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008285; GO:0040009; GO:0042802 identical protein binding [GO:0042802] AQVPPLSWIRQCYR 0.99803 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7595 0 0 0 0 0 0 0 0 0 0 0 0 13.228 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.1519 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.2669 0 0 0 0 0 0 0 Q8IXP5 CK053_HUMAN Protein POU2AF2 (POU class 2 homeobox-associating factor 2) POU2AF2 C11orf53 Homo sapiens (Human) RVYQGVR 0.99803 -10.107 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.4215 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14828 SCAM3_HUMAN "Secretory carrier-associated membrane protein 3, Secretory carrier membrane protein 3" SCAMP3 C1orf3 PROPIN1 Homo sapiens (Human) post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588] extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; ubiquitin protein ligase binding [GO:0031625]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031] GO:0006892; GO:0015031; GO:0016021; GO:0031625; GO:0032588; GO:0043231; GO:0055038; GO:0070062 ubiquitin protein ligase binding [GO:0031625] TGASFQK 0.99804 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O75795 UDB17_HUMAN "UDP-glucuronosyltransferase 2B17, UDPGT 2B17, UGT2B17, EC 2.4.1.17 (C19-steroid-specific UDP-glucuronosyltransferase, C19-steroid-specific UDPGT)" UGT2B17 Homo sapiens (Human) cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020] endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202] GO:0005789; GO:0008202; GO:0008210; GO:0015020; GO:0016020; GO:0016021; GO:0052695 glucuronosyltransferase activity [GO:0015020] CCLFCFR 0.99804 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.9879 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6272 12.4904 0 0 0 0 0 11.6156 0 0 11.6862 0 11.5963 12.1299 0 0 0 0 12.8946 12.2734 0 12.1812 0 13.7269 14.5438 14.5275 0 0 0 12.5287 0 15.6892 0 13.9752 13.7829 0 0 13.4754 0 0 0 13.05 0 0 0 14.4863 13.2503 0 0 0 12.6731 0 0 13.2098 13.1697 0 0 12.5723 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P23284 PPIB_HUMAN "Peptidyl-prolyl cis-trans isomerase B, PPIase B, EC 5.2.1.8 (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin, SCYLP)" PPIB CYPB Homo sapiens (Human) bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790] cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by host of viral process [GO:0044794]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821] GO:0000413; GO:0003723; GO:0003755; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006457; GO:0016018; GO:0016020; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044794; GO:0044829; GO:0048471; GO:0050821; GO:0051082; GO:0060348; GO:0061077; GO:0070062; GO:0070063 cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082] GDGTGGK 0.99804 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7408 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q13410 BT1A1_HUMAN "Butyrophilin subfamily 1 member A1, BT" BTN1A1 BTN Homo sapiens (Human) regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852] GO:0001817; GO:0005102; GO:0005615; GO:0005886; GO:0005887; GO:0009897; GO:0038023; GO:0050852 signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102] AVFPSSGLPR 0.99804 -10.114 0 0 0 0 0 0 0 9.84361 0 0 0 0 0 0 0 0 10.9841 0 0 0 0 0 0 10.4015 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1648 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5143 0 0 0 0 11.6732 11.1936 0 13.2619 13.3112 0 0 0 13.4818 0 0 0 0 13.2748 0 0 0 11.2423 0 0 0 0 0 0 13.9215 13.4802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7475 0 0 0 0 12.2594 0 0 0 12.9662 0 9.8851 0 0 0 0 13.373 0 0 0 0 0 0 11.1679 10.7487 0 0 0 0 0 11.7587 0 0 0 0 0 0 0 0 0 11.4119 12.7195 0 0 0 0 0 0 0 0 Q17RF5 ODAPH_HUMAN Odontogenesis associated phosphoprotein ODAPH C4orf26 Homo sapiens (Human) positive regulation of biomineral tissue development [GO:0070169]; positive regulation of enamel mineralization [GO:0070175] extracellular region [GO:0005576] extracellular region [GO:0005576]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of enamel mineralization [GO:0070175] GO:0005576; GO:0070169; GO:0070175 GSSSEES 0.99804 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.3422 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.1917 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8IYI0 SHLD1_HUMAN Shieldin complex subunit 1 (RINN1-REV7-interacting novel NHEJ regulator 3) (Shield complex subunit 1) SHLD1 C20orf196 RINN3 Homo sapiens (Human) DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247] chromatin [GO:0000785]; chromosome [GO:0005694]; site of double-strand break [GO:0035861] chromatin [GO:0000785]; chromosome [GO:0005694]; site of double-strand break [GO:0035861]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247] GO:0000785; GO:0002208; GO:0005694; GO:0006281; GO:0035861; GO:0043247; GO:0045830; GO:2000042; GO:2001034 PNPGLSK 0.99804 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7686 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8385 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1322 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.797 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1693 0 0 0 0 0 0 0 0 Q9H2J1 CI037_HUMAN Uncharacterized protein ARRDC1-AS1 (ARRDC1 antisense RNA 1) (ARRDC1 antisense gene protein 1) ARRDC1-AS1 C9orf37 AD038 Homo sapiens (Human) PGSGASR 0.99804 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6802 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95848 NUD14_HUMAN "Uridine diphosphate glucose pyrophosphatase NUDT14, UDPG pyrophosphatase, UGPPase, EC 3.6.1.45 (Nucleoside diphosphate-linked moiety X motif 14, Nudix motif 14)" NUDT14 UGPP Homo sapiens (Human) nucleoside phosphate metabolic process [GO:0006753]; protein N-linked glycosylation via asparagine [GO:0018279]; ribose phosphate metabolic process [GO:0019693] cytosol [GO:0005829] cytosol [GO:0005829]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; protein N-linked glycosylation via asparagine [GO:0018279]; ribose phosphate metabolic process [GO:0019693] GO:0005829; GO:0006753; GO:0008768; GO:0018279; GO:0019693; GO:0042802; GO:0046872; GO:0047631 ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768] RSLVLVK 0.9981 -10.107 0 0 0 0 0 0 0 0 0 0 10.7819 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8678 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9622 0 0 0 0 12.2226 11.8305 11.8025 0 0 0 13.1595 0 0 0 0 0 0 0 11.7894 0 11.9885 0 0 Q3MIP1 IPIL2_HUMAN "Inositol 1,4,5-trisphosphate receptor-interacting protein-like 2" ITPRIPL2 Homo sapiens (Human) integral component of membrane [GO:0016021] integral component of membrane [GO:0016021] GO:0016021 ALRDLGARGLDSAAATQWGR 0.9981 -10.118 0 0 0 0 11.6546 0 0 0 0 11.9804 0 0 12.3976 0 0 13.9172 12.2607 0 0 0 0 14.5044 13.6427 16.0088 0 0 14.0047 0 12.0511 0 0 0 14.6657 0 0 0 13.6388 0 0 12.0492 0 12.3366 12.2143 0 0 13.5513 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.3919 0 0 16.1712 15.4005 0 15.0684 14.6972 0 0 14.165 15.8128 14.6901 15.0557 15.5194 0 0 0 14.2409 0 15.5619 0 13.2235 0 15.0868 0 0 13.961 0 14.4067 0 13.5799 0 14.4398 0 15.8094 14.8838 14.47 14.4608 0 14.7446 0 14.1646 14.601 0 0 0 0 0 15.4469 0 14.9728 13.3174 15.7404 0 12.3785 13.9722 14.6843 0 15.1634 0 0 14.7104 15.4085 0 15.0827 0 0 13.9834 0 14.0409 0 0 0 0 0 0 15.2403 0 0 14.9429 0 0 0 14.3957 15.3339 15.8328 16.072 14.8178 0 0 0 0 12.9128 12.0855 13.2989 0 13.2652 0 0 0 0 12.7743 0 13.0029 13.1322 0 14.8107 0 0 0 0 14.581 14.0567 Q8IV76 PASD1_HUMAN "Circadian clock protein PASD1 (Cancer/testis antigen 63, CT63) (OX-TES-1) (PAS domain-containing protein 1)" PASD1 Homo sapiens (Human) "circadian regulation of gene expression [GO:0032922]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" CLOCK-BMAL transcription complex [GO:1990513]; Cry-Per complex [GO:1990512]; nuclear speck [GO:0016607]; nucleus [GO:0005634] "CLOCK-BMAL transcription complex [GO:1990513]; Cry-Per complex [GO:1990512]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription factor binding [GO:0140297]; transcription regulator inhibitor activity [GO:0140416]; circadian regulation of gene expression [GO:0032922]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]" GO:0005634; GO:0006357; GO:0016607; GO:0032922; GO:0042754; GO:0045892; GO:0140297; GO:0140416; GO:1990512; GO:1990513 DNA-binding transcription factor binding [GO:0140297]; transcription regulator inhibitor activity [GO:0140416] EQLQQLR 0.9981 -10.116 0 0 0 0 0 0 0 0 0 0 11.8981 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.61771 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2938 0 15.1841 0 13.801 0 0 13.9699 12.8549 0 0 12.2235 0 12.6395 0 0 0 0 0 0 0 0 0 0 0 0 13.3778 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8264 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.9954 0 0 0 0 0 0 0 0 0 0 0 0 11.0643 0 0 0 0 0 0 0 0 0 0 0 0 Q8IXQ9 ETKMT_HUMAN "Electron transfer flavoprotein beta subunit lysine methyltransferase, EC 2.1.1.- (ETFB lysine methyltransferase, ETFB-KMT) (Protein N-lysine methyltransferase METTL20)" ETFBKMT C12orf72 METTL20 Homo sapiens (Human) negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991] cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279]; negative regulation of electron transfer activity [GO:1904733]; negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:1904736]; peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479] GO:0005737; GO:0005759; GO:0006479; GO:0008276; GO:0016279; GO:0018022; GO:0018023; GO:0031072; GO:0032991; GO:1904733; GO:1904736 heat shock protein binding [GO:0031072]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279] LLTPRCK 0.9981 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NCM2 KCNH5_HUMAN "Potassium voltage-gated channel subfamily H member 5 (Ether-a-go-go potassium channel 2, hEAG2) (Voltage-gated potassium channel subunit Kv10.2)" KCNH5 EAG2 Homo sapiens (Human) potassium ion transmembrane transport [GO:0071805]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886] cell surface [GO:0009986]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of ion transmembrane transport [GO:0034765]; regulation of membrane potential [GO:0042391] GO:0005249; GO:0005516; GO:0005886; GO:0005887; GO:0009986; GO:0010389; GO:0034765; GO:0042391; GO:0044325; GO:0044877; GO:0071805 calmodulin binding [GO:0005516]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249] ADICVHLNR 0.9981 -10.111 0 0 0 0 0 0 0 0 0 0 0 0 12.3186 0 0 0 0 0 0 0 0 0 0 0 11.9407 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.4263 0 13.4499 13.0298 13.0336 13.9383 13.543 12.7833 0 0 12.3599 0 0 0 0 12.4441 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4573 0 0 0 0 0 0 0 0 0 14.111 0 0 0 0 0 0 0 13.8378 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.9608 Q9BQ95 ECSIT_HUMAN "Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)" ECSIT Homo sapiens (Human) innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635] GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005829; GO:0032981; GO:0045087; GO:0051341; GO:0061635 GHIDFIYLALRKMR 0.9981 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.5326 0 12.8199 0 0 0 13.4463 12.6549 13.0691 0 14.2416 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.4645 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8816 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9GZP8 IMUP_HUMAN "Immortalization up-regulated protein (Hepatocyte growth factor activator inhibitor type 2-related small protein, H2RSP, HAI-2-related small protein)" IMUP C19orf33 Homo sapiens (Human) cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886] GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886 SHAAGSK 0.9981 -10.12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0767 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.8835 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9624 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.1821 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q9UBP6 TRMB_HUMAN "tRNA (guanine-N(7)-)-methyltransferase, EC 2.1.1.33 (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase, EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase, EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase)" METTL1 C12orf1 Homo sapiens (Human) RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527] cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; RNA (guanine-N7)-methylation [GO:0036265]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400] GO:0000049; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006400; GO:0008176; GO:0030488; GO:0036265; GO:0043527 tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049] VLRNGGK 0.9981 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.7229 0 0 0 0 0 0 0 13.5093 0 0 0 14.599 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.186 13.9874 0 0 0 0 0 0 0 0 0 13.1772 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6528 0 0 0 0 0 0 0 13.4841 0 0 0 0 0 0 13.5739 0 0 0 0 0 0 0 0 0 13.6506 0 0 13.6247 0 0 0 0 0 0 0 0 0 13.9941 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2853 0 0 0 0 0 0 0 Q5RI15 COX20_HUMAN "Cytochrome c oxidase assembly protein COX20, mitochondrial" COX20 FAM36A Homo sapiens (Human) mitochondrial cytochrome c oxidase assembly [GO:0033617] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739] integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; mitochondrial cytochrome c oxidase assembly [GO:0033617] GO:0005739; GO:0005743; GO:0016021; GO:0033617 HNGSSSN 0.99811 -10.12 0 0 0 0 0 0 0 0 10.5188 0 12.3277 0 0 12.2937 0 0 0 0 0 0 0 0 0 0 12.5729 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.7456 0 0 9.62699 0 0 12.3901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.3595 13.3159 0 0 0 12.3262 0 0 0 0 0 0 0 12.8301 0 0 0 0 0 0 12.6267 0 0 0 0 10.6744 0 0 0 0 0 0 0 0 11.9936 0 11.2445 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.9117 0 0 0 0 0 0 0 0 0 14.4781 10.7561 13.7022 0 0 0 15.0604 0 0 0 0 13.5463 13.8229 14.1783 0 0 0 0 12.6242 0 12.863 0 0 O43186 CRX_HUMAN Cone-rod homeobox protein CRX CORD2 Homo sapiens (Human) "animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575] "chromatin [GO:0000785]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription, DNA-templated [GO:0006355]; response to stimulus [GO:0050896]; visual perception [GO:0007601]" GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001216; GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007399; GO:0007601; GO:0009887; GO:0016922; GO:0030154; GO:0043522; GO:0045944; GO:0050896; GO:0061629; GO:0090575; GO:1990837 "DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; nuclear receptor binding [GO:0016922]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]" QQRQQQK 0.99817 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6043 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P61457 PHS_HUMAN "Pterin-4-alpha-carbinolamine dehydratase, PHS, EC 4.2.1.96 (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha, DCoH, Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase, PCD)" PCBD1 DCOH PCBD Homo sapiens (Human) tetrahydrobiopterin biosynthetic process [GO:0006729] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654] cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; transcription coactivator activity [GO:0003713]; tetrahydrobiopterin biosynthetic process [GO:0006729] GO:0003713; GO:0004505; GO:0005654; GO:0005829; GO:0006729; GO:0008124; GO:0042802; GO:0070062 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; transcription coactivator activity [GO:0003713] MAGKAHR 0.99817 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0087 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6416 0 0 0 0 0 0 0 0 0 0 0 12.4116 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6448 12.8529 0 0 0 0 0 0 0 0 0 0 13.733 0 13.2255 0 0 0 0 0 0 0 0 0 0 0 Q49MI3 CERKL_HUMAN Ceramide kinase-like protein CERKL Homo sapiens (Human) negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750] cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphingolipid binding [GO:0046625]; negative regulation of apoptotic process [GO:0043066]; phosphorylation [GO:0016310]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665] GO:0001727; GO:0001750; GO:0001917; GO:0003951; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0006665; GO:0016310; GO:0030148; GO:0043066; GO:0046625; GO:0048471 lipid kinase activity [GO:0001727]; NAD+ kinase activity [GO:0003951]; sphingolipid binding [GO:0046625] AEDCEISFLPFNSSDDVQERR 0.99817 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4949 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9711 14.7642 12.4135 0 0 0 0 0 0 0 0 0 0 0 14.306 0 14.3049 0 0 13.764 0 14.3291 0 16.9663 0 0 0 14.4427 0 0 0 0 0 0 0 0 0 0 14.0659 14.3415 13.4795 13.9579 13.6659 13.9862 0 0 0 0 0 0 0 0 0 0 14.8193 0 0 14.8648 0 0 0 11.0308 14.3323 13.9056 17.4515 13.7987 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7856 0 0 0 0 14.1528 0 0 0 0 0 0 0 0 0 13.7445 0 0 10.7031 14.7874 13.0028 0 0 0 0 0 0 0 Q8NI28 R32DT_HUMAN Putative transmenbrane protein RNF32-DT (RNF32 divergent transcript) RNF32-DT C7orf13 LINC01006 MY040 Homo sapiens (Human) cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] cytoplasm [GO:0005737]; integral component of membrane [GO:0016021] GO:0005737; GO:0016021 VVRAEPR 0.99817 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9958 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96DH6 MSI2H_HUMAN "RNA-binding protein Musashi homolog 2, Musashi-2" MSI2 Homo sapiens (Human) central nervous system development [GO:0007417]; regulation of translation [GO:0006417]; stem cell development [GO:0048864] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; polysome [GO:0005844] cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; polysome [GO:0005844]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; central nervous system development [GO:0007417]; regulation of translation [GO:0006417]; stem cell development [GO:0048864] GO:0003723; GO:0003729; GO:0005737; GO:0005829; GO:0005844; GO:0006417; GO:0007417; GO:0008266; GO:0042802; GO:0043231; GO:0048864 identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723] MVTRTKK 0.99817 -10.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.912 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.2455 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q96PK6 RBM14_HUMAN "RNA-binding protein 14 (Paraspeckle protein 2, PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein, SYT-interacting protein)" RBM14 SIP Homo sapiens (Human) "activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; SMAD protein signal transduction [GO:0060395]" cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription regulator complex [GO:0005667] "cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription regulator complex [GO:0005667]; mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; activation of innate immune response [GO:0002218]; centriole assembly [GO:0098534]; histone deacetylation [GO:0016575]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725]; SMAD protein signal transduction [GO:0060395]" GO:0000398; GO:0002218; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005737; GO:0009725; GO:0016575; GO:0016607; GO:0030374; GO:0045087; GO:0045944; GO:0046600; GO:0060395; GO:0098534; GO:1990904 mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723] DRSPLRR 0.99817 -10.113 0 0 0 11.1032 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A0A0A0MS00 LV332_HUMAN Probable non-functional immunoglobulin lambda variable 3-32 IGLV3-32 Homo sapiens (Human) adaptive immune response [GO:0002250]; immune response [GO:0006955] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886] extracellular space [GO:0005615]; immunoglobulin complex [GO:0019814]; plasma membrane [GO:0005886]; adaptive immune response [GO:0002250]; immune response [GO:0006955] GO:0002250; GO:0005615; GO:0005886; GO:0006955; GO:0019814 PSRIPER 0.99823 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O14653 GOSR2_HUMAN Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin) GOSR2 GS27 Homo sapiens (Human) intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; vesicle fusion [GO:0006906] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; SNARE complex [GO:0031201] endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; vesicle fusion [GO:0006906] GO:0000139; GO:0000149; GO:0005484; GO:0005789; GO:0005794; GO:0006891; GO:0006906; GO:0012507; GO:0015031; GO:0016020; GO:0016021; GO:0031201; GO:0031902; GO:0033116 SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149] TQRLTLK 0.99823 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P51159 RB27A_HUMAN "Ras-related protein Rab-27A, Rab-27, EC 3.6.5.2 (GTP-binding protein Ram)" RAB27A RAB27 Homo sapiens (Human) antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; specific granule lumen [GO:0035580]; Weibel-Palade body [GO:0033093] apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; specific granule lumen [GO:0035580]; Weibel-Palade body [GO:0033093]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904]; antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; synaptic vesicle transport [GO:0048489]; vesicle-mediated transport [GO:0016192] GO:0001750; GO:0003924; GO:0003925; GO:0005525; GO:0005576; GO:0005764; GO:0005770; GO:0005794; GO:0005829; GO:0006887; GO:0007596; GO:0010628; GO:0016192; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0030667; GO:0031489; GO:0032400; GO:0032402; GO:0032585; GO:0033093; GO:0033162; GO:0035580; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0045921; GO:0048489; GO:0050766; GO:0070062; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182 G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904] EKGACGC 0.99823 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.352 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P58549 FXYD7_HUMAN FXYD domain-containing ion transport regulator 7 FXYD7 Homo sapiens (Human) ion transport [GO:0006811]; regulation of ion transport [GO:0043269] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ion channel regulator activity [GO:0099106]; ion transport [GO:0006811]; regulation of ion transport [GO:0043269] GO:0005886; GO:0006811; GO:0016021; GO:0043269; GO:0099106 ion channel regulator activity [GO:0099106] CRKADSR 0.99823 -10.111 0 0 0 9.89239 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.98028 0 0 0 0 0 0 0 13.0969 0 0 0 0 0 0 0 0 0 0 0 12.24 0 9.74772 0 0 0 0 0 0 0 0 0 10.5551 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.5221 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.1053 0 0 0 0 0 0 0 0 0 0 12.4637 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5663 0 0 0 0 0 0 0 0 0 12.9332 0 0 0 0 12.5817 0 0 0 0 12.8859 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q5VT03 NTM2D_HUMAN NUT family member 2D NUTM2D FAM22D Homo sapiens (Human) AHTGMAR 0.99823 -10.113 0 0 0 0 0 0 0 0 11.4524 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.1158 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O95971 BY55_HUMAN "CD160 antigen (Natural killer cell receptor BY55) (CD antigen CD160) [Cleaved into: CD160 antigen, soluble form ]" CD160 BY55 Homo sapiens (Human) "adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; mucosal immune response [GO:0002385]; negative regulation of adaptive immune memory response [GO:1905675]; negative regulation of angiogenesis [GO:0016525]; negative regulation of CD4-positive, alpha-beta T cell costimulation [GO:1900280]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated immune response to tumor cell [GO:0002857]; T cell costimulation [GO:0031295]" anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; plasma membrane [GO:0005886] "anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; activating MHC class I receptor activity [GO:0032397]; kinase binding [GO:0019900]; MHC class I protein complex binding [GO:0023024]; MHC class I receptor activity [GO:0032393]; MHC class Ib receptor activity [GO:0032394]; signaling receptor binding [GO:0005102]; adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; mucosal immune response [GO:0002385]; negative regulation of adaptive immune memory response [GO:1905675]; negative regulation of angiogenesis [GO:0016525]; negative regulation of CD4-positive, alpha-beta T cell costimulation [GO:1900280]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated immune response to tumor cell [GO:0002857]; T cell costimulation [GO:0031295]" GO:0001525; GO:0002250; GO:0002385; GO:0002729; GO:0002857; GO:0005102; GO:0005576; GO:0005886; GO:0014065; GO:0016525; GO:0019900; GO:0023024; GO:0031295; GO:0032393; GO:0032394; GO:0032397; GO:0032729; GO:0043323; GO:0045087; GO:0045954; GO:0046658; GO:0050829; GO:0050860; GO:1900280; GO:1905675; GO:2000353 activating MHC class I receptor activity [GO:0032397]; kinase binding [GO:0019900]; MHC class I protein complex binding [GO:0023024]; MHC class I receptor activity [GO:0032393]; MHC class Ib receptor activity [GO:0032394]; signaling receptor binding [GO:0005102] SQKSGIR 0.9983 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 14.6845 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q8NH08 O10AC_HUMAN Olfactory receptor 10AC1 (Olfactory receptor OR7-5) OR10AC1 OR10AC1P Homo sapiens (Human) integral component of membrane [GO:0016021]; plasma membrane [GO:0005886] integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] GO:0004930; GO:0004984; GO:0005886; GO:0016021 G protein-coupled receptor activity [GO:0004930]; olfactory receptor activity [GO:0004984] CPKGRGK 0.9983 -10.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2696 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 A6NLC8 TFKL2_HUMAN TATA-box binding protein associated factor 11 like protein 2 TAF11L2 Homo sapiens (Human) RNA polymerase II preinitiation complex assembly [GO:0051123] transcription factor TFIID complex [GO:0005669] transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; RNA polymerase II preinitiation complex assembly [GO:0051123] GO:0003713; GO:0005669; GO:0046982; GO:0051123 protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713] DLKGSKK 0.99836 -10.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.7579 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 O15479 MAGB2_HUMAN "Melanoma-associated antigen B2 (Cancer/testis antigen 3.2, CT3.2) (DSS-AHC critical interval MAGE superfamily 6, DAM6) (MAGE XP-2 antigen) (MAGE-B2 antigen)" MAGEB2 Homo sapiens (Human) negative regulation of transcription by RNA polymerase II [GO:0000122] nucleus [GO:0005634] nucleus [GO:0005634]; negative regulation of transcription by RNA polymerase II [GO:0000122] GO:0000122; GO:0005634 DEEKAGV 0.99836 -10.113 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6077 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.6272 0 12.4694 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.5627 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P09228 CYTT_HUMAN Cystatin-SA (Cystatin-2) (Cystatin-S5) CST2 Homo sapiens (Human) detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of cysteine-type endopeptidase activity [GO:2000117] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; vesicle [GO:0031982] cytoplasm [GO:0005737]; extracellular space [GO:0005615]; vesicle [GO:0031982]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of cysteine-type endopeptidase activity [GO:2000117] GO:0001580; GO:0004869; GO:0005615; GO:0005737; GO:0031982; GO:2000117 cysteine-type endopeptidase inhibitor activity [GO:0004869] MSLVNSRCQEA 0.99843 -10.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.0981 0 0 12.7887 0 0 0 0 0 0 0 12.2406 0 0 0 0 12.913 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.3181 0 0 13.35 13.8194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.7875 0 0 0 0 0 13.0045 0 0 0 0 0 0 0 0 0 13.3333 0 0 13.9197 0 0 0 0 0 0 0 0 0 0 0 14.1472 0 0 0 12.7543 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12.945 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q14397 GCKR_HUMAN "Glucokinase regulatory protein, GKRP, Glucokinase regulator" GCKR Homo sapiens (Human) carbohydrate derivative metabolic process [GO:1901135]; carbohydrate metabolic process [GO:0005975]; glucose homeostasis [GO:0042593]; negative regulation of glucokinase activity [GO:0033132]; protein import into nucleus [GO:0006606]; response to fructose [GO:0009750]; triglyceride homeostasis [GO:0070328]; urate metabolic process [GO:0046415] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654] cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; fructose-6-phosphate binding [GO:0070095]; carbohydrate derivative metabolic process [GO:1901135]; carbohydrate metabolic process [GO:0005975]; glucose homeostasis [GO:0042593]; negative regulation of glucokinase activity [GO:0033132]; protein import into nucleus [GO:0006606]; response to fructose [GO:0009750]; triglyceride homeostasis [GO:0070328]; urate metabolic process [GO:0046415] GO:0004857; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005975; GO:0006606; GO:0009750; GO:0019899; GO:0030246; GO:0033132; GO:0042593; GO:0046415; GO:0070095; GO:0070328; GO:1901135 carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; fructose-6-phosphate binding [GO:0070095] KVAAGKK 0.99849 -10.111 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16.0667 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0